PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Chen, Y; Zhang, J; Ge, X; Du, J; Deb, DK; Li, YC				Chen, Yunzi; Zhang, Jing; Ge, Xin; Du, Jie; Deb, Dilip K.; Li, Yan Chun			Vitamin D Receptor Inhibits Nuclear Factor kappa B Activation by Interacting with I kappa B Kinase beta Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1,25-DIHYDROXYVITAMIN D-3; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; TRANSCRIPTIONAL REPRESSION; GENE-TRANSCRIPTION; DOWN-REGULATION; P65 SUBUNIT; DNA ELEMENT; EXPRESSION; CELLS; HORMONE	1,25-Dihydroxyvitamin D (1,25(OH)(2)D-3) is known to suppress NF-kappa B activity, but the underlying mechanism remains poorly understood. Here we show that the vitamin D receptor (VDR) physically interacts with I kappa B kinase beta(IKK beta) to block NF-kappa B activation. 1,25(OH)(2)D-3 rapidly attenuates TNF alpha-induced p65 nuclear translocation and NF-kappa B activity in a VDR-dependent manner. VDR overexpression inhibits IKK beta-induced NF-kappa B activity. GST pull-down assays and coimmunoprecipitation experiments demonstrated that VDR physically interacts with IKK beta and that this interaction is enhanced by 1,25(OH)(2)D-3. Protein mapping reveals that VDR-IKK beta interaction occurs between the C-terminal portions of the VDR and IKK beta proteins. Reconstitution of VDR-/- cells with the VDR C terminus restores the ability to block TNF alpha-induced NF-kappa B activation and IL-6 up-regulation. VDR-IKK beta interaction disrupts the formation of the IKK complex and, thus, abrogates IKK beta phosphorylation at Ser-177 and abolishes IKK activity to phosphorylate I kappa B alpha. Consequently, stabilization of I kappa B alpha arrests p65/ p50 nuclear translocation. Together, these data define a novel mechanism whereby 1,25(OH)(2)D-3-VDR inhibits NF-kappa B activation.	[Chen, Yunzi; Ge, Xin; Du, Jie; Li, Yan Chun] China Med Univ, Lab Metab Dis Res & Drug Dev, Shenyang 110000, Peoples R China; [Chen, Yunzi; Deb, Dilip K.; Li, Yan Chun] Univ Chicago, Div Biol Sci, Dept Med, Chicago, IL 60637 USA; [Zhang, Jing] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Jiangsu, Peoples R China	China Medical University; University of Chicago; Nanjing University	Li, YC (corresponding author), Univ Chicago, Dept Med, 900 E 57th St,KCBD 9110, Chicago, IL 60637 USA.	cyan@medicine.bsd.uchicago.edu			National Institutes of Health [HL085793]; Foundation for Clinical Research in Inflammatory Bowel Disease (FCRIBD); government of Liaoning Province, China; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085793] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for Clinical Research in Inflammatory Bowel Disease (FCRIBD); government of Liaoning Province, China; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL085793. This work was also supported by a Foundation for Clinical Research in Inflammatory Bowel Disease (FCRIBD) grant and by a research grant from the government of Liaoning Province, China.	ALROY I, 1995, MOL CELL BIOL, V15, P5789; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Bouillon R, 2008, ENDOCR REV, V29, P726, DOI 10.1210/er.2008-0004; Chen SC, 2005, J AM SOC NEPHROL, V16, P329, DOI 10.1681/ASN.2004090797; Chen YZ, 2013, J IMMUNOL, V190, P3687, DOI 10.4049/jimmunol.1203273; Chen YZ, 2011, ARCH BIOCHEM BIOPHYS, V507, P241, DOI 10.1016/j.abb.2010.12.020; D'Ambrosio D, 1998, J CLIN INVEST, V101, P252, DOI 10.1172/JCI1050; Deb DK, 2009, AM J PHYSIOL-RENAL, V296, pF1212, DOI 10.1152/ajprenal.00002.2009; Dong XY, 2003, J BIOL CHEM, V278, P49378, DOI 10.1074/jbc.M308448200; Giarratana N, 2004, J IMMUNOL, V173, P2280, DOI 10.4049/jimmunol.173.4.2280; Harant H, 1998, FEBS LETT, V436, P329, DOI 10.1016/S0014-5793(98)01153-3; Haussler MR, 1998, J BONE MINER RES, V13, P325, DOI 10.1359/jbmr.1998.13.3.325; Li YC, 2001, AM J PHYSIOL-ENDOC M, V281, pE558, DOI 10.1152/ajpendo.2001.281.3.E558; Lu XH, 2004, J CELL BIOCHEM, V92, P833, DOI 10.1002/jcb.20143; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Murayama A, 2004, EMBO J, V23, P1598, DOI 10.1038/sj.emboj.7600157; Nakanishi C, 2005, NAT REV CANCER, V5, P297, DOI 10.1038/nrc1588; Nishishita T, 1998, J BIOL CHEM, V273, P10901, DOI 10.1074/jbc.273.18.10901; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Palmer HG, 2001, J CELL BIOL, V154, P369, DOI 10.1083/jcb.200102028; Polly P, 2000, FASEB J, V14, P1455, DOI 10.1096/fj.14.10.1455; Riis JL, 2004, ARCH DERMATOL RES, V296, P195, DOI 10.1007/s00403-004-0509-9; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Sanchez-Martinez R, 2008, MOL CELL BIOL, V28, P3817, DOI 10.1128/MCB.01909-07; Shah S, 2006, MOL CELL, V21, P799, DOI 10.1016/j.molcel.2006.01.037; Sun J, 2006, AM J PHYSIOL-ENDOC M, V291, pE315, DOI 10.1152/ajpendo.00590.2005; Sutton ALM, 2003, MOL ENDOCRINOL, V17, P777, DOI 10.1210/me.2002-0363; Tan XY, 2008, J AM SOC NEPHROL, V19, P1741, DOI 10.1681/ASN.2007060666; Towers TL, 1998, J BIOL CHEM, V273, P10338, DOI 10.1074/jbc.273.17.10338; YU XP, 1995, P NATL ACAD SCI USA, V92, P10990, DOI 10.1073/pnas.92.24.10990; Yuan WH, 2007, J BIOL CHEM, V282, P29821, DOI 10.1074/jbc.M705495200; Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360; Zhang Z, 2007, KIDNEY INT, V72, P193, DOI 10.1038/sj.ki.5002296	33	209	214	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19450	19458		10.1074/jbc.M113.467670	http://dx.doi.org/10.1074/jbc.M113.467670			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23671281	hybrid, Green Published			2022-12-25	WOS:000321515800013
J	Tarumoto, Y; Kanoh, J; Ishikawa, F				Tarumoto, Yusuke; Kanoh, Junko; Ishikawa, Fuyuki			Receptor for Activated C-Kinase (RACK1) Homolog Cpc2 Facilitates the General Amino Acid Control Response through Gcn2 Kinase in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA-BINDING; TRANSLATIONAL CONTROL; EUKARYOTIC TRANSLATION; SCAFFOLD PROTEIN; MAMMALIAN RACK1; STRESS-RESPONSE; RIBOSOME; INITIATION; EXPRESSION; INTERACTS	General amino acid control (GAAC) is crucial for sensing and adaptation to nutrient availability. Amino acid starvation activates protein kinase Gcn2, which plays a central role in the GAAC response by phosphorylating the alpha-subunit of eukaryotic initiation factor 2 (eIF2 alpha), leading to the translational switch to stimulate selective expression of stress-responsive genes. We report here that in fission yeast Schizosaccharomyces pombe, Cpc2, a homolog of mammalian receptor for activated C-kinase (RACK1), is important for the GAAC response. Deletion of S. pombe cpc2 impairs the amino acid starvation-induced phosphorylation of eIF2 alpha and the expression of amino acid biosynthesis genes, thereby rendering cells severely sensitive to amino acid limitation. Unlike the Saccharomyces cerevisiae Cpc2 ortholog, which normally suppresses the GAAC response, our findings suggest that S. pombe Cpc2 promotes the GAAC response. We also found that S. pombe Cpc2 is required for starvation-induced Gcn2 autophosphorylation, which is essential for Gcn2 function. These results indicate that S. pombe Cpc2 facilitates the GAAC response through the regulation of Gcn2 activation and provide a novel insight for the regulatory function of RACK1 on Gcn2-mediated GAAC response.	[Tarumoto, Yusuke; Kanoh, Junko; Ishikawa, Fuyuki] Kyoto Univ, Grad Sch Biostudies, Dept Gene Mech, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University	Ishikawa, F (corresponding author), Kyoto Univ, Grad Sch Biostudies, Dept Gene Mech, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	fishikaw@lif.kyoto-u.ac.jp	Kanoh, Junko/AGM-9632-2022; Tarumoto, Yusuke/AAV-5246-2020; Ishikawa, Fuyuki/AAU-4056-2021; Tarumoto, Yusuke/H-6698-2014	Tarumoto, Yusuke/0000-0001-6652-9618; Ishikawa, Fuyuki/0000-0002-5580-2305; 	Kyoto University; Ministry of Education, Culture, Sports, Science and Technology, Japan	Kyoto University; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Kyoto University start-up grant-in-aid for young scientists (to Y. T.) and a grant-in-aid for cancer research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to F. I.).	Ameri K, 2008, INT J BIOCHEM CELL B, V40, P14, DOI 10.1016/j.biocel.2007.01.020; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; Baum S, 2004, BIOCHEM J, V380, P823, DOI 10.1042/BJ20031962; Ceci M, 2003, NATURE, V426, P579, DOI 10.1038/nature02160; Cherkasova VA, 2003, GENE DEV, V17, P859, DOI 10.1101/gad.1069003; Cherkasova V, 2010, MOL CELL BIOL, V30, P2862, DOI 10.1128/MCB.00183-10; Coyle SM, 2009, MOL CELL BIOL, V29, P1626, DOI 10.1128/MCB.01718-08; Dong JS, 2000, MOL CELL, V6, P269, DOI 10.1016/S1097-2765(00)00028-9; Garcia-Barrio M, 2002, J BIOL CHEM, V277, P30675, DOI 10.1074/jbc.M203187200; Gerbasi VR, 2004, MOL CELL BIOL, V24, P8276, DOI 10.1128/MCB.24.18.8276-8287.2004; Gomez EB, 2005, MOL CELL BIOL, V25, P8887, DOI 10.1128/MCB.25.20.8887-8903.2005; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hoffmann B, 1999, MOL MICROBIOL, V31, P807, DOI 10.1046/j.1365-2958.1999.01219.x; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Kanoh J, 2005, CURR BIOL, V15, P1808, DOI 10.1016/j.cub.2005.09.041; Kouba T, 2012, NUCLEIC ACIDS RES, V40, P2683, DOI 10.1093/nar/gkr1083; KRUGER D, 1990, CURR GENET, V18, P211, DOI 10.1007/BF00318383; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; McCahill A, 2002, MOL PHARMACOL, V62, P1261, DOI 10.1124/mol.62.6.1261; McLeod M, 2000, MOL CELL BIOL, V20, P4016, DOI 10.1128/MCB.20.11.4016-4027.2000; MORENO S, 1991, METHOD ENZYMOL, V194, P795; MUELLER PP, 1986, CELL, V45, P201, DOI 10.1016/0092-8674(86)90384-3; MULLER F, 1995, MOL GEN GENET, V248, P162, DOI 10.1007/BF02190797; Narasimhan J, 2004, J BIOL CHEM, V279, P22820, DOI 10.1074/jbc.M402228200; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; Nemoto N, 2010, J MOL BIOL, V404, P183, DOI 10.1016/j.jmb.2010.09.016; Nilsson J, 2004, EMBO REP, V5, P1137, DOI 10.1038/sj.embor.7400291; Nunez A, 2009, MOL BIOL CELL, V20, P3996, DOI 10.1091/mbc.E09-05-0388; Padyana AK, 2005, J BIOL CHEM, V280, P29289, DOI 10.1074/jbc.M504096200; Qiu HF, 1998, MOL CELL BIOL, V18, P2697, DOI 10.1128/MCB.18.5.2697; Robles MS, 2010, SCIENCE, V327, P463, DOI 10.1126/science.1180067; Romano PR, 1998, MOL CELL BIOL, V18, P2282, DOI 10.1128/MCB.18.4.2282; Sattlegger E, 2005, J BIOL CHEM, V280, P16514, DOI 10.1074/jbc.M414566200; Sattlegger E, 2004, J BIOL CHEM, V279, P29952, DOI 10.1074/jbc.M404009200; Sengupta J, 2004, NAT STRUCT MOL BIOL, V11, P957, DOI 10.1038/nsmb822; Shor B, 2003, J BIOL CHEM, V278, P49119, DOI 10.1074/jbc.M303968200; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Spriggs KA, 2010, MOL CELL, V40, P228, DOI 10.1016/j.molcel.2010.09.028; Udagawa T, 2008, J BIOL CHEM, V283, P22063, DOI 10.1074/jbc.M710017200; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; WEK SA, 1995, MOL CELL BIOL, V15, P4497; Zhan K, 2004, GENETICS, V168, P1867, DOI 10.1534/genetics.104.031443; Zhu SH, 1998, J BIOL CHEM, V273, P1808, DOI 10.1074/jbc.273.3.1808	46	12	12	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					19260	19268		10.1074/jbc.M112.445270	http://dx.doi.org/10.1074/jbc.M112.445270			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23671279	Green Published, hybrid			2022-12-25	WOS:000321335800058
J	Chatterjee, S; Alsaeedi, N; Hou, J; Bandaru, VVR; Wu, L; Halushka, MK; Pili, R; Ndikuyeze, G; Haughey, NJ				Chatterjee, Subroto; Alsaeedi, Nezar; Hou, Jennifer; Bandaru, Veera Venkata Ratnam; Wu, Lan; Halushka, Marc K.; Pili, Roberto; Ndikuyeze, Georges; Haughey, Norman J.			Use of a Glycolipid Inhibitor to Ameliorate Renal Cancer in a Mouse Model	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; C-FOS EXPRESSION; SPHINGOLIPID METABOLISM; GLYCOSPHINGOLIPID BIOSYNTHESIS; GLUCOSYLCERAMIDE SYNTHASE; LACTOSYLCERAMIDE; CELLS; RECEPTOR; CHOLESTEROL; ADHESION	In a xenograft model wherein, live renal cancer cells were implanted under the kidney capsule in mice, revealed a 30-fold increase in tumor volume over a period of 26 days and this was accompanied with a 32-fold increase in the level of lactosylceramide (LacCer). Mice fed D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (D-PDMP), an inhibitor of glucosylceramide synthase and lactosylceramide synthase (LCS: b-1,4-GalT-V), showed marked reduction in tumor volume. This was accompanied by a decrease in the mass of lactosylceramide and an increase in glucosylceramide (GlcCer) level. Mechanistic studies revealed that D-PDMP inhibited cell proliferation and angiogenesis by inhibiting p44MAPK, p-AKT-1 pathway and mammalian target for rapamycin (mTOR). By linking glycosphingolipid synthesis with tumor growth, renal cancer progression and regression can be evaluated. Thus inhibiting glycosphingolipid synthesis can be a bonafide target to prevent the progression of other types of cancer.	[Chatterjee, Subroto; Alsaeedi, Nezar; Hou, Jennifer; Wu, Lan] Johns Hopkins Med Inst, Dept Pediat, Div Pediat Cardiol, Baltimore, MD 21205 USA; [Bandaru, Veera Venkata Ratnam; Haughey, Norman J.] Johns Hopkins Med Inst, Dept Neurol, Baltimore, MD 21205 USA; [Halushka, Marc K.] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; [Pili, Roberto] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA; [Ndikuyeze, Georges] Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Roswell Park Cancer Institute; Johns Hopkins University; Johns Hopkins Medicine	Chatterjee, S (corresponding author), Johns Hopkins Med Inst, Dept Pediat, Div Pediat Cardiol, Baltimore, MD 21205 USA.	schatte2@jhmi.edu		Halushka, Marc/0000-0002-7112-7389; Hou, Jennifer/0000-0003-4022-2452	National Institutes of Health [PO-1-HL-107153-01]; TEDCO, State of Maryland grant, Johns Hopkins University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK090868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH075673, R21MH072534, R01MH077542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023471] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); TEDCO, State of Maryland grant, Johns Hopkins University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project was funded through TEDCO, State of Maryland grant, Johns Hopkins University institutional support and a National Institutes of Health grant PO-1-HL-107153-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 1996, J BIOL CHEM, V271, P14383, DOI 10.1074/jbc.271.24.14383; Bandaru VVR, 2009, NEUROBIOL AGING, V30, P591, DOI 10.1016/j.neurobiolaging.2007.07.024; Bhunia AK, 1996, J BIOL CHEM, V271, P10660, DOI 10.1074/jbc.271.18.10660; Bhunia AK, 1998, J BIOL CHEM, V273, P34349, DOI 10.1074/jbc.273.51.34349; Bietrix F, 2010, ARTERIOSCL THROM VAS, V30, P931, DOI 10.1161/ATVBAHA.109.201673; Bischoff SC, 2007, NAT REV IMMUNOL, V7, P93, DOI 10.1038/nri2018; Cabot MC, 2002, CERAMIDE SIGNALING; Chatteriee S, 2008, BBA-GEN SUBJECTS, V1780, P370, DOI 10.1016/j.bbagen.2007.08.010; Chatterjee S, 1996, GLYCOCONJUGATE J, V13, P481, DOI 10.1007/BF00731481; Chatterjee S, 1997, GLYCOBIOLOGY, V7, P703, DOI 10.1093/glycob/7.5.703; Chatterjee S, 1996, J LIPID RES, V37, P1334; CHATTERJEE S, 1993, BIOCHIM BIOPHYS ACTA, V1167, P339, DOI 10.1016/0005-2760(93)90238-5; Chatterjee S, 2000, METHOD ENZYMOL, V311, P73; Chatterjee S, 2009, United States patent, Patent No. [US 20090202439, 20090202439]; Glaros EN, 2005, J BIOL CHEM, V280, P24515, DOI 10.1074/jbc.M413862200; Haughey NJ, 2004, ANN NEUROL, V55, P257, DOI 10.1002/ana.10828; INOKUCHI J, 1987, CANCER LETT, V38, P23, DOI 10.1016/0304-3835(87)90196-0; INOKUCHI J, 1990, CANCER RES, V50, P6731; Iwamoto T, 2001, J BIOL CHEM, V276, P46031, DOI 10.1074/jbc.M104464200; Jiang JH, 2006, GLYCOBIOLOGY, V16, P1045, DOI 10.1093/glycob/cwl027; KARLSSON KA, 1973, BIOCHIM BIOPHYS ACTA, V306, P307, DOI 10.1016/0005-2760(73)90236-1; Karman J, 2010, INT IMMUNOL, V22, P593, DOI 10.1093/intimm/dxq044; Kolmakova A, 2009, GLYCOCONJUGATE J, V26, P547, DOI 10.1007/s10719-008-9206-9; Lloyd Mark C, 2010, J Pathol Inform, V1, P29, DOI 10.4103/2153-3539.74186; Natoli TA, 2010, NAT MED, V16, P788, DOI 10.1038/nm.2171; Pannu R, 2004, J NEUROSCI, V24, P5942, DOI 10.1523/JNEUROSCI.1271-04.2004; RADIN NS, 1993, ADV LIPID RES, V26, P183; Rajesh M, 2005, CIRC RES, V97, P796, DOI 10.1161/01.RES.0000185327.45463.A8; RANI CSS, 1995, J BIOL CHEM, V270, P2859, DOI 10.1074/jbc.270.6.2859; Rusciani A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014010; Selvin E, 2010, ATHEROSCLEROSIS, V208, P69, DOI 10.1016/j.atherosclerosis.2009.06.025; SHUKLA GS, 1991, BIOCHIM BIOPHYS ACTA, V1083, P101, DOI 10.1016/0005-2760(91)90130-A; Stancevic B, 2010, FEBS LETT, V584, P1728, DOI 10.1016/j.febslet.2010.02.026; Tamboli IY, 2005, J BIOL CHEM, V280, P28110, DOI 10.1074/jbc.M414525200; Veldman RJ, 2002, FASEB J, V16, P1111, DOI 10.1096/fj.01-0863fje; Wang F, 1999, J BIOL CHEM, V274, P35343, DOI 10.1074/jbc.274.50.35343; Wei YY, 2010, J BIOCHEM, V148, P263, DOI 10.1093/jb/mvq061; Wei YY, 2010, BIOCHEM BIOPH RES CO, V396, P602, DOI 10.1016/j.bbrc.2010.04.110; Yeh LH, 2001, J VASC RES, V38, P551, DOI 10.1159/000051091	39	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63726	10.1371/journal.pone.0063726	http://dx.doi.org/10.1371/journal.pone.0063726			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671696	gold, Green Submitted, Green Published			2022-12-25	WOS:000319737700058
J	Jin, AZ; Koh, WP; Chow, KY; Yuan, JM; Jafar, TH				Jin, Aizhen; Koh, Woon-Puay; Chow, Khuan Yew; Yuan, Jian-Min; Jafar, Tazeen Hasan			Smoking and Risk of Kidney Failure in the Singapore Chinese Health Study	PLOS ONE			English	Article							STAGE RENAL-DISEASE; BLOOD-PRESSURE; MYOCARDIAL-INFARCTION; ETHNIC-DIFFERENCES; CARE; HYPERTENSION; PROGRESSION; PREVALENCE; MANAGEMENT; MORTALITY	Background: The relationship between smoking and risk of kidney failure, especially in people of Chinese origin, is not clear. We analyzed data from the Singapore Chinese Health Study to investigate whether smoking increases the risk of kidney failure. Methods: The Singapore Chinese Health Study is a population-based cohort of 63,257 Chinese adults enrolled between 1993 and 1998. Information on smoking status was collected at baseline. Incidence of kidney failure was identified via record linkage with the nationwide Singapore Renal Registry until 2008. Kidney failure was defined by one of the following: 1) serum creatinine level of more than or equal to 500 mmol/l (5.7 mg/dl), 2) estimated glomerular filtration rate of less than 15 ml/min/1.73 m(2), 3) undergoing hemodialysis or peritoneal dialysis, 4) undergone kidney transplantation. Cox proportional hazard regression analysis was performed for the outcome of kidney failure after adjusting for age, education, dialect, herbal medications, body mass index, sex, physician-diagnosed hypertension and diabetes mellitus. Results: The mean age of subjects was 55.6 years at baseline, and 44% were men. Overall 30.6% were ever smokers (current or former) at baseline. A total of 674 incident cases of kidney failure occurred during a median follow-up of 13.3 years. Among men, smokers had a significant increase in the adjusted risk of kidney failure [hazard ratio (HR): 1.29; 95% CI: 1.02-1.64] compared to never smokers. There was a strong dose-dependent association between number of years of smoking and kidney failure, (p for trend = 0.011). The risk decreased with prolonged cessation (quitting >= 10 years since baseline). The number of women smokers was too few for conclusive relationship. Limitation: Information on baseline kidney function was not available. Conclusions: Cigarette smoking is associated with increased risk of kidney failure among Chinese men. The risk appears to be dose- and duration-dependent and modifiable after long duration of cessation.	[Jin, Aizhen; Chow, Khuan Yew] Hlth Promot Board, Natl Registry Dis Off, Singapore, Singapore; [Koh, Woon-Puay] Duke NUS Grad Med Sch, Off Clin Sci, Singapore, Singapore; [Koh, Woon-Puay] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Dept Epidemiol, Singapore 117548, Singapore; [Yuan, Jian-Min] Univ Pittsburgh, Inst Canc, Div Canc Control & Populat Sci, Pittsburgh, PA USA; [Yuan, Jian-Min] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; [Jafar, Tazeen Hasan] Duke NUS Grad Med Sch, Lab Cardiovasc & Renal Risk Reduct Hlth Serv & Sy, Singapore, Singapore	National University of Singapore; National University of Singapore; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National University of Singapore	Jafar, TH (corresponding author), Duke NUS Grad Med Sch, Lab Cardiovasc & Renal Risk Reduct Hlth Serv & Sy, Singapore, Singapore.	tazeen.jafar@duke-nus.edu.sg		Yuan, Jian-Min/0000-0002-4620-3108	National Institutes of Health, USA [RO1 CA55069, R35 CA53890, R01 CA80205, R01 CA144034]; NATIONAL CANCER INSTITUTE [R01CA144034, R01CA080205, R35CA053890, R01CA055069] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was funded by National Institutes of Health, USA (RO1 CA55069, R35 CA53890, R01 CA80205, and R01 CA144034). No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cravedi P, 2008, KIDNEY INT, V74, pS2, DOI 10.1038/ki.2008.511; DOLL R, 1976, BRIT MED J, V2, P1525, DOI 10.1136/bmj.2.6051.1525; EVANS RW, 1985, NEW ENGL J MED, V312, P553, DOI 10.1056/NEJM198502283120905; Fischbacher CM, 2003, DIABETIC MED, V20, P31, DOI 10.1046/j.1464-5491.2003.00822.x; Hallan SI, 2011, KIDNEY INT, V80, P516, DOI 10.1038/ki.2011.157; Hankin JH, 2001, NUTR CANCER, V39, P187, DOI 10.1207/S15327914nc392_5; Hossain MP, 2009, AM J KIDNEY DIS, V53, P166, DOI 10.1053/j.ajkd.2007.10.047; Hwang SJ, 2010, NEPHROLOGY, V15, P3, DOI 10.1111/j.1440-1797.2010.01304.x; Ikeda F, 2012, TOB CONTROL, V21, P416, DOI 10.1136/tc.2010.039362; Jafar TH, 2003, ANN INTERN MED, V139, P244, DOI 10.7326/0003-4819-139-4-200308190-00006; Johnson S, 2008, J HEALTH CARE POOR U, V19, P90, DOI 10.1353/hpu.2008.0007; Klag MJ, 1996, NEW ENGL J MED, V334, P13, DOI 10.1056/NEJM199601043340103; Lai MN, 2009, NEPHROLOGY, V14, P227, DOI 10.1111/j.1440-1797.2008.01061.x; Lash JP, 2006, AM J KIDNEY DIS, V47, P956, DOI 10.1053/j.ajkd.2006.02.175; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Lim SH, 2011, TOB CONTROL; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; MCALISTER NH, 1986, BRIT MED J, V293, P670, DOI 10.1136/bmj.293.6548.670; Mudur G, 2005, BRIT MED J, V330, P920, DOI 10.1136/bmj.330.7497.920-a; Muntner P, 2003, J AM SOC NEPHROL, V14, P1568, DOI 10.1097/01.ASN.0000067420.83632.C1; Pinto-Sietsma SJ, 2000, ANN INTERN MED, V133, P585, DOI 10.7326/0003-4819-133-8-200010170-00008; Powe NR, 2005, MED CLIN N AM, V89, P475, DOI 10.1016/j.mcna.2004.11.004; ROSENBERG L, 1990, NEW ENGL J MED, V322, P213, DOI 10.1056/NEJM199001253220401; Tamura MK, 2009, NEW ENGL J MED, V361, P1539, DOI 10.1056/NEJMoa0904655; Tsuchiya M, 2002, CIRCULATION, V105, P1155, DOI 10.1161/hc1002.105935; Xue JL, 2007, J AM SOC NEPHROL, V18, P1299, DOI 10.1681/ASN.2006050524; Yach D, 2003, LANCET, V361, P611, DOI 10.1016/S0140-6736(03)12532-9; Yang GH, 2010, BIOMED ENVIRON SCI, V23, P422, DOI 10.1016/S0895-3988(11)60002-0; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6	29	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e62962	10.1371/journal.pone.0062962	http://dx.doi.org/10.1371/journal.pone.0062962			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671645	Green Published, gold, Green Accepted			2022-12-25	WOS:000319737700029
J	Koike, M; Tanida, I; Nanao, T; Tada, N; Iwata, J; Ueno, T; Kominami, E; Uchiyama, Y				Koike, Masato; Tanida, Isei; Nanao, Tomohisa; Tada, Norihiro; Iwata, Jun-ichi; Ueno, Takashi; Kominami, Eiki; Uchiyama, Yasuo			Enrichment of GABARAP Relative to LC3 in the Axonal Initial Segments of Neurons	PLOS ONE			English	Article							LYSOSOMAL TURNOVER; MOUSE MODELS; PROTEIN; RECEPTOR; AUTOPHAGY; TRANSPORT; EXPRESSION; GATE-16; CONJUGATION; DEFICIENT	GABA(A) receptor-associated protein (GABARAP) was initially identified as a protein that interacts with GABA(A) receptor. Although LC3 (microtubule-associated protein 1 light chain 3), a GABARAP homolog, has been localized in the dendrites and cell bodies of neurons under normal conditions, the subcellular distribution of GABARAP in neurons remains unclear. Subcellular fractionation indicated that endogenous GABARAP was localized to the microsome-enriched and synaptic vesicle-enriched fractions of mouse brain as GABARAP-I, an unlipidated form. To investigate the distribution of GABARAP in neurons, we generated GFP-GABARAP transgenic mice. Immunohistochemistry in these transgenic mice showed that positive signals for GFP-GABARAP were widely distributed in neurons in various brain regions, including the hippocampus and cerebellum. Interestingly, intense diffuse and/or fibrillary expression of GFP-GABARAP was detected along the axonal initial segments (AIS) of hippocampal pyramidal neurons and cerebellar Purkinje cells, in addition to the cell bodies and dendrites of these neurons. In contrast, only slight amounts of LC3 were detected along the AIS of these neurons, while diffuse and/or fibrillary staining for LC3 was mainly detected in their cell bodies and dendrites. These results indicated that, compared with LC3, GABARAP is enriched in the AIS, in addition to the cell bodies and dendrites, of these hippocampal pyramidal neurons and cerebellar Purkinje cells.	[Koike, Masato; Nanao, Tomohisa; Uchiyama, Yasuo] Juntendo Univ, Sch Med, Dept Cell Biol & Neurosci, Tokyo 113, Japan; [Tanida, Isei; Iwata, Jun-ichi; Ueno, Takashi; Kominami, Eiki] Juntendo Univ, Sch Med, Dept Biochem, Tokyo 113, Japan; [Tanida, Isei] Natl Inst Infect Dis, Dept Biochem & Cell Biol, Shinjuku Ku, Tokyo 1628640, Japan; [Tada, Norihiro] Juntendo Univ, Sch Med, Res Inst Dis Old Ages, Div Genome Res, Tokyo 113, Japan	Juntendo University; Juntendo University; National Institute of Infectious Diseases (NIID); Juntendo University	Tanida, I (corresponding author), Juntendo Univ, Sch Med, Dept Biochem, Tokyo 113, Japan.	tanida@nih.go.jp; y-uchi@juntendo.ac.jp	Koike, Masato/F-9584-2010	Koike, Masato/0000-0002-3174-5684; Tanida, Isei/0000-0001-8999-3990	Ministry of Health, Labor, and Welfare of Japan; Ministry of Education, Science, Sports and Culture, Japan (MEXT) [23659102]; MEXT-supported Program for the Strategic Research Foundation at Private Universities; Research Grant from the Takeda Science Foundation;  [14380308];  [16370063]	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Science, Sports and Culture, Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT-supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Grant from the Takeda Science Foundation; ; 	This study was supported, in part, by grants-in-aid from the Ministry of Health, Labor, and Welfare of Japan (IT, TU, HK, and EK), Grants-in-aid for Scientific Research (B) (14380308 and 16370063 to TU), Grants-in-Aid for Scientific Research on Priority Areas "Proteolysis in the Regulation of Biological Processes'' (to IT, MK, and TU), and challenging Exploratory Research (23659102 to YU) from the Ministry of Education, Science, Sports and Culture, Japan (MEXT). TU and YU were supported by MEXT-supported Program for the Strategic Research Foundation at Private Universities. TU was supported by a Research Grant from the Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buffington SA, 2011, EUR J NEUROSCI, V34, P1609, DOI 10.1111/j.1460-9568.2011.07875.x; Chen CG, 2011, J BIOL CHEM, V286, P15106, DOI 10.1074/jbc.M111.230896; Chen L, 2000, P NATL ACAD SCI USA, V97, P11557, DOI 10.1073/pnas.190133497; Chen ZW, 2007, J NEUROCHEM, V100, P279, DOI 10.1111/j.1471-4159.2006.04206.x; Clark BD, 2009, NEUROSCIENTIST, V15, P651, DOI 10.1177/1073858409341973; Cook JL, 2008, CIRC RES, V102, P1539, DOI 10.1161/CIRCRESAHA.108.176594; DEFELIPE J, 1985, J COMP NEUROL, V231, P364, DOI 10.1002/cne.902310307; Green F, 2002, FEBS LETT, V518, P101, DOI 10.1016/S0014-5793(02)02655-8; Hell JW, 2005, CELL BIOL 4 VOLUME S, P85; Iwakura A, 2012, J NEUROSCI, V32, P9438, DOI 10.1523/JNEUROSCI.1651-12.2012; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kanematsu T, 2002, EMBO J, V21, P1004, DOI 10.1093/emboj/21.5.1004; Kittler JT, 2001, MOL CELL NEUROSCI, V18, P13, DOI 10.1006/mcne.2001.1005; Kneussel M, 2000, P NATL ACAD SCI USA, V97, P8594, DOI 10.1073/pnas.97.15.8594; Koike M, 2005, AM J PATHOL, V167, P1713, DOI 10.1016/S0002-9440(10)61253-9; Koike M, 2008, AM J PATHOL, V172, P454, DOI 10.2353/ajpath.2008.070876; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; KORDELI E, 1995, J BIOL CHEM, V270, P2352, DOI 10.1074/jbc.270.5.2352; Kouno T, 2005, J BIOL CHEM, V280, P24610, DOI 10.1074/jbc.M413565200; Lainez S, 2010, FASEB J, V24, P1958, DOI 10.1096/fj.09-151472; Legesse-Miller A, 1998, J BIOL CHEM, V273, P3105, DOI 10.1074/jbc.273.5.3105; Marino G, 2007, J BIOL CHEM, V282, P18573, DOI 10.1074/jbc.M701194200; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Nakajima K, 2012, NEURON, V76, P945, DOI 10.1016/j.neuron.2012.10.012; Nakata T, 2003, J CELL BIOL, V162, P1045, DOI 10.1083/jcb.200302175; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Nusser Z, 1996, P NATL ACAD SCI USA, V93, P11939, DOI 10.1073/pnas.93.21.11939; Nusser Z, 2009, TRENDS NEUROSCI, V32, P267, DOI 10.1016/j.tins.2009.01.003; O'Sullivan GA, 2005, EUR J NEUROSCI, V22, P2644, DOI 10.1111/j.1460-9568.2005.04448.x; Okazaki N, 2000, MOL BRAIN RES, V85, P1, DOI 10.1016/S0169-328X(00)00218-7; Reining SC, 2009, AM J PHYSIOL-RENAL, V296, pF1118, DOI 10.1152/ajprenal.90492.2008; Sagiv Y, 2000, EMBO J, V19, P1494, DOI 10.1093/emboj/19.7.1494; Schwarten M, 2009, AUTOPHAGY, V5, P690, DOI 10.4161/auto.5.5.8494; Sou Y, 2006, J BIOL CHEM, V281, P3017, DOI 10.1074/jbc.M505888200; Takagi-Akiba M, 2012, AM J PHYSIOL-RENAL, V302, pF380, DOI 10.1152/ajprenal.00502.2010; Tanida I, 2004, J BIOL CHEM, V279, P36268, DOI 10.1074/jbc.M401461200; Tanida I, 2003, BIOCHEM BIOPH RES CO, V300, P637, DOI 10.1016/S0006-291X(02)02907-8; Tanida I, 2002, J BIOL CHEM, V277, P13739, DOI 10.1074/jbc.M200385200; Tanida I, 2001, J BIOL CHEM, V276, P1701, DOI 10.1074/jbc.C000752200; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Tanida I, 2006, AUTOPHAGY, V2, P264, DOI 10.4161/auto.2871; Tanida I, 2006, FEBS J, V273, P2553, DOI 10.1111/j.1742-4658.2006.05260.x; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Vernier-Magnin S, 2001, BIOCHEM BIOPH RES CO, V284, P118, DOI 10.1006/bbrc.2001.4908; Wang HB, 1999, NATURE, V397, P69, DOI 10.1038/16264; Yue ZY, 2009, METHOD ENZYMOL, V453, P159, DOI 10.1016/S0076-6879(08)04008-1	46	15	15	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63568	10.1371/journal.pone.0063568	http://dx.doi.org/10.1371/journal.pone.0063568			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671684	gold, Green Published, Green Submitted			2022-12-25	WOS:000319737700053
J	Kurahashi, I; Fujita, Y; Arao, T; Kurata, T; Koh, Y; Sakai, K; Matsumoto, K; Tanioka, M; Takeda, K; Takiguchi, Y; Yamamoto, N; Tsuya, A; Matsubara, N; Mukai, H; Minami, H; Chayahara, N; Yamanaka, Y; Miwa, K; Takahashi, S; Takahashi, S; Nakagawa, K; Nishio, K				Kurahashi, Issei; Fujita, Yoshihiko; Arao, Tokuzo; Kurata, Takayasu; Koh, Yasuhiro; Sakai, Kazuko; Matsumoto, Koji; Tanioka, Maki; Takeda, Koji; Takiguchi, Yuichi; Yamamoto, Nobuyuki; Tsuya, Asuka; Matsubara, Nobuaki; Mukai, Hirofumi; Minami, Hironobu; Chayahara, Naoko; Yamanaka, Yasuhiro; Miwa, Keisuke; Takahashi, Shin; Takahashi, Shunji; Nakagawa, Kazuhiko; Nishio, Kazuto			A Microarray-Based Gene Expression Analysis to Identify Diagnostic Biomarkers for Unknown Primary Cancer	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; DEPENDENT PROTEIN-KINASE; PHASE-II TRIAL; MOLECULAR CLASSIFICATION; RIBOSOMAL BIOGENESIS; PRIMARY SITE; METASTASIS; CARCINOMA; CELLS; ORIGIN	Background: The biological basis for cancer of unknown primary (CUP) at the molecular level remains largely unknown, with no evidence of whether a common biological entity exists. Here, we assessed the possibility of identifying a common diagnostic biomarker for CUP using a microarray gene expression analysis. Methods: Tumor mRNA samples from 60 patients with CUP were analyzed using the Affymetrix U133A Plus 2.0 GeneChip and were normalized by asinh (hyperbolic arc sine) transformation to construct a mean gene-expression profile specific to CUP. A gene-expression profile specific to non-CUP group was constructed using publicly available raw microarray datasets. The t-tests were performed to compare the CUP with non-CUP groups and the top 59 CUP specific genes with the highest fold change were selected (p-value<0.001). Results: Among the 44 genes that were up-regulated in the CUP group, 6 genes for ribosomal proteins were identified. Two of these genes (RPS7 and RPL11) are known to be involved in the Mdm2-p53 pathway. We also identified several genes related to metastasis and apoptosis, suggesting a biological attribute of CUP. Conclusions: The protein products of the up-regulated and down-regulated genes identified in this study may be clinically useful as unique biomarkers for CUP.	[Kurahashi, Issei] Univ Tokyo, Dept Planning Informat & Management, Tokyo, Japan; [Fujita, Yoshihiko; Arao, Tokuzo; Sakai, Kazuko; Nishio, Kazuto] Kinki Univ, Sch Med, Dept Genome Biol, Osaka 589, Japan; [Kurata, Takayasu; Nakagawa, Kazuhiko] Kinki Univ, Sch Med, Dept Med Oncol, Osaka 589, Japan; [Koh, Yasuhiro] Shizuoka Canc Ctr, Res Inst, Div Drug Discovery & Dev, Shizuoka, Japan; [Matsumoto, Koji; Tanioka, Maki] Hyogo Canc Ctr, Div Med Oncol, Akashi, Hyogo, Japan; [Takeda, Koji; Tsuya, Asuka] Osaka City Gen Hosp, Dept Clin Oncol, Osaka, Japan; [Takiguchi, Yuichi] Chiba Univ, Grad Sch Med, Dept Med Oncol, Chiba, Japan; [Yamamoto, Nobuyuki] Shizuoka Canc Ctr, Div Thorac Oncol, Shizuoka, Japan; [Matsubara, Nobuaki; Mukai, Hirofumi] Natl Canc Ctr Hosp East, Div Hematol & Oncol, Chiba, Japan; [Minami, Hironobu; Chayahara, Naoko] Kobe Univ, Grad Sch Med, Div Med Oncol Hematol, Kobe, Hyogo 657, Japan; [Yamanaka, Yasuhiro] Tochigi Canc Ctr, Dept Med Oncol, Utsunomiya, Tochigi, Japan; [Miwa, Keisuke] Saitama Med Univ, Dept Med Oncol, Ctr Comprehens Canc, Int Med Ctr, Saitama, Japan; [Takahashi, Shin] Tohoku Univ, Dept Clin Oncol, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Takahashi, Shunji] Canc Inst Hosp, Div Med Oncol, Tokyo, Japan	University of Tokyo; Kindai University (Kinki University); Kindai University (Kinki University); Shizuoka Cancer Center; Hyogo Cancer Center; Osaka City General Hospital; Chiba University; Shizuoka Cancer Center; National Cancer Center - Japan; Kobe University; Tochigi Prefectural Cancer Center; Saitama Medical University; Tohoku University; Japanese Foundation for Cancer Research	Nishio, K (corresponding author), Kinki Univ, Sch Med, Dept Genome Biol, Osaka 589, Japan.	knishio@med.kindai.ac.jp	Takahashi, Shin/AAE-5011-2019; Matsumoto, Koji/GVT-8176-2022; Matsumoto, Koji/AHB-3532-2022	Takahashi, Shin/0000-0001-6695-3099; Matsumoto, Koji/0000-0003-1907-0247; Tanioka, Maki/0000-0002-6558-2246	Ministry of Health, Labour and Welfare; Grants-in-Aid for Scientific Research [25462006, 24591186, 23591136] Funding Source: KAKEN	Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the grant-in-aid for Scientific Research from the Ministry of Health, Labour and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBRUZZESE JL, 1995, J CLIN ONCOL, V13, P2094, DOI 10.1200/JCO.1995.13.8.2094; ABBRUZZESE JL, 1994, J CLIN ONCOL, V12, P1272, DOI 10.1200/JCO.1994.12.6.1272; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Anderberg M. R., 1973, CLUSTER ANAL APPL; Bandres E, 2004, ONCOL REP, V12, P287; Banh A, 2011, CANCER RES, V71, P4423, DOI 10.1158/0008-5472.CAN-10-4157; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bloom G, 2004, AM J PATHOL, V164, P9, DOI 10.1016/S0002-9440(10)63090-8; Dai MS, 2008, J CELL BIOCHEM, V105, P670, DOI 10.1002/jcb.21895; de Marval PM, 2011, CANCER PREV RES, V4, P851, DOI 10.1158/1940-6207.CAPR-10-0360; Dennis JL, 2005, CLIN CANCER RES, V11, P3766, DOI 10.1158/1078-0432.CCR-04-2236; Durbin B, 2003, BIOINFORMATICS, V19, P1360, DOI 10.1093/bioinformatics/btg178; Fu ZY, 2011, BIOMED PHARMACOTHER, V65, P163, DOI 10.1016/j.biopha.2011.02.004; Giordano TJ, 2001, AM J PATHOL, V159, P1231, DOI 10.1016/S0002-9440(10)62509-6; Greco FA, 2002, J CLIN ONCOL, V20, P1651, DOI 10.1200/JCO.20.6.1651; Hainsworth JD, 2007, J CLIN ONCOL, V25, P1747, DOI 10.1200/JCO.2006.09.3047; Hastie T., 2017, ELEMENT STAT LEARNIN; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Iurisci I, 2009, ANTICANCER RES, V29, P403; Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040; Jiffar T, 2011, ONCOGENE, V30, P3163, DOI 10.1038/onc.2011.39; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Kurahashi I, 2007, J JAPAN STAT SOC, V36, P147; Kwee TC, 2009, EUR RADIOL, V19, P731, DOI 10.1007/s00330-008-1194-4; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Li XJ, 2011, CANCER RES, V71, P3162, DOI 10.1158/0008-5472.CAN-10-3557; Macha MA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-655; Maelandsmo GM, 1997, INT J CANCER, V74, P464, DOI 10.1002/(SICI)1097-0215(19970822)74:4<464::AID-IJC19>3.0.CO;2-9; Maier HJ, 2010, CANCER LETT, V295, P214, DOI 10.1016/j.canlet.2010.03.003; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mao P, 2011, J BIOL CHEM, V286, P19381, DOI 10.1074/jbc.M111.218040; Matta A, 2012, EXPERT OPIN THER TAR, V16, P515, DOI 10.1517/14728222.2012.668185; Melle C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003767; Park Jong Sun, 2011, BMC Res Notes, V4, P56, DOI 10.1186/1756-0500-4-56; Pavlidis N, 2003, EUR J CANCER, V39, P1990, DOI 10.1016/S0959-8049(03)00547-1; Pimiento JM, 2007, AM J SURG, V194, P833, DOI 10.1016/j.amjsurg.2007.08.039; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Rodnina MV, 2009, CURR OPIN CELL BIOL, V21, P435, DOI 10.1016/j.ceb.2009.01.023; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; Schneider BJ, 2007, CANCER-AM CANCER SOC, V110, P770, DOI 10.1002/cncr.22857; Shedden KA, 2003, AM J PATHOL, V163, P1985, DOI 10.1016/S0002-9440(10)63557-2; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Sokol JP, 2005, BREAST CANCER RES, V7, pR844, DOI 10.1186/bcr1312; Soucy Teresa A, 2010, Genes Cancer, V1, P708, DOI 10.1177/1947601910382898; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; Su AI, 2001, CANCER RES, V61, P7388; Sun XX, 2010, J BIOL CHEM, V285, P25812, DOI 10.1074/jbc.M109.098442; Tang DJ, 2010, HEPATOLOGY, V51, P1255, DOI 10.1002/hep.23451; Tothill RW, 2005, CANCER RES, V65, P4031, DOI 10.1158/0008-5472.CAN-04-3617; Um JH, 2004, J PHARMACOL EXP THER, V311, P1062, DOI 10.1124/jpet.104.070938; Varadhachary GR, 2008, LANCET ONCOL, V9, P596, DOI 10.1016/S1470-2045(08)70151-7; Zhao Y, 2006, CANCER RES, V66, P5354, DOI 10.1158/0008-5472.CAN-05-4275; Zhu Y, 2009, MOL CELL, V35, P316, DOI 10.1016/j.molcel.2009.07.014	55	19	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63249	10.1371/journal.pone.0063249	http://dx.doi.org/10.1371/journal.pone.0063249			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671674	Green Published, gold, Green Submitted			2022-12-25	WOS:000319737700050
J	Nichols, TA; Spraker, TR; Rigg, TD; Meyerett-Reid, C; Hoover, C; Michel, B; Bian, JF; Hoover, E; Gidlewski, T; Balachandran, A; O'Rourke, K; Telling, GC; Bowen, R; Zabel, MD; VerCauteren, KC				Nichols, Tracy A.; Spraker, Terry R.; Rigg, Tara D.; Meyerett-Reid, Crystal; Hoover, Clare; Michel, Brady; Bian, Jifeng; Hoover, Edward; Gidlewski, Thomas; Balachandran, Aru; O'Rourke, Katherine; Telling, Glenn C.; Bowen, Richard; Zabel, Mark D.; VerCauteren, Kurt C.			Intranasal Inoculation of White-Tailed Deer (Odocoileus virginianus) with Lyophilized Chronic Wasting Disease Prion Particulate Complexed to Montmorillonite Clay	PLOS ONE			English	Article							DENDRITIC CELLS; MULE DEER; NASAL-MUCOSA; ORAL-TRANSMISSION; INFECTIOUS PRIONS; PROTEIN; TRANSPORT; HEMIONUS; PATHWAYS; DELIVERY	Chronic wasting disease (CWD), the only known prion disease endemic in wildlife, is a persistent problem in both wild and captive North American cervid populations. This disease continues to spread and cases are found in new areas each year. Indirect transmission can occur via the environment and is thought to occur by the oral and/or intranasal route. Oral transmission has been experimentally demonstrated and although intranasal transmission has been postulated, it has not been tested in a natural host until recently. Prions have been shown to adsorb strongly to clay particles and upon oral inoculation the prion/clay combination exhibits increased infectivity in rodent models. Deer and elk undoubtedly and chronically inhale dust particles routinely while living in the landscape while foraging and rutting. We therefore hypothesized that dust represents a viable vehicle for intranasal CWD prion exposure. To test this hypothesis, CWD-positive brain homogenate was mixed with montmorillonite clay (Mte), lyophilized, pulverized and inoculated intranasally into white-tailed deer once a week for 6 weeks. Deer were euthanized at 95, 105, 120 and 175 days post final inoculation and tissues examined for CWD-associated prion proteins by immunohistochemistry. Our results demonstrate that CWD can be efficiently transmitted utilizing Mte particles as a prion carrier and intranasal exposure.	[Nichols, Tracy A.; Rigg, Tara D.; Gidlewski, Thomas; VerCauteren, Kurt C.] US Anim & Plant Hlth Inspect Serv, Natl Wildlife Res Ctr, USDA, Wildlife Serv, Ft Collins, CO USA; [Spraker, Terry R.] Colorado State Univ, Diagnost Lab, Ft Collins, CO 80523 USA; [Spraker, Terry R.; Meyerett-Reid, Crystal; Hoover, Clare; Michel, Brady; Bian, Jifeng; Hoover, Edward; Telling, Glenn C.; Zabel, Mark D.] Colorado State Univ, Prion Res Ctr, Ft Collins, CO 80523 USA; [Spraker, Terry R.; Meyerett-Reid, Crystal; Hoover, Clare; Michel, Brady; Bian, Jifeng; Hoover, Edward; Telling, Glenn C.; Zabel, Mark D.] Colorado State Univ, Prion Res Ctr, Dept Microbiol Immunol & Pathol, Coll Vet Med & Biomed Sci, Ft Collins, CO 80523 USA; [Bowen, Richard] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Biomed Sci, Ft Collins, CO 80523 USA; [Balachandran, Aru] Canadian Food Inspect Agcy, Natl & OIE Reference Lab Scrapie & Chron Wasting, Ottawa, ON, Canada; [O'Rourke, Katherine] USDA, ARS, Pullman, WA USA	United States Department of Agriculture (USDA); Colorado State University; Colorado State University; Colorado State University; Colorado State University; Canadian Food Inspection Agency; United States Department of Agriculture (USDA)	Nichols, TA (corresponding author), US Anim & Plant Hlth Inspect Serv, Natl Wildlife Res Ctr, USDA, Wildlife Serv, Ft Collins, CO USA.	tracy.a.nichols@aphis.usda.gov	Bian, Jifeng/AAE-6262-2019; Telling, Glenn C/G-1217-2019	Bian, Jifeng/0000-0001-6838-9938; Telling, Glenn C/0000-0002-6294-1805	U.S. Department of Agriculture, Animal and Plant Health Inspection Service, Veterinary Services (VS)	U.S. Department of Agriculture, Animal and Plant Health Inspection Service, Veterinary Services (VS)	Funding was provided by U.S. Department of Agriculture, Animal and Plant Health Inspection Service, Veterinary Services (VS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annacker O, 2005, J EXP MED, V202, P1051, DOI 10.1084/jem.20040662; ARTHUR WJ, 1979, J RANGE MANAGE, V32, P67, DOI 10.2307/3897389; Bessen RA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000837; Bessen RA, 2009, J VIROL, V83, P6435, DOI 10.1128/JVI.00018-09; Bian JF, 2010, J VIROL, V84, P8322, DOI 10.1128/JVI.00633-10; Denkers ND, 2013, J VIROL, V87, P1890, DOI 10.1128/JVI.02852-12; Donaldson DS, 2012, MUCOSAL IMMUNOL, V5, P216, DOI 10.1038/mi.2011.68; Dong YC, 2005, BIOMATERIALS, V26, P6068, DOI 10.1016/j.biomaterials.2005.03.021; ESIRI MM, 1984, J NEUROL SCI, V64, P213, DOI 10.1016/0022-510X(84)90039-X; Feng SS, 2009, BIOMATERIALS, V30, P3297, DOI 10.1016/j.biomaterials.2009.02.045; FLEXNER S, 1913, P SOC EXP BIOL MED, V10, P1; Fox KA, 2006, J GEN VIROL, V87, P3451, DOI 10.1099/vir.0.81999-0; Gee G.W., 1986, METHODS SOIL ANAL 1, P399; Haley NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004848; Hartmann E, 2006, CLIN VACCINE IMMUNOL, V13, P1278, DOI 10.1128/CVI.00172-06; Heppner FL, 2001, NAT MED, V7, P976, DOI 10.1038/nm0901-976; Hewitt D G., 2011, BIOL MANGAMENT WHITE; HOLT PG, 1989, CLIN EXP ALLERGY, V19, P597, DOI 10.1111/j.1365-2222.1989.tb02752.x; Holt PG, 2000, J ALLERGY CLIN IMMUN, V105, P421, DOI 10.1067/mai.2000.105010; Huang FP, 2004, ADV DRUG DELIVER REV, V56, P901, DOI 10.1016/j.addr.2003.09.006; Huang FP, 2002, J GEN VIROL, V83, P267, DOI 10.1099/0022-1317-83-1-267; JANI PU, 1992, INT J PHARMACEUT, V86, P239, DOI 10.1016/0378-5173(92)90202-D; Jepson MA, 1996, J ANAT, V189, P507; Johnson CJ, 2007, PLOS PATHOG, V3, P874, DOI 10.1371/journal.ppat.0030093; Johnson CJ, 2006, PLOS PATHOG, V2, P296, DOI 10.1371/journal.ppat.0020032; Karberg NJ, 2009, BIOL INVASIONS, V11, P761, DOI 10.1007/s10530-008-9290-6; Kawase M, 2004, BIOL PHARM BULL, V27, P2049, DOI 10.1248/bpb.27.2049; Keeler Shamus P., 2011, Journal of the Pennsylvania Academy of Science, V85, P183; Kelly AC, 2008, PRION, V2, P28, DOI 10.4161/pri.2.1.6321; Kincaid AE, 2007, J VIROL, V81, P4482, DOI 10.1128/JVI.02649-06; Kincaid AE, 2012, J VIROL, V86, P12731, DOI 10.1128/JVI.01930-12; Klaassen C.D., 2001, CASARETT DOULLS TOXI; KleinJan A, 2006, J ALLERGY CLIN IMMUN, V118, P1117, DOI 10.1016/j.jaci.2006.05.030; KleinJan A, 2011, CURR OPIN ALLERGY CL, V11, P12, DOI 10.1097/ACI.0b013e328342335f; LAFAY F, 1991, VIROLOGY, V183, P320, DOI 10.1016/0042-6822(91)90145-2; Larsson P, 2000, TOXICOL SCI, V55, P383, DOI 10.1093/toxsci/55.2.383; Le Pichon CE, 2008, J COMP NEUROL, V508, P487, DOI 10.1002/cne.21698; Mabbott NA, 2012, PRION, V6, P322, DOI 10.4161/pri.20676; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; Mathiason CK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005916; MCWILLIAM AS, 1995, IMMUNOL CELL BIOL, V73, P405, DOI 10.1038/icb.1995.63; Michel B, 2012, SCI REP-UK, V2, DOI 10.1038/srep00440; Miller MW, 2012, J WILDLIFE DIS, V48, P526, DOI 10.7589/0090-3558-48.2.526; Miller MW, 2003, NATURE, V425, P35, DOI 10.1038/425035a; Miller MW, 2004, EMERG INFECT DIS, V10, P1003, DOI 10.3201/eid1006.040010; Nelson HS, 2007, J ALLERGY CLIN IMMUN, V119, P872, DOI 10.1016/j.jaci.2006.12.613; Nichols TA, 2009, PRION, V3, P171, DOI 10.4161/pri.3.3.9819; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Pulford B, 2012, J WILDLIFE DIS, V48, P425, DOI 10.7589/0090-3558-48.2.425; Rajapaksa TE, 2010, J CONTROL RELEASE, V142, P196, DOI 10.1016/j.jconrel.2009.10.033; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Rigou P, 2006, ENVIRON SCI TECHNOL, V40, P1497, DOI 10.1021/es0516965; Robinson SJ, 2012, ECOL APPL, V22, P1050, DOI 10.1890/11-0907.1; Sansonetti PJ, 1999, SEMIN IMMUNOL, V11, P193, DOI 10.1006/smim.1999.0175; Saunders SE, 2012, EMERG INFECT DIS, V18, P369, DOI 10.3201/eid1803.110685; Saunders SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018752; Sbriccoli M, 2009, ACTA NEUROPATHOL, V117, P175, DOI 10.1007/s00401-008-0474-z; Sigurdson CJ, 1999, J GEN VIROL, V80, P2757, DOI 10.1099/0022-1317-80-10-2757; Sigurdson CJ, 2002, J GEN VIROL, V83, P2617, DOI 10.1099/0022-1317-83-10-2617; Spraker TR, 2002, J VET DIAGN INVEST, V14, P3, DOI 10.1177/104063870201400102; Strotmann J, 2001, CELL MOL LIFE SCI, V58, P531, DOI 10.1007/PL00000878; Takano K, 2005, J HISTOCHEM CYTOCHEM, V53, P611, DOI 10.1369/jhc.4A6539.2005; Tweill DEaT JW, 2002, N AM ELK ECOLOGY MAN; Upham JW, 2003, RESPIROLOGY, V8, P140, DOI 10.1046/j.1440-1843.2003.00465.x; Wiggins RC, 2009, NEUROCHEM RES, V34, P158, DOI 10.1007/s11064-008-9741-6; XIA WJ, 1995, J EXP MED, V181, P1275, DOI 10.1084/jem.181.4.1275; Yeo NK, 2010, INHAL TOXICOL, V22, P1038, DOI 10.3109/08958378.2010.516282	67	32	32	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e62455	10.1371/journal.pone.0062455	http://dx.doi.org/10.1371/journal.pone.0062455			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671598	Green Published, gold, Green Submitted			2022-12-25	WOS:000319737700011
J	Stoffels, K; Allix-Beguec, C; Groenen, G; Wanlin, M; Berkvens, D; Mathys, V; Supply, P; Fauville-Dufaux, M				Stoffels, Karolien; Allix-Beguec, Caroline; Groenen, Guido; Wanlin, Maryse; Berkvens, Dirk; Mathys, Vanessa; Supply, Philip; Fauville-Dufaux, Maryse			From Multidrug- to Extensively Drug-Resistant Tuberculosis: Upward Trends as Seen from a 15-Year Nationwide Study	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; MEROPENEM-CLAVULANATE; MIRU-VNTRPLUS; XDR-TB; IDENTIFICATION; EPIDEMIOLOGY; COMBINATION; EMERGENCE	Background: Emergence of extensively drug-resistant tuberculosis (XDR-TB) represents an enormous challenge to Public Health globally. Methods: Progression towards XDR-TB was investigated in Belgium, a country with a typically low TB incidence, by analyzing the magnitude, characteristics, and treatment success of multidrug-resistant tuberculosis (MDR-TB) through a population-based study from 1994 to 2008. Results: Among the 174 MDR-TB patients, 81% were foreign-born, 48% of these being asylum seekers. Although the number of MDR-TB patients remained stable through the study period at around 15 new cases annually, frequencies of resistance of the patients' first MDR-TB isolate to second-line drugs increased, as well as the total number of antibiotics it was resistant to (p<0.001). XDR-TB cases were detected from 2002 onwards. For 24 patients, additional resistance to several second-line drugs was acquired during treatment. Molecular-guided investigations indicated little to no contribution of in-country clonal spread or exogenous re-infection. The increase of pre-XDR and XDR cases could be attributed to rising proportions of patients from Asia and Central and Eastern Europe (p<0.001) and an increase in the isolation of Beijing strains in these groups (p<0.001). Despite augmented resistance, the treatment success rate improved from 63.0% to 75.8% (p = 0.080) after implementation in 2005 of improved surveillance measures and therapeutic access. Conclusions: Increasing severity in drug resistance patterns leading to more XDR- and "panresistant" TB cases in a country with a low TB incidence like Belgium represents a strong alert on worsening situations in other world regions and requires intense public health measures.	[Stoffels, Karolien; Allix-Beguec, Caroline; Mathys, Vanessa; Fauville-Dufaux, Maryse] Natl Reference Ctr TB & Mycobacteria Communicable, Sci Inst Publ Hlth, Brussels, Belgium; [Allix-Beguec, Caroline] Genoscreen, Lille, France; [Groenen, Guido; Wanlin, Maryse] Belgian Lung & TB Assoc, Brussels, Belgium; [Berkvens, Dirk] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Supply, Philip] INSERM, U1019, F-59045 Lille, France; [Supply, Philip] Inst Pasteur, Ctr Immunol & Biol Parasitaire, CNRS, UMR 8204, F-59019 Lille, France; [Supply, Philip] Inst Pasteur, Ctr Infect & Immun Lille, F-59019 Lille, France; [Supply, Philip] Univ Lille Nord France, Lille, France	Institute of Tropical Medicine (ITM); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille	Mathys, V (corresponding author), Natl Reference Ctr TB & Mycobacteria Communicable, Sci Inst Publ Hlth, Brussels, Belgium.	vmathys@wiv-isp.be; maryse.fauville@gmail.com	Allix-Béguec, Caroline/AAI-4645-2021; Supply, Philip/A-9580-2019	Allix-Béguec, Caroline/0000-0001-7642-4844; Supply, Philip/0000-0003-3690-3853	Belgian Federal Science Policy Office	Belgian Federal Science Policy Office(Belgian Federal Science Policy Office)	This work was supported by the Belgian Federal Science Policy Office granted to the Scientific Institute of Public Health, Belgium, for Karolien Stoffels. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate E, 2012, J ANTIMICROB CHEMOTH, V67, P473, DOI 10.1093/jac/dkr500; Allix C, 2004, CLIN INFECT DIS, V39, P783, DOI 10.1086/423383; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Amaral Leonard, 2011, Recent Pat Antiinfect Drug Discov, V6, P84; Banerjee R, 2008, CLIN INFECT DIS, V47, P450, DOI 10.1086/590009; Bonnet M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023081; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; CANETTI G, 1963, B WORLD HEALTH ORGAN, V29, P565; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P301; Cox H, 2012, INT J TUBERC LUNG D, V16, P447, DOI 10.5588/ijtld.11.0451; Cox HS, 2008, NEW ENGL J MED, V359, P2398, DOI 10.1056/NEJMc0805644; ECDC, 2012, TUB SURV MON EUR 201; Fonds des Affections Respiratoires (FARES), 2008, REG BELG TUB 2008; Fonds des Affections Respiratoires (FARES)/Vlaamse Vereniging voor Respir-atoire Gezondheidzorg en Tuberculosebestrijding (VRGT), 2010, DIAGN TREATM TUB PRA; Herrera-Leon L, 2005, ANTIMICROB AGENTS CH, V49, P144, DOI 10.1128/AAC.49.1.144-147.2005; Hugonnet JE, 2009, SCIENCE, V323, P1215, DOI 10.1126/science.1167498; Jacob V, 2009, ACTA CLIN BELG, V64, P113, DOI 10.1179/acb.2009.020; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kim DH, 2010, AM J RESP CRIT CARE, V182, P113, DOI 10.1164/rccm.200911-1656OC; Migliori GB, 2007, EUR RESPIR J, V29, P423, DOI 10.1183/09031936.00001307; Migliori GB, 2007, EUROSURVEILLANCE, V12; Niemann S, 2010, J CLIN MICROBIOL, V48, P3544, DOI 10.1128/JCM.00715-10; Payen MC, 2012, INT J TUBERC LUNG D, V16, P558, DOI 10.5588/ijtld.11.0414; Pfyffer GE, 1999, J CLIN MICROBIOL, V37, P3179, DOI 10.1128/JCM.37.10.3179-3186.1999; Scorpio A, 1997, ANTIMICROB AGENTS CH, V41, P540, DOI 10.1128/AAC.41.3.540; Shah NS, 2008, JAMA-J AM MED ASSOC, V300, P2153, DOI 10.1001/jama.300.18.2153; Sotgiu G, 2009, EUR RESPIR J, V33, P871, DOI 10.1183/09031936.00168008; StataCorp, 2019, STATA STAT SOFTWARE; Stoffels K, 2012, ANTIMICROB AGENTS CH, V56, P5186, DOI 10.1128/AAC.05385-11; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Udwadia ZF, 2012, CLIN INFECT DIS, V54, P579, DOI 10.1093/cid/cir889; Van Rie A, 2006, LANCET, V368, P1554, DOI 10.1016/S0140-6736(06)69575-5; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Velayati AA, 2009, CHEST, V136, P420, DOI 10.1378/chest.08-2427; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; World Health Organisation, 2008, WHOHTMTB2008402; World Health Organisation, 2011, WHOHTMTB201116; World Health Organization, 2010, WHOHTMTB20103	38	23	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63128	10.1371/journal.pone.0063128	http://dx.doi.org/10.1371/journal.pone.0063128			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671662	gold, Green Published, Green Submitted			2022-12-25	WOS:000319737700041
J	Wang, LX; Mei, ZY; Zhou, JH; Yao, YS; Li, YH; Xu, YH; Li, JX; Gao, XN; Zhou, MH; Jiang, MM; Gao, L; Ding, Y; Lu, XC; Shi, JL; Luo, XF; Wang, J; Wang, LL; Qu, CF; Bai, XF; Yu, L				Wang, Li-Xin; Mei, Zhen-Yang; Zhou, Ji-Hao; Yao, Yu-Shi; Li, Yong-Hui; Xu, Yi-Han; Li, Jing-Xin; Gao, Xiao-Ning; Zhou, Min-Hang; Jiang, Meng-Meng; Gao, Li; Ding, Yi; Lu, Xue-Chun; Shi, Jin-Long; Luo, Xu-Feng; Wang, Jia; Wang, Li-Li; Qu, Chunfeng; Bai, Xue-Feng; Yu, Li			Low Dose Decitabine Treatment Induces CD80 Expression in Cancer Cells and Stimulates Tumor Specific Cytotoxic T Lymphocyte Responses	PLOS ONE			English	Article							CLASS-I ANTIGENS; MHC CLASS-I; UP-REGULATION; TESTIS ANTIGENS; 5-AZA-2'-DEOXYCYTIDINE; MELANOMA; COSTIMULATION; MOLECULES; INDUCTION; REJECTION	Lack of immunogenicity of cancer cells has been considered a major reason for their failure in induction of a tumor specific T cell response. In this paper, we present evidence that decitabine (DAC), a DNA methylation inhibitor that is currently used for the treatment of myelodysplastic syndrome (MDS), acute myeloid leukemia (AML) and other malignant neoplasms, is capable of eliciting an anti-tumor cytotoxic T lymphocyte (CTL) response in mouse EL4 tumor model. C57BL/6 mice with established EL4 tumors were treated with DAC (1.0 mg/kg body weight) once daily for 5 days. We found that DAC treatment resulted in infiltration of IFN-gamma producing T lymphocytes into tumors and caused tumor rejection. Depletion of CD8(+), but not CD4(+) T cells resumed tumor growth. DAC-induced CTL response appeared to be elicited by the induction of CD80 expression on tumor cells. Epigenetic evidence suggests that DAC induces CD80 expression in EL4 cells via demethylation of CpG dinucleotide sites in the promoter of CD80 gene. In addition, we also showed that a transient, low-dose DAC treatment can induce CD80 gene expression in a variety of human cancer cells. This study provides the first evidence that epigenetic modulation can induce the expression of a major T cell co-stimulatory molecule on cancer cells, which can overcome immune tolerance, and induce an efficient anti-tumor CTL response. The results have important implications in designing DAC-based cancer immunotherapy.	[Wang, Li-Xin; Mei, Zhen-Yang; Zhou, Ji-Hao; Yao, Yu-Shi; Li, Yong-Hui; Xu, Yi-Han; Li, Jing-Xin; Gao, Xiao-Ning; Zhou, Min-Hang; Jiang, Meng-Meng; Gao, Li; Ding, Yi; Lu, Xue-Chun; Shi, Jin-Long; Luo, Xu-Feng; Wang, Jia; Wang, Li-Li; Yu, Li] Chinese Peoples Liberat Army Gen Hosp, Dept Hematol, Beijing, Peoples R China; [Wang, Li-Xin] Navy Gen Hosp, Dept Hematol, Beijing, Peoples R China; [Wang, Li-Xin; Bai, Xue-Feng] Ohio State Univ, Med Ctr, Dept Pathol, Columbus, OH 43210 USA; [Wang, Li-Xin; Bai, Xue-Feng] Ohio State Univ, Med Ctr, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Qu, Chunfeng] Chinese Acad Med Sci, State Key Lab Mol Oncol, Canc Inst Hosp, Beijing 100730, Peoples R China	Chinese People's Liberation Army General Hospital; Sixth Medical Center of Chinese PLA General Hospital; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS	Bai, XF (corresponding author), Ohio State Univ, Med Ctr, Dept Pathol, Columbus, OH 43210 USA.	Xue-Feng.Bai@osumc.edu; chunhuiliyu@yahoo.com	Bai, Xue-Feng/H-5164-2013; wang, lili/HDL-7210-2022; Bai, Xue-feng/E-2681-2011	Bai, Xue-Feng/0000-0001-9476-8376; Yu, Li/0000-0001-6872-2665	National Basic Research Program of China [2005CB522400]; National Natural Science Foundation of China [90919044, 30971297, 81000221, 81170518]; High and New Technology Program of PLA [2010gxjs091]; Capital Medical Development Scientific Research Fund [2007-2040]; NATIONAL CANCER INSTITUTE [R01CA138427] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); High and New Technology Program of PLA; Capital Medical Development Scientific Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Basic Research Program of China (2005CB522400), National Natural Science Foundation of China (90919044, 30971297, 81000221, and 81170518), High and New Technology Program of PLA (2010gxjs091), Capital Medical Development Scientific Research Fund (No. 2007-2040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai XF, 2001, CANCER RES, V61, P6860; Bai XF, 2001, J IMMUNOL, V167, P3936, DOI 10.4049/jimmunol.167.7.3936; Blum W, 2007, J CLIN ONCOL, V25, P3884, DOI 10.1200/JCO.2006.09.4169; Calabro L, 2005, J CELL PHYSIOL, V202, P474, DOI 10.1002/jcp.20133; Cashen AF, 2010, J CLIN ONCOL, V28, P556, DOI 10.1200/JCO.2009.23.9178; CHEN LP, 1992, CELL, V71, P1093, DOI 10.1016/S0092-8674(05)80059-5; Coral S, 1999, J IMMUNOTHER, V22, P16, DOI 10.1097/00002371-199901000-00003; Coral S, 2002, CLIN CANCER RES, V8, P2690; Dubovsky JA, 2009, CLIN CANCER RES, V15, P3406, DOI 10.1158/1078-0432.CCR-08-2099; Fonsatti E, 2007, CLIN CANCER RES, V13, P3333, DOI 10.1158/1078-0432.CCR-06-3091; Gollob JA, 2007, CLIN CANCER RES, V13, P5219, DOI 10.1158/1078-0432.CCR-07-0816; Guo ZS, 2006, CANCER RES, V66, P1105, DOI 10.1158/0008-5472.CAN-05-3020; Issa JPJ, 2004, BLOOD, V103, P1635, DOI 10.1182/blood-2003-03-0687; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; Juergens RA, 2011, CANCER DISCOV, V1, P598, DOI 10.1158/2159-8290.CD-11-0214; Kantarjian H, 2006, CANCER-AM CANCER SOC, V106, P1794, DOI 10.1002/cncr.21792; Konkankit VV, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-192; Maeda T, 2000, BLOOD, V96, P3847, DOI 10.1182/blood.V96.12.3847.h8003847_3847_3856; Magner WJ, 2000, J IMMUNOL, V165, P7017, DOI 10.4049/jimmunol.165.12.7017; Mapara MY, 2004, J CLIN ONCOL, V22, P1136, DOI 10.1200/JCO.2004.10.041; Odobasic D, 2008, IMMUNOLOGY, V124, P503, DOI 10.1111/j.1365-2567.2007.02802.x; Oki Y, 2008, BLOOD, V111, P2382, DOI 10.1182/blood-2007-07-103960; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; RAMARATHINAM L, 1994, J EXP MED, V179, P1205, DOI 10.1084/jem.179.4.1205; REITER H, 1979, CANCER RES, V39, P4856; Seliger B, 1997, IMMUNOL TODAY, V18, P292, DOI 10.1016/S0167-5699(97)01052-9; Serrano A, 2001, INT J CANCER, V94, P243, DOI 10.1002/ijc.1452; Sigalotti L, 2005, SEMIN ONCOL, V32, P473, DOI 10.1053/j.seminoncol.2005.07.005; Silverman LR, 2002, J CLIN ONCOL, V20, P2429, DOI 10.1200/JCO.2002.04.117; Thurner B, 1999, J EXP MED, V190, P1669, DOI 10.1084/jem.190.11.1669; TOWNSEND SE, 1993, SCIENCE, V259, P368, DOI 10.1126/science.7678351; Tsai HC, 2012, CANCER CELL, V21, P430, DOI 10.1016/j.ccr.2011.12.029; UYTTENHOVE C, 1983, J EXP MED, V157, P1040, DOI 10.1084/jem.157.3.1040; Wang LX, 2012, SCAND J IMMUNOL, V75, P273, DOI 10.1111/j.1365-3083.2011.02662.x; WEBER J, 1994, CANCER RES, V54, P1766; WU TC, 1995, J EXP MED, V182, P1415, DOI 10.1084/jem.182.5.1415; Yee C, 2002, P NATL ACAD SCI USA, V99, P16168, DOI 10.1073/pnas.242600099; Zheng P, 1998, NATURE, V396, P373, DOI 10.1038/24628; Zou WP, 2008, NAT REV IMMUNOL, V8, P467, DOI 10.1038/nri2326; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	40	86	96	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e62924	10.1371/journal.pone.0062924	http://dx.doi.org/10.1371/journal.pone.0062924			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671644	Green Submitted, Green Published, gold			2022-12-25	WOS:000319737700028
J	Hashimoto, Y; Akiyama, Y; Yuasa, Y				Hashimoto, Yutaka; Akiyama, Yoshimitsu; Yuasa, Yasuhito			Multiple-to-Multiple Relationships between MicroRNAs and Target Genes in Gastric Cancer	PLOS ONE			English	Article							COLORECTAL-CANCER; SCIRRHOUS CARCINOMA; CELLS; PROLIFERATION; DIFFERENTIATION; CARCINOGENESIS; ESTABLISHMENT; METHYLATION; EXPRESSION; INHIBITORS	MicroRNAs (miRNAs) act as transcriptional regulators and play pivotal roles in carcinogenesis. According to miRNA target databases, one miRNA may regulate many genes as its targets, while one gene may be targeted by many miRNAs. These findings indicate that relationships between miRNAs and their targets may not be one-to-one. However, many reports have described only a one-to-one, one-to-multiple or multiple-to-one relationship between miRNA and its target gene in human cancers. Thus, it is necessary to determine whether or not a combination of some miRNAs would regulate multiple targets and be involved in carcinogenesis. To find some groups of miRNAs that may synergistically regulate their targets in human gastric cancer (GC), we re-analyzed our previous miRNA expression array data and found that 50 miRNAs were up-regulated on treatment with 5-aza-2'-deoxycytidine in a GC cell line. The "TargetScan'' miRNA target database predicted that some of these miRNAs have common target genes. We also referred to the GEO database for expression of these common target genes in human GCs, which might be related to gastric carcinogenesis. In this study, we analyzed two miRNA combinations, miR-224 and -452, and miR-181c and -340. Over-expression of both miRNA combinations dramatically down-regulated their target genes, DPYSL2 and KRAS, and KRAS and MECP2, respectively. These miRNA combinations synergistically decreased cell proliferation upon transfection. Furthermore, we revealed that these miRNAs were down-regulated through promoter hypermethylation in GC cells. Thus, it is likely that the relationships between miRNAs and their targets are not one-to-one but multiple-to-multiple in GCs, and that these complex relationships may be related to gastric carcinogenesis.	[Hashimoto, Yutaka; Akiyama, Yoshimitsu; Yuasa, Yasuhito] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Mol Oncol, Tokyo, Japan	Tokyo Medical & Dental University (TMDU)	Yuasa, Y (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Mol Oncol, Tokyo, Japan.	yuasa.monc@tmd.ac.jp	Hashimoto, Yutaka/B-9821-2017	Hashimoto, Yutaka/0000-0003-2188-2957	Japan Society for the Promotion of Science (JSPS)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by grants from the A3 Foresight Program of the Japan Society for the Promotion of Science (JSPS) (YY), and Research Fellowships of the JSPS for Young Scientists (YH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Cheung HH, 2011, ONCOGENE, V30, P3404, DOI 10.1038/onc.2011.60; Creighton CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034546; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Gokhale A, 2010, J CANCER RES THER, V6, P521, DOI 10.4103/0973-1482.77072; Grady WM, 2008, ONCOGENE, V27, P3880, DOI 10.1038/onc.2008.10; Hashimoto Y, 2010, CARCINOGENESIS, V31, P777, DOI 10.1093/carcin/bgq013; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Jimeno A, 2009, J CLIN ONCOL, V27, P1130, DOI 10.1200/JCO.2008.19.8168; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; Mavrakis KJ, 2011, NAT GENET, V43, P673, DOI 10.1038/ng.858; Mencia N, 2011, BIOCHEM PHARMACOL, V82, P1572, DOI 10.1016/j.bcp.2011.08.009; Merritt WM, 2010, CANCER RES, V70, P2571, DOI 10.1158/0008-5472.CAN-09-2536; Ooi CH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002415; Shimada S, 2012, GUT, V61, P344, DOI 10.1136/gutjnl-2011-300050; Tahimic CGT, 2006, BIOCHEM BIOPH RES CO, V340, P1244, DOI 10.1016/j.bbrc.2005.12.132; Toyota M, 2008, CANCER RES, V68, P4123, DOI 10.1158/0008-5472.CAN-08-0325; Wang Y, 2008, J BIOL CHEM, V283, P13205, DOI 10.1074/jbc.M707629200; Wen XZ, 2004, BIOCHEM BIOPH RES CO, V316, P100, DOI 10.1016/j.bbrc.2004.02.016; White NMA, 2010, BRIT J CANCER, V102, P1244, DOI 10.1038/sj.bjc.6605634; Yanagihara K, 2004, CANCER SCI, V95, P575, DOI 10.1111/j.1349-7006.2004.tb02489.x; YANAGIHARA K, 1993, INT J CANCER, V54, P200, DOI 10.1002/ijc.2910540207; Yuasa Y, 2003, NAT REV CANCER, V3, P592, DOI 10.1038/nrc1141	26	166	170	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62589	10.1371/journal.pone.0062589	http://dx.doi.org/10.1371/journal.pone.0062589			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667495	gold, Green Submitted, Green Published			2022-12-25	WOS:000319055600030
J	Ng, SSM; Li, A; Pavlakis, GN; Ozato, K; Kino, T				Ng, Sinnie Sin Man; Li, Andrew; Pavlakis, George N.; Ozato, Keiko; Kino, Tomoshige			Viral Infection Increases Glucocorticoid-Induced Interleukin-10 Production through ERK-Mediated Phosphorylation of the Glucocorticoid Receptor in Dendritic Cells: Potential Clinical Implications	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; DOUBLE-STRANDED-RNA; STRESS HORMONES; GENE-EXPRESSION; INNATE IMMUNITY; IL-10 GENE; IN-VIVO; INDUCTION; RESPONSES; INFLAMMATION	The hypothalamic-pituitary-adrenal axis plays a central role in the adaptive response to stress including infection of pathogens through glucocorticoids. Physical and/or mental stress alter susceptibility to viral infection possibly by affecting this regulatory system, thus we explored potential cellular targets and mechanisms that underlie this phenomenon in key immune components dendritic cells (DCs). Dexamethasone (DEX) treatment and subsequent Newcastle disease virus (NDV) infection most significantly and cooperatively stimulated mRNA expression of the interleukin (IL)-10 in murine bone marrow-derived DCs among 89 genes involved in the Toll-like receptor signaling pathways. NDV increased DEX-induced IL-10 mRNA and protein expression by 7- and 3-fold, respectively, which was observed from 3 hours after infection. Conventional DCs (cDCs), but not plasmacytoid DCs (pDCs) were major sources of IL-10 in bone marrow-derived DCs treated with DEX and/or infected with NDV. Murine cytomegalovirus and DEX increased serum IL-10 cooperatively in female mice. Pre-treatment of DCs with the extracellular signal-regulated kinase (ERK) inhibitor U0126 abolished cooperative induction of IL-10 by DEX and NDV. Further, ERK overexpression increased IL-10 promoter activity stimulated by wild-type human GR but not by its mutant defective in serine 203, whereas ERK knockdown abolished NDV/DEX cooperation on IL-10 mRNA and phosphorylation of the mouse GR at serine 213. NDV also increased DEX-induced mRNA expression of three known glucocorticoid-responsive genes unrelated to the Toll-like receptor signaling pathways in DCs. These results indicate that virus and glucocorticoids cooperatively increase production of anti-inflammatory cytokine IL-10 by potentiating the transcriptional activity of GR in DCs, through which virus appears to facilitate its own propagation in infected hosts. The results may further underlie in part known exacerbation of IL-10/T helper-2-related allergic disorders by stress and viral infection.	[Ng, Sinnie Sin Man; Li, Andrew; Kino, Tomoshige] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Unit Mol Hormone Act, Program Reprod & Adult Endocrinol, NIH, Bethesda, MD USA; [Ng, Sinnie Sin Man] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China; [Ng, Sinnie Sin Man; Pavlakis, George N.] NCI, Human Retrovirus Pathogenesis Sect, Vaccine Branch, Ctr Canc Res, Frederick, MD 21701 USA; [Ozato, Keiko] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Lab Mol Growth & Regulat, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Chinese University of Hong Kong; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Kino, T (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Unit Mol Hormone Act, Program Reprod & Adult Endocrinol, NIH, Bethesda, MD USA.	kinot@mail.nih.gov			Eunice Kennedy Shriver National Institute of Child Health, Bethesda, MD; National Cancer Institute, Frederick, MD; National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008732, ZIAHD001310, ZIAHD000615] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIABC010749, ZIABC010750] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health, Bethesda, MD; National Cancer Institute, Frederick, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by the intramural research program of the Eunice Kennedy Shriver National Institute of Child Health, Bethesda, MD, and the National Cancer Institute, Frederick, MD, the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal SK, 1998, J INTERF CYTOK RES, V18, P1059, DOI 10.1089/jir.1998.18.1059; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Boonstra A, 2006, J IMMUNOL, V177, P7551, DOI 10.4049/jimmunol.177.11.7551; BOUMPAS DT, 1993, ANN INTERN MED, V119, P1198, DOI 10.7326/0003-4819-119-12-199312150-00007; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Busse WW, 2010, LANCET, V376, P826, DOI 10.1016/S0140-6736(10)61380-3; Chrousos GP, 2009, ANN NY ACAD SCI, V1179, P153, DOI 10.1111/j.1749-6632.2009.04988.x; Chrousos GP, 2005, J INFECT DIS, V192, P551, DOI 10.1086/432135; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Dillon S, 2004, J IMMUNOL, V172, P4733, DOI 10.4049/jimmunol.172.8.4733; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; Elenkov IJ, 1999, TRENDS ENDOCRIN MET, V10, P359, DOI 10.1016/S1043-2760(99)00188-5; Elenkov IJ, 2004, ANN NY ACAD SCI, V1024, P138, DOI 10.1196/annals.1321.010; Godbout JP, 2006, J NEUROIMMUNE PHARM, V1, P421, DOI 10.1007/s11481-006-9036-0; Goldsmith M, 2009, MOL IMMUNOL, V46, P1979, DOI 10.1016/j.molimm.2009.03.009; Hinzey A, 2011, ENDOCRINOLOGY, V152, P483, DOI 10.1210/en.2010-0774; Honda K, 2003, P NATL ACAD SCI USA, V100, P10872, DOI 10.1073/pnas.1934678100; Honer C, 2003, MOL PHARMACOL, V63, P1012, DOI 10.1124/mol.63.5.1012; Jung ID, 2010, INT IMMUNOPHARMACOL, V10, P760, DOI 10.1016/j.intimp.2010.04.006; Kino T, 2007, HORM METAB RES, V39, P420, DOI 10.1055/s-2007-980193; Kino T, 2007, MOL ENDOCRINOL, V21, P1552, DOI 10.1210/me.2006-0345; Kino T, 2007, TRENDS ENDOCRIN MET, V18, P159, DOI 10.1016/j.tem.2007.03.003; Lu NZ, 2006, PHARMACOL REV, V58, P782, DOI 10.1124/pr.58.4.9; Luft T, 2002, BLOOD, V100, P1362, DOI 10.1182/blood-2001-12-0360; Maggi LB, 2003, J BIOL CHEM, V278, P16683, DOI 10.1074/jbc.M211744200; Mallia P, 2006, CHEST, V130, P1203, DOI 10.1378/chest.130.4.1203; Marshall GD, 2000, ALLERGY ASTHMA PROC, V21, P241, DOI 10.2500/108854100778248917; Medzhitov R, 2010, CELL, V140, P771, DOI 10.1016/j.cell.2010.03.006; Mege JL, 2006, LANCET INFECT DIS, V6, P557, DOI 10.1016/S1473-3099(06)70577-1; Menconi M, 2008, J CELL BIOCHEM, V105, P353, DOI 10.1002/jcb.21833; Monick MM, 2005, J BIOL CHEM, V280, P2147, DOI 10.1074/jbc.M408745200; Monick MM, 2001, J IMMUNOL, V166, P2681, DOI 10.4049/jimmunol.166.4.2681; Morelli AE, 2003, TRENDS IMMUNOL, V24, P108, DOI 10.1016/S1471-4906(03)00023-1; Murray PJ, 2006, CURR OPIN PHARMACOL, V6, P379, DOI 10.1016/j.coph.2006.01.010; Nader N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0026751; Nader N, 2010, MOL ENDOCRINOL, V24, P1748, DOI 10.1210/me.2010-0192; Park JM, 2005, IMMUNITY, V23, P319, DOI 10.1016/j.immuni.2005.08.010; Redpath S, 1999, J IMMUNOL, V162, P6701; Rosenkranz MA, 2005, P NATL ACAD SCI USA, V102, P13319, DOI 10.1073/pnas.0504365102; Sacher T, 2012, EUR J CELL BIOL, V91, P70, DOI 10.1016/j.ejcb.2011.02.002; Samarasinghe R, 2006, J INTERF CYTOK RES, V26, P893, DOI 10.1089/jir.2006.26.893; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Smit JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001720; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Tailor P, 2007, IMMUNITY, V27, P228, DOI 10.1016/j.immuni.2007.06.009; Takayama T, 2001, TRANSPLANTATION, V71, P1334, DOI 10.1097/00007890-200105150-00027; Tamassia N, 2008, J IMMUNOL, V181, P6563, DOI 10.4049/jimmunol.181.9.6563; Tarrega C, 2005, J BIOL CHEM, V280, P37885, DOI 10.1074/jbc.M504366200; Tone M, 2000, J IMMUNOL, V165, P286, DOI 10.4049/jimmunol.165.1.286; Unterberger C, 2008, MOL IMMUNOL, V45, P3230, DOI 10.1016/j.molimm.2008.02.020; Xiang LB, 2011, NEUROIMMUNOMODULAT, V18, P1, DOI 10.1159/000311450; Xu YK, 2007, J IMMUNOL, V179, P7577, DOI 10.4049/jimmunol.179.11.7577; Yoneyama M, 2007, J BIOL CHEM, V282, P15315, DOI 10.1074/jbc.R700007200	55	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63587	10.1371/journal.pone.0063587	http://dx.doi.org/10.1371/journal.pone.0063587			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667643	Green Submitted, Green Published, gold			2022-12-25	WOS:000319055600065
J	El Bakkali, A; Haouane, H; Moukhli, A; Costes, E; Van Damme, P; Khadari, B				El Bakkali, Ahmed; Haouane, Hicham; Moukhli, Abdelmajid; Costes, Evelyne; Van Damme, Patrick; Khadari, Bouchaib			Construction of Core Collections Suitable for Association Mapping to Optimize Use of Mediterranean Olive (Olea europaea L.) Genetic Resources	PLOS ONE			English	Article							SIMPLE SEQUENCE REPEAT; LINKAGE DISEQUILIBRIUM; POPULATION-STRUCTURE; SAMPLING STRATEGIES; GENOMIC SELECTION; CANDIDATE GENES; DIVERSITY; MARKERS; CULTIVARS; ALGORITHM	Phenotypic characterisation of germplasm collections is a decisive step towards association mapping analyses, but it is particularly expensive and tedious for woody perennial plant species. Characterisation could be more efficient if focused on a reasonably sized subset of accessions, or so-called core collection (CC), reflecting the geographic origin and variability of the germplasm. The questions that arise concern the sample size to use and genetic parameters that should be optimized in a core collection to make it suitable for association mapping. Here we investigated these questions in olive (Olea europaea L.), a perennial fruit species. By testing different sampling methods and sizes in a worldwide olive germplasm bank (OWGB Marrakech, Morocco) containing 502 unique genotypes characterized by nuclear and plastid loci, a two-step sampling method was proposed. The Shannon- Weaver diversity index was found to be the best criterion to be maximized in the first step using the CORE HUNTER program. A primary core collection of 50 entries (CC50)was defined that captured more than 80% of the diversity. This latter was subsequently used as a kernel with the MSTRAT program to capture the remaining diversity. 200 core collections of 94 entries (CC94) were thus built for flexibility in the choice of varieties to be studied. Most entries of both core collections (CC50 and CC94) were revealed to be unrelated due to the low kinship coefficient, whereas a genetic structure spanning the eastern and western/central Mediterranean regions was noted. Linkage disequilibrium was observed in CC94 which was mainly explained by a genetic structure effect as noted for OWGB Marrakech. Since they reflect the geographic origin and diversity of olive germplasm and are of reasonable size, both core collections will be of major interest to develop long-term association studies and thus enhance genomic selection in olive species.	[El Bakkali, Ahmed; Haouane, Hicham; Costes, Evelyne; Khadari, Bouchaib] INRA, UMR Ameliorat Genet & Adaptat Plantes AGAP, F-34060 Montpellier, France; [El Bakkali, Ahmed; Haouane, Hicham] Montpellier SupAgro, UMR AGAP, Montpellier, France; [El Bakkali, Ahmed] INRA Meknes, UR Ameliorat Plantes & Conservat Ressources Phyto, Meknes, Morocco; [El Bakkali, Ahmed; Van Damme, Patrick] Univ Ghent, Dept Plant Prod, B-9000 Ghent, Belgium; [Moukhli, Abdelmajid] INRA Marrakech, UR Ameliorat Plantes, Marrakech, Morocco; [Van Damme, Patrick] Czech Univ Life Sci Prague, Inst Trop & Subtrop, Prague, Czech Republic; [Khadari, Bouchaib] Conservatoire Bot Natl Mediterraneen, UMR AGAP, Montpellier, France	INRAE; Institut Agro; Montpellier SupAgro; Universite de Montpellier; Moulay Ismail University of Meknes; Ghent University; Czech University of Life Sciences Prague; Universite de Montpellier	Khadari, B (corresponding author), INRA, UMR Ameliorat Genet & Adaptat Plantes AGAP, F-34060 Montpellier, France.	khadari@supagro.inra.fr	, Patrick/AAI-8779-2020; Khadari, Bouchaib/K-7965-2015; Van Damme, Patrick/H-6693-2018	Van Damme, Patrick/0000-0002-2548-633X; Moukhli, Abdelmajid/0000-0001-5933-7167; Ahmed, El Bakkali/0000-0002-2936-8197	Merit Scholarship Program for High Technology of the Islamic Development Bank (IDB) [1430H/2009]; Agropolis Foundation FruitMed [0901-007]	Merit Scholarship Program for High Technology of the Islamic Development Bank (IDB); Agropolis Foundation FruitMed	This study was supported by the Merit Scholarship Program for High Technology 1430H/2009 of the Islamic Development Bank (IDB) and by Agropolis Foundation FruitMed No 0901-007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdurakhmonov Ibrokhim Y, 2008, Int J Plant Genomics, V2008, P574927, DOI 10.1155/2008/574927; Agrama HA, 2007, MOL BREEDING, V19, P341, DOI 10.1007/s11032-006-9066-6; Angiolillo A, 1999, THEOR APPL GENET, V98, P411, DOI 10.1007/s001220051087; Antunes AFS, 1999, ACTA HORTIC, P103, DOI 10.17660/ActaHortic.1999.474.17; Aranzana MJ, 2005, PLOS GENET, V1, P531, DOI 10.1371/journal.pgen.0010060; Arunyawat U, 2012, TREE GENET GENOMES, V8, P737, DOI 10.1007/s11295-011-0460-9; Baldoni L, 2009, MOL BREEDING, V24, P213, DOI 10.1007/s11032-009-9285-8; Balfourier F, 2007, THEOR APPL GENET, V114, P1265, DOI 10.1007/s00122-007-0517-1; Barnaud A, 2006, THEOR APPL GENET, V112, P708, DOI 10.1007/s00122-005-0174-1; Bartolini G, 1999, ACTA HORTIC, P159, DOI 10.17660/ActaHortic.1999.474.30; Bartolini G, 2002, CLASSIFICATION ORIGI, P85; Bartolini G., 1998, OLIVE GERMPLASM CULT; Bartolini G., 2005, OLIVE GERMPLASM CULT; Bartolini G, 2008, OLIVE GERMPLASM OLEA; Belaj A, 2012, TREE GENET GENOMES, V8, P365, DOI 10.1007/s11295-011-0447-6; Bellini E., 2008, Advances in Horticultural Science, V22, P73; Ben Sadok I, 2013, TREE GENET GENOMES, V9, P205, DOI 10.1007/s11295-012-0548-x; Besnard G, 2001, GENET SEL EVOL, V33, pS251, DOI 10.1186/BF03500883; Besnard G, 2001, J AM SOC HORTIC SCI, V126, P668, DOI 10.21273/JASHS.126.6.668; Besnard G, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-80; Blair MW, 2009, THEOR APPL GENET, V119, P955, DOI 10.1007/s00122-009-1064-8; Brachi B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000940; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; BROWN AHD, 1989, GENOME, V31, P818, DOI 10.1139/g89-144; Cao K, 2012, TREE GENET GENOMES, V8, P975, DOI 10.1007/s11295-012-0477-8; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Collard BCY, 2005, EUPHYTICA, V142, P169, DOI 10.1007/s10681-005-1681-5; Borba TCD, 2010, GENET MOL BIOL, V33, P515, DOI 10.1590/S1415-47572010005000065; Del Carpio DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019624; Diez CM, 2012, CROP SCI, V52, P211, DOI 10.2135/cropsci2011.02.0110; Ehrenreich IM, 2007, GENETICS, V176, P1223, DOI 10.1534/genetics.107.071928; El Aabidine AZ, 2010, CROP SCI, V50, P2291, DOI 10.2135/cropsci2009.10.0632; Escribano P, 2008, ANN APPL BIOL, V153, P25, DOI 10.1111/j.1744-7348.2008.00232.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Feng JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006121; Franco J, 2006, CROP SCI, V46, P854, DOI 10.2135/cropsci2005.07-0201; Franco J, 2005, CROP SCI, V45, P1035, DOI 10.2135/cropsci2004.0292; Frankel O.H., 1984, CROP GENETIC RESOURC, P249; Gonzalez-Martinez SC, 2006, GENETICS, V172, P1915, DOI 10.1534/genetics.105.047126; Gouesnard B, 2001, J HERED, V92, P93, DOI 10.1093/jhered/92.1.93; Grenier C, 2000, THEOR APPL GENET, V101, P190, DOI 10.1007/s001220051468; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Haouane H, 2011, GENETICA, V139, P1083, DOI 10.1007/s10709-011-9608-7; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Heffner EL, 2009, CROP SCI, V49, P1, DOI 10.2135/cropsci2008.08.0512; Hu J, 2000, THEOR APPL GENET, V101, P264, DOI 10.1007/s001220051478; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jannink JL, 2010, BRIEF FUNCT GENOMICS, V9, P166, DOI 10.1093/bfgp/elq001; Jestin C, 2011, MOL BREEDING, V27, P271, DOI 10.1007/s11032-010-9429-x; Aranzana MJ, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-69; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Khadari B, 2003, THEOR APPL GENET, V106, P521, DOI 10.1007/s00122-002-1079-x; Khadari B, 2010, J AM SOC HORTIC SCI, V135, P548, DOI 10.21273/JASHS.135.6.548; Laucou V, 2011, THEOR APPL GENET, V122, P1233, DOI 10.1007/s00122-010-1527-y; Le Cunff L, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-31; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Mackay I, 2007, TRENDS PLANT SCI, V12, P57, DOI 10.1016/j.tplants.2006.12.001; Malosetti M, 2007, GENETICS, V175, P879, DOI 10.1534/genetics.105.054932; Marita JM, 2000, GENET RESOUR CROP EV, V47, P515, DOI 10.1023/A:1008784610962; McKhann HI, 2004, PLANT J, V38, P193, DOI 10.1111/j.1365-313X.2004.02034.x; Mendil M., 2006, CATALOGUE VARIETES A; Mezmouk S, 2011, THEOR APPL GENET, V122, P1149, DOI 10.1007/s00122-010-1519-y; Miranda C, 2010, J AM SOC HORTIC SCI, V135, P428, DOI 10.21273/JASHS.135.5.428; Moutier N, 2004, IDENTIFICATION CARAC, V1; Myles S, 2009, PLANT CELL, V21, P2194, DOI 10.1105/tpc.109.068437; Nei M., 1987, MOL EVOLUTIONARY GEN; Padula G., 2008, Advances in Horticultural Science, V22, P87; Perrier X., 2003, GENETIC DIVERSITY CU, P43; Pessoa-Filho M, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-127; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Pritsa T, 1999, ACTA HORTIC, P117, DOI 10.17660/ActaHortic.1999.474.20; Rafalski JA, 2010, CURR OPIN PLANT BIOL, V13, P174, DOI 10.1016/j.pbi.2009.12.004; Reale S, 2006, GENOME, V49, P1193, DOI 10.1139/G06-068; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Richards CM, 2009, J AM SOC HORTIC SCI, V134, P228, DOI 10.21273/JASHS.134.2.228; Ripa V., 2008, Advances in Horticultural Science, V22, P95; Rosati A, 2010, SCI HORTIC-AMSTERDAM, V126, P200, DOI 10.1016/j.scienta.2010.07.010; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sarri V, 2006, GENOME, V49, P1606, DOI 10.1139/G06-126; SCHOEN DJ, 1993, P NATL ACAD SCI USA, V90, P10623, DOI 10.1073/pnas.90.22.10623; Shannon C., 1964, MATH THEORY COMMUNIC; Skot L, 2007, GENETICS, V177, P535, DOI 10.1534/genetics.107.071522; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Thachuk C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-243; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; Thumma BR, 2005, GENETICS, V171, P1257, DOI 10.1534/genetics.105.042028; Trigui A, 2002, OLIVIERS TUNISIE CAT, V1; Van Hintum T. J. L., 2000, IPGRI TECHNICAL B; Varshney RK, 2009, TRENDS BIOTECHNOL, V27, P522, DOI 10.1016/j.tibtech.2009.05.006; Wang YZ, 2011, SCI HORTIC-AMSTERDAM, V128, P311, DOI 10.1016/j.scienta.2011.01.025; Wei XM, 2006, THEOR APPL GENET, V114, P155, DOI 10.1007/s00122-006-0418-8; Weiss KM, 2002, TRENDS GENET, V18, P19, DOI 10.1016/S0168-9525(01)02550-1; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhao WG, 2010, MOL BREEDING, V26, P639, DOI 10.1007/s11032-010-9400-x; Zohary D, 2000, DOMESTICATION PLANTS, DOI DOI 10.1006/ANBO.2001.1505	98	58	59	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e61265	10.1371/journal.pone.0061265	http://dx.doi.org/10.1371/journal.pone.0061265			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667437	Green Submitted, Green Published, gold			2022-12-25	WOS:000319654700011
J	Lima, FM; Souza, RT; Santori, FR; Santos, MF; Cortez, DR; Barros, RM; Cano, MI; Valadares, HMS; Macedo, AM; Mortara, RA; da Silveira, JF				Lima, Fabio Mitsuo; Souza, Renata Torres; Santori, Fabio Rinaldo; Santos, Michele Fernandes; Cortez, Danielle Rodrigues; Barros, Roberto Moraes; Cano, Maria Isabel; Silva Valadares, Helder Magno; Macedo, Andrea Mara; Mortara, Renato Arruda; da Silveira, Jose Franco			Interclonal Variations in the Molecular Karyotype of Trypanosoma cruzi: Chromosome Rearrangements in a Single Cell-Derived Clone of the G Strain	PLOS ONE			English	Article							POPULATION-STRUCTURE; CHAGAS-DISEASE; SIZE; GENES; DNA; VARIABILITY; TELOMERE; RNA; TRYPOMASTIGOTES; IDENTIFICATION	Trypanosoma cruzi comprises a pool of populations which are genetically diverse in terms of DNA content, growth and infectivity. Inter- and intra-strain karyotype heterogeneities have been reported, suggesting that chromosomal rearrangements occurred during the evolution of this parasite. Clone D11 is a single-cell-derived clone of the T. cruzi G strain selected by the minimal dilution method and by infecting Vero cells with metacyclic trypomastigotes. Here we report that the karyotype of clone D11 differs from that of the G strain in both number and size of chromosomal bands. Large chromosomal rearrangement was observed in the chromosomes carrying the tubulin loci. However, most of the chromosome length polymorphisms were of small amplitude, and the absence of one band in clone D11 in relation to its reference position in the G strain could be correlated to the presence of a novel band migrating above or below this position. Despite the presence of chromosomal polymorphism, large syntenic groups were conserved between the isolates. The appearance of new chromosomal bands in clone D11 could be explained by chromosome fusion followed by a chromosome break or interchromosomal exchange of large DNA segments. Our results also suggest that telomeric regions are involved in this process. The variant represented by clone D11 could have been induced by the stress of the cloning procedure or could, as has been suggested for Leishmania infantum, have emerged from a multiclonal, mosaic parasite population submitted to frequent DNA amplification/deletion events, leading to a 'mosaic' structure with different individuals having differently sized versions of the same chromosomes. If this is the case, the variant represented by clone D11 would be better adapted to survive the stress induced by cloning, which includes intracellular development in the mammalian cell. Karyotype polymorphism could be part of the T. cruzi arsenal for responding to environmental pressure.	[Lima, Fabio Mitsuo; Souza, Renata Torres; Santos, Michele Fernandes; Cortez, Danielle Rodrigues; Barros, Roberto Moraes; Mortara, Renato Arruda; da Silveira, Jose Franco] Univ Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil; [Santori, Fabio Rinaldo] NYU, Sch Med, Ctr Canc, Skirball Inst Biomol Med, New York, NY USA; [Cano, Maria Isabel] Univ Estadual Paulista, Inst Biociencias, Dept Genet, Botucatu, SP, Brazil; [Silva Valadares, Helder Magno; Macedo, Andrea Mara] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Silva Valadares, Helder Magno] Univ Fed Sao Joao del Rey, Divinopolis, MG, Brazil	Universidade Federal de Sao Paulo (UNIFESP); New York University; Universidade Estadual Paulista; Universidade Federal de Minas Gerais; Universidade Federal de Sao Joao del-Rei	da Silveira, JF (corresponding author), Univ Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil.	jose.franco@unifesp.br	Cano, Maria Isabel/M-7691-2019; de Moraes Barros, Roberto Rudge/F-4973-2018; Macedo, Andréa M/C-1506-2013; Cano, Maria Isabel/A-4020-2008; da Silveira, Jose Franco/F-5390-2012; Mortara, Renato A./C-1864-2012; Lima, Fabio Mitsuo/GQH-9488-2022; Santori, Fabio/GRF-1002-2022; Lima, Fabio Mitsuo/AHD-6582-2022; Lima, Fabio M/C-9018-2013	Cano, Maria Isabel/0000-0001-9798-6627; de Moraes Barros, Roberto Rudge/0000-0002-0155-8431; Mortara, Renato A./0000-0002-2311-8349; Lima, Fabio Mitsuo/0000-0002-1953-2950; Lima, Fabio Mitsuo/0000-0002-1953-2950; Lima, Fabio M/0000-0002-1953-2950; Santori, Fabio/0000-0002-0220-8935	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo/FAPESP; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/CNPq; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior/CAPES (Brazil); CAPES-REUNI; FAPESP	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo/FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior/CAPES (Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES-REUNI(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo/FAPESP (www.fapesp.br), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico/CNPq (www.cnpq.br) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior/CAPES (www.capes.gov.br) (Brazil) to JFS. FML and DRC were awarded postdoctoral and doctoral fellowships by CAPES-REUNI and FAPESP, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argueso JL, 2008, P NATL ACAD SCI USA, V105, P11845, DOI 10.1073/pnas.0804529105; Barnabe C, 2000, PARASITOLOGY, V120, P513, DOI 10.1017/S0031182099005661; BASTIEN P, 1990, MOL BIOCHEM PARASIT, V40, P53, DOI 10.1016/0166-6851(90)90079-2; Campos RMF, 1996, MEM I OSWALDO CRUZ, V91, P795, DOI 10.1590/S0074-02761996000600029; CANO MI, 1995, MOL BIOCHEM PARASIT, V71, P273, DOI 10.1016/0166-6851(95)00066-A; COMEAU AM, 1986, MOL BIOCHEM PARASIT, V21, P161, DOI 10.1016/0166-6851(86)90019-8; DEGRAVE W, 1988, MOL BIOCHEM PARASIT, V27, P63, DOI 10.1016/0166-6851(88)90025-4; DVORAK JA, 1982, J PROTOZOOL, V29, P430, DOI 10.1111/j.1550-7408.1982.tb05427.x; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Freitas-Junior LH, 2000, NATURE, V407, P1018, DOI 10.1038/35039531; Freitas-Junior LHG, 1999, NUCLEIC ACIDS RES, V27, P2451, DOI 10.1093/nar/27.12.2451; Frias C, 2012, FRONT BIOSCI-LANDMRK, V17, P2181, DOI 10.2741/4044; Galindo M, 2007, FEBS LETT, V581, P2022, DOI 10.1016/j.febslet.2007.03.093; HENRIKSSON J, 1990, MOL BIOCHEM PARASIT, V42, P213, DOI 10.1016/0166-6851(90)90164-H; Henriksson J, 1996, PARASITOL TODAY, V12, P108, DOI 10.1016/0169-4758(96)80670-3; Henriksson J, 2002, PARASITOLOGY, V124, P277, DOI 10.1017/S0031182001001093; HENRIKSSON J, 1993, EXP PARASITOL, V77, P334, DOI 10.1006/expr.1993.1091; Kim D, 2005, GENE, V346, P153, DOI 10.1016/j.gene.2004.10.014; LANAR DE, 1981, MOL BIOCHEM PARASIT, V3, P327, DOI 10.1016/0166-6851(81)90006-2; LEBLANCQ SM, 1991, NUCLEIC ACIDS RES, V19, P4405, DOI 10.1093/nar/19.16.4405; Lephart PR, 2005, EUKARYOT CELL, V4, P733, DOI 10.1128/EC.4.4.733-741.2005; Lewis MD, 2009, INT J PARASITOL, V39, P1305, DOI 10.1016/j.ijpara.2009.04.001; Lima FM, 2010, NEW BIOTECHNOL, V27, P837, DOI 10.1016/j.nbt.2010.02.003; LIMA MF, 1989, MOL BIOCHEM PARASIT, V33, P159, DOI 10.1016/0166-6851(89)90030-3; Llewellyn MS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000410; MAINGON R, 1988, EUR J BIOCHEM, V171, P285, DOI 10.1111/j.1432-1033.1988.tb13788.x; MCDANIEL JP, 1993, MOL BIOCHEM PARASIT, V57, P213, DOI 10.1016/0166-6851(93)90197-6; Minning TA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-139; Mortara RA, 2005, AN ACAD BRAS CIENC, V77, P77, DOI 10.1590/S0001-37652005000100006; Mortara RA, 1999, MEM I OSWALDO CRUZ, V94, P135, DOI 10.1590/S0074-02761999000700014; MORTARA RA, 1991, EXP PARASITOL, V73, P1, DOI 10.1016/0014-4894(91)90002-E; Oliveira RP, 1998, P NATL ACAD SCI USA, V95, P3776, DOI 10.1073/pnas.95.7.3776; PAGES M, 1989, MOL BIOCHEM PARASIT, V36, P161, DOI 10.1016/0166-6851(89)90188-6; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pedroso A, 2003, MOL BIOCHEM PARASIT, V129, P79, DOI 10.1016/S0166-6851(03)00096-3; PONZI M, 1990, MOL BIOCHEM PARASIT, V41, P73, DOI 10.1016/0166-6851(90)90098-7; ROVAI L, 1992, MOL BIOCHEM PARASIT, V50, P115, DOI 10.1016/0166-6851(92)90249-J; Santori F.R., 1991, CHARACTERIZATION PRO; Valadares HMS, 2008, INT J PARASITOL, V38, P839, DOI 10.1016/j.ijpara.2007.10.017; Souto RP, 1996, MOL BIOCHEM PARASIT, V83, P141, DOI 10.1016/S0166-6851(96)02755-7; Souza RT, 2007, EUKARYOT CELL, V6, P1228, DOI 10.1128/EC.00036-07; Souza RT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023042; Upcroft JA, 2005, EUKARYOT CELL, V4, P484, DOI 10.1128/EC.4.2.484-486.2005; Vargas N, 2004, MOL BIOCHEM PARASIT, V138, P131, DOI 10.1016/j.molbiopara.2004.08.005; Weatherly DB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-255; YOSHIDA N, 1983, INFECT IMMUN, V40, P836, DOI 10.1128/IAI.40.2.836-839.1983; Zingales B, 2012, INFECT GENET EVOL, V12, P240, DOI 10.1016/j.meegid.2011.12.009	47	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63738	10.1371/journal.pone.0063738	http://dx.doi.org/10.1371/journal.pone.0063738			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667668	Green Submitted, gold, Green Published			2022-12-25	WOS:000319654700183
J	Maliwal, BP; Fudala, R; Raut, S; Kokate, R; Sorensen, TJ; Laursen, BW; Gryczynski, Z; Gryczynski, I				Maliwal, Badri P.; Fudala, Rafal; Raut, Sangram; Kokate, Rutika; Sorensen, Thomas J.; Laursen, Bo W.; Gryczynski, Zygmunt; Gryczynski, Ignacy			Long-Lived Bright Red Emitting Azaoxa-Triangulenium Fluorophores	PLOS ONE			English	Article							ORGANIC-DYES; LIPID-MEMBRANES; FLUORESCENT; DIPHENYLHEXATRIENE; DYNAMICS; FLUIDITY; PROBES; ACIDS	The fluorescence lifetimes of most red emitting organic probes are under 4 nanoseconds, which is a limiting factor in studying interactions and conformational dynamics of macromolecules. In addition, the nanosecond background autofluorescence is a significant interference during fluorescence measurements in cellular environment. Therefore, red fluorophores with longer lifetimes will be immensely helpful. Azaoxa-triangulenium fluorophores ADOTA and DAOTA are red emitting small organic molecules with high quantum yield, long fluorescence lifetime and high limiting anisotropy. In aqueous environment, ADOTA and DAOTA absorption and emission maxima are respectively 540 nm and 556 nm, and 556 nm and 589 nm. Their emission extends beyond 700 nm. Both probes have the limiting anisotropy between 0.36-0.38 at their absorption peak. In both protic and aprotic solvents, their lifetimes are around 20 ns, making them among the longest-lived red emitting organic fluorophores. Upon labeling of avidin, streptavidin and immunoglobulin their absorption and fluorescence are red-shifted. Unlike in free form, the protein-conjugated probes have heterogeneous fluorescence decays, with the presence of both significantly quenched and unquenched populations. Despite the presence of significant local motions due to a flexible trimethylene linker, we successfully measured both intermediate nanosecond intra-protein motions and slower rotational correlation times approaching 100 ns. Their long lifetimes are unaffected by the cell membrane (hexadecyl-ADOTA) and the intra-cellular (DAOTA-Arginine) localization. Their long lifetimes also enabled successful time-gating of the cellular autofluorescence resulting in background-free fluorescence lifetime based images. ADOTA and DAOTA retain a long fluorescence lifetime when free, as protein conjugate, in membranes and inside the cell. Our successful measurements of intermediate nanosecond internal motions and long correlations times of large proteins suggest that these probes will be highly useful to study slower intra-molecular motions and interactions among macromolecules. The fluorescence lifetime facilitated gating of cellular nanosecond autofluorescence should be of considerable help in in vitro and in vivo applications.	[Maliwal, Badri P.; Fudala, Rafal; Raut, Sangram; Gryczynski, Ignacy] Univ N Texas, Hlth Sci Ctr, Dept Mol Biol & Immunol, Ctr Commercializat Fluorescence Technol, Ft Worth, TX USA; [Kokate, Rutika] Univ N Texas, Hlth Sci Ctr, Dept Mol Biol & Immunol, Ft Worth, TX USA; [Sorensen, Thomas J.; Laursen, Bo W.] Univ Copenhagen, Nanosci Ctr, Copenhagen, Denmark; [Sorensen, Thomas J.; Laursen, Bo W.] Univ Copenhagen, Dept Chem, Copenhagen, Denmark; [Gryczynski, Zygmunt] Texas Christian Univ, Dept Phys, Ft Worth, TX 76129 USA; [Gryczynski, Zygmunt] Texas Christian Univ, Dept Astron, Ft Worth, TX 76129 USA; [Gryczynski, Ignacy] Univ N Texas, Hlth Sci Ctr, Dept Cell Biol & Anat, Ft Worth, TX USA	University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center; University of Copenhagen; University of Copenhagen; Texas Christian University; Texas Christian University; University of North Texas System; University of North Texas Health Science Center	Maliwal, BP (corresponding author), Univ N Texas, Hlth Sci Ctr, Dept Mol Biol & Immunol, Ctr Commercializat Fluorescence Technol, Ft Worth, TX USA.	bpmal001@gmail.com; Ignacy.Gryczynski@unthsc.edu	Laursen, Bo/B-4453-2015; Raut, Sangram/P-6921-2014; Sørensen, Thomas Just/C-2521-2013; Raut, Sangram/I-9788-2019	Laursen, Bo/0000-0002-1120-3191; Sørensen, Thomas Just/0000-0003-1491-5116; Raut, Sangram/0000-0002-1219-3968	National Institutes of Health [R01EB12003-01]; Danish Council for Independent Research, Technology and Production Sciences [10-093546]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB012003] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Council for Independent Research, Technology and Production Sciences(Det Frie Forskningsrad (DFF)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by National Institutes of Health grants R01EB12003-01 (ZG) (http://nih.gov/) and the Danish Council for Independent Research, Technology and Production Sciences (http://fivu.dk) grant 10-093546 (TJS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilefu S, 2010, CHEM REV, V110, P2575, DOI 10.1021/cr1001113; [Anonymous], 2010, MOL PROBES HDB GUIDE, P11; BENNETT WS, 1984, CRC CR REV BIOCH MOL, V15, P291, DOI 10.3109/10409238409117796; Berlman I. B., 1971, HDB FLUORESCENCE SPE; BEST L, 1987, EUR BIOPHYS J BIOPHY, V15, P87, DOI 10.1007/BF00257502; Brand L, 2008, METHOD ENZYMOL, V450, P1; Bunzli JCG, 2010, CHEM REV, V110, P2729, DOI 10.1021/cr900362e; Chen HM, 2010, J AM CHEM SOC, V132, P7244, DOI 10.1021/ja100500k; DALE RE, 1977, J BIOL CHEM, V252, P7500; Dileesh S, 2004, J PHOTOCH PHOTOBIO A, V162, P115, DOI 10.1016/S1010-6030(03)00318-6; Doose S, 2005, CHEMPHYSCHEM, V6, P2277, DOI 10.1002/cphc.200500191; Germain RN, 2012, SCIENCE, V336, P1676, DOI 10.1126/science.1221063; GERSTEIN M, 1994, BIOCHEMISTRY-US, V33, P6739, DOI 10.1021/bi00188a001; Goldys EM, 2009, FLUORESCENCE APPL BI, P367; Gonzalez MW, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002819; Jameson DM, 2010, CHEM REV, V110, P2685, DOI 10.1021/cr900267p; Laursen BW, 2001, CHEM-EUR J, V7, P1773; LENTZ BR, 1989, CHEM PHYS LIPIDS, V50, P171, DOI 10.1016/0009-3084(89)90049-2; Marme N, 2003, BIOCONJUGATE CHEM, V14, P1133, DOI 10.1021/bc0341324; MARTIN JC, 1964, J AM CHEM SOC, V86, P2252, DOI 10.1021/ja01065a030; Mateo CR, 1996, BIOPHYS J, V71, P2177, DOI 10.1016/S0006-3495(96)79419-5; Michalet X, 2003, ANNU REV BIOPH BIOM, V32, P161, DOI 10.1146/annurev.biophys.32.110601.142525; PAP EHW, 1994, BIOPHYS CHEM, V48, P337, DOI 10.1016/0301-4622(93)E0069-H; Reynisson J, 2002, PHOTOCH PHOTOBIO SCI, V1, P763, DOI 10.1039/b204954f; Rich RM, 2013, ANAL BIOANAL CHEM, V405, P2065, DOI 10.1007/s00216-012-6623-1; Selvin PR, 2002, ANNU REV BIOPH BIOM, V31, P275, DOI 10.1146/annurev.biophys.31.101101.140927; Shi D, 2012, LANGMUIR, V28, P8608, DOI 10.1021/la301454y; SKLAR LA, 1977, BIOCHEMISTRY-US, V16, P819, DOI 10.1021/bi00624a002; Sorensen TJ, 2009, CHEM PHYS LETT, V476, P46, DOI 10.1016/j.cplett.2009.05.064; Sorensen TJ, 2013, METHODS APPL FLUORES, V1, DOI 10.1088/2050-6120/1/2/025001; Sun QF, 2012, J PHYS CHEM B, V116, P660, DOI 10.1021/jp2100304; Thyrhaug E, 2013, J PHYS CHEM A, V117, P2160, DOI 10.1021/jp312376k; Viallet PM, 2005, METH MOL B, V300, P165; Westerlund F, 2011, PHOTOCH PHOTOBIO SCI, V10, P1963, DOI 10.1039/c1pp05253e	34	41	41	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63043	10.1371/journal.pone.0063043	http://dx.doi.org/10.1371/journal.pone.0063043			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667570	Green Published, Green Submitted, gold			2022-12-25	WOS:000319654700102
J	Roperto, S; Russo, V; Ozkul, A; Corteggio, A; Sepici-Dincel, A; Catoi, C; Esposito, I; Riccardi, MG; Urraro, C; Luca, R; Ceccarelli, DM; Longo, M; Roperto, F				Roperto, Sante; Russo, Valeria; Ozkul, Ayhan; Corteggio, Annunziata; Sepici-Dincel, Aylin; Catoi, Cornel; Esposito, Iolanda; Riccardi, Marita G.; Urraro, Chiara; Luca, Roberta; Ceccarelli, Dora M.; Longo, Michele; Roperto, Franco			Productive Infection of Bovine Papillomavirus Type 2 in the Urothelial Cells of Naturally Occurring Urinary Bladder Tumors in Cattle and Water Buffaloes	PLOS ONE			English	Article							L1 CAPSID PROTEIN; ORGANIZATION; PROGRESSION; LESIONS; CANCER; CYCLE	Background: Papillomaviruses (PVs) are highly epitheliotropic as they usually establish productive infections within squamous epithelia of the skin, the anogenital tract and the oral cavity. In this study, early (E) and late (L) protein expression of bovine papillomavirus type 2 (BPV-2) in the urothelium of the urinary bladder is described in cows and water buffaloes suffering from naturally occurring papillomavirus-associated urothelial bladder tumors. Methods and Findings: E5 protein, the major oncoprotein of the BPV-2, was detected in all tumors. L1 DNA was amplified by PCR, cloned and sequenced and confirmed to be L1 DNA. The major capsid protein, L1, believed to be only expressed in productive papillomavirus infection was detected by Western blot analysis. Immunohistochemical investigations confirmed the presence of L1 protein both in the cytoplasm and nuclei of cells of the neoplastic urothelium. Finally, the early protein E2, required for viral DNA replication and known to be a pivotal factor for both productive and persistent infection, was detected by Western blot and immunohistochemically. Electron microscopic investigations detected electron dense particles, the shape and size of which are consistent with submicroscopic features of viral particles, in nuclei of neoplastic urothelium. Conclusion: This study shows that both active and productive infections by BPV-2 in the urothelium of the bovine and bubaline urinary bladder can occur in vivo.	[Roperto, Sante] Univ Naples Federico II, Dipartimento Med Vet & Prod Anim, Sez Malattie Infett, Naples, Italy; [Russo, Valeria; Corteggio, Annunziata; Esposito, Iolanda; Riccardi, Marita G.; Urraro, Chiara; Luca, Roberta; Ceccarelli, Dora M.] Univ Naples Federico II, Dipartimento Med Vet & Prod Anim, Sez Patol Gen, Naples, Italy; [Ozkul, Ayhan] Ankara Univ, Fac Vet Med, Dept Pathol, TR-06100 Ankara, Turkey; [Sepici-Dincel, Aylin] Gazi Univ, Fac Med, Hlth Res & Practice Ctr, Ankara, Turkey; [Catoi, Cornel] Univ Agr Sci & Vet Med, Fac Vet Med, Dept Pathol, Cluj Napoca, Romania; [Longo, Michele] CNR, Ist Endocrinol & Oncol Sperimentale Gaetano Salva, I-80125 Naples, Italy; [Roperto, Franco] Univ Naples Federico II, Dipartimento Biol, Naples, Italy	University of Naples Federico II; University of Naples Federico II; Ankara University; Gazi University; University of Agricultural Sciences & Veterinary Medicine Cluj Napoca; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II	Roperto, S (corresponding author), Univ Naples Federico II, Dipartimento Med Vet & Prod Anim, Sez Malattie Infett, Naples, Italy.	sante.roperto@unina.it	riccardi, marita georgia/AAD-3454-2020; Corteggio, Annunziata/AAL-5277-2021; Longo, Michele/AAB-5972-2020; Vecchio, Domenico/I-4102-2013; LONGO, Michele/AAB-9188-2019	riccardi, marita georgia/0000-0002-9097-8939; Vecchio, Domenico/0000-0002-8766-7224; LONGO, Michele/0000-0003-4798-0504; Corteggio, Annunziata/0000-0002-9017-317X; roperto, sante/0000-0001-6210-5519	Ministero Italiano dell'Universita e della Ricerca Scientifica (MIUR); Ministero Italiano delle Politiche Agricole, Agroalimentari e Forestali (MIPAAF); Assessorato alla Sanita della Regione Basilicata; Assessorato alla Sanita della Regione Campania	Ministero Italiano dell'Universita e della Ricerca Scientifica (MIUR)(Ministry of Education, Universities and Research (MIUR)); Ministero Italiano delle Politiche Agricole, Agroalimentari e Forestali (MIPAAF); Assessorato alla Sanita della Regione Basilicata; Assessorato alla Sanita della Regione Campania	This work was sponsored by grants from the Ministero Italiano dell'Universita e della Ricerca Scientifica (MIUR), Ministero Italiano delle Politiche Agricole, Agroalimentari e Forestali (MIPAAF), and Assessorato alla Sanita della Regione Basilicata and della Regione Campania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez J, 2010, AIDS, V24, P2355, DOI 10.1097/QAD.0b013e32833db9ea; [Anonymous], 2007, IARC MON EV CARC RIS; Bodily J, 2011, TRENDS MICROBIOL, V19, P33, DOI 10.1016/j.tim.2010.10.002; Borzacchiello G, 2006, ONCOGENE, V25, P1251, DOI 10.1038/sj.onc.1209152; Campo M. S., 1992, CANCER RES, V53, P1; Campo MS, 2006, PAPILLOMAVIRUS RESEARCH: FROM NATURAL HISTORY TO VACCINES AND BEYOND, P1; Campo MS, 2002, VIRUS RES, V89, P249, DOI 10.1016/S0168-1702(02)00193-4; Das Ghosh D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044678; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Doorbar J, 2007, DIS MARKERS, V23, P297, DOI 10.1155/2007/613150; dos Santos RCS, 1998, J GEN VIROL, V79, P2127, DOI 10.1099/0022-1317-79-9-2127; Graham SV, 2006, PAPILLOMAVIRUS RESEARCH: FROM NATURAL HISTORY TO VACCINES AND BEYOND, P193; Griesser H, 2009, AM J CLIN PATHOL, V132, P840, DOI 10.1309/AJCPCU0HBFFFGDTV; Hernandez J, 2011, AM J CLIN PATHOL, V135, P436, DOI 10.1309/AJCPR5VD6NSQRWBN; Johansson C, 2012, EMBO J, V31, P3212, DOI 10.1038/emboj.2012.147; Lunardi M, 2013, VET MICROBIOL, V162, P207, DOI 10.1016/j.vetmic.2012.08.030; Melsheimer P, 2003, ACTA CYTOL, V47, P124, DOI 10.1159/000326491; Middleton K, 2003, J VIROL, V77, P10186, DOI 10.1128/JVI.77.19.10186-10201.2003; Modis Y, 2002, EMBO J, V21, P4754, DOI 10.1093/emboj/cdf494; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Morgan IM, 2006, PAPILLOMAVIRUS RESEARCH: FROM NATURAL HISTORY TO VACCINES AND BEYOND, P73; Muller M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002761; Pathania S, 2012, TRANSBOUND EMERG DIS, V59, P79, DOI 10.1111/j.1865-1682.2011.01248.x; Peek RM, 2005, CANCER RES, V65, P8583, DOI 10.1158/0008-5472.CAN-05-1777; Pett M, 2007, J PATHOL, V212, P356, DOI 10.1002/path.2192; Roperto S, 2010, J COMP PATHOL, V142, P95, DOI 10.1016/j.jcpa.2009.08.156; Roperto S, 2008, J GEN VIROL, V89, P3027, DOI 10.1099/vir.0.2008/004457-0; Roperto S, 2013, J GEN VIROL, V94, P403, DOI 10.1099/vir.0.047662-0; Roperto S, 2012, RES VET SCI, V93, P1361, DOI 10.1016/j.rvsc.2012.06.009; Roperto S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033569; Roperto S, 2011, J GEN VIROL, V92, P1787, DOI 10.1099/vir.0.031740-0; Roperto S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010299; Sarmadi S, 2012, ARCH GYNECOL OBSTET, V285, P779, DOI 10.1007/s00404-011-2010-y; Shafti-Keramat S, 2009, VIROLOGY, V393, P1, DOI 10.1016/j.virol.2009.07.036; Shigehara K, 2011, J MED VIROL, V83, P277, DOI 10.1002/jmv.21966; Shigehara K, 2011, CANCER-AM CANCER SOC, V117, P2067, DOI 10.1002/cncr.25777; Somvanshi R, 2011, TRANSBOUND EMERG DIS, V58, P327, DOI 10.1111/j.1865-1682.2011.01211.x; Somvanshi R, 2012, TROP ANIM HEALTH PRO, V44, P855, DOI 10.1007/s11250-011-9978-y; Wosiaki SR, 2005, MEM I O CRUZ, V101, P635; Xiao W, 2010, ACTA CYTOL, V54, P661, DOI 10.1159/000325229; Yemelyanova A, 2013, MODERN PATHOL, V26, P268, DOI 10.1038/modpathol.2012.156; Zhu W, 2012, ARCH VIROL, V157, P85, DOI 10.1007/s00705-011-1140-7; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	43	27	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62227	10.1371/journal.pone.0062227	http://dx.doi.org/10.1371/journal.pone.0062227			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667460	gold, Green Submitted, Green Published			2022-12-25	WOS:000319654700027
J	Tanikawa, C; Okada, Y; Takahashi, A; Oda, K; Kamatani, N; Kubo, M; Nakamura, Y; Matsuda, K				Tanikawa, Chizu; Okada, Yukinori; Takahashi, Atsushi; Oda, Katsutoshi; Kamatani, Naoyuki; Kubo, Michiaki; Nakamura, Yusuke; Matsuda, Koichi			Genome Wide Association Study of Age at Menarche in the Japanese Population	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; ESTROGEN-RECEPTOR-ALPHA; SEQUENCE VARIANTS; LINKAGE SCAN; RISK-FACTORS; METAANALYSIS; PUBERTY; IDENTIFICATION; POLYMORPHISMS; COMPONENTS	Age at menarche (AAM) is a complex trait involving both genetic and environmental factors. To identify the genetic factors associated with AAM, we conducted a large-scale meta-analysis of genome-wide association studies using more than 15,000 Japanese female samples. Here, we identified an association between SNP (single nucleotide polymorphism) rs364663 at the LIN28B locus and AAM, with a P-value of 5.49x10(-7) and an effect size of 0.089 (year). We also evaluated 33 SNPs that were previously reported to be associated with AAM in women of European ancestry. Among them, two SNPs rs4452860 and rs7028916 in TMEM38B indicated significant association with AAM in the same directions as reported in previous studies (P = 0.0013 with an effect size of 0.051) even after Bonferroni correction for the 33 SNPs. In addition, six loci in or near CCDC85A, LOC100421670, CA10, ZNF483, ARNTL, and RXRG exhibited suggestive association with AAM (P<0.05). Our findings elucidated the impact of genetic variations on AAM in the Japanese population.	[Tanikawa, Chizu; Nakamura, Yusuke; Matsuda, Koichi] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo, Japan; [Okada, Yukinori; Takahashi, Atsushi; Kamatani, Naoyuki; Kubo, Michiaki] Inst Phys & Chem Res RIKEN, Ctr Genom Med, Kanagawa, Japan; [Okada, Yukinori] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Okada, Yukinori] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Oda, Katsutoshi] Univ Tokyo, Fac Med, Dept Obstet & Gynecol, Tokyo 113, Japan; [Nakamura, Yusuke] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Nakamura, Yusuke] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Nakamura, Yusuke] Univ Chicago, Ctr Personalized Therapeut, Chicago, IL 60637 USA	University of Tokyo; RIKEN; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Tokyo; University of Chicago; University of Chicago; University of Chicago	Matsuda, K (corresponding author), Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo, Japan.	koichima@ims.u-tokyo.ac.jp	Kubo, Michiaki/N-7947-2015; Matsuda, Koichi/D-4597-2011	Matsuda, Koichi/0000-0001-7292-2686	Ministry of Education, Culture, Sports, Science and Technology of the Japanese government; Ministry of Education, Culture, Sports, Science and Technology; Shiseido female researcher science grant	Ministry of Education, Culture, Sports, Science and Technology of the Japanese government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Shiseido female researcher science grant(Shiseido Company, Limited)	This work was conducted as a part of the BioBank Japan Project that was supported by the Ministry of Education, Culture, Sports, Science and Technology of the Japanese government. This work was also supported by grant from the Ministry of Education, Culture, Sports, Science and Technology (C. Tanikawa and K. Matsuda) and Shiseido female researcher science grant (C. Tanikawa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBROS V, 1984, SCIENCE, V226, P409, DOI 10.1126/science.6494891; Anderson CA, 2008, J CLIN ENDOCR METAB, V93, P3965, DOI 10.1210/jc.2007-2568; Anderson CA, 2007, BEHAV GENET, V37, P668, DOI 10.1007/s10519-007-9163-2; Bhalla K, 2008, AM J HUM GENET, V83, P703, DOI 10.1016/j.ajhg.2008.10.020; Cooper GS, 1999, EPIDEMIOLOGY, V10, P255, DOI 10.1097/00001648-199905000-00011; Cui R, 2011, GUT, V60, P799, DOI 10.1136/gut.2010.215947; Elks CE, 2010, NAT GENET, V42, P1077, DOI 10.1038/ng.714; Eriksson N, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-53; Freedman David S, 2003, BMC Pediatr, V3, P3, DOI 10.1186/1471-2431-3-3; Fujiwara S, 1997, J BONE MINER RES, V12, P998, DOI 10.1359/jbmr.1997.12.7.998; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Guerin A, 2012, AM J MED GENETICS A; Guo Y, 2006, J CLIN ENDOCR METAB, V91, P1009, DOI 10.1210/jc.2005-2179; Guo Y, 2006, HUM MOL GENET, V15, P2401, DOI 10.1093/hmg/ddl155; Guo YQ, 2006, GENE, V384, P51, DOI 10.1016/j.gene.2006.07.011; He CY, 2010, HUM GENET, V128, P515, DOI 10.1007/s00439-010-0878-4; He CY, 2009, NAT GENET, V41, P724, DOI 10.1038/ng.385; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Kaltiala-Heino R, 2003, J ADOLESCENCE, V26, P531, DOI 10.1016/S0140-1971(03)00053-8; Kaltiala-Heino R, 2001, J ADOLESCENT HEALTH, V28, P346, DOI 10.1016/S1054-139X(01)00195-1; KJAER K, 1992, J CLIN ENDOCR METAB, V75, P524, DOI 10.1210/jc.75.2.524; Krude H, 2002, J CLIN INVEST, V109, P475, DOI 10.1172/JC1200214341; Kumar V, 2011, NAT GENET IN PRESS; Kumar V, 2011, NAT GENET, V43, P455, DOI 10.1038/ng.809; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Li J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034486; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Mbarek H, 2011, HUM MOL GENET, V20, P3884, DOI 10.1093/hmg/ddr301; Melzer D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000072; Nakamura Yusuke, 2007, Clin Adv Hematol Oncol, V5, P696; Okada Y, 2012, NAT GENET, V44, P904, DOI 10.1038/ng.2352; Okada Y, 2012, NAT GENET, V44, P302, DOI 10.1038/ng.1086; Okada Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002067; Okada Y, 2011, HUM MOL GENET, V20, P1224, DOI 10.1093/hmg/ddq551; Okada Y, 2010, HUM MOL GENET, V19, P2303, DOI 10.1093/hmg/ddq091; Okada Y, 2010, HUM MOL GENET, V19, P2079, DOI 10.1093/hmg/ddq080; Ong KK, 2009, NAT GENET, V41, P729, DOI 10.1038/ng.382; Onland-Moret NC, 2005, AM J EPIDEMIOL, V162, P623, DOI 10.1093/aje/kwi260; Parent AS, 2003, ENDOCR REV, V24, P668, DOI 10.1210/er.2002-0019; Perry JRB, 2009, NAT GENET, V41, P648, DOI 10.1038/ng.386; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rothenbuhler A, 2006, J CLIN ENDOCR METAB, V91, P3534, DOI 10.1210/jc.2006-0150; Stavrou I, 2006, HUM REPROD, V21, P554, DOI 10.1093/humrep/dei326; Stavrou I, 2002, HUM REPROD, V17, P1101, DOI 10.1093/humrep/17.4.1101; Sulem P, 2009, NAT GENET, V41, P734, DOI 10.1038/ng.383; SUSMAN EJ, 1985, J YOUTH ADOLESCENCE, V14, P245, DOI 10.1007/BF02090322; Tanikawa C, 2012, NAT GENET IN PRESS; Tena-Sempere M, 2006, HUM REPROD UPDATE, V12, P631, DOI 10.1093/humupd/dml023; Towne B, 2005, AM J PHYS ANTHROPOL, V128, P210, DOI 10.1002/ajpa.20106; TRELOAR SA, 1990, AM J HUM GENET, V47, P137; Urabe Y, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002541; Velie Ellen M, 2005, Breast Dis, V24, P17; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Volodarsky M, 2013, HUM MUTAT; Xita N, 2005, MOL HUM REPROD, V11, P459, DOI 10.1093/molehr/gah178; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019; Yazawa M, 2007, NATURE, V448, P78, DOI 10.1038/nature05928; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhu H, 2010, NAT GENET, V42, P626, DOI 10.1038/ng.593	60	29	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63821	10.1371/journal.pone.0063821	http://dx.doi.org/10.1371/journal.pone.0063821			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667675	Green Published, Green Submitted, gold			2022-12-25	WOS:000319654700187
J	von Alvensleben, N; Stookey, K; Magnusson, M; Heimann, K				von Alvensleben, Nicolas; Stookey, Katherine; Magnusson, Marie; Heimann, Kirsten			Salinity Tolerance of Picochlorum atomus and the Use of Salinity for Contamination Control by the Freshwater Cyanobacterium Pseudanabaena limnetica	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; BIOFUEL PRODUCTION; TETRASELMIS-CHUI; NITROGEN-SOURCES; LIPID-CONTENT; NITRIC-OXIDE; GREEN-ALGAE; MICROALGAE; GROWTH; NITRATE	Microalgae are ideal candidates for waste-gas and -water remediation. However, salinity often varies between different sites. A cosmopolitan microalga with large salinity tolerance and consistent biochemical profiles would be ideal for standardised cultivation across various remediation sites. The aims of this study were to determine the effects of salinity on Picochlorum atomus growth, biomass productivity, nutrient uptake and biochemical profiles. To determine if target end-products could be manipulated, the effects of 4-day nutrient limitation were also determined. Culture salinity had no effect on growth, biomass productivity, phosphate, nitrate and total nitrogen uptake at 2, 8, 18, 28 and 36 ppt. 11 ppt, however, initiated a significantly higher total nitrogen uptake. While salinity had only minor effects on biochemical composition, nutrient depletion was a major driver for changes in biomass quality, leading to significant increases in total lipid, fatty acid and carbohydrate quantities. Fatty acid composition was also significantly affected by nutrient depletion, with an increased proportion of saturated and mono-unsaturated fatty acids. Having established that P. atomus is a euryhaline microalga, the effects of culture salinity on the development of the freshwater cyanobacterial contaminant Pseudanabaena limnetica were determined. Salinity at 28 and 36 ppt significantly inhibited establishment of P. limnetica in P. atomus cultures. In conclusion, P. atomus can be deployed for bioremediation at sites with highly variable salinities without effects on end-product potential. Nutrient status critically affected biochemical profiles - an important consideration for end-product development by microalgal industries. 28 and 36 ppt slow the establishment of the freshwater cyanobacterium P. limnetica, allowing for harvest of low contaminant containing biomass.	[von Alvensleben, Nicolas; Stookey, Katherine; Magnusson, Marie; Heimann, Kirsten] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [von Alvensleben, Nicolas; Stookey, Katherine; Magnusson, Marie; Heimann, Kirsten] James Cook Univ, Ctr Sustainable Fisheries & Aquaculture, Townsville, Qld 4811, Australia; [Heimann, Kirsten] James Cook Univ, Comparat Genom Ctr, Townsville, Qld 4811, Australia; [Heimann, Kirsten] James Cook Univ, Ctr Biodiscovery & Mol Dev Therapeut, Townsville, Qld 4811, Australia	James Cook University; James Cook University; James Cook University; James Cook University	Heimann, K (corresponding author), James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia.	Kirsten.heimann@jcu.edu.au	Heimann, Kirsten/N-1512-2013; Heimann, Kirsten/M-4814-2019; Magnusson, Marie/D-8996-2012	Heimann, Kirsten/0000-0003-2691-9659; Heimann, Kirsten/0000-0003-2691-9659; Magnusson, Marie/0000-0002-3141-8544	Advanced Manufacturing Cooperative Research Centre, Melbourne, Australia; AMCRC PhD scholarship	Advanced Manufacturing Cooperative Research Centre, Melbourne, Australia(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); AMCRC PhD scholarship(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This work was funded through the Advanced Manufacturing Cooperative Research Centre, Melbourne, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research is part of the MBD Energy Research and Development program for Biological Carbon Capture and Storage. Nicolas von Alvensleben was supported by an AMCRC PhD scholarship.	Acinas SG, 2009, ISME J, V3, P31, DOI 10.1038/ismej.2008.78; Ahlgren G, 2003, J PHYCOL, V39, P906, DOI 10.1046/j.1529-8817.2003.02026.x; Andersen R. A., 2005, ALGAL CULTURING TECH, P429, DOI DOI 10.1016/B978-012088426-1/50027-5; Arbib Z, 2012, INT J PHYTOREMEDIAT, V14, P714, DOI 10.1080/15226514.2011.619237; BAREA JL, 1975, ARCH MICROBIOL, V105, P21, DOI 10.1007/BF00447107; Becker EW, 2007, BIOTECHNOL ADV, V25, P207, DOI 10.1016/j.biotechadv.2006.11.002; Becker E.W., 1994, MICROALGAE BIOTECHNO; BENAMOTZ A, 1985, J PHYCOL, V21, P72; Borowitzka M.A., 2005, ALGAL CULTURING TECH, P205; BROWN LM, 1982, J PHYCOL, V18, P483; Cha TS, 2011, BIORESOURCE TECHNOL, V102, P10633, DOI 10.1016/j.biortech.2011.09.042; Chen TY, 2012, AQUACULTURE, V338, P82, DOI 10.1016/j.aquaculture.2012.01.011; Chiang IZ, 2004, J PHYCOL, V40, P474, DOI 10.1111/j.1529-8817.2004.03096.x; Cho SH, 2007, FISHERIES SCI, V73, P1050, DOI 10.1111/j.1444-2906.2007.01435.x; Churro C, 2010, HYDROBIOLOGIA, V649, P195, DOI 10.1007/s10750-010-0245-4; COHEN Z, 1988, J PHYCOL, V24, P328, DOI 10.1111/j.1529-8817.1988.tb04474.x; de la Vega M, 2011, BIOTECHNOL PROGR, V27, P1535, DOI 10.1002/btpr.686; de Morais MG, 2007, ENERG CONVERS MANAGE, V48, P2169, DOI 10.1016/j.enconman.2006.12.011; DORTCH Q, 1984, MAR BIOL, V81, P237, DOI 10.1007/BF00393218; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Geider RJ, 1998, EUR J PHYCOL, V33, P315, DOI 10.1080/09670269810001736813; Gosch BJ, 2012, GCB BIOENERGY, V4, P919, DOI 10.1111/j.1757-1707.2012.01175.x; Gronlund E, 2004, ECOL ENG, V22, P155, DOI 10.1016/j.ecoleng.2004.03.002; HA KS, 1991, PLANT PHYSIOL, V97, P921, DOI 10.1104/pp.97.3.921; Harikrishnan R, 2010, AQUACULTURE, V309, P1, DOI 10.1016/j.aquaculture.2010.09.011; Hay ME, 2009, ANNU REV MAR SCI, V1, P193, DOI 10.1146/annurev.marine.010908.163708; Henley WJ, 2004, PHYCOLOGIA, V43, P641, DOI 10.2216/i0031-8884-43-6-641.1; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; Huerlimann R, 2010, BIOTECHNOL BIOENG, V107, P245, DOI 10.1002/bit.22809; Huertas E, 2000, AQUACULT ENG, V22, P181, DOI 10.1016/S0144-8609(99)00038-2; IGNARRO LJ, 1993, P NATL ACAD SCI USA, V90, P8103, DOI 10.1073/pnas.90.17.8103; Jarvie HP, 2006, SCI TOTAL ENVIRON, V360, P246, DOI 10.1016/j.scitotenv.2005.08.038; Joint I, 2002, AQUAT MICROB ECOL, V29, P145, DOI 10.3354/ame029145; KIRST GO, 1990, ANNU REV PLANT PHYS, V41, P21, DOI 10.1146/annurev.pp.41.060190.000321; Komarek J, 2003, HYDROBIOLOGIA, V502, P367, DOI 10.1023/B:HYDR.0000004294.17755.fe; LEVASSEUR M, 1993, J PHYCOL, V29, P587, DOI 10.1111/j.0022-3646.1993.00587.x; Lewis T, 2000, J MICROBIOL METH, V43, P107, DOI 10.1016/S0167-7012(00)00217-7; Li YQ, 2008, APPL MICROBIOL BIOT, V81, P629, DOI 10.1007/s00253-008-1681-1; Lim DKY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040751; LINCOLN EP, 1983, AQUACULTURE, V32, P331, DOI 10.1016/0044-8486(83)90230-2; MacIntyre H.L., 2005, ALGAL CULTURING TECH, P287, DOI [10.1016/B978-012088426-1/50020-2, DOI 10.1016/B978-012088426-1/50020-2, 10.1007/s10811-017-1254-8]; Malerba ME, 2012, LIMNOL OCEANOGR, V57, P1555, DOI 10.4319/lo.2012.57.5.1555; Meseck SL, 2007, J SHELLFISH RES, V26, P1071, DOI 10.2983/0730-8000(2007)26[1071:IOACCL]2.0.CO;2; Meseck SL, 2007, AQUACULTURE, V273, P566, DOI 10.1016/j.aquaculture.2007.10.043; Mischke U, 2003, ACTA OECOL, V24, pS11, DOI 10.1016/S1146-609X(03)00003-1; Nagase H, 2001, BIOCHEM ENG J, V7, P241, DOI 10.1016/S1369-703X(00)00122-4; NEGORO M, 1991, APPL BIOCHEM BIOTECH, V28-9, P877, DOI 10.1007/BF02922657; PIORRECK M, 1984, PHYTOCHEMISTRY, V23, P207, DOI 10.1016/S0031-9422(00)80304-0; RAI LC, 1991, J PLANT PHYSIOL, V138, P68, DOI 10.1016/S0176-1617(11)80732-7; RAJASEKHAR VK, 1987, PHYSIOL PLANTARUM, V71, P517, DOI 10.1111/j.1399-3054.1987.tb02893.x; REITAN KI, 1994, J PHYCOL, V30, P972, DOI 10.1111/j.0022-3646.1994.00972.x; Rodriguez-Ruiz J, 1998, BIOTECHNOL TECH, V12, P689, DOI 10.1023/A:1008812904017; ROESSLER PG, 1990, J PHYCOL, V26, P393, DOI 10.1111/j.0022-3646.1990.00393.x; Roncarati A, 2004, J WORLD AQUACULT SOC, V35, P401, DOI 10.1111/j.1749-7345.2004.tb00104.x; Sandra P., 2002, AGILENT TECHNOLOGIES; Schenk PM, 2008, BIOENERG RES, V1, P20, DOI 10.1007/s12155-008-9008-8; Sharma KK, 2012, ENERGIES, V5, P1532, DOI 10.3390/en5051532; SHIFRIN NS, 1981, J PHYCOL, V17, P374, DOI 10.1111/j.0022-3646.1981.00374.x; Simopoulos AP, 2002, BIOMED PHARMACOTHER, V56, P365, DOI 10.1016/S0753-3322(02)00253-6; SIMS GG, 1978, J SCI FOOD AGR, V29, P281, DOI 10.1002/jsfa.2740290314; Stephens E, 2010, TRENDS PLANT SCI, V15, P554, DOI 10.1016/j.tplants.2010.06.003; Su CH, 2011, J APPL PHYCOL, V23, P903, DOI 10.1007/s10811-010-9609-4; Sunda WG, 2007, LIMNOL OCEANOGR, V52, P2496, DOI 10.4319/lo.2007.52.6.2496; Sydney EB, 2011, APPL ENERG, V88, P3291, DOI 10.1016/j.apenergy.2010.11.024; VOLKMAN JK, 1989, J EXP MAR BIOL ECOL, V128, P219, DOI 10.1016/0022-0981(89)90029-4; Wang B, 2011, BIORESOURCE TECHNOL, V102, P5639, DOI 10.1016/j.biortech.2011.02.054; Willame R, 2006, J PHYCOL, V42, P1312, DOI 10.1111/j.1529-8817.2006.00284.x; WITT U, 1981, AQUACULTURE, V23, P171, DOI 10.1016/0044-8486(81)90012-0	68	61	62	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63569	10.1371/journal.pone.0063569	http://dx.doi.org/10.1371/journal.pone.0063569			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667639	Green Published, Green Accepted, gold			2022-12-25	WOS:000319654700162
J	Wang, J; Wang, L; Xia, B; Yang, CH; Lai, HW; Chen, XD				Wang, Jie; Wang, Li; Xia, Bing; Yang, Chuanhong; Lai, Huangwen; Chen, Xiaodong			BSP Gene Silencing Inhibits Migration, Invasion, and Bone Metastasis of MDA-MB-231BO Human Breast Cancer Cells	PLOS ONE			English	Article							SIALOPROTEIN-II; COLONY FORMATION; IN-VIVO; EXPRESSION; ANTIBODY; OSTEOPONTIN; ADHESION; BINDING; ALPHA-V-BETA-3; PROLIFERATION	Bone sialoprotein (BSP) has been implicated in a variety of physiological and pathophysiological events, including tumor cell invasion, bone homing, adhesion, and matrix degradation. To explore the potential involvement of BSP in human breast cancer cell invasion and metastasis, we used retrovirus-mediated RNAi to deplete BSP levels in the human bone-seeking breast cancer cell line MDA-MB-231BO (231BO) and established the 231BO-BSP27 and 231BO-BSP81 cell clones. Cell proliferation, colony formation, wound healing, and the ability to invade into matrigel of these BSP-depleted clones were all decreased. Both 231BO-BSP27 cells and 231BO-BSP81 cells showed a significant (15.4% and 28.6% respectively) reduction of bone metastatic potential following intracardiac injection as determined by X-ray detection and by hematoxylin and eosin staining. Moreover, the expression of integrins alpha v beta 3 and beta 3 was decreased in the BSP-silenced cells whereas ectopic BSP expression increased the integrins alpha v beta 3 and beta 3 levels. These results together suggest that BSP silencing decreased the integrin alpha v beta 3 and beta 3 levels, in turn inhibiting cell migration and invasion and decreasing the ability of the cells to metastasize to bone.	[Wang, Jie; Wang, Li; Xia, Bing; Yang, Chuanhong; Lai, Huangwen] Guangzhou Gen Hosp Guangzhou Mil Command, Dept Med Res, Guangzhou, Guangdong, Peoples R China; [Chen, Xiaodong] Guangzhou Gen Hosp Guangzhou Mil Command, Dept Pathol, Guangzhou, Guangdong, Peoples R China	Southern Theater Command General Hospital; Southern Theater Command General Hospital	Wang, J (corresponding author), Guangzhou Gen Hosp Guangzhou Mil Command, Dept Med Res, Guangzhou, Guangdong, Peoples R China.	jiew@tom.com		Wang, Li/0000-0001-8321-102X	Guangdong Natural Science Foundation, China [06104396]	Guangdong Natural Science Foundation, China(National Natural Science Foundation of Guangdong Province)	This work was supported by Guangdong Natural Science Foundation (06104396), China (http://gdsf.gdstc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study design, data collection and analysis were supported by Guangdong Natural Science Foundation (06104396), China. We also want to thank Fred Bogott, M.D., Ph.D., at Austin Medical Center, Austin of Minnesota, and Dr. D. Joshua Liao at Hormel Institute, Austin of Minnesota, for their excellent English editing of this manuscript.	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Adwan H, 2004, INT J ONCOL, V24, P1235; Adwan H, 2004, CANCER GENE THER, V11, P109, DOI 10.1038/sj.cgt.7700659; Bauerle T, 2006, INT J ONCOL, V28, P573; Bauerle T, 2005, INT J CANCER, V115, P177, DOI 10.1002/ijc.20840; BELLAHCENE A, 1994, CANCER RES, V54, P2823; Bellahcene A, 1996, J BONE MINER RES, V11, P665; Bellahcene A, 2008, NAT REV CANCER, V8, P212, DOI 10.1038/nrc2345; Boudiffa M, 2010, J BONE MINER RES, V25, P2393, DOI 10.1002/jbmr.245; Byzova TV, 2000, EXP CELL RES, V254, P299, DOI 10.1006/excr.1999.4765; Cogan G, 2004, CONNECT TISSUE RES, V45, P60, DOI 10.1080/03008200490278151; Diel IJ, 1999, CLIN CANCER RES, V5, P3914; Elazar V, 2010, INT J CANCER, V126, P1749, DOI 10.1002/ijc.24890; Goldberg HA, 2001, CONNECT TISSUE RES, V42, P25, DOI 10.3109/03008200109014246; Gordon JAR, 2009, J CELL BIOCHEM, V107, P1118, DOI 10.1002/jcb.22211; Guise TA, 1996, J CLIN INVEST, V98, P1544, DOI 10.1172/JCI118947; Harris NL, 2000, BONE, V27, P795, DOI 10.1016/S8756-3282(00)00392-6; Jensen AO, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-29; Liu DB, 2011, J BIOL CHEM, V286, P24500, DOI 10.1074/jbc.M110.211847; Liu H, 2012, NAT CELL BIOL, V14, P567, DOI 10.1038/ncb2491; Onishi T, 2010, NAT REV CLIN ONCOL, V7, P641, DOI 10.1038/nrclinonc.2010.134; Pecheur I, 2002, FASEB J, V16, P1266, DOI 10.1096/fj.01-0911fje; Peterschmitt J, 2007, CLIN EXP METASTAS, V24, P449, DOI 10.1007/s10585-007-9082-x; Sterling JA, 2011, BONE, V48, P6, DOI 10.1016/j.bone.2010.07.015; Sung V, 1998, J CELL PHYSIOL, V176, P482, DOI 10.1002/(SICI)1097-4652(199809)176:3<482::AID-JCP5>3.0.CO;2-K; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Tu QS, 2009, J CELL PHYSIOL, V218, P135, DOI 10.1002/jcp.21576; Wang Li, 2011, Sheng Wu Gong Cheng Xue Bao, V27, P233; Wu YJ, 2012, J NEURO-ONCOL, V110, P27, DOI 10.1007/s11060-012-0942-0; Wuttke M, 2001, J BIOL CHEM, V276, P36839, DOI 10.1074/jbc.M105689200; Yoneda T, 1998, EUR J CANCER, V34, P240, DOI 10.1016/S0959-8049(97)10132-0; Yoneda T, 2001, J BONE MINER RES, V16, P1486, DOI 10.1359/jbmr.2001.16.8.1486; Zhang JH, 2003, INT J ONCOL, V23, P1043	33	18	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62936	10.1371/journal.pone.0062936	http://dx.doi.org/10.1371/journal.pone.0062936			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667544	gold, Green Published, Green Submitted			2022-12-25	WOS:000319654700083
J	Kilgore, JA; Du, XL; Melito, L; Wei, SG; Wang, CG; Chin, HG; Posner, B; Pradhan, S; Ready, JM; Williams, NS				Kilgore, Jessica A.; Du, Xinlin; Melito, Lisa; Wei, Shuguang; Wang, Changguang; Chin, Hang Gyeong; Posner, Bruce; Pradhan, Sriharsa; Ready, Joseph M.; Williams, Noelle S.			Identification of DNMT1 Selective Antagonists Using a Novel Scintillation Proximity Assay	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CANCER-CELLS; DNA CYTOSINE-5 METHYLTRANSFERASE; DE-NOVO; MAINTENANCE METHYLATION; CHROMATIN-STRUCTURE; CPG-ISLANDS; AZACITIDINE; EXPRESSION; MUTATION; BINDING	A novel scintillation proximity high throughput assay (SPA) to identify inhibitors of DNA methyltransferases was developed and used to screen over 180,000 compounds. The majority of the validated hits shared a quinone core and several were found to generate the reactive oxygen species, H2O2. Inhibition of the production of H2O2 by the addition of catalase blocked the ability of this group of compounds to inhibit DNA methyltransferase (DNMT) activity. However, a related compound, SW155246, was identified that existed in an already reduced form of the quinone. This compound did not generate H2O2, and catalase did not block its ability to inhibit DNA methyltransferase. SW155246 showed a 30-fold preference for inhibition of human DNMT1 versus human or murine DNMT3A or -3B, inhibited global methylation in HeLa cells, and reactivated expression of the tumor suppressor gene RASSF1A in A549 cells. To our knowledge, this work represents the first description of selective chemical inhibitors of the DNMT1 enzyme.	[Kilgore, Jessica A.; Du, Xinlin; Melito, Lisa; Wei, Shuguang; Wang, Changguang; Posner, Bruce; Ready, Joseph M.; Williams, Noelle S.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Chin, Hang Gyeong; Pradhan, Sriharsa] New England Biolabs Inc, Ipswich, MA 01938 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; New England Biolabs	Williams, NS (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Noelle.Williams@UTSouthwestern.edu			National Institutes of Health [P01 CA095471]; NATIONAL CANCER INSTITUTE [P01CA095471] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 CA095471 (to S. L. McKnight).	Beaulieu N, 2002, J BIOL CHEM, V277, P28176, DOI 10.1074/jbc.M204734200; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Ceccaldi A, 2013, ACS CHEM BIOL, V8, P543, DOI 10.1021/cb300565z; Chen TP, 2007, NAT GENET, V39, P391, DOI 10.1038/ng1982; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Cyr AR, 2011, ANTIOXID REDOX SIGN, V15, P551, DOI 10.1089/ars.2010.3492; Dhasarathy A, 2008, MUTAT RES-FUND MOL M, V647, P39, DOI 10.1016/j.mrfmmm.2008.07.007; Eads CA, 2002, CANCER RES, V62, P1296; Foulks JM, 2012, J BIOMOL SCREEN, V17, P2, DOI 10.1177/1087057111421212; Hollenbach PW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009001; Ito K, 2004, BIOCHEM BIOPH RES CO, V315, P240, DOI 10.1016/j.bbrc.2004.01.046; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; Jair KW, 2006, CANCER RES, V66, P682, DOI 10.1158/0008-5472.CAN-05-1980; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Johnston PA, 2008, ASSAY DRUG DEV TECHN, V6, P505, DOI 10.1089/adt.2008.151; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; Jurkowska RZ, 2011, CHEMBIOCHEM, V12, P206, DOI 10.1002/cbic.201000195; Kantarjian H, 2006, CANCER-AM CANCER SOC, V106, P1794, DOI 10.1002/cncr.21792; Kilgore JA, 2007, METHODS, V41, P320, DOI 10.1016/j.ymeth.2006.08.008; Kok RM, 2007, CLIN CHEM LAB MED, V45, P903, DOI 10.1515/CCLM.2007.137; Kuck D, 2010, MOL CANCER THER, V9, P3015, DOI 10.1158/1535-7163.MCT-10-0609; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Liang GG, 2002, MOL CELL BIOL, V22, P480, DOI 10.1128/MCB.22.2.480-491.2002; McCabe MT, 2009, CLIN CANCER RES, V15, P3927, DOI 10.1158/1078-0432.CCR-08-2784; Min NY, 2012, BIOCHEM BIOPH RES CO, V421, P91, DOI 10.1016/j.bbrc.2012.03.120; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Pfeifer GP, 2000, CURR TOP MICROBIOL, V249, P1; Pradhan S, 1999, J BIOL CHEM, V274, P33002, DOI 10.1074/jbc.274.46.33002; Pradhan S, 2003, BIOCHEMISTRY-US, V42, P5321, DOI 10.1021/bi034160+; Prokhortchouk A, 2001, GENE DEV, V15, P1613, DOI 10.1101/gad.198501; Schluckebier G, 1997, J MOL BIOL, V265, P56, DOI 10.1006/jmbi.1996.0711; Silverman LR, 2006, J CLIN ONCOL, V24, P3895, DOI 10.1200/JCO.2005.05.4346; Suzuki M, 2004, CANCER RES, V64, P3137, DOI 10.1158/0008-5472.CAN-03-3046; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; TAZI J, 1990, CELL, V60, P909, DOI 10.1016/0092-8674(90)90339-G; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhao ZJ, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/737535	38	32	33	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19673	19684		10.1074/jbc.M112.443895	http://dx.doi.org/10.1074/jbc.M112.443895			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23671287	hybrid, Green Published			2022-12-25	WOS:000321515800038
J	Kirkwood, JS; Legette, LL; Miranda, CL; Jiang, Y; Stevens, JF				Kirkwood, Jay S.; Legette, LeeCole L.; Miranda, Cristobal L.; Jiang, Yuan; Stevens, Jan F.			A Metabolomics-driven Elucidation of the Anti-obesity Mechanisms of Xanthohumol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID OXIDATION; ADENINE-NUCLEOTIDE TRANSLOCASE; DIET-INDUCED OBESITY; HUMULUS-LUPULUS; INSULIN SENSITIVITY; DICARBOXYLIC-ACIDS; QUINONE REDUCTASE; STRESS-RESPONSE; LIFE-SPAN; CELLS	Mild, mitochondrial uncoupling increases energy expenditure and can reduce the generation of reactive oxygen species (ROS). Activation of cellular, adaptive stress response pathways can result in an enhanced capacity to reduce oxidative damage. Together, these strategies target energy imbalance and oxidative stress, both underlying factors of obesity and related conditions such as type 2 diabetes. Here we describe a metabolomics-driven effort to uncover the anti-obesity mechanism(s) of xanthohumol (XN), a prenylated flavonoid from hops. Metabolomics analysis of fasting plasma from obese, Zucker rats treated with XN revealed decreases in products of dysfunctional fatty acid oxidation and ROS, prompting us to explore the effects of XN on muscle cell bioenergetics. At low micromolar concentrations, XN acutely increased uncoupled respiration in several different cell types, including myocytes. Tetrahydroxanthohumol also increased respiration, suggesting electrophilicity did not play a role. At higher concentrations, XN inhibited respiration in a ROS-dependent manner. In myocytes, time course metabolomics revealed acute activation of glutathione recycling and long term induction of glutathione synthesis as well as several other changes indicative of short term elevated cellular stress and a concerted adaptive response. Based on these findings, we hypothesize that XN may ameliorate metabolic syndrome, at least in part, through mitochondrial uncoupling and stress response induction. In addition, time course metabolomics appears to be an effective strategy for uncovering metabolic events that occur during a stress response.	[Kirkwood, Jay S.; Legette, LeeCole L.; Miranda, Cristobal L.; Stevens, Jan F.] Oregon State Univ, Linus Pauling Inst, Corvallis, OR 97331 USA; [Kirkwood, Jay S.; Legette, LeeCole L.; Miranda, Cristobal L.; Stevens, Jan F.] Oregon State Univ, Dept Pharmaceut Sci, Corvallis, OR 97331 USA; [Jiang, Yuan] Oregon State Univ, Dept Stat, Corvallis, OR 97331 USA	Oregon State University; Oregon State University; Oregon State University	Stevens, JF (corresponding author), Oregon State Univ, Linus Pauling Inst, Linus Pauling Sci Ctr 307, Corvallis, OR 97331 USA.	fred.stevens@oregonstate.edu		Jiang, Yuan/0000-0001-6409-9159; Stevens, Jan Frederik/0000-0002-6348-9347	National Institutes of Health [R21AT005294, S10RR027878, P30ES000210]; Cell Imaging and Analysis Facilities and Services Core of the Environmental Health Sciences Center, Oregon State University, NIEHS, National Institutes of Health [P30 ES00210]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R21AT005294] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cell Imaging and Analysis Facilities and Services Core of the Environmental Health Sciences Center, Oregon State University, NIEHS, National Institutes of Health; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R21AT005294, S10RR027878, and P30ES000210.; We thank Dr. Chrissa Kioussi (Oregon State University-OSU College of Pharmacy) for the C2C12 myocytes and Jeff Morre of the OSU mass spectrometry facility. The brown preadipocytes were a kind gift from Dr. Bruce Spiegelman (Harvard Medical School Department of Cell Biology). For help with the Seahorse XF Analyzer, we acknowledge Justin X. Zhang and Jeffrey A. Greenwood, Director, Cell Imaging and Analysis Facilities and Services Core of the Environmental Health Sciences Center, Oregon State University Grant P30 ES00210, NIEHS, National Institutes of Health.	Agresti A., 2012, CATEGORICAL DATA ANA, P274; Amara CE, 2007, P NATL ACAD SCI USA, V104, P1057, DOI 10.1073/pnas.0610131104; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Anderson EJ, 2007, J BIOL CHEM, V282, P31257, DOI 10.1074/jbc.M706129200; Ashfaq S, 2008, HYPERTENSION, V52, P80, DOI 10.1161/HYPERTENSIONAHA.107.097386; Bell JA, 2010, J CLIN ENDOCR METAB, V95, P3400, DOI 10.1210/jc.2009-1596; BERGSTROM J, 1974, J APPL PHYSIOL, V36, P693, DOI 10.1152/jappl.1974.36.6.693; Berkeley LI, 2003, J BIOCHEM MOL TOXIC, V17, P95, DOI 10.1002/jbt.10069; Bowtell JL, 2002, NUTRITION, V18, P222, DOI 10.1016/S0899-9007(01)00795-X; Brand MD, 2005, BIOCHEM J, V392, P353, DOI 10.1042/BJ20050890; Brown GC, 2004, BBA-BIOENERGETICS, V1658, P44, DOI 10.1016/j.bbabio.2004.03.016; Buckley BJ, 2000, AM J PHYSIOL-CELL PH, V279, pC1168, DOI 10.1152/ajpcell.2000.279.4.C1168; CAHILL GF, 1966, J CLIN INVEST, V45, P1751, DOI 10.1172/JCI105481; Calabrese EJ, 2009, ARCH TOXICOL, V83, P227, DOI 10.1007/s00204-009-0411-5; Camacho A, 2012, EXP NEUROL, V237, P396, DOI 10.1016/j.expneurol.2012.06.031; Dietz BM, 2005, CHEM RES TOXICOL, V18, P1296, DOI 10.1021/tx050058x; Echtay KS, 2003, EMBO J, V22, P4103, DOI 10.1093/emboj/cdg412; FDA F.D.A., 2005, GUID IND EST MAX SAF, P7; Festa M, 2011, J NAT PROD, V74, P2505, DOI 10.1021/np200390x; Findeisen HM, 2011, OBESITY, V19, P2429, DOI 10.1038/oby.2011.298; Garcia J, 2010, J BIOL CHEM, V285, P39646, DOI 10.1074/jbc.M110.164160; GREGO AV, 1995, CLIN NUTR, V14, P143, DOI 10.1016/S0261-5614(95)80011-5; Guzy J, 2010, FEBS LETT, V584, P567, DOI 10.1016/j.febslet.2009.11.098; Harper ME, 2008, ANNU REV NUTR, V28, P13, DOI 10.1146/annurev.nutr.28.061807.155357; Harvey CJ, 2009, FREE RADICAL BIO MED, V46, P443, DOI 10.1016/j.freeradbiomed.2008.10.040; Hirata H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049415; HUGHES RE, 1964, NATURE, V203, P1068, DOI 10.1038/2031068a0; Kirkwood JS, 2012, J BIOL CHEM, V287, P3833, DOI 10.1074/jbc.M111.316018; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Lee BC, 2011, FREE RADICAL BIO MED, V50, P221, DOI 10.1016/j.freeradbiomed.2010.11.008; Lee HR, 2008, MOL CELL BIOCHEM, V318, P23, DOI 10.1007/s11010-008-9853-y; Legette L, 2012, MOL NUTR FOOD RES, V56, P466, DOI 10.1002/mnfr.201100554; Legette LL, 2013, PHYTOCHEMISTRY, V91, P236, DOI 10.1016/j.phytochem.2012.04.018; Lehmann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011519; Li LX, 2011, J BIOL CHEM, V286, P17809, DOI 10.1074/jbc.M110.180893; Loh K, 2009, CELL METAB, V10, P260, DOI 10.1016/j.cmet.2009.08.009; Luo Y, 2007, J AM SOC MASS SPECTR, V18, P2226, DOI 10.1016/j.jasms.2007.09.015; Mailloux RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000690; Mailloux RJ, 2011, J BIOL CHEM, V286, P21865, DOI 10.1074/jbc.M111.240242; Mao WG, 1999, FEBS LETT, V443, P326, DOI 10.1016/S0014-5793(98)01713-X; Marti A, 2001, INT J OBESITY, V25, P68, DOI 10.1038/sj.ijo.0801484; MASORO EJ, 1967, J BIOL CHEM, V242, P1111; McStay GP, 2002, BIOCHEM J, V367, P541, DOI 10.1042/BJ20011672; Mesquita A, 2010, P NATL ACAD SCI USA, V107, P15123, DOI 10.1073/pnas.1004432107; Mihalik SJ, 2010, OBESITY, V18, P1695, DOI 10.1038/oby.2009.510; Miranda CL, 2000, CANCER LETT, V149, P21, DOI 10.1016/S0304-3835(99)00328-6; MORTENSEN PB, 1992, BIOCHIM BIOPHYS ACTA, V1124, P71, DOI 10.1016/0005-2760(92)90128-I; Nozawa H, 2005, BIOCHEM BIOPH RES CO, V336, P754, DOI 10.1016/j.bbrc.2005.08.159; Ozaki S, 2008, PHYS CHEM CHEM PHYS, V10, P4449, DOI 10.1039/b803458c; Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314; Rodriguez AM, 2001, OBES RES, V9, P579, DOI 10.1038/oby.2001.75; Rohas LM, 2007, P NATL ACAD SCI USA, V104, P7933, DOI 10.1073/pnas.0702683104; Rose G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029650; Steiner C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025006; Stevens JF, 1997, PHYTOCHEMISTRY, V44, P1575, DOI 10.1016/S0031-9422(96)00744-3; Stevens JF, 1999, J AGR FOOD CHEM, V47, P2421, DOI 10.1021/jf990101k; Strathmann J, 2010, FASEB J, V24, P2938, DOI 10.1096/fj.10-155846; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Tserng KY, 1996, METABOLISM, V45, P162, DOI 10.1016/S0026-0495(96)90047-5; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Wada F, 1977, Biochim Biophys Acta, V487, P361; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Zarse K, 2012, CELL METAB, V15, P451, DOI 10.1016/j.cmet.2012.02.013; Zmijewski JW, 2010, J BIOL CHEM, V285, P33154, DOI 10.1074/jbc.M110.143685; Zoll J, 2003, J CELL PHYSIOL, V194, P186, DOI 10.1002/jcp.10224	65	62	64	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					19000	19013		10.1074/jbc.M112.445452	http://dx.doi.org/10.1074/jbc.M112.445452			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23673658	Green Published, hybrid			2022-12-25	WOS:000321335800036
J	Tartof, S; Cohn, A; Tarbangdo, F; Djingarey, MH; Messonnier, N; Clark, TA; Kambou, JL; Novak, R; Diomande, FVK; Medah, I; Jackson, ML				Tartof, Sara; Cohn, Amanda; Tarbangdo, Felix; Djingarey, Mamoudou H.; Messonnier, Nancy; Clark, Thomas A.; Kambou, Jean Ludovic; Novak, Ryan; Diomande, Fabien V. K.; Medah, Isaie; Jackson, Michael L.			Identifying Optimal Vaccination Strategies for Serogroup A Neisseria meningitidis Conjugate Vaccine in the African Meningitis Belt	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; MENINGOCOCCAL CARRIAGE; UNITED-KINGDOM; ANTIBODY PERSISTENCE; EPIDEMIC MENINGITIS; DISEASE; IMPACT; MODEL; IMMUNOGENICITY; TRANSMISSION	Objective: The optimal long-term vaccination strategies to provide population-level protection against serogroup A Neisseria meningitidis (MenA) are unknown. We developed an age-structured mathematical model of MenA transmission, colonization, and disease in the African meningitis belt, and used this model to explore the impact of various vaccination strategies. Methods: The model stratifies the simulated population into groups based on age, infection status, and MenA antibody levels. We defined the model parameters (such as birth and death rates, age-specific incidence rates, and age-specific duration of protection) using published data and maximum likelihood estimation. We assessed the validity of the model by comparing simulated incidence of invasive MenA and prevalence of MenA carriage to observed incidence and carriage data. Results: The model fit well to observed age-and season-specific prevalence of carriage (mean pseudo-R2 0.84) and incidence of invasive disease (mean R2 0.89). The model is able to reproduce the observed dynamics of MenA epidemics in the African meningitis belt, including seasonal increases in incidence, with large epidemics occurring every eight to twelve years. Following a mass vaccination campaign of all persons 1-29 years of age, the most effective modeled vaccination strategy is to conduct mass vaccination campaigns every 5 years for children 1-5 years of age. Less frequent campaigns covering broader age groups would also be effective, although somewhat less so. Introducing conjugate MenA vaccine into the EPI vaccination schedule at 9 months of age results in higher predicted incidence than periodic mass campaigns. Discussion: We have developed the first mathematical model of MenA in Africa to incorporate age structures and progressively waning protection over time. Our model accurately reproduces key features of MenA epidemiology in the African meningitis belt. This model can help policy makers consider vaccine program effectiveness when determining the feasibility and benefits of MenA vaccination strategies.	[Tartof, Sara; Cohn, Amanda; Messonnier, Nancy; Clark, Thomas A.; Novak, Ryan; Diomande, Fabien V. K.] Ctr Dis Control & Prevent, Meningitis & Vaccine Preventable Dis Branch, Atlanta, GA 30333 USA; [Tarbangdo, Felix; Kambou, Jean Ludovic; Medah, Isaie] Minist Sante, Direct Lutte Malad, Ouagadougou, Burkina Faso; [Djingarey, Mamoudou H.; Diomande, Fabien V. K.] WHO, Intercountry Support Team West Africa, Ouagadougou, Burkina Faso; [Jackson, Michael L.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA	Centers for Disease Control & Prevention - USA; World Health Organization; Group Health Cooperative	Tartof, S (corresponding author), Ctr Dis Control & Prevent, Meningitis & Vaccine Preventable Dis Branch, Atlanta, GA 30333 USA.	startof@gmail.com		Tartof, Sara/0000-0003-2336-8476	Centers for Disease Control and Prevention [797VE0001]; Modeling Vaccination Strategies for Serogroup A Meningococcal Disease in Africa	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Modeling Vaccination Strategies for Serogroup A Meningococcal Disease in Africa	This work was funded by the Centers for Disease Control and Prevention under contract #797VE0001, Modeling Vaccination Strategies for Serogroup A Meningococcal Disease in Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RM, 1985, J HYG-CAMBRIDGE, V94, P365, DOI 10.1017/S002217240006160X; Andrews N, 2003, CLIN DIAGN LAB IMMUN, V10, P780, DOI 10.1128/CDLI.10.5.780-786.2003; Bicaba A, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-S1-S12; BLAKEBROUGH IS, 1982, J INFECT DIS, V146, P626, DOI 10.1093/infdis/146.5.626; Borrow R, 2010, CLIN VACCINE IMMUNOL, V17, P154, DOI 10.1128/CVI.00384-09; Campagne G, 1999, B WORLD HEALTH ORGAN, V77, P499; Coen PG, 1999, EPIDEMIOL INFECT, V123, P389, DOI 10.1017/S0950268899002952; Djingarey M, 2008, 16 INT PATH NEISS C; Frasch CE, 2009, VACCINE, V27, pB112, DOI 10.1016/j.vaccine.2009.04.065; Goldstein Susan, 2011, Morbidity and Mortality Weekly Report, V60, P1520; GREENWOOD BM, 1985, LANCET, V2, P829, DOI 10.1016/S0140-6736(85)90812-8; Irving TJ, 2011, EPIDEMIOL INFECT, P1; Jackson ML, 2012, EMERG INFECT DIS, V18, P13, DOI 10.3201/eid1801.110336; Jodar L, 2003, LANCET, V361, P1902, DOI 10.1016/S0140-6736(03)13494-0; Kristiansen PA, 2012, CLIN INFECT IN PRESS; Kristiansen PA, 2011, CLIN VACCINE IMMUNOL, V18, P435, DOI 10.1128/CVI.00479-10; Kshirsagar N, 2007, VACCINE, V25, pA101, DOI 10.1016/j.vaccine.2007.04.050; LaForce FM, 2007, VACCINE, V25, pA97, DOI 10.1016/j.vaccine.2007.04.049; LAPEYSSONNIE L, 1963, Bull World Health Organ, V28 Suppl, P1; Maiden MCJ, 2008, J INFECT DIS, V197, P737, DOI 10.1086/527401; Mcveron J, 2008, EPIDEMIOL INFECT, V136, P800, DOI 10.1017/S0950268807009168; Molesworth AM, 2003, EMERG INFECT DIS, V9, P1287; Molesworth AM, 2002, T ROY SOC TROP MED H, V96, P242, DOI 10.1016/S0035-9203(02)90089-1; MOORE PS, 1992, CLIN INFECT DIS, V14, P515, DOI 10.1093/clinids/14.2.515; MOORE PS, 1989, LANCET, V2, P260; Mueller JE, 2010, INT J INFECT DIS, V14, pE553, DOI 10.1016/j.ijid.2009.08.013; Novak RT, 2012, LANCET INFECT DIS; Odusanya OO, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-381; Ouandaogo CR, 2012, VACCINE; Perrett KP, 2010, CLIN INFECT DIS, V50, P1601, DOI 10.1086/652765; Roberts L, 2008, SCIENCE, V320, P1710, DOI 10.1126/science.320.5884.1710; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Snape MD, 2008, BRIT MED J, V336, P1487, DOI 10.1136/bmj.39563.545255.AE; Sow SO, 2011, NEW ENGL J MED, V364, P2293, DOI 10.1056/NEJMoa1003812; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Taha MK, 2002, TRENDS MICROBIOL, V10, P376, DOI 10.1016/S0966-842X(02)02402-2; Teyssou R, 2007, VACCINE, V25, pA3, DOI 10.1016/j.vaccine.2007.04.032; Trotter CL, 2006, EPIDEMIOL INFECT, V134, P556, DOI 10.1017/S0950268805005339; Trotter CL, 2007, LANCET INFECT DIS, V7, P797, DOI 10.1016/S1473-3099(07)70288-8; Trotter CL, 2005, AM J EPIDEMIOL, V162, P89, DOI 10.1093/aje/kwi160; Trotter CL, 2004, LANCET, V364, P365, DOI 10.1016/S0140-6736(04)16725-1; *WHO, 1998, WHOEMCBAC983; World Health Organization, 2011, WHO MEN WEEKL REP; World Health Organization, 2012, WHO MEN WEEKL REP	44	31	31	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63605	10.1371/journal.pone.0063605	http://dx.doi.org/10.1371/journal.pone.0063605			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671685	gold, Green Submitted, Green Published			2022-12-25	WOS:000319737700054
J	Leclerc, M; Dore, T; Gilligan, CA; Lucas, P; Filipe, JAN				Leclerc, Melen; Dore, Thierry; Gilligan, Christopher A.; Lucas, Philippe; Filipe, Joao A. N.			Host Growth Can Cause Invasive Spread of Crops by Soilborne Pathogens	PLOS ONE			English	Article							RHIZOCTONIA-SOLANI; BIOLOGICAL-CONTROL; DISEASE EPIDEMICS; ROOT-ROT; DYNAMICS; BEHAVIOR; MODELS; PERSISTENCE; DISPERSAL; PROBABILITY	Invasive soilborne plant pathogens cause substantial damage to crops and natural populations, but our understanding of how to prevent their epidemics or reduce their damage is limited. A key and experimentally-tested concept in the epidemiology of soilborne plant diseases is that of a threshold spacing between hosts below which epidemics (invasive spread) can occur. We extend this paradigm by examining how plant-root growth may alter the conditions for occurrence of soilborne pathogen epidemics in plant populations. We hypothesise that host-root growth can 1) increase the probability of pathogen transmission between neighbouring plants and, consequently, 2) decrease the threshold spacing for epidemics to occur. We predict that, in systems initially below their threshold conditions, root growth can trigger soilborne pathogen epidemics through a switch from non-invasive to invasive behaviour, while in systems above threshold conditions root growth can enhance epidemic development. As an example pathosystem, we studied the fungus Rhizoctonia solani on sugar beet in field experiments. To address hypothesis 1, we recorded infections within inoculum-donor and host-recipient pairs of plants with differing spacing. We translated these observations into the individual-level concept of pathozone, a host-centred form of dispersal kernel. To test hypothesis 2 and our prediction, we used the pathozone to parameterise a stochastic model of pathogen spread in a host population, contrasting scenarios of spread with and without host growth. Our results support our hypotheses and prediction. We suggest that practitioners of agriculture and arboriculture account for root system expansion in order to reduce the risk of soilborne-disease epidemics. We discuss changes in crop design, including increasing plant spacing and using crop mixtures, for boosting crop resilience to invasion and damage by soilborne pathogens. We speculate that the disease-induced root growth observed in some pathosystems could be a pathogen strategy to increase its population through host manipulation.	[Leclerc, Melen; Lucas, Philippe] Univ Rennes 1, Agrocampus Ouest, INRA, Inst Genet Environm & Plant Protect, Le Rheu, France; [Dore, Thierry] AgroParisTech, Agron Grp, Thiverval Grignon, France; [Dore, Thierry] INRA, Agron Grp, F-78850 Thiverval Grignon, France; [Gilligan, Christopher A.; Filipe, Joao A. N.] Univ Cambridge, Dept Plant Sci, Epidemiol & Modelling Grp, Cambridge, England	INRAE; Institut Agro; Agrocampus Ouest; Universite de Rennes; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Cambridge	Leclerc, M (corresponding author), Univ Rennes 1, Agrocampus Ouest, INRA, Inst Genet Environm & Plant Protect, Le Rheu, France.	melenleclerc@gmail.com		Leclerc, Melen/0000-0002-5314-461X; Filipe, Joao/0000-0002-2353-7981	Institut Technique francais de la Betterave industrielle (ITB); UK's Biotechnology and Biological Sciences Research Council (BBSRC)	Institut Technique francais de la Betterave industrielle (ITB); UK's Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	ML thanks the Institut Technique francais de la Betterave industrielle (ITB) for funding this project. CAG and JANF were funded by the UK's Biotechnology and Biological Sciences Research Council (BBSRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RM, 1986, PHILOS T ROY SOC B, V314, P533, DOI 10.1098/rstb.1986.0072; Aoyagi T, 1998, PLANT DIS, V82, P857, DOI 10.1094/PDIS.1998.82.8.857; Arnott SA, 2000, P ROY SOC B-BIOL SCI, V267, P657, DOI 10.1098/rspb.2000.1052; Bailey DJ, 2000, NEW PHYTOL, V146, P535, DOI 10.1046/j.1469-8137.2000.00660.x; Bailey DJ, 1997, NEW PHYTOL, V136, P359, DOI 10.1046/j.1469-8137.1997.00774.x; Bailey DJ, 2004, PHYTOPATHOLOGY, V94, P535, DOI 10.1094/PHYTO.2004.94.5.535; Bailey NTJ, 1975, MATH THEORY INFECT D; Bolton MD, 2010, PHYTOPATHOLOGY, V100, P689, DOI 10.1094/PHYTO-100-7-0689; Boswell GP, 2007, B MATH BIOL, V69, P605, DOI 10.1007/s11538-005-9056-6; Brown DH, 2004, B MATH BIOL, V66, P341, DOI 10.1016/j.bulm.2003.08.006; Burdon JJ, 2006, ANNU REV PHYTOPATHOL, V44, P19, DOI 10.1146/annurev.phyto.43.040204.140238; BURDON JJ, 1982, ANNU REV PHYTOPATHOL, V20, P143, DOI 10.1146/annurev.py.20.090182.001043; Cairney JWG, 2005, MYCOL RES, V109, P7, DOI 10.1017/S0953756204001753; Cobb RC, 2012, J ECOL, V100, P712, DOI 10.1111/j.1365-2745.2012.01960.x; Ferrandino FJ, 2008, PHYTOPATHOLOGY, V98, P492, DOI 10.1094/PHYTO-98-5-0492; FERRISS RS, 1981, PHYTOPATHOLOGY, V71, P1229; Filipe JAN, 2004, B MATH BIOL, V66, P373, DOI 10.1016/j.bulm.2003.09.002; Filipe JAN, 2001, B MATH BIOL, V63, P603, DOI 10.1006/bulm.2001.0234; Filipe JAN, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002328; Gibson GJ, 2006, STAT COMPUT, V16, P391, DOI 10.1007/s11222-006-0019-z; Gilligan C. A., 1997, New Phytologist, V136, P343, DOI 10.1046/j.1469-8137.1997.00768.x; GILLIGAN CA, 1985, PHYTOPATHOLOGY, V75, P61, DOI 10.1094/Phyto-75-61; GRASSBERGER P, 1983, MATH BIOSCI, V63, P157, DOI 10.1016/0025-5564(82)90036-0; HORDIJK PL, 1992, NEUROSCI LETT, V136, P193, DOI 10.1016/0304-3940(92)90047-B; Jacobs H, 2004, MYCOL RES, V108, P453, DOI 10.1017/S0953756204009840; Jeger MJ, 2004, ANNU REV PHYTOPATHOL, V42, P61, DOI 10.1146/annurev.phyto.42.040803.140427; JEGER MJ, 1987, NEW PHYTOL, V107, P459, DOI 10.1111/j.1469-8137.1987.tb00197.x; JEGER MJ, 1986, PLANT PATHOL, V35, P355, DOI 10.1111/j.1365-3059.1986.tb02026.x; Kleczkowski A, 1997, P ROY SOC B-BIOL SCI, V264, P979, DOI 10.1098/rspb.1997.0135; Kohl M, 2007, PLANT SOIL, V298, P145, DOI 10.1007/s11104-007-9347-9; Kot M, 1996, ECOLOGY, V77, P2027, DOI 10.2307/2265698; Lannou C, 2012, ANNU REV PHYTOPATHOL, V50, P319, DOI 10.1146/annurev-phyto-081211-173031; Lion S, 2006, P ROY SOC B-BIOL SCI, V273, P1063, DOI 10.1098/rspb.2005.3412; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Madden L. V., 2007, STUDY PLANT DIS EPID; Minogue KP, 1989, SPATIAL COMPONENTS P; Mordecai EA, 2011, ECOL MONOGR, V81, P429, DOI 10.1890/10-2241.1; Motisi N, 2013, PLANT PATHOL, V62, P69, DOI 10.1111/j.1365-3059.2012.02618.x; Motisi N, 2009, FIELD CROP RES, V113, P238, DOI 10.1016/j.fcr.2009.05.011; Mundt CC, 2002, ANNU REV PHYTOPATHOL, V40, P381, DOI 10.1146/annurev.phyto.40.011402.113723; Nandris D, 1996, EUR J FOREST PATHOL, V26, P25; NEWTON AC, 2009, DIS CONTROL CROPS BI, P162; Nilsson O, 1997, PHYSIOL PLANTARUM, V100, P463, DOI [10.1111/j.1399-3054.1997.tb03050.x, 10.1034/j.1399-3054.1997.1000307.x]; OGOSHI A, 1987, ANNU REV PHYTOPATHOL, V25, P125, DOI 10.1146/annurev.py.25.090187.001013; Otten W, 2005, ECOLOGY, V86, P1948, DOI 10.1890/04-1122; Park AW, 2001, OIKOS, V94, P162, DOI 10.1034/j.1600-0706.2001.10489.x; R Core Team, 2022, R LANG ENV STAT COMP; Raaijmakers JM, 2009, PLANT SOIL, V321, P341, DOI 10.1007/s11104-008-9568-6; RITZ K, 1995, FEMS MICROBIOL ECOL, V16, P269, DOI 10.1016/0168-6496(94)00090-J; ROBINSON D, 1994, NEW PHYTOL, V127, P635, DOI 10.1111/j.1469-8137.1994.tb02969.x; Sapoukhina N, 2010, ECOL MODEL, V221, P2793, DOI 10.1016/j.ecolmodel.2010.08.020; Stacey AJ, 2001, NEW PHYTOL, V150, P169, DOI 10.1046/j.1469-8137.2001.00082.x; Thrall PH, 1997, J ECOL, V85, P313, DOI 10.2307/2960504; Wilkinso D.J., 2006, STOCHASTIC MODELLING	56	7	7	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63003	10.1371/journal.pone.0063003	http://dx.doi.org/10.1371/journal.pone.0063003			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667560	Green Published, Green Submitted, gold			2022-12-25	WOS:000319055600050
J	Mackay, DF; Haw, S; Newby, DE; Langhorne, P; Lloyd, SM; McConnachie, A; Pell, JP				Mackay, Daniel F.; Haw, Sally; Newby, David E.; Langhorne, Peter; Lloyd, Suzanne M.; McConnachie, Alex; Pell, Jill P.			Impact of Scotland's Comprehensive, Smoke-Free Legislation on Stroke	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CIGARETTE-SMOKING; SECONDHAND SMOKE; PASSIVE SMOKING; ISCHEMIC-STROKE; RISK-FACTOR; HOSPITAL ADMISSIONS; CHINESE WOMEN; HEART-DISEASE; IMPLEMENTATION	Background: Previous studies have reported a reduction in acute coronary events following smoke-free legislation. Evidence is lacking on whether stroke is also reduced. The aim was to determine whether the incidence of stroke, overall and by sub-type, fell following introduction of smoke-free legislation across Scotland on 26 March 2006. Methods and Findings: A negative binomial regression model was used to determine whether the introduction of smoke-free legislation resulted in a step and/or slope change in stroke incidence. The model was adjusted for age-group, sex, socioeconomic deprivation quintile, urban/rural residence and month. Interaction tests were also performed. Routine hospital administrative data and death certificates were used to identify all hospital admissions and pre-hospital deaths due to stroke (ICD10 codes I61, I63 and I64) in Scotland between 2000 and 2010 inclusive. Prior to the legislation, rates of all stroke, intracerebral haemorrhage and unspecified stroke were decreasing, whilst cerebral infarction was increasing at 0.97% per annum. Following the legislation, there was a dramatic fall in cerebral infarctions that persisted for around 20 months. No visible effect was observed for other types of stroke. The model confirmed an 8.90% (95% CI 4.85, 12.77, p < 0.001) stepwise reduction in cerebral infarction at the time the legislation was implemented, after adjustment for potential confounders. Conclusions: Following introduction of national, comprehensive smoke-free legislation there was a selective reduction in cerebral infarction that was not apparent in other types of stroke.	[Mackay, Daniel F.; Lloyd, Suzanne M.; McConnachie, Alex; Pell, Jill P.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Haw, Sally] Univ Stirling, Sch Nursing Midwifery & Hlth, Stirling FK9 4LA, Scotland; [Newby, David E.] Univ Edinburgh, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland; [Langhorne, Peter] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland	University of Glasgow; University of Stirling; University of Edinburgh; University of Glasgow	Pell, JP (corresponding author), Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland.	jill.pell@glasgow.ac.uk	Newby, David Ernest/AAB-1364-2019; Lloyd, Suzanne/H-7424-2013	Pell, Jill/0000-0002-8898-7035	NHS Health Scotland; British Heart Foundation [RG/10/9/28286] Funding Source: researchfish	NHS Health Scotland; British Heart Foundation(British Heart Foundation)	This study was funded by a project grant from NHS Health Scotland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CS, 2004, STROKE, V35, P633, DOI 10.1161/01.STR.0000115751.45473.48; Barnoya J, 2005, CIRCULATION, V111, P2684, DOI 10.1161/CIRCULATIONAHA.104.492215; Bonita R, 1999, TOB CONTROL, V8, P156, DOI 10.1136/tc.8.2.156; DINTENFASS L, 1975, MED J AUSTRALIA, V1, P617, DOI 10.5694/j.1326-5377.1975.tb111612.x; DONNAN GA, 1989, LANCET, V2, P643; Edwards R, 2008, TOB CONTROL, V17, DOI 10.1136/tc.2007.020347; GILL JS, 1989, ARCH INTERN MED, V149, P2053, DOI 10.1001/archinte.149.9.2053; Glantz S, 1995, JAMA-J AM MED ASSOC, V272, P1047; Haw SJ, 2007, BRIT MED J, V335, P549, DOI 10.1136/bmj.39315.670208.47; He Y, 2008, CIRCULATION, V118, P1535, DOI 10.1161/CIRCULATIONAHA.108.784801; Herman PM, 2011, AM J PUBLIC HEALTH, V101, P491, DOI 10.2105/AJPH.2009.179572; Juster HR, 2007, AM J PUBLIC HEALTH, V97, P2035, DOI 10.2105/AJPH.2006.099994; KANNEL WB, 1982, NEW ENGL J MED, V306, P1018, DOI 10.1056/NEJM198204293061703; Law MR, 2003, PROG CARDIOVASC DIS, V46, P31, DOI 10.1016/S0033-0620(03)00078-1; Mackay DF, 2010, HEART, V96, P1525, DOI 10.1136/hrt.2010.199026; Mackay DF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026188; MCGILL HC, 1979, PREV MED, V8, P390, DOI 10.1016/0091-7435(79)90016-1; MEHTA P, 1982, PROSTA LEUKOTR MED, V9, P141, DOI 10.1016/0262-1746(82)90002-6; Naiman A, 2010, CAN MED ASSOC J, V182, P761, DOI 10.1503/cmaj.091130; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Ovbiagele B, 2006, CEREBROVASC DIS, V21, P260, DOI 10.1159/000091224; Panagiotakos DB, 2004, AM J MED, V116, P145, DOI 10.1016/j.amjmed.2003.07.019; Pell JP, 2008, NEW ENGL J MED, V359, P482, DOI 10.1056/NEJMsa0706740; Puranik R, 2003, PROG CARDIOVASC DIS, V45, P443, DOI 10.1053/pcad.2003.YPCAD13; Qureshi AI, 2005, STROKE, V36, pE74, DOI 10.1161/01.STR.0000177475.30281.7f; Raupach T, 2006, EUR HEART J, V27, P386, DOI 10.1093/eurheartj/ehi601; ROGERS RL, 1983, JAMA-J AM MED ASSOC, V250, P2796, DOI 10.1001/jama.250.20.2796; SANDLER DP, 1989, AM J PUBLIC HEALTH, V79, P163, DOI 10.2105/AJPH.79.2.163; Scottish Stroke Care Audit, 2011, NAT REP STROK SERV S; Semple S, 2007, TOB CONTROL, V16, P127, DOI 10.1136/tc.2006.018119; SHINTON R, 1989, BMJ-BRIT MED J, V298, P789, DOI 10.1136/bmj.298.6676.789; Whincup PH, 2004, BRIT MED J, V329, P200, DOI 10.1136/bmj.38146.427188.55; You RX, 1999, AM J PUBLIC HEALTH, V89, P572, DOI 10.2105/AJPH.89.4.572; Zhang XL, 2005, AM J EPIDEMIOL, V161, P213, DOI 10.1093/aje/kwi028	34	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62597	10.1371/journal.pone.0062597	http://dx.doi.org/10.1371/journal.pone.0062597			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	145YI	23667497	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000319055600032
J	van Knippenberg, I; Fragkoudis, R; Elliott, RM				van Knippenberg, Ingeborg; Fragkoudis, Rennos; Elliott, Richard M.			The Transient Nature of Bunyamwera Orthobunyavirus NSs Protein Expression: Effects of Increased Stability of NSs Protein on Virus Replication	PLOS ONE			English	Article							INTERFERON REGULATORY FACTOR-3; UBIQUITIN-PROTEASOME SYSTEM; CULTURED-CELLS; MOSQUITO CELLS; INHIBITION; INDUCTION; PRODUCT; STAT2; PHOSPHORYLATION; PARAMYXOVIRUSES	The NSs proteins of bunyaviruses are the viral interferon antagonists, counteracting the host's antiviral response to infection. During high-multiplicity infection of cultured mammalian cells with Bunyamwera orthobunyavirus (BUNV), NSs is rapidly degraded after reaching peak levels of expression at 12hpi. Through the use of inhibitors this was shown to be the result of proteasomal degradation. A recombinant virus (rBUN4KR), in which all four lysine residues in NSs were replaced by arginine residues, expresses an NSs protein (NSs4KR) that is resistant to degradation, confirming that degradation is lysine-dependent. However, despite repeated attempts, no direct ubiquitylation of NSs in infected cells could be demonstrated. This suggests that degradation of NSs, although lysine-dependent, may be achieved through an indirect mechanism. Infection of cultured mammalian cells or mice indicated no disadvantage for the virus in having a non-degradable NSs protein: in fact rBUN4KR had a slight growth advantage over wtBUNV in interferon-competent cells, presumably due to the increased and prolonged presence of NSs. In cultured mosquito cells there was no difference in growth between wild-type BUNV and rBUN4KR, but surprisingly NSs4KR was not stabilised compared to the wild-type NSs protein.	[van Knippenberg, Ingeborg; Elliott, Richard M.] Univ St Andrews, Biomed Sci Res Ctr, St Andrews, Fife, Scotland; [Fragkoudis, Rennos] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; [Fragkoudis, Rennos] Univ Edinburgh, Ctr Infect Dis, Edinburgh, Midlothian, Scotland	University of St Andrews; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Elliott, RM (corresponding author), Univ Glasgow, MRC, Ctr Virus Res, Glasgow, Lanark, Scotland.	richard.elliott@glasgow.ac.uk			Wellcome Trust [079810, 099220]; BBSRC [BBS/E/I/00001735, BBS/E/I/00001699] Funding Source: UKRI; MRC [G0801822] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001699, BBS/E/I/00001735] Funding Source: researchfish; Medical Research Council [G0801822] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Wellcome Trust (Programme Grant 079810 and Senior Investigator Award 099220 to RME). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bridgen A, 1996, P NATL ACAD SCI USA, V93, P15400, DOI 10.1073/pnas.93.26.15400; Bridgen A, 2001, P NATL ACAD SCI USA, V98, P664, DOI 10.1073/pnas.98.2.664; Brower CS, 2002, P NATL ACAD SCI USA, V99, P10353, DOI 10.1073/pnas.162424199; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; Chen YI, 2008, J VIROL METHODS, V151, P95, DOI 10.1016/j.jviromet.2008.03.016; Colon-Ramos DA, 2003, MOL BIOL CELL, V14, P4162, DOI 10.1091/mbc.E03-03-0139; Contin R, 2011, J VIROL, V85, P2781, DOI 10.1128/JVI.01631-10; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Delboy MG, 2008, J VIROL, V82, P3381, DOI 10.1128/JVI.02296-07; Elliott J, 2007, J VIROL, V81, P3428, DOI 10.1128/JVI.02303-06; Elliott RM, 2009, VIRUSES-BASEL, V1, P1003, DOI 10.3390/v1031003; Elliott RM, 2011, MOL BIOL ORTHOBUNYAV; Fernandez-Garcia MD, 2011, J VIROL, V85, P2980, DOI 10.1128/JVI.02483-10; Fragkoudis R, 2007, J GEN VIROL, V88, P3373, DOI 10.1099/vir.0.83191-0; Garigliany MM, 2012, ANTIVIR RES, V95, P82, DOI 10.1016/j.antiviral.2012.05.014; Hale BG, 2009, VIROLOGY, V383, P6, DOI 10.1016/j.virol.2008.10.002; Hart TJ, 2009, ZOONOSES PUBLIC HLTH, V56, P285, DOI 10.1111/j.1863-2378.2008.01166.x; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hilton L, 2006, J VIROL, V80, P11723, DOI 10.1128/JVI.01145-06; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Khor R, 2003, TRAFFIC, V4, P857, DOI 10.1046/j.1398-9219.2003.0140.x; Killip MJ, 2012, J GEN VIROL, V93, P299, DOI 10.1099/vir.0.037531-0; Kohl A, 2003, J VIROL, V77, P7999, DOI 10.1128/JVI.77.14.7999-8008.2003; Leonard VHJ, 2006, J VIROL, V80, P9667, DOI 10.1128/JVI.00822-06; Liu J, 2007, VIRUS GENES, V35, P719, DOI 10.1007/s11262-007-0147-3; Lopez T, 2011, J VIROL, V85, P11964, DOI 10.1128/JVI.05286-11; Lowen AC, 2005, J VIROL, V79, P6940, DOI 10.1128/JVI.79.11.6940-6946.2005; Lowen AC, 2004, VIROLOGY, V330, P493, DOI 10.1016/j.virol.2004.10.009; Lupfer C, 2010, VIRUS RES, V149, P36, DOI 10.1016/j.virusres.2009.12.010; Neznanov N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001887; Nichol ST, 2001, CH49 BUN; Ohh M, 2002, EMBO REP, V3, P177, DOI 10.1093/embo-reports/kvf028; PATEL AH, 1992, J GEN VIROL, V73, P389, DOI 10.1099/0022-1317-73-2-389; Precious B, 2005, J VIROL, V79, P13434, DOI 10.1128/JVI.79.21.13434-13441.2005; Precious B, 2005, J GEN VIROL, V86, P151, DOI 10.1099/vir.0.80263-0; Raaben M, 2010, J VIROL, V84, P7869, DOI 10.1128/JVI.00485-10; SCALLAN MF, 1992, J GEN VIROL, V73, P53, DOI 10.1099/0022-1317-73-1-53; Seago J, 2010, J GEN VIROL, V91, P721, DOI 10.1099/vir.0.015545-0; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Szemiel AM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001823; Teale A, 2009, J VIROL, V83, P2099, DOI 10.1128/JVI.01753-08; Thomas D, 2004, J BIOL CHEM, V279, P31471, DOI 10.1074/jbc.M400938200; van Knippenberg I, 2010, J GEN VIROL, V91, P2002, DOI 10.1099/vir.0.021774-0; Wang HB, 2010, NAT GENET, V42, P83, DOI 10.1038/ng.498; Weber F, 2002, J VIROL, V76, P7949, DOI 10.1128/JVI.76.16.7949-7955.2002; Weber F, 2001, VIROLOGY, V281, P67, DOI 10.1006/viro.2000.0774; Yang YL, 2007, CANCER RES, V67, P9472, DOI 10.1158/0008-5472.CAN-07-0568; Young JA, 2011, J BIOL CHEM, V286, P6521, DOI 10.1074/jbc.M110.172288; Zhadina M, 2007, P NATL ACAD SCI USA, V104, P20031, DOI 10.1073/pnas.0708002104	49	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e64137	10.1371/journal.pone.0064137	http://dx.doi.org/10.1371/journal.pone.0064137			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667701	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000319055600086
J	Li, X; Wang, H; Gan, SH; Jiang, DQ; Tian, GM; Zhang, ZJ				Li, Xia; Wang, Hang; Gan, ShaoHua; Jiang, DaQian; Tian, GuangMing; Zhang, ZhiJian			Eco-Stoichiometric Alterations in Paddy Soil Ecosystem Driven by Phosphorus Application	PLOS ONE			English	Article							ECOENZYMATIC STOICHIOMETRY; ENZYME-ACTIVITY; ORGANIC-CARBON; CROP ROTATIONS; NUTRIENT; NITROGEN; FERTILIZER; FIELD; MANURE; LIMITATION	Agricultural fertilization may change processes of elemental biogeochemical cycles and alter the ecological function. Ecoenzymatic stoichiometric feature plays a critical role in global soil carbon (C) metabolism, driving element cycles, and mediating atmospheric composition in response to agricultural nutrient management. Despite the importance on crop growth, the role of phosphorous (P) in compliance with eco-stoichiometry on soil C and nitrogen (N) sequestration in the paddy field remains poorly understood in the context of climate change. Here, we collected soil samples from a field experiment after 6 years of chemical P application at a gradient of 0 (P-0), 30 (P-30), 60 (P-60), and 90 (P-90) kg ha(-1) in order to evaluate the role of P on stoichiometric properties in terms of soil chemical, microbial biomass, and eco-enzyme activities as well as greenhouse gas (GHG: CO2, N2O and CH4) emissions. Continuous P input increased soil total organic C and N by 1.3-9.2% and 3%-13%, respectively. P input induced C and N limitations as indicated by the decreased ratio of C:P and N:P in the soil and microbial biomass. A synergistic mechanism among the ecoenzymatic stoichiometry, which regulated the ecological function of microbial C and N acquisition and were stoichiometrically related to P input, stimulated soil C and N sequestration in the paddy field. The lower emissions of N2O and CH4 under the higher P application (P-60 and P-90) in July and the insignificant difference in N2O emission in August compared to P-30; however, continuous P input enhanced CO2 fluxes for both samplings. There is a technical conflict for simultaneously regulating three types of GHGs in terms of the eco-stoichiometry mechanism under P fertilization. Thus, it is recommended that the P input in paddy fields not exceed 60 kg ha(-1) may maximize soil C sequestration, minimize P export, and guarantee grain yields.	[Li, Xia; Wang, Hang; Gan, ShaoHua; Tian, GuangMing; Zhang, ZhiJian] Zhejiang Univ, Coll Environm & Resource Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Jiang, DaQian; Zhang, ZhiJian] Columbia Univ, Dept Earth & Environm Engn, New York, NY USA; [Zhang, ZhiJian] Zhejiang Univ, China Acad West Reg Dev, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Columbia University; Zhejiang University	Zhang, ZJ (corresponding author), Zhejiang Univ, Coll Environm & Resource Sci, Hangzhou 310003, Zhejiang, Peoples R China.	zhangzhijian@zju.edu.cn			Natural Science Foundation of China [40701162]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by Natural Science Foundation of China (40701162)(http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adviento-Borbe MAA, 2007, GLOBAL CHANGE BIOL, V13, P1972, DOI 10.1111/j.1365-2486.2007.01421.x; Allen AP, 2009, ECOL LETT, V12, P369, DOI 10.1111/j.1461-0248.2009.01302.x; Bao S.D., 2000, AGROCHEMICAL ANAL SO, P78; Bell LW, 2012, AGR ECOSYST ENVIRON, V158, P156, DOI 10.1016/j.agee.2012.06.006; Bradford MA, 2008, FUNCT ECOL, V22, P964, DOI 10.1111/j.1365-2435.2008.01404.x; BROOKES PC, 1982, SOIL BIOL BIOCHEM, V14, P319, DOI 10.1016/0038-0717(82)90001-3; Cai ZC, 2012, SCI CHINA EARTH SCI, V55, P173, DOI 10.1007/s11430-011-4309-8; Cherif M, 2009, P ROY SOC B-BIOL SCI, V276, P487, DOI 10.1098/rspb.2008.0560; Ciampitti IA, 2011, SOIL SCI SOC AM J, V75, P616, DOI 10.2136/sssaj2010.0168; Cleveland CC, 2007, BIOGEOCHEMISTRY, V85, P235, DOI 10.1007/s10533-007-9132-0; Davidson EA, 2009, NAT GEOSCI, V2, P659, DOI 10.1038/NGEO608; Falkowski P, 2000, SCIENCE, V290, P291, DOI 10.1126/science.290.5490.291; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; German DP, 2011, SOIL BIOL BIOCHEM, V43, P1387, DOI 10.1016/j.soilbio.2011.03.017; Hall EK, 2011, ECOSYSTEMS, V14, P261, DOI 10.1007/s10021-010-9408-4; Hessen DO, 2004, ECOLOGY, V85, P1179, DOI 10.1890/02-0251; Hill BH, 2012, ECOL INDIC, V18, P540, DOI 10.1016/j.ecolind.2012.01.007; Hobbie SE, 2002, PLANT SOIL, V242, P163, DOI 10.1023/A:1019670731128; Huang QR, 2009, PEDOSPHERE, V19, P727, DOI 10.1016/S1002-0160(09)60168-5; IRRI, 2009, WORLD RIC STAT ROUGH; Lee CH, 2010, AGR ECOSYST ENVIRON, V138, P343, DOI 10.1016/j.agee.2010.05.011; Liu DY, 2011, BIORESOURCE TECHNOL, V102, P9040, DOI 10.1016/j.biortech.2011.07.052; Ma K, 2011, FEMS MICROBIOL ECOL, V75, P446, DOI 10.1111/j.1574-6941.2010.01018.x; Marichal R, 2011, SOIL BIOL BIOCHEM, V43, P1528, DOI 10.1016/j.soilbio.2011.04.001; Marklein AR, 2012, NEW PHYTOL, V193, P696, DOI 10.1111/j.1469-8137.2011.03967.x; Moorhead DL, 2006, ECOL MONOGR, V76, P151, DOI 10.1890/0012-9615(2006)076[0151:ATMOLD]2.0.CO;2; OECD, 2000, ENV IND AGR METH RES; Peng PQ, 2005, CHIN J APPL ECOL, V16, P1872; Reganold JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012346; Saiya-Cork KR, 2002, SOIL BIOL BIOCHEM, V34, P1309, DOI 10.1016/S0038-0717(02)00074-3; Sander T, 2008, GEODERMA, V145, P303, DOI 10.1016/j.geoderma.2008.03.024; Shang QY, 2011, GLOBAL CHANGE BIOL, V17, P2196, DOI 10.1111/j.1365-2486.2010.02374.x; Shange RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040338; Shrestha M, 2010, ISME J, V4, P1545, DOI 10.1038/ismej.2010.89; Sims JT, 1998, J ENVIRON QUAL, V27, P277, DOI 10.2134/jeq1998.00472425002700020006x; Sinsabaugh RL, 2008, ECOL LETT, V11, P1252, DOI 10.1111/j.1461-0248.2008.01245.x; Sinsabaugh RL, 2012, ANNU REV ECOL EVOL S, V43, P313, DOI 10.1146/annurev-ecolsys-071112-124414; Sinsabaugh RL, 2009, NATURE, V462, P795, DOI 10.1038/nature08632; Snyder CS, 2009, AGR ECOSYST ENVIRON, V133, P247, DOI 10.1016/j.agee.2009.04.021; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Taylor PG, 2010, NATURE, V464, P1178, DOI 10.1038/nature08985; Vitousek PM, 2009, SCIENCE, V324, P1519, DOI 10.1126/science.1170261; Vitousek PM, 2010, ECOL APPL, V20, P5, DOI 10.1890/08-0127.1; Wang DanYing, 2010, Acta Agriculturae Zhejiangensis, V22, P330; Wang K, 2001, CHEMOSPHERE, V42, P209, DOI 10.1016/S0045-6535(00)00127-2; WU J, 1990, SOIL BIOL BIOCHEM, V22, P1167, DOI 10.1016/0038-0717(90)90046-3; Yu Q, 2010, ECOL LETT, V13, P1390, DOI 10.1111/j.1461-0248.2010.01532.x; Zhang Y., 2012, PLOS ONE, V7; Zhang ZJ, 2011, ENVIRON TECHNOL, V32, P197, DOI 10.1080/09593330.2010.494689; Zhang ZJ, 2007, ENVIRON POLLUT, V145, P425, DOI 10.1016/j.envpol.2006.05.031	50	22	27	9	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e61141	10.1371/journal.pone.0061141	http://dx.doi.org/10.1371/journal.pone.0061141			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667435	Green Published, gold, Green Submitted			2022-12-25	WOS:000319654700010
J	Monson, BB; Han, S; Purves, D				Monson, Brian B.; Han, Shui'Er; Purves, Dale			Are Auditory Percepts Determined by Experience?	PLOS ONE			English	Article							BASILAR-MEMBRANE; LOUDNESS; PITCH; STATISTICS; FREQUENCY; INTENSITY; RESPONSES; SPEECH; TONES; SOUND	Audition-what listeners hear-is generally studied in terms of the physical properties of sound stimuli and physiological properties of the auditory system. Based on recent work in vision, we here consider an alternative perspective that sensory percepts are based on past experience. In this framework, basic auditory qualities (e.g., loudness and pitch) are based on the frequency of occurrence of stimulus patterns in natural acoustic stimuli. To explore this concept of audition, we examined five well-documented psychophysical functions. The frequency of occurrence of acoustic patterns in a database of natural sound stimuli (speech) predicts some qualitative aspects of these functions, but with substantial quantitative discrepancies. This approach may offer a rationale for auditory phenomena that are difficult to explain in terms of the physical attributes of the stimuli as such.	[Monson, Brian B.; Han, Shui'Er; Purves, Dale] Duke NUS Grad Med Sch, Neurosci & Behav Disorders Program, Singapore, Singapore; [Purves, Dale] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Purves, Dale] Duke Univ, Ctr Cognit Neurosci, Durham, NC USA	National University of Singapore; Duke University; Duke University	Monson, BB (corresponding author), Duke NUS Grad Med Sch, Neurosci & Behav Disorders Program, Singapore, Singapore.	brian.monson@duke-nus.edu.sg		Monson, Brian/0000-0002-0179-8179	NSF [0924181]; Duke-NUS Block Grant	NSF(National Science Foundation (NSF)); Duke-NUS Block Grant	This work was funded in part by NSF Award 0924181 and part of the study was funded by a Duke-NUS Block Grant awarded to author DP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, AC NORM EQ LOUDN LEV; ANSI, 2007, PROC COMP LOUDN STEA; Attias H, 1997, ADV NEUR IN, V9, P27; BECK J, 1961, AM J PSYCHOL, V74, P242, DOI 10.2307/1419409; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Boersma P., 1993, IFA P, V17, P97; Buus S, 1998, J ACOUST SOC AM, V104, P399, DOI 10.1121/1.423295; COHEN A, 1961, J ACOUST SOC AM, V33, P1363, DOI 10.1121/1.1908441; Cousineau M, 2010, J ACOUST SOC AM, V128, pEL236, DOI 10.1121/1.3499701; Fletcher H, 1934, J ACOUST SOC AM, V6, P59, DOI 10.1121/1.1915704; Fletcher H, 1933, J ACOUST SOC AM, V5, P82, DOI 10.1121/1.1915637; FLETCHER H, 1950, J ACOUST SOC AM, V22, P89, DOI 10.1121/1.1906605; Geisler WS, 2002, NAT NEUROSCI, V5, P508, DOI 10.1038/nn0602-508; Helmholtz Hv, 1924, HELMHOLTZS TREATISE; Houtsma AJM, 1995, PITCH PERCEPTION, P267; Jesteadt W, 2011, SPRINGER HANDB AUDIT, V37, P109, DOI 10.1007/978-1-4419-6712-1_5; Koohler W, 1947, GESTALT PSYCHOL INTR, V5, P3; LADEFOGED P, 1957, J ACOUST SOC AM, V29, P98, DOI 10.1121/1.1908694; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; Lewicki MS, 2002, NAT NEUROSCI, V5, P356, DOI 10.1038/nn831; Lotto AJ, 2006, PERCEPT PSYCHOPHYS, V68, P178, DOI 10.3758/BF03193667; Lythgoe JN, 1979, ECOLOGY VISION, Vxii; McDermott JH, 2011, NEURON, V71, P926, DOI 10.1016/j.neuron.2011.06.032; Miskiewicz A, 2012, J ACOUST SOC AM, V131, P987, DOI 10.1121/1.3651094; Monson BB, 2012, J ACOUST SOC AM, V132, P1754, DOI 10.1121/1.4742724; Moore BC, 2012, INTRO PSYCHOL HEARIN; Moore BCJ, 1997, J AUDIO ENG SOC, V45, P224; Moore BCJ, 2003, OTOL NEUROTOL, V24, P243, DOI 10.1097/00129492-200303000-00019; Moore BCJ, 2002, HEARING RES, V163, P101, DOI 10.1016/S0378-5955(01)00390-2; MORGAN CT, 1951, J ACOUST SOC AM, V23, P658, DOI 10.1121/1.1906817; Plack CJ, 2005, SPR HDB AUD, V24, P7; POLLACK I, 1952, J ACOUST SOC AM, V24, P323, DOI 10.1121/1.1906900; Purves D, 2011, P NATL ACAD SCI USA, V108, P15588, DOI 10.1073/pnas.1012178108; Purves D, 2011, WHY WE SEE WHAT WE DO REDUX: A WHOLLY EMPIRICAL THEORY OF VISION, P1; Relkin EM, 1997, J ACOUST SOC AM, V101, P2735, DOI 10.1121/1.418561; Ruggero M A, 1992, Curr Opin Neurobiol, V2, P449, DOI 10.1016/0959-4388(92)90179-O; Ruggero MA, 1997, J ACOUST SOC AM, V101, P2151, DOI 10.1121/1.418265; Russell IJ, 1997, P NATL ACAD SCI USA, V94, P2660, DOI 10.1073/pnas.94.6.2660; Schwartz DA, 2004, HEARING RES, V194, P31, DOI 10.1016/j.heares.2004.01.019; Smith EC, 2006, NATURE, V439, P978, DOI 10.1038/nature04485; Stevens SS, 1941, AM J PSYCHOL, V53, P329; Stevens SS, 1936, PSYCHOL REV, V43, P405, DOI 10.1037/h0058773; Stevens SS, 1935, J ACOUST SOC AM, V6, P150, DOI 10.1121/1.1915715; STEVENS SS, 1970, SCIENCE, V170, P1043, DOI 10.1126/science.170.3962.1043; Suzuki Y, 2004, J ACOUST SOC AM, V116, P918, DOI 10.1121/1.1763601; WARREN RM, 1974, COGNITIVE PSYCHOL, V6, P237, DOI 10.1016/0010-0285(74)90012-7; WEHNER R, 1987, J COMP PHYSIOL A, V161, P511, DOI 10.1007/BF00603659; ZENG FG, 1994, SCIENCE, V264, P564, DOI 10.1126/science.8160013; ZWICKER E, 1965, PSYCHOL REV, V72, P3, DOI 10.1037/h0021703	49	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63728	10.1371/journal.pone.0063728	http://dx.doi.org/10.1371/journal.pone.0063728			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667666	gold, Green Published, Green Submitted			2022-12-25	WOS:000319654700182
J	Smith, TC; Gebreyes, WA; Abley, MJ; Harper, AL; Forshey, BM; Male, MJ; Martin, HW; Molla, BZ; Sreevatsan, S; Thakur, S; Thiruvengadam, M; Davies, PR				Smith, Tara C.; Gebreyes, Wondwossen A.; Abley, Melanie J.; Harper, Abby L.; Forshey, Brett M.; Male, Michael J.; Martin, H. Wayne; Molla, Bayleyegn Z.; Sreevatsan, Srinand; Thakur, Siddhartha; Thiruvengadam, Madhumathi; Davies, Peter R.			Methicillin-Resistant Staphylococcus aureus in Pigs and Farm Workers on Conventional and Antibiotic-Free Swine Farms in the USA	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; HIGH PREVALENCE; NASAL CARRIAGE; ST398; MRSA; COLONIZATION; EPIDEMIOLOGY; TRANSMISSION; PNEUMONIA; EMERGENCE	Much uncertainty remains about the origin and public health implications of livestock-associated methicillin-resistant Staphylococcus aureus (LA-MRSA). This study aimed to investigate the occurrence and prevalence of MRSA in general and LA-MRSA in particular in pigs and farm workers in five states. We collected nasal swabs from pigs and farm workers at 45 swine herds (21 antibiotic-free herds; 24 conventional herds) in Illinois, Iowa, Minnesota, North Carolina and Ohio. MRSA was isolated from 50 of 1085 pigs (4.6%) and 31 of 148 (20.9%) of farm workers. MRSA-positive pigs and people were clustered in four conventional swine farms in Iowa and Illinois. Based on genotyping, spa type t034, a common livestock associated variant, was predominant among both human and swine isolates. These results confirm the presence of LA-MRSA in pigs and swine farm workers in the USA, but the prevalence found is relatively low compared with European studies.	[Smith, Tara C.; Harper, Abby L.; Forshey, Brett M.; Male, Michael J.] Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Ctr Emerging Infect Dis, Iowa City, IA 52242 USA; [Gebreyes, Wondwossen A.; Abley, Melanie J.; Molla, Bayleyegn Z.] Ohio State Univ, Dept Vet Prevent Med, Columbus, OH 43210 USA; [Martin, H. Wayne; Sreevatsan, Srinand; Thiruvengadam, Madhumathi; Davies, Peter R.] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA; [Thakur, Siddhartha] N Carolina State Univ, Coll Vet Med, Dept Populat Hlth & Pathobiol, Raleigh, NC USA	University of Iowa; University System of Ohio; Ohio State University; University of Minnesota System; University of Minnesota Twin Cities; University of North Carolina; North Carolina State University	Smith, TC (corresponding author), Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Ctr Emerging Infect Dis, Iowa City, IA 52242 USA.	tara-smith@uiowa.edu	Sreevatsan, Srinand/V-6808-2019	Sreevatsan, Srinand/0000-0002-5162-2403; Smith, Tara C./0000-0003-3747-1116; Thakur, Siddhartha/0000-0003-3787-9939	National Pork Board [08-178, 08-179, 08-180]	National Pork Board	Funded under grants 08-178, 08-179, and 08-180 from the National Pork Board (http://www.pork.org/Home.aspx#.UBgPJ7pCN8E). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup FM, 2010, VET MICROBIOL, V142, P455, DOI 10.1016/j.vetmic.2009.10.021; Cavaco LM, 2010, ANTIMICROB AGENTS CH, V54, P3605, DOI 10.1128/AAC.00058-10; Cavaco LM, 2011, VET MICROBIOL, V150, P344, DOI 10.1016/j.vetmic.2011.02.014; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476; Cuny C, 2010, INT J MED MICROBIOL, V300, P109, DOI 10.1016/j.ijmm.2009.11.002; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; Davies PR, 2011, EMERG INFECT DIS, V17, P1152, DOI [10.3201/eid/1706.101394, 10.3201/eid1706.101394]; de Neeling AJ, 2007, VET MICROBIOL, V122, P366, DOI 10.1016/j.vetmic.2007.01.027; Ekkelenkamp M B, 2006, Ned Tijdschr Geneeskd, V150, P2442; European Food Safety Authority (EFSA), 2009, EFSA J, V993, P1, DOI [10.2903/j.efsa.2009.993, DOI 10.2903/J.EFSA.2009.993]; Gibbs SG, 2006, ENVIRON HEALTH PERSP, V114, P1032, DOI 10.1289/ehp.8910; Graham PL, 2006, ANN INTERN MED, V144, P318, DOI 10.7326/0003-4819-144-5-200603070-00006; Graveland H, 2011, INT J MED MICROBIOL, V301, P630, DOI 10.1016/j.ijmm.2011.09.004; Graveland H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016830; Hartmeyer GN, 2010, SCAND J INFECT DIS, V42, P318, DOI 10.3109/00365540903510708; HUIJSDENS XW, 2009, EURO SURVEILL, V14; Khanna T, 2008, VET MICROBIOL, V128, P298, DOI 10.1016/j.vetmic.2007.10.006; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Koreen L, 2004, J CLIN MICROBIOL, V42, P792, DOI 10.1128/JCM.42.2.792-799.2004; Laupland KB, 2008, J INFECT DIS, V198, P336, DOI 10.1086/589717; Mammina C, 2010, SCAND J INFECT DIS, V42, P955, DOI 10.3109/00365548.2010.524662; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Shopsin B, 1999, J CLIN MICROBIOL, V37, P3556, DOI 10.1128/JCM.37.11.3556-3563.1999; Smith TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004258; Stefani S, 2010, INT J INFECT DIS, V14, pS19, DOI 10.1016/j.ijid.2010.05.009; van Cleef BAGL, 2010, EPIDEMIOL INFECT, V138, P756, DOI 10.1017/S0950268810000245; van Cleef BAGL, 2011, EMERG INFECT DIS, V17, P502, DOI 10.3201/eid1703.101036; van Cleef BAGL, 2011, J CLIN MICROBIOL, V49, P1030, DOI 10.1128/JCM.00493-10; van der Mee-Marquet N, 2011, CLIN INFECT DIS, V52, P152, DOI 10.1093/cid/ciq053; van Duijkeren E, 2008, VET MICROBIOL, V126, P383, DOI 10.1016/j.vetmic.2007.07.021; Vandendriessche S, 2011, J ANTIMICROB CHEMOTH, V66, P2455, DOI 10.1093/jac/dkr348; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428; Weese JS, 2011, ZOONOSES PUBLIC HLTH, V58, P238, DOI 10.1111/j.1863-2378.2010.01340.x; Weese JS, 2010, ILAR J, V51, P233, DOI 10.1093/ilar.51.3.233; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Wulf MWH, 2008, CLIN MICROBIOL INFEC, V14, P29, DOI 10.1111/j.1469-0691.2007.01873.x; Wulf MWH, 2012, EUR J CLIN MICROBIOL, V31, P61, DOI 10.1007/s10096-011-1269-z	37	89	93	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63704	10.1371/journal.pone.0063704	http://dx.doi.org/10.1371/journal.pone.0063704			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667659	Green Published, gold, Green Submitted			2022-12-25	WOS:000319654700177
J	Turdi, S; Hu, N; Ren, J				Turdi, Subat; Hu, Nan; Ren, Jun			Tauroursodeoxycholic Acid Mitigates High Fat Diet-Induced Cardiomyocyte Contractile and Intracellular Ca2+ Anomalies	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; ACTIVATED PROTEIN-KINASE; ER STRESS; URSODEOXYCHOLIC ACID; ISCHEMIA/REPERFUSION INJURY; CARDIOVASCULAR-DISEASE; CHEMICAL CHAPERONES; INSULIN-RESISTANCE; ADIPOSE-TISSUE; IN-VIVO	Objectives: The endoplasmic reticulum (ER) chaperone tauroursodeoxycholic acid (TUDCA) has exhibited promises in the treatment of obesity, although its impact on obesity-induced cardiac dysfunction is unknown. This study examined the effect of TUDCA on cardiomyocyte function in high-fat diet-induced obesity. Methods: Adult mice were fed low or high fat diet for 5 months prior to treatment of TUDCA (300 mg/kg. i.p., for 15d). Intraperitoneal glucose tolerance test (IPGTT), cardiomyocyte mechanical and intracellular Ca2+ property, insulin signaling molecules including IRS-1, Akt, AMPK, ACC, GSK-3 beta, c-Jun, ERK and c-Jun N terminal kinase (JNK) as well as ER stress and intracellular Ca2+ regulatory proteins were examined. Myocardial ultrastructure was evaluated using transmission electron microscopy (TEM). Results: High-fat diet depressed peak shortening (PS) and maximal velocity of shortening/relengthenin as well as prolonged relengthening duration. TUDCA reversed or overtly ameliorated high fat diet-induced cardiomyocyte dysfunction including prolongation in relengthening. TUDCA alleviated high-fat diet-induced decrease in SERCA2a and phosphorylation of phospholamban, increase in ER stress (GRP78/BiP, CHOP, phosphorylation of PERK, IRE1 alpha and eIF2 alpha), ultrastructural changes and mitochondrial permeation pore opening. High-fat diet feeding inhibited phosphorylation of AMPK and promoted phosphorylation of GSK-3 beta. TUDCA prevented high fat-induced dephosphorylation of AMPK but not GSK-3 beta. High fat diet promoted phosphorylation of IRS-1 (Ser(307)), JNK, and ERK without affecting c-Jun phosphorylation, the effect of which with the exception of ERK phosphorylation was attenuated by TUDCA. Conclusions: These data depict that TUDCA may ameliorate high fat diet feeding-induced cardiomyocyte contractile and intracellular Ca2+ defects through mechanisms associated with mitochondrial integrity, AMPK, JNK and IRS-1 serine phosphorylation.	[Turdi, Subat; Hu, Nan; Ren, Jun] Univ Wyoming, Coll Hlth Sci, Div Pharmaceut Sci, Ctr Cardiovasc Res & Alternat Med, Laramie, WY 82071 USA	University of Wyoming	Ren, J (corresponding author), Univ Wyoming, Coll Hlth Sci, Div Pharmaceut Sci, Ctr Cardiovasc Res & Alternat Med, Laramie, WY 82071 USA.	jren@uwyo.edu	Ren, Jun/ACG-5366-2022	Ren, Jun/0000-0002-0275-0783	American Diabetes Association [7-08-RA-130]; National Institutes of Health (NIH)/National Center for Research Resource (NCRR) [P20 RR016474]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016474] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); National Institutes of Health (NIH)/National Center for Research Resource (NCRR); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by American Diabetes Association 7-08-RA-130 and National Institutes of Health (NIH)/National Center for Research Resource (NCRR) P20 RR016474. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azfer A, 2006, AM J PHYSIOL-HEART C, V291, pH1411, DOI 10.1152/ajpheart.01378.2005; Boden G, 2008, DIABETES, V57, P2438, DOI 10.2337/db08-0604; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; Ceylan-Isik AF, 2011, J MOL CELL CARDIOL, V50, P107, DOI 10.1016/j.yjmcc.2010.10.023; Ceylan-Isik AF, 2010, J MOL CELL CARDIOL, V48, P367, DOI 10.1016/j.yjmcc.2009.11.003; Chen Y, 2008, AM J NEPHROL, V28, P1014, DOI 10.1159/000148209; Dong F, 2007, DIABETES, V56, P2201, DOI 10.2337/db06-1596; Dong F, 2009, OBESITY, V17, P262, DOI 10.1038/oby.2008.545; Dong YZ, 2010, DIABETES, V59, P1386, DOI 10.2337/db09-1637; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Eldar-Finkelman H, 1999, DIABETES, V48, P1662, DOI 10.2337/diabetes.48.8.1662; Engin F, 2010, DIABETES OBES METAB, V12, P108, DOI 10.1111/j.1463-1326.2010.01282.x; Fang YW, 2007, MOL PHARMACOL, V71, P1122, DOI 10.1124/mol.106.032060; Fu HY, 2008, CARDIOVASC RES, V79, P600, DOI 10.1093/cvr/cvn128; Groenendyk J, 2010, CIRC RES, V107, P1185, DOI 10.1161/CIRCRESAHA.110.227033; Guo R, 2009, J MOL CELL CARDIOL, V47, P228, DOI 10.1016/j.yjmcc.2009.03.018; Hardie DG, 2004, J CLIN INVEST, V114, P465, DOI 10.1172/JCI200422683; Hintz KK, 2003, INT J OBESITY, V27, P1196, DOI 10.1038/sj.ijo.0802389; Hwang JH, 2009, DIABETES, V58, P965, DOI 10.2337/db08-1183; Ikegami T, 2008, HEPATOL RES, V38, P123, DOI 10.1111/j.1872-034X.2007.00297.x; Kars M, 2010, DIABETES, V59, P1899, DOI 10.2337/db10-0308; Kim DS, 2007, BIOCHEM BIOPH RES CO, V363, P140, DOI 10.1016/j.bbrc.2007.08.151; Liu XH, 2008, SHOCK, V30, P422, DOI 10.1097/SHK.0b013e318164ca29; Martindale JJ, 2006, CIRC RES, V98, P1186, DOI 10.1161/01.RES.0000220643.65941.8d; Miki T, 2009, DIABETES, V58, P2863, DOI 10.2337/db09-0158; Minamino T, 2010, J MOL CELL CARDIOL, V48, P1105, DOI 10.1016/j.yjmcc.2009.10.026; Nickson P, 2007, CARDIOVASC RES, V73, P48, DOI 10.1016/j.cardiores.2006.10.001; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Oka S, 2011, CELL METAB, V14, P598, DOI 10.1016/j.cmet.2011.10.001; Okada K, 2004, CIRCULATION, V110, P705, DOI 10.1161/01.CIR.0000137836.95625.D4; Ouwens DM, 2007, DIABETOLOGIA, V50, P1938, DOI 10.1007/s00125-007-0735-8; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Ren J, 2009, OBESITY, V17, P1114, DOI 10.1038/oby.2009.8; Sohn J, 2003, CANCER LETT, V191, P83, DOI 10.1016/S0304-3835(02)00624-9; SULLIVAN PW, 2008, OBESITY SILVER SPRIN; Sussman MA, 2011, PHYSIOL REV, V91, P1023, DOI 10.1152/physrev.00024.2010; Szegezdi E, 2006, BIOCHEM BIOPH RES CO, V349, P1406, DOI 10.1016/j.bbrc.2006.09.009; Terai K, 2005, MOL CELL BIOL, V25, P9554, DOI 10.1128/MCB.25.21.9554-9575.2005; Toth Ambrus, 2007, Cardiovascular & Hematological Disorders - Drug Targets, V7, P205, DOI 10.2174/187152907781745260; Turdi S, 2011, J MOL CELL CARDIOL, V50, P712, DOI 10.1016/j.yjmcc.2010.12.007; Wilson CR, 2007, BIOCHEM J, V406, P457, DOI 10.1042/BJ20070392; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yie Q, 2002, HEPATOLOGY, V36, P592, DOI 10.1053/jhep.2002.35441; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Zalesin KC, 2008, ENDOCRIN METAB CLIN, V37, P663, DOI 10.1016/j.ecl.2008.06.004; Zhu JA, 2011, AM J PHYSIOL-HEART C, V300, pH922, DOI 10.1152/ajpheart.00860.2010	47	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63615	10.1371/journal.pone.0063615	http://dx.doi.org/10.1371/journal.pone.0063615			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667647	Green Published, gold, Green Submitted			2022-12-25	WOS:000319654700168
J	Vasireddy, V; Mills, JA; Gaddameedi, R; Basner-Tschakarjan, E; Kohnke, M; Black, AD; Alexandrov, K; Zhou, SZ; Maguire, AM; Chung, DC; Mac, H; Sullivan, L; Gadue, P; Bennicelli, JL; French, DL; Bennett, J				Vasireddy, Vidyullatha; Mills, Jason A.; Gaddameedi, Rajashekhar; Basner-Tschakarjan, Etiena; Kohnke, Monika; Black, Aaron D.; Alexandrov, Krill; Zhou, Shangzhen; Maguire, Albert M.; Chung, Daniel C.; Mac, Helen; Sullivan, Lisa; Gadue, Paul; Bennicelli, Jeannette L.; French, Deborah L.; Bennett, Jean			AAV-Mediated Gene Therapy for Choroideremia: Preclinical Studies in Personalized Models	PLOS ONE			English	Article							RAB ESCORT PROTEIN-1; PLURIPOTENT STEM-CELLS; LEBERS CONGENITAL AMAUROSIS; RETINAL-PIGMENT EPITHELIUM; CHM GENE; GERANYLGERANYL TRANSFERASE; EXPRESSION; TRANSGENE; MUTATIONS; DEGENERATION	Choroideremia (CHM) is an X- linked retinal degeneration that is symptomatic in the 1st or 2nd decade of life causing nyctalopia and loss of peripheral vision. The disease progresses through mid-life, when most patients become blind. CHM is a favorable target for gene augmentation therapy, as the disease is due to loss of function of a protein necessary for retinal cell health, Rab Escort Protein 1 (REP1). The CHM cDNA can be packaged in recombinant adeno-associated virus (rAAV), which has an established track record in human gene therapy studies, and, in addition, there are sensitive and quantitative assays to document REP1 activity. An animal model that accurately reflects the human condition is not available. In this study, we tested the ability to restore REP1 function in personalized in vitro models of CHM: lymphoblasts and induced pluripotent stems cells (iPSCs) from human patients. The initial step of evaluating safety of the treatment was carried out by evaluating for acute retinal histopathologic effects in normal-sighted mice and no obvious toxicity was identified. Delivery of the CHM cDNA to affected cells restores REP1 enzymatic activity and also restores proper protein trafficking. The gene transfer is efficient and the preliminary safety data are encouraging. These studies pave the way for a human clinical trial of gene therapy for CHM.	[Vasireddy, Vidyullatha; Gaddameedi, Rajashekhar; Black, Aaron D.; Maguire, Albert M.; Chung, Daniel C.; Bennicelli, Jeannette L.; Bennett, Jean] Univ Penn, Sch Med, Scheie Eye Inst, FM Kirby Ctr Mol Ophthalmol, Philadelphia, PA 19104 USA; [Mills, Jason A.; Basner-Tschakarjan, Etiena; Zhou, Shangzhen; Maguire, Albert M.; Chung, Daniel C.; Mac, Helen; Gadue, Paul; French, Deborah L.; Bennett, Jean] Childrens Hosp Philadelphia, Ctr Cellular & Mol Therapeut, Philadelphia, PA 19104 USA; [Kohnke, Monika; Alexandrov, Krill] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia; [Sullivan, Lisa] Childrens Hosp Philadelphia, Dept Anat Pathol, Philadelphia, PA 19104 USA; [Gadue, Paul; French, Deborah L.] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Queensland; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Bennett, J (corresponding author), Univ Penn, Sch Med, Scheie Eye Inst, FM Kirby Ctr Mol Ophthalmol, Philadelphia, PA 19104 USA.	jebennet@mail.med.upenn.edu			Choroideremia Research Foundation; Foundation Fighting Blindness Wynne-Gund TRAP Therapy [TA-GT-1211-05640UPA-WG]; Center for Cellular and Molecular Therapeutics at The Children's Hospital of Philadelphia; Paul and Evanina Mackall Foundation Trust; F.M. Kirby Center for Molecular Ophthalmology; Treatrush; Knights Templar Foundation; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R24EY019861] Funding Source: NIH RePORTER	Choroideremia Research Foundation; Foundation Fighting Blindness Wynne-Gund TRAP Therapy; Center for Cellular and Molecular Therapeutics at The Children's Hospital of Philadelphia; Paul and Evanina Mackall Foundation Trust; F.M. Kirby Center for Molecular Ophthalmology; Treatrush; Knights Templar Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors are grateful for support from The Choroideremia Research Foundation, Foundation Fighting Blindness Wynne-Gund TRAP Therapy grant TA-GT-1211-05640UPA-WG, the Center for Cellular and Molecular Therapeutics at The Children's Hospital of Philadelphia, Treatrush, Knights Templar Foundation, Research to Prevent Blindness, the Paul and Evanina Mackall Foundation Trust, and the F.M. Kirby Center for Molecular Ophthalmology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDROV K, 1994, EMBO J, V13, P5262, DOI 10.1002/j.1460-2075.1994.tb06860.x; Amado D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000659; Arland V, 2003, VISION RES, V43, P919, DOI 10.1016/S0042-6989(02)00389-9; Basiji DA, 2007, CLIN LAB MED, V27, P653, DOI 10.1016/j.cll.2007.05.008; Bennett J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002865; Coussa RG, 2012, OPHTHALMIC GENET, V33, P57, DOI 10.3109/13816810.2011.620056; Coussa RG, 2012, OPHTHALMIC GENET, V33, P66, DOI 10.3109/13816810.2011.623261; CREMERS FPM, 1994, J BIOL CHEM, V269, P2111; CREMERS FPM, 1990, AM J HUM GENET, V47, P622; Cremers Frans P. M., 1992, Human Molecular Genetics, V1, P71, DOI 10.1093/hmg/1.2.71; FLANNERY JG, 1990, INVEST OPHTH VIS SCI, V31, P229; Forsythe P, 1997, EXP EYE RES, V64, P487, DOI 10.1006/exer.1996.0200; Grimm D, 2003, BLOOD, V102, P2412, DOI 10.1182/blood-2003-02-0495; Herzog RW, 1999, THROMB HAEMOSTASIS, V82, P540, DOI 10.1055/s-0037-1615877; Hoffman LM, 1997, INVEST OPHTH VIS SCI, V38, P2224; Keiser NW, 2005, MOL VIS, V11, P1052; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Lerou PH, 2008, NAT PROTOC, V3, P923, DOI 10.1038/nprot.2008.60; Lerou PH, 2008, NAT BIOTECHNOL, V26, P212, DOI 10.1038/nbt1378; Lipinski D.M., 2012, PROG RETIN EYE RES; MacDonald IM, 2009, SURV OPHTHALMOL, V54, P401, DOI 10.1016/j.survophthal.2009.02.008; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Maguire AM, 2009, LANCET, V374, P1597, DOI 10.1016/S0140-6736(09)61836-5; McGrath KE, 2008, J IMMUNOL METHODS, V336, P91, DOI 10.1016/j.jim.2008.04.012; Meyer JS, 2009, P NATL ACAD SCI USA, V106, P16698, DOI 10.1073/pnas.0905245106; Perez-Cano HJ, 2009, AM J MED GENET A, V149A, P2134, DOI 10.1002/ajmg.a.32727; Pfeffer S, 2004, NAT REV MOL CELL BIO, V5, P886, DOI 10.1038/nrm1500; Phillips MJ, 2012, INVEST OPHTH VIS SCI, V53, P2007, DOI 10.1167/iovs.11-9313; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Polo JM, 2010, CELL STEM CELL, V7, P5, DOI 10.1016/j.stem.2010.05.018; Pylypenko O, 2003, MOL CELL, V11, P483, DOI 10.1016/S1097-2765(03)00044-3; Rafuse E V, 1968, Can J Ophthalmol, V3, P347; Rak A, 2004, CELL, V117, P749, DOI 10.1016/j.cell.2004.05.017; Raper SE, 2003, MOL GENET METAB, V80, P148, DOI 10.1016/j.ymgme.2003.08.016; SANKILA EM, 1992, NAT GENET, V1, P109, DOI 10.1038/ng0592-109; Seabra M. C., 2005, INVEST OPHTH VIS SCI, V46, P3556; SEABRA MC, 1992, CELL, V70, P1049, DOI 10.1016/0092-8674(92)90253-9; SEABRA MC, 1993, SCIENCE, V259, P377, DOI 10.1126/science.8380507; SEABRA MC, 1995, J BIOL CHEM, V270, P24420, DOI 10.1074/jbc.270.41.24420; Seabra MC, 1996, OPHTHALMIC GENET, V17, P43, DOI 10.3109/13816819609057869; Sergeev YV, 2009, MUTAT RES-FUND MOL M, V665, P44, DOI 10.1016/j.mrfmmm.2009.02.015; Simonelli F, 2010, MOL THER, V18, P643, DOI 10.1038/mt.2009.277; Somers A, 2010, STEM CELLS, V28, P1728, DOI 10.1002/stem.495; Strunnikova NV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008402; Tolmachova T, 2006, J CLIN INVEST, V116, P386, DOI 10.1172/JCI26617; Tolmachova T, 2012, J GENE MED, V14, P158, DOI 10.1002/jgm.1652; VANBOKHOVEN H, 1994, HUM MOL GENET, V3, P1047, DOI 10.1093/hmg/3.7.1047; vandenHurk JAJM, 1997, HUM MUTAT, V9, P110, DOI 10.1002/(SICI)1098-1004(1997)9:2<110::AID-HUMU2>3.3.CO;2-9; Vasireddy V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021193; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325	52	58	67	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e61396	10.1371/journal.pone.0061396	http://dx.doi.org/10.1371/journal.pone.0061396			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667438	Green Published, Green Submitted, gold			2022-12-25	WOS:000319654700012
J	Ryu, SW; Yoon, J; Yim, N; Choi, K; Choi, C				Ryu, Seung-Wook; Yoon, Jonghee; Yim, Nambin; Choi, Kyungsun; Choi, Chulhee			Downregulation of OPA3 Is Responsible for Transforming Growth Factor-beta-Induced Mitochondrial Elongation and F-Actin Rearrangement in Retinal Pigment Epithelial ARPE-19 Cells	PLOS ONE			English	Article							TGF-BETA; DYNAMICS; BIOGENESIS; FUSION; LIGASE; CANCER	Transforming growth factor-beta signaling is known to be a key signaling pathway in the induction of epithelial-mesenchymal transition. However, the mechanism of TGF-beta signaling in the modulation of EMT remains unclear. In this study, we found that TGF-beta treatment resulted in elongation of mitochondria accompanied by induction of N-cadherin, vimentin, and F-actin in retinal pigment epithelial cells. Moreover, OPA3, which plays a crucial role in mitochondrial dynamics, was downregulated following TGF-beta treatment. Suppression of TGF-beta signaling using Smad2 siRNA prevented loss of OPA3 induced by TGF-beta. Knockdown of OPA3 by siRNA and inducible shRNA significantly increased stress fiber levels, cell length, cell migration and mitochondrial elongation. In contrast, forced expression of OPA3 in ARPE-19 cells inhibited F-actin rearrangement and induced mitochondrial fragmentation. We also showed that Drp1 depletion increased cell length and induced rearrangement of F-actin. Depletion of Mfn1 blocked the increase in cell length during TGF-beta-mediated EMT. These results collectively substantiate the involvement of mitochondrial dynamics in TGF-beta-induced EMT.	[Ryu, Seung-Wook; Yoon, Jonghee; Yim, Nambin; Choi, Kyungsun; Choi, Chulhee] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea; [Ryu, Seung-Wook; Choi, Chulhee] Korea Adv Inst Sci & Technol, KI Biocentury, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Ryu, SW (corresponding author), Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea.	ryus@kaist.ac.kr; cchoi@kaist.ac.kr	Choi, Chulhee/C-1642-2011	Choi, Chulhee/0000-0001-5542-9136; Yoon, Jonghee/0000-0003-3886-2792	Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2012007370]; Korean Health Technology R & D project, the Ministry of Health & Welfare, Republic of Korea [A111025]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korean Health Technology R & D project, the Ministry of Health & Welfare, Republic of Korea	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (2012007370), and by the Korean Health Technology R & D project, the Ministry of Health & Welfare, Republic of Korea (A111025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alirol E, 2006, ONCOGENE, V25, P4706, DOI 10.1038/sj.onc.1209600; Arakaki N, 2006, BIOL PHARM BULL, V29, P1962, DOI 10.1248/bpb.29.1962; Braschi E, 2009, EMBO REP, V10, P748, DOI 10.1038/embor.2009.86; Chang CR, 2007, EMBO REP, V8, P1088, DOI 10.1038/sj.embor.7401118; Chen HC, 2005, HUM MOL GENET, V14, pR283, DOI 10.1093/hmg/ddi270; Choi K, 2012, MOL VIS, V18, P1010; Cicchini C, 2008, EXP CELL RES, V314, P143, DOI 10.1016/j.yexcr.2007.09.005; Favre C, 2010, ONCOGENE, V29, P3964, DOI 10.1038/onc.2010.146; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Groppe J, 2008, MOL CELL, V29, P157, DOI 10.1016/j.molcel.2007.11.039; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Jezek P, 2009, INT J BIOCHEM CELL B, V41, P1790, DOI 10.1016/j.biocel.2009.02.014; Kar R, 2010, BIOCHEM BIOPH RES CO, V399, P548, DOI 10.1016/j.bbrc.2010.07.108; Lee S, 2007, J BIOL CHEM, V282, P22977, DOI 10.1074/jbc.M700679200; Margineantu DH, 2002, MITOCHONDRION, V1, P425, DOI 10.1016/S1567-7249(02)00006-5; Martinez-Diez M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000107; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Park YY, 2010, J CELL SCI, V123, P619, DOI 10.1242/jcs.061481; Ryu SW, 2010, CELL MOL LIFE SCI, V67, P2839, DOI 10.1007/s00018-010-0365-z; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Wang XY, 2008, BBA-MOL BASIS DIS, V1782, P51, DOI 10.1016/j.bbadis.2007.11.002; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002	25	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e63495	10.1371/journal.pone.0063495	http://dx.doi.org/10.1371/journal.pone.0063495			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658835	Green Published, gold, Green Submitted			2022-12-25	WOS:000321202100068
J	Mello, A; Ding, GC; Piceno, YM; Napoli, C; Tom, LM; DeSantis, TZ; Andersen, GL; Smalla, K; Bonfante, P				Mello, Antonietta; Ding, Guo-Chun; Piceno, Yvette M.; Napoli, Chiara; Tom, Lauren M.; DeSantis, Todd Z.; Andersen, Gary L.; Smalla, Kornelia; Bonfante, Paola			Truffle Brules Have an Impact on the Diversity of Soil Bacterial Communities	PLOS ONE			English	Article							MYCORRHIZA HELPER BACTERIA; BLACK TRUFFLE; MICROBIAL COMMUNITIES; TUBER-MAGNATUM; RHIZOSPHERE; AMPLIFICATION; POPULATIONS; VOLATILES; PLANTS; DGGE	Background: The development of Tuber melanosporum mycorrhizal symbiosis is associated with the production of an area devoid of vegetation (commonly referred to by the French word 'brule') around the symbiotic plants and where the fruiting bodies of T. melanosporum are usually collected. The extent of the ecological impact of such an area is still being discovered. While the relationship between T. melanosporum and the other fungi present in the brule has been assessed, no data are available on the relationship between this fungus and the bacteria inhabiting the brule. Methodology/Principal Findings: We used DGGE and DNA microarrays of 16S rRNA gene fragments to compare the bacterial and archaeal communities inside and outside of truffle brules. Soil samples were collected in 2008 from four productive T. melanosporum/Quercus pubescens truffle-grounds located in Cahors, France, showing characteristic truffle brule. All the samples were analyzed by DGGE and one truffle-ground was analyzed also using phylogenetic microarrays. DGGE profiles showed differences in the bacterial community composition, and the microarrays revealed a few differences in relative richness between the brule interior and exterior zones, as well as differences in the relative abundance of several taxa. Conclusions/Significance: The different signal intensities we have measured for members of bacteria and archaea inside versus outside the brule are the first demonstration, to our knowledge, that not only fungal communities, but also other microorganisms are affected by T. melanosporum. Firmicutes (e.g., Bacillus), several genera of Actinobacteria, and a few Cyanobacteria had greater representation inside the brule compared with outside, whereas Pseudomonas and several genera within the class Flavobacteriaceae had higher relative abundances outside the brule. The findings from this study may contribute to future searches for microbial bio-indicators of brules.	[Mello, Antonietta] CNR, Turin UOS, Inst Plant Protect, I-00185 Rome, Italy; [Ding, Guo-Chun; Smalla, Kornelia] Julius Kuhn Inst, Braunschweig, Germany; [Piceno, Yvette M.; Tom, Lauren M.; DeSantis, Todd Z.; Andersen, Gary L.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Napoli, Chiara; Bonfante, Paola] Dept Life Sci & Syst Biol, Turin, Italy; [DeSantis, Todd Z.] Second Genome Inc, San Bruno, CA USA	Consiglio Nazionale delle Ricerche (CNR); Julius Kuhn-Institut; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Mello, A (corresponding author), CNR, Turin UOS, Inst Plant Protect, I-00185 Rome, Italy.	a.mello@ipp.cnr.it	Smalla, Kornelia/H-4002-2011; Bonfante, Paola/ABE-6733-2020; Mello, Antonietta/B-9101-2015; Mello, Antonietta/AFX-6601-2022; Andersen, Gary/G-2792-2015; ding, guo-chun/A-6821-2012; Tom, Lauren/E-9739-2015; Piceno, Yvette/I-6738-2016	Mello, Antonietta/0000-0002-6311-377X; Mello, Antonietta/0000-0002-6311-377X; Andersen, Gary/0000-0002-1618-9827; ding, guo-chun/0000-0001-6702-3782; Piceno, Yvette/0000-0002-7915-4699; Bonfante, Paola/0000-0003-3576-8530; ding, guo-chun/0000-0002-5468-5979	Regione Piemonte for the project "Carta del suolo del Tuber melanosporum''	Regione Piemonte for the project "Carta del suolo del Tuber melanosporum''	The source of funding is Regione Piemonte for the project "Carta del suolo del Tuber melanosporum.'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnelli A, 2004, SOIL BIOL BIOCHEM, V36, P859, DOI 10.1016/j.soilbio.2004.02.004; Barbieri E, 2000, APPL ENVIRON MICROB, V66, P5035, DOI 10.1128/AEM.66.11.5035-5042.2000; Barbieri E, 2005, FEMS MICROBIOL LETT, V247, P23, DOI 10.1016/j.femsle.2005.04.027; Barbieri E, 2007, ENVIRON MICROBIOL, V9, P2234, DOI 10.1111/j.1462-2920.2007.01338.x; Barbieri E, 2010, FUNGAL BIOL-UK, V114, P936, DOI 10.1016/j.funbio.2010.09.001; Bonet JA, 2006, AGRON SUSTAIN DEV, V26, P69, DOI 10.1051/agro:2005059; Bonfante P, 2009, ANNU REV MICROBIOL, V63, P363, DOI 10.1146/annurev.micro.091208.073504; Buzzini P, 2005, ARCH MICROBIOL, V184, P187, DOI 10.1007/s00203-005-0043-y; Ceruti A., 2003, SPECIE EUROPEE GENER; Chevalier G, 2010, METHODE RAISONNEE TR, P55; Delmas J., 1983, TRUFFE SA CULTURE; Delmont TO, 2011, J MICROBIOL METH, V86, P397, DOI 10.1016/j.mimet.2011.06.013; Ding GC, 2012, BIOMETRICAL J, V54, P94, DOI 10.1002/bimj.201000164; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; Frey-Klett P, 2007, NEW PHYTOL, V176, P22, DOI 10.1111/j.1469-8137.2007.02191.x; Frey-Klett P, 2005, NEW PHYTOL, V168, P4, DOI 10.1111/j.1469-8137.2005.01553.x; Garbeva P, 2003, MICROB ECOL, V45, P302, DOI 10.1007/s00248-002-2034-8; Giri BS, 2012, APPL BIOCHEM BIOTECH, V167, P1744, DOI 10.1007/s12010-012-9647-2; Gomes NCM, 2005, FEMS MICROBIOL ECOL, V54, P21, DOI 10.1016/j.femsec.2005.02.005; Gomes NCM, 2001, PLANT SOIL, V232, P167, DOI 10.1023/A:1010350406708; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Heuer H., 1997, Modern soil microbiology., P353; Heuer H, 2001, ENVIRONMENTAL MOLECULAR MICROBIOLOGY : PROTOCOLS AND APPLICATIONS, P177; Heuer H, 1997, APPL ENVIRON MICROB, V63, P3233, DOI 10.1128/AEM.63.8.3233-3241.1997; Kropfa S, 2004, J MICROBIOL METH, V57, P187, DOI 10.1016/j.mimet.2004.01.002; Lloyd-Jones G, 2005, J MICROBIOL METH, V60, P217, DOI 10.1016/j.mimet.2004.09.011; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Martin F, 2010, NATURE, V464, P1033, DOI 10.1038/nature08867; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Mello A, 2011, MYCOLOGIA, V103, P1184, DOI 10.3852/11-027; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; Milling A, 2004, PLANT SOIL, V266, P23; Muyzer G, 1998, ANTON LEEUW INT J G, V73, P127, DOI 10.1023/A:1000669317571; Napoli C, 2010, NEW PHYTOL, V185, P237, DOI 10.1111/j.1469-8137.2009.03053.x; Nubel U, 1996, J BACTERIOL, V178, P5636; Pacioni G, 2007, MYCOL RES, V111, P1450, DOI 10.1016/j.mycres.2007.08.016; PLATTNER I, 1995, MYCOL RES, V99, P1367, DOI 10.1016/S0953-7562(09)81223-9; Sbrana C, 2002, FEMS MICROBIOL LETT, V211, P195, DOI 10.1111/j.1574-6968.2002.tb11224.x; Schafer H, 2010, J EXP BOT, V61, P315, DOI 10.1093/jxb/erp355; Sourzat P, 2010, PRINCIPE PRECAUTION, P32; Splivallo R, 2007, NEW PHYTOL, V175, P417, DOI 10.1111/j.1469-8137.2007.02141.x; Splivallo R, 2011, NEW PHYTOL, V189, P688, DOI 10.1111/j.1469-8137.2010.03523.x; Streiblova E, 2012, FEMS MICROBIOL ECOL, V80, P1, DOI 10.1111/j.1574-6941.2011.01283.x; TALOU T, 1987, J AGR FOOD CHEM, V35, P774, DOI 10.1021/jf00077a031; Tarkka MT, 2009, CURR GENET, V55, P233, DOI 10.1007/s00294-009-0241-2; Trivedi P, 2012, ISME J, V6, P363, DOI 10.1038/ismej.2011.100; Warnes GR, 2011, GPLOTS VARIOUS R PRO; Weinert N, 2011, FEMS MICROBIOL ECOL, V75, P497, DOI 10.1111/j.1574-6941.2010.01025.x; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Werner JJ, 2012, ISME J, V6, P94, DOI 10.1038/ismej.2011.82; Wilson KH, 2002, APPL ENVIRON MICROB, V68, P2535, DOI 10.1128/AEM.68.5.2535-2541.2002	51	43	46	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2013	8	4							e61945	10.1371/journal.pone.0061945	http://dx.doi.org/10.1371/journal.pone.0061945			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146GG	23667413	Green Published, Green Submitted, gold			2022-12-25	WOS:000319077300020
J	Yao, JH; Liu, XK; Sakuno, T; Li, WZ; Xi, YX; Aravamudhan, P; Joglekar, A; Li, W; Watanabe, Y; He, XW				Yao, Jianhui; Liu, Xingkun; Sakuno, Takeshi; Li, Wenzhu; Xi, Yuanxin; Aravamudhan, Pavithra; Joglekar, Ajit; Li, Wei; Watanabe, Yoshinori; He, Xiangwei			Plasticity and Epigenetic Inheritance of Centromere-specific Histone H3 (CENP-A)-containing Nucleosome Positioning in the Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENP-A NUCLEOSOMES; CHROMOSOME SEGREGATION; HETEROCHROMATIN INTEGRITY; CHROMATIN; PROTEIN; KINETOCHORE; VPS75; RNAI; ORGANIZATION; MAINTENANCE	Nucleosomes containing the specific histone H3 variant CENP-A mark the centromere locus on each chromatin and initiate kinetochore assembly. For the common type of regional centromeres, little is known in molecular detail of centromeric chromatin organization, its propagation through cell division, and how distinct organization patterns may facilitate kinetochore assembly. Here, we show that in the fission yeast S. pombe, a relatively small number of CENP-A/Cnp1 nucleosomes are found within the centromeric core and that their positioning relative to underlying DNA varies among genetically homogenous cells. Consistent with the flexible positioning of Cnp1 nucleosomes, a large portion of the endogenous centromere is dispensable for its essential activity in mediating chromosome segregation. We present biochemical evidence that Cnp1 occupancy directly correlates with silencing of the underlying reporter genes. Furthermore, using a newly developed pedigree analysis assay, we demonstrated the epigenetic inheritance of Cnp1 positioning and quantified the rate of occasional repositioning of Cnp1 nucleosomes throughout cell generations. Together, our results reveal the plasticity and the epigenetically inheritable nature of centromeric chromatin organization.	[Yao, Jianhui; Liu, Xingkun; Li, Wenzhu; He, Xiangwei] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Xi, Yuanxin; Li, Wei] Baylor Coll Med, Dan L Duncan Canc Ctr, Div Biostat, Houston, TX 77030 USA; [Xi, Yuanxin; Li, Wei] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Sakuno, Takeshi; Watanabe, Yoshinori] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Chromosome Dynam, Tokyo 1130032, Japan; [Aravamudhan, Pavithra; Joglekar, Ajit] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Tokyo; University of Michigan System; University of Michigan	He, XW (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza T926, Houston, TX 77030 USA.	xhe@bcm.edu	Sakuno, Takeshi/Y-9478-2019; Yao, Jianhui/D-1952-2014	Joglekar, Ajit/0000-0002-0607-5332; Li, Wei/0000-0001-9931-5990; Watanabe, Yoshinori/0000-0002-5488-4812	National Institutes of Health [GM068676]; Ministry of Education, Culture, Sports, Science, and Technology of Japan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068676] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [21000010] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grant GM068676 (to X. H.). This work was also supported by a Grant-in-Aid for Specially Promoted Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to Y.W.).	ALLSHIRE RC, 1994, CELL, V76, P157, DOI 10.1016/0092-8674(94)90180-5; ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; Allshire RC, 2008, NAT REV GENET, V9, P923, DOI 10.1038/nrg2466; Bayne EH, 2010, CELL, V140, P666, DOI 10.1016/j.cell.2010.01.038; Berndsen CE, 2008, NAT STRUCT MOL BIOL, V15, P948, DOI 10.1038/nsmb.1459; Black BE, 2008, CURR OPIN CELL BIOL, V20, P91, DOI 10.1016/j.ceb.2007.11.007; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; Bowman A, 2011, MOL CELL, V41, P398, DOI 10.1016/j.molcel.2011.01.025; Buchwitz BJ, 1999, NATURE, V401, P547, DOI 10.1038/44062; Buscaino A, 2010, CURR OPIN GENET DEV, V20, P118, DOI 10.1016/j.gde.2010.01.006; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Carroll CW, 2010, J CELL BIOL, V189, P1143, DOI 10.1083/jcb.201001013; Carroll CW, 2009, NAT CELL BIOL, V11, P896, DOI 10.1038/ncb1899; Castillo AG, 2007, PLOS GENET, V3, P1264, DOI 10.1371/journal.pgen.0030121; Choi ES, 2011, J BIOL CHEM, V286, P23600, DOI 10.1074/jbc.M111.228510; Coffman VC, 2011, J CELL BIOL, V195, P563, DOI 10.1083/jcb.201106078; Dohke K, 2008, GENES CELLS, V13, P1027, DOI 10.1111/j.1365-2443.2008.01225.x; Dunleavy EM, 2007, MOL CELL, V28, P1029, DOI 10.1016/j.molcel.2007.10.010; Folco HD, 2008, SCIENCE, V319, P94, DOI 10.1126/science.1150944; Gassmann R, 2012, NATURE, V484, P534, DOI 10.1038/nature10973; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Howman EV, 2000, P NATL ACAD SCI USA, V97, P1148, DOI 10.1073/pnas.97.3.1148; Ishii K, 2008, SCIENCE, V321, P1088, DOI 10.1126/science.1158699; Ishii K, 2009, CURR OPIN MICROBIOL, V12, P616, DOI 10.1016/j.mib.2009.09.007; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; Jin CY, 2007, GENE DEV, V21, P1519, DOI 10.1101/gad.1547707; Joglekar AP, 2008, J CELL BIOL, V181, P587, DOI 10.1083/jcb.200803027; Ketel C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000400; Lando D, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120078; Lawrimore J, 2011, J CELL BIOL, V195, P573, DOI 10.1083/jcb.201106036; Mellone BG, 2009, BIOCHEM CELL BIOL, V87, P255, DOI 10.1139/O08-121; Meluh PB, 1998, CELL, V94, P607, DOI 10.1016/S0092-8674(00)81602-5; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nechemia-Arbely Y, 2012, EXP CELL RES, V318, P1353, DOI 10.1016/j.yexcr.2012.04.007; Okada T, 2007, CELL, V131, P1287, DOI 10.1016/j.cell.2007.10.045; PALMER DK, 1987, J CELL BIOL, V104, P805, DOI 10.1083/jcb.104.4.805; Pearson CG, 2004, CURR BIOL, V14, P1962, DOI 10.1016/j.cub.2004.09.086; Pidoux AL, 2005, PHILOS T R SOC B, V360, P569, DOI 10.1098/rstb.2004.1611; Pidoux AL, 2003, J CELL BIOL, V161, P295, DOI 10.1083/jcb.200212110; Pidoux AL, 2009, MOL CELL, V33, P299, DOI 10.1016/j.molcel.2009.01.019; Przewloka MR, 2009, ANNU REV GENET, V43, P439, DOI 10.1146/annurev-genet-102108-134310; Ribeiro SA, 2010, P NATL ACAD SCI USA, V107, P10484, DOI 10.1073/pnas.1002325107; Schuh M, 2007, CURR BIOL, V17, P237, DOI 10.1016/j.cub.2006.11.051; Scott KC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001099; Sekulic N, 2012, TRENDS BIOCHEM SCI, V37, P220, DOI 10.1016/j.tibs.2012.01.003; Sekulic N, 2010, NATURE, V467, P347, DOI 10.1038/nature09323; Selth L, 2007, J BIOL CHEM, V282, P12358, DOI 10.1074/jbc.C700012200; Selth LA, 2009, MOL CELL BIOL, V29, P4220, DOI 10.1128/MCB.01882-08; Song JS, 2008, GENOME RES, V18, P1064, DOI 10.1101/gr.075374.107; Sullivan BA, 2004, NAT STRUCT MOL BIOL, V11, P1076, DOI 10.1038/nsmb845; Sullivan KF, 2001, CURR OPIN GENET DEV, V11, P182, DOI 10.1016/S0959-437X(00)00177-5; Takahashi K, 2000, SCIENCE, V288, P2215, DOI 10.1126/science.288.5474.2215; Takayama Y, 2008, MOL BIOL CELL, V19, P682, DOI 10.1091/mbc.E07-05-0504; Torras-Llort M, 2009, EMBO J, V28, P2337, DOI 10.1038/emboj.2009.174; Verdaasdonk JS, 2011, NAT REV MOL CELL BIO, V12, P320, DOI 10.1038/nrm3107	56	13	13	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					19184	19196		10.1074/jbc.M113.471276	http://dx.doi.org/10.1074/jbc.M113.471276			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23661703	Green Published, hybrid			2022-12-25	WOS:000321335800052
J	Fujiwara, Y; Takeshita, K; Nakagawa, A; Okamura, Y				Fujiwara, Yuichiro; Takeshita, Kohei; Nakagawa, Atsushi; Okamura, Yasushi			Structural Characteristics of the Redox-sensing Coiled Coil in the Voltage-gated H+ Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON CHANNEL; 2 PORES; PROTEIN; HV1; DOMAIN	Oxidation is an important biochemical defense mechanism, but it also elicits toxicity; therefore, oxidation must be under strict control. In phagocytotic events in neutrophils, the voltage-gated H+ (Hv) channel is a key regulator of the production of reactive oxygen species against invading bacteria. The cytoplasmic domain of the Hv channel forms a dimeric coiled coil underpinning a dimerized functional unit. Importantly, in the alignment of the coiled-coil core, a conserved cysteine residue forms a potential intersubunit disulfide bond. In this study, we solved the crystal structures of the coiled-coil domain in reduced, oxidized, and mutated (Cys -> Ser) states. The crystal structures indicate that a pair of Cys residues forms an intersubunit disulfide bond dependent on the redox conditions. CD spectroscopy revealed that the disulfide bond increases the thermal stability of the coiled-coil protein. We also reveal that two thiol modifier molecules are able to bind to Cys in a redox-dependent manner without disruption of the dimeric coiled-coil assembly. Thus, the biochemical properties of the cytoplasmic coiled-coil domain in the Hv channel depend on the redox condition, which may play a role in redox sensing in the phagosome.	[Fujiwara, Yuichiro; Takeshita, Kohei; Okamura, Yasushi] Osaka Univ, Grad Sch Med, Dept Physiol, Osaka 5650871, Japan; [Takeshita, Kohei; Nakagawa, Atsushi] Osaka Univ, Inst Prot Res, Res Ctr State Art Funct Prot Anal, Osaka 5650871, Japan; [Nakagawa, Atsushi; Okamura, Yasushi] Osaka Univ, Grad Sch Frontier Biosci, Osaka 5650871, Japan	Osaka University; Osaka University; Osaka University	Fujiwara, Y (corresponding author), Osaka Univ, Grad Sch Med, Dept Physiol, Yamadaoka 2-2, Suita, Osaka 5650871, Japan.	fujiwara@phys2.med.osaka-u.ac.jp	Fujiwara, Yuichiro/GOP-2340-2022; Nakagawa, Atsushi/M-5731-2019; Nakagawa, Atsushi/D-4329-2009	Fujiwara, Yuichiro/0000-0002-9628-4073; Nakagawa, Atsushi/0000-0002-1700-7861; Nakagawa, Atsushi/0000-0002-1700-7861	KAKENHI; Hiroshi and Aya Irisawa Memorial Promotion Award for Young Physiologists; Grants-in-Aid for Scientific Research [25670108] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Hiroshi and Aya Irisawa Memorial Promotion Award for Young Physiologists; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by KAKENHI grants-in-aid for scientific research (to Y. F. and Y. O.) and the Hiroshi and Aya Irisawa Memorial Promotion Award for Young Physiologists (to Y. F.).	Chakraborty S, 2010, J AM CHEM SOC, V132, P13240, DOI 10.1021/ja101812c; Decoursey TE, 2003, PHYSIOL REV, V83, P475, DOI 10.1152/physrev.00028.2002; Devasagayam T P A, 2004, J Assoc Physicians India, V52, P794; El Chemaly A, 2012, MOL CELL ENDOCRINOL, V353, P82, DOI 10.1016/j.mce.2011.10.005; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujiwara Y, 2013, J PHYSIOL-LONDON, V591, P627, DOI 10.1113/jphysiol.2012.243006; Fujiwara Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1823; Gonzalez C, 2010, NAT STRUCT MOL BIOL, V17, P51, DOI 10.1038/nsmb.1739; Howard RJ, 2007, NEURON, V53, P663, DOI 10.1016/j.neuron.2007.02.010; Koch HP, 2008, P NATL ACAD SCI USA, V105, P9111, DOI 10.1073/pnas.0801553105; Lee SY, 2008, P NATL ACAD SCI USA, V105, P7692, DOI 10.1073/pnas.0803277105; Li SJ, 2010, J BIOL CHEM, V285, P12047, DOI 10.1074/jbc.M109.040360; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Okochi Y, 2009, BIOCHEM BIOPH RES CO, V382, P274, DOI 10.1016/j.bbrc.2009.03.036; Rada Balazs, 2008, V15, P164, DOI 10.1159/000136357; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Sahinoglu Tulin, 1996, Methods (Orlando), V9, P628, DOI 10.1006/meth.1996.0069; Sakata S, 2010, P NATL ACAD SCI USA, V107, P2313, DOI 10.1073/pnas.0911868107; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; Shinkai A, 2007, J MOL BIOL, V372, P1293, DOI 10.1016/j.jmb.2007.07.051; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Strelkov SV, 2002, J STRUCT BIOL, V137, P54, DOI 10.1006/jsbi.2002.4454; Su B, 2008, CURR ALZHEIMER RES, V5, P525, DOI 10.2174/156720508786898451; Tombola F, 2008, NEURON, V58, P546, DOI 10.1016/j.neuron.2008.03.026; Tombola F, 2010, NAT STRUCT MOL BIOL, V17, P44, DOI 10.1038/nsmb.1738; Vinson C, 2002, MOL CELL BIOL, V22, P6321, DOI 10.1128/MCB.22.18.6321-6335.2002; Waris G, 2006, J CARCINOG, V5, P14, DOI [10.1186/1477-3163-5-14, DOI 10.1186/1477-3163-5-14]; ZHOU NE, 1993, BIOCHEMISTRY-US, V32, P3178, DOI 10.1021/bi00063a033	28	20	20	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					17968	17975		10.1074/jbc.M113.459024	http://dx.doi.org/10.1074/jbc.M113.459024			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23667254	Green Published, hybrid			2022-12-25	WOS:000320721900004
J	Bowens, SR; Glatt, DP; Pratt, SC				Bowens, Sean R.; Glatt, Daniel P.; Pratt, Stephen C.			Visual Navigation during Colony Emigration by the Ant Temnothorax rugatulus	PLOS ONE			English	Article							NEST-SITE SELECTION; DECISION-MAKING; LEPTOTHORAX-UNIFASCIATUS; ORIENTATION; RECRUITMENT; MEMORY; CUES; HYMENOPTERA; MECHANISMS; LANDMARKS	Many ants rely on both visual cues and self-generated chemical signals for navigation, but their relative importance varies across species and context. We evaluated the roles of both modalities during colony emigration by Temnothorax rugatulus. Colonies were induced to move from an old nest in the center of an arena to a new nest at the arena edge. In the midst of the emigration the arena floor was rotated 60 degrees around the old nest entrance, thus displacing any substrate-bound odor cues while leaving visual cues unchanged. This manipulation had no effect on orientation, suggesting little influence of substrate cues on navigation. When this rotation was accompanied by the blocking of most visual cues, the ants became highly disoriented, suggesting that they did not fall back on substrate cues even when deprived of visual information. Finally, when the substrate was left in place but the visual surround was rotated, the ants' subsequent headings were strongly rotated in the same direction, showing a clear role for visual navigation. Combined with earlier studies, these results suggest that chemical signals deposited by Temnothorax ants serve more for marking of familiar territory than for orientation. The ants instead navigate visually, showing the importance of this modality even for species with small eyes and coarse visual acuity.	[Bowens, Sean R.; Pratt, Stephen C.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Glatt, Daniel P.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	Arizona State University; Arizona State University-Tempe; Princeton University	Pratt, SC (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	stephen.pratt@asu.edu			Pew Charitable Trusts [2000-002558]	Pew Charitable Trusts	Funding was provided by Pew Charitable Trusts (award 2000-002558), www.pewtrusts.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARON S, 1988, INSECT SOC, V35, P355, DOI 10.1007/BF02225811; ARON S, 1986, INSECT SOC, V33, P338, DOI 10.1007/BF02224249; ARON S, 1993, INSECT SOC, V40, P369, DOI 10.1007/BF01253900; Aron S, 1999, P ROY SOC B-BIOL SCI, V266, P173, DOI 10.1098/rspb.1999.0618; Cammaerts MC, 1996, BEHAV PROCESS, V37, P21, DOI 10.1016/0376-6357(95)00064-X; Cheng K, 2009, BEHAV PROCESS, V80, P261, DOI 10.1016/j.beproc.2008.10.015; Collett M, 2000, BIOL CYBERN, V83, P245, DOI 10.1007/s004220000168; Collett M, 2010, P NATL ACAD SCI USA, V107, P11638, DOI 10.1073/pnas.1001401107; Collett TS, 2006, ADV STUD BEHAV, V36, P123, DOI 10.1016/S0065-3454(06)36003-2; Collett TS, 1997, EXS, V84, P41; CREIGHTON W. S., 1950, BULL MUS COMP ZOOL HARVARD UNIV, V104, P1; Czaczkes TJ, 2013, J EXP BIOL, V216, P188, DOI 10.1242/jeb.076570; Czaczkes TJ, 2011, BIOL LETTERS, V7, P521, DOI 10.1098/rsbl.2011.0067; Devigne C, 2004, ANIM BEHAV, V67, P1023, DOI 10.1016/j.anbehav.2003.09.012; Durier V, 2003, CURR BIOL, V13, P1614, DOI 10.1016/j.cub.2003.08.024; Gruter C, 2011, BEHAV ECOL SOCIOBIOL, V65, P141, DOI 10.1007/s00265-010-1020-2; HARRISON JF, 1989, ANIM BEHAV, V37, P869, DOI 10.1016/0003-3472(89)90076-6; Headley A. E., 1943, ANN ENT SOC AMERICA, V36, P743; HOLLDOBLER B, 1976, BEHAV ECOL SOCIOBIOL, V1, P3, DOI 10.1007/BF00299951; Holldobler B., 1990, pi; Lenoir A, 2009, J CHEM ECOL, V35, P913, DOI 10.1007/s10886-009-9669-6; Mallon EB, 2001, BEHAV ECOL SOCIOBIOL, V50, P352, DOI 10.1007/s002650100377; MASCHWITZ U, 1986, EXPERIENTIA, V42, P1173, DOI 10.1007/BF01941298; McLeman MA, 2002, INSECT SOC, V49, P203, DOI 10.1007/s00040-002-8302-2; MOGLICH M, 1978, INSECT SOC, V25, P205, DOI 10.1007/BF02224742; Philippides A, 2011, J EXP BIOL, V214, P445, DOI 10.1242/jeb.046755; Pratt SC, 2005, INSECT SOC, V52, P383, DOI 10.1007/s00040-005-0823-z; Pratt SC, 2001, ETHOLOGY, V107, P1125, DOI 10.1046/j.1439-0310.2001.00749.x; Pratt SC, 2001, ANIM BEHAV, V62, P281, DOI 10.1006/anbe.2001.1777; R Core Team, 2021, R LANG ENV STAT COMP; Richardson TO, 2007, CURR BIOL, V17, P1520, DOI 10.1016/j.cub.2007.08.032; ROSENGREN R, 1986, INSECT SOC, V33, P306, DOI 10.1007/BF02224248; Salo O, 2001, ETHOLOGY, V107, P737, DOI 10.1046/j.1439-0310.2001.00702.x; Stroeymeyt N, 2011, J EXP BIOL, V214, P3046, DOI 10.1242/jeb.059188; Visscher PK, 2007, ANNU REV ENTOMOL, V52, P255, DOI 10.1146/annurev.ento.51.110104.151025; Wehner R, 2009, MYRMECOL NEWS, V12, P85; Wystrach A, 2012, ANIM BEHAV, V84, P13, DOI 10.1016/j.anbehav.2012.04.017	37	10	10	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e64367	10.1371/journal.pone.0064367	http://dx.doi.org/10.1371/journal.pone.0064367			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671713	Green Published, gold			2022-12-25	WOS:000319737700071
J	Huang, L; Han, YT; Zhou, Y; Gutscher, H; Bi, J				Huang, Lei; Han, Yuting; Zhou, Ying; Gutscher, Heinz; Bi, Jun			How Do the Chinese Perceive Ecological Risk in Freshwater Lakes?	PLOS ONE			English	Article							PSYCHOMETRIC PARADIGM; ENVIRONMENTAL-HEALTH; PUBLIC PERCEPTIONS; LOCAL ACCEPTANCE; NUCLEAR; COMMUNICATION; WILLINGNESS; BELIEFS; PEOPLE; TAIHU	In this study, we explore the potential contributions of a risk perception framework in understanding public perceptions of unstable ecosystems. In doing so, we characterize one type of common ecological risk-harmful algal blooms (HABs)-in four of the most seriously eutrophicated freshwater lakes in China. These lakes include Chaohu, Dianchi, Hongze, and Taihu, where a total of 2000 residents living near these sites were interviewed. Regional discrepancies existed in the pilot study regarding public perceptions of ecological changes and public concerns for ecological risk. Comparing HABs and other kinds of risks (earthquake, nuclear, and public traffic) through the psychometric paradigm method, Knowledge, Effect, and Trust were three key factors formulating the risk perception model. The results indicated that Knowledge and risk tolerance levels had significant negative correlations in the higher economic situation while correlations in the lower economic situation were significantly positive. Effect and risk tolerance levels had significant negative correlations in the high and middle education situation while correlations in the low education situation were close to zero or insignificant. For residents from Taihu with comparatively higher economic and educational levels, more investment in risk prevention measures and stronger policies are needed. And for residents from Hongze and Dianchi with comparatively low economic and educational levels, improvement of the government's credibility (Trust) was the most important factor of risk tolerance, so efforts to eliminate ecological problems with the stepwise development of economic and educational levels should be implemented and gradually strengthened. In turn, this could prevent public discontent and ensure support for ecological protection policies.	[Huang, Lei; Han, Yuting; Bi, Jun] Nanjing Univ, State Key Lab Pollut Control & Resource Reuse, Sch Environm, Nanjing 210008, Jiangsu, Peoples R China; [Zhou, Ying] Emory Univ, Rollins Sch Publ Hlth, Dept Environm Hlth, Atlanta, GA 30322 USA; [Gutscher, Heinz] Univ Zurich, Dept Psychol, Zurich, Switzerland	Nanjing University; Emory University; Rollins School Public Health; University of Zurich	Bi, J (corresponding author), Nanjing Univ, State Key Lab Pollut Control & Resource Reuse, Sch Environm, Nanjing 210008, Jiangsu, Peoples R China.	jbi@nju.edu.cn	Han, Yu/GZA-9220-2022	Huang, Lei/0000-0002-9279-878X	Chinese Natural Sciences Foundation [41271014, 41171411]; Sino-America Collaborative Research Program [2010DFA91910]; 863 Program [2013AA06A309]	Chinese Natural Sciences Foundation(National Natural Science Foundation of China (NSFC)); Sino-America Collaborative Research Program; 863 Program(National High Technology Research and Development Program of China)	This research was supported by Chinese Natural Sciences Foundation (41271014 and 41171411), the Sino-America Collaborative Research Program (2010DFA91910) and 863 Program (2013AA06A309). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anhui Statistical Bureau, 2010, ANH STAT YB; [Anonymous], 2002, ENV QUAL STAND SURF; [Anonymous], 2004, STAT ENV CHIN 2003; Arvai J, 2003, ENVIRON SCI TECHNOL, V37, P1469, DOI 10.1021/es020762p; Backer LC, 2010, TOXICON, V55, P909, DOI 10.1016/j.toxicon.2009.07.006; Bi J., 1996, GeoJournal, V40, P9; Brewer NT, 2004, ANN BEHAV MED, V27, P125, DOI 10.1207/s15324796abm2702_7; Bronfman NC, 2003, RISK ANAL, V23, P1271, DOI 10.1111/j.0272-4332.2003.00400.x; Bronfman NC, 2007, J RISK RES, V10, P527, DOI 10.1080/13669870701315872; Cabrera NL, 2009, HISPANIC J BEHAV SCI, V31, P258, DOI 10.1177/0739986309331877; Cervantes O, 2008, ENVIRON MANAGE, V42, P249, DOI 10.1007/s00267-008-9104-8; Chen J, 2009, SCI TOTAL ENVIRON, V407, P3317, DOI 10.1016/j.scitotenv.2009.02.005; Chung JB, 2008, RISK ANAL, V28, P1021, DOI 10.1111/j.1539-6924.2008.01074.x; de Groot JIM, 2010, RISK ANAL, V30, P1363, DOI 10.1111/j.1539-6924.2010.01419.x; Dorevitch S, 2012, ENVIRON HEALTH PERSP, V120, P192, DOI 10.1289/ehp.1103934; Grothmann T, 2006, NAT HAZARDS, V38, P101, DOI 10.1007/s11069-005-8604-6; Guo L, 2007, SCIENCE, V317, P1166, DOI 10.1126/science.317.5842.1166; Hammitt JK, 2004, J RISK UNCERTAINTY, V28, P73, DOI 10.1023/B:RISK.0000009437.24783.e1; Ho MC, 2008, RISK ANAL, V28, P635, DOI 10.1111/j.1539-6924.2008.01040.x; Hohl K, 2008, RISK ANAL, V28, P311, DOI 10.1111/j.1539-6924.2008.01021.x; Huang L, 2010, ENVIRON MANAGE, V45, P1065, DOI 10.1007/s00267-010-9480-8; Huang L, 2010, HUM ECOL RISK ASSESS, V16, P365, DOI 10.1080/10807031003670394; Huang L, 2010, FRONT ENVIRON SCI EN, V4, P73, DOI 10.1007/s11783-009-0151-z; Hunter PD, 2012, SCI TOTAL ENVIRON, V426, P32, DOI 10.1016/j.scitotenv.2012.02.017; J XC, 1995, ENV CHINESE LAKES; Jiangsu Statical Bureau, 2010, JIANGS STAT YB; Katsuya T, 2002, POLIT PSYCHOL, V23, P191, DOI 10.1111/0162-895X.00277; Kosenius AK, 2010, ECOL ECON, V69, P528, DOI 10.1016/j.ecolecon.2009.08.030; Kuhar SE, 2009, RISK ANAL, V29, P963, DOI 10.1111/j.1539-6924.2009.01228.x; Lazo JK, 2000, RISK ANAL, V20, P179, DOI 10.1111/0272-4332.202019; Lind N, 2002, RELIAB ENG SYST SAFE, V78, P21, DOI 10.1016/S0951-8320(02)00051-0; Marchwinska-Wyrwal E, 2012, EUR J PUBLIC HEALTH, V22, P742, DOI 10.1093/eurpub/ckr109; May H, 1996, RISK ANAL, V16, P459, DOI 10.1111/j.1539-6924.1996.tb01093.x; MCCALL CH, 1982, SAMPLING STAT HDB RE; MCDANIELS T, 1995, RISK ANAL, V15, P575, DOI 10.1111/j.1539-6924.1995.tb00754.x; McFarlane BL, 2008, RISK ANAL, V28, P203, DOI 10.1111/j.1539-6924.2008.01013.x; Mrozek JR, 2002, J POLICY ANAL MANAG, V21, P253, DOI 10.1002/pam.10026; PARKER GR, 1989, PUBLIC OPIN QUART, V53, P175, DOI 10.1086/269502; Peters E, 1996, J APPL SOC PSYCHOL, V26, P1427, DOI 10.1111/j.1559-1816.1996.tb00079.x; Petty R. E., 1981, ATTITUDES PERSUASION; Purvis-Roberts KL, 2007, RISK ANAL, V27, P291, DOI 10.1111/j.1539-6924.2007.00882.x; Qu CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046793; Rizak SN, 2006, ENVIRON SCI TECHNOL, V40, P5244, DOI 10.1021/es0520417; Rogers GO, 1985, DETERMINING PUBLIC A, P483; Salihoglu G, 2004, ENVIRON MANAGE, V33, P899, DOI 10.1007/s00267-004-2864-x; Siegrist M, 2005, RISK ANAL, V25, P211, DOI 10.1111/j.0272-4332.2005.00580.x; Sjoberg L, 2004, RISK ANAL, V24, P737, DOI 10.1111/j.0272-4332.2004.00472.x; Slimak MW, 2006, RISK ANAL, V26, P1689, DOI 10.1111/j.1539-6924.2006.00832.x; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Slovic P., 1980, SOC RISK ASSESSMENT, P181, DOI [10.1007/978-1-4899-0445-4_9, DOI 10.1007/978-1-4899-0445-4_9]; Slovic P, 1989, TRUST EMOTION SEX PO, P277; Sukharomana R, 1998, AGR EC, V46; Viscusi WK, 2003, J RISK UNCERTAINTY, V27, P5, DOI 10.1023/A:1025598106257; Wallquist L, 2010, ENVIRON SCI TECHNOL, V44, P6557, DOI 10.1021/es1005412; Willis HH, 2007, RISK ANAL, V27, P1365, DOI 10.1111/j.1539-6924.2007.00958.x; You M, 2012, ENV LAW REPORTER NEW, V42, P10482; Yunnan Statistical Bureau, 2010, YUNN STAT YB	58	7	8	4	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e62486	10.1371/journal.pone.0062486	http://dx.doi.org/10.1371/journal.pone.0062486			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	155HD	23671602	Green Published, gold, Green Submitted			2022-12-25	WOS:000319737700013
J	Snodgrass, SM; Cihil, KM; Cornuet, PK; Myerburg, MM; Swiatecka-Urban, A				Snodgrass, Steven M.; Cihil, Kristine M.; Cornuet, Pamela K.; Myerburg, Michael M.; Swiatecka-Urban, Agnieszka			Tgf-beta 1 Inhibits Cftr Biogenesis and Prevents Functional Rescue of Delta F508-Cftr in Primary Differentiated Human Bronchial Epithelial Cells	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; GROWTH-FACTOR-BETA; CYSTIC-FIBROSIS LUNG; FLUID TRANSPORT; GENE-EXPRESSION; ION-TRANSPORT; INFLAMMATION; PATHOPHYSIOLOGY; IDENTIFICATION; DEGRADATION	CFTR is an integral transmembrane glycoprotein and a cAMP-activated Cl- channel. Mutations in the CFTR gene lead to Cystic Fibrosis (CF)-an autosomal recessive disease with majority of the morbidity and mortality resulting from airway infection, inflammation, and fibrosis. The most common disease-associated mutation in the CFTR gene-deletion of Phe508 (Delta F508) leads to a biosynthetic processing defect of CFTR. Correction of the defect and delivery of Delta F508-CFTR to the cell surface has been highly anticipated as a disease modifying therapy. Compared to promising results in cultured cell this approach was much less effective in CF patients in an early clinical trial. Although the cause of failure to rescue Delta F508-CFTR in the clinical trial has not been determined, presence of factor(s) that interfere with the rescue in vivo could be considered. The cytokine TGF-beta 1 is frequently elevated in CF patients. TGF-b1 has pleiotropic effects in different disease models and genetic backgrounds and little is known about TGF-beta 1 effects on CFTR in human airway epithelial cells. Moreover, there are no published studies examining TGF-beta 1 effects on the functional rescue of Delta F508-CFTR. Here we found that TGF-beta 1 inhibits CFTR biogenesis by reducing mRNA levels and protein abundance in primary differentiated human bronchial epithelial (HBE) cells from non-CF individuals. TGF-beta 1 inhibits CFTR biogenesis without compromising the epithelial phenotype or integrity of HBE cells. TGF-beta 1 also inhibits biogenesis and impairs the functional rescue of Delta F508-CFTR in HBE cells from patients homozygous for the Delta F508 mutation. Our data indicate that activation of TGF-b1 signaling may inhibit CFTR function in non-CF individuals and may interfere with therapies directed at correcting the processing defect of Delta F508-CFTR in CF patients.	[Snodgrass, Steven M.] Childrens Hosp Pittsburgh, Div Pediat Pulmonol, Pittsburgh, PA 15213 USA; [Cihil, Kristine M.; Cornuet, Pamela K.; Myerburg, Michael M.; Swiatecka-Urban, Agnieszka] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15260 USA; [Myerburg, Michael M.] Univ Pittsburgh, Sch Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA USA; [Swiatecka-Urban, Agnieszka] Childrens Hosp Pittsburgh, Div Pediat Nephrol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Swiatecka-Urban, A (corresponding author), Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15260 USA.	asurban@pitt.edu	Swiatecka-Urban, Agnieszka/AAP-6041-2020; SWIATECKA-URBAN, AGNIESZKA/H-6494-2015	SWIATECKA-URBAN, AGNIESZKA/0000-0002-6575-0334	National Institutes of Health [R01HL090767, R01HL090767-02S1, P30DK072506]; Cystic Fibrosis Foundation Research Development Program Grant [R883-CR07]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112863, R01HL090767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation Research Development Program Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the National Institutes of Health Grants R01HL090767, R01HL090767-02S1 (to A.S-U.), P30DK072506 (Joseph M. Pilewski, Cystic Fibrosis Research Center Epithelial Cell Core at the University of Pittsburgh School of Medicine, Pittsburgh, PA), and the Cystic Fibrosis Foundation Research Development Program Grant R883-CR07 (to S.M.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahner A, 2013, MOL BIOL CELL, V24, P74, DOI 10.1091/mbc.E12-09-0678; Bartram U, 2004, CHEST, V125, P754, DOI 10.1378/chest.125.2.754; Bertrand CA, 2003, AM J PHYSIOL-CELL PH, V285, pC1, DOI 10.1152/ajpcell.00554.2002; BESANCON F, 1994, AM J PHYSIOL-CELL PH, V267, pC1398, DOI 10.1152/ajpcell.1994.267.5.C1398; Boucher RC, 2004, EUR RESPIR J, V23, P146, DOI 10.1183/09031936.03.00057003; Brazova J, 2006, CLIN IMMUNOL, V121, P350, DOI 10.1016/j.clim.2006.08.015; Brouillard F, 2001, J BIOL CHEM, V276, P9486, DOI 10.1074/jbc.M006636200; Celliere G, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-184; Cihil KM, 2012, J BIOL CHEM, V287, P15087, DOI 10.1074/jbc.M112.341875; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; Collaco JM, 2008, CURR OPIN PULM MED, V14, P559, DOI 10.1097/MCP.0b013e3283121cdc; Cutting GR, 2010, ANN NY ACAD SCI, V1214, P57, DOI 10.1111/j.1749-6632.2010.05879.x; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Devor DC, 2000, AM J PHYSIOL-CELL PH, V279, pC461, DOI 10.1152/ajpcell.2000.279.2.C461; Dorfman R, 2008, J CLIN INVEST, V118, P1040, DOI [10.1172/JCI337S4, 10.1172/JCI33754]; Frank J, 2003, J BIOL CHEM, V278, P43939, DOI 10.1074/jbc.M304882200; Galietta LJV, 2002, J IMMUNOL, V168, P839, DOI 10.4049/jimmunol.168.2.839; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; Grainger DJ, 1999, HUM MOL GENET, V8, P93, DOI 10.1093/hmg/8.1.93; Gravdal K, 2007, CLIN CANCER RES, V13, P7003, DOI 10.1158/1078-0432.CCR-07-1263; Gray T, 2004, AM J PHYSIOL-LUNG C, V286, pL320, DOI 10.1152/ajplung.00440.2002; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Harris WT, 2011, PEDIATR PULM, V46, P688, DOI 10.1002/ppul.21430; Harris WT, 2009, PEDIATR PULM, V44, P1057, DOI 10.1002/ppul.21079; He L, 2012, FASEB J; Hilliard TN, 2007, THORAX, V62, P1074, DOI 10.1136/thx.2006.074641; Howard M, 2000, AM J PHYSIOL-CELL PH, V279, pC375, DOI 10.1152/ajpcell.2000.279.2.C375; Howe KL, 2004, EXP CELL RES, V298, P473, DOI 10.1016/j.yexcr.2004.04.026; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kim IY, 2005, J BIOCHEM MOL BIOL, V38, P1; Lubamba B, 2012, CLIN BIOCHEM, V45, P1132, DOI 10.1016/j.clinbiochem.2012.05.034; Molina-Molina M, 2006, ARCH BRONCONEUMOL, V42, P380, DOI 10.1016/S1579-2129(06)60550-8; Molinski S, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00160; Murphy SJ, 2004, MOL BIOL CELL, V15, P2853, DOI 10.1091/mbc.E04-02-0097; Myerburg MM, 2010, AM J RESP CELL MOL, V42, P676, DOI 10.1165/2009-0147OC; Myerburg MM, 2007, AM J PHYSIOL-LUNG C, V292, pL1352, DOI 10.1152/ajplung.00328.2006; Nichols D, 2008, CLIN REV ALLERG IMMU, V34, P146, DOI 10.1007/s12016-007-8039-9; Pruliere-Escabasse V, 2005, AM J PHYSIOL-LUNG C, V288, pL77, DOI 10.1152/ajplung.00048.2004; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Roux J, 2010, J BIOL CHEM, V285, P4278, DOI 10.1074/jbc.M109.036731; Ryder MI, 2002, ORAL MICROBIOL IMMUN, V17, P331, DOI 10.1034/j.1399-302X.2002.170601.x; Skowron-Zwarg M, 2007, EXP CELL RES, V313, P2695, DOI 10.1016/j.yexcr.2007.02.035; Tarran R, 2006, ANNU REV PHYSIOL, V68, P543, DOI 10.1146/annurev.physiol.68.072304.112754; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Wang XW, 2012, NUCLEIC ACIDS RES, V40, pD1144, DOI 10.1093/nar/gkr1013; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Yang YC, 2012, ALLERGY, V67, P1193, DOI 10.1111/j.1398-9995.2012.02880.x; Ye SY, 2010, J BIOL CHEM, V285, P27008, DOI 10.1074/jbc.M110.139881; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zieba A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013482	53	50	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63167	10.1371/journal.pone.0063167	http://dx.doi.org/10.1371/journal.pone.0063167			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671668	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000319737700046
J	Argyros, R; Nelson, S; Kull, A; Chen, MT; Stadheim, TA; Jiang, B				Argyros, Rebecca; Nelson, Stephanie; Kull, Angela; Chen, Ming-Tang; Stadheim, Terrance A.; Jiang, Bo			A Phenylalanine to Serine Substitution within an O-Protein Mannosyltransferase Led to Strong Resistance to PMT-Inhibitors in Pichia pastoris	PLOS ONE			English	Article							CANDIDA-ALBICANS; YEAST; GLYCOSYLATION; MANNOSYLATION; FAMILY; MANNOSE	Protein O-mannosyltransferases (PMTs) catalyze the initial reaction of protein O-mannosylation by transferring the first mannose unit onto serine and threonine residues of a nascent polypeptide being synthesized in the endoplasmic reticulum (ER). The PMTs are well conserved in eukaryotic organisms, and in vivo defects of these enzymes result in cell death in yeast and congenital diseases in humans. A group of rhodanine-3-acetic acid derivatives (PMTi) specifically inhibits PMT activity both in vitro and in vivo. As such, these chemical compounds have been effectively used to minimize the extent of O-mannosylation on heterologously produced proteins from different yeast expression hosts. However, very little is known about how these PMT-inhibitors interact with the PMT enzyme, or what structural features of the PMTs are required for inhibitor-protein interactions. To better understand the inhibitor-enzyme interactions, and to gain potential insights for developing more effective PMT-inhibitors, we isolated PMTi-resistant mutants in Pichia pastoris. In this study, we report the identification and characterization of a point mutation within the PpPMT2 gene. We demonstrate that this F664S point mutation resulted in a near complete loss of PMTi sensitivity, both in terms of growth-inhibition and reduction in O-mannosylglycan site occupancy. Our results provide genetic evidence demonstrating that the F664 residue plays a critical role in mediating the inhibitory effects of these PMTi compounds. Our data also indicate that the main target of these PMT-inhibitors in P. pastoris is Pmt2p, and that the F664 residue most likely interacts directly with the PMTi-compounds.	[Argyros, Rebecca; Nelson, Stephanie; Kull, Angela; Chen, Ming-Tang; Stadheim, Terrance A.; Jiang, Bo] GlycoFi Inc, Lebanon, NH USA		Jiang, B (corresponding author), GlycoFi Inc, Lebanon, NH USA.	bo_jiang@merck.com			Merck	Merck(Merck & Company)	All authors are employees of Merck. The research was fully funded by Merck. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo J, 2011, MOL MICROBIOL, V79, P1529, DOI 10.1111/j.1365-2958.2011.07537.x; Balashov SV, 2006, ANTIMICROB AGENTS CH, V50, P2058, DOI 10.1128/AAC.01653-05; Barnard GC, 2010, J IND MICROBIOL BIOT, V37, P961, DOI 10.1007/s10295-010-0746-1; Beltran-Valero de Bernabe D, 2002, AM J HUM GENET, V71, P1033, DOI 10.1086/342975; Cantero PD, 2007, MOL MICROBIOL, V64, P1115, DOI 10.1111/j.1365-2958.2007.05723.x; Chen MT, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-91; Choi BK, 2012, APPL MICROBIOL BIOT, V95, P671, DOI 10.1007/s00253-012-4067-3; Cregg JM, 2009, METHOD ENZYMOL, V463, P169, DOI 10.1016/S0076-6879(09)63013-5; Desai R, 2009, Patent No. [WO 2009/143041 A1, 2009143041]; Ernst JF, 2001, MED MYCOL, V39, P67, DOI 10.1080/714031008; Gentzsch M, 1996, EMBO J, V15, P5752, DOI 10.1002/j.1460-2075.1996.tb00961.x; Girrbach V, 2003, J BIOL CHEM, V278, P12554, DOI 10.1074/jbc.M212582200; Girrbach V, 2000, J BIOL CHEM, V275, P19288, DOI 10.1074/jbc.M001771200; Goto M, 2007, BIOSCI BIOTECH BIOCH, V71, P1415, DOI 10.1271/bbb.70080; Hamilton SR, 2006, SCIENCE, V313, P1441, DOI 10.1126/science.1130256; Hopkins D, 2011, GLYCOBIOLOGY, V21, P1616, DOI 10.1093/glycob/cwr108; Kuroda K, 2008, APPL ENVIRON MICROB, V74, P446, DOI 10.1128/AEM.02106-07; Lehle L, 2006, ANGEW CHEM INT EDIT, V45, P6802, DOI 10.1002/anie.200601645; Li HJ, 2006, NAT BIOTECHNOL, V24, P210, DOI 10.1038/nbt1178; Li HJ, 2009, CURR OPIN BIOTECH, V20, P678, DOI 10.1016/j.copbio.2009.10.009; Lommel M, 2011, J BIOL CHEM, V286, P39768, DOI 10.1074/jbc.M111.281196; Lommel M, 2009, GLYCOBIOLOGY, V19, P816, DOI 10.1093/glycob/cwp066; Morio F, 2010, DIAGN MICR INFEC DIS, V66, P373, DOI 10.1016/j.diagmicrobio.2009.11.006; Nett JH, 2013, PLOS ONE UNPUB; Orchard MG, 2004, BIOORG MED CHEM LETT, V14, P3975, DOI 10.1016/j.bmcl.2004.05.050; Peman J, 2009, EXPERT REV ANTI-INFE, V7, P453, DOI [10.1586/eri.09.18, 10.1586/ERI.09.18]; Perlin DS, 2007, DRUG RESIST UPDATE, V10, P121, DOI 10.1016/j.drup.2007.04.002; Potgieter TI, 2009, J BIOTECHNOL, V139, P318, DOI 10.1016/j.jbiotec.2008.12.015; Spiro RG, 2002, GLYCOBIOLOGY, V12, p43R, DOI 10.1093/glycob/12.4.43R; Stadheim TA, 2008, NAT PROTOC, V3, P1026, DOI 10.1038/nprot.2008.76; Strahl-Bolsinger S, 1999, J BIOL CHEM, V274, P9068, DOI 10.1074/jbc.274.13.9068; Willer T, 2005, MOL MICROBIOL, V57, P156, DOI 10.1111/j.1365-2958.2005.04692.x; Winston F., 2008, CURR PROTOC MOL BIOL, DOI DOI 10.1002/0471142727.MB1303BS82	33	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62229	10.1371/journal.pone.0062229	http://dx.doi.org/10.1371/journal.pone.0062229			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667461	Green Published, gold, Green Submitted			2022-12-25	WOS:000319055600018
J	Chatterjee, S; Wang, Y; Duncan, MK; Naik, UP				Chatterjee, Sharmila; Wang, Yan; Duncan, Melinda K.; Naik, Ulhas P.			Junctional Adhesion Molecule-A Regulates Vascular Endothelial Growth Factor Receptor-2 Signaling-Dependent Mouse Corneal Wound Healing	PLOS ONE			English	Article							VEGF-A; JAM-A; EXPRESSION; NEOVASCULARIZATION; FIBROBLAST; CELL; ANGIOGENESIS; NEUTROPHIL; INHIBITION; RELEASE	Inflammation and angiogenesis are integral parts of wound healing. However, excessive and persistent wound-induced inflammation and angiogenesis in an avascular tissue such as the cornea may be associated with scarring and visual impairment. Junctional adhesion molecule A (Jam-A) is a tight junction protein that regulates leukocyte transmigration as well as fibroblast growth factor-2 (FGF-2)-induced angiogenesis. However its function in wound-induced inflammation and angiogenesis is still unknown. In this study, we report spontaneous corneal opacity in Jam-A deficient mice associated with inflammation, angiogenesis and the presence of myofibroblasts. Since wounds and/or corneal infections cause corneal opacities, we tested the role of Jam-A in wound-induced inflammation, angiogenesis and scarring by subjecting Jam-A deficient mice to full thickness corneal wounding. Analysis of these wounds demonstrated increased inflammation, angiogenesis, and increased number of myofibroblasts thereby indicating that Jam-A regulates the wound-healing response by controlling wound-induced inflammation, angiogenesis and scarring in the cornea. These effects were not due to inflammation alone since the inflammation-induced wound-healing response in Jam-A deficient mice was similar to wild type mice. In order to determine the molecular mechanism associated with the observed aberrant corneal wound healing in Jam-A deficient mice, we assessed the expression of the components of vascular endothelial growth factor A (VEGF-A)/vascular endothelial growth factor receptor-2 (VEGFR-2) signaling pathway. Interestingly, we observed increased levels of VEGF-A mRNA in Jam-A deficient eyes. We also observed nuclear localization of phosphorylated SMAD3 (pSMAD3) indicative of TGF beta pathway activation in the Jam-A deficient eyes. Furthermore the increased wound-induced corneal inflammation, angiogenesis, and scarring in Jam-A deficient mice was attenuated by treatment with DC101, an anti-vascular endothelial growth factor receptor-2 (VEGFR-2) antibody. Our results suggest that in the absence of Jam-A, the VEGF-A/VEGFR-2 pathway is upregulated, thereby augmenting wound induced corneal inflammation, angiogenesis, and myofibroblast accumulation leading to scarring.	[Chatterjee, Sharmila; Wang, Yan; Duncan, Melinda K.; Naik, Ulhas P.] Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA; [Naik, Ulhas P.] Univ Delaware, Dept Biochem & Chem, Newark, DE USA; [Naik, Ulhas P.] Univ Delaware, Delaware Cardiovasc Res Ctr, Newark, DE USA; [Naik, Ulhas P.] Univ Delaware, Delaware Biotechnol Inst, Newark, DE USA	University of Delaware; University of Delaware; University of Delaware; University of Delaware	Naik, UP (corresponding author), Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA.	unaik@udel.edu		Duncan, Melinda/0000-0003-1570-322X	National Institutes of Health [HL63960, EY12221]; INBRE program [P20 RR16472]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016472] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012221] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063960, R01HL119374] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); INBRE program; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grant HL63960 to UPN, EY12221 to MKD, and INBRE program grant P20 RR16472 supporting the University of Delaware Core Imaging facility. The funders had no role in study deign, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambati BK, 2006, NATURE, V443, P993, DOI 10.1038/nature05249; Aramwit P, 2009, J BIOSCI BIOENG, V107, P556, DOI 10.1016/j.jbiosc.2008.12.012; Ardi VC, 2007, P NATL ACAD SCI USA, V104, P20262, DOI 10.1073/pnas.0706438104; Bao Philip, 2009, J Surg Res, V153, P347, DOI 10.1016/j.jss.2008.04.023; Blanco-Mezquita JT, 2011, INVEST OPHTH VIS SCI, V52, P8505, DOI 10.1167/iovs.11-8194; Burgu B, 2006, BJU INT, V98, P217, DOI 10.1111/j.1464-410X.2006.06215.x; Bystrom B, 2007, HISTOCHEM CELL BIOL, V127, P657, DOI 10.1007/s00418-007-0288-4; Cera MR, 2009, J CELL SCI, V122, P268, DOI 10.1242/jcs.037127; Christoffersson G, 2012, BLOOD; Cooke VG, 2006, ARTERIOSCL THROM VAS, V26, P2005, DOI 10.1161/01.ATV.0000234923.79173.99; Cursiefen C, 2004, J CLIN INVEST, V113, P1040, DOI 10.1172/JCI200420465; Fini ME, 1999, PROG RETIN EYE RES, V18, P529, DOI 10.1016/S1350-9462(98)00033-0; Ford KM, 2012, INVEST OPHTH VIS SCI, V53, P7520, DOI 10.1167/iovs.12-10098; Franco M, 2011, BLOOD, V118, P2906, DOI 10.1182/blood-2011-01-331694; Gan LS, 2004, ACTA OPHTHALMOL SCAN, V82, P557, DOI 10.1111/j.1600-0420.2004.00312.x; Gong Y, 2010, CELL TISSUE RES, V339, P437, DOI 10.1007/s00441-009-0908-5; Hood JD, 2003, J CELL BIOL, V162, P933, DOI 10.1083/jcb.200304105; Hosseini H, 2007, CLIN EXP OPHTHALMOL, V35, P745, DOI 10.1111/j.1442-9071.2007.01572.x; Jester JV, 1999, PROG RETIN EYE RES, V18, P311, DOI 10.1016/S1350-9462(98)00021-4; Kang LI, 2007, INT J BIOCHEM CELL B, V39, P576, DOI 10.1016/j.biocel.2006.10.016; Lee KS, 2008, EUR RESPIR J, V31, P523, DOI 10.1183/09031936.00125007; Li DM, 2009, MICROVASC RES, V77, P134, DOI 10.1016/j.mvr.2008.09.007; Li ZQ, 2009, INVEST OPHTH VIS SCI, V50, P5217, DOI 10.1167/iovs.08-2662; Lim JY, 2012, J CELL PHYSIOL, V227, P1081, DOI 10.1002/jcp.22824; Lin TC, 2005, ANESTH ANALG, V100, P1554, DOI 10.1213/01.ANE.0000154307.92060.84; Mak P, 2010, CANCER CELL, V17, P319, DOI 10.1016/j.ccr.2010.02.030; Mandell KJ, 2007, INVEST OPHTH VIS SCI, V48, P3928, DOI 10.1167/iovs.06-1536; Matsuda A, 1999, INVEST OPHTH VIS SCI, V40, P1071; Mochida Y, 2009, MATRIX BIOL, V28, P44, DOI 10.1016/j.matbio.2008.11.003; Mohan RR, 2011, CURR MOL MED, V11, P110; Moldovan NI, 2000, CIRC RES, V87, P378; Murakami M, 2011, J CLIN INVEST, V121, P2668, DOI 10.1172/JCI44762; Myrna KE, 2012, INVEST OPHTH VIS SCI, V53, P811, DOI 10.1167/iovs.11-7982; Naik MU, 2006, J CELL SCI, V119, P490, DOI 10.1242/jcs.02771; Naik MU, 2003, BLOOD, V102, P2108, DOI 10.1182/blood-2003-04-1114; Naik MU, 2003, ARTERIOSCL THROM VAS, V23, P2165, DOI 10.1161/01.ATV.0000093982.84451.87; Nupponen I, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.1.e12; Orosz ZZ, 2011, CLIN CHIM ACTA, V412, P271, DOI 10.1016/j.cca.2010.10.017; Pal-Ghosh S, 2011, J CELL SCI, V124, P2666, DOI 10.1242/jcs.085480; Perez-Santonja JJ, 2010, AM J OPHTHALMOL, V150, P519, DOI 10.1016/j.ajo.2010.04.024; Phillipson M, 2011, NAT MED, V17, P1381, DOI 10.1038/nm.2514; Reed NA, 2001, J IMMUNOL METHODS, V253, P243, DOI 10.1016/S0022-1759(01)00374-X; Retini C, 1996, INFECT IMMUN, V64, P2897, DOI 10.1128/IAI.64.8.2897-2903.1996; Russell REK, 2002, AM J RESP CELL MOL, V26, P602, DOI 10.1165/ajrcmb.26.5.4685; Sakimoto T, 2012, EXP EYE RES, V97, P98, DOI 10.1016/j.exer.2012.02.015; Samolov B, 2005, EXP EYE RES, V80, P159, DOI 10.1016/j.exer.2004.08.023; Seghezzi G, 1998, J CELL BIOL, V141, P1659, DOI 10.1083/jcb.141.7.1659; Shi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032128; Shibuya Masabumi, 2011, Genes Cancer, V2, P1097, DOI 10.1177/1947601911423031; Stalmans I, 2010, Verh K Acad Geneeskd Belg, V72, P41; Tandon A, 2010, CURR MOL MED, V10, P565; Vial C, 2011, J BIOL CHEM, V286, P24242, DOI 10.1074/jbc.M110.189365; Vosseler S, 2005, CANCER RES, V65, P1294, DOI 10.1158/0008-5472.CAN-03-3986; West-Mays JA, 2006, INT J BIOCHEM CELL B, V38, P1625, DOI 10.1016/j.biocel.2006.03.010; Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214; Wilson K, 1997, Nurs Crit Care, V2, P291; Zhang C, 2012, AM J PHYSIOL-CELL PH, V302, pC1213, DOI 10.1152/ajpcell.00179.2011; Zhang Z, 2010, CELL DEATH DIFFER, V17, P499, DOI 10.1038/cdd.2009.152	58	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63674	10.1371/journal.pone.0063674	http://dx.doi.org/10.1371/journal.pone.0063674			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667656	Green Published, Green Submitted, gold			2022-12-25	WOS:000319055600067
J	Martens, KAE; Pieruccini-Faria, F; Almeida, QJ				Martens, Kaylena A. Ehgoetz; Pieruccini-Faria, Frederico; Almeida, Quincy J.			Could Sensory Mechanisms Be a Core Factor That Underlies Freezing of Gait in Parkinson's Disease?	PLOS ONE			English	Article							BILATERAL COORDINATION; INFORMATION; LOCOMOTION; DEFICITS	The main objective of this study was to determine how manipulating the amount of sensory information available about the body and surrounding environment influenced freezing of gait (FOG), while walking through a doorway. It was hypothesized that the more limited the sensory information, the greater the occurrence of freezing of gait. Nineteen patients with Parkinson's disease who experience freezing of gait (PD-FOG) walked through a doorway or into open space in complete darkness. The three doorway conditions included: (i) FRAME (DARK) - walking through the remembered door frame; (ii) FRAME - walking through the door with the door frame illuminated; (iii) FRAME+BODY - walking through the door (both the door and the limbs illuminated). Additionally, two conditions of walking away from the doorway included: (iv) NO FRAME (DARK) - walking into open space; (v) NO FRAME+BODY - walking into open space with the limbs illuminated, to evaluate whether perception (or fear) of the doorway might account for FOG behaviour. Key outcome measures included: the number of freezing of gait episodes recorded, total duration of freezing of gait, and the percentage of time spent frozen. Significantly more freezing of gait episodes occurred when participants walked toward the doorway in complete darkness compared to walking into open space (p < 0.05). Similar to previous studies, velocity (p < 0.001) and step length (p < 0.0001) significantly decreased when walking through the door in complete darkness, compared to all other conditions. Significant increases in step width variability were also identified but only when walking into open space (p < 0.005). These results support the notion that sensory deficits may have a profound impact on freezing of gait that need to be carefully considered.	[Martens, Kaylena A. Ehgoetz] Univ Waterloo, Dept Psychol, Waterloo, ON N2L 3G1, Canada; [Martens, Kaylena A. Ehgoetz; Pieruccini-Faria, Frederico; Almeida, Quincy J.] Wilfrid Laurier Univ, Sun Life Financial Movement Disorders Res & Rehab, Waterloo, ON N2L 3C5, Canada	University of Waterloo; Wilfrid Laurier University	Almeida, QJ (corresponding author), Wilfrid Laurier Univ, Sun Life Financial Movement Disorders Res & Rehab, Waterloo, ON N2L 3C5, Canada.	qalmeida@wlu.ca	Pieruccini-Faria, Frederico/ABD-8020-2020; Faria, Frederico P/C-4020-2015; Ehgoetz Martens, Kaylena/G-9997-2016	Faria, Frederico P/0000-0002-7659-4285; Ehgoetz Martens, Kaylena/0000-0002-8488-2295	Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Foundation for Innovation (CFI); Canadian Institutes of Health	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work has been funded by the Natural Sciences and Engineering Research Council of Canada (NSERC), Canadian Foundation for Innovation (CFI), and Canadian Institutes of Health.	Almeida QJ, 2010, J NEUROL NEUROSUR PS, V81, P513, DOI 10.1136/jnnp.2008.160580; Almeida QJ, 2005, NEUROSCIENCE, V134, P283, DOI 10.1016/j.neuroscience.2005.02.050; Bartels AL, 2003, J CLIN NEUROSCI, V10, P584, DOI 10.1016/S0967-5868(03)00192-9; Bhatt H, 2012, PARKINSONISM RELAT D; Cowie D, 2012, MOVEMENT DISORD, V27, P492, DOI 10.1002/mds.23990; Cowie D, 2010, NEUROPSYCHOLOGIA, V48, P2750, DOI 10.1016/j.neuropsychologia.2010.05.022; Darmon A, 1999, REV NEUROL-FRANCE, V155, P1047; FAHN S, 1995, ADV NEUROL, V67, P53; Franklin S, 2012, J NEUROPHYSIOL, V108, P467, DOI 10.1152/jn.01123.2011; Giladi N, 2001, ADV NEUROL, V86, P273; GILADI N, 1992, NEUROLOGY, V42, P333, DOI 10.1212/WNL.42.2.333; Hausdorff JM, 2003, EXP BRAIN RES, V149, P187, DOI 10.1007/s00221-002-1354-8; Henderson JM, 2003, BEHAV BRAIN RES, V139, P105, DOI 10.1016/S0166-4328(02)00087-6; Iansek R, 2006, MOVEMENT DISORD, V21, P1419, DOI 10.1002/mds.20998; Jiang Y, 2006, CLIN REHABIL, V20, P36, DOI 10.1191/0269215506cr925oa; Keijsers NLW, 2005, EUR J NEUROSCI, V21, P239, DOI 10.1111/j.1460-9568.2004.03840.x; Knobl P, 2012, J NEUROL NEUROSUR PS, V83, P98, DOI 10.1136/jnnp-2011-300869; Lajoie Y, 1996, NEUROLOGY, V47, P109, DOI 10.1212/WNL.47.1.109; Lewis SJG, 2009, PARKINSONISM RELAT D, V15, P333, DOI 10.1016/j.parkreldis.2008.08.006; Martens DJ, 1996, BRAIN RES, V733, P253, DOI 10.1016/0006-8993(96)00547-1; Martens KAE, 2012, MOVEMENT DISORD, V27, P387, DOI 10.1002/mds.24042; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Morris ME, 1996, BRAIN, V119, P551, DOI 10.1093/brain/119.2.551; Morris TR, 2012, PARKINSONISM RELAT D, V18, P572, DOI 10.1016/j.parkreldis.2012.03.001; Naismith SL, 2010, MOVEMENT DISORD, V25, P1000, DOI 10.1002/mds.23005; O'Connor CM, 2007, GAIT POSTURE, V25, P469, DOI 10.1016/j.gaitpost.2006.05.016; Plotnik M, 2008, MOVEMENT DISORD, V23, pS444, DOI 10.1002/mds.21984; Schrader C, 2008, CLIN NEUROPHYSIOL, V119, P1139, DOI 10.1016/j.clinph.2008.01.005; Snijders AH, 2011, BRAIN, V134, P59, DOI 10.1093/brain/awq324; Voss M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002866; Yogev G, 2007, EXP BRAIN RES, V177, P336, DOI 10.1007/s00221-006-0676-3	31	48	48	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62602	10.1371/journal.pone.0062602	http://dx.doi.org/10.1371/journal.pone.0062602			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667499	gold, Green Published, Green Submitted			2022-12-25	WOS:000319055600034
J	Pawlik, JR; Loh, TL; McMurray, SE; Finelli, CM				Pawlik, Joseph R.; Loh, Tse-Lynn; McMurray, Steven E.; Finelli, Christopher M.			Sponge Communities on Caribbean Coral Reefs Are Structured by Factors That Are Top-Down, Not Bottom-Up	PLOS ONE			English	Article							ECOSYSTEM-BASED MANAGEMENT; RESOURCE TRADE-OFF; FLORIDA-KEYS; XESTOSPONGIA-MUTA; CHEMICAL DEFENSES; PREDATORY FISHES; MYCALE-LAEVIS; GROWTH; DIVERSITY; ECOLOGY	Caribbean coral reefs have been transformed in the past few decades with the demise of reef-building corals, and sponges are now the dominant habitat-forming organisms on most reefs. Competing hypotheses propose that sponge communities are controlled primarily by predatory fishes (top-down) or by the availability of picoplankton to suspension-feeding sponges (bottom-up). We tested these hypotheses on Conch Reef, off Key Largo, Florida, by placing sponges inside and outside predator-excluding cages at sites with less and more planktonic food availability (15 m vs. 30 m depth). There was no evidence of a bottom-up effect on the growth of any of 5 sponge species, and 2 of 5 species grew more when caged at the shallow site with lower food abundance. There was, however, a strong effect of predation by fishes on sponge species that lacked chemical defenses. Sponges with chemical defenses grew slower than undefended species, demonstrating a resource trade-off between growth and the production of secondary metabolites. Surveys of the benthic community on Conch Reef similarly did not support a bottom-up effect, with higher sponge cover at the shallower depth. We conclude that the structure of sponge communities on Caribbean coral reefs is primarily top-down, and predict that removal of sponge predators by overfishing will shift communities toward faster-growing, undefended species that better compete for space with threatened reef-building corals.	[Pawlik, Joseph R.; Loh, Tse-Lynn; McMurray, Steven E.; Finelli, Christopher M.] Univ N Carolina, Ctr Marine Sci, Dept Biol & Marine Biol, Wilmington, NC 28401 USA	University of North Carolina; University of North Carolina Wilmington	Pawlik, JR (corresponding author), Univ N Carolina, Ctr Marine Sci, Dept Biol & Marine Biol, Wilmington, NC 28401 USA.	pawlikj@uncw.edu	Pawlik, Joseph R/I-5718-2012	Pawlik, Joseph/0000-0002-8559-8456; Loh, Tse-Lynn/0000-0003-1360-1991; McMurray, Steven/0000-0002-1187-5916	National Science Foundation's Biological Oceanography Program [1029515]; National Oceanic and Atmospheric Administration	National Science Foundation's Biological Oceanography Program(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA)	This work was supported by a grant from the National Science Foundation's Biological Oceanography Program (1029515) and funding from the National Oceanic and Atmospheric Administration's Aquarius Reef Base and Coral Reef Conservation Programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainley DG, 2010, PROG OCEANOGR, V84, P242, DOI 10.1016/j.pocean.2009.10.001; ALBRIZIO S, 1995, J NAT PRODUCTS, V58, P647, DOI 10.1021/np50119a002; Assmann M, 2000, MAR ECOL PROG SER, V207, P255, DOI 10.3354/meps207255; CHANAS B, 1995, MAR ECOL PROG SER, V127, P195, DOI 10.3354/meps127195; Chanas B, 1996, OECOLOGIA, V107, P225, DOI 10.1007/BF00327906; CHIAPPONE M, 1994, B MAR SCI, V54, P747; Colella MA, 2012, CORAL REEFS, V31, P621, DOI 10.1007/s00338-012-0880-5; Denyer JL, 2010, J ECOL, V98, P498, DOI 10.1111/j.1365-2745.2009.01633.x; Duckworth AR, 2012, MAR ECOL PROG SER, V462, P67, DOI 10.3354/meps09853; Dunlap M, 1996, MAR BIOL, V126, P117, DOI 10.1007/BF00571383; Erwin PM, 2008, MAR ECOL PROG SER, V362, P139, DOI 10.3354/meps07464; Freeman CJ, 2011, LIMNOL OCEANOGR, V56, P1577, DOI 10.4319/lo.2011.56.5.1577; Freidenburg TL, 2007, J EXP MAR BIOL ECOL, V347, P8, DOI 10.1016/j.jembe.2007.02.012; FRETWELL SD, 1987, OIKOS, V50, P291, DOI 10.2307/3565489; HALL SJ, 1990, AM NAT, V136, P657, DOI 10.1086/285121; Huang DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034459; HUNTER MD, 1992, ECOLOGY, V73, P724; Kaandorp JA, 1999, MAR BIOL, V134, P295, DOI 10.1007/s002270050547; Kubanek J, 2000, MAR ECOL PROG SER, V207, P69, DOI 10.3354/meps207069; Leichter JJ, 2005, J PHYS OCEANOGR, V35, P1945, DOI 10.1175/JPO2808.1; Leichter JJ, 1998, MAR ECOL PROG SER, V166, P83, DOI 10.3354/meps166083; Leong W, 2010, OIKOS, V119, P1417, DOI 10.1111/j.1600-0706.2010.18092.x; Leong W, 2010, MAR ECOL PROG SER, V406, P71, DOI 10.3354/meps08541; Lesser MP, 2009, J EXP MAR BIOL ECOL, V375, P1, DOI 10.1016/j.jembe.2009.05.009; Lesser MP, 2006, J EXP MAR BIOL ECOL, V328, P277, DOI 10.1016/j.jembe.2005.07.010; Levin SA, 2008, BIOSCIENCE, V58, P27, DOI 10.1641/B580107; Loh TL, 2012, MAR ECOL PROG SER, V465, P111, DOI 10.3354/meps09904; Loh TL, 2009, J EXP MAR BIOL ECOL, V374, P45, DOI 10.1016/j.jembe.2009.04.007; Lopez-Legentil S, 2009, CORAL REEFS, V28, P157, DOI 10.1007/s00338-008-0430-3; Madrigal J, 2011, ECOLOGY, V92, P282, DOI 10.1890/10-0643.1; Maliao RJ, 2008, MAR BIOL, V154, P841, DOI 10.1007/s00227-008-0977-0; Marasco RJ, 2007, CAN J FISH AQUAT SCI, V64, P928, DOI 10.1139/F07-062; McLean EL, 2012, MAR ECOL IN PRESS; McMurray SE, 2008, MAR BIOL, V155, P159, DOI 10.1007/s00227-008-1014-z; McMurray SE, 2011, LIMNOL OCEANOGR, V56, P2243, DOI 10.4319/lo.2011.56.6.2243; McMurray SE, 2010, ECOLOGY, V91, P560, DOI 10.1890/08-2060.1; Menge BA, 2000, J EXP MAR BIOL ECOL, V250, P257, DOI 10.1016/S0022-0981(00)00200-8; Miller SL, 2000, MAR TECHNOL SOC J, V34, P69, DOI 10.4031/MTSJ.34.4.9; Mougi A, 2012, SCIENCE, V337, P349, DOI 10.1126/science.1220529; Mumby PJ, 2007, NATURE, V450, P98, DOI 10.1038/nature06252; Mumby PJ, 2009, CORAL REEFS, V28, P761, DOI 10.1007/s00338-009-0506-8; Naeem S, 2012, SCIENCE, V336, P1401, DOI 10.1126/science.1215855; Nagelkerken I, 2008, AQUAT BOT, V89, P155, DOI 10.1016/j.aquabot.2007.12.007; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Pawlik, 1997, P 8 INT COR REEF S, V2, P1255; Pawlik JR, 2008, MAR ECOL PROG SER, V368, P137, DOI 10.3354/meps07615; Pawlik JR, 2007, MAR ECOL PROG SER, V339, P93, DOI 10.3354/meps339093; Pawlik JR, 2011, BIOSCIENCE, V61, P888, DOI 10.1525/bio.2011.61.11.8; Pawlik JR, 2002, J CHEM ECOL, V28, P1103, DOI 10.1023/A:1016221415028; Pawlik JR, 1998, LIMNOL OCEANOGR, V43, P1396, DOI 10.4319/lo.1998.43.6.1396; PAWLIK JR, 1995, MAR ECOL PROG SER, V127, P183, DOI 10.3354/meps127183; Puyana M, 2001, THESIS UCSD LA JOLLA; RANDALL JE, 1968, MAR BIOL, V1, P216, DOI 10.1007/BF00347115; Ruckelshaus M, 2008, BIOSCIENCE, V58, P53, DOI 10.1641/B580110; Stokes MD, 2011, MAR ECOL-EVOL PERSP, V32, P364, DOI 10.1111/j.1439-0485.2011.00469.x; Trussell GC, 2006, MAR ECOL PROG SER, V323, P149, DOI 10.3354/meps323149; Walters KD, 2005, INTEGR COMP BIOL, V45, P352, DOI 10.1093/icb/45.2.352; Wilson DM, 1999, J CHEM ECOL, V25, P2811, DOI 10.1023/A:1020811810223	58	54	56	2	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62573	10.1371/journal.pone.0062573	http://dx.doi.org/10.1371/journal.pone.0062573			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667492	Green Submitted, Green Published, gold			2022-12-25	WOS:000319055600029
J	Johansson, KSL; Vrede, T; Lebret, K; Johnson, RK				Johansson, Karin S. L.; Vrede, Tobias; Lebret, Karen; Johnson, Richard K.			Zooplankton Feeding on the Nuisance Flagellate Gonyostomum semen	PLOS ONE			English	Article							DIEL VERTICAL MIGRATION; ALGAL SIZE; LAKES; PHYTOPLANKTON; DYNAMICS; DAPHNIA; RAPHIDOPHYCEAE; RESPONSES; RESERVOIR; INVASION	The large bloom-forming flagellate Gonyostomum semen has been hypothesized to be inedible to naturally occurring zooplankton due to its large cell size and ejection of long slimy threads (trichocysts) induced by physical stimulation. In a grazing experiment using radiolabelled algae and zooplankton collected from lakes with recurring blooms of G. semen and lakes that rarely experience blooms, we found that Eudiaptomus gracilis and Holopedium gibberum fed on G. semen at high rates, whereas Daphnia cristata and Ceriodaphnia spp. did not. Grazing rates of E. gracilis were similar between bloom-lakes and lakes with low biomass of G. semen, indicating that the ability to feed on G. semen was not a result of local adaptation. The high grazing rates of two of the taxa in our experiment imply that some of the nutrients and energy taken up by G. semen can be transferred directly to higher trophic levels, although the predominance of small cladocerans during blooms may limit the importance of G. semen as a food resource. Based on grazing rates and previous observations on abundances of E. gracilis and H. gibberum, we conclude that there is a potential for grazer control of G. semen and discuss why blooms of G. semen still occur.	[Johansson, Karin S. L.; Vrede, Tobias; Johnson, Richard K.] Swedish Univ Agr Sci, Dept Aquat Sci & Assessment, Uppsala, Sweden; [Lebret, Karen] Lund Univ, Dept Biol, Lund, Sweden	Swedish University of Agricultural Sciences; Lund University	Johansson, KSL (corresponding author), Swedish Univ Agr Sci, Dept Aquat Sci & Assessment, Uppsala, Sweden.	karin.johansson@slu.se	Lebret, Karen/G-8822-2013; Vrede, Tobias/C-1956-2015; Johnson, Richard K./P-4991-2014; Vrede, Tobias/AAC-6469-2019	Lebret, Karen/0000-0002-5262-8954; Vrede, Tobias/0000-0001-8235-9890; Johnson, Richard K./0000-0001-7979-6563; Vrede, Tobias/0000-0001-8235-9890; Lebret, Karen/0000-0002-3853-1662				Brohan P., 2006, J GEOPHYS RES-ATMOS, V111; BURNS CW, 1968, LIMNOL OCEANOGR, V13, P675, DOI 10.4319/lo.1968.13.4.0675; CRONBERG G, 1988, HYDROBIOLOGIA, V161, P217, DOI 10.1007/BF00044113; DEMOTT WR, 1991, J PLANKTON RES, V13, P1203, DOI 10.1093/plankt/13.6.1203; Figueroa RI, 2006, J PHYCOL, V42, P859, DOI 10.1111/j.1529-8817.2006.00240.x; GLIWICZ ZM, 1990, ECOLOGY, V71, P691, DOI 10.2307/1940323; GUILLARD RR, 1972, J PHYCOL, V8, P10, DOI 10.1111/j.0022-3646.1972.00010.x; Gutseit K, 2007, FRESHWATER BIOL, V52, P28, DOI 10.1111/j.1365-2427.2006.01668.x; Hansson LA, 2000, ECOLOGY, V81, P842, DOI 10.2307/177381; HONGVE D, 1988, PROC INT ASSOC THE 1, V23, P430; HORN W, 1981, INT REV GES HYDROBIO, V66, P787, DOI 10.1002/iroh.19810660603; Johansson KSL, 2013, AQUAT SCI, V75, P447, DOI 10.1007/s00027-013-0291-x; Lampert W., 1985, Advances in Limnology, V21, P311; LAMPERT W, 1988, B MAR SCI, V43, P620; Landsberg JH, 2002, REV FISH SCI, V10, P113, DOI 10.1080/20026491051695; Lebret K, 2012, LIMNOL OCEANOGR, V57, P727, DOI 10.4319/lo.2012.57.3.0727; LECOHU R, 1989, ARCH HYDROBIOL, V117, P225; LEPISTO L, 1994, HYDROBIOLOGIA, V273, P1, DOI 10.1007/BF00126764; Lundgren A, 1978, VERH INT VER LIMNOL, V20, P863; Monteith DT, 2007, NATURE, V450, P537, DOI 10.1038/nature06316; MURTAUGH PA, 1985, J PLANKTON RES, V7, P415, DOI 10.1093/plankt/7.3.415; Negro AI, 2000, HYDROBIOLOGIA, V424, P25, DOI 10.1023/A:1003940625437; Olin M, 2006, HYDROBIOLOGIA, V553, P67, DOI 10.1007/s10750-005-0786-0; Pithart David, 1997, Archiv fuer Hydrobiologie Supplement, V119, P119; Poniewozik M, 2011, OCEANOL HYDROBIOL ST, V40, P22, DOI 10.2478/s13545-011-0013-8; Rengefors K, 2012, HARMFUL ALGAE, V18, P65, DOI 10.1016/j.hal.2012.04.005; Salonen K, 2000, J PLANKTON RES, V22, P1841, DOI 10.1093/plankt/22.10.1841; Tessier A.J., 1986, ECOLOGY, V67, P286; Trigal C, 2013, HARMFUL ALG IN PRESS; Trigal C, 2011, FRESHWATER BIOL, V56, P1937, DOI 10.1111/j.1365-2427.2011.02615.x; VANDERPLOEG HA, 1988, B MAR SCI, V43, P377; WALTERS CJ, 1990, CAN J FISH AQUAT SCI, V47, P401, DOI 10.1139/f90-042; WEBSTER KE, 1978, LIMNOL OCEANOGR, V23, P1238, DOI 10.4319/lo.1978.23.6.1238; Williamson CE, 1996, LIMNOL OCEANOGR, V41, P224, DOI 10.4319/lo.1996.41.2.0224	34	20	20	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62557	10.1371/journal.pone.0062557	http://dx.doi.org/10.1371/journal.pone.0062557			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667489	gold, Green Published, Green Submitted			2022-12-25	WOS:000319654700047
J	Jones, EF; Sinha, SP; Newitt, DC; Klifa, C; Kornak, J; Park, CC; Hylton, NM				Jones, Ella F.; Sinha, Sumedha P.; Newitt, David C.; Klifa, Catherine; Kornak, John; Park, Catherine C.; Hylton, Nola M.			MRI Enhancement in Stromal Tissue Surrounding Breast Tumors: Association with Recurrence Free Survival following Neoadjuvant Chemotherapy	PLOS ONE			English	Article							CANCER; EXPRESSION; ANGIOGENESIS; CELLS; RISK; VIVO	Rationale and Objectives: Normal-appearing stromal tissues surrounding breast tumors can harbor abnormalities that lead to increased risk of local recurrence. The objective of this study was to develop a new imaging methodology to characterize the signal patterns of stromal tissue and to investigate their association with recurrence-free survival following neoadjuvant chemotherapy. Materials and Methods: Fifty patients with locally-advanced breast cancer were imaged with dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) before (V1) and after one cycle (V2) of adriamycin-cytoxan therapy. Contrast enhancement in normal-appearing stroma around the tumor was characterized by the mean percent enhancement (PE) and mean signal enhancement ratio (SER) in distance bands of 5 mm from the tumor edge. Global PE and SER were calculated by averaging all stromal bands 5 to 40 mm from tumor. Proximity-dependent PE and SER were analyzed using a linear mixed effects model and Cox proportional hazards model for recurrence-free survival. Results: The mixed effects model displayed a decreasing radial trend in PE at both V1 and V2. An increasing trend was less pronounced in SER. Survival analysis showed that the hazard ratio estimates for each unit decrease in global SER was statistically significant at V1 [estimated hazard ratio = 0.058, 95% Wald CI (0.003, 1.01), likelihood ratio p = 0.03]; but was not so for V2. Conclusions: These findings show that stromal tissue outside the tumor can be quantitatively characterized by DCE-MRI, and suggest that stromal enhancement measurements may be further developed for use as a potential predictor of recurrence/disease-free survival following therapy.	[Jones, Ella F.; Sinha, Sumedha P.; Newitt, David C.; Klifa, Catherine; Kornak, John; Park, Catherine C.; Hylton, Nola M.] Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Jones, EF (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	ella.jones@ucsf.edu	Hylton, Nola/AAF-7861-2019; Jones, Ella/AAZ-6292-2020; Jones, Ella F./W-2725-2019	Jones, Ella/0000-0001-8700-2129; 	Komen Grant [SAC110017]; NIH [R01 CA69587, R01 116182, R21 CA 152499]; American Cancer Society [RSG-07-1110-01]; NATIONAL CANCER INSTITUTE [R01CA069587, R21CA152499] Funding Source: NIH RePORTER	Komen Grant(Susan G. Komen Breast Cancer Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Komen Grant SAC110017, NIH R01 CA69587, NIH R01 116182, NIH R21 CA 152499 and the American Cancer Society: RSG-07-1110-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, ACR PRACT GUID PERF; Beck AH, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002564; Boyd NF, 1998, CANCER EPIDEM BIOMAR, V7, P1133; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Graham SJ, 1997, MAGNET RESON MED, V38, P669, DOI 10.1002/mrm.1910380422; GRAY RJ, 1992, J AM STAT ASSOC, V87, P942, DOI 10.2307/2290630; Griffiths L, 1997, CANCER RES, V57, P570; Guidi AJ, 1997, CANCER, V80, P1945, DOI 10.1002/(SICI)1097-0142(19971115)80:10<1945::AID-CNCR11>3.0.CO;2-Y; Hattangadi J, 2008, AM J ROENTGENOL, V190, P1630, DOI 10.2214/AJR.07.2533; Hylton N M, 1999, Magn Reson Imaging Clin N Am, V7, P411; Hylton NM, 1999, MAGN RESON IMAGING C, V7, px; Hylton N, 2006, J CLIN ONCOL, V24, P3293, DOI 10.1200/JCO.2006.06.8080; Klifa C, 2004, P ANN INT IEEE EMBS, V26, P1667; Kurose K, 2002, NAT GENET, V32, P355, DOI 10.1038/ng1013; Li KL, 2008, RADIOLOGY, V248, P79, DOI 10.1148/radiol.2481070846; Li SP, 2011, RADIOLOGY, V260, P68, DOI 10.1148/radiol.11102493; Li T, 2005, CANCER EPIDEM BIOMAR, V14, P343, DOI 10.1158/1055-9965.EPI-04-0490; Nabavizadeh N, 2011, INTEGR BIOL-UK, V3, P490, DOI 10.1039/c0ib00089b; Partridge SC, 2010, J MAGN RESON IMAGING, V31, P339, DOI 10.1002/jmri.22045; Partridge SC, 2005, AM J ROENTGENOL, V184, P1774, DOI 10.2214/ajr.184.6.01841774; Partridge SC, 2002, AM J ROENTGENOL, V179, P1193, DOI 10.2214/ajr.179.5.1791193; Partridge SC, 1999, ST HEAL T, V62, P259; Roskelley CD, 2001, CANCER RES, V61, P6788; Singer L, 2012, ACAD RADIOL, V19, P526, DOI 10.1016/j.acra.2011.11.003; Tlsty TD, 2001, CURR OPIN GENET DEV, V11, P54, DOI 10.1016/S0959-437X(00)00156-8	26	37	39	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e61969	10.1371/journal.pone.0061969	http://dx.doi.org/10.1371/journal.pone.0061969			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667451	Green Published, Green Submitted, gold			2022-12-25	WOS:000319654700020
J	Mitchell, JG; Seuront, L; Doubell, MJ; Losic, D; Voelcker, NH; Seymour, J; Lal, R				Mitchell, James G.; Seuront, Laurent; Doubell, Mark J.; Losic, Dusan; Voelcker, Nicolas H.; Seymour, Justin; Lal, Ratnesh			The Role of Diatom Nanostructures in Biasing Diffusion to Improve Uptake in a Patchy Nutrient Environment	PLOS ONE			English	Article							PHAEOCYSTIS-GLOBOSA; PHYTOPLANKTON; SIZE; PATCHINESS; PHOSPHORUS; TURBULENCE; PATTERNS; SEAWATER; PLANKTON; NITRATE	Background: Diatoms are important single-celled autotrophs that dominate most lit aquatic environments and are distinguished by surficial frustules with intricate designs of unknown function. Principal Findings: We show that some frustule designs constrain diffusion to positively alter nutrient uptake. In nutrient gradients of 4 to 160 times over <5 cm, the screened-chambered morphology of Coscincodiscus sp. biases the nutrient diffusion towards the cell by at least 3.8 times the diffusion to the seawater. In contrast, the open-chambers of Thalassiosira eccentrica produce at least a 1.3 times diffusion advantage to the membrane over Coscincodiscus sp. when nutrients are homogeneous. Significance: Diffusion constraint explains the success of particular diatom species at given times and the overall success of diatoms. The results help answer the unresolved question of how adjacent microplankton compete. Furthermore, diffusion constraint by supramembrane nanostructures to alter molecular diffusion suggests that microbes compete via supramembrane topology, a competitive mechanism not considered by the standard smooth-surface equations used for nutrient uptake nor in microbial ecology and cell physiology.	[Mitchell, James G.; Seuront, Laurent] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; [Seuront, Laurent; Doubell, Mark J.] South Australian Res & Dev Inst, West Beach, SA, Australia; [Seuront, Laurent] Univ Sci & Technol Lille, CNRS, Lab Oceanol & Geosci, Stn Marine, Wimereux, France; [Losic, Dusan] Univ Adelaide, Sch Chem Engn, Adelaide, SA, Australia; [Voelcker, Nicolas H.] Univ S Australia, Mawson Inst, Adelaide, SA 5001, Australia; [Seymour, Justin] Univ Technol Sydney, Plant Funct Biol & Climate Change Cluster, Sydney, NSW 2007, Australia; [Lal, Ratnesh] Univ Calif San Diego, Dept Mech & Aerosp Engn & Bioengn, La Jolla, CA 92093 USA	Flinders University South Australia; South Australian Research & Development Institute (SARDI); Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; University of Adelaide; University of South Australia; University of Technology Sydney; University of California System; University of California San Diego	Mitchell, JG (corresponding author), Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia.	jim.mitchell@flinders.edu.au	Voelcker, Nicolas H/D-6199-2012; Losic, Dusan/B-2436-2009; Lal, Ratnesh/AAG-5424-2019; Doubell, Mark/F-2884-2016	Voelcker, Nicolas H/0000-0002-1536-7804; Losic, Dusan/0000-0002-1930-072X; Seymour, Justin/0000-0002-3745-6541; Seuront, Laurent/0000-0002-0051-5202; Mitchell, Jim/0000-0002-8445-0935; Doubell, Mark/0000-0003-3272-9659	Australian Research Council (ARC); Flinders University; Australian Antarctic Division; ARC; US National Institutes of Health	Australian Research Council (ARC)(Australian Research Council); Flinders University; Australian Antarctic Division; ARC(Australian Research Council); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	J.G.M., L.S., N.H.V., J.S. and D.L. were supported by the Australian Research Council (ARC) and Flinders University. J.G.M. and L.S. were supported by the Australian Antarctic Division. R.L. was supported by the ARC and the US National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747; Bach LT, 2012, MAR BIOL, V159, P1853, DOI 10.1007/s00227-012-1945-2; BERG HC, 1977, BIOPHYS J, V20, P193, DOI 10.1016/S0006-3495(77)85544-6; BIENFANG PK, 1982, MAR BIOL, V67, P295, DOI 10.1007/BF00397670; Blackburn N, 1998, SCIENCE, V282, P2254, DOI 10.1126/science.282.5397.2254; Cardenas MB, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035343; Chatterjee S, 2012, VIRUSES-BASEL, V4, P3162, DOI 10.3390/v4113162; Doubell MJ, 2006, APPL ENVIRON MICROB, V72, P4475, DOI 10.1128/AEM.02959-05; Durham WM, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.238102; Franck VM, 2006, MARINE ECOLOGY PROGR, V252, P15; FUHRMAN JA, 1986, MAR ECOL PROG SER, V33, P237, DOI 10.3354/meps033237; Gradmann D, 1999, EUR BIOPHYS J BIOPHY, V28, P591, DOI 10.1007/s002490050241; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; HASLE GR, 1970, T AM MICROSC SOC, V89, P469, DOI 10.2307/3224555; Hood RR, 2006, HARMFUL ALGAE, V5, P459, DOI 10.1016/j.hal.2006.04.014; KarpBoss L, 1996, OCEANOGR MAR BIOL, V34, P71; LEHMAN JT, 1982, SCIENCE, V216, P729, DOI 10.1126/science.216.4547.729; Menden-Deuer S, 2000, LIMNOL OCEANOGR, V45, P569, DOI 10.4319/lo.2000.45.3.0569; Miklasz KA, 2010, LIMNOL OCEANOGR, V55, P2513, DOI 10.4319/lo.2010.55.6.2513; MITCHELL JG, 1985, NATURE, V316, P58, DOI 10.1038/316058a0; Musielak MM, 2009, J FLUID MECH, V638, P401, DOI 10.1017/S0022112009991108; Peters F, 2006, J MARINE SYST, V61, P134, DOI 10.1016/j.jmarsys.2005.11.012; Pomeroy LR, 2007, OCEANOGRAPHY, V20, P28, DOI 10.5670/oceanog.2007.45; Sanudo-Wilhelmy SA, 2004, NATURE, V432, P897, DOI 10.1038/nature03125; Schapira M, 2008, J MAR BIOL ASSOC UK, V88, P649, DOI 10.1017/S0025315408001306; Schlimpert S, 2012, CELL, V151, P1270, DOI 10.1016/j.cell.2012.10.046; Schneider IC, 2005, BIOPHYS J, V89, P1420, DOI 10.1529/biophysj.105.061218; Seuront L, 2007, BIOGEOCHEMISTRY, V83, P173, DOI 10.1007/s10533-007-9097-z; Seuront L, 2005, MAR ECOL PROG SER, V302, P93, DOI 10.3354/meps302093; Seuront L, 2002, MAR ECOL PROG SER, V232, P29, DOI 10.3354/meps232029; Seuront L, 2001, DEEP-SEA RES PT I, V48, P1199, DOI 10.1016/S0967-0637(00)00089-3; Seuront L, 2006, LIMNOL OCEANOGR-METH, V4, P260, DOI 10.4319/lom.2006.4.260; Seymour JR, 2008, ESTUAR COAST SHELF S, V80, P589, DOI 10.1016/j.ecss.2008.09.011; Stocker R, 2012, SCIENCE, V338, P628, DOI 10.1126/science.1208929; Taylor JR, 2012, SCIENCE, V338, P675, DOI 10.1126/science.1219417; Thorpe SA, 2007, INTRO OCEAN TURBULEN, P240; Villareal TA, 1999, NATURE, V397, P423, DOI 10.1038/17103; Yamashita H, 2012, J MOL BIOL, V422, P300, DOI 10.1016/j.jmb.2012.05.018	39	34	34	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e59548	10.1371/journal.pone.0059548	http://dx.doi.org/10.1371/journal.pone.0059548			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667421	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000319654700004
J	Shao, L; Oshima, S; Duong, B; Advincula, R; Barrera, J; Malynn, BA; Ma, A				Shao, Ling; Oshima, Shigeru; Duong, Bao; Advincula, Rommel; Barrera, Julio; Malynn, Barbara A.; Ma, Averil			A20 Restricts Wnt Signaling in Intestinal Epithelial Cells and Suppresses Colon Carcinogenesis	PLOS ONE			English	Article							NF-KAPPA-B; COLORECTAL-CANCER; BETA-CATENIN; ENZYME A20; TNFAIP3; UBIQUITIN; INFLAMMATION; ASSOCIATION; ACTIVATION; MUTATIONS	Colon carcinogenesis consists of a multistep process during which a series of genetic and epigenetic adaptations occur that lead to malignant transformation. Here, we have studied the role of A20 (also known as TNFAIP3), a ubiquitin-editing enzyme that restricts NF kappa B and cell death signaling, in intestinal homeostasis and tumorigenesis. We have found that A20 expression is consistently reduced in human colonic adenomas than in normal colonic tissues. To further investigate A20's potential roles in regulating colon carcinogenesis, we have generated mice lacking A20 specifically in intestinal epithelial cells and interbred these with mice harboring a mutation in the adenomatous polyposis coli gene (APC(min)). While A20(FL/FL) villin-Cre mice exhibit uninflamed intestines without polyps, A20(FL/FL) villin-Cre APC(min/+) mice contain far greater numbers and larger colonic polyps than control APC(min) mice. We find that A20 binds to the beta-catenin destruction complex and restricts canonical wnt signaling by supporting ubiquitination and degradation of beta-catenin in intestinal epithelial cells. Moreover, acute deletion of A20 from intestinal epithelial cells in vivo leads to enhanced expression of the beta-catenin dependent genes cyclinD1 and c-myc, known promoters of colon cancer. Taken together, these findings demonstrate new roles for A20 in restricting beta-catenin signaling and preventing colon tumorigenesis.	[Shao, Ling; Duong, Bao; Advincula, Rommel; Barrera, Julio; Malynn, Barbara A.; Ma, Averil] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Oshima, Shigeru] Tokyo Med & Dent Univ, Dept Adv Therapeut Gastrointestinal Dis, Tokyo, Japan	University of California System; University of California San Francisco; Tokyo Medical & Dental University (TMDU)	Ma, A (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	averil.ma@ucsf.edu	Oshima, Shigeru/C-9865-2015	Oshima, Shigeru/0000-0003-1186-9177	National Institutes of Health; histopathology core of the University of California San Francisco Liver Center; Crohn's and Colitis Foundation of America;  [T32 DK007007]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007007, R01DK095693, P30DK026743] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); histopathology core of the University of California San Francisco Liver Center; Crohn's and Colitis Foundation of America; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health (AM), by the histopathology core of the University of California San Francisco Liver Center. LS was partly supported by T32 DK007007. SO was partly supported by a career development award from the Crohn's and Colitis Foundation of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrianto I, 2011, NAT GENET, V43, P253, DOI 10.1038/ng.766; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Bavi P, 2011, CLIN EPIGENETICS, V2, P417, DOI 10.1007/s13148-011-0049-z; Beyaert R, 2000, BIOCHEM PHARMACOL, V60, P1143, DOI 10.1016/S0006-2952(00)00404-4; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; da Costa LT, 1999, ONCOGENE, V18, P5010, DOI 10.1038/sj.onc.1202872; DeValck D, 1996, FEBS LETT, V384, P61, DOI 10.1016/0014-5793(96)00283-9; EKBOM A, 1990, LANCET, V336, P357, DOI 10.1016/0140-6736(90)91889-I; EKBOM A, 1990, NEW ENGL J MED, V323, P1228, DOI 10.1056/NEJM199011013231802; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; EVANS GS, 1992, J CELL SCI, V101, P219; Fung EYMG, 2009, GENES IMMUN, V10, P188, DOI 10.1038/gene.2008.99; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He KL, 2002, MOL CELL BIOL, V22, P6034, DOI 10.1128/MCB.22.17.6034-6045.2002; Hitotsumatsu O, 2008, IMMUNITY, V28, P381, DOI 10.1016/j.immuni.2008.02.002; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; Kolodziej LE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026352; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Ma A, 2012, NAT REV IMMUNOL, V12, P774, DOI 10.1038/nri3313; Malynn BA, 2009, J EXP MED, V206, P977, DOI 10.1084/jem.20090765; Metzger D, 2001, METHODS, V24, P71, DOI 10.1006/meth.2001.1159; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; MOSER AR, 1995, DEV DYNAM, V203, P422, DOI 10.1002/aja.1002030405; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; Musone SL, 2011, GENES IMMUN, V12, P176, DOI 10.1038/gene.2010.64; Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; Rhee L, 2012, AM J PHYSIOL-GASTR L, V303, pG220, DOI 10.1152/ajpgi.00077.2012; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Tauriello DVF, 2010, CELL CYCLE, V9, P3700, DOI 10.4161/cc.9.18.13204; Tavares RM, 2010, IMMUNITY, V33, P181, DOI 10.1016/j.immuni.2010.07.017; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; Ullman TA, 2011, GASTROENTEROLOGY, V140, P1807, DOI 10.1053/j.gastro.2011.01.057; Ungerback J, 2012, CARCINOGENESIS, V33, P2126, DOI 10.1093/carcin/bgs256; Vereecke L, 2010, J EXP MED, V207, P1513, DOI 10.1084/jem.20092474; Vlantis K, 2011, J CLIN INVEST, V121, P2781, DOI 10.1172/JCI45349; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794	47	34	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e62223	10.1371/journal.pone.0062223	http://dx.doi.org/10.1371/journal.pone.0062223			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671587	Green Published, Green Submitted, gold			2022-12-25	WOS:000321390200016
J	Gao, TP; Shih, CK; Rasnitsyn, AP; Ren, D				Gao, Taiping; Shih, Chungkun; Rasnitsyn, Alexandr P.; Ren, Dong			Hoplitolyda duolunica gen. et sp nov (Insecta, Hymenoptera, Praesiricidae), the Hitherto Largest Sawfly from the Mesozoic of China	PLOS ONE			English	Article							INNER-MONGOLIA; BODY-SIZE; OXYGEN; PELECINIDAE; DISPERSAL; EVOLUTION; GROWTH	Background: Large body size of an insect, in general, enhances its capability of predation, competition, and defense, resulting in better survivability and reproduction. Hymenopterans, most being phytophagous or parasitic, have a relatively small to medium body size, typically under 50.0 mm in body length. Principal Findings: Herein, we describe Hoplitolyda duolunica gen. et sp. nov., assigned to Praesiricidae, from the Early Cretaceous Yixian Formation of China. This new species is the largest fossil hymenopteran hitherto with body estimated >55.0 mm long and wing span >92.0 mm. H. duolunica is, to our knowledge, the only sawfly with Sc present in the hind wing but not in the forewing. Its Rs1 and M1 meeting each other at 145 degrees angle represents an intermediate in the transition from "Y" to "T" shapes. Even though Hoplitolyda differs significantly from all previously described genera in two subfamilies of Praesricidae, we leave the new genus unplaced in existing subfamilies, pending discovery of material with more taxonomic structure. Conclusions/Significance: Hoplitolyda has many unique and interesting characters which might have benefitted its competition, survival, and reproduction: large body size and head with robust and strong mandibles for defense and/or sexual selection, unique wing venation and setal arrangements for flight capability and mobility, dense hairs on body and legs for sensing and protection, etc. Considering the reported ferocious predators of feathered dinosaurs, pterosaurs, birds, and mammals coexisting in the same eco-system, Hoplitolyda is an interesting case of "survival of the fittest" in facing its evolutionary challenges.	[Gao, Taiping; Shih, Chungkun; Ren, Dong] Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China; [Rasnitsyn, Alexandr P.] Russian Acad Sci, Inst Paleontol, Moscow, Russia; [Rasnitsyn, Alexandr P.] Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England	Capital Normal University; Russian Academy of Sciences; Natural History Museum London	Ren, D (corresponding author), Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China.	rendong@mail.cnu.edu.cn	Rasnitsyn, Alexandr/P-2393-2015; Gao, Taiping/Z-3987-2019	Rasnitsyn, Alexandr/0000-0002-6350-0040	National Basic Research Program of China (973 Program) [2012CB821906]; National Natural Science Foundation of China [31230065, 31272352, 41272006]; Project of Great Wall Scholar; Beijing Municipal Commission of Education [KZ201310028033]; China Geological Survey [1212011120115]; Presidium RAS Program "Origin and evolution of the geo-biological system"	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Great Wall Scholar; Beijing Municipal Commission of Education(Beijing Municipal Commission of Education); China Geological Survey(China Geological Survey); Presidium RAS Program "Origin and evolution of the geo-biological system"	This research is supported by the National Basic Research Program of China (973 Program) (grant 2012CB821906), the National Natural Science Foundation of China (grants 31230065, 31272352, 41272006), Project of Great Wall Scholar and KEY project of Beijing Municipal Commission of Education Project (grants KZ201310028033), China Geological Survey (grant 1212011120115) to DR, and the Presidium RAS Program "Origin and evolution of the geo-biological system", to RAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archibald SB, 2011, P ROY SOC B-BIOL SCI, V278, P3679, DOI 10.1098/rspb.2011.0729; Bradbury J. W., 2011, PRINCIPLES ANIMAL CO; Callier V, 2011, P NATL ACAD SCI USA, V108, P14664, DOI 10.1073/pnas.1106556108; Chang MM, 2008, JEHOL FOSSILS: THE EMERGENCE OF FEATHERED DINOSAURS, BEAKED BIRDS AND FLOWERING PLANTS, P11; DAMUTH J, 1981, NATURE, V290, P699, DOI 10.1038/290699a0; Dudley R, 1998, J EXP BIOL, V201, P1043; Emlen DJ, 2012, SCIENCE, V337, P860, DOI 10.1126/science.1224286; Gao TP, 2012, CURR BIOL, V22, P732, DOI 10.1016/j.cub.2012.03.012; Gao TP, 2010, ANN SOC ENTOMOL FR, V46, P148, DOI 10.1080/00379271.2010.10697650; Harrison JF, 2011, ANNU REV PHYSIOL, V73, P95, DOI 10.1146/annurev-physiol-012110-142155; Hu YM, 2005, NATURE, V433, P149, DOI 10.1038/nature03102; Huber TH, 1993, HYMENOPTERA WORLD ID; McNab BK, 2001, J MAMMAL, V82, P709, DOI 10.1644/1545-1542(2001)082<0709:SDASOE>2.0.CO;2; Rasnitsyn A.P., 1980, Trudy Paleontologicheskogo Instituta, V174, P1; Rasnitsyn A.P., 1977, PALEONTOL ZH, V3, P98; Rasnitsyn A.P., 1969, T PALEONTOL I ACAD S, V123, P1; Rasnitsyn A.P., 1968, JURASSIC INSECTS KAR; Rasnitsyn AP, 2006, PALAEONTOLOGY, V49, P907, DOI 10.1111/j.1475-4983.2006.00574.x; Rasnitsyn AP, 1983, PALEONTOLOGICHESKIY, V2, P54; Ren D., 1995, FAUNAE STRATIGRAPHY; Ren D., 2010, SILENT STORIES INSEC; SHEAR WA, 1990, CAN J ZOOL, V68, P1807, DOI 10.1139/z90-262; Shih CK, 2010, ANN ENTOMOL SOC AM, V103, P875, DOI 10.1603/AN09043; Shih CK, 2009, ANN ENTOMOL SOC AM, V102, P20, DOI 10.1603/008.102.0103; Swisher CC, 1999, NATURE, V400, P58, DOI 10.1038/21872; Taeger A, 2010, ZOOTAXA, P1, DOI 10.11646/zootaxa.2580.1.1; Wan XQ, 2007, ACTA GEOL SIN-ENGL, V81, P957; Wang XL, 2005, NATURE, V437, P875, DOI 10.1038/nature03982; Xu X, 2010, NATURE, V464, P1338, DOI 10.1038/nature08965; Zhou ZH, 2005, P NATL ACAD SCI USA, V102, P18998, DOI 10.1073/pnas.0507106102; Zhou ZH, 2003, NATURE, V421, P807, DOI 10.1038/nature01420	31	15	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62420	10.1371/journal.pone.0062420	http://dx.doi.org/10.1371/journal.pone.0062420			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23671596	gold, Green Published, Green Submitted			2022-12-25	WOS:000321202100008
J	Sun, MM; Li, JF; Guo, LL; Xiao, HT; Dong, L; Wang, F; Huang, FB; Cao, D; Qin, T; Yin, XH; Li, JM; Wang, SL				Sun, M. M.; Li, J. F.; Guo, L. L.; Xiao, H. T.; Dong, L.; Wang, F.; Huang, F. B.; Cao, D.; Qin, T.; Yin, X. H.; Li, J. M.; Wang, S. L.			TGF-beta 1 suppression of microRNA-450b-5p expression: a novel mechanism for blocking myogenic differentiation of rhabdomyosarcoma	ONCOGENE			English	Article						rhabdomyosarcoma; TGF-beta 1; miR-450b-5p; differentiation	TGF-BETA; MUSCLE DIFFERENTIATION; CELL-PROLIFERATION; SKELETAL-MUSCLE; GROWTH; CANCER; SMAD3; TRANSFORMING-GROWTH-FACTOR-BETA-1; QUANTIFICATION; TRANSCRIPTION	Transforming growth factor beta 1 (TGF-beta 1) is the most potent inhibitor of myogenic differentiation (MyoD) of rhabdomyosarcoma (RMS); however, the underlying mechanisms of this inhibition remain unclear. In this study, we identified novel TGF-beta 1-related microRNAs (miRNAs); among these, miR-450b-5p is significantly regulated by TGF-beta 1. We provide evidence that TGF-beta 1 exerts it function by suppressing miR-450b-5p. Both in cultured cells and tumor implants, miR-450b-5p significantly arrested the growth of RMS and promoted its MyoD. Utilizing a bioinformatics approach, we identified miR-450b-5p target mRNAs. Among these candidates, only the expression of ecto-NOX disulfide-thiol exchanger 2 (ENOX2) and paired box 9 (PAX9) was augmented by miR-450b-5p knockdown examined by western blot; the engineered inhibition antagonized TGF-beta 1-mediated differentiation inhibition. Furthermore, we found that the Smad3 and Smad4 pathways, but not Smad2, are the principal mediator of TGF-beta 1 suppression of miR-450b-5p. Taken together, these results suggest that disrupting the TGF-beta 1 suppression of miR-450b-5p, or knockdown of ENOX2 and PAX9, are effective approaches in inducing RMS MyoD.	[Sun, M. M.; Qin, T.; Yin, X. H.] Soochow Univ, Sch Med, Dept Anat, Suzhou 215123, Peoples R China; [Li, J. F.] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Pathol, Hangzhou 310003, Zhejiang, Peoples R China; [Guo, L. L.; Dong, L.; Wang, F.; Huang, F. B.; Cao, D.; Li, J. M.; Wang, S. L.] Soochow Univ, Sch Med, Dept Pathol, Suzhou 215123, Peoples R China; [Xiao, H. T.] Sichuan Univ, West China Hosp, Dept Burn & Plast Surg, Chengdu 610064, Peoples R China	Soochow University - China; Zhejiang University; Soochow University - China; Sichuan University	Wang, SL (corresponding author), Soochow Univ, Sch Med, Dept Pathol, Suzhou 215123, Peoples R China.	jianmingli@suda.edu.cn; wangsoly112@hotmail.com			Chinese Nature Science Foundation [81072186, 81272738]; Jiangsu Provincial Nature Science Foundation [SBK20110743]; Jiangsu Provincial Higher Institution Nature Science Foundation [10KJB320018]; Suzhou Applied Basic Research Programs [SYS201207]; Jiangsu Overseas Research and Training Program for University Prominent Young and Middle-aged Teachers and Presidents	Chinese Nature Science Foundation; Jiangsu Provincial Nature Science Foundation; Jiangsu Provincial Higher Institution Nature Science Foundation; Suzhou Applied Basic Research Programs; Jiangsu Overseas Research and Training Program for University Prominent Young and Middle-aged Teachers and Presidents	We would like to thank the West China Hospital of Sichuan University for providing us with the tumor specimens. This work was supported partially by the Chinese Nature Science Foundation (81072186, 81272738), Jiangsu Provincial Nature Science Foundation (SBK20110743), Jiangsu Provincial Higher Institution Nature Science Foundation (10KJB320018), Suzhou Applied Basic Research Programs (SYS201207), and Sponsorship of Jiangsu Overseas Research and Training Program for University Prominent Young and Middle-aged Teachers and Presidents.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bouche M, 2000, FASEB J, V14, P1147, DOI 10.1096/fasebj.14.9.1147; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Ge XJ, 2011, CELL RES, V21, P1591, DOI 10.1038/cr.2011.72; Guo H, 2007, CHINESE MED J-PEKING, V120, P515, DOI 10.1097/00029330-200703020-00016; Hatley ME, 2012, CANCER CELL, V22, P536, DOI 10.1016/j.ccr.2012.09.004; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Li Y, 2004, AM J PATHOL, V164, P1007, DOI 10.1016/S0002-9440(10)63188-4; Liu D, 2004, EMBO J, V23, P1557, DOI 10.1038/sj.emboj.7600179; Liu D, 2001, GENE DEV, V15, P2950, DOI 10.1101/gad.925901; Liu NC, 2012, J AGR FOOD CHEM, V60, P2758, DOI 10.1021/jf204869w; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mishra PJ, 2009, J CLIN INVEST, V119, P2119, DOI 10.1172/JCI40107; Rodrigo I, 2003, DEVELOPMENT, V130, P473, DOI 10.1242/dev.00240; Schmittgen TD, 2008, METHODS, V44, P31, DOI 10.1016/j.ymeth.2007.09.006; Sebire NJ, 2003, J CLIN PATHOL, V56, P412, DOI 10.1136/jcp.56.6.412; Segev H, 2004, STEM CELLS, V22, P265, DOI 10.1634/stemcells.22-3-265; Shoji Y, 1996, J CLIN PATHOL, V49, P134, DOI 10.1136/jcp.49.2.134; Sun Q, 2008, NUCLEIC ACIDS RES, V36, P2690, DOI 10.1093/nar/gkn032; Suzuki HI, 2011, J BIOCHEM, V149, P15, DOI 10.1093/jb/mvq113; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; TAPSCOTT SJ, 1993, SCIENCE, V259, P1450, DOI 10.1126/science.8383879; Wang B, 2010, ONCOGENE, V29, P1787, DOI 10.1038/onc.2009.468; Wang SL, 2010, CANCER SCI, V101, P1108, DOI 10.1111/j.1349-7006.2010.01512.x; Wang SL, 2009, CANCER GENET CYTOGEN, V190, P8, DOI 10.1016/j.cancergencyto.2008.10.013; Wang V, 2009, BIODRUGS, V23, P15, DOI 10.2165/00063030-200923010-00002; Wurdinger T, 2007, PHARMACOGENOMICS J, V7, P297, DOI 10.1038/sj.tpj.6500429; Yamagata K, 2009, MOL CELL, V36, P340, DOI 10.1016/j.molcel.2009.08.017; Yang ZH, 2009, GENE DEV, V23, P694, DOI 10.1101/gad.1765109; Ye L, 2005, CHINESE MED J-PEKING, V118, P678; Zeng ZM, 2012, EXP CELL RES, V318, P1759, DOI 10.1016/j.yexcr.2012.04.021	35	37	40	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 17	2014	33	16					2075	2086		10.1038/onc.2013.165	http://dx.doi.org/10.1038/onc.2013.165			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AF3GH	23665678				2022-12-25	WOS:000334599100007
J	Ortiz, D; Gossack, L; Quast, U; Bryan, J				Ortiz, David; Gossack, Lindsay; Quast, Ulrich; Bryan, Joseph			Reinterpreting the Action of ATP Analogs on K-ATP Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE POTASSIUM CHANNELS; CONSERVED GLUTAMATE RESIDUE; NUCLEOTIDE-BINDING DOMAINS; SULFONYLUREA RECEPTOR 1; CRYSTAL-STRUCTURE; ABC TRANSPORTER; ESTERS ACTIVATE; COA ESTERS; MECHANISM; INHIBITION	Neuroendocrine-type K-ATP channels, (SUR1/Kir6.2)(4), couple the transmembrane flux of K+, and thus membrane potential, with cellular metabolism in various cell types including insulin-secreting beta-cells. Mutant channels with reduced activity are a cause of congenital hyperinsulinism, whereas hyperactive channels are a cause of neonatal diabetes. Acurrent regulatory model proposes that ATP hydrolysis is required to switch SUR1 into post-hydrolytic conformations able to antagonize the inhibitory action of nucleotide binding at the Kir6.2 pore, thus coupling enzymatic and channel activities. Alterations in SUR1 ATPase activity are proposed to contribute to neonatal diabetes and type 2 diabetes risk. The regulatory model is partly based on the reduced ability of ATP analogs such as adenosine 5'-(beta,gamma-imino)triphosphate (AMP-PNP) and adenosine 5'-O-(thiotriphosphate) (ATP gamma S) to stimulate channel activity, presumably by reducing hydrolysis. This study uses a substitution at the catalytic glutamate, SUR1E1507Q, with a significantly increased affinity for ATP, to probe the action of these ATP analogs on conformational switching. ATP gamma S, a slowly hydrolyzable analog, switches SUR1 conformations, albeit with reduced affinity. Nonhydrolyzable AMP-PNP and adenosine 5'-(beta,gamma-methylenetriphosphate) (AMP-PCP) alone fail to switch SUR1, but do reverse ATP-induced switching. AMP-PCP displaces 8-azido-[P-32] ATP from the noncanonical NBD1 of SUR1. This is consistent with structural data on an asymmetric bacterial ABC protein that shows that AMP-PNP binds selectively to the noncanonical NBD to prevent conformational switching. The results imply that MgAMP-PNP and MgAMP-PCP (AMP-PxP) fail to activate K-ATP channels because they do not support NBD dimerization and conformational switching, rather than by limiting enzymatic activity.	[Bryan, Joseph] Pacific NW Diabet Res Inst, Seattle, WA 98122 USA; [Quast, Ulrich] Eberhard Karls Univ Hosp & Clin, Inst Expt & Clin Pharmacol & Toxicol, Dept Pharmacol & Expt Therapy, D-72074 Tubingen, Germany	Pacific Northwest Diabetes Research Institute (PNDRI); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Bryan, J (corresponding author), Pacific NW Diabet Res Inst, 720 Broadway, Seattle, WA 98122 USA.	jbryan@pnri.org			American Diabetes Association [ADA 1-10-BS21]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008280] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Diabetes Association Grant ADA 1-10-BS21 (to J. B.).	Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; Aittoniemi J, 2009, PHILOS T R SOC B, V364, P257, DOI 10.1098/rstb.2008.0142; Aleksandrov L, 2002, J BIOL CHEM, V277, P15419, DOI 10.1074/jbc.M111713200; Aleksandrov L, 2001, J BIOL CHEM, V276, P12918, DOI 10.1074/jbc.M100515200; Alekseev AE, 2005, J MOL CELL CARDIOL, V38, P895, DOI 10.1016/j.yjmcc.2005.02.022; ASHCROFT FM, 1989, J PHYSIOL-LONDON, V416, P349, DOI 10.1113/jphysiol.1989.sp017765; Babenko AP, 2008, J BIOL CHEM, V283, P8778, DOI 10.1074/jbc.C700243200; Baukrowitz T, 2000, EUR J BIOCHEM, V267, P5842, DOI 10.1046/j.1432-1327.2000.01672.x; Baukrowitz T, 1998, SCIENCE, V282, P1141, DOI 10.1126/science.282.5391.1141; Best L, 2011, J PHYSIOL-LONDON, V589, P1307, DOI 10.1113/jphysiol.2010.200741; Branstrom R, 2004, DIABETOLOGIA, V47, P277, DOI 10.1007/s00125-003-1299-x; Branstrom R, 1997, J BIOL CHEM, V272, P17390, DOI 10.1074/jbc.272.28.17390; Branstrom R, 1998, J BIOL CHEM, V273, P31395, DOI 10.1074/jbc.273.47.31395; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Christesen H. B. T., 2005, HORM RES, V64, P135; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; de Wet H, 2007, FEBS J, V274, P3532, DOI 10.1111/j.1742-4658.2007.05879.x; DUNNE MJ, 1989, FEBS LETT, V250, P262, DOI 10.1016/0014-5793(89)80734-3; DUNNE MJ, 1990, BRIT J PHARMACOL, V99, P169, DOI 10.1111/j.1476-5381.1990.tb14672.x; Enkvetchakul D, 2000, BIOPHYS J, V78, P2334, DOI 10.1016/S0006-3495(00)76779-8; Fan Z, 1999, J GEN PHYSIOL, V114, P251, DOI 10.1085/jgp.114.2.251; FINDLAY I, 1987, PFLUG ARCH EUR J PHY, V410, P313, DOI 10.1007/BF00580282; FINDLAY I, 1988, J MEMBRANE BIOL, V101, P83, DOI 10.1007/BF01872823; Gribble FM, 1998, J BIOL CHEM, V273, P26383, DOI 10.1074/jbc.273.41.26383; HEHL S, 1994, EUR BIOPHYS J BIOPHY, V23, P231, DOI 10.1007/BF00213573; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; Hohl M, 2012, NAT STRUCT MOL BIOL, V19, P395, DOI 10.1038/nsmb.2267; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; LEDERER WJ, 1989, J PHYSIOL-LONDON, V419, P193, DOI 10.1113/jphysiol.1989.sp017869; Loffler-Walz C, 1998, BRIT J PHARMACOL, V123, P1395, DOI 10.1038/sj.bjp.0701756; Lubelski J, 2006, BIOCHEMISTRY-US, V45, P648, DOI 10.1021/bi051276s; Mannikko R, 2011, DIABETES, V60, P1813, DOI 10.2337/db10-1583; Matsuo M, 2005, J MOL CELL CARDIOL, V38, P907, DOI 10.1016/j.yjmcc.2004.11.021; Matsuo M, 1999, J BIOL CHEM, V274, P37479, DOI 10.1074/jbc.274.52.37479; Mikhailov MV, 2005, EMBO J, V24, P4166, DOI 10.1038/sj.emboj.7600877; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oldham ML, 2011, P NATL ACAD SCI USA, V108, P15152, DOI 10.1073/pnas.1108858108; Orelle C, 2003, J BIOL CHEM, V278, P47002, DOI 10.1074/jbc.M308268200; Ortiz D, 2012, J BIOL CHEM, V287, P17985, DOI 10.1074/jbc.M112.349019; Pratt EB, 2011, CHANNELS, V5, P314, DOI 10.4161/chan.5.4.16510; Pratt EB, 2011, J GEN PHYSIOL, V137, P299, DOI 10.1085/jgp.201010557; Procko E, 2009, FASEB J, V23, P1287, DOI 10.1096/fj.08-121855; Procko E, 2006, MOL CELL, V24, P51, DOI 10.1016/j.molcel.2006.07.034; Proks P, 2010, J GEN PHYSIOL, V136, P389, DOI 10.1085/jgp.201010475; Qin L, 2008, BIOCHEMISTRY-US, V47, P13952, DOI 10.1021/bi801532g; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Riedel MJ, 2003, DIABETES, V52, P2630, DOI 10.2337/diabetes.52.10.2630; Schulze D, 2003, J PHYSIOL-LONDON, V552, P357, DOI 10.1113/jphysiol.2003.047035; SCHWANSTECHER C, 1994, BRIT J PHARMACOL, V111, P302, DOI 10.1111/j.1476-5381.1994.tb14060.x; Schwanstecher M, 1998, EMBO J, V17, P5529, DOI 10.1093/emboj/17.19.5529; SCHWANSTECHER M, 1992, BRIT J PHARMACOL, V105, P531, DOI 10.1111/j.1476-5381.1992.tb09014.x; Shyng SL, 2000, P NATL ACAD SCI USA, V97, P937, DOI 10.1073/pnas.97.2.937; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; TAKANO M, 1990, AM J PHYSIOL, V258, pH45, DOI 10.1152/ajpheart.1990.258.1.H45; Tombline G, 2004, J BIOL CHEM, V279, P46518, DOI 10.1074/jbc.M408052200; TREHERNE JM, 1992, P ROY SOC B-BIOL SCI, V247, P121, DOI 10.1098/rspb.1992.0017; Ueda K, 1997, J BIOL CHEM, V272, P22983, DOI 10.1074/jbc.272.37.22983; Wyman J, 1990, BINDING LINKAGE FUNC; YOUNT RG, 1975, ADV ENZYMOL RAMB, V43, P1; Zingman LV, 2001, NEURON, V31, P233, DOI 10.1016/S0896-6273(01)00356-7	62	21	21	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18894	18902		10.1074/jbc.M113.476887	http://dx.doi.org/10.1074/jbc.M113.476887			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23665564	hybrid, Green Published			2022-12-25	WOS:000321335800027
J	Ranaweera, RS; Yang, XL				Ranaweera, Ruchira S.; Yang, Xiaolu			Auto-ubiquitination of Mdm2 Enhances Its Substrate Ubiquitin Ligase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONJUGATING ENZYMES; IN-VIVO; P53; DEGRADATION; UBIQUITYLATION; ACTIVATION; CASPASES; DOMAINS; COMPLEX; CHAINS	The RING domain E3 ubiquitin ligase Mdm2 is the master regulator of the tumor suppressor p53. It targets p53 for proteasomal degradation, restraining the potent activity of p53 and enabling cell survival and proliferation. Like most E3 ligases, Mdm2 can also ubiquitinate itself. How Mdm2 auto-ubiquitination may influence its substrate ubiquitin ligase activity is undefined. Here we show that auto-ubiquitination of Mdm2 is an activating event. Mdm2 that has been conjugated to polyubiquitin chains, but not to single ubiquitins, exhibits substantially enhanced activity to polyubiquitinate p53. Mechanistically, auto-ubiquitination of Mdm2 facilitates the recruitment of the E2 ubiquitin-conjugating enzyme. This occurs through non-covalent interactions between the ubiquitin chains on Mdm2 and the ubiquitin binding domain on E2s. Mutations that diminish the noncovalent interactions render auto-ubiquitination unable to stimulate Mdm2 substrate E3 activity. These results suggest a model in which polyubiquitin chains on an E3 increase the local concentration of E2 enzymes and permit the processivity of substrate ubiquitination. They also support the notion that autocatalysis may be a prevalent mode for turning on the activity of latent enzymes.	[Yang, Xiaolu] Univ Penn, Perelman Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA; [Yang, Xiaolu] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Yang, XL (corresponding author), Univ Penn, Perelman Sch Med, Dept Canc Biol, 421 Curie Blvd, Philadelphia, PA 19104 USA.	xyang@mail.med.upenn.edu		Ranaweera, Ruchira/0000-0002-0671-2936	National Institutes of Health [CA08868]; NATIONAL CANCER INSTITUTE [F32CA008868, P30CA016520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA08868 (to X. Y.).	Beal RE, 1998, BIOCHEMISTRY-US, V37, P2925, DOI 10.1021/bi972514p; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; Chang DW, 2003, EMBO J, V22, P4132, DOI 10.1093/emboj/cdg414; Chang HY, 2000, MICROBIOL MOL BIOL R, V64, P821, DOI 10.1128/MMBR.64.4.821-846.2000; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Eletr ZM, 2005, NAT STRUCT MOL BIOL, V12, P933, DOI 10.1038/nsmb984; Fuchs SY, 1998, ONCOGENE, V17, P2543, DOI 10.1038/sj.onc.1202200; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; HERSHKO A, 1991, J BIOL CHEM, V266, P16376; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Huang L, 2011, P NATL ACAD SCI USA, V108, P12001, DOI 10.1073/pnas.1102309108; Jiang P, 2011, NAT CELL BIOL, V13, P310, DOI 10.1038/ncb2172; Kawai H, 2007, CANCER RES, V67, P6026, DOI 10.1158/0008-5472.CAN-07-1313; Kleiger G, 2009, CELL, V139, P957, DOI 10.1016/j.cell.2009.10.030; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; Linares LK, 2003, P NATL ACAD SCI USA, V100, P12009, DOI 10.1073/pnas.2030930100; Linke K, 2008, CELL DEATH DIFFER, V15, P841, DOI 10.1038/sj.cdd.4402309; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Poyurovsky MV, 2007, EMBO J, V26, P90, DOI 10.1038/sj.emboj.7601465; Saville MK, 2004, J BIOL CHEM, V279, P42169, DOI 10.1074/jbc.M403362200; Tang J, 2006, NAT CELL BIOL, V8, P855, DOI 10.1038/ncb1442; Tanimura S, 1999, FEBS LETT, V447, P5, DOI 10.1016/S0014-5793(99)00254-9; Uldrijan S, 2007, EMBO J, V26, P102, DOI 10.1038/sj.emboj.7601469; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Yang XL, 1998, MOL CELL, V1, P319, DOI 10.1016/S1097-2765(00)80032-5; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780	30	43	46	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18939	18946		10.1074/jbc.M113.454470	http://dx.doi.org/10.1074/jbc.M113.454470			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23671280	Green Published, hybrid			2022-12-25	WOS:000321335800031
J	Mullins, PD; Bondarenko, VE				Mullins, Paula D.; Bondarenko, Vladimir E.			A Mathematical Model of the Mouse Ventricular Myocyte Contraction	PLOS ONE			English	Article							FORCE-FREQUENCY-RELATIONSHIP; TRANSGENIC MICE; CARDIAC-MUSCLE; TROPONIN-I; SARCOMERE-LENGTH; CA2+; MECHANISMS; PHOSPHORYLATION; REPOLARIZATION; RELAXATION	Mathematical models of cardiac function at the cellular level include three major components, such as electrical activity, Ca2+ dynamics, and cellular shortening. We developed a model for mouse ventricular myocyte contraction which is based on our previously published comprehensive models of action potential and Ca2+ handling mechanisms. The model was verified with extensive experimental data on mouse myocyte contraction at room temperature. In the model, we implemented variable sarcomere length and indirect modulation of the tropomyosin transition rates by Ca2+ and troponin. The resulting model described well steady-state force-calcium relationships, dependence of the contraction force on the sarcomere length, time course of the contraction force and myocyte shortening, frequency dependence of the contraction force and cellular contraction, and experimentally measured derivatives of the myocyte length variation. We emphasized the importance of the inclusion of variable sarcomere length into a model for ventricular myocyte contraction. Differences in contraction force and cell shortening for epicardial and endocardial ventricular myocytes were investigated. Model applicability for the experimental studies and model limitations were discussed.	[Mullins, Paula D.; Bondarenko, Vladimir E.] Georgia State Univ, Dept Math & Stat, Atlanta, GA 30303 USA; [Bondarenko, Vladimir E.] Georgia State Univ, Inst Neurosci, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University	Bondarenko, VE (corresponding author), Georgia State Univ, Dept Math & Stat, Atlanta, GA 30303 USA.	vbondarenko@gsu.edu			American Heart Association [10GRNT4720012]; Georgia State University Seed Grant from Brain and Behavior Program; Research Initiation Grant	American Heart Association(American Heart Association); Georgia State University Seed Grant from Brain and Behavior Program; Research Initiation Grant	This work was supported by the American Heart Association (10GRNT4720012) (www.heart.org), Georgia State University Seed Grant from Brain and Behavior Program (www.gsu.edu), and Research Initiation Grant to V. E. Bondarenko. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader PL, 2011, P NATL ACAD SCI USA, V108, P15432, DOI 10.1073/pnas.1112667108; Bers D.M., 2001, EXCITATION CONTRACTI, V2nd ed.; Bondarenko VE, 2004, AM J PHYSIOL-HEART C, V287, pH1378, DOI 10.1152/ajpheart.00185.2003; Bondarenko VE, 2007, AM J PHYSIOL-HEART C, V293, pH1816, DOI 10.1152/ajpheart.00471.2007; Bondarenko VE, 2010, AM J PHYSIOL-HEART C, V299, pH454, DOI 10.1152/ajpheart.00907.2009; Brunet S, 2004, J PHYSIOL-LONDON, V559, P103, DOI 10.1113/jphysiol.2004.063347; Campbell SG, 2008, PHILOS T R SOC A, V366, P3361, DOI 10.1098/rsta.2008.0088; Chu GX, 2002, CARDIOVASC RES, V54, P105, DOI 10.1016/S0008-6363(02)00230-4; Cortassa S, 2006, BIOPHYS J, V91, P1564, DOI [10.1529/biophysj.105.076174, 10.1529/biophysj.106.076174]; Dilly KW, 2006, J PHYSIOL-LONDON, V572, P227, DOI 10.1113/jphysiol.2005.102020; F'entzke RC, 1999, J PHYSIOL-LONDON, V517, P143, DOI 10.1111/j.1469-7793.1999.0143z.x; Flagg TP, 2009, CIRC RES, V104, P95, DOI 10.1161/CIRCRESAHA.108.186809; Fox JJ, 2002, AM J PHYSIOL-HEART C, V282, pH516, DOI 10.1152/ajpheart.00612.2001; Gao WD, 1999, J CLIN INVEST, V103, P661, DOI 10.1172/JCI5220; Glukhov AV, 2010, CIRC RES, V106, P981, DOI 10.1161/CIRCRESAHA.109.204891; Huang L, 2001, AM J PHYSIOL-CELL PH, V280, pC1114, DOI 10.1152/ajpcell.2001.280.5.C1114; HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255, DOI 10.1016/S0096-4174(18)30128-8; Ito K, 2000, CIRC RES, V87, P588, DOI 10.1161/01.RES.87.7.588; Ito K, 2001, CIRC RES, V89, P422, DOI 10.1161/hh1701.095522; Jones LR, 1998, J CLIN INVEST, V101, P1385, DOI 10.1172/JCI1362; Jouven X, 2005, NEW ENGL J MED, V352, P1951, DOI 10.1056/NEJMoa043012; Keener J, 2009, MATH PHYSL, VII; Kirchhefer U, 2003, CARDIOVASC RES, V59, P369, DOI 10.1016/S0008-6363(03)00432-2; Kogler H, 2001, AM J PHYSIOL-HEART C, V280, pH2623, DOI 10.1152/ajpheart.2001.280.6.H2623; Konhilas JP, 2003, J PHYSIOL-LONDON, V547, P951, DOI 10.1113/jphysiol.2002.038117; Kushnir A, 2010, P NATL ACAD SCI USA, V107, P10274, DOI 10.1073/pnas.1005843107; Land S, 2012, J PHYSIOL-LONDON, V590, P4553, DOI 10.1113/jphysiol.2012.231928; London B, 2007, J PHYSIOL-LONDON, V578, P115, DOI 10.1113/jphysiol.2006.122622; Matsuoka S, 2004, PROG BIOPHYS MOL BIO, V85, P279, DOI 10.1016/j.pbiomolbio.2004.01.006; McCloskey DT, 2008, AM J PHYSIOL-HEART C, V294, pH205, DOI 10.1152/ajpheart.00829.2007; McCloskey DT, 2003, J MOL CELL CARDIOL, V35, P1207, DOI 10.1016/S0022-2828(03)00227-X; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; ORCHARD CH, 1991, CIRC RES, V68, P69, DOI 10.1161/01.RES.68.1.69; Petkova-Kirova PS, 2012, AM J PHYSIOL-HEART C, V302, pH934, DOI 10.1152/ajpheart.00493.2011; Prabhakar R, 2001, J MOL CELL CARDIOL, V33, P1815, DOI 10.1006/jmcc.2001.1445; Preckel B, 2000, ANESTH ANALG, V91, P1327, DOI 10.1097/00000539-200012000-00003; Ramirez-Correa GA, 2010, J MOL CELL CARDIOL, V48, P943, DOI 10.1016/j.yjmcc.2010.01.004; Rice JJ, 1999, AM J PHYSIOL-HEART C, V276, pH1734, DOI 10.1152/ajpheart.1999.276.5.H1734; Rice JJ, 2000, AM J PHYSIOL-HEART C, V278, pH913, DOI 10.1152/ajpheart.2000.278.3.H913; Rice JJ, 2008, BIOPHYS J, V95, P2368, DOI 10.1529/biophysj.107.119487; Schneider NS, 2006, J MOL CELL CARDIOL, V41, P522, DOI 10.1016/j.yjmcc.2006.06.003; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Stuyvers BD, 2002, J PHYSIOL-LONDON, V544, P817, DOI 10.1113/jphysiol.2002.024430; Trayanova NA, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00043; Valverde CA, 2006, CARDIOVASC RES, V70, P335, DOI 10.1016/j.cardiores.2006.01.018	45	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63141	10.1371/journal.pone.0063141	http://dx.doi.org/10.1371/journal.pone.0063141			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671664	Green Published, gold			2022-12-25	WOS:000319737700042
J	Mustafa, M; Farooq, MA; Hayat, T; Alsaedi, A				Mustafa, Meraj; Farooq, Muhammad A.; Hayat, Tasawar; Alsaedi, Ahmed			Numerical and Series Solutions for Stagnation-Point Flow of Nanofluid over an Exponentially Stretching Sheet	PLOS ONE			English	Article							BOUNDARY-LAYER-FLOW; MASS-TRANSFER; HEAT-TRANSFER; VISCOELASTIC FLUID; THERMAL-RADIATION; POROUS-MEDIUM; SURFACE	This investigation is concerned with the stagnation-point flow of nanofluid past an exponentially stretching sheet. The presence of Brownian motion and thermophoretic effects yields a coupled nonlinear boundary-value problem (BVP). Similarity transformations are invoked to reduce the partial differential equations into ordinary ones. Local similarity solutions are obtained by homotopy analysis method (HAM), which enables us to investigate the effects of parameters at a fixed location above the sheet. The numerical solutions are also derived using the built-in solver bvp4c of the software MATLAB. The results indicate that temperature and the thermal boundary layer thickness appreciably increase when the Brownian motion and thermophoresis effects are strengthened. Moreover the nanoparticles volume fraction is found to increase when the thermophoretic effect intensifies.	[Mustafa, Meraj] Natl Univ Sci & Technol, Res Ctr Modeling & Simulat, Islamabad, Pakistan; [Farooq, Muhammad A.] Natl Univ Sci & Technol, Ctr Adv Math & Phys, Islamabad, Pakistan; [Hayat, Tasawar] Quaid I Azam Univ, Dept Math, Islamabad, Pakistan; [Hayat, Tasawar; Alsaedi, Ahmed] King Abdulaziz Univ, Dept Math, Fac Sci, Jeddah 21413, Saudi Arabia	National University of Sciences & Technology - Pakistan; National University of Sciences & Technology - Pakistan; Quaid I Azam University; King Abdulaziz University	Mustafa, M (corresponding author), Natl Univ Sci & Technol, Res Ctr Modeling & Simulat, Islamabad, Pakistan.	meraj_mm@hotmail.com	Alsaedi, Ahmed/A-2094-2013; Hayat, Tasawar/A-3853-2013; Farooq, Muhammad Asif/W-6601-2019; Hayat, Tasawar/Y-2524-2019; Mustafa Hashmi, Meraj/P-1769-2014; Hayat, Tasawar/E-9449-2015	Alsaedi, Ahmed/0000-0003-3452-8922; Farooq, Muhammad Asif/0000-0001-6262-145X; 	King Abdulaziz University (KAU) [10-130/1433]	King Abdulaziz University (KAU)	The paper was funded by the Deanship of Scientific Research, King Abdulaziz University (KAU), under grant no. (10-130/1433 Hi Ci). The authors, therefore, acknowledge the technical and financial support of KAU. The support is in the form of project for academic research at KAU. This is to certify that this work is not funded through any external source/research organization including industry etc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasbandy S, 2012, INT J NUMER METH FL, V70, P1324, DOI 10.1002/fld.2752; Abbasbandy S, 2011, COMMUN NONLINEAR SCI, V16, P112, DOI 10.1016/j.cnsns.2010.04.004; Bachok N, 2010, PHYS LETT A, V374, P4075, DOI 10.1016/j.physleta.2010.08.032; Bachok N, 2010, INT J THERM SCI, V49, P1663, DOI 10.1016/j.ijthermalsci.2010.01.026; BLASIUS H., 1908, Z MATH PHYS, V56, P1; Cortell R, 2007, CHEM ENG PROCESS, V46, P721, DOI 10.1016/j.cep.2006.09.008; CRANE LJ, 1970, Z ANGEW MATH PHYS, V21, P645, DOI 10.1007/BF01587695; Daungthongsuk W, 2007, RENEW SUST ENERG REV, V11, P797, DOI 10.1016/j.rser.2005.06.005; Elbashbeshy E. M. A., 2001, Archives of Mechanics, V53, P643; Fang TG, 2012, APPL MATH COMPUT, V218, P7241, DOI 10.1016/j.amc.2011.12.094; Hayat T, 2011, APPL MATH MECH-ENGL, V32, P167, DOI 10.1007/s10483-011-1403-7; Hayat T, 2010, NONLINEAR ANAL-REAL, V11, P3186, DOI 10.1016/j.nonrwa.2009.11.012; Kakac S, 2009, INT J HEAT MASS TRAN, V52, P3187, DOI 10.1016/j.ijheatmasstransfer.2009.02.006; Khan SK, 2005, INT J HEAT MASS TRAN, V48, P1534, DOI 10.1016/j.ijheatmasstransfer.2004.10.032; Khan WA, 2010, INT J HEAT MASS TRAN, V53, P2477, DOI 10.1016/j.ijheatmasstransfer.2010.01.032; Kuznetsov AV, 2010, INT J THERM SCI, V49, P243, DOI 10.1016/j.ijthermalsci.2009.07.015; Liao SJ, 2010, COMMUN NONLINEAR SCI, V15, P2003, DOI 10.1016/j.cnsns.2009.09.002; Liao SJ, 2010, COMMUN NONLINEAR SCI, V15, P1421, DOI 10.1016/j.cnsns.2009.06.008; Liao SJ, 2009, COMMUN NONLINEAR SCI, V14, P983, DOI 10.1016/j.cnsns.2008.04.013; Magyari E, 1999, J PHYS D APPL PHYS, V32, P577, DOI 10.1088/0022-3727/32/5/012; Mahapatra TR, 2004, INT J NONLINEAR MECH, V39, P811, DOI 10.1016/S0020-7462(03)00044-1; Makinde OD, 2011, INT J THERM SCI, V50, P1326, DOI 10.1016/j.ijthermalsci.2011.02.019; Mustafa M, 2012, MECCANICA, V47, P1581, DOI 10.1007/s11012-012-9536-3; Mustafa M, 2012, J APPL MECH-T ASME, V79, DOI 10.1115/1.4005560; Mustafa M, 2011, INT J HEAT MASS TRAN, V54, P5588, DOI 10.1016/j.ijheatmasstransfer.2011.07.021; Mustafa M, 2012, Z NATURFORSCH A, V67, P70, DOI 10.5560/ZNA.2011-0057; Nadeem S, 2010, Z NATURFORSCH A, V65, P495, DOI 10.1515/zna-2010-6-703; Nield DA, 2009, INT J HEAT MASS TRAN, V52, P5792, DOI 10.1016/j.ijheatmasstransfer.2009.07.024; RAJAGOPAL KR, 1984, RHEOL ACTA, V23, P213, DOI 10.1007/BF01332078; Rana P, 2012, COMMUN NONLINEAR SCI, V17, P212, DOI 10.1016/j.cnsns.2011.05.009; Rashidi MM, 2011, COMMUN NONLINEAR SCI, V16, P1874, DOI 10.1016/j.cnsns.2010.08.016; Sajid M, 2008, INT COMMUN HEAT MASS, V35, P347, DOI 10.1016/j.icheatmasstransfer.2007.08.006; SAKIADIS BC, 1961, AICHE J, V7, P26, DOI 10.1002/aic.690070108; Shampine LF, 2003, SOLVING BOUNDARY VAL; Wang XQ, 2008, BRAZ J CHEM ENG, V25, P631, DOI 10.1590/S0104-66322008000400002; Wang XQ, 2008, BRAZ J CHEM ENG, V25, P613, DOI 10.1590/S0104-66322008000400001; Yacob NA, 2011, INT COMMUN HEAT MASS, V38, P149, DOI 10.1016/j.icheatmasstransfer.2010.12.003	37	40	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e61859	10.1371/journal.pone.0061859	http://dx.doi.org/10.1371/journal.pone.0061859			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671576	gold, Green Submitted, Green Published			2022-12-25	WOS:000319737700007
J	Parker, JC; Thavagnanam, S; Skibinski, G; Lyons, J; Bell, J; Heaney, LG; Shields, MD				Parker, Jeremy C.; Thavagnanam, Surendran; Skibinski, Grzegorz; Lyons, Jeremy; Bell, Jennifer; Heaney, Liam G.; Shields, Michael D.			Chronic IL9 and IL-13 Exposure Leads to an Altered Differentiation of Ciliated Cells in a Well-Differentiated Paediatric Bronchial Epithelial Cell Model	PLOS ONE			English	Article							ASTHMA; INFLAMMATION; PATHOGENESIS; CULTURE	Asthma is a chronic inflammatory disease characterised by airways remodelling. In mouse models IL-9 and IL-13 have been implicated in airways remodelling including mucus hypersecretion and goblet cell hyperplasia. Their role, especially that of IL-9, has been much less studied in authentic human ex vivo models of the bronchial epithelium from normal and asthmatic children. We assessed the effects of IL-9, IL-13 and an IL-9/IL-13 combination, during differentiation of bronchial epithelial cells from normal (n = 6) and asthmatic (n = 8) children. Cultures were analysed for morphological markers and factors associated with altered differentiation (MUC5AC, SPDEF and MMP-7). IL-9, IL-9/IL-13 combination and IL-13 stimulated bronchial epithelial cells from normal children had fewer ciliated cells [14.8% (SD 8.9), p = 0.048, 12.4 (SD 6.1), p = 0.016 and 7.3% (SD 6.6), p = 0.031] respectively compared with unstimulated [(21.4% (SD 9.6)]. IL-9 stimulation had no effect on goblet cell number in either group whereas IL-9/IL-13 combination and IL-13 significantly increased goblet cell number [24.8% (SD 8.8), p = 0.02), 32.9% (SD 8.6), p = 0.007] compared with unstimulated normal bronchial cells [(18.6% (SD 6.2)]. All stimulations increased MUC5AC mRNA in bronchial epithelial cells from normal children and increased MUC5AC mucin secretion. MMP-7 localisation was dysregulated in normal bronchial epithelium stimulated with Th2 cytokines which resembled the unstimulated bronchial epithelium of asthmatic children. All stimulations resulted in a significant reduction in transepithelial electrical resistance values over time suggesting a role in altered tight junction formation. We conclude that IL-9 does not increase goblet cell numbers in bronchial epithelial cell cultures from normal or asthmatic children. IL-9 and IL-13 alone and in combination, reduce ciliated cell numbers and transepithelial electrical resistance during differentiation of normal epithelium, which clinically could inhibit mucociliary clearance and drive an altered repair mechanism. This suggests an alternative role for IL-9 in airways remodelling and reaffirms IL-9 as a potential therapeutic target.	[Parker, Jeremy C.; Skibinski, Grzegorz; Bell, Jennifer; Heaney, Liam G.; Shields, Michael D.] Queens Univ Belfast, Ctr Infect & Immun, Belfast, Antrim, North Ireland; [Shields, Michael D.] Belfast Hlth & Social Care Trust, Royal Belfast Hosp Sick Children, Belfast, Antrim, North Ireland; [Lyons, Jeremy] Belfast Hlth & Social Care Trust, Royal Hosp, Belfast, Antrim, North Ireland; [Thavagnanam, Surendran] Univ Malaya, Med Ctr, Dept Paediat, Kuala Lumpur, Malaysia	Queens University Belfast; Universiti Malaya	Heaney, LG (corresponding author), Queens Univ Belfast, Ctr Infect & Immun, Belfast, Antrim, North Ireland.	l.heaney@qub.ac.uk		thavagnanam, surendran/0000-0002-4414-7915; Parker, Jeremy/0000-0002-3935-7563	Northern Ireland Chest Heart and Stroke Association [200546]; The Royal Belfast Hospital for Sick Children; The Irish Thoracic Society Boehringer Ingleheim Research Fellowship; Medimmune; Novartis UK; Genentech Inc; Glaxo Smith Kline; Merck Sharpe Dohme; Nycomed; Novartis; Astra Zeneca; Chiesi; Public Health Agency [RRG/3244/05] Funding Source: researchfish	Northern Ireland Chest Heart and Stroke Association; The Royal Belfast Hospital for Sick Children; The Irish Thoracic Society Boehringer Ingleheim Research Fellowship; Medimmune(AstraZenecaMedimmune); Novartis UK(Novartis); Genentech Inc(Roche HoldingGenentech); Glaxo Smith Kline(GlaxoSmithKline); Merck Sharpe Dohme(Merck & Company); Nycomed; Novartis(Novartis); Astra Zeneca(AstraZeneca); Chiesi(Chiesi Pharmaceuticals Inc); Public Health Agency	This work was supported by the Northern Ireland Chest Heart and Stroke Association (grant number 200546), The Royal Belfast Hospital for Sick Children and The Irish Thoracic Society Boehringer Ingleheim Research Fellowship. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The following authors have declared that no competing interests exist: Jeremy Parker, Surendran Thavagnanam, Grzegorz Skibinski, Jennifer Bell, Jeremy Lyons. The authors have read the journal's policy and have the following conflicts: Liam Heaney has received grant funding from Medimmune, Novartis UK, Genentech Inc, and Glaxo Smith Kline, has taken part in Advisory Boards and given lectures at meetings supported by Glaxo Smith Kline, Merck Sharpe & Dohme, Nycomed, Novartis and Astra Zeneca. He has received support funding to attend International Respiratory meetings (Astra Zeneca, Chiesi, Novartis and Glaxo Smith Kline) and has taken part in asthma clinical trials (GSK and Genentech) for which his Institution was remunerated. None of these activities have any direct relationship to the content of this manuscript. Michael Shields has no direct competing interests relating to this study but does declare that he has delivered lectures at educational events and received honoraria from GlaxoSmithKline, AstraZeneca, Merck Sharp & Dohme, Novartis and Alk Abello. In addition, he has received educational grant support to attend the British Thoracic and European Respiratory Societies annual meetings from Novartis and GlaxoSmithKline. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Bateman ED, 2008, ALLERGY, V63, P932, DOI 10.1111/j.1398-9995.2008.01724.x; Bousquet J, 2000, AM J RESP CRIT CARE, V161, P1720, DOI 10.1164/ajrccm.161.5.9903102; Coyle PV, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-41; Cutz E, 2002, Histopathology, V41, P22; Doherty GM, 2003, CLIN EXP ALLERGY, V33, P1221, DOI 10.1046/j.1365-2222.2003.01752.x; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; Global Initiative for Asthma (GINA), 2011, GLOB STRAT ASTHM MAN; Gray TE, 1996, AM J RESP CELL MOL, V14, P104, DOI 10.1165/ajrcmb.14.1.8534481; Haitchi HM, 2011, AM J RESP CRIT CARE, V183, pA2771; Holgate ST, 2007, J ALLERGY CLIN IMMUN, V120, P1233, DOI 10.1016/j.jaci.2007.10.025; Holgate ST, 2010, DISCOV MED, V9, P439; Holgate ST, 2009, IMMUNITY, V31, P362, DOI 10.1016/j.immuni.2009.08.013; Jeffery PK, 2001, AM J RESP CRIT CARE, V164, pS28, DOI 10.1164/ajrccm.164.supplement_2.2106061; Lenney W, 2012, MEDICINE, V40, P238; Longphre M, 1999, J CLIN INVEST, V104, P1375, DOI 10.1172/JCI6097; Nicolaides NC, 1997, P NATL ACAD SCI USA, V94, P13175, DOI 10.1073/pnas.94.24.13175; Parker J, 2010, PEDIATR RES, V67, P17, DOI 10.1203/PDR.0b013e3181c0b200; Parker JM, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-14; Pezzulo AA, 2011, AM J PHYSIOL-LUNG C, V300, pL25, DOI 10.1152/ajplung.00256.2010; Pohunek P, 2005, PEDIAT ALLERG IMM-UK, V16, P43, DOI 10.1111/j.1399-3038.2005.00239.x; Takeyama K, 1999, P NATL ACAD SCI USA, V96, P3081, DOI 10.1073/pnas.96.6.3081; Temann UA, 2007, INT IMMUNOL, V19, P1, DOI 10.1093/intimm/dxl117; Thavagnanam S, 2011, PEDIATR RES, V69, P95, DOI 10.1203/PDR.0b013e318204edb5; Thomas B, 2010, J ALLERGY CLIN IMMUN, V126, P722, DOI 10.1016/j.jaci.2010.05.046; Vermeer PD, 2003, AM J RESP CELL MOL, V28, P286, DOI 10.1165/rcmb.4887; Wadsworth SJ, 2010, J ALLERGY CLIN IMMUN, V126, P366, DOI 10.1016/j.jaci.2010.05.015; Xiang LL, 2008, AM J RESP CELL MOL, V38, P310, DOI 10.1165/rcmb.2007-0078OC; Xiao C, 2011, J ALLERGY CLIN IMMUN, V128, P549, DOI 10.1016/j.jaci.2011.05.038; Xing JC, 2011, J ASTHMA, V48, P115, DOI 10.3109/02770903.2011.554944; Zhou YH, 2001, RESP RES, V2, P80, DOI 10.1186/rr42	30	34	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e61023	10.1371/journal.pone.0061023	http://dx.doi.org/10.1371/journal.pone.0061023			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671562	Green Submitted, Green Published, gold			2022-12-25	WOS:000319737700001
J	Qin, Z; Lv, HJ; Zhu, XL; Meng, C; Quan, TY; Wang, MC; Xia, GM				Qin, Zhen; Lv, Hongjun; Zhu, Xinlei; Meng, Chen; Quan, Taiyong; Wang, Mengcheng; Xia, Guangmin			Ectopic Expression of a Wheat WRKY Transcription Factor Gene TaWRKY71-1 Results in Hyponastic Leaves in Arabidopsis thaliana	PLOS ONE			English	Article							AUXIN HOMEOSTASIS; AGROPYRON-ELONGATUM; LEAF; GROWTH; OSWRKY71; MUTATION; MUTANTS; ENCODES	Leaf type is an important trait that closely associates with crop yield. WRKY transcription factors exert diverse regulatory effects in plants, but their roles in the determination of leaf type have not been reported so far. In this work, we isolated a WRKY transcription factor gene TaWRKY71-1 from a wheat introgression line SR3, which has larger leaves, superior growth capacity and higher yield than its parent common wheat JN177. TaWRKY71-1 specifically expressed in leaves, and produced more mRNA in SR3 than in JN177. TaWRKY71-1 localized in the nucleus and had no transcriptional activation activity. TaWRKY71-1 overexpression in Arabidopsis resulted in hyponastic rosette leaves, and the hyponastic strength was closely correlative with the transcription level of the transgene. The spongy mesophyll cells at abaxial side of leaves were drastically compacted by TaWRKY71-1 overexpression. In TaWRKY71-1 overexpression Arabidopsis, the expression of IAMT1 that encodes a methyltransferase converting free indole-3-acetic acid (IAA) to methyl-IAA ester (MeIAA) to alter auxin homeostatic level was induced, and the induction level was dependent on the abundance of TaWRKY71-1 transcripts. Besides, several TCP genes that had found to be restricted by IAMT1 had lower expression levels as well. Our results suggest that TaWRKY71-1 causes hyponastic leaves through altering auxin homeostatic level by promoting the conversion of IAA to MeIAA.	[Qin, Zhen; Lv, Hongjun; Zhu, Xinlei; Meng, Chen; Quan, Taiyong; Wang, Mengcheng; Xia, Guangmin] Shandong Univ, Sch Life Sci, Minist Educ, Key Lab Plant Cell Engn & Germplasm Innovat, Jinan 250100, Shandong, Peoples R China	Shandong University	Wang, MC (corresponding author), Shandong Univ, Sch Life Sci, Minist Educ, Key Lab Plant Cell Engn & Germplasm Innovat, Jinan 250100, Shandong, Peoples R China.	wangmc@sdu.edu.cn; xiagm@sdu.edu.cn			National Transgenic Project [2011ZX08002-002]; National Basic Research 973 Program of China [2012CB114204, 2009CB118300]; Natural Science Foundation of China [31030053, 31171175]; Excellent Young Scientist Award Foundation of Shandong Province [BS2009SW023]; College Innovation Foundation of Jinan City [200906021]	National Transgenic Project; National Basic Research 973 Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Excellent Young Scientist Award Foundation of Shandong Province; College Innovation Foundation of Jinan City	This work was supported by National Transgenic Project (2011ZX08002-002), National Basic Research 973 Program of China (2012CB114204; 2009CB118300), Major Program of Natural Science Foundation of China (31030053), Natural Science Foundation of China (31171175), Excellent Young Scientist Award Foundation of Shandong Province (BS2009SW023), College Innovation Foundation of Jinan City (200906021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlier I, 2000, P NATL ACAD SCI USA, V97, P14819, DOI 10.1073/pnas.260502697; Chen Z, 2001, JIANGSU AGR RES, V22, P81; Cheng YF, 2007, PLANT CELL, V19, P2430, DOI 10.1105/tpc.107.053009; Chujo T, 2008, BIOSCI BIOTECH BIOCH, V72, P240, DOI 10.1271/bbb.70553; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; D'Auria JC, 2003, RECENT ADV PHYTOCHEM, V37, P95, DOI DOI 10.1016/S0079-9920(03)80026-6; Delarue M, 1998, PLANT J, V14, P603, DOI 10.1046/j.1365-313X.1998.00163.x; Govaerts YM, 1996, APPL OPTICS, V35, P6585, DOI 10.1364/AO.35.006585; Harper RM, 2000, PLANT CELL, V12, P757, DOI 10.1105/tpc.12.5.757; Jackson RG, 2002, PLANT J, V32, P573, DOI 10.1046/j.1365-313X.2002.01445.x; Kiehl TR, 2011, CYTOM PART A, V79A, P560, DOI 10.1002/cyto.a.21076; King JJ, 1995, PLANT CELL, V7, P2023, DOI 10.1105/tpc.7.12.2023; Kosugi S, 2003, PLANT PHYSIOL, V132, P2012, DOI 10.1104/pp.103.025080; Lang YouZhong, 2004, Acta Agronomica Sinica, V30, P883; Lee SS, 2003, PLANT J, V33, P825, DOI 10.1046/j.1365-313X.2003.01672.x; Li LC, 2008, NEW PHYTOL, V179, P751, DOI 10.1111/j.1469-8137.2008.02514.x; Li X, 2008, PLANT MOL BIOL, V66, P315, DOI 10.1007/s11103-007-9272-6; LINCOLN C, 1990, PLANT CELL, V2, P1071, DOI 10.1105/tpc.2.11.1071; Liu SW, 2008, THEOR APPL GENET, V116, P325, DOI 10.1007/s00122-007-0669-z; Liu XQ, 2007, J PLANT PHYSIOL, V164, P969, DOI 10.1016/j.jplph.2006.07.006; Nath U, 2003, SCIENCE, V299, P1404, DOI 10.1126/science.1079354; Qin GJ, 2005, PLANT CELL, V17, P2693, DOI 10.1105/tpc.105.034959; ROMANO CP, 1995, PLANT MOL BIOL, V27, P1071, DOI 10.1007/BF00020881; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Tadege M, 2011, PLANT CELL, V23, P2125, DOI 10.1105/tpc.111.085340; Tao Q, 2013, PLANT CELL, DOI tpc.113.109223; Ulmasov T, 1999, P NATL ACAD SCI USA, V96, P5844, DOI 10.1073/pnas.96.10.5844; Varaud E, 2011, PLANT CELL, V23, P973, DOI 10.1105/tpc.110.081653; Xia GM, 2003, THEOR APPL GENET, V107, P299, DOI 10.1007/s00122-003-1247-7; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yuan L.P., 1997, HYBRID RICE, V12, P1, DOI DOI 10.16267/J.CNKI.1005-3956.1997.06.001; Zhao YD, 2001, SCIENCE, V291, P306, DOI 10.1126/science.291.5502.306; Zubieta C, 2003, PLANT CELL, V15, P1704, DOI 10.1105/tpc.014548	33	14	19	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63033	10.1371/journal.pone.0063033	http://dx.doi.org/10.1371/journal.pone.0063033			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671653	gold, Green Submitted, Green Published			2022-12-25	WOS:000319737700035
J	Chen, K; Hsu, LT; Wu, CY; Chang, SY; Huang, HT; Chen, W				Chen, Kevin; Hsu, Lih-Tao; Wu, Cheng-Yi; Chang, Shiun-Yin; Huang, Hui-Ting; Chen, Wannhsin			CBARA1 Plays a Role in Stemness and Proliferation of Human Embryonic Stem Cells	PLOS ONE			English	Article							SELF-RENEWAL; ADHESION MOLECULE; CA2+ UPTAKE; DIFFERENTIATION; PLURIPOTENCY; MAINTENANCE; CULTURE; COMPLEX; PROTEIN; GROWTH	Human embryonic stem cells (hESCs) are capable of unlimited self-renewal and can generate almost all of the cells in the body. Although some pluripotency factors have been identified, much remains unclear regarding the molecules and mechanisms that regulate hESC self-renewal and pluripotency. In this study, we identified a mitochondrial gene, CBARA1, that is expressed in undifferentiated hESCs and that is down-regulated rapidly after cellular differentiation. To study its role in hESCs, endogenous CBARA1 expression was knocked down using shRNA. CBARA1 knockdown in hESCs resulted in down-regulation of Oct4 and Nanog expression, attenuated cell growth, and G0/G1 phase cell cycle arrest; however, knockdown did not noticeably affect apoptosis. Taken together, these results suggest that CBARA1 is a marker for undifferentiated hESCs that plays a role in maintaining stemness, cell cycle progression, and proliferation.	[Chen, Kevin; Hsu, Lih-Tao; Wu, Cheng-Yi; Chang, Shiun-Yin; Huang, Hui-Ting; Chen, Wannhsin] Ind Technol Res Inst, Fac Biomed Technol & Device Res, Dept Tissue Regenerat Prod Technol, Hsinchu, Taiwan	Industrial Technology Research Institute - Taiwan	Chen, K (corresponding author), Ind Technol Res Inst, Fac Biomed Technol & Device Res, Dept Tissue Regenerat Prod Technol, Hsinchu, Taiwan.	k.chen@itri.org.tw			Ministry of Economic Affairs of Taiwan	Ministry of Economic Affairs of Taiwan(Ministry of Economic Affairs, Taiwan)	This research was supported by funding from the Advanced Research Program Fund from the Ministry of Economic Affairs of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichberger KJ, 2005, J IMMUNOL, V175, P1286, DOI 10.4049/jimmunol.175.2.1286; Armstrong L, 2006, HUM MOL GENET, V15, P1894, DOI 10.1093/hmg/ddl112; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Besser D, 2004, J BIOL CHEM, V279, P45076, DOI 10.1074/jbc.M404979200; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bruce SJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-365; Cai JL, 2006, STEM CELLS, V24, P516, DOI 10.1634/stemcells.2005-0143; Chen ACH, 2012, CELL TISSUE RES, V350, P289, DOI 10.1007/s00441-012-1476-7; Chen HF, 2010, TISSUE ENG PT A, V16, P2901, DOI 10.1089/ten.tea.2009.0722; Cheng EH, 2008, REPROD BIOMED ONLINE, V17, P436, DOI 10.1016/S1472-6483(10)60229-5; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Eiselleova L, 2009, STEM CELLS, V27, P1847, DOI 10.1002/stem.128; Forristal CE, 2010, REPRODUCTION, V139, P85, DOI 10.1530/REP-09-0300; Gerrard L, 2005, STEM CELLS, V23, P1234, DOI 10.1634/stemcells.2005-0110; Hyslop L, 2005, STEM CELLS, V23, P1035, DOI 10.1634/stemcells.2005-0080; Levenstein ME, 2006, STEM CELLS, V24, P568, DOI 10.1634/stemcells.2005-0247; Li J, 2007, DIFFERENTIATION, V75, P299, DOI 10.1111/j.1432-0436.2006.00143.x; Li L, 2012, CELL ADHES MIGR, V6, P59, DOI 10.4161/cam.19583; Lu TY, 2010, J BIOL CHEM, V285, P8719, DOI 10.1074/jbc.M109.077081; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Mandal S, 2011, STEM CELLS, V29, P486, DOI 10.1002/stem.590; Matin MM, 2004, STEM CELLS, V22, P659, DOI 10.1634/stemcells.22-5-659; Nunez L, 2006, J PHYSIOL-LONDON, V571, P57, DOI 10.1113/jphysiol.2005.100586; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Prigione A, 2010, STEM CELLS, V28, P721, DOI 10.1002/stem.404; Richards M, 2002, NAT BIOTECHNOL, V20, P933, DOI 10.1038/nbt726; Schieke SM, 2008, J BIOL CHEM, V283, P28506, DOI 10.1074/jbc.M802763200; Shen JH, 2011, MOL CELL BIOL, V31, P4902, DOI 10.1128/MCB.05629-11; Son YS, 2011, STEM CELLS, V29, P2094, DOI 10.1002/stem.754; Spitkovsky D, 2004, FASEB J, V18, P1300, DOI 10.1096/fj.03-0520fje; Tan SM, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm704; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Todd LR, 2010, AUTOPHAGY, V6, P821, DOI 10.1091/mbc.E09-11-0937; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Varum S, 2009, STEM CELL RES, V3, P142, DOI 10.1016/j.scr.2009.07.002; Wong CK, 2012, J CELL PHYSIOL, V227, P2519, DOI 10.1002/jcp.22990; Wong Raymond C B, 2012, Methods Mol Biol, V874, P167, DOI 10.1007/978-1-61779-800-9_13	38	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63653	10.1371/journal.pone.0063653	http://dx.doi.org/10.1371/journal.pone.0063653			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667653	Green Published, Green Submitted, gold			2022-12-25	WOS:000319055600066
J	Krotova, O; Starodubova, E; Petkov, S; Kostic, L; Agapkina, J; Hallengard, D; Viklund, A; Latyshev, O; Gelius, E; Dillenbeck, T; Karpov, V; Gottikh, M; Belyakov, IM; Lukashov, V; Isaguliants, MG				Krotova, Olga; Starodubova, Elizaveta; Petkov, Stefan; Kostic, Linda; Agapkina, Julia; Hallengard, David; Viklund, Alecia; Latyshev, Oleg; Gelius, Eva; Dillenbeck, Tomas; Karpov, Vadim; Gottikh, Marina; Belyakov, Igor M.; Lukashov, Vladimir; Isaguliants, Maria G.			Consensus HIV-1 FSU-A Integrase Gene Variants Electroporated into Mice Induce Polyfunctional Antigen-Specific CD4+and CD8+T Cells	PLOS ONE			English	Article							CD4(+) T-CELLS; DRUG-RESISTANCE MUTATIONS; HIGH-LEVEL EXPRESSION; DNA VACCINE; REVERSE-TRANSCRIPTASE; LYMPHOCYTE RESPONSES; PARTIAL PROTECTION; IMMUNE-RESPONSES; IMMUNOGENICITY; IDENTIFICATION	Our objective is to create gene immunogens targeted against drug-resistant HIV-1, focusing on HIV-1 enzymes as critical components in viral replication and drug resistance. Consensus-based gene vaccines are specifically fit for variable pathogens such as HIV-1 and have many advantages over viral genes and their expression-optimized variants. With this in mind, we designed the consensus integrase (IN) of the HIV-1 clade A strain predominant in the territory of the former Soviet Union and its inactivated derivative with and without mutations conferring resistance to elvitegravir. Humanized IN gene was synthesized; and inactivated derivatives (with 64D in the active site mutated to V) with and without elvitegravir-resistance mutations were generated by site-mutagenesis. Activity tests of IN variants expressed in E coli showed the consensus IN to be active, while both D64V-variants were devoid of specific activities. IN genes cloned in the DNA-immunization vector pVax1 (pVaxIN plasmids) were highly expressed in human and murine cell lines (>0.7 ng/cell). Injection of BALB/c mice with pVaxIN plasmids followed by electroporation generated potent IFN-gamma and IL-2 responses registered in PBMC by day 15 and in splenocytes by day 23 after immunization. Multiparametric FACS demonstrated that CD8+ and CD4+ T cells of gene-immunized mice stimulated with IN-derived peptides secreted IFN-gamma, IL-2, and TNF-alpha. The multi-cytokine responses of CD8+ and CD4+ T-cells correlated with the loss of in vivo activity of the luciferase reporter gene co-delivered with pVaxIN plasmids. This indicated the capacity of IN-specific CD4+ and CD8+ T-cells to clear IN/reporter coexpressing cells from the injection sites. Thus, the synthetic HIV-1 clade A integrase genes acted as potent immunogens generating polyfunctional Th1-type CD4+ and CD8+ T cells. Generation of such response is highly desirable for an effective HIV-1 vaccine as it offers a possibility to attack virus-infected cells via both MHC class I and II pathways.	[Krotova, Olga; Starodubova, Elizaveta; Petkov, Stefan; Kostic, Linda; Hallengard, David; Viklund, Alecia; Isaguliants, Maria G.] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Krotova, Olga; Latyshev, Oleg; Lukashov, Vladimir; Isaguliants, Maria G.] DI Ivanovskii Inst Virol, Moscow, Russia; [Krotova, Olga; Starodubova, Elizaveta; Agapkina, Julia; Karpov, Vadim] WA Engelhardt Inst Mol Biol, Moscow, Russia; [Gelius, Eva; Dillenbeck, Tomas] Mabtech AB, Stockholm, Sweden; [Gottikh, Marina] Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow, Russia; [Belyakov, Igor M.] Univ Michigan, Sch Med, Michigan Nanotechnol Inst Med & Biol Sci, Ann Arbor, MI USA; [Belyakov, Igor M.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Lukashov, Vladimir] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands	Karolinska Institutet; Russian Academy of Medical Sciences; Gamaleya National Research Center for Epidemiology & Microbiology, RAMS; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Lomonosov Moscow State University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Amsterdam; Academic Medical Center Amsterdam	Isaguliants, MG (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	Maria.Issagouliantis@ki.se	Gottikh, Marina/D-7575-2012; Agapkina, Julia/I-5558-2012; Starodubova, Elizaveta S/Q-4439-2016; , ISSAGOULIANTIS/AAI-3148-2021; Eliseeva, Olesia/AGN-6838-2022; Karpov, Vadim/G-7932-2014	Starodubova, Elizaveta S/0000-0003-2183-0858; , ISSAGOULIANTIS/0000-0001-9382-2254; Latyshev, Oleg/0000-0002-5757-3809	Swedish Research Council [K2011-79X-21744-01-6]; Swedish Institute; Russian Foundation for Basic Research [11-04-01569-a]; Russian Federal Agency for Science and Innovation [02.512.11.2291]; Russian Federation for young PhDs [MK-5287.2011.4]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Institute; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Federal Agency for Science and Innovation(Federal Agency for Science & Innovations (FASI)); Russian Federation for young PhDs	Financial support in the form of Swedish Research Council grant K2011-79X-21744-01-6 (www.vr.se); the New Visby program of the Swedish Institute (http://www.studyinsweden.se/Scholarships/SI-scholarships/Visby-Program/); Russian Foundation for Basic Research (http://www.rfbr.ru/rffi/ru/) grant 11-04-01569-a; Russian Federal Agency for Science and Innovation (http://www.fasi.gov.ru/), grant 02.512.11.2291; and a grant from the President of the Russian Federation for young PhDs (http://grants.extech.ru/z_otch2004.php?mlevel = 100/) MK-5287.2011.4 are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulhaqq SA, 2008, IMMUNOL RES, V42, P219, DOI 10.1007/s12026-008-8076-3; Agapkina J, 2006, J BIOL CHEM, V281, P11530, DOI 10.1074/jbc.M512271200; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Almeida JR, 2009, BLOOD, V113, P6351, DOI 10.1182/blood-2009-02-206557; [Anonymous], 2012, GLOB REP UNAIDS REP; Arenas M, 2010, CURR HIV RES, V8, P613, DOI 10.2174/157016210794088263; Asante-Appiah E, 1999, ADV VIRUS RES, V52, P351, DOI 10.1016/S0065-3527(08)60306-1; Azzi S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0016001; Bahloul C, 2006, VACCINE, V24, P1063, DOI 10.1016/j.vaccine.2005.09.016; Barouch DH, 2010, ANNU REV MED, V61, P153, DOI 10.1146/annurev.med.042508.093728; Belyakov IM, 2006, BLOOD, V107, P3258, DOI 10.1182/blood-2005-11-4374; Belz GT, 2001, J IMMUNOL, V166, P4627, DOI 10.4049/jimmunol.166.7.4627; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Blanco JL, 2011, J INFECT DIS, V203, P1204, DOI 10.1093/infdis/jir025; Boberg A, 2008, EXPERT REV VACCINES, V7, P131, DOI 10.1586/14760584.7.1.131; Bobkov AF, 2004, J MED VIROL, V74, P191, DOI 10.1002/jmv.20177; Boyd SD, 2011, ANTIVIR THER, V16, P257, DOI 10.3851/IMP1749; Breathnach CC, 2006, VACCINE, V24, P1180, DOI 10.1016/j.vaccine.2005.08.091; Brown DM, 2012, J VIROL, V86, P6792, DOI 10.1128/JVI.07172-11; Brown DM, 2009, CELL IMMUNOL, V257, P69, DOI 10.1016/j.cellimm.2009.03.002; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Casimiro DR, 2002, J VIROL, V76, P185, DOI 10.1128/JVI.76.1.185-194.2002; Ceccherini-Silberstein F, 2009, AIDS REV, V11, P17; Cherepanov P, 2000, FASEB J, V14, P1389, DOI 10.1096/fj.14.10.1389; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Delelis O, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-114; Dooms H, 2007, J EXP MED, V204, P547, DOI 10.1084/jem.20062381; DRELICH M, 1992, VIROLOGY, V188, P459, DOI 10.1016/0042-6822(92)90499-F; Durali D, 1998, J VIROL, V72, P3547, DOI 10.1128/JVI.72.5.3547-3553.1998; Fioretti D, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/174378; Fonseca SG, 2006, AIDS, V20, P2263, DOI 10.1097/01.aids.0000253353.48331.5f; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; Frahm N., 2008, HIV MOL IMMUNOLOGY, V2008, P3; Gea-Banacloche JC, 2000, J IMMUNOL, V165, P1082, DOI 10.4049/jimmunol.165.2.1082; Geretti AM, 2012, CURR OPIN INFECT DIS, V25, P677, DOI 10.1097/QCO.0b013e32835a1de7; Haas G, 1998, AIDS, V12, P1427, DOI 10.1097/00002030-199812000-00004; Harro CD, 2009, AIDS RES HUM RETROV, V25, P103, DOI 10.1089/aid.2008.0212; Havlir D, 2012, NEW ENGL J MED, V367, P685, DOI 10.1056/NEJMp1207138; Hurt CB, 2011, ANTIVIR THER, V16, P137, DOI 10.3851/IMP1750; Hutnick NA, 2012, VACCINE, V30, P3202, DOI 10.1016/j.vaccine.2012.02.069; Isaguliants MG, 2004, AIDS RES HUM RETROV, V20, P191, DOI 10.1089/088922204773004914; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Keefer MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041936; Klimov NA, 2010, RUSSIAN J AIDS CANC, V13; Klingstrom J, 2004, VACCINE, V22, P4029, DOI 10.1016/j.vaccine.2004.03.045; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KULKOSKY J, 1992, MOL CELL BIOL, V12, P2331, DOI 10.1128/MCB.12.5.2331; La Gruta NL, 2004, J IMMUNOL, V172, P5553, DOI 10.4049/jimmunol.172.9.5553; Leh H, 2000, BIOCHEMISTRY-US, V39, P9285, DOI 10.1021/bi000398b; Letvin NL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002351; Li FS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020479; Li JZ, 2011, JAMA-J AM MED ASSOC, V305, P1327, DOI 10.1001/jama.2011.375; Lichterfeld M, 2004, BLOOD, V104, P487, DOI 10.1182/blood-2003-12-4341; Limberis MP, 2009, GENE THER, V16, P441, DOI 10.1038/gt.2008.177; Lloyd AG, 2007, VIROLOGY, V360, P129, DOI 10.1016/j.virol.2006.10.007; Masopust D, 2009, J INTERN MED, V265, P125, DOI 10.1111/j.1365-2796.2008.02054.x; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; Mouscadet JF, 2010, DRUG RESIST UPDATE, V13, P139, DOI 10.1016/j.drup.2010.05.001; Mulder LCF, 2000, J BIOL CHEM, V275, P29749, DOI 10.1074/jbc.M004670200; Murashev Boris, 2007, Biotechnology Journal, V2, P871, DOI 10.1002/biot.200700024; Mwau M, 2004, J GEN VIROL, V85, P911, DOI 10.1099/vir.0.19701-0; Myers RE, 2008, J VIROL, V82, P9228, DOI 10.1128/JVI.01535-07; Nelson MH, 2011, J REPROD IMMUNOL, V89, P10, DOI 10.1016/j.jri.2011.01.013; Owen RE, 2010, AIDS, V24, P1095, DOI 10.1097/QAD.0b013e3283377a1e; Pendri A, 2011, EXPERT OPIN THER PAT, V21, P1173, DOI 10.1517/13543776.2011.586631; Precopio ML, 2007, J EXP MED, V204, P1405, DOI 10.1084/jem.20062363; Propato A, 2001, HUM IMMUNOL, V62, P561, DOI 10.1016/S0198-8859(01)00245-2; Puigbo P, 2007, NUCLEIC ACIDS RES, V35, pW126, DOI 10.1093/nar/gkm219; Rhee SY, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-74; Rodriguez William R, 2004, J Transl Med, V2, P15, DOI 10.1186/1479-5876-2-15; Roos AK, 2009, MOL THER, V17, P1637, DOI 10.1038/mt.2009.120; Rumyantseva OA, 2009, AIDS RES HUM RETROV, V25, P931, DOI 10.1089/aid.2009.0075; Sabado RL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004256; Sabbaj S, 2003, JAIDS-J ACQ IMM DEF, V33, P426, DOI 10.1097/00126334-200308010-00003; Sacha JB, 2009, P NATL ACAD SCI USA, V106, P9791, DOI 10.1073/pnas.0813106106; Samri A, 2000, J VIROL, V74, P9306, DOI 10.1128/JVI.74.19.9306-9312.2000; Santra S, 2008, P NATL ACAD SCI USA, V105, P10489, DOI 10.1073/pnas.0803352105; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Sierra-Aragon S, 2012, INTERVIROLOGY, V55, P84, DOI 10.1159/000331995; Soghoian DZ, 2010, EXPERT REV VACCINES, V9, P1453, DOI 10.1586/ERV.10.132; Starodubova E, 2012, MOL IMAGING, V11, P471, DOI 10.2310/7290.2012.00011; Stephenson KE, 2012, J VIROL, V86, P11434, DOI 10.1128/JVI.01779-12; Stratov I, 2005, J VIROL, V79, P7728, DOI 10.1128/JVI.79.12.7728-7737.2005; Swain SL, 2012, NAT REV IMMUNOL, V12, P136, DOI 10.1038/nri3152; Tena-Coki NG, 2010, AM J RESP CRIT CARE, V182, P120, DOI 10.1164/rccm.200912-1862OC; Thomson MM, 2009, JAIDS-J ACQ IMM DEF, V51, P332, DOI 10.1097/QAI.0b013e31819c1757; Varshavsky A., 2011, PROTEIN SCI; Watanabe T, 2011, MICROBES INFECT, V13, P160, DOI 10.1016/j.micinf.2010.10.006; Weaver EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018314; Weiner DB, 2010, VACCINE, V28, P1893, DOI 10.1016/j.vaccine.2010.01.052; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Wilson CC, 2001, J VIROL, V75, P4195, DOI 10.1128/JVI.75.9.4195-4207.2001; Yan J, 2011, VACCINE, V29, P7173, DOI 10.1016/j.vaccine.2011.05.076; Young B, 2011, ANTIVIR THER, V16, P253, DOI 10.3851/IMP1748; Zheng N, 2009, J VIROL, V83, P7668, DOI 10.1128/JVI.00513-09	95	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62720	10.1371/journal.pone.0062720	http://dx.doi.org/10.1371/journal.pone.0062720			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667513	Green Published, gold, Green Submitted			2022-12-25	WOS:000319055600041
J	Mita, P; Savas, JN; Ha, S; Djouder, N; Yates, JR; Logan, SK				Mita, Paolo; Savas, Jeffrey N.; Ha, Susan; Djouder, Nabil; Yates, John R., III; Logan, Susan K.			Analysis of URI Nuclear Interaction with RPB5 and Components of the R2TP/Prefoldin-Like Complex	PLOS ONE			English	Article							RNA-POLYMERASE-II; RPB5-MEDIATING PROTEIN; CYTOSOLIC CHAPERONIN; CANCER CELLS; IN-VIVO; TRANSCRIPTION; PREFOLDIN; RECEPTOR; PHOSPHORYLATION; IDENTIFICATIONS	Unconventional prefoldin RPB5 Interactor (URI) was identified as a transcriptional repressor that binds RNA polymerase II (pol II) through interaction with the RPB5/POLR2E subunit. Despite the fact that many other proteins involved in transcription regulation have been shown to interact with URI, its nuclear function still remains elusive. Previous mass spectrometry analyses reported that URI is part of a novel protein complex called R2TP/prefoldin-like complex responsible for the cytoplasmic assembly of RNA polymerase II. We performed a mass spectrometry (MS)-based proteomic analysis to identify nuclear proteins interacting with URI in prostate cells. We identified all the components of the R2TP/prefoldin-like complex as nuclear URI interactors and we showed that URI binds and regulates RPB5 protein stability and transcription. Moreover, we validated the interaction of URI to the P53 and DNA damage-Regulated Gene 1 (PDRG1) and show that PDRG1 protein is also stabilized by URI binding. We present data demonstrating that URI nuclear/cytoplasmic shuttling is affected by compounds that stall pol II on the DNA (alpha-amanitin and actinomycin-D) and by leptomycin B, an inhibitor of the CRM1 exportin that mediates the nuclear export of pol II subunits. These data suggest that URI, and probably the entire R2TP/prefoldin-like complex is exported from the nucleus through CRM1. Finally we identified putative URI sites of phosphorylation and acetylation and confirmed URI sites of post-transcriptional modification identified in previous large-scale analyses the importance of which is largely unknown. However URI post-transcriptional modification was shown to be essential for URI function and therefore characterization of novel sites of URI modification will be important to the understanding of URI function.	[Mita, Paolo; Logan, Susan K.] New York Univ Sch Med, Dept Biochem & Mol Pharmacol, New York, NY USA; [Savas, Jeffrey N.; Yates, John R., III] Scripps Res Inst CA, Dept Physiol Chem, La Jolla, CA USA; [Ha, Susan] New York Univ Sch Med, Dept Urol, New York, NY USA; [Djouder, Nabil] Fdn Banco Bilbao Vizcaya F BBVA CNIO Canc Cell Bi, CNIO, Madrid, Spain	New York University; New York University; Centro Nacional de Investigaciones Oncologicas (CNIO)	Logan, SK (corresponding author), New York Univ Sch Med, Dept Biochem & Mol Pharmacol, New York, NY USA.	susan.logan@nyumc.org		Logan, Susan/0000-0002-7904-5927	National Institute of Health [R01 CA112226, W81XWH-10-1-0431, P41 GM103533, R01 MH067880]; National Institute of Aging fellowship [F32AG039127]; Urology department at New York University School of Medicine; NATIONAL CANCER INSTITUTE [F31CA113285, R01CA112226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG039127] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Aging fellowship; Urology department at New York University School of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Grant support was received from the National Institute of Health (R01 CA112226 [S.K.L.], W81XWH-10-1-0431 [P.M.] P41 GM103533 and R01 MH067880 [J.R.Y.]), the National Institute of Aging fellowship (F32AG039127 [J.N.S.]) and the Urology department at New York University School of Medicine (S.K.L). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulon S, 2010, MOL CELL, V39, P912, DOI 10.1016/j.molcel.2010.08.023; Cloutier P, 2009, METHODS, V48, P381, DOI 10.1016/j.ymeth.2009.05.005; Cociorva Daniel, 2007, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1304s16; Delgermaa L, 2004, MOL CELL BIOL, V24, P8556, DOI 10.1128/MCB.24.19.8556-8566.2004; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Djouder N, 2007, MOL CELL, V28, P28, DOI 10.1016/j.molcel.2007.08.010; Dorjsuren D, 1998, MOL CELL BIOL, V18, P7546, DOI 10.1128/MCB.18.12.7546; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Gallant P, 2007, TRENDS CELL BIOL, V17, P187, DOI 10.1016/j.tcb.2007.02.005; Gstaiger M, 2003, SCIENCE, V302, P1208, DOI 10.1126/science.1088401; Izumi N, 2012, NUCLEUS-PHILA, V3, P29, DOI 10.4161/nucl.18926; Izumi N, 2012, CANCER SCI, V103, P50, DOI 10.1111/j.1349-7006.2011.02112.x; Jiang LY, 2011, CANCER BIOL THER, V11, P567, DOI 10.4161/cbt.11.6.14412; Luo XQ, 2003, ONCOGENE, V22, P7247, DOI 10.1038/sj.onc.1207010; Martin-Benito J, 2002, EMBO J, V21, P6377, DOI 10.1093/emboj/cdf640; McDonald WH, 2004, RAPID COMMUN MASS SP, V18, P2162, DOI 10.1002/rcm.1603; Mita P, 2011, MOL CELL BIOL, V31, P3639, DOI 10.1128/MCB.05429-11; Nguyen VT, 1996, NUCLEIC ACIDS RES, V24, P2924, DOI 10.1093/nar/24.15.2924; Nwachukwu JC, 2009, CANCER RES, V69, P3140, DOI 10.1158/0008-5472.CAN-08-3738; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Sadygov RG, 2002, J PROTEOME RES, V1, P211, DOI 10.1021/pr015514r; Sardiu ME, 2008, P NATL ACAD SCI USA, V105, P1454, DOI 10.1073/pnas.0706983105; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Theurillat JP, 2011, CANCER CELL, V19, P317, DOI 10.1016/j.ccr.2011.01.019; Vainberg IE, 1998, CELL, V93, P863, DOI 10.1016/S0092-8674(00)81446-4; Wei WX, 2003, CELL RES, V13, P111, DOI 10.1038/sj.cr.7290155; Yang Y, 2000, Zhonghua Gan Zang Bing Za Zhi, V8, P15; Yart A, 2005, MOL CELL BIOL, V25, P5052, DOI 10.1128/MCB.25.12.5052-5060.2005	30	42	43	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63879	10.1371/journal.pone.0063879	http://dx.doi.org/10.1371/journal.pone.0063879			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667685	Green Published, gold, Green Submitted			2022-12-25	WOS:000319055600079
J	Mowrey, D; Chen, Q; Liang, YH; Liang, J; Xu, Y; Tang, P				Mowrey, David; Chen, Qiang; Liang, Yuhe; Liang, Jie; Xu, Yan; Tang, Pei			Signal Transduction Pathways in the Pentameric Ligand-Gated Ion Channels	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; TRANSMEMBRANE DOMAIN INTERFACE; AGONIST-BINDING-SITES; CYS-LOOP; PROPAGATION; COUPLES; PRE-M1	The mechanisms of allosteric action within pentameric ligand-gated ion channels (pLGICs) remain to be determined. Using crystallography, site-directed mutagenesis, and two-electrode voltage clamp measurements, we identified two functionally relevant sites in the extracellular (EC) domain of the bacterial pLGIC from Gloeobacter violaceus (GLIC). One site is at the C-loop region, where the NQN mutation (D91N, E177Q, and D178N) eliminated inter-subunit salt bridges in the open-channel GLIC structure and thereby shifted the channel activation to a higher agonist concentration. The other site is below the C-loop, where binding of the anesthetic ketamine inhibited GLIC currents in a concentration dependent manner. To understand how a perturbation signal in the EC domain, either resulting from the NQN mutation or ketamine binding, is transduced to the channel gate, we have used the Perturbation-based Markovian Transmission (PMT) model to determine dynamic responses of the GLIC channel and signaling pathways upon initial perturbations in the EC domain of GLIC. Despite the existence of many possible routes for the initial perturbation signal to reach the channel gate, the PMT model in combination with Yen's algorithm revealed that perturbation signals with the highest probability flow travel either via the beta 1-beta 2 loop or through pre-TM1. The beta 1-beta 2 loop occurs in either intra- or inter-subunit pathways, while pre-TM1 occurs exclusively in inter-subunit pathways. Residues involved in both types of pathways are well supported by previous experimental data on nAChR. The direct coupling between pre-TM1 and TM2 of the adjacent subunit adds new insight into the allosteric signaling mechanism in pLGICs.	[Mowrey, David; Chen, Qiang; Liang, Yuhe; Xu, Yan; Tang, Pei] Univ Pittsburgh, Sch Med, Dept Anesthesiol, Pittsburgh, PA 15261 USA; [Xu, Yan; Tang, Pei] Univ Pittsburgh, Sch Med, Dept Chem Biol & Pharmacol, Pittsburgh, PA USA; [Xu, Yan] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA USA; [Mowrey, David; Tang, Pei] Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA USA; [Liang, Jie] Univ Illinois, Dept Bioengn, Chicago, IL USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Tang, P (corresponding author), Univ Pittsburgh, Sch Med, Dept Anesthesiol, Pittsburgh, PA 15261 USA.	TangP@anes.upmc.edu		Tang, Pei/0000-0002-2869-2737; Xu, Yan/0000-0003-2773-8024	National Institutes of Health [R01GM066358, R01GM056257, R37GM049202]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056257, R37GM049202, R01GM066358] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by grants from the National Institutes of Health (R01GM066358, R01GM056257, and R37GM049202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andersen N, 2011, J NEUROSCI, V31, P3662, DOI 10.1523/JNEUROSCI.5940-10.2011; Auerbach A, 2010, J PHYSIOL-LONDON, V588, P573, DOI 10.1113/jphysiol.2009.182774; Bafna PA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002515; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; Cadugan DJ, 2010, BIOPHYS J, V99, P798, DOI 10.1016/j.bpj.2010.05.008; Chakrapani S, 2004, J GEN PHYSIOL, V123, P341, DOI 10.1085/jgp.200309004; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chennubhotla C, 2007, PLOS COMPUT BIOL, V3, P1716, DOI 10.1371/journal.pcbi.0030172; Chennubhotla C, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100075; del Sol A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r92; del Sol A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100063; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; Haliloglu T, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000164; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jansen M, 2008, J GEN PHYSIOL, V131, P137, DOI 10.1085/jgp.200709896; Jha A, 2007, J GEN PHYSIOL, V130, P547, DOI 10.1085/jgp.200709856; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee WY, 2009, J NEUROSCI, V29, P3189, DOI 10.1523/JNEUROSCI.6185-08.2009; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Lu HM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000526; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Mowrey D, 2013, J AM CHEM SOC; Mowrey D, 2010, J PHYS CHEM B, V114, P7649, DOI 10.1021/jp1009675; Mukhtasimova N, 2013, BIOPHYS J, V104, P355, DOI 10.1016/j.bpj.2012.12.013; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Pan JJ, 2012, STRUCTURE, V20, P1463, DOI 10.1016/j.str.2012.08.009; Park K, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S23; Prevost MS, 2012, NAT STRUCT MOL BIOL, V19, P642, DOI 10.1038/nsmb.2307; Purohit P, 2007, J GEN PHYSIOL, V130, P559, DOI 10.1085/jgp.200709857; Purohit P, 2007, J GEN PHYSIOL, V130, P569, DOI 10.1085/jgp.200709858; Purohit P, 2010, J GEN PHYSIOL, V135, P321, DOI 10.1085/jgp.200910384; Schrodinger L., 2020, PYMOL; Sidje RB, 1999, COMPUT STAT DATA AN, V29, P345, DOI 10.1016/S0167-9473(98)00062-0; Tassonyi E, 2002, BRAIN RES BULL, V57, P133, DOI 10.1016/S0361-9230(01)00740-7; Thompson AJ, 2010, Q REV BIOPHYS, V43, P449, DOI 10.1017/S0033583510000168; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Weng Y, 2010, ANESTH ANALG, V110, P59, DOI 10.1213/ANE.0b013e3181c4bc69; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xiu XN, 2005, J BIOL CHEM, V280, P41655, DOI 10.1074/jbc.M508635200; YEN JY, 1971, MANAGE SCI, V17, P712, DOI 10.1287/mnsc.17.11.712	49	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e64326	10.1371/journal.pone.0064326	http://dx.doi.org/10.1371/journal.pone.0064326			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667707	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000319055600089
J	Nozoye, T; Nakanishi, H; Nishizawa, NK				Nozoye, Tomoko; Nakanishi, Hiromi; Nishizawa, Naoko K.			Characterizing the Crucial Components of Iron Homeostasis in the Maize Mutants ys1 and ys3	PLOS ONE			English	Article							NICOTIANAMINE SYNTHASE GENES; REGULATED METAL TRANSPORTER; LONG-DISTANCE TRANSPORT; FE-DEFICIENT CONDITIONS; GRAMINEOUS PLANTS; PHYTOSIDEROPHORE TRANSPORTER; APOPLASMIC IRON; YELLOW STRIPE1; RICE PLANTS; CLONING	To acquire iron (Fe), graminaceous plants secrete mugineic acid family phytosiderophores through the phytosiderophore efflux transporter TOM1 and take up Fe in the form of Fe(III)-phytosiderophore complexes. Yellow stripe 1 (ys1) and ys3 are recessive mutants of maize (Zea mays L.) that show typical symptoms of Fe deficiency, i.e., interveinal chlorosis of the leaves. The ys1 mutant is defective in the Fe(III)-phytosiderophore transporter YS1 and is therefore unable to take up Fe(III)-phytosiderophore complexes. While the ys3 mutant has been shown to be defective in phytosiderophores release, the causative gene has not been identified. The present study was performed to characterize the expression profiles of the genes in ys1 and ys3 mutants to extend our understanding of Fe homeostasis in maize. Using quantitative real-time polymerase chain reaction, we assessed changes in the levels of gene expression in response to Fe deficiency of genes involved in Fe homeostasis, such as those related to phytosiderophore biosynthesis and Fe transport. As with other crops, these Fe deficiency-inducible genes were also upregulated in maize. In addition, these Fe deficiency-inducible genes were upregulated in both the ys1 and ys3 mutants, even under Fe-sufficient conditions. Indeed, the Fe concentrations in the roots of ys1 and ys3 plants were lower than that of wild-type controls. These results suggest that ys1 and ys3 are Fe-deficient during growth in the presence of Fe. In agreement with previous reports, the level of YS1 expression decreased in the ys1 mutant. Moreover, the expression level of a homolog of TOM1 in maize decreased significantly in the ys3 mutant. Unspliced introns of ZmTOM1 were detected only in ys3, and not in YS1YS3 or ys1, suggesting that ZmTOM1 may be involved in the ys3 phenotype.	[Nozoye, Tomoko; Nakanishi, Hiromi; Nishizawa, Naoko K.] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Global Agr Sci, Tokyo, Japan; [Nishizawa, Naoko K.] Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Nonoichi, Ishikawa, Japan	University of Tokyo; Ishikawa Prefecture University	Nishizawa, NK (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Global Agr Sci, Tokyo, Japan.	annaoko@mail.ecc.u-tokyo.ac.jp	Nakanishi, Hiromi/C-6461-2015	Nakanishi, Hiromi/0000-0001-5556-5058	Ministry of Education, Culture, Sportes, Science and Technology, Japan [17078008]; Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN); Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation) [GMB0001]; Grants-in-Aid for Scientific Research [23248011] Funding Source: KAKEN	Ministry of Education, Culture, Sportes, Science and Technology, Japan; Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN); Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation)(Ministry of Agriculture Forestry & Fisheries - Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by a Grant-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sportes, Science and Technology, Japan (no. 17078008 to NKN), the Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN), and a grant from the Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation, GMB0001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama T, 2009, PLANT MOL BIOL, V70, P681, DOI 10.1007/s11103-009-9500-3; Bashir K, 2006, PLANT SIGNAL BEHAV, V1, P290, DOI 10.4161/psb.1.6.3590; Bashir K, 2006, J BIOL CHEM, V281, P32395, DOI 10.1074/jbc.M604133200; Bashir K, 2011, SOIL SCI PLANT NUTR, V57, P803, DOI 10.1080/00380768.2011.637305; Bashir K, 2010, RICE, V3, P122, DOI 10.1007/s12284-010-9042-y; BELL WILLIAM D., 1962, BOT GAZ, V124, P1, DOI 10.1086/336166; BELL WILLIAM D., 1958, BOT GAZ, V120, P36, DOI 10.1086/335995; BROWN JC, 1969, SOIL SCI SOC AM PRO, V33, P99, DOI 10.2136/sssaj1969.03615995003300010027x; Bughio N, 2002, J EXP BOT, V53, P1677, DOI 10.1093/jxb/erf004; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Curie C, 2001, NATURE, V409, P346, DOI 10.1038/35053080; DiDonato RJ, 2004, PLANT J, V39, P403, DOI 10.1111/j.1365-313X.2004.02128.x; Eide D, 1996, P NATL ACAD SCI USA, V93, P5624, DOI 10.1073/pnas.93.11.5624; Gendre D, 2007, PLANT J, V49, P1, DOI 10.1111/j.1365-313X.2006.02937.x; Herbik A, 1999, EUR J BIOCHEM, V265, P231, DOI 10.1046/j.1432-1327.1999.00717.x; Higuchi K, 1999, PLANT PHYSIOL, V119, P471, DOI 10.1104/pp.119.2.471; Higuchi K, 2001, PLANT J, V25, P159, DOI 10.1046/j.1365-313x.2001.00951.x; Inoue H, 2003, PLANT J, V36, P366, DOI 10.1046/j.1365-313X.2003.01878.x; Inoue H, 2009, J BIOL CHEM, V284, P3470, DOI 10.1074/jbc.M806042200; Inoue H, 2008, PLANT MOL BIOL, V66, P193, DOI 10.1007/s11103-007-9262-8; Ishimaru Y, 2006, PLANT J, V45, P335, DOI 10.1111/j.1365-313X.2005.02624.x; Ishimaru Y, 2012, SCI REP, V2; Ishimaru Y, 2012, PLANT SIGNALING BEHA, V7; Ishimaru Y, 2011, PLANT SIGNAL BEHAV, V6, P1624, DOI 10.4161/psb.6.10.17694; Ishimaru Y, 2011, J BIOL CHEM, V286, P24649, DOI 10.1074/jbc.M111.221168; Ishimaru Y, 2010, PLANT J, V62, P379, DOI 10.1111/j.1365-313X.2010.04158.x; Kakei Y, 2012, PLANT MOL B IN PRESS; Kobayashi T, 2005, J EXP BOT, V56, P1305, DOI 10.1093/jxb/eri131; Kobayashi T, 2012, ANNU REV PLANT BIOL, V63, P131, DOI 10.1146/annurev-arplant-042811-105522; Koike S, 2004, PLANT J, V39, P415, DOI 10.1111/j.1365-313X.2004.02146.x; Lanfranchi S, 2002, MAYDICA, V47, P181; Le Jean M, 2005, PLANT J, V44, P769, DOI 10.1111/j.1365-313X.2005.02569.x; Lee S, 2009, PLANT PHYSIOL, V150, P786, DOI 10.1104/pp.109.135418; Ma JF, 1999, J EXP BOT, V50, P723, DOI 10.1093/jexbot/50.334.723; MA JF, 1993, PLANT PHYSIOL, V102, P373, DOI 10.1104/pp.102.2.373; MARSCHNER H, 1986, J PLANT NUTR, V9, P695, DOI 10.1080/01904168609363475; Marschner H., 1995, MINERAL NUTR HIGHER, V2nd ed.; Mihashi S., 1989, Biology of Metals, V2, P146, DOI 10.1007/BF01142553; Mizuno D, 2003, PLANT PHYSIOL, V132, P1989, DOI 10.1104/pp.102.019869; Mori S, 1999, CURR OPIN PLANT BIOL, V2, P250, DOI 10.1016/S1369-5266(99)80043-0; MORI S, 1987, PLANT CELL PHYSIOL, V28, P1081; Nozoye T, 2011, J BIOL CHEM, V286, P5446, DOI 10.1074/jbc.M110.180026; Ogo Y, 2007, PLANT J, V51, P366, DOI 10.1111/j.1365-313X.2007.03149.x; Ogo Y, 2006, J EXP BOT, V57, P2867, DOI 10.1093/jxb/erl054; Ogo Y, 2011, PLANT MOL BIOL, V75, P593, DOI 10.1007/s11103-011-9752-6; Roberts LA, 2004, PLANT PHYSIOL, V135, P112, DOI 10.1104/pp.103.037572; Robinson NJ, 1999, NATURE, V397, P694, DOI 10.1038/17800; Schaaf G, 2004, SOIL SCI PLANT NUTR, V50, P989, DOI 10.1080/00380768.2004.10408565; Schaaf G, 2005, PLANT CELL PHYSIOL, V46, P762, DOI 10.1093/pcp/pci081; Schaaf G, 2004, J BIOL CHEM, V279, P9091, DOI 10.1074/jbc.M311799200; SHOJIMA S, 1990, PLANT PHYSIOL, V93, P1497, DOI 10.1104/pp.93.4.1497; TAKAGI SI, 1976, SOIL SCI PLANT NUTR, V22, P423, DOI 10.1080/00380768.1976.10433004; Takahashi M, 1999, PLANT PHYSIOL, V121, P947, DOI 10.1104/pp.121.3.947; Takahashi M, 2003, PLANT CELL, V15, P1263, DOI 10.1105/tpc.010256; Takahashi R, 2011, J EXP BOT, V62, P4843, DOI 10.1093/jxb/err136; Vert G, 2002, PLANT CELL, V14, P1223, DOI 10.1105/tpc.001388; VONWIREN N, 1994, PLANT PHYSIOL, V106, P71, DOI 10.1104/pp.106.1.71; Waters BM, 2006, PLANT PHYSIOL, V141, P1446, DOI 10.1104/pp.106.082586; Zheng LQ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-166	59	36	38	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62567	10.1371/journal.pone.0062567	http://dx.doi.org/10.1371/journal.pone.0062567			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667491	Green Submitted, gold, Green Published			2022-12-25	WOS:000319055600028
J	Thies, FG; Laurindo, MFL; Perez, EC; Brito, RRNE; Mariano, M; Popi, AF				Thies, Felipe Garutti; Lucatelli Laurindo, Maria Fernanda; Perez, Elizabeth Cristina; Novaes e Brito, Ronni Romulo; Mariano, Mario; Popi, Ana Flavia			Cross Talk between Peritoneal Macrophages and B-1 Cells In Vitro	PLOS ONE			English	Article							B-CELLS; AUTOIMMUNE-DISEASE; IMMUNE-SYSTEM; T-CELLS; MICE; IL-6; INTERLEUKIN-10; INFECTION; KINETICS; LUPUS	B-1 cells constitute a distinct B cell population with unique phenotypic and functional characteristics. They represent the main B cell population found in mouse peritoneal and pleural cavities. The communication between B-1 cells and peritoneal macrophages has been previously studied, and the effect this interaction has on macrophages has been previously described. Using an in vitro co-culture model, herein we demonstrated that peritoneal macrophages were able to increase survival rates and to stimulate proliferation of B-1 cells. IL-6 was also found to be important in B-1 cell survival; recombinant IL-6 increases the percentage of viable B-1 cells in culture. Furthermore, molecules involved in the IL-6 signaling pathway, such as STAT-3 and Bcl-2, were highly expressed in B-1 cells after co-culture with peritoneal macrophages. IL-6-deficient peritoneal macrophages were not able to increase B-1 cell survival, confirming the importance of this cytokine. Altogether, our results indicate a novel mechanism in which peritoneal macrophages are able to regulate the B-1 population via IL-6 secretion.	[Thies, Felipe Garutti; Lucatelli Laurindo, Maria Fernanda; Perez, Elizabeth Cristina; Novaes e Brito, Ronni Romulo; Mariano, Mario; Popi, Ana Flavia] Univ Fed Sao Paulo, Dept Microbiol Immunol & Parasitol, Discipline Immunol, Sao Paulo, Brazil; [Perez, Elizabeth Cristina; Mariano, Mario] Univ Paulista UNIP, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Paulista	Popi, AF (corresponding author), Univ Fed Sao Paulo, Dept Microbiol Immunol & Parasitol, Discipline Immunol, Sao Paulo, Brazil.	afpopi@unifesp.br	Pérez, Elizabeth C/E-8057-2012; Popi, Ana Flavia/V-4437-2019; Mariano, Mario/L-2557-2015; Novaes e Brito, Ronni Romulo/F-2419-2012	Pérez, Elizabeth C/0000-0003-3038-9902; Popi, Ana Flavia/0000-0001-9814-4181; Novaes e Brito, Ronni Romulo/0000-0002-4870-4133	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2008/58561-0, 2011/50256-6]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research received financial support from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (2008/58561-0 and 2011/50256-6) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahao TB, 2003, IMMUNOBIOLOGY, V208, P401, DOI 10.1078/0171-2985-00287; Almeida SR, 2001, INT IMMUNOL, V13, P1193, DOI 10.1093/intimm/13.9.1193; Berland R, 2002, ANNU REV IMMUNOL, V20, P253, DOI 10.1146/annurev.immunol.20.100301.064833; Bogsan CSB, 2005, INT J EXP PATHOL, V86, P257, DOI 10.1111/j.0959-9673.2005.00433.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; De Lorenzo BHP, 2007, IMMUNOL LETT, V114, P110, DOI 10.1016/j.imlet.2007.09.013; Dempsey PW, 2003, CELL MOL LIFE SCI, V60, P2604, DOI 10.1007/s00018-003-3180-y; Diehl S, 2002, MOL IMMUNOL, V39, P531, DOI 10.1016/S0161-5890(02)00210-9; Duan B, 2006, AUTOIMMUN REV, V5, P403, DOI 10.1016/j.autrev.2005.10.007; GODIN IE, 1993, NATURE, V364, P67, DOI 10.1038/364067a0; Hayakawa K, 2000, CURR OPIN IMMUNOL, V12, P346, DOI 10.1016/S0952-7915(00)00098-4; HAYAKAWA K, 1986, EUR J IMMUNOL, V16, P450, DOI 10.1002/eji.1830160423; HAYAKAWA K, 1983, J EXP MED, V157, P202, DOI 10.1084/jem.157.1.202; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; HERZENBERG LA, 1986, IMMUNOL REV, V93, P81, DOI 10.1111/j.1600-065X.1986.tb01503.x; Hirano T, 1998, Int Rev Immunol, V16, P249; Huang H, 2005, FRONT BIOSCI-LANDMRK, V10, P192, DOI 10.2741/1521; Ishihara K, 2002, CYTOKINE GROWTH F R, V13, P357, DOI 10.1016/S1359-6101(02)00027-8; KANNO K, 1993, AUTOIMMUNITY, V14, P205, DOI 10.3109/08916939309077367; KANTOR AB, 1993, ANNU REV IMMUNOL, V11, P501, DOI 10.1146/annurev.immunol.11.1.501; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; Laurindo MF, 2012, IMMUNOBIOLOGY; Moroni L, 2012, AUTOIMMUN REV, V11, pA386, DOI 10.1016/j.autrev.2011.11.012; Mussalem JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033955; Neurath MF, 2011, CYTOKINE GROWTH F R, V22, P83, DOI 10.1016/j.cytogfr.2011.02.003; Nogueira-Martins MF, 2010, IMMUNOBIOLOGY, V215, P264, DOI 10.1016/j.imbio.2009.05.007; OGARRA A, 1992, EUR J IMMUNOL, V22, P711, DOI 10.1002/eji.1830220314; Oliveira HC, 2010, IMMUNOBIOLOGY, V215, P215, DOI 10.1016/j.imbio.2009.03.009; Otero DC, 2006, J IMMUNOL, V177, P6593, DOI 10.4049/jimmunol.177.10.6593; Palos MC, 2012, INFLAMM RES, V61, P1187, DOI 10.1007/s00011-012-0514-y; Parkin J, 2001, LANCET, V357, P1777, DOI 10.1016/S0140-6736(00)04904-7; Perez EC, 2008, CANCER SCI, V99, P920, DOI 10.1111/j.1349-7006.2008.00776.x; Popi AF, 2004, IMMUNOLOGY, V113, P348, DOI 10.1111/j.1365-2567.2004.01969.x; Popi AF, 2008, MICROBES INFECT, V10, P817, DOI 10.1016/j.micinf.2008.04.012; Russo RT, 2010, IMMUNOBIOLOGY, V215, P1005, DOI 10.1016/j.imbio.2010.01.003; Ryan GA, 2010, J IMMUNOL, V185, P2800, DOI 10.4049/jimmunol.1000856; SWAAK AJ, 1988, SCAND J RHEUMATOL, V17, P469, DOI 10.3109/03009748809098809; THEOFILOPOULOS AN, 1985, ADV IMMUNOL, V37, P269, DOI 10.1016/S0065-2776(08)60342-9; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Wang Y, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00281; Wong SC, 2010, EUR J IMMUNOL, V40, P2296, DOI 10.1002/eji.200940288; Yamanishi S, 2006, INFECT IMMUN, V74, P248, DOI 10.1128/IAI.74.1.248-256.2006; Yue C, 2010, RHEUMATOL INT, V30, P1553, DOI 10.1007/s00296-009-1179-x	43	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62805	10.1371/journal.pone.0062805	http://dx.doi.org/10.1371/journal.pone.0062805			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667522	gold, Green Submitted, Green Published			2022-12-25	WOS:000319055600045
J	Kateete, DP; Kabugo, U; Baluku, H; Nyakarahuka, L; Kyobe, S; Okee, M; Najjuka, CF; Joloba, ML				Kateete, David Patrick; Kabugo, Usuf; Baluku, Hannington; Nyakarahuka, Luke; Kyobe, Samuel; Okee, Moses; Najjuka, Christine Florence; Joloba, Moses Lutaakome			Prevalence and Antimicrobial Susceptibility Patterns of Bacteria from Milkmen and Cows with Clinical Mastitis in and around Kampala, Uganda	PLOS ONE			English	Article							COAGULASE-NEGATIVE STAPHYLOCOCCI; AUTOMATED MICROBIOLOGY SYSTEM; BOVINE MASTITIS; UDDER PATHOGENS; DAIRY-COWS; IDENTIFICATION; AUREUS; RESISTANCE; CATTLE; ENTEROBACTERIACEAE	Background: Identification of pathogens associated with bovine mastitis is helpful in treatment and management decisions. However, such data from sub-Saharan Africa is scarce. Here we describe the distribution and antimicrobial susceptibility patterns of bacteria from cows with clinical mastitis in Kampala, Uganda. Due to high concern of zoonotic infections, isolates from milkmen are also described. Methodology/Principal Findings: Ninety seven milk samples from cows with clinical mastitis and 31 nasal swabs from milkmen were collected (one sample per cow/human). Fifty eight (60%) Gram-positive isolates namely Staphylococci (21), Enterococci (16), Streptococci (13), Lactococci (5), Micrococci (2) and Arcanobacteria (1) were detected in cows; only one grew Staphylococcus aureus. Furthermore, 24 (25%) coliforms namely Escherichia coli (12), Klebsiella oxytoca (5), Proteus vulgaris (2), Serratia (2), Citrobacter (1), Cedecea (1) and Leclercia (1) were identified. From humans, 24 Gram-positive bacteria grew, of which 11 were Staphylococci (35%) including four Staphylococcus aureus. Upon susceptibility testing, methicillin-resistant coagulase-negative staphylococci (CoNS) were prevalent; 57%, 12/21 in cows and 64%, 7/11 in humans. However, methicillin-resistant Staphylococcus aureus was not detected. Furthermore, methicillin and vancomycin resistant CoNS were detected in cows (Staphylococcus hominis, Staphylococcus lugdunensis) and humans (Staphylococcus scuiri). Also, vancomycin and daptomycin resistant Enterococci (Enterococcus faecalis and Enterococcus faecium, respectively) were detected in cows. Coliforms were less resistant with three pan-susceptible isolates. However, multidrug resistant Klebsiella, Proteus, Serratia, Cedecea, and Citrobacter were detected. Lastly, similar species grew from human and bovine samples but on genotyping, the isolates were found to be different. Interestingly, human and bovine Staphylococcus aureus were genetically similar (spa-CC435, spa-type t645 corresponding to ST121) but with different susceptibility patterns. Conclusions/Significance: CoNS, Enterococci, Streptococci, and Escherichia coli are the predominant pathogens associated with clinical bovine-mastitis in Kampala, Uganda. Multidrug resistant bacteria are also prevalent. While similar species occurred in humans and cows, transmission was not detected.	[Kateete, David Patrick; Kabugo, Usuf; Baluku, Hannington; Kyobe, Samuel; Okee, Moses; Najjuka, Christine Florence; Joloba, Moses Lutaakome] Makerere Univ, Coll Hlth Sci, Sch Biomed Sci, Dept Med Microbiol, Kampala, Uganda; [Kabugo, Usuf; Nyakarahuka, Luke] Makerere Univ, Coll Vet Med & Biosecur, Kampala, Uganda	Makerere University; Makerere University	Kateete, DP (corresponding author), Makerere Univ, Coll Hlth Sci, Sch Biomed Sci, Dept Med Microbiol, Kampala, Uganda.	davidkateete@gmail.com	Nyakarahuka, Luke/AGH-2432-2022; Nyakarahuka, Luke/W-8164-2019; Kateete, David Patrick/HCH-5603-2022	Nyakarahuka, Luke/0000-0002-2944-9157; Nyakarahuka, Luke/0000-0002-2944-9157; Kateete, David Patrick/0000-0001-8075-3069; Joloba, Moses/0000-0002-0334-9983	Swedish International Development Cooperation (Sida) through Makerere University School of Graduate Studies; National Institutes of Health [RO3 AI062849, RO1 AI075637]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI062849, R01AI075637] Funding Source: NIH RePORTER	Swedish International Development Cooperation (Sida) through Makerere University School of Graduate Studies; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The Phoenix 100 ID/AST BDexpert system was purchased with support from the Swedish International Development Cooperation (Sida) through Makerere University School of Graduate Studies. Activities in the Laboratories of the Department of Medical Microbiology have been funded by the National Institutes of Health (Grant #s RO3 AI062849 and RO1 AI075637). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahmsen M, 2012, PREVALENCE SUBCLINIC; Bakir M, 2011, VET WORLD, V4, P537, DOI 10.5455/vetworld.2011.537-541; Bengtsson B, 2009, VET MICROBIOL, V136, P142, DOI 10.1016/j.vetmic.2008.10.024; Blanco R, 2011, J CLIN MICROBIOL, V49, P433, DOI 10.1128/JCM.02201-10; Bradley AJ, 2007, VET REC, V160, P253, DOI 10.1136/vr.160.8.253; Bradley AJ, 2002, VET J, V164, P116, DOI 10.1053/tvjl.2002.0724; Byarugaba DK, 2008, LIVESTOCK RES RURAL, V20; Carroll KC, 2006, J CLIN MICROBIOL, V44, P3506, DOI 10.1128/JCM.00994-06; Carroll KC, 2006, J CLIN MICROBIOL, V44, P2072, DOI 10.1128/JCM.02636-05; Cheng DR, 2010, AFR J MICROBIOL RES, V4, P1110; Claesson C, 2012, STAPHYLOCOCCI ENTERO; DEVRIESE LA, 1987, INT J SYST BACTERIOL, V37, P257, DOI 10.1099/00207713-37-3-257; Fessler AT, 2010, J ANTIMICROB CHEMOTH, V65, P1576, DOI 10.1093/jac/dkq172; Gaze W, 2008, ADV APPL MICROBIOL, V63, P249, DOI 10.1016/S0065-2164(07)00007-X; Hagnestam-Nielsen C, 2009, ANIMAL, V3, P315, DOI 10.1017/S1751731108003352; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Hendriksen RS, 2008, ACTA VET SCAND, V50, DOI 10.1186/1751-0147-50-28; Hijazin M, 2011, J DAIRY SCI, V94, P1813, DOI 10.3168/jds.2010-3678; HONKANENBUZALSKI T, 1994, J VET MED B, V41, P344, DOI 10.1111/j.1439-0450.1994.tb00237.x; Huber H, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-6; Huijsdens Xander W, 2006, Ann Clin Microbiol Antimicrob, V5, P26, DOI 10.1186/1476-0711-5-26; Human Research Affairs/Research Management, 2007, PAYM HUM SUBJ PART R; Kalmus P, 2011, ACTA VET SCAND, V53, DOI 10.1186/1751-0147-53-4; Kateete David P, 2011, BMC Res Notes, V4, P326, DOI 10.1186/1756-0500-4-326; Kateete DP, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-23; Koneman EW, 1997, COLOUR ATLAS TXB DIA, V6 th, P171; Krause DO, 2011, ZOONOTIC PATHOGENS IN THE FOOD CHAIN, P1; Madut N. A., 2009, Journal of Cell and Animal Biology, V3, P071; Makita K, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-60; MAYER L W, 1988, Clinical Microbiology Reviews, V1, P228; McCarthy AJ, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-104; O'Hara CM, 2006, J CLIN MICROBIOL, V44, P928, DOI 10.1128/JCM.44.3.928-933.2006; Persson Y, 2011, ACTA VET SCAND, V53, DOI 10.1186/1751-0147-53-36; Pyorala S, 2009, VET MICROBIOL, V134, P3, DOI 10.1016/j.vetmic.2008.09.015; Reinoso E, 2004, MICROBIOL RES, V159, P245, DOI 10.1016/j.micres.2004.04.002; Ruegg PL, 2011, TREATMENT CLIN MASTI; Schroeder J, 2012, BOVINE MASTITIS MILK; Seni J, 2012, THESIS MAKERERE U KA; Shearer JES, 2011, G3-GENES GENOM GENET, V1, P581, DOI 10.1534/g3.111.000760; Sumathi BR, 2008, VET WORLD, V1, P37; Taponen S, 2009, VET MICROBIOL, V134, P29, DOI 10.1016/j.vetmic.2008.09.011; Thomson K, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-15; Zadoks RN, 2011, J MAMMARY GLAND BIOL, V16, P357, DOI 10.1007/s10911-011-9236-y	43	56	59	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63413	10.1371/journal.pone.0063413	http://dx.doi.org/10.1371/journal.pone.0063413			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667611	Green Submitted, Green Published, gold			2022-12-25	WOS:000319654700139
J	Lee, IR; Yang, LT; Sebetso, G; Allen, R; Doan, THN; Blundell, R; Lui, EYL; Morrow, CA; Fraser, JA				Lee, I. Russel; Yang, Liting; Sebetso, Gaseene; Allen, Rebecca; Doan, Thi H. N.; Blundell, Ross; Lui, Edmund Y. L.; Morrow, Carl A.; Fraser, James A.			Characterization of the Complete Uric Acid Degradation Pathway in the Fungal Pathogen Cryptococcus neoformans	PLOS ONE			English	Article							URATE OXIDASE REACTION; ASPERGILLUS-NIDULANS; SACCHAROMYCES-CEREVISIAE; CAENORHABDITIS-ELEGANS; FUNCTIONAL-ANALYSIS; GENETIC-ANALYSIS; SEXUAL CYCLE; PROTEIN; VIRULENCE; IDENTIFICATION	Degradation of purines to uric acid is generally conserved among organisms, however, the end product of uric acid degradation varies from species to species depending on the presence of active catabolic enzymes. In humans, most higher primates and birds, the urate oxidase gene is non-functional and hence uric acid is not further broken down. Uric acid in human blood plasma serves as an antioxidant and an immune enhancer; conversely, excessive amounts cause the common affliction gout. In contrast, uric acid is completely degraded to ammonia in most fungi. Currently, relatively little is known about uric acid catabolism in the fungal pathogen Cryptococcus neoformans even though this yeast is commonly isolated from uric acid-rich pigeon guano. In addition, uric acid utilization enhances the production of the cryptococcal virulence factors capsule and urease, and may potentially modulate the host immune response during infection. Based on these important observations, we employed both Agrobacterium-mediated insertional mutagenesis and bioinformatics to predict all the uric acid catabolic enzyme-encoding genes in the H99 genome. The candidate C. neoformans uric acid catabolic genes identified were named: URO1 (urate oxidase), URO2 (HIU hydrolase), URO3 (OHCU decarboxylase), DAL1 (allantoinase), DAL2,3,3 (allantoicase- ureidoglycolate hydrolase fusion protein), and URE1 (urease). All six ORFs were then deleted via homologous recombination; assaying of the deletion mutants' ability to assimilate uric acid and its pathway intermediates as the sole nitrogen source validated their enzymatic functions. While Uro1, Uro2, Uro3, Dal1 and Dal2,3,3 were demonstrated to be dispensable for virulence, the significance of using a modified animal model system of cryptococcosis for improved mimicking of human pathogenicity is discussed.	[Lee, I. Russel; Yang, Liting; Sebetso, Gaseene; Allen, Rebecca; Doan, Thi H. N.; Blundell, Ross; Lui, Edmund Y. L.; Morrow, Carl A.; Fraser, James A.] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia; [Lee, I. Russel; Yang, Liting; Sebetso, Gaseene; Allen, Rebecca; Doan, Thi H. N.; Blundell, Ross; Lui, Edmund Y. L.; Morrow, Carl A.; Fraser, James A.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Fraser, JA (corresponding author), Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia.	jafraser@uq.edu.au	Fraser, James A/B-4918-2012; Lee, Russel/HDN-2358-2022	Fraser, James A/0000-0001-5724-5285; Morrow, Carl/0000-0002-3650-0117	University of Queensland International Research Tuition Award (UQIRTA); University of Queensland Research Scholarship (UQRS); National Health and Medical Research Council (NHMRC) [CDA 569673]	University of Queensland International Research Tuition Award (UQIRTA); University of Queensland Research Scholarship (UQRS)(University of Queensland); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the University of Queensland International Research Tuition Award (UQIRTA) and University of Queensland Research Scholarship (UQRS) awarded to IRL, and the National Health and Medical Research Council (NHMRC) CDA 569673 grant awarded to JF. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; Behrens MD, 2008, BLOOD, V111, P1472, DOI 10.1182/blood-2007-10-117184; BRENNER S, 1974, GENETICS, V77, P71; Casadevall A, 1998, CRYPTOCOCCUS NEOFORM; Cox GM, 2000, INFECT IMMUN, V68, P443, DOI 10.1128/IAI.68.2.443-448.2000; Cusa E, 1999, J BACTERIOL, V181, P7479, DOI 10.1128/JB.181.24.7479-7484.1999; D'Souza CA, 2001, MOL CELL BIOL, V21, P3179, DOI 10.1128/MCB.21.9.3179-3191.2001; Davidson RC, 2002, MICROBIOL-SGM, V148, P2607, DOI 10.1099/00221287-148-8-2607; DRIFT CVD, 1970, ARCH BIOCHEM BIOPHYS, V136, P273, DOI 10.1016/0003-9861(70)90351-6; Dueber JE, 2009, NAT BIOTECHNOL, V27, P753, DOI 10.1038/nbt.1557; ELION GB, 1989, SCIENCE, V244, P41, DOI 10.1126/science.2649979; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Fraser JA, 2003, EUKARYOT CELL, V2, P1036, DOI 10.1128/EC.2.5.1036-1045.2003; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; Gournas C, 2011, FUNGAL GENET BIOL, V48, P840, DOI 10.1016/j.fgb.2011.03.004; HALL AP, 1967, AM J MED, V42, P27, DOI 10.1016/0002-9343(67)90004-6; HAWKINS AR, 1987, CURR GENET, V11, P491, DOI 10.1007/BF00384611; Hayashi S, 2000, CELL BIOCHEM BIOPHYS, V32, P123, DOI 10.1385/CBB:32:1-3:123; Heitman Joseph, 2011, Fungal Biology Reviews, V25, P48, DOI 10.1016/j.fbr.2011.01.003; Hennebry SC, 2006, J MOL BIOL, V359, P1389, DOI 10.1016/j.jmb.2006.04.057; HONDA S, 1993, J GERONTOL, V48, pB57, DOI 10.1093/geronj/48.2.B57; Hynes MJ, 2008, GENETICS, V178, P1355, DOI 10.1534/genetics.107.085795; Idnurm A, 2005, PLOS BIOL, V3, P615, DOI 10.1371/journal.pbio.0030095; Idnurm A, 2004, EUKARYOT CELL, V3, P420, DOI 10.1128/EC.3.2.420-429.2004; Jung DK, 2006, P NATL ACAD SCI USA, V103, P9790, DOI 10.1073/pnas.0600523103; Jung WH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040045; Kahn K, 1997, J AM CHEM SOC, V119, P5435, DOI 10.1021/ja970375t; Kahn K, 1998, BIOCHEMISTRY-US, V37, P11651, DOI 10.1021/bi980446g; KWONCHUNG KJ, 1982, A VAN LEEUW J MICROB, V48, P25, DOI 10.1007/BF00399484; LAWTHER RP, 1974, J BACTERIOL, V119, P461, DOI 10.1128/JB.119.2.461-468.1974; Lee IR, 2011, GENETICS, V188, P309, DOI 10.1534/genetics.111.128538; Lee Y, 2005, FEBS LETT, V579, P4769, DOI 10.1016/j.febslet.2005.07.056; Magasanik B, 2000, P NATL ACAD SCI USA, V97, P14044, DOI 10.1073/pnas.97.26.14044; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Marzluf GA, 1997, MICROBIOL MOL BIOL R, V61, P17, DOI 10.1128/.61.1.17-32.1997; MODRIC N, 1992, TETRAHEDRON LETT, V33, P6691, DOI 10.1016/S0040-4039(00)61021-3; Munoz A, 2001, PLANT PHYSIOL, V125, P828, DOI 10.1104/pp.125.2.828; Mylonakis E, 2002, P NATL ACAD SCI USA, V99, P15675, DOI 10.1073/pnas.232568599; Navarathna DHMLP, 2010, FEMS YEAST RES, V10, P209, DOI 10.1111/j.1567-1364.2010.00602.x; Nielsen K, 2007, EUKARYOT CELL, V6, P949, DOI 10.1128/EC.00097-07; Oda M, 2002, MOL BIOL EVOL, V19, P640, DOI 10.1093/oxfordjournals.molbev.a004123; Olszewski MA, 2004, AM J PATHOL, V164, P1761, DOI 10.1016/S0002-9440(10)63734-0; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Ramazzina I, 2006, NAT CHEM BIOL, V2, P144, DOI 10.1038/nchembio768; Reumann S, 2007, PLANT CELL, V19, P3170, DOI 10.1105/tpc.107.050989; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schultz AC, 2001, J BACTERIOL, V183, P3293, DOI 10.1128/JB.183.11.3293-3302.2001; Schwartz J, 2003, SEMIN HEMATOL, V40, P87, DOI 10.1053/shem.2003.50007; SGRAVENMADE EJ, 1970, BIOCHIM BIOPHYS ACTA, V198, P569, DOI 10.1016/0005-2744(70)90134-8; Shi MQ, 2010, J CLIN INVEST, V120, P1683, DOI 10.1172/JCI41963; Southern E, 2006, NAT PROTOC, V1, P518, DOI 10.1038/nprot.2006.73; STAIB F, 1978, MYCOPATHOLOGIA, V65, P73, DOI 10.1007/BF00447178; STAIB F, 1976, ZBL BAKT-INT J MED M, V236, P374; Tavazzi B, 2005, CLIN BIOCHEM, V38, P997, DOI 10.1016/j.clinbiochem.2005.08.002; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Todd CD, 2006, J EXP BOT, V57, P5, DOI 10.1093/jxb/erj013; VOGELS GD, 1976, BACTERIOL REV, V40, P403, DOI 10.1128/MMBR.40.2.403-468.1976; Walker UA, 2006, AIDS, V20, P1556, DOI 10.1097/01.aids.0000237374.16068.de; Werner AK, 2008, PLANT PHYSIOL, V146, P418, DOI 10.1104/pp.107.110809; Werner AK, 2010, NAT CHEM BIOL, V6, P19, DOI [10.1038/NCHEMBIO.265, 10.1038/nchembio.265]; WILLIAMSON PR, 1994, J BACTERIOL, V176, P656, DOI 10.1128/jb.176.3.656-664.1994; WINKLER RG, 1988, PLANT PHYSIOL, V86, P1084, DOI 10.1104/pp.86.4.1084; Wong KH, 2008, EUKARYOT CELL, V7, P917, DOI 10.1128/EC.00076-08; Wong S, 2005, NAT GENET, V37, P777, DOI 10.1038/ng1584; WU XW, 1994, P NATL ACAD SCI USA, V91, P742, DOI 10.1073/pnas.91.2.742; Xue CY, 2007, CELL HOST MICROBE, V1, P263, DOI 10.1016/j.chom.2007.05.005; Zanotti G, 2006, J MOL BIOL, V363, P1, DOI 10.1016/j.jmb.2006.07.079	68	27	27	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e64292	10.1371/journal.pone.0064292	http://dx.doi.org/10.1371/journal.pone.0064292			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667704	Green Submitted, Green Published, gold			2022-12-25	WOS:000319654700206
J	Li, LX; Chen, L; Meng, XZ; Chen, BH; Chen, SQ; Zhao, Y; Zhao, LF; Liang, Y; Zhang, YH				Li, Lu-Xi; Chen, Li; Meng, Xiang-Zhou; Chen, Bing-Heng; Chen, Shang-Qin; Zhao, Yan; Zhao, Li-Fang; Liang, Yuan; Zhang, Yun-Hui			Exposure Levels of Environmental Endocrine Disruptors in Mother-Newborn Pairs in China and Their Placental Transfer Characteristics	PLOS ONE			English	Article							POLYBROMINATED DIPHENYL ETHERS; UMBILICAL-CORD BLOOD; BROMINATED FLAME RETARDANTS; BREAST-MILK; PHTHALATE METABOLITES; MATERNAL SERUM; ADIPOSE-TISSUE; CHEMICALS; PBDE; POPULATION	There is a growing concern about the potential health effects of exposure to various environmental chemicals during pregnancy and infancy. The placenta is expected to be an effective barrier protecting the developing embryo against some endocrine disruptors (EDs) circulating in maternal blood. The current study was designed to assess in utero exposure levels of non-persistent organic pollutants (non-POPs) and persistent organic pollutants (POPs) in Chinese newborns and potential role of placenta barrier against fetal exposure to these commonly-used environmental endocrine disruptors. A total of 230 newborn-mother pairs were enrolled during 2010-2011, 201 pairs of which were recruited from Shanghai, and the other 29 pairs came from Wenzhou. Maternal blood, cord blood, and meconium specimens were collected in the subject population from Shanghai and analyzed for non-POPs, including mono-2-ethylhexyl phthalate (MEHP), octylphenol (OP) and 4-nonylphenol (4-NP). A total of 19 polybrominated diphenyl ethers (PBDEs) congeners, which belong to POPs, were detected in maternal and cord blood specimens from the other 29 pairs. Fetal-maternal ratios (F-M ratios) and regression coefficients were presented to assess potential function of placenta on barricading the mother/fetal transfer of these EDs. Concentrations of the detected non-POPs in cord blood samples were approximately 20% lower than those in maternal blood, and regression coefficients of which were all over 0.80. In contrast, PBDEs levels in cord blood samples were significantly higher than those in maternal blood. MEHP levels in meconium were much higher than those in cord blood samples, and highly correlated. Therefore, observations demonstrated that the placental barrier slightly decreased the fetal exposure to most non-POPs, while PBDEs seemed to be totally transferred across the placenta and finally reached the fetus. For in utero exposure assessment of Di-2-ethylhexyl phthalate (DEHP), MEHP level in meconium may be a useful biomarker.	[Li, Lu-Xi; Chen, Li; Chen, Bing-Heng; Zhao, Yan; Zhang, Yun-Hui] Fudan Univ, Sch Publ Hlth, Minist Educ, Key Lab Publ Hlth Safety, Shanghai 200433, Peoples R China; [Meng, Xiang-Zhou; Zhao, Li-Fang] Tongji Univ, Coll Environm Sci & Engn, State Key Lab Pollut Control & Resources Reuse, Shanghai 200092, Peoples R China; [Chen, Shang-Qin; Liang, Yuan] Wenzhou Med Coll, Affiliated Hosp 2, Wenzhou, Peoples R China	Fudan University; Tongji University; Wenzhou Medical University	Zhang, YH (corresponding author), Fudan Univ, Sch Publ Hlth, Minist Educ, Key Lab Publ Hlth Safety, Shanghai 200433, Peoples R China.	yhzhang@shmu.edu.cn			Natural Science Foundation of China [81072263]; Shanghai Natural Science Foundation [10ZR1402000]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai)	This research was financially supported by the Natural Science Foundation of China (Grant 81072263, to Y.Z.) and Shanghai Natural Science Foundation (Grant 10ZR1402000, to Y.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antignac JP, 2009, ENVIRON POLLUT, V157, P164, DOI 10.1016/j.envpol.2008.07.008; Calafat AM, 2006, CHEMOSPHERE, V63, P490, DOI 10.1016/j.chemosphere.2005.08.028; Chao HR, 2007, ENVIRON INT, V33, P239, DOI 10.1016/j.envint.2006.09.013; Chen ML, 2008, CHEMOSPHERE, V73, pS239, DOI 10.1016/j.chemosphere.2007.04.091; Chen ML, 2008, ENVIRON INT, V34, P79, DOI 10.1016/j.envint.2007.07.004; Duan YP, 2010, ENVIRON SCI POLLUT R, V17, P948, DOI 10.1007/s11356-010-0295-1; Fay M, 1999, TOXICOL IND HEALTH, V15, P651, DOI 10.1177/074823379901500801; Feeley M, 2000, FOOD ADDIT CONTAM, V17, P325, DOI 10.1080/026520300283397; Foster WG, 2011, CHEMOSPHERE, V84, P1301, DOI 10.1016/j.chemosphere.2011.05.028; Frederiksen M, 2010, INT J HYG ENVIR HEAL, V213, P233, DOI 10.1016/j.ijheh.2010.04.008; Gomara B, 2007, ENVIRON SCI TECHNOL, V41, P6961, DOI 10.1021/es0714484; Guvenius DM, ENV HLTH PERSPECT, V111, P1235; Hale RC, 2002, CHEMOSPHERE, V46, P729, DOI 10.1016/S0045-6535(01)00237-5; Herbstman JB, 2010, ENVIRON HEALTH PERSP, V118, P712, DOI 10.1289/ehp.0901340; Hogberg J, 2008, ENVIRON HEALTH PERSP, V116, P334, DOI 10.1289/ehp.10788; Kang CS, 2010, CHEMOSPHERE, V80, P116, DOI 10.1016/j.chemosphere.2010.04.009; Kasper-Sonnenberg M, 2012, INT J HYG ENVIR HEAL, V215, P373, DOI 10.1016/j.ijheh.2011.09.004; Kato K, 2006, ANAL CHEM, V78, P6651, DOI 10.1021/ac0608220; Kawaguchi M, 2004, J CHROMATOGR B, V799, P119, DOI 10.1016/j.jchromb.2003.10.021; Kawashiro Y, 2008, ENDOCR J, V55, P1071, DOI 10.1507/endocrj.K08E-155; Kim TH, 2009, J TOXICOL ENV HEAL A, V72, P1318, DOI 10.1080/15287390903212436; Koo HJ, 2004, J TOXICOL ENV HEAL A, V67, P1901, DOI 10.1080/15287390490513300; La Guardia MJ, 2006, ENVIRON SCI TECHNOL, V40, P6247, DOI 10.1021/es060630m; Lee SK, 2005, J TOXICOL ENV HEAL A, V68, P763, DOI 10.1080/15287390590930243; Lin S, 2011, CHEMOSPHERE, V82, P947, DOI 10.1016/j.chemosphere.2010.10.073; Mai BX, 2005, ENVIRON SCI TECHNOL, V39, P3521; Mazdai A, 2003, ENVIRON HEALTH PERSP, V111, P1249, DOI 10.1289/ehp.6146; Meijer L, 2008, ENVIRON SCI TECHNOL, V42, P3428, DOI 10.1021/es702446p; Miller KP, 2004, TOXICOL APPL PHARM, V198, P111, DOI 10.1016/j.taap.2003.07.016; Silva MJ, 2004, B ENVIRON CONTAM TOX, V72, P1226, DOI 10.1007/s00128-004-0374-4; Silva MJ, 2003, ARCH TOXICOL, V77, P561, DOI 10.1007/s00204-003-0486-3; Tan BLL, 2003, TALANTA, V61, P385, DOI 10.1016/S0039-9140(03)00281-9; Unuvar T, 2012, J CLIN RES PEDIATR E, V4, P51, DOI [10.4274/Jcrpe.569, 10.4274/jcrpe.569]; Vizcaino E, 2011, ENVIRON INT, V37, P152, DOI 10.1016/j.envint.2010.08.011; WILLIAMS CM, 1986, HUM NUTR-CLIN NUTR, V40C, P15; Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P319, DOI 10.1016/j.ijheh.2007.01.037; Wu KS, 2010, ENVIRON SCI TECHNOL, V44, P813, DOI 10.1021/es9024518; Zeng F, 2009, J HAZARD MATER, V164, P1171, DOI 10.1016/j.jhazmat.2008.09.029; Zhu LY, 2009, ENVIRON SCI TECHNOL, V43, P6963, DOI 10.1021/es901296t	39	77	84	4	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62526	10.1371/journal.pone.0062526	http://dx.doi.org/10.1371/journal.pone.0062526			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667484	Green Published, Green Submitted, gold			2022-12-25	WOS:000319654700042
J	Torella, A; Fanin, M; Mutarelli, M; Peterle, E; Blanco, FD; Rispoli, R; Savarese, M; Garofalo, A; Piluso, G; Morandi, L; Ricci, G; Siciliano, G; Angelini, C; Nigro, V				Torella, Annalaura; Fanin, Marina; Mutarelli, Margherita; Peterle, Enrico; Blanco, Francesca Del Vecchio; Rispoli, Rossella; Savarese, Marco; Garofalo, Arcomaria; Piluso, Giulio; Morandi, Lucia; Ricci, Giulia; Siciliano, Gabriele; Angelini, Corrado; Nigro, Vincenzo			Next-Generation Sequencing Identifies Transportin 3 as the Causative Gene for LGMD1F	PLOS ONE			English	Article							GIRDLE MUSCULAR-DYSTROPHY; PROTEIN; MUTATIONS; DOMAIN; VARIANTS; RECEPTOR; DATABASE; SR	Limb-girdle muscular dystrophies (LGMD) are genetically and clinically heterogeneous conditions. We investigated a large family with autosomal dominant transmission pattern, previously classified as LGMD1F and mapped to chromosome 7q32. Affected members are characterized by muscle weakness affecting earlier the pelvic girdle and the ileopsoas muscles. We sequenced the whole exome of four family members and identified a shared heterozygous frame-shift variant in the Transportin 3 (TNPO3) gene, encoding a member of the importin-beta super-family. The TNPO3 gene is mapped within the LGMD1F critical interval and its 923-amino acid human gene product is also expressed in skeletal muscle. In addition, we identified an isolated case of LGMD with a new missense mutation in the same gene. We localized the mutant TNPO3 around the nucleus, but not inside. The involvement of gene related to the nuclear transport suggests a novel disease mechanism leading to muscular dystrophy.	[Torella, Annalaura; Mutarelli, Margherita; Rispoli, Rossella; Savarese, Marco; Nigro, Vincenzo] TIGEM Telethon Inst Genet & Med, Naples, Italy; [Torella, Annalaura; Blanco, Francesca Del Vecchio; Savarese, Marco; Garofalo, Arcomaria; Piluso, Giulio; Nigro, Vincenzo] Univ Naples 2, Dipartimento Biochim Biofis & Patol Gen, Naples, Italy; [Fanin, Marina; Peterle, Enrico; Angelini, Corrado] Univ Padua, Dipartimento Neurosci, Padua, Italy; [Rispoli, Rossella] Canc Res UK, London, England; [Morandi, Lucia] Fdn IRCCS Ist Neurol C Besta, Milan, Italy; [Ricci, Giulia; Siciliano, Gabriele] Univ Pisa, Dipartimento Med Clin & Sperimentale, Pisa, Italy; [Angelini, Corrado] IRCSS S Camillo, Venice, Italy	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Universita della Campania Vanvitelli; University of Padua; Cancer Research UK; IRCCS Istituto Neurologico Besta; University of Pisa; IRCCS Ospedale San Camillo	Nigro, V (corresponding author), TIGEM Telethon Inst Genet & Med, Naples, Italy.	vincenzo.nigro@unina2.it	Nigro, Vincenzo/AAB-2274-2022; Ricci, Giulia/K-6731-2016; Mutarelli, Margherita/K-1910-2019; Angelini, Corrado I/J-3655-2019; PILUSO, Giulio/AAA-3400-2019; Piluso, Giulio/AAA-3661-2019; Savarese, Marco/J-8307-2016	Ricci, Giulia/0000-0002-6612-5995; Angelini, Corrado I/0000-0002-9554-8794; PILUSO, Giulio/0000-0001-9418-125X; Savarese, Marco/0000-0002-2591-244X; Torella, Annalaura/0000-0003-2479-6018; Nigro, Vincenzo/0000-0002-3378-5006; Mutarelli, Margherita/0000-0002-2168-5059	Telethon, Italy [TGM11Z06, GTB12001]; Telethon-UILDM (Unione Italiana Lotta alla Distrofia Muscolare) [GUP 10006, GUP11006]; Association Francaise contre les Myopathies [13859, 14999/16216]; TIGEM Bioinformatics Core; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UC2HL102923, RC2HL102926, RC2HL102924, RC2HL103010, RC2HL102925, UC2HL102925, UC2HL103010, RC2HL102923, UC2HL102926, UC2HL102924] Funding Source: NIH RePORTER	Telethon, Italy(Fondazione Telethon); Telethon-UILDM (Unione Italiana Lotta alla Distrofia Muscolare)(Fondazione Telethon); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); TIGEM Bioinformatics Core; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was mainly supported by grants from Telethon, Italy (TGM11Z06 to V.N. and GTB12001 to C.A.) and Telethon-UILDM (Unione Italiana Lotta alla Distrofia Muscolare) (GUP 10006 and GUP11006 to V.N.). This work was also supported by grants from the Association Francaise contre les Myopathies (13859 to M.F. and 14999/16216 to C.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all the patients and their families for their contribution to this work. We acknowledge the Neuromuscular Bank of Tissues and DNA samples (NMTB) for collecting samples (C.A. and M.F.), Stefania Crispi and Luigi Leone at the IGB Facility of Next Generation Sequencing using the SOLID platform, and Anna Cuomo and Rosalba Erpice for Sanger sequencing. The authors would like to thank the NHLBI GO Exome Sequencing Project and its ongoing studies which produced and provided exome variant calls for comparison: the Lung GO Sequencing Project (HL-102923), the WHI Sequencing Project (HL-102924), the Broad GO Sequencing Project (HL-102925), the Seattle GO Sequencing Project (HL-102926) and the Heart GO Sequencing Project (HL-103010). We also thank Gopuraja Dharmalingam and the TIGEM Bioinformatics Core for support in exome data analysis and Giuseppina Di Fruscio for the analysis of isolated cases of LGMD and Marina Mora for helpful suggestions.	Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Cenacchi G, 2012, NEUROPATHOLOGY; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Fanin M, 2009, NEUROLOGY, V72, P1432, DOI 10.1212/WNL.0b013e3181a1885e; Gamez J, 2001, NEUROLOGY, V56, P450, DOI 10.1212/WNL.56.4.450; Goode DL, 2010, GENOME RES, V20, P301, DOI 10.1101/gr.102210.109; Harms MB, 2012, ANN NEUROL, V71, P407, DOI 10.1002/ana.22683; Hirschfield GM, 2010, NAT GENET, V42, P655, DOI 10.1038/ng.631; Kataoka N, 1999, J CELL BIOL, V145, P1145, DOI 10.1083/jcb.145.6.1145; Kley RA, 2012, BRAIN, V135, P2642, DOI 10.1093/brain/aws200; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lai MC, 2000, J BIOL CHEM, V275, P7950, DOI 10.1074/jbc.275.11.7950; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; Logue EC, 2011, J VIROL, V85, P12950, DOI 10.1128/JVI.05384-11; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Mercuri E, 2005, NEUROMUSCULAR DISORD, V15, P164, DOI 10.1016/j.nmd.2004.10.008; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Nigro V, 2003, Acta Myol, V22, P35; Nigro V, 2011, CURR OPIN NEUROL, V24, P429, DOI 10.1097/WCO.0b013e32834aa38d; Palenzuela L, 2003, NEUROLOGY, V61, P404, DOI 10.1212/01.WNL.0000073984.46546.4F; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Pollard VW, 1996, CELL, V86, P985, DOI 10.1016/S0092-8674(00)80173-7; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Sarparanta J, 2012, NAT GENET, V44, P450, DOI 10.1038/ng.1103; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shamsher MK, 2002, P NATL ACAD SCI USA, V99, P14195, DOI 10.1073/pnas.212518199; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; ten Dam L, 2012, NEUROLOGY, V79, P1716, DOI 10.1212/WNL.0b013e31826e9b73; Thorvaldsdottir H, 2012, BRIEF BIOINFORM; Vorgerd M, 2005, AM J HUM GENET, V77, P297, DOI 10.1086/431959; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wattjes MP, 2010, EUR RADIOL, V20, P2447, DOI 10.1007/s00330-010-1799-2	35	47	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63536	10.1371/journal.pone.0063536	http://dx.doi.org/10.1371/journal.pone.0063536			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667635	Green Published, Green Submitted, gold			2022-12-25	WOS:000319654700159
J	Rosado, LA; Vasconcelos, IB; Palma, MS; Frappier, V; Najmanovich, RJ; Santos, DS; Basso, LA				Rosado, Leonardo Astolfi; Vasconcelos, Igor Bordin; Palma, Mario Sergio; Frappier, Vincent; Najmanovich, Rafael Josef; Santos, Diogenes Santiago; Basso, Luiz Augusto			The Mode of Action of Recombinant Mycobacterium tuberculosis Shikimate Kinase: Kinetics and Thermodynamics Analyses	PLOS ONE			English	Article							HEAT-CAPACITY; CRYSTAL-STRUCTURE; LIGAND-BINDING; PATHWAY; ENZYMES; ACID; GENOME; QUANTITIES; MAGNESIUM; PROTEINS	Tuberculosis remains as one of the main cause of mortality worldwide due to a single infectious agent, Mycobacterium tuberculosis. The aroK-encoded M. tuberculosis Shikimate Kinase (MtSK), shown to be essential for survival of bacilli, catalyzes the phosphoryl transfer from ATP to the carbon-3 hydroxyl group of shikimate (SKH), yielding shikimate-3-phosphate and ADP. Here we present purification to homogeneity, and oligomeric state determination of recombinant MtSK. Biochemical and biophysical data suggest that the chemical reaction catalyzed by monomeric MtSK follows a rapid-equilibrium random order of substrate binding, and ordered product release. Isothermal titration calorimetry (ITC) for binding of ligands to MtSK provided thermodynamic signatures of non-covalent interactions to each process. A comparison of steady-state kinetics parameters and equilibrium dissociation constant value determined by ITC showed that ATP binding does not increase the affinity of MtSK for SKH. We suggest that MtSK would more appropriately be described as an aroL-encoded type II shikimate kinase. Our manuscript also gives thermodynamic description of SKH binding to MtSK and data for the number of protons exchanged during this bimolecular interaction. The negative value for the change in constant pressure heat capacity (Delta C-p) and molecular homology model building suggest a pronounced contribution of desolvation of non-polar groups upon binary complex formation. Thermodynamic parameters were deconvoluted into hydrophobic and vibrational contributions upon MtSK:SKH binary complex formation. Data for the number of protons exchanged during this bimolecular interaction are interpreted in light of a structural model to try to propose the likely amino acid side chains that are the proton donors to bulk solvent following MtSK:SKH complex formation.	[Rosado, Leonardo Astolfi; Vasconcelos, Igor Bordin; Santos, Diogenes Santiago; Basso, Luiz Augusto] Pontificia Univ Catolica Rio Grande do Sul, INCT TB, CPBMF, Porto Alegre, RS, Brazil; [Santos, Diogenes Santiago; Basso, Luiz Augusto] Pontificia Univ Catolica Rio Grande do Sul, Programa Posgrad Med & Ciencias Saude, Porto Alegre, RS, Brazil; [Rosado, Leonardo Astolfi; Vasconcelos, Igor Bordin; Santos, Diogenes Santiago; Basso, Luiz Augusto] Pontificia Univ Catolica Rio Grande do Sul, Programa Posgrad Biol Celular & Mol, Porto Alegre, RS, Brazil; [Palma, Mario Sergio] Univ Estadual Paulista UNESP, Inst Biociencias Rio Claro, Ctr Estudos Insetos Sociais, Lab Biol Estrutural & Zooquim,Dept Biol, Rio Claro, SP, Brazil; [Frappier, Vincent; Najmanovich, Rafael Josef] Univ Sherbrooke, Fac Med, Dept Biochem, Sherbrooke, PQ, Canada	Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Universidade Estadual Paulista; University of Sherbrooke	Santos, DS (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, INCT TB, CPBMF, Porto Alegre, RS, Brazil.	diogenes@pucrs.br; luiz.basso@pucrs.br	Palma, Mario/N-3903-2019; Basso, Luiz Augusto/T-9308-2019; Fapesp, Biota/F-8655-2017; Palma, Mario Sergio/E-7800-2012; Tuberculose, Inct/K-2302-2013	Basso, Luiz Augusto/0000-0003-0903-2407; Fapesp, Biota/0000-0002-9887-8449; Palma, Mario Sergio/0000-0002-7363-8211; Najmanovich, Rafael/0000-0002-6971-7224; Astolfi Rosado, Leonardo/0000-0002-4349-0244	Decit/SCTIE/MS-MCT-CNPq-FNDCT-CAPES; FAPERGS-CNPq-PRONEX-2009; National Research Council of Brazil (CNPq) [520182/99-5, 304051/1975-06, 500079/90-0]; CNPq	Decit/SCTIE/MS-MCT-CNPq-FNDCT-CAPES; FAPERGS-CNPq-PRONEX-2009; National Research Council of Brazil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by funds awarded by Decit/SCTIE/MS-MCT-CNPq-FNDCT-CAPES to National Institute of Science and Technology on Tuberculosis (INCT-TB) to D.S.S. and L.A.B. L.A.B. and D.S.S. also acknowledge financial support awarded by FAPERGS-CNPq-PRONEX-2009. L.A.B. (CNPq, 520182/99-5), D.S.S. (CNPq, 304051/1975-06), and M.S.P. (CNPq, 500079/90-0) are Research Career Awardees of the National Research Council of Brazil (CNPq). R.J.N. is part of Centre de Recherche Clinique Etienne-Le Bel and a member of the Institut de Pharmacologie de Sherbrooke and PROTEO, the Quebec network for research on protein function, structure and engineering. L.A.R. has been supported by a scholarship awarded by CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almonacid DE, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000700; [Anonymous], 2010, MULTIDRUG EXTENSIVEL; Balganesh TS, 2008, TRENDS PHARMACOL SCI, V29, P576, DOI 10.1016/j.tips.2008.08.001; BENTLEY R, 1990, CRIT REV BIOCHEM MOL, V25, P307, DOI 10.3109/10409239009090615; Dias MVB, 2007, ACTA CRYSTALLOGR F, V63, P1, DOI 10.1107/S1744309106046823; Bianconi ML, 2007, BIOPHYS CHEM, V126, P59, DOI 10.1016/j.bpc.2006.05.017; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Campbell SA, 2004, INT J PARASITOL, V34, P5, DOI 10.1016/j.ijpara.2003.10.006; Chassaigne H, 1998, ANALYST, V123, P2125, DOI 10.1039/a804713h; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cook PF, 2007, GARLAND SCI, P19; Cooper A, 2005, BIOPHYS CHEM, V115, P89, DOI 10.1016/j.bpc.2004.12.011; Dhaliwal B, 2004, FEBS LETT, V574, P49, DOI 10.1016/j.febslet.2004.08.005; Ducati RG, 2007, CURR DRUG TARGETS, V8, P423, DOI 10.2174/138945007780059004; EDMAN P, 1967, EUR J BIOCHEM, V1, P80, DOI 10.1111/j.1432-1033.1967.tb00047.x; Edsall JT, 1935, J AM CHEM SOC, V57, P1506, DOI 10.1021/ja01311a501; Engel P.C., 1977, ENZYME KINETICS; ESWAR N, 2006, CURR PROTOC BIOINF S, V15; Fukada H, 1998, PROTEINS, V33, P159, DOI 10.1002/(SICI)1097-0134(19981101)33:2<159::AID-PROT2>3.3.CO;2-F; Gan JH, 2006, BIOCHEMISTRY-US, V45, P8539, DOI 10.1021/bi0606290; GILL SJ, 1976, P NATL ACAD SCI USA, V73, P2955, DOI 10.1073/pnas.73.9.2955; Goldberg RN, 2002, J PHYS CHEM REF DATA, V31, P231, DOI 10.1063/1.1416902; Gu YJ, 2002, J MOL BIOL, V319, P779, DOI 10.1016/S0022-2836(02)00339-X; Gurney R.W., 1953, IONIC PROCESSES SOLU; Hartmann MD, 2006, J MOL BIOL, V364, P411, DOI 10.1016/j.jmb.2006.09.001; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HIREL PH, 1989, P NATL ACAD SCI USA, V86, P8247, DOI 10.1073/pnas.86.21.8247; Irudayam SJ, 2009, J PHYS CHEM B, V113, P5871, DOI 10.1021/jp809968p; Jencks W. P., 1975, CATALYSIS CHEM ENZYM; KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7; Keeling PJ, 1999, NATURE, V397, P219, DOI 10.1038/16618; Krell T, 2001, PROTEIN SCI, V10, P1137, DOI 10.1110/ps.52501; Ladbury JE, 2010, NAT REV DRUG DISCOV, V9, P23, DOI 10.1038/nrd3054; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Maguire ME, 2002, BIOMETALS, V15, P203, DOI 10.1023/A:1016058229972; McConkey BJ, 2002, BIOINFORMATICS, V18, P1365, DOI 10.1093/bioinformatics/18.10.1365; McConkey GA, 2004, TRENDS PARASITOL, V20, P60, DOI 10.1016/j.pt.2003.11.001; McConkey GA, 1999, ANTIMICROB AGENTS CH, V43, P175, DOI 10.1128/AAC.43.1.175; McFadden GI, 1996, NATURE, V381, P482, DOI 10.1038/381482a0; MILLAR G, 1986, BIOCHEM J, V237, P427, DOI 10.1042/bj2370427; O'Brien R, 2004, BIOCALORIMETRY 2 APP; Oliveira JS, 2001, PROTEIN EXPRES PURIF, V22, P430, DOI 10.1006/prep.2001.1457; Parish T, 2002, MICROBIOL-SGM, V148, P3069, DOI 10.1099/00221287-148-10-3069; Pereira JH, 2004, ACTA CRYSTALLOGR D, V60, P2310, DOI 10.1107/S090744490402517X; PITTARD AJ, 1996, ESCHERICHIA COLI SAL; Roberts CW, 2002, J INFECT DIS, V185, pS25, DOI 10.1086/338004; Roberts F, 1998, NATURE, V393, P801, DOI 10.1038/31723; Robertson JG, 2007, CURR OPIN STRUC BIOL, V17, P674, DOI 10.1016/j.sbi.2007.08.008; Robertson JG, 2005, BIOCHEMISTRY-US, V44, P5561, DOI 10.1021/bi050247e; Segel IH., 1993, ENZYME KINETICS BEHA; Starcevic A, 2008, P NATL ACAD SCI USA, V105, P2533, DOI 10.1073/pnas.0707388105; STURTEVANT JM, 1977, P NATL ACAD SCI USA, V74, P2236, DOI 10.1073/pnas.74.6.2236; TAKAHASHI K, 1985, BIOCHEMISTRY-US, V24, P297, DOI 10.1021/bi00323a009; Velayati AA, 2009, EUR RESPIR J, V34, P1202, DOI 10.1183/09031936.00081909; VONRHEIN C, 1995, STRUCTURE, V3, P483, DOI 10.1016/S0969-2126(01)00181-2; Weber G, 1975, Adv Protein Chem, V29, P1, DOI 10.1016/S0065-3233(08)60410-6; WHIPP MJ, 1995, J BACTERIOL, V177, P1627, DOI 10.1128/jb.177.6.1627-1629.1995; WHO, 2010, GLOB TUB CONTR 2010; Zhang YJ, 2006, CURR OPIN CHEM BIOL, V10, P658, DOI 10.1016/j.cbpa.2006.09.020	59	11	11	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e61918	10.1371/journal.pone.0061918	http://dx.doi.org/10.1371/journal.pone.0061918			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671579	Green Published, Green Submitted, gold			2022-12-25	WOS:000321390200012
J	Medjkane, S; Perichon, M; Marsolier, J; Dairou, J; Weitzman, JB				Medjkane, S.; Perichon, M.; Marsolier, J.; Dairou, J.; Weitzman, J. B.			Theileria induces oxidative stress and HIF1 alpha activation that are essential for host leukocyte transformation	ONCOGENE			English	Article						leukocyte transformation; Warburg effect; metabolism; Theileria; host-parasite interactions	GLUCOSE-METABOLISM; CANCER; CELLS; ANNULATA; PARVA; HIF-1; TUMOR; SURVIVAL; HYPOXIA; GROWTH	Complex links between infection and cancer suggest that we still can learn much about tumorigenesis by studying how infectious agents hijack the host cell machinery. We studied the effects of an intracellular parasite called Theileria that infects bovine leukocytes and turns them into invasive cancer-like cells. We investigated the host cells pathways that are deregulated in infected leukocytes and might link infection and lymphoproliferative disease. We show that intracellular Theileria parasites drive a Warburg-like phenotype in infected host leukocytes, characterized by increased expression of metabolic regulators, increased glucose uptake and elevated lactate production, which were lost when the parasite was eliminated. The cohabitation of the parasites within the host cells leads to disruption of the redox balance (as measured by reduced/oxidized glutathione ratio) and elevated ROS (reactive oxygen species) levels, associated with chronic stabilization of the hypoxia-inducible factor 1 alpha (HIF1 alpha). Inhibition of HIF1 alpha (pharmacologically or genetically), or treatment with antioxidants, led to a marked reduction in expression of aerobic glycolytic genes and inhibited the transformed phenotype. These data show that stabilization of HIF1a, following increased ROS production, modulates host glucose metabolism and is critical for parasite-induced transformation. Our study expands knowledge about the molecular strategy used by the parasite Theileria to induce the transformed phenotypes of infected cells via reprogramming of glucose metabolism and redox signaling.	[Medjkane, S.; Perichon, M.; Marsolier, J.; Weitzman, J. B.] Univ Paris Diderot, Sorbonne Paris Cite, UMR 7216 CNRS, F-75013 Paris, France; [Dairou, J.] Univ Paris Diderot, Sorbonne Paris Cite, Lab Biol Fonctionnelle & Adaptat, Equipe RMCX, F-75013 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Weitzman, JB (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, UMR 7216 CNRS, Batiment Lamarck,35 Rue Helene Brion, F-75013 Paris, France.	jonathan.weitzman@univ-paris-diderot.fr		Marsolier, Justine/0000-0001-8464-9306; Medjkane, Souhila/0000-0001-7973-7707	Association pour la Recherche contre le Cancer (ARC) [4975, 7990]; Association for International Cancer Research (AICR) [08-0111]; appel d'offre 'Actions Specifiques Universite Paris Diderot	Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); Association for International Cancer Research (AICR); appel d'offre 'Actions Specifiques Universite Paris Diderot	We thank Slimane Ait-Si-Ali and Pierre-Antoine Defossez for critical reading of the manuscript and members of the UMR 7216 for helpful discussions. We thank Gordon Langsley for the generous gift of reagents, the Theileria-infected cell lines, the AP1-Luciferase reporter and for helpful discussions about our work. We thank Peter Staller (Biotech Research & Innovation Center, Denmark) for kindly providing the 5xHRE-luciferase constructs and Sebastien Jauliac for providing the NF-kappa B-Luciferase reporter. We also thank the Bioprofiler facility (Universite Paris Diderot) for HPLC analysis. We thank Ayad Eddaoudi (Institute of Child Health, London, UK) for expert technical support in flow cytometry analysis. This work was supported by grants from the Association pour la Recherche contre le Cancer (ARC no. 4975 and 7990) (JBW), the Association for International Cancer Research (AICR, no. 08-0111) (JBW) and appel d'offre 'Actions Specifiques 2012' Universite Paris Diderot. All infected bovine cell lines used in this study have been previously characterized and published.	Ballatori N, 2009, BIOL CHEM, V390, P191, DOI 10.1515/BC.2009.033; Baumgartner M, 2000, CELL MICROBIOL, V2, P329, DOI 10.1046/j.1462-5822.2000.00062.x; Chaussepied M, 1996, RES IMMUNOL, V147, P127, DOI 10.1016/0923-2494(96)83165-8; Chaussepied M, 1998, MOL BIOCHEM PARASIT, V94, P215, DOI 10.1016/S0166-6851(98)00070-X; Chaussepied M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001197; Dang CV, 1999, TRENDS BIOCHEM SCI, V24, P68, DOI 10.1016/S0968-0004(98)01344-9; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Dessauge G, 2005, ONCOGENE, V24, P1075, DOI 10.1038/sj.onc.1208314; Dobbelaere D, 1999, ANNU REV MICROBIOL, V53, P1, DOI 10.1146/annurev.micro.53.1.1; DOBBELAERE DAE, 1988, P NATL ACAD SCI USA, V85, P4730, DOI 10.1073/pnas.85.13.4730; Dobbelaere DAE, 2003, CURR OPIN MICROBIOL, V6, P377, DOI 10.1016/S1369-5274(03)00085-7; Favier J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007094; Fruehauf JP, 2007, CLIN CANCER RES, V13, P789, DOI 10.1158/1078-0432.CCR-06-2082; Galley Y, 1997, P NATL ACAD SCI USA, V94, P5119, DOI 10.1073/pnas.94.10.5119; Gao P, 2007, CANCER CELL, V12, P230, DOI 10.1016/j.ccr.2007.08.004; Gatenby RA, 2006, CANCER RES, V66, P5216, DOI 10.1158/0008-5472.CAN-05-4193; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gillies RJ, 2008, J NUCL MED, V49, p24S, DOI 10.2967/jnumed.107.047258; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; HUDSON AT, 1985, PARASITOLOGY, V90, P45, DOI 10.1017/S0031182000049003; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Lizundia R, 2006, CANCER RES, V66, P6105, DOI 10.1158/0008-5472.CAN-05-3861; Lopez-Lazaro M, 2007, CANCER LETT, V252, P1, DOI 10.1016/j.canlet.2006.10.029; Lopez-Lazaro M, 2007, INT J CANCER, V120, P1378, DOI 10.1002/ijc.22493; Masella R, 2005, J NUTR BIOCHEM, V16, P577, DOI 10.1016/j.jnutbio.2005.05.013; Mentis AFA, 2010, ASIAN PAC J CANCER P, V11, P1437; Moreau MF, 1999, INFECT IMMUN, V67, P6678; Muraguri GR, 1999, VET PARASITOL, V87, P25, DOI 10.1016/S0304-4017(99)00154-5; Narayanan BA, 2006, CURR CANCER DRUG TAR, V6, P711, DOI 10.2174/156800906779010218; OLOBO JO, 1989, VET IMMUNOL IMMUNOP, V20, P165, DOI 10.1016/0165-2427(89)90096-2; Poyton RO, 2009, TRENDS ENDOCRIN MET, V20, P332, DOI 10.1016/j.tem.2009.04.001; Ralph SJ, 2010, MOL ASPECTS MED, V31, P145, DOI 10.1016/j.mam.2010.02.008; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2007, J BIOENERG BIOMEMBR, V39, P231, DOI 10.1007/s10863-007-9081-2; Seyfried TN, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-7; Shaw RJ, 2006, CURR OPIN CELL BIOL, V18, P598, DOI 10.1016/j.ceb.2006.10.005; Shiels B, 2006, INT J PARASITOL, V36, P9, DOI 10.1016/j.ijpara.2005.09.002; SHIELS BR, 1986, PARASITE IMMUNOL, V8, P69, DOI 10.1111/j.1365-3024.1986.tb00834.x; Somerville RPT, 1998, PARASITOLOGY, V116, P223, DOI 10.1017/S0031182097002151; Spear W, 2006, CELL MICROBIOL, V8, P339, DOI 10.1111/j.1462-5822.2005.00628.x; THEILEN GH, 1968, JNCI-J NATL CANCER I, V40, P737; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wellen KE, 2010, MOL CELL, V40, P323, DOI 10.1016/j.molcel.2010.10.004; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Wiley M, 2010, J BIOL CHEM, V285, P26852, DOI 10.1074/jbc.M110.147041; Yeung SJ, 2008, CELL MOL LIFE SCI, V65, P3981, DOI 10.1007/s00018-008-8224-x; Zhang HF, 2008, P NATL ACAD SCI USA, V105, P19579, DOI 10.1073/pnas.0809763105	50	23	24	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 3	2014	33	14					1809	1817		10.1038/onc.2013.134	http://dx.doi.org/10.1038/onc.2013.134			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AE9RE	23665677				2022-12-25	WOS:000334345500007
J	Wiesinger, C; Kunze, M; Regelsberger, G; Forss-Petter, S; Berger, J				Wiesinger, Christoph; Kunze, Markus; Regelsberger, Guenther; Forss-Petter, Sonja; Berger, Johannes			Impaired Very Long-chain Acyl-CoA beta-Oxidation in Human X-linked Adrenoleukodystrophy Fibroblasts Is a Direct Consequence of ABCD1 Transporter Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEROXISOMAL MEMBRANE-PROTEIN; FATTY-ACIDS; SACCHAROMYCES-CEREVISIAE; SKIN FIBROBLASTS; CHILDHOOD ADRENOLEUKODYSTROPHY; ZELLWEGER-SYNDROME; EXPRESSION; LOCALIZATION; SYNTHETASE; ALDP	X-linked adrenoleukodystrophy (X-ALD), an inherited peroxisomal disorder, is caused by mutations in the ABCD1 gene encoding the peroxisomal ATP-binding cassette (ABC) transporter ABCD1 (adrenoleukodystrophy protein, ALDP). Biochemically, X-ALD is characterized by an accumulation of very long-chain fatty acids and partially impaired peroxisomal beta-oxidation. In this study, we used primary human fibroblasts from X-ALD and Zellweger syndrome patients to investigate the peroxisomal beta-oxidation defect. Our results show that the degradation of C26:0-CoA esters is as severely impaired as degradation of unesterified very long-chain fatty acids in X-ALD and is abolished in Zellweger syndrome. Interestingly, the beta-oxidation rates for both C26:0-CoA and C22:0-CoA were similarly affected, although C22:0 does not accumulate in patient fibroblasts. Furthermore, we show that the beta-oxidation defect in X-ALD is directly caused by ABCD1 dysfunction as blocking ABCD1 function with a specific antibody reduced beta-oxidation to levels observed in X-ALD fibroblasts. By quantification of mRNA and protein levels of the peroxisomal ABC transporters and by blocking with specific antibodies, we found that residual beta-oxidation activity toward C26:0-CoA in X-ALD fibroblasts is mediated by ABCD3, although the efficacy of ABCD3 appeared to be much lower than that of ABCD1. Finally, using isolated peroxisomes, we show that beta-oxidation of C26:0-CoA is independent of additional CoA but requires a cytosolic factor of >10-kDa molecular mass that is resistant to N-ethylmaleimide and heat inactivation. In conclusion, our findings in human cells suggest that, in contrast to yeast cells, very long-chain acyl-CoA esters are transported into peroxisomes by ABCD1 independently of additional synthetase activity.	[Wiesinger, Christoph; Kunze, Markus; Forss-Petter, Sonja; Berger, Johannes] Med Univ Vienna, Ctr Brain Res, A-1090 Vienna, Austria; [Regelsberger, Guenther] Med Univ Vienna, Inst Neurol, A-1097 Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Berger, J (corresponding author), Med Univ Vienna, Dept Pathobiol Nervous Syst, Ctr Brain Res, Spitalgasse 4, A-1090 Vienna, Austria.	johannes.berger@meduniwien.ac.at	Berger, Johannes/A-9122-2014	Berger, Johannes/0000-0003-0182-2658; Regelsberger, Gunther/0000-0002-3233-1491; Wiesinger, Christoph/0000-0003-1257-4522	European Union [HEALTH-F2-2010-241622]	European Union(European Commission)	This work was supported by FP7 European Union Project "LEUKOTREAT" Grant HEALTH-F2-2010-241622.	Agrimi G, 2012, BIOCHEM J, V443, P241, DOI 10.1042/BJ20111420; Antonenkov VD, 2005, CELL MOL LIFE SCI, V62, P2886, DOI 10.1007/s00018-005-5233-x; Berger J, 1999, EUR J BIOCHEM, V265, P719, DOI 10.1046/j.1432-1327.1999.00772.x; Berger J, 2010, BRAIN PATHOL, V20, P845, DOI 10.1111/j.1750-3639.2010.00393.x; Bezman L, 2001, ANN NEUROL, V49, P512, DOI 10.1002/ana.101; Braiterman LT, 1998, HUM MOL GENET, V7, P239, DOI 10.1093/hmg/7.2.239; Coelho D, 2012, NAT GENET, V44, P1152, DOI 10.1038/ng.2386; Ferrer I, 2010, BRAIN PATHOL, V20, P817, DOI 10.1111/j.1750-3639.2010.00390.x; Flavigny E, 1999, FEBS LETT, V448, P261, DOI 10.1016/S0014-5793(99)00379-8; Guimaraes CP, 2004, BBA-MOL BASIS DIS, V1689, P235, DOI 10.1016/j.bbadis.2004.04.001; HASHMI M, 1986, FEBS LETT, V196, P247, DOI 10.1016/0014-5793(86)80256-3; Hettema EH, 1996, EMBO J, V15, P3813, DOI 10.1002/j.1460-2075.1996.tb00755.x; Hillebrand M, 2007, J BIOL CHEM, V282, P26997, DOI 10.1074/jbc.M702122200; Hinz A, 2012, BIOCHEMISTRY-US, V51, P4981, DOI 10.1021/bi300128f; Hipfner DR, 1999, J BIOL CHEM, V274, P15420, DOI 10.1074/jbc.274.22.15420; Holzinger A, 1997, BIOCHEM BIOPH RES CO, V239, P261, DOI 10.1006/bbrc.1997.7391; Jia ZZ, 2007, J BIOL CHEM, V282, P20573, DOI 10.1074/jbc.M700568200; KAMIJO K, 1990, J BIOL CHEM, V265, P4534; Kashiwayama Y, 2009, EXP CELL RES, V315, P190, DOI 10.1016/j.yexcr.2008.10.031; Kemp S, 1998, NAT MED, V4, P1261, DOI 10.1038/3242; Kemp S, 2012, BBA-MOL BASIS DIS, V1822, P1465, DOI 10.1016/j.bbadis.2012.03.012; Kunze M, 2011, J BIOL CHEM, V286, P45048, DOI 10.1074/jbc.M111.301853; Langmann T, 2003, CLIN CHEM, V49, P230, DOI 10.1373/49.2.230; LAZO O, 1988, P NATL ACAD SCI USA, V85, P7647, DOI 10.1073/pnas.85.20.7647; Liu LX, 1999, J BIOL CHEM, V274, P32738, DOI 10.1074/jbc.274.46.32738; LombardPlatet G, 1996, P NATL ACAD SCI USA, V93, P1265, DOI 10.1073/pnas.93.3.1265; LOWRY OH, 1951, J BIOL CHEM, V193, P265; McGuinness MC, 2003, MOL CELL BIOL, V23, P744, DOI 10.1128/MCB.23.2.744-753.2003; Morita M, 2012, BBA-MOL BASIS DIS, V1822, P1387, DOI 10.1016/j.bbadis.2012.02.009; Moser AB, 1999, PRENATAL DIAG, V19, P46, DOI 10.1002/(SICI)1097-0223(199901)19:1<46::AID-PD501>3.0.CO;2-E; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; Netik A, 1999, HUM MOL GENET, V8, P907, DOI 10.1093/hmg/8.5.907; Ofman R, 2010, EMBO MOL MED, V2, P90, DOI 10.1002/emmm.201000061; Sanders RJ, 2005, J LIPID RES, V46, P1001, DOI 10.1194/jlr.M400510-JLR200; Sandhir R, 1998, J LIPID RES, V39, P2161; SCHUTGENS RBH, 1993, CLIN CHEM, V39, P1632; Shani N, 1996, ANN NY ACAD SCI, V804, P770, DOI 10.1111/j.1749-6632.1996.tb18697.x; SINGH H, 1987, ARCH BIOCHEM BIOPHYS, V254, P526, DOI 10.1016/0003-9861(87)90133-0; Smith BT, 2000, EXP CELL RES, V254, P309, DOI 10.1006/excr.1999.4757; Steinberg SJ, 1999, ANN NEUROL, V46, P409, DOI 10.1002/1531-8249(199909)46:3<409::AID-ANA18>3.0.CO;2-9; Troffer-Charlier N, 1998, EUR J CELL BIOL, V75, P254, DOI 10.1016/S0171-9335(98)80121-0; Unterberger U, 2007, CLIN BIOCHEM, V40, P1037, DOI 10.1016/j.clinbiochem.2007.04.015; van Roermund CWT, 2012, J BIOL CHEM, V287, P20144, DOI 10.1074/jbc.M111.332833; van Roermund CWT, 2011, BBA-MOL CELL BIOL L, V1811, P148, DOI 10.1016/j.bbalip.2010.11.010; van Roermund CWT, 2008, FASEB J, V22, P4201, DOI 10.1096/fj.08-110866; Visser WF, 2007, BIOCHEM J, V401, P365, DOI 10.1042/BJ20061352; WANDERS RJA, 1987, CLIN CHIM ACTA, V165, P321, DOI 10.1016/0009-8981(87)90177-X; WANDERS RJA, 1988, J INHERIT METAB DIS, V11, P173, DOI 10.1007/BF01804228; WATKINS PA, 1991, ARCH BIOCHEM BIOPHYS, V289, P329, DOI 10.1016/0003-9861(91)90419-J; Watkins PA, 2008, J BIOL CHEM, V283, P1773, DOI 10.1074/jbc.R700037200; Watkins PA, 2012, BBA-MOL BASIS DIS, V1822, P1411, DOI 10.1016/j.bbadis.2012.02.010	51	92	95	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					19269	19279		10.1074/jbc.M112.445445	http://dx.doi.org/10.1074/jbc.M112.445445			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23671276	Green Published, hybrid			2022-12-25	WOS:000321335800059
J	Wilson, PC; Lee, MH; Appleton, KM; El-Shewy, HM; Morinelli, TA; Peterson, YK; Luttrell, LM; Jaffa, AA				Wilson, Parker C.; Lee, Mi-Hye; Appleton, Kathryn M.; El-Shewy, Hesham M.; Morinelli, Thomas A.; Peterson, Yuri K.; Luttrell, Louis M.; Jaffa, Ayad A.			The Arrestin-selective Angiotensin AT(1) Receptor Agonist [Sar(1),Ile(4),Ile(8)]-AngII Negatively Regulates Bradykinin B-2 Receptor Signaling via AT(1)-B-2 Receptor Heterodimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KALLIKREIN-KININ SYSTEM; OXIDE-GENERATING VASODILATORS; VASCULAR SMOOTH-MUSCLE; G-PROTEIN; BETA-ARRESTIN; NITRIC-OXIDE; IN-VIVO; DIABETIC-NEPHROPATHY; HEART-FAILURE; BIASED LIGAND	The renin-angiotensin and kallikrein-kinin systems are key regulators of vascular tone and inflammation. Angiotensin II, the principal effector of the renin-angiotensin system, promotes vasoconstriction by activating angiotensin AT(1) receptors. The opposing effects of the kallikrein-kinin system are mediated by bradykinin acting on B-1 and B-2 bradykinin receptors. The renin-angiotensin and kallikrein-kinin systems engage in cross-talk at multiple levels, including the formation of AT(1)-B-2 receptor heterodimers. In primary vascular smooth muscle cells, we find that the arrestin pathway-selective AT(1) agonist, [Sar(1),Ile(4),Ile(8)]-AngII, but not the neutral AT(1) antagonist, losartan, inhibits endogenous B-2 receptor signaling. In a transfected HEK293 cell model that recapitulates this effect, we find that the actions of [Sar(1), Ile(4), Ile(8)]-AngII require the AT(1) receptor and result from arrestin-dependent co-internalization of AT(1)-B-2 heterodimers. BRET50 measurements indicate that AT(1) and B-2 receptors efficiently heterodimerize. In cells expressing both receptors, pretreatment with [Sar(1),Ile(4),Ile(8)]-AngII blunts B-2 receptor activation of G(q/11)-dependent intracellular calcium influx and G(i/o)-dependent inhibition of adenylyl cyclase. In contrast, [Sar(1),Ile(4),Ile(8)]-AngII has no effect on B-2 receptor ligand affinity or bradykinin-induced arrestin3 recruitment. Both radioligand binding assays and quantitative microscopy-based analysis demonstrate that [Sar(1),Ile(4),Ile(8)]-AngII promotes internalization of AT(1)-B-2 heterodimers. Thus, [Sar(1),Ile(4),Ile(8)]-AngII exerts lateral allosteric modulation of B-2 receptor signaling by binding to the orthosteric ligand binding site of the AT(1) receptor and promoting co-sequestration of AT(1)-B-2 heterodimers. Given the opposing roles of the renin-angiotensin and kallikrein-kinin systems in vivo, the distinct properties of arrestin pathway-selective and neutral AT(1) receptor ligands may translate into different pharmacologic actions.	[Wilson, Parker C.; Lee, Mi-Hye; El-Shewy, Hesham M.; Morinelli, Thomas A.; Luttrell, Louis M.; Jaffa, Ayad A.] Med Univ S Carolina, Coll Med, Dept Med, Charleston, SC 29425 USA; [Luttrell, Louis M.] Med Univ S Carolina, Coll Med, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Appleton, Kathryn M.; Peterson, Yuri K.] Med Univ S Carolina, Coll Pharm, Dept Pharmaceut & Biomed Sci, Charleston, SC 29425 USA; [Luttrell, Louis M.] Ralph H Johnson Vet Affairs Med Ctr, Res Serv, Charleston, SC 29401 USA; [Jaffa, Ayad A.] Amer Univ Beirut, Dept Biochem, Beirut 11072020, Lebanon; [Jaffa, Ayad A.] Amer Univ Beirut, Dept Mol Genet, Beirut 11072020, Lebanon	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; American University of Beirut; American University of Beirut	Luttrell, LM (corresponding author), Med Univ S Carolina, Dept Med, Div Endocrinol Diabet & Med Genet, 96 Jonathan Lucas St,Suite 816CSB,MSC624, Charleston, SC 29425 USA.	luttrell@musc.edu		Luttrell, Louis/0000-0003-2805-6949; Wilson, Parker/0000-0001-8647-9662	National Institutes of Health [R01 HL087986, HL077192, R01 DK55524, F30 DK083208]; National Center for Research Resources [S10 RR027777]; Research Service of the Ralph H. Johnson Veterans Affairs Medical Center; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027777] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077192, R01HL087986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK083208, R01DK055524] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Research Service of the Ralph H. Johnson Veterans Affairs Medical Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL087986 and HL077192 (to A. A. J.), R01 DK55524 (to L. M. L.), and F30 DK083208 (to P. C. W.) and National Center for Research Resources Grant S10 RR027777 (to T. A. M. and L. M. L.). This work was also supported by the Research Service of the Ralph H. Johnson Veterans Affairs Medical Center.	AbdAlla S, 2000, NATURE, V407, P94, DOI 10.1038/35024095; AbdAlla S, 2001, NAT MED, V7, P1003, DOI 10.1038/nm0901-1003; AbdAlla S, 2005, J MOL NEUROSCI, V26, P185, DOI 10.1385/JMN:26:2-3:185; Achour L, 2011, METHODS MOL BIOL, V756, P183, DOI 10.1007/978-1-61779-160-4_9; Appleton KM, 2013, METHOD ENZYMOL, V522, P229, DOI 10.1016/B978-0-12-407865-9.00013-3; Barki-Harrington L, 2003, CIRCULATION, V108, P1611, DOI 10.1161/01.CIR.0000092166.30360.78; Binkowski BF, 2011, METHODS MOL BIOL, V756, P263, DOI 10.1007/978-1-61779-160-4_14; Boerrigter G, 2012, CIRC-HEART FAIL, V5, P627, DOI 10.1161/CIRCHEARTFAILURE.112.969220; Boerrigter G, 2011, CIRC-HEART FAIL, V4, P770, DOI 10.1161/CIRCHEARTFAILURE.111.962571; Bonde MM, 2011, REGUL PEPTIDES, V167, P21, DOI 10.1016/j.regpep.2010.11.003; BRINER VA, 1993, AM J PHYSIOL, V264, pF322, DOI 10.1152/ajprenal.1993.264.2.F322; Devi LA, 2001, TRENDS PHARMACOL SCI, V22, P532, DOI 10.1016/S0165-6147(00)01799-5; Duka I, 2001, CIRC RES, V88, P275, DOI 10.1161/01.RES.88.3.275; Ernst OP, 2007, P NATL ACAD SCI USA, V104, P10859, DOI 10.1073/pnas.0701967104; GARG UC, 1989, J CLIN INVEST, V83, P1774, DOI 10.1172/JCI114081; GARG UC, 1989, AM J PHYSIOL, V257, pF60, DOI 10.1152/ajprenal.1989.257.1.F60; George SR, 2000, J BIOL CHEM, V275, P26128, DOI 10.1074/jbc.M000345200; Gul R, 2012, CARDIORENAL MED, V2, P268, DOI 10.1159/000343456; Hamdan FF, 2005, J BIOMOL SCREEN, V10, P463, DOI 10.1177/1087057105275344; Hansen JL, 2009, J BIOL CHEM, V284, P1831, DOI 10.1074/jbc.M804607200; Hermann A, 1999, IMMUNOPHARMACOLOGY, V45, P135, DOI 10.1016/S0162-3109(99)00066-1; Hunyady L, 2006, MOL ENDOCRINOL, V20, P953, DOI 10.1210/me.2004-0536; Jaffa AA, 2003, DIABETES, V52, P1215, DOI 10.2337/diabetes.52.5.1215; Jaffa MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044714; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Kenakin T, 2010, PHARMACOL REV, V62, P265, DOI 10.1124/pr.108.000992; Kichuk MR, 1996, CIRCULATION, V94, P44, DOI 10.1161/01.CIR.94.1.44; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Lee MH, 2008, J BIOL CHEM, V283, P2088, DOI 10.1074/jbc.M706892200; Leonard AP, 2013, MICROSC MICROANAL, V19, P150, DOI 10.1017/S1431927612014067; Luttrell LM, 2011, METHODS MOL BIOL, V756, P3, DOI 10.1007/978-1-61779-160-4_1; Lyngso C, 2009, MOL CELL ENDOCRINOL, V302, P203, DOI 10.1016/j.mce.2008.09.018; Maione A, 2011, NEPHROL DIAL TRANSPL, V26, P2827, DOI 10.1093/ndt/gfq792; MOMBOULI JV, 1995, ANNU REV PHARMACOL, V35, P679, DOI 10.1146/annurev.pa.35.040195.003335; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nemeth EF, 2004, J PHARMACOL EXP THER, V308, P627, DOI 10.1124/jpet.103.057273; Oliveira L, 2007, PHYSIOL REV, V87, P565, DOI 10.1152/physrev.00040.2005; Quitterer U, 2011, BIOCHEM BIOPH RES CO, V409, P544, DOI 10.1016/j.bbrc.2011.05.041; Sainz IM, 2007, THROMB HAEMOSTASIS, V98, P77, DOI 10.1160/Th07-04-0250; Sauliere A, 2012, NAT CHEM BIOL, V8, P622, DOI [10.1038/NCHEMBIO.961, 10.1038/nchembio.961]; Schmaier AH, 2003, AM J PHYSIOL-REG I, V285, pR1, DOI 10.1152/ajpregu.00535.2002; Schmaier AH, 2002, J CLIN INVEST, V109, P1007, DOI 10.1172/JCI200215490; Schmaier AH, 2008, INT IMMUNOPHARMACOL, V8, P161, DOI 10.1016/j.intimp.2007.08.022; Schremmer-Danninger E, 1998, BIOCHEM BIOPH RES CO, V243, P246, DOI 10.1006/bbrc.1997.7999; Simaan M, 2005, CELL SIGNAL, V17, P1074, DOI 10.1016/j.cellsig.2004.12.001; Siragy HM, 1997, HYPERTENSION, V29, P757, DOI 10.1161/01.HYP.29.3.757; Spillmann F, 2002, INT IMMUNOPHARMACOL, V2, P1823, DOI 10.1016/S1567-5769(02)00174-1; Tan Y, 2004, AM J PHYSIOL-HEART C, V286, pH926, DOI 10.1152/ajpheart.00757.2003; Tan Y, 2007, AM J PHYSIOL-RENAL, V293, pF1026, DOI 10.1152/ajprenal.00203.2007; Thomas WG, 2000, J BIOL CHEM, V275, P2893, DOI 10.1074/jbc.275.4.2893; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Xu ZG, 2009, NEPHROL DIAL TRANSPL, V24, P1744, DOI 10.1093/ndt/gfn703; Zaman MA, 2002, NAT REV DRUG DISCOV, V1, P621, DOI 10.1038/nrd873; Zhang Q, 2012, EXP BIOL MED, V237, P903, DOI 10.1258/ebm.2012.012032; Zimmerman B, 2009, CELL SIGNAL, V21, P103, DOI 10.1016/j.cellsig.2008.09.013	56	38	38	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18872	18884		10.1074/jbc.M113.472381	http://dx.doi.org/10.1074/jbc.M113.472381			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23661707	Green Published, hybrid			2022-12-25	WOS:000321335800025
J	Kong, GY; Du, J; Liu, YG; Meline, B; Chang, YI; Ranheim, EA; Wang, JY; Zhang, J				Kong, Guangyao; Du, Juan; Liu, Yangang; Meline, Benjamin; Chang, Yuan-I; Ranheim, Erik A.; Wang, Jinyong; Zhang, Jing			Notch1 Gene Mutations Target KRAS G12D-expressing CD8(+) Cells and Contribute to Their Leukemogenic Transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; CANCER STEM-CELLS; ONCOGENIC NRAS; T-ALL; MOLECULAR PATHOGENESIS; ACTIVATION; PATHWAYS; EVENTS; MODEL; STAGE	Acute T-cell lymphoblastic leukemia/lymphoma (T-ALL) is an aggressive hematopoietic malignancy affecting both children and adults. Previous studies of T-ALL mouse models induced by different genetic mutations have provided highly diverse results on the issues of T-cell leukemia/lymphomainitiating cells (T-LICs) and potential mechanisms contributing to T-LIC transformation. Here, we show that oncogenic Kras (Kras G12D) expressed from its endogenous locus is a potent inducer of T-ALL even in a less sensitized BALB/c background. Notch1 mutations, including exon 34 mutations and recently characterized type 1 and 2 deletions, are detected in 100% of Kras G12D-induced T-ALL tumors. Although these mutations are not detected at the pre-leukemia stage, incremental up-regulation of NOTCH1 surface expression is observed at the pre-leukemia and leukemia stages. As secondary genetic hits in the Kras G12D model, Notch1 mutations target CD8(+) T-cells but not hematopoietic stem cells to further promote T-ALL progression. Pre-leukemia T-cells without detectable Notch1 mutations do not induce T-ALL in secondary recipient mice compared with T-ALL tumor cells with Notch1 mutations. We found huge variations in T-LIC frequency and immunophenotypes of cells enriched for T-LICs. Unlike Pten deficiency-induced T-ALL, oncogenic Kras-initiated T-ALL is not associated with up-regulation of the Wnt/beta-catenin pathway. Our results suggest that up-regulation of NOTCH1 signaling, through either overexpression of surface NOTCH1 or acquired gain-of-function mutations, is involved in both T-ALL initiation and progression. Notch1 mutations and Kras G12D contribute cooperatively to leukemogenic transformation of normal T-cells.	[Kong, Guangyao; Du, Juan; Liu, Yangang; Chang, Yuan-I; Wang, Jinyong; Zhang, Jing] Univ Wisconsin Madison, McArdle Lab Canc Res, Madison, WI 53706 USA; [Meline, Benjamin] Univ Wisconsin Madison, Dept Mol & Cellular Pharmacol, Madison, WI 53706 USA; [Ranheim, Erik A.] Univ Wisconsin, Carbone Canc Ctr, Sch Med & Publ Hlth, Dept Pathol & Lab Med, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Zhang, J (corresponding author), Univ Wisconsin Madison, McArdle Lab Canc Res, Madison, WI 53706 USA.	zhang@oncology.wisc.edu	Chang, Yuan-I/AAY-1711-2021; Kong, Guangyao/L-2162-2013; Ranheim, Erik/AAY-6505-2021		National Institutes of Health from NCI [R01 CA152108, P30 CA014520]; Elsa Pardee Foundation; Greater Milwaukee Foundation; American Society of Hematology; V Foundation for Cancer Research; University of Wisconsin Carbone Cancer Center; NATIONAL CANCER INSTITUTE [R01CA152108, P30CA014520] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Elsa Pardee Foundation; Greater Milwaukee Foundation; American Society of Hematology; V Foundation for Cancer Research; University of Wisconsin Carbone Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA152108 (to J. Z.) and P30 CA014520 (to the University of Wisconsin Comprehensive Cancer Center) from NCI. This work was also supported by a research grant from the Elsa Pardee Foundation, a Shaw Scientist Award from the Greater Milwaukee Foundation, an ASH Scholar Award from the American Society of Hematology, a V Scholar Award from the V Foundation for Cancer Research, and an Investigator Initiated Grant from the University of Wisconsin Carbone Cancer Center (to J. Z.).	Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; Ashworth TD, 2010, BLOOD, V116, P5455, DOI 10.1182/blood-2010-05-286328; Bagley BN, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003034; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; BRUNNING RD, 2001, PATHOLOGY GENETICS T, P110; Chiang MY, 2008, J CLIN INVEST, V118, P3181, DOI 10.1172/JCI35090; DIETRICH WF, 1993, CELL, V75, P631, DOI 10.1016/0092-8674(93)90484-8; Du J, 2013, LEUKEMIA, V27, P754, DOI 10.1038/leu.2012.251; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Genot E, 2000, CURR OPIN IMMUNOL, V12, P289, DOI 10.1016/S0952-7915(00)00089-3; Grabher C, 2006, NAT REV CANCER, V6, P347, DOI 10.1038/nrc1880; Guo W, 2008, NATURE, V453, P529, DOI 10.1038/nature06933; Guo ZY, 2007, BLOOD, V109, P5463, DOI 10.1182/blood-2006-11-059071; Gutierrez A, 2007, CANCER CELL, V12, P411, DOI 10.1016/j.ccr.2007.10.027; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kindler T, 2008, BLOOD, V112, P3373, DOI 10.1182/blood-2008-03-147587; Li XY, 2008, J EXP MED, V205, P2851, DOI 10.1084/jem.20081561; Mansour MR, 2007, CLIN CANCER RES, V13, P6964, DOI 10.1158/1078-0432.CCR-07-1474; Parikh C, 2007, CANCER RES, V67, P7139, DOI 10.1158/0008-5472.CAN-07-0778; Perentesis JP, 2004, LEUKEMIA, V18, P685, DOI 10.1038/sj.leu.2403272; Sabnis AJ, 2009, PLOS BIOL, V7, P537, DOI 10.1371/journal.pbio.1000059; Teitell MA, 2009, ANNU REV PATHOL-MECH, V4, P175, DOI 10.1146/annurev.pathol.4.110807.092227; Uckun FM, 1997, J CLIN ONCOL, V15, P2214, DOI 10.1200/JCO.1997.15.6.2214; van Grotel M, 2008, LEUKEMIA, V22, P124, DOI 10.1038/sj.leu.2404957; Van Meter MEM, 2007, BLOOD, V109, P3945, DOI 10.1182/blood-2006-09-047530; von Lintig FC, 2000, CLIN CANCER RES, V6, P1804; Wang JY, 2011, BLOOD, V118, P368, DOI 10.1182/blood-2010-12-326058; Wang JY, 2010, BLOOD, V116, P5991, DOI 10.1182/blood-2010-04-281527; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Zhang J, 2009, BLOOD, V113, P1304, DOI 10.1182/blood-2008-01-134262; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhang XW, 1998, BLOOD, V92, P3829, DOI 10.1182/blood.V92.10.3829	32	27	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18219	18227		10.1074/jbc.M113.475376	http://dx.doi.org/10.1074/jbc.M113.475376			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23673656	hybrid, Green Published			2022-12-25	WOS:000320721900026
J	Firmat, C; Alibert, P; Losseau, M; Baroiller, JF; Schliewen, UK				Firmat, Cyril; Alibert, Paul; Losseau, Michele; Baroiller, Jean-Francois; Schliewen, Ulrich K.			Successive Invasion-Mediated Interspecific Hybridizations and Population Structure in the Endangered Cichlid Oreochromis mossambicus	PLOS ONE			English	Article							NILE TILAPIA; GENETIC-STRUCTURE; INTROGRESSIVE HYBRIDIZATION; TEMPORAL VARIATION; GENOTYPING ERRORS; NILOTICUS PISCES; LIMPOPO RIVER; MITOCHONDRIAL; HYBRIDS; EVOLUTION	Hybridization between invasive and native species accounts among the major and pernicious threats to biodiversity. The Mozambique tilapia Oreochromis mossambicus, a widely used freshwater aquaculture species, is especially imperiled by this phenomenon since it is recognized by the IUCN as an endangered taxon due to genetic admixture with O. niloticus an invasive congeneric species. The Lower Limpopo and the intermittent Changane River (Mozambique) drain large wetlands of potentially great importance for conservation of O. mossambicus, but their populations have remained unstudied until today. Therefore we aimed (1) to estimate the autochthonous diversity and population structure among genetically pure O. mossambicus populations to provide a baseline for the conservation genetics of this endangered species, (2) to quantify and describe genetic variation of the invasive populations and investigate the most likely factors influencing their spread, (3) to identify O. mossambicus populations unaffected by hybridization. Bayesian assignment tests based on 423 AFLP loci and the distribution of 36 species-specific mitochondrial haplotypes both indicate a low frequency of invasive and hybrid genotypes throughout the system, but nevertheless reveal evidence for limited expansion of two alien species (O. niloticus and O. andersonii) and their hybrids in the Lower Limpopo. O. mossambicus populations with no traces of hybridization are identified. They exhibit a significant genetic structure. This contrasts with previously published estimates and provides rather promising auspices for the conservation of O. mossambicus. Especially, parts of the Upper Changane drainage and surrounding wetlands are identified as refugial zones for O. mossambicus populations. They should therefore receive high conservation priority and could represent valuable candidates for the development of aquaculture strains based on local genetic resources.	[Firmat, Cyril; Alibert, Paul] Univ Bourgogne, UMR CNRS Biogeosci 6282, Dijon, France; [Firmat, Cyril] Norwegian Univ Sci & Technol NTNU, Dept Biol, CBD, Trondheim, Norway; [Losseau, Michele] Polana Canico A, Maputo, Mozambique; [Baroiller, Jean-Francois] UMR110 Cirad Ifremer INTREPID, Montpellier, France; [Schliewen, Ulrich K.] Bavarian State Collect Zool ZSM, Dept Ichthyol, Munich, Germany	Universite de Bourgogne; Norwegian University of Science & Technology (NTNU); CIRAD	Firmat, C (corresponding author), Univ Bourgogne, UMR CNRS Biogeosci 6282, Dijon, France.	cyril.firmat@ntnu.no	Baroiller, Jean-Francois/I-3455-2013	baroiller, jean-francois/0000-0002-0992-1725	BQR from University of Burgundy [nu2009 BQRl 01 4]; PARI grant from the Region Bourgogne [079]; Rotary International travel grant; German Academic Exchange Service (DAAD); Laboratory Biogeosciences	BQR from University of Burgundy; PARI grant from the Region Bourgogne(Region Bourgogne-Franche-Comte); Rotary International travel grant; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Laboratory Biogeosciences	This study was funded by a BQR grant nu2009 BQRl 01 4 from the University of Burgundy (www.u-bourgogne.fr), a PARI grant no079 from the Region Bourgogne (www.region-bourgogne.fr), a Rotary International travel grant, a German Academic Exchange Service (DAAD, www.daad.de) travel grant and financial support from the Laboratory Biogeosciences (http://biogeosciences.u-bourgogne.fr, Team BioME). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnese J-F, 1998, GENETICS AQUACULTURE; Agnese JF, 2008, MAR GENOM, V1, P103, DOI 10.1016/j.margen.2008.10.004; Agustin LQ, 1997, TILAPIA AQUACULTURE, P75; Allendorf FW, 2001, TRENDS ECOL EVOL, V16, P613, DOI 10.1016/S0169-5347(01)02290-X; Anderson EC, 2002, GENETICS, V160, P1217; Anderson EC, 2008, PHILOS T R SOC B, V363, P2841, DOI 10.1098/rstb.2008.0043; Angienda PO, 2011, CONSERV GENET, V12, P243, DOI 10.1007/s10592-010-0136-2; [Anonymous], 1983, TILAPIINE FISHES GEN; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Bezault E, 2012, INT J EVOLUTIONARY B, V2012, P7; Bezault E, 2012, INT J EVOLUTIONARY B, V2012, P10; Bezault E, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-102; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Brummett RE, 2009, REV FISH SCI, V17, P70, DOI 10.1080/10641260802083174; BRUMMETT RE, 2008, WORLD AQUACULTURE, V39, P46; Cambray JA., 2007, IUCN RED LIST THREAT, DOI http://doi.org/10.2305/IUCN.UK.2007.RLTS.T63338A12659743.en; Canonico GC, 2005, AQUAT CONSERV, V15, P463, DOI 10.1002/aqc.699; Consuegra S, 2011, EVOL APPL, V4, P660, DOI 10.1111/j.1752-4571.2011.00189.x; Costa-Pierce BA, 2003, BIOL INVASIONS, V5, P71, DOI 10.1023/A:1024094606326; Crispo E, 2011, BIOESSAYS, V33, P508, DOI 10.1002/bies.201000154; Crispo E, 2010, J HERED, V101, P97, DOI 10.1093/jhered/esp078; D'Amato ME, 2007, CONSERV GENET, V8, P475, DOI 10.1007/s10592-006-9186-x; DAGET J, 1981, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V3, P689; Darling JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017828; Desprez D, 2006, AQUACULTURE, V251, P231, DOI 10.1016/j.aquaculture.2005.06.024; Eknath AE, 2009, REV AQUACULT, V1, P197, DOI 10.1111/j.1753-5131.2009.01017.x; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Facon B, 2005, J EVOLUTION BIOL, V18, P524, DOI 10.1111/j.1420-9101.2005.00887.x; Facon B, 2008, CURR BIOL, V18, P363, DOI 10.1016/j.cub.2008.01.063; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; FAO Subregional Office for Southern and East Africa Harare, 2004, DROUGHT IMP MIT PREV; Firmat C, 2012, BIOL J LINN SOC, V105, P369, DOI 10.1111/j.1095-8312.2011.01802.x; Gregg RE, 1998, J FISH BIOL, V52, P1, DOI 10.1111/j.1095-8649.1998.tb01547.x; Guillot G, 2011, OPEN STAT PROBABILIT, V3, P7, DOI DOI 10.2174/1876527001103010007; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Herder F, 2008, EVOLUTION, V62, P2178, DOI 10.1111/j.1558-5646.2008.00447.x; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Hugues RH, 1992, DIRECTORY AFRICAN WE; Hulata G., 1995, Aquaculture Research, V26, P765, DOI 10.1111/j.1365-2109.1995.tb00869.x; Klett V, 2002, MOL BIOL EVOL, V19, P865, DOI 10.1093/oxfordjournals.molbev.a004144; Kumar S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-357; Lind CE, 2012, REV AQUACULT, V4, P125, DOI 10.1111/j.1753-5131.2012.01068.x; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Lowe S, 2000, COMMUNICATION; MAIR GC, 1991, THEOR APPL GENET, V82, P153, DOI 10.1007/BF00226206; Mateo D., 2004, New dimensions on farmed tilapia. Proceedings, 6th International Symposium on Tilapia in Aquaculture, Manila, Philippines, 12-16 September, 2004, P426; McKinna EM, 2010, AQUAC RES, V41, pe730, DOI 10.1111/j.1365-2109.2010.02539.x; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Moor de IJ, 1978, ATLAS ALIEN TRANSLOC; Moralee RD, 2000, WATER SA, V26, P263; Muhlfeld CC, 2009, BIOL LETTERS, V5, P328, DOI 10.1098/rsbl.2009.0033; Nagl S, 2001, MOL PHYLOGENET EVOL, V20, P361, DOI 10.1006/mpev.2001.0979; Nei M., 1987, MOL EVOLUTIONARY GEN; Nolte AW, 2010, TRENDS GENET, V26, P54, DOI 10.1016/j.tig.2009.12.001; Nolte AW, 2005, P ROY SOC B-BIOL SCI, V272, P2379, DOI 10.1098/rspb.2005.3231; Nyingi DW, 2007, J FISH BIOL, V70, P148, DOI 10.1111/j.1095-8649.2007.01327.x; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Prentis PJ, 2008, TRENDS PLANT SCI, V13, P288, DOI 10.1016/j.tplants.2008.03.004; Pritchard JK, 2000, GENETICS, V155, P945; Pullin RSV, 1988, INT CTR LIV AQ RES M; R Development Core Team, 2008, R LANG ENV STAT COMP; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Rognon X, 2003, MOL ECOL, V12, P435, DOI 10.1046/j.1365-294X.2003.01739.x; Schliewen Ulrich K, 2004, Front Zool, V1, P5, DOI 10.1186/1742-9994-1-5; Schneider MF, 2003, B INVESTIGACAO FLORE, V2003, P31; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Seehausen O, 2008, MOL ECOL, V17, P30, DOI 10.1111/j.1365-294X.2007.03529.x; Sievers C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038404; Simberloff D, 2009, ANNU REV ECOL EVOL S, V40, P81, DOI 10.1146/annurev.ecolsys.110308.120304; Simler I, 2005, 192 IFPRI FCND; Skelton P. H, 2001, COMPLETE GUTIDE FRES; TEMPLETON AR, 1992, GENETICS, V132, P619; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tweddle D, 2007, FINAL REPORT PREPARE; van der Bank F. H., 2007, African Journal of Aquatic Science, V32, P193, DOI 10.2989/AJAS.2007.32.2.11.265; van der Waal BCW, 2000, S AFR J SCI, V96, P47; Vekemans X, 2002, MOL ECOL, V11, P139, DOI 10.1046/j.0962-1083.2001.01415.x; Verhoeven KJF, 2011, P ROY SOC B-BIOL SCI, V278, P2, DOI 10.1098/rspb.2010.1272; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Watanabe WO, 2006, TILAPIA BIOL CULTURE; Weyl OLF, 2008, AQUAT CONSERV, V18, P839, DOI 10.1002/aqc.897; WorldFish Center, 2002, NAIR DECL CONS AQ BI; Zengeya TA, 2013, AQUAT CONSERV, V23, P51, DOI 10.1002/aqc.2258; Zengeya TA, 2011, ENVIRON BIOL FISH, V92, P479, DOI 10.1007/s10641-011-9865-4; Zhivotovsky LA, 1999, MOL ECOL, V8, P907, DOI 10.1046/j.1365-294x.1999.00620.x	89	34	36	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63880	10.1371/journal.pone.0063880	http://dx.doi.org/10.1371/journal.pone.0063880			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671704	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000319737700062
J	Liu, CG; Liu, LM; Chen, XJ; Shen, JJ; Shan, JJ; Xu, YM; Yang, Z; Wu, L; Xia, F; Bie, P; Cui, YH; Bian, XW; Qian, C				Liu, Chungang; Liu, Limei; Chen, Xuejiao; Shen, Junjie; Shan, Juanjuan; Xu, Yanmin; Yang, Zhi; Wu, Lin; Xia, Feng; Bie, Ping; Cui, Youhong; Bian, Xiu-wu; Qian, Cheng			Decrease of 5-Hydroxymethylcytosine Is Associated with Progression of Hepatocellular Carcinoma through Downregulation of TET1	PLOS ONE			English	Article							PROTEINS; 5-METHYLCYTOSINE; CONVERSION; 5HMC; 5MC	DNA methylation is an important epigenetic modification and is frequently altered in cancer. Convert of 5-methylcytosine (5 mC) to 5-hydroxymethylcytosine (5 hmC) by ten-eleven translocation (TET) family enzymes plays important biological functions in embryonic stem cells, development, aging and disease. Recent reports showed that level of 5 hmC was altered in various types of cancers. However, the change of 5 hmC level in hepatocellular carcinoma (HCC) and association with clinical outcome were not well defined. Here, we reported that level of 5 hmC was decreased in HCC tissues, as compared with non-tumor tissues. Clincopathological analysis showed the decreased level of 5 hmC in HCC was associated with tumor size, AFP level and poor overall survival. We also found that the decreased level of 5 hmC in non-tumor tissues was associated with tumor recurrence in the first year after surgical resection. In an animal model with carcinogen DEN-induced HCC, we found that the level of 5 hmC was gradually decreased in the livers during the period of induction. There was further reduction of 5 hmC in tumor tissues when tumors were developed. In contrast, level of 5 mC was increased in HCC tissues and the increased 5 mC level was associated with capsular invasion, vascular thrombosis, tumor recurrence and overall survival. Furthermore, our data showed that expression of TET1, but not TET2 and TET3, was downregulated in HCC. Taken together, our data indicated 5 hmC may be served as a prognostic marker for HCC and the decreased expression of TET1 is likely one of the mechanisms underlying 5 hmC loss in HCC.	[Liu, Chungang; Liu, Limei; Chen, Xuejiao; Shen, Junjie; Shan, Juanjuan; Xu, Yanmin; Yang, Zhi; Cui, Youhong; Bian, Xiu-wu; Qian, Cheng] Third Mil Med Univ, Southwest Hosp, Inst Pathol, Chongqing, Peoples R China; [Liu, Chungang; Liu, Limei; Chen, Xuejiao; Shen, Junjie; Shan, Juanjuan; Xu, Yanmin; Yang, Zhi; Cui, Youhong; Bian, Xiu-wu; Qian, Cheng] Third Mil Med Univ, Southwest Hosp, Southwest Canc Ctr, Chongqing, Peoples R China; [Wu, Lin; Xia, Feng; Bie, Ping] Third Mil Med Univ, Southwest Hosp, Inst Hepatobiliary Surg, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University	Qian, C (corresponding author), Third Mil Med Univ, Southwest Hosp, Inst Pathol, Chongqing, Peoples R China.	cqian3184@yahoo.com.cn	Bian, Xiu-Wu/D-4736-2017	Bian, Xiu-Wu/0000-0003-4383-0197	National Natural Sciences Foundation of China [81090423, 81020108026, 81000966, 81101630]; National Basic Research Program of China (973 Program) [2010CB529406]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by funds from National Natural Sciences Foundation of China (No. 81090423, 81020108026, 81000966 and 81101630) and National Basic Research Program of China (973 Program, No.2010CB529406). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Haffner MC, 2011, ONCOTARGET, V2, P627; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Iyer LM, 2009, CELL CYCLE, V8, P1698, DOI 10.4161/cc.8.11.8580; Lee S, 2003, AM J PATHOL, V163, P1371, DOI 10.1016/S0002-9440(10)63495-5; Lian CG, 2012, CELL, V150, P1135, DOI 10.1016/j.cell.2012.07.033; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Shan JJ, 2012, HEPATOLOGY, V56, P1004, DOI 10.1002/hep.25745; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tan L, 2012, DEVELOPMENT, V139, P1895, DOI 10.1242/dev.070771; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Yang H, 2013, ONCOGENE, V32, P663, DOI 10.1038/onc.2012.67	19	58	65	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e62828	10.1371/journal.pone.0062828	http://dx.doi.org/10.1371/journal.pone.0062828			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671639	Green Submitted, Green Published, gold			2022-12-25	WOS:000319737700024
J	Parikh, NA; Lasky, RE; Kennedy, KA; McDavid, G; Tyson, JE				Parikh, Nehal A.; Lasky, Robert E.; Kennedy, Kathleen A.; McDavid, Georgia; Tyson, Jon E.			Perinatal Factors and Regional Brain Volume Abnormalities at Term in a Cohort of Extremely Low Birth Weight Infants	PLOS ONE			English	Article							PATENT DUCTUS-ARTERIOSUS; WEEKS GESTATIONAL-AGE; PRETERM INFANTS; NEURODEVELOPMENTAL OUTCOMES; INDOMETHACIN PROPHYLAXIS; EQUIVALENT AGE; CHILDREN; INJURY; PREMATURITY; DISABILITY	Our objective was to investigate diverse clinical antecedents of total and regional brain volume abnormalities and white matter hyperintensity volume on term MRI in extremely low birth weight (birth weight <= 1000 g) survivors. A consecutive cohort of extremely low birth weight infants who survived to 38 weeks postmenstrual age (n = 122) and a control group of 16 healthy term newborns underwent brain MRI at term-equivalent age. Brain volumes were measured using semi-automated and manual segmentation methods. Using multivariable linear regression, clinical antecedents were correlated with volumes of total brain tissue, white matter hyperintensities, and regional tissues/structures, adjusted for age at MRI, total cranial volume, and total tissue volume. Regional brain volumes were markedly reduced in extremely low birth weight infants as compared to term newborns (relative difference range: -11.0%, -35.9%). Significant adverse clinical associations for total brain tissue volume included: small for gestational age, seizures, caffeine therapy/apnea of prematurity, duration of parenteral nutrition, pulmonary hemorrhage, and white matter injury (p<0.01 for each; relative difference range: -1.4% to -15.0%). Surgery for retinopathy of prematurity and surgery for necrotizing enterocolitis or spontaneous intestinal perforation were significantly associated with increasing volume of white matter hyperintensities. Regional brain volumes are sensitive to multiple perinatal factors and neonatal morbidities or interventions. Brain growth measurements in extremely low birth weight infants can advance our understanding of perinatal brain injury and development.	[Parikh, Nehal A.; Lasky, Robert E.; Kennedy, Kathleen A.; McDavid, Georgia; Tyson, Jon E.] Univ Texas Houston, Sch Med, Dept Pediat, Houston, TX 77030 USA; [Parikh, Nehal A.; Lasky, Robert E.; Kennedy, Kathleen A.; McDavid, Georgia; Tyson, Jon E.] Childrens Mem Hermann Hosp, Houston, TX USA; [Parikh, Nehal A.] Nationwide Childrens Hosp, Res Inst, Ctr Perinatal Res, Columbus, OH USA; [Parikh, Nehal A.] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [Lasky, Robert E.; Kennedy, Kathleen A.; Tyson, Jon E.] Univ Texas Houston, Sch Med, Ctr Clin Res & Evidence Based Med, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University of Texas System; University of Texas Health Science Center Houston	Parikh, NA (corresponding author), Univ Texas Houston, Sch Med, Dept Pediat, Houston, TX 77030 USA.	nehal.parikh@nationwidechildrens.org	Parikh, Nehal/AAB-9981-2022	Parikh, Nehal/0000-0002-1375-1247	National Institutes of Health [K23-NS048152]; National Institute of Neurological Disorders and Stroke [UL1 RR024148]; National Center for Research Resources; University of Texas Health Science Center at Houston Center for Clinical and Translational Sciences; Clinical Investigator Award from the Center for Clinical Research and Evidence-Based Medicine at the University of Texas Houston Medical School; Eunice Shriver National Institute of Child Health & Human Development Neonatal Research Network [U10 HD021373]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U10HD021373] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS048152] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); University of Texas Health Science Center at Houston Center for Clinical and Translational Sciences; Clinical Investigator Award from the Center for Clinical Research and Evidence-Based Medicine at the University of Texas Houston Medical School; Eunice Shriver National Institute of Child Health & Human Development Neonatal Research Network; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by a National Institutes of Health grant K23-NS048152, National Institute of Neurological Disorders and Stroke grant UL1 RR024148, National Center for Research Resources and University of Texas Health Science Center at Houston Center for Clinical and Translational Sciences, a Clinical Investigator Award from the Center for Clinical Research and Evidence-Based Medicine at the University of Texas Houston Medical School (NAP), and the Eunice Shriver National Institute of Child Health & Human Development Neonatal Research Network grant U10 HD021373 (KAK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badr LK, 2009, EARLY HUM DEV, V85, P279, DOI 10.1016/j.earlhumdev.2008.11.005; Boardman JP, 2007, ANN NEUROL, V62, P185, DOI 10.1002/ana.21171; Bonifacio SL, 2010, J PEDIATR-US, V157, P726, DOI 10.1016/j.jpeds.2010.05.026; Buyse M, 2010, NAT REV CLIN ONCOL, V7, P309, DOI 10.1038/nrclinonc.2010.43; Clouchoux C, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.10.002; Counsell SJ, 2008, BRAIN, V131, P3201, DOI 10.1093/brain/awn268; Doyle LW, 2001, PEDIATRICS, V108, P134, DOI 10.1542/peds.108.1.134; Dyet LE, 2006, PEDIATRICS, V118, P536, DOI 10.1542/peds.2005-1866; Fanaroff AA, 2003, SEMIN PERINATOL, V27, P281, DOI 10.1016/S0146-0005(03)00055-7; Hack M, 2005, PEDIATRICS, V116, P333, DOI 10.1542/peds.2005-0173; Hintz SR, 2005, PEDIATRICS, V115, P1645, DOI 10.1542/peds.2004-2215; Inder TE, 2005, PEDIATRICS, V115, P286, DOI 10.1542/peds.2004-0326; Iwata S, 2012, PEDIATRICS, V129, pE1138, DOI 10.1542/peds.2011-1735; Judas M, 2005, AM J NEURORADIOL, V26, P2671; Kabra NS, 2007, J PEDIATR-US, V150, P229, DOI 10.1016/j.jpeds.2006.11.039; Keihaninejad S, 2010, NEUROIMAGE, V50, P1427, DOI 10.1016/j.neuroimage.2010.01.064; Kidokoro H, 2011, AM J NEURORADIOL, V32, P2005, DOI 10.3174/ajnr.A2703; Lind A, 2010, EUR CHILD ADOLES PSY, V19, P407, DOI 10.1007/s00787-009-0070-3; Littman A, 2006, ACAD RADIOL, V13, P1; Lodygensky GA, 2008, PEDIATR RES, V63, P438, DOI 10.1203/PDR.0b013e318165c005; Lorenz JM, 1998, ARCH PEDIAT ADOL MED, V152, P425, DOI 10.1001/archpedi.152.5.425; Maalouf EF, 1999, J PEDIATR-US, V135, P351, DOI 10.1016/S0022-3476(99)70133-2; Madan JC, 2009, PEDIATRICS, V123, P674, DOI 10.1542/peds.2007-2781; Ment LR, 2009, LANCET NEUROL, V8, P1042, DOI 10.1016/S1474-4422(09)70257-1; Nisari M, 2012, SURG RADIOL ANAT, V34, P825, DOI 10.1007/s00276-012-0971-6; Nosarti C, 2008, BRAIN, V131, P205, DOI 10.1093/brain/awm282; Parikh NA, 2007, PEDIATRICS, V119, P265, DOI 10.1542/peds.2006-1354; Peterson BS, 2000, JAMA-J AM MED ASSOC, V284, P1939, DOI 10.1001/jama.284.15.1939; Peterson BS, 2003, PEDIATRICS, V111, P939, DOI 10.1542/peds.111.5.939; Reiman M, 2008, J PEDIATR-US, V152, P642, DOI 10.1016/j.jpeds.2007.09.051; Roberts G, 2010, ARCH DIS CHILD-FETAL, V95, pF90, DOI 10.1136/adc.2009.165480; Schmidt B, 2003, JAMA-J AM MED ASSOC, V289, P1124, DOI 10.1001/jama.289.9.1124; Schulzke SM, 2007, ARCH PEDIAT ADOL MED, V161, P583, DOI 10.1001/archpedi.161.6.583; Srinivasan L, 2007, PEDIATRICS, V119, P759, DOI 10.1542/peds.2006-2508; Tam EWY, 2011, J PEDIATR-US, V158, P245, DOI 10.1016/j.jpeds.2010.07.049; Thompson DK, 2008, ANN NEUROL, V63, P642, DOI 10.1002/ana.21367; Thompson DK, 2007, BRAIN, V130, P667, DOI 10.1093/brain/awl277; Tyson JE, 2008, NEW ENGL J MED, V358, P1672, DOI 10.1056/NEJMoa073059; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Wilson-Costello D, 2005, PEDIATRICS, V115, P997, DOI 10.1542/peds.2004-0221; Woodward LJ, 2005, BRAIN, V128, P2578, DOI 10.1093/brain/awh618; Yu XT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013874	42	40	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e62804	10.1371/journal.pone.0062804	http://dx.doi.org/10.1371/journal.pone.0062804			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671636	Green Published, Green Submitted, gold			2022-12-25	WOS:000319737700021
J	Sakai, H; Sato, T; Sakurai, H; Yamamoto, T; Hanaoka, K; Montarras, D; Sehara-Fujisawa, A				Sakai, Hiroshi; Sato, Takahiko; Sakurai, Hidetoshi; Yamamoto, Takuya; Hanaoka, Kazunori; Montarras, Didier; Sehara-Fujisawa, Atsuko			Fetal Skeletal Muscle Progenitors Have Regenerative Capacity after Intramuscular Engraftment in Dystrophin Deficient Mice	PLOS ONE			English	Article							STEM-CELL FUNCTION; SATELLITE CELLS; MYOGENIC PROGENITORS; SELF-RENEWAL; ADULT MUSCLE; DETERMINATION GENE; HIGHLY EFFICIENT; SOMITIC ORIGIN; QUIESCENT; MYF5	Muscle satellite cells (SCs) are stem cells that reside in skeletal muscles and contribute to regeneration upon muscle injury. SCs arise from skeletal muscle progenitors expressing transcription factors Pax3 and/or Pax7 during embryogenesis in mice. However, it is unclear whether these fetal progenitors possess regenerative ability when transplanted in adult muscle. Here we address this question by investigating whether fetal skeletal muscle progenitors (FMPs) isolated from Pax3(GFP/+) embryos have the capacity to regenerate muscle after engraftment into Dystrophin-deficient mice, a model of Duchenne muscular dystrophy. The capacity of FMPs to engraft and enter the myogenic program in regenerating muscle was compared with that of SCs derived from adult Pax3(GFP/+) mice. Transplanted FMPs contributed to the reconstitution of damaged myofibers in Dystrophin-deficient mice. However, despite FMPs and SCs having similar myogenic ability in culture, the regenerative ability of FMPs was less than that of SCs in vivo. FMPs that had activated MyoD engrafted more efficiently to regenerate myofibers than MyoD-negative FMPs. Transcriptome and surface marker analyses of these cells suggest the importance of myogenic priming for the efficient myogenic engraftment. Our findings suggest the regenerative capability of FMPs in the context of muscle repair and cell therapy for degenerative muscle disease.	[Sakai, Hiroshi; Sato, Takahiko; Sehara-Fujisawa, Atsuko] Kyoto Univ, Inst Frontier Med Sci, Dept Growth Regulat, Kyoto, Japan; [Sakurai, Hidetoshi] Kyoto Univ, Dept Clin Applicat, Ctr iPS Cell Res & Applicat, Kyoto, Japan; [Yamamoto, Takuya] Kyoto Univ, Dept Reprogramming Sci, Ctr iPS Cell Res & Applicat, Kyoto, Japan; [Hanaoka, Kazunori] Kitasato Univ, Sch Sci, Dept Biosci, Mol Embryol Lab, Kanagawa, Japan; [Montarras, Didier] Inst Pasteur, Paris, France	Kyoto University; Kyoto University; Kyoto University; Kitasato University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Sato, T (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Dept Growth Regulat, Kyoto, Japan.	takahiko@frontier.kyoto-u.ac.jp; asehara@frontier.kyoto-u.ac.jp	Yamamoto, Takuya/H-2792-2017; Hiroshi, SAKAI/B-1450-2016	Yamamoto, Takuya/0000-0002-0022-3947; Hiroshi, SAKAI/0000-0001-9456-0911; Sato, Takahiko/0000-0003-3836-7978	Ministry of Health, Labor, and Welfare; Ministry of Education, Culture, Sports, Science and Technology (MEXT); Center for Frontier Medicine of the Kyoto University Global COE Program; Grants-in-Aid for Scientific Research [22122007] Funding Source: KAKEN	Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Center for Frontier Medicine of the Kyoto University Global COE Program; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Research Grant for Nervous and Mental Disorders from the Ministry of Health, Labor, and Welfare (A. S), grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), the project for realization of Regenerative Medicine (H.Sakurai and A. S.), and molecular mechanisms underlying reconstruction of 3D structures during regeneration (T. S.). H.Sakai and T. S. were supported by a research assistantship and postdoctoral fellowship from the Center for Frontier Medicine of the Kyoto University Global COE Program, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auda-Boucher G, 2003, J HISTOCHEM CYTOCHEM, V51, P1255, DOI 10.1177/002215540305101002; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Buckingham M, 2007, ANNU REV CELL DEV BI, V23, P645, DOI 10.1146/annurev.cellbio.23.090506.123438; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Cheung TH, 2012, NATURE, V482, P524, DOI 10.1038/nature10834; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721; Crist CG, 2012, CELL STEM CELL, V11, P118, DOI 10.1016/j.stem.2012.03.011; Darabi R, 2008, NAT MED, V14, P134, DOI 10.1038/nm1705; Darabi R, 2012, CELL STEM CELL, V10, P610, DOI 10.1016/j.stem.2012.02.015; Djian-Zaouche J, 2012, PIGM CELL MELANOMA R, V25, P545, DOI 10.1111/j.1755-148X.2012.01024.x; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Fukada SI, 2007, STEM CELLS, V25, P2448, DOI 10.1634/stemcells.2007-0019; Gayraud-Morel B, 2007, DEV BIOL, V312, P13, DOI 10.1016/j.ydbio.2007.08.059; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Gros J, 2005, NATURE, V435, P954, DOI 10.1038/nature03572; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hutcheson DA, 2009, GENE DEV, V23, P997, DOI 10.1101/gad.1769009; Kanisicak O, 2009, DEV BIOL, V332, P131, DOI 10.1016/j.ydbio.2009.05.554; Kassar-Duchossoy L, 2005, GENE DEV, V19, P1426, DOI 10.1101/gad.345505; Kudoh H, 2005, BIOCHEM BIOPH RES CO, V328, P507, DOI 10.1016/j.bbrc.2004.12.191; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Mitchell PO, 2005, DEV BIOL, V283, P240, DOI 10.1016/j.ydbio.2005.04.016; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Mummery CL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000558; Muntoni F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Neal A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037950; Pallafacchina G, 2010, STEM CELL RES, V4, P77, DOI 10.1016/j.scr.2009.10.003; Parker MH, 2012, STEM CELLS, V30, P2212, DOI 10.1002/stem.1181; PARTRIDGE TA, 1989, NATURE, V337, P176, DOI 10.1038/337176a0; Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145; Pichavant C, 2011, MOL THER, V19, P830, DOI 10.1038/mt.2011.59; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Schienda J, 2006, P NATL ACAD SCI USA, V103, P945, DOI 10.1073/pnas.0510164103; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tedesco FS, 2010, J CLIN INVEST, V120, P11, DOI 10.1172/JCI40373; Ustanina S, 2007, STEM CELLS, V25, P2006, DOI 10.1634/stemcells.2006-0736; Wang YX, 2012, NAT REV MOL CELL BIO, V13, P127, DOI 10.1038/nrm3265; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035	47	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63016	10.1371/journal.pone.0063016	http://dx.doi.org/10.1371/journal.pone.0063016			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671652	Green Published, Green Submitted, gold			2022-12-25	WOS:000319737700034
J	Weicksel, SE; Xu, J; Sagerstrom, CG				Weicksel, Steven E.; Xu, Jia; Sagerstroem, Charles G.			Dynamic Nucleosome Organization at hox Promoters during Zebrafish Embryogenesis	PLOS ONE			English	Article							NUCLEAR REORGANIZATION; CHROMATIN-STRUCTURE; RETINOIC ACID; SACCHAROMYCES-CEREVISIAE; EMBRYONIC-DEVELOPMENT; GENE-EXPRESSION; HIGH-RESOLUTION; GENOME-WIDE; DNA; TRANSCRIPTION	Nucleosome organization at promoter regions plays an important role in regulating gene activity. Genome-wide studies in yeast, flies, worms, mammalian embryonic stem cells and transformed cell lines have found well-positioned nucleosomes flanking a nucleosome depleted region (NDR) at transcription start sites. This nucleosome arrangement depends on DNA sequence (cis-elements) as well as DNA binding factors and ATP-dependent chromatin modifiers (trans-factors). However, little is understood about how the nascent embryonic genome positions nucleosomes during development. This is particularly intriguing since the embryonic genome must undergo a broad reprogramming event upon fusion of sperm and oocyte. Using four stages of early embryonic zebrafish development, we map nucleosome positions at the promoter region of 37 zebrafish hox genes. We find that nucleosome arrangement at the hox promoters is a progressive process that takes place over several stages. At stages immediately after fertilization, nucleosomes appear to be largely disordered at hox promoter regions. At stages after activation of the embryonic genome, nucleosomes are detectable at hox promoters, with positions becoming more uniform and more highly occupied. Since the genomic sequence is invariant during embryogenesis, this progressive change in nucleosome arrangement suggests that trans-factors play an important role in organizing nucleosomes during embryogenesis. Separating hox genes into expressed and non-expressed groups shows that expressed promoters have better positioned and occupied nucleosomes, as well as distinct NDRs, than non-expressed promoters. Finally, by blocking the retinoic acid-signaling pathway, we disrupt early hox gene transcription, but observe no effect on nucleosome positions, suggesting that active hox transcription is not a driving force behind the arrangement of nucleosomes at the promoters of hox genes during early development.	[Weicksel, Steven E.; Sagerstroem, Charles G.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Xu, Jia] Univ Massachusetts, Sch Med, Bioinformat Core, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Sagerstrom, CG (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA.	charles.sagerstrom@umassmed.edu	Weicksel, Steven/AAN-8698-2021	Weicksel, Steven/0000-0002-1679-9684	National Institutes of Health [NS038183]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038183, R56NS038183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grant NS038183 to CGS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; ALMER A, 1986, EMBO J, V5, P2689, DOI 10.1002/j.1460-2075.1986.tb04552.x; Anderson JD, 2000, J MOL BIOL, V296, P979, DOI 10.1006/jmbi.2000.3531; Andreu-Vieyra C, 2011, MOL CELL BIOL, V31, P4648, DOI 10.1128/MCB.05934-11; Badis G, 2008, MOL CELL, V32, P878, DOI 10.1016/j.molcel.2008.11.020; Bai L, 2011, MOL CELL, V42, P465, DOI 10.1016/j.molcel.2011.03.028; Berkes CA, 2004, MOL CELL, V14, P465, DOI 10.1016/S1097-2765(04)00260-6; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Chambeyron S, 2005, DEVELOPMENT, V132, P2215, DOI 10.1242/dev.01813; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Dennis JH, 2007, GENOME RES, V17, P928, DOI 10.1101/gr.5636607; Ercan S, 2011, GENOME RES, V21, P237, DOI 10.1101/gr.115931.110; FEDOR MJ, 1989, MOL CELL BIOL, V9, P1721, DOI 10.1128/MCB.9.4.1721; Fu YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000138; Gilchrist DA, 2008, GENE DEV, V22, P1921, DOI 10.1101/gad.1643208; Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; Hughes AL, 2012, MOL CELL, V48, P5, DOI 10.1016/j.molcel.2012.07.003; Ioshikhes I, 1996, J MOL BIOL, V262, P129, DOI 10.1006/jmbi.1996.0503; Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878; IYER V, 1995, EMBO J, V14, P2570, DOI 10.1002/j.1460-2075.1995.tb07255.x; Jin CY, 2007, GENE DEV, V21, P1519, DOI 10.1101/gad.1547707; Johnson SM, 2006, GENOME RES, V16, P1505, DOI 10.1101/gr.5560806; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kharchenko PV, 2008, GENOME RES, V18, P1554, DOI 10.1101/gr.075952.107; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Koide T, 2001, GENE DEV, V15, P2111, DOI 10.1101/gad.908801; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Li M, 2010, MOL CELL BIOL, V30, P1067, DOI 10.1128/MCB.00183-09; Mahony S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r2; Maves L, 2005, DEV BIOL, V285, P593, DOI 10.1016/j.ydbio.2005.07.015; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; MCPHERSON CE, 1993, CELL, V75, P387, DOI 10.1016/0092-8674(93)80079-T; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Morey C, 2007, DEVELOPMENT, V134, P909, DOI 10.1242/dev.02779; Noordermeer D, 2011, SCIENCE, V334, P222, DOI 10.1126/science.1207194; Ozsolak F, 2007, NAT BIOTECHNOL, V25, P244, DOI 10.1038/nbt1279; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; Peckham HE, 2007, GENOME RES, V17, P1170, DOI 10.1101/gr.6101007; Pengelly AR, 2013, SCIENCE, V339, P698, DOI 10.1126/science.1231382; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Perz-Edwards A, 2001, DEV BIOL, V229, P89, DOI 10.1006/dbio.2000.9979; Sasaki S, 2009, SCIENCE, V323, P401, DOI 10.1126/science.1163183; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Shim EY, 1998, GENE DEV, V12, P5, DOI 10.1101/gad.12.1.5; Suter B, 2000, NUCLEIC ACIDS RES, V28, P4083, DOI 10.1093/nar/28.21.4083; Thastrom A, 1999, J MOL BIOL, V288, P213, DOI 10.1006/jmbi.1999.2686; Tillo D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009129; Tirosh I, 2008, GENOME RES, V18, P1084, DOI 10.1101/gr.076059.108; Valouev A, 2008, GENOME RES, V18, P1051, DOI 10.1101/gr.076463.108; Vastenhouw NL, 2010, NATURE, V464, P922, DOI 10.1038/nature08866; Weiner A, 2010, GENOME RES, V20, P90, DOI 10.1101/gr.098509.109; Widom J, 1998, ANNU REV BIOPH BIOM, V27, P285, DOI 10.1146/annurev.biophys.27.1.285; Xi YX, 2011, GENOME RES, V21, P718, DOI 10.1101/gr.117101.110; Xiao H, 2001, MOL CELL, V8, P531, DOI 10.1016/S1097-2765(01)00345-8; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Yuan GC, 2008, PLOS COMPUT BIOL, V4, DOI [10.1371/journal.pcbi.0040013, 10.1371/journal.pcbi.0040013.eor]	65	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63175	10.1371/journal.pone.0063175	http://dx.doi.org/10.1371/journal.pone.0063175			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671670	gold, Green Published, Green Submitted			2022-12-25	WOS:000319737700048
J	Ezzat, L; Merle, PL; Furla, P; Buttler, A; Ferrier-Pages, C				Ezzat, Leila; Merle, Pierre-Laurent; Furla, Paola; Buttler, Alexandre; Ferrier-Pages, Christine			The Response of the Mediterranean Gorgonian Eunicella singularis to Thermal Stress Is Independent of Its Nutritional Regime	PLOS ONE			English	Article							CORAL CLADOCORA-CAESPITOSA; BENTHIC SUSPENSION FEEDERS; MASS-MORTALITY; PARAMURICEA-CLAVATA; PROLONGED DARKNESS; STYLOPHORA-PISTILLATA; SCLERACTINIAN CORALS; OCULINA-PATAGONICA; DIATOM MORTALITY; TEMPERATE CORAL	Over the last few decades, sessile benthic organisms from the Mediterranean Sea have suffered from the global warming of the world's oceans, and several mass mortality events were observed during warm summers. It has been hypothesized that mortality could have been due to a nutrient (food) shortage following the stratification of the water column. However, the symbiotic gorgonian Eunicella singularis has also presented a locally exceptional mortality, despite its autotrophic capacities through the photosynthesis of its dinoflagellate symbionts. Thus, this study has experimentally investigated the response of E. singularis to a thermal stress (temperature increase from 18 to 26 degrees C), with colonies maintained more than 2 months under four nutritional diets: autotrophy only (AO), autotrophy and inorganic nitrogen addition (AN), autotrophy and heterotrophy (AH), heterotrophy only (HO). At 18 degrees C, and contrary to many other anthozoans, supplementation of autotrophy with either inorganic nitrogen or food (heterotrophy) had no effect on the rates of respiration, photosynthesis, as well as in the chlorophyll, lipid and protein content. In the dark, heterotrophy maintained the gorgonian's metabolism, except a bleaching (loss of pigments), which did not affect the rates of photosynthesis. At 24 degrees C, rates of respiration, and photosynthesis significantly decreased in all treatments. At 26 degrees C, in addition to a decrease in the lipid content of all treatments, a bleaching was observed after 1 week in the AO treatment, while the AH and AN treatments resisted three weeks before bleaching. These last results suggest that, temperatures above 24 degrees C impair the energetic reserves of this species and might explain the mortality events in the Mediterranean.	[Ezzat, Leila; Buttler, Alexandre] Ecole Polytech Fed Lausanne, Sch Architecture Civil & Environm Engn ENAC, CH-1015 Lausanne, Switzerland; [Merle, Pierre-Laurent; Furla, Paola] Univ Nice Sophia Antipolis, UMR UNS UPMC CNRS Equipe Symbiose Marine SYMAR 71, Nice, France; [Ezzat, Leila; Ferrier-Pages, Christine] Ctr Sci Monaco, Ecophysiol Team, Monaco, Monaco; [Buttler, Alexandre] Swiss Fed Inst Forest Snow & Landscape Res WSL, Lausanne, Switzerland; [Buttler, Alexandre] Univ Franche Comte, UMR CNRS 6249, Lab Chronoenvironm, F-25030 Besancon, France	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; UDICE-French Research Universities; Sorbonne Universite; Universite Cote d'Azur; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Universite de Franche-Comte	Ezzat, L (corresponding author), Ecole Polytech Fed Lausanne, Sch Architecture Civil & Environm Engn ENAC, CH-1015 Lausanne, Switzerland.	Leila.Ezzat@gmail.com	Buttler, Alexandre AB/K-1137-2012	Furla, Paola/0000-0001-9899-942X; Ferrier-Pages, Christine/0000-0002-0357-4486	Government of the Principality of Monaco through the Centre Scientifique de Monaco; Centre Scientifique de Monaco	Government of the Principality of Monaco through the Centre Scientifique de Monaco; Centre Scientifique de Monaco	This study was funded by the Government of the Principality of Monaco through the Centre Scientifique de Monaco. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank S. Sikorski, C. Rottier and T. Zamoum for laboratory assistance, Rodolphe Schlaepfer (EPFL), P. Tremblay, J-O Irisson (Laboratoire d'Oceanographie de Villefranche-sur-Mer), E. Beraud for statistical advices, and D. Allemand, Director of the Centre Scientifique de Monaco, for financial and scientific support. Many thanks to the undergraduate students: A. Degli-Albizi, S. Tahiri and L. Monticelli, who participated in soluble protein extraction and in algal density determination. Finally, we wish to thank two anonymous reviewers for providing constructive and helpful comments.	Anthony KRN, 2000, J EXP MAR BIOL ECOL, V252, P221, DOI 10.1016/S0022-0981(00)00237-9; Bally M, 2007, GLOBAL CHANGE BIOL, V13, P2078, DOI 10.1111/j.1365-2486.2007.01423.x; BEARDALL J, 1994, J PLANKTON RES, V16, P1401, DOI 10.1093/plankt/16.10.1401; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borell EM, 2008, J EXP MAR BIOL ECOL, V364, P116, DOI 10.1016/j.jembe.2008.07.033; BROWN BE, 1990, CORAL REEFS, V8, P163, DOI 10.1007/BF00265007; BUDDEMEIER RW, 1993, BIOSCIENCE, V43, P320, DOI 10.2307/1312064; Cerrano C, 2000, ECOL LETT, V3, P284, DOI 10.1046/j.1461-0248.2000.00152.x; Cerrano C, 2005, AQUAT CONSERV, V15, P147, DOI 10.1002/aqc.661; COLES SL, 1991, CORAL REEFS, V9, P231, DOI 10.1007/BF00290427; Coma R, 2003, OIKOS, V101, P205, DOI 10.1034/j.1600-0706.2003.12028.x; Coma R, 2002, LIMNOL OCEANOGR, V47, P324, DOI 10.4319/lo.2002.47.1.0324; COMA R, 1994, MAR ECOL PROG SER, V115, P257, DOI 10.3354/meps115257; Coma R, 2006, MAR ECOL PROG SER, V327, P51, DOI 10.3354/meps327051; Deventer B, 1996, AQUAT SCI, V58, P241, DOI 10.1007/BF00877511; Ferrier-Pages C, 2010, J EXP MAR BIOL ECOL, V390, P118, DOI 10.1016/j.jembe.2010.05.007; Ferrier-Pages C, 2009, J EXP BIOL, V212, P3007, DOI 10.1242/jeb.031823; Garrabou J, 2009, GLOBAL CHANGE BIOL, V15, P1090, DOI 10.1111/j.1365-2486.2008.01823.x; Garrabou J, 2001, MASS MORTALITY EVENT, P217; GATES RD, 1992, BIOL BULL, V182, P324, DOI 10.2307/1542252; GLYNN PW, 1993, CORAL REEFS, V12, P1, DOI 10.1007/BF00303779; Gori A, 2007, MAR BIOL, V151, P1571, DOI 10.1007/s00227-006-0595-7; Gori A, 2012, MAR BIOL, V159, P1485, DOI 10.1007/s00227-012-1928-3; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell D, 2004, FRONT ECOL ENVIRON, V2, P375, DOI 10.1890/1540-9295(2004)002[0375:TRTOOD]2.0.CO;2; Hoogenboom M, 2010, J EXP BIOL, V213, P2399, DOI 10.1242/jeb.040147; Houlbreque F, 2009, BIOL REV, V84, P1, DOI 10.1111/j.1469-185X.2008.00058.x; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Jones RJ, 2001, PLANT CELL ENVIRON, V24, P89, DOI 10.1046/j.1365-3040.2001.00648.x; KEVIN KM, 1979, J EXP MAR BIOL ECOL, V36, P157, DOI 10.1016/0022-0981(79)90106-0; Lesser MP, 2007, P NATL ACAD SCI USA, V104, P5259, DOI 10.1073/pnas.0700910104; Linares C, 2005, IMMEDIATE DELAYED EF; Linares C, 2008, J APPL ECOL, V45, P688, DOI 10.1111/j.1365-2664.2007.01419.x; Marubini F, 1996, MAR BIOL, V127, P319, DOI 10.1007/BF00942117; MILLER MW, 1995, MAR ECOL PROG SER, V122, P217, DOI 10.3354/meps122217; MUSCATINE L, 1981, LIMNOL OCEANOGR, V26, P601, DOI 10.4319/lo.1981.26.4.0601; ODUM HT, 1955, ECOL MONOGR, V25, P291, DOI 10.2307/1943285; Perez T, 2000, CR ACAD SCI III-VIE, V323, P853, DOI 10.1016/S0764-4469(00)01237-3; Peters E, 1996, J EXP MAR BIOL ECOL, V207, P25, DOI 10.1016/S0022-0981(96)02520-8; Peters E, 1996, J EXP MAR BIOL ECOL, V207, P43, DOI 10.1016/0022-0981(95)02519-7; Pey A, 2011, J EXP MAR BIOL ECOL, V404, P73, DOI 10.1016/j.jembe.2011.05.007; Portner HO, 2010, J EXP BIOL, V213, P881, DOI 10.1242/jeb.037523; Previati M, 2010, J EXP MAR BIOL ECOL, V390, P39, DOI 10.1016/j.jembe.2010.04.025; Ritchie RJ, 2006, PHOTOSYNTH RES, V89, P27, DOI 10.1007/s11120-006-9065-9; Rodolfo-Metalpa R, 2008, CORAL REEFS, V27, P17, DOI 10.1007/s00338-007-0283-1; Rodolfo-Metalpa R, 2008, MAR ECOL PROG SER, V369, P103, DOI 10.3354/meps07608; Rodolfo-Metalpa R, 2008, J EXP BIOL, V211, P1579, DOI 10.1242/jeb.016345; Rodolfo-Metalpa R, 2006, MAR BIOL, V150, P45, DOI 10.1007/s00227-006-0329-x; Rossi S, 2004, MAR BIOL, V144, P89, DOI 10.1007/s00227-003-1168-7; Rossi S, 2006, MAR BIOL, V149, P643, DOI 10.1007/s00227-005-0229-5; SCHREIBER U, 1986, PHOTOSYNTH RES, V10, P51, DOI 10.1007/BF00024185; Stambler N, 1998, SYMBIOSIS, V24, P127; Suggett DJ, 2008, J PHYCOL, V44, P948, DOI 10.1111/j.1529-8817.2008.00537.x; Titlyanov E, 2000, MAR BIOL, V137, P463, DOI 10.1007/s002270000370; Tremblay P, 2012, J EXP BIOL, V215, P1384, DOI 10.1242/jeb.065201; WEINBERG S, 1979, BIJDR DIERKD, V48, P127, DOI 10.1163/26660644-04802003; Weinberg S, 1991, FAUT IL PROTEGER GOR, P47; WENDT P H, 1985, Journal of the Elisha Mitchell Scientific Society, V101, P187; Wild C, 2004, NATURE, V428, P66, DOI 10.1038/nature02344; Williams E, 1990, ATOLL RES B, V335, P77; Younes WAN, 2003, OCEANOL ACTA, V26, P311, DOI 10.1016/S0399-1784(03)00037-9; Zehr JP, 2009, SCIENCE, V326, P945, DOI 10.1126/science.1181277	63	21	22	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e64370	10.1371/journal.pone.0064370	http://dx.doi.org/10.1371/journal.pone.0064370			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667711	Green Published, Green Submitted, gold			2022-12-25	WOS:000319055600091
J	Khan, I; Ali, F; Shafie, S				Khan, Ilyas; Ali, Farhad; Shafie, Sharidan			Stokes' Second Problem for Magnetohydrodynamics Flow in a Burgers' Fluid: The Cases gamma = lambda(2)/4 and gamma >lambda(2)/4	PLOS ONE			English	Article							OLDROYD-B FLUID; NON-NEWTONIAN FLUIDS; MHD FLOW; 2ND-GRADE FLUID; 1ST PROBLEM; THERMAL-RADIATION; MAXWELL FLUID; HALL CURRENT	The present work is concerned with exact solutions of Stokes second problem for magnetohydrodynamics (MHD) flow of a Burgers' fluid. The fluid over a flat plate is assumed to be electrically conducting in the presence of a uniform magnetic field applied in outward transverse direction to the flow. The equations governing the flow are modeled and then solved using the Laplace transform technique. The expressions of velocity field and tangential stress are developed when the relaxation time satisfies the condition gamma = lambda(2)/4 or gamma>lambda(2)/4. The obtained closed form solutions are presented in the form of simple or multiple integrals in terms of Bessel functions and terms with only Bessel functions. The numerical integration is performed and the graphical results are displayed for the involved flow parameters. It is found that the velocity decreases whereas the shear stress increases when the Hartmann number is increased. The solutions corresponding to the Stokes' first problem for hydrodynamic Burgers' fluids are obtained as limiting cases of the present solutions. Similar solutions for Stokes' second problem of hydrodynamic Burgers' fluids and those for Newtonian and Oldroyd-B fluids can also be obtained as limiting cases of these solutions.	[Khan, Ilyas; Ali, Farhad; Shafie, Sharidan] Univ Teknol Malaysia, Fac Sci, Dept Math Sci, Skudai, Malaysia	Universiti Teknologi Malaysia	Khan, I (corresponding author), Univ Teknol Malaysia, Fac Sci, Dept Math Sci, Skudai, Malaysia.	ilyaskhanqau@yahoo.com	Ali, Farhad/Y-5301-2018; SHAFIE, SHARIDAN/A-2210-2013; Khan, Ilyas/C-8770-2019	SHAFIE, SHARIDAN/0000-0001-7795-2278; Khan, Ilyas/0000-0002-2056-9371				ALI F, 2011, EUR J SCI RES, V57, P293; ANDERSSON HI, 1992, ACTA MECH, V95, P227, DOI 10.1007/BF01170814; Christov IC, 2010, MECH RES COMMUN, V37, P717, DOI 10.1016/j.mechrescom.2010.09.006; Ersoy HV, 1999, INT J ENG SCI, V37, P1973, DOI 10.1016/S0020-7225(99)00010-5; Fakhar K, 2011, COMPUT MATH APPL, V61, P980, DOI 10.1016/j.camwa.2010.12.046; Fetecau C, 2011, ACTA MECH, V216, P359, DOI 10.1007/s00707-010-0398-2; Ghasemi E., 2011, INT J PHYS SCI, V6, P5022; Hameed A, 2007, J MATH ANAL APPL, V325, P724, DOI 10.1016/j.jmaa.2006.02.002; Hammouch Z, 2008, EUR J PURE APPL MATH, V1, P11; Hayat T, 2008, NONLINEAR ANAL-REAL, V9, P1619, DOI 10.1016/j.nonrwa.2007.04.006; Hayat T, 2008, PHYS LETT A, V372, P1639, DOI 10.1016/j.physleta.2007.10.036; Hayat T, 2008, J POROUS MEDIA, V11, P389, DOI 10.1615/JPorMedia.v11.i4.50; Hayat T, 2007, TRANSPORT POROUS MED, V68, P249, DOI 10.1007/s11242-006-9043-x; Hayat T, 2007, COMPUT MATH APPL, V54, P407, DOI 10.1016/j.camwa.2006.12.036; Hayat T, 2002, MATH COMPUT MODEL, V36, P987, DOI 10.1016/S0895-7177(02)00252-2; Hayat T, 2010, INT J HEAT MASS TRAN, V53, P4780, DOI 10.1016/j.ijheatmasstransfer.2010.06.014; Hayat T, 2010, Z NATURFORSCH A, V65, P1111, DOI 10.1515/zna-2010-1216; Hayat T, 2010, Z NATURFORSCH A, V65, P950, DOI 10.1515/zna-2010-1107; KASIVISWANATHAN SR, 1992, INT J ENG SCI, V30, P409, DOI 10.1016/0020-7225(92)90033-D; Khan I, 2012, TRANSPORT POROUS MED, V91, P49, DOI 10.1007/s11242-011-9832-8; KHAN I, 2010, WORLD APPL SCI J, V9, P55; Khan I, 2011, J PHYS SOC JPN, V80, DOI 10.1143/JPSJ.80.104401; Khan I, 2011, J PHYS SOC JPN, V80, DOI 10.1143/JPSJ.80.064401; Khan M, 2011, Z ANGEW MATH PHYS, V62, P749, DOI 10.1007/s00033-011-0141-4; Khan M, 2013, COMMUN THEOR PHYS, V59, P99, DOI 10.1088/0253-6102/59/1/18; Khan M, 2012, NUCL ENG DES, V243, P20, DOI 10.1016/j.nucengdes.2011.11.024; Khan M, 2011, CHEM ENG COMMUN, V198, P1415, DOI 10.1080/00986445.2011.560521; Kumar AS., 2010, J ENG TECH RES, V2, P73; Liu YQ, 2011, COMPUT MATH APPL, V61, P443, DOI 10.1016/j.camwa.2010.11.021; Rana MA, 2008, PHYS LETT A, V372, P562, DOI 10.1016/j.physleta.2007.08.008; RAO AR, 1985, INT J ENG SCI, V23, P1387, DOI 10.1016/0020-7225(85)90117-X; Rathee R, 2011, INT J PHYS SCI, V6, P2497; SARPKAYA T, 1961, AICHE J, V7, P324, DOI 10.1002/aic.690070231; Seth G.S., 2010, INT J ENG SCI TECHNO, V2, P1; Siddiqui AA, 2008, MATH MODEL ANAL, V13, P565, DOI 10.3846/1392-6292.2008.13.565-576; Siddiqui AM, 2008, COMMUN NONLINEAR SCI, V13, P1554, DOI 10.1016/j.cnsns.2006.10.005; SREEHARIREDDY P, 2009, J SCI RES, V1, P220; SURI PK, 1981, INDIAN J PURE AP MAT, V12, P907; Sweet E, 2011, COMMUN NONLINEAR SCI, V16, P266, DOI 10.1016/j.cnsns.2010.03.019; Uddin MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049499; Vieru D, 2008, APPL MATH COMPUT, V197, P76, DOI 10.1016/j.amc.2007.07.033; Zheng LC, 2011, MATH COMPUT MODEL, V54, P780, DOI 10.1016/j.mcm.2011.03.025; Zheng LC, 2012, NONLINEAR ANAL-REAL, V13, P513, DOI 10.1016/j.nonrwa.2011.02.016	43	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e61531	10.1371/journal.pone.0061531	http://dx.doi.org/10.1371/journal.pone.0061531			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667442	gold, Green Submitted, Green Published			2022-12-25	WOS:000319055600012
J	Lee, YJ; Shi, RH; Witt, SN				Lee, Yong Joo; Shi, Runhua; Witt, Stephan N.			The Small Molecule Triclabendazole Decreases the Intracellular Level of Cyclic AMP and Increases Resistance to Stress in Saccharomyces cerevisiae	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; CHRONOLOGICAL LIFE-SPAN; MAMMALIAN ADENYLYL-CYCLASE; P-SITE INHIBITION; ALPHA-SYNUCLEIN; REGULATORY SUBUNIT; INDUCED APOPTOSIS; BINDING-AFFINITY; STATIONARY-PHASE; KINETIC-ANALYSIS	The Ras-adenylyl cyclase-protein kinase A nutrient-sensing pathway controls metabolism, proliferation and resistance to stress in Saccharomyces cerevisiae. The genetic disruption of this pathway increases resistance to a variety of stresses. We show here that the pharmacological inhibition of this pathway by the drug triclabendazole increases resistance to oxidants, heat stress and extends the chronological life. Evidence is presented that triclabendazole decreases the intracellular level of cyclic AMP by inhibiting adenylyl cyclase and triggers the parallel rapid translocation of the stress-resistance transcription factor Msn2 from the cytosol into the nucleus, as deduced from experiments employing a strain in which MSN2 is replaced with MSN2-GFP (GFP, green fluorescent protein). Msn2 and Msn4 are responsible for activating the transcription of numerous genes that encode proteins that protect cells from stress. The results are consistent with triclabendazole either inhibiting the association of Ras with adenylyl cyclase or directly inhibiting adenylyl cyclase, which in turn triggers Msn2/4 to enter the nucleus and activate stress-responsible element gene expression.	[Lee, Yong Joo; Witt, Stephan N.] Louisiana State Univ, Hlth Sci Ctr Shreveport, Dept Biochem & Mol Biol, Shreveport, LA 71105 USA; [Shi, Runhua] Louisiana State Univ, Hlth Sci Ctr Shreveport, Feist Weiller Canc Ctr, Shreveport, LA 71105 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Witt, SN (corresponding author), Louisiana State Univ, Hlth Sci Ctr Shreveport, Dept Biochem & Mol Biol, Shreveport, LA 71105 USA.		Witt, Stephan N/M-7922-2013	Witt, Stephan N/0000-0002-6462-2840	National Institutes of Health [NS057656]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057656] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by grant NS057656 (to SNW) from the National Institutes of Health (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bharucha JP, 2008, MOL BIOL CELL, V19, P1032, DOI 10.1091/mbc.E07-05-0499; BHATTACHARYA S, 1995, P NATL ACAD SCI USA, V92, P2984, DOI 10.1073/pnas.92.7.2984; Bonawitz ND, 2007, CELL METAB, V5, P265, DOI 10.1016/j.cmet.2007.02.009; BROEK D, 1985, CELL, V41, P763, DOI 10.1016/S0092-8674(85)80057-X; Dessauer CW, 1997, J BIOL CHEM, V272, P27787, DOI 10.1074/jbc.272.44.27787; Dong CM, 2011, J BIOL CHEM, V286, P43361, DOI 10.1074/jbc.M111.267286; ENGELBERG D, 1990, EMBO J, V9, P641, DOI 10.1002/j.1460-2075.1990.tb08156.x; Fabrizio P, 2004, J CELL BIOL, V166, P1055, DOI 10.1083/jcb.200404002; Fabrizio P, 2003, GENETICS, V163, P35; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Fairweather I, 1999, VET J, V158, P81, DOI 10.1053/tvjl.1999.0377; Flower TR, 2005, J MOL BIOL, V351, P1081, DOI 10.1016/j.jmb.2005.06.060; Gitler AD, 2009, NAT GENET, V41, P308, DOI 10.1038/ng.300; Granot D, 2003, FEMS YEAST RES, V4, P7, DOI 10.1016/S1567-1356(03)00154-5; GRANOT D, 1991, P NATL ACAD SCI USA, V88, P5724, DOI 10.1073/pnas.88.13.5724; GREGA DS, 1987, J NEUROSCI, V7, P700; Hampsey M, 1997, YEAST, V13, P1099, DOI 10.1002/(SICI)1097-0061(19970930)13:12<1099::AID-YEA177>3.3.CO;2-Z; Hurley JH, 1999, J BIOL CHEM, V274, P7599, DOI 10.1074/jbc.274.12.7599; Jourdain I, 2009, CELL MOTIL CYTOSKEL, V66, P509, DOI 10.1002/cm.20351; Keiser J, 2005, EXPERT OPIN INV DRUG, V14, P1513, DOI 10.1517/13543784.14.12.1513; KURET J, 1988, J BIOL CHEM, V263, P9149; Lee YJ, 2011, BIOCHEM BIOPH RES CO, V414, P205, DOI 10.1016/j.bbrc.2011.09.057; Lee YJ, 2011, J BIOL CHEM, V286, P20267, DOI 10.1074/jbc.M110.209379; Lee YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015946; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Longo VD, 2012, CELL METAB, V16, P18, DOI 10.1016/j.cmet.2012.06.002; LOUTAN L, 1989, LANCET, V2, P383; LUBEGA GW, 1991, EXP PARASITOL, V73, P203, DOI 10.1016/0014-4894(91)90023-P; Madia F, 2009, J CELL BIOL, V186, P509, DOI 10.1083/jcb.200906011; MATSUMOTO K, 1984, J BACTERIOL, V157, P277, DOI 10.1128/JB.157.1.277-282.1984; MATSUMOTO K, 1982, P NATL ACAD SCI-BIOL, V79, P2355, DOI 10.1073/pnas.79.7.2355; MITSUZAWA H, 1989, GENETICS, V123, P739; NEAL SE, 1988, J BIOL CHEM, V263, P19718; Pan Y, 2011, CELL METAB, V13, P668, DOI 10.1016/j.cmet.2011.03.018; Park JI, 2005, J BIOL CHEM, V280, P2529, DOI 10.1074/jbc.M407900200; Parrou JL, 1997, ANAL BIOCHEM, V248, P186, DOI 10.1006/abio.1997.2138; Pierre S, 2009, NAT REV DRUG DISCOV, V8, P321, DOI 10.1038/nrd2827; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Reinders A, 1998, GENE DEV, V12, P2943, DOI 10.1101/gad.12.18.2943; Roosen J, 2005, MOL MICROBIOL, V55, P862, DOI 10.1111/j.1365-2958.2004.04429.x; Saint-Marc C, 2009, GENETICS, V183, P529, DOI 10.1534/genetics.109.105858; Snyder SH, 2011, P NATL ACAD SCI USA, V108, P18869, DOI 10.1073/pnas.1114346108; TATCHELL K, 1985, P NATL ACAD SCI USA, V82, P3785, DOI 10.1073/pnas.82.11.3785; Tesmer JJG, 2000, BIOCHEMISTRY-US, V39, P14464, DOI 10.1021/bi0015562; TODA T, 1987, MOL CELL BIOL, V7, P1371, DOI 10.1128/MCB.7.4.1371; TODA T, 1987, CELL, V50, P277, DOI 10.1016/0092-8674(87)90223-6; TODA T, 1985, CELL, V40, P27, DOI 10.1016/0092-8674(85)90305-8; Villegas F, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001720; Wang C, 2009, GENETICS, V183, P1373, DOI 10.1534/genetics.109.107797; Wang SX, 2012, P NATL ACAD SCI USA, V109, P16119, DOI 10.1073/pnas.1206286109; WIEGN P, 1993, ANAL BIOCHEM, V208, P217, DOI 10.1006/abio.1993.1035	51	16	17	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e64337	10.1371/journal.pone.0064337	http://dx.doi.org/10.1371/journal.pone.0064337			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667708	Green Published, gold, Green Submitted			2022-12-25	WOS:000319055600090
J	Abd-Alla, AMM; Kariithi, HM; Mohamed, AH; Lapiz, E; Parker, AG; Vreysen, MJB				Abd-Alla, Adly M. M.; Kariithi, Henry M.; Mohamed, Abdul Hasim; Lapiz, Edgardo; Parker, Andrew G.; Vreysen, Marc J. B.			Managing Hytrosavirus Infections in Glossina pallidipes Colonies: Feeding Regime Affects the Prevalence of Salivary Gland Hypertrophy Syndrome	PLOS ONE			English	Article							TSETSE FLIES GLOSSINA; LOP-EARED RABBITS; DNA VIRUS; AUSTENI NEWST; MORSITANS CENTRALIS; LIVING HOST; DIPTERA; MEMBRANE; ABSENCE	Many species of tsetse flies are infected by a virus that causes salivary gland hypertrophy (SGH) syndrome and the virus isolated from Glossina pallidipes (GpSGHV) has recently been sequenced. Flies with SGH have a reduced fecundity and fertility. Due to the deleterious impact of SGHV on G. pallidipes colonies, several approaches were investigated to develop a virus management strategy. Horizontal virus transmission is the major cause of the high prevalence of the GpSGHV in tsetse colonies. Implementation of a "clean feeding'' regime (fresh blood offered to each set of flies so that there is only one feed per membrane), instead of the regular feeding regime (several successive feeds per membrane), was among the proposed approaches to reduce GpSGHV infections. However, due to the absence of disposable feeding equipment (feeding trays and silicone membranes), the implementation of a clean feeding approach remains economically difficult. We developed a new clean feeding approach applicable to large-scale tsetse production facilities using existing resources. The results indicate that implementing this approach is feasible and leads to a significant reduction in virus load from 10(9) virus copies in regular colonies to an average of 10(2.5) and eliminates the SGH syndrome from clean feeding colonies by28 months post implementation of this approach. The clean feeding approach also reduced the virus load from an average of 10(8) virus copy numbers to an average of 10(3) virus copies and SGH prevalence of 10% to 4% in flies fed after the clean fed colony. Taken together, these data indicate that the clean feeding approach is applicable in large-scale G. pallidipes production facilities and eliminates the deleterious effects of the virus and the SGH syndrome in these colonies.	[Abd-Alla, Adly M. M.; Kariithi, Henry M.; Mohamed, Abdul Hasim; Lapiz, Edgardo; Parker, Andrew G.; Vreysen, Marc J. B.] Joint FAO IAEA Programme Nucl Tech Food & Agr, Insect Pest Control Lab, Vienna, Austria; [Kariithi, Henry M.] Wageningen Univ, Virol Lab, NL-6700 AP Wageningen, Netherlands	International Atomic Energy Agency; Wageningen University & Research	Abd-Alla, AMM (corresponding author), Joint FAO IAEA Programme Nucl Tech Food & Agr, Insect Pest Control Lab, Vienna, Austria.	a.m.m.abd-alla@iaea.org		ABD-ALLA, Adly/0000-0001-7540-4462; Kariithi, Henry/0000-0002-9250-9108; Parker, Andrew Gordon/0000-0001-8187-1278	Netherlands Fellowship Program Grant [CF7548/2011]	Netherlands Fellowship Program Grant	HMK is a recipient of a Netherlands Fellowship Program Grant award CF7548/2011 (www.nuffic.nl) for Sandwich PhD Programme at Wageningen University, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Alla A, 2007, J VIROL METHODS, V139, P143, DOI 10.1016/j.jviromet.2006.09.018; Abd-Alla AMM, 2008, J VIROL, V82, P4595, DOI 10.1128/JVI.02588-07; Abd-Alla AMM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038417; Abd-Alla AMM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001220; Abd-Alla AMM, 2010, VIRUS RES, V150, P103, DOI 10.1016/j.virusres.2010.03.001; Abd-Alla AMM, 2009, ARCH VIROL, V154, P909, DOI 10.1007/s00705-009-0398-5; Abd-Alla AMM, 2009, VIRUS RES, V139, P48, DOI 10.1016/j.virusres.2008.10.006; Alemu T., 2007, P325, DOI 10.1007/978-1-4020-6059-5_30; [Anonymous], 2010, R LANG ENV STAT COMP; Baier T, 2007, COMPUTATION STAT, V22, P91, DOI 10.1007/s00180-007-0023-6; BAUER B, 1976, B ENTOMOL RES, V65, P563, DOI 10.1017/S0007485300006246; Feldmann U, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P701, DOI 10.1007/1-4020-4051-2_27; Feldmann U, 1994, TECHNIQUES INSECT RE, P13; Feldmann U, 1994, TECHNIQUES INSECT RE, P449; Feldmann U, 1992, P SEM JOINTL ORG INT, P167; FELDMANN U, 1993, MANAGEMENT INSECT PE, P579; Geerts S, 2001, TRENDS PARASITOL, V17, P25, DOI 10.1016/S1471-4922(00)01827-4; Gooding R. H., 1997, The molecular biology of insect disease vectors: a methods manual., P41; Hendrichs J., 2007, P3; Jordan A, 1986, TRYPANOSOMIASIS CONT; JORDAN AM, 1968, B ENTOMOL RES, V58, P399, DOI 10.1017/S0007485300056923; JORDAN AM, 1967, ANN TROP MED PARASIT, V61, P182, DOI 10.1080/00034983.1967.11686477; JURA WGZO, 1989, CURR MICROBIOL, V18, P1, DOI 10.1007/BF01568821; Kariithi HM, 2013, J INVERTEBR PATHOL, V112, pS123, DOI 10.1016/j.jip.2012.04.016; Kariithi HM, 2013, J GEN VIROL, V94, P193, DOI 10.1099/vir.0.047423-0; Kariithi HM, 2010, J GEN VIROL, V91, P3065, DOI 10.1099/vir.0.023671-0; LANGLEY PA, 1969, NATURE, V221, P855, DOI 10.1038/221855a0; LANGLEY PA, 1972, T ROY SOC TROP MED H, V66, P310, DOI 10.1016/0035-9203(72)90172-1; LANGLEY PA, 1972, B ENTOMOL RES, V62, P215, DOI 10.1017/S0007485300047672; Leak SGA., 1998, TSETSE BIOL ECOLOGY, DOI [10.1079/9780851993003.0000, DOI 10.1079/9780851993003.0000]; Lietze VU, 2011, ANNU REV ENTOMOL, V56, P63, DOI 10.1146/annurev-ento-120709-144841; MEWS AR, 1977, B ENTOMOL RES, V67, P119, DOI 10.1017/S0007485300010944; Mews AR, 1972, TECHNIQUES USED IAEA, P243; Mutika GN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042188; NASH TAM, 1966, ANN TROP MED PARASIT, V60, P39, DOI 10.1080/00034983.1966.11686383; PAGOT J, 1972, CR ACAD SCI D NAT, V275, P911; Sang RC, 1996, J INVERTEBR PATHOL, V68, P253, DOI 10.1006/jipa.1996.0093; Sang RC, 1998, MEM I OSWALDO CRUZ, V93, P861, DOI 10.1590/S0074-02761998000600030; Sokal R. R, 1981, BIOMETRY; STEELMAN CD, 1976, ANNU REV ENTOMOL, V21, P155, DOI 10.1146/annurev.en.21.010176.001103; Vreysen MJB, 2000, J ECON ENTOMOL, V93, P123, DOI 10.1603/0022-0493-93.1.123; WHO, 2001, WHO TDR COMM REP	42	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e61875	10.1371/journal.pone.0061875	http://dx.doi.org/10.1371/journal.pone.0061875			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667448	Green Submitted, Green Published, gold			2022-12-25	WOS:000319654700017
J	Armas, P; Margarit, E; Mouguelar, VS; Allende, ML; Calcaterra, NB				Armas, Pablo; Margarit, Ezequiel; Mouguelar, Valeria S.; Allende, Miguel L.; Calcaterra, Nora B.			Beyond the Binding Site: In Vivo Identification of tbx2, smarca5 and wnt5b as Molecular Targets of CNBP during Embryonic Development	PLOS ONE			English	Article							MYOTONIC-DYSTROPHY; PROTEIN; GENES; PROLIFERATION; EXPRESSION; DNA; REPRESSES; EXPANSION; YEAST	CNBP is a nucleic acid chaperone implicated in vertebrate craniofacial development, as well as in myotonic dystrophy type 2 (DM2) and sporadic inclusion body myositis (sIBM) human muscle diseases. CNBP is highly conserved among vertebrates and has been implicated in transcriptional regulation; however, its DNA binding sites and molecular targets remain elusive. The main goal of this work was to identify CNBP DNA binding sites that might reveal target genes involved in vertebrate embryonic development. To accomplish this, we used a recently described yeast one-hybrid assay to identify DNA sequences bound in vivo by CNBP. Bioinformatic analyses revealed that these sequences are G-enriched and show high frequency of putative G-quadruplex DNA secondary structure. Moreover, an in silico approach enabled us to establish the CNBP DNA-binding site and to predict CNBP putative targets based on gene ontology terms and synexpression with CNBP. The direct interaction between CNBP and candidate genes was proved by EMSA and ChIP assays. Besides, the role of CNBP upon the identified genes was validated in loss-of-function experiments in developing zebrafish. We successfully confirmed that CNBP up-regulates tbx2b and smarca5, and down-regulates wnt5b gene expression. The highly stringent strategy used in this work allowed us to identify new CNBP target genes functionally important in different contexts of vertebrate embryonic development. Furthermore, it represents a novel approach toward understanding the biological function and regulatory networks involving CNBP in the biology of vertebrates.	[Armas, Pablo; Margarit, Ezequiel; Mouguelar, Valeria S.; Calcaterra, Nora B.] Univ Nacl Rosario, Inst Biol Mol & Celular Rosario IBR, Consejo Nacl Invest Cient & Tecn CONICET, Fac Ciencias Bioquim & Farmaceut, RA-2000 Rosario, Santa Fe, Argentina; [Allende, Miguel L.] Univ Chile, Fac Ciencias, FONDAP Ctr Genome Regulat, Santiago, Chile	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; Universidad de Chile	Calcaterra, NB (corresponding author), Univ Nacl Rosario, Inst Biol Mol & Celular Rosario IBR, Consejo Nacl Invest Cient & Tecn CONICET, Fac Ciencias Bioquim & Farmaceut, S2000FHQ, RA-2000 Rosario, Santa Fe, Argentina.	calcaterra@ibr-conicet.gov.ar	Calcaterra, Nora/AAP-7469-2021; Allende, Miguel L/C-5167-2008	Allende, Miguel L/0000-0002-2783-2152; Margarit, Ezequiel/0000-0003-0031-2779; Armas, Pablo/0000-0002-0454-1424; , Nora/0000-0003-4259-9800	FONDAP [15090007]; ICGEB [CRP/CHI11-01]; ANPCyT [PICT 07-00648, PICT 11-1540]; CONICET [PIP 00480, PIP 00773]	FONDAP; ICGEB; ANPCyT(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MLA was funded by FONDAP (15090007) and ICGEB (CRP/CHI11-01). NBC and PA were funded by ANPCyT (PICT 07-00648 and PICT 11-1540) and CONICET (PIP 00480 and PIP 00773).	Abe Y, 2006, DEV BIOL, V295, P116, DOI 10.1016/j.ydbio.2006.03.012; Abrahams A, 2010, IUBMB LIFE, V62, P92, DOI 10.1002/iub.275; Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Armas P, 2004, GENE, V337, P151, DOI 10.1016/j.gene.2004.04.031; Armas P, 2008, J MOL BIOL, V382, P1043, DOI 10.1016/j.jmb.2008.07.079; Armas P, 2008, J CELL BIOCHEM, V103, P1013, DOI 10.1002/jcb.21474; Askanas V, 2007, CURR OPIN RHEUMATOL, V19, P550, DOI 10.1097/BOR.0b013e3282efdc7c; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Borgognone M, 2010, BIOCHEM J, V428, P491, DOI 10.1042/BJ20100038; Bradley EW, 2011, J CELL PHYSIOL, V226, P1683, DOI 10.1002/jcp.22499; Calcaterra NB, 2010, IUBMB LIFE, V62, P707, DOI 10.1002/iub.379; Chen W, 2003, DEVELOPMENT, V130, P1367, DOI 10.1242/dev.00349; Dale RM, 2009, ZEBRAFISH, V6, P9, DOI 10.1089/zeb.2008.0563; Dheen T, 1999, DEVELOPMENT, V126, P2703; Fernando H, 2009, NUCLEIC ACIDS RES, V37, P6716, DOI 10.1093/nar/gkp740; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Huichalaf C, 2009, J NEUROSCI, V29, P9042, DOI 10.1523/JNEUROSCI.1983-09.2009; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Kilian B, 2003, MECH DEVELOP, V120, P467, DOI 10.1016/S0925-4773(03)00004-2; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kudoh T, 2001, GENOME RES, V11, P1979, DOI 10.1101/gr.209601; LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139; Li J, 2006, J NEUROPATH EXP NEUR, V65, P826, DOI 10.1097/01.jnen.0000228204.19915.69; Lindeman LC, 2009, METHODS MOL BIOL, V567, P75, DOI 10.1007/978-1-60327-414-2_5; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu JA, 2010, BBA-REV CANCER, V1806, P268, DOI 10.1016/j.bbcan.2010.07.001; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Milla LA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-2; Niedowicz DM, 2010, NEUROSCI LETT, V482, P57, DOI 10.1016/j.neulet.2010.07.006; Nojima H, 2010, DEVELOPMENT, V137, P923, DOI 10.1242/dev.046425; Prince S, 2004, CANCER RES, V64, P1669, DOI 10.1158/0008-5472.CAN-03-3286; Ranum LPW, 2004, AM J HUM GENET, V74, P793, DOI 10.1086/383590; Rauch GJ, 1997, COLD SPRING HARB SYM, V62, P227, DOI 10.1101/SQB.1997.062.01.028; Redmond KL, 2010, ONCOGENE, V29, P3252, DOI 10.1038/onc.2010.84; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Scherrer T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r3; Schneider-Gold C, 2010, REV NEUROSCIENCE, V21, P19; Showell C, 2004, DEV DYNAM, V229, P201, DOI 10.1002/dvdy.10480; Sun HC, 2010, BIOINFORMATICS, V26, P405, DOI 10.1093/bioinformatics/btp681; Tang RY, 2007, ACTA BIOCH BIOPH SIN, V39, P384, DOI 10.1111/j.1745-7270.2007.00283.x; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Weiner AMJ, 2007, J CELL BIOCHEM, V102, P1553, DOI 10.1002/jcb.21380; Weiner AMJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029574; Weiner AMJ, 2011, DEV GROWTH DIFFER, V53, P934, DOI 10.1111/j.1440-169X.2011.01298.x; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Zeng J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1117	47	11	11	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63234	10.1371/journal.pone.0063234	http://dx.doi.org/10.1371/journal.pone.0063234			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667590	Green Published, gold, Green Submitted			2022-12-25	WOS:000319654700120
J	Gerstein, H; Hullinger, R; Lindstrom, MJ; Burger, C				Gerstein, Hilary; Hullinger, Rikki; Lindstrom, Mary J.; Burger, Corinna			A Behavioral Paradigm to Evaluate Hippocampal Performance in Aged Rodents for Pharmacological and Genetic Target Validation	PLOS ONE			English	Article							MORRIS WATER MAZE; OBJECT LOCATION MEMORY; INDIVIDUAL-DIFFERENCES; SPATIAL MEMORY; COGNITIVE IMPAIRMENT; CONTEXT RECOGNITION; SYNAPTIC PLASTICITY; BASAL FOREBRAIN; DENTATE GYRUS; TEMPORAL-LOBE	Aged-related cognitive ability is highly variable, ranging from unimpaired to severe impairments. The Morris water maze (a reliable tool for assessing memory) has been used to distinguish aged rodents that are superior learners from those that are learning impaired. This task, however, is not practical for pre- and post-pharmacological treatment, as the memory of the task is long lasting. In contrast, the object location memory task, also a spatial learning paradigm, results in a less robust memory that decays quickly. We demonstrate for the first time how these two paradigms can be used together to assess hippocampal cognitive impairments before and after pharmacological or genetic manipulations in rodents. Rats were first segregated into superior learning and learning impaired groups using the object location memory task, and their performance was correlated with future outcome on this task and on the Morris water maze. This method provides a tool to evaluate the effect of treatments on cognitive impairment associated with aging and neurodegenerative disorders.	[Gerstein, Hilary; Burger, Corinna] Univ Wisconsin, Dept Neurol, Med Sci Ctr, Madison, WI 53706 USA; [Gerstein, Hilary; Hullinger, Rikki] Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA; [Lindstrom, Mary J.] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Burger, C (corresponding author), Univ Wisconsin, Dept Neurol, Med Sci Ctr, Madison, WI 53706 USA.	burger@neurology.wisc.edu	Gerstein, Hertzel C/B-1235-2013	Gerstein, Hertzel C/0000-0001-8072-2836; Burger, Corinna/0000-0002-9432-0114	Department of Neurology, University of Wisconsin-Madison; University of Wisconsin Neuroscience Training Program Grant United States National Institutes of Health (NIH)/NIGMS [T32GM007507]; Clinical and Translational Science Award (CTSA) program [1UL1RR025011]; National Center for Advancing Translational Sciences (NCATS) [9U54TR000021]; UW-Madison Graduate School; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007507] Funding Source: NIH RePORTER	Department of Neurology, University of Wisconsin-Madison; University of Wisconsin Neuroscience Training Program Grant United States National Institutes of Health (NIH)/NIGMS; Clinical and Translational Science Award (CTSA) program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); UW-Madison Graduate School; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by funds from the Department of Neurology, University of Wisconsin-Madison to C.B. H.G. and R.H. were supported by the University of Wisconsin Neuroscience Training Program Grant United States National Institutes of Health (NIH)/NIGMS T32GM007507. M.J.L. was supported by grant 1UL1RR025011 from the Clinical and Translational Science Award (CTSA) program, previously through the National Center for Research Resources (NCRR), and now by the National Center for Advancing Translational Sciences (NCATS), grant 9U54TR000021. H.G. was also supported by the UW-Madison Graduate School. Finally, we would also like to acknowledge the rat subjects who contributed to this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balderas I, 2008, LEARN MEMORY, V15, P618, DOI 10.1101/lm.1028008; Bizon JL, 2009, NEUROBIOL AGING, V30, P646, DOI 10.1016/j.neurobiolaging.2007.08.004; Brody DL, 2006, EXP NEUROL, V197, P330, DOI 10.1016/j.expneurol.2005.10.020; Burger C, 2008, NEUROBIOL LEARN MEM, V89, P379, DOI 10.1016/j.nlm.2007.11.006; Burger C, 2007, NEUROBIOL LEARN MEM, V87, P21, DOI 10.1016/j.nlm.2006.05.003; Burger C, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00140; Colombo PJ, 2002, HIPPOCAMPUS, V12, P285, DOI 10.1002/hipo.10016; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Day LB, 1999, BEHAV NEUROSCI, V113, P914, DOI 10.1037/0735-7044.113.5.914; Dellu F, 1997, NEUROBIOL LEARN MEM, V67, P121, DOI 10.1006/nlme.1996.3750; DETOLEDOMORRELL L, 1988, NEUROBIOL AGING, V9, P581, DOI 10.1016/S0197-4580(88)80117-9; Diniz DG, 2010, EUR J NEUROSCI, V32, P509, DOI 10.1111/j.1460-9568.2010.07296.x; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; Doyere V, 2000, BEHAV BRAIN RES, V114, P153, DOI 10.1016/S0166-4328(00)00223-0; Ennaceur A, 1997, EXP BRAIN RES, V113, P509, DOI 10.1007/PL00005603; Foster TC, 2007, NEUROBIOL LEARN MEM, V87, P522, DOI 10.1016/j.nlm.2006.12.009; GAGE FH, 1984, NEUROBIOL AGING, V5, P43, DOI 10.1016/0197-4580(84)90084-8; GAGE FH, 1986, J NEUROSCI, V6, P2837; GALLAGHER M, 1993, BEHAV NEUROSCI, V107, P618, DOI 10.1037/0735-7044.107.4.618; GALLAGHER M, 1989, NEUROBIOL AGING, V10, P691, DOI 10.1016/0197-4580(89)90006-7; Gallagher M, 2006, AGE, V28, P221, DOI 10.1007/s11357-006-9017-5; Gerstein H, 2013, NEUROBIOL AGING, DOI [10.1016/j.neurobiolaging.2013.02.006, DOI 10.1016/J.NEUR0BI0LAGING.2013.02.006.[]; Gulinello M, 2009, BEHAV BRAIN RES, V196, P220, DOI 10.1016/j.bbr.2008.09.002; Koh MT, 2010, NEUROPSYCHOPHARMACOL, V35, P1016, DOI 10.1038/npp.2009.207; Lindner MD, 1997, NEUROBIOL LEARN MEM, V68, P203, DOI 10.1006/nlme.1997.3782; Luparini MR, 2000, AGING-CLIN EXP RES, V12, P264, DOI 10.1007/BF03339846; MARKOWSKA AL, 1990, NEUROBIOL AGING, V11, P491, DOI 10.1016/0197-4580(90)90109-D; MARKOWSKA AL, 1989, NEUROBIOL AGING, V10, P31, DOI 10.1016/S0197-4580(89)80008-9; MartinezSerrano A, 1996, P NATL ACAD SCI USA, V93, P6355, DOI 10.1073/pnas.93.13.6355; Matzel LD, 2003, J NEUROSCI, V23, P6423; Matzel LD, 2008, LEARN MEMORY, V15, P733, DOI 10.1101/lm.954808; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Mumby DG, 2002, LEARN MEMORY, V9, P49, DOI 10.1101/lm.41302; Murai T, 2007, PHYSIOL BEHAV, V90, P116, DOI 10.1016/j.physbeh.2006.09.013; Paban V, 2005, NEUROSCIENCE, V132, P13, DOI 10.1016/j.neuroscience.2004.11.024; Paban W, 2005, BEHAV NEUROSCI, V119, P933, DOI 10.1037/0735-7044.119.4.933; Robitsek RJ, 2008, J NEUROSCI, V28, P8945, DOI 10.1523/JNEUROSCI.1893-08.2008; Rossato JI, 2007, LEARN MEMORY, V14, P36, DOI 10.1101/lm.422607; Schulz D, 2002, EUR J NEUROSCI, V16, P2175, DOI 10.1046/j.1460-9568.2002.02282.x; Stefanko DP, 2009, P NATL ACAD SCI USA, V106, P9447, DOI 10.1073/pnas.0903964106; Wu K, 2012, NEUROBIOL LEARN MEM, V97, P69, DOI 10.1016/j.nlm.2011.09.006	41	12	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62360	10.1371/journal.pone.0062360	http://dx.doi.org/10.1371/journal.pone.0062360			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667471	Green Submitted, gold, Green Published			2022-12-25	WOS:000319654700032
J	Hauer, D; Schelling, G; Gola, H; Campolongo, P; Morath, J; Roozendaal, B; Hamuni, G; Karabatsiakis, A; Atsak, P; Vogeser, M; Kolassa, IT				Hauer, Daniela; Schelling, Gustav; Gola, Hannah; Campolongo, Patrizia; Morath, Julia; Roozendaal, Benno; Hamuni, Gilava; Karabatsiakis, Alexander; Atsak, Piray; Vogeser, Michael; Kolassa, Iris-Tatjana			Plasma Concentrations of Endocannabinoids and Related Primary Fatty Acid Amides in Patients with Post-Traumatic Stress Disorder	PLOS ONE			English	Article							RISK-FACTORS; SYSTEM; ANANDAMIDE; VALIDATION; DISEASE; MEMORY; OBESE; PTSD	Background: Endocannabinoids (ECs) and related N-acyl-ethanolamides (NAEs) play important roles in stress response regulation, anxiety and traumatic memories. In view of the evidence that circulating EC levels are elevated under acute mild stressful conditions in humans, we hypothesized that individuals with traumatic stress exposure and post-traumatic stress disorder (PTSD), an anxiety disorder characterized by the inappropriate persistence and uncontrolled retrieval of traumatic memories, show measurable alterations in plasma EC and NAE concentrations. Methods: We determined plasma concentrations of the ECs anandamide (ANA) and 2-arachidonoylglycerol (2-AG) and the NAEs palmitoylethanolamide (PEA), oleoylethanolamide (OEA), stearoylethanolamine (SEA), and N-oleoyldopamine (OLDA) by HPLC-MS-MS in patients with PTSD (n = 10), trauma-exposed individuals without evidence of PTSD (n = 9) and in healthy control subjects (n = 29). PTSD was diagnosed according to DSM-IV criteria by administering the Clinician Administered PTSD Scale (CAPS), which also assesses traumatic events. Results: Individuals with PTSD showed significantly higher plasma concentrations of ANA (0.48 +/- 0.11 vs. 0.36 +/- 0.14 ng/ml, p = 0.01), 2-AG (8.93 +/- 3.20 vs. 6.2 +/- 62.10 ng/ml, p<0.01), OEA (5.90 +/- 2.10 vs. 3.88 +/- 1.85 ng/ml, p<0.01), SEA (2.70 +/- 3.37 vs. 0.83 +/- 0.47, ng/ml, p<0.05) and significantly lower plasma levels of OLDA (0.12 +/- 0.05 vs. 0.45 +/- 0.59 ng/ml, p<0.05) than healthy controls. Moreover, PTSD patients had higher 2-AG plasma levels (8.93 +/- 3.20 vs. 6.01 +/- 1.32 ng/ml, p = 0.03) and also higher plasma concentrations of PEA (4.06 +/- 1.87 vs. 2.63 +/- 1.34 ng/ml, p<0.05) than trauma-exposed individuals without evidence of PTSD. CAPS scores in trauma-exposed individuals with and without PTSD (n = 19) correlated positively with PEA (r = 0.55, p = 0.02) and negatively with OLDA plasma levels (r = -0.68, p<0.01). CAPS subscores for intrusions (r = -0.65, p<0.01), avoidance (r = -0.60, p<0.01) and hyperarousal (r = -0.66, p<0.01) were all negatively related to OLDA plasma concentrations. Conclusions: PTSD appears to be associated with changes in plasma EC/NAE concentrations. This may have pathophysiological and diagnostic consequences but will need to be reproduced in larger cohorts.	[Hauer, Daniela; Schelling, Gustav] Univ Munich, Dept Anaesthesiol, Munich, Germany; [Karabatsiakis, Alexander] Univ Ulm, Dept Clin & Biol Psychol, Inst Psychol & Educ, D-89069 Ulm, Germany; [Campolongo, Patrizia] Univ Roma La Sapienza, Dept Physiol & Pharmacol, Rome, Italy; [Gola, Hannah; Morath, Julia; Hamuni, Gilava; Kolassa, Iris-Tatjana] Univ Konstanz, Dept Psychol, Dept Clin & Neuropsychol, Constance, Germany; [Roozendaal, Benno; Atsak, Piray] Radboud Univ Nijmegen, Dept Cognit Neurosci, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Roozendaal, Benno; Atsak, Piray] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Vogeser, Michael] Univ Munich, Dept Clin Chem, Munich, Germany	University of Munich; Ulm University; Sapienza University Rome; University of Konstanz; Radboud University Nijmegen; Radboud University Nijmegen; University of Munich	Schelling, G (corresponding author), Univ Munich, Dept Anaesthesiol, Munich, Germany.	gustav.schelling@med.uni-muenchen.de	Atsak, Piray/GPX-9702-2022; Roozendaal, Benno/B-8403-2013; Atsak, piray/I-5880-2013; Kolassa, Iris Tatjana/Y-3032-2018; Schelling, Gustav/U-2603-2018; Atsak, Piray/AAB-1451-2019; Campolongo, Patrizia/D-4628-2009; Karabatsiakis, Alexander/AAY-7114-2020	Schelling, Gustav/0000-0002-6538-0652; Atsak, Piray/0000-0003-1828-2061; Campolongo, Patrizia/0000-0002-2827-8755; Karabatsiakis, Alexander/0000-0002-5822-0108	Department of Anaesthesiology of the University of Munich	Department of Anaesthesiology of the University of Munich	The study was financed by departmental funds from the Department of Anaesthesiology of the University of Munich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atsak P, 2012, P NATL ACAD SCI USA, V109, P3504, DOI 10.1073/pnas.1200742109; Balvers MGJ, 2009, J CHROMATOGR B, V877, P1583, DOI 10.1016/j.jchromb.2009.04.010; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Boscarino JA, 2008, PSYCHOSOM MED, V70, P668, DOI 10.1097/PSY.0b013e31817bccaf; Campolongo P, 2009, P NATL ACAD SCI USA, V106, P8027, DOI 10.1073/pnas.0903038106; Campolongo P, 2009, P NATL ACAD SCI USA, V106, P4888, DOI 10.1073/pnas.0900835106; Centonze D, 2008, CURR PHARM DESIGN, V14, P2370, DOI 10.2174/138161208785740018; Chouker A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010752; Cornelius JR, 2010, ADDICT BEHAV, V35, P91, DOI 10.1016/j.addbeh.2009.09.007; Cote M, 2007, INT J OBESITY, V31, P692, DOI 10.1038/sj.ijo.0803539; De Petrocellis L, 2004, BRIT J PHARMACOL, V141, P765, DOI 10.1038/sj.bjp.0705666; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; Di Filippo M, 2008, J NEUROL NEUROSUR PS, V79, P1224, DOI 10.1136/jnnp.2007.139071; Di Marzo V, 2009, EUR J ENDOCRINOL, V161, P715, DOI 10.1530/EJE-09-0643; Dlugos A, 2012, NEUROPSYCHOPHARMACOL, V37, P2416, DOI 10.1038/npp.2012.100; Fanelli F, 2012, J LIPID RES, V53, P481, DOI 10.1194/jlr.M021378; Feuerecker M, 2012, EUR J APPL PHYSIOL, V112, P2777, DOI 10.1007/s00421-011-2237-0; Fraser GA, 2009, CNS NEUROSCI THER, V15, P84, DOI 10.1111/j.1755-5949.2008.00071.x; Ganon-Elazar E, 2012, NEUROPSYCHOPHARMACOL, V37, P456, DOI 10.1038/npp.2011.204; Glaser ST, 2006, J PHARMACOL EXP THER, V316, P1088, DOI 10.1124/jpet.105.094748; Grimaldi C, 2011, CURR MED CHEM, V18, P1575, DOI 10.2174/092986711795471374; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hauer D, 2008, ANESTHESIOLOGY, V109, pA1015; Hauer D, 2012, REV NEUROSCIENCE, V23, P681, DOI 10.1515/revneuro-2012-0058; Heyman E, 2012, PSYCHONEUROENDOCRINO, V37, P844, DOI 10.1016/j.psyneuen.2011.09.017; Hill MN, 2008, PHARMACOPSYCHIATRY, V41, P48, DOI 10.1055/s-2007-993211; Hill MN, 2010, P NATL ACAD SCI USA, V107, P9406, DOI 10.1073/pnas.0914661107; Hill MN, 2009, NEUROPSYCHOPHARMACOL, V34, P2733, DOI 10.1038/npp.2009.114; Hill MN, 2009, PSYCHONEUROENDOCRINO, V34, P1257, DOI 10.1016/j.psyneuen.2009.03.013; Jean-Gilles L, 2010, IMMUNOBIOLOGY, V215, P606, DOI 10.1016/j.imbio.2009.12.006; Kulisch C, 2013, BEHAV BRAIN RES, V236, P344, DOI 10.1016/j.bbr.2012.09.003; Maccarrone M, 2002, MOL CELL NEUROSCI, V21, P126, DOI 10.1006/mcne.2002.1164; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Moreira FA, 2010, CURR TOP BEHAV NEURO, V2, P429, DOI 10.1007/7854_2009_16; Pacher P, 2009, SEMIN IMMUNOPATHOL, V31, P63, DOI 10.1007/s00281-009-0145-8; Patel S, 2008, EUR J NEUROSCI, V27, P2821, DOI 10.1111/j.1460-9568.2008.06266.x; Rief W, 2003, PSYCHOSOMATICS, V44, P492, DOI 10.1176/appi.psy.44.6.492; Schauer M, 2011, NARRATIVE EXPOSURE T, P77; Schmidt A, 2006, BIOMED CHROMATOGR, V20, P336, DOI 10.1002/bmc.568; Schwarz Emanuel, 2011, Front Biosci (Elite Ed), V3, P308, DOI 10.2741/e246; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Stoll C, 1999, INTENS CARE MED, V25, P697, DOI 10.1007/s001340050932; Sugamura K, 2009, CIRCULATION, V119, P28, DOI 10.1161/CIRCULATIONAHA.108.811992; Vogeser M, 2006, CLIN CHEM LAB MED, V44, P488, DOI 10.1515/CCLM.2006.065; Vogeser M, 2007, CLIN CHEM LAB MED, V45, P1023, DOI 10.1515/CCLM.2007.197; Weis F, 2010, BRIT J ANAESTH, V105, P139, DOI 10.1093/bja/aeq117	46	119	122	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62741	10.1371/journal.pone.0062741	http://dx.doi.org/10.1371/journal.pone.0062741			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667516	gold, Green Submitted, Green Published			2022-12-25	WOS:000319654700060
J	Kaimori, JY; Iwai, S; Hatanaka, M; Teratani, T; Obi, Y; Tsuda, H; Isaka, Y; Yokawa, T; Kuroda, K; Ichimaru, N; Okumi, M; Yazawa, K; Rakugi, H; Nonomura, N; Takahara, S; Kobayashi, E				Kaimori, Jun-Ya; Iwai, Satomi; Hatanaka, Masaki; Teratani, Takumi; Obi, Yoshitsugu; Tsuda, Hidetoshi; Isaka, Yoshitaka; Yokawa, Takashi; Kuroda, Kagayaki; Ichimaru, Naotsugu; Okumi, Masayoshi; Yazawa, Koji; Rakugi, Hiromi; Nonomura, Norio; Takahara, Shiro; Kobayashi, Eiji			Non-Invasive Magnetic Resonance Imaging in Rats for Prediction of the Fate of Grafted Kidneys from Cardiac Death Donors	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; NORMOTHERMIC RECIRCULATION; PLASMINOGEN-ACTIVATOR; DIFFUSION; ISCHEMIA; PRESERVATION; PERFUSION; PATHOGENESIS; OBSTRUCTION; INJURY	The main objective of this study was to assess cardiac death (CD) kidney grafts before transplantation to determine whether blood oxygen level-dependent (BOLD) and diffusion MRI techniques can predict damage to these grafts after transplantation. We assessed CD kidney tissue by BOLD and diffusion MRI. We also examined pathological and gene expression changes in CD kidney grafts before and after transplantation. Although there was significantly more red cell congestion (RCC) in the inner stripe of the outer medulla (IS) in both 1 h after cardiac death (CD1h) and CD2h kidneys destined for grafts before transplantation compared with CD0h (p<0.05), CD2h, but not CD1h, kidney grafts had significantly different RCC in the IS 2 days after transplantation (p<0.05). Consistent with these pathological findings, tissue plasminogen activator (tPA) gene expression was increased only in the cortex and medulla of CD2h kidney grafts after transplantation. BOLD MRI successfully and non-invasively imaged and quantified RCC in the IS in both CD1h and CD2h kidney grafts (p<0.05). Diffusion MRI also non-invasively assessed increased the apparent diffusion coefficient in the IS and decreased it in the outer stripe (OS) of CD2h grafts, in concordance with interstitial edema in the IS and tubule cellular edema in the OS. These two types of edema in the outer medulla could explain the prolonged RCC in the IS only of CD2h kidney grafts, creating part of a vicious cycle inhibiting red cells coming out of capillary vessels in the IS. Perfusion with University of Wisconsin solution before MRI measurements did not diminish the difference in tissue damage between CD1h and CD2h kidney grafts. BOLD and diffusion MRI, which are readily available non-invasive tools for evaluating CD kidney grafts tissue damage, can predict prolonged organ damage, and therefore the outcome, of transplanted CD kidney grafts.	[Kaimori, Jun-Ya; Tsuda, Hidetoshi; Ichimaru, Naotsugu; Takahara, Shiro] Osaka Univ, Grad Sch Med, Dept Adv Technol Transplantat, Osaka, Japan; [Iwai, Satomi] Kitasato Univ, Sch Vet Med, Lab Small Anim Surg 1, Aomori, Japan; [Kaimori, Jun-Ya; Hatanaka, Masaki; Obi, Yoshitsugu; Isaka, Yoshitaka; Rakugi, Hiromi] Osaka Univ, Grad Sch Med, Dept Geriatr & Nephrol, Osaka, Japan; [Teratani, Takumi; Kobayashi, Eiji] Jichi Med Univ, Ctr Dev Adv Med Technol, Shimotsuke, Tochigi, Japan; [Yokawa, Takashi] BioView, Tokyo, Japan; [Kuroda, Kagayaki] Tokai Univ, Dept Human & Informat Sci, Sch Informat Sci & Technol, Hiratsuka, Kanagawa 25912, Japan; [Okumi, Masayoshi; Yazawa, Koji; Nonomura, Norio] Osaka Univ, Grad Sch Med, Dept Specif Organ Regulat Urol, Osaka, Japan	Osaka University; Kitasato University; Osaka University; Jichi Medical University; Tokai University; Osaka University	Isaka, Y (corresponding author), Osaka Univ, Grad Sch Med, Dept Geriatr & Nephrol, Osaka, Japan.	isaka@kid.med.osaka-u.ac.jp	Obi, Yoshitsugu/G-5764-2017	Obi, Yoshitsugu/0000-0001-7032-4383; Kuroda, Kagayaki/0000-0001-7065-1464; Rakugi, Hiromi/0000-0001-6508-4338	Ministry of Health, Labor, and Welfare of Japan; Japan Society for Organ Preservation, Medical Biology; JSPS [24659714]	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for Organ Preservation, Medical Biology; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was suported by a Grant-in-Aid for Progressive Renal Disease Research from the Ministry of Health, Labor, and Welfare of Japan, a research promoting grant of the Japan Society for Organ Preservation, Medical Biology and JSPS Grant-in-Aid for Challenging Exploratory Research Grant Number 24659714. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bock HA, 1997, NEPHRON, V76, P130; BOHLE A, 1990, AM J NEPHROL, V10, P374, DOI 10.1159/000168153; Garcia-Valdecasas JC, 2010, CURR OPIN ORGAN TRAN, V15, P173, DOI 10.1097/MOT.0b013e3283373488; Fondevila C, 2007, AM J TRANSPLANT, V7, P1849, DOI 10.1111/j.1600-6143.2007.01846.x; Gueler F, 2008, J IMMUNOL, V181, P1179, DOI 10.4049/jimmunol.181.2.1179; HELLBERG POA, 1990, KIDNEY INT, V37, P1240, DOI 10.1038/ki.1990.107; Iwai S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033157; KRISTENSEN P, 1984, FEBS LETT, V168, P33, DOI 10.1016/0014-5793(84)80201-X; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; LORENZ CH, 1991, MAGN RESON MED, V19, P254, DOI 10.1002/mrm.1910190211; Maathuis MHJ, 2007, TRANSPLANTATION, V83, P1289, DOI 10.1097/01.tp.0000265586.66475.cc; MASON J, 1987, KIDNEY INT, V31, P65, DOI 10.1038/ki.1987.10; Matthews PM, 2004, J NEUROL NEUROSUR PS, V75, P6; Moers C, 2010, NEPHROL DIAL TRANSPL, V25, P666, DOI 10.1093/ndt/gfp717; Moers C, 2012, TRANSPL INT, V25, P210, DOI 10.1111/j.1432-2277.2011.01383.x; MULLER MF, 1994, RADIOLOGY, V193, P711; Net M, 2005, AM J TRANSPLANT, V5, P2385, DOI 10.1111/j.1600-6143.2005.01052.x; OJTEG G, 1987, ACTA PHYSIOL SCAND, V129, P295, DOI 10.1111/j.1748-1716.1987.tb08072.x; Prasad PV, 2006, AM J PHYSIOL-RENAL, V290, pF958, DOI 10.1152/ajprenal.00114.2005; Ries M, 2003, J MAGN RESON IMAGING, V17, P104, DOI 10.1002/jmri.10224; Togao O, 2010, RADIOLOGY, V255, P772, DOI 10.1148/radiol.10091735; Valero R, 2000, TRANSPLANT INT, V13, P303, DOI 10.1111/j.1432-2277.2000.tb01086.x; WOLGAST M, 1991, KLIN WOCHENSCHR, V69, P1077, DOI 10.1007/BF01645162	24	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63573	10.1371/journal.pone.0063573	http://dx.doi.org/10.1371/journal.pone.0063573			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667641	Green Published, Green Submitted, gold			2022-12-25	WOS:000319654700164
J	Kassing, V; Engelmann, J; Kurtz, R				Kassing, Vanessa; Engelmann, Jacob; Kurtz, Rafael			Monitoring of Single-Cell Responses in the Optic Tectum of Adult Zebrafish with Dextran-Coupled Calcium Dyes Delivered via Local Electroporation	PLOS ONE			English	Article							STARBURST AMACRINE CELLS; LARVAL ZEBRAFISH; IN-VIVO; DIRECTION SELECTIVITY; NEURAL CIRCUIT; VISUAL-SYSTEM; NEURONS; GOLDFISH; UNITS; FLY	The zebrafish (Danio rerio) has become one of the major animal models for in vivo examination of sensory and neuronal computation. Similar to Xenopus tadpoles neural activity in the optic tectum, the major region controlling visually guided behavior, can be examined in zebrafish larvae by optical imaging. Prerequisites of these approaches are usually the transparency of larvae up to a certain age and the use of two-photon microscopy. This principle of fluorescence excitation was necessary to suppress crosstalk between signals from individual neurons, which is a critical issue when using membrane-permeant dyes. This makes the equipment to study neuronal processing costly and limits the approach to the study of larvae. Thus there is lack of knowledge about the properties of neurons in the optic tectum of adult animals. We established a procedure to circumvent these problems, enabling in vivo calcium imaging in the optic tectum of adult zebrafish. Following local application of dextran-coupled dyes single-neuron activity of adult zebrafish can be monitored with conventional widefield microscopy, because dye labeling remains restricted to tens of neurons or less. Among the neurons characterized with our technique we found neurons that were selective for a certain pattern orientation as well as neurons that responded in a direction-selective way to visual motion. These findings are consistent with previous studies and indicate that the functional integrity of neuronal circuits in the optic tectum of adult zebrafish is preserved with our staining technique. Overall, our protocol for in vivo calcium imaging provides a useful approach to monitor visual responses of individual neurons in the optic tectum of adult zebrafish even when only widefield microscopy is available. This approach will help to obtain valuable insight into the principles of visual computation in adult vertebrates and thus complement previous work on developing visual circuits.	[Kassing, Vanessa; Engelmann, Jacob] Univ Bielefeld, AG Act Sensing, D-33615 Bielefeld, Germany; [Kassing, Vanessa; Engelmann, Jacob] Univ Bielefeld, Ctr Excellence Cognit Interact Technol, D-33615 Bielefeld, Germany; [Kurtz, Rafael] Univ Bielefeld, Dept Neurobiol, D-33615 Bielefeld, Germany	University of Bielefeld; University of Bielefeld; University of Bielefeld	Kurtz, R (corresponding author), Univ Bielefeld, Dept Neurobiol, D-33615 Bielefeld, Germany.	rafael.kurtz@uni-bielefeld.de	Kurtz, Rafael/G-4782-2011		Deutsche Forschungsgemeinschaft (DFG) - Excellence Cluster 277: Cognitive Interaction Technology (CITEC); Deutsche Forschungsgemeinschaft; Open Access Publication Funds of Bielefeld University Library	Deutsche Forschungsgemeinschaft (DFG) - Excellence Cluster 277: Cognitive Interaction Technology (CITEC); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publication Funds of Bielefeld University Library	VK was funded by a scholarship of the "Deutsche Forschungsgemeinschaft (DFG) - Excellence Cluster 277: Cognitive Interaction Technology (CITEC)," http://www.dfg.de/en/research_funding/programmes/list/projectdetails/index.jsp?id = 39113330. The authors acknowledge support for the article processing charge by the Deutsche Forschungsgemeinschaft and the Open Access Publication Funds of Bielefeld University Library. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson T, 2009, THESIS STANFORD U; Baier H, 2009, CURR OPIN NEUROBIOL, V19, P553, DOI 10.1016/j.conb.2009.08.001; Batschelet E, 1981, CIRCULAR STAT BIOL; Bell CC, 2008, ANNU REV NEUROSCI, V31, P1, DOI 10.1146/annurev.neuro.30.051606.094225; Bollmann JH, 2009, NEURON, V61, P895, DOI 10.1016/j.neuron.2009.01.018; BURRILL JD, 1994, J COMP NEUROL, V346, P583, DOI 10.1002/cne.903460410; CHANG HT, 1993, BRAIN RES BULL, V30, P115, DOI 10.1016/0361-9230(93)90046-E; Del Bene F, 2010, SCIENCE, V330, P669, DOI 10.1126/science.1192949; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Friedrich RW, 2010, CURR BIOL, V20, pR371, DOI 10.1016/j.cub.2010.02.039; Fujiwara T, 2009, NEUROREPORT, V20, P1061, DOI 10.1097/WNR.0b013e32832e7d93; Gabriel JP, 2012, NEURON, V76, P1147, DOI 10.1016/j.neuron.2012.12.003; Gahtan E, 2005, J NEUROSCI, V25, P9294, DOI 10.1523/JNEUROSCI.2678-05.2005; Garaschuk O, 2006, PFLUG ARCH EUR J PHY, V453, P385, DOI 10.1007/s00424-006-0150-x; Grama A, 2012, FRONT NEURAL CIRCUIT, V6, DOI [10.3389/fncir.2012.00125, 10.3389/fncir.2012.00059]; Haas K, 2001, NEURON, V29, P583, DOI 10.1016/S0896-6273(01)00235-5; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Hausselt SE, 2007, PLOS BIOL, V5, P1474, DOI 10.1371/journal.pbio.0050185; Hennig P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003092; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Kelsh RN, 1996, DEVELOPMENT, V123, P369; KIRSCHBAUM F, 1975, Wilhelm Roux's Archives of Developmental Biology, V177, P129, DOI 10.1007/BF00848526; Kobbert C, 2000, PROG NEUROBIOL, V62, P327, DOI 10.1016/S0301-0082(00)00019-8; Li ZR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040132; Lister JA, 1999, DEVELOPMENT, V126, P3757; Maurer CM, 2011, REV NEUROSCIENCE, V22, P5, DOI 10.1515/RNS.2011.003; Maximov V, 2005, ANN NY ACAD SCI, V1048, P198, DOI 10.1196/annals.1342.018; Mobbs P., 1994, MICROELECTRODE TECHN, V2nd, P361; Nevian T, 2007, PFLUG ARCH EUR J PHY, V454, P675, DOI 10.1007/s00424-007-0234-2; Nevin LM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-126; Niell CM, 2005, NEURON, V45, P941, DOI 10.1016/j.neuron.2005.01.047; Nieuwenhuys R., 1998, CENTRAL NERVOUS SYST; Nikolaou N, 2012, NEURON, V76, P317, DOI 10.1016/j.neuron.2012.08.040; OBENAR JD, 1976, BRAIN RES BULL, V1, P529, DOI 10.1016/0361-9230(76)90080-0; Podgorski K, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001236; Ramdya P, 2008, NAT NEUROSCI, V11, P1083, DOI 10.1038/nn.2166; Renninger SL, 2011, NEUROGENETICS, V12, P97, DOI 10.1007/s10048-011-0273-x; Robles E, 2011, FRONT NEURAL CIRCUIT, V5, DOI 10.3389/fncir.2011.00001; Roeser T, 2003, J NEUROSCI, V23, P3726; SAJOVIC P, 1983, BRAIN RES, V271, P227, DOI 10.1016/0006-8993(83)90285-8; SAJOVIC P, 1982, NEUROSCIENCE, V7, P2407, DOI 10.1016/0306-4522(82)90204-4; SAJOVIC P, 1982, NEUROSCIENCE, V7, P2427, DOI 10.1016/0306-4522(82)90205-6; SCHELLART NAM, 1979, VISION RES, V19, P459, DOI 10.1016/0042-6989(79)90113-5; SCHMUED LC, 1993, J HISTOCHEM CYTOCHEM, V41, P777, DOI 10.1177/41.5.7682231; Scott EK, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.013.2009; Spalthoff C, 2012, FRONT NEURAL CIRCUIT, V6, P1, DOI 10.3389/fncir.2012.00072; Spalthoff C, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-36; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Straw Andrew D, 2008, Front Neuroinform, V2, P4, DOI 10.3389/neuro.11.004.2008; Sumbre G, 2008, NATURE, V456, P102, DOI 10.1038/nature07351; Walker AS, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00034; WARTZOK D, 1973, J NEUROPHYSIOL, V36, P588, DOI 10.1152/jn.1973.36.4.588	54	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62846	10.1371/journal.pone.0062846	http://dx.doi.org/10.1371/journal.pone.0062846			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667529	Green Submitted, Green Published, gold			2022-12-25	WOS:000319654700068
J	Li, Q; Cui, N; Du, YJ; Ma, HJ; Zhang, Y				Li, Qian; Cui, Na; Du, Yuanjie; Ma, Huijie; Zhang, Yi			Anandamide Reduces Intracellular Ca2+ Concentration through Suppression of Na+/Ca2+ Exchanger Current in Rat Cardiac Myocytes	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; VENTRICULAR MYOCYTES; CANNABINOID RECEPTOR; ISOLATED HEARTS; SODIUM/CALCIUM EXCHANGER; INTERMITTENT HYPOXIA; HYPERTENSIVE-RATS; INFARCT SIZE; CALCIUM; CB1	Purpose: Anandamide, one of the endocannabinoids, has been reported to exhibit cardioprotective properties, particularly in its ability to limit the damage produced by ischemia reperfusion injury. However, the mechanisms underlying the effect are not well known. This study is to investigate whether anandamide alter Na+/Ca2+ exchanger and the intracellular free Ca2+ concentration ([Ca2+](i)). Methods: Na+/Ca2+ exchanger current (I-NCX) was recorded and analysed by using whole-cell patch-clamp technique and [Ca2+](i) was measured by loading myocytes with the fluorescent Ca2+ indicator Fura-2/AM. Results: We found that I-NCX was enhanced significantly after perfusion with simulated ischemic external solution; [Ca2+](i) was also significantly increased by simulated ischemic solution. The reversal potential of I-NCX was shifted to negative potentials in simulated ischemic external solution. Anandamide (1-100 nM) failed to affect I-NCX and [Ca2+](i) in normal solution. However, anandamide (1-100 nM) suppressed the increase in INCX in simulated ischemic external solution concentration-dependently and normalized I-NCX reversal potential. Furthermore, anandamide (100 nM) significantly attenuated the increase in [Ca2+](i) in simulated ischemic solution. Blocking CB1 receptors with the specific antagonist AM251 (500 nM) failed to affect the effects of anandamide on I-NCX and [Ca2+](i) in simulated ischemic solution. CB2 receptor antagonist AM630 (100 nM) eliminated the effects of anandamide on I-NCX and [Ca2+](i) in simulated ischemic solution, and CB2 receptor agonist JWH133 (100 nM) simulated the effects of anandamide that suppressed the increase in I-NCX and [Ca2+](i) in simulated ischemic solution. In addition, pretreatment with the Gi/o-specific inhibitor pertussis toxin (PTX, 500 ng/ml) eliminated the effects of anandamide and JWH133 on I-NCX in simulated ischemic solution. Conclusions: Collectively, these findings suggest that anandamide suppresses calcium overload through inhibition of I-NCX during perfusion with simulated ischemic solution; the effects may be mediated by CB2 receptor via PTX-sensitive Gi/o proteins. This mechanism is importantly involved in the anti-ischemia injury caused by endocannabinoids.	[Li, Qian; Ma, Huijie; Zhang, Yi] Hebei Med Univ, Dept Physiol, Shijiazhuang, Peoples R China; [Cui, Na; Du, Yuanjie] Hebei Med Univ, Hosp 2, Dept Reprod, Shijiazhuang, Peoples R China	Hebei Medical University; Hebei Medical University	Zhang, Y (corresponding author), Hebei Med Univ, Dept Physiol, Shijiazhuang, Peoples R China.	zhyhenry@hotmail.com			National Natural Science Funds of China [31100823]; Hebei Province Health Bureau Scientific Research Funds [20110039]; Hebei Provincial Universities Outstanding Youth Science Funds [Y2012022]	National Natural Science Funds of China(National Natural Science Foundation of China (NSFC)); Hebei Province Health Bureau Scientific Research Funds; Hebei Provincial Universities Outstanding Youth Science Funds	This work was supported by the National Natural Science Funds of China (NO: 31100823); Hebei Province Health Bureau Scientific Research Funds (NO: 20110039), and Hebei Provincial Universities Outstanding Youth Science Funds (NO: Y2012022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonz A, 2003, J CARDIOVASC PHARM, V41, P657, DOI 10.1097/00005344-200304000-00020; Chen L, 2006, AM J PHYSIOL-CELL PH, V290, pC1221, DOI 10.1152/ajpcell.00526.2005; CORDEIRO JM, 1994, CARDIOVASC RES, V28, P1794, DOI 10.1093/cvr/28.12.1794; Currie S, 2008, J MOL CELL CARDIOL, V45, P804, DOI 10.1016/j.yjmcc.2008.07.005; Dipolo R, 2006, PHYSIOL REV, V86, P155, DOI 10.1152/physrev.00018.2005; Egger M, 1999, J MEMBRANE BIOL, V168, P107, DOI 10.1007/s002329900502; Evans RM, 2004, BRIT J PHARMACOL, V141, P1223, DOI 10.1038/sj.bjp.0705723; Felder CC, 1998, ANNU REV PHARMACOL, V38, P179, DOI 10.1146/annurev.pharmtox.38.1.179; Ford WR, 2002, BRIT J PHARMACOL, V135, P1191, DOI 10.1038/sj.bjp.0704565; Gardiner SM, 2001, BRIT J PHARMACOL, V133, P445, DOI 10.1038/sj.bjp.0704100; Grant I, 2005, CLIN NEUROSCI RES, V5, P185, DOI 10.1016/j.cnr.2005.08.015; Grynkiewicz G, 1985, J BIOL CHEM, V260, P3440; Hiley CR, 2009, J CARDIOVASC PHARM, V53, P267, DOI 10.1097/FJC.0b013e318192671d; Hiley CR, 2004, BIOL REV, V79, P187, DOI 10.1017/S1464793103006201; Imahashi K, 2005, CIRC RES, V97, P916, DOI 10.1161/01.RES.0000187456.06162.cb; KIEDROWSKI L, 1994, NEURON, V12, P295, DOI 10.1016/0896-6273(94)90272-0; Krylatov A. V., 2002, Eksperimental'naya i Klinicheskaya Farmakologiya, V65, P6; Krylatov AV, 2002, B EXP BIOL MED+, V133, P122, DOI 10.1023/A:1015574100494; Lake KD, 1997, HYPERTENSION, V29, P1204, DOI 10.1161/01.HYP.29.5.1204; Layland J, 2002, J PHYSIOL-LONDON, V540, P457, DOI 10.1113/jphysiol.2001.014126; Lee BK, 2012, J NEUROSCI RES, V90, P860, DOI 10.1002/jnr.22818; Lepicier P, 2003, BRIT J PHARMACOL, V139, P805, DOI 10.1038/sj.bjp.0705313; Lepicier P, 2007, LIFE SCI, V81, P1373, DOI 10.1016/j.lfs.2007.08.042; Li Q, 2012, AM J PHYSIOL-CELL PH, V302, pC924, DOI 10.1152/ajpcell.00228.2011; Li Q, 2009, BRIT J PHARMACOL, V158, P2022, DOI 10.1111/j.1476-5381.2009.00518.x; Mato S, 2009, GLIA, V57, P295, DOI 10.1002/glia.20757; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; Montecucco F, 2009, J MOL CELL CARDIOL, V46, P612, DOI 10.1016/j.yjmcc.2008.12.014; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; MURPHY E, 1991, CIRC RES, V68, P1250, DOI 10.1161/01.RES.68.5.1250; Murphy E, 1999, CIRC RES, V84, P1469; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Namekata I, 2006, EUR J PHARMACOL, V543, P108, DOI 10.1016/j.ejphar.2006.06.012; Pacher P, 2008, BRIT J PHARMACOL, V153, P252, DOI 10.1038/sj.bjp.0707582; Patterson M, 2007, J GEN PHYSIOL, V129, P29, DOI 10.1085/jgp.200609660; Pertwee RG, 1997, PHARMACOL THERAPEUT, V74, P129, DOI 10.1016/S0163-7258(97)82001-3; Ralevic V, 2002, LIFE SCI, V71, P2577, DOI 10.1016/S0024-3205(02)02086-6; Stein EA, 1996, BRIT J PHARMACOL, V119, P107, DOI 10.1111/j.1476-5381.1996.tb15683.x; Sterin-Borda L, 2005, BIOCHEM PHARMACOL, V69, P1705, DOI 10.1016/j.bcp.2005.03.027; Stojilkovic SS, 2009, ANN NY ACAD SCI, V1152, P174, DOI 10.1111/j.1749-6632.2008.03994.x; Tang Q, 2012, PFLUG ARCH EUR J PHY, V463, P513, DOI 10.1007/s00424-011-1070-y; Taniguchi S, 2004, J CARDIOVASC PHARM, V43, P629, DOI 10.1097/00005344-200405000-00004; Ugdyzhekova DS, 2001, B EXP BIOL MED+, V131, P251, DOI 10.1023/A:1017651432193; Underdown NJ, 2005, BRIT J PHARMACOL, V146, P809, DOI 10.1038/sj.bjp.0706391; Wang J, 2007, PHYSIOL RES, V56, P17, DOI 10.33549/physiolres.930894; Wang YG, 2003, CIRC RES, V93, P776, DOI 10.1161/01.RES.0000094746.24774.DC; Yamamoto W, 2008, EUR J PHARMACOL, V583, P56, DOI 10.1016/j.ejphar.2008.01.010; Yu SP, 1997, EUR J NEUROSCI, V9, P1273, DOI 10.1111/j.1460-9568.1997.tb01482.x; Zhang Y, 2000, LIFE SCI, V67, P2465, DOI 10.1016/S0024-3205(00)00832-8	49	15	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63386	10.1371/journal.pone.0063386	http://dx.doi.org/10.1371/journal.pone.0063386			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667607	Green Published, gold, Green Submitted			2022-12-25	WOS:000319654700136
J	Liu, CC; Sun, S; Sui, SF				Liu, Cui-Cui; Sun, Shan; Sui, Sen-Fang			The Role of the N-D1 Linker of the N-Ethylmaleimide-Sensitive Factor in the SNARE Disassembly	PLOS ONE			English	Article							NSF ATTACHMENT PROTEINS; INTERPROTOMER MOTION-TRANSMISSION; AAA ATPASE P97; FUSION PROTEIN; MEMBRANE-FUSION; CRYSTAL-STRUCTURE; VESICULAR TRANSPORT; TERMINAL DOMAIN; COMPLEX; BINDING	N-ethylmaleimide-sensitive factor (NSF) is a member of the type II AAA+ (ATPase associated with various cellular activities) family. It plays a critical role in intracellular membrane trafficking by disassembling soluble NSF attachment protein receptor (SNARE) complexes. Each NSF protomer consists of an N-terminal domain (N domain) followed by two AAA ATPase domains (D1 and D2) in tandem. The N domain is required for SNARE/alpha-SNAP binding and the D1 domain accounts for the majority of ATP hydrolysis. Little is known about the role of the N-D1 linker in the NSF function. This study presents detailed mutagenesis analyses of NSF N-D1 linker, dissecting its role in the SNARE disassembly, the SNARE/alpha-SNAP complex binding, the basal ATPase activity and the SNARE/alpha-SNAP stimulated ATPase activity. Our results show that the N-terminal region of the N-D1 linker associated mutants cause severe defect in SNARE complex disassembly, but little effects on the SNARE/alpha-SNAP complex binding, the basal and the SNARE/alpha-SNAP stimulated ATPase activity, suggesting this region may be involved in the motion transmission from D1 to N domain. Mutating the residues in middle and C-terminal region of the N-D1 linker increases the basal ATPase activity, indicating it may play a role in autoinhibiting NSF activity until it encounters SNARE/alpha-SNAP complex substrate. Moreover, mutations at the C-terminal sequence GIGG exhibit completely abolished or severely reduced activities of the substrate binding, suggesting that the flexibility of N-D1 linker is critical for the movement of the N domain that is required for the substrate binding. Taken together, these data suggest that the whole N-D1 linker is critical for the biological function of NSF to disassemble SNARE complex substrate with different regions responsible for different roles.	[Liu, Cui-Cui; Sun, Shan; Sui, Sen-Fang] Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China	Tsinghua University	Sun, S (corresponding author), Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	shansun@mail.tsinghua.edu.cn; suisf@mail.tsinghua.edu.cn			National Basic Research Program of China [2011CB910500/2010CB833706]; National Natural Science Foundation of China [31230016]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2011CB910500/2010CB833706) and the National Natural Science Foundation of China (31230016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonin W, 2002, NAT STRUCT BIOL, V9, P107, DOI 10.1038/nsb746; BLOCK MR, 1988, P NATL ACAD SCI USA, V85, P7852, DOI 10.1073/pnas.85.21.7852; Chang LF, 2012, NAT STRUCT MOL BIOL, V19, P268, DOI 10.1038/nsmb.2237; CLARY DO, 1990, CELL, V61, P709, DOI 10.1016/0092-8674(90)90482-T; Fleming KG, 1998, J BIOL CHEM, V273, P15675, DOI 10.1074/jbc.273.25.15675; Huang CD, 2012, P NATL ACAD SCI USA, V109, P9792, DOI 10.1073/pnas.1205853109; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Li GT, 2012, P NATL ACAD SCI USA, V109, P3737, DOI 10.1073/pnas.1200255109; Manno A, 2010, GENES CELLS, V15, P911, DOI 10.1111/j.1365-2443.2010.01428.x; Matveeva E, 1998, FEBS LETT, V435, P211, DOI 10.1016/S0014-5793(98)01071-0; Matveeva EA, 1997, J BIOL CHEM, V272, P26413, DOI 10.1074/jbc.272.42.26413; Matveeva EA, 2002, BIOCHEMISTRY-US, V41, P530, DOI 10.1021/bi015632s; May AP, 2001, J BIOL CHEM, V276, P21991, DOI 10.1074/jbc.R100013200; Merrill SA, 2010, J BIOL CHEM, V285, P35428, DOI 10.1074/jbc.M110.126318; Moeller A, 2012, J STRUCT BIOL, V177, P335, DOI 10.1016/j.jsb.2011.12.018; MORGAN A, 1994, J BIOL CHEM, V269, P29347; NAGIEC EE, 1995, J BIOL CHEM, V270, P29182, DOI 10.1074/jbc.270.49.29182; Niwa H, 2012, J BIOL CHEM, V287, P8561, DOI 10.1074/jbc.M111.302778; Smith GR, 2004, J STRUCT BIOL, V146, P189, DOI 10.1016/j.jsb.2003.11.022; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Steel GJ, 1998, FEBS LETT, V423, P113, DOI 10.1016/S0014-5793(98)00072-6; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; SUMIDA M, 1994, J BIOL CHEM, V269, P20636; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; TAGAYA M, 1993, J BIOL CHEM, V268, P2662; Tang WK, 2010, EMBO J, V29, P2217, DOI 10.1038/emboj.2010.104; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; WHITEHEART SW, 1994, J CELL BIOL, V126, P945, DOI 10.1083/jcb.126.4.945; Whiteheart SW, 2004, J STRUCT BIOL, V146, P32, DOI 10.1016/j.jsb.2003.09.015; Yu RC, 1999, MOL CELL, V4, P97, DOI 10.1016/S1097-2765(00)80191-4; Zhang T, 2012, PROTEINS, V80, P2758, DOI 10.1002/prot.24159; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X; Zhao CX, 2007, FEBS LETT, V581, P2140, DOI 10.1016/j.febslet.2007.03.032; Zhao CX, 2012, BBA-MOL CELL RES, V1823, P159, DOI 10.1016/j.bbamcr.2011.06.003; Zhao CX, 2010, J BIOL CHEM, V285, P761, DOI 10.1074/jbc.M109.056739	36	5	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e64346	10.1371/journal.pone.0064346	http://dx.doi.org/10.1371/journal.pone.0064346			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667709	Green Published, Green Submitted, gold			2022-12-25	WOS:000319654700207
J	Ma, YN; Wang, J; Dong, GH; Liu, MM; Wang, D; Liu, YQ; Zhao, Y; Ren, WH; Lee, YL; Zhao, YD; He, QC				Ma, Ya-Nan; Wang, Jing; Dong, Guang-Hui; Liu, Miao-Miao; Wang, Da; Liu, Yu-Qin; Zhao, Yang; Ren, Wan-Hui; Lee, Yungling Leo; Zhao, Ya-Dong; He, Qin-Cheng			Predictive Equations Using Regression Analysis of Pulmonary Function for Healthy Children in Northeast China	PLOS ONE			English	Article							SPIROMETRIC REFERENCE VALUES; ASTHMA-RELATED SYMPTOMS; LUNG-FUNCTION; HONG-KONG; ADOLESCENTS; STANDARDIZATION; GAP	Background: There have been few published studies on spirometric reference values for healthy children in China. We hypothesize that there would have been changes in lung function that would not have been precisely predicted by the existing spirometric reference equations. The objective of the study was to develop more accurate predictive equations for spirometric reference values for children aged 9 to 15 years in Northeast China. Methodology/Principal Findings: Spirometric measurements were obtained from 3,922 children, including 1,974 boys and 1,948 girls, who were randomly selected from five cities of Liaoning province, Northeast China, using the ATS (American Thoracic Society) and ERS (European Respiratory Society) standards. The data was then randomly split into a training subset containing 2078 cases and a validation subset containing 1844 cases. Predictive equations used multiple linear regression techniques with three predictor variables: height, age and weight. Model goodness of fit was examined using the coefficient of determination or the R-2 and adjusted R-2. The predicted values were compared with those obtained from the existing spirometric reference equations. The results showed the prediction equations using linear regression analysis performed well for most spirometric parameters. Paired t-tests were used to compare the predicted values obtained from the developed and existing spirometric reference equations based on the validation subset. The t-test for males was not statistically significant (p>0.01). The predictive accuracy of the developed equations was higher than the existing equations and the predictive ability of the model was also validated. Conclusion/Significance: We developed prediction equations using linear regression analysis of spirometric parameters for children aged 9-15 years in Northeast China. These equations represent the first attempt at predicting lung function for Chinese children following the ATS/ERS Task Force 2005 guidelines on spirometry standardization.	[Ma, Ya-Nan; Dong, Guang-Hui; Liu, Miao-Miao; Wang, Da; Liu, Yu-Qin; Zhao, Yang; He, Qin-Cheng] China Med Univ, Sch Publ Hlth, Dept Biostat & Epidemiol, Shenyang, Liaoning Provin, Peoples R China; [Wang, Jing] St Louis Univ, Dept Biostat, Sch Publ Hlth, St Louis, MO 63103 USA; [Ren, Wan-Hui] Shenyang Environm Monitoring Ctr, Dept Ambient Air Pollut Monitor, Shenyang, Liaoning Provin, Peoples R China; [Lee, Yungling Leo] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 100, Taiwan; [Zhao, Ya-Dong] China Med Univ, Affiliated Hosp 1, Inst Resp Dis, Shenyang, Liaoning Provin, Peoples R China	China Medical University; Saint Louis University; National Taiwan University; China Medical University	Dong, GH (corresponding author), China Med Univ, Sch Publ Hlth, Dept Biostat & Epidemiol, Shenyang, Liaoning Provin, Peoples R China.	ghdong@mail.cmu.edu.cn; qche@mail.cmu.edu.cn	Lee, Yungling/S-7011-2018; Dong, Guanghui/AAN-4630-2020	Lee, Yungling/0000-0002-2234-9479; Dong, Guang-Hui/0000-0002-2578-3369; Liu, Miao/0000-0002-7975-6702	Liaoning Province Science and Technology Foundation [2005225003-1]; China Environmental Protection Foundation [CEPF2008-123-1-5, CEPF2010-123-1-3]	Liaoning Province Science and Technology Foundation; China Environmental Protection Foundation	This research was supported by grants from Liaoning Province Science and Technology Foundation (No. 2005225003-1) and grants from China Environmental Protection Foundation (CEPF2008-123-1-5; CEPF2010-123-1-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandraki S, 2010, IN VIVO, V24, P195; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Blonshine S, 2012, GLOBAL LUNGS INITIAT; Boskabady MH, 2004, RESPIROLOGY, V9, P535, DOI 10.1111/j.1440-1843.2004.00623.x; Chhabra S K, 2012, Indian J Chest Dis Allied Sci, V54, P59; CONNETT GJ, 1994, THORAX, V49, P901, DOI 10.1136/thx.49.9.901; Dong GH, 2008, J INVEST ALLERG CLIN, V18, P207; Enright P, 2008, MT SINAI J MED, V75, P109, DOI 10.1002/msj.20027; Feng K, 2011, J KOREAN MED SCI, V26, P1469, DOI 10.3346/jkms.2011.26.11.1469; Ferguson GT, 2000, CHEST, V117, P1146, DOI 10.1378/chest.117.4.1146; Gao Y, 2012, ARCH DIS CH IN PRESS, V12; Golshan M, 2003, EUR RESPIR J, V22, P529, DOI 10.1183/09031936.03.00003603; GREENOUGH A, 1991, PEDIATR PULM, V11, P207, DOI 10.1002/ppul.1950110305; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Harik-Khan RI, 2001, AM J RESP CRIT CARE, V164, P1647, DOI 10.1164/ajrccm.164.9.2106075; Ip MSM, 2000, AM J RESP CRIT CARE, V162, P424, DOI 10.1164/ajrccm.162.2.9905057; Ip MSM, 2000, AM J RESP CRIT CARE, V162, P430, DOI 10.1164/ajrccm.162.2.9905058; Jeng MJ, 2009, PEDIATR PULM, V44, P676, DOI 10.1002/ppul.21038; Liang BM, 2012, RESPIROLOGY, V17, P611, DOI 10.1111/j.1440-1843.2012.02149.x; Liu GH, 1990, NATL NORMAL VALUES P, P10; Musafiri S, 2012, RESPIRATION IN PRESS, V11; National Bureau of Statistics of China, 2010, 6 NAT CENS DAT; Nysom K, 1997, EUR RESPIR J, V10, P1591, DOI 10.1183/09031936.97.10071591; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Salo PM, 2004, ANN EPIDEMIOL, V14, P543, DOI 10.1016/j.annepidem.2003.09.015; Stanojevic S, 2010, EUR RESPIR J, V36, P12, DOI 10.1183/09031936.00143209; Subbarao P, 2004, PEDIATR PULM, V37, P515, DOI 10.1002/ppul.20015; Tabka Z, 1995, Tunis Med, V73, P125; Takase M, 2012, PEDIAT PULMONOL, V19, P1; TAUSSIG LM, 1980, J PEDIATR-US, V97, P668, DOI 10.1016/S0022-3476(80)80039-4; Tsai MC, 2010, J CHIN MED ASSOC, V73, P21, DOI 10.1016/S1726-4901(10)70017-4; Vijayan V K, 2000, Indian J Chest Dis Allied Sci, V42, P147; *WHO, 1995, TECHN REP SER WHO, V854; Wu YH, 2009, J OCCUP HEALTH, V51, P471, DOI 10.1539/joh.L9006; Zhang JF, 2002, ENVIRON HEALTH PERSP, V110, P961, DOI 10.1289/ehp.02110961	35	28	28	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63875	10.1371/journal.pone.0063875	http://dx.doi.org/10.1371/journal.pone.0063875			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667682	Green Submitted, gold, Green Published			2022-12-25	WOS:000319654700192
J	Merz, K; Lie, DC				Merz, Katharina; Lie, D. Chichung			Evidence that Doublecortin Is Dispensable for the Development of Adult Born Neurons in Mice	PLOS ONE			English	Article							SUBCORTICAL LAMINAR HETEROTOPIA; MICROTUBULE-ASSOCIATED PROTEIN; OLFACTORY-BULB; HIPPOCAMPAL NEUROGENESIS; MAMMALIAN BRAIN; GRANULE CELLS; KNOCKOUT MICE; MIGRATION; EXPRESSION; MATURATION	In mammals, adult neural stem cells give rise to new hippocampal dentate granule neurons and interneurons of the olfactory bulb throughout life. The microtubule associated protein Doublecortin (DCX) is expressed by migrating neuroblasts and immature neurons, and is widely used as a stage-specific marker of adult neurogenesis and as a marker to identify neurogenic activity in the adult brain per se. Mutations in the DCX gene have been causally linked to human lissencephalic syndromes. Moreover, embryonic loss of DCX function interferes with neuronal migration and dendritic patterning in a species- and region-specific manner. A putative function of DCX in adult neurogenesis has not been directly explored. Here we show that overexpression of DCX in newly generated dentate granule neurons of the adult mouse brain has no effect on morphological maturation or migration. We also show that micro (mi) RNA-mediated retroviral knockdown of DCX does not alter morphological maturation of adult born dentate granule cells or migration of new neurons in either adult neurogenic niche. Thus, the present data indicate that DCX is dispensable for the development of new neurons in adult mice.	[Merz, Katharina; Lie, D. Chichung] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Dev Genet, Res Grp Adult Neurogenesis & Neural Stem Cells, Munich, Germany; [Lie, D. Chichung] Univ Erlangen Nurnberg, Inst Biochem, Emil Fischer Ctr, D-91054 Erlangen, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Erlangen Nuremberg	Lie, DC (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Dev Genet, Res Grp Adult Neurogenesis & Neural Stem Cells, Munich, Germany.	c.lie@biochem.uni-erlangen.de	Lie, Dieter Chichung/S-7914-2017; Lie, Dieter Chichung/AAS-8604-2020	Lie, Dieter Chichung/0000-0002-6035-6442; Lie, Dieter Chichung/0000-0002-6035-6442	European Young Investigator Award of the European Science Foundation [DFG 858/6-3]; Marie Curie Excellence Team Program of the European Union; Marie Curie Reintegration Program of the European Union; Bavarian Research Network on Adult Neural Stem Cells "FORNEUROCELL"; Helmholtz Alliance for Mental Health in an Ageing Society; BMBF Network "Cell Based Regenerative Medicine''; European Commission Coordination Action ENINET (Network of European Neuroscience Institutes) [LSHM-CT-2005-19063]	European Young Investigator Award of the European Science Foundation; Marie Curie Excellence Team Program of the European Union; Marie Curie Reintegration Program of the European Union; Bavarian Research Network on Adult Neural Stem Cells "FORNEUROCELL"; Helmholtz Alliance for Mental Health in an Ageing Society; BMBF Network "Cell Based Regenerative Medicine''; European Commission Coordination Action ENINET (Network of European Neuroscience Institutes)	This work was supported by the European Young Investigator Award of the European Science Foundation (DFG 858/6-3), the Marie Curie Excellence Team Program and the Marie Curie Reintegration Program of the European Union, the Bavarian Research Network on Adult Neural Stem Cells "FORNEUROCELL'', the Helmholtz Alliance for Mental Health in an Ageing Society, the BMBF Network "Cell Based Regenerative Medicine'', and the European Commission Coordination Action ENINET (Network of European Neuroscience Institutes; contract number LSHM-CT-2005-19063). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Belvindrah R, 2011, J NEUROSCI, V31, P7551, DOI 10.1523/JNEUROSCI.6716-10.2011; Brandt MD, 2003, MOL CELL NEUROSCI, V24, P603, DOI 10.1016/S1044-7431(03)00207-0; Corbo JC, 2002, J NEUROSCI, V22, P7548; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Couillard-Despres S, 2006, EUR J NEUROSCI, V24, P1535, DOI 10.1111/j.1460-9568.2006.05039.x; des Portes V, 1998, HUM MOL GENET, V7, P1063, DOI 10.1093/hmg/7.7.1063; des Portes V, 1998, CELL, V92, P51; Deuel TAS, 2006, NEURON, V49, P41, DOI 10.1016/j.neuron.2005.10.038; Dijkmans Thomas Frederik, 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P32; Ehm O, 2010, J NEUROSCI, V30, P13794, DOI 10.1523/JNEUROSCI.1567-10.2010; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; Jagasia R, 2009, J NEUROSCI, V29, P7966, DOI 10.1523/JNEUROSCI.1054-09.2009; Jessberger S, 2007, J NEUROSCI, V27, P9400, DOI 10.1523/JNEUROSCI.2002-07.2007; Kappeler C, 2006, HUM MOL GENET, V15, P1387, DOI 10.1093/hmg/ddl062; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kim JY, 2009, NEURON, V63, P761, DOI 10.1016/j.neuron.2009.08.008; Kim MH, 2003, NAT STRUCT BIOL, V10, P324, DOI 10.1038/nsb918; Klempin F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025760; Koizumi H, 2006, NEURON, V49, P55, DOI 10.1016/j.neuron.2005.10.040; Koizumi H, 2006, NAT NEUROSCI, V9, P779, DOI 10.1038/nn1704; Lemasson M, 2005, J NEUROSCI, V25, P6816, DOI 10.1523/JNEUROSCI.1114-05.2005; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Mathews EA, 2010, J COMP NEUROL, V518, P4479, DOI 10.1002/cne.22489; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mu LF, 2012, J NEUROSCI, V32, P3067, DOI 10.1523/JNEUROSCI.4679-11.2012; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P4095, DOI 10.1523/JNEUROSCI.5508-05.2006; Parent JM, 1997, J NEUROSCI, V17, P3727; Petreanu L, 2002, J NEUROSCI, V22, P6106; Piatti VC, 2011, J NEUROSCI, V31, P7715, DOI 10.1523/JNEUROSCI.1380-11.2011; Ramos RL, 2006, CEREB CORTEX, V16, P1323, DOI 10.1093/cercor/bhj074; Reiner O, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-188; Rottach A, 2008, HYBRIDOMA, V27, P337, DOI 10.1089/hyb.2008.0031; Saaltink DJ, 2012, J COMP NEUROL, V520, P2805, DOI 10.1002/cne.23144; Tanaka T, 2006, CEREB CORTEX, V16, pI69, DOI 10.1093/cercor/bhk005; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Tuy FPD, 2008, DEV NEUROSCI-BASEL, V30, P171, DOI 10.1159/000109861; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	40	15	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62693	10.1371/journal.pone.0062693	http://dx.doi.org/10.1371/journal.pone.0062693			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667508	Green Published, gold, Green Submitted			2022-12-25	WOS:000319654700056
J	Noor, AM; Alegana, VA; Kamwi, RN; Hansford, CF; Ntomwa, B; Katokele, S; Snow, RW				Noor, Abdisalan M.; Alegana, Victor A.; Kamwi, Richard N.; Hansford, Clifford F.; Ntomwa, Benson; Katokele, Stark; Snow, Robert W.			Malaria Control and the Intensity of Plasmodium falciparum Transmission in Namibia 1969-1992	PLOS ONE			English	Article							LIMITS	Background: Historical evidence of the levels of intervention scale up and its relationships to changing malaria risks provides important contextual information for current ambitions to eliminate malaria in various regions of Africa today. Methods: Community-based Plasmodium falciparum prevalence data from 3,260 geo-coded time-space locations between 1969 and 1992 were assembled from archives covering an examination of 230,174 individuals located in northern Namibia. These data were standardized the age-range 2 to less than 10 years and used within a Bayesian model-based geo-statistical framework to examine the changes of malaria risk in the years 1969, 1974, 1979, 1984 and 1989 at 565 km spatial resolution. This changing risk was described against rainfall seasons and the wide-scale use of indoor-residual house-spraying and mass drug administration. Results: Most areas of Northern Namibia experienced low intensity transmission during a ten-year period of wide-scale control activities between 1969 and 1979. As control efforts waned, flooding occurred, drug resistance emerged and the war for independence intensified the spatial extent of moderate-to-high malaria transmission expanded reaching a peak in the late 1980s. Conclusions: Targeting vectors and parasite in northern Namibia was likely to have successfully sustained a situation of low intensity transmission, but unraveled quickly to a peak of transmission intensity following a sequence of events by the early 1990s.	[Noor, Abdisalan M.; Alegana, Victor A.; Snow, Robert W.] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Malaria Publ Hlth Dept, Nairobi, Kenya; [Noor, Abdisalan M.; Snow, Robert W.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England; [Kamwi, Richard N.] Minist Hlth & Social Serv, Off Minister, Windhoek, Namibia; [Hansford, Clifford F.] Natl Inst Trop Dis, Tzaneen, South Africa; [Ntomwa, Benson; Katokele, Stark] Minist Hlth & Social Serv, Directorate Special Programmes, Natl Vectorborne Dis Control Programme, Windhoek, Namibia	Kenya Medical Research Institute; University of Oxford	Noor, AM (corresponding author), Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Malaria Publ Hlth Dept, Nairobi, Kenya.	anoor@nairobi.kemri-wellcome.org	Snow, Robert William/AFR-1436-2022; Alegana, Victor/P-6579-2019	Snow, Robert William/0000-0003-3725-6088; Alegana, Victor/0000-0001-5177-9227	Wellcome Trust [Intermediate Research Fellowship] [095127]; Principal Research Fellowship [079080]; Wellcome Trust Major Overseas Programme [092654]	Wellcome Trust [Intermediate Research Fellowship](Wellcome Trust); Principal Research Fellowship; Wellcome Trust Major Overseas Programme(Wellcome Trust)	This work was supported by the Wellcome Trust [Intermediate Research Fellowship grant to AMN (#095127) and a Principal Research Fellowship grant (#079080) to RWS]. Programmatic support for this study was also provided through a Wellcome Trust Major Overseas Programme grant to the Kenya Medical Research Institute/Wellcome Trust Research Programme (#092654). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], LEAPS REGRESSION SUB; Banerjee S, 2004, MONOGRAPHS STAT APPL, V101; Botha L., HIST DROUGHTS NAMIBI; Cohen JM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-213; De Meillon B., 1951, Bulletin of the World Health Organization, V4, P333; Diggle P, 2002, J R STAT SOC C-APPL, V51, P493, DOI 10.1111/1467-9876.00283; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; Gething PW, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-92; Gosoniu L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009322; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Hansford CF, 1990, MALARIA CONTRO UNPUB; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; ISAACS EH, 1989, APPL GEOSTATISTICS; Kamwi RN, 2005, THESIS U NAMIBIA NAM; Kazembe LN, 2006, INT J HEALTH GEOGR, V5, pe41; Mabaso MLH, 2004, TROP MED INT HEALTH, V9, P846, DOI 10.1111/j.1365-3156.2004.01263.x; Mendelsohn JM, 2002, ATLAS NAMIBIA COMPRE; Miller AJ, 2002, SUBSET SELECTION REG, DOI DOI 10.1201/9781420035933; Ministry of Health and Social Services, 2010, NAT VECT BORN DIS CO; Ministry of Health and Social Services, 1995, NAT POL STRAT MAL CO; Ministry of Health and Social Services, 2005, NAT MAL POL; Noor AM, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-180; Noor AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002081; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Smith DL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-131; Snow R.W., 2010, ESTIMATING DISTRIBUT; Snow RW, 2012, ADV PARASIT, V78, P169, DOI 10.1016/B978-0-12-394303-3.00010-4	28	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63350	10.1371/journal.pone.0063350	http://dx.doi.org/10.1371/journal.pone.0063350			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667604	Green Submitted, gold, Green Published			2022-12-25	WOS:000319654700133
J	O'Farrell, B; Benzie, JAH; McGinnity, P; de Eyto, E; Dillane, E; Coughlan, J; Cross, TF				O'Farrell, Brian; Benzie, John A. H.; McGinnity, Phil; de Eyto, Elvira; Dillane, Eileen; Coughlan, James; Cross, Tom F.			Selection and Phylogenetics of Salmonid MHC Class I: Wild Brown Trout (Salmo trutta) Differ from a Non-Native Introduced Strain	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; PEPTIDE-BINDING REGION; RAINBOW-TROUT; NATURAL-SELECTION; ONCORHYNCHUS-MYKISS; PARASITE RESISTANCE; BALANCING SELECTION; GENETIC DIVERSITY; MATE CHOICE; POLYMORPHISM	We tested how variation at a gene of adaptive importance, MHC class I (UBA), in a wild, endemic Salmo trutta population compared to that in both a previously studied non-native S. trutta population and a co-habiting Salmo salar population ( a sister species). High allelic diversity is observed and allelic divergence is much higher than that noted previously for cohabiting S. salar. Recombination was found to be important to population-level divergence. The alpha 1 and alpha 2 domains of UBA demonstrate ancient lineages but novel lineages are also identified at both domains in this work. We also find examples of recombination between UBA and the non-classical locus, ULA. Evidence for strong diversifying selection was found at a discrete suite of S. trutta UBA amino acid sites. The pattern was found to contrast with that found in re-analysed UBA data from an artificially stocked S. trutta population.	[O'Farrell, Brian; Benzie, John A. H.] Natl Univ Ireland Univ Coll Cork, Environm Res Inst, Cork, Ireland; [Benzie, John A. H.; McGinnity, Phil; Dillane, Eileen; Coughlan, James; Cross, Tom F.] Natl Univ Ireland Univ Coll Cork, Aquaculture & Fisheries Dev Ctr, Sch Biol Earth & Environm Sci, Cork, Ireland; [McGinnity, Phil; de Eyto, Elvira] Inst Marine, Newport, County Mayo, Ireland	University College Cork; University College Cork; Marine Institute Ireland	O'Farrell, B (corresponding author), Natl Univ Ireland Univ Coll Cork, Environm Res Inst, Cork, Ireland.	Eb.ofarrell@ucc.ie	Benzie, John A.H./L-6208-2018; McGinnity, Philip/P-6781-2015	Benzie, John/0000-0001-9599-8683; de Eyto, Elvira/0000-0003-2281-2491; McGinnity, Philip/0000-0001-5199-5632	Higher Education Authority Programme for Research in Third-Level Institutions; Beaufort Marine Research Award: Fish population genetics	Higher Education Authority Programme for Research in Third-Level Institutions; Beaufort Marine Research Award: Fish population genetics	Funding provided by the Higher Education Authority Programme for Research in Third-Level Institutions Cycle 3; Beaufort Marine Research Award: Fish population genetics. Irish Government National Development Plan (2007-2014) administered by the Marine Institute; Science Foundation Ireland (Microbial Phylogeography 05/FE1/B882). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Aoyagi K, 2002, J IMMUNOL, V168, P260, DOI 10.4049/jimmunol.168.1.260; Bernatchez L, 2003, J EVOLUTION BIOL, V16, P363, DOI 10.1046/j.1420-9101.2003.00531.x; Bos DH, 2006, MOL BIOL EVOL, V23, P137, DOI 10.1093/molbev/msj016; Carroll LS, 2002, P NATL ACAD SCI USA, V99, P2187, DOI 10.1073/pnas.042244899; CLARKE B, 1966, NATURE, V211, P999, DOI 10.1038/211999a0; Collins EJ, 2008, IMMUNOL RES, V41, P267, DOI 10.1007/s12026-008-8040-2; Consuegra S, 2005, IMMUNOGENETICS, V57, P16, DOI 10.1007/s00251-004-0765-z; Consuegra S, 2005, MOL BIOL EVOL, V22, P1095, DOI 10.1093/molbev/msi096; Consuegra S, 2008, P ROY SOC B-BIOL SCI, V275, P1397, DOI 10.1098/rspb.2008.0066; Coughlan J, 2006, ICES J MAR SCI, V63, P1248, DOI 10.1016/j.icesjms.2006.03.025; DOHERTY PC, 1975, NATURE, V256, P50, DOI 10.1038/256050a0; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Garrigan D, 2003, EVOLUTION, V57, P1707; Gebremedhin B, 2009, ANIM CONSERV, V12, P107, DOI 10.1111/j.1469-1795.2009.00255.x; Go Y, 2003, IMMUNOGENETICS, V55, P450, DOI 10.1007/s00251-003-0613-6; Grimholt U, 2002, IMMUNOGENETICS, V54, P570, DOI 10.1007/s00251-002-0499-8; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Hansen JD, 1999, J IMMUNOL, V163, P774; Hansen JD, 1996, DEV COMP IMMUNOL, V20, P417, DOI 10.1016/S0145-305X(96)00030-4; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kaufman J, 1999, IMMUNOGENETICS, V50, P228, DOI 10.1007/s002510050597; Kiryu I, 2005, FISH SHELLFISH IMMUN, V18, P243, DOI 10.1016/j.fsi.2004.07.007; Klein J, 1998, ANNU REV ECOL SYST, V29, P1, DOI 10.1146/annurev.ecolsys.29.1.1; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kurtz J, 2004, P ROY SOC B-BIOL SCI, V271, P197, DOI 10.1098/rspb.2003.2567; Landry C, 2001, P ROY SOC B-BIOL SCI, V268, P1279, DOI 10.1098/rspb.2001.1659; Lenz TL, 2011, EVOLUTION, V65, P2380, DOI 10.1111/j.1558-5646.2011.01288.x; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; Miller HC, 2004, MOL ECOL, V13, P3709, DOI 10.1111/j.1365-294X.2004.02368.x; Miller KM, 2001, GENETICA, V111, P237, DOI 10.1023/A:1013716020351; Miller KM, 2006, IMMUNOGENETICS, V58, P571, DOI 10.1007/s00251-006-0125-2; Muirhead CA, 2001, EVOLUTION, V55, P1532; Neff BD, 2008, HEREDITY, V101, P175, DOI 10.1038/hdy.2008.43; O'Farrell B, 2012, J FISH BIOL, V81, P1357, DOI 10.1111/j.1095-8649.2012.03421.x; O'Farrell B, 2012, HEREDITY, V108, P403, DOI 10.1038/hdy.2011.87; OBRIEN SJ, 1988, TRENDS ECOL EVOL, V3, P254, DOI 10.1016/0169-5347(88)90058-4; Phillips RB, 2003, IMMUNOGENETICS, V55, P561, DOI 10.1007/s00251-003-0615-4; Pitcher TE, 2006, MOL ECOL, V15, P2357, DOI 10.1111/j.1365-294X.2006.02942.x; R Core Team, 2022, R LANG ENV STAT COMP; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sette A, 2003, IMMUNOGENETICS, V54, P830, DOI 10.1007/s00251-002-0530-0; Shiina T, 2005, IMMUNOGENETICS, V56, P878, DOI 10.1007/s00251-004-0755-1; Shum BP, 1999, IMMUNOGENETICS, V49, P479, DOI 10.1007/s002510050524; Shum BP, 2002, IMMUNOGENETICS, V54, P193, DOI 10.1007/s00251-002-0450-z; Shum BP, 2001, J IMMUNOL, V166, P3297, DOI 10.4049/jimmunol.166.5.3297; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; SLADE RW, 1992, GENETICS, V132, P861; Spurgin LG, 2010, P ROY SOC B-BIOL SCI, V277, P979, DOI 10.1098/rspb.2009.2084; Stet RJM, 2002, IMMUNOGENETICS, V54, P320, DOI 10.1007/s00251-002-0477-1; Stewart-Jones GBE, 2005, J IMMUNOL, V175, P2459, DOI 10.4049/jimmunol.175.4.2459; Takahata N, 1998, GENETICA, V102-3, P157, DOI 10.1023/A:1017029613342; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; van Oosterhout C, 2009, P ROY SOC B-BIOL SCI, V276, P657, DOI 10.1098/rspb.2008.1299; WAKELAND EK, 1990, IMMUNOL RES, V9, P115, DOI 10.1007/BF02918202; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Weber DS, 2004, MOL ECOL, V13, P711, DOI 10.1111/j.1365-294X.2004.02095.x; Wilson DJ, 2006, GENETICS, V172, P1411, DOI 10.1534/genetics.105.044917; Xia C, 2002, FISH SHELLFISH IMMUN, V12, P287, DOI 10.1006/fsim.2001.0371; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yeager M, 1999, IMMUNOL REV, V167, P45, DOI 10.1111/j.1600-065X.1999.tb01381.x; Yeager M, 1997, MOL BIOL EVOL, V14, P1035, DOI 10.1093/oxfordjournals.molbev.a025709; Zhu M, 1999, NATURE, V397, P607, DOI 10.1038/17594	68	3	3	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63035	10.1371/journal.pone.0063035	http://dx.doi.org/10.1371/journal.pone.0063035			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667568	Green Published, Green Submitted, gold			2022-12-25	WOS:000319654700100
J	Park, EY; Lim, MK; Oh, JK; Cho, H; Bae, MJ; Yun, EH; Kim, DI; Shin, HR				Park, Eun Young; Lim, Min Kyung; Oh, Jin-Kyoung; Cho, Heeyoun; Bae, Mi Jin; Yun, E. Hwa; Kim, Dong-il; Shin, Hai-Rim			Independent and Supra-Additive Effects of Alcohol Consumption, Cigarette Smoking, and Metabolic Syndrome on the Elevation of Serum Liver Enzyme Levels	PLOS ONE			English	Article							GAMMA-GLUTAMYL-TRANSFERASE; FATTY LIVER; ALANINE AMINOTRANSFERASE; CARDIOVASCULAR-DISEASE; SOCIOECONOMIC-STATUS; HEPATIC STEATOSIS; NATURAL-HISTORY; RISK; PREVALENCE; PREDICTOR	We investigated the independent and combined effects of alcohol consumption, cigarette smoking and metabolic syndrome on abnormal liver function, i.e., the elevation of serum liver enzyme levels. Participants of a Korean populationbased prospective cohort aged >= 30 years without liver disease, diabetes, or cardiovascular diseases were included. Information on alcohol consumption, smoking status, and metabolic syndrome, defined as per the criteria of the Adult Treatment Panel III, were applied to evaluate their impact on serum levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), and gamma-glutamyl transferase (GGT). Alcohol consumption, cigarette smoking and metabolic syndrome were the significant individual factors that elevated serum liver enzyme levels. Supra-additive effects of metabolic syndrome and either alcohol consumption or cigarette smoking were also identified. The combination of heavy drinking (>= 24 g/day) and metabolic syndrome conferred an effect that was higher than the sum of the two individual effects (Synergic Index (SI): AST, 2.37 [1.20-4.67]; GGT, 1.91 [1.17-3.13]). Only GGT level (odds ratio 6.04 [3.68-9.94], SI 2.33 [1.24-4.41]) was significantly elevated when the effect of moderate drinking (<24 g/day) and metabolic syndrome was combined. The combined effect of any level of alcohol consumption and cigarette smoking was also supra-additive on the elevation of GGT level with SIs of 5.57 for drinking <24 g/day and smoking <= 20 pack years, 5.12 for <24 g/day and >20 pack years, 1.80 for >= 24 g/day and <= 20 pack years, 2.03 for >= 24 g/day and >20 pack years, while only the combined effect of drinking >= 24 g/day and smoking >20 pack years elevated the AST level (SI 4.55 [3.12-6.61]). The combined effect of cigarette smoking and metabolic syndrome was not supra-additive. To prevent fatty liver disease and other related diseases, a multifactorial prevention strategy that includes limited alcohol consumption, smoking cessation and rectification of adverse metabolic profiles is required.	[Park, Eun Young; Lim, Min Kyung; Oh, Jin-Kyoung; Cho, Heeyoun; Bae, Mi Jin; Yun, E. Hwa; Shin, Hai-Rim] Natl Canc Ctr, Natl Canc Control Inst, Goyang, South Korea; [Park, Eun Young] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Kim, Dong-il] Sungkunkwan Univ, Sch Med, Samsung Med Ctr, Dept Occupat & Environm Med, Suwon, South Korea; [Shin, Hai-Rim] WHO, Western Pacific Reg Off, Non Communicable Dis & Hlth Promot, Manila, Philippines	National Cancer Center - Korea (NCC); Seoul National University (SNU); Sungkyunkwan University (SKKU); Samsung Medical Center; WHO Western Pacific Regional Office; World Health Organization	Lim, MK (corresponding author), Natl Canc Ctr, Natl Canc Control Inst, Goyang, South Korea.	mickey@ncc.re.kr	Lim, Min Kyung/AAL-5271-2020	Lim, Min Kyung/0000-0002-8224-2171; Oh, Jin-Kyoung/0000-0001-9331-3054	National Cancer Center, Korea	National Cancer Center, Korea	The sole supporter of this study was the intramural research fund of the National Cancer Center, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2008, J GASTROEN HEPATOL, V23, P1089, DOI 10.1111/j.1440-1746.2008.05451.x; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; Azzalini L, 2010, HEPATOLOGY, V51, P1567, DOI 10.1002/hep.23516; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bataller R, 2006, HEPATOLOGY, V44, P1394, DOI 10.1002/hep.21484; Bedogni G, 2005, HEPATOLOGY, V42, P44, DOI 10.1002/hep.20734; Bellentani S, 1997, GUT, V41, P845, DOI 10.1136/gut.41.6.845; BELLENTANI S, 1994, HEPATOLOGY, V20, P1442, DOI 10.1002/hep.1840200611; Bellentani S, 2010, DIGEST DIS, V28, P155, DOI 10.1159/000282080; Bellentani S, 2009, ANN HEPATOL, V8, pS4, DOI 10.1016/S1665-2681(19)31820-4; Blachier M, 2013, J HEPATOL, V58, P593, DOI 10.1016/j.jhep.2012.12.005; Breitling LP, 2009, HEPATOLOGY, V49, P802, DOI 10.1002/hep.22727; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Clark JM, 2002, GASTROENTEROLOGY, V122, P1649, DOI 10.1053/gast.2002.33573; Clark JM, 2003, AM J GASTROENTEROL, V98, P960, DOI [10.1016/S0002-9270(03)00265-X, 10.1111/j.1572-0241.2003.07486.x]; El-Zayadi AR, 2006, WORLD J GASTROENTERO, V12, P6098, DOI 10.3748/wjg.v12.i38.6098; Farrell GC, 2013, NAFLD ASIA AS COMMON; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Gunji T, 2009, AM J GASTROENTEROL, V104, P2189, DOI 10.1038/ajg.2009.361; Hamabe A, 2011, J GASTROENTEROL, V46, P769, DOI 10.1007/s00535-011-0376-z; Hamaguchi M, 2007, WORLD J GASTROENTERO, V13, P1579, DOI 10.3748/wjg.v13.i10.1579; Hamaguchi M, 2012, WORLD J GASTROENTERO, V18, P156, DOI 10.3748/wjg.v18.i2.156; Haren MT, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-454; Hiramine Y, 2011, J GASTROENTEROL, V46, P519, DOI 10.1007/s00535-010-0336-z; Hsieh MH, 2009, INT J OBESITY, V33, P1309, DOI 10.1038/ijo.2009.172; Kim HC, 2004, BMJ-BRIT MED J, V328, P983, DOI 10.1136/bmj.38050.593634.63; Koh WP, 2011, BRIT J CANCER, V105, P1430, DOI 10.1038/bjc.2011.360; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Lanthier N, 2009, CURR OPIN CLIN NUTR, V12, P404, DOI 10.1097/MCO.0b013e32832c7819; Lee DH, 2001, INT J EPIDEMIOL, V30, P766, DOI 10.1093/ije/30.4.766; Li M, 2009, OBESITY, V17, P809, DOI 10.1038/oby.2008.617; Lim H, 2012, DIABETES CARE, V35, P2028, DOI 10.2337/dc11-1841; Liou I, 2006, J CLIN GASTROENTEROL, V40, pS11; McClain CJ, 2004, ALCOHOL, V34, P67, DOI 10.1016/j.alcohol.2004.07.007; Meisinger C, 2006, ATHEROSCLEROSIS, V189, P297, DOI 10.1016/j.atherosclerosis.2006.01.010; National Cholesterol Education Program, 2002, DET EV TREATM HIGH B; National Institute on Alcohol Abuse and Alcoholism, 1992, MOD DRINK ALC AL NO; Nobili V, 2009, WORLD J GASTROENTERO, V15, P6017, DOI 10.3748/wjg.15.6017; Oh SY, 2006, METABOLISM, V55, P1604, DOI 10.1016/j.metabol.2006.07.021; Park SJ, 2012, DIABETES RES CLIN PR, V96, P400, DOI 10.1016/j.diabres.2011.12.025; Pessione F, 2001, HEPATOLOGY, V34, P121, DOI 10.1053/jhep.2001.25385; Puukka K, 2006, AM J CLIN NUTR, V83, P1351, DOI 10.1093/ajcn/83.6.1351; Sakugawa H, 2004, WORLD J GASTROENTERO, V10, P1052; Sattar N, 2007, DIABETES, V56, P984, DOI 10.2337/db06-1256; Schindhelm RK, 2007, ATHEROSCLEROSIS, V191, P391, DOI 10.1016/j.atherosclerosis.2006.04.006; Schwimmer JB, 2010, GASTROENTEROLOGY, V138, P1357, DOI 10.1053/j.gastro.2009.12.052; Shin A, 2009, J AM DIET ASSOC, V109, P633, DOI 10.1016/j.jada.2008.12.015; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528; Yoon YS, 2006, OBESITY, V14, P909, DOI 10.1038/oby.2006.105; Zheng MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043736	51	29	30	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63439	10.1371/journal.pone.0063439	http://dx.doi.org/10.1371/journal.pone.0063439			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667618	Green Published, Green Submitted, gold			2022-12-25	WOS:000319654700145
J	Wu, LB; Jiang, X; Huang, LF; Chen, SL				Wu, Labin; Jiang, Xue; Huang, Linfang; Chen, Shilin			Processing Technology Investigation of Loquat (Eriobotrya japonica) Leaf by Ultra-Performance Liquid Chromatography-Quadrupole Time-of-Flight Mass Spectrometry Combined with Chemometrics	PLOS ONE			English	Article							CONSTITUENTS; TRITERPENOIDS; MACROPHAGES; LINDL.; LEAVES; LINES; ACID	Ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry (UPLC-QTOF/MS) and multivariate statistical analysis were used to investigate the processing technology of Loquat (Eriobotrya japonica) leaf (pipaye, PPY). The differences in samples processed using different methods were revealed by unsupervised principal component analysis (PCA). In the scores plot of PCA, honey-processed PPY (PPPY), crude PPY (CPPY), and heated PPY (HPPY) were clearly discriminated. Furthermore, samples processed at different temperatures could also be distinguished; indeed, our PCA results demonstrated the importance of temperature during processing. Two unique marker ions were found to discriminate between PPPY and CPPY by orthogonal partial least squares discriminant analysis (OPLS-DA), which could be used as potential chemical markers. The method was further confirmed by a verification test with commercial PPY. The orthogonal array experiment revealed an optimized processing condition with 50% honey at 140 degrees C for 20 min after 4 h of moistening time, a process that provides significant information for standardized production.	[Huang, Linfang] Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Huang, LF (corresponding author), Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100730, Peoples R China.	lfhuang@implad.ac.cn			National Natural Science Foundation of China [81274013]; Key National Natural Science Foundation of China [81130069]; Chinese National S&T Special Project on Major New Drug Innovation [2011ZX09307-002-01]; program for Changjiang Scholars and Innovative Research Team in University of Ministry of Education of China [IRT1150]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese National S&T Special Project on Major New Drug Innovation; program for Changjiang Scholars and Innovative Research Team in University of Ministry of Education of China	The study was supported by grants from the National Natural Science Foundation of China (No. 81274013), Key National Natural Science Foundation of China (81130069), and The Chinese National S&T Special Project on Major New Drug Innovation (2011ZX09307-002-01). The program for Changjiang Scholars and Innovative Research Team in University of Ministry of Education of China (IRT1150). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez ME, 2000, FARMACO, V55, P502, DOI 10.1016/S0014-827X(00)00067-7; Banno N, 2005, BIOL PHARM BULL, V28, P1995, DOI 10.1248/bpb.28.1995; [陈飞平 Chen Feiping], 2012, [食品科学, Food Science], V33, P336; Chen J, 2008, PHYTOMEDICINE, V15, P98, DOI 10.1016/j.phymed.2006.12.014; Chen JM, 1987, BEN CAO MENG QUAN; Chiang LC, 2003, AM J CHINESE MED, V31, P37, DOI 10.1142/S0192415X03000825; Churchwell MI, 2005, J CHROMATOGR B, V825, P134, DOI 10.1016/j.jchromb.2005.05.037; Cunha WR, 2003, PLANTA MED, V69, P470, DOI 10.1055/s-2003-39719; DETOMMASI N, 1991, PLANTA MED, V57, P414, DOI 10.1055/s-2006-960137; Diaz AM, 2000, BIOL PHARM BULL, V23, P1307, DOI 10.1248/bpb.23.1307; Farina C, 1998, FARMACO, V53, P22, DOI 10.1016/S0014-827X(97)00013-X; Guo Y, 2007, STUDIES CHEM REFEREN; Ito H, 2000, CHEM PHARM BULL, V48, P687, DOI 10.1248/cpb.48.687; Jeong HG, 1999, TOXICOL LETT, V105, P215, DOI 10.1016/S0378-4274(99)00004-1; [鞠建华 Ju Jianhua], 2003, [中国药学杂志, Chinese Pharmaceutical Journal], V38, P752; Kim SH, 2009, TOXICOL IN VITRO, V23, P1215, DOI 10.1016/j.tiv.2009.07.036; Li EN, 2009, PHYTOCHEM ANALYSIS, V20, P338, DOI 10.1002/pca.1134; Li SC, 1958, LEI GONG PAO ZHI YAO; Li SL, 2010, J PHARMACEUT BIOMED, V52, P468, DOI 10.1016/j.jpba.2010.01.032; Lin GM, 2010, CHINESE J EXPT TRADI, V16, P21; Lin JY, 2008, FOOD CHEM, V107, P1587, DOI 10.1016/j.foodchem.2007.10.025; Lin SQ, 2007, ACTA HORTIC, P37, DOI 10.17660/ActaHortic.2007.750.2; Qi YanFei, 2011, Zhongcaoyao = Chinese Traditional and Herbal Drugs, V42, P1217; Shao M, 2012, J ASIAN NAT PROD RES, V14, P348, DOI 10.1080/10286020.2011.653964; SHIMIZU M, 1986, CHEM PHARM BULL, V34, P2614; State Pharmacopoeia Committee, 2010, PHARM PEOPL REP CHIN; Su J., 1981, XIN XIU BEN CAO; Taniguchi S, 2002, PHYTOCHEMISTRY, V59, P315, DOI 10.1016/S0031-9422(01)00455-1; Wang A, 1997, BEN CAO BEI YAO; Woldemichael GM, 2003, Z NATURFORSCH C, V58, P70; Woo SS, 2004, PHYTOCHEMISTRY, V65, P2751, DOI 10.1016/j.phytochem.2004.08.039; Wu YL, 1958, BEN CAO CONG XIN; You HJ, 2001, FEBS LETT, V509, P156, DOI 10.1016/S0014-5793(01)03161-1; Zheng WH, 2005, PROG CHEM, V17, P122; Zhou W, 2010, MOLECULES, V15, P6217, DOI 10.3390/molecules15096217	35	8	10	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e64178	10.1371/journal.pone.0064178	http://dx.doi.org/10.1371/journal.pone.0064178			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667702	Green Published, gold, Green Submitted			2022-12-25	WOS:000319654700204
J	Yang, Y; Liu, Q; Ji, RR; Gao, Y				Yang, You; Liu, Qiong; Ji, Rongrong; Gao, Yue			Remote Dynamic Three-Dimensional Scene Reconstruction	PLOS ONE			English	Article							TECHNOLOGY	Remote dynamic three-dimensional (3D) scene reconstruction renders the motion structure of a 3D scene remotely by means of both the color video and the corresponding depth maps. It has shown a great potential for telepresence applications like remote monitoring and remote medical imaging. Under this circumstance, video-rate and high resolution are two crucial characteristics for building a good depth map, which however mutually contradict during the depth sensor capturing. Therefore, recent works prefer to only transmit the high-resolution color video to the terminal side, and subsequently the scene depth is reconstructed by estimating the motion vectors from the video, typically using the propagation based methods towards a video-rate depth reconstruction. However, in most of the remote transmission systems, only the compressed color video stream is available. As a result, color video restored from the streams has quality losses, and thus the extracted motion vectors are inaccurate for depth reconstruction. In this paper, we propose a precise and robust scheme for dynamic 3D scene reconstruction by using the compressed color video stream and their inaccurate motion vectors. Our method rectifies the inaccurate motion vectors by analyzing and compensating their quality losses, motion vector absence in spatial prediction, and dislocation in near-boundary region. This rectification ensures the depth maps can be compensated in both video-rate and high resolution at the terminal side towards reducing the system consumption on both the compression and transmission. Our experiments validate that the proposed scheme is robust for depth map and dynamic scene reconstruction on long propagation distance, even with high compression ratio, outperforming the benchmark approaches with at least 3.3950 dB quality gains for remote applications.	[Yang, You; Liu, Qiong] Huazhong Univ Sci & Technol, Dept Elect & Informat Engn, Wuhan 430074, Hubei, Peoples R China; [Yang, You] Tsinghua Univ, Dept Automat, Beijing 100084, Peoples R China; [Ji, Rongrong] Xiamen Univ, Dept Cognit Sci, Sch Informat Sci & Engn, Xiamen, Fujian, Peoples R China; [Gao, Yue] Natl Univ Singapore, Sch Comp, Singapore 117548, Singapore	Huazhong University of Science & Technology; Tsinghua University; Xiamen University; National University of Singapore	Liu, Q (corresponding author), Huazhong Univ Sci & Technol, Dept Elect & Informat Engn, Wuhan 430074, Hubei, Peoples R China.	q.liu@hust.edu.cn; rrji@xmu.edu.cn	Yang, You/O-5723-2019; Yang, You/A-9497-2019	Yang, You/0000-0002-5695-1046	National Natural Science Foundation of China [61170194, 61202301]; International S&T Cooperation Program of China [2012DFG12010]; Xiamen University 985 Project	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International S&T Cooperation Program of China; Xiamen University 985 Project	This work was supported by National Natural Science Foundation of China (No.61170194 and 61202301), International S&T Cooperation Program of China (No.2012DFG12010), and Xiamen University 985 Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergrath S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036796; Bjontegaard G., 2001, VCEG M33 CALCULATION; Cho JH, 2008, IEEE T CONSUM ELECTR, V54, P1514, DOI 10.1109/TCE.2008.4711195; Fehn C, 2004, PROC SPIE, V5291, P93, DOI 10.1117/12.524762; Gao Y, 2012, IEEE T IMAGE PROCESS, V21, P4290, DOI 10.1109/TIP.2012.2199502; Gao Y, 2012, IEEE T IMAGE PROCESS, V21, P2269, DOI 10.1109/TIP.2011.2170081; Gao Y, 2010, PATTERN RECOGN, V43, P1142, DOI 10.1016/j.patcog.2009.07.012; Granot Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002075; Harding G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035950; Henry P., 2010, P ADV REAS DEPTH CAM, P1; Jung JH, 2010, OPT EXPRESS, V18, P26373, DOI 10.1364/OE.18.026373; Kitazaki M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003177; Kolb Andreas, 2008, 2008 IEEE Computer Society Conference on Computer Vision and Pattern Recognition Workshops (CVPR Workshops), P1, DOI 10.1109/CVPRW.2008.4563159; Lee C, 2008, JTC1SC29WG11 ISOIEC; Leyvand T, 2011, COMPUTER, V44, P94, DOI 10.1109/MC.2011.114; Magara F, 2010, PLOS ONE, V5, DOI DOI 10.1371/JOURNAL.PONE.0014094; Meir A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007974; Muller K, 2008, EURASIP J IMAGE VIDE, DOI 10.1155/2008/438148; Ohm JR, 2011, JTC1SC29WG11 ISOIEC; ORCHARD MT, 1994, IEEE T IMAGE PROCESS, V3, P693, DOI 10.1109/83.334974; Smolic A, 2006, INT C MULT EXP; Tanimoto M, 2012, SIGNAL PROCESS-IMAGE, V27, P555, DOI 10.1016/j.image.2012.02.016; Valverde-Islas LE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014754; Varekamp C, 2007, 4 EUR C VIS MED PROD, P1; Wang Y., 2002, VIDEO PROCESSING COM; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Wiegand T, 2003, IEEE T CIRC SYST VID, V13, P560, DOI 10.1109/TCSVT.2003.815165; Worringham C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014669; Yan X., 2011, 3DTV C TRUE VIS CAPT, P1, DOI DOI 10.1109/3DTV.2011.5877167; Yang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047041	30	7	7	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e55586	10.1371/journal.pone.0055586	http://dx.doi.org/10.1371/journal.pone.0055586			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667417	gold, Green Submitted, Green Published			2022-12-25	WOS:000319654700001
J	Yun, JH; Ko, S; Lee, CK; Cheong, HK; Cheong, C; Yoon, JB; Lee, W				Yun, Ji-Hye; Ko, Sunggeon; Lee, Chung-Kyung; Cheong, Hae-Kap; Cheong, Chaejoon; Yoon, Jong-Bok; Lee, Weontae			Solution Structure and Rpn1 Interaction of the UBL Domain of Human RNA Polymerase II C-Terminal Domain Phosphatase	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME SYSTEM; 26S PROTEASOME; CHEMICAL-SHIFT; SOLUTION NMR; PROTEINS; RELAXATION; SUBUNIT; FAMILY; PROGRAM; PATHWAY	The ubiquitin-like modifier (UBL) domain of ubiquitin-like domain proteins (UDPs) interacts specifically with subunits of the 26 S proteasome. A novel UDP, ubiquitin-like domain-containing C-terminal domain phosphatase (UBLCP1), has been identified as an interacting partner of the 26 S proteasome. We determined the high-resolution solution structure of the UBL domain of human UBLCP1 by nuclear magnetic resonance spectroscopy. The UBL domain of hUBLCP1 has a unique beta-strand (beta 3) and beta 3-alpha 2 loop, instead of the canonical beta 4 observed in other UBL domains. The molecular topology and secondary structures are different from those of known UBL domains including that of fly UBLCP1. Data from backbone dynamics shows that the beta 3-alpha 2 loop is relatively rigid although it might have intrinsic dynamic profile. The positively charged residues of the beta 3-alpha 2 loop are involved in interacting with the C-terminal leucine-rich repeat-like domain of Rpn1.	[Yun, Ji-Hye; Ko, Sunggeon; Yoon, Jong-Bok; Lee, Weontae] Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, Seoul 120749, South Korea; [Lee, Chung-Kyung; Cheong, Hae-Kap; Cheong, Chaejoon] KBSI, Div Magnet Resonance, Cheongwon, Chungbuk, South Korea	Yonsei University; Korea Basic Science Institute (KBSI)	Lee, W (corresponding author), Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, Seoul 120749, South Korea.	wlee@spin.yonsei.ac.kr	LEE, WEON TAE/AAQ-9088-2021; Cheong, Chaejoon/GWC-3135-2022	Lee, Weontae/0000-0003-2347-1262; Yoon, Jong-Bok/0000-0002-3563-0702	Korea Research Foundation Grant [KRF-2008-313-C00524]; WCU (World Class University) program [R33-2009-000-10123-0]; High Field NMR Research Program of Korea Basic Science Institute	Korea Research Foundation Grant(National Research Foundation of Korea); WCU (World Class University) program; High Field NMR Research Program of Korea Basic Science Institute	This work was supported by Korea Research Foundation Grant (KRF-2008-313-C00524 to W. L.), WCU (World Class University) program (R33-2009-000-10123-0) and High Field NMR Research Program of Korea Basic Science Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cho H, 1999, GENE DEV, V13, P1540, DOI 10.1101/gad.13.12.1540; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Cole R, 2003, J BIOMOL NMR, V26, P203, DOI 10.1023/A:1023808801134; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Gomes AV, 2006, CIRC RES, V99, P362, DOI 10.1161/01.RES.0000237386.98506.f7; GRZESIEK S, 1992, BIOCHEMISTRY-US, V31, P8180, DOI 10.1021/bi00150a009; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Guo X, 2011, P NATL ACAD SCI USA, V108, P18649, DOI 10.1073/pnas.1113170108; Hartmann-Petersen R, 2004, SEMIN CELL DEV BIOL, V15, P247, DOI 10.1016/j.semcdb.2003.12.006; Hartmann-Petersen R, 2004, CELL MOL LIFE SCI, V61, P1589, DOI 10.1007/s00018-004-4132-x; Jentsch S, 2000, TRENDS CELL BIOL, V10, P335, DOI 10.1016/S0962-8924(00)01785-2; Ko S, 2009, B KOREAN CHEM SOC, V30, P1039; Ko S, 2009, BIOCHEMISTRY-US, V48, P827, DOI 10.1021/bi801270g; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lehman NL, 2009, ACTA NEUROPATHOL, V118, P329, DOI 10.1007/s00401-009-0560-x; Mueller TD, 2003, EMBO J, V22, P4634, DOI 10.1093/emboj/cdg467; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Sakata E, 2003, EMBO REP, V4, P301, DOI 10.1038/sj.embor.embor764; Sass HJ, 2000, J BIOMOL NMR, V18, P303, DOI 10.1023/A:1026703605147; Schauber C, 1998, NATURE, V391, P715, DOI 10.1038/35661; Valafar H, 2004, J MAGN RESON, V167, P228, DOI 10.1016/j.jmr.2003.12.012; Walters KJ, 2002, BIOCHEMISTRY-US, V41, P1767, DOI 10.1021/bi011892y; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939; Zheng HR, 2005, BIOCHEM BIOPH RES CO, V331, P1401, DOI 10.1016/j.bbrc.2005.04.065; Zong C, 2006, CIRC RES, V99, P372, DOI 10.1161/01.RES.0000237389.40000.02	31	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62981	10.1371/journal.pone.0062981	http://dx.doi.org/10.1371/journal.pone.0062981			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667555	Green Published, Green Submitted, gold			2022-12-25	WOS:000319654700093
J	Zhang, X; Jia, DY; Liu, HJ; Zhu, N; Zhang, W; Feng, J; Yin, J; Hao, B; Cui, DX; Deng, YZ; Xie, D; He, L; Li, BJ				Zhang, Xin; Jia, Deyong; Liu, Huijuan; Zhu, Na; Zhang, Wei; Feng, Jun; Yin, Jun; Hao, Bin; Cui, Daxiang; Deng, Yuezhen; Xie, Dong; He, Lin; Li, Baojie			Identification of 5-Iodotubercidin as a Genotoxic Drug with Anti-Cancer Potential	PLOS ONE			English	Article							ADENOSINE KINASE INHIBITORS; DNA-DAMAGE RESPONSE; ATAXIA-TELANGIECTASIA; G(2) ARREST; CANCER; P53; ATM; ACTIVATION; TARGET; PHOSPHORYLATION	Tumor suppressor p53, which is activated by various stress and oncogene activation, is a target for anti-cancer drug development. In this study, by screening panels of protein kinase inhibitors and protein phosphatase inhibitors, we identified 5-Iodotubercidin as a strong p53 activator. 5-Iodotubercidin is purine derivative and is used as an inhibitor for various kinases including adenosine kinase. We found that 5-Iodotubercidin could cause DNA damage, verified by induction of DNA breaks and nuclear foci positive for gamma H2AX and TopBP1, activation of Atm and Chk2, and S15 phosphorylation and up-regulation of p53. As such, 5-Iodotubercidin induces G2 cell cycle arrest in a p53-dependent manner. Itu also induces cell death in p53-dependent and -independent manners. DNA breaks were likely generated by incorporation of 5-Iodotubercidin metabolite into DNA. Moreover, 5-Iodotubercidin showed anti-tumor activity as it could reduce the tumor size in carcinoma xenograft mouse models in p53-dependent and -independent manners. These findings reveal 5-Iodotubercidin as a novel genotoxic drug that has chemotherapeutic potential.	[Zhang, Xin; Jia, Deyong; Liu, Huijuan; He, Lin; Li, Baojie] Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Bio X Inst, Shanghai 200030, Peoples R China; [Zhu, Na] Shanghai Jiao Tong Univ, Instrumental Anal Ctr, Shanghai 200030, Peoples R China; [Zhang, Wei; Feng, Jun; Yin, Jun] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China; [Hao, Bin] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200030, Peoples R China; [Cui, Daxiang] Shanghai Jiao Tong Univ, Res Inst Micro Nano Sci & Technol, Shanghai 200030, Peoples R China; [Deng, Yuezhen; Xie, Dong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Li, BJ (corresponding author), Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Bio X Inst, Shanghai 200030, Peoples R China.	libj@sjtu.edu.cn	Jia, Deyong/GSJ-0327-2022; Jia, Deyong/GQP-9611-2022	Jia, Deyong/0000-0003-2034-0363; Xie, Dong/0000-0002-1150-8657	National Natural Science Foundation of China [81130039, 31071229, 81121001]; Ministry of Science and Technology of China (The National Key Scientific Program) [2012CB966901]; Shanghai Pujiang Program [10PJ1405000]; Cheung Kong Scholars Program of the Ministry of Education	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China (The National Key Scientific Program); Shanghai Pujiang Program(Shanghai Pujiang Program); Cheung Kong Scholars Program of the Ministry of Education	The work was supported by grants from the National Natural Science Foundation of China (81130039, 31071229, and 81121001), the Ministry of Science and Technology of China (The National Key Scientific Program (2012CB966901, to B.L.)), Shanghai Pujiang Program (10PJ1405000), Cheung Kong Scholars Program of the Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boison Detlev, 2010, Open Neurosci J, V4, P93; BRATTAIN MG, 1980, CANCER RES, V40, P2142; Browning JL, 2005, BIOL PSYCHIAT, V57, P617, DOI 10.1016/j.biopsych.2004.12.002; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chau JFL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1832; Chene P, 2003, NAT REV CANCER, V3, P102, DOI 10.1038/nrc991; Cortez D, 2003, J BIOL CHEM, V278, P37139, DOI 10.1074/jbc.M307088200; COTTAM HB, 1993, J MED CHEM, V36, P3424, DOI 10.1021/jm00074a024; Di Micco R, 2011, NAT CELL BIOL, V13, P292, DOI 10.1038/ncb2170; Ewald B, 2008, ONCOGENE, V27, P6522, DOI 10.1038/onc.2008.316; Ewald B, 2007, MOL CANCER THER, V6, P1239, DOI 10.1158/1535-7163.MCT-06-0633; Farnebo M, 2010, BIOCHEM BIOPH RES CO, V396, P85, DOI 10.1016/j.bbrc.2010.02.152; Fassett JT, 2011, AM J PHYSIOL-HEART C, V300, pH1722, DOI 10.1152/ajpheart.00684.2010; FluckigerIsler R, 1996, BBA-MOL CELL RES, V1311, P77, DOI 10.1016/0167-4889(95)00196-4; FLUCKIGERISLER RE, 1993, BIOCHEM J, V292, P85; Fournel M, 2008, MOL CANCER THER, V7, P759, DOI 10.1158/1535-7163.MCT-07-2026; Fujita K, 2010, NAT CELL BIOL, V12, P1205, DOI 10.1038/ncb2123; GOLEMBIOWSKA K, 1995, BRAIN RES, V699, P315, DOI 10.1016/0006-8993(95)00926-H; Gouder N, 2004, J NEUROSCI, V24, P692, DOI 10.1523/JNEUROSCI.4781-03.2004; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jiang N, 1997, EUR J PHARMACOL, V320, P131, DOI 10.1016/S0014-2999(96)00905-3; Karnitz LM, 2005, MOL PHARMACOL, V68, P1636, DOI 10.1124/mol.105.012716; Lai KP, 2010, EMBO J, V29, P2994, DOI 10.1038/emboj.2010.166; Lane DP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001222; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Li TF, 2008, J CLIN INVEST, V118, P571, DOI 10.1172/JCI33737; Liu XJ, 2008, MOL CANCER THER, V7, P133, DOI 10.1158/1535-7163.MCT-07-0416; Liu XJ, 2005, CANCER RES, V65, P6874, DOI 10.1158/0008-5472.CAN-05-0288; Lukas C, 2011, NAT CELL BIOL, V13, P243, DOI 10.1038/ncb2201; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Ma G, 2012, J MOL CELL BIOL, V4, P118, DOI 10.1093/jmcb/mjs006; MASSILLON D, 1994, BIOCHEM J, V299, P123, DOI 10.1042/bj2990123; Pavet V, 2011, ONCOGENE, V30, P1, DOI 10.1038/onc.2010.460; Peart J, 2001, CARDIOVASC RES, V52, P120, DOI 10.1016/S0008-6363(01)00360-1; Pignataro G, 2007, J CEREBR BLOOD F MET, V27, P1, DOI 10.1038/sj.jcbfm.9600334; Shangary S, 2009, ANNU REV PHARMACOL, V49, P223, DOI 10.1146/annurev.pharmtox.48.113006.094723; Shen ZY, 2011, J MOL CELL BIOL, V3, P1, DOI 10.1093/jmcb/mjq057; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Ugarkar BG, 2000, J MED CHEM, V43, P2883, DOI 10.1021/jm000024g; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wang X, 2011, CELL DEATH DIFFER, V18, P5, DOI 10.1038/cdd.2010.106; Wang ZF, 2010, PROTEIN CELL, V1, P1063, DOI 10.1007/s13238-010-0140-9; Wilson PM, 2011, NUCLEIC ACIDS RES, V39, pE112, DOI 10.1093/nar/gkr350; Zannini L, 2012, J MOL CELL BIOL, V4, P294, DOI 10.1093/jmcb/mjs035; Zimmermann J, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-18	48	18	20	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62527	10.1371/journal.pone.0062527	http://dx.doi.org/10.1371/journal.pone.0062527			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667485	Green Published, gold, Green Submitted			2022-12-25	WOS:000319654700043
J	Katayama, M; Ohmura, K; Yukawa, N; Terao, C; Hashimoto, M; Yoshifuji, H; Kawabata, D; Fujii, T; Iwakura, Y; Mimori, T				Katayama, Masaki; Ohmura, Koichiro; Yukawa, Naoichiro; Terao, Chikashi; Hashimoto, Motomu; Yoshifuji, Hajime; Kawabata, Daisuke; Fujii, Takao; Iwakura, Yoichiro; Mimori, Tsuneyo			Neutrophils Are Essential as a Source of IL-17 in the Effector Phase of Arthritis	PLOS ONE			English	Article							AUTOANTIBODY-INDUCED ARTHRITIS; COLLAGEN-INDUCED ARTHRITIS; T-CELLS; RHEUMATOID-ARTHRITIS; MAST-CELLS; INTERLEUKIN-17; INITIATION; CYTOKINES; RECEPTOR; DISEASE	Objective: Th17 has been shown to have a pivotal role in the development of arthritis. However, the role of IL-17 in the T cell-independent effector phase has not fully been examined. We investigated whether IL-17 is involved in the effector phase of arthritis by using K/BxN serum-induced arthritis model. Methods: K/BxN serum was transferred into IL-17 knockout (KO) mice, SCID mice and their control mice, and arthritis was evaluated over time. In order to clarify the source of IL-17 in the effector phase, neutrophils or CD4+ T cells collected from IL-17 KO or control mice were injected into IL-17 KO recipient mice together with K/BxN serum. To examine if neutrophils secrete IL-17 upon stimulation, neutrophils were stimulated with immune complex in vitro and IL-17 in the supernatant was measured by ELISA. Results: K/BxN serum-induced arthritis was much less severe in IL-17 KO mice than in WT mice. Since K/BxN serum-transferred SCID mice developed severe arthritis with high serum IL-17 concentration, we speculated neutrophils are the responsible player as an IL-17 source. When wild type (WT) but not IL-17 KO neutrophils were co-injected with K/BxN serum into IL-17 KO mice, arthritis was exacerbated, whereas co-injection of WT CD4+ T cells had no effect. In vitro, stimulation of neutrophils with immune complexcaused IL-17 secretion. Conclusions: Neutrophils are essential as a source of IL-17 in the effector phase of arthritis. The trigger of secreting IL-17 from neutrophils may be immune complex.	[Katayama, Masaki; Ohmura, Koichiro; Yukawa, Naoichiro; Terao, Chikashi; Yoshifuji, Hajime; Kawabata, Daisuke; Mimori, Tsuneyo] Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kyoto, Japan; [Terao, Chikashi] Kyoto Univ, Grad Sch Med, Ctr Genet Med, Kyoto, Japan; [Hashimoto, Motomu; Fujii, Takao] Kyoto Univ, Grad Sch Med, Dept Control Rheumat Dis, Kyoto, Japan; [Iwakura, Yoichiro] Univ Tokyo, Inst Med Sci, Ctr Expt Med & Syst Biol, Tokyo, Japan	Kyoto University; Kyoto University; Kyoto University; University of Tokyo	Ohmura, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kyoto, Japan.	ohmurako@kuhp.kyoto-u.ac.jp	Iwakura, Yoichiro/E-5457-2011; Yoshifuji, Hajime/AAZ-1657-2020	Iwakura, Yoichiro/0000-0002-9934-5775; 	Japan Society for Promotion of Science; Ministry of Health and Welfare of Japan; Grants-in-Aid for Scientific Research [24659274] Funding Source: KAKEN	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants from the Japan Society for Promotion of Science and the Ministry of Health and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chabaud M, 1999, ARTHRITIS RHEUM-US, V42, P963, DOI 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E; Ferretti S, 2003, J IMMUNOL, V170, P2106, DOI 10.4049/jimmunol.170.4.2106; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Hoshino A, 2008, J AUTOIMMUN, V31, P79, DOI 10.1016/j.jaut.2008.03.006; Hueber AJ, 2010, J IMMUNOL, V184, P3336, DOI 10.4049/jimmunol.0903566; Ito Y, 2009, ARTHRITIS RHEUM-US, V60, P2294, DOI 10.1002/art.24687; Jacobs JP, 2009, P NATL ACAD SCI USA, V106, P21789, DOI 10.1073/pnas.0912152106; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Ji H, 2002, J EXP MED, V196, P77, DOI 10.1084/jem.20020439; Jovanovic DV, 1998, J IMMUNOL, V160, P3513; Korganow AS, 1999, IMMUNITY, V10, P451, DOI 10.1016/S1074-7613(00)80045-X; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; Li L, 2010, J CLIN INVEST, V120, P331, DOI 10.1172/JCI38702; Lin AM, 2011, J IMMUNOL, V187, P490, DOI 10.4049/jimmunol.1100123; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; Matsumoto I, 1999, SCIENCE, V286, P1732, DOI 10.1126/science.286.5445.1732; Michel ML, 2008, P NATL ACAD SCI USA, V105, P19845, DOI 10.1073/pnas.0806472105; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Nakae S, 2003, P NATL ACAD SCI USA, V100, P5986, DOI 10.1073/pnas.1035999100; Sadik CD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026342; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Wipke BT, 2004, J IMMUNOL, V172, P7694, DOI 10.4049/jimmunol.172.12.7694; Wipke BT, 2001, J IMMUNOL, V167, P1601, DOI 10.4049/jimmunol.167.3.1601; Yao ZB, 1995, IMMUNITY, V3, P811, DOI 10.1016/1074-7613(95)90070-5	25	60	63	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e62231	10.1371/journal.pone.0062231	http://dx.doi.org/10.1371/journal.pone.0062231			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671588	Green Published, Green Submitted, gold			2022-12-25	WOS:000321390200017
J	Yang, Y; Yan, XL; Duan, WX; Yan, JJ; Yi, W; Liang, ZX; Wang, N; Li, Y; Chen, WS; Yu, SQ; Jin, ZX; Yi, DH				Yang, Yang; Yan, Xiaolong; Duan, Weixun; Yan, Juanjuan; Yi, Wei; Liang, Zhenxin; Wang, Ning; Li, Yue; Chen, Wensheng; Yu, Shiqiang; Jin, Zhenxiao; Yi, Dinghua			Pterostilbene Exerts Antitumor Activity via the Notch1 Signaling Pathway in Human Lung Adenocarcinoma Cells	PLOS ONE			English	Article							CANCER CELLS; INHIBITION; APOPTOSIS; ACTIVATION; RESVERATROL; INDUCTION; TARGET; GROWTH; TUMORS; MICE	Although pterostilbene (PTE) has been shown to have potent antitumor activities against various cancer types, the molecular mechanisms of these activities remain unclear. In this study, we investigated the antitumor activity of PTE against human lung adenocarcinoma in vitro and in vivo and explored the role of the Notch1 signaling pathway in this process. PTE treatment resulted in a dose-and time-dependent decrease in the viability of A549 cells. Additionally, PTE exhibited strong antitumor activity, as evidenced not only by a reduced mitochondrial membrane potential (MMP) and a decreased intracellular glutathione content but also by increases in the apoptotic index and the level of reactive oxygen species (ROS). Furthermore, PTE treatment induced the activation of the Notch1 Intracellular Domain (NICD) protein and activated Hes1. DAPT (a gamma secretase inhibitor) and Notch1 siRNA prevented the induction of NICD and Hes1 activation by PTE treatment and sensitized the cells to PTE treatment. The down-regulation of Notch signaling also prevented the activation of pro-survival pathways (most notably the PI3K/Akt pathway) after PTE treatment. In summary, lung adenocarcinoma cells may enhance Notch1 activation as a protective mechanism in response to PTE treatment. Combining a gamma secretase inhibitor with PTE treatment may represent a novel approach for treating lung adenocarcinoma by inhibiting the survival pathways of cancer cells.	[Yang, Yang; Duan, Weixun; Yi, Wei; Liang, Zhenxin; Wang, Ning; Li, Yue; Chen, Wensheng; Yu, Shiqiang; Jin, Zhenxiao; Yi, Dinghua] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiovasc Surg, Xian 710032, Peoples R China; [Yan, Xiaolong] Fourth Mil Med Univ, Tangdu Hosp, Dept Thorac Surg, Xian 710032, Peoples R China; [Yan, Juanjuan] Fourth Mil Med Univ, Sch Stomatol, Dept Prosthodont, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Jin, ZX (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Cardiovasc Surg, Xian 710032, Peoples R China.	zhenxiaojin210@126.com; dinghuayi210@126.com	Jin, Zhenxiao/AAJ-5777-2020; Li, Yue/AAU-1580-2021	Yu, Shiqiang/0000-0003-3519-0943; Yi, Wei/0000-0002-4349-910X; Yan, Xiaolong/0000-0003-2419-9707	12th National Five Years Supporting Project of China [2011BAI11B20]; National Natural Science Foundation of China [81102687, 81070198]; Academic Promotion Project of Xijing Hospital [XJZT09 M16, XJZT10 M12]; Social Development Project of Shaanxi Province [2012JQ4001]	12th National Five Years Supporting Project of China(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Academic Promotion Project of Xijing Hospital; Social Development Project of Shaanxi Province	This study was supported by grants from the 12th National Five Years Supporting Project of China (2011BAI11B20), the National Natural Science Foundation of China (81102687 and 81070198), the Academic Promotion Project of Xijing Hospital (XJZT09 M16 and XJZT10 M12), and Social Development Project of Shaanxi Province (2012JQ4001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyoshi T, 2008, GASTROENTEROLOGY, V134, P131, DOI 10.1053/j.gastro.2007.10.008; Allen TD, 2011, CANCER RES, V71, P6010, DOI 10.1158/0008-5472.CAN-11-0595; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Chakraborty A, 2012, MOL CELL ENDOCRINOL, V355, P25, DOI 10.1016/j.mce.2012.01.009; Chan SM, 2007, BLOOD, V110, P278, DOI 10.1182/blood-2006-08-039883; Chen YB, 2007, CANCER RES, V67, P7954, DOI 10.1158/0008-5472.CAN-07-1229; Chen YQ, 2011, CANCER BIOL THER, V11, P14, DOI 10.4161/cbt.11.1.13730; Cichocki M, 2008, MOL NUTR FOOD RES, V52, pS62, DOI 10.1002/mnfr.200700466; Franko-Tobin LG, 2012, ONCOLOGIST, V17, P220, DOI 10.1634/theoncologist.2011-0269; Guo DM, 2011, LEUKEMIA LYMPHOMA, V52, P1200, DOI 10.3109/10428194.2011.564696; Huang PH, 2011, J MOL CELL CARDIOL, V51, P109, DOI 10.1016/j.yjmcc.2011.03.008; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Ji XM, 2011, J CELL BIOCHEM, V112, P2773, DOI 10.1002/jcb.23184; Li YY, 2011, J NUTR BIOCHEM, V22, P799, DOI 10.1016/j.jnutbio.2010.11.001; Lin H, 2011, ONCOL REP, V26, P925, DOI 10.3892/or.2011.1380; Lin VCH, 2012, J AGR FOOD CHEM, V60, P6399, DOI 10.1021/jf301499e; Liu ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037841; McAuliffe SM, 2012, P NATL ACAD SCI USA, V109, pE2939, DOI 10.1073/pnas.1206400109; McCormack D, 2012, J SURG RES, V173, pE53, DOI 10.1016/j.jss.2011.09.054; Mena S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044524; Meng RD, 2009, CANCER RES, V69, P573, DOI 10.1158/0008-5472.CAN-08-2088; Moon D, 2013, J SURG RES, V180, P208, DOI 10.1016/j.jss.2012.04.027; Mungamuri SK, 2006, CANCER RES, V66, P4715, DOI 10.1158/0008-5472.CAN-05-3830; Muto J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033431; Naganuma S, 2012, AM J CANCER RES, V2, P459; Nair P, 2003, J VIROL, V77, P7106, DOI 10.1128/JVI.77.12.7106-7112.2003; Pan MH, 2009, CARCINOGENESIS, V30, P1234, DOI 10.1093/carcin/bgp121; Ren XL, 2009, CANCER LETT, V281, P134, DOI 10.1016/j.canlet.2009.02.036; Ruiz MJ, 2009, J AGR FOOD CHEM, V57, P3180, DOI 10.1021/jf803579e; Sade H, 2004, J BIOL CHEM, V279, P2937, DOI 10.1074/jbc.M309924200; Shen XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041773; Somasundaram K, 2005, ONCOGENE, V24, P7073, DOI 10.1038/sj.onc.1208865; Stylianou S, 2006, CANCER RES, V66, P1517, DOI 10.1158/0008-5472.CAN-05-3054; Truong M, 2011, ANN SURG ONCOL, V18, P1506, DOI 10.1245/s10434-010-1488-z; Wang H, 2013, MODERN PATHOL, V26, P139, DOI 10.1038/modpathol.2012.143; Westhoff B, 2009, P NATL ACAD SCI USA, V106, P22293, DOI 10.1073/pnas.0907781106; Zhang W, 2011, J MED CHEM, V54, P1288, DOI 10.1021/jm101248v; Zhao YF, 2012, EUR J PHARMACOL, V688, P6, DOI 10.1016/j.ejphar.2012.05.003	38	7	7	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62652	10.1371/journal.pone.0062652	http://dx.doi.org/10.1371/journal.pone.0062652			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23671619	Green Published, Green Submitted, gold			2022-12-25	WOS:000321202100028
J	Li, BQ; Huang, T; Zhang, J; Zhang, N; Huang, GH; Liu, L; Cai, YD				Li, Bi-Qing; Huang, Tao; Zhang, Jian; Zhang, Ning; Huang, Guo-Hua; Liu, Lei; Cai, Yu-Dong			An Ensemble Prognostic Model for Colorectal Cancer	PLOS ONE			English	Article							HUMAN COLON; HOMEOSTATIC SWITCH; EXPRESSION; GENE; PREDICTION; GROWTH; OVEREXPRESSION; METHYLATION; ACTIVATION; PROMOTER	Colorectal cancer can be grouped into Dukes A, B, C, and D stages based on its developments. Generally speaking, more advanced patients have poorer prognosis. To integrate progression stage prediction systems with recurrence prediction systems, we proposed an ensemble prognostic model for colorectal cancer. In this model, each patient was assigned a most possible stage and a most possible recurrence status. If a patient was predicted to be recurrence patient in advanced stage, he would be classified into high risk group. The ensemble model considered both progression stages and recurrence status. High risk patients and low risk patients predicted by the ensemble model had a significant different disease free survival (log-rank test p-value, 0.0016) and disease specific survival (log-rank test p-value, 0.0041). The ensemble model can better distinguish the high risk and low risk patients than the stage prediction model and the recurrence prediction model alone. This method could be applied to the studies of other diseases and it could significantly improve the prediction performance by ensembling heterogeneous information.	[Huang, Guo-Hua; Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Li, Bi-Qing; Liu, Lei] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Huang, Tao] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA; [Zhang, Jian] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Ophthalmol, Shanghai 200030, Peoples R China; [Zhang, Ning] Tianjin Univ, Dept Biomed Engn, Tianjin Key Lab BME Measurement, Tianjin 300072, Peoples R China	Shanghai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Icahn School of Medicine at Mount Sinai; Shanghai Jiao Tong University; Tianjin University	Liu, L (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China.	leiliu@sibs.ac.cn; cai_yud@yahoo.com.cn	Huang, Guohua/A-2215-2019	Huang, Guohua/0000-0001-6954-3933; Zhang, Ning/0000-0002-1559-111X; cai, yudong/0000-0001-5664-7979	National Basic Research Program of China [2011CB510102, 2011CB510101]; Innovation Program of Shanghai Municipal Education Commission [12ZZ087]; grant of "The First-class Discipline of Universities in Shanghai"	National Basic Research Program of China(National Basic Research Program of China); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); grant of "The First-class Discipline of Universities in Shanghai"	This work was supported by grants from National Basic Research Program of China (2011CB510102, 2011CB510101), Innovation Program of Shanghai Municipal Education Commission (12ZZ087), and the grant of "The First-class Discipline of Universities in Shanghai." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquaviva F, 2005, J CELL SCI, V118, P3917, DOI 10.1242/jcs.02516; Aslan JE, 2009, MOL CELL, V34, P497, DOI 10.1016/j.molcel.2009.04.011; ASTLER VB, 1954, ANN SURG, V139, P846, DOI 10.1097/00000658-195406000-00015; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chano T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015737; Chano T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011404; de Sousa EMF, 2011, CLIN CANCER RES, V17, P647, DOI 10.1158/1078-0432.CCR-10-1204; Dukes CE, 1932, J PATHOL BACTERIOL, V35, P323, DOI 10.1002/path.1700350303; Eschrich S, 2005, J CLIN ONCOL, V23, P3526, DOI 10.1200/JCO.2005.00.695; Favaro E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010345; Galamb O, 2008, CANCER EPIDEM BIOMAR, V17, P2835, DOI 10.1158/1055-9965.EPI-08-0231; GAO YF, 2013, MOL BIOSYSTEMS; Goel Manish Kumar, 2010, Int J Ayurveda Res, V1, P274, DOI 10.4103/0974-7788.76794; Gustavsson E, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-187; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025297; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008126; Ichikawa M, 2011, MOL CANCER RES, V9, P133, DOI 10.1158/1541-7786.MCR-10-0394; Ikebuchi K, 2009, INT J CANCER, V125, P861, DOI 10.1002/ijc.24466; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jin KT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028384; Jorissen RN, 2009, CLIN CANCER RES, V15, P7642, DOI 10.1158/1078-0432.CCR-09-1431; Katoh M, 2008, CURR DRUG TARGETS, V9, P565, DOI 10.2174/138945008784911750; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Kontani K, 2003, INT J MOL MED, V12, P767; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lancaster JM, 2006, INT J GYNECOL CANCER, V16, P1733, DOI 10.1111/j.1525-1438.2006.00660.x; Lee JH, 2011, CLIN CANCER RES, V17, P7551, DOI 10.1158/1078-0432.CCR-11-1026; Li BQ, 2013, PROTEIN PEPTIDE LETT, V20, P352; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045854; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043927; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039308; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033393; Li BQ, 2012, J PROTEOMICS, V75, P1654, DOI 10.1016/j.jprot.2011.12.003; Lin YH, 2007, CLIN CANCER RES, V13, P498, DOI 10.1158/1078-0432.CCR-05-2734; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Naik S, 2009, CLIN CANCER RES, V15, P7529, DOI 10.1158/1078-0432.CCR-09-0336; Patlolla JMR, 2004, ONCOL REP, V11, P957; Paun BC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007715; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Potapenko IO, 2010, MOL ONCOL, V4, P98, DOI 10.1016/j.molonc.2009.12.001; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Sotgia F, 2009, AM J PATHOL, V174, P613, DOI 10.2353/ajpath.2009.080653; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Terasaki H, 2002, INT J MOL MED, V9, P107; Von Stein P, 2008, GASTROENTEROLOGY, V134, P1869, DOI 10.1053/j.gastro.2008.02.083; Voronkov AE, 2008, DOKL BIOCHEM BIOPHYS, V419, P75, DOI 10.1134/S1607672908020087; Wang HQ, 2012, BIOCHEM BIOPH RES CO, V417, P62, DOI 10.1016/j.bbrc.2011.11.055; Weigle B, 2005, ONCOL REP, V13, P139; You HH, 2009, CELL CYCLE, V8, P2679, DOI 10.4161/cc.8.17.9327; Zhang N, 2012, MOL BIOSYST, V8, P2946, DOI 10.1039/c2mb25185j; Zhong Haihong, 2006, Proceedings of the American Association for Cancer Research Annual Meeting, V47, P1082; Zou HF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039379	53	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63494	10.1371/journal.pone.0063494	http://dx.doi.org/10.1371/journal.pone.0063494			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658834	Green Published, gold, Green Submitted			2022-12-25	WOS:000321200500074
J	Bjorkelid, C; Bergfors, T; Raichurkar, AKV; Mukherjee, K; Malolanarasimhan, K; Bandodkar, B; Jones, TA				Bjorkelid, Christofer; Bergfors, Terese; Raichurkar, Anand Kumar V.; Mukherjee, Kakoli; Malolanarasimhan, Krishnan; Bandodkar, Balachandra; Jones, T. Alwyn			Structural and Biochemical Characterization of Compounds Inhibiting Mycobacterium tuberculosis Pantothenate Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-A; FEEDBACK-REGULATION; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; ENZYME ACTION; LOCATION; GENE; REFINEMENT; QUALITY; ERRORS	Mycobacterium tuberculosis, the bacterial causative agent of tuberculosis, currently affects millions of people. The emergence of drug-resistant strains makes development of new antibiotics targeting the bacterium a global health priority. Pantothenate kinase, a key enzyme in the universal biosynthesis of the essential cofactor CoA, was targeted in this study to find new tuberculosis drugs. The biochemical characterizations of two new classes of compounds that inhibit pantothenate kinase from M. tuberculosis are described, along with crystal structures of their enzyme-inhibitor complexes. These represent the first crystal structures of this enzyme with engineered inhibitors. Both classes of compounds bind in the active site of the enzyme, overlapping with the binding sites of the natural substrate and product, pantothenate and phosphopantothenate, respectively. One class of compounds also interferes with binding of the cofactor ATP. The complexes were crystallized in two crystal forms, one of which is in a new space group for this enzyme and diffracts to the highest resolution reported for any pantothenate kinase structure. These two crystal forms allowed, for the first time, modeling of the cofactor-binding loop in both open and closed conformations. The structures also show a binding mode of ATP different from that previously reported for the M. tuberculosis enzyme but similar to that in the pantothenate kinases of other organisms.	[Bjorkelid, Christofer; Bergfors, Terese; Jones, T. Alwyn] Uppsala Univ, Dept Cell & Mol Biol, Biomed Ctr, SE-75124 Uppsala, Sweden; [Raichurkar, Anand Kumar V.; Mukherjee, Kakoli; Malolanarasimhan, Krishnan; Bandodkar, Balachandra] AstraZeneca India Private Ltd, Bangalore 560024, Karnataka, India	Uppsala University; AstraZeneca	Bjorkelid, C (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, Biomed Ctr, Box 596, SE-75124 Uppsala, Sweden.	christofer@xray.bmc.uu.se		Bjorkelid, Christofer/0000-0002-2780-7424	Foundation for Strategic Research; Uppsala University; Swedish Research Council	Foundation for Strategic Research; Uppsala University; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Foundation for Strategic Research, the Swedish Research Council, and Uppsala University.	Awasthy D, 2010, MICROBIOL-SGM, V156, P2691, DOI 10.1099/mic.0.040717-0; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Brand LA, 2005, J BIOL CHEM, V280, P20185, DOI 10.1074/jbc.C500044200; Chetnani B, 2011, ACTA CRYSTALLOGR D, V67, P774, DOI 10.1107/S0907444911024462; Chetnani B, 2010, J MOL BIOL, V400, P171, DOI 10.1016/j.jmb.2010.04.064; Chetnani B, 2009, ACTA CRYSTALLOGR D, V65, P312, DOI 10.1107/S0907444909002170; Das S, 2006, ACTA CRYSTALLOGR D, V62, P628, DOI 10.1107/S0907444906012728; DUNN SD, 1979, J BACTERIOL, V140, P805, DOI 10.1128/JB.140.3.805-808.1979; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Franzblau SG, 1998, J CLIN MICROBIOL, V36, P362, DOI 10.1128/JCM.36.2.362-366.1998; Harris M, 2001, ACTA CRYSTALLOGR D, V57, P1201, DOI 10.1107/S0907444901007697; Ivey RA, 2004, J BIOL CHEM, V279, P35622, DOI 10.1074/jbc.M403152200; JACKOWSKI S, 1981, J BACTERIOL, V148, P926, DOI 10.1128/JB.148.3.926-932.1981; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kleywegt GJ, 1996, STRUCTURE, V4, P1395, DOI 10.1016/S0969-2126(96)00147-5; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P525, DOI 10.1016/S0076-6879(97)77029-0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leonardi R, 2005, J BIOL CHEM, V280, P3314, DOI 10.1074/jbc.M411608200; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Rock CO, 2002, GENE, V291, P35, DOI 10.1016/S0378-1119(02)00564-4; SONG WJ, 1994, J BIOL CHEM, V269, P27051; VALLARI DS, 1987, J BIOL CHEM, V262, P2468; Venkatraman J, 2012, J BIOMOL SCREEN, V17, P293, DOI 10.1177/1087057111423069; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang K, 2006, J BACTERIOL, V188, P5532, DOI 10.1128/JB.00469-06; Yun M, 2000, J BIOL CHEM, V275, P28093; Zhou B, 2001, NAT GENET, V28, P345, DOI 10.1038/ng572	34	30	31	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18260	18270		10.1074/jbc.M113.476473	http://dx.doi.org/10.1074/jbc.M113.476473			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23661699	Green Published, hybrid			2022-12-25	WOS:000320721900030
J	Schramm, C; Edwards, MA; Krenz, M				Schramm, Christine; Edwards, Michelle A.; Krenz, Maike			New Approaches to Prevent LEOPARD Syndrome-associated Cardiac Hypertrophy by Specifically Targeting Shp2-dependent Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; TYROSINE-PHOSPHATASE SHP-2; NOONAN-SYNDROME; MICE LACKING; PTPN11 GENE; VENTRICULAR HYPERTROPHY; GLUCOSE-HOMEOSTASIS; GROWTH; MUTATIONS; CARDIOMYOPATHY	In LEOPARD syndrome (LS) patients, mutations in the protein tyrosine phosphatase Shp2 cause hypertrophic cardiomyopathy. The prohypertrophic effects of mutant Shp2 are mediated downstream by hyperactivation of mammalian target of rapamycin. Our goal was to further define the signaling cascade that is essential for the underlying pathomechanism, thus expanding the list of potential future therapeutic targets. Using cultured neonatal rat cardiomyocytes with adenoviral gene delivery and pharmacological inhibitors, we found that hypertrophy induced by a particularly aggressive LS mutation in Shp2 depends on hyperactivation of Akt and focal adhesion kinase as well as mammalian target of rapamycin. Dissecting domain-specific functions of Shp2 using double and truncation mutants, we determined that the hypertrophic effects of mutant Shp2 depend on the two SH2 domains and on an intact catalytic center. The latter finding prompted us to test the efficacy of a Shp2 inhibitor targeted directly at the catalytic pocket. This compound, PHPS1, effectively prevented mutant Shp2-induced hypertrophy. In summary, we identified three novel targets for pharmacological therapy of LS-associated cardiac hypertrophy. Of particular importance is the finding that intervention directly at the mutant Shp2 protein is effective because this would facilitate custom-tailored therapeutic approaches for patients carrying LS mutations in Shp2.	[Schramm, Christine; Edwards, Michelle A.; Krenz, Maike] Univ Missouri, Dept Med Pharmacol & Physiol, Dalton Cardiovasc Res Ctr, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Krenz, M (corresponding author), Dalton Cardiovasc Res Ctr, 134 Res Pk Dr, Columbia, MO 65211 USA.	krenzm@missouri.edu		Krenz, Maike/0000-0003-3784-287X	American Heart Association [0635472N]; University of Missouri research board grant	American Heart Association(American Heart Association); University of Missouri research board grant	This work was supported in part by American Heart Association Scientist Development Grant 0635472N (to M. K.) and by a University of Missouri research board grant (to M. K).	Agazie YM, 2003, MOL CELL BIOL, V23, P7875, DOI 10.1128/MCB.23.21.7875-7886.2003; Cerrato F, 2008, CARDIOL YOUNG, V18, P575, DOI 10.1017/S104795110800320X; Chen LW, 2006, MOL PHARMACOL, V70, P562, DOI 10.1124/mol.106.025536; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; DeBosch B, 2006, CIRCULATION, V113, P2097, DOI 10.1161/CIRCULATIONAHA.105.595231; DeBosch B, 2006, J BIOL CHEM, V281, P32841, DOI 10.1074/jbc.M513087200; Dhandapany PS, 2011, J MOL CELL CARDIOL, V51, P4, DOI 10.1016/j.yjmcc.2011.03.001; Digilio MC, 2002, AM J HUM GENET, V71, P389, DOI 10.1086/341528; DiMichele LA, 2009, CIRC RES, V104, P1201, DOI 10.1161/CIRCRESAHA.109.195941; Doherty JT, 2010, GENESIS, V48, P492, DOI 10.1002/dvg.20650; Dummler B, 2006, MOL CELL BIOL, V26, P8042, DOI 10.1128/MCB.00722-06; Edouard T, 2010, MOL CELL BIOL, V30, P2498, DOI 10.1128/MCB.00646-09; Faienza MF, 2009, PEDIATR CARDIOL, V30, P1012, DOI 10.1007/s00246-009-9473-7; Feng H, 2012, ONCOGENE, V31, P2691, DOI 10.1038/onc.2011.436; Fragale A, 2004, HUM MUTAT, V23, P267, DOI 10.1002/humu.20005; GORLIN RJ, 1969, AM J DIS CHILD, V117, P652, DOI 10.1001/archpedi.1969.02100030654006; Hanna N, 2006, FEBS LETT, V580, P2477, DOI 10.1016/j.febslet.2006.03.088; Heidkamp MC, 2002, CIRC RES, V90, P1282, DOI 10.1161/01.RES.0000023201.41774.EA; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Hellmuth K, 2008, P NATL ACAD SCI USA, V105, P7275, DOI 10.1073/pnas.0710468105; Ishida H, 2011, AM J PHYSIOL-HEART C, V301, pH1531, DOI 10.1152/ajpheart.00216.2011; Jakob S, 2008, J BIOL CHEM, V283, P33155, DOI 10.1074/jbc.M805138200; Karisch R, 2011, CELL, V146, P826, DOI 10.1016/j.cell.2011.07.020; Kontaridis MI, 2006, J BIOL CHEM, V281, P6785, DOI 10.1074/jbc.M513068200; Krenz M, 2005, CIRC RES, V97, P813, DOI 10.1161/01.RES.0000186194.06514.b0; Legius E, 2002, J MED GENET, V39, P571, DOI 10.1136/jmg.39.8.571; Manes S, 1999, MOL CELL BIOL, V19, P3125; Marian AJ, 2010, EUR J CLIN INVEST, V40, P360, DOI 10.1111/j.1365-2362.2010.02268.x; Marin TM, 2011, J CLIN INVEST, V121, P1026, DOI 10.1172/JCI44972; Merritt R, 2006, BBA-MOL CELL RES, V1763, P45, DOI 10.1016/j.bbamcr.2005.11.013; Mollmann H, 2008, J INT MED RES, V36, P810; Nakamura T, 2007, J CLIN INVEST, V117, P2123, DOI 10.1172/JCI30756; Oishi K, 2009, HUM MOL GENET, V18, P193, DOI 10.1093/hmg/ddn336; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Peng X, 2008, P NATL ACAD SCI USA, V105, P6638, DOI 10.1073/pnas.0802319105; Schramm C, 2012, AM J PHYSIOL-HEART C, V302, pH231, DOI 10.1152/ajpheart.00665.2011; Stewart RA, 2010, DEV CELL, V18, P750, DOI [10.1016/j.devcel.2010.03.009, 10.1016/j.devce1.2010.03.009]; Takahashi K, 2005, EUR J PEDIATR, V164, P497, DOI 10.1007/s00431-005-1679-y; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Vadali K, 2007, IUBMB LIFE, V59, P709, DOI 10.1080/15216540701694245; von Wichert G, 2003, EMBO J, V22, P5023, DOI 10.1093/emboj/cdg492; Wang LJ, 2002, CIRC RES, V91, P821, DOI 10.1161/01.RES.0000041029.97988.E9; Xia H, 2004, J BIOL CHEM, V279, P33024, DOI 10.1074/jbc.M313265200; Yang ZZ, 2005, MOL CELL BIOL, V25, P10407, DOI 10.1128/MCB.25.23.10407-10418.2005	45	16	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18335	18344		10.1074/jbc.M113.483800	http://dx.doi.org/10.1074/jbc.M113.483800			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23673659	Green Published, hybrid			2022-12-25	WOS:000320721900037
J	Betous, R; Glick, GG; Zhao, RX; Cortez, D				Betous, Remy; Glick, Gloria G.; Zhao, Runxiang; Cortez, David			Identification and Characterization of SMARCAL1 Protein Complexes	PLOS ONE			English	Article							WERNER-SYNDROME PROTEIN; REPLICATION FORK; HELICASE ACTIVITY; GENOME STABILITY; SYNDROME GENE; DNA-DAMAGE; IN-VIVO; WRN; PHOSPHORYLATION; DOMAIN	SMARCAL1 is an ATPase in the SNF2 family that functions at damaged replication forks to promote their stability and restart. It acts by translocating on DNA to catalyze DNA strand annealing, branch migration, and fork regression. Many SNF2 enzymes work as motor subunits of large protein complexes. To determine if SMARCAL1 is also a member of a protein complex and to further understand how it functions in the replication stress response, we used a proteomics approach to identify interacting proteins. In addition to the previously characterized interaction with replication protein A (RPA), we found that SMARCAL1 forms complexes with several additional proteins including DNA-PKcs and the WRN helicase. SMARCAL1 and WRN co-localize at stalled replication forks independently of one another. The SMARCAL1 interaction with WRN is indirect and is mediated by RPA acting as a scaffold. SMARCAL1 and WRN act independently to prevent MUS81 cleavage of the stalled fork. Biochemical experiments indicate that both catalyze fork regression with SMARCAL1 acting more efficiently and independently of WRN. These data suggest that RPA brings a complex of SMARCAL1 and WRN to stalled forks, but that they may act in different pathways to promote fork repair and restart.	[Betous, Remy; Glick, Gloria G.; Zhao, Runxiang; Cortez, David] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA	Vanderbilt University	Cortez, D (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA.	david.cortez@vanderbilt.edu	Bétous, Rémy/ABF-4789-2020; Classen, Scott/AAY-8176-2020	Bétous, Rémy/0000-0003-0518-1763; 	National Institutes of Health [R01 CA136933, R01GM160342]; Department of Defense Breast Cancer Research Program post-doctoral fellowship [W81XWH-10-1-0581]; NATIONAL CANCER INSTITUTE [P01CA092584, R01CA160432, R01CA136933] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research Program post-doctoral fellowship(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grants R01 CA136933 and R01GM160342 to D.C., and a Department of Defense Breast Cancer Research Program post-doctoral fellowship W81XWH-10-1-0581 to R.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammazzalorso F, 2010, EMBO J, V29, P3156, DOI 10.1038/emboj.2010.205; Ball HL, 2007, MOL CELL BIOL, V27, P3367, DOI 10.1128/MCB.02238-06; Ball HL, 2005, MOL BIOL CELL, V16, P2372, DOI 10.1091/mbc.e04-11-1006; Bansbach CE, 2009, GENE DEV, V23, P2405, DOI 10.1101/gad.1839909; Baradaran-Heravi A, 2012, AM J MED GENET A, V158A, P2204, DOI 10.1002/ajmg.a.35532; Betous R, 2012, GENE DEV, V26, P151, DOI 10.1101/gad.178459.111; Boerkoel CF, 2002, NAT GENET, V30, P215, DOI 10.1038/ng821; Bohr VA, 2000, EXP GERONTOL, V35, P695, DOI 10.1016/S0531-5565(00)00145-5; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Brosh RM, 1999, J BIOL CHEM, V274, P18341, DOI 10.1074/jbc.274.26.18341; Carroll C, 2013, PEDIAT BLOO IN PRESS; Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682; Ciccia A, 2012, MOL CELL; Ciccia A, 2009, GENE DEV, V23, P2415, DOI 10.1101/gad.1832309; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Constantinou A, 2000, EMBO REP, V1, P80, DOI 10.1093/embo-reports/kvd004; Damerla RR, 2012, CELL CYCLE, V11, P3036, DOI 10.4161/cc.21399; Doherty KM, 2005, J BIOL CHEM, V280, P29494, DOI 10.1074/jbc.M500653200; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Franchitto A, 2008, J CELL BIOL, V183, P241, DOI 10.1083/jcb.200803173; Karmakar P, 2002, J BIOL CHEM, V277, P18291, DOI 10.1074/jbc.M111523200; Lee SJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000801; Machwe A, 2006, BIOCHEMISTRY-US, V45, P13939, DOI 10.1021/bi0615487; Mirkin EV, 2007, MICROBIOL MOL BIOL R, V71, P13, DOI 10.1128/MMBR.00030-06; Murfuni I, 2012, CARCINOGENESIS, V33, P1655, DOI 10.1093/carcin/bgs206; Pichierri P, 2003, ONCOGENE, V22, P1491, DOI 10.1038/sj.onc.1206169; Pirzio LM, 2008, J CELL BIOL, V180, P305, DOI 10.1083/jcb.200705126; Postow L, 2009, J BIOL CHEM, V284, P35951, DOI 10.1074/jbc.M109.048330; Shao RG, 1999, EMBO J, V18, P1397, DOI 10.1093/emboj/18.5.1397; Shen JC, 2003, MECH AGEING DEV, V124, P921, DOI 10.1016/S0047-6374(03)00164-7; Yan H, 1998, NAT GENET, V19, P375, DOI 10.1038/1263; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258; Yuan JS, 2009, GENE DEV, V23, P2394, DOI 10.1101/gad.1836409; Yusufzai T, 2008, SCIENCE, V322, P748, DOI 10.1126/science.1161233; Yusufzai T, 2009, GENE DEV, V23, P2400, DOI 10.1101/gad.1831509	35	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63149	10.1371/journal.pone.0063149	http://dx.doi.org/10.1371/journal.pone.0063149			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671665	gold, Green Published, Green Submitted			2022-12-25	WOS:000319737700043
J	Kasera, R; Singh, AB; Lavasa, S; Nagendra, K; Arora, N				Kasera, Ramkrashan; Singh, Anand Bahadur; Lavasa, Shakuntala; Nagendra, Komarla; Arora, Naveen			Purification and Immunobiochemical Characterization of a 31 kDa Cross-Reactive Allergen from Phaseolus vulgaris (Kidney Bean)	PLOS ONE			English	Article							LIPID TRANSFER PROTEIN; MAJOR PEANUT ALLERGEN; BIRCH POLLEN; ATOPIC-DERMATITIS; IDENTIFICATION; RHINITIS; IMMUNOTHERAPY; BLACKGRAM; BET-V-1; VICILIN	Background: Legumes are a rich source of proteins but are also potential elicitors of IgE-mediated food allergy. This study aimed to isolate and characterize a major allergen of Phaseolus vulgaris (kidney bean) and determine its allergenicity. Methodology: Kidney bean allergen was purified using Q Sepharose column (anion exchanger) and eluates with high intensity were pooled to purify protein using Superdex 75 (gel filtration) and C-18 column (RP-HPLC). Patients with history of kidney bean allergy were skin prick tested (SPT) with crude kidney bean extract and the purified protein. Specific IgE was estimated in sera by enzyme-linked immunosorbent assay (ELISA). Characterization of purified protein and its cross-reactivity was investigated by immunobiochemical methods. Identification of purified protein was carried out by tandem mass spectrometry. Principal Findings: Purified protein appeared as a single band at 31 kDa on SDS-PAGE and showed IgE binding to 88% patients' sera by ELISA and immunoblotting. SPT with purified protein identified 78% hypersensitive patients of kidney bean. Significant release of histamine from sensitized basophils was observed after challenge with purified protein. PAS staining suggested it to be a glycoprotein, but no change in IgE binding was observed after periodate oxidation. The 31 kDa protein remained stable for 60 min on incubation with pepsin. The purified protein had high allergenic potential since it required only 102 ng of self protein for 50% IgE inhibition. Mass spectrometric analysis identified it as Phytohemagglutinin. It also showed hemagglutination with human RBCs. Cross-reactivity was observed with peanut and black gram with IC50 of 185 and 228 ng respectively. Conclusion/Significance: A 31 kDa major allergen of kidney bean was purified and identified as phytohemagglutinin with cross-reactivity to peanut and black gram.	[Kasera, Ramkrashan; Singh, Anand Bahadur; Arora, Naveen] CSIR Inst Genom & Integrat Biol, Allergy & Immunol Sect, Delhi, India; [Kasera, Ramkrashan; Arora, Naveen] Univ Pune, Pune, Maharashtra, India; [Lavasa, Shakuntala] USLavasa Med & Res Ctr, Chandigarh, India; [Nagendra, Komarla] Bengaluru Allergy Ctr, Bangalore, Karnataka, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Savitribai Phule Pune University	Arora, N (corresponding author), CSIR Inst Genom & Integrat Biol, Allergy & Immunol Sect, Delhi, India.	naveen@igib.res.in						Akkerdaas J, 2012, INT ARCH ALLERGY IMM, V157, P51, DOI 10.1159/000324946; [Anonymous], 1991, AM REV RESPIR DIS, V144, P1202, DOI 10.1164/ajrccm/144.5.1202; Blanc F, 2008, MOL NUTR FOOD RES, V52, pS166, DOI 10.1002/mnfr.200700283; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Bollen MA, 2007, MOL NUTR FOOD RES, V51, P1527, DOI 10.1002/mnfr.200700119; Bousquet J, 2001, J ALLERGY CLIN IMMUN, V108, pS147, DOI 10.1067/mai.2001.118891; Bublin M, 2010, J ALLERGY CLIN IMMUN, V125, P687, DOI 10.1016/j.jaci.2009.10.017; BURKS AW, 1992, J ALLERGY CLIN IMMUN, V90, P962, DOI 10.1016/0091-6749(92)90469-I; BURKS AW, 1991, J ALLERGY CLIN IMMUN, V88, P172, DOI 10.1016/0091-6749(91)90325-I; Carvalho LMJ, 2012, FOOD NUTR RES, V56, DOI 10.3402/fnr.v56i0.15618; Chanana V, 2004, ACTA CRYSTALLOGR D, V60, P2100, DOI 10.1107/S0907444904023868; Food and Agriculture Organization [FAO], 1993, FOOD AGR ORG FAO PRO, V26; Hamilton RG, 2004, J ALLERGY CLIN IMMUN, V114, P213, DOI 10.1016/j.jaci.2004.06.046; Hoffmann-Sommergruber K, 2008, MOL NUTR FOOD RES, V52, pS159, DOI 10.1002/mnfr.200800466; Ibanez MD, 2003, ALLERGOL IMMUNOPATH, V31, P1511; Kasera R, 2012, FOOD CHEM TOXICOL, V50, P3456, DOI 10.1016/j.fct.2012.07.031; Kasera R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027193; Kleber-Janke T, 1999, INT ARCH ALLERGY IMM, V119, P265, DOI 10.1159/000024203; Kumar R, 2007, IMMUNOBIOLOGY, V212, P141, DOI 10.1016/j.imbio.2006.11.006; Kumari D, 2006, ALLERGY, V61, P104, DOI 10.1111/j.1398-9995.2006.00990.x; Kumari D, 2012, IMMUNOBIOLOGY, V217, P895, DOI 10.1016/j.imbio.2011.12.011; Larche M, 2006, NAT REV IMMUNOL, V6, P761, DOI 10.1038/nri1934; Lauer I, 2009, CLIN EXP ALLERGY, V39, P1427, DOI 10.1111/j.1365-2222.2009.03312.x; Liu B, 2012, APPL MICROBIOL BIOT, V94, P1337, DOI 10.1007/s00253-012-4006-3; Lopez-Torrejon G, 2003, J ALLERGY CLIN IMMUN, V112, P1208, DOI 10.1016/j.jaci.2003.08.035; Marsh J, 2008, MOL NUTR FOOD RES, V52, pS272, DOI 10.1002/mnfr.200700524; Misra A, 2010, FOOD CHEM TOXICOL, V48, P2725, DOI 10.1016/j.fct.2010.06.047; Misra A, 2009, IMMUNOPHARM IMMUNOT, V31, P186, DOI 10.1080/08923970802578782; Mittag D, 2005, CLIN EXP ALLERGY, V35, P1049, DOI 10.1111/j.1365-2222.2005.02309.x; Mittag D, 2004, J ALLERGY CLIN IMMUN, V114, P1410, DOI 10.1016/j.jaci.2004.09.014; Moverare R, 2002, ALLERGY, V57, P423, DOI 10.1034/j.1398-9995.2002.13248.x; PARIHAR H, 1984, Indian Journal of Pediatrics, V51, P7, DOI 10.1007/BF02753518; Pereira M J, 2002, Allergol Immunopathol (Madr), V30, P346; Pons L, 2002, ALLERGY, V57, P88, DOI 10.1034/j.1398-9995.57.s72.16.x; Qureshi IA, 2006, ACTA CRYSTALLOGR F, V62, P869, DOI 10.1107/S1744309106028077; Rabjohn P, 1999, J CLIN INVEST, V103, P535, DOI 10.1172/JCI5349; Rigby NM, 2008, MOL NUTR FOOD RES, V52, pS251, DOI 10.1002/mnfr.200800083; Rouge P, 2011, ALLERGY, V66, P301, DOI 10.1111/j.1398-9995.2010.02466.x; SCHIAVINO D, 1992, ALLERGY, V47, P121, DOI 10.1111/j.1398-9995.1992.tb05099.x; Sharman Jyotsna, 2000, Indian Journal of Pediatrics, V67, P713, DOI 10.1007/BF02723925; SINGH BP, 1992, BIOCHEM INT, V27, P477; Singh S, 2012, J PROTEOME RES; Treudler R, 2012, CURR ALLERGY ASTHM R; Tsuji H, 1997, BIOSCI BIOTECH BIOCH, V61, P942, DOI 10.1271/bbb.61.942; Valenta R, 2002, NAT REV IMMUNOL, V2, P446, DOI 10.1038/nri824; Verma AK, 2012, TOXICOL LETT, V210, P24, DOI 10.1016/j.toxlet.2012.01.011; Zoccatelli G, 2010, MOL IMMUNOL, V47, P1561, DOI 10.1016/j.molimm.2010.01.009	47	12	13	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63063	10.1371/journal.pone.0063063	http://dx.doi.org/10.1371/journal.pone.0063063			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671655	Green Published, Green Submitted, gold			2022-12-25	WOS:000319737700036
J	Gong, P; Kortus, MG; Nix, JC; Davis, RE; Peersen, OB				Gong, Peng; Kortus, Matthew G.; Nix, Jay C.; Davis, Ralph E.; Peersen, Olve B.			Structures of Coxsackievirus, Rhinovirus, and Poliovirus Polymerase Elongation Complexes Solved by Engineering RNA Mediated Crystal Contacts	PLOS ONE			English	Article							KINETIC-ANALYSIS; VIRUS; MECHANISM; FIDELITY; 3D(POL); TRANSLOCATION; INITIATION; DIVERSITY; INSIGHTS; BINDING	RNA-dependent RNA polymerases play a vital role in the growth of RNA viruses where they are responsible for genome replication, but do so with rather low fidelity that allows for the rapid adaptation to different host cell environments. These polymerases are also a target for antiviral drug development. However, both drug discovery efforts and our understanding of fidelity determinants have been hampered by a lack of detailed structural information about functional polymerase-RNA complexes and the structural changes that take place during the elongation cycle. Many of the molecular details associated with nucleotide selection and catalysis were revealed in our recent structure of the poliovirus polymerase-RNA complex solved by first purifying and then crystallizing stalled elongation complexes. In the work presented here we extend that basic methodology to determine nine new structures of poliovirus, coxsackievirus, and rhinovirus elongation complexes at 2.2-2.9 A resolution. The structures highlight conserved features of picornaviral polymerases and the interactions they make with the template and product RNA strands, including a tight grip on eight basepairs of the nascent duplex, a fully pre-positioned templating nucleotide, and a conserved binding pocket for the +2 position template strand base. At the active site we see a pre-bound magnesium ion and there is conservation of a non-standard backbone conformation of the template strand in an interaction that may aid in triggering RNA translocation via contact with the conserved polymerase motif B. Moreover, by engineering plasticity into RNA-RNA contacts, we obtain crystal forms that are capable of multiple rounds of in-crystal catalysis and RNA translocation. Together, the data demonstrate that engineering flexible RNA contacts to promote crystal lattice formation is a versatile platform that can be used to solve the structures of viral RdRP elongation complexes and their catalytic cycle intermediates.	[Gong, Peng; Kortus, Matthew G.; Peersen, Olve B.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Nix, Jay C.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Adv Light Source, Mol Biol Consortium, Berkeley, CA 94720 USA; [Davis, Ralph E.] Cocrystal Discovery Inc, Mountain View, CA USA	Colorado State University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Peersen, OB (corresponding author), Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA.	Olve.Peersen@ColoState.edu	Peersen, Olve/P-5587-2016; Gong, Peng/ABD-6333-2021		National Institutes of Health [R01-AI059130]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059130] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health research grant R01-AI059130 to O.B.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agudo R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001072; Arias A, 2008, J VIROL, V82, P12346, DOI 10.1128/JVI.01297-08; Arnold JJ, 2000, J BIOL CHEM, V275, P5329, DOI 10.1074/jbc.275.8.5329; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Campagnola G, 2008, J VIROL, V82, P9458, DOI 10.1128/JVI.00647-08; Coffey LL, 2011, J VIROL, V85, P1025, DOI 10.1128/JVI.01918-10; Domingo E, 2006, CURR TOP MICROBIOL, V299, P51; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FALKE JJ, 1994, Q REV BIOPHYS, V27, P219, DOI 10.1017/S0033583500003012; Ferrer-Orta C, 2006, EMBO J, V25, P880, DOI 10.1038/sj.emboj.7600971; Ferrer-Orta C, 2004, J BIOL CHEM, V279, P47212, DOI 10.1074/jbc.M405465200; Ferrer-Orta C, 2007, P NATL ACAD SCI USA, V104, P9463, DOI 10.1073/pnas.0700518104; Gnadig NF, 2012, P NATL ACAD SCI USA, V109, pE2294, DOI 10.1073/pnas.1204022109; Gohara DW, 1999, PROTEIN EXPRES PURIF, V17, P128, DOI 10.1006/prep.1999.1100; Golosov AA, 2010, STRUCTURE, V18, P83, DOI 10.1016/j.str.2009.10.014; Gong P, 2010, P NATL ACAD SCI USA, V107, P22505, DOI 10.1073/pnas.1007626107; Gong P, 2009, ANAL BIOCHEM, V391, P45, DOI 10.1016/j.ab.2009.04.035; Hobdey SE, 2010, J VIROL, V84, P8072, DOI 10.1128/JVI.02147-09; Hong Z, 2001, VIROLOGY, V285, P6, DOI 10.1006/viro.2001.0948; Jin ZN, 2012, J BIOL CHEM, V287, P10674, DOI 10.1074/jbc.M111.325530; Kortus MG, 2012, J MOL BIOL, V417, P263, DOI 10.1016/j.jmb.2012.01.049; Lavery R, 2009, NUCLEIC ACIDS RES, V37, P5917, DOI 10.1093/nar/gkp608; Levi LI, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001163; Mosley RT, 2012, J VIROLOGY; Moustafa IM, 2011, J MOL BIOL, V410, P159, DOI 10.1016/j.jmb.2011.04.078; Pata JD, 2010, STRUCTURE, V18, P4, DOI 10.1016/j.str.2009.12.003; Pfeiffer JK, 2006, P NATL ACAD SCI USA, V103, P5520, DOI 10.1073/pnas.0600834103; Pfeiffer JK, 2003, P NATL ACAD SCI USA, V100, P7289, DOI 10.1073/pnas.1232294100; Pfeiffer JK, 2005, PLOS PATHOG, V1, P102, DOI 10.1371/journal.ppat.0010011; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Shen HJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002851; Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542; Theobald DL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040043; Theobald DL, 2006, P NATL ACAD SCI USA, V103, P18521, DOI 10.1073/pnas.0508445103; Thompson AA, 2007, J MOL BIOL, V366, P1459, DOI 10.1016/j.jmb.2006.11.070; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Weeks SA, 2012, J BIOL CHEM, V287, P31618, DOI 10.1074/jbc.C112.401471; Yang XR, 2012, STRUCTURE, V20, P1519, DOI 10.1016/j.str.2012.06.012; Yang XR, 2010, BIOCHEMISTRY-US, V49, P9361, DOI 10.1021/bi100833r; Yin YW, 2004, CELL, V116, P393, DOI 10.1016/S0092-8674(04)00120-5; Zamyatkin DF, 2008, J BIOL CHEM, V283, P7705, DOI 10.1074/jbc.M709563200	42	55	56	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e60272	10.1371/journal.pone.0060272	http://dx.doi.org/10.1371/journal.pone.0060272			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667424	gold, Green Submitted, Green Published			2022-12-25	WOS:000319055600004
J	Lammens, A; Baehner, M; Kohnert, U; Niewoehner, J; von Proff, L; Schraeml, M; Lammens, K; Hopfner, KP				Lammens, Alfred; Baehner, Monika; Kohnert, Ulrich; Niewoehner, Jens; von Proff, Leopold; Schraeml, Michael; Lammens, Katja; Hopfner, Karl-Peter			Crystal Structure of Human TWEAK in Complex with the Fab Fragment of a Neutralizing Antibody Reveals Insights into Receptor Binding	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; FIBROBLAST GROWTH FACTOR-INDUCIBLE-14; CYSTEINE-RICH DOMAIN; WEAK INDUCER; PATHWAY ACTIVATION; CELL-PROLIFERATION; FUNCTIONAL EXPRESSION; SIGNAL-TRANSDUCTION; SUPERFAMILY MEMBER	The tumor necrosis factor-like weak inducer of apoptosis (TWEAK) is a multifunctional cytokine playing a key role in tissue regeneration and remodeling. Dysregulation of TWEAK signaling is involved in various pathological processes like autoimmune diseases and cancer. The unique interaction with its cognate receptor Fn14 makes both ligand and receptor promising targets for novel therapeutics. To gain insights into this important signaling pathway, we determined the structure of soluble human TWEAK in complex with the Fab fragment of an antibody selected for inhibition of receptor binding. In the crystallized complex TWEAK is bound by three Fab fragments of the neutralizing antibody. Homology modeling shows that Fab binding overlaps with the putative Fn14 binding site of TWEAK. Docking of the Fn14 cysteine rich domain (CRD) to that site generates a highly complementary interface with perfectly opposing charged and hydrophobic residues. Taken together the presented structure provides new insights into the biology of TWEAK and the TWEAK/Fn14 pathway, which will help to optimize the therapeutic strategy for treatment of related cancer types and autoimmune diseases.	[Lammens, Alfred; Hopfner, Karl-Peter] Ctr Integrated Prot Sci CIPSM, Munich, Germany; [Lammens, Alfred; Lammens, Katja; Hopfner, Karl-Peter] Univ Munich, Dept Biochem, Munich, Germany; [Lammens, Alfred; Lammens, Katja; Hopfner, Karl-Peter] Univ Munich, Gene Ctr, Munich, Germany; [Baehner, Monika; Kohnert, Ulrich; Niewoehner, Jens] Roche Pharma Res & Early Dev pRED, Biol Res, Penzberg, Germany; [von Proff, Leopold; Schraeml, Michael] Roche Profess Diagnost, Res & Dev, Penzberg, Germany	University of Munich; University of Munich; University of Munich	Hopfner, KP (corresponding author), Ctr Integrated Prot Sci CIPSM, Munich, Germany.	hopfner@lmb.uni-muenchen.de	Hopfner, Karl-Peter/B-6864-2014	Hopfner, Karl-Peter/0000-0002-4528-8357	DFG [Sonderforschungsbereich 684]; German Excellence Initiative (CIPSM cluster);  [SFB 1054]	DFG(German Research Foundation (DFG)); German Excellence Initiative (CIPSM cluster); 	KPH is supported by the DFG (Sonderforschungsbereich 684) and the German Excellence Initiative (CIPSM cluster). KPH and KL acknowledge support by the SFB 1054. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonine PV, 2005, ACTA CRYSTALLOGR D, V61, P850, DOI 10.1107/S0907444905007894; Bossen C, 2008, BLOOD, V111, P1004, DOI 10.1182/blood-2007-09-110874; Brown SA, J BIOL CHEM, V285, P17432; Brown SAN, 2003, BIOCHEM J, V371, P395, DOI 10.1042/BJ20021730; Brown SAN, 2006, BIOCHEM J, V397, P297, DOI 10.1042/BJ20051362; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Burkly LC, 2007, CYTOKINE, V40, P1, DOI 10.1016/j.cyto.2007.09.007; Chicheportiche Y, 1997, J BIOL CHEM, V272, P32401, DOI 10.1074/jbc.272.51.32401; Dai L, 2009, CANCER LETT, V283, P159, DOI 10.1016/j.canlet.2009.03.036; Davies DR, 1996, P NATL ACAD SCI USA, V93, P7, DOI 10.1073/pnas.93.1.7; Desplat-Jego S, 2009, J LEUKOCYTE BIOL, V85, P132, DOI 10.1189/jlb.0608347; Dogra C, 2007, J BIOL CHEM, V282, P15000, DOI 10.1074/jbc.M608668200; Dohi T, 2009, GASTROENTEROLOGY, V136, P912, DOI 10.1053/j.gastro.2008.11.017; Donohue PJ, 2003, ARTERIOSCL THROM VAS, V23, P594, DOI 10.1161/01.ATV.0000062883.93715.37; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Felli N, 2005, J IMMUNOL, V175, P1464, DOI 10.4049/jimmunol.175.3.1464; Feng SLY, 2000, AM J PATHOL, V156, P1253, DOI 10.1016/S0002-9440(10)64996-6; Fick A, 2012, J BIOL CHEM, V287, P484, DOI 10.1074/jbc.M111.287656; Girgenrath M, 2006, EMBO J, V25, P5826, DOI 10.1038/sj.emboj.7601441; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; Haile WB, 2010, NEUROSCIENCE, V171, P1256, DOI 10.1016/j.neuroscience.2010.10.029; Haile WB, 2010, NEUROSCIENCE; Han SY, 2003, BIOCHEM BIOPH RES CO, V305, P789, DOI 10.1016/S0006-291X(03)00852-0; Harada N, 2002, BIOCHEM BIOPH RES CO, V299, P488, DOI 10.1016/S0006-291X(02)02670-0; He F, 2009, PROTEIN SCI, V18, P650, DOI 10.1002/pro.49; Hendriks J, 2005, CELL DEATH DIFFER, V12, P637, DOI 10.1038/sj.cdd.4401647; Ho DH, 2004, CANCER RES, V64, P8968, DOI 10.1158/0008-5472.CAN-04-1879; Huard B, 2008, J CLIN INVEST, V118, P2887, DOI 10.1172/JCI33760; Ingold K, 2005, J EXP MED, V201, P1375, DOI 10.1084/jem.20042309; Inta I, 2008, J NEUROL SCI, V275, P117, DOI 10.1016/j.jns.2008.08.005; Iocca HA, 2008, J NEUROIMMUNOL, V194, P97, DOI 10.1016/j.jneuroim.2007.12.003; Jakubowski A, 2005, J CLIN INVEST, V115, P2330, DOI 10.1172/JCI23486; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Kamata K, 2006, J IMMUNOL, V177, P6433, DOI 10.4049/jimmunol.177.9.6433; Kaplan MJ, 2002, J IMMUNOL, V169, P6020, DOI 10.4049/jimmunol.169.10.6020; Kawakita T, 2005, INT J ONCOL, V26, P87; Kawakita T, 2004, BIOCHEM BIOPH RES CO, V318, P726, DOI 10.1016/j.bbrc.2004.04.084; Kimberley FC, 2009, FASEB J, V23, P1584, DOI 10.1096/fj.08-124669; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Leng RX, 2010, MOL BIOL REP; Lynch CN, 1999, J BIOL CHEM, V274, P8455, DOI 10.1074/jbc.274.13.8455; Maecker H, 2005, CELL, V123, P931, DOI 10.1016/j.cell.2005.09.022; Marsters SA, 1998, CURR BIOL, V8, P525, DOI 10.1016/S0960-9822(98)70204-0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meighan-Mantha RL, 1999, J BIOL CHEM, V274, P33166, DOI 10.1074/jbc.274.46.33166; Michaelson JS, 2005, ONCOGENE, V24, P2613, DOI 10.1038/sj.onc.1208208; Mittel A, 2010, AM J PATHOL, V177, P1732, DOI 10.2353/ajpath.2010.100335; Munoz-Garcia B, 2009, ARTERIOSCL THROM VAS, V29, P2061, DOI 10.1161/ATVBAHA.109.194852; Novoyatleva T, 2010, CARDIOVASC RES, V85, P681, DOI 10.1093/cvr/cvp360; Perper SJ, 2006, J IMMUNOL, V177, P2610, DOI 10.4049/jimmunol.177.4.2610; Polavarapu R, 2005, J NEUROSCI, V25, P10094, DOI 10.1523/JNEUROSCI.3382-05.2005; Polek TC, 2003, J BIOL CHEM, V278, P32317, DOI 10.1074/jbc.M302518200; Potrovita I, 2004, J NEUROSCI, V24, P8237, DOI 10.1523/JNEUROSCI.1089-04.2004; Roos C, 2010, J IMMUNOL, V185, P1593, DOI 10.4049/jimmunol.0903555; Saitoh T, 2003, J BIOL CHEM, V278, P36005, DOI 10.1074/jbc.M304266200; Sakurai D, 2007, BLOOD, V109, P2961, DOI 10.1182/blood-2006-08-041772; Sanz AB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008955; Schneider P, 1998, J EXP MED, V187, P1205, DOI 10.1084/jem.187.8.1205; Serafini B, 2008, J NEUROPATH EXP NEUR, V67, P1137, DOI 10.1097/NEN.0b013e31818dab90; Tanabe K, 2003, J NEUROSCI, V23, P9675; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Tirnitz-Parker JEE, 2010, HEPATOLOGY, V52, P291, DOI 10.1002/hep.23663; Tran NL, 2005, J BIOL CHEM, V280, P3483, DOI 10.1074/jbc.M409906200; Tran NL, 2003, AM J PATHOL, V162, P1313, DOI 10.1016/S0002-9440(10)63927-2; Vendrell J, 2010, J CLIN ENDOCR METAB, V95, P2983, DOI 10.1210/jc.2009-2481; Wajant H, 2001, ONCOGENE, V20, P4101, DOI 10.1038/sj.onc.1204558; Wako M, 2008, SPINE, V33, P2489, DOI 10.1097/BRS.0b013e318186b343; Wang DF, 2010, CANCER LETT, V294, P91, DOI 10.1016/j.canlet.2010.01.027; Whitsett TG, 2012, AM J PATHOL, V181, P111, DOI 10.1016/j.ajpath.2012.03.026; Wiley SR, 2001, IMMUNITY, V15, P837, DOI 10.1016/S1074-7613(01)00232-1; Willis AL, 2008, MOL CANCER RES, V6, P725, DOI 10.1158/1541-7786.MCR-08-0005; Winkles JA, 2006, CANCER LETT, V235, P11, DOI 10.1016/j.canlet.2005.03.048	73	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62697	10.1371/journal.pone.0062697	http://dx.doi.org/10.1371/journal.pone.0062697			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667509	Green Published, gold, Green Submitted			2022-12-25	WOS:000319055600039
J	Phillips, PPJ; Fielding, K; Nunn, AJ				Phillips, Patrick P. J.; Fielding, Katherine; Nunn, Andrew J.			An Evaluation of Culture Results during Treatment for Tuberculosis as Surrogate Endpoints for Treatment Failure and Relapse	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; CLINICAL-TRIALS; MYCOBACTERIUM-TUBERCULOSIS; DESIGN ISSUES; PHASE-III; MOXIFLOXACIN; MULTICENTER; BIOMARKERS; SPUTUM; TB	It is widely acknowledged that new regimens are urgently needed for the treatment of tuberculosis. The primary endpoint in the Phase III trials is a composite outcome of failure at the end of treatment or relapse after stopping treatment. Such trials are usually both long and expensive. Valid surrogate endpoints measured during or at the end of treatment could dramatically reduce both the time and cost of assessing the effectiveness of new regimens. The objective of this study was to evaluate sputum culture results on solid media during treatment as surrogate endpoints for poor outcome. Data were obtained from twelve randomised controlled trials conducted by the British Medical Research Council in the 1970s and 80s in East Africa and East Asia, consisting of 6974 participants and 49 different treatment regimens. The month two culture result was shown to be a poor surrogate in East Africa but a good surrogate in Hong Kong. In contrast, the month three culture was a good surrogate in trials conducted in East Africa but not in Hong Kong. As well as differences in location, ethnicity and probable strain of Mycobacteria tuberculosis, Hong Kong trials more often evaluated regimens with rifampicin throughout and intermittent regimens, and patients in East African trials more often presented with extensive cavitation and were slower to convert to culture negative during treatment. An endpoint that is a summary measure of the longitudinal profile of culture results over time or that is able to detect the presence of M. tuberculosis later in treatment is more likely to be a better endpoint for a phase II trial than a culture result at a single time point and may prove to be an acceptable surrogate. More data are needed before any endpoint can be used as a surrogate in a confirmatory phase III trial.	[Phillips, Patrick P. J.; Nunn, Andrew J.] Med Res Council Clin Trials Unit, London, England; [Fielding, Katherine] London Sch Hyg & Trop Med, London WC1, England	Medical Research Council Clinical Trials Unit; University of London; London School of Hygiene & Tropical Medicine	Phillips, PPJ (corresponding author), Med Res Council Clin Trials Unit, London, England.	patrick.phillips@ctu.mrc.ac.uk	Phillips, Patrick/B-6347-2008	Phillips, Patrick/0000-0002-6336-7024; Nunn, Andrew/0000-0002-9158-4595; Fielding, Katherine/0000-0002-6524-3754	British Medical Research Council PhD studentship; MRC [MC_EX_G0800814, MC_U122888469] Funding Source: UKRI; Medical Research Council [MC_EX_G0800814, MR/K012126/1, MC_U122888469] Funding Source: researchfish	British Medical Research Council PhD studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by a British Medical Research Council PhD studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aber V R, 1978, Bull Int Union Tuberc, V53, P276; [Anonymous], 2011, GLOB TUB CONTR 2011; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Baker Stuart G, 2003, BMC Med Res Methodol, V3, P16, DOI 10.1186/1471-2288-3-16; Barry C, 2001, TUBERCULOSIS, V81, P1, DOI 10.1054/tube.2001.0288; Benator D, 2002, LANCET, V360, P528, DOI 10.1016/S0140-6736(02)09742-8; Blakemore R, 2011, AM J RESP CRIT CARE, V184, P1076, DOI 10.1164/rccm.201103-0536OC; Burman WJ, 2009, EMERG INFECT DIS, V15, P1061, DOI 10.3201/eid1507.081253; Burzykowski T, 2005, EVALUATION SURROGATE; Chaisson RE, 2010, J INFECT DIS, V201, P653, DOI 10.1086/650531; Christie DA, 2005, SHORT COURS CHEM TUB; Daniels MJ, 1997, STAT MED, V16, P1965, DOI 10.1002/(SICI)1097-0258(19970915)16:17<1965::AID-SIM630>3.3.CO;2-D; Davies GR, 2010, TUBERCULOSIS, V90, P171, DOI 10.1016/j.tube.2010.03.007; DESOPO ND, 1982, AM REV RESPIR DIS, V125, P85; Dorman SE, 2009, AM J RESP CRIT CARE, V180, P273, DOI 10.1164/rccm.200901-0078OC; *E CENTR AFR BRIT, 1983, TUBERCLE, V64, P153; Fox W, 1999, INT J TUBERC LUNG D, V3, pS231; Honeyborne I, 2011, J CLIN MICROBIOL, V49, P3905, DOI 10.1128/JCM.00547-11; Horne DJ, 2010, LANCET INFECT DIS, V10, P387, DOI 10.1016/S1473-3099(10)70071-2; Jindani A, 2004, LANCET, V364, P1244, DOI 10.1016/S0140-6736(04)17141-9; Karim SSA, 2009, LANCET, V374, P921, DOI 10.1016/S0140-6736(09)60916-8; Lambert ML, 2003, LANCET INFECT DIS, V3, P282, DOI 10.1016/S1473-3099(03)00607-8; Mac Kenzie WR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018358; Madras Tuberculosis Chemotherapy Centre, 1960, B WORLD HEALTH ORGAN, V23, P535; Merle CSC, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-61; Mitchison D A, 1996, Soc Appl Bacteriol Symp Ser, V25, p72S; MITCHISON DA, 1993, AM REV RESPIR DIS, V147, P1062, DOI 10.1164/ajrccm/147.4.1062; Mukamolova GV, 2010, AM J RESP CRIT CARE, V181, P174, DOI 10.1164/rccm.200905-0661OC; Nahid P, 2011, AM J RESP CRIT CARE; Nahid P, 2011, AM J RESP CRIT CARE, V184, P972, DOI 10.1164/rccm.201105-0827WS; Nahid P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010753; Nunn AJ, 2008, TUBERCULOSIS, V88, pS85, DOI 10.1016/S1472-9792(08)70039-8; Perrin FMR, 2007, LANCET INFECT DIS, V7, P481, DOI 10.1016/S1473-3099(07)70112-3; Phillips PPJ, 2010, FUTURE MED CHEM, V2, P1273, DOI 10.4155/FMC.10.221; Phillips PP, 2012, J INFECT DIS; PRENTICE RL, 1989, STAT MED, V8, P431, DOI 10.1002/sim.4780080407; Rachow A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020458; Rustomjee R, 2008, INT J TUBERC LUNG D, V12, P128; SIMON G, 1966, BMJ-BRIT MED J, V2, P491, DOI 10.1136/bmj.2.5512.491; Sirgel FA, 2000, J ANTIMICROB CHEMOTH, V45, P859, DOI 10.1093/jac/45.6.859; Spigelman MK, 2007, J INFECT DIS, V196, pS28, DOI 10.1086/518663; Wallis RS, 2007, EXPERT REV ANTI-INFE, V5, P163, DOI 10.1586/14787210.5.2.163; Wallis RS, 2010, LANCET INFECT DIS, V10, P68, DOI 10.1016/S1473-3099(10)70003-7; Youmans GP, 1979, TUBERCULOSIS; ZUMLA A, 2008, JOINT TDR EC EXPERT	46	56	56	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63840	10.1371/journal.pone.0063840	http://dx.doi.org/10.1371/journal.pone.0063840			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667677	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000319055600076
J	Zhang, HJ; An, XL; Zhou, YY; Zhang, BZ; Zhang, S; Li, D; Chen, ZR; Li, Y; Bai, SJ; Lv, JL; Zheng, W; Tian, Y; Zheng, TL				Zhang, Huajun; An, Xinli; Zhou, Yanyan; Zhang, Bangzhou; Zhang, Su; Li, Dong; Chen, Zhangran; Li, Yi; Bai, Shijie; Lv, Jinglin; Zheng, Wei; Tian, Yun; Zheng, Tianling			Effect of Oxidative Stress Induced by Brevibacterium sp BS01 on a HAB Causing Species-Alexandrium tamarense	PLOS ONE			English	Article							RED-TIDE; GENE-EXPRESSION; ANTIOXIDANT RESPONSES; CORALLINA-PILULIFERA; OPTICAL-PROPERTIES; CYANOBACTERIA; ALGA; PHAEOCYSTIS; INHIBITION; DAMAGE	Harmful algal blooms occur all over the world, destroying aquatic ecosystems and threatening other organisms. The culture supernatant of the marine algicidal actinomycete BS01 was able to lysis dinoagellate Alexandrium tamarense ATGD98-006. Physiological and biochemical responses to oxidative stress in A. tamarense were investigated to elucidate the mechanism involved in BS01 inhibition of algal growth. Transmission electron microscope analysis revealed that there were some chloroplast abnormalities in response to BS01 supernatant. The decrease in cellular-soluble protein content suggested that cell growth was greatly inhibited at high concentration of BS01 supernatant. The increase in the levels of reactive oxygen species (ROS) and malondialdehyde contents following exposure to BS01 supernatant indicated that algal cells suffered from oxidative damage. The content of pigment was significantly decreased after 12 h treatment, which indicated that the accumulation of ROS destroyed pigment synthesis. Moreover, the decrease of Fv/Fm ratio suggested that in the photosynthetic system, the dominant sites producing ROS were destroyed by the supernatant of the BS01 culture. The activities of the antioxidant enzymes including superoxide dismutase and peroxidase increased in a short time and decreased slightly with increasing exposure time. A real-time PCR assay showed changes in the transcript abundances of two photosynthetic genes, psbA and psbD. The results showed that BS01 supernatant reduced the expression of the psbA gene after 2 h exposure, but the expression of the psbD gene was increased at concentrations of 1.0 and 1.5%. Our results demonstrated that the expression of the psbA gene was inhibited by the BS01 supernatant, which might block the electron transport chain, significantly enhancing ROS level and excess activity of the antioxidant system. The accumulation of ROS destoryed pigment synthesis and membrane integrity, and inhibited or ultimately killed the algal cells.	[Zhang, Huajun; An, Xinli; Zhou, Yanyan; Zhang, Bangzhou; Zhang, Su; Li, Dong; Chen, Zhangran; Li, Yi; Bai, Shijie; Lv, Jinglin; Zheng, Wei; Tian, Yun; Zheng, Tianling] Xiamen Univ, Sch Life Sci, State Key Lab Marine Environm Sci, Xiamen, Peoples R China; [Zhang, Huajun; An, Xinli; Zhou, Yanyan; Zhang, Bangzhou; Zhang, Su; Li, Dong; Chen, Zhangran; Li, Yi; Bai, Shijie; Lv, Jinglin; Zheng, Wei; Tian, Yun; Zheng, Tianling] Xiamen Univ, Sch Life Sci, Key Lab Minist Educ Coastal & Wetland Ecosyst, Xiamen, Peoples R China; [Li, Dong] Huaqiao Univ, Coll Chem Engn, Xiamen, Peoples R China	Xiamen University; Xiamen University; Huaqiao University	Tian, Y (corresponding author), Xiamen Univ, Sch Life Sci, State Key Lab Marine Environm Sci, Xiamen, Peoples R China.	tianyun@xmu.edu.cn; microzh@xmu.edu.cn			National Nature Science Foundation of China [40930847]; Special Fund for Ph.D. Program in University [20120121130001]; Public Science and Technology Research Funds Projects of Ocean [201305016, 201305041, 201305022];  [MELRI1003]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Ph.D. Program in University; Public Science and Technology Research Funds Projects of Ocean; 	National Nature Science Foundation of China (40930847) http://isis.nsfc.gov.cn/portal/Proj_List.asp, Special Fund for Ph.D. Program in University (20120121130001) http://211.68.23.117/SSO/loginshow?u=null, Public Science and Technology Research Funds Projects of Ocean (201305016, 201305041, 201305022) http://www.soanbu.com/and MELRI1003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alboresi A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-62; Allen JF, 2001, TRENDS PLANT SCI, V6, P317, DOI 10.1016/S1360-1385(01)02010-6; Anderson DM, 1997, NATURE, V388, P513, DOI 10.1038/41415; Anderson DM, 1997, LIMNOL OCEANOGR, V42, P1009, DOI 10.4319/lo.1997.42.5_part_2.1009; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Bai SJJ, 2011, CURR MICROBIOL, V62, P1774, DOI 10.1007/s00284-011-9927-z; Berger J, 2004, BIOLOGIA, V59, P9; BORNMAN JF, 1991, J EXP BOT, V42, P547, DOI 10.1093/jxb/42.4.547; Brussaard CPD, 2007, BIOGEOCHEMISTRY, V83, P201, DOI 10.1007/s10533-007-9096-0; Cai WW, 2011, APPL ENVIRON MICROB, V77, P7837, DOI 10.1128/AEM.05783-11; Choi HJ, 2005, BIOL CONTROL, V33, P335, DOI 10.1016/j.biocontrol.2005.03.007; Doucette GJ, 1999, J PHYCOL, V35, P1447, DOI 10.1046/j.1529-8817.1999.3561447.x; Drabkova M, 2007, ENVIRON SCI TECHNOL, V41, P309, DOI 10.1021/es060746i; ERICKSON JM, 1986, EMBO J, V5, P1745, DOI 10.1002/j.1460-2075.1986.tb04422.x; Perez-Perez ME, 2012, PLANT PHYSIOL, V160, P156, DOI 10.1104/pp.112.199992; Perez-Perez ME, 2012, AUTOPHAGY, V8, P376, DOI 10.4161/auto.18864; Gallacher S, 1997, APPL ENVIRON MICROB, V63, P239, DOI 10.1128/AEM.63.1.239-245.1997; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; He YY, 2002, J PHOTOCH PHOTOBIO B, V66, P73, DOI 10.1016/S1011-1344(01)00278-0; Hong Y, 2009, AQUAT TOXICOL, V91, P262, DOI 10.1016/j.aquatox.2008.11.014; INSKEEP WP, 1985, PLANT PHYSIOL, V77, P483, DOI 10.1104/pp.77.2.483; Jeong JH, 2000, J APPL PHYCOL, V12, P37, DOI 10.1023/A:1008139129057; Kim JD, 2007, BIOL CONTROL, V41, P296, DOI 10.1016/j.biocontrol.2007.02.010; Kommalapati M, 2007, PHOTOSYNTH RES, V92, P315, DOI 10.1007/s11120-007-9186-9; Kumar M, 2011, ENVIRON EXP BOT, V72, P194, DOI 10.1016/j.envexpbot.2011.03.007; Kwok CT, 2012, HARMFUL ALGAE, V13, P40, DOI 10.1016/j.hal.2011.10.001; Leitao MAD, 2003, ARCH ENVIRON CON TOX, V45, P59, DOI 10.1007/s00244-002-0208-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo MB, 2011, J EXP MAR BIOL ECOL, V409, P223, DOI 10.1016/j.jembe.2011.08.023; Miyazono A, 2012, HARMFUL ALGAE, V16, P81, DOI 10.1016/j.hal.2012.02.001; Moss VA, 1977, BR HOM J, V66, P169, DOI [10.1016/S0007-0785(77)80010-0, DOI 10.1016/S0007-0785(77)80010-0]; Mu RM, 2007, J ENVIRON SCI-CHINA, V19, P1336, DOI 10.1016/S1001-0742(07)60218-6; Nakashima T, 2006, APPL MICROBIOL BIOT, V73, P684, DOI 10.1007/s00253-006-0507-2; Ni LX, 2012, CHEMOSPHERE, V88, P1051, DOI 10.1016/j.chemosphere.2012.05.009; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Parkhill JP, 1999, J PLANKTON RES, V21, P939, DOI 10.1093/plankt/21.5.939; Pei HY, 2005, J ENVIRON SCI-CHINA, V17, P205; Pierce RH, 2004, HARMFUL ALGAE, V3, P141, DOI 10.1016/j.hal.2003.09.003; Qian HF, 2008, AQUAT TOXICOL, V88, P301, DOI 10.1016/j.aquatox.2008.05.009; Qian HF, 2009, CHEMOSPHERE, V75, P368, DOI 10.1016/j.chemosphere.2008.12.040; Ryu B, 2009, RADIAT PHYS CHEM, V78, P98, DOI 10.1016/j.radphyschem.2008.09.001; Schoemann V, 2005, J SEA RES, V53, P43, DOI 10.1016/j.seares.2004.01.008; Sengco MR, 2004, J EUKARYOT MICROBIOL, V51, P169, DOI 10.1111/j.1550-7408.2004.tb00541.x; Shao JH, 2009, CHEMOSPHERE, V75, P924, DOI 10.1016/j.chemosphere.2009.01.021; Solovchenko AE, 2011, RUSS J PLANT PHYSL+, V58, P9, DOI 10.1134/S1021443710061056; Srivastava A, 1998, BBA-BIOENERGETICS, V1364, P326, DOI 10.1016/S0005-2728(98)00014-0; Su JQ, 2011, BIOL CONTROL, V56, P132, DOI 10.1016/j.biocontrol.2010.10.004; Su RQ, 2007, HARMFUL ALGAE, V6, P799, DOI 10.1016/j.hal.2007.04.004; Suikkanen S, 2004, J EXP MAR BIOL ECOL, V308, P85, DOI 10.1016/j.jembe.2004.02.012; van Rijssel M, 2000, J SEA RES, V43, P297, DOI 10.1016/S1385-1101(00)00013-7; Wang BX, 2010, LETT APPL MICROBIOL, V51, P552, DOI 10.1111/j.1472-765X.2010.02936.x; Wang BX, 2012, HARMFUL ALGAE, V13, P83, DOI 10.1016/j.hal.2011.10.006; Wang X, 2010, BIOL CONTROL, V52, P123, DOI 10.1016/j.biocontrol.2009.10.004; WHYTE LG, 1985, J APPL BACTERIOL, V58, P195, DOI 10.1111/j.1365-2672.1985.tb01447.x; Yang CY, 2011, PESTIC BIOCHEM PHYS, V100, P93, DOI 10.1016/j.pestbp.2011.02.014; Yin LY, 2005, TOXICON, V46, P507, DOI 10.1016/j.toxicon.2005.06.015; Yoshinaga I, 1997, FISHERIES SCI, V63, P94, DOI 10.2331/fishsci.63.94; Zhang SL, 2011, J PLANT PHYSIOL, V168, P639, DOI 10.1016/j.jplph.2010.10.005	58	41	46	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63018	10.1371/journal.pone.0063018	http://dx.doi.org/10.1371/journal.pone.0063018			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667564	Green Submitted, Green Published, gold			2022-12-25	WOS:000319055600053
J	McDowell, SC; Lopez-Marques, RL; Poulsen, LR; Palmgren, MG; Harper, JF				McDowell, Stephen C.; Lopez-Marques, Rosa L.; Poulsen, Lisbeth R.; Palmgren, Michael G.; Harper, Jeffrey F.			Loss of the Arabidopsis thaliana P-4-ATPase ALA3 Reduces Adaptability to Temperature Stresses and Impairs Vegetative, Pollen, and Ovule Development	PLOS ONE			English	Article							P-TYPE ATPASE; INTRACELLULAR VESICLE TRAFFICKING; FATTY-ACID UNSATURATION; PLASMA-MEMBRANE; SALT TOLERANCE; COLD STRESS; AMINOPHOSPHOLIPID TRANSLOCASES; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; BIOLOGICAL FUNCTIONS	Members of the P-4 subfamily of P-type ATPases are thought to help create asymmetry in lipid bilayers by flipping specific lipids between the leaflets of a membrane. This asymmetry is believed to be central to the formation of vesicles in the secretory and endocytic pathways. In Arabidopsis thaliana, a P-4-ATPase associated with the trans-Golgi network (ALA3) was previously reported to be important for vegetative growth and reproductive success. Here we show that multiple phenotypes for ala3 knockouts are sensitive to growth conditions. For example, ala3 rosette size was observed to be dependent upon both temperature and soil, and varied between 40% and 80% that of wild-type under different conditions. We also demonstrate that ala3 mutants have reduced fecundity resulting from a combination of decreased ovule production and pollen tube growth defects. In-vitro pollen tube growth assays showed that ala3 pollen germinated similar to 2 h slower than wild-type and had approximately 2-fold reductions in both maximal growth rate and overall length. In genetic crosses under conditions of hot days and cold nights, pollen fitness was reduced by at least 90-fold; from similar to 18% transmission efficiency (unstressed) to less than 0.2% (stressed). Together, these results support a model in which ALA3 functions to modify endomembranes in multiple cell types, enabling structural changes, or signaling functions that are critical in plants for normal development and adaptation to varied growth environments.	[McDowell, Stephen C.; Harper, Jeffrey F.] Univ Nevada, Dept Biochem & Mol Biol, Reno, NV 89557 USA; [Lopez-Marques, Rosa L.; Poulsen, Lisbeth R.; Palmgren, Michael G.] Univ Copenhagen, Danish Natl Res Fdn, Dept Plant Biol & Biotechnol, Ctr Membrane Pumps Cells & Dis PUMPKIN, Frederiksberg, Denmark	Nevada System of Higher Education (NSHE); University of Nevada Reno; Danmarks Grundforskningsfond; University of Copenhagen	Harper, JF (corresponding author), Univ Nevada, Dept Biochem & Mol Biol, Reno, NV 89557 USA.	jfharper@unr.edu	Marques, Rosa Laura Lopez/AAI-8071-2020; Poulsen, Lisbeth R/I-1843-2014; Palmgren, Michael/A-9808-2013; Lopez-Marques, Rosa L/F-8536-2014; Poulsen, Lisbeth Rosager/AAP-1301-2020	Marques, Rosa Laura Lopez/0000-0002-5663-7903; Poulsen, Lisbeth R/0000-0002-9133-3358; Palmgren, Michael/0000-0002-9982-6114; Lopez-Marques, Rosa L/0000-0002-5663-7903; 	National Science Foundation (NSF) [DBI-0420033]; National Institutes of Health (NIH) [1RO1 GM070813-01]; US Department of Energy [DE-FG03-94ER20152]; INBRE Program of the National Center for Research Resources (NIH grant) [P20 RR-016464]; COBRE program of the National Institutes of Health (NIH COBRE) [RR024210]; Danish Council for Independent Research Natural Sciences (FNU) [10-083406]; Danish National Research Foundation through the PUMPKIN Center of Excellence; National Science Foundation's EPSCoR program [EPS-0236913]; State of Kansas through Kansas Technology Enterprise Corporation; Kansas State University; Danish Government's Globalization Fund; Danish Council for Independent Research, Natural Sciences (FNU) [10-083406]; Danish National Research Foundation (DGF) [DNRF85]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016464, P20RR024210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070813, P20GM103554] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Energy(United States Department of Energy (DOE)); INBRE Program of the National Center for Research Resources (NIH grant); COBRE program of the National Institutes of Health (NIH COBRE); Danish Council for Independent Research Natural Sciences (FNU)(Det Frie Forskningsrad (DFF)Danish Natural Science Research Council); Danish National Research Foundation through the PUMPKIN Center of Excellence; National Science Foundation's EPSCoR program; State of Kansas through Kansas Technology Enterprise Corporation; Kansas State University; Danish Government's Globalization Fund; Danish Council for Independent Research, Natural Sciences (FNU)(Det Frie Forskningsrad (DFF)Danish Natural Science Research Council); Danish National Research Foundation (DGF); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants to JFH from the National Science Foundation (http://www.nsf.gov, NSF DBI-0420033) for stress-dependent phenotype screens, from the National Institutes of Health (http://www.nih.gov, NIH 1RO1 GM070813-01) for studies on pollen tube tip growth, and from the US Department of Energy (http://www.energy.gov, DE-FG03-94ER20152) for studies on membrane biogenesis and genetic analyses of ALAs. Bioinformatics was made possible by the INBRE Program of the National Center for Research Resources (http://www.nih.gov, NIH grant P20 RR-016464). Confocal microscopy was made possible by support from by the COBRE program of the National Institutes of Health (http://www.nih.gov, NIH COBRE grant RR024210). Funding was also received by RLLM from The Danish Council for Independent Research Natural Sciences (http://en.fi.dk/, FNU project number 10-083406) and by MGP from the Danish National Research Foundation through the PUMPKIN Center of Excellence. The Kansas Lipidomics Research Center was supported by the National Science Foundation's EPSCoR program (http://www.nsf.gov, EPS-0236913) with matching support from the State of Kansas through Kansas Technology Enterprise Corporation and Kansas State University. The Danish Government's Globalization Fund (LRP); The Danish Council for Independent Research, Natural Sciences (FNU, project number 10-083406, RLLM); and the Danish National Research Foundation (DGF, project number DNRF85, MGP). Additional funding during the revision process was provided by: The Danish Government's Globalization Fund (LRP); The Danish Council for Independent Research, Natural Sciences (FNU, project number 10-083406, RLLM); and the Danish National Research Foundation (DGF, project number DNRF85, MGP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder-Baerens N, 2006, MOL BIOL CELL, V17, P1632, DOI 10.1091/mbc.E05-10-0912; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Amiri RM, 2010, J INTEGR PLANT BIOL, V52, P289, DOI 10.1111/j.1744-7909.2010.00890.x; Axelsen KB, 2001, PLANT PHYSIOL, V126, P696, DOI 10.1104/pp.126.2.696; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Bate N, 1998, PLANT MOL BIOL, V37, P859, DOI 10.1023/A:1006095023050; Baxter I, 2003, PLANT PHYSIOL, V132, P618, DOI 10.1104/pp.103.021923; Baxter IR, 2008, P NATL ACAD SCI USA, V105, P12081, DOI 10.1073/pnas.0804175105; Boavida LC, 2007, PLANT J, V52, P570, DOI 10.1111/j.1365-313X.2007.03248.x; Bove J, 2008, PLANT PHYSIOL, V147, P1646, DOI 10.1104/pp.108.120212; Chen CY, 1999, J CELL BIOL, V147, P1223, DOI 10.1083/jcb.147.6.1223; Cheung AY, 2008, ANNU REV PLANT BIOL, V59, P547, DOI 10.1146/annurev.arplant.59.032607.092921; Coleman JA, 2009, J BIOL CHEM, V284, P32670, DOI 10.1074/jbc.M109.047415; de Win AHN, 1999, BIOPHYS J, V76, P1648, DOI 10.1016/S0006-3495(99)77324-8; Dowhan W, 2012, BBA-BIOMEMBRANES, V1818, P1097, DOI 10.1016/j.bbamem.2011.09.013; Gall WE, 2002, CURR BIOL, V12, P1623, DOI 10.1016/S0960-9822(02)01148-X; Gomes E, 2000, PLANT CELL, V12, P2441, DOI 10.1105/tpc.12.12.2441; Graham TR, 2010, CURR OPIN CELL BIOL, V22, P430, DOI 10.1016/j.ceb.2010.05.002; Guschina IA, 2006, FEBS LETT, V580, P5477, DOI 10.1016/j.febslet.2006.06.066; Hayward SAL, 2007, ADV EXP MED BIOL, V594, P132; HAZEL JR, 1988, AM J PHYSIOL, V255, pR622, DOI 10.1152/ajpregu.1988.255.4.R622; HAZEL JR, 1995, ANNU REV PHYSIOL, V57, P19, DOI 10.1146/annurev.ph.57.030195.000315; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Ho LW, 2010, FUNCT PLANT BIOL, V37, P962, DOI 10.1071/FP10049; Honys D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r85; Hua ZL, 2003, MOL BIOL CELL, V14, P4971, DOI 10.1091/mbc.E03-07-0463; HUGLY S, 1992, PLANT PHYSIOL, V99, P197, DOI 10.1104/pp.99.1.197; Iba K, 2002, ANNU REV PLANT BIOL, V53, P225, DOI 10.1146/annurev.arplant.53.100201.160729; IshizakiNishizawa O, 1996, NAT BIOTECHNOL, V14, P1003, DOI 10.1038/nbt0896-1003; Iwata Y, 2012, TRENDS PLANT SCI; Lee YJ, 2008, CURR OPIN PLANT BIOL, V11, P662, DOI 10.1016/j.pbi.2008.10.002; Leshem Y, 2007, PLANT J, V51, P185, DOI 10.1111/j.1365-313X.2007.03134.x; Leshem Y, 2006, P NATL ACAD SCI USA, V103, P18008, DOI 10.1073/pnas.0604421103; Levine A, 2001, J BIOL CHEM, V276, P46284, DOI 10.1074/jbc.M107375200; Levine A, 2002, PLANT PHYSIOL BIOCH, V40, P531, DOI 10.1016/S0981-9428(02)01398-0; Lindberg S, 2005, PLANT PHYSIOL BIOCH, V43, P261, DOI 10.1016/j.plaphy.2005.02.003; Lopez-Marques RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033042; Lopez-Marques RL, 2010, MOL BIOL CELL, V21, P791, DOI 10.1091/mbc.E09-08-0656; Mazel A, 2004, PLANT PHYSIOL, V134, P118, DOI 10.1104/pp.103.025379; MIQUEL M, 1993, P NATL ACAD SCI USA, V90, P6208, DOI 10.1073/pnas.90.13.6208; Moellering ER, 2011, TRENDS PLANT SCI, V16, P98, DOI 10.1016/j.tplants.2010.11.004; Orlean P, 2007, J LIPID RES, V48, P993, DOI 10.1194/jlr.R700002-JLR200; Orlova IV, 2003, PLANT CELL PHYSIOL, V44, P447, DOI 10.1093/pcp/pcg047; OVERSTREET JW, 1979, FERTIL STERIL, V31, P162; Palmgren MG, 1998, BBA-BIOENERGETICS, V1365, P37, DOI 10.1016/S0005-2728(98)00041-3; Paulusma CC, 2010, FEBS LETT, V584, P2708, DOI 10.1016/j.febslet.2010.04.071; Pedersen CNS, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00031; Penfield S, 2008, NEW PHYTOL, V179, P615, DOI 10.1111/j.1469-8137.2008.02478.x; Pomorski T, 2006, CELL MOL LIFE SCI, V63, P2908, DOI 10.1007/s00018-006-6167-7; Pomorski T, 2004, J CELL SCI, V117, P805, DOI 10.1242/jcs.01055; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; Poulsen LR, 2008, CELL MOL LIFE SCI, V65, P3119, DOI 10.1007/s00018-008-8341-6; Poulsen LR, 2008, PLANT CELL, V20, P658, DOI 10.1105/tpc.107.054767; Qin Y, 2011, SEMIN CELL DEV BIOL, V22, P816, DOI 10.1016/j.semcdb.2011.06.004; Qin Y, 2009, PLOS GENET, V5, DOI [10.1371/journal.pgen.1000621, 10.1109/BMEI.2009.5304794]; Richter S, 2009, TRAFFIC, V10, P819, DOI 10.1111/j.1600-0854.2009.00916.x; RIPMASTER TL, 1993, MOL CELL BIOL, V13, P7901, DOI 10.1128/MCB.13.12.7901; ROBERTSON JC, 1995, AM J PHYSIOL-REG I, V269, pR1113, DOI 10.1152/ajpregu.1995.269.5.R1113; Rousseeuw PJ, 1999, AM STAT, V53, P382, DOI 10.2307/2686061; Sakamoto A, 2004, PLANT CELL ENVIRON, V27, P99, DOI 10.1046/j.0016-8025.2003.01131.x; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sebastian TT, 2012, BBA-MOL CELL BIOL L, V1821, P1068, DOI 10.1016/j.bbalip.2011.12.007; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; Siegmund A, 1998, J BIOL CHEM, V273, P34399, DOI 10.1074/jbc.273.51.34399; SOMERVILLE C, 1991, SCIENCE, V252, P80, DOI 10.1126/science.252.5002.80; Tanaka K, 2011, J BIOCHEM, V149, P131, DOI 10.1093/jb/mvq140; Tasseva G, 2004, PLANT PHYSIOL BIOCH, V42, P811, DOI 10.1016/j.plaphy.2004.10.001; TWELL D, 1991, GENE DEV, V5, P496, DOI 10.1101/gad.5.3.496; Upchurch RG, 2008, BIOTECHNOL LETT, V30, P967, DOI 10.1007/s10529-008-9639-z; Van Meer G, 2011, COLD SPRING HARB PER; WADA H, 1994, P NATL ACAD SCI USA, V91, P4273, DOI 10.1073/pnas.91.10.4273; Wallis JG, 2002, PROG LIPID RES, V41, P254, DOI 10.1016/S0163-7827(01)00027-3; Wang LC, 2011, J EXP BOT, V62, P3609, DOI 10.1093/jxb/err060; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; Wicky S, 2004, MOL CELL BIOL, V24, P7402, DOI 10.1128/MCB.24.17.7402-7418.2004; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Yadav SK, 2010, AGRON SUSTAIN DEV, V30, P515, DOI 10.1051/agro/2009050; Zhang X, 2009, PLANT J; Zhou XM, 2009, P NATL ACAD SCI USA, V106, P16586, DOI 10.1073/pnas.0904293106; Zonia L, 2008, J EXP BOT, V59, P861, DOI 10.1093/jxb/ern007	80	25	27	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62577	10.1371/journal.pone.0062577	http://dx.doi.org/10.1371/journal.pone.0062577			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667493	Green Published, Green Submitted, gold			2022-12-25	WOS:000319654700049
J	Poggi, A; Boero, S; Musso, A; Zocchi, MR				Poggi, Alessandro; Boero, Silvia; Musso, Alessandra; Zocchi, Maria Raffaella			Selective Role of Mevalonate Pathway in Regulating Perforin but Not FasL and TNFalpha Release in Human Natural Killer Cells	PLOS ONE			English	Article							LIPID-LOWERING DRUGS; CALCIUM-CHANNELS; LEUKEMIA-CELLS; STATINS; CYTOTOXICITY; APOPTOSIS; CANCER; ACTIVATION; RECEPTORS; RITUXIMAB	We have analyzed the effects of fluvastatin, an inhibitor of the enzyme 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase involved in mevalonate synthesis, on human NK cell-mediated anti-tumor cytolysis. Fluvastatin inhibited the activation of the small guanosin triphosphate binding protein (GTP) RhoA and the consequent actin redistribution induced by ligation of LFA1 involved in NK-tumor target cell adhesion. Also, fluvastatin reduced ganglioside M1 rafts formation triggered through the engagement of NK cell activating receptors as Fc gamma RIIIA (CD16), NKG2D and DNAM1. Cytolysis of tumor targets was inhibited up to 90% when NK cells were cultured with fluvastatin by affecting i) receptor-mediated increase of the intracellular free calcium concentration, ii) activation of akt1/PKB and iii) perforin and granzyme release. Fluvastatin displayed a stronger inhibiting effect on NKG2D, DNAM1, 2B4, NKp30, NKp44 and NKp46 than on CD16-mediated NK cell triggering. This was in line with the impairment of surface expression of all these receptors but not of CD16. Remarkably, fluvastatin did not affect the expression of the inhibiting receptors CD94, KIR2D and LAIR1. FasL release elicited by either NK-tumor cell interaction or CD16 or NKG2D engagement, as well as FasL-mediated killing, were not sensitive to fluvastatin. Moreover, TNF alpha secretion triggered in NK cells upon incubation with tumor target cells or engagement of NKG2D receptor was not impaired in fluvastatin-treated NK cells. Likewise, antibody dependent cellular cytotoxicity (ADCC) triggered through Fc gamma RIIIA engagement with the humanized monoclonal antibody rituximab or trastuzumab was only marginally affected in fluvastatin-treated NK cells. Altogether these findings suggest that interference with mevalonate synthesis impairs activation and assembly of cytoskeleton, degranulation and cytotoxic effect of perforins and granzyme but not FasL- and TNF alpha-mediated cytotoxicity.	[Poggi, Alessandro; Boero, Silvia; Musso, Alessandra] IRCCS AOU San Martino IST Natl Inst Canc Res, Mol Oncol & Angiogenesis Unit, Genoa, Italy; [Zocchi, Maria Raffaella] Ist Sci San Raffaele, Div Immunol Transplants & Infect Dis, I-20132 Milan, Italy	University of Genoa; IRCCS AOU San Martino IST; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Poggi, A (corresponding author), IRCCS AOU San Martino IST Natl Inst Canc Res, Mol Oncol & Angiogenesis Unit, Genoa, Italy.	alessandro.poggi@istge.it	Poggi, Alessandro/K-6664-2016	Poggi, Alessandro/0000-0002-1860-430X; Zocchi, Maria Raffaella/0000-0002-0022-8385	Italian Association for cancer Research (AIRC) [IG8761, IG8727]; Compagnia di San Paolo [2007.2065, 2010.2065]	Italian Association for cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Compagnia di San Paolo(Compagnia di San Paolo)	This work was partially supported by grants from the Italian Association for cancer Research (AIRC) 2009 to AP (IG8761) and to MRZ (IG8727), Compagnia di San Paolo n. 2007.2065 and 2010.2065 to AP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beum PV, 2004, J IMMUNOL METHODS, V289, P97, DOI 10.1016/j.jim.2004.03.012; Bryceson YT, 2006, IMMUNOL REV, V214, P73, DOI 10.1111/j.1600-065X.2006.00457.x; Chapman-Shimshoni D, 2003, EXP HEMATOL, V31, P779, DOI 10.1016/S0301-472X(03)00192-9; Chichili GR, 2009, CELL MOL LIFE SCI, V66, P2319, DOI 10.1007/s00018-009-0022-6; Contini P, 2007, LEUKEMIA, V21, P253, DOI 10.1038/sj.leu.2404494; Ferris RL, 2010, J CLIN ONCOL, V28, P4390, DOI 10.1200/JCO.2009.27.6360; Fildes JE, 2009, CANCER IMMUNOL IMMUN, V58, P461, DOI 10.1007/s00262-008-0541-2; Greenwood J, 2006, NAT REV IMMUNOL, V6, P358, DOI 10.1038/nri1839; Gruenbacher G, 2010, CANCER; Hindler K, 2006, ONCOLOGIST, V11, P306, DOI 10.1634/theoncologist.11-3-306; Jiang K, 2000, NAT IMMUNOL, V1, P419, DOI 10.1038/80859; Kotamraju S, 2007, CANCER RES, V67, P7386, DOI 10.1158/0008-5472.CAN-07-0993; Kute T, 2012, ONCOIMMUNOLOGY, V1, P810, DOI 10.4161/onci.20447; Kwak BR, 2003, AUTOIMMUN REV, V2, P332, DOI 10.1016/S1568-9972(03)00049-1; Li HY, 2003, BLOOD, V101, P3628, DOI 10.1182/blood-2002-07-2283; Liu DF, 2009, IMMUNITY, V31, P99, DOI 10.1016/j.immuni.2009.05.009; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Murtola TJ, 2011, EUR J PHARMACOL, V673, P96, DOI 10.1016/j.ejphar.2011.10.022; Musso A, 2011, HAEMATOL-HEMATOL J, V96, P16, DOI 10.3324/haematol.2010.031633; Pahan K, 2006, CELL MOL LIFE SCI, V63, P1165, DOI 10.1007/s00018-005-5406-7; PAN HY, 1990, J CLIN PHARMACOL, V30, P1128, DOI 10.1002/j.1552-4604.1990.tb01856.x; Pani B, 2009, CELL CALCIUM, V45, P625, DOI 10.1016/j.ceca.2009.02.009; Pasvolsky R, 2008, J IMMUNOL, V180, P2815, DOI 10.4049/jimmunol.180.5.2815; Patra D, 2013, NANOSCALE, V5, P1273, DOI 10.1039/c2nr32600k; Pedersen TR, 2009, CURR ATHEROSCLER REP, V11, P350, DOI 10.1007/s11883-009-0053-3; Pende D, 2002, CANCER RES, V62, P6178; POGGI A, 1989, EUR J IMMUNOL, V19, P2069, DOI 10.1002/eji.1830191115; Poggi A, 2005, J IMMUNOL, V175, P6352, DOI 10.4049/jimmunol.175.10.6352; Poggi A, 2011, CURR MED CHEM, V18, P5196, DOI 10.2174/092986711798184244; Poggi A, 2009, LEUKEMIA, V23, P641, DOI 10.1038/leu.2008.354; Poggi A, 1998, J BIOL CHEM, V273, P7205, DOI 10.1074/jbc.273.13.7205; Raemer PC, 2009, EUR J IMMUNOL, V39, P1456, DOI 10.1002/eji.200838863; Regazzi MB, 2005, THER DRUG MONIT, V27, P785, DOI 10.1097/01.ftd.0000184162.60197.c1; Salih HR, 2003, BLOOD, V102, P1389, DOI 10.1182/blood-2003-01-0019; Sassano A, 2007, CANCER RES, V67, P4524, DOI 10.1158/0008-5472.CAN-06-3686; Shibuya A, 1996, IMMUNITY, V4, P573, DOI 10.1016/S1074-7613(00)70060-4; Spaggiari GM, 2002, BLOOD, V99, P1706, DOI 10.1182/blood.V99.5.1706; Spaggiari GM, 2002, BLOOD, V100, P4098, DOI 10.1182/blood-2002-04-1284; Sun JC, 2011, NAT REV IMMUNOL, V11, P645, DOI 10.1038/nri3044; Tanaka T, 2007, INT IMMUNOL, V19, P163, DOI 10.1093/intimm/dxl133; TASWELL C, 1981, J IMMUNOL, V126, P1614; Tokuyama H, 2008, INT J CANCER, V122, P2526, DOI 10.1002/ijc.23365; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Winiarska M, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050064; Wong WWL, 2002, LEUKEMIA, V16, P508, DOI 10.1038/sj.leu.2402476; Zocchi MR, 1998, J IMMUNOL, V161, P2938	47	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62932	10.1371/journal.pone.0062932	http://dx.doi.org/10.1371/journal.pone.0062932			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667543	Green Submitted, gold, Green Published			2022-12-25	WOS:000319654700082
J	Vazquez, A				Vazquez, Alexei			Metabolic States Following Accumulation of Intracellular Aggregates: Implications for Neurodegenerative Diseases	PLOS ONE			English	Article							MITOCHONDRIAL ATP PRODUCTION; INCLUSION-BODY MYOSITIS; PROTEIN AGGREGATION; HUNTINGTONS-DISEASE; ALZHEIMERS-DISEASE; SKELETAL-MUSCLE; NEURAL ACTIVITY; GENOME-SCALE; BRAIN; CELL	The formation of intracellular aggregates is a common etiology of several neurodegenerative diseases. Mitochondrial defects and oxidative stress has been pointed as the major mechanistic links between the accumulation of intracellular aggregates and cell death. In this work we propose a "metabolic cell death by overcrowding" as an alternative hypothesis. Using a model of neuron metabolism, we predict that as the concentration of protein aggregates increases the neurons transit through three different metabolic phases. The first phase (0-6 mM) corresponds with the normal neuron state, where the neuronal activity is sustained by the oxidative phosphorylation of lactate. The second phase (6-8.6 mM) is characterized by a mixed utilization of lactate and glucose as energy substrates and a switch from ammonia uptake to ammonia release by neurons. In the third phase (8.6-9.3 mM) neurons are predicted to support their energy demands from glycolysis and an alternative pathway for energy generation, involving reactions from serine synthesis, one carbon metabolism and the glycine cleavage system. The model also predicts a decrease in the maximum neuronal capacity for energy generation with increasing the concentration of protein aggregates. Ultimately this maximum capacity becomes zero when the protein aggregates reach a concentration of about 9.3 mM, predicting the cessation of neuronal activity.	[Vazquez, Alexei] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst New Jersey, Dept Radiat Oncol, New Brunswick, NJ USA; [Vazquez, Alexei] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst New Jersey, Ctr Syst Biol, New Brunswick, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Vazquez, A (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst New Jersey, Dept Radiat Oncol, New Brunswick, NJ USA.	vazqueal@umdnj.edu						Alberts B., 2008, MOL BIOL CELL, Vxxxiii; Alberts B, 2008, MOL BIOL CELL; Askanas V, 2002, CURR OPIN NEUROL, V15, P525, DOI 10.1097/00019052-200210000-00002; Baloyannis Stavros J, 2004, Am J Alzheimers Dis Other Demen, V19, P89, DOI 10.1177/153331750401900205; Brocchieri L, 2005, NUCLEIC ACIDS RES, V33, P3390, DOI 10.1093/nar/gki615; Ceru S, 2010, BIOL CELL, V102, P319, DOI 10.1042/BC20090163; FRAME KK, 1990, BIOTECHNOL BIOENG, V36, P191, DOI 10.1002/bit.260360211; GLAS U, 1966, J CELL BIOL, V29, P507, DOI 10.1083/jcb.29.3.507; Harms L, 1997, J NEUROL NEUROSUR PS, V62, P27, DOI 10.1136/jnnp.62.1.27; Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001; Hoffner G, 2002, BIOCHIMIE, V84, P273, DOI 10.1016/S0300-9084(02)01398-6; Hou XY, 2002, CLIN PHYSIOL FUNCT I, V22, P226, DOI 10.1046/j.1475-097X.2002.00423.x; HOYER S, 1990, NEUROSCI LETT, V117, P358, DOI 10.1016/0304-3940(90)90691-2; Hu YB, 1997, J NEUROCHEM, V69, P1484; Irvine GB, 2008, MOL MED, V14, P451, DOI 10.2119/2007-00100.Irvine; JENKINS BG, 1993, NEUROLOGY, V43, P2689, DOI 10.1212/WNL.43.12.2689; Jerby L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.56; Kasischke KA, 2004, SCIENCE, V305, P99, DOI 10.1126/science.1096485; Kim J, 2010, HUM MOL GENET, V19, P3919, DOI 10.1093/hmg/ddq306; Kopeikina KJ, 2011, AM J PATHOL, V179, P2071, DOI 10.1016/j.ajpath.2011.07.004; LEE B, 1983, P NATL ACAD SCI USA, V80, P622, DOI 10.1073/pnas.80.2.622; Lewis NE, 2010, NAT BIOTECHNOL, V28, P1279, DOI 10.1038/nbt.1711; Maisonneuve E, 2008, J BACTERIOL, V190, P6070, DOI 10.1128/JB.00736-08; Mangia S, 2003, NEUROSCIENCE, V118, P7, DOI 10.1016/S0306-4522(02)00792-3; Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200; Mo ML, 2007, MOL BIOSYST, V3, P598, DOI 10.1039/b705597h; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; Roos PM, 2011, ACTA NEUROL SCAND, V124, P215, DOI 10.1111/j.1600-0404.2010.01461.x; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Roth J, 2008, HISTOCHEM CELL BIOL, V129, P163, DOI 10.1007/s00418-007-0366-7; SAVINELL JM, 1992, J THEOR BIOL, V154, P421, DOI 10.1016/S0022-5193(05)80161-4; Schomburg I, 2002, NUCLEIC ACIDS RES, V30, P47, DOI 10.1093/nar/30.1.47; SCHWERZMANN K, 1989, P NATL ACAD SCI USA, V86, P1583, DOI 10.1073/pnas.86.5.1583; Seiler N, 2002, NEUROCHEM INT, V41, P189, DOI 10.1016/S0197-0186(02)00041-4; Sheikh K, 2005, BIOTECHNOL PROGR, V21, P112, DOI 10.1021/bp0498138; Sheng BY, 2012, J NEUROCHEM, V120, P419, DOI 10.1111/j.1471-4159.2011.07581.x; Shlomi T, 2008, NAT BIOTECHNOL, V26, P1003, DOI 10.1038/nbt.1487; Short KR, 2001, AM J PHYSIOL-ENDOC M, V280, pE761, DOI 10.1152/ajpendo.2001.280.5.E761; Trojanowski JQ, 1998, CELL DEATH DIFFER, V5, P832, DOI 10.1038/sj.cdd.4400432; Trushina E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032737; Vazquez A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025881; Vazquez A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019538; Vazquez A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-58; Vazquez A, 2010, J THEOR BIOL, V264, P356, DOI 10.1016/j.jtbi.2010.02.024; Vazquez A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000195; Wanker EE, 2000, BIOL CHEM, V381, P937, DOI 10.1515/BC.2000.114; WIBOM R, 1992, J APPL PHYSIOL, V73, P2004, DOI 10.1152/jappl.1992.73.5.2004; Yang E, 2003, GENOME RES, V13, P1863, DOI 10.1101/gr.1272403; Zhou EH, 2009, P NATL ACAD SCI USA, V106, P10632, DOI 10.1073/pnas.0901462106; ZIMMERMAN SB, 1991, J MOL BIOL, V222, P599, DOI 10.1016/0022-2836(91)90499-V	50	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63822	10.1371/journal.pone.0063822	http://dx.doi.org/10.1371/journal.pone.0063822			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667676	Green Submitted, Green Published, gold			2022-12-25	WOS:000319654700188
J	Hastilestari, BR; Mudersbach, M; Tomala, F; Vogt, H; Biskupek-Korell, B; Van Damme, P; Guretzki, S; Papenbrock, J				Hastilestari, Bernadetta Rina; Mudersbach, Marina; Tomala, Filip; Vogt, Hartmut; Biskupek-Korell, Bettina; Van Damme, Patrick; Guretzki, Sebastian; Papenbrock, Jutta			Euphorbia tirucalli L.-Comprehensive Characterization of a Drought Tolerant Plant with a Potential as Biofuel Source	PLOS ONE			English	Article							CRASSULACEAN ACID METABOLISM; P-ENOLPYRUVATE CARBOXYLASE; CHLOROPHYLL FLUORESCENCE; PHOTOSYNTHETIC PATHWAYS; CAM; EXPRESSION; ENERGY; CARBON; LATEX; PRODUCTIVITY	Of late, decrease in mineral oil supplies has stimulated research on use of biomass as an alternative energy source. Climate change has brought problems such as increased drought and erratic rains. This, together with a rise in land degeneration problems with concomitant loss in soil fertility has inspired the scientific world to look for alternative bio-energy species. Euphorbia tirucalli L., a tree with C-3/CAM metabolism in leaves/stem, can be cultivated on marginal, arid land and could be a good alternative source of biofuel. We analyzed a broad variety of E. tirucalli plants collected from different countries for their genetic diversity using AFLP. Physiological responses to induced drought stress were determined in a number of genotypes by monitoring growth parameters and influence on photosynthesis. For future breeding of economically interesting genotypes, rubber content and biogas production were quantified. Cluster analysis shows that the studied genotypes are divided into two groups, African and mostly non-African genotypes. Different genotypes respond significantly different to various levels of water. Malate measurement indicates that there is induction of CAM in leaves following drought stress. Rubber content varies strongly between genotypes. An investigation of the biogas production capacities of six E. tirucalli genotypes reveals biogas yields higher than from rapeseed but lower than maize silage.	[Hastilestari, Bernadetta Rina; Guretzki, Sebastian; Papenbrock, Jutta] Leibniz Univ Hannover, Inst Bot, D-30167 Hannover, Germany; [Mudersbach, Marina; Tomala, Filip; Vogt, Hartmut; Biskupek-Korell, Bettina] Univ Appl Sci Hannover, Hannover, Germany; [Van Damme, Patrick] Univ Ghent, Dept Plant Prod, Lab Trop & Subtrop Agr & Ethnobotany, B-9000 Ghent, Belgium; [Van Damme, Patrick] Czech Univ Life Sci Prague, Inst Trop & Subtrop, Prague, Czech Republic	Leibniz University Hannover; Ghent University; Czech University of Life Sciences Prague	Papenbrock, J (corresponding author), Leibniz Univ Hannover, Inst Bot, D-30167 Hannover, Germany.	Jutta.Papenbrock@botanik.uni-hannover.de	Van Damme, Patrick/H-6693-2018; , Patrick/AAI-8779-2020	Van Damme, Patrick/0000-0002-2548-633X; 	Katholischer Akademischer Auslander-Dienst (KAAD); Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of Leibniz Universitat Hannover	Katholischer Akademischer Auslander-Dienst (KAAD); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of Leibniz Universitat Hannover	B.R. Hastilestari was supported by Katholischer Akademischer Auslander-Dienst (KAAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Samples from India were kindly provided by Dr. Vijendra Shekhawat, University of Mumbai, India. We would like to thank the gardeners for growing plants and Pamela von Trzebiatowski for malate analysis. We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Leibniz Universitat Hannover.	Akpan AU, 2007, J AGR SOC SCI, V3, P1813; Aylward JH, 2008, Treatment of prostate cancer, Patent No. [US 7378445, 7378445]; BATANOUNY KH, 1991, OECOLOGIA, V87, P565, DOI 10.1007/BF00320421; BENDER MM, 1971, PHYTOCHEMISTRY, V10, P1239, DOI 10.1016/S0031-9422(00)84324-1; Binder R, 2009, GEFAHRENPOTENTIAL SC; Blaschek W., 1998, HAGERS HDB PHARM PRA, V5th; BLOOM AJ, 1979, OECOLOGIA, V38, P35, DOI 10.1007/BF00347822; Borland A, 2006, J EXP BOT, V57, P319, DOI 10.1093/jxb/erj028; Borland AM, 1998, PLANTA, V205, P342, DOI 10.1007/s004250050329; Brouwer R., 1963, SOME ASPECTS EQUILIB, P31; Bruyns PV, 2006, TAXON, V55, P397, DOI 10.2307/25065587; CALVIN M, 1978, PURE APPL CHEM, V50, P407, DOI 10.1351/pac197850050407; CALVIN M, 1980, NATURWISSENSCHAFTEN, V67, P525, DOI 10.1007/BF00450661; CUSHMAN JC, 1992, EUR J BIOCHEM, V208, P259, DOI 10.1111/j.1432-1033.1992.tb17181.x; Cushman JC, 2002, PLANT CELL ENVIRON, V25, P295, DOI 10.1046/j.0016-8025.2001.00760.x; Dai AG, 2013, NAT CLIM CHANGE, V3, P52, DOI [10.1038/nclimate1633, 10.1038/NCLIMATE1633]; Dias PC, 2007, J PLANT PHYSIOL, V164, P1639, DOI 10.1016/j.jplph.2006.12.004; DITTRICH P, 1973, PLANT PHYSIOL, V52, P357, DOI 10.1104/pp.52.4.357; Duke J. A., 1983, HDB ENERGY CROPS; FURSTENBERGER G, 1977, EXPERIENTIA, V33, P986; GRAVATT DA, 1992, OECOLOGIA, V92, P532, DOI 10.1007/BF00317845; Gurib-Fakim A., 2008, PLANT RESOURCES TROP; Heldt H.-W, 2011, PLANT BIOCH; Herrera A, 2009, ANN BOT-LONDON, V103, P645, DOI 10.1093/aob/mcn145; HOLTUM JAM, 1982, PLANTA, V155, P8, DOI 10.1007/BF00402925; Janssens MJJ, 2009, J AGR RURAL DEV TROP, V110, P39; JEFFERIES RA, 1994, PHYSIOL PLANTARUM, V90, P93, DOI 10.1034/j.1399-3054.1994.900114.x; Kalita D, 2008, RENEW SUST ENERG REV, V12, P455, DOI 10.1016/j.rser.2006.07.008; KLUGE M, 1973, PLANTA, V113, P333, DOI 10.1007/BF00387316; KLUGE M, 1973, PLANTA, V112, P357, DOI 10.1007/BF00390308; KLUGE M, 1971, PLANTA, V98, P20, DOI 10.1007/BF00387020; Krasensky J, 2012, J EXP BOT, V63, P1593, DOI 10.1093/jxb/err460; Kumar A., 1999, SOME POTENTIAL PLANT, P1; Lirio LG, 1998, PHARM BIOL, V36, P357, DOI 10.1076/phbi.36.5.357.4656; Liu F, 2004, SCI HORTIC-AMSTERDAM, V102, P15, DOI 10.1016/j.scienta.2003.11.014; LOESCHEN VS, 1993, INT J PLANT SCI, V154, P100, DOI 10.1086/297095; Loke J., 2011, EUPHORBIA TIRUCALLI; MARTIN CE, 1986, PHOTOSYNTH RES, V8, P17, DOI 10.1007/BF00028473; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Murali R, 1998, INT C DOM COMM NONT; Mwine J., 2011, Scientific Research and Essays, V6, P4905; NIELSEN PE, 1979, PHYTOCHEMISTRY, V18, P103, DOI 10.1016/S0031-9422(00)90923-3; Nishiyama Y, 2006, BBA-BIOENERGETICS, V1757, P742, DOI 10.1016/j.bbabio.2006.05.013; NUERNBERGK EL, 1960, PLANTA, V56, P28, DOI 10.1007/BF01894844; Orwa C, 2009, AGROFORESTRY TREE DA; OSMOND CB, 1978, ANNU REV PLANT PHYS, V29, P379, DOI 10.1146/annurev.pp.29.060178.002115; OSTREM JA, 1990, J BIOL CHEM, V265, P3497; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; PEARCY RW, 1975, PLANT PHYSIOL, V55, P1054, DOI 10.1104/pp.55.6.1054; Rahuman AA, 2008, PARASITOL RES, V102, P867, DOI 10.1007/s00436-007-0839-6; Scasselati-sforzolini G, 1916, I AGR COLONIALE ITAL, V25, P40; Schenk HJ, 2002, J ECOL, V90, P480, DOI 10.1046/j.1365-2745.2002.00682.x; Schieder D, 2003, WATER SCI TECHNOL, V48, P209, DOI 10.2166/wst.2003.0256; Schluter PM, 2006, MOL ECOL NOTES, V6, P569, DOI 10.1111/j.1471-8286.2006.01225.x; Smith B., 1982, CRC HDB BIOSOLAR RES, V1, P99; Souza RP, 2004, ENVIRON EXP BOT, V51, P45, DOI 10.1016/S0098-8472(03)00059-5; SOW D, 1989, MIRCEN J APPL MICROB, V5, P547, DOI 10.1007/BF01741832; Syed M., 2006, Canadian Biosystems Engineering, V48, pB1; Taybi T, 2004, PLANT PHYSIOL, V135, P587, DOI 10.1104/pp.103.036962; TING IP, 1968, PLANT PHYSIOL, V43, P1919, DOI 10.1104/pp.43.12.1919; TING IP, 1993, BOT ACTA, V106, P313, DOI 10.1111/j.1438-8677.1993.tb00754.x; TING IP, 1985, PLANT PHYSIOL, V78, P246, DOI 10.1104/pp.78.2.246; Tomala F, 2012, THESIS U APPL SCI HA; Uchida H, 2009, PLANTA, V229, P1243, DOI 10.1007/s00425-009-0906-6; UZABAKILIHO B, 1987, PHYTOCHEMISTRY, V26, P3041, DOI 10.1016/S0031-9422(00)84589-6; Van Damme P, 1990, AFR FOCUS, V6, P19; Van Damme P., 1989, AFR FOCUS, V5, P176, DOI [10.21825/af.v5i3-4.6476, DOI 10.21825/AF.V5I3-4.6476]; Van Damme PLJ, 2001, COMBATING DESERTIFICATION WITH PLANTS, P169; VASSILIADES G, 1984, REV ELEV MED VET PAY, V37, P32; VDI 4630, 2006, VEREIN DTSCH INGENIE; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; WEBSTER G L, 1975, Taxon, V24, P593, DOI 10.2307/1220725; Weiland P, 2003, APPL BIOCHEM BIOTECH, V109, P263, DOI 10.1385/ABAB:109:1-3:263; Zhang JA, 2011, PLANTA, V234, P891, DOI 10.1007/s00425-011-1434-8	74	32	32	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e63501	10.1371/journal.pone.0063501	http://dx.doi.org/10.1371/journal.pone.0063501			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658836	Green Submitted, Green Published, gold			2022-12-25	WOS:000321202100069
J	Nan, R; Tetchner, S; Rodriguez, E; Pao, PJ; Gor, J; Lengyel, I; Perkins, SJ				Nan, Ruodan; Tetchner, Stuart; Rodriguez, Elizabeth; Pao, Po-Jung; Gor, Jayesh; Lengyel, Imre; Perkins, Stephen J.			Zinc-induced Self-association of Complement C3b and Factor H IMPLICATIONS FOR INFLAMMATION AND AGE-RELATED MACULAR DEGENERATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY; SEDIMENTATION-VELOCITY; SCATTERING DATA; FACTOR-B; FACTOR-I; BINDING; POLYMORPHISM; VARIANT; PROTEIN; LIGAND	The sub-retinal pigment epithelial deposits that are a hallmark of age-related macular degeneration contain both C3b and millimolar levels of zinc. C3 is the central protein of complement, whereas C3u is formed by the spontaneous hydrolysis of the thioester bridge in C3. During activation, C3 is cleaved to form active C3b, then C3b is inactivated by Factor I and Factor H to form the C3c and C3d fragments. The interaction of zinc with C3 was quantified using analytical ultracentrifugation and x-ray scattering. C3, C3u, and C3b associated strongly in >100 mu M zinc, whereas C3c and C3d showed weak association. With zinc, C3 forms soluble oligomers, whereas C3u and C3b precipitate. We conclude that the C3, C3u, and C3b association with zinc depended on the relative positions of C3d and C3c in each protein. Computational predictions showed that putative weak zinc binding sites with different capacities exist in all five proteins, in agreement with experiments. Factor H forms large oligomers in >10 mu M zinc. In contrast to C3b or Factor H alone, the solubility of the central C3b-Factor H complex was much reduced at 60 mu M zinc and even more so at >100 mu M zinc. The removal of the C3b-Factor H complex by zinc explains the reduced C3u/C3b inactivation rates by zinc. Zinc-induced precipitation may contribute to the initial development of sub-retinal pigment epithelial deposits in the retina as well as reducing the progression to advanced age-related macular degeneration in higher risk patients.	[Perkins, Stephen J.] UCL, Dept Struct & Mol Biol, London WC1E 6BT, England; [Lengyel, Imre] UCL Inst Ophthalmol, Dept Ocular Biol & Therapeut, London EC1V 9EL, England	University of London; University College London; University of London; University College London	Perkins, SJ (corresponding author), UCL, Dept Struct & Mol Biol, Darwin Bldg,Gower St, London WC1E 6BT, England.	s.perkins@ucl.ac.uk	Lengyel, Imre/B-5217-2009	Lengyel, Imre/0000-0001-7467-2174	Medical Research Council; Wellcome Trust; Fight For Sight; Mercer Fund from Fight for Sight; Bill Brown Charitable Trust; BBSRC [BB/E013104/1] Funding Source: UKRI; MRC [G0801724] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E013104/1] Funding Source: researchfish; Medical Research Council [G0801724] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Fight For Sight; Mercer Fund from Fight for Sight; Bill Brown Charitable Trust; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council (to R. N.), the Wellcome Trust (to S. T.), and Fight For Sight (to P.-J. P.).; Supported by the Mercer Fund from Fight for Sight, the Special Trustees of Moorfields Eye Hospital, and the Bill Brown Charitable Trust.	An E, 2006, J PROTEOME RES, V5, P2599, DOI 10.1021/pr060121j; Auld DS, 2001, BIOMETALS, V14, P271, DOI 10.1023/A:1012976615056; BIRD AC, 1992, BRIT J OPHTHALMOL, V76, P166, DOI 10.1136/bjo.76.3.166; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Blom AM, 2003, ARCH BIOCHEM BIOPHYS, V418, P108, DOI 10.1016/j.abb.2003.08.018; Bok D, 2005, P NATL ACAD SCI USA, V102, P7053, DOI 10.1073/pnas.0502819102; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Craddock TJA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033552; CROSSLEY LG, 1980, BIOCHEM J, V191, P173, DOI 10.1042/bj1910173; DODDS AW, 1993, METHOD ENZYMOL, V223, P46; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Fernando AN, 2007, J MOL BIOL, V368, P564, DOI 10.1016/j.jmb.2007.02.038; GALIN MA, 1962, INVEST OPHTH VISUAL, V1, P142; Gilbert HE, 2005, J MOL BIOL, V346, P859, DOI 10.1016/j.jmb.2004.12.006; Glatter O., 1982, SMALL ANGLE XRAY SCA, P17; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Grahn BH, 2001, J AM COLL NUTR, V20, P106, DOI 10.1080/07315724.2001.10719022; Gros P, 2008, NAT REV IMMUNOL, V8, P48, DOI 10.1038/nri2231; Guinier A., 1955, SMALL ANGLE SCATTERI, P126; Guthridge JM, 2001, BIOCHEMISTRY-US, V40, P5931, DOI 10.1021/bi0101749; Guymer R, 1998, RETINAL PIGMENT EPIT, P693; Haase H, 2010, CELLULAR AND MOLECULAR BIOLOGY OF METALS, P181, DOI 10.1201/9781420059984-c8; Hageman GS, 2006, ANN MED, V38, P592, DOI 10.1080/07853890601097030; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; HOWELL GA, 1984, NATURE, V308, P736, DOI 10.1038/308736a0; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; JENCKS WP, 1981, P NATL ACAD SCI-BIOL, V78, P4046, DOI 10.1073/pnas.78.7.4046; Jokiranta TS, 2000, J BIOL CHEM, V275, P27657; Kajander T, 2011, P NATL ACAD SCI USA, V108, P2897, DOI 10.1073/pnas.1017087108; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Khan S, 2012, BIOCHEM J, V444, P417, DOI 10.1042/BJ20120183; Klein ML, 2008, OPHTHALMOLOGY, V115, P1019, DOI 10.1016/j.ophtha.2008.01.036; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Krezel A, 2006, J BIOL INORG CHEM, V11, P1049, DOI 10.1007/s00775-006-0150-5; Law S.K.A., 1995, COMPLEMENT; Lengyel I, 2007, EXP EYE RES, V84, P772, DOI 10.1016/j.exer.2006.12.015; Lengyel I, 2008, EXPERT REV OPHTHALMO, V3, P1, DOI 10.1586/17469899.3.1.1; Li KY, 2008, J MOL BIOL, V384, P137, DOI 10.1016/j.jmb.2008.08.084; Li KY, 2010, BIOCHEM J, V431, P63, DOI 10.1042/BJ20100759; Luo C, 2011, MOL VIS, V17, P1588; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Maret W, 2009, CHEM REV, V109, P4682, DOI 10.1021/cr800556u; Morgan HP, 2011, NAT STRUCT MOL BIOL, V18, P463, DOI 10.1038/nsmb.2018; Nagar B, 1998, SCIENCE, V280, P1277, DOI 10.1126/science.280.5367.1277; Nan R, 2011, J MOL BIOL, V408, P714, DOI 10.1016/j.jmb.2011.03.006; Nan R, 2008, J MOL BIOL, V384, P1341, DOI 10.1016/j.jmb.2008.10.030; Narayanan T, 2001, NUCL INSTRUM METH A, V467, P1005, DOI 10.1016/S0168-9002(01)00553-8; NEWSOME DA, 1992, CURR EYE RES, V11, P213, DOI 10.3109/02713689209001772; Nolan EM, 2009, ACCOUNTS CHEM RES, V42, P193, DOI 10.1021/ar8001409; Okemefuna AI, 2008, J MOL BIOL, V375, P80, DOI 10.1016/j.jmb.2007.09.026; Okemefuna AI, 2010, J BIOL CHEM, V285, P1053, DOI 10.1074/jbc.M109.044529; Okemefuna AI, 2009, J MOL BIOL, V391, P98, DOI 10.1016/j.jmb.2009.06.010; PERKINS SJ, 1986, EUR J BIOCHEM, V157, P169, DOI 10.1111/j.1432-1033.1986.tb09653.x; PERKINS SJ, 1991, BIOCHEMISTRY-US, V30, P2847, DOI 10.1021/bi00225a017; Perkins SJ, 2008, METHOD CELL BIOL, V84, P375, DOI 10.1016/S0091-679X(07)84013-1; Perkins SJ, 2012, IMMUNOBIOLOGY, V217, P281, DOI 10.1016/j.imbio.2011.10.003; Perkins SJ, 2011, METHODS, V54, P181, DOI 10.1016/j.ymeth.2011.01.004; Schmidt C, 2008, REV ECON POLIT, V118, P3; Schuck P, 1998, BIOPHYS J, V75, P1503, DOI 10.1016/S0006-3495(98)74069-X; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Sodhi JS, 2004, J MOL BIOL, V342, P307, DOI 10.1016/j.jmb.2004.07.019; Spencer KL, 2007, HUM MOL GENET, V16, P1986, DOI 10.1093/hmg/ddm146; Szakonyi G, 2001, SCIENCE, V292, P1725, DOI 10.1126/science.1059118; Tsiftsoglou SA, 2004, J IMMUNOL, V173, P367, DOI 10.4049/jimmunol.173.1.367; Ugarte M, 2001, PROG NEUROBIOL, V64, P219, DOI 10.1016/S0301-0082(00)00057-5; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Wiesmann C, 2006, NATURE, V444, P217, DOI 10.1038/nature05263; Wu J, 2009, NAT IMMUNOL, V10, P728, DOI 10.1038/ni.1755; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618	74	33	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					19197	19210		10.1074/jbc.M113.476143	http://dx.doi.org/10.1074/jbc.M113.476143			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23661701	hybrid, Green Published			2022-12-25	WOS:000321335800053
J	Hoover, DJ; Zhu, V; Chen, R; Briley, K; Rameshwar, P; Cohen, S; Coffman, FD				Hoover, Daniel J.; Zhu, Viola; Chen, Ru; Briley, Ken; Rameshwar, Pranela; Cohen, Stanley; Coffman, Frederick D.			Expression of the Chitinase Family Glycoprotein YKL-40 in Undifferentiated, Differentiated and Trans-Differentiated Mesenchymal Stem Cells	PLOS ONE			English	Article							MARROW STROMAL CELLS; HUMAN CARTILAGE GP-39; SERUM YKL-40; BONE-MARROW; IN-VITRO; RHEUMATOID-ARTHRITIS; PLASMA YKL-40; PROTEIN; MARKER; CHI3L1	The glycoprotein YKL-40 (CHI3L1) is a secreted chitinase family protein that induces angiogenesis, cell survival, and cell proliferation, and plays roles in tissue remodeling and immune regulation. It is expressed primarily in cells of mesenchymal origin, is overexpressed in numerous aggressive carcinomas and sarcomas, but is rarely expressed in normal ectodermal tissues. Bone marrow-derived mesenchymal stem cells (MSCs) can be induced to differentiate into various mesenchymal tissues and trans-differentiate into some non-mesenchymal cell types. Since YKL-40 has been used as a mesenchymal marker, we followed YKL-40 expression as undifferentiated MSCs were induced to differentiate into bone, cartilage, and neural phenotypes. Undifferentiated MSCs contain significant levels of YKL-40 mRNA but do not synthesize detectable levels of YKL-40 protein. MSCs induced to differentiate into chondrocytes and osteocytes soon began to express and secrete YKL-40 protein, as do ex vivo cultured chondrocytes and primary osteocytes. In contrast, MSCs induced to trans-differentiate into neurons did not synthesize YKL-40 protein, consistent with the general absence of YKL-40 protein in normal CNS parenchyma. However, these trans-differentiated neurons retained significant levels of YKL-40 mRNA, suggesting the mechanisms which prevented YKL-40 translation in undifferentiated MSCs remained in place, and that these trans-differentiated neurons differ in at least this way from neurons derived from neuronal stem cells. Utilization of a differentiation protocol containing beta-mercaptoethanol resulted in cells that expressed significant amounts of intracellular YKL-40 protein that was not secreted, which is not seen in normal cells. Thus the synthesis of YKL-40 protein is a marker for MSC differentiation into mature mesenchymal phenotypes, and the presence of untranslated YKL-40 mRNA in non-mesenchymal cells derived from MSCs reflects differences between differentiated and trans-differentiated phenotypes.	[Hoover, Daniel J.; Cohen, Stanley; Coffman, Frederick D.] UMDNJ NJMS, Ctr Biophys Pathol, Newark, NJ USA; [Zhu, Viola] BU Med Ctr, Dept Med, Div Hematol Oncol, Boston, MA USA; [Chen, Ru] Ethicon Endosurg, Cincinnati, OH USA; [Briley, Ken] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA; [Rameshwar, Pranela] UMDNJ NJMS, Dept Med, Newark, NJ USA; [Coffman, Frederick D.] UMDNJ NJMS, Dept Pathol & Lab Med, Newark, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Johnson & Johnson; Johnson & Johnson USA; University of Pennsylvania; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Coffman, FD (corresponding author), UMDNJ NJMS, Ctr Biophys Pathol, Newark, NJ USA.	coffmafd@umdnj.edu			Department of Pathology developmental funds; New Jersey Medical School	Department of Pathology developmental funds; New Jersey Medical School	This project was funded by Department of Pathology developmental funds that were made available by the Chair, and by intramural funds from the New Jersey Medical School supplied to the Center for Biophysical Pathology for research support. No funding was supplied by for-profit companies or entities, nor were there any stipulations or limitations that accompanied the funding that was received. The study design, data collection and analysis, decision to publish, and manuscript preparation were performed solely by the authors of this manuscript, with no input or control of any sort from the Pathology Department or the Center for Biophysical Pathology or the Medical School. Neither the authors (or their families), nor the Department, nor the Center for Biophysical Pathology, nor the Medical School, have any financial interest in this study, nor any financial interest that would be impacted in any way by this study.	Ahmad M, 1999, BIOMATERIALS, V20, P211, DOI 10.1016/S0142-9612(98)00152-5; Bae S, 2009, CELL TISSUE RES, V335, P565, DOI 10.1007/s00441-008-0729-y; Barnabe GF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005222; Bonneh-Barkay D, 2008, AM J PATHOL, V173, P130, DOI 10.2353/ajpath.2008.080045; Bonneh-Barkay D, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-34; Choi KS, 2005, BIOCHEM BIOPH RES CO, V330, P1299, DOI 10.1016/j.bbrc.2005.03.111; Chupp GL, 2007, NEW ENGL J MED, V357, P2016, DOI 10.1056/NEJMoa073600; Cintin C, 1999, BRIT J CANCER, V79, P1494, DOI 10.1038/sj.bjc.6690238; Cintin C, 2002, CANCER-AM CANCER SOC, V95, P267, DOI 10.1002/cncr.10644; Coffman F, 2008, CRIT REV CL LAB SCI, V45, P531, DOI [10.1080/10408360802334743, 10.1080/10408360802334743 ]; Connor JR, 2000, OSTEOARTHR CARTILAGE, V8, P87, DOI 10.1053/joca.1999.0276; Eberhardt M, 2006, BIOCHEM BIOPH RES CO, V345, P1167, DOI 10.1016/j.bbrc.2006.05.016; Francescone RA, 2011, J BIOL CHEM, V286, P15332, DOI 10.1074/jbc.M110.212514; Greco SJ, 2007, STEM CELLS DEV, V16, P811, DOI 10.1089/scd.2007.0011; Guo L, 2011, EXP HEMATOL, V39, P608, DOI 10.1016/j.exphem.2011.01.011; HAKALA BE, 1993, J BIOL CHEM, V268, P25803; Hogdall EVS, 2003, ONCOL REP, V10, P1535; Jacques C, 2007, OSTEOARTHR CARTILAGE, V15, P138, DOI 10.1016/j.joca.2006.07.003; Jensen BV, 2003, CLIN CANCER RES, V9, P4423; Jeon SJ, 2007, MOL CELL NEUROSCI, V34, P59, DOI 10.1016/j.mcn.2006.10.003; Johansen JS, 2000, J HEPATOL, V32, P911, DOI 10.1016/S0168-8278(00)80095-1; Johansen JS, 2003, BREAST CANCER RES TR, V80, P15, DOI 10.1023/A:1024431000710; Johansen JS, 1996, BRIT J RHEUMATOL, V35, P553; Johansen JS, 1997, SCAND J GASTROENTERO, V32, P582, DOI 10.3109/00365529709025104; Johansen JS, 2007, J HISTOCHEM CYTOCHEM, V55, P1213, DOI 10.1369/jhc.7A7245.2007; Johansen JS, 2006, DAN MED BULL, V53, P172; Kim Steve H, 2007, World J Surg Oncol, V5, P17, DOI 10.1186/1477-7819-5-17; Ku BM, 2011, INT J CANCER, V128, P1316, DOI 10.1002/ijc.25466; Kubo H, 2009, GENES CELLS, V14, P407, DOI 10.1111/j.1365-2443.2009.01281.x; Liu QH, 2009, J NEURO-ONCOL, V94, P1, DOI 10.1007/s11060-009-9919-z; Ong SY, 2006, BIOMATERIALS, V27, P4087, DOI 10.1016/j.biomaterials.2006.03.022; Pelloski CE, 2005, CLIN CANCER RES, V11, P3326, DOI 10.1158/1078-0432.CCR-04-1765; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Recklies AD, 2005, J BIOL CHEM, V280, P41213, DOI 10.1074/jbc.M510146200; Recklies AD, 2002, BIOCHEM J, V365, P119, DOI 10.1042/BJ20020075; Rehli M, 1997, GENOMICS, V43, P221, DOI 10.1006/geno.1997.4778; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Shao R, 2009, ONCOGENE, V28, P4456, DOI 10.1038/onc.2009.292; Si YL, 2011, AGEING RES REV, V10, P93, DOI 10.1016/j.arr.2010.08.005; Steenbakkers PGA, 2003, J IMMUNOL, V170, P5719, DOI 10.4049/jimmunol.170.11.5719; Tanwar MK, 2002, CANCER RES, V62, P4364; Vij R, 2012, TRANSL RES, V159, P218, DOI 10.1016/j.trsl.2012.01.012; Volck B, 2001, OSTEOARTHR CARTILAGE, V9, P203, DOI 10.1053/joca.2000.0377; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Xu Y, 2007, BIOCHEM BIOPH RES CO, V359, P311, DOI 10.1016/j.bbrc.2007.05.098; Zurita M, 2008, NEUROSCI RES, V60, P275, DOI 10.1016/j.neures.2007.11.006	46	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e62491	10.1371/journal.pone.0062491	http://dx.doi.org/10.1371/journal.pone.0062491			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671604	Green Published, Green Submitted, gold			2022-12-25	WOS:000319737700014
J	Kikusato, M; Toyomizu, M				Kikusato, Motoi; Toyomizu, Masaaki			Crucial Role of Membrane Potential in Heat Stress-Induced Overproduction of Reactive Oxygen Species in Avian Skeletal Muscle Mitochondria	PLOS ONE			English	Article							SUPEROXIDE-PRODUCTION; UNCOUPLING PROTEIN; OXIDATIVE-PHOSPHORYLATION; PROTON CONDUCTANCE; RADICAL GENERATION; FATTY-ACIDS; COMPLEX-I; RAT; SUBSTANCES; MECHANISM	Heat stress is an environmental factor that causes oxidative stress. We found previously that acute heat stress stimulates the production of reactive oxygen species (ROS) in the skeletal muscle mitochondria of birds, and that this was accompanied by an increase of the mitochondrial membrane potential (Delta Psi) due to increased substrate oxidation by the electron transport chain. We also showed that avian uncoupling protein (avUCP) expression is decreased by the heat exposure. The present study clarifies whether Delta Psi is a major determinant of the overproduction of ROS due to acute heat stress, and if the decrease in avUCP expression is responsible for the elevation in Delta Psi. Control (24 degrees C) and acute heat-stressed (34 degrees C for 12 h) birds exhibited increased succinate-driven mitochondrial ROS production as indicated by an elevation of Delta Psi, with this increase being significantly higher in the heat-stressed group compared with the control group. In glutamate/malate-energized mitochondria, no difference in the ROS production between the groups was observed, though the mitochondrial Delta Psi was significantly higher in the heat-stressed groups compared with the control group. Furthermore, mitochondria energized with either succinate/glutamate or succinate/malate showed increased ROS production and Delta Psi in the heat-stressed group compared with mitochondria from the control group. These results suggest that succinate oxidation could play an important role in the heat stress-induced overproduction of mitochondrial ROS in skeletal muscle. In agreement with the notion of a decrease in avUCP expression in response to heat stress, proton leak, which was likely mediated by UCP (that part which is GDP-inhibited and arachidonic acid-sensitive), was reduced in the heat-exposed group. We suggest that the acute heat stress-induced overproduction of mitochondrial ROS may depend on Delta Psi, which may in turn result not only from increased substrate oxidation but also from a decrease in the mitochondrial avUCP content.	[Kikusato, Motoi; Toyomizu, Masaaki] Tohoku Univ, Grad Sch Agr Sci, Sendai, Miyagi 980, Japan	Tohoku University	Toyomizu, M (corresponding author), Tohoku Univ, Grad Sch Agr Sci, Sendai, Miyagi 980, Japan.	toyomizu@bios.tohoku.ac.jp	Toyomizu, Masaaki/AAE-3439-2019; Toyomizu, Masaaki/AAM-6168-2020	Toyomizu, Masaaki/0000-0003-4157-2817	Japan Society for the Promotion of Science (JSPS) [21380165, 08J07429]; Tohoku University Institute for International Advanced Research and Education	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Tohoku University Institute for International Advanced Research and Education	This work was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS, http://www.jsps.go.jp/english/e-grants/index.html) (No. 21380165, M.T.; No. 08J07429, M.K.), and by Tohoku University Institute for International Advanced Research and Education (http://www.iiare.tohoku.ac.jp/e/education/index.html, M.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altan O, 2003, BRIT POULTRY SCI, V44, P545, DOI 10.1080/00071660310001618334; ANDREYEV AY, 1989, EUR J BIOCHEM, V182, P585, DOI 10.1111/j.1432-1033.1989.tb14867.x; Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003; Brand MD, 2000, EXP GERONTOL, V35, P811, DOI 10.1016/S0531-5565(00)00135-2; BROWN RE, 1989, ANAL BIOCHEM, V180, P136, DOI 10.1016/0003-2697(89)90101-2; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; Cadenas S, 2002, J BIOL CHEM, V277, P2773, DOI 10.1074/jbc.M109736200; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Goglia F, 2003, FASEB J, V17, P1585, DOI 10.1096/fj.03-0159hyp; Haak JL, 2009, AM J PHYSIOL-REG I, V296, pR812, DOI 10.1152/ajpregu.90708.2008; Hansford RG, 1997, J BIOENERG BIOMEMBR, V29, P89, DOI 10.1023/A:1022420007908; Kasanuma Y, 1998, TOHOKU J EXP MED, V185, P79, DOI 10.1620/tjem.185.79; Kikusato M, 2010, FEBS LETT, V584, P3143, DOI 10.1016/j.febslet.2010.05.057; Klingenberg M, 2001, BIOCHEM SOC T, V29, P806; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; Lombardi A, 2008, BBA-BIOENERGETICS, V1777, P826, DOI 10.1016/j.bbabio.2008.04.019; Lombardi A, 2010, J BIOL CHEM, V285, P16599, DOI 10.1074/jbc.M110.102699; Miwa S, 2003, FREE RADICAL BIO MED, V35, P938, DOI 10.1016/S0891-5849(03)00464-7; Mujahid A, 2006, POULTRY SCI, V85, P1259, DOI 10.1093/ps/85.7.1259; Mujahid A, 2005, POULTRY SCI, V84, P307, DOI 10.1093/ps/84.2.307; Mujahid Ahmad, 2007, Journal of Poultry Science, V44, P439, DOI 10.2141/jpsa.44.439; Mujahid A, 2007, FEBS LETT, V581, P3461, DOI 10.1016/j.febslet.2007.06.051; Mujahid A, 2009, AM J PHYSIOL-REG I, V297, pR690, DOI 10.1152/ajpregu.90974.2008; Muller FL, 2008, BIOCHEM J, V409, P491, DOI 10.1042/BJ20071162; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Papa S, 1997, MOL CELL BIOCHEM, V174, P305, DOI 10.1023/A:1006873518427; Rey Benjamin, 2010, BMC Physiology, V10, P5, DOI 10.1186/1472-6793-10-5; REYNAFARJE B, 1985, ANAL BIOCHEM, V145, P406, DOI 10.1016/0003-2697(85)90381-1; Ricquier D, 2000, BIOCHEM J, V345, P161, DOI 10.1042/0264-6021:3450161; ROLFE DFS, 1994, BBA-BIOENERGETICS, V1188, P405, DOI 10.1016/0005-2728(94)90062-0; ROTTENBERG H, 1983, P NATL ACAD SCI-BIOL, V80, P3313, DOI 10.1073/pnas.80.11.3313; Sanz A, 2006, FASEB J, V20, P1064, DOI 10.1096/fj.05-5568com; SKULACHEV VP, 1991, FEBS LETT, V294, P158, DOI 10.1016/0014-5793(91)80658-P; Skulachev VP, 1996, Q REV BIOPHYS, V29, P169, DOI 10.1017/S0033583500005795; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Talbot DA, 2004, J PHYSIOL-LONDON, V558, P123, DOI 10.1113/jphysiol.2004.063768; Toime LJ, 2010, FREE RADICAL BIO MED, V49, P606, DOI 10.1016/j.freeradbiomed.2010.05.010; Toyomizu M, 2011, COMP BIOCHEM PHYS A, V159, P75, DOI 10.1016/j.cbpa.2011.01.020; Tretter L, 2004, J NEUROSCI, V24, P7771, DOI 10.1523/JNEUROSCI.1842-04.2004; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Votyakova TV, 2001, J NEUROCHEM, V79, P266, DOI 10.1046/j.1471-4159.2001.00548.x	44	68	71	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e64412	10.1371/journal.pone.0064412	http://dx.doi.org/10.1371/journal.pone.0064412			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671714	Green Published, Green Submitted, gold			2022-12-25	WOS:000319737700072
J	Bargagna-Mohan, P; Deokule, SP; Thompson, K; Wizeman, J; Srinivasan, C; Vooturi, S; Kompella, UB; Mohan, R				Bargagna-Mohan, Paola; Deokule, Sunil P.; Thompson, Kyle; Wizeman, John; Srinivasan, Cidambi; Vooturi, Sunil; Kompella, Uday B.; Mohan, Royce			Withaferin A Effectively Targets Soluble Vimentin in the Glaucoma Filtration Surgical Model of Fibrosis	PLOS ONE			English	Article							INTERMEDIATE-FILAMENT NETWORKS; FIBRILLARY ACIDIC PROTEIN; P27(KIP1) DEGRADATION; CAPSULE FIBROBLASTS; TRABECULAR MESHWORK; CELL ARCHITECTURE; GROWTH-FACTOR; LIVING CELLS; IN-VIVO; SURGERY	Withaferin A (WFA) is a natural product that binds to soluble forms of the type III intermediate filament (IF) vimentin. Currently, it is unknown under what pathophysiological contexts vimentin is druggable, as cytoskeltal vimentin-IFs are abundantly expressed. To investigate druggability of vimentin, we exploited rabbit Tenon's capsule fibroblast (RbTCF) cell cultures and the rabbit glaucoma filtration surgical (GFS) model of fibrosis. WFA potently caused G(0)/G(1) cell cycle inhibition (IC50 25 nM) in RbTCFs, downregulating ubiquitin E3 ligase skp2 and inducing p27(Kip1) expression. Transforming growth factor (TGF)-beta-induced myofibroblast transformation caused development of cell spheroids with numerous elongated invadopodia, which WFA blocked potently by downregulating soluble vimentin and alpha-smooth muscle actin (SMA) expression. In the pilot proof-of-concept study using the GFS model, subconjunctival injections of a low WFA dose reduced skp2 expression in Tenon's capsule and increased p27(Kip1) expression without significant alteration to vimentin-IFs. This treatment maintains significant nanomolar WFA concentrations in anterior segment tissues that correspond to WFA's cell cycle targeting activity. A ten-fold higher WFA dose caused potent downregulation of soluble vimentin and skp2 expression, but as found in cell cultures, no further increase in p27(Kip1) expression was observed. Instead, this high WFA dose potently induced vimentin-IF disruption and downregulated alpha-SMA expression that mimicked WFA activity in TGF-beta-treated RbTCFs that blocked cell contractile activity at submicromolar concentrations. These findings illuminate that localized WFA injection to ocular tissues exerts pharmacological control over the skp2-p27(Kip1) pathway by targeting of soluble vimentin in a model of surgical fibrosis.	[Bargagna-Mohan, Paola; Wizeman, John; Mohan, Royce] Univ Connecticut Hlth Ctr, Farmington, CT USA; [Deokule, Sunil P.; Thompson, Kyle; Srinivasan, Cidambi] Univ Kentucky, Lexington, KY USA; [Vooturi, Sunil; Kompella, Uday B.] Univ Colorado Denver, Aurora, CO USA	University of Connecticut; University of Kentucky; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Mohan, R (corresponding author), Univ Connecticut Hlth Ctr, Farmington, CT USA.	MOHAN@uchc.edu			National Institutes of Health (NIH) [R01EY016782, R01 CA131059, R01EY018940]; Susan Hart through the University of Connecticut Foundation; John A. and Florence Mattern Solomon Endowed Chair foundation grants; NATIONAL CANCER INSTITUTE [R01CA131059] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY016782, R01EY018940] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan Hart through the University of Connecticut Foundation; John A. and Florence Mattern Solomon Endowed Chair foundation grants; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was funded in part by National Institutes of Health (NIH) grants R01EY016782 and R01 CA131059 and John A. and Florence Mattern Solomon Endowed Chair foundation grants and a private donation from Susan Hart through the University of Connecticut Foundation to R.M. This research was also partly supported by an NIH grant R01EY018940 to U.B.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auld CA, 2007, J CELL PHYSIOL, V211, P101, DOI 10.1002/jcp.20915; Bar H, 2005, P NATL ACAD SCI USA, V102, P15099, DOI 10.1073/pnas.0504568102; Bargagna-Mohan P, 2007, CHEM BIOL, V14, P623, DOI 10.1016/j.chembiol.2007.04.010; Bargagna-Mohan P, 2006, INVEST OPHTH VIS SCI, V47, P4138, DOI 10.1167/iovs.05-1452; Bargagna-Mohan P, 2012, J BIOL CHEM, V287, P989, DOI 10.1074/jbc.M111.297150; Bargagna-Mohan P, 2010, J BIOL CHEM, V285, P7657, DOI 10.1074/jbc.M109.093765; Blanch R J, 2009, J R Army Med Corps, V155, P279; Burns WC, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001481; CARY RB, 1994, J CELL SCI, V107, P1609; Challa AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042989; Chou YH, 2007, EXP CELL RES, V313, P2236, DOI 10.1016/j.yexcr.2007.04.008; Clarke EJ, 2002, CURR BIOL, V12, pR596, DOI 10.1016/S0960-9822(02)01102-8; Colakoglu G, 2009, J CELL BIOL; Crowston JG, 1998, INVEST OPHTH VIS SCI, V39, P449; Dinsdale D, 2004, AM J PATHOL, V164, P395, DOI 10.1016/S0002-9440(10)63130-6; Eckes B, 1998, J CELL SCI, V111, P1897; Eckes B, 2000, J CELL SCI, V113, P2455; Eriksson JE, 2004, J CELL SCI, V117, P919, DOI 10.1242/jcs.00906; Esson DW, 2004, INVEST OPHTH VIS SCI, V45, P4450, DOI 10.1167/iovs.04-0375; Esson DW, 2004, INVEST OPHTH VIS SCI, V45, P485, DOI 10.1167/iovs.03-0485; FRANKE WW, 1982, CELL, V30, P103, DOI 10.1016/0092-8674(82)90016-2; Galichon P, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-11; Gaudana R, 2010, AAPS J, V12, P348, DOI 10.1208/s12248-010-9183-3; Goldman RD, 2008, CURR OPIN CELL BIOL, V20, P28, DOI 10.1016/j.ceb.2007.11.003; Grin B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039065; Guarino M, 2009, HUM PATHOL, V40, P1365, DOI 10.1016/j.humpath.2009.02.020; Helfand BT, 2011, MOL BIOL CELL, V22, P1274, DOI 10.1091/mbc.E10-08-0699; Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197; Herrmann H, 2009, J CLIN INVEST, V119, P1772, DOI 10.1172/JCI38214; Iliev ME, 1997, EXP EYE RES, V64, P1013, DOI 10.1006/exer.1997.0300; Inuzuka H, 2012, CELL, V150, P179, DOI 10.1016/j.cell.2012.05.038; Ivaska Johanna, 2011, Small GTPases, V2, P51; Izawa I, 2006, CANCER SCI, V97, P167, DOI 10.1111/j.1349-7006.2006.00161.x; JAMPEL HD, 1988, ARCH OPHTHALMOL-CHIC, V106, P89; Johnson CP, 2007, SCIENCE, V317, P663, DOI 10.1126/science.1139857; Kadam RS, 2010, J PHARMACOL EXP THER, V332, P1107, DOI 10.1124/jpet.109.161570; KHAW PT, 1992, ARCH OPHTHALMOL-CHIC, V110, P1150, DOI 10.1001/archopht.1992.01080200130040; Korff T, 1998, J CELL BIOL, V143, P1341, DOI 10.1083/jcb.143.5.1341; Kossatz U, 2004, GENE DEV, V18, P2602, DOI 10.1101/gad.321004; Lahat G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010105; Lynch CD, 2013, MOL BIOL CELL, V24, P21, DOI 10.1091/mbc.E12-05-0377; Maxwell SA, 2011, LEUKEMIA LYMPHOMA, V52, P849, DOI 10.3109/10428194.2010.551793; Mead AL, 2003, INVEST OPHTH VIS SCI, V44, P3394, DOI 10.1167/iovs.02-0978; Mendez MG, 2010, FASEB J, V24, P1838, DOI 10.1096/fj.09-151639; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Mohan Royce, 2004, Angiogenesis, V7, P115, DOI 10.1007/s10456-004-1026-3; Mucke N, 2004, J MOL BIOL, V340, P97, DOI 10.1016/j.jmb.2004.04.039; Pekny M, 2004, J PATHOL, V204, P428, DOI 10.1002/path.1645; Perng MD, 2008, MOL BIOL CELL, V19, P4521, DOI 10.1091/mbc.E08-03-0284; Phua DCY, 2009, MOL BIOL CELL, V20, P2841, DOI 10.1091/mbc.E08-02-0199; Plodinec M, 2011, J STRUCT BIOL, V174, P476, DOI 10.1016/j.jsb.2011.03.011; Prahlad V, 1998, J CELL BIOL, V143, P159, DOI 10.1083/jcb.143.1.159; Prendes MA, 2013, BR J OPHTHALMOL; Pucilowska JB, 2000, AM J PHYSIOL-GASTR L, V279, pG653; Quinlan Roy, 2002, Prog Mol Subcell Biol, V28, P219; Robertson J, 2003, J CELL BIOL, V160, P939, DOI 10.1083/jcb.200205027; Rogel MR, 2011, FASEB J; Sakamoto Y, 2013, J CELL BIOL, V200, P249, DOI 10.1083/jcb.201206010; Salim S, 2012, CURR OPIN OPHTHALMOL, V23, P89, DOI 10.1097/ICU.0b013e32834ff401; Schoumacher M, 2010, J CELL BIOL, V189, P541, DOI 10.1083/jcb.200909113; Sherwood Mark Brian, 2006, Trans Am Ophthalmol Soc, V104, P478; SOELLNER P, 1985, P NATL ACAD SCI USA, V82, P7929, DOI 10.1073/pnas.82.23.7929; Stahnke T, 2012, EXP EYE RES, V100, P88, DOI 10.1016/j.exer.2012.04.015; Stevens C, 2012, GUT; Suzuki S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036249; Thaiparambil JT, 2011, INT J CANC; Thakur A, 2011, DRUG METAB DISPOS, V39, P771, DOI 10.1124/dmd.110.037408; Wang F, 2010, INVEST OPHTH VIS SCI, V51, P1475, DOI 10.1167/iovs.09-4363; Wu YZ, 2007, BBA-MOL CELL RES, V1773, P427, DOI 10.1016/j.bbamcr.2006.11.017; Yang JG, 2009, ACTA PHARMACOL SIN, V30, P413, DOI 10.1038/aps.2009.23; Yokota Y, 2006, BIOORG MED CHEM LETT, V16, P2603, DOI 10.1016/j.bmcl.2006.02.039; Yoon M, 1998, J CELL BIOL, V143, P147, DOI 10.1083/jcb.143.1.147; Yoshida K, 2002, INVEST OPHTH VIS SCI, V43, P364; Zhao XJ, 2004, INVEST OPHTH VIS SCI, V45, P4023, DOI 10.1167/iovs.04-0535	74	26	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63881	10.1371/journal.pone.0063881	http://dx.doi.org/10.1371/journal.pone.0063881			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667686	gold, Green Published, Green Submitted			2022-12-25	WOS:000319055600080
J	Gracio, F; Cabral, J; Tidor, B				Gracio, Filipe; Cabral, Joaquim; Tidor, Bruce			Modeling Stem Cell Induction Processes	PLOS ONE			English	Article							GENE-EXPRESSION; PLURIPOTENCY; OCT4; STOCHASTICITY; FIBROBLASTS; NANOG; NOISE; SOX2; TRANSCRIPTION; EPIGENETICS	Technology for converting human cells to pluripotent stem cell using induction processes has the potential to revolutionize regenerative medicine. However, the production of these so called iPS cells is still quite inefficient and may be dominated by stochastic effects. In this work we build mass-action models of the core regulatory elements controlling stem cell induction and maintenance. The models include not only the network of transcription factors NANOG, OCT4, SOX2, but also important epigenetic regulatory features of DNA methylation and histone modification. We show that the network topology reported in the literature is consistent with the observed experimental behavior of bistability and inducibility. Based on simulations of stem cell generation protocols, and in particular focusing on changes in epigenetic cellular states, we show that cooperative and independent reaction mechanisms have experimentally identifiable differences in the dynamics of reprogramming, and we analyze such differences and their biological basis. It had been argued that stochastic and elite models of stem cell generation represent distinct fundamental mechanisms. Work presented here suggests an alternative possibility that they represent differences in the amount of information we have about the distribution of cellular states before and during reprogramming protocols. We show further that unpredictability and variation in reprogramming decreases as the cell progresses along the induction process, and that identifiable groups of cells with elite-seeming behavior can come about by a stochastic process. Finally we show how different mechanisms and kinetic properties impact the prospects of improving the efficiency of iPS cell generation protocols.	[Gracio, Filipe; Cabral, Joaquim] Inst Super Tecn, IBB, Ctr Biol & Chem Engn, Lisbon, Portugal; [Gracio, Filipe; Tidor, Bruce] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Tidor, Bruce] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Tidor, Bruce] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA	Universidade de Lisboa; Instituto Superior Tecnico; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Tidor, B (corresponding author), MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tidor@mit.edu	Cabral, Joaquim M S/G-2052-2010	Cabral, Joaquim M S/0000-0002-2405-5845; /0000-0002-3320-3969	Fundacao para a Ciencia e Tecnologia [BD 42942]; US National Institutes of Health [CA112967]; Singapore-MIT Alliance for Research and Technology; US National Science Foundation [0821391]; MIT Portugal Program	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Singapore-MIT Alliance for Research and Technology(Singapore-MIT Alliance for Research & Technology Centre (SMART)); US National Science Foundation(National Science Foundation (NSF)); MIT Portugal Program	This research was supported by the MIT Portugal Program, Fundacao para a Ciencia e Tecnologia (BD 42942), the US National Institutes of Health (CA112967), the Singapore-MIT Alliance for Research and Technology, the US National Science Foundation (0821391), and a gift of computing hardware from Intel Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amabile G, 2009, TRENDS MOL MED, V15, P59, DOI 10.1016/j.molmed.2008.12.003; Atkinson S, 2008, CELL TISSUE RES, V331, P23, DOI 10.1007/s00441-007-0536-x; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bao SQ, 2009, NATURE, V461, P1292, DOI 10.1038/nature08534; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Becskei A, 2005, NAT GENET, V37, P937, DOI 10.1038/ng1616; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chickarmane V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003478; Cover TM, 1991, ELEMENTS INFORM THEO; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Dittami GM, 2012, JOVE-J VIS EXP, DOI 10.3791/3842; Djuric U, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt3; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Feng B, 2009, CELL STEM CELL, V4, P301, DOI 10.1016/j.stem.2009.03.005; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hochedlinger K, 2009, DEVELOPMENT, V136, P509, DOI 10.1242/dev.020867; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; Klumpp S, 2008, P NATL ACAD SCI USA, V105, P18159, DOI 10.1073/pnas.0806084105; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Levine AD, 2011, CELL STEM CELL, V8, P132, DOI 10.1016/j.stem.2011.01.002; Li YQ, 2011, CELL RES, V21, P196, DOI 10.1038/cr.2010.142; Li ZH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2059; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Loh K, 2009, CELL STEM CELL, V5, P491; MacKay D. J. C., 2003, INFORM THEORY INFERE; Mali P, 2010, STEM CELLS, V28, P713, DOI 10.1002/stem.402; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Neuert G, 2013, SCIENCE, V339, P584, DOI 10.1126/science.1231456; Nishikawa S, 2008, NAT REV MOL CELL BIO, V9, P725, DOI 10.1038/nrm2466; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Papapetrou EP, 2009, P NATL ACAD SCI USA, V106, P12759, DOI 10.1073/pnas.0904825106; Pasi CE, 2011, CELL DEATH DIFFER, V18, P745, DOI 10.1038/cdd.2011.9; Patel M, 2010, STEM CELL REV REP, V6, P367, DOI 10.1007/s12015-010-9123-8; Pera MF, 2011, NATURE, V471, P46, DOI 10.1038/471046a; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Remenyi A, 2003, GENE DEV, V17, P2048, DOI 10.1101/gad.269303; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Rolletschek A, 2009, BIOL CHEM, V390, P845, DOI 10.1515/BC.2009.103; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Wang J, 2008, P NATL ACAD SCI USA, V105, P6326, DOI 10.1073/pnas.0802288105; Williams DC, 2004, J BIOL CHEM, V279, P1449, DOI 10.1074/jbc.M309790200; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267; Zhurinsky J, 2010, CURR BIOL, V20, P2010, DOI 10.1016/j.cub.2010.10.002	58	4	4	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e60240	10.1371/journal.pone.0060240	http://dx.doi.org/10.1371/journal.pone.0060240			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667423	gold, Green Published, Green Submitted			2022-12-25	WOS:000319055600003
J	Lippert, MT; Takagaki, K; Kayser, C; Ohl, FW				Lippert, Michael T.; Takagaki, Kentaroh; Kayser, Christoph; Ohl, Frank W.			Asymmetric Multisensory Interactions of Visual and Somatosensory Responses in a Region of the Rat Parietal Cortex	PLOS ONE			English	Article							SUPERIOR COLLICULUS NEURONS; PRIMARY AUDITORY-CORTEX; SOURCE-DENSITY ANALYSIS; POSTERIOR PARIETAL; HEMODYNAMIC-RESPONSES; SYNAPTIC ACTIVITY; NEURAL ACTIVITY; INTEGRATION; NEOCORTEX; ORGANIZATION	Perception greatly benefits from integrating multiple sensory cues into a unified percept. To study the neural mechanisms of sensory integration, model systems are required that allow the simultaneous assessment of activity and the use of techniques to affect individual neural processes in behaving animals. While rodents qualify for these requirements, little is known about multisensory integration and areas involved for this purpose in the rodent. Using optical imaging combined with laminar electrophysiological recordings, the rat parietal cortex was identified as an area where visual and somatosensory inputs converge and interact. Our results reveal similar response patterns to visual and somatosensory stimuli at the level of current source density (CSD) responses and multi-unit responses within a strip in parietal cortex. Surprisingly, a selective asymmetry was observed in multisensory interactions: when the somatosensory response preceded the visual response, supra-linear summation of CSD was observed, but the reverse stimulus order resulted in sub-linear effects in the CSD. This asymmetry was not present in multi-unit activity however, which showed consistently sub-linear interactions. These interactions were restricted to a specific temporal window, and pharmacological tests revealed significant local intra-cortical contributions to this phenomenon. Our results highlight the rodent parietal cortex as a system to model the neural underpinnings of multisensory processing in behaving animals and at the cellular level.	[Lippert, Michael T.; Takagaki, Kentaroh; Ohl, Frank W.] Leibniz Inst Neurobiol, Dept Syst Physiol Learning, Magdeburg, Germany; [Kayser, Christoph] Max Planck Inst Biol Cybernet, Dept Physiol Cognit Proc, D-72076 Tubingen, Germany; [Kayser, Christoph] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland; [Lippert, Michael T.; Ohl, Frank W.] Otto von Guericke Univ, Inst Biol, Magdeburg, Germany; [Ohl, Frank W.] Ctr Behav Brain Sci, Magdeburg, Germany	Leibniz Institut fur Neurobiologie (LIN); Max Planck Society; University of Glasgow; Otto von Guericke University	Lippert, MT (corresponding author), Leibniz Inst Neurobiol, Dept Syst Physiol Learning, Magdeburg, Germany.	mlippert@lin-magdeburg.de	Takagaki, Kentaroh/A-9829-2009; Kayser, Christoph/A-3203-2012	Takagaki, Kentaroh/0000-0002-1852-529X; Kayser, Christoph/0000-0001-7362-5704	Deutsche Forschungsgemeinschaft DFG [SFB 779, SFB TRR 31]; federal state of Saxony-Anhalt; a(sic)oeEuropean Regional Developement Funda(sic)oe (ERDF); Center for Behavioral Brain Sciences (CBBS) [FKZ: 1211080005]; Max-Planck-Society; Alexander von Humboldt-Foundation	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); federal state of Saxony-Anhalt; a(sic)oeEuropean Regional Developement Funda(sic)oe (ERDF); Center for Behavioral Brain Sciences (CBBS); Max-Planck-Society(Max Planck Society); Alexander von Humboldt-Foundation(Alexander von Humboldt Foundation)	This work was supported by the Deutsche Forschungsgemeinschaft DFG (SFB 779 and SFB TRR 31), by the federal state of Saxony-Anhalt and the a(sic)oeEuropean Regional Developement Funda(sic)oe (ERDF 2007-2013), Center for Behavioral Brain Sciences (CBBS) FKZ: 1211080005 and by the Max-Planck-Society. K. Takagaki was supported by a fellowship from the Alexander von Humboldt-Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, BEHAV LAB RAT HDB TE; Avillac M, 2005, NAT NEUROSCI, V8, P941, DOI 10.1038/nn1480; Avillac M, 2007, J NEUROSCI, V27, P1922, DOI 10.1523/JNEUROSCI.2646-06.2007; Beauchamp MS, 2004, NAT NEUROSCI, V7, P1190, DOI 10.1038/nn1333; Bizley JK, 2009, HEARING RES, V258, P55, DOI 10.1016/j.heares.2009.06.017; Blanke O, 2012, NAT REV NEUROSCI, V13, P556, DOI 10.1038/nrn3292; Brett-Green B, 2003, J COMP NEUROL, V460, P223, DOI 10.1002/cne.10637; Broussard J, 2006, NEUROSCIENCE, V143, P407, DOI 10.1016/j.neuroscience.2006.08.030; Budinger E, 2000, EUR J NEUROSCI, V12, P2425, DOI 10.1046/j.1460-9568.2000.00142.x; Cahill L, 1996, NEUROBIOL LEARN MEM, V65, P213, DOI 10.1006/nlme.1996.0026; Calvert GA, 2001, CEREB CORTEX, V11, P1110, DOI 10.1093/cercor/11.12.1110; Clement EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002004; COLAVITA FB, 1974, PERCEPT PSYCHOPHYS, V16, P409, DOI 10.3758/BF03203962; CRAGG BG, 1971, BRAIN RES, V34, P53, DOI 10.1016/0006-8993(71)90350-7; Dahl CD, 2009, J NEUROSCI, V29, P11924, DOI 10.1523/JNEUROSCI.3437-09.2009; Dehner LR, 2004, CEREB CORTEX, V14, P387, DOI 10.1093/cercor/bhg135; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Douglas RJ, 2007, CURR BIOL, V17, pR496, DOI 10.1016/j.cub.2007.04.024; Driver J, 2008, NEURON, V57, P11, DOI 10.1016/j.neuron.2007.12.013; Felsen G, 2008, NEURON, V60, P137, DOI 10.1016/j.neuron.2008.09.019; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; Fetsch CR, 2012, NAT NEUROSCI, V15, P146, DOI 10.1038/nn.2983; Flusberg BA, 2008, NAT METHODS, V5, P935, DOI 10.1038/nmeth.1256; Foxe JJ, 2005, NEUROREPORT, V16, P419, DOI 10.1097/00001756-200504040-00001; Foxworthy WA, 2013, J COMP NEUROL, V521, P1867, DOI 10.1002/cne.23264; Foxworthy WA, 2013, EUR J NEUROSCI, V37, P910, DOI 10.1111/ejn.12085; Frostig RD, 2008, J NEUROSCI, V28, P13274, DOI 10.1523/JNEUROSCI.4074-08.2008; Fujisaki W, 2004, NAT NEUROSCI, V7, P773, DOI 10.1038/nn1268; GAREY LJ, 1971, PROC R SOC SER B-BIO, V179, P41, DOI 10.1098/rspb.1971.0080; Ghazanfar AA, 2006, TRENDS COGN SCI, V10, P278, DOI 10.1016/j.tics.2006.04.008; GIVRE SJ, 1994, VISION RES, V34, P415, DOI 10.1016/0042-6989(94)90156-2; Gleiss S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045677; Green AM, 2010, CURR OPIN NEUROBIOL, V20, P353, DOI 10.1016/j.conb.2010.04.009; Greenberg DS, 2008, NAT NEUROSCI, V11, P749, DOI 10.1038/nn.2140; Gu Y, 2008, NAT NEUROSCI, V11, P1201, DOI 10.1038/nn.2191; Gu Y, 2011, NEURON, V71, P750, DOI 10.1016/j.neuron.2011.06.015; Happel MFK, 2010, J NEUROSCI, V30, P11114, DOI 10.1523/JNEUROSCI.0689-10.2010; Harvey CD, 2012, NATURE, V484, P62, DOI 10.1038/nature10918; Hirokawa J, 2008, NEUROSCIENCE, V153, P1402, DOI 10.1016/j.neuroscience.2008.01.011; Ionta S, 2011, NEURON, V70, P363, DOI 10.1016/j.neuron.2011.03.009; Iurilli G, 2012, NEURON, V73, P814, DOI 10.1016/j.neuron.2011.12.026; Kayser C, 2008, CEREB CORTEX, V18, P1560, DOI 10.1093/cercor/bhm187; Kayser C, 2007, BRAIN STRUCT FUNCT, V212, P121, DOI 10.1007/s00429-007-0154-0; Kayser C, 2010, CURR BIOL, V20, P19, DOI 10.1016/j.cub.2009.10.068; KENANVAKNIN G, 1994, BRAIN RES, V635, P37, DOI 10.1016/0006-8993(94)91421-4; KOLB B, 1994, CEREB CORTEX, V4, P664, DOI 10.1093/cercor/4.6.664; Kurt S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001735; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Laurienti PJ, 2005, EXP BRAIN RES, V166, P289, DOI 10.1007/s00221-005-2370-2; Lemus L, 2010, NEURON, V67, P335, DOI 10.1016/j.neuron.2010.06.015; Lewis R, 2010, J NEUROSCI, V30, P12329, DOI 10.1523/JNEUROSCI.5745-09.2010; Lippert M, 2007, BRAIN RES, V1173, P102, DOI 10.1016/j.brainres.2007.07.050; Lippert MT, 2010, MAGN RESON IMAGING, V28, P1087, DOI 10.1016/j.mri.2009.12.028; Ludvig N, 2012, BRAIN RES, V1441, P1, DOI 10.1016/j.brainres.2011.12.050; MEANEY MJ, 1981, ANIM BEHAV, V29, P34, DOI 10.1016/S0003-3472(81)80149-2; Menzel RR, 2005, CEREB CORTEX, V15, P1690, DOI 10.1093/cercor/bhi045; Meredith MA, 2009, NEUROREPORT, V20, P126, DOI 10.1097/WNR.0b013e32831d7bb6; MEREDITH MA, 1987, J NEUROSCI, V7, P3215; Meredith MA, 1996, J NEUROPHYSIOL, V75, P1843, DOI 10.1152/jn.1996.75.5.1843; MEREDITH MA, 1983, SCIENCE, V221, P389, DOI 10.1126/science.6867718; MILLER MW, 1984, J COMP NEUROL, V226, P184, DOI 10.1002/cne.902260204; Miyawaki A, 2003, NAT CELL BIOL, pS1, DOI 10.1038/ncb1031; Montemurro MA, 2007, J NEUROPHYSIOL, V98, P1871, DOI 10.1152/jn.00593.2007; Nemoto M, 2004, J NEUROSCI, V24, P3850, DOI 10.1523/JNEUROSCI.4870-03.2004; NICHOLSON C, 1975, J NEUROPHYSIOL, V38, P356, DOI 10.1152/jn.1975.38.2.356; Ohshiro T, 2011, NAT NEUROSCI, V14, P775, DOI 10.1038/nn.2815; Otazu GH, 2009, NAT NEUROSCI, V12, P646, DOI 10.1038/nn.2306; Pasalar S, 2010, EUR J NEUROSCI, V31, P1783, DOI 10.1111/j.1460-9568.2010.07193.x; Paxinos G., 2004, RAT BRAIN STEREOTAXI; PINTOHAMUY T, 1987, BEHAV BRAIN RES, V25, P221, DOI 10.1016/0166-4328(87)90070-2; Pitts W.H., 1952, CYBERNETICS, P159; Raposo D, 2012, J NEUROSCI, V32, P3726, DOI 10.1523/JNEUROSCI.4998-11.2012; Sakata S, 2009, NEURON, V64, P404, DOI 10.1016/j.neuron.2009.09.020; Schei JL, 2009, APPL OPTICS, V48, pD121, DOI 10.1364/AO.48.00D121; Schulz D, 2011, NAT METHODS, V8, P347, DOI [10.1038/nmeth.1582, 10.1038/NMETH.1582]; Sirotin YB, 2009, P NATL ACAD SCI USA, V106, P18390, DOI 10.1073/pnas.0905509106; Spence C, 2009, PROG BRAIN RES, V176, P245, DOI 10.1016/S0079-6123(09)17615-X; Stanford TR, 2007, NEUROREPORT, V18, P787, DOI 10.1097/WNR.0b013e3280c1e315; Stein BE, 2008, NAT REV NEUROSCI, V9, P255, DOI 10.1038/nrn2331; Stein BE, 2010, EUR J NEUROSCI, V31, P1713, DOI 10.1111/j.1460-9568.2010.07206.x; Stein BE, 2009, EXP BRAIN RES, V198, P113, DOI 10.1007/s00221-009-1880-8; Stein BE., 1993, MERGING SENSES; Sugihara T, 2006, J NEUROSCI, V26, P11138, DOI 10.1523/JNEUROSCI.3550-06.2006; Takagaki K, 2008, NEUROSCI LETT, V431, P191, DOI 10.1016/j.neulet.2007.11.069; Tees RC, 1999, BEHAV BRAIN RES, V106, P55, DOI 10.1016/S0166-4328(99)00092-3; TOLDI J, 1986, NEUROSCIENCE, V18, P461, DOI 10.1016/0306-4522(86)90166-1; Wallace MT, 2004, P NATL ACAD SCI USA, V101, P2167, DOI 10.1073/pnas.0305697101; Wilent WB, 2005, NAT NEUROSCI, V8, P1364, DOI 10.1038/nn1545; Winters BD, 2010, J NEUROSCI, V30, P6253, DOI 10.1523/JNEUROSCI.6073-09.2010; Xu WF, 2007, NEURON, V55, P119, DOI 10.1016/j.neuron.2007.06.016; Yamauchi T, 2000, EUR J NEUROSCI, V12, P3433, DOI 10.1046/j.1460-9568.2000.00248.x; Yang Y, 2008, NAT NEUROSCI, V11, P1262, DOI 10.1038/nn.2211	93	26	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63631	10.1371/journal.pone.0063631	http://dx.doi.org/10.1371/journal.pone.0063631			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667650	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000319654700171
J	Ma, JX; Wang, ZW; Zhu, CW; Liu, SM; Wang, QY; Wu, ZC				Ma, Jinxing; Wang, Zhiwei; Zhu, Chaowei; Liu, Shumeng; Wang, Qiaoying; Wu, Zhichao			Analysis of Nitrification Efficiency and Microbial Community in a Membrane Bioreactor Fed with Low COD/N-Ratio Wastewater	PLOS ONE			English	Article							ACTIVATED-SLUDGE; HETEROTROPHIC BACTERIA; BIOFILM REACTORS; NITROGEN REMOVAL; RETENTION TIME; ORGANIC-CARBON; PERFORMANCE; POPULATION; AMMONIUM; RECOVERY	In this study, an approach using influent COD/N ratio reduction was employed to improve process performance and nitrification efficiency in a membrane bioreactor (MBR). Besides sludge reduction, membrane fouling alleviation was observed during 330 d operation, which was attributed to the decreased production of soluble microbial products (SMP) and efficient carbon metabolism in the autotrophic nitrifying community. 454 high-throughput 16S rRNA gene pyrosequencing revealed that the diversity of microbial sequences was mainly determined by the feed characteristics, and that microbes could derive energy by switching to a more autotrophic metabolism to resist the environmental stress. The enrichment of nitrifiers in an MBR with a low COD/N-ratio demonstrated that this condition stimulated nitrification, and that the community distribution of ammonia oxidizing bacteria (AOB) and nitrite oxidizing bacteria (NOB) resulted in faster nitrite uptake rates. Further, ammonia oxidation was the rate-limiting step during the full nitrification.	[Ma, Jinxing; Wang, Zhiwei; Liu, Shumeng; Wang, Qiaoying; Wu, Zhichao] Tongji Univ, Sch Environm Sci & Engn, State Key Lab Pollut Control & Resource Reuse, Shanghai 200092, Peoples R China; [Zhu, Chaowei] Chinese Res Inst Environm Sci, Beijing, Peoples R China	Tongji University; Chinese Research Academy of Environmental Sciences	Wang, ZW (corresponding author), Tongji Univ, Sch Environm Sci & Engn, State Key Lab Pollut Control & Resource Reuse, Shanghai 200092, Peoples R China.	zwwang@tongji.edu.cn	Wang, Zhiwei/F-5666-2012; Wang, Qiaoying/AAN-6945-2020; Ma, Jinxing/D-9981-2013	Wang, Zhiwei/0000-0001-6729-2237; Ma, Jinxing/0000-0002-5087-3972	Sino-French Scientific and Technological Cooperation Project in the Domain of Water [2011DFA90400]; National Natural Science Foundation of China [51008217]; Fundamental Research Funds for the Central Universities	Sino-French Scientific and Technological Cooperation Project in the Domain of Water; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was financially supported by the Sino-French Scientific and Technological Cooperation Project in the Domain of Water (2011DFA90400), the National Natural Science Foundation of China (grant No. 51008217) and by the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JH, 2011, ENVIRON SCI TECHNOL, V45, P2734, DOI 10.1021/es103534g; American Public Health Association (APHA), 2012, STANDARD METHODS EXA, DOI [10.2105/SMWW.2882?gclid=CjwKCAiA25v_BRBNEiwAZb4-ZRdKz6ceq6, DOI 10.2105/SMWW.2882?GCLID=CJWKCAIA25V_BRBNEIWAZB4-ZRDKZ6CEQ6]; Bassin JP, 2012, ENVIRON SCI TECHNOL, V46, P1546, DOI 10.1021/es203356z; Bengtsson MM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-261; Butler MD, 2009, WATER RES, V43, P1265, DOI 10.1016/j.watres.2008.12.027; Cho BD, 2002, J MEMBRANE SCI, V209, P391, DOI 10.1016/S0376-7388(02)00321-6; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Han SS, 2005, PROCESS BIOCHEM, V40, P2393, DOI 10.1016/j.procbio.2004.09.017; HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2; He Z, 2009, ENVIRON SCI TECHNOL, V43, P3391, DOI 10.1021/es803492c; Hocaoglu SM, 2011, BIORESOURCE TECHNOL, V102, P6665, DOI 10.1016/j.biortech.2011.03.096; Huang ZH, 2010, WATER RES, V44, P4351, DOI 10.1016/j.watres.2010.05.037; Judd S, 2006, MBR BOOK; Keskes S, 2012, BIORESOURCE TECHNOL, V103, P28, DOI 10.1016/j.biortech.2011.09.063; Kindaichi T, 2004, APPL ENVIRON MICROB, V70, P1641, DOI 10.1128/AEM.70.3.1641-1650.2004; Kragelund C, 2007, FEMS MICROBIOL ECOL, V59, P671, DOI 10.1111/j.1574-6941.2006.00251.x; Lee LY, 2004, BIORESOURCE TECHNOL, V95, P209, DOI 10.1016/j.biortech.2003.05.004; Li F, 2006, WATER SA, V32, P199; Lu L, 2012, WATER RES, V46, P2425, DOI 10.1016/j.watres.2012.02.005; Ma JX, 2013, CHEM ENG J, V219, P190, DOI 10.1016/j.cej.2012.12.085; Ma JX, 2013, WATER RES, V47, P859, DOI 10.1016/j.watres.2012.11.013; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Nogueira R, 2002, WATER RES, V36, P469, DOI 10.1016/S0043-1354(01)00229-9; Ohashi A, 1995, WATER SCI TECHNOL, V32, P75, DOI 10.1016/0273-1223(96)00010-8; Racz L, 2010, BIORESOURCE TECHNOL, V101, P6454, DOI 10.1016/j.biortech.2010.03.058; Ramdani A, 2010, WATER RES, V44, P2179, DOI 10.1016/j.watres.2009.12.037; VERHAGEN FJM, 1991, APPL ENVIRON MICROB, V57, P3255, DOI 10.1128/AEM.57.11.3255-3263.1991; Virdis B, 2008, WATER RES, V42, P3013, DOI 10.1016/j.watres.2008.03.017; Wang P, 2011, J MEMBRANE SCI, V382, P60, DOI 10.1016/j.memsci.2011.07.044; Wang QY, 2011, CHEM ENG J, V172, P929, DOI 10.1016/j.cej.2011.07.004; Wang ZW, 2009, CHEM ENG J, V150, P396, DOI 10.1016/j.cej.2009.01.018; Ye L, 2011, WATER RES, V45, P4390, DOI 10.1016/j.watres.2011.05.028; Yuan Z, 2003, FOCUS BIOTECHNOL, V3C, P187	33	17	20	0	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63059	10.1371/journal.pone.0063059	http://dx.doi.org/10.1371/journal.pone.0063059			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667573	Green Published, gold, Green Submitted			2022-12-25	WOS:000319654700105
J	Neto, JM; Gordinho, L; Belda, EJ; Marin, M; Monros, JS; Fearon, P; Crates, R				Neto, Julio M.; Gordinho, Luis; Belda, Eduardo J.; Marin, Marcial; Monros, Juan S.; Fearon, Peter; Crates, Ross			Phenotypic Divergence among West European Populations of Reed Bunting Emberiza schoeniclus: The Effects of Migratory and Foraging Behaviours	PLOS ONE			English	Article							BILL SIZE; SEXUAL-DIMORPHISM; WING-LENGTH; BODY-SIZE; MORPHOLOGY; SPECIATION; EVOLUTION; TRAITS; SHAPE; PASSERINES	Divergent selection and local adaptation are responsible for many phenotypic differences between populations, potentially leading to speciation through the evolution of reproductive barriers. Here we evaluated the morphometric divergence among west European populations of Reed Bunting in order to determine the extent of local adaptation relative to two important selection pressures often associated with speciation in birds: migration and diet. We show that, as expected by theory, migratory E. s. schoeniclus had longer and more pointed wings and a slightly smaller body mass than the resident subspecies, with the exception of E. s. lusitanica, which despite having rounder wings was the smallest of all subspecies. Tail length, however, did not vary according to the expectation (shorter tails in migrants) probably because it is strongly correlated with wing length and might take longer to evolve. E. s. witherbyi, which feed on insects hiding inside reed stems during the winter, had a very thick, stubby bill. In contrast, northern populations, which feed on seeds, had thinner bills. Despite being much smaller, the southern E. s. lusitanica had a significantly thicker, longer bill than migratory E. s. schoeniclus, whereas birds from the UK population had significantly shorter, thinner bills. Geometric morphometric analyses revealed that the southern subspecies have a more convex culmen than E. s. schoeniclus, and E. s. lusitanica differs from the nominate subspecies in bill shape to a greater extent than in linear bill measurements, especially in males. Birds with a more convex culmen are thought to exert a greater strength at the bill tip, which is in agreement with their feeding technique. Overall, the three subspecies occurring in Western Europe differ in a variety of traits following the patterns predicted from their migratory and foraging behaviours, strongly suggesting that these birds have became locally adapted through natural selection.	[Neto, Julio M.; Gordinho, Luis] Lund Univ, Dept Biol, MEMEG, Mol Ecol & Evolut Lab, Lund, Sweden; [Neto, Julio M.; Gordinho, Luis] Univ Porto, CIBIO UP Ctr Invest Biodiversidade & Recursos Gen, Vairao, Portugal; [Belda, Eduardo J.; Marin, Marcial] Univ Politecn Valencia, Inst Invest Gest Integrada Zonas Costeras, E-46071 Valencia, Spain; [Monros, Juan S.] Univ Valencia, Inst Cavanilles Biodivers & Evolutionary Biol, Paterna, Spain; [Fearon, Peter] Bootle, Liverpool, Merseyside, England; [Crates, Ross] Univ Oxford, Dept Zool, Edward Grey Inst, Oxford OX1 3PS, England	Lund University; Universidade do Porto; Universitat Politecnica de Valencia; University of Valencia; University of Oxford	Neto, JM (corresponding author), Lund Univ, Dept Biol, MEMEG, Mol Ecol & Evolut Lab, Lund, Sweden.	julio.m.neto@gmail.com	Neto, Júlio Manuel/D-1853-2009; Monros, Juan/AAA-3726-2020; Belda, Eduardo/A-6684-2013; de Oliveira Gordinho, Luís/C-9164-2009; Monros, Juan S/L-9750-2014; Crates, Ross/AAG-2161-2021	Neto, Júlio Manuel/0000-0002-4855-3988; Monros, Juan/0000-0002-0952-2089; Belda, Eduardo/0000-0003-1995-1271; de Oliveira Gordinho, Luís/0000-0003-0413-6346; Monros, Juan S/0000-0002-0952-2089; 	ICETA, University of Porto; Portuguese Foundation for Science and Technology [SFRH/BD/64645/2009, SFRH/BPD/40667/2007]; Ministerio de Ciencia e Innovacion (Spain) [CGL2005-02041/BOS, CGL2010-21933-C02-02]	ICETA, University of Porto; Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Some fieldwork in Portugal was supported financially by ICETA, University of Porto. LG and JMN were supported financially by the Portuguese Foundation for Science and Technology through grants SFRH/BD/64645/2009 and SFRH/BPD/40667/2007, respectively. JSM and EJB were funded by the projects CGL2005-02041/BOS and CGL2010-21933-C02-02 granted by Ministerio de Ciencia e Innovacion (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atienza JC, 2006, ESCRIBANO PALUSTRE E; Baldwin MW, 2010, J EVOLUTION BIOL, V23, P1050, DOI 10.1111/j.1420-9101.2010.01975.x; Ballentine B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010229; Bearhop S, 2005, SCIENCE, V310, P502, DOI 10.1126/science.1115661; Belda EJ, 2009, ARDEOLA, V56, P85; Benkman CW, 2003, EVOLUTION, V57, P1176; Bensch S, 2009, MOL ECOL, V18, P3087, DOI 10.1111/j.1365-294X.2009.04210.x; Berns CM, 2010, AUK, V127, P626, DOI 10.1525/auk.2010.09213; Byers C, 1995, SPARROWS BUNTINGS GU; Clements J.F., 2011, CLEMENTS CHECKLIST B; Cooper IA, 2011, EVOLUTION, V65, P2553, DOI 10.1111/j.1558-5646.2011.01332.x; Copete JL, 1999, BIRD STUDY, V46, P100, DOI 10.1080/00063659909461119; Cramp S., 1994, HDB BIRDS EUROPE MID, V9; De La Puente Javier, 2001, Ringing and Migration, V20, P221; del Hoyo J., 2011, HDB BIRDS WORLD; Forschler MI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018732; Foster DJ, 2008, J EVOLUTION BIOL, V21, P263, DOI 10.1111/j.1420-9101.2007.01449.x; Funk DJ, 2006, P NATL ACAD SCI USA, V103, P3209, DOI 10.1073/pnas.0508653103; Gosler AG, 1998, BIRD STUDY, V45, P92, DOI 10.1080/00063659809461082; Grant PR, 2002, SCIENCE, V296, P707, DOI 10.1126/science.1070315; Grapputo A, 1998, MOL ECOL, V7, P1173, DOI 10.1046/j.1365-294x.1998.00441.x; Greenberg R, 2012, EVOLUTION, V66, P3825, DOI 10.1111/j.1558-5646.2012.01726.x; Greenberg R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040933; Greenberg R, 2012, ECOGRAPHY, V35, P146, DOI 10.1111/j.1600-0587.2011.07002.x; Greenberg R, 2010, ECOLOGY, V91, P2428, DOI 10.1890/09-1136.1; Hedenstrom A, 2008, PHILOS T R SOC B, V363, P287, DOI 10.1098/rstb.2007.2140; IBM Corp, 2011, IBM SPSS STAT WIND V; Irwin Darren E., 2005, P27; JENNI L, 1989, BIRD STUDY, V36, P1, DOI 10.1080/00063658909476996; KAISER A, 1993, J FIELD ORNITHOL, V64, P246; Kaliontzopoulou A, 2007, J MORPHOL, V268, P152, DOI 10.1002/jmor.10494; Keller LF, 2001, HEREDITY, V87, P325, DOI 10.1046/j.1365-2540.2001.00900.x; Klingenberg CP, 1996, NATO ADV SCI INST SE, V284, P23; Kozak GM, 2011, P ROY SOC B-BIOL SCI, V278, P2604, DOI 10.1098/rspb.2010.2466; Kvist L, 2011, J ORNITHOL, V152, P681, DOI 10.1007/s10336-011-0646-9; Lleonart J, 2000, J THEOR BIOL, V205, P85, DOI 10.1006/jtbi.2000.2043; Marcus LF, 1996, NATO ASI SERIES A; Matessi G, 2000, J AVIAN BIOL, V31, P96, DOI 10.1034/j.1600-048X.2000.310113.x; Matessi G, 2002, BIOL J LINN SOC, V75, P21, DOI 10.1046/j.1095-8312.2002.00003.x; Mila B, 2008, CONDOR, V110, P335, DOI 10.1525/cond.2008.8396; Navarro J, 2009, ZOOLOGY, V112, P128, DOI 10.1016/j.zool.2008.05.001; Orlowski G, 2007, AGR ECOSYST ENVIRON, V118, P244, DOI 10.1016/j.agee.2006.05.026; Orlowski G, 2013, BIOL J LINN SOC, V108, P429, DOI 10.1111/j.1095-8312.2012.02026.x; Perez-Tris J, 2003, BIRD STUDY, V50, P146, DOI 10.1080/00063650309461306; Podos J, 2001, NATURE, V409, P185, DOI 10.1038/35051570; Prys-Jones R.P., 1984, Gerfaut, V74, P15; Rohlf F. J., 2010, MORPHOMETRICS SUNY S; Rohlf F. J., 2003, TPSSMALL VERSION 1 2; ROHLF F. J., 2010, TPSDIG SUNY STONY BR; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J; Rohlf FJ, 1999, J CLASSIF, V16, P197, DOI 10.1007/s003579900054; Rohlf FJ, 2010, TPS UTILITY PROGRAM; Rohlf FJ, 2010, TPSDIG VERSION 2 16; Rohwer S, 2011, AUK, V128, P419, DOI 10.1525/auk.2011.10176; Ruegg KC, 2002, P ROY SOC B-BIOL SCI, V269, P1375, DOI 10.1098/rspb.2002.2032; Ryan PG, 2007, SCIENCE, V315, P1420, DOI 10.1126/science.1138829; Servedio MR, 2011, TRENDS ECOL EVOL, V26, P389, DOI 10.1016/j.tree.2011.04.005; Shaw KL, 2011, GENETICA, V139, P649, DOI 10.1007/s10709-011-9562-4; STEINBACHER F., 1930, JOUR ORNITHOLOGIE, V78, P471, DOI 10.1007/BF01953149; Svensson L., 1992, IDENTIFICATION GUIDE; Tarka M, 2012, THESIS LUND U SWEDEN; Tarka M, 2010, P ROY SOC B-BIOL SCI, V277, P2361, DOI 10.1098/rspb.2010.0033; van Doorn GS, 2009, SCIENCE, V326, P1704, DOI 10.1126/science.1181661; VAURIE CHARLES, 1956, AMER MUS NOVITATES, V1795, P1; VAURIE CHARLES, 1958, AMER MUS NOVITATES, V1898., P1; Via S, 2009, P NATL ACAD SCI USA, V106, P9939, DOI 10.1073/pnas.0901397106; Wernham C., 2002, MIGRATION ATLAS MOVE; Whitlock MC, 2008, MOL ECOL, V17, P1885, DOI 10.1111/j.1365-294X.2008.03712.x; Winker Kevin, 2010, Ornithological Monographs, V67, P6; Zelditch M.L., 2004, GEOMETRIC MORPHOMETR, DOI DOI 10.1016/B978-0-12-778460-1.X5000-5; Zink RM, 2008, J ORNITHOL, V149, P399, DOI 10.1007/s10336-008-0276-z	72	17	20	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63248	10.1371/journal.pone.0063248	http://dx.doi.org/10.1371/journal.pone.0063248			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667594	Green Submitted, Green Published, gold			2022-12-25	WOS:000319654700124
J	Sheng, YW; Durazo, A; Schumacher, M; Gralla, EB; Cascio, D; Cabelli, DE; Valentine, JS				Sheng, Yuewei; Durazo, Armando; Schumacher, Mikhail; Gralla, Edith Butler; Cascio, Duilio; Cabelli, Diane E.; Valentine, Joan Selverstone			Tetramerization Reinforces the Dimer Interface of MnSOD	PLOS ONE			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; MALATE-DEHYDROGENASE; CRYSTAL-STRUCTURES; CANDIDA-ALBICANS; PROTEIN; STABILITY; YEAST; CRYSTALLIZATION	Two yeast manganese superoxide dismutases (MnSOD), one from Saccharomyces cerevisiae mitochondria (ScMnSOD) and the other from Candida albicans cytosol (CaMnSODc), have most biochemical and biophysical properties in common, yet ScMnSOD is a tetramer and CaMnSODc is a dimer or "loose tetramer'' in solution. Although CaMnSODc was found to crystallize as a tetramer, there is no indication from the solution properties that the functionality of CaMnSODc in vivo depends upon the formation of the tetrameric structure. To elucidate further the functional significance of MnSOD quaternary structure, wild-type and mutant forms of ScMnSOD (K182R, A183P mutant) and CaMnSODc (K184R, L185P mutant) with the substitutions at dimer interfaces were analyzed with respect to their oligomeric states and resistance to pH, heat, and denaturant. Dimeric CaMnSODc was found to be significantly more subject to thermal or denaturant-induced unfolding than tetrameric ScMnSOD. The residue substitutions at dimer interfaces caused dimeric CaMnSODc but not tetrameric ScMnSOD to dissociate into monomers. We conclude that the tetrameric assembly strongly reinforces the dimer interface, which is critical for MnSOD activity.	[Sheng, Yuewei; Durazo, Armando; Schumacher, Mikhail; Gralla, Edith Butler; Valentine, Joan Selverstone] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA; [Cascio, Duilio] Univ Calif Los Angeles, Dept Energy, Inst Genom & Prote, Los Angeles, CA USA; [Durazo, Armando] Univ Arizona, Dept Chem & Environm Engn, Tucson, AZ USA; [Cabelli, Diane E.] Brookhaven Natl Lab, Dept Chem, Upton, NY 11973 USA; [Valentine, Joan Selverstone] Ewha Womans Univ, Dept Bioinspired Sci, Seoul, South Korea	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Arizona; United States Department of Energy (DOE); Brookhaven National Laboratory; Ewha Womans University	Cabelli, DE (corresponding author), Brookhaven Natl Lab, Dept Chem, Upton, NY 11973 USA.	cabelli@bnl.gov; jsv@chem.ucla.edu	Valentine, Joan S/B-6665-2008	Valentine, Joan S/0000-0002-7174-925X	United States Department of Energy; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences;  [DK46828];  [DE-AC02-98CH10886]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046828] Funding Source: NIH RePORTER	United States Department of Energy(United States Department of Energy (DOE)); Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences(United States Department of Energy (DOE)); ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grant DK46828 to J.S.V. Radiolysis studies were carried out at Center for Radiation Chemistry Research at BNL, which is funded under contract DE-AC02-98CH10886 with the United States Department of Energy and supported by its Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu IA, 2008, BIOCHEMISTRY-US, V47, P2350, DOI 10.1021/bi7016206; Abreu IA, 2010, BBA-PROTEINS PROTEOM, V1804, P263, DOI 10.1016/j.bbapap.2009.11.005; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ali MH, 2005, BIOORGAN MED CHEM, V13, P5013, DOI 10.1016/j.bmc.2005.05.037; Andre I, 2008, P NATL ACAD SCI USA, V105, P16148, DOI 10.1073/pnas.0807576105; Arroyo-Reyna A, 2004, ANAL BIOCHEM, V328, P123, DOI 10.1016/j.ab.2004.02.021; Barnese K, 2010, J AM CHEM SOC, V132, P12525, DOI 10.1021/ja104179r; Bjork A, 2004, J MOL BIOL, V341, P1215, DOI 10.1016/j.jmb.2004.06.079; Bjork A, 2003, FEBS LETT, V553, P423, DOI 10.1016/S0014-5793(03)01076-7; Borders CL, 1998, BIOCHEMISTRY-US, V37, P11323, DOI 10.1021/bi980167t; BORGSTAHL GEO, 1992, CELL, V71, P107, DOI 10.1016/0092-8674(92)90270-M; Borgstahl GEO, 1996, BIOCHEMISTRY-US, V35, P4287, DOI 10.1021/bi951892w; Edwards RA, 1998, J BIOL INORG CHEM, V3, P161, DOI 10.1007/s007750050217; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fluckiger S, 2002, J IMMUNOL, V168, P1267, DOI 10.4049/jimmunol.168.3.1267; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; Greenleaf WB, 2004, BIOCHEMISTRY-US, V43, P7038, DOI 10.1021/bi049888k; Hearn AS, 2004, J BIOL CHEM, V279, P5861, DOI 10.1074/jbc.M311310200; Hernandez-Saavedra D, 2010, FREE RADICAL BIO MED, V48, P1202, DOI 10.1016/j.freeradbiomed.2010.02.001; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hsieh JY, 2009, J BIOL CHEM, V284, P18096, DOI 10.1074/jbc.M109.005082; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lamarre C, 2001, J BIOL CHEM, V276, P43784, DOI 10.1074/jbc.M108095200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller AF, 2012, FEBS LETT, V586, P585, DOI 10.1016/j.febslet.2011.10.048; Mizuno K, 2004, J BIOL CHEM, V279, P27339, DOI 10.1074/jbc.M400813200; Muren EM, 1999, J BIOL CHEM, V274, P19397, DOI 10.1074/jbc.274.27.19397; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Potter SZ, 2007, J AM CHEM SOC, V129, P4575, DOI 10.1021/ja066690+; Rao NA, 2003, BBA-PROTEINS PROTEOM, V1647, P24, DOI 10.1016/S1570-9639(03)00043-8; RAVINDRANATH SD, 1975, J BIOL CHEM, V250, P6107; Schwarz H., BNL PULSE RADIOLYSIS; Sheng YW, 2012, P NATL ACAD SCI USA, V109, P14314, DOI 10.1073/pnas.1212367109; Sheng YW, 2011, J AM CHEM SOC, V133, P20878, DOI 10.1021/ja2077476; Shishova EY, 2007, BIOCHEMISTRY-US, V46, P1941, DOI 10.1021/bi0622524; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Trinh CH, 2008, ACTA CRYSTALLOGR F, V64, P1110, DOI 10.1107/S1744309108037056; Vance CK, 2001, BIOCHEMISTRY-US, V40, P13079, DOI 10.1021/bi0113317; WAGNER UG, 1993, PROTEIN SCI, V2, P814, DOI 10.1002/pro.5560020511; Walter TS, 2006, STRUCTURE, V14, P1617, DOI 10.1016/j.str.2006.09.005; Whittaker MM, 2011, ARCH BIOCHEM BIOPHYS, V505, P213, DOI 10.1016/j.abb.2010.10.021; Whittaker MM, 1997, BIOCHEMISTRY-US, V36, P8923, DOI 10.1021/bi9704212; Wichmann C, 2010, BLOOD, V116, P603, DOI 10.1182/blood-2009-10-248047; Zheng J, 2007, BIOCHEMISTRY-US, V46, P14830, DOI 10.1021/bi7014103	45	11	11	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62446	10.1371/journal.pone.0062446	http://dx.doi.org/10.1371/journal.pone.0062446			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667478	gold, Green Published, Green Submitted			2022-12-25	WOS:000319654700037
J	Shimmura-Tomita, M; Wang, MC; Taniguchi, H; Akiba, H; Yagita, H; Hori, J				Shimmura-Tomita, Machiko; Wang, Mingcong; Taniguchi, Hiroko; Akiba, Hisaya; Yagita, Hideo; Hori, Junko			Galectin-9-Mediated Protection from Allo-Specific T Cells as a Mechanism of Immune Privilege of Corneal Allografts	PLOS ONE			English	Article							ALLOIMMUNE RESPONSES; ANTERIOR-CHAMBER; GRAFT FAILURE; AQUEOUS-HUMOR; FAS LIGAND; TIM-3; INDUCTION; APOPTOSIS; ANTIGENS; MICE	The eye is an immune-privileged organ, and corneal transplantation is therefore one of the most successful organ transplantation. The immunosuppressive intraocular microenvironment is known as one of the mechanisms underlying immune privilege in the eye. T-cell immunoglobulin and mucin domain (Tim)-3 is a regulatory molecule for T-cell function, and galectin (Gal)-9 is a Tim-3 ligand. We investigated the role of this pathway in establishing the immune-privileged status of corneal allografts in mice. Gal-9 is constitutively expressed on the corneal epithelium, endothelium and iris-ciliary body in normal mouse eyes and eyes bearing surviving allografts, and Tim-3 was expressed on CD8 T cells infiltrating the allografts. Allograft survival in recipients treated with anti-Tim-3 monoclonal antibody (mAb) or anti-Gal-9 mAb was significantly shorter than that in control recipients. In vitro, destruction of corneal endothelial cells by allo-reactive T cells was enhanced when the cornea was pretreated with anti-Gal-9 mAb. Blockade of Tim-3 or Gal-9 did not abolish anterior chamber-associated immune deviation. We propose that constitutive expression of Gal-9 plays an immunosuppressive role in corneal allografts. Gal-9 expressed on corneal endothelial cells protects them from destruction by allo-reactive T cells within the cornea.	[Shimmura-Tomita, Machiko; Wang, Mingcong; Taniguchi, Hiroko; Hori, Junko] Nippon Med Sch, Dept Ophthalmol, Tokyo 113, Japan; [Shimmura-Tomita, Machiko] Jichi Med Univ, Saitama Med Ctr, Dept Ophthalmol, Saitama, Japan; [Shimmura-Tomita, Machiko] Ichikawa Gen Hosp, Tokyo Dent Coll, Dept Ophthalmol, Ichikawa, Chiba, Japan; [Akiba, Hisaya; Yagita, Hideo] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 113, Japan	Nippon Medical School; Jichi Medical University; Tokyo Dental College; Juntendo University	Shimmura-Tomita, M (corresponding author), Nippon Med Sch, Dept Ophthalmol, 1-1-5 Sendagi, Tokyo 113, Japan.	machiko@jichi.ac.jp	Hori, Junko/AAB-9857-2019	Hori, Junko/0000-0002-4248-5742; TANIGUCHI, HIROKO/0000-0002-1473-6276	Japan society for the promotion of science [23592619]; Grants-in-Aid for Scientific Research [25461503] Funding Source: KAKEN	Japan society for the promotion of science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work had supported by Grant-in-Aid for Scientific Research (KAKENHI) from the Japan society for the promotion of science. The grant number is 23592619 and the URL is http://www.jsps.go.jp/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AC, 2007, SCIENCE, V318, P1141, DOI 10.1126/science.1148536; Apte RS, 1998, J IMMUNOL, V160, P5693; BARKER CF, 1977, ADV IMMUNOL, V25, P1; BOISJOLY HM, 1993, OPHTHALMOLOGY, V100, P1728; Fukushima A, 2008, INT ARCH ALLERGY IMM, V146, P36, DOI 10.1159/000112501; Geng H, 2006, J IMMUNOL, V176, P1411, DOI 10.4049/jimmunol.176.3.1411; GRIFFITH TS, 1995, SCIENCE, V270, P1189, DOI 10.1126/science.270.5239.1189; Gupta S, 2012, J CLIN INVEST; Gupta S, 2012, J CLIN INVEST, V122, P2395, DOI 10.1172/JCI45138; Hamrah P, 2002, INVEST OPHTH VIS SCI, V43, P639; Hirashima M, 2002, GLYCOCONJUGATE J, V19, P593, DOI 10.1023/B:GLYC.0000014090.63206.2f; Hirofumi A, 2002, J IMMUNOL, V169, P5912, DOI 10.4049/jimmunol.169.10.5912; Hori J, 2000, INVEST OPHTH VIS SCI, V41, P3032; Hori J, 2003, STEM CELLS, V21, P405, DOI 10.1634/stemcells.21-4-405; Hori J, 2001, INVEST OPHTH VIS SCI, V42, P1820; Hori J, 2000, INVEST OPHTH VIS SCI, V41, P443; Hori J, 2006, J IMMUNOL, V177, P5928, DOI 10.4049/jimmunol.177.9.5928; Hori J, 2010, INVEST OPHTH VIS SCI, V51, P6556, DOI 10.1167/iovs.09-4959; Kaiser C J, 1989, Reg Immunol, V2, P42; KAPLAN HJ, 1977, J IMMUNOL, V118, P809; KENNEDY MC, 1995, J CLIN INVEST, V95, P82, DOI 10.1172/JCI117679; MEDAWAR PB, 1948, BRIT J EXP PATHOL, V29, P58; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Namba K, 2002, J LEUKOCYTE BIOL, V72, P946; Niederkorn J Y, 1990, Adv Immunol, V48, P191, DOI 10.1016/S0065-2776(08)60755-5; Oikawa T, 2006, J IMMUNOL, V177, P4281, DOI 10.4049/jimmunol.177.7.4281; Rodriguez-Manzanet R, 2009, IMMUNOL REV, V229, P259, DOI 10.1111/j.1600-065X.2009.00772.x; Sabatos CA, 2003, NAT IMMUNOL, V4, P1102, DOI 10.1038/ni988; Sanchez-Fueyo A, 2003, NAT IMMUNOL, V4, P1093, DOI 10.1038/ni987; Sehrawat S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000882; Sehrawat S, 2009, J IMMUNOL, V182, P3191, DOI 10.4049/jimmunol.0803673; Seki M, 2008, CLIN IMMUNOL, V127, P78, DOI 10.1016/j.clim.2008.01.006; Seki M, 2007, ARTHRITIS RHEUM-US, V56, P3968, DOI 10.1002/art.23076; Sheibani N, 2000, BIOCHEM BIOPH RES CO, V267, P257, DOI 10.1006/bbrc.1999.1903; Sohn JH, 2000, INVEST OPHTH VIS SCI, V41, P4195; SONODA Y, 1993, J IMMUNOL, V150, P1727; SONODA Y, 1992, TRANSPLANTATION, V54, P694, DOI 10.1097/00007890-199210000-00026; Sosnova M, 2005, STEM CELLS, V23, P507, DOI 10.1634/stemcells.2004-0291; STREILEIN JW, 1979, NATURE, V282, P326, DOI 10.1038/282326a0; STREILEIN JW, 1987, FASEB J, V1, P199, DOI 10.1096/fasebj.1.3.2957263; Stuart PM, 1997, J CLIN INVEST, V99, P396, DOI 10.1172/JCI119173; Sugita S, 2000, BRIT J OPHTHALMOL, V84, P1130, DOI 10.1136/bjo.84.10.1130; Taylor AW, 1998, INVEST OPHTH VIS SCI, V39, P1372; TRESELER PA, 1986, TRANSPLANTATION, V41, P248, DOI 10.1097/00007890-198602000-00022; Ueno T, 2008, J CLIN INVEST, V118, P742, DOI 10.1172/JCI32451; Vaitaitis GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038708; WANG HM, 1987, INVEST OPHTH VIS SCI, V28, P1383; WHITSETT CF, 1984, INVEST OPHTH VIS SCI, V25, P519; WILBANKS GA, 1992, EUR J IMMUNOL, V22, P165, DOI 10.1002/eji.1830220125; WILLIAMS KA, 1992, OPHTHALMOLOGY, V99, P403; WILLIAMS KA, 1985, INVEST OPHTH VIS SCI, V26, P23; WILSON SE, 1990, SURV OPHTHALMOL, V34, P325, DOI 10.1016/0039-6257(90)90110-H; Xiao S, 2007, J EXP MED, V204, P1691, DOI 10.1084/jem.20062498; Zhou Q, 2011, BLOOD, V117, P4501, DOI 10.1182/blood-2010-10-310425; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	55	26	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63620	10.1371/journal.pone.0063620	http://dx.doi.org/10.1371/journal.pone.0063620			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667648	Green Published, gold			2022-12-25	WOS:000319654700169
J	Wu, Q; Wang, HY; Li, J; Zhou, P; Wang, QL; Zhao, L; Fan, R; Wang, YM; Xu, XZ; Yi, DH; Yu, SQ; Pei, JM				Wu, Qi; Wang, Hai-Yan; Li, Juan; Zhou, Peng; Wang, Qiu-Lin; Zhao, Lei; Fan, Rong; Wang, Yue-Min; Xu, Xue-Zeng; Yi, Ding-Hua; Yu, Shi-Qiang; Pei, Jian-Ming			kappa-Opioid Receptor Stimulation Improves Endothelial Function in Hypoxic Pulmonary Hypertension	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; REACTIVE OXYGEN; NADPH OXIDASE; EXPRESSION; ARTERY; RATS; PEROXYNITRITE; CAVEOLIN-1; CHEMISTRY; U50,488H	The present study was designed to investigate the effect of kappa-opioid receptor stimulation with U50,488H on endothelial function and underlying mechanism in rats with hypoxic pulmonary hypertension (HPH). Chronic hypoxia-induced HPH was simulated by exposing the rats to 10% oxygen for 2 wk. After hypoxia, mean pulmonary arterial pressure (mPAP), right ventricular pressure (RVP) and right ventricular hypertrophy index (RVHI) were measured. Relaxation of pulmonary artery in response to acetylcholine (ACh) was determined. Expression and activity of endothelial nitric oxide (NO) synthase (eNOS) and inducible NO synthase (iNOS) with NO production, total antioxidant capacity (T-AOC), gp91(phox) expression and nitrotyrosine content were measured. The effect of U50,488H administration during chronic hypoxia was investigated. Administration of U50,488H significantly decreased mPAP and right ventricular hypertrophy as evidenced by reduction in RVP and RVHI. These effects were mediated by kappa-opioid receptor. In the meantime, treatment with U50,488H significantly improved endothelial function as evidenced by enhanced relaxation in response to ACh. Moreover, U50,488H resulted in a significant increase in eNOS phosphorylation, NO content in serum, and T-AOC in pulmonary artery of HPH rats. In addition, the activity of eNOS was enhanced, but the activity of iNOS was attenuated in the pulmonary artery of chronic hypoxic rats treated with U50,488H. On the other hand, U50,488H markedly blunted HPH-induced elevation of gp91(phox) expression and nitrotyrosine content in pulmonary artery, and these effects were blocked by nor-BNI, a selective kappa-opioid receptor antagonist. These data suggest that kappa-opioid receptor stimulation with U50,488H improves endothelial function in rats with HPH. The mechanism of action might be attributed to the preservation of eNOS activity, enhancement of eNOS phosphorylation, downregulation of iNOS activity and its antioxidative/nitrative effect.	[Wu, Qi; Zhou, Peng; Wang, Qiu-Lin] Chengdu Med Coll, Dept Cardiol, Chengdu, Peoples R China; [Wang, Hai-Yan] Fourth Mil Med Univ, Tangdu Hosp, Dept Cardiol, Xian 710032, Peoples R China; [Li, Juan; Zhao, Lei; Fan, Rong; Wang, Yue-Min; Pei, Jian-Ming] Fourth Mil Med Univ, Natl Key Discipline Cell Biol, Dept Physiol, Xian 710032, Peoples R China; [Xu, Xue-Zeng; Yi, Ding-Hua; Yu, Shi-Qiang] Fourth Mil Med Univ, Dept Cardiosurg, Xijing Hosp, Xian 710032, Peoples R China	Chengdu Medical College; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Yu, SQ (corresponding author), Fourth Mil Med Univ, Dept Cardiosurg, Xijing Hosp, Xian 710032, Peoples R China.	yushiqiang2009@hotmail.com; jmpei8@fmmu.edu.cn	Zhao, Lei/AAF-3066-2020	Zhao, Lei/0000-0003-1263-1742; Yu, Shiqiang/0000-0003-3519-0943	National Natural Science Foundation of China [30900535, 30971060, 81270402, 30900525]; Shaanxi Province of China [2010K01-195, 2011JM4001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shaanxi Province of China	This work was supported by research grants from the National Natural Science Foundation of China (No.30900535, 30971060, 81270402, 30900525) and grants from Shaanxi Province of China (NOs.2010K01-195, 2011JM4001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal D, 2009, HYPERTENSION, V54, P1393, DOI 10.1161/HYPERTENSIONAHA.109.135459; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; BECKMAN JS, 1994, METHOD ENZYMOL, V233, P229; Farber HW, 2004, NEW ENGL J MED, V351, P1655, DOI 10.1056/NEJMra035488; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gallantine EL, 2008, BASIC CLIN PHARMACOL, V103, P419, DOI 10.1111/j.1742-7843.2008.00306.x; Gallis B, 1999, J BIOL CHEM, V274, P30101, DOI 10.1074/jbc.274.42.30101; GIAID A, 1995, NEW ENGL J MED, V333, P214, DOI 10.1056/NEJM199507273330403; Govers R, 2001, AM J PHYSIOL-RENAL, V280, pF193, DOI 10.1152/ajprenal.2001.280.2.F193; Gratton JP, 2000, J BIOL CHEM, V275, P22268, DOI 10.1074/jbc.M001644200; Hampl V, 2000, PHYSIOL REV, V80, P1337, DOI 10.1152/physrev.2000.80.4.1337; HECKER M, 1991, FEBS LETT, V294, P221, DOI 10.1016/0014-5793(91)81434-A; HIRATA K, 1995, HYPERTENSION, V25, P180, DOI 10.1161/01.HYP.25.2.180; JANSSENS SP, 1992, J BIOL CHEM, V267, P14519; Ji LL, 2010, AM J PHYSIOL-ENDOC M, V298, pE871, DOI 10.1152/ajpendo.00623.2009; Ju H, 1997, J BIOL CHEM, V272, P18522, DOI 10.1074/jbc.272.30.18522; Komai H, 2001, CARDIOVASC PATHOL, V10, P29, DOI 10.1016/S1054-8807(00)00063-6; Lee JH, 2003, J BIOL CHEM, V278, P51360, DOI 10.1074/jbc.M302332200; Li R, 2007, AM J PHYSIOL-ENDOC M, V293, pE1703, DOI 10.1152/ajpendo.00462.2007; Liu JQ, 2005, CHEST, V128, p594S, DOI 10.1378/chest.128.6_suppl.594S; Liu JQ, 2003, AM J PHYSIOL-LUNG C, V285, pL322, DOI 10.1152/ajplung.00337.2002; Mason NA, 1998, J PATHOL, V185, P313, DOI 10.1002/(SICI)1096-9896(199807)185:3<313::AID-PATH93>3.0.CO;2-8; MCQUILLAN LP, 1994, AM J PHYSIOL-HEART C, V267, pH1921; Michelakis ED, 2002, CIRCULATION, V105, P244, DOI 10.1161/hc0202.101974; Mikkelsen RB, 2003, ONCOGENE, V22, P5734, DOI 10.1038/sj.onc.1206663; MONCADA S, 1988, HYPERTENSION, V12, P365, DOI 10.1161/01.HYP.12.4.365; Murata T, 2002, J BIOL CHEM, V277, P44085, DOI 10.1074/jbc.M205934200; Nisbet RE, 2009, AM J RESP CELL MOL, V40, P601, DOI 10.1165/2008-0145OC; Osorio H, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/542042; Ostergaard L, 2007, AM J PHYSIOL-HEART C, V293, pH2894, DOI 10.1152/ajpheart.01230.2006; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Patel HH, 2006, AM J PHYSIOL-HEART C, V291, pH344, DOI 10.1152/ajpheart.01100.2005; Pei JM, 2006, J CARDIOVASC PHARM, V47, P594, DOI 10.1097/01.fjc.0000211737.55583.15; Peng P, 2009, ANAT REC, V292, P1062, DOI 10.1002/ar.20911; Rabinovitch M, 2001, J CLIN INVEST, V108, P1109; Rueckschloss U, 2003, ANTIOXID REDOX SIGN, V5, P171, DOI 10.1089/152308603764816532; SESSA WC, 1992, J BIOL CHEM, V267, P15274; Sharon D, 2003, J IMMUNOL, V171, P3225; Sun X, 2006, LIFE SCI, V78, P2516, DOI 10.1016/j.lfs.2005.10.042; Toyoshima H, 1998, J CARDIOVASC PHARM, V32, P543, DOI 10.1097/00005344-199810000-00006; Veyssier-Belot C, 1999, CARDIOVASC RES, V44, P274, DOI 10.1016/S0008-6363(99)00230-8; Voelkel NF, 2000, J CLIN INVEST, V106, P733, DOI 10.1172/JCI11144; Wang J, 1997, J CLIN INVEST, V100, P2347, DOI 10.1172/JCI119774; Weissmann N, 2001, AM J PHYSIOL-LUNG C, V280, pL638, DOI 10.1152/ajplung.2001.280.4.L638; Xu W, 2006, J PHARMACOL EXP THER, V317, P1295, DOI 10.1124/jpet.105.099507	45	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e60850	10.1371/journal.pone.0060850	http://dx.doi.org/10.1371/journal.pone.0060850			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667430	gold, Green Submitted, Green Published			2022-12-25	WOS:000319654700008
J	Andrade, BB; Kumar, NP; Mayer-Barber, KD; Barber, DL; Sridhar, R; Rekha, VVB; Jawahar, MS; Nutman, TB; Sher, A; Babu, S				Andrade, Bruno B.; Kumar, Nathella Pavan; Mayer-Barber, Katrin D.; Barber, Daniel L.; Sridhar, Rathinam; Rekha, Vaithilingam V. Banu; Jawahar, Mohideen S.; Nutman, Thomas B.; Sher, Alan; Babu, Subash			Plasma Heme Oxygenase-1 Levels Distinguish Latent or Successfully Treated Human Tuberculosis from Active Disease	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; CARBON-MONOXIDE; INFECTION; DIAGNOSIS; NEOPTERIN; PROMOTES	Background: Tuberculosis (TB) is associated with oxidative stress and the induction of host anti-oxidants to counteract this response. Heme oxygenase-1 (HO-1) is a critical promoter of cytoprotection in diverse disease models including mycobacterial infection. Nevertheless, the pattern of expression of HO-1 in human tuberculosis has not been studied. Here, we examine expression of HO-1 in M. tuberculosis-exposed and -infected individuals and test its ability to distinguish active from latent and successfully treated TB cases. In addition, we assess correlations between plasma levels of HO-1 and cytokines closely associated with the immunopathogenesis of TB. Methods: Cross-sectional and longitudinal analyses of levels of HO-1, acute phase proteins and pro-inflammatory cytokines were performed in plasma samples from individuals with active pulmonary, extra-pulmonary or latent TB infection and healthy controls as part of a prospective cohort study in South India. Results: Systemic levels of HO-1 were dramatically increased in individuals with active pulmonary and extra-pulmonary tuberculosis and particularly those with bilateral lung lesions and elevated bacillary loads in sputum. HO-1 levels effectively discriminated active from latent tuberculosis with higher predictive values than either C-reactive protein or serum amyloid protein. Moreover, there was a marked reduction in HO-1 levels in active TB cases following anti-tuberculous therapy but not in those who failed treatment. Pulmonary TB patients displaying the highest concentrations of HO-1 in plasma exhibited significantly elevated plasma levels of interleukin (IL)-10, interferon (IFN)-gamma and IL-17 and diminished levels of tumor necrosis factor (TNF)-alpha. Conclusion: These findings establish HO-1 levels as a potentially useful parameter for distinguishing active from latent or treated pulmonary tuberculosis, that is superior in this respect to the measurement of other acute inflammatory proteins.	[Andrade, Bruno B.; Mayer-Barber, Katrin D.; Barber, Daniel L.; Nutman, Thomas B.; Sher, Alan; Babu, Subash] NIH, Parasit Dis Lab, Bethesda, MD 20892 USA; [Kumar, Nathella Pavan; Babu, Subash] Int Ctr Excellence Res, Natl Inst Hlth, Madras, Tamil Nadu, India; [Sridhar, Rathinam] Govt Stanley Med Hosp, Madras, Tamil Nadu, India; [Rekha, Vaithilingam V. Banu; Jawahar, Mohideen S.] Natl Inst Res TB, Madras, Tamil Nadu, India; [Babu, Subash] NCI, Sci Applicat Int Corp, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	Andrade, BB (corresponding author), NIH, Parasit Dis Lab, Bethesda, MD 20892 USA.	bruno.andrade@nih.gov	Babu, Subash/GXG-4746-2022; Andrade, Bruno/J-9111-2012; Kumar, Nathella Pavan/AAU-2328-2021; Andrade, Bruno/AAI-2248-2020	Andrade, Bruno/0000-0001-6833-3811; 	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001065, T32AI007610, ZIAAI000843, ZIAAI000197] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzurri A, 2005, MICROBES INFECT, V7, P1, DOI 10.1016/j.micinf.2004.09.004; Cannas A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-333; CHAN CHS, 1995, EUR RESPIR J, V8, P70, DOI 10.1183/09031936.95.08010070; Davies PDO, 2008, INT J TUBERC LUNG D, V12, P1226; DEBEER FC, 1984, THORAX, V39, P196, DOI 10.1136/thx.39.3.196; Demir T, 2002, INT J TUBERC LUNG D, V6, P155; Deveci F, 2005, MEDIAT INFLAMM, P256, DOI 10.1155/MI.2005.256; Flynn JL, 1998, J IMMUNOL, V160, P1796; Frahm M, 2011, TUBERCULOSIS, V91, P250, DOI 10.1016/j.tube.2011.02.006; Gopi PG, 2003, INT J TUBERC LUNG D, V7, P1154; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Hosp M, 1997, LUNG, V175, P265, DOI 10.1007/PL00007573; Immanuel C, 2001, INT J TUBERC LUNG D, V5, P185; Kumar A, 2008, J BIOL CHEM, V283, P18032, DOI 10.1074/jbc.M802274200; Lagrange PH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043739; Lee TS, 2002, NAT MED, V8, P240, DOI 10.1038/nm0302-240; Luz NF, 2012, J IMMUNOL, V188, P4460, DOI 10.4049/jimmunol.1103072; Madebo T, 2003, AM J CLIN NUTR, V78, P117, DOI 10.1093/ajcn/78.1.117; Mazurek Gerald H., 2005, Morbidity and Mortality Weekly Report, V54, P49; Mendonca VRR, 2012, INFECT IMMUN, V80, P1445, DOI 10.1128/IAI.05933-11; Morse D, 2005, AM J RESP CRIT CARE, V172, P660, DOI 10.1164/rccm.200404-465SO; Pai M, 2007, CLIN INFECT DIS, V44, P74, DOI 10.1086/509927; Redford PS, 2011, MUCOSAL IMMUNOL, V4, P261, DOI 10.1038/mi.2011.7; Regev D, 2012, LAB INVEST, V92, P1541, DOI 10.1038/labinvest.2012.125; Saukkonen K, 2010, SHOCK, V34, P558, DOI 10.1097/SHK.0b013e3181e14de9; Shiloh MU, 2008, CELL HOST MICROBE, V3, P323, DOI 10.1016/j.chom.2008.03.007; Taylor Z, 2000, INT J TUBERC LUNG D, V4, P931; TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748; Verbon A, 1999, CLIN EXP IMMUNOL, V115, P110; Wallis RS, 2009, LANCET INFECT DIS, V9, P162, DOI 10.1016/S1473-3099(09)70042-8; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; WHO, 2012, WHO GLOB TUB REP 201	32	48	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e62618	10.1371/journal.pone.0062618	http://dx.doi.org/10.1371/journal.pone.0062618			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671613	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000321390200031
J	Corcoran, AJ; Wagner, RD; Conner, WE				Corcoran, Aaron J.; Wagner, Ryan D.; Conner, William E.			Optimal Predator Risk Assessment by the Sonar-Jamming Arctiine Moth Bertholdia trigona	PLOS ONE			English	Article							BIG BROWN BAT; FLIGHT-INITIATION DISTANCE; PERCEIVED ECHO AMPLITUDES; SKINK EUMECES LATICEPS; AUTOMATIC GAIN-CONTROL; DOGBANE TIGER MOTH; ECHOLOCATING BATS; EPTESICUS-FUSCUS; BEHAVIOR; THREAT	Nearly all animals face a tradeoff between seeking food and mates and avoiding predation. Optimal escape theory holds that an animal confronted with a predator should only flee when benefits of flight (increased survival) outweigh the costs (energetic costs, lost foraging time, etc.). We propose a model for prey risk assessment based on the predator's stage of attack. Risk level should increase rapidly from when the predator detects the prey to when it commits to the attack. We tested this hypothesis using a predator - the echolocating bat - whose active biosonar reveals its stage of attack. We used a prey defense - clicking used for sonar jamming by the tiger moth Bertholdia trigona-that can be readily studied in the field and laboratory and is enacted simultaneously with evasive flight. We predicted that prey employ defenses soon after being detected and targeted, and that prey defensive thresholds discriminate between legitimate predatory threats and false threats where a nearby prey is attacked. Laboratory and field experiments using playbacks of ultrasound signals and naturally behaving bats, respectively, confirmed our predictions. Moths clicked soon after bats detected and targeted them. Also, B. trigona clicking thresholds closely matched predicted optimal thresholds for discriminating legitimate and false predator threats for bats using search and approach phase echolocation - the period when bats are searching for and assessing prey. To our knowledge, this is the first quantitative study to correlate the sensory stimuli that trigger defensive behaviors with measurements of signals provided by predators during natural attacks in the field. We propose theoretical models for explaining prey risk assessment depending on the availability of cues that reveal a predator's stage of attack.	[Corcoran, Aaron J.; Wagner, Ryan D.; Conner, William E.] Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA	Wake Forest University	Corcoran, AJ (corresponding author), Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA.	corcaj8@wfu.edu			National Science Foundation [IOS-0615164, IOS-0951160]	National Science Foundation(National Science Foundation (NSF))	Funding was provided by National Science Foundation (www.nsf.gov) grant number IOS-0615164 and IOS-0951160 to W. E. C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Barber JR, 2006, J EXP BIOL, V209, P2637, DOI 10.1242/jeb.02295; Barber JR, 2007, P NATL ACAD SCI USA, V104, P9331, DOI 10.1073/pnas.0703627104; Barber JR, 2009, J EXP BIOL, V212, P2141, DOI 10.1242/jeb.029991; Bateman PW, 2011, J ZOOL, V285, P316, DOI 10.1111/j.1469-7998.2011.00846.x; Bazley E, 1976, AC74 NAT PHYS LAB AC; Blumstein DT, 2010, BEHAV ECOL, V21, P440, DOI 10.1093/beheco/arq030; Blumstein DT, 2005, J APPL ECOL, V42, P943, DOI 10.1111/j.1365-2664.2005.01071.x; Blumstein DT, 2003, J WILDLIFE MANAGE, V67, P852, DOI 10.2307/3802692; Boonman A, 2002, J EXP BIOL, V205, P2865; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Broom M, 2005, BEHAV ECOL, V16, P534, DOI 10.1093/beheco/ari024; Caro Tim, 2005, pXIII; Conner WE, 2012, ANNU REV ENTOMOL, V57, P21, DOI 10.1146/annurev-ento-121510-133537; Cooper WE, 1997, COPEIA, P613, DOI 10.2307/1447569; Cooper WE, 2005, CAN J ZOOL, V83, P1045, DOI 10.1139/Z05-104; Cooper WE, 1997, HERPETOLOGICA, V53, P464; Cooper WE, 1998, BEHAVIOUR, V135, P55; Cooper WE, 2007, J THEOR BIOL, V244, P59, DOI 10.1016/j.jtbi.2006.07.011; William EC, 2006, ETHOLOGY, V112, P858, DOI 10.1111/j.1439-0310.2006.01240.x; Cooper WE, 2012, BEHAV ECOL, V23, P790, DOI 10.1093/beheco/ars032; Cooper William E. Jr., 2009, Current Zoology, V55, P123; Corcoran A. J., 2007, THESIS HUMBOLDT STAT; Corcoran AJ, 2012, J EXP BIOL, V215, P4278, DOI 10.1242/jeb.076943; Corcoran AJ, 2011, J EXP BIOL, V214, P2416, DOI 10.1242/jeb.054783; Corcoran AJ, 2010, CURR ZOOL, V56, P358, DOI 10.1093/czoolo/56.3.358; Corcoran AJ, 2009, SCIENCE, V325, P325, DOI 10.1126/science.1174096; Elemans CPH, 2011, SCIENCE, V333, P1885, DOI 10.1126/science.1207309; Endler JA., 1986, PREDATORPREY RELATIO, P169; Fullard JH, 2007, J EXP BIOL, V210, P2481, DOI 10.1242/jeb.001909; Fullard JH, 2003, J EXP BIOL, V206, P281, DOI 10.1242/jeb.00085; FULLARD JH, 1984, J COMP PHYSIOL, V154, P249, DOI 10.1007/BF00604990; FULLARD JH, 1979, J COMP PHYSIOL, V129, P79, DOI 10.1007/BF00679914; FULLARD JH, 1994, J EXP BIOL, V194, P285; Ghose K, 2003, J ACOUST SOC AM, V114, P1120, DOI 10.1121/1.1589754; Goerlitz HR, 2010, CURR BIOL, V20, P1568, DOI 10.1016/j.cub.2010.07.046; Griffin D. R., 1960, Animal Behaviour, V8, P141, DOI 10.1016/0003-3472(60)90022-1; HARTLEY DJ, 1992, J ACOUST SOC AM, V91, P1120, DOI 10.1121/1.402639; HARTLEY DJ, 1992, J ACOUST SOC AM, V91, P1133, DOI 10.1121/1.402640; HARTLEY DJ, 1989, J ACOUST SOC AM, V85, P1348, DOI 10.1121/1.397466; Helfman GS, 1997, ETHOLOGY, V103, P369; HELFMAN GS, 1989, BEHAV ECOL SOCIOBIOL, V24, P47, DOI 10.1007/BF00300117; Hiryu S, 2007, J ACOUST SOC AM, V121, P1749, DOI 10.1121/1.2431337; Holderied MW, 2003, P ROY SOC B-BIOL SCI, V270, P2293, DOI 10.1098/rspb.2003.2487; Hoy RR, 1998, SPR HDB AUD, V10, P1; Hristov NI, 2005, NATURWISSENSCHAFTEN, V92, P164, DOI 10.1007/s00114-005-0611-7; Jakobsen L, 2010, P NATL ACAD SCI USA, V107, P13930, DOI 10.1073/pnas.1006630107; KICK SA, 1984, J NEUROSCI, V4, P2725; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Moss CF, 2001, J ACOUST SOC AM, V110, P2207, DOI 10.1121/1.1398051; Pinhiero J., 2009, NLME LINEAR NONLINEA, P1; Ratcliffe JM, 2005, J EXP BIOL, V208, P4689, DOI 10.1242/jeb.01927; Ratcliffe JM, 2008, NATURE, V455, P96, DOI 10.1038/nature07087; Ratcliffe JM, 2009, BIOL LETTERS, V5, P368, DOI 10.1098/rsbl.2009.0079; Roeder KD, 1967, NERVE CELLS INSECT B; Sokal RR, 1994, BIOMETRY PRINCIPLES, V3rd; Stankowich T, 2005, P ROY SOC B-BIOL SCI, V272, P2627, DOI 10.1098/rspb.2005.3251; Stankowich T, 2006, BEHAV ECOL, V17, P246, DOI 10.1093/beheco/arj020; STAPELLS DR, 1982, J ACOUST SOC AM, V72, P74, DOI 10.1121/1.388026; Svoboda T, 2005, PRESENCE-VIRTUAL AUG, V14, P407, DOI 10.1162/105474605774785325; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; YDENBERG RC, 1986, ADV STUD BEHAV, V16, P229, DOI 10.1016/S0065-3454(08)60192-8; Zuur Alain F., 2009, P1	63	15	15	2	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e63609	10.1371/journal.pone.0063609	http://dx.doi.org/10.1371/journal.pone.0063609			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671686	Green Submitted, gold, Green Published			2022-12-25	WOS:000321390200052
J	Francescone, R; Ngernyuang, N; Yan, W; Bentley, B; Shao, R				Francescone, R.; Ngernyuang, N.; Yan, W.; Bentley, B.; Shao, R.			Tumor-derived mural-like cells coordinate with endothelial cells: role of YKL-40 in mural cell-mediated angiogenesis	ONCOGENE			English	Article						YKL-40; cadherins; vessel permeability; mural cells; tumor angiogenesis; VEGF	CHITINASE PROTEIN FAMILY; VE-CADHERIN; GROWTH-FACTOR; VESSEL MATURATION; BREAST-CANCER; N-CADHERIN; VASCULAR MORPHOGENESIS; COLORECTAL-CANCER; ADHERENS JUNCTION; ANDES VIRUS	Tumor neo-vasculature is characterized by spatial coordination of endothelial cells with mural cells, which delivers oxygen and nutrients. Here, we explored a key role of the secreted glycoprotein YKL-40, a mesenchymal marker, in the interaction between endothelial cells and mesenchymal mural-like cells for tumor angiogenesis. Xenotransplantation of tumor-derived mural-like cells (GSDCs) expressing YKL-40 in mice developed extensive and stable blood vessels covered with more GSDCs than those in YKL-40 gene knockdown tumors. YKL-40 expressed by GSDCs was associated with increased interaction of neural cadherin/beta-catenin/smooth muscle alpha actin; thus, mediating cell-cell adhesion and permeability. YKL-40 also induced the interaction of vascular endothelial cadherin/beta-catenin/actin in endothelial cells (HMVECs). In cell co-culture systems, YKL-40 enhanced both GSDC and HMVEC contacts, restricted vascular leakage, and stabilized vascular networks. Collectively, the data inform new mechanistic insights into the cooperation of mural cells with endothelial cells induced by YKL-40 during tumor angiogenesis, and also enhance our understanding of YKL-40 in both mural and endothelial cell biology.	[Francescone, R.; Shao, R.] Univ Massachusetts, Morrill Sci Ctr, Mol & Cellular Biol Program, Amherst, MA 01003 USA; [Ngernyuang, N.] Khon Khaen Univ, Grad Sch, Khon Khaen, Thailand; [Yan, W.; Bentley, B.; Shao, R.] Pioneer Valley Life Sci Inst, Springfield, MA USA; [Shao, R.] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; Khon Kaen University; University of Massachusetts System; University of Massachusetts Amherst	Shao, R (corresponding author), Univ Massachusetts Amherst, Pioneer Valley Life Sci Inst, Springfield, MA 01107 USA.	rong.shao@bhs.org		Francescone, Ralph/0000-0002-3149-6825; Ngernyuang, Nipaporn/0000-0002-8586-6115	NCI [R01 CA120659]; CEAR grant, John Adams Innovation Institute, Massachusetts; NATIONAL CANCER INSTITUTE [R01CA120659] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CEAR grant, John Adams Innovation Institute, Massachusetts; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI R01 CA120659 and CEAR grant, John Adams Innovation Institute, Massachusetts (RS).	Abramsson A, 2003, J CLIN INVEST, V112, P1142, DOI 10.1172/JCI200318549; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Bergers G, 2003, J CLIN INVEST, V111, P1287, DOI 10.1172/JCI200317929; Bergmann OJ, 2005, CLIN CANCER RES, V11, P8644, DOI 10.1158/1078-0432.CCR-05-1317; Bloch W, 2000, FASEB J, V14, P2373; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Carmeliet P, 2011, NAT REV DRUG DISCOV, V10, P417, DOI 10.1038/nrd3455; Chambers RC, 2003, AM J PATHOL, V162, P533, DOI 10.1016/S0002-9440(10)63847-3; Chen XL, 2012, DEV CELL, V22, P146, DOI 10.1016/j.devcel.2011.11.002; Cintin C, 1999, BRIT J CANCER, V79, P1494, DOI 10.1038/sj.bjc.6690238; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Elenbaas B, 2001, EXP CELL RES, V264, P169, DOI 10.1006/excr.2000.5133; Erber R, 2003, FASEB J, V17, P338, DOI 10.1096/fj.03-0271fje; Faibish M, 2011, MOL CANCER THER, V10, P742, DOI 10.1158/1535-7163.MCT-10-0868; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Francescone R, 2012, J BIOL CHEM, V287, P24821, DOI 10.1074/jbc.M111.334540; Francescone RA, 2011, J BIOL CHEM, V286, P15332, DOI 10.1074/jbc.M110.212514; Fusetti F, 2003, J BIOL CHEM, V278, P37753, DOI 10.1074/jbc.M303137200; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Gerhardt H, 2000, DEV DYNAM, V218, P472, DOI 10.1002/1097-0177(200007)218:3<472::AID-DVDY1008>3.0.CO;2-#; Gerhardt H, 2008, J MOL MED, V86, P135, DOI 10.1007/s00109-007-0258-2; Gorbunova E, 2010, J VIROL, V84, P7405, DOI 10.1128/JVI.00576-10; Greenberg JI, 2008, NATURE, V456, P809, DOI 10.1038/nature07424; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hanahan D, 1997, SCIENCE, V277, P48, DOI 10.1126/science.277.5322.48; Helfrich I, 2010, J EXP MED, V207, P491, DOI 10.1084/jem.20091846; Hellberg C, 2010, RECENT RESULTS CANC, V180, P103, DOI 10.1007/978-3-540-78281-0_7; Hellstrom M, 2001, J CELL BIOL, V153, P543, DOI 10.1083/jcb.153.3.543; Hogdall EVS, 2003, ONCOL REP, V10, P1535; Hottinger AF, 2011, ANN NEUROL, V70, P163, DOI 10.1002/ana.22360; Hu B, 1996, J BIOL CHEM, V271, P19415, DOI 10.1074/jbc.271.32.19415; Huang FJ, 2010, DEV BIOL, V344, P1035, DOI 10.1016/j.ydbio.2010.06.023; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Jayson GC, 2005, J CLIN ONCOL, V23, P973, DOI 10.1200/JCO.2005.01.032; Jensen BV, 2003, CLIN CANCER RES, V9, P4423; JOHANSEN JS, 1992, J BONE MINER RES, V7, P501; Kzhyshkowska J, 2007, BIOMARK INSIGHTS, V2, P128; Lambeng N, 2005, CIRC RES, V96, P384, DOI 10.1161/01.RES.0000156652.99586.9f; Lin MI, 2007, CANCER RES, V67, P2849, DOI 10.1158/0008-5472.CAN-06-4082; Liu JQ, 2011, CLIN CANCER RES, V17, P3638, DOI 10.1158/1078-0432.CCR-10-2456; Luo Y, 2006, DEV BIOL, V299, P517, DOI 10.1016/j.ydbio.2006.09.003; Nakamura Y, 2008, CIRC RES, V102, P1182, DOI 10.1161/CIRCRESAHA.107.167080; NYIRKOS P, 1990, BIOCHEM J, V269, P265, DOI 10.1042/bj2690265; Orlova VV, 2006, J EXP MED, V203, P2703, DOI 10.1084/jem.20051730; Paik JH, 2004, GENE DEV, V18, P2392, DOI 10.1101/gad.1227804; Pelloski CE, 2005, CLIN CANCER RES, V11, P3326, DOI 10.1158/1078-0432.CCR-04-1765; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Rehli M, 1997, GENOMICS, V43, P221, DOI 10.1006/geno.1997.4778; Renkema GH, 1998, EUR J BIOCHEM, V251, P504, DOI 10.1046/j.1432-1327.1998.2510504.x; SHACKELTON LM, 1995, J BIOL CHEM, V270, P13076, DOI 10.1074/jbc.270.22.13076; Shao R, 2009, ONCOGENE, V28, P4456, DOI 10.1038/onc.2009.292; Shay-Salit A, 2002, P NATL ACAD SCI USA, V99, P9462, DOI 10.1073/pnas.142224299; Shrivastava-Ranjan P, 2010, J VIROL, V84, P11227, DOI 10.1128/JVI.01405-10; Stockmann C, 2008, NATURE, V456, P814, DOI 10.1038/nature07445; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014; Weis S, 2004, J CELL BIOL, V167, P223, DOI 10.1083/jcb.200408130; Yan W, 2008, MOL BIOL CELL, V19, P2278, DOI 10.1091/mbc.E07-10-1068; Yan W, 2010, J BIOL CHEM, V285, P14042, DOI 10.1074/jbc.M110.105262; Yonenaga Y, 2005, ONCOLOGY-BASEL, V69, P159, DOI 10.1159/000087840	61	25	26	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 17	2014	33	16					2110	2122		10.1038/onc.2013.160	http://dx.doi.org/10.1038/onc.2013.160			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AF3GH	23665676	Green Accepted			2022-12-25	WOS:000334599100010
J	Xu, S; Hayashi, Y; Takagishi, Y; Itoh, M; Murata, Y				Xu, Sai; Hayashi, Yoshitaka; Takagishi, Yoshiko; Itoh, Mariko; Murata, Yoshiharu			Aristaless-Related Homeobox Plays a Key Role in Hyperplasia of the Pancreas Islet alpha-Like Cells in Mice Deficient in Proglucagon-Derived Peptides	PLOS ONE			English	Article							GLUCAGON DEFICIENCY; ENDOCRINE PANCREAS; ARX; EXPRESSION; GENE; HYPERGLUCAGONEMIA; PHENOTYPES; MUTATION; RECEPTOR; GLUCOSE	Defects in glucagon action can cause hyperplasia of islet alpha-cells, however, the underlying mechanisms remain largely to be elucidated. Mice homozygous for a glucagon-GFP knock-in allele (Gcg(gfp/gfp)) completely lack proglucagon-derived peptides and exhibit hyperplasia of GFP-positive alpha-like cells. Expression of the transcription factor, aristaless-related homeobox (ARX), is also increased in the Gcg(gfp/gfp) pancreas. Here, we sought to elucidate the role of ARX in the hyperplasia of alpha-like cells through analyses of two Arx mutant alleles (Arx(P355L/Y) and Arx([330insGCG]7/Y)) that have different levels of impairment of their function. Expression of Gfp and Arx genes was higher and the size and number of islets increased in the Gcg(gfp/gfp) pancreas compared to and Gcg(gfp/+) pancreas at 2 weeks of age. In male Gcg(gfp/gfp) mice that are hemizygous for the Arx(P355L/Y) mutation that results in a protein with a P355L amino acid substitution, expression of Gfp mRNA in the pancreas was comparable to that in control Gcg(gfp/+)Arx(+/Y) mice. The increases in islet size and number were also reduced in these mice. Immunohistochemical analysis showed that the number of GFP-positive cells was comparable in Gcg(gfp/gfp) Arx(P355L/Y) and Gcg(gfp/+)Arx(+/Y) mice. These results indicate that the hyperplasia is reduced by introduction of an Arx mutation. Arx(P355L/Y) mice appeared to be phenotypically normal; however, Arx([330insGCG]7/Y) mice that have a mutant ARX protein with expansion of the polyalanine tract had a reduced body size and shortened life span. The number of GFP-positive cells was further reduced in the Gcg(gfp/gfp) Arx([330insGCG]7/Y) mice. Taken together, our findings show that the function of ARX is one of the key modifiers for hyperplasia of islet alpha-like cells in the absence of proglucagon-derived peptides.	[Xu, Sai; Hayashi, Yoshitaka; Takagishi, Yoshiko; Murata, Yoshiharu] Nagoya Univ, Environm Med Res Inst, Dept Genet, Div Stress Adaptat & Protect, Nagoya, Aichi 464, Japan; [Itoh, Mariko] Nagoya Univ, Environm Med Res Inst, Tech Dept, Nagoya, Aichi 464, Japan	Nagoya University; Nagoya University	Hayashi, Y (corresponding author), Nagoya Univ, Environm Med Res Inst, Dept Genet, Div Stress Adaptat & Protect, Nagoya, Aichi 464, Japan.	hayashiy@riem.nagoya-u.ac.jp	Hayashi, Yoshitaka/I-6168-2014	Hayashi, Yoshitaka/0000-0002-7557-4303	Japan Society for the Promotion of Science [23591351, 24659451]; Ministry of Education, Culture, Sports, Science and Technology [23122507]; Grants-in-Aid for Scientific Research [23591351] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (grant number 23591351 to YM and grant number 24659451 to YH) and a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (grant number 23122507 to YH) [http://kaken.nii.ac.jp/d/p/23591351.en.html; http://kaken.nii.ac.jp/d/p/24659451.en.html; http://kaken.nii.ac.jp/d/p/23122507.en.html; http://www.jsps.go.jp/english/; http://www.mext.go.jp/english/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2011, J CLIN INVEST, V121, P1917, DOI 10.1172/JCI43615; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Bock T, 2003, DIABETES, V52, P1716, DOI 10.2337/diabetes.52.7.1716; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; Collombat P, 2007, J CLIN INVEST, V117, P961, DOI 10.1172/JCI29115; Ellingsgaard H, 2008, P NATL ACAD SCI USA, V105, P13163, DOI 10.1073/pnas.0801059105; Fukami A, 2013, DIABETES, V62, P510, DOI 10.2337/db12-0294; Furuta M, 1997, P NATL ACAD SCI USA, V94, P6646, DOI 10.1073/pnas.94.13.6646; Futaki S, 2003, J BIOL CHEM, V278, P50691, DOI 10.1074/jbc.M304985200; Gecz J, 2006, CURR OPIN GENET DEV, V16, P308, DOI 10.1016/j.gde.2006.04.003; Gelling RW, 2003, P NATL ACAD SCI USA, V100, P1438, DOI 10.1073/pnas.0237106100; Habener JF, 2012, TRENDS ENDOCRINOL ME; Hancock AS, 2010, MOL ENDOCRINOL, V24, P1605, DOI 10.1210/me.2010-0120; Hayashi Y, 2011, DIABETES OBES METAB, V13, P151, DOI 10.1111/j.1463-1326.2011.01456.x; Hayashi Y, 2009, MOL ENDOCRINOL, V23, P1990, DOI 10.1210/me.2009-0296; Itoh M, 2010, DIFFERENTIATION, V80, P118, DOI 10.1016/j.diff.2010.05.003; Kitamura K, 2002, NAT GENET, V32, P359, DOI 10.1038/ng1009; Kitamura K, 2009, HUM MOL GENET, V18, P3708, DOI 10.1093/hmg/ddp318; Longuet C, 2012, DIABETES; Miura H, 1997, MECH DEVELOP, V65, P99, DOI 10.1016/S0925-4773(97)00062-2; Sugiyama C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043745; Unger RH, 2012, J CLIN INVEST, V122, P4, DOI 10.1172/JCI60016; Watanabe C, 2012, DIABETES, V61, P74, DOI 10.2337/db11-0739; Zhou CQ, 2009, PANCREAS, V38, P941, DOI 10.1097/MPA.0b013e3181b2bb03	24	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e64415	10.1371/journal.pone.0064415	http://dx.doi.org/10.1371/journal.pone.0064415			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671715	Green Published, gold, Green Submitted			2022-12-25	WOS:000319737700073
J	Ditroilo, M; Watsford, M; Murphy, A; De Vito, G				Ditroilo, Massimiliano; Watsford, Mark; Murphy, Aron; De Vito, Giuseppe			Sources of Variability in Musculo-Articular Stiffness Measurement	PLOS ONE			English	Article							MUSCULOTENDINOUS STIFFNESS; ACTIVE STIFFNESS; MUSCLE-STIFFNESS; RELIABILITY; INJURY; ANKLE; LEG	The assessment of musculo-articular stiffness (MAS) with the free-oscillation technique is a popular method with a variety of applications. This study examined the sources of variability (load applied and frequency of oscillation) when MAS is assessed. Over two testing occasions, 14 healthy men (27.7 +/- 5.2 yr, 1.82 +/- 0.04 m, 79.5 +/- 8.4 kg) were measured for isometric maximum voluntary contraction and MAS of the knee flexors using submaximal loads relative to the individual's maximum voluntary contraction (MAS(%MVC)) and a single absolute load (MAS(ABS)). As assessment load increased, MAS(%MVC) (coefficient of variation (CV) = 8.1-12.1%; standard error of measurement (SEM) = 51.6-98.8 Nm(-1)) and frequency (CV = 4.8-7.0%; SEM = 0.060-0.075 s(-1)) variability increased consequently. Further, similar levels of variability arising from load (CV = 6.7%) and frequency (CV = 4.8-7.0%) contributed to the overall MAS(%MVC) variability. The single absolute load condition yielded better reliability scores for MAS(ABS) (CV = 6.5%; SEM = 40.2 Nm(-1)) and frequency (CV = 3.3%; SEM = 0.039 s(-1)). Low and constant loads for MAS assessment, which are particularly relevant in the clinical setting, exhibited superior reliability compared to higher loads expressed as a percentage of maximum voluntary contraction, which are more suitable for sporting situations. Appropriate sample size and minimum detectable change can therefore be determined when prospective studies are carried out.	[Ditroilo, Massimiliano; De Vito, Giuseppe] Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Populat Sci, Dublin 2, Ireland; [Ditroilo, Massimiliano] Univ Hull, Fac Sci, Dept Sport Hlth & Exercise Sci, Kingston Upon Hull HU6 7RX, N Humberside, England; [Watsford, Mark; Murphy, Aron] Univ Technol Sydney, UTS Hlth, Sport & Exercise Grp, Sydney, NSW 2007, Australia; [De Vito, Giuseppe] Univ Coll Dublin, Inst Sport & Hlth, Dublin 2, Ireland	University College Dublin; University of Hull; University of Technology Sydney; University College Dublin	Ditroilo, M (corresponding author), Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Populat Sci, Dublin 2, Ireland.	m.ditroilo@hull.ac.uk	Ditroilo, Massimiliano/X-5394-2019; De Vito, Giuseppe/J-4499-2012	Ditroilo, Massimiliano/0000-0003-1021-0362; De Vito, Giuseppe/0000-0002-6855-9180				Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Bell DR, 2012, KNEE SURG SPORT TR A, V20, P361, DOI 10.1007/s00167-011-1577-y; Blackburn JT, 2004, CLIN BIOMECH, V19, P36, DOI 10.1016/j.clinbiomech.2003.09.003; Coveney VA, 2001, J BIOMECH, V34, P827, DOI 10.1016/S0021-9290(01)00017-3; Ditroilo M, 2011, SPORTS MED, V41, P1019, DOI 10.2165/11591470-000000000-00000; Ditroilo M, 2011, J ELECTROMYOGR KINES, V21, P492, DOI 10.1016/j.jelekin.2010.11.004; Ditroilo M, 2011, MED SCI SPORT EXER, V43, P837, DOI 10.1249/MSS.0b013e3182012261; Faria A, 2009, CLIN BIOMECH, V24, P866, DOI 10.1016/j.clinbiomech.2009.07.015; Granata KP, 2004, J ELECTROMYOGR KINES, V14, P599, DOI 10.1016/j.jelekin.2004.03.005; Jaskolski A, 2007, J ELECTROMYOGR KINES, V17, P568, DOI 10.1016/j.jelekin.2006.05.002; Jennings AG, 1998, CLIN BIOMECH, V13, P138, DOI 10.1016/S0268-0033(97)00085-5; McLachlan KA, 2006, J APPL BIOMECH, V22, P296, DOI 10.1123/jab.22.4.296; MCNAIR PJ, 1992, CLIN BIOMECH, V7, P131, DOI 10.1016/0268-0033(92)90027-2; Missenard O, 2009, MUSCLE NERVE, V40, P1019, DOI 10.1002/mus.21331; Murphy AJ, 2003, PHYS THER SPORT, V4, P175, DOI 10.1016/S1466-853X(03)00077-4; Panjabi MM, 2001, BIOMECHANICS MUSCULO, P131; Shorten MR, 1987, MED SPORT SCI, V25, P1; Spurrs RW, 2003, EUR J APPL PHYSIOL, V89, P1, DOI 10.1007/s00421-002-0741-y; Taylor J. R., 1982, INTRO ERROR ANAL, P40; Walshe AD, 1996, EUR J APPL PHYSIOL O, V73, P332, DOI 10.1007/BF02425495; Watsford M, 2010, MED SCI SPORT EXER, V42, P1324, DOI 10.1249/MSS.0b013e3181ce509d; Watsford ML, 2010, AM J SPORT MED, V38, P2058, DOI 10.1177/0363546510370197; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; WILSON GJ, 1991, INT J SPORTS MED, V12, P403, DOI 10.1055/s-2007-1024702; Winter D. A., 2005, BIOMECHANICS MOTOR C, P59	25	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63719	10.1371/journal.pone.0063719	http://dx.doi.org/10.1371/journal.pone.0063719			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667662	gold, Green Published, Green Submitted			2022-12-25	WOS:000319055600070
J	Rahman, MM; Azirun, SM; Boyce, AN				Rahman, Motior M.; Azirun, Sofian M.; Boyce, Amru N.			Enhanced Accumulation of Copper and Lead in Amaranth (Amaranthus paniculatus), Indian Mustard (Brassica juncea) and Sunflower (Helianthus annuus)	PLOS ONE			English	Article							HEAVY-METALS; PHYTOEXTRACTION CAPACITY; CONTAMINATED SOIL; ELEMENTAL SULFUR; CADMIUM UPTAKE; SOLUBILITY; PLANTS; ZINC; CD; PHYTOREMEDIATION	Background: Soil contamination by copper (Cu) and lead (Pb) is a widespread environmental problem. For phytoextraction to be successful and viable in environmental remediation, strategies that can improve plant uptake must be identified. In the present study we investigated the use of nitrogen (N) fertilizer as an efficient way to enhance accumulation of Cu and Pb from contaminated industrial soils into amaranth, Indian mustard and sunflower. Methods/Principal Findings: Plants were grown in a greenhouse and fertilized with N fertilizer at rates of 0, 190 and 380 mg kg(-1) soil. Shoots, roots and total accumulation of Cu and Pb, transfer factor (TF), translocation index were assessed to evaluate the transport and translocation ability of tested plants. Addition of N fertilizer acidified the industrial soil and caused the pH to decrease to 5.5 from an initial pH of 6.9. Industrial soil amended with N fertilizer resulted in the highest accumulation of Pb and Cu (for Pb 10.1-15.5 mg kg(-1), for Cu 11.6-16.8 mg kg(-1)) in the shoots, which was two to four folds higher relative to the concentration in roots in all the three plants used. Sunflower removed significantly higher Pb (50-54%) and Cu (34-38%) followed by amaranth and Indian mustard from industrial soils with the application of N fertilizer. The TF was <1 while the shoot and root concentration (SC/RC) ratios of Pb and Cu were between 1.3-4.3 and 1.8-3.8, respectively, regardless of plant species. Conclusions: Sunflower is the best plant species to carry out phytoextraction of Pb and Cu. In contrast, Pb and Cu removal by Indian mustard and amaranth shows great potential as quick and short duration vegetable crops. The results suggest that the application of N fertilizer in contaminated industrial soil is an effective amendment for the phytoextraction of Pb and Cu from contaminated industrial soils.	[Rahman, Motior M.; Azirun, Sofian M.; Boyce, Amru N.] Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur, Malaysia	Universiti Malaya	Rahman, MM (corresponding author), Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur, Malaysia.	mmotiorrahman@gmail.com	RAHMAN, DR. MD. MOTIOR/B-8988-2010; AZIRUN, MOHD SOFIAN/B-9127-2010; NASRULHAQ BOYCE, AMRU/B-8224-2010	Rahman, Md Motior/0000-0002-2847-1870	University of Malaya, Kuala Lumpur, Malaysia	University of Malaya, Kuala Lumpur, Malaysia(Universiti Malaya)	This research work was financially supported by the University of Malaya, Kuala Lumpur, Malaysia. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriano D. C, 2003, TRACE ELEMENTS TERRE; [Anonymous], 2001, TRACE METALS SOILS P; BC MOE, 1989, CRIT MAN CONT SOILS; Blaylock MJ, 2000, PHYTOREMEDIATION OF TOXIC METALS, P53; BROWN SL, 1995, SOIL SCI SOC AM J, V59, P125, DOI 10.2136/sssaj1995.03615995005900010020x; Chaney RL, 2005, Z NATURFORSCH C, V60, P190; Cieslinski G, 1996, PLANT SOIL, V182, P115, DOI 10.1007/BF00011000; Cobb GP, 2000, ENVIRON TOXICOL CHEM, V19, P600, DOI [10.1002/etc.5620190311, 10.1897/1551-5028(2000)019&lt;0600:AOHMBV&gt;2.3.CO;2]; Cui YS, 2004, COMMUN SOIL SCI PLAN, V35, P2905, DOI 10.1081/LCSS-200036494; Cui YS, 2004, ENVIRON INT, V30, P323, DOI 10.1016/S0160-4120(03)00182-X; Cunningham SD, 2000, PHYTOREMEDIATION OF CONTAMINATED SOIL AND WATER, P359; Dede G, 2012, INT J ENVIRON SCI TE, V9, P559, DOI 10.1007/s13762-012-0058-2; Demirezen D, 2007, CHEMOSPHERE, V66, P553, DOI 10.1016/j.chemosphere.2006.05.045; do Nascimento CWA, 2006, SCI AGR, V63, P299, DOI 10.1590/S0103-90162006000300014; Eriksson J., 1997, 4778 SWED ENV PROT A; Garbisu C, 2001, BIORESOURCE TECHNOL, V77, P229, DOI 10.1016/S0960-8524(00)00108-5; Ghosh M., 2005, Applied Ecology and Environmental Research, V3, P67; Gupta AK, 2007, BIORESOURCE TECHNOL, V98, P442, DOI 10.1016/j.biortech.2006.01.015; Gupta AK, 2007, BIORESOURCE TECHNOL, V98, P1788, DOI 10.1016/j.biortech.2006.06.028; HOLMGREN GGS, 1993, J ENVIRON QUAL, V22, P335, DOI 10.2134/jeq1993.00472425002200020015x; Jarup L, 2003, BRIT MED BULL, V68, P167, DOI 10.1093/bmb/ldg032; Kaplan M, 2005, AGR ECOSYST ENVIRON, V111, P41, DOI 10.1016/j.agee.2005.04.023; Khan S, 2008, ENVIRON POLLUT, V152, P686, DOI 10.1016/j.envpol.2007.06.056; Kirpichtchikova TA, 2006, GEOCHIM COSMOCHIM AC, V70, P2163, DOI 10.1016/j.gca.2006.02.006; Lasat M. M., 1999, J HAZARD SUBSTANCE R, V2, P1, DOI 10.4148/1090-7025.1015; Lin CC, 2009, ENVIRON EXP BOT, V65, P410, DOI 10.1016/j.envexpbot.2008.12.003; Ling W, 2007, AUST J SOIL RES, V45, P618, DOI 10.1071/SR07079; Liu XM, 2005, INT J PHYTOREMEDIAT, V7, P43, DOI 10.1080/16226510590915800; LUBBEN S, 1991, WATER AIR SOIL POLL, V57-8, P239, DOI 10.1007/BF00282887; Luo CL, 2005, CHEMOSPHERE, V59, P1, DOI 10.1016/j.chemosphere.2004.09.100; Madejon E, 2006, ENVIRON POLLUT, V139, P40, DOI 10.1016/j.envpol.2005.04.034; Maimon A., 2009, Advances in Environmental Biology, V3, P314; Martens SN, 2000, ECOL MODEL, V126, P79, DOI 10.1016/S0304-3800(99)00188-X; Martinez CE, 2000, ENVIRON POLLUT, V107, P153, DOI 10.1016/S0269-7491(99)00111-6; Maslin P., 2000, BIOREMEDIAT J, V4, P295, DOI [10.1080/10889860091114266, DOI 10.1080/10889860091114266]; McBride M. B., 1994, ENV CHEM SOILS; McLaughlin MJ, 2000, COMMUN SOIL SCI PLAN, V31, P1661, DOI 10.1080/00103620009370531; Mun HW, 2008, J ENVIRON SCI, V20, P1341, DOI 10.1016/S1001-0742(08)62231-7; Nowack B, 2006, ENVIRON SCI TECHNOL, V40, P5225, DOI 10.1021/es0604919; Pais I., 2000, HDB TRACE ELEMENTS; Paiva Haroldo Nogueira de, 2002, Rev. Árvore, V26, P467, DOI 10.1590/S0100-67622002000400009; Putnam DH, 1990, OPLINGER ES PUBLIC A, VA3005; Rahman MM, 2011, AUST J CROP SCI, V5, P347; Rosen CJ, 2002, LEAD HOME GARDEN URB; Salt DE, 1998, ANNU REV PLANT PHYS, V49, P643, DOI 10.1146/annurev.arplant.49.1.643; SAS 2003 SAS Institute, 2002, SAS I SAS VERS 9 1 2, P449; Schmidt U, 2003, J ENVIRON QUAL, V32, P1939, DOI 10.2134/jeq2003.1939; Singh BP, 1992, 2 INT S SPEC EX VEG; Syakalima MS, 2001, B ENVIRON CONTAM TOX, V67, P438; Thomas G.W., 1996, SOIL PH SOIL ACIDI 3, P475, DOI DOI 10.2136/SSSABOOKSER5.3.C16; Turgut C, 2004, ENVIRON POLLUT, V131, P147, DOI 10.1016/j.envpol.2004.01.017; Wang AS, 2006, PLANT SOIL, V281, P325, DOI 10.1007/s11104-005-4642-9; Wu LH, 2004, ENVIRON GEOCHEM HLTH, V26, P331, DOI 10.1023/B:EGAH.0000039598.24033.4e; Wuana R.A., 2011, ISRN ECOL, V2011, P1, DOI [DOI 10.5402/2011/402647, 10.5402/2011/402647]; XIAN XF, 1989, WATER AIR SOIL POLL, V45, P265, DOI 10.1007/BF00283457; [杨兵 Yang Bing], 2005, [生态学报, Acta Ecologica Sinica], V25, P45; Zaurov DE, 1999, J PLANT NUTR, V22, P977, DOI 10.1080/01904169909365687; Zhang MK, 2010, COMMUN SOIL SCI PLAN, V41, P820, DOI 10.1080/00103621003592341; Zhou Q, 2003, B ENVIRON CONTAM TOX, V71, P338, DOI 10.1007/s00128-003-0169-z	59	32	34	2	124	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62941	10.1371/journal.pone.0062941	http://dx.doi.org/10.1371/journal.pone.0062941			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667546	Green Submitted, Green Published, gold			2022-12-25	WOS:000319055600048
J	Wildgruber, D; Szameitat, DP; Ethofer, T; Bruck, C; Alter, K; Grodd, W; Kreifelts, B				Wildgruber, Dirk; Szameitat, Diana P.; Ethofer, Thomas; Brueck, Carolin; Alter, Kai; Grodd, Wolfgang; Kreifelts, Benjamin			Different Types of Laughter Modulate Connectivity within Distinct Parts of the Laughter Perception Network	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; EMOTIONAL PROSODY; WORKING-MEMORY; BRAIN-REGIONS; RESPONSE CONFLICT; SOCIAL COGNITION; RIGHT-HEMISPHERE; FACE PERCEPTION; FMRI; AMYGDALA	Laughter is an ancient signal of social communication among humans and non-human primates. Laughter types with complex social functions (e.g., taunt and joy) presumably evolved from the unequivocal and reflex-like social bonding signal of tickling laughter already present in non-human primates. Here, we investigated the modulations of cerebral connectivity associated with different laughter types as well as the effects of attention shifts between implicit and explicit processing of social information conveyed by laughter using functional magnetic resonance imaging (fMRI). Complex social laughter types and tickling laughter were found to modulate connectivity in two distinguishable but partially overlapping parts of the laughter perception network irrespective of task instructions. Connectivity changes, presumably related to the higher acoustic complexity of tickling laughter, occurred between areas in the prefrontal cortex and the auditory association cortex, potentially reflecting higher demands on acoustic analysis associated with increased information load on auditory attention, working memory, evaluation and response selection processes. In contrast, the higher degree of socio-relational information in complex social laughter types was linked to increases of connectivity between auditory association cortices, the right dorsolateral prefrontal cortex and brain areas associated with mentalizing as well as areas in the visual associative cortex. These modulations might reflect automatic analysis of acoustic features, attention direction to informative aspects of the laughter signal and the retention of those in working memory during evaluation processes. These processes may be associated with visual imagery supporting the formation of inferences on the intentions of our social counterparts. Here, the right dorsolateral precentral cortex appears as a network node potentially linking the functions of auditory and visual associative sensory cortices with those of the mentalizing-associated anterior mediofrontal cortex during the decoding of social information in laughter.	[Wildgruber, Dirk; Szameitat, Diana P.; Ethofer, Thomas; Brueck, Carolin; Kreifelts, Benjamin] Univ Tubingen, Dept Psychiat & Psychotherapy, Tubingen, Germany; [Alter, Kai] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Wildgruber, Dirk; Ethofer, Thomas] Univ Tubingen, Dept Biomed Magnet Resonance, Tubingen, Germany; [Grodd, Wolfgang] Univ Aachen, Dept Psychiat & Psychotherapy, Aachen, Germany	Eberhard Karls University of Tubingen; Newcastle University - UK; Eberhard Karls University of Tubingen; RWTH Aachen University	Kreifelts, B (corresponding author), Univ Tubingen, Dept Psychiat & Psychotherapy, Tubingen, Germany.	benjamin.kreifelts@med.uni-tuebingen.de		Kreifelts, Benjamin/0000-0002-9233-3800; Alter, Kai/0000-0003-4575-9494	German Research Foundation [DFG WI 2101/2-1, DFG SZ 267/1-1]; Open Access Publishing Fund of Tuebingen University	German Research Foundation(German Research Foundation (DFG)); Open Access Publishing Fund of Tuebingen University	This study was financially supported by the German Research Foundation (DFG WI 2101/2-1 and DFG SZ 267/1-1; ULR: http://www.dfg.de) and the Open Access Publishing Fund of Tuebingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Bea J. A., 2003, Entropy, V5, DOI 10.3390/e5020205; Belin P, 2004, TRENDS COGN SCI, V8, P129, DOI 10.1016/j.tics.2004.01.008; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; Bruck C, 2011, PHYS LIFE REV, V8, P383, DOI 10.1016/j.plrev.2011.10.002; Brunet E, 2000, NEUROIMAGE, V11, P157, DOI 10.1006/nimg.1999.0525; Buchanan TW, 2007, PSYCHOL BULL, V133, P761, DOI 10.1037/0033-2909.133.5.761; Buchanan TW, 2000, COGNITIVE BRAIN RES, V9, P227, DOI 10.1016/S0926-6410(99)00060-9; Bunge SA, 2002, NEUROIMAGE, V17, P1562, DOI 10.1006/nimg.2002.1252; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Casey BJ, 2000, P NATL ACAD SCI USA, V97, P8728, DOI 10.1073/pnas.97.15.8728; Chen JL, 2008, J COGNITIVE NEUROSCI, V20, P226, DOI 10.1162/jocn.2008.20018; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Davila-Ross M, 2011, EMOTION, V11, P1013, DOI 10.1037/a0022594; DAVITZ JR, 1964, COMMUNICATION EMOTIO, P13; Ekman M, 2012, P NATL ACAD SCI USA, V109, P16714, DOI 10.1073/pnas.1207523109; Ethofer T, 2006, NEUROIMAGE, V30, P580, DOI 10.1016/j.neuroimage.2005.09.059; Ethofer T, 2009, J COGNITIVE NEUROSCI, V21, P1255, DOI 10.1162/jocn.2009.21099; Ethofer T, 2009, CURR BIOL, V19, P1028, DOI 10.1016/j.cub.2009.04.054; Fecteau S, 2007, NEUROIMAGE, V36, P480, DOI 10.1016/j.neuroimage.2007.02.043; Friston K J, 1994, Hum Brain Mapp, V1, P210, DOI 10.1002/hbm.460010306; Friston KJ, 2002, NEUROIMAGE, V16, P484, DOI 10.1006/nimg.2002.1091; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; GEISSER S, 1958, ANN MATH STAT, V29, P885, DOI 10.1214/aoms/1177706545; George MS, 1996, ARCH NEUROL-CHICAGO, V53, P665, DOI 10.1001/archneur.1996.00550070103017; Gervais M, 2005, Q REV BIOL, V80, P395, DOI 10.1086/498281; Gitelman DR, 2003, NEUROIMAGE, V19, P200, DOI 10.1016/S1053-8119(03)00058-2; Gruber O, 2000, NEUROREPORT, V11, P1689, DOI 10.1097/00001756-200006050-00019; Guye M, 2008, CURR OPIN NEUROL, V21, P393, DOI 10.1097/WCO.0b013e3283065cfb; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Ishai A, 2010, ARCH ITAL BIOL, V148, P1; Jancke L, 2002, NEUROIMAGE, V15, P733, DOI 10.1006/nimg.2001.1027; Kampe KKW, 2003, J NEUROSCI, V23, P5258; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kotz SA, 2012, HUM BRAIN M IN PRESS; Leitman DI, 2011, FRONT HUM NEUROSCI, V5, DOI [10.3389/fnhum.2011.00096, 10.3389/fnhum.2010.00019]; Mar RA, 2011, ANNU REV PSYCHOL, V62, P103, DOI 10.1146/annurev-psych-120709-145406; Marrelec G, 2006, J PHYSIOL-PARIS, V100, P171, DOI 10.1016/j.jphysparis.2007.01.003; Meyer M, 2005, COGNITIVE BRAIN RES, V24, P291, DOI 10.1016/j.cogbrainres.2005.02.008; Meyer M, 2007, BEHAV BRAIN RES, V182, P245, DOI 10.1016/j.bbr.2007.04.023; Mitchell JP, 2005, NEUROIMAGE, V28, P757, DOI 10.1016/j.neuroimage.2005.03.011; Mitchell RLC, 2007, NEUROIMAGE, V36, P1015, DOI 10.1016/j.neuroimage.2007.03.016; Nakai Toshiharu, 2005, Magn Reson Med Sci, V4, P75, DOI 10.2463/mrms.4.75; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; O'Craven KM, 2000, J COGNITIVE NEUROSCI, V12, P1013, DOI 10.1162/08989290051137549; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Panksepp A, 2000, CURR DIR PSYCHOL SCI, V9, P183; Panksepp J, 2003, PHYSIOL BEHAV, V79, P533, DOI 10.1016/S0031-9384(03)00159-8; Price CJ, 2010, ANN NY ACAD SCI, V1191, P62, DOI 10.1111/j.1749-6632.2010.05444.x; Purdon PL, 1998, HUM BRAIN MAPP, V6, P239, DOI 10.1002/(SICI)1097-0193(1998)6:4<239::AID-HBM4>3.3.CO;2-0; Rama P, 2005, NEUROIMAGE, V24, P224, DOI 10.1016/j.neuroimage.2004.08.024; Ross MD, 2009, CURR BIOL, V19, P1106, DOI 10.1016/j.cub.2009.05.028; Sander K, 2005, J COGNITIVE NEUROSCI, V17, P1519, DOI 10.1162/089892905774597227; Sander K, 2003, BRAIN RES PROTOC, V11, P81, DOI 10.1016/S1385-299X(03)00018-7; Sander K, 2001, COGNITIVE BRAIN RES, V12, P181, DOI 10.1016/S0926-6410(01)00045-3; SCHERER KR, 1985, ADV STUD BEHAV, V15, P189, DOI 10.1016/S0065-3454(08)60490-8; Schirmer A, 2006, TRENDS COGN SCI, V10, P24, DOI 10.1016/j.tics.2005.11.009; Szameitat DP, 2010, NEUROIMAGE, V53, P1264, DOI 10.1016/j.neuroimage.2010.06.028; Szameitat DP, 2009, J ACOUST SOC AM, V126, P354, DOI 10.1121/1.3139899; Szameitat DP, 2009, EMOTION, V9, P397, DOI 10.1037/a0015692; Tschacher W, 2010, PSYCHOTHER RES, V20, P576, DOI 10.1080/10503307.2010.493538; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Overwalle F, 2009, NEUROIMAGE, V48, P564, DOI 10.1016/j.neuroimage.2009.06.009; von Kriegstein K, 2006, PLOS BIOL, V4, P1809, DOI 10.1371/journal.pbio.0040326; Walter H, 2004, J COGNITIVE NEUROSCI, V16, P1854, DOI 10.1162/0898929042947838; Wiethoff S, 2008, NEUROIMAGE, V39, P885, DOI 10.1016/j.neuroimage.2007.09.028; Wildgruber D, 2006, PROG BRAIN RES, V156, P249, DOI 10.1016/S0079-6123(06)56013-3; Wildgruber D, 2005, NEUROIMAGE, V24, P1233, DOI 10.1016/j.neuroimage.2004.10.034; Wildgruber D., 2009, INT J SPEECH-LANG PA, V11, P277, DOI [10.1080/17549500902943043, DOI 10.1080/17549500902943043]; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P74, DOI 10.1002/(SICI)1097-0193(1996)4:1<74::AID-HBM5>3.0.CO;2-M	70	19	19	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63441	10.1371/journal.pone.0063441	http://dx.doi.org/10.1371/journal.pone.0063441			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	145YI	23667619	Green Submitted, Green Published, gold			2022-12-25	WOS:000319055600060
J	Da Re, S; Jaione, V; Charbonnel, N; Beloin, C; Latour-Lambert, P; Faure, P; Turlin, E; Le Bouguenec, C; Renauld-Mongenie, G; Forestier, C; Ghigo, JM				Da Re, Sandra; Jaione, Valle; Charbonnel, Nicolas; Beloin, Christophe; Latour-Lambert, Patricia; Faure, Philippe; Turlin, Evelyne; Le Bouguenec, Chantal; Renauld-Mongenie, Genevieve; Forestier, Christiane; Ghigo, Jean-Marc			Identification of Commensal Escherichia coli Genes Involved in Biofilm Resistance to Pathogen Colonization	PLOS ONE			English	Article							GASTROINTESTINAL-TRACT; BACTERIAL BIOFILMS; LOW-TEMPERATURE; HOST; INTESTINE; EXPRESSION; REVEALS; DISEASE; FLORA; POLYSACCHARIDE	Protection provided by host bacterial microbiota against microbial pathogens is a well known but ill-understood property referred to as the barrier effect, or colonization resistance. Despite recent genome-wide analyses of host microbiota and increasing therapeutic interest, molecular analysis of colonization resistance is hampered by the complexity of direct in vivo experiments. Here we developed an in vitro-to-in vivo approach to identification of genes involved in resistance of commensal bacteria to exogenous pathogens. We analyzed genetic responses induced in commensal Escherichia coli upon entry of a diarrheagenic enteroaggregative E. coli or an unrelated Klebsiella pneumoniae pathogen into a biofilm community. We showed that pathogens trigger specific responses in commensal bacteria and we identified genes involved in limiting colonization of incoming pathogens within commensal biofilm. We tested the in vivo relevance of our findings by comparing the extent of intestinal colonization by enteroaggregative E. coli and K. pneumoniae pathogens in mice pre-colonized with E. coli wild type commensal strain, or mutants corresponding to identified colonization resistance genes. We demonstrated that the absence of yiaF and bssS (yceP) differentially alters pathogen colonization in the mouse gut. This study therefore identifies previously uncharacterized colonization resistance genes and provides new approaches to unravelling molecular aspects of commensal/pathogen competitive interactions.	[Da Re, Sandra; Jaione, Valle; Beloin, Christophe; Latour-Lambert, Patricia; Ghigo, Jean-Marc] Inst Pasteur, Dept Microbiol, Unite Genet Biofilms, Paris, France; [Charbonnel, Nicolas; Forestier, Christiane] Univ Auvergne Clermont 1, Bacteriol Lab, Clermont Ferrand, France; [Faure, Philippe] Univ Paris 06, Equipe Neurophysiol & Comportement NPC, UMR 7102, Paris, France; [Turlin, Evelyne] Inst Pasteur, Dept Microbiol, Unite Membranes Bacteriennes, Paris, France; [Le Bouguenec, Chantal] Inst Pasteur, Dept Microbiol, Unite Biol Bacteries Pathogenes Gram Positif, Paris, France; [Renauld-Mongenie, Genevieve] Sanofi Pasteur, Dept Discovery, Marcy Letoile, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universite Clermont Auvergne (UCA); UDICE-French Research Universities; Sorbonne Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Sanofi-Aventis; Sanofi France	Ghigo, JM (corresponding author), Inst Pasteur, Dept Microbiol, Unite Genet Biofilms, Paris, France.	jmghigo@pasteur.fr	BELOIN, Christophe/F-9284-2012; Da Re, Sandra/F-6383-2011; jaione, valle/N-8005-2019; jaione, valle/G-6213-2011; GHIGO, Jean-Marc/AAP-4011-2021	BELOIN, Christophe/0000-0002-0344-3443; Da Re, Sandra/0000-0003-3579-9185; jaione, valle/0000-0003-3115-0207; jaione, valle/0000-0003-3115-0207; GHIGO, Jean-Marc/0000-0001-6528-118X; Faure, Philippe/0000-0003-3573-4971	Sanofi-Pasteur; Institut Pasteur; CNRS (Centre National de la Recherche Scientifique); URA (Unite de echerche Associee) [2172]; Network of Excellence EuroPathoGenomics [LSHB-CT-2005-512061]; French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" [ANR-10-LABX-62-IBEID]	Sanofi-Pasteur; Institut Pasteur(European Commission); CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); URA (Unite de echerche Associee); Network of Excellence EuroPathoGenomics; French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases"(French National Research Agency (ANR))	SDR was supported by Sanofi-Pasteur. JV was a Marie-Curie Fellow. This work was supported by grants from the Institut Pasteur, CNRS (Centre National de la Recherche Scientifique), URA (Unite de echerche Associee) 2172, the Network of Excellence EuroPathoGenomics; LSHB-CT-2005-512061, and the French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" (grant noANR-10-LABX-62-IBEID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An DD, 2006, P NATL ACAD SCI USA, V103, P3828, DOI 10.1073/pnas.0511323103; Aoki SK, 2008, MOL MICROBIOL, V70, P323, DOI 10.1111/j.1365-2958.2008.06404.x; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Balestrino D, 2008, ENVIRON MICROBIOL, V10, P685, DOI 10.1111/j.1462-2920.2007.01491.x; Beloin C, 2008, CURR TOP MICROBIOL, V322, P249; Bernier C, 2002, INFECT IMMUN, V70, P4302, DOI 10.1128/IAI.70.8.4302-4311.2002; Blango MG, 2009, CURR OPIN MICROBIOL, V12, P177, DOI 10.1016/j.mib.2009.01.011; Boles BR, 2004, P NATL ACAD SCI USA, V101, P16630, DOI 10.1073/pnas.0407460101; Bourlioux P, 2003, AM J CLIN NUTR, V78, P675, DOI 10.1093/ajcn/78.4.675; Campbell A. M., 1996, ESCHERICHIA COLI SAL, P2041; Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x; Chang DE, 2004, P NATL ACAD SCI USA, V101, P7427, DOI 10.1073/pnas.0307888101; Chaveroche MK, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e97; Conway T, 2004, ESCHERICHIA COLI SAL; Coudeyras S, 2008, INFECT IMMUN, V76, P4633, DOI 10.1128/IAI.00356-08; Da Re S, 2007, APPL ENVIRON MICROB, V73, P3391, DOI 10.1128/AEM.02625-06; Daw MA, 1996, MICRON, V27, P467, DOI 10.1016/S0968-4328(96)00028-5; Domka J, 2006, APPL ENVIRON MICROB, V72, P2449, DOI 10.1128/AEM.72.4.2449-2459.2006; Favre-Bonte S, 1999, INFECT IMMUN, V67, P554, DOI 10.1128/IAI.67.2.554-561.1999; Garcia-Contreras R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002394; Ghigo JM, 2001, NATURE, V412, P442, DOI 10.1038/35086581; Gibbs KA, 2008, SCIENCE, V321, P256, DOI 10.1126/science.1160033; Girard V, 2010, J BIOL CHEM, V285, P10616, DOI 10.1074/jbc.M109.069070; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hansen SK, 2007, NATURE, V445, P533, DOI 10.1038/nature05514; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Jayaraman A, 2008, ANNU REV BIOMED ENG, V10, P145, DOI 10.1146/annurev.bioeng.10.061807.160536; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Lai EM, 2004, MOL MICROBIOL, V52, P1029, DOI 10.1111/j.1365-2958.2004.04040.x; Leser TD, 2009, ENVIRON MICROBIOL, V11, P2194, DOI 10.1111/j.1462-2920.2009.01941.x; Macfarlane S, 2007, J APPL MICROBIOL, V102, P1187, DOI 10.1111/j.1365-2672.2007.03287.x; Marteau P, 2004, MINI-REV MED CHEM, V4, P889, DOI 10.2174/1389557043403369; Martinez-Jehanne V, 2009, INFECT IMMUN, V77, P1442, DOI 10.1128/IAI.01039-08; Moal VLL, 2006, CLIN MICROBIOL REV, V19, P315, DOI 10.1128/CMR.19.2.315-337.2006; Nonaka G, 2006, GENE DEV, V20, P1776, DOI 10.1101/gad.1428206; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Polissi A, 2003, RES MICROBIOL, V154, P573, DOI 10.1016/S0923-2508(03)00167-0; POULSEN LK, 1994, INFECT IMMUN, V62, P5191, DOI 10.1128/IAI.62.11.5191-5194.1994; Ramsey MM, 2009, P NATL ACAD SCI USA, V106, P1578, DOI 10.1073/pnas.0809533106; Reid G, 2001, TRENDS MICROBIOL, V9, P424, DOI 10.1016/S0966-842X(01)02132-1; Rendueles O, 2012, FEMS MICROBIOL REV, V36, P972, DOI 10.1111/j.1574-6976.2012.00328.x; Rendueles O, 2011, MBIO, V2, DOI 10.1128/mBio.00043-11; ROLFE RD, 1984, REV INFECT DIS, V6, pS73; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Skurnik M, 2006, INT J MED MICROBIOL, V296, P5, DOI 10.1016/j.ijmm.2005.09.002; Sonnenburg JL, 2006, PLOS BIOL, V4, P2213, DOI 10.1371/journal.pbio.0040413; Stecher B, 2008, TRENDS MICROBIOL, V16, P107, DOI 10.1016/j.tim.2007.12.008; Steidler L, 2003, NAT BIOTECHNOL, V21, P785, DOI 10.1038/nbt840; STOUT V, 1991, J BACTERIOL, V173, P1738, DOI 10.1128/jb.173.5.1738-1747.1991; Swidsinski A, 2005, J CLIN MICROBIOL, V43, P3380, DOI 10.1128/JCM.43.7.3380-3389.2005; Tait K, 2002, J APPL MICROBIOL, V93, P345, DOI 10.1046/j.1365-2672.2002.01692.x; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Ulett GC, 2007, INFECT IMMUN, V75, P3233, DOI 10.1128/IAI.01952-06; Valle J, 2008, J BACTERIOL, V190, P264, DOI 10.1128/JB.01405-07; Valle J, 2006, P NATL ACAD SCI USA, V103, P12558, DOI 10.1073/pnas.0605399103; Vianney A, 2005, MICROBIOL-SGM, V151, P2487, DOI 10.1099/mic.0.27913-0; VOLLAARD EJ, 1994, ANTIMICROB AGENTS CH, V38, P409, DOI 10.1128/AAC.38.3.409; Walters M, 2006, INT J MED MICROBIOL, V296, P125, DOI 10.1016/j.ijmm.2006.01.041; White-Ziegler CA, 2008, MICROBIOL-SGM, V154, P148, DOI 10.1099/mic.0.2007/012021-0; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001	64	21	21	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e61628	10.1371/journal.pone.0061628	http://dx.doi.org/10.1371/journal.pone.0061628			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667443	Green Published, gold, Green Submitted			2022-12-25	WOS:000319654700015
J	Igawa, T; Maeda, A; Haraya, K; Tachibana, T; Iwayanagi, Y; Mimoto, F; Higuchi, Y; Ishii, S; Tamba, S; Hironiwa, N; Nagano, K; Wakabayashi, T; Tsunoda, H; Hattori, K				Igawa, Tomoyuki; Maeda, Atsuhiko; Haraya, Kenta; Tachibana, Tatsuhiko; Iwayanagi, Yuki; Mimoto, Futa; Higuchi, Yoshinobu; Ishii, Shinya; Tamba, Shigero; Hironiwa, Naoka; Nagano, Kozue; Wakabayashi, Tetsuya; Tsunoda, Hiroyuki; Hattori, Kunihiro			Engineered Monoclonal Antibody with Novel Antigen-Sweeping Activity In Vivo	PLOS ONE			English	Article							NEONATAL FC-RECEPTOR; THERAPEUTIC ANTIBODIES; HUMAN IGG1; HALF-LIFE; LIGAND INTERACTIONS; CYNOMOLGUS MONKEYS; IMMUNOGLOBULIN-G; AFFINITY; PHARMACOKINETICS; BINDING	Monoclonal antibodies are widely used to target disease-related antigens. However, because conventional antibody binds to the antigen but cannot eliminate the antigen from plasma, and rather increases the plasma antigen concentration by reducing the clearance of the antigen, some clinically important antigens are still difficult to target with monoclonal antibodies because of the huge dosages required. While conventional antibody can only bind to the antigen, some natural endocytic receptors not only bind to the ligands but also continuously eliminate them from plasma by pH-dependent dissociation of the ligands within the acidic endosome and subsequent receptor recycling to the cell surface. Here, we demonstrate that an engineered antibody, named sweeping antibody, having both pH-dependent antigen binding (to mimic the receptor-ligand interaction) and increased binding to cell surface neonatal Fc receptor (FcRn) at neutral pH (to mimic the cell-bound form of the receptor), selectively eliminated the antigen from plasma. With this novel antigen-sweeping activity, antibody without in vitro neutralizing activity exerted in vivo efficacy by directly eliminating the antigen from plasma. Moreover, conversion of conventional antibody with in vitro neutralizing activity into sweeping antibody further potentiated the in vivo efficacy. Depending on the binding affinity to FcRn at neutral pH, sweeping antibody reduced antigen concentration 50- to 1000-fold compared to conventional antibody. Thereby, sweeping antibody antagonized excess amounts of antigen in plasma against which conventional antibody was completely ineffective, and could afford marked reduction of dosage to a level that conventional antibody can never achieve. Thus, the novel mode of action of sweeping antibody provides potential advantages over conventional antibody and may allow access to the target antigens which were previously undruggable by conventional antibody.	[Igawa, Tomoyuki; Maeda, Atsuhiko; Haraya, Kenta; Tachibana, Tatsuhiko; Iwayanagi, Yuki; Mimoto, Futa; Higuchi, Yoshinobu; Ishii, Shinya; Tamba, Shigero; Hironiwa, Naoka; Nagano, Kozue; Wakabayashi, Tetsuya; Tsunoda, Hiroyuki; Hattori, Kunihiro] Chugai Pharmaceut Co Ltd, Div Res, Shizuoka, Japan	Chugai Pharmaceutical Co., Ltd.; Roche Holding	Igawa, T (corresponding author), Chugai Pharmaceut Co Ltd, Div Res, Shizuoka, Japan.	igawatmy@chugai-pharm.co.jp	HARAYA, KENTA/AAW-4267-2020	HARAYA, KENTA/0000-0002-9142-5607; Tachibana, Tatsuhiko/0000-0001-8339-3986				Betts AM, 2010, J PHARMACOL EXP THER, V333, P2, DOI 10.1124/jpet.109.164129; Byrd JC, 2007, CLIN CANCER RES, V13, P4448, DOI 10.1158/1078-0432.CCR-06-1463; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Dall'Acqua WF, 2002, J IMMUNOL, V169, P5171, DOI 10.4049/jimmunol.169.9.5171; Dall'Acqua WF, 2006, J BIOL CHEM, V281, P23514, DOI 10.1074/jbc.M604292200; Datta-Mannan A, 2007, J BIOL CHEM, V282, P1709, DOI 10.1074/jbc.M607161200; Davda JP, 2010, MABS-AUSTIN, V2, P576, DOI 10.4161/mabs.2.5.12833; Davis CB, 1999, DRUG DELIV, V6, P171, DOI 10.1080/107175499266922; Deng R, 2012, MABS-AUSTIN, V4, P101, DOI 10.4161/mabs.4.1.18543; Deng R, 2010, DRUG METAB DISPOS, V38, P600, DOI 10.1124/dmd.109.031310; Feinberg H, 2000, J BIOL CHEM, V275, P35176, DOI 10.1074/jbc.M005557200; Finch DK, 2011, J MOL BIOL, V411, P791, DOI 10.1016/j.jmb.2011.06.031; FINKELMAN FD, 1993, J IMMUNOL, V151, P1235; FRENCH AR, 1995, J BIOL CHEM, V270, P4334, DOI 10.1074/jbc.270.9.4334; Haringman JJ, 2006, ARTHRITIS RHEUM, V54, P2387, DOI 10.1002/art.21975; Hinton PR, 2006, J IMMUNOL, V176, P346, DOI 10.4049/jimmunol.176.1.346; Igawa T, 2010, NAT BIOTECHNOL, V28, P1203, DOI 10.1038/nbt.1691; Jayson GC, 2005, EUR J CANCER, V41, P555, DOI 10.1016/j.ejca.2004.11.021; Jostock T, 2001, EUR J BIOCHEM, V268, P160, DOI 10.1046/j.1432-1327.2001.01867.x; Martin PL, 2005, J IMMUNOTOXICOL, V3, P131; Ober RJ, 2001, INT IMMUNOL, V13, P1551, DOI 10.1093/intimm/13.12.1551; Okazaki M, 2002, IMMUNOL LETT, V84, P231, DOI 10.1016/S0165-2478(02)00202-X; Ozbek S, 2001, ONCOGENE, V20, P972, DOI 10.1038/sj.onc.1204180; Petkova SB, 2006, INT IMMUNOL, V18, P1759, DOI 10.1093/intimm/dxl110; Preithner S, 2006, MOL IMMUNOL, V43, P1183, DOI 10.1016/j.molimm.2005.07.010; RASHID A, 1992, J IMMUNOL, V148, P1382; Rathanaswami P, 2005, BIOCHEM BIOPH RES CO, V334, P1004, DOI 10.1016/j.bbrc.2005.07.002; Roopenian DC, 2010, METHODS MOL BIOL, V602, P93, DOI 10.1007/978-1-60761-058-8_6; Vaccaro C, 2005, NAT BIOTECHNOL, V23, P1283, DOI 10.1038/nbt1143; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744; Xiao JJ, 2010, AAPS J, V12, P646, DOI 10.1208/s12248-010-9222-0; Yamamoto T, 2008, BIOCHEMISTRY-US, V47, P11647, DOI 10.1021/bi801117t; Yeung YA, 2009, J IMMUNOL, V182, P7663, DOI 10.4049/jimmunol.0804182; Zalevsky J, 2010, NAT BIOTECHNOL, V28, P157, DOI 10.1038/nbt.1601; Zareba KM, 2007, DRUGS TODAY, V43, P539, DOI 10.1358/dot.2007.43.8.1130446	35	55	77	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63236	10.1371/journal.pone.0063236	http://dx.doi.org/10.1371/journal.pone.0063236			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667591	gold, Green Published, Green Submitted			2022-12-25	WOS:000319654700121
J	Isaksson, L; Mayzel, M; Saline, M; Pedersen, A; Rosenlow, J; Brutscher, B; Karlsson, BG; Orekhov, VY				Isaksson, Linnea; Mayzel, Maxim; Saline, Maria; Pedersen, Anders; Rosenlow, Joakim; Brutscher, Bernhard; Karlsson, B. Goran; Orekhov, Vladislav Y.			Highly Efficient NMR Assignment of Intrinsically Disordered Proteins: Application to B- and T Cell Receptor Domains	PLOS ONE			English	Article							COMPLETE SEQUENCE; ACTIVATION MOTIF; CHEMICAL-SHIFTS; SPECTROSCOPY; VALIDATION; EXPRESSION; INITIATION; RECOGNITION; MODELS; SYSTEM	We present an integrated approach for efficient characterization of intrinsically disordered proteins. Batch cell-free expression, fast data acquisition, automated analysis, and statistical validation with data resampling have been combined for achieving cost-effective protein expression, and rapid automated backbone assignment. The new methodology is applied for characterization of five cytosolic domains from T- and B-cell receptors in solution.	[Isaksson, Linnea; Mayzel, Maxim; Saline, Maria; Pedersen, Anders; Rosenlow, Joakim; Karlsson, B. Goran; Orekhov, Vladislav Y.] Univ Gothenburg, Swedish NMR Ctr, Gothenburg, Sweden; [Brutscher, Bernhard] Univ Grenoble, Inst Biol Struct, CEA, CNRS, Grenoble, France	University of Gothenburg; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Orekhov, VY (corresponding author), Univ Gothenburg, Swedish NMR Ctr, Gothenburg, Sweden.	vladislav.orekhov@nmr.gu.se	Orekhov, Vladislav/AAD-8464-2019; Mayzel, Maksim/AAM-1393-2020; Karlsson, Göran/E-8686-2011; Pedersen, Anders/N-3888-2014; Orekhov, Vladislav/AAC-8357-2022	Orekhov, Vladislav/0000-0002-7892-6896; Pedersen, Anders/0000-0001-8704-5129; Karlsson, Goran/0000-0002-1821-4715	Swedish Research Council [621-2005-2951, 2011-5994]; Wenner-Gren Foundation (Stockholm); European Commis-sion (FP7-I3-Bio-NMR project) [261863]; European Commis-sion (FP7-ITN-IDPbyNMR) [264257]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Wenner-Gren Foundation (Stockholm); European Commis-sion (FP7-I3-Bio-NMR project); European Commis-sion (FP7-ITN-IDPbyNMR)	The work was supported by the Swedish Research Council (621-2005-2951, 2011-5994), Wenner-Gren Foundation (Stockholm), and the European Commis-sion (FP7-I3-Bio-NMR project No. 261863 and FP7-ITN-IDPbyNMR contract No. 264257). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagaria A, 2012, PROTEIN SCI, V21, P229, DOI 10.1002/pro.2007; Bermel W, 2006, J AM CHEM SOC, V128, P3918, DOI 10.1021/ja0582206; BRUNGER AT, 1993, SCIENCE, V261, P328, DOI 10.1126/science.8332897; Buck M, 1998, Q REV BIOPHYS, V31, P297, DOI 10.1017/S003358359800345X; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DYSON HJ, 1992, J MOL BIOL, V226, P819, DOI 10.1016/0022-2836(92)90634-V; DYSON HJ, 1992, J MOL BIOL, V226, P795, DOI 10.1016/0022-2836(92)90633-U; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Efron B, 1993, INTRO BOOTSTRAP, Vxvi; Efron B, 1982, JACKKNIFE BOOTSTRAP, Vvii; Favier A, 2011, J BIOMOL NMR, V49, P9, DOI 10.1007/s10858-010-9461-5; Gaul BS, 2000, J BIOL CHEM, V275, P16174, DOI 10.1074/jbc.M909044199; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Jaravine V, 2006, NAT METHODS, V3, P605, DOI 10.1038/NMETH900; Jaravine VA, 2008, J AM CHEM SOC, V130, P3927, DOI 10.1021/ja077282o; Jaravine VA, 2006, J AM CHEM SOC, V128, P13421, DOI 10.1021/ja062146p; Kanter G, 2007, BLOOD, V109, P3393, DOI 10.1182/blood-2006-07-030593; Kazimierczuk K, 2011, ANGEW CHEM INT EDIT, V50, P5556, DOI 10.1002/anie.201100370; Kigawa T, 1999, FEBS LETT, V442, P15, DOI 10.1016/S0014-5793(98)01620-2; Kjaergaard M, 2012, PROG NUCL MAG RES SP, V60, P42, DOI 10.1016/j.pnmrs.2011.10.001; Klammt C, 2004, EUR J BIOCHEM, V271, P568, DOI 10.1111/j.1432-1033.2003.03959.x; Kurotani A, 2010, FASEB J, V24, P1095, DOI 10.1096/fj.09-139527; Mantylahti S, 2010, J BIOMOL NMR, V47, P171, DOI 10.1007/s10858-010-9421-0; Mittag T, 2007, CURR OPIN STRUC BIOL, V17, P3, DOI 10.1016/j.sbi.2007.01.009; Modig K, 2007, FEBS LETT, V581, P4965, DOI 10.1016/j.febslet.2007.09.027; Moseley HNB, 2004, J BIOMOL NMR, V28, P341, DOI 10.1023/B:JNMR.0000015420.44364.06; Motackova V, 2010, J BIOMOL NMR, V48, P169, DOI 10.1007/s10858-010-9447-3; Narayanan RL, 2010, J AM CHEM SOC, V132, P11906, DOI 10.1021/ja105657f; Orekhov VY, 2011, PROG NUCL MAG RES SP, V59, P271, DOI 10.1016/j.pnmrs.2011.02.002; Orekhov VY, 2001, J BIOMOL NMR, V20, P49, DOI 10.1023/A:1011234126930; Ozawa K, 2004, EUR J BIOCHEM, V271, P4084, DOI 10.1111/j.1432-1033.2004.04346.x; Pedersen A, 2011, NEW BIOTECHNOL, V28, P218, DOI 10.1016/j.nbt.2010.06.015; Salmon L, 2010, J AM CHEM SOC, V132, P8407, DOI 10.1021/ja101645g; SEGAWA S, 1991, BIOPOLYMERS, V31, P497, DOI 10.1002/bip.360310505; Sigalov A, 2004, BIOCHEMISTRY-US, V43, P2049, DOI 10.1021/bi035900h; Sigalov AB, 2006, BIOCHEMISTRY-US, V45, P15731, DOI 10.1021/bi061108f; Solyom Z, 2013, J BIOMOL NM IN PRESS, DOI [10.1007/s10858-013-9715-0, DOI 10.1007/S10858-013-9715-0:IN]; Stein A, 2009, FEBS J, V276, P5390, DOI 10.1111/j.1742-4658.2009.07251.x; Tompa P, 2010, STRUCTURE FUNCTION I, Vxxvii; Tugarinov V, 2005, CHEMBIOCHEM, V6, P1567, DOI 10.1002/cbic.200500110; Tzakos AG, 2006, ANNU REV BIOPH BIOM, V35, P319, DOI 10.1146/annurev.biophys.35.040405.102034; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; van den Berg S, 2006, J BIOTECHNOL, V121, P291, DOI 10.1016/j.jbiotec.2005.08.006; Vinarov DA, 2004, NAT METHODS, V1, P149, DOI 10.1038/NMETH716; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang BW, 2010, J BIOMOL NMR, V47, P85, DOI 10.1007/s10858-010-9407-y; Woodrow KA, 2006, J PROTEOME RES, V5, P3288, DOI 10.1021/pr050459y; Zhang HY, 2003, J BIOMOL NMR, V25, P173, DOI 10.1023/A:1022836027055	48	37	37	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62947	10.1371/journal.pone.0062947	http://dx.doi.org/10.1371/journal.pone.0062947			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667548	Green Published, gold, Green Submitted			2022-12-25	WOS:000319654700086
J	Song, JY; Qin, W; Liu, Y; Duan, YY; Liu, JQ; He, XX; Li, KC; Zhang, XQ; Jiang, TZ; Yu, CS				Song, Jinyu; Qin, Wen; Liu, Yong; Duan, Yunyun; Liu, Jieqiong; He, Xiaoxi; Li, Kuncheng; Zhang, Xinqing; Jiang, Tianzi; Yu, Chunshui			Aberrant Functional Organization within and between Resting-State Networks in AD	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; DEFAULT-MODE NETWORK; DISTINCT BRAIN NETWORKS; ALZHEIMERS-DISEASE; CONNECTIVITY NETWORKS; POSTERIOR CINGULATE; VISUAL-ATTENTION; MRI DATA; FMRI; DEMENTIA	Altered functional characteristics have been reported in amnestic mild cognitive impairment (aMCI) and Alzheimer's disease (AD); nonetheless, comprehensive analyses of the resting-state networks (RSNs) are rare. This study combined multiple imaging modalities to investigate the functional and structural changes within each RSN and between RSNs in aMCI/AD patients. Eight RSNs were identified from functional MRI data from 35 AD, 18 aMCI and 21 normal control subjects using independent component analysis. We compared functional connectivity (FC) within each RSN and found decreased FC in the several cognitive-related RSNs in AD, including the bilateral precuneus of the precuneus network, the posterior cingulate cortex and left precuneus of the posterior default mode network (DMN), and the left superior parietal lobule of the left frontoparietal network (LFP). We further compared the grey matter volumes and amplitudes of low-frequency fluctuations of these regions and found decreases in these measures in AD. Importantly, we found decreased inter-network connectivity between the visual network and the LFP and between the anterior and posterior DMNs in AD. All indices in aMCI patients were numerically between those of controls and AD patients. These results suggest that the brain networks supporting complex cognitive processes are specifically and progressively impaired over the course of AD, and the FC impairments are present not only within networks but also between networks.	[Song, Jinyu; Qin, Wen; He, Xiaoxi; Yu, Chunshui] Tianjin Med Univ, Gen Hosp, Dept Radiol, Tianjin, Peoples R China; [Liu, Yong; Jiang, Tianzi] Chinese Acad Sci, Inst Automat, Natl Lab Pattern Recognit, Beijing, Peoples R China; [Liu, Jieqiong; Zhang, Xinqing] Capital Med Univ, Xuanwu Hosp, Dept Neurol, Beijing, Peoples R China; [Duan, Yunyun; Li, Kuncheng] Capital Med Univ, Xuanwu Hosp, Dept Radiol, Beijing, Peoples R China	Tianjin Medical University; Chinese Academy of Sciences; Institute of Automation, CAS; Capital Medical University; Capital Medical University	Zhang, XQ (corresponding author), Capital Med Univ, Xuanwu Hosp, Dept Neurol, Beijing, Peoples R China.	xinqingzhang@263.net; jiangtz@nlpr.ia.ac.cn; chunshuiyu@yahoo.cn	Jiang, Tianzi/I-4256-2012; Liu, Yong/F-2682-2011; QIN, WEN/F-3783-2015	Jiang, Tianzi/0000-0001-9531-291X; Liu, Yong/0000-0002-1862-3121; QIN, WEN/0000-0002-9121-8296; Yu, Chunshui/0000-0001-5648-5199	Natural Science Foundation of Tianjin [11JCZDJC19300]; National Basic Research Program of China (973 program) [2011CB707801]; Natural Science Foundation of China [81271551, 60831004, 30900476]; International Cooperation and Exchanges NSFC [30370434]	Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin); National Basic Research Program of China (973 program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Cooperation and Exchanges NSFC	This work was supported by the Natural Science Foundation of Tianjin (No. 11JCZDJC19300), the National Basic Research Program of China (973 program, No. 2011CB707801), the Natural Science Foundation of China (Nos. 81271551, 60831004, 30900476), and the International Cooperation and Exchanges NSFC (No. 30370434). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta F, 2012, NEUROBIOL AGING, V33, P1564, DOI 10.1016/j.neurobiolaging.2011.06.007; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bai F, 2008, NEUROSCI LETT, V438, P111, DOI 10.1016/j.neulet.2008.04.021; Bai F, 2012, CORTEX, V48, P604, DOI 10.1016/j.cortex.2011.02.011; Bai F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024271; Bai F, 2009, BRAIN RES, V1302, P167, DOI 10.1016/j.brainres.2009.09.028; Binnewijzend MAA, 2012, NEUROBIOL AGING, V33, P2018, DOI 10.1016/j.neurobiolaging.2011.07.003; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bokde ALW, 2008, PSYCHIAT RES-NEUROIM, V163, P248, DOI 10.1016/j.pscychresns.2007.08.013; Brier MR, 2012, J NEUROSCI, V32, P8890, DOI 10.1523/JNEUROSCI.5698-11.2012; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Buckner RL, 2004, NEURON, V44, P195, DOI 10.1016/j.neuron.2004.09.006; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Calhoun VD, 2001, HUM BRAIN MAPP, V13, P43, DOI 10.1002/hbm.1024; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Chadick JZ, 2011, NAT NEUROSCI, V14, P830, DOI 10.1038/nn.2823; Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Damoiseaux JS, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.06.024; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Dorfel D, 2009, EUR J NEUROSCI, V30, P1947, DOI 10.1111/j.1460-9568.2009.06973.x; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Edison P, 2007, NEUROLOGY, V68, P501, DOI 10.1212/01.wnl.0000244749.20056.d4; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Fita IG, 2011, ROM J MORPHOL EMBRYO, V52, P975; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Galvin JE, 2011, NEUROLOGY, V76, P1797, DOI 10.1212/WNL.0b013e31821ccc83; Greicius MD, 2004, J COGNITIVE NEUROSCI, V16, P1484, DOI 10.1162/0898929042568532; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Hanggi J, 2011, J ALZHEIMERS DIS, V26, P719, DOI 10.3233/JAD-2011-101260; Han SH, 2004, HUM BRAIN MAPP, V22, P321, DOI 10.1002/hbm.20044; Hao J, 2005, NEUROSCI LETT, V385, P18, DOI 10.1016/j.neulet.2005.05.028; He Y, 2009, NEUROSCIENTIST, V15, P333, DOI 10.1177/1073858409334423; Hedden T, 2006, NAT NEUROSCI, V9, P863, DOI 10.1038/nn0706-863; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Jin MW, 2012, MAGN RESON IMAGING, V30, P48, DOI 10.1016/j.mri.2011.07.007; Karas G, 2007, NEURORADIOLOGY, V49, P967, DOI 10.1007/s00234-007-0269-2; Kastner S, 2001, NEUROPSYCHOLOGIA, V39, P1263, DOI 10.1016/S0028-3932(01)00116-6; KAWASHIMA R, 1995, CEREB CORTEX, V5, P111, DOI 10.1093/cercor/5.2.111; Kjaer TW, 2002, NEUROIMAGE, V17, P1080, DOI 10.1006/nimg.2002.1230; Kjaer TW, 2001, CONSCIOUS COGN, V10, P356, DOI 10.1006/ccog.2001.0509; Koechlin E, 2007, TRENDS COGN SCI, V11, P229, DOI 10.1016/j.tics.2007.04.005; Li R, 2012, AJNR AM J N IN PRESS; Li R, 2012, HUM BRAIN MAPP, V33, P1076, DOI 10.1002/hbm.21269; Liao W, 2010, NEUROIMAGE, V52, P1549, DOI 10.1016/j.neuroimage.2010.05.010; Liao W, 2010, BIOL CYBERN, V102, P57, DOI 10.1007/s00422-009-0350-5; Lou HC, 2004, P NATL ACAD SCI USA, V101, P6827, DOI 10.1073/pnas.0400049101; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Lundstrom BN, 2005, NEUROIMAGE, V27, P824, DOI 10.1016/j.neuroimage.2005.05.008; Lundstrom BN, 2003, NEUROIMAGE, V20, P1934, DOI 10.1016/j.neuroimage.2003.07.017; Lustig C, 2003, P NATL ACAD SCI USA, V100, P14504, DOI 10.1073/pnas.2235925100; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; McKeown MJ, 1998, HUM BRAIN MAPP, V6, P160, DOI 10.1002/(SICI)1097-0193(1998)6:3<160::AID-HBM5>3.0.CO;2-1; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Neufang S, 2011, J ALZHEIMERS DIS, V25, P309, DOI 10.3233/JAD-2011-102154; Onoda K, 2012, J COGN NEUR IN PRESS; Perry RJ, 1999, BRAIN, V122, P383, DOI 10.1093/brain/122.3.383; Perry RJ, 2000, NEUROPSYCHOLOGIA, V38, P252, DOI 10.1016/S0028-3932(99)00079-2; Petersen R C, 1997, Int Psychogeriatr, V9 Suppl 1, P65, DOI 10.1017/S1041610297004717; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Petrella JR, 2011, NEUROLOGY, V76, P511, DOI 10.1212/WNL.0b013e31820af94e; Petrella JR, 2007, RADIOLOGY, V245, P224, DOI 10.1148/radiol.2451061847; Pignatti R, 2005, J CLIN EXP NEUROPSYC, V27, P436, DOI 10.1080/13803390490520427; Putcha D, 2011, J NEUROSCI, V31, P17680, DOI 10.1523/JNEUROSCI.4740-11.2011; Qi ZG, 2010, NEUROIMAGE, V50, P48, DOI 10.1016/j.neuroimage.2009.12.025; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rajapakse JC, 1997, IEEE T MED IMAGING, V16, P176, DOI 10.1109/42.563663; Reid W, 1996, ARCH NEUROL-CHICAGO, V53, P1056, DOI 10.1001/archneur.1996.00550100142023; Rombouts SARB, 2009, HUM BRAIN MAPP, V30, P256, DOI 10.1002/hbm.20505; Roosendaal SD, 2010, BRAIN, V133, P1612, DOI 10.1093/brain/awq058; Rosler A, 2005, CORTEX, V41, P512, DOI 10.1016/S0010-9452(08)70191-6; Schwindt GC, 2012, CEREB CORTE IN PRESS; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Sheline YI, 2010, BIOL PSYCHIAT, V67, P584, DOI 10.1016/j.biopsych.2009.08.024; Shomstein S, 2012, NEUROPSYCHOLOGIA, V50, P1202, DOI 10.1016/j.neuropsychologia.2012.02.009; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Steffener J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044421; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Tales A, 2002, NEUROPSYCHOLOGIA, V40, P2000, DOI 10.1016/S0028-3932(02)00057-X; van de Ven V, 2008, HUM BRAIN MAPP, V29, P1450, DOI 10.1002/hbm.20479; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Vannini P, 2007, PSYCHIAT RES-NEUROIM, V156, P43, DOI 10.1016/j.pscychresns.2007.02.003; Veer IM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00041; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Vogt BA, 2005, PROG BRAIN RES, V150, P205, DOI 10.1016/S0079-6123(05)50015-3; Wang ZQ, 2011, HUM BRAIN MAPP, V32, P1720, DOI 10.1002/hbm.21140; Weintraub S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006171; Wenderoth N, 2005, EUR J NEUROSCI, V22, P235, DOI 10.1111/j.1460-9568.2005.04176.x; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zhang H, 2010, NEUROIMAGE, V51, P1414, DOI 10.1016/j.neuroimage.2010.03.039; Zhang HY, 2009, BEHAV BRAIN RES, V197, P103, DOI 10.1016/j.bbr.2008.08.012; Zhou J, 2010, BRAIN, V133, P1352, DOI 10.1093/brain/awq075	105	42	47	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63727	10.1371/journal.pone.0063727	http://dx.doi.org/10.1371/journal.pone.0063727			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667665	Green Submitted, Green Published, gold			2022-12-25	WOS:000319654700181
J	Struck, TH				Struck, Torsten H.			The Impact of Paralogy on Phylogenomic Studies - A Case Study on Annelid Relationships	PLOS ONE			English	Article							18S RDNA; SEQUENCE DATA; MITOCHONDRIAL GENOME; MOLECULAR PHYLOGENY; BILATERIAN ANIMALS; DATA SUPPORT; SISTER GROUP; 28S RDNA; POLYCHAETA; COELOMATA	Phylogenomic studies based on hundreds of genes derived from expressed sequence tags libraries are increasingly used to reveal the phylogeny of taxa. A prerequisite for these studies is the assignment of genes into clusters of orthologous sequences. Sophisticated methods of orthology prediction are used in such analyses, but it is rarely assessed whether paralogous sequences have been erroneously grouped together as orthologous sequences after the prediction, and whether this had an impact on the phylogenetic reconstruction using a super-matrix approach. Herein, I tested the impact of paralogous sequences on the reconstruction of annelid relationships based on phylogenomic datasets. Using single-partition analyses, screening for bootstrap support, blast searches and pruning of sequences in the supermatrix, wrongly assigned paralogous sequences were found in eight partitions and the placement of five taxa (the annelids Owenia, Scoloplos, Sthenelais and Eurythoe and the nemertean Cerebratulus) including the robust bootstrap support could be attributed to the presence of paralogous sequences in two partitions. Excluding these sequences resulted in a different, weaker supported placement for these taxa. Moreover, the analyses revealed that paralogous sequences impacted the reconstruction when only a single taxon represented a previously supported higher taxon such as a polychaete family. One possibility of a priori detection of wrongly assigned paralogous sequences could combine 1) a screening of single-partition analyses based on criteria such as nodal support or internal branch length with 2) blast searches of suspicious cases as presented herein. Also possible are a posteriori approaches in which support for specific clades is investigated by comparing alternative hypotheses based on differences in per-site likelihoods. Increasing the sizes of EST libraries will also decrease the likelihood of wrongly assigned paralogous sequences, and in the case of orthology prediction methods like HaMStR it is likewise decreased by using more than one reference taxon.	Zool Res Museum Alexander Koenig, Bonn, Germany	Zoologisches Forschungsmuseum Alexander Koenig (ZFMK)	Struck, TH (corresponding author), Zool Res Museum Alexander Koenig, Bonn, Germany.	torsten.struck.zfmk@uni-bonn.de			German Science Foundation DFG [STR-683/7-1]; DFG [STR-683/8-1]	German Science Foundation DFG(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	The German Science Foundation DFG STR-683/7-1 and DFG STR-683/8-1 funded this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade SCS, 2012, CLADISTICS, V28, P141, DOI 10.1111/j.1096-0031.2011.00376.x; [Anonymous], 2010, RIBOSOMAL PROTEIN GE; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Bleidorn C, 2006, GENE, V370, P96, DOI 10.1016/j.gene.2005.11.018; Bleidorn C, 2003, J ZOOL SYST EVOL RES, V41, P186, DOI 10.1046/j.1439-0469.2003.00212.x; Bleidorn C, 2003, MOL PHYLOGENET EVOL, V29, P279, DOI 10.1016/S1055-7903(03)00107-6; Bleidorn C, 2005, ZOOL J LINN SOC-LOND, V144, P59, DOI 10.1111/j.1096-3642.2005.00160.x; Bleidorn C, 2007, MOL BIOL EVOL, V24, P1690, DOI 10.1093/molbev/msm086; Brown S, 1999, AUST J ZOOL, V47, P499, DOI 10.1071/ZO99026; Campbell LI, 2011, P NATL ACAD SCI USA, V108, P15920, DOI 10.1073/pnas.1105499108; Colgan DJ, 2006, ORG DIVERS EVOL, V6, P220, DOI 10.1016/j.ode.2005.11.002; Dordel J, 2010, J ZOOL SYST EVOL RES, V48, P197, DOI 10.1111/j.1439-0469.2010.00567.x; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Ebersberger I, 2007, MOL BIOL EVOL, V24, P2266, DOI 10.1093/molbev/msm156; Ebersberger I, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-157; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Erseus C, 2004, ZOOL SCR, V33, P187, DOI 10.1111/j.1463-6409.2004.00146.x; Evans NM, 2010, MOL BIOL EVOL, V27, P2733, DOI 10.1093/molbev/msq159; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FISHER EMC, 1990, CELL, V63, P1205, DOI 10.1016/0092-8674(90)90416-C; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; Gee H, 2003, NATURE, V425, P782, DOI 10.1038/425782a; Hall KA, 2004, J MAR BIOL ASSOC UK, V84, P949, DOI 10.1017/S0025315404010240h; Hallstrom BM, 2007, MOL BIOL EVOL, V24, P2059, DOI 10.1093/molbev/msm136; Hartmann S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-95; Hausdorf B, 2007, MOL BIOL EVOL, V24, P2723, DOI 10.1093/molbev/msm214; Hejnol A, 2009, P ROY SOC B-BIOL SCI, V276, P4261, DOI 10.1098/rspb.2009.0896; Holton TA, 2010, GENOME BIOL EVOL, V2, P310, DOI 10.1093/gbe/evq016; Irimia M, 2007, MOL BIOL EVOL, V24, P1604, DOI 10.1093/molbev/msm105; Jamieson Barrie G.M., 2006, P235; Jeffroy O, 2006, TRENDS GENET, V22, P225, DOI 10.1016/j.tig.2006.02.003; Jordens J, 2004, J ZOOL SYST EVOL RES, V42, P270, DOI 10.1111/j.1439-0469.2004.00265.x; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kim K, 2011, BIOINFORMATICS, V27, P1731, DOI 10.1093/bioinformatics/btr259; Kocot KM, 2011, NATURE, V477, P452, DOI 10.1038/nature10382; Kojima S, 1998, MOL PHYLOGENET EVOL, V9, P255, DOI 10.1006/mpev.1997.0472; Kuck P, 2010, MOL PHYLOGENET EVOL, V56, P1115, DOI 10.1016/j.ympev.2010.04.024; Kumar S, 2012, MOL BIOL EVOL, V29, P457, DOI 10.1093/molbev/msr202; Lanterbecq D, 2006, SYST BIOL, V55, P208, DOI 10.1080/10635150500481317; Lartillot N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S4; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Marletaz F, 2006, CURR BIOL, V16, pR577, DOI 10.1016/j.cub.2006.07.016; Martin P, 2001, P ROY SOC B-BIOL SCI, V268, P1089, DOI 10.1098/rspb.2001.1616; McHugh D, 2000, CAN J ZOOL, V78, P1873, DOI 10.1139/cjz-78-11-1873; McHugh D, 2005, HYDROBIOLOGIA, V535, P309, DOI 10.1007/s10750-004-4414-1; McHugh D, 1997, P NATL ACAD SCI USA, V94, P8006, DOI 10.1073/pnas.94.15.8006; Meusemann K, 2010, MOL BIOL EVOL, V27, P2451, DOI 10.1093/molbev/msq130; Nesnidal MP, 2010, MOL BIOL EVOL, V27, P2095, DOI 10.1093/molbev/msq097; Paps J, 2009, MOL BIOL EVOL, V26, P2397, DOI 10.1093/molbev/msp150; Paps J, 2009, P ROY SOC B-BIOL SCI, V276, P1245, DOI 10.1098/rspb.2008.1574; Passamaneck Y, 2006, MOL PHYLOGENET EVOL, V40, P20, DOI 10.1016/j.ympev.2006.02.001; Passamaneck YJ, 2004, MOL PHYLOGENET EVOL, V32, P25, DOI 10.1016/j.ympev.2003.12.016; Philip GK, 2005, MOL BIOL EVOL, V22, P1175, DOI 10.1093/molbev/msi102; Philippe H, 2005, MOL BIOL EVOL, V22, P1246, DOI 10.1093/molbev/msi111; Philippe H, 2004, MOL BIOL EVOL, V21, P1740, DOI 10.1093/molbev/msh182; Philippe H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000717; Philippe H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000602; Philippe H, 2011, NATURE, V470, P255, DOI 10.1038/nature09676; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; Rodriguez-Ezpeleta N, 2007, CURR BIOL, V17, P1420, DOI 10.1016/j.cub.2007.07.036; Roeding F, 2007, MOL PHYLOGENET EVOL, V45, P942, DOI 10.1016/j.ympev.2007.09.002; Rota-Stabelli O, 2011, P ROY SOC B-BIOL SCI, V278, P298, DOI 10.1098/rspb.2010.0590; Rouse GW, 1997, ZOOL SCR, V26, P139, DOI 10.1111/j.1463-6409.1997.tb00412.x; Rousset V, 2007, CLADISTICS, V23, P41, DOI 10.1111/j.1096-0031.2006.00128.x; Roy SW, 2008, MOL BIOL EVOL, V25, P620, DOI 10.1093/molbev/msn035; Roy SW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004568; Roy SW, 2005, P NATL ACAD SCI USA, V102, P4403, DOI 10.1073/pnas.0409891102; Ruiz-Trillo I, 2002, P NATL ACAD SCI USA, V99, P11246, DOI 10.1073/pnas.172390199; Ruiz-Trillo I, 2008, MOL BIOL EVOL, V25, P664, DOI 10.1093/molbev/msn006; Sanderson MJ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-155; Schulze A, 2007, MOL PHYLOGENET EVOL, V42, P171, DOI 10.1016/j.ympev.2006.06.012; Shi GQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020892; Smith SA, 2008, BIOINFORMATICS, V24, P715, DOI 10.1093/bioinformatics/btm619; Smith SA, 2011, NATURE, V480, P364, DOI 10.1038/nature10526; Sperling EA, 2009, MOL BIOL EVOL, V26, P2261, DOI 10.1093/molbev/msp148; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Struck TH, 2005, MAR BIOL RES, V1, P243, DOI 10.1080/17451000500261951; Struck TH, 2008, MOL PHYLOGENET EVOL, V48, P628, DOI 10.1016/j.ympev.2008.05.015; Struck TH, 2008, MOL BIOL EVOL, V25, P728, DOI 10.1093/molbev/msn019; Struck TH, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-57; Struck TH, 2011, NATURE, V471, P95, DOI 10.1038/nature09864; von Reumont BM, 2012, MOL BIOL EVOL, V29, P1031, DOI 10.1093/molbev/msr270; Wiklund H, 2005, MOL PHYLOGENET EVOL, V37, P494, DOI 10.1016/j.ympev.2005.07.005; Wolf YI, 2004, GENOME RES, V14, P29, DOI 10.1101/gr.1347404; Zrzavy J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-189	86	46	46	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62892	10.1371/journal.pone.0062892	http://dx.doi.org/10.1371/journal.pone.0062892			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667537	gold, Green Submitted, Green Published			2022-12-25	WOS:000319654700076
J	Zhao, XS; Yang, CH; Simon, MA				Zhao, Xuesong; Yang, Chung-hui; Simon, Michael A.			The Drosophila Cadherin Fat Regulates Tissue Size and Planar Cell Polarity through Different Domains	PLOS ONE			English	Article							HIPPO SIGNALING PATHWAY; TUMOR-SUPPRESSOR GENE; IMAGINAL DISC GROWTH; PROMOTES APOPTOSIS; IN-VIVO; PROLIFERATION ARREST; PROTEIN-KINASE; CYCLE EXIT; EYE; EXPRESSION	The Drosophila Cadherin Fat (Ft) has been identified as a crucial regulator of tissue size and Planar Cell Polarity (PCP). However, the precise mechanism by which Ft regulates these processes remains unclear. In order to advance our understanding of the action of Ft, we have sought to identify the crucial Ft effector domains. Here we report that a small region of the Ft cytoplasmic domain (H2 region) is both necessary and sufficient, when membrane localized, to support viability and prevent tissue overgrowth. Interestingly, the H2 region is dispensable for regulating PCP signaling, whereas the mutant Ft lacking the H2 region is fully capable of directing PCP. This result suggests that Ft's roles in PCP signaling and tissue size control are separable, and each can be carried out independently. Surprisingly, the crucial regions of Ft identified in our structure-function study do not overlap with the previously reported interaction regions with Atrophin, Dco, or Lowfat.	[Zhao, Xuesong; Yang, Chung-hui; Simon, Michael A.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University	Simon, MA (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	msimon@stanford.edu	Zhao, Xuesong/B-2762-2012	Zhao, Xuesong/0000-0003-3007-7124	National Institutes of Health (NIH) [R01 GM069923]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069923] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by National Institutes of Health (NIH) grant R01 GM069923 to MAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelrod JD, 2009, SEMIN CELL DEV BIOL, V20, P964, DOI 10.1016/j.semcdb.2009.08.001; Bayly R, 2011, NAT REV GENET, V12, P385, DOI 10.1038/nrg2956; Bennett FC, 2006, CURR BIOL, V16, P2101, DOI 10.1016/j.cub.2006.09.045; BRAND AH, 1993, DEVELOPMENT, V118, P401; BRYANT PJ, 1988, DEV BIOL, V129, P541, DOI 10.1016/0012-1606(88)90399-5; Buckles GR, 2001, DEVELOPMENT, V128, P3533; Cho E, 2006, NAT GENET, V38, P1142, DOI 10.1038/ng1887; Cooper MTD, 1999, NATURE, V397, P526, DOI 10.1038/17395; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Edgar BA, 2006, CELL, V124, P267, DOI 10.1016/j.cell.2006.01.005; Fanto M, 2003, DEVELOPMENT, V130, P763, DOI 10.1242/dev.00304; Feng YQ, 2007, P NATL ACAD SCI USA, V104, P20362, DOI 10.1073/pnas.0706722105; Feng YQ, 2009, P NATL ACAD SCI USA, V106, P11989, DOI 10.1073/pnas.0811540106; Garoia F, 2000, MECH DEVELOP, V94, P95, DOI 10.1016/S0925-4773(00)00306-3; Hariharan IK, 2006, CURR BIOL, V16, pR1037, DOI 10.1016/j.cub.2006.11.012; Hariharan IK, 2006, ANNU REV GENET, V40, P335, DOI 10.1146/annurev.genet.39.073003.100738; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Harvey KF, 2012, COLD SPRING HARB PER; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Ishiuchi T, 2009, J CELL BIOL, V185, P959, DOI 10.1083/jcb.200811030; Jia JH, 2003, GENE DEV, V17, P2514, DOI 10.1101/gad.1134003; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kango-Singh M, 2002, DEVELOPMENT, V129, P5719, DOI 10.1242/dev.00168; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Lawrence PA, 1999, DEVELOPMENT, V126, P2441; Lawrence PA, 2007, NAT REV GENET, V8, P555, DOI 10.1038/nrg2125; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Ma D, 2003, NATURE, V421, P543, DOI 10.1038/nature01366; MAHONEY PA, 1991, CELL, V67, P853, DOI 10.1016/0092-8674(91)90359-7; Mao YP, 2006, DEVELOPMENT, V133, P2539, DOI 10.1242/dev.02427; Mao Y, 2009, DEVELOPMENT, V136, P3223, DOI 10.1242/dev.036152; Matakatsu H, 2004, DEVELOPMENT, V131, P3785, DOI 10.1242/dev.01254; Matakatsu H, 2008, CURR BIOL, V18, P1390, DOI 10.1016/j.cub.2008.07.067; Matakatsu H, 2006, DEVELOPMENT, V133, P2315, DOI 10.1242/dev.02401; Matakatsu H, 2012, DEVELOPMENT, V139, P1498, DOI 10.1242/dev.070367; Oh H, 2008, DEVELOPMENT, V135, P1081, DOI 10.1242/dev.015255; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Pan GH, 2013, DEVELOPMENT, V140, P831, DOI 10.1242/dev.088534; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Schroeder MC, 2012, SEMIN CELL DEV BIOL; Silva E, 2006, CURR BIOL, V16, P2081, DOI 10.1016/j.cub.2006.09.004; Simon MA, 2004, DEVELOPMENT, V131, P6175, DOI 10.1242/dev.01550; Sopko R, 2009, CURR BIOL, V19, P1112, DOI 10.1016/j.cub.2009.05.049; Staley BK, 2012, DEV DYNAM, V241, P3, DOI 10.1002/dvdy.22723; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; STRUHL G, 1993, CELL, V74, P331, DOI 10.1016/0092-8674(93)90424-O; Strutt D, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000489; Tang CY, 2002, GENESIS, V34, P39, DOI 10.1002/gene.10135; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Thomas C, 2012, DEV DYNAM, V241, P27, DOI 10.1002/dvdy.22736; TOMLINSON A, 1987, DEV BIOL, V123, P264, DOI 10.1016/0012-1606(87)90448-9; Tree DRP, 2002, SEMIN CELL DEV BIOL, V13, P217, DOI 10.1016/S1084-9521(02)00042-3; Tyler D, 2006, GENES AFFECTING CELL; Tyler DM, 2007, DEV BIOL, V305, P187, DOI 10.1016/j.ydbio.2007.02.004; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Willecke M, 2006, CURR BIOL, V16, P2090, DOI 10.1016/j.cub.2006.09.005; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; XU T, 1993, DEVELOPMENT, V117, P1223; XU TA, 1995, DEVELOPMENT, V121, P1053; Yang CH, 2002, CELL, V108, P675, DOI 10.1016/S0092-8674(02)00658-X	61	14	15	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62998	10.1371/journal.pone.0062998	http://dx.doi.org/10.1371/journal.pone.0062998			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667559	Green Submitted, gold, Green Published			2022-12-25	WOS:000319654700096
J	Xu, ZX; Wang, L; Chen, G; Rao, XP; Xu, FQ				Xu, Zhixiang; Wang, Li; Chen, Guo; Rao, Xiaoping; Xu, Fuqiang			Roles of GSK3 beta in Odor Habituation and Spontaneous Neural Activity of the Mouse Olfactory Bulb	PLOS ONE			English	Article							LONG-TERM POTENTIATION; SCHIZOPHRENIC-PATIENTS; ALZHEIMERS-DISEASE; SYNAPTIC VESICLES; LOW GSK-3-BETA; SYSTEM; MEMORY; PHOSPHORYLATION; STIMULATION; DYSFUNCTION	Glycogen synthase kinase 3 beta (GSK3 beta), a multifaceted kinase, is abundantly expressed in the brain, including the olfactory bulb (OB). In resting cells, GSK3 beta is constitutively active, and its over-activation is presumably involved in numerous brain diseases, such as Alzheimer's disease. However, the functions of the constitutively active GSK3 beta in the adult brain under physiological conditions are not well understood. Here, we studied the possible functions of GSK3 beta activity in the OB. Odor stimulation, or blockade of peripheral olfactory inputs caused by either transgenic knock-out or ZnSO4 irrigation to the olfactory epithelium, all affected the expression level of GSK3 beta in the OB. When GSK3 beta activity was reduced by a selective inhibitor, the spontaneous oscillatory activity was significantly decreased in the granule cell layer of the OB. Furthermore, local inhibition of GSK3 beta activity in the OB significantly impaired the odor habituation ability. These results suggest that GSK3 beta plays important roles in both spontaneous neural activity and odor information processing in the OB, deepening our understanding of the potential functions of the constitutively active GSK3 beta in the brain under physiological conditions.	[Xu, Zhixiang; Wang, Li; Rao, Xiaoping; Xu, Fuqiang] Chinese Acad Sci, Wuhan Inst Phys & Math, State Key Lab Magnet Resonance & Atom & Mol Phys, Wuhan, Peoples R China; [Xu, Zhixiang; Wang, Li; Rao, Xiaoping] Univ Chinese Acad Sci, Beijing, Peoples R China; [Chen, Guo] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Xu, Fuqiang] Wuhan Natl Lab Optoelect, Wuhan, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Physics & Mathematics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Wuhan University; Huazhong University of Science & Technology	Xu, FQ (corresponding author), Chinese Acad Sci, Wuhan Inst Phys & Math, State Key Lab Magnet Resonance & Atom & Mol Phys, Wuhan, Peoples R China.	fuqiang.xu@wipm.ac.cn	xu, fuqiang/AAI-1571-2019	Xu, Zhixiang/0000-0002-0962-7702; xu, fu qiang/0000-0002-4382-9797	National Natural Science Foundation of China [91132307/H09, 31171061/C090208, 20921004]; Chinese Academy of Science [XDB02050500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Science(Chinese Academy of Sciences)	The work is supported by National Natural Science Foundation of China (91132307/H09, 31171061/C090208 and 20921004) to FX, Chinese Academy of Science (XDB02050500) to FX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson F, 2008, J NEUROSCI, V28, P3925, DOI 10.1523/JNEUROSCI.1754-07.2008; Bhat RV, 2004, J NEUROCHEM, V89, P1313, DOI 10.1111/j.1471-4159.2004.02422.x; BRAFF DL, 1992, ARCH GEN PSYCHIAT, V49, P206; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; Calof AL, 1998, J NEUROBIOL, V36, P190, DOI 10.1002/(SICI)1097-4695(199808)36:2<190::AID-NEU7>3.0.CO;2-X; Chiang A, 2009, DEVELOPMENT, V136, P1273, DOI 10.1242/dev.031377; Christoffersen GRJ, 1997, PROG NEUROBIOL, V53, P45, DOI 10.1016/S0301-0082(97)00031-2; Clayton EL, 2008, J NEUROSCI, V28, P6627, DOI 10.1523/JNEUROSCI.1445-08.2008; Clayton EL, 2010, NAT NEUROSCI, V13, P845, DOI 10.1038/nn.2571; Devore S, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00059; Devore S, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00052; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Guerin D, 2008, BEHAV NEUROSCI, V122, P816, DOI 10.1037/a0012522; GUTHRIE KM, 1990, J NEUROSCI, V10, P3402; Harata N, 2001, P NATL ACAD SCI USA, V98, P12748, DOI 10.1073/pnas.171442798; Hooper C, 2007, EUR J NEUROSCI, V25, P81, DOI 10.1111/j.1460-9568.2006.05245.x; HUGHES K, 1993, EMBO J, V12, P803, DOI 10.1002/j.1460-2075.1993.tb05715.x; ISSEROFF RG, 1987, BIOL PSYCHIAT, V22, P922, DOI 10.1016/0006-3223(87)90093-X; Kaidanovich-Beilin O, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00040; Kozlovsky N, 2005, EUR NEUROPSYCHOPHARM, V15, P1, DOI 10.1016/j.euroneuro.2004.02.003; Kozlovsky N, 2000, AM J PSYCHIAT, V157, P831, DOI 10.1176/appi.ajp.157.5.831; Martinez A, 2002, J MED CHEM, V45, P1292, DOI 10.1021/jm011020u; McBride K, 2003, CHEM SENSES, V28, P659, DOI 10.1093/chemse/bjg053; McNamara AM, 2008, LEARN MEMORY, V15, P117, DOI 10.1101/lm.785608; Mesholam RI, 1998, ARCH NEUROL-CHICAGO, V55, P84, DOI 10.1001/archneur.55.1.84; Moberg PJ, 1999, NEUROPSYCHOPHARMACOL, V21, P325, DOI 10.1016/S0893-133X(99)00019-6; Murphy C, 1999, PHYSIOL BEHAV, V66, P177, DOI 10.1016/S0031-9384(98)00262-5; Parrish-Aungst S, 2011, BRAIN RES, V1382, P70, DOI 10.1016/j.brainres.2011.01.068; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Rankin CH, 2009, NEUROBIOL LEARN MEM, V92, P135, DOI 10.1016/j.nlm.2008.09.012; RAVEL N, 1994, BEHAV NEUROSCI, V108, P317, DOI 10.1037/0735-7044.108.2.317; Restrepo D, 2004, HORM BEHAV, V46, P247, DOI 10.1016/j.yhbeh.2004.02.009; Salcedo E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025441; Shipley MT, 1996, J NEUROBIOL, V30, P123; Turetsky BI, 2000, AM J PSYCHIAT, V157, P828, DOI 10.1176/appi.ajp.157.5.828; Wesson DW, 2010, J NEUROSCI, V30, P505, DOI 10.1523/JNEUROSCI.4622-09.2010; Williams SK, 2004, J COMP NEUROL, V470, P50, DOI 10.1002/cne.11045; Wilson DA, 2008, J NEUROPHYSIOL, V100, P2, DOI 10.1152/jn.90479.2008; Wolf FW, 2007, P NATL ACAD SCI USA, V104, P4653, DOI 10.1073/pnas.0700493104; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Xu Z, 2013, NEUROSCI LETT, V20, P00139; Zhao HQ, 2001, CELL, V104, P651, DOI 10.1016/S0092-8674(02)01107-8; Zhu LQ, 2007, J NEUROSCI, V27, P12211, DOI 10.1523/JNEUROSCI.3321-07.2007	45	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e63598	10.1371/journal.pone.0063598	http://dx.doi.org/10.1371/journal.pone.0063598			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658842	Green Published, Green Submitted, gold			2022-12-25	WOS:000321202100073
J	Childs, KS; Randall, RE; Goodbourn, S				Childs, Kay S.; Randall, Richard E.; Goodbourn, Stephen			LGP2 Plays a Critical Role in Sensitizing mda-5 to Activation by Double-Stranded RNA	PLOS ONE			English	Article							PARAMYXOVIRUS V-PROTEINS; INDUCIBLE GENE-I; INNATE IMMUNE SENSOR; IFN-BETA PROMOTER; RIG-I; ANTIVIRAL RESPONSES; HELICASE LGP2; SIGNAL-TRANSDUCTION; INTERFERON-BETA; RECOGNITION	The DExD/H box RNA helicases retinoic acid-inducible gene-I (RIG-I) and melanoma differentiation associated gene-5 (mda-5) sense viral RNA in the cytoplasm of infected cells and activate signal transduction pathways that trigger the production of type I interferons (IFNs). Laboratory of genetics and physiology 2 (LGP2) is thought to influence IFN production by regulating the activity of RIG-I and mda-5, although its mechanism of action is not known and its function is controversial. Here we show that expression of LGP2 potentiates IFN induction by polyinosinic-polycytidylic acid [poly(I:C)], commonly used as a synthetic mimic of viral dsRNA, and that this is particularly significant at limited levels of the inducer. The observed enhancement is mediated through co-operation with mda-5, which depends upon LGP2 for maximal activation in response to poly(I:C). This co-operation is dependent upon dsRNA binding by LGP2, and the presence of helicase domain IV, both of which are required for LGP2 to interact with mda-5. In contrast, although RIG-I can also be activated by poly(I:C), LGP2 does not have the ability to enhance IFN induction by RIG-I, and instead acts as an inhibitor of RIG-I-dependent poly(I:C) signaling. Thus the level of LGP2 expression is a critical factor in determining the cellular sensitivity to induction by dsRNA, and this may be important for rapid activation of the IFN response at early times post-infection when the levels of inducer are low.	[Childs, Kay S.; Goodbourn, Stephen] Univ London, Div Biomed Sci, London, England; [Randall, Richard E.] Univ St Andrews, Sch Biol, St Andrews, Fife, Scotland	University of London; University of St Andrews	Goodbourn, S (corresponding author), Univ London, Div Biomed Sci, London, England.	s.goodbourn@sgul.ac.uk		Goodbourn, Stephen/0000-0002-4530-1179; Randall, Richard/0000-0002-9304-6678; Childs, Kay/0000-0003-1564-3503	Wellcome Trust [AL087751/B, 087751/A/08/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by The Wellcome Trust (Grant Numbers AL087751/B to SG and 087751/A/08/Z to RER). (http://www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Bamming D, 2009, J BIOL CHEM, V284, P9700, DOI 10.1074/jbc.M807365200; Berke IC, 2012, P NATL ACAD SCI USA, V109, P18437, DOI 10.1073/pnas.1212186109; Berke IC, 2012, EMBO J, V31, P1714, DOI 10.1038/emboj.2012.19; Binder M, 2011, J BIOL CHEM, V286, P27278, DOI 10.1074/jbc.M111.256974; Bruns AM, 2013, J BIOL CHEM, V288, P938, DOI 10.1074/jbc.M112.424416; Childs KS, 2009, J VIROL, V83, P1465, DOI 10.1128/JVI.01768-08; Childs K, 2007, VIROLOGY, V359, P190, DOI 10.1016/j.virol.2006.09.023; Childs K, 2012, J VIROL, V86, P3411, DOI 10.1128/JVI.06405-11; Didcock L, 1999, J VIROL, V73, P9928, DOI 10.1128/JVI.73.12.9928-9933.1999; Goodbourn S, 2009, J INTERF CYTOK RES, V29, P539, DOI 10.1089/jir.2009.0071; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; JOHNSTON MD, 1981, J GEN VIROL, V56, P175, DOI 10.1099/0022-1317-56-1-175; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Killip MJ, 2011, VIROLOGY, V415, P39, DOI 10.1016/j.virol.2011.03.027; Killip MJ, 2013, J VIROL IN PRESS; KING P, 1994, J BIOL CHEM, V269, P30609; Komuro A, 2006, J VIROL, V80, P12332, DOI 10.1128/JVI.01325-06; Kumagai Y, 2010, J ALLERGY CLIN IMMUN, V125, P985, DOI 10.1016/j.jaci.2010.01.058; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; Leung DW, 2012, CURR OPIN STRUC BIOL, V22, P297, DOI 10.1016/j.sbi.2012.03.011; Levy DE, 2011, CURR OPIN VIROL, V1, P476, DOI 10.1016/j.coviro.2011.11.001; Li XJ, 2009, J BIOL CHEM, V284, P13881, DOI 10.1074/jbc.M900818200; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; MARAIS R, 1995, EMBO J, V14, P3136, DOI 10.1002/j.1460-2075.1995.tb07316.x; MASSON N, 1992, MOL CELL BIOL, V12, P1096, DOI 10.1128/MCB.12.3.1096; Peisley A, 2011, P NATL ACAD SCI USA, V108, P21010, DOI 10.1073/pnas.1113651108; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pichlmair A, 2009, J VIROL, V83, P10761, DOI 10.1128/JVI.00770-09; Pippig DA, 2009, NUCLEIC ACIDS RES, V37, P2014, DOI 10.1093/nar/gkp059; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Strahle L, 2006, VIROLOGY, V351, P101, DOI 10.1016/j.virol.2006.03.022; Venkataraman T, 2007, J IMMUNOL, V178, P6444, DOI 10.4049/jimmunol.178.10.6444; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851	39	72	74	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e64202	10.1371/journal.pone.0064202	http://dx.doi.org/10.1371/journal.pone.0064202			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671710	Green Published, Green Accepted, gold			2022-12-25	WOS:000319737700068
J	Devhare, PB; Chatterjee, SN; Arankalle, VA; Lole, KS				Devhare, Pradip B.; Chatterjee, Subhashis N.; Arankalle, Vidya A.; Lole, Kavita S.			Analysis of Antiviral Response in Human Epithelial Cells Infected with Hepatitis E Virus	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; INNATE IMMUNE RECEPTORS; CYTOKINE PRODUCTION; UBIQUITIN LIGASE; HEPATOMA-CELLS; ORF3 PROTEIN; C VIRUS; EXPRESSION; HEV; PATHWAYS	Hepatitis E virus (HEV) is a major cause of enterically transmitted acute hepatitis in developing nations and occurs in sporadic and epidemic forms. The disease may become severe with high mortality (20%) among pregnant women. Due to lack of efficient cell culture system and small animal model, early molecular events of HEV infection are not yet known. In the present study, human lung epithelial cells, A549, were infected with HEV to monitor expression levels of genes/proteins in antiviral pathways. Both live and UV inactivated virus elicited robust induction of inflammatory cytokines/chemokines such as IL-6, IL-8, TNF-alpha, and RANTES within 12 h of infection. Cells exposed to soluble capsid protein showed no induction suggesting the capsid structure and not the protein being detected as the pathogen pattern by cells. A delayed upregulation of type I interferon genes only by the live virus at 48 h post HEV infection indicated the need of virus replication. However, absence of secreted interferons till 96 h suggested possible involvement of post-transcriptional regulation of type I IFN expression. HEV infected cells showed activation of both NF-kappa B and IRF3 transcription factors when seen at protein levels; however, reporter gene assays showed predominant expression via NF-kB promoter as compared to IRF3 promoter. Knockdown experiments done using siRNAs showed involvement of MyD88 and TRIF adaptors in generating antiviral response thus indicating role of TLR2, TLR4 and TLR3 in sensing viral molecules. MAVS knockdown surprisingly enhanced only proinflammatory cytokines and not type I IFNs. This suggested that HEV not only down-regulates RIG-I helicase like receptor mediated IFN induction but also employs MAVS in curtailing host inflammatory response. Our findings uncover an early cellular response in HEV infection and associated molecular mechanisms suggesting the potential role of inflammatory response triggered by HEV infection in host immune response and pathogenesis.	[Devhare, Pradip B.; Chatterjee, Subhashis N.; Arankalle, Vidya A.; Lole, Kavita S.] Natl Inst Virol, Hepatitis Div, Pune, Maharashtra, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV)	Lole, KS (corresponding author), Natl Inst Virol, Hepatitis Div, Microbial Containment Complex, Pune, Maharashtra, India.	lolekavita37@yahoo.com		Arankalle, Vidya/0000-0002-9940-3437; Devhare, Pradip/0000-0002-6546-3407	National Institute of Virology, Indian Council of Medical Research (ICMR), Pune, India	National Institute of Virology, Indian Council of Medical Research (ICMR), Pune, India	This study was funded by the National Institute of Virology, Indian Council of Medical Research (ICMR), Pune, India. P. Devhare is the recipient of an ICMR senior research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2011, HEPATOLOGY, V54, P2218, DOI 10.1002/hep.24674; Ahmad I, 2011, VIRUS RES, V161, P47, DOI 10.1016/j.virusres.2011.02.011; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Arankalle VA, 2009, VACCINE, V27, P1032, DOI 10.1016/j.vaccine.2008.11.097; Chatterjee SN, 2012, J CLIN MICROBIOL, V50, P1467, DOI 10.1128/JCM.06717-11; Deshmukh TM, 2007, VACCINE, V25, P4350, DOI 10.1016/j.vaccine.2007.03.040; Dong C, 2012, HEPATOLOGY, V55, P1324, DOI 10.1002/hep.25530; Emerson SU, 2006, J VIROL, V80, P10457, DOI 10.1128/JVI.00892-06; Emerson SU, 2010, J VIROL, V84, P9059, DOI 10.1128/JVI.00593-10; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Goffic RL, 2010, J IMMUNOL, V185, P4812; Goffic RL, 2007, J IMMUNOL, V178, P3368; Graff J, 2008, J VIROL, V82, P1185, DOI 10.1128/JVI.01219-07; Ishii KJ, 2008, CELL HOST MICROBE, V3, P352, DOI 10.1016/j.chom.2008.05.003; Jensen S, 2012, J VIROL, V86, P2900, DOI 10.1128/JVI.05738-11; Julkunen I, 2001, CYTOKINE GROWTH F R, V12, P171, DOI 10.1016/S1359-6101(00)00026-5; Karpe YA, 2011, J GEN VIROL, V92, P2088, DOI 10.1099/vir.0.033738-0; Kawagoe T, 2008, NAT IMMUNOL, V9, P684, DOI 10.1038/ni.1606; Keskinen P, 1999, VIROLOGY, V263, P364, DOI 10.1006/viro.1999.9983; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Li K, 2005, J BIOL CHEM, V280, P16739, DOI 10.1074/jbc.M414139200; McInerney GM, 2009, J INNATE IMMUN, V1, P599, DOI 10.1159/000235861; Mogensen TH, 2001, MICROBIOL MOL BIOL R, V65, P131, DOI 10.1128/MMBR.65.1.131-150.2001; Prabhu SB, 2011, J VIRAL HEPATITIS, V18, P587, DOI 10.1111/j.1365-2893.2010.01338.x; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Rehman S, 2008, VIROLOGY, V370, P77, DOI 10.1016/j.virol.2007.07.036; Shimizu Y, 2001, HEPATOLOGY, V34, P311, DOI 10.1053/jhep.2001.26631; Siren J, 2006, MICROBES INFECT, V8, P2013, DOI 10.1016/j.micinf.2006.02.028; Soo HM, 2002, VIROLOGY, V303, P253, DOI 10.1006/viro.2002.1617; Srivastava R, 2008, J VIRAL HEPATITIS, V15, P910, DOI 10.1111/j.1365-2893.2008.01036.x; Takahashi M, 2010, J CLIN MICROBIOL, V48, P1112, DOI 10.1128/JCM.02002-09; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; TAM AW, 1991, VIROLOGY, V185, P120, DOI 10.1016/0042-6822(91)90760-9; Thompson MR, 2011, VIRUSES-BASEL, V3, P920, DOI 10.3390/v3060920; Tissari J, 2005, J IMMUNOL, V174, P4289, DOI 10.4049/jimmunol.174.7.4289; Triantafilou K, 2004, J VIROL, V78, P11313, DOI 10.1128/JVI.78.20.11313-11320.2004; Tripathy AS, 2012, EUR J CLIN MICROBIOL, V31, P179, DOI 10.1007/s10096-011-1291-1; Tripathy AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031822; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Yokota SI, 2010, MEDIAT INFLAMM, P1; Yu C, 2010, J VIROL, V84, P11264, DOI 10.1128/JVI.01205-10; Zafrullah M, 1997, J VIROL, V71, P9045, DOI 10.1128/JVI.71.12.9045-9053.1997	42	54	58	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63793	10.1371/journal.pone.0063793	http://dx.doi.org/10.1371/journal.pone.0063793			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671700	Green Published, gold, Green Submitted			2022-12-25	WOS:000319737700060
J	Molto-Puigmarti, C; Jansen, E; Heinrich, J; Standl, M; Mensink, RP; Plat, J; Penders, J; Mommers, M; Koppelman, GH; Postma, DS; Thijs, C				Molto-Puigmarti, Carolina; Jansen, Eugene; Heinrich, Joachim; Standl, Marie; Mensink, Ronald P.; Plat, Jogchum; Penders, John; Mommers, Monique; Koppelman, Gerard H.; Postma, Dirkje S.; Thijs, Carel			Genetic Variation in FADS Genes and Plasma Cholesterol Levels in 2-Year-Old Infants: KOALA Birth Cohort Study	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; CORONARY-ARTERY-DISEASE; PRESCHOOL-CHILDREN; BLOOD CHOLESTEROL; SERUM-CHOLESTEROL; LIPOPROTEIN CONCENTRATIONS; MULTIRACIAL SAMPLE; LIPID-LEVELS; ASSOCIATION; VARIANTS	Objective: Single nucleotide polymorphisms (SNPs) in genes involved in fatty acid metabolism (FADS1 FADS2 gene cluster) are associated with plasma lipid levels. We aimed to investigate whether these associations are already present early in life and compare the relative contribution of FADS SNPs vs traditional (non-genetic) factors as determinants of plasma lipid levels. Methods: Information on infants' plasma total cholesterol levels, genotypes of five FADS SNPs (rs174545, rs174546, rs174556, rs174561, and rs3834458), anthropometric data, maternal characteristics, and breastfeeding history was available for 521 2-year-old children from the KOALA Birth Cohort Study. For 295 of these 521 children, plasma HDLc and non-HDLc levels were also known. Multivariable linear regression analysis was used to study the associations of genetic and nongenetic determinants with cholesterol levels. Results: All FADS SNPs were significantly associated with total cholesterol levels. Heterozygous and homozygous for the minor allele children had about 4% and 8% lower total cholesterol levels than major allele homozygotes. In addition, homozygous for the minor allele children had about 7% lower HDLc levels. This difference reached significance for the SNPs rs174546 and rs3834458. The associations went in the same direction for non-HDLc, but statistical significance was not reached. The percentage of total variance of total cholesterol levels explained by FADS SNPs was relatively low (lower than 3%) but of the same order as that explained by gender and the non-genetic determinants together. Conclusions: FADS SNPs are associated with plasma total cholesterol and HDLc levels in preschool children. This brings a new piece of evidence to explain how blood lipid levels may track from childhood to adulthood. Moreover, the finding that these SNPs explain a similar amount of variance in total cholesterol levels as the non-genetic determinants studied reveals the potential importance of investigating the effects of genetic variations in early life.	[Molto-Puigmarti, Carolina; Penders, John; Mommers, Monique; Thijs, Carel] Maastricht Univ, Med Ctr, CAPHRI Sch Publ Hlth & Primary Care, Dept Epidemiol, Maastricht, Netherlands; [Jansen, Eugene] Natl Inst Publ Hlth & Environm, Ctr Hlth Protect, NL-3720 BA Bilthoven, Netherlands; [Heinrich, Joachim; Standl, Marie] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 1, Neuherberg, Germany; [Standl, Marie] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Mensink, Ronald P.; Plat, Jogchum] Maastricht Univ, Med Ctr, Dept Human Biol, Maastricht, Netherlands; [Penders, John] Maastricht Univ, Med Ctr, CAPHRI Sch Publ Hlth & Primary Care, Dept Med Microbiol, Maastricht, Netherlands; [Koppelman, Gerard H.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat Pulmonol & Pediat Allergol, Beatrix Childrens Hosp,GRIAC Res Inst, Groningen, Netherlands; [Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Med & TB, GRIAC Res Inst, Groningen, Netherlands	Maastricht University; Netherlands National Institute for Public Health & the Environment; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Maastricht University; Maastricht University; University of Groningen; University of Groningen	Molto-Puigmarti, C (corresponding author), Maastricht Univ, Med Ctr, CAPHRI Sch Publ Hlth & Primary Care, Dept Epidemiol, Maastricht, Netherlands.	Carolina.molto@maastrichtuniversity.nl	Thijs, Carel/H-8340-2019; Penders, John/A-1280-2011; Heinrich, Joachim/N-1720-2013; Koppelman, Gerard/AAG-9187-2020	Thijs, Carel/0000-0001-6646-5458; Penders, John/0000-0001-9146-5919; Heinrich, Joachim/0000-0002-9620-1629; Molto-Puigmarti, Carolina/0000-0001-6831-6210; Standl, Marie/0000-0002-5345-2049; Koppelman, Gerard/0000-0001-8567-3252	Fundacion Alfonso Martin Escudero (Spain); Netherlands Organisation for Scientific Research (NWO); Munich Center of Health Sciences (MCHEALTH); Ministry of Public Health, Welfare and Sport, the Netherlands; AstraZeneca; Chiesi; GSK	Fundacion Alfonso Martin Escudero (Spain); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Munich Center of Health Sciences (MCHEALTH); Ministry of Public Health, Welfare and Sport, the Netherlands; AstraZeneca(AstraZeneca); Chiesi(Chiesi Pharmaceuticals Inc); GSK(GlaxoSmithKline)	Carolina Molto -Puigmarti was supported by a postdoctoral grant from "Fundacion Alfonso Martin Escudero'' (Spain) http://www.fundame.org/.DNA collection was supported by the Netherlands Organisation for Scientific Research (NWO Spinoza award of Prof. D.S. Postma) http://www.nwo.nl/. Genotyping was supported partly by the Munich Center of Health Sciences (MCHEALTH) http://www.en.mc-health.uni-muenchen.de/index.html. Blood lipids determinations were funded by the Ministry of Public Health, Welfare and Sport, the Netherlands http://www.government.nl/ministries/vws (Kennisvraag 5.4.1a, 2006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: The University of Groningen has received an unrestricted educational grant for research from AstraZeneca, Chiesi, GSK, performed by the group of Prof Postma. Travel to ERS and/or ATS has been partially funded to the University of Groiningen by AstraZeneca, Chiesi, GSK, Nycomed. Fees for consultancies were given to the University of Groningen by AZ, Boehringer Ingelheim, Chiesi, GSK, Nycomed and TEVA. In addition, the authors' confirm that this does not alter their adherence to all the PLOS ONE policies on sharing data and materials.	Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Bastiaanssen JM, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-1; Bekkers MBM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025533; Bottema RWB, 2008, EUR RESPIR J, V32, P593, DOI 10.1183/09031936.00162407; Chasman DI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000730; Cowin I, 2000, INT J OBESITY, V24, P330, DOI 10.1038/sj.ijo.0801133; Cowin IS, 2001, EUR J CLIN NUTR, V55, P39, DOI 10.1038/sj.ejcn.1601120; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Dedoussis GVZ, 2007, AM J MED SCI, V333, P10, DOI 10.1097/00000441-200701000-00002; DESTEFANO F, 1995, EPIDEMIOLOGY, V6, P446, DOI 10.1097/00001648-199507000-00024; Dumitrescu L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002138; Dumont J, 2011, J NUTR, V141, P1247, DOI 10.3945/jn.111.140392; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Fredriks AM, 2000, ARCH DIS CHILD, V82, P107, DOI 10.1136/adc.82.2.107; FREEDMAN DS, 1992, PEDIATRICS, V90, P80; FREEDMAN DS, 1992, PREV MED, V21, P162, DOI 10.1016/0091-7435(92)90016-B; FRIEDMAN G, 1975, AM J CLIN NUTR, V28, P42, DOI 10.1093/ajcn/28.1.42; Gieger C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000282; Hellstrand S, 2012, J LIPID RES, V53, P1183, DOI 10.1194/jlr.P023721; Hicks AA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000672; KALLIO MJT, 1992, PEDIATRICS, V89, P663; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Katzmarzyk PT, 2001, J CLIN EPIDEMIOL, V54, P190, DOI 10.1016/S0895-4356(00)00315-2; Kroger J, 2011, AM J CLIN NUTR, V93, P127, DOI 10.3945/ajcn.110.005447; Kummeling I, 2005, PEDIATR ALLERGY IMMU, V16, P679, DOI 10.1111/j.1399-3038.2005.00333.x; Kwak JH, 2011, ATHEROSCLEROSIS, V214, P94, DOI 10.1016/j.atherosclerosis.2010.10.004; Lattka E, 2010, CURR OPIN LIPIDOL, V21, P64, DOI 10.1097/MOL.0b013e3283327ca8; LAUER RM, 1992, PEDIATRICS, V89, P495; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; Lu YC, 2010, AM J CLIN NUTR, V92, P258, DOI 10.3945/ajcn.2009.29130; Malerba G, 2008, LIPIDS, V43, P289, DOI 10.1007/s11745-008-3158-5; McGill HC, 2000, AM J CLIN NUTR, V72, p1307S, DOI 10.1093/ajcn/72.5.1307s; MIZE CE, 1991, ANN NY ACAD SCI, V623, P455, DOI 10.1111/j.1749-6632.1991.tb43769.x; Molto-Puigmarti C, 2010, AM J CLIN NUTR, V91, P1368, DOI 10.3945/ajcn.2009.28789; Nakayama K, 2010, HUM GENET, V127, P685, DOI 10.1007/s00439-010-0815-6; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Owen CG, 2002, PEDIATRICS, V110, P597, DOI 10.1542/peds.110.3.597; Rona RJ, 1996, J EPIDEMIOL COMMUN H, V50, P512, DOI 10.1136/jech.50.5.512; Rzehak P, 2009, BRIT J NUTR, V101, P20, DOI 10.1017/S0007114508992564; Rzehak P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013261; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Sambrook J, 2007, MOL CLONING LAB MANU, V3 rd; Schaeffer L, 2006, HUM MOL GENET, V15, P1745, DOI 10.1093/hmg/ddl117; Schisterman EF, 2009, EPIDEMIOLOGY, V20, P488, DOI 10.1097/EDE.0b013e3181a819a1; Srinivasan SR, 2006, PEDIATRICS, V118, P201, DOI 10.1542/peds.2005-1856; Stancakova A, 2011, DIABETES, V60, P1608, DOI 10.2337/db10-1655; Standl M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037780; Tanaka T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000338; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Truong H, 2009, AM J CLIN NUTR, V89, P920, DOI 10.3945/ajcn.2008.27107; WARD SD, 1980, AM J CLIN NUTR, V33, P63, DOI 10.1093/ajcn/33.1.63; Waterworth DM, 2010, ARTERIOSCL THROM VAS, V30, P2264, DOI 10.1161/ATVBAHA.109.201020	52	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e61671	10.1371/journal.pone.0061671	http://dx.doi.org/10.1371/journal.pone.0061671			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667444	Green Published, gold, Green Submitted			2022-12-25	WOS:000319055600013
J	Wang, YL; Zhu, BJ; Qi, ZZ; Wang, HJ; Zhou, XD				Wang, Yu-Liang; Zhu, Bing-Jing; Qi, Zhan-Zhong; Wang, Hai-Jing; Zhou, Xiang-Dong			Akt1 Enhances CA916798 Expression through mTOR Pathway	PLOS ONE			English	Article							LUNG-CANCER CELLS; DRUG-RESISTANCE; KINASE; CHEMOTHERAPY; INHIBITION; PI3K/AKT; MECHANISMS; APOPTOSIS; INVASION; PROTEIN	Multi-drug resistance leads to the failure of chemotherapy for cancers. Our previous study showed that overexpression of CA916798 led to multi-drug resistance. However, the underlying mechanisms remain unknown. In the current study, we observed that the levels of phosphorylated AKT, phosphorylated mTOR and CA916798 all increased in the drug resistant human adenocarcinoma samples and paralleled with the change of drug resistance. The results of immunofluorescence and Co-IP indicated that the positive correlation of CA916798 expression with AKT1 activation might be associated with drug resistance of lung adenocarcinoma. Furthermore, AKT1 stimulated CA916798 expression through mTOR pathway in both A549 and A549/CDDP cell lines, which was also observed in the xenografted tumor in nude mice. The results showed that CA916798 located in the downstream of PI3K/AKT/mTOR pathway. Inhibition of PI3K by LY294002 could efficiently reduce CA916798 expression and tumor size in vivo as well. Additionally, LY294002 combined with rapamycin inhibited CA916798 expression and tumor size stronger than LY294002 alone. Our findings may also provide a new explanation for synergistic anti-tumor effects of PI3K and mTORC1 inhibitors.	[Wang, Yu-Liang; Zhu, Bing-Jing; Qi, Zhan-Zhong; Wang, Hai-Jing; Zhou, Xiang-Dong] Third Mil Med Univ, Southwest Hosp, Dept Resp Med, Chongqing, Peoples R China	Army Medical University	Zhou, XD (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Resp Med, Chongqing, Peoples R China.	xiangdongzhou@126.com			Chinese National Natural Science Foundation [CA916798, 30971308]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	The study was supported by Chinese National Natural Science Foundation: CA916798 induce cisplatin resistance in lung cancer through PI3K/AKT pathway (30971308) [http://www.nsfc.gov.cn/Portal0/default124.htm]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELLACOSA A, 1991, SCIENCE, V254, P274, DOI 10.1126/science.1833819; Bocca C, 2010, CHEM-BIOL INTERACT, V183, P187, DOI 10.1016/j.cbi.2009.09.022; Brognard J, 2001, CANCER RES, V61, P3986; Carnero A, 2010, CURR PHARM DESIGN, V16, P34, DOI 10.2174/138161210789941865; Chen JZ, 2010, CHEM-BIOL INTERACT, V186, P250, DOI 10.1016/j.cbi.2010.03.052; Cheng JQ, 2005, ONCOGENE, V24, P7482, DOI 10.1038/sj.onc.1209088; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; Gerhard DS, 2004, GENOME RES, V14, P2121, DOI 10.1101/gr.2596504; Gibbons James J, 2009, Semin Oncol, V36 Suppl 3, pS3, DOI 10.1053/j.seminoncol.2009.10.011; Gu M, 2009, CANCER RES, V69, P9465, DOI 10.1158/0008-5472.CAN-09-2805; Hosoi H, 1999, CANCER RES, V59, P886; Jiang BH, 2008, DRUG RESIST UPDATE, V11, P63, DOI 10.1016/j.drup.2008.03.001; KOBERLE B, 2010, BIOCH BIOPHYS ACTA; Lamesch P, 2007, GENOMICS, V89, P307, DOI 10.1016/j.ygeno.2006.11.012; Liu DX, 2009, CANCER RES, V69, P7311, DOI 10.1158/0008-5472.CAN-09-1077; Liu LZ, 2007, CANCER RES, V67, P6325, DOI 10.1158/0008-5472.CAN-06-4261; Ma Patrick C, 2012, Cleve Clin J Med, V79 Electronic Suppl 1, peS56, DOI 10.3949/ccjm.79.s2.12; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Paez Juan, 2003, Cancer Treat Res, V115, P145; Papadimitrakopoulou V., 2012, J THORAC ONCOL; Ramaswamy S, 1999, P NATL ACAD SCI USA, V96, P2110, DOI 10.1073/pnas.96.5.2110; Redmond KM, 2008, FRONT BIOSCI-LANDMRK, V13, P5138, DOI 10.2741/3070; Romanuik TL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-476; Seufferlein T, 1996, CANCER RES, V56, P3895; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Tanaka K, 2011, CANCER DISCOV, V1, P524, DOI 10.1158/2159-8290.CD-11-0124; Tsvetkova E, 2012, CURR ONCOL, V19, pS45, DOI 10.3747/co.19.1113; Tykodi SS, 2008, CLIN CANCER RES, V14, P5260, DOI 10.1158/1078-0432.CCR-08-0028; Wang HJ, 2011, ASIAN PAC J CANCER P, V12, P3403; Xu CX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020899; Yin P, 2012, CELL SIGNAL, V24, P1229, DOI 10.1016/j.cellsig.2012.02.003; Yoeli-Lerner M, 2006, CELL CYCLE, V5, P603, DOI 10.4161/cc.5.6.2561; Zhou Xiang-dong, 2002, Ai Zheng, V21, P341	35	4	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62327	10.1371/journal.pone.0062327	http://dx.doi.org/10.1371/journal.pone.0062327			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667466	gold, Green Submitted, Green Published			2022-12-25	WOS:000319055600021
J	Foster, JM; Moreno, P; Fabregat, A; Hermjakob, H; Steinbeck, C; Apweiler, R; Wakelam, MJO; Vizcaino, JA				Foster, Joseph M.; Moreno, Pablo; Fabregat, Antonio; Hermjakob, Henning; Steinbeck, Christoph; Apweiler, Rolf; Wakelam, Michael J. O.; Vizcaino, Juan Antonio			LipidHome: A Database of Theoretical Lipids Optimized for High Throughput Mass Spectrometry Lipidomics	PLOS ONE			English	Article							ELECTROSPRAY-IONIZATION; PHOSPHOLIPIDS	Protein sequence databases are the pillar upon which modern proteomics is supported, representing a stable reference space of predicted and validated proteins. One example of such resources is UniProt, enriched with both expertly curated and automatic annotations. Taken largely for granted, similar mature resources such as UniProt are not available yet in some other "omics" fields, lipidomics being one of them. While having a seasoned community of wet lab scientists, lipidomics lies significantly behind proteomics in the adoption of data standards and other core bioinformatics concepts. This work aims to reduce the gap by developing an equivalent resource to UniProt called 'LipidHome', providing theoretically generated lipid molecules and useful metadata. Using the 'FASTLipid' Java library, a database was populated with theoretical lipids, generated from a set of community agreed upon chemical bounds. In parallel, a web application was developed to present the information and provide computational access via a web service. Designed specifically to accommodate high throughput mass spectrometry based approaches, lipids are organised into a hierarchy that reflects the variety in the structural resolution of lipid identifications. Additionally, cross-references to other lipid related resources and papers that cite specific lipids were used to annotate lipid records. The web application encompasses a browser for viewing lipid records and a 'tools' section where an MS1 search engine is currently implemented. LipidHome can be accessed at http://www.ebi.ac.uk/apweiler-srv/lipidhome.	[Foster, Joseph M.; Moreno, Pablo; Fabregat, Antonio; Hermjakob, Henning; Steinbeck, Christoph; Apweiler, Rolf; Vizcaino, Juan Antonio] European Bioinformat Inst, EMBL Outstn, Cambridge, England; [Wakelam, Michael J. O.] Babraham Inst, Cambridge, England	European Molecular Biology Laboratory (EMBL); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Foster, JM (corresponding author), European Bioinformat Inst, EMBL Outstn, Wellcome Trust Genome Campus, Cambridge, England.	jfoster@ebi.ac.uk	Vizcaino, Juan Antonio/C-3691-2009; Moreno, Pablo/AAC-7057-2020; Hermjakob, Henning/AFM-3497-2022	Vizcaino, Juan Antonio/0000-0002-3905-4335; Moreno, Pablo/0000-0002-9856-1679; Hermjakob, Henning/0000-0001-8479-0262; Apweiler, Rolf/0000-0001-7078-200X; Steinbeck, Christoph/0000-0001-6966-0814; Wakelam, Michael/0000-0003-4059-9276; Fabregat Mundo, Antonio/0000-0002-3288-8599	BBSRC CASE studentship; BBSRC; Philips; EU FP7 grant LipidomicNet [202272]; EU FP7 grant ProteomeXchange [260558]; Wellcome Trust [WT085949MA]; EMBL Student Fellowship; BBSRC [BBS/E/B/0000S227, BBS/E/B/000C0415] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0415, BBS/E/B/0000S227] Funding Source: researchfish	BBSRC CASE studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Philips; EU FP7 grant LipidomicNet; EU FP7 grant ProteomeXchange; Wellcome Trust(Wellcome TrustEuropean Commission); EMBL Student Fellowship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	JMF is supported by a BBSRC CASE studentship funded by the BBSRC and Philips. MJOW, AF and JAV are supported by the EU FP7 grant LipidomicNet [grant number 202272]. JAV is also supported by the EU FP7 grant ProteomeXchange [grant number 260558] and by the Wellcome Trust [grant number WT085949MA]. MJOW is also supported by the BBSRC. PM is supported by an EMBL Student Fellowship. (http://www.bbsrc.ac.uk/home/home.aspx; http://www.embl.de; http://cordis.europa.eu/fp7/home_en.html; http://www.research.philips.com/.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Bolton EE, 2010, ANN REP COMP CHEM, V4, P217, DOI 10.1016/S1574-1400(08)00012-1; Brown SHJ, 2011, BBA-MOL CELL BIOL L, V1811, P807, DOI 10.1016/j.bbalip.2011.04.015; CAFFREY M, 1992, CHEM PHYS LIPIDS, V61, P1, DOI 10.1016/0009-3084(92)90002-7; Cotter D, 2006, NUCLEIC ACIDS RES, V34, pD507, DOI 10.1093/nar/gkj122; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; de Matos P, 2010, NUCLEIC ACIDS RES, V38, pD249, DOI 10.1093/nar/gkp886; Fahy E, 2011, BBA-MOL CELL BIOL L, V1811, P637, DOI 10.1016/j.bbalip.2011.06.009; Fahy E, 2009, J LIPID RES, V50, pS9, DOI 10.1194/jlr.R800095-JLR200; Gorden DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022775; Han XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021643; HAN XL, 1994, P NATL ACAD SCI USA, V91, P10635, DOI 10.1073/pnas.91.22.10635; Hartler J, 2011, BIOINFORMATICS, V27, P572, DOI 10.1093/bioinformatics/btq699; Herzog R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029851; Hsu FF, 2008, J AM SOC MASS SPECTR, V19, P1673, DOI 10.1016/j.jasms.2008.07.007; Hsu FF, 2009, J CHROMATOGR B, V877, P2673, DOI 10.1016/j.jchromb.2009.02.033; Hu CX, 2011, MOL BIOSYST, V7, P3271, DOI 10.1039/c1mb05342f; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; KIM HY, 1994, ANAL CHEM, V66, P3977, DOI 10.1021/ac00094a020; Liebisch G, 2013, J LIPID RES IN PRESS; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Oresic M, 2013, SCI NATURE, V2, P26; Oresic M, 2012, GENOME MED, V4, DOI 10.1186/gm300; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; Rebholz-Schuhmann D, 2008, BIOINFORMATICS, V24, P296, DOI 10.1093/bioinformatics/btm557; Steinbeck C, 2003, J CHEM INF COMP SCI, V43, P493, DOI 10.1021/ci025584y; Sud M, 2007, NUCLEIC ACIDS RES, V35, pD527, DOI 10.1093/nar/gkl838; Sud M, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-23; Watanabe K, 2000, TRENDS GLYCOSCI GLYC, V12, P175, DOI 10.4052/tigg.12.175	29	45	47	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e61951	10.1371/journal.pone.0061951	http://dx.doi.org/10.1371/journal.pone.0061951			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667450	Green Published, Green Submitted, gold			2022-12-25	WOS:000319654700019
J	Ireland, KB; Hardy, GES; Kriticos, DJ				Ireland, Kylie B.; Hardy, Giles E. St J.; Kriticos, Darren J.			Combining Inferential and Deductive Approaches to Estimate the Potential Geographical Range of the Invasive Plant Pathogen, Phytophthora ramorum	PLOS ONE			English	Article							SUDDEN OAK DEATH; 3 CLONAL LINEAGES; TREE MORTALITY; IN-VITRO; FOREST; RISK; CALIFORNIA; TEMPERATURE; DISEASE; SUSCEPTIBILITY	Phytophthora ramorum, an invasive plant pathogen of unknown origin, causes considerable and widespread damage in plant industries and natural ecosystems of the USA and Europe. Estimating the potential geographical range of P. ramorum has been complicated by a lack of biological and geographical data with which to calibrate climatic models. Previous attempts to do so, using either invaded range data or surrogate species approaches, have delivered varying results. A simulation model was developed using CLIMEX to estimate the global climate suitability patterns for establishment of P. ramorum. Growth requirements and stress response parameters were derived from ecophysiological laboratory observations and site-level transmission and disease factors related to climate data in the field. Geographical distribution data from the USA (California and Oregon) and Norway were reserved from model-fitting and used to validate the models. The model suggests that the invasion of P. ramorum in both North America and Europe is still in its infancy and that it is presently occupying a small fraction of its potential range. Phytophthora ramorum appears to be climatically suited to large areas of Africa, Australasia and South America, where it could cause biodiversity and economic losses in plant industries and natural ecosystems with susceptible hosts if introduced.	[Ireland, Kylie B.; Hardy, Giles E. St J.; Kriticos, Darren J.] Cooperat Res Ctr Natl Plant Biosecur, Canberra, ACT, Australia; [Ireland, Kylie B.; Hardy, Giles E. St J.] Murdoch Univ, Sch Vet & Life Sci, Ctr Phytophthora Sci & Management, Perth, WA, Australia; [Kriticos, Darren J.] CSIRO, Ecosyst Sci, Canberra, ACT, Australia	Murdoch University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Kriticos, DJ (corresponding author), Cooperat Res Ctr Natl Plant Biosecur, Canberra, ACT, Australia.	Darren.Kriticos@csiro.au	Ireland, Kylie/L-8014-2019; Kriticos, Darren J/A-4170-2008; Hardy, Giles/B-2432-2013	Ireland, Kylie/0000-0002-2337-3227; Kriticos, Darren J/0000-0003-2599-8105; Hardy, Giles/0000-0001-7419-5064	Australian Government's Cooperative Research Centres Program; Cooperative Research Centre for National Plant Biosecurity; Australian Government Department of Sustainability, Environment, Water, Population and Communities; School of Biological Sciences at Murdoch University	Australian Government's Cooperative Research Centres Program(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Cooperative Research Centre for National Plant Biosecurity(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Government Department of Sustainability, Environment, Water, Population and Communities(Australian Government); School of Biological Sciences at Murdoch University	The authors would like to acknowledge the support of the Australian Government's Cooperative Research Centres Program and the Cooperative Research Centre for National Plant Biosecurity in particular. We also acknowledge the financial support of the Australian Government Department of Sustainability, Environment, Water, Population and Communities and the School of Biological Sciences at Murdoch University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank A. Kanaskie, R. Meentemeyer, T. Rafoss, A. Rytkonen and T. Vaclavik for assistance with obtaining point location data for P. ramorum. Thanks also to N. Brouwers for assistance with ArcGIS and my PhD supervisors Daniel Huberli, Bernard Dell and Ian Smith for valuable editorial support. The authors would like to acknowledge the support of the Cooperative Research Centre for National Plant Biosecurity, especially for supporting key collaborative opportunities. We would also like to acknowledge the efforts of three anonymous reviewers and thank them for their valuable feedback.	Brasier C, 2003, MYCOL RES, V107, P258, DOI 10.1017/S0953756203227660; Brasier C, 2012, SUDD OAK DEATH 5 SCI; Brasier C, 2006, PROGR RES PHYTOPHTHO, P166; Brasier CM, 2008, PLANT PATHOL, V57, P792, DOI 10.1111/j.1365-3059.2008.01886.x; Brasier CM, 2010, PLANT PATHOL, V59, P595, DOI 10.1111/j.1365-3059.2010.02278.x; Brasier C. M., 1994, Bulletin OEPP, V24, P221, DOI 10.1111/j.1365-2338.1994.tb01063.x; Brasier C, 2010, NATURE, V466, P824, DOI 10.1038/466824a; Browning M, 2008, MYCOLOGIA, V100, P236, DOI 10.3852/mycologia.100.2.236; COMTF, 2010, CAL OAK MORT TASK FO; COMTF, 2011, CAL OAK MORT TASK FO; Davidson J. M., 2002, General Technical Report - Pacific Southwest Research Station, USDA Forest Service, P741; Davidson JM, 2011, PHYTOPATHOLOGY, V101, P492, DOI 10.1094/PHYTO-03-10-0064; Davidson JM, 2005, PHYTOPATHOLOGY, V95, P587, DOI 10.1094/PHYTO-95-0587; Dehnen-Schmutz K, 2010, SCI HORTIC-AMSTERDAM, V125, P1, DOI 10.1016/j.scienta.2010.02.017; Elliott M, 2011, FOREST PATHOL, V41, P7, DOI 10.1111/j.1439-0329.2009.00627.x; Englander L, 2006, MYCOLOGIA, V98, P365, DOI 10.3852/mycologia.98.3.365; FAO, 2006, INT STAND PHYT MEAS, P1; Fichtner EJ, 2007, PHYTOPATHOLOGY, V97, P1366, DOI 10.1094/PHYTO-97-10-1366; Fichtner EJ, 2009, PHYTOPATHOLOGY, V99, P608, DOI 10.1094/PHYTO-99-5-0608; Forestry Commission, 2011, PHYT RAM LARCH TREES; Fowler G., 2006, General Technical Report - Pacific Southwest Research Station, USDA Forest Service, P329; Goheen E. M., 2006, General Technical Report - Pacific Southwest Research Station, USDA Forest Service, P113; Goss EM, 2009, MOL ECOL, V18, P1161, DOI 10.1111/j.1365-294X.2009.04089.x; Grunwald NJ, 2009, PHYTOPATHOLOGY, V99, P792, DOI 10.1094/PHYTO-99-7-0792; Guo QH, 2005, ECOL MODEL, V182, P75, DOI 10.1016/j.ecolmodel.2004.07.012; Guo QH, 2007, GISCI REMOTE SENS, V44, P24, DOI 10.2747/1548-1603.44.1.24; Hansen EM, 2008, CAN J FOREST RES, V38, P1133, DOI 10.1139/X07-217; Hardham AR, 2005, MOL PLANT PATHOL, V6, P589, DOI 10.1111/J.1364-3703.2005.00308.X; Huberli D, 2008, AUSTRALAS PLANT PATH, V37, P615, DOI 10.1071/AP08064; Ireland KB, 2012, FOREST PATHOL, V42, P305, DOI 10.1111/j.1439-0329.2011.00755.x; Ireland KB, 2012, PLANT PATHOL, V61, P234, DOI 10.1111/j.1365-3059.2011.02513.x; Ivors K, 2006, MOL ECOL, V15, P1493, DOI 10.1111/j.1365-294X.2006.02864.x; Kanaskie A., 2008, General Technical Report - Pacific Southwest Research Station, USDA Forest Service, P15; Kelly M, 2002, PHOTOGRAMM ENG REM S, V68, P1001; Kliejunas JT, 2010, PSWGTR234 US DEP AGR; Kluza DA, 2007, PLANT PATHOL, V56, P580, DOI 10.1111/j.1365-3059.2007.01602.x; Kriticos DJ, 2003, BIOL INVASIONS, V5, P147, DOI 10.1023/A:1026193424587; Kriticos DJ, 2012, METHODS ECOL EVOL, V3, P53, DOI 10.1111/j.2041-210X.2011.00134.x; Kriticos DJ, 2010, ECOGRAPHY, V33, P115, DOI 10.1111/j.1600-0587.2009.06042.x; Kriticos DJ, 2005, WEED RES, V45, P246, DOI 10.1111/j.1365-3180.2005.00458.x; Magarey RD, 2007, PLANT DIS, V91, P336, DOI 10.1094/PDIS-91-4-0336; Maloney PE, 2005, J ECOL, V93, P899, DOI 10.1111/j.1365-2745.2005.01031.x; McKenney D, 2003, ENVIRON MONIT ASSESS, V88, P445, DOI 10.1023/A:1025502030803; Meentemeyer R, 2004, FOREST ECOL MANAG, V200, P195, DOI 10.1016/j.foreco.2004.06.021; Meentemeyer RK, 2008, BIOL INVASIONS, V10, P1243, DOI 10.1007/s10530-007-9199-5; Meentemeyer RK, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00192.1; Pinkard EA, 2010, ECOL MODEL, V221, P2828, DOI 10.1016/j.ecolmodel.2010.08.017; Rizzo DM, 2005, ANNU REV PHYTOPATHOL, V43, P309, DOI 10.1146/annurev.phyto.42.040803.140418; Rizzo DM, 2003, FRONT ECOL ENVIRON, V1, P197, DOI 10.1890/1540-9295(2003)001[0197:SODECA]2.0.CO;2; Rizzo DM, 2002, PLANT DIS, V86, P205, DOI 10.1094/PDIS.2002.86.3.205; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Sansford C. E., 2009, REPORT RISK ENTRY ES; Scherm H, 1999, AGR SYST, V59, P301, DOI 10.1016/S0308-521X(99)00011-6; Sundheim L., 2009, PEST RISK ASSESSMENT; Sutherst R W, 2007, CLIMEX VERSION 3 USE; Sutherst R. W., 2004, CLIMEX V2 USERS GUID; Sutherst RW, 2003, J BIOGEOGR, V30, P805, DOI 10.1046/j.1365-2699.2003.00861.x; SUTHERST RW, 1985, AGR ECOSYST ENVIRON, V13, P281, DOI 10.1016/0167-8809(85)90016-7; Swiecki TJ, 2007, PHYTOSPHERE RES; Tjosvold SA, 2008, PLANT DIS, V92, P1566, DOI 10.1094/PDIS-92-11-1566; Tjosvold SA, 2009, PLANT DIS, V93, P371, DOI 10.1094/PDIS-93-4-0371; Tooley PW, 2008, PLANT DIS, V92, P431, DOI 10.1094/PDIS-92-3-0431; Tooley PW, 2007, PLANT DIS, V91, P435, DOI 10.1094/PDIS-91-4-0435; Tooley PW, 2009, PHYTOPATHOLOGY, V99, P1045, DOI 10.1094/PHYTO-99-9-1045; Tooley PW, 2009, PLANT DIS, V93, P249, DOI 10.1094/PDIS-93-3-0249; Tsopelas P, 2011, PLANT DIS, V95, P223, DOI 10.1094/PDIS-08-10-0607; Turner J, 2008, MANAGEMENT CONTAINME; Turner J, 2005, PHYTOPHTHORA RAMORUM; USDA, 2004, USDA PUBL; Vaclavik T, 2010, FOREST ECOL MANAG, V260, P1026, DOI 10.1016/j.foreco.2010.06.026; Vaclavik T, 2009, ECOL MODEL, V220, P3248, DOI 10.1016/j.ecolmodel.2009.08.013; VANNINI A, 2009, PHYTOPHTHORAS FOREST, P54; Venette RC, 2006, FOREST ECOL MANAG, V231, P18, DOI 10.1016/j.foreco.2006.04.036; Watt MS, 2009, FOREST ECOL MANAG, V257, P1505, DOI 10.1016/j.foreco.2008.12.026; Webber J, 2009, PHYTOPHTHORA RAMORUM; Webber J. F., 2010, New Disease Reports, V22, P19, DOI 10.5197/j.2044-0588.2010.022.019; Webber J.F., 2004, MYCOLOGICAL RES, V108, P1110, DOI [10.1017/S0953756204221244, DOI 10.1017/S0953756204221244]; Werres S, 2005, MYCOL RES, V109, P860, DOI 10.1017/S0953756205003369; Werres S, 2001, MYCOL RES, V105, P1155, DOI 10.1016/S0953-7562(08)61986-3; Yonow T, 2004, PHYTOPATHOLOGY, V94, P805, DOI 10.1094/PHYTO.2004.94.8.805	80	22	23	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63508	10.1371/journal.pone.0063508	http://dx.doi.org/10.1371/journal.pone.0063508			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667628	gold, Green Published			2022-12-25	WOS:000319654700153
J	Nogales, M; Gonzalez-Castro, A; Marrero, P; Bonnaud, E; Traveset, A				Nogales, Manuel; Gonzalez-Castro, Aaron; Marrero, Patricia; Bonnaud, Elsa; Traveset, Anna			Contrasting Selective Pressures on Seed Traits of Two Congeneric Species by Their Main Native Guilds of Dispersers on Islands	PLOS ONE			English	Article							GALLOTIA-GALLOTI LACERTIDAE; FRUGIVOROUS BIRDS; FLESHY FRUITS; XERIC HABITAT; GERMINATION; CONSTRAINTS; RUBIACEAE; PASSAGE; PATTERNS; LIZARDS	Many fleshy-fruited plants from the Mediterranean and Macaronesian islands are dispersed through endozoochory. In mainland Mediterranean areas, reciprocal adaptations have been found between plants and animals, although evidence is scarce. On small isolated oceanic islands, such reciprocal adaptations might well be more prevalent due to intrinsic island traits. Here we evaluate the existence of selective pressures exerted by two different disperser guilds (lizards and birds) on two seed traits (seed coat thickness and seed germination pattern) of two congeneric species present on Mediterranean and Macaronesian islands. In the continental Balearic Islands, Rubia peregrina has evolved mostly with birds, although frugivorous lizards are present in some of these islands and are known to eventually consume its fruits. By contrast, R. fruticosa, endemic to the Macaronesian archipelago, has evolved mostly interacting with lizards and only recently with birds. We hypothesized that R. fruticosa would be especially adapted to saurochory, with thicker seed coats and higher germination proportion, whereas R. peregrina would be more adapted to ornithocory, with thinner seed coats and showing a lower germination percentage after being ingested by lizards. Captivity experiments of seed ingestions by natural and non-natural dispersers (i.e., frugivores that have not evolved with those plants) were conducted. Results suggest that dispersers did not exert any strong enough selective pressure to induce changes in germination patterns. We attribute this to the fact that the Rubiaceae is an ancestral family in the Mediterranean (both on continent and islands) and thus probably interacted with lizards in the past. Lastly, although we hold that the seed coat structure of R. fruticosa is probably associated with its evolutionary success after a long interaction with insular lizards, our findings support the idea that the relationship between endozoochorous plants and the guild of dispersers with whom they evolved is rather unspecific.	[Nogales, Manuel; Gonzalez-Castro, Aaron; Marrero, Patricia; Bonnaud, Elsa] CSIC, Inst Prod Nat & Agrobiol, Isl Ecol & Evolut Res Grp, San Cristobal la Laguna, Canary Islands, Spain; [Marrero, Patricia] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Bonnaud, Elsa] Univ Paris 11, Unite Ecol Systemat & Evolut, Equipe Ecol Populat & Communautes, Paris, France; [Traveset, Anna] Univ Illes Balears, CSIC, Lab Int Cambio Global, Inst Meditarrani Estudis Avancats, Esporles, Balearic Island, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Productos Naturales y Agrobiologia (IPNA); University of East Anglia; UDICE-French Research Universities; Universite Paris Saclay; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears	Gonzalez-Castro, A (corresponding author), CSIC, Inst Prod Nat & Agrobiol, Isl Ecol & Evolut Res Grp, San Cristobal la Laguna, Canary Islands, Spain.	agcastro@ipna.csic.es	Nogales, Manuel/I-9831-2014; González-Castro, Aarón/K-3290-2016; Marrero, Patricia/B-8394-2014; Traveset, Anna V/D-7802-2011	Nogales, Manuel/0000-0002-5327-3104; González-Castro, Aarón/0000-0002-5311-1017; MARRERO, PATRICIA/0000-0002-8156-8006	Spanish National Research Council; Spanish Ministry of Education; Ministry of Education and Science of the Spanish Government [CGL2007-61165/BOS, CGL2010-18759/BOS]; European Union	Spanish National Research Council; Spanish Ministry of Education(Spanish Government); Ministry of Education and Science of the Spanish Government(Spanish Government); European Union(European Commission)	A. Gonzalez-Castro (JAE-pre) and E. Bonnaud (JAE-doc) were funded by two grants from the Spanish National Research Council. P. Marrero has a postdoctoral fellowship from the Spanish Ministry of Education. This paper is framed within projects CGL2007-61165/BOS and CGL2010-18759/BOS financed by the Ministry of Education and Science of the Spanish Government and partially funded by the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcover A., 1981, QUIMERES PASSAT ELS; [Anonymous], 2001, ANIM BEHAV, V61, P271, DOI [10.1016/S0003-3472(15)00461-3, 10.1006/anbe.2000.1652]; Baskin C.C, 2001, SEEDS ECOLOGY BIOGEO; Bover P, 2008, QUATERN INT, V182, P135, DOI 10.1016/j.quaint.2007.06.039; BREMER B, 1992, BIOL J LINN SOC, V47, P79, DOI 10.1111/j.1095-8312.1992.tb00657.x; Brokaw NLV, 1986, FRUGIVORE SEED DISPE, P323; Cardinali A., 2006, PHYTOCHEM ADV RES, V661, P23; Illera JC, 2012, QUATERNARY SCI REV, V50, P14, DOI 10.1016/j.quascirev.2012.07.013; Cox SC, 2010, MOL PHYLOGENET EVOL, V56, P747, DOI 10.1016/j.ympev.2010.03.020; Dennis A.J., 2007, SEED DISPERSAL THEOR; Eriksson O, 2000, OIKOS, V156, P47; Fleming T. H., 1993, FRUGIVORY SEED DISPE; Gonzalez-Castro A, 2012, J BIOGEOGR, V39, P1938, DOI 10.1111/j.1365-2699.2012.02693.x; Gutterman Y., 1993, SEED GERMINATION DES; Herrera C.M., 1986, VERTEBRATE DISPERSED, P5, DOI DOI 10.1007/978-94-009-4812-9_2; Herrera C.M., 2001, ECOSISTEMAS MEDITERR, P125; Herrera Carlos M., 2002, P185; HERRERA CM, 1995, ANNU REV ECOL SYST, V26, P705, DOI 10.1146/annurev.es.26.110195.003421; HERRERA CM, 1984, ECOLOGY, V65, P609, DOI 10.2307/1941423; Herrera CM, 1998, ECOL MONOGR, V68, P511, DOI 10.1890/0012-9615(1998)068[0511:LTDOMF]2.0.CO;2; HERRERA CM, 1985, OIKOS, V44, P132, DOI 10.2307/3544054; HERRERA CM, 1984, ECOL MONOGR, V54, P1, DOI 10.2307/1942454; HOWE HF, 1984, AM NAT, V123, P764, DOI 10.1086/284238; HOWE HF, 1977, ECOLOGY, V58, P539, DOI 10.2307/1939003; HOWE HF, 1977, AM NAT, V111, P817, DOI 10.1086/283216; JANZEN DH, 1982, SCIENCE, V215, P19, DOI 10.1126/science.215.4528.19; JOHNSON RA, 1985, ECOLOGY, V66, P819, DOI 10.2307/1940543; JORDANO P, 1995, AM NAT, V145, P163, DOI 10.1086/285735; JORDANO P, 1981, IBIS, V123, P502, DOI 10.1111/j.1474-919X.1981.tb04055.x; JORDANO P, 1994, OIKOS, V71, P479, DOI 10.2307/3545836; Levey D.J., 2002, SEED DISPERSAL FRUGI, Vfirst; LIEBERMAN M, 1986, Journal of Tropical Ecology, V2, P113; Lopez-Darias M, 2008, J ARID ENVIRON, V72, P926, DOI 10.1016/j.jaridenv.2007.12.006; MANEN JF, 1994, PLANT SYST EVOL, V190, P195, DOI 10.1007/BF00986193; McKey D., 1975, COEVOLUTION ANIMALS, P151; Meyer GA, 1998, AM MIDL NAT, V140, P129, DOI 10.1674/0003-0031(1998)140[0129:IOSPBF]2.0.CO;2; Nogales M, 1995, ACTA OECOL, V16, P585; Nogales M, 2005, FUNCT ECOL, V19, P429, DOI 10.1111/j.0269-8463.2005.00975.x; Nogales M, 2001, J BIOGEOGR, V28, P1137, DOI 10.1046/j.1365-2699.2001.00622.x; Nogales M, 1999, ECOSCIENCE, V6, P56, DOI 10.1080/11956860.1999.11952193; Nogales M, 2009, FLORA, V204, P543, DOI 10.1016/j.flora.2008.07.006; Oliverio M, 2000, J BIOGEOGR, V27, P1403, DOI 10.1046/j.1365-2699.2000.00517.x; Perez-Tris J, 2004, EVOLUTION, V58, P1819, DOI 10.1554/03-731; Pijl van der L., 1972, PRINCIPLES DISPERSAL; Pulido F, 2008, J BIOGEOGR, V35, P1425, DOI 10.1111/j.1365-2699.2008.01898.x; R Development Core Team, 2012, R LANG ENV STAT COMP; RICK CM, 1961, EVOLUTION, V15, P407, DOI 10.2307/2406309; Ridley H., 1930, J ECOL, DOI DOI 10.2307/2255951; Robertson AW, 2006, FUNCT ECOL, V20, P58, DOI 10.1111/j.1365-2435.2005.01057.x; Rodriguez A, 2008, J HERPETOL, V42, P213, DOI 10.1670/07-0752.1; Rodriguez-Perez J, 2005, FUNCT ECOL, V19, P699, DOI 10.1111/j.0269-8463.2005.00971.x; Rumeu B, 2011, PLANT ECOL, V212, P911, DOI 10.1007/s11258-010-9875-x; Saez E, 1993, HERPETOL REV, V26, P1212; Samuels IA, 2005, FUNCT ECOL, V19, P365, DOI 10.1111/j.1365-2435.2005.00973.x; Schupp E. W., 2007, Seed dispersal: theory and its application in a changing world, P445, DOI 10.1079/9781845931650.0445; Schupp EW, 2010, NEW PHYTOL, V188, P333, DOI 10.1111/j.1469-8137.2010.03402.x; SNOW DW, 1971, IBIS, V113, P194, DOI 10.1111/j.1474-919X.1971.tb05144.x; SORENSEN AE, 1984, J ANIM ECOL, V53, P545, DOI 10.2307/4533; Traveset A, 2005, CONSERV BIOL, V19, P421, DOI 10.1111/j.1523-1739.2005.00019.x; TRAVESET A, 1995, ACTA OECOL, V16, P171; Traveset A, 2001, FUNCT ECOL, V15, P669, DOI 10.1046/j.0269-8463.2001.00561.x; Traveset A, 2008, ECOLOGY, V89, P95, DOI 10.1890/07-0094.1; Traveset Anna, 1998, Perspectives in Plant Ecology Evolution and Systematics, V1, P151, DOI 10.1078/1433-8319-00057; Tsou CH, 2002, BOT BULL ACAD SINICA, V43, P37; Valido A, 2003, J HERPETOL, V37, P741, DOI 10.1670/15-02AN; Valido A, 2011, J EVOLUTION BIOL, V24, P751, DOI 10.1111/j.1420-9101.2010.02206.x; Valido A, 2003, AMPHIBIA-REPTILIA, V24, P331, DOI 10.1163/156853803322440790; VALIDO A, 1994, OIKOS, V70, P403, DOI 10.2307/3545778; Valido A., 1999, ECOLOGIA DISPERSION; Verdu M, 2005, ECOLOGY, V86, P1385, DOI 10.1890/04-1647; Voelker G, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-163; WHEELWRIGHT NT, 1982, AM NAT, V119, P402, DOI 10.1086/283918; WILLSON MF, 1990, CONDOR, V92, P545, DOI 10.2307/1368671	73	5	5	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63266	10.1371/journal.pone.0063266	http://dx.doi.org/10.1371/journal.pone.0063266			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667598	Green Published, gold, Green Submitted			2022-12-25	WOS:000319654700128
J	Singh, H; Ansari, HR; Raghava, GPS				Singh, Harinder; Ansari, Hifzur Rahman; Raghava, Gajendra P. S.			Improved Method for Linear B-Cell Epitope Prediction Using Antigen's Primary Sequence	PLOS ONE			English	Article							PROTEIN; RESIDUES; NETWORK; SETS	One of the major challenges in designing a peptide-based vaccine is the identification of antigenic regions in an antigen that can stimulate B-cell's response, also called B-cell epitopes. In the past, several methods have been developed for the prediction of conformational and linear (or continuous) B-cell epitopes. However, the existing methods for predicting linear B-cell epitopes are far from perfection. In this study, an attempt has been made to develop an improved method for predicting linear B-cell epitopes. We have retrieved experimentally validated B-cell epitopes as well as non B-cell epitopes from Immune Epitope Database and derived two types of datasets called Lbtope_Variable and Lbtope_Fixed length datasets. The Lbtope_Variable dataset contains 14876 B-cell epitope and 23321 non-epitopes of variable length where as Lbtope_Fixed length dataset contains 12063 B-cell epitopes and 20589 non-epitopes of fixed length. We also evaluated the performance of models on above datasets after removing highly identical peptides from the datasets. In addition, we have derived third dataset Lbtope_Confirm having 1042 epitopes and 1795 non-epitopes where each epitope or non-epitope has been experimentally validated in at least two studies. A number of models have been developed to discriminate epitopes and non-epitopes using different machine-learning techniques like Support Vector Machine, and K-Nearest Neighbor. We achieved accuracy from similar to 54% to 86% using diverse s features like binary profile, dipeptide composition, AAP (amino acid pair) profile. In this study, for the first time experimentally validated non B-cell epitopes have been used for developing method for predicting linear B-cell epitopes. In previous studies, random peptides have been used as non B-cell epitopes. In order to provide service to scientific community, a web server LBtope has been developed for predicting and designing B-cell epitopes (http://crdd.osdd.net/raghava/lbtope/).	[Singh, Harinder; Ansari, Hifzur Rahman; Raghava, Gajendra P. S.] Inst Microbial Technol, Bioinformat Ctr, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Raghava, GPS (corresponding author), Inst Microbial Technol, Bioinformat Ctr, Chandigarh, India.	raghava@imtech.res.in	Singh, Harinder/V-7699-2019; Raghava, Gajendra P.S./AAA-2413-2022; Raghava, Gajendra/B-1717-2009	Singh, Harinder/0000-0003-4897-9759; Raghava, Gajendra P.S./0000-0002-8902-2876; Ansari, Hifzur Rahman/0000-0002-0646-1743	Council of Scientific and Industrial Research (CSIR), Government of India; Department of Biotechnology (DBT), Government of India	Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India)	The authors are thankful to the Council of Scientific and Industrial Research (CSIR) and Department of Biotechnology (DBT), Government of India for financial assistance is duly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024039; Ansari HR, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-160; Ansari Hifzur Rahman, 2010, Immunome Res, V6, P6, DOI 10.1186/1745-7580-6-6; Bryson CJ, 2010, BIODRUGS, V24, P1, DOI 10.2165/11318560-000000000-00000; Chen J, 2007, AMINO ACIDS, V33, P423, DOI 10.1007/s00726-006-0485-9; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; Dudek NL, 2010, CURR PHARM DESIGN, V16, P3149; El-Manzalawy Y, 2008, J MOL RECOGNIT, V21, P243, DOI 10.1002/jmr.893; El-Manzalawy Yasser, 2010, Immunome Res, V6 Suppl 2, pS2, DOI 10.1186/1745-7580-6-S2-S2; Huang J, 2007, GENOME INFORM SER, V19, P40; Kringelum JV, 2013, MOL IMMUNOL, V53, P24, DOI 10.1016/j.molimm.2012.06.001; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078; Steere AC, 2011, CLIN INFECT DIS, V52, pS259, DOI 10.1093/cid/ciq117; Sweredoski MJ, 2009, PROTEIN ENG DES SEL, V22, P113, DOI 10.1093/protein/gzn075; Tomar N, 2010, IMMUNOLOGY, V131, P153, DOI 10.1111/j.1365-2567.2010.03330.x; Vacic V, 2006, BIOINFORMATICS, V22, P1536, DOI 10.1093/bioinformatics/btl151; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004; Xingdong Y, 2009, REV MED VIROL, V19, P77; Yang ZR, 2004, BRIEF BIOINFORM, V5, P328, DOI 10.1093/bib/5.4.328; [No title captured]	22	157	166	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62216	10.1371/journal.pone.0062216	http://dx.doi.org/10.1371/journal.pone.0062216			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667458	gold, Green Published, Green Submitted			2022-12-25	WOS:000319654700025
J	Gentry, M; Meyer, P				Gentry, Matthew; Meyer, Peter			An 11bp Region with Stem Formation Potential Is Essential for de novo DNA Methylation of the RPS Element	PLOS ONE			English	Article							SIRNA ACCUMULATION; ARABIDOPSIS; HETEROCHROMATIN; MAINTENANCE; ARGONAUTE4; NUCLEATION	The initiation of DNA methylation in Arabidopsis is controlled by the RNA-directed DNA methylation (RdDM) pathway that uses 24nt siRNAs to recruit de novo methyltransferase DRM2 to the target site. We previously described the REPETITIVE PETUNIA SEQUENCE (RPS) fragment that acts as a hot spot for de novo methylation, for which it requires the cooperative activity of all three methyltransferases MET1, CMT3 and DRM2, but not the RdDM pathway. RPS contains two identical 11nt elements in inverted orientation, interrupted by a 18nt spacer, which resembles the features of a stemloop structure. The analysis of deletion/substitution derivatives of this region showed that deletion of one 11nt element RPS is sufficient to eliminate de novo methylation of RPS. In addition, deletion of a 10nt region directly adjacent to one of the 11nt elements, significantly reduced de novo methylation. When both 11nt regions were replaced by two 11nt elements with altered DNA sequence but unchanged inverted repeat homology, DNA methylation was not affected, indicating that de novo methylation was not targeted to a specific DNA sequence element. These data suggest that de novo DNA methylation is attracted by a secondary structure to which the two 11nt elements contribute, and that the adjacent 10nt region influences the stability of this structure. This resembles the recognition of structural features by DNA methyltransferases in animals and suggests that similar mechanisms exist in plants.	[Gentry, Matthew; Meyer, Peter] Univ Leeds, Ctr Plant Sci, Leeds, W Yorkshire, England	University of Leeds	Meyer, P (corresponding author), Univ Leeds, Ctr Plant Sci, Leeds, W Yorkshire, England.	p.meyer@leeds.ac.uk	Gentry, Matthew/L-1675-2017	Gentry, Matthew/0000-0002-8476-589X	BBSRC Departmental Training Grant	BBSRC Departmental Training Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	MG was supported by a BBSRC Departmental Training Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BESTOR T, 1987, NUCLEIC ACIDS RES, V15, P3835, DOI 10.1093/nar/15.9.3835; Bestor TH, 1996, NAT GENET, V12, P363, DOI 10.1038/ng0496-363; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Clark Jarrod, 2008, Cancer Genomics & Proteomics, V5, P241; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Freitag M, 2004, SCIENCE, V304, P1939, DOI 10.1126/science.1099709; Gendrel AV, 2002, SCIENCE, V297, P1871, DOI 10.1126/science.1074950; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Guieysse AL, 1997, J MOL BIOL, V267, P289, DOI 10.1006/jmbi.1997.0884; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hellens R, 2000, TRENDS PLANT SCI, V5, P446, DOI 10.1016/S1360-1385(00)01740-4; Herbert A, 1999, GENETICA, V106, P37, DOI 10.1023/A:1003768526018; Hetzl J, 2007, PLANT J, V51, P526, DOI 10.1111/j.1365-313X.2007.03152.x; HORWITZ MSZ, 1988, SCIENCE, V241, P703, DOI 10.1126/science.2456617; Jia ST, 2004, SCIENCE, V304, P1971, DOI 10.1126/science.1099035; Lewis ZA, 2008, GENOME RES; Muller A, 2002, PLANT MOL BIOL, V48, P383, DOI 10.1023/A:1014091131490; Shlyakhtenko LS, 2000, J MOL BIOL, V296, P1169, DOI 10.1006/jmbi.2000.3542; Singh A, 2008, PLANT J, V56, P814, DOI 10.1111/j.1365-313X.2008.03640.x; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Tamaru H, 2003, MOL CELL BIOL, V23, P2379, DOI 10.1128/MCB.23.7.2379-2394.2003; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Yamada T, 2005, MOL CELL, V20, P173, DOI 10.1016/j.molcel.2005.10.002; Yoder JA, 1997, J MOL BIOL, V270, P385, DOI 10.1006/jmbi.1997.1125; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zheng XW, 2007, EMBO J, V26, P1691, DOI 10.1038/sj.emboj.7601603; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695; Zilberman D, 2004, CURR BIOL, V14, P1214, DOI 10.1016/j.cub.2004.06.055; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	31	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e63652	10.1371/journal.pone.0063652	http://dx.doi.org/10.1371/journal.pone.0063652			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671690	Green Published, gold			2022-12-25	WOS:000321390200055
J	Ramadanovic, B; Vasarhelyi, K; Nadaf, A; Wittenberg, RW; Montaner, JSG; Wood, E; Rutherford, AR				Ramadanovic, Bojan; Vasarhelyi, Krisztina; Nadaf, Ali; Wittenberg, Ralf W.; Montaner, Julio S. G.; Wood, Evan; Rutherford, Alexander R.			Changing Risk Behaviours and the HIV Epidemic: A Mathematical Analysis in the Context of Treatment as Prevention	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; INJECTION-DRUG USERS; SEXUAL RISK; POSITIVE MEN; TREATMENT OPTIMISM; TRANSMISSION RISK; HOMOSEXUAL-MEN; VIRAL LOAD; IMPACT; INFECTION	Background: Expanding access to highly active antiretroviral therapy (HAART) has become an important approach to HIV prevention in recent years. Previous studies suggest that concomitant changes in risk behaviours may either help or hinder programs that use a Treatment as Prevention strategy. Analysis: We consider HIV-related risk behaviour as a social contagion in a deterministic compartmental model, which treats risk behaviour and HIV infection as linked processes, where acquiring risk behaviour is a prerequisite for contracting HIV. The equilibrium behaviour of the model is analysed to determine epidemic outcomes under conditions of expanding HAART coverage along with risk behaviours that change with HAART coverage. We determined the potential impact of changes in risk behaviour on the outcomes of Treatment as Prevention strategies. Model results show that HIV incidence and prevalence decline only above threshold levels of HAART coverage, which depends strongly on risk behaviour parameter values. Expanding HAART coverage with simultaneous reduction in risk behaviour act synergistically to accelerate the drop in HIV incidence and prevalence. Above the thresholds, additional HAART coverage is always sufficient to reverse the impact of HAART optimism on incidence and prevalence. Applying the model to an HIV epidemic in Vancouver, Canada, showed no evidence of HAART optimism in that setting. Conclusions: Our results suggest that Treatment as Prevention has significant potential for controlling the HIV epidemic once HAART coverage reaches a threshold. Furthermore, expanding HAART coverage combined with interventions targeting risk behaviours amplify the preventive impact, potentially driving the HIV epidemic to elimination.	[Ramadanovic, Bojan; Nadaf, Ali; Rutherford, Alexander R.] Simon Fraser Univ, IRMACS Ctr, Burnaby, BC V5A 1S6, Canada; [Vasarhelyi, Krisztina; Montaner, Julio S. G.; Wood, Evan] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Vasarhelyi, Krisztina] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Nadaf, Ali; Wittenberg, Ralf W.; Rutherford, Alexander R.] Simon Fraser Univ, Dept Math, Burnaby, BC V5A 1S6, Canada; [Montaner, Julio S. G.; Wood, Evan] Univ British Columbia, Fac Med, Dept Med, Div Aids, Vancouver, BC, Canada	Simon Fraser University; B.C. Centre for Excellence in HIV/AIDS; Simon Fraser University; Simon Fraser University; University of British Columbia	Rutherford, AR (corresponding author), Simon Fraser Univ, IRMACS Ctr, Burnaby, BC V5A 1S6, Canada.	sandyr@irmacs.sfu.ca			Canadian Institute of Health Research [103129]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institute of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) grant number: 103129. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam B, 2011, J INT AIDS SOC S2, V14, P52; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Auld MC, 2002, J HLTH EC, V22, P361; Bacaer N, 2008, J MATH BIOL, V57, P557, DOI 10.1007/s00285-008-0177-z; Bauer AL, 2008, MATH MODEL NAT PHENO, V3, P229, DOI 10.1051/mmnp:2008051; BC-CDC, 2010, TECHNICAL REPORT; Bezemer D, 2008, AIDS, V22, P1071, DOI 10.1097/QAD.0b013e3282fd167c; Bezemer D, 2010, EPIDEMICS-NETH, V2, P66, DOI 10.1016/j.epidem.2010.04.001; Bhunu CP, 2009, B MATH BIOL, V71, P1745, DOI 10.1007/s11538-009-9423-9; Blower SM, 2000, SCIENCE, V287, P650, DOI 10.1126/science.287.5453.650; Blyuss KB, 2005, APPL MATH COMPUT, V160, P177, DOI 10.1016/j.amc.2003.10.033; Bouhnik AD, 2002, J EPIDEMIOL COMMUN H, V56, P349, DOI 10.1136/jech.56.5.349; Bunnell R, 2006, AIDS, V20, P85, DOI 10.1097/01.aids.0000196566.40702.28; Cassell MM, 2006, BMJ-BRIT MED J, V332, P605, DOI 10.1136/bmj.332.7541.605; Chowell-Puente D, 2007, MATH THEORETICAL BIO, VMTBI-04-08M; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Couzin J, 2009, SCIENCE, V323, P454, DOI [10.1126/science.323.5913.454, 10.1126/science.323.5913.456]; Crepaz N, 2004, JAMA-J AM MED ASSOC, V292, P224, DOI 10.1001/jama.292.2.224; Dangerfield BC, 2001, SYST DYNAM REV, V17, P119, DOI 10.1002/sdr.211; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; De Cock KM, 2009, B WORLD HEALTH ORGAN, V87, P488, DOI 10.2471/BLT.09.067330; Dieffenbach CW, 2009, JAMA-J AM MED ASSOC, V301, P2380, DOI 10.1001/jama.2009.828; Do AN, 2001, AIDS, V15, P1149, DOI 10.1097/00002030-200106150-00010; Dodds JP, 2000, BRIT MED J, V320, P1510, DOI 10.1136/bmj.320.7248.1510; Gill VS, 2010, CLIN INFECT DIS, V50, P98, DOI 10.1086/648729; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Gray RH, 2003, AIDS, V17, P1941, DOI 10.1097/00002030-200309050-00013; Halkitis PN, 2004, AIDS EDUC PREV, V16, P448, DOI 10.1521/aeap.16.5.448.48739; Hosseinipour M, 2002, CLIN INFECT DIS, V34, P1391, DOI 10.1086/340403; Huebner DM, 2004, JAIDS-J ACQ IMM DEF, V37, P1514, DOI 10.1097/01.qai.0000127027.55052.22; Huebner DM, 2001, ANN BEHAV MED, V23, P304, DOI 10.1207/S15324796ABM2304_10; Joseph HA, 2010, AIDS CARE, V22, P29, DOI 10.1080/09540120903012627; Kalichman SC, 2006, J BEHAV MED, V29, P401, DOI 10.1007/s10865-006-9066-3; KAULT DA, 1992, MATH COMPUT MODEL, V16, P3, DOI 10.1016/0895-7177(92)90101-P; Kerr T, 2010, AM J PUBLIC HEALTH, V100, P1449, DOI 10.2105/AJPH.2009.178467; Kirschner D, 1999, THEOR POPUL BIOL, V55, P94, DOI 10.1006/tpbi.1998.1382; Law MG, 2001, AIDS, V15, P1287, DOI 10.1097/00002030-200107060-00011; Li JQ, 2008, ROCKY MT J MATH, V38, P1457, DOI 10.1216/RMJ-2008-38-5-1457; Lindenburg CEA, 2006, AIDS, V20, P1771, DOI 10.1097/01.aids.0000242824.59377.53; Long EF, 2009, OPER RES, V56, P1366; Lou J, 2009, BMC PUBLIC HEALTH, V75, P213; Marshall BDL, 2010, AIDS, V24, P2271, DOI 10.1097/QAD.0b013e32833dd101; MASSAD E, 1993, MATH COMPUT MODEL, V17, P7, DOI 10.1016/0895-7177(93)90013-O; Miller M, 2000, AIDS, V14, pF33, DOI 10.1097/00002030-200003100-00001; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Murphy EL, 2001, ANN INTERN MED, V135, P17, DOI 10.7326/0003-4819-135-1-200107030-00005; Mushayabasa S, 2011, BIOSYSTEMS, V103, P27, DOI 10.1016/j.biosystems.2010.09.008; Nguyen VK, 2011, AIDS, V25, P291, DOI 10.1097/QAD.0b013e3283402c3e; Ostrow DE, 2002, AIDS, V16, P775, DOI 10.1097/00002030-200203290-00013; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Pinkerton SD, 2008, AIDS BEHAV, V12, P677, DOI 10.1007/s10461-007-9329-1; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Raboud JM, 2003, J URBAN HEALTH, V80, P302, DOI 10.1093/jurban/jtg033; Remien RH, 2005, AIDS BEHAV, V9, P167, DOI 10.1007/s10461-005-3898-7; Roeger LIW, 2009, MATH BIOSCI ENG, V6, P815, DOI 10.3934/mbe.2009.6.815; Salomon JA, 2008, AIDS, V22, pS149, DOI 10.1097/01.aids.0000327636.82542.87; Sarna A, 2008, INT J STD AIDS, V19, P85, DOI 10.1258/ijsa.2007.007097; Scheer S, 2001, LANCET, V357, P432, DOI 10.1016/S0140-6736(00)04007-1; Scherer CW, 2003, RISK ANAL, V23, P261, DOI 10.1111/1539-6924.00306; Schwarcz S, 2007, AM J PUBLIC HEALTH, V97, P1067, DOI 10.2105/AJPH.2005.072249; Sharomi O, 2008, MATH BIOSCI ENG, V5, P145; Smit C, 2006, ADDICTION, V101, P433, DOI 10.1111/j.1360-0443.2006.01339.x; Smith KP, 2008, ANNU REV SOCIOL, V34, P405, DOI 10.1146/annurev.soc.34.040507.134601; Sorathiya A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S67; Stephenson JM, 2003, SEX TRANSM INFECT, V79, P7, DOI 10.1136/sti.79.1.7; Stolte IG, 2004, AIDS, V18, P1943, DOI 10.1097/00002030-200409240-00010; Strathdee Steffanie A, 2010, Curr HIV/AIDS Rep, V7, P99, DOI 10.1007/s11904-010-0043-7; Sullivan PS, 2007, AIDS BEHAV, V11, P123, DOI 10.1007/s10461-006-9100-z; Truong HHM, 2006, SEX TRANSM INFECT, V82, P461, DOI 10.1136/sti.2006.019950; UNAIDS, 2011, TECHNICAL REPORT; Vanable PA, 2000, HEALTH PSYCHOL, V19, P134, DOI 10.1037//0278-6133.19.2.134; Velasco-Hernandez JX, 2002, LANCET INFECT DIS, V2, P487, DOI 10.1016/S1473-3099(02)00346-8; Venkatesh KK, 2011, AIDS, V25, P1939, DOI 10.1097/QAD.0b013e32834b4ced; Williams B, 2011, J INT AIDS SOC, V14, P56; Wood E, 2000, AIDS, V14, P1229, DOI 10.1097/00002030-200006160-00021; Wood E, 2009, TECHNICAL REPORT; Wood E, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1649	78	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e62321	10.1371/journal.pone.0062321	http://dx.doi.org/10.1371/journal.pone.0062321			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	177QL	23671592	Green Submitted, Green Published, gold			2022-12-25	WOS:000321390200019
J	Siddique, HR; Parray, A; Tarapore, RS; Wang, L; Mukhtar, H; Karnes, RJ; Deng, YB; Konety, BR; Saleem, M				Siddique, Hifzur Rahman; Parray, Aijaz; Tarapore, Rohinton S.; Wang, Lei; Mukhtar, Hasan; Karnes, R. Jeffery; Deng, Yibin; Konety, Badrinath R.; Saleem, Mohammad			BMI1 Polycomb Group Protein Acts as a Master Switch for Growth and Death of Tumor Cells: Regulates TCF4-Transcriptional Factor-Induced BCL2 Signaling	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; ANDROGEN RECEPTOR; IN-VITRO; RECURRENCE; DOCETAXEL; EXPRESSION; PATHWAYS; PROGRESSION; RESISTANCE; INHIBITORS	For advanced prostate cancer (CaP), the progression of tumors to the state of chemoresistance and paucity of knowledge about the mechanism of chemoresistance are major stumbling blocks in the management of this disease. Here, we provide compelling evidence that BMI1 polycomb group protein and a stem cell factor plays a crucial role in determining the fate of tumors vis-a-vis chemotherapy. We show that progressive increase in the levels of BMI1 occurs during the progression of CaP disease in humans. We show that BMI1-rich tumor cells are non-responsive to chemotherapy whereas BMI1-silenced tumor cells are responsive to therapy. By employing microarray, ChIP, immunoblot and Luciferase reporter assays, we identified a unique mechanism through which BMI1 rescues tumor cells from chemotherapy. We found that BMI1 regulates (i) activity of TCF4 transcriptional factor and (ii) binding of TCF4 to the promoter region of anti-apoptotic BCL2 gene. Notably, an increased TCF4 occupancy on BCL2 gene was observed in prostatic tissues exhibiting high BMI1 levels. Using tumor cells other than CaP, we also showed that regulation of TCF4-mediated BCL2 by BMI1 is universal. It is noteworthy that forced expression of BMI1 was observed to drive normal cells to hyperproliferative mode. We show that targeting BMI1 improves the outcome of docetaxel therapy in animal models bearing chemoresistant prostatic tumors. We suggest that BMI1 could be exploited as a potential molecular target for therapeutics to treat chemoresistant tumors.	[Siddique, Hifzur Rahman; Parray, Aijaz; Saleem, Mohammad] Univ Minnesota, Hormel Inst, Dept Mol Chemoprevent & Therapeut, Austin, MN 55912 USA; [Tarapore, Rohinton S.; Mukhtar, Hasan] Univ Wisconsin, Dept Dermatol, Madison, WI USA; [Wang, Lei; Deng, Yibin] Univ Minnesota, Hormel Inst, Dept Cell Death & Canc Genet, Austin, MN 55912 USA; [Karnes, R. Jeffery] Mayo Clin & Mayo Fdn, Mayo Med Sch, Dept Urol, Rochester, MN 55905 USA; [Karnes, R. Jeffery] Mayo Clin, Rochester, MN USA; [Konety, Badrinath R.; Saleem, Mohammad] Univ Minnesota, Dept Urol, Minneapolis, MN USA; [Saleem, Mohammad] Univ Minnesota, Dept Lab Med Pathol, Minneapolis, MN USA	University of Minnesota System; University of Wisconsin System; University of Wisconsin Madison; University of Minnesota System; Mayo Clinic; Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Saleem, M (corresponding author), Univ Minnesota, Hormel Inst, Dept Mol Chemoprevent & Therapeut, 801 16th Ave NE, Austin, MN 55912 USA.	msbhat@umn.edu	Saleem, Mohammad/GVS-9221-2022; Siddique, Hifzur R/H-4049-2019	Saleem, Mohammad/0000-0002-7422-7967; Siddique, Hifzur R/0000-0001-8736-0487; Deng, Yibin/0000-0001-5711-3565	Department of Defense CDMRP [W81XWH-08-1-0605]; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER	Department of Defense CDMRP(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Department of Defense CDMRP grant W81XWH-08-1-0605 to MS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bigelow RLH, 2004, J BIOL CHEM, V279, P1197, DOI 10.1074/jbc.M310589200; Brunelle JK, 2009, J CELL SCI, V122, P437, DOI 10.1242/jcs.031682; Casimiro M, 2007, CANCER RES, V67, P4364, DOI 10.1158/0008-5472.CAN-06-1898; Catalona WJ, 1998, J UROLOGY, V160, P2428, DOI 10.1016/S0022-5347(01)62204-3; Chen KG, 2012, CLIN CANCER RES, V18, P1863, DOI 10.1158/1078-0432.CCR-11-1590; Crea F, 2011, INT J CANCER, V128, P1946, DOI 10.1002/ijc.25522; Cui HJ, 2007, AM J PATHOL, V170, P1370, DOI 10.2353/ajpath.2007.060754; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Han M, 2003, J UROLOGY, V169, P517, DOI 10.1016/S0022-5347(05)63946-8; Hegde GV, 2008, MOL CANCER THER, V7, P1450, DOI 10.1158/1535-7163.MCT-07-2118; Huber GF, 2011, CANCER-AM CANCER SOC, V117, P4659, DOI 10.1002/cncr.26100; Jacobs JJL, 1999, GENE DEV, V13, P2678, DOI 10.1101/gad.13.20.2678; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kang MK, 2007, BRIT J CANCER, V96, P126, DOI 10.1038/sj.bjc.6603529; Kang MH, 2009, CLIN CANCER RES, V15, P1126, DOI 10.1158/1078-0432.CCR-08-0144; Kanwar SS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-212; Klein KA, 1997, NAT MED, V3, P402, DOI 10.1038/nm0497-402; Kotb AF, 2011, PROSTATE CANCER, V2011, DOI 10.1155/2011/485189; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Mackler NJ, 2005, NAT CLIN PRACT UROL, V2, P92, DOI 10.1038/ncpuro0099; Mahindroo N, 2009, J MED CHEM, V52, P3829, DOI 10.1021/jm801420y; Mahon KL, 2011, ENDOCR-RELAT CANCER, V18, pR103, DOI 10.1530/ERC-10-0343; O'Neill AJ, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-126; Parray A, 2012, BIOL-TARGETS THER, V6, P267, DOI 10.2147/BTT.S23954; Petrylak Daniel P, 2007, Rev Urol, V9 Suppl 2, pS3; Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591; Rohrs S, 2009, CELL BIOL INT, V33, P501, DOI 10.1016/j.cellbi.2009.01.016; Ross RW, 2008, CANCER-AM CANCER SOC, V112, P521, DOI 10.1002/cncr.23195; Saleem M, 2006, CANCER EPIDEM BIOMAR, V15, P217, DOI 10.1158/1055-9965.EPI-05-0737; Sanchez C, 2011, PROSTATE, V71, P1810, DOI 10.1002/pros.21398; Schug Jonathan, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0206s21; Siddique HR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052993; Siddique HR, 2012, CURR DRUG TARGETS, V13, P1907; Siddique HR, 2012, INT J CANCER, V131, P1720, DOI 10.1002/ijc.27409; Siddique HR, 2012, STEM CELLS, V30, P372, DOI 10.1002/stem.1035; Siddique HR, 2011, CLIN CANCER RES, V17, P5379, DOI 10.1158/1078-0432.CCR-11-0916; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Song LB, 2009, J CLIN INVEST, V119, P3626, DOI 10.1172/JCI39374; Straten PT, 2010, ONCOTARGET, V1, P239; Wang EF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017918; Zhang LL, 2012, J CANCER RES CLIN, V138, P675, DOI 10.1007/s00432-011-1146-2	42	20	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e60664	10.1371/journal.pone.0060664	http://dx.doi.org/10.1371/journal.pone.0060664			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671559	Green Published, Green Submitted, gold			2022-12-25	WOS:000321390200002
J	Friis, S; Sales, KU; Godiksen, S; Peters, DE; Lin, CY; Vogel, LK; Bugge, TH				Friis, Stine; Sales, Katiuchia Uzzun; Godiksen, Sine; Peters, Diane E.; Lin, Chen-Yong; Vogel, Lotte K.; Bugge, Thomas H.			A Matriptase-Prostasin Reciprocal Zymogen Activation Complex with Unique Features PROSTASIN AS A NON-ENZYMATIC CO-FACTOR FOR MATRIPTASE ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL SODIUM-CHANNEL; EPIDERMAL BARRIER FUNCTION; SERINE-PROTEASE INHIBITOR; HAIR FOLLICLE DEVELOPMENT; NEURAL-TUBE CLOSURE; PLASMINOGEN ACTIVATION; CELL-SURFACE; PLACENTAL DEVELOPMENT; MONOCLONAL-ANTIBODY; PROTEOLYTIC CASCADE	Matriptase and prostasin are part of a cell surface proteolytic pathway critical for epithelial development and homeostasis. Here we have used a reconstituted cell-based system and transgenic mice to investigate the mechanistic interrelationship between the two proteases. We show that matriptase and prostasin form a reciprocal zymogen activation complex with unique features. Prostasin serves as a critical co-factor for matriptase activation. Unexpectedly, however, prostasin-induced matriptase activation requires neither prostasin zymogen conversion nor prostasin catalytic activity. Prostasin zymogen conversion to active prostasin is dependent on matriptase but does not require matriptase zymogen conversion. Consistent with these findings, wild type prostasin, activation cleavage site-mutated prostasin, and catalytically inactive prostasin all were biologically active in vivo when overexpressed in the epidermis of transgenic mice, giving rise to a severe skin phenotype. Our finding of non-enzymatic stimulation of matriptase activation by prostasin and activation of prostasin by the matriptase zymogen provides a tentative mechanistic explanation for several hitherto unaccounted for genetic and biochemical observations regarding these two membrane-anchored serine proteases and their downstream targets.	[Bugge, Thomas H.] NIDCR, Proteases & Tissue Remodeling Sect, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA; [Sales, Katiuchia Uzzun] NIDCR, Clin Res Core, NIH, Bethesda, MD 20892 USA; [Friis, Stine; Godiksen, Sine; Vogel, Lotte K.] Univ Copenhagen, Fac Hlth Sci, Dept Cellular & Mol Med, DK-2200 Copenhagen, Denmark; [Godiksen, Sine] Univ Copenhagen, Fac Sci, Dept Biol, DK-2200 Copenhagen, Denmark; [Peters, Diane E.] Tufts Univ, Sch Med, Program Pharmacol & Expt Therapeut, Boston, MA 02111 USA; Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Copenhagen; University of Copenhagen; Tufts University; Georgetown University	Bugge, TH (corresponding author), NIDCR, Proteases & Tissue Remodeling Sect, Oral & Pharyngeal Canc Branch, NIH, 30 Convent Dr,Rm 211, Bethesda, MD 20892 USA.	thomas.bugge@nih.gov	sales, katiuchia u/J-4880-2012	sales, katiuchia/0000-0002-3768-5790; Vogel, Lotte K./0000-0001-9920-0982; Peters, Diane/0000-0003-4185-6203	National Institutes of Health, NIDCR, Intramural Research Program; Harboe Foundation; Lundbeck Foundation; Foundation of 17.12.1981; Augustinus Foundation; Kobmand Kristian Kjaer og Hustrus Foundation; Kjaer-Foundation; Dagmar Marshalls Foundation; Snedkermester Sophus Jacobsen og Hustru Astrid Jacobsens Foundation; Grosserer Valdemar Foersom og Hustru Thyra Foersoms Foundation; Fabrikant Einar Willumsens Mindelegat; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000699] Funding Source: NIH RePORTER; Lundbeck Foundation [R93-2011-8735] Funding Source: researchfish	National Institutes of Health, NIDCR, Intramural Research Program; Harboe Foundation; Lundbeck Foundation(Lundbeckfonden); Foundation of 17.12.1981; Augustinus Foundation; Kobmand Kristian Kjaer og Hustrus Foundation; Kjaer-Foundation; Dagmar Marshalls Foundation; Snedkermester Sophus Jacobsen og Hustru Astrid Jacobsens Foundation; Grosserer Valdemar Foersom og Hustru Thyra Foersoms Foundation; Fabrikant Einar Willumsens Mindelegat; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Lundbeck Foundation(Lundbeckfonden)	This work was supported, in whole or in part, by the National Institutes of Health, NIDCR, Intramural Research Program (to T. H. B). This work was also supported by the Harboe Foundation, the Lundbeck Foundation, and the Foundation of 17.12.1981 (to S. F.) and the Augustinus Foundation, the Kobmand Kristian Kjaer og Hustrus Foundation, the Kjaer-Foundation, the Dagmar Marshalls Foundation, the Snedkermester Sophus Jacobsen og Hustru Astrid Jacobsens Foundation, the Grosserer Valdemar Foersom og Hustru Thyra Foersoms Foundation, and Fabrikant Einar Willumsens Mindelegat (to S.G.).	ALAM J, 1990, ANAL BIOCHEM, V188, P245, DOI 10.1016/0003-2697(90)90601-5; Andreasen D, 2006, J AM SOC NEPHROL, V17, P968, DOI 10.1681/ASN.2005060637; Bergum C, 2012, J CELL PHYSIOL, V227, P1604, DOI 10.1002/jcp.22877; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Bugge TH, 2009, J BIOL CHEM, V284, P23177, DOI 10.1074/jbc.R109.021006; Buzza MS, 2013, J BIOL CHEM, V288, P10328, DOI 10.1074/jbc.M112.443432; Camerer E, 2010, DEV CELL, V18, P25, DOI 10.1016/j.devcel.2009.11.014; Chen YW, 2010, J BIOL CHEM, V285, P31755, DOI 10.1074/jbc.M110.150367; Cheng MF, 2007, EUR J DERMATOL, V17, P375; Cho EG, 2001, J BIOL CHEM, V276, P44581, DOI 10.1074/jbc.M107059200; ELLIS V, 1991, J BIOL CHEM, V266, P12752; ELLIS V, 1993, J BIOL CHEM, V268, P4806; Firsov D, 1998, EMBO J, V17, P344, DOI 10.1093/emboj/17.2.344; Frateschi S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1162; Friis S, 2011, J BIOL CHEM, V286, P5793, DOI 10.1074/jbc.M110.186874; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Guipponi M, 2002, HUM MOL GENET, V11, P2829, DOI 10.1093/hmg/11.23.2829; Inouye K, 2010, J BIOL CHEM, V285, P33394, DOI 10.1074/jbc.M110.115816; Inouye K, 2010, J BIOCHEM, V147, P485, DOI 10.1093/jb/mvp190; Kilpatrick LM, 2006, BLOOD, V108, P2616, DOI 10.1182/blood-2006-02-001073; Kim MG, 1999, IMMUNOGENETICS, V49, P420, DOI 10.1007/s002510050515; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; Lin CY, 1999, J BIOL CHEM, V274, P18237, DOI 10.1074/jbc.274.26.18237; Lin CY, 1999, J BIOL CHEM, V274, P18231, DOI 10.1074/jbc.274.26.18231; Lin CY, 1997, J BIOL CHEM, V272, P9147; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2003, J CELL BIOL, V163, P901, DOI 10.1083/jcb.200304161; List K, 2005, GENE DEV, V19, P1934, DOI 10.1101/gad.1300705; List K, 2006, MOL MED, V12, P1, DOI 10.2119/2006-00022.List; Macao B, 2006, NAT STRUCT MOL BIOL, V13, P71, DOI 10.1038/nsmb1035; MURILLAS R, 1995, EMBO J, V14, P5216, DOI 10.1002/j.1460-2075.1995.tb00206.x; Netzel-Arnett S, 2006, J BIOL CHEM, V281, P32941, DOI 10.1074/jbc.C600208200; Nonoguchi H., 2002, J CLIN INVEST, V109, P401; Oberst MD, 2003, J BIOL CHEM, V278, P26773, DOI 10.1074/jbc.M304282200; Planes C, 2010, EMBO MOL MED, V2, P26, DOI 10.1002/emmm.200900050; Rossier BC, 2002, ANNU REV PHYSIOL, V64, P877, DOI 10.1146/annurev.physiol.64.082101.143243; Shipway A, 2004, BIOCHEM BIOPH RES CO, V324, P953, DOI 10.1016/j.bbrc.2004.09.123; Spacek DV, 2010, EXP DERMATOL, V19, P527, DOI 10.1111/j.1600-0625.2009.01054.x; Szabo R, 2007, ONCOGENE, V26, P1546, DOI 10.1038/sj.onc.1209966; Szabo R, 2008, J BIOL CHEM, V283, P29495, DOI 10.1074/jbc.M801970200; Szabo R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002937; Szabo R, 2011, ANNU REV CELL DEV BI, V27, P213, DOI 10.1146/annurev-cellbio-092910-154247; Szabo R, 2009, DEVELOPMENT, V136, P2653, DOI 10.1242/dev.038430; Szabo R, 2009, AM J PATHOL, V174, P2015, DOI 10.2353/ajpath.2009.090053; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Takeuchi T, 1999, P NATL ACAD SCI USA, V96, P11054, DOI 10.1073/pnas.96.20.11054; Tong ZY, 2004, AM J PHYSIOL-LUNG C, V287, pL928, DOI 10.1152/ajplung.00160.2004; Tseng IC, 2008, AM J PHYSIOL-CELL PH, V295, pC423, DOI 10.1152/ajpcell.00164.2008; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; Vuagniaux G, 2002, J GEN PHYSIOL, V120, P191, DOI 10.1085/jgp.20028598; YU JX, 1995, J BIOL CHEM, V270, P13483, DOI 10.1074/jbc.270.22.13483	51	61	61	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					19028	19039		10.1074/jbc.M113.469932	http://dx.doi.org/10.1074/jbc.M113.469932			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23673661	Green Published, hybrid			2022-12-25	WOS:000321335800038
J	Zhang, YY; Zhao, Y; Li, H; Li, YH; Cai, XL; Shen, Y; Shi, H; Li, LL; Liu, Q; Zhang, XD; Ye, LH				Zhang, Yingyi; Zhao, Yu; Li, Hang; Li, Yinghui; Cai, Xiaoli; Shen, Yu; Shi, Hui; Li, Leilei; Liu, Qian; Zhang, Xiaodong; Ye, Lihong			The Nuclear Import of Oncoprotein Hepatitis B X-interacting Protein Depends on Interacting with c-Fos and Phosphorylation of Both Proteins in Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; PROMOTE PROLIFERATION; TRANSPORT RECEPTORS; CENTROSOME DYNAMICS; CELLULAR TARGET; HBXIP; JUN; EXPRESSION; ERK1/2; SIGNAL	Aberrant nuclear localization of oncogenic transcription factors and coactivators always leads to the development of cancer. We have reported that the oncoprotein hepatitis B X-interacting protein (HBXIP) acts as a novel transcriptional coactivator to promote proliferation and migration of breast cancer cells. However, the mechanism of regulating the nuclear import of HBXIP remains unclear. In the present study, we found that HBXIP interacted with c-Fos through their leucine zipper domains in vitro and in vivo. Interestingly, the leucine zipper mutant of HBXIP (or c-Fos) was unavailable to bind to c-Fos (or HBXIP), resulting in the disappearance of nuclear localization of HBXIP. Moreover, we revealed that the nuclear import of HBXIP was required for phosphorylation of c-Fos at Thr232, Thr325, Thr331, and Ser374 by ERK1/2. In addition, the mutant of HBXIP at the Ser108 phosphorylation site failed to import into the nucleus. Strikingly, we found that the kinase ataxia telangiectasia mutated (ATM) phosphorylated HBXIP at Ser108. The knockdown of ATM by siRNA remarkably decreased the levels of serine phosphorylation and blocked the nuclear import of HBXIP. Then, we identified that ATM could bind to HBXIP. Moreover, we validated that the nuclear import of HBXIP contributed to its nuclear function. Therefore, we conclude that the nuclear import of the oncoprotein HBXIP requires interaction with c-Fos through their leucine zipper domains and phosphorylation of both proteins in breast cancer cells. Thus, our findings provide new insights into the mechanism of the nuclear import of HBXIP. Therapeutically, the block of the nuclear import of HBXIP is significant in breast cancer.	[Zhang, Yingyi; Zhao, Yu; Li, Hang; Li, Yinghui; Cai, Xiaoli; Shen, Yu; Shi, Hui; Li, Leilei; Liu, Qian; Ye, Lihong] Nankai Univ, Coll Life Sci, Dept Biochem, Tianjin 300071, Peoples R China; [Zhang, Xiaodong] Nankai Univ, Coll Life Sci, Inst Mol Biol, Dept Canc Res, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Zhang, XD (corresponding author), Nankai Univ, Coll Life Sci, Inst Mol Biol, Dept Canc Res, Tianjin 300071, Peoples R China.	zhangxd@nankai.edu.cn; yelihong@nankai.edu.cn	Li, Leilei/AAE-4472-2020; zhao, yu/AAD-9494-2021					Arnold M, 2006, J BIOL CHEM, V281, P20883, DOI 10.1074/jbc.M602189200; Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Belguise K, 2012, ONCOGENE, V31, P4889, DOI 10.1038/onc.2011.659; Bian X, 2011, P NATL ACAD SCI USA, V108, P3976, DOI 10.1073/pnas.1101643108; Burgos-Rivera B, 2008, PLANT MOL BIOL, V68, P619, DOI 10.1007/s11103-008-9398-1; Chambellan A, 2009, NITRIC OXIDE-BIOL CH, V20, P143, DOI 10.1016/j.niox.2008.12.004; Chatterjee TK, 2003, J BIOL CHEM, V278, P30272, DOI 10.1074/jbc.M212688200; Chiu CZ, 2010, CLIN SCI, V119, P273, DOI 10.1042/CS20100084; Cingolani G, 2002, MOL CELL, V10, P1345, DOI 10.1016/S1097-2765(02)00727-X; Cui W, 2010, CANCER BIOL THER, V10, P232; Cui WJ, 2012, FEBS LETT, V586, P766, DOI 10.1016/j.febslet.2012.01.039; Fujii R, 2006, CANCER RES, V66, P9099, DOI 10.1158/0008-5472.CAN-06-1886; Garcia-Saez I, 2011, J MOL BIOL, V405, P331, DOI 10.1016/j.jmb.2010.10.046; Higashi N, 2004, GENES CELLS, V9, P233, DOI 10.1111/j.1356-9597.2004.00715.x; Hu N, 2011, J BIOL CHEM, V286, P13714, DOI 10.1074/jbc.M110.204131; Jakel S, 1999, EMBO J, V18, P2411, DOI 10.1093/emboj/18.9.2411; Katche C, 2010, P NATL ACAD SCI USA, V107, P349, DOI 10.1073/pnas.0912931107; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lee SH, 2003, ADV DRUG DELIVER REV, V55, P717, DOI 10.1016/S0169-409X(03)00052-8; Liu Q, 2013, INT J CANCER, V133, P1310, DOI 10.1002/ijc.28154; Liu SP, 2012, J BIOL CHEM, V287, P30228, DOI 10.1074/jbc.M112.343947; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Malnou CE, 2010, J BIOL CHEM, V285, P6552, DOI 10.1074/jbc.M109.032680; Gonzalez JM, 2008, J CELL BIOL, V183, P653, DOI 10.1083/jcb.200805049; Marusawa H, 2003, EMBO J, V22, P2729, DOI 10.1093/emboj/cdg263; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McBride KM, 2002, EMBO J, V21, P1754, DOI 10.1093/emboj/21.7.1754; Melegari M, 1998, J VIROL, V72, P1737, DOI 10.1128/JVI.72.3.1737-1743.1998; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Nardozzi JD, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-32; Ndlovu MN, 2009, MOL CELL BIOL, V29, P5488, DOI 10.1128/MCB.01657-08; Ozanne BW, 2007, ONCOGENE, V26, P1, DOI 10.1038/sj.onc.1209759; RANSONE LJ, 1989, GENE DEV, V3, P770, DOI 10.1101/gad.3.6.770; Rodriguez J, 2010, J CELL BIOL, V191, P967, DOI 10.1083/jcb.201004067; Romano G, 2012, P NATL ACAD SCI USA, V109, P16570, DOI 10.1073/pnas.1207917109; SONOBE MH, 1995, ONCOGENE, V10, P689; Sun MN, 2012, J MOL CELL BIOL, V4, P304, DOI 10.1093/jmcb/mjs048; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Waldmann I, 2007, J BIOL CHEM, V282, P27685, DOI 10.1074/jbc.M703301200; Wang FZ, 2007, ACTA PHARMACOL SIN, V28, P431, DOI 10.1111/j.1745-7254.2007.00531.x; Wang L, 2009, J BIOL CHEM, V284, P14693, DOI 10.1074/jbc.C109.002907; Wen YF, 2008, J BIOL CHEM, V283, P2793, DOI 10.1074/jbc.M708419200; Xu FQ, 2013, CANCER LETT, V333, P124, DOI 10.1016/j.canlet.2013.01.029; Yamaguchi K, 2005, J BIOL CHEM, V280, P32569, DOI 10.1074/jbc.M503201200; Yoneda Y, 1997, J BIOCHEM, V121, P811; Yue L, 2013, CARCINOGENESIS, V34, P927, DOI 10.1093/carcin/bgs399; Zhu YWT, 2009, J BIOL CHEM, V284, P14485, DOI 10.1074/jbc.M900935200	48	27	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18961	18974		10.1074/jbc.M113.458638	http://dx.doi.org/10.1074/jbc.M113.458638			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23667255	Green Published, hybrid			2022-12-25	WOS:000321335800033
J	Lonsdale, CL; Taba, B; Queralto, N; Lukaszewski, RA; Martino, RA; Rhodes, PA; Lim, SH				Lonsdale, Claire L.; Taba, Brian; Queralto, Nuria; Lukaszewski, Roman A.; Martino, Raymond A.; Rhodes, Paul A.; Lim, Sung H.			The Use of Colorimetric Sensor Arrays to Discriminate between Pathogenic Bacteria	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; IN-HOSPITAL ENVIRONMENT; ELECTRONIC NOSE; STAPHYLOCOCCUS-AUREUS; MASS-SPECTROMETRY; IDENTIFICATION; CLASSIFICATION; MICROORGANISMS; METABOLITES; PSEUDOMONAS	A colorimetric sensor array is a high-dimensional chemical sensor that is cheap, compact, disposable, robust, and easy to operate, making it a good candidate technology to detect pathogenic bacteria, especially potential bioterrorism agents like Yersinia pestis and Bacillus anthracis which feature on the Center for Disease Control and Prevention's list of potential biothreats. Here, a colorimetric sensor array was used to continuously monitor the volatile metabolites released by bacteria in solid media culture in an Advisory Committee on Dangerous Pathogen Containment Level 3 laboratory. At inoculum concentrations as low as 8 colony-forming units per plate, 4 different bacterial species were identified with 100% accuracy using logistic regression to classify the kinetic profile of sensor responses to culture headspace gas. The sensor array was able to further discriminate between different strains of the same species, including 5 strains of Yersinia pestis and Bacillus anthracis. These preliminary results suggest that disposable colorimetric sensor arrays can be an effective, low-cost tool to identify pathogenic bacteria.	[Lonsdale, Claire L.; Lukaszewski, Roman A.] Def Sci & Technol Lab, Salisbury, Wilts, England; [Taba, Brian; Queralto, Nuria; Martino, Raymond A.; Rhodes, Paul A.; Lim, Sung H.] Specif Technol, Mountain View, CA USA	Defence Science & Technology Laboratory	Lonsdale, CL (corresponding author), Def Sci & Technol Lab, Salisbury, Wilts, England.	cllonsdale@mail.dstl.gov.uk; slim@isensesystems.com			UK Ministry of Defence and Specific Technologies	UK Ministry of Defence and Specific Technologies	This work was supported by the UK Ministry of Defence and Specific Technologies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carey JR, 2011, J AM CHEM SOC, V133, P7571, DOI 10.1021/ja201634d; Centers for Disease Control and Prevention, BIOT AG DIS; Demirev PA, 2008, ANNU REV ANAL CHEM, V1, P71, DOI 10.1146/annurev.anchem.1.031207.112838; Dorai-Raj S., 2009, BINOM BINOMIAL CONFI; Dutta R, 2005, SENSOR ACTUAT B-CHEM, V109, P355, DOI 10.1016/j.snb.2005.01.013; Dutta R, 2006, SENSOR ACTUAT B-CHEM, V120, P156, DOI 10.1016/j.snb.2006.02.013; Elgaali H, 2002, J BASIC MICROB, V42, P373, DOI 10.1002/1521-4028(200212)42:6<373::AID-JOBM373>3.0.CO;2-4; Enserink M, 2001, SCIENCE, V294, P1266, DOI 10.1126/science.294.5545.1266; Feng LA, 2010, ANAL CHEM, V82, P9433, DOI 10.1021/ac1020886; Filipiak W, 2012, MICROBIOL-SGM, V158, P3044, DOI 10.1099/mic.0.062687-0; Filipiak W, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-113; Gardner JW, 1998, MEAS SCI TECHNOL, V9, P120, DOI 10.1088/0957-0233/9/1/016; Gibson TD, 1997, SENSOR ACTUAT B-CHEM, V44, P413, DOI 10.1016/S0925-4005(97)00235-9; Holmberg M, 1998, BIOTECHNOL TECH, V12, P319, DOI 10.1023/A:1008862617082; Horsmon J. R., 2008, CHARACTERIZATION VOL; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V288, P1849; Janzen MC, 2006, ANAL CHEM, V78, P3591, DOI 10.1021/ac052111s; Kai M, 2009, APPL MICROBIOL BIOT, V81, P1001, DOI 10.1007/s00253-008-1760-3; Karasinski J, 2005, ANAL CHEM, V77, P7941, DOI 10.1021/ac0512150; Koo CK, 2011, CHEM COMMUN, V47, P11435, DOI 10.1039/c1cc14871k; Lim SH, 2009, NAT CHEM, V1, P562, DOI [10.1038/NCHEM.360, 10.1038/nchem.360]; McEntegart CM, 2000, SENSOR ACTUAT B-CHEM, V70, P170, DOI 10.1016/S0925-4005(00)00561-X; Meyer D., 2012, E1071 MISC FUNCTIONS; Moens M, 2006, LETT APPL MICROBIOL, V42, P121, DOI 10.1111/j.1472-765X.2005.01822.x; Oliphant TE, 2007, COMPUT SCI ENG, V9, P10, DOI 10.1109/MCSE.2007.58; Peterson P, 2009, INT J COMPUT SCI ENG, V4, P296, DOI 10.1504/IJCSE.2009.029165; Pile JC, 1998, ARCH INTERN MED, V158, P429, DOI 10.1001/archinte.158.5.429; R Development Core Team, 2012, R LANG ENV STAT COMP; Rao SS, 2010, J MICROBIOL METH, V82, P1, DOI 10.1016/j.mimet.2010.04.005; Rossi V, 1995, J MICROBIOL METH, V24, P183, DOI 10.1016/0167-7012(95)00069-0; Schulz S, 2007, NAT PROD REP, V24, P814, DOI 10.1039/b507392h; Scotter JM, 2006, J MICROBIOL METH, V65, P628, DOI 10.1016/j.mimet.2005.09.016; Setkus A, 2008, SENSOR ACTUAT B-CHEM, V130, P351, DOI 10.1016/j.snb.2007.09.048; Song LN, 2005, EMERG INFECT DIS, V11, P1629; Suslick BA, 2010, ANAL CHEM, V82, P2067, DOI 10.1021/ac902823w; US National Institutes of Health, IMAGEJ; Wang TS, 2004, INT J MASS SPECTROM, V233, P245, DOI 10.1016/j.ijms.2003.12.024; ZECHMAN JM, 1986, J CHROMATOGR, V377, P49, DOI 10.1016/S0378-4347(00)80760-4; Zhu JJ, 2010, J CLIN MICROBIOL, V48, P4426, DOI 10.1128/JCM.00392-10	39	37	38	3	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e62726	10.1371/journal.pone.0062726	http://dx.doi.org/10.1371/journal.pone.0062726			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671629	Green Published, gold, Green Submitted			2022-12-25	WOS:000319737700019
J	Meyer, FRL; Grausgruber, H; Binter, C; Mair, GE; Guelly, C; Vogl, C; Steinborn, R				Meyer, Florian R. L.; Grausgruber, Heinrich; Binter, Claudia; Mair, Georg E.; Guelly, Christian; Vogl, Claus; Steinborn, Ralf			Cross-Platform Microarray Meta-Analysis for the Mouse Jejunum Selects Novel Reference Genes with Highly Uniform Levels of Expression	PLOS ONE			English	Article							REAL-TIME PCR; HOUSEKEEPING GENES; RT-PCR; DATA REPOSITORY; NORMALIZATION; IDENTIFICATION; VALIDATION; TOOL; TRANSCRIPTOME; ARABIDOPSIS	Reference genes (RGs) with uniform expression are used for normalization of reverse transcription quantitative PCR (RT-qPCR) data. Their optimization for a specific biological context, e. g. a specific tissue, has been increasingly considered. In this article, we compare RGs identified by expression data meta-analysis restricted to the context tissue, the jejunum of Mus musculus domesticus, i) to traditional RGs, ii) to expressed interspersed repeated DNA elements, and iii) to RGs identified by meta-analysis of expression data from diverse tissues and conditions. To select the set of candidate RGs, we developed a novel protocol for the cross-platform meta-analysis of microarray data. The expression stability of twenty-four putative RGs was analysed by RT-qPCR in at least 14 jejunum samples of the mouse strains C57Bl/6N, CD1, and OF1. Across strains, the levels of expression of the novel RGs Plekha7, Zfx, and Ube2v1 as well as of Oaz1 varied less than two-fold irrespective of genotype, sex or their combination. The gene set consisting of Plekha7 and Oaz1 showed superior expression stability analysed with the tool RefFinder. The novel RGs are functionally diverse. This facilitates expression studies over a wide range of conditions. The highly uniform expression of the optimized RGs in the jejunum points towards their involvement in tightly regulated pathways in this tissue. We also applied our novel protocol of cross-microarray platform meta-analysis to the identification of RGs in the duodenum, the ileum and the entire small intestine. The selection of RGs with improved expression stability in a specific biological context can reduce the number of RGs for the normalization step of RT-qPCR expression analysis, thus reducing the number of samples and experimental costs.	[Meyer, Florian R. L.; Mair, Georg E.; Steinborn, Ralf] Univ Vet Med, VetCore, Genom Core Facil, Vienna, Austria; [Meyer, Florian R. L.] Univ Vet Med, Inst Anat Histol & Embryol, Vienna, Austria; [Grausgruber, Heinrich] Univ Nat Resources & Life Sci, Dept Crop Sci, Tulln, Austria; [Binter, Claudia] Univ Vet Med, Inst Anim Nutr & Funct Plant Cpds, Vienna, Austria; [Guelly, Christian] Med Univ Graz, Med Res Ctr, Graz, Austria; [Vogl, Claus] Univ Vet Med, Inst Anim Breeding & Genet, Vienna, Austria	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Natural Resources & Life Sciences, Vienna; University of Veterinary Medicine Vienna; Medical University of Graz; University of Veterinary Medicine Vienna	Steinborn, R (corresponding author), Univ Vet Med, VetCore, Genom Core Facil, Vienna, Austria.	Ralf.Steinborn@vetmeduni.ac.at	Grausgruber, Heinrich/D-9776-2019	Grausgruber, Heinrich/0000-0003-4790-0922	Austrian Science Fund (FWF) [P23336]; Austrian Science Fund (FWF) [P 23336] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Microarray expression data was funded by the Austrian Ministry of Health (www.bmg.gv.at). FM was supported in part by the Austrian Science Fund (FWF; project P23336). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Akilesh S, 2003, GENOME RES, V13, P1719, DOI 10.1101/gr.533003; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Axtner Jan, 2009, BMC Res Notes, V2, P264, DOI 10.1186/1756-0500-2-264; Bargaje R, 2010, RNA, V16, P16, DOI 10.1261/rna.1688110; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Bisognin A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-201; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cailotto C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005650; Chapin Robert E., 1997, Environmental Health Perspectives, V105, P199, DOI 10.2307/3433407; Chari R, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-32; Chen DL, 2011, J CELL PHYSIOL, V226, P2469, DOI 10.1002/jcp.22725; Cheng WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017347; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; Coker JS, 2003, BIOTECHNIQUES, V35, P740, DOI 10.2144/03354st04; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; De Santis C, 2010, MAR BIOTECHNOL NY; Du D, 2010, MOL BIOL REP, V37, P1867, DOI 10.1007/s11033-009-9622-3; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Feil R, 2006, MUTAT RES, V600, P57; Ferguson BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015208; Galiveti CR, 2010, RNA, V16, P450, DOI 10.1261/rna.1755810; Germain RN, 2001, SCIENCE, V293, P240, DOI 10.1126/science.1062946; GRUBBS FE, 1950, ANN MATH STAT, V21, P27, DOI 10.1214/aoms/1177729885; Haller F, 2004, ANAL BIOCHEM, V335, P1, DOI 10.1016/j.ab.2004.08.024; Hannibal J, 2001, J NEUROSCI, V21, P4883, DOI 10.1523/JNEUROSCI.21-13-04883.2001; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Hu PZ, 2006, INFORM SYST FRONT, V8, P9, DOI 10.1007/s10796-005-6099-z; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Jin P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-55; Kapetis D, 2012, BIOTECHNIQUES, V53, P33, DOI 10.2144/0000113889; Karaghiosoff M, 2003, NAT IMMUNOL, V4, P471, DOI 10.1038/ni910; Khanlou KM, 2012, PLANTA, V236, P1381, DOI 10.1007/s00425-012-1682-2; Konishi T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003555; Kosir R, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-60; Kwon MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006162; Lefever S, 2009, NUCLEIC ACIDS RES, V37, pD942, DOI 10.1093/nar/gkn777; Marshall OJ, 2004, BIOINFORMATICS, V20, P2471, DOI 10.1093/bioinformatics/bth254; Marullo M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r9; McGlincy NJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r54; Mehta R, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-39; Pang W, 2008, ENDOCRINOLOGY, V149, P42; Parkinson H, 2009, NUCLEIC ACIDS RES, V37, pD868, DOI 10.1093/nar/gkn889; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pradervand S, 2009, RNA, V15, P493, DOI 10.1261/rna.1295509; Richard H, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq041; Rieu I, 2008, PLANT J, V53, P488, DOI 10.1111/j.1365-313X.2007.03356.x; Roberts A, 2007, MAMM GENOME, V18, P473, DOI 10.1007/s00335-007-9045-1; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Sinicropi D, 2007, BIOMEMS BIOMEDICAL N, VII, P540; Spandidos A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-633; Speed T, 2003, STAT ANAL GENE EXPRE, P224; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Tai HH, 2009, PLANT MOL BIOL REP, V27, P315, DOI 10.1007/s11105-009-0089-0; Tseng GC, 2012, NUCLEIC ACIDS RES, V40, P3785, DOI 10.1093/nar/gkr1265; Upton GJG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-613; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Waxman S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-243; Xia XQ, 2009, BIOINFORMATICS, V25, P2425, DOI 10.1093/bioinformatics/btp430; Yalcin B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001085; Yan H, 2002, NAT GENET, V30, P25, DOI 10.1038/ng799; Zhu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044405; Zsori KS, 2013, INT J MOL SCI, V14, P3456, DOI 10.3390/ijms14023456	68	11	11	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63125	10.1371/journal.pone.0063125	http://dx.doi.org/10.1371/journal.pone.0063125			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671661	Green Published, gold, Green Submitted			2022-12-25	WOS:000319737700040
J	Muller, R; Jenny, A; Stanley, P				Mueller, Reto; Jenny, Andreas; Stanley, Pamela			The EGF Repeat-Specific O-GlcNAc-Transferase Eogt Interacts with Notch Signaling and Pyrimidine Metabolism Pathways in Drosophila	PLOS ONE			English	Article							LINKED-N-ACETYLGLUCOSAMINE; CELL-ADHESION; WING MUTANTS; MUTATIONS; GLYCOSYLTRANSFERASE; MELANOGASTER; DOMAIN; RUDIMENTARY; EXPRESSION; DUMPY	The O-GlcNAc transferase Eogt modifies EGF repeats in proteins that transit the secretory pathway, including Dumpy and Notch. In this paper, we show that the Notch ligands Delta and Serrate are also substrates of Eogt, that mutation of a putative UDP-GlcNAc binding DXD motif greatly reduces enzyme activity, and that Eogt and the cytoplasmic O-GlcNAc transferase Ogt have distinct substrates in Drosophila larvae. Loss of Eogt is larval lethal and disrupts Dumpy functions, but does not obviously perturb Notch signaling. To identify novel genetic interactions with eogt, we investigated dominant modification of wing blister formation caused by knock-down of eogt. Unexpectedly, heterozygosity for several members of the canonical Notch signaling pathway suppressed wing blister formation. And importantly, extensive genetic interactions with mutants in pyrimidine metabolism were identified. Removal of pyrimidine synthesis alleles suppressed wing blister formation, while removal of uracil catabolism alleles was synthetic lethal with eogt knock-down. Therefore, Eogt may regulate protein functions by O-GlcNAc modification of their EGF repeats, and cellular metabolism by affecting pyrimidine synthesis and catabolism. We propose that eogt knock-down in the wing leads to metabolic and signaling perturbations that increase cytosolic uracil levels, thereby causing wing blister formation.	[Mueller, Reto; Stanley, Pamela] Albert Einstein Coll Med, Dept Cell Biol, New York, NY USA; [Jenny, Andreas] Albert Einstein Coll Med, Dept Dev & Mol Biol, New York, NY USA; [Jenny, Andreas] Albert Einstein Coll Med, Dept Genet, New York, NY USA	Yeshiva University; Yeshiva University; Yeshiva University	Jenny, A (corresponding author), Albert Einstein Coll Med, Dept Dev & Mol Biol, New York, NY USA.	andreas.jenny@einstein.yu.edu; pamela.stanley@einstein.yu.edu		Stanley, Pamela/0000-0001-5704-3747	NCI [RO1 CA036434]; NIGMS [RO1 GM088202]; Cancer Center of the Albert Einstein College of Medicine (NCI) [PO1 13330]; NATIONAL CANCER INSTITUTE [R01CA036434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088202] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Cancer Center of the Albert Einstein College of Medicine (NCI); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NCI grant RO1 CA036434 (to P.S.), NIGMS grant RO1 GM088202 (to A.J.), and the Cancer Center of the Albert Einstein College of Medicine (NCI grant PO1 13330). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar M, 2008, CELL, V132, P247, DOI 10.1016/j.cell.2007.12.016; Alfaro JF, 2012, P NATL ACAD SCI USA, V109, P7280, DOI 10.1073/pnas.1200425109; BLASS DH, 1980, MOL GEN GENET, V178, P437, DOI 10.1007/BF00270496; Bokel C, 2005, J CELL SCI, V118, P633, DOI 10.1242/jcs.01619; Borycz J, 2012, J EXP BIOL, V215, P1399, DOI 10.1242/jeb.060699; BRAND AH, 1993, DEVELOPMENT, V118, P401; Breton C, 1998, J BIOCHEM, V123, P1000; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CAREY FG, 1960, BIOCHIM BIOPHYS ACTA, V41, P178, DOI 10.1016/0006-3002(60)90395-4; Carmon A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012319; Carmon A, 2010, FLY, V4, P117, DOI 10.4161/fly.4.2.11953; CAVENER DR, 1987, NUCLEIC ACIDS RES, V15, P1353, DOI 10.1093/nar/15.4.1353; CLYNES MM, 1976, J INSECT PHYSIOL, V22, P1709, DOI 10.1016/0022-1910(76)90064-0; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; DECELIS JF, 1994, GENETICS, V136, P183; FAUSTOSTERLING A, 1977, BIOCHEM GENET, V15, P803, DOI 10.1007/BF00484105; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Halfon MS, 2002, GENESIS, V34, P135, DOI 10.1002/gene.10136; Hanover JA, 2012, NAT REV MOL CELL BIO, V13, P312, DOI 10.1038/nrm3334; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; HARTLEY DA, 1987, EMBO J, V6, P3407, DOI 10.1002/j.1460-2075.1987.tb02664.x; Hassed SJ, 2012, AM J HUM GENET, V91, P391, DOI 10.1016/j.ajhg.2012.07.005; Herranz H, 2006, EMBO REP, V7, P297, DOI 10.1038/sj.embor.7400617; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hutterer A, 2005, EMBO REP, V6, P836, DOI 10.1038/sj.embor.7400500; Irvine KD, 1999, CURR OPIN GENET DEV, V9, P434, DOI 10.1016/S0959-437X(99)80066-5; Ise H, 2010, GLYCOBIOLOGY, V20, P843, DOI 10.1093/glycob/cwq039; KELLEY MR, 1987, CELL, V51, P539, DOI 10.1016/0092-8674(87)90123-1; KJAER T, 1987, HEREDITAS, V107, P213; Kopan R, 1999, Sci STKE, V1999, pPE1, DOI 10.1126/stke.1999.9.pe1; Leonardi J, 2011, DEVELOPMENT, V138, P3569, DOI 10.1242/dev.068361; Li YX, 2003, DEVELOPMENT, V130, P2829, DOI 10.1242/dev.00498; Mahoney MB, 2006, GENETICS, V172, P2309, DOI 10.1534/genetics.104.035170; Martin D, 1999, J CELL BIOL, V145, P191, DOI 10.1083/jcb.145.1.191; Matsuura A, 2008, J BIOL CHEM, V283, P35486, DOI 10.1074/jbc.M806202200; Meyer V, 1998, MOL CELL BIOL, V18, P1835, DOI 10.1128/MCB.18.4.1835; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Morris DH, 2012, GENETICS, V191, P1227, DOI 10.1534/genetics.112.141101; Muller R, 2009, GLYCOBIOLOGY, V19, P1337; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Phillips AM, 2005, GENE, V351, P131, DOI 10.1016/j.gene.2005.03.013; PISKUR J, 1993, MOL GEN GENET, V241, P335, DOI 10.1007/BF00284686; Prout M, 1997, GENETICS, V146, P275; Ramakrishnan B, 2004, CURR OPIN STRUC BIOL, V14, P593, DOI 10.1016/j.sbi.2004.09.006; Rawls JM, 2006, GENETICS, V172, P1665, DOI 10.1534/genetics.105.052753; Reed BH, 2004, CURR BIOL, V14, P372, DOI 10.1016/j.cub.2004.02.029; RIZKI RM, 1965, SCIENCE, V150, P222, DOI 10.1126/science.150.3693.222; Sakaidani Y, 2012, BIOCHEM BIOPH RES CO, V419, P14, DOI 10.1016/j.bbrc.2012.01.098; Sakaidani Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1591; Shaheen R, 2013, AM J HUM GE IN PRESS; Simmons AJ, 1999, J MOL BIOL, V287, P277, DOI 10.1006/jmbi.1999.2618; Smyk A, 2006, FEBS J, V273, P4728, DOI 10.1111/j.1742-4658.2006.05477.x; Stanley P, 2010, CURR TOP DEV BIOL, V92, P131, DOI 10.1016/S0070-2153(10)92004-8; STROMAN P, 1974, HEREDITAS, V78, P157; STROMAN P, 1973, HEREDITAS, V73, P239; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; THORIG GEW, 1987, BIOCHEM GENET, V25, P7, DOI 10.1007/BF00498948; Tsubota SI, 2011, FLY AUSTIN, V5; Varki A., 2009, ESSENTIALS GLYCOBIOL; Waddington CH, 1940, J GENET, V41, P75, DOI 10.1007/BF02982977; Walsh EP, 1998, GENETICS, V150, P791; Wilkin MB, 2000, CURR BIOL, V10, P559, DOI 10.1016/S0960-9822(00)00482-6; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; WOJCIK E, 1994, GENETICS, V138, P1163	69	46	47	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e62835	10.1371/journal.pone.0062835	http://dx.doi.org/10.1371/journal.pone.0062835			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671640	Green Submitted, gold, Green Published			2022-12-25	WOS:000319737700025
J	Bjork, P; Kallberg, E; Wellmar, U; Riva, M; Olsson, A; He, ZF; Torngren, M; Liberg, D; Ivars, F; Leanderson, T				Bjork, Per; Kallberg, Eva; Wellmar, Ulf; Riva, Matteo; Olsson, Anders; He, Zhifei; Torngren, Marie; Liberg, David; Ivars, Fredrik; Leanderson, Tomas			Common Interactions between S100A4 and S100A9 Defined by a Novel Chemical Probe	PLOS ONE			English	Article							ANTI-ANGIOGENIC AGENT; PROSTATE-CANCER; TASQUINIMOD ABR-215050; METASTATIC PHENOTYPE; AUTOIMMUNE-DISEASE; MYELOID CELLS; PROTEIN; EXPRESSION; BINDING; CHEMOATTRACTANTS	S100A4 and S100A9 proteins have been described as playing roles in the control of tumor growth and metastasis. We show here that a chemical probe, oxyclozanide (OX), selected for inhibiting the interaction between S100A9 and the receptor for advanced glycation end-products (RAGE) interacts with both S100A9 and S100A4. Furthermore, we show that S100A9 and S100A4 interact with RAGE and TLR4; interactions that can be inhibited by OX. Hence, S100A4 and S100A9 display similar functional elements despite their primary sequence diversity. This was further confirmed by showing that S100A4 and S100A9 dimerize both in vitro and in vivo. All of these interactions required levels of Zn++ that are found in the extracellular space but not intracellularly. Interestingly, S100A4 and S100A9 are expressed by distinct CD11b(+) subpopulations both in healthy animals and in animals with either inflammatory disease or tumor burden. The functions of S100A9 and S100A4 described in this paper, including heterodimerization, may therefore reflect S100A9 and S100A4 that are released into the extra-cellular milieu.	[Kallberg, Eva; Riva, Matteo; He, Zhifei; Ivars, Fredrik; Leanderson, Tomas] Lund Univ, Immunol Grp, Lund, Sweden; [Bjork, Per; Wellmar, Ulf; Olsson, Anders; Torngren, Marie; Liberg, David] Act Biotech AB, Lund, Sweden	Lund University	Leanderson, T (corresponding author), Lund Univ, Immunol Grp, Lund, Sweden.	tomas.leanderson@med.lu.se		Riva, Matteo/0000-0003-2697-6717	Swedish Cancer Society; Kocks Foundation; Osterlund foundation; Active Biotech AB	Swedish Cancer Society(Swedish Cancer Society); Kocks Foundation; Osterlund foundation; Active Biotech AB	This work was supported by grants from the Swedish Cancer Society, Kocks Foundation and the Osterlund foundation. The funders had no role in study design, data collection, decision to publish, or preparation of the manuscript.; UW, DL, AO, PB and MT are full time employees of Active Biotech AB that develops S100A9 binding molecules for commercial development. TL is a part time employee of Active Biotech AB. FI receives a research grant from Active Biotech AB. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Ambartsumian N, 2001, ONCOGENE, V20, P4685, DOI 10.1038/sj.onc.1204636; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Bjork P, 2009, PLOS BIOL, V7, P800, DOI 10.1371/journal.pbio.1000097; Boye K, 2010, EUR J CANCER, V46, P2919, DOI 10.1016/j.ejca.2010.07.013; Cheng PY, 2008, J EXP MED, V205, P2235, DOI 10.1084/jem.20080132; DAVIES BR, 1993, ONCOGENE, V8, P999; Foell D, 2004, ARTHRITIS RHEUM-US, V50, P3762, DOI 10.1002/art.20631; Foell D, 2007, J LEUKOCYTE BIOL, V81, P28, DOI 10.1189/jlb.0306170; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Garrett SC, 2006, J BIOL CHEM, V281, P677, DOI 10.1074/jbc.R500017200; Gebhardt C, 2008, J EXP MED, V205, P275, DOI 10.1084/jem.20070679; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; Hermani A, 2005, CLIN CANCER RES, V11, P5146, DOI 10.1158/1078-0432.CCR-05-0352; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Isaacs JT, 2006, PROSTATE, V66, P1768, DOI 10.1002/pros.20509; Itou H, 2002, J MOL BIOL, V316, P265, DOI 10.1006/jmbi.2001.5340; Jennbacken K, 2012, PROSTATE, V72, P913, DOI 10.1002/pros.21495; Jin YL, 2010, CANCER RES, V70, P2516, DOI 10.1158/0008-5472.CAN-09-3950; Kallberg E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034207; Kriajevska M, 2000, BBA-MOL CELL RES, V1498, P252, DOI 10.1016/S0167-4889(00)00100-2; Lominadze G, 2005, J IMMUNOL, V174, P7257, DOI 10.4049/jimmunol.174.11.7257; Maelandsmo GM, 1996, CANCER RES, V56, P5490; Maelandsmo GM, 2009, TUMOR BIOL, V30, P15, DOI 10.1159/000199447; Manitz MP, 2003, MOL CELL BIOL, V23, P1034, DOI 10.1128/MCB.23.3.1034-1043.2003; Marenholz I, 2004, BIOCHEM BIOPH RES CO, V322, P1111, DOI 10.1016/j.bbrc.2004.07.096; Miranda KJ, J BIOL CHEM, V285, P31517; Olsson A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-107; Riva M, 2012, IMMUNOLOGY, V137, P172, DOI 10.1111/j.1365-2567.2012.03619.x; Roth J, 2003, TRENDS IMMUNOL, V24, P155, DOI 10.1016/S1471-4906(03)00062-0; Rudland PS, 2000, CANCER RES, V60, P1595; Xie R, 2009, LAB INVEST, V89, P937, DOI 10.1038/labinvest.2009.52; Yammani RR, 2006, ARTHRITIS RHEUM-US, V54, P2901, DOI 10.1002/art.22042	32	26	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63012	10.1371/journal.pone.0063012	http://dx.doi.org/10.1371/journal.pone.0063012			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667563	Green Published, gold, Green Submitted			2022-12-25	WOS:000319055600052
J	Fietz, D; Bakhaus, K; Wapelhorst, B; Grosser, G; Gunther, S; Alber, J; Doring, B; Kliesch, S; Weidner, W; Galuska, CE; Hartmann, MF; Wudy, SA; Bergmann, M; Geyer, J				Fietz, Daniela; Bakhaus, Katharina; Wapelhorst, Britta; Grosser, Gary; Guenther, Sabine; Alber, Joerg; Doering, Barbara; Kliesch, Sabine; Weidner, Wolfgang; Galuska, Christina E.; Hartmann, Michaela F.; Wudy, Stefan A.; Bergmann, Martin; Geyer, Joachim			Membrane Transporters for Sulfated Steroids in the Human Testis - Cellular Localization, Expression Pattern and Functional Analysis	PLOS ONE			English	Article							SOLUTE-CARRIER-PROTEIN; CONJUGATED NEUTRAL STEROIDS; ORGANIC ANION TRANSPORTER; ESTROGEN-RECEPTORS ALPHA; DEHYDROEPIANDROSTERONE-SULFATE; SEMINIFEROUS TUBULES; PREGNENOLONE SULFATE; MESSENGER-RNA; CELLS; RAT	Sulfated steroid hormones are commonly considered to be biologically inactive metabolites, but may be reactivated by the steroid sulfatase into biologically active free steroids, thereby having regulatory function via nuclear androgen and estrogen receptors which are widespread in the testis. However, a prerequisite for this mode of action would be a carrier-mediated import of the hydrophilic steroid sulfate molecules into specific target cells in reproductive tissues such as the testis. In the present study we detected predominant expression of the Sodium-dependent Organic Anion Transporter (SOAT), the Organic Anion Transporting Polypeptide 6A1, and the Organic Solute Carrier Partner 1 in human testis biopsies. All of these showed significantly lower or even absent mRNA expression in severe disorders of spermatogenesis (arrest at the level of spermatocytes or spermatogonia, Sertoli cell only syndrome). Only SOAT was significantly lower expressed in biopsies showing hypospermatogenesis. By use of immunohistochemistry SOAT was localized to germ cells at various stages in human testis biopsies showing normal spermatogenesis. SOAT immunoreactivity was detected in zygotene primary spermatocytes of stage V, pachytene spermatocytes of all stages (I-V), secondary spermatocytes of stage VI, and round spermatids (step 1 and step 2) in stages I and II. Furthermore, SOAT transport function for steroid sulfates was analyzed with a novel liquid chromatography tandem mass spectrometry procedure capable of profiling steroid sulfate molecules from cell lysates. With this technique, the cellular inward-directed SOAT transport was verified for the established substrates dehydroepiandrosterone sulfate and estrone-3-sulfate. Additionally, beta-estradiol-3-sulfate and androstenediol-3-sulfate were identified as novel SOAT substrates.	[Fietz, Daniela; Wapelhorst, Britta; Guenther, Sabine; Bergmann, Martin] Univ Giessen, Inst Vet Anat Histol & Embryol, D-35390 Giessen, Germany; [Bakhaus, Katharina; Grosser, Gary; Alber, Joerg; Doering, Barbara; Geyer, Joachim] Univ Giessen, Inst Vet Pharmacol & Toxicol, D-35390 Giessen, Germany; [Kliesch, Sabine] Univ Hosp Munster, Ctr Reprod Med & Androl, Dept Clin Androl, Munster, Germany; [Weidner, Wolfgang] Univ Giessen, Clin Urol Pediat Urol & Androl, D-35390 Giessen, Germany; [Galuska, Christina E.; Hartmann, Michaela F.; Wudy, Stefan A.] Univ Giessen, Steroid Res & Mass Spectrometry Unit, Div Paediat Endocrinol & Diabetol, Ctr Child & Adolescent Med, D-35390 Giessen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; University of Munster; Justus Liebig University Giessen; Justus Liebig University Giessen	Fietz, D (corresponding author), Univ Giessen, Inst Vet Anat Histol & Embryol, D-35390 Giessen, Germany.	Daniela.Fietz@vetmed.uni-giessen.de	Wudy, Stefan/ABC-7173-2020; Geyer, Joachim/AAQ-4593-2021		German Research Foundation [DFG FOR1369]	German Research Foundation(German Research Foundation (DFG))	The present study has been supported by German Research Foundation grant DFG FOR1369. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGMANN M, 1989, CELL TISSUE RES, V256, P183; Bergmann M, 2010, ANDROLOGY: MALE REPRODUCTIVE HEALTH AND DYSFUNCTION, THIRD EDITION, P155, DOI 10.1007/978-3-540-78355-8_11; Carreau S, 2012, ADV MED SCI-POLAND, V57, P31, DOI 10.2478/v10039-012-0005-y; Carreau S, 2011, REPROD BIOL, V11, P174, DOI 10.1016/S1642-431X(12)60065-5; Cavaco JEB, 2009, SYST BIOL REPROD MED, V55, P137, DOI 10.1080/19396360902855733; Galuska CE, 2012, ANAL CHEM UNPUB; Geyer J, 2006, N-S ARCH PHARMACOL, V372, P413, DOI 10.1007/s00210-006-0043-8; Geyer J, 2004, BIOCHEM BIOPH RES CO, V316, P300, DOI 10.1016/j.bbrc.2004.02.048; Geyer J, 2007, J BIOL CHEM, V282, P19728, DOI 10.1074/jbc.M702663200; Hagenbuch B, 2004, PFLUG ARCH EUR J PHY, V447, P566, DOI 10.1007/s00424-003-1130-z; Hess R. A., 2004, Animal Reproduction, V1, P5; Hess Rex A, 2003, Reprod Biol Endocrinol, V1, P52, DOI 10.1186/1477-7827-1-52; Hiratsuka K, 2008, MOL REPROD DEV, V75, P1495, DOI 10.1002/mrd.20893; Hiratsuka K, 2011, HISTOCHEM CELL BIOL, V135, P229, DOI 10.1007/s00418-011-0790-6; Izuno H, 2007, LIFE SCI, V81, P1183, DOI 10.1016/j.lfs.2007.08.012; Kobayashi Y, 2005, J BIOL CHEM, V280, P32332, DOI 10.1074/jbc.M504246200; Kobayashi Y, 2007, DRUG METAB DISPOS, V35, P1239, DOI 10.1124/dmd.107.014795; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; LAATIKAINEN T, 1971, J CLIN ENDOCR METAB, V32, P59, DOI 10.1210/jcem-32-1-59; Labrie F, 2001, FRONT NEUROENDOCRIN, V22, P185, DOI 10.1006/frne.2001.0216; Lekhkota O, 2006, HISTOCHEM CELL BIOL, V125, P259, DOI 10.1007/s00418-005-0008-x; Lekhkota O, 2007, ANATGES2007, P67; LYKKESFELDT G, 1985, CLIN ENDOCRINOL, V23, P385, DOI 10.1111/j.1365-2265.1985.tb01096.x; LYKKESFELDT G, 1985, EUR J PEDIATR, V144, P273, DOI 10.1007/BF00451960; Morris KT, 2001, SURGERY, V130, P947, DOI 10.1067/msy.2001.118378; MOUHADJER N, 1989, REPROD NUTR DEV, V29, P277, DOI 10.1051/rnd:19890305; Nakamura N, 2010, J PHARMACOL SCI, V112, P255, DOI 10.1254/jphs.09R03CR; Pasqualini JR, 2005, J STEROID BIOCHEM, V93, P221, DOI 10.1016/j.jsbmb.2005.02.007; PAYNE AH, 1971, J CLIN ENDOCR METAB, V33, P582, DOI 10.1210/jcem-33-4-582; PAYNE AH, 1975, J CLIN ENDOCR METAB, V40, P102, DOI 10.1210/jcem-40-1-102; PAYNE AH, 1973, J CLIN ENDOCR METAB, V37, P448, DOI 10.1210/jcem-37-3-448; PAYNE AH, 1970, ENDOCRINOLOGY, V87, P316, DOI 10.1210/endo-87-2-316; Petzinger E, 2006, N-S ARCH PHARMACOL, V372, P465, DOI 10.1007/s00210-006-0042-9; Pizzagalli F, 2002, MOL ENDOCRINOL, V16, P2283, DOI 10.1210/me.2001-0309; Reed MJ, 2005, ENDOCR REV, V26, P171, DOI 10.1210/er.2004-0003; Robillard KR, 2012, J PHARMACOL EXP THER, V340, P96, DOI 10.1124/jpet.111.186916; RUOKONEN A, 1972, BIOCHEMISTRY-US, V11, P1411, DOI 10.1021/bi00758a013; RUOKONEN A, 1978, J STEROID BIOCHEM, V9, P939, DOI 10.1016/0022-4731(78)90054-7; RUOKONEN AO, 1983, J ANDROL, V4, P104; Schumacher V, 2008, MOL REPROD DEV, V75, P1484, DOI 10.1002/mrd.20889; Selcer KW, 2002, STEROIDS, V67, P821, DOI 10.1016/S0039-128X(02)00030-2; Stanway SJ, 2007, ONCOLOGIST, V12, P370, DOI 10.1634/theoncologist.12-4-370; Steger K, 1998, MOL HUM REPROD, V4, P939, DOI 10.1093/molehr/4.10.939; Strott CA, 2002, ENDOCR REV, V23, P703, DOI 10.1210/er.2001-0040; Suzuki T, 2003, MOL ENDOCRINOL, V17, P1203, DOI 10.1210/me.2002-0304; Walker WH, 2010, PHILOS T R SOC B, V365, P1557, DOI 10.1098/rstb.2009.0258; Walker WH, 2009, STEROIDS, V74, P602, DOI 10.1016/j.steroids.2008.11.017	47	44	44	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62638	10.1371/journal.pone.0062638	http://dx.doi.org/10.1371/journal.pone.0062638			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667501	Green Submitted, gold, Green Published			2022-12-25	WOS:000319055600036
J	Ekins, S; Reynolds, RC; Franzblau, SG; Wan, BJ; Freundlich, JS; Bunin, BA				Ekins, Sean; Reynolds, Robert C.; Franzblau, Scott G.; Wan, Baojie; Freundlich, Joel S.; Bunin, Barry A.			Enhancing Hit Identification in Mycobacterium tuberculosis Drug Discovery Using Validated Dual-Event Bayesian Models	PLOS ONE			English	Article							HIGH-THROUGHPUT SCREEN; IN-VIVO ACTIVITIES; KINASE INHIBITORS; LIBRARY; ANALOGS; PA-824; PHARMACOLOGY; RESISTANCE; PREDICTION; SCAFFOLDS	High-throughput screening (HTS) in whole cells is widely pursued to find compounds active against Mycobacterium tuberculosis (Mtb) for further development towards new tuberculosis (TB) drugs. Hit rates from these screens, usually conducted at 10 to 25 mu M concentrations, typically range from less than 1% to the low single digits. New approaches to increase the efficiency of hit identification are urgently needed to learn from past screening data. The pharmaceutical industry has for many years taken advantage of computational approaches to optimize compound libraries for in vitro testing, a practice not fully embraced by academic laboratories in the search for new TB drugs. Adapting these proven approaches, we have recently built and validated Bayesian machine learning models for predicting compounds with activity against Mtb based on publicly available large-scale HTS data from the Tuberculosis Antimicrobial Acquisition Coordinating Facility. We now demonstrate the largest prospective validation to date in which we computationally screened 82,403 molecules with these Bayesian models, assayed a total of 550 molecules in vitro, and identified 124 actives against Mtb. Individual hit rates for the different datasets varied from 15-28%. We have identified several FDA approved and late stage clinical candidate kinase inhibitors with activity against Mtb which may represent starting points for further optimization. The computational models developed herein and the commercially available molecules derived from them are now available to any group pursuing Mtb drug discovery.	[Ekins, Sean; Bunin, Barry A.] Collaborat Drug Discovery, Burlingame, CA USA; [Ekins, Sean] Collaborat Chem, Fuquay Varina, NC USA; [Reynolds, Robert C.] So Res Inst, Birmingham, AL 35255 USA; [Freundlich, Joel S.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07103 USA; [Franzblau, Scott G.; Wan, Baojie] Univ Illinois, Inst TB Res, Chicago, IL USA; [Freundlich, Joel S.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Med, Ctr Emerging & Reemerging Pathogens, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Rutgers State University New Brunswick; Rutgers State University Medical Center	Ekins, S (corresponding author), Collaborat Drug Discovery, Burlingame, CA USA.	ekinssean@yahoo.com		Franzblau, Scott/0000-0002-8698-0243	Bill and Melinda Gates Foundation [49852]; National Library of Medicine [R43 LM011152-01]; American Reinvestment and Recovery Act [1RC1AI086677-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC1AI086677] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R43LM011152] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); American Reinvestment and Recovery Act; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The CDD TB has been developed thanks to funding from the Bill and Melinda Gates Foundation (Grant#49852 "Collaborative drug discovery for TB through a novel database of SAR data optimized to promote data archiving and sharing''). The project described was supported by Award Number R43 LM011152-01 "Biocomputation across distributed private datasets to enhance drug discovery'' from the National Library of Medicine. RCR and SGF acknowledge the American Reinvestment and Recovery Act Grant 1RC1AI086677-01 (National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID)) - "Targeting MDR-TB.'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alber T, 2009, CURR OPIN STRUC BIOL, V19, P650, DOI 10.1016/j.sbi.2009.10.017; Ananthan S, 2009, TUBERCULOSIS, V89, P334, DOI 10.1016/j.tube.2009.05.008; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; ASHTEKAR DR, 1993, ANTIMICROB AGENTS CH, V37, P183, DOI 10.1128/AAC.37.2.183; Balganesh TS, 2008, TRENDS PHARMACOL SCI, V29, P576, DOI 10.1016/j.tips.2008.08.001; Ballell L, 2005, ANTIMICROB AGENTS CH, V49, P2153, DOI 10.1128/AAC.49.6.2153-2163.2005; Ballester PJ, 2012, J R SOC INTERFACE; Barry CE, 2000, BIOCHEM PHARMACOL, V59, P221, DOI 10.1016/S0006-2952(99)00253-1; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Bender A, 2007, CHEMMEDCHEM, V2, P861, DOI 10.1002/cmdc.200700026; Blaser A, 2012, J MED CHEM, V55, P312, DOI 10.1021/jm2012276; Bruns H, 2012, J IMMUNOL, V189, P4069, DOI 10.4049/jimmunol.1201538; Cavazos A, 2012, J MOL BIOL, V422, P488, DOI 10.1016/j.jmb.2012.06.011; Chapman TM, 2012, BIOORG MED CHEM LETT, V22, P3349, DOI 10.1016/j.bmcl.2012.02.107; Cho SH, 2007, ANTIMICROB AGENTS CH, V51, P1380, DOI 10.1128/AAC.00055-06; Cho Y, 2008, J MED CHEM, V51, P5984, DOI 10.1021/jm800328v; Collins LA, 1997, ANTIMICROB AGENTS CH, V41, P1004, DOI 10.1128/AAC.41.5.1004; Dalton T, 2012, LANCET, V380, P1406, DOI 10.1016/S0140-6736(12)60734-X; Ekins S, 2007, BRIT J PHARMACOL, V152, P9, DOI 10.1038/sj.bjp.0707305; Ekins S, 2010, MOL BIOSYST, V6, P2316, DOI 10.1039/c0mb00104j; Ekins S, 2013, CHEM BIOL, V20, P370, DOI 10.1016/j.chembiol.2013.01.011; Ekins S, 2011, PHARM RES-DORDR, V28, P1785, DOI 10.1007/s11095-011-0486-6; Ekins S, 2011, PHARM RES-DORDR, V28, P1859, DOI 10.1007/s11095-011-0413-x; Ekins S, 2011, DRUG DISCOV TODAY, V16, P298, DOI 10.1016/j.drudis.2011.02.016; Ekins S, 2011, TRENDS MICROBIOL, V19, P65, DOI 10.1016/j.tim.2010.10.005; Ekins S, 2010, MOL BIOSYST, V6, P840, DOI 10.1039/b917766c; Falzari K, 2005, ANTIMICROB AGENTS CH, V49, P1447, DOI 10.1128/AAC.49.4.1447-1454.2005; Feng BY, 2007, J MED CHEM, V50, P2385, DOI 10.1021/jm061317y; Garcia-Garcia A, 2005, J BIOMOL SCREEN, V10, P206, DOI 10.1177/1087057104273486; Gold B, 2012, P NATL ACAD SCI USA, V109, P16004, DOI 10.1073/pnas.1214188109; Hassan M, 2006, MOL DIVERS, V10, P283, DOI 10.1007/s11030-006-9041-5; Hohman M, 2009, DRUG DISCOV TODAY, V14, P261, DOI 10.1016/j.drudis.2008.11.015; Jones DR, 2007, DRUG METAB DISPOS, V35, P1466, DOI 10.1124/dmd.106.014613; Kaneko T, 2011, FUTURE MED CHEM, V3, P1373, DOI [10.4155/fmc.11.115, 10.4155/FMC.11.115]; Kinnings SL, 2011, J CHEM INF MODEL, V51, P408, DOI 10.1021/ci100369f; Klon AE, 2006, J CHEM INF MODEL, V46, P1945, DOI 10.1021/ci0601315; Koul A, 2004, NAT REV MICROBIOL, V2, P189, DOI 10.1038/nrmicro840; Koul A, 2011, NATURE, V469, P483, DOI 10.1038/nature09657; Lopez AD, 2006, ANN TROP MED PARASIT, V100, P481, DOI 10.1179/136485906X97417; Macarron R, 2011, NAT REV DRUG DISCOV, V10, P188, DOI 10.1038/nrd3368; Maddry JA, 2009, TUBERCULOSIS, V89, P354, DOI 10.1016/j.tube.2009.07.006; Magnet S, 2010, TUBERCULOSIS, V90, P354, DOI 10.1016/j.tube.2010.09.001; Maiga M, 2012, J INFECT DIS, V205, P1705, DOI 10.1093/infdis/jis269; Mak PA, 2012, ACS CHEM BIOL, V7, P1190, DOI 10.1021/cb2004884; McGovern SL, 2003, J MED CHEM, V46, P1478, DOI 10.1021/jm020427b; Miller K, 2012, BIOMED COMPUT REV SU, P20; Napier RJ, 2011, CELL HOST MICROBE, V10, P475, DOI 10.1016/j.chom.2011.09.010; Oprea TI, 2001, J CHEM INF COMP SCI, V41, P1308, DOI 10.1021/ci010366a; Palmer BD, 2010, J MED CHEM, V53, P282, DOI 10.1021/jm901207n; Prathipati P, 2008, J CHEM INF MODEL, V48, P2362, DOI 10.1021/ci800143n; Qian F, 2009, CANCER RES, V69, P8009, DOI 10.1158/0008-5472.CAN-08-4889; Reynolds RC, 2012, TUBERCULOSIS, V92, P72, DOI 10.1016/j.tube.2011.05.005; Rogers D, 2005, J BIOMOL SCREEN, V10, P682, DOI 10.1177/1087057105281365; Sarker M, 2012, PHARM RES-DORDR, V29, P2115, DOI 10.1007/s11095-012-0741-5; Scior T, 2012, J CHEM INF MODEL, V52, P867, DOI 10.1021/ci200528d; Singh N, 2012, J CHEM INF MODEL, V52, P2559, DOI 10.1021/ci300336v; Planche AS, 2009, MOL DIVERS, V13, P445, DOI 10.1007/s11030-009-9129-9; Stanley SA, 2012, ACS CHEM BIOL, V7, P1377, DOI 10.1021/cb300151m; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103; Teo M, 2012, ONKOLOGIE, V35, P514, DOI 10.1159/000341829; Thompson AM, 2011, J MED CHEM, V54, P6563, DOI 10.1021/jm200377r; Thompson AM, 2009, J MED CHEM, V52, P637, DOI 10.1021/jm801087e; Voelker R, 2013, JAMA-J AM MED ASSOC, V309, P430, DOI 10.1001/jama.2013.94; Walsh CT, 2009, P NATL ACAD SCI USA, V106, P1689, DOI 10.1073/pnas.0813405106; Ying Z, 2005, ANNU REV PHARMACOL, V45, P529, DOI 10.1146/annurev.pharmtox.45.120403.100120; You WK, 2011, CANCER RES, V71, P4758, DOI 10.1158/0008-5472.CAN-10-2527	67	38	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63240	10.1371/journal.pone.0063240	http://dx.doi.org/10.1371/journal.pone.0063240			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667592	Green Published, Green Submitted, gold			2022-12-25	WOS:000319654700122
J	Herder, V; Hansmann, F; Wohlsein, P; Peters, M; Varela, M; Palmarini, M; Baumgartner, W				Herder, Vanessa; Hansmann, Florian; Wohlsein, Peter; Peters, Martin; Varela, Mariana; Palmarini, Massimo; Baumgaertner, Wolfgang			Immunophenotyping of Inflammatory Cells Associated with Schmallenberg Virus Infection of the Central Nervous System of Ruminants	PLOS ONE			English	Article							AKABANE VIRUS; CONGENITAL-ABNORMALITIES; DIARRHEA VIRUS; TRANSPLACENTAL INFECTION; VIRAL-INFECTION; OVINE FETUSES; CATTLE; DISEASE; LESIONS; MODEL	Schmallenberg virus (SBV) is a recently discovered Bunyavirus associated mainly with abortions, stillbirths and malformations of the skeletal and central nervous system (CNS) in newborn ruminants. In this study, a detailed immunophenotyping of the inflammatory cells of the CNS of affected animals was carried out in order to increase our understanding of SBV pathogenesis. A total of 82 SBV-polymerase chain reaction (PCR) positive neonatal ruminants (46 sheep lambs, 34 calves and 2 goat kids) were investigated for the presence of inflammation in the brain and spinal cord. The study focused on 15 out of 82 animals (18.3%) showing inflammation in the CNS. All 15 neonates displayed lymphohistiocytic meningoencephalomyelitis affecting most frequently the mesencephalon and the parietal and temporal lobes. The majority of infiltrating cells were CD3-positive T cells, followed by CD79 alpha-positive B cells and CD68-positive microglia/macrophages. Malformations like por- and hydranencephaly, frequently found in the temporal lobe, showed associated demyelination and axonal loss. SBV antigen was detected in 37 out of 82 (45.1%) neonatal brains by immunohistochemistry. In particular, SBV antigen was found in 93.3% (14 out of 15 ruminants) and 32.8% (22 out of 67 ruminants) of animals with and without encephalitis, respectively. Highest amounts of virus-protein expression levels were found in the temporal lobe. Our findings suggest that: (i) different brain regions display differential susceptibility to SBV infection; (ii) inflammatory cells in the CNS are found only in a minority of virus infected animals; (iii) malformations occur in association with and without inflammation in the CNS; and (iv) viral antigen is strongly associated with the presence of inflammation in naturally infected animals. Further studies are required to explore the cell tropism and pathogenesis of SBV infection in ruminants.	[Herder, Vanessa; Hansmann, Florian; Wohlsein, Peter; Baumgaertner, Wolfgang] Univ Vet Med, Dept Pathol, Hannover, Lower Saxony, Germany; [Peters, Martin] Staatl Vet Untersuchungsamt, Arnsberg, North Rhine Wes, Germany; [Varela, Mariana; Palmarini, Massimo] Univ Glasgow, MRC Ctr Virus Res, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Baumgaertner, Wolfgang] Ctr Syst Neurosci, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation; University of Glasgow	Baumgartner, W (corresponding author), Univ Vet Med, Dept Pathol, Hannover, Lower Saxony, Germany.	wolfgang.baumgaertner@tiho-hannover.de	Herder, Vanessa/AAG-6647-2020	Hansmann, Florian/0000-0001-6064-7728; Palmarini, Massimo/0000-0001-7007-4070; Herder, Vanessa/0000-0003-4814-1382	Medical Research Council [G0801822] Funding Source: Medline; MRC [G0801822] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ali H, 2012, TRANSBOUND EMERG DIS, V59, P11, DOI 10.1111/j.1865-1682.2011.01240.x; [Anonymous], 2012, VET REC, V171, P140, DOI 10.1136/vr.e5373; [Anonymous], 2012, Vet Rec, V170, P660; Beer M, 2013, EPIDEMIOL INFECT, V141, P1, DOI 10.1017/S0950268812002245; BINKHORST GJ, 1983, VET QUART, V5, P145, DOI 10.1080/01652176.1983.9693889; BOLLO E, 1986, ACTA NEUROPATHOL, V72, P69, DOI 10.1007/BF00687949; Burck H, 1982, HISTOLOGISCHE TECHNI, P136; De Regge N, 2012, TRANSBOUND EMERG DIS, V59, P471, DOI 10.1111/tbed.12000; EDWARDS JF, 1989, VET PATHOL, V26, P33, DOI 10.1177/030098588902600106; Elbers ARW, 2013, EMERG INFECT DIS, V19, P106, DOI 10.3201/eid1901.121054; Elbers ARW, 2012, EMERG INFECT DIS, V18, P1065, DOI 10.3201/eid1807.120323; FERNANDEZ A, 1989, VET PATHOL, V26, P26, DOI 10.1177/030098588902600105; Garigliany MM, 2012, ANTIVIR RES, V95, P82, DOI 10.1016/j.antiviral.2012.05.014; Garten L, 2007, J CHILD NEUROL, V22, P645, DOI 10.1177/0883073807302618; Goller KV, 2012, EMERG INFECT DIS, V18, P1644, DOI 10.3201/eid1810.120835; Hahn K, 2013, EMERG INFECT DIS, V19, P154, DOI 10.3201/eid1901.120764; Harding B, 1997, GREENFIELDS NEUROPAT, P397; Herder V, 2012, VET PATHOL, V49, P588, DOI 10.1177/0300985812447831; Herder V, 2012, J NEUROIMMUNOL, V244, P84, DOI 10.1016/j.jneuroim.2012.01.010; HEWICKERTRAUTWEIN M, 1994, ACTA NEUROPATHOL, V87, P385; HEWICKERTRAUTWEIN M, 1995, J VET MED B, V42, P65, DOI 10.1111/j.1439-0450.1995.tb00684.x; Hoffmann AR, 2012, J VIROL, V86, P4793, DOI 10.1128/JVI.06858-11; Hoffmann B, 2012, EMERG INFECT DIS, V18, P469, DOI 10.3201/eid1803.111905; Hoper D, 2012, DT TIERARZTEBLATT, V4, P500; Huang CC, 2003, VET MICROBIOL, V94, P1, DOI 10.1016/S0378-1135(03)00062-2; Kamata H, 2009, J COMP PATHOL, V140, P187, DOI 10.1016/j.jcpa.2008.12.001; KIRKLAND PD, 1988, VET REC, V122, P582, DOI 10.1136/vr.122.24.582; Kitani H, 2000, VET MICROBIOL, V73, P269, DOI 10.1016/S0378-1135(00)00158-9; KONNO S, 1982, VET PATHOL, V19, P246, DOI 10.1177/030098588201900304; KONNO S, 1982, VET PATHOL, V19, P267, DOI 10.1177/030098588201900305; Kono R, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-20; Kreutzer M, 2012, BRAIN PATHOL, V22, P454, DOI 10.1111/j.1750-3639.2011.00541.x; Kupferschmidt K, 2012, SCIENCE, V335, P1028, DOI 10.1126/science.335.6072.1028; Maclachlan NJ, 2009, J COMP PATHOL, V141, P1, DOI 10.1016/j.jcpa.2009.04.003; Meroc E, 2013, TRANSBOUND EMERG DIS, V60, P4, DOI 10.1111/tbed.12042; Otter A, 2009, VET REC, V164, P771, DOI 10.1136/vr.164.25.771; PARSONSON IM, 1988, J COMP PATHOL, V99, P215, DOI 10.1016/0021-9975(88)90073-4; PARSONSON IM, 1981, VET MICROBIOL, V6, P209, DOI 10.1016/0378-1135(81)90014-6; PLANT JW, 1983, AUST VET J, V60, P137, DOI 10.1111/j.1751-0813.1983.tb05926.x; Rasmussen LD, 2012, EMERG INFECT DIS, V18, P1204, DOI 10.3201/eid1807.120385; Seehusen F, 2010, BRAIN PATHOL, V20, P551, DOI 10.1111/j.1750-3639.2009.00332.x; Summers BA., 1995, VET NEUROPATHOLOGY, P68; Tarlinton R, 2012, VET J, V194, P10, DOI 10.1016/j.tvjl.2012.08.017; Tizard I, 2013, VET IMMUNOLOGY INTRO, V9th, P225; Tsunoda I, 2002, SPRINGER SEMIN IMMUN, V24, P105, DOI 10.1007/s00281-002-0105-z; Varela M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003133; Vercauteren G, 2008, TRANSBOUND EMERG DIS, V55, P293, DOI 10.1111/j.1865-1682.2008.01034.x; WOHRMANN T, 1992, J VET MED B, V39, P599, DOI 10.1111/j.1439-0450.1992.tb01211.x; Zachary J, 2007, NERVOUS SYSTEM, P833	49	20	25	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62939	10.1371/journal.pone.0062939	http://dx.doi.org/10.1371/journal.pone.0062939			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667545	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000319654700084
J	Hirooka, Y; Akiba, M; Ichihara, Y; Masuya, H; Takahata, Y; Suda, T; Yada, Y; Yamamoto, S; Kubono, T				Hirooka, Yuuri; Akiba, Mitsuteru; Ichihara, Yu; Masuya, Hayato; Takahata, Yoshihiro; Suda, Tomohisa; Yada, Yutaka; Yamamoto, Shigehiro; Kubono, Takanori			A Novel Approach of Preventing Japanese Cedar Pollen Dispersal That Is the Cause of Japanese Cedar Pollinosis (JCP) Using Pollen-Specific Fungal Infection	PLOS ONE			English	Article							EXPRESSED SEQUENCE TAGS; CRY-J-I; CRYPTOMERIA-JAPONICA; BIOLOGICAL-CONTROL; MAJOR ALLERGEN; GENES	In Japan, Japanese cedar pollen dispersal is one of the major causes of pollinosis. Sydowia japonica is an ascomycetous fungus that grows exclusively on the male strobili of Japanese cedar, suggesting a possible mechanism for controlling pollen dispersal. To evaluate this possibility, eleven isolates of S. japonica were collected from around Japan and used as an inoculum to male strobili of Japanese cedar. The treatment demonstrated that the fungus infected only the pollen and prevented pollen dispersal. The fungus did not cause any additional symptoms to other parts of Japanese cedar, such as needles, stems, and buds. All S. japonica isolates collected around Japan could serve to control pollen dispersal. Periodic observation of the fungal pathogenesis with stereomicroscope and scanning electron microscope showed that hyphal fragments and conidia of S. japonica germinated on the surface of male strobili, and the germ tube entered pollen sacs through opening microsporophylls. Within the pollen sacs, the hyphae penetrated pollen gradually, such that all pollen was infected by the fungus by approximately one month before the pollen dispersal season. The infected pollen was destroyed due to the fungal infection and was never released. Our data suggests a novel approach of preventing pollen dispersal using pollen-specific fungal infection.	[Hirooka, Yuuri; Akiba, Mitsuteru; Masuya, Hayato; Kubono, Takanori] Forestry & Forest Prod Res Inst, Dept Forest Microbiol, Tsukuba, Ibaraki 305, Japan; [Ichihara, Yu] Forestry & Forest Prod Res Inst, Tohoku Res Ctr, Morioka, Iwate, Japan; [Takahata, Yoshihiro] Forestry & Forest Prod Res Inst, Kyushu Res Ctr, Kumamoto, Japan; [Suda, Tomohisa] Fukushima Prefectural Forestry Res Ctr, Koriyama, Fukushima, Japan; [Yada, Yutaka] Ishikawa Forest Expt Stn, Haku San, Ishikawa, Japan; [Yamamoto, Shigehiro] Forestry & Forest Prod Res Ctr, Shizuoka Prefectural Res Inst Agr & Forestry, Hamamatsu, Shizuoka, Japan	Forestry & Forest Products Research Institute - Japan; Forestry & Forest Products Research Institute - Japan; Forestry & Forest Products Research Institute - Japan	Hirooka, Y (corresponding author), Forestry & Forest Prod Res Inst, Dept Forest Microbiol, Tsukuba, Ibaraki 305, Japan.	yuurihirooka@gmail.com	Masuya, Hayato/AAN-8998-2021		MAFF practical technology development project [22023]	MAFF practical technology development project	The authors' study was supported by the MAFF practical technology development project grant No. 22023 "Development on the scattering prevention of cedar and cypress pollen by using fungi''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS PB, 1990, ANNU REV PHYTOPATHOL, V28, P59, DOI 10.1146/annurev.py.28.090190.000423; Baba K, 2008, PROG MED, V28, P2001; Bateman R., 2001, Fungi as biocontrol agents: progress, problems and potential, P289, DOI 10.1079/9780851993560.0289; Bills GF, 2004, STUD MYCOL, P149; Bills GF, 1999, MYCOL RES, V103, P179, DOI 10.1017/S095375629800687X; Butt T. M., 2001, Fungi as biocontrol agents: progress, problems and potential, P377, DOI 10.1079/9780851993560.0377; Cook R. J., 1983, The nature and practice of biological control of plant pathogens.; DAY RW, 1989, ECOL MONOGR, V59, P433, DOI 10.2307/1943075; Deacon J. W., 1991, Biocontrol Science and Technology, V1, P5, DOI 10.1080/09583159109355181; Elad Y, 1996, EUR J PLANT PATHOL, V102, P719, DOI 10.1007/BF01877146; FAO, 2007, STAT WORLDS FOR 2007; Farr D. F., 2012, FUNGAL DATABASES SYS; Fukui M, 2001, PLANT CELL PHYSIOL, V42, P566, DOI 10.1093/pcp/pce069; Futamura N, 2007, INT ARCH ALLERGY IMM, V143, P59, DOI 10.1159/000098225; Futamura N, 2006, TREE PHYSIOL, V26, P1517, DOI 10.1093/treephys/26.12.1517; Futamura N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-383; Gorbushina AA, 2008, STUD MYCOL, P91, DOI 10.3114/sim.2008.61.09; Hashizume H., 1992, Research Bulletin of the Tottori University Forests, V21, P51; Hayashi Y, 1951, B GOVT FOREST EXPT S, V48, P1; Hirooka Y, 2012, MYCOLOGICAL IN PRESS; Honma Tamaki, 2003, Biol Sci Space, V17, P48, DOI 10.2187/bss.17.48; Ishii K, 2011, PLANT BIOTECHNOL-NAR, V28, P103, DOI 10.5511/plantbiotechnology.10.0906a; Ito K., 1952, Bulletin of the Government Forest Experiment Station = Ringyo Shikenjo kenkyu hokoku, P79; Kaneko Y, 2005, INT ARCH ALLERGY IMM, V136, P365, DOI 10.1159/000084256; Kasai M, 1917, J PLANT PROT, V4, P23; Kobayashi T., 1970, Transactions of the Mycological Society of Japan, V11, P57; Koshio K., 2011, Journal of the Japanese Forest Society, V93, P43, DOI 10.4005/jjfs.93.43; Koshio K, 2000, J FOR RES, V5, P77; Magan N., 2001, Fungi as biocontrol agents: progress, problems and potential, P239, DOI 10.1079/9780851993560.0239; Onofri S, 2007, ADV SPACE RES, V40, P1657, DOI 10.1016/j.asr.2007.06.004; PALMER FE, 1990, NEW PHYTOL, V116, P613, DOI 10.1111/j.1469-8137.1990.tb00546.x; Samuels GJ, 1991, MYCOL PAP, V164, P1; Statistic Department Minister's Secretariat Ministry of Agriculture Forestry and Fisheries, 2005, 79 STAT YB MIN AGR F, P378; Sterflinger K, 1998, ANTON LEEUW INT J G, V74, P271, DOI 10.1023/A:1001753131034; SUTTON JC, 1993, ANNU REV PHYTOPATHOL, V31, P473, DOI 10.1146/annurev.py.31.090193.002353; Taira H., 1993, Journal of the Japanese Forestry Society, V75, P377; TANIAI M, 1993, MOL IMMUNOL, V30, P183; TANIGUCHI Y, 1995, ALLERGY, V50, P90, DOI 10.1111/j.1398-9995.1995.tb02489.x; TODA R, 1974, New Zealand Journal of Forestry Science, V4, P410; Tsubomura M, 2008, COMB P INT PLANT PRO, V58, P421; Tsuneda A, 2004, MYCOLOGIA, V96, P1128, DOI 10.2307/3762094; Ueuma H, 2009, J FOREST RES-JPN, V14, P123, DOI 10.1007/s10310-009-0114-z; YASUEDA H, 1983, J ALLERGY CLIN IMMUN, V71, P77, DOI 10.1016/0091-6749(83)90550-X	43	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62875	10.1371/journal.pone.0062875	http://dx.doi.org/10.1371/journal.pone.0062875			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667533	Green Submitted, gold, Green Published			2022-12-25	WOS:000319654700072
J	Hu, RZ; Wallace, J; Dahlem, TJ; Grunwald, DJ; O'Connell, RM				Hu, Ruozhen; Wallace, Jared; Dahlem, Timothy J.; Grunwald, David Jonah; O'Connell, Ryan M.			Targeting Human MicroRNA Genes Using Engineered Tal-Effector Nucleases (TALENs)	PLOS ONE			English	Article							SYSTEM; EXPRESSION; ROLES	MicroRNAs (miRNAs) have quickly emerged as important regulators of mammalian physiology owing to their precise control over the expression of critical protein coding genes. Despite significant progress in our understanding of how miRNAs function in mice, there remains a fundamental need to be able to target and edit miRNA genes in the human genome. Here, we report a novel approach to disrupting human miRNA genes ex vivo using engineered TAL-effector (TALE) proteins to function as nucleases (TALENs) that specifically target and disrupt human miRNA genes. We demonstrate that functional TALEN pairs can be designed to enable disruption of miRNA seed regions, or removal of entire hairpin sequences, and use this approach to successfully target several physiologically relevant human miRNAs including miR-155*, miR-155, miR-146a and miR-125b. This technology will allow for a substantially improved capacity to study the regulation and function of miRNAs in human cells, and could be developed into a strategic means by which miRNAs can be targeted therapeutically during human disease.	[Hu, Ruozhen; Wallace, Jared; O'Connell, Ryan M.] Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA; [Dahlem, Timothy J.; Grunwald, David Jonah] Univ Utah, Dept Human Genet, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	O'Connell, RM (corresponding author), Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA.	ryan.oconnell@path.utah.edu			University of Utah Research Foundation; National Institutes of Health [1R21HD073847-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD073847] Funding Source: NIH RePORTER	University of Utah Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the University of Utah Research Foundation (R.M.O. and D.J.G.) and National Institutes of Health 1R21HD073847-01 (D.J.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Dahlem TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002861; Doyon Y, 2011, NAT METHODS, V8, P74, DOI 10.1038/NMETH.1539; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Filipowicz W, 2011, PROG DRUG RES, V67, P221, DOI 10.1007/978-3-7643-8989-5_11; Holkers M, 2012, NUCL ACIDS RES; Hu RZ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4131; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Mallanna SK, 2010, DEV BIOL, V344, P16, DOI 10.1016/j.ydbio.2010.05.014; Meza-Sosa KF, 2012, J NEUROSCI RES, V90, P1, DOI 10.1002/jnr.22701; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Ono K, 2011, FEBS J, V278, P1619, DOI 10.1111/j.1742-4658.2011.08090.x; Paraboschi EM, 2011, INT J MOL SCI, V12, P8695, DOI 10.3390/ijms12128695; Szczepek M, 2007, NAT BIOTECHNOL, V25, P786, DOI 10.1038/nbt1317	17	27	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63074	10.1371/journal.pone.0063074	http://dx.doi.org/10.1371/journal.pone.0063074			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667577	Green Published, gold			2022-12-25	WOS:000319654700109
J	Klimova, L; Lachova, J; Machon, O; Sedlacek, R; Kozmik, Z				Klimova, Lucie; Lachova, Jitka; Machon, Ondrej; Sedlacek, Radislav; Kozmik, Zbynek			Generation of mRx-Cre Transgenic Mouse Line for Efficient Conditional Gene Deletion in Early Retinal Progenitors	PLOS ONE			English	Article							HOMEOBOX GENE; EYE DEVELOPMENT; EXPRESSION; MORPHOGENESIS; MUTATIONS; LENS; PAX6; TOOL; RAX	During mouse eye development, all retinal cell types are generated from the population of retina-committed progenitors originating from the neuroepithelium of the optic vesicle. Conditional gene inactivation provides an efficient tool for studying the genetic basis of the developing retina; however, the number of retina-specific Cre lines is limited. Here we report generation of the mRx-Cre BAC transgenic mouse line in which the expression of Cre recombinase is controlled by regulatory sequences of the mouse Rx gene, one of the earliest determinants of retinal development. When mRx-Cre transgenic mice were crossbred with the ROSA26R or ROSA26R-EYFP reporter lines, the Cre activity was observed in the optic sulcus from embryonic day 8.5 onwards and later in all progenitors residing in the neuroepithelium of the optic cup. Our results suggest that mRx-Cre provides a unique tool for functional genetic studies in very early stages of retinal development. Moreover, since eye organogenesis is dependent on the inductive signals between the optic vesicle and head surface ectoderm, the inductive ability of the optic vesicle can be analyzed using mRx-Cre transgenic mice.	[Klimova, Lucie; Lachova, Jitka; Machon, Ondrej; Sedlacek, Radislav; Kozmik, Zbynek] Acad Sci Czech Republ, Inst Mol Genet, Prague, Czech Republic; [Klimova, Lucie] Charles Univ Prague, Dept Genet & Microbiol, Fac Sci, Prague, Czech Republic	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Charles University Prague	Kozmik, Z (corresponding author), Acad Sci Czech Republ, Inst Mol Genet, Prague, Czech Republic.	kozmik@img.cas.cz	Sedlacek, Radislav/G-4408-2014; Kozmik, Zbynek/G-3581-2014; Machon, Ondrej/G-3587-2014; Kozmik, Zbynek/I-8807-2014	Kozmik, Zbynek/0000-0002-5850-2105	Grant Agency of the Czech Republic [P305/11/2198]; Grant Agency of Charles University in Prague [GAUK 43-251054]; Czech Ministry of Education Grant [LK11214, LM2011032]; GACR [P305/10/2143]; Operational Program Research and Development for Innovations by Ministry of School and Education, Czech Republic [CZ.1.05/1.1.00/02.0109]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Grant Agency of Charles University in Prague; Czech Ministry of Education Grant; GACR(Grant Agency of the Czech Republic); Operational Program Research and Development for Innovations by Ministry of School and Education, Czech Republic	This study was supported by the Grant Agency of the Czech Republic (P305/11/2198), Grant Agency of Charles University in Prague (GAUK 43-251054), Czech Ministry of Education Grant LK11214, by LM2011032 and CZ.1.05/1.1.00/02.0109 (Operational Program Research and Development for Innovations by Ministry of School and Education, Czech Republic), and by GACR (P305/10/2143) to RS, and by IMG institutional support RVO68378050. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey TJ, 2004, INT J DEV BIOL, V48, P761, DOI 10.1387/ijdb.041878tb; Casarosa S, 1997, MECH DEVELOP, V61, P187, DOI 10.1016/S0925-4773(96)00640-5; Chow RL, 2001, ANNU REV CELL DEV BI, V17, P255, DOI 10.1146/annurev.cellbio.17.1.255; Fuhrmann S, 2010, CURR TOP DEV BIOL, V93, P61, DOI [10.1016/B978-0-12-385044-7.00003-5, 10.1016/S0070-2153(10)93003-2]; Furukawa T, 1997, P NATL ACAD SCI USA, V94, P3088, DOI 10.1073/pnas.94.7.3088; Furuta Y, 2000, GENESIS, V26, P130, DOI 10.1002/(SICI)1526-968X(200002)26:2<130::AID-GENE9>3.0.CO;2-I; Graw J, 2010, CURR TOP DEV BIOL, V90, P343, DOI 10.1016/S0070-2153(10)90010-0; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; HOGAN BLM, 1986, J EMBRYOL EXP MORPH, V97, P95; Kreslova J, 2007, GENESIS, V45, P157, DOI 10.1002/dvg.20277; Lakowski J, 2007, DEV BIOL, V307, P498, DOI 10.1016/j.ydbio.2007.04.015; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Loosli F, 2003, EMBO REP, V4, P894, DOI 10.1038/sj.embor.embor919; Loosli F, 2001, DEVELOPMENT, V128, P4035; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Mathers PH, 1997, NATURE, V387, P603, DOI 10.1038/42475; Rowan S, 2004, DEV BIOL, V271, P388, DOI 10.1016/j.ydbio.2004.03.039; Sato S, 2007, GENESIS, V45, P502, DOI 10.1002/dvg.20318; Shaham O, 2012, PROG RETIN EYE RES, V31, P351, DOI 10.1016/j.preteyeres.2012.04.002; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Swindell EC, 2006, GENESIS, V44, P361, DOI 10.1002/dvg.20225; Voronina VA, 2004, HUM MOL GENET, V13, P315, DOI 10.1093/hmg/ddh025	24	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63029	10.1371/journal.pone.0063029	http://dx.doi.org/10.1371/journal.pone.0063029			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667567	gold, Green Submitted, Green Published			2022-12-25	WOS:000319654700099
J	Monteiro, DCF; Kamdoum, WVP; Paci, E				Monteiro, Diana C. F.; Kamdoum, Wilfride V. Petnga; Paci, Emanuele			Growth Kinetics of Bacterial Pili from Pairwise Pilin Association Rates	PLOS ONE			English	Article							DONOR-STRAND EXCHANGE; SUBUNIT SPECIFICITY; MOLECULAR-DYNAMICS; FIMBRIAE; ADHESIN	Bacterial pilogenesis is a remarkable example of biological non-templated self-assembly where a small number of different building blocks are arranged in a specific order resulting in a macroscopic hair-like fiber containing up to thousands copies of protein subunits. A number of advanced experimental techniques have been used to understand pilus growth. While details such as the conformation of the protein building blocks before and after the elementary polymerization step have enhanced our understanding of this mechanism, such information does not explain the high efficiency of this growth process. In this study, we focused on the growth of the Escherichia coli P-pilus, which is formed by the assembly of six subunits, structurally similar incomplete Ig-like domains. These subunits undergo polymerization through fold complementation by the donation of a beta-sheet strand in a specific conserved order. All pairwise rates of association of the individual subunits with the corresponding beta-sheet donor strand peptides have been previously determined through non-covalent mass-spectrometry. Here we use computational simulations to determine donor-strand exchange rates and subunit concentrations necessary to warrant the growth of pili showing similar lengths and subunit orders to those observed in vivo. Our findings confirm that additional factors must be involved in the modulation of the donor-strand exchange rate and/or pilin subunit concentration at the usher must be important for the precise ordering and rapid polymerization rates observed in vivo.	[Monteiro, Diana C. F.; Kamdoum, Wilfride V. Petnga; Paci, Emanuele] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England	University of Leeds	Paci, E (corresponding author), Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England.	e.paci@leeds.ac.uk	Paci, Emanuele/B-1893-2010; Monteiro, Diana/G-1834-2011	Paci, Emanuele/0000-0002-4891-2768; Monteiro, Diana/0000-0002-6318-7306	Wellcome Trust [096686/Z/11/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a Wellcome Trust PhD studentship (to DCFM) [096686/Z/11/Z]. http://www.wellcome.ac.uk/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Anderson GG, 2008, CURR TOP MICROBIOL, V322, P85; Barnhart MM, 2003, J BACTERIOL, V185, P2723, DOI 10.1128/JB.185.9.2723-2730.2003; BULLITT E, 1995, NATURE, V373, P164, DOI 10.1038/373164a0; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; DODSON KW, 1993, P NATL ACAD SCI USA, V90, P3670, DOI 10.1073/pnas.90.8.3670; Duncan MJ, 2005, J BIOL CHEM, V280, P37707, DOI 10.1074/jbc.M501249200; EDEN CS, 1978, INFECT IMMUN, V21, P229; JACOBDUBUISSON F, 1994, J BIOL CHEM, V269, P12447; JACOBDUBUISSON F, 1993, EMBO J, V12, P837, DOI 10.1002/j.1460-2075.1993.tb05724.x; Jass J, 2004, BIOPHYS J, V87, P4271, DOI 10.1529/biophysj.104.044867; Lee YM, 2007, J BACTERIOL, V189, P5276, DOI 10.1128/JB.01648-06; Leney AC, 2011, J AM SOC MASS SPECTR, V22, P1214, DOI 10.1007/s13361-011-0146-4; Morrissey B, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015289; Nishiyama M, 2008, SCIENCE, V320, P376, DOI 10.1126/science.1154994; Phan G, 2011, NATURE, V474, P49, DOI 10.1038/nature10109; Remaut H, 2006, MOL CELL, V22, P831, DOI 10.1016/j.molcel.2006.05.033; ROBERTS JA, 1994, P NATL ACAD SCI USA, V91, P11889, DOI 10.1073/pnas.91.25.11889; Rose RJ, 2008, P NATL ACAD SCI USA, V105, P12873, DOI 10.1073/pnas.0802177105; Rose RJ, 2008, J MOL BIOL, V375, P908, DOI 10.1016/j.jmb.2007.10.077; Sauer FG, 1999, SCIENCE, V285, P1058, DOI 10.1126/science.285.5430.1058; Saulino ET, 1998, EMBO J, V17, P2177, DOI 10.1093/emboj/17.8.2177; Verger D, 2008, STRUCTURE, V16, P1724, DOI 10.1016/j.str.2008.08.012; Vitagliano L, 2007, J MOL BIOL, V367, P935, DOI 10.1016/j.jmb.2007.01.034; Vitagliano L, 2009, J PEPT SCI, V15, P192, DOI 10.1002/psc.1084; Waksman G, 2009, NAT REV MICROBIOL, V7, P765, DOI 10.1038/nrmicro2220	25	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63065	10.1371/journal.pone.0063065	http://dx.doi.org/10.1371/journal.pone.0063065			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667575	Green Published, Green Submitted, gold			2022-12-25	WOS:000319654700107
J	Moodley, D; Reddy, L; Mahungo, W; Masha, R				Moodley, Dhayendre; Reddy, Leanne; Mahungo, Wisani; Masha, Rebotile			Factors Associated with Coverage of Cotrimoxazole Prophylaxis in HIV-Exposed Children in South Africa	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RANDOMIZED CONTROLLED-TRIAL; PMTCT PROGRAM; DOUBLE-BLIND; TRANSMISSION; COHORT; PREVENTION; NEVIRAPINE; INFECTION; EFFICACY	Background: The World Health Organisation and the Joint United Nations Programme in 2006 reaffirmed the earlier recommendation of 2000 that all HIV-exposed infants in resource-poor countries should commence cotrimoxazole (CTX) prophylaxis at 6-weeks of life. CTX prophylaxis should be continued until the child is confirmed HIV-uninfected and there is no further exposure to breastmilk transmission. We determined CTX coverage and explored factors associated with CTX administration in HIV-exposed infants at a primary health clinic in South Africa. Methods: In a cross-sectional study of HIV-exposed infants 6-18 months of age attending a child immunisation clinic, data from the current visit and previous visits related to CTX prophylaxis, feeding practice and infant HIV testing were extracted from the child's immunisation record. Further information related to the administration of CTX prophylaxis was obtained from an interview with the child's mother. Results: One-third (33.0%) HIV-exposed infants had not initiated CTX at all and breastfed infants were more likely to have commenced CTX prophylaxis as compared to their non-breastfed counterparts (78.7% vs 63.4%) (p = 0.008). Availability of infant's HIV status was strongly associated with continuation or discontinuation of CTX after 6 months of age or after breastfeeding cessation. Maternal self-reports indicated that only 52.5% (95%CI 47.5-57.5) understood the reason for CTX prophylaxis, 126 (47%) did not dose during weekends; 55 (21%) dosed their infants 3 times a day and 70 (26%) dosed their infants twice daily. Conclusion: A third of HIV-exposed children attending a primary health care facility in this South African setting did not receive CTX prophylaxis. Not commencing CTX prophylaxis was strongly associated with infants not breastfeeding and unnecessary continued exposure to CTX in this paediatric population was due to limited availability of early infant diagnosis. Attendance at immunization clinics can be seen as missed opportunities for early infant diagnosis of HIV and related care.	[Moodley, Dhayendre; Reddy, Leanne; Mahungo, Wisani; Masha, Rebotile] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Dept Obstet & Gynaecol, Womens Hlth & HIV Res Unit, Durban, South Africa	University of Kwazulu Natal	Moodley, D (corresponding author), Univ KwaZulu Natal, Nelson R Mandela Sch Med, Dept Obstet & Gynaecol, Womens Hlth & HIV Res Unit, Durban, South Africa.	moodleyd1@ukzn.ac.za	Moodley, Dhayendre/U-6802-2019					[Anonymous], 2009, HIV INF FEED REV PRI; Bobat R, 1996, PEDIATR INFECT DIS J, V15, P604, DOI 10.1097/00006454-199607000-00009; Chintu C, 2004, LANCET, V364, P1865, DOI 10.1016/S0140-6736(04)17442-4; Coovadia HM, 2012, LANCET, V379, P221, DOI 10.1016/S0140-6736(11)61653-X; Coutsoudis A, 2001, AIDS, V15, P379, DOI 10.1097/00002030-200102160-00011; Department of Health, 2010, NAT ANT SENT HIV SYP; Doherty T, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-406; Gill CJ, 2008, B WORLD HEALTH ORGAN, V86, P929, DOI 10.2471/BLT.07.049668; Goga A, 2011, ROM IT 6 INT AIDS SO; Graham SM, 2002, LANCET, V360, P1966, DOI 10.1016/S0140-6736(02)11921-0; Horwood C, 2010, TROP MED INT HEALTH, V15, P992, DOI 10.1111/j.1365-3156.2010.02576.x; le Roux DM, 2011, PEDIATR INFECT DIS J, V30, P904, DOI 10.1097/INF.0b013e318220a68b; Moodley D, 2003, J INFECT DIS, V187, P725, DOI 10.1086/367898; National Department of Health, 2010, CLIN GUID PREV MOTH; National Department of Health, 2011, S AFR J CLIN NUTR, V24, P214; National Department of Health, 2008, POL GUID IMPL PMTCT; Taha TE, 2011, CLIN INFECT DIS, V53, P388, DOI 10.1093/cid/cir413; *UNAIDS UNICEF WHO, 2007, CHILDR AIDS STOCKT R; UNAIDS UNICEF WHO, 2010, 5 UNAIDS UNICEF WHO; WHO/UNAIDS/UNICEF, 2004, JOINT WHO UNAIDS UNI; Wiktor SZ, 1999, LANCET, V353, P1469, DOI 10.1016/S0140-6736(99)03465-0; World Health Organisation Joint United Nations Programme on HIV/AIDS and United Nations Children Fund, 2010, UN ACC SCAL PRIOR HI, P88; World Health Organization, 2021, ANT DRUGS TREAT PREG	23	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63273	10.1371/journal.pone.0063273	http://dx.doi.org/10.1371/journal.pone.0063273			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667599	gold, Green Published, Green Submitted			2022-12-25	WOS:000319654700129
J	Nassuato, C; Boender, GJ; Eble, PL; Alborali, L; Bellini, S; Hagenaars, TJ				Nassuato, Claudia; Boender, Gert Jan; Eble, Phaedra L.; Alborali, Loris; Bellini, Silvia; Hagenaars, Thomas J.			Spatial Transmission of Swine Vesicular Disease Virus in the 2006-2007 Epidemic in Lombardy	PLOS ONE			English	Article								In 2006 and 2007 pig farming in the region of Lombardy, in the north of Italy, was struck by an epidemic of Swine Vesicular Disease virus (SVDV). In fact this epidemic could be viewed as consisting of two sub-epidemics, as the reported outbreaks occurred in two separate time periods. These periods differed in terms of the provinces or municipalities that were affected and also in terms of the timing of implementation of movement restrictions. Here we use a simple mathematical model to analyse the epidemic data, quantifying between-farm transmission probability as a function of between-farm distance. The results show that the distance dependence of between-farm transmission differs between the two periods. In the first period transmission over relatively long distances occurred with higher probability than in the second period, reflecting the effect of movement restrictions in the second period. In the second period however, more intensive transmission occurred over relatively short distances. Our model analysis explains this in terms of the relatively high density of pig farms in the area most affected in this period, which exceeds a critical farm density for between-farm transmission. This latter result supports the rationale for the additional control measure taken in 2007 of pre-emptively culling farms in that area.	[Nassuato, Claudia; Alborali, Loris; Bellini, Silvia] IZSLER, Brescia, Italy; [Boender, Gert Jan; Eble, Phaedra L.; Hagenaars, Thomas J.] Cent Vet Inst Wageningen UR CVI, Lelystad, Netherlands	IZS Lombardia e Emilia; Wageningen University & Research	Hagenaars, TJ (corresponding author), Cent Vet Inst Wageningen UR CVI, Lelystad, Netherlands.	thomas.hagenaars@wur.nl	; Alborali, Giovanni Loris/J-2174-2018	Eble, Phaedra/0000-0003-0229-4068; Alborali, Giovanni Loris/0000-0002-4693-6395	EU Network of Excellence, EPIZONE [FOOD - CT 2006-016236]; Dutch Ministry of Economic Affairs [WOT-01-003-011, KB-08-006-006]	EU Network of Excellence, EPIZONE; Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands)	This work was supported by the EU Network of Excellence, EPIZONE (Contract No. FOOD - CT 2006-016236), and by the Dutch Ministry of Economic Affairs (project codes WOT-01-003-011 and KB-08-006-006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellini S, 2010, REV SCI TECH OIE, V29, P639, DOI 10.20506/rst.29.3.2006; Boender GJ, 2007, PLOS COMPUT BIOL, V3, P704, DOI 10.1371/journal.pcbi.0030071; Boender GJ, 2010, EPIDEMICS-NETH, V2, P36, DOI 10.1016/j.epidem.2010.03.001; BROCCHI E, 1995, J VIROL METHODS, V52, P155, DOI 10.1016/0166-0934(94)00158-D; de Koeijer AA, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-53; Dorigatti I, 2010, Epidemics, V2, P29, DOI 10.1016/j.epidem.2010.01.002; EFSA Panel on Animal Health and Welfare, 2012, EFSA J, V10, P2631; R Core Team, 2012, R LANG ENV STAT COMP; Wolfram Research Inc., 2010, MATHEMATICA	9	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62878	10.1371/journal.pone.0062878	http://dx.doi.org/10.1371/journal.pone.0062878			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667534	Green Published, gold, Green Submitted			2022-12-25	WOS:000319654700073
J	Yamaoka, M; Asami, S; Funaki, N; Kimura, S; Liao, YJ; Fukuda, T; Yamashita, M				Yamaoka, Miki; Asami, Shun-suke; Funaki, Nayuta; Kimura, Sho; Liao Yingjie; Fukuda, Takeshi; Yamashita, Makoto			Preparation of Organic Light-Emitting Diode Using Coal Tar Pitch, a Low-Cost Material, for Printable Devices	PLOS ONE			English	Article							GRAPHENE OXIDE; FLUORESCENCE; FRACTIONATION; SPECTROSCOPY; SOLUBILITY; SPECTRA	We have identified coal tar pitch, a very cheap organic material made from coal during the iron-making process, as a source from which could be obtained emissive molecules for organic light-emitting diodes. Coal tar pitch was separated by simple dissolution in organic solvent, and subsequent separation by preparative thin-layer chromatography was used to obtain emissive organic molecules. The retardation factor of preparative thin-layer chromatography played a major role in deciding the emission characteristics of the solution as photoluminescence spectra and emission-excitation matrix spectra could be controlled by modifying the solution preparation method. In addition, the device characteristics could be improved by modifying the solution preparation method. Two rounds of preparative thin-layer chromatography separation could improve the luminance of organic light-emitting diodes with coal tar pitch, indicating that less polar components are favorable for enhancing the luminance and device performance. By appropriate choice of the solvent, the photoluminescence peak wavelength of separated coal tar pitch could be shifted from 429 nm (cyclohexane) to 550 nm (chloroform), and consequently, the optical properties of the coal tar pitch solution could be easily tuned. Hence, the use of such multicomponent materials is advantageous for fine-tuning the net properties at a low cost. Furthermore, an indium tin oxide/poly(3,4-ethylenedioxythiophene): poly(styrenesulfonate)/coal tar pitch/LiF/Al system, in which the emissive layer was formed by spin-coating a tetrahydrofuran solution of coal tar pitch on the substrate, showed a luminance of 176 cd/m(2). In addition, the emission spectrum of coal tar pitch was narrowed after the preparative thin-layer chromatography process by removing the excess emissive molecules.	[Yamaoka, Miki; Funaki, Nayuta; Kimura, Sho; Liao Yingjie; Fukuda, Takeshi] Saitama Univ, Dept Funct Mat Sci, Fac Engn, Saitama 3388570, Japan; [Asami, Shun-suke; Yamashita, Makoto] Chuo Univ, Dept Appl Chem, Fac Sci & Engn, Bunkyo Ku, Tokyo, Japan	Saitama University; Chuo University	Fukuda, T (corresponding author), Saitama Univ, Dept Funct Mat Sci, Fac Engn, Saitama 3388570, Japan.	fukuda@fms.saitama-u.ac.jp; makoto@oec.chem.chuo-u.ac.jp	Liao, Yingjie/L-8678-2013; Yamashita, Makoto/E-4607-2010; Fukuda, Takeshi/G-8647-2011	Yamashita, Makoto/0000-0002-3665-5311; 	Ministry of Education, Culture, Sports, Science, and Technology [23656507]	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by a Grant-in-Aid for Scientific Research (23656507 to M. Yamashita) from Ministry of Education, Culture, Sports, Science, and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI C, 1988, JPN J APPL PHYS 2, V27, pL269, DOI 10.1143/JJAP.27.L269; Alcaniz-Monge J, 2001, FUEL, V80, P41, DOI 10.1016/S0016-2361(00)00057-0; Bachilo SM, 2002, SCIENCE, V298, P2361, DOI 10.1126/science.1078727; Baldo MA, 1998, NATURE, V395, P151, DOI 10.1038/25954; BURROUGHES JH, 1990, NATURE, V347, P539, DOI 10.1038/347539a0; Chien CT, 2012, ANGEW CHEM INT EDIT, V51, P6662, DOI 10.1002/anie.201200474; Commodo M, 2012, ENERG FUEL, V26, P2191, DOI 10.1021/ef300049g; DRAKE JAG, 1978, FUEL, V57, P663, DOI 10.1016/0016-2361(78)90017-0; Eda G, 2010, ADV MATER, V22, P505, DOI 10.1002/adma.200901996; Englert JM, 2011, NAT CHEM, V3, P279, DOI [10.1038/NCHEM.1010, 10.1038/nchem.1010]; FEI YQ, 1990, FUEL, V69, P261, DOI 10.1016/0016-2361(90)90186-T; Gan ZX, 2011, NANO LETT, V11, P3951, DOI 10.1021/nl202240s; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Geim AK, 2009, SCIENCE, V324, P1530, DOI 10.1126/science.1158877; Gokus T, 2009, ACS NANO, V3, P3963, DOI 10.1021/nn9012753; GRANDA M, 1990, FUEL, V69, P702, DOI 10.1016/0016-2361(90)90032-L; GRANDA M, 1993, FUEL, V72, P19, DOI 10.1016/0016-2361(93)90370-H; GUILLEN MD, 1992, FUEL, V71, P295, DOI 10.1016/0016-2361(92)90077-2; Hagestuen ED, 1999, TALANTA, V49, P547, DOI 10.1016/S0039-9140(99)00040-5; HEROD AA, 1995, J CHROMATOGR A, V708, P143, DOI 10.1016/0021-9673(95)00356-R; John HS, 1984, FUEL, V63, P1187; KALLMANN H, 1960, J CHEM PHYS, V32, P300, DOI 10.1063/1.1700925; KALLMANN H, 1960, NATURE, V186, P31, DOI 10.1038/186031a0; Lazaro MJ, 1999, FUEL, V78, P795, DOI 10.1016/S0016-2361(98)00201-4; Lee HW, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1545; Lu J, 2009, ACS NANO, V3, P2367, DOI 10.1021/nn900546b; Luo ZT, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3098358; Mathews JP, 2012, FUEL, V96, P1, DOI 10.1016/j.fuel.2011.11.025; Mei QS, 2010, CHEM COMMUN, V46, P7319, DOI 10.1039/c0cc02374d; Milian M, 2005, RAPID COMMUN MASS SP, V19, P1867, DOI 10.1002/rcm.1997; Patra D, 2003, APPL SPECTROSC REV, V38, P155, DOI 10.1081/ASR-120021166; Subrahmanyam KS, 2010, SOLID STATE COMMUN, V150, P1774, DOI 10.1016/j.ssc.2010.07.017; Sun XM, 2008, NANO RES, V1, P203, DOI 10.1007/s12274-008-8021-8; TANG CW, 1987, APPL PHYS LETT, V51, P913, DOI 10.1063/1.98799; White KL, 1999, IND ENG CHEM RES, V38, P3360, DOI 10.1021/ie990119k; ZANDER M, 1993, FUEL, V72, P1281, DOI 10.1016/0016-2361(93)90126-M	36	6	6	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62903	10.1371/journal.pone.0062903	http://dx.doi.org/10.1371/journal.pone.0062903			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667539	Green Published, Green Submitted			2022-12-25	WOS:000319654700078
J	Chen, C; Wang, JC; Shi, Q; Zhou, W; Zhang, XM; Zhang, J; Tian, C; Gao, C; Dong, XP				Chen, Cao; Wang, Ji-Chun; Shi, Qi; Zhou, Wei; Zhang, Xiao-Mei; Zhang, Jin; Tian, Chan; Gao, Chen; Dong, Xiao-Ping			Analyses of the Survival Time and the Influencing Factors of Chinese Patients with Prion Diseases Based on the Surveillance Data from 2008-2011	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; MEDICAL RISK-FACTORS; POLYMORPHISM; ASSOCIATION; VARIANT; CJD; FREQUENCY; MUTATIONS; DEMENTIA; SPECTRUM	Background: Prion diseases are kinds of progressive, incurable neurodegenerative disorders. So far, survival time of the patients with these diseases in China is unclear. Methods: Based upon the surveillance data from Chinese Creutzfeldt-Jakob disease (CJD) surveillance network from January 2008 to December 2011, a retrospective follow-up survey was performed. The survival times of Chinese patients with prion diseases and the possible influencing factors were analyzed. Results: Median survival time of 121 deceased patients was 7.1 months, while those for sporadic CJD (sCJD), familial CJD (fCJD) and fatal familial insomnia (FFI) cases were 6.1, 3.1 and 8.2 months, respectively. 74.0% of sCJD patients, 100% of fCJD cases and 91.7% FFI cases died within one year. The general socio-demographic factors, abnormalities in clinical examinations, clinical manifestations, and social factors did not significantly influence the survival times of Chinese prion patients. Conclusions: Survival time of Chinese patients with prion diseases was comparable with that of many Western countries, but obviously shorter than that of Japan. Patients with acute onset and rapid progression had significantly short survival times.	[Chen, Cao; Shi, Qi; Zhou, Wei; Zhang, Xiao-Mei; Zhang, Jin; Tian, Chan; Gao, Chen; Dong, Xiao-Ping] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Wang, Ji-Chun] Chinese Ctr Dis Control & Prevent, Div Sci & Technol, Beijing, Peoples R China; [Dong, Xiao-Ping] Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Chinese Academy of Sciences; Institute of Microbiology, CAS	Dong, XP (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	dongxp238@sina.com	Chen, Cao/CAF-1246-2022	Chen, Cao/0000-0002-5193-9283	China Mega-Project for Infectious Disease [2011ZX10004-101, 2012 ZX10004215]; Young Scholar Scientific Research Foundation of China CDC [2012A102]; State Key Laboratory for Infectious Disease Prevention and Control (SKLID) [2012SKLID102, 2011SKLID211]; Chinese National Natural Science Foundation [81100980, 81101302, 31100117]	China Mega-Project for Infectious Disease; Young Scholar Scientific Research Foundation of China CDC; State Key Laboratory for Infectious Disease Prevention and Control (SKLID); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by China Mega-Project for Infectious Disease (2011ZX10004-101, 2012 ZX10004215), Young Scholar Scientific Research Foundation of China CDC (2012A102), State Key Laboratory for Infectious Disease Prevention and Control (SKLID) Development Grant (2012SKLID102, 2011SKLID211) and Chinese National Natural Science Foundation Grant (81100980, 81101302 and 31100117). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahantes JC, 2007, EUR J EPIDEMIOL, V22, P457, DOI 10.1007/s10654-007-9146-x; Almer G, 1999, BRAIN, V122, P5, DOI 10.1093/brain/122.1.5; Bratosiewicz-Wasik J, 2012, PRION, V6, P413, DOI 10.4161/pri.21773; BUDKA H, 1995, BRAIN PATHOL, V5, P459, DOI 10.1111/j.1750-3639.1995.tb00625.x; Collins S, 1999, LANCET, V353, P693, DOI 10.1016/S0140-6736(98)08138-0; Collins SJ, 2006, BRAIN, V129, P2278, DOI 10.1093/brain/awl159; DAVANIPOUR Z, 1985, NEUROLOGY, V35, P1483, DOI 10.1212/WNL.35.10.1483; Finckh U, 2000, ANN NY ACAD SCI, V920, P100; Gao C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024231; Golanska E, 2004, NEUROLOGY, V62, P313, DOI 10.1212/01.WNL.0000103290.74549.DC; HARRIESJONES R, 1988, J NEUROL NEUROSUR PS, V51, P1113, DOI 10.1136/jnnp.51.9.1113; Heinemann U, 2007, BRAIN, V130, P1350, DOI 10.1093/brain/awm063; Jeong BH, 2008, EUR J NEUROL, V15, P846, DOI 10.1111/j.1468-1331.2008.02203.x; KONDO K, 1982, ANN NEUROL, V11, P377, DOI 10.1002/ana.410110410; Kovacs GG, 2005, HUM GENET, V118, P166, DOI 10.1007/s00439-005-0020-1; Kovacs GG, 2002, J NEUROL, V249, P1567, DOI 10.1007/s00415-002-0896-9; Krasnianski A, 2009, NEUROBIOL AGING, V30, P615, DOI 10.1016/j.neurobiolaging.2007.07.014; Li XH, 2005, ANN NEUROL, V58, P858, DOI 10.1002/ana.20646; Lin SH, 2003, CHIN J NEUROIMMUNOL, V10, P4; Lundberg PO, 1998, J NEUROL NEUROSUR PS, V65, P836, DOI 10.1136/jnnp.65.6.836; Mead S, 2001, AM J HUM GENET, V69, P1225, DOI 10.1086/324710; Nagoshi K, 2011, J EPIDEMIOL, V21, P255, DOI 10.2188/jea.JE20100085; Nakamura Y, 2000, J Epidemiol, V10, P399; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Roeber S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002147; van Duijn CM, 1998, LANCET, V351, P1081, DOI 10.1016/S0140-6736(97)09468-3; Vollmert C, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.040931; WHO, 2003, WHO COMM DIS SURV RE; Wieser HG, 2006, CLIN NEUROPHYSIOL, V117, P935, DOI 10.1016/j.clinph.2005.12.007; Will RG, 2003, BRIT MED BULL, V66, P255, DOI 10.1093/bmb/66.1.255; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; WILL RG, 1982, J NEUROL NEUROSUR PS, V45, P235, DOI 10.1136/jnnp.45.3.235; Zerr I, 2000, J CLIN EPIDEMIOL, V53, P747, DOI 10.1016/S0895-4356(99)00207-3; Zerr I, 2009, BRAIN, V231, P10	34	10	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e62553	10.1371/journal.pone.0062553	http://dx.doi.org/10.1371/journal.pone.0062553			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671608	Green Published, Green Submitted, gold			2022-12-25	WOS:000321390200028
J	Funamizu, A; Kanzaki, R; Takahashi, H				Funamizu, Akihiro; Kanzaki, Ryohei; Takahashi, Hirokazu			Pre-Attentive, Context-Specific Representation of Fear Memory in the Auditory Cortex of Rat	PLOS ONE			English	Article							SPECTROTEMPORAL RECEPTIVE-FIELDS; CORTICAL MAP REORGANIZATION; DEPENDENT NEURONAL-ACTIVITY; MEDIAL PREFRONTAL CORTEX; COMBINED TONE; PLASTICITY; NOISE; HIPPOCAMPAL; SENSITIVITY; RESPONSES	Neural representation in the auditory cortex is rapidly modulated by both top-down attention and bottom-up stimulus properties, in order to improve perception in a given context. Learning-induced, pre-attentive, map plasticity has been also studied in the anesthetized cortex; however, little attention has been paid to rapid, context-dependent modulation. We hypothesize that context-specific learning leads to pre-attentively modulated, multiplex representation in the auditory cortex. Here, we investigate map plasticity in the auditory cortices of anesthetized rats conditioned in a context-dependent manner, such that a conditioned stimulus (CS) of a 20-kHz tone and an unconditioned stimulus (US) of a mild electrical shock were associated only under a noisy auditory context, but not in silence. After the conditioning, although no distinct plasticity was found in the tonotopic map, tone-evoked responses were more noise-resistive than pre-conditioning. Yet, the conditioned group showed a reduced spread of activation to each tone with noise, but not with silence, associated with a sharpening of frequency tuning. The encoding accuracy index of neurons showed that conditioning deteriorated the accuracy of tone-frequency representations in noisy condition at off-CS regions, but not at CS regions, suggesting that arbitrary tones around the frequency of the CS were more likely perceived as the CS in a specific context, where CS was associated with US. These results together demonstrate that learning-induced plasticity in the auditory cortex occurs in a context-dependent manner.	[Funamizu, Akihiro] JSPS, Chiyoda Ku, Tokyo, Japan; [Funamizu, Akihiro] Okinawa Inst Sci & Technol, Neural Computat Unit, Okinawa, Japan; [Funamizu, Akihiro; Kanzaki, Ryohei; Takahashi, Hirokazu] Univ Tokyo, Grad Sch Informat Sci & Technol, Bunkyo Ku, Tokyo, Japan; [Kanzaki, Ryohei; Takahashi, Hirokazu] Univ Tokyo, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo, Japan; [Takahashi, Hirokazu] JST, PRESTO, Kawaguchi, Saitama, Japan	Japan Society for the Promotion of Science; Okinawa Institute of Science & Technology Graduate University; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST)	Takahashi, H (corresponding author), Univ Tokyo, Grad Sch Informat Sci & Technol, Bunkyo Ku, Tokyo, Japan.	takahashi@i.u-tokyo.ac.jp	Funamizu, Akihiro/N-1502-2014	Funamizu, Akihiro/0000-0001-8085-1048	KAKENHI [23135507]; SCOPE [121803022]; Grants-in-Aid for Scientific Research [11J08760] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); SCOPE; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partially supported by KAKENHI (23135507) and SCOPE (121803022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELES M, 1982, J NEUROSCI METH, V5, P317, DOI 10.1016/0165-0270(82)90002-4; Ahrens MB, 2008, J NEUROSCI, V28, P1929, DOI 10.1523/JNEUROSCI.3377-07.2008; Amenedo E, 2000, EUR J NEUROSCI, V12, P2570, DOI 10.1046/j.1460-9568.2000.00114.x; Antunes R, 2010, J NEUROSCI, V30, P9782, DOI 10.1523/JNEUROSCI.1037-10.2010; Atiani S, 2009, NEURON, V61, P467, DOI 10.1016/j.neuron.2008.12.027; Bar-Yosef O, 2007, FRONT COMPUT NEUROSC, V1, DOI [10.3389/neuro.10/003.2007, 10.3389/neuro.10.003.2007]; Berlau KM, 2008, NEUROBIOL LEARN MEM, V89, P153, DOI 10.1016/j.nlm.2007.07.004; Bieszczad KM, 2012, EUR J NEUROSCI, V35, P598, DOI 10.1111/j.1460-9568.2011.07974.x; Binder JR, 2004, NAT NEUROSCI, V7, P295, DOI 10.1038/nn1198; Bishop C.M., 2006, PATTERN RECOGNITION; Blake DT, 2002, J NEUROPHYSIOL, V88, P3409, DOI 10.1152/jn.00233.2002; Blake DT, 2002, P NATL ACAD SCI USA, V99, P10114, DOI 10.1073/pnas.092278099; Brosch M, 2005, J NEUROSCI, V25, P6797, DOI 10.1523/JNEUROSCI.1571-05.2005; Brown M, 2004, CEREB CORTEX, V14, P952, DOI 10.1093/cercor/bhh056; Buonomano DV, 2009, NAT REV NEUROSCI, V10, P113, DOI 10.1038/nrn2558; Burwell RD, 1998, J COMP NEUROL, V398, P179, DOI 10.1002/(SICI)1096-9861(19980824)398:2<179::AID-CNE3>3.0.CO;2-Y; CAMPEAU S, 1995, J NEUROSCI, V15, P2312, DOI 10.1523/JNEUROSCI.15-03-02312.1995; Carandini M, 2012, NAT REV NEUROSCI, V13, P51, DOI 10.1038/nrn3136; Corcoran KA, 2007, J NEUROSCI, V27, P840, DOI 10.1523/JNEUROSCI.5327-06.2007; David SV, 2009, J NEUROSCI, V29, P3374, DOI 10.1523/JNEUROSCI.5249-08.2009; Doron NN, 2002, J COMP NEUROL, V453, P345, DOI 10.1002/cne.10412; Eggermont JJ, 2011, HEARING RES, V271, P123, DOI 10.1016/j.heares.2010.01.014; Ego-Stengel V, 2001, J NEUROPHYSIOL, V86, P422, DOI 10.1152/jn.2001.86.1.422; Ehret G, 2000, HEARING RES, V141, P107, DOI 10.1016/S0378-5955(99)00213-0; Elhilali M, 2004, J NEUROSCI, V24, P1159, DOI 10.1523/JNEUROSCI.3825-03.2004; Ernst SMA, 2010, NEUROIMAGE, V49, P835, DOI 10.1016/j.neuroimage.2009.07.014; Freeman JH, 1996, J NEUROSCI, V16, P1538; Fritz J, 2003, NAT NEUROSCI, V6, P1216, DOI 10.1038/nn1141; Fritz JB, 2007, CURR OPIN NEUROBIOL, V17, P437, DOI 10.1016/j.conb.2007.07.011; Funamizu A, 2011, NEURAL NETWORKS, V24, P321, DOI 10.1016/j.neunet.2010.12.010; Ganguly K, 2011, NAT NEUROSCI, V14, P662, DOI 10.1038/nn.2797; GEISLER CD, 1980, HEARING RES, V3, P317; Gerlai R, 1998, BEHAV BRAIN RES, V95, P191, DOI 10.1016/S0166-4328(97)00144-7; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; Gourevitch B, 2009, CEREB CORTEX, V19, P1448, DOI 10.1093/cercor/bhn184; Hirata A, 2006, J NEUROSCI, V26, P4426, DOI 10.1523/JNEUROSCI.5298-05.2006; Hirata A, 2010, J NEUROPHYSIOL, V103, P1147, DOI 10.1152/jn.00955.2009; HIRSH R, 1974, BEHAV BIOL, V12, P421, DOI 10.1016/S0091-6773(74)92231-7; Hobin JA, 2003, J NEUROSCI, V23, P8410; Holland PC, 1999, CURR OPIN NEUROBIOL, V9, P195, DOI 10.1016/S0959-4388(99)80027-0; HORIKAWA J, 1988, P JPN ACAD B-PHYS, V64, P260, DOI 10.2183/pjab.64.260; Hwang JH, 2007, AUDIOL NEURO-OTOL, V12, P285, DOI 10.1159/000103209; Itskov PM, 2012, J NEUROPHYSIOL, V107, P1822, DOI 10.1152/jn.00404.2011; Jakkamsetti V, 2012, J NEUROPHYSIOL, V107, P1457, DOI 10.1152/jn.01057.2010; Kalatsky VA, 2005, P NATL ACAD SCI USA, V102, P13325, DOI 10.1073/pnas.0505592102; Kalisch R, 2006, J NEUROSCI, V26, P9503, DOI 10.1523/JNEUROSCI.2021-06.2006; KIANG NYS, 1974, J ACOUST SOC AM, V55, P620, DOI 10.1121/1.1914572; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Knudsen EI, 1998, SCIENCE, V279, P1531, DOI 10.1126/science.279.5356.1531; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee CC, 2011, NAT NEUROSCI, V14, P108, DOI 10.1038/nn.2713; Liang K, 2008, NEUROBIOL LEARN MEM, V90, P138, DOI 10.1016/j.nlm.2008.02.006; Ma XF, 2009, J NEUROSCI, V29, P4888, DOI 10.1523/JNEUROSCI.0167-09.2009; Mante V, 2005, NAT NEUROSCI, V8, P1690, DOI 10.1038/nn1556; Maren S, 2007, LEARN MEMORY, V14, P318, DOI 10.1101/lm.477007; Marguet SL, 2011, J NEUROSCI, V31, P6414, DOI 10.1523/JNEUROSCI.5773-10.2011; McDonald RJ, 2007, EXP BRAIN RES, V177, P509, DOI 10.1007/s00221-006-0699-9; Mesgarani N, 2012, NATURE, V485, P233, DOI 10.1038/nature11020; Moita MAP, 2003, NEURON, V37, P485, DOI 10.1016/S0896-6273(03)00033-3; Montague PR, 2004, NATURE, V431, P760, DOI 10.1038/nature03015; Noudoost B, 2011, NATURE, V474, P372, DOI 10.1038/nature09995; O'Reilly RC, 2001, PSYCHOL REV, V108, P311, DOI 10.1037//0033-295X.108.2.311; Ohl FW, 2005, CURR OPIN NEUROBIOL, V15, P470, DOI 10.1016/j.conb.2005.07.002; Ohl FW, 1996, EUR J NEUROSCI, V8, P1001, DOI 10.1111/j.1460-9568.1996.tb01587.x; PHILLIPS DP, 1992, CEREB CORTEX, V2, P134, DOI 10.1093/cercor/2.2.134; PHILLIPS DP, 1986, J ACOUST SOC AM, V80, P177, DOI 10.1121/1.394178; PHILLIPS DP, 1985, HEARING RES, V19, P253, DOI 10.1016/0378-5955(85)90145-5; PHILLIPS DP, 1985, HEARING RES, V18, P87, DOI 10.1016/0378-5955(85)90112-1; PHILLIPS DP, 1990, BEHAV BRAIN RES, V37, P197, DOI 10.1016/0166-4328(90)90132-X; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Pienkowski M, 2011, NEUROSCI BIOBEHAV R, V35, P2117, DOI 10.1016/j.neubiorev.2011.02.002; Polley DB, 2007, J NEUROPHYSIOL, V97, P3621, DOI 10.1152/jn.01298.2006; Polley DB, 2006, J NEUROSCI, V26, P4970, DOI 10.1523/JNEUROSCI.3771-05.2006; Quirk GJ, 1997, NEURON, V19, P613, DOI 10.1016/S0896-6273(00)80375-X; Rabinowitz NC, 2011, NEURON, V70, P1178, DOI 10.1016/j.neuron.2011.04.030; RECANZONE GH, 1993, J NEUROSCI, V13, P87; Recanzone GH, 2000, J NEUROPHYSIOL, V83, P2315, DOI 10.1152/jn.2000.83.4.2315; Reed A, 2011, NEURON, V70, P121, DOI 10.1016/j.neuron.2011.02.038; Renvall H, 2012, CEREB CORTEX, V22, P132, DOI 10.1093/cercor/bhr095; Rodgers KM, 2008, CEREB CORTEX, V18, P2941, DOI 10.1093/cercor/bhn054; ROMANSKI LM, 1993, CEREB CORTEX, V3, P515, DOI 10.1093/cercor/3.6.515; ROMANSKI LM, 1992, J NEUROSCI, V12, P4501; Rutkowski RG, 2005, P NATL ACAD SCI USA, V102, P13664, DOI 10.1073/pnas.0506838102; Rutkowski RG, 2003, HEARING RES, V181, P116, DOI 10.1016/S0378-5955(03)00182-5; Sacco T, 2010, SCIENCE, V329, P649, DOI 10.1126/science.1183165; SAKURAI Y, 1994, J NEUROSCI, V14, P2606; Sakurai Y, 1996, J NEUROSCI, V16, P2809; Scheich H, 1998, EUR J NEUROSCI, V10, P803, DOI 10.1046/j.1460-9568.1998.00086.x; Shetake JA, 2011, EUR J NEUROSCI, V34, P1823, DOI 10.1111/j.1460-9568.2011.07887.x; Shulz DE, 2000, NATURE, V403, P549, DOI 10.1038/35000586; Takahashi H, 2011, NEUROSCIENCE, V199, P243, DOI 10.1016/j.neuroscience.2011.09.046; Takahashi H, 2010, BIOSYSTEMS, V101, P37, DOI 10.1016/j.biosystems.2010.04.003; Vertes RP, 2006, NEUROSCIENCE, V142, P1, DOI 10.1016/j.neuroscience.2006.06.027; Wang XQ, 2007, HEARING RES, V229, P81, DOI 10.1016/j.heares.2007.01.019; Weinberger NM, 2004, NAT REV NEUROSCI, V5, P279, DOI 10.1038/nrn1366; Weinberger NM, 2007, LEARN MEMORY, V14, P1, DOI 10.1101/lm.421807; Winer JA, 2006, HEARING RES, V212, P1, DOI 10.1016/j.heares.2005.06.014; Yokota R, 2012, NEUROSCIENCE, V223, P377, DOI 10.1016/j.neuroscience.2012.07.051	99	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e63655	10.1371/journal.pone.0063655	http://dx.doi.org/10.1371/journal.pone.0063655			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671691	Green Submitted, gold, Green Published			2022-12-25	WOS:000321390200056
J	Krishnan, K; Duncan, MJ				Krishnan, Karthik; Duncan, Margaret J.			Role of Sodium in the RprY-Dependent Stress Response in Porphyromonas gingivalis	PLOS ONE			English	Article							BACTEROIDES-FRAGILIS; ESCHERICHIA-COLI; EPITHELIAL-CELLS; OXIDATIVE STRESS; GENE-EXPRESSION; POLYHYDROXYALKANOATES; IDENTIFICATION; PERIODONTITIS; PROTEIN; OPERON	Porphyromonas gingivalis is a Gram-negative oral anaerobe which is strongly associated with periodontal disease. Environmental changes in the gingival sulcus trigger the growth of P. gingivalis and a concurrent shift from periodontal health to disease. Bacteria adjust their physiology in response to environmental changes and gene regulation by two-component phospho-relay systems is one mechanism by which such adjustments are effected. In P. gingivalis RprY is an orphan response regulator and previously we showed that the RprY regulon included genes associated with oxidative stress and sodium metabolism. The goals of the present study were to identify environmental signals that induce rprY and clarify the role of the regulator in the stress response. In Escherichia coli an RprY-LacZ fusion protein was induced in sodium-depleted medium and a P. gingivalis rprY mutant was unable to grow in similar medium. By several approaches we established that sodium depletion induced up-regulation of genes involved in oxidative stress. In addition, we demonstrated that RprY interacted directly with the promoters of several molecular chaperones. Further, both genetic and transcription data suggest that the regulator acts as a repressor. We conclude that RprY is one of the regulators that controls stress responses in P. gingivalis, possibly by acting as a repressor since an rprY mutant showed a superstress reponse in sodium-depleted medium which we propose inhibited growth.	[Krishnan, Karthik; Duncan, Margaret J.] Forsyth Inst, Dept Microbiol, Cambridge, MA USA; [Krishnan, Karthik] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA	Harvard University; Forsyth Institute; Harvard University; Harvard School of Dental Medicine	Duncan, MJ (corresponding author), Forsyth Inst, Dept Microbiol, Cambridge, MA USA.	mduncan@forsyth.org			National Institutes of Health [R01-DE015931]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015931] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health grant R01-DE015931 (MJD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SB, 2012, OSTEOARTHR CARTILAGE, V20, P64, DOI 10.1016/j.joca.2011.10.010; An D, 2010, P NATL ACAD SCI U S1, V1, P4666; Ayub ND, 2009, EXTREMOPHILES, V13, P59, DOI 10.1007/s00792-008-0197-z; Bacic MK, 2007, PLASMID, V58, P23, DOI 10.1016/j.plasmid.2006.11.005; Bernhardt TG, 2004, MOL MICROBIOL, V52, P1255, DOI 10.1111/j.1365-2958.2004.04063.x; Bostanci N, 2012, FEMS MICROBIOL LETT, V333, P1, DOI 10.1111/j.1574-6968.2012.02579.x; Colombo AV, 2007, J PERIODONTAL RES, V42, P236, DOI 10.1111/j.1600-0765.2006.00938.x; Deuerling E, 1999, NATURE, V400, P693, DOI 10.1038/23301; Diaz PI, 2006, J BACTERIOL, V188, P2454, DOI 10.1128/JB.188.7.2454-2462.2006; Duran-Pinedo AE, 2007, MOL MICROBIOL, V64, P1061, DOI 10.1111/j.1365-2958.2007.05717.x; FLETCHER HM, 1995, INFECT IMMUN, V63, P1521, DOI 10.1128/IAI.63.4.1521-1528.1995; Gardner RG, 1996, APPL ENVIRON MICROB, V62, P196, DOI 10.1128/AEM.62.1.196-202.1996; Guisbert E, 2008, MICROBIOL MOL BIOL R, V72, P545, DOI 10.1128/MMBR.00007-08; Hase CC, 2001, MICROBIOL MOL BIOL R, V65, P353, DOI 10.1128/MMBR.65.3.353-370.2001; Henry LG, 2012, FUTURE MICROBIOL, V7, P497, DOI [10.2217/FMB.12.17, 10.2217/fmb.12.17]; Hoefer P, 2010, FRONT BIOSCI-LANDMRK, V15, P93, DOI 10.2741/3609; Hoffmann A, 2010, BBA-MOL CELL RES, V1803, P650, DOI 10.1016/j.bbamcr.2010.01.017; Holt SC, 2005, PERIODONTOL 2000, V38, P72, DOI 10.1111/j.1600-0757.2005.00113.x; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Hosogi Y, 2005, INFECT IMMUN, V73, P2327, DOI 10.1128/IAI.73.4.2327-2335.2005; Kim DY, 2007, J MICROBIOL, V45, P87; Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244, DOI 10.1128/MMBR.62.4.1244-1263.1998; Lawton KA, 2008, PHARMACOGENOMICS, V9, P383, DOI 10.2217/14622416.9.4.383; Lewis JP, 2012, INFECT IMMUN, V80, P3319, DOI 10.1128/IAI.00561-12; Lewis JP, 2009, MICROBIOL-SGM, V155, P3758, DOI 10.1099/mic.0.027953-0; Liaqat I, 2008, CURR MICROBIOL, V57, P340, DOI 10.1007/s00284-008-9200-2; Meuric V, 2010, FUTURE MICROBIOL, V5, P717, DOI 10.2217/FMB.10.32; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Narberhaus F, 1999, MOL MICROBIOL, V31, P1, DOI 10.1046/j.1365-2958.1999.01166.x; Nichols FC, 2004, J LIPID RES, V45, P2317, DOI 10.1194/jlr.M400278-JLR200; Ohara N, 2006, MICROBIOL-SGM, V152, P955, DOI 10.1099/mic.0.28537-0; RASMUSSEN BA, 1993, MOL MICROBIOL, V7, P765, DOI 10.1111/j.1365-2958.1993.tb01167.x; Rudney JD, 2006, ARCH ORAL BIOL, V51, P291, DOI 10.1016/j.archoralbio.2005.09.003; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; SMITH CJ, 1990, PLASMID, V24, P100, DOI 10.1016/0147-619X(90)90012-2; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Spence C, 2006, J BACTERIOL, V188, P4663, DOI 10.1128/JB.00125-06; Sund CJ, 2008, MOL MICROBIOL, V67, P129, DOI 10.1111/j.1365-2958.2007.06031.x; Thorgersen MP, 2009, MICROBIOL-SGM, V155, P295, DOI 10.1099/mic.0.020727-0; Tomoyasu T, 1998, MOL MICROBIOL, V30, P567, DOI 10.1046/j.1365-2958.1998.01090.x; Ximenez-Fyvie LA, 2000, J CLIN PERIODONTOL, V27, P648, DOI 10.1034/j.1600-051x.2000.027009648.x; Yanamandra SS, 2012, MOL ORAL MICROBIOL, V27, P202, DOI 10.1111/j.2041-1014.2012.00643.x; ZUBER U, 1994, J BACTERIOL, V176, P1359, DOI 10.1128/jb.176.5.1359-1363.1994	45	12	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e63180	10.1371/journal.pone.0063180	http://dx.doi.org/10.1371/journal.pone.0063180			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671672	gold, Green Published, Green Submitted			2022-12-25	WOS:000321390200045
J	Lu, YH; Soong, TD; Elemento, O				Lu, Yuheng; Soong, T. David; Elemento, Olivier			A Novel Approach for Characterizing Microsatellite Instability in Cancer Cells	PLOS ONE			English	Article							DNA MISMATCH REPAIR; PROSTATE-CANCER; COLORECTAL-CANCER; GENE-EXPRESSION; TRANSCRIPTOME; MUTATIONS; LINES; MECHANISMS; LEUKEMIA; DEFECTS	Microsatellite instability (MSI) is characterized by the expansion or contraction of DNA repeat tracts as a consequence of DNA mismatch repair deficiency (MMRD). Accurate detection of MSI in cancer cells is important since MSI is associated with several cancer subtypes and can help inform therapeutic decisions. Although experimental assays have been developed to detect MSI, they typically depend on a small number of known microsatellite loci or mismatch repair genes and have limited reliability. Here, we report a novel genome-wide approach for MSI detection based on the global detection of insertions and deletions (indels) in microsatellites found in expressed genes. Our large-scale analyses of 20 cancer cell lines and 123 normal individuals revealed striking indel features associated with MSI: there is a significant increase of short microsatellite deletions in MSI samples compared to microsatellite stable (MSS) ones, suggesting a mechanistic bias of repair efficiency between insertions and deletions in normal human cells. By incorporating this observation into our MSI scoring metric, we show that our approach can correctly distinguish between MSI and MSS cancer cell lines. Moreover, when we applied this approach to primal tumor samples, our metric is also well consistent with diagnosed MSI status. Thus, our study offers new insight into DNA mismatch repair system, and also provides a novel MSI diagnosis method for clinical oncology with better reliability.	[Lu, Yuheng; Soong, T. David; Elemento, Olivier] Cornell Univ, Dept Physiol & Biophys, Weill Cornell Med Coll, New York, NY 10021 USA; [Soong, T. David; Elemento, Olivier] Cornell Univ, Inst Computat Biomed, Weill Cornell Med Coll, New York, NY 10021 USA	Cornell University; Cornell University	Elemento, O (corresponding author), Cornell Univ, Dept Physiol & Biophys, Weill Cornell Med Coll, New York, NY 10021 USA.	ole2001@med.cornell.edu			National Science Foundation (NSF) [1054964]; Direct For Biological Sciences [1054964] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	OE would like to acknowledge receipt of National Science Foundation (NSF) Career Grant 1054964. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Berger MF, 2010, GENOME RES, V20, P413, DOI 10.1101/gr.103697.109; Boland CR, 1998, CANCER RES, V58, P5248; BOYER JC, 1995, CANCER RES, V55, P6063; Chen Y, 2001, CANCER RES, V61, P4112; de la Chapelle A, 2003, NEW ENGL J MED, V349, P209, DOI 10.1056/NEJMp038099; Dietmaier W, 1997, CANCER RES, V57, P4749; Edgren H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r6; Faulkner RD, 2004, BRIT J HAEMATOL, V124, P160, DOI 10.1046/j.1365-2141.2003.04750.x; Griffith M, 2010, NAT METHODS, V7, P843, DOI [10.1038/NMETH.1503, 10.1038/nmeth.1503]; Jiang YW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040332; Koeppel M, 2011, NUCLEIC ACIDS RES, V39, P6069, DOI 10.1093/nar/gkr028; Laghi L, 2012, CLIN CANCER RES, V18, P3142, DOI 10.1158/1078-0432.CCR-12-0175; Lee S, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1015; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Matheson EC, 2003, CARCINOGENESIS, V24, P31, DOI 10.1093/carcin/24.1.31; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Prensner JR, 2011, NAT BIOTECHNOL, V29, P742, DOI 10.1038/nbt.1914; Rajadhyaksha AM, 2010, AM J HUM GENET, V87, P643, DOI 10.1016/j.ajhg.2010.10.013; Sam LT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017305; Seitz S, 2003, GENE CHROMOSOME CANC, V37, P29, DOI 10.1002/gcc.10196; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sia EA, 1997, MOL CELL BIOL, V17, P2851, DOI 10.1128/MCB.17.5.2851; Sinicrope FA, 2012, CLIN CANCER RES, V18, P1506, DOI 10.1158/1078-0432.CCR-11-1469; Sun XD, 2006, PROSTATE, V66, P660, DOI 10.1002/pros.20390; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; van der Heijden MS, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-3; Verstrepen KJ, 2005, NAT GENET, V37, P986, DOI 10.1038/ng1618; Wacker SA, 2012, NAT CHEM BIOL, V8, P235, DOI [10.1038/NCHEMBIO.779, 10.1038/nchembio.779]; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Yeh CC, 2001, BIOCHEM BIOPH RES CO, V285, P409, DOI 10.1006/bbrc.2001.5187	34	35	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e63056	10.1371/journal.pone.0063056	http://dx.doi.org/10.1371/journal.pone.0063056			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671654	Green Published, gold, Green Submitted			2022-12-25	WOS:000321390200041
J	Nolte, A; Funk, NW; Mukunda, L; Gawalek, P; Werckenthin, A; Hansson, BS; Wicher, D; Stengl, M				Nolte, Andreas; Funk, Nico W.; Mukunda, Latha; Gawalek, Petra; Werckenthin, Achim; Hansson, Bill S.; Wicher, Dieter; Stengl, Monika			In situ Tip-Recordings Found No Evidence for an Orco-Based Ionotropic Mechanism of Pheromone-Transduction in Manduca sexta	PLOS ONE			English	Article							DROSOPHILA ODORANT RECEPTORS; SENSITIVE TRICHOID SENSILLA; OLFACTORY RECEPTOR; MEMBRANE TOPOLOGY; EXPRESSION; IDENTIFICATION; PROTEINS; NEURONS; FAMILY; MOTH	The mechanisms of insect odor transduction are still controversial. Insect odorant receptors (ORs) are 7TM receptors with inverted membrane topology. They colocalize with a conserved coreceptor (Orco) with chaperone and ion channel function. Some studies suggest that insects employ exclusively ionotropic odor transduction via OR-Orco heteromers. Other studies provide evidence for different metabotropic odor transduction cascades, which employ second messenger-gated ion channel families for odor transduction. The hawkmoth Manduca sexta is an established model organism for studies of insect olfaction, also due to the availability of the hawkmoth-specific pheromone blend with its main component bombykal. Previous patch-clamp studies on primary cell cultures of M. sexta olfactory receptor neurons provided evidence for a pheromone-dependent activation of a phospholipase C beta. Pheromone application elicited a sequence of one rapid, apparently IP3-dependent, transient and two slower Ca2+-dependent inward currents. It remains unknown whether additionally an ionotropic pheromone-transduction mechanism is employed. If indeed an OR-Orco ion channel complex underlies an ionotropic mechanism, then Orco agonist-dependent opening of the OR-Orco channel pore should add up to pheromone-dependent opening of the pore. Here, in tip-recordings from intact pheromone-sensitive sensilla, perfusion with the Orco agonist VUAA1 did not increase pheromone-responses within the first 1000 ms. However, VUAA1 increased spontaneous activity of olfactory receptor neurons Zeitgebertime-and dose-dependently. We conclude that we find no evidence for an Orco-dependent ionotropic pheromone transduction cascade in M. sexta. Instead, in M. sexta Orco appears to be a slower, second messenger-dependent pacemaker channel which affects kinetics and threshold of pheromone-detection via changes of intracellular Ca2+ baseline concentrations.	[Nolte, Andreas; Funk, Nico W.; Gawalek, Petra; Werckenthin, Achim] Univ Kassel, Dept Anim Physiol, D-34125 Kassel, Germany; [Mukunda, Latha; Hansson, Bill S.; Wicher, Dieter; Stengl, Monika] Max Planck Inst Chem Ecol, Dept Evolutionary Neuroethol, Jena, Germany	Universitat Kassel; Max Planck Society	Stengl, M (corresponding author), Max Planck Inst Chem Ecol, Dept Evolutionary Neuroethol, Jena, Germany.	stengl@uni-kassel.de	Hansson, Bill S/G-2774-2013	Hansson, Bill S/0000-0002-4811-1223	Max Planck Society; DFG [STE 531/20-1, STE 531/20-2, HA 5871/2-1, WI 1422/3-2]	Max Planck Society(Max Planck SocietyFoundation CELLEX); DFG(German Research Foundation (DFG))	This study was supported by the Max Planck Society (L.M., B.S.H., D.W.) and DFG grants STE 531/20-1, -2, HA 5871/2-1 and WI 1422/3-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altner H., 1980, International Review of Cytology, V67, P69, DOI 10.1016/S0074-7696(08)62427-4; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; Bohbot JD, 2012, NEUROPHARMACOLOGY, V62, P2086, DOI 10.1016/j.neuropharm.2012.01.004; Chen SS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0050456, 10.1371/journal.pone.0036784, 10.1371/journal.pone.0049275, 10.1371/journal.pone.0045763]; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Deng Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018605; Dolzer J, 2003, J EXP BIOL, V206, P1575, DOI 10.1242/jeb.00302; Elmore T, 2003, J NEUROSCI, V23, P9906; Flecke C, 2006, J EXP BIOL, V209, P3898, DOI 10.1242/jeb.02432; Flecke C, 2010, J EXP BIOL, V213, P842, DOI 10.1242/jeb.032839; Flecke C, 2009, J COMP PHYSIOL A, V195, P529, DOI 10.1007/s00359-009-0429-4; Forstner M, 2008, CHEM SENSES, V33, P291, DOI 10.1093/chemse/bjm087; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; German PF, 2013, INSECT BIOCHEM MOLEC, V43, P138, DOI 10.1016/j.ibmb.2012.11.002; Grosse-Wilde E, 2011, P NATL ACAD SCI USA, V108, P7449, DOI 10.1073/pnas.1017963108; Grosse-Wilde E, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00022; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Jin X, 2008, P NATL ACAD SCI USA, V105, P10996, DOI 10.1073/pnas.0803309105; Jones PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030304; Jones PL, 2011, P NATL ACAD SCI USA, V108, P8821, DOI 10.1073/pnas.1102425108; Jones WD, 2005, CURR BIOL, V15, pR119, DOI 10.1016/j.cub.2005.02.007; Jordan MD, 2009, CHEM SENSES, V34, P383, DOI 10.1093/chemse/bjp010; Krieger J, 2003, J COMP PHYSIOL A, V189, P519, DOI 10.1007/s00359-003-0427-x; Krieger J, 2002, EUR J NEUROSCI, V16, P619, DOI 10.1046/j.1460-9568.2002.02109.x; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lundin C, 2007, FEBS LETT, V581, P5601, DOI 10.1016/j.febslet.2007.11.007; Malpel S, 2008, INSECT MOL BIOL, V17, P587, DOI 10.1111/j.1365-2583.2008.00830.x; Melo ACA, 2004, CHEM SENSES, V29, P403, DOI 10.1093/chemse/bjh041; Nakagawa T, 2009, CURR OPIN NEUROBIOL, V19, P284, DOI 10.1016/j.conb.2009.07.015; Nakagawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032372; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Nichols AS, 2011, CHEM SENSES, V36, P781, DOI 10.1093/chemse/bjr053; Pask GM, 2013, CHEM SENSES; Pask GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028774; Patch HM, 2009, CHEM SENSES, V34, P305, DOI 10.1093/chemse/bjp002; Pitts RJ, 2004, P NATL ACAD SCI USA, V101, P5058, DOI 10.1073/pnas.0308146101; Rogers ME, 1997, J BIOL CHEM, V272, P14792, DOI 10.1074/jbc.272.23.14792; Rogers ME, 2001, CELL TISSUE RES, V303, P433, DOI 10.1007/s004410000305; Rogers ME, 2001, J NEUROBIOL, V49, P47, DOI 10.1002/neu.1065; Rollecke K, 2011, CHARACTERIZATION BLO; Sargsyan V, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00005; SASAKI M, 1984, PHYSIOL ENTOMOL, V9, P315, DOI 10.1111/j.1365-3032.1984.tb00713.x; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Schendzielorz T, 2012, J BIOL RHYTHM, V27, P388, DOI 10.1177/0748730412456265; Schuckel J, 2007, CELL TISSUE RES, V330, P271, DOI 10.1007/s00441-007-0471-x; Smart R, 2008, INSECT BIOCHEM MOLEC, V38, P770, DOI 10.1016/j.ibmb.2008.05.002; STENGL M, 1993, J EXP BIOL, V178, P125; STENGL M, 1992, ANNU REV PHYSIOL, V54, P665; STENGL M, 1994, J COMP PHYSIOL A, V174, P187; Stengl M, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00133; Stocker RF, 2001, MICROSC RES TECHNIQ, V55, P284, DOI 10.1002/jemt.1178; Stortkuhl KF, 2001, P NATL ACAD SCI USA, V98, P9381, DOI 10.1073/pnas.151105698; Su CY, 2012, NATURE, V492, P66, DOI 10.1038/nature11712; Taylor RW, 2012, ACS CHEM BIOL, V7, P1647, DOI 10.1021/cb300331z; Tsitoura P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015428; Vogt RG, 2009, INSECT BIOCHEM MOLEC, V39, P448, DOI 10.1016/j.ibmb.2009.03.007; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Vosshall LB, 2011, CHEM SENSES, V36, P497, DOI 10.1093/chemse/bjr022; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Wistrand M, 2006, PROTEIN SCI, V15, P509, DOI 10.1110/ps.051745906; Yang Y, 2012, INT J BIOL SCI, V8, P159, DOI 10.7150/ijbs.8.159	65	23	23	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62648	10.1371/journal.pone.0062648	http://dx.doi.org/10.1371/journal.pone.0062648			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23671617	gold, Green Submitted, Green Published			2022-12-25	WOS:000321202100026
J	Nordgard, O; Singh, G; Solberg, S; Jorgensen, L; Halvorsen, AR; Smaaland, R; Brustugun, OT; Helland, A				Nordgard, Oddmund; Singh, Gurpartap; Solberg, Steinar; Jorgensen, Lars; Halvorsen, Ann Rita; Smaaland, Rune; Brustugun, Odd Terje; Helland, Aslaug			Novel Molecular Tumor Cell Markers in Regional Lymph Nodes and Blood Samples from Patients Undergoing Surgery for Non-Small Cell Lung Cancer	PLOS ONE			English	Article							QUANTITATIVE RT-PCR; MESSENGER-RNA; COLORECTAL-CANCER; MICROMETASTASES; EXPRESSION; SURVIVAL; TRIAL	Introduction: Recent evidence suggests that microscopic lymph node metastases and circulating tumor cells may have clinical importance in lung cancer. The purpose of this study was to identify new molecular markers for tumor cells in regional lymph nodes (LNs) and peripheral blood (PB) from patients with non-small cell lung cancer (NSCLC). Methods: Candidate markers were selected based on digital transcript profiling and previous literature. KRT19, CEACAM5, EPCAM, DSG3, SFTPA, SFTPC and SFTPB mRNA levels were initially validated by real-time reverse transcription PCR-based quantification in 16 NSCLC tumors and 22 LNs and 12 PB samples from individuals without known cancer. Five of the candidate markers were selected for secondary validation by quantification in parallel tumor biopsies, regional LNs and PB samples from 55 patients undergoing surgery for NSCLC. LN and PB marker status were compared to clinicopathological patient data. Results: All selected markers except DSG3 were present at high levels in the primary tumors and at very low or non-detectable levels in normal LNs and PB in the first round of validation, indicating a potential for detecting tumor cells in NSCLC patients. The expression profiles of KRT19, CEACAM5, DSG3, SFTPA and SFTPC mRNA were confirmed in the larger group during the secondary validation. Using the highest normal LN level of each marker as threshold, 39 (71%) of the 55 patients had elevated levels of at least one marker in regional LNs. Similarly, 26 (47%) patients had elevated levels of at least one marker in PB. A significantly higher number of patients with adenocarcinomas had positive LN status for these markers, compared with other histological types (P = 0.004). Conclusions: Several promising molecular tumor cell markers in regional LNs and PB were identified, including the new SFTPA and SFTPC mRNAs. Clinical follow-up in a larger cohort is needed to elucidate their prognostic value.	[Nordgard, Oddmund; Singh, Gurpartap; Smaaland, Rune; Brustugun, Odd Terje; Helland, Aslaug] Stavanger Univ Hosp, Dept Hematol & Oncol, Stavanger, Norway; [Solberg, Steinar; Jorgensen, Lars] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Cardiothorac Surg, N-0027 Oslo, Norway; [Halvorsen, Ann Rita; Brustugun, Odd Terje; Helland, Aslaug] Norwegian Radium Hosp, Oslo Univ Hosp, Dept Genet, Oslo, Norway; [Brustugun, Odd Terje; Helland, Aslaug] Norwegian Radium Hosp, Oslo Univ Hosp, Dept Oncol, Oslo, Norway	Stavanger University Hospital; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo	Nordgard, O (corresponding author), Stavanger Univ Hosp, Dept Hematol & Oncol, Stavanger, Norway.	nood@sus.no	Smaaland, Rune/AAH-2149-2021; Helland, Åslaug/H-3910-2015; Nordgard, Oddmund/AAJ-1029-2020	Helland, Åslaug/0000-0002-5520-0275; Nordgard, Oddmund/0000-0002-5847-6752	South-Eastern Norway Regional Health Authority; Folke Hermansen Fund	South-Eastern Norway Regional Health Authority; Folke Hermansen Fund	This work was supported by 1) South-Eastern Norway Regional Health Authority and 2) Folke Hermansen Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bednarz-Knoll N, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2940; Benlloch S, 2009, ANN ONCOL, V20, P91, DOI 10.1093/annonc/mdn538; Cancer Registry of Norway, 2012, CANC INC MORT SURV P; Edge S, 2010, AJCC CANC STAGING MA; Effenberger KE, 2007, CANCER TREAT RES, P167; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Heinrich S, 2006, CURR MED CHEM, V13, P3239, DOI 10.2174/092986706778773112; Hou JM, 2012, J CLIN ONCOL, V30, P525, DOI 10.1200/JCO.2010.33.3716; Jolliffe, 2002, PRINCIPAL COMPONENT; Krebs MG, 2011, J CLIN ONCOL, V29, P1556, DOI 10.1200/JCO.2010.28.7045; Kubuschok B, 1999, J CLIN ONCOL, V17, P19, DOI 10.1200/JCO.1999.17.1.19; Lardinois D, 2006, EUR J CARDIO-THORAC, V30, P787, DOI 10.1016/j.ejcts.2006.08.008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lucci A, 2012, LANCET ONCOL, V13, P688, DOI 10.1016/S1470-2045(12)70209-7; Nordgard O, 2012, ANN SURG ONCOL, V19, P3719, DOI 10.1245/s10434-012-2454-8; Nordgard O, 2009, ANN SURG, V249, P602, DOI 10.1097/SLA.0b013e31819ec923; Ohlsson L, 2006, BRIT J CANCER, V95, P218, DOI 10.1038/sj.bjc.6603206; Perez-Gil J, 2010, PHYSIOLOGY, V25, P132, DOI 10.1152/physiol.00006.2010; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Punnoose EA, 2012, CLIN CANCER RES, V18, P2391, DOI 10.1158/1078-0432.CCR-11-3148; Qiu Y, 2010, JPN J CLIN ONCOL, V40, P146, DOI 10.1093/jjco/hyp144; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Rusch VW, 2011, J CLIN ONCOL, V29, P4313, DOI 10.1200/JCO.2011.35.2500; Saintigny P, 2005, INT J CANCER, V115, P777, DOI 10.1002/ijc.20942; Tjensvoll K, 2013, INT J CANC IN PRESS; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Xi LQ, 2006, CLIN CANCER RES, V12, P2484, DOI 10.1158/1078-0432.CCR-05-2037; Xi LQ, 2006, CLIN CHEM, V52, P520, DOI 10.1373/clinchem.2005.062844; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522	29	12	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62153	10.1371/journal.pone.0062153	http://dx.doi.org/10.1371/journal.pone.0062153			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23671585	Green Submitted, Green Published, gold			2022-12-25	WOS:000321202100007
J	Rise, MB; Pellerud, A; Rygg, LO; Steinsbekk, A				Rise, Marit B.; Pellerud, Anneli; Rygg, Lisbeth O.; Steinsbekk, Aslak			Making and Maintaining Lifestyle Changes after Participating in Group Based Type 2 Diabetes Self-Management Educations: A Qualitative Study	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; CARE MANAGEMENT; PEOPLE; METAANALYSIS; MEDICATION; BEHAVIORS; MELLITUS.; STANDARDS; EXERCISE; PROGRAM	Background: Disease management is crucial in type 2 diabetes. Diabetes self-management education aims to provide the knowledge necessary to make and maintain lifestyle changes. However, few studies have investigated the processes after such courses. The aim of this study was to investigate how participants make and maintain lifestyle changes after participating in group-based type 2 diabetes self-management education. Methods: Data was collected through qualitative semi-structured interviews with 23 patients who attended educational group programs in Central Norway. The participants were asked how they had used the advice given and what they had changed after the course. Results: Knowledge was essential for making lifestyle changes following education. Three factors affected whether lifestyle changes were implemented: obtaining new knowledge, taking responsibility, and receiving confirmation of an already healthy lifestyle. Four factors motivated individuals to maintain changes: support from others, experiencing an effect, fear of complications, and the formation of new habits. Conclusion: Knowledge was used to make and maintain changes in diet, medication and physical activity. Knowledge also acted as confirmation of an already adequate lifestyle. Knowledge led to no changes if diabetes appeared "not that scary'' or if changes appeared too time consuming. Those involved in diabetes education need to be aware of the challenges in convincing asymptomatic patients about the benefits of adherence to self-management behaviour.	[Rise, Marit B.; Pellerud, Anneli; Rygg, Lisbeth O.; Steinsbekk, Aslak] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway; [Rygg, Lisbeth O.] Helse Nord Trondelag Hosp Trust, Levanger, Norway	Norwegian University of Science & Technology (NTNU)	Rise, MB (corresponding author), Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway.	marit.b.rise@ntnu.no	Steinsbekk, Aslak/E-9223-2012; Albertin, Paloma C/X-1093-2018	Steinsbekk, Aslak/0000-0001-9090-0739; Rygg, Lisbeth Ostgaard/0000-0002-8415-8715	Central Norway Health Authorities [46011600-47]	Central Norway Health Authorities	The study was funded by The Central Norway Health Authorities (grant number 46011600-47). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm-Roijer Carin, 2004, Eur J Cardiovasc Nurs, V3, P321; Balcou-Debussche M, 2009, QUAL HEALTH RES, V19, P1100, DOI 10.1177/1049732309341642; Bandura A, 2004, HEALTH EDUC BEHAV, V31, P143, DOI 10.1177/1090198104263660; Barlow JH, 2005, J HEALTH PSYCHOL, V10, P863, DOI 10.1177/1359105305057320; Blissmer B, 2010, J HEALTH PSYCHOL, V15, P205, DOI 10.1177/1359105309345555; Burge S, 2005, FAM MED, V37, P712; Eigenmann C, 2007, OUTCOMES INDICATORS; Farmer A, 2006, DIABETIC MED, V23, P265, DOI 10.1111/j.1464-5491.2005.01778.x; Fredrickson BL, 2005, AM PSYCHOL, V60, P678, DOI 10.1037/0003-066X.60.7.678; Funnell MM, 2012, DIABETES CARE, V35, pS101, DOI 10.2337/dc12-s101; Gazmararian JA, 2009, DIABETES EDUCATOR, V35, P778, DOI 10.1177/0145721709338527; Giorgi A., 2009, DESCRIPTIVE PHENOMEN; Hibbard JH, 2010, PATIENT EDUC COUNS, V78, P377, DOI 10.1016/j.pec.2009.12.015; HISCOCK J, 2001, LISTENING DIABETES S; HORTON ES, 1988, DIABETES CARE, V11, P201, DOI 10.2337/diacare.11.2.201; Khunti K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2333; Kvale S., 1996, INTERVIEWS INTRO QUA; Lawton J, 2005, SOC SCI MED, V60, P1423, DOI 10.1016/j.socscimed.2004.08.013; Malpass A, 2009, PATIENT EDUC COUNS, V74, P258, DOI 10.1016/j.pec.2008.08.018; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; Malterud K, 2012, SCAND J PUBLIC HEALT, V40, P795, DOI 10.1177/1403494812465030; Manderson L, 2009, CHRONIC ILLN, V5, P21, DOI 10.1177/1742395309102243; Marks DF, 2008, J HEALTH PSYCHOL, V13, P977, DOI 10.1177/1359105308098002; Minet L, 2010, PATIENT EDUC COUNS, V80, P29, DOI 10.1016/j.pec.2009.09.033; Moser A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-91; Mulcahy K, 2003, DIABETES EDUCATOR, V29, P768, DOI 10.1177/014572170302900509; MURPHY E, 1995, FAM PRACT, V12, P184, DOI 10.1093/fampra/12.2.184; Norris SL, 2002, DIABETES CARE, V25, P1159, DOI 10.2337/diacare.25.7.1159; Ockleford E, 2008, CHRONIC ILLN, V4, P28, DOI 10.1177/1742395307086673; Parry O, 2006, HEALTH EDUC RES, V21, P97, DOI 10.1093/her/cyh044; Peel E, 2004, PATIENT EDUC COUNS, V53, P269, DOI 10.1016/j.pec.2003.07.010; Peel E, 2010, BRIT J GEN PRACT, V60, P570, DOI 10.3399/bjgp10X515061; Polonsky WH, 2003, DIABETES CARE, V26, P3048, DOI 10.2337/diacare.26.11.3048; PROCHASKA JO, 1992, AM PSYCHOL, V47, P1102, DOI 10.1037/0003-066X.47.9.1102; Rygg LO, 2012, PATIENT EDUC COUNS, V86, P98, DOI 10.1016/j.pec.2011.04.008; Rygg LO, 2010, SCAND J PUBLIC HEALT, V38, P788, DOI 10.1177/1403494810382475; Shariff F, 2009, QUAL HEALTH RES, V19, P1037, DOI 10.1177/1049732309341189; Snoek FJ, 2002, INT J CLIN PRACT, P80; Steinsbekk A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-213; Tucker M, 2002, J NUTR EDUC BEHAV, V34, pS14, DOI 10.1016/S1499-4046(06)60306-0; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Zimmerman GL, 2000, AM FAM PHYSICIAN, V61, P1409	42	43	44	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e64009	10.1371/journal.pone.0064009	http://dx.doi.org/10.1371/journal.pone.0064009			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	155HD	23671705	Green Published, Green Submitted, gold			2022-12-25	WOS:000319737700063
J	Tryjanowski, P; Sparks, TH; Kuzniak, S; Czechowski, P; Jerzak, L				Tryjanowski, Piotr; Sparks, Tim H.; Kuzniak, Stanislaw; Czechowski, Pawel; Jerzak, Leszek			Bird Migration Advances More Strongly in Urban Environments	PLOS ONE			English	Article							CLIMATE-CHANGE; ARRIVAL DATES; URBANIZATION; PHENOLOGY; ECOLOGY; AREAS	Urbanization has a marked effect on the reproduction and other ecological and behavioural traits of many living organisms, including birds. In migrant birds, survival and reproductive output is influenced by the (mis) synchronization of arrival with the availability of resources. Many recent studies have shown that arrival timing is related to temperatures en-route and at destination. Because urban areas are "heat islands'', with higher temperatures that influence earlier vegetation and invertebrate development, this should favour earlier arrival of migrant birds to cities rather than to rural areas. In this paper, we analysed differences between urban and rural habitats in mean dates and trends of first arrival dates of 18 species of migratory bird species in western Poland during 1983-2010. For many individual species, and overall, mean first arrival date was significantly earlier in rural areas than in urban areas (significant for 11 species). However, the trend towards earlier first arrival dates was stronger in urban areas for 15 of the 18 species (significantly stronger in four species). Consequently, arrival dates in urban areas are fast approaching, or have now matched or passed those in rural areas. These findings suggest that recent environmental changes may have more rapidly changed the migratory habits of birds occupying urban habitats than those occupying rural habitats.	[Tryjanowski, Piotr; Sparks, Tim H.; Kuzniak, Stanislaw] Poznan Univ Life Sci, Inst Zool, Poznan, Poland; [Sparks, Tim H.] Tech Univ Munich, Fachgebiet Okoklimatol, Freising Weihenstephan, Germany; [Sparks, Tim H.] Tech Univ Munich, Inst Adv Study, Garching, Germany; [Sparks, Tim H.] Coventry Univ, Fac Engn & Comp, Coventry, W Midlands, England; [Czechowski, Pawel] State Higher Vocat Sch Sulechow, Inst Tourism & Recreat, Sulechow, Poland; [Jerzak, Leszek] Univ Zielona Gora, Fac Biol Sci, Zielona Gora, Poland	Poznan University of Life Sciences; Technical University of Munich; Technical University of Munich; Coventry University; University of Zielona Gora	Tryjanowski, P (corresponding author), Poznan Univ Life Sci, Inst Zool, Poznan, Poland.	piotr.tryjanowski@gmail.com		Sparks, Tim/0000-0003-4382-7051; Tryjanowski, Piotr/0000-0002-8358-0797	Technische Universitat Munchen - Institute for Advanced Study; German Excellence Initiative	Technische Universitat Munchen - Institute for Advanced Study; German Excellence Initiative	THS acknowledges the support of the Technische Universitat Munchen - Institute for Advanced Study, funded by the German Excellence Initiative. The analysis and data collection was partially financed by sources from the authors' universities. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banaszak-Cibicka W, 2012, J INSECT CONSERV, V16, P331, DOI 10.1007/s10841-011-9419-2; Biadun W, 2011, POL J ECOL, V59, P381; Buyantuyev A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051260; DIAMOND JM, 1986, NATURE, V324, P107, DOI 10.1038/324107a0; Draper N.R., 1998, WILEY SERIES PROBABI, V326; Evans KL, 2011, GLOBAL CHANGE BIOL, V17, P32, DOI 10.1111/j.1365-2486.2010.02247.x; Gilbert O.L., 1989, ECOLOGY URBAN HABITA; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Horak P, 1998, IBIS, V140, P205, DOI 10.1111/j.1474-919X.1998.tb04380.x; Hurlbert AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031662; Imhoff ML, 2010, REMOTE SENS ENVIRON, V114, P504, DOI 10.1016/j.rse.2009.10.008; Jochner SC, 2012, INT J BIOMETEOROL, V56, P387, DOI 10.1007/s00484-011-0444-3; Jonzen N, 2006, SCIENCE, V312, P1959, DOI 10.1126/science.1126119; Konvicka M, 2011, EUR J ENTOMOL, V108, P219, DOI 10.14411/eje.2011.030; Lehikoinen Esa, 2010, P89; Lu PL, 2006, AGR FOREST METEOROL, V138, P120, DOI 10.1016/j.agrformet.2006.04.002; Matteson Kevin C., 2010, Urban Ecosystems, V13, P333, DOI 10.1007/s11252-010-0122-y; Mimet A, 2009, INT J BIOMETEOROL, V53, P287, DOI 10.1007/s00484-009-0214-7; Moller AP, 2008, P NATL ACAD SCI USA, V105, P16195, DOI 10.1073/pnas.0803825105; Moller AP, 2010, BEHAV ECOL, V21, P365, DOI 10.1093/beheco/arp199; Moller AP, 2009, OECOLOGIA, V159, P849, DOI 10.1007/s00442-008-1259-8; Neil Kaesha, 2006, Urban Ecosystems, V9, P243, DOI 10.1007/s11252-006-9354-2; Raupp MJ, 2010, ANNU REV ENTOMOL, V55, P19, DOI 10.1146/annurev-ento-112408-085351; Satterthwaite D, 2010, ENVIRON URBAN ASIA, V1, P1, DOI 10.1177/097542530900100102; Shochat E, 2006, TRENDS ECOL EVOL, V21, P186, DOI 10.1016/j.tree.2005.11.019; Sparks TH, 2005, GLOBAL CHANGE BIOL, V11, P22, DOI 10.1111/j.1365-2486.2004.00887.x; Tryjanowski P, 2005, J ORNITHOL, V146, P200, DOI 10.1007/s10336-005-0079-4; Visser ME, 2009, GLOBAL CHANGE BIOL, V15, P1859, DOI 10.1111/j.1365-2486.2009.01865.x; White MA, 2002, ECOSYSTEMS, V5, P260, DOI 10.1007/s10021-001-0070-8	30	53	55	6	126	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63482	10.1371/journal.pone.0063482	http://dx.doi.org/10.1371/journal.pone.0063482			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667625	Green Submitted, Green Published, gold			2022-12-25	WOS:000319055600061
J	Yan, XH; Lyu, TJ; Jia, N; Yu, YH; Hua, KQ; Feng, WW				Yan, Xiaohui; Lyu, Tianjiao; Jia, Nan; Yu, Yinhua; Hua, Keqin; Feng, Weiwei			Huaier Aqueous Extract Inhibits Ovarian Cancer Cell Motility via the AKT/GSK3 beta/beta-Catenin Pathway	PLOS ONE			English	Article							BETA-CATENIN; CYCLIN D1; COMPONENTS; EXPRESSION; TARGET; WNT	Traditional Chinese medicine has gained popularity due to its ability to kill tumor cells. Recently, the apoptotic and anti-angiogenic effects of Trametes robiniophila murr (Huaier) have been investigated. The aim of this study was to investigate its effect on cell mobility and tumor growth in ovarian cancer. Cell viability and motility were measured using SRB, scratch and migration assays. Cell apoptosis was analysed by annexin V/PI staining. Using a reverse-phase protein array (RPPA) assay, we analyzed the levels of 153 proteins and/or phosphorylations in Huaier-treated and untreated cells. Huaier inhibited cell viability and induced both early and late apoptosis in SKOV3, SKOV3.ip1 and Hey cells in a time-and dosedependent manner. Cell invasiveness and migration were also suppressed significantly. The RPPA results showed significant differences (of at least 30%; P < 0.05) in the levels of 7 molecules in SKOV3 cells and 10 in SKOV3.ip1 cells between the untreated and treated cells. Most of the molecules identified play roles in cell proliferation, apoptosis or cell adhesion/invasion. Western blot analysis further validated that Huaier treatment resulted in decreased AKT phosphorylation, enhanced expression of total GSK3 beta, inhibition of the phosphorylation of GSK3 beta on S9, reduction of both cytoplasmic beta-catenin expression and nuclear beta-catenin translocation, and transcriptional repression of several Wnt/beta-catenin target genes (DIXDC1, LRP6, WNT5A, and cyclin D1). After knocking down GSK3 beta, beta-catenin expression could not be inhibited by Huaier. Finally, Huaier inhibited the growth of ovarian tumor xenografts in vivo. These studies indicate that Huaier inhibits tumor cell mobility in ovarian cancer via the AKT/GSK3 beta/beta-catenin signaling pathway.	[Yan, Xiaohui; Lyu, Tianjiao; Jia, Nan; Yu, Yinhua; Hua, Keqin; Feng, Weiwei] Fudan Univ, Dept Gynecol, Obstet & Gynecol Hosp, Shanghai 200433, Peoples R China; [Yan, Xiaohui; Lyu, Tianjiao; Jia, Nan; Yu, Yinhua; Hua, Keqin; Feng, Weiwei] Fudan Univ, Shanghai Key Lab Female Reprod Endocrine Related, Obstet & Gynecol Hosp, Shanghai 200433, Peoples R China; [Yu, Yinhua] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	Fudan University; Fudan University; University of Texas System; UTMD Anderson Cancer Center	Hua, KQ (corresponding author), Fudan Univ, Dept Gynecol, Obstet & Gynecol Hosp, Shanghai 200433, Peoples R China.	huakeqin@126.com; jingsakura@gmail.com			National Natural Science Foundation of China [30973185]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by National Natural Science Foundation of China, grant number 30973185 (http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Burger RA, 2011, NEW ENGL J MED, V365, P2473, DOI 10.1056/NEJMoa1104390; Burkhalter RJ, 2011, J BIOL CHEM, V286, P23467, DOI 10.1074/jbc.M110.199539; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dihlmann S, 2005, INT J CANCER, V113, P515, DOI 10.1002/ijc.20609; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Guo Y., 1992, J CHINA PHARM U, V23, P155; Guo Y., 1993, CHIN J BIOCH PHARM, V63, P56; He Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031087; Huang T, 2001, CHIN J TUBERC RESP D, V24, P487; Li CX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027053; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; McCulloch M, 2006, J CLIN ONCOL, V24, P419, DOI 10.1200/JCO.2005.03.6392; McDonald SL, 2009, BRIT J CANCER, V101, P209, DOI 10.1038/sj.bjc.6605174; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Niessen CM, 2008, BBA-BIOMEMBRANES, V1778, P562, DOI 10.1016/j.bbamem.2007.12.015; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Ren JZ, 2009, J HUAZHONG U SCI-MED, V29, P198, DOI 10.1007/s11596-009-0212-3; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Takahashi-Yanaga F, 2008, CELL SIGNAL, V20, P581, DOI 10.1016/j.cellsig.2007.10.018; Tibes R, 2006, MOL CANCER THER, V5, P2512, DOI 10.1158/1535-7163.MCT-06-0334; Wang CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031195; Wang L, 2009, CANCER SCI, V100, P1801, DOI 10.1111/j.1349-7006.2009.01246.x; Wang XL, 2012, ONCOL REP, V28, P1167, DOI 10.3892/or.2012.1961; Weinberg RA, 2007, BIOL CANC; Willems L, 2012, CURR ONCOL REP, V14, P129, DOI 10.1007/s11912-012-0227-y; YU DH, 1993, CANCER RES, V53, P891; Zhang N, 2010, CANCER SCI, V101, P2375, DOI 10.1111/j.1349-7006.2010.01680.x	31	55	60	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63731	10.1371/journal.pone.0063731	http://dx.doi.org/10.1371/journal.pone.0063731			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667667	Green Published, gold, Green Submitted			2022-12-25	WOS:000319055600072
J	Fiore-Donno, AM; Clissmann, F; Meyer, M; Schnittler, M; Cavalier-Smith, T				Fiore-Donno, Anna Maria; Clissmann, Fionn; Meyer, Marianne; Schnittler, Martin; Cavalier-Smith, Thomas			Two-Gene Phylogeny of Bright-Spored Myxomycetes (Slime Moulds, Superorder Lucisporidia)	PLOS ONE			English	Article							GROUP-I INTRONS; MULTIGENE ANALYSES; CAPILLITIUM; EVOLUTION; TAXONOMY; LIGHT	Myxomycetes, or plasmodial slime-moulds, are one of the largest groups in phylum Amoebozoa. Nonetheless, only similar to 10% are in the database for the small subunit (SSU) ribosomal RNA gene, the most widely used gene for phylogenetics and barcoding. Most sequences belong to dark-spored Myxomycetes (order Fuscisporida); the 318 species of superorder Lucisporidia (bright-spored) are represented by only eleven genuine sequences. To compensate for this, we provide 66 new sequences, 37 SSU rRNA and 29 elongation factor 1-alpha (EF-1 alpha), for 82% of the genera of Lucisporidia. Phylogenetic analyses of single-and two-gene alignments produce congruent topologies and reveal both morphological characters that have been overemphasised and those that have been overlooked in past classifications. Both classical orders, Liceida and Trichiida, and several families and genera are para/polyphyletic; some previously unrecognised clades emerge. We discuss possible evolutionary pathways. Our study fills a gap in the phylogeny of Amoebozoa and provides an extensive SSU rRNA sequence reference database for environmental sampling and barcoding. We report a new group I intron insertion site for Myxomycetes in one Licea.	[Fiore-Donno, Anna Maria; Cavalier-Smith, Thomas] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Fiore-Donno, Anna Maria; Clissmann, Fionn; Schnittler, Martin] Ernst Moritz Arndt Univ Greifswald, Inst Bot & Landscape Ecol, Greifswald, Germany	University of Oxford; Ernst Moritz Arndt Universitat Greifswald	Fiore-Donno, AM (corresponding author), Univ Cologne, Inst Zool, Weyertal 119, Cologne, Germany.	afiore-donno6@infomaniak.ch		Fiore-Donno, Anna Maria/0000-0001-6265-1907	Leverhulme Trust research grant [R1008101]; Deutsche Forschungsgemeinschaft grant [SCHN1080-2/1]	Leverhulme Trust research grant(Leverhulme Trust); Deutsche Forschungsgemeinschaft grant(German Research Foundation (DFG))	This work was supported by the Leverhulme Trust research grant R1008101 to the first and last authors and the Deutsche Forschungsgemeinschaft grant SCHN1080-2/1 to the first and fourth authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXOPOULOS CJ, 1960, MYCOLOGIA, V52, P1, DOI 10.2307/3756246; Baldauf SL, 1997, P NATL ACAD SCI USA, V94, P12007, DOI 10.1073/pnas.94.22.12007; Bhattacharya D, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-68; Bisby GR, 1914, AM J BOT, V1, P274, DOI 10.2307/2435103; BLACKWELL M, 1974, ARCH MICROBIOL, V99, P331, DOI 10.1007/BF00696247; Cannone JJ, 2002, BMC BIOINF; Cavalier-Smith T, 2012, EUR J PROTI IN PRESS, DOI http://dx.doi.org/10.1016/j.ejop.2012.06.001; CHARVAT I, 1973, PROTOPLASMA, V78, P1, DOI 10.1007/BF01281519; CHARVAT I, 1973, PROTOPLASMA, V80, P207, DOI 10.1007/BF01666360; Clark J, 2004, MYCOLOGIA, V96, P36, DOI 10.2307/3761985; ELIASSON U, 1977, BOT NOTISER, V130, P483; ELLIS TT, 1973, T AM MICROSC SOC, V92, P65, DOI 10.2307/3225172; Fiore-Donno AM, 2005, J EUKARYOT MICROBIOL, V52, P201, DOI 10.1111/j.1550-7408.2005.00032.x; Fiore-Donno AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035359; Fiore-Donno AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022872; Fiore-Donno AM, 2010, PROTIST, V161, P55, DOI 10.1016/j.protis.2009.05.002; Fiore-Donno AM, 2009, MYCOLOGIA, V101, P773, DOI 10.3852/08-075; Gilert E, 1997, NORD J BOT, V16, P705; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hampl V, 2009, P NATL ACAD SCI USA, V106, P3859, DOI 10.1073/pnas.0807880106; Harper RA, 1914, ANN BOT-LONDON, V28, P1; Haskins EF, 1978, PUB WISSENSCH FILM S, V11, P1; Hatano Takami, 1999, Hikobia, V13, P47; Haugen P, 2005, TRENDS GENET, V21, P111, DOI 10.1016/j.tig.2004.12.007; Haugen P, 2003, J EUKARYOT MICROBIOL, V50, P283, DOI 10.1111/j.1550-7408.2003.tb00135.x; Huelsenbeck JP, MR BAYES V3 0B4; Iwata D, 2003, J NAT PROD, V66, P1611, DOI 10.1021/np030308e; Jobb G, 2008, TREEFINDER VERSION O; Johansen S, 2001, RNA, V7, P935, DOI 10.1017/S1355838201010500; Kalyanasundaram I, 1973, TAXONOMY FUNGI, P9; Lado C, 1997, MYXOMYCETES; Lahr DJG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022780; Lister A, 1894, MONOGRAPH MYCETOZOA; Lundblad EW, 2004, MOL BIOL EVOL, V21, P1283, DOI 10.1093/molbev/msh126; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; MIMS CW, 1969, MYCOLOGIA, V61, P784, DOI 10.2307/3757468; MIMS CW, 1975, MYCOLOGIA, V67, P638, DOI 10.2307/3758399; NANNENGABREMEKAMP NE, 1982, P K NED AKAD C BIOL, V85, P541; Neubert H., 1993, MYXOMYCETEN DEUTSCHL, V1; Olive LS, 1975, MYCETOZOANS; Parfrey LW, 2010, SYST BIOL, V59, P518, DOI 10.1093/sysbio/syq037; Pawlowski J, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001419; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Poulain M, 2011, LES MYXOMYCETES; Shadwick LL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006754; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stephenson SL, 2011, SOIL BIOL BIOCHEM, V43, P2237, DOI 10.1016/j.soilbio.2011.07.007; Tekle YI, 2008, MOL PHYLOGENET EVOL, V47, P339, DOI 10.1016/j.ympev.2007.11.015; WELDEN AL, 1955, MYCOLOGIA, V47, P714, DOI 10.2307/3755581	49	57	65	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62586	10.1371/journal.pone.0062586	http://dx.doi.org/10.1371/journal.pone.0062586			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667494	Green Submitted, gold, Green Published			2022-12-25	WOS:000319654700050
J	Liu, J; Wei, W; Kuang, H; Zhao, F; Tsien, JZ				Liu, Jun; Wei, Wei; Kuang, Hui; Zhao, Fang; Tsien, Joe Z.			Changes in Heart Rate Variability Are Associated with Expression of Short-Term and Long-Term Contextual and Cued Fear Memories	PLOS ONE			English	Article							FREELY BEHAVING RAT; CONDITIONED FEAR; NMDA RECEPTOR; HIPPOCAMPUS; MICE; RESPONSES; AMYGDALA; NEURONS; TRACES; BRAIN	Heart physiology is a highly useful indicator for measuring not only physical states, but also emotional changes in animals. Yet changes of heart rate variability during fear conditioning have not been systematically studied in mice. Here, we investigated changes in heart rate and heart rate variability in both short-term and long-term contextual and cued fear conditioning. We found that while fear conditioning could increase heart rate, the most significant change was the reduction in heart rate variability which could be further divided into two distinct stages: a highly rhythmic phase (stage-I) and a more variable phase (stage-II). We showed that the time duration of the stage-I rhythmic phase were sensitive enough to reflect the transition from short-term to long-term fear memories. Moreover, it could also detect fear extinction effect during the repeated tone recall. These results suggest that heart rate variability is a valuable physiological indicator for sensitively measuring the consolidation and expression of fear memories in mice.	[Liu, Jun; Wei, Wei] E China Normal Univ, Inst Brain Funct Genom, Minist Educ, Key Lab Brain Funct Genom, Shanghai 200062, Peoples R China; [Kuang, Hui; Zhao, Fang; Tsien, Joe Z.] Banna Biomed Res Inst, Xishuangbanna, Yunnan, Peoples R China; [Liu, Jun; Wei, Wei; Kuang, Hui; Zhao, Fang; Tsien, Joe Z.] Georgia Regents Univ, Med Coll Georgia, Brain & Behav Discovery Inst, Augusta, GA USA; [Liu, Jun; Wei, Wei; Kuang, Hui; Zhao, Fang; Tsien, Joe Z.] Georgia Regents Univ, Med Coll Georgia, Dept Neurol, Augusta, GA USA	East China Normal University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Zhao, F (corresponding author), Banna Biomed Res Inst, Xishuangbanna, Yunnan, Peoples R China.	zhaofang.magic@gmail.com; jtsien@gru.edu	Kuang, Hui/I-1006-2013	Kuang, Hui/0000-0002-7806-2864	National Institutes of Health [NS079774, AG034663-01, MH060236]; Shanghai Commission of Science and Technology [10140900500]; Yunnan Province Department of Science and Technology [2012BA009]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034663] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shanghai Commission of Science and Technology(Shanghai Science & Technology Committee); Yunnan Province Department of Science and Technology; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Grant support the National Institutes of Health (NS079774; AG034663-01; and MH060236), Shanghai Commission of Science and Technology (Grant # 10140900500), and Yunnan Province Department of Science and Technology (Grant # 2012BA009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bangasser DA, 2006, J NEUROSCI, V26, P8702, DOI 10.1523/JNEUROSCI.1742-06.2006; BERGER TW, 1978, P NATL ACAD SCI USA, V75, P1572, DOI 10.1073/pnas.75.3.1572; BERGER TW, 1976, SCIENCE, V192, P483, DOI 10.1126/science.1257783; BERRY SD, 1978, SCIENCE, V200, P1298, DOI 10.1126/science.663612; BLANCHARD DC, 1972, J COMP PHYSIOL PSYCH, V81, P281, DOI 10.1037/h0033521; Chan PK, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-11; Charlet A, 2011, PHYSIOL BEHAV, V104, P694, DOI 10.1016/j.physbeh.2011.07.004; Chen GF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008256; Cui ZZ, 2004, NEURON, V41, P781, DOI 10.1016/S0896-6273(04)00072-8; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; DAVIS M, 1987, PSYCHOL LEARNING MEM; DISTERHOFT JF, 1986, P NATL ACAD SCI USA, V83, P2733, DOI 10.1073/pnas.83.8.2733; FANSELOW MS, 1984, TRENDS NEUROSCI, V7, P460; GABRIEL M, 1976, PHYSIOL PSYCHOL, V4, P275; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Hurst JL, 2010, NAT METHODS, V7, P825, DOI [10.1038/nmeth.1500, 10.1038/NMETH.1500]; IWATA J, 1988, BEHAV NEUROSCI, V102, P66, DOI 10.1037/0735-7044.102.1.66; KIM JJ, 1992, BEHAV NEUROSCI, V106, P591, DOI 10.1037/0735-7044.106.4.591; Kim JJ, 2006, NEUROSCI BIOBEHAV R, V30, P188, DOI 10.1016/j.neubiorev.2005.06.005; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Lin LN, 2006, J NEUROSCI METH, V155, P28, DOI 10.1016/j.jneumeth.2005.12.032; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; McCauley Mark D, 2010, J Vis Exp, DOI 10.3791/1739; McEchron MD, 2003, J NEUROSCI, V23, P1535, DOI 10.1523/JNEUROSCI.23-04-01535.2003; OLDS J, 1972, J NEUROPHYSIOL, V35, P202, DOI 10.1152/jn.1972.35.2.202; Pennartz CMA, 2004, J NEUROSCI, V24, P6446, DOI 10.1523/JNEUROSCI.0575-04.2004; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; Romcy-Pereira RN, 2009, PHYSIOL BEHAV, V98, P44, DOI 10.1016/j.physbeh.2009.04.010; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Steenland HW, 2009, J NEUROSCI METH, V177, P355, DOI 10.1016/j.jneumeth.2008.10.020; Stiedl O, 2004, AUTON NEUROSCI-BASIC, V115, P15, DOI 10.1016/j.autneu.2004.07.006; Stiedl O, 1997, BEHAV NEUROSCI, V111, P703, DOI 10.1037/0735-7044.111.4.703; Thompson RE, 2005, ANNU REV PSYCHOL, V56, P1, DOI 10.1146/annurev.psych.56.091103.070239; THOMPSON RF, 1994, ANNU REV NEUROSCI, V17, P519, DOI 10.1146/annurev.neuro.17.1.519; Zhang WN, 2004, BEHAV BRAIN RES, V154, P199, DOI 10.1016/j.bbr.2004.02.016	38	12	13	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63590	10.1371/journal.pone.0063590	http://dx.doi.org/10.1371/journal.pone.0063590			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667644	Green Published, Green Submitted, gold			2022-12-25	WOS:000319654700165
J	Machado, RB; Tufik, S; Suchecki, D				Machado, Ricardo Borges; Tufik, Sergio; Suchecki, Deborah			Role of Corticosterone on Sleep Homeostasis Induced by REM Sleep Deprivation in Rats	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; POSTTRAUMATIC-STRESS-DISORDER; SLOW-WAVE ACTIVITY; PROHORMONE CONVERTASES PC1; PITUITARY-ADRENAL AXIS; CENTRAL-NERVOUS-SYSTEM; EYE-MOVEMENT SLEEP; EEG POWER SPECTRA; PARADOXICAL SLEEP; ENERGY-METABOLISM	Sleep is regulated by humoral and homeostatic processes. If on one hand chronic elevation of stress hormones impair sleep, on the other hand, rapid eye movement (REM) sleep deprivation induces elevation of glucocorticoids and time of REM sleep during the recovery period. In the present study we sought to examine whether manipulations of corticosterone levels during REM sleep deprivation would alter the subsequent sleep rebound. Adult male Wistar rats were fit with electrodes for sleep monitoring and submitted to four days of REM sleep deprivation under repeated corticosterone or metyrapone (an inhibitor of corticosterone synthesis) administration. Sleep parameters were continuously recorded throughout the sleep deprivation period and during 3 days of sleep recovery. Plasma levels of adrenocorticotropic hormone and corticosterone were also evaluated. Metyrapone treatment prevented the elevation of corticosterone plasma levels induced by REM sleep deprivation, whereas corticosterone administration to REM sleep-deprived rats resulted in lower corticosterone levels than in non-sleep deprived rats. Nonetheless, both corticosterone and metyrapone administration led to several alterations on sleep homeostasis, including reductions in the amount of non-REM and REM sleep during the recovery period, although corticosterone increased delta activity (1.0-4.0 Hz) during REM sleep deprivation. Metyrapone treatment of REM sleep-deprived rats reduced the number of REM sleep episodes. In conclusion, reduction of corticosterone levels during REM sleep deprivation resulted in impairment of sleep rebound, suggesting that physiological elevation of corticosterone levels resulting from REM sleep deprivation is necessary for plentiful recovery of sleep after this stressful event.	[Machado, Ricardo Borges; Tufik, Sergio; Suchecki, Deborah] Univ Fed Sao Paulo, Dept Psychobiol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP)	Machado, RB (corresponding author), Univ Fed Sao Paulo, Dept Psychobiol, Sao Paulo, Brazil.	machado.ricardoborges@gmail.com	Suchecki, Deborah/B-9790-2014; Machado, Ricardo/GXM-8198-2022; Suchecki, Deborah/B-7654-2012; Machado, Ricardo/A-2789-2012	Suchecki, Deborah/0000-0003-1697-8663; Machado, Ricardo/0000-0001-5878-554X	Associacao Fundo de Incentivo a Pesquisa (AFIP); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP [98/14303-3]; FAPESP [04/02213-2]; National Research Council (CNPq)	Associacao Fundo de Incentivo a Pesquisa (AFIP); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Associacao Fundo de Incentivo a Pesquisa (AFIP) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP (Grant #98/14303-3). Ricardo Borges Machado was the recipient of PhD fellowship from FAPESP (04/02213-2). Deborah Suchecki and Sergio Tufik are the recipients of a scholarship from the National Research Council (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achermann P, 2003, FRONT BIOSCI-LANDMRK, V8, pS683, DOI 10.2741/1064; Benington JH, 1999, SLEEP, V22, P1033; BENINGTON JH, 1995, PROG NEUROBIOL, V45, P347, DOI 10.1016/0301-0082(94)00057-O; BERGMANN BM, 1987, SLEEP, V10, P1; BERGMANN BM, 1987, SLEEP, V10, P523; Borbely AA, 1999, J BIOL RHYTHM, V14, P557, DOI 10.1177/074873099129000894; BORBELY AA, 1981, ELECTROEN CLIN NEURO, V51, P483, DOI 10.1016/0013-4694(81)90225-X; Bradbury MJ, 1998, AM J PHYSIOL-REG I, V275, pR555, DOI 10.1152/ajpregu.1998.275.2.R555; BRUNNER DP, 1990, ELECTROEN CLIN NEURO, V75, P492, DOI 10.1016/0013-4694(90)90136-8; Burade VS, 1996, NEUROREPORT, V8, P139, DOI 10.1097/00001756-199612200-00028; CARTWRIGHT RD, 1991, PSYCHIAT RES, V39, P199, DOI 10.1016/0165-1781(91)90088-7; Chang FC, 1998, AM J PHYSIOL-REG I, V275, pR793, DOI 10.1152/ajpregu.1998.275.3.R793; Chang FC, 2001, NEUROSCI BIOBEHAV R, V25, P445, DOI 10.1016/S0149-7634(01)00024-0; CHASTRETTE N, 1985, NEUROSCI LETT, V62, P365, DOI 10.1016/0304-3940(85)90576-2; COENEN AML, 1985, PHYSIOL BEHAV, V35, P501, DOI 10.1016/0031-9384(85)90130-1; Cui RJ, 2007, ACTA MED OKAYAMA, V61, P319; DAY R, 1992, MOL ENDOCRINOL, V6, P485, DOI 10.1210/me.6.3.485; DEMENT W, 1960, SCIENCE, V131, P1705, DOI 10.1126/science.131.3415.1705; DeSouza EB, 1995, PSYCHONEUROENDOCRINO, V20, P789, DOI 10.1016/0306-4530(95)00011-9; DESOUZA EB, 1985, J NEUROSCI, V5, P3189; DIJK DJ, 1993, BRAIN RES, V626, P190, DOI 10.1016/0006-8993(93)90579-C; Drouet JB, 2011, EUR J PHARMACOL, V652, P60, DOI 10.1016/j.ejphar.2010.10.071; EBERLY LB, 1983, PEPTIDES, V4, P837, DOI 10.1016/0196-9781(83)90077-3; EHLERS CL, 1986, NEUROENDOCRINOLOGY, V42, P467, DOI 10.1159/000124489; Endo T, 1997, PSYCHIAT RES, V66, P97, DOI 10.1016/S0165-1781(96)03029-6; FEISE G, 1977, BRAIN RES, V126, P263, DOI 10.1016/0006-8993(77)90725-9; Ferrara M, 1999, Sleep Res Online, V2, P15; Franken P, 2001, J NEUROSCI, V21, P2610, DOI 10.1523/JNEUROSCI.21-08-02610.2001; GALVAO MD, 2009, PSYCHONEUROENDOCRINO; Garcia-Borreguero D, 2000, J CLIN ENDOCR METAB, V85, P4201, DOI 10.1210/jc.85.11.4201; Gip P, 2004, AM J PHYSIOL-REG I, V286, pR1057, DOI 10.1152/ajpregu.00528.2003; GRAHNSTEDT S, 1985, BEHAV BRAIN RES, V18, P233, DOI 10.1016/0166-4328(85)90031-2; Held K, 2004, J PSYCHIATR RES, V38, P129, DOI 10.1016/S0022-3956(03)00076-1; Huntsman MM, 1999, SCIENCE, V283, P541, DOI 10.1126/science.283.5401.541; Igarreta P, 1999, LIFE SCI, V64, P2285, DOI 10.1016/S0024-3205(99)00179-4; Igaz P, 2008, CURR MED CHEM, V15, P2734, DOI 10.2174/092986708786242921; Jahn H, 2003, SLEEP, V26, P823, DOI 10.1093/sleep/26.7.823; KANT GJ, 1995, PHYSIOL BEHAV, V57, P359; LANCEL M, 1992, SLEEP, V15, P102, DOI 10.1093/sleep/15.2.102; LANCEL M, 1992, BRAIN RES, V596, P285, DOI 10.1016/0006-8993(92)91559-W; Lancel M, 2002, J PSYCHIAT RES, V36, P197, DOI 10.1016/S0022-3956(02)00009-2; Lee SN, 2007, J ENDOCRINOL, V192, P515, DOI 10.1677/JOE-06-0145; Liu XL, 2003, BRAIN RES, V991, P1, DOI 10.1016/j.brainres.2003.07.003; Ma X, 2011, TOXICOLOGY, V285, P83, DOI 10.1016/j.tox.2011.04.007; Machado RB, 2005, BEHAV BRAIN RES, V160, P356, DOI 10.1016/j.bbr.2005.01.001; Machado RB, 2004, BRAIN RES, V1004, P45, DOI 10.1016/j.brainres.2004.01.019; Machado RB, 2008, PSYCHONEUROENDOCRINO, V33, P1211, DOI 10.1016/j.psyneuen.2008.06.007; Machado RB, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/326151; MAJEWSKA MD, 1985, BRAIN RES, V339, P178, DOI 10.1016/0006-8993(85)90641-9; Marinesco S, 1999, NEUROSCIENCE, V92, P921, DOI 10.1016/S0306-4522(99)00045-7; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; Mellman TA, 2002, AM J PSYCHIAT, V159, P1696, DOI 10.1176/appi.ajp.159.10.1696; MILCU SM, 1967, ELECTROEN CLIN NEURO, V22, P574; Mongrain V, 2010, SLEEP, V33, P1147, DOI 10.1093/sleep/33.9.1147; Morimoto M, 1996, NEUROSCI RES, V26, P235, DOI 10.1016/S0168-0102(96)01105-4; Morin CM, 2003, PSYCHOSOM MED, V65, P259, DOI 10.1097/01.PSY.0000030391.09558.A3; Neylan TC, 2003, NEUROPSYCHOPHARMACOL, V28, P1666, DOI 10.1038/sj.npp.1300215; Opp MR, 1997, PHYSIOL BEHAV, V63, P67, DOI 10.1016/S0031-9384(97)00390-9; Ortego J, 2002, NEUROSCI LETT, V333, P49, DOI 10.1016/S0304-3940(02)00028-9; Pawlyk AC, 2005, BIOL PSYCHIAT, V57, P268, DOI 10.1016/j.biopsych.2004.11.008; Philbert J, 2011, BEHAV BRAIN RES, V221, P149, DOI 10.1016/j.bbr.2011.02.039; RATCHESON RA, 1981, J NEUROCHEM, V36, P1952, DOI 10.1111/j.1471-4159.1981.tb10820.x; Rechtschaffen A, 1999, SLEEP, V22, P1038, DOI 10.1093/sleep/22.8.1038; Rechtschaffen A, 1999, SLEEP, V22, P11, DOI 10.1093/sleep/22.1.11; REUL JMHM, 1986, J STEROID BIOCHEM, V24, P269, DOI 10.1016/0022-4731(86)90063-4; Romanowski CPN, 2010, SLEEP, V33, P427, DOI 10.1093/sleep/33.4.427; ROSENBERG RS, 1976, PHYSIOL BEHAV, V17, P931, DOI 10.1016/0031-9384(76)90011-1; Ross RJ, 1999, BIOL PSYCHIAT, V45, P938, DOI 10.1016/S0006-3223(98)00233-9; Rotllant D, 2005, NEUROSCIENCE, V130, P427, DOI 10.1016/j.neuroscience.2004.09.007; Rotllant D, 2002, EUR J NEUROSCI, V16, P693, DOI 10.1046/j.1460-9568.2002.02120.x; Sanford LD, 2010, SLEEP, V33, P621, DOI 10.1093/sleep/33.5.621; Schwierin B, 1999, NEUROSCI LETT, V261, P61, DOI 10.1016/S0304-3940(98)01006-4; SOUSA RJ, 1989, MOL ENDOCRINOL, V3, P481, DOI 10.1210/mend-3-3-481; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Suchecki D, 2000, BRAIN RES, V875, P14, DOI 10.1016/S0006-8993(00)02531-2; Suchecki D, 2003, J NEUROENDOCRINOL, V15, P815, DOI 10.1046/j.1365-2826.2003.01067.x; Suchecki Deborah, 2012, Front Neurol, V3, P41, DOI 10.3389/fneur.2012.00041; Tiba PA, 2008, SLEEP, V31, P505, DOI 10.1093/sleep/31.4.505; TIMOIARIA C, 1970, PHYSIOL BEHAV, V5, P1057, DOI 10.1016/0031-9384(70)90162-9; TOBLER I, 1990, BEHAV BRAIN RES, V36, P73, DOI 10.1016/0166-4328(90)90161-7; TOBLER I, 1986, ELECTROEN CLIN NEURO, V64, P74, DOI 10.1016/0013-4694(86)90044-1; TOBLER I, 1983, NEUROSCI LETT, V35, P297, DOI 10.1016/0304-3940(83)90333-6; Vazquez-Palacios G, 2001, PHARMACOL BIOCHEM BE, V70, P305, DOI 10.1016/S0091-3057(01)00620-7; Vazquez-Palacios G, 2000, PHYSIOL BEHAV, V71, P23, DOI 10.1016/S0031-9384(00)00285-7; VONKROSIGK M, 1993, SCIENCE, V261, P361, DOI 10.1126/science.8392750; WETZEL W, 1994, PEPTIDES, V15, P237, DOI 10.1016/0196-9781(94)90008-6; Wetzel W, 1997, NEUROPEPTIDES, V31, P41, DOI 10.1016/S0143-4179(97)90018-4; Zallocchi M, 2004, CAN J PHYSIOL PHARM, V82, P422, DOI 10.1139/Y04-035	88	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63520	10.1371/journal.pone.0063520	http://dx.doi.org/10.1371/journal.pone.0063520			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667630	Green Published, gold, Green Submitted			2022-12-25	WOS:000319654700155
J	Olsen, K; Danielsen, K; Wilsgaard, T; Sangvik, M; Sollid, JUE; Thune, I; Eggen, AE; Simonsen, GS; Furberg, AS				Olsen, Karina; Danielsen, Kjersti; Wilsgaard, Tom; Sangvik, Maria; Sollid, Johanna U. E.; Thune, Inger; Eggen, Anne E.; Simonsen, Gunnar S.; Furberg, Anne-Sofie			Obesity and Staphylococcus aureus Nasal Colonization among Women and Men in a General Population	PLOS ONE			English	Article							BODY-FAT DISTRIBUTION; BETA-DEFENSIN 3; PERINEAL CARRIAGE; SEXUAL-DIMORPHISM; SKIN; RISK; INFECTIONS; PREVALENCE; CARRIERS; TROMSO	Background: Obesity and diabetes mellitus (DM) have been linked to increased risk of infections, and Staphylococcus aureus nasal colonization is a major risk factor for developing infections with the microbe. We therefore sought to find whether body mass index (BMI) and waist circumference (WC) could be associated with S. aureus colonization independent of DM. Methodology: S. aureus colonization was assessed by nasal swab cultures among 2,169 women and 1,709 men, aged 30-87 years, in the population-based Tromso Staph and Skin Study in 2007-08. Height (cm), weight (kg), WC (cm), and glycated haemoglobin (HbA1c,%) were measured. Multivariable logistic regression analyses including information on DM, HbA1c, hormonal contraceptive use and other potential confounders were used. Results: In the female population, each 2.5 kg/m(2) increase in BMI was associated with a 7% higher odds of S. aureus nasal colonization (P = 0.01). When comparing obese and lean women aged 30-43 years, we observed that BMI >= 32.5 versus <22.5 kg/m(2) and WC >= 101 versus <80 cm was associated with a 2.60 and 2.12 times higher odds of S. aureus colonization, respectively (95% confidence intervals 1.35-4.98 and 1.17-3.85). Among men, high WC was also associated with S. aureus nasal colonization. The associations did not change significantly when the analysis was restricted to participants without signs of pre-diabetes (HbA1c <6.0%) among women and men, and to non-users of hormonal contraceptives among women. Conclusion: Our results support that obesity is a possible determinant for S. aureus nasal colonization independent of DM, in particular for premenopausal women. The role of obesity at different ages and by sex should be addressed in future prospective studies of S. aureus colonization.	[Olsen, Karina; Simonsen, Gunnar S.; Furberg, Anne-Sofie] Univ Hosp North Norway, Dept Microbiol & Infect Control, Tromso, Norway; [Olsen, Karina; Danielsen, Kjersti; Wilsgaard, Tom; Thune, Inger; Eggen, Anne E.; Furberg, Anne-Sofie] Univ Tromso, Dept Community Med, Fac Hlth Sci, Tromso, Norway; [Danielsen, Kjersti] Univ Hosp North Norway, Dept Dermatol, Tromso, Norway; [Sangvik, Maria; Sollid, Johanna U. E.; Simonsen, Gunnar S.] Univ Tromso, Fac Hlth Sci, Dept Med Biol, Res Grp Host Microbe Interact, Tromso, Norway; [Thune, Inger] Oslo Univ Hosp, Dept Oncol, Oslo, Norway	UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; University of Oslo	Olsen, K (corresponding author), Univ Hosp North Norway, Dept Microbiol & Infect Control, Tromso, Norway.	karina.olsen@unn.no		Ericson, Johanna Ulrica/0000-0001-5196-4932	Research Council of Norway [191264]; Northern Norway Regional Health Authority [7150.00003, SFP877-09, SFP920-10]; Odd Berg Group Medical Research Grant	Research Council of Norway(Research Council of Norway); Northern Norway Regional Health Authority; Odd Berg Group Medical Research Grant	The study was supported by grants from the Research Council of Norway (grant number 191264), URL: http://www.forskningsradet.no/servlet/Satellite?c=Page&cid=1177315753906&p=1177315753906&pagename=ForskningsradetEngelsk%2FHovedsidemal; Northern Norway Regional Health Authority, 2009 (project number 7150.00003, grant numbers SFP877-09 and SFP920-10), URL: http://www.helse-nord.no/and the Odd Berg Group Medical Research Grant 2007. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baik I, 2000, ARCH INTERN MED, V160, P3082, DOI 10.1001/archinte.160.20.3082; Beery Theresa A, 2003, Crit Care Nurs Clin North Am, V15, P55, DOI 10.1016/S0899-5885(02)00028-X; Biswas B, 2011, AM J REPROD IMMUNOL, V65, P557, DOI 10.1111/j.1600-0897.2010.00937.x; Bode LGM, 2010, NEW ENGL J MED, V362, P9, DOI 10.1056/NEJMoa0808939; CHOBAN PS, 1995, AM SURGEON, V61, P1001; Choban PS, 1997, J AM COLL SURGEONS, V185, P593, DOI 10.1016/S1072-7515(97)00109-9; Eggen AE, 2013, SCAND J PUBLIC HEALT, V41, P65, DOI 10.1177/1403494812469851; Falagas ME, 2006, LANCET INFECT DIS, V6, P438, DOI 10.1016/S1473-3099(06)70523-0; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; Han JH, 2010, CYTOKINE, V49, P209, DOI 10.1016/j.cyto.2009.09.005; Herwaldt LA, 2004, INFECT CONT HOSP EP, V25, P481, DOI 10.1086/502426; HOEGER PH, 1992, J INFECT DIS, V165, P1064, DOI 10.1093/infdis/165.6.1064; Jacobsen BK, 2012, INT J EPIDEMIOL, V41, P961, DOI 10.1093/ije/dyr049; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kanda N, 2008, ENDOCRINOLOGY, V149, P5189, DOI 10.1210/en.2008-0343; Karlsson EA, 2010, EXP BIOL MED, V235, P1412, DOI 10.1258/ebm.2010.010227; King AE, 2003, J REPROD IMMUNOL, V59, P1, DOI 10.1016/S0165-0378(02)00083-9; KOTANI K, 1994, INT J OBESITY, V18, P207; Lamaro-Cardoso J, 2009, J CLIN MICROBIOL, V47, P3991, DOI 10.1128/JCM.01322-09; Liedtke S, 2012, OBESITY, V20, P1088, DOI 10.1038/oby.2011.383; LIPSKY BA, 1987, DIABETES CARE, V10, P483, DOI 10.2337/diacare.10.4.483; Little RR, 2011, CLIN CHEM, V57, P205, DOI 10.1373/clinchem.2010.148841; Marriott I, 2006, IMMUNOL RES, V34, P177, DOI 10.1385/IR:34:3:177; Meli R, 2004, ENDOCRINOLOGY, V145, P3115, DOI 10.1210/en.2004-0129; Myles TD, 2002, OBSTET GYNECOL, V100, P959, DOI 10.1016/S0029-7844(02)02323-2; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Nouwen J.L., 2004, THESIS ERASMUS U MED; Olsen K, 2012, EUR J CLIN MICROBIOL, V31, P465, DOI 10.1007/s10096-011-1331-x; Olsen K, 2012, EPIDEMIOL INFECT, P1; Pandey Shilpi, 2010, J Hum Reprod Sci, V3, P62, DOI 10.4103/0974-1208.69332; PEDERSEN SB, 1995, EUR J ENDOCRINOL, V133, P200, DOI 10.1530/eje.0.1330200; Phillips LK, 2008, CURR HYPERTENS REP, V10, P156, DOI 10.1007/s11906-008-0029-7; Pickkers P, 2004, NETH J MED, V62, P143; RIDLEY M, 1959, BRIT MED J, V1, P270, DOI 10.1136/bmj.1.5117.270; Rohrmann S, 2011, CANCER CAUSE CONTROL, V22, P1141, DOI 10.1007/s10552-011-9790-z; Sangvik M, 2011, J CLIN MICROBIOL, V49, P4213, DOI 10.1128/JCM.05290-11; Strandberg L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007605; van Belkum A, 2009, INFECT GENET EVOL, V9, P32, DOI 10.1016/j.meegid.2008.09.012; VARGA DT, 1961, J CLIN INVEST, V40, P2209, DOI 10.1172/JCI104447; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Wertheim HFL, 2005, ANTIMICROB AGENTS CH, V49, P1465, DOI 10.1128/AAC.49.4.1465-1467.2005; Wertheim HFL, 2004, LANCET, V364, P703, DOI 10.1016/S0140-6736(04)16897-9; WILLIAMS RE, 1963, BACTERIOL REV, V27, P56, DOI 10.1128/MMBR.27.1.56-71.1963; World Health Organization, 2008, WAIST CIRCUMFERENCE; World Health Organization, GLOB DAT BOD MASS IN; Zanger P, 2012, CLIN INFECT DIS, V55, P1625, DOI 10.1093/cid/cis778; Zanger P, 2011, INFECT IMMUN, V79, P2658, DOI 10.1128/IAI.00101-11; Zanger P, 2010, INFECT IMMUN, V78, P3112, DOI 10.1128/IAI.00078-10; Zeigler CC, 2012, OBESITY, V20, P157, DOI 10.1038/oby.2011.305	50	39	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63716	10.1371/journal.pone.0063716	http://dx.doi.org/10.1371/journal.pone.0063716			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667661	Green Published, gold, Green Submitted			2022-12-25	WOS:000319654700179
J	Oslaj, M; Cluzeau, J; Orkic, D; Kopitar, G; Mrak, P; Casar, Z				Oslaj, Matej; Cluzeau, Jerome; Orkic, Damir; Kopitar, Gregor; Mrak, Peter; Casar, Zdenko			A Highly Productive, Whole-Cell DERA Chemoenzymatic Process for Production of Key Lactonized Side-Chain Intermediates in Statin Synthesis	PLOS ONE			English	Article							HMG-COA REDUCTASE; RECOMBINANT ESCHERICHIA-COLI; ASYMMETRIC ALDOL REACTIONS; INDUSTRIAL BIOCATALYSIS; FINE CHEMICALS; DIRECTED EVOLUTION; 2-DEOXYRIBOSE-5-PHOSPHATE ALDOLASE; DEOXYRIBOSE-5-PHOSPHATE ALDOLASE; ENANTIOSELECTIVE SYNTHESIS; ORGANIC-CHEMISTRY	Employing DERA (2-deoxyribose-5-phosphate aldolase), we developed the first whole-cell biotransformation process for production of chiral lactol intermediates useful for synthesis of optically pure super-statins such as rosuvastatin and pitavastatin. Herein, we report the development of a fed-batch, high-density fermentation with Escherichia coli BL21 (DE3) overexpressing the native E. coli deoC gene. High activity of this biomass allows direct utilization of the fermentation broth as a whole-cell DERA biocatalyst. We further show a highly productive bioconversion processes with this biocatalyst for conversion of 2-substituted acetaldehydes to the corresponding lactols. The process is evaluated in detail for conversion of acetyloxy-acetaldehyde with the first insight into the dynamics of reaction intermediates, side products and enzyme activity, allowing optimization of the feeding strategy of the aldehyde substrates for improved productivities, yields and purities. The resulting process for production of ((2S,4R)-4,6-dihydroxytetrahydro-2H-pyran-2-yl)methyl acetate (acetyloxymethylene-lactol) has a volumetric productivity exceeding 40 g L-1 h(-1) (up to 50 g L(-)1 h(-1)) with >80% yield and >80% chromatographic purity with titers reaching 100 g L-1. Stereochemical selectivity of DERA allows excellent enantiomeric purities (ee >99.9%), which were demonstrated on downstream advanced intermediates. The presented process is highly cost effective and environmentally friendly. To our knowledge, this is the first asymmetric aldol condensation process achieved with whole-cell DERA catalysis and it simplifies and extends previously developed DERA-catalyzed approaches based on the isolated enzyme. Finally, applicability of the presented process is demonstrated by efficient preparation of a key lactol precursor, which fits directly into the lactone pathway to optically pure super-statins.	[Oslaj, Matej; Kopitar, Gregor; Mrak, Peter] Lek Pharmaceut Dd, Genet, Antiinfect, Menges, Slovenia; [Cluzeau, Jerome; Orkic, Damir; Casar, Zdenko] Lek Pharmaceut Dd, API Dev, Sandoz Dev Ctr Slovenia, Menges, Slovenia; [Casar, Zdenko] Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia	Novartis; Novartis; Sandoz; University of Ljubljana	Mrak, P (corresponding author), Lek Pharmaceut Dd, Genet, Antiinfect, Menges, Slovenia.	peter.mrak@sandoz.com; zdenko.casar@sandoz.com	Casar, Zdenko/AAJ-1528-2020		Lek pharmaceuticals d.d.a Sandoz company	Lek pharmaceuticals d.d.a Sandoz company	This work nwas funded by Lek pharmaceuticals d.d. a Sandoz company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by Lek pharmaceuticals d.d., a Sandoz company. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The authors of this work are employed by Lek pharmaceuticals d.d., a Sandoz company. The interests of this commercial funder are pursued through the patent applications: WO2008119810 and WO2009092702. The sole purpose of this work is to share the findings obtained during the development of the described process with the scientific community and the publication has no impact on any products; in development or marketed. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaide B, 2008, ANGEW CHEM INT EDIT, V47, P4632, DOI 10.1002/anie.200801231; Almuti K, 2006, INT J CARDIOL, V109, P7, DOI 10.1016/j.ijcard.2005.05.056; BARBAS CF, 1990, J AM CHEM SOC, V112, P2013, DOI 10.1021/ja00161a064; Bersano A, 2008, CURR MED CHEM, V15, P2380, DOI 10.2174/092986708785909139; Bertau M, 2002, CURR ORG CHEM, V6, P987, DOI 10.2174/1385272023373752; Bolt A, 2008, ARCH BIOCHEM BIOPHYS, V474, P318, DOI 10.1016/j.abb.2008.01.005; Brautbar A, 2011, NAT REV CARDIOL, V8, P253, DOI 10.1038/nrcardio.2011.2; Casar Z, 2008, CHEM ABSTR, Patent No. WO 2008119810 A2; Casar Z, 2008, SYNLETT, P2036, DOI 10.1055/s-2008-1077957; Casar Z, 2010, J ORG CHEM, V75, P6681, DOI 10.1021/jo101050z; Casar Z, 2010, CURR ORG CHEM, V14, P816, DOI 10.2174/138527210791111858; Casar Z, 2010, ACTA CHIM SLOV, V57, P66; Casar Z, 2009, SYNLETT, P1144, DOI 10.1055/s-0028-1088152; CHEN LR, 1992, J AM CHEM SOC, V114, P741, DOI 10.1021/ja00028a050; Chiang SM, 2012, ARCH BIOCHEM BIOPHYS, V525, P161, DOI 10.1016/j.abb.2012.02.007; Chuang CY, 2002, CHIRALITY, V14, P151, DOI 10.1002/chir.10050; Clapes P, 2010, CURR OPIN CHEM BIOL, V14, P154, DOI 10.1016/j.cbpa.2009.11.029; CLIVE DLJ, 1988, J AM CHEM SOC, V110, P6914, DOI 10.1021/ja00228a067; Cluzeau J., 2009, PCT Int. Appl., Patent No. [WO2009092702, 2009092702, WO/2009/092702 A2]; Craig EA, 2003, CURR OPIN MICROBIOL, V6, P157, DOI 10.1016/S1369-5274(03)00030-4; Crestia D, 2001, J MOL CATAL B-ENZYM, V11, P207, DOI 10.1016/S1381-1177(00)00074-6; DASGIP Technology, 2002, DASGIP APPL NOT HIGH; de Carvalho CCCR, 2011, BIOTECHNOL ADV, V29, P75, DOI 10.1016/j.biotechadv.2010.09.001; de Maria PD, 2008, ADV SYNTH CATAL, V350, P165, DOI 10.1002/adsc.200700230; Dean SM, 2007, ADV SYNTH CATAL, V349, P1308, DOI 10.1002/adsc.200700115; Ema T, 2008, ADV SYNTH CATAL, V350, P2039, DOI 10.1002/adsc.200800292; ENDO A, 1993, NAT PROD REP, V10, P541, DOI 10.1039/np9931000541; ENDO A, 1976, J ANTIBIOT, V29, P1346, DOI 10.7164/antibiotics.29.1346; ENDO A, 1992, J LIPID RES, V33, P1569; Endo A, 2008, NAT MED, V14, P1050, DOI 10.1038/nm1008-1050; Faber K, 2011, BIOTRANSFORMATIONS O, P9; Fabris J, 2012, SYNTHESIS-STUTTGART, V44, P1700, DOI 10.1055/s-0031-1290916; Franke D, 2004, METHOD ENZYMOL, V388, P224; Fukuda H, 2008, TRENDS BIOTECHNOL, V26, P668, DOI 10.1016/j.tibtech.2008.08.001; GIJSEN HJM, 1995, J AM CHEM SOC, V117, P7585, DOI 10.1021/ja00134a001; Gijsen HJM, 1996, CHEM REV, V96, P443, DOI 10.1021/cr950031q; GIJSEN HJM, 1994, J AM CHEM SOC, V116, P8422, DOI 10.1021/ja00097a082; Greenberg W., 2004, Patent, Patent No. [WO 2004027075, 2004027075, WO 2004/027075 A2]; Greenberg WA, 2004, P NATL ACAD SCI USA, V101, P5788, DOI 10.1073/pnas.0307563101; Groger H, 2007, ADV SYNTH CATAL, V349, P709, DOI 10.1002/adsc.200600606; Guisbert E, 2008, MICROBIOL MOL BIOL R, V72, P545, DOI 10.1128/MMBR.00007-08; Gutsulyak DV, 2012, ADV SYNTH CATAL, V354, P607, DOI 10.1002/adsc.201100693; HABEEB AFS, 1968, ARCH BIOCHEM BIOPHYS, V126, P16, DOI 10.1016/0003-9861(68)90554-7; Heine A, 2004, J MOL BIOL, V343, P1019, DOI 10.1016/j.jmb.2004.08.066; Heine A, 2001, SCIENCE, V294, P369, DOI 10.1126/science.1063601; Hudlicky T, 2009, CHEM SOC REV, V38, P3117, DOI 10.1039/b901172m; Ikunaka M, 2007, ORG PROCESS RES DEV, V11, P495, DOI 10.1021/op050161t; Ishige T, 2005, CURR OPIN CHEM BIOL, V9, P174, DOI 10.1016/j.cbpa.2005.02.001; Istvan ES, 2001, SCIENCE, V292, P1160, DOI 10.1126/science.1059344; Jennewein Stefan, 2006, Biotechnology Journal, V1, P537, DOI 10.1002/biot.200600020; Kidd J, 2006, NAT REV DRUG DISCOV, V5, P813, DOI 10.1038/nrd2156; Kierkels J. G. T., 2003, DSM IP Assets B.V., Patent No. [WO2003/006656A3, 2003006656]; Koeller KM, 2001, NATURE, V409, P232, DOI 10.1038/35051706; Lahera V, 2007, CURR MED CHEM, V14, P243, DOI 10.2174/092986707779313381; lamparuthi E, 2012, SYNTHETIC COMMUN, V35, P2801; LEE TJ, 1985, TETRAHEDRON LETT, V26, P4995, DOI 10.1016/S0040-4039(01)80835-2; Liese A, 1999, CURR OPIN BIOTECH, V10, P595, DOI 10.1016/S0958-1669(99)00040-3; Liljeblad A, 2009, CURR ORG SYNTH, V6, P362, DOI 10.2174/157017909789108738; Ma SK, 2010, GREEN CHEM, V12, P81, DOI 10.1039/b919115c; Machajewski TD, 2000, ANGEW CHEM INT EDIT, V39, P1352, DOI 10.1002/(SICI)1521-3773(20000417)39:8<1352::AID-ANIE1352>3.0.CO;2-J; Matsuyama A, 2002, ORG PROCESS RES DEV, V6, P558, DOI 10.1021/op025514s; Mestres R, 2004, GREEN CHEM, V6, P583, DOI 10.1039/b409143b; Mlynarski J, 2008, CHEM SOC REV, V37, P1502, DOI 10.1039/b710577k; MORI Y, 1990, J CHEM SOC PERK T 1, P1809, DOI 10.1039/p19900001809; Muller M, 2005, ANGEW CHEM INT EDIT, V44, P362, DOI 10.1002/anie.200460852; O'Connor CJ, 1998, AUST J CHEM, V51, P455, DOI 10.1071/C97212; Panke S, 2005, CURR OPIN CHEM BIOL, V9, P188, DOI 10.1016/j.cbpa.2005.02.007; Panke S, 2004, CURR OPIN BIOTECH, V15, P272, DOI 10.1016/j.copbio.2004.06.011; Paraskevas KI, 2007, CURR PHARM DESIGN, V13, P3622, DOI 10.2174/138161207782794194; Park CP, 2010, ORG LETT, V12, P2450, DOI 10.1021/ol1001686; Patel RN, 2002, ENZYME MICROB TECH, V31, P804, DOI 10.1016/S0141-0229(02)00186-2; Pollard DJ, 2007, TRENDS BIOTECHNOL, V25, P66, DOI 10.1016/j.tibtech.2006.12.005; PRAVDIC N, 1971, CARBOHYD RES, V19, P339, DOI 10.1016/S0008-6215(00)86164-9; PRICER WE, 1960, J BIOL CHEM, V235, P1292; RACKER E, 1952, J BIOL CHEM, V196, P347; RAJAGOPAL S, 1992, J MOL CATAL, V75, P199, DOI 10.1016/0304-5102(92)80122-W; Sakuraba H, 2007, APPL ENVIRON MICROB, V73, P7427, DOI 10.1128/AEM.01101-07; Samland AK, 2006, APPL MICROBIOL BIOT, V71, P253, DOI 10.1007/s00253-006-0422-6; Schmid A, 2001, NATURE, V409, P258, DOI 10.1038/35051736; SCHMIDT RR, 1986, TETRAHEDRON LETT, V27, P481, DOI 10.1016/S0040-4039(00)85510-0; Schoemaker HE, 2003, SCIENCE, V299, P1694, DOI 10.1126/science.1079237; Schulze B, 1999, CURR OPIN BIOTECH, V10, P609, DOI 10.1016/S0958-1669(99)00042-7; Schurmann M., 2010, GREEN CHEM PHARM IND, P127; Sharma A., 1999, INTRO FLUORESCENCE S; SHARMA M, 1990, CARBOHYD RES, V198, P205, DOI 10.1016/0008-6215(90)84293-4; Shiloach J, 2005, BIOTECHNOL ADV, V23, P345, DOI 10.1016/j.biotechadv.2005.04.004; Shojaosadati Seyed Abbas, 2008, Iranian Journal of Biotechnology, V6, P63; Steinfeld J.I., 1999, CHEM KINETICS DYNAMI; Straathof AJJ, 2002, CURR OPIN BIOTECH, V13, P548, DOI 10.1016/S0958-1669(02)00360-9; Suau T, 2005, BIOCATAL BIOTRANSFOR, V23, P241, DOI 10.1080/10242420500208720; Suau T, 2009, BIOCATAL BIOTRANSFOR, V27, P136, DOI 10.1080/10242420802607876; Sukumaran J, 2005, CHEM SOC REV, V34, P530, DOI 10.1039/b412490a; Switzer JA, 2006, EXPERT REV NEUROTHER, V6, P192; Tobert JA, 2003, NAT REV DRUG DISCOV, V2, P517, DOI 10.1038/nrd1112; Troiani V, 2011, ORG PROCESS RES DEV, V15, P622, DOI 10.1021/op100341m; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Udovic M, 2011, CHEM ABSTR, Patent No. 2011064249 A1; Vasic-Racki D., 2006, IND BIOTRANSFORMATIO, P1, DOI DOI 10.1002/9783527608188.CH1; Wandrey C, 2000, ORG PROCESS RES DEV, V4, P286, DOI 10.1021/op990101l; Wang AM, 2011, BIORESOURCE TECHNOL, V102, P469, DOI 10.1016/j.biortech.2010.08.048; Whalen LJ, 2006, ALDRICHIM ACTA, V39, P63; WILD R, 1994, TETRAHEDRON-ASYMMETR, V5, P2195, DOI 10.1016/S0957-4166(00)86295-3; Wohlgemuth R, 2009, NEW BIOTECHNOL, V25, P204, DOI 10.1016/j.nbt.2009.01.002; Xiao ZJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008860; Yazbeck DR, 2004, TETRAHEDRON-ASYMMETR, V15, P2757, DOI 10.1016/j.tetasy.2004.07.050; Yoshida Y, 2005, CHEM ABSTR, V143; Yuryev R, 2010, CHEMCATCHEM, V2, P103, DOI 10.1002/cctc.200900126; Zaks A, 2001, CURR OPIN CHEM BIOL, V5, P130, DOI 10.1016/S1367-5931(00)00181-2	108	38	39	2	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62250	10.1371/journal.pone.0062250	http://dx.doi.org/10.1371/journal.pone.0062250			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667462	Green Submitted, Green Published, gold			2022-12-25	WOS:000319654700028
J	Yu, R; Leung, J; Woo, J				Yu, Ruby; Leung, Jason; Woo, Jean			Housework Reduces All-Cause and Cancer Mortality in Chinese Men	PLOS ONE			English	Article							EXERCISE ACTIVITY THERMOGENESIS; PHYSICAL-ACTIVITY; ENERGY-EXPENDITURE; SOCIAL-STATUS; POPULATION; INTENSITY; PATTERNS; HEALTH; WOMEN	Background: Leisure time physical activity has been extensively studied. However, the health benefits of non-leisure time physical activity, particular those undertaken at home on all-cause and cancer mortality are limited, particularly among the elderly. Methods: We studied physical activity in relation to all-cause and cancer mortality in a cohort of 4,000 community-dwelling elderly aged 65 and older. Leisure time physical activity (sport/recreational activity and lawn work/yard care/gardening) and non-leisure time physical activity (housework, home repairs and caring for another person) were self-reported on the Physical Activity Scale for the Elderly. Subjects with heart diseases, stroke, cancer or diabetes at baseline were excluded (n = 1,133). Results: Among the 2,867 subjects with a mean age of 72 years at baseline, 452 died from all-cause and 185 died from cancer during the follow-up period (2001-2012). With the adjustment for age, education level and lifestyle factors, we found an inverse association between risk of all-cause mortality and heavy housework among men, with the adjusted hazard ratio (HR) of 0.72 ( 95%CI = 0.57-0.92). Further adjustment for BMI, frailty index, living arrangement, and leisure time activity did not change the result (HR = 0.71, 95%CI = 0.56-0.91). Among women, however, heavy housework was not associated with all-cause mortality. The risk of cancer mortality was significantly lower among men who participated in heavy housework (HR = 0.52, 95%CI = 0.35-0.78), whereas among women the risk was not significant. Men participated in light housework also were at lower risk of cancer mortality than were their counterparts, however, the association was not significant. Leisure time physical activity was not related to all-cause or cancer mortality in either men or women. Conclusion: Heavy housework is associated with reduced mortality and cancer deaths over a 9-year period. The underlying mechanism needs further study.	[Yu, Ruby; Woo, Jean] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Leung, Jason] Chinese Univ Hong Kong, Jockey Club Ctr Osteoporosis Care & Control, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Yu, R (corresponding author), Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China.	rubyyu@cuhk.edu.hk	Yu, Ruby/N-5006-2015; Woo, Jean/K-2625-2014	Woo, Jean/0000-0001-7593-3081	SH Ho Centre for Gerontology and Geriatrics, Faculty of Medicine, The Chinese University of Hong Kong	SH Ho Centre for Gerontology and Geriatrics, Faculty of Medicine, The Chinese University of Hong Kong	The authors wish to thank Dr. Edith Lau for setting up the elderly cohort and the support from the SH Ho Centre for Gerontology and Geriatrics, Faculty of Medicine, The Chinese University of Hong Kong.	Adler NE, 2000, HEALTH PSYCHOL, V19, P586, DOI 10.1037/0278-6133.19.6.586; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; *AM COLL SPORTS ME, 2009, GUID EX TEST PRESCR; Besson H, 2008, MED SCI SPORT EXER, V40, P1909, DOI 10.1249/MSS.0b013e318180bcad; *CDP SPORTS SCI PH, 2012, HLTH EX ALL CAMP PHY; Centers for Disease Control and Prevention (CDC); National Center for Health Statistics, 2011, DATA2010 HLTH PEOPL; DALLOSSO HM, 1988, J EPIDEMIOL COMMUN H, V42, P121, DOI 10.1136/jech.42.2.121; Dong Linda, 2004, Int J Behav Nutr Phys Act, V1, P4, DOI 10.1186/1479-5868-1-4; Glass TA, 1999, BRIT MED J, V319, P478, DOI 10.1136/bmj.319.7208.478; Goggins WB, 2005, J GERONTOL A-BIOL, V60, P1046, DOI 10.1093/gerona/60.8.1046; Jurj AL, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-213; Lawlor DA, 2002, J EPIDEMIOL COMMUN H, V56, P473, DOI 10.1136/jech.56.6.473; Leitzmann MF, 2007, ARCH INTERN MED, V167, P2453, DOI 10.1001/archinte.167.22.2453; Levine JA, 2006, ARTERIOSCL THROM VAS, V26, P729, DOI 10.1161/01.ATV.0000205848.83210.73; Levine JA, 2002, BEST PRACT RES CL EN, V16, P679, DOI 10.1053/beem.2002.0227; Lin YP, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-428; Lollgen H, 2009, INT J SPORTS MED, V30, P213, DOI 10.1055/s-0028-1128150; Manini TM, 2006, JAMA-J AM MED ASSOC, V296, P171, DOI 10.1001/jama.296.2.171; Matthews CE, 2007, AM J EPIDEMIOL, V165, P1343, DOI 10.1093/aje/kwm088; Mitnitski A B, 2001, ScientificWorldJournal, V1, P323; Moore SC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001335; Morley JE, 2009, CURR PHARM DESIGN, V15, P3384, DOI 10.2174/138161209789105045; Moschny A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-559; Sabia S, 2012, AM J PUBLIC HEALTH, V102, P698, DOI 10.2105/AJPH.2011.300257; Scott J, 2012, GENDERED LIVES: GENDER INEQUALITIES IN PRODUCTION AND REPRODUCTION, P1; Stamatakis E, 2009, AM J EPIDEMIOL, V169, P1191, DOI 10.1093/aje/kwp042; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4; Weller I, 1998, EPIDEMIOLOGY, V9, P632, DOI 10.1097/00001648-199811000-00012; Wen CP, 2011, LANCET, V378, P1244, DOI 10.1016/S0140-6736(11)60749-6; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Woo J, 2008, WOMEN HEALTH, V48, P209, DOI 10.1080/03630240802313563; Woo J, 2012, J AM GERIATR SOC, V60, P1478, DOI 10.1111/j.1532-5415.2012.04074.x	32	28	30	7	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e61529	10.1371/journal.pone.0061529	http://dx.doi.org/10.1371/journal.pone.0061529			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	154EP	23667441	Green Submitted, Green Published, gold			2022-12-25	WOS:000319654700014
J	Devambez, I; Agha, MA; Mitri, C; Bockaert, J; Parmentier, ML; Marion-Poll, F; Grau, Y; Soustelle, L				Devambez, Isabelle; Agha, Moutaz Ali; Mitri, Christian; Bockaert, Joel; Parmentier, Marie-Laure; Marion-Poll, Frederic; Grau, Yves; Soustelle, Laurent			G alpha o Is Required for L-Canavanine Detection in Drosophila	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; CANDIDATE TASTE RECEPTORS; 2ND INTRACELLULAR LOOP; GUSTATORY RECEPTORS; MULTIPLE RECEPTORS; SUGAR PERCEPTION; UMAMI TASTE; G-PROTEINS; TRANSDUCTION; MELANOGASTER	Taste is an essential sense for the survival of most organisms. In insects, taste is particularly important as it allows to detect and avoid ingesting many plant toxins, such as L-canavanine. We previously showed that L-canavanine is toxic for Drosophila melanogaster and that flies are able to detect this toxin in the food. L-canavanine is a ligand of DmXR, a variant G-protein coupled receptor (GPCR) belonging to the metabotropic glutamate receptor subfamily that is expressed in bitter-sensitive taste neurons of Drosophila. To transduce the signal intracellularly, GPCR activate heterotrimeric G proteins constituted of alpha, beta and gamma subunits. The aim of this study was to identify which G alpha protein was required for L-canavanine detection in Drosophila. By using a pharmacological approach, we first demonstrated that DmXR has the best coupling with G alpha(o) protein subtype. Then, by using genetic, behavioral assays and electrophysiology, we found that G alpha o47A is required in bitter-sensitive taste neurons for L-canavanine sensitivity. In conclusion, our study revealed that G alpha o47A plays a crucial role in L-canavanine detection.	[Devambez, Isabelle; Bockaert, Joel; Parmentier, Marie-Laure; Grau, Yves; Soustelle, Laurent] CNRS, Inst Genom Fonctionnelle, UMR 5203, Montpellier, France; [Devambez, Isabelle; Bockaert, Joel; Parmentier, Marie-Laure; Grau, Yves; Soustelle, Laurent] INSERM, U661, Montpellier, France; [Devambez, Isabelle; Bockaert, Joel; Parmentier, Marie-Laure; Grau, Yves; Soustelle, Laurent] Univ Montpellier I, Montpellier, France; [Devambez, Isabelle; Bockaert, Joel; Parmentier, Marie-Laure; Grau, Yves; Soustelle, Laurent] Univ Montpellier 2, UMR 5203, Montpellier, France; [Agha, Moutaz Ali; Marion-Poll, Frederic] INRA, UMR 1272, F-78026 Versailles, France; [Agha, Moutaz Ali; Marion-Poll, Frederic] Univ Paris 06, UMR Physiol Insecte 1272, Versailles, France; [Agha, Moutaz Ali; Marion-Poll, Frederic] AgroParisTech, Dept Sci Vie & Sante, Paris, France; [Mitri, Christian] Inst Pasteur, CNRS, URA3012, Unite Genet & Genom Insectes Vecteurs, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; INRAE; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Soustelle, L (corresponding author), CNRS, Inst Genom Fonctionnelle, UMR 5203, Montpellier, France.	Laurent.Soustelle@igf.cnrs.fr	Parmentier, Marie-Laure/N-9915-2017; Frederic, Marion-Poll/I-1358-2019	Parmentier, Marie-Laure/0000-0001-6133-3413; Frederic, Marion-Poll/0000-0001-6824-0180; Soustelle, Laurent/0000-0003-1034-2955; Mitri, Christian/0000-0003-3882-2029	French Ministry of Research and Technology; Syrian government	French Ministry of Research and Technology; Syrian government	ID was supported by a fellowship from the French Ministry of Research and Technology. MAA was funded by a grant from the Syrian government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bessis AS, 2002, P NATL ACAD SCI USA, V99, P11097, DOI 10.1073/pnas.162138699; Bredendiek N, 2011, CHEM SENSES, V36, P69, DOI 10.1093/chemse/bjq100; Cabrera-Vera TM, 2003, ENDOCR REV, V24, P765, DOI 10.1210/er.2000-0026; Cameron P, 2010, NATURE, V465, P91, DOI 10.1038/nature09011; Chen ZJ, 2010, J NEUROSCI, V30, P6247, DOI 10.1523/JNEUROSCI.0627-10.2010; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Dethier VG, 1976, HUNGRY FLY; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; Ferris J, 2006, NAT NEUROSCI, V9, P1036, DOI 10.1038/nn1738; Giannone F, 2010, J MOL ENDOCRINOL, V44, P259, DOI 10.1677/JME-09-0134; Gomeza J, 1996, J BIOL CHEM, V271, P2199, DOI 10.1074/jbc.271.4.2199; Hiroi M, 2002, ZOOL SCI, V19, P1009, DOI 10.2108/zsj.19.1009; Ishimoto H, 2005, EMBO J, V24, P3259, DOI 10.1038/sj.emboj.7600796; Jiao YC, 2008, CURR BIOL, V18, P1797, DOI 10.1016/j.cub.2008.10.009; Kain P, 2010, CHEM SENSES, V35, P663, DOI 10.1093/chemse/bjq055; Kang K, 2010, NATURE, V464, P597, DOI 10.1038/nature08848; Katanaev VL, 2005, CELL, V120, P111, DOI 10.1016/j.cell.2004.11.014; Lee Y, 2012, J NEUROSCI, V32, P1429, DOI 10.1523/JNEUROSCI.4630-11.2012; Lee Y, 2010, NEURON, V67, P555, DOI 10.1016/j.neuron.2010.07.006; Liman E. R., 2007, V179, P287; Liu L, 2003, NEURON, V39, P133, DOI 10.1016/S0896-6273(03)00394-5; MarionPoll F, 1996, ENTOMOL EXP APPL, V80, P113, DOI 10.1007/BF00194738; MarionPoll F, 1996, ENTOMOL EXP APPL, V80, P116, DOI 10.1007/BF00194739; Milligan G, 2006, BRIT J PHARMACOL, V147, pS46, DOI 10.1038/sj.bjp.0706405; Milligan G, 1996, TRENDS PHARMACOL SCI, V17, P235, DOI 10.1016/0165-6147(96)10026-2; Mitri C, 2004, J BIOL CHEM, V279, P9313, DOI 10.1074/jbc.M310878200; Mitri C, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000147; Miyamoto T, 2008, NAT NEUROSCI, V11, P874, DOI 10.1038/nn.2161; Moon SJ, 2006, CURR BIOL, V16, P1812, DOI 10.1016/j.cub.2006.07.024; Moon SJ, 2009, CURR BIOL, V19, P1623, DOI 10.1016/j.cub.2009.07.061; MOSS J, 1988, ADV ENZYMOL RAMB, V61, P303; Ouyang Q, 2009, COMP BIOCHEM PHYS A, V153, P309, DOI 10.1016/j.cbpa.2009.03.004; Parmentier ML, 2000, NEUROPHARMACOLOGY, V39, P1119, DOI 10.1016/S0028-3908(99)00204-X; PIN JP, 1995, CURR OPIN NEUROBIOL, V5, P342, DOI 10.1016/0959-4388(95)80047-6; PIN JP, 1995, BIOCHEM SOC T, V23, P91, DOI 10.1042/bst0230091; PROVOST NM, 1988, J BIOL CHEM, V263, P12070; Rosenthal GA, 2001, AMINO ACIDS, V21, P319, DOI 10.1007/s007260170017; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Sato K, 2011, P NATL ACAD SCI USA, V108, P11680, DOI 10.1073/pnas.1019622108; Simon SA, 2006, NAT REV NEUROSCI, V7, P890, DOI 10.1038/nrn2006; Ueno K, 2006, J NEUROSCI, V26, P6143, DOI 10.1523/JNEUROSCI.0857-06.2006; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Watanabe K, 2011, BEHAV GENET, V41, P746, DOI 10.1007/s10519-011-9461-6; Weiss LA, 2011, NEURON, V69, P258, DOI 10.1016/j.neuron.2011.01.001; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Yarmolinsky DA, 2009, CELL, V139, P234, DOI 10.1016/j.cell.2009.10.001; Yasumatsu K, 2012, J PHYSIOL-LONDON, V590, P1155, DOI 10.1113/jphysiol.2011.211920; Yasumatsu K, 2009, AM J CLIN NUTR, V90, p747S, DOI 10.3945/ajcn.2009.27462J; Zhang HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024111; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	52	12	12	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e63484	10.1371/journal.pone.0063484	http://dx.doi.org/10.1371/journal.pone.0063484			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671680	gold, Green Published, Green Submitted			2022-12-25	WOS:000321390200050
J	Fekete, T; Wilf, M; Rubin, D; Edelman, S; Malach, R; Mujica-Parodi, LR				Fekete, Tomer; Wilf, Meytal; Rubin, Denis; Edelman, Shimon; Malach, Rafael; Mujica-Parodi, Lilianne R.			Combining Classification with fMRI-Derived Complex Network Measures for Potential Neurodiagnostics	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; BRAIN NETWORKS; EEG; SCHIZOPHRENIA; COHERENCE; HEALTH	Complex network analysis (CNA), a subset of graph theory, is an emerging approach to the analysis of functional connectivity in the brain, allowing quantitative assessment of network properties such as functional segregation, integration, resilience, and centrality. Here, we show how a classification framework complements complex network analysis by providing an efficient and objective means of selecting the best network model characterizing given functional connectivity data. We describe a novel kernel-sum learning approach, block diagonal optimization (BDopt), which can be applied to CNA features to single out graph-theoretic characteristics and/or anatomical regions of interest underlying discrimination, while mitigating problems of multiple comparisons. As a proof of concept for the method's applicability to future neurodiagnostics, we apply BDopt classification to two resting state fMRI data sets: a trait (between-subjects) classification of patients with schizophrenia vs. controls, and a state (within-subjects) classification of wake vs. sleep, demonstrating powerful discriminant accuracy for the proposed framework.	[Fekete, Tomer; Rubin, Denis; Mujica-Parodi, Lilianne R.] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA; [Wilf, Meytal; Malach, Rafael] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Edelman, Shimon] Cornell Univ, Dept Psychol, Ithaca, NY 14853 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Weizmann Institute of Science; Cornell University	Mujica-Parodi, LR (corresponding author), SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA.	lmujicaparodi@gmail.com		Rubin, Denis/0000-0002-0483-9458; Mujica-Parodi, Lilianne Rivka/0000-0002-3752-5519; Fekete, Tomer/0000-0003-3164-125X; Wilf, Meytal/0000-0002-4037-8505	Office of Naval Research [N000140410051]; National Science Foundation [0954643]; Div Of Chem, Bioeng, Env, & Transp Sys [0954643, 1141995] Funding Source: National Science Foundation	Office of Naval Research(Office of Naval Research); National Science Foundation(National Science Foundation (NSF)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This research was supported by the Office of Naval Research, Grant #N000140410051 (LRMP) and the National Science Foundation, Grant #0954643 (LRMP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Anand A, 2005, NEUROPSYCHOPHARMACOL, V30, P1334, DOI 10.1038/sj.npp.1300725; [Anonymous], NEUROIMAGE; [Anonymous], J NEUROSCIENCE METHO; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Bassett DS, 2009, CURR OPIN NEUROL, V22, P340, DOI 10.1097/WCO.0b013e32832d93dd; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Chang C.-C., 2011, ACM T INTEL SYST TEC, V2, P1, DOI [10.1145/1961189.1961199, DOI 10.1145/1961189.1961199]; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Fan JQ, 2008, ANN STAT, V36, P2605, DOI 10.1214/07-AOS504; Fekete T, 2009, J COMPUT NEUROSCI, V27, P211, DOI 10.1007/s10827-009-0138-6; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Friston KJ, 1995, HUM BRAIN MAPP, V3, P56, DOI 10.1002/hbm.460030106; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Iturria-Medina Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019071; Jeong J, 2001, CLIN NEUROPHYSIOL, V112, P827, DOI 10.1016/S1388-2457(01)00513-2; Lanckriet GRG, 2004, J MACH LEARN RES, V5, P27; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Leung CC, 2007, PHYSICA A, V378, P591, DOI 10.1016/j.physa.2006.12.022; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lord A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041282; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Massimini M, 2005, SCIENCE, V309, P2228, DOI 10.1126/science.1117256; Massimini M, 2010, COGN NEUROSCI-UK, V1, P176, DOI 10.1080/17588921003731578; Murias M, 2007, BIOL PSYCHIAT, V62, P270, DOI 10.1016/j.biopsych.2006.11.012; Na SH, 2002, CLIN NEUROPHYSIOL, V113, P1954, DOI 10.1016/S1388-2457(02)00197-9; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Nyssen E., 1998, Advances in Pattern Recognition. Joint IAPR International Workshops SSPR'98 and SPR'98. Proceedings, P890, DOI 10.1007/BFb0033316; Power JD, 2011, NEUROIMAGE; Radulescu AR, 2008, NEUROPSYCHOBIOLOGY, V57, P206, DOI 10.1159/000151731; Rissman J, 2004, NEUROIMAGE, V23, P752, DOI 10.1016/j.neuroimage.2004.06.035; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Salomon R, 2011, J NEUROSCI, V31, P12972, DOI 10.1523/JNEUROSCI.2987-11.2011; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Siegle GJ, 2007, BIOL PSYCHIAT, V61, P198, DOI 10.1016/j.biopsych.2006.05.048; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Spoormaker VI, 2010, J NEUROSCI, V30, P11379, DOI 10.1523/JNEUROSCI.2015-10.2010; Sun FT, 2004, NEUROIMAGE, V21, P647, DOI 10.1016/j.neuroimage.2003.09.056; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2010, J NEUROSCI, V30, P15915, DOI 10.1523/JNEUROSCI.2874-10.2010; Wang LA, 2010, J NEUROSCI, V30, P13171, DOI 10.1523/JNEUROSCI.3514-10.2010; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zhang JR, 2011, BIOL PSYCHIAT, V70, P334, DOI 10.1016/j.biopsych.2011.05.018	47	33	33	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e62867	10.1371/journal.pone.0062867	http://dx.doi.org/10.1371/journal.pone.0062867			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671641	Green Submitted, gold, Green Published			2022-12-25	WOS:000321390200039
J	Kristensen, NP; De Barro, PJ; Schellhorn, NA				Kristensen, Nadiah P.; De Barro, Paul J.; Schellhorn, Nancy A.			The Initial Dispersal and Spread of an Intentional Invader at Three Spatial Scales	PLOS ONE			English	Article							LONG-DISTANCE DISPERSAL; TABACI GENNADIUS HEMIPTERA; BIOLOGICAL-CONTROL AGENT; BEMISIA-TABACI; ERETMOCERUS-EREMICUS; HYMENOPTERA-APHELINIDAE; GONATOCERUS-ASHMEADI; ENCARSIA-FORMOSA; FLIGHT BEHAVIOR; INVASION	The way an invasion progresses through space is a theme of interest common to invasion ecology and biological pest control. Models and mark-release studies of arthropods have been used extensively to extend and inform invasion processes of establishment and spread. However, the extremely common single-scale approach of monitoring initial spread leads to misinterpretation of rate and mode. Using the intentional release of a novel biological control agent (a parasitic hymenoptera, Eretmocerus hayati Zolnerowich & Rose (Hymenoptera: Aphelinidae), we studied its initial dispersal and spread at three different spatial scales, the local scale (tens of metres), field scale (hundreds of metres) and landscape scale (kilometres) around the release point. We fit models to each observed spread pattern at each spatial scale. We show that E. hayati exhibits stratified dispersal; moving further, faster and by a different mechanism than would have been concluded with a single local-scale post-release sampling design. In fact, interpretation of each scale independent of other scales gave three different models of dispersal, and three different impressions of the dominant dispersal mechanisms. Our findings demonstrate that using a single-scale approach may lead to quite erroneous conclusions, hence the necessity of using a multiple-scale hierarchical sampling design for inferring spread and the dominant dispersal mechanism of either human intended or unintended invasions.	[Kristensen, Nadiah P.; De Barro, Paul J.; Schellhorn, Nancy A.] Commonwealth Sci & Ind Res Org, Brisbane, Qld, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Schellhorn, NA (corresponding author), Commonwealth Sci & Ind Res Org, Brisbane, Qld, Australia.	nancy.schellhorn@csiro.au	Schellhorn, Nancy/B-6716-2009; De Barro, Paul J/C-1724-2008		Horticulture Australia from the vegetable industry levy; Australian Government	Horticulture Australia from the vegetable industry levy; Australian Government(Australian GovernmentCGIAR)	The project was funded by Horticulture Australia from the vegetable industry levy and matched funds from the Australian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTOLIN MF, 1987, OECOLOGIA, V73, P288, DOI 10.1007/BF00377520; Asplen MK, 2009, PHYSIOL ENTOMOL, V34, P350, DOI 10.1111/j.1365-3032.2009.00698.x; Bellamy DE, 2001, ECOL ENTOMOL, V26, P571, DOI 10.1046/j.1365-2311.2001.00370.x; BLACKMER JL, 1993, PHYSIOL ENTOMOL, V18, P223, DOI 10.1111/j.1365-3032.1993.tb00592.x; Blackmer JL, 2001, ENTOMOL EXP APPL, V100, P295, DOI 10.1023/A:1019278205175; BLACKMER JL, 1993, PHYSIOL ENTOMOL, V18, P336, DOI 10.1111/j.1365-3032.1993.tb00606.x; Bled F, 2011, ECOL APPL, V21, P290, DOI 10.1890/09-1877.1; Brewster CC, 1997, ENVIRON ENTOMOL, V26, P473, DOI 10.1093/ee/26.3.473; Brewster CC, 1997, ENVIRON ENTOMOL, V26, P603, DOI 10.1093/ee/26.3.603; Byrne D, 2001, 148 NCR; Chauzat MP, 2002, ANN APPL BIOL, V141, P293, DOI 10.1111/j.1744-7348.2002.tb00221.x; CHEEK S, 1994, PESTIC SCI, V42, P135, DOI 10.1002/ps.2780420211; De Barro PJ, 2009, B ENTOMOL RES, V99, P193, DOI 10.1017/S0007485308006445; De Barro PJ, 2000, AUST J ENTOMOL, V39, P259, DOI 10.1046/j.1440-6055.2000.00194.x; De Barro PJ, 2001, ENTOMOL EXP APPL, V99, P225, DOI 10.1046/j.1570-7458.2001.00821.x; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; Ehler LE, 1998, BIOL CONTROL, V13, P127, DOI 10.1006/bcon.1998.0649; Elzinga JA, 2007, BASIC APPL ECOL, V8, P75, DOI 10.1016/j.baae.2006.04.003; Fagan WF, 2002, ECOL LETT, V5, P148, DOI 10.1046/j.1461-0248.2002.0_285.x; Fauvergue X, 2009, POPUL ECOL, V51, P385, DOI 10.1007/s10144-009-0147-3; Ferguson CM, 1997, PROCEEDINGS OF THE FIFTIETH NEW ZEALAND PLANT PROTECTION CONFERENCE, P41, DOI 10.30843/nzpp.1997.50.11274; FREEMAN JA, 1945, J ANIM ECOL, V14, P128, DOI 10.2307/1389; Gerling D, 1998, BIOCONTROL, V43, P289, DOI 10.1023/A:1009905525300; Gilbert M, 2004, J ANIM ECOL, V73, P459, DOI 10.1111/j.0021-8790.2004.00820.x; Glick PA, 1939, DISTRIBUTION INSECTS; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; Grillenberger BK, 2009, ENTOMOL EXP APPL, V132, P147, DOI 10.1111/j.1570-7458.2009.00881.x; GUNNING RV, 1995, J AUST ENTOMOL SOC, V34, P116; Hastings A, 2005, ECOL LETT, V8, P91, DOI 10.1111/j.1461-0248.2004.00687.x; Hastings A, 2000, PARASITOID POPULATION BIOLOGY, P70; Havel JE, 2006, BIOL INVASIONS, V8, P459, DOI 10.1007/s10530-005-6410-4; Hirose Y, 2009, APPL ENTOMOL ZOOL, V44, P175, DOI 10.1303/aez.2009.175; Ims Rolf A., 2001, P203; KAREIVA PM, 1983, OECOLOGIA, V57, P322, DOI 10.1007/BF00377175; Koch FH, 2012, J ECON ENTOMOL, V105, P438, DOI 10.1603/EC11270; Kot M, 1996, ECOLOGY, V77, P2027, DOI 10.2307/2265698; Kristensen N, ENV ENTOM UNPUB; LeBrun EG, 2008, BIOL INVASIONS, V10, P989, DOI 10.1007/s10530-007-9177-y; LIEBHOLD AM, 1992, J BIOGEOGR, V19, P513, DOI 10.2307/2845770; Liebhold AM, 2008, ANNU REV ENTOMOL, V53, P387, DOI 10.1146/annurev.ento.52.110405.091401; MCCLURE MS, 1990, ENVIRON ENTOMOL, V19, P36, DOI 10.1093/ee/19.1.36; Moiroux J, 2010, ECOL ENTOMOL, V35, P727, DOI 10.1111/j.1365-2311.2010.01233.x; Nathan R, 2005, DIVERS DISTRIB, V11, P125, DOI 10.1111/j.1366-9516.2005.00159.x; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Pauchard A, 2006, BIOL INVASIONS, V8, P399, DOI 10.1007/s10530-005-6419-8; PERRY JN, 1995, J ANIM ECOL, V64, P303, DOI 10.2307/5892; Perry JN, 2002, ECOSCIENCE, V9, P133, DOI 10.1080/11956860.2002.11682699; Perry JN, 1999, ECOL LETT, V2, P106, DOI 10.1046/j.1461-0248.1999.22057.x; Petit JN, 2008, BIOL CONTROL, V45, P344, DOI 10.1016/j.biocontrol.2008.01.020; Petit JN, 2009, BIOCONTROL, V54, P485, DOI 10.1007/s10526-008-9204-7; Puth LM, 2005, ECOL LETT, V8, P715, DOI 10.1111/j.1461-0248.2005.00774.x; Qiu YT, 2004, EUR J ENTOMOL, V101, P83, DOI 10.14411/eje.2004.017; Shea K, 2000, J APPL ECOL, V37, P77, DOI 10.1046/j.1365-2664.2000.00467.x; Shigesada N, 1997, BIOL INVASIONS THEOR; Simmons GS, 2000, THESIS U ARIZONA TUC; Suarez AV, 2001, P NATL ACAD SCI USA, V98, P1095, DOI 10.1073/pnas.98.3.1095; Turchin Peter, 1998; Venette RC, 2004, ANN ENTOMOL SOC AM, V97, P219, DOI 10.1603/0013-8746(2004)097[0219:ATIBSA]2.0.CO;2; Villanueva-Jimenez JA, 2012, BIOL CONTROL, V63, P333, DOI 10.1016/j.biocontrol.2012.09.002; WIENS JA, 1993, OIKOS, V66, P369, DOI 10.2307/3544931; Williamson M., 1996, BIOL INVASIONS; With KA, 2002, CONSERV BIOL, V16, P1192, DOI 10.1046/j.1523-1739.2002.01064.x; Wright MG, 2001, BIOL CONTROL, V22, P29, DOI 10.1006/bcon.2001.0948	63	14	14	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e62407	10.1371/journal.pone.0062407	http://dx.doi.org/10.1371/journal.pone.0062407			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671595	Green Published, Green Submitted, gold			2022-12-25	WOS:000321390200022
J	Covey, DP; Juliano, SA; Garris, PA				Covey, Dan P.; Juliano, Steven A.; Garris, Paul A.			Amphetamine Elicits Opposing Actions on Readily Releasable and Reserve Pools for Dopamine	PLOS ONE			English	Article							VESICULAR MONOAMINE TRANSPORTER-2; MEDIAL FOREBRAIN-BUNDLE; RAT NUCLEUS-ACCUMBENS; FREELY MOVING RATS; EXTRACELLULAR DOPAMINE; UPTAKE INHIBITORS; CAUDATE-PUTAMEN; INVIVO VOLTAMMETRY; STIMULATED RELEASE; SYNAPTIC VESICLES	Amphetamine, a highly addictive drug with therapeutic efficacy, exerts paradoxical effects on the fundamental communication modes employed by dopamine neurons in modulating behavior. While amphetamine elevates tonic dopamine signaling by depleting vesicular stores and driving non-exocytotic release through reverse transport, this psychostimulant also activates phasic dopamine signaling by up-regulating vesicular dopamine release. We hypothesized that these seemingly incongruent effects arise from amphetamine depleting the reserve pool and enhancing the readily releasable pool. This novel hypothesis was tested using in vivo voltammetry and stimulus trains of varying duration to access different vesicular stores. We show that amphetamine actions are stimulus dependent in the dorsal striatum. Specifically, amphetamine up-regulated vesicular dopamine release elicited by a short-duration train, which interrogates the readily releasable pool, but depleted release elicited by a long-duration train, which interrogates the reserve pool. These opposing actions of vesicular dopamine release were associated with concurrent increases in tonic and phasic dopamine responses. A link between vesicular depletion and tonic signaling was supported by results obtained for amphetamine in the ventral striatum and cocaine in both striatal sub-regions, which demonstrated augmented vesicular release and phasic signals only. We submit that amphetamine differentially targeting dopamine stores reconciles the paradoxical activation of tonic and phasic dopamine signaling. Overall, these results further highlight the unique and region-distinct cellular mechanisms of amphetamine and may have important implications for its addictive and therapeutic properties.	[Covey, Dan P.; Juliano, Steven A.; Garris, Paul A.] Illinois State Univ, Sch Biol Sci, Normal, IL 61761 USA	Illinois State University	Garris, PA (corresponding author), Illinois State Univ, Sch Biol Sci, Normal, IL 61761 USA.	pagarri@ilstu.edu	Covey, Dan/Y-6333-2019	Juliano, Steven/0000-0002-6178-4553	National Science Foundation [DBI-0754615]; National Institutes of Health (NIH) [DA 021770]; Weigel grant through Phi Sigma at Illinois State University; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA021770] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Weigel grant through Phi Sigma at Illinois State University; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Science Foundation DBI-0754615 (http://www.nsf.gov/) and National Institutes of Health (NIH) DA 021770 (http://www.nih.gov/). DPC was also supported through a Weigel grant through Phi Sigma at Illinois State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BB, 1998, BRAIN RES, V788, P294, DOI 10.1016/S0006-8993(98)00040-7; Aragona BJ, 2008, J NEUROSCI, V28, P8821, DOI 10.1523/JNEUROSCI.2225-08.2008; Avelar AJ, 2013, J NEUROCHEM IN PRESS; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; BENWELL MEM, 1993, PSYCHOPHARMACOLOGY, V112, P467, DOI 10.1007/BF02244896; Borland LM, 2005, J NEUROSCI METH, V146, P149, DOI 10.1016/j.jneumeth.2005.02.002; BOWYER JF, 1987, J PHARMACOL EXP THER, V240, P177; CARBONI E, 1989, NEUROSCIENCE, V28, P653, DOI 10.1016/0306-4522(89)90012-2; CASS WA, 1992, J NEUROCHEM, V59, P259, DOI 10.1111/j.1471-4159.1992.tb08899.x; Cheer JF, 2005, P NATL ACAD SCI USA, V102, P19150, DOI 10.1073/pnas.0509607102; Cheer JF, 2007, J NEUROSCI, V27, P791, DOI 10.1523/JNEUROSCI.4152-06.2007; CHEN GY, 1995, BRAIN RES, V701, P167, DOI 10.1016/0006-8993(95)00989-9; Daberkow DP, 2013, J NEUROSCI, V33, P452, DOI 10.1523/JNEUROSCI.2136-12.2013; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; DUGAST C, 1994, NEUROSCIENCE, V62, P647, DOI 10.1016/0306-4522(94)90466-9; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; EWING AG, 1983, SCIENCE, V221, P169, DOI 10.1126/science.6857277; Fleckenstein AE, 2007, ANNU REV PHARMACOL, V47, P681, DOI 10.1146/annurev.pharmtox.47.120505.105140; Fleckenstein AE, 2009, NEUROPHARMACOLOGY, V56, P133, DOI 10.1016/j.neuropharm.2008.07.002; Floor E, 1996, NEUROSCI LETT, V215, P53, DOI 10.1016/S0304-3940(96)12963-3; Hermans A, 2008, ANAL CHEM, V80, P4040, DOI 10.1021/ac800108j; Hondebrink L, 2009, J NEUROCHEM, V111, P624, DOI 10.1111/j.1471-4159.2009.06357.x; Howell LL, 2008, BIOCHEM PHARMACOL, V75, P196, DOI 10.1016/j.bcp.2007.08.003; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Ingram SL, 2002, NAT NEUROSCI, V5, P971, DOI 10.1038/nn920; John CE, 2007, NEUROPHARMACOLOGY, V52, P1596, DOI 10.1016/j.neuropharm.2007.03.004; Jones SR, 1998, J NEUROSCI, V18, P1979; JONES SR, 1995, J PHARMACOL EXP THER, V274, P396; Keithley RB, 2011, ACS CHEM NEUROSCI, V2, P514, DOI 10.1021/cn200035u; KELLAND MD, 1990, SYNAPSE, V6, P207, DOI 10.1002/syn.890060213; Kile BM, 2010, J NEUROSCI, V30, P9762, DOI 10.1523/JNEUROSCI.2071-09.2010; Koulchitsky S, 2012, NEUROPSYCHOPHARMACOL, V37, P1559, DOI 10.1038/npp.2011.339; KUCZENSKI R, 1975, NEUROPHARMACOLOGY, V14, P1, DOI 10.1016/0028-3908(75)90060-X; KUCZENSKI R, 1991, J NEUROSCI, V11, P2703; Kuczenski R, 1997, J PHARMACOL EXP THER, V282, P591; KUHR WG, 1985, J PHARMACOL EXP THER, V232, P388; KUHR WG, 1986, J NEUROSCI, V6, P974; KUHR WG, 1987, BRAIN RES, V418, P122, DOI 10.1016/0006-8993(87)90968-1; Lee TH, 2001, SYNAPSE, V41, P301, DOI 10.1002/syn.1087; LEW R, 1992, BRAIN RES, V584, P266, DOI 10.1016/0006-8993(92)90905-O; MARSHALL JF, 1990, NEUROSCIENCE, V37, P11, DOI 10.1016/0306-4522(90)90187-9; MAY LJ, 1988, J NEUROCHEM, V51, P1060, DOI 10.1111/j.1471-4159.1988.tb03069.x; MICHAEL AC, 1987, BRAIN RES, V421, P325, DOI 10.1016/0006-8993(87)91302-3; MICHAEL AC, 1987, NEUROSCI LETT, V76, P81, DOI 10.1016/0304-3940(87)90196-0; Michael D, 1998, ANAL CHEM, V70; Montague PR, 2004, J NEUROSCI, V24, P1754, DOI 10.1523/JNEUROSCI.4279-03.2004; Mosharov EV, 2003, J NEUROSCI, V23, P5835; Mundorf ML, 1999, J NEUROCHEM, V73, P2397, DOI 10.1046/j.1471-4159.1999.0732397.x; NOMIKOS GG, 1990, SYNAPSE, V6, P106, DOI 10.1002/syn.890060113; Oleson EB, 2009, NEUROSCI LETT, V467, P144, DOI 10.1016/j.neulet.2009.10.025; Owesson-White CA, 2012, J NEUROCHEM, V121, P252, DOI 10.1111/j.1471-4159.2012.07677.x; Paladini CA, 2001, NAT NEUROSCI, V4, P275, DOI 10.1038/85124; Patel J, 2003, J NEUROCHEM, V85, P898, DOI 10.1046/j.1471-4159.2003.01732.x; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; Ramsson ES, 2011, J NEUROCHEM, V119, P1162, DOI 10.1111/j.1471-4159.2011.07407.x; Ramsson ES, 2011, J NEUROCHEM, V117, P937, DOI 10.1111/j.1471-4159.2011.07258.x; Riddle EL, 2007, EUR J PHARMACOL, V571, P25, DOI 10.1016/j.ejphar.2007.05.044; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Robinson DL, 2008, CHEM REV, V108, P2554, DOI 10.1021/cr068081q; Robinson DL, 2009, ALCOHOL CLIN EXP RES, V33, P1187, DOI 10.1111/j.1530-0277.2009.00942.x; Schmitz Y, 2001, J NEUROSCI, V21, P5916, DOI 10.1523/JNEUROSCI.21-16-05916.2001; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Scorza MC, 1997, BIOCHEM PHARMACOL, V54, P1361, DOI 10.1016/S0006-2952(97)00405-X; Shi WX, 2000, J NEUROSCI, V20, P3504, DOI 10.1523/JNEUROSCI.20-09-03504.2000; Sitte HH, 1998, J NEUROCHEM, V71, P1289; STAMFORD JA, 1986, NEUROSCI LETT, V69, P70, DOI 10.1016/0304-3940(86)90416-7; Stuber GD, 2005, NEUROPSYCHOPHARMACOL, V30, P853, DOI 10.1038/sj.npp.1300619; SULZER D, 1995, J NEUROSCI, V15, P4102; Sulzer D, 2011, NEURON, V69, P628, DOI 10.1016/j.neuron.2011.02.010; Venton BJ, 2006, J NEUROSCI, V26, P3206, DOI 10.1523/JNEUROSCI.4901-04.2006; Venton BJ, 2003, J NEUROCHEM, V87, P1284, DOI 10.1046/j.1471-4159.2003.02109.x; Volkow ND, 2011, P NATL ACAD SCI USA, V108, P15037, DOI 10.1073/pnas.1010654108; Volz TJ, 2007, J PHARMACOL EXP THER, V323, P738, DOI 10.1124/jpet.107.126888; WESTERINK BHC, 1987, N-S ARCH PHARMACOL, V336, P502, DOI 10.1007/BF00169306; Wiecki TV, 2010, PROG BRAIN RES, V183, P275, DOI 10.1016/S0079-6123(10)83014-6; Wightman RM, 2007, EUR J NEUROSCI, V26, P2046, DOI 10.1111/j.1460-9568.2007.05772.x; WIGHTMAN RM, 1988, NEUROSCIENCE, V25, P513, DOI 10.1016/0306-4522(88)90255-2; Wu Q, 2001, J NEUROSCI METH, V112, P119, DOI 10.1016/S0165-0270(01)00459-9; Wu Q, 2001, J NEUROSCI, V21, P6338, DOI 10.1523/JNEUROSCI.21-16-06338.2001; Yavich L, 2000, BRAIN RES, V870, P73, DOI 10.1016/S0006-8993(00)02403-3	80	30	30	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e60763	10.1371/journal.pone.0060763	http://dx.doi.org/10.1371/journal.pone.0060763			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23671560	Green Published, Green Submitted, gold			2022-12-25	WOS:000321202100001
J	Dutta, S; Dattagupta, JK; Biswas, S				Dutta, Sruti; Dattagupta, Jiban Kanti; Biswas, Sampa			Enhancement of Proteolytic Activity of a Thermostable Papain-Like Protease by Structure-Based Rational Design	PLOS ONE			English	Article							PLANT CYSTEINE PROTEASE; SUBSTRATE-SPECIFICITY; TROPICAL PLANT; SITE	Ervatamins (A, B and C) are papain-like cysteine proteases from the plant Ervatamia coronaria. Among Ervatamins, Ervatamin-C is a thermostable protease, but it shows lower catalytic efficiency. In contrast, Ervatamin-A which has a high amino acid sequence identity (similar to 90%) and structural homology (C alpha rmsd 0.4 angstrom) with Ervatamin-C, has much higher catalytic efficiency (similar to 57 times). From the structural comparison of Ervatamin-A and -C, two residues Thr32 and Tyr67 in the catalytic cleft of Ervatamin-A have been identified whose contributions for higher activity of Ervatamin-A are established in our earlier studies. In this study, these two residues have been introduced in Ervatamin-C by site directed mutagenesis to enhance the catalytic efficiency of the thermostable protease. Two single mutants (S32T and A67Y) and one double mutant (S32T/A67Y) of Ervatamin-C have been generated and characterized. All the three mutants show similar to 8 times higher catalytic efficiency (k(cat)/K-m) than the wild-type. The thermostability of all the three mutant enzymes remained unchanged. The double mutant does not achieve the catalytic efficiency of the template enzyme Ervatamin-A. By modeling the structure of the double mutant and probing the role of active site residues by docking a substrate, the mechanistic insights of higher activity of the mutant protease have been addressed. The in-silico study demonstrates that the residues beyond the catalytic cleft also influence the substrate binding and positioning of the substrate at the catalytic centre, thus controlling the catalytic efficiency of an enzyme.	[Dutta, Sruti; Dattagupta, Jiban Kanti; Biswas, Sampa] Saha Inst Nucl Phys, Crystallog & Mol Biol Div, Kolkata, India	Saha Institute of Nuclear Physics	Biswas, S (corresponding author), Saha Inst Nucl Phys, Crystallog & Mol Biol Div, Kolkata, India.	sampa.biswas@saha.ac.in			Department of Atomic Energy (DAE); Council of Scientific and Industrial Research (CSIR) [21/0653/06/EMR-II]; Department of Biotechnology (DBT), Govt. of India [BT/PR13895/BRB/10/789/2010]	Department of Atomic Energy (DAE)(Department of Atomic Energy (DAE)); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology (DBT), Govt. of India(Department of Biotechnology (DBT) India)	In addition to institute funding from Department of Atomic Energy (DAE), this work was supported by Council of Scientific and Industrial Research (CSIR), (21/0653/06/EMR-II) and Department of Biotechnology (DBT) (BT/PR13895/BRB/10/789/2010), Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker PJ, 2012, BIOMACROMOLECULES, V13, P947, DOI 10.1021/bm201862z; Barrett A. J., 1998, HDB PROTEOLYTIC ENZY; Behnke JM, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-29; BLOW DM, 1974, ISRAEL J CHEM, V12, P483; Cheng YS, 2012, APPL MICROBIOL BIOT, V95, P661, DOI 10.1007/s00253-011-3791-4; Choudhury D, 2010, PROTEIN ENG DES SEL, V23, P457, DOI 10.1093/protein/gzq016; Dardenne LE, 2003, PROTEINS, V52, P236, DOI 10.1002/prot.10368; Dutta S, 2011, FEBS J, V278, P3012, DOI 10.1111/j.1742-4658.2011.08221.x; Dutta S, 2010, PROCESS BIOCHEM, V45, P1307, DOI 10.1016/j.procbio.2010.04.020; Gao DQ, 2009, MOL PHARMACOL, V75, P318, DOI 10.1124/mol.108.049486; Ghosh R, 2008, FEBS J, V275, P421, DOI 10.1111/j.1742-4658.2007.06211.x; Ghosh R, 2007, BIOCHEM BIOPH RES CO, V362, P965, DOI 10.1016/j.bbrc.2007.08.098; Grudkowska M, 2004, ACTA BIOCHIM POL, V51, P609; Hu W, 2012, BIOCHIMIE, V94, P656, DOI 10.1016/j.biochi.2011.09.018; Huang X, 2011, ORG BIOMOL CHEM, V9, P4138, DOI 10.1039/c0ob00972e; MOLE JE, 1973, BIOCHEMISTRY-US, V12, P816, DOI 10.1021/bi00729a005; Reddy SY, 2002, J AM CHEM SOC, V124, P12979, DOI 10.1021/ja020918l; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Sundd M, 1998, BIOSCI BIOTECH BIOCH, V62, P1947, DOI 10.1271/bbb.62.1947; Thakurta PG, 2004, BIOCHEMISTRY-US, V43, P1532, DOI 10.1021/bi0357659; Tuck SA, 2012, INT J CHRONIC OBSTR, V7, P21, DOI 10.2147/COPD.S27312; Turk D, 1998, BIOL CHEM, V379, P137, DOI 10.1515/bchm.1998.379.2.137; Turner P, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-9	23	3	3	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62619	10.1371/journal.pone.0062619	http://dx.doi.org/10.1371/journal.pone.0062619			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23671614	Green Submitted, Green Published, gold			2022-12-25	WOS:000321202100021
J	Almine, JF; Wise, SG; Hiob, M; Singh, NK; Tiwari, KK; Vali, S; Abbasi, T; Weiss, AS				Almine, Jessica F.; Wise, Steven G.; Hiob, Matti; Singh, Neeraj Kumar; Tiwari, Krishna Kumar; Vali, Shireen; Abbasi, Taher; Weiss, Anthony S.			Elastin sequences trigger transient proinflammatory responses by human dermal fibroblasts	FASEB JOURNAL			English	Article						signaling; wound healing	HUMAN TROPOELASTIN; UP-REGULATION; PEPTIDES; EXPRESSION; PATHWAY; CHEMOKINES; MATRIX; PROLIFERATION; COACERVATION; INDUCTION	Following penetrating injury of the skin, a highly orchestrated and overlapping sequence of events helps to facilitate wound resolution. Inflammation is a hallmark that is initiated early, but the reciprocal relationship between cells and matrix molecules that triggers and maintains inflammation is poorly appreciated. Elastin is enriched in the deep dermis of skin. We propose that deep tissue injury encompasses elastin damage, yielding solubilized elastin that triggers inflammation. As dermal fibroblasts dominate the deep dermis, this means that a direct interaction between elastin sequences and fibroblasts would reveal a proinflammatory signature. Tropoelastin was used as a surrogate for elastin sequences. Tropoelastin triggered fibroblast expression of the metalloelastase MMP-12, which is normally expressed by macrophages. MMP-12 expression increased 1056 +/- 286-fold by 6 h and persisted for 24 h. Chemokine expression was more transient, as chemokine C-X-C motif ligand 8 (CXCL8), CXCL1, and CXCL5 transcripts increased 11.8 +/- 2.6-, 10.2 +/- 0.4-, and 8593 +/- 996-fold, respectively, by 6-12 h and then decreased. Through the use of specific inhibitors and protein truncation, we found that transduction of the tropoelastin signal was mediated by the fibroblast elastin binding protein (EBP). In silico modeling using a predictive computational fibroblast model confirmed the up-regulation, and simulations revealed PKA as a key part of the signaling circuit. We tested this prediction with 1 M PKA inhibitor H-89 and found that 2 h of exposure correspondingly reduced expression of MMP-12 (63.9 +/- 12.3%) and all chemokine markers, consistent with the levels seen with EBP inhibition, and validated PKA as a novel node and druggable target to ameliorate the proinflammatory state. A separate trigger that utilized C-terminal RKRK of tropoelastin reduced marker expression to 65.0-76.5% and suggests the parallel involvement of integrin (V3). We propose that the solubilization of elastin as a result of dermal damage leads to rapid chemokine up-regulation by fibroblasts that is quenched when exposed elastin is removed by MMP-12.Almine, J. F., Wise, S. G., Hiob, M., Kumar Singh, N. K., Tiwari, K. K., Vali, S., Abbasi, T., and Weiss, A. S. Elastin sequences trigger transient proinflammatory responses by human dermal fibroblasts.	[Almine, Jessica F.; Wise, Steven G.; Hiob, Matti; Weiss, Anthony S.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Weiss, Anthony S.] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia; [Weiss, Anthony S.] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia; [Wise, Steven G.] Heart Res Inst, Sydney, NSW, Australia; [Singh, Neeraj Kumar; Tiwari, Krishna Kumar; Vali, Shireen] Cellworks Res India Ltd, Bangalore, Karnataka, India; [Vali, Shireen; Abbasi, Taher] Cellworks Grp, San Jose, CA USA	University of Sydney; University of Sydney; University of Sydney; University of Sydney; Heart Research Institute	Weiss, AS (corresponding author), Univ Sydney, Sch Mol Biosci G08, Sydney, NSW 2006, Australia.	tony.weiss@sydney.edu.au	Wise, Steven/AAB-8170-2021; Weiss, Anthony S/GYV-0157-2022; Weiss, Anthony S/F-8103-2010; Wise, Steven/B-1858-2009	Weiss, Anthony S/0000-0002-8106-4836; Tiwari, Krishna/0000-0002-3699-0937; Wise, Steven/0000-0001-7964-819X; Almine, Jessica/0000-0003-2260-0560	Australian Research Council; Australian Defense Health Foundation; Australian National Health and Medical Research Council; U.S. National Institutes of Health [EB014283]; Australian Postgraduate Award; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB014283] Funding Source: NIH RePORTER	Australian Research Council(Australian Research Council); Australian Defense Health Foundation; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Postgraduate Award(Australian Government); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	A.S.W. acknowledges support from the Australian Research Council, Australian Defense Health Foundation, Australian National Health and Medical Research Council, and the U.S. National Institutes of Health (EB014283). A.S.W. is the scientific founder of Elastagen Pty. Ltd. J.F.A received an Australian Postgraduate Award. The authors thank their colleagues at Concord Hospital for the generous donation of human dermal fibroblasts; A/Prof. Gareth Denyer, Dr. Dale Hancock, Mrs. Sarah Martinez, Ms. Yannie Poon, and Ms. Kate Nieuwendyk for their technical assistance; and Dr. Suzanne Mithieux and Dr.Daniel Bax for advice on the text of this article. The authors declare no conflicts of interest.	Adair-Kirk TL, 2008, INT J BIOCHEM CELL B, V40, P1101, DOI 10.1016/j.biocel.2007.12.005; Amadeu TP, 2004, WOUND REPAIR REGEN, V12, P169, DOI 10.1111/j.1067-1927.2004.012209.x; [Anonymous], 2001, CURR PROTOC CELL BIO, DOI [10.1002/0471143030.cb0901s00, DOI 10.1002/0471143030.CB0901S00]; Antonicelli F, 2007, CURR TOP DEV BIOL, V79, P99, DOI 10.1016/S0070-2153(06)79005-6; Brassart B, 2001, J BIOL CHEM, V276, P5222, DOI 10.1074/jbc.M003642200; Cantarelli B, 2009, FEBS LETT, V583, P2385, DOI 10.1016/j.febslet.2009.06.037; Devalaraja RM, 2000, J INVEST DERMATOL, V115, P234, DOI 10.1046/j.1523-1747.2000.00034.x; Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184; Duca L, 2005, MOL PHARMACOL, V67, P1315, DOI 10.1124/mol.104.002725; Duca L, 2004, CRIT REV ONCOL HEMAT, V49, P235, DOI 10.1016/j.critrevonc.2003.09.007; Duca L, 2002, FEBS LETT, V524, P193, DOI 10.1016/S0014-5793(02)03057-0; Engelhardt E, 1998, AM J PATHOL, V153, P1849, DOI 10.1016/S0002-9440(10)65699-4; Flavell SJ, 2008, BRIT J PHARMACOL, V153, pS241, DOI 10.1038/sj.bjp.0707487; Fujimoto N, 2000, J INVEST DERMATOL, V115, P633, DOI 10.1046/j.1523-1747.2000.00117.x; Gillitzer R, 2001, J LEUKOCYTE BIOL, V69, P513; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Harvey LE, 2013, SCI REP-UK, V3, DOI 10.1038/srep01232; Heinz A, 2010, FEBS J, V277, P1939, DOI 10.1111/j.1742-4658.2010.07616.x; Jawad R, 2012, PHARM RES-DORDR, V29, P511, DOI 10.1007/s11095-011-0575-6; Jones PL, 1999, J CELL SCI, V112, P435; Kamoun A, 1995, CELL ADHES COMMUN, V3, P273, DOI 10.3109/15419069509081013; Kielty CM, 2002, J CELL SCI, V115, P2817; MARTIN SL, 1995, GENE, V154, P159, DOI 10.1016/0378-1119(94)00848-M; Matter ML, 2001, J BIOL CHEM, V276, P27757, DOI 10.1074/jbc.M102014200; Murdoch C, 2000, BLOOD, V95, P3032; Nenan S, 2005, MEM I OSWALDO CRUZ, V100, P167, DOI 10.1590/S0074-02762005000900028; Pierce RA, 2006, AM J PHYSIOL-LUNG C, V291, pL391, DOI 10.1152/ajplung.00441.2004; Raghunath M, 1996, J INVEST DERMATOL, V106, P1090, DOI 10.1111/1523-1747.ep12339373; Rajendran P, 2012, J CELL PHYSIOL, V227, P2184, DOI 10.1002/jcp.22954; Robinet A, 2005, J CELL SCI, V118, P343, DOI 10.1242/jcs.01613; Roten SV, 1996, J CUTAN PATHOL, V23, P37, DOI 10.1111/j.1600-0560.1996.tb00775.x; Schultz GS, 2011, WOUND REPAIR REGEN, V19, P134, DOI 10.1111/j.1524-475X.2011.00673.x; SENIOR RM, 1982, J CLIN INVEST, V70, P614, DOI 10.1172/JCI110654; SENIOR RM, 1984, J CELL BIOL, V99, P870, DOI 10.1083/jcb.99.3.870; Smith RS, 1997, AM J PATHOL, V151, P317; Taddese S, 2009, MATRIX BIOL, V28, P84, DOI 10.1016/j.matbio.2008.12.002; Tajima S, 1997, ARCH DERMATOL RES, V289, P489, DOI 10.1007/s004030050227; Tasken K, 2004, PHYSIOL REV, V84, P137, DOI 10.1152/physrev.00021.2003; Watanabe T, 2012, ARCH ORAL BIOL, V57, P52, DOI 10.1016/j.archoralbio.2011.07.010; Waterhouse A, 2011, PHARM RES-DORDR, V28, P1415, DOI 10.1007/s11095-010-0327-z; Wise SG, 2009, INT J BIOCHEM CELL B, V41, P494, DOI 10.1016/j.biocel.2008.03.017; Wu WJ, 1999, EUR J BIOCHEM, V266, P308, DOI 10.1046/j.1432-1327.1999.00891.x; Yeo GC, 2011, ADV COLLOID INTERFAC, V167, P94, DOI 10.1016/j.cis.2010.10.003	43	29	29	0	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2013	27	9					3455	3465		10.1096/fj.13-231787	http://dx.doi.org/10.1096/fj.13-231787			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	277SV	23671273	Green Published			2022-12-25	WOS:000328840500006
J	Uchiyama, T; Miyazaki, K; Yaoi, K				Uchiyama, Taku; Miyazaki, Kentaro; Yaoi, Katsuro			Characterization of a Novel beta-Glucosidase from a Compost Microbial Metagenome with Strong Transglycosylation Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMITE NEOTERMES-KOSHUNENSIS; SULFOLOBUS-SOLFATARICUS; SUBSTRATE-SPECIFICITY; ASPERGILLUS-ORYZAE; TRICHODERMA-REESEI; PURIFICATION; GLYCOSIDASE; CLONING; EXPRESSION; TOLERANCE	The beta-glucosidase encoded by the td2f2 gene was isolated from a compost microbial metagenomic library by functional screening. The protein was identified to be a member of the glycoside hydrolase family 1 and was overexpressed in Escherichia coli, purified, and biochemically characterized. The recombinant beta-glucosidase, Td2F2, exhibited enzymatic activity with beta-glycosidic substrates, with preferences for glucose, fucose, and galactose. Hydrolysis occurred at the nonreducing end and in an exo manner. The order of catalytic efficiency for glucodisaccharides and cellooligosaccharides was sophorose > cellotetraose > cellotriose > laminaribiose > cellobiose > cellopentaose > gentiobiose, respectively. Intriguingly, the p-nitrophenyl-beta-D-glucopyranoside hydrolysis activity of Td2F2 was activated by various monosaccharides and sugar alcohols. At a D-glucose concentration of 1000 mM, enzyme activity was 6.7-fold higher than that observed in the absence of D-glucose. With 31.3 mM D-glucose, Td2F2 catalyzed transglycosylation to generate sophorose, laminaribiose, cellobiose, and gentiobiose. Transglycosylation products were detected under all activated conditions, suggesting that the activity enhancement induced by monosaccharides and sugar alcohols may be due to the transglycosylation activity of the enzyme. These results show that Td2F2 obtained from a compost microbial metagenome may be a potent candidate for industrial applications.	[Uchiyama, Taku; Miyazaki, Kentaro; Yaoi, Katsuro] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba, Ibaraki, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Yaoi, K (corresponding author), Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Cent 6,1-1-1 Higashi, Tsukuba, Ibaraki 3058566, Japan.	k-yaoi@aist.go.jp	Yaoi, Katsuro/K-1491-2018; Miyazaki, Kentaro/F-7022-2010	Yaoi, Katsuro/0000-0002-4037-0087; Miyazaki, Kentaro/0000-0002-4349-566X	New Energy and Industrial Technology Development Organization; Grants-in-Aid for Scientific Research [24119515] Funding Source: KAKEN	New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by in part by grants from the New Energy and Industrial Technology Development Organization.	Aguilar CF, 1997, J MOL BIOL, V271, P789, DOI 10.1006/jmbi.1997.1215; Bhatia Y, 2002, CRIT REV BIOTECHNOL, V22, P375, DOI 10.1080/07388550290789568; CHEN HZ, 1992, BIOCHIM BIOPHYS ACTA, V1121, P54, DOI 10.1016/0167-4838(92)90336-C; Decker CH, 2001, APPL MICROBIOL BIOT, V55, P157, DOI 10.1007/s002530000462; Di Lauro B, 2006, EXTREMOPHILES, V10, P301, DOI 10.1007/s00792-005-0500-1; Fang ZM, 2010, J MICROBIOL BIOTECHN, V20, P1351, DOI 10.4014/jmb.1003.03011; Hancock SM, 2005, CHEMBIOCHEM, V6, P866, DOI 10.1002/cbic.200400341; Hong J, 2006, APPL MICROBIOL BIOT, V73, P80, DOI 10.1007/s00253-006-0428-0; Jeng WY, 2011, J STRUCT BIOL, V173, P46, DOI 10.1016/j.jsb.2010.07.008; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Marques AR, 2003, BIOCHEM J, V370, P793, DOI 10.1042/BJ20021249; McIlvaine TC, 1921, J BIOL CHEM, V49, P183; Nomura T, 2008, J BIOL CHEM, V283, P34650, DOI 10.1074/jbc.M806953200; NUCCI R, 1993, BIOTECHNOL APPL BIOC, V17, P239; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PEREZPONS JA, 1995, BBA-PROTEIN STRUCT M, V1251, P145, DOI 10.1016/0167-4838(95)00074-5; Riou C, 1998, APPL ENVIRON MICROB, V64, P3607; Suzuki H, 2006, J BIOL CHEM, V281, P30251, DOI 10.1074/jbc.M605726200; Uchima CA, 2011, APPL MICROBIOL BIOT, V89, P1761, DOI 10.1007/s00253-010-2963-y; Uchiyama T, 2008, NAT PROTOC, V3, P1202, DOI 10.1038/nprot.2008.96; Vladimir K, 1997, CHEM SOC REV, V26, P463; Watanabe H, 2010, ANNU REV ENTOMOL, V55, P609, DOI 10.1146/annurev-ento-112408-085319; WOOD TM, 1988, METHOD ENZYMOL, V160, P19; WOODWARD J, 1982, ENZYME MICROB TECH, V4, P73, DOI 10.1016/0141-0229(82)90084-9; Zanoelo FF, 2004, FEMS MICROBIOL LETT, V240, P137, DOI 10.1016/j.femsle.2004.09.021; Zhou JM, 2002, PLANT PHYSIOL, V129, P1252, DOI 10.1104/pp.010863	26	92	100	3	52	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18325	18334		10.1074/jbc.M113.471342	http://dx.doi.org/10.1074/jbc.M113.471342			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23661705	Green Published, hybrid			2022-12-25	WOS:000320721900036
J	Echeverry-Galvis, MA; Hau, M				Echeverry-Galvis, Maria Angela; Hau, Michaela			Flight Performance and Feather Quality: Paying the Price of Overlapping Moult and Breeding in a Tropical Highland Bird	PLOS ONE			English	Article							CURRENT REPRODUCTIVE EFFORT; EUROPEAN STARLINGS; PIED FLYCATCHERS; BODY CONDITION; TRADE-OFF; ENERGY-EXPENDITURE; MIGRATORY BEHAVIOR; PREDATION RISK; TAKE-OFF; MASS	A temporal separation of energetically costly life history events like reproduction and maintenance of the integumentary system is thought to be promoted by selection to avoid trade-offs and maximize fitness. It has therefore remained somewhat of a paradox that certain vertebrate species can undergo both events simultaneously. Identifying potential costs of overlapping two demanding life history stages will further our understanding of the selection pressures that shape the temporal regulation of life history events in vertebrates. We studied free-living tropical Slaty brush-finches (Atlapetes schistaceus), in which individuals spontaneously overlap reproduction and moult or undergo both events in separation. To assess possible costs of such an overlap we quantified feather quality and flight performance of individuals in different states. We determined individual's life history state by measuring gonad size and scoring moult stage, and collected a newly grown 7 th primary wing feather for later analysis of feather quality. Finally, we quantified flight performance for each individual in the wild. Overlapping individuals produced lighter and shorter wing feathers than individuals just moulting, with females decreasing feather quality more strongly during the overlap than males. Moreover, overlapping individuals had a reduced flight speed during escape flights, while their foraging flight speed was unaffected. Despite overlappers being larger and having a smaller wing area, their lower body mass resulted in a similar wing load as in breeders or moulters. Individuals measured repeatedly in different states also showed significant decreases in feather quality and escape flight speed during the overlap. Reduced escape flight speed may represent a major consequence of the overlap by increasing predation risk. Our data document costs to undergoing two life history stages simultaneously, which likely arise from energetic trade-offs. Impairments in individual quality and performance may represent important factors that select for temporal separation of life history stages in other species.	[Echeverry-Galvis, Maria Angela] Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA; [Hau, Michaela] Max Planck Inst Ornithol, Evolutionary Physiol Grp, Radolfzell am Bodensee, Germany; [Hau, Michaela] Univ Konstanz, Dept Biol, Constance, Germany	Princeton University; Max Planck Society; University of Konstanz	Echeverry-Galvis, MA (corresponding author), Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA.	mechever@princeton.edu		Echeverry-Galvis, Maria Angela/0000-0002-5273-8694	Princeton University Program for Latin America Studies and of Ecology and Department of Evolutionary Biology; Max Planck Society	Princeton University Program for Latin America Studies and of Ecology and Department of Evolutionary Biology; Max Planck Society(Max Planck SocietyFoundation CELLEX)	MAEG thanks Princeton University Program for Latin America Studies and of Ecology and Department of Evolutionary Biology for funding, and Pontificia Universidad Javeriana-Bogota for logistical aid. MH acknowledges funding by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerstam T, 1998, J AVIAN BIOL, V29, P343, DOI 10.2307/3677155; ANKNEY CD, 1980, AUK, V97, P684; Barta Z, 2008, PHILOS T R SOC B, V363, P211, DOI 10.1098/rstb.2007.2136; BENSCH S, 1993, CONDOR, V95, P305, DOI 10.2307/1369353; Bowlin MS, 2007, AUK, V124, P1388, DOI 10.1642/0004-8038(2007)124[1388:SWSAWP]2.0.CO;2; BUTLER LK, 2006, CONDOR, V108, P647, DOI DOI 10.1650/0010-5422(2006)108[647:PMAMMI]2.0.CO;2; Butler LK, 2008, J AVIAN BIOL, V39, P629, DOI 10.1111/j.1600-048X.2008.04432.x; Butler MW, 2010, PHYSIOL BIOCHEM ZOOL, V83, P78, DOI 10.1086/648483; Cleasby Ian R., 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-431; Cooper WE, 2011, ACTA HERPETOL, V6, P247; Cooper WE, 2010, REV BIOL TROP, V58, P1199; Corning WR, 1998, J EXP BIOL, V201, P3057; Dawson A, 2000, P ROY SOC B-BIOL SCI, V267, P2093, DOI 10.1098/rspb.2000.1254; Dawson A, 2003, IBIS, V145, pE69, DOI 10.1046/j.1474-919X.2003.00161.x; de la Hera I, 2010, J AVIAN BIOL, V41, P609, DOI 10.1111/j.1600-048X.2010.05075.x; de la Hera I, 2010, AUK, V127, P647, DOI 10.1525/auk.2010.09120; de la Hera I, 2010, J AVIAN BIOL, V41, P342, DOI 10.1111/j.1600-048X.2009.04835.x; de la Hera I, 2009, J AVIAN BIOL, V40, P461, DOI 10.1111/j.1600-048X.2008.04689.x; de la Hera I, 2009, BIOL J LINN SOC, V97, P98, DOI 10.1111/j.1095-8312.2008.01189.x; DesRochers DW, 2009, COMP BIOCHEM PHYS A, V152, P46, DOI 10.1016/j.cbpa.2008.08.034; Echeverry-Galvis MA, 2008, B B O C, V126, P291; Echeverry-Galvis MA, 2012, J EXP BIOL, V215, P1957, DOI 10.1242/jeb.065474; Echeverry-Galvis MA, 2008, ORNITOL NEOTROP, V19, P197; Fernandez-Juricic E, 2006, EVOL ECOL RES, V8, P731; FOSTER MS, 1975, CONDOR, V77, P304, DOI 10.2307/1366226; FOSTER MS, 1974, EVOLUTION, V28, P182, DOI 10.1111/j.1558-5646.1974.tb00739.x; Gardner JL, 2008, EMU, V108, P90, DOI 10.1071/MU06058; Garlich-Miller J., 2011, STATUS REV PACIFIC W; Ginn HB, 1995, MOULT BIRDS; Hau M, 1998, P ROY SOC B-BIOL SCI, V265, P89, DOI 10.1098/rspb.1998.0268; Hedenstrom A, 2003, J AVIAN BIOL, V34, P324, DOI 10.1111/j.0908-8857.2003.03324.x; Hemborg C, 1999, IBIS, V141, P226, DOI 10.1111/j.1474-919X.1999.tb07545.x; Hemborg C, 1999, J ANIM ECOL, V68, P429, DOI 10.1046/j.1365-2656.1999.00295.x; Higginson AD, 2012, AM NAT, V179, P338, DOI 10.1086/664457; Jenni L., 1994, BIOL MOULT BIRDS; Johnson EI, 2012, J AVIAN BIOL, V43, P141, DOI 10.1111/j.1600-048X.2011.05574.x; Jovani R, 2004, J EVOLUTION BIOL, V17, P294, DOI 10.1111/j.1420-9101.2003.00680.x; KLAASSEN M, 1995, OECOLOGIA, V104, P424, DOI 10.1007/BF00341339; Labocha MK, 2012, J ORNITHOL, V153, P1, DOI 10.1007/s10336-011-0706-1; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Li CW, 2011, APPL ANIM BEHAV SCI, V129, P146, DOI 10.1016/j.applanim.2010.11.013; Lind J, 2001, P ROY SOC B-BIOL SCI, V268, P1915, DOI 10.1098/rspb.2001.1740; Lind J, 2001, FUNCT ECOL, V15, P29; LINDSTROM A, 1993, PHYSIOL ZOOL, V66, P490, DOI 10.1086/physzool.66.4.30163805; Miller DA, 2011, J AVIAN BIOL, V42, P151, DOI 10.1111/j.1600-048X.2010.05124.x; Moreno J, 2001, OECOLOGIA, V129, P492, DOI 10.1007/s004420100767; Moya-Larano J, 2008, J ANIM ECOL, V77, P1099, DOI 10.1111/j.1365-2656.2008.01433.x; Murphy MT, 2007, AUK, V124, P1010, DOI 10.1642/0004-8038(2007)124[1010:LRSOFE]2.0.CO;2; Nilsson JA, 1996, P ROY SOC B-BIOL SCI, V263, P711, DOI 10.1098/rspb.1996.0106; Norberg UML, 2002, J MORPHOL, V252, P52, DOI 10.1002/jmor.10013; O'Dwyer TW, 2006, FUNCT ECOL, V20, P806, DOI 10.1111/j.1365-2435.2006.01168.x; Olson KA, 2010, J ARID ENVIRON, V74, P1435, DOI 10.1016/j.jaridenv.2010.05.022; Park KJ, 2001, J EXP BIOL, V204, P2741; Payne R, 1972, MECH CONTROL MOLT, V2, P103; PAYNE RB, 1969, CONDOR, V71, P140, DOI 10.2307/1366075; PAYNTER R A JR, 1972, Bulletin of the Museum of Comparative Zoology, V143, P297; Portugal SJ, 2007, J EXP BIOL, V210, P1391, DOI 10.1242/jeb.004598; Ricklefs RE, 2013, J ORNITHOL, V154, P145, DOI 10.1007/s10336-012-0880-9; Ricklefs RE, 2011, J ORNITHOL, V152, P481, DOI 10.1007/s10336-010-0614-9; Ricklefs T.E., 1974, Publications Nuttall Orn Club, VNo. 15, P152; Rohwer S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000132; Schaub M, 2009, J ANIM ECOL, V78, P625, DOI 10.1111/j.1365-2656.2008.01508.x; Schulte-Hostedde AI, 2005, ECOLOGY, V86, P155, DOI 10.1890/04-0232; Senar JC, 2002, BEHAV ECOL, V13, P725, DOI 10.1093/beheco/13.6.725; Spencer KA, 2010, BEHAV ECOL, V21, P999, DOI 10.1093/beheco/arq090; STEARNS SC, 1989, FUNCT ECOL, V3, P259, DOI 10.2307/2389364; Strochlic DE, 2008, COMP BIOCHEM PHYS A, V149, P68, DOI 10.1016/j.cbpa.2007.10.011; Swaddle JP, 1998, J AVIAN BIOL, V29, P172, DOI 10.2307/3677195; Swaddle JP, 1997, CAN J ZOOL, V75, P948, DOI 10.1139/z97-114; Swaddle JP, 1999, J AVIAN BIOL, V30, P351, DOI 10.2307/3677007; Verea C, 2009, ORNITOL NEOTROP, V20, P181; WEBSTER W. D., 1986, OCCASIONAL PAPERS MU, V100, P1; Wiersma P, 2005, J EXP BIOL, V208, P4091, DOI 10.1242/jeb.01854; Williams EV, 2003, J AVIAN BIOL, V34, P371, DOI 10.1111/j.0908-8857.2003.02964.x; Wingfield JC, 2008, PHILOS T R SOC B, V363, P425, DOI 10.1098/rstb.2007.2149; Wingfield JC, 2008, PHILOS T R SOC B, V363, P1581, DOI 10.1098/rstb.2007.0012; Zera AJ, 2001, ANNU REV ECOL SYST, V32, P95, DOI 10.1146/annurev.ecolsys.32.081501.114006	77	39	39	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e61106	10.1371/journal.pone.0061106	http://dx.doi.org/10.1371/journal.pone.0061106			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667431	Green Submitted, Green Published, gold			2022-12-25	WOS:000319055600007
J	Gupta, P; Goel, R; Pathak, S; Srivastava, A; Singh, SP; Sangwan, RS; Asif, MH; Trivedi, PK				Gupta, Parul; Goel, Ridhi; Pathak, Sumya; Srivastava, Apeksha; Singh, Surya Pratap; Sangwan, Rajender Singh; Asif, Mehar Hasan; Trivedi, Prabodh Kumar			De Novo Assembly, Functional Annotation and Comparative Analysis of Withania somnifera Leaf and Root Transcriptomes to Identify Putative Genes Involved in the Withanolides Biosynthesis	PLOS ONE			English	Article							EXPRESSED SEQUENCE TAGS; STEROIDAL LACTONES; MEDICINAL-PLANT; GLYCOSYLTRANSFERASES; CYTOCHROME-P450; REPEATS; GINSENG; CLONING; STRESS; BARLEY	Withania somnifera is one of the most valuable medicinal plants used in Ayurvedic and other indigenous medicine systems due to bioactive molecules known as withanolides. As genomic information regarding this plant is very limited, little information is available about biosynthesis of withanolides. To facilitate the basic understanding about the withanolide biosynthesis pathways, we performed transcriptome sequencing for Withania leaf (101L) and root (101R) which specifically synthesize withaferin A and withanolide A, respectively. Pyrosequencing yielded 8,34,068 and 7,21,755 reads which got assembled into 89,548 and 1,14,814 unique sequences from 101L and 101R, respectively. A total of 47,885 (101L) and 54,123 (101R) could be annotated using TAIR10, NR, tomato and potato databases. Gene Ontology and KEGG analyses provided a detailed view of all the enzymes involved in withanolide backbone synthesis. Our analysis identified members of cytochrome P450, glycosyltransferase and methyltransferase gene families with unique presence or differential expression in leaf and root and might be involved in synthesis of tissue-specific withanolides. We also detected simple sequence repeats (SSRs) in transcriptome data for use in future genetic studies. Comprehensive sequence resource developed for Withania, in this study, will help to elucidate biosynthetic pathway for tissue-specific synthesis of secondary plant products in non-model plant organisms as well as will be helpful in developing strategies for enhanced biosynthesis of withanolides through biotechnological approaches.	[Gupta, Parul; Goel, Ridhi; Pathak, Sumya; Srivastava, Apeksha; Asif, Mehar Hasan; Trivedi, Prabodh Kumar] CSIR, Natl Bot Res Inst, Lucknow, Uttar Pradesh, India; [Sangwan, Rajender Singh] CSIR, Cent Inst Med & Aromat Plants, Lucknow, Uttar Pradesh, India; [Singh, Surya Pratap] Banaras Hindu Univ, Fac Sci, Dept Biochem, Varanasi 221005, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Institute of Medicinal & Aromatic Plants (CIMAP); Banaras Hindu University (BHU)	Trivedi, PK (corresponding author), CSIR, Natl Bot Res Inst, Rana Pratap Marg, Lucknow, Uttar Pradesh, India.	prabodht@hotmail.com		Singh, Surya/0000-0001-5668-1712	Council of Scientific and Industrial Research, New Delhi, Govt. of India under; New Millennium Indian Technology Leadership Initiative (NMITLI) scheme	Council of Scientific and Industrial Research, New Delhi, Govt. of India under; New Millennium Indian Technology Leadership Initiative (NMITLI) scheme	The authors are thankful to the Council of Scientific and Industrial Research, New Delhi, Govt. of India, for providing the financial support to carry out this work under New Millennium Indian Technology Leadership Initiative (NMITLI) scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar N, 2013, PROTOPLASMA, V250, P613, DOI 10.1007/s00709-012-0450-2; Alam N, 2012, PHYTOCHEM REV, V11, P97, DOI 10.1007/s11101-011-9221-5; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bharti SK, 2011, MAGN RESON CHEM, V49, P659, DOI 10.1002/mrc.2817; Bowles D, 2006, ANNU REV PLANT BIOL, V57, P567, DOI 10.1146/annurev.arplant.57.032905.105429; Cardle L, 2000, GENETICS, V156, P847; Chaturvedi P, 2012, MOL BIOL REP, V39, P9755, DOI 10.1007/s11033-012-1841-3; Chaurasiya ND, 2012, PLANT CELL REP, V31, P1889, DOI 10.1007/s00299-012-1302-4; Chaurasiya ND, 2009, FITOTERAPIA, V80, P496, DOI 10.1016/j.fitote.2009.06.012; Coon MJ, 2005, ANNU REV PHARMACOL, V45, P1, DOI 10.1146/annurev.pharmtox.45.120403.100030; Der JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-99; Desgagne-Penix I, 2012, PLANT MOL BIOL, V79, P295, DOI 10.1007/s11103-012-9913-2; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Grover A, 2012, J BIOMOL STRUCT DYN, V29, P651, DOI 10.1080/07391102.2012.10507408; Gupta P, 2013, PROTOPLASMA, V250, P285, DOI 10.1007/s00709-012-0410-x; Gupta P, 2011, PLANT GROWTH REGUL, V65, P93, DOI 10.1007/s10725-011-9578-x; Hatlestad GJ, 2012, NAT GENET, V44, P816, DOI 10.1038/ng.2297; Kaileh M, 2007, J ETHNOPHARMACOL, V113, P510, DOI 10.1016/j.jep.2007.07.008; Kantety RV, 2002, PLANT MOL BIOL, V48, P501, DOI 10.1023/A:1014875206165; Kota R, 2001, HEREDITAS, V135, P145, DOI 10.1111/j.1601-5223.2001.00145.x; Kushwaha S, 2012, PARASITE IMMUNOL, V34, P199, DOI 10.1111/j.1365-3024.2012.01352.x; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Li Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-268; Madina BR, 2007, BBA-PROTEINS PROTEOM, V1774, P1199, DOI 10.1016/j.bbapap.2007.06.015; Mansour HH, 2012, ECOTOX ENVIRON SAFE, V80, P14, DOI 10.1016/j.ecoenv.2012.02.003; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Mirjalili MH, 2009, MOLECULES, V14, P2373, DOI 10.3390/molecules14072373; Mizutani M, 2010, ANNU REV PLANT BIOL, V61, P291, DOI 10.1146/annurev-arplant-042809-112305; Morant M, 2003, CURR OPIN BIOTECH, V14, P151, DOI 10.1016/S0958-1669(03)00024-7; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Murthy M. R. Ven, 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P238; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Parkinson John, 2009, V533, P1, DOI 10.1007/978-1-60327-136-3_1; Prakash J, 2001, PHYTOTHER RES, V15, P240, DOI 10.1002/ptr.779; Sangwan RS, 2008, PHYSIOL PLANTARUM, V133, P278, DOI 10.1111/j.1399-3054.2008.01076.x; Sehgal N, 2012, P NATL ACAD SCI USA, V109, P3510, DOI 10.1073/pnas.1112209109; Senthil K, 2010, MOL BIOL REP, V37, P893, DOI 10.1007/s11033-009-9696-y; Sharma LK, 2007, ARCH BIOCHEM BIOPHYS, V460, P48, DOI 10.1016/j.abb.2007.01.024; Sidhu OP, 2011, PHYTOCHEM ANALYSIS, V22, P492, DOI 10.1002/pca.1307; Standeven R, 1998, EUR J HERBAL MED, V4, P17; Stekel DJ, 2000, GENOME RES, V10, P2055, DOI 10.1101/gr.GR-1325RR; Sun C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-262; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang W, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-465; Zeng SH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-94	46	62	64	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62714	10.1371/journal.pone.0062714	http://dx.doi.org/10.1371/journal.pone.0062714			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667511	Green Published, Green Submitted, gold			2022-12-25	WOS:000319055600040
J	Keith, DA; Rodriguez, JP; Rodriguez-Clark, KM; Nicholson, E; Aapala, K; Alonso, A; Asmussen, M; Bachman, S; Basset, A; Barrow, EG; Benson, JS; Bishop, MJ; Bonifacio, R; Brooks, TM; Burgman, MA; Comer, P; Comin, FA; Essl, F; Faber-Langendoen, D; Fairweather, PG; Holdaway, RJ; Jennings, M; Kingsford, RT; Lester, RE; Mac Nally, R; McCarthy, MA; Moat, J; Oliveira-Miranda, MA; Pisanu, P; Poulin, B; Regan, TJ; Riecken, U; Spalding, MD; Zambrano-Martinez, S				Keith, David A.; Rodriguez, Jon Paul; Rodriguez-Clark, Kathryn M.; Nicholson, Emily; Aapala, Kaisu; Alonso, Alfonso; Asmussen, Marianne; Bachman, Steven; Basset, Alberto; Barrow, Edmund G.; Benson, John S.; Bishop, Melanie J.; Bonifacio, Ronald; Brooks, Thomas M.; Burgman, Mark A.; Comer, Patrick; Comin, Francisco A.; Essl, Franz; Faber-Langendoen, Don; Fairweather, Peter G.; Holdaway, Robert J.; Jennings, Michael; Kingsford, Richard T.; Lester, Rebecca E.; Mac Nally, Ralph; McCarthy, Michael A.; Moat, Justin; Oliveira-Miranda, Maria A.; Pisanu, Phil; Poulin, Brigitte; Regan, Tracey J.; Riecken, Uwe; Spalding, Mark D.; Zambrano-Martinez, Sergio			Scientific Foundations for an IUCN Red List of Ecosystems	PLOS ONE			English	Article							EXTINCTION RISK; RELATIVE RESILIENCE; BIODIVERSITY LOSS; GLOBAL SYNTHESIS; PLANT DIVERSITY; FUNCTIONAL-ROLE; CLIMATE-CHANGE; THREAT STATUS; CORAL-REEFS; CONSERVATION	An understanding of risks to biodiversity is needed for planning action to slow current rates of decline and secure ecosystem services for future human use. Although the IUCN Red List criteria provide an effective assessment protocol for species, a standard global assessment of risks to higher levels of biodiversity is currently limited. In 2008, IUCN initiated development of risk assessment criteria to support a global Red List of ecosystems. We present a new conceptual model for ecosystem risk assessment founded on a synthesis of relevant ecological theories. To support the model, we review key elements of ecosystem definition and introduce the concept of ecosystem collapse, an analogue of species extinction. The model identifies four distributional and functional symptoms of ecosystem risk as a basis for assessment criteria: A) rates of decline in ecosystem distribution; B) restricted distributions with continuing declines or threats; C) rates of environmental (abiotic) degradation; and D) rates of disruption to biotic processes. A fifth criterion, E) quantitative estimates of the risk of ecosystem collapse, enables integrated assessment of multiple processes and provides a conceptual anchor for the other criteria. We present the theoretical rationale for the construction and interpretation of each criterion. The assessment protocol and threat categories mirror those of the IUCN Red List of species. A trial of the protocol on terrestrial, subterranean, freshwater and marine ecosystems from around the world shows that its concepts are workable and its outcomes are robust, that required data are available, and that results are consistent with assessments carried out by local experts and authorities. The new protocol provides a consistent, practical and theoretically grounded framework for establishing a systematic Red List of the world's ecosystems. This will complement the Red List of species and strengthen global capacity to report on and monitor the status of biodiversity	[Keith, David A.; Kingsford, Richard T.] Univ New S Wales, Australian Wetlands Rivers & Landscapes Ctr, Sydney, NSW, Australia; [Keith, David A.] New South Wales Off Environm & Heritage, Hurstville, NSW, Australia; [Rodriguez, Jon Paul; Rodriguez-Clark, Kathryn M.; Asmussen, Marianne; Zambrano-Martinez, Sergio] Inst Venezolano Invest Cient, Ctr Ecol, Caracas, Venezuela; [Rodriguez, Jon Paul; Oliveira-Miranda, Maria A.] Provita, Caracas, Venezuela; [Rodriguez, Jon Paul; Asmussen, Marianne] EcoHlth Alliance, New York, NY USA; [Rodriguez, Jon Paul; Brooks, Thomas M.] IUCN Commiss Ecosyst Management, Gland, Switzerland; [Rodriguez, Jon Paul; Brooks, Thomas M.] IUCN Species Survival Commiss, Gland, Switzerland; [Nicholson, Emily; McCarthy, Michael A.; Regan, Tracey J.] Univ Melbourne, Ctr Excellence Environm Decis, Melbourne, Vic 3010, Australia; [Aapala, Kaisu] Finnish Environm Inst, Helsinki, Finland; [Alonso, Alfonso] Smithsonian Inst, Natl Zool Pk, Smithsonian Conservat Biol Inst, Washington, DC 20008 USA; [Bachman, Steven; Moat, Justin] Royal Bot Gardens, Richmond, England; [Basset, Alberto] Univ Salento, Ecotekne Ctr, Dept Biol & Environm Sci, Lecce, Italy; [Barrow, Edmund G.] IUCN Global Ecosyst Management Programme, Nairobi, Kenya; [Benson, John S.] Royal Bot Gardens Trust, Sydney, NSW, Australia; [Bishop, Melanie J.] Macquarie Univ, Dept Biol Sci, N Ryde, NSW 2109, Australia; [Bonifacio, Ronald; Pisanu, Phil] Sci Resource Ctr, Dept Environm & Nat Resources, Adelaide, SA, Australia; [Brooks, Thomas M.; Faber-Langendoen, Don] NatureServe, Arlington, VA USA; [Burgman, Mark A.] Univ Melbourne, Australian Ctr Excellence Risk Assessment, Melbourne, Vic 3010, Australia; [Comer, Patrick] NatureServe, Boulder, CO USA; [Comin, Francisco A.] Pyrenean Inst Ecol, Zaragoza, Spain; [Essl, Franz] Environm Agcy Austria, Vienna, Austria; [Essl, Franz] Univ Vienna, Dept Conservat Biol Vegetat & Landscape Ecol, Vienna, Austria; [Fairweather, Peter G.] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; [Holdaway, Robert J.] Landcare Res, Lincoln, New Zealand; [Jennings, Michael] Univ Idaho, Dept Geog, Moscow, ID 83843 USA; [Lester, Rebecca E.] Deakin Univ, Sch Life & Environm Sci, Warrnambool, Vic, Australia; [Mac Nally, Ralph] Monash Univ, Sch Biol Sci, Australian Ctr Biodivers, Clayton, Vic 3800, Australia; [Poulin, Brigitte] Tour du Valat Res Ctr, Arles, France; [Riecken, Uwe] German Fed Agcy Nat Conservat, Bonn, Germany; [Spalding, Mark D.] Univ Cambridge, Dept Zool, Nat Conservancy & Conservat Sci Grp, Cambridge, England	University of New South Wales Sydney; Office of Environment & Heritage - New South Wales; Venezuelan Institute Science Research; EcoHealth Alliance; University of Melbourne; Finnish Environment Institute; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Royal Botanic Gardens, Kew; University of Salento; Macquarie University; Nature Conservancy; University of Melbourne; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Pirenaico de Ecologia (IPE); University of Vienna; Flinders University South Australia; Landcare Research - New Zealand; Idaho; University of Idaho; Deakin University; Monash University; University of Cambridge	Keith, DA (corresponding author), Univ New S Wales, Australian Wetlands Rivers & Landscapes Ctr, Sydney, NSW, Australia.	david.keith@unsw.edu.au	Bishop, Melanie/AGA-7862-2022; Rodriguez, Jon P/G-7224-2012; Lester, Rebecca/H-3907-2011; Rodriguez, Jon P/A-1491-2009; Essl, Franz/ABE-7064-2020; Faber-Langendoen, Don/AAU-1071-2021; McCarthy, Michael A/O-5655-2014; Spalding, Mark/GVU-0739-2022; Nicholson, Emily/H-9001-2013	Lester, Rebecca/0000-0003-2682-6495; Rodriguez, Jon P/0000-0001-5019-2870; Essl, Franz/0000-0001-8253-2112; McCarthy, Michael A/0000-0003-1039-7980; Nicholson, Emily/0000-0003-2199-3446; Comer, Patrick/0000-0002-5869-2105; Rodriguez-Clark, Kathryn/0000-0002-1356-9998; Moat, Justin/0000-0002-5513-3615; Aapala, Kaisu/0000-0002-6933-9673; Spalding, Mark/0000-0001-9456-4533; Kingsford, Richard/0000-0001-6565-4134; Bishop, Melanie/0000-0001-8210-6500; Bachman, Steven/0000-0003-1085-6075; Keith, David/0000-0002-7627-4150; Burgman, Mark/0000-0003-0435-4829; Fairweather, Peter/0000-0001-5927-3044; Brooks, Thomas/0000-0001-8159-3116	MAVA Foundation; Gordon and Betty Moore Foundation; Smithsonian Institution; EcoHealth Alliance, Provita; Fulbright Program; Tour du Valat,; Australian Centre of Excellence for Environmental Decisions and Centre de Suive Ecologique	MAVA Foundation; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Smithsonian Institution(Smithsonian Institution); EcoHealth Alliance, Provita; Fulbright Program; Tour du Valat,; Australian Centre of Excellence for Environmental Decisions and Centre de Suive Ecologique	The authors gratefully acknowledge funding support from the MAVA Foundation, Gordon and Betty Moore Foundation, Smithsonian Institution, EcoHealth Alliance, Provita, the Fulbright Program, Tour du Valat, the Australian Centre of Excellence for Environmental Decisions and Centre de Suive Ecologique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcakaya HR, 2000, CONSERV BIOL, V14, P1001, DOI 10.1046/j.1523-1739.2000.99125.x; Allen CR, 2005, ECOSYSTEMS, V8, P958, DOI 10.1007/s10021-005-0147-x; Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; Andren H, 1996, OIKOS, V76, P235, DOI 10.2307/3546195; Araoz E, 2010, ECOSYSTEMS, V13, P992, DOI 10.1007/s10021-010-9369-7; Ayensu E, 1999, SCIENCE, V286, P685, DOI 10.1126/science.286.5440.685; BAILLIE JEM, 2004, IUCN RED LIST THREAT; Barbone E, 2010, REND LINCEI-SCI FIS, V21, P301, DOI 10.1007/s12210-010-0090-4; Benson J. S., 2006, Cunninghamia, V9, P331; BLAB J, 1995, LANDSCAPE ECOL, V10, P41, DOI 10.1007/BF00158552; Blodgett N, 2010, INT J WILDLAND FIRE, V19, P415, DOI 10.1071/WF08162; Briske DD, 2005, RANGELAND ECOL MANAG, V58, P1, DOI 10.2111/1551-5028(2005)58&lt;1:SMTARH&gt;2.0.CO;2; Burgman M., 2005, RISKS DECISIONS CONS; Burgman MA, 1999, RISK ANAL, V19, P585, DOI 10.1023/A:1007073301150; Burgman MA, 2003, ANIM CONSERV, V6, P19, DOI 10.1017/S1367943003003044; Burgman MA, 1993, RISK ASSESSMENT CONS; Butchart SHM, 2004, PLOS BIOL, V2, P2294, DOI 10.1371/journal.pbio.0020383; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Byrne M, 2008, BIOL J LINN SOC, V93, P177, DOI 10.1111/j.1095-8312.2007.00946.x; Cabezas A, 2009, HYDROL EARTH SYST SC, V13, P273, DOI 10.5194/hess-13-273-2009; Calcagno V, 2011, AM NAT, V177, pE1, DOI 10.1086/657436; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Carpenter S, 2001, ECOSYSTEMS, V4, P765, DOI 10.1007/s10021-001-0045-9; Carpenter SR, 2003, EXCELLENCE ECOLOGY S; CAUGHLEY G, 1994, J ANIM ECOL, V63, P215, DOI 10.2307/5542; Chytry M, 2002, J VEG SCI, V13, P79, DOI 10.1111/j.1654-1103.2002.tb02025.x; Clarke PJ, 2005, J VEG SCI, V16, P237, DOI 10.1111/j.1654-1103.2005.tb02361.x; Comuin FA., 2010, ECOLOGICAL RESTORATI; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; Costello MJ, 2009, MAR ECOL PROG SER, V397, P253, DOI 10.3354/meps08317; Costello MJ, 2010, ENVIRON SCI TECHNOL, V44, P8821, DOI 10.1021/es1012752; Cowling RM, 2008, P NATL ACAD SCI USA, V105, P9483, DOI 10.1073/pnas.0706559105; Curran LM, 2006, P NATL ACAD SCI USA, V103, P12663, DOI 10.1073/pnas.0605449103; Czembor CA, 2009, FOREST ECOL MANAG, V259, P165, DOI 10.1016/j.foreco.2009.10.002; Danovaro R, 2008, CURR BIOL, V18, P1, DOI 10.1016/j.cub.2007.11.056; del Moral R, 2007, J VEG SCI, V18, P479, DOI 10.1111/j.1654-1103.2007.tb02562.x; DIAMOND JM, 1989, PHILOS T ROY SOC B, V325, P469, DOI 10.1098/rstb.1989.0100; Dirzo R, 2003, ANNU REV ENV RESOUR, V28, P137, DOI 10.1146/annurev.energy.28.050302.105532; Duffy JE, 2007, ECOL LETT, V10, P522, DOI 10.1111/j.1461-0248.2007.01037.x; Eisenhauer N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016055; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Arias-Gonzalez JE, 2012, BIODIVERS CONSERV, V21, P115, DOI 10.1007/s10531-011-0169-y; Essl F, 2012, BIODIVERS CONSERV, V21, P655, DOI 10.1007/s10531-011-0206-x; Estes JA, 2009, PHILOS T R SOC B, V364, P1647, DOI 10.1098/rstb.2008.0231; Faber-Langendoen D., 2009, B ECOL SOC AM, V90, P87, DOI DOI 10.1890/0012-9623-90.1.87; Fischer J, 2007, ECOSYSTEMS, V10, P964, DOI 10.1007/s10021-007-9071-6; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Fontaine C, 2006, PLOS BIOL, V4, P129, DOI 10.1371/journal.pbio.0040001; Fritz H, 2011, ECOGRAPHY, V34, P196, DOI 10.1111/j.1600-0587.2010.06537.x; Fukami T, 2005, P ROY SOC B-BIOL SCI, V272, P2105, DOI 10.1098/rspb.2005.3277; Fulton EA, 2011, FISH FISH, V12, P171, DOI 10.1111/j.1467-2979.2011.00412.x; Gaston KJ, 2008, TRENDS ECOL EVOL, V23, P14, DOI 10.1016/j.tree.2007.11.001; Gaston KJ, 1993, RARITY; Goudard A, 2008, AM NAT, V171, P91, DOI 10.1086/523945; Green PT, 2011, ECOLOGY, V92, P1758, DOI 10.1890/11-0050.1; Hahs AK, 2009, ECOL LETT, V12, P1165, DOI 10.1111/j.1461-0248.2009.01372.x; Hallenbeck WH, 1986, QUANTITATIVE RISK AS; Hannah J, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007591; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Harpole WS, 2007, NATURE, V446, P791, DOI 10.1038/nature05684; Hartley S, 2003, CONSERV BIOL, V17, P1559, DOI 10.1111/j.1523-1739.2003.00015.x; He FL, 2011, NATURE, V473, P368, DOI 10.1038/nature09985; Hector A, 2007, NATURE, V448, P188, DOI 10.1038/nature05947; Heemsbergen DA, 2004, SCIENCE, V306, P1019, DOI 10.1126/science.1101865; Hobbs R.J., 2009, NEW MODELS ECOSYSTEM; Hobbs RJ, 2006, GLOBAL ECOL BIOGEOGR, V15, P1, DOI 10.1111/j.1466-822x.2006.00212.x; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Holling CS, 2001, ECOSYSTEMS, V4, P390, DOI 10.1007/s10021-001-0101-5; Hong S, 2010, J CLIMATE, V23, P4669, DOI 10.1175/2010JCLI3697.1; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Huth N, 2011, J APPL ECOL, V48, P293, DOI 10.1111/j.1365-2664.2010.01936.x; Isbell F, 2011, NATURE, V477, P199, DOI 10.1038/nature10282; IUCN, 2011, GUIDELINES APPL IUCN; IUCNInternational Union for Conservation of Nature, 2001, SPEC SURV COMM INT U; Jacquez GM, 2008, ENVIRON ECOL STAT, V15, P403, DOI 10.1007/s10651-007-0066-4; Jax K, 1998, OIKOS, V82, P253, DOI 10.2307/3546965; Jennings MD, 2009, ECOL MONOGR, V79, P173, DOI 10.1890/07-1804.1; Keith DA, 1998, CONSERV BIOL, V12, P1076, DOI 10.1046/j.1523-1739.1998.97202.x; Keith DA, 2004, BIOL CONSERV, V117, P41, DOI 10.1016/S0006-3207(03)00261-1; Keith DA, 2007, J ECOL, V95, P1324, DOI 10.1111/j.1365-2745.2007.01302.x; Keith DA, 2009, BIOL CONSERV, V142, P1469, DOI 10.1016/j.biocon.2009.02.015; Keith David A., 2009, Ecological Management & Restoration, V10, pS3, DOI 10.1111/j.1442-8903.2009.00453.x; King KJ, 2006, INT J WILDLAND FIRE, V15, P527, DOI 10.1071/WF05076; Klemas V, 2010, J COASTAL RES, V26, P789, DOI 10.2112/10A-00012.1; Kontula T, 2009, BIODIVERS CONSERV, V18, P3861, DOI 10.1007/s10531-009-9684-5; Lapointe NWR, 2010, J FISH BIOL, V76, P446, DOI 10.1111/j.1095-8649.2009.02470.x; Larsen TH, 2005, ECOL LETT, V8, P538, DOI 10.1111/j.1461-0248.2005.00749.x; LEE JK, 1992, PHOTOGRAMM ENG REM S, V58, P1579; Lester RE, 2011, ECOL MODEL, V222, P2690, DOI 10.1016/j.ecolmodel.2011.05.009; Likens GE., 1992, ECOSYSTEM APPROACH I; Lindenmayer D, 2006, HABITAT FRAGMENTATIO; Lindenmayer DB, 2012, AUSTRAL ECOL, V37, P745, DOI 10.1111/j.1442-9993.2011.02351.x; Lindenmayer DB, 2011, ECOSYSTEMS, V14, P47, DOI 10.1007/s10021-010-9394-6; Loreau M, 2000, OIKOS, V91, P3, DOI 10.1034/j.1600-0706.2000.910101.x; Loreau M, 2003, P NATL ACAD SCI USA, V100, P12765, DOI 10.1073/pnas.2235465100; Loreau M, 2010, PHILOS T R SOC B, V365, P49, DOI 10.1098/rstb.2009.0155; Ludwig JA, 2007, ECOL INDIC, V7, P442, DOI 10.1016/j.ecolind.2006.05.001; Lundberg J, 2003, ECOSYSTEMS, V6, P87, DOI 10.1007/s10021-002-0150-4; Mac Nally R, 2011, WATER RESOUR RES, V47, DOI 10.1029/2011WR010383; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; McCarthy MA, 2008, J APPL ECOL, V45, P1428, DOI 10.1111/j.1365-2664.2008.01521.x; McKnight MW, 2007, PLOS BIOL, V5, P2424, DOI 10.1371/journal.pbio.0050272; Mearns A. J., 2010, Water Environment Research, V82, P2001, DOI 10.2175/106143010X12756668802175; Metternicht GI, 2003, REMOTE SENS ENVIRON, V85, P1, DOI 10.1016/S0034-4257(02)00188-8; Micklin P, 2006, EURASIAN GEOGR ECON, V47, P546, DOI 10.2747/1538-7216.47.5.546; Midgley GF, 2010, ECOGRAPHY, V33, P612, DOI 10.1111/j.1600-0587.2009.06000.x; Miller G, 2010, RANGELAND J, V32, P353, DOI 10.1071/RJ09076; Miller RM, 2007, CONSERV BIOL, V21, P684, DOI 10.1111/j.1523-1739.2007.00656.x; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Molnar JL, 2008, FRONT ECOL ENVIRON, V6, P485, DOI 10.1890/070064; Mucina L., 2006, VEGETATION S AFRICA; Nicholson E, 2009, CONSERV BIOL, V23, P259, DOI 10.1111/j.1523-1739.2008.01158.x; Noss RF, 1996, TRENDS ECOL EVOL, V11, P351, DOI 10.1016/0169-5347(96)20058-8; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Patrick WS, 2010, FISH B-NOAA, V108, P305; Rodriguez JP, 2011, CONSERV BIOL, V25, P21, DOI 10.1111/j.1523-1739.2010.01598.x; Peterson CH, 2003, SCIENCE, V302, P2082, DOI 10.1126/science.1084282; Peterson G, 1998, ECOSYSTEMS, V1, P6, DOI 10.1007/s100219900002; PICKETT S T A, 1989, P110; Pickett STA, 2002, ECOSYSTEMS, V5, P1, DOI 10.1007/s10021-001-0051-y; Pickett STA, 2001, APPL VEG SCI, V4, P41, DOI 10.1111/j.1654-109X.2001.tb00233.x; Possingham HP, 2002, TRENDS ECOL EVOL, V17, P503, DOI 10.1016/S0169-5347(02)02614-9; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; RACKHAM Oliver, 1986, HIST COUNTRYSIDE; Radford JQ, 2005, BIOL CONSERV, V124, P317, DOI 10.1016/j.biocon.2005.01.039; Ramirez-Llodra E, 2010, BIOGEOSCIENCES, V7, P2851, DOI 10.5194/bg-7-2851-2010; Regan HM, 2002, ECOL APPL, V12, P618, DOI 10.2307/3060967; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Riecken U, 2002, NATUR LANDSCHAFT, V77, P397; Ripple WJ, 2004, BIOSCIENCE, V54, P755, DOI 10.1641/0006-3568(2004)054[0755:WATEOF]2.0.CO;2; Rodrigues ASL, 2006, TRENDS ECOL EVOL, V21, P71, DOI 10.1016/j.tree.2005.10.010; Rodriguez JP, 2007, BIODIVERS CONSERV, V16, P183, DOI 10.1007/s10531-006-9102-1; Rodriguez JP, 2012, SAPIENS, V5, P6; ROGERS CS, 1990, MAR ECOL PROG SER, V62, P185, DOI 10.3354/meps062185; Rosensweig ML, 1995, SPECIES DIVERSITY SP; Rumpff L, 2011, BIOL CONSERV, V144, P1224, DOI 10.1016/j.biocon.2010.10.026; Sang A, 2010, BIOL CONSERV, V143, P1405, DOI 10.1016/j.biocon.2010.03.015; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Schmitz OJ, 2000, AM NAT, V155, P141, DOI 10.1086/303311; Scholze M, 2006, P NATL ACAD SCI USA, V103, P13116, DOI 10.1073/pnas.0601816103; Shi JM, 2010, BIODIVERS CONSERV, V19, P1279, DOI 10.1007/s10531-009-9757-5; Solow AR, 2005, MATH BIOSCI, V195, P47, DOI 10.1016/j.mbs.2005.02.001; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Springer AM, 2003, P NATL ACAD SCI USA, V100, P12223, DOI 10.1073/pnas.1635156100; Srivastava DS, 2005, ANNU REV ECOL EVOL S, V36, P267, DOI 10.1146/annurev.ecolsys.36.102003.152636; Staver AC, 2009, ECOL APPL, V19, P1909, DOI 10.1890/08-1907.1; Stoddard JL, 2008, J N AM BENTHOL SOC, V27, P878, DOI 10.1899/08-053.1; Tansley AG, 1935, ECOLOGY, V16, P284, DOI 10.2307/1930070; Thebault E, 2005, AM NAT, V166, pE95, DOI 10.1086/444403; Thebault E, 2007, OIKOS, V116, P163, DOI 10.1111/j.2006.0030-1299.15007.x; Thompson John N., 1997, P285; Tierney GL, 2009, FRONT ECOL ENVIRON, V7, P308, DOI 10.1890/070176; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Todd BJ, 2006, BENTHIC HABITAT SUN; UNDERWOOD AJ, 1989, TRENDS ECOL EVOL, V4, P16, DOI 10.1016/0169-5347(89)90008-6; Vazquez DP, 2003, ECOL LETT, V6, P1077, DOI 10.1046/j.1461-0248.2003.00534.x; Visconti P, 2010, BIOL CONSERV, V143, P756, DOI 10.1016/j.biocon.2009.12.018; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Vrijenhoek RC, 2010, MOL ECOL, V19, P4391, DOI 10.1111/j.1365-294X.2010.04789.x; Walker B, 1999, ECOSYSTEMS, V2, P95, DOI 10.1007/s100219900062; Walters C, 2001, CAN J FISH AQUAT SCI, V58, P39, DOI 10.1139/cjfas-58-1-39; Watling L, 1998, CONSERV BIOL, V12, P1180, DOI 10.1046/j.1523-1739.1998.0120061180.x; WESTOBY M, 1989, J RANGE MANAGE, V42, P266, DOI 10.2307/3899492; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Willis AJ, 1997, FUNCT ECOL, V11, P268, DOI 10.1111/j.1365-2435.1997.00081.x; Wilson EO, 1967, THEORY ISLAND BIOGEO; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463; Yamano H, 2004, REMOTE SENS ENVIRON, V90, P86, DOI 10.1016/j.rse.2003.12.005; Zhao HL, 2005, J ARID ENVIRON, V62, P309, DOI 10.1016/j.jaridenv.2004.11.009	175	306	328	12	272	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62111	10.1371/journal.pone.0062111	http://dx.doi.org/10.1371/journal.pone.0062111			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667454	Green Submitted, Green Published, gold			2022-12-25	WOS:000319055600016
J	Wu, LL; Feng, Z; Cui, SY; Hou, K; Tang, L; Zhou, JH; Cai, GY; Xie, YS; Hong, Q; Fu, B; Chen, XM				Wu, Lingling; Feng, Zhe; Cui, Shaoyuan; Hou, Kai; Tang, Li; Zhou, Jianhui; Cai, Guangyan; Xie, Yuansheng; Hong, Quan; Fu, Bo; Chen, Xiangmei			Rapamycin Upregulates Autophagy by Inhibiting the mTOR-ULK1 Pathway, Resulting in Reduced Podocyte Injury	PLOS ONE			English	Article							MTORC1 ACTIVATION; MAMMALIAN TARGET; DIFFERENTIATION; CYTOSKELETON; BIOLOGY	The podocyte functions as a glomerular filtration barrier. Autophagy of postmitotic cells is an important protective mechanism that is essential for maintaining the homeostasis of podocytes. Exploring an in vivo rat model of passive Heymann nephritis and an in vitro model of puromycin amino nucleotide (PAN)-cultured podocytes, we examined the specific mechanisms underlying changing autophagy levels and podocyte injury. In the passive Heymann nephritis model rats, the mammalian target-of-rapamycin (mTOR) levels were upregulated in injured podocytes while autophagy was inhibited. In PAN-treated podocytes, mTOR lowered the level of autophagy through the mTOR-ULK1 pathway resulting in damaged podocytes. Rapamycin treatment of these cells reduced podocyte injury by raising the levels of autophagy. These in vivo and in vitro experiments demonstrate that podocyte injury is associated with changes in autophagy levels, and that rapamycin can reduce podocyte injury by increasing autophagy levels via inhibition of the mTOR-ULK1 pathway. These results provide an important theoretical basis for future treatment of diseases involving podocyte injury.	[Wu, Lingling; Feng, Zhe; Cui, Shaoyuan; Hou, Kai; Tang, Li; Zhou, Jianhui; Cai, Guangyan; Xie, Yuansheng; Hong, Quan; Fu, Bo; Chen, Xiangmei] Peoples Liberat Army Gen Hosp, Dept Nephrol, State Key Lab Kidney Dis, Beijing, Peoples R China; [Wu, Lingling; Feng, Zhe; Cui, Shaoyuan; Hou, Kai; Tang, Li; Zhou, Jianhui; Cai, Guangyan; Xie, Yuansheng; Hong, Quan; Fu, Bo; Chen, Xiangmei] Mil Med Postgrad Coll, Beijing, Peoples R China; [Wu, Lingling] Nankai Univ, Coll Med, Tianjin 300071, Peoples R China	Chinese People's Liberation Army General Hospital; Nankai University	Feng, Z (corresponding author), Peoples Liberat Army Gen Hosp, Dept Nephrol, State Key Lab Kidney Dis, Beijing, Peoples R China.	zhezhe_4025@126.com; xmchen301@126.com	hou, kai/GWU-6579-2022; Wu, Ling/GZN-2235-2022		Programs of the National Natural Science Foundation of China [30800521, 81102673]; National Basic Research Program of China [2011CB944000, 2012CB530800]	Programs of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by grants from Programs of the National Natural Science Foundation of China (30800521, 81102673) and the National Basic Research Program of China (2011CB944000, 2012CB530800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asanuma K, 2003, FASEB J, V17, P1165, DOI 10.1096/fj.02-0580fje; Ballou Lisa M, 2008, J Chem Biol, V1, P27, DOI 10.1007/s12154-008-0003-5; Barisoni L, 2003, AM J NEPHROL, V23, P353, DOI 10.1159/000072917; Chan EY, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.284pe51; Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239; Hartleben B, 2010, J CLIN INVEST, V120, P1084, DOI 10.1172/JCI39492; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Huber TB, 2011, KIDNEY INT, V79, P502, DOI 10.1038/ki.2010.457; Inoki K, 2012, CURR OPIN NEPHROL HY, V21, P251, DOI 10.1097/MNH.0b013e3283520f38; Inoki K, 2011, J CLIN INVEST, V121, P2181, DOI 10.1172/JCI44771; Ito N, 2011, LAB INVEST, V91, P1584, DOI 10.1038/labinvest.2011.135; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; Kundu M, 2011, ANTIOXID REDOX SIGN, V14, P1953, DOI 10.1089/ars.2010.3809; Lee EJ, 2011, AUTOPHAGY, V7, P689, DOI 10.4161/auto.7.7.15450; Lee JHW, 2009, J HYDRO-ENVIRON RES, V3, P1, DOI 10.1016/j.jher.2009.05.002; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Lieberthal W, 2012, AM J PHYSIOL-RENAL, V303, pF1, DOI 10.1152/ajprenal.00014.2012; Lieberthal W, 2009, J AM SOC NEPHROL, V20, P2493, DOI 10.1681/ASN.2008111186; Mehrpour M, 2010, CELL RES, V20, P748, DOI 10.1038/cr.2010.82; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Mundel P, 2002, J AM SOC NEPHROL, V13, P3005, DOI 10.1097/01.ASN.0000039661.06947.FD; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Perez JCR, 2011, NEFROLOGIA, V31, P251, DOI 10.3265/Nefrologia.pre2011.Apr.10947; SALANT DJ, 1988, METHODS ENZYMOL, V162, P421; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; SUCCAR L, 2011, ROLE MAMMALIAN TARGE, P184; Tanaka Y, 2012, EXP DIABETES RES, DOI 10.1155/2012/628978; Vollenbroker B, 2009, AM J PHYSIOL-RENAL, V296, pF418, DOI 10.1152/ajprenal.90319.2008; Wang LM, 2008, KIDNEY BLOOD PRESS R, V31, P111, DOI 10.1159/000121531; Weide T, 2011, CELL TISSUE RES, V343, P467, DOI 10.1007/s00441-010-1115-0; Wen DH, 2011, AM J NEPHROL, V34, P423, DOI 10.1159/000331701; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	36	84	97	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63799	10.1371/journal.pone.0063799	http://dx.doi.org/10.1371/journal.pone.0063799			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667674	gold, Green Submitted, Green Published			2022-12-25	WOS:000319055600075
J	Esterlechner, J; Reichert, N; Iltzsche, F; Krause, M; Finkernagel, F; Gaubatz, S				Esterlechner, Jasmina; Reichert, Nina; Iltzsche, Fabian; Krause, Michael; Finkernagel, Florian; Gaubatz, Stefan			LIN9, a Subunit of the DREAM Complex, Regulates Mitotic Gene Expression and Proliferation of Embryonic Stem Cells	PLOS ONE			English	Article							B-MYB; SELF-RENEWAL; MOUSE EMBRYOS; G(2)/M GENES; PROTEIN; CYCLE; TRANSCRIPTION; MICE; DIFFERENTIATION; IDENTIFICATION	The DREAM complex plays an important role in regulation of gene expression during the cell cycle. We have previously shown that the DREAM subunit LIN9 is required for early embryonic development and for the maintenance of the inner cell mass in vitro. In this study we examined the effect of knocking down LIN9 on ESCs. We demonstrate that depletion of LIN9 alters the cell cycle distribution of ESCs and results in an accumulation of cells in G2 and M and in an increase of polyploid cells. Genome-wide expression studies showed that the depletion of LIN9 results in downregulation of mitotic genes and in upregulation of differentiation-specific genes. ChIP-on chip experiments showed that mitotic genes are direct targets of LIN9 while lineage specific markers are regulated indirectly. Importantly, depletion of LIN9 does not alter the expression of pluripotency markers SOX2, OCT4 and Nanog and LIN9 depleted ESCs retain alkaline phosphatase activity. We conclude that LIN9 is essential for proliferation and genome stability of ESCs by activating genes with important functions in mitosis and cytokinesis.	[Esterlechner, Jasmina; Reichert, Nina; Iltzsche, Fabian; Gaubatz, Stefan] Univ Wurzburg, Theodor Boveri Inst, Bioctr, D-97070 Wurzburg, Germany; [Krause, Michael; Finkernagel, Florian] Univ Marburg, Inst Mol Biol & Tumor Res IMT, Marburg, Germany	University of Wurzburg; Philipps University Marburg	Gaubatz, S (corresponding author), Univ Wurzburg, Theodor Boveri Inst, Bioctr, D-97070 Wurzburg, Germany.	stefan.gaubatz@biozentrum.uni-wuerzburg.de		Gaubatz, Stefan/0000-0001-8751-4191	DFG: (Deutsche Forschungsgemeinschaft) [575/5-2, TR17 B1]	DFG: (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This work was supported by grants from the DFG: (Deutsche Forschungsgemeinschaft) (575/5-2 and TR17 B1) towards SG; URL: http://www.dfg.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; Brandeis M, 1998, P NATL ACAD SCI USA, V95, P4344, DOI 10.1073/pnas.95.8.4344; Cutts SM, 1999, HUM MOL GENET, V8, P1145, DOI 10.1093/hmg/8.7.1145; Driegen S, 2005, TRANSGENIC RES, V14, P477, DOI 10.1007/s11248-005-7220-2; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; He SH, 2009, ANNU REV CELL DEV BI, V25, P377, DOI 10.1146/annurev.cellbio.042308.113248; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Howman EV, 2000, P NATL ACAD SCI USA, V97, P1148, DOI 10.1073/pnas.97.3.1148; Kalitsis P, 2000, GENE DEV, V14, P2277, DOI 10.1101/gad.827500; Kim J, 2009, NAT PROTOC, V4, P506, DOI 10.1038/nprot.2009.23; Kleinschmidt MA, 2008, NUCLEIC ACIDS RES, V36, P3202, DOI 10.1093/nar/gkn166; Knight AS, 2009, ONCOGENE, V28, P1737, DOI 10.1038/onc.2009.22; Korenjak M, 2004, CELL, V119, P181, DOI 10.1016/j.cell.2004.09.034; Lange C, 2010, CELL CYCLE, V9, P1893, DOI 10.4161/cc.9.10.11598; Lewis PW, 2004, GENE DEV, V18, P2929, DOI 10.1101/gad.1255204; Li VC, 2012, P NATL ACAD SCI USA, V109, P12550, DOI 10.1073/pnas.1206740109; Litovchick L, 2007, MOL CELL, V26, P539, DOI 10.1016/j.molcel.2007.04.015; Lorvellec M, 2010, STEM CELLS, V28, P1751, DOI 10.1002/stem.496; Lu LY, 2008, MOL CELL BIOL, V28, P6870, DOI 10.1128/MCB.00392-08; Minato Y, 2007, GENE, V403, P89, DOI 10.1016/j.gene.2007.08.011; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Osterloh L, 2007, EMBO J, V26, P144, DOI 10.1038/sj.emboj.7601478; Pilkinton M, 2007, J BIOL CHEM, V282, P168, DOI 10.1074/jbc.M609924200; Reichert N, 2010, MOL CELL BIOL, V30, P2896, DOI 10.1128/MCB.00028-10; Schmit F, 2007, CELL CYCLE, V6, P1903, DOI 10.4161/cc.6.15.4512; Singh AM, 2009, CELL STEM CELL, V5, P141, DOI 10.1016/j.stem.2009.07.003; SNOW MHL, 1978, J EMBRYOL EXP MORPH, V47, P39; Stead E, 2002, ONCOGENE, V21, P8320, DOI 10.1038/sj.onc.1206015; Tanaka Y, 1999, J BIOL CHEM, V274, P28067, DOI 10.1074/jbc.274.40.28067; Tarasov KV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002478; Tavner F, 2007, ONCOGENE, V26, P2727, DOI 10.1038/sj.onc.1210087; Weaver BAA, 2003, J CELL BIOL, V162, P551, DOI 10.1083/jcb.200303167; White J, 2005, MOL BIOL CELL, V16, P2018, DOI 10.1091/mbc.e04-12-1056; White J, 2005, STEM CELL REV, V1, P131, DOI 10.1385/SCR:1:2:131; Woo AJ, 2008, MOL CELL BIOL, V28, P2675, DOI 10.1128/MCB.01945-07; Yoshikawa T, 2006, GENE EXPR PATTERNS, V6, P213, DOI 10.1016/j.modgep.2005.06.003; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042350	39	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62882	10.1371/journal.pone.0062882	http://dx.doi.org/10.1371/journal.pone.0062882			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667535	Green Published, Green Submitted, gold			2022-12-25	WOS:000319654700074
J	Haddad, NF; Teodoro, AJ; de Oliveira, FL; Soares, N; de Mattos, RM; Hecht, F; Dezonne, RS; Vairo, L; Goldenberg, RCD; Gomes, FCA; de Carvalho, DP; Gadelha, MR; Nasciutti, LE; Miranda-Alves, L				Haddad, Natalia F.; Teodoro, Anderson J.; de Oliveira, Felipe Leite; Soares, Nathalia; de Mattos, Romulo Medina; Hecht, Fabio; Dezonne, Romulo Sperduto; Vairo, Leandro; dos Santos Goldenberg, Regina Coeli; Alcantara Gomes, Flavia Carvalho; de Carvalho, Denise Pires; Gadelha, Monica R.; Nasciutti, Luiz Eurico; Miranda-Alves, Leandro			Lycopene and Beta-Carotene Induce Growth Inhibition and Proapoptotic Effects on ACTH-Secreting Pituitary Adenoma Cells	PLOS ONE			English	Article							GAP JUNCTIONAL COMMUNICATION; COLON ADENOCARCINOMA CELLS; HEPATIC STELLATE CELLS; PROSTATE-CANCER CELLS; RETINOIC ACID; CYCLE ARREST; DOWN-REGULATION; TUMOR-CELLS; IN-VITRO; SOMATOSTATIN RECEPTORS	Pituitary adenomas comprise approximately 10-15% of intracranial tumors and result in morbidity associated with altered hormonal patterns, therapy and compression of adjacent sella turcica structures. The use of functional foods containing carotenoids contributes to reduce the risk of chronic diseases such as cancer and vascular disorders. In this study, we evaluated the influence of different concentrations of beta-carotene and lycopene on cell viability, colony formation, cell cycle, apoptosis, hormone secretion, intercellular communication and expression of connexin 43, Skp2 and p27(kip1) in ACTH-secreting pituitary adenoma cells, the AtT20 cells, incubated for 48 and 96 h with these carotenoids. We observed a decrease in cell viability caused by the lycopene and beta-carotene treatments; in these conditions, the clonogenic ability of the cells was also significantly decreased. Cell cycle analysis revealed that beta-carotene induced an increase of the cells in S and G2/M phases; furthermore, lycopene increased the proportion of these cells in G0/G1 while decreasing the S and G2/M phases. Also, carotenoids induced apoptosis after 96 h. Lycopene and beta-carotene decreased the secretion of ACTH in AtT20 cells in a dose-dependent manner. Carotenoids blocked the gap junction intercellular communication. In addition, the treatments increased the expression of phosphorylated connexin43. Finally, we also demonstrate decreased expression of S-phase kinase-associated protein 2 (Skp2) and increased expression of p27(kip1) in carotenoid-treated cells. These results show that lycopene and beta-carotene were able to negatively modulate events related to the malignant phenotype of AtT20 cells, through a mechanism that could involve changes in the expression of connexin 43, Skp2 and p27(kip1); and suggest that these compounds might provide a novel pharmacological approach to the treatment of Cushing's disease.	[Haddad, Natalia F.; Teodoro, Anderson J.; de Oliveira, Felipe Leite; Soares, Nathalia; de Mattos, Romulo Medina; Dezonne, Romulo Sperduto; Alcantara Gomes, Flavia Carvalho; Nasciutti, Luiz Eurico; Miranda-Alves, Leandro] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, BR-21941 Rio De Janeiro, Brazil; [Haddad, Natalia F.; Hecht, Fabio; de Carvalho, Denise Pires; Gadelha, Monica R.] Univ Fed Rio de Janeiro, Serv Endocrinol, Hosp Univ Clementino Fraga Filho, BR-21941 Rio De Janeiro, Brazil; [Vairo, Leandro; dos Santos Goldenberg, Regina Coeli] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil; [Teodoro, Anderson J.] Univ Estado Rio de Janeiro, Programa Nutr & Alimentos, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade do Estado do Rio de Janeiro	Miranda-Alves, L (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, BR-21941 Rio De Janeiro, Brazil.	lmiranda@ufrj.br	Dezonne, Romulo Sperdudo/ABB-4292-2021; Gomes, Flavia/AAX-6354-2021; Oliveira, Felipe L/H-9902-2012; Goldenberg, Regina/ABI-2609-2020; Vairo, Leandro/J-9938-2013; Carvalho, Denise P/H-6306-2012; Teodoro, Anderson Junger/F-9608-2015; Hecht, Fabio/R-9004-2017; Gomes, Flavia/C-5383-2013; Miranda-Alves, Leandro/D-9932-2014	Goldenberg, Regina/0000-0002-0886-9603; Carvalho, Denise P/0000-0001-6933-6424; Teodoro, Anderson Junger/0000-0002-0949-9528; Hecht, Fabio/0000-0001-9110-2587; Gomes, Flavia/0000-0003-2966-0638; Dezonne, Romulo/0000-0002-5838-0881; Miranda-Alves, Leandro/0000-0001-7832-8717	Conselho Nacional de Desenvolvimento Cientifico (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)	Conselho Nacional de Desenvolvimento Cientifico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico (CNPq) and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Wadei HAN, 2009, INT J ONCOL, V34, P1093, DOI 10.3892/ijo_00000236; Bangaru MLY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009893; Ben-Dor A, 2001, ARCH BIOCHEM BIOPHYS, V391, P295, DOI 10.1006/abbi.2001.2412; Bertram JS, 2004, BIOCHEM SOC T, V32, P985, DOI 10.1042/BST0320985; BUONASSISI V, 1962, P NATL ACAD SCI USA, V48, P1184, DOI 10.1073/pnas.48.7.1184; Chalabi N, 2007, J HISTOCHEM CYTOCHEM, V55, P877, DOI 10.1369/jhc.7A7185.2007; Daly AF, 2007, HORM RES, V68, P195, DOI 10.1159/000110624; Dbouk HA, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-4; Florio T, 2008, FRONT BIOSCI-LANDMRK, V13, P822, DOI 10.2741/2722; Fornelli F, 2007, TOXICOL IN VITRO, V21, P217, DOI 10.1016/j.tiv.2006.09.024; FURTH J, 1953, P SOC EXP BIOL MED, V84, P253; Giacomini D, 2006, ENDOCRINOLOGY, V147, P247, DOI 10.1210/en.2005-0958; He WW, 2012, CANCER BIOTHER RADIO, V27, P399, DOI 10.1089/cbr.2010.0802; Hix LA, 2004, CANCER LETT, V211, P25, DOI 10.1016/j.canlet.2004.01.036; Hix LM, 2004, REDOX REP, V9, P181, DOI 10.1179/135100004225005967; Hofland LJ, 2010, NEUROENDOCRINOLOGY, V92, P11, DOI 10.1159/000314296; Huang HC, 2011, J AGR FOOD CHEM, V59, P6765, DOI 10.1021/jf201096v; Hwang ES, 2004, J MED FOOD, V7, P284, DOI 10.1089/1096620041938614; Ishida E, 2011, ENDOCR J, V58, P287, DOI 10.1507/endocrj.K10E-158; Jang SH, 2009, ANN NY ACAD SCI, V1171, P156, DOI 10.1111/j.1749-6632.2009.04711.x; Kanemitsu MY, 1998, CELL GROWTH DIFFER, V9, P13; Kelkel M, 2011, FREE RADICAL RES, V45, P925, DOI 10.3109/10715762.2011.564168; Kiec-Wilk B, 2011, NUTR CANCER, V63, P1053, DOI 10.1080/01635581.2011.596644; KLEIN SB, 1992, J CELL PHYSIOL, V151, P326, DOI 10.1002/jcp.1041510214; Kotake-Nara E, 2001, J NUTR, V131, P3303, DOI 10.1093/jn/131.12.3303; Labeur M, 2006, FRONT HORM RES, V35, P169, DOI 10.1159/000094325; Labeur M, 2009, REV ENDOCR METAB DIS, V10, P103, DOI 10.1007/s11154-008-9080-6; Lampe PD, 1998, J CELL SCI, V111, P833; Leithe E, 2010, TOXICOL APPL PHARM, V247, P10, DOI 10.1016/j.taap.2010.05.006; Libe R, 2012, NEW ENGL J MED, V366, P2134, DOI 10.1056/NEJMc1204078; Liu NA, 2011, P NATL ACAD SCI USA, V108, P8414, DOI 10.1073/pnas.1018091108; Long AC, 2010, CURR EYE RES, V35, P670, DOI 10.3109/02713681003770746; Lu MD, 2012, MED ONCOL, V29, P3409, DOI 10.1007/s12032-012-0275-z; Marquez-Rosado L, 2012, BBA-BIOMEMBRANES, V1818, P1985, DOI 10.1016/j.bbamem.2011.07.028; Martucci RB, 2004, J CELL BIOCHEM, V92, P414, DOI 10.1002/jcb.20073; Miller M, 2008, ENDOCRINOLOGY, V149, P4158, DOI 10.1210/en.2007-1760; Moennikes O, 2003, CARCINOGENESIS, V24, P1561, DOI 10.1093/carcin/bgg099; Nahum A, 2001, ONCOGENE, V20, P3428, DOI 10.1038/sj.onc.1204452; Nahum A, 2006, EUR J NUTR, V45, P275, DOI 10.1007/s00394-006-0595-x; Neggers SJ, 2011, HORM RES PAEDIAT, V76, P102, DOI 10.1159/000329189; Palozza P, 2002, CARCINOGENESIS, V23, P11, DOI 10.1093/carcin/23.1.11; Palozza P, 2007, BRIT J NUTR, V98, P789, DOI 10.1017/S0007114507746883; Palozza P, 2010, CARCINOGENESIS, V31, P1813, DOI 10.1093/carcin/bgq157; Palozza P, 2009, BRIT J NUTR, V102, P207, DOI 10.1017/S0007114508169902; Pan SY, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-372; Pivonello R, 2004, J CLIN ENDOCR METAB, V89, P4493, DOI 10.1210/jc.2003-031746; RUCH RJ, 1987, TOXICOL APPL PHARM, V87, P111, DOI 10.1016/0041-008X(87)90089-5; Sakagami Y, 2010, YAKUGAKU ZASSHI, V130, P1445, DOI 10.1248/yakushi.130.1445; Sathyapalan T, 2012, EXPERT REV ANTICANC, V12, P669, DOI [10.1586/ERA.12.27, 10.1586/era.12.27]; Schaaf C, 2009, ENDOCR-RELAT CANCER, V16, P1339, DOI 10.1677/ERC-09-0129; Schaaf C, 2010, NEUROENDOCRINOLOGY, V91, P200, DOI 10.1159/000287236; Stahl W, 1998, INT J VITAM NUTR RES, V68, P354; Sun SH, 2012, EUR J PHARMACOL, V690, P22, DOI 10.1016/j.ejphar.2012.05.036; Talvas J, 2010, AM J CLIN NUTR, V91, P1716, DOI 10.3945/ajcn.2009.28666; Tang FY, 2008, MOL NUTR FOOD RES, V52, P646, DOI 10.1002/mnfr.200700272; Tani Y, 2011, ENDOCR J, V58, P297, DOI 10.1507/endocrj.K10E-389; Teodoro AJ, 2009, EUR J NUTR, V48, P261, DOI 10.1007/s00394-009-0001-6; Teodoro AJ, 2012, CANCER CELL INT, V12, DOI 10.1186/1475-2867-12-36; Theodoropoulou M, 2010, FRONT HORM RES, V38, P158, DOI 10.1159/000318506; VINDELOV LL, 1977, VIRCHOWS ARCH B, V24, P227; Vinken M, 2012, BBA-BIOMEMBRANES, V1818, P2002, DOI 10.1016/j.bbamem.2011.06.011; Vogt TM, 2002, AM J EPIDEMIOL, V155, P1023, DOI 10.1093/aje/155.11.1023; Yang CM, 2011, MOL NUTR FOOD RES, V55, P606, DOI 10.1002/mnfr.201000308; Yang ZF, 2008, INT J VITAM NUTR RES, V78, P105, DOI 10.1024/0300-9831.78.3.105	64	27	27	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62773	10.1371/journal.pone.0062773	http://dx.doi.org/10.1371/journal.pone.0062773			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667519	gold, Green Published, Green Submitted			2022-12-25	WOS:000319654700062
J	Johnstone, VPA; Yan, EB; Alwis, DS; Rajan, R				Johnstone, Victoria Philippa Anne; Yan, Edwin Bingbing; Alwis, Dasuni Sathsara; Rajan, Ramesh			Cortical Hypoexcitation Defines Neuronal Responses in the Immediate Aftermath of Traumatic Brain Injury	PLOS ONE			English	Article							RAT BARREL CORTEX; FLUID-PERCUSSION INJURY; SPREADING DEPRESSION; INTRATHECAL BACLOFEN; PYRAMIDAL NEURONS; POSTTRAUMATIC EPILEPSY; SOMATOSENSORY CORTEX; RECEPTOR AGONISTS; WHISKER VIBRATION; HIPPOCAMPAL CA1	Traumatic brain injury (TBI) from a blow to the head is often associated with complex patterns of brain abnormalities that accompany deficits in cognitive and motor function. Previously we reported that a long-term consequence of TBI, induced with a closed-head injury method modelling human car and sporting accidents, is neuronal hyper-excitation in the rat sensory barrel cortex that receives tactile input from the face whiskers. Hyper-excitation occurred only in supra-granular layers and was stronger to complex than simple stimuli. We now examine changes in the immediate aftermath of TBI induced with same injury method. At 24 hours post-trauma significant sensorimotor deficits were observed and characterisation of the cortical population neuronal responses at that time revealed a depth-dependent suppression of neuronal responses, with reduced responses from supragranular layers through to input layer IV, but not in infragranular layers. In addition, increased spontaneous firing rate was recorded in cortical layers IV and V. We postulate that this early post-injury suppression of cortical processing of sensory input accounts for immediate post-trauma sensory morbidity and sets into train events that resolve into long-term cortical hyper-excitability in upper sensory cortex layers that may account for long-term sensory hyper-sensitivity in humans with TBI.	[Johnstone, Victoria Philippa Anne; Yan, Edwin Bingbing; Alwis, Dasuni Sathsara; Rajan, Ramesh] Monash Univ, Dept Physiol, Monash, Vic, Australia	Monash University	Rajan, R (corresponding author), Monash Univ, Dept Physiol, Monash, Vic, Australia.	ramesh.rajan@monash.edu	Johnstone, Victoria/B-5083-2015; rajan, ramesh/L-4842-2019	Johnstone, Victoria/0000-0001-9885-3607; Rajan, Ramesh/0000-0001-9862-0520	National Health & Medical Research Council of Australia [APP1029311]	National Health & Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by the National Health & Medical Research Council of Australia (grant no. APP1029311). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson-Mitchell N, 2008, J CLIN NURS, V17, P46, DOI 10.1111/j.1365-2702.2007.01941.x; Akasu T, 2002, NEUROSCI LETT, V329, P305, DOI 10.1016/S0304-3940(02)00707-3; Alloway KD, 2008, CEREB CORTEX, V18, P979, DOI 10.1093/cercor/bhm138; Alwis DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052169; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Arabzadeh E, 2004, J NEUROSCI, V24, P6011, DOI 10.1523/JNEUROSCI.1389-04.2004; Arabzadeh E, 2003, J NEUROSCI, V23, P9146; BOHNEN N, 1991, J NEUROL, V238, P443, DOI 10.1007/BF00314651; BOHNEN N, 1992, J NEUROL NEUROSUR PS, V55, P222, DOI 10.1136/jnnp.55.3.222; BRANDS D.W.A., 2002, PREDICTING BRAIN MEC; Brecht M, 2002, J PHYSIOL-LONDON, V543, P49, DOI 10.1113/jphysiol.2002.018465; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Church AJ, 2005, J NEUROTRAUM, V22, P277, DOI 10.1089/neu.2005.22.277; Clarkson AN, 2010, NATURE, V468, P305, DOI 10.1038/nature09511; Cohen AS, 2007, PROG BRAIN RES, V161, P143, DOI 10.1016/S0079-6123(06)61010-8; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; D'Ambrosio R, 1999, J NEUROSCI, V19, P8152; de Kock CPJ, 2007, J PHYSIOL-LONDON, V581, P139, DOI 10.1113/jphysiol.2006.124321; DIETRICH WD, 1994, J NEUROTRAUM, V11, P629, DOI 10.1089/neu.1994.11.629; Ding MC, 2011, J NEUROSCI, V31, P14085, DOI 10.1523/JNEUROSCI.3572-11.2011; Dischinger PC, 1998, ACCIDENT ANAL PREV, V30, P831, DOI 10.1016/S0001-4575(98)00036-0; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Feldmeyer D, 2005, J NEUROSCI, V25, P3423, DOI 10.1523/JNEUROSCI.5227-04.2005; Feldmeyer D, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00024; Francisco GE, 2007, BRAIN INJURY, V21, P335, DOI 10.1080/02699050701311018; Fraser PA, 2011, FREE RADICAL BIO MED, V51, P967, DOI 10.1016/j.freeradbiomed.2011.06.003; Fujioka H, 2004, STROKE, V35, pE346, DOI 10.1161/01.STR.0000130990.28734.9c; Fukuda K, 1996, J NEUROTRAUM, V13, P255, DOI 10.1089/neu.1996.13.255; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Griesemer D, 2007, J NEUROTRAUM, V24, P1823, DOI 10.1089/neu.2006.0237; Hall KD, 2010, BRAIN RES, V1323, P161, DOI 10.1016/j.brainres.2010.01.067; Hartmann MJ, 2003, J NEUROSCI, V23, P6510; Hellewell SC, 2010, J NEUROTRAUM, V27, P1997, DOI 10.1089/neu.2009.1245; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Hendricks S, 2012, J SPORT SCI, V30, P1215, DOI 10.1080/02640414.2012.707328; HERNANDEZCACERES J, 1987, BRAIN RES, V437, P360, DOI 10.1016/0006-8993(87)91652-0; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hooks BM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000572; Hunt RF, 2011, J NEUROSCI, V31, P6880, DOI 10.1523/JNEUROSCI.0032-11.2011; JENSEN KF, 1987, J NEUROSCI, V7, P3529; Kao T, 2011, J NEUROPHYSIOL, V106, P2662, DOI 10.1152/jn.01017.2010; KELLER A, 1985, BRAIN RES, V343, P159, DOI 10.1016/0006-8993(85)91171-0; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Koerner C, 2004, NEUROSCI LETT, V361, P21, DOI 10.1016/j.neulet.2003.12.074; KORALEK KA, 1988, BRAIN RES, V463, P346, DOI 10.1016/0006-8993(88)90408-8; Lamy M, 2013, MED BIOL ENG COMPUT, V51, P353, DOI 10.1007/s11517-012-1004-7; Larsen DD, 2006, J COMP NEUROL, V494, P398, DOI 10.1002/cne.20754; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Learoyd AE, 2012, BEHAV BRAIN RES, V226, P197, DOI 10.1016/j.bbr.2011.09.016; Lei ZG, 2012, J NEUROTRAUM, V29, P235, DOI 10.1089/neu.2010.1537; Levchakov A, 2006, J NEUROTRAUM, V23, P1570, DOI 10.1089/neu.2006.23.1570; Lew HL, 2004, AM J PHYS MED REHAB, V83, P428, DOI 10.1097/00002060-200406000-00004; Li HF, 2002, J NEUROPHYSIOL, V88, P2, DOI 10.1152/jn.00507.2001; Li Y, 2011, J NEUROTRAUM, V28, P1767, DOI 10.1089/neu.2010.1687; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Lubke J, 2003, CEREB CORTEX, V13, P1051, DOI 10.1093/cercor/13.10.1051; Manns ID, 2004, J PHYSIOL-LONDON, V556, P601, DOI 10.1113/jphysiol.2003.053132; Maravall M, 2007, PLOS BIOL, V5, P323, DOI 10.1371/journal.pbio.0050019; Marino S, 2007, J NEUROL NEUROSUR PS, V78, P501, DOI 10.1136/jnnp.2006.099796; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McNamara KCS, 2010, J NEUROTRAUM, V27, P695, DOI 10.1089/neu.2009.1237; Meyer HS, 2010, CEREB CORTEX, V20, P2287, DOI 10.1093/cercor/bhq069; Meythaler JM, 1999, ARCH PHYS MED REHAB, V80, P13, DOI 10.1016/S0003-9993(99)90301-5; Mulders WHAM, 2009, NEUROSCIENCE, V164, P733, DOI 10.1016/j.neuroscience.2009.08.036; Nance ML, 2006, ANN SURG, V243, P121, DOI 10.1097/01.sla.0000193838.11102.56; NELLGARD B, 1992, ACTA PHYSIOL SCAND, V146, P497, DOI 10.1111/j.1748-1716.1992.tb09451.x; NEUMANNHAEFELIN T, 1995, NEUROSCI LETT, V193, P101, DOI 10.1016/0304-3940(95)11677-O; Oberlaender M, 2012, CEREB CORTEX, V22, P2375, DOI 10.1093/cercor/bhr317; Pavlov I, 2011, NEUROSCIENCE, V194, P208, DOI 10.1016/j.neuroscience.2011.07.074; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Pinto DJ, 2000, J NEUROPHYSIOL, V83, P1158, DOI 10.1152/jn.2000.83.3.1158; Piot-Grosjean O, 2001, NEUROBIOL DIS, V8, P1082, DOI 10.1006/nbdi.2001.0450; Rajan R, 2007, EUR J NEUROSCI, V25, P2383, DOI 10.1111/j.1460-9568.2007.05481.x; Rajan R, 2006, J NEUROSCI METH, V157, P103, DOI 10.1016/j.jneumeth.2006.04.008; Reinert M, 2000, Neurosurg Focus, V8, pe10; RIBAK CE, 1982, CAN J PHYSIOL PHARM, V60, P864, DOI 10.1139/y82-122; Ritt JT, 2008, NEURON, V57, P599, DOI 10.1016/j.neuron.2007.12.024; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Salin P, 1995, J NEUROSCI, V15, P8234; Sanders MJ, 2001, BRAIN RES, V904, P141, DOI 10.1016/S0006-8993(01)02424-6; Sarno S, 2003, BRAIN INJURY, V17, P413, DOI 10.1080/0269905031000070161; Schiene K, 1996, J CEREBR BLOOD F MET, V16, P906, DOI 10.1097/00004647-199609000-00014; Schubert D, 2006, CEREB CORTEX, V16, P223, DOI 10.1093/cercor/bhi100; Shimizu T, 2002, BRAIN, V125, P1896, DOI 10.1093/brain/awf183; Shojo H, 2010, NEUROSCIENCE, V171, P1273, DOI 10.1016/j.neuroscience.2010.10.018; Signoretti S, 2010, MOL CELL BIOCHEM, V333, P269, DOI 10.1007/s11010-009-0228-9; SMITH ML, 1984, ACTA NEUROPATHOL, V64, P319, DOI 10.1007/BF00690397; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Staiger JF, 2004, CEREB CORTEX, V14, P690, DOI 10.1093/cercor/bhh029; Takano T, 2007, NAT NEUROSCI, V10, P754, DOI 10.1038/nn1902; Turner MS, 2003, ACT NEUR S, V87, P81; Tuttolomondo A, 2009, CURR TOP MED CHEM, V9, P1317, DOI 10.2174/156802609789869646; WADDELL PA, 1984, ACTA NEUROL SCAND, V69, P270, DOI 10.1111/j.1600-0404.1984.tb07812.x; Wilson SM, 2012, NEUROSCIENCE, V210, P451, DOI 10.1016/j.neuroscience.2012.02.038; Wood DP, 2005, P I MECH ENG D-J AUT, V219, P183, DOI 10.1243/095440705X6703; Xu J, 2008, NEUROPHARMACOLOGY, V54, P1029, DOI 10.1016/j.neuropharm.2008.01.014; Yan EB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-147; Yan WY, 2011, COMPUT METHOD BIOMEC, V14, P1049, DOI 10.1080/10255842.2010.506435; Yang L, 2010, J NEUROTRAUM, V27, P1541, DOI 10.1089/neu.2009.1244; Ydenius A, 2010, TRAFFIC INJ PREV, V11, P526, DOI 10.1080/15389588.2010.492053; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Zhao H, 2010, INT J CRASHWORTHINES, V15, P313, DOI 10.1080/13588260903335290; Zhou C, 2008, J NEUROSCI RES, V86, P2973, DOI 10.1002/jnr.21728	105	35	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63454	10.1371/journal.pone.0063454	http://dx.doi.org/10.1371/journal.pone.0063454			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667624	Green Published, Green Submitted, gold			2022-12-25	WOS:000319654700150
J	Li, Q; Wang, YR; Zhang, Y; Li, W; Zhu, J; Zheng, Y; Chen, JJ; Zhao, LY; Zhou, ZY; Liu, YJ; Wang, W; Tian, J				Li, Qiang; Wang, Yarong; Zhang, Yi; Li, Wei; Zhu, Jia; Zheng, Ying; Chen, Jiajie; Zhao, Liyan; Zhou, Zhenyu; Liu, Yijun; Wang, Wei; Tian, Jie			Assessing Cue-Induced Brain Response as a Function of Abstinence Duration in Heroin-Dependent Individuals: An Event-Related fMRI Study	PLOS ONE			English	Article							MEDIAL FRONTAL-CORTEX; NEURAL RESPONSES; MOTOR IMAGERY; SMOKING CUES; ADDICTION; WITHDRAWAL; TIME; ORGANIZATION; CONSUMPTION; DYSFUNCTION	The brain activity induced by heroin-related cues may play a role in the maintenance of heroin dependence. Whether the reinforcement or processing biases construct an everlasting feature of heroin addiction remains to be resolved. We used an event-related fMRI paradigm to measure brain activation in response to heroin cue-related pictures versus neutral pictures as the control condition in heroin-dependent patients undergoing short-term and long-term abstinence. The self-reported craving scores were significantly increased after cue exposure in the short-term abstinent patients (t = 3.000, P = 0.008), but no increase was found in the long-term abstinent patients (t = 1.510, P = 0.149). However, no significant differences in cue-induced craving changes were found between the two groups (t = 1.193, P = 0.850). Comparing between the long-term abstinence and short-term abstinence groups, significant decreases in brain activation were detected in the bilateral anterior cingulated cortex, left medial prefrontal cortex, caudate, middle occipital gyrus, inferior parietal lobule and right precuneus. Among all of the heroin dependent patients, the abstinence duration was negatively correlated with brain activation in the left medial prefrontal cortex and left inferior parietal lobule. These findings suggest that long-term abstinence may be useful for heroin-dependent patients to diminish their saliency value of heroin-related cues and possibly lower the relapse vulnerability to some extent.	[Li, Qiang; Wang, Yarong; Li, Wei; Zhu, Jia; Zheng, Ying; Chen, Jiajie; Wang, Wei; Tian, Jie] Fourth Mil Med Univ, Dept Radiol, Tangdu Hosp, Xian 710032, Peoples R China; [Zhang, Yi; Tian, Jie] Xidian Univ, Life Sci Res Ctr, Sch Life Sci & Technol, Xian, Peoples R China; [Zhao, Liyan] Peking Univ, Natl Inst Drug Dependence, Beijing 100871, Peoples R China; [Liu, Yijun] Univ Florida, Dept Psychiat, McKnight Brain Inst, Gainesville, FL 32611 USA; [Zhou, Zhenyu; Liu, Yijun] Peking Univ, Coll Engn, Beijing 100871, Peoples R China; [Tian, Jie] Chinese Acad Sci, Inst Automat, Beijing, Peoples R China	Air Force Military Medical University; Xidian University; Peking University; State University System of Florida; University of Florida; Peking University; Chinese Academy of Sciences; Institute of Automation, CAS	Wang, W (corresponding author), Fourth Mil Med Univ, Dept Radiol, Tangdu Hosp, Xian 710032, Peoples R China.	m_d_Wang@hotmail.com; tian@ieee.org	Tian, Jie/H-1190-2011; Zhang, Yi/J-7496-2017; Zhang, Yi/M-9408-2013	Tian, Jie/0000-0003-0498-0432; Zhang, Yi/0000-0003-0859-9735; Zhang, Yi/0000-0001-6657-403X	National Natural Science Foundation of China [81201081, 81071142, 81071143, 60901064]; Development Project of Science and Technology of Shaanxi Province [2008K12-02, 2009K01-65, 2010K16-03-01, 2010K16-03-02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Development Project of Science and Technology of Shaanxi Province	This work was supported by grants from the National Natural Science Foundation of China (Nos. 81201081, 81071142, 81071143 and 60901064) and the Development Project of Science and Technology of Shaanxi Province (Nos. 2008K12-02, 2009K01-65, 2010K16-03-01 and 2010K16-03-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baler RD, 2006, TRENDS MOL MED, V12, P559, DOI 10.1016/j.molmed.2006.10.005; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Due DL, 2002, AM J PSYCHIAT, V159, P954, DOI 10.1176/appi.ajp.159.6.954; Filbey FM, 2009, P NATL ACAD SCI USA, V106, P13016, DOI 10.1073/pnas.0903863106; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Franklin TR, 2007, NEUROPSYCHOPHARMACOL, V32, P2301, DOI 10.1038/sj.npp.1301371; Fu LP, 2008, NEUROSCI LETT, V438, P322, DOI 10.1016/j.neulet.2008.04.033; Garavan H, 2000, AM J PSYCHIAT, V157, P1789, DOI 10.1176/appi.ajp.157.11.1789; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; Grimm JW, 2001, NATURE, V412, P141, DOI 10.1038/35084134; Hahn B, 2007, J NEUROSCI, V27, P3477, DOI 10.1523/JNEUROSCI.5129-06.2007; Haruno M, 2004, J NEUROSCI, V24, P1660, DOI 10.1523/JNEUROSCI.3417-03.2004; Hser YI, 2007, EVAL PROGRAM PLANN, V30, P187, DOI 10.1016/j.evalprogplan.2006.10.008; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Kiefer F, 2006, ADDICTION, V101, P1215, DOI 10.1111/j.1360-0443.2006.01541.x; Langleben DD, 2008, AM J PSYCHIAT, V165, P390, DOI 10.1176/appi.ajp.2007.07010070; Li CSR, 2008, NEUROSCI BIOBEHAV R, V32, P581, DOI 10.1016/j.neubiorev.2007.10.003; Li Q, 2012, BRAIN RES, V1469, P63, DOI 10.1016/j.brainres.2012.06.024; Liu JX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023098; Lou MW, 2012, SUBST USE MISUSE, V47, P631, DOI 10.3109/10826084.2011.646381; Lu L, 2004, NEUROPHARMACOLOGY, V47, P214, DOI 10.1016/j.neuropharm.2004.06.027; Majdandzic J, 2007, NEUROIMAGE, V37, P589, DOI 10.1016/j.neuroimage.2007.04.071; Malouin F, 2003, HUM BRAIN MAPP, V19, P47, DOI 10.1002/hbm.10103; Mintzer MZ, 2002, DRUG ALCOHOL DEPEN, V67, P41, DOI 10.1016/S0376-8716(02)00013-3; Ogiso T, 2000, NEUROREPORT, V11, P1345, DOI 10.1097/00001756-200004270-00039; Rushworth MFS, 2007, CURR OPIN NEUROBIOL, V17, P220, DOI 10.1016/j.conb.2007.03.001; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Sell LA, 2000, DRUG ALCOHOL DEPEN, V60, P207, DOI 10.1016/S0376-8716(99)00158-1; Shalev U, 2001, PSYCHOPHARMACOLOGY, V156, P98, DOI 10.1007/s002130100748; Sinha R, 2006, ARCH GEN PSYCHIAT, V63, P324, DOI 10.1001/archpsyc.63.3.324; Tang YL, 2006, ADDICTION, V101, P657, DOI 10.1111/j.1360-0443.2006.01367.x; Volkow ND, 2011, P NATL ACAD SCI USA, V108, P15037, DOI 10.1073/pnas.1010654108; Wang W, 2011, AM J DRUG ALCOHOL AB, V37, P123, DOI 10.3109/00952990.2010.543997; Wang Z, 2007, J NEUROSCI, V27, P14035, DOI 10.1523/JNEUROSCI.2966-07.2007; Weerts EM, 2006, ALCOHOL CLIN EXP RES, V30, P2026, DOI 10.1111/j.1530-0277.2006.00249.x; Yang Z, 2009, HUM BRAIN MAPP, V30, P766, DOI 10.1002/hbm.20542; Zijlstra F, 2009, DRUG ALCOHOL DEPEN, V99, P183, DOI 10.1016/j.drugalcdep.2008.07.012	37	27	33	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62911	10.1371/journal.pone.0062911	http://dx.doi.org/10.1371/journal.pone.0062911			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667541	Green Submitted, Green Published, gold			2022-12-25	WOS:000319654700080
J	Otjacques, E; Binsfeld, M; Rocks, N; Blacher, S; Vanderkerken, K; Noel, A; Beguin, Y; Cataldo, D; Caers, J				Otjacques, Eleonore; Binsfeld, Marilene; Rocks, Natacha; Blacher, Silvia; Vanderkerken, Karin; Noel, Agnes; Beguin, Yves; Cataldo, Didier; Caers, Jo			Mithramycin Exerts an Anti-Myeloma Effect and Displays Anti-Angiogenic Effects through Up-Regulation of Anti-Angiogenic Factors	PLOS ONE			English	Article							BONE-MARROW ANGIOGENESIS; TUMOR-NECROSIS-FACTOR; MULTIPLE-MYELOMA; IN-VIVO; COMBINATORIAL BIOSYNTHESIS; PANCREATIC-CANCER; SP1 BINDING; CELLS; INHIBITION; ANTITUMOR	Mithramycin (MTM), a cytotoxic compound, is currently being investigated for its anti-angiogenic activity that seems to be mediated through an inhibition of the transcription factor SP1. In this study we evaluated its anti-myeloma effects in the syngenic 5TGM1 model in vitro as well as in vivo. In vitro, MTM inhibited DNA synthesis of 5TGM1 cells with an IC50 of 400 nM and induced an arrest in cell cycle progression at the G1/S transition point. Western-blot revealed an up-regulation of p53, p21 and p27 and an inhibition of c-Myc, while SP1 remained unaffected. In rat aortic ring assays, a strong anti-angiogenic effect was seen, which could be explained by a decrease of VEGF production and an up-regulation of anti-angiogenic proteins such as IP10 after MTM treatment. The administration of MTM to mice injected with 5TGM1 decreased 5TGM1 cell invasion into bone marrow and myeloma neovascularisation. These data suggest that MTM displays anti-myeloma and anti-angiogenic effects that are not mediated by an inhibition of SP1 but rather through c-Myc inhibition and p53 activation.	[Otjacques, Eleonore; Binsfeld, Marilene; Beguin, Yves; Caers, Jo] Univ Liege, Hematol Lab, Grp Interdisciplinaire Genoprote Appl GIGA Res, Liege, Belgium; [Otjacques, Eleonore; Rocks, Natacha; Blacher, Silvia; Noel, Agnes; Cataldo, Didier] Univ Liege, Lab Tumour & Dev Biol, Grp Interdisciplinaire Genoprote Appl GIGA Res, Liege, Belgium; [Vanderkerken, Karin] Vrije Univ Brussel, Dept Hematol & Immunol, Myeloma Ctr Brussels, Brussels, Belgium	University of Liege; University of Liege; Vrije Universiteit Brussel	Caers, J (corresponding author), Univ Liege, Hematol Lab, Grp Interdisciplinaire Genoprote Appl GIGA Res, Liege, Belgium.	jo.caers@chu.ulg.ac.be	Vanderkerken, Karin/I-3513-2013; Binsfeld, Marilene/AAG-9121-2020; Cataldo, Didier/GPG-3453-2022	Caers, Jo/0000-0002-3175-1195; Vanderkerken, Karin/0000-0002-2137-7179; Cataldo, Didier/0000-0002-3079-7941; Noel, Agnes/0000-0002-7670-6179	Belgian Foundation Against Cancer; Fonds de la Recherche Scientifique Medicale; Fonds National de la Recherche Scientifique (Belgium); Fonds speciaux de la Recherche (University of Liege); DGO6 from the "Region Wallonne" (Belgium); Interuniversity Attraction Poles Program - Belgian Science Policy IUAP program (Brussels, Belgium) [7/30]	Belgian Foundation Against Cancer; Fonds de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS); Fonds National de la Recherche Scientifique (Belgium)(Fonds de la Recherche Scientifique - FNRS); Fonds speciaux de la Recherche (University of Liege)(University of Liege); DGO6 from the "Region Wallonne" (Belgium); Interuniversity Attraction Poles Program - Belgian Science Policy IUAP program (Brussels, Belgium)	The study was in part supported by funds from the Belgian Foundation Against Cancer, the Fonds de la Recherche Scientifique Medicale, the Fonds National de la Recherche Scientifique (Belgium), the Fonds speciaux de la Recherche (University of Liege), the DGO6 from the "Region Wallonne" (Belgium), and the Interuniversity Attraction Poles Program - Belgian Science Policy IUAP program 7/30 (Brussels, Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguayo A, 2000, BLOOD, V96, P2240, DOI 10.1182/blood.V96.6.2240.h8002240_2240_2245; Ahn SY, 2004, AM J PATHOL, V164, P1663, DOI 10.1016/S0002-9440(10)63725-X; Anderson KC, 2011, ANNU REV PATHOL-MECH, V6, P249, DOI 10.1146/annurev-pathol-011110-130249; ANGIOLILLO AL, 1995, J EXP MED, V182, P155, DOI 10.1084/jem.182.1.155; Anthony ET, 2009, CLIN EXP DERMATOL, V34, P409, DOI 10.1111/j.1365-2230.2008.02901.x; Barcelo F, 2010, BIOCHEMISTRY-US, V49, P10543, DOI 10.1021/bi101398s; Bergsagel PL, 2005, BLOOD, V106, P296, DOI 10.1182/blood-2005-01-0034; Blacher Silvia, 2001, Angiogenesis, V4, P133, DOI 10.1023/A:1012251229631; BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; Caers J, 2008, BRIT J CANCER, V98, P1966, DOI 10.1038/sj.bjc.6604388; Caers J, 2008, EUR J HAEMATOL, V81, P329, DOI 10.1111/j.1600-0609.2008.01127.x; Chesi M, 2011, HEMATOL-AM SOC HEMAT, P344, DOI 10.1182/asheducation-2011.1.344; Coluccia AML, 2008, BLOOD, V112, P1346, DOI 10.1182/blood-2007-10-116590; Deshpande A, 2005, ONCOGENE, V24, P2909, DOI 10.1038/sj.onc.1208618; Detry B, 2012, BLOOD, V119, P5048, DOI 10.1182/blood-2011-12-400267; Ely S, 2005, CANCER RES, V65, P11345, DOI 10.1158/0008-5472.CAN-05-2159; Farnebo M, 2010, BIOCHEM BIOPH RES CO, V396, P85, DOI 10.1016/j.bbrc.2010.02.152; Fulciniti M, 2011, CLIN CANCER RES, V17, P6500, DOI 10.1158/1078-0432.CCR-11-1036; Gao Y, 2011, CANCER RES, V71, P5182, DOI 10.1158/0008-5472.CAN-10-2016; Garrett IR, 1997, BONE, V20, P515, DOI 10.1016/S8756-3282(97)00056-2; Gerlo S, 2008, CELL SIGNAL, V20, P1489, DOI 10.1016/j.cellsig.2008.04.004; GREEN L, 1984, CANCER TREAT REP, V68, P1379; Hose D, 2009, BLOOD, V114, P128, DOI 10.1182/blood-2008-10-184226; Jia ZL, 2007, CANCER RES, V67, P4878, DOI 10.1158/0008-5472.CAN-06-3494; Koutsodontis G, 2004, ONCOGENE, V23, P9190, DOI 10.1038/sj.onc.1208141; Lombo F, 2006, APPL MICROBIOL BIOT, V73, P1, DOI 10.1007/s00253-006-0511-6; Malek A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035130; Masson Veronique, 2002, Biological Procedures Online, V4, P24, DOI 10.1251/bpo30; Ohgami T, 2010, CANCER SCI, V101, P1387, DOI 10.1111/j.1349-7006.2010.01543.x; Otjacques E, 2011, INT J HEMATOL, V94, P505, DOI 10.1007/s12185-011-0963-z; Oyajobi BO, 2007, MOL CANCER THER, V6, P1701, DOI 10.1158/1535-7163.MCT-07-0121; Patten SG, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-683; Ping DS, 2000, J BIOL CHEM, V275, P1708, DOI 10.1074/jbc.275.3.1708; Presta M, 2002, LEUKEMIA, V16, P1490, DOI 10.1038/sj.leu.2402646; Previdi S, 2010, GYNECOL ONCOL, V118, P182, DOI 10.1016/j.ygyno.2010.03.020; RADL J, 1979, J IMMUNOL, V122, P609; RADL J, 1988, AM J PATHOL, V132, P593; Rajkumar SV, 2002, CLIN CANCER RES, V8, P2210; Remsing LL, 2003, J AM CHEM SOC, V125, P5745, DOI 10.1021/ja034162h; Rocks N, 2008, CANCER RES, V68, P9541, DOI 10.1158/0008-5472.CAN-08-0548; Safe S, 2005, EUR J CANCER, V41, P2438, DOI 10.1016/j.ejca.2005.08.006; SNYDER RC, 1991, BIOCHEMISTRY-US, V30, P4290, DOI 10.1021/bi00231a027; Spurrell JCL, 2005, AM J PHYSIOL-LUNG C, V289, pL85, DOI 10.1152/ajplung.00397.2004; VACCA A, 1994, BRIT J HAEMATOL, V87, P503, DOI 10.1111/j.1365-2141.1994.tb08304.x; Van Valckenborgh E, 2002, BRIT J CANCER, V86, P796, DOI 10.1038/sj.bjc.6600137; Wang LW, 2008, INT J ONCOL, V33, P161; Yuan P, 2007, CANCER-AM CANCER SOC, V110, P2682, DOI 10.1002/cncr.23092	47	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62818	10.1371/journal.pone.0062818	http://dx.doi.org/10.1371/journal.pone.0062818			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667526	Green Published, gold, Green Submitted			2022-12-25	WOS:000319654700066
J	Takasugi, N; Sasaki, T; Ebinuma, I; Osawa, S; Isshiki, H; Takeo, K; Tomita, T; Iwatsubo, T				Takasugi, Nobumasa; Sasaki, Tomoki; Ebinuma, Ihori; Osawa, Satoko; Isshiki, Hayato; Takeo, Koji; Tomita, Taisuke; Iwatsubo, Takeshi			FTY720/Fingolimod, a Sphingosine Analogue, Reduces Amyloid-beta Production in Neurons	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; IMMUNOMODULATORY DRUG FTY720; GAMMA-SECRETASE ACTIVITY; MULTIPLE-SCLEROSIS; ALZHEIMERS-DISEASE; T-CELLS; A-BETA; PROTEIN; SPHINGOSINE-1-PHOSPHATE; PRESENILIN	Sphingosine-1-phosphate (S1P) is a pluripotent lipophilic mediator working as a ligand for G-protein coupled S1P receptors (S1PR), which is currently highlighted as a therapeutic target for autoimmune diseases including relapsing forms of multiple sclerosis. Sphingosine related compounds, FTY720 and KRP203 known as S1PR modulators, are phosphorylated by sphingosine kinase 2 (SphK2) to yield the active metabolites FTY720-P and KRP203-P, which work as functional antagonists for S1PRs. Here we report that FTY720 and KRP203 decreased production of Amyloid-beta peptide (A beta), a pathogenic proteins causative for Alzheimer disease (AD), in cultured neuronal cells. Pharmacological analyses suggested that the mechanism of FTY720-mediated A beta decrease in cells was independent of known downstream signaling pathways of S1PRs. Unexpectedly, 6-days treatment of APP transgenic mice with FTY720 resulted in a decrease in A beta 40, but an increase in A beta 42 levels in brains. These results suggest that S1PR modulators are novel type of regulators for A beta metabolisms that are active in vitro and in vivo.	[Takasugi, Nobumasa; Sasaki, Tomoki; Ebinuma, Ihori; Osawa, Satoko; Takeo, Koji; Tomita, Taisuke; Iwatsubo, Takeshi] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Neuropathol & Neurosci, Tokyo, Japan; [Takasugi, Nobumasa; Isshiki, Hayato; Iwatsubo, Takeshi] Univ Tokyo, Grad Sch Med, Dept Neuropathol, Tokyo, Japan; [Takasugi, Nobumasa; Isshiki, Hayato; Tomita, Taisuke; Iwatsubo, Takeshi] Univ Tokyo, Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tokyo, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo	Tomita, T (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Neuropathol & Neurosci, Tokyo, Japan.	taisuke@mol.f.u-tokyo.ac.jp	Tomita, Taisuke/L-5427-2015	Tomita, Taisuke/0000-0002-0075-5943; TAKASUGI, NOBUMASA/0000-0002-6059-2082	Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science & Technology in Japan; Ministry of Health, Labor and Welfare of Japan (Comprehensive Research on Aging and Health); Core Research for Evolutional Science and Technology of JST	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science & Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan (Comprehensive Research on Aging and Health)(Ministry of Health, Labour and Welfare, Japan); Core Research for Evolutional Science and Technology of JST	This work is supported in part by Grants-in-Aid for Young Scientists (S) (for T.T.) and (B) (for N.T.) from Japan Society for the Promotion of Science (JSPS), by the Grant-in-Aid for Scientific Research on Innovative Areas (Brain Environment) from the Ministry of Education, Culture, Sports, Science & Technology in Japan (for T.T.), by the Ministry of Health, Labor and Welfare of Japan (Comprehensive Research on Aging and Health) (for T.T.), by Core Research for Evolutional Science and Technology of JST (for T.T., T.I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas O, 2010, NAT REV NEUROL, V6, P373, DOI 10.1038/nrneurol.2010.76; Becuwe M, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/242764; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Choi JW, 2011, P NATL ACAD SCI USA, V108, P751, DOI 10.1073/pnas.1014154108; Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; Don AS, 2007, J BIOL CHEM, V282, P15833, DOI 10.1074/jbc.M609124200; Foster CA, 2007, J PHARMACOL EXP THER, V323, P469, DOI 10.1124/jpet.107.127183; Fujino M, 2003, J PHARMACOL EXP THER, V305, P70, DOI 10.1124/jpet.102.045658; Fukumoto H, 1999, NEUROREPORT, V10, P2965, DOI 10.1097/00001756-199909290-00017; Gomez-Raja J, 2012, EUKARYOT CELL, V11, P683, DOI 10.1128/EC.05211-11; Grimm MOW, 2012, EXP BRAIN RES, V217, P365, DOI 10.1007/s00221-011-2975-6; Han XL, 2002, J NEUROCHEM, V82, P809, DOI 10.1046/j.1471-4159.2002.00997.x; Haughey NJ, 2010, BBA-MOL CELL BIOL L, V1801, P878, DOI 10.1016/j.bbalip.2010.05.003; He XX, 2010, NEUROBIOL AGING, V31, P398, DOI 10.1016/j.neurobiolaging.2008.05.010; Hognauer K, 2008, CHEMMEDCHEM, V3, P1027, DOI 10.1002/cmdc.200800037; Holmes O, 2012, BIOCHEMISTRY-US, V51, P3565, DOI 10.1021/bi300303g; Imamura Y, 2009, J AM CHEM SOC, V131, P7353, DOI 10.1021/ja9001458; Iwata H, 2001, J BIOL CHEM, V276, P21678, DOI 10.1074/jbc.M007989200; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Kalvodova L, 2005, J BIOL CHEM, V280, P36815, DOI 10.1074/jbc.M504484200; Kan T, 2003, CHEM COMMUN, P2244, DOI 10.1039/b306970b; Kaneider NC, 2004, FASEB J, V18, P1309, DOI 10.1096/fj.03-1050fje; Kaneko T, 2006, BIOCHEM BIOPH RES CO, V345, P85, DOI 10.1016/j.bbrc.2006.04.067; Karlstrom H, 2002, J BIOL CHEM, V277, P6763, DOI 10.1074/jbc.C100649200; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; Lee MJ, 1996, J BIOL CHEM, V271, P11272, DOI 10.1074/jbc.271.19.11272; Lieven CJ, 2012, INVEST OPHTH VIS SCI, V53, P3990, DOI 10.1167/iovs.11-9321; Liu X, 2012, CELL RES; Merhi A, 2012, MOL CELL BIOL, V32, P4510, DOI 10.1128/MCB.00463-12; Miron VE, 2008, ANN NEUROL, V63, P61, DOI 10.1002/ana.21227; Mullershausen F, 2007, J NEUROCHEM, V102, P1151, DOI 10.1111/j.1471-4159.2007.04629.x; Ni YX, 2006, NAT MED, V12, P1390, DOI 10.1038/nm1485; Osawa S, 2008, J BIOL CHEM, V283, P19283, DOI 10.1074/jbc.M705954200; Osenkowski P, 2008, J BIOL CHEM, V283, P22529, DOI 10.1074/jbc.M801925200; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Suzuki K, 2012, NEURON, V76, P410, DOI 10.1016/j.neuron.2012.10.003; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Takasugi N, 2011, J NEUROSCI, V31, P6850, DOI 10.1523/JNEUROSCI.6467-10.2011; Tanaka S, 2007, J BIOL CHEM, V282, P10506, DOI 10.1074/jbc.M700911200; Thathiah A, 2012, NAT MED; Thathiah A, 2009, SCIENCE, V323, P946, DOI 10.1126/science.1160649; Tomita T, 1999, J NEUROSCI, V19, P10627, DOI 10.1523/JNEUROSCI.19-24-10627.1999; Tomita T, 1997, P NATL ACAD SCI USA, V94, P2025, DOI 10.1073/pnas.94.5.2025; Tomita T, 2009, EXPERT REV NEUROTHER, V9, P661, DOI [10.1586/ern.09.24, 10.1586/ERN.09.24]; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Vetrivel KS, 2010, BBA-MOL CELL BIOL L, V1801, P860, DOI 10.1016/j.bbalip.2010.03.007; Wei SH, 2005, NAT IMMUNOL, V6, P1228, DOI 10.1038/ni1269; Yamada K, 2009, J NEUROSCI, V29, P11393, DOI 10.1523/JNEUROSCI.2021-09.2009; Zemann B, 2006, BLOOD, V107, P1454, DOI 10.1182/blood-2005-07-2628	52	65	74	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e64050	10.1371/journal.pone.0064050	http://dx.doi.org/10.1371/journal.pone.0064050			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667698	Green Published, gold, Green Submitted			2022-12-25	WOS:000319654700201
J	Villabona-Arenas, CJ; Mondini, A; Bosch, I; Schimitt, D; Calzavara-Silva, CE; Zanotto, PMD; Nogueira, ML				Villabona-Arenas, Christian Julian; Mondini, Adriano; Bosch, Irene; Schimitt, Diane; Calzavara-Silva, Carlos E.; Zanotto, Paolo M. de A.; Nogueira, Mauricio L.			Dengue Virus Type 3 Adaptive Changes during Epidemics in Sao Jose de Rio Preto, Brazil, 2006-2007	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; POSITIVE SELECTION; PHYLOGENETIC ANALYSIS; MOLECULAR EPIDEMIOLOGY; DE-JANEIRO; EVOLUTION; VACCINE; DYNAMICS; SITES; TRANSMISSION	Global dengue virus spread in tropical and sub-tropical regions has become a major international public health concern. It is evident that DENV genetic diversity plays a significant role in the immunopathology of the disease and that the identification of polymorphisms associated with adaptive responses is important for vaccine development. The investigation of naturally occurring genomic variants may play an important role in the comprehension of different adaptive strategies used by these mutants to evade the human immune system. In order to elucidate this role we sequenced the complete polyprotein-coding region of thirty-three DENV-3 isolates to characterize variants circulating under high endemicity in the city of Sao Jose de Rio Preto, Brazil, during the onset of the 2006-07 epidemic. By inferring the evolutionary history on a local-scale and estimating rates of synonymous (dS) and nonsynonimous (dN) substitutions, we have documented at least two different introductions of DENV-3 into the city and detected 10 polymorphic codon sites under significant positive selection (dN/dS > 1) and 8 under significant purifying selection (dN/dS < 1). We found several polymorphic amino acid coding sites in the envelope (15), NS1 (17), NS2A ( 11), and NS5 (24) genes, which suggests that these genes may be experiencing relatively recent adaptive changes. Furthermore, some polymorphisms correlated with changes in the immunogenicity of several epitopes. Our study highlights the existence of significant and informative DENV variability at the spatio-temporal scale of an urban outbreak.	[Villabona-Arenas, Christian Julian; Zanotto, Paolo M. de A.] Univ Sao Paulo, Inst Ciencias Biomed, Dept Microbiol, LEMB, BR-05508 Sao Paulo, Brazil; [Mondini, Adriano] Univ Estadual Paulista Julio de Mesquita Filho Ar, Fac Ciencias Farmaceut, Dept Ciencias Biol, Lab Saude Publ, Sao Paulo, Brazil; [Bosch, Irene] MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Schimitt, Diane] Tufts Univ, Dept Infect Dis & Global Hlth, Cummings Sch Vet Med, North Grafton, MA USA; [Calzavara-Silva, Carlos E.] Fundacao Oswaldo Cruz Fiocruz, Ctr Pesquisas Rene Rachou CPqRR, LICM, Belo Horizonte, MG, Brazil; [Nogueira, Mauricio L.] Fac Med Sao Jose do Rio Preto, Lab Pesquisas Virol, Sao Jose Do Rio Preto, SP, Brazil	Universidade de Sao Paulo; Massachusetts Institute of Technology (MIT); Tufts University; Fundacao Oswaldo Cruz; Universidade de Sao Paulo; Faculdade de Medicina de Sao Jose do Rio Preto (FAMERP)	Nogueira, ML (corresponding author), Fac Med Sao Jose do Rio Preto, Lab Pesquisas Virol, Sao Jose Do Rio Preto, SP, Brazil.	mnogueira@famerp.br	de A. Zanotto, Paolo M./B-9286-2019; Nogueira, Mauricio L/B-7599-2012; Mondini, Adriano/AAB-4358-2020; Mondini, Adriano/F-7446-2012; Calzavara-Silva, Carlos/ABF-2829-2021	de A. Zanotto, Paolo M./0000-0002-8167-0625; Nogueira, Mauricio L/0000-0003-1102-2419; Mondini, Adriano/0000-0002-5557-9721; Mondini, Adriano/0000-0002-5557-9721; Calzavara-Silva, Carlos/0000-0002-1406-6401; Villabona Arenas, Christian Julian/0000-0001-9928-3968	CNPq-PQ; INCT - Dengue; FAPESP [2011/17071-2, 10/19059-7, 2012/11733-6, 2011/10458-9]; PRONEX-Dengue (CNPq)	CNPq-PQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); INCT - Dengue; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); PRONEX-Dengue (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	CJVA holds a FAPESP scholarship (2011/17071-2); PMAZ and MLN hold a CNPq-PQ scholarship, AM holds an INCT - Dengue scholarship. This work was funded by FAPESP process number 10/19059-7 (PMAZ), by INCT-Dengue and PRONEX-Dengue (CNPq to MLN) and FAPESP Grants # 2012/11733-6 and 2011/10458-9 to MLN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1989, NEUTRAL THEORY MOL E; Aquino VH, 2006, AM J TROP MED HYG, V75, P710, DOI 10.4269/ajtmh.2006.75.710; Aquino VH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007299; Araujo JMG, 2009, INFECT GENET EVOL, V9, P716, DOI 10.1016/j.meegid.2008.10.005; Beaute J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-521; Bennett SN, 2006, J GEN VIROL, V87, P885, DOI 10.1099/vir.0.81309-0; Bennett SN, 2003, MOL BIOL EVOL, V20, P1650, DOI 10.1093/molbev/msg182; Casali Clarisse Guimarães, 2004, Rev. Soc. Bras. Med. Trop., V37, P296, DOI 10.1590/S0037-86822004000400002; Castaneda-Orjuela Carlos, 2012, Value Health Reg Issues, V1, P123, DOI 10.1016/j.vhri.2012.09.014; Chen RB, 2008, J MOL EVOL, V66, P655, DOI 10.1007/s00239-008-9119-z; Costa RL, 2012, INFECT GENET EVOL, V12, P309, DOI 10.1016/j.meegid.2011.12.011; Danecek P, 2010, J MOL BIOL, V396, P550, DOI 10.1016/j.jmb.2009.11.070; dos Santos FB, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-387; Drummond A, 2005, MOL BIOL; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ferguson NM, 1999, PHILOS T R SOC B, V354, P757, DOI 10.1098/rstb.1999.0428; Figueiredo LB, 2008, EMERG INFECT DIS, V14, P314, DOI 10.3201/eid1402.070278; Garg P, 2008, T ROY SOC TROP MED H, V102, P570, DOI 10.1016/j.trstmh.2008.02.015; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05; Guy B, 2008, COMP IMMUNOL MICROB, V31, P239, DOI 10.1016/j.cimid.2007.07.011; Guzman M, 2010, NATURE REV; Guzman MG, 2012, INT J INFECT DIS, V16, pE198, DOI 10.1016/j.ijid.2011.09.026; Halasa YA, 2012, AM J TROP MED HYG, V86, P745, DOI 10.4269/ajtmh.2012.11-0784; Halstead SB, 2012, LANCET, V380, P1535, DOI 10.1016/S0140-6736(12)61510-4; Harris E, 2012, NAT MED, V18, P1622, DOI 10.1038/nm.2997; Holmes EC, 2003, J VIROL, V77, P11296, DOI 10.1128/JVI.77.20.11296-11298.2003; Villabona-Arenas CJ, 2009, TROP MED INT HEALTH, V14, P1241, DOI 10.1111/j.1365-3156.2009.02339.x; Khan AM, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000272; King CC, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-63; Kochel T, 2008, MOL EPIDEMIOLOGY DEN; Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346; Luz PM, 2009, TROP MED INT HEALTH, V14, P237, DOI 10.1111/j.1365-3156.2008.02203.x; MADDISON D. R., 2005, MACCLADE 4 ANAL PHYL; Mondini A, 2005, REV SAUDE PUBL, V39, P444, DOI 10.1590/S0034-89102005000300016; Mondini A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000448; Nei M., 1987, MOL EVOLUTIONARY GEN; Nogueira RMR, 2001, MEM I OSWALDO CRUZ, V96, P925, DOI 10.1590/S0074-02762001000700007; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Raghwani J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002064; RICOHESSE R, 1990, VIROLOGY, V174, P479, DOI 10.1016/0042-6822(90)90102-W; Rodpothong P, 2012, VIRUS GENES, V44, P408, DOI 10.1007/s11262-011-0709-2; Rodriguez F, 1990, J THEORETICAL BIOL; Ross H, 2002, J VIROLOGY; Barrero PR, 2008, VIRUS RES, V135, P83, DOI 10.1016/j.virusres.2008.02.013; Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7; Saude SdVe, 2008, INFORME EPIDEMIOLOGI; Saude SdVe, 2007, INFORME DPIDEMIOLOGI; Schmidt DJ, 2011, INFECT GENET EVOL, V11, P2011, DOI 10.1016/j.meegid.2011.09.010; Shepard DS, 2011, AM J TROP MED HYG, V84, P200, DOI 10.4269/ajtmh.2011.10-0503; Sheridan I, 2004, J VIROL, V78, P3447, DOI 10.1128/JVI.78.7.3447-3454.2004; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; Suzuki Y, 2008, GENE, V427, P111, DOI 10.1016/j.gene.2008.09.012; TAJIMA F, 1989, GENETICS, V123, P585; Twiddy SS, 2002, VIROLOGY, V298, P63, DOI 10.1006/viro.2002.1447; Twiddy SS, 2002, J GEN VIROL, V83, P1679, DOI 10.1099/0022-1317-83-7-1679; Usme-Ciro J, 2008, VIROL J, V10, P1; Uzcategui NY, 2003, J GEN VIROL, V84, P1569, DOI 10.1099/vir.0.18807-0; Villabona-Arenas CJ, 2011, IEEE AER C, P1, DOI DOI 10.1109/AERO.2011.5747269; Zanotto PMAGEA, 2002, MOL EPIDEMIOLOGY EVO; Zanotto PMD, 1999, GENETICS, V153, P1077; Zanotto PMD, 1996, P NATL ACAD SCI USA, V93, P548, DOI 10.1073/pnas.93.2.548; Zanotto PMD, 1996, J VIROL, V70, P6083, DOI 10.1128/JVI.70.9.6083-6096.1996	70	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63496	10.1371/journal.pone.0063496	http://dx.doi.org/10.1371/journal.pone.0063496			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667626	Green Published, gold, Green Submitted			2022-12-25	WOS:000319654700151
J	Bauer, MHA; Kuhnt, D; Barbieri, S; Klein, J; Becker, A; Freisleben, B; Hahn, HK; Nimsky, C				Bauer, Miriam H. A.; Kuhnt, Daniela; Barbieri, Sebastiano; Klein, Jan; Becker, Andreas; Freisleben, Bernd; Hahn, Horst K.; Nimsky, Christopher			Reconstruction of White Matter Tracts via Repeated Deterministic Streamline Tracking - Initial Experience	PLOS ONE			English	Article							NEURONAL FIBER PATHWAYS; DIFFUSION-TENSOR; GLIOBLASTOMA-MULTIFORME; DTI SEGMENTATION; THALAMIC NUCLEI; WILD BOOTSTRAP; GLIOMA REMOVAL; TRACTOGRAPHY; BRAIN; MRI	Diffusion Tensor Imaging (DTI) and fiber tractography are established methods to reconstruct major white matter tracts in the human brain in-vivo. Particularly in the context of neurosurgical procedures, reliable information about the course of fiber bundles is important to minimize postoperative deficits while maximizing the tumor resection volume. Since routinely used deterministic streamline tractography approaches often underestimate the spatial extent of white matter tracts, a novel approach to improve fiber segmentation is presented here, considering clinical time constraints. Therefore, fiber tracking visualization is enhanced with statistical information from multiple tracking applications to determine uncertainty in reconstruction based on clinical DTI data. After initial deterministic fiber tracking and centerline calculation, new seed regions are generated along the result's midline. Tracking is applied to all new seed regions afterwards, varying in number and applied offset. The number of fibers passing each voxel is computed to model different levels of fiber bundle membership. Experimental results using an artificial data set of an anatomical software phantom are presented, using the Dice Similarity Coefficient (DSC) as a measure of segmentation quality. Different parameter combinations were classified to be superior to others providing significantly improved results with DSCs of 81.02%+/- 4.12%, 81.32%+/- 4.22% and 80.99%+/- 3.81% for different levels of added noise in comparison to the deterministic fiber tracking procedure using the two-ROI approach with average DSCs of 65.08%+/- 5.31%, 64.73%+/- 6.02% and 65.91%+/- 6.42%. Whole brain tractography based on the seed volume generated by the calculated seeds delivers average DSCs of 67.12%+/- 0.86%, 75.10%+/- 0.28% and 72.91%+/- 0.15%, original whole brain tractography delivers DSCs of 67.16%, 75.03% and 75.54%, using initial ROIs as combined include regions, which is clearly improved by the repeated fiber tractography method.	[Bauer, Miriam H. A.; Kuhnt, Daniela; Becker, Andreas; Nimsky, Christopher] Univ Marburg, Dept Neurosurg, Marburg, Germany; [Bauer, Miriam H. A.; Freisleben, Bernd] Univ Marburg, Dept Math & Comp Sci, Marburg, Germany; [Bauer, Miriam H. A.] St Annes Univ Hosp Brno, Int Clin Res Ctr, Brno, Czech Republic; [Barbieri, Sebastiano; Klein, Jan; Hahn, Horst K.] Fraunhofer MEVIS Inst Med Image Comp, Bremen, Germany	Philipps University Marburg; Philipps University Marburg; St Anne's University Hospital Brno (FNUSA-ICRC)	Bauer, MHA (corresponding author), Univ Marburg, Dept Neurosurg, Marburg, Germany.	bauermi@med.uni-marburg.de	Nimsky, Christopher/E-3702-2014	Nimsky, Christopher/0000-0002-8216-9410; Freisleben, Bernd/0000-0002-7205-8389; Bopp, Miriam H. A./0000-0003-1574-7572; Klein, Jan/0000-0001-9421-3549	German Research Foundation [DFG NI 568/3-1, DFG PE 199/21-1]; von Behring-Rontgen-Foundation [58-0044]; European Regional Development Fund-Project FNUSA-ICRC [CZ.1.05/1.1.00/02.0123]	German Research Foundation(German Research Foundation (DFG)); von Behring-Rontgen-Foundation; European Regional Development Fund-Project FNUSA-ICRC	This project was funded in part by the German Research Foundation (DFG NI 568/3-1 and DFG PE 199/21-1), the von Behring-Rontgen-Foundation (Project 58-0044) and the European Regional Development Fund-Project FNUSA-ICRC (No. CZ.1.05/1.1.00/02.0123). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aganj I, 2011, MED IMAGE ANAL, V15, P414, DOI 10.1016/j.media.2011.01.003; Arsigny V, 2006, MAGN RESON MED, V56, P411, DOI 10.1002/mrm.20965; Awate SP, 2007, IEEE T MED IMAGING, V26, P1525, DOI 10.1109/TMI.2007.907301; Barbieri S, 2010, JOINT ANN M ISMRM ES, P1672; Barbieri S., 2010, P SPIE, V7623; Barbieri S, 2012, NEUROIMAGE, V60, P1025, DOI 10.1016/j.neuroimage.2012.01.076; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Basser PJ., 1998, P 6 ANN M ISMRM, P1226; Bauer MHA, 2011, INT J COMPUT ASS RAD, V6, P1, DOI 10.1007/s11548-010-0423-x; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Beppu T, 2003, J NEURO-ONCOL, V63, P109, DOI 10.1023/A:1023977520909; Black PM, 1997, NEUROSURGERY, V41, P831, DOI 10.1097/00006123-199710000-00013; Bohinski RJ, 2001, NEUROSURGERY, V48, P731, DOI 10.1227/00006123-200104000-00007; Brun A, 2004, LECT NOTES COMPUT SC, V3216, P368; Clark CA, 2003, NEUROIMAGE, V20, P1601, DOI 10.1016/j.neuroimage.2003.07.022; Collins DL, 1998, IEEE T MED IMAGING, V17, P463, DOI 10.1109/42.712135; Conturo TE, 1999, P NATL ACAD SCI USA, V96, P10422, DOI 10.1073/pnas.96.18.10422; Descoteaux M, 2009, THESIS NICE SOPHIA A; Descoteaux M, 2009, IEEE T MED IMAGING, V28, P269, DOI 10.1109/TMI.2008.2004424; Ding ZH, 2003, MAGNET RESON MED, V49, P716, DOI 10.1002/mrm.10415; Ding ZH, 2001, IEEE VISUAL, P453, DOI 10.1109/VISUAL.2001.964549; Fletcher PT, 2007, SIGNAL PROCESS, V87, P250, DOI 10.1016/j.sigpro.2005.12.018; Friman O, 2006, IEEE T MED IMAGING, V25, P965, DOI 10.1109/TMI.2006.877093; Hahn HK, 2006, ACTA NEUROCHIR SUPPL, V98, P33; Hall WA, 2000, NEUROSURGERY, V46, P632, DOI 10.1097/00006123-200003000-00022; Hatiboglu MA, 2009, NEUROSURGERY, V64, P1073, DOI 10.1227/01.NEU.0000345647.58219.07; Hattingen E, 2009, NEUROSURG REV, V32, P445, DOI 10.1007/s10143-009-0197-1; Jbabdi S, 2007, NEUROIMAGE, V37, P116, DOI 10.1016/j.neuroimage.2007.04.039; Jbabdi S, 2008, INT J BIOMED IMAGING, V2008, DOI 10.1155/2008/320195; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jonasson L, 2007, SIGNAL PROCESS, V87, P309, DOI 10.1016/j.sigpro.2005.12.017; Jones D., 1998, 6 ANN M INT SOC MAGN, P531; Jones DK, 2008, IEEE T MED IMAGING, V27, P1268, DOI 10.1109/TMI.2008.922191; Jones DK, 2005, MAGNET RESON MED, V53, P1143, DOI 10.1002/mrm.20466; Kinoshita M, 2005, NEUROIMAGE, V25, P424, DOI 10.1016/j.neuroimage.2004.07.076; Klein J, 2007, AUTOMATIC QUANTIFICA, P272; Koch M, 2001, NEUROIMAGE, V13, pS176; Kreher BW, 2008, MAGN RESON MED, V60, P953, DOI 10.1002/mrm.21749; Kreher BW, 2007, JOINT ANN M ISMRM ES, P1554; Kuhnt D, 2011, NEUROSURGERY; Kuhnt D, 2013, NEUROSURGERY, V72, pA165, DOI 10.1227/NEU.0b013e318270d9fb; Kuhnt D, 2011, NEUROSURGERY, V69, P852, DOI 10.1227/NEU.0b013e318225ea6b; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; Lamborn KR, 2004, NEURO-ONCOLOGY, V6, P227, DOI 10.1215/S1152851703000620; Laws ER, 2003, ACT NEUR S, V85, P47; Lazar M, 2003, HUM BRAIN MAPP, V18, P306, DOI 10.1002/hbm.10102; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Le Bihan D, 2002, NMR BIOMED, V15, P431, DOI 10.1002/nbm.798; Lenglet C, 2005, LECT NOTES COMPUT SC, V3565, P591; Lin JJ, 2008, EPILEPSY RES, V82, P162, DOI 10.1016/j.eplepsyres.2008.07.020; Melonakos J, 2007, LECT NOTES COMPUT SC, V4791, P36; Merhof D, 2005, PROC SPIE, V5744, P165, DOI 10.1117/12.594621; Merhof D, 2010, FIBER SELECTION DIFF, P147; Merhof D, 2006, LECT NOTES COMPUT SC, V4191, P225; Merhof D, 2009, STEREOT FUNCT NEUROS, V87, P50, DOI 10.1159/000195720; Michailovich O, 2011, IEEE T MED IMAGING, V30, P1100, DOI 10.1109/TMI.2011.2142189; Michailovich O, 2010, LECT NOTES COMPUT SC, V6361, P607; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Mori S, 2007, INTRO DIFFUSION TENS; Nimsky C, 2004, NEUROSURGERY, V55, P358, DOI 10.1227/01.NEU.0000129694.64671.91; Nimsky C, 2005, ACAD RADIOL, V12, P1065, DOI 10.1016/j.acra.2005.05.020; Nimsky C, 2004, RADIOLOGY, V233, P67, DOI 10.1148/radiol.2331031352; Nimsky C, 2006, INT J COMPUT ASS RAD, V1, P13, DOI 10.1007/s11548-006-0003-2; Nimsky C, 2006, NEUROIMAGE, V30, P1219, DOI 10.1016/j.neuroimage.2005.11.001; PAJEVIC S, 1999, 7 ANN M ISMRM, P1790; Parker GJM, 2002, IEEE T MED IMAGING, V21, P505, DOI 10.1109/TMI.2002.1009386; Parker GJM, 2003, J MAGN RESON IMAGING, V18, P242, DOI 10.1002/jmri.10350; Pennec X, 2006, INT J COMPUT VISION, V66, P41, DOI 10.1007/s11263-005-3222-z; Poupon C, 2000, NEUROIMAGE, V12, P184, DOI 10.1006/nimg.2000.0607; Reisert M, 2011, NEUROIMAGE, V54, P955, DOI 10.1016/j.neuroimage.2010.09.016; Schneider JP, 2005, NEURORADIOLOGY, V47, P489, DOI 10.1007/s00234-005-1397-1; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Stieltjes B, 2001, NEUROIMAGE, V14, P723, DOI 10.1006/nimg.2001.0861; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; VECHT CJ, 1990, J NEUROL NEUROSUR PS, V53, P466, DOI 10.1136/jnnp.53.6.466; Vernooij MW, 2007, NEUROIMAGE, V35, P1064, DOI 10.1016/j.neuroimage.2006.12.041; Wang ZZ, 2005, IEEE T MED IMAGING, V24, P1267, DOI 10.1109/TMI.2005.854516; Wang ZZ, 2004, LECT NOTES COMPUT SC, V2034, P304; Weiler F, 2009, 2 WORKSH SOFTW ASS M, P1485; Weinstein D., 1999, Proceedings Visualization '99 (Cat. No.99CB37067), P249, DOI 10.1109/VISUAL.1999.809894; Whitcher B, 2005, 13 ANN M INT SOC MAG, P1333; Whitcher B, 2008, HUM BRAIN MAPP, V29, P346, DOI 10.1002/hbm.20395; Wiegell MR, 2003, NEUROIMAGE, V19, P391, DOI 10.1016/S1053-8119(03)00044-2; Witwer BP, 2002, J NEUROSURG, V97, P568, DOI 10.3171/jns.2002.97.3.0568; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Yamada K, 2003, RADIOLOGY, V227, P295, DOI 10.1148/radiol.2271020313; Zhukov L, 2003, J ELECTRON IMAGING, V12, P125, DOI 10.1117/1.1527628; Ziyan U, 2006, LECT NOTES COMPUT SC, V4191, P807; Zou KH, 2004, ACAD RADIOL, V11, P178, DOI 10.1016/S1076-6332(03)00671-8	94	6	6	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e63082	10.1371/journal.pone.0063082	http://dx.doi.org/10.1371/journal.pone.0063082			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671656	Green Submitted, Green Published, gold			2022-12-25	WOS:000321390200042
J	Brem, FMR; Parris, MJ; Padgett-Flohr, GE				Brem, Forrest M. R.; Parris, Matthew J.; Padgett-Flohr, Gretchen E.			Re-Isolating Batrachochytrium dendrobatidis from an Amphibian Host Increases Pathogenicity in a Subsequent Exposure	PLOS ONE			English	Article							FROG-KILLING FUNGUS; CHYTRID PATHOGEN; TEMPERATURE; CHYTRIDIOMYCOSIS; ANTIBIOTICS; BEAUVERIA; VIRULENCE; ANURANS; DISEASE	Controlled exposure experiments can be very informative, however, they are based on the assumption that pathogens maintained on artificial media under long-term storage retain the infective and pathogenic properties of the reproducing pathogen as it occurs in a host. We observed that JEL284, an in vitro cultured and maintained isolate of Batrachochytrium dendrobatidis (Bd), was becoming less infectious with successive uses. We hypothesized that passing an isolate propagated on artificial media through an amphibian host would make the isolate more infectious and pathogenic in subsequent exposures. To test our hypothesis, we used two discreet steps, a reisolation step (step 1) and a comparative exposure step (step 2). In step 1, we exposed eastern spadefoot toads, Scaphiopus holbrooki, to JEL284 and JEL197, another isolate that had been maintained in vitro for over six years. We then re-isolated JEL284 only from a successful infection and named this new isolate JEL284(FMBa). JEL197 did not infect any amphibians and, thus, did not proceed to step 2. In step 2, we compared infectivity and pathogenicity (mortality and survival time) of JEL284 and JEL284(FMBa) by exposing 54 naive S. holbrooki to three treatments (JEL284, JEL284(FMBa), and negative control) with 18 individuals per group. We found that JEL284(FMBa) caused higher mortality and decreased survival time in infected individuals when compared to JEL284 and negative controls. Thus, our data show that pathogenicity of Bd can decrease when cultured successively in media only and can be partially restored by passage through an amphibian host. Therefore, we have demonstrated that pathogenicity shifts can occur rapidly in this pathogen. Given the potential for shifts in pathogenicity demonstrated here, we suspect Bd to have similar potential in natural populations. We suggest that, when possible, the use of freshly isolated or cryopreserved Bd would improve the quality of controlled exposure experiments using this pathogen.	[Brem, Forrest M. R.; Parris, Matthew J.] Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA; [Padgett-Flohr, Gretchen E.] So Illinois Univ, Dept Zool, Carbondale, IL 62901 USA	University of Memphis; Southern Illinois University System; Southern Illinois University	Brem, FMR (corresponding author), Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA.	fbrem@memphis.edu			Chester Zoo/North England Zoological Society	Chester Zoo/North England Zoological Society	Funding was provided by a conservation grant from the Chester Zoo/North England Zoological Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altizer S, 2003, TRENDS ECOL EVOL, V18, P589, DOI 10.1016/j.tree.2003.08.013; Baer CF, 2007, NAT REV GENET, V8, P619, DOI 10.1038/nrg2158; Berger L, 2005, DIS AQUAT ORGAN, V68, P47, DOI 10.3354/dao068047; Berger L, 2004, AUST VET J, V82, P434, DOI 10.1111/j.1751-0813.2004.tb11137.x; Butt TM, 2006, ECOLOGICAL SOC APPRO, V2, DOI [10.1007/978-1-4020-4401-4_10, DOI 10.1007/978-1-4020-4401-4_]; Davidson EW, 2003, COPEIA, P601, DOI 10.1643/CP-02-120R1; DEBONO M, 1994, ANNU REV MICROBIOL, V48, P471, DOI 10.1146/annurev.mi.48.100194.002351; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; Feller G, 2003, NAT REV MICROBIOL, V1, P200, DOI 10.1038/nrmicro773; Fernandes EKK, 2008, J INVERTEBR PATHOL, V98, P69, DOI 10.1016/j.jip.2007.10.011; Fisher MC, 2009, MOL ECOL, V18, P415, DOI 10.1111/j.1365-294X.2008.04041.x; Gahl MK, 2012, CONSERV BIOL, V26, P135, DOI 10.1111/j.1523-1739.2011.01801.x; Gilbert MA, 2001, J PARASITOL, V87, P101, DOI 10.1645/0022-3395(2001)087[0101:PIOMCT]2.0.CO;2; Idnurm A, 2007, SEX FUNGI MOL DETERM; Inglis GD, 1996, BIOL CONTROL, V7, P131, DOI 10.1006/bcon.1996.0076; James TY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000458; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; MCDONOUGH ES, 1960, J LAB CLIN MED, V55, P116; Morehouse EA, 2003, MOL ECOL, V12, P395, DOI 10.1046/j.1365-294X.2003.01732.x; Morgan JAT, 2007, P NATL ACAD SCI USA, V104, P13845, DOI 10.1073/pnas.0701838104; Padgett-Flohr GE, 2011, HERPETOL CONSERV BIO, V6, P99; Parris MJ, 2004, ECOLOGY, V85, P3385, DOI 10.1890/04-0383; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Rosenblum EB, 2008, P NATL ACAD SCI USA, V105, P17034, DOI 10.1073/pnas.0804173105; Savage AE, 2011, P NATL ACAD SCI USA, V108, P16705, DOI 10.1073/pnas.1106893108; Scully LR, 2005, CAN J MICROBIOL, V51, P185, DOI 10.1139/W04-124; Searle CL, 2011, CONSERV BIOL, V25, P965, DOI 10.1111/j.1523-1739.2011.01708.x; Tupper Todd A., 2011, Herpetological Review, V42, P62; Velo-Anton G, 2012, BIOL CONSERV, V146, P213, DOI 10.1016/j.biocon.2011.12.003; Venesky MD, 2009, ECOHEALTH, V6, P565, DOI 10.1007/s10393-009-0272-7; Venesky MD, 2010, J PARASITOL, V96, P552, DOI 10.1645/GE-2353.1; Voyles J, 2012, ECOL EVOL, V2, P2241, DOI 10.1002/ece3.334; Voyles J, 2011, FUNGAL ECOL, V4, P196, DOI [10.1016/j.funeco.2010.12.003, 10.1016/j.funeco.2010.12.00]; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; Woodhams DC, 2003, DIS AQUAT ORGAN, V55, P65, DOI 10.3354/dao055065	35	17	18	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e61260	10.1371/journal.pone.0061260	http://dx.doi.org/10.1371/journal.pone.0061260			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671564	Green Published, Green Submitted, gold			2022-12-25	WOS:000321390200004
J	Kosulin, K; Hoffmann, F; Clauditz, TS; Wilczak, W; Dobner, T				Kosulin, Karin; Hoffmann, Franziska; Clauditz, Till Sebastian; Wilczak, Waldemar; Dobner, Thomas			Presence of Adenovirus Species C in Infiltrating Lymphocytes of Human Sarcoma	PLOS ONE			English	Article							CELL-TRANSFORMATION; HUMAN TONSIL; T-CELLS; IN-VIVO; DNA; SEQUENCES; CANCER; EXPRESSION; PATIENT; PROTEIN	Human adenoviruses are known to persist in T-lymphocytes of tonsils, adenoids and intestinal tract. The oncogenic potential of different adenovirus types has been widely studied in rodents, in which adenovirus inoculation can induce multiple tumors such as undifferentiated sarcomas, adenocarcinomas and neuroectodermal tumors. However, the oncogenic potential of this virus has never been proven in human subjects. Using a highly sensitive broad-spectrum qRT-PCR, we have screened a set of different human sarcomas including leiomyosarcoma, liposarcoma and gastro intestinal stroma tumors. Primers binding the viral oncogene E1A and the capsid-coding gene Hexon were used to detect the presence of adenovirus DNA in tumor samples. We found that 18% of the tested leiomyosarcomas and 35% of the liposarcomas were positive for the presence of adenovirus DNA, being species C types the most frequently detected adenoviruses. However, only in one sample of the gastro intestinal stroma tumors the virus DNA could be detected. The occurrence of adenovirus in the tumor sections was confirmed by subsequent fluorescence in-situ-hybridization analysis and co-staining with the transcription factor Bcl11b gives evidence for the presence of the virus in infiltrating T-lymphocytes within the tumors. Together these data underline, for the first time, the persistence of adenovirus in T-lymphocytes infiltrated in muscular and fatty tissue tumor samples. If an impaired immune system leads to the viral persistence and reactivation of the virus is involved in additional diseases needs further investigation.	[Kosulin, Karin; Hoffmann, Franziska; Dobner, Thomas] Heinrich Pette Inst, Leibniz Inst Expt Virol, Dept Mol Virol, Hamburg, Germany; [Clauditz, Till Sebastian; Wilczak, Waldemar] Univ Med Ctr Hamburg Eppendorf, Dept Pathol, Hamburg, Germany	Heinrich Pette Institute; University of Hamburg; University Medical Center Hamburg-Eppendorf	Dobner, T (corresponding author), Heinrich Pette Inst, Leibniz Inst Expt Virol, Dept Mol Virol, Hamburg, Germany.	thomas.dobner@hpi.uni-hamburg.de	Kosulin, Karin/AAB-2471-2019	Kosulin, Karin/0000-0001-7397-9692	Wilhelm-Sander-Stiftung [2007.109.1]; Stiftung fur neurovirale Erkrankungen (NVE), Hamburg, Germany; Freie und Hansestadt Hamburg; Bundesministerium fur Gesundheit (BMG)	Wilhelm-Sander-Stiftung; Stiftung fur neurovirale Erkrankungen (NVE), Hamburg, Germany; Freie und Hansestadt Hamburg; Bundesministerium fur Gesundheit (BMG)	This work was supported by the the Wilhelm-Sander-Stiftung (Grant #2007.109.1) and the Stiftung fur neurovirale Erkrankungen (NVE), Hamburg, Germany and by the Freie und Hansestadt Hamburg and the Bundesministerium fur Gesundheit (BMG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albu DI, 2010, METHODS MOL BIOL, V647, P377, DOI 10.1007/978-1-60761-738-9_23; Atkinson RL, 2010, INT J PEDIATR OBES, V5, P157, DOI 10.3109/17477160903111789; Ducimetiere F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020294; Ebner K, 2005, J CLIN MICROBIOL, V43, P3049, DOI 10.1128/JCM.43.7.3049-3053.2005; Endter C, 2004, CURR TOP MICROBIOL, V273, P163; Fallaux FJ, 1996, HUM GENE THER, V7, P215, DOI 10.1089/hum.1996.7.2-215; Fernandez-Soria V, 2002, ONCOL REP, V9, P897; Ferrari R, 2008, SCIENCE, V321, P1086, DOI 10.1126/science.1155546; Garnett CT, 2009, J VIROL, V83, P2417, DOI 10.1128/JVI.02392-08; Garnett CT, 2002, J VIROL, V76, P10608, DOI 10.1128/JVI.76.21.10608-10616.2002; Glaunsinger BA, 2001, EMBO J, V20, P5578, DOI 10.1093/emboj/20.20.5578; GRAHAM FL, 1984, J CELL PHYSIOL, P151; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; GREEN M, 1979, P NATL ACAD SCI USA, V76, P6606, DOI 10.1073/pnas.76.12.6606; Groitl Peter, 2007, Methods Mol Med, V130, P29; Gutierrez A, 2011, P NATL ACAD SCI USA, V108, P16386, DOI 10.1073/pnas.1106127108; Hartl B, 2008, ONCOGENE, V27, P3673, DOI 10.1038/sj.onc.1211039; HAWLEYNELSON P, 1989, EMBO J, V8, P3905, DOI 10.1002/j.1460-2075.1989.tb08570.x; Hogg JC, 2001, AM J RESP CRIT CARE, V164, pS71, DOI 10.1164/ajrccm.164.supplement_2.2106063; Hohlweg U, 2004, CURR TOP MICROBIOL, V273, P215; Honkaniemi E, 2010, BRIT J CANCER, V102, P796, DOI 10.1038/sj.bjc.6605581; JAVIER R, 1991, J VIROL, V65, P3192, DOI 10.1128/JVI.65.6.3192-3202.1991; Jones MS, 2007, J VIROL, V81, P5978, DOI 10.1128/JVI.02650-06; JONSSON N, 1977, CANCER, V39, P2513, DOI 10.1002/1097-0142(197706)39:6<2513::AID-CNCR2820390631>3.0.CO;2-7; Kaneko H, 2011, BRIT J OPHTHALMOL, V95, P32, DOI 10.1136/bjo.2009.178772; Konig M, 2002, BRIT J HAEMATOL, V116, P758, DOI 10.1046/j.0007-1048.2002.03340.x; Kosulin K, 2007, J VIROL, V81, P7629, DOI 10.1128/JVI.00355-07; Kuwano K, 1997, EUR RESPIR J, V10, P1445, DOI 10.1183/09031936.97.10071445; Kuwano K, 1997, J CANCER RES CLIN, V123, P377, DOI 10.1007/BF01240120; Lion T, 2003, BLOOD, V102, P1114, DOI 10.1182/blood-2002-07-2152; Lion T, 2010, LEUKEMIA, V24, P706, DOI 10.1038/leu.2010.4; Madisch I, 2006, J MED VIROL, V78, P1210, DOI 10.1002/jmv.20683; MAJOR FJ, 1993, CANCER-AM CANCER SOC, V71, P1702, DOI 10.1002/cncr.2820710440; McNees AL, 2004, J VIROL, V78, P6955, DOI 10.1128/JVI.78.13.6955-6966.2004; Mende Y, 2004, VIRUS RES, V104, P81, DOI 10.1016/j.virusres.2004.02.039; Nevels M, 1997, P NATL ACAD SCI USA, V94, P1206, DOI 10.1073/pnas.94.4.1206; Nevels M, 2001, J VIROL, V75, P3089, DOI 10.1128/JVI.75.7.3089-3094.2001; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; Roy S, 2011, PLOS ONE; Roy S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024859; Segerman A, 2006, VIROLOGY, V349, P96, DOI 10.1016/j.virol.2005.12.044; Sengupta S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018091; Seto D, 2011, J VIROL, V85, P5701, DOI 10.1128/JVI.00354-11; Solovei I, 2010, METHODS MOL BIOL, V659, P117, DOI 10.1007/978-1-60761-789-1_8; Szmuness W, 1978, Prog Med Virol, V24, P40; Tatsis N, 2007, BLOOD, V110, P1916, DOI 10.1182/blood-2007-02-062117; TRENTIN JJ, 1962, SCIENCE, V137, P835, DOI 10.1126/science.137.3533.835; Watzinger F, 2004, J CLIN MICROBIOL, V42, P5189, DOI 10.1128/JCM.42.11.5189-5198.2004; Whigham LD, 2006, AM J PHYSIOL-REG I, V290, pR190, DOI 10.1152/ajpregu.00479.2005; Wold W.S.M., 2007, FIELDS VIROLOGY, V7th, P2395	50	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e63646	10.1371/journal.pone.0063646	http://dx.doi.org/10.1371/journal.pone.0063646			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671688	Green Published, gold, Green Submitted			2022-12-25	WOS:000321390200054
J	Sekonyela, R; Palmer, JM; Bok, JW; Jain, S; Berthier, E; Forseth, R; Schroeder, F; Keller, NP				Sekonyela, Relebohile; Palmer, Jonathan M.; Bok, Jin-Woo; Jain, Sachin; Berthier, Erwin; Forseth, Ry; Schroeder, Frank; Keller, Nancy P.			RsmA Regulates Aspergillus fumigatus Gliotoxin Cluster Metabolites Including Cyclo(L-Phe-L-Ser), a Potential New Diagnostic Marker for Invasive Aspergillosis	PLOS ONE			English	Article							OXIDATIVE STRESS-RESPONSE; SECONDARY METABOLISM; TRANSCRIPTIONAL REGULATOR; VIRULENCE FACTOR; GENE; LAEA; CONTRIBUTES; GROWTH; GLIP; DIFFERENTIATION	Dimeric basic leucine zipper (bZIP) proteins are conserved transcriptional enhancers found in all eukaryotes. A recently reported and novel function for bZIPs is association of these proteins with secondary metabolite production in filamentous fungi. In particular a Yap-like bZIP termed RsmA (restorer of secondary metabolism A) was identified in Aspergillus nidulans that positively regulates the carcinogen sterigmatocystin. To assess for conserved function for RsmA, we examined a role of this protein in secondary metabolism in the pathogen A. fumigatus. RsmA was found to positively regulate gliotoxin where overexpression (OE) of rsmA led to 2-100 fold increases of twelve gli cluster metabolites in culture medium including the newly identified gli metabolite cyclo(L-Phe-L-Ser). Lungs from both wild type and OErsmA infected mice contained gliotoxin (2.3 fold higher in OErsmA treatment) as well as the gliotoxin precursor cyclo(L-Phe-L-Ser) (3.2 fold higher in OErsmA treatment). The data here presents a conserved role for RsmA in secondary metabolite cluster activation and suggests cyclo(L-Phe-L-Ser) may serve as an alternative marker for diagnosis of invasive aspergillosis.	[Sekonyela, Relebohile; Jain, Sachin; Keller, Nancy P.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Palmer, Jonathan M.; Bok, Jin-Woo; Berthier, Erwin; Keller, Nancy P.] Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA; [Forseth, Ry; Schroeder, Frank] Cornell Univ, Boyce Thompson Inst, Ithaca, NY USA; [Forseth, Ry; Schroeder, Frank] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Cornell University; Boyce Thompson Institute for Plant Research; Cornell University	Keller, NP (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	npkeller@wisc.edu	Bok, Jin Woo/F-7140-2010; Palmer, Jonathan/A-3890-2009; Keller, Nancy P./ABC-5911-2021	Berthier, Erwin/0000-0002-4421-9034; Schroeder, Frank/0000-0002-4420-0237; Palmer, Jonathan/0000-0003-0929-3658	National Institutes of Health (NIH) [R01 Al065728-01, GM008500]; DuPont Young Professor Award; American Asthma Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008500] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DuPont Young Professor Award; American Asthma Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by National Institutes of Health (NIH) (R01 Al065728-01 to NPK and GM008500 to RRF), a DuPont Young Professor Award (to FCS) and a grant from the American Asthma Foundation to NPK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaike S, 2009, EUKARYOT CELL, V8, P1051, DOI 10.1128/EC.00088-09; Asano Y, 2007, BIOSCI BIOTECH BIOCH, V71, P1800, DOI 10.1271/bbb.70133; Berthier E, 2010, INTEGR BIOL-UK, V2, P630, DOI 10.1039/c0ib00030b; Bok JW, 2006, INFECT IMMUN, V74, P6761, DOI 10.1128/IAI.00780-06; Bok JW, 2005, EUKARYOT CELL, V4, P1574, DOI 10.1128/EC.4.9.1574-1582.2005; Bok JW, 2004, EUKARYOT CELL, V3, P527, DOI 10.1128/EC.3.2.527-535.2004; Butchko RAE, 2012, FUNGAL GENET BIOL, V49, P602, DOI 10.1016/j.fgb.2012.06.003; Calvo AM, 2004, APPL ENVIRON MICROB, V70, P4733, DOI 10.1128/AEM.70.8.4733-4739.2004; Carberry S, 2012, FUNGAL GENET BIOL, V49, P302, DOI 10.1016/j.fgb.2012.02.003; Cramer RA, 2006, EUKARYOT CELL, V5, P972, DOI 10.1128/EC.00049-06; Dagenais TRT, 2009, CLIN MICROBIOL REV, V22, P447, DOI 10.1128/CMR.00055-08; Domingo MP, 2012, DIAGN MICR INFEC DIS, V73, P57, DOI 10.1016/j.diagmicrobio.2012.01.012; Fernandes M, 1998, MOL MICROBIOL, V28, P1355, DOI 10.1046/j.1365-2958.1998.00907.x; Forseth RR, 2011, J AM CHEM SOC, V133, P9678, DOI 10.1021/ja2029987; Hoffmeister D, 2007, NAT PROD REP, V24, P393, DOI 10.1039/b603084j; Kupfahl C, 2006, MOL MICROBIOL, V62, P292, DOI 10.1111/j.1365-2958.2006.05373.x; Latge JP, 2001, TRENDS MICROBIOL, V9, P382, DOI 10.1016/S0966-842X(01)02104-7; Lessing F, 2007, EUKARYOT CELL, V6, P2290, DOI 10.1128/EC.00267-07; Lewis RE, 2005, J CLIN MICROBIOL, V43, P6120, DOI 10.1128/JCM.43.12.6120-6122.2005; McDonald T, 2005, MOL PLANT MICROBE IN, V18, P539, DOI 10.1094/MPMI-18-0539; Murayama T, 1996, EUR RESPIR J, V9, P293, DOI 10.1183/09031936.96.09020293; Pahl HL, 1996, J EXP MED, V183, P1829, DOI 10.1084/jem.183.4.1829; Palmer JM, 2008, EUKARYOT CELL, V7, P2052, DOI 10.1128/EC.00224-08; Puri A, 2010, BIOMED CHROMATOGR, V24, P887, DOI 10.1002/bmc.1382; Qiao JJ, 2008, MED MYCOL, V46, P773, DOI 10.1080/13693780802054215; Ramirez-Ortiz ZG, 2011, CELL HOST MICROBE, V9, P415, DOI 10.1016/j.chom.2011.04.007; Reverberi M, 2007, FOOD ADDIT CONTAM A, V24, P1070, DOI 10.1080/02652030701553244; Reverberi M, 2012, APPL MICROBIOL BIOT, V95, P1293, DOI 10.1007/s00253-012-3985-4; Roze LV, 2011, J BIOL CHEM, V286, P35137, DOI 10.1074/jbc.M111.253468; Sambrook J., 2001, MOL CLONING LAB MANU; Scharf DH, 2010, J AM CHEM SOC, V132, P10136, DOI 10.1021/ja103262m; Schrettl M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000952; Shaaban MI, 2010, EUKARYOT CELL, V9, P1816, DOI 10.1128/EC.00189-10; Shah D T, 1998, Infect Dis Obstet Gynecol, V6, P168, DOI 10.1155/S1064744998000349; Shi LN, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-11; Shimizu K, 2001, GENETICS, V157, P591; Speth C, 2011, MOL IMMUNOL, V48, P2122, DOI 10.1016/j.molimm.2011.07.005; Spikes S, 2008, J INFECT DIS, V197, P479, DOI 10.1086/525044; Stanzani M, 2005, BLOOD, V105, P2258, DOI 10.1182/blood-2004-09-3421; Sugui JA, 2007, EUKARYOT CELL, V6, P1552, DOI 10.1128/EC.00140-07; Sugui JA, 2007, EUKARYOT CELL, V6, P1562, DOI 10.1128/EC.00141-07; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Temme N, 2012, MOL PLANT PATHOL, V13, P704, DOI 10.1111/j.1364-3703.2011.00778.x; Wagner D, 2010, EUKARYOT CELL, V9, P1588, DOI 10.1128/EC.00146-10; Wiemann P, 2010, MOL MICROBIOL, V77, P972, DOI 10.1111/j.1365-2958.2010.07263.x; WOLOSHUK CP, 1994, APPL ENVIRON MICROB, V60, P2408, DOI 10.1128/AEM.60.7.2408-2414.1994; Wu DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002542; Xue T, 2004, ARCH MICROBIOL, V182, P346, DOI 10.1007/s00203-004-0707-z; Yin WB, 2013, MICROBIOL-SGM, V159, P77, DOI 10.1099/mic.0.063370-0; Yin WB, 2012, MOL MICROBIOL, V83, P1024, DOI 10.1111/j.1365-2958.2012.07986.x; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001	51	32	34	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e62591	10.1371/journal.pone.0062591	http://dx.doi.org/10.1371/journal.pone.0062591			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671611	Green Published, gold, Green Submitted			2022-12-25	WOS:000321390200029
J	Rajala, A; Dighe, R; Agbaga, MP; Anderson, RE; Rajala, RVS				Rajala, Ammaji; Dighe, Radhika; Agbaga, Martin-Paul; Anderson, Robert E.; Rajala, Raju V. S.			Insulin Receptor Signaling in Cones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE B-GAMMA; MOLECULAR-CLONING; PROTEIN-KINASE; PHOSPHOINOSITIDE 3-KINASE; RETINAL DEGENERATION; BRAIN INSULIN; PHOTORECEPTOR CELLS; MESSENGER-RNA; MOUSE RETINA; MICE LACKING	In humans, age-related macular degeneration and diabetic retinopathy are the most common disorders affecting cones. In retinitis pigmentosa (RP), cone cell death precedes rod cell death. Systemic administration of insulin delays the death of cones in RP mouse models lacking rods. To date there are no studies on the insulin receptor signaling in cones; however, mRNA levels of IR signaling proteins are significantly higher in cone-dominant neural retina leucine zipper (Nrl) knock-out mouse retinas compared with wild type rod-dominant retinas. We previously reported that conditional deletion of the p85 alpha subunit of phosphoinositide 3-kinase (PI3K) in cones resulted in age-related cone degeneration, and the phenotype was not rescued by healthy rods, raising the question of why cones are not protected by the rod-derived cone survival factors. Interestingly, systemic administration of insulin has been shown to delay the death of cones in mouse models of RP lacking rods. These observations led to the hypothesis that cones may have their own endogenous neuroprotective pathway, or rod-derived cone survival factors may be signaled through cone PI3K. To test this hypothesis we generated p85 alpha(-/-) /Nrl(-/-) double knock-out mice and also rhodopsin mutant mice lacking p85 alpha and examined the effect of the p85 alpha. subunit of PI3K on cone survival. We found that the rate of cone degeneration is significantly faster in both of these models compared with respective mice with competent p85 alpha. These studies suggest that cones may have their own endogenous PI3K-mediated neuroprotective pathway in addition to the cone viability survival signals derived from rods.	Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, Oklahoma City, OK 73104 USA; [Anderson, Robert E.; Rajala, Raju V. S.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA; [Rajala, Raju V. S.] Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK 73104 USA; [Rajala, Ammaji; Dighe, Radhika; Agbaga, Martin-Paul; Anderson, Robert E.; Rajala, Raju V. S.] Dean A McGee Eye Inst, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Rajala, RVS (corresponding author), Univ Oklahoma, Hlth Sci Ctr, 608 Stanton L Young Blvd, Oklahoma City, OK 73104 USA.	raju-rajala@ouhsc.edu			National Institutes of Health [EY016507, EY00871, RR17703, EY12190, EY021725]; Research to Prevent Blindness, Inc.; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017703] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY000871, R01EY016507, P30EY012190, P30EY021725] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY016507, EY00871, RR17703, EY12190, and EY021725. This work was also supported by an unrestricted departmental grant from Research to Prevent Blindness, Inc.	Adler R, 1999, MOL VIS, V5; Barber AJ, 2001, J BIOL CHEM, V276, P32814, DOI 10.1074/jbc.M104738200; Baskin DG, 1999, BRAIN RES, V848, P114, DOI 10.1016/S0006-8993(99)01974-5; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; Brodbeck D, 1999, J BIOL CHEM, V274, P9133, DOI 10.1074/jbc.274.14.9133; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P263, DOI 10.1002/cne.901880205; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Cheng ZY, 2010, TRENDS ENDOCRIN MET, V21, P589, DOI 10.1016/j.tem.2010.06.005; Chiang GG, 2005, J BIOL CHEM, V280, P25485, DOI 10.1074/jbc.M501707200; Cho NC, 2000, ARCH OPHTHALMOL-CHIC, V118, P1393; COFFER PJ, 1991, EUR J BIOCHEM, V201, P475, DOI 10.1111/j.1432-1033.1991.tb16305.x; Daniele LL, 2005, INVEST OPHTH VIS SCI, V46, P2156, DOI 10.1167/iovs.04-1427; Deng YQ, 2009, AM J PATHOL, V175, P2089, DOI 10.2353/ajpath.2009.090157; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Elias R, 2004, MOL VIS, V10, P672; Feathers KL, 2008, INVEST OPHTH VIS SCI, V49, P1126, DOI 10.1167/iovs.07-1234; FLIESLER SJ, 1983, PROG LIPID RES, V22, P79; Frolich L, 1998, J NEURAL TRANSM, V105, P423, DOI 10.1007/s007020050068; Gao YL, 2012, CELL MOL NEUROBIOL, V32, P523, DOI 10.1007/s10571-011-9792-0; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Gomez-Vicente V, 2005, CELL DEATH DIFFER, V12, P796, DOI 10.1038/sj.cdd.4401621; Hamel CP, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-7; HAVRANKOVA J, 1978, NATURE, V272, P827, DOI 10.1038/272827a0; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; HEIDENREICH KA, 1993, ANN NY ACAD SCI, V692, P72; Ivanovic I, 2011, INVEST OPHTH VIS SCI, V52, P6355, DOI 10.1167/iovs.10-7138; Ivanovic I, 2011, INVEST OPHTH VIS SCI, V52, P3775, DOI 10.1167/iovs.10-7139; JONES PF, 1991, CELL REGUL, V2, P1001, DOI 10.1091/mbc.2.12.1001; JONES PF, 1991, P NATL ACAD SCI USA, V88, P4171, DOI 10.1073/pnas.88.10.4171; Kellner U, 1993, Ger J Ophthalmol, V2, P170; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kohl S, 2009, OPHTHALMOLOGE, V106, P109, DOI 10.1007/s00347-008-1864-2; Kryger Z, 1998, VISUAL NEUROSCI, V15, P685, DOI 10.1017/S0952523898154081; Le YZ, 2004, MOL VIS, V10, P1011; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; Li GY, 2007, J NEUROSCI, V27, P203, DOI 10.1523/JNEUROSCI.0445-06.2007; Li GY, 2008, J NEUROCHEM, V107, P1382, DOI 10.1111/j.1471-4159.2008.05707.x; Linton JD, 2010, P NATL ACAD SCI USA, V107, P8599, DOI 10.1073/pnas.1002471107; Liu Y, 2011, J PATHOL, V225, P54, DOI 10.1002/path.2912; Luo J, 2005, MOL CELL BIOL, V25, P9491, DOI 10.1128/MCB.25.21.9491-9502.2005; Majewski N, 2004, MOL CELL, V16, P819, DOI 10.1016/j.molcel.2004.11.014; Masure S, 1999, EUR J BIOCHEM, V265, P353, DOI 10.1046/j.1432-1327.1999.00774.x; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; NAASH MI, 1993, P NATL ACAD SCI USA, V90, P5499, DOI 10.1073/pnas.90.12.5499; Nakatani K, 1999, BIOCHEM BIOPH RES CO, V257, P906, DOI 10.1006/bbrc.1999.0559; Nikonov SS, 2008, NEURON, V59, P462, DOI 10.1016/j.neuron.2008.06.011; Nikonov SS, 2005, J GEN PHYSIOL, V125, P287, DOI 10.1085/jgp.200409208; Nork T M, 2000, Trans Am Ophthalmol Soc, V98, P331; Okawa H, 2008, CURR BIOL, V18, P1917, DOI 10.1016/j.cub.2008.10.029; Park SH, 2003, DIABETOLOGIA, V46, P1260, DOI 10.1007/s00125-003-1177-6; Punzo C, 2012, J BIOL CHEM, V287, P1642, DOI 10.1074/jbc.R111.304428; Punzo C, 2009, NAT NEUROSCI, V12, P44, DOI 10.1038/nn.2234; Rajala A, 2008, J BIOL CHEM, V283, P19781, DOI 10.1074/jbc.M802374200; Rehen SK, 1999, EUR J NEUROSCI, V11, P4349, DOI 10.1046/j.1460-9568.1999.00868.x; Reiter CEN, 2006, DIABETES, V55, P1148, DOI 10.2337/diabetes.55.04.06.db05-0744; ROBINSON LJ, 1994, ENDOCRINOLOGY, V135, P2568, DOI 10.1210/en.135.6.2568; Sanghera KP, 2011, MOL CELL NEUROSCI, V47, P145, DOI 10.1016/j.mcn.2011.03.010; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; SCHWARTZ MW, 1992, ENDOCRINOLOGY, V130, P3608, DOI 10.1210/en.130.6.3608; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Shen JK, 2005, J CELL PHYSIOL, V203, P457, DOI 10.1002/jcp.20346; STAAL SP, 1987, P NATL ACAD SCI USA, V84, P5034, DOI 10.1073/pnas.84.14.5034; Stone EM, 2004, NEW ENGL J MED, V351, P346, DOI 10.1056/NEJMoa040833; Stuck MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032484; Takahashi M, 1996, NEUROSCI LETT, V204, P201, DOI 10.1016/0304-3940(96)12357-0; Tan E, 2004, INVEST OPHTH VIS SCI, V45, P764, DOI 10.1167/iovs.03-1114; Tsang SH, 1996, SCIENCE, V272, P1026, DOI 10.1126/science.272.5264.1026; Wang XM, 2006, PHYSIOLOGY, V21, P362, DOI 10.1152/physiol.00024.2006; Wu XH, 2004, J BIOL CHEM, V279, P9167, DOI 10.1074/jbc.M312397200; Yang Y, 2009, MOL THER, V17, P787, DOI 10.1038/mt.2009.28; Zhou FT, 2011, J NEUROSCI RES, V89, P1859, DOI 10.1002/jnr.22714; Zhu XM, 2003, J NEUROSCI, V23, P6152, DOI 10.1523/JNEUROSCI.23-14-06152.2003	76	40	40	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19503	19515		10.1074/jbc.M113.469064	http://dx.doi.org/10.1074/jbc.M113.469064			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23673657	Green Published, hybrid			2022-12-25	WOS:000321515800017
J	Kaipparettu, BA; Ma, YW; Park, JH; Lee, TL; Zhang, YQ; Yotnda, P; Creighton, CJ; Chan, WY; Wong, LJC				Kaipparettu, Benny Abraham; Ma, Yewei; Park, Jun Hyoung; Lee, Tin-Lap; Zhang, Yiqun; Yotnda, Patricia; Creighton, Chad J.; Chan, Wai-Yee; Wong, Lee-Jun C.			Crosstalk from Non-Cancerous Mitochondria Can Inhibit Tumor Properties of Metastatic Cells by Suppressing Oncogenic Pathways	PLOS ONE			English	Article							VITAMIN-E ANALOGS; DNA MUTATIONS; PATHOGENIC MUTATIONS; CANCER; APOPTOSIS; MTDNA; DEPLETION; DEATH	Mitochondrial-nucleus cross talks and mitochondrial retrograde regulation can play a significant role in cellular properties. Transmitochondrial cybrid systems (cybrids) are an excellent tool to study specific effects of altered mitochondria under a defined nuclear background. The majority of the studies using the cybrid model focused on the significance of specific mitochondrial DNA variations in mitochondrial function or tumor properties. However, most of these variants are benign polymorphisms without known functional significance. From an objective of rectifying mitochondrial defects in cancer cells and to establish mitochondria as a potential anticancer drug target, understanding the role of functional mitochondria in reversing oncogenic properties under a cancer nuclear background is very important. Here we analyzed the potential reversal of oncogenic properties of a highly metastatic cell line with the introduction of non-cancerous mitochondria. Cybrids were established by fusing the mitochondria DNA depleted 143B TK- rho 0 cells from an aggressive osteosarcoma cell line with mitochondria from benign breast epithelial cell line MCF10A, moderately metastatic breast cancer cell line MDA-MB-468 and 143B cells. In spite of the uniform cancerous nuclear background, as observed with the mitochondria donor cells, cybrids with benign mitochondria showed high mitochondrial functional properties including increased ATP synthesis, oxygen consumption and respiratory chain activities compared to cybrids with cancerous mitochondria. Interestingly, benign mitochondria could reverse different oncogenic characteristics of 143B TK- cell including cell proliferation, viability under hypoxic condition, anti-apoptotic properties, resistance to anti-cancer drug, invasion, and colony formation in soft agar, and in vivo tumor growth in nude mice. Microarray analysis suggested that several oncogenic pathways observed in cybrids with cancer mitochondria are inhibited in cybrids with non-cancerous mitochondria. These results suggest the critical oncogenic regulation by mitochondrial-nuclear cross talk and highlights rectifying mitochondrial functional properties as a promising target in cancer therapy.	[Kaipparettu, Benny Abraham; Ma, Yewei; Park, Jun Hyoung; Wong, Lee-Jun C.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Kaipparettu, Benny Abraham; Zhang, Yiqun; Creighton, Chad J.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Lee, Tin-Lap; Chan, Wai-Yee] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Dev Gen, NIH, Bethesda, MD USA; [Lee, Tin-Lap; Chan, Wai-Yee] Chinese Univ Hong Kong, Sch Biomed Sci, Fac Med, Hong Kong, Hong Kong, Peoples R China; [Yotnda, Patricia] Baylor Coll Med, Ctr Gene Therapy, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Chinese University of Hong Kong; Baylor College of Medicine	Kaipparettu, BA (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	kaippare@bcm.edu; ljwong@bcm.edu	Lee, Tin-Lap/W-6595-2019; Lee, Tin-Lap/A-7853-2009; Zhang, YiQun/HCI-2427-2022; Chan, Wai Yee/R-7442-2018	Lee, Tin-Lap/0000-0002-6654-0988; Lee, Tin-Lap/0000-0002-6654-0988; Chan, Wai Yee/0000-0002-9714-0936; Kaipparettu, Benny/0000-0003-3444-4307	DOD [W81XWH-11-1-0292]; National Institutes of Health/National Cancer Institute (NIH/NCI) [U54-CA149196]; DLD Cancer Center Pilot Project; NIH/NCI grant [R01 CA-100023]; NATIONAL CANCER INSTITUTE [R01CA100023, U54CA149196] Funding Source: NIH RePORTER	DOD(United States Department of Defense); National Institutes of Health/National Cancer Institute (NIH/NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DLD Cancer Center Pilot Project; NIH/NCI grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partially supported by DOD (W81XWH-11-1-0292), National Institutes of Health/National Cancer Institute (NIH/NCI) (U54-CA149196 Pilot Project) and DLD Cancer Center Pilot Project to B. Kaipparettu and NIH/NCI (R01 CA-100023) grant to L. Wong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; Augenlicht LH, 2001, NAT GENET, V28, P104, DOI 10.1038/88800; Bayona-Bafaluy MP, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng100; Berridge MV, 1996, J IMMUNOL, V156, P4092; Biasutto L, 2010, MITOCHONDRION, V10, P670, DOI 10.1016/j.mito.2010.06.004; Chen X, 2010, NEUROSCIENCE, V165, P705, DOI 10.1016/j.neuroscience.2009.11.007; Chonghaile TN, 2011, SCIENCE, V334, P1129, DOI 10.1126/science.1206727; Creighton CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001816; Dasgupta S, 2008, CANCER RES, V68, P700, DOI 10.1158/0008-5472.CAN-07-5532; Davids MS, 2012, J CLIN ONCOL, V30, P3127, DOI 10.1200/JCO.2011.37.0981; Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549; Dong LF, 2007, CANCER RES, V67, P11906, DOI 10.1158/0008-5472.CAN-07-3034; Garber K, 2006, SCIENCE, V312, P1158, DOI 10.1126/science.312.5777.1158; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Ghelli A, 2003, J BIOL CHEM, V278, P4145, DOI 10.1074/jbc.M210285200; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Kaipparettu BA, 2010, ANN NY ACAD SCI, V1201, P137, DOI 10.1111/j.1749-6632.2010.05621.x; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Kirches E, 2001, INT J CANCER, V93, P534, DOI 10.1002/ijc.1375; Kulawiec M, 2009, J HUM GENET, V54, P647, DOI 10.1038/jhg.2009.89; Liu VWS, 2001, CANCER RES, V61, P5998; Ma YW, 2010, BBA-BIOENERGETICS, V1797, P29, DOI 10.1016/j.bbabio.2009.07.008; McLennan HR, 2000, J BIOENERG BIOMEMBR, V32, P153, DOI 10.1023/A:1005507913372; Minocherhomji S, 2012, EPIGENETICS-US, V7, P326, DOI 10.4161/epi.19547; Modica-Napolitano JS, 2007, CURR MOL MED, V7, P121, DOI 10.2174/156652407779940495; Neuzil J, 2007, J BIOENERG BIOMEMBR, V39, P65, DOI 10.1007/s10863-006-9060-z; Neuzil J, 2013, MITOCHONDRION, V13, P199, DOI 10.1016/j.mito.2012.07.112; Ohta H, 2009, BRIT J CANCER, V100, P389, DOI 10.1038/sj.bjc.6604846; Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102; Shidara Y, 2005, CANCER RES, V65, P1655, DOI 10.1158/0008-5472.CAN-04-2012; Shock LS, 2011, P NATL ACAD SCI USA, V108, P3630, DOI 10.1073/pnas.1012311108; Tan DJ, 2003, GENE CHROMOSOME CANC, V37, P186, DOI 10.1002/gcc.10217; Tan DJ, 2002, CANCER RES, V62, P972; Tu YF, 2011, BBA-BIOENERGETICS, V1807, P1125, DOI 10.1016/j.bbabio.2011.04.015; Venegas V, 2011, CURR PROTOC HUM GENE, V19; Vithayathil SA, 2012, METHODS MOL BIOL, V837, P219, DOI 10.1007/978-1-61779-504-6_15; Wang J, 2009, MOL GENET METAB, V96, P59, DOI 10.1016/j.ymgme.2008.10.006; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Ware SM, 2009, J MED GENET, V46, P308, DOI 10.1136/jmg.2008.063149; Yamazaki H, 2008, ONCOL REP, V19, P1545; Yen HC, 2005, ANN NY ACAD SCI, V1042, P516, DOI 10.1196/annals.1338.047; Zhang JM, 2009, AM J RESP CELL MOL, V40, P135, DOI 10.1165/rcmb.2007-0277OC	42	64	65	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e61747	10.1371/journal.pone.0061747	http://dx.doi.org/10.1371/journal.pone.0061747			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671572	Green Submitted, gold, Green Published			2022-12-25	WOS:000319737700005
J	Gaugue, I; Oberto, J; Putzer, H; Plumbridge, J				Gaugue, Isabelle; Oberto, Jacques; Putzer, Harald; Plumbridge, Jacqueline			The Use of Amino Sugars by Bacillus subtilis: Presence of a Unique Operon for the Catabolism of Glucosamine	PLOS ONE			English	Article							ESCHERICHIA-COLI K-12; PHOSPHOTRANSFERASE SYSTEM; N-ACETYLGLUCOSAMINE; N-ACETYLGLUCOSAMINE-6-PHOSPHATE DEACETYLASE; GLUCOSAMINE-6-PHOSPHATE DEAMINASE; 6-PHOSPHATE DEAMINASE; METABOLISM; EXPRESSION; GENE; GENOME	B. subtilis grows more rapidly using the amino sugar glucosamine as carbon source, than with N-acetylglucosamine. Genes for the transport and metabolism of N-acetylglucosamine (nagP and nagAB) are found in all the sequenced Bacilli (except Anoxybacillus flavithermus). In B. subtilis there is an additional operon (gamAP) encoding second copies of genes for the transport and catabolism of glucosamine. We have developed a method to make multiple deletion mutations in B. subtilis employing an excisable spectinomycin resistance cassette. Using this method we have analysed the contribution of the different genes of the nag and gam operons for their role in utilization of glucosamine and N-acetylglucosamine. Faster growth on glucosamine is due to the presence of the gamAP operon, which is strongly induced by glucosamine. Although the gamA and nagB genes encode isozymes of GlcN6P deaminase, catabolism of N-acetylglucosamine relies mostly upon the gamA gene product. The genes for use of N-acetylglucosamine, nagAB and nagP, are repressed by YvoA (NagR), a GntR family regulator, whose gene is part of the nagAB yvoA(nagR) operon. The gamAP operon is repressed by YbgA, another GntR family repressor, whose gene is expressed divergently from gamAP. The nagAB yvoA synton is found throughout the Bacilli and most firmicutes. On the other hand the ybgA-gamAP synton, which includes the ybgB gene for a small protein of unknown provenance, is only found in B. subtilis (and a few very close relatives). The origin of ybgBA-gamAP grouping is unknown but synteny analysis suggests lateral transfer from an unidentified donor. The presence of gamAP has enabled B. subtilis to efficiently use glucosamine as carbon source.	[Gaugue, Isabelle; Putzer, Harald; Plumbridge, Jacqueline] Univ Diderot, Sorbonne Paris Cite, Inst Biol Phys Chim, CNRS UPR9073, Paris, France; [Oberto, Jacques] Univ Paris 11, Inst Genet & Microbiol, CNRS UMR8621, F-91405 Orsay, France	UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay	Plumbridge, J (corresponding author), Univ Diderot, Sorbonne Paris Cite, Inst Biol Phys Chim, CNRS UPR9073, Paris, France.	Jackie.Plumbridge@ibpc.fr	Putzer, Harald/GRY-6203-2022	Isabelle, Gaugue/0000-0001-6618-3899	CNRS; Universite Paris 7 Denis Diderot; GRONAG [ANR-09-BLAN-0399]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Paris 7 Denis Diderot; GRONAG	This work was supported by funds from the CNRS, Universite Paris 7 Denis Diderot and ANR-09-BLAN-0399 (GRONAG)(http://www.agence-nationale-recherche.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alice AF, 2003, MICROBIOL-SGM, V149, P1687, DOI 10.1099/mic.0.26231-0; Alvarez-Anorve LI, 2009, J BACTERIOL, V191, P6401, DOI 10.1128/JB.00633-09; Alvarez-Anorve LI, 2005, J BACTERIOL, V187, P2974, DOI 10.1128/JB.187.9.2974-2982.2005; BATES CJ, 1965, BIOCHEM J, V96, P147, DOI 10.1042/bj0960147; BATES CJ, 1965, BIOCHEM J, V96, P155, DOI 10.1042/bj0960155; Bechhofer DH, 2008, METHOD ENZYMOL, V447, P259, DOI 10.1016/S0076-6879(08)02214-3; Bertram R, 2011, J BACTERIOL, V193, P3525, DOI 10.1128/JB.00264-11; Borriss R, 2011, INT J SYST EVOL MICR, V61, P1786, DOI 10.1099/ijs.0.023267-0; Bryksin AV, 2010, BIOTECHNIQUES, V48, P463, DOI 10.2144/000113418; CALCAGNO M, 1984, BIOCHIM BIOPHYS ACTA, V787, P165, DOI 10.1016/0167-4838(84)90076-1; Cao M, 2003, J BACTERIOL, V185, P4883, DOI 10.1128/JB.185.16.4883-4890.2003; Cho EK, 2011, BMB REP, V44, P193, DOI 10.5483/BMBRep.2011.44.3.193; CHOMCZYNSKI P, 1992, ANAL BIOCHEM, V201, P134, DOI 10.1016/0003-2697(92)90185-A; CLARKE JS, 1962, BIOCHEM J, V84, P185, DOI 10.1042/bj0840185; COMB DG, 1958, J BIOL CHEM, V232, P807; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de Goes KCGP, 2012, J MICROBIOL BIOTECHN, V22, P437, DOI 10.4014/jmb.1109.09007; Despalins A, 2011, BIOINFORMATICS, V27, P2905, DOI 10.1093/bioinformatics/btr473; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Earl AM, 2012, J BACTERIOL, V194, P2378, DOI 10.1128/JB.05675-11; Ferreira FM, 2006, J MOL BIOL, V359, P308, DOI 10.1016/j.jmb.2006.03.024; GueroutFleury AM, 1995, GENE, V167, P335, DOI 10.1016/0378-1119(95)00652-4; Hall RS, 2007, BIOCHEMISTRY-US, V46, P7942, DOI 10.1021/bi700543x; Hanson KG, 2002, MICROBIOL-SGM, V148, P1805, DOI 10.1099/00221287-148-6-1805; Harwood C., 1990, MOL BIOL METHODS BAC, P1; Herskovitz MA, 2000, MOL MICROBIOL, V38, P1027, DOI 10.1046/j.1365-2958.2000.02185.x; HEUSTERSPREUTE M, 1985, GENE, V39, P299, DOI 10.1016/0378-1119(85)90327-0; Horjales E, 1999, STRUCTURE, V7, P527, DOI 10.1016/S0969-2126(99)80069-0; Lerat E, 2003, PLOS BIOL, V1, P101, DOI 10.1371/journal.pbio.0000019; LERECLUS D, 1989, FEMS MICROBIOL LETT, V60, P211, DOI 10.1016/0378-1097(89)90511-9; Markowitz VM, 2009, BIOINFORMATICS, V25, P2271, DOI 10.1093/bioinformatics/btp393; MARTINVERSTRAETE I, 1990, J MOL BIOL, V214, P657, DOI 10.1016/0022-2836(90)90284-S; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Oberto J, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-4; Oliva G, 1995, STRUCTURE, V3, P1323, DOI 10.1016/S0969-2126(01)00270-2; Pennetier C, 2008, MOL MICROBIOL, V67, P364, DOI 10.1111/j.1365-2958.2007.06041.x; PLUMBRIDGE JA, 1993, J BACTERIOL, V175, P4951, DOI 10.1128/JB.175.16.4951-4956.1993; Postma P. W., 1996, ESCHERICHIA COLI SAL, V1, P1149; Reizer J, 1999, MICROBIOL-UK, V145, P3419, DOI 10.1099/00221287-145-12-3419; Resch M, 2010, NUCLEIC ACIDS RES, V38, P2485, DOI 10.1093/nar/gkp1191; Rigali S, 2008, EMBO REP, V9, P670, DOI 10.1038/embor.2008.83; Sampson MN, 1998, MICROBIOL-SGM, V144, P2189, DOI 10.1099/00221287-144-8-2189; Souza JM, 1997, ARCH BIOCHEM BIOPHYS, V340, P338, DOI 10.1006/abbi.1997.9780; STRAGIER P, 1988, CELL, V52, P697, DOI 10.1016/0092-8674(88)90407-2; Stulke J, 1997, MOL MICROBIOL, V25, P65, DOI 10.1046/j.1365-2958.1997.4351797.x; Tremblay LW, 2006, BIOCHEMISTRY-US, V45, P1183, DOI 10.1021/bi051842j; Tsigos I, 2000, TRENDS BIOTECHNOL, V18, P305, DOI 10.1016/S0167-7799(00)01462-1; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; UZAN M, 1988, P NATL ACAD SCI USA, V85, P8895, DOI 10.1073/pnas.85.23.8895; Vincent F, 2005, J BIOL CHEM, V280, P19649, DOI 10.1074/jbc.M502131200; Vincent F, 2004, J BIOL CHEM, V279, P2809, DOI 10.1074/jbc.M310165200; Vlamakis H, 2013, NAT REV MICROBIOL, V11, P157, DOI 10.1038/nrmicro2960; VOGLER AP, 1989, MOL GEN GENET, V219, P97, DOI 10.1007/BF00261163; Wang SL, 2006, CARBOHYD RES, V341, P2507, DOI 10.1016/j.carres.2006.06.027; WHITE RJ, 1968, BIOCHEM J, V106, P847, DOI 10.1042/bj1060847	56	30	30	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63025	10.1371/journal.pone.0063025	http://dx.doi.org/10.1371/journal.pone.0063025			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667565	Green Published, gold, Green Submitted			2022-12-25	WOS:000319055600054
J	Usatyuk, PV; Burns, M; Mohan, V; Pendyala, S; He, DH; Ebenezer, DL; Harijith, A; Fu, PF; Huang, LS; Bear, JE; Garcia, JGN; Natarajan, V				Usatyuk, Peter V.; Burns, Michael; Mohan, Vijay; Pendyala, Srikanth; He, Donghong; Ebenezer, David L.; Harijith, Anantha; Fu, Panfeng; Huang, Long Shuang; Bear, James E.; Garcia, Joe G. N.; Natarajan, Viswanathan			Coronin 1B Regulates S1P-Induced Human Lung Endothelial Cell Chemotaxis: Role of PLD2, Protein Kinase C and Rac1 Signal Transduction	PLOS ONE			English	Article							STRESS FIBER FORMATION; BRONCHIAL EPITHELIAL-CELLS; PHOSPHOLIPASE-D ACTIVITY; ACTIN-BINDING-PROTEIN; SPHINGOSINE 1-PHOSPHATE; PHOSPHATIDIC-ACID; NUCLEOTIDE EXCHANGE; INTRACELLULAR TRAFFICKING; INTERLEUKIN-8 SECRETION; NADPH OXIDASE	Coronins are a highly conserved family of actin binding proteins that regulate actin-dependent processes such as cell motility and endocytosis. We found that treatment of human pulmonary artery endothelial cells (HPAECs) with the bioactive lipid, sphingosine-1-phosphate (S1P) rapidly stimulates coronin 1B translocation to lamellipodia at the cell leading edge, which is required for S1P-induced chemotaxis. Further, S1P-induced chemotaxis of HPAECs was attenuated by pretreatment with small interfering RNA (siRNA) targeting coronin 1B (similar to 36%), PLD2 (similar to 45%) or Rac1 (similar to 50%) compared to scrambled siRNA controls. Down regulation PLD2 expression by siRNA also attenuated S1P-induced coronin 1B translocation to the leading edge of the cell periphery while PLD1 silencing had no effect. Also, S1P-induced coronin 1B redistribution to cell periphery and chemotaxis was attenuated by inhibition of Rac1 and over-expression of dominant negative PKC delta, epsilon and zeta isoforms in HPAECs. These results demonstrate that S1P activation of PLD2, PKC and Rac1 is part of the signaling cascade that regulates coronin 1B translocation to the cell periphery and the ensuing cell chemotaxis.	[Usatyuk, Peter V.; Burns, Michael; Mohan, Vijay; Pendyala, Srikanth; He, Donghong; Ebenezer, David L.; Fu, Panfeng; Huang, Long Shuang; Garcia, Joe G. N.; Natarajan, Viswanathan] Univ Illinois, Inst Personalized Resp Med, Chicago, IL 60680 USA; [Usatyuk, Peter V.; Mohan, Vijay; Pendyala, Srikanth; He, Donghong; Ebenezer, David L.; Fu, Panfeng; Huang, Long Shuang; Natarajan, Viswanathan] Univ Illinois, Dept Pharmacol, Chicago, IL USA; [Harijith, Anantha] Univ Illinois, Dept Pediat, Chicago, IL USA; [Bear, James E.] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC USA; [Garcia, Joe G. N.; Natarajan, Viswanathan] Univ Illinois, Dept Med, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of North Carolina; University of North Carolina Chapel Hill; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Natarajan, V (corresponding author), Univ Illinois, Inst Personalized Resp Med, Chicago, IL 60680 USA.	visnatar@uic.edu	Harijith, Anantha/AAA-5708-2021; Fu, Panfeng/F-7345-2015; Huang, Longshuang/H-9553-2016	Fu, Panfeng/0000-0001-8813-9258; 	National Institutes of Health [P01 HL 98050]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL058064, P01HL098050] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grant P01 HL 98050 to VN. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amiri A, 2007, MOL CANCER RES, V5, P933, DOI 10.1158/1541-7786.MCR-06-0362; Argraves Kelley M, 2010, World J Biol Chem, V1, P291, DOI 10.4331/wjbc.v1.i10.291; Berdyshev EV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016571; Brieher WM, 2006, J CELL BIOL, V175, P315, DOI 10.1083/jcb.200603149; Cai L, 2005, J BIOL CHEM, V280, P31913, DOI 10.1074/jbc.M504146200; Cai L, 2008, CELL, V134, P828, DOI 10.1016/j.cell.2008.06.054; Chen Q, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003257; Clarke M, 2006, MOL BIOL CELL, V17, P4866, DOI 10.1091/mbc.E06-04-0365; Cockcroft S, 2009, BBA-MOL CELL BIOL L, V1791, P905, DOI 10.1016/j.bbalip.2009.03.007; Cummings R, 2002, MOL CELL BIOCHEM, V234, P99, DOI 10.1023/A:1015944828973; Cummings RJ, 2002, J BIOL CHEM, V277, P30227, DOI 10.1074/jbc.M111078200; DEHOSTOS EL, 1991, EMBO J, V10, P4097, DOI 10.1002/j.1460-2075.1991.tb04986.x; DEHOSTOS EL, 1993, J CELL BIOL, V120, P163, DOI 10.1083/jcb.120.1.163; Desire L, 2005, J BIOL CHEM, V280, P37516, DOI 10.1074/jbc.M507913200; Du GW, 2004, MOL BIOL CELL, V15, P1024, DOI 10.1091/mbc.E03-09-0673; English D, 2000, FASEB J, V14, P2255, DOI 10.1096/fj.00-0134com; Erickson RW, 1999, J BIOL CHEM, V274, P22243, DOI 10.1074/jbc.274.32.22243; Estrada R, 2008, J BIOL CHEM, V283, P30363, DOI 10.1074/jbc.M804392200; Foger N, 2006, SCIENCE, V313, P839, DOI 10.1126/science.1130563; Freyberg Z, 2001, MOL BIOL CELL, V12, P943, DOI 10.1091/mbc.12.4.943; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; GERISCH G, 1995, CURR BIOL, V5, P1280, DOI 10.1016/S0960-9822(95)00254-5; Gil Pilar Rivera, 2010, Cytoskeleton (Hoboken), V67, P773, DOI 10.1002/cm.20486; Gorshkova I, 2008, J BIOL CHEM, V283, P11794, DOI 10.1074/jbc.M800250200; Hammad SM, 2010, J LIPID RES, V51, P3074, DOI 10.1194/jlr.D008532; Harrington EO, 1997, J BIOL CHEM, V272, P7390, DOI 10.1074/jbc.272.11.7390; Hashimoto M, 2008, AM J RESP CELL MOL, V39, P356, DOI 10.1165/rcmb.2006-0427OC; Hashimoto Y, 2008, BBA-MOL CELL RES, V1783, P153, DOI 10.1016/j.bbamcr.2007.08.011; Hilpela P, 2004, CURR TOP MICROBIOL, V282, P117; Hirai T, 2003, J BIOCHEM, V133, P1, DOI 10.1093/jb/mvg017; Hotulainen P, 2005, MOL BIOL CELL, V16, P649, DOI 10.1091/mbc.E04-07-0555; Humphries CL, 2002, J CELL BIOL, V159, P993, DOI 10.1083/jcb.200206113; Iglesias PA, 2008, CURR OPIN CELL BIOL, V20, P35, DOI 10.1016/j.ceb.2007.11.011; Jarquin-Pardo M, 2007, J CELL BIOCHEM, V100, P112, DOI 10.1002/jcb.21027; Jenkins GM, 2005, CELL MOL LIFE SCI, V62, P2305, DOI 10.1007/s00018-005-5195-z; Jeon H, 2011, CELL SIGNAL, V23, P1320, DOI 10.1016/j.cellsig.2011.03.014; Jones DR, 2000, FEBS LETT, V476, P160, DOI 10.1016/S0014-5793(00)01702-6; Kam Y, 2001, MOL CELL BIOL, V21, P4055, DOI 10.1128/MCB.21.12.4055-4066.2001; Knapek K, 2010, MOL CELL BIOL, V30, P4492, DOI 10.1128/MCB.00229-10; Koh E, 2007, CELL SIGNAL, V19, P1328, DOI 10.1016/j.cellsig.2007.01.005; Komati H, 2005, MOL BIOL CELL, V16, P1232, DOI 10.1091/mbc.E04-06-0459; Kueh HY, 2008, J CELL BIOL, V182, P341, DOI 10.1083/jcb.200801027; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lee JF, 2006, J BIOL CHEM, V281, P29190, DOI 10.1074/jbc.M604310200; Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X; Li Z, 2005, PROSTAG OTH LIPID M, V76, P95, DOI 10.1016/j.prostaglandins.2005.02.002; LIMATOLA C, 1994, BIOCHEM J, V304, P1001, DOI 10.1042/bj3041001; Liscovitch M, 1996, J LIPID MEDIAT CELL, V14, P215, DOI 10.1016/0929-7855(96)00528-7; Mahankali M, 2011, P NATL ACAD SCI USA, V108, P19617, DOI 10.1073/pnas.1114692108; MANIAK M, 1995, CELL, V83, P915, DOI 10.1016/0092-8674(95)90207-4; Mao YS, 2007, PFLUG ARCH EUR J PHY, V455, P5, DOI 10.1007/s00424-007-0286-3; Min J, MOL PHARM, V80, P760; Mishima M, 1999, J CELL SCI, V112, P2833; Morris AJ, 2007, BIOCHEM SOC SYMP, V74, P247, DOI 10.1042/BSS2007c20; Natarajan V, 1996, CHEM PHYS LIPIDS, V80, P103, DOI 10.1016/0009-3084(96)02548-0; NATARAJAN V, 1994, AM J RESP CELL MOL, V11, P221, DOI 10.1165/ajrcmb.11.2.8049083; Okamoto H, 2000, THROMB RES, V99, P259, DOI 10.1016/S0049-3848(00)00251-6; Oubaha M, 2012, BLOOD, V120, P3371, DOI 10.1182/blood-2012-03-419721; Paik JH, 2001, J BIOL CHEM, V276, P11830, DOI 10.1074/jbc.M009422200; Parri M, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-23; Pfaendtner J, 2010, P NATL ACAD SCI USA, V107, P7299, DOI 10.1073/pnas.0911675107; Pilquil C, 2006, J BIOL CHEM, V281, P38418, DOI 10.1074/jbc.M601670200; Porcelli AM, 2002, CELL SIGNAL, V14, P75, DOI 10.1016/S0898-6568(01)00222-4; Regier DS, 2000, J BIOL CHEM, V275, P28406, DOI 10.1074/jbc.M004703200; SADAHIRA Y, 1992, P NATL ACAD SCI USA, V89, P9686, DOI 10.1073/pnas.89.20.9686; Sauer B, 2004, J BIOL CHEM, V279, P38471, DOI 10.1074/jbc.M313557200; Snider AJ, 2010, AM J PHYSIOL-CELL PH, V298, pC163, DOI 10.1152/ajpcell.00001.2009; Spiering D, 2011, CELL ADHES MIGR, V5, P170, DOI 10.4161/cam.5.2.14403; Sun XG, 2012, AM J RESP CELL MOL, V47, P628, DOI 10.1165/rcmb.2012-0048OC; Takuwa Y, 2008, BBA-MOL CELL BIOL L, V1781, P483, DOI 10.1016/j.bbalip.2008.04.003; TILNEY LG, 1981, J CELL BIOL, V90, P485, DOI 10.1083/jcb.90.2.485; Usatyuk PV, 2009, J BIOL CHEM, V284, P15339, DOI 10.1074/jbc.M109.005439; Usatyuk PV KS, 2012, PULM CIRCUL IN PRESS; Van Brocklyn JR, 2003, CANCER LETT, V199, P53, DOI 10.1016/S0304-3835(03)00334-3; Venkataraman K, 2008, CIRC RES, V102, P669, DOI 10.1161/CIRCRESAHA.107.165845; Wang L, 2008, HISTOCHEM CELL BIOL, V129, P579, DOI 10.1007/s00418-008-0389-8; Wang LX, 2002, BIOCHEM J, V367, P751, DOI 10.1042/BJ20020586; Wegener J, 2000, EXP CELL RES, V259, P158, DOI 10.1006/excr.2000.4919; Williams HC, 2012, CIRC RES, V111, P56, DOI 10.1161/CIRCRESAHA.111.255745; Williams Michael J, 2012, Small GTPases, V3, P1, DOI 10.4161/sgtp.20335; Wu M, 2010, TOXICOL LETT, V196, P168, DOI 10.1016/j.toxlet.2010.04.014; Ruiz-Loredo AY, 2011, J CELL PHYSIOL, V226, P414, DOI 10.1002/jcp.22347; Zeiller C, 2009, BBA-MOL CELL RES, V1793, P1236, DOI 10.1016/j.bbamcr.2009.04.001; Zheng Y, 2006, J BIOL CHEM, V281, P15862, DOI 10.1074/jbc.M600660200	84	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63007	10.1371/journal.pone.0063007	http://dx.doi.org/10.1371/journal.pone.0063007			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667561	gold, Green Published, Green Submitted			2022-12-25	WOS:000319055600051
J	Jessopp, M; Cronin, M; Hart, T				Jessopp, Mark; Cronin, Michelle; Hart, Tom			Habitat-Mediated Dive Behavior in Free-Ranging Grey Seals	PLOS ONE			English	Article							FORAGING BEHAVIOR; DIET; TRACKING; PREY; ASSOCIATIONS; ACCURACY; GPS	Understanding the links between foraging behaviour and habitat use of key species is essential to addressing fundamental questions about trophic interactions and ecosystem functioning. Eight female grey seals (Halichoerus grypus) were equipped with time-depth recorders linked to Fastloc GPS tags following the annual moult in southwest Ireland. Individual dives were coupled with environmental correlates to investigate the habitat use and dive behaviour of free-ranging seals. Dives were characterised as either pelagic, benthic, or shallow (where errors in location and charted water depth made differentiating between pelagic and benthic dives unreliable). Sixty-nine percent of dives occurring in water >50 m were benthic. Pelagic dives were more common at night than during the day. Seals performed more pelagic dives over fine sediments (mud/sand), and more benthic dives when foraging over more three-dimensionally complex rock substrates. We used Markov chain analysis to determine the probability of transiting between dive states. A low probability of repeat pelagic dives suggests that pelagic prey were encountered en route to the seabed. This approach could be applied to make more accurate predictions of habitat use in data-poor areas, and investigate contentious issues such as resource overlap and competition between top predators and fisheries, essential for the effective conservation of these key marine species.	[Jessopp, Mark; Cronin, Michelle] Natl Univ Ireland Univ Coll Cork, Coastal & Marine Res Ctr, Environm Res Inst, Cork, Ireland; [Hart, Tom] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University College Cork; University of Oxford	Jessopp, M (corresponding author), Natl Univ Ireland Univ Coll Cork, Coastal & Marine Res Ctr, Environm Res Inst, Cork, Ireland.	mjessopp@gmail.com	Jessopp, Mark/AAI-4786-2020	Jessopp, Mark/0000-0002-2692-3730	Beaufort Marine Research Award; Strategy for Science Technology and Innovation; Marine Institute; Marine Research Sub-Programme of the National Development Plan; Higher Education Authority Ireland [PTRLI4]	Beaufort Marine Research Award; Strategy for Science Technology and Innovation; Marine Institute; Marine Research Sub-Programme of the National Development Plan; Higher Education Authority Ireland	MJ and MC were supported by a Beaufort Marine Research Award carried out under the Sea Change Strategy and the Strategy for Science Technology and Innovation (2006-2013), with the support of the Marine Institute, funded under the Marine Research Sub-Programme of the National Development Plan 2007-2013, and Higher Education Authority Ireland PTRLI4 funding mechanism. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TJ, 2009, J EXP MAR BIOL ECOL, V379, P34, DOI 10.1016/j.jembe.2009.07.033; Arnould JPY, 2007, AQUAT CONSERV, V17, pS53, DOI 10.1002/aqc.908; Austin D, 2006, J ANIM ECOL, V75, P408, DOI 10.1111/j.1365-2656.2006.01057.x; Beck CA, 2007, J ANIM ECOL, V76, P490, DOI 10.1111/j.1365-2656.2007.01215.x; Boelens RGV, 1999, IRELANDS MARINE COAS; Bowen WD, 2006, CONSERV BIOL SER, P63, DOI 10.1017/CBO9780511541964.006; BOYD IL, 1994, J ANIM ECOL, V63, P703, DOI 10.2307/5235; Bradshaw CJA, 2004, ICES J MAR SCI, V61, P1014, DOI 10.1016/j.icesjms.2004.07.012; Brown SL, 2012, J MAR BIOL ASSOC UK, V92, P1711, DOI 10.1017/S0025315411002050; Burns JM, 2008, DEEP-SEA RES PT II, V55, P500, DOI 10.1016/j.dsr2.2007.11.012; Chittaro PM, 2004, CORAL REEFS, V23, P235, DOI 10.1007/s00338-004-0376-z; Costa DP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008677; Cronin M, 2013, MAR BIOL, V160, P531, DOI 10.1007/s00227-012-2109-0; Cronin MA, 2012, BIOL CONSERV, V150, P136, DOI 10.1016/j.biocon.2012.02.013; Cronin MA, 2011, MAR POLICY, V35, P748, DOI 10.1016/j.marpol.2011.01.006; Gosch M, 2010, THESIS U COLL CORK C; Hays GC, 2001, ANIM BEHAV, V61, P1035, DOI 10.1006/anbe.2001.1685; Hazel J, 2009, J EXP MAR BIOL ECOL, V374, P58, DOI 10.1016/j.jembe.2009.04.009; Hooker SK, 2007, DEEP-SEA RES PT II, V54, P177, DOI 10.1016/j.dsr2.2007.01.001; Hooker SK, 2002, MAR MAMMAL SCI, V18, P680, DOI 10.1111/j.1748-7692.2002.tb01066.x; Jaud T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047444; Kamenos NA, 2004, ICES J MAR SCI, V61, P422, DOI 10.1016/j.icesjms.2004.02.004; Lea MA, 2003, ICES J MAR SCI, V60, P990, DOI 10.1016/S1054-3139(03)00101-2; McConnell BJ, 1999, J APPL ECOL, V36, P573, DOI 10.1046/j.1365-2664.1999.00429.x; MCCONNELL BJ, 1992, ANTARCT SCI, V4, P393, DOI 10.1017/S0954102092000580; Parrish FA, 2000, MAR MAMMAL SCI, V16, P392, DOI 10.1111/j.1748-7692.2000.tb00932.x; Ridoux V, 2007, J MAR BIOL ASSOC UK, V87, P255, DOI 10.1017/S002531540705463X; Ryan PG, 2004, MAR BIOL, V145, P215, DOI 10.1007/s00227-004-1328-4; Simmons SE, 2007, MAR ECOL PROG SER, V346, P265, DOI 10.3354/meps07014; Tollit DJ, 1998, J ZOOL, V244, P209, DOI 10.1111/j.1469-7998.1998.tb00026.x; Viviant M, 2010, POLAR BIOL, V33, P713, DOI 10.1007/s00300-009-0750-y; Williams A, 2001, MAR FRESHWATER RES, V52, P513, DOI 10.1071/MF00017; Wilson RP, 2012, MAR ECOL PROG SER, V451, P245, DOI 10.3354/meps09608; WILSON RP, 1993, MAR ECOL PROG SER, V94, P101	34	24	24	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63720	10.1371/journal.pone.0063720	http://dx.doi.org/10.1371/journal.pone.0063720			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667663	Green Published, gold, Green Submitted			2022-12-25	WOS:000319654700180
J	Krishnan, M; Kannan, TR; Baseman, JB				Krishnan, Manickam; Kannan, T. R.; Baseman, Joel B.			Mycoplasma pneumoniae CARDS Toxin Is Internalized via Clathrin-Mediated Endocytosis	PLOS ONE			English	Article							SHIGA TOXIN; PULMONARY INFLAMMATION; DIPHTHERIA-TOXIN; BINDING-PROTEIN; ORGAN-CULTURE; MURINE MODEL; COATED PITS; CELLS; INFECTION; MECHANISMS	Bacterial toxins possess specific mechanisms of binding and uptake by mammalian cells. Mycoplasma pneumoniae CARDS (Community Acquired Respiratory Distress Syndrome) toxin is a 68 kDa protein, which demonstrates high binding affinity to human surfactant protein-A and exhibits specific biological activities including mono-ADP ribosylation and vacuolization. These properties lead to inflammatory processes in the airway and a range of cytopathologies including ciliostasis, loss of tissue integrity and injury, and cell death. However, the process by which CARDS toxin enters target cells is unknown. In this study, we show that CARDS toxin binds to mammalian cell surfaces and is internalized rapidly in a dose and time-dependent manner using a clathrin-mediated pathway, as indicated by inhibition of toxin internalization by monodansylcadaverine but not by methyl-beta-cyclodextrin or filipin. Furthermore, the internalization of CARDS toxin was markedly inhibited in clathrin-depleted cells.	[Krishnan, Manickam; Kannan, T. R.; Baseman, Joel B.] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Baseman, JB (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA.	baseman@uthscsa.edu			National Institute of Allergy and Infectious Diseases [U19AI070412]; Kleberg Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070412] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Kleberg Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by an award number U19AI070412 from the National Institute of Allergy and Infectious Diseases and The Kleberg Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baseman JB, 1997, EMERG INFECT DIS, V3, P21, DOI 10.3201/eid0301.970103; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; COHEN G, 1967, ANN NY ACAD SCI, V143, P85, DOI 10.1111/j.1749-6632.1967.tb27648.x; COLLIER AM, 1971, P SOC EXP BIOL MED, V136, P569, DOI 10.3181/00379727-136-35313; DIDSBURY JR, 1983, MOL CELL BIOL, V3, P1283, DOI 10.1128/MCB.3.7.1283; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; GIL JC, 1993, ANN ALLERGY, V70, P23; Hardy RD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007562; Hardy RD, 2002, INFECT IMMUN, V70, P649, DOI 10.1128/IAI.70.2.649-654.2002; Hardy RD, 2001, INFECT IMMUN, V69, P3869, DOI 10.1128/IAI.69.6.3869-3876.2001; Hinrichsen L, 2003, J BIOL CHEM, V278, P45160, DOI 10.1074/jbc.M307290200; Horiguchi H, 2006, COMPREHENSIVE SOURCE, P106; HU PC, 1975, INFECT IMMUN, V11, P704, DOI 10.1128/IAI.11.4.704-710.1975; Johannes L, 2002, TRAFFIC, V3, P443, DOI 10.1034/j.1600-0854.2002.30701.x; Johnson C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022877; Kannan TR, 2011, J INFECT DIS, V204, P1596, DOI 10.1093/infdis/jir557; Kannan TR, 2010, MOL MICROBIOL, V76, P1127, DOI 10.1111/j.1365-2958.2010.07092.x; Kannan TR, 2006, P NATL ACAD SCI USA, V103, P6724, DOI 10.1073/pnas.0510644103; Kannan TR, 2005, INFECT IMMUN, V73, P2828, DOI 10.1128/IAI.73.5.2828-2834.2005; KRUEGER KM, 1995, CLIN MICROBIOL REV, V8, P34, DOI 10.1128/CMR.8.1.34; Lauvrak SU, 2004, J CELL SCI, V117, P2321, DOI 10.1242/jcs.01081; MIDDLEBROOK JL, 1984, MICROBIOL REV, V48, P199, DOI 10.1128/MMBR.48.3.199-221.1984; MORRIS RE, 1983, INFECT IMMUN, V40, P806, DOI 10.1128/IAI.40.2.806-811.1983; MOYA M, 1985, J CELL BIOL, V101, P548, DOI 10.1083/jcb.101.2.548; Muir MT, 2011, CHEST, V139, P305, DOI 10.1378/chest.10-1222; MURPHY GF, 1980, VIRCHOWS ARCH A, V389, P93, DOI 10.1007/BF00428670; Navarro-Garcia F, 2007, MICROBIOL-SGM, V153, P2828, DOI 10.1099/mic.0.2007/007088-0; Nisar N, 2007, POSTGRAD MED J, V83, P100, DOI 10.1136/pgmj.2006.049023; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Papatheodorou P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010673; Peters J, 2011, CHEST, V140, P401, DOI 10.1378/chest.11-0221; Rappoport J, 2004, TRAFFIC, V5, P327, DOI 10.1111/j.1600-0854.2004.00187.x; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; ROGEL A, 1992, J BIOL CHEM, V267, P22599; Sanchez-Vargas FM, 2008, CLIN MICROBIOL INFEC, V14, P105, DOI 10.1111/j.1469-0691.2007.01834.x; Sandvig K, 2002, ANNU REV CELL DEV BI, V18, P1, DOI 10.1146/annurev.cellbio.18.011502.142107; SANDVIG K, 1989, J CELL BIOL, V108, P1331, DOI 10.1083/jcb.108.4.1331; Sandvig K, 2002, HISTOCHEM CELL BIOL, V117, P131, DOI 10.1007/s00418-001-0346-2; Sandvig K, 2011, CURR OPIN CELL BIOL, V23, P413, DOI 10.1016/j.ceb.2011.03.007; SEGGEV JS, 1986, ANN ALLERGY, V57, P263; Torgersen ML, 2001, J CELL SCI, V114, P3737; Torgersen ML, 2005, FEBS J, V272, P4103, DOI 10.1111/j.1742-4658.2005.04835.x; Waites KB, 2004, CLIN MICROBIOL REV, V17, P697, DOI 10.1128/CMR.17.4.697-728.2004	43	27	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62706	10.1371/journal.pone.0062706	http://dx.doi.org/10.1371/journal.pone.0062706			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667510	Green Published, gold, Green Submitted			2022-12-25	WOS:000319654700057
J	MacKinnon, CD; Allen, DP; Shiratori, T; Rogers, MW				MacKinnon, Colum D.; Allen, David P.; Shiratori, Takako; Rogers, Mark W.			Early and Unintentional Release of Planned Motor Actions during Motor Cortical Preparation	PLOS ONE			English	Article							MOVEMENT-RELATED POTENTIALS; SIMPLE REACTION-TIME; ACOUSTIC STARTLE; PREMOTOR CORTEX; PREDICTABILITY; INITIATION; DIRECTION; HUMANS; ONSET	Voluntary movements are often preceded by a movement-related potential beginning as much as two seconds prior to the onset of movement. In light of evidence that motor actions can be prepared and initiated in less than 200 ms, the function of this early activity has remained enigmatic. We hypothesized that the movement-related potential reflects the state of preparation of the planned movement. This was tested by delivering a startling acoustic stimulus during the preparation phase of a load-release task. The cue to release the load was presented either 3.5 seconds after a warning cue (PREDICT condition) or randomly between 4-12 seconds (REACT condition). Electroencephalographic, electromyographic and limb and load kinematic signals were recorded. In a subset of trials, a startle stimulus was delivered at -1500, -1000, -500, -250, -100 or 0 ms before the release cue. A contingent-negative variation (CNV) waveform, with a late phase of slowrising negativity beginning an average of 1459 ms prior to movement, was observed for the PREDICT condition but not the REACT condition. For both conditions, the startle stimulus frequently evoked the early and unintentional release of the loadrelease sequence. The incidence of release was significantly (p<0.001) correlated with the late phase of the CNV for the PREDICT condition but not the REACT condition. For the REACT condition, the incidence of movement release was subjectspecific, constant across the preparation interval, and uncorrelated with cortical activity. The onset of movement release by the startle stimulus was significantly shorter (p<0.001) for the PREDICT compared to the REACT condition. These findings provide evidence that the late phase of the CNV reflects cortical activity mediating the progressive preparation and storage of the forthcoming movement and that during this phase an intense sensory stimulus can evoke early and unintentional release of the planned action.	[MacKinnon, Colum D.; Allen, David P.; Shiratori, Takako] Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA; [MacKinnon, Colum D.] Northwestern Univ, Feinberg Sch Med, Dept Phys Therapy & Human Movement Sci, Chicago, IL 60611 USA; [Rogers, Mark W.] Univ Maryland, Sch Med, Dept Neurol, Dept Phys Therapy & Rehabil Sci, Baltimore, MD 21201 USA; [Rogers, Mark W.] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Dept Phys Therapy & Rehabil Sci, Baltimore, MD 21201 USA	University of Minnesota System; University of Minnesota Twin Cities; Northwestern University; Feinberg School of Medicine; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	MacKinnon, CD (corresponding author), Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA.	cmackinn@umn.edu		Shiratori, Takako/0000-0001-7916-2499	National Institutes of Health [RO1 NS054199]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070264, R01NS054199] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding provided by National Institutes of Health Grant RO1 NS054199. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibiglou L, 2012, J PHYSIOL-LONDON, V590, DOI 10.1113/jphysiol.2011.219592; Brass M, 2008, NEUROSCIENTIST, V14, P319, DOI 10.1177/1073858408317417; Carlsen AN, 2004, EXP BRAIN RES, V159, P301, DOI 10.1007/s00221-004-1924-z; Carlsen AN, 2010, BRAIN RES, V1322, P38, DOI 10.1016/j.brainres.2010.01.076; Churchland MM, 2010, NEURON, V68, P387, DOI 10.1016/j.neuron.2010.09.015; Churchland MM, 2006, NEURON, V52, P1085, DOI 10.1016/j.neuron.2006.10.034; Cisek P, 2005, NEURON, V45, P801, DOI 10.1016/j.neuron.2005.01.027; Colebatch JG, 2007, MOVEMENT DISORD, V22, P601, DOI 10.1002/mds.21323; Confais J, 2012, J NEUROSCI, V32, P15359, DOI 10.1523/JNEUROSCI.1768-12.2012; Cui RQ, 2009, EXP BRAIN RES, V194, P477, DOI 10.1007/s00221-009-1725-5; CUNNINGTON R, 1995, BRAIN, V118, P935, DOI 10.1093/brain/118.4.935; DEECKE L, 1976, BIOL CYBERN, V23, P99, DOI 10.1007/BF00336013; Diggle P, 1990, TIME SERIES BIOSTATI; Duque J, 2010, J NEUROSCI, V30, P3793, DOI 10.1523/JNEUROSCI.5722-09.2010; Duque J, 2009, CEREB CORTEX, V19, P2013, DOI 10.1093/cercor/bhn230; Floeter MK, 1999, NEUROLOGY, V53, P664, DOI 10.1212/WNL.53.4.664; Gilbertson T, 2005, J NEUROSCI, V25, P7771, DOI 10.1523/JNEUROSCI.1762-05.2005; Hallett M, 2007, CLIN NEUROPHYSIOL, V118, P1179, DOI 10.1016/j.clinph.2007.03.019; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Hodges PW, 1996, ELECTROMYOGR MOTOR C, V101, P511, DOI 10.1016/S0013-4694(96)95190-5; HUGON M, 1982, PFLUG ARCH EUR J PHY, V393, P292, DOI 10.1007/BF00581412; Jankelowitz SK, 2002, EXP BRAIN RES, V147, P98, DOI 10.1007/s00221-002-1220-8; Jenkins IH, 2000, BRAIN, V123, P1216, DOI 10.1093/brain/123.6.1216; Jenkinson N, 2011, TRENDS NEUROSCI, V34, P611, DOI 10.1016/j.tins.2011.09.003; KLEMMER ET, 1956, J EXP PSYCHOL, V51, P179, DOI 10.1037/h0042317; KORNHUBE.HH, 1965, PFLUG ARCH GES PHYS, V284, P1, DOI 10.1007/BF00412364; LIBET B, 1983, BRAIN, V106, P623, DOI 10.1093/brain/106.3.623; MacKinnon CD, 2007, J NEUROPHYSIOL, V97, P4368, DOI 10.1152/jn.01136.2006; MCADAM DW, 1969, PSYCHOPHYSIOLOGY, V5, P349, DOI 10.1111/j.1469-8986.1969.tb02833.x; NIEMI P, 1981, PERCEPT MOTOR SKILL, V53, P615, DOI 10.2466/pms.1981.53.2.615; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Prochazka A, 2000, EXP BRAIN RES, V130, P417, DOI 10.1007/s002219900250; Rektor I, 2002, CLIN NEUROPHYSIOL, V113, P1998, DOI 10.1016/S1388-2457(02)00286-9; RIEHLE A, 1993, BEHAV BRAIN RES, V53, P35, DOI 10.1016/S0166-4328(05)80264-5; Shibasaki H, 2006, CLIN NEUROPHYSIOL, V117, P2341, DOI 10.1016/j.clinph.2006.04.025; TANJI J, 1976, J NEUROPHYSIOL, V39, P1062, DOI 10.1152/jn.1976.39.5.1062; Valls-Sole J, 1999, J PHYSIOL-LONDON, V516, P931, DOI 10.1111/j.1469-7793.1999.0931u.x; Valls-Sole J, 2008, EXP BRAIN RES, V187, P497, DOI 10.1007/s00221-008-1402-0; VALLSSOLE J, 1995, NEUROSCI LETT, V195, P97, DOI 10.1016/0304-3940(94)11790-P; WALTER WG, 1964, NATURE, V203, P380, DOI 10.1038/203380a0	41	20	20	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63417	10.1371/journal.pone.0063417	http://dx.doi.org/10.1371/journal.pone.0063417			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667613	Green Published, gold, Green Submitted			2022-12-25	WOS:000319654700141
J	Ozcelik, S; Fraser, G; Castets, P; Schaeffer, V; Skachokova, Z; Breu, K; Clavaguera, F; Sinnreich, M; Kappos, L; Goedert, M; Tolnay, M; Winkler, DT				Ozcelik, Sefika; Fraser, Graham; Castets, Perrine; Schaeffer, Veronique; Skachokova, Zhiva; Breu, Karin; Clavaguera, Florence; Sinnreich, Michael; Kappos, Ludwig; Goedert, Michel; Tolnay, Markus; Winkler, David Theo			Rapamycin Attenuates the Progression of Tau Pathology in P301S Tau Transgenic Mice	PLOS ONE			English	Article							MOUSE MODEL; ALZHEIMERS-DISEASE; MAMMALIAN TARGET; HUMAN TAUOPATHY; AUTOPHAGY INDUCTION; TUBEROUS SCLEROSIS; AMYLOID-BETA; PROTEIN; NEURODEGENERATION; PHOSPHORYLATION	Altered autophagy contributes to the pathogenesis of Alzheimer's disease and other tauopathies, for which curative treatment options are still lacking. We have recently shown that trehalose reduces tau pathology in a tauopathy mouse model by stimulation of autophagy. Here, we studied the effect of the autophagy inducing drug rapamycin on the progression of tau pathology in P301S mutant tau transgenic mice. Rapamycin treatment resulted in a significant reduction in cortical tau tangles, less tau hyperphosphorylation, and lowered levels of insoluble tau in the forebrain. The favourable effect of rapamycin on tau pathology was paralleled by a qualitative reduction in astrogliosis. These effects were visible with early preventive or late treatment. We further noted an accumulation of the autophagy associated proteins p62 and LC3 in aged tangle bearing P301S mice that was lowered upon rapamycin treatment. Thus, rapamycin treatment defers the progression of tau pathology in a tauopathy animal model and autophagy stimulation may constitute a therapeutic approach for patients suffering from tauopathies.	[Ozcelik, Sefika; Skachokova, Zhiva; Breu, Karin; Clavaguera, Florence; Tolnay, Markus; Winkler, David Theo] Univ Basel Hosp, Inst Pathol, CH-4031 Basel, Switzerland; [Ozcelik, Sefika; Castets, Perrine; Skachokova, Zhiva; Breu, Karin; Sinnreich, Michael; Kappos, Ludwig; Winkler, David Theo] Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland; [Fraser, Graham; Schaeffer, Veronique; Goedert, Michel] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Castets, Perrine; Sinnreich, Michael] Univ Basel Hosp, Dept Biomed, Neuromuscular Res Ctr, CH-4031 Basel, Switzerland	University of Basel; University of Basel; MRC Laboratory Molecular Biology; University of Basel	Winkler, DT (corresponding author), Univ Basel Hosp, Inst Pathol, CH-4031 Basel, Switzerland.	winklerd@uhbs.ch		Sinnreich, Michael/0000-0002-9835-1276; Schaeffer, Veronique/0000-0002-2564-9012	Swiss National Science Foundation [310030_135214, 32323B_123812]; Velux Foundation, Switzerland; MRC [MC_U105184291] Funding Source: UKRI; Alzheimers Research UK [ART-PG2004A-5] Funding Source: researchfish; Medical Research Council [MC_U105184291] Funding Source: researchfish; Parkinson&quot;s UK [K-1012] Funding Source: researchfish	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Velux Foundation, Switzerland; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Parkinson&quot;s UK(Parkinson&apos;s UK)	MT and DTW are supported by the Swiss National Science Foundation (310030_135214 to MT and 32323B_123812 to D.T.W.), and by the Velux Foundation, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen B, 2002, J NEUROSCI, V22, P9340; Asuni AA, 2007, J NEUROSCI, V27, P9115, DOI 10.1523/JNEUROSCI.2361-07.2007; Bi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026860; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Caccamo A, 2010, J BIOL CHEM, V285, P13107, DOI 10.1074/jbc.M110.100420; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Delobel P, 2008, AM J PATHOL, V172, P123, DOI 10.2353/ajpath.2008.070627; Forman MS, 2005, J NEUROSCI, V25, P3539, DOI 10.1523/JNEUROSCI.0081-05.2005; Franz DN, 2006, ANN NEUROL, V59, P490, DOI 10.1002/ana.20784; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Hampton DW, 2010, J NEUROSCI, V30, P9973, DOI 10.1523/JNEUROSCI.0834-10.2010; Hegedus B, 2008, CANCER RES, V68, P1520, DOI 10.1158/0008-5472.CAN-07-5916; Hosokawa M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052389; JUCKER M, 1994, NEUROSCIENCE, V60, P875, DOI 10.1016/0306-4522(94)90269-0; Kruger U, 2012, NEUROBIOL AGING, V33, P2291, DOI 10.1016/j.neurobiolaging.2011.11.009; Kuusisto E, 2001, NEUROREPORT, V12, P2085, DOI 10.1097/00001756-200107200-00009; Majumder S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025416; MAWALDEWAN M, 1994, J BIOL CHEM, V269, P30981; Meikle L, 2008, J NEUROSCI, V28, P5422, DOI 10.1523/JNEUROSCI.0955-08.2008; Menzies FM, 2010, BRAIN, V133, P93, DOI 10.1093/brain/awp292; Meske V, 2008, J BIOL CHEM, V283, P100, DOI 10.1074/jbc.M704292200; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Morita T, 2009, J BIOL CHEM, V284, P27734, DOI 10.1074/jbc.M109.008177; Mueller DM, 2010, J CHROMATOGR B, V878, P1007, DOI 10.1016/j.jchromb.2010.02.029; Noble W, 2005, P NATL ACAD SCI USA, V102, P6990, DOI 10.1073/pnas.0500466102; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Pritchard SM, 2011, J CELL MOL MED, V15, P1621, DOI 10.1111/j.1582-4934.2011.01273.x; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Schaeffer V, 2012, BRAIN, V135, P2169, DOI 10.1093/brain/aws143; van Eersel J, 2010, P NATL ACAD SCI USA, V107, P13888, DOI 10.1073/pnas.1009038107; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Winkler DT, 2001, J NEUROSCI, V21, P1619, DOI 10.1523/JNEUROSCI.21-05-01619.2001; Wyttenbach A, 2008, AUTOPHAGY, V4, P542, DOI 10.4161/auto.6059; Yang DS, 2011, BRAIN, V134, P258, DOI 10.1093/brain/awq341; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010	37	151	154	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62459	10.1371/journal.pone.0062459	http://dx.doi.org/10.1371/journal.pone.0062459			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667480	Green Published, Green Submitted, gold			2022-12-25	WOS:000319654700039
J	Shean, K; Streicher, E; Pieterson, E; Symons, G; Smit, RV; Theron, G; Lehloenya, R; Padanilam, X; Wilcox, P; Victor, TC; van Helden, P; Groubusch, M; Warren, R; Badri, M; Dheda, K				Shean, Karen; Streicher, Elizabeth; Pieterson, Elize; Symons, Greg; Smit, Richard van Zyl; Theron, Grant; Lehloenya, Rannakoe; Padanilam, Xavier; Wilcox, Paul; Victor, Tommie C.; van Helden, Paul; Groubusch, Martin; Warren, Robin; Badri, Motasim; Dheda, Keertan			Drug-Associated Adverse Events and Their Relationship with Outcomes in Patients Receiving Treatment for Extensively Drug-Resistant Tuberculosis in South Africa	PLOS ONE			English	Article							MULTIDRUG-RESISTANT; MYCOBACTERIUM-TUBERCULOSIS; EPIDEMIOLOGY; THERAPY; HIV	Background: Treatment-related outcomes in patients with extensively drug-resistant tuberculosis (XDR-TB) are poor. However, data about the type, frequency and severity of presumed drug-associated adverse events (AEs) and their association with treatment-related outcomes in patients with XDR-TB are scarce. Methods: Case records of 115 South-African XDR-TB patients were retrospectively reviewed by a trained researcher. AEs were estimated and graded according to severity [grade 0 = none; grade 1-2 = mild to moderate; and grade 3-5 = severe (drug stopped, life-threatening or death)]. Findings: 161 AEs were experienced by 67/115(58%) patients: 23/67(34%) required modification of treatment, the offending drug was discontinued in 19/67(28%), reactions were life-threatening in 2/67(3.0%), and 6/67(9.0%) died. similar to 50% of the patients were still on treatment at the time of data capture. Sputum culture-conversion was less likely in those with severe (grade 3-5) vs. grade 0-2 AEs [2/27(7%) vs. 24/88(27%); p = 0.02]. The type, frequency and severity of AEs was similar in HIV-infected and uninfected patients. Capreomycin, which was empirically administered in most cases, was withdrawn in 14/104(14%) patients, implicated in (14/34) 41% of the total drug withdrawals, and was associated with all 6 deaths in the severe AE group (renal failure in five patients and hypokalemia in one patient). Conclusion: Drug-associated AEs occur commonly with XDR-TB treatment, are often severe, frequently interrupt therapy, and negatively impact on culture conversion outcomes. These preliminary data inform on the need for standardised strategies (including pre-treatment counselling, early detection, monitoring, and follow-up) and less toxic drugs to optimally manage patients with XDR-TB.	[Shean, Karen; Pieterson, Elize; Symons, Greg; Smit, Richard van Zyl; Theron, Grant; Lehloenya, Rannakoe; Wilcox, Paul; Badri, Motasim; Dheda, Keertan] Univ Cape Town, Div Pulmonol, Lung Infect & Immun Unit, ZA-7925 Cape Town, South Africa; [Shean, Karen; Pieterson, Elize; Symons, Greg; Smit, Richard van Zyl; Theron, Grant; Lehloenya, Rannakoe; Wilcox, Paul; Badri, Motasim; Dheda, Keertan] Univ Cape Town, Dept Med, UCT Lung Inst, ZA-7925 Cape Town, South Africa; [Dheda, Keertan] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Dheda, Keertan] UCL, Sch Med, Dept Infect, London W1N 8AA, England; [Padanilam, Xavier; Groubusch, Martin] Sizwe Trop Dis Hosp, Johannesburg, South Africa; [Groubusch, Martin] Univ Witwatersrand, Natl Hlth Lab Serv, Johannesburg, South Africa; [Groubusch, Martin] Univ Witwatersrand, Div Clin Microbiol & Infect Dis, Johannesburg, South Africa; [Padanilam, Xavier; Groubusch, Martin] Univ Witwatersrand, Dept Med, Fac Hlth Sci, Div Infect Dis, ZA-2001 Johannesburg, South Africa; [Streicher, Elizabeth; Victor, Tommie C.; van Helden, Paul; Warren, Robin] Univ Stellenbosch, MRC Ctr Mol & Cellular Biol, DST NRF Ctr Excellence Biomed TB Res, ZA-7600 Stellenbosch, South Africa; [Groubusch, Martin] Univ Amsterdam, Dept Infect Dis, Ctr Trop Med & Travel Med, Div Internal Med,Amsterdam Med Ctr, Amsterdam, Netherlands; [Badri, Motasim] King Saud Bin Abdulaziz Univ Hlth Sci, Coll Med, Riyadh, Saudi Arabia	University of Cape Town; University of Cape Town; University of Cape Town; University of London; University College London; UCL Medical School; National Health Laboratory Service; University of Witwatersrand; University of Witwatersrand; University of Witwatersrand; National Research Foundation - South Africa; Stellenbosch University; University of Amsterdam; Academic Medical Center Amsterdam; King Saud Bin Abdulaziz University for Health Sciences	Dheda, K (corresponding author), Univ Cape Town, Div Pulmonol, Lung Infect & Immun Unit, ZA-7925 Cape Town, South Africa.	keertan.dheda@uct.ac.za	Streicher, Elizabeth/O-9597-2019; Streicher, Elizabeth M/I-7780-2018; Theron, Grant/ABB-1167-2020; Lehloenya, Rannakoe J/C-5672-2012; Badri, Motasim/E-1141-2013	Streicher, Elizabeth/0000-0003-3901-1981; Streicher, Elizabeth M/0000-0003-3901-1981; Theron, Grant/0000-0002-9216-2415; van Zyl-Smit, Richard/0000-0002-4115-5362; Lehloenya, Rannakoe J/0000-0002-1281-1789; Warren, Robin/0000-0001-5741-7358; Badri, Motasim/0000-0002-5268-6492	South Africa MRC Fellowship; EU [FW7 TB Susgent]; EDCTP European and Developing Countries Clinical Trails Partnership	South Africa MRC Fellowship; EU(European Commission); EDCTP European and Developing Countries Clinical Trails Partnership	KD is supported by a South Africa MRC Fellowship, the EU (FW7 TB Susgent) and the EDCTP European and Developing Countries Clinical Trails Partnership. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Desouza GA, MOL CELL PROTEOMICS; Dheda K, 2010, INFECT DIS IN PRESS; Dheda K, 2010, INFECT DIS CLIN N AM, V24, P705, DOI 10.1016/j.idc.2010.05.001; Dheda K, 2010, LANCET, V375, P1798, DOI 10.1016/S0140-6736(10)60492-8; Furin JJ, 2001, INT J TUBERC LUNG D, V5, P648; Javadi MR, 2007, PHARMACOEPIDEM DR S, V16, P1104, DOI 10.1002/pds.1468; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Lawn SD, 2012, CLIN INFECT DIS; Marks DJB, 2009, INT J STD AIDS, V20, P339, DOI 10.1258/ijsa.2008.008361; Marra F, 2007, INT J TUBERC LUNG D, V11, P868; Migliori GB, 2008, EUR RESPIR J, V31, P1155, DOI 10.1183/09031936.00028708; Mitnick CD, 2008, NEW ENGL J MED, V359, P563, DOI 10.1056/NEJMoa0800106; Nathanson E, 2004, INT J TUBERC LUNG D, V8, P1382; O'Donnell MR, 2009, INT J TUBERC LUNG D, V13, P855; Shean KP, 2008, INT J TUBERC LUNG D, V12, P1182; Shin SS, 2007, INT J TUBERC LUNG D, V11, P1314; Shin SY, 2004, CHEST, V125, P974, DOI 10.1378/chest.125.3.974; Streicher EM, 2007, J CLIN MICROBIOL, V45, P237, DOI 10.1128/JCM.01429-06; Torun T, 2005, INT J TUBERC LUNG D, V9, P1373; Warren R, 2006, J CLIN MICROBIOL, V44, P254, DOI 10.1128/JCM.44.1.254-256.2006; Yee D, 2003, AM J RESP CRIT CARE, V167, P1472, DOI 10.1164/rccm.200206-626OC	21	69	71	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63057	10.1371/journal.pone.0063057	http://dx.doi.org/10.1371/journal.pone.0063057			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667572	Green Published, gold, Green Submitted			2022-12-25	WOS:000319654700104
J	Toppozini, L; Dies, H; Deamer, DW; Rheinstadter, MC				Toppozini, Laura; Dies, Hannah; Deamer, David W.; Rheinstaedter, Maikel C.			Adenosine Monophosphate Forms Ordered Arrays in Multilamellar Lipid Matrices: Insights into Assembly of Nucleic Acid for Primitive Life	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; POLYMERIZATION; MEMBRANES; MACROMOLECULES; ENCAPSULATION; TEMPLATE; MEDIA	A fundamental question of biology is how nucleic acids first assembled and then were incorporated into the earliest forms of cellular life 4 billion years ago. The polymerization of nucleotides is a condensation reaction in which phosphodiester bonds are formed. This reaction cannot occur in aqueous solutions, but guided polymerization in an anhydrous lipid environment could promote a non-enzymatic condensation reaction in which oligomers of single stranded nucleic acids are synthesized. We used X-ray scattering to investigate 5'-adenosine monophosphate (AMP) molecules captured in a multilamellar phospholipid matrix composed of dimyristoylphosphatidylcholine. Bragg peaks corresponding to the lateral organization of the confined AMP molecules were observed. Instead of forming a random array, the AMP molecules are highly entangled, with the phosphate and ribose groups in close proximity. This structure may facilitate polymerization of the nucleotides into RNA-like polymers.	[Toppozini, Laura; Dies, Hannah; Rheinstaedter, Maikel C.] McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada; [Toppozini, Laura; Rheinstaedter, Maikel C.] McMaster Univ, Origins Inst, Hamilton, ON L8S 4M1, Canada; [Deamer, David W.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Rheinstaedter, Maikel C.] Natl Res Council Canada, Chalk River Labs, Canadian Neutron Beam Ctr, Chalk River, ON, Canada	McMaster University; McMaster University; University of California System; University of California Santa Cruz; Atomic Energy of Canada Limited; National Research Council Canada	Toppozini, L (corresponding author), McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada.	toppozl@mcmaster.ca; deamer@soe.ucsc.edu; rheinstadter@mcmaster.ca	Rheinstadter, Maikel C/D-5322-2009; Bacon, Hannah/AAQ-9604-2021	Rheinstadter, Maikel C/0000-0002-0558-7475; Bacon, Hannah/0000-0002-2772-141X	Natural Sciences and Engineering Research Council of Canada (NSERC); National Research Council Canada (NRC); Canada Foundation for Innovation (CFI); Ontario Ministry of Economic Development and Innovation; NSERC-Undergraduate Student Research Award; Early Researcher Award of the Province of Ontario; QEII scholarship through the Origins Institute at McMaster; Lonsdale Research Award	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Research Council Canada (NRC); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Ontario Ministry of Economic Development and Innovation; NSERC-Undergraduate Student Research Award(Natural Sciences and Engineering Research Council of Canada (NSERC)); Early Researcher Award of the Province of Ontario; QEII scholarship through the Origins Institute at McMaster; Lonsdale Research Award	This research was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC), the National Research Council Canada (NRC), the Canada Foundation for Innovation (CFI) and the Ontario Ministry of Economic Development and Innovation. H.D. is the recipient of an NSERC-Undergraduate Student Research Award, M.C.R. is the recipient of an Early Researcher Award of the Province of Ontario. L.T. is supported through a QEII scholarship through the Origins Institute at McMaster. D.W.D. is the recipient of the Lonsdale Research Award that supports research on the origin of life. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRALL EM, 1979, J MACROMOL SCI R M C, VC17, P137; Barrett MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034357; BARTELL LS, 1970, INORG CHEM, V9, P1903, DOI 10.1021/ic50090a021; BLUMSTEIN A, 1971, MOL CRYST LIQ CRYST, V12, P215, DOI 10.1080/15421407108082774; de Groot BL, 2002, BIOPHYS J, V82, P2934, DOI 10.1016/S0006-3495(02)75634-8; de Meyer FJM, 2010, J PHYS CHEM B, V114, P10451, DOI 10.1021/jp103903s; Deamer D, 2012, CHEM SOC REV, V41, P5375, DOI 10.1039/c2cs35042d; DEAMER DW, 1982, J MOL EVOL, V18, P203, DOI 10.1007/BF01733047; KRAUT J, 1963, ACTA CRYSTALLOGR, V16, P79, DOI 10.1107/S0365110X63000207; Kuruma Y, 2009, BBA-BIOMEMBRANES, V1788, P567, DOI 10.1016/j.bbamem.2008.10.017; LOHRMANN R, 1973, NATURE, V244, P418, DOI 10.1038/244418a0; MABREY S, 1976, P NATL ACAD SCI USA, V73, P3862, DOI 10.1073/pnas.73.11.3862; Malathi R, 2001, J BIOMOL STRUCT DYN, V18, P709, DOI 10.1080/07391102.2001.10506701; Mansy SS, 2008, NATURE, V454, P122, DOI 10.1038/nature07018; Mills TT, 2008, BIOPHYS J, V95, P669, DOI 10.1529/biophysj.107.127845; Mulkidjanian AY, 2012, P NATL ACAD SCI USA, V109, pE821, DOI 10.1073/pnas.1117774109; NEIDLE S, 1976, ACTA CRYSTALLOGR B, V32, P1850, DOI 10.1107/S0567740876006511; Nomura K, 2011, J PHYS CHEM B, V115, P14991, DOI 10.1021/jp208958a; Oliynyk V, 2007, BBA-BIOMEMBRANES, V1768, P236, DOI 10.1016/j.bbamem.2006.10.007; Radler JO, 1997, SCIENCE, V275, P810, DOI 10.1126/science.275.5301.810; Rajamani S, 2008, ORIGINS LIFE EVOL B, V38, P57, DOI 10.1007/s11084-007-9113-2; Richter R, 2003, BIOPHYS J, V85, P3035, DOI 10.1016/S0006-3495(03)74722-5; SHEW RL, 1985, BIOCHIM BIOPHYS ACTA, V816, P1, DOI 10.1016/0005-2736(85)90386-4; Szostak JW, 2001, NATURE, V409, P387, DOI 10.1038/35053176; TIDSWELL IM, 1990, PHYS REV B, V41, P1111, DOI 10.1103/PhysRevB.41.1111; Tristram-Nagle S, 2002, BIOPHYS J, V83, P3324, DOI 10.1016/S0006-3495(02)75333-2; USHER DA, 1976, SCIENCE, V192, P53, DOI 10.1126/science.1257755; VERLANDER MS, 1973, J MOL EVOL, V2, P303, DOI 10.1007/BF01654098; WATTS TH, 1984, P NATL ACAD SCI-BIOL, V81, P7564, DOI 10.1073/pnas.81.23.7564	29	34	42	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62810	10.1371/journal.pone.0062810	http://dx.doi.org/10.1371/journal.pone.0062810			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667523	Green Submitted, Green Published, gold			2022-12-25	WOS:000319654700064
J	Zhang, X; Zhang, ZY; Wang, QL; Chen, P; Chen, GP; Zhou, RY				Zhang, Xin; Zhang, Zhiyong; Wang, Qinglian; Chen, Peng; Chen, Guoping; Zhou, Ruiyang			Effects of Rootstocks on Cryotolerance and Overwintering Survivorship of Genic Male Sterile Lines in Upland Cotton (Gossypium hirsutum L.)	PLOS ONE			English	Article							PERENNIAL COTTON; FROST DAMAGE; YIELD; HETEROSIS; RESPONSES; RECOVERY; TISSUES; HYBRIDS; LEAVES	Grafting desirable scion on stress-tolerant rootstocks provides an opportunity to improve the cryotolerance of scion. Genic male sterile (GMS) lines of plant could be used as sterile line and maintainer in breeding, and they have the conspicuous characteristics that the fertility of which is easy to regain but hard to maintain by sexual reproduction. In order to maintain the fertility of GMS cotton by means of its perennial growth on the basis of frostless winters in Nanning, Guangxi autonomous region, GMS line A4 was grafted onto 7 cryotolerant rootstocks (F118, F697, F098, F112, F113, P098 and P113), and the cryotolerance and the overwintering survivorship of scions were investigated. In consequence, when compared with control (self-grafted A4), the relative conductivity of the grafted plants in shoot bark was reduced (8.80%), the content of soluble sugar, soluble protein and free proline were higher, 25.00, 1.55, 3.46%, respectively; the overwintering survival rate and the height of regeneration bud under field condition of grafted plants were higher, 10.44, 15.75%, respectively; the order of the grafted plants based on the average subordinate function value of overwintering survivorship was A4/F113>A4/F118>A4/F098>A4/F697>A4/F112>A4/P098>A4/P113>A4/A4(CK); the correlation analyses indicated that the physiological parameters of cryotolerance could be used for forecasting the overwintering survivorship, and the relative conductivity could be chosen as the first physiological parameter for forecasting cryotolerance or overwintering survivorship. The results indicate that the cryotolerance and the overwintering survivorship of GMS cotton could be improved by grafting, and F113 appeared to be a valuable rootstock.	[Zhang, Xin; Chen, Peng; Chen, Guoping; Zhou, Ruiyang] Guangxi Univ, Coll Agron, Nanning 530004, Guangxi, Peoples R China; [Zhang, Xin; Zhang, Zhiyong; Wang, Qinglian] Henan Inst Sci & Technol, Cotton Res Inst, Xinxiang, Henan, Peoples R China	Guangxi University; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Henan Institute of Science & Technology	Zhou, RY (corresponding author), Guangxi Univ, Coll Agron, Nanning 530004, Guangxi, Peoples R China.	ruiyangzhou@yahoo.com.cn	Zhang, Xin/ABI-7149-2020		State Science and Technology Support Project [2006BAD01A05-xz02]; Innovation Project of Guangxi Postgraduate Education of China [2008105930901D015]	State Science and Technology Support Project; Innovation Project of Guangxi Postgraduate Education of China	This project is partially supported by the State Science and Technology Support Project (2006BAD01A05-xz02) and the Innovation Project of Guangxi Postgraduate Education (2008105930901D015) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SJ, 1999, SCI HORTIC-AMSTERDAM, V81, P397, DOI 10.1016/S0304-4238(99)00042-4; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen CY, 2007, J HERED, V98, P1; [陈国平 Chen Guoping], 2010, [西北农业学报, Acat Agriculturae Boreali-Occidentalis Sinica], V19, P53; Chen ZH, 2005, EUPHYTICA, V144, P353, DOI 10.1007/s10681-005-8188-y; Choudhary B., 2013, BT COTTON INDIA COUN; DEANS JD, 1995, FORESTRY, V68, P25, DOI 10.1093/forestry/68.1.25; DESOUZA JG, 1987, J EXP BOT, V38, P1211, DOI 10.1093/jxb/38.7.1211; DESOUZA NA, 1993, PESQUI AGROPECU BRAS, V28, P797; Dionisio-Sese ML, 1998, PLANT SCI, V135, P1, DOI 10.1016/S0168-9452(98)00025-9; Dong HH, 2008, J EXP BOT, V59, P1295, DOI 10.1093/jxb/ern035; Dong J, 2006, EUPHYTICA, V151, P71, DOI 10.1007/s10681-006-9129-0; Galanopoulou-Sendouca S, 1999, EUR J AGRON, V11, P53, DOI 10.1016/S1161-0301(99)00018-0; Hao JunJie, 2010, Scientia Agricultura Sinica, V43, P3974; HEARN AB, 1980, OUTLOOK AGR, V10, P159, DOI 10.1177/003072708001000402; Jin SX, 2006, PLANT CELL TISS ORG, V85, P181, DOI 10.1007/s11240-005-9068-9; Li B, 2012, J PLANT PHYSIOL, V169, P327, DOI 10.1016/j.jplph.2011.10.009; Li JianYong, 2008, Agricultural Sciences in China, V7, P570, DOI 10.1016/S1671-2927(08)60054-1; Luo JH, 1999, PLANT CELL TISS ORG, V57, P211, DOI 10.1023/A:1006393009094; Malcolm P, 2007, SCI HORTIC-AMSTERDAM, V112, P58, DOI 10.1016/j.scienta.2006.12.003; MCCLURE MA, 1974, J NEMATOL, V6, P17; MURRAY MB, 1989, NEW PHYTOL, V113, P307, DOI 10.1111/j.1469-8137.1989.tb02408.x; Nunes MES, 2003, CROP SCI, V43, P1349, DOI 10.2135/cropsci2003.1349; Srivastava HK, 2000, CURR SCI INDIA, V79, P176; STEPONKUS PL, 1984, ANNU REV PLANT PHYS, V35, P543, DOI 10.1146/annurev.pp.35.060184.002551; Venema JH, 2008, ENVIRON EXP BOT, V63, P359, DOI 10.1016/j.envexpbot.2007.12.015; Verslues PE, 2006, PLANT J, V45, P523, DOI 10.1111/j.1365-313X.2005.02593.x; Wang X, 2007, J PLANT PHYSIOL, V164, P1062, DOI 10.1016/j.jplph.2006.06.003; Wen B, 2009, PROTOPLASMA, V236, P29, DOI 10.1007/s00709-009-0044-9; WILNER J., 1960, CANADIAN JOUR PLANT SCI, V40, P630; Xia XT, 2000, MEAS SCI TECHNOL, V11, P430, DOI 10.1088/0957-0233/11/4/314; YAMAKAWA K, 1982, JARQ-JPN AGR RES Q, V15, P175; Zhang JL, 2009, SCI HORTIC-AMSTERDAM, V122, P125, DOI 10.1016/j.scienta.2009.04.002; Zhang T., 1999, HETEROSIS HYBRID SEE, P149; Zhang Xin, 2009, Journal of Tropical and Subtropical Botany, V17, P489; Zhang X, 2012, J INTEGR AGR, V11, P537, DOI 10.1016/S2095-3119(12)60040-9; Zhang Xin, 2010, Guangxi Zhiwu / Guihaia, V30, P391	38	6	6	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63534	10.1371/journal.pone.0063534	http://dx.doi.org/10.1371/journal.pone.0063534			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667634	Green Submitted, Green Published, gold			2022-12-25	WOS:000319654700158
J	Dong, HM; Guo, H; Xie, LX; Wang, G; Zhong, XY; Khoury, T; Tan, DF; Zhang, H				Dong, Hongmei; Guo, Hong; Xie, Liangxi; Wang, Geng; Zhong, Xueyun; Khoury, Thaer; Tan, Dongfeng; Zhang, Hao			The Metastasis-Associated Gene MTA3, a Component of the Mi-2/NuRD Transcriptional Repression Complex, Predicts Prognosis of Gastroesophageal Junction Adenocarcinoma	PLOS ONE			English	Article							LYMPH-NODE INVOLVEMENT; E-CADHERIN EXPRESSION; GASTRIC-CANCER; BREAST-CANCER; SNAIL; FAMILY; PROGRESSION; CARCINOMAS; ESOPHAGEAL; SURVIVAL	Gastroesophageal junction (GEJ) adenocarcinoma carries a poor prognosis that is largely attributable to early and frequent metastasis. The acquisition of metastatic potential in cancer involves epithelial-to-mesenchymal transition (EMT). The metastasis-associated gene MTA3, a novel component of the Mi-2/NuRD transcriptional repression complex, was identified as master regulator of EMT through inhibition of Snail to increase E-cadherin expression in breast cancer. Here, we evaluated the expression pattern of the components of MTA3 pathway and the corresponding prognostic significance in GEJ adenocarcinoma. MTA3 expression was decreased at both protein and mRNA levels in tumor tissues compared to the non-tumorous and lowed MTA3 levels were noted in tumor cell lines with stronger metastatic potential. Immunohistochemical analysis of a cohort of 128 cases exhibited that patients with lower expression of MTA3 had poorer outcomes. Combined misexpression of MTA3, Snail and E-cadherin had stronger correlation with malignant properties. Collectively, results suggest that the MTA3-regulated EMT pathway is altered to favor EMT and, therefore, disease progression and that MTA3 expression was an independent prognostic factor in patients with GEJ adenocarcinoma.	[Dong, Hongmei; Zhang, Hao] Shantou Univ, Coll Med, Affiliated Canc Hosp, Dept Integrat Oncol, Shantou, Peoples R China; [Zhang, Hao] Shantou Univ, Coll Med, Affiliated Canc Hosp, Tumor Tissue Bank, Shantou, Peoples R China; [Guo, Hong; Xie, Liangxi] Shantou Univ, Coll Med, Affiliated Canc Hosp, Dept Radiat Oncol, Shantou, Peoples R China; [Wang, Geng] Shantou Univ, Coll Med, Affiliated Canc Hosp, Dept Thorac Surg, Shantou, Peoples R China; [Dong, Hongmei; Zhang, Hao] Shantou Univ, Coll Med, Canc Res Ctr, Shantou, Peoples R China; [Zhong, Xueyun] Jinan Univ, Coll Med, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Khoury, Thaer] Roswell Pk Canc Inst, Dept Pathol, Buffalo, NY 14263 USA; [Tan, Dongfeng] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA	Shantou University; Shantou University; Shantou University; Shantou University; Shantou University; Jinan University; Roswell Park Cancer Institute; University of Texas System; UTMD Anderson Cancer Center	Zhang, H (corresponding author), Shantou Univ, Coll Med, Affiliated Canc Hosp, Dept Integrat Oncol, Shantou, Peoples R China.	haozhang@stu.edu.cn			National Natural Science Foundation of China [30973508, 81071736, 81171994]; The University of Texas MD Anderson Cancer Center; Cancer Center Support Grant from the National Institutes of Health [CA016672]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); The University of Texas MD Anderson Cancer Center; Cancer Center Support Grant from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work is supported in part by National Natural Science Foundation of China grants 30973508 (HZ), 81071736 (HZ), and 81171994 (LX); The University of Texas MD Anderson Cancer Center is supported in part by a Cancer Center Support Grant (CA016672) from the National Institutes of Health. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain GH, 2010, ONCOLOGIST, V15, P270, DOI 10.1634/theoncologist.2009-0293; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bruning A, 2010, HISTOL HISTOPATHOL, V25, P1447, DOI 10.14670/HH-25.1447; Bruning A, 2009, HISTOCHEM CELL BIOL, V132, P33, DOI 10.1007/s00418-009-0595-z; Chan AOO, 2006, WORLD J GASTROENTERO, V12, P199, DOI 10.3748/wjg.v12.i2.199; Chen X, 2003, MOL BIOL CELL, V14, P3208, DOI 10.1091/mbc.E02-12-0833; Dannenmann C, 2008, CANCER BIOL THER, V7, P1462, DOI 10.4161/cbt.7.9.6427; Fearon ER, 2003, CANCER CELL, V3, P307, DOI 10.1016/S1535-6108(03)00087-4; Fujita N, 2004, CELL, V119, P75, DOI 10.1016/j.cell.2004.09.014; Fujita N, 2003, CELL, V113, P207, DOI 10.1016/S0092-8674(03)00234-4; Gu Y, 2006, CANCER-AM CANCER SOC, V106, P1017, DOI 10.1002/cncr.21693; Gulmann C, 2003, APPL IMMUNOHISTO M M, V11, P230; He HY, 2012, CANCER SCI, V103, P1296, DOI 10.1111/j.1349-7006.2012.02295.x; Hosokawa Y, 2012, ANN SURG ONCOL, V19, P677, DOI 10.1245/s10434-011-1983-x; Kim SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015074; Lagarde SM, 2007, ANN SURG ONCOL, V14, P977, DOI 10.1245/s10434-006-9262-y; Lagarde SM, 2006, AM J SURG PATHOL, V30, P171, DOI 10.1097/01.pas.0000189182.92815.12; Li X, 2009, BLOOD, V114, P5464, DOI 10.1182/blood-2009-06-227777; Maeda H, 2008, J AM COLL SURGEONS, V206, P306, DOI 10.1016/j.jamcollsurg.2007.06.306; Manavathi B, 2007, J BIOL CHEM, V282, P1529, DOI 10.1074/jbc.R600029200; Menges M, 2009, J CANCER RES CLIN, V135, P29, DOI 10.1007/s00432-008-0425-z; Moehler M, 2008, WORLD J GASTROENTERO, V14, P3773, DOI 10.3748/wjg.14.3773; Mylonas I, 2012, HISTOPATHOLOGY, V60, P665, DOI 10.1111/j.1365-2559.2011.04103.x; Nakamura M, 2012, AM SURGEON, V78, P567; Natsugoe S, 2007, ONCOL REP, V17, P517; Pedrazzani C, 2007, J THORAC CARDIOV SUR, V134, P378, DOI 10.1016/j.jtcvs.2007.03.034; Rosivatz E, 2006, VIRCHOWS ARCH, V448, P277, DOI 10.1007/s00428-005-0118-9; Rosivatz E, 2002, AM J PATHOL, V161, P1881, DOI 10.1016/S0002-9440(10)64464-1; Singh RR, 2007, J MAMMARY GLAND BIOL, V12, P115, DOI 10.1007/s10911-007-9043-7; Sobin LH, 2010, CANCER-AM CANCER SOC, V116, P5336, DOI 10.1002/cncr.25537; Stanculescu D, 2011, ROM J MORPHOL EMBRYO, V52, P1107; Uchikado Y, 2011, GASTRIC CANCER, V14, P41, DOI 10.1007/s10120-011-0004-x; Zhang H, 2006, CLIN CANCER RES, V12, P1479, DOI 10.1158/1078-0432.CCR-05-1519; Zhang H, 2006, GENE DEV, V20, P2943, DOI 10.1101/gad.1461706	34	21	23	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62986	10.1371/journal.pone.0062986	http://dx.doi.org/10.1371/journal.pone.0062986			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23671646	gold, Green Published, Green Submitted			2022-12-25	WOS:000321202100049
J	Ou, HY; Wang, CY; Yang, YC; Chen, MF; Chang, CJ				Ou, Horng-Yih; Wang, Chih-Yuan; Yang, Yi-Ching; Chen, Ming-Fong; Chang, Chih-Jen			The Association between Nonalcoholic Fatty Pancreas Disease and Diabetes	PLOS ONE			English	Article							LIVER-DISEASE; METABOLIC SYNDROME; RISK-FACTORS; ALANINE AMINOTRANSFERASE; INSULIN-RESISTANCE; ABDOMINAL OBESITY; ACCUMULATION; STEATOSIS; PATHOGENESIS; INDEXES	Background: Fatty infiltration of the pancreas has been shown to interfere with insulin secretion. Both insulin sensitivity and secretion are important in the pathogenesis of diabetes and prediabetes. However, the relationship between diabetes, prediabetes, and fatty pancreas remains unknown. We aim to investigate the relationships that fatty pancreas and nonalcoholic fatty liver disease (NAFLD) have with prediabetes and diabetes in a Chinese population. Patients and Methods: This was a cross-sectional study. A total of 7,464 subjects were recruited. NAFLD and fatty pancreas were assessed by sonography. Clinico-metabolic parameters were compared among subjects with normoglycemia, prediabetes, and diabetes. Multinomial logistic regression was used to evaluate the relationship between fatty pancreas and NAFLD and diabetes or prediabetes with adjustment for cardiometabolic risk factors. Results: With an increase in glycemia, a significantly greater proportion of subjects had NAFLD and fatty pancreas (test for trend p<0.05). Similar trends were also found for hypertension, general and central obesity, low-HDL cholesterol, and hypertriglyceridemia. In the logistic regression analysis, age, hypertension, male gender, hypertriglyceridemia, and central obesity were significantly associated with prediabetes and diabetes. Furthermore, the ORs of prediabetes and diabetes for NAFLD were 1.798 (95% CI 1.544-2.094) and 2.578 (95% CI 2.024-3.284), respectively. In addition, fatty pancreas was independently related to diabetes (OR, 1.379; 95% CI, 1.047-1.816) and prediabetes (OR, 1.222; 95% CI, 1.002-1.491) in male subjects. Conclusions: Both NAFLD and fatty pancreas were associated with diabetes independent of age, gender, adiposity, and other cardiometabolic risk factors. Fatty pancreas was also related to prediabetes in males.	[Ou, Horng-Yih] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan 70101, Taiwan; [Wang, Chih-Yuan; Chen, Ming-Fong] Natl Taiwan Univ, Coll Med, Dept Internal Med, Natl Taiwan Univ Hosp, Taipei, Taiwan; [Yang, Yi-Ching; Chang, Chih-Jen] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Family Med, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Taiwan University; National Taiwan University Hospital; National Cheng Kung University; National Cheng Kung University Hospital	Chen, MF (corresponding author), Natl Taiwan Univ, Coll Med, Dept Internal Med, Natl Taiwan Univ Hosp, Taipei, Taiwan.	mfchen@ntu.edu.tw; em75210@email.ncku.edu.tw	Chen, Ming/GVU-8412-2022; Yang, Yi-Ching/C-7033-2014	Yang, Yi-Ching/0000-0003-1391-8040; WANG, CHIH-YUAN/0000-0002-6742-3935				Adams LA, 2005, J HEPATOL, V42, P132, DOI 10.1016/j.jhep.2004.09.012; Al-Haddad M, 2009, PANCREAS, V38, P672, DOI 10.1097/MPA.0b013e3181a9d5af; ALZAID A, 1993, DIABETIC MED, V10, P759, DOI 10.1111/j.1464-5491.1993.tb00160.x; American Diabetes Association, 2010, DIABETES CARE S, V1, pS62; Balkau B, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-56; Cornier MA, 2008, ENDOCR REV, V29, P777, DOI 10.1210/er.2008-0024; Coutinho T, 2011, J AM COLL CARDIOL, V57, P1877, DOI 10.1016/j.jacc.2010.11.058; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Fernandes-Santos C, 2009, PANCREAS, V38, pE80, DOI 10.1097/MPA.0b013e3181987d9d; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Fraser A, 2009, DIABETES CARE, V32, P741, DOI 10.2337/dc08-1870; Fraulob JC, 2010, J CLIN BIOCHEM NUTR, V46, P212, DOI 10.3164/jcbn.09-83; Gaujoux S, 2010, SURGERY, V148, P15, DOI 10.1016/j.surg.2009.12.005; Goossens GH, 2008, PHYSIOL BEHAV, V94, P206, DOI 10.1016/j.physbeh.2007.10.010; Hannukainen JC, 2011, J HEPATOL, V54, P545, DOI 10.1016/j.jhep.2010.07.029; Heni M, 2010, DIABETES-METAB RES, V26, P200, DOI 10.1002/dmrr.1073; Kahn SE, 2001, J CLIN ENDOCR METAB, V86, P4047, DOI 10.1210/jc.86.9.4047; Kharroubi I, 2004, ENDOCRINOLOGY, V145, P5087, DOI 10.1210/en.2004-0478; Kim HJ, 2004, ARCH INTERN MED, V164, P2169, DOI 10.1001/archinte.164.19.2169; Kotronen A, 2008, ARTERIOSCL THROM VAS, V28, P27, DOI 10.1161/ATVBAHA.107.147538; Kotronen A, 2007, J CLIN ENDOCR METAB, V92, P3490, DOI 10.1210/jc.2007-0482; Le KA, 2011, DIABETES CARE, V34, P485, DOI 10.2337/dc10-0760; Lee CMY, 2008, J CLIN EPIDEMIOL, V61, P646, DOI 10.1016/j.jclinepi.2007.08.012; Lee JS, 2009, WORLD J GASTROENTERO, V15, P1869, DOI 10.3748/wjg.15.1869; LEE Y, 1994, P NATL ACAD SCI USA, V91, P10878, DOI 10.1073/pnas.91.23.10878; Lonardo A, 2006, J HEPATOL, V44, P1196, DOI 10.1016/j.jhep.2006.03.005; Loria P, 2013, HEPATOL RES, V43, P51, DOI 10.1111/j.1872-034X.2012.01031.x; MARKS WM, 1980, RADIOLOGY, V137, P475, DOI 10.1148/radiology.137.2.7433680; Mathur Abhishek, 2007, HPB (Oxford), V9, P312, DOI 10.1080/13651820701504157; Mathur A, 2007, ANN SURG, V246, P1058, DOI 10.1097/SLA.0b013e31814a6906; Mathur A, 2009, J AM COLL SURGEONS, V208, P989, DOI 10.1016/j.jamcollsurg.2008.12.026; Nannipieri M, 2005, DIABETES CARE, V28, P1757, DOI 10.2337/diacare.28.7.1757; Pitt Henry A, 2007, HPB (Oxford), V9, P92, DOI 10.1080/13651820701286177; Porepa L, 2010, CAN MED ASSOC J, V182, pE526, DOI 10.1503/cmaj.092144; Rasmussen BB, 2002, J CLIN INVEST, V110, P1687, DOI 10.1172/JCI200215715; Rossi AP, 2011, OBESITY, V19, P1747, DOI 10.1038/oby.2011.114; Ruckert IM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022932; Schwenzer NF, 2008, INVEST RADIOL, V43, P330, DOI 10.1097/RLI.0b013e31816a88c6; Sepe PS, 2011, GASTROINTEST ENDOSC, V73, P987, DOI 10.1016/j.gie.2011.01.015; Seppala-Lindroos A, 2002, J CLIN ENDOCR METAB, V87, P3023, DOI 10.1210/jc.87.7.3023; Shimabukuro M, 1998, J BIOL CHEM, V273, P32487, DOI 10.1074/jbc.273.49.32487; Smits MM, 2011, NAT REV GASTRO HEPAT, V8, P169, DOI 10.1038/nrgastro.2011.4; Stefan N, 2008, ENDOCR REV, V29, P939, DOI 10.1210/er.2008-0009; Suzuki A, 2005, HEPATOLOGY, V41, P64, DOI 10.1002/hep.20543; Targher G, 2005, DIABETES, V54, P3541, DOI 10.2337/diabetes.54.12.3541; Tseng CH, 2010, ATHEROSCLEROSIS, V210, P585, DOI 10.1016/j.atherosclerosis.2009.12.015; Tushuizen ME, 2007, DIABETES CARE, V30, P2916, DOI 10.2337/dc07-0326; Utzschneider KM, 2006, J CLIN ENDOCR METAB, V91, P4753, DOI 10.1210/jc.2006-0587; van der Zijl NJ, 2011, J CLIN ENDOCR METAB, V96, P459, DOI 10.1210/jc.2010-1722; van Geenen EJM, 2010, PANCREAS, V39, P1185, DOI 10.1097/MPA.0b013e3181f6fce2; van Raalte DH, 2010, CURR OPIN CLIN NUTR, V13, P478, DOI 10.1097/MCO.0b013e32833aa1ef; Vanni E, 2010, DIGEST LIVER DIS, V42, P320, DOI 10.1016/j.dld.2010.01.016; Vozarova B, 2002, DIABETES, V51, P1889, DOI 10.2337/diabetes.51.6.1889; Zhang XL, 2008, PANCREAS, V37, pE31, DOI 10.1097/MPA.0b013e3181744b50	54	98	105	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62561	10.1371/journal.pone.0062561	http://dx.doi.org/10.1371/journal.pone.0062561			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23671610	Green Published, Green Submitted, gold			2022-12-25	WOS:000321202100016
J	Yu, HJ; Rathore, SS; Shen, JS				Yu, Haijia; Rathore, Shailendra S.; Shen, Jingshi			Synip Arrests Soluble N-Ethylmaleimide-sensitive Factor Attachment Protein Receptor (SNARE)-dependent Membrane Fusion as a Selective Target Membrane SNARE-binding Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-DIMENSIONAL STRUCTURE; COMPLEX; EXOCYTOSIS; MUNC18C; MECHANISMS; SECRETION; PHOSPHORYLATION; RECONSTITUTION; IDENTIFICATION; TRAFFICKING	The vesicle fusion reaction in regulated exocytosis requires the concerted action of soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) core fusion engine and a group of SNARE-binding regulatory factors. The regulatory mechanisms of vesicle fusion remain poorly understood in most exocytic pathways. Here, we reconstituted the SNARE-dependent vesicle fusion reaction of GLUT4 exocytosis in vitro using purified components. Using this defined fusion system, we discovered that the regulatory factor synip binds to GLUT4 exocytic SNAREs and inhibits the docking, lipid mixing, and content mixing of the fusion reaction. Synip arrests fusion by binding the target membrane SNARE (t-SNARE) complex and preventing the initiation of ternary SNARE complex assembly. Although synip also interacts with the syntaxin-4 monomer, it does not inhibit the pairing of syntaxin-4 with SNAP-23. Interestingly, synip selectively arrests the fusion reactions reconstituted with its cognate SNAREs, suggesting that the defined system recapitulates the biological functions of the vesicle fusion proteins. We further showed that the inhibitory function of synip is dominant over the stimulatory activity of Sec1/Munc18 proteins. Importantly, the inhibitory function of synip is distinct from how other fusion inhibitors arrest SNARE-dependent membrane fusion and therefore likely represents a novel regulatory mechanism of vesicle fusion.	[Yu, Haijia; Rathore, Shailendra S.; Shen, Jingshi] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Shen, JS (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	jingshi.shen@colorado.edu	Yu, Haijia/GXV-5159-2022	Yu, Haijia/0000-0002-7193-8034; YU, HAIJIA/0000-0002-3049-7850; SHEN, JINGSHI/0000-0001-9595-1148	National Institutes of Health [DK080080, DK095367]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK080080, R56DK095367, R01DK095367, R00DK080080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102217] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Pathway to Independence Award DK080080 and Grant DK095367 (to J. S.).	Bai L, 2007, CELL METAB, V5, P47, DOI 10.1016/j.cmet.2006.11.013; BIRNBAUM MJ, 1989, CELL, V57, P305, DOI 10.1016/0092-8674(89)90968-9; Blot V, 2008, MOL BIOL CELL, V19, P3477, DOI 10.1091/mbc.E08-03-0236; Brandhorst D, 2006, P NATL ACAD SCI USA, V103, P2701, DOI 10.1073/pnas.0511138103; Brandie FM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004074; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Burgoyne RD, 2007, CURR BIOL, V17, pR255, DOI 10.1016/j.cub.2007.02.006; Burgoyne RD, 2009, ANN NY ACAD SCI, V1152, P76, DOI 10.1111/j.1749-6632.2008.03987.x; Carr CM, 2010, CURR OPIN CELL BIOL, V22, P488, DOI 10.1016/j.ceb.2010.04.006; CHARRON MJ, 1989, P NATL ACAD SCI USA, V86, P2535, DOI 10.1073/pnas.86.8.2535; D'Andrea-Merrins M, 2007, J BIOL CHEM, V282, P16553, DOI 10.1074/jbc.M610818200; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Fernandez I, 1998, CELL, V94, P841, DOI 10.1016/S0092-8674(00)81742-0; Gao Y, 2012, SCIENCE, V337, P1340, DOI 10.1126/science.1224492; Giraudo CG, 2006, SCIENCE, V313, P676, DOI 10.1126/science.1129450; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; JAMES DE, 1989, NATURE, V338, P83, DOI 10.1038/338083a0; Jewell JL, 2011, J CELL BIOL, V193, P185, DOI 10.1083/jcb.201007176; Jewell JL, 2010, AM J PHYSIOL-REG I, V298, pR517, DOI 10.1152/ajpregu.00597.2009; Kramer L, 2011, MOL BIOL CELL, V22, P2601, DOI 10.1091/mbc.E11-02-0104; Kummel D, 2011, NAT STRUCT MOL BIOL, V18, P927, DOI 10.1038/nsmb.2101; Latham CF, 2006, TRAFFIC, V7, P1408, DOI 10.1111/j.1600-0854.2006.00474.x; LAVAN BE, 1994, BIOCHEM SOC T, V22, P676, DOI 10.1042/bst0220676; Lizunov VA, 2012, AM J PHYSIOL-ENDOC M, V302, pE950, DOI 10.1152/ajpendo.00466.2011; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Melia TJ, 2002, J CELL BIOL, V158, P929, DOI 10.1083/jcb.200112081; Min J, 1999, MOL CELL, V3, P751, DOI 10.1016/S1097-2765(01)80007-1; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; NOVICK P, 1979, P NATL ACAD SCI USA, V76, P1858, DOI 10.1073/pnas.76.4.1858; Ohya T, 2009, NATURE, V459, P1091, DOI 10.1038/nature08107; Pobbati AV, 2006, SCIENCE, V313, P673, DOI 10.1126/science.1129486; Rathore SS, 2010, P NATL ACAD SCI USA, V107, P22399, DOI 10.1073/pnas.1012997108; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Rizo J, 2012, ANNU REV CELL DEV BI, V28, P279, DOI 10.1146/annurev-cellbio-101011-155818; Rowland AF, 2011, TRAFFIC, V12, P672, DOI 10.1111/j.1600-0854.2011.01178.x; Saito T, 2003, J BIOL CHEM, V278, P36718, DOI 10.1074/jbc.M305114200; Sano H, 2005, BIOCHEM BIOPH RES CO, V332, P880, DOI 10.1016/j.bbrc.2005.05.027; Schekman R., 2004, CELL, V116, pS13, DOI [10.1016/s0092-8674(03)00972-3, DOI 10.1016/S0092-8674(03)00972-3]; Schwartz ML, 2009, J CELL BIOL, V185, P535, DOI 10.1083/jcb.200811082; Scott BL, 2003, METHOD ENZYMOL, V372, P274; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Shen JS, 2010, J CELL BIOL, V190, P55, DOI 10.1083/jcb.201003148; Shi L, 2012, SCIENCE, V335, P1355, DOI 10.1126/science.1214984; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; TELLAM JT, 1995, J BIOL CHEM, V270, P5857, DOI 10.1074/jbc.270.11.5857; Toonen RFG, 2007, TRENDS NEUROSCI, V30, P564, DOI 10.1016/j.tins.2007.08.008; Vicogne J, 2006, P NATL ACAD SCI USA, V103, P14761, DOI 10.1073/pnas.0606881103; Wang CC, 2004, DEV CELL, V7, P359, DOI 10.1016/j.devcel.2004.08.002; Watson RT, 2006, TRENDS BIOCHEM SCI, V31, P215, DOI 10.1016/j.tibs.2006.02.007; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; Xu YK, 2011, J CELL BIOL, V193, P643, DOI 10.1083/jcb.201008135; Yamada E., 2005, J CELL BIOL; Yu HJ, 2013, MOL BIOL CELL, V24, P1176, DOI 10.1091/mbc.E12-11-0810	62	15	15	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18885	18893		10.1074/jbc.M113.465450	http://dx.doi.org/10.1074/jbc.M113.465450			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23665562	hybrid, Green Published			2022-12-25	WOS:000321335800026
J	Aragam, NR; Thayer, KM; Nge, N; Hoffman, I; Martinson, F; Kamwendo, D; Lin, FC; Sutherland, C; Bailey, JA; Juliano, JJ				Aragam, Nagesh R.; Thayer, Kelly M.; Nge, Nabi; Hoffman, Irving; Martinson, Francis; Kamwendo, Debbie; Lin, Feng-Chang; Sutherland, Colin; Bailey, Jeffrey A.; Juliano, Jonathan J.			Diversity of T Cell Epitopes in Plasmodium falciparum Circumsporozoite Protein Likely Due to Protein-Protein Interactions	PLOS ONE			English	Article							MALARIA VACCINE; SELECTION; CANDIDATE; POLYMORPHISMS; SPOROZOITES; RECOGNITION; CHLOROQUINE; SOFTWARE; EFFICACY; PARASITE	Circumsporozoite protein (CS) is a leading vaccine antigen for falciparum malaria, but is highly polymorphic in natural parasite populations. The factors driving this diversity are unclear, but non-random assortment of the T cell epitopes TH2 and TH3 has been observed in a Kenyan parasite population. The recent publication of the crystal structure of the variable C terminal region of the protein allows the assessment of the impact of diversity on protein structure and T cell epitope assortment. Using data from the Gambia (55 isolates) and Malawi (235 isolates), we evaluated the patterns of diversity within and between epitopes in these two distantly-separated populations. Only non-synonymous mutations were observed with the vast majority in both populations at similar frequencies suggesting strong selection on this region. A non-random pattern of T cell epitope assortment was seen in Malawi and in the Gambia, but structural analysis indicates no intramolecular spatial interactions. Using the information from these parasite populations, structural analysis reveals that polymorphic amino acids within TH2 and TH3 colocalize to one side of the protein, surround, but do not involve, the hydrophobic pocket in CS, and predominately involve charge switches. In addition, free energy analysis suggests residues forming and behind the novel pocket within CS are tightly constrained and well conserved in all alleles. In addition, free energy analysis shows polymorphic residues tend to be populated by energetically unfavorable amino acids. In combination, these findings suggest the diversity of T cell epitopes in CS may be primarily an evolutionary response to intermolecular interactions at the surface of the protein potentially counteracting antibody-mediated immune recognition or evolving host receptor diversity.	[Aragam, Nagesh R.; Hoffman, Irving; Juliano, Jonathan J.] Univ N Carolina, Sch Med, Div Infect Dis, Chapel Hill, NC USA; [Thayer, Kelly M.; Bailey, Jeffrey A.] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01605 USA; [Nge, Nabi; Sutherland, Colin] London Sch Hyg & Trop Med, Dept Immunol & Infect, London WC1, England; [Martinson, Francis; Kamwendo, Debbie] UNC Project Malawi, Lilongwe, Malawi; [Lin, Feng-Chang] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Bailey, Jeffrey A.] Univ Massachusetts, Sch Med, Div Transfus Med, Worcester, MA USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Massachusetts System; University of Massachusetts Worcester; University of London; London School of Hygiene & Tropical Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of Massachusetts System; University of Massachusetts Worcester	Bailey, JA (corresponding author), Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01605 USA.	jeffrey.bailey@umassmed.edu	Sutherland, Colin/AAN-3939-2020; Lin, Feng-Chang/ABE-9659-2020	Sutherland, Colin/0000-0003-1592-6407; 	National Institutes of Health [1R01AI0898119, KL2RR025746, UL1RR025747]; UK Health Protection Agency;  [1KL2RR031981]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000161, KL2TR000160] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR031981, UL1RR025747, KL2RR025746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089819] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UK Health Protection Agency; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health [grant numbers: 1R01AI0898119, KL2RR025746, and UL1RR025747]. JAB is specifically supported by 1KL2RR031981. CJS is supported by the UK Health Protection Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Agresti A, 2007, INTRO CATEGORICAL DA; Alloueche A, 2003, AM J TROP MED HYG, V68, P97, DOI 10.4269/ajtmh.2003.68.97; Alloueche A, 2000, MOL BIOCHEM PARASIT, V106, P273, DOI 10.1016/S0166-6851(99)00221-2; Bailey JA, 2012, J INFECT DIS, V206, P580, DOI 10.1093/infdis/jis329; Barry AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008497; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; CERAMI C, 1992, CELL, V70, P1021, DOI 10.1016/0092-8674(92)90251-7; Chenet SM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-93; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DNASTAR Inc, 2008, SEQ AN US DNASTARS L; Doud MB, 2012, P NATL ACAD SCI USA, V109, P7817, DOI 10.1073/pnas.1205737109; Enosse S, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010005; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gonzalez-Ceron L, 1999, INFECT IMMUN, V67, P410, DOI 10.1128/IAI.67.1.410-412.1999; GOOD MF, 1988, ANNU REV IMMUNOL, V6, P663, DOI 10.1146/annurev.iy.06.040188.003311; GOOD MF, 1988, P NATL ACAD SCI USA, V85, P1199, DOI 10.1073/pnas.85.4.1199; HOFFMAN SL, 1989, J IMMUNOL, V142, P1299; Hudson RR, 2000, GENETICS, V155, P2011; HUGHES AL, 1991, GENETICS, V127, P345; JONGWUTIWES S, 1994, AM J TROP MED HYG, V51, P659, DOI 10.4269/ajtmh.1994.51.659; Kumkhaek C, 2005, J IMMUNOL, V175, P3935, DOI 10.4049/jimmunol.175.6.3935; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Menard R, 1997, NATURE, V385, P336, DOI 10.1038/385336a0; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; Ord R, 2007, J INFECT DIS, V196, P1613, DOI 10.1086/522154; Publishing SAS, 2010, SAS 9 2 LANGUAGE REF; Rathore D, 2000, P NATL ACAD SCI USA, V97, P8530, DOI 10.1073/pnas.140224597; RILEY EM, 1990, T ROY SOC TROP MED H, V84, P648, DOI 10.1016/0035-9203(90)90133-Y; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; SINNIS P, 1994, J EXP MED, V180, P297, DOI 10.1084/jem.180.1.297; STEWART MJ, 1988, J PROTOZOOL, V35, P389, DOI 10.1111/j.1550-7408.1988.tb04115.x; Stiebritz MT, 2006, ACTA CRYSTALLOGR D, V62, P648, DOI 10.1107/S0907444906013333; Sutherland CJ, 2003, AM J TROP MED HYG, V69, P19, DOI 10.4269/ajtmh.2003.69.19; Takala SL, 2009, PARASITE IMMUNOL, V31, P560, DOI 10.1111/j.1365-3024.2009.01138.x; Takala SL, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000257; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thera MA, 2011, NEW ENGL J MED, V365, P1004, DOI 10.1056/NEJMoa1008115; Waitumbi JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007849; Weedall GD, 2007, INT J PARASITOL, V37, P77, DOI 10.1016/j.ijpara.2006.09.001	40	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62427	10.1371/journal.pone.0062427	http://dx.doi.org/10.1371/journal.pone.0062427			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667476	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000319654700035
J	Duong, CPM; Westwood, JA; Yong, CSM; Murphy, A; Devaud, C; John, LB; Darcy, PK; Kershaw, MH				Duong, Connie P. M.; Westwood, Jennifer A.; Yong, Carmen S. M.; Murphy, Amanda; Devaud, Christel; John, Liza B.; Darcy, Phillip K.; Kershaw, Michael H.			Engineering T Cell Function Using Chimeric Antigen Receptors Identified Using a DNA Library Approach	PLOS ONE			English	Article							CD28 COSTIMULATION; TUMOR; ACTIVATION; LYMPHOCYTES; EXPRESSION; IMMUNOGLOBULIN; RECOGNITION; DOMAINS; COMPLEX	Genetic engineering of cellular function holds much promise for the treatment of a variety of diseases including gene deficiencies and cancer. However, engineering the full complement of cellular functions can be a daunting genetic exercise since many molecular triggers need to be activated to achieve complete function. In the case of T cells, genes encoding chimeric antigen receptors (CARs) covalently linking antibodies to cytoplasmic signaling domains can trigger some, but not all, cellular functions against cancer cells. To date, relatively few CAR formats have been investigated using a candidate molecule approach, in which rationally chosen molecules were trialed one by one. Therefore, to expedite this arduous process we developed an innovative screening method to screen many thousands of CAR formats to identify genes able to enhance the anticancer ability of T cells. We used a directional in-frame library of randomly assembled signaling domains in a CAR specific for the tumor associated antigen erbB2. Several new and original CARs were identified, one of which had an enhanced ability to lyse cancer cells and inhibit tumor growth in mice. This study highlights novel technology that could be used to screen a variety of molecules for their capacity to induce diverse functions in cells.	[Duong, Connie P. M.; Westwood, Jennifer A.; Yong, Carmen S. M.; Murphy, Amanda; Devaud, Christel; John, Liza B.; Darcy, Phillip K.; Kershaw, Michael H.] Univ Melbourne, Canc Immunol Res Program, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia; [Duong, Connie P. M.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Darcy, Phillip K.; Kershaw, Michael H.] Monash Univ, Dept Immunol, Prahran, Vic, Australia	Peter Maccallum Cancer Center; University of Melbourne; University of Melbourne; Monash University	Kershaw, MH (corresponding author), Univ Melbourne, Canc Immunol Res Program, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia.	michael.kershaw@petermac.org	Devaud, Christel'/W-8141-2019	Devaud, Christel'/0000-0003-3511-3219; Kershaw, Michael/0000-0002-2697-487X; Darcy, Phillip/0000-0002-5303-9561; Duong, Connie/0000-0002-9067-8557	National Health and Medical Research Council of Australia [1006188]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Funding was provided by the National Health and Medical Research Council of Australia, grant number 1006188 (www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Camino V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007174; BESTWICK RK, 1988, P NATL ACAD SCI USA, V85, P5404, DOI 10.1073/pnas.85.15.5404; Bridgeman JS, 2010, CURR GENE THER, V10, P77; Carpenito C, 2009, P NATL ACAD SCI USA, V106, P3360, DOI 10.1073/pnas.0813101106; ESHHAR Z, 1993, P NATL ACAD SCI USA, V90, P720, DOI 10.1073/pnas.90.2.720; Friedmann-Morvinski D, 2005, BLOOD, V105, P3087, DOI 10.1182/blood-2004-09-3737; Gilham DE, 2002, J IMMUNOTHER, V25, P139, DOI 10.1097/00002371-200203000-00002; Haynes NM, 2002, BLOOD, V100, P3155, DOI 10.1182/blood-2002-04-1041; Lam JS, 1996, HUM GENE THER, V7, P1415, DOI 10.1089/hum.1996.7.12-1415; Lo ASY, 2010, CLIN CANCER RES, V16, P2769, DOI 10.1158/1078-0432.CCR-10-0043; Ma QZ, 2004, CANCER GENE THER, V11, P297, DOI 10.1038/sj.cgt.7700685; Maher J, 2002, NAT BIOTECHNOL, V20, P70, DOI 10.1038/nbt0102-70; Marin V, 2007, EXP HEMATOL, V35, P1388, DOI 10.1016/j.exphem.2007.05.018; Marzo AL, 1999, CANCER RES, V59, P1071; Moeller M, 2004, CANCER GENE THER, V11, P371, DOI 10.1038/sj.cgt.7700710; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Morgan RA, 2012, HUM GENE THER; Padhan K, 2010, IMMUNOLOGY, V129, P322, DOI 10.1111/j.1365-2567.2009.03241.x; Savoldo B, 2011, J CLIN INVEST, V121, P1822, DOI 10.1172/JCI46110; SHILONI E, 1993, CANCER IMMUNOL IMMUN, V37, P286, DOI 10.1007/BF01518450; Song DG, 2012, BLOOD, V119, P696, DOI 10.1182/blood-2011-03-344275; Torikai H, 2012, BLOOD, V119, P5697, DOI 10.1182/blood-2012-01-405365; VITIELLO A, 1991, J EXP MED, V173, P1007, DOI 10.1084/jem.173.4.1007; Wilkie S, 2008, J IMMUNOL, V180, P4901, DOI 10.4049/jimmunol.180.7.4901; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Zhong XS, 2010, MOL THER, V18, P413, DOI 10.1038/mt.2009.210	26	36	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63037	10.1371/journal.pone.0063037	http://dx.doi.org/10.1371/journal.pone.0063037			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667569	Green Published, gold			2022-12-25	WOS:000319654700101
J	Egger, C; Cannet, C; Gerard, C; Jarman, E; Jarai, G; Feige, A; Suply, T; Micard, A; Dunbar, A; Tigani, B; Beckmann, N				Egger, Christine; Cannet, Catherine; Gerard, Christelle; Jarman, Elizabeth; Jarai, Gabor; Feige, Agnes; Suply, Thomas; Micard, Arthur; Dunbar, Andrew; Tigani, Bruno; Beckmann, Nicolau			Administration of Bleomycin via the Oropharyngeal Aspiration Route Leads to Sustained Lung Fibrosis in Mice and Rats as Quantified by UTE-MRI and Histology	PLOS ONE			English	Article							INDUCED PULMONARY-FIBROSIS; DIGITAL IMAGE-ANALYSIS; POLARIZED-LIGHT MICROSCOPY; FIBRILLAR COLLAGEN CONTENT; DIASTOLIC FUNCTION ROLE; QUANTITATIVE ASSESSMENT; SUBEPITHELIAL FIBROSIS; NONINVASIVE ASSESSMENT; ANTINEOPLASTIC AGENTS; FIBROTIC LESIONS	Pulmonary fibrosis can be experimentally induced in small rodents by bleomycin. The antibiotic is usually administered via the intratracheal or intranasal routes. In the present study, we investigated the oropharyngeal aspiration of bleomycin as an alternative route for the induction of lung fibrosis in rats and mice. The development of lung injury was followed in vivo by ultrashort echo time magnetic resonance imaging (UTE-MRI) and by post- mortem analyses (histology of collagen, hydroxyproline determination, and qRT-PCR). In C57BL/6 mice, oropharyngeal aspiration of bleomycin led to more prominent lung fibrosis as compared to intranasal administration. Consequently, the oropharyngeal aspiration route allowed a dose reduction of bleomycin and, therewith, a model refinement. Moreover, the distribution of collagen after oropharyngeal aspiration of bleomycin was more homogenous than after intranasal administration: for the oropharyngeal aspiration route, fibrotic areas appeared all over the lung lobes, while for the intranasal route fibrotic lesions appeared mainly around the largest superior airways. Thus, oropharyngeal aspiration of bleomycin induced morphological changes that were more comparable to the human disease than the intranasal administration route did. Oropharyngeal aspiration of bleomycin led to a homogeneous fibrotic injury also in rat lungs. The present data suggest oropharyngeal aspiration of bleomycin as a less invasive means to induce homogeneous and sustained fibrosis in the lungs of mice and rats.	[Egger, Christine; Cannet, Catherine; Gerard, Christelle; Micard, Arthur; Dunbar, Andrew; Tigani, Bruno; Beckmann, Nicolau] Novartis Inst BioMed Res, Global Imaging Grp, Basel, Switzerland; [Egger, Christine] Univ Basel, Bioctr, CH-4056 Basel, Switzerland; [Jarman, Elizabeth; Jarai, Gabor] Novartis Inst BioMed Res, Dept Resp Dis, Horsham, W Sussex, England; [Feige, Agnes; Suply, Thomas] Novartis Inst BioMed Res, Dev & Mol Pathways Dept, Basel, Switzerland	Novartis; University of Basel; Novartis; Novartis	Beckmann, N (corresponding author), Novartis Inst BioMed Res, Global Imaging Grp, Basel, Switzerland.	nicolau.beckmann@novartis.com	Beckmann, Nicolau/H-7616-2019		Novartis Pharma AG	Novartis Pharma AG	Novartis Pharma AG, is the funder of this study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Adachi K, 2010, J TOXICOL SCI, V35, P503, DOI 10.2131/jts.35.503; Andrade GB, 1997, EUR J HISTOCHEM, V41, P203; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; Babin AL, 2012, MAGN RESON MED, V67, P499, DOI 10.1002/mrm.23009; Babin AL, 2011, J MAGN RESON IMAGING, V33, P603, DOI 10.1002/jmri.22476; Ble FX, 2008, RADIOLOGY, V248, P834, DOI 10.1148/radiol.2482071452; BOSANQUET AG, 1986, CANCER CHEMOTH PHARM, V17, P1, DOI 10.1007/BF00299858; Bradshaw AD, 2010, AM J PHYSIOL-HEART C, V298, pH614, DOI 10.1152/ajpheart.00474.2009; Bradshaw AD, 2009, CIRCULATION, V119, P269, DOI 10.1161/CIRCULATIONAHA.108.773424; BREWSTER CEP, 1990, AM J RESP CELL MOL, V3, P507, DOI 10.1165/ajrcmb/3.5.507; Chua F, 2005, AM J RESP CELL MOL, V33, P9, DOI 10.1165/rcmb.2005-0062TR; Corbel M, 2001, J PATHOL, V193, P538, DOI 10.1002/path.826; De Vooght V, 2009, TOXICOLOGY, V259, P84, DOI 10.1016/j.tox.2009.02.007; Degryse AL, 2010, AM J PHYSIOL-LUNG C, V299, pL442, DOI 10.1152/ajplung.00026.2010; Encarnacion MMD, 2004, AM J TRANSPLANT, V4, P248, DOI 10.1046/j.1600-6143.2003.00311.x; England KA, 2011, AM J PHYSIOL-LUNG C, V301, pL519, DOI 10.1152/ajplung.00383.2009; Farris AB, 2011, J AM SOC NEPHROL, V22, P176, DOI 10.1681/ASN.2009091005; Foster WM, 2001, J APPL PHYSIOL, V90, P1111, DOI 10.1152/jappl.2001.90.3.1111; Galli GG, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002711; Gold LI, 2006, J INVEST DERM SYMP P, V11, P57, DOI 10.1038/sj.jidsymp.5650011; Gong LK, 2005, J ETHNOPHARMACOL, V96, P537, DOI 10.1016/j.jep.2004.09.046; Gong LK, 2004, BIOL PHARM BULL, V27, P634, DOI 10.1248/bpb.27.634; Gross TJ, 2001, NEW ENGL J MED, V345, P517, DOI 10.1056/NEJMra003200; HAY J, 1991, ARCH TOXICOL, V65, P81, DOI 10.1007/BF02034932; Holgate ST, 2000, J ALLERGY CLIN IMMUN, V105, P193, DOI 10.1016/S0091-6749(00)90066-6; Iwasawa T, 2012, EUR J RADIO IN PRESS, DOI [10.1016/j.ejrad.2012.02.014, DOI 10.1016/J.EJRAD.2012.02.014)]; Izbicki G, 2002, INT J EXP PATHOL, V83, P111, DOI 10.1046/j.1365-2613.2002.00220.x; Jeffery PK, 2001, AM J RESP CRIT CARE, V164, pS28, DOI 10.1164/ajrccm.164.supplement_2.2106061; Katzenstein ALA, 1998, AM J RESP CRIT CARE, V157, P1301, DOI 10.1164/ajrccm.157.4.9707039; Lakatos HF, 2006, EXP LUNG RES, V32, P181, DOI 10.1080/01902140600817465; LAZENBY AJ, 1990, AM REV RESPIR DIS, V142, P206, DOI 10.1164/ajrccm/142.1.206; MONTES GS, 1991, MEM I OSWALDO CRUZ, V86, P1; Moon JCC, 2004, J AM COLL CARDIOL, V43, P2260, DOI 10.1016/j.jacc.2004.03.035; Moore BB, 2008, AM J PHYSIOL-LUNG C, V294, pL152, DOI 10.1152/ajplung.00313.2007; Morgan DL, 2008, TOXICOL SCI, V103, P169, DOI 10.1093/toxsci/kfn016; MORRIS L, 1991, DEVELOPMENT, V112, P517; Nart P, 2004, J COMP PATHOL, V130, P235, DOI 10.1016/j.jcpa.2003.11.002; Ophof R, 2004, WOUND REPAIR REGEN, V12, P528, DOI 10.1111/j.1067-1927.2004.012505.x; PICKERING JG, 1991, AM J PATHOL, V138, P1225; Rao GVS, 2003, J TOXICOL ENV HEAL A, V66, P1441, DOI 10.1080/15287390306417; ROCHE WR, 1989, LANCET, V1, P520; ROSSI GA, 1987, AM REV RESPIR DIS, V135, P448; SCHRIER DJ, 1983, AM REV RESPIR DIS, V127, P63, DOI 10.1164/arrd.1983.127.1.63; SHAPIRO SD, 1992, J BIOL CHEM, V267, P4664; SHAPIRO SD, 1993, J BIOL CHEM, V268, P23824; SNIDER GL, 1978, AM REV RESPIR DIS, V117, P1099; Southam DS, 2002, AM J PHYSIOL-LUNG C, V282, pL833, DOI 10.1152/ajplung.00173.2001; Takahashi M, 2010, J MAGN RESON IMAGING, V32, P326, DOI 10.1002/jmri.22267; Takemasa A, 2012, EUR RESPIR J, V40, P1475, DOI 10.1183/09031936.00127011; THRALL RS, 1979, AM J PATHOL, V95, P117; UEDA Y, 1983, ANTIMICROB AGENTS CH, V23, P374, DOI 10.1128/AAC.23.3.374; van Echteld CJA, 2011, J PHARMACOL EXP THER, V337, P335, DOI 10.1124/jpet.110.172635; WHITTAKER P, 1994, BASIC RES CARDIOL, V89, P397, DOI 10.1007/BF00788278; Zhang H, 2006, J BIOMED MATER RES A, V76A, P120, DOI 10.1002/jbm.a.30491; Zurek M, 2012, MAGN RESON MED, V68, P898, DOI 10.1002/mrm.23281	55	69	71	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63432	10.1371/journal.pone.0063432	http://dx.doi.org/10.1371/journal.pone.0063432			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667616	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000319654700143
J	Gonsalves, L; Law, B; Webb, C; Monamy, V				Gonsalves, Leroy; Law, Brad; Webb, Cameron; Monamy, Vaughan			Foraging Ranges of Insectivorous Bats Shift Relative to Changes in Mosquito Abundance	PLOS ONE			English	Article							AUSTRALIA; FOREST; INSECTS; BEETLE; VESPERTILIONIDAE; FRAGMENTATION; CHIROPTERA; PATTERNS; DENSITY; ECOLOGY	The need to develop effective management strategies for insectivorous bat populations requires an understanding of factors influencing habitat use. Availability of pest prey, such as mosquitoes is likely to be one such factor. To assess whether this is the case, we radio-tracked Vespadelus vulturnus Thomas (little forest bat), a predator of Aedes vigilax Skuse (saltmarsh mosquito), in saltmarsh and adjacent coastal swamp forest during periods of high and low Ae. vigilax abundance. When mosquito abundance in structurally-open saltmarsh was similar to the more cluttered coastal swamp forest, use of saltmarsh by V. vulturnus was disproportionately greater than its availability, with saltmarsh selected preferentially for foraging. However, at times of low Ae. vigilax abundance in saltmarsh, use of saltmarsh by V. vulturnus was reduced and all habitats were used in proportion to availability in the study area. This is the first radio-tracking study to demonstrate a shift in foraging range by an insectivorous bat species correlated with fluctuations in the distribution and abundance of a particular prey resource. The shift in foraging range by V. vulturnus, corresponding with a spatio-temporal variation in abundance of Ae. vigilax highlights the importance of mosquitoes as a dietary item. Broadscale pest control of Ae. vigilax may have ecological implications for the diet and habitat use of V. vulturnus. An adaptive management approach is proposed, whereby careful monitoring of insectivorous bat populations is recommended before and after any application of broadscale mosquito control measures. We also suggest a precautionary approach is taken such that broadscale control of mosquitoes avoids the lactation period of bats, a time when their energetic demands are greatest and when there is reduced risk of contracting mosquito-borne diseases transmitted by Ae. vigilax.	[Gonsalves, Leroy; Monamy, Vaughan] Australian Catholic Univ, Sch Arts & Sci, Sydney, NSW 2059, Australia; [Law, Brad] Forest Sci Ctr, Dept Primary Ind, Beecroft, NSW, Australia; [Webb, Cameron] Westmead Hosp, Dept Med Entomol, Wentworthville, NSW, Australia; [Webb, Cameron] Univ Sydney, Wentworthville, NSW, Australia	Australian Catholic University; University of Sydney; University of Sydney	Gonsalves, L (corresponding author), Australian Catholic Univ, Sch Arts & Sci, Sydney, NSW 2059, Australia.	leroy.gonsalves@acu.edu.au		Webb, Cameron/0000-0003-1029-5140; Law, Bradley/0000-0002-3991-3865	New South Wales Environmental Trust	New South Wales Environmental Trust	Funding for this research was provided by the New South Wales Environmental Trust (http://www.environment.nsw.gov.au/grants/envtrust.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam P, 2009, AUSTRALIAN SALTMARSH ECOLOGY, P1; Adams MD, 2009, FOREST ECOL MANAG, V258, P2090, DOI 10.1016/j.foreco.2009.08.002; AEBISCHER NJ, 1993, ECOLOGY, V74, P1313, DOI 10.2307/1940062; Aguirre LF, 2003, FUNCT ECOL, V17, P201, DOI 10.1046/j.1365-2435.2003.00721.x; ALDRIDGE HDJN, 1988, J MAMMAL, V69, P379, DOI 10.2307/1381393; Belbase S., 2005, THESIS AUSTR CATHOLI; BELL GP, 1982, BEHAV ECOL SOCIOBIOL, V10, P217, DOI 10.1007/BF00299688; Bell SAJ, 2010, NATURAL VEGETATION G; Brigham RM, 1997, CAN J ZOOL, V75, P131, DOI 10.1139/z97-017; Campbell S, 2000, THESIS U MELBOURNE M; Chen XL, 2004, J ARID ENVIRON, V56, P559, DOI 10.1016/S0140-1963(03)00079-X; Churchill S., 2009, AUSTR BATS; De Little SC, 2009, ENVIRON ENTOMOL, V38, P1013, DOI 10.1603/022.038.0408; DEFOLIART G, 1992, CROP PROT, V11, P395, DOI 10.1016/0261-2194(92)90020-6; Driscoll DA, 2005, CONSERV BIOL, V19, P182, DOI 10.1111/j.1523-1739.2005.00586.x; FENTON MB, 1990, CAN J ZOOL, V68, P411, DOI 10.1139/z90-061; FOSTER WA, 1995, ANNU REV ENTOMOL, V40, P443, DOI 10.1146/annurev.en.40.010195.002303; Fukui D, 2006, J ANIM ECOL, V75, P1252, DOI 10.1111/j.1365-2656.2006.01146.x; GERELL R, 1993, BIOL CONSERV, V65, P153, DOI 10.1016/0006-3207(93)90444-6; Gonsalves L, 2012, THESIS AUSTR CATHOLI; Gonsalves Leroy, 2012, Pacific Conservation Biology, V18, P282; Gonsalves L, 2013, WILDLIFE RES, V40, P10, DOI 10.1071/WR12148; Griffin D. R., 1960, Animal Behaviour, V8, P141, DOI 10.1016/0003-3472(60)90022-1; Herr A, 1998, THESIS C STURT U THU; Hoye, 2002, PILOT SURVEY MICROCH; Hutson A, 2001, MICROCHIROPTERAN BAT; Irmler U, 2002, BIODIVERS CONSERV, V11, P1129, DOI 10.1023/A:1016018021533; KLEIN BC, 1989, ECOLOGY, V70, P1715, DOI 10.2307/1938106; Kokkinn MJ, 2009, MED VET ENTOMOL, V23, P85, DOI 10.1111/j.1365-2915.2008.00787.x; Laegdsgaard P., 2004, WETLANDS, V22, P29; Lamb S, 2009, THESIS AUSTR CATHOLI; Law B, 2002, J APPL ECOL, V39, P605, DOI 10.1046/j.1365-2664.2002.00739.x; Law BS, 2000, AUSTRAL ECOL, V25, P352, DOI 10.1046/j.1442-9993.2000.01046.x; LUNNEY D, 1988, Australian Mammalogy, V11, P167; Major RE, 2003, BIOL CONSERV, V113, P35, DOI 10.1016/S0006-3207(02)00347-6; Pavey CR, 2001, BIOTROPICA, V33, P670, DOI 10.1646/0006-3606(2001)033[0670:DBOTFB]2.0.CO;2; Payne R, 2006, MICROBAT SMALL MAMMA; Poulin B, 2010, J APPL ECOL, V47, P884, DOI 10.1111/j.1365-2664.2010.01821.x; Rainho A, 2010, J APPL ECOL, V47, P850, DOI 10.1111/j.1365-2664.2010.01820.x; Rodgers A. R., 2005, HRT HOME RANGE TOOLS; Rohe D.L., 1979, Bulletin of the Society of Vector Ecologists, V4, P24; Russell R. C., 1995, Review of Medical and Veterinary Entomology, V83, P141; Russell RC, 1998, INT J PARASITOL, V28, P955, DOI 10.1016/S0020-7519(98)00053-8; RUSSELL RC, 1996, COLOUR PHOTO ATLAS M; Russell TL, 2008, AUST J ENTOMOL, V47, P232, DOI 10.1111/j.1440-6055.2008.00642.x; Rydell J., 1990, Bats (Austin), V8, P8; Saintilan N, 1999, GLOBAL ECOL BIOGEOGR, V8, P117, DOI 10.1046/j.1365-2699.1999.00133.x; Schnitzler HU, 1998, ECHOLOCATING BATS SE, P183; SPEAKMAN JR, 1991, MAMMAL REV, V21, P123, DOI 10.1111/j.1365-2907.1991.tb00114.x; STUDIER EH, 1973, COMP BIOCHEM PHYSIOL, V44, P467, DOI 10.1016/0300-9629(73)90499-4; Webb C, 2002, THESIS U SYDNEY SYDN; Webb CE, 2011, ANN REPORT MOSQUITO; WYATT TD, 1988, ECOL ENTOMOL, V13, P453, DOI 10.1111/j.1365-2311.1988.tb00378.x	53	34	35	1	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e64081	10.1371/journal.pone.0064081	http://dx.doi.org/10.1371/journal.pone.0064081			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667699	Green Submitted, Green Published, gold			2022-12-25	WOS:000319654700202
J	Muhumuza, S; Olsen, A; Katahoire, A; Nuwaha, F				Muhumuza, Simon; Olsen, Annette; Katahoire, Anne; Nuwaha, Fred			Uptake of Preventive Treatment for Intestinal Schistosomiasis among School Children in Jinja District, Uganda: A Cross Sectional Study	PLOS ONE			English	Article							NEGLECTED TROPICAL DISEASES; SOIL-TRANSMITTED HELMINTHS; PRAZIQUANTEL; INFECTION; EFFICACY; MANSONI; IMPACT; INTERVENTIONS; CHEMOTHERAPY; MANAGEMENT	Background: In Uganda, the current national health sector strategic and investment plan underscores schistosomiasis as one of the diseases targeted for elimination by the year 2015. However, uptake of treatment among school children is unknown but suspected to be low. We estimated the uptake and predictors of preventive treatment with praziquantel. Methods: In a cross sectional study carried out in Jinja district of Uganda, a random sample of 1,010 children in 12 primary schools was questioned about their uptake of praziquantel, knowledge and perceptions about schistosomiasis, support for taking preventive treatment and the dangers of taking praziquantel. The prevalence and mean intensity of infection with Schistosoma mansoni were determined. Results: Self reported uptake of praziquantel at last mass treatment was 28.2% (95% confidence interval (CI): 22.9%-33.6%). Overall prevalence and mean intensity of S. mansoni infection was 35% (95% CI: 25.4%-37.9%) and 116.1 eggs per gram (epg) of stool (95% CI: 98.3-137.1) respectively. Uptake of praziquantel was more likely if a child was from a school with high prevalence of infection, had knowledge about schistosomiasis transmission and prevention, and reported teachers' support to take praziquantel. Of the 285 children who took praziquantel, 142 (49.8%) developed side effects. Of the 725 children who did not take the drug, 522 (72.0%) reported fear of side effects as a major reason for non-uptake. Conclusions: Uptake of praziquantel in this population is very low. Fear of side effects of praziquantel, lack of knowledge about schistosomiasis transmission and prevention and lack of teacher support are some of the major factors associated with low uptake.	[Muhumuza, Simon; Katahoire, Anne] Makerere Univ, Sch Med, Child Hlth & Dev Ctr, Kampala, Uganda; [Olsen, Annette] Univ Copenhagen, Fac Hlth & Med Sci, Sect Parasitol Hlth & Dev, Copenhagen, Denmark; [Nuwaha, Fred] Makerere Univ, Sch Publ Hlth, Kampala, Uganda	Makerere University; University of Copenhagen; Makerere University	Muhumuza, S (corresponding author), Makerere Univ, Sch Med, Child Hlth & Dev Ctr, Kampala, Uganda.	simonmhmz@yahoo.com		Olsen, Annette/0000-0001-9352-621X	DANIDA	DANIDA	DANIDA: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen T, 2012, LANCET, V379, P1097, DOI 10.1016/S0140-6736(12)60159-7; Brooker S, 2001, TROP MED INT HEALTH, V6, P1075, DOI 10.1046/j.1365-3156.2001.00806.x; Chitsulo L, 2000, ACTA TROP, V77, P41, DOI 10.1016/S0001-706X(00)00122-4; DFID, 2012, UK PROT 140 MILL NEG; Engels D, 2002, ACTA TROP, V82, P139, DOI 10.1016/S0001-706X(02)00045-1; Fleming FM, 2009, PARASITOLOGY, V136, P1759, DOI 10.1017/S0031182009990709; Frenzel K, 1999, AM J TROP MED HYG, V60, P927, DOI 10.4269/ajtmh.1999.60.927; Glinz D, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000754; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Guyatt HL, 2001, B WORLD HEALTH ORGAN, V79, P695; Hatz CF, 1998, AM J TROP MED HYG, V59, P775, DOI 10.4269/ajtmh.1998.59.775; Hotez P.J., 2006, HELMINTH INFECT SOIL; Jukes MCH, 2002, TROP MED INT HEALTH, V7, P104, DOI 10.1046/j.1365-3156.2002.00843.x; Kabatereine NB, 2007, B WORLD HEALTH ORGAN, V85, P91, DOI 10.2471/BLT.06.030353; Kabatereine NB, 2003, T ROY SOC TROP MED H, V97, P599, DOI 10.1016/S0035-9203(03)80044-5; Kabatereine NB, 2004, TROP MED INT HEALTH, V9, P372, DOI 10.1046/j.1365-3156.2003.01176.x; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; Khairy A. A. M., 1995, Eastern Mediterranean Health Journal, V1, P215; Kironde Samson, 2002, Afr Health Sci, V2, P16; Krug EG, 2002, LANCET, V360, P1083, DOI 10.1016/S0140-6736(02)11133-0; Lansdown R, 2002, HEALTH EDUC RES, V17, P425, DOI 10.1093/her/17.4.425; M.O.H, 2010, HLTH SECT STRAT INV; Mafe MA, 2005, ACTA TROP, V93, P181, DOI 10.1016/j.actatropica.2004.11.004; Magnussen P, 2001, T ROY SOC TROP MED H, V95, P58, DOI 10.1016/S0035-9203(01)90333-5; Montresor A., 1998, WORLD HLTH ORG; Montresor A, 2011, T ROY SOC TROP MED H, V105, P361, DOI 10.1016/j.trstmh.2011.04.003; Muhumuza S, 2009, TROP MED INT HEALTH, V14, P612, DOI 10.1111/j.1365-3156.2009.02273.x; N'Goran EK, 2003, ANN TROP MED PARASIT, V97, P37, DOI 10.1179/000349803125002553; Nsungwa-Sabiiti J, 2004, TROP MED INT HEALTH, V9, P1191, DOI 10.1111/j.1365-3156.2004.01319.x; Nuwaha F, 1997, E AFR MED J, V74, P690; Parker M, 2012, J BIOSOC SCI, V27, P1; Parker M, 2008, J BIOSOC SCI, V40, P161, DOI 10.1017/S0021932007002301; Parker M, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-3; Savioli L, 2009, PARASITOLOGY, V136, P1677, DOI 10.1017/S0031182009991181; Schall V, 2001, MEM I OSWALDO CRUZ, V96, P35, DOI 10.1590/S0074-02762001000900005; Sousa-Figueiredo JC, 2010, INT HEALTH, V2, P103, DOI 10.1016/j.inhe.2010.02.003; Utzinger J, 2003, ANTIMICROB AGENTS CH, V47, P1487, DOI 10.1128/AAC.47.5.1487-1495.2003; World Health Organization, 2002, PREV CONTR SCHIST SO; Yuan LP, 2005, ACTA TROP, V96, P248, DOI 10.1016/j.actatropica.2005.07.019	39	39	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63438	10.1371/journal.pone.0063438	http://dx.doi.org/10.1371/journal.pone.0063438			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	154EP	23667617	gold, Green Published, Green Submitted			2022-12-25	WOS:000319654700144
J	Wang, S; Hou, WG; Dong, HL; Jiang, HC; Huang, LQ; Wu, G; Zhang, CL; Song, ZQ; Zhang, Y; Ren, HL; Zhang, J; Zhang, L				Wang, Shang; Hou, Weiguo; Dong, Hailiang; Jiang, Hongchen; Huang, Liuqin; Wu, Geng; Zhang, Chuanlun; Song, Zhaoqi; Zhang, Yong; Ren, Huilei; Zhang, Jing; Zhang, Li			Control of Temperature on Microbial Community Structure in Hot Springs of the Tibetan Plateau	PLOS ONE			English	Article							YELLOWSTONE-NATIONAL-PARK; 16S RIBOSOMAL-RNA; MOLECULAR CHARACTERIZATION; SPECIES COMPOSITION; GENOME SEQUENCE; SP-NOV.; DIVERSITY; BACTERIA; HYDROGEN; MATS	The Tibetan Plateau in Northwest China hosts a number of hot springs that represent a biodiversity hotspot for thermophiles, yet their diversity and relationship to environmental conditions are poorly explored in these habitats. In this study we investigated microbial diversity and community composition in 13 Tibetan hot springs with a wide range of temperatures (22.1-75 degrees C) and other geochemical conditions by using the 16S rRNA gene pyrosequencing approach. Bacteria (10(8)-10(11) copy/g; 42 bacterial phyla) in Tibetan hot springs were more abundant and far more diverse than Archaea (10(7)-10(10) copy/g; 5 archaeal phyla). The dominant bacterial phyla systematically varied with temperature. Moderate temperatures (75-66 degrees C) favored Aquificae, GAL35, and novel Bacteria, whereas low temperatures (60-22.1 degrees C) selected for Deinococcus-Thermus, Cyanobacteria, and Chloroflexi. The relative abundance of Aquificae was correlated positively with temperature, but the abundances of Deinococcus-Thermus, Cyanobacteria, and Chloroflexi were negatively correlated with temperature. Cyanobacteria and Chloroflexi were abundant in Tibetan hot springs and their abundances were positively correlated at low temperatures (55-43 degrees C) but negatively correlated at moderate temperatures (75-55 degrees C). These correlation patterns suggest a complex physiological relationship between these two phyla. Most archaeal sequences were related to Crenarchaeota with only a few related to Euryarchaeota and Thaumarchaeota. Despite the fact that microbial composition in Tibetan hot springs was strongly shaped by temperature, microbial diversity (richness, evenness and Shannon diversity) was not significantly correlated with temperature change. The results of this study expand our current understanding of microbial ecology in Tibetan hot springs and provide a basis for a global comparison.	[Wang, Shang; Hou, Weiguo; Dong, Hailiang; Huang, Liuqin; Zhang, Yong; Ren, Huilei] China Univ Geosci, State Key Lab Biogeol & Environm Geol, Beijing, Peoples R China; [Wang, Shang; Hou, Weiguo; Dong, Hailiang; Huang, Liuqin; Zhang, Yong; Ren, Huilei] China Univ Geosci, Sch Earth Sci & Resources, Beijing, Peoples R China; [Dong, Hailiang; Zhang, Jing; Zhang, Li] Miami Univ, Dept Geol & Environm Earth Sci, Oxford, OH 45056 USA; [Jiang, Hongchen; Wu, Geng] China Univ Geosci, State Key Lab Biogeol & Environm Geol, Wuhan 430074, Peoples R China; [Zhang, Chuanlun] Tongji Univ, State Key Lab Marine Geol, Sch Ocean Earth Sci, Shanghai 200092, Peoples R China; [Zhang, Chuanlun] Univ Georgia, Dept Marine Sci, Athens, GA 30602 USA; [Song, Zhaoqi] Yunnan Univ, Lab Conservat & Utilizat Bioresources, Yunnan Inst Microbiol, Kunming, Peoples R China	China University of Geosciences; China University of Geosciences; University System of Ohio; Miami University; China University of Geosciences; Tongji University; University System of Georgia; University of Georgia; Yunnan University	Dong, HL (corresponding author), China Univ Geosci, State Key Lab Biogeol & Environm Geol, Beijing, Peoples R China.	dongh@cugb.edu.cn; hongchen.jiang@gmail.com	Wu, Geng/G-9740-2018; hou, wei/GWM-4800-2022; Jiang, Hongchen/I-5838-2016; Jiang, Hongchen/Y-9471-2018; WU, Geng/F-8840-2010	Jiang, Hongchen/0000-0003-1271-7028; WU, Geng/0000-0002-7259-1044; Dong, Hailiang/0000-0002-7468-1350	National Natural Science Foundation grants of China [41030211, 41002123, 40972211]; Key Project of International Cooperation of China Ministry of Science & Technology (MOST) [2013DFA31980]; Scientific Research Funds for the 1000 "Talents'' Program Plan from China University of Geosciences-Beijing; Tongji University; National Science Foundation [OISE-0968421, DBI REU 1005223, ETBC-1024614]; Program for New Century Excellent Talents in University [NCET-12-0954]	National Natural Science Foundation grants of China(National Natural Science Foundation of China (NSFC)); Key Project of International Cooperation of China Ministry of Science & Technology (MOST); Scientific Research Funds for the 1000 "Talents'' Program Plan from China University of Geosciences-Beijing; Tongji University; National Science Foundation(National Science Foundation (NSF)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by the National Natural Science Foundation grants of China (41030211, 41002123 and 40972211), the Key Project of International Cooperation of China Ministry of Science & Technology (MOST) (No. 2013DFA31980), the Scientific Research Funds for the 1000 "Talents'' Program Plan from China University of Geosciences-Beijing (H.D.) and Tongji University (C.Z.), and National Science Foundation grants (OISE-0968421, DBI REU 1005223, and ETBC-1024614), and the Program for New Century Excellent Talents in University (NCET-12-0954). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2010, R LANG ENV STAT COMP; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Belkova NL, 2007, MICROBIOL RES, V162, P99, DOI 10.1016/j.micres.2006.01.006; Blank CE, 2002, APPL ENVIRON MICROB, V68, P5123, DOI 10.1128/AEM.68.10.5123-5135.2002; Bonch-Osmolovskaya EA, 1999, MICROBIOLOGY+, V68, P343; Boomer SM, 2009, APPL ENVIRON MICROB, V75, P2464, DOI 10.1128/AEM.01802-08; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cole JK, 2012, ISME J, DOI [10.1038/ismej.2012.1157, DOI 10.1038/ISMEJ.2012.1157]; Costa KC, 2009, EXTREMOPHILES, V13, P447, DOI 10.1007/s00792-009-0230-x; Cox A, 2011, CHEM GEOL, V280, P344, DOI 10.1016/j.chemgeo.2010.11.022; Dodsworth JA, 2011, ENVIRON MICROBIOL, V13, P2371, DOI 10.1111/j.1462-2920.2011.02508.x; Eberl D.D., 2003, 0378 US GEOL SURV, P47; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Everroad RC, 2012, MICROBES ENVIRON, V27, P374, DOI 10.1264/jsme2.ME11350; Finke N, 2013, ENVIRON MICROBIOL, V15, P1532, DOI 10.1111/1462-2920.12032; Gadd GM, 2010, MICROBIOL-SGM, V156, P609, DOI 10.1099/mic.0.037143-0; Gumerov VM, 2011, MICROBIOLOGY+, V80, P244, DOI 10.1134/S002626171102007X; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hall JR, 2008, APPL ENVIRON MICROB, V74, P4910, DOI 10.1128/AEM.00233-08; Hanada S., 2003, MICROBES ENVIRON, V18, P51, DOI [10.1264/jsme2.18.51, DOI 10.1264/JSME2.18.51]; Hjorleifsdottir S, 2001, MICROBIAL ECOL, V42, P117; Hobel CFV, 2005, APPL ENVIRON MICROB, V71, P2771, DOI 10.1128/AEM.71.5.2771-2776.2005; Hou WG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053350; Huang QY, 2011, EXTREMOPHILES, V15, P549, DOI 10.1007/s00792-011-0386-z; Jiang HC, 2010, APPL ENVIRON MICROB, V76, P4538, DOI 10.1128/AEM.00143-10; Kanokratana P, 2004, J BASIC MICROB, V44, P430, DOI 10.1002/jobm.200410388; Klatt CG, 2007, ENVIRON MICROBIOL, V9, P2067, DOI 10.1111/j.1462-2920.2007.01323.x; Kubo K, 2011, SYST APPL MICROBIOL, V34, P293, DOI 10.1016/j.syapm.2010.12.002; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Kuznetsov BB, 2011, J BACTERIOL, V193, P321, DOI 10.1128/JB.00931-10; Lalonde SV, 2005, GEOBIOLOGY, V3, P41, DOI 10.1111/j.1472-4669.2005.00042.x; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Lau CY, 2008, GEOBIOLOGY, V6, P136, DOI 10.1111/j.1472-4669.2007.00124.x; Lau MCY, 2009, EXTREMOPHILES, V13, P139, DOI 10.1007/s00792-008-0205-3; Lebedeva EV, 2011, FEMS MICROBIOL ECOL, V75, P195, DOI 10.1111/j.1574-6941.2010.01006.x; Liu ZF, 2011, ISME J, V5, P1279, DOI 10.1038/ismej.2011.37; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Meyer-Dombard DR, 2005, GEOBIOLOGY, V3, P211, DOI 10.1111/j.1472-4669.2005.00052.x; Miller SR, 2009, APPL ENVIRON MICROB, V75, P4565, DOI 10.1128/AEM.02792-08; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nakagawa T, 2003, APPL ENVIRON MICROB, V69, P7044, DOI 10.1128/AEM.69.12.7044-7057.2003; Nakagawa T, 2002, J GEN APPL MICROBIOL, V48, P211, DOI 10.2323/jgam.48.211; Nobre MF, 1996, INT J SYST BACTERIOL, V46, P604, DOI 10.1099/00207713-46-2-604; Nubel U, 2001, APPL ENVIRON MICROB, V67, P4365, DOI 10.1128/AEM.67.9.4365-4371.2001; Nubel U, 1997, APPL ENVIRON MICROB, V63, P3327; Ochsenreiter T, 2003, ENVIRON MICROBIOL, V5, P787, DOI 10.1046/j.1462-2920.2003.00476.x; Osburn MR, 2011, GEOCHIM COSMOCHIM AC, V75, P4830, DOI 10.1016/j.gca.2011.05.038; Otaki H, 2012, MICROBES ENVIRON, V27, P293, DOI 10.1264/jsme2.ME11348; Pearson A, 2008, APPL ENVIRON MICROB, V74, P3523, DOI 10.1128/AEM.02450-07; Purcell D, 2007, FEMS MICROBIOL ECOL, V60, P456, DOI 10.1111/j.1574-6941.2007.00302.x; Reysenbach A.L., 2005, GEOTHERMAL BIOL GEOC, P129; Reysenbach AL, 2009, J BACTERIOL, V191, P1992, DOI 10.1128/JB.01645-08; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2004, MICROBIOL MOL BIOL R, V68, P686, DOI 10.1128/MMBR.68.4.686-691.2004; Skirnisdottir S, 2000, APPL ENVIRON MICROB, V66, P2835, DOI 10.1128/AEM.66.7.2835-2841.2000; Sompong U, 2005, FEMS MICROBIOL ECOL, V52, P365, DOI 10.1016/j.femsec.2004.12.007; Spear JR, 2005, P NATL ACAD SCI USA, V102, P2555, DOI 10.1073/pnas.0409574102; Spear JR, 2005, GEOTHERMAL BIOL GEOC, P113; STRAUSS G, 1993, EUR J BIOCHEM, V215, P633, DOI 10.1111/j.1432-1033.1993.tb18074.x; Takai K, 2003, INT J SYST EVOL MICR, V53, P1947, DOI 10.1099/ijs.0.02773-0; Tang KH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-334; Tobler DJ, 2011, EXTREMOPHILES, V15, P473, DOI 10.1007/s00792-011-0378-z; Tringe SG, 2008, CURR OPIN MICROBIOL, V11, P442, DOI 10.1016/j.mib.2008.09.011; van der Meer MTJ, 2000, ENVIRON MICROBIOL, V2, P428, DOI 10.1046/j.1462-2920.2000.00124.x; Vick TJ, 2010, GEOBIOLOGY, V8, P140, DOI 10.1111/j.1472-4669.2009.00228.x; Ward DM, 1998, MICROBIOL MOL BIOL R, V62, P1353, DOI 10.1128/MMBR.62.4.1353-1370.1998; Ward DM, 1987, ECOLOGY MICROBIAL CO, P179; Wittebolle L, 2009, NATURE, V458, P623, DOI 10.1038/nature07840; Yamada T, 2006, INT J SYST EVOL MICR, V56, P1331, DOI 10.1099/ijs.0.64169-0; Yamada T, 2009, MICROBES ENVIRON, V24, P205, DOI 10.1264/jsme2.ME09151S; Yim LC, 2006, FEMS MICROBIOL ECOL, V57, P80, DOI 10.1111/j.1574-6941.2006.00104.x; Zhang CL, 2008, APPL ENVIRON MICROB, V74, P6417, DOI 10.1128/AEM.00843-08; Zhao P, 2002, ACTA PETROL SIN, V18, P539; [No title captured]	77	99	107	2	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62901	10.1371/journal.pone.0062901	http://dx.doi.org/10.1371/journal.pone.0062901			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667538	gold, Green Published, Green Submitted			2022-12-25	WOS:000319654700077
J	Gu, WJ; Wang, XF; Zhai, CY; Zhou, T; Xie, XY				Gu, Wanjun; Wang, Xiaofei; Zhai, Chuanying; Zhou, Tong; Xie, Xueying			Biological Basis of miRNA Action when Their Targets Are Located in Human Protein Coding Region	PLOS ONE			English	Article							RNA SECONDARY STRUCTURE; SYNONYMOUS CODON USAGE; MICRORNA TARGETS; TRANSLATION EFFICIENCY; ARABIDOPSIS-THALIANA; SPLICING ENHANCERS; MESSENGER-RNAS; EVOLUTION; SELECTION; SITES	Recent analyses have revealed many functional microRNA (miRNA) targets in mammalian protein coding regions. But, the mechanisms that ensure miRNA function when their target sites are located in protein coding regions of mammalian mRNA transcripts are largely unknown. In this paper, we investigate some potential biological factors, such as target site accessibility and local translation efficiency. We computationally analyze these two factors using experimentally identified miRNA targets in human protein coding region. We find site accessibility is significantly increased in miRNA target region to facilitate miRNA binding. At the mean time, local translation efficiency is also selectively decreased near miRNA target region. GC-poor codons are preferred in the flank region of miRNA target sites to ease the access of miRNA targets. Within-genome analysis shows substantial variations of site accessibility and local translation efficiency among different miRNA targets in the genome. Further analyses suggest target gene's GC content and conservation level could explain some of the differences in site accessibility. On the other hand, target gene's functional importance and conservation level can affect local translation efficiency near miRNA target region. We hence propose both site accessibility and local translation efficiency are important in miRNA action when miRNA target sites are located in mammalian protein coding regions.	[Gu, Wanjun; Wang, Xiaofei; Zhai, Chuanying; Xie, Xueying] Southeast Univ, Res Ctr Learning Sci, Nanjing, Jiangsu, Peoples R China; [Zhou, Tong] Univ Illinois, Inst Personalized Resp Med, Chicago, IL USA; [Zhou, Tong] Univ Illinois, Dept Med, Sect Pulm Crit Care Sleep & Allergy, Chicago, IL USA	Southeast University - China; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Gu, WJ (corresponding author), Southeast Univ, Res Ctr Learning Sci, Nanjing, Jiangsu, Peoples R China.	wanjungu@gmail.com; tongzhou@uic.edu; xxying.rcls@seu.edu.cn	Gu, Wanjun/P-5389-2019	Gu, Wanjun/0000-0003-4501-0539	National Basic Research Program of China [2012CB316501]; National High Technology Research and Development Program of China [2012AA020401]; National Natural Science Foundation of China [30900836, 61171143, 61001175]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry, China	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry, China(Scientific Research Foundation for the Returned Overseas Chinese ScholarsMinistry of Education, China)	This work was supported by grants from the National Basic Research Program of China (2012CB316501), the National High Technology Research and Development Program of China (2012AA020401), the National Natural Science Foundation of China (30900836, 61171143 and 61001175), and a Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi H, 1998, CURR OPIN GENET DEV, V8, P688, DOI 10.1016/S0959-437X(98)80038-5; Axtell MJ, 2008, TRENDS PLANT SCI, V13, P343, DOI 10.1016/j.tplants.2008.03.009; Axtell MJ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-221; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brest P, 2011, NAT GENET, V43, P242, DOI 10.1038/ng.762; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Chamary JV, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r75; Chamary JV, 2005, TRENDS GENET, V21, P256, DOI 10.1016/j.tig.2005.03.001; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; dos Reis M, 2004, NUCLEIC ACIDS RES, V32, P5036, DOI 10.1093/nar/gkh834; Duret L, 2002, CURR OPIN GENET DEV, V12, P640, DOI 10.1016/S0959-437X(02)00353-2; Ehrenreich IM, 2008, PLANT SIGNAL BEHAV, V3, P829, DOI 10.4161/psb.3.10.5914; Fahlgren N, 2010, PLANT CELL, V22, P1074, DOI 10.1105/tpc.110.073999; Fang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018067; Forman JJ, 2010, CELL CYCLE, V9, P1533, DOI 10.4161/cc.9.8.11202; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gu S, 2009, NAT STRUCT MOL BIOL, V16, P144, DOI 10.1038/nsmb.1552; Gu WJ, 2012, EVOL BIOINFORM, V8, P565, DOI 10.4137/EBO.S10362; Gu WJ, 2012, MOL BIOL EVOL, V29, P3037, DOI 10.1093/molbev/mss109; Gu WJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000664; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hausser J, 2009, GENOME RES, V19, P2009, DOI 10.1101/gr.091181.109; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Hurst LD, 2006, J MOL EVOL, V63, P174, DOI 10.1007/s00239-005-0273-2; Hurst LD, 2011, NATURE, V471, P582, DOI 10.1038/471582a; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; Itzkovitz S, 2010, GENOME RES, V20, P1582, DOI 10.1101/gr.105072.110; Kersey PJ, 2010, NUCLEIC ACIDS RES, V38, pD563, DOI 10.1093/nar/gkp871; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Komar AA, 1999, FEBS LETT, V462, P387, DOI 10.1016/S0014-5793(99)01566-5; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Lin HR, 2011, P NATL ACAD SCI USA, V108, P5148, DOI 10.1073/pnas.1102033108; Lin MF, 2011, GENOME RES, V21, P1916, DOI 10.1101/gr.108753.110; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Morton BR, 2007, MOL BIOL EVOL, V24, P122, DOI 10.1093/molbev/msl139; Parmley JL, 2006, MOL BIOL EVOL, V23, P301, DOI 10.1093/molbev/msj035; Reczko M, 2012, BIOINFORMATICS, V28, P771, DOI 10.1093/bioinformatics/bts043; Richter AS, 2010, BIOINFORMATICS, V26, P1, DOI 10.1093/bioinformatics/btp609; Rigoutsos I, 2009, CANCER RES, V69, P3245, DOI 10.1158/0008-5472.CAN-09-0352; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Schnall-Levin M, 2011, GENOME RES, V21, P1395, DOI 10.1101/gr.121210.111; Schnall-Levin M, 2010, P NATL ACAD SCI USA, V107, P15751, DOI 10.1073/pnas.1006172107; Seffens W, 1999, NUCLEIC ACIDS RES, V27, P1578, DOI 10.1093/nar/27.7.1578; Stoletzki N, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-224; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Thanaraj TA, 1996, PROTEIN SCI, V5, P1594, DOI 10.1002/pro.5560050814; Tuller T, 2010, P NATL ACAD SCI USA, V107, P3645, DOI 10.1073/pnas.0909910107; Vinogradov AE, 2003, NUCLEIC ACIDS RES, V31, P1838, DOI 10.1093/nar/gkg296; Waldman YY, 2010, NUCLEIC ACIDS RES, V38, P2964, DOI 10.1093/nar/gkq009; Warnecke T, 2007, MOL BIOL EVOL, V24, P2755, DOI 10.1093/molbev/msm210; Warnecke T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000250; Wilke CO, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002296; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Ying XM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022705; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhou T, 2009, MOL BIOL EVOL, V26, P1571, DOI 10.1093/molbev/msp070	63	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e63403	10.1371/journal.pone.0063403	http://dx.doi.org/10.1371/journal.pone.0063403			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671676	gold, Green Published, Green Submitted			2022-12-25	WOS:000321390200047
J	Triep, M; Hess, D; Chaves, H; Brucker, C; Balmert, A; Westhoff, G; Bleckmann, H				Triep, Michael; Hess, David; Chaves, Humberto; Bruecker, Christoph; Balmert, Alexander; Westhoff, Guido; Bleckmann, Horst			3D Flow in the Venom Channel of a Spitting Cobra: Do the Ridges in the Fangs Act as Fluid Guide Vanes?	PLOS ONE			English	Article							NAJA-NIGRICOLLIS; SERPENTES; ELAPIDAE; SEQUENCES; BEHAVIOR	The spitting cobra Naja pallida can eject its venom towards an offender from a distance of up to two meters. The aim of this study was to understand the mechanisms responsible for the relatively large distance covered by the venom jet although the venom channel is only of micro-scale. Therefore, we analysed factors that influence secondary flow and pressure drop in the venom channel, which include the physical-chemical properties of venom liquid and the morphology of the venom channel. The cobra venom showed shear-reducing properties and the venom channel had paired ridges that span from the last third of the channel to its distal end, terminating laterally and in close proximity to the discharge orifice. To analyze the functional significance of these ridges we generated a numerical and an experimental model of the venom channel. Computational fluid dynamics (CFD) and Particle-Image Velocimetry (PIV) revealed that the paired interior ridges shape the flow structure upstream of the sharp 90 degrees bend at the distal end. The occurrence of secondary flow structures resembling Dean-type vortical structures in the venom channel can be observed, which induce additional pressure loss. Comparing a venom channel featuring ridges with an identical channel featuring no ridges, one can observe a reduction of pressure loss of about 30%. Therefore it is concluded that the function of the ridges is similar to guide vanes used by engineers to reduce pressure loss in curved flow channels.	[Triep, Michael; Hess, David; Chaves, Humberto; Bruecker, Christoph] TU Bergakad Freiberg, Inst Mech & Fluiddynam, Freiberg, Germany; [Balmert, Alexander; Westhoff, Guido; Bleckmann, Horst] Univ Bonn, Inst Zool, Bonn, Germany	Technical University Freiberg; University of Bonn	Triep, M (corresponding author), TU Bergakad Freiberg, Inst Mech & Fluiddynam, Freiberg, Germany.	Michael.Triep@imfd.tu-freiberg.de	Chaves, Humberto/A-9707-2012	Chaves, Humberto/0000-0002-8709-8834; Bruecker, Christoph/0000-0001-5834-3020	Deutsche Forschungsgemeinschaft [BR 1494/16-1, BL 242/17-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by Deutsche Forschungsgemeinschaft (BR 1494/16-1 and BL 242/17-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balmert A, 2010, P 103 ANN M DTSCH ZO; Berthe R. A., 2011, THESIS RHEINISCHE FR; Berthe RA, 2009, J COMP PHYSIOL A, V195, P753, DOI 10.1007/s00359-009-0451-6; Bird R., 2006, WILEY INT EDITION; Bogert Charles Mitchill, 1943, BULL AMER MUS NAT HIST, V81, P285; Cascardi J, 1999, TOXICON, V37, P1271, DOI 10.1016/S0041-0101(98)00264-5; Dean WR, 1927, LONDON EDINBURGH DUB, V7, P208; Greene H.W., 1988, Biology of Reptilia, V16, P1; Haynes, 2004, P 15 AUSTR FLUID MEC; HORTON CW, 1948, COPEIA, P23; LEVY Y, 1990, AIAA J, V28, P1347, DOI 10.2514/3.25224; Prandtl L, 1957, FUHRER DURCH STROMUN; RASMUSSEN S, 1995, J ZOOL, V237, P27, DOI 10.1111/j.1469-7998.1995.tb02743.x; Slowinski JB, 1997, MOL PHYLOGENET EVOL, V8, P349, DOI 10.1006/mpev.1997.0434; WARRELL DA, 1976, AM J TROP MED HYG, V25, P525, DOI 10.4269/ajtmh.1976.25.525; Westhoff G, 2005, J COMP PHYSIOL A, V191, P873, DOI 10.1007/s00359-005-0010-8; WUSTER W, 1992, HERPETOLOGICA, V48, P424; Wuster W, 2007, MOL PHYLOGENET EVOL, V45, P437, DOI 10.1016/j.ympev.2007.07.021; Young BA, 2004, J EXP BIOL, V207, P3483, DOI 10.1242/jeb.01170; Young BA, 2001, ANAT REC, V264, P415, DOI 10.1002/ar.10015; Young BA, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.198103; Young BA, 2009, PHYSIOL BIOCHEM ZOOL, V82, P80, DOI 10.1086/595589; Zug G. R., 2001, HERPETOLOGY INTRO BI, P630	23	7	8	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e61548	10.1371/journal.pone.0061548	http://dx.doi.org/10.1371/journal.pone.0061548			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671569	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000321390200008
J	Zeng, V; Ewen-Campen, B; Horch, HW; Roth, S; Mito, T; Extavour, CG				Zeng, Victor; Ewen-Campen, Ben; Horch, Hadley W.; Roth, Siegfried; Mito, Taro; Extavour, Cassandra G.			Developmental Gene Discovery in a Hemimetabolous Insect: De Novo Assembly and Annotation of a Transcriptome for the Cricket Gryllus bimaculatus	PLOS ONE			English	Article							PERIPHERAL NERVOUS-SYSTEM; RECENT IMPROVEMENTS; PROXIMODISTAL AXIS; SIGNALING PATHWAY; SPECIATION GENES; GENOME SEQUENCES; PROTEIN FAMILIES; LEG REGENERATION; PEA APHID; DATABASE	Most genomic resources available for insects represent the Holometabola, which are insects that undergo complete metamorphosis like beetles and flies. In contrast, the Hemimetabola (direct developing insects), representing the basal branches of the insect tree, have very few genomic resources. We have therefore created a large and publicly available transcriptome for the hemimetabolous insect Gryllus bimaculatus (cricket), a well-developed laboratory model organism whose potential for functional genetic experiments is currently limited by the absence of genomic resources. cDNA was prepared using mRNA obtained from adult ovaries containing all stages of oogenesis, and from embryo samples on each day of embryogenesis. Using 454 Titanium pyrosequencing, we sequenced over four million raw reads, and assembled them into 21,512 isotigs (predicted transcripts) and 120,805 singletons with an average coverage per base pair of 51.3. We annotated the transcriptome manually for over 400 conserved genes involved in embryonic patterning, gametogenesis, and signaling pathways. BLAST comparison of the transcriptome against the NCBI non-redundant protein database (nr) identified significant similarity to nr sequences for 55.5% of transcriptome sequences, and suggested that the transcriptome may contain 19,874 unique transcripts. For predicted transcripts without significant similarity to known sequences, we assessed their similarity to other orthopteran sequences, and determined that these transcripts contain recognizable protein domains, largely of unknown function. We created a searchable, web-based database to allow public access to all raw, assembled and annotated data. This database is to our knowledge the largest de novo assembled and annotated transcriptome resource available for any hemimetabolous insect. We therefore anticipate that these data will contribute significantly to more effective and higher-throughput deployment of molecular analysis tools in Gryllus.	[Zeng, Victor; Ewen-Campen, Ben; Extavour, Cassandra G.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Horch, Hadley W.] Bowdoin Coll, Dept Biol, Brunswick, ME 04011 USA; [Horch, Hadley W.] Bowdoin Coll, Dept Neurosci, Brunswick, ME 04011 USA; [Roth, Siegfried] Univ Cologne, Cologne Bioctr, Inst Dev Biol, D-50931 Cologne, Germany; [Mito, Taro] Univ Tokushima, Grad Sch, Inst Sci & Technol, Dept Life Syst, Tokushima 770, Japan	Harvard University; Bowdoin College; Bowdoin College; University of Cologne; Tokushima University	Extavour, CG (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	extavour@oeb.harvard.edu	Roth, Siegfried/E-8241-2010; Extavour, Cassandra G/I-4567-2012	Roth, Siegfried/0000-0001-5772-3558; Extavour, Cassandra G/0000-0003-2922-5855; Ewen-Campen, Ben/0000-0002-4326-3033	Harvard Stem Cell Institute [SG-0057-10-00]; Ellison Medical Foundation [AG-NS-07010-10]; National Science Foundation (NSF) [IOS-0817678]; Bowdoin College; DFG Collaborative Research Centre 680; JSPS KAKENHI [22124003/22370080/23687033]	Harvard Stem Cell Institute; Ellison Medical Foundation(Lawrence Ellison Foundation); National Science Foundation (NSF)(National Science Foundation (NSF)); Bowdoin College; DFG Collaborative Research Centre 680; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partially supported by Harvard Stem Cell Institute Seed Grant SG-0057-10-00, Ellison Medical Foundation New Scholar Award AG-NS-07010-10, and National Science Foundation (NSF) Grant IOS-0817678 to CE, an NSF Predoctoral Fellowship to BEC, a Fletcher Family award from Bowdoin College to HH, DFG Collaborative Research Centre 680 funds to SR, and JSPS KAKENHI 22124003/22370080/23687033 to TM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Andres JA, 2008, P ROY SOC B-BIOL SCI, V275, P1975, DOI 10.1098/rspb.2008.0423; Attwood TK, 2003, NUCLEIC ACIDS RES, V31, P400, DOI 10.1093/nar/gkg030; Attwood TK, 2012, DATABASE 2012; Badisco L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017274; Bando T, 2013, DEVELOPMENT, V140, P959, DOI 10.1242/dev.084590; Bando T, 2011, DEV DYNAM, V240, P1440, DOI 10.1002/dvdy.22647; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bru C, 2005, NUCLEIC ACIDS RES, V33, pD212, DOI 10.1093/nar/gki034; Buning J., 1994, INSECT OVARY ULTRAST, Vfirst; Bussiere LF, 2006, EVOLUTION, V60, P792, DOI 10.1554/05-378.1; Ceccato P, 2007, INT J PEST MANAGE, V53, P7, DOI 10.1080/09670870600968826; Chen F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000383; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Danbara Y, 2010, J INSECT PHYSIOL, V56, P1738, DOI 10.1016/j.jinsphys.2010.07.002; Danley PD, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-109; Ellison CK, 2011, J EVOLUTION BIOL, V24, P1110, DOI 10.1111/j.1420-9101.2011.02244.x; Ewen-Campen B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-61; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fedorka KM, 2004, NATURE, V429, P65, DOI 10.1038/nature02492; Feuillet C, 2011, TRENDS PLANT SCI, V16, P77, DOI 10.1016/j.tplants.2010.10.005; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Gregory TR, 2005, NAT REV GENET, V6, P699, DOI 10.1038/nrg1674; Grimaldi David, 2005, pi; Haft DH, 2003, NUCLEIC ACIDS RES, V31, P371, DOI 10.1093/nar/gkg128; Hanrahan SJ, 2011, CHROMOSOME RES, V19, P809, DOI 10.1007/s10577-011-9231-6; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Howard DJ, 2002, AM NAT, V159, pS8, DOI 10.1086/338369; Huber F, 1989, INSECT ENDOCRINOLOGY, P13; Huebner E, 2007, COMP BIOCHEM PHYS A, V148, pS130, DOI 10.1016/j.cbpa.2007.06.325; Hulo N, 2004, NUCLEIC ACIDS RES, V32, pD134, DOI 10.1093/nar/gkh044; Ingham PW, 2011, NAT REV GENET, V12, P393, DOI 10.1038/nrg2984; Inoue Y, 2002, MECH DEVELOP, V110, P245, DOI 10.1016/S0925-4773(01)00584-6; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jaroszewski L, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000205; Kainz F, 2009, CELL COMMUNICATION P; Kainz F, 2011, DEVELOPMENT, V138, P5015, DOI 10.1242/dev.073395; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kang L, 2004, P NATL ACAD SCI USA, V101, P17611, DOI 10.1073/pnas.0407753101; Kirkness EF, 2010, P NATL ACAD SCI USA, V107, P12168, DOI 10.1073/pnas.1003379107; Kitisin Krit, 2007, Sci STKE, V2007, pcm1, DOI 10.1126/stke.3992007cm1; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kumar S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-571; Letunic I, 2002, NUCLEIC ACIDS RES, V30, P242, DOI 10.1093/nar/30.1.242; Lin GW, 2009, MECH DEVELOP, V126, pS252, DOI 10.1016/j.mod.2009.06.661; Liu DM, 2010, GENETICS, V184, P1025, DOI 10.1534/genetics.110.114017; Lomer CJ, 2001, ANNU REV ENTOMOL, V46, P667, DOI 10.1146/annurev.ento.46.1.667; Lu HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028051; Lynch JA, 2010, CURR BIOL, V20, P1042, DOI 10.1016/j.cub.2010.04.023; Ma C, 2012, MOL ECOLOGY; Ma ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-11; Maroja LS, 2008, HEREDITY, V101, P435, DOI 10.1038/hdy.2008.75; Megy K, 2012, NUCLEIC ACIDS RES, V40, pD729, DOI 10.1093/nar/gkr1089; MEIER T, 1991, DEVELOPMENT, V112, P241; MEIER T, 1991, J COMP NEUROL, V305, P201, DOI 10.1002/cne.903050204; MEIER T, 1990, J NEUROBIOL, V21, P592, DOI 10.1002/neu.480210407; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Mito T, 2002, MECH DEVELOP, V114, P27, DOI 10.1016/S0925-4773(02)00052-7; Mito T, 2007, DEV BIOL, V303, P202, DOI 10.1016/j.ydbio.2006.11.003; Mito T, 2011, DEVELOPMENT, V138, P3823, DOI 10.1242/dev.060681; Miyawaki K, 2004, MECH DEVELOP, V121, P119, DOI 10.1016/j.mod.2004.01.002; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Nakamura T, 2008, CELL MOL LIFE SCI, V65, P64, DOI 10.1007/s00018-007-7432-0; Nakamura T, 2008, DEV BIOL, V319, P46, DOI 10.1016/j.ydbio.2008.04.002; Nakamura T, 2010, CURR BIOL, V20, P1641, DOI 10.1016/j.cub.2010.07.044; NOLTE DJ, 1963, NATURE, V200, P660, DOI 10.1038/200660a0; Nusse R, 2012, EMBO J, V31, P2670, DOI 10.1038/emboj.2012.146; O'Neil ST, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-310; Pearl FMG, 2000, NUCLEIC ACIDS RES, V28, P277, DOI 10.1093/nar/28.1.277; Pfreundt U, 2010, NUCLEIC ACIDS RES, V38, pD443, DOI 10.1093/nar/gkp910; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Roche, 2011, 454 SEQ SYST SOFTW C; Schatz MC, 2010, GENOME RES, V20, P1165, DOI 10.1101/gr.101360.109; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; Shaw KL, 2007, MOL ECOL, V16, P2879, DOI 10.1111/j.1365-294X.2007.03321.x; Shaw KL, 2009, P NATL ACAD SCI USA, V106, P9737, DOI 10.1073/pnas.0900229106; Shigenobu S, 2010, INSECT MOL BIOL, V19, P47, DOI 10.1111/j.1365-2583.2009.00944.x; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Takagi A, 2012, DEV GROWTH DIFFER, V54, P227, DOI 10.1111/j.1440-169X.2011.01325.x; Takahashi T, 2009, J NEUROSCI METH, V179, P9, DOI 10.1016/j.jneumeth.2009.01.002; Tomioka K, 2012, J COMP PHYSIOL B, V182, P729, DOI 10.1007/s00360-012-0651-1; Tomioka K, 2010, CELL MOL LIFE SCI, V67, P1397, DOI 10.1007/s00018-009-0232-y; Tordjmann T, 2011, CLIN RES HEPATOLOGY; Watanabe T, 2012, NATURE COMM IN PRESS; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; Wu CH, 2004, NUCLEIC ACIDS RES, V32, pD112, DOI 10.1093/nar/gkh097; Yandell M, 2006, PLOS COMPUT BIOL, V2, P113, DOI 10.1371/journal.pcbi.0020015; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zdobnov EM, 2007, TRENDS GENET, V23, P16, DOI 10.1016/j.tig.2006.10.004; Zeng V, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas048; Zeng V, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-581; Zera AJ, 2006, COMP BIOCHEM PHYS A, V144, P365, DOI 10.1016/j.cbpa.2005.11.026	98	37	39	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e61479	10.1371/journal.pone.0061479	http://dx.doi.org/10.1371/journal.pone.0061479			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671567	Green Submitted, gold, Green Published			2022-12-25	WOS:000321390200007
J	Narayanan, A; Iordanskiy, S; Das, R; Van Duyne, R; Santos, S; Jaworski, E; Guendel, I; Sampey, G; Dalby, E; Iglesias-Ussel, M; Popratiloff, A; Hakami, R; Kehn-Hall, K; Young, M; Subra, C; Gilbert, C; Bailey, C; Romerio, F; Kashanchi, F				Narayanan, Aarthi; Iordanskiy, Sergey; Das, Ravi; Van Duyne, Rachel; Santos, Steven; Jaworski, Elizabeth; Guendel, Irene; Sampey, Gavin; Dalby, Elizabeth; Iglesias-Ussel, Maria; Popratiloff, Anastas; Hakami, Ramin; Kehn-Hall, Kylene; Young, Mary; Subra, Caroline; Gilbert, Caroline; Bailey, Charles; Romerio, Fabio; Kashanchi, Fatah			Exosomes Derived from HIV-1-infected Cells Contain Trans-activation Response Element RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICRORNA BIOGENESIS; INFECTED-CELLS; VIRAL MIRNAS; HIV-1; VIRUS; IDENTIFICATION; NEF; INTERFERENCE; VESICLES; COMPLEXES	Exosomes are nano-sized vesicles produced by healthy and virus-infected cells. Exosomes derived from infected cells have been shown to contain viral microRNAs (miRNAs). HIV-1 encodes its own miRNAs that regulate viral and host gene expression. The most abundant HIV-1-derived miRNA, first reported by us and later by others using deep sequencing, is the trans-activation response element (TAR) miRNA. In this study, we demonstrate the presence of TAR RNA in exosomes from cell culture supernatants of HIV-1-infected cells and patient sera. TAR miRNA was not in Ago2 complexes outside the exosomes but enclosed within the exosomes. We detected the host miRNA machinery proteins Dicer and Drosha in exosomes from infected cells. We report that transport of TAR RNA from the nucleus into exosomes is a CRM1 (chromosome region maintenance 1)-dependent active process. Prior exposure of naive cells to exosomes from infected cells increased susceptibility of the recipient cells to HIV-1 infection. Exosomal TAR RNA down-regulated apoptosis by lowering Bim and Cdk9 proteins in recipient cells. We found 10(4)-10(6) copies/ml TAR RNA in exosomes derived from infected culture supernatants and 10(3) copies/ml TAR RNA in the serum exosomes of highly active antiretroviral therapy-treated patients or long term nonprogressors. Taken together, our experiments demonstrated that HIV-1-infected cells produced exosomes that are uniquely characterized by their proteomic and RNA profiles that may contribute to disease pathology in AIDS.	[Narayanan, Aarthi; Iordanskiy, Sergey; Das, Ravi; Van Duyne, Rachel; Jaworski, Elizabeth; Guendel, Irene; Sampey, Gavin; Dalby, Elizabeth; Hakami, Ramin; Kehn-Hall, Kylene; Bailey, Charles; Kashanchi, Fatah] George Mason Univ, Natl Ctr Biodef & Infect Dis, Manassas, VA 20110 USA; [Iordanskiy, Sergey; Van Duyne, Rachel; Santos, Steven; Popratiloff, Anastas] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC 20037 USA; [Iglesias-Ussel, Maria; Romerio, Fabio] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Young, Mary] Georgetown Univ, Med Ctr, Washington Metropolitan Womens Interagency HIV St, Div Infect Dis, Washington, DC 20007 USA; [Subra, Caroline; Gilbert, Caroline] Univ Laval, Ctr Hosp Univ Quebec, Res Ctr, Dept Microbiol Infectiol & Immunol,Med Fac, Quebec City, PQ G1R 2J6, Canada	George Mason University; George Washington University; University System of Maryland; University of Maryland Baltimore; Georgetown University; Laval University	Kashanchi, F (corresponding author), George Mason Univ, Natl Ctr Biodef & Infect Dis, Discovery Hall,Rm 182,10900 Univ Blvd,MS 1H8, Manassas, VA 20110 USA.	fkashanc@gmu.edu	Kehn-Hall, Kylene/I-5752-2013; Van Duyne, Rachel/I-7365-2019; Van Duyne, Rachel/ABI-2429-2020	Van Duyne, Rachel/0000-0003-2914-6874; Subra, Caroline/0000-0001-5272-0972; Das, Ravi/0000-0002-4301-0642; Gilbert, Caroline/0000-0003-2722-1180; Kehn-Hall, Kylene/0000-0001-8036-7213	National Institutes of Health [AI078859, AI074410, AI043894]; NCI; NIDA; NIDCD; NCRR UCSF-CTSI [UL1 RR024131]; District of Columbia Developmental Center for AIDS Research Grant [5P30AI087714-02]; United States Department of Energy [DE-SC0001599]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD032632] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI034989, R01AI043894, R21AI074410, P30AI087714, U01AI035004, U01AI034994, U01AI034993, U01AI031834, R21AI078859, U01AI042590] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS099029] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NCRR UCSF-CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); District of Columbia Developmental Center for AIDS Research Grant; United States Department of Energy(United States Department of Energy (DOE)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI078859, AI074410, and AI043894 (to F. K.), NCI, NIDA, NIDCD, and NCRR UCSF-CTSI Grant UL1 RR024131, and District of Columbia Developmental Center for AIDS Research Grant 5P30AI087714-02 (to S. I.). This work was also supported by United States Department of Energy Grant DE-SC0001599 (to F. K. and C. B.).	Agrawal N, 2003, MICROBIOL MOL BIOL R, V67, P657, DOI 10.1128/MMBR.67.4.657-685.2003; Ali SA, 2010, AIDS RES HUM RETROV, V26, P173, DOI 10.1089/aid.2009.0068; Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Anand Paras K, 2010, Commun Integr Biol, V3, P405, DOI 10.4161/cib.3.5.12474; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Barth S, 2011, BBA-GENE REGUL MECH, V1809, P631, DOI 10.1016/j.bbagrm.2011.05.010; Bentham M, 2006, J GEN VIROL, V87, P563, DOI 10.1099/vir.0.81200-0; Bivalkar-Mehla S, 2011, VIRUS RES, V155, P1, DOI 10.1016/j.virusres.2010.10.003; Booth AM, 2006, J CELL BIOL, V172, P923, DOI 10.1083/jcb.200508014; Boss IW, 2009, TRENDS MICROBIOL, V17, P544, DOI 10.1016/j.tim.2009.09.002; Boucheix C, 2001, CELL MOL LIFE SCI, V58, P1189, DOI 10.1007/PL00000933; Brandano L, 2012, J VIROL, V86, P2347, DOI 10.1128/JVI.06047-11; Brocker C, 2010, CURR BIOL, V20, pR943, DOI 10.1016/j.cub.2010.09.015; Campbell TD, 2008, ETHN DIS, V18; Cantin R, 2008, J IMMUNOL METHODS, V338, P21, DOI 10.1016/j.jim.2008.07.007; Carpio Lawrence, 2010, J RNAi Gene Silencing, V6, pE386; Carpio Lawrence, 2010, J RNAi Gene Silencing, V6, P386; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Coley W, 2010, J BIOL CHEM, V285, P31930, DOI 10.1074/jbc.M110.101709; de Vries W, 2008, INT J BIOCHEM CELL B, V40, P2007, DOI 10.1016/j.biocel.2008.04.015; Denzer K, 2000, J CELL SCI, V113, P3365; Dimov I, 2009, THESCIENTIFICWORLDJO, V9, P1107, DOI 10.1100/tsw.2009.128; Dolken L, 2009, VIRUS GENES, V38, P355, DOI 10.1007/s11262-009-0347-0; Duijvesz D, 2011, EUR UROL, V59, P823, DOI 10.1016/j.eururo.2010.12.031; Easley R, 2010, VIROLOGY, V405, P322, DOI 10.1016/j.virol.2010.06.009; Eldh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015353; Fang Y, 2007, PLOS BIOL, V5, P1267, DOI 10.1371/journal.pbio.0050158; Furnes C, 2008, ARCH VIROL, V153, P357, DOI 10.1007/s00705-007-1095-x; Gan X, 2011, MOL BIOL CELL, V22, P817, DOI 10.1091/mbc.E10-07-0625; Geanacopoulos Mark, 2005, Science Progress, V88, P49, DOI 10.3184/003685005783238444; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gourzones C, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-271; Grishok A, 2005, FEBS LETT, V579, P5932, DOI 10.1016/j.febslet.2005.08.001; Grundhoff A, 2006, RNA, V12, P733, DOI 10.1261/rna.2326106; Haasnoot J, 2011, METHODS MOL BIOL, V721, P23, DOI 10.1007/978-1-61779-037-9_2; Klase Z, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-63; Klase Z, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-38; Klase Z, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-18; Lamers SL, 2010, BIOSYSTEMS, V101, P88, DOI 10.1016/j.biosystems.2010.05.001; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lejeune E, 2011, CURR OPIN CELL BIOL, V23, P258, DOI 10.1016/j.ceb.2011.03.005; Lenassi M, 2010, TRAFFIC, V11, P110, DOI 10.1111/j.1600-0854.2009.01006.x; Lin J, 2007, J VIROL, V81, P12218, DOI 10.1128/JVI.01390-07; Ludwig AK, 2012, INT J BIOCHEM CELL B, V44, P11, DOI 10.1016/j.biocel.2011.10.005; Marini A, 2008, J IMMUNOL, V181, P7713, DOI 10.4049/jimmunol.181.11.7713; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Mohammed KD, 2011, J VIROL, V85, P4654, DOI 10.1128/JVI.02374-10; Montgomery Mary K, 2004, Methods Mol Biol, V265, P3; Muratori C, 2009, CELL HOST MICROBE, V6, P218, DOI 10.1016/j.chom.2009.06.009; Nair V, 2006, TRENDS MICROBIOL, V14, P169, DOI 10.1016/j.tim.2006.02.007; Naqvi AR, 2009, INT J BIOL SCI, V5, P97; Narayanan A, 2011, EXPERT OPIN BIOL TH, V11, P17, DOI 10.1517/14712598.2011.540564; Omoto Shinya, 2004, Retrovirology, V1, P44, DOI 10.1186/1742-4690-1-44; Ouellet DL, 2008, NUCLEIC ACIDS RES, V36, P2353, DOI 10.1093/nar/gkn076; Paolucci S, 2011, CURR HIV RES, V9, P17, DOI 10.2174/157016211794582641; Pegtel DM, 2011, BBA-GENE REGUL MECH, V1809, P715, DOI 10.1016/j.bbagrm.2011.08.002; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Perron MP, 2008, FRONT BIOSCI-LANDMRK, V13, P2537, DOI 10.2741/2865; Perron Marjorie P., 2009, V487, P369, DOI 10.1007/978-1-60327-547-7_18; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Plaisance-Bonstaff K, 2011, METHODS MOL BIOL, V721, P43, DOI 10.1007/978-1-61779-037-9_3; Poe JA, 2009, J MOL BIOL, V394, P329, DOI 10.1016/j.jmb.2009.09.047; Pols MS, 2009, EXP CELL RES, V315, P1584, DOI 10.1016/j.yexcr.2008.09.020; Rana S, 2011, BIOCHEM SOC T, V39, P559, DOI 10.1042/BST0390559; Record M, 2011, BIOCHEM PHARMACOL, V81, P1171, DOI 10.1016/j.bcp.2011.02.011; Sandonis V, 2009, VIROLOGY, V391, P73, DOI 10.1016/j.virol.2009.05.022; Scaria V, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-68; Schopman NCT, 2012, NUCLEIC ACIDS RES, V40, P414, DOI 10.1093/nar/gkr719; Schuetz S, 2006, VIROLOGY, V344, P151, DOI 10.1016/j.virol.2005.09.034; Shelton MN, 2012, J VIROL, V86, P406, DOI 10.1128/JVI.05720-11; Shen BY, 2011, J BIOL CHEM, V286, P14383, DOI 10.1074/jbc.M110.208660; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Van Duyne R, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-21; Van Rij RP, 2006, TRENDS BIOTECHNOL, V24, P186, DOI 10.1016/j.tibtech.2006.02.006; Venkatachari NJ, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-119; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Wang SH, 2008, BIOMED ENVIRON SCI, V21, P485, DOI 10.1016/S0895-3988(09)60007-6; Wang Z, 2012, PROTEOMICS, V12, P329, DOI 10.1002/pmic.201100477; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Yeung ML, 2009, NUCLEIC ACIDS RES, V37, P6575, DOI 10.1093/nar/gkp707; Yunta M, 2003, CELL SIGNAL, V15, P559, DOI 10.1016/S0898-6568(02)00147-X; Zhu JY, 2009, J VIROL, V83, P3333, DOI 10.1128/JVI.01689-08; Zofall M, 2006, COLD SPRING HARB SYM, V71, P487, DOI 10.1101/sqb.2006.71.059; Zomer Anoek, 2010, Commun Integr Biol, V3, P447, DOI 10.4161/cib.3.5.12339; Zou SP, 2011, J NEUROVIROL, V17, P41, DOI 10.1007/s13365-010-0016-z	93	205	216	3	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					20014	20033		10.1074/jbc.M112.438895	http://dx.doi.org/10.1074/jbc.M112.438895			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23661700	Green Published, hybrid			2022-12-25	WOS:000321515800065
J	Li, YK; Li, CG				Li, Yuke; Li, Chunguang			Synergies between Intrinsic and Synaptic Plasticity Based on Information Theoretic Learning	PLOS ONE			English	Article							NONLINEAR ADAPTIVE PREDICTION; EXCITABILITY; NEURONS; ALGORITHM	In experimental and theoretical neuroscience, synaptic plasticity has dominated the area of neural plasticity for a very long time. Recently, neuronal intrinsic plasticity (IP) has become a hot topic in this area. IP is sometimes thought to be an information-maximization mechanism. However, it is still unclear how IP affects the performance of artificial neural networks in supervised learning applications. From an information-theoretical perspective, the error-entropy minimization (MEE) algorithm has newly been proposed as an efficient training method. In this study, we propose a synergistic learning algorithm combining the MEE algorithm as the synaptic plasticity rule and an information-maximization algorithm as the intrinsic plasticity rule. We consider both feedforward and recurrent neural networks and study the interactions between intrinsic and synaptic plasticity. Simulations indicate that the intrinsic plasticity rule can improve the performance of artificial neural networks trained by the MEE algorithm.	Zhejiang Univ, Dept Informat Sci & Elect Engn, Hangzhou 310027, Zhejiang, Peoples R China	Zhejiang University	Li, CG (corresponding author), Zhejiang Univ, Dept Informat Sci & Elect Engn, Hangzhou 310027, Zhejiang, Peoples R China.	cgli@zju.edu.cn	Li, Yuke/P-2327-2016; Li, Chunguang/F-1458-2016	Li, Chunguang/0000-0003-3147-1553	National Natural Science Foundation of China [61171153, 61101045]; Foundation for the Author of National Excellent Doctoral Dissertation of PR China; Scientific Research Foundation for the Returned Overseas Chinese Scholars; Zhejiang Provincial Natural Science Foundation of China [LR12F01001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for the Author of National Excellent Doctoral Dissertation of PR China(Foundation for the Author of National Excellent Doctoral Dissertation of China); Scientific Research Foundation for the Returned Overseas Chinese Scholars(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work was supported by the National Natural Science Foundation of China (Grant Nos. 61171153 and 61101045), the Foundation for the Author of National Excellent Doctoral Dissertation of PR China, the Scientific Research Foundation for the Returned Overseas Chinese Scholars, and Zhejiang Provincial Natural Science Foundation of China (Grant No. LR12F01001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley R, 1997, P ROY SOC B-BIOL SCI, V264, P1775, DOI 10.1098/rspb.1997.0246; Baltersee J, 1998, IEEE T SIGNAL PROCES, V46, P2207, DOI 10.1109/78.705435; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Cudmore RH, 2004, J NEUROPHYSIOL, V92, P341, DOI 10.1152/jn.01059.2003; Daoudal G, 2003, LEARN MEMORY, V10, P456, DOI 10.1101/lm.64103; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; Erdogmus D, 2002, IEEE T SIGNAL PROCES, V50, P1780, DOI 10.1109/TSP.2002.1011217; Erdogmus D, 2000, P ICA HELS FINL; Glass L, 1998, CLOCK CHAOS; HAYKIN S, 1995, IEEE T SIGNAL PROCES, V43, P526, DOI 10.1109/78.348134; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; Lazar A, 2009, FRONT COMPUT NEUROSC, V3, DOI 10.3389/neuro.10.023.2009; Li CG, 2013, IEEE T AUTON MENT DE, V5, P62, DOI 10.1109/TAMD.2012.2211101; Li CG, 2011, IEEE T AUTON MENT DE, V3, P277, DOI 10.1109/TAMD.2011.2159379; Mandic DP, 1999, IEEE T NEURAL NETWOR, V10, P1435, DOI 10.1109/72.809088; Marder E, 1996, P NATL ACAD SCI USA, V93, P13481, DOI 10.1073/pnas.93.24.13481; Mozzachiodi R, 2010, TRENDS NEUROSCI, V33, P17, DOI 10.1016/j.tins.2009.10.001; Neumann K, 2011, LECT NOTES COMPUT SC, V6791, P339, DOI 10.1007/978-3-642-21735-7_42; PARZEN E, 1962, ANN MATH STAT, V33, P1065, DOI 10.1214/aoms/1177704472; Principe JC, 2010, INFORM SCI STAT, P1, DOI 10.1007/978-1-4419-1570-2; Principe JC, 1999, NEURAL ADAPTIVE SYST; Schrauwen B, 2008, NEUROCOMPUTING, V71, P1159, DOI 10.1016/j.neucom.2007.12.020; Steil JJ, 2007, NEURAL NETWORKS, V20, P353, DOI 10.1016/j.neunet.2007.04.011; Stemmler M, 1999, NAT NEUROSCI, V2, P521, DOI 10.1038/9173; Triesch J, 2005, LECT NOTES COMPUT SC, V3696, P65, DOI 10.1007/11550822_11; Triesch J, 2007, NEURAL COMPUT, V19, P885, DOI 10.1162/neco.2007.19.4.885; Watt A. J., 2010, FRONT SYNAPTIC NEURO, V2; Williams R.J., 1995, BACKPROPAGATION THEO, V1, P433; Williams RJ, 1989, NEURAL COMPUT, V1, P270, DOI 10.1162/neco.1989.1.2.270; Zhang M, 2004, J NEUROBIOL, V61, P277, DOI 10.1002/neu.20045; Zhang W, 2003, NAT REV NEUROSCI, V4, P885, DOI 10.1038/nrn1248	31	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e62894	10.1371/journal.pone.0062894	http://dx.doi.org/10.1371/journal.pone.0062894			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671642	gold, Green Submitted, Green Published			2022-12-25	WOS:000319737700026
J	Briscoe, AG; Goodacre, S; Masta, SE; Taylor, MI; Arnedo, MA; Penney, D; Kenny, J; Creer, S				Briscoe, Andrew G.; Goodacre, Sara; Masta, Susan E.; Taylor, Martin I.; Arnedo, Miquel A.; Penney, David; Kenny, John; Creer, Simon			Can Long-Range PCR Be Used to Amplify Genetically Divergent Mitochondrial Genomes for Comparative Phylogenetics? A Case Study within Spiders (Arthropoda: Araneae)	PLOS ONE			English	Article							CONTROL-REGION; DNA-SEQUENCE; GENE ORDER; EVOLUTION; AMPLIFICATION; SYSTEMATICS; TOOL; UTILITY; BIRDS; FIELD	The development of second generation sequencing technology has resulted in the rapid production of large volumes of sequence data for relatively little cost, thereby substantially increasing the quantity of data available for phylogenetic studies. Despite these technological advances, assembling longer sequences, such as that of entire mitochondrial genomes, has not been straightforward. Existing studies have been limited to using only incomplete or nominally intra-specific datasets resulting in a bottleneck between mitogenome amplification and downstream high-throughput sequencing. Here we assess the effectiveness of a wide range of targeted long-range PCR strategies, encapsulating single and dual fragment primer design approaches to provide full mitogenomic coverage within the Araneae (Spiders). Despite extensive rounds of optimisation, full mitochondrial genome PCR amplifications were stochastic in most taxa, although 454 Roche sequencing confirmed the successful amplification of 10 mitochondrial genomes out of the 33 trialled species. The low success rates of amplification using long-Range PCR highlights the difficulties in consistently obtaining genomic amplifications using currently available DNA polymerases optimised for large genomic amplifications and suggests that there may be opportunities for the use of alternative amplification methods.	[Briscoe, Andrew G.; Taylor, Martin I.; Creer, Simon] Bangor Univ, Coll Nat Sci, Environm Ctr Wales Bldg, Mol Ecol & Fisheries Genet Lab,Sch Biol Sci, Bangor, Gwynedd, Wales; [Goodacre, Sara] Univ Nottingham, Queens Med Ctr, Inst Genet, Nottingham NG7 2RD, England; [Masta, Susan E.] Portland State Univ, Dept Biol, Portland, OR 97207 USA; [Arnedo, Miquel A.] Univ Barcelona, Dept Biol Anim, Barcelona, Spain; [Penney, David] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Kenny, John] Univ Liverpool, Sch Biol Sci, Ctr Genom Res, Liverpool L69 3BX, Merseyside, England	Bangor University; University of Nottingham; Portland State University; University of Barcelona; University of Manchester; University of Liverpool	Creer, S (corresponding author), Bangor Univ, Coll Nat Sci, Environm Ctr Wales Bldg, Mol Ecol & Fisheries Genet Lab,Sch Biol Sci, Bangor, Gwynedd, Wales.	s.creer@bangor.ac.uk	Arnedo, Miquel/E-9086-2011; Kenny, John/HCI-1952-2022	Arnedo, Miquel/0000-0003-1402-4727; Kenny, John/0000-0003-2994-6169; Briscoe, Andrew/0000-0002-9422-6056; Goodacre, Sara L./0000-0002-0887-6563	CoSyst Grant; Bangor University; Natural Environment Research Council [NBAF010002] Funding Source: researchfish; NERC [NBAF010002] Funding Source: UKRI	CoSyst Grant; Bangor University; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by a CoSyst Grant awarded to SC and a Bangor University funded PhD studentship to AGB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan C, 2011, NAT METHODS, V8, P61, DOI 10.1038/NMETH.1527; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ayoub NA, 2007, MOL PHYLOGENET EVOL, V42, P394, DOI 10.1016/j.ympev.2006.07.018; BARNES WM, 1994, P NATL ACAD SCI USA, V91, P2216, DOI 10.1073/pnas.91.6.2216; Barrett RDH, 2005, CAN J ZOOL, V83, P481, DOI 10.1139/Z05-024; Beard C.B., 1993, Insect Molecular Biology, V2, P103, DOI 10.1111/j.1365-2583.1993.tb00131.x; Benjamin SP, 2008, CLADISTICS, V24, P708, DOI 10.1111/j.1096-0031.2008.00202.x; Blackledge TA, 2009, P NATL ACAD SCI USA, V106, P5229, DOI 10.1073/pnas.0901377106; Bodner MR, 2012, MOL PHYLOGENET EVOL, V65, P213, DOI 10.1016/j.ympev.2012.06.005; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Boore JL, 1998, CURR OPIN GENET DEV, V8, P668, DOI 10.1016/S0959-437X(98)80035-X; Corp. I, 2011, CORP 1 REL 2011 IBM; CUMMINGS MP, 1995, MOL BIOL EVOL, V12, P814; Dellaporta SL, 2006, P NATL ACAD SCI USA, V103, P8751, DOI 10.1073/pnas.0602076103; Delsuc F, 2005, NAT REV GENET, V6, P361, DOI 10.1038/nrg1603; Dermauw W, 2010, GENOME, V53, P285, DOI [10.1139/g10-004, 10.1139/G10-004]; Dimitrov D, 2013, CLADISTICS, V29, P132, DOI 10.1111/j.1096-0031.2012.00419.x; Dimitrov D, 2012, P ROY SOC B-BIOL SCI, V279, P1341, DOI 10.1098/rspb.2011.2011; Dordel J, 2010, J ZOOL SYST EVOL RES, V48, P197, DOI 10.1111/j.1439-0469.2010.00567.x; Ernsting BR, 2009, EXP APPL ACAROL, V49, P305, DOI 10.1007/s10493-009-9263-1; Gai YH, 2008, MOL PHYLOGENET EVOL, V49, P574, DOI 10.1016/j.ympev.2008.08.010; Glenn TC, 2011, MOL ECOL RESOUR, V11, P759, DOI 10.1111/j.1755-0998.2011.03024.x; Goodacre SL, 2006, MOL ECOL, V15, P517, DOI 10.1111/j.1365-294X.2005.02802.x; Groenenberg DSJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-114; Hosseini R, 2007, BIOL CONTROL, V40, P128, DOI 10.1016/j.biocontrol.2006.10.007; Hu M, 2007, NAT PROTOC, V2, P2339, DOI 10.1038/nprot.2007.358; Hwang UW, 2001, MOL PHYLOGENET EVOL, V19, P345, DOI 10.1006/mpev.2001.0940; Jiang ST, 2009, INT J BIOL SCI, V5, P351; Kane N, 2012, AM J BOT, V99, P320, DOI 10.3732/ajb.1100570; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Mardulyn P, 2003, J MOL EVOL, V56, P38, DOI 10.1007/s00239-002-2378-1; Masta SE, 2004, MOL BIOL EVOL, V21, P893, DOI 10.1093/molbev/msh096; Masta SE, 2008, MOL BIOL EVOL, V25, P949, DOI 10.1093/molbev/msn051; Masta SE, 2010, MOL PHYLOGENET EVOL, V57, P59, DOI 10.1016/j.ympev.2010.06.020; Morin PA, 2010, GENOME RES, V20, P908, DOI 10.1101/gr.102954.109; MORITZ C, 1987, ANNU REV ECOL SYST, V18, P269, DOI 10.1146/annurev.es.18.110187.001413; Murchison EP, 2010, SCIENCE, V327, P84, DOI 10.1126/science.1180616; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Penney D., 2011, FOSSIL SPIDERS EVOLU; Penney D, 2012, ZOOKEYS, P1, DOI 10.3897/zookeys.192.3093; Platnick NI, 2012, WORLD SPIDER CATALOG, DOI [10.5531/db.iz.0001, DOI 10.5531/DB.IZ.0001:AMERICAN]; Prosdocimi F, 2012, MOL BIOL REP, V39, P2767, DOI 10.1007/s11033-011-1034-5; QUINN TW, 1993, J MOL EVOL, V37, P417; Rokas A, 2000, TRENDS ECOL EVOL, V15, P454, DOI 10.1016/S0169-5347(00)01967-4; Rozen S, 2000, Methods Mol Biol, V132, P365; Sorenson MD, 1999, MOL PHYLOGENET EVOL, V12, P105, DOI 10.1006/mpev.1998.0602; Struck TH, 2011, NATURE, V471, P95, DOI 10.1038/nature09864; SUNDERLAND KD, 1986, J APPL ECOL, V23, P433, DOI 10.2307/2404027; Tang S, 2005, J NEMATOL, V37, P236; Timmermans MJTN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq807; Venkatesh B, 1999, P NATL ACAD SCI USA, V96, P10267, DOI 10.1073/pnas.96.18.10267; WENINK PW, 1994, MOL BIOL EVOL, V11, P22; WERLE E, 1994, NUCLEIC ACIDS RES, V22, P4354, DOI 10.1093/nar/22.20.4354; Willerslev E, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-95; Zhang DX, 1997, BIOCHEM SYST ECOL, V25, P99, DOI 10.1016/S0305-1978(96)00042-7; Zhang HH, 2011, MOL BIOL REP, V38, P1651, DOI 10.1007/s11033-010-0276-y	56	10	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62404	10.1371/journal.pone.0062404	http://dx.doi.org/10.1371/journal.pone.0062404			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667474	gold, Green Published, Green Submitted			2022-12-25	WOS:000319055600024
J	Tworzydlo, W; Kisiel, E; Bilinski, SM				Tworzydlo, Waclaw; Kisiel, Elzbieta; Bilinski, Szczepan M.			Embryos of the Viviparous Dermapteran, Arixenia esau Develop Sequentially in Two Compartments: Terminal Ovarian Follicles and the Uterus	PLOS ONE			English	Article							OOGENESIS; EVOLUTION; COCKROACH; DIPTERA; MILK	Three main reproductive strategies have been described among insects: most common oviparity, ovoviviparity and viviparity. In the latter strategy, the embryonic development takes place within the body of the mother which provides gas exchange and nutrients for embryos. Here we present the results of histological and EM analyses of the female reproductive system of the viviparous earwig, Arixenia esau, focusing on all the modifications related to the viviparity. We show that in the studied species the embryonic development consists of two "physiological phases" that take place in two clearly disparate compartments, i.e. the terminal ovarian follicle and the uterus. In both compartments the embryos are associated with synthetically active epithelial cells. We suggest that these cells are involved in the nourishment of the embryo. Our results indicate that viviparity in arixeniids is more complex than previously considered. We propose the new term "pseudoplacento-uterotrophic viviparity" for this unique two-phase reproductive strategy.	[Tworzydlo, Waclaw; Kisiel, Elzbieta; Bilinski, Szczepan M.] Jagiellonian Univ, Inst Zool, Dept Dev Biol & Morphol Invertebrates, PL-30060 Krakow, Poland	Jagiellonian University	Tworzydlo, W (corresponding author), Jagiellonian Univ, Inst Zool, Dept Dev Biol & Morphol Invertebrates, PL-30060 Krakow, Poland.	w.tworzydlo@uj.edu.pl	Tworzydlo, Waclaw/AAJ-1343-2020	Tworzydlo, Waclaw/0000-0003-1481-1050	National Science Center (NCN) in Krakow, Poland [2011/01/D/NZ4/00137]	National Science Center (NCN) in Krakow, Poland	Financial support for this study was received by WT from National Science Center (NCN) in Krakow, Poland (project: 2011/01/D/NZ4/00137). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS RM, 1994, PHYSIOL ZOOL, V67, P1006, DOI 10.1086/physzool.67.4.30163876; Attardo GM, 2008, J INSECT PHYSIOL, V54, P1236, DOI 10.1016/j.jinsphys.2008.06.008; Attardo GM, 2006, J INSECT PHYSIOL, V52, P1128, DOI 10.1016/j.jinsphys.2006.07.007; Bermingham J, 2009, PHYSIOL ENTOMOL, V34, P103, DOI 10.1111/j.1365-3032.2008.00669.x; Bilinski SM, 1996, HISTOCHEM J, V28, P651, DOI 10.1007/BF02331386; Buning J, 1998, INT J INSECT MORPHOL, V27, P3, DOI 10.1016/S0020-7322(97)00028-7; Buning J., 1994, INSECT OVARY ULTRAST, Vfirst; Haas F, 2001, EUR J ENTOMOL, V98, P445, DOI 10.14411/eje.2001.065; Hagan HR., 1951, EMBRYOLOGY VIVIPAROU; Herter K, 1943, Z MORPHOLOGIE OKOLOG, V40, P158, DOI DOI 10.1007/BF00421680; Holbrook GL, 2004, P NATL ACAD SCI USA, V101, P5595, DOI 10.1073/pnas.0400209101; HOWELL WM, 1980, EXPERIENTIA, V36, P1014, DOI 10.1007/BF01953855; JUNQUERA P, 1984, ROUX ARCH DEV BIOL, V193, P197, DOI 10.1007/BF01260339; Kathirithamby J., 1992, Frustula Entomologica, V13, P1; Kocarek P, 2009, TROP ZOOL, V22, P237; Kunkel J.G., 1985, P83; Margaritis L.H., 1985, P153; Meier R, 1999, BIOL REV, V74, P199, DOI 10.1017/S0006323199005320; NAKATA S, 1974, PAC INSECTS, V16, P307; Ochs RL, 1998, METHOD CELL BIOL, V53, P303; Pellegrini A, 2011, TISSUE CELL, V43, P1, DOI 10.1016/j.tice.2010.10.005; POPHAM EJ, 1985, Z ZOOL SYST EVOL, V23, P199; Ramon, 1903, TRAB LAB INVEST BIOL, V2, P129; Retnakaran A., 1985, P231; Sabri A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018847; SCHUPBACH PM, 1983, INT J INSECT MORPHOL, V12, P211, DOI 10.1016/0020-7322(83)90018-1; SOUSA M, 1987, CAN J ZOOL, V65, P2607, DOI 10.1139/z87-395; SOUSA M, 1988, INT J INVER REP DEV, V13, P1; Thompson SW, 1966, SELECTED HISTOCHEMIC; TOBE SS, 1973, TISSUE CELL, V5, P633, DOI 10.1016/S0040-8166(73)80050-3; TOBE SS, 1978, ANNU REV ENTOMOL, V23, P283, DOI 10.1146/annurev.en.23.010178.001435; Tworzydlo W, 2005, GENESIS, V43, P49, DOI 10.1002/gene.20155; Tworzydlo W, 2013, ZOOL ANZ, V252, P410, DOI 10.1016/j.jcz.2012.11.002; Tworzydlo W, 2010, ARTHROPOD STRUCT DEV, V39, P360, DOI 10.1016/j.asd.2010.05.004; Wheeler DE, 2003, ENCY INSECTS, P991; Williford A, 2004, EVOL DEV, V6, P67, DOI 10.1111/j.1525-142X.2004.04012.x; Youngsteadt E, 2005, J INSECT PHYSIOL, V51, P803, DOI 10.1016/j.jinsphys.2005.03.008	37	17	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e64087	10.1371/journal.pone.0064087	http://dx.doi.org/10.1371/journal.pone.0064087			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667700	Green Published, gold, Green Submitted			2022-12-25	WOS:000319055600085
J	Chakraborty, P; Kulkarni, S; Rajan, R; Sainis, K				Chakraborty, Pampi; Kulkarni, Savita; Rajan, Ramakrishna; Sainis, Krishna			Drug Resistant Clinical Isolates of Mycobacterium tuberculosis from Different Genotypes Exhibit Differential Host Responses in THP-1 Cells	PLOS ONE			English	Article							BEIJING FAMILY STRAINS; HUMAN MACROPHAGES; IN-VITRO; MURINE MACROPHAGES; TNF-ALPHA; VIRULENT; APOPTOSIS; INDUCTION; GROWTH; COMPLEX	Mycobacterium tuberculosis (MTB) persistently infects and survives within the host macrophages. Substantial genotypic variation exists among MTB strains which correlate with their interactions with the host. The present study was designed to establish a correlation, if any, between infection and induction of innate immune response by genetically diverse drug resistant MTB isolates from India. For this purpose, three clinical isolates from ancient and modern lineages, along with H37Ra and H37Rv were evaluated for intracellular growth, phagocytic index, induction of proinflammatory cytokines and apoptosis following infection in THP-1 cell line. A wide variation in the induction of cytokines was revealed subsequent to infection with different strains. EAI-5 strain from ancient lineage 1, induced higher proinflammatory responses, higher apoptosis and moderate intracellular growth compared to other strains, in contrast, for Beijing strain of modern lineage 2, all three parameters were lowest among the clinical isolates. Further, the responses induced by LAM-6 from modern lineage 4 were at a moderate level, similar to the laboratory strain H37Rv which also belongs to lineage 4. Thus, these profiles were specific to their respective lineages and/or genotypes and independent of their drug resistance status. Further, a positive correlation, among TNF-alpha, IL-1 beta, IL-6 and IL-12 induced in infected THP-1 cells was demonstrated. In addition, induction of all pro-inflammatory cytokines correlated well with the host cell apoptosis. A positive correlation was observed between phagocytic index in the category of '>10 bacilli/cell' and induction of apoptosis, only for virulent strains, indicating that initial accumulation of MTB strains inside the host cell may be an important determining factor for different innate responses.	[Chakraborty, Pampi; Kulkarni, Savita; Rajan, Ramakrishna; Sainis, Krishna] Bhabha Atom Res Ctr, Radiat Med Ctr, Biomed Grp, Bombay 400085, Maharashtra, India	Bhabha Atomic Research Center (BARC)	Kulkarni, S (corresponding author), Bhabha Atom Res Ctr, Radiat Med Ctr, Biomed Grp, Bombay 400085, Maharashtra, India.	savita.kulkarni1@gmail.com			Bhabha Atomic Research Centre which is part of Department of Atomic Energy (DAE), Government of India; Homi Bhabha National Institute, Mumbai	Bhabha Atomic Research Centre which is part of Department of Atomic Energy (DAE), Government of India; Homi Bhabha National Institute, Mumbai	This was funded by the authors' own department, Bhabha Atomic Research Centre which is part of Department of Atomic Energy (DAE), Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge Homi Bhabha National Institute, Mumbai for providing Research Fellowship to Mrs Pampi Chakraborty. We are grateful to Mr. Mukti Kanta Ray for his support for radiorespirometry measurements for this study.	Almeida D, 2005, CLIN INFECT DIS, V40, P881, DOI 10.1086/427940; [Anonymous], 2012, WHO TUB GLOB FACTSH; Bifani PJ, 2002, TRENDS MICROBIOL, V10, P45, DOI 10.1016/S0966-842X(01)02277-6; Boeuf P, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-5; Bosio CM, 2000, J IMMUNOL, V164, P6417, DOI 10.4049/jimmunol.164.12.6417; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Chacon-Salinas R, 2005, CLIN EXP IMMUNOL, V140, P443, DOI 10.1111/j.1365-2249.2005.02797.x; Ciaramella A, 2002, J INFECT DIS, V186, P1277, DOI 10.1086/344645; Comas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000600; Cooper AM, 2008, IMMUNOL REV, V226, P191, DOI 10.1111/j.1600-065X.2008.00702.x; Domenech P, 2009, MICROBIOL-SGM, V155, P3532, DOI 10.1099/mic.0.029199-0; Duan L, 2001, J IMMUNOL, V166, P7469, DOI 10.4049/jimmunol.166.12.7469; Freeman S, 2006, J INTERF CYTOK RES, V26, P27, DOI 10.1089/jir.2006.26.27; GANATRA RD, 1980, J NUCL MED, V21, P480; Hoal-Van Helden EG, 2001, CELL BIOL INT, V25, P83, DOI 10.1006/cbir.2000.0680; Honore-Bouakline S, 2003, J CLIN MICROBIOL, V41, P2323, DOI 10.1128/JCM.41.6.2323-2329.2003; Ignatova A, 2006, J MED MICROBIOL, V55, P1413, DOI 10.1099/jmm.0.46575-0; Keane J, 2000, J IMMUNOL, V164, P2016, DOI 10.4049/jimmunol.164.4.2016; Kulkarni S, 2005, RES MICROBIOL, V156, P588, DOI 10.1016/j.resmic.2005.01.005; LAMBRECHT RS, 1988, APPL ENVIRON MICROB, V54, P910, DOI 10.1128/AEM.54.4.910-916.1988; Lan NTN, 2003, EMERG INFECT DIS, V9, P1633, DOI 10.3201/eid0912.030169; Lasunskaia E, 2010, MICROBES INFECT, V12, P467, DOI 10.1016/j.micinf.2010.02.008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez B, 2003, CLIN EXP IMMUNOL, V133, P30, DOI 10.1046/j.1365-2249.2003.02171.x; Manca C, 2004, INFECT IMMUN, V72, P5511, DOI 10.1128/IAI.72.9.5511-5514.2004; Manca C, 1999, J IMMUNOL, V162, P6740; Marquina-Castillo B, 2009, IMMUNOLOGY, V128, P123, DOI 10.1111/j.1365-2567.2008.03004.x; Narayanan S, 2008, INFECT GENET EVOL, V8, P474, DOI 10.1016/j.meegid.2007.09.007; Lazzarini LCO, 2008, J CLIN MICROBIOL, V46, P2175, DOI 10.1128/JCM.00065-08; Park JS, 2006, J LEUKOCYTE BIOL, V79, P80, DOI 10.1189/jlb.0505250; Parwati I, 2010, LANCET INFECT DIS, V10, P103, DOI 10.1016/S1473-3099(09)70330-5; Pitchappan RM, 1997, J BIOSCIENCE, V22, P47, DOI 10.1007/BF02703617; Portevin D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001307; Pravica V, 2000, HUM IMMUNOL, V61, P863, DOI 10.1016/S0198-8859(00)00167-1; Rajavelu P, 2007, MICROBIOL IMMUNOL, V51, P201, DOI 10.1111/j.1348-0421.2007.tb03902.x; Rojas M, 1999, J IMMUNOL, V162, P6122; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Sarkar R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043170; SCHLESINGER LS, 1993, J IMMUNOL, V150, P2920; Silver RF, 1998, INFECT IMMUN, V66, P1190, DOI 10.1128/IAI.66.3.1190-1199.1998; Sinsimer D, 2008, INFECT IMMUN, V76, P3027, DOI 10.1128/IAI.01663-07; Sohn H, 2009, SCAND J IMMUNOL, V69, P43, DOI 10.1111/j.1365-3083.2008.02188.x; Supply P, 2001, J CLIN MICROBIOL, V39, P3563, DOI 10.1128/JCM.39.10.3563-3571.2001; Tanveer M, 2009, T ROY SOC TROP MED H, V103, P581, DOI 10.1016/j.trstmh.2009.03.014; Theus SA, 2005, J INFECT DIS, V191, P453, DOI 10.1086/425936; Thuong NTT, 2007, GENES IMMUN, V8, P422, DOI 10.1038/sj.gene.6364405; Torrelles JB, 2008, J BIOL CHEM, V283, P31417, DOI 10.1074/jbc.M806350200; Tripathy NK, 2004, CLIN EXP IMMUNOL, V138, P369, DOI 10.1111/j.1365-2249.2004.02613.x; van der Spuy GD, 2009, TUBERCULOSIS, V89, P120, DOI 10.1016/j.tube.2008.09.003; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; von Groll A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010191; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; Wolf AJ, 2007, J IMMUNOL, V179, P2509, DOI 10.4049/jimmunol.179.4.2509; Zhang M, 1998, INFECT IMMUN, V66, P794, DOI 10.1128/IAI.66.2.794-799.1998	55	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62966	10.1371/journal.pone.0062966	http://dx.doi.org/10.1371/journal.pone.0062966			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667550	Green Submitted, gold, Green Published			2022-12-25	WOS:000319654700088
J	Chen, HL; Zhang, ZP				Chen, Hailin; Zhang, Zuping			A Semi-Supervised Method for Drug-Target Interaction Prediction with Consistency in Networks	PLOS ONE			English	Article							DIVERSITY-ORIENTED SYNTHESIS; PHARMACOLOGY; INTEGRATION; MODEL	Computational prediction of interactions between drugs and their target proteins is of great importance for drug discovery and design. The difficulties of developing computational methods for the prediction of such potential interactions lie in the rarity of known drug-protein interactions and no experimentally verified negative drug-target interaction sample. Furthermore, target proteins need also to be predicted for some new drugs without any known target interaction information. In this paper, a semi-supervised learning method NetCBP is presented to address this problem by using labeled and unlabeled interaction information. Assuming coherent interactions between the drugs ranked by their relevance to a query drug, and the target proteins ranked by their relevance to the hidden target proteins of the query drug, we formulate a learning framework maximizing the rank coherence with respect to the known drug-target interactions. When applied to four classes of important drug-target interaction networks, our method improves previous methods in terms of cross-validation and some strongly predicted interactions are confirmed by the publicly accessible drug target databases, which indicates the usefulness of our method. Finally, a comprehensive prediction of drug-target interactions enables us to suggest many new potential drug-target interactions for further studies.	[Chen, Hailin; Zhang, Zuping] Cent S Univ, Sch Informat Sci & Engn, Changsha, Hunan, Peoples R China; [Chen, Hailin] Hunan Univ Humanities Sci & Technol, Dept Comp Sci & Technol, Loudi, Peoples R China	Central South University; Hunan University Of Humanities, Science & Technology	Zhang, ZP (corresponding author), Cent S Univ, Sch Informat Sci & Engn, Changsha, Hunan, Peoples R China.	zpzhang@mail.csu.edu.cn		Chen, Hailin/0000-0002-5119-4517	National Natural Science Foundation of China [60970095, 61003124, M1121008]; Research Fund for the Doctoral Program of Higher Education of China [20120162110077]; National High Technology Research and Development Program of China (863 Program) [2012AA011205]; Program for New Century Excellent Talents in University [NCET-12-0547]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This research was supported by the National Natural Science Foundation of China (Grants 60970095, 61003124 and M1121008), Research Fund for the Doctoral Program of Higher Education of China (Grant no. 20120162110077), the National High Technology Research and Development Program of China (863 Program, no. 2012AA011205), and the Program for New Century Excellent Talents in University (NCET-12-0547). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Bleakley K, 2009, BIOINFORMATICS, V25, P2397, DOI 10.1093/bioinformatics/btp433; Chen X, 2012, MOL BIOSYST, V8, P1970, DOI 10.1039/c2mb00002d; Cheng AC, 2007, NAT BIOTECHNOL, V25, P71, DOI 10.1038/nbt1273; Cheng FX, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002503; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Gonen M, 2012, BIOINFORMATICS, V28, P2304, DOI 10.1093/bioinformatics/bts360; Haggarty SJ, 2003, CHEM BIOL, V10, P383, DOI 10.1016/S1074-5521(03)00095-4; Hattori M, 2003, J AM CHEM SOC, V125, P11853, DOI 10.1021/ja036030u; Hecker N, 2012, NUCLEIC ACIDS RES, V40, pD1113, DOI 10.1093/nar/gkr912; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Hwang TH, 2011, BIOINFORMATICS, V27, P2692, DOI 10.1093/bioinformatics/btr463; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Kuruvilla FG, 2002, NATURE, V416, P653, DOI 10.1038/416653a; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Stettner M, 2007, MOL CANCER THER, V6, P2626, DOI 10.1158/1535-7163.MCT-07-0197; Tiihonen J, 2009, LANCET, V374, P620, DOI 10.1016/S0140-6736(09)60742-X; Xia Z, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S2-S6; Xie L, 2012, ANNU REV PHARMACOL, V52, P361, DOI 10.1146/annurev-pharmtox-010611-134630; Yamanishi Y, 2008, BIOINFORMATICS, V24, pI232, DOI 10.1093/bioinformatics/btn162; Zhou DY, 2004, ADV NEUR IN, V16, P321; Zhu SF, 2005, BIOINFORMATICS, V21, P245, DOI 10.1093/bioinformatics/bti1141	27	95	96	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62975	10.1371/journal.pone.0062975	http://dx.doi.org/10.1371/journal.pone.0062975			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667553	gold, Green Published, Green Submitted			2022-12-25	WOS:000319654700091
J	Damsker, JM; Dillingham, BC; Rose, MC; Balsley, MA; Heier, CR; Watson, AM; Stemmy, EJ; Jurjus, RA; Huynh, T; Tatem, K; Uaesoontrachoon, K; Berry, DM; Benton, AS; Freishtat, RJ; Hoffman, EP; McCall, JM; Gordish-Dressman, H; Constant, SL; Reeves, EKM; Nagaraju, K				Damsker, Jesse M.; Dillingham, Blythe C.; Rose, Mary C.; Balsley, Molly A.; Heier, Christopher R.; Watson, Alan M.; Stemmy, Erik J.; Jurjus, Roslyn A.; Huynh, Tony; Tatem, Kathleen; Uaesoontrachoon, Kitipong; Berry, Dana M.; Benton, Angela S.; Freishtat, Robert J.; Hoffman, Eric P.; McCall, John M.; Gordish-Dressman, Heather; Constant, Stephanie L.; Reeves, Erica K. M.; Nagaraju, Kanneboyina			VBP15, a Glucocorticoid Analogue, Is Effective at Reducing Allergic Lung Inflammation in Mice	PLOS ONE			English	Article							INHALED CORTICOSTEROIDS; PROMOTER ACTIVITY; DNA-BINDING; MAST-CELLS; ASTHMA; RECEPTOR; MECHANISMS; EPITHELIUM; RESPONSES; INTERLEUKIN-10	Asthma is a chronic inflammatory condition of the lower respiratory tract associated with airway hyperreactivity and mucus obstruction in which a majority of cases are due to an allergic response to environmental allergens. Glucocorticoids such as prednisone have been standard treatment for many inflammatory diseases for the past 60 years. However, despite their effectiveness, long-term treatment is often limited by adverse side effects believed to be caused by glucocorticoid receptor-mediated gene transcription. This has led to the pursuit of compounds that retain the anti-inflammatory properties yet lack the adverse side effects associated with traditional glucocorticoids. We have developed a novel series of steroidal analogues (VBP compounds) that have been previously shown to maintain anti-inflammatory properties such as NFkB-inhibition without inducing glucocorticoid receptor-mediated gene transcription. This study was undertaken to determine the effectiveness of the lead compound, VBP15, in a mouse model of allergic lung inflammation. We show that VBP15 is as effective as the traditional glucocorticoid, prednisolone, at reducing three major hallmarks of lung inflammation-NFkB activity, leukocyte degranulation, and pro-inflammatory cytokine release from human bronchial epithelial cells obtained from patients with asthma. Moreover, we found that VBP15 is capable of reducing inflammation of the lung in vivo to an extent similar to that of prednisone. We found that prednisolone-but not VBP15 shortens the tibia in mice upon a 5 week treatment regimen suggesting effective dissociation of side effects from efficacy. These findings suggest that VBP15 may represent a potent and safer alternative to traditional glucocorticoids in the treatment of asthma and other inflammatory diseases.	[Damsker, Jesse M.; Dillingham, Blythe C.; Hoffman, Eric P.; McCall, John M.; Reeves, Erica K. M.; Nagaraju, Kanneboyina] ReveraGen BioPharma, Rockville, MD USA; [Dillingham, Blythe C.; Rose, Mary C.; Heier, Christopher R.; Watson, Alan M.; Huynh, Tony; Tatem, Kathleen; Uaesoontrachoon, Kitipong; Berry, Dana M.; Benton, Angela S.; Freishtat, Robert J.; Hoffman, Eric P.; Gordish-Dressman, Heather; Nagaraju, Kanneboyina] Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA; [Rose, Mary C.; Freishtat, Robert J.; Hoffman, Eric P.; Gordish-Dressman, Heather; Nagaraju, Kanneboyina] Childrens Natl Med Ctr, Dept Integrat Syst Biol, Washington, DC 20010 USA; [Rose, Mary C.; Freishtat, Robert J.; Hoffman, Eric P.; Gordish-Dressman, Heather; Nagaraju, Kanneboyina] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA; [Balsley, Molly A.; Stemmy, Erik J.; Jurjus, Roslyn A.; Constant, Stephanie L.] George Washington Univ, Med Ctr, Dept Microbiol Immunol & Trop Med, Washington, DC 20037 USA; [Huynh, Tony] Endocrine Res Unit, Canberra, ACT, Australia; [Huynh, Tony] Australian Natl Univ, Sch Med, Canberra Hosp, Canberra, ACT 0200, Australia; [McCall, John M.] PharMac LLC, Boca Grande, FL USA	Children's National Health System; Children's National Health System; George Washington University; George Washington University; Australian National University; Canberra Hospital	Damsker, JM (corresponding author), ReveraGen BioPharma, Rockville, MD USA.	Jesse.Damsker@reveragen.com	Huynh, Tony/AAU-9811-2020; Nagaraju, Kanneboyina/AAV-7684-2021; Huynh, Tony/J-6783-2014; Nagaraju, Kanneboyina/ABA-6525-2021; Jurjus, Rosalyn A./AAG-7853-2020	Huynh, Tony/0000-0002-7909-3670; Huynh, Tony/0000-0002-7909-3670; Heier, Christopher/0000-0001-7914-2068; Hoffman, Eric/0000-0001-6470-5139; Jurjus, Rosalyn A./0000-0003-3912-8020; Freishtat, Robert/0000-0002-7411-2342; Dillingham, Blythe/0000-0001-9183-7057	NIH [1R41HL104939-01B, 1K26RR032082, 1P50AR060836-01, 1U54HD071601, 2R24HD050846-06, R01 HL033152-25]; DOD [W81XWH-11-1-0330, W81XWH-11-1-0782, W81XWH-10-1-0659, W81XWH-11-1-0809, W81XWH-09-1-0599]; MDA; Parent Project Muscular Dystrophy (PPMD); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050846, U54HD071601] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K26RR032082] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033152, R41HL104939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR060836] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K26OD011171] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); MDA(Muscular Dystrophy Association); Parent Project Muscular Dystrophy (PPMD); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported in part by grants from the NIH (1R41HL104939-01B; 1K26RR032082; 1P50AR060836-01; 1U54HD071601; 2R24HD050846-06, R01 HL033152-25), DOD grants (W81XWH-11-1-0330; W81XWH-11-1-0782; W81XWH-10-1-0659; W81XWH-11-1-0809; W81XWH-09-1-0599) a translational research grant from MDA, pilot grant from Parent Project Muscular Dystrophy (PPMD), and a contribution from the Clark Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock IM, 2008, LANCET, V372, P1073, DOI 10.1016/S0140-6736(08)61449-X; Akinbami Lara J, 2011, Natl Health Stat Report, P1; Balsley MA, 2010, J IMMUNOL, V185, P7663, DOI 10.4049/jimmunol.1001707; Baudy AR, 2012, J PHARMACOL EXP THER, V343, P225, DOI 10.1124/jpet.112.194340; Baudy AR, 2009, INT IMMUNOPHARMACOL, V9, P1209, DOI 10.1016/j.intimp.2009.07.001; Busse W, 1999, AM J RESP CRIT CARE, V160, P1035, DOI 10.1164/ajrccm.160.3.9902064; Busse W, 2004, AM J RESP CRIT CARE, V170, P683, DOI 10.1164/rccm.200311-1539WS; Campbell JD, 2009, J EXP MED, V206, P1535, DOI 10.1084/jem.20082901; Castro-Rodriguez JA, 2013, CURR OPIN PULM MED, V19, P54, DOI 10.1097/MCP.0b013e32835b1165; CHROUSOS GA, 1993, JAMA-J AM MED ASSOC, V269, P2110, DOI 10.1001/jama.269.16.2110; Coghlan MJ, 2003, CURR TOP MED CHEM, V3, P1617, DOI 10.2174/1568026033451718; Cohn L, 2004, ANNU REV IMMUNOL, V22, P789, DOI 10.1146/annurev.immunol.22.012703.104716; Davies DE, 2002, INT J BIOCHEM CELL B, V34, P1520, DOI 10.1016/S1357-2725(02)00048-1; De Bosscher K, 2010, J STEROID BIOCHEM, V120, P96, DOI 10.1016/j.jsbmb.2010.02.027; Dougherty RH, 2009, CLIN EXP ALLERGY, V39, P193, DOI 10.1111/j.1365-2222.2008.03157.x; Epps D.E., 1997, ANTIOXIDANTS HLTH DI, P95; Eskdale J, 1997, IMMUNOGENETICS, V46, P120, DOI 10.1007/s002510050250; FREISHTAT RJ, 2011, AM J RESP CELL MOL B; Freishtat RJ, 2010, J INVEST MED, V58, P19, DOI 10.2310/JIM.0b013e3181b91654; GALLI SJ, 1995, ALLERGY, V50, P851, DOI 10.1111/j.1398-9995.1995.tb02490.x; Garbe E, 1997, JAMA-J AM MED ASSOC, V277, P722, DOI 10.1001/jama.277.9.722; Gessner A, 2005, J IMMUNOL, V174, P1063, DOI 10.4049/jimmunol.174.2.1063; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Gwinn WM, 2006, J IMMUNOL, V177, P4870, DOI 10.4049/jimmunol.177.7.4870; Hackett TL, 2011, AM J RESP CELL MOL, V45, P1090, DOI 10.1165/rcmb.2011-0031OC; Herrlich P, 2001, ONCOGENE, V20, P2465, DOI 10.1038/sj.onc.1204388; Hillier SG, 2007, J ENDOCRINOL, V195, P1, DOI 10.1677/JOE-07-0309; Hinz M, 2002, J EXP MED, V196, P605, DOI 10.1084/jem.20020062; Holgate ST, 1999, CLIN EXP ALLERGY, V29, P90, DOI 10.1046/j.1365-2222.1999.00016.x; HOLGATE ST, 1988, ALLERGY, V43, P22, DOI 10.1111/j.1398-9995.1988.tb05044.x; ITO T, 1979, JPN CIRC J, V43, P1043, DOI 10.1253/jcj.43.1043; John M, 1998, AM J RESP CRIT CARE, V157, P256, DOI 10.1164/ajrccm.157.1.9703079; Kabra S. K., 2003, Indian Journal of Pediatrics, V70, P63, DOI 10.1007/BF02722747; Kelly HW, 2012, NEW ENGL J MED, V367, P904, DOI 10.1056/NEJMoa1203229; Kicic A, 2006, AM J RESP CRIT CARE, V174, P1110, DOI 10.1164/rccm.200603-392OC; King EM, 2009, J BIOL CHEM, V284, P26803, DOI 10.1074/jbc.M109.028381; KUBE D, 1995, CYTOKINE, V7, P1, DOI 10.1006/cyto.1995.1001; Larche M, 2003, J ALLERGY CLIN IMMUN, V111, P450, DOI 10.1067/mai.2003.169; Larj Michael J, 2004, Chest, V126, p138S, DOI 10.1378/chest.126.2_suppl_1.138S; Liu L, 2005, INFLAMM RES, V54, P37, DOI 10.1007/s00011-004-1320-y; Manzur AY, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003725.pub3; Mayr SI, 2002, J IMMUNOL, V169, P2061, DOI 10.4049/jimmunol.169.4.2061; Mcmillan SJ, 2004, CLIN EXP ALLERGY, V34, P497, DOI 10.1111/j.1365-2222.2004.01895.x; Moriuchi H, 1997, J IMMUNOL, V158, P3483; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; Newton R, 2007, MOL PHARMACOL, V72, P799, DOI 10.1124/mol.107.038794; Reeves EKM, 2013, BIOORGAN MED CHEM, V21, P2241, DOI 10.1016/j.bmc.2013.02.009; Rehman Q, 2003, MED PEDIATR ONCOL, V41, P212, DOI 10.1002/mpo.10339; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; Reichardt HM, 2001, EMBO J, V20, P7168, DOI 10.1093/emboj/20.24.7168; Renzi PM, 1999, CAN MED ASSOC J, V160, P217; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Rissmiller RW, 2004, CHEST, V125, P1590, DOI 10.1378/chest.125.4.1590; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Sharek PJ, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.1.e8; Stahn C, 2007, MOL CELL ENDOCRINOL, V275, P71, DOI 10.1016/j.mce.2007.05.019; TRUSS M, 1993, ENDOCR REV, V14, P459, DOI 10.1210/er.14.4.459; Tuckermann Jan, 2010, Mol Endocrinol, V24, P1311, DOI 10.1210/me.2010-0083; vanderBurg B, 1997, TRENDS ENDOCRIN MET, V8, P152, DOI 10.1016/S1043-2760(97)00006-4; Wills-Karp M, 1999, ANNU REV IMMUNOL, V17, P255, DOI 10.1146/annurev.immunol.17.1.255; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wordinger RJ, 1999, PROG RETIN EYE RES, V18, P629, DOI 10.1016/S1350-9462(98)00035-4; Ying S, 1996, EUR J IMMUNOL, V26, P70, DOI 10.1002/eji.1830260111; Zhou J, 2008, ALLERGY, V63, P1177, DOI 10.1111/j.1398-9995.2008.01725.x	64	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63871	10.1371/journal.pone.0063871	http://dx.doi.org/10.1371/journal.pone.0063871			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667681	Green Submitted, gold, Green Published			2022-12-25	WOS:000319654700191
J	Guimond, DM; Cam, NR; Hirve, N; Duan, W; Lambris, JD; Croft, M; Tsoukas, CD				Guimond, David M.; Cam, Nicholas R.; Hirve, Nupura; Duan, Wei; Lambris, John D.; Croft, Michael; Tsoukas, Constantine D.			Regulation of Immune Responsiveness In Vivo by Disrupting an Early T-Cell Signaling Event Using a Cell-Permeable Peptide	PLOS ONE			English	Article							TH2 EFFECTOR FUNCTION; TYROSINE KINASE; AIRWAY HYPERRESPONSIVENESS; ALLERGIC-ASTHMA; MICE LACKING; ITK; FAMILY; ACTIVATION; DIFFERENTIATION; INFLAMMATION	The inducible T cell kinase (ITK) regulates type 2 (Th2) cytokines that provide defense against certain parasitic and bacterial infections and are involved in the pathogenesis of lung inflammation such as allergic asthma. Activation of ITK requires the interaction of its SH3 domain with the poly-proline region of its signaling partner, the SH2 domain containing leukocyte phosphoprotein of 76 kilodaltons (SLP-76). The specific disruption of the ITK-SH3/SLP-76 poly-proline interaction in vitro by a cell-permeable competitive inhibitor peptide (R9-QQP) interferes with the activation of ITK and the transduction of its cellular functions in T lymphocytes. In the present investigation, we assessed the effects of R9-QQP treatment on the induction of an in vivo immune response as represented by lung inflammation in a murine model of allergic asthma. We found that mice treated with R9-QQP and sensitized and challenged with the surrogate allergen ovalbumin (OVA) display significant inhibition of lung inflammation in a peptide-specific manner. Thus, parameters of the allergic response, such as airway hyper-responsiveness, suppression of inflammatory cell infiltration, reduction of bronchial mucus accumulation, and production of relevant cytokines from draining lymph nodes were significantly suppressed. These findings represent the first demonstration of the biological significance of the interaction between ITK and SLP-76 in the induction of an immune response in a whole animal model and specifically underscore the significance of the ITK-SH3 domain interaction with the poly-proline region of SLP-76 in the development of an inflammatory response. Furthermore, the experimental approach of intracellular peptide-mediated inhibition might be applicable to the study of other important intracellular interactions thus providing a paradigm for dissecting signal transduction pathways.	[Guimond, David M.; Cam, Nicholas R.; Hirve, Nupura; Tsoukas, Constantine D.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Guimond, David M.; Cam, Nicholas R.; Hirve, Nupura; Tsoukas, Constantine D.] San Diego State Univ, Ctr Microbial Sci, San Diego, CA 92182 USA; [Duan, Wei; Croft, Michael] La Jolla Inst Allergy & Immunol, Div Immune Regulat, San Diego, CA USA; [Lambris, John D.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	California State University System; San Diego State University; California State University System; San Diego State University; La Jolla Institute for Immunology; University of Pennsylvania	Tsoukas, CD (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	ctsoukas@mail.sdsu.edu	Lambris, John/Q-5633-2018	Lambris, John/0000-0002-9370-5776	National Institutes of Health [AI082321, AI060687, AI070535, CA91837]; NATIONAL CANCER INSTITUTE [R01CA091837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI082321, U19AI070535, R01AI060687] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health (http://www.niaid.nih.gov and http://www.cancer.gov) to CDT (AI082321), JDL (AI060687), and MC (AI070535 and CA91837). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreotti AH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002287; Au-Yeung BB, 2006, J IMMUNOL, V176, P3895, DOI 10.4049/jimmunol.176.7.3895; Bochner BS, 2005, J ALLERGY CLIN IMMUN, V115, P953, DOI 10.1016/j.jaci.2005.02.032; Bogin Y, 2007, P NATL ACAD SCI USA, V104, P6638, DOI 10.1073/pnas.0609771104; Bunnell SC, 2000, J BIOL CHEM, V275, P2219, DOI 10.1074/jbc.275.3.2219; Burton OT, 2011, IMMUNOL REV, V242, P128, DOI 10.1111/j.1600-065X.2011.01024.x; Ferrara TJ, 2006, J ALLERGY CLIN IMMUN, V117, P780, DOI 10.1016/j.jaci.2005.12.1330; Fowell DJ, 2009, CYTOKINE, V46, P1, DOI 10.1016/j.cyto.2008.12.023; Fowell DJ, 1999, IMMUNITY, V11, P399, DOI 10.1016/S1074-7613(00)80115-6; Grasis JA, 2003, J IMMUNOL, V170, P3971, DOI 10.4049/jimmunol.170.8.3971; Grasis Juris A, 2011, J Signal Transduct, V2011, P297868, DOI 10.1155/2011/297868; Grasis JA, 2010, MOL CELL BIOL, V30, P3596, DOI 10.1128/MCB.01657-09; Hamelmann E, 1999, ALLERGY, V54, P297, DOI 10.1034/j.1398-9995.1999.00085.x; Hogan SP, 2008, CLIN EXP ALLERGY, V38, P709, DOI 10.1111/j.1365-2222.2008.02958.x; Holgate ST, 2008, NAT REV IMMUNOL, V8, P218, DOI 10.1038/nri2262; Jordan MS, 2008, IMMUNITY, V28, P359, DOI 10.1016/j.immuni.2008.01.010; Kim HY, 2010, NAT IMMUNOL, V11, P577, DOI 10.1038/ni.1892; Labno CM, 2003, CURR BIOL, V13, P1619, DOI 10.1016/j.cub.2003.08.005; Matsushita M, 2001, J NEUROSCI, V21, P6000, DOI 10.1523/JNEUROSCI.21-16-06000.2001; Miller AT, 2004, IMMUNITY, V21, P67, DOI 10.1016/j.immuni.2004.06.009; Mueller C, 2003, J IMMUNOL, V170, P5056, DOI 10.4049/jimmunol.170.10.5056; Noguchi H, 2004, NAT MED, V10, P305, DOI 10.1038/nm994; Rothbard JB, 2000, NAT MED, V6, P1253, DOI 10.1038/81359; Schaeffer EM, 2001, NAT IMMUNOL, V2, P1183, DOI 10.1038/ni734; Stevens WW, 2007, J IMMUNOL METHODS, V327, P63, DOI 10.1016/j.jim.2007.07.011; Su YW, 1999, EUR J IMMUNOL, V29, P3702, DOI 10.1002/(SICI)1521-4141(199911)29:11<3702::AID-IMMU3702>3.0.CO;2-R; Takesono A, 2004, CURR BIOL, V14, P917, DOI 10.1016/j.cub.2004.04.011; Williams CMM, 2012, TOXICOL PATHOL, V40, P205, DOI 10.1177/0192623311430694; Yang WC, 2000, IMMUNITY, V12, P373, DOI 10.1016/S1074-7613(00)80189-2	29	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63645	10.1371/journal.pone.0063645	http://dx.doi.org/10.1371/journal.pone.0063645			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667652	Green Published, gold			2022-12-25	WOS:000319654700173
J	Marcolino-Gomes, J; Rodrigues, FA; Oliveira, MCN; Farias, JRB; Neumaier, N; Abdelnoor, RV; Marcelino-Guimaraes, FC; Nepomuceno, AL				Marcolino-Gomes, Juliana; Rodrigues, Fabiana Aparecida; Neves Oliveira, Maria Cristina; Boucas Farias, Jose Renato; Neumaier, Norman; Abdelnoor, Ricardo Vilela; Marcelino-Guimaraes, Francismar Correa; Nepomuceno, Alexandre Lima			Expression Patterns of GmAP2/EREB-Like Transcription Factors Involved in Soybean Responses to Water Deficit	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; ERF GENE FAMILY; FUNCTIONAL-ANALYSIS; DROUGHT; ARABIDOPSIS; RICE; PCR; OVEREXPRESSION; NORMALIZATION; ORGANIZATION	Soybean farming has faced several losses in productivity due to drought events in the last few decades. However, plants have molecular mechanisms to prevent and protect against water deficit injuries, and transcription factors play an important role in triggering different defense mechanisms. Understanding the expression patterns of transcription factors in response to water deficit and to environmental diurnal changes is very important for unveiling water deficit stress tolerance mechanisms. Here, we analyzed the expression patterns of ten APETALA2/Ethylene Responsive Element Binding-like (AP2/EREB-like) transcription factors in two soybean genotypes (BR16: drought-sensitive; and Embrapa 48: drought-tolerant). According to phylogenetic and domain analyses, these genes can be included in the DREB and ERF subfamilies. We also analyzed a GmDRIP-like gene that encodes a DREB negative regulator. We detected the up-regulation of 9 GmAP2/EREB-like genes and identified transcriptional differences that were dependent on the levels of the stress applied and the tissue type analyzed (the expression of the GmDREB1F-like gene, for example, was four times higher in roots than in leaves). The GmDRIP-like gene was not induced by water deficit in BR16 during the longest periods of stress, but was significantly induced in Embrapa 48; this suggests a possible genetic/molecular difference between the responses of these cultivars to water deficit stress. Additionally, RNAseq gene expression analysis over a 24-h time course indicates that the expression patterns of several GmDREB-like genes are subject to oscillation over the course of the day, indicating a possible circadian regulation.	[Marcolino-Gomes, Juliana] Univ Estadual Londrina, Dept Biol, Londrina, Brazil; [Marcolino-Gomes, Juliana; Rodrigues, Fabiana Aparecida; Neves Oliveira, Maria Cristina; Boucas Farias, Jose Renato; Neumaier, Norman; Abdelnoor, Ricardo Vilela; Marcelino-Guimaraes, Francismar Correa; Nepomuceno, Alexandre Lima] Brazilian Enterprise Agr Res Embrapa Soybean, Londrina, Brazil; [Nepomuceno, Alexandre Lima] ARS, Embrapa LABEX US Plant Biotechnol, USDA, Ctr Plant Gene Express, Albany, NY USA	Universidade Estadual de Londrina; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); United States Department of Agriculture (USDA)	Nepomuceno, AL (corresponding author), Brazilian Enterprise Agr Res Embrapa Soybean, Londrina, Brazil.	nepo@cnpso.embrapa.br	Abdelnoor, Ricardo V/F-7011-2012; Abdelnoor, Ricardo V/F-7707-2017; Neumaier, Norman/I-9545-2014; Marcelino Guimaraes, Francismar/F-9973-2017	Marcelino Guimaraes, Francismar/0000-0002-5828-7249	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [552735/2007-8]; Coordenacao de Pessoal de Nivel Superior (CAPES)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by the Brazilian agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq [http://www.cnpq.br/] Genosoja grant 552735/2007-8) and Coordenacao de Pessoal de Nivel Superior (CAPES [http://www.capes.gov.br/]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida AM, 2007, IN VITRO CELL DEV-PL, V43, P167, DOI 10.1007/s11627-006-9024-3; Almoguera C, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-75; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Baerenfaller K, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.39; Bates B, 2008, INTRO CLIMATE CHANGE; Chen M, 2009, J EXP BOT, V60, P121, DOI 10.1093/jxb/ern269; Chen M, 2007, BIOCHEM BIOPH RES CO, V353, P299, DOI 10.1016/j.bbrc.2006.12.027; do Nascimento LC, 2012, GENET MOL BIOL, V35, P203, DOI 10.1590/S1415-47572012000200002; Dong CJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-47; FEHR W. R., 1971, Crop science, V11, P929, DOI 10.2135/cropsci1971.0011183X001100060051x; Hand ML, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-94; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Hudson KA, 2010, PLANT GENOME-US, V3, P3, DOI 10.3835/plantgenome2009.08.0025; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Jiang Y, 2011, RUSS J PLANT PHYSL+, V58, P928, DOI 10.1134/S1021443711040066; Kidokoro S, 2009, PLANT PHYSIOL, V151, P2046, DOI 10.1104/pp.109.147033; Krishnaswamy S, 2011, PLANT MOL BIOL, V75, P107, DOI 10.1007/s11103-010-9711-7; Kuriakose B, 2009, PLANT SCI, V177, P390, DOI 10.1016/j.plantsci.2009.06.016; Lee YP, 2009, PLANT BIOLOGY, V11, P273, DOI 10.1111/j.1438-8677.2008.00122.x; Lin R, 2007, PHYSIOL MOL PLANT P, V70, P60, DOI 10.1016/j.pmpp.2007.06.002; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Martins PK, 2008, GENET MOL BIOL, V31, P512, DOI 10.1590/S1415-47572008000300019; Melcher K, 2009, NATURE, V462, P602, DOI 10.1038/nature08613; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Oh SJ, 2009, PLANT PHYSIOL, V150, P1368, DOI 10.1104/pp.109.137554; Oya T, 2004, PLANT PROD SCI, V7, P129, DOI 10.1626/pps.7.129; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Polizel AM, 2011, GENET MOL RES, V10, P3641, DOI 10.4238/2011.October.21.4; Qin F, 2004, PLANT CELL PHYSIOL, V45, P1042, DOI 10.1093/pcp/pch118; Qin F, 2008, PLANT CELL, V20, P1693, DOI 10.1105/tpc.107.057380; Rodrigues FA, 2012, GENET MOL BIOL, V35, P304, DOI 10.1590/S1415-47572012000200011; Sakuma Y, 2006, PLANT CELL, V18, P1292, DOI 10.1105/tpc.105.035881; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Silva EN, 2010, ENVIRON EXP BOT, V69, P279, DOI 10.1016/j.envexpbot.2010.05.001; Stolf-Moreira R, 2011, PESQUI AGROPECU BRAS, V46, P58, DOI 10.1590/S0100-204X2011000100008; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Uzilday B, 2012, PLANT SCI, V182, P59, DOI 10.1016/j.plantsci.2011.03.015; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang SC, 2009, PLANT MOL BIOL, V69, P167, DOI 10.1007/s11103-008-9414-5; Wang XM, 2010, PLANT MOL BIOL REP, V28, P664, DOI 10.1007/s11105-010-0196-y; Yamaguchi-Shinozaki K, 2005, TRENDS PLANT SCI, V10, P88, DOI 10.1016/j.tplants.2004.12.012; Zhang GY, 2009, J EXP BOT, V60, P3781, DOI 10.1093/jxb/erp214; Zhang GY, 2008, J EXP BOT, V59, P4095, DOI 10.1093/jxb/ern248; Zhuang J, 2008, BIOCHEM BIOPH RES CO, V371, P468, DOI 10.1016/j.bbrc.2008.04.087; Zhuang J, 2009, SCI HORTIC-AMSTERDAM, V123, P73, DOI 10.1016/j.scienta.2009.08.002	47	24	24	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62294	10.1371/journal.pone.0062294	http://dx.doi.org/10.1371/journal.pone.0062294			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667465	Green Published, gold, Green Submitted			2022-12-25	WOS:000319654700029
J	Rasche, L; Duell, J; Morgner, C; Chatterjee, M; Hensel, F; Rosenwald, A; Einsele, H; Topp, MS; Brandlein, S				Rasche, Leo; Duell, Johannes; Morgner, Charlotte; Chatterjee, Manik; Hensel, Frank; Rosenwald, Andreas; Einsele, Hermann; Topp, Max S.; Braendlein, Stephanie			The Natural Human IgM Antibody PAT-SM6 Induces Apoptosis in Primary Human Multiple Myeloma Cells by Targeting Heat Shock Protein GRP78	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; CLINICAL-TRIAL; STRESS INDUCTION; PROSTATE-CANCER; EXPRESSION; SURVIVAL; THERAPY; CYTOTOXICITY; CHAPERONE; ACTIVATION	In contrast to other haematological malignancies, targeted immunotherapy has not entered standard treatment regimens for de novo or relapsed multiple myeloma (MM) yet. While a number of IgG-formatted monoclonal antibodies are currently being evaluated in clinical trials in MM, our study aimed to investigate whether the fully human IgM monoclonal antibody PAT-SM6 that targets a tumour-specific variant of the heat shock protein GRP78 might be an attractive candidate for future immunotherapeutic approaches. We here show that GRP78 is stably and consistently expressed on the surface on tumour cells from patients with de novo, but also relapsed MM and that binding of PAT-SM6 to MM cells can specifically exert cytotoxic effects on malignant plasma cells, whereas non-malignant cells are not targeted. We demonstrate that the induction of apoptosis and, to a lesser extent, complement dependent cytotoxicity is the main mode of action of PAT-SM6, whereas antibody dependent cellular cytotoxicity does not appear to contribute to the cytotoxic properties of this antibody. Given the favourable safety profile of PAT-SM6 in monkeys, but also in a recent phase I trial in patients with malignant melanoma, our results form the basis for a planned phase I study in patients with relapsed MM.	[Rasche, Leo; Duell, Johannes; Einsele, Hermann; Topp, Max S.] Univ Hosp Wurzburg, Dept Internal Med 2, Wurzburg, Germany; [Morgner, Charlotte; Rosenwald, Andreas; Braendlein, Stephanie] Univ Wurzburg, Inst Pathol, Wurzburg, Germany; [Chatterjee, Manik] Comprehens Canc Ctr Mainfranken, Wurzburg, Germany; [Hensel, Frank] Patrys GmbH, Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg	Brandlein, S (corresponding author), Univ Wurzburg, Inst Pathol, Josef Schneider Str 2, Wurzburg, Germany.	stephanie.braendlein@uni-wuerzburg.de			IZKF Wuerzburg Erstantragstellerprogramm [Z-3/15]; Deutsche Forschungsgemeinschaft (DFG) [KFO 216]; Patrys Ltd, Australia	IZKF Wuerzburg Erstantragstellerprogramm; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Patrys Ltd, Australia	LR was supported by IZKF Wuerzburg Erstantragstellerprogramm (Projekt Z-3/15) and the Deutsche Forschungsgemeinschaft (DFG) (KFO 216). This work was supported by research funding from Patrys Ltd, Australia, a company currently conducting clinical trials of PAT-SM6 as a potential anti-cancer treatment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KC, 2011, HEMATOL-AM SOC HEMAT, P184, DOI 10.1182/asheducation-2011.1.184; Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; Brandlein S, 2003, CANCER RES, V63, P7995; Brandlein S, 2007, MOL CANCER THER, V6, P326, DOI 10.1158/1535-7163.MCT-06-0399; Brocke-Heidrich K, 2004, BLOOD, V103, P242, DOI 10.1182/blood-2003-04-1048; Chanan-Khan AA, 2010, J CLIN ONCOL, V28, P2612, DOI 10.1200/JCO.2009.25.4250; Chatterjee M, 2007, BLOOD, V109, P720, DOI 10.1182/blood-2006-05-024372; Daneshmand S, 2007, HUM PATHOL, V38, P1547, DOI 10.1016/j.humpath.2007.03.014; Davenport EL, 2007, BLOOD, V110, P2641, DOI 10.1182/blood-2006-11-053728; de Weers M, 2011, J IMMUNOL, V186, P1840, DOI 10.4049/jimmunol.1003032; Derkx B, 1999, CLIN INFECT DIS, V28, P770, DOI 10.1086/515184; Feldman DE, 2005, MOL CANCER RES, V3, P597, DOI 10.1158/1541-7786.MCR-05-0221; Gerritsen AF, 2010, J IMMUNOL METHODS, V352, P140, DOI 10.1016/j.jim.2009.10.009; Gonzalez-Gronow M, 2006, CANCER RES, V66, P11424, DOI 10.1158/0008-5472.CAN-06-1721; Hendershot LM, 2004, MT SINAI J MED, V71, P289; Irie RF, 2004, CANCER IMMUNOL IMMUN, V53, P110, DOI 10.1007/s00262-003-0436-1; Kumar SK, 2008, BLOOD, V111, P2516, DOI 10.1182/blood-2007-10-116129; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Li JZ, 2006, CURR MOL MED, V6, P45, DOI 10.2174/156652406775574523; MacMillan ML, 2007, BLOOD, V109, P2657, DOI 10.1182/blood-2006-08-013995; MASHIMA T, 1995, BIOCHEM BIOPH RES CO, V209, P907, DOI 10.1006/bbrc.1995.1584; Misra UK, 2004, CELL SIGNAL, V16, P929, DOI 10.1016/j.cellsig.2004.01.003; Mitsiades CS, 2006, BLOOD, V107, P1092, DOI 10.1182/blood-2005-03-1158; Mossner E, 2010, BLOOD, V115, P4393, DOI 10.1182/blood-2009-06-225979; MORDOH J, 1995, J IMMUNOTHER, V17, P151, DOI 10.1097/00002371-199504000-00004; Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442; Pohle T, 2004, CANCER RES, V64, P3900, DOI 10.1158/0008-5472.CAN-03-3149; PRICOP L, 1993, J IMMUNOL, V151, P3018; RANDALL TD, 1992, P NATL ACAD SCI USA, V89, P962, DOI 10.1073/pnas.89.3.962; Rauschert N, 2008, LAB INVEST, V88, P375, DOI 10.1038/labinvest.2008.2; Richardson PG, 2011, BRIT J HAEMATOL, V154, P745, DOI 10.1111/j.1365-2141.2011.08790.x; Sawada R, 2011, CLIN CANCER RES, V17, P1024, DOI 10.1158/1078-0432.CCR-10-2640; Stuhmer T, 2010, BRIT J HAEMATOL, V149, P529, DOI 10.1111/j.1365-2141.2010.08126.x; Tai YT, 2008, BLOOD, V112, P1329, DOI 10.1182/blood-2007-08-107292; Tchoudakova A, 2009, MABS, V1, P163, DOI 10.4161/mabs.1.2.7945; Valasek CCJ, 2011, BIOPROCESS INT, V9, P28; van de Donk NWCJ, 2012, LEUKEMIA, V26, P199, DOI 10.1038/leu.2011.214; Weiner LM, 2009, LANCET, V373, P1033, DOI 10.1016/S0140-6736(09)60251-8; Yang J, 2011, AM J BLOOD RES, V1, P22; Zhang Y, 2010, J BIOL CHEM, V285, P15065, DOI 10.1074/jbc.M109.087445	41	47	47	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63414	10.1371/journal.pone.0063414	http://dx.doi.org/10.1371/journal.pone.0063414			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667612	Green Published, gold, Green Submitted			2022-12-25	WOS:000319654700140
J	Richardson, TG; Thomas, EC; Sessions, RB; Lawlor, DA; Tavare, JM; Day, INM				Richardson, Tom G.; Thomas, Elaine C.; Sessions, Richard B.; Lawlor, Debbie A.; Tavare, Jeremy M.; Day, Ian N. M.			Structural and Population-Based Evaluations of TBC1D1 p.Arg125Trp	PLOS ONE			English	Article							TRANSMISSION DISEQUILIBRIUM TEST; BODY-MASS INDEX; LINKAGE DISEQUILIBRIUM; TRANSMISSION/DISEQUILIBRIUM TEST; STRUCTURE PREDICTION; PROTEIN-STRUCTURE; GASTRIC BYPASS; SEVERE OBESITY; I-TASSER; INSULIN	Obesity is now a leading cause of preventable death in the industrialised world. Understanding its genetic influences can enhance insight into molecular pathogenesis and potential therapeutic targets. A non-synonymous polymorphism (rs35859249, p.Arg125Trp) in the N-terminal TBC1D1 phosphotyrosine-binding (PTB) domain has shown a replicated association with familial obesity in women. We investigated these findings in the Avon Longitudinal Study of Parents and Children (ALSPAC), a large European birth cohort of mothers and offspring, and by generating a predicted model of the structure of this domain. Structural prediction involved the use of three separate algorithms; Robetta, HHpred/MODELLER and I-TASSER. We used the transmission disequilibrium test (TDT) to investigate familial association in the ALSPAC study cohort (N = 2,292 mother-offspring pairs). Linear regression models were used to examine the association of genotype with mean measurements of adiposity (Body Mass Index (BMI), waist circumference and Dual-energy X-ray absorptiometry (DXA) assessed fat mass), and logistic regression was used to examine the association with odds of obesity. Modelling showed that the R125W mutation occurs in a location of the TBC1D1 PTB domain that is predicted to have a function in a putative protein: protein interaction. We did not detect an association between R125W and BMI (mean per allele difference 0.27 kg/m(2) (95% Confidence Interval: 0.00, 0.53) P = 0.05) or obesity (odds ratio 1.01 (95% Confidence Interval: 0.77, 1.31, P = 0.96) in offspring after adjusting for multiple comparisons. Furthermore, there was no evidence to suggest that there was familial association between R125W and obesity (chi(2) = 0.06, P = 0.80). Our analysis suggests that R125W in TBC1D1 plays a role in the binding of an effector protein, but we find no evidence that the R125W variant is related to mean BMI or odds of obesity in a general population sample.	[Richardson, Tom G.; Day, Ian N. M.] Univ Bristol, Bristol Genet Epidemiol Labs, Sch Social & Community Med, Bristol, Avon, England; [Thomas, Elaine C.; Sessions, Richard B.; Tavare, Jeremy M.] Univ Bristol, Sch Biochem, Bristol, Avon, England; [Lawlor, Debbie A.; Day, Ian N. M.] Univ Bristol, MRC Ctr Causal Anal Translat Epidemiol CAiTE, Sch Social & Community Med, Bristol, Avon, England	University of Bristol; University of Bristol; University of Bristol	Richardson, TG (corresponding author), Univ Bristol, Bristol Genet Epidemiol Labs, Sch Social & Community Med, Oakfield House, Bristol, Avon, England.	Tom.G.Richardson@bristol.ac.uk		Richardson, Tom/0000-0002-7918-2040; Lawlor, Debbie A/0000-0002-6793-2262; Sessions, Richard/0000-0003-0320-0895; Thomas, Elaine/0000-0002-9435-3653	British Heart Foundation [PG/10/008]; Wellcome Trust [092731]; MRC [MC_UU_12013/5] Funding Source: UKRI; British Heart Foundation [PG/10/008/28186] Funding Source: researchfish; Medical Research Council [1170461, MC_UU_12013/5, G9815508] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the British Heart Foundation (Ref: PG/10/008). The UK Medical Research Council and the Wellcome Trust (Grant ref: 092731) and the University of Bristol provide core support for ALSPAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. TR is a UK MRC PhD student.	Adams TD, 2005, CONTEMP CLIN TRIALS, V26, P534, DOI 10.1016/j.cct.2005.05.003; An D, 2010, DIABETES, V59, P1358, DOI 10.2337/db09-1266; Balding DJ, 2007, HDB STAT GENETICS, V1, P1271; Bonferroni C., 1936, PUBBL R 1 SUPER SCI, V8, P3; Chadt A, 2008, NAT GENET, V40, P1354, DOI 10.1038/ng.244; Chen SA, 2008, BIOCHEM J, V409, P449, DOI 10.1042/BJ20071114; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; CURTIS D, 1995, AM J HUM GENET, V56, P811; DiNitto JP, 2006, BBA-MOL CELL BIOL L, V1761, P850, DOI 10.1016/j.bbalip.2006.04.008; Dudbridge F, 2000, AM J HUM GENET, V66, P2009, DOI 10.1086/302915; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Forman-Kay JD, 1999, CURR OPIN STRUC BIOL, V9, P690, DOI 10.1016/S0959-440X(99)00031-7; Fraser A, 2013, INT J EPIDEMIOL, V42, P97, DOI 10.1093/ije/dys066; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Gordon D, 2004, EUR J HUM GENET, V12, P752, DOI 10.1038/sj.ejhg.5201219; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Koumanov F, 2011, J BIOL CHEM, V286, P16574, DOI 10.1074/jbc.M111.226092; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; Loos RJF, 2003, J INTERN MED, V254, P401, DOI 10.1046/j.1365-2796.2003.01242.x; Meyre D, 2008, HUM MOL GENET, V17, P1798, DOI 10.1093/hmg/ddn070; Morton NE, 1998, P NATL ACAD SCI USA, V95, P11389, DOI 10.1073/pnas.95.19.11389; Pehmoller C, 2009, AM J PHYSIOL-ENDOC M, V297, pE665, DOI 10.1152/ajpendo.00115.2009; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Risch N, 1998, GENOME RES, V8, P1273, DOI 10.1101/gr.8.12.1273; Roach WG, 2007, BIOCHEM J, V403, P353, DOI 10.1042/BJ20061798; Rodriguez S, 2009, AM J EPIDEMIOL, V169, P505, DOI 10.1093/aje/kwn359; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Sebastiani P, 2004, GENETICS, V168, P2329, DOI 10.1534/genetics.103.025841; Smith EM, 2006, GENOMICS, V88, P407, DOI 10.1016/j.ygeno.2006.04.004; SMITH SC, 1995, OBES SURG, V5, P314, DOI 10.1381/096089295765557700; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Stone S, 2002, AM J HUM GENET, V70, P1459, DOI 10.1086/340670; Stone S, 2006, HUM MOL GENET, V15, P2709, DOI 10.1093/hmg/ddl204; STUNKARD AJ, 1986, JAMA-J AM MED ASSOC, V256, P51, DOI 10.1001/jama.256.1.51; STUNKARD AJ, 1990, NEW ENGL J MED, V322, P1483, DOI 10.1056/NEJM199005243222102; Sun FZ, 1999, AM J EPIDEMIOL, V150, P97; Taylor EB, 2008, J BIOL CHEM, V283, P9787, DOI 10.1074/jbc.M708839200; Thusberg J, 2011, HUM MUTAT, V32, P358, DOI 10.1002/humu.21445; WILLIAMS RR, 1988, AM J PUBLIC HEALTH, V78, P1283, DOI 10.2105/AJPH.78.10.1283; Wormser D, 2011, LANCET, V377, P1085, DOI 10.1016/S0140-6736(11)60105-0; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702; Zhou MM, 1996, NAT STRUCT BIOL, V3, P388, DOI 10.1038/nsb0496-388	47	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63897	10.1371/journal.pone.0063897	http://dx.doi.org/10.1371/journal.pone.0063897			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667688	Green Published, Green Submitted, gold			2022-12-25	WOS:000319654700194
J	Roy, C; Gupta, A; Fisette, A; Lapointe, M; Poursharifi, P; Richard, D; Lu, HL; Lu, B; Gerard, N; Gerard, C; Cianflone, K				Roy, Christian; Gupta, Abhishek; Fisette, Alexandre; Lapointe, Marc; Poursharifi, Pegah; Richard, Denis; Lu, HuiLing; Lu, Bao; Gerard, Norma; Gerard, Craig; Cianflone, Katherine			C5a Receptor Deficiency Alters Energy Utilization and Fat Storage	PLOS ONE			English	Article							ADIPOSE-TISSUE; CHEMOATTRACTANT RECEPTOR; INSULIN-RESISTANCE; COMPLEMENT; C5L2; ADIPOCYTE; PROTEIN; SYSTEM; INFLAMMATION; EXPRESSION	Objective: To investigate the impact of whole body C5a receptor (C5aR) deficiency on energy metabolism and fat storage. Design: Male wildtype (WT) and C5aR knockout (C5aRKO) mice were fed a low fat (CHOW) or a high fat high sucrose diet-induced obesity (DIO) diet for 14 weeks. Body weight and food intake were measured weekly. Indirect calorimetry, dietary fatload clearance, insulin and glucose tolerance tests were also evaluated. Liver, muscle and adipose tissue mRNA gene expression were measured by RT-PCR. Results: At week one and 12, C5aRKO mice on DIO had increased oxygen consumption. After 12 weeks, although food intake was comparable, C5aRKO mice had lower body weight (-7% CHOW, -12% DIO) as well as smaller gonadal (-38% CHOW, -36% DIO) and inguinal (-29% CHOW, -30% DIO) fat pads than their WT counterparts. Conversely, in WT mice, C5aR was upregulated in DIO vs CHOW diets in gonadal adipose tissue, muscle and liver, while C5L2 mRNA expression was lower in C5aRKO on both diet. Furthermore, blood analysis showed lower plasma triglyceride and non-esterified fatty acid levels in both C5aRKO groups, with faster postprandial triglyceride clearance after a fatload. Additionally, C5aRKO mice showed lower CD36 expression in gonadal and muscle on both diets, while DGAT1 expression was higher in gonadal (CHOW) and liver (CHOW and DIO) and PPAR gamma was increased in muscle and liver. Conclusion: These observations point towards a role (either direct or indirect) for C5aR in energy expenditure and fat storage, suggesting a dual role for C5aR in metabolism as well as in immunity.	[Roy, Christian; Gupta, Abhishek; Fisette, Alexandre; Lapointe, Marc; Poursharifi, Pegah; Richard, Denis; Lu, HuiLing; Cianflone, Katherine] Univ Laval, Ctr Rech, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Lu, Bao; Gerard, Norma; Gerard, Craig] Harvard Univ, Childrens Hosp, Sch Med, Ina Sue Perlmutter Lab, Boston, MA 02115 USA	Laval University; Harvard University; Boston Children's Hospital; Harvard Medical School	Cianflone, K (corresponding author), Univ Laval, Ctr Rech, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada.	katherine.cianflone@criucpq.ulaval.ca	Poursharifi, Pegah/K-4420-2019	Poursharifi, Pegah/0000-0002-7804-4359; Fisette, Alexandre/0000-0002-0466-0845; Lapointe, Marc/0000-0003-0461-2576	CIHR (Canadian Institutes of Health Research) [77532]; CIHR-HOPE fellowship	CIHR (Canadian Institutes of Health Research)(Canadian Institutes of Health Research (CIHR)); CIHR-HOPE fellowship	Funding for this study was provided by a grant from CIHR (Canadian Institutes of Health Research www.cihr-irsc.gc.ca/) #77532 to KC. KC holds a Canada Research Chair in Adipose Tissue. CR and AF are both supported by CIHR doctoral fellowships. AG is supported by a CIHR-HOPE fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamberg CE, 2010, J BIOL CHEM, V285, P7633, DOI 10.1074/jbc.M109.092106; Cain SA, 2002, J BIOL CHEM, V277, P7165, DOI 10.1074/jbc.C100714200; Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113; Cui W, 2009, MOL IMMUNOL, V46, P3207, DOI 10.1016/j.molimm.2009.08.013; Fisette A, 2013, IMMUNOBIOLOGY, V218, P127, DOI 10.1016/j.imbio.2012.04.001; FLIER JS, 1989, RECENT PROG HORM RES, V45, P567; Fruhbeck G, 2001, AM J PHYSIOL-ENDOC M, V280, pE827, DOI 10.1152/ajpendo.2001.280.6.E827; Gao HW, 2005, FASEB J, V19, P1003, DOI 10.1096/fj.04-3424fje; Gauvreau D, 2012, MOL IMMUNOL, V51, P73, DOI 10.1016/j.molimm.2012.02.110; Gavrilyuk V, 2005, J NEUROCHEM, V92, P1140, DOI 10.1111/j.1471-4159.2004.02942.x; Gerard NP, 2005, J BIOL CHEM, V280, P39677, DOI 10.1074/jbc.C500287200; Hopken UE, 1996, NATURE, V383, P86, DOI 10.1038/383086a0; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Iyer A, 2010, NAT REV ENDOCRINOL, V6, P71, DOI 10.1038/nrendo.2009.264; Lim J, 2013, FASEB J, V27, P822, DOI 10.1096/fj.12-220582; Mamane Y, 2009, DIABETES, V58, P2006, DOI 10.2337/db09-0323; Moreno-Navarrete JM, 2010, DIABETES, V59, P200, DOI 10.2337/db09-0700; Markiewski MM, 2007, AM J PATHOL, V171, P715, DOI 10.2353/ajpath.2007.070166; Maslowska M, 2006, J LIPID RES, V47, P643, DOI 10.1194/jlr.M500500-JLR200; Maslowska M, 2005, VITAM HORM, V70, P309, DOI 10.1016/S0083-6729(05)70010-8; MCLEAN RH, 1980, HUM HERED, V30, P149, DOI 10.1159/000153119; Monk PN, 2007, BRIT J PHARMACOL, V152, P429, DOI 10.1038/sj.bjp.0707332; Muscari A, 2007, DIABETES CARE, V30, P2362, DOI 10.2337/dc07-0637; Nataf S, 1999, TRENDS NEUROSCI, V22, P397, DOI 10.1016/S0166-2236(98)01390-3; O'Barr SA, 2001, J IMMUNOL, V166, P4154, DOI 10.4049/jimmunol.166.6.4154; Ohno M, 2000, MOL IMMUNOL, V37, P407, DOI 10.1016/S0161-5890(00)00067-5; Okinaga S, 2003, BIOCHEMISTRY-US, V42, P9406, DOI 10.1021/bi034489v; Paglialunga S, 2008, AM J PHYSIOL-ENDOC M, V294, pE521, DOI 10.1152/ajpendo.00590.2007; Paglialunga S, 2007, J ENDOCRINOL, V194, P293, DOI 10.1677/JOE-07-0205; Pattrick M, 2009, MOL IMMUNOL, V46, P755, DOI 10.1016/j.molimm.2008.09.013; Persson L, 2004, ARTERIOSCL THROM VAS, V24, P1062, DOI 10.1161/01.ATV.0000127302.24266.40; Poursharifi P, 2013, CELL SIGNAL, V25, P910, DOI 10.1016/j.cellsig.2012.12.010; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rittirsch D, 2008, NAT MED, V14, P551, DOI 10.1038/nm1753; Roy C, 2008, AM J PHYSIOL-ENDOC M, V294, pE1051, DOI 10.1152/ajpendo.00689.2007; Roy C, 2011, AM J PHYSIOL-ENDOC M, V301, pE232, DOI 10.1152/ajpendo.00476.2010; Schaffaler A, 2010, TRENDS IMMUNOL, V31, P228, DOI 10.1016/j.it.2010.03.001; Scola AM, 2009, MOL IMMUNOL, V46, P1149, DOI 10.1016/j.molimm.2008.11.001; SISSONS JGP, 1976, NEW ENGL J MED, V294, P461, DOI 10.1056/NEJM197602262940902; Tokodai K, 2011, TRANSPL P, V43, P3179, DOI 10.1016/j.transproceed.2011.10.006; VOGT W, 1986, Complement, V3, P177; Ward PA, 2004, NAT REV IMMUNOL, V4, P133, DOI 10.1038/nri1269; WILLIAMS CA, 1985, J NEUROIMMUNOL, V9, P29, DOI 10.1016/S0165-5728(85)80004-7; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Yuan J, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3873	46	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62531	10.1371/journal.pone.0062531	http://dx.doi.org/10.1371/journal.pone.0062531			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667486	gold, Green Published, Green Submitted			2022-12-25	WOS:000319654700044
J	Shen, ML; Zhou, TT; Xie, WB; Ling, T; Zhu, QY; Zong, L; Lyu, GL; Gao, QQ; Zhang, FX; Tao, W				Shen, Meili; Zhou, Tingting; Xie, Wenbing; Ling, Te; Zhu, Qiaoyun; Zong, Le; Lyu, Guoliang; Gao, Qianqian; Zhang, Feixiong; Tao, Wei			The Chromatin Remodeling Factor CSB Recruits Histone Acetyltransferase PCAF to rRNA Gene Promoters in Active State for Transcription Initiation	PLOS ONE			English	Article							POLYMERASE-I TRANSCRIPTION; GROUP-B PROTEIN; COCKAYNE-SYNDROME; COUPLING FACTOR; DNA-DAMAGE; REPAIR; COMPLEX; ACETYLATION; BROMODOMAIN; BINDING	The promoters of poised rRNA genes (rDNA) are marked by both euchromatic and heterochromatic histone modifications and are associated with two transcription factors, UBF and SL1 that nucleate transcription complex formation. Active rRNA genes contain only euchromatic histone modifications and are loaded with all components of transcriptional initiation complex including RNA polymerase I. Coupled with histone acetylation and RNA polymerase I targeting, poised promoters can be converted to active ones by ATP-dependent chromatin remodeling factor CSB for initiation of rDNA transcription. However, it is not clear how dynamic histone modifications induce the assembly of polymerase I transcription initiation complex to active promoters during such conversion. Here we show that a complex consisting of CSB, RNA polymerase I and histone acetyltransferase PCAF is present at the rDNA promoters in active state. CSB is required for the association of PCAF with rDNA, which induces acetylation of histone H4 and histone H3K9. Overexpression of CSB promotes the association of PCAF with rDNA. Knockdown of PCAF leads to decreased levels of H4ac and H3K9ac at rDNA promoters, prevents the association of RNA polymerase I and inhibits pre-rRNA synthesis. The results demonstrate that CSB recruits PCAF to rDNA, which allows histone acetylation that is required for the assembly of polymerase I transcription initiation complex during the transition from poised to active state of rRNA genes, suggesting that CSB and PCAF play cooperative roles to establish the active state of rRNA genes by histone acetylation.	[Shen, Meili; Zhou, Tingting; Xie, Wenbing; Ling, Te; Zhu, Qiaoyun; Zong, Le; Lyu, Guoliang; Gao, Qianqian; Tao, Wei] Peking Univ, Key Lab Cell Proliferat & Differentiat, Natl Key Lab Prot Engn & Plant Gene Engn, Coll Life Sci, Beijing 100871, Peoples R China; [Ling, Te; Zhang, Feixiong] Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China	Peking University; Capital Normal University	Tao, W (corresponding author), Peking Univ, Key Lab Cell Proliferat & Differentiat, Natl Key Lab Prot Engn & Plant Gene Engn, Coll Life Sci, Beijing 100871, Peoples R China.	weitao@pku.edu.cn	tao, wei/GXN-4445-2022; Xie, Wenbing/J-7962-2014; Xie, Wenbing/AAD-5987-2019	Xie, Wenbing/0000-0003-2546-2415; Xie, Wenbing/0000-0003-2546-2415; Ling, Te/0000-0002-0315-2662	National Natural Science Foundation of China (NSFC) [30871377, 31171255, 30971453, 91219101, 31071116]; National Basic Research Program of China (973 Program) [2013CB530700]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	Work in WT lab was supported by the National Natural Science Foundation of China (NSFC, grant #30871377, 31171255, 30971453, 91219101 and 31071116) and the National Basic Research Program of China (973 Program, Grant No. 2013CB530700. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awad S, 2008, ANN NY ACAD SCI, V1138, P366, DOI 10.1196/annals.1414.038; Bradsher J, 2002, MOL CELL, V10, P819, DOI 10.1016/S1097-2765(02)00678-0; Carrozza MJ, 2003, TRENDS GENET, V19, P321, DOI 10.1016/S0168-9525(03)00115-X; Chen DY, 2004, P NATL ACAD SCI USA, V101, P15106, DOI 10.1073/pnas.0404767101; Citterio E, 2000, MOL CELL BIOL, V20, P7643, DOI 10.1128/MCB.20.20.7643-7653.2000; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Hirschler-Laszkiewicz I, 2001, NUCLEIC ACIDS RES, V29, P4114, DOI 10.1093/nar/29.20.4114; Inari A, 2004, J BIOL CHEM, V279, P30830, DOI 10.1074/jbc.M402403200; Korzus E, 1998, SCIENCE, V279, P703, DOI 10.1126/science.279.5351.703; Laine JP, 2006, TRENDS GENET, V22, P430, DOI 10.1016/j.tig.2006.06.006; Liu L, 1999, MOL CELL BIOL, V19, P1202; McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259; Moss T, 2004, CURR OPIN GENET DEV, V14, P210, DOI 10.1016/j.gde.2004.02.005; Mujtaba S, 2002, MOL CELL, V9, P575, DOI 10.1016/S1097-2765(02)00483-5; Muth V, 2001, EMBO J, V20, P1353, DOI 10.1093/emboj/20.6.1353; Newman JC, 2006, P NATL ACAD SCI USA, V103, P9613, DOI 10.1073/pnas.0510909103; Pazin MJ, 1997, CELL, V88, P737, DOI 10.1016/S0092-8674(00)81918-2; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Russell J, 2006, BIOCHEM SOC SYMP, V73, P203; Santoro R, 2001, MOL CELL, V8, P719, DOI 10.1016/S1097-2765(01)00317-3; Selby CP, 1997, P NATL ACAD SCI USA, V94, P11205, DOI 10.1073/pnas.94.21.11205; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Tantin D, 1997, MOL CELL BIOL, V17, P6803, DOI 10.1128/MCB.17.12.6803; VENEMA J, 1990, P NATL ACAD SCI USA, V87, P4707, DOI 10.1073/pnas.87.12.4707; VetteseDadey M, 1996, EMBO J, V15, P2508, DOI 10.1002/j.1460-2075.1996.tb00608.x; Vintermist A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019184; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Xie WB, 2012, P NATL ACAD SCI USA, V109, P8161, DOI 10.1073/pnas.1201262109; Yu AD, 2000, MOL CELL, V5, P801, DOI 10.1016/S1097-2765(00)80320-2; Yuan XJ, 2007, MOL CELL, V27, P585, DOI 10.1016/j.molcel.2007.06.021; Zhou YG, 2002, EMBO J, V21, P4632, DOI 10.1093/emboj/cdf460	32	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62668	10.1371/journal.pone.0062668	http://dx.doi.org/10.1371/journal.pone.0062668			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667505	gold, Green Published, Green Submitted			2022-12-25	WOS:000319654700053
J	Thompson, RC; Vardinogiannis, I; Gilmore, TD				Thompson, Ryan C.; Vardinogiannis, Iosif; Gilmore, Thomas D.			The Sensitivity of Diffuse Large B-Cell Lymphoma Cell Lines to Histone Deacetylase Inhibitor-Induced Apoptosis Is Modulated by BCL-2 Family Protein Activity	PLOS ONE			English	Article							SUBEROYLANILIDE HYDROXAMIC ACID; NF-KAPPA-B; BH3 MIMETIC ABT-737; IN-VITRO; REVERSIBLE ACETYLATION; FRAMESHIFT MUTATIONS; EXPRESSION; MCL-1; GENE; VORINOSTAT	Background: Diffuse large B-cell lymphoma (DLBCL) is a genetically heterogeneous disease and this variation can often be used to explain the response of individual patients to chemotherapy. One cancer therapeutic approach currently in clinical trials uses histone deacetylase inhibitors (HDACi's) as monotherapy or in combination with other agents. Methodology/Principal Findings: We have used a variety of cell-based and molecular/biochemical assays to show that two pan-HDAC inhibitors, trichostatin A and vorinostat, induce apoptosis in seven of eight human DLBCL cell lines. Consistent with previous reports implicating the BCL-2 family in regulating HDACi-induced apoptosis, ectopic over-expression of anti-apoptotic proteins BCL-2 and BCL-XL or pro-apoptotic protein BIM in these cell lines conferred further resistance or sensitivity, respectively, to HDACi treatment. Additionally, BCL-2 family antgonist ABT-737 increased the sensitivity of several DLBCL cell lines to vorinostat-induced apoptosis, including one cell line (SUDHL6) that is resistant to vorinostat alone. Moreover, two variants of the HDACi-sensitive SUDHL4 cell line that have decreased sensitivity to vorinostat showed up-regulation of BCL-2 family anti-apoptotic proteins such as BCL-XL and MCL-1, as well as decreased sensitivity to ABT-737. These results suggest that the regulation and overall balance of anti- to pro-apoptotic BCL-2 family protein expression is important in defining the sensitivity of DLBCL to HDACi-induced apoptosis. However, the sensitivity of DLBCL cell lines to HDACi treatment does not correlate with expression of any individual BCL-2 family member. Conclusions/Significance: These studies indicate that the sensitivity of DLBCL to treatment with HDACi's is dependent on the complex regulation of BCL-2 family members and that BCL-2 antagonists may enhance the response of a subset of DLBCL patients to HDACi treatment.	[Thompson, Ryan C.; Vardinogiannis, Iosif; Gilmore, Thomas D.] Boston Univ, Dept Biol, Boston, MA 02215 USA	Boston University	Gilmore, TD (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.	gilmore@bu.edu			NIH grant [CA047763]; ARRA supplement [CA047763-21S3]; NHLBI Hematology Training Grant [T32 HL007501]; NATIONAL CANCER INSTITUTE [R29CA047763, R01CA047763] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007501] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARRA supplement; NHLBI Hematology Training Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by NIH grant CA047763 and ARRA supplement CA047763-21S3 (both to T.D.G.). R.C.T. was partially supported by NHLBI Hematology Training Grant T32 HL007501. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Allaman-Pillet N, 2011, OPHTHALMIC IN PRESS; Bhattacharya S, 2005, BIOCHEM J, V392, P335, DOI 10.1042/BJ20050465; Bodo J, 2011, APOPTOSIS, V16, P914, DOI 10.1007/s10495-011-0617-x; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Brimmell M, 1998, ONCOGENE, V16, P1803, DOI 10.1038/sj.onc.1201704; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chen S, 2007, CANCER RES, V67, P782, DOI 10.1158/0008-5472.CAN-06-3964; Chen SW, 2009, J ELECTRON MATER, V38, P1, DOI 10.1007/s11664-008-0572-7; Chen Zu-jin, 2011, Zhonghua Zhong Liu Za Zhi, V33, P891; Chin M, 2009, ONCOGENE, V28, P2100, DOI 10.1038/onc.2009.74; Cotto M, 2010, CLIN TRANSL ONCOL, V12, P401, DOI 10.1007/s12094-010-0527-3; Crump M, 2008, ANN ONCOL, V19, P964, DOI 10.1093/annonc/mdn031; Dalgard CL, 2008, CLIN CANCER RES, V14, P3113, DOI 10.1158/1078-0432.CCR-07-4836; Dasmahapatra G, 2010, BLOOD, V115, P4478, DOI 10.1182/blood-2009-12-257261; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Debien E, 2011, CLIN EPIGENETICS, V2, P369, DOI 10.1007/s13148-011-0035-5; Ding BB, 2008, BLOOD, V111, P1515, DOI 10.1182/blood-2007-04-087734; Faber AC, 2011, CANCER DISCOV, V1, P352, DOI 10.1158/2159-8290.CD-11-0106; Faber AC, 2009, P NATL ACAD SCI USA, V106, P19503, DOI 10.1073/pnas.0905056106; Fang H, 2011, CLIN CANCER RES, V17, P7093, DOI 10.1158/1078-0432.CCR-11-0578; Fantin VR, 2008, CANCER RES, V68, P3785, DOI 10.1158/0008-5472.CAN-07-6091; Fitzgerald DJ, 2011, LEUKEMIA LYMPHOMA, V52, P79, DOI 10.3109/10428194.2011.569961; Garbati MR, 2011, CANCER LETT, V302, P76, DOI 10.1016/j.canlet.2010.12.018; Gilmore TD, 2003, VIROLOGY, V316, P9, DOI 10.1016/S0042-6822(03)00562-2; Gupta M, 2012, LEUKEMIA, V26, P1356, DOI 10.1038/leu.2011.340; Henderson C, 2003, J BIOL CHEM, V278, P12579, DOI 10.1074/jbc.M213093200; Hrzenjak A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-49; Hunt KE, 2008, ARCH PATHOL LAB MED, V132, P118, DOI 10.1043/1543-2165(2008)132[118:DLBL]2.0.CO;2; Ishitsuka K, 2012, CANCER LETT, V317, P218, DOI 10.1016/j.canlet.2011.11.030; Jing H, 2011, GENE DEV, V25, P2137, DOI 10.1101/gad.17620611; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Leonard JP, 2008, SEMIN HEMATOL, V45, pS11, DOI 10.1053/j.seminhematol.2008.07.004; Longe HO, 2009, INT J CANCER, V124, P473, DOI 10.1002/ijc.23946; Mestre-Escorihuela C, 2007, BLOOD, V109, P271, DOI 10.1182/blood-2006-06-026500; Mohammad RM, 2007, CLIN CANCER RES, V13, P2226, DOI 10.1158/1078-0432.CCR-06-1574; Moore VD, 2007, J CLIN INVEST, V117, P112, DOI 10.1172/JCI28281; Morales AA, 2011, BLOOD, V118, P1329, DOI 10.1182/blood-2011-01-327197; Morales JC, 2010, CANCER LETT, V297, P91, DOI 10.1016/j.canlet.2010.04.029; Nusinzon I, 2003, P NATL ACAD SCI USA, V100, P14742, DOI 10.1073/pnas.2433987100; O'Connor OA, 2006, J CLIN ONCOL, V24, P166, DOI 10.1200/JCO.2005.01.9679; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Paoluzzi L, 2008, BLOOD, V112, P2906, DOI 10.1182/blood-2007-12-130781; Pasqualucci L, 2011, NATURE, V471, P189, DOI 10.1038/nature09730; Pitts TM, 2009, MOL CANCER THER, V8, P342, DOI 10.1158/1535-7163.MCT-08-0534; Rampino N, 1997, SCIENCE, V275, P967, DOI 10.1126/science.275.5302.967; Ribble D, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-12; Risberg K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024012; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Sakajiri S, 2005, EXP HEMATOL, V33, P53, DOI 10.1016/j.exphem.2004.09.008; Sevilla L, 2001, HISTOL HISTOPATHOL, V16, P595, DOI 10.14670/HH-16.595; Shamas-Din A, 2011, BBA-MOL CELL RES, V1813, P508, DOI 10.1016/j.bbamcr.2010.11.024; Strasser A, 2011, EMBO J, V30, P3667, DOI 10.1038/emboj.2011.307; Sturm I, 2006, CELL DEATH DIFFER, V13, P619, DOI 10.1038/sj.cdd.4401782; Thompson RC, 2011, J BIOL CHEM, V286, P1675, DOI 10.1074/jbc.M110.177063; Tsutsui M, 2010, INT J LAB HEMATOL, V32, P419, DOI 10.1111/j.1751-553X.2009.01204.x; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Walensky LD, 2011, TRENDS BIOCHEM SCI, V36, P642, DOI 10.1016/j.tibs.2011.08.009; Wenzel SS, 2012, LEUKEMIA; Whitecross KF, 2009, BLOOD, V113, P1982, DOI 10.1182/blood-2008-05-156851; Wiegmans AP, 2011, CANCER RES, V71, P3603, DOI 10.1158/0008-5472.CAN-10-3289; Wright G, 2003, P NATL ACAD SCI USA, V100, P9991, DOI 10.1073/pnas.1732008100; Yarkoni S, 1996, J NATL CANCER I, V88, P973, DOI 10.1093/jnci/88.14.973; Yecies D, 2010, BLOOD, V115, P3304, DOI 10.1182/blood-2009-07-233304; Yeo AT, 2012, CANCER LETT, V318, P53, DOI 10.1016/j.canlet.2011.11.035; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166; Zhao Y, 2005, P NATL ACAD SCI USA, V102, P16090, DOI 10.1073/pnas.0505585102	70	27	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62822	10.1371/journal.pone.0062822	http://dx.doi.org/10.1371/journal.pone.0062822			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667527	Green Published, gold			2022-12-25	WOS:000319654700067
J	Bocharova, N; Treu, G; Czirjak, GA; Krone, O; Stefanski, V; Wibbelt, G; Unnsteinsdottir, ER; Hersteinsson, P; Schares, G; Doronina, L; Goltsman, M; Greenwood, AD				Bocharova, Natalia; Treu, Gabriele; Czirjak, Gabor Arpad; Krone, Oliver; Stefanski, Volker; Wibbelt, Gudrun; Unnsteinsdottir, Ester Rut; Hersteinsson, Pall; Schares, Gereon; Doronina, Lilia; Goltsman, Mikhail; Greenwood, Alex D.			Correlates between Feeding Ecology and Mercury Levels in Historical and Modern Arctic Foxes (Vulpes lagopus)	PLOS ONE			English	Article							ALOPEX-LAGOPUS; URSUS-MARITIMUS; HAIR; DIET; CONTAMINANTS; GREENLAND; SEABIRDS; ELEMENTS; METALS; RATIOS	Changes in concentration of pollutants and pathogen distribution can vary among ecotypes (e.g. marine versus terrestrial food resources). This may have important implications for the animals that reside within them. We examined 1) canid pathogen presence in an endangered arctic fox (Vulpes lagopus) population and 2) relative total mercury (THg) level as a function of ecotype ('coastal' or 'inland') for arctic foxes to test whether the presence of pathogens or heavy metal concentration correlate with population health. The Bering Sea populations on Bering and Mednyi Islands were compared to Icelandic arctic fox populations with respect to inland and coastal ecotypes. Serological and DNA based pathogen screening techniques were used to examine arctic foxes for pathogens. THg was measured by atomic absorption spectrometry from hair samples of historical and modern collected arctic foxes and samples from their prey species (hair and internal organs). Presence of pathogens did not correlate with population decline from Mednyi Island. However, THg concentration correlated strongly with ecotype and was reflected in the THg concentrations detected in available food sources in each ecotype. The highest concentration of THg was found in ecotypes where foxes depended on marine vertebrates for food. Exclusively inland ecotypes had low THg concentrations. The results suggest that absolute exposure to heavy metals may be less important than the feeding ecology and feeding opportunities of top predators such as arctic foxes which may in turn influence population health and stability. A higher risk to wildlife of heavy metal exposure correlates with feeding strategies that rely primarily on a marine based diet.	[Bocharova, Natalia; Doronina, Lilia; Goltsman, Mikhail] Moscow MV Lomonosov State Univ, Fac Biol, Dept Vertebrate Zool, Moscow, Russia; [Treu, Gabriele; Czirjak, Gabor Arpad; Krone, Oliver; Wibbelt, Gudrun; Greenwood, Alex D.] Leibniz Inst Zoo & Wildlife Res, Dept Wildlife Dis, Berlin, Germany; [Stefanski, Volker] Univ Hohenheim, Stuttgart, Germany; [Unnsteinsdottir, Ester Rut; Hersteinsson, Pall] Univ Iceland, Dept Life & Environm Sci, Reykjavik, Iceland; [Schares, Gereon] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Epidemiol, Wusterhausen, Germany	Lomonosov Moscow State University; Leibniz Institut fur Zoo und Wildtierforschung; University Hohenheim; University of Iceland; Friedrich Loeffler Institute	Greenwood, AD (corresponding author), Leibniz Inst Zoo & Wildlife Res, Dept Wildlife Dis, Berlin, Germany.	greenwood@izw-berlin.de	Greenwood, Alex/GWU-8292-2022; Czirják, Gábor Árpád/F-5440-2011; Schares, Gereon R.M./F-9850-2019	Czirják, Gábor Árpád/0000-0001-9488-0069; Schares, Gereon R.M./0000-0002-3217-289X	Deutscher Akademischer Austauschdienst - DAAD; Russian Foundation of Basic Research	Deutscher Akademischer Austauschdienst - DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); Russian Foundation of Basic Research(Russian Foundation for Basic Research (RFBR))	Natalia A. Bocharova was funded in part by the Deutscher Akademischer Austauschdienst - DAAD. Research on Mednyi Island is funded by a grant from Russian Foundation of Basic Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abolitis AS, 1987, EFFICIENT UTILIZATIO, P144; AMAP, 2011, ASS 2011 MERC ARCT A; AMAP, 2005, AMAP ASS 2002 HEAV M; AMAP, 2004, AMAP ASS 2002 PRES O; Audet Alexandra M., 2002, Mammalian Species, V713, P1, DOI 10.1644/1545-1410(2002)713<0001:AL>2.0.CO;2; Bank MS, 2006, BIOL CONSERV, V130, P230, DOI 10.1016/j.biocon.2005.12.033; Bernhard M., 1984, CHANGING METAL CYCLE, P143; BORN EW, 1991, POLAR RES, V9, P113, DOI 10.1111/j.1751-8369.1991.tb00607.x; Braestrup F. W., 1941, Meddelelser om Gronland, V131, P1; Buckman AH, 2004, ENVIRON POLLUT, V128, P327, DOI 10.1016/j.envpol.2003.09.017; Campbell LM, 2005, SCI TOTAL ENVIRON, V351, P247, DOI 10.1016/j.scitotenv.2005.02.043; Castellini JM, 2012, ECOHEALTH, V9, P267, DOI 10.1007/s10393-012-0784-4; Dalerum F, 2000, ARCTIC, V53, P1; Das K, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-52; Dietz C, 2013, SCI TOTAL ENVIRON, V443, P775, DOI [10.1016/j.scitotenv.2012.11.046, DOI 10.1016/J.SCIT0TENV.2012.11.046]; Dietz R, 2009, SCI TOTAL ENVIRON, V407, P6120, DOI 10.1016/j.scitotenv.2009.08.036; Egeland GM, 2009, ENVIRON RES, V109, P281, DOI 10.1016/j.envres.2008.11.004; Elliott JE, 2005, ENVIRON TOXICOL CHEM, V24, P3099, DOI 10.1897/04-474R.1; Fitzgerald WF, 2005, ENVIRON SCI TECHNOL, V39, P557, DOI 10.1021/es049128x; Fuglei E, 2007, ENVIRON POLLUT, V146, P128, DOI 10.1016/j.envpol.2006.06.036; GEPTNER VG, 1967, MAMMALS USSR 1; Goltsman M., 1996, Oryx, V30, P251; Goltsman ME, 2011, BIOL BULL+, V38, P709, DOI 10.1134/S1062359010151014; Hersteinsson P, 1996, J ZOOL, V240, P457, DOI 10.1111/j.1469-7998.1996.tb05298.x; Hersteinsson P, 2007, POLAR BIOL, V30, P1047, DOI 10.1007/s00300-007-0264-4; Ikemoto T, 2004, ENVIRON POLLUT, V127, P83, DOI 10.1016/S0269-7491(03)00251-3; Il'ina ED, 1950, FUR FARMING ISLANDS; Kim EY, 1996, ARCH ENVIRON CON TOX, V30, P259; Klobes U, 1998, INT J ENVIRON AN CH, V69, P67, DOI 10.1080/03067319808032575; Lindberg SE, 2002, ENVIRON SCI TECHNOL, V36, P1245, DOI 10.1021/es0111941; Morton J, 2002, ANAL CHIM ACTA, V455, P23, DOI 10.1016/S0003-2670(01)01578-1; Naumov N.P., 1981, P31; NODA K, 1995, ENVIRON POLLUT, V90, P51, DOI 10.1016/0269-7491(94)00089-V; Outridge PM, 2008, ENVIRON CHEM, V5, P89, DOI 10.1071/EN08002; Pagh S, 2008, POLAR RES, V27, P44, DOI 10.1111/j.1751-8369.2008.00042.x; Sanger G.A., 1987, P229; Sonne C, 2010, ENVIRON INT, V36, P461, DOI 10.1016/j.envint.2010.03.002; Stern GA, 2012, SCI TOTAL ENVIRON, V414, P22, DOI 10.1016/j.scitotenv.2011.10.039; Unnsteinsdottir ER, 2009, J ZOOL, V277, P232, DOI 10.1111/j.1469-7998.2008.00532.x; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY; Wikelski M, 2004, ECOL SOC, V9; Wyatt KB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003602; Zagrebel'nyi SV, 2000, ZOOL ZH, V79, P595; Zalkin VI, 1944, ZOOL J MOSCOW, V28	44	40	40	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e60879	10.1371/journal.pone.0060879	http://dx.doi.org/10.1371/journal.pone.0060879			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671561	Green Submitted, Green Published, gold			2022-12-25	WOS:000321390200003
J	Frosig, C; Jensen, TE; Jeppesen, J; Pehmoller, C; Treebak, JT; Maarbjerg, SJ; Kristensen, JM; Sylow, L; Alsted, TJ; Schjerling, P; Kiens, B; Wojtaszewski, JFP; Richter, EA				Frosig, Christian; Jensen, Thomas E.; Jeppesen, Jacob; Pehmoller, Christian; Treebak, Jonas T.; Maarbjerg, Stine J.; Kristensen, Jonas M.; Sylow, Lykke; Alsted, Thomas J.; Schjerling, Peter; Kiens, Bente; Wojtaszewski, Jorgen F. P.; Richter, Erik A.			AMPK and Insulin Action - Responses to Ageing and High Fat Diet	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ACETYL-COA CARBOXYLASE; SKELETAL-MUSCLE; GLUCOSE-TRANSPORT; RESISTANCE; EXERCISE; SENSITIVITY; HOMEOSTASIS; MICE; METABOLISM	The 5'-AMP-activated protein kinase (AMPK) is considered "a metabolic master-switch" in skeletal muscle reducing ATP-consuming processes whilst stimulating ATP regeneration. Within recent years, AMPK has also been proposed as a potential target to attenuate insulin resistance, although the exact role of AMPK is not well understood. Here we hypothesized that mice lacking alpha 2AMPK activity in muscle would be more susceptible to develop insulin resistance associated with ageing alone or in combination with high fat diet. Young (similar to 4 month) or old (similar to 18 month) wild type and muscle specific alpha 2AMPK kinase-dead mice on chow diet as well as old mice on 17 weeks of high fat diet were studied for whole body glucose homeostasis (OGTT, ITT and HOMA-IR), insulin signaling and insulin-stimulated glucose uptake in muscle. We demonstrate that high fat diet in old mice results in impaired glucose homeostasis and insulin stimulated glucose uptake in both the soleus and extensor digitorum longus muscle, coinciding with reduced insulin signaling at the level of Akt (pSer473 and pThr308), TBC1D1 (pThr590) and TBC1D4 (pThr642). In contrast to our hypothesis, the impact of ageing and high fat diet on insulin action was not worsened in mice lacking functional alpha 2AMPK in muscle. It is concluded that alpha 2AMPK deficiency in mouse skeletal muscle does not cause muscle insulin resistance in young and old mice and does not exacerbate obesity-induced insulin resistance in old mice suggesting that decreased alpha 2AMPK activity does not increase susceptibility for insulin resistance in skeletal muscle.	[Frosig, Christian; Jensen, Thomas E.; Jeppesen, Jacob; Pehmoller, Christian; Treebak, Jonas T.; Maarbjerg, Stine J.; Kristensen, Jonas M.; Sylow, Lykke; Alsted, Thomas J.; Kiens, Bente; Wojtaszewski, Jorgen F. P.; Richter, Erik A.] Univ Copenhagen, August Krogh Inst, Dept Nutr Exercise & Sports, Sect Mol Physiol, DK-2100 Copenhagen, Denmark; [Schjerling, Peter] Univ Copenhagen, Bispebjerg Hosp, Dept Orthoped Surg M, Inst Sports Med, Copenhagen, Denmark; [Schjerling, Peter] Univ Copenhagen, Fac Hlth Sci, Ctr Hlth Aging, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen	Frosig, C (corresponding author), Univ Copenhagen, August Krogh Inst, Dept Nutr Exercise & Sports, Sect Mol Physiol, DK-2100 Copenhagen, Denmark.	cfrosig@ifi.ku.dk	Wojtaszewski, Jørgen FP/P-6583-2014; Richter, Erik A./Y-8131-2019; Schjerling, Peter/F-6194-2011; Treebak, Jonas Thue/B-4521-2017; Frøsig, Christian/A-3750-2015; Jensen, Thomas/E-1215-2015; Sylow, Lykke/C-8997-2015; Kristensen, Jonas/A-3249-2017; Kiens, Bente/B-1375-2015	Wojtaszewski, Jørgen FP/0000-0001-9785-6830; Richter, Erik A./0000-0002-6850-3056; Schjerling, Peter/0000-0001-7138-3211; Treebak, Jonas Thue/0000-0003-1488-7012; Frøsig, Christian/0000-0001-9302-9328; Jensen, Thomas/0000-0001-6139-8268; Pehmoller, Christian/0000-0001-7102-7727; Sylow, Lykke/0000-0003-0905-5932; Kristensen, Jonas/0000-0002-8296-975X; wojtaszewski, jorgen/0000-0001-8185-3408; Kiens, Bente/0000-0001-5705-5625	Lundbaek Foundation, Denmark; Danish Medical Research Council, Denmark; Danish Agency of Science, Technology and Innovation; Danish Ministry of Food, Agriculture and Fisheries; Novo Nordisk Foundation; Danish Diabetes Association; Danish Ministry of Science, Technology and Innovation; Danish Agency for Science, Technology and Innovation; Alfred Benzon Foundation; Nordea Foundation	Lundbaek Foundation, Denmark; Danish Medical Research Council, Denmark(Danish Medical Research Council); Danish Agency of Science, Technology and Innovation; Danish Ministry of Food, Agriculture and Fisheries; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Diabetes Association; Danish Ministry of Science, Technology and Innovation; Danish Agency for Science, Technology and Innovation; Alfred Benzon Foundation; Nordea Foundation	This work was supported by grants from the Lundbaek Foundation, Denmark, The Danish Medical Research Council, Denmark, The Danish Agency of Science, Technology and Innovation, The Danish Ministry of Food, Agriculture and Fisheries, The Novo Nordisk Foundation, and the Danish Diabetes Association. The Molecular Physiology group, Department of Nutrition, Exercise and Sports is part of the August Krogh Centre and the UNIversal Kit Project: Food, Fitness & Pharma for Health and Disease, supported by the Danish Ministry of Science, Technology and Innovation. TEJ and JTT were supported by a postdoctoral fellowship from The Danish Agency for Science, Technology and Innovation. JJ was supported by a research fellowship from The Alfred Benzon Foundation. PS was supported by the Nordea Foundation (Healthy Aging Grant). The Novo Nordisk Foundation Center for Basic Metabolic Research is an independent Research Center, based at the University of Copenhagen, Denmark and partially funded by an unconditional donation from the Novo Nordisk Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Broome CS, 2006, FASEB J, V20, P1549, DOI 10.1096/fj.05-4935fje; Bruce CR, 2009, DIABETES, V58, P550, DOI 10.2337/db08-1078; Cartee GD, 2007, APPL PHYSIOL NUTR ME, V32, P557, DOI 10.1139/H07-026; Chen SA, 2008, BIOCHEM J, V409, P449, DOI 10.1042/BJ20071114; Chen SA, 2011, CELL METAB, V13, P68, DOI 10.1016/j.cmet.2010.12.005; Choi CS, 2007, P NATL ACAD SCI USA, V104, P16480, DOI 10.1073/pnas.0706794104; DAVIES SP, 1990, EUR J BIOCHEM, V187, P183, DOI 10.1111/j.1432-1033.1990.tb15293.x; DEFRONZO RA, 1981, DIABETES, V30, P1000, DOI 10.2337/diab.30.12.1000; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Escriva F, 1997, ENDOCRINOLOGY, V138, P49, DOI 10.1210/en.138.1.49; Fujii N, 2005, J BIOL CHEM, V280, P39033, DOI 10.1074/jbc.M504208200; Fujii N, 2008, DIABETES, V57, P2958, DOI 10.2337/db07-1187; Fujii N, 2007, DIABETES RES CLIN PR, V77, pS92, DOI 10.1016/j.diabres.2007.01.040; Gabriely I, 2002, DIABETES, V51, P2951, DOI 10.2337/diabetes.51.10.2951; Gupte AA, 2008, J APPL PHYSIOL, V105, P839, DOI 10.1152/japplphysiol.00148.2008; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hardie DG, 2004, REV ENDOCR METAB DIS, V5, P119, DOI 10.1023/B:REMD.0000021433.63915.bb; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hu CC, 2004, OBES RES, V12, P1264, DOI 10.1038/oby.2004.160; Jorgensen SB, 2009, DIABETOLOGIA, V52, P2395, DOI 10.1007/s00125-009-1483-8; Koh HJ, 2006, MOL CELL BIOL, V26, P8217, DOI 10.1128/MCB.00979-06; Lauritzen HPMM, 2008, DIABETES, V57, P13, DOI 10.2337/db07-0516; Maarbjerg SJ, 2009, AM J PHYSIOL-ENDOC M, V297, pE924, DOI 10.1152/ajpendo.90653.2008; Manetta J, 2001, METABOLISM, V50, P349, DOI 10.1053/meta.2001.20205; Matos A, 2010, ACTA PHYSIOL, V198, P61, DOI 10.1111/j.1748-1716.2009.02031.x; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; Morino K, 2008, DIABETES, V57, P2644, DOI 10.2337/db06-0454; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Mu J, 2003, BIOCHEM SOC T, V31, P236, DOI 10.1042/bst0310236; Perreault M, 2001, NAT MED, V7, P1138, DOI 10.1038/nm1001-1138; Richter EA, 2009, BIOCHEM J, V418, P261, DOI 10.1042/BJ20082055; Sakamoto K, 2008, AM J PHYSIOL-ENDOC M, V295, pE29, DOI 10.1152/ajpendo.90331.2008; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Standaert ML, 2004, J BIOL CHEM, V279, P24929, DOI 10.1074/jbc.M402440200; Treebak JT, 2008, INT J OBESITY, V32, pS13, DOI 10.1038/ijo.2008.117; Turdi S, 2011, J MOL CELL CARDIOL, V50, P712, DOI 10.1016/j.yjmcc.2010.12.007; Vind BF, 2012, DIABETOLOGIA, V55, P1435, DOI 10.1007/s00125-012-2482-8; Zierath JB, 1997, DIABETES, V46, P215, DOI 10.2337/diabetes.46.2.215	40	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e62338	10.1371/journal.pone.0062338	http://dx.doi.org/10.1371/journal.pone.0062338			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671593	Green Submitted, Green Published, gold			2022-12-25	WOS:000321390200020
J	Lockwood, WW; Chandel, SK; Stewart, GL; Erdjument-Bromage, H; Beverly, LJ				Lockwood, William W.; Chandel, Sahiba K.; Stewart, Greg L.; Erdjument-Bromage, Hediye; Beverly, Levi J.			The Novel Ubiquitin Ligase Complex, SCFFbxw4, Interacts with the COP9 Signalosome in an F-Box Dependent Manner, Is Mutated, Lost and Under-Expressed in Human Cancers	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; HAND FOOT MALFORMATION; BETA-CATENIN; PROTEIN; GENE; SHFM3; PROTEOLYSIS; 10Q24; NOTCH; FBW7	Identification of novel proteins that can potentially contribute to carcinogenesis is a requisite venture. Herein, we report the first biochemical characterization of the novel F-box and WD40 containing protein, FBXW4. We have identified interacting protein partners and demonstrated that FBXW4 is part of a ubiquitin ligase complex. Furthermore, the Fbxw4 locus is a common site of proviral insertion in a variety of retroviral insertional mutagenesis murine cancer models and Fbxw4 mRNA is highly expressed in the involuting murine mammary gland. To begin to characterize the biochemical function of Fbxw4, we used proteomic analysis to demonstrate that Fbxw4 interacts with Skp1 (SKP1), Cullin1 (CUL1), Ring-box1 (RBX1) and all components of the COP9 signalosome. All of these interactions are dependent on an intact F-box domain of Fbxw4. Furthermore, Fbxw4 is capable of interacting with ubiquitinated proteins within cells in an F-box dependent manner. Finally, we demonstrate that FBXW4 is mutated, lost and under-expressed in a variety of human cancer cell lines and clinical patient samples. Importantly, expression of FBXW4 correlates with survival of patients with non-small cell lung cancer. Taken together, we suggest that FBXW4 may be a novel tumor suppressor that regulates important cellular processes.	[Chandel, Sahiba K.; Beverly, Levi J.] Univ Louisville, James Graham Brown Canc Ctr, Div Hematol & Oncol, Dept Med, Louisville, KY 40292 USA; [Lockwood, William W.] NHGRI, Canc Biol & Genet Sect, Canc Genet Branch, NIH, Bethesda, MD 20892 USA; [Stewart, Greg L.] Columbia Canc Res Ctr, Vancouver, BC, Canada; [Erdjument-Bromage, Hediye] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	University of Louisville; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Memorial Sloan Kettering Cancer Center	Beverly, LJ (corresponding author), Univ Louisville, James Graham Brown Canc Ctr, Div Hematol & Oncol, Dept Med, Louisville, KY 40292 USA.	Levi.Beverly@Louisville.edu		Erdjument-Bromage, Hediye/0000-0003-0224-3594	National Institutes of Health (NIH), Molecular Targets COBRE [8P20GM103482-10]; Wendy Will Case Cancer Fund [GB220413]; Kosair Pediatric Cancer Research Program award; NCI [P30 CA08748]; NIH [P01 CA94060, PO1 CA129243-01]; NIH intramural NCI; NHGRI; NATIONAL CANCER INSTITUTE [P01CA094060, P01CA129243, P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103482] Funding Source: NIH RePORTER	National Institutes of Health (NIH), Molecular Targets COBRE; Wendy Will Case Cancer Fund; Kosair Pediatric Cancer Research Program award; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH intramural NCI; NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (NIH), Molecular Targets COBRE, 8P20GM103482-10 (to LJB), Wendy Will Case Cancer Fund, GB220413 (to LJB), Kosair Pediatric Cancer Research Program award (to LJB). This work was also supported by NCI Cancer Center support grant P30 CA08748 to Microchemistry and Proteomics Core Laboratory (to HEB), Memorial Sloan-Kettering Cancer Center. This work was also supported, in part, by NIH Grant P01 CA94060 and PO1 CA129243-01 (to Harold Varmus) and by NIH intramural NCI and NHGRI funds (to Harold Varmus). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsterdam A, 2009, MOL CANCER RES, V7, P841, DOI 10.1158/1541-7786.MCR-08-0555; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Basel D, 2003, CLIN GENET, V64, P350, DOI 10.1034/j.1399-0004.2003.00153.x; Beverly LJ, 2012, P NATL ACAD SCI USA, V109, P119, DOI 10.1073/pnas.1119167109; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; CHAMOVITZ DA, 1995, CELL, V82, P353, DOI 10.1016/0092-8674(95)90423-9; de Mollerat XJ, 2003, HUM MOL GENET, V12, P1959, DOI 10.1093/hmg/ddg212; Demarest RM, 2008, ONCOGENE, V27, P5082, DOI 10.1038/onc.2008.222; Duijf PHG, 2003, HUM MOL GENET, V12, pR51, DOI 10.1093/hmg/ddg090; Elliott AM, 2005, CLIN GENET, V68, P501, DOI 10.1111/j.1399-0004.2005.00530.x; Gurrieri F, 1996, AM J MED GENET, V62, P427; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Ianakiev P, 1999, BIOCHEM BIOPH RES CO, V261, P64, DOI 10.1006/bbrc.1999.0963; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kano H, 2007, P NATL ACAD SCI USA, V104, P19034, DOI 10.1073/pnas.0705483104; Kawakami K, 2000, CURR BIOL, V10, P463, DOI 10.1016/S0960-9822(00)00444-9; Latres E, 1999, ONCOGENE, V18, P849, DOI 10.1038/sj.onc.1202653; Latres E, 2001, P NATL ACAD SCI USA, V98, P2515, DOI 10.1073/pnas.041475098; Lau AW, 2012, FRONT BIOSCI-LANDMRK, V17, P2197, DOI 10.2741/4045; Lee M. H., 2011, CELL CYCLE, V10, P3057, DOI [DOI 10.4161/CC.10.18, 10.4161/cc.10.18.17320, DOI 10.4161/CC.10.18.17320]; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Malyukova A, 2007, CANCER RES, V67, P5611, DOI 10.1158/0008-5472.CAN-06-4381; O'Hagan RC, 2000, GENE DEV, V14, P2185, DOI 10.1101/gad.827200; O'Neil J, 2007, J EXP MED, V204, P1813, DOI 10.1084/jem.20070876; Ozen RS, 1999, AM J HUM GENET, V64, P1646, DOI 10.1086/302403; Palomero T, 2009, CLIN LYMPHOMA MYELOM, V9, pS205, DOI 10.3816/CLM.2009.s.013; RaasRothschild A, 1996, J MED GENET, V33, P996, DOI 10.1136/jmg.33.12.996; Richardson KS, 2005, MOL CANCER RES, V3, P645, DOI 10.1158/1541-7786.MCR-05-0233; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Schwechheimer C, 2004, BBA-MOL CELL RES, V1695, P45, DOI 10.1016/j.bbamcr.2004.09.023; Sidow A, 1999, NAT GENET, V23, P104, DOI 10.1038/12709; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Tomoda K, 2002, J BIOL CHEM, V277, P2302, DOI 10.1074/jbc.M104431200; Wei N, 2003, ANNU REV CELL DEV BI, V19, P261, DOI 10.1146/annurev.cellbio.19.111301.112449; WEI N, 1994, CELL, V78, P117, DOI 10.1016/0092-8674(94)90578-9; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270	37	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63610	10.1371/journal.pone.0063610	http://dx.doi.org/10.1371/journal.pone.0063610			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658844	Green Published, gold, Green Submitted			2022-12-25	WOS:000321200500078
J	Moore, BS; Mirshahi, UL; Ebersole, TL; Mirshahi, T				Moore, Bryn S.; Mirshahi, Uyenlinh L.; Ebersole, Tonya L.; Mirshahi, Tooraj			A Conserved Mechanism for Gating in an Ionotropic Glutamate Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING CORE; LURCHER MUTATION; TRANSMEMBRANE HELIX; POTASSIUM CHANNELS; MEMBRANE-PROTEINS; K+ CHANNELS; AMPA; DESENSITIZATION; ACTIVATION; CONFORMATION	Ionotropic glutamate receptor (iGluR) channels control synaptic activity. The crystallographic structure of GluA2, the prototypical iGluR, reveals a clamshell-like ligand-binding domain (LBD) that closes in the presence of glutamate to open a gate on the pore lining alpha-helix. How LBD closure leads to gate opening remains unclear. Here, we show that bending the pore helix at a highly conserved alanine residue (Ala-621) below the gate is responsible for channel opening. Substituting Ala-621 with the smaller more flexible glycine resulted in a basally active, nondesensitizing channel with similar to 39-fold increase in glutamate potency without affecting surface expression or binding. On GluA2(A621G), the partial agonist kainate showed efficacy similar to a full agonist, and competitive antagonists CNQX and DNQX acted as a partial agonists. Met-629 in GluA2 sits above the gate and is critical in transmitting LBD closure to the gate. Substituting Met-629 with the flexible glycine resulted in reduced channel activity and glutamate potency. The pore regions in potassium channels are structurally similar to iGluRs. Whereas potassium channels typically use glycines as a hinge for gating, iGluRs use the less flexible alanine as a hinge at a similar position to maintain low basal activity allowing for ligand-mediated gating.	[Moore, Bryn S.; Mirshahi, Uyenlinh L.; Ebersole, Tonya L.; Mirshahi, Tooraj] Weis Ctr Res, Geisinger Clin, Danville, PA 17822 USA		Mirshahi, T (corresponding author), Weis Ctr Res, Geisinger Clin, 100 North Acad Ave, Danville, PA 17822 USA.	tmirshahi@geisinger.edu		Moore, Bryn/0000-0002-8758-7611	Geisinger Clinic	Geisinger Clinic	This work was supported by funds from the Geisinger Clinic.	Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Armstrong N, 2006, CELL, V127, P85, DOI 10.1016/j.cell.2006.08.037; BENNETT JA, 1995, NEURON, V14, P373, DOI 10.1016/0896-6273(95)90293-7; Chen GQ, 1998, PROTEIN SCI, V7, P2623, DOI 10.1002/pro.5560071216; Deupi X, 2010, J STRUCT BIOL, V169, P116, DOI 10.1016/j.jsb.2009.09.009; Dong H, 2012, BIOCHEMISTRY-US, V51, P4779, DOI 10.1021/bi300090x; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Eilers M, 2000, P NATL ACAD SCI USA, V97, P5796, DOI 10.1073/pnas.97.11.5796; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Hardman RM, 2007, J BIOL CHEM, V282, P31972, DOI 10.1074/jbc.M705835200; Javadpour MM, 1999, BIOPHYS J, V77, P1609, DOI 10.1016/S0006-3495(99)77009-8; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jin TH, 2002, MOL CELL, V10, P469, DOI 10.1016/S1097-2765(02)00659-7; Klein RM, 2004, J NEUROSCI, V24, P4941, DOI 10.1523/JNEUROSCI.0660-04.2004; Kohda K, 2000, NAT NEUROSCI, V3, P315, DOI 10.1038/73877; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Mayer ML, 2011, STRUCTURE, V19, P1370, DOI 10.1016/j.str.2011.08.009; Menuz K, 2007, SCIENCE, V318, P815, DOI 10.1126/science.1146317; Mirshahi T, 2002, J BIOL CHEM, V277, P7348, DOI 10.1074/jbc.M109999200; Rosenhouse-Dantsker A, 2007, CHANNELS, V1, P189, DOI 10.4161/chan.4475; Schlesinger F, 2005, BRIT J PHARMACOL, V145, P656, DOI 10.1038/sj.bjp.0706233; SCHREIBMAYER W, 1994, PFLUG ARCH EUR J PHY, V426, P453, DOI 10.1007/BF00388310; Sobolevsky AI, 2003, J NEUROSCI, V23, P7559; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Stern-Bach Y, 1998, NEURON, V21, P907, DOI 10.1016/S0896-6273(00)80605-4; Taverna F, 2000, J BIOL CHEM, V275, P8475, DOI 10.1074/jbc.275.12.8475; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Wollmuth LP, 2000, J NEUROSCI, V20, P5973, DOI 10.1523/JNEUROSCI.20-16-05973.2000; Zuo J, 1997, NATURE, V388, P769, DOI 10.1038/42009	31	9	9	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18842	18852		10.1074/jbc.M113.465187	http://dx.doi.org/10.1074/jbc.M113.465187			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23671286	Green Published, hybrid			2022-12-25	WOS:000321335800022
J	Saito, S; Hosoda, N; Hoshino, S				Saito, Syuhei; Hosoda, Nao; Hoshino, Shin-ichi			The Hbs1-Dom34 Protein Complex Functions in Non-stop mRNA Decay in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NO-GO DECAY; EXON JUNCTION COMPLEX; TERMINATION FACTOR ERF3; E3 UBIQUITIN LIGASE; TRANSLATION TERMINATION; QUALITY-CONTROL; ENDONUCLEOLYTIC CLEAVAGE; STRUCTURAL BASIS; NONSENSE CODONS; RELEASE FACTORS	In yeast, aberrant mRNAs lacking in-frame termination codons are recognized and degraded by the non-stop decay (NSD) pathway. The recognition of non-stop mRNAs involves a member of the eRF3 family of GTP-binding proteins, Ski7. Ski7 is thought to bind the ribosome stalled at the 3'-end of the mRNA poly(A) tail and recruit the exosome to degrade the aberrant message. However, Ski7 is not found in mammalian cells, and even the presence of the NSD mechanism itself has remained enigmatic. Here, we show that unstable non-stop mRNA is degraded in a translation-dependent manner in mammalian cells. The decay requires another eRF3 family member (Hbs1), its binding partner Dom34, and components of the exosome-Ski complex (Ski2/Mtr4 and Dis3). Hbs1-Dom34 binds to form a complex with the exosome-Ski complex. Also, the elimination of aberrant proteins produced from non-stop transcripts requires the RING finger protein listerin. These findings demonstrate that the NSD mechanism exists in mammalian cells and involves Hbs1, Dom34, and the exosome-Ski complex.	[Hoshino, Shin-ichi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Biol Chem, Nagoya, Aichi 4678603, Japan	Nagoya City University	Hoshino, S (corresponding author), Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Biol Chem, 3-1 Tanabe Dori, Nagoya, Aichi 4678603, Japan.	hoshino@phar.nagoya-cu.ac.jp		Hoshino, Shinichi/0000-0001-6135-7896	Ministry of Education, Culture, Sports, Science and Technology of Japan [20112005]; Japan Society for the Promotion of Science [21370080]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-aid for Scientific Research on Innovative Areas "RNA Regulation" 20112005 from the Ministry of Education, Culture, Sports, Science and Technology of Japan and Grant-in-aid for Scientific Research (B) 21370080 from the Japan Society for the Promotion of Science (to S. H.).	Akimitsu N, 2007, EMBO J, V26, P2327, DOI 10.1038/sj.emboj.7601679; Amrani N, 2004, NATURE, V432, P112, DOI 10.1038/nature03060; Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Araki Y, 2001, EMBO J, V20, P4684, DOI 10.1093/emboj/20.17.4684; Becker T, 2012, NATURE, V482, P501, DOI 10.1038/nature10829; Becker T, 2011, NAT STRUCT MOL BIOL, V18, P715, DOI 10.1038/nsmb.2057; Bengtson MH, 2010, NATURE, V467, P470, DOI 10.1038/nature09371; Brown JT, 2000, RNA, V6, P449, DOI 10.1017/S1355838200991787; Carr-Schmid A, 2002, MOL CELL BIOL, V22, P2564, DOI 10.1128/MCB.22.8.2564-2574.2002; Chatr-aryamontri A, 2004, HUM MUTAT, V24, P526, DOI 10.1002/humu.20117; Chen LM, 2010, NAT STRUCT MOL BIOL, V17, P1233, DOI 10.1038/nsmb.1922; Chu J, 2009, P NATL ACAD SCI USA, V106, P2097, DOI 10.1073/pnas.0812819106; Czaplinski K, 1998, GENE DEV, V12, P1665, DOI 10.1101/gad.12.11.1665; Doma MK, 2006, NATURE, V440, P561, DOI 10.1038/nature04530; Eberle AB, 2009, NAT STRUCT MOL BIOL, V16, P49, DOI 10.1038/nsmb.1530; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; FROLOVA L, 1994, NATURE, V372, P701, DOI 10.1038/372701a0; Funakoshi Y, 2007, GENE DEV, V21, P3135, DOI 10.1101/gad.1597707; Harigaya Y, 2010, WIRES RNA, V1, P132, DOI 10.1002/wrna.17; HENTZE MW, 1988, GENE, V72, P201, DOI 10.1016/0378-1119(88)90145-X; Hoshino S, 1998, J BIOL CHEM, V273, P22254, DOI 10.1074/jbc.273.35.22254; Hoshino S, 1999, J BIOL CHEM, V274, P16677, DOI 10.1074/jbc.274.24.16677; Hosoda N, 2003, J BIOL CHEM, V278, P38287, DOI 10.1074/jbc.C300300200; Hosoda N, 2011, EMBO J, V30, P1311, DOI 10.1038/emboj.2011.37; Huntzinger E, 2008, RNA, V14, P2609, DOI 10.1261/rna.1386208; Inada T, 2005, EMBO J, V24, P1584, DOI 10.1038/sj.emboj.7600636; Ito-Harashima S, 2007, GENE DEV, V21, P519, DOI 10.1101/gad.1490207; Kashima I, 2006, GENE DEV, V20, P355, DOI 10.1101/gad.1389006; Kim VN, 2001, SCIENCE, V293, P1832, DOI 10.1126/science.1062829; Klauer AA, 2012, WIRES RNA, V3, P649, DOI 10.1002/wrna.1124; Kobayashi K, 2010, P NATL ACAD SCI USA, V107, P17575, DOI 10.1073/pnas.1009598107; Kong J, 2007, NAT STRUCT MOL BIOL, V14, P670, DOI 10.1038/nsmb1256; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Lebreton A, 2008, NATURE, V456, P993, DOI 10.1038/nature07480; Lee HH, 2007, MOL CELL, V27, P938, DOI 10.1016/j.molcel.2007.07.019; Lykke-Andersen J, 2001, SCIENCE, V293, P1836, DOI 10.1126/science.1062786; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; MUHLRAD D, 1994, NATURE, V370, P578, DOI 10.1038/370578a0; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Onouchi H, 2005, GENE DEV, V19, P1799, DOI 10.1101/gad.1317105; Passos DO, 2009, MOL BIOL CELL, V20, P3025, DOI 10.1091/mbc.E09-01-0028; Pisareva VP, 2011, EMBO J, V30, P1804, DOI 10.1038/emboj.2011.93; Ruan L, 2010, J BIOL CHEM, V285, P27624, DOI 10.1074/jbc.M110.138867; Schaeffer D, 2011, P NATL ACAD SCI USA, V108, P2366, DOI 10.1073/pnas.1013180108; Schaeffer D, 2009, NAT STRUCT MOL BIOL, V16, P56, DOI 10.1038/nsmb.1528; Shoemaker CJ, 2011, P NATL ACAD SCI USA, V108, pE1392, DOI 10.1073/pnas.1113956108; Shoemaker CJ, 2010, SCIENCE, V330, P369, DOI 10.1126/science.1192430; STANSFIELD I, 1995, EMBO J, V14, P4365, DOI 10.1002/j.1460-2075.1995.tb00111.x; Thermann R, 1998, EMBO J, V17, P3484, DOI 10.1093/emboj/17.12.3484; Tomecki R, 2010, EMBO J, V29, P2342, DOI 10.1038/emboj.2010.121; Torres-Torronteras J, 2011, HUM MUTAT, V32, pE2061, DOI 10.1002/humu.21447; Tsuboi T, 2012, MOL CELL, V46, P518, DOI 10.1016/j.molcel.2012.03.013; van den Elzen AMG, 2010, NAT STRUCT MOL BIOL, V17, P1446, DOI 10.1038/nsmb.1963; van Hoof A, 2005, GENETICS, V171, P1455, DOI 10.1534/genetics.105.044057; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272; Wallrapp C, 1998, FEBS LETT, V440, P387, DOI 10.1016/S0014-5793(98)01492-6; Wang LN, 2005, RNA, V11, P1291, DOI 10.1261/rna.2060405; Wilson MA, 2007, GENETICS, V177, P773, DOI 10.1534/genetics.107.073205; ZHOURAVLEVA G, 1995, EMBO J, V14, P4065, DOI 10.1002/j.1460-2075.1995.tb00078.x	59	52	56	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17832	17843		10.1074/jbc.M112.448977	http://dx.doi.org/10.1074/jbc.M112.448977			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23667253	hybrid, Green Published			2022-12-25	WOS:000320380600072
J	Laird, RM; Wolf, BJ; Princiotta, MF; Hayes, SM				Laird, Renee M.; Wolf, Benjamin J.; Princiotta, Michael F.; Hayes, Sandra M.			gamma delta T Cells Acquire Effector Fates in the Thymus and Differentiate into Cytokine-Producing Effectors in a Listeria Model of Infection Independently of CD28 Costimulation	PLOS ONE			English	Article							MONOCYTOGENES INFECTION; THYMOCYTE DEVELOPMENT; B7-CD28 INTERACTION; INTERFERON-GAMMA; GLUCOSE-UPTAKE; ALPHA-BETA; PRE-T; EXPRESSION; LYMPHOCYTES; ACTIVATION	Both antigen recognition and CD28 costimulation are required for the activation of naive alpha beta T cells and their subsequent differentiation into cytokine-producing or cytotoxic effectors. Notably, this two-signal paradigm holds true for all alpha beta T cell subsets, regardless of whether they acquire their effector function in the periphery or the thymus. Because of contradictory results, however, it remains unresolved as to whether CD28 costimulation is necessary for gamma delta T cell activation and differentiation. Given that gamma delta T cells have been recently shown to acquire their effector fates in the thymus, it is conceivable that the contradictory results may be explained, in part, by a differential requirement for CD28 costimulation in the development or differentiation of each gamma delta T cell effector subset. To test this, we examined the role of CD28 in gamma delta T cell effector fate determination and function. We report that, although IFN gamma-producing gamma delta T (gamma delta-IFN gamma) cells express higher levels of CD28 than IL-17-producing gamma delta T (gamma delta-17) cells, CD28-deficiency had no effect on the thymic development of either subset. Also, following Listeria infection, we found that the expansion and differentiation of gamma delta-17 and gamma delta-IFN gamma effectors were comparable between CD28(+/+) and CD28(-/-) mice. To understand why CD28 costimulation is dispensable for gamma delta T cell activation and differentiation, we assessed glucose uptake and utilization by gamma delta T cells, as CD28 costimulation is known to promote glycolysis in alpha beta T cells. Importantly, we found that gamma delta T cells express higher surface levels of glucose transporters than alpha beta T cells and, when activated, exhibit effector functions over a broader range of glucose concentrations than activated alpha beta T cells. Together, these data not only demonstrate an enhanced glucose metabolism in gamma delta T cells but also provide an explanation for why gamma delta T cells are less dependent on CD28 costimulation than alpha beta T cells.	[Laird, Renee M.; Wolf, Benjamin J.; Princiotta, Michael F.; Hayes, Sandra M.] SUNY Upstate Med Univ, Dept Microbiol & Immunol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Hayes, SM (corresponding author), SUNY Upstate Med Univ, Dept Microbiol & Immunol, Syracuse, NY 13210 USA.	HayesSa@upstate.edu			American Heart Association [0835319N]; National Institutes of Health [R21 AI090516-01, R56 AI091908]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI090516, R56AI091908] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by grants from American Heart Association (0835319N) and National Institutes of Health (R21 AI090516-01 and R56 AI091908). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuto O, 2003, NAT REV IMMUNOL, V3, P939, DOI 10.1038/nri1248; Agosti V, 2004, J EXP MED, V199, P867, DOI 10.1084/jem.20031983; Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; Awasthi A, 2009, J IMMUNOL, V182, P5904, DOI 10.4049/jimmunol.0900732; Aydintug MK, 2008, MOL IMMUNOL, V45, P3253, DOI 10.1016/j.molimm.2008.02.031; Bautista JL, 2009, NAT IMMUNOL, V10, P610, DOI 10.1038/ni.1739; Benlagha K, 2005, J EXP MED, V202, P485, DOI 10.1084/jem.20050456; Benlagha K, 2002, SCIENCE, V296, P553, DOI 10.1126/science.1069017; BOISE LH, 1995, IMMUNITY, V3, P87, DOI 10.1016/1074-7613(95)90161-2; Brzoza KL, 2004, J IMMUNOL, V173, P2641, DOI 10.4049/jimmunol.173.4.2641; Butte MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040032; ELASED K, 1994, INFECT IMMUN, V62, P5157, DOI 10.1128/IAI.62.11.5157-5160.1994; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Fu YC, 2004, BLOOD CELL MOL DIS, V32, P182, DOI 10.1016/j.bcmd.2003.09.002; Ganguly A, 2007, AM J PHYSIOL-ENDOC M, V292, pE1241, DOI 10.1152/ajpendo.00344.2006; Haas J, 2009, NATION, V289, P6; Hamada S, 2008, J IMMUNOL, V181, P3456, DOI 10.4049/jimmunol.181.5.3456; Hamada S, 2008, IMMUNOLOGY, V125, P170, DOI 10.1111/j.1365-2567.2008.02841.x; HARDING FA, 1992, NATURE, V356, P607, DOI 10.1038/356607a0; Hayes SM, 2005, IMMUNITY, V22, P583, DOI 10.1016/j.immuni.2005.03.014; Hayes SM, 2002, IMMUNITY, V16, P827, DOI 10.1016/S1074-7613(02)00320-5; Huang JX, 2005, J IMMUNOL, V175, P4858, DOI 10.4049/jimmunol.175.8.4858; Jacobs SR, 2008, J IMMUNOL, V180, P4476, DOI 10.4049/jimmunol.180.7.4476; JENKINS MK, 1991, J IMMUNOL, V147, P2461; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; Kang JS, 1998, IMMUNITY, V8, P713, DOI 10.1016/S1074-7613(00)80576-2; Laird RM, 2010, J IMMUNOL, V185, P6518, DOI 10.4049/jimmunol.1002766; Laird RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008899; Li C, 1999, INFECT IMMUN, V67, P4435, DOI 10.1128/IAI.67.9.4435-4442.1999; Lind EF, 2001, J EXP MED, V194, P127, DOI 10.1084/jem.194.2.127; LINDSTEN T, 1989, SCIENCE, V244, P339, DOI 10.1126/science.2540528; Maratou E, 2007, EUR J CLIN INVEST, V37, P282, DOI 10.1111/j.1365-2362.2007.01786.x; Marko AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015425; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Meeks KD, 2009, J IMMUNOL, V183, P8026, DOI 10.4049/jimmunol.0901588; Miller J, 2009, IMMUNOL RES, V45, P159, DOI 10.1007/s12026-009-8097-6; Mittrucker HW, 2001, J IMMUNOL, V167, P5620, DOI 10.4049/jimmunol.167.10.5620; Park K, 2010, EMBO J, V29, P2329, DOI 10.1038/emboj.2010.113; Pellicci DG, 2002, J EXP MED, V195, P835, DOI 10.1084/jem.20011544; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Rathmell JC, 2000, MOL CELL, V6, P683, DOI 10.1016/S1097-2765(00)00066-6; Ribot JC, 2012, J IMMUNOL, V189, P1202, DOI 10.4049/jimmunol.1200268; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Shah DK, 2004, J IMMUNOL, V172, P2296, DOI 10.4049/jimmunol.172.4.2296; Shedlock DJ, 2003, J IMMUNOL, V170, P2053, DOI 10.4049/jimmunol.170.4.2053; Silva-Santos B, 2005, SCIENCE, V307, P925, DOI 10.1126/science.1103978; SIM GK, 1995, J IMMUNOL, V154, P5821; Simpson IA, 2008, AM J PHYSIOL-ENDOC M, V295, pE242, DOI 10.1152/ajpendo.90388.2008; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Tai XG, 2005, NAT IMMUNOL, V6, P152, DOI 10.1038/ni1160; TAN P, 1993, J EXP MED, V177, P165, DOI 10.1084/jem.177.1.165; Teague TK, 2010, INT IMMUNOL, V22, P387, DOI 10.1093/intimm/dxq020; Telford W, 2005, CYTOM PART A, V68A, P36, DOI 10.1002/cyto.a.20182; vonFreedenJeffry U, 1997, IMMUNITY, V7, P147, DOI 10.1016/S1074-7613(00)80517-8; WILDER MS, 1967, J BACTERIOL, V93, P538, DOI 10.1128/JB.93.2.538-543.1967; Williams JA, 2005, J IMMUNOL, V175, P4199, DOI 10.4049/jimmunol.175.7.4199; Williams JA, 2008, J IMMUNOL, V181, P907, DOI 10.4049/jimmunol.181.2.907; Wofford JA, 2008, BLOOD, V111, P2101, DOI 10.1182/blood-2007-06-096297; Wolf BJ, 2011, MOL IMMUNOL, V48, P463, DOI 10.1016/j.molimm.2010.10.002; Wolf BJ, 2013, J IMMUNOL; Xu S, 2010, J IMMUNOL, V185, P5879, DOI 10.4049/jimmunol.1001763; Yu Q, 2003, J EXP MED, V197, P475, DOI 10.1084/jem.20021765; Zheng XC, 2004, J IMMUNOL, V173, P2253, DOI 10.4049/jimmunol.173.4.2253; Zheng XC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002703	64	14	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63178	10.1371/journal.pone.0063178	http://dx.doi.org/10.1371/journal.pone.0063178			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671671	Green Submitted, Green Published, gold			2022-12-25	WOS:000319737700049
J	Barbizan, R; Castro, MV; Rodrigues, AC; Barraviera, B; Ferreira, RS; Oliveira, ALR				Barbizan, Roberta; Castro, Mateus V.; Rodrigues, Antonio C.; Barraviera, Benedito; Ferreira, Rui S.; Oliveira, Alexandre L. R.			Motor Recovery and Synaptic Preservation after Ventral Root Avulsion and Repair with a Fibrin Sealant Derived from Snake Venom	PLOS ONE			English	Article							CROTALUS-DURISSUS-TERRIFICUS; SPINAL-CORD IMPLANTATION; REDUCES MOTONEURON DEATH; FOCAL CEREBRAL-ISCHEMIA; BRACHIAL-PLEXUS INJURY; BLOOD-BRAIN-BARRIER; CNS SCAR TISSUE; FUNCTIONAL RECOVERY; ADULT-RAT; REGENERATION	Background: Ventral root avulsion is an experimental model of proximal axonal injury at the central/peripheral nervous system interface that results in paralysis and poor clinical outcome after restorative surgery. Root reimplantation may decrease neuronal degeneration in such cases. We describe the use of a snake venom-derived fibrin sealant during surgical reconnection of avulsed roots at the spinal cord surface. The present work investigates the effects of this fibrin sealant on functional recovery, neuronal survival, synaptic plasticity, and glial reaction in the spinal motoneuron microenvironment after ventral root reimplantation. Methodology/Principal Findings: Female Lewis rats (7 weeks old) were subjected to VRA and root replantation. The animals were divided into two groups: 1) avulsion only and 2) replanted roots with fibrin sealant derived from snake venom. Post-surgical motor performance was evaluated using the CatWalk system twice a week for 12 weeks. The rats were sacrificed 12 weeks after surgery, and their lumbar intumescences were processed for motoneuron counting and immunohistochemistry (GFAP, Iba-1 and synaptophysin antisera). Array based qRT-PCR was used to evaluate gene regulation of several neurotrophic factors and receptors as well as inflammatory related molecules. The results indicated that the root reimplantation with fibrin sealant enhanced motor recovery, preserved the synaptic covering of the motoneurons and improved neuronal survival. The replanted group did not show significant changes in microglial response compared to VRA-only. However, the astroglial reaction was significantly reduced in this group. Conclusions/Significance: In conclusion, the present data suggest that the repair of avulsed roots with snake venom fibrin glue at the exact point of detachment results in neuroprotection and preservation of the synaptic network at the microenvironment of the lesioned motoneurons. Also such procedure reduced the astroglial reaction and increased mRNA levels to neurotrophins and anti-inflammatory cytokines that may in turn, contribute to improving recovery of motor function.	[Barbizan, Roberta; Castro, Mateus V.; Oliveira, Alexandre L. R.] Univ Estadual Campinas, UNICAMP, Dept Struct & Funct Biol, Lab Nerve Regenerat, Campinas, SP, Brazil; [Rodrigues, Antonio C.] FOB USP, Bauru, Brazil; [Barraviera, Benedito; Ferreira, Rui S.] CEVAP Unesp, Botucatu, SP, Brazil	Universidade Estadual de Campinas	Oliveira, ALR (corresponding author), Univ Estadual Campinas, UNICAMP, Dept Struct & Funct Biol, Lab Nerve Regenerat, Campinas, SP, Brazil.	alroliv@unicamp.br	Oliveira, Alexandre L. R./C-4436-2012; Ferreira, Rui Seabra/R-5920-2019; Oliveira, Alexandre/AAI-6815-2020; Barraviera, Benedito/C-6511-2012; Ferreira, Rui Seabra/D-1285-2012; Castro, Mateus Vidigal de/CAA-2167-2022; Rodrigues, Antonio/G-6851-2012; Ferreira, Rui/D-1285-2012	Oliveira, Alexandre L. R./0000-0003-4224-4575; Ferreira, Rui Seabra/0000-0001-6952-0512; Oliveira, Alexandre/0000-0003-4224-4575; Barraviera, Benedito/0000-0002-9855-5594; Ferreira, Rui Seabra/0000-0001-6952-0512; Castro, Mateus Vidigal de/0000-0002-8895-652X; Ferreira, Rui/0000-0003-1856-2792	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [2010/0986-5, 2013/06574-9, 2010/00729-2]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq [563582/2010-3]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior CAPES (AUX-PE Toxinology) [1219/2011, 23038.000823/2011-21]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior CAPES (AUX-PE Toxinology)	The present work was supported by grants from: Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP (2010/0986-5, 2013/06574-9), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (563582/2010-3) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior CAPES (AUX-PE Toxinology 1219/2011, 23038.000823/2011-21). RSF is a CNPq DTI fellow researcher (310207/2011-8). ALRO is a CNPq fellow researcher (300789/2009-2). RB was supported by a scholarship from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP (2010/00729-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1946, J ANAT, V80, P37; Aldskogius H, 1999, J NEUROSCI RES, V58, P33, DOI 10.1002/(SICI)1097-4547(19991001)58:1<33::AID-JNR5>3.3.CO;2-D; ALEXANDER G, 1988, TOXICON, V26, P953, DOI 10.1016/0041-0101(88)90260-7; Arvanian VL, 2001, EUR J NEUROSCI, V14, P1800, DOI 10.1046/j.0953-816x.2001.01811.x; Asher R A, 2001, Prog Brain Res, V132, P611; BAIN JR, 1989, PLAST RECONSTR SURG, V83, P129, DOI 10.1097/00006534-198901000-00024; Barrabin H, 1978, TOXINS ANIMALS PLANT, P133; Barros LC, 2009, J TOXICOL ENV HEAL B, V12, P553, DOI 10.1080/10937400903442514; Bigbee AJ, 2007, EXP NEUROL, V204, P273, DOI 10.1016/j.expneurol.2006.11.003; Bitar-Alatorre WE, 2011, NEUROSCI LETT, V491, P18, DOI 10.1016/j.neulet.2010.12.062; Brannstrom T, 1998, EXP BRAIN RES, V118, P1, DOI 10.1007/s002210050249; CARLSTEDT T, 1986, ACTA PHYSIOL SCAND, V128, P645, DOI 10.1111/j.1748-1716.1986.tb08024.x; Carlstedt T, 2008, RESTOR NEUROL NEUROS, V26, P225; Carlstedt T, 2009, NEUROSURG CLIN N AM, V20, P39, DOI 10.1016/j.nec.2008.07.020; CARLSTEDT TP, 1993, J NEUROL NEUROSUR PS, V56, P649, DOI 10.1136/jnnp.56.6.649; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; CULLHEIM S, 1989, NEUROSCIENCE, V29, P725, DOI 10.1016/0306-4522(89)90144-9; Cullheim S, 2007, BRAIN RES REV, V55, P89, DOI 10.1016/j.brainresrev.2007.03.012; de Vries J, 2002, SURG NEUROL, V57, P415, DOI 10.1016/S0090-3019(02)00736-X; DELGADOGARCIA JM, 1988, NEUROSCIENCE, V24, P143, DOI 10.1016/0306-4522(88)90319-3; Eggers R, 2010, EXP NEUROL, V223, P207, DOI 10.1016/j.expneurol.2009.07.021; Freria CM, 2011, SYNAPSE, V66, P128; FRISEN J, 1993, INT J DEV NEUROSCI, V11, P461, DOI 10.1016/0736-5748(93)90020-E; Gasparini Andréa Licre Pessina, 2007, Acta ortop. bras., V15, P285, DOI 10.1590/S1413-78522007000500011; Gordon T, 2003, J PERIPHER NERV SYST, V8, P236, DOI 10.1111/j.1085-9489.2003.03029.x; Griffiths MR, 2009, J NEUROPATH EXP NEUR, V68, P217, DOI 10.1097/NEN.0b013e3181996688; Hallin RG, 1999, EXP BRAIN RES, V124, P304, DOI 10.1007/s002210050627; Havton LA, 2009, CURR OPIN NEUROL, V22, P570, DOI 10.1097/WCO.0b013e328331b63f; Hoke A, 1996, PROG BRAIN RES, V108, P149, DOI 10.1016/S0079-6123(08)62538-8; Hoke A, 2006, NAT CLIN PRACT NEURO, V2, P448, DOI 10.1038/ncpneuro0262; Kachramanoglou C, 2013, NEUROREHAB NEURAL RE, V27, P118, DOI 10.1177/1545968312457825; Kalmar B, 2002, EXP NEUROL, V176, P87, DOI 10.1006/exnr.2002.7945; Kawano H, 2012, CELL TISSUE RES, V349, P169, DOI 10.1007/s00441-012-1336-5; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kishino A, 1997, EXP NEUROL, V144, P273, DOI 10.1006/exnr.1996.6367; KOLIATSOS VE, 1994, J COMP NEUROL, V342, P35, DOI 10.1002/cne.903420105; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; KUNO M, 1970, J PHYSIOL-LONDON, V210, P823, DOI 10.1113/jphysiol.1970.sp009244; Loddick SA, 1998, J CEREBR BLOOD F MET, V18, P176, DOI 10.1097/00004647-199802000-00008; LOWERY OH, 1951, J BIOL CHEM, V193, P265; Marland FS, 1977, CHEM BIOL TROMBIN, P71; MOLANDER C, 1985, J COMP NEUROL, V237, P476, DOI 10.1002/cne.902370405; NOVIKOV L, 1995, NEUROSCI LETT, V200, P45, DOI 10.1016/0304-3940(95)12078-I; Ohlsson M, 2006, EXP BRAIN RES, V170, P52, DOI 10.1007/s00221-005-0188-6; Oliet SHR, 2001, SCIENCE, V292, P923, DOI 10.1126/science.1059162; Oliveira ALR, 2000, NEUROSCI LETT, V293, P131, DOI 10.1016/S0304-3940(00)01506-8; Oliveira ALR, 2004, P NATL ACAD SCI USA, V101, P17843, DOI 10.1073/pnas.0408154101; Penas C, 2011, J NEUROTRAUM, V28, P831, DOI 10.1089/neu.2010.1674; Penas C, 2009, J NEUROTRAUM, V26, P763, DOI [10.1089/neu.2008.0661, 10.1089/neu.2008-0661]; Piehl F, 1999, J NEUROIMMUNOL, V101, P87, DOI 10.1016/S0165-5728(99)00136-8; Pinter S, 2010, J NEUROTRAUM, V27, P2273, DOI 10.1089/neu.2010.1445; PURVES D, 1975, J PHYSIOL-LONDON, V252, P429, DOI 10.1113/jphysiol.1975.sp011151; RISLING M, 1993, BRAIN RES BULL, V30, P405, DOI 10.1016/0361-9230(93)90272-D; RISLING M, 1989, BRAIN RES, V494, P13, DOI 10.1016/0006-8993(89)90138-8; SENDTNER M, 1991, J CELL SCI, P103; Shimazawa M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015307; SJOGREN A, 1991, BRAIN RES, V559, P276, DOI 10.1016/0006-8993(91)90012-K; TAKATA M, 1983, NEUROSCIENCE, V10, P23, DOI 10.1016/0306-4522(83)90077-5; Terzis JK, 2001, WORLD J SURG, V25, P1049, DOI 10.1007/s00268-001-0058-8; Tom VJ, 2004, J NEUROSCI, V24, P6531, DOI 10.1523/JNEUROSCI.0994-04.2004; TOULMOND S, 1992, NEUROSCI LETT, V144, P49, DOI 10.1016/0304-3940(92)90713-H; Unoki M, 2003, INT J ONCOL, V22, P1217; Wang DD, 2008, PROG NEUROBIOL, V86, P342, DOI 10.1016/j.pneurobio.2008.09.015; Wu JC, 2009, J NEUROSURG, V110, P775, DOI 10.3171/2008.8.JNS08328; WU WT, 1993, NEUROSCI LETT, V153, P121, DOI 10.1016/0304-3940(93)90303-3; Yang K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S4-S8; Zhang ZH, 2008, NEUROSCI LETT, V444, P227, DOI 10.1016/j.neulet.2008.08.049	67	49	49	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63260	10.1371/journal.pone.0063260	http://dx.doi.org/10.1371/journal.pone.0063260			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667596	gold, Green Submitted, Green Published			2022-12-25	WOS:000319654700126
J	Berndt, B; Haverkampf, S; Reith, G; Keil, S; Niggemann, B; Zanker, KS; Dittmar, T				Berndt, Benjamin; Haverkampf, Sonja; Reith, Georg; Keil, Silvia; Niggemann, Bernd; Zaenker, Kurt S.; Dittmar, Thomas			Fusion of CCL21 Non-Migratory Active Breast Epithelial and Breast Cancer Cells Give Rise to CCL21 Migratory Active Tumor Hybrid Cell Lines	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CCR7; LYMPH-NODE METASTASIS; TUMORIGENIC HYBRIDS; HEMATOPOIETIC STEM; LIGANDS; ACTIVATION; CXCR4; MACROPHAGES; CHEMOTAXIS; EXPRESSION	The biological phenomenon of cell fusion has been linked to tumor progression because several data provided evidence that fusion of tumor cells and normal cells gave rise to hybrid cell lines exhibiting novel properties, such as increased metastatogenic capacity and an enhanced drug resistance. Here we investigated M13HS hybrid cell lines, derived from spontaneous fusion events between M13SV1-EGFP-Neo breast epithelial cells exhibiting stem cell characteristics and HS578T-Hyg breast cancer cells, concerning CCL21/CCR7 signaling. Western Blot analysis showed that all cell lines varied in their CCR7 expression levels as well as differed in the induction and kinetics of CCR7 specific signal transduction cascades. Flow cytometry-based calcium measurements revealed that a CCL21 induced calcium influx was solely detected in M13HS hybrid cell lines. Cell migration demonstrated that only M13HS hybrid cell lines, but not parental derivatives, responded to CCL21 stimulation with an increased migratory activity. Knockdown of CCR7 expression by siRNA completely abrogated the CCL21 induced migration of hybrid cell lines indicating the necessity of CCL21/CCR7 signaling. Because the CCL21/CCR7 axis has been linked to metastatic spreading of breast cancer to lymph nodes we conclude from our data that cell fusion could be a mechanism explaining the origin of metastatic cancer (hybrid) cells.	[Berndt, Benjamin; Haverkampf, Sonja; Reith, Georg; Keil, Silvia; Niggemann, Bernd; Zaenker, Kurt S.; Dittmar, Thomas] Univ Witten Herdecke, Inst Immunol, Ctr Biomed Educ & Res ZBAF, Witten, Germany	Witten Herdecke University	Dittmar, T (corresponding author), Univ Witten Herdecke, Inst Immunol, Ctr Biomed Educ & Res ZBAF, Witten, Germany.	thomas.dittmar@uni-wh.de	Dittmar, Thomas/T-6679-2019; Dittmar, Thomas/X-3691-2019		Verein zur Forderung der Krebsforschung e.V., Berlin, Germany; Westermann-Westdorp-Foundation, Essen, Germany; Fritz-Bender-Foundation, Munich, Germany	Verein zur Forderung der Krebsforschung e.V., Berlin, Germany; Westermann-Westdorp-Foundation, Essen, Germany; Fritz-Bender-Foundation, Munich, Germany	This work was supported by the Verein zur Forderung der Krebsforschung e.V., Berlin, Germany, the Westermann-Westdorp-Foundation, Essen, Germany and the Fritz-Bender-Foundation, Munich, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichel O., 1911, ZELLVERSCHMELZUNG QU; Andersen TL, 2007, J PATHOL, V211, P10, DOI 10.1002/path.2078; Balz LM, 2012, J PATHOL, V227, P234, DOI 10.1002/path.3991; Bardi G, 2001, EUR J IMMUNOL, V31, P3291, DOI 10.1002/1521-4141(200111)31:11<3291::AID-IMMU3291>3.0.CO;2-Z; Berndt Benjamin, 2013, Critical Reviews in Oncogenesis, V18, P97; Borroni EM, 2008, IMMUNOL INVEST, V37, P483, DOI 10.1080/08820130802191318; Britschgi MR, 2010, EUR J IMMUNOL, V40, P1266, DOI 10.1002/eji.200939921; Busund LTR, 2002, INT J CANCER, V100, P407, DOI 10.1002/ijc.10502; Busund LTR, 2002, INT J CANCER, V98, P573, DOI 10.1002/ijc.10249; Cabioglu N, 2005, CLIN CANCER RES, V11, P5686, DOI 10.1158/1078-0432.CCR-05-0014; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Chakraborty AK, 2001, GENE, V275, P103, DOI 10.1016/S0378-1119(01)00647-3; Chakraborty AK, 2000, CANCER RES, V60, P2512; Chang CC, 2001, RADIAT RES, V155, P201, DOI 10.1667/0033-7587(2001)155[0201:AHBECT]2.0.CO;2; Comerford I, 2007, BIOESSAYS, V29, P237, DOI 10.1002/bies.20537; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cunningham HD, 2010, TRANSL ONCOL, V3, P354, DOI 10.1593/tlo.10178; Davies PS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006530; Dittma T, 2008, CLIN EXP METASTAS, V25, P11, DOI 10.1007/s10585-007-9095-5; Dittmar T, 2000, ANTISENSE NUCLEIC A, V10, P401, DOI 10.1089/oli.1.2000.10.401; Dittmar T, 2012, CURRENT MOL IN PRESS; Dittmar T, 2011, CELL FUSION HLTH DIS, P1; Dittmar T, 2011, CLIN EXP METASTAS, V28, P75, DOI 10.1007/s10585-010-9359-3; Dittmar T, 2009, MED HYPOTHESES, V73, P542, DOI 10.1016/j.mehy.2009.05.044; Duelli D, 2003, CANCER CELL, V3, P445, DOI 10.1016/S1535-6108(03)00114-4; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Gergely L, 1997, CLIN DIAGN LAB IMMUN, V4, P70, DOI 10.1128/CDLI.4.1.70-74.1997; Goldenberg DM, 2012, INT J CANCER, V131, P49, DOI 10.1002/ijc.26327; GOLDENBERG DM, 1974, NATURE, V250, P649, DOI 10.1038/250649a0; GOLDENBERG DM, 1971, CANCER RES, V31, P1148; Gollmer K, 2009, BLOOD, V114, P580, DOI 10.1182/blood-2009-01-200923; Gunn MD, 1998, P NATL ACAD SCI USA, V95, P258, DOI 10.1073/pnas.95.1.258; Haessler U, 2011, P NATL ACAD SCI USA, V108, P5614, DOI 10.1073/pnas.1014920108; Heyder C, 2005, CLIN EXP METASTAS, V22, P99, DOI 10.1007/s10585-005-4335-z; Jacob A, 2002, J BIOL CHEM, V277, P23420, DOI 10.1074/jbc.M202485200; Jacobsen BM, 2006, CANCER RES, V66, P8274, DOI 10.1158/0008-5472.CAN-06-1456; Kassmer SH, 2008, BIOL CHEM, V389, P863, DOI 10.1515/BC.2008.099; Kochetkova M, 2009, CELL DEATH DIFFER, V16, P664, DOI 10.1038/cdd.2008.190; Kohout TA, 2004, J BIOL CHEM, V279, P23214, DOI 10.1074/jbc.M402125200; Kollet O, 2002, BLOOD, V100, P2778, DOI 10.1182/blood-2002-02-0564; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARIZZA L, 1984, CANCER METAST REV, V3, P193, DOI 10.1007/BF00048385; Li J, 2011, DIGEST LIVER DIS, V43, P40, DOI 10.1016/j.dld.2010.05.013; Liu YX, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-16; LopezIlasaca M, 1997, SCIENCE, V275, P394, DOI 10.1126/science.275.5298.394; Lu X, 2009, CANCER RES, V69, P8536, DOI 10.1158/0008-5472.CAN-09-2159; Lu X, 2009, P NATL ACAD SCI USA, V106, P9385, DOI 10.1073/pnas.0900108106; Luo C, 1998, EXP CELL RES, V243, P282, DOI 10.1006/excr.1998.4170; Mekler L B, 1971, Vestn Akad Med Nauk SSSR, V26, P75; Mekler L B, 1971, Vestn Akad Med Nauk SSSR, V26, P80; MILLER FR, 1989, CANCER RES, V49, P4316; MILLER FR, 1988, J CELL BIOCHEM, V36, P129, DOI 10.1002/jcb.240360204; Nagler C, 2011, CANCER CELL INT, V11, DOI 10.1186/1475-2867-11-21; Ozel C, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-10; Otero C, 2006, J IMMUNOL, V177, P2314, DOI 10.4049/jimmunol.177.4.2314; Parris GE, 2005, MED HYPOTHESES, V64, P1011, DOI 10.1016/j.mehy.2004.11.012; Pawelek JM, 2008, NAT REV CANCER, V8, P377, DOI 10.1038/nrc2371; Powell AE, 2011, CANCER RES, V71, P1497, DOI 10.1158/0008-5472.CAN-10-3223; Rachkovsky M, 1998, CLIN EXP METASTAS, V16, P299; Rachkovsky M, 1999, CELL GROWTH DIFFER, V10, P517; Rappa G, 2012, AM J PATHOL, V180, P2504, DOI 10.1016/j.ajpath.2012.02.020; Redondo-Munoz J, 2008, BLOOD, V111, P383, DOI 10.1182/blood-2007-08-107300; Sanchez-Sanchez N, 2006, J IMMUNOL, V176, P5153, DOI 10.4049/jimmunol.176.9.5153; Seidel J, 2007, STEM CELLS DEV, V16, P827, DOI 10.1089/scd.2007.0004; Silvestris F, 2011, ADV EXP MED BIOL, V714, P113, DOI 10.1007/978-94-007-0782-5_5; Sullivan SK, 1999, BIOCHEM BIOPH RES CO, V263, P685, DOI 10.1006/bbrc.1999.1442; Townson JR, 2002, EUR J IMMUNOL, V32, P1230, DOI 10.1002/1521-4141(200205)32:5<1230::AID-IMMU1230>3.0.CO;2-L; vonWillebrand M, 1996, EUR J BIOCHEM, V235, P828; WAKELING WF, 1994, CELL BIOL INT, V18, P207, DOI 10.1006/cbir.1994.1063; Wang J, 2005, ONCOGENE, V24, P5897, DOI 10.1038/sj.onc.1208740; Wang RX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042653; Wennstrom S, 1999, MOL CELL BIOL, V19, P4279; Wiley HE, 2001, J NATL CANCER I, V93, P1638, DOI 10.1093/jnci/93.21.1638; Willimann K, 1998, EUR J IMMUNOL, V28, P2025, DOI 10.1002/(SICI)1521-4141(199806)28:06<2025::AID-IMMU2025>3.0.CO;2-C; Yang JY, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-388; Zidar DA, 2009, P NATL ACAD SCI USA, V106, P9649, DOI 10.1073/pnas.0904361106; Zmajkovicova K, 2013, MOL CELL, DOI DOI 10.1016/J.M0LCEL.2013.1001.1037	78	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63711	10.1371/journal.pone.0063711	http://dx.doi.org/10.1371/journal.pone.0063711			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667660	Green Published, gold, Green Submitted			2022-12-25	WOS:000319654700178
J	Fukata, M; Ishikawa, F; Najima, Y; Yamauchi, T; Saito, Y; Takenaka, K; Miyawaki, K; Shimazu, H; Shimoda, K; Kanemaru, T; Nakamura, K; Odashiro, K; Nagafuji, K; Harada, M; Akashi, K				Fukata, Mitsuhiro; Ishikawa, Fumihiko; Najima, Yuho; Yamauchi, Takuji; Saito, Yoriko; Takenaka, Katsuto; Miyawaki, Kohta; Shimazu, Hideki; Shimoda, Kazuya; Kanemaru, Takaaki; Nakamura, Kei-ichiro; Odashiro, Keita; Nagafuji, Koji; Harada, Mine; Akashi, Koichi			Contribution of Bone Marrow-Derived Hematopoietic Stem/Progenitor Cells to the Generation of Donor-Marker(+) Cardiomyocytes In Vivo	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; ACUTE MYOCARDIAL-INFARCTION; VASCULAR ENDOTHELIUM; MYELOMONOCYTIC CELLS; PURKINJE NEURONS; PROGENITOR CELLS; SKELETAL-MUSCLE; HOST ORIGIN; FUSION; HEART	Background: Definite identification of the cell types and the mechanism relevant to cardiomyogenesis is essential for effective cardiac regenerative medicine. We aimed to identify the cell populations that can generate cardiomyocytes and to clarify whether generation of donor-marker(+) cardiomyocytes requires cell fusion between BM-derived cells and recipient cardiomyocytes. Methodology/Principal Findings: Purified BM stem/progenitor cells from green fluorescence protein (GFP) mice were transplanted into C57BL/6 mice or cyan fluorescence protein (CFP)-transgenic mice. Purified human hematopoietic stem cells (HSCs) from cord blood were transplanted into immune-compromised NOD/SCID/IL2r gamma(null) mice. GFP(+) cells in the cardiac tissue were analyzed for the antigenecity of a cardiomyocyte by confocal microscopy following immunofluorescence staining. GFP(+) donor-derived cells, GFP(+)CFP(+) fused cells, and CFP+ recipient-derived cells were distinguished by linear unmixing analysis. Hearts of xenogeneic recipients were evaluated for the expression of human cardiomyocyte genes by real-time quantitative polymerase chain reaction. In C57BL/6 recipients, Lin(-/low)CD45(+) hematopoietic cells generated greater number of GFP(+) cardiomyocytes than Lin(-/low)CD45(-) mesenchymal cells (37.0+/-23.9 vs 0.00+/-0.00 GFP(+) cardiomyocytes per a recipient, P = 0.0095). The number of transplanted purified HSCs (Lin(-/low)Sca-1(+) or Lin(-)Sca-1(+)c-Kit(+) or CD34(-)Lin(-)Sca-1(+)c-Kit(+)) showed correlation to the number of GFP(+) cardiomyocytes (P<0.05 in each cell fraction), and the incidence of GFP(+) cardiomyocytes per injected cell dose was greatest in CD34(-)Lin(-)Sca-1(+)c-Kit(+) recipients. Of the hematopoietic progenitors, total myeloid progenitors generated greater number of GFP(+) cardiomyocytes than common lymphoid progenitors (12.8+/-10.7 vs 0.67+/-1.00 GFP(+) cardiomyocytes per a recipient, P = 0.0021). In CFP recipients, all GFP(+) cardiomyocytes examined coexpressed CFP. Human troponin C and myosin heavy chain 6 transcripts were detected in the cardiac tissue of some of the xenogeneic recipients. Conclusions/Significance: Our results indicate that HSCs resulted in the generation of cardiomyocytes via myeloid intermediates by fusion-dependent mechanism. The use of myeloid derivatives as donor cells could potentially allow more effective cell-based therapy for cardiac repair.	[Fukata, Mitsuhiro; Ishikawa, Fumihiko; Yamauchi, Takuji; Takenaka, Katsuto; Miyawaki, Kohta; Shimazu, Hideki; Odashiro, Keita; Harada, Mine; Akashi, Koichi] Kyushu Univ, Grad Sch Med Sci, Dept Med & Biosyst Sci, Fukuoka 812, Japan; [Ishikawa, Fumihiko; Najima, Yuho; Saito, Yoriko] RIKEN Res Ctr Allergy & Immunol, Lab Human Dis Models, Yokohama, Kanagawa, Japan; [Shimoda, Kazuya] Miyazaki Univ, Fac Med, Dept Gastroenterol & Hematol, Miyazaki, Japan; [Kanemaru, Takaaki] Kyushu Univ, Morphol Core, Fukuoka 812, Japan; [Nakamura, Kei-ichiro] Kurume Univ, Sch Med, Dept Anat 2, Kurume, Fukuoka 830, Japan; [Nagafuji, Koji] Kurume Univ, Sch Med, Dept Med, Div Hematol & Oncol, Kurume, Fukuoka 830, Japan; [Akashi, Koichi] Kyushu Univ Hosp, Ctr Cellular & Mol Med, Fukuoka 812, Japan	Kyushu University; RIKEN; University of Miyazaki; Kyushu University; Kurume University; Kurume University; Kyushu University	Fukata, M (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Med & Biosyst Sci, Fukuoka 812, Japan.	mfukata-circ@umin.net; f_ishika@rcai.riken.jp	Najima, Yuho/W-3858-2019; 石川, 文彦/L-4488-2014	Najima, Yuho/0000-0001-8910-0021; Odashiro, Keita/0000-0003-0347-6330	Grants-in-Aid for Scientific Research [24659463] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Bailey AS, 2006, P NATL ACAD SCI USA, V103, P13156, DOI 10.1073/pnas.0604203103; Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Barile L, 2011, J CELL MOL MED, V15, P63, DOI 10.1111/j.1582-4934.2009.00968.x; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Breitbach M, 2007, BLOOD, V110, P1362, DOI 10.1182/blood-2006-12-063412; Bruneau BG, 2002, CIRC RES, V90, P509, DOI 10.1161/01.RES.0000013072.51957.B7; Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Camargo FD, 2004, J CLIN INVEST, V113, P1266, DOI 10.1172/JCI200421301; Camargo FD, 2003, NAT MED, V9, P1520, DOI 10.1038/nm963; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Dayan V, 2011, BASIC RES CARDIOL, V106, P1299, DOI 10.1007/s00395-011-0221-9; Dimmeler S, 2005, J CLIN INVEST, V115, P572, DOI 10.1172/JCI200524283; Doyonnas R, 2004, P NATL ACAD SCI USA, V101, P13507, DOI 10.1073/pnas.0405361101; Ferreira-Martins J, 2012, CIRC RES, V110, P701, DOI 10.1161/CIRCRESAHA.111.259507; Genead R, 2010, STEM CELLS DEV, V19, P1601, DOI 10.1089/scd.2009.0483; Harris RG, 2004, SCIENCE, V305, P90, DOI 10.1126/science.1098925; Helming L, 2007, IMMUNOBIOLOGY, V212, P785, DOI 10.1016/j.imbio.2007.09.012; Herzog EL, 2007, FASEB J, V21, P2592, DOI 10.1096/fj.06-7861com; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Ishikawa F, 2006, FASEB J, V20, P950, DOI 10.1096/fj.05-4863fje; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; Jang YY, 2004, NAT CELL BIOL, V6, P532, DOI 10.1038/ncb1132; Jeevanantham V, 2012, CIRCULATION, V126, P551, DOI 10.1161/CIRCULATIONAHA.111.086074; Kajstura J, 2005, CIRC RES, V96, P127, DOI 10.1161/01.RES.0000151843.79801.60; Kawada H, 2004, BLOOD, V104, P3581, DOI 10.1182/blood-2004-04-1488; Koide Y, 2007, STEM CELLS, V25, P1213, DOI 10.1634/stemcells.2006-0325; Kucia M, 2007, LEUKEMIA, V21, P297, DOI 10.1038/sj.leu.2404470; Laflamme MA, 2002, CIRC RES, V90, P634, DOI 10.1161/01.RES.0000014822.62629.EB; LAVER J, 1987, BLOOD, V70, P1966; Metzele R, 2011, FASEB J, V25, P830, DOI 10.1096/fj.09-153221; Meyer GP, 2006, CIRCULATION, V113, P1287, DOI 10.1161/CIRCULATIONAHA.105.575118; Muller P, 2002, CIRCULATION, V106, P31, DOI 10.1161/01.CIR.0000022405.68464.CA; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Neijssen J, 2007, PROG BIOPHYS MOL BIO, V94, P207, DOI 10.1016/j.pbiomolbio.2007.03.008; Noiseux N, 2006, MOL THER, V14, P840, DOI 10.1016/j.ymthe.2006.05.016; Nygren JM, 2004, NAT MED, V10, P494, DOI 10.1038/nm1040; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Pearson T, 2008, CLIN EXP IMMUNOL, V154, P270, DOI 10.1111/j.1365-2249.2008.03753.x; Quaini F, 2002, NEW ENGL J MED, V346, P5, DOI 10.1056/NEJMoa012081; Rose RA, 2008, STEM CELLS, V26, P2884, DOI 10.1634/stemcells.2008-0329; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SIMMONS PJ, 1987, NATURE, V328, P429, DOI 10.1038/328429a0; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Weimann JM, 2003, NAT CELL BIOL, V5, P959, DOI 10.1038/ncb1053; Willenbring H, 2004, NAT MED, V10, P744, DOI 10.1038/nm1062; Yamauchi T, 2013, BLOOD, V121, P1316, DOI 10.1182/blood-2012-06-440354	50	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62506	10.1371/journal.pone.0062506	http://dx.doi.org/10.1371/journal.pone.0062506			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667482	Green Published, gold, Green Submitted			2022-12-25	WOS:000319654700040
J	Lou, QF; He, YH; Cheng, CY; Zhang, ZH; Li, J; Huang, SW; Chen, JF				Lou, Qunfeng; He, Yuhua; Cheng, Chunyan; Zhang, Zhonghua; Li, Ji; Huang, Sanwen; Chen, Jinfeng			Integration of High-Resolution Physical and Genetic Map Reveals Differential Recombination Frequency between Chromosomes and the Genome Assembling Quality in Cucumber	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; CYTOGENETIC MAP; SATIVUS L.; RICE; PACHYTENE; FISH; DNA; REARRANGEMENTS; CONSTRUCTION; CENTROMERE	Cucumber is an important model crop and the first species sequenced in Cucurbitaceae family. Compared to the fast increasing genetic and genomics resources, the molecular cytogenetic researches in cucumber are still very limited, which results in directly the shortage of relation between plenty of physical sequences or genetic data and chromosome structure. We mapped twenty-three fosmids anchored by SSR markers from LG-3, the longest linkage group, and LG-4, the shortest linkage group on pachytene chromosomes 3 and 4, using uorescence in situ hybridization (FISH). Integrated molecular cytogenetic maps of chromosomes 3 and 4 were constructed. Except for three SSR markers located on heterochromatin region, the cytological order of markers was concordant with those on the linkage maps. Distinct structural differences between chromosomes 3 and 4 were revealed by the high resolution pachytene chromosomes. The extreme difference of genetic length between LG-3 and LG-4 was mainly attributed to the difference of overall recombination frequency. The significant differentiation of heterochromatin contents in chromosomes 3 and 4 might have a direct correlation with recombination frequency. Meanwhile, the uneven distribution of recombination frequency along chromosome 4 was observed, and recombination frequency of the long arm was nearly 3.5 times higher than that of the short arm. The severe suppression of recombination was exhibited in centromeric and heterochromatin domains of chromosome 4. Whereas a close correlation between the gene density and recombination frequency was observed in chromosome 4, no significant correlation was observed between them along chromosome 3. The comparison between cytogenetic and sequence maps revealed a large gap on the pericentromeric heterochromatin region of sequence map of chromosome 4. These results showed that integrated molecular cytogenetic maps can provide important information for the study of genetic and genomics in cucumber.	[Lou, Qunfeng; He, Yuhua; Cheng, Chunyan; Li, Ji; Chen, Jinfeng] Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China; [Zhang, Zhonghua; Huang, Sanwen] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Beijing 100193, Peoples R China	Nanjing Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS	Chen, JF (corresponding author), Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China.	jfchen@njau.edu.cn	Huang, Sanwen/ABE-9053-2020	Huang, Sanwen/0000-0002-8547-5309; zhang, zhonghua/0000-0002-1034-227X	National Basic Research Program of China (973 Program) [2012CB113900]; '863' Programs [2012AA100102]; National Natural Science Foundation of China [U1178307];  [31272174]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); '863' Programs(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 	This research was partially supported by National Basic Research Program of China (973 Program) (2012CB113900); the '863' Programs (2012AA100102); the Program 31272174, and U1178307 from the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P208, DOI [10.1007/BF02672069, DOI 10.1007/BF02672069]; Chen J, 2003, THEOR APPL GENET, V106, P688, DOI 10.1007/s00122-002-1118-7; Cheng ZK, 2001, GENETICS, V157, P1749; Cheng ZK, 2002, CHROMOSOME RES, V10, P379, DOI 10.1023/A:1016849618707; de Jong JH, 1999, TRENDS PLANT SCI, V4, P258; Findley SD, 2010, GENETICS, V185, P727, DOI 10.1534/genetics.109.113753; FLAVELL RB, 1974, BIOCHEM GENET, V12, P257, DOI 10.1007/BF00485947; Guo SG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-384; Han YH, 2008, CYTOGENET GENOME RES, V122, P80, DOI 10.1159/000151320; Han YH, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-18; Havey MJ, 1997, J HERED, V88, P232, DOI 10.1093/oxfordjournals.jhered.a023094; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Iovene M, 2008, GENETICS, V180, P1307, DOI 10.1534/genetics.108.093179; JEFFREY C, 1980, BOT J LINN SOC, V81, P233, DOI 10.1111/j.1095-8339.1980.tb01676.x; Jiang JM, 2006, GENOME, V49, P1057, DOI 10.1139/G06-076; Kim JS, 2005, GENETICS, V169, P955, DOI 10.1534/genetics.104.026765; Kim JS, 2005, GENETICS, V171, P1963, DOI 10.1534/genetics.105.048215; Kulikova O, 2001, PLANT J, V27, P49, DOI 10.1046/j.1365-313x.2001.01057.x; Kunzel G, 2000, GENETICS, V154, P397; Lou QF, 2010, CHROMOSOMA, V119, P435, DOI 10.1007/s00412-010-0269-6; Ohmido N, 2010, CHROMOSOME RES, V18, P287, DOI 10.1007/s10577-009-9103-5; Ren Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005795; ROBERTS PA, 1965, NATURE, V205, P725, DOI 10.1038/205725b0; Tang XM, 2008, GENETICS, V180, P1319, DOI 10.1534/genetics.108.093211; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; Wai CM, 2012, CHROMOSOME RES, V20, P753, DOI 10.1007/s10577-012-9312-1; Wang CJR, 2006, PLANT CELL, V18, P529, DOI 10.1105/tpc.105.037838; Woycicki R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022728; Yan HH, 2005, PLANT CELL, V17, P3227, DOI 10.1105/tpc.105.037945; Yang LM, 2012, PLANT J, V71, P895, DOI 10.1111/j.1365-313X.2012.05017.x; Zhang WW, 2012, THEOR APPL GENET, V124, P249, DOI 10.1007/s00122-011-1701-x	31	24	28	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e62676	10.1371/journal.pone.0062676	http://dx.doi.org/10.1371/journal.pone.0062676			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671621	Green Published, Green Submitted, gold			2022-12-25	WOS:000321390200033
J	Murata, T; Iwata, S; Siddiquey, MNA; Kanazawa, T; Goshima, F; Kawashima, D; Kimura, H; Tsurumi, T				Murata, Takayuki; Iwata, Seiko; Siddiquey, Mohammed Nure Alam; Kanazawa, Tetsuhiro; Goshima, Fumi; Kawashima, Daisuke; Kimura, Hiroshi; Tsurumi, Tatsuya			Heat Shock Protein 90 Inhibitors Repress Latent Membrane Protein 1 (LMP1) Expression and Proliferation of Epstein-Barr Virus-Positive Natural Killer Cell Lymphoma	PLOS ONE			English	Article							SIGNAL BINDING-PROTEIN; J-KAPPA; GENE-EXPRESSION; TRANSCRIPTION FACTORS; HSP90 INHIBITORS; HODGKIN LYMPHOMA; DOWN-REGULATION; NK CELLS; B-CELLS; LINES	Epstein-Barr virus (EBV) LMP1 is a major oncoprotein expressed in latent infection. It functions as a TNFR family member and constitutively activates cellular signals, such as NFkB, MAPK, JAK/STAT and AKT. We here screened small molecule inhibitors and isolated HSP90 inhibitors, Radicicol and 17-AAG, as candidates that suppress LMP1 expression and cell proliferation not only in EBV-positive SNK6 Natural Killer (NK) cell lymphoma cells, but also in B and T cells. Tumor formation in immunodefficient NOD/Shi-scid/IL-2R gamma(null) (NOG) mice was also retarded. These results suggest that HSP90 inhibitors can be alternative treatments for patients with EBV-positive malignancies.	[Murata, Takayuki; Kawashima, Daisuke; Tsurumi, Tatsuya] Aichi Canc Ctr, Res Inst, Div Virol, Nagoya, Aichi 464, Japan; [Iwata, Seiko; Siddiquey, Mohammed Nure Alam; Kanazawa, Tetsuhiro; Goshima, Fumi; Kimura, Hiroshi] Nagoya Univ, Dept Virol, Grad Sch Med, Nagoya, Aichi 4648601, Japan	Aichi Cancer Center; Nagoya University	Kimura, H (corresponding author), Nagoya Univ, Dept Virol, Grad Sch Med, Nagoya, Aichi 4648601, Japan.	hkimura@med.nagoya-u.ac.jp; ttsurumi@aichi-cc.jp	Murata, Takayuki/I-2621-2013; Kimura, Hiroshi/I-2246-2012; GOSHIMA, Fumi/I-7241-2014	Murata, Takayuki/0000-0001-7228-0839; Kimura, Hiroshi/0000-0001-8063-5660; Siddiquey, Mohammed Nure Alam/0000-0001-8803-3242	Ministry of Education, Science, Sports, Culture and Technology [20390137, 21022055]; Ministry of Health, Labour, and Welfare; Uehara Memorial Research Fund; Takeda Science Foundation; Yasuda Medical Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Senshin Medical Research Foundation; Kanae Foundation for Promotion of Medical Science; Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Science, Sports, Culture and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan); Uehara Memorial Research Fund(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Yasuda Medical Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Senshin Medical Research Foundation(SENSHIN Medical Research Foundation); Kanae Foundation for Promotion of Medical Science; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for Scientific Research from the Ministry of Education, Science, Sports, Culture and Technology (no. 20390137, 21022055 to T. T.), the Ministry of Health, Labour, and Welfare (to T. T. & H. K.) and partly by the Uehara Memorial Research Fund (to T. T. & T. M.), the Takeda Science Foundation (to T. T. & T. M.), the Yasuda Medical Foundation, the Mochida Memorial Foundation for Medical and Pharmaceutical Research, the Senshin Medical Research Foundation, and the Kanae Foundation for Promotion of Medical Science (to T. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. N. Shimizu for SNK6 and SNT13 cells. Panels of small molecule inhibitors were kindly provided by the Screening Committee of Anticancer Drugs (SCADS), which is supported by a Grant-in-Aid for Scientific Research on Innovative Areas, Scientific Support Programs for Cancer Research, from the Ministry of Education, Culture, Sports, Science and Technology of Japan. We would further like to express our appreciation to T. Kanda & T. Gamano for technical assistance.	Chen HL, 2003, J VIROL, V77, P4139, DOI 10.1128/JVI.77.7.4139-4148.2003; Chen HL, 2001, J VIROL, V75, P2929, DOI 10.1128/JVI.75.6.2929-2937.2001; Dirmeier U, 2005, ONCOGENE, V24, P1711, DOI 10.1038/sj.onc.1208367; Fox Christopher P, 2011, Herpesviridae, V2, P8, DOI 10.1186/2042-4280-2-8; GROSSMAN SR, 1994, P NATL ACAD SCI USA, V91, P7568, DOI 10.1073/pnas.91.16.7568; Imadome KI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002326; Jeon YK, 2007, J PATHOL, V213, P170, DOI 10.1002/path.2219; Jhaveri K, 2012, BBA-MOL CELL RES, V1823, P742, DOI 10.1016/j.bbamcr.2011.10.008; JOHANNSEN E, 1995, J VIROL, V69, P253, DOI 10.1128/JVI.69.1.253-262.1995; Kawa K, 2001, BLOOD, V98, P3173, DOI 10.1182/blood.V98.10.3173; Kieser A, 1999, EMBO J, V18, P2511, DOI 10.1093/emboj/18.9.2511; Kilger E, 1998, EMBO J, V17, P1700, DOI 10.1093/emboj/17.6.1700; Kimura H, 2001, BLOOD, V98, P280, DOI 10.1182/blood.V98.2.280; Kimura H, 2006, REV MED VIROL, V16, P251, DOI 10.1002/rmv.505; Kimura M, 2008, FEBS LETT, V582, P2833, DOI 10.1016/j.febslet.2008.07.033; Kis LL, 2006, BLOOD, V107, P2928, DOI 10.1182/blood-2005-06-2569; Kis LL, 2011, BLOOD, V117, P165, DOI 10.1182/blood-2010-01-265272; Kis LL, 2010, P NATL ACAD SCI USA, V107, P872, DOI 10.1073/pnas.0912920107; Konforte D, 2008, VIROLOGY, V374, P100, DOI 10.1016/j.virol.2007.12.027; Kulwichit W, 1998, P NATL ACAD SCI USA, V95, P11963, DOI 10.1073/pnas.95.20.11963; Kwong YL, 2005, LEUKEMIA, V19, P2186, DOI 10.1038/sj.leu.2403955; Lam N, 2003, EMBO J, V22, P3027, DOI 10.1093/emboj/cdg284; Lam N, 2003, CELL SIGNAL, V15, P9, DOI 10.1016/S0898-6568(02)00083-9; LAUX G, 1994, EMBO J, V13, P5624, DOI 10.1002/j.1460-2075.1994.tb06900.x; MILLER G, 1973, P NATL ACAD SCI USA, V70, P190, DOI 10.1073/pnas.70.1.190; Morceau F, 2008, BIOFACTORS, V34, P313, DOI [10.1002/biof.5520340407, 10.3233/BIO-2009-1085]; Murata T, 2012, J VIROL, V86, P4752, DOI 10.1128/JVI.06768-11; Nagata H, 2001, BLOOD, V97, P708, DOI 10.1182/blood.V97.3.708; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; Noda C, 2011, J BIOL CHEM, V286, P42524, DOI 10.1074/jbc.M111.271734; Okawa Y, 2009, BLOOD, V113, P846, DOI 10.1182/blood-2008-04-151928; PAINE E, 1995, J VIROL, V69, P4572, DOI 10.1128/JVI.69.7.4572-4576.1995; Rakitina TV, 2003, CANCER RES, V63, P8600; Schoof N, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-17; Shair KHY, 2007, PLOS PATHOG, V3, P1669, DOI 10.1371/journal.ppat.0030166; SJOBLOM A, 1995, J GEN VIROL, V76, P2679, DOI 10.1099/0022-1317-76-11-2679; SJOBLOM A, 1995, J GEN VIROL, V76, P2669, DOI 10.1099/0022-1317-76-11-2669; Soni V, 2007, ADV EXP MED BIOL, V597, P173; Sun XP, 2010, P NATL ACAD SCI USA, V107, P3146, DOI 10.1073/pnas.0910717107; Takahara M, 2006, INT J CANCER, V119, P2775, DOI 10.1002/ijc.22139; Uchida J, 1999, SCIENCE, V286, P300, DOI 10.1126/science.286.5438.300; Usmani Saad Z, 2011, Clin Lymphoma Myeloma Leuk, V11 Suppl 1, pS77, DOI 10.1016/j.clml.2011.03.027; WALTZER L, 1994, EMBO J, V13, P5633, DOI 10.1002/j.1460-2075.1994.tb06901.x; Wang X, 2006, CANCER RES, V66, P1089, DOI 10.1158/0008-5472.CAN-05-2698; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Workman P, 2007, ANN NY ACAD SCI, V1113, P202, DOI 10.1196/annals.1391.012; Zhang Y, 2003, BRIT J HAEMATOL, V121, P805, DOI 10.1046/j.1365-2141.2003.04359.x; Zhou J, 2002, J IMMUNOL, V169, P1319, DOI 10.4049/jimmunol.169.3.1319	48	30	31	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e63566	10.1371/journal.pone.0063566	http://dx.doi.org/10.1371/journal.pone.0063566			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658841	Green Submitted, Green Published, gold			2022-12-25	WOS:000321202100072
J	Saaristo, M; Tomkins, P; Allinson, M; Allinson, G; Wong, BBM				Saaristo, Minna; Tomkins, Patrick; Allinson, Mayumi; Allinson, Graeme; Wong, Bob B. M.			An Androgenic Agricultural Contaminant Impairs Female Reproductive Behaviour in a Freshwater Fish	PLOS ONE			English	Article							MOSQUITOFISH GAMBUSIA-HOLBROOKI; GROWTH PROMOTER 17-BETA-TRENBOLONE; TRENBOLONE ACETATE; SEXUAL SELECTION; MATE CHOICE; 17-ALPHA-ETHINYL ESTRADIOL; POMATOSCHISTUS-MINUTUS; WESTERN MOSQUITOFISH; EASTERN MOSQUITOFISH; AGGRESSIVE-BEHAVIOR	Endocrine disrupting chemicals (EDCs) are a large group of environmental pollutants that can interfere with the endocrine system function of organisms at very low levels. One compound of great concern is trenbolone, which is widely used as a growth promoter in the cattle industry in many parts of the world. The aim of this study was to test how short-term (21-day) exposure to an environmentally relevant concentration of 17 beta-trenbolone (measured concentration 6 ng/L) affects reproductive behaviour and fin morphology in the eastern mosquitofish (Gambusia holbrooki). The mosquitofish is a sexually dimorphic livebearer with males inseminating females using their modified anal fin, the gonopodium, as an intromittent organ. Although the species has a coercive mating system, females are able to exert some control over the success of male mating attempts by selectively associating with, or avoiding, certain males over others. We found that females exposed to trenbolone approached males less and spent more time swimming away from males than non-exposed (control) females. By contrast, we found no difference in the behaviour of exposed and non-exposed males. Furthermore, exposure did not affect the anal fin morphology of males or females. This is the first study to demonstrate that exposure to an androgenic EDC can impair female (but not male) behaviour. Our study illustrates how anthropogenic contaminants can have sex-specific effects, and highlights the need to examine the behavioural responses of environmental contaminants in both sexes.	[Saaristo, Minna; Tomkins, Patrick; Wong, Bob B. M.] Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia; [Allinson, Mayumi; Allinson, Graeme] Univ Melbourne, CAPIM, Inst Bio21, Melbourne, Vic, Australia; [Allinson, Graeme] DPI, DPI Queenscliff, Melbourne, Vic, Australia	Monash University; University of Melbourne	Saaristo, M (corresponding author), Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia.	minna.saaristo@monash.edu		Wong, Bob/0000-0001-9352-6500; Allinson, Mayumi/0000-0001-9424-4599	Finnish Academy; Australian Research Council; Monash University; Centre for Aquatic Pollution, Identification and Management (CAPIM); Victorian Science Agenda Investment Fund; Melbourne Water, Department of Primary Industries (Victoria); Environment Protection Authority (Victoria)	Finnish Academy(Academy of Finland); Australian Research Council(Australian Research Council); Monash University(Monash University); Centre for Aquatic Pollution, Identification and Management (CAPIM); Victorian Science Agenda Investment Fund; Melbourne Water, Department of Primary Industries (Victoria); Environment Protection Authority (Victoria)	This work was supported by the Finnish Academy, the Australian Research Council, Monash University and The Centre for Aquatic Pollution, Identification and Management (CAPIM). CAPIM is funded by The Victorian Science Agenda Investment Fund managed by the Department of Business and Innovation (DBI) (www.innovation.vic.gov.au) with partner funding contributed from Melbourne Water, Department of Primary Industries (Victoria), and Environment Protection Authority (Victoria). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus RA, 2001, GEN COMP ENDOCR, V123, P222, DOI 10.1006/gcen.2001.7669; Ankley GT, 2003, ENVIRON TOXICOL CHEM, V22, P1350, DOI [10.1897/1551-5028(2003)022&lt;1350:EOTAGP&gt;2.0.CO;2, 10.1002/etc.5620220623]; Bangsgaard K, 2006, AQUAT TOXICOL, V80, P23, DOI 10.1016/j.aquatox.2006.07.009; Bartelt-Hunt SL, 2012, ENVIRON SCI TECHNOL, V46, P1352, DOI 10.1021/es202680q; Batty J, 1999, ARCH ENVIRON CON TOX, V36, P301, DOI 10.1007/s002449900475; BISAZZA A, 1995, ETHOL ECOL EVOL, V7, P169, DOI 10.1080/08927014.1995.9522963; Bisazza A, 1996, J FISH BIOL, V48, P726, DOI 10.1111/j.1095-8649.1996.tb01468.x; Bisazza A, 2001, BEHAV ECOL, V12, P59, DOI 10.1093/oxfordjournals.beheco.a000379; BORTONE SA, 1994, BIOSCIENCE, V44, P165, DOI 10.2307/1312253; Brockmeier EK, 2013, AQUAT TOXICOL, V128, P163, DOI 10.1016/j.aquatox.2012.12.007; Buchanan KL, 2012, BEHAVIOURAL RESPONSES TO A CHANGING WORLD: MECHANISMS AND CONSEQUENCES, P32; Colman JR, 2009, AQUAT TOXICOL, V91, P346, DOI 10.1016/j.aquatox.2008.12.001; Constantz G.D., 1989, P33; Cunha FEA, 2006, J FISH BIOL, V69, P1504, DOI 10.1111/j.1095-8649.2006.01213.x; Dosen LD, 2004, BEHAV ECOL SOCIOBIOL, V55, P266, DOI 10.1007/s00265-003-0710-4; Doyle CJ, 2005, ECOTOX ENVIRON SAFE, V61, P392, DOI 10.1016/j.ecoenv.2004.10.012; Doyle CJ, 2002, ECOTOX ENVIRON SAFE, V61, P392; Dreze V, 2000, ECOTOXICOLOGY, V9, P93, DOI 10.1023/A:1008976431227; Durhan EJ, 2006, ENVIRON HEALTH PERSP, V114, P65, DOI 10.1289/ehp.8055; Gall HE, 2011, ENVIRON SCI TECHNOL, V45, P8755, DOI 10.1021/es2011435; GUILLETTE LJ, 1994, ENVIRON HEALTH PERSP, V102, P680, DOI 10.2307/3432198; HAYNES JL, 1995, J FISH BIOL, V46, P1026, DOI 10.1111/j.1095-8649.1995.tb01407.x; HERBST AL, 1971, NEW ENGL J MED, V284, P878, DOI 10.1056/NEJM197104222841604; HOWELL WM, 1980, COPEIA, P676; Jensen KM, 2006, ENVIRON SCI TECHNOL, V40, P3112, DOI 10.1021/es052174s; Jobling S, 1998, ENVIRON SCI TECHNOL, V32, P2498, DOI 10.1021/es9710870; Kahn AT, 2010, BIOL LETTERS, V6, P55, DOI 10.1098/rsbl.2009.0637; Larsen MG, 2010, ENVIRON TOXICOL CHEM, V29, P1828, DOI 10.1002/etc.214; Lephart ED, 1996, BRAIN RES REV, V22, P1; Leusch FDL, 2006, ARCH ENVIRON CON TOX, V50, P562, DOI 10.1007/s00244-005-1040-5; Lundholm CE, 1997, COMP BIOCHEM PHYS C, V118, P113, DOI 10.1016/S0742-8413(97)00105-9; Majewski AR, 2002, WATER QUAL RES J CAN, V37, P697, DOI 10.2166/wqrj.2002.047; MARTIN RG, 1975, COPEIA, P445, DOI 10.2307/1443641; Martinovic D, 2007, ENVIRON TOXICOL CHEM, V26, P271, DOI 10.1897/06-065R.1; Maunder RJ, 2007, BIOL REPROD, V77, P999, DOI 10.1095/biolreprod.107.062240; MCPEEK MA, 1992, BEHAV ECOL, V3, P1, DOI 10.1093/beheco/3.1.1; Mills LJ, 2005, SCI TOTAL ENVIRON, V343, P1, DOI 10.1016/j.scitotenv.2004.12.070; Morthorst JE, 2010, AQUAT TOXICOL, V98, P336, DOI 10.1016/j.aquatox.2010.03.008; Orlando EF, 2007, AQUAT TOXICOL, V84, P399, DOI 10.1016/j.aquatox.2007.06.018; Pelletier F, 2012, BEHAVIOURAL RESPONSES TO A CHANGING WORLD: MECHANISMS AND CONSEQUENCES, P159; Pyke GH, 2005, REV FISH BIOL FISHER, V15, P339, DOI 10.1007/s11160-006-6394-x; Quinn MJ, 2007, CHEMOSPHERE, V66, P1191, DOI 10.1016/j.chemosphere.2006.07.085; Saaristo M, 2010, AQUAT TOXICOL, V97, P285, DOI 10.1016/j.aquatox.2009.12.015; Saaristo M, 2010, CHEMOSPHERE, V79, P541, DOI 10.1016/j.chemosphere.2010.02.019; Saaristo M, 2009, HORM BEHAV, V56, P315, DOI 10.1016/j.yhbeh.2009.06.010; Saaristo M, 2009, HORM BEHAV, V55, P530, DOI 10.1016/j.yhbeh.2009.01.006; Schiffer B, 2001, ENVIRON HEALTH PERSP, V109, P1145, DOI 10.2307/3454862; Schlupp I, 1997, BEHAV ECOL, V8, P104, DOI 10.1093/beheco/8.1.104; Sone K, 2005, GEN COMP ENDOCR, V143, P151, DOI 10.1016/j.ygcen.2005.03.007; Swan SH, 2000, APMIS, V108, P793, DOI 10.1111/j.1600-0463.2000.tb00001.x; Toft G, 2004, AQUAT TOXICOL, V70, P213, DOI 10.1016/j.aquatox.2004.09.002; Turner CL, 1942, J EXP ZOOL, V91, P167, DOI 10.1002/jez.1400910205; Wierman ME, 2007, ADV PHYSIOL EDUC, V31, P26, DOI 10.1152/advan.00086.2006; Wong BBM, 2006, AM NAT, V167, P136, DOI 10.1086/498278; Wong BBM, 2005, BEHAV ECOL, V16, P818, DOI 10.1093/beheco/ari058; Wong BBM, 2009, BEHAV ECOL, V20, P278, DOI 10.1093/beheco/arp010; Yarrow JF, 2010, STEROIDS, V75, P377, DOI 10.1016/j.steroids.2010.01.019; Zala SM, 2004, ANIM BEHAV, V68, P649, DOI 10.1016/j.anbehav.2004.01.005	58	33	33	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62782	10.1371/journal.pone.0062782	http://dx.doi.org/10.1371/journal.pone.0062782			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23671634	Green Published, gold			2022-12-25	WOS:000321202100040
J	Witasp, A; Ryden, M; Carrero, JJ; Qureshi, AR; Nordfors, L; Naslund, E; Hammarqvist, F; Arefin, S; Kublickiene, K; Stenvinkel, P				Witasp, Anna; Ryden, Mikael; Carrero, Juan Jesus; Qureshi, Abdul Rashid; Nordfors, Louise; Naslund, Erik; Hammarqvist, Folke; Arefin, Samsul; Kublickiene, Karolina; Stenvinkel, Peter			Elevated Circulating Levels and Tissue Expression of Pentraxin 3 in Uremia: A Reflection of Endothelial Dysfunction	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; C-REACTIVE PROTEIN; ACUTE MYOCARDIAL-INFARCTION; RECOGNITION RECEPTOR PTX3; HUMAN ADIPOSE-TISSUE; CARDIOVASCULAR-DISEASE; HEMODIALYSIS-PATIENTS; INFLAMMATORY MARKER; INSULIN-RESISTANCE	Elevated systemic pentraxin 3 (PTX3) levels appear to be a powerful marker of inflammatory status and a superior outcome predictor in patients with chronic kidney disease (CKD). As previous data imply that PTX3 is involved in vascular pathology and that adipose tissue mass may influence circulating PTX3 levels, we aimed to study the importance of adipose tissue expression of PTX3 in the uremic milieu and its relation to endothelial dysfunction parameters. Plasma PTX3 and abdominal subcutaneous adipose tissue (SAT) PTX3 mRNA levels were quantified in 56 stage 5 CKD patients (median age 57 [range 25-75] years, 30 males) and 40 age and gender matched controls (median age 58 [range 20-79] years, 27 males). Associations between PTX3 measures and an extensive panel of clinical parameters, including surrogate markers of endothelial function, were assessed. Functional ex vivo studies on endothelial status and immunohistochemical staining for PTX3 were conducted in resistance subcutaneous arteries isolated from SAT. SAT PTX3 mRNA expression correlated with plasma PTX3 concentrations (rho = 0.54, p = 0.0001) and was increased (3.7 [0.4-70.3] vs. 1.2 [0.2-49.3] RQ, p = 0.02) in CKD patients with cardiovascular disease (CVD), but was not significantly different between patients and controls. The association to CVD was lost after adjustments. SAT PTX3 mRNA levels were independently correlated to asymmetric dimethylarginine and basal resistance artery tone developed after inhibition with nitric oxide synthase and cyclooxygenase (rho = -0.58, p = 0.002). Apparent positive PTX3 immunoreactivity was observed in both patient and control arteries. In conclusion, fat PTX3 mRNA levels are associated with measures of endothelial cell function in patients with CKD. PTX3 may be involved in adipose tissue-orchestrated mechanisms that are restricted to the uremic milieu and modify inflammation and vascular complications in CKD patients.	[Witasp, Anna; Carrero, Juan Jesus; Qureshi, Abdul Rashid; Nordfors, Louise; Stenvinkel, Peter] Karolinska Inst, Div Renal Med & Baxter Novum, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Ryden, Mikael] Karolinska Inst, Dept Med H7, Stockholm, Sweden; [Carrero, Juan Jesus; Nordfors, Louise] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Carrero, Juan Jesus; Nordfors, Louise] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden; [Naslund, Erik] Karolinska Inst, Ctr Gender Med, Stockholm, Sweden; [Hammarqvist, Folke] Karolinska Inst, Dept Clin Sci, Danderyd Hosp, Stockholm, Sweden; [Hammarqvist, Folke] Karolinska Inst, Div Surg, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Arefin, Samsul; Kublickiene, Karolina] Karolinska Inst, Dept Clin Sci Intervent & Technol, Div Obstet & Gynecol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Danderyds Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Stenvinkel, P (corresponding author), Karolinska Inst, Div Renal Med & Baxter Novum, Dept Clin Sci Intervent & Technol, Stockholm, Sweden.	peter.stenvinkel@ki.se	Qureshi, Abdul Rashid Tony/G-1358-2010	Qureshi, Abdul Rashid Tony/0000-0003-0536-5327; Stenvinkel, Peter/0000-0002-8785-4820; Carrero, Juan Jesus/0000-0003-4763-2024; Kublickiene, Karolina/0000-0002-4841-6836	Strategic Research Programme in Diabetes at Karolinska Institutet (Swedish Research Council) [2009-1068]; Swedish Research Council [15320-07-6, 2011-2349]; Centre for Gender Medicine at Karolinska Institutet; Stiftelsen Olle Engkvist Byggare	Strategic Research Programme in Diabetes at Karolinska Institutet (Swedish Research Council); Swedish Research Council(Swedish Research CouncilEuropean Commission); Centre for Gender Medicine at Karolinska Institutet(Karolinska Institutet); Stiftelsen Olle Engkvist Byggare(Swedish Research Council)	This study is supported by The Strategic Research Programme in Diabetes at Karolinska Institutet (Swedish Research Council 2009-1068) and grants from Swedish Research Council (15320-07-6; 2011-2349) (PS, JJS), Centre for Gender Medicine at Karolinska Institutet (PS, JJS, KK) as well as from Stiftelsen Olle Engkvist Byggare (FH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti L, 2009, ATHEROSCLEROSIS, V202, P455, DOI 10.1016/j.atherosclerosis.2008.05.015; ALLES VV, 1994, BLOOD, V84, P3483; Arner P, 2008, J CLIN ENDOCR METAB, V93, P2249, DOI 10.1210/jc.2008-0206; Axelsson J, 2004, AM J CLIN NUTR, V80, P1222, DOI 10.1093/ajcn/80.5.1222; Axelsson J, 2006, AM J KIDNEY DIS, V48, P916, DOI 10.1053/j.ajkd.2006.08.022; Aydogdu A, 2012, GYNECOL ENDOCRINOL, V28, P722, DOI 10.3109/09513590.2011.652719; Boehme M, 2007, NEPHROL DIAL TRANSPL, V22, P2224, DOI 10.1093/ndt/gfl747; BREVIARIO F, 1992, J BIOL CHEM, V267, P22190; Brugger-Andersen T, 2009, THROMB HAEMOSTASIS, V102, P555, DOI 10.1160/TH09-02-0137; Bussolati B, 2003, J IMMUNOL, V170, P1466, DOI 10.4049/jimmunol.170.3.1466; Carrero JJ, 2010, SEMIN DIALYSIS, V23, P498, DOI 10.1111/j.1525-139X.2010.00784.x; Carrero JJ, 2012, CLIN J AM SOC NEPHRO, V7, P207, DOI 10.2215/CJN.06840711; Cieslik P, 2012, AUTOIMMUNITY, V45, P119, DOI 10.3109/08916934.2011.611549; Cordeiro AC, 2010, NEPHROL DIAL TRANSPL, V25, P562, DOI 10.1093/ndt/gfp492; Cozzi V, 2012, PLACENTA, V33, P1039, DOI 10.1016/j.placenta.2012.09.009; Doni A, 2003, EUR J IMMUNOL, V33, P2886, DOI 10.1002/eji.200324390; Dubin R, 2012, AM HEART J, V163, P274, DOI 10.1016/j.ahj.2011.11.007; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; Garlanda C, 2011, CURR PHARM DESIGN, V17, P38, DOI 10.2174/138161211795049750; Imperatore G, 1998, DIABETES, V47, P821, DOI 10.2337/diabetes.47.5.821; Jaillon S, 2007, J EXP MED, V204, P793, DOI 10.1084/jem.20061301; Klouche M, 2004, ATHEROSCLEROSIS, V175, P221, DOI 10.1016/j.atherosclerosis.2004.03.020; Kume N, 2011, J CARDIOL, V58, P38, DOI 10.1016/j.jjcc.2011.03.006; Latini R, 2004, CIRCULATION, V110, P2349, DOI 10.1161/01.CIR.0000145167.30987.2E; LEE GW, 1993, J IMMUNOL, V150, P1804; Luchetti MM, 2000, CLIN EXP IMMUNOL, V119, P196, DOI 10.1046/j.1365-2249.2000.01110.x; Luksha L, 2008, AM J PHYSIOL-REG I, V294, pR510, DOI 10.1152/ajpregu.00458.2007; Luksha L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036056; Luksha R, 2011, CLIN SCI, V120, P525, DOI 10.1042/CS20100277; Manfredi AA, 2008, CURR OPIN IMMUNOL, V20, P538, DOI 10.1016/j.coi.2008.05.004; Miyaki A, 2010, J ATHEROSCLER THROMB, V17, P278, DOI 10.5551/jat.2741; Miyamoto T, 2011, CLIN J AM SOC NEPHRO, V6, P2785, DOI 10.2215/CJN.02320311; Moczulski DK, 1998, DIABETES, V47, P1164, DOI 10.2337/diabetes.47.7.1164; Morishita T, 2012, J ATHEROSCLER THROMB, V19, P149, DOI 10.5551/jat.10074; Norata GD, 2009, CIRCULATION, V120, P699, DOI 10.1161/CIRCULATIONAHA.108.806547; Ogawa T, 2010, OBESITY, V18, P1871, DOI 10.1038/oby.2009.507; Osorio-Conles O, 2011, AM J PHYSIOL-ENDOC M, V301, pE1254, DOI 10.1152/ajpendo.00163.2011; Ramkumar N, 2004, J RENAL NUTR, V14, P201, DOI 10.1053/j.jm.2004.07.009; Ramos LF, 2008, J AM SOC NEPHROL, V19, P593, DOI 10.1681/ASN.2007030355; Reape TJ, 1999, ATHEROSCLEROSIS, V147, P213, DOI 10.1016/S0021-9150(99)00346-9; Rolph MS, 2002, ARTERIOSCL THROM VAS, V22, pE10, DOI 10.1161/01.ATV.0000015595.95497.2F; Roubicek T, 2009, NUTRITION, V25, P762, DOI 10.1016/j.nut.2008.12.012; Ryu WS, 2012, ATHEROSCLEROSIS, V220, P581, DOI 10.1016/j.atherosclerosis.2011.11.036; Salio M, 2008, CIRCULATION, V117, P1055, DOI 10.1161/CIRCULATIONAHA.107.749234; Sanches FMR, 2008, AM J KIDNEY DIS, V52, P66, DOI 10.1053/j.ajkd.2008.02.004; Stenvinkel P, 1999, KIDNEY INT, V55, P1899, DOI 10.1046/j.1523-1755.1999.00422.x; Stenvinkel P, 2010, J INTERN MED, V268, P456, DOI 10.1111/j.1365-2796.2010.02269.x; Stenvinkel P, 2001, NEPHROL DIAL TRANSPL, V16, P1968, DOI 10.1093/ndt/16.10.1968; Stenvinkel P, 2008, CLIN J AM SOC NEPHRO, V3, P505, DOI 10.2215/CJN.03670807; Suliman ME, 2008, QJM-INT J MED, V101, P397, DOI 10.1093/qjmed/hcn019; Suliman ME, 2008, CLIN J AM SOC NEPHRO, V3, P976, DOI 10.2215/CJN.03960907; Teplan V, 2010, WIEN KLIN WOCHENSCHR, V122, P466, DOI 10.1007/s00508-010-1409-y; Tong M, 2007, CLIN J AM SOC NEPHRO, V2, P889, DOI 10.2215/CJN.00870207; Tsimikas S, 2006, J AM COLL CARDIOL, V47, pC19, DOI 10.1016/j.jacc.2005.10.066; van Rossum AP, 2006, ARTHRITIS RHEUM-US, V54, P986, DOI 10.1002/art.21669; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Witasp A, 2011, J INTERN MED, V269, P410, DOI 10.1111/j.1365-2796.2010.02293.x; Yilmaz MI, 2011, CLIN J AM SOC NEPHRO, V6, P785, DOI 10.2215/CJN.09231010; Yilmaz MI, 2009, CLIN J AM SOC NEPHRO, V4, P535, DOI 10.2215/CJN.04330808	60	36	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e63493	10.1371/journal.pone.0063493	http://dx.doi.org/10.1371/journal.pone.0063493			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658833	gold, Green Published, Green Submitted			2022-12-25	WOS:000321202100067
J	Xu, Y; Liu, YF; Lee, JG; Ye, YH				Xu, Yue; Liu, Yanfen; Lee, Jin-Gu; Ye, Yihong			A Ubiquitin-like Domain Recruits an Oligomeric Chaperone to a Retrotranslocation Complex in Endoplasmic Reticulum-associated Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUALITY-CONTROL; MEMBRANE-PROTEINS; LIGASE; HRD1P; GP78; BAT3; DIMETHYLATION; POLYPEPTIDES; ELIMINATION; INTEGRATION	The Bag6-Ubl4A-Trc35 complex is a multifunctional chaperone that regulates various cellular processes. The diverse functions of Bag6 are supported by its ubiquitous localization to the cytoplasm, the nucleus, and membranes of the endoplasmic reticulum (ER) in cells. In ER-associated degradation (ERAD) pathways, Bag6 can interact with the membrane-associated ubiquitin ligase gp78 via its ubiquitin-like (UBL) domain, but the relative low affinity of this interaction does not reconcile with the fact that a fraction of Bag6 is tightly bound to the membranes. Here, we demonstrate that the UBL domain of Bag6 is required for interaction with the ER membranes. We find that in addition to gp78, the Bag6 UBL domain also binds a UBL-binding motif in UbxD8, an essential component of the gp78 ubiquitinating machinery. Importantly, Bag6 contains a proline-rich (PR) domain termed PDP (Proline rich-DUF3587-Proline rich) that forms homo-oligomer, allowing the UBL domain to form multivalent interactions with gp78 and UbxD8, which are essential for recruitment of Bag6 to the ER membrane. Furthermore, the PR domain comprises largely intrinsically disordered segments, which are sufficient for interaction with an unfolded substrate. We propose that simultaneous association with multiple ERAD factors helps to anchor a disordered chaperone oligomer to the site of retrotranslocation to prevent protein aggregation in ERAD.	[Xu, Yue; Liu, Yanfen; Lee, Jin-Gu; Ye, Yihong] NIH, NIDDK, Mol Biol Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Ye, YH (corresponding author), NIH, NIDDK, Mol Biol Lab, 5 Ctr Dr, Bethesda, MD 20892 USA.	yihongy@mail.nih.gov	Xu, Yue/F-8188-2015	Lee, Jin-Gu/0000-0001-9477-6990	NIDDK at the National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK033008] Funding Source: NIH RePORTER	NIDDK at the National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Intramural Research Program of the NIDDK at the National Institutes of Health.	Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Carvalho P, 2010, CELL, V143, P579, DOI 10.1016/j.cell.2010.10.028; Chartron JW, 2012, CELL REP, V2, P1620, DOI 10.1016/j.celrep.2012.10.010; Chen ZL, 2012, CURR PROTEIN PEPT SC, V13, P414, DOI 10.2174/138920312802430590; Claessen JHL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028542; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Flierman D, 2003, J BIOL CHEM, V278, P34774, DOI 10.1074/jbc.M303360200; Gauss R, 2006, EMBO J, V25, P1827, DOI 10.1038/sj.emboj.7601088; Gauss R, 2006, NAT CELL BIOL, V8, P849, DOI 10.1038/ncb1445; Hampton RY, 2012, CURR OPIN CELL BIOL, V24, P460, DOI 10.1016/j.ceb.2012.05.010; Hessa T, 2011, NATURE, V475, P394, DOI 10.1038/nature10181; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Kawahara H, 2013, J BIOCHEM, V153, P147, DOI 10.1093/jb/mvs149; Lee JG, 2013, BIOESSAYS, V35, P377, DOI 10.1002/bies.201200159; Leznicki P, 2010, J CELL SCI, V123, P2170, DOI 10.1242/jcs.066738; Li LY, 2008, BBA-MOL CELL RES, V1783, P1140, DOI 10.1016/j.bbamcr.2008.01.029; Li W, 2009, P NATL ACAD SCI USA, V106, P3722, DOI 10.1073/pnas.0808564106; Mariappan M, 2010, NATURE, V466, P1120, DOI 10.1038/nature09296; Minami R, 2010, J CELL BIOL, V190, P637, DOI 10.1083/jcb.200908092; Mueller TD, 2003, EMBO J, V22, P4634, DOI 10.1093/emboj/cdg467; Nguyen P, 2008, MOL CELL BIOL, V28, P6720, DOI 10.1128/MCB.00568-08; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rosenbaum JC, 2011, MOL CELL, V41, P93, DOI 10.1016/j.molcel.2010.12.004; Sasaki T, 2007, GENE DEV, V21, P848, DOI 10.1101/gad.1534107; Sato BK, 2009, MOL CELL, V34, P212, DOI 10.1016/j.molcel.2009.03.010; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Soetandyo N, 2010, J CELL SCI, V123, P1031, DOI 10.1242/jcs.059758; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; van der Veen AG, 2012, ANNU REV BIOCHEM, V81, P323, DOI 10.1146/annurev-biochem-093010-153308; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wakeman TP, 2012, EMBO J, V31, P2169, DOI 10.1038/emboj.2012.50; Wang QY, 2011, MOL CELL, V42, P758, DOI 10.1016/j.molcel.2011.05.010; Xu Y, 2012, CELL REP, V2, P1633, DOI 10.1016/j.celrep.2012.11.010; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Zhong XY, 2004, J BIOL CHEM, V279, P45676, DOI 10.1074/jbc.M409034200	35	48	48	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18068	18076		10.1074/jbc.M112.449199	http://dx.doi.org/10.1074/jbc.M112.449199			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23665563	Green Published, hybrid			2022-12-25	WOS:000320721900013
J	Aliyu, G; El-Kamary, SS; Abimiku, A; Brown, C; Tracy, K; Hungerford, L; Blattner, W				Aliyu, Gambo; El-Kamary, Samer S.; Abimiku, Alash'le; Brown, Clayton; Tracy, Kathleen; Hungerford, Laura; Blattner, William			Prevalence of Non-Tuberculous Mycobacterial Infections among Tuberculosis Suspects in Nigeria	PLOS ONE			English	Article							DIRECT ASSAY; COMPLEX; DISEASE; AFRICA; SILICA; IDENTIFICATION; MACROPHAGES; MENINGITIS; SPECIMENS; BACILLI	Background: Nigeria is ranked in the top five countries for tuberculosis deaths worldwide. This study investigated the mycobacterial agents associated with presumptive clinical pulmonary tuberculosis (TB) in Nigeria and evaluated the pattern and frequency of mycobacterial infections over twelve calendar months period. Methods: Sputum samples from 1,603 consecutive new cases with presumptive diagnosis of TB were collected from August 2010 to July 2011. All sputum samples were incubated for detection of mycobacterial growth and those with positive acid fast bacilli (AFB) growth were tested to detect mycobacterium tuberculosis (MTB) complex and characterized to differentiate between MTB complex species. Cultures suggestive of Non-tuberculous mycobacterial infections (NTM) were sub-cultured and characterized. Results: Of the 1,603 patients screened, 444 (28%) culture-positive cases of pulmonary tuberculosis were identified. Of these, 375 (85%) were due to strains of MTB complex (354 cases of M. tuberculosis, 20 M. africanum and one case of M. bovis) and 69 (15%) were due to infection with NTM. In contrast to the MTB complex cases, the NTM cases were more likely to have been diagnosed during the calendar months of the Harmattan dust season (OR = 2.34, 1.28-4.29; p = 0.01), and aged older than 35 years (OR = 2.77, 1.52-5.02, p = 0.0007), but less likely to have AFB identified on their sputum smear (OR = 0.06, 0.02-0.14, p<0.0001). Among those with NTM infection, cases 35 years or younger were more likely to have co-infection with HIV (3.76, 1.72-8.22; p = 0.0009) compared to those older than 35 years. Interpretation: The high proportion of younger patients with clinical pulmonary TB due to NTM and co-infection with HIV and the likely role of the seasonal dust exposure in the occurrence of the disease, present novel public health challenges for prevention and treatment.	[Aliyu, Gambo; Abimiku, Alash'le; Blattner, William] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [El-Kamary, Samer S.; Brown, Clayton; Tracy, Kathleen; Hungerford, Laura; Blattner, William] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Aliyu, G (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA.	algambo@yahoo.com			Fogarty AIDS International Training and Research Program [D43TW001041]; FOGARTY INTERNATIONAL CENTER [D43TW001041] Funding Source: NIH RePORTER	Fogarty AIDS International Training and Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported by the Fogarty AIDS International Training and Research Program (Grant no: D43TW001041. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo Kk, 2007, Ghana Med J, V41, P52; Agliari E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055017; Amorim A, 2010, SCAND J INFECT DIS, V42, P626, DOI 10.3109/00365541003754485; ANJORIN FI, 1984, T ROY SOC TROP MED H, V78, P577, DOI 10.1016/0035-9203(84)90209-8; Bonard D, 2004, AIDS, V18, P1961, DOI 10.1097/00002030-200409240-00015; Buijtels PCAM, 2010, CLIN MICROBIOL INFEC, V16, P1142, DOI 10.1111/j.1469-0691.2009.03072.x; Buijtels PCAM, 2005, J CLIN MICROBIOL, V43, P6020, DOI 10.1128/JCM.43.12.6020-6026.2005; Cadmus S, 2006, J CLIN MICROBIOL, V44, P29, DOI 10.1128/JCM.44.1.29-34.2006; Corbett EL, 2000, AIDS, V14, P2759, DOI 10.1097/00002030-200012010-00016; Crump JA, 2009, EMERG INFECT DIS, V15, P53, DOI 10.3201/eid1501.081093; ELLIS RC, 1993, J CLIN PATHOL, V46, P559, DOI 10.1136/jcp.46.6.559; GHIO AJ, 1990, LANCET, V336, P967, DOI 10.1016/0140-6736(90)92421-D; Gomgnimbou MK, 2012, EMERG INFECT DIS, V18, P117, DOI 10.3201/eid1801.110275; Gopinath K, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000615; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Hamilton RF, 2008, FREE RADICAL BIO MED, V44, P1246, DOI 10.1016/j.freeradbiomed.2007.12.027; Hooja Saroj, 2011, Indian J Tuberc, V58, P72; Kiraz N, 2010, J MED MICROBIOL, V59, P930, DOI 10.1099/jmm.0.013490-0; LAWANDE RV, 1984, ANN ALLERGY, V52, P47; Marlowe EM, 2011, J CLIN MICROBIOL, V49, P1621, DOI 10.1128/JCM.02214-10; Marras TK, 2002, CLIN CHEST MED, V23, P553, DOI 10.1016/S0272-5231(02)00019-9; Mohapatra H, 2010, J ENVIRON BIOL, V31, P953; Monkongdee P, 2009, AM J RESP CRIT CARE, V180, P903, DOI 10.1164/rccm.200905-0692OC; Niobe-Eyangoh SN, 2003, J CLIN MICROBIOL, V41, P2547, DOI 10.1128/JCM.41.6.2547-2553.2003; Park HH, 2009, AM J IND MED, V52, P901, DOI 10.1002/ajim.20767; Pasula R, 2009, J IMMUNOL, V182, P7102, DOI 10.4049/jimmunol.0803642; Pokam Benjamin Thumamo, 2012, Tuberc Res Treat, V2012, P301056, DOI 10.1155/2012/301056; Rees D, 2007, INT J TUBERC LUNG D, V11, P474; Roberts L, 2008, SCIENCE, V320, P1710, DOI 10.1126/science.320.5884.1710; Rodrigues C, 2009, INDIAN J MED MICROBI, V27, P217, DOI 10.4103/0255-0857.53203; Sakatani M, 1999, Kekkaku, V74, P377; Seagar AL, 2008, J MED MICROBIOL, V57, P605, DOI 10.1099/jmm.0.47484-0; Singh S, 2007, JPN J INFECT DIS, V60, P14; Somoskovi A, 2008, J CLIN MICROBIOL, V46, P1854, DOI 10.1128/JCM.00105-07; Sultan B, 2005, PLOS MED, V2, P43, DOI 10.1371/journal.pmed.0020006; Tiwari Rajnarayan R, 2007, Indian J Occup Environ Med, V11, P61, DOI 10.4103/0019-5278.34530; Traore B, 2012, INT J TUBERCULOSIS L; Van Deun A, 2008, INT J TUBERC LUNG D, V12, P108; Weinstein JP, 2010, CHEMOSPHERE, V78, P980, DOI 10.1016/j.chemosphere.2009.12.022; ZYKOV MP, 1967, B WORLD HEALTH ORGAN, V37, P947; ZYKOV MP, 1967, B WORLD HEALTH ORGAN, V37, P927	41	60	65	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63170	10.1371/journal.pone.0063170	http://dx.doi.org/10.1371/journal.pone.0063170			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671669	Green Published, gold, Green Submitted			2022-12-25	WOS:000319737700047
J	Anderson, M; Amin, S; Luise, F; Zeef, L; Bobola, N				Anderson, Megan; Amin, Shilu; Luise, Fabiana; Zeef, Leo; Bobola, Nicoletta			Differential Distribution of the Ca (2+) Regulator Pcp4 in the Branchial Arches Is Regulated by Hoxa2	PLOS ONE			English	Article							HOMEOTIC TRANSFORMATION; GENE; PEP-19; DISRUPTION; EXPRESSION; SIX2; BODY	Branchial arches are externally visible tissue bands in the head region of all vertebrate embryos. Although initially formed from similar components, each arch will give rise to different head and neck structures. In a screen designed to characterize the molecular control of branchial arch identity in mouse, we identified Pcp4 as a second branchial arch-specific molecular signature. We further show that the transcription factor Hoxa2 binds to Pcp4 chromatin and regulates Pcp4 expression in the second arch. Hoxa2 is also sufficient to induce Pcp4 expression in anterior first arch cells, which are Pcp4-negative.	[Anderson, Megan] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Med & Human Sci, Manchester, Lancs, England; [Amin, Shilu; Luise, Fabiana; Bobola, Nicoletta] Univ Manchester, Sch Dent, Fac Med & Human Sci, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Zeef, Leo] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Bobola, Nicoletta] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Med & Human Sci, Ctr Endocrinol & Diabet,Inst Human Dev, Manchester, Lancs, England	University of Manchester; University of Manchester; University of Manchester; University of Manchester	Bobola, N (corresponding author), Univ Manchester, Sch Dent, Fac Med & Human Sci, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England.	Nicoletta.Bobola@manchester.ac.uk			Biotechnology and Biological Sciences Research Council [BB/H018123/2]; Biotechnology and Biological Sciences Research Council [1085991, BB/E017355/1] Funding Source: researchfish; BBSRC [BB/E017355/1, BB/H018123/2] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council BB/H018123/2 to N.B and facilitated by the Manchester Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abzhanov A, 2006, NATURE, V442, P563, DOI 10.1038/nature04843; Baltzinger M, 2005, DEV DYNAM, V234, P858, DOI 10.1002/dvdy.20567; Barrow JR, 1999, DEVELOPMENT, V126, P5011; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Depew MJ, 2002, SCIENCE, V298, P381, DOI 10.1126/science.1075703; Donaldson IJ, 2012, NUCLEIC ACIDS RES, V40, P3990, DOI 10.1093/nar/gkr1240; Erhardt JA, 2000, NEUROREPORT, V11, P3719, DOI 10.1097/00001756-200011270-00026; GENDRONMAGUIRE M, 1993, CELL, V75, P1317, DOI 10.1016/0092-8674(93)90619-2; Harashima S, 2011, J NEUROSCI RES, V89, P1519, DOI 10.1002/jnr.22688; Jacobson AC, 2009, MOL IMMUNOL, V46, P1488, DOI 10.1016/j.molimm.2008.12.030; Johanson RA, 2000, J NEUROSCI, V20, P2860; Kameda Y, 2003, CELL TISSUE RES, V311, P343, DOI 10.1007/s00441-002-0681-1; Kameda Y, 2002, DEV BIOL, V247, P197, DOI 10.1006/dbio.2002.0689; Kanzler B, 1998, DEVELOPMENT, V125, P2587; Kirilenko P, 2011, MOL CELL BIOL, V31, P1301, DOI 10.1128/MCB.00705-10; Kleerekoper QK, 2009, J BIOL CHEM, V284, P7455, DOI 10.1074/jbc.M808067200; Kutejova E, 2005, DEVELOPMENT, V132, P469, DOI 10.1242/dev.01536; Kutejova E, 2008, DEVELOPMENT, V135, P1463, DOI 10.1242/dev.017624; Mallo M, 1997, DEV BIOL, V184, P175, DOI 10.1006/dbio.1997.8519; Manley NR, 1997, DEV BIOL, V192, P274, DOI 10.1006/dbio.1997.8765; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Putkey JA, 2008, J BIOL CHEM, V283, P1401, DOI 10.1074/jbc.M703831200; RIJLI FM, 1993, CELL, V75, P1333, DOI 10.1016/0092-8674(93)90620-6; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Thomas S, 2003, GENE EXPR PATTERNS, V3, P93, DOI 10.1016/S1567-133X(02)00100-X; Wei P, 2011, MOL CELL BIOL, V31, P2838, DOI 10.1128/MCB.05208-11; Xiao JG, 2008, MOL CELL BIOCHEM, V309, P143, DOI 10.1007/s11010-007-9652-x	29	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63160	10.1371/journal.pone.0063160	http://dx.doi.org/10.1371/journal.pone.0063160			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671666	Green Submitted, gold, Green Published			2022-12-25	WOS:000319737700044
J	Bay, LK; Guerecheau, A; Andreakis, N; Ulstrup, KE; Matz, MV				Bay, Line K.; Guerecheau, Aurelie; Andreakis, Nikos; Ulstrup, Karin E.; Matz, Mikhail V.			Gene Expression Signatures of Energetic Acclimatisation in the Reef Building Coral Acropora millepora	PLOS ONE			English	Article							THERMAL-STRESS; CLIMATE-CHANGE; ENVIRONMENTAL-STRESS; CARBONIC-ANHYDRASE; PROTEIN EXPRESSION; LIPID-CONTENT; PHOTOSYNTHESIS; SYMBIODINIUM; RESILIENCE; PLASTICITY	Background: Understanding the mechanisms by which natural populations cope with environmental stress is paramount to predict their persistence in the face of escalating anthropogenic impacts. Reef-building corals are increasingly exposed to local and global stressors that alter nutritional status causing reduced fitness and mortality, however, these responses can vary considerably across species and populations. Methodology/Principal Findings: We compare the expression of 22 coral host genes in individuals from an inshore and an offshore reef location using quantitative Reverse Transcription-PCR (qRT-PCR) over the course of 26 days following translocation into a shaded, filtered seawater environment. Declines in lipid content and PSII activity of the algal endosymbionts (Symbiodinium ITS-1 type C2) over the course of the experiment indicated that heterotrophic uptake and photosynthesis were limited, creating nutritional deprivation conditions. Regulation of coral host genes involved in metabolism, CO2 transport and oxidative stress could be detected already after five days, whereas PSII activity took twice as long to respond. Opposing expression trajectories of Tgl, which releases fatty acids from the triacylglycerol storage, and Dgat1, which catalyses the formation of triglycerides, indicate that the decline in lipid content can be attributed, at least in part, by mobilisation of triacylglycerol stores. Corals from the inshore location had initially higher lipid content and showed consistently elevated expression levels of two genes involved in metabolism (aldehyde dehydrogenase) and calcification (carbonic anhydrase). Conclusions/Significance: Coral host gene expression adjusts rapidly upon change in nutritional conditions, and therefore can serve as an early signature of imminent coral stress. Consistent gene expression differences between populations indicate that corals acclimatize and/or adapt to local environments. Our results set the stage for analysis of these processes in natural coral populations, to better understand the responses of coral communities to global climate change and to develop more efficient management strategies.	[Bay, Line K.; Guerecheau, Aurelie; Andreakis, Nikos] Australian Inst Marine Sci, Climate Change & Ocean Acidificat Team, Townsville, Qld 4810, Australia; [Ulstrup, Karin E.] Univ Copenhagen, Dept Biol, Helsingor, Denmark; [Matz, Mikhail V.] Univ Texas Austin, Integrat Biol Sect, Austin, TX 78712 USA	Australian Institute of Marine Science; University of Copenhagen; University of Texas System; University of Texas Austin	Bay, LK (corresponding author), Australian Inst Marine Sci, Climate Change & Ocean Acidificat Team, PMB 3, Townsville, Qld 4810, Australia.	l.bay@aims.gov.au	Andreakis, Nikos/A-4010-2010; Matz, Mikhail V/K-4392-2017	Andreakis, Nikos/0000-0001-7120-4279; Matz, Mikhail V/0000-0001-5453-9819; Bay, Line/0000-0002-9760-2977	Marine and Tropical Sciences Research Facility; ARC Centre of Excellence for Coral Reef Studies; Australian Institute of Marine Science	Marine and Tropical Sciences Research Facility; ARC Centre of Excellence for Coral Reef Studies(Australian Research Council); Australian Institute of Marine Science	Funding was provided by the Marine and Tropical Sciences Research Facility, the ARC Centre of Excellence for Coral Reef Studies and the Australian Institute of Marine Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth TD, 2008, J EXP MAR BIOL ECOL, V364, P63, DOI 10.1016/j.jembe.2008.06.032; Allemand D, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P119, DOI 10.1007/978-94-007-0114-4_9; Anthony KRN, 2009, FUNCT ECOL, V23, P539, DOI 10.1111/j.1365-2435.2008.01531.x; Anthony KRN, 2003, OECOLOGIA, V134, P23, DOI 10.1007/s00442-002-1095-1; Anthony KRN, 2000, J EXP MAR BIOL ECOL, V252, P221, DOI 10.1016/S0022-0981(00)00237-9; Baird AH, 2009, TRENDS ECOL EVOL, V24, P16, DOI 10.1016/j.tree.2008.09.005; Barrientos A, 2002, GENE, V286, P53, DOI 10.1016/S0378-1119(01)00803-4; Barshis DJ, 2010, MOL ECOL, V19, P1705, DOI 10.1111/j.1365-294X.2010.04574.x; Barshis DJ, 2013, P NATL ACAD SCI USA, V110, P1387, DOI 10.1073/pnas.1210224110; Bates D, 2005, R NEWS, V5, P4; Bay LK, 2009, MAR GENOM, V2, P119, DOI 10.1016/j.margen.2009.07.004; Bay LK, 2009, MOL ECOL, V18, P3062, DOI 10.1111/j.1365-294X.2009.04257.x; Benjamini Y, 2001, ANN STAT, V29, P1165; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Brown BE, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P421, DOI 10.1007/978-94-007-0114-4_24; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Cantin NE, 2009, CORAL REEFS, V28, P405, DOI 10.1007/s00338-009-0478-8; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Carr HS, 2003, ACCOUNTS CHEM RES, V36, P309, DOI 10.1021/ar0200807; Castilho PC, 2009, MOL ECOL, V18, P2092, DOI 10.1111/j.1365-294X.2009.04174.x; Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E; Coles SL, 2003, ADV MAR BIOL, V46, P183, DOI 10.1016/S0065-2881(03)46004-5; Connolly SR, 2012, CORAL REEFS, V31, P951, DOI 10.1007/s00338-012-0925-9; Cooper TF, 2011, ESTUARINE COASTAL SH, V83, P186; Cooper TF, 2007, ESTUAR COAST SHELF S, V74, P458, DOI 10.1016/j.ecss.2007.05.020; Cooper TF, 2011, P ROY SOC B-BIOL SCI, V278, P1840, DOI 10.1098/rspb.2010.2321; Cossins A, 2006, J EXP BIOL, V209, P2328, DOI 10.1242/jeb.02256; Csaszar NBM, 2009, MAR ECOL PROG SER, V392, P93, DOI 10.3354/meps08194; Dalziel AC, 2009, MOL ECOL, V18, P4997, DOI 10.1111/j.1365-294X.2009.04427.x; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Desalvo MK, 2008, MOL ECOL, V17, P3952, DOI 10.1111/j.1365-294X.2008.03879.x; DeSalvo MK, 2010, MAR ECOL PROG SER, V402, P97, DOI 10.3354/meps08372; Donner SD, 2005, GLOBAL CHANGE BIOL, V11, P2251, DOI 10.1111/j.1365-2486.2005.01073.x; Drew JE, 2011, J MOL DIAGN, V13, P233, DOI 10.1016/j.jmoldx.2010.10.001; Dunn SR, 2004, CELL DEATH DIFFER, V11, P1213, DOI 10.1038/sj.cdd.4401484; Edge SE, 2008, J EXP MAR BIOL ECOL, V355, P114, DOI 10.1016/j.jembe.2007.12.004; Edge SE, 2005, MAR POLLUT BULL, V51, P507, DOI 10.1016/j.marpolbul.2005.07.007; Edmunds PJ, 2008, MAR ECOL PROG SER, V361, P307, DOI 10.3354/meps07556; Ferrier-Pages C, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P215, DOI 10.1007/978-94-007-0114-4_15; Fitt WK, 2009, J EXP MAR BIOL ECOL, V373, P102, DOI 10.1016/j.jembe.2009.03.011; Foret S, 2007, CORAL REEFS, V26, P475, DOI 10.1007/s00338-007-0206-1; Furla P, 2000, AM J PHYSIOL-REG I, V278, pR870, DOI 10.1152/ajpregu.2000.278.4.R870; Ganot P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002187; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Geel C, 1997, PHOTOSYNTH RES, V51, P61, DOI 10.1023/A:1005779112140; Grasso LC, 2011, DEV BIOL, V353, P411, DOI 10.1016/j.ydbio.2011.02.010; Grasso LC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-540; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; Grottoli AG, 2004, MAR BIOL, V145, P621, DOI 10.1007/s00227-004-1337-3; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hansen MM, 2012, MOL ECOL, V21, P1311, DOI 10.1111/j.1365-294X.2011.05463.x; HARLAND AD, 1992, MAR BIOL, V112, P253, DOI 10.1007/BF00702469; Hennige SJ, 2009, CORAL REEFS, V28, P179, DOI 10.1007/s00338-008-0444-x; Hill R, 2004, MAR BIOL, V144, P633, DOI 10.1007/s00227-003-1226-1; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hofmann GE, 2010, ANNU REV PHYSIOL, V72, P127, DOI 10.1146/annurev-physiol-021909-135900; Hoogenboom M, 2010, CORAL REEFS, V29, P21, DOI 10.1007/s00338-009-0558-9; Hoogenboom M, 2010, J EXP BIOL, V213, P2399, DOI 10.1242/jeb.040147; Houlbreque F, 2003, J EXP MAR BIOL ECOL, V296, P145, DOI 10.1016/S0022-0981(03)00259-4; Houlbreque F, 2009, BIOL REV, V84, P1, DOI 10.1111/j.1469-185X.2008.00058.x; Howells EJ, 2012, NAT CLIM CHANGE, V2, P116, DOI 10.1038/NCLIMATE1330; Huey R.B., 1996, Society for Experimental Biology Seminar Series, V59, P205; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Imagawa S, 2004, COMP BIOCHEM PHYS B, V137, P11, DOI 10.1016/j.cbpc.2003.09.011; Jackson JBC, 2008, P NATL ACAD SCI USA, V105, P11458, DOI 10.1073/pnas.0802812105; Kenkel CD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026914; Knowlton N, 2001, P NATL ACAD SCI USA, V98, P5419, DOI 10.1073/pnas.091092998; Kortschak RD, 2003, CURR BIOL, V13, P2190, DOI 10.1016/j.cub.2003.11.030; Krueger Charlene, 2004, Biol Res Nurs, V6, P151, DOI 10.1177/1099800404267682; Kvennefors ECE, 2008, DEV COMP IMMUNOL, V32, P1582, DOI 10.1016/j.dci.2008.05.010; Leuzinger S, 2012, MAR BIOL, V159, P177, DOI 10.1007/s00227-011-1797-1; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; MALY IP, 1988, HISTOCHEMISTRY, V88, P387; Meyer E, 2011, MOL ECOL, V20, P3599, DOI 10.1111/j.1365-294X.2011.05205.x; Meyer E, 2009, MAR ECOL PROG SER, V392, P81, DOI 10.3354/meps08208; Middlebrook R, 2008, J EXP BIOL, V211, P1050, DOI 10.1242/jeb.013284; Middlebrook R, 2010, J EXP BIOL, V213, P1026, DOI 10.1242/jeb.031633; Miller DJ, 2007, GENOME BIOL, P8; Morgan MB, 2005, MAR POLLUT BULL, V51, P524, DOI 10.1016/j.marpolbul.2005.09.023; Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Oliver TA, 2011, CORAL REEFS, V30, P429, DOI 10.1007/s00338-011-0721-y; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pigliucci M, 2005, TRENDS ECOL EVOL, V20, P481, DOI 10.1016/j.tree.2005.06.001; PIGLIUCCI M, 1993, TRENDS ECOL EVOL, V8, P379, DOI 10.1016/0169-5347(93)90225-E; PLATT T, 1980, J MAR RES, V38, P687; Putnam HM, 2010, INVERTEBR BIOL, V129, P199, DOI 10.1111/j.1744-7410.2010.00199.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Rai AJ, 2009, ANAL BIOANAL CHEM, V393, P1505, DOI 10.1007/s00216-008-2436-7; Ralph PJ, 2005, AQUAT BOT, V82, P222, DOI 10.1016/j.aquabot.2005.02.006; Ranz JM, 2006, TRENDS ECOL EVOL, V21, P29, DOI 10.1016/j.tree.2005.09.002; Reyes-Bermudez A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-178; Rocker MM, 2012, THERMAL STRESS RELAT; Rodrigues LJ, 2007, LIMNOL OCEANOGR, V52, P1874, DOI 10.4319/lo.2007.52.5.1874; Rowan R, 1997, NATURE, V388, P265, DOI 10.1038/40843; Schrader M, 2006, BBA-MOL CELL RES, V1763, P1755, DOI 10.1016/j.bbamcr.2006.09.006; Schreiber U, 2004, ADV PHOTO RESPIRAT, V19, P279; Schwarz JA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-435; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Smith-Keune C, 2006, CORAL REEFS, V25, P493, DOI 10.1007/s00338-006-0129-2; Souter P, 2011, MOL ECOL RESOUR, V11, P328, DOI 10.1111/j.1755-0998.2010.02923.x; Tambutte S, 2011, J EXP MAR BIOL ECOL, V408, P58, DOI 10.1016/j.jembe.2011.07.026; Tocher DR, 2003, REV FISH SCI, V11, P107, DOI 10.1080/713610925; Toller WW, 2001, BIOL BULL, V201, P348, DOI 10.2307/1543613; Tomanek L, 2011, ANNU REV MAR SCI, V3, P373, DOI 10.1146/annurev-marine-120709-142729; Ulstrup KE, 2006, MAR BIOL, V149, P1325, DOI 10.1007/s00227-006-0286-4; Ulstrup KE, 2006, MAR ECOL PROG SER, V314, P135, DOI 10.3354/meps314135; Unuma T, 2003, J EXP BIOL, V206, P365, DOI 10.1242/jeb.00102; Van Oppen MJH, 2006, MOL ECOL, V15, P3863, DOI 10.1111/j.1365-294X.2006.03026.x; van Oppen MJH, 2011, MOL ECOL, V20, P4899, DOI 10.1111/j.1365-294X.2011.05328.x; van Oppen MJH, 2001, P ROY SOC B-BIOL SCI, V268, P1759, DOI 10.1098/rspb.2001.1733; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vidal-Dupiol Jeremie, 2009, BMC Physiology, V9, P14, DOI 10.1186/1472-6793-9-14; Voolstra CR, 2009, MOL ECOL, V18, P1823, DOI 10.1111/j.1365-294X.2009.04167.x; Voolstra CR, 2011, PLOS ONE, V6; Webster N, 2013, MOL ECOL, V22, P1854, DOI 10.1111/mec.12213; WEIS VM, 1989, MAR BIOL, V100, P195, DOI 10.1007/BF00391958; WEIS VM, 1993, J EXP MAR BIOL ECOL, V174, P209, DOI 10.1016/0022-0981(93)90018-J; WEIS VM, 1991, BIOL BULL, V180, P496, DOI 10.2307/1542351; West J, 2003, COMMENTARY, V115, P17; Yamashiro H, 2005, FISHERIES SCI, V71, P448, DOI 10.1111/j.1444-2906.2005.00983.x; YOUNG SD, 1973, INT J BIOCHEM, V4, P339, DOI 10.1016/0020-711X(73)90056-6; Yuyama I, 2011, MAR BIOTECHNOL, V13, P32, DOI 10.1007/s10126-010-9265-3	124	19	19	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e61736	10.1371/journal.pone.0061736	http://dx.doi.org/10.1371/journal.pone.0061736			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671571	Green Submitted, Green Published, gold			2022-12-25	WOS:000319737700004
J	Kandiah, V; Shepelyansky, DL				Kandiah, Vivek; Shepelyansky, Dima L.			Google Matrix Analysis of DNA Sequences	PLOS ONE			English	Article								For DNA sequences of various species we construct the Google matrix G of Markov transitions between nearby words composed of several letters. The statistical distribution of matrix elements of this matrix is shown to be described by a power law with the exponent being close to those of outgoing links in such scale-free networks as the World Wide Web (WWW). At the same time the sum of ingoing matrix elements is characterized by the exponent being significantly larger than those typical for WWW networks. This results in a slow algebraic decay of the PageRank probability determined by the distribution of ingoing elements. The spectrum of G is characterized by a large gap leading to a rapid relaxation process on the DNA sequence networks. We introduce the PageRank proximity correlator between different species which determines their statistical similarity from the view point of Markov chains. The properties of other eigenstates of the Google matrix are also discussed. Our results establish scale-free features of DNA sequence networks showing their similarities and distinctions with the WWW and linguistic networks.	[Kandiah, Vivek; Shepelyansky, Dima L.] Univ Toulouse, UPS, Lab Phys Theor CNRS, IRSAMC, Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Shepelyansky, DL (corresponding author), Univ Toulouse, UPS, Lab Phys Theor CNRS, IRSAMC, Toulouse, France.	dima@irsamc.ups-tlse.fr	Shepelyansky, Dima L/G-6050-2016	Shepelyansky, Dima L/0000-0002-2752-0765	EC FET Open project "New tools and algorithms for directed network analysis" (NADINE) [288956]; France-Armenia collaboration grant CNRS/SCS [24943 (IE-017)]; CNRS - Region Midi-Pyrenees grant	EC FET Open project "New tools and algorithms for directed network analysis" (NADINE); France-Armenia collaboration grant CNRS/SCS; CNRS - Region Midi-Pyrenees grant(Region Occitanie)	This research is supported in part by the EC FET Open project "New tools and algorithms for directed network analysis" (NADINE No. 288956); the France-Armenia collaboration grant CNRS/SCS No. 24943 (IE-017) on "Classical and quantum chaos"; VK is supported by CNRS - Region Midi-Pyrenees grant. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRENDEL V, 1986, J BIOMOL STRUCT DYN, V4, P11, DOI 10.1080/07391102.1986.10507643; Brin M., 2002, INTRO DYNAMICAL SYST; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Burden CJ, 2012, STAT APPL GENET MOL, V11, DOI 10.2202/1544-6115.1724; Cancho RFI, 2001, P ROY SOC B-BIOL SCI, V268, P2261, DOI 10.1098/rspb.2001.1800; Dai Q, 2008, BIOINFORMATICS, V24, P2296, DOI 10.1093/bioinformatics/btn436; Donato D, 2004, EUR PHYS J B, V38, P239, DOI 10.1140/epjb/e2004-00056-6; Dorogovtsev SN, 2001, P ROY SOC B-BIOL SCI, V268, P2603, DOI 10.1098/rspb.2001.1824; Ermann L, 2012, J PHYS A-MATH THEOR, V45, DOI 10.1088/1751-8113/45/27/275101; Ermann L, 2012, PHYSICA D, V241, P514, DOI 10.1016/j.physd.2011.11.012; Ermann L, 2012, ARXIV12121068CSIR; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Frahm KM, 2012, EUR PHYS J B, V85, DOI 10.1140/epjb/e2012-30599-6; Frahm KM, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.016214; Frahm KM, 2011, J PHYS A-MATH THEOR, V44, DOI 10.1088/1751-8113/44/46/465101; Frahm KM, 2010, EUR PHYS J B, V76, P57, DOI 10.1140/epjb/e2010-00190-6; Frenkel ZM, 2009, J THEOR BIOL, V260, P438, DOI 10.1016/j.jtbi.2009.07.004; Froyland G, 2009, PHYSICA D, V238, P1507, DOI 10.1016/j.physd.2009.03.002; Giraud O, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026107; Halpern D, 2007, PLOS GENET, V3, P1614, DOI 10.1371/journal.pgen.0030153; Langville A., 2006, GOOGLES PAGERANK SCI; MANTEGNA RN, 1995, PHYS REV E, V52, P2939, DOI 10.1103/PhysRevE.52.2939; Markov A., 1906, IZVESTIYA FIZIKOMATE, V2, P135; Pandurangan G, 2006, INTERNET MATH, V3, P1, DOI 10.1080/15427951.2006.10129114; Popov O, 1996, BIOSYSTEMS, V38, P65, DOI 10.1016/0303-2647(95)01568-X; Reinert G, 2009, J COMPUT BIOL, V16, P1615, DOI 10.1089/cmb.2009.0198; ROBIN S, 2005, DNA WORDS MODELS; Shepelyansky DL, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.036213; Ulam S. M., 1960, INTERSCIENCE TRACS P, V8, P73; Zhirov AO, 2010, EUR PHYS J B, V77, P523, DOI 10.1140/epjb/e2010-10500-7; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL	31	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e61519	10.1371/journal.pone.0061519	http://dx.doi.org/10.1371/journal.pone.0061519			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671568	Green Submitted, gold, Green Published			2022-12-25	WOS:000319737700003
J	Lee, WH; Wee, JH; Kim, DK; Rhee, CS; Lee, CH; Ahn, S; Lee, JH; Cho, YS; Lee, KH; Kim, KS; Kim, SW; Lee, A; Kim, JW				Lee, Woo Hyun; Wee, Jee Hye; Kim, Dong-Kyu; Rhee, Chae-Seo; Lee, Chul Hee; Ahn, Soyeon; Lee, Ju Hyun; Cho, Yang-Sun; Lee, Kun Hee; Kim, Kyung Soo; Kim, Si Whan; Lee, Ari; Kim, Jeong-Whun			Prevalence of Subjective Olfactory Dysfunction and Its Risk Factors: Korean National Health and Nutrition Examination Survey	PLOS ONE			English	Article							SMELL IDENTIFICATION; ADULT-POPULATION; MITRAL CELLS; AGE; SENSITIVITY; IMPAIRMENT; SMOKING; BULB	Background: Population-based studies for olfactory dysfunction are lacking. The aim of this study is to evaluate the prevalence of subjective olfactory dysfunction and its risk factors in the Korean general population. Methods: The data were obtained from the 2009 Korea National Health and Nutrition Examination Survey (KNHANES), which was a cross-sectional survey of non-institutionalized population all around the country (n = 10,533). All interviewees underwent medical interviews, physical examinations, endoscopic examination and blood/urine tests. Whether sense of smell has been normal or abnormal during the last 3 months was asked. Complete olfaction data were obtained from 7,306 participants and the participants were divided into normosmic and hyposmic group. Multivariate logistic regression analyses were performed to identify its risk factors. Results: The weighted prevalence of subjective olfactory dysfunction was 4.5%. Its increased prevalence was significantly associated with the increasing age for both men and women. In the multivariate analyses, low income (adjusted odds ratio [OR] = 1.43, 95% Confidence Interval [CI] = 1.01-2.03), habitual exposure to air pollutants (adjusted OR = 2.18, CI = 1.33-3.55), a history of hepatitis B (adjusted OR = 3.10, CI = 1.25-7.68), rhinitis (adjusted OR = 1.78, CI = 1.26-2.51) and chronic sinusitis (adjusted OR = 14.55, CI = 10.06-21.05) were risk factors of olfactory dysfunction. Conclusion: Our population-based study showed that olfactory dysfunction was quite prevalent and several risk factors were associated with impaired sense of smell. Given its prevalence, further researches for its prevention and management are required.	[Lee, Woo Hyun; Wee, Jee Hye; Kim, Dong-Kyu; Rhee, Chae-Seo; Lee, Chul Hee; Kim, Jeong-Whun] Seoul Natl Univ, Bundang Hosp, Dept Otorhinolaryngol, Songnam, South Korea; [Lee, Woo Hyun; Wee, Jee Hye; Kim, Dong-Kyu; Rhee, Chae-Seo; Lee, Chul Hee; Kim, Jeong-Whun] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Ahn, Soyeon; Lee, Ju Hyun] Seoul Natl Univ, Bundang Hosp, Med Res Collaborating Ctr, Songnam, South Korea; [Cho, Yang-Sun] Sungkyunkwan Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [Lee, Kun Hee] Kyung Hee Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [Kim, Kyung Soo] Yonsei Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul 120749, South Korea; [Kim, Si Whan] Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea; [Lee, Ari] Korea Ctr Dis Control & Prevent, Div Chron Dis Surveillance, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Sungkyunkwan University (SKKU); Kyung Hee University; Yonsei University; Yonsei University Health System; Hallym University; Korea Centers for Disease Control & Prevention (KCDC)	Kim, JW (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Otorhinolaryngol, Songnam, South Korea.	kimemail@snu.ac.kr	Lee, Kun Hee/AAH-9967-2020; Cho, Yang Sun/F-4611-2014	Lee, Kun Hee/0000-0002-5380-3726; 				Amoore J. E., 1986, TOXICOLOGY NASAL PAS; BHATNAGAR KP, 1987, ANAT REC, V218, P73, DOI 10.1002/ar.1092180112; Bramerson A, 2004, LARYNGOSCOPE, V114, P733; Doty RL, 1995, CHEM SENSES, V20, P645, DOI 10.1093/chemse/20.6.645; Doty RL., 2003, HDB OLFACTION GUSTAT, V2nd; Gobba F, 2006, INT ARCH OCC ENV HEA, V79, P322, DOI 10.1007/s00420-005-0043-x; HENKIN RI, 1971, LANCET, V1, P823; Hoffman HJ, 1998, ANN NY ACAD SCI, V855, P716, DOI 10.1111/j.1749-6632.1998.tb10650.x; HUBERT HB, 1980, SCIENCE, V208, P607, DOI 10.1126/science.7189296; Jernigan TL, 2001, NEUROBIOL AGING, V22, P581, DOI 10.1016/S0197-4580(01)00217-2; Jones N, 1998, J LARYNGOL OTOL, V112, P11, DOI 10.1017/S0022215100139829; JOYNER RE, 1964, ARCHIV OTOLARYNGOL, V80, P576; Lafreniere D, 2009, OTOLARYNG CLIN N AM, V42, P123, DOI 10.1016/j.otc.2008.09.001; Landis BN, 2004, LARYNGOSCOPE, V114, P1764, DOI 10.1097/00005537-200410000-00017; Meisami E, 1998, ANN NY ACAD SCI, V855, P708, DOI 10.1111/j.1749-6632.1998.tb10649.x; Murphy C, 2002, JAMA-J AM MED ASSOC, V288, P2307, DOI 10.1001/jama.288.18.2307; NAKASHIMA T, 1984, ARCH OTOLARYNGOL, V110, P641; Nordin S, 2004, ACTA OTO-LARYNGOL, V124, P1171, DOI 10.1080/00016480410017468; Schubert CR, 2012, CHEM SENSES, V37, P325, DOI 10.1093/chemse/bjr102; SHIP JA, 1993, J GERONTOL, V48, pM26, DOI 10.1093/geronj/48.1.M26; Ship JA, 1996, J GERONTOL A-BIOL, V51, pM86, DOI 10.1093/gerona/51A.2.M86; Temmel AFP, 2005, WIEN KLIN WOCHENSCHR, V117, P26, DOI 10.1007/s00508-004-0303-x; Van Toller S, 1999, CHEM SENSES, V24, P705, DOI 10.1093/chemse/24.6.705; VENSTROM D, 1968, J FOOD SCI, V33, P264, DOI 10.1111/j.1365-2621.1968.tb01364.x; WEINSTOCK RS, 1993, PHYSIOL BEHAV, V53, P17, DOI 10.1016/0031-9384(93)90005-Z	25	60	60	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e62725	10.1371/journal.pone.0062725	http://dx.doi.org/10.1371/journal.pone.0062725			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671628	Green Published, gold, Green Submitted			2022-12-25	WOS:000319737700018
J	Werner, MU; Petersen, KL; Rowbotham, MC; Dahl, JB				Werner, Mads U.; Petersen, Karin L.; Rowbotham, Michael C.; Dahl, Jorgen B.			Healthy Volunteers Can Be Phenotyped Using Cutaneous Sensitization Pain Models	PLOS ONE			English	Article							HEAT-CAPSAICIN SENSITIZATION; ACUTE INFLAMMATORY PAIN; HYPERALGESIA; GABAPENTIN; ANALGESIA; AGREEMENT; MORPHINE; TWIN	Background: Human experimental pain models leading to development of secondary hyperalgesia are used to estimate efficacy of analgesics and antihyperalgesics. The ability to develop an area of secondary hyperalgesia varies substantially between subjects, but little is known about the agreement following repeated measurements. The aim of this study was to determine if the areas of secondary hyperalgesia were consistently robust to be useful for phenotyping subjects, based on their pattern of sensitization by the heat pain models. Methods: We performed post-hoc analyses of 10 completed healthy volunteer studies (n = 342 [409 repeated measurements]). Three different models were used to induce secondary hyperalgesia to monofilament stimulation: the heat/capsaicin sensitization (H/C), the brief thermal sensitization (BTS), and the burn injury (BI) models. Three studies included both the H/C and BTS models. Results: Within-subject compared to between-subject variability was low, and there was substantial strength of agreement between repeated induction-sessions in most studies. The intraclass correlation coefficient (ICC) improved little with repeated testing beyond two sessions. There was good agreement in categorizing subjects into 'small area' (1st quartile [<25%]) and 'large area' (4th quartile [>75%]) responders: 56-76% of subjects consistently fell into same 'small-area' or 'large-area' category on two consecutive study days. There was moderate to substantial agreement between the areas of secondary hyperalgesia induced on the same day using the H/C (forearm) and BTS (thigh) models. Conclusion: Secondary hyperalgesia induced by experimental heat pain models seem a consistent measure of sensitization in pharmacodynamic and physiological research. The analysis indicates that healthy volunteers can be phenotyped based on their pattern of sensitization by the heat [and heat plus capsaicin] pain models.	[Werner, Mads U.] Copenhagen Univ Hosp, Rigshosp, Ctr Multidisciplinary Pain, Neurosci Ctr, Copenhagen, Denmark; [Petersen, Karin L.; Rowbotham, Michael C.] Calif Pacific Med Ctr, Res Inst, San Francisco, CA USA; [Dahl, Jorgen B.] Rigshosp, Copenhagen Univ Hosp, Ctr Head & Orthopaed, Dept Anaesthesia, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; California Pacific Medical Center; California Pacific Medical Center Research Institute; Rigshospitalet; University of Copenhagen	Werner, MU (corresponding author), Copenhagen Univ Hosp, Rigshosp, Ctr Multidisciplinary Pain, Neurosci Ctr, Copenhagen, Denmark.	mads.u.werner@gmail.com	Rowbotham, Michael/AAA-3606-2019	Werner, Mads/0000-0003-1540-8845	Schwab Gift Fund at University of California, San Francisco (UCSF); Neuropathic Pain Research Gift Fund at California Pacific Medical Center Research Institute (CPMCRI)	Schwab Gift Fund at University of California, San Francisco (UCSF); Neuropathic Pain Research Gift Fund at California Pacific Medical Center Research Institute (CPMCRI)	Support was provided from institutional and departmental sources at Copenhagen University Hospital, from the Schwab Gift Fund at University of California, San Francisco (UCSF), and the Neuropathic Pain Research Gift Fund at California Pacific Medical Center Research Institute (CPMCRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angst MS, 2012, PAIN, V153, P1397, DOI 10.1016/j.pain.2012.02.022; Armitage P, 2002, STAT METHODS MED RES, P648; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1177/096228029900800204; Dirks J, 2000, ANESTH ANALG, V91, P967, DOI 10.1097/00000539-200010000-00037; Dirks J, 2003, J PAIN, V4, P122, DOI 10.1054/jpai.2003.10; Dirks J, 2002, ANESTHESIOLOGY, V97, P102, DOI 10.1097/00000542-200207000-00015; Dirks J, 2001, REGION ANESTH PAIN M, V26, P414, DOI 10.1097/00115550-200109000-00005; Frymoyer AR, 2007, J PAIN, V8, P19, DOI 10.1016/j.jpain.2006.05.010; Geber C, 2011, PAIN, V152, P548, DOI 10.1016/j.pain.2010.11.013; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Martinez V, 2012, PAIN, V153, P1478, DOI 10.1016/j.pain.2012.04.004; Mikkelsen S, 2001, BRIT J ANAESTH, V86, P871, DOI 10.1093/bja/86.6.871; Norbury TA, 2007, BRAIN, V130, P3041, DOI 10.1093/brain/awm233; Pedersen JL, 1998, PAIN, V74, P139, DOI 10.1016/S0304-3959(97)00160-7; Petersen KL, 2008, PAIN, V137, P395, DOI 10.1016/j.pain.2007.09.019; Petersen KL, 2001, ANESTHESIOLOGY, V94, P15, DOI 10.1097/00000542-200101000-00008; Pfau DB, 2011, PAIN, V152, P1532, DOI 10.1016/j.pain.2011.02.037; Ravn Pernille, 2012, J Pain Res, V5, P313, DOI 10.2147/JPR.S33925; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Werner MU, 2004, ANESTHESIOLOGY, V100, P115, DOI 10.1097/00000542-200401000-00020; Werner MU, REG ANESTH PAIN MED, V26, P322; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030	22	33	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e62733	10.1371/journal.pone.0062733	http://dx.doi.org/10.1371/journal.pone.0062733			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671631	Green Published, Green Submitted, gold			2022-12-25	WOS:000319737700020
J	Wu, Y; You, HH; Ma, P; Li, L; Yuan, Y; Li, JQ; Ye, X; Liu, XD; Yao, HC; Chen, RC; Lai, KF; Yang, X				Wu, Yang; You, Huihui; Ma, Ping; Li, Li; Yuan, Ye; Li, Jinquan; Ye, Xin; Liu, Xudong; Yao, Hanchao; Chen, Ruchong; Lai, Kefang; Yang, Xu			Role of Transient Receptor Potential Ion Channels and Evoked Levels of Neuropeptides in a Formaldehyde-Induced Model of Asthma in Balb/c Mice	PLOS ONE			English	Article							SUBSTANCE-P; NEUROGENIC INFLAMMATION; AIRWAY HYPERRESPONSIVENESS; IGE ANTIBODIES; TRP CHANNELS; CELLS; PAIN; MACROPHAGES; MECHANISMS; EXPRESSION	Objective: Asthma is a complex pulmonary inflammatory disease characterized by the hyper-responsiveness, remodeling and inflammation of airways. Formaldehyde is a common indoor air pollutant that can cause asthma in people experiencing long-term exposure. The irritant effect and adjuvant effect are the two possible pathways of formaldehyde promoted asthma. Methodology/Principal Findings: To explore the neural mechanisms and adjuvant effect of formaldehyde, 48 Balb/c mice in six experimental groups were exposed to (a) vehicle control; (b) ovalbumin; (c) formaldehyde (3.0 mg/m(3)); (d) ovalbumin+formaldehyde (3.0 mg/m(3)); (e) ovalbumin+formaldehyde (3.0 mg/m(3))+HC-030031 (transient receptor potential ankyrin 1 antagonist); (f) ovalbumin+formaldehyde (3.0 mg/m(3))+capsazepine (transient receptor potential vanilloid 1 antagonist). Experiments were conducted after 4 weeks of combined exposure and 1-week challenge with aerosolized ovalbumin. Airway hyper-responsiveness, pulmonary tissue damage, eosinophil infiltration, and increased levels of interleukin-4, interleukin-6, interleukin-1 beta, immunoglobulin E, substance P and calcitonin gene-related peptide in lung tissues were found in the ovalbumin+formaldehyde (3.0 mg/m(3)) group compared with the values seen in ovalbumin -only immunized mice. Except for interleukin-1 beta levels, other changes in the levels of biomarker could be inhibited by HC-030031 and capsazepine. Conclusions/Significance: Formaldehyde might be a key risk factor for the rise in asthma cases. Transient receptor potential ion channels and neuropeptides have important roles in formaldehyde promoted-asthma.	[Wu, Yang; You, Huihui; Ma, Ping; Li, Li; Yuan, Ye; Li, Jinquan; Ye, Xin; Liu, Xudong; Yao, Hanchao; Yang, Xu] Cent China Normal Univ, Sect Environm Biomed, Hubei Key Lab Genet Regulat & Integrat Biol, Coll Life Sci, Wuhan, Peoples R China; [Wu, Yang; Chen, Ruchong] Guangzhou Med Univ, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [Ma, Ping] Hubei Univ Sci & Technol, Coll Basic Med Sci, Xianning, Peoples R China	Central China Normal University; Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Hubei University of Science & Technology	Lai, KF (corresponding author), Guangzhou Med Univ, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.	klai@163.com; yangxu@mail.ccnu.edu.cn		li, jinquan/0000-0003-0498-5399	National Natural Science Foundation of China [51136002, 51076079]; State Key Laboratory of Respiratory Disease of China [2007DA780154F0906]; China Key Technologies RD Program [2012BAJ02B03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Respiratory Disease of China; China Key Technologies RD Program	This work was funded by the National Natural Science Foundation of China (51136002 and 51076079), the Open Project of State Key Laboratory of Respiratory Disease of China (2007DA780154F0906), and the China Key Technologies R&D Program (No. 2012BAJ02B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, IARC MON EV CARC RIS, V88, P196; Apgar JM, 1998, J MICROSC-OXFORD, V191, P20; ATSDR (Agenct for Toxic Disease SUbstances Registry), 2010, TOX PROF FORM, P4; BANGLE R, 1954, J HISTOCHEM CYTOCHEM, V2, P62, DOI 10.1177/2.1.62; Barnes PJ, 2001, RESP PHYSIOL, V125, P145, DOI 10.1016/S0034-5687(00)00210-3; Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; Bautista DM, 2013, ANNU REV PHYSIOL, V75, P181, DOI 10.1146/annurev-physiol-030212-183811; Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Belvisi MG, 2002, CURR OPIN PHARMACOL, V2, P211, DOI 10.1016/S1471-4892(02)00145-5; Bessac BF, 2008, PHYSIOLOGY, V23, P360, DOI 10.1152/physiol.00026.2008; Biro T, 1998, BLOOD, V91, P1332, DOI 10.1182/blood.V91.4.1332; Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; Caceres AI, 2009, P NATL ACAD SCI USA, V106, P9099, DOI 10.1073/pnas.0900591106; Capuron L, 2011, PHARMACOL THERAPEUT, V130, P226, DOI 10.1016/j.pharmthera.2011.01.014; Carlsten C, 2012, CURR OPIN ALLERGY CL, V12, P455, DOI 10.1097/ACI.0b013e328357cc55; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Dakhama A, 2005, AM J PHYSIOL-LUNG C, V288, pL761, DOI 10.1152/ajplung.00143.2004; de Vries A, 2006, CLIN EXP ALLERGY, V36, P1192, DOI 10.1111/j.1365-2222.2006.02549.x; Drazen JM, 1999, ANNU REV PHYSIOL, V61, P593, DOI 10.1146/annurev.physiol.61.1.593; Ezratty V, 2007, ENVIRON HEALTH PERSP, V115, P210, DOI 10.1289/ehp.9414; Fahy John V, 2009, Proc Am Thorac Soc, V6, P256, DOI 10.1513/pats.200808-087RM; Geppetti P, 2008, BJU INT, V101, P2, DOI 10.1111/j.1464-410X.2008.07493.x; Germonpre PR, 1999, EUR RESPIR J, V14, P776, DOI 10.1034/j.1399-3003.1999.14d08.x; Giovanna P, 2009, INFLAMM ALLERGY DRUG, V8, P176; Grant J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031697; Hamid Q, 2009, ANNU REV PHYSIOL, V71, P489, DOI 10.1146/annurev.physiol.010908.163200; Han B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017236; Han Y, 2012, NEUROSCI BULL, V28, P165, DOI 10.1007/s12264-012-1211-0; Ho WZ, 1997, J IMMUNOL, V159, P5654; Joos GF, 2000, ALLERGY, V55, P321, DOI 10.1034/j.1398-9995.2000.00112.x; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Jung WW, 2007, ENVIRON TOXICOL PHAR, V24, P174, DOI 10.1016/j.etap.2007.05.001; KRAMPS JA, 1989, CLIN EXP ALLERGY, V19, P509, DOI 10.1111/j.1365-2222.1989.tb02425.x; Larson SD, 2004, AM J PHYSIOL-LUNG C, V287, pL286, DOI 10.1152/ajplung.00369.2003; Lee LY, 2001, RESP PHYSIOL, V125, P47, DOI 10.1016/S0034-5687(00)00204-8; Leikauf GD, 2002, ENVIRON HEALTH PERSP, V110, P505, DOI 10.1289/ehp.02110s4505; LIDEN S, 1993, ALLERGY, V48, P525, DOI 10.1111/j.1398-9995.1993.tb01109.x; Liu DD, 2011, J IMMUNOTOXICOL, V8, P305, DOI 10.3109/1547691X.2011.600738; Locksley RM, 2010, CELL, V140, P777, DOI 10.1016/j.cell.2010.03.004; Lu Z, 2008, INDOOR AIR, V18, P77, DOI 10.1111/j.1600-0668.2008.00524.x; Lu ZS, 2005, FRONT BIOSCI-LANDMRK, V10, P2527, DOI 10.2741/1717; McAlexander MA, 2011, ADV EXP MED BIOL, V704, P969, DOI 10.1007/978-94-007-0265-3_50; McGwin G, 2010, ENVIRON HEALTH PERSP, V118, P313, DOI 10.1289/ehp.0901143; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Mendell MJ, 2007, INDOOR AIR, V17, P259, DOI 10.1111/j.1600-0668.2007.00478.x; Mostafa GA, 2009, EGYPT J PEDIATR ALLE, V7, P45; Nambu Aya, 2010, Allergology International, V59, P125, DOI 10.2332/allergolint.10-RAI-0190; Nassini R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042454; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; O'Connor TM, 2004, J CELL PHYSIOL, V201, P167, DOI 10.1002/jcp.20061; Qiao Y, 2009, INHAL TOXICOL, V21, P1200, DOI 10.3109/08958370902806159; Ramalho R, 2013, ALLERGY, V68, P48, DOI 10.1111/all.12052; Richardson JD, 2002, J PHARMACOL EXP THER, V302, P839, DOI 10.1124/jpet.102.032797; Rumchev KB, 2002, EUR RESPIR J, V20, P403, DOI 10.1183/09031936.02.00245002; Sadakane Kaori, 2002, Journal of Environmental Pathology Toxicology and Oncology, V21, P267; Salthammer T, 2010, CHEM REV, V110, P2536, DOI 10.1021/cr800399g; Schmiedeberg L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004636; Singer K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057929; Sousa AR, 1996, AM J RESP CRIT CARE, V154, P1061, DOI 10.1164/ajrccm.154.4.8887608; Tang XJ, 2009, ENVIRON INT, V35, P1210, DOI 10.1016/j.envint.2009.06.002; Tano JYK, 2012, CHANNELS, V6, P141, DOI 10.4161/chan.20292; TARKOWSKI M, 1995, INT ARCH ALLERGY IMM, V106, P422, DOI 10.1159/000236876; Tong ZQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010234; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Undem Bradley J, 2002, Curr Allergy Asthma Rep, V2, P159, DOI 10.1007/s11882-002-0011-4; Yates AB, 2005, ATOPY ASTHMA ENCY LI, P1; Zhang D, 2012, PHYSIOL RES, V61, P113, DOI 10.33549/physiolres.932053	67	30	36	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e62827	10.1371/journal.pone.0062827	http://dx.doi.org/10.1371/journal.pone.0062827			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671638	gold, Green Published, Green Submitted			2022-12-25	WOS:000319737700023
J	Yu, XF; Lu, CL; Liu, H; Rao, SX; Cai, JR; Liu, SP; Kriegel, AJ; Greene, AS; Liang, MY; Ding, XQ				Yu, Xiaofang; Lu, Chunlai; Liu, Hong; Rao, Shengxiang; Cai, Jieru; Liu, Shaopeng; Kriegel, Alison J.; Greene, Andrew S.; Liang, Minyu; Ding, Xiaoqiang			Hypoxic Preconditioning with Cobalt of Bone Marrow Mesenchymal Stem Cells Improves Cell Migration and Enhances Therapy for Treatment of Ischemic Acute Kidney Injury	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; INDUCIBLE FACTOR; CXCR4 EXPRESSION; STROMAL CELLS; INDUCTION; DIFFERENTIATION; CHEMOKINE; INHIBITION; PROTECTION; RECOVERY	Mesenchymal stem cell (MSC) administration is known to enhance the recovery of the kidney following injury. Here we tested the potential of hypoxic-preconditioned-MSC transplantation to enhance the efficacy of cell therapy on acute kidney injury (AKI) by improving MSC migration to the injured kidney. Cobalt was used as hypoxia mimetic preconditioning (HMP). MSC were subjected to HMP through 24 h culture in 200 mu mol/L cobalt. Compared to normoxia cultured MSC (NP-MSC), HMP significantly increased the expression of HIF-1 alpha and CXCR4 in MSC and enhanced the migration of MSC in vitro. This effect was lost when MSC were treated with siRNA targeting HIF-1 alpha or CXCR4 antagonist. SPIO labeled MSC were administered to rats with I/R injury followed immediately by magnetic resonance imaging. Imaging clearly showed that HMP-MSC exhibited greater migration and a longer retention time in the ischemic kidney than NP-MSC. Histological evaluation showed more HMP-MSC in the glomerular capillaries of ischemic kidneys than in the kidneys receiving NP-MSC. Occasional tubules showed iron labeling in the HMP group, while no tubules had iron labeling in NP group, indicating the possibility of tubular transdifferentiation after HMP. These results were also confirmed by fluorescence microscopy study using CM-DiI labeling. The increased recruitment of HMP-MSC was associated with reduced kidney injury and enhanced functional recovery. This effect was also related to the increased paracrine action by HMP-MSC. Thus we suggest that by enhancing MSC migration and prolonging kidney retention, hypoxic preconditioning of MSC may be a useful approach for developing AKI cell therapy.	[Yu, Xiaofang; Cai, Jieru; Liu, Shaopeng; Ding, Xiaoqiang] Fudan Univ, Dept Nephrol, Zhongshan Hosp, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Lu, Chunlai] Fudan Univ, Dept Thorac Surg, Zhongshan Hosp, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Liu, Hong] TCM, Hangzhou Hosp, Dept Nephrol, Hangzhou, Zhejiang, Peoples R China; [Rao, Shengxiang] Fudan Univ, Dept Radiol, Zhongshan Hosp, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Kriegel, Alison J.; Greene, Andrew S.; Liang, Minyu] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA	Fudan University; Fudan University; Fudan University; Medical College of Wisconsin	Yu, XF (corresponding author), Fudan Univ, Dept Nephrol, Zhongshan Hosp, Shanghai Med Coll, Shanghai 200433, Peoples R China.	yu.xiaofang@zs-hospital.sh.cn; ding.xiaoqiang@zs-hospital.sh.cn	Rao, Sheng-Xiang/I-8612-2019; Greene, Andrew S/B-9696-2015; Liang, Mingyu/A-2331-2008; Rao, Sheng-Xiang/AGL-7232-2022	Rao, Sheng-Xiang/0000-0001-7722-8327; Rao, Sheng-Xiang/0000-0001-7722-8327; Greene, Andrew/0000-0002-3191-2112	National Natural Science Funds of China [81000307, 81100524]; Major Project of Technology Committee in Shanghai of China [12DJ1400200]	National Natural Science Funds of China(National Natural Science Foundation of China (NSFC)); Major Project of Technology Committee in Shanghai of China	This study was supported by grants from National Natural Science Funds of China (Nos. 81000307 and 81100524) and the Major Project of Technology Committee in Shanghai of China (No. 12DJ1400200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadbeigi N, 2010, CELL BIOL INT, V34, P687, DOI 10.1042/CBI20090415; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bussolati B, 2008, AM J NEPHROL, V28, P813, DOI 10.1159/000137681; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chacko SM, 2010, AM J PHYSIOL-CELL PH, V299, pC1562, DOI 10.1152/ajpcell.00221.2010; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Das R, 2010, TISSUE ENG PART B-RE, V16, P159, DOI 10.1089/ten.TEB.2009.0296; Demirjian SG, 2011, CONTRIB NEPHROL, V174, P242, DOI 10.1159/000329402; El Sabbahy M, 2011, WIRES SYST BIOL MED, V3, P606, DOI 10.1002/wsbm.133; Fang Y, 2010, BLOOD PURIFICAT, V30, P120, DOI 10.1159/000319972; GOLDBERG MA, 1988, SCIENCE, V242, P1412, DOI 10.1126/science.2849206; Grayson WL, 2007, BIOCHEM BIOPH RES CO, V358, P948, DOI 10.1016/j.bbrc.2007.05.054; Hagiwara M, 2008, HUM GENE THER, V19, P807, DOI [10.1089/hum.2008.016, 10.1089/hgt.2008.016]; Hara Y, 2011, TRANSPL INT, V24, P1112, DOI 10.1111/j.1432-2277.2011.01328.x; Harrison JS, 2002, BLOOD, V99, P394, DOI 10.1182/blood.V99.1.394; Harting MT, 2008, CYTOTHERAPY, V10, P243, DOI 10.1080/14653240801950000; Hashimoto O, 2011, PATHOBIOLOGY, V78, P181, DOI 10.1159/000325538; Hauger O, 2006, RADIOLOGY, V238, P200, DOI 10.1148/radiol.2381041668; Honczarenko M, 2006, STEM CELLS, V24, P1030, DOI 10.1634/stemcells.2005-0319; Horiguchi H, 2004, TOXICOL LETT, V151, P459, DOI 10.1016/j.toxlet.2004.03.018; Ishikawa T, 2009, ONCOL REP, V21, P707, DOI 10.3892/or_00000275; Ittrich H, 2007, J MAGN RESON IMAGING, V25, P1179, DOI 10.1002/jmri.20925; Jiang HT, 2011, J SURG RES, V168, P127, DOI 10.1016/j.jss.2009.07.035; Jiang SH, 2007, CELL BIOCHEM FUNCT, V25, P335, DOI 10.1002/cbf.1395; Kim KS, 2006, J IMMUNOL, V177, P7211, DOI 10.4049/jimmunol.177.10.7211; Lange C, 2005, KIDNEY INT, V68, P1613, DOI 10.1111/j.1523-1755.2005.00573.x; Le Blanc K, 2003, CYTOTHERAPY, V5, P485, DOI 10.1080/14653240310003611; Liu HB, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034608, 10.1371/journal.pone.0050785]; Liu HB, 2010, BIOCHEM BIOPH RES CO, V401, P509, DOI 10.1016/j.bbrc.2010.09.076; Liu KD, 2008, CRIT CARE MED, V36, pS187, DOI 10.1097/CCM.0b013e318168ca4a; Lotan D, 2008, PEDIATR NEPHROL, V23, P71, DOI 10.1007/s00467-007-0648-2; Matsumoto M, 2003, J AM SOC NEPHROL, V14, P1825, DOI 10.1097/01.ASN.0000074239.22357.06; Moll NM, 2010, EXPERT REV HEMATOL, V3, P315, DOI 10.1586/EHM.10.16; Nervi B, 2006, J CELL BIOCHEM, V99, P690, DOI 10.1002/jcb.21043; Ohtomo S, 2008, NEPHROL DIAL TRANSPL, V23, P1166, DOI 10.1093/ndt/gfm715; Pacary E, 2006, J CELL SCI, V119, P2667, DOI 10.1242/jcs.03004; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Sagrinati C, 2008, TRENDS MOL MED, V14, P277, DOI 10.1016/j.molmed.2008.05.005; Salnikow K, 2004, J BIOL CHEM, V279, P40337, DOI 10.1074/jbc.M403057200; Schioppa T, 2003, J EXP MED, V198, P1391, DOI 10.1084/jem.20030267; Semedo P, 2007, TRANSPL P, V39, P421, DOI 10.1016/j.transproceed.2007.01.036; Song YR, 2010, NEPHROL DIAL TRANSPL, V25, P77, DOI 10.1093/ndt/gfp454; Sun JH, 2008, SWISS MED WKLY, V138, P404, DOI 2008/27/smw-12000; Tanaka T, 2005, KIDNEY INT, V68, P2714, DOI 10.1111/j.1523-1755.2005.00742.x; Tanaka T, 2005, LAB INVEST, V85, P1292, DOI 10.1038/labinvest.3700328; Tang YL, 2009, CIRC RES, V104, P1209, DOI 10.1161/CIRCRESAHA.109.197723; Togel F, 2005, AM J PHYSIOL-RENAL, V289, pF31, DOI 10.1152/ajprenal.00007.2005; Togel F, 2005, KIDNEY INT, V67, P1772, DOI 10.1111/j.1523-1755.2005.00275.x; Togel F, 2007, AM J PHYSIOL-RENAL, V292, pF1626, DOI 10.1152/ajprenal.00339.2006; Wang XB, 2008, BIOCHEM BIOPH RES CO, V371, P283, DOI 10.1016/j.bbrc.2008.04.055; Wang Y, 2008, BRAIN RES, V1195, P104, DOI 10.1016/j.brainres.2007.11.068	51	51	56	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e62703	10.1371/journal.pone.0062703	http://dx.doi.org/10.1371/journal.pone.0062703			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671625	Green Published, gold, Green Submitted			2022-12-25	WOS:000319737700017
J	Lobsien, D; Dreyer, AY; Stroh, A; Boltze, J; Hoffmann, KT				Lobsien, Donald; Dreyer, Antje Y.; Stroh, Albrecht; Boltze, Johannes; Hoffmann, Karl-Titus			Imaging of VSOP Labeled Stem Cells in Agarose Phantoms with Susceptibility Weighted and T2*Weighted MR Imaging	PLOS ONE			English	Article							IRON-OXIDE PARTICLES; IN-VIVO; CLINICAL-APPLICATIONS; ISCHEMIC-STROKE; BRAIN; TRACKING; NANOPARTICLES; RAT; GUIDELINES; MANAGEMENT	Objective: This study aimed to evaluate the detectability of stem cells labeled with very small iron oxide particles (VSOP) at 3T with susceptibility weighted (SWI) and T2* weighted imaging as a methodological basis for subsequent examinations in a large animal stroke model (sheep). Materials and Methods: We examined ovine mesenchymal stem cells labeled with VSOP in agarose layer phantoms. The experiments were performed in 2 different groups, with quantities of 0-100,000 labeled cells per layer. 15 different SWI-and T2*-weighted sequences and 3 RF coils were used. All measurements were carried out on a clinical 3T MRI. Images of Group A were analyzed by four radiologists blinded for the number of cells, and rated for detectability according to a four-step scale. Images of Group B were subject to a ROI-based analysis of signal intensities. Signal deviations of more than the 0.95 confidence interval in cell containing layers as compared to the mean of the signal intensity of non cell bearing layers were considered significant. Results: Group A: 500 or more labeled cells were judged as confidently visible when examined with a SWI-sequence with 0.15 mm slice thickness. Group B: 500 or more labeled cells showed a significant signal reduction in SWI sequences with a slice thickness of 0.25 mm. Slice thickness and cell number per layer had a significant influence on the amount of detected signal reduction. Conclusion: 500 VSOP labeled stem cells could be detected with SWI imaging at 3 Tesla using an experimental design suitable for large animal models.	[Lobsien, Donald; Hoffmann, Karl-Titus] Univ Hosp Leipzig, Dept Neuroradiol, Leipzig, Germany; [Dreyer, Antje Y.; Boltze, Johannes] Fraunhofer Inst Cell Therapy & Immunol, Leipzig, Germany; [Dreyer, Antje Y.; Boltze, Johannes] Univ Leipzig, Translat Ctr Regenerat Med, D-04109 Leipzig, Germany; [Stroh, Albrecht] Johannes Gutenberg Univ Mainz, Res Grp Mol Imaging & Optogenet, Inst Microscop Anat & Neurobiol, Focus Program Translat Neurosci, D-55122 Mainz, Germany; [Boltze, Johannes] Massachusetts Gen Hosp, Charlestown, MA USA; [Boltze, Johannes] Harvard Univ, Sch Med, Ctr Neurosci, Charlestown, MA USA	Leipzig University; Fraunhofer Gesellschaft; Leipzig University; Johannes Gutenberg University of Mainz; Harvard University; Massachusetts General Hospital; Harvard University	Lobsien, D (corresponding author), Univ Hosp Leipzig, Dept Neuroradiol, Leipzig, Germany.	donald.lobsien@medizin.uni-leipzig.de	Stroh, Albrecht/AAE-8004-2021	Stroh, Albrecht/0000-0001-9410-4086; Hoffmann, Karl-Titus/0000-0001-7693-887X; Boltze, Johannes/0000-0003-3956-4164				Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; Berman SMC, 2011, WIRES NANOMED NANOBI, V3, P343, DOI 10.1002/wnan.140; Boltze J, 2008, J CEREBR BLOOD F MET, V28, P1951, DOI 10.1038/jcbfm.2008.89; Burns TC, 2011, EXPERT OPIN BIOL TH, V11, P447, DOI 10.1517/14712598.2011.552883; Burns TC, 2009, J COMP NEUROL, V515, P125, DOI 10.1002/cne.22038; Carpenter CR, 2011, J EMERG MED, V40, P82, DOI 10.1016/j.jemermed.2010.05.009; Chavhan GB, 2009, RADIOGRAPHICS, V29, P1433, DOI 10.1148/rg.295095034; Chen CL, 2011, MOL IMAGING BIOL, V13, P825, DOI 10.1007/s11307-010-0430-x; Daadi MM, 2012, CELL TRANSPLANT; Dai YM, 2011, J MAGN RESON IMAGING, V34, P318, DOI 10.1002/jmri.22607; Deistung A, 2006, Z MED PHYS, V16, P261, DOI 10.1078/0939-3889-00324; Denic A, 2011, NEUROTHERAPEUTICS, V8, P3, DOI 10.1007/s13311-010-0002-4; Dreyer A, 2012, ADV PRECLINICAL STUD, P21; Eibofner F, 2010, MAGN RESON MED, V64, P1027, DOI 10.1002/mrm.22498; England T, 2009, INT J STROKE, V4, P101, DOI 10.1111/j.1747-4949.2009.00253.x; Fleige G, 2002, INVEST RADIOL, V37, P482, DOI 10.1097/00004424-200209000-00002; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Heymer A, 2008, BIOMATERIALS, V29, P1473, DOI 10.1016/j.biomaterials.2007.12.003; Hoehn M, 2002, P NATL ACAD SCI USA, V99, P16267, DOI 10.1073/pnas.242435499; Jendelova P, 2003, MAGNET RESON MED, V50, P767, DOI 10.1002/mrm.10585; Kalladka D, 2011, NEUROCHEM INT, V59, P367, DOI 10.1016/j.neuint.2011.03.016; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5; Lees KR, 2010, LANCET, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; Liu W, 2009, EUR J RADIOL, V70, P258, DOI 10.1016/j.ejrad.2008.09.021; Liu YP, 2009, ACTA NEUROPATHOL, V117, P469, DOI 10.1007/s00401-009-0516-1; Magnitsky S, 2005, NEUROIMAGE, V26, P744, DOI 10.1016/j.neuroimage.2005.02.029; Mahmoudi M, 2011, CHEM REV, V111, P253, DOI 10.1021/cr1001832; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; Pillai DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016091; Sehgal V, 2005, J MAGN RESON IMAGING, V22, P439, DOI 10.1002/jmri.20404; Stroh A, 2005, NEUROIMAGE, V24, P635, DOI 10.1016/j.neuroimage.2004.09.014; Stroh A, 2004, FREE RADICAL BIO MED, V36, P976, DOI 10.1016/j.freeradbiomed.2004.01.016; Stroh A, 2006, NEUROIMAGE, V33, P886, DOI 10.1016/j.neuroimage.2006.07.009; Takahashi M, 2003, EUR J RADIOL, V46, P45, DOI 10.1016/S0720-048X(02)00331-5; Taupitz M, 2000, J MAGN RESON IMAGING, V12, P905, DOI 10.1002/1522-2586(200012)12:6<905::AID-JMRI14>3.0.CO;2-5; The STEPS Participants, 2008, STROKE, V40, P510; Weissleder R, 1997, J MAGN RESON IMAGING, V7, P258, DOI 10.1002/jmri.1880070140; Wu SY, 2010, CYTOTHERAPY, V12, P859, DOI 10.3109/14653241003587652	40	13	13	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62644	10.1371/journal.pone.0062644	http://dx.doi.org/10.1371/journal.pone.0062644			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667503	Green Published, Green Submitted, gold			2022-12-25	WOS:000319055600037
J	Wang, W; Liu, ZH; Qu, P; Zhou, ZD; Zeng, YG; Fan, J; Liu, Y; Guo, YF; Qiu, JX				Wang, Wei; Liu, Zhihong; Qu, Ping; Zhou, Zhengdong; Zeng, Yigang; Fan, Jie; Liu, Yong; Guo, Yifeng; Qiu, Jianxin			Knockdown of Regulator of Cullins-1 (ROC1) Expression Induces Bladder Cancer Cell Cycle Arrest at the G2 Phase and Senescence	PLOS ONE			English	Article							NEDD8-ACTIVATING ENZYME; CHECKPOINTS; INHIBITOR	Regulator of Cullins-1 (ROC1) is a key subunit in the Cullin-RING ligase (CRL) protein complex. Overexpression of ROC1 protein is associated with tumor progression and poor prognosis of non-muscle invasive bladder transitional cell carcinoma (NMIBC). This study was designed to assess the effects of ROC1 knockdown in bladder cancer cells and to determine the potential mechanisms involved. A total of 112 bladder cancer tissue specimens were recruited for immunohistochemical analyses of ROC1 overexpression. Bladder cancer cell lines were used to knockdown ROC1 expression using ROC1 siRNA. Our data showed that ROC1 knockdown remarkably inhibited bladder cancer cell growth, arrested cells at the G2 phase of the cell cycle, and induced the p53-dependent cell senescence. Molecularly, G2 arrest was associated with upregulation of p21, p27, cyclin B1, and Cdc2 proteins. ROC1 knockdown induced-senescence functioned through p53/p21 pathway. Knockdown of p21 expression partially rescued ROC1 knockdown-induced growth inhibition in cancer cells. Furthermore, nude mouse xenograft analyses confirmed these in vitro data. In conclusion, data from the current study indicate that ROC1 plays an essential role in bladder cancer progression and could serve as a novel anticancer target for bladder transitional cell carcinoma (BTCC).	[Wang, Wei; Liu, Zhihong; Zeng, Yigang; Fan, Jie; Liu, Yong; Guo, Yifeng; Qiu, Jianxin] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Urol, Shanghai 200030, Peoples R China; [Wang, Wei; Qu, Ping; Zhou, Zhengdong] Nantong Univ, Yancheng Peoples Hosp 1, Affiliated Hosp 4, Dept Urol, Nantong, Jiangsu, Peoples R China	Shanghai Jiao Tong University; Nantong University	Qiu, JX (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Urol, Shanghai 200030, Peoples R China.	jasonqiu@sjtu.edu.cn	Qiu, Jason/B-3502-2012	Qiu, Jason/0000-0003-1067-3199	Shanghai Academic Leaders' Program of the Health System [XBR2011038]	Shanghai Academic Leaders' Program of the Health System	This work was supported by Shanghai Academic Leaders' Program of the Health System (No. XBR2011038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Gabrielli B, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00009; Jacobs BL, 2010, CA-CANCER J CLIN, V60, P244, DOI 10.3322/caac.20077; Jia LJ, 2011, J BIOL CHEM, V286, P3379, DOI 10.1074/jbc.M110.188425; Jia LJ, 2009, CANCER RES, V69, P4974, DOI 10.1158/0008-5472.CAN-08-4671; Kaufman DS, 2009, LANCET, V374, P239, DOI 10.1016/S0140-6736(09)60491-8; Lee CT, 2001, CLIN CANCER RES, V7, P210; Lin DI, 2006, MOL CELL, V24, P355, DOI 10.1016/j.molcel.2006.09.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Milhollen MA, 2010, BLOOD, V116, P1515, DOI 10.1182/blood-2010-03-272567; Mitra AP, 2007, WORLD J UROL, V25, P563, DOI 10.1007/s00345-007-0197-0; Mitra AP, 2009, ANNU REV PATHOL-MECH, V4, P251, DOI 10.1146/annurev.pathol.4.110807.092230; Nai G, 2011, PATHOL RES PRACT, V207, P174, DOI 10.1016/j.prp.2011.01.001; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Pan H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048799; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Prasad SM, 2011, NAT REV UROL, V8, P631, DOI 10.1038/nrurol.2011.144; Schauble S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042150; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Tan M, 2009, P NATL ACAD SCI USA, V106, P6203, DOI 10.1073/pnas.0812425106; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Yang D, 2013, CELL DEATH DIFFER, V20, P235, DOI 10.1038/cdd.2012.113; Yang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034079	27	18	19	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62734	10.1371/journal.pone.0062734	http://dx.doi.org/10.1371/journal.pone.0062734			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667514	Green Published, gold, Green Submitted			2022-12-25	WOS:000319055600042
J	Pedersen, J; Jensen, TB; Carlsen, THR; Schonning, K; Christensen, PB; Laursen, AL; Krarup, H; Bukh, J; Weis, N				Pedersen, Jannie; Jensen, Tanja B.; Carlsen, Thomas H. R.; Schonning, Kristian; Christensen, Peer Brehm; Laursen, Alex Lund; Krarup, Henrik; Bukh, Jens; Weis, Nina			Neutralizing Antibodies in Patients with Chronic Hepatitis C, Genotype 1, against a Panel of Genotype 1 Culture Viruses: Lack of Correlation to Treatment Outcome	PLOS ONE			English	Article							ALPHA-2B PLUS RIBAVIRIN; HYPERVARIABLE REGION-1; ANTIVIRAL TREATMENT; IMMUNE-RESPONSES; INFECTION; PEGINTERFERON; TELAPREVIR; INTERFERON; CLEARANCE; TRANSMISSION	The correlation of neutralizing antibodies to treatment outcome in patients with chronic hepatitis C virus (HCV) infection has not been established. The aim of this study was to determine whether neutralizing antibodies could be used as an outcome predictor in patients with chronic HCV, genotype 1, infection treated with pegylated interferon-alpha and ribavirin. Thirty-nine patients with chronic hepatitis C, genotype 1a or 1b, with either sustained virologic response (n = 23) or non-sustained virologic response (n = 16) were enrolled. Samples taken prior to treatment were tested for their ability to neutralize 6 different HCV genotype 1 cell culture recombinants (1a: H77/JFH1, TN/JFH1, DH6/JFH1; 1b: J4/JFH1, DH1/JFH1, DH5/JFH1). The results were expressed as the highest dilution yielding 50% neutralization (NAb(50)-titer). We observed no genotype or subtype specific differences in NAb(50)-titers between patients with chronic HCV infection with and without sustained virologic response when tested against any of the included culture viruses. However, NAb(50)-titers varied significantly with a mean reciprocal NAb(50)-titer of 800 (range: 100-6400) against DH6/JFH1 compared to a mean NAb(50)-titer of 50 (range: <50-400) against all other included isolates. Subsequent studies demonstrated that the efficient neutralization of DH6/JFH1 could be linked to engineered adaptive mutations in the envelope-2 protein. In analysis of envelope 1 and 2 sequences of HCV, recovered from a subset of patients, we observed no apparent link between relatedness of patient sequences with culture viruses used and the corresponding neutralization results. In conclusion, pre-treatment levels of neutralizing antibodies against HCV genotype 1 isolates could not predict treatment outcome in patients with chronic HCV infection. High neutralization susceptibility of DH6/JFH1 could be correlated with adaptive envelope mutations previously highlighted as important for neutralization. Our study emphasizes the importance of using multiple culture viruses for neutralization studies and contributes to the current knowledge about neutralizing epitopes, important for future therapeutic- and vaccine-studies.	[Pedersen, Jannie; Weis, Nina] Copenhagen Univ Hosp, Dept Infect Dis, Hvidovre, Denmark; [Pedersen, Jannie; Jensen, Tanja B.; Carlsen, Thomas H. R.; Bukh, Jens] Copenhagen Univ Hosp, Copenhagen Hepatitis Program CO HEP C, Dept Infect Dis, Hvidovre, Denmark; [Pedersen, Jannie; Jensen, Tanja B.; Carlsen, Thomas H. R.; Bukh, Jens] Copenhagen Univ Hosp, Clin Res Ctr, Hvidovre, Denmark; [Schonning, Kristian] Copenhagen Univ Hosp, Dept Clin Microbiol, Hvidovre, Denmark; [Christensen, Peer Brehm] Odense Univ Hosp, Dept Infect Dis, DK-5000 Odense, Denmark; [Laursen, Alex Lund] Aarhus Univ Hosp, Dept Infect Dis, Skejby, Denmark; [Krarup, Henrik] Aalborg Univ Hosp, Dept Clin Biochem, Aalborg, Denmark; [Weis, Nina] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Pedersen, Jannie; Jensen, Tanja B.; Carlsen, Thomas H. R.; Bukh, Jens] Univ Copenhagen, Dept Int Hlth Immunol & Microbiol, Fac Hlth & Med Sci, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Southern Denmark; Odense University Hospital; Aarhus University; Aalborg University; Aalborg University Hospital; University of Copenhagen; University of Copenhagen	Bukh, J (corresponding author), Copenhagen Univ Hosp, Copenhagen Hepatitis Program CO HEP C, Dept Infect Dis, Hvidovre, Denmark.	jbukh@sund.ku.dk; ninaweis@dadlnet.dk	Weis, Nina/GLT-4232-2022; Christensen, Peer B./B-8042-2015	Christensen, Peer Brehm/0000-0003-1394-058X; Weis, Nina/0000-0002-3133-2724; Laursen, Alex Lund/0000-0002-1206-156X; Pedersen, Jannie/0000-0003-2822-3014; Bukh, Jens/0000-0002-7815-4806; Krarup, Henrik/0000-0001-5294-2428	A.P. Moller Foundation for the Advancement of Medical Science; Danish Agency for Science Technology and Innovation; Capital Region of Denmarks Research Foundation; Lundbeck Foundation; Danish Cancer Society; Novo Nordisk Foundation; Danish Medical Research Council; Faculty of Health Science, University of Copenhagen; Novo Nordisk Fonden [NNF12OC0002037] Funding Source: researchfish	A.P. Moller Foundation for the Advancement of Medical Science; Danish Agency for Science Technology and Innovation; Capital Region of Denmarks Research Foundation; Lundbeck Foundation(Lundbeckfonden); Danish Cancer Society(Danish Cancer Society); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Faculty of Health Science, University of Copenhagen; Novo Nordisk Fonden(Novo Nordisk Foundation)	The A.P. Moller Foundation for the Advancement of Medical Science (grant support to NW), the Danish Agency for Science Technology and Innovation (NW, JP); The Capital Region of Denmarks Research Foundation (JB), the Lundbeck Foundation (JB), the Danish Cancer Society (JB), the Novo Nordisk Foundation (JB), The Danish Medical Research Council (JB), and Ph.D stipends from the Faculty of Health Science, University of Copenhagen (THRC, TBJ) supported the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askarieh G, 2010, HEPATOLOGY, V51, P1523, DOI 10.1002/hep.23509; Bartosch B, 2005, J VIROL, V79, P8217, DOI 10.1128/JVI.79.13.8217-8229.2005; Boo I, 2007, J CLIN VIROL, V39, P288, DOI 10.1016/j.jcv.2007.04.019; Christensen PB, 2007, SCAND J INFECT DIS, V39, P245, DOI 10.1080/00365540600978864; Clausen LN, 2011, J VIRAL HEPATITIS, V18, pe66, DOI 10.1111/j.1365-2893.2010.01392.x; Corbet S, 2003, J CLIN MICROBIOL, V41, P1091, DOI 10.1128/JCM.41.3.1091-1100.2003; Darling JM, 2011, HEPATOLOGY, V53, P14, DOI 10.1002/hep.24056; Davis GL, 2003, HEPATOLOGY, V38, P645, DOI 10.1053/jhep.2003.50364; Farci P, 1999, J INFECT DIS, V179, P1007, DOI 10.1086/314653; Fofana I, 2012, GASTROENTEROLOGY, V143, P223, DOI 10.1053/j.gastro.2012.04.006; Freeman AJ, 2001, HEPATOLOGY, V34, P809, DOI 10.1053/jhep.2001.27831; Gerotto M, 2001, BLOOD, V98, P2657, DOI 10.1182/blood.V98.9.2657; Giang E, 2012, P NATL ACAD SCI USA, V109, P6205, DOI 10.1073/pnas.1114927109; Gottwein JM, 2007, GASTROENTEROLOGY, V133, P1614, DOI 10.1053/j.gastro.2007.08.005; Gottwein JM, 2010, J VIROL, V84, P5277, DOI 10.1128/JVI.02667-09; Gottwein JM, 2009, HEPATOLOGY, V49, P364, DOI 10.1002/hep.22673; Hansen N, 2009, J VIRAL HEPATITIS, V16, P659, DOI 10.1111/j.1365-2893.2009.01126.x; Hansen N, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-177; Helle F, 2007, J VIROL, V81, P8101, DOI 10.1128/JVI.00127-07; HOHNE M, 1994, ARCH VIROL, V137, P25, DOI 10.1007/BF01311170; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Jensen TB, 2008, J INFECT DIS, V198, P1756, DOI 10.1086/593021; Keck ZY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002653; Keck Z, 2013, J VIROL, V87, P37, DOI 10.1128/JVI.01941-12; Kolykhalov AA, 1997, SCIENCE, V277, P570, DOI 10.1126/science.277.5325.570; Kong L, 2012, P NATL ACAD SCI USA, V109, P9499, DOI 10.1073/pnas.1202924109; Kumada H, 2012, J HEPATOL, V56, P78, DOI 10.1016/j.jhep.2011.07.016; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Law M, 2008, NAT MED, V14, P25, DOI 10.1038/nm1698; Lechner F, 2000, J EXP MED, V191, P1499, DOI 10.1084/jem.191.9.1499; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Liu L, 2010, J VIROL, V84, P5067, DOI 10.1128/JVI.02265-09; Logvinoff C, 2004, P NATL ACAD SCI USA, V101, P10149, DOI 10.1073/pnas.0403519101; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Meuleman P, 2011, HEPATOLOGY, V53, P755, DOI 10.1002/hep.24171; Meunier JC, 2005, P NATL ACAD SCI USA, V102, P4560, DOI 10.1073/pnas.0501275102; Missale G, 1996, J CLIN INVEST, V98, P706, DOI 10.1172/JCI118842; Pestka JM, 2007, P NATL ACAD SCI USA, V104, P6025, DOI 10.1073/pnas.0607026104; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Prentoe J, 2011, J VIROL, V85, P2224, DOI 10.1128/JVI.01594-10; Raghuraman S, 2012, J INFECT DIS, V205, P763, DOI 10.1093/infdis/jir835; Ramirez S, 2010, J GEN VIROL, V91, P1183, DOI 10.1099/vir.0.018929-0; Rehermann B, 2009, J CLIN INVEST, V119, P1745, DOI 10.1172/JCI39133; Salmeron J, 2006, DIGEST DIS SCI, V51, P960, DOI 10.1007/s10620-006-9347-2; Sasayama Mikiko, 2010, Kobe J Med Sci, V56, pE60; Scheel TKH, 2008, P NATL ACAD SCI USA, V105, P997, DOI 10.1073/pnas.0711044105; Scheel TKH, 2011, J VIROL, V85, P2891, DOI 10.1128/JVI.01605-10; Sherman KE, 2011, NEW ENGL J MED, V365, P1014, DOI 10.1056/NEJMoa1014463; Von Hahn T, 2007, GASTROENTEROLOGY, V132, P667, DOI 10.1053/j.gastro.2006.12.008; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Yi MK, 2007, J VIROL, V81, P629, DOI 10.1128/JVI.01890-06; Zeuzem S, 2004, GASTROENTEROLOGY, V127, P1724, DOI 10.1053/j.gastro.2004.09.050; Zhang P, 2009, P NATL ACAD SCI USA, V106, P7537, DOI 10.1073/pnas.0902749106	54	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62674	10.1371/journal.pone.0062674	http://dx.doi.org/10.1371/journal.pone.0062674			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667506	Green Published, Green Submitted, gold			2022-12-25	WOS:000319654700054
J	Ranghini, E; Mora, CF; Edgar, D; Kenny, SE; Murray, P; Wilm, B				Ranghini, Egon; Mora, Cristina Fuente; Edgar, David; Kenny, Simon E.; Murray, Patricia; Wilm, Bettina			Stem Cells Derived from Neonatal Mouse Kidney Generate Functional Proximal Tubule-Like Cells and Integrate into Developing Nephrons In Vitro	PLOS ONE			English	Article							PROGENITOR CELLS; METANEPHRIC MESENCHYME; ADULT KIDNEY; DIFFERENTIATION; REGENERATION; REPAIR; IDENTIFICATION; MICE	We have recently shown that kidney-derived stem cells (KSCs) isolated from the mouse newborn kidney differentiate into a range of kidney-specific cell types. However, the functionality and integration capacity of these mouse KSCs remain unknown. Therefore, the main objectives of this study were (1) to determine if proximal tubule-like cells, generated in vitro from KSCs, displayed absorptive function typical of proximal tubule cells in vivo, and (2) to establish whether the ability of KSCs to integrate into developing nephrons was comparable with that of metanephric mesenchyme (MM), a transient population of progenitor cells that gives rise to the nephrons during kidney organogenesis. We found that proximal tubule-like cells generated in vitro from mouse KSCs displayed megalin-dependent absorptive function. Subsequently, we used a chimeric kidney rudiment culture system to show that the KSCs could generate proximal tubule cells and podocytes that were appropriately located within the developing nephrons. Finally, we compared the ability of KSCs to integrate into developing kidneys ex vivo with that of metanephric mesenchyme cells. We found that KSCs integrated into nascent nephrons to a similar extent as metanephric mesenchyme cells while both were excluded from ureteric bud branches. Our analysis of the behavior of the two cell types shows that some, but not all KSC characteristics are similar to those of the MM.	[Ranghini, Egon; Mora, Cristina Fuente; Edgar, David; Murray, Patricia; Wilm, Bettina] Univ Liverpool, Inst Translat Med, Fac Hlth & Life Sci, Liverpool L69 3BX, Merseyside, England; [Kenny, Simon E.] Alder Hey Childrens NHS Trust, Dept Paediat Surg & Urol, Liverpool, Merseyside, England	University of Liverpool; Alder Hey Children's NHS Foundation Trust	Murray, P (corresponding author), Univ Liverpool, Inst Translat Med, Fac Hlth & Life Sci, Liverpool L69 3BX, Merseyside, England.	p.a.murray@liv.ac.uk; bwilm@liv.ac.uk	Wilm, Bettina/V-8621-2018	Wilm, Bettina/0000-0002-9245-993X; Murray, Patricia/0000-0003-1316-148X; Kenny, Simon/0000-0002-5917-8554	Biotechnology and Biological Sciences Research Council (BBSRC); Medical Research Council (MRC); Alder Hey Children's Kidney Fund [10991]; KIDSTEM European Union Framework Programme 6 Research Training Network Grant; Medical Research Council [G0700654B, G0802548] Funding Source: researchfish; MRC [G0802548] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alder Hey Children's Kidney Fund; KIDSTEM European Union Framework Programme 6 Research Training Network Grant; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding was provided by (1) Biotechnology and Biological Sciences Research Council (BBSRC); (2) Medical Research Council (MRC); (3) Alder Hey Children's Kidney Fund 10991; and (4) KIDSTEM European Union Framework Programme 6 Research Training Network Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelotti ML, 2012, STEM CELLS, V30, P1714, DOI 10.1002/stem.1130; Barak H, 2012, DEV CELL, V22, P1191, DOI 10.1016/j.devcel.2012.04.018; Bussolati B, 2005, AM J PATHOL, V166, P545, DOI 10.1016/S0002-9440(10)62276-6; CARROLL TJ, 2003, KIDNEY NORMAL DEV CO, P343; DAVIES JA, 1995, DEV BIOL, V167, P50, DOI 10.1006/dbio.1995.1006; Dickinson H, 2005, AM J PHYSIOL-RENAL, V289, pF273, DOI 10.1152/ajprenal.00400.2004; Diep CQ, 2011, NATURE, V470, P95, DOI 10.1038/nature09669; Donovan MJ, 1999, DEV GENET, V24, P252, DOI 10.1002/(SICI)1520-6408(1999)24:3/4<252::AID-DVG8>3.0.CO;2-K; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; Dressler GR, 2009, ORGANOGENESIS, V5, P73, DOI 10.4161/org.5.2.8930; Dudley AT, 1999, GENE DEV, V13, P1601, DOI 10.1101/gad.13.12.1601; Hartman HA, 2007, DEV BIOL, V310, P379, DOI 10.1016/j.ydbio.2007.08.021; Humphreys BD, 2008, CELL STEM CELL, V2, P284, DOI 10.1016/j.stem.2008.01.014; Humphreys BD, 2011, P NATL ACAD SCI USA, V108, P9226, DOI 10.1073/pnas.1100629108; Itaranta P, 2002, GENESIS, V32, P259, DOI 10.1002/gene.10079; Kim D, 2005, J AM SOC NEPHROL, V16, P3527, DOI 10.1681/ASN.2005050544; Kispert A, 1998, DEVELOPMENT, V125, P4225; Kuure S, 2007, J AM SOC NEPHROL, V18, P1130, DOI 10.1681/ASN.2006111206; Kuzma-Kuzniarska M, 2012, DIFFERENTIATION, V83, P128, DOI 10.1016/j.diff.2011.11.004; Lee PT, 2010, STEM CELLS, V28, P573, DOI 10.1002/stem.310; Leheste JR, 1999, AM J PATHOL, V155, P1361, DOI 10.1016/S0002-9440(10)65238-8; Lindgren D, 2011, AM J PATHOL, V178, P828, DOI 10.1016/j.ajpath.2010.10.026; Lusis M, 2010, STEM CELL RES, V5, P23, DOI 10.1016/j.scr.2010.03.003; Maeshima A, 2006, J AM SOC NEPHROL, V17, P188, DOI 10.1681/ASN.2005040370; Mora CF, 2012, STEM CELLS DEV, V21, P296, DOI 10.1089/scd.2010.0470; Mundel P, 1997, J CELL BIOL, V139, P193, DOI 10.1083/jcb.139.1.193; Nielsen R, 2010, PEDIATR NEPHROL, V25, P813, DOI 10.1007/s00467-009-1381-9; Oliver JA, 2004, J CLIN INVEST, V114, P795, DOI 10.1172/JCI200420921; Osafune K, 2006, DEVELOPMENT, V133, P151, DOI 10.1242/dev.02174; Pleniceanu O, 2010, STEM CELLS, V28, P1649, DOI 10.1002/stem.486; Rak-Raszewska A, 2012, ORGANOGENESIS, V8, P125, DOI 10.4161/org.22597; Rak-Raszewska A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032650; Reimschuessel R, 2002, ILAR J, V42, P285; Ronconi E, 2009, J AM SOC NEPHROL, V20, P322, DOI 10.1681/ASN.2008070709; Sagrinati C, 2006, J AM SOC NEPHROL, V17, P2443, DOI 10.1681/ASN.2006010089; Sallustio F, 2013, KIDNEY INT, V83, P392, DOI 10.1038/ki.2012.413; Saxen L., 1987, ORGANOGENESIS KIDNEY; Siegel N, 2010, HUM MOL GENET, V19, P3320, DOI 10.1093/hmg/ddq236; Slack JMW, 2008, SCIENCE, V322, P1498, DOI 10.1126/science.1162782; Smeets B, 2013, J PATHOL, V229, P645, DOI 10.1002/path.4125; Torres M, 1995, DEVELOPMENT, V121, P4057; Unbekandt M, 2010, KIDNEY INT, V77, P407, DOI 10.1038/ki.2009.482; Vize P.D., 2003, KIDNEY NORMAL DEV CO; Ward HH, 2011, BBA-MOL BASIS DIS, V1812, P1344, DOI 10.1016/j.bbadis.2011.01.010; Zhai XY, 2000, KIDNEY INT, V58, P1523, DOI 10.1046/j.1523-1755.2000.00314.x; Zhou WB, 2010, AM J PHYSIOL-RENAL, V299, pF1040, DOI 10.1152/ajprenal.00394.2010	46	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62953	10.1371/journal.pone.0062953	http://dx.doi.org/10.1371/journal.pone.0062953			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667549	Green Published, Green Submitted, gold			2022-12-25	WOS:000319654700087
J	Srivastava, A; Mohanty, SK				Srivastava, Akanksha; Mohanty, Sanjay K.			Age and Sex Pattern of Cardiovascular Mortality, Hospitalisation and Associated Cost in India	PLOS ONE			English	Article							PREVENTING CHRONIC DISEASES; MIDDLE-INCOME COUNTRIES; RISK-FACTORS; DETERMINANTS; OUTCOMES; CONTEXT; DEATH	Context: Though the cardiovascular diseases are the leading cause of mortality in India, little is known about the human and economic loss attributed to the disease. The aim of this paper is to account the age and sex pattern of mortality, hospitalisation and the cost of hospitalisation for cardiovascular diseases in India. Data and Methods: Data for the present study has been drawn from multiple sources; 52nd and 60th rounds of the National Sample Survey, Special Survey of Death, 2001-03 and the Sample Registration System 2004-2010. Under the changing demographics and constant assumptions of mortality, hospitalisation and cost of hospitalisation, we have estimated the deaths, hospitalisation and cost of hospitalisation for cardiovascular diseases in India during 2004 to 2021. Descriptive analyses and multivariate techniques were used to understand the socio-economic differentials in cost of hospitalisation for cardiovascular diseases in India. Findings: In India, the cardiovascular diseases accounted for an estimated 1.4 million deaths in 2004 and it is likely to be 2.1 million in 2021. An estimated 6.7 million people were hospitalised for cardiovascular diseases in 2004, and projected to be 10.9 million by 2021. Unlike mortality, majority of the hospitalisation due to cardiovascular diseases will be in the prime working age group (25-59). The estimated cost of hospitalisation for cardiovascular diseases was 94/- billion rupees in 2004 and expected to be 152/- billion rupees by 2021, at 2004 prices. The cost of hospitalisation for cardiovascular diseases was significantly high in private health centres, high fertility states and among high socio-economic groups. Conclusion: The cardiovascular mortality and hospitalisation will be largely concentrated in the prime working age group and the cost of hospitalisation is expected to increase substantially in coming years. This calls for mobilising resources, increasing access to health insurance and devising strategies for the prevention, control and treatment of cardiovascular diseases in India.	[Srivastava, Akanksha] Int Inst Populat Sci, Bombay, Maharashtra, India; [Mohanty, Sanjay K.] Int Inst Populat Sci, Dept Fertil Studies, Bombay, Maharashtra, India	International Institute for Population Sciences; International Institute for Population Sciences	Srivastava, A (corresponding author), Int Inst Populat Sci, Bombay, Maharashtra, India.	akankshaleo@gmail.com	Mohanty, Sanjay K/AAR-7658-2020	Mohanty, Sanjay K/0000-0001-9041-5952				Adeyi O, 2007, DIR DEV, P1, DOI 10.1596/978-0-8213-7044-5; Ala L, 2004, J HUM HYPERTENS, V18, P775, DOI 10.1038/sj.jhh.1001750; Alwan A, 2010, LANCET, V376, P1861, DOI 10.1016/S0140-6736(10)61853-3; [Anonymous], 2005, UPDATED PROJECTIONS; [Anonymous], 2011, CENSUS INDIA 2011 PR, P1; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; AZAMBUJA MIR, 2008, EC BURDEN SEVERE CAR; Beaglehole R, 2007, LANCET, V370, P2152, DOI 10.1016/S0140-6736(07)61700-0; Bhutta ZA, 2006, PLOS MED, V3, P163, DOI 10.1371/journal.pmed.0030103; Cecchini M, 2010, LANCET, V376, P1775, DOI 10.1016/S0140-6736(10)61514-0; Chadha SL, 1997, B WORLD HEALTH ORGAN, V75, P31; Ezeamama AE, 2006, SOC SCI MED, V63, P2533, DOI 10.1016/j.socscimed.2006.06.023; Gaziano TA, 2007, LANCET, V370, P1939, DOI 10.1016/S0140-6736(07)61697-3; Geneau R, 2010, LANCET, V376, P1689, DOI 10.1016/S0140-6736(10)61414-6; Goyal A, 2006, INDIAN J MED RES, V124, P235; Gupta R, 1995, Indian Heart J, V47, P331; HEINDENREICH PA, FORECASTING FUTURE C; Huffman MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020821; Jeemon P, 2010, INDIAN J MED RES, V132, P617; Jha P, 2006, PLOS MED, V3, P191, DOI 10.1371/journal.pmed.0030018; JORDAN JEE, 2005, LANCET, V366, P1667; Joshi R, 2006, INT J EPIDEMIOL, V35, P1522, DOI 10.1093/ije/dyl168; Leeder S, 2004, RACE TIME CHALLENGE; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Ministry of Health and Family Welfare Government of India, NAT PROGR PREV CONTR; Miranda JJ, 2008, TROP MED INT HEALTH, V13, P1225, DOI 10.1111/j.1365-3156.2008.02116.x; Msyamboza KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020316; *NSSO, 2006, 507602501 NSSO GOV I; *NSSO, 1998, 441522501 NSSO GOV I; Office of the Registrar General and Census Commissioner (ORGI), 2006, POP PROJ IND STAT 20; Office of the Registrar General (RGI) India, 2009, REP CAUS DEATH IND 2; *ORGI, 2006, SAMPL REG SYST STAT; *ORGI, 2012, SAMPL REG SYST STAT; Patel V, 2011, LANCET, V377, P413, DOI 10.1016/S0140-6736(10)61188-9; PEDNEKAR MS, 2011, ILLITERACY LOW ED ST; *PLANN COMM GOVT I, 2011, HIGH LEV EXP GROUP R; Rao KD, 2011, INDIAN J MED RES, V133, P57; Reddy KS, 2005, LANCET, V366, P1744, DOI [10.1016/s0140-6736(05)67343-6, 10.1016/S0140-6736(05)67343-6]; REDDY KS, 1998, CIRCULATION, V70, P945; Reddy N Krishna, 2002, Indian Heart J, V54, P697; *RGI, 1990, MED CERT CAUS DEATH; *RGI, 2004, MED CERT CAUS DEATH; RISSAM HS, 2001, INDIAN ACAD CLIN MED, V2, P128; Samb B, 2010, LANCET, V376, P1785, DOI 10.1016/S0140-6736(10)61353-0; SARVOTHHAM SG, 1968, CIRCULATION, V32; Stanciole A., 2006, ESTIMATION EC IMPACT; Strong K, 2005, LANCET, V366, P1578, DOI 10.1016/S0140-6736(05)67341-2; SUGATHAN TN, 2008, BEHAV RISK FACTORS N; SUHRCKE M, 2006, 1845 CESIFO; Taylor M., 2009, WHAT IS SENSITIVITY; United Nations Department of Economic and Social Affairs, 2010, WORLD POP PROSP; United Nations Department of Economic and Social Affairs Population Division, 2010, WORLD POP PROSP 2010; Vorster HH, 2002, PUBLIC HEALTH NUTR, V5, P239, DOI 10.1079/PHN2001299; Wang LD, 2005, LANCET, V366, P1821, DOI 10.1016/S0140-6736(05)67344-8; Whitehead M, 2001, LANCET, V358, P833, DOI 10.1016/S0140-6736(01)05975-X; WHO, 2011, NCD COUNTR PROF; Xavier D, 2008, LANCET, V371, P1435, DOI 10.1016/S0140-6736(08)60623-6; YANG L, 2012, ESTIMATES CANC INCID; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zhou BF, 2003, AM J PUBLIC HEALTH, V93, P2049, DOI 10.2105/AJPH.93.12.2049	60	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62134	10.1371/journal.pone.0062134	http://dx.doi.org/10.1371/journal.pone.0062134			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667455	Green Published, Green Submitted, gold			2022-12-25	WOS:000319654700023
J	Thouin, A; Griffiths, PG; Hudson, G; Chinnery, PF; Yu-Wai-Man, P				Thouin, Anais; Griffiths, Philip G.; Hudson, Gavin; Chinnery, Patrick F.; Yu-Wai-Man, Patrick			Raised Intraocular Pressure as a Potential Risk Factor for Visual Loss in Leber Hereditary Optic Neuropathy	PLOS ONE			English	Article							MITOCHONDRIAL DYSFUNCTION; MTDNA MUTATIONS; CELL-DEATH; GLAUCOMA; INVOLVEMENT; RELEASE; DISEASE; QUALITY; VIRUS; MODEL	Leber Hereditary Optic Neuropathy (LHON) is an important cause of inherited mitochondrial blindness among young adults. The majority of patients carry one of three mitochondrial DNA (mtDNA) point mutations: m. 3460G>A, m. 11778G> A and m. 14484T>C, all of which affect critical complex I subunits of the mitochondrial respiratory chain. LHON is characterised by marked incomplete penetrance, clearly implying that the mtDNA mutation is insufficient on its own to trigger retinal ganglion cell dysfunction and visual loss. In this case series of three affected patients harbouring the m. 11778G>A mutation, we provide evidence suggesting that raised intraocular pressure could be a risk factor triggering visual loss in atrisk LHON carriers.	[Thouin, Anais; Chinnery, Patrick F.] Royal Victoria Infirm, Dept Neurol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Thouin, Anais] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Griffiths, Philip G.; Yu-Wai-Man, Patrick] Royal Victoria Infirm, Dept Ophthalmol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Hudson, Gavin; Chinnery, Patrick F.; Yu-Wai-Man, Patrick] Newcastle Univ, Inst Med Genet, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Yu-Wai-Man, P (corresponding author), Royal Victoria Infirm, Dept Ophthalmol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.	Patrick.Yu-Wai-Man@ncl.ac.uk	Hudson, Gavin/E-7117-2017	Chinnery, Patrick/0000-0002-7065-6617; Hudson, Gavin/0000-0001-7210-2733	Medical Research Council (MRC, UK); Wellcome Trust; MRC [G0701386, MR/K000608/1, G1002570] Funding Source: UKRI; Medical Research Council [G0701386, MR/K000608/1, G1002570] Funding Source: researchfish; National Institute for Health Research [NF-SI-0509-10011] Funding Source: researchfish	Medical Research Council (MRC, UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the Medical Research Council (MRC, UK) and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasieh M, 2012, PROG RETIN EYE RES, V31, P152, DOI 10.1016/j.preteyeres.2011.11.002; BORRUAT FX, 1994, KLIN MONATSBL AUGENH, V204, P400, DOI 10.1055/s-2008-1035568; Burr JM, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16290; Burr J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004399.pub3; Carelli V, 2007, ENVIRON HEALTH PERSP, V115, P113, DOI 10.1289/ehp.9245; Carelli V, 2009, BBA-BIOENERGETICS, V1787, P518, DOI 10.1016/j.bbabio.2009.02.024; Dandekar SS, 2002, EUR J OPHTHALMOL, V12, P537, DOI 10.1177/112067210201200615; De Marinis M, 2001, J NEUROL, V248, P818, DOI 10.1007/s004150170103; Edwards TL, 2007, NEURO-OPHTHALMOLOGY, V31, P87, DOI 10.1080/01658100701501125; Fraser JA, 2010, SURV OPHTHALMOL, V55, P299, DOI 10.1016/j.survophthal.2009.10.002; Ju WK, 2008, INVEST OPHTH VIS SCI, V49, P4903, DOI 10.1167/iovs.07-1661; Ju WK, 2009, MOL VIS, V15, P120; Kirkman MA, 2009, BRAIN, V132, P2317, DOI 10.1093/brain/awp158; Kirkman MA, 2009, INVEST OPHTH VIS SCI, V50, P3112, DOI 10.1167/iovs.08-3166; Klopstock T, 2011, BRAIN, V134, P2677, DOI 10.1093/brain/awr170; Lascaratos G, 2012, MITOCHONDRION, V12, P202, DOI 10.1016/j.mito.2011.11.004; Lin CS, 2012, P NATL ACAD SCI USA, V109, P20065, DOI 10.1073/pnas.1217113109; Mackey DA, 2003, EYE, V17, P312, DOI 10.1038/sj.eye.6700362; Mackey DA, 1996, AM J HUM GENET, V59, P481; Man PYW, 2003, AM J HUM GENET, V72, P333, DOI 10.1016/j.ajhg.2016.05.015; Nagai A, 2005, JPN J OPHTHALMOL, V49, P65, DOI 10.1007/s10384-004-0140-5; Nikoskelainen EK, 1996, OPHTHALMOLOGY, V103, P504; Nucci C, 2013, INT OPHTHALMOL, V33, P75, DOI 10.1007/s10792-012-9623-4; Ou Y, 2011, OPHTHALMOLOGY, V118, P1017, DOI 10.1016/j.ophtha.2011.03.038; Pan BX, 2012, INVEST OPHTH VIS SCI, V53, P7608, DOI 10.1167/iovs.12-10452; Rahman ML, 2010, INVEST OPHTH VIS SCI, V51, P2512, DOI 10.1167/iovs.09-4270; Redmill B, 2001, EYE, V15, P544, DOI 10.1038/eye.2001.172; Sadun A A, 2000, Trans Am Ophthalmol Soc, V98, P223; Sadun A.A., 2000, T AM OPHTHAL SOC, V98, P232; Seo JH, 2010, CLIN EXP OPHTHALMOL, V38, P363, DOI 10.1111/j.1442-9071.2010.02240.x; Sugisaka E, 2007, CLIN EXP OPHTHALMOL, V35, P868, DOI 10.1111/j.1442-9071.2007.01628.x; Yu H, 2012, P NATL ACAD SCI USA, V109, pE1238, DOI 10.1073/pnas.1119577109; Yu-Wai-Man P, 2012, INVEST OPHTH VIS SCI, V53, P2438, DOI 10.1167/iovs.12-9815; Yu-Wai-Man P, 2011, PROG RETIN EYE RES, V30, P81, DOI 10.1016/j.preteyeres.2010.11.002	34	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63446	10.1371/journal.pone.0063446	http://dx.doi.org/10.1371/journal.pone.0063446			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667621	Green Published, gold, Green Submitted			2022-12-25	WOS:000319654700147
J	Estalrrich, A; Rosas, A				Estalrrich, Almudena; Rosas, Antonio			Handedness in Neandertals from the El Sidron (Asturias, Spain): Evidence from Instrumental Striations with Ontogenetic Inferences	PLOS ONE			English	Article							HUMAN ANTERIOR TEETH; MODERN HUMANS; CUTMARKS; MIDDLE; (ASTURIAS; ATAPUERCA; WEAR; HOMO; SIMA	The developed cognitive capabilities for Homo sapiens seems to be the result of a specialized and lateralized brain, and as a result of this, humans display the highest degree of manual specialization or handedness among the primates. Studies regarding its emergence and distribution within the genus Homo show that handedness is present very early. The mode in which it was articulated and spread across the different species during the course of human evolution could provide information about our own cognitive capacities. Here we report the manual laterality attributed to eleven 49,000 old Neandertal individuals from El Sidron cave (Spain), through the study of instrumental or cultural striations on the anterior dentition. Our results show a predominant pattern addressed to right-handers. These results fit within the modern human handedness distribution pattern and provide indirect evidence for behavior and brain lateralization on Neandertals. They support the early establishment of handedness in our genus. Moreover, the individual identified as Juvenile 1 (6-8 years old at death), displays the same striation pattern as the adult Neandertals from the sample, and thereby the ontogenic development of manual laterality in that Neandertal population seems to be similar to that of living modern humans.	[Estalrrich, Almudena; Rosas, Antonio] Museo Nacl Ciencias Nat MNCN CSIC, PaleoAnthropol Grp, Dept Paleobiol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Estalrrich, A (corresponding author), Museo Nacl Ciencias Nat MNCN CSIC, PaleoAnthropol Grp, Dept Paleobiol, Madrid, Spain.	aestalrrich@mncn.csic.es	Rosas, Antonio/D-9742-2016; Estalrrich, Almudena/ABF-1891-2020	Rosas, Antonio/0000-0002-5829-9952; Estalrrich, Almudena/0000-0003-2295-5396	Spanish Ministerio de Economia y Competitividad [CGL2009-09013, CGL2012-36682, BES-2010-033914]	Spanish Ministerio de Economia y Competitividad(Spanish Government)	This research is funded by the Spanish Ministerio de Economia y Competitividad (Projects CGL2009-09013 and CGL2012-36682). El Sidron site is being excavated with the support of the Consejeria de Cultura of the Asturias Autonomous Government. A. E. has the benefit of a predoctoral FPI fellowship of the Spanish Ministerio de Economia y Competitividad (BES-2010-033914) (http://www.mineco.gob.es/portal/site/mineco/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams DM, 2012, J R SOC INTERFACE, V9, P2718, DOI 10.1098/rsif.2012.0211; [Anonymous], 1994, HUMAN EVOLUTION, DOI DOI 10.1007/BF02437262; ARENSBURG B, 1989, NATURE, V338, P758, DOI 10.1038/338758a0; Bargallo A, 2013, TARR LAT C SPAIN; Bax JS, 1999, INT J OSTEOARCHAEOL, V9, P189, DOI 10.1002/(SICI)1099-1212(199905/06)9:3<189::AID-OA474>3.0.CO;2-N; Brace CL, 1975, CURR ANTHROPOL, V16, P809; BROMAGE TG, 1987, SCANNING MICROSCOPY, V1, P607; BROMAGE TG, 1984, AM J PHYS ANTHROPOL, V65, P359, DOI 10.1002/ajpa.1330650404; Cashmore L, 2008, J ANTHROPOL SCI, V86, P7; DECASTRO JMB, 1988, J HUM EVOL, V17, P403, DOI 10.1016/0047-2484(88)90029-2; DELUMLEY MA, 1973, ET QUATERN, V2, P311; Faurie C, 2005, CURR ANTHROPOL, V46, P142, DOI 10.1086/427101; Fennell E.B., 1986, EXPT TECHNIQUES HUMA, P15; Fox CL, 1997, INT J OSTEOARCHAEOL, V7, P133, DOI 10.1002/(SICI)1099-1212(199703)7:2<133::AID-OA326>3.0.CO;2-4; Frayer DW, 2012, LATERALITY, V17, P51, DOI 10.1080/1357650X.2010.529451; Frayer DW, 2010, J ANTHROPOL SCI, V88, P113; Green TJ, 1998, AM ANTIQUITY, V63, P437, DOI 10.2307/2694629; Hillson SW, 2010, J HUM EVOL, V59, P493, DOI 10.1016/j.jhevol.2010.06.004; Holloway R. L., 2009, ENCY NEUROSCIENCE, P1326; Krause J, 2007, CURR BIOL, V17, P1908, DOI 10.1016/j.cub.2007.10.008; Lalueza-Fox C., 1992, INT J OSTEOARCHAEOL, V2, P155, DOI DOI 10.1002/0A.1390020207; Lalueza-Fox C, 2011, P NATL ACAD SCI USA, V108, P250, DOI 10.1073/pnas.1011553108; Lozano M, 2008, J HUM EVOL, V55, P713, DOI 10.1016/j.jhevol.2008.04.007; Lozano M, 2009, EVOL HUM BEHAV, V30, P369, DOI 10.1016/j.evolhumbehav.2009.03.001; Lozano-Ruiz M, 2004, J ARCHAEOL SCI, V31, P1127, DOI 10.1016/j.jas.2004.02.005; Lucaks HR, 1988, AM J PHYS ANTHROPOL, V76, P377; Martin H, 1923, HOMME FOSSILE QUINA; Martinez-Maza C, 2011, BIOL LETTERS, V7, P593, DOI 10.1098/rsbl.2010.1188; Molnar P, 2008, AM J PHYS ANTHROPOL, V136, P423, DOI 10.1002/ajpa.20824; Nelson EL, 2013, INFANT BEHAV DEV, V36, P181, DOI 10.1016/j.infbeh.2013.01.009; Olle A., 2003, THESIS U ROVIRA VIRG; Pena-Melian A, 2011, ANAT REC, V294, P1370, DOI 10.1002/ar.21427; Pickering TR, 2008, J ARCHAEOL SCI, V35, P310, DOI 10.1016/j.jas.2007.03.012; Prieto J.L., 2005, MONOGRAFIAS MUSEO AL, V20, P397; Radovcic J, 1988, KRAPINA HOMINIDS ILU; Rasband W. S., 1997, IMAGE J IMAGE PROCES; Rosas A, 2006, P NATL ACAD SCI USA, V103, P19266, DOI 10.1073/pnas.0609662104; Rosas A, 2012, ANTHROPOLOGIE, V116, P57, DOI 10.1016/j.anthro.2011.12.003; Sacrey LAR, 2013, DEV PSYCHOBIOL, V55, P902, DOI 10.1002/dev.21083; SHIPMAN P, 1983, J ANTHROPOL ARCHAEOL, V2, P57, DOI 10.1016/0278-4165(83)90008-9; Steele J, 2005, STONE KNAPPING NECES, P217; Torres T., 2010, ARCHAEOMETRY, V52, P680; TRINKAUS E, 1994, AM J PHYS ANTHROPOL, V93, P1, DOI 10.1002/ajpa.1330930102; Trinkaus E, 1983, SHANIDAR NEADERTALS; Uomini NT, 2011, VERTEBR PALEOBIOL PA, P139, DOI 10.1007/978-94-007-0415-2_14; Volpato V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043949; Wood RE, 2013, ARCHAEOMETRY, V55, P148, DOI 10.1111/j.1475-4754.2012.00671.x	47	39	39	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e62797	10.1371/journal.pone.0062797	http://dx.doi.org/10.1371/journal.pone.0062797			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	177QL	23671635	Green Published, gold, Green Submitted			2022-12-25	WOS:000321390200038
J	Ning, J; Wang, MX; Li, CL; Sun, S				Ning, Juan; Wang, Minxiao; Li, Chaolun; Sun, Song			Transcriptome Sequencing and De Novo Analysis of the Copepod Calanus sinicus Using 454 GS FLX	PLOS ONE			English	Article							GENE-EXPRESSION; YELLOW SEA; EGG-PRODUCTION; RNA-SEQ; DIAPAUSE; FINMARCHICUS; REPRODUCTION; ANNOTATION; DROSOPHILA; DISCOVERY	Background: Despite their species abundance and primary economic importance, genomic information about copepods is still limited. In particular, genomic resources are lacking for the copepod Calanus sinicus, which is a dominant species in the coastal waters of East Asia. In this study, we performed de novo transcriptome sequencing to produce a large number of expressed sequence tags for the copepod C. sinicus. Results: Copepodid larvae and adults were used as the basic material for transcriptome sequencing. Using 454 pyrosequencing, a total of 1,470,799 reads were obtained, which were assembled into 56,809 high quality expressed sequence tags. Based on their sequence similarity to known proteins, about 14,000 different genes were identified, including members of all major conserved signaling pathways. Transcripts that were putatively involved with growth, lipid metabolism, molting, and diapause were also identified among these genes. Differentially expressed genes related to several processes were found in C. sinicus copepodid larvae and adults. We detected 284,154 single nucleotide polymorphisms (SNPs) that provide a resource for gene function studies. Conclusion: Our data provide the most comprehensive transcriptome resource available for C. sinicus. This resource allowed us to identify genes associated with primary physiological processes and SNPs in coding regions, which facilitated the quantitative analysis of differential gene expression. These data should provide foundation for future genetic and genomic studies of this and related species.	[Ning, Juan; Wang, Minxiao; Li, Chaolun; Sun, Song] Chinese Acad Sci, Inst Oceanol, Key Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China; [Ning, Juan] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Sun, Song] Chinese Ecosyst Res Network, Jiaozhou Bay Marine Ecosyst Res Stn, Qingdao, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, CL (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China.	lcl@qdio.ac.cn; sunsong@qido.ac.cn	Li, Chao/GSM-8117-2022	Li, Chao/0000-0001-6110-6210; Li, Chaolun/0000-0003-1890-0587; Minxiao, Wang/0000-0002-6567-3295	National Key Basic Research Program of China [2011CB403604]; National Natural Science Foundation of China [41076099]; National Marine Public Welfare Project of China [201005018]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Marine Public Welfare Project of China	This research was supported by special funds from National Key Basic Research Program of China (2011CB403604), National Natural Science Foundation of China (41076099), and National Marine Public Welfare Project of China (201005018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aruda AM, 2011, J INSECT PHYSIOL, V57, P665, DOI 10.1016/j.jinsphys.2011.03.007; Barreto FS, 2011, MOL ECOL, V20, P560, DOI 10.1111/j.1365-294X.2010.04963.x; Beaugrand G, 2003, NATURE, V426, P661, DOI 10.1038/nature02164; Bi H., 2001, ACTA ECOL SIN, V21, P177; Brockman W, 2008, GENOME RES, V18, P763, DOI 10.1101/gr.070227.107; Bron JE, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-22; Chen, 1964, OCEANOL LIMNOL SIN, V6, P272; Chen ZZ, 2005, PROG BIOCHEM BIOPHYS, V32, P187; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Collins LJ, 2008, GENOME INFORM SER, V21, P3; Denlinger DL, 2002, ANNU REV ENTOMOL, V47, P93, DOI 10.1146/annurev.ento.47.091201.145137; Dubrovsky EB, 2005, TRENDS ENDOCRIN MET, V16, P6, DOI 10.1016/j.tem.2004.11.003; Eichner C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-126; Emrich SJ, 2007, GENOME RES, V17, P69, DOI 10.1101/gr.5145806; Ewen-Campen B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-61; Frangoulis C, 2005, ADV MAR BIOL, V47, P253; Fraser BA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-202; Gregory R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017418; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Helvig C, 2004, P NATL ACAD SCI USA, V101, P4024, DOI 10.1073/pnas.0306980101; HENRICH VC, 1993, DEV GENET, V14, P369, DOI 10.1002/dvg.1020140506; Hou R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021560; Hudson ME, 2008, MOL ECOL RESOUR, V8, P3, DOI 10.1111/j.1471-8286.2007.02019.x; Hulsemann Kuni, 1994, Invertebrate Taxonomy, V8, P1461, DOI 10.1071/IT9941461; HUMES AG, 1994, HYDROBIOLOGIA, V293, P1, DOI 10.1007/BF00229916; Irigoien X, 2004, J PLANKTON RES, V26, P259, DOI 10.1093/plankt/fbh030; Jakobsson A, 2006, PROG LIPID RES, V45, P237, DOI 10.1016/j.plipres.2006.01.004; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kang Hyung-Ku, 2011, Ocean Science Journal, V46, P133, DOI 10.1007/s12601-011-0012-0; Kidokoro K, 2006, J INSECT PHYSIOL, V52, P473, DOI 10.1016/j.jinsphys.2006.01.001; Li TR, 2000, DEVELOPMENT, V127, P2897; Liu Qing-Ming, 2010, Chinese Bulletin of Entomology, V47, P247; MacRae TH, 2010, CELL MOL LIFE SCI, V67, P2405, DOI 10.1007/s00018-010-0311-0; Marguerat S, 2010, CELL MOL LIFE SCI, V67, P569, DOI 10.1007/s00018-009-0180-6; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; O'Neil ST, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-310; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Pierceall WE, 1999, MOL CELL ENDOCRINOL, V150, P73, DOI 10.1016/S0303-7207(99)00022-2; Pu XM, 2004, J PLANKTON RES, V26, P1059, DOI 10.1093/plankt/fbh101; REIF DW, 1992, FREE RADICAL BIO MED, V12, P417, DOI 10.1016/0891-5849(92)90091-T; Richardson AJ, 2008, ICES J MAR SCI, V65, P279, DOI 10.1093/icesjms/fsn028; Riddiford LM, 2008, J INSECT PHYSIOL, V54, P895, DOI 10.1016/j.jinsphys.2008.01.014; Rothberg JM, 2008, NAT BIOTECHNOL, V26, P1117, DOI 10.1038/nbt1485; Sun Song, 2005, GLOBEC International Newsletter, V11, P34; Tarrant AM, 2008, MAR ECOL PROG SER, V355, P193, DOI 10.3354/meps07207; Tillman JA, 1999, INSECT BIOCHEM MOLEC, V29, P481, DOI 10.1016/S0965-1748(99)00016-8; Uye S, 2000, ICES J MAR SCI, V57, P1850, DOI 10.1006/jmsc.2000.0965; Vannini L, 2010, ARCH INSECT BIOCHEM, V75, P92, DOI 10.1002/arch.20382; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Vos MJ, 2008, BIOCHEMISTRY-US, V47, P7001, DOI 10.1021/bi800639z; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang M, 2010, THESIS CHINESE ACAD; Wang MX, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-73; Wang S. W., 2009, THESIS CHINESE ACAD; Wang SW, 2009, MAR ECOL PROG SER, V379, P123, DOI 10.3354/meps07902; Zeng V, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-581; Zhang WC, 2009, HYDROBIOLOGIA, V636, P257, DOI 10.1007/s10750-009-9955-x	59	42	43	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e63741	10.1371/journal.pone.0063741	http://dx.doi.org/10.1371/journal.pone.0063741			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671698	Green Published, Green Submitted, gold			2022-12-25	WOS:000321390200060
J	Suter, LG; Paltiel, AD; Rome, BN; Solomon, DH; Thornhill, TS; Abrams, SK; Katz, JN; Losina, E				Suter, Lisa G.; Paltiel, A. David; Rome, Benjamin N.; Solomon, Daniel H.; Thornhill, Thomas S.; Abrams, Stanley K.; Katz, Jeffrey N.; Losina, Elena			Placing a Price on Medical Device Innovation: The Example of Total Knee Arthroplasty	PLOS ONE			English	Article							CROSS-LINKED POLYETHYLENE; SURGEON PROCEDURE VOLUME; TOTAL HIP-ARTHROPLASTY; QUALITY-OF-LIFE; COST-EFFECTIVENESS; PATIENT OUTCOMES; TOTAL JOINT; REPLACEMENT; WEAR; ASSOCIATION	Background: Total knee arthroplasty (TKA) is common, effective, and cost-effective. Innovative implants promising reduced long-term failure at increased cost are under continual development. We sought to define the implant cost and performance thresholds under which innovative TKA implants are cost-effective. Methods: We performed a cost-effectiveness analysis using a validated, published computer simulation model of knee osteoarthritis. Model inputs were derived using published literature, Medicare claims, and National Health and Nutrition Examination Survey data. We compared projected TKA implant survival, quality-adjusted life expectancy (QALE), lifetime costs, and cost-effectiveness (incremental cost-effectiveness ratios or ICERs) of standard versus innovative TKA implants. We assumed innovative implants offered 5-70% decreased long-term TKA failure rates at costs 20-400% increased above standard implants. We examined the impact of patient age, comorbidity, and potential increases in short-term failure on innovative implant cost-effectiveness. Results: Implants offering >= 50% decrease in long-term TKA failure at <= 50% increased cost offered ICERs, <$100,000 regardless of age or baseline comorbidity. An implant offering a 20% decrease in long-term failure at 50% increased cost provided ICERs <$150,000 per QALY gained only among healthy 50-59-year-olds. Increasing short-term failure, consistent with recent device failures, reduced cost-effectiveness across all groups. Increasing the baseline likelihood of long-term TKA failure among younger, healthier and more active individuals further enhanced innovative implant cost-effectiveness among younger patients. Conclusions: Innovative implants must decrease actual TKA failure, not just radiographic wear, by 50-55% or more over standard implants to be broadly cost-effective. Comorbidity and remaining life span significantly affect innovative implant cost-effectiveness and should be considered in the development, approval and implementation of novel technologies, particularly in orthopedics. Model-based evaluations such as this offer valuable, unique insights for evaluating technological innovation in medical devices.	[Suter, Lisa G.] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Suter, Lisa G.] VA Connecticut Healthcare Syst, Dept Med, West Haven, CT USA; [Paltiel, A. David] Yale Univ, Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT 06510 USA; [Rome, Benjamin N.; Abrams, Stanley K.; Katz, Jeffrey N.; Losina, Elena] Brigham & Womens Hosp, Dept Orthoped Surg, Orthoped & Arthrit Ctr Outcomes Res, Boston, MA 02115 USA; [Solomon, Daniel H.; Katz, Jeffrey N.; Losina, Elena] Brigham & Womens Hosp, Dept Med, Clin Sci Sect, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Solomon, Daniel H.; Thornhill, Thomas S.; Katz, Jeffrey N.; Losina, Elena] Harvard Univ, Sch Med, Boston, MA USA; [Thornhill, Thomas S.; Katz, Jeffrey N.; Losina, Elena] Brigham & Womens Hosp, Dept Orthoped Surg, Boston, MA 02115 USA; [Katz, Jeffrey N.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Losina, Elena] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA	Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Boston University	Suter, LG (corresponding author), Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA.	lisa.suter@yale.edu		Paltiel, A. David/0000-0002-4861-3290; Rome, Benjamin/0000-0001-5776-3293; Losina, ELENA/0000-0002-3424-0892	United States National Institutes of Health (NIH)/NIAMS [R01 AR053112]; NIH [K23 AR054095-01]; Arthritis Foundation; VA Connecticut Healthcare System; Centers for Medicare & Medicaid Services, an agency of the U.S. Department of Health and Human Services; NIH/NIAMS [K24 AR057827, R01AR064320]; Orthopedic and Education Research Foundation (OREF); Orthopedic Medical Grants Administration (OMeGA); DePuy;  [HHSM-500-2008-0025I/HHSM-500-T0001];  [000005]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR047782, K24AR057827, R01AR053112, R01AR064320, K23AR054095] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation; VA Connecticut Healthcare System(US Department of Veterans Affairs); Centers for Medicare & Medicaid Services, an agency of the U.S. Department of Health and Human Services; NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Orthopedic and Education Research Foundation (OREF); Orthopedic Medical Grants Administration (OMeGA); DePuy; ; ; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by United States National Institutes of Health (NIH)/NIAMS R01 AR053112. Dr. Suter was supported by an NIH K23 AR054095-01 Mentored Career Development Award and an Arthritis Foundation Arthritis Investigator Award and is currently supported in part by the VA Connecticut Healthcare System and by Contract Number HHSM-500-2008-0025I/HHSM-500-T0001, Modification No. 000005, entitled "Measure & Instrument Development and Support (MIDS)-Development and Re-evaluation of the CMS Hospital Outcomes and Efficiency Measures,'' funded by the Centers for Medicare & Medicaid Services, an agency of the U.S. Department of Health and Human Services. Dr. Losina is supported in part by NIH/NIAMS K24 AR057827 and R01AR064320 and Drs. Losina, Katz and Solomon by NIH/NIAMS P60 AR47782. Dr. Thornhill currently receives support from the Orthopedic and Education Research Foundation (OREF) and the Orthopedic Medical Grants Administration (OMeGA), as well as consulting fees and royalties from DePuy, and he owns stock in Conformis SAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand Rajan, 2011, J Bone Joint Surg Am, V93 Suppl 3, P51, DOI 10.2106/JBJS.K.00867; [Anonymous], 2010, SEARCH 510 K PREM NO; [Anonymous], 2009, HOSP MAT MANAGEMENT, V34, P9; [Anonymous], 1 KNEE TEST 30 SIM Y; [Anonymous], 2008, RED BOOK PHARM FUND; Bozic KJ, 2006, J BONE JOINT SURG AM, V88A, P706, DOI 10.2106/JBJS.E.00614; CALLAHAN CM, 1994, JAMA-J AM MED ASSOC, V271, P1349, DOI 10.1001/jama.271.17.1349; Centers for Disease Control and Prevention (CDC), 2006, 2005 2006 NAT HLTH N; Centers for Disease Control and Prevention (CDC), 2008, 2007 2008 NAT HLTH N; Centers for Medicare & Medicaid Services [CMS], 2008, PHYS FEE SCHED SEARC; Challoner DR, 2011, NEW ENGL J MED, V365, P977, DOI 10.1056/NEJMp1109150; Crowninshield RD, 2006, CLIN ORTHOP RELAT R, P266, DOI 10.1097/01.blo.0000188066.01833.4f; Curfman GD, 2011, NEW ENGL J MED, V365, P975, DOI 10.1056/NEJMp1109094; Fisman DN, 2001, CLIN INFECT DIS, V32, P419, DOI 10.1086/318502; Freeman JV, 2011, ANN INTERN MED, V154, P1, DOI 10.7326/0003-4819-154-1-201101040-00289; Frost & Sullivan, 2005, US AS MARK ORTH JOIN; Gandhi R, 2009, J BONE JOINT SURG BR, V91B, P889, DOI 10.1302/0301-620X.91B7.21702; Glyn-Jones S, 2008, J BONE JOINT SURG BR, V90B, P556, DOI 10.1302/0301-620X.90B5.20545; Glyn-Jones S, 2008, J ARTHROPLASTY, V23, P337, DOI 10.1016/j.arth.2006.12.117; Gold MR, 1996, COST EFFECTIVENESS H; Hawker G, 1998, J BONE JOINT SURG AM, V80A, P163, DOI 10.2106/00004623-199802000-00003; Healthcare Cost and Utilization Project (HCUP), 2008, NAT INP SAMPL NIS; Healy WL, 2007, CLIN ORTHOP RELAT R, P57, DOI 10.1097/BLO.0b013e31803372e0; Heck DA, 1998, CLIN ORTHOP RELAT R, P93, DOI 10.1097/00003086-199811000-00015; Heisel C, 2004, J BONE JOINT SURG AM, V86A, P748, DOI 10.2106/00004623-200404000-00012; Holt HL, 2011, OSTEOARTHR CARTILAGE, V19, P44, DOI 10.1016/j.joca.2010.10.009; Institute of Medicine (IOM), 2011, MED DEV PUBL HLTH FD; International Monetary Fund, 2009, WORLD EC OUTL DAT; Kalisvaart MM, 2012, J BONE JOINT SURG AM, V94A, P481, DOI 10.2106/JBJS.K.00315; Katz JN, 2007, ARTHRITIS RHEUM, V56, P568, DOI 10.1002/art.22333; Katz JN, 2004, J BONE JOINT SURG AM, V86A, P1909, DOI 10.2106/00004623-200409000-00008; Kurtz SM., 2004, UHMWPE HDB, V1; Kurtz SM, 2009, CLIN ORTHOP RELAT R, V467, P2606, DOI 10.1007/s11999-009-0834-6; Lee D W, 2001, Value Health, V4, P329, DOI 10.1046/j.1524-4733.2001.44012.x; Losina E, 2012, J BONE JOINT SURG AM, V94A, P201, DOI [10.2106/JBJS.J.01958, 10.2106/JBJS.K.00009, 10.2106/JBJS.J.101958]; Losina E, 2011, ANN INTERN MED, V154, P217, DOI 10.7326/0003-4819-154-4-201102150-00001; Losina E, 2009, ARCH INTERN MED, V169, P1113, DOI 10.1001/archinternmed.2009.136; Luo R, 2012, J ARTHROPLASTY; Martell JM, 2003, J ARTHROPLASTY, V18, P55, DOI 10.1016/S0883-5403(03)00341-3; McEwen HMJ, 2005, J BIOMECH, V38, P357, DOI 10.1016/j.jbiomech.2004.02.015; McKinsey Global Institute, 2008, ACC COST US HLTH CAR; MD Buyline Inc, 2008, IMP CONS ORTH JOINT; Melnikow J, 2008, MED CARE, V46, P946, DOI 10.1097/MLR.0b013e318179250f; Mendenhall Stan, 2004, OR Manager, V20, P32; Mundy A, 2009, WALL STREET J; Muratoglu OK, 2004, J ARTHROPLASTY, V19, P887, DOI 10.1016/j.arth.2004.03.019; Muratoglu OK, 2003, J BONE JOINT SURG AM, V85A, P7, DOI 10.2106/00004623-200300001-00003; Muratoglu OK, 2002, CLIN ORTHOP RELAT R, P89, DOI 10.1097/01.blo.0000036526.46246.6c; Muratoglu OK, 2007, J ARTHROPLASTY, V22, P435, DOI 10.1016/j.arth.2006.07.014; Park JW, 2011, J BONE JOINT SURG BR, V93B, P1479, DOI 10.1302/0301-620X.93B11.27507; Paxton EW, 2010, J BONE JOINT SURG AM, V92A, P117, DOI 10.2106/JBJS.J.00807; Reichmann WM, 2009, ARTHRIT RHEUM-ARTHR, V61, P1046, DOI 10.1002/art.24839; Rinfret S, 2005, CIRCULATION, V111, P165, DOI 10.1161/01.CIR.0000151810.69732.41; Robinson JC, 2012, J BONE JOINT SURG AM; Skinner J, 2006, J BONE JOINT SURG AM, V88A, P2159, DOI 10.2106/JBJS.E.00271; Smith AJ, 2012, LANCET, V379, P1199, DOI 10.1016/S0140-6736(12)60353-5; Suter LG, 2011, NEW ENGL J MED, V365, P1464, DOI 10.1056/NEJMp1109285; Taylor DCA, 2009, EUR J HEALTH ECON, V10, P255, DOI 10.1007/s10198-008-0126-1; Teeny SM, 2003, J ARTHROPLASTY, V18, P954, DOI 10.1016/j.arth.2003.09.001; Weaver M, 2001, ARCH INTERN MED, V161, P111, DOI 10.1001/archinte.161.1.111; World Health Organization, CHOOSING INT AR COST; World Health Organization, 2001, MACR HLTH INV HLTH E; Wylde V, 2008, J BONE JOINT SURG BR, V90B, P1172, DOI 10.1302/0301-620X.90B9.21031; Zuckerman DM, 2011, ARCH INTERN MED, V171, P1006, DOI 10.1001/archinternmed.2011.30	64	42	42	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e62709	10.1371/journal.pone.0062709	http://dx.doi.org/10.1371/journal.pone.0062709			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671626	Green Published, Green Submitted, gold			2022-12-25	WOS:000321390200034
J	Kalb, A; von Haefen, C; Sifringer, M; Tegethoff, A; Paeschke, N; Kostova, M; Feldheiser, A; Spies, CD				Kalb, Alexander; von Haefen, Clarissa; Sifringer, Marco; Tegethoff, Annalena; Paeschke, Nadine; Kostova, Mariya; Feldheiser, Aarne; Spies, Claudia D.			Acetylcholinesterase Inhibitors Reduce Neuroinflammation and -Degeneration in the Cortex and Hippocampus of a Surgery Stress Rat Model	PLOS ONE			English	Article							POSTOPERATIVE COGNITIVE DYSFUNCTION; CHOLINERGIC ANTIINFLAMMATORY PATHWAY; ELDERLY-PATIENTS; NONCARDIAC SURGERY; SYSTEMIC INFLAMMATION; PERIPHERAL INFECTION; MEMORY CONSOLIDATION; ALZHEIMERS-DISEASE; IMPROVES SURVIVAL; DENTATE GYRUS	Exogenous stress like tissue damage and pathogen invasion during surgical trauma could lead to a peripheral inflammatory response and induce neuroinflammation, which can result in postoperative cognitive dysfunction (POCD). The cholinergic anti-inflammatory pathway is a neurohumoral mechanism that plays a prominent role by suppressing the inflammatory response. Treatments with acetylcholinesterase inhibitors enhance cholinergic transmission and may therefore act as a potential approach to prevent neuroinflammation. In the presence or absence of acetylcholinesterase inhibitors, adult Wistar rats underwent surgery alone or were additionally treated with lipopolysaccharide (LPS). Physostigmine, which can overcome the blood-brain barrier or neostigmine acting only peripheral, served as acetylcholinesterase inhibitors. The expression of pro- and anti-inflammatory cytokines in the cortex, hippocampus, spleen and plasma was measured after 1 h, 24 h, 3 d and 7 d using Real-Time PCR, western blot analysis or cytometric bead array (CBA). Fluoro-Jade B staining of brain slices was employed to elucidate neurodegeneration. The activity of acetylcholinesterase was estimated using a spectrofluorometric method. Surgery accompanied by LPS-treatment led to increased IL-1beta gene and protein upregulation in the cortex and hippocampus but was significantly reduced by physostigmine and neostigmine. Furthermore, surgery in combination with LPS-treatment caused increased protein expression of IL-1, TNF-alpha and IL-10 in the spleen and plasma. Physostigmine and neostigmine significantly decreased the protein expression of IL-1 and TNF-alpha. Neuronal degeneration and the activity of acetylcholinesterase were elevated after surgery with LPS-treatment and reduced by physostigmine and neostigmine. Along with LPS-treatment, acetylcholinesterase inhibitors reduce the pro-inflammatory response as well as neurodegeneration after surgery in the cortex and hippocampus. This combination may represent a tool to break the pathogenesis of POCD.	[Spies, Claudia D.] Univ Med Berlin, Charite, Campus Charite Mitte, Dept Anesthesiol & Intens Care Med, Berlin, Germany; Univ Med Berlin, Charite, Campus Virchow Klinikum, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Spies, CD (corresponding author), Univ Med Berlin, Charite, Campus Charite Mitte, Dept Anesthesiol & Intens Care Med, Berlin, Germany.	claudia.spies@charite.de	Feldheiser, Aarne/AAH-1503-2019; Feldheiser, Aarne/GRS-9593-2022	Feldheiser, Aarne/0000-0002-0014-8879; Spies, Claudia/0000-0002-1062-0495				Abildstrom H, 2000, ACTA ANAESTH SCAND, V44, P1246, DOI 10.1034/j.1399-6576.2000.441010.x; Ancelin ML, 2001, BRIT J PSYCHIAT, V178, P360, DOI 10.1192/bjp.178.4.360; Andersson U, 2012, J EXP MED, V209, P1057, DOI 10.1084/jem.20120571; Andersson U, 2012, ANNU REV IMMUNOL, V30, P313, DOI 10.1146/annurev-immunol-020711-075015; Barrientos RM, 2006, NEUROBIOL AGING, V27, P723, DOI 10.1016/j.neurobiolaging.2005.03.010; Barrientos RM, 2002, BEHAV BRAIN RES, V134, P291, DOI 10.1016/S0166-4328(02)00043-8; Barrientos RM, 2012, J NEUROSCI, V32, P14641, DOI 10.1523/JNEUROSCI.2173-12.2012; Barrientos RM, 2009, BRAIN BEHAV IMMUN, V23, P46, DOI 10.1016/j.bbi.2008.07.002; Bernik TR, 2002, J EXP MED, V195, P781, DOI 10.1084/jem.20011714; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Cao XZ, 2010, PROG NEURO-PSYCHOPH, V34, P1426, DOI 10.1016/j.pnpbp.2010.07.027; Caza N, 2008, PROG BRAIN RES, V169, P409, DOI 10.1016/S0079-6123(07)00026-X; Cibelli M, 2010, ANN NEUROL, V68, P360, DOI 10.1002/ana.22082; Cooke SF, 2006, BRAIN, V129, P1659, DOI 10.1093/brain/awl082; Fidalgo AR, 2011, NEUROSCIENCE, V190, P194, DOI 10.1016/j.neuroscience.2011.05.073; Fidalgo AR, 2011, NEUROSCI LETT, V498, P63, DOI 10.1016/j.neulet.2011.04.063; Fong HK, 2006, ANESTH ANALG, V102, P1255, DOI 10.1213/01.ane.0000198602.29716.53; Hofer S, 2008, CRIT CARE MED, V36, P404, DOI 10.1097/01.CCM.0B013E31816208B3; Huston JM, 2012, SURG INFECT, V13, P187, DOI 10.1089/sur.2012.126; Kelly A, 2003, J BIOL CHEM, V278, P19453, DOI 10.1074/jbc.M301938200; Li Q, 2011, LIFE SCI, V89, P395, DOI 10.1016/j.lfs.2011.07.008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynch AM, 2004, J NEUROCHEM, V88, P635, DOI 10.1046/j.1471-4159.2003.02157.x; Lynch AM, 2002, EUR J NEUROSCI, V15, P1779, DOI 10.1046/j.1460-9568.2002.02012.x; MARCANTONIO ER, 1994, JAMA-J AM MED ASSOC, V272, P1518, DOI 10.1001/jama.272.19.1518; Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0; Monk TG, 2008, ANESTHESIOLOGY, V108, P18, DOI 10.1097/01.anes.0000296071.19434.1e; Muller SV, 2004, Z GERONTOL GERIATR, V37, P475, DOI 10.1007/s00391-004-0212-7; Newman S, 2007, ANESTHESIOLOGY, V106, P572, DOI 10.1097/00000542-200703000-00023; O'Donnell E, 2000, EUR J NEUROSCI, V12, P345, DOI 10.1046/j.1460-9568.2000.00900.x; Olofsson PS, 2012, IMMUNOL REV, V248, P188, DOI 10.1111/j.1600-065X.2012.01138.x; Parrish WR, 2008, MOL MED, V14, P567, DOI 10.2119/2008-00079.Parrish; Patel HC, 2003, ANN NY ACAD SCI, V992, P39, DOI 10.1111/j.1749-6632.2003.tb03136.x; Pavlov VA, 2006, BIOCHEM SOC T, V34, P1037, DOI 10.1042/BST0341037; Pavlov VA, 2007, CRIT CARE MED, V35, P1139, DOI 10.1097/01.CCM.0000259381.56526.96; Pavlov VA, 2009, BRAIN BEHAV IMMUN, V23, P41, DOI 10.1016/j.bbi.2008.06.011; Pohanka M, 2012, EXPERT OPIN THER PAT, V22, P871, DOI 10.1517/13543776.2012.701620; Radtke FM, 2012, J INT MED RES, V40, P612, DOI 10.1177/147323001204000223; Rosas-Ballina M, 2009, J INTERN MED, V265, P663, DOI 10.1111/j.1365-2796.2009.02098.x; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Rothwell NJ, 2000, TRENDS NEUROSCI, V23, P618, DOI 10.1016/S0166-2236(00)01661-1; Singh A, 2010, CURR OPIN ANESTHESIO, V23, P449, DOI 10.1097/ACO.0b013e328339ef22; Small DH, 1996, NEUROCHEM INT, V28, P453, DOI 10.1016/0197-0186(95)00099-2; Steinmetz J, 2009, ANESTHESIOLOGY, V110, P548, DOI 10.1097/ALN.0b013e318195b569; Terrando N, 2010, CRIT CARE, V14, DOI 10.1186/cc9019; Toiber D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003108; Tracey KJ, 2010, NAT IMMUNOL, V11, P561, DOI 10.1038/ni0710-561; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Tyagi E, 2010, NEUROCHEM INT, V56, P135, DOI 10.1016/j.neuint.2009.09.011; van Munster BC, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-21; Vereker E, 2001, EUR J NEUROSCI, V14, P1809, DOI 10.1046/j.0953-816x.2001.01809.x; Wan YJ, 2007, ANESTHESIOLOGY, V106, P436, DOI 10.1097/00000542-200703000-00007; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; WANG P, 1995, J BIOL CHEM, V270, P9558, DOI 10.1074/jbc.270.16.9558; Wilson CJ, 2002, J AM GERIATR SOC, V50, P2041, DOI 10.1046/j.1532-5415.2002.50619.x; Young S, 2010, BIOORG MED CHEM LETT, V20, P2987, DOI 10.1016/j.bmcl.2010.02.102; Zhang XJ, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00040; Zimmerman G, 2006, CELL TISSUE RES, V326, P655, DOI 10.1007/s00441-006-0239-8	58	63	71	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62679	10.1371/journal.pone.0062679	http://dx.doi.org/10.1371/journal.pone.0062679			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23671623	gold, Green Submitted, Green Published			2022-12-25	WOS:000321202100032
J	Tao, WJ; Yuan, J; Zhou, LY; Sun, LN; Sun, YL; Yang, SJ; Li, MH; Zeng, S; Huang, BF; Wang, DH				Tao, Wenjing; Yuan, Jing; Zhou, Linyan; Sun, Lina; Sun, Yunlv; Yang, Shijie; Li, Minghui; Zeng, Sheng; Huang, Baofeng; Wang, Deshou			Characterization of Gonadal Transcriptomes from Nile Tilapia (Oreochromis niloticus) Reveals Differentially Expressed Genes	PLOS ONE			English	Article							SEX-DETERMINING REGION; DM-DOMAIN GENE; RAINBOW-TROUT; MOLECULAR-CLONING; RNA-SEQ; REVERSAL; AROMATASE; FISH; OVARY; DISCOVERY	Four pairs of XX and XY gonads from Nile tilapia were sequenced at four developmental stages, 5, 30, 90, and 180 days after hatching (dah) using Illumina Hiseq (TM) technology. This produced 28 Gb sequences, which were mapped to 21,334 genes. Of these, 259 genes were found to be specifically expressed in XY gonads, and 69 were found to be specific to XX gonads. Totally, 187 XX- and 1,358 XY-enhanced genes were identified, and 2,978 genes were found to be co-expressed in XX and XY gonads. Almost all steroidogenic enzymes, including cyp19a1a, were up-regulated in XX gonads at 5 dah; but in XY gonads these enzymes, including cyp11b2, were significantly up-regulated at 90 dah, indicating that, at a time critical to sex determination, the XX fish produced estrogen and the XY fish did not produce androgens. The most pronounced expression of steroidogenic enzyme genes was observed at 30 and 90 dah for XX and XY gonads, corresponding to the initiation of germ cell meiosis in the female and male gonads, respectively. Both estrogen and androgen receptors were found to be expressed in XX gonads, but only estrogen receptors were expressed in XY gonads at 5 dah. This could explain why exogenous steroid treatment induced XX and XY sex reversal. The XX-enhanced expression of cyp19a1a and cyp19a1b at all stages suggests an important role for estrogen in female sex determination and maintenance of phenotypic sex. This work is the largest collection of gonadal transcriptome data in tilapia and lays the foundation for future studies into the molecular mechanisms of sex determination and maintenance of phenotypic sex in non-model teleosts.	[Tao, Wenjing; Yuan, Jing; Zhou, Linyan; Sun, Lina; Sun, Yunlv; Yang, Shijie; Li, Minghui; Zeng, Sheng; Huang, Baofeng; Wang, Deshou] Southwest Univ, Sch Life Sci, Key Lab Freshwater Fish Reprod & Dev, Minist Educ,Key Lab Aquat Sci Chongqing, Chongqing, Peoples R China	Southwest University - China	Wang, DH (corresponding author), Southwest Univ, Sch Life Sci, Key Lab Freshwater Fish Reprod & Dev, Minist Educ,Key Lab Aquat Sci Chongqing, Chongqing, Peoples R China.	wdeshou@swu.edu.cn	Wang, Deshou/ABD-6014-2021	Wang, Deshou/0000-0002-4967-524X	National Natural Science Foundation of China [31030063, 30871905]; NSFC-RGC Joint Research Scheme from the National Science Foundation of China [NSFC:30831160508]; National Basic Research Program of China [2009CB941200, 2010CB134405, 2012CB723205]; National High Technology Research and Development Program (863 program) of China [2011AA100404]; Program for Changjiang Scholars and Innovative Research Team in University [IRT0859]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20090182110008]; Natural Science Foundation Project of Chongqing, Chongqing Science and Technology Commission [CQ CSTC 2008BB1006, 2008AC1016]; Excellent Ph.D Thesis Fellowship of Southwest University [kb2010009, kb2011007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSFC-RGC Joint Research Scheme from the National Science Foundation of China; National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program (863 program) of China(National High Technology Research and Development Program of China); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation Project of Chongqing, Chongqing Science and Technology Commission; Excellent Ph.D Thesis Fellowship of Southwest University	This work was supported by grants 31030063 and 30871905 from the National Natural Science Foundation of China; the NSFC-RGC Joint Research Scheme from the National Science Foundation of China (NSFC:30831160508); grants 2009CB941200, 2010CB134405, and 2012CB723205 from the National Basic Research Program of China; grant 2011AA100404 from the National High Technology Research and Development Program (863 program) of China; grant IRT0859 from the Program for Changjiang Scholars and Innovative Research Team in University; grant 20090182110008 from the Specialized Research Fund for the Doctoral Program of Higher Education of China; grants CQ CSTC 2008BB1006 and 2008AC1016 from the Natural Science Foundation Project of Chongqing, Chongqing Science and Technology Commission, and grants kb2010009 and kb2011007 from the Excellent Ph.D Thesis Fellowship of Southwest University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achermann JC, 1999, NAT GENET, V22, P125, DOI 10.1038/9629; Afonso LOB, 2001, J EXP ZOOL, V290, P177, DOI 10.1002/jez.1047; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Baroiller JF, 2009, SEX DEV, V3, P118, DOI 10.1159/000223077; BAROILLER JF, 1995, J EXP ZOOL, V273, P216, DOI 10.1002/jez.1402730306; Baron D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-357; Beardmore JA, 2001, AQUACULTURE, V197, P283, DOI 10.1016/S0044-8486(01)00590-7; Benjamini Y, 2001, ANN STAT, V29, P1165; Benjamini Y, 2005, GENETICS, V171, P783, DOI 10.1534/genetics.104.036699; Bhandari RK, 2006, GEN COMP ENDOCR, V145, P20, DOI 10.1016/j.ygcen.2005.06.014; Chen WB, 2012, FISH PHYSIOL BIOCHEM, V38, P1843, DOI 10.1007/s10695-012-9681-6; Chu SL, 2006, AQUACULTURE, V251, P537, DOI 10.1016/j.aquaculture.2005.05.040; Clement TM, 2007, REPRODUCTION, V134, P455, DOI 10.1530/REP-06-0341; Coveney D, 2001, BIOL REPROD, V65, P613, DOI 10.1095/biolreprod65.2.613; Difilippantonio S, 2005, NAT CELL BIOL, V7, P675, DOI 10.1038/ncb1270; Duncan FE, 2005, DEV BIOL, V280, P38, DOI 10.1016/j.ydbio.2004.12.034; Eddy EM, 1999, REV REPROD, V4, P23, DOI 10.1530/revreprod/4.1.23; Eshel O, 2012, G3-GENES GENOM GENET, V2, P35, DOI 10.1534/g3.111.001545; Eshel O, 2011, ANIM GENET, V42, P222, DOI 10.1111/j.1365-2052.2010.02128.x; Ezaz MT, 2004, MAR BIOTECHNOL, V6, P435, DOI 10.1007/s10126-004-3004-6; Ghiselli F, 2012, MOL BIOL EVOL, V29, P771, DOI 10.1093/molbev/msr248; Guiguen Y, 1999, MOL REPROD DEV, V54, P154, DOI 10.1002/(SICI)1098-2795(199910)54:2&lt;154::AID-MRD7&gt;3.0.CO;2-5; Guiguen Y, 2010, GEN COMP ENDOCR, V165, P352, DOI 10.1016/j.ygcen.2009.03.002; Hale MC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-203; Harvey SC, 2003, CYTOGENET GENOME RES, V101, P314, DOI 10.1159/000074355; Hattori RS, 2012, P NATL ACAD SCI USA, V109, P2955, DOI 10.1073/pnas.1018392109; Heikkila M, 2001, J EXP ZOOL, V290, P616, DOI 10.1002/jez.1112; Ijiri S, 2008, BIOL REPROD, V78, P333, DOI 10.1095/biolreprod.107.064246; Jameson SA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002575; Kanai Y, 2005, J BIOCHEM, V138, P13, DOI 10.1093/jb/mvi098; Katoh-Fukui Y, 1998, NATURE, V393, P688, DOI 10.1038/31482; Kobayashi T, 2003, CYTOGENET GENOME RES, V101, P289, DOI 10.1159/000074351; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Lee BY, 2011, MAR BIOTECHNOL, V13, P557, DOI 10.1007/s10126-010-9326-7; Lee BY, 2003, ANIM GENET, V34, P379, DOI 10.1046/j.1365-2052.2003.01035.x; Lee TL, 2010, BIOINFORMATICS, V26, P585, DOI 10.1093/bioinformatics/btp695; Li MH, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096248; Lin YT, 2006, RNA, V12, P1486, DOI 10.1261/rna.42206; Liu ZH, 2007, J ENDOCRINOL, V194, P223, DOI 10.1677/JOE-07-0135; Lui WY, 2003, BBA-MOL CELL RES, V1593, P121, DOI 10.1016/S0167-4889(02)00348-8; Ma KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039727; Matsuda M, 2002, NATURE, V417, P559, DOI 10.1038/nature751; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagahama Y, 2000, INT S REPR PHYS FIS, P211; Navarro-Martin L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002447; Nef S, 2005, DEV BIOL, V287, P361, DOI 10.1016/j.ydbio.2005.09.008; Ocalewicz K, 2009, CHROMOSOME RES, V17, P773, DOI 10.1007/s10577-009-9071-9; Raymond CS, 1998, NATURE, V391, P691, DOI 10.1038/35618; Schwartz TS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-694; Senthikumaran B, 2009, MOL CELL ENDOCRINOL, V299, P146, DOI 10.1016/j.mce.2008.11.008; Sheng Y, 2006, J BIOL CHEM, V281, P35048, DOI 10.1074/jbc.M605086200; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Small CM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-579; Smith CA, 2004, BIOESSAYS, V26, P120, DOI 10.1002/bies.10400; Sun YL, 2012, FISH PHYSIOL BIOCHEM, V38, P1427, DOI 10.1007/s10695-012-9630-4; Swain A, 1996, NAT GENET, V12, P404, DOI 10.1038/ng0496-404; TIMPL R, 1979, J BIOL CHEM, V254, P9933; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; Uda M, 2004, HUM MOL GENET, V13, P1171, DOI 10.1093/hmg/ddh124; Wang DS, 2005, FISH PHYSIOL BIOCHEM, V31, P255, DOI 10.1007/s10695-006-0033-2; Wang DS, 2007, MOL ENDOCRINOL, V21, P712, DOI 10.1210/me.2006-0248; Wang DS, 2010, ENDOCRINOLOGY, V151, P1331, DOI 10.1210/en.2009-0999; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wen CM, 2005, DEV DYNAM, V232, P171, DOI 10.1002/dvdy.20210; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Wu YJ, 2011, CELL TISSUE RES, V344, P355, DOI 10.1007/s00441-011-1151-4; Yano A, 2012, CURR BIOL, V22, P1423, DOI 10.1016/j.cub.2012.05.045; Yano A, 2011, MOL REPROD DEV, V78, P172, DOI 10.1002/mrd.21279; Ybot-Gonzalez P, 2005, DEV DYNAM, V233, P1013, DOI 10.1002/dvdy.20383; Yoshimoto S, 2008, P NATL ACAD SCI USA, V105, P2469, DOI 10.1073/pnas.0712244105; Yoshiura Y, 2003, BIOL REPROD, V68, P1545, DOI 10.1095/biolreprod.102.010843; Zhang WL, 2010, GEN COMP ENDOCR, V165, P34, DOI 10.1016/j.ygcen.2009.05.018; Zhang ZP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018379; Zhou LY, 2007, ENDOCRINOLOGY, V148, P4282, DOI 10.1210/en.2007-0487	76	154	161	2	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e63604	10.1371/journal.pone.0063604	http://dx.doi.org/10.1371/journal.pone.0063604			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658843	Green Published, Green Submitted, gold			2022-12-25	WOS:000321202100074
J	Gu, SH; Hsieh, YC; Young, SC; Lin, PL				Gu, Shi-Hong; Hsieh, Yun-Chin; Young, Shun-Chieh; Lin, Pei-Ling			Involvement of Phosphorylation of Adenosine 5 '-Monophosphate-Activated Protein Kinase in PTTH-Stimulated Ecdysteroidogenesis in Prothoracic Glands of the Silkworm, Bombyx mori	PLOS ONE			English	Article							HORMONE STIMULATION; MOLECULAR-CLONING; MAMMALIAN TARGET; CELL-GROWTH; CYCLIC-AMP; ACTIVATION; EXPRESSION; RAPAMYCIN; RECEPTOR; CALCIUM	In this study, we investigated inhibition of the phosphorylation of adenosine 5'-monophosphate-activated protein kinase (AMPK) by prothoracicotropic hormone (PTTH) in prothoracic glands of the silkworm, Bombyx mori. We found that treatment with PTTH in vitro inhibited AMPK phosphorylation in time- and dose-dependent manners, as seen on Western blots of glandular lysates probed with antibody directed against AMPK alpha phosphorylated at Thr172. Moreover, in vitro inhibition of AMPK phosphorylation by PTTH was also verified by in vivo experiments: injection of PTTH into day 7 last instar larvae greatly inhibited glandular AMPK phosphorylation. PTTH-inhibited AMPK phosphorylation appeared to be partially reversed by treatment with LY294002, indicating involvement of phosphatidylinositol 3-kinase (PI3K) signaling. A chemical activator of AMPK (5-aminoimidazole-4-carboxamide-1-b=beta-d-ribofuranoside, AICAR) increased both basal and PTTH-inhibited AMPK phosphorylation. Treatment with AICAR also inhibited PTTH-stimulated ecdysteroidogenesis of prothoracic glands. The mechanism underlying inhibition of PTTH-stimulated ecdysteroidogenesis by AICAR was further investigated by determining the phosphorylation of eIF4E-binding protein (4E-BP) and p70 ribosomal protein S6 kinase (S6K), two known downstream signaling targets of the target of rapamycin complex 1 (TORC1). Upon treatment with AICAR, decreases in PTTH-stimulated phosphorylation of 4E-BP and S6K were detected. In addition, treatment with AICAR did not affect PTTH-stimulated extracellular signal-regulated kinase (ERK) phosphorylation, indicating that AMPK phosphorylation is not upstream signaling for ERK phosphorylation. Examination of gene expression levels of AMPK alpha, beta, and gamma by quantitative real-time PCR (qRT-PCR) showed that PTTH did not affect AMPK transcription. From these results, it is assumed that inhibition of AMPK phosphorylation, which lies upstream of PTTH-stimulated TOR signaling, may play a role in PTTH stimulation of ecdysteroidogenesis.	[Gu, Shi-Hong; Hsieh, Yun-Chin; Young, Shun-Chieh; Lin, Pei-Ling] Natl Museum Nat Sci, Dept Zool, Taichung, Taiwan		Gu, SH (corresponding author), Natl Museum Nat Sci, Dept Zool, Taichung, Taiwan.	gu330@mail.nmns.edu.tw			National Science Council, Taipei, Taiwan [NSC99-2628-B-178-002-MY3, NSC100-2313-B-001-MY3]	National Science Council, Taipei, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the National Science Council, Taipei, Taiwan (NSC99-2628-B-178-002-MY3 and NSC100-2313-B-001-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolster DR, 2002, J BIOL CHEM, V277, P23977, DOI 10.1074/jbc.C200171200; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Fellner SK, 2005, INSECT BIOCHEM MOLEC, V35, P263, DOI 10.1016/j.ibmb.2004.11.006; Gilbert LI, 2002, ANNU REV ENTOMOL, V47, P883, DOI 10.1146/annurev.ento.47.091201.145302; Gu SH, 1998, INSECT BIOCHEM MOLEC, V28, P861, DOI 10.1016/S0965-1748(98)00074-5; Gu SH, 1996, MOL CELL ENDOCRINOL, V120, P99, DOI 10.1016/0303-7207(96)03821-X; Gu SH, 2012, INSECT BIOCHEM MOLEC, V42, P296, DOI 10.1016/j.ibmb.2011.12.010; Gu SH, 2011, INSECT BIOCHEM MOLEC, V41, P197, DOI 10.1016/j.ibmb.2010.12.004; Gu SH, 2010, J INSECT PHYSIOL, V56, P93, DOI 10.1016/j.jinsphys.2009.09.008; Gu SH, 2009, INSECT BIOCHEM MOLEC, V39, P171, DOI 10.1016/j.ibmb.2008.10.012; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Horman S, 2006, J BIOL CHEM, V281, P5335, DOI 10.1074/jbc.M506850200; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Johnson EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012799; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; KAWAKAMI A, 1990, SCIENCE, V247, P1333, DOI 10.1126/science.2315701; Kovacic S, 2003, J BIOL CHEM, V278, P39422, DOI 10.1074/jbc.M305371200; Lee JH, 2007, NATURE, V447, P1017, DOI 10.1038/nature05828; Lim CT, 2010, J MOL ENDOCRINOL, V44, P87, DOI 10.1677/JME-09-0063; Lin JL, 2007, J INSECT PHYSIOL, V53, P622, DOI 10.1016/j.jinsphys.2007.03.004; Marchal E, 2010, PEPTIDES, V31, P506, DOI 10.1016/j.peptides.2009.08.020; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Ning JY, 2011, ENDOCRINOLOGY, V152, P3143, DOI 10.1210/en.2011-0155; NOGUTI T, 1995, FEBS LETT, V376, P251, DOI 10.1016/0014-5793(95)01296-8; OREILLY DR, 1995, INSECT BIOCHEM MOLEC, V25, P475, DOI 10.1016/0965-1748(94)00087-F; Pan DA, 2002, BIOCHEM J, V367, P179, DOI 10.1042/BJ20020703; Rewitz KF, 2009, SCIENCE, V326, P1403, DOI 10.1126/science.1176450; Rewitz KF, 2009, INSECT BIOCHEM MOLEC, V39, P475, DOI 10.1016/j.ibmb.2009.04.005; Rybczynski R, 2001, MOL CELL ENDOCRINOL, V184, P1, DOI 10.1016/S0303-7207(01)00664-5; Rybczynski R, 2006, MOL CELL ENDOCRINOL, V251, P78, DOI 10.1016/j.mce.2006.02.015; Smith W, 2003, INSECT BIOCHEM MOLEC, V33, P1317, DOI 10.1016/j.ibmb.2003.06.003; SMITH WA, 1984, MOL CELL ENDOCRINOL, V37, P285, DOI 10.1016/0303-7207(84)90098-4; SMITH WA, 1985, MOL CELL ENDOCRINOL, V39, P71, DOI 10.1016/0303-7207(85)90093-0; Smith WA, 2012, INSECT ENDOCRINOLOGY, P1, DOI [10.1016/B978-0-12-384749-2.10001-9, DOI 10.1016/B978-0-12-384749-2.10001-9]; SONG QS, 1995, INSECT BIOCHEM MOLEC, V25, P591, DOI 10.1016/0965-1748(94)00100-V; SONG QS, 1994, DEV GENET, V15, P332, DOI 10.1002/dvg.1020150404; Song QS, 1997, J BIOL CHEM, V272, P4429, DOI 10.1074/jbc.272.7.4429; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; TAKEDA S, 1986, Bulletin of the Sericultural Experiment Station (Tokyo), V30, P361; Tohyama D, 2010, BIOCHEM BIOPH RES CO, V394, P112, DOI 10.1016/j.bbrc.2010.02.126; Tosca L, 2007, BIOL REPROD, V76, P368, DOI 10.1095/biolreprod.106.055749; Young SC, 2012, J INSECT PHYSIOL, V58, P102, DOI 10.1016/j.jinsphys.2011.10.005; ZHUO S, 1993, J BIOL CHEM, V268, P17754	46	10	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63102	10.1371/journal.pone.0063102	http://dx.doi.org/10.1371/journal.pone.0063102			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671658	Green Published, gold, Green Submitted			2022-12-25	WOS:000319737700038
J	Wang, BB; Zhe, MJ; Chen, ZY; Li, CF; Meng, CC; Zhang, MT; Liu, GQ				Wang, Binbin; Zhe, Mingjia; Chen, Zongyan; Li, Chuanfeng; Meng, Chunchun; Zhang, Miaotao; Liu, Guangqing			Construction and Applications of Rabbit Hemorrhagic Disease Virus Replicon	PLOS ONE			English	Article							GENOME-LINKED PROTEIN; 3C-LIKE PROTEASE; VPG; IDENTIFICATION; CALICIVIRUS; SYSTEM; RNAS	The study of rabbit hemorrhagic disease virus (RHDV) has long been hindered by the absence of an in vitro culture system. In this study, using RHDV as a model, a series of DNA-based reporter replicons were constructed in which the firefly luciferase (Fluc) gene was fused in-frame with the open reading frame of the replicon. In this construct, the Fluc gene was inserted where the coding region of viral structural protein was deleted and was under the control of a minimal cytomegalovirus (CMV) immediate-early promoter. Fluc activity analysis showed that these reporter replicons replicate efficiently in mammalian cells. On the basis of the replicon, 5'non-coding regions (5'NCR) and genome-linked protein (VPg) were deleted, and the effect on the expression of replicon was analyzed. The results showed that the expression level of Fluc was reduced in the absence of 5'NCR and VPg, suggesting that the 5'NCR and VPg may play an important role in replication and/or translation of RHDV. To further verify the speculation, we also constructed a replication deficient mutant (pRHDV-luc/Delta 3D), and the impact of 5'NCR and VPg deletion on viral translation efficiency was analyzed, our results indicated that both VPg and 5'NCR were involved in RHDV translation.	[Wang, Binbin; Zhe, Mingjia; Chen, Zongyan; Li, Chuanfeng; Meng, Chunchun; Liu, Guangqing] CAAS, Shanghai Vet Res Inst, Shanghai, Peoples R China; [Wang, Binbin; Zhe, Mingjia; Zhang, Miaotao] Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Northwest A&F University - China	Liu, GQ (corresponding author), CAAS, Shanghai Vet Res Inst, Shanghai, Peoples R China.	liugq@shvri.ac.cn	chen, zongyan/ABG-9170-2021		Chinese Natural Sciences Foundation [31270194, 31101848]; Fundamental Research Funds for the Central Institutes program [2011JB06, 2011JB13]; Special Fund for Agro-scientific Research in the Public Interest [201003012]; National Advanced Technology Research and Development Program of China (863 Program) [2011AA10A200]	Chinese Natural Sciences Foundation(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Institutes program; Special Fund for Agro-scientific Research in the Public Interest; National Advanced Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by the Chinese Natural Sciences Foundation (31270194, 31101848), the Fundamental Research Funds for the Central Institutes program (2011JB06, 2011JB13), Special Fund for Agro-scientific Research in the Public Interest (201003012), and the National Advanced Technology Research and Development Program of China (863 Program) (2011AA10A200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrantes J, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-12; Chang KO, 2006, VIROLOGY, V353, P463, DOI 10.1016/j.virol.2006.06.006; Clarke IN, 1997, J GEN VIROL, V78, P291, DOI 10.1099/0022-1317-78-2-291; CUBBIT D, 1995, ARCH VIROL         S, V10, P359; Daughenbaugh KF, 2003, EMBO J, V22, P2852, DOI 10.1093/emboj/cdg251; Goodfellow I, 2005, EMBO REP, V6, P968, DOI 10.1038/sj.embor.7400510; Goodfellow I, 2011, CURR OPIN VIROL, V1, P355, DOI 10.1016/j.coviro.2011.09.003; Han KR, 2010, J GEN VIROL, V91, P1711, DOI 10.1099/vir.0.020461-0; Hass M, 2004, J VIROL, V78, P13793, DOI 10.1128/JVI.78.24.13793-13803.2004; Herbert TP, 1997, J GEN VIROL, V78, P1033, DOI 10.1099/0022-1317-78-5-1033; Joubert P, 2000, J GEN VIROL, V81, P481, DOI 10.1099/0022-1317-81-2-481; LAWSON M, 1995, NATURE, V378, P531, DOI 10.1038/378531b0; Liu GQ, 2006, CHINESE SCI BULL, V51, P1698, DOI 10.1007/s11434-006-2044-x; Liu GQ, 2008, J GEN VIROL, V89, P3080, DOI 10.1099/vir.0.2008/003525-0; Machin A, 2001, J BIOL CHEM, V276, P27787, DOI 10.1074/jbc.M100707200; MEYERS G, 1991, VIROLOGY, V184, P677, DOI 10.1016/0042-6822(91)90437-G; Mitra T, 2004, J VIROL, V78, P4931, DOI 10.1128/JVI.78.9.4931-4935.2004; RASSCHAERT D, 1995, VIRUS GENES, V9, P121, DOI 10.1007/BF01702655; Thiel HJ, 1999, VET MICROBIOL, V69, P55, DOI 10.1016/S0378-1135(99)00088-7; WIRBLICH C, 1995, J VIROL, V69, P7159, DOI 10.1128/JVI.69.11.7159-7168.1995	20	4	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e60316	10.1371/journal.pone.0060316	http://dx.doi.org/10.1371/journal.pone.0060316			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667425	Green Published, Green Submitted, gold			2022-12-25	WOS:000319055600005
J	Barbosa, CEA; Misiewicz, TM; Fine, PVA; Costa, FRC				Barbosa, Carlos Eduardo A.; Misiewicz, Tracy M.; Fine, Paul V. A.; Costa, Flavia R. C.			Plant Ontogeny, Spatial Distance, and Soil Type Influence Patterns of Relatedness in a Common Amazonian Tree	PLOS ONE			English	Article							MESOSCALE DISTRIBUTION PATTERNS; RAIN-FOREST TREE; GENETIC-STRUCTURE; NEOTROPICAL TREE; SEED DISPERSAL; TROPICAL TREE; COMPUTER-PROGRAM; HABITAT SPECIALIZATION; SCALE; POPULATION	The formation of spatial genetic structure (SGS) may originate from different patterns of seed deposition in the landscape, and is mostly determined by seed dispersal limitation. After dispersal, mechanisms such as filtering by environmental factors or attack by herbivores/pathogens throughout plant development stages, and potentially either disrupt or intensify SGS patterns. We investigated how the genotype of Protium subserratum (Burseraceae), a common tree species in the Ducke Reserve, Brazil, is distributed across the landscape. We used seven microsatellite markers to assess the SGS among plants at different life stages and in different environments. By quantifying the patterns of relatedness among plants of different sizes, we inferred the ontogenetic stage in which SGS changes occurred, and compared these effects across soil types. Relatedness among seedlings decreased when distance between seedlings increased, especially for the youngest seedlings. However, this trend was not continued by older plants, as relatedness values were higher among neighboring individuals of the juvenile and adult size class. Contrasting relatedness patterns between seedlings and larger individuals suggests a trade-off between the negative effects of being near closely-related adults (e. g. due to herbivore and pathogen attack) and the advantage of being in a site favorable to establishment. We also found that soil texture strongly influenced density-dependence patterns, as young seedlings in clay soils were more related to each other than were seedlings in bottomland sandy soils, suggesting that the mechanisms that create and maintain patterns of SGS within a population may interact with environmental heterogeneity.	[Barbosa, Carlos Eduardo A.] INPA, Grad Program Ecol, Manaus, Amazonas, Brazil; [Misiewicz, Tracy M.; Fine, Paul V. A.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Costa, Flavia R. C.] INPA, Manaus, Amazonas, Brazil	Institute Nacional de Pesquisas da Amazonia; University of California System; University of California Berkeley; Institute Nacional de Pesquisas da Amazonia	Barbosa, CEA (corresponding author), INPA, Grad Program Ecol, Manaus, Amazonas, Brazil.	cadubarbosa@gmail.com	Costa, Flavia/K-4386-2014; de Araujo Barbosa, Carlos Eduardo/E-2232-2012	Costa, Flavia/0000-0002-9600-4625; Fine, Paul/0000-0002-0550-5628; Misiewicz, Tracy/0000-0002-2683-8405	Brazilian National Research Council (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); CNPq/Universal [473447/2008-5]; CNPq/CT-Amazonia [575637/2008-0]; National Science Foundation [DEB 0919567]; Vincent Coates Fund at the University of California, Berkeley	Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq/Universal(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq/CT-Amazonia(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Science Foundation(National Science Foundation (NSF)); Vincent Coates Fund at the University of California, Berkeley(University of California System)	This study was funded with a PhD fellowship from the Brazilian National Research Council (CNPq) to CEAB during field work and manuscript elaboration and a Sandwich fellowship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) throughout laboratory work. Financial support was granted by CNPq/Universal (473447/2008-5) to FRCC, CNPq/CT-Amazonia (575637/2008-0) to Bruce W. Nelson, the National Science Foundation (DEB 0919567) and the Vincent Coates Fund at the University of California, Berkeley to PVAF. Logistical support was provided by Instituto Nacional de Pesquisas da Amazonia (INPA) and Brazilian Biodiversity Research Program (PPBio). Data repositories are maintained by PPBio, Brazilian Long-Term Ecological Research Program (PELD) and the National Institute of Science and Technology for Amazonian Biodiversity (INCT - CENBAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Loayza P, 2011, J ECOL, V99, P1045, DOI 10.1111/j.1365-2745.2011.01835.x; Blouin MS, 2003, TRENDS ECOL EVOL, V18, P503, DOI 10.1016/S0169-5347(03)00225-8; Born C, 2008, MOL ECOL, V17, P2041, DOI 10.1111/j.1365-294X.2007.03685.x; Brenes-Arguedas T, 2005, OIKOS, V108, P410, DOI 10.1111/j.0030-1299.2005.13473.x; Costa FRC, 2010, NAT CONSERVACAO, V8, P3, DOI 10.4322/natcon.00801001; Choo J, 2012, MOL ECOL, V21, P1019, DOI 10.1111/j.1365-294X.2011.05425.x; CLARK DA, 1984, AM NAT, V124, P769, DOI 10.1086/284316; Comita LS, 2010, SCIENCE, V329, P330, DOI 10.1126/science.1190772; CONNELL J H, 1971, P298; Costa FRC, 2009, J VEG SCI, V20, P69, DOI 10.1111/j.1654-1103.2009.05314.x; Costa FRC, 2005, J ECOL, V93, P863, DOI 10.1111/j.1365-2745.2005.01020.x; CRAWLEY MJ, 1990, PHILOS T R SOC B, V330, P125, DOI 10.1098/rstb.1990.0187; Daly DC, 2011, SYST BOT, V36, P939, DOI 10.1600/036364411X604958; De Steven D, 2002, ECOLOGY, V83, P2315, DOI 10.1890/0012-9658(2002)083[2315:COVRFS]2.0.CO;2; Epperson Bryan K., 2000, Plant Species Biology, V15, P269, DOI 10.1046/j.1442-1984.2000.00046.x; Fine PVA, 2006, ECOLOGY, V87, pS150, DOI 10.1890/0012-9658(2006)87[150:TGTAHS]2.0.CO;2; Fine PVA, 2013, J BIOGEOGR, V40, P646, DOI 10.1111/j.1365-2699.2011.02645.x; Fine PVA, 2004, SCIENCE, V305, P663, DOI 10.1126/science.1098982; Fisher R.A., 1958, STAT METHODS RES WOR; Gonzales E, 2010, J HERED, V101, P133, DOI 10.1093/jhered/esp101; GUILLAUMET J-L, 1982, Acta Amazonica, V12, P61; Hampe A, 2010, MOL ECOL, V19, P459, DOI 10.1111/j.1365-294X.2009.04492.x; Hamrick JL, 2011, ACTA OECOL, V37, P641, DOI 10.1016/j.actao.2011.05.008; HAMRICK JL, 1993, VEGETATIO, V108, P281; Hardesty BD, 2005, HEREDITY, V95, P290, DOI 10.1038/sj.hdy.6800714; Hardy OJ, 2006, MOL ECOL, V15, P559, DOI 10.1111/j.1365-294X.2005.02785.x; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Herrera CM, 1998, AM NAT, V152, P576, DOI 10.1086/286191; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Jones FA, 2006, MOL ECOL, V15, P3205, DOI 10.1111/j.1365-294X.2006.03023.x; Kalinowski ST, 2006, MOL ECOL NOTES, V6, P576, DOI 10.1111/j.1471-8286.2006.01256.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Karubian J, 2010, MOL ECOL, V19, P1745, DOI 10.1111/j.1365-294X.2010.04600.x; Kinupp VF, 2005, J TROP ECOL, V21, P363, DOI 10.1017/S0266467405002440; LANGENHEIM JH, 1983, BIOCHEM SYST ECOL, V11, P97, DOI 10.1016/0305-1978(83)90006-6; Latouche-Halle C, 2003, HEREDITY, V91, P181, DOI 10.1038/sj.hdy.6800296; Leishman M. R., 2000, Seeds: the ecology of regeneration in plant communities, P31, DOI 10.1079/9780851994321.0031; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Magnusson William E., 2005, Biota Neotrop., V5, P19, DOI 10.1590/S1676-06032005000300002; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; Misiewicz TM, 2012, AM J BOT, V99, pE465, DOI 10.3732/ajb.1200229; MOLOFSKY J, 1992, ECOLOGY, V73, P68, DOI 10.2307/1938721; Muller-Landau H. C., 2002, Seed dispersal and frugivory: ecology, evolution and conservation. Third International Symposium-Workshop on Frugivores and Seed Dispersal, Sao Pedro, Brazil, 6-11 August 2000, P35, DOI 10.1079/9780851995250.0035; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Poorter L, 2007, AM NAT, V169, P433, DOI 10.1086/512045; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Ribeiro J.E.L. da S., 1999, FLORA RESERVA DUCKE; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Schietti J, 2014, PLANT ECOL DIVERS, V7, P241, DOI 10.1080/17550874.2013.783642; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Schupp E. W., 2007, Seed dispersal: theory and its application in a changing world, P445, DOI 10.1079/9781845931650.0445; SCHUPP EW, 1995, AM J BOT, V82, P399, DOI 10.2307/2445586; Schurr FM, 2008, J ECOL, V96, P628, DOI 10.1111/j.1365-2745.2008.01371.x; Sezen UU, 2009, P ROY SOC B-BIOL SCI, V276, P2037, DOI 10.1098/rspb.2008.1793; Smith DS, 2012, PLANT SOIL, V352, P243, DOI 10.1007/s11104-011-0992-7; Smouse PE, 1999, HEREDITY, V82, P561, DOI 10.1038/sj.hdy.6885180; Smouse PE, 2008, MOL ECOL, V17, P3389, DOI 10.1111/j.1365-294X.2008.03839.x; Steinitz O, 2011, MOL ECOL, V20, P4152, DOI 10.1111/j.1365-294X.2011.05203.x; Thomas SC, 1996, EVOL ECOL, V10, P517, DOI 10.1007/BF01237882; Troupin D, 2006, MOL ECOL, V15, P3617, DOI 10.1111/j.1365-294X.2006.03047.x; Vekemans X, 2004, MOL ECOL, V13, P921, DOI 10.1046/j.1365-294X.2004.02076.x; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809; Zhou HP, 2010, J ECOL, V98, P1168, DOI 10.1111/j.1365-2745.2010.01683.x	63	4	4	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62639	10.1371/journal.pone.0062639	http://dx.doi.org/10.1371/journal.pone.0062639			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667502	Green Published, gold, Green Submitted			2022-12-25	WOS:000319654700052
J	Ding, C; Li, L; Su, YC; Xiang, RL; Cong, X; Yu, HK; Li, SL; Wu, LL; Yu, GY				Ding, Chong; Li, Li; Su, Yun-Chao; Xiang, Ruo-Lan; Cong, Xin; Yu, Hong-Kui; Li, Sheng-Lin; Wu, Li-Ling; Yu, Guang-Yan			Adiponectin Increases Secretion of Rat Submandibular Gland via Adiponectin Receptors-Mediated AMPK Signaling	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; TIGHT JUNCTION; EPITHELIAL-CELLS; EXPRESSION; SALIVARY; ASSOCIATION; HYPOADIPONECTINEMIA; PERMEABILITY; BARRIER	Adiponectin and adiponectin receptors (AdipoR1/2) are expressed in various tissues and are involved in the regulation of multiple functions such as energy metabolism and inflammatory responses. However, the effect of adiponectin and AdipoRs in submandibular glands has not been fully evaluated. In the present study, we found that mRNA and protein of both adiponectin and AdipoR1/2 were expressed in rat submandibular glands and in the SMG-C6 cell line, as evidenced by RT-PCR and Western blot analysis. Immunofluorescence staining showed that adiponectin was diffused in the cytoplasm, while AdipoR1/2 was concentrated in the membrane of acinar cells. Saliva flow was significantly increased by full length adiponectin (fAd) or globular adiponectin (gAd) perfusion in isolated rat submandibular glands. 5-Aminoimidazole-4carboxamide- 1-4-ribofuranoside (AICAR), an adenosine monophosphate activated protein kinase (AMPK) activator, also increased saliva secretion. fAd, gAd, and AICAR all increased the average width of apical tight junctions in perfused submandibular glands, and decreased transepithelial electrical resistance (TER) in SMG-C6 cells, suggesting that adiponectin promoted secretion by modulating paracellular permeability. fAd and gAd increased p-AMPK levels, while AraA, an AMPK antagonist, abolished fAd- and gAd-induced changes in secretion, tight junction ultrastructure, and TER. Moreover, both AdipoR1 and AdipoR2 were required for fAd- or gAd-induced p-AMPK and TER responses, suggesting from their inhibition following AdipoR1 or AdipoR2 knockdown, and co-knockdown of AdipoRs by RNA interference. Our results suggest that adiponectin functions as a promoter of salivary secretion in rat submandibular glands via activation of AdipoRs, AMPK, and paracellular permeability.	[Ding, Chong; Li, Sheng-Lin] Peking Univ, Sch & Hosp Stomatol, Ctr Salivary Gland Dis, Beijing 100871, Peoples R China; [Ding, Chong; Li, Sheng-Lin] Peking Univ, Sch & Hosp Stomatol, Ctr Lab, Beijing 100871, Peoples R China; [Li, Li; Su, Yun-Chao; Xiang, Ruo-Lan; Cong, Xin; Wu, Li-Ling] Peking Univ, Hlth Sci Ctr, Dept Physiol & Pathophysiol, Beijing 100871, Peoples R China; [Li, Li; Su, Yun-Chao; Xiang, Ruo-Lan; Cong, Xin; Wu, Li-Ling] Minist Educ, Key Lab Mol Cardiovasc Sci, Beijing, Peoples R China; [Yu, Hong-Kui; Yu, Guang-Yan] Peking Univ, Sch & Hosp Stomatol, Dept Oral & Maxillofacial Surg, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University; Peking University	Wu, LL (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Physiol & Pathophysiol, Beijing 100871, Peoples R China.	pathophy@bjmu.edu.cn; gyyu@263.net	Xiang, Ruo-Lan/T-6845-2019		National Natural Science Foundation of China [30973316, 81070847, 81271161]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Natural Science Foundation of China (Nos. 30973316, 81070847, and 81271161). (Website:http://www.nsfc.gov.cn.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERBERG EK, 1993, PHARMACEUT RES, V10, P857, DOI 10.1023/A:1018909210879; BAUM BJ, 1993, ANN NY ACAD SCI, V694, P17; Berner HS, 2004, BONE, V35, P842, DOI 10.1016/j.bone.2004.06.008; Bjursell M, 2007, DIABETES, V56, P583, DOI 10.2337/db06-1432; Civitarese AE, 2004, DIABETOLOGIA, V47, P816, DOI 10.1007/s00125-004-1359-x; Cong X, 2012, LAB INVEST, V92, P753, DOI 10.1038/labinvest.2012.12; Corbetta S, 2005, J CLIN ENDOCR METAB, V90, P2397, DOI 10.1210/jc.2004-1553; Dadson Keith, 2011, Front Endocrinol (Lausanne), V2, P62, DOI 10.3389/fendo.2011.00062; Ding C, 2011, J PROTEOME RES, V10, P2206, DOI 10.1021/pr100965q; Garrett JR, 1999, NEURAL MECH SALIVARY; Groschl M, 2001, J CLIN ENDOCR METAB, V86, P5234, DOI 10.1210/jc.86.11.5234; Guo ZX, 2007, METABOLISM, V56, P1363, DOI 10.1016/j.metabol.2007.05.005; Guo ZX, 2011, J PHARM PHARMACOL, V63, P87, DOI 10.1111/j.2042-7158.2010.01157.x; Hug C, 2004, P NATL ACAD SCI USA, V101, P10308, DOI 10.1073/pnas.0403382101; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Katsiougiannis S, 2006, ARTHRITIS RHEUM, V54, P2295, DOI 10.1002/art.21944; Katsiougiannis S, 2010, ARTHRITIS RHEUM-US, V62, P414, DOI 10.1002/art.27239; Kawedia JD, 2008, J PHARMACOL EXP THER, V326, P829, DOI 10.1124/jpet.107.135798; Kraus D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030716; Kumada M, 2003, ARTERIOSCL THROM VAS, V23, P85, DOI 10.1161/01.ATV.0000048856.22331.50; Li YM, 2006, LIFE SCI, V79, P2091, DOI 10.1016/j.lfs.2006.07.017; Ma TH, 1999, J BIOL CHEM, V274, P20071, DOI 10.1074/jbc.274.29.20071; Mamali I, 2012, PEPTIDES, V33, P120, DOI 10.1016/j.peptides.2011.11.007; Matsuzaki T, 1999, CELL TISSUE RES, V295, P513, DOI 10.1007/s004410051257; Mitic LL, 1998, ANNU REV PHYSIOL, V60, P121, DOI 10.1146/annurev.physiol.60.1.121; Mizumachi-Kubono M, 2012, ARCH ORAL BIOL, V57, P877, DOI 10.1016/j.archoralbio.2012.02.006; Nighot PK, 2010, AM J PHYSIOL-GASTR L, V299, pG449, DOI 10.1152/ajpgi.00520.2009; Ogawa Y, 2003, PROG HISTOCHEM CYTO, V38, P343, DOI 10.1016/S0079-6336(03)80001-3; Peng LY, 2009, J NUTR, V139, P1619, DOI 10.3945/jn.109.104638; Pineiro R, 2005, FEBS LETT, V579, P5163, DOI 10.1016/j.febslet.2005.07.098; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; Quissell D O, 1997, In Vitro Cell Dev Biol Anim, V33, P164; Saito Y, 2007, AM J PHYSIOL-HEART C, V293, pH3490, DOI 10.1152/ajpheart.00310.2007; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Shibata R, 2004, NAT MED, V10, P1384, DOI 10.1038/nm1137; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Shibata R, 2007, J MOL CELL CARDIOL, V42, P1065, DOI 10.1016/j.yjmcc.2007.03.808; Staiger K, 2005, J CLIN ENDOCR METAB, V90, P6707, DOI 10.1210/jc.2005-0467; Thundyil J, 2011, BRIT J PHARMACOL, V165, P313; Toda M, 2007, ACTA DIABETOL, V44, P20, DOI 10.1007/s00592-007-0236-8; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Turner JR, 1997, AM J PHYSIOL-CELL PH, V273, pC1378, DOI 10.1152/ajpcell.1997.273.4.C1378; Waki H, 2005, ENDOCRINOLOGY, V146, P790, DOI 10.1210/en.2004-1096; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Yamauchi T, 2008, INT J OBESITY, V32, pS13, DOI 10.1038/ijo.2008.233; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Zhang L, 2006, P NATL ACAD SCI USA, V103, P17272, DOI 10.1073/pnas.0608531103; Zheng B, 2007, P NATL ACAD SCI USA, V104, P819, DOI 10.1073/pnas.0610157104; Zhou YH, 2005, GENE EXPR PATTERNS, V5, P711, DOI 10.1016/j.modgep.2005.02.002	50	21	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63878	10.1371/journal.pone.0063878	http://dx.doi.org/10.1371/journal.pone.0063878			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667684	gold, Green Published, Green Submitted			2022-12-25	WOS:000319654700193
J	Giannini, C; Kloss, A; Gohlke, S; Mishto, M; Nicholson, TP; Sheppard, PW; Kloetzel, PM; Dahlmann, B				Giannini, Carolin; Kloss, Alexander; Gohlke, Sabrina; Mishto, Michele; Nicholson, Thomas P.; Sheppard, Paul W.; Kloetzel, Peter-Michael; Dahlmann, Burkhardt			Poly-Ub-Substrate-Degradative Activity of 26S Proteasome Is Not Impaired in the Aging Rat Brain	PLOS ONE			English	Article							OXIDATIVE STRESS; 20S PROTEASOME; PROTEOLYTIC ACTIVITY; TISSUE DISTRIBUTION; INTERFERON-GAMMA; SKELETAL-MUSCLE; IMMUNOPROTEASOME; PROTEINS; AGE; DISEASES	Proteostasis is critical for the maintenance of life. In neuronal cells an imbalance between protein synthesis and degradation is thought to be involved in the pathogenesis of neurodegenerative diseases during aging. Partly, this seems to be due to a decrease in the activity of the ubiquitin-proteasome system, wherein the 20S/26S proteasome complexes catalyse the proteolytic step. We have characterised 20S and 26S proteasomes from cerebrum, cerebellum and hippocampus of 3 weeks old (young) and 24 month old (aged) rats. Our data reveal that the absolute amount of the proteasome is not dfferent between both age groups. Within the majority of standard proteasomes in brain the minute amounts of immuno-subunits are slightly increased in aged rat brain. While this goes along with a decrease in the activities of 20S and 26S proteasomes to hydrolyse synthetic fluorogenic tripeptide substrates from young to aged rats, the capacity of 26S proteasomes for degradation of poly-Ub-model substrates and its activation by poly-Ub-substrates is not impaired or even slightly increased in brain of aged rats. We conclude that these alterations in proteasome properties are important for maintaining proteostasis in the brain during an uncomplicated aging process.	[Giannini, Carolin; Kloss, Alexander; Gohlke, Sabrina; Mishto, Michele; Kloetzel, Peter-Michael; Dahlmann, Burkhardt] Charite, Inst Biochem, D-13353 Berlin, Germany; [Nicholson, Thomas P.; Sheppard, Paul W.] Enzo Life Sci UK Ltd, Exeter, Devon, England	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Dahlmann, B (corresponding author), Charite, Inst Biochem, D-13353 Berlin, Germany.	burkhardt.dahlmann@charite.de	mishto, michele/A-5592-2010	mishto, michele/0000-0003-3042-2792	Sonnenfeld-Stiftung, Berlin; Berliner Krebsgesellschaft [KOFF201102]; excellence cluster NeuroCure; Deutsche Forschunsgemeinschaft [SFB TRR 34]; EU [LSHC-CT-2005-018683]	Sonnenfeld-Stiftung, Berlin; Berliner Krebsgesellschaft; excellence cluster NeuroCure; Deutsche Forschunsgemeinschaft(German Research Foundation (DFG)); EU(European Commission)	C.G. was supported by a PhD studentship from the Sonnenfeld-Stiftung, Berlin. M. M. was supported by Berliner Krebsgesellschaft (KOFF201102). P.-M.K. was supported by the excellence cluster NeuroCure and the Deutsche Forschunsgemeinschaft (SFB TRR 34). P.W.S. and T.P.N. were supported by the EU Network of Excellence 'Role of ubiquitin and ubiquitin-like modifiers in cellular recognition (RUBICON)' Project number LSHC-CT-2005-018683. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Akaishi T, 1996, BIOCHEM MOL BIOL INT, V39, P1017; AZARYAN A, 1989, NEUROCHEM RES, V14, P995, DOI 10.1007/BF00965934; Bech-Otschir D, 2009, NAT STRUCT MOL BIOL, V16, P219, DOI 10.1038/nsmb.1547; Bedford L, 2010, TRENDS CELL BIOL, V20, P391, DOI 10.1016/j.tcb.2010.03.007; Bellavista E, 2013, CURR PHARM DESIGN, V19, P702, DOI 10.2174/138161213804581927; Chondrogianni N, 2005, EXP GERONTOL, V40, P931, DOI 10.1016/j.exger.2005.09.004; Cook C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005888; Cooper HJ, 2004, ANAL CHEM, V76, P6982, DOI 10.1021/ac0401063; DAHLMANN B, 1995, BIOCHEM J, V309, P195, DOI 10.1042/bj3090195; Dahlmann B, 2000, J MOL BIOL, V303, P643, DOI 10.1006/jmbi.2000.4185; Dasuri K, 2009, MECH AGEING DEV, V130, P777, DOI 10.1016/j.mad.2009.10.003; Ding QX, 2006, ANTIOXID REDOX SIGN, V8, P163, DOI 10.1089/ars.2006.8.163; Dudek EJ, 2005, FASEB J, V19, P1707, DOI 10.1096/fj.05-4049fje; El Mohsen MMA, 2005, BIOCHEM BIOPH RES CO, V336, P386, DOI 10.1016/j.bbrc.2005.07.201; Ferrington DA, 2005, FASEB J, V19, P664, DOI 10.1096/fj.04-2578fje; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Gallastegui N, 2010, TRENDS BIOCHEM SCI, V35, P634, DOI 10.1016/j.tibs.2010.05.005; Gavilan MP, 2009, J NEUROCHEM, V108, P260, DOI 10.1111/j.1471-4159.2008.05762.x; Gillardon F, 2007, J NEUROCHEM, V101, P1483, DOI 10.1111/j.1471-4159.2006.04438.x; Huber EM, 2012, CELL, V148, P727, DOI 10.1016/j.cell.2011.12.030; KAMAKURA K, 1988, J NEUROSCI RES, V20, P473, DOI 10.1002/jnr.490200410; Keller JN, 2000, NEUROSCIENCE, V98, P149, DOI 10.1016/S0306-4522(00)00067-1; Keller JN, 2000, MECH AGEING DEV, V113, P61, DOI 10.1016/S0047-6374(99)00101-3; Kimura Y, 2000, J BIOL CHEM, V275, P4635, DOI 10.1074/jbc.275.7.4635; Kremer M, 2010, J IMMUNOL, V185, P5549, DOI 10.4049/jimmunol.1001517; KUEHN L, 1986, Ciencia Biologica Molecular and Cellular Biology, V11, P107; Li XH, 2009, BIOCHEM J, V421, P397, DOI 10.1042/BJ20090528; Martinez-Vicente M, 2005, EXP GERONTOL, V40, P622, DOI 10.1016/j.exger.2005.07.005; Medicherla B, 2008, J CELL BIOL, V182, P663, DOI 10.1083/jcb.200803022; Mishto M, 2006, NEUROBIOL AGING, V27, P54, DOI 10.1016/j.neurobiolaging.2004.12.004; Mishto M, 2010, BIOCHEM RES TRENDS, P225; Mishto M, 2011, BIOCHEM BIOPH RES CO, V408, P65, DOI 10.1016/j.bbrc.2011.03.117; Mouton PR, 2002, BRAIN RES, V956, P30, DOI 10.1016/S0006-8993(02)03475-3; Noda C, 2000, BIOCHEM BIOPH RES CO, V277, P348, DOI 10.1006/bbrc.2000.3676; Opitz E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002233; Piccinini M, 2000, MOL BRAIN RES, V76, P103, DOI 10.1016/S0169-328X(99)00337-X; Piccinini M, 2003, J NEUROIMMUNOL, V135, P135, DOI 10.1016/S0165-5728(02)00439-3; Pintado C, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-87; Ponnappan S, 2013, MECH AGEING DEV; Rechsteiner M, 2005, TRENDS CELL BIOL, V15, P27, DOI 10.1016/j.tcb.2004.11.003; Rodriguez KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035890; Schmidt F, 2006, PROTEOMICS, V6, P4622, DOI 10.1002/pmic.200500920; Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036; Shringarpure R, 2003, J BIOL CHEM, V278, P311, DOI 10.1074/jbc.M206279200; Stohwasser R, 2000, GLIA, V29, P355, DOI 10.1002/(SICI)1098-1136(20000215)29:4<355::AID-GLIA6>3.0.CO;2-4; Tai H. C., 2010, FRONT MOL NEUROSCI, V3, P1; TANAKA K, 1986, J BIOL CHEM, V261, P5197; Tonoki A, 2009, MOL CELL BIOL, V29, P1095, DOI 10.1128/MCB.01227-08; Vernace VA, 2007, FASEB J, V21, P2672, DOI 10.1096/fj.06-6751com; Vigouroux S, 2003, J NEUROCHEM, V84, P392, DOI 10.1046/j.1471-4159.2003.01534.x; WEEKE B, 1973, SCAND J IMMUNOL, V2, P37, DOI 10.1111/j.1365-3083.1973.tb03777.x; Wehren A, 1996, BIOL CHEM, V377, P497; Zeng BY, 2005, MECH AGEING DEV, V126, P760, DOI 10.1016/j.mad.2005.01.008	54	22	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e64042	10.1371/journal.pone.0064042	http://dx.doi.org/10.1371/journal.pone.0064042			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667697	Green Submitted, gold, Green Published			2022-12-25	WOS:000319654700200
J	Gramatzki, D; Herrmann, C; Happold, C; Becker, KA; Gulbins, E; Weller, M; Tabatabai, G				Gramatzki, Dorothee; Herrmann, Caroline; Happold, Caroline; Becker, Katrin Anne; Gulbins, Erich; Weller, Michael; Tabatabai, Ghazaleh			Glioma Cell Death Induced by Irradiation or Alkylating Agent Chemotherapy Is Independent of the Intrinsic Ceramide Pathway	PLOS ONE			English	Article							RADIATION-INDUCED APOPTOSIS; CENTRAL-NERVOUS-SYSTEM; HUMAN COLON-CANCER; GLUCOSYLCERAMIDE SYNTHASE; ACID SPHINGOMYELINASE; ADJUVANT TEMOZOLOMIDE; MULTIDRUG-RESISTANCE; GLIOBLASTOMA CELLS; BREAST-CARCINOMA; MALIGNANT GLIOMA	Background/Aims: Resistance to genotoxic therapy is a characteristic feature of glioma cells. Acid sphingomyelinase (ASM) hydrolyzes sphingomyelin to ceramide and glucosylceramide synthase (GCS) catalyzes ceramide metabolism. Increased ceramide levels have been suggested to enhance chemotherapy-induced death of cancer cells. Methods: Microarray and clinical data for ASM and GCS in astrocytomas WHO grade II-IV were acquired from the Rembrandt database. Moreover, the glioblastoma database of the Cancer Genome Atlas network (TCGA) was used for survival data of glioblastoma patients. For in vitro studies, increases in ceramide levels were achieved either by ASM overexpression or by the GCS inhibitor DL-threo-1-phenyl-2-palmitoylamino-3-morpholino-1-propanol (PPMP) in human glioma cell lines. Combinations of alkylating chemotherapy or irradiation and ASM overexpression, PPMP or exogenous ceramide were applied in parental cells. The anti-glioma effects were investigated by assessing proliferation, metabolic activity, viability and clonogenicity. Finally, viability and clonogenicity were assessed in temozolomide (TMZ)-resistant cells upon treatment with PPMP, exogenous ceramide, alkylating chemotherapy, irradiation or their combinations. Results: Interrogations from the Rembrandt and TCGA database showed a better survival of glioblastoma patients with low expression of ASM or GCS. ASM overexpression or PPMP treatment alone led to ceramide accumulation but did not enhance the anti-glioma activity of alkylating chemotherapy or irradiation. PPMP or exogenous ceramide induced acute cytotoxicity in glioblastoma cells. Combined treatments with chemotherapy or irradiation led to additive, but not synergistic effects. Finally, no synergy was found when TMZ-resistant cells were treated with exogenous ceramide or PPMP alone or in combination with TMZ or irradiation. Conclusion: Modulation of intrinsic glioma cell ceramide levels by ASM overexpression or GCS inhibition does not enhance the anti-glioma activity of alkylating chemotherapy or irradiation.	[Gramatzki, Dorothee; Happold, Caroline; Weller, Michael; Tabatabai, Ghazaleh] Univ Zurich Hosp, Dept Neurol, Lab Mol Neurooncol, CH-8091 Zurich, Switzerland; [Herrmann, Caroline] Univ Hosp Tuebingen, Dept Preclin Imaging & Radiopharm, Tubingen, Germany; [Becker, Katrin Anne; Gulbins, Erich] Univ Duisburg Essen, Dept Mol Biol, Essen, Germany; [Weller, Michael; Tabatabai, Ghazaleh] Univ Zurich, Neurosci Ctr Zurich, Zurich, Switzerland; [Weller, Michael; Tabatabai, Ghazaleh] Swiss Fed Inst Technol, Zurich, Switzerland	University of Zurich; University Zurich Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Duisburg Essen; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Tabatabai, G (corresponding author), Univ Zurich Hosp, Dept Neurol, Lab Mol Neurooncol, CH-8091 Zurich, Switzerland.	ghazaleh.tabatabai@usz.ch	Gulbins, Erich/L-6989-2014; Tabatabai, Ghazaleh/A-6365-2015	Gulbins, Erich/0000-0002-3117-1342; Tabatabai, Ghazaleh/0000-0003-3702-923X; Tabatabai, Ghazaleh/0000-0002-3542-8782; Weller, Michael/0000-0002-1748-174X	German Research Council (DFG) [SFB773]; NCCR Neural Plasticity and Repair	German Research Council (DFG)(German Research Foundation (DFG)); NCCR Neural Plasticity and Repair(Swiss National Science Foundation (SNSF))	This study was funded by the German Research Council (DFG, SFB773) and by the NCCR Neural Plasticity and Repair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu S, 2004, GLYCOCONJUGATE J, V20, P563; Becker KA, 2010, AM J RESP CELL MOL, V42, P716, DOI 10.1165/rcmb.2009-0174OC; Boyle PJ, 2006, GLYCOCONJUGATE J, V23, P175, DOI 10.1007/s10719-006-7923-5; Brada M, 2010, J CLIN ONCOL, V28, P4601, DOI 10.1200/JCO.2009.27.1932; Brenner B, 1998, CELL DEATH DIFFER, V5, P29, DOI 10.1038/sj.cdd.4400307; Chatterjee M, 2001, MOL CARCINOGEN, V30, P47, DOI 10.1002/1098-2744(200101)30:1<47::AID-MC1012>3.0.CO;2-3; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; CIFONE MG, 1994, J EXP MED, V180, P1547, DOI 10.1084/jem.180.4.1547; Demaison C, 2002, HUM GENE THER, V13, P803, DOI 10.1089/10430340252898984; Dumitru CA, 2009, J CELL PHYSIOL, V221, P688, DOI 10.1002/jcp.21907; Eberhardt O, 2000, J NEUROSCI, V20, P9126; FERLINZ K, 1994, BIOCHEM J, V301, P855, DOI 10.1042/bj3010855; Garcia-Barros M, 2004, CANCER RES, V64, P8285, DOI 10.1158/0008-5472.CAN-04-2715; Giussani P, 2012, CANCER INVEST, V30, P27, DOI 10.3109/07357907.2011.629379; Gloeckner H, 2001, J IMMUNOL METHODS, V252, P131, DOI 10.1016/S0022-1759(01)00347-7; Gouaze V, 2004, MOL CANCER THER, V3, P633; Grammatikos G, 2007, ANTIOXID REDOX SIGN, V9, P1449, DOI 10.1089/ars.2007.1673; Grassme H, 2007, PROG LIPID RES, V46, P161, DOI 10.1016/j.plipres.2007.03.002; GRECO WR, 1995, PHARMACOL REV, V47, P331; Gulbins E, 2002, BBA-MOL CELL BIOL L, V1585, P139, DOI 10.1016/S1388-1981(02)00334-7; GULBINS E, 1995, IMMUNITY, V2, P341, DOI 10.1016/1074-7613(95)90142-6; Happold C, 2012, J NEUROCHEM, V122, P444, DOI 10.1111/j.1471-4159.2012.07781.x; Hara S, 2004, CELL DEATH DIFFER, V11, P853, DOI 10.1038/sj.cdd.4401428; Hermisson M, 2006, J NEUROCHEM, V96, P766, DOI 10.1111/j.1471-4159.2005.03583.x; Hsiao LL, 2001, PHYSIOL GENOMICS, V7, P97, DOI 10.1152/physiolgenomics.00040.2001; Johnson DR, 2012, CANCER-AM CANCER SOC, V118, P5608, DOI 10.1002/cncr.27590; Lacour S, 2004, CANCER RES, V64, P3593, DOI 10.1158/0008-5472.CAN-03-2787; Liu YY, 2011, INT J ONCOL, V39, P425, DOI 10.3892/ijo.2011.1052; Liu YY, 1999, J BIOL CHEM, V274, P1140, DOI 10.1074/jbc.274.2.1140; Liu YY, 2001, FASEB J, V15, P719, DOI 10.1096/fj.00-0223com; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lovat PE, 2004, JNCI-J NATL CANCER I, V96, P1288, DOI 10.1093/jnci/djh254; Madhavan S, 2009, MOL CANCER RES, V7, P157, DOI 10.1158/1541-7786.MCR-08-0435; Maurer BJ, 2000, JNCI-J NATL CANCER I, V92, P1897, DOI 10.1093/jnci/92.23.1897; Maurer BJ, 1999, JNCI-J NATL CANCER I, V91, P1138, DOI 10.1093/jnci/91.13.1138; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Pena LA, 2000, CANCER RES, V60, P321; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Preusser M, 2011, ANN NEUROL, V70, P9, DOI 10.1002/ana.22425; Prinetti A, 2006, BIOCHEM J, V395, P311, DOI 10.1042/BJ20051184; Riboni L, 2002, GLIA, V39, P105, DOI 10.1002/glia.10087; Roth W, 2000, BRAIN PATHOL, V10, P223, DOI 10.1111/j.1750-3639.2000.tb00256.x; Rylova SN, 1998, BIOCHEMISTRY-MOSCOW+, V63, P1057; Sanchenkov A, 2001, JNCI-J NATL CANCER I, V93, P347, DOI 10.1093/jnci/93.5.347; Santana P, 1996, CELL, V86, P189, DOI 10.1016/S0092-8674(00)80091-4; SCHUTZE S, 1992, CELL, V71, P765, DOI 10.1016/0092-8674(92)90553-O; Selzner M, 2001, CANCER RES, V61, P1233; Shayman JA, 2000, METHOD ENZYMOL, V311, P373; Smith EL, 2008, FASEB J, V22, P3419, DOI 10.1096/fj.08-108043; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Tabatabai G, 2007, ANN NEUROL, V61, P153, DOI 10.1002/ana.21057; Tabatabai G, 2010, INT J ONCOL, V36, P1409, DOI 10.3892/ijo_00000626; Tepper AD, 2000, J BIOL CHEM, V275, P34810, DOI 10.1074/jbc.M005142200; van den Bent MJ, 2009, J CLIN ONCOL, V27, P1268, DOI 10.1200/JCO.2008.17.5984; Veldman RJ, 2003, FASEB J, V17, P1144, DOI 10.1096/fj.02-1053fje; Wagenknecht B, 2001, CELL DEATH DIFFER, V8, P595, DOI 10.1038/sj.cdd.4400848; Weller M, 2013, NEURO-ONCOLOGY, V15, P4, DOI 10.1093/neuonc/nos273; Wick A, 2004, J NEUROCHEM, V91, P1067, DOI 10.1111/j.1471-4159.2004.02774.x; Xie P, 2008, LEUKEMIA RES, V32, P475, DOI 10.1016/j.leukres.2007.07.006	60	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63527	10.1371/journal.pone.0063527	http://dx.doi.org/10.1371/journal.pone.0063527			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667632	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000319654700156
J	Khoury, DS; Barron, AB; Myerscough, MR				Khoury, David S.; Barron, Andrew B.; Myerscough, Mary R.			Modelling Food and Population Dynamics in Honey Bee Colonies	PLOS ONE			English	Article							DIVISION-OF-LABOR; BEHAVIORAL MATURATION; SURVIVAL; TEMPERATURE; NUTRITION; WORK	Honey bees (Apis mellifera) are increasingly in demand as pollinators for various key agricultural food crops, but globally honey bee populations are in decline, and honey bee colony failure rates have increased. This scenario highlights a need to understand the conditions in which colonies flourish and in which colonies fail. To aid this investigation we present a compartment model of bee population dynamics to explore how food availability and bee death rates interact to determine colony growth and development. Our model uses simple differential equations to represent the transitions of eggs laid by the queen to brood, then hive bees and finally forager bees, and the process of social inhibition that regulates the rate at which hive bees begin to forage. We assume that food availability can influence both the number of brood successfully reared to adulthood and the rate at which bees transition from hive duties to foraging. The model predicts complex interactions between food availability and forager death rates in shaping colony fate. Low death rates and high food availability results in stable bee populations at equilibrium (with population size strongly determined by forager death rate) but consistently increasing food reserves. At higher death rates food stores in a colony settle at a finite equilibrium reflecting the balance of food collection and food use. When forager death rates exceed a critical threshold the colony fails but residual food remains. Our model presents a simple mathematical framework for exploring the interactions of food and forager mortality on colony fate, and provides the mathematical basis for more involved simulation models of hive performance.	[Khoury, David S.; Myerscough, Mary R.] Univ Sydney, Sch Math & Stat, Sydney, NSW 2006, Australia; [Barron, Andrew B.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; [Myerscough, Mary R.] Univ Sydney, Ctr Math Biol, Sydney, NSW 2006, Australia	University of Sydney; Macquarie University; University of Sydney	Myerscough, MR (corresponding author), Univ Sydney, Sch Math & Stat, Sydney, NSW 2006, Australia.	mary.myerscough@sydney.edu.au	Khoury, David/AAD-8772-2020	Khoury, David/0000-0002-2663-1551; Barron, Andrew/0000-0002-8135-6628; Myerscough, Mary/0000-0002-4993-765X	Hermon Slade Foundation grant	Hermon Slade Foundation grant	This work was supported by a Hermon Slade Foundation grant to ABB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becher MA, 2010, ECOL MODEL, V221, P769, DOI 10.1016/j.ecolmodel.2009.11.016; Beshers SN, 2001, ANNU REV ENTOMOL, V46, P413, DOI 10.1146/annurev.ento.46.1.413; Blaschon B, 1999, ENTOMOL GEN, V24, P49; Brodschneider R, 2010, APIDOLOGIE, V41, P278, DOI 10.1051/apido/2010012; DEGRANDIHOFFMAN G, 1989, ECOL MODEL, V45, P133, DOI 10.1016/0304-3800(89)90088-4; Fahrbach SE, 1996, DEV NEUROSCI-BASEL, V18, P102, DOI 10.1159/000111474; FRANKS NR, 1994, ANIM BEHAV, V48, P470, DOI 10.1006/anbe.1994.1261; HARBO JR, 1993, J APICULT RES, V32, P11, DOI 10.1080/00218839.1993.11101282; HARBO JR, 1986, J APICULT RES, V25, P22, DOI 10.1080/00218839.1986.11100687; Huang ZY, 1999, INFORMATION PROCESSING IN SOCIAL INSECTS, P165; Huang ZY, 1996, BEHAV ECOL SOCIOBIOL, V39, P147, DOI 10.1007/s002650050276; Jones JC, 2005, J COMP PHYSIOL A, V191, P1121, DOI 10.1007/s00359-005-0035-z; Kearns C. A., 1993, TECHNIQUES POLLINATI; Khoury DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018491; Leoncini I, 2004, P NATL ACAD SCI USA, V101, P17559, DOI 10.1073/pnas.0407652101; Lindauer M., 1971, COMMUNICATION SOCIAL, DOI 10.4159/harvard.9780674424531; MAKELA ME, 1993, ECOL MODEL, V67, P259, DOI 10.1016/0304-3800(93)90009-H; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Oldroyd BP, 2007, PLOS BIOL, V5, P1195, DOI 10.1371/journal.pbio.0050168; ROBINSON GE, 1992, ETHOLOGY, V90, P336, DOI 10.1111/j.1439-0310.1992.tb00844.x; Robson SK, 1997, ANIM BEHAV, V53, P214, DOI 10.1006/anbe.1996.0290; Rosenkranz P., 2008, REPORT LANDESANSTALT; Russell R, 2013, ECOLOGICAL IN PRESS; Schmickl T, 2002, BEHAV ECOL SOCIOBIOL, V51, P415, DOI 10.1007/s00265-002-0457-3; Schmickl T, 2001, J COMP PHYSIOL A, V187, P541, DOI 10.1007/s003590100226; Schmickl T, 2007, ECOL MODEL, V204, P219, DOI 10.1016/j.ecolmodel.2007.01.001; Schulz DJ, 1998, BEHAV ECOL SOCIOBIOL, V42, P295, DOI 10.1007/s002650050442; Seeley T., 1995, WISDOM HIVE; Toth AL, 2005, ANIM BEHAV, V69, P427, DOI 10.1016/j.anbehav.2004.03.017; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Watanabe ME, 2008, BIOSCIENCE, V58, P384, DOI 10.1641/B580503	31	99	100	6	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e59084	10.1371/journal.pone.0059084	http://dx.doi.org/10.1371/journal.pone.0059084			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667418	gold, Green Published, Green Submitted			2022-12-25	WOS:000319654700002
J	Komeilipoor, N; Pizzolato, F; Daffertshofer, A; Cesari, P				Komeilipoor, Naeem; Pizzolato, Fabio; Daffertshofer, Andreas; Cesari, Paola			Excitability of Motor Cortices as a Function of Emotional Sounds	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; SELF-INDUCED SADNESS; HEMISPHERIC-ASYMMETRY; AUTOMATIC EVALUATION; CORTEX EXCITABILITY; BRAIN ACTIVITY; EAR ASYMMETRY; BLOOD-FLOW; PERCEPTION; LATERALIZATION	We used transcranial magnetic stimulation (TMS) to clarify how non-verbal emotionally-characterized sounds modulate the excitability of the corticospinal motor tract (CST). While subjects were listening to sounds (monaurally and binaurally), single TMS pulses were delivered to either left or right primary motor cortex (M1), and electromyographic activities were recorded from the contralateral abductor pollicis brevis muscle. We found a significant increase in CST excitability in response to unpleasant as compared to neutral sounds. The increased excitability was lateralized as a function of stimulus valence: Unpleasant stimuli resulted in a significantly higher facilitation of motor potentials evoked in the left hemisphere, while pleasant stimuli yielded a greater CST excitability in the right one. Furthermore, TMS induced higher motor evoked potentials when listening to unpleasant sounds with the left than with the right ear. Taken together, our findings provide compelling evidence for an asymmetric modulation of CST excitability as a function of emotional sounds along with ear laterality.	[Komeilipoor, Naeem; Pizzolato, Fabio; Cesari, Paola] Univ Verona, Dept Neurol Neuropsychol Morphol & Movement Sci, I-37100 Verona, Italy; [Komeilipoor, Naeem; Daffertshofer, Andreas] Univ Amsterdam, Vrije Univ, MOVE Res Inst, Amsterdam, Netherlands	University of Verona; University of Amsterdam; Vrije Universiteit Amsterdam	Cesari, P (corresponding author), Univ Verona, Dept Neurol Neuropsychol Morphol & Movement Sci, I-37100 Verona, Italy.	paola.cesari@univr.it		Cesari, Paola/0000-0002-1705-6065; Daffertshofer, Andreas/0000-0001-9107-3552	Netherlands Organisation for Scientific Research (NWO) [400-08-127]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	AD received financial support from the Netherlands Organisation for Scientific Research (NWO grant #400-08-127).	Adolphs R, 2000, J NEUROSCI, V20, P2683; Adolphs R, 1996, J NEUROSCI, V16, P7678; Adolphs R, 2001, J COGNITIVE NEUROSCI, V13, P232, DOI 10.1162/089892901564289; AHERN GL, 1985, NEUROPSYCHOLOGIA, V23, P745, DOI 10.1016/0028-3932(85)90081-8; Amunts K, 1996, NEUROIMAGE, V4, P216, DOI 10.1006/nimg.1996.0073; Baumert A, 2011, COGN AFFECT BEHAV NE, V11, P404, DOI 10.3758/s13415-011-0044-z; Baumgartner T, 2007, NEUROREPORT, V18, P261, DOI 10.1097/WNR.0b013e328012272e; BEST CT, 1994, J EXP PSYCHOL HUMAN, V20, P751, DOI 10.1037/0096-1523.20.4.751; Bloom JS, 2005, NEUROPSYCHOL REV, V15, P59, DOI 10.1007/s11065-005-6252-y; BOROD JC, 1992, J CONSULT CLIN PSYCH, V60, P339, DOI 10.1037/0022-006X.60.3.339; Borod JC, 1998, NEUROPSYCHOLOGY, V12, P446, DOI 10.1037/0894-4105.12.3.446; BOWERS D, 1985, BRAIN COGNITION, V4, P258, DOI 10.1016/0278-2626(85)90020-X; Bradley MM, 1999, INT AFFECTIVE DIGITI; BRYDEN MP, 1963, J EXP PSYCHOL, V65, P103, DOI 10.1037/h0042773; BUCK R, 1980, CORTEX, V16, P351, DOI 10.1016/S0010-9452(80)80037-2; CARMON A, 1973, ACTA PSYCHOL, V37, P351, DOI 10.1016/0001-6918(73)90002-4; Chen M, 1999, PERS SOC PSYCHOL B, V25, P215, DOI 10.1177/0146167299025002007; Coelho CM, 2010, NEUROSCI LETT, V481, P135, DOI 10.1016/j.neulet.2010.03.027; Coombes SA, 2006, NEUROSCI LETT, V396, P192, DOI 10.1016/j.neulet.2005.11.048; Coombes SA, 2005, J MOTOR BEHAV, V37, P425, DOI 10.3200/JMBR.37.6.425-436; Coombes SA, 2007, EMOTION, V7, P275, DOI 10.1037/1528-3542.7.2.275; Coombes SA, 2009, COGN AFFECT BEHAV NE, V9, P380, DOI 10.3758/CABN.9.4.380; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Darwin C., 2002, EXPRESSION EMOTIONS; DAVIDSON RJ, 1982, SCIENCE, V218, P1235, DOI 10.1126/science.7146906; DAVIDSON RJ, 1990, J PERS SOC PSYCHOL, V58, P330, DOI 10.1037/0022-3514.58.2.330; de Gelder B, 2004, P NATL ACAD SCI USA, V101, P16701, DOI 10.1073/pnas.0407042101; Duckworth KL, 2002, PSYCHOL SCI, V13, P513, DOI 10.1111/1467-9280.00490; EKMAN P, 1993, PSYCHOL SCI, V4, P342, DOI 10.1111/j.1467-9280.1993.tb00576.x; Facchinetti LD, 2006, NEUROSCI LETT, V410, P52, DOI 10.1016/j.neulet.2006.09.063; Frijda NH, 1987, STUDIES EMOTION SOCI; Gagnon L, 2000, BRAIN COGNITION, V43, P206; Gainotti G, 2012, NEUROPSYCHOLOGIA, V50, P205, DOI 10.1016/j.neuropsychologia.2011.12.005; George MS, 1996, BIOL PSYCHIAT, V40, P859, DOI 10.1016/0006-3223(95)00572-2; GORELICK PB, 1987, J NEUROL NEUROSUR PS, V50, P553, DOI 10.1136/jnnp.50.5.553; Goycoolea M, 2005, ACTA OTO-LARYNGOL, V125, P513, DOI 10.1080/00016480510026250; Grezes J, 2007, NEUROIMAGE, V35, P959, DOI 10.1016/j.neuroimage.2006.11.030; HAGGARD MP, 1971, Q J EXP PSYCHOL, V23, P168, DOI 10.1080/14640747108400237; Hajcak G, 2007, PSYCHOPHYSIOLOGY, V44, P91, DOI 10.1111/j.1469-8986.2006.00487.x; Harciarek M, 2009, J CLIN EXP NEUROPSYC, V31, P322, DOI 10.1080/13803390802119930; Hellige, 1993, PERSPECTIVES COGNITI; Hillman CH, 2004, BIOL PSYCHOL, V66, P51, DOI 10.1016/j.biopsycho.2003.07.005; HIRSCHMAN RS, 1982, CORTEX, V18, P569, DOI 10.1016/S0010-9452(82)80054-3; Huang YX, 2006, NEUROSCI LETT, V398, P91, DOI 10.1016/j.neulet.2005.12.074; KALLMAN HJ, 1977, NEUROPSYCHOLOGIA, V15, P833, DOI 10.1016/0028-3932(77)90017-3; KALLMAN HJ, 1975, PERCEPT PSYCHOPHYS, V17, P368, DOI 10.3758/BF03199348; Ketter TA, 1996, ARCH GEN PSYCHIAT, V53, P59; KIMURA D, 1961, CAN J PSYCHOLOGY, V15, P166, DOI 10.1037/h0083219; Kimura D., 1967, CORTEX, V3, P163, DOI DOI 10.1016/S0010-9452(67)80010-8; KING FL, 1972, CAN J PSYCHOLOGY, V26, P111, DOI 10.1037/h0082420; KOIKE KJ, 1994, OTOLARYNG HEAD NECK, V111, P625, DOI 10.1016/S0194-5998(94)70531-3; Lane RD, 1997, AM J PSYCHIAT, V154, P926; Lane RD, 1997, NEUROPSYCHOLOGIA, V35, P1437, DOI 10.1016/S0028-3932(97)00070-5; Lee Gregory P, 2004, Cogn Behav Neurol, V17, P9, DOI 10.1097/00146965-200403000-00002; Ley R G, 1982, Brain Cogn, V1, P3, DOI 10.1016/0278-2626(82)90002-1; Lezak M.D., 2012, NEUROPSYCHOLOGICAL A; MAHONEY AM, 1987, BRAIN COGNITION, V6, P216, DOI 10.1016/0278-2626(87)90122-9; Mandal MK, 1999, J NERV MENT DIS, V187, P603, DOI 10.1097/00005053-199910000-00003; Mills C.K., 1912, T COLLEGE PHYSICIANS, V34, P381; Onal-Hartmann C, 2012, PSYCHOL RES-PSYCH FO, V76, P311, DOI 10.1007/s00426-011-0337-4; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oliveri M, 2003, EXP BRAIN RES, V149, P214, DOI 10.1007/s00221-002-1346-8; PANTEV C, 1986, AUDIOLOGY, V25, P54; PARTIOT A, 1995, NEUROREPORT, V6, P1397, DOI 10.1097/00001756-199507100-00009; REITE M, 1981, ELECTROEN CLIN NEURO, V51, P388, DOI 10.1016/0013-4694(81)90102-4; REUTERLORENZ P, 1981, NEUROPSYCHOLOGIA, V19, P609, DOI 10.1016/0028-3932(81)90030-0; Rodway P, 2007, BRAIN COGNITION, V63, P31, DOI 10.1016/j.bandc.2006.07.008; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Rotteveel M, 2004, EMOTION, V4, P156, DOI 10.1037/1528-3542.4.2.156; SACKEIM HA, 1982, ARCH NEUROL-CHICAGO, V39, P210, DOI 10.1001/archneur.1982.00510160016003; SAFER MA, 1977, J EXP PSYCHOL HUMAN, V3, P75, DOI 10.1037/0096-1523.3.1.75; Scheffler K, 1998, CEREB CORTEX, V8, P156, DOI 10.1093/cercor/8.2.156; Schneider F, 1995, PSYCHIAT RES-NEUROIM, V61, P265, DOI 10.1016/0925-4927(95)02678-Q; Schutter DJLG, 2008, PSYCHOPHYSIOLOGY, V45, P345, DOI 10.1111/j.1469-8986.2007.00635.x; SILBERMAN EK, 1986, BRAIN COGNITION, V5, P322, DOI 10.1016/0278-2626(86)90035-7; Stach B, 2008, CLIN AUDIOLOGY INTRO; Stins JF, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-83; Tormos JM, 1997, NEUROLOGY, V49, P487, DOI 10.1212/WNL.49.2.487; van Loon AM, 2010, COGN AFFECT BEHAV NE, V10, P174, DOI 10.3758/CABN.10.2.174; Voyer D, 2009, NEUROPSYCHOLOGIA, V47, P23, DOI 10.1016/j.neuropsychologia.2008.08.022; Wager TD, 2003, NEUROIMAGE, V19, P513, DOI 10.1016/S1053-8119(03)00078-8; Waldstein SR, 2000, BIOL PSYCHOL, V55, P3, DOI 10.1016/S0301-0511(00)00065-X	82	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63060	10.1371/journal.pone.0063060	http://dx.doi.org/10.1371/journal.pone.0063060			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	154EP	23667574	Green Submitted, Green Published, gold			2022-12-25	WOS:000319654700106
J	Marano, RJ; Tickner, J; Redmond, SL				Marano, Robert J.; Tickner, Jennifer; Redmond, Sharon L.			Prolactin Expression in the Cochlea of Aged BALB/c Mice Is Gender Biased and Correlates to Loss of Bone Mineral Density and Hearing Loss	PLOS ONE			English	Article							KAPPA-B LIGAND/OSTEOPROTEGERIN; RECEPTOR ACTIVATOR; INNER-EAR; GENE; ESTROGEN; BRAIN; PROMOTER; IDENTIFICATION; SCHIZOPHRENIA; PRESBYCUSIS	Prolactin is a versatile hormone with over 300 known functions and predominantly expressed in the pituitary. However, its expression has additionally been found in a number of extrapituitary organs. Recently, we described the expression of prolactin in the inner ear of mice, where it was correlated to age. Previous research has shown prolactin to be linked to abnormal bone metabolism and hearing loss due to changes in morphology of the bony otic capsule. Here we further investigated the relationship between prolactin, hearing loss and cochlea bone metabolism. BALB/c mice were tested for hearing using ABR at 6 and 12 months of age. Bone mineral density of the cochlea was evaluated using microCT scanning. Prolactin expression was calculated using quantitative real time PCR. Expression of the key regulators of bone metabolism, osteoprotegerin and receptor activator of nuclear factor-kappaB ligand were also determined. We found that prolactin expression was exclusive to the female mice. This also correlated to a greater threshold shift in hearing for the females between 6 and 12 months of age. Analyses of the cochlea also show that the bone mineral density was lower in females compared to males. However, no gender differences in expression of osteoprotegerin or receptor activator of nuclear factor-kappaB ligand could be found. Further analysis of cochlea histological sections revealed larger ostocyte lacunae in the females. These results provide a possible mechanism for an age related hearing loss sub-type that is associated with gender and provides clues as to how this gender bias in hearing loss develops. In addition, it has the potential to lead to treatment for this specific type of hearing loss.	[Marano, Robert J.; Redmond, Sharon L.] Ear Sci Inst Australia, Subiaco, WA, Australia; [Marano, Robert J.; Redmond, Sharon L.] Univ Western Australia, Ear Sci Ctr, Sch Surg, Nedlands, WA 6009, Australia; [Tickner, Jennifer] Univ Western Australia, Sch Pathol & Lab Med, QEII Med Ctr, Nedlands, WA 6009, Australia	Ear Science Institute Australia; University of Western Australia; University of Western Australia	Marano, RJ (corresponding author), Ear Sci Inst Australia, Subiaco, WA, Australia.	rob.marano@earscience.org.au	Tickner, Jennifer/H-5965-2014; Marano, Robert/A-3552-2015	Tickner, Jennifer/0000-0002-5020-0671; Marano, Robert/0000-0001-9565-3167	Garnet Passe and Rodney Williams Memorial Foundation; Ear Science Institute Australia; HEARing Cooperative Research Centre (CRC); Australian Government's Cooperative Research Centres Program; Victorian State Government's Operational Infrastructure Support Program; Australian Government's National Health and Medical Research Council's (NHMRC) Independent Research Institutes Infrastructure Support Scheme (IRIISS); University, State and Commonwealth Governments	Garnet Passe and Rodney Williams Memorial Foundation; Ear Science Institute Australia; HEARing Cooperative Research Centre (CRC); Australian Government's Cooperative Research Centres Program(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Victorian State Government's Operational Infrastructure Support Program; Australian Government's National Health and Medical Research Council's (NHMRC) Independent Research Institutes Infrastructure Support Scheme (IRIISS)(National Health and Medical Research Council (NHMRC) of Australia); University, State and Commonwealth Governments	This work was primarily supported by the Garnet Passe and Rodney Williams Memorial Foundation Project Grant (Grant # 2008) and Fellowship Award program and the Ear Science Institute Australia. Further support was provided by the HEARing Cooperative Research Centre (CRC), established and supported under the Australian Government's Cooperative Research Centres Program; the Victorian State Government's Operational Infrastructure Support Program and the Australian Government's National Health and Medical Research Council's (NHMRC) Independent Research Institutes Infrastructure Support Scheme (IRIISS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Dr Rachel Burt, Dr Marina Carpinelli and Ms Anne Cooray from the Murdoch Children's Research Institute and the Walter and Eliza Hall Institute of Medical Research, Parkville 3052 VIC, Australia for their assistance in obtaining the ABR data. The authors also wish to acknowledge the facilities, scientific and technical assistance of the Australian Microscopy & Microanalysis Research Facility at the Centre for Microscopy, Characterisation and Analysis, The University of Western Australia, a facility funded by the University, State and Commonwealth Governments.	Abraham G, 2003, AM J PSYCHIAT, V160, P1618, DOI 10.1176/appi.ajp.160.9.1618; Adamson AD, 2008, ENDOCRINOLOGY, V149, P687, DOI 10.1210/en.2007-1066; Atkins GJ, 2012, OSTEOPOROSIS INT, V23, P2067, DOI 10.1007/s00198-012-1915-z; Ben-Jonathan N, 2008, ENDOCR REV, V29, P1, DOI 10.1210/er.2007-0017; BenJonathan N, 1996, ENDOCR REV, V17, P639, DOI 10.1210/er.17.6.639; BERWAER M, 1994, MOL ENDOCRINOL, V8, P635, DOI 10.1210/me.8.5.635; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; Brandebourg T, 2007, DIABETES OBES METAB, V9, P464, DOI 10.1111/j.1463-1326.2006.00671.x; Carpinelli MR, 2011, HEARING RES, V275, P105, DOI 10.1016/j.heares.2010.12.009; Charoenphandhu N, 2008, CAN J PHYSIOL PHARM, V86, P240, DOI [10.1139/Y08-037, 10.1139/y08-037]; Colao A, 2000, CLIN ENDOCRINOL, V52, P319, DOI 10.1046/j.1365-2265.2000.00902.x; Duan RQ, 2008, MOL CELL ENDOCRINOL, V281, P9, DOI 10.1016/j.mce.2007.10.004; Egli M, 2010, REPRODUCTION, V140, P643, DOI 10.1530/REP-10-0033; EMANUELE NV, 1992, MOL ENDOCRINOL, V6, P35, DOI 10.1210/me.6.1.35; Fetoni AR, 2011, EXP GERONTOL, V46, P413, DOI 10.1016/j.exger.2010.12.003; Freeman ME, 2000, PHYSIOL REV, V80, P1523, DOI 10.1152/physrev.2000.80.4.1523; Horiguchi K, 2007, J REPROD DEVELOP, V53, P515, DOI 10.1262/jrd.18119; Horner KC, 2007, AM J PHYSIOL-ENDOC M, V293, pE1224, DOI 10.1152/ajpendo.00279.2007; Johnson KR, 1997, HEARING RES, V114, P83, DOI 10.1016/S0378-5955(97)00155-X; Johnson KR, 2000, GENOMICS, V70, P171, DOI 10.1006/geno.2000.6377; Liu XZ, 2007, J PATHOL, V211, P188, DOI 10.1002/path.2102; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marano RJ, 2012, AGING CLIN EXP RES, V24, P603, DOI 10.3275/8590; Meaney AM, 2003, J PSYCHOPHARMACOL, V17, P455, DOI 10.1177/0269881103174011; Misra M, 2004, J CLIN PSYCHIAT, V65, P1607, DOI 10.4088/JCP.v65n1205; Nelson EG, 2006, LARYNGOSCOPE, V116, P1, DOI 10.1097/01.mlg.0000236089.44566.62; Ohlemiller KK, 2009, BRAIN RES, V1277, P70, DOI 10.1016/j.brainres.2009.02.079; Qing H, 2009, INT J ORAL SCI, V1, P59, DOI 10.4248/ijos.09019; Ramesh R, 2000, CELL TISSUE RES, V299, P371, DOI 10.1007/s004410050035; Riddle O, 1933, AM J PHYSIOL, V105, P191, DOI 10.1152/ajplegacy.1933.105.1.191; Roselli CE, 2008, NEUROENDOCRINOLOGY, V87, P206, DOI 10.1159/000114643; Seriwatanachai D, 2008, CELL BIOL INT, V32, P1126, DOI 10.1016/j.cellbi.2008.04.026; Seriwatanachai D, 2008, BONE, V42, P535, DOI 10.1016/j.bone.2007.11.008; Sharashenidze N, 2007, Georgian Med News, P14; Simonoska R, 2009, J ENDOCRINOL, V201, P397, DOI 10.1677/JOE-09-0060; Stenberg AE, 2001, HEARING RES, V157, P87, DOI 10.1016/S0378-5955(01)00280-5; Torner L, 2004, EUR J NEUROSCI, V19, P1601, DOI 10.1111/j.1460-9568.2004.03264.x; Willott JF, 1998, HEARING RES, V115, P162, DOI 10.1016/S0378-5955(97)00189-5	38	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63952	10.1371/journal.pone.0063952	http://dx.doi.org/10.1371/journal.pone.0063952			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667691	Green Published, gold, Green Submitted			2022-12-25	WOS:000319654700196
J	Peng, ZK; Liu, N; Huang, DM; Duan, CJ; Li, YJ; Tang, XW; Mei, WH; Zhu, F; Tang, FQ				Peng, Zhengke; Liu, Na; Huang, Damao; Duan, Chaojun; Li, Yuejin; Tang, Xiaowei; Mei, Wenhua; Zhu, Feng; Tang, Faqing			N,N '-Dinitrosopiperazine-Mediated Heat-Shock Protein 70-2 Expression Is Involved in Metastasis of Nasopharyngeal Carcinoma	PLOS ONE			English	Article							CERVICAL-CARCINOMA; GENE-EXPRESSION; HSP70 FAMILY; CELL GROWTH; SALTED FISH; ANTIGEN 9; CANCER; SUSCEPTIBILITY; IDENTIFICATION; CHAPERONES	N,N'-Dinitrosopiperazine (DNP) is invovled in nasopharyngeal carcinoma (NPC) development and metastasis, and it shows organ specificity to the nasopharyngeal epithelium. Herein, we demonstrate that DNP induces heat-shock protein (HSP) 70-2 expression in NPC cells (6-10B) at a non-cytotoxic concentration. DNP induced HSP70-2 expression in a dose- and time-dependent manner, but showed no effect on other HSP70 family members. Furthermore, DNP also increased HSP70-2 RNA transcription through directly binding to the hypoxia-responsive elements (HRE) and heat shock elements (HSE) located in the HSP70-2 promoter. DNP-mediated HSP70-2 expression might act through enhancing the transcription of HSP70-2 RNA. Importantly, DNP induced motility and invasion of 6-10B cells dose- and time-dependently, and DNP-mediated NPC metastasis was confirmed in nude mice, which showed high HSP70-2 expression in the metastatic tumor tissue. However, the motility and invasion of NPC cells that were stably transfected using short interfering RNA against HSP70-2 could not effectively induce DNP. These results indicate that DNP induces HSP70-2 expression through increasing HSP70-2 transcription, increases the motility and invasion of cells, and promotes NPC tumor metastasis. Therefore, DNP mediated HSP70-2 expression may be an important factor of NPC-high metastasis.	[Peng, Zhengke; Li, Yuejin; Mei, Wenhua; Tang, Faqing] Jinan Univ, Med Res Ctr, Zhuhai Hosp, Zhuhai Peoples Hosp, Zhuhai, Peoples R China; [Peng, Zhengke; Li, Yuejin; Mei, Wenhua; Tang, Faqing] Jinan Univ, Clin Lab, Zhuhai Hosp, Zhuhai Peoples Hosp, Zhuhai, Peoples R China; [Liu, Na; Huang, Damao; Duan, Chaojun; Tang, Faqing] Cent S Univ, Med Res Ctr, Xiangya Hosp, Changsha, Hunan, Peoples R China; [Liu, Na; Huang, Damao; Duan, Chaojun; Tang, Faqing] Cent S Univ, Clin Lab, Xiangya Hosp, Changsha, Hunan, Peoples R China; [Tang, Xiaowei] Cent S Univ, Changsha, Hunan, Peoples R China; [Zhu, Feng] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA	Jinan University; Jinan University; Central South University; Central South University; Central South University; University of Minnesota System	Tang, FQ (corresponding author), Jinan Univ, Med Res Ctr, Zhuhai Hosp, Zhuhai Peoples Hosp, Zhuhai, Peoples R China.	tangfaqing33@hotmail.com	LI, Yue/GRS-8071-2022		National Natural Science Foundation of China [81071718, 81000881, 30973400]; Fundamental Research Funds for the Central Universities [21611612]; Foundation of State Key Laboratory of Oncology in South China [HN2011-04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Foundation of State Key Laboratory of Oncology in South China	This work was in part supported by the National Natural Science Foundation of China (81071718,81000881 and 30973400), Fundamental Research Funds for the Central Universities (21611612), and Foundation of State Key Laboratory of Oncology in South China (HN2011-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank National Natural Science Foundation of China (81071718, 81000881 and 30973400), Fundamental Research Funds for the Central Universities (21611612), and Foundation of State Key Laboratory of Oncology in South China (HN2011-04) for support.	Al-Sarraf M, 1998, J CLIN ONCOL, V16, P1310, DOI 10.1200/JCO.1998.16.4.1310; Armstrong RW, 1998, INT J CANCER, V77, P228, DOI 10.1002/(SICI)1097-0215(19980717)77:2&lt;228::AID-IJC11&gt;3.0.CO;2-7; Attiga FA, 2000, CANCER RES, V60, P4629; BARTSCH H, 1992, PHARMACOGENETICS, V2, P272, DOI 10.1097/00008571-199212000-00005; BONNYCASTLE LLC, 1994, GENOMICS, V23, P85, DOI 10.1006/geno.1994.1462; Chen Kai, 2008, Ai Zheng, V27, P650; Chen Z C, 1991, IARC Sci Publ, P434; Chew MMS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-574; Chua DTT, 1998, INT J RADIAT ONCOL, V41, P379, DOI 10.1016/S0360-3016(98)00063-7; Daugaard M, 2005, CELL CYCLE, V4, P877, DOI 10.4161/cc.4.7.1838; Dix DJ, 1996, P NATL ACAD SCI USA, V93, P3264, DOI 10.1073/pnas.93.8.3264; Gallicchio L, 2006, INT J CANCER, V119, P1125, DOI 10.1002/ijc.21946; Garg M, 2010, CANCER-AM CANCER SOC, V116, P3785, DOI 10.1002/cncr.25218; Garg M, 2010, EUR J CANCER, V46, P207, DOI 10.1016/j.ejca.2009.10.020; Garg M, 2009, CANCER-AM CANCER SOC, V115, P2671, DOI 10.1002/cncr.24293; Henderson B E, 1978, IARC Sci Publ, P251; HUANG SC, 1985, INT J RADIAT ONCOL, V11, P1789, DOI 10.1016/0360-3016(85)90033-1; Huang WJ, 2009, INT J CANCER, V124, P298, DOI 10.1002/ijc.23906; Jalbout M, 2003, CANCER LETT, V193, P75, DOI 10.1016/S0304-3835(02)00697-3; Kang S, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-136; Kanojia D, 2009, CANCER EPIDEM BIOMAR, V18, P630, DOI 10.1158/1055-9965.EPI-08-0629; Kong QL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000940; Krone PH, 2003, SEMIN CELL DEV BIOL, V14, P267, DOI 10.1016/j.semcdb.2003.09.018; Lamitina T, 2012, VIRULENCE, V3, P238, DOI 10.4161/viru.20794; Leung TW, 2005, HEAD NECK-J SCI SPEC, V27, P555, DOI 10.1002/hed.20189; Maugeri N, 2010, HUM MOL GENET, V19, P4939, DOI 10.1093/hmg/ddq418; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Meschler JP, 1999, PHARMACOL BIOCHEM BE, V62, P473, DOI 10.1016/S0091-3057(98)00195-6; Mitani N, 2001, CANCER LETT, V165, P35, DOI 10.1016/S0304-3835(00)00710-2; Muir C, 1987, IARC SCI PUBL, V5, P1; Rohde M, 2005, GENE DEV, V19, P570, DOI 10.1101/gad.305405; ROSARIO MO, 1992, DEV BIOL, V150, P1, DOI 10.1016/0012-1606(92)90002-X; Son WY, 2000, FERTIL STERIL, V73, P1138, DOI 10.1016/S0015-0282(00)00496-9; Song HM, 2010, J PLANT PHYSIOL, V167, P1172, DOI 10.1016/j.jplph.2010.03.016; Tahara T, 2009, ANTICANCER RES, V29, P3453; Tang FQ, 2009, CANCER SCI, V100, P216, DOI 10.1111/j.1349-7006.2008.01028.x; Tang FQ, 2011, J BIOL CHEM, V286, P36956, DOI 10.1074/jbc.M111.259234; Tang FQ, 2009, J BIOL CHEM, V284, P27456, DOI 10.1074/jbc.M109.033795; Tavaria M, 1996, CELL STRESS CHAPERON, V1, P23, DOI 10.1379/1466-1268(1996)001<0023:AHSGTT>2.3.CO;2; Tian DF, 2009, J ZHEJIANG UNIV-SC B, V10, P172, DOI 10.1631/jzus.B0820186; Wadhwa R, 2002, CELL STRESS CHAPERON, V7, P309, DOI 10.1379/1466-1268(2002)007<0309:AHFCMM>2.0.CO;2; Wang YZ, 2010, CLIN CHEM LAB MED, V48, P1657, DOI 10.1515/CCLM.2010.304; Yang XY, 2005, CELL ONCOL, V27, P215; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Young P, 2008, J GEN VIROL, V89, P866, DOI 10.1099/vir.0.83414-0; YU MC, 1989, INT J CANCER, V43, P1077, DOI 10.1002/ijc.2910430621; YU MC, 1986, CANCER RES, V46, P956; Yuan JM, 2000, INT J CANCER, V85, P358, DOI 10.1002/(SICI)1097-0215(20000201)85:3&lt;358::AID-IJC11&gt;3.0.CO;2-E; Zhu DH, 1997, DEVELOPMENT, V124, P3007; Zou J, 2000, J Radiat Res, V41 Suppl, P53	50	7	7	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62908	10.1371/journal.pone.0062908	http://dx.doi.org/10.1371/journal.pone.0062908			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667540	Green Published, gold, Green Submitted			2022-12-25	WOS:000319654700079
J	Tovar, C; Arnillas, CA; Cuesta, F; Buytaert, W				Tovar, Carolina; Alberto Arnillas, Carlos; Cuesta, Francisco; Buytaert, Wouter			Diverging Responses of Tropical Andean Biomes under Future Climate Conditions	PLOS ONE			English	Article							LAND-USE CHANGE; CHANGE IMPACTS; SPECIES DISTRIBUTIONS; ICE-AGE; BIODIVERSITY; CONSERVATION; FOREST; VEGETATION; MIGRATION; PATTERNS	Observations and projections for mountain regions show a strong tendency towards upslope displacement of their biomes under future climate conditions. Because of their climatic and topographic heterogeneity, a more complex response is expected for biodiversity hotspots such as tropical mountain regions. This study analyzes potential changes in the distribution of biomes in the Tropical Andes and identifies target areas for conservation. Biome distribution models were developed using logistic regressions. These models were then coupled to an ensemble of 8 global climate models to project future distribution of the Andean biomes and their uncertainties. We analysed projected changes in extent and elevational range and identified regions most prone to change. Our results show a heterogeneous response to climate change. Although the wetter biomes exhibit an upslope displacement of both the upper and the lower boundaries as expected, most dry biomes tend to show downslope expansion. Despite important losses being projected for several biomes, projections suggest that between 74.8% and 83.1% of the current total Tropical Andes will remain stable, depending on the emission scenario and time horizon. Between 3.3% and 7.6% of the study area is projected to change, mostly towards an increase in vertical structure. For the remaining area (13.1%-17.4%), there is no agreement between model projections. These results challenge the common believe that climate change will lead to an upslope displacement of biome boundaries in mountain regions. Instead, our models project diverging responses, including downslope expansion and large areas projected to remain stable. Lastly, a significant part of the area expected to change is already affected by land use changes, which has important implications for management. This, and the inclusion of a comprehensive uncertainty analysis, will help to inform conservation strategies in the Tropical Andes, and to guide similar assessments for other tropical mountains.	[Tovar, Carolina; Alberto Arnillas, Carlos] Univ Nacl Agr La Molina, Ctr Datos Conservac, Lima, Peru; [Tovar, Carolina] Univ Oxford, Dept Zool, Biodivers Inst, Long Term Ecol Lab, Oxford OX1 3PS, England; [Cuesta, Francisco] Consorcio Desarrollo Sostenible Ecorreg Andina, Quito, Ecuador; [Buytaert, Wouter] Univ London Imperial Coll Sci Technol & Med, London, England; [Buytaert, Wouter] Univ London Imperial Coll Sci Technol & Med, Grantham Inst Climate Change, London, England	University Nacional Agraria La Molina; University of Oxford; Imperial College London; Imperial College London	Tovar, C (corresponding author), Univ Nacl Agr La Molina, Ctr Datos Conservac, Lima, Peru.	ctovar@lamolina.edu.pe	Buytaert, Wouter/AFU-2595-2022; Buytaert, Wouter/D-9912-2011; Tovar, Carolina/AAT-7070-2020	Buytaert, Wouter/0000-0001-6994-4454; Buytaert, Wouter/0000-0001-6994-4454; Tovar, Carolina/0000-0002-8256-9174; Cuesta, Francisco/0000-0002-5150-073X	World Bank; Andean Regional Program of the Spanish Agency for International Cooperation and Development	World Bank(The World Bank India); Andean Regional Program of the Spanish Agency for International Cooperation and Development	The Project was funded by the World Bank, and the Andean Regional Program of the Spanish Agency for International Cooperation and Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MB, 2011, ECOL LETT, V14, P484, DOI 10.1111/j.1461-0248.2011.01610.x; Armenteras D, 2003, BIOL CONSERV, V113, P245, DOI 10.1016/S0006-3207(02)00359-2; Bader MY, 2007, PLANT ECOL, V191, P33, DOI 10.1007/s11258-006-9212-6; Barry S, 2006, J APPL ECOL, V43, P413, DOI 10.1111/j.1365-2664.2006.01136.x; Beaumont LJ, 2011, P NATL ACAD SCI USA, V108, P2306, DOI 10.1073/pnas.1007217108; Bush MB, 2010, GLOBAL CHANGE BIOL, V16, P3223, DOI 10.1111/j.1365-2486.2010.02203.x; Bush MB, 2005, J QUATERNARY SCI, V20, P703, DOI 10.1002/jqs.983; Bush MB, 2002, GLOBAL ECOL BIOGEOGR, V11, P463, DOI 10.1046/j.1466-822X.2002.00305.x; Bush MB, 2004, SCIENCE, V303, P827, DOI 10.1126/science.1090795; Buytaert W, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR011755; Buytaert W, 2011, GLOBAL ECOL BIOGEOGR, V20, P19, DOI 10.1111/j.1466-8238.2010.00585.x; Buytaert W, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL037048; Crimmins SM, 2011, SCIENCE, V331, P324, DOI 10.1126/science.1199040; de Chazal J, 2009, GLOBAL ENVIRON CHANG, V19, P306, DOI 10.1016/j.gloenvcha.2008.09.007; Di Pasquale G, 2008, PALAEOGEOGR PALAEOCL, V259, P17, DOI 10.1016/j.palaeo.2006.12.016; Dirnbock T, 2003, J BIOGEOGR, V30, P401, DOI 10.1046/j.1365-2699.2003.00839.x; Dulhoste R, 2010, THESIS U LOS ANDES; Etter A, 2006, AGR ECOSYST ENVIRON, V114, P369, DOI 10.1016/j.agee.2005.11.013; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Feeley KJ, 2011, J BIOGEOGR, V38, P783, DOI 10.1111/j.1365-2699.2010.02444.x; Feeley KJ, 2010, GLOBAL CHANGE BIOL, V16, P3215, DOI 10.1111/j.1365-2486.2010.02197.x; Fitzpatrick MC, 2009, BIODIVERS CONSERV, V18, P2255, DOI 10.1007/s10531-009-9584-8; Gonzalez P, 2010, GLOBAL ECOL BIOGEOGR, V19, P755, DOI 10.1111/j.1466-8238.2010.00558.x; GRABHERR G, 1994, NATURE, V369, P448, DOI 10.1038/369448a0; Harrison PA, 2006, ENVIRON SCI POLICY, V9, P116, DOI 10.1016/j.envsci.2005.11.003; HESS CG, 1990, MT RES DEV, V10, P333, DOI 10.2307/3673495; Higgins PAT, 2007, GLOBAL ECOL BIOGEOGR, V16, P197, DOI 10.1111/j.1466-8238.2006.00278.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hillyer R, 2010, GLOBAL CHANGE BIOL, V16, P3205, DOI 10.1111/j.1365-2486.2010.02268.x; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Hooghiemstra H, 2004, PHILOS T ROY SOC B, V359, P173, DOI 10.1098/rstb.2003.1420; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Josse C, 2009, ECOBONA INTERCOOPERA; Jump AS, 2005, ECOL LETT, V8, P1010, DOI 10.1111/j.1461-0248.2005.00796.x; Killeen TJ, 2007, J BIOGEOGR, V34, P1357, DOI 10.1111/j.1365-2699.2006.01682.x; Kullman L, 2002, J ECOL, V90, P68, DOI 10.1046/j.0022-0477.2001.00630.x; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Lloyd AH, 2003, ECOSCIENCE, V10, P176, DOI 10.1080/11956860.2003.11682765; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Lopez RP, 2006, BIODIVERS CONSERV, V15, P2163, DOI 10.1007/s10531-004-6898-4; Malcolm JR, 2002, J BIOGEOGR, V29, P835, DOI 10.1046/j.1365-2699.2002.00702.x; Malcolm JR, 2006, CONSERV BIOL, V20, P538, DOI 10.1111/j.1523-1739.2006.00364.x; Maraun D, 2010, REV GEOPHYS, V48, DOI 10.1029/2009RG000314; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Midgley GF, 2003, BIOL CONSERV, V112, P87, DOI 10.1016/S0006-3207(02)00414-7; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Ni J, 2000, MT RES DEV, V20, P80, DOI 10.1659/0276-4741(2000)020[0080:ASOBOT]2.0.CO;2; Nunez CI, 1999, J VEG SCI, V10, P357, DOI 10.2307/3237064; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Opdam P, 2004, BIOL CONSERV, V117, P285, DOI 10.1016/j.biocon.2003.12.008; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pauli H, 2007, GLOBAL CHANGE BIOL, V13, P147, DOI 10.1111/j.1365-2486.2006.01282.x; Penuelas J, 2003, GLOBAL CHANGE BIOL, V9, P131, DOI 10.1046/j.1365-2486.2003.00566.x; Rivas-Martinez S., 1999, ITINERA GEOBOT, V12, P5; Roman-Cuesta RM, 2011, FOREST ECOL MANAG, V261, P1987, DOI 10.1016/j.foreco.2011.02.025; Sanz-Elorza M, 2003, ANN BOT-LONDON, V92, P273, DOI 10.1093/aob/mcg130; Thuiller W, 2008, PERSPECT PLANT ECOL, V9, P137, DOI 10.1016/j.ppees.2007.09.004; Tovar C, 2013, LANDSCAPE URBAN PLAN, V112, P40, DOI 10.1016/j.landurbplan.2012.12.003; United Nations, 2006, STAT YB LAT AM CAR; Urrutia R, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD011021; Valencia BG, 2010, J BIOGEOGR, V37, P1637, DOI 10.1111/j.1365-2699.2010.02318.x; Vuille M, 2008, EARTH-SCI REV, V89, P79, DOI 10.1016/j.earscirev.2008.04.002; Young B, 2011, CLIMATE CHANGE BIODI, P170; Zapata-Caldas E, 2012, POTENCIALES IMPACTOS; Zelazowski P, 2011, PHILOS T R SOC A, V369, P137, DOI 10.1098/rsta.2010.0238	65	58	62	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63634	10.1371/journal.pone.0063634	http://dx.doi.org/10.1371/journal.pone.0063634			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667651	gold, Green Submitted, Green Published			2022-12-25	WOS:000319654700172
J	Zhang, SL; Fujita, H; Mitsui, H; Yanofsky, VR; Fuentes-Duculan, J; Pettersen, JS; Suarez-Farinas, M; Gonzalez, J; Wang, CQF; Krueger, JG; Felsen, D; Carucci, JA				Zhang, Shali; Fujita, Hideki; Mitsui, Hiroshi; Yanofsky, Valerie R.; Fuentes-Duculan, Judilyn; Pettersen, Julia S.; Suarez-Farinas, Mayte; Gonzalez, Juana; Wang, Claire Q. F.; Krueger, James G.; Felsen, Diane; Carucci, John A.			Increased Tc22 and Treg/CD8 Ratio Contribute to Aggressive Growth of Transplant Associated Squamous Cell Carcinoma	PLOS ONE			English	Article							REGULATORY T-CELLS; SKIN-CANCER; SIGNAL TRANSDUCER; DENDRITIC CELLS; TRANSCRIPTION 3; EXPRESSION; INTERLEUKIN-22; RECIPIENTS; ACTIVATION; IL-22	Immune suppressed organ transplant recipients suffer increased morbidity and mortality from primary cutaneous SCC. We studied tumor microenvironment in transplant-associated SCC (TSCC), immune-competent SCC and normal skin by IHC, IF and RT-PCR on surgical discard. We determined T cell polarization in TSCC and SCC by intracellular cytokine staining of T cell crawl outs from human skin explants. We studied the effects of IL-22, an inducer of keratinocyte proliferation, on SCC proliferation in vitro. SCC and TSCC are both associated with significantly higher numbers of CD3(+) and CD8(+) T cells compared to normal skin. TSCC showed a higher proportion of Foxp3(+) T regs to CD8(+) T cells compared to SCC and a lower percentage of IFN-gamma producing CD4(+) T cells. TSCC, however, had a higher percentage of IL-22 producing CD8(+) T cells compared to SCC. TSCC showed more diffuse Ki67 and IL-22 receptor (IL-22R) expression by IHC. IL-2 induced SCC proliferation in vitro despite serum starvation. Diminished cytotoxic T cell function in TSCC due to decreased CD8/T-reg ratio may permit tumor progression. Increased IL-22 and IL-22R expression could accelerate tumor growth in transplant patients. IL-22 may be an attractive candidate for targeted therapy of SCC without endangering allograft survival.	[Zhang, Shali; Carucci, John A.] NYU, Ronald O Perelman Dept Dermatol, Langone Med Ctr, New York, NY 10003 USA; [Fujita, Hideki; Mitsui, Hiroshi; Fuentes-Duculan, Judilyn; Suarez-Farinas, Mayte; Wang, Claire Q. F.; Krueger, James G.] Rockefeller Univ, Invest Dermatol Lab, New York, NY 10021 USA; [Yanofsky, Valerie R.] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Pettersen, Julia S.] Weill Cornell Med Coll, Dept Dermatol, New York, NY USA; [Gonzalez, Juana] Rockefeller Univ, Translat Immunomonitoring Resource Ctr, New York, NY 10021 USA; [Felsen, Diane] Weill Cornell Med Coll, Inst Pediat Urol, New York, NY USA	New York University; NYU Langone Medical Center; Rockefeller University; Yeshiva University; Albert Einstein College of Medicine; Cornell University; Rockefeller University; Cornell University	Carucci, JA (corresponding author), NYU, Ronald O Perelman Dept Dermatol, Langone Med Ctr, New York, NY 10003 USA.	john.carucci@nyumc.org	Suarez-Farinas, Mayte/I-3558-2012	Suarez-Farinas, Mayte/0000-0001-8712-3553; carucci, john/0000-0001-6817-9439	Dana Foundation Human Immunology Consortium Grant; Milstein Medical Program; National Institutes of Health (NIH) [8 KL2 TR000151]; National Center for Research Resources, NIH [8 UL1 TR000043]; NIH from National Center for Advancing Translational Sciences [8 UL1b TR000043]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000043, KL2TR000151] Funding Source: NIH RePORTER	Dana Foundation Human Immunology Consortium Grant; Milstein Medical Program; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH from National Center for Advancing Translational Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported in part by the Dana Foundation Human Immunology Consortium Grant (JAC, JSP). HM, MSF, CQFW, and JGK were supported by the Milstein Medical Program and in part by the National Institutes of Health (NIH) grant 8 KL2 TR000151. JFD is supported in part by grant # 8 UL1 TR000043 from the National Center for Research Resources, NIH. JG is supported by the NIH grant 8 UL1b TR000043 from National Center for Advancing Translational Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aune G, 2011, INT J CLIN EXP PATHO, V4, P444; Bard JD, 2008, LEUKEMIA, V22, P1595, DOI 10.1038/leu.2008.129; Bates GJ, 2006, J CLIN ONCOL, V24, P5373, DOI 10.1200/JCO.2006.05.9584; Berg D, 2002, J AM ACAD DERMATOL, V47, P1, DOI 10.1067/mjd.2002.125579; Beyer M, 2006, BLOOD, V108, P804, DOI 10.1182/blood-2006-02-002774; Beyer M, 2006, BLOOD, V107, P3940, DOI 10.1182/blood-2005-09-3671; Bluth MJ, 2009, J INVEST DERMATOL, V129, P2451, DOI 10.1038/jid.2009.96; Boniface K, 2007, CLIN EXP IMMUNOL, V150, P407, DOI 10.1111/j.1365-2249.2007.03511.x; Carucci JA, 2004, J INVEST DERMATOL, V123, P809, DOI 10.1111/j.1523-1747.2004.23440.x; Chan KS, 2008, ONCOGENE, V27, P1087, DOI 10.1038/sj.onc.1210726; Chan KS, 2004, J CLIN INVEST, V114, P720, DOI 10.1172/JCI200421032; Chung YS, 2006, CELL RES, V16, P902, DOI 10.1038/sj.cr.7310106; Curd LM, 2012, CLIN EXP IMMUNOL, V168, P192, DOI 10.1111/j.1365-2249.2012.04570.x; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Dumoutier L, 2000, J IMMUNOL, V164, P1814, DOI 10.4049/jimmunol.164.4.1814; Dumoutier L, 2000, GENES IMMUN, V1, P488, DOI 10.1038/sj.gene.6363716; Euvrard S, 2003, NEW ENGL J MED, V348, P1681, DOI 10.1056/NEJMra022137; Fuentes-Duculan J, 2010, J INVEST DERMATOL, V130, P2412, DOI 10.1038/jid.2010.165; Gelebart P, 2011, TRANSL ONCOL, V4, P9, DOI 10.1593/tlo.10172; Guba M, 2004, TRANSPLANTATION, V77, P1777, DOI 10.1097/01.tp.0000120181.89206.54; Haider AS, 2006, J INVEST DERMATOL, V126, P869, DOI 10.1038/sj.jid.5700157; Ikeda H, 2002, CYTOKINE GROWTH F R, V13, P95, DOI 10.1016/S1359-6101(01)00038-7; Jabbari A, 2011, GIORN ITAL DERMAT V, V146, P17; Jensen P, 1999, J AM ACAD DERMATOL, V40, P177, DOI 10.1016/S0190-9622(99)70185-4; Jiang RQ, 2011, HEPATOLOGY, V54, P900, DOI 10.1002/hep.24486; Kaporis HG, 2007, J INVEST DERMATOL, V127, P2391, DOI 10.1038/sj.jid.5700884; Kim DJ, 2009, ONCOGENE, V28, P950, DOI 10.1038/onc.2008.453; Kim ST, 2012, AM J CLIN ONCOL; Kretz-Rommel A, 2007, J IMMUNOL, V178, P5595, DOI 10.4049/jimmunol.178.9.5595; Krynitz B, 2012, INT J CANC; Ladstein RG, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-140; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Lindelof B, 2000, BRIT J DERMATOL, V143, P513, DOI 10.1046/j.1365-2133.2000.03703.x; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Nagalakshmi ML, 2004, INT IMMUNOPHARMACOL, V4, P679, DOI 10.1016/j.intimp.2004.01.008; Ng WF, 2001, BLOOD, V98, P2736, DOI 10.1182/blood.V98.9.2736; Nograles KE, 2009, J ALLERGY CLIN IMMUN, V123, P1244, DOI 10.1016/j.jaci.2009.03.041; Pan HN, 2004, CELL MOL IMMUNOL, V1, P43; Patel GK, 2012, J INVEST DERMATOL, V132, P401, DOI 10.1038/jid.2011.317; Pettersen JS, 2011, J INVEST DERMATOL, V131, P1322, DOI [10.1038/jid.2011.9, 10.103/jid.2011.9]; Res PCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014108; Rosenberg SA, 2005, NAT CLIN PRACT ONCOL, V2, P115, DOI 10.1038/ncponc0101; Rutella S, 2004, IMMUNOL LETT, V94, P11, DOI 10.1016/j.imlet.2004.04.015; Sano S, 2005, CANCER RES, V65, P5720, DOI 10.1158/0008-5472.CAN-04-4359; Tamai H, 2008, CLIN IMMUNOL, V127, P66, DOI 10.1016/j.clim.2007.12.001; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Toes REM, 1999, J EXP MED, V189, P753, DOI 10.1084/jem.189.5.753; Topalian SL, 2011, J CLIN ONCOL, V29, P4828, DOI 10.1200/JCO.2011.38.0899; Ulrich C, 2008, AM J TRANSPLANT, V8, P2192, DOI 10.1111/j.1600-6143.2008.02386.x; UNOS, 2012, DATABASE; Warner CL, 2011, AM J CLIN DERMATOL, V12, P147, DOI 10.2165/11539420-000000000-00000; Witte E, 2010, CYTOKINE GROWTH F R, V21, P365, DOI 10.1016/j.cytogfr.2010.08.002; Wolf D, 2005, CLIN CANCER RES, V11, P8326, DOI 10.1158/1078-0432.CCR-05-1244; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Wolk K, 2010, SEMIN IMMUNOPATHOL, V32, P17, DOI 10.1007/s00281-009-0188-x; Xie MH, 2000, J BIOL CHEM, V275, P31335, DOI 10.1074/jbc.M005304200; Yu P, 2006, LAB INVEST, V86, P231, DOI 10.1038/labinvest.3700389; Zhang N, 2011, MOL CELL BIOCHEM, V353, P41, DOI 10.1007/s11010-011-0772-y; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Ziesche E, 2007, J BIOL CHEM, V282, P16006, DOI 10.1074/jbc.M611040200; Zwald FO, 2011, J AM ACAD DERMATOL, V65, P253, DOI 10.1016/j.jaad.2010.11.062; Zwald FO, 2011, J AM ACAD DERMATOL, V65, P263, DOI 10.1016/j.jaad.2010.11.063; Zwald FO, 2011, J AM ACAD DERMATOL, V65, P280	63	36	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62154	10.1371/journal.pone.0062154	http://dx.doi.org/10.1371/journal.pone.0062154			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667456	Green Submitted, Green Published, gold			2022-12-25	WOS:000319654700024
J	Haug, I; Setaro, S; Suarez, JP				Haug, Ingeborg; Setaro, Sabrina; Pablo Suarez, Juan			Reforestation Sites Show Similar and Nested AMF Communities to an Adjacent Pristine Forest in a Tropical Mountain Area of South Ecuador	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; ABANDONED PASTURES; NETWORK STRUCTURE; GLOBAL DIVERSITY; SPECIES-RICH; ROOTS; SOIL; BIODIVERSITY; ARCHITECTURE; DISTURBANCE	Arbuscular mycorrhizae are important for growth and survival of tropical trees. We studied the community of arbuscular mycorrhizal fungi in a tropical mountain rain forest and in neighbouring reforestation plots in the area of Reserva Biologica San Francisco (South Ecuador). The arbuscular mycorrhizal fungi were analysed with molecular methods sequencing part of the 18 S rDNA. The sequences were classified as Operational Taxonomic Units (OTUs). We found high fungal species richness with OTUs belonging to Glomerales, Diversisporales and Archaeosporales. Despite intensive sampling, the rarefaction curves are still unsaturated for the pristine forest and the reforestation plots. The communities consisted of few frequent and many rare species. No specific interactions are recognizable. The plant individuals are associated with one to ten arbuscular mycorrhizal fungi and mostly with one to four. The fungal compositions associated with single plant individuals show a great variability and variety within one plant species. Planted and naturally occurring plants show high similarities in their fungal communities. Pristine forest and reforestation plots showed similar richness, similar diversity and a significantly nested structure of plant-AMF community. The results indicate that small-scale fragmentation presently found in this area has not destroyed the natural AMF community, at least yet. Thus, the regeneration potential of natural forest vegetation at the tested sites is not inhibited by a lack of appropriate mycobionts.	[Haug, Ingeborg] Univ Tubingen, Inst Evolut & Ecol, Tubingen, Germany; [Setaro, Sabrina] Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA; [Pablo Suarez, Juan] Univ Tecn Particular Loja, Dept Ciencias Nat, Loja, Ecuador	Eberhard Karls University of Tubingen; Wake Forest University; Universidad Tecnica Particular de Loja	Haug, I (corresponding author), Univ Tubingen, Inst Evolut & Ecol, Tubingen, Germany.	ingeborg.haug@uni-tuebingen.de	Suárez, Juan Pablo/D-1839-2009; Suárez, Juan Pablo/AHB-9751-2022	Suárez, Juan Pablo/0000-0002-9453-5545; Suárez, Juan Pablo/0000-0002-9453-5545	DFG (Research Unit 816) [HA2029/2-1]; Tuebingen University; Deutsche Forschungsgemeinschaft	DFG (Research Unit 816); Tuebingen University; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was funded by DFG (Research Unit 816, HA2029/2-1). We acknowledge support by Open Access Publishing Fund of Tuebingen University and Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre NM, 2007, SILVICULTURAL DISTRI; Alguacil MM, 2012, SOIL BIOL BIOCHEM, V49, P132, DOI 10.1016/j.soilbio.2012.02.024; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bascompte J, 2010, SCIENCE, V329, P765, DOI 10.1126/science.1194255; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Batagelj V, 2004, MATH VIS, P77; Blaskowski J, 2008, MYCOTAXON, V106, P247; Bluethgen Nico, 2006, BMC Ecology, V6, P9, DOI 10.1186/1472-6785-6-9; Brehm G, 2005, J BIOGEOGR, V32, P1621, DOI 10.1111/j.1365-2699.2005.01304.x; Brummitt N, 2003, CONSERV BIOL, V17, P1442, DOI 10.1046/j.1523-1739.2003.02344.x; Cesaro P, 2008, APPL ENVIRON MICROB, V74, P5776, DOI 10.1128/AEM.00719-08; Chagnon PL, 2012, NEW PHYTOL, V194, P307, DOI 10.1111/j.1469-8137.2011.04044.x; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Chao A, 2006, BIOMETRICS, V62, P361, DOI 10.1111/j.1541-0420.2005.00489.x; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; Davison J, 2011, FEMS MICROBIOL ECOL, V78, P103, DOI 10.1111/j.1574-6941.2011.01103.x; Alguacil MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034887; Dormann C.F., 2008, R NEWS, V8, P8, DOI DOI 10.1159/000265935; Dumbrell AJ, 2010, J ECOL, V98, P419, DOI 10.1111/j.1365-2745.2009.01622.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fitter AH, 2005, J ECOL, V93, P231, DOI 10.1111/j.0022-0477.2005.00990.x; Fortuna MA, 2006, ECOL LETT, V9, P278, DOI 10.1111/j.1461-0248.2005.00868.x; Fortuna MA, 2010, J ANIM ECOL, V79, P811, DOI 10.1111/j.1365-2656.2010.01688.x; Goker M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006319; GRACE C, 1991, MYCOL RES, V95, P1160, DOI 10.1016/S0953-7562(09)80005-1; Gunter S, 2009, FOREST ECOL MANAG, V258, P81, DOI 10.1016/j.foreco.2009.03.042; Guimaraes PR, 2006, ENVIRON MODELL SOFTW, V21, P1512, DOI 10.1016/j.envsoft.2006.04.002; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Haug I, 2010, TROP ECOL, V51, P125; HOMEIER J, 2007, ECOTROPICAL MONOGRAP, V4, P15; Homeier J, 2010, BIOTROPICA, V42, P140, DOI 10.1111/j.1744-7429.2009.00547.x; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Husband R, 2002, MOL ECOL, V11, P2669, DOI 10.1046/j.1365-294X.2002.01647.x; Husband R, 2002, FEMS MICROBIOL ECOL, V42, P131, DOI 10.1111/j.1574-6941.2002.tb01002.x; Jacquemyn H, 2011, NEW PHYTOL, V192, P518, DOI 10.1111/j.1469-8137.2011.03796.x; Joppa LN, 2010, EVOL ECOL RES, V12, P35; Jost Lou, 2011, P66; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kiers ET, 2011, SCIENCE, V333, P880, DOI 10.1126/science.1208473; Kivlin SN, 2011, SOIL BIOL BIOCHEM, V43, P2294, DOI 10.1016/j.soilbio.2011.07.012; Kottke I., 2013, ECOSYSTEM SERVICES B, P187, DOI DOI 10.1007/978-3-642-38137-9_14; Kottke I, 2008, BASIC APPL ECOL, V9, P13, DOI 10.1016/j.baae.2007.03.007; Kruger M, 2012, NEW PHYTOL, V193, P970, DOI 10.1111/j.1469-8137.2011.03962.x; Kuptz D, 2010, TREES-STRUCT FUNCT, V24, P117, DOI 10.1007/s00468-009-0385-1; Lee J, 2008, FEMS MICROBIOL ECOL, V65, P339, DOI 10.1111/j.1574-6941.2008.00531.x; Lekberg Y, 2012, J ECOL, V100, P151, DOI 10.1111/j.1365-2745.2011.01894.x; Liu YJ, 2011, FEMS MICROBIOL ECOL, V78, P355, DOI 10.1111/j.1574-6941.2011.01163.x; Martos F, 2012, MOL ECOL, V21, P5098, DOI 10.1111/j.1365-294X.2012.05692.x; Medan D, 2007, J THEOR BIOL, V246, P510, DOI 10.1016/j.jtbi.2006.12.033; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Meskens C, 2011, ECOL ENTOMOL, V36, P480, DOI 10.1111/j.1365-2311.2011.01294.x; Montesinos-Navarro A, 2012, NEW PHYTOL, V194, P536, DOI 10.1111/j.1469-8137.2011.04045.x; Moora M, 2011, J BIOGEOGR, V38, P1305, DOI 10.1111/j.1365-2699.2011.02478.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Opik M, 2009, NEW PHYTOL, V184, P424, DOI 10.1111/j.1469-8137.2009.02920.x; Opik M, 2012, NEW PHYTOL, V194, P304, DOI 10.1111/j.1469-8137.2012.04121.x; Opik M, 2008, NEW PHYTOL, V179, P867, DOI 10.1111/j.1469-8137.2008.02515.x; Opik M, 2006, J ECOL, V94, P778, DOI 10.1111/j.1365-2745.2006.01136.x; Palomeque X, 2012, NATURAL SUCCESSION T; Mello MAR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017395; Schnoor TK, 2011, MYCORRHIZA, V21, P211, DOI 10.1007/s00572-010-0325-3; Swofford DL, 2001, PAUP PHYLOGENETIC AN; Sykorova Z, 2007, MYCORRHIZA, V18, P1, DOI 10.1007/s00572-007-0147-0; Thompson J. N., 2005, INTERSPEC INTERACT; Weber M., 2008, V198, P431; White T., 1990, PCR PROTOCOLS GUIDE, P315; Wirsel SGR, 2004, FEMS MICROBIOL ECOL, V48, P129, DOI 10.1016/j.femsec.2004.01.006	68	16	16	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e63524	10.1371/journal.pone.0063524	http://dx.doi.org/10.1371/journal.pone.0063524			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671682	Green Published, gold, Green Submitted			2022-12-25	WOS:000321390200051
J	McDowell, SC; Akmakjian, G; Sladek, C; Mendoza-Cozatl, D; Morrissey, JB; Saini, N; Mittler, R; Baxter, I; Salt, DE; Ward, JM; Schroeder, JI; Guerinot, ML; Harper, JF				McDowell, Stephen C.; Akmakjian, Garo; Sladek, Chris; Mendoza-Cozatl, David; Morrissey, Joe B.; Saini, Nick; Mittler, Ron; Baxter, Ivan; Salt, David E.; Ward, John M.; Schroeder, Julian I.; Guerinot, Mary Lou; Harper, Jeffrey F.			Elemental Concentrations in the Seed of Mutants and Natural Variants of Arabidopsis thaliana Grown under Varying Soil Conditions	PLOS ONE			English	Article							CAP-BINDING-PROTEIN; QUANTITATIVE TRAIT LOCI; NUCLEOTIDE-GATED CHANNEL; SIGNAL-TRANSDUCTION; FUNCTIONAL-CHARACTERIZATION; SACCHAROMYCES-CEREVISIAE; MINERAL CONCENTRATIONS; PLANT DEVELOPMENT; GENETIC-ANALYSIS; SALT TOLERANCE	The concentrations of mineral nutrients in seeds are critical to both the life cycle of plants as well as human nutrition. These concentrations are strongly influenced by soil conditions, as shown here by quantifying the concentration of 14 elements in seeds from Arabidopsis thaliana plants grown under four different soil conditions: standard, or modified with NaCl, heavy metals, or alkali. Each of the modified soils resulted in a unique change to the seed ionome (the mineral nutrient content of the seeds). To help identify the genetic networks regulating the seed ionome, changes in elemental concentrations were evaluated using mutants corresponding to 760 genes as well as 10 naturally occurring accessions. The frequency of ionomic phenotypes supports an estimate that as much as 11% of the A. thaliana genome encodes proteins of functional relevance to ion homeostasis in seeds. A subset of mutants were analyzed with two independent alleles, providing five examples of genes important for regulation of the seed ionome: SOS2, ABH1, CCC, At3g14280 and CNGC2. In a comparison of nine different accessions to a Col-0 reference, eight accessions were observed to have reproducible differences in elemental concentrations, seven of which were dependent on specific soil conditions. These results indicate that the A. thaliana seed ionome is distinct from the vegetative ionome, and that elemental analysis is a sensitive approach to identify genes controlling ion homeostasis, including those that regulate gene expression, phospho-regulation, and ion transport.	[McDowell, Stephen C.; Sladek, Chris; Saini, Nick; Harper, Jeffrey F.] Univ Nevada, Dept Biochem & Mol Biol, Reno, NV 89557 USA; [Akmakjian, Garo; Mendoza-Cozatl, David; Schroeder, Julian I.] Univ Calif San Diego, Div Biol Sci, San Diego, CA 92103 USA; [Morrissey, Joe B.; Guerinot, Mary Lou] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Salt, David E.] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland; [Ward, John M.] Univ Minnesota, Dept Plant Biol, St Paul, MN USA; [Mittler, Ron] Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA; [Baxter, Ivan] ARS, USDA, Plant Genet Res Unit, Donald Danforth Plant Sci Ctr, St Louis, MO USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; University of California System; University of California San Diego; Dartmouth College; University of Aberdeen; University of Minnesota System; University of Minnesota Twin Cities; University of North Texas System; University of North Texas Denton; Donald Danforth Plant Science Center; United States Department of Agriculture (USDA)	Harper, JF (corresponding author), Univ Nevada, Dept Biochem & Mol Biol, Reno, NV 89557 USA.	jfharper@unr.edu	Baxter, Ivan R/A-1052-2009; Mittler, Ron/ABE-6496-2020	Baxter, Ivan R/0000-0001-6680-1722; Ward, John/0000-0001-8185-0434; Schroeder, Julian/0000-0002-3283-5972; Mendoza Cozatl, David/0000-0002-9616-0791	National Science Foundation [DBI-0077378]; National Institutes of Health [1RO1 GM070813-01, P42 ES010337]; Department of Energy [DE-FG03-94ER20152, DE-FG02-03ER15449]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078536, R01GM070813] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The seed ionome mutant screen was supported by a grant from the National Science Foundation (http://www.nsf.gov, DBI-0077378) to MLG/JFH/JIS/JW. Grants to JFH from the National Institutes of Health (http://www.nih.gov, 1RO1 GM070813-01) and the Department of Energy (http://www.energy.gov, DE-FG03-94ER20152) supported genetic studies on CNGCs/ACAs, and ALAs, respectively. Grants to JIS from the Department of Energy (http://www.energy.gov, DE-FG02-03ER15449) and the National Institutes of Health (http://www.nih.gov, P42 ES010337) in part supported sos mutant analysis and metal accession analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali R, 2007, PLANT CELL, V19, P1081, DOI 10.1105/tpc.106.045096; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Balatsos NAA, 2006, J BIOL CHEM, V281, P4517, DOI 10.1074/jbc.M508590200; Baxter I, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000004; Baxter I, 2007, PLANT PHYSIOL, V143, P600, DOI 10.1104/pp.106.092528; Baxter I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035121; Baxter I, 2012, SCIENCE, V336, P1661, DOI 10.1126/science.1219992; Baxter I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001193; Baxter I, 2010, BRIEF FUNCT GENOMICS, V9, P149, DOI 10.1093/bfgp/elp055; Baxter I, 2009, CURR OPIN PLANT BIOL, V12, P381, DOI 10.1016/j.pbi.2009.05.002; Baxter IR, 2008, P NATL ACAD SCI USA, V105, P12081, DOI 10.1073/pnas.0804175105; Bentsink L, 2003, THEOR APPL GENET, V106, P1234, DOI 10.1007/s00122-002-1177-9; Buescher E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011081; Bush MS, 2009, PLANT J, V59, P400, DOI 10.1111/j.1365-313X.2009.03882.x; Chan CWM, 2003, PLANT PHYSIOL, V132, P728, DOI 10.1104/pp.102.019216; Chen XM, 2008, DEV CELL, V14, P811, DOI 10.1016/j.devcel.2008.05.012; Chen Z, 2009, NEW PHYTOL, V181, P795, DOI 10.1111/j.1469-8137.2008.02730.x; Clough SJ, 2000, P NATL ACAD SCI USA, V97, P9323, DOI 10.1073/pnas.150005697; Colmenero-Flores JM, 2007, PLANT J, V50, P278, DOI 10.1111/j.1365-313X.2007.03048.x; Conn SJ, 2012, NEW PHYTOL, V193, P859, DOI 10.1111/j.1469-8137.2011.03977.x; Danku JMC, 2009, J ANAL ATOM SPECTROM, V24, P103, DOI 10.1039/b803529f; Eide DJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r77; Ernst WHO, 2000, ENVIRON EXP BOT, V43, P55, DOI 10.1016/S0098-8472(99)00048-9; Frietsch S, 2007, P NATL ACAD SCI USA, V104, P14531, DOI 10.1073/pnas.0701781104; Ghandilyan A, 2009, NEW PHYTOL, V184, P180, DOI 10.1111/j.1469-8137.2009.02953.x; Ghandilyan A, 2009, J EXP BOT, V60, P1409, DOI 10.1093/jxb/erp084; Gobert A, 2006, J EXP BOT, V57, P791, DOI 10.1093/jxb/erj064; Gollery M, 2007, TRENDS PLANT SCI, V12, P492, DOI 10.1016/j.tplants.2007.08.018; Gollery M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r57; Gregory BD, 2008, DEV CELL, V14, P854, DOI 10.1016/j.devcel.2008.04.005; Grennan AK, 2006, PLANT PHYSIOL, V141, P1164, DOI 10.1104/pp.104.900198; Guo KM, 2010, PHYSIOL PLANTARUM, V139, P303, DOI 10.1111/j.1399-3054.2010.01366.x; HAMM J, 1990, CELL, V63, P109, DOI 10.1016/0092-8674(90)90292-M; Hoekenga OA, 2003, PLANT PHYSIOL, V132, P936, DOI 10.1104/pp.103.023085; Huang GT, 2012, MOL BIOL REP, V39, P969, DOI 10.1007/s11033-011-0823-1; Hugouvieux V, 2001, CELL, V106, P477, DOI 10.1016/S0092-8674(01)00460-3; Hugouvieux V, 2002, PLANT PHYSIOL, V130, P1276, DOI 10.1104/pp.009480; IZAURRALDE E, 1992, J CELL BIOL, V118, P1287, DOI 10.1083/jcb.118.6.1287; Kim S, 2008, PLANT CELL PHYSIOL, V49, P1634, DOI 10.1093/pcp/pcn146; Kobayashi Y, 2002, PLANT CELL PHYSIOL, V43, P1526, DOI 10.1093/pcp/pcf174; Kong XQ, 2011, PLANT MOL BIOL, V75, P567, DOI 10.1007/s11103-011-9744-6; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Krysan PJ, 1996, P NATL ACAD SCI USA, V93, P8145, DOI 10.1073/pnas.93.15.8145; Kuhn JM, 2008, CURR TOP MICROBIOL, V326, P139; Lahner B, 2003, NAT BIOTECHNOL, V21, P1215, DOI 10.1038/nbt865; Laubinger S, 2008, P NATL ACAD SCI USA, V105, P8795, DOI 10.1073/pnas.0802493105; Leng Q, 1999, PLANT PHYSIOL, V121, P753, DOI 10.1104/pp.121.3.753; Leng Q, 2002, PLANT PHYSIOL, V128, P400, DOI 10.1104/pp.010832; Liu JP, 2000, P NATL ACAD SCI USA, V97, P3730, DOI 10.1073/pnas.060034197; Loudet O, 2007, NAT GENET, V39, P896, DOI 10.1038/ng2050; Ma W, 2006, PLANT PHYSIOL BIOCH, V44, P494, DOI 10.1016/j.plaphy.2006.08.007; Mahajan S, 2008, ARCH BIOCHEM BIOPHYS, V471, P146, DOI 10.1016/j.abb.2008.01.010; Marschner H., 1995, MINERAL NUTR HIGHER, V2nd ed.; Maser P, 2001, PLANT PHYSIOL, V126, P1646, DOI 10.1104/pp.126.4.1646; Maser P, 2002, FEBS LETT, V531, P157, DOI 10.1016/S0014-5793(02)03488-9; Morrissey J, 2009, PLANT CELL, V21, P3326, DOI 10.1105/tpc.109.069401; Munns R, 2012, NAT BIOTECHNOL, V30, P360, DOI 10.1038/nbt.2120; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Payne KA, 2004, NEW PHYTOL, V162, P535, DOI 10.1111/j.1469-8137.2004.01026.x; Prinzenberg AE, 2010, PLANT PHYSIOL, V154, P1361, DOI 10.1104/pp.110.161398; Qiu QS, 2004, J BIOL CHEM, V279, P207, DOI 10.1074/jbc.M307982200; Qiu QS, 2002, P NATL ACAD SCI USA, V99, P8436, DOI 10.1073/pnas.122224699; Quintero FJ, 2002, P NATL ACAD SCI USA, V99, P9061, DOI 10.1073/pnas.132092099; Raczynska KD, 2010, NUCLEIC ACIDS RES, V38, P265, DOI 10.1093/nar/gkp869; Rus A, 2006, PLOS GENET, V2, P1964, DOI 10.1371/journal.pgen.0020210; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; Salt DE, 2008, ANNU REV PLANT BIOL, V59, P709, DOI 10.1146/annurev.arplant.59.032607.092942; Salt DE, 2004, PLANT PHYSIOL, V136, P2451, DOI 10.1104/pp.104.047753; Sanchez-Rodriguez E, 2010, PLANT SOIL, V335, P339, DOI 10.1007/s11104-010-0422-2; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; Shi HZ, 2000, P NATL ACAD SCI USA, V97, P6896, DOI 10.1073/pnas.120170197; Shi HZ, 2002, PLANT CELL, V14, P465, DOI 10.1105/tpc.010371; Soric R, 2011, MAYDICA, V56, P323; SUNDARESAN V, 1995, GENE DEV, V9, P1797, DOI 10.1101/gad.9.14.1797; Tian H, 2010, PLANT CELL, V22, P3963, DOI 10.1105/tpc.110.080010; Tissier AF, 1999, PLANT CELL, V11, P1841, DOI 10.1105/tpc.11.10.1841; Vreugdenhil D, 2004, PLANT CELL ENVIRON, V27, P828, DOI 10.1111/j.1365-3040.2004.01189.x; Woody ST, 2007, J PLANT RES, V120, P157, DOI 10.1007/s10265-006-0048-x; Zhu JK, 2003, CURR OPIN PLANT BIOL, V6, P441, DOI 10.1016/S1369-5266(03)00085-2; Zhu JK, 1998, PLANT CELL, V10, P1181, DOI 10.1105/tpc.10.7.1181	81	14	15	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e63014	10.1371/journal.pone.0063014	http://dx.doi.org/10.1371/journal.pone.0063014			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671651	Green Submitted, Green Published, gold			2022-12-25	WOS:000321390200040
J	Willis, L; Graham, TA; Alarcon, T; Alison, MR; Tomlinson, IPM; Page, KM				Willis, Lisa; Graham, Trevor A.; Alarcon, Tomas; Alison, Malcolm R.; Tomlinson, Ian P. M.; Page, Karen M.			What Can Be Learnt about Disease Progression in Breast Cancer Dormancy from Relapse Data?	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CIRCULATING TUMOR-CELLS; ANGIOGENIC SWITCH; REGRESSION; RECURRENCE; MECHANISMS; PROPOSAL; SURGERY; GROWTH; MODEL	Breast cancer patients have an anomalously high rate of relapse many years-up to 25 years-after apparently curative surgery removed the primary tumour. Disease progression during the intervening years between resection and relapse is poorly understood. There is evidence that the disease persists as dangerous, tiny metastases that remain at a growth restricted, clinically undetectable size until a transforming event restarts growth. This is the starting point for our study, where patients who have metastases that are all tiny and growth-restricted are said to have cancer dormancy. Can long-term follow-up relapse data from breast cancer patients be used to extract knowledge about the progression of the undetected disease? Here, we evaluate whether this is the case by introducing and analysing four simple mathematical models of cancer dormancy. These models extend the common assumption that a random transforming event, such as a mutation, can restart growth of a tiny, growth-restricted metastasis; thereafter, cancer dormancy progresses to detectable metastasis. We find that physiopathological details, such as the number of random transforming events that metastases must undergo to escape from growth restriction, cannot be extracted from relapse data. This result is unsurprising. However, the same analysis suggested a natural question that does have a surprising answer: why are interesting trends in long-term relapse data not more commonly observed? Further, our models indicate that (a) therapies which induce growth restriction among metastases but do not prevent increases in metastases' tumourigenicity may introduce a time post-surgery when more patients are prone to relapse; and (b), if a number of facts about disease progression are first established, how relapse data might be used to estimate clinically relevant variables, such as the likely numbers of undetected growth-restricted metastases. This work is a necessary, early step in building a quantitative mechanistic understanding of cancer dormancy.	[Willis, Lisa; Graham, Trevor A.; Page, Karen M.] UCL, Ctr Math & Phys Life Sci & Expt Biol, London, England; [Willis, Lisa] Univ Cambridge, Sainsbury Lab, Cambridge, England; [Graham, Trevor A.] Univ Calif San Francisco, Dept Surg, Ctr Evolut & Canc, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA; [Alarcon, Tomas] Ctr Recerca Matemat, Barcelona, Spain; [Alison, Malcolm R.] Barts & London Queen Marys Sch Med & Dent, Barts Canc Inst, Ctr Tumour Biol, London, England; [Tomlinson, Ian P. M.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Page, Karen M.] UCL, Dept Math, London, England	University of London; University College London; University of Cambridge; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Centre de Recerca Matematica (CRM); University of London; Queen Mary University London; University of Oxford; Wellcome Centre for Human Genetics; University of London; University College London	Willis, L (corresponding author), UCL, Ctr Math & Phys Life Sci & Expt Biol, London, England.	lw464@cam.ac.uk	Alison, Malcolm/H-6961-2019; Alarcon, Tomas/AAW-2908-2021; Alarcon, Tomas/D-9083-2013	Alarcon, Tomas/0000-0002-8566-3676; Alarcon, Tomas/0000-0002-8566-3676; Graham, Trevor/0000-0001-9582-1597	British Engineering and Physical Sciences Research Council; Engineering and Physical Sciences Research Council United Kingdom; National Institute for Mathematical and Biological Synthesis, Knoxville, Tennessee; Direct For Biological Sciences [1300426] Funding Source: National Science Foundation	British Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council United Kingdom(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute for Mathematical and Biological Synthesis, Knoxville, Tennessee; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the British Engineering and Physical Sciences Research Council. LW was supported by an Engineering and Physical Sciences Research Council United Kingdom studentship. KMP gratefully acknowledges the support of a Leverhulme Research Fellowship and a sabbatical fellowship at the National Institute for Mathematical and Biological Synthesis, Knoxville, Tennessee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Almog N, 2009, CANCER RES, V69, P836, DOI 10.1158/0008-5472.CAN-08-2590; [Anonymous], GRAPHCLICK VERS 3 0; ARMITAGE P, 1954, BRIT J CANCER, V8, P1, DOI 10.1038/bjc.1954.1; Bos SD, 1996, SCAND J UROL NEPHROL, V30, P489, DOI 10.3109/00365599609182329; Bouck N, 1996, ADV CANCER RES, V69, P135, DOI 10.1016/S0065-230X(08)60862-3; Chambers AF, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2197; Chia SK, 2004, J CLIN ONCOL, V22, P1630, DOI 10.1200/JCO.2004.09.070; Demicheli R, 1998, BREAST CANCER RES TR, V51, P133, DOI 10.1023/A:1005887422022; Demicheli R, 2001, SEMIN CANCER BIOL, V11, P297, DOI 10.1006/scbi.2001.0385; Demicheli R, 1997, ANN ONCOL, V8, P1075, DOI 10.1023/A:1008263116022; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; GIMBRONE MA, 1972, J EXP MED, V136, P261, DOI 10.1084/jem.136.2.261; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; HOLMGREN L, 1995, NAT MED, V1, P149, DOI 10.1038/nm0295-149; Hornsby C, 2007, LANCET ONCOL, V8, P1030, DOI 10.1016/S1470-2045(07)70343-1; Hudis CA, 2007, J CLIN ONCOL, V25, P2127, DOI 10.1200/JCO.2006.10.3523; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Karrison TG, 1999, JNCI-J NATL CANCER I, V91, P80, DOI 10.1093/jnci/91.1.80; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; MELTZER A, 1990, J SURG ONCOL, V43, P181, DOI 10.1002/jso.2930430312; Meng SD, 2004, CLIN CANCER RES, V10, P8152, DOI 10.1158/1078-0432.CCR-04-1110; Naumov GN, 2006, JNCI-J NATL CANCER I, V98, P316, DOI 10.1093/jnci/djj068; Naumov GN, 2001, SEMIN CANCER BIOL, V11, P271, DOI 10.1006/scbi.2001.0382; Nussenbaum F, 2010, J ONCOL, V2010, DOI 10.1155/2010/132641; OGIHARA Y, 1994, CANCER, V74, P2798, DOI 10.1002/1097-0142(19941115)74:10<2798::AID-CNCR2820741009>3.0.CO;2-2; OReilly MS, 1996, NAT MED, V2, P689, DOI 10.1038/nm0696-689; Paterlini-Brechot P, 2007, CANCER LETT, V253, P180, DOI 10.1016/j.canlet.2006.12.014; Radisky DC, 2008, CELL STEM CELL, V2, P511, DOI 10.1016/j.stem.2008.05.007; Rayson D, 1997, CANCER, V79, P605; Retsky MW, 2008, APMIS, V116, P730, DOI 10.1111/j.1600-0463.2008.00990.x; Retsky MW, 1997, BREAST CANCER RES TR, V45, P193, DOI 10.1023/A:1005849301420; Saphner T, 1996, J CLIN ONCOL, V14, P2738, DOI 10.1200/JCO.1996.14.10.2738; Uhra JW, 2011, P NATL ACAD SCI USA, V108, P12396, DOI 10.1073/pnas.1106613108; WEINHOLD KJ, 1977, NATURE, V270, P59, DOI 10.1038/270059a0; Willis L, 2010, CANCER RES, V70, P4310, DOI 10.1158/0008-5472.CAN-09-3144; Yin WJ, 2009, BREAST CANCER RES TR, V114, P527, DOI 10.1007/s10549-008-0022-5	39	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e62320	10.1371/journal.pone.0062320	http://dx.doi.org/10.1371/journal.pone.0062320			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671591	Green Published, Green Submitted, gold			2022-12-25	WOS:000321390200018
J	Boycott, HE; Dallas, ML; Elies, J; Pettinger, L; Boyle, JP; Scragg, JL; Gamper, N; Peers, C				Boycott, Hannah E.; Dallas, Mark L.; Elies, Jacobo; Pettinger, Louisa; Boyle, John P.; Scragg, Jason L.; Gamper, Nikita; Peers, Chris			Carbon monoxide inhibition of Cav3.2 T-type Ca2+ channels reveals tonic modulation by thioredoxin	FASEB JOURNAL			English	Article						heme oxygenase 1; gasotransmitter; redox modulation; patch clamp	HEME OXYGENASE-1/CARBON MONOXIDE; GATED CALCIUM-CHANNELS; SENSORY NEURONS; REDOX MODULATION; ION CHANNELS; EXPRESSION; RAT; PROLIFERATION; PATHWAY; PHARMACOLOGY	T-type Ca2+ channels play diverse roles in tissues such as sensory neurons, vascular smooth muscle, and cancers, where increased expression of the cytoprotective enzyme, heme oxygenase-1 (HO-1) is often found. Here, we report regulation of T-type Ca2+ channels by carbon monoxide (CO) a HO-1 by-product. CO (applied as CORM-2) caused a concentration-dependent, poorly reversible inhibition of all T-type channel isoforms (Cav3.1-3.3, IC50 approximate to 3 M) expressed in HEK293 cells, and native T-type channels in NG108-15 cells and primary rat sensory neurons. No recognized CO-sensitive signaling pathway could account for the CO inhibition of Cav3.2. Instead, CO sensitivity was mediated by an extracellular redox-sensitive site, which was also highly sensitive to thioredoxin (Trx). Trx depletion (using auranofin, 2-5 M) reduced Cav3.2 currents and their CO sensitivity by >50% but increased sensitivity to dithiothreitol approximate to 3-fold. By contrast, Cav3.1 and Cav3.3 channels, and their sensitivity to CO, were unaffected in identical experiments. Our data propose a novel signaling pathway in which Trx acts as a tonic, endogenous regulator of Cav3.2 channels, while HO-1-derived CO disrupts this regulation, causing channel inhibition. CO modulation of T-type channels has widespread implications for diverse physiological and pathophysiological mechanisms, such as excitability, contractility, and proliferation.Boycott, H. E., Dallas, M. L., Elies, J., Pettinger, L., Boyle, J. P., Scragg, J. L., Gamper, N., Peers, C. Carbon monoxide inhibition of Cav3.2 T-type Ca2+ channels reveals tonic modulation by thioredoxin.	[Boycott, Hannah E.; Dallas, Mark L.; Elies, Jacobo; Boyle, John P.; Scragg, Jason L.; Gamper, Nikita; Peers, Chris] Univ Leeds, Fac Med & Hlth, Leeds Inst Genet Hlth & Therapeut, Leeds, W Yorkshire, England; [Pettinger, Louisa] Univ Leeds, Fac Biol Sci, Leeds, W Yorkshire, England	University of Leeds; University of Leeds	Peers, C (corresponding author), Univ Leeds, Fac Med & Hlth, LIGHT, Div Cardiovasc & Diabet Res, Clarendon Way, Leeds, W Yorkshire, England.	c.s.peers@leeds.ac.uk	Boyle, John/N-4868-2016; Dallas, Mark/Q-6117-2019; Elies, Jacobo/K-7684-2017; Dallas, Mark L/A-6654-2013	Dallas, Mark/0000-0002-5190-0522; Elies, Jacobo/0000-0002-2518-8412; Peers, Chris/0000-0002-8354-346X; Gamper, Nikita/0000-0001-5806-0207	Alzheimer's Research UK; UK Medical Research Council; British Heart Foundation; MRC [G1002183] Funding Source: UKRI; British Heart Foundation [PG/11/84/29146, PG/09/013/26885, FS/12/42/29585, FS/10/010/28169] Funding Source: researchfish; Medical Research Council [G1002183] Funding Source: researchfish	Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors are most grateful to Dr. E. Perez-Reyes (University of Virginia, Charlottesville, VA, USA) for provision of T-type channel expressing HEK293 cells, and Dr. Ian Wood (University of Leeds) for NG108-15 cells. This work was supported by Alzheimer's Research UK, the UK Medical Research Council, and the British Heart Foundation.	Al-Owais MMA, 2012, J BIOL CHEM, V287, P24754, DOI 10.1074/jbc.M112.357012; Bachnoff N, 2011, FREE RADICAL BIO MED, V50, P1355, DOI 10.1016/j.freeradbiomed.2011.02.026; Banerjee R, 2012, J BIOL CHEM, V287, P4397, DOI 10.1074/jbc.R111.287995; Cain SM, 2010, CHANNELS, V4, P475, DOI 10.4161/chan.4.6.14106; CARBONE E, 1984, NATURE, V310, P501, DOI 10.1038/310501a0; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Chang TJ, 2008, AM J PHYSIOL-HEART C, V295, pH999, DOI 10.1152/ajpheart.01289.2007; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Dallas ML, 2008, NEUROREPORT, V19, P345, DOI 10.1097/WNR.0b013e3282f51045; Dallas ML, 2011, FASEB J, V25, P1519, DOI 10.1096/fj.10-173450; Ding YY, 2006, FEBS J, V273, P5333, DOI 10.1111/j.1742-4658.2006.05526.x; Dolphin AC, 1999, J PHYSIOL-LONDON, V519, P35, DOI 10.1111/j.1469-7793.1999.0035o.x; Durante W, 2003, J CELL PHYSIOL, V195, P373, DOI 10.1002/jcp.10274; Durante W, 2006, J CELL MOL MED, V10, P672, DOI 10.1111/j.1582-4934.2006.tb00427.x; Fearon IM, 2000, PFLUG ARCH EUR J PHY, V441, P181, DOI 10.1007/s004240000424; Gray LS, 2006, CELL CALCIUM, V40, P115, DOI 10.1016/j.ceca.2006.04.014; Iftinca MC, 2009, TRENDS PHARMACOL SCI, V30, P32, DOI 10.1016/j.tips.2008.10.004; Joksovic PM, 2006, J PHYSIOL-LONDON, V574, P415, DOI 10.1113/jphysiol.2006.110395; Jozkowicz A, 2007, ANTIOXID REDOX SIGN, V9, P2099, DOI 10.1089/ars.2007.1659; Kang HW, 2006, J BIOL CHEM, V281, P4823, DOI 10.1074/jbc.M510197200; Karmazinova M, 2010, PFLUG ARCH EUR J PHY, V460, P1015, DOI 10.1007/s00424-010-0874-5; Kim HP, 2006, ANNU REV PHARMACOL, V46, P411, DOI 10.1146/annurev.pharmtox.46.120604.141053; Kuga T, 1996, CIRC RES, V79, P14, DOI 10.1161/01.RES.79.1.14; Kuo IYT, 2011, J PHYSIOL-LONDON, V589, P783, DOI 10.1113/jphysiol.2010.199497; Linley JE, 2008, J NEUROSCI, V28, P11240, DOI 10.1523/JNEUROSCI.2297-08.2008; Lipskaia L, 2009, PFLUG ARCH EUR J PHY, V457, P673, DOI 10.1007/s00424-007-0428-7; Liu BY, 2010, J CLIN INVEST, V120, P1240, DOI 10.1172/JCI41084; Magnusson S, 2000, NEUROSCIENCE, V95, P821; McGivern JG, 2006, DRUG DISCOV TODAY, V11, P245, DOI 10.1016/S1359-6446(05)03662-7; Miwa K, 2005, CIRC J, V69, P291, DOI 10.1253/circj.69.291; Nelson MT, 2007, J NEUROSCI, V27, P12577, DOI 10.1523/JNEUROSCI.2206-07.2007; Nelson MT, 2007, J NEUROSCI, V27, P8250, DOI 10.1523/JNEUROSCI.1800-07.2007; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; Otterbein LE, 2003, NAT MED, V9, P183, DOI 10.1038/nm817; PEERS C, 1990, J PHYSIOL-LONDON, V421, P293, DOI 10.1113/jphysiol.1990.sp017945; Peers C, 2011, EXP PHYSIOL, V96, P836, DOI 10.1113/expphysiol.2011.059063; Peng J, 2001, NEUROPEPTIDES, V35, P297, DOI 10.1054/npep.2001.0880; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; RICHARD S, 1992, BIOCHIM BIOPHYS ACTA, V1160, P95, DOI 10.1016/0167-4838(92)90042-C; Rodman DM, 2005, CIRC RES, V96, P864, DOI 10.1161/01.RES.0000163066.07472.ff; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Scragg JL, 2008, J BIOL CHEM, V283, P24412, DOI 10.1074/jbc.M803037200; Steiner AA, 2001, BRIT J PHARMACOL, V132, P1673, DOI 10.1038/sj.bjp.0704014; Taylor JT, 2008, WORLD J GASTROENTERO, V14, P4984, DOI 10.3748/wjg.14.4984; Todorovic SM, 2011, BRIT J PHARMACOL, V163, P484, DOI 10.1111/j.1476-5381.2011.01256.x; Todorovic SM, 2001, NEURON, V31, P75, DOI 10.1016/S0896-6273(01)00338-5; Tzeng BH, 2012, CARDIOVASC RES, V96, P533, DOI 10.1093/cvr/cvs257; Was H, 2010, CURR DRUG TARGETS, V11, P1551, DOI 10.2174/1389450111009011551; Wilkinson WJ, 2011, J PHYSIOL-LONDON, V589, P3055, DOI 10.1113/jphysiol.2011.206706; Wu LY, 2005, PHARMACOL REV, V57, P585, DOI 10.1124/pr.57.4.3; Xu SZ, 2008, NATURE, V451, P69, DOI 10.1038/nature06414	51	27	29	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2013	27	8					3395	3407		10.1096/fj.13-227249	http://dx.doi.org/10.1096/fj.13-227249			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292BT	23671274				2022-12-25	WOS:000329877600044
J	Li, C; Wei, J; Li, Y; He, X; Zhou, Q; Yan, J; Zhang, J; Liu, Y; Liu, Y; Shu, HB				Li, Chao; Wei, Jin; Li, Ying; He, Xiao; Zhou, Qian; Yan, Jie; Zhang, Jing; Liu, Ying; Liu, Yu; Shu, Hong-Bing			Transmembrane Protein 214 (TMEM214) Mediates Endoplasmic Reticulum Stress-induced Caspase 4 Enzyme Activation and Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER; INVOLVEMENT; MECHANISMS; PATHWAY; CELLS; CRMA; CHOP	Endoplasmic reticulum (ER) stress caused by excessive aggregation of misfolded proteins induces apoptosis. Although ER stress-induced apoptosis has been implicated in many diseases, the detailed mechanisms are not well understood. Here, we identified human transmembrane protein 214 (TMEM214) as a critical mediator of ER stress-induced apoptosis. Overexpression of TMEM214 induced apoptosis, whereas knockdown of TMEM214 inhibited ER stress-induced apoptosis. TMEM214 was localized on the outer membrane of the ER and constitutively associated with procaspase 4, which was also critical for ER stress induced apoptosis. TMEM214-induced apoptosis was abolished by a dominant negative mutant of procaspase 4, whereas caspase 4-induced apoptosis was inhibited by knockdown of TMEM214. Furthermore, knockdown of TMEM214 inhibited the activation and cleavage of procaspase 4 by impairing its recruitment to the ER. Our findings suggest that TMEM214 is essential for ER stress-induced apoptosis by acting as an anchor for recruitment of procaspase 4 to the ER and its subsequent activation.	[Li, Chao; Wei, Jin; Li, Ying; He, Xiao; Zhou, Qian; Yan, Jie; Zhang, Jing; Liu, Ying; Liu, Yu; Shu, Hong-Bing] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China	Wuhan University	Shu, HB (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China.	shuh@whu.edu.cn	WEI, JIN/ABE-6512-2021	Wei, Jin/0000-0002-2832-1610; Liu, Ying/0000-0001-7915-7294; ZHOU, Qian/0000-0002-2249-0739	Chinese Ministry of Science and Technology [2012CB910201]; National Science Foundation of China [91029302, 31130020, 31221061]; Chinese 111 Project Grant [B06018]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese 111 Project Grant	This work was supported by Chinese Ministry of Science and Technology Grant 2012CB910201, by National Science Foundation of China Grants 91029302, 31130020, and 31221061, and by Chinese 111 Project Grant B06018.	Bian ZM, 2009, INVEST OPHTH VIS SCI, V50, P6006, DOI 10.1167/iovs.09-3628; Fischer H, 2002, BIOCHEM BIOPH RES CO, V293, P722, DOI 10.1016/S0006-291X(02)00289-9; Han KJ, 2004, J BIOL CHEM, V279, P15652, DOI 10.1074/jbc.M311629200; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Kamada S, 1997, CELL DEATH DIFFER, V4, P473, DOI 10.1038/sj.cdd.4400268; Lehner B, 2004, GENOME RES, V14, P1315, DOI 10.1101/gr.2122004; Li B, 2011, CELL SIGNAL, V23, P35, DOI 10.1016/j.cellsig.2010.07.019; Marani M, 2002, MOL CELL BIOL, V22, P3577, DOI 10.1128/MCB.22.11.3577-3589.2002; Moon DO, 2011, BIOCHEM PHARMACOL, V82, P1641, DOI 10.1016/j.bcp.2011.08.019; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Santos CXC, 2009, ANTIOXID REDOX SIGN, V11, P2409, DOI 10.1089/ARS.2009.2625; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yamamuro A, 2011, J PHARMACOL SCI, V115, P239, DOI 10.1254/jphs.10217SC; Zhou Q, 1997, J BIOL CHEM, V272, P7797, DOI 10.1074/jbc.272.12.7797	24	47	52	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17908	17917		10.1074/jbc.M113.458836	http://dx.doi.org/10.1074/jbc.M113.458836			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23661706	hybrid, Green Published			2022-12-25	WOS:000320380600078
J	Fernandes, AM; Herlofsen, SR; Karlsen, TA; Kuchler, AM; Floisand, Y; Brinchmann, JE				Fernandes, Amilton M.; Herlofsen, Sarah R.; Karlsen, Tommy A.; Kuchler, Axel M.; Floisand, Yngvar; Brinchmann, Jan E.			Similar Properties of Chondrocytes from Osteoarthritis Joints and Mesenchymal Stem Cells from Healthy Donors for Tissue Engineering of Articular Cartilage	PLOS ONE			English	Article							ANTERIOR CRUCIATE LIGAMENT; X COLLAGEN; BONE-MARROW; KNEE; DEFECTS; DIFFERENTIATION; EXPRESSION; PROTEIN; GROWTH; REPAIR	Lesions of hyaline cartilage do not heal spontaneously, and represent a therapeutic challenge. In vitro engineering of articular cartilage using cells and biomaterials may prove to be the best solution. Patients with osteoarthritis (OA) may require tissue engineered cartilage therapy. Chondrocytes obtained from OA joints are thought to be involved in the disease process, and thus to be of insufficient quality to be used for repair strategies. Bone marrow (BM) derived mesenchymal stem cells (MSCs) from healthy donors may represent an alternative cell source. We have isolated chondrocytes from OA joints, performed cell culture expansion and tissue engineering of cartilage using a disc-shaped alginate scaffold and chondrogenic differentiation medium. We performed real-time reverse transcriptase quantitative PCR and fluorescence immunohistochemistry to evaluate mRNA and protein expression for a range of molecules involved in chondrogenesis and OA pathogenesis. Results were compared with those obtained by using BM-MSCs in an identical tissue engineering strategy. Finally the two populations were compared using genome-wide mRNA arrays. At three weeks of chondrogenic differentiation we found high and similar levels of hyaline cartilage-specific type II collagen and fibrocartilage-specific type I collagen mRNA and protein in discs containing OA and BM-MSC derived chondrocytes. Aggrecan, the dominant proteoglycan in hyaline cartilage, was more abundantly distributed in the OA chondrocyte extracellular matrix. OA chondrocytes expressed higher mRNA levels also of other hyaline extracellular matrix components. Surprisingly BM-MSC derived chondrocytes expressed higher mRNA levels of OA markers such as COL10A1, SSP1 (osteopontin), ALPL, BMP2, VEGFA, PTGES, IHH, and WNT genes, but lower levels of MMP3 and S100A4. Based on the results presented here, OA chondrocytes may be suitable for tissue engineering of articular cartilage.	[Fernandes, Amilton M.; Herlofsen, Sarah R.; Karlsen, Tommy A.; Kuchler, Axel M.; Brinchmann, Jan E.] Univ Oslo, Norwegian Ctr Stem Cell Res, Oslo, Norway; [Fernandes, Amilton M.; Herlofsen, Sarah R.; Karlsen, Tommy A.; Kuchler, Axel M.; Brinchmann, Jan E.] Univ Oslo, Rikshosp, Oslo Univ Hosp, Inst Immunol, N-0027 Oslo, Norway; [Floisand, Yngvar] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Hematol, N-0027 Oslo, Norway	University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway	Brinchmann, JE (corresponding author), Univ Oslo, Norwegian Ctr Stem Cell Res, Oslo, Norway.	jan.brinchmann@rr-research.no			South-Eastern Norway Regional Health Authority; Research Council of Norway; Gidske and Peter Jacob Sorensens Foundation for the Promotion of Science	South-Eastern Norway Regional Health Authority; Research Council of Norway(Research Council of Norway); Gidske and Peter Jacob Sorensens Foundation for the Promotion of Science	This work was supported by a grant from South-Eastern Norway Regional Health Authority, Storforsk and Stamceller grants from the Research Council of Norway and the Gidske and Peter Jacob Sorensens Foundation for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed TAE, 2010, TISSUE ENG PART B-RE, V16, P305, DOI [10.1089/ten.teb.2009.0590, 10.1089/ten.TEB.2009.0590]; Aroen A, 2004, AM J SPORT MED, V32, P211, DOI 10.1177/0363546503259345; Aspden RM, 2008, RHEUMATOLOGY, V47, P1452, DOI 10.1093/rheumatology/ken199; Ballock RT, 2003, J BONE JOINT SURG AM, V85A, P715, DOI 10.2106/00004623-200304000-00021; BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7; Berardini TZ, 2010, NUCLEIC ACIDS RES, V38, pD331, DOI 10.1093/nar/gkp1018; Boeuf S, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt31; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Chu CR, 2010, TISSUE ENG PART B-RE, V16, P105, DOI [10.1089/ten.teb.2009.0452, 10.1089/ten.TEB.2009.0452]; Corr M, 2008, NAT CLIN PRACT RHEUM, V4, P550, DOI 10.1038/ncprheum0904; Crofford LJ, 2001, GASTROENTEROL CLIN N, V30, P863, DOI 10.1016/S0889-8553(05)70217-X; Curl WW, 1997, ARTHROSCOPY, V13, P456, DOI 10.1016/S0749-8063(97)90124-9; Dieppe PA, 2005, LANCET, V365, P965, DOI 10.1016/S0140-6736(05)71086-2; Drissi Hicham, 2005, Molecular Aspects of Medicine, V26, P169, DOI 10.1016/j.mam.2005.01.003; Dysvik B, 2001, BIOINFORMATICS, V17, P369, DOI 10.1093/bioinformatics/17.4.369; Goldring MB, 2011, CURR OPIN RHEUMATOL, V23, P471, DOI 10.1097/BOR.0b013e328349c2b1; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Gomoll AH, 2010, J BONE JOINT SURG AM, V92A, P2470; Grigolo B, 2005, J BONE JOINT SURG AM, V87A, P46, DOI 10.2106/JBJS.C.01685; Grigolo B, 2009, TISSUE ENG PART C-ME, V15, P647, DOI [10.1089/ten.tec.2008.0569, 10.1089/ten.TEC.2008.0569]; Herlofsen SR, 2011, TISSUE ENG PT A, V17, P1003, DOI [10.1089/ten.TEA.2010.0499, 10.1089/ten.tea.2010.0499]; Hjelle K, 2002, ARTHROSCOPY, V18, P730, DOI 10.1053/jars.2002.32839; Jakobsen RB, 2010, KNEE SURG SPORT TR A, V18, P1407, DOI 10.1007/s00167-009-1017-4; Karlsen TA, 2011, TISSUE ENG PART C-ME, V17, P219, DOI [10.1089/ten.tec.2010.0200, 10.1089/ten.TEC.2010.0200]; Karlsson C, 2007, J ORTHOP RES, V25, P152, DOI 10.1002/jor.20287; KIELTY CM, 1985, BIOCHEM J, V227, P545, DOI 10.1042/bj2270545; Knutsen G, 2007, J BONE JOINT SURG AM, V89A, P2105, DOI 10.2106/JBJS.G.00003; KRISTIANSEN A, 2007, EUR BIOPHARM REV SPR, P34; Lin AC, 2009, NAT MED, V15, P1421, DOI 10.1038/nm.2055; Lohmander LS, 2004, ARTHRITIS RHEUM-US, V50, P3145, DOI 10.1002/art.20589; Mackie EJ, 2011, J ENDOCRINOL, V211, P109, DOI 10.1530/JOE-11-0048; Marlovits S, 2006, EUR J RADIOL, V57, P24, DOI 10.1016/j.ejrad.2005.08.009; Matricali GA, 2010, ACTA ORTHOP BELG, V76, P669; Melvik J-E, 2006, US Patent, Patent No. [2006/0159823 A1, 20060159823]; Mueller-Rath R, 2007, BIO-MED MATER ENG, V17, P357; Oslejskova L, 2008, ANN RHEUM DIS, V67, P1499, DOI 10.1136/ard.2007.079905; Pitsillides AA, 2011, NAT REV RHEUMATOL, V7, P654, DOI 10.1038/nrrheum.2011.129; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pullig O, 2000, MATRIX BIOL, V19, P245, DOI 10.1016/S0945-053X(00)00068-8; Roos H, 1995, OSTEOARTHR CARTILAGE, V3, P261, DOI 10.1016/S1063-4584(05)80017-2; Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269; SCHMID TM, 1990, ANN NY ACAD SCI, V580, P64, DOI 10.1111/j.1749-6632.1990.tb17918.x; SCHMID TM, 1985, J CELL BIOL, V100, P598, DOI 10.1083/jcb.100.2.598; SCHMID TM, 1990, DEV BIOL, V138, P53, DOI 10.1016/0012-1606(90)90176-J; Schu S, 2011, J CELL MOL MED; Shahdadfar A, 2008, TISSUE ENG PT A, V14, P1999, DOI 10.1089/ten.tea.2007.0344; Shen G, 2005, Orthod Craniofac Res, V8, P11, DOI 10.1111/j.1601-6343.2004.00308.x; Tchetina EV, 2005, J RHEUMATOL, V32, P876; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; van der Kraan PM, 2012, OSTEOARTHR CARTILAGE, V20, P223, DOI 10.1016/j.joca.2011.12.003; Vasiliadis HS, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003323.pub3; Widuchowski W, 2007, KNEE, V14, P177, DOI 10.1016/j.knee.2007.02.001	53	32	35	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e62994	10.1371/journal.pone.0062994	http://dx.doi.org/10.1371/journal.pone.0062994			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671648	gold, Green Published, Green Submitted			2022-12-25	WOS:000319737700031
J	Kumar, A; Lo Nigro, A; Gysemans, C; Cai, Q; Esguerra, C; Nelson-Holte, M; Heremans, Y; Jimenez-Gonzalez, M; Porciuncula, A; Mathieu, C; Binas, B; Heimberg, H; Prosper, F; Hering, B; Verfaillie, CM; Barajas, M				Kumar, Anujith; Lo Nigro, Antonio; Gysemans, Conny; Cai, Qing; Esguerra, Camila; Nelson-Holte, Molly; Heremans, Yves; Jimenez-Gonzalez, Maria; Porciuncula, Angelo; Mathieu, Chantal; Binas, Bert; Heimberg, Harry; Prosper, Felipe; Hering, Bernhard; Verfaillie, Catherine M.; Barajas, Miguel			Reversal of Hyperglycemia by Insulin-Secreting Rat Bone Marrow- and Blastocyst-Derived Hypoblast Stem Cell-Like Cells	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; PROGENITOR CELLS; MOUSE PANCREAS; IN-VIVO; DIFFERENTIATION; ENDODERM; GENE; EXPRESSION; CULTURE; LIVER	beta-cell replacement may efficiently cure type 1 diabetic (T1D) patients whose insulin-secreting beta-cells have been selectively destroyed by autoantigen-reactive T cells. To generate insulin-secreting cells we used two cell sources: rat multipotent adult progenitor cells (rMAPC) and the highly similar rat extra-embryonic endoderm precursor (rXEN-P) cells isolated under rMAPC conditions from blastocysts (rHypoSC). rMAPC/rHypoSC were sequentially committed to definitive endoderm, pancreatic endoderm, and beta-cell like cells. On day 21, 20% of rMAPC/rHypoSC progeny expressed Pdx1 and C-peptide. rMAPCr/HypoSC progeny secreted C-peptide under the stimulus of insulin agonist carbachol, and was inhibited by the L-type voltage-dependent calcium channel blocker nifedipine. When rMAPC or rHypoSC differentiated d21 progeny were grafted under the kidney capsule of streptozotocin-induced diabetic nude mice, hyperglycemia reversed after 4 weeks in 6/10 rMAPC-and 5/10 rHypoSC-transplanted mice. Hyperglycemia recurred within 24 hours of graft removal and the histological analysis of the retrieved grafts revealed presence of Pdx1-, Nkx6.1- and C-peptide-positive cells. The ability of both rMAPC and HypoSC to differentiate to functional beta-cell like cells may serve to gain insight into signals that govern beta-cell differentiation and aid in developing culture systems to commit other (pluripotent) stem cells to clinically useful beta-cells for cell therapy of T1D.	[Kumar, Anujith; Lo Nigro, Antonio; Cai, Qing; Esguerra, Camila; Nelson-Holte, Molly; Verfaillie, Catherine M.] Katholieke Univ Leuven, Stamcel Inst Leuven, Louvain, Belgium; [Gysemans, Conny; Mathieu, Chantal] Katholieke Univ Leuven, Lab Expt Med & Endocrinol, Louvain, Belgium; [Heremans, Yves; Verfaillie, Catherine M.; Barajas, Miguel] Univ Minnesota, Stem Cell Inst, Minneapolis, MN USA; [Heremans, Yves; Heimberg, Harry] Vrije Univ Brussel, Diabet Res Ctr, Brussels, Belgium; [Jimenez-Gonzalez, Maria; Porciuncula, Angelo; Prosper, Felipe; Barajas, Miguel] Univ Navarra, Univ Navarra Clin, E-31080 Pamplona, Spain; [Jimenez-Gonzalez, Maria; Porciuncula, Angelo; Prosper, Felipe; Barajas, Miguel] Univ Navarra, Fdn Appl Med Res, Div Oncol, E-31080 Pamplona, Spain; [Binas, Bert] Hanyang Univ, Coll Sci & Technol, Div Mol & Life Sci, Ansan, South Korea; [Hering, Bernhard] Univ Minnesota, Diabet Inst Immunol & Transplantat, Minneapolis, MN USA; [Kumar, Anujith] Manipal Inst Regenerat Med, Bangalore, Karnataka, India	KU Leuven; KU Leuven; University of Minnesota System; University of Minnesota Twin Cities; Vrije Universiteit Brussel; University of Navarra; University of Navarra; Hanyang University; University of Minnesota System; University of Minnesota Twin Cities; Manipal Academy of Higher Education (MAHE)	Verfaillie, CM (corresponding author), Katholieke Univ Leuven, Stamcel Inst Leuven, Louvain, Belgium.	catherine.verfaillie@med.kuleuven.be; mbarajas@unav.es	mathieu, chantal/ABD-5505-2021; Esguerra, Camila/N-6159-2015; Prosper, Felipe/H-6859-2017; Esguerra, Camila/D-7657-2014; Barajas, Miguel/AAG-8408-2019; Verfaillie, Catherine/H-5148-2013	mathieu, chantal/0000-0002-4055-5233; Esguerra, Camila/0000-0002-2271-8094; Prosper, Felipe/0000-0001-6115-8790; Esguerra, Camila/0000-0001-7891-1427; Barajas, Miguel/0000-0003-4004-1432; gysemans, conny/0000-0003-3559-6089; Heimberg, Harry/0000-0003-1954-7375; Lo Nigro, Antonio/0000-0003-0137-4525; , ANUJITH/0000-0002-9889-1985; Verfaillie, Catherine/0000-0001-7564-4079	NIH [U19 DK61244]; UCSF/Minnesota Center grant from JDRF; Odysseus grant from FWO [G.0667.07]; K.U.Leuven [IUAPVII-07, EF/05/011, PF/10/019, GOA/11/012]; FWO [G.0601.07]; European Community's Health Seventh Framework Programme [241447]; Fundacion Mutua Madrilena and Caja de Ahorros de Navarra; Instituto de Salud Carlos III [FIS PS09/01250, ISCIII-RETIC RD12/0019/0031]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U19DK061244] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF/Minnesota Center grant from JDRF; Odysseus grant from FWO(FWO); K.U.Leuven(KU Leuven); FWO(FWO); European Community's Health Seventh Framework Programme; Fundacion Mutua Madrilena and Caja de Ahorros de Navarra; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH award U19 DK61244; a UCSF/Minnesota Center grant from JDRF; the G.0667.07 Odysseus grant from FWO; IUAPVII-07, EF/05/011, PF/10/019 and GOA/11/012 funding from the K.U.Leuven to CMV, the FWO grant G.0601.07 to CMV, CG and CM. CG is supported by the European Community's Health Seventh Framework Programme (FP7/2009-2014 under grant agreement 241447 with acronym NAIMIT) and the K.U.Leuven. This work was also supported by the Fundacion Mutua Madrilena and Caja de Ahorros de Navarra, and grants from Instituto de Salud Carlos III (FIS PS09/01250 and ISCIII-RETIC RD12/0019/0031) to FP and MB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguayo-Mazzucato C, 2011, DIABETOLOGIA, V54, P583, DOI 10.1007/s00125-010-2026-z; Baharvand H, 2006, DEV GROWTH DIFFER, V48, P323, DOI 10.1111/j.1440-169x.2006.00867.x; BLACK MA, 1994, CELL SIGNAL, V6, P897, DOI 10.1016/0898-6568(94)90022-1; Collombat P, 2009, CELL, V138, P449, DOI 10.1016/j.cell.2009.05.035; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Debeb BG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007216; Dichmann DS, 2006, DEV DYNAM, V235, P3016, DOI 10.1002/dvdy.20953; Harmon EB, 2004, DEVELOPMENT, V131, P6163, DOI 10.1242/dev.01535; Hebrok M, 1998, GENE DEV, V12, P1705, DOI 10.1101/gad.12.11.1705; HIRIART M, 1993, MOL CELL ENDOCRINOL, V93, P63, DOI 10.1016/0303-7207(93)90140-F; Huotari MA, 2002, ENDOCRINOLOGY, V143, P4437, DOI 10.1210/en.2002-220382; Jacquemin P, 2000, MOL CELL BIOL, V20, P4445, DOI 10.1128/MCB.20.12.4445-4454.2000; Jacquemin P, 2003, DEV BIOL, V258, P105, DOI 10.1016/S0012-1606(03)00115-5; Jiang W, 2007, CELL RES, V17, P333, DOI 10.1038/cr.2007.28; Jung JN, 1999, SCIENCE, V284, P1998, DOI 10.1126/science.284.5422.1998; Kataoka K, 2002, J BIOL CHEM, V277, P49903, DOI 10.1074/jbc.M206796200; Kojima H, 2003, NAT MED, V9, P596, DOI 10.1038/nm867; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kwon GS, 2008, DEV CELL, V15, P509, DOI 10.1016/j.devcel.2008.07.017; Nigro A, 2012, J MOL CELL BIOL, V4, P423, DOI 10.1093/jmcb/mjs046; Matveyenko AV, 2010, AM J PHYSIOL-ENDOC M, V299, pE713, DOI 10.1152/ajpendo.00279.2010; Mfopou JK, 2010, GASTROENTEROLOGY, V138, P2233, DOI 10.1053/j.gastro.2010.02.056; Movassat J, 2002, J CLIN ENDOCR METAB, V87, P4775, DOI 10.1210/jc.2002-020137; Roelandt P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012101; Sancho-Bru P, 2011, J HEPATOL, V54, P98, DOI 10.1016/j.jhep.2010.06.014; Sander M, 2000, DEVELOPMENT, V127, P5533; Serafimidis I, 2008, STEM CELLS, V26, P3, DOI 10.1634/stemcells.2007-0194; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Shi Y, 2005, STEM CELLS, V23, P656, DOI 10.1634/stemcells.2004-0241; SMITH DE, 1992, DEVELOPMENT, V116, P555; Smith SB, 1999, MOL CELL BIOL, V19, P8272; Subramanian K, 2010, METHODS MOL BIOL, V636, P55, DOI 10.1007/978-1-60761-691-7_4; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Ulloa-Montoya F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r163; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Yamaguchi TP, 2001, CURR BIOL, V11, pR713, DOI 10.1016/S0960-9822(01)00417-1; Yechoor V, 2009, DEV CELL, V16, P358, DOI 10.1016/j.devcel.2009.01.012	37	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63491	10.1371/journal.pone.0063491	http://dx.doi.org/10.1371/journal.pone.0063491			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671681	gold, Green Published			2022-12-25	WOS:000319737700052
J	Byun, SH; Ma, SH; Jun, JK; Jung, KW; Park, B				Byun, Sang-Ho; Ma, Seung Hyun; Jun, Jae Kwan; Jung, Kyu-Won; Park, Boyoung			Screening for Diabetic Retinopathy and Nephropathy in Patients with Diabetes: A Nationwide Survey in Korea	PLOS ONE			English	Article							QUALITY-OF-CARE; DIRECT MEDICAL COSTS; UNITED-STATES; GLOBAL PREVALENCE; EYE EXAMINATIONS; COMPLICATIONS; POPULATION; HEALTH; RISK; DISPARITIES	This study was performed to identify factors associated with screening for diabetic retinopathy and nephropathy. Data from the Korean National Health and Nutrition Examination Survey between 2007 and 2009 were analyzed. Of 24,871 participants, 1,288 patients diagnosed with diabetes at >= 30 years of age were included. 36.3% received screening for diabetic retinopathy, and 40.5% received screening for diabetic nephropathy during the previous year. Patients living in rural areas, those with less education, those who had not received education about diabetes care, and those who did not receive medical care for diabetes were screened less often for retinopathy or nephropathy. Patients with poorer self-reported health status were screened more often. Occupation, smoking status, and diabetes duration were associated with retinopathy screening. Lower family income was associated with decreased nephropathy screening. Receiving education about diabetes care and receiving medical care for diabetes were significant factors in patients with a shorter duration of diabetes ( the significant odds ratio [OR] of not receiving education varied between 0.27 and 0.51, and that of not receiving medical care varied between 0.34 and 0.42). Sociodemographic factors and health-related factors as well as education and medical care influenced screening for diabetic complications among those with a longer duration of diabetes ( for retinopathy and nephropathy, the significant OR of living in a rural area varied between 0.56 and 0.61; for retinopathy, the significant OR of current smokers was 0.55, and the p-trend of subjective health status was <0.001; for nephropathy, the significant OR of a monthly household income of <3000 dollars was 0.61 and the p-trends of education and subjective health status were 0.030 and 0.007, respectively). Efforts to decrease sociodemographic disparities should be combined with education about diabetes care to increase the screening, especially for those with a longer duration of diabetes.	[Byun, Sang-Ho; Ma, Seung Hyun] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Jun, Jae Kwan; Jung, Kyu-Won; Park, Boyoung] Natl Canc Ctr, Natl Canc Control Inst, Goyang Si, Gyeonggi Do, South Korea	Seoul National University (SNU); National Cancer Center - Korea (NCC)	Park, B (corresponding author), Natl Canc Ctr, Natl Canc Control Inst, Goyang Si, Gyeonggi Do, South Korea.	hayejine@ncc.re.kr			National Cancer Center of Korea [1310230]	National Cancer Center of Korea	This study was supported by a Grant-in-Aid for Cancer Research and Control from the National Cancer Center of Korea (#1310230. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler AI, 2003, KIDNEY INT, V63, P225, DOI 10.1046/j.1523-1755.2003.00712.x; Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; [Anonymous], 2012, DIABETES CARE S1, V35, pS4, DOI DOI 10.2337/DC12-S004; Brown AF, 2005, DIABETES CARE, V28, P2864, DOI 10.2337/diacare.28.12.2864; Choi YJ, 2009, DIABETES CARE, V32, P2016, DOI 10.2337/dc08-2228; Cutler DM, 2010, J HEALTH ECON, V29, P1, DOI 10.1016/j.jhealeco.2009.10.003; Dervan E, 2008, IRISH J MED SCI, V177, P303, DOI 10.1007/s11845-008-0192-5; Do YK, 2011, INT J QUAL HEALTH C, V23, P397, DOI 10.1093/intqhc/mzr035; Fioretto P, 2006, J AM SOC NEPHROL, V17, pS86, DOI 10.1681/ASN.2005121343; Fowles JB, 1999, INT J QUAL HEALTH C, V11, P407, DOI 10.1093/intqhc/11.5.407; Girach A, 2006, INT J CLIN PRACT, V60, P1471, DOI 10.1111/j.1742-1241.2006.01175.x; Kim TH, 2012, J KOREAN MED SCI, V27, P876, DOI 10.3346/jkms.2012.27.8.876; Lee YH, 2012, DIABETES CARE, V35, P1723, DOI 10.2337/dc11-2347; Lim H, 2012, DIABETES CARE, V35, P2028, DOI 10.2337/dc11-1841; Mangione CM, 2006, ANN INTERN MED, V145, P107, DOI 10.7326/0003-4819-145-2-200607180-00008; Moon Sangho, 2007, World Health Popul, V9, P95; Muller A, 2006, OPTOMETRY VISION SCI, V83, P96, DOI 10.1097/01.opx.0000200678.77515.2e; O'Brien JA, 2003, BMC HEALTH SERV RES, V3, DOI 10.1186/1472-6963-3-7; O'Brien JA, 2003, CLIN THER, V25, P1017, DOI 10.1016/S0149-2918(03)80122-4; Onakpoya OH, 2010, EUR J INTERN MED, V21, P176, DOI 10.1016/j.ejim.2010.01.009; Ramsey Fred, 2008, Morbidity and Mortality Weekly Report, V57, P1; Rossing K, 2004, KIDNEY INT, V66, P1596, DOI 10.1111/j.1523-1755.2004.00925.x; Saaddine JB, 2006, ANN INTERN MED, V144, P465, DOI 10.7326/0003-4819-144-7-200604040-00005; Saadine JB, 2008, RETINA-J RET VIT DIS, V28, P195, DOI 10.1097/IAE.0b013e318115169a; Si DM, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-169; Sundling V, 2008, BMC HEALTH SERV RES, V8, DOI [10.1186/1472-6963-8-38, 10.1186/1472-6963-8-159]; Tapp RJ, 2004, DIABETES CARE, V27, P688, DOI 10.2337/diacare.27.3.688; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Williams R, 2002, DIABETOLOGIA, V45, pS13, DOI 10.1007/s00125-002-0859-9; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909; Yoon JY, 2012, J KOREAN MED SCI, V27, P512, DOI 10.3346/jkms.2012.27.5.512; 신광훈, 2009, [Journal of The Korean Ophthalmological Society, 대한안과학회지], V50, P1319	32	27	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62991	10.1371/journal.pone.0062991	http://dx.doi.org/10.1371/journal.pone.0062991			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	145YI	23667557	Green Submitted, Green Published, gold			2022-12-25	WOS:000319055600049
J	Cao, WF; Zhang, B; Ding, F; Zhang, WR; Sun, BC; Liu, ZH				Cao, Wenfeng; Zhang, Bin; Ding, Fang; Zhang, Weiran; Sun, Baocun; Liu, Zhihua			Expression of SLP-2 Was Associated with Invasion of Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							STOMATIN-LIKE PROTEIN-2; BREAST-CANCER; PROGNOSTIC-FACTOR; GROWTH; OVEREXPRESSION; PROGRESSION; ACTIVATION; MICROARRAY; KINASE; GENES	Introduction: Stomatin-like protein 2 (SLP-2), a member of the Stomatin superfamily, has been identified as an oncogenic-related protein and found to be up-regulated in multi-cancers. Nonetheless, the expression pattern and regulation of SLP-2 in human esophageal squamous cell carcinoma (ESCC) remain unexplored. Methods: Immunohistochemistry and immunofluorescence staining analysis were performed to show SLP-2 expression and location. RNAi method was used to inhibit specific protein expression. Transwell assay was done to investigate cells invasive capability. RT-PCR and Western blot analysis were used to detect mRNA and protein expression levels. Results: Immunohistochemical analysis showed that up-regulation of SLP-2 was found in invasive front compared with cancer central tissue in ESCC. Inhibition of SLP-2 by SLP-2 siRNA can decrease ESCC cells invasive capability through MMP-2 dependent manner. Up-regulation of SLP-2 was effectively abrogated by the ERK1/2 inhibitors either PD98059 or U0126, but no effect was showed by the treatment of AKT inhibitors either LY294002 or MK-2206. So the regulation of SLP-2 was involved in activation of the MAPK/ERK pathway. Conclusions: We found that PMA/EGF could induce the up-regulated expression of SLP-2 probably through activating ERK signalling. The current study suggests that SLP-2 may represent an important molecular hallmark that is clinically relevant to the invasion of ESCC.	[Cao, Wenfeng; Sun, Baocun] Tianjin Med Univ Canc Inst & Hosp, Dept Pathol, Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China; [Cao, Wenfeng; Ding, Fang; Liu, Zhihua] Chinese Acad Med Sci, Inst Canc, State Key Lab Mol Oncol, Beijing 100021, Peoples R China; [Cao, Wenfeng; Ding, Fang; Liu, Zhihua] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhang, Bin; Zhang, Weiran] Tianjin Med Univ Canc Inst & Hosp, Dept Breast Canc, State Key Lab Breast Canc Res, Tianjin, Peoples R China	Tianjin Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Tianjin Medical University	Sun, BC (corresponding author), Tianjin Med Univ Canc Inst & Hosp, Dept Pathol, Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China.	baocunsun@eyou.com; liuzh@cicams.ac.cn			Subject of Science and Technology Development Fund of Tianjin Education Commission [20060108]; Tianjin Municipal Science and Technology Commission Research Fund [10JCYBJC14100]; Tianjin Medical University Cancer Hospital Research Funds	Subject of Science and Technology Development Fund of Tianjin Education Commission; Tianjin Municipal Science and Technology Commission Research Fund; Tianjin Medical University Cancer Hospital Research Funds	This work was partially supported by the grant: Subject of Science and Technology Development Fund of Tianjin Education Commission (20060108), Tianjin Municipal Science and Technology Commission Research Fund (10JCYBJC14100), Tianjin Medical University Cancer Hospital Research Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyinka A, 2002, CLIN CANCER RES, V8, P1747; Albanell J, 2001, CANCER RES, V61, P6500; Brown M, 2010, HISTOPATHOLOGY, V56, P893, DOI 10.1111/j.1365-2559.2010.03559.x; Cao WF, 2007, HUM PATHOL, V38, P747, DOI 10.1016/j.humpath.2006.11.004; Cao WF, 2007, AM J CLIN PATHOL, V128, P430, DOI 10.1309/C6X54HRB580EP2NQ; Cao WF, 2011, PATHOLOGY, V43, P713, DOI 10.1097/PAT.0b013e32834c34ed; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Groblewska M, 2012, FOLIA HISTOCHEM CYTO, V50, P12, DOI [10.5603/FHC.2012.0002, 10.2478/18691]; Ljuslinder I, 2011, INT J CANCER, V128, P2031, DOI 10.1002/ijc.25559; Lu JY, 2001, INT J CANCER, V91, P288, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1063>3.0.CO;2-S; Luo AP, 2004, ONCOGENE, V23, P1291, DOI 10.1038/sj.onc.1207218; Mandell JW, 1998, AM J PATHOL, V153, P1411, DOI 10.1016/S0002-9440(10)65728-8; Oberst MD, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-189; Ohike N, 2010, AM J SURG PATHOL, V34, P1417, DOI 10.1097/PAS.0b013e3181f0b05a; Owczarek CM, 2001, CYTOGENET CELL GENET, V92, P196, DOI 10.1159/000056902; Segal E, 2005, NAT GENET, V37, pS38, DOI 10.1038/ng1561; SHIMADA Y, 1992, CANCER, V69, P277, DOI 10.1002/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C; Tasioudi KE, 2012, PATHOL RES PRACT, V208, P398, DOI 10.1016/j.prp.2012.05.009; Wang YJ, 2000, J BIOL CHEM, V275, P8062, DOI 10.1074/jbc.275.11.8062; Wang YQ, 2009, CANCER BIOL THER, V8, P1658, DOI 10.4161/cbt.8.17.9283; Zhang J, 2005, J PATHOL, V207, P402, DOI 10.1002/path.1846; Zhang Li-Yong, 2005, Ai Zheng, V24, P155; Zhang LY, 2006, CLIN CANCER RES, V12, P1639, DOI 10.1158/1078-0432.CCR-05-1858; Zhang LY, 2004, WORLD CHIN J DIGESTO, V12, P1517; Zhi HY, 2003, INT J CANCER, V106, P327, DOI 10.1002/ijc.11225	25	17	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63890	10.1371/journal.pone.0063890	http://dx.doi.org/10.1371/journal.pone.0063890			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667687	gold, Green Submitted, Green Published			2022-12-25	WOS:000319055600081
J	Cook, S; Leon, DA; Kiryanov, N; Ploubidis, GB; De Stavola, BL				Cook, Sarah; Leon, David A.; Kiryanov, Nikolay; Ploubidis, George B.; De Stavola, Bianca L.			Alcohol-Related Dysfunction in Working-Age Men in Izhevsk, Russia: An Application of Structural Equation Models to Study the Association with Education	PLOS ONE			English	Article							MORTALITY; DRINKING; HANGOVER; CONSUMPTION; POPULATION; PATTERNS; TRENDS; COHORT; ADULTS; LEVEL	Background: Acute alcohol-related dysfunctional behaviours, such as hangover, are predictive of poor health and mortality. Although much is known about the association of education with alcohol consumption, little is known about its association with these dysfunctional behaviours. Methods: The study population was 1,705 male drinkers aged 25-54 years resident in the city of Izhevsk, Russia who participated in a cross-sectional survey (2003-6). Structural equation modelling was used to examine the relationships between education, beverage and non-beverage alcohol intake, drinking patterns, and acute alcohol-related dysfunction score among these drinkers. Results: Dysfunction was related to all other drinking variables, with the strongest predictors being spirit intake, non-beverage alcohol consumption and drinking patterns. There was a strong relationship between education and acute dysfunction which was not explained by adjusting for alcohol intake and drinking patterns (mean adjusted dysfunction score 0.35 SD (95% CI 0.10, 0.61) lower in men with higher versus secondary education). Conclusions: Although by definition one or more aspects of alcohol consumption should explain the educational differences in alcohol-related dysfunction, detailed information on drinking only partly accounted for the observed patterns. Thus beyond their intrinsic interest, these results illustrate the challenges in constructing statistical models that convincingly identify the pathways that link educational differences to health-related outcomes.	[Cook, Sarah; Leon, David A.; Ploubidis, George B.; De Stavola, Bianca L.] London Sch Hyg & Trop Med, London WC1, England; [Kiryanov, Nikolay] Izhevsk State Med Acad, Izhevsk, Russia	University of London; London School of Hygiene & Tropical Medicine	Cook, S (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	sarah.cook@lshtm.ac.uk	Leon, David A/G-2195-2010; Ploubidis, George B/G-9531-2011	Leon, David A/0000-0001-9747-1762; Ploubidis, George B/0000-0002-8198-5790; De Stavola, Bianca Lucia/0000-0001-7853-0528; Cook, Sarah/0000-0003-1250-2967	Wellcome Trust [067232, 078557]	Wellcome Trust(Wellcome TrustEuropean Commission)	The Izhevsk Family Study was funded by the Wellcome Trust (grant numbers 067232 and 078557). S.C. received a UK Medical Research Council PhD Studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames GM, 1997, J STUD ALCOHOL, V58, P37, DOI 10.15288/jsa.1997.58.37; Bessudnov A, 2012, EUR J PUBLIC HEALTH, V22, P332, DOI 10.1093/eurpub/ckr130; Bobak M, 2004, J EPIDEMIOL COMMUN H, V58, P238, DOI 10.1136/jech.2003.011825; Bobrova N, 2009, SUBST USE MISUSE, V44, P1821, DOI 10.3109/10826080802490717; Carlson P, 1998, EUR J PUBLIC HEALTH, V8, P280, DOI 10.1093/eurpub/8.4.280; Cook S, 2011, ALCOHOL ALCOHOLISM, V46, P702, DOI 10.1093/alcalc/agr076; Gil A, 2009, ALCOHOL CLIN EXP RES, V33, P79, DOI 10.1111/j.1530-0277.2008.00813.x; Hills, 1993, STAT MODELS EPIDEMIO; Kline RB, 2005, PRINCIPLES PRACTICE; Leon DA, 2007, LANCET, V369, P2001, DOI 10.1016/S0140-6736(07)60941-6; Leon DA, 2009, ADDICTION, V104, P1630, DOI 10.1111/j.1360-0443.2009.02655.x; Malyutina S, 2004, ALCOHOL ALCOHOLISM, V39, P64, DOI 10.1093/alcalc/agh022; Midanik LT, 1999, ADDICTION, V94, P887, DOI 10.1046/j.1360-0443.1999.94688711.x; Murphy M, 2006, AM J PUBLIC HEALTH, V96, P1293, DOI 10.2105/AJPH.2004.056929; Muthen L.K., 1998, MPLUS USERS GUIDE, V8th; Nemtsov AV, 2002, ADDICTION, V97, P1413, DOI 10.1046/j.1360-0443.2002.00262.x; Nicholson A, 2005, B WORLD HEALTH ORGAN, V83, P812; Paljarvi T, 2011, ADDICTION; Paljarvi T, 2011, ALCOHOL ALCOHOLISM, V46, P607, DOI 10.1093/alcalc/agr072; POIKOLAINEN K, 1983, INT J EPIDEMIOL, V12, P151, DOI 10.1093/ije/12.2.151; Popova S, 2007, ALCOHOL ALCOHOLISM, V42, P465, DOI 10.1093/alcalc/agl124; Prat G, 2009, HUM PSYCHOPHARM CLIN, V24, P259, DOI 10.1002/hup.1023; Pridemore WA, 2010, EUROPEAN J PUBLIC HL; Rohsenow DJ, 2010, ALCOHOL CLIN EXP RES, V34, P509, DOI 10.1111/j.1530-0277.2009.01116.x; Shkolnikov VM, 1998, SOC SCI MED, V47, P357, DOI 10.1016/S0277-9536(98)00096-3; StataCorp, 2019, STATA STAT SOFTWARE; Stephens R, 2008, ALCOHOL ALCOHOLISM, V43, P163, DOI 10.1093/alcalc/agm160; Streiner DL, 2006, CAN J PSYCHIAT, V51, P317, DOI 10.1177/070674370605100507; Tabachnik BG, 2013, USING MULTIVARIATE S, V6th; Tomkins S, 2007, ADDICTION, V102, P544, DOI 10.1111/j.1360-0443.2006.01693.x; Verster JC, 2008, ALCOHOL ALCOHOLISM, V43, P124, DOI 10.1093/alcalc/agm163; Wiese JG, 2000, ANN INTERN MED, V132, P897, DOI 10.7326/0003-4819-132-11-200006060-00008; World Health Organization, 2011, GLOB STAT REP ALC HL; Zaridze D, 2009, INT J EPIDEMIOL, V38, P143, DOI 10.1093/ije/dyn160; Zaridze D, 2009, LANCET, V373, P2201, DOI 10.1016/S0140-6736(09)61034-5	35	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63792	10.1371/journal.pone.0063792	http://dx.doi.org/10.1371/journal.pone.0063792			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	145YI	23667673	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000319055600074
J	Lewis, KB; Hughes, RJ; Epstein, MS; Josephson, NC; Kempton, CL; Kessler, CM; Key, NS; Howard, TE; Kruse-Jarres, R; Lusher, JM; Walsh, CE; Watts, RG; Ettinger, RA; Pratt, KP				Lewis, Kenneth B.; Hughes, Richard J.; Epstein, Melinda S.; Josephson, Neil C.; Kempton, Christine L.; Kessler, Craig M.; Key, Nigel S.; Howard, Tom E.; Kruse-Jarres, Rebecca; Lusher, Jeanne M.; Walsh, Christopher E.; Watts, Raymond G.; Ettinger, Ruth A.; Pratt, Kathleen P.		PATH Personalized Alternative	Phenotypes of Allo- and Autoimmune Antibody Responses to FVIII Characterized by Surface Plasmon Resonance	PLOS ONE			English	Article							FACTOR-VIII ANTIBODIES; HEMOPHILIA-A; IGG4 ANTIBODIES; BETHESDA ASSAY; B-CELL; MONOCLONAL-ANTIBODIES; INHIBITOR ANTIBODIES; DOMAIN ANTIBODIES; IMMUNOGLOBULIN-G; EPITOPE	Evidence of antibody isotype/ subtype switching may provide prognostic value regarding the state of immune responses to therapeutic proteins, e.g. anti-factor VIII (FVIII) antibodies that develop in many hemophilia A patients, clinically termed "inhibitors''. A sensitive, high-information-content surface plasmon resonance (SPR) assay has been developed to quantify IgG subtype distributions and the domain specificity of anti-drug antibodies. Plasma samples from 22 subjects with an alloor auto-immune reaction to FVIII were analyzed. Pre-analytical treatment protocols were developed to minimize nonspecific binding and specific matrix interference due to von Willebrand factor-FVIII interactions. The dynamic range for IgG quantification was 0.2-5 mu g/ml (similar to 1-33 nM), allowing characterization of inhibitor-positive samples. Subtype-specific monoclonal antibodies were used to quantify the IgG subtype distribution of FVIII-specific antibodies. Most samples obtained from multiply-infused inhibitor subjects contained IgG(4) antibodies. Several distinct phenotypes were assigned based on the IgG subtype distribution: IgG(1), IgG(4), IgG(1) & IgG(4), and IgG(1), IgG(2) & IgG(4). An IgG(1)-only response was found in mild/moderate HA subjects during early FVIII infusions, and analysis of serial samples followed antibody class switching as several subjects' immune responses developed. Competition studies utilizing a recombinant FVIII-C2 domain indicated 40-80% of FVIII-specific antibodies in most samples were directed against this domain.	[Lewis, Kenneth B.; Josephson, Neil C.; Ettinger, Ruth A.; Pratt, Kathleen P.] Puget Sound Blood Ctr, Res Inst, Seattle, WA 98104 USA; [Hughes, Richard J.; Epstein, Melinda S.; Howard, Tom E.] Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA USA; [Josephson, Neil C.; Pratt, Kathleen P.] Univ Washington, Div Hematol, Seattle, WA 98195 USA; [Kempton, Christine L.] Emory Univ, Atlanta, GA 30322 USA; [Kessler, Craig M.] Georgetown Univ, Washington, DC USA; [Key, Nigel S.] Univ N Carolina, Chapel Hill, NC USA; [Howard, Tom E.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA; [Howard, Tom E.] USC, Keck Sch Med, Dept Pathol & Lab Med, Los Angeles, CA USA; [Kruse-Jarres, Rebecca] Tulane Univ, New Orleans, LA 70118 USA; [Lusher, Jeanne M.] Wayne State Univ, Detroit, MI USA; [Walsh, Christopher E.] Mt Sinai Sch Med, New York, NY USA; [Watts, Raymond G.] Univ Alabama Birmingham, Birmingham, AL USA	Puget Sound Blood Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of Washington; University of Washington Seattle; Emory University; Georgetown University; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Southern California; University of Southern California Keck Hospital; Tulane University; Wayne State University; Icahn School of Medicine at Mount Sinai; University of Alabama System; University of Alabama Birmingham	Pratt, KP (corresponding author), Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA.	KathleenP@psbc.org	Kempton, Christine/ABG-4398-2020; Pratt, Kathleen P/E-9489-2019	Kempton, Christine/0000-0002-2391-2016; Curran, Joanne/0000-0002-6898-155X; Carless, Melanie/0000-0001-8350-2302; Pratt, Kathleen/0000-0001-6837-6133	NHLBI [1RC2 HL101851]; Bayer HealthCare LLC; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL101851] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Bayer HealthCare LLC(Bayer AGBayer Healthcare Pharmaceuticals); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Major support for this work was from NHLBI 1RC2 HL101851: "Mechanisms of Race-Based Differences in Factor VIII Immunogenicity in Hemophilia A" (PIs TE Howard and KP Pratt). Minor support for this work was from: 1. Unrestricted research support was received under a CSL Behring Foundation Hemophilia grant: "Do Non-Synonymous Single Nucleotide Polymorphisms in Factor VIII Lead to T-Cell Responses and Subsequent Inhibitor Development in Black Hemophilia A Patients?" (PI: KP Pratt), funder: CSL Behring Foundation for Research and Advancement of Patient Health, http://www.cslbehringfoundation.com/.2. Unrestricted research support was received from a Bayer Healthcare LLC grant: "Repository for Human HLA-restricted T-Cell Clones" (PI: KP Pratt), funder: Bayer HealthCare LLC, http://grants-contributions.bayerweb.com/en/home/index. php, 800 Dwight Way, Berkeley, California 94710. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following interests. Dr's. Pratt and Lewis are inventors on a patent describing the SPR methodology described in this study. Dr. Pratt received travel support from GE Health Sciences to present preliminary SPR studies at the 2011 DiPia meeting in Boston, Massachusetts. This study was partly funded by Bayer HealthCare LLC. The authors thank Dr. Jason Schuman (GE Health Sciences) for technical advice and Bill Church (Green Mountain Antibodies, Burlington, Vermont) for donations of monoclonal antibodies. Drs. Lewis and Pratt are inventors on the following patent: International Patent Application No. PCT/US2012/61/553, 660, Title: Antibody Response Phenotyping, Filed: October 31, 2012, Inventors: Kathleen Pratt, PhD; Kenneth Lewis, PhD. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	AALBERSE RC, 1983, J IMMUNOL, V130, P722; Albert T, 2008, THROMB HAEMOSTASIS, V99, P634, DOI 10.1160/TH07-06-0400; Barrow RT, 2000, BLOOD, V95, P564, DOI 10.1182/blood.V95.2.564; Bergmann-Leitner ES, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-129; EHRENFORTH S, 1992, LANCET, V339, P594, DOI 10.1016/0140-6736(92)90874-3; Ejima D, 2005, ANAL BIOCHEM, V345, P250, DOI 10.1016/j.ab.2005.07.004; FULCHER CA, 1987, BLOOD, V69, P1475; FULCHER CA, 1988, BLOOD, V72, P1348; Gibbs E, 2008, J INTERF CYTOK RES, V28, P713, DOI 10.1089/jir.2008.0144; GILLES JGG, 1993, BLOOD, V82, P2452; Gouw SC, 2007, BLOOD, V109, P4693, DOI 10.1182/blood-2006-11-056317; HAMILTON RG, 1993, J IMMUNOL METHODS, V158, P107, DOI 10.1016/0022-1759(93)90263-7; Irigoyen MB, 2011, HAEMOPHILIA, V17, P267, DOI 10.1111/j.1365-2516.2010.02406.x; Jacquemin MG, 1998, BLOOD, V92, P496, DOI 10.1182/blood.V92.2.496.414k16_496_506; KASPER CK, 1975, THROMB DIATH HAEMOST, V34, P612; Kessel C, 2008, MOL IMMUNOL, V46, P8, DOI 10.1016/j.molimm.2008.06.015; Kolfschoten MV, 2007, SCIENCE, V317, P1554, DOI 10.1126/science.1144603; Kopecky EM, 2006, J IMMUNOL METHODS, V308, P90, DOI 10.1016/j.jim.2005.10.016; Krudysz-Amblo J, 2009, BLOOD, V113, P2587, DOI 10.1182/blood-2008-08-174987; Labrijn AF, 2009, NAT BIOTECHNOL, V27, P767, DOI 10.1038/nbt.1553; Lavigne-Lissalde G, 2008, THROMB HAEMOSTASIS, V99, P1090, DOI 10.1160/TH07-08-0497; Lewis KB, 2009, MOL IMMUNOL, V46, P3488, DOI 10.1016/j.molimm.2009.07.009; Ling M, 2001, BRIT J HAEMATOL, V114, P861, DOI 10.1046/j.1365-2141.2001.03067.x; LOLLAR P, 1988, J BIOL CHEM, V263, P10451; Lollar P, 1997, THROMB HAEMOSTASIS, V78, P647; Meeks SL, 2008, BLOOD, V112, P1151, DOI 10.1182/blood-2008-01-132639; Meeks SL, 2007, BLOOD, V110, P4234, DOI 10.1182/blood-2007-06-096842; Narita M, 1997, CLIN DIAGN VIROL, V8, P233, DOI 10.1016/S0928-0197(97)10007-1; Parkkinen J, 2006, VOX SANG, V90, P97, DOI 10.1111/j.1423-0410.2005.00731.x; Paschal RD, 2013, HAEMOPHILIA IN PRESS; Pratt K, 2009, CLIN REV ALLERG IMMU, V37, P80, DOI 10.1007/s12016-009-8120-7; Prescott R, 1997, BLOOD, V89, P3663, DOI 10.1182/blood.V89.10.3663.3663_3663_3671; Raut S, 2003, THROMB HAEMOSTASIS, V90, P385, DOI 10.1160/TH02-09-0086; Reding MT, 2002, THROMB HAEMOSTASIS, V88, P568; Sahud MA, 2007, HAEMOPHILIA, V13, P317, DOI 10.1111/j.1365-2516.2007.01450.x; SANCHEZCUENCA JM, 1990, THROMB RES, V57, P897, DOI 10.1016/0049-3848(90)90156-7; SCANDELLA D, 1989, BLOOD, V74, P1618; SCANDELLA D, 1995, BLOOD, V86, P1811, DOI 10.1182/blood.V86.5.1811.bloodjournal8651811; Shetty S, 2003, ACTA HAEMATOL-BASEL, V109, P18, DOI 10.1159/000067272; Towfighi F, 2005, ACTA HAEMATOL-BASEL, V114, P84, DOI 10.1159/000086580; van Helden PMW, 2008, BRIT J HAEMATOL, V142, P644, DOI 10.1111/j.1365-2141.2008.07232.x; VERBRUGGEN B, 1995, THROMB HAEMOSTASIS, V73, P247; Zakarija A, 2011, HAEMOPHILIA, V17, P636, DOI 10.1111/j.1365-2516.2010.02468.x	43	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e61120	10.1371/journal.pone.0061120	http://dx.doi.org/10.1371/journal.pone.0061120			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667433	Green Submitted, gold, Green Published			2022-12-25	WOS:000319055600009
J	Zhong, J; Sakaki, M; Okada, H; Ahrens, ET				Zhong, Jia; Sakaki, Masashi; Okada, Hideho; Ahrens, Eric T.			In Vivo Intracellular Oxygen Dynamics in Murine Brain Glioma and Immunotherapeutic Response of Cytotoxic T Cells Observed by Fluorine-19 Magnetic Resonance Imaging	PLOS ONE			English	Article							TUMOR OXYGENATION; TENSION; HYPOXIA; VACCINATION; SPECTROSCOPY; RESISTANCE; REGRESSION; RELAXATION; SURVIVAL	Noninvasive biomarkers of anti-tumoral efficacy are of great importance to the development of therapeutic agents. Tumor oxygenation has been shown to be an important indicator of therapeutic response. We report the use of intracellular labeling of tumor cells with perfluorocarbon (PFC) molecules, combined with quantitative F-19 spin-lattice relaxation rate (R-1) measurements, to assay tumor cell oxygen dynamics in situ. In a murine central nervous system (CNS) GL261 glioma model, we visualized the impact of Pmel-1 cytotoxic T cell immunotherapy, delivered intravenously, on intracellular tumor oxygen levels. GL261 glioma cells were labeled ex vivo with PFC and inoculated into the mouse striatum. The R-1 of F-19 labeled cells was measured using localized single-voxel magnetic resonance spectroscopy, and the absolute intracellular partial pressure of oxygen (pO(2)) was ascertained. Three days after tumor implantation, mice were treated with 2x10(7) cytotoxic T cells intravenously. At day five, a transient spike in pO(2) was observed indicating an influx of T cells into the CNS and putative tumor cell apoptosis. Immunohistochemistry and quantitative flow cytometry analysis confirmed that the pO(2) was causally related to the T cells infiltration. Surprisingly, the pO(2) spike was detected even though few (similar to 4x10(4)) T cells actually ingress into the CNS and with minimal tumor shrinkage. These results indicate the high sensitivity of this approach and its utility as a non-invasive surrogate biomarker of anti-cancer immunotherapeutic response in preclinical models.	[Zhong, Jia; Ahrens, Eric T.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Zhong, Jia; Ahrens, Eric T.] Carnegie Mellon Univ, Pittsburgh NMR Ctr Biomed Res, Pittsburgh, PA 15213 USA; [Sakaki, Masashi; Okada, Hideho] Univ Pittsburgh, Sch Med, Dept Neurol Surg, Brain Tumor Program,Canc Inst, Pittsburgh, PA 15261 USA	Carnegie Mellon University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ahrens, ET (corresponding author), Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA.	eta@andrew.cmu.edu	Sakaki, Masashi/ABA-6069-2021	Sakaki, Masashi/0000-0002-4431-3493	National Institutes of Health; Dana Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation	This work is supported in part by grants from the National Institutes of Health and the Dana Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens ET, 2005, NAT BIOTECHNOL, V23, P983, DOI 10.1038/nbt1121; Alberts B, 2002, MOL BIOL CELL; Baldwin NJ, 1996, MAGN RESON IMAGING, V14, P541, DOI 10.1016/0730-725X(96)00049-5; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; DARDZINSKI BJ, 1994, MAGNET RESON MED, V32, P88, DOI 10.1002/mrm.1910320112; di Carlo E, 2007, CANCER IMMUNOL IMMUN, V56, P1323, DOI 10.1007/s00262-007-0326-z; Duong TQ, 2001, MAGN RESON MED, V45, P61, DOI 10.1002/1522-2594(200101)45:1<61::AID-MRM1010>3.0.CO;2-8; El Andaloussi A, 2006, J NEUROSURG, V105, P430, DOI 10.3171/jns.2006.105.3.430; Fujita M, 2009, CANCER RES, V69, P1587, DOI 10.1158/0008-5472.CAN-08-2915; GUO QZ, 1994, ARTIF CELL BLOOD SUB, V22, P1449, DOI 10.3109/10731199409138849; HEES PS, 1993, MAGNET RESON MED, V29, P303, DOI 10.1002/mrm.1910290305; HOLLADAY FP, 1992, NEUROSURGERY, V31, P528, DOI 10.1227/00006123-199209000-00015; Hou HA, 2003, ANESTH ANALG, V96, P1467, DOI 10.1213/01.ANE.0000055648.41152.63; Iwadate Y, 2003, INT J ONCOL, V23, P483; Kadayakkara DKK, 2010, MAGN RESON MED, V64, P1252, DOI 10.1002/mrm.22506; Kalinski P, 2010, SEMIN IMMUNOL, V22, P173, DOI 10.1016/j.smim.2010.03.002; Krohn KA, 2008, J NUCL MED, V49, p129S, DOI 10.2967/jnumed.107.045914; Laukemper-Ostendorf S, 2002, MAGN RESON MED, V47, P82, DOI 10.1002/mrm.10008; Lyng H, 1997, RADIOTHER ONCOL, V44, P163, DOI 10.1016/S0167-8140(97)01920-8; Maes W, 2009, NEURO-ONCOLOGY, V11, P529, DOI 10.1215/15228517-2009-004; MASON RP, 1993, MAGNET RESON MED, V29, P296, DOI 10.1002/mrm.1910290304; MASON RP, 1994, INT J RADIAT ONCOL, V29, P95, DOI 10.1016/0360-3016(94)90231-3; Matsumoto S, 2008, J CLIN INVEST, V118, P1965, DOI 10.1172/JCI34928; NASTALA CL, 1994, J IMMUNOL, V153, P1697; Nishimura F, 2006, CANCER RES, V66, P4478, DOI 10.1158/0008-5472.CAN-05-3825; O I, 2002, ANTICANCER RES, V22, P613; Okada H, 2011, J CLIN ONCOL, V29, P330, DOI 10.1200/JCO.2010.30.7744; Okada H, 2009, CRIT REV IMMUNOL, V29, P1; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; PARHAMI P, 1983, J PHYS CHEM-US, V87, P1928, DOI 10.1021/j100234a020; Perret R, 2008, TISSUE ANTIGENS, V72, P187, DOI 10.1111/j.1399-0039.2008.01088.x; Prins RM, 2003, CANCER RES, V63, P8487; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Tatum JL, 2006, INT J RADIAT BIOL, V82, P699, DOI 10.1080/09553000601002324; TEICHER BA, 1995, HEMATOL ONCOL CLIN N, V9, P475; Van der Sanden BPJ, 1999, INT J RADIAT ONCOL, V44, P649, DOI 10.1016/S0360-3016(98)00555-0; Vaupel P, 2001, MED ONCOL, V18, P243, DOI 10.1385/MO:18:4:243; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Xia MN, 2006, PHYS MED BIOL, V51, P45, DOI 10.1088/0031-9155/51/1/004; Yu JS, 2001, CANCER RES, V61, P842; Yu JX, 2005, CURR MED CHEM, V12, P819, DOI 10.2174/0929867053507342; Zhao DW, 2009, MAGN RESON MED, V62, P357, DOI 10.1002/mrm.22020; Zhao DW, 2004, METHOD ENZYMOL, V386, P378; Zhu XM, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-10	45	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e59479	10.1371/journal.pone.0059479	http://dx.doi.org/10.1371/journal.pone.0059479			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667419	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000319055600001
J	Auguy, F; Fahr, M; Moulin, P; Brugel, A; Laplaze, L; El Mzibri, M; Filali-Maltouf, A; Doumas, P; Smouni, A				Auguy, Florence; Fahr, Mouna; Moulin, Patricia; Brugel, Anais; Laplaze, Laurent; El Mzibri, Mohamed; Filali-Maltouf, Abdelkarim; Doumas, Patrick; Smouni, Abdelaziz			Lead Tolerance and Accumulation in Hirschfeldia incana, a Mediterranean Brassicaceae from Metalliferous Mine Spoils	PLOS ONE			English	Article							METAL HYPERACCUMULATION; ARABIDOPSIS METALLOTHIONEINS; P-1B-TYPE ATPASE; TRACE-ELEMENTS; CADMIUM; PLANT; GENE; ZINC; EXPRESSION; DETOXIFICATION	Lead is a heavy metal of particular concern with respect to environmental quality and health. The lack of plant species that accumulate and tolerate Pb is a limiting factor to understand the molecular mechanisms involved in Pb tolerance. In this study we identified Hirschfeldia incana, a Brassicaceae collected from metalliferous mine spoils in Morocco, as a Pb accumulator plant. H. incana exhibited high Pb accumulation in mine soils and in hydroponic cultures. Major Pb accumulation occurred in the roots and a part of Pb translocated from the roots to the shoots, even to the siliques. These findings demonstrated that H. incana is a Pb accumulator species. The expression of several candidate genes after Pb-exposure was measured by quantitative PCR and two of them, HiHMA4 and HiMT2a, coding respectively for a P1B-type ATPase and a metallothionein, were particularly induced by Pb-exposure in both roots and leaves. The functional characterization of HiHMA4 and HiMT2a was achieved using Arabidopsis T-DNA insertional mutants. Pb content and primary root growth analysis confirmed the role of these two genes in Pb tolerance and accumulation. H. incana could be considered as a good experimental model to identify genes involved in lead tolerance and accumulation in plants.	[Auguy, Florence; Brugel, Anais; Laplaze, Laurent; Doumas, Patrick] Inst Rech Dev, Unite Mixte Rech Diversite Adaptat & Dev Plantes, Montpellier, France; [Auguy, Florence; Fahr, Mouna; El Mzibri, Mohamed; Doumas, Patrick; Smouni, Abdelaziz] Ctr Natl Energie Sci & Tech Nucl, Lab Biotechnol Plantes, Rabat, Morocco; [Auguy, Florence; Fahr, Mouna; Moulin, Patricia; El Mzibri, Mohamed; Filali-Maltouf, Abdelkarim; Doumas, Patrick] Univ Mohammed V Agdal, Lab Mixte Int, Rabat, Morocco; [Fahr, Mouna; Smouni, Abdelaziz] Univ Mohammed V Agdal, Lab Physiol & Biotechnol Vegetale, Rabat, Morocco; [Moulin, Patricia] Univ Mohammed V Agdal, Inst Rech Dev, Unite Serv Instrumentat Moyens Analyt Observ Geop, Lab Microbiol & Biol Mol, Rabat, Morocco; [Laplaze, Laurent] Inst Rech Dev, Lab Mixte Int Adaptat Plantes & Microorganismes A, Lab Commun Microbiol, Dakar, Senegal; [Filali-Maltouf, Abdelkarim] Univ Mohammed V Agdal, Lab Microbiol & Biol Mol, Rabat, Morocco; [Doumas, Patrick] INRA, Unite Mixte Rech Biochim & Physiol Mol Plantes, Montpellier, France	Institut de Recherche pour le Developpement (IRD); Mohammed V University in Rabat; Mohammed V University in Rabat; Institut de Recherche pour le Developpement (IRD); Mohammed V University in Rabat; Institut de Recherche pour le Developpement (IRD); Mohammed V University in Rabat; INRAE; Institut Agro; Montpellier SupAgro; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Doumas, P (corresponding author), Inst Rech Dev, Unite Mixte Rech Diversite Adaptat & Dev Plantes, Montpellier, France.	patrick.doumas@supagro.inra.fr	FAHR, Mouna/AAF-4184-2020; SMOUNI, Abdelaziz/GQZ-1979-2022; Laplaze, Laurent/I-5435-2016; Filali-Maltouf, Abdelkarim/AAD-3681-2022	Laplaze, Laurent/0000-0002-6568-6504; Filali-Maltouf, Abdelkarim/0000-0002-2727-3389; Fahr, Mouna/0000-0002-3818-7304; Smouni, Abdelaziz/0000-0003-2456-038X; Doumas, Patrick/0000-0002-6340-2651	International Joint Laboratory "Laboratoire de Biotechnologie Microbienne et Vegetale"; Centre National de l'Energie, des Sciences et Techniques Nucleaires (CNESTEN)/Institut de Recherche pour le Developpement (IRD)/Universite Mohamed V Agdal, Rabat, Morocco; IRD through a BESCD	International Joint Laboratory "Laboratoire de Biotechnologie Microbienne et Vegetale"; Centre National de l'Energie, des Sciences et Techniques Nucleaires (CNESTEN)/Institut de Recherche pour le Developpement (IRD)/Universite Mohamed V Agdal, Rabat, Morocco; IRD through a BESCD	This research was supported by grants from the International Joint Laboratory "Laboratoire de Biotechnologie Microbienne et Vegetale", Centre National de l'Energie, des Sciences et Techniques Nucleaires (CNESTEN)/Institut de Recherche pour le Developpement (IRD)/Universite Mohamed V Agdal, Rabat, Morocco. Abdelaziz Smouni gratefully acknowledges the support from IRD through a BESCD grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CWN, 1999, J GEOCHEM EXPLOR, V67, P407, DOI 10.1016/S0375-6742(99)00055-2; BAKER A J M, 1989, Biorecovery, V1, P81; BAKER AJM, 1994, NEW PHYTOL, V127, P61, DOI 10.1111/j.1469-8137.1994.tb04259.x; Bernard C, 2004, FEBS LETT, V569, P140, DOI 10.1016/j.febslet.2004.05.036; BROUGHTON WJ, 1971, BIOCHEM J, V125, P1075, DOI 10.1042/bj1251075; Cobbett C, 2002, ANNU REV PLANT BIOL, V53, P159, DOI 10.1146/annurev.arplant.53.100301.135154; Deng DM, 2008, J INTEGR PLANT BIOL, V50, P691, DOI 10.1111/j.1744-7909.2008.00669.x; Dong CJ, 2010, J INTEGR PLANT BIOL, V52, P914, DOI 10.1111/j.1744-7909.2010.00966.x; Gisbert C, 2006, ENVIRON EXP BOT, V56, P19, DOI 10.1016/j.envexpbot.2004.12.002; Gravot A, 2004, FEBS LETT, V561, P22, DOI 10.1016/S0014-5793(04)00072-9; Guo WJ, 2008, PLANT PHYSIOL, V146, P1697, DOI 10.1104/pp.108.115782; Gupta DK, 2010, J HAZARD MATER, V177, P437, DOI 10.1016/j.jhazmat.2009.12.052; Hanikenne M, 2008, NATURE, V453, P391, DOI 10.1038/nature06877; Huang GY, 2009, CHEMOSPHERE, V77, P1026, DOI 10.1016/j.chemosphere.2009.07.073; Hussain D, 2004, PLANT CELL, V16, P1327, DOI 10.1105/tpc.020487; Jin SM, 2006, BIOTECHNOL LETT, V28, P1749, DOI 10.1007/s10529-006-9152-1; Kim DY, 2007, PLANT J, V50, P207, DOI 10.1111/j.1365-313X.2007.03044.x; Kim DY, 2006, PLANT PHYSIOL, V140, P922, DOI 10.1104/pp.105.074146; Kramer U, 2010, ANNU REV PLANT BIOL, V61, P517, DOI 10.1146/annurev-arplant-042809-112156; Kupper H, 2017, METAL IONS LIFE SCI, V17, P491, DOI [10.1590/S1677-04202005000100004, 10.1515/9783110434330-015]; Kushnir S, 2001, PLANT CELL, V13, P89, DOI 10.1105/tpc.13.1.89; Lee J, 2004, PLANT MOL BIOL, V54, P805, DOI 10.1007/s11103-004-0190-6; Lee M, 2005, PLANT PHYSIOL, V138, P827, DOI 10.1104/pp.104.058107; Ma M, 2003, PLANT SCI, V164, P51, DOI 10.1016/S0168-9452(02)00334-5; Madejon P, 2007, CHEMOSPHERE, V67, P20, DOI 10.1016/j.chemosphere.2006.10.008; Margui E, 2005, ANAL CHIM ACTA, V549, P197, DOI 10.1016/j.aca.2005.06.035; Mills RF, 2005, FEBS LETT, V579, P783, DOI 10.1016/j.febslet.2004.12.040; Mills RF, 2003, PLANT J, V35, P164, DOI 10.1046/j.1365-313X.2003.01790.x; Morel M, 2009, PLANT PHYSIOL, V149, P894, DOI 10.1104/pp.108.130294; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Murphy A, PLANT PHYSL, V109, P945; Papoyan A, 2004, PLANT PHYSIOL, V136, P3814, DOI 10.1104/pp.104.044503; Poschenrieder C, 2001, PLANT SOIL, V230, P247, DOI 10.1023/A:1010374732486; Pourrut B, 2011, REV ENVIRON CONTAM T, V213, P113, DOI 10.1007/978-1-4419-9860-6_4; Reeves R, 2006, NATO SCI S SS IV EAR, V68, P25; Roosens NH, 2004, FEBS LETT, V577, P9, DOI 10.1016/j.febslet.2004.08.084; Scholl RL, 2000, PLANT PHYSIOL, V124, P1477, DOI 10.1104/pp.124.4.1477; Smouni A, 2010, CAH AGRIC, V19, P273, DOI 10.1684/agr.2010.0413; Sunkar R, 2000, PLANT J, V24, P533, DOI 10.1046/j.1365-313x.2000.00901.x; Temminghoff E.J., 2004, PLANT ANAL PROCEDURE, V2nd, P16; Van Nevel L, 2007, ENVIRON POLLUT, V150, P34, DOI 10.1016/j.envpol.2007.05.024; Verbruggen N, 2009, NEW PHYTOL, V181, P759, DOI 10.1111/j.1469-8137.2008.02748.x; Verret F, 2004, FEBS LETT, V576, P306, DOI 10.1016/j.febslet.2004.09.023; Walker DJ, 2004, WATER AIR SOIL POLL, V151, P361, DOI 10.1023/B:WATE.0000009901.89000.40; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Wong CKE, 2009, NEW PHYTOL, V181, P71, DOI 10.1111/j.1469-8137.2008.02638.x; Xiao S, 2008, PLANT J, V54, P141, DOI 10.1111/j.1365-313X.2008.03402.x; Xiao S, 2008, PLANT SIGNAL BEHAV, V3, P693, DOI 10.4161/psb.3.9.5845; Xu YF, 2007, CHINESE SCI BULL, V52, P2203, DOI 10.1007/s11434-007-0335-5; Yanqun Z., 2004, CHINA ENV INT, V30, P567, DOI DOI 10.1016/J.ENVINT.2003.10.012; Yu LH, 1998, GENE, V206, P29, DOI 10.1016/S0378-1119(97)00577-5; Zhu W, 2009, J PLANT BIOL, V52, P585, DOI 10.1007/s12374-009-9076-0; Zientara K, 2009, J BIOTECHNOL, V139, P258, DOI 10.1016/j.jbiotec.2008.12.001	53	26	26	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e61932	10.1371/journal.pone.0061932	http://dx.doi.org/10.1371/journal.pone.0061932			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667449	Green Submitted, Green Published, gold			2022-12-25	WOS:000319654700018
J	Crociara, P; Parolisi, R; Conte, D; Fumagalli, M; Bonfanti, L				Crociara, Paola; Parolisi, Roberta; Conte, Daniele; Fumagalli, Marta; Bonfanti, Luca			Cellular and Molecular Characterization of Multipolar Map5-Expressing Cells: A Subset of Newly Generated, Stage-Specific Parenchymal Cells in the Mammalian Central Nervous System	PLOS ONE			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; NEURAL STEM-CELLS; ADULT-RAT BRAIN; SPINAL-CORD; NG2 CELLS; NEUROFIBRILLARY TANGLES; STRUCTURAL PLASTICITY; NG2-EXPRESSING CELLS; MAP1B EXPRESSION; PROGENITOR CELLS	Although extremely interesting in adult neuro-glio-genesis and promising as an endogenous source for repair, parenchymal progenitors remain largely obscure in their identity and physiology, due to a scarce availability of stage-specific markers. What appears difficult is the distinction between real cell populations and various differentiation stages of the same population. Here we focused on a subset of multipolar, polydendrocyte-like cells (mMap5 cells) expressing the microtubule associated protein 5 (Map5), which is known to be present in most neurons. We characterized the morphology, phenotype, regional distribution, proliferative dynamics, and stage-specific marker expression of these cells in the rabbit and mouse CNS, also assessing their existence in other mammalian species. mMap5 cells were never found to co-express the Ng2 antigen. They appear to be a population of glial cells sharing features but also differences with Ng2+progenitor cells. We show that mMap5 cells are newly generated, postmitotic parenchymal elements of the oligodendroglial lineage, thus being a stage-specific population of polydendrocytes. Finally, we report that the number of mMap5 cells, although reduced within the brain of adult/old animals, can increase in neurodegenerative and traumatic conditions.	[Crociara, Paola; Parolisi, Roberta; Conte, Daniele; Bonfanti, Luca] Univ Turin, Neurosci Inst Cavalieri Ottolenghi, Turin, Italy; [Crociara, Paola; Parolisi, Roberta; Conte, Daniele; Bonfanti, Luca] Univ Turin, Dept Vet Sci, Turin, Italy; [Conte, Daniele] Univ Turin, Ctr Mol Biotechnol, Turin, Italy; [Fumagalli, Marta] Univ Milan, Dept Pharmacol Sci, Milan, Italy	University of Turin; University of Turin; University of Turin; University of Milan	Bonfanti, L (corresponding author), Univ Turin, Neurosci Inst Cavalieri Ottolenghi, Turin, Italy.	luca.bonfanti@unito.it	Bonfanti, Luca/AAW-2997-2021; Crociara, Paola/N-4862-2019; Fumagalli, Marta/AEP-4117-2022	Crociara, Paola/0000-0001-7446-1609; Fumagalli, Marta/0000-0002-0158-842X; Parolisi, Roberta/0000-0002-1948-7766	Compagnia di San Paolo [NEUROTRANSPLANT 2008.2192]; Universita di Torino, Regione Piemonte	Compagnia di San Paolo(Compagnia di San Paolo); Universita di Torino, Regione Piemonte	Funding provided by Compagnia di San Paolo (NEUROTRANSPLANT 2008.2192), Universita di Torino, Regione Piemonte. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2005, NATURE, V438, P224, DOI 10.1038/nature04256; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; BLACK MM, 1994, J NEUROSCI, V14, P857; BLOOM GS, 1985, P NATL ACAD SCI USA, V82, P5404, DOI 10.1073/pnas.82.16.5404; Boda E, 2011, GLIA, V59, P1958, DOI 10.1002/glia.21237; Bonfanti L, 2007, PROG NEUROBIOL, V83, P24, DOI 10.1016/j.pneurobio.2006.11.002; Bonfanti L, 2011, EUR J NEUROSCI, V34, P930, DOI 10.1111/j.1460-9568.2011.07832.x; Bonfanti L, 2011, THESCIENTIFICWORLDJO, V11, P1270, DOI 10.1100/tsw.2011.113; Bradl M, 2010, ACTA NEUROPATHOL, V119, P37, DOI 10.1007/s00401-009-0601-5; Butt AM, 2005, J ANAT, V207, P695, DOI 10.1111/j.1469-7580.2005.00458.x; CALVERT R, 1985, EMBO J, V4, P1171, DOI 10.1002/j.1460-2075.1985.tb03756.x; Chauhan N, 1997, NEUROCHEM RES, V22, P713, DOI 10.1023/A:1027306227402; Chen Y, 2009, NAT NEUROSCI, V12, P1398, DOI 10.1038/nn.2410; Cheng AW, 1999, DEV BRAIN RES, V113, P107, DOI 10.1016/S0165-3806(99)00006-1; Ciana P, 2006, EMBO J, V25, P4615, DOI 10.1038/sj.emboj.7601341; Coffee RL, 2012, HUM MOL GENET, V21, P900, DOI 10.1093/hmg/ddr527; Dawson MRL, 2003, MOL CELL NEUROSCI, V24, P476, DOI 10.1016/S1044-7431(03)00210-0; Emery B, 2010, SCIENCE, V330, P779, DOI 10.1126/science.1190927; FISCHER I, 1990, J NEUROSCI RES, V27, P112, DOI 10.1002/jnr.490270117; Frohlich N, 2011, J ANAT, V219, P18, DOI 10.1111/j.1469-7580.2011.01392.x; Fumagalli M, 2011, J BIOL CHEM, V286, P10593, DOI 10.1074/jbc.M110.162867; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gonzalez-Billault C, 2001, MOL BIOL CELL, V12, P2087, DOI 10.1091/mbc.12.7.2087; GREENE LA, 1983, J CELL BIOL, V96, P76, DOI 10.1083/jcb.96.1.76; HASEGAWA M, 1990, NEURON, V4, P909, DOI 10.1016/0896-6273(90)90144-5; Ihrie RA, 2011, NEURON, V70, P674, DOI 10.1016/j.neuron.2011.05.004; Kawakami SI, 2003, CELL MOL NEUROBIOL, V23, P887, DOI 10.1023/B:CEMN.0000005317.79634.27; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; Keirstead HS, 1998, GLIA, V22, P161, DOI 10.1002/(SICI)1098-1136(199802)22:2<161::AID-GLIA7>3.3.CO;2-Z; Kozorovitskiy Y, 2003, J CLIN EXP NEUROPSYC, V25, P721, DOI 10.1076/jcen.25.5.721.14580; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kukley M, 2010, J NEUROSCI, V30, P8320, DOI 10.1523/JNEUROSCI.0854-10.2010; Lecca D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003579; Ligon KL, 2006, GLIA, V54, P1, DOI 10.1002/glia.20273; Lu R, 2004, P NATL ACAD SCI USA, V101, P15201, DOI 10.1073/pnas.0404995101; Luzzati F, 2006, J NEUROSCI, V26, P609, DOI 10.1523/JNEUROSCI.4371-05.2006; Lytle JM, 2009, GLIA, V57, P270, DOI 10.1002/glia.20755; Ma D, 2000, NEUROSCIENCE, V99, P157, DOI 10.1016/S0306-4522(00)00141-X; Ma D, 1997, J NEUROSCI RES, V49, P319, DOI 10.1002/(SICI)1097-4547(19970801)49:3<319::AID-JNR7>3.0.CO;2-F; Ma DL, 1999, BRAIN RES, V823, P141, DOI 10.1016/S0006-8993(99)01148-8; Majewska B, 2000, INT J DEV NEUROSCI, V18, P113, DOI 10.1016/S0736-5748(99)00070-2; Mansfield SG, 1991, J NEUROCYTOL, V21, P1007; Nishiyama A, 1996, J NEUROSCI RES, V43, P299, DOI 10.1002/(SICI)1097-4547(19960201)43:3<299::AID-JNR5>3.0.CO;2-E; Nishiyama A, 2007, NEUROSCIENTIST, V13, P62, DOI 10.1177/1073858406295586; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Nothias F, 1996, J COMP NEUROL, V368, P317, DOI 10.1002/(SICI)1096-9861(19960506)368:3<317::AID-CNE1>3.0.CO;2-8; Ohyu J, 1997, BRAIN DEV-JPN, V19, P541, DOI 10.1016/S0387-7604(97)00075-2; Oudega M, 1995, J ANAT, V187, P723; Pevny LH, 2010, INT J BIOCHEM CELL B, V42, P421, DOI 10.1016/j.biocel.2009.08.018; Polito A, 2005, J ANAT, V207, P707, DOI 10.1111/j.1469-7580.2005.00454.x; Ponti G, 2006, DEV BIOL, V294, P168, DOI 10.1016/j.ydbio.2006.02.037; Ponti G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002366; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; RamonCueto A, 1997, NEUROSCIENCE, V77, P485, DOI 10.1016/S0306-4522(96)00437-X; Richardson WD, 2011, NEURON, V70, P661, DOI 10.1016/j.neuron.2011.05.013; RIEDERER B, 1986, J NEUROCYTOL, V15, P763, DOI 10.1007/BF01625193; Riederer BM, 2007, BRAIN RES BULL, V71, P541, DOI 10.1016/j.brainresbull.2006.11.012; RIEDERER BM, 1995, J NEUROCYTOL, V24, P45, DOI 10.1007/BF01370159; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; Rudrabhatla P, 2011, FASEB J, V25, P3896, DOI 10.1096/fj.11-181297; SCHOENFELD TA, 1989, J NEUROSCI, V9, P1712; Simon C, 2011, GLIA, V59, P869, DOI 10.1002/glia.21156; Soares S, 1998, J COMP NEUROL, V396, P193; Soares S, 2007, EUR J NEUROSCI, V26, P1446, DOI 10.1111/j.1460-9568.2007.05794.x; STALLCUP WB, 1981, DEV BIOL, V83, P154, DOI 10.1016/S0012-1606(81)80018-8; Stolt CC, 2010, INT J BIOCHEM CELL B, V42, P437, DOI 10.1016/j.biocel.2009.07.014; Trotter J, 2010, BRAIN RES REV, V63, P72, DOI 10.1016/j.brainresrev.2009.12.006; TUCKER RP, 1989, NEURON, V2, P1245, DOI 10.1016/0896-6273(89)90309-7; TUCKER RP, 1990, BRAIN RES REV, V15, P101, DOI 10.1016/0165-0173(90)90013-E; Ulfig N, 2000, NEUROSCI RES, V38, P397, DOI 10.1016/S0168-0102(00)00189-9; ULLOA L, 1994, GLIA, V10, P266, DOI 10.1002/glia.440100405; Velez-Fort M, 2009, GLIA, V57, P1104, DOI 10.1002/glia.20834; VIERECK C, 1989, J NEUROSCI, V9, P3547; VOUYIOUKLIS DA, 1993, J NEUROSCI RES, V35, P257, DOI 10.1002/jnr.490350305; Vouyiouklis DA, 1995, J NEUROSCI RES, V42, P803, DOI 10.1002/jnr.490420609; Watanabe M, 2006, J NEUROSCI RES, V84, P525, DOI 10.1002/jnr.20950; Wu HY, 2001, MOL CELL NEUROSCI, V17, P292, DOI 10.1006/mcne.2000.0941; Zhao LX, 2006, MOL BIOL CELL, V17, P4179, DOI 10.1091/mbc.E06-04-0355	78	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63258	10.1371/journal.pone.0063258	http://dx.doi.org/10.1371/journal.pone.0063258			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667595	Green Submitted, Green Published, gold			2022-12-25	WOS:000319654700125
J	Mughal, N; Coppotelli, G; Callegari, S; Gastaldello, S; Masucci, MG				Mughal, Nouman; Coppotelli, Giuseppe; Callegari, Simone; Gastaldello, Stefano; Masucci, Maria G.			Interaction of Gamma-Herpesvirus Genome Maintenance Proteins with Cellular Chromatin	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; SARCOMA-ASSOCIATED HERPESVIRUS; NUCLEAR ANTIGEN 1; KAPOSIS-SARCOMA; DNA-SEQUENCES; PROTEASOMAL DEGRADATION; METAPHASE CHROMOSOMES; GENE-EXPRESSION; ENCODED LANA; VIRAL GENOME	The capacity of gamma-herpesviruses to establish lifelong infections is dependent on the expression of genome maintenance proteins (GMPs) that tether the viral episomes to cellular chromatin and allow their persistence in latently infected proliferating cells. Here we have characterized the chromatin interaction of GMPs encoded by viruses belonging to the genera Lymphocryptovirus (LCV) and Rhadinovirus (RHV). We found that, in addition to a similar diffuse nuclear localization and comparable detergent resistant interaction with chromatin in transfected cells, all GMPs shared the capacity to promote the decondensation of heterochromatin in the A03-1 reporter cell line. They differed, however, in their mobility measured by fluorescence recovery after photobleaching (FRAP), and in the capacity to recruit accessory molecules required for the chromatin remodeling function. While the AT-hook containing GMPs of LCVs were highly mobile, a great variability was observed among GMPs encoded by RHV, ranging from virtually immobile to significantly reduced mobility compared to LCV GMPs. Only the RHV GMPs recruited the bromo- and extra terminal domain (BET) proteins BRD2 and BRD4 to the site of chromatin remodeling. These findings suggest that differences in the mode of interaction with cellular chromatin may underlie different strategies adopted by these viruses for reprogramming of the host cells during latency.	[Mughal, Nouman; Coppotelli, Giuseppe; Callegari, Simone; Gastaldello, Stefano; Masucci, Maria G.] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden	Karolinska Institutet	Masucci, MG (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden.	maria.masucci@ki.se	Coppotelli, Giuliano/P-5558-2014; Gastaldello, Stefano/AAM-6768-2020; Gastaldello, Stefano/AAD-3788-2020; Masucci, Maria/AAC-6666-2019	Gastaldello, Stefano/0000-0001-7369-8452; Masucci, Maria/0000-0002-5541-2809	Kasrolisnka Institutet; Swedish research Council; Swedish Cancer Research Foundation	Kasrolisnka Institutet; Swedish research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Research Foundation	Funding provided by Kasrolisnka Institutet, Swedish research Council, Swedish Cancer Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	BAER R, 1984, NATURE, V310, P207, DOI 10.1038/310207a0; Barbera AJ, 2006, SCIENCE, V311, P856, DOI 10.1126/science.1120541; Belkina AC, 2012, NAT REV CANCER, V12, P465, DOI 10.1038/nrc3256; Blake N, 2010, J GEN VIROL, V91, P829, DOI 10.1099/vir.0.018242-0; Burnside KL, 2006, VIROLOGY, V354, P103, DOI 10.1016/j.virol.2006.06.022; Canaan A, 2009, P NATL ACAD SCI USA, V106, P22421, DOI 10.1073/pnas.0911676106; Cesarman E, 2011, CANCER LETT, V305, P163, DOI 10.1016/j.canlet.2011.03.003; Cleynen I, 2008, INT J ONCOL, V32, P289; Coppotelli G, 2013, NUCL ACIDS IN PRESS; Coppotelli G, 2011, J BIOL CHEM, V286, P19565, DOI 10.1074/jbc.M111.224782; Dresang LR, 2009, J VIROL, V83, P2930, DOI 10.1128/JVI.01974-08; FALK K, 1995, J GEN VIROL, V76, P779, DOI 10.1099/0022-1317-76-4-779; Feeney KM, 2009, P ROY SOC B-BIOL SCI, V276, P1535, DOI 10.1098/rspb.2008.1642; Hirai H, 2010, INT J DEV BIOL, V54, P1589, DOI 10.1387/ijdb.103194hh; Jourdan N, 2012, J VIROL, V86, P5314, DOI 10.1128/JVI.06303-11; Katano H, 1999, AM J PATHOL, V155, P47, DOI 10.1016/S0002-9440(10)65097-3; Krithivas A, 2002, J VIROL, V76, P11596, DOI 10.1128/JVI.76.22.11596-11604.2002; Lu F, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-262; Marechal V, 1999, J VIROL, V73, P4385, DOI 10.1128/JVI.73.5.4385-4392.1999; Mcwilliam H, 2009, NUCLEIC ACIDS RES, V37, pW6, DOI 10.1093/nar/gkp302; Moore PS, 1996, J VIROL, V70, P549, DOI 10.1128/JVI.70.1.549-558.1996; Ottinger M, 2006, J VIROL, V80, P10772, DOI 10.1128/JVI.00804-06; Phair RD, 2004, METHOD ENZYMOL, V375, P393; Reeves R, 2010, BBA-GENE REGUL MECH, V1799, P3, DOI 10.1016/j.bbagrm.2009.09.001; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; Robinett CC, 1996, J CELL BIOL, V135, P1685, DOI 10.1083/jcb.135.6.1685; Sears J, 2004, J VIROL, V78, P11487, DOI 10.1128/JVI.78.21.11487-11505.2004; Sharipo A, 2001, FEBS LETT, V499, P137, DOI 10.1016/S0014-5793(01)02542-X; Shinohara H, 2002, J VIROL, V76, P12917, DOI 10.1128/JVI.76.24.12917-12924.2002; Shire K, 1999, J VIROL, V73, P2587, DOI 10.1128/JVI.73.4.2587-2595.1999; Si HX, 2008, J VIROL, V82, P6734, DOI 10.1128/JVI.00342-08; Smeenk G, 2010, J CELL BIOL, V190, P741, DOI 10.1083/jcb.201001048; Sompallae R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012052; Soutoglou E, 2002, SCIENCE, V295, P1901, DOI 10.1126/science.1068356; Stuber G, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-28; Tumbar T, 1999, J CELL BIOL, V145, P1341, DOI 10.1083/jcb.145.7.1341; Verma SC, 2003, J VIROL, V77, P12494, DOI 10.1128/JVI.77.23.12494-12506.2003; Virgin HW, 1997, J VIROL, V71, P5894, DOI 10.1128/JVI.71.8.5894-5904.1997; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weidner-Glunde M, 2010, FRONT BIOSCI-LANDMRK, V15, P537, DOI 10.2741/3632; Woodard C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002972; Yates JL, 1996, VIROLOGY, V222, P1, DOI 10.1006/viro.1996.0392; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111	43	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62783	10.1371/journal.pone.0062783	http://dx.doi.org/10.1371/journal.pone.0062783			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667520	Green Published, gold, Green Submitted			2022-12-25	WOS:000319654700063
J	Nishioka, M; Imaizumi, A; Ando, T; Tochikubo, O				Nishioka, Manabu; Imaizumi, Akira; Ando, Toshihiko; Tochikubo, Osamu			The Overnight Effect of Dietary Energy Balance on Postprandial Plasma Free Amino Acid (PFAA) Profiles in Japanese Adult Men	PLOS ONE			English	Article							DIURNAL-VARIATIONS; LUNG-CANCER; PROTEIN; METABOLISM; INGESTION; DIAGNOSIS; RESPONSES; REAGENTS; CASEIN; MUSCLE	The plasma free amino acid (PFAA) profile is affected by various nutritional conditions, such as the dietary energy balance. Regarding the clinical use of PFAA profiling, it is of concern that differences in food ingestion patterns may generate systematic errors in a plasma amino acid profile and constitute a confounding factor in assessment. In this study, the overnight impact of the dietary energy balance on the postprandial plasma amino acid profile was investigated to elucidate in particular the effects of high protein meals typical in Japanese cuisine. We conducted diet-controlled, crossover trials in eleven healthy male volunteers aged 40-61 y. They consumed either a normal meal (meal N) or high protein meal (meal H) at dinner. Forearm venous blood was collected, and plasma amino acid concentrations were measured before dinner and the next morning. We found that a high protein meal in the evening that contained 40% energy would significantly increase the PFAA concentration the next morning, even more than 12 hours after the meal. Among amino acids, the most significant difference was observed in the branched-chain amino acids (BCAAs) and in some urea-cycle related compounds. If the subject consumed the high protein diet at dinner, the PFAA profile after overnight fasting might be still affected by the meal even 12 hours after the meal, suggesting that the PFAA profile does not reflect the subject's health condition, but rather the acute effect of high protein ingestion.	[Nishioka, Manabu] Comfort Med Fdn, Liberty Sq Clin, Kawasaki, Kanagawa, Japan; [Imaizumi, Akira] Ajinomoto Co Inc, Inst Innovat, Kawasaki, Kanagawa, Japan; [Ando, Toshihiko] Ajinomoto Co Inc, Dept AminoIndex, Tokyo, Japan; [Tochikubo, Osamu] Kanagawa Hlth Serv Assoc, Yokohama, Kanagawa, Japan	Ajinomoto Co Inc; Ajinomoto Co Inc	Imaizumi, A (corresponding author), Ajinomoto Co Inc, Inst Innovat, Kawasaki, Kanagawa, Japan.	akira_imaizumi@ajinomoto.com		Imaizumi, Akira/0000-0002-8615-1007	Ministry of Education, Culture, Sports, Science and Technology of Japan [17390195]; Ajinomoto, CO., Inc.	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ajinomoto, CO., Inc.	This work has been supported by a Grant-in-Aid for Scientific Research on Basic Research B (No. 17390195) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (http://kaken.nii.ac.jp/d/p/17390195.ja.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Ajinomoto, CO., Inc. did have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts. Akira Imaizumi and Toshihiko Ando are employees of Ajinomoto, CO., Inc. Osamu Tochikubo received a research grant from Ajinomoto, CO., Inc. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	ASHLEY DV, 1982, AM J CLIN NUTR, V36, P143, DOI 10.1093/ajcn/36.1.143; Boirie Y, 1997, P NATL ACAD SCI USA, V94, P14930, DOI 10.1073/pnas.94.26.14930; Bossola M, 2009, J RENAL NUTR, V19, P2, DOI 10.1053/j.jrn.2008.10.003; Cheng SS, 2012, CIRCULATION, V125, P2222, DOI 10.1161/CIRCULATIONAHA.111.067827; FERNSTROM JD, 1979, AM J CLIN NUTR, V32, P1912, DOI 10.1093/ajcn/32.9.1912; FERNSTROM JD, 1979, AM J CLIN NUTR, V32, P1923, DOI 10.1093/ajcn/32.9.1923; FISCHER JE, 1975, SURGERY, V78, P276; Fischer K, 2002, PHYSIOL BEHAV, V75, P411, DOI 10.1016/S0031-9384(01)00676-X; GARIBOTTO G, 1993, NEPHRON, V64, P216, DOI 10.1159/000187317; HEBER D, 1985, CANCER, V55, P225, DOI 10.1002/1097-0142(19850101)55:1+<225::AID-CNCR2820551304>3.0.CO;2-7; Hisamatsu T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031131; KERN KA, 1988, JPEN-PARENTER ENTER, V12, P286, DOI 10.1177/0148607188012003286; Lacroix M, 2006, AM J CLIN NUTR, V84, P1070, DOI 10.1093/ajcn/84.5.1070; Maeda J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-690; Magnusson M, 2012, EUR HEART J; MARRS TC, 1975, BRIT J NUTR, V34, P259, DOI 10.1017/S000711457500030X; Miyagi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024143; MORRISON WL, 1988, EUR J CLIN INVEST, V18, P648, DOI 10.1111/j.1365-2362.1988.tb01282.x; Nakamura M, 1998, P YAMANASHI MED COL, V15, P35; NASSET ES, 1979, J NUTR, V109, P621, DOI 10.1093/jn/109.4.621; Noguchi Y, 2006, AM J CLIN NUTR, V83, p513S; Noguchi Y, 2008, PHYSIOL GENOMICS, V34, P315, DOI 10.1152/physiolgenomics.00007.2008; OKAMOTO N, 2011, NINGEN DOCK, V26, P454; Polge A, 1997, AGE AGEING, V26, P457, DOI 10.1093/ageing/26.6.457; Proenza AM, 2003, J NUTR BIOCHEM, V14, P133, DOI 10.1016/S0955-2863(02)00225-5; Riggio O, 1989, Recenti Prog Med, V80, P591; Shikata N, 2007, AMINO ACIDS, V33, P113, DOI 10.1007/s00726-006-0412-0; Shimbo K, 2010, BIOMED CHROMATOGR, V24, P683, DOI 10.1002/bmc.1346; Shimbo K, 2009, ANAL CHEM, V81, P5172, DOI 10.1021/ac900470w; Shimbo K, 2009, RAPID COMMUN MASS SP, V23, P1483, DOI 10.1002/rcm.4026; TORRES N, 1995, J NUTR, V125, P1884, DOI 10.1093/jn/125.7.1884; Tremblay F, 2007, ANNU REV NUTR, V27, P293, DOI 10.1146/annurev.nutr.25.050304.092545; Tsai PJ, 2000, J FORMOS MED ASSOC, V99, P151; van Loon LJC, 2000, AM J CLIN NUTR, V72, P96; Velazquez A, 2000, ARCH MED RES, V31, P145, DOI 10.1016/S0188-4409(00)00053-9; Vissers YLJ, 2005, AM J CLIN NUTR, V81, P1142; Volpi E, 2001, JAMA-J AM MED ASSOC, V286, P1206, DOI 10.1001/jama.286.10.1206; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Yamakado M, 2012, CLIN OBES, V2, P29, DOI 10.1111/j.1758-8111.2012.00039.x; Zhang QW, 2006, HEPATOL RES, V34, P170, DOI 10.1016/j.hepres.2005.12.006	40	19	20	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62929	10.1371/journal.pone.0062929	http://dx.doi.org/10.1371/journal.pone.0062929			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667542	Green Published, gold, Green Submitted			2022-12-25	WOS:000319654700081
J	Wang, Q; Wagner, RT; Cooney, AJ				Wang, Qin; Wagner, Ryan T.; Cooney, Austin J.			Regulatable In Vivo Biotinylation Expression System in Mouse Embryonic Stem Cells	PLOS ONE			English	Article							KRUPPEL-LIKE FACTOR-4; NANOG GENE-EXPRESSION; SELF-RENEWAL; TRANSCRIPTIONAL NETWORK; SIGNALING PATHWAYS; ES CELLS; DIFFERENTIATION; PLURIPOTENCY; KLF4; STATE	Embryonic stem (ES) cells have several unique attributes, the two most important of which are they can differentiate into all cell types in the body and they can proliferate indefinitely. To study the regulation of these phenomena, we developed a regulatable in vivo biotinylation expression system in mouse ES cells. The E. coli biotin ligase gene BirA, whose protein product can biotinylate a 15-aa peptide sequence, called the AviTag, was cloned downstream of an IRES. The primary vector containing the doxycycline controlled transactivator gene tTA and IRES-BirA was knocked into the ROSA26 locus by homologous recombination. The secondary vector containing the AviTag tagged hKlf4 gene was exchanged into the ROSA26 locus using Cre recombinase. Western blot analysis showed that the doxycycline induced BirA protein can biotinylate the doxycycline induced AviTag tagged hKlf4 protein. The induction of hKlf4 repressed cell growth in the presence or absence of LIF. Chromatin immunoprecipitation assays using streptavidin beads showed that the AviTag tagged hKlf4 protein could enrich the Nanog enhancer. Our results suggested that the regulatable biotinylation system is promising for the gene function studies in mouse ES cells.	[Wang, Qin; Wagner, Ryan T.; Cooney, Austin J.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine	Cooney, AJ (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	acooney@bcm.edu			National Institute of General Medical Sciences [P01GM081627]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081627] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by a grant to A.J.C. from the National Institute of General Medical Sciences (P01GM081627). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourillot PY, 2009, STEM CELLS, V27, P1760, DOI 10.1002/stem.110; Bruce SJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-365; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Ghaleb AM, 2005, CELL RES, V15, P92, DOI 10.1038/sj.cr.7290271; Gu PL, 2005, MOL CELL BIOL, V25, P8507, DOI 10.1128/MCB.25.19.8507-8519.2005; Gu PL, 2005, MOL CELL BIOL, V25, P3492, DOI 10.1128/MCB.25.9.3492-3505.2005; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hall J, 2009, CELL STEM CELL, V5, P597, DOI 10.1016/j.stem.2009.11.003; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; Li Y, 2005, BLOOD, V105, P635, DOI 10.1182/blood-2004-07-2681; Lu R, 2011, J BIOL CHEM, V286, P8425, DOI 10.1074/jbc.M110.202150; Masui S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni043; McConnell BB, 2007, BIOESSAYS, V29, P549, DOI 10.1002/bies.20581; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Parisi S, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-128; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Schulz H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006804; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; van den Berg DLC, 2008, MOL CELL BIOL, V28, P5986, DOI 10.1128/MCB.00301-08; Wagner RT, 2010, STEM CELLS, V28, P1794, DOI 10.1002/stem.502; Whitney EM, 2006, GENE EXPRESSION, V13, P85, DOI 10.3727/000000006783991908; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhang PL, 2010, J BIOL CHEM, V285, P9180, DOI 10.1074/jbc.M109.077958	34	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63532	10.1371/journal.pone.0063532	http://dx.doi.org/10.1371/journal.pone.0063532			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667633	Green Published, gold, Green Submitted			2022-12-25	WOS:000319654700157
J	Wang, YN; Gao, D; Chen, Z; Li, SF; Gao, CM; Cao, DL; Liu, F; Liu, HX; Jiang, Y				Wang, Yini; Gao, Dan; Chen, Zhe; Li, Shangfu; Gao, Chunmei; Cao, Deliang; Liu, Feng; Liu, Hongxia; Jiang, Yuyang			Acridone Derivative 8a Induces Oxidative Stress-Mediated Apoptosis in CCRF-CEM Leukemia Cells: Application of Metabolomics in Mechanistic Studies of Antitumor Agents	PLOS ONE			English	Article							CANCER-CELLS; REVEALS; LINES; METABONOMICS; METABOLISM; ALKALOIDS; RESPONSES; TOXICITY; LIGANDS; ACID	A new acridone derivative, 2-aminoacetamido-10-(3, 5-dimethoxy)-benzyl-9(10H)-acridone hydrochloride (named 8a) synthesized in our lab shows potent antitumor activity, but the mechanism of action remains unclear. Herein, we report the use of an UPLC/Q-TOF MS metabolomic approach to study the effects of three compounds with structures optimized step-by-step, 9(10H)-acridone (A), 10-(3,5-dimethoxy)benzyl-9(10H)-acridone (I), and 8a, on CCRF-CEM leukemia cells and to shed new light on the probable antitumor mechanism of 8a. Acquired data were processed by principal component analysis (PCA) and orthogonal partial least squares discriminant analysis (OPLS-DA) to identify potential biomarkers. Comparing 8a-treated CCRF-CEM leukemia cells with vehicle control (DMSO), 23 distinct metabolites involved in five metabolic pathways were identified. Metabolites from glutathione (GSH) and glycerophospholipid metabolism were investigated in detail, and results showed that GSH level and the reduced/oxidized glutathione (GSH/GSSG) ratio were significantly decreased in 8a-treated cells, while L-cysteinyl-glycine (L-Cys-Gly) and glutamate were greatly increased. In glycerophospholipid metabolism, cell membrane components phosphatidylcholines (PCs) were decreased in 8a-treated cells, while the oxidative products lysophosphatidylcholines (LPCs) were significantly increased. We further found that in 8a-treated cells, the reactive oxygen species (ROS) and lipid peroxidation product malondialdehyde (MDA) were notably increased, accompanied with decrease of mitochondrial transmembrane potential, release of cytochrome C and activation of caspase-3. Taken together our results suggest that the acridone derivative 8a induces oxidative stress-mediated apoptosis in CCRF-CEM leukemia cells. The UPLC/Q-TOF MS based metabolomic approach provides novel insights into the mechanistic studies of antitumor drugs from a point distinct from traditional biological investigations.	[Wang, Yini] Tsinghua Univ, Dept Chem, Beijing 100084, Peoples R China; [Wang, Yini; Gao, Dan; Liu, Hongxia] Key Lab Tumor Metabol Shenzhen, Shenzhen, Peoples R China; [Gao, Dan; Chen, Zhe; Li, Shangfu; Gao, Chunmei; Cao, Deliang; Liu, Feng; Liu, Hongxia; Jiang, Yuyang] Tsinghua Univ, Grad Sch Shenzhen, State Key Lab Breeding Base Shenzhen Key Lab Chem, Shenzhen 518057, Peoples R China; [Jiang, Yuyang] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; Tsinghua University	Liu, HX (corresponding author), Key Lab Tumor Metabol Shenzhen, Shenzhen, Peoples R China.	liuhx@sz.tsinghua.edu.cn; jiangyy@sz.tsinghua.edu.cn			Chinese National Natural Science Foundation of China [21172129, 20902053]; China Postdoctoral Science Foundation [2012M510407]; China Ministry of Science and Technology [2012ZX09506001-010]; International S&T Cooperation Program of China [2011DFA30620]	Chinese National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); China Ministry of Science and Technology(Ministry of Science and Technology, China); International S&T Cooperation Program of China	The research work was supported in part by the Chinese National Natural Science Foundation of China (Nos. 21172129), a finance supported by Chinese National Natural Science Foundation of China (20902053), China Postdoctoral Science Foundation (number 2012M510407), China Ministry of Science and Technology under Contract (number 2012ZX09506001-010), and International S&T Cooperation Program of China (number 2011DFA30620). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baguley BC, 2003, CURR MED CHEM, V10, P2643, DOI 10.2174/0929867033456332; Blaise BJ, 2007, P NATL ACAD SCI USA, V104, P19808, DOI 10.1073/pnas.0707393104; Bundy JG, 2006, CANCER RES, V66, P7606, DOI 10.1158/0008-5472.CAN-05-2999; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; Cai S, 2009, BIOMED CHROMATOGR, V23, P782, DOI 10.1002/bmc.1185; Catala A, 2009, CHEM PHYS LIPIDS, V157, P1, DOI 10.1016/j.chemphyslip.2008.09.004; Cholewinski G, 2011, PHARMACOL REP, V63, P305, DOI 10.1016/S1734-1140(11)70499-6; Chukaew A, 2008, PHYTOCHEMISTRY, V69, P2616, DOI 10.1016/j.phytochem.2008.08.007; Cuenca F, 2009, BIOORG MED CHEM LETT, V19, P5109, DOI 10.1016/j.bmcl.2009.07.033; Dietmair S, 2010, ANAL BIOCHEM, V404, P155, DOI 10.1016/j.ab.2010.04.031; Dunn WB, 2007, METABOLOMICS, V3, P413, DOI 10.1007/s11306-007-0063-5; Fernandez-Calienes A, 2011, BIOMED PHARMACOTHER, V65, P210, DOI 10.1016/j.biopha.2011.04.001; Gao CM, 2008, BIOORGAN MED CHEM, V16, P8670, DOI 10.1016/j.bmc.2008.07.086; Gao CM, 2012, TETRAHEDRON, V68, P7920, DOI 10.1016/j.tet.2012.07.016; Gao CM, 2010, BIOORGAN MED CHEM, V18, P7507, DOI 10.1016/j.bmc.2010.08.058; Giustarini D, 2003, FREE RADICAL BIO MED, V35, P1365, DOI 10.1016/j.freeradbiomed.2003.08.013; Griffin Julian L, 2004, Drug Discov Today Technol, V1, P285, DOI 10.1016/j.ddtec.2004.10.011; Indran IR, 2011, CANCER RES, V71, P266, DOI 10.1158/0008-5472.CAN-10-1588; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Jin S, 2010, ANN ONCOL, V21, P263, DOI 10.1093/annonc/mdp499; Koba M, 2011, MED CHEM RES, V20, P1385, DOI 10.1007/s00044-010-9487-y; Kuiper HA, 2003, CURR OPIN BIOTECH, V14, P238, DOI 10.1016/S0958-1669(03)00021-1; Li SF, 2011, J CHROMATOGR B, V879, P2369, DOI 10.1016/j.jchromb.2011.06.018; Lin SH, 2010, TALANTA, V83, P262, DOI 10.1016/j.talanta.2010.09.019; Lin SH, 2010, RAPID COMMUN MASS SP, V24, P1312, DOI 10.1002/rcm.4516; Michael JP, 2005, NAT PROD REP, V22, P627, DOI 10.1039/b413750g; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Moolenaar SH, 2003, ANN CLIN BIOCHEM, V40, P16, DOI 10.1258/000456303321016132; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; Prasad VVSR, 2011, EUR J PHARM SCI, V43, P217, DOI 10.1016/j.ejps.2011.04.010; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Raza A, 2012, INVEST NEW DRUG, V30, P1443, DOI 10.1007/s10637-011-9720-7; Roseghini R, 2009, PLANTA MED, V75, P488, DOI 10.1055/s-0029-1185316; Salimon J, 2010, ARAB J CHEM, V3, P205, DOI 10.1016/j.arabjc.2010.06.001; SCHOLZ RW, 1989, ANN NY ACAD SCI, V570, P514; Sellick CA, 2010, METABOLOMICS, V6, P427, DOI 10.1007/s11306-010-0216-9; Spencer SL, 2011, CELL, V144, P926, DOI 10.1016/j.cell.2011.03.002; Stankiewicz-Drogon A, 2010, J MED CHEM, V53, P3117, DOI 10.1021/jm901741p; Su TL, 2005, PLANTA MED, V71, P28, DOI 10.1055/s-2005-837747; Tiziani S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004251; Valdes Ayme Fernandez-Calienes, 2011, Open Med Chem J, V5, P11, DOI 10.2174/1874104501105010011; Wang C, 2009, J BIOL CHEM, V284, P26742, DOI 10.1074/jbc.M109.022897; Wang MX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015441; Want EJ, 2010, NAT PROTOC, V5, P1005, DOI 10.1038/nprot.2010.50; Wishart DS, 2008, TRENDS FOOD SCI TECH, V19, P482, DOI 10.1016/j.tifs.2008.03.003; Wright MM, 2004, BIOCHEM CELL BIOL, V82, P18, DOI 10.1139/o03-092; Yan C, 2011, EXP TOXICOL PATHOL, V63, P413, DOI 10.1016/j.etp.2010.02.018; Yan RL, 2007, INT J CANCER, V121, P2301, DOI 10.1002/ijc.22933	49	10	11	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63572	10.1371/journal.pone.0063572	http://dx.doi.org/10.1371/journal.pone.0063572			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667640	Green Published, Green Submitted, gold			2022-12-25	WOS:000319654700163
J	Wen, MS; Wang, CY; Lin, SL; Hung, KC				Wen, Ming-Shien; Wang, Chao-Yung; Lin, Shuei-Liong; Hung, Kuo-Chun			Decrease in Irisin in Patients with Chronic Kidney Disease	PLOS ONE			English	Article							RESTING ENERGY-EXPENDITURE; CHRONIC-RENAL-FAILURE; HDL-CHOLESTEROL; ENDURANCE EXERCISE; INSULIN-RESISTANCE; RISK-FACTORS; METABOLISM	Patients with chronic kidney disease have abnormal energy expenditure and metabolism. The mechanisms underlying altered energy expenditure in uremia are unknown and remain to be elucidated. Irisin is a peroxisome proliferator-activated receptor gamma coactivator 1-alpha-dependent myokine, and it increases energy expenditure in the absence of changes in food intake or activity. We hypothesize that chronic kidney disease patients have altered irisin levels. We measured resting irisin levels in 38 patients with stage 5 chronic kidney disease and in 19 age-and sex-matched normal subjects. Plasma irisin levels were significantly decreased in chronic kidney disease patients (58.59%; 95% CI 47.9%-69.2%, p<0.0001). The decrease in irisin levels was inversely correlated with the levels of blood urea nitrogen and creatinine. Further association analysis revealed that irisin level is independently associated with high-density lipoprotein cholesterol level. Our results suggest that chronic kidney disease patients have lower than normal irisin levels at rest. Furthermore, irisin may play a major role in affecting high-density lipoprotein cholesterol levels and abnormal energy expenditure in chronic kidney disease patients.	[Wen, Ming-Shien; Wang, Chao-Yung; Hung, Kuo-Chun] Chang Gung Mem Hosp, Dept Cardiol, Tao Yuan, Taiwan; [Wen, Ming-Shien; Wang, Chao-Yung; Hung, Kuo-Chun] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Lin, Shuei-Liong] Natl Taiwan Univ Hosp, Div Renal, Dept Med, Taipei, Taiwan; [Lin, Shuei-Liong] Natl Taiwan Univ, Coll Med, Grad Inst Physiol, Taipei 10764, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Wen, MS (corresponding author), Chang Gung Mem Hosp, Dept Cardiol, Tao Yuan, Taiwan.	ocean.laboratory@me.com	Lin, Shuei-Liong/AGR-2002-2022; Wang, Chao-Yung/ABA-6757-2021	Lin, Shuei-Liong/0000-0002-1041-5571; Wang, Chao-Yung/0000-0003-1546-7298	National Health Research Institute [NHRI-EX100-9925SC]; National Science Council [101-2314-B-182A-009, 101-2314-B-182A- 098-MY3, 101-2321-B-002-060]; Chang Gung Memorial Hospital [CMRPG3B1641, CMRPG 371953, CMRPG3A1072]; Mrs. Hsiu-Chin Lee Kidney Research Foundation; National Research Program for Biopharmaceuticals [PMRPG3B0091]	National Health Research Institute(National Health Research Institutes - Taiwan); National Science Council(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Mrs. Hsiu-Chin Lee Kidney Research Foundation; National Research Program for Biopharmaceuticals	CYW received support from National Health Research Institute (NHRI-EX100-9925SC), National Science Council (101-2314-B-182A-009, 101-2314-B-182A- 098-MY3), and Chang Gung Memorial Hospital (CMRPG3B1641). KCH received support from Chang Gung Memorial Hospital (CMRPG 371953). LSL received support from the National Science Council (101-2321-B-002-060) and Mrs. Hsiu-Chin Lee Kidney Research Foundation. MSW received support from National Research Program for Biopharmaceuticals (PMRPG3B0091) and Chang Gung Memorial Hospital (CMRPG3A1072). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avesani CM, 2011, J RENAL NUTR, V21, P27, DOI 10.1053/j.jrn.2010.10.013; Avesani CM, 2004, NEPHROL DIAL TRANSPL, V19, P3091, DOI 10.1093/ndt/gfh547; Badimon L, 2012, ANN NY ACAD SCI, V1254, P18, DOI 10.1111/j.1749-6632.2012.06480.x; Barreto FC, 2009, CLIN J AM SOC NEPHRO, V4, P1551, DOI 10.2215/CJN.03980609; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Brenner Ingrid, 2008, CANNT J, V18, P36; Chen J, 2003, J AM SOC NEPHROL, V14, P469, DOI 10.1097/01.ASN.0000046029.53933.09; Chyu KY, 2011, CURR ATHEROSCLER REP, V13, P405, DOI 10.1007/s11883-011-0189-9; Couillard C, 2001, ARTERIOSCL THROM VAS, V21, P1226, DOI 10.1161/hq0701.092137; Degoma EM, 2011, NAT REV CARDIOL, V8, P266, DOI 10.1038/nrcardio.2010.200; DURSTINE JL, 1983, METABOLISM, V32, P993, DOI 10.1016/0026-0495(83)90141-5; Holzer M, 2011, J AM SOC NEPHROL, V22, P1631, DOI 10.1681/ASN.2010111144; Huh JY, 2012, METAB CLIN EXP, DOI [10.1016/j.metabol.2012.09.002, DOI 10.1016/J.METAB0L.2012.09.002]; Kamimura MA, 2007, EUR J CLIN NUTR, V61, P362, DOI 10.1038/sj.ejcn.1602516; Kamimura MA, 2011, NEPHROL DIAL TRANSPL, V26, P544, DOI 10.1093/ndt/gfq452; Kelly DP, 2012, SCIENCE, V336, P42, DOI 10.1126/science.1221688; Kobayashi S, 2005, AM J KIDNEY DIS, V45, P275, DOI 10.1053/j.ajkd.2004.09.034; Kuhlmann U, 2001, J RENAL NUTR, V11, P202, DOI 10.1053/jren.2001.26981; Lekawanvijit S, 2012, CIRC RES, V111, P1470, DOI 10.1161/CIRCRESAHA.112.278457; Lekawanvijit S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041281; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Matsuki N, 1999, FREE RADICAL RES, V31, P1, DOI 10.1080/10715769900300551; Panesar A, 2003, CLIN NEPHROL, V59, P360; Sacks FM, 2000, CIRCULATION, V102, P1893, DOI 10.1161/01.CIR.102.16.1893; SCHNEEWEISS B, 1990, AM J CLIN NUTR, V52, P596, DOI 10.1093/ajcn/52.4.596; Stengel B, 2010, J NEPHROL, V23, P253; Thompson PD, 2001, ARTERIOSCL THROM VAS, V21, P1097, DOI 10.1161/hq0701.092147; Verma A, 2007, J AM COLL CARDIOL, V50, P1238, DOI 10.1016/j.jacc.2007.06.018; Villarroya F, 2012, CELL METAB, V15, P277, DOI 10.1016/j.cmet.2012.02.010; Wang AYM, 2011, J RENAL NUTR, V21, P31, DOI 10.1053/j.jrn.2010.10.018; ZURLO F, 1990, J CLIN INVEST, V86, P1423, DOI 10.1172/JCI114857	31	135	143	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e64025	10.1371/journal.pone.0064025	http://dx.doi.org/10.1371/journal.pone.0064025			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667695	gold, Green Submitted, Green Published			2022-12-25	WOS:000319654700199
J	Zhang, T; Kedzierska-Mieszkowska, S; Liu, HT; Cheng, CM; Ganta, RR; Zolkiewski, M				Zhang, Ting; Kedzierska-Mieszkowska, Sabina; Liu, Huitao; Cheng, Chuanmin; Ganta, Roman R.; Zolkiewski, Michal			Aggregate-Reactivation Activity of the Molecular Chaperone ClpB from Ehrlichia chaffeensis	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; AMINO-TERMINAL DOMAIN; ESCHERICHIA-COLI; BACTERIAL-INFECTION; HSP100 CHAPERONES; STRESS TOLERANCE; MIDDLE DOMAIN; ATPASE CLPB; THERMOTOLERANCE; DISAGGREGATION	Rickettsiale diseases, including human monocytic ehrlichiosis caused by Ehrlichia chaffeensis, are the second leading cause of the tick-borne infections in the USA and a growing health concern. Little is known about how E. chaffeensis survives the host-induced stress in vertebrate and tick hosts. A molecular chaperone ClpB from several microorganisms has been reported to reactivate aggregated proteins in cooperation with the co-chaperones DnaK/DnaJ/GrpE (KJE). In this study, we performed the first biochemical characterization of ClpB from E. chaffeensis. The transcript of E. chaffeensis ClpB (EhClpB) is strongly upregulated after infection of cultured macrophages and its level remains high during the Ehrlichia replicative stage. EhClpB forms ATP-dependent oligomers and catalyzes the ATP hydrolysis, similar to E. coli ClpB (EcClpB), but its ATPase activity is insensitive to the EcClpB activators, casein and poly-lysine. EhClpB in the presence of E. coli KJE efficiently reactivates the aggregated glucose-6-phosphate dehydrogenase (G6PDH) and firefly luciferase. Unlike EcClpB, which requires the co-chaperones for aggregate reactivation, EhClpB reactivates G6PDH even in the absence of KJE. Moreover, EhClpB is functionally distinct from EcClpB as evidenced by its failure to rescue a temperature-sensitive phenotype of the clpB-null E. coli. The clpB expression pattern during the E. chaffeensis infection progression correlates with the pathogen's replicating stage inside host cells and suggests an essential role of the disaggregase activity of ClpB in the pathogen's response to the host-induced stress. This study sets the stage for assessing the importance of the chaperone activity of ClpB for E. chaffeensis growth within the mammalian and tick hosts.	[Zhang, Ting; Zolkiewski, Michal] Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA; [Kedzierska-Mieszkowska, Sabina] Univ Gdansk, Dept Biochem, PL-80952 Gdansk, Poland; [Liu, Huitao; Cheng, Chuanmin; Ganta, Roman R.] Kansas State Univ, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA	Kansas State University; Fahrenheit Universities; University of Gdansk; Kansas State University	Zolkiewski, M (corresponding author), Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA.	michalz@ksu.edu	Kędzierska-Mieszkowska, Sabina/AAF-2737-2021	Kędzierska-Mieszkowska, Sabina/0000-0001-5756-3013	National Institutes of Health [AI070908]; Kansas Agricultural Experiment Station [13-184-J]; Kansas State University Open Access Publishing Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI070908, R01AI070908] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kansas Agricultural Experiment Station; Kansas State University Open Access Publishing Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health grant AI070908 and by the Kansas Agricultural Experiment Station (contribution 13-184-J). Publication of this article was funded in part by the Kansas State University Open Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acebron SP, 2009, FEBS LETT, V583, P2991, DOI 10.1016/j.febslet.2009.08.020; Akoev V, 2004, PROTEIN SCI, V13, P567, DOI 10.1110/ps.03422604; ANDERSON BE, 1991, J CLIN MICROBIOL, V29, P2838, DOI 10.1128/JCM.29.12.2838-2842.1991; Barnett ME, 2000, J BIOL CHEM, V275, P37565, DOI 10.1074/jbc.M005211200; Barnett ME, 2005, J BIOL CHEM, V280, P34940, DOI 10.1074/jbc.M505653200; Capestany CA, 2008, J BACTERIOL, V190, P1436, DOI 10.1128/JB.01632-07; Cheng C, 2008, CURR PROTOC MICROBIO, V9; DAWSON JE, 1992, AM J VET RES, V53, P1322; Dawson JE, 1996, J PARASITOL, V82, P52, DOI 10.2307/3284115; Dedonder SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036749; DeSantis ME, 2012, BBA-MOL CELL RES, V1823, P29, DOI 10.1016/j.bbamcr.2011.07.014; Doyle SM, 2009, TRENDS BIOCHEM SCI, V34, P40, DOI 10.1016/j.tibs.2008.09.010; Dumler JS, 1998, ANNU REV MED, V49, P201, DOI 10.1146/annurev.med.49.1.201; DUMLER JS, 1995, J CLIN MICROBIOL, V33, P1704, DOI 10.1128/JCM.33.7.1704-1711.1995; Estorninho M, 2010, MICROBIOL-SGM, V156, P3445, DOI 10.1099/mic.0.042275-0; Fuhrmann M, 2004, PLANT MOL BIOL, V55, P869, DOI 10.1007/s11103-004-2150-6; Ganta RR, 2009, FRONT BIOSCI-LANDMRK, V14, P3259, DOI 10.2741/3449; Gayle A, 2001, AM FAM PHYSICIAN, V64, P461; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Goloubinoff P, 1999, P NATL ACAD SCI USA, V96, P13732, DOI 10.1073/pnas.96.24.13732; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Haslberger T, 2007, MOL CELL, V25, P247, DOI 10.1016/j.molcel.2006.11.008; Henderson B, 2006, INFECT IMMUN, V74, P3693, DOI 10.1128/IAI.01882-05; Kannan TR, 2008, INFECT IMMUN, V76, P5082, DOI 10.1128/IAI.00698-08; Kedzierska S, 2003, BIOCHEMISTRY-US, V42, P14242, DOI 10.1021/bi035573d; Krobitsch S, 1999, CELL STRESS CHAPERON, V4, P191; Lindquist S, 1996, P NATL ACAD SCI USA, V93, P5301, DOI 10.1073/pnas.93.11.5301; Liu ZH, 2002, J MOL BIOL, V321, P111, DOI 10.1016/S0022-2836(02)00591-0; Lourdault K, 2011, INFECT IMMUN, V79, P3711, DOI 10.1128/IAI.05168-11; Lum R, 2004, J BIOL CHEM, V279, P29139, DOI 10.1074/jbc.M403777200; Meibom KL, 2008, MOL MICROBIOL, V67, P1384, DOI 10.1111/j.1365-2958.2008.06139.x; Miot M, 2011, P NATL ACAD SCI USA, V108, P6915, DOI 10.1073/pnas.1102828108; de Oliveira NEM, 2011, MICROBIOL-SGM, V157, P656, DOI 10.1099/mic.0.041897-0; Motohashi K, 1999, P NATL ACAD SCI USA, V96, P7184, DOI 10.1073/pnas.96.13.7184; Nagy M, 2010, J MOL BIOL, V396, P697, DOI 10.1016/j.jmb.2009.11.059; Nagy M, 2009, PROTEIN SCI, V18, P287, DOI 10.1002/pro.36; Neckers L, 2008, CELL HOST MICROBE, V4, P519, DOI 10.1016/j.chom.2008.10.011; Neuwald AF, 1999, GENOME RES, V9, P27; Paddock CD, 2003, CLIN MICROBIOL REV, V16, P37, DOI 10.1128/CMR.16.1.37-64.2003; Parola P, 2001, CLIN INFECT DIS, V32, P897, DOI 10.1086/319347; POPOV VL, 1995, J MED MICROBIOL, V43, P411, DOI 10.1099/00222615-43-6-411; Rikihisa Y, 1997, J INFECT DIS, V175, P210, DOI 10.1093/infdis/175.1.210; Rikihisa Y, 2010, NAT REV MICROBIOL, V8, P328, DOI 10.1038/nrmicro2318; Schlieker C, 2004, NAT STRUCT MOL BIOL, V11, P607, DOI 10.1038/nsmb787; Sielaff B, 2010, J MOL BIOL, V402, P30, DOI 10.1016/j.jmb.2010.07.030; SQUIRES CL, 1991, J BACTERIOL, V173, P4254, DOI 10.1128/JB.173.14.4254-4262.1991; Stafford III WF, 1994, SEDIMENTATION BOUNDA, P119; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; Stewart GR, 2004, CURR OPIN IMMUNOL, V16, P506, DOI 10.1016/j.coi.2004.05.007; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Walker DH, 2008, MED CLIN N AM, V92, P1345, DOI 10.1016/j.mcna.2008.06.002; Walker DH, 1996, EMERG INFECT DIS, V2, P18, DOI 10.3201/eid0201.960102; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Weibezahn J, 2003, J BIOL CHEM, V278, P32608, DOI 10.1074/jbc.M303653200; WELLMAN ML, 1988, IN VITRO CELL DEV B, V24, P223, DOI 10.1007/BF02623551; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Winkler J, 2012, J CELL BIOL, V198, P387, DOI 10.1083/jcb.201201074; Zhang JZ, 2007, CELL MICROBIOL, V9, P610, DOI 10.1111/j.1462-5822.2006.00812.x; Zhang T, 2012, PROTEINS, V80, P2758, DOI 10.1002/prot.24159; Zietkiewicz S, 2006, J BIOL CHEM, V281, P7022, DOI 10.1074/jbc.M507893200; Zolkiewski M, 1999, J BIOL CHEM, V274, P28083, DOI 10.1074/jbc.274.40.28083; Zolkiewski M, 2012, ARCH BIOCHEM BIOPHYS, V520, P1, DOI 10.1016/j.abb.2012.01.012	62	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62454	10.1371/journal.pone.0062454	http://dx.doi.org/10.1371/journal.pone.0062454			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667479	gold, Green Published, Green Submitted			2022-12-25	WOS:000319654700038
J	Yamasaki, K; Kawanami, T; Yatera, K; Fukuda, K; Noguchi, S; Nagata, S; Nishida, C; Kido, T; Ishimoto, H; Taniguchi, H; Mukae, H				Yamasaki, Kei; Kawanami, Toshinori; Yatera, Kazuhiro; Fukuda, Kazumasa; Noguchi, Shingo; Nagata, Shuya; Nishida, Chinatsu; Kido, Takashi; Ishimoto, Hiroshi; Taniguchi, Hatsumi; Mukae, Hiroshi			Significance of Anaerobes and Oral Bacteria in Community-Acquired Pneumonia	PLOS ONE			English	Article							FIBEROPTIC BRONCHOSCOPY; BRONCHOALVEOLAR LAVAGE; PULMONARY INFECTIONS; SEQUENCE-ANALYSIS; ETIOLOGY; ADULTS; MICROBIOME; GUIDELINES; MANAGEMENT; DIAGNOSIS	Background: Molecular biological modalities with better detection rates have been applied to identify the bacteria causing infectious diseases. Approximately 10-48% of bacterial pathogens causing community-acquired pneumonia are not identified using conventional cultivation methods. This study evaluated the bacteriological causes of community-acquired pneumonia using a cultivation-independent clone library analysis of the 16S ribosomal RNA gene of bronchoalveolar lavage specimens, and compared the results with those of conventional cultivation methods. Methods: Patients with community-acquired pneumonia were enrolled based on their clinical and radiological findings. Bronchoalveolar lavage specimens were collected from pulmonary pathological lesions using bronchoscopy and evaluated by both a culture-independent molecular method and conventional cultivation methods. For the culture-independent molecular method, approximately 600 base pairs of 16S ribosomal RNA genes were amplified using polymerase chain reaction with universal primers, followed by the construction of clone libraries. The nucleotide sequences of 96 clones randomly chosen for each specimen were determined, and bacterial homology was searched. Conventional cultivation methods, including anaerobic cultures, were also performed using the same specimens. Results: In addition to known common pathogens of community-acquired pneumonia [Streptococcus pneumoniae (18.8%), Haemophilus influenzae (18.8%), Mycoplasma pneumoniae (17.2%)], molecular analysis of specimens from 64 patients with community-acquired pneumonia showed relatively higher rates of anaerobes (15.6%) and oral bacteria (15.6%) than previous reports. Conclusion: Our findings suggest that anaerobes and oral bacteria are more frequently detected in patients with community-acquired pneumonia than previously believed. It is possible that these bacteria may play more important roles in community-acquired pneumonia.	[Yamasaki, Kei; Kawanami, Toshinori; Yatera, Kazuhiro; Noguchi, Shingo; Nagata, Shuya; Nishida, Chinatsu; Kido, Takashi; Ishimoto, Hiroshi; Mukae, Hiroshi] Univ Occupat & Environm Hlth, Dept Resp Med, Kitakyushu, Fukuoka 807, Japan; [Fukuda, Kazumasa; Taniguchi, Hatsumi] Univ Occupat & Environm Hlth, Dept Microbiol, Kitakyushu, Fukuoka 807, Japan	University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan	Mukae, H (corresponding author), Univ Occupat & Environm Hlth, Dept Resp Med, Kitakyushu, Fukuoka 807, Japan.	hmukae@med.uoeh-u.ac.jp	千夏, 西田/GRJ-3050-2022	Ishimoto, Hiroshi/0000-0002-4374-2894	University of Occupational and Environmental Health, Japan; Ministry of Education, Science, Sports and Culture [23591173]	University of Occupational and Environmental Health, Japan(University of Occupational & Environmental Health - Japan); Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was partially supported by a High Altitude Research Grant from the University of Occupational and Environmental Health, Japan, and was partially supported by a Ministry of Education, Science, Sports and Culture Grant-in-Aid for Scientific Research (C), 23591173, 2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Bousbia S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032486; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Cilloniz C, 2011, THORAX, V66, P340, DOI 10.1136/thx.2010.143982; Drancourt M, 2000, J CLIN MICROBIOL, V38, P3623, DOI 10.1128/JCM.38.10.3623-3630.2000; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Friend JAR, 2001, THORAX, V56, P1, DOI 10.1136/thorax.56.1.1; Han MK, 2012, THORAX, V67, P456, DOI 10.1136/thoraxjnl-2011-201183; Harris JK, 2007, P NATL ACAD SCI USA, V104, P20529, DOI 10.1073/pnas.0709804104; Ishida Tadashi, 2004, Journal of Infection and Chemotherapy, V10, P359, DOI 10.1007/s10156-004-0351-1; JIMENEZ P, 1993, CHEST, V103, P1023, DOI 10.1378/chest.103.4.1023; Johansson N, 2010, CLIN INFECT DIS, V50, P202, DOI 10.1086/648678; Kawanami T, 2011, TOHOKU J EXP MED, V225, P65, DOI 10.1620/tjem.225.65; Kawanami T, 2011, CHEST, V139, P600, DOI 10.1378/chest.10-0460; Kawanami T, 2009, J CLIN MICROBIOL, V47, P496, DOI 10.1128/JCM.01429-08; Lambotte O, 2002, CHEST, V122, P1389, DOI 10.1378/chest.122.4.1389; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Lim WS, 2001, THORAX, V56, P296, DOI 10.1136/thorax.56.4.296; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; MARRIE TJ, 1993, CLIN INVEST MED, V16, P38; Marston BJ, 1997, ARCH INTERN MED, V157, P1709, DOI 10.1001/archinte.157.15.1709; Ministry of Health Labour and Welfare of Japan, SUMM VIT STAT TRENDS; Miyashita N, 2005, J MED MICROBIOL, V54, P395, DOI 10.1099/jmm.0.45920-0; National Center for Health Statistics, HLTH US 2011 CHARTB; Park DR, 2001, J INFECT DIS, V184, P268, DOI 10.1086/322040; Ruiz M, 1999, AM J RESP CRIT CARE, V160, P397, DOI 10.1164/ajrccm.160.2.9808045; Saito Atsushi, 2006, Journal of Infection and Chemotherapy, V12, P63, DOI 10.1007/s10156-005-0425-8; Shinzato T, 1995, CLIN INFECT DIS, V21, pS238, DOI 10.1093/clind/21.Supplement_3.S238; Sze MA, 2012, AM J RESP CRIT CARE, V185, P1073, DOI 10.1164/rccm.201111-2075OC; WIMBERLEY N, 1979, AM REV RESPIR DIS, V119, P337; WIMBERLEY NW, 1982, CHEST, V81, P556, DOI 10.1378/chest.81.5.556	32	80	84	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e63103	10.1371/journal.pone.0063103	http://dx.doi.org/10.1371/journal.pone.0063103			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671659	Green Published, Green Submitted, gold			2022-12-25	WOS:000321390200043
J	Lu, JY; Chen, MY; Ren, XR; Wang, JB; Lyerly, HK; Barak, L; Chen, W				Lu, Jiuyi; Chen, Minyong; Ren, Xiu-Rong; Wang, Jiangbo; Lyerly, H. Kim; Barak, Larry; Chen, Wei			Regulation of Hedgehog Signaling by Myc-Interacting Zinc Finger Protein 1, Miz1	PLOS ONE			English	Article							PRIMARY CILIUM; PATHWAY; EXPRESSION; MEDULLOBLASTOMA; ACTIVATION; GLI; LOCALIZATION; ASSOCIATION; MECHANISMS; REPRESSION	Smoothened (Smo) mediated Hedgehog (Hh) signaling plays an essential role in regulating embryonic development and postnatal tissue homeostasis. Aberrant activation of the Hh pathway contributes to the formation and progression of various cancers. In vertebrates, however, key regulatory mechanisms responsible for transducing signals from Smo to the nucleus remain to be delineated. Here, we report the identification of Myc-interacting Zinc finger protein 1 (Miz1) as a Smo and Gli2 binding protein that positively regulates Hh signaling. Overexpression of Miz1 increases Gli luciferase reporter activity, whereas knockdown of endogenous Miz1 has the opposite effect. Activation of Smo induces translocation of Miz1 to the primary cilia together with Smo and Gli2. Furthermore, Miz1 is localized to the nucleus upon Hh activation in a Smo-dependent manner, and loss of Miz1 prevents the nuclear translocation of Gli2. More importantly, silencing Miz1 expression inhibits cell proliferation in vitro and the growth of Hh-driven medulloblastoma tumors allografted in SCID mice. Taken together, these results identify Miz1 as a novel regulator in the Hh pathway that plays an important role in mediating Smo-dependent oncogenic signaling.	[Lu, Jiuyi; Chen, Minyong; Ren, Xiu-Rong; Wang, Jiangbo; Chen, Wei] Duke Univ, Dept Med, Durham, NC 27708 USA; [Lyerly, H. Kim] Duke Univ, Dept Surg, Durham, NC USA; [Barak, Larry] Duke Univ, Dept Cell Biol, Durham, NC USA	Duke University; Duke University; Duke University	Chen, W (corresponding author), Duke Univ, Dept Med, Durham, NC 27708 USA.	w.chen@duke.edu	Lyerly, Herbert K/B-6528-2014; Lyerly, Herbert Kim/AAX-4925-2020	Lyerly, Herbert K/0000-0002-0063-4770; Lyerly, Herbert Kim/0000-0002-0063-4770; Chen, Wei/0000-0002-9934-4000	Clinical Oncology Research Center Development Grant [5K12-CA100639-08]; National Institutes of Health Grant [5R01CA113656-03, 1U01-DA022950]; Fred and Alice Stanback; NATIONAL CANCER INSTITUTE [R01CA113656, K12CA100639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA022950] Funding Source: NIH RePORTER	Clinical Oncology Research Center Development Grant; National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fred and Alice Stanback; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This project was supported in part by a Clinical Oncology Research Center Development Grant 5K12-CA100639-08 (to MC), National Institutes of Health Grant 5R01CA113656-03 (to WC), National Institutes of Health Grant 1U01-DA022950 (to LSB), and Fred and Alice Stanback (HKL). WC is a V Foundation Scholar and an American Cancer Society Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary S, 2003, MOL CELL BIOL, V23, P7648, DOI 10.1128/MCB.23.21.7648-7657.2003; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Chen Y, 2011, J BIOL CHEM, V286, P13502, DOI 10.1074/jbc.M110.217604; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Dahmane N, 1997, NATURE, V389, P876, DOI 10.1038/39918; Gilbertson RJ, 2008, ANNU REV PATHOL-MECH, V3, P341, DOI 10.1146/annurev.pathmechdis.3.121806.151518; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Humke EW, 2010, GENE DEV, V24, P670, DOI 10.1101/gad.1902910; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Kim J, 2009, P NATL ACAD SCI USA, V106, P21666, DOI 10.1073/pnas.0912180106; Kovacs JJ, 2008, SCIENCE, V320, P1777, DOI 10.1126/science.1157983; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; Miao L, 2010, ONCOGENE, V29, P711, DOI 10.1038/onc.2009.372; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Patel JH, 2007, J BIOL CHEM, V282, P5, DOI 10.1074/jbc.M609138200; Peukert K, 1997, EMBO J, V16, P5672, DOI 10.1093/emboj/16.18.5672; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Sakurai T, 2004, J BIOL CHEM, V279, P15505, DOI 10.1074/jbc.M310437200; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Sinha S, 2006, NAT CHEM BIOL, V2, P29, DOI 10.1038/nchembio753; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Tukachinsky H, 2010, J CELL BIOL, V191, P415, DOI 10.1083/jcb.201004108; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Wang JB, 2010, P NATL ACAD SCI USA, V107, P9323, DOI 10.1073/pnas.0910712107; Wanzel M, 2003, TRENDS CELL BIOL, V13, P146, DOI 10.1016/S0962-8924(03)00003-5; Wen XH, 2010, MOL CELL BIOL, V30, P1910, DOI 10.1128/MCB.01089-09; Wu SQ, 2003, ONCOGENE, V22, P351, DOI 10.1038/sj.onc.1206145; Zhao NX, 2004, J CELL BIOCHEM, V92, P65, DOI 10.1002/jcb.20025; Ziegelbauer J, 2004, P NATL ACAD SCI USA, V101, P458, DOI 10.1073/pnas.0307562100	34	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e63353	10.1371/journal.pone.0063353	http://dx.doi.org/10.1371/journal.pone.0063353			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23671675	Green Published, gold, Green Submitted			2022-12-25	WOS:000321202100064
J	Benod, C; Carlsson, J; Uthayaruban, R; Hwang, P; Irwin, JJ; Doak, AK; Shoichet, BK; Sablin, EP; Fletterick, RJ				Benod, Cindy; Carlsson, Jens; Uthayaruban, Rubatharshini; Hwang, Peter; Irwin, John J.; Doak, Allison K.; Shoichet, Brian K.; Sablin, Elena P.; Fletterick, Robert J.			Structure-based Discovery of Antagonists of Nuclear Receptor LRH-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING PATHWAYS; MOLECULAR DOCKING; ESTROGEN-RECEPTOR; BETA-CATENIN; CANCER-CELLS; FORCE-FIELD; HOMOLOG-1; EXPRESSION; GENE; INHIBITORS	Liver receptor homolog 1 (nuclear receptor LRH-1, NR5A2) is an essential regulator of gene transcription, critical for maintenance of cell pluripotency in early development and imperative for the proper functions of the liver, pancreas, and intestines during the adult life. Although physiological hormones of LRH-1 have not yet been identified, crystallographic and biochemical studies demonstrated that LRH-1 could bind regulatory ligands and suggested phosphatidylinositols as potential hormone candidates for this receptor. No synthetic antagonists of LRH-1 are known to date. Here, we identify the first small molecule antagonists of LRH-1 activity. Our search for LRH-1 modulators was empowered by screening of 5.2 million commercially available compounds via molecular docking followed by verification of the top-ranked molecules using in vitro direct binding and transcriptional assays. Experimental evaluation of the predicted ligands identified two compounds that inhibit the transcriptional activity of LRH-1 and diminish the expression of the receptor's target genes. Among the affected transcriptional targets are co-repressor SHP (small heterodimer partner) as well as cyclin E1 (CCNE1) and G0S2 genes that are known to regulate cell growth and proliferation. Treatments of human pancreatic (AsPC-1), colon (HT29), and breast adenocarcinoma cells T47D and MDA-MB-468 with the LRH-1 antagonists resulted in the receptor-mediated inhibition of cancer cell proliferation. Our data suggest that specific antagonists of LRH-1 could be used as specific molecular probes for elucidating the roles of the receptor in different types of malignancies.	[Benod, Cindy; Uthayaruban, Rubatharshini; Hwang, Peter; Sablin, Elena P.; Fletterick, Robert J.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Carlsson, Jens; Irwin, John J.; Doak, Allison K.; Shoichet, Brian K.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Fletterick, RJ (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, 600 16th St,GH S412E, San Francisco, CA 94158 USA.	Robert.Fletterick@ucsf.edu		Irwin, John/0000-0002-1195-6417; Carlsson, Jens/0000-0003-4623-2977	National Institutes of Health [GM59957, R01 DK078075, R21 CA140751]; Department of Defense Grant [W81XWH-12-1-0396]; California Breast Cancer Research Program; Knut and Alice Wallenberg Foundation; NATIONAL CANCER INSTITUTE [R21CA140751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071630, U01GM094614, R01GM059957] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Grant(United States Department of Defense); California Breast Cancer Research Program; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM59957 (to B. K. S.) and R01 DK078075 and R21 CA140751 (to R. J. F.). This work was also supported by Department of Defense Grant W81XWH-12-1-0396 (to R. J. F.), by a fellowship from the California Breast Cancer Research Program (to C. B.), and a fellowship from the Knut and Alice Wallenberg Foundation (to J. C.).	Annicotte JS, 2005, ONCOGENE, V24, P8167, DOI 10.1038/sj.onc.1208950; Benod C, 2011, P NATL ACAD SCI USA, V108, P16927, DOI 10.1073/pnas.1112047108; Botrugno OA, 2004, MOL CELL, V15, P499, DOI 10.1016/j.molcel.2004.07.009; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Carlsson J, 2010, J MED CHEM, V53, P3748, DOI 10.1021/jm100240h; Chand AL, 2010, ENDOCR-RELAT CANCER, V17, P965, DOI 10.1677/ERC-10-0179; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Clyne CD, 2004, MOL CELL ENDOCRINOL, V215, P39, DOI 10.1016/j.mce.2003.11.001; Coan KED, 2008, J AM CHEM SOC, V130, P9606, DOI 10.1021/ja802977h; di Magliano MP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001155; Doak AK, 2010, J MED CHEM, V53, P4259, DOI 10.1021/jm100254w; Doman TN, 2002, J MED CHEM, V45, P2213, DOI 10.1021/jm010548w; Dube C, 2009, CANCER LETT, V275, P127, DOI 10.1016/j.canlet.2008.10.008; Estebanez-Perpina E, 2005, J BIOL CHEM, V280, P8060, DOI 10.1074/jbc.M407046200; Fayard E, 2003, J BIOL CHEM, V278, P35725, DOI 10.1074/jbc.M302370200; Fayard E, 2004, TRENDS CELL BIOL, V14, P250, DOI 10.1016/j.tcb.2004.03.008; Gu PL, 2005, MOL CELL BIOL, V25, P3492, DOI 10.1128/MCB.25.9.3492-3505.2005; Heng JCD, 2010, CELL STEM CELL, V6, P167, DOI 10.1016/j.stem.2009.12.009; Huang DZ, 2006, J AM CHEM SOC, V128, P5436, DOI 10.1021/ja0573108; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Irwin JJ, 2009, J MED CHEM, V52, P5712, DOI 10.1021/jm9006966; Kim JW, 2004, J CLIN ENDOCR METAB, V89, P3042, DOI 10.1210/jc.2003-031599; Krylova IN, 2005, CELL, V120, P343, DOI 10.1016/j.cell.2005.01.024; Lee JM, 2011, NATURE, V474, P506, DOI 10.1038/nature10111; Lee MB, 2005, MOL CELL BIOL, V25, P1879, DOI 10.1128/MCB.25.5.1879-1890.2005; Lee YK, 2006, J BIOL CHEM, V281, P7850, DOI 10.1074/jbc.M509115200; Li JB, 1998, J PHYS CHEM A, V102, P1820, DOI 10.1021/jp972682r; Lorber DM, 2005, CURR TOP MED CHEM, V5, P739, DOI 10.2174/1568026054637683; Lorber DM, 1998, PROTEIN SCI, V7, P938; Mataki C, 2007, MOL CELL BIOL, V27, P8330, DOI 10.1128/MCB.00852-07; Musille PM, 2012, NAT STRUCT MOL BIOL, V19, P532, DOI 10.1038/nsmb.2279; Mysinger MM, 2010, J CHEM INF MODEL, V50, P1561, DOI 10.1021/ci100214a; Ortlund EA, 2005, NAT STRUCT MOL BIOL, V12, P357, DOI 10.1038/nsmb910; Pike ACW, 2001, STRUCTURE, V9, P145, DOI 10.1016/S0969-2126(01)00568-8; Powers RA, 2002, STRUCTURE, V10, P1013, DOI 10.1016/S0969-2126(02)00799-2; Qin J, 2004, MOL ENDOCRINOL, V18, P2424, DOI 10.1210/me.2004-0009; Rey J, 2012, CHEMMEDCHEM, V7, P1909, DOI 10.1002/cmdc.201200307; Sablin EP, 2008, P NATL ACAD SCI USA, V105, P18390, DOI 10.1073/pnas.0808936105; Saif MW, 2010, CANCER J, V16, P196, DOI 10.1097/PPO.0b013e3181e076af; Schapira M, 2003, P NATL ACAD SCI USA, V100, P7354, DOI 10.1073/pnas.1131854100; Schoonjans K, 2005, P NATL ACAD SCI USA, V102, P2058, DOI 10.1073/pnas.0409756102; Sheela SG, 2005, DEV BIOL, V286, P377, DOI 10.1016/j.ydbio.2005.06.023; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Sidler D, 2011, ONCOGENE, V30, P2411, DOI 10.1038/onc.2010.629; Sonoda J, 2008, FEBS LETT, V582, P2, DOI 10.1016/j.febslet.2007.11.016; Takebe N, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2876; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Thiruchelvam PTR, 2011, BREAST CANCER RES TR, V127, P385, DOI 10.1007/s10549-010-0994-9; Villanueva A, 2007, SEMIN LIVER DIS, V27, P55, DOI 10.1055/s-2006-960171; Wagner RT, 2010, STEM CELLS, V28, P1794, DOI 10.1002/stem.502; Wang SL, 2008, MOL CELL BIOCHEM, V308, P93, DOI 10.1007/s11010-007-9616-1; Wang W, 2005, P NATL ACAD SCI USA, V102, P7505, DOI 10.1073/pnas.0409482102; WEINER SJ, 1986, J COMPUT CHEM, V7, P230, DOI 10.1002/jcc.540070216; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; Whitby RJ, 2011, J MED CHEM, V54, P2266, DOI 10.1021/jm1014296; Wilkinson JM, 2008, J BIOMOL SCREEN, V13, P755, DOI 10.1177/1087057108322155; Wu YL, 2005, MOL CELL, V18, P413, DOI 10.1016/j.molcel.2005.04.014; Yumoto F, 2012, P NATL ACAD SCI USA, V109, P143, DOI 10.1073/pnas.1117036108	58	68	69	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19830	19844		10.1074/jbc.M112.411686	http://dx.doi.org/10.1074/jbc.M112.411686			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23667258	Green Published, hybrid			2022-12-25	WOS:000321515800051
J	Yi, TF; Papadopoulos, E; Hagner, PR; Wagner, G				Yi, Tingfang; Papadopoulos, Evangelos; Hagner, Patrick R.; Wagner, Gerhard			Hypoxia-inducible Factor-1 alpha (HIF-1 alpha) Promotes Cap-dependent Translation of Selective mRNAs through Up-regulating Initiation Factor eIF4E1 in Breast Cancer Cells under Hypoxia Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; GENE-EXPRESSION; TUMOR-GROWTH; STEM-CELLS; PROTEIN-SYNTHESIS; FACTOR EIF-4E; FACTOR 4E; OVEREXPRESSION; ANGIOGENESIS; PHOSPHORYLATION	Hypoxia promotes tumor evolution and metastasis, and hypoxia-inducible factor-1 alpha (HIF-1 alpha) is a key regulator of hypoxia-related cellular processes in cancer. The eIF4E translation initiation factors, eIF4E1, eIF4E2, and eIF4E3, are essential for translation initiation. However, whether and how HIF-1 alpha affects cap-dependent translation through eIF4Es in hypoxic cancer cells has been unknown. Here, we report that HIF-1 alpha promoted cap-dependent translation of selective mRNAs through up-regulation of eIF4E1 in hypoxic breast cancer cells. Hypoxia-promoted breast cancer tumorsphere growth was HIF-1 alpha-dependent. We found that eIF4E1, not eIF4E2 or eIF4E3, is the dominant eIF4E family member in breast cancer cells under both normoxia and hypoxia conditions. eIF4E3 expression was largely sequestered in breast cancer cells at normoxia and hypoxia. Hypoxia up-regulated the expression of eIF4E1 and eIF4E2, but only eIF4E1 expression was HIF-1 alpha-dependent. In hypoxic cancer cells, HIF-1 alpha-up-regulated eIF4E1 enhanced cap-dependent translation of a subset of mRNAs encoding proteins important for breast cancer cell mammosphere growth. In searching for correlations, we discovered that human eIF4E1 promoter harbors multiple potential hypoxia response elements. Furthermore, using chromatin immunoprecipitation (ChIP) and luciferase and point mutation assays, we found that HIF-1 alpha utilized hypoxia response elements in the human eIF4E1 proximal promoter region to activate eIF4E1 expression. Our study suggests that HIF-1 alpha promotes cap-dependent translation of selective mRNAs through up-regulating eIF4E1, which contributes to tumorsphere growth of breast cancer cells at hypoxia. The data shown provide new insights into protein synthesis mechanisms in cancer cells at low oxygen levels.	[Yi, Tingfang; Papadopoulos, Evangelos; Hagner, Patrick R.; Wagner, Gerhard] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Wagner, G (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA.	Gerhard_Wagner@hms.harvard.edu			National Institutes of Health [RO1 CA068262]; NATIONAL CANCER INSTITUTE [R01CA068262] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA068262 (to G. W.).	Aitken CE, 2012, NAT STRUCT MOL BIOL, V19, P568, DOI 10.1038/nsmb.2303; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bauer C, 2002, INT J CANCER, V98, P181, DOI 10.1002/ijc.10180; Blais JD, 2004, MOL CELL BIOL, V24, P7469, DOI 10.1128/MCB.24.17.7469-7482.2004; Bolat F, 2010, PATHOL RES PRACT, V206, P19, DOI 10.1016/j.prp.2009.07.017; Bos R, 2005, HISTOPATHOLOGY, V46, P31, DOI 10.1111/j.1365-2559.2005.02045.x; Braunstein S, 2007, MOL CELL, V28, P501, DOI 10.1016/j.molcel.2007.10.019; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Chung J, 2006, ONCOGENE, V25, P3079, DOI 10.1038/sj.onc.1209328; Coleman LJ, 2009, BRIT J CANCER, V100, P1393, DOI 10.1038/sj.bjc.6605044; Connolly E, 2006, MOL CELL BIOL, V26, P3955, DOI 10.1128/MCB.26.10.3955-3965.2006; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Elson DA, 2000, CANCER RES, V60, P6189; Fan SQ, 2009, CANCER BIOL THER, V8, P1463, DOI 10.4161/cbt.8.15.8960; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; FREDERICKSON RM, 1991, MOL CELL BIOL, V11, P2896, DOI 10.1128/MCB.11.5.2896; Graff JR, 2009, CANCER RES, V69, P3866, DOI 10.1158/0008-5472.CAN-08-3472; Guo P, 2003, CANCER RES, V63, P4684; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Heddleston JM, 2010, BRIT J CANCER, V102, P789, DOI 10.1038/sj.bjc.6605551; Hoskin PJ, 2003, BRIT J CANCER, V89, P1290, DOI 10.1038/sj.bjc.6601260; Ince TA, 2007, CANCER CELL, V12, P160, DOI 10.1016/j.ccr.2007.06.013; Jiang BH, 1997, CANCER RES, V57, P5328; Joshi B, 2004, EUR J BIOCHEM, V271, P2189, DOI 10.1111/j.1432-1033.2004.04149.x; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Knaup KX, 2009, MOL CANCER RES, V7, P88, DOI 10.1158/1541-7786.MCR-08-0288; Koritzinsky M, 2006, EMBO J, V25, P1114, DOI 10.1038/sj.emboj.7600998; Lang SA, 2007, CLIN CANCER RES, V13, P6459, DOI 10.1158/1078-0432.CCR-07-1104; Liu LP, 2006, MOL CELL, V21, P521, DOI 10.1016/j.molcel.2006.01.010; Liu NA, 2011, P NATL ACAD SCI USA, V108, P8414, DOI 10.1073/pnas.1018091108; Mamane Y, 2004, ONCOGENE, V23, P3172, DOI 10.1038/sj.onc.1207549; Marintchev A, 2004, Q REV BIOPHYS, V37, P197, DOI 10.1017/S0033583505004026; Mathupala SP, 2001, J BIOL CHEM, V276, P43407, DOI 10.1074/jbc.M108181200; Maxwell PH, 1997, P NATL ACAD SCI USA, V94, P8104, DOI 10.1073/pnas.94.15.8104; MIYAGI Y, 1995, CANCER LETT, V91, P247, DOI 10.1016/0304-3835(95)03737-H; Moerke NJ, 2007, CELL, V128, P257, DOI 10.1016/j.cell.2006.11.046; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Noske A, 2008, ONCOL REP, V20, P1409, DOI 10.3892/or_00000160; Osborne MJ, 2013, P NATL ACAD SCI USA, V110, P3877, DOI 10.1073/pnas.1216862110; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Rhoads RE, 2009, J BIOL CHEM, V284, P16711, DOI 10.1074/jbc.R900002200; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Salehi Z, 2006, CLIN BIOCHEM, V39, P404, DOI 10.1016/j.clinbiochem.2005.11.007; Scarpino S, 2004, J PATHOL, V202, P352, DOI 10.1002/path.1522; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Talks KL, 2000, AM J PATHOL, V157, P411, DOI 10.1016/S0002-9440(10)64554-3; Tanaka H, 2006, CANCER RES, V66, P11263, DOI 10.1158/0008-5472.CAN-06-1699; Tejada S, 2009, J HISTOCHEM CYTOCHEM, V57, P503, DOI 10.1369/jhc.2009.952929; Thomas JD, 2008, RNA, V14, P771, DOI 10.1261/rna.857308; Thumma SC, 2007, CANCER LETT, V258, P1, DOI 10.1016/j.canlet.2007.08.022; Uniacke J, 2012, NATURE, V486, P126, DOI 10.1038/nature11055; van den Beucken T, 2006, CANCER BIOL THER, V5, P749, DOI 10.4161/cbt.5.7.2972; von der Haar T, 2004, NAT STRUCT MOL BIOL, V11, P503, DOI 10.1038/nsmb779; Wendel HG, 2007, GENE DEV, V21, P3232, DOI 10.1101/gad.1604407; Yi TF, 2010, J BIOL CHEM, V285, P17811, DOI 10.1074/jbc.M110.130740; Yin XY, 2003, ONCOGENE, V22, P6151, DOI 10.1038/sj.onc.1206641; Young RM, 2008, J BIOL CHEM, V283, P16309, DOI 10.1074/jbc.M710079200; Zhang HJ, 2012, BLOOD, V119, P2595, DOI 10.1182/blood-2011-10-387381; Zhong H, 1999, CANCER RES, V59, P5830; Zhu KY, 2009, CANCER RES, V69, P1836, DOI 10.1158/0008-5472.CAN-08-4103	64	45	47	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18732	18742		10.1074/jbc.M113.471466	http://dx.doi.org/10.1074/jbc.M113.471466			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23667251	hybrid, Green Published			2022-12-25	WOS:000321335800009
J	Lenart, A; Dudkiewicz, M; Grynberg, M; Pawlowski, K				Lenart, Anna; Dudkiewicz, Malgorzata; Grynberg, Marcin; Pawlowski, Krzysztof			CLCAs - A Family of Metalloproteases of Intriguing Phylogenetic Distribution and with Cases of Substituted Catalytic Sites	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; MATRIX METALLOPROTEINASES; PROTEIN; DOMAIN; SEQUENCE; PROTEASES; CLEAVAGE; REVEALS; CHANNEL; DATABASE	The zinc-dependent metalloproteases with His-Glu-x-x-His (HExxH) active site motif, zincins, are a broad group of proteins involved in many metabolic and regulatory functions, and found in all forms of life. Human genome contains more than 100 genes encoding proteins with known zincin-like domains. A survey of all proteins containing the HExxH motif shows that approximately 52% of HExxH occurrences fall within known protein structural domains (as defined in the Pfam database). Domain families with majority of members possessing a conserved HExxH motif include, not surprisingly, many known and putative metalloproteases. Furthermore, several HExxH-containing protein domains thus identified can be confidently predicted to be putative peptidases of zincin fold. Thus, we predict zincin-like fold for eight uncharacterised Pfam families. Besides the domains with the HExxH motif strictly conserved, and those with sporadic occurrences, intermediate families are identified that contain some members with a conserved HExxH motif, but also many homologues with substitutions at the conserved positions. Such substitutions can be evolutionarily conserved and non-random, yet functional roles of these inactive zincins are not known. The CLCAs are a novel zincin-like protease family with many cases of substituted active sites. We show that this allegedly metazoan family has a number of bacterial and archaeal members. An extremely patchy phylogenetic distribution of CLCAs in prokaryotes and their conserved protein domain composition strongly suggests an evolutionary scenario of horizontal gene transfer (HGT) from multicellular eukaryotes to bacteria, providing an example of eukaryote-derived xenologues in bacterial genomes. Additionally, in a protein family identified here as closely homologous to CLCA, the CLCA_X (CLCA-like) family, a number of proteins is found in phages and plasmids, supporting the HGT scenario.	[Lenart, Anna; Pawlowski, Krzysztof] Polish Acad Sci, Dept Cellular & Mol Neurobiol, Nencki Inst Expt Biol, Warsaw, Poland; [Dudkiewicz, Malgorzata; Pawlowski, Krzysztof] Warsaw Univ Life Sci, Fac Agr & Biol, Warsaw, Poland; [Grynberg, Marcin] Polish Acad Sci, Inst Biochem & Biophys, Dept Genet, Warsaw, Poland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Warsaw University of Life Sciences; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Pawlowski, K (corresponding author), Polish Acad Sci, Dept Cellular & Mol Neurobiol, Nencki Inst Expt Biol, Warsaw, Poland.	krzysztof_pawlowski@sggw.pl	Pawłowski, Krzysztof/C-2949-2013; Dudkiewicz, Małgorzata/AAG-4553-2020	Pawłowski, Krzysztof/0000-0002-5367-0935; Grynberg, Marcin/0000-0003-1887-7209; Dudkiewicz, Malgorzata/0000-0003-4432-2530	Ministry of of Science and Higher Education, Republic of Poland [N N301 3165 33]	Ministry of of Science and Higher Education, Republic of Poland	AL, MD, MG and KP were supported by the grant N N301 3165 33 from the Ministry of of Science and Higher Education, Republic of Poland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alva V, 2010, PROTEIN SCI, V19, P124, DOI 10.1002/pro.297; Anderson MT, 2011, MBIO, V2, DOI 10.1128/mBio.00005-11; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Bateman A, 2003, TRENDS BIOCHEM SCI, V28, P234, DOI 10.1016/S0968-0004(03)00061-6; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bateman A, 2010, ACTA CRYSTALLOGR F, V66, P1148, DOI 10.1107/S1744309110001685; Blanchard H, 2011, BIOCHIMIE, V93, P87, DOI 10.1016/j.biochi.2010.03.002; BODE W, 1993, FEBS LETT, V331, P134, DOI 10.1016/0014-5793(93)80312-I; Bothe MK, 2012, MOL CELLS, V33, P251, DOI 10.1007/s10059-012-2217-1; Bothe M, 2011, MOL CELLS, V32, P535, DOI 10.1007/s10059-011-0158-8; Brown CK, 2001, P NATL ACAD SCI USA, V98, P3127, DOI 10.1073/pnas.051633198; Cai W, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-33; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cerda-Costa N, 2011, MOL MICROBIOL, V79, P119, DOI 10.1111/j.1365-2958.2010.07434.x; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cudic M, 2009, CURR PROTEIN PEPT SC, V10, P297, DOI 10.2174/138920309788922207; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, P345; Dudkiewicz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032138; Eggermont Jan, 2004, Proc Am Thorac Soc, V1, P22, DOI 10.1513/pats.2306010; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Gattiker Alexandre, 2002, Appl Bioinformatics, V1, P107; Goulas T, 2011, P NATL ACAD SCI USA, V108, P1856, DOI 10.1073/pnas.1012173108; HARTLEY BS, 1960, ANNU REV BIOCHEM, V29, P45, DOI 10.1146/annurev.bi.29.070160.000401; HOOPER NM, 1994, FEBS LETT, V354, P1, DOI 10.1016/0014-5793(94)01079-X; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; Iwashita H, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-55; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Jaroszewski L, 2011, NUCLEIC ACIDS RES, V39, pW38, DOI 10.1093/nar/gkr441; Jaroszewski L, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000205; Joint Center for Structural Genomics, 2010, CRYST STRUCT MET BAC; Keeling PJ, 2009, CURR OPIN GENET DEV, V19, P613, DOI 10.1016/j.gde.2009.10.001; KNIGHT CG, 1995, BIOCHEM J, V308, P145, DOI 10.1042/bj3080145; Kondo N, 2002, P NATL ACAD SCI USA, V99, P14280, DOI 10.1073/pnas.222228199; Kong Lesheng, 2008, BMC Bioinformatics, V9 Suppl 1, pS22, DOI 10.1186/1471-2105-9-S1-S22; Koonin EV, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00119; Koonin EV, 2001, ANNU REV MICROBIOL, V55, P709, DOI 10.1146/annurev.micro.55.1.709; Kosowska K, 2002, J BIOL CHEM, V277, P11987, DOI 10.1074/jbc.M110883200; Lattka E, 2010, CURR OPIN LIPIDOL, V21, P64, DOI 10.1097/MOL.0b013e3283327ca8; Leplae R, 2010, NUCLEIC ACIDS RES, V38, pD57, DOI 10.1093/nar/gkp938; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu HQ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-276; Lobocka MB, 2004, J BACTERIOL, V186, P7032, DOI 10.1128/JB.186.21.7032-7068.2004; Loewen ME, 2005, PHYSIOL REV, V85, P1061, DOI 10.1152/physrev.00016.2004; MATTHEWS BW, 1988, ACCOUNTS CHEM RES, V21, P333, DOI 10.1021/ar00153a003; MCKERROW JH, 1987, J BIOL CHEM, V262, P5943; Morais DADL, 2011, NUCLEIC ACIDS RES, V39, pD427, DOI 10.1093/nar/gkq1130; Mundhenk L, 2012, AM J RESP CELL MOL, V47, P87, DOI 10.1165/rcmb.2010-0508OC; Nakjang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030287; NEURATH H, 1976, P NATL ACAD SCI USA, V73, P3825, DOI 10.1073/pnas.73.11.3825; Nishimura H, 2001, DEV BIOL, V233, P204, DOI 10.1006/dbio.2001.0166; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Oh JS, 2009, MOL CELLS, V28, P441, DOI 10.1007/s10059-009-0140-x; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Patel AC, 2009, ANNU REV PHYSIOL, V71, P425, DOI 10.1146/annurev.physiol.010908.163253; Pauli BU, 2000, CLIN EXP PHARMACOL P, V27, P901, DOI 10.1046/j.1440-1681.2000.03358.x; Pawlowski K, 2006, PROTEINS, V63, P424, DOI 10.1002/prot.20887; Pawlowski K, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-590; Podell S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-419; Poole AM, 2009, RES MICROBIOL, V160, P473, DOI 10.1016/j.resmic.2009.07.009; RAWLINGS ND, 1993, BIOCHEM J, V290, P205, DOI 10.1042/bj2900205; Rawlings ND, 2014, NUCLEIC ACIDS RES, V42, pD503, DOI [10.1093/nar/gkt953, 10.1093/nar/gkr987]; Rychlewski L, 2000, PROTEIN SCI, V9, P232, DOI 10.1110/ps.9.2.232; Sadreyev RI, 2009, CURR OPIN STRUC BIOL, V19, P321, DOI 10.1016/j.sbi.2009.04.009; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Soding J, 2006, NUCLEIC ACIDS RES, V34, pW374, DOI 10.1093/nar/gkl195; Steuber H, 2010, CURR TOP MED CHEM, V10, P323, DOI 10.2174/156802610790725470; Tallant C, 2010, BBA-MOL CELL RES, V1803, P20, DOI 10.1016/j.bbamcr.2009.04.003; Tanikawa C, 2012, NEOPLASIA, V14, P141, DOI 10.1593/neo.111700; Turk B, 2007, FEBS LETT, V581, P2761, DOI 10.1016/j.febslet.2007.05.038; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Turk B, 2012, EMBO J, V31, P1630, DOI 10.1038/emboj.2012.42; Walia V, 2012, ONCOGENE, V31, P2237, DOI 10.1038/onc.2011.392; Winpenny John P., 2009, Inflammation & Allergy Drug Targets, V8, P146; Gomis-Ruth FX, 2009, J BIOL CHEM, V284, P15353, DOI 10.1074/jbc.R800069200; Xu QP, 2012, J BACTERIOL, V194, P2987, DOI 10.1128/JB.00038-12; Yurtsever Z, 2012, J BIOL CHEM, V287, P42138, DOI 10.1074/jbc.M112.410282	79	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e62272	10.1371/journal.pone.0062272	http://dx.doi.org/10.1371/journal.pone.0062272			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671590	Green Submitted, Green Published, gold			2022-12-25	WOS:000319737700010
J	Rillich, J; Stevenson, PA; Pflueger, HJ				Rillich, Jan; Stevenson, Paul A.; Pflueger, Hans-Joachim			Flight and Walking in Locusts-Cholinergic Co-Activation, Temporal Coupling and Its Modulation by Biogenic Amines	PLOS ONE			English	Article							CENTRAL PATTERN GENERATOR; CENTRAL NERVOUS CONTROL; MOTOR PATTERN; BIFUNCTIONAL MUSCLES; RHYTHMIC PATTERNS; THORACIC GANGLIA; NEURAL-CONTROL; DUM NEURONS; OCTOPAMINE; BEHAVIOR	Walking and flying in locusts are exemplary rhythmical behaviors generated by central pattern generators (CPG) that are tuned in intact animals by phasic sensory inputs. Although these two behaviors are mutually exclusive and controlled by independent CPGs, leg movements during flight can be coupled to the flight rhythm. To investigate potential central coupling between the underlying CPGs, we used the muscarinic agonist pilocarpine and the amines octopamine and tyramine to initiate fictive flight and walking in deafferented locust preparations. Our data illustrate that fictive walking is readily evoked by comparatively lower concentrations of pilocarpine, whereas higher concentrations are required to elicit fictive flight. Interestingly, fictive flight did not suppress fictive walking so that the two patterns were produced simultaneously. Frequently, leg motor units were temporally coupled to the flight rhythm, so that each spike in a step cycle volley occurred synchronously with wing motor units firing at flight rhythm frequency. Similarly, tyramine also induced fictive walking and flight, but mostly without any coupling between the two rhythms. Octopamine in contrast readily evoked fictive flight but generally failed to elicit fictive walking. Despite this, numerous leg motor units were recruited, whereby each was temporarily coupled to the flight rhythm. Our results support the notion that the CPGs for walking and flight are largely independent, but that coupling can be entrained by aminergic modulation. We speculate that octopamine biases the whole motor machinery of a locust to flight whereas tyramine primarily promotes walking.	[Rillich, Jan; Pflueger, Hans-Joachim] Free Univ Berlin, Inst Neurobiol, Berlin, Germany; [Stevenson, Paul A.] Univ Leipzig, Inst Biol, D-04109 Leipzig, Germany	Free University of Berlin; Leipzig University	Rillich, J (corresponding author), Free Univ Berlin, Inst Neurobiol, Berlin, Germany.	jan.rillich@fu-berlin.de	Stevenson, Paul A/A-2048-2010		Deutsche Forschungsgemeinschaft - Forschergruppe [FOR 1363 Pf 128/30-1]	Deutsche Forschungsgemeinschaft - Forschergruppe(German Research Foundation (DFG))	Funded by Deutsche Forschungsgemeinschaft - Forschergruppe: Biogenic amines in insects: coordination of physiological processes and behaviour FOR 1363 Pf 128/30-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausborn J, 2007, J NEUROSCI, V27, P9319, DOI 10.1523/JNEUROSCI.0907-07.2007; Ayali A, 2010, J INSECT PHYSIOL, V56, P834, DOI 10.1016/j.jinsphys.2010.03.015; Baudoux S, 1998, J NEUROPHYSIOL, V79, P361, DOI 10.1152/jn.1998.79.1.361; Braunig P, 2001, ADV INSECT PHYSIOL, V28, P185, DOI 10.1016/S0065-2806(01)28011-4; Brembs B, 2007, J NEUROSCI, V27, P11122, DOI 10.1523/JNEUROSCI.2704-07.2007; Buschges A, 2011, CURR BIOL, V21, pR513, DOI 10.1016/j.cub.2011.05.029; Buhl E, 2008, J EXP BIOL, V211, P2346, DOI 10.1242/jeb.017384; BURROWS M, 1975, J EXP BIOL, V63, P735; BUSCHGES A, 1995, J EXP BIOL, V198, P435; Campbell JI, 1961, R F P ZOOL SOC LOND, V137, P403; CLAASSEN DE, 1986, J NEUROBIOL, V17, P1, DOI 10.1002/neu.480170102; Duch C, 1999, J COMP PHYSIOL A, V184, P489, DOI 10.1007/s003590050349; DUCH C, 1995, J EXP BIOL, V198, P1963; DUGARD JJ, 1967, J INSECT PHYSIOL, V13, P1055, DOI 10.1016/0022-1910(67)90107-2; EVANS PD, 1981, J PHYSIOL-LONDON, V318, P99; Evans Peter D., 2005, Invertebrate Neuroscience, V5, P111, DOI 10.1007/s10158-005-0001-z; Heinrich R, 2002, MICROSC RES TECHNIQ, V56, P292, DOI 10.1002/jemt.10033; Heinrich R, 2001, J COMP PHYSIOL A, V187, P155, DOI 10.1007/s003590100188; HENNIG RM, 1990, J COMP PHYSIOL A, V167, P617; Homberg U, 2013, J COMP NEUR IN PRESS; Hustert R, 2012, J PHYSL IN PRESS; Johnson BR, 2011, J NEUROPHYSIOL, V105, P293, DOI 10.1152/jn.00809.2010; Johnston Rebecca M., 2002, Invertebrate Neuroscience, V4, P175, DOI 10.1007/s10158-002-0019-4; KINNAMON SC, 1984, J NEUROBIOL, V15, P283, DOI 10.1002/neu.480150405; Kononenko NL, 2009, J COMP NEUROL, V512, P433, DOI 10.1002/cne.21911; Lange AB, 2009, GEN COMP ENDOCR, V162, P18, DOI 10.1016/j.ygcen.2008.05.021; Libersat F, 2004, BIOSCIENCE, V54, P17, DOI 10.1641/0006-3568(2004)054[0017:MATOOB]2.0.CO;2; LOREZ M, 1995, J EXP BIOL, V198, P869; Marder E, 2007, ANNU REV PHYSIOL, V69, P291, DOI 10.1146/annurev.physiol.69.031905.161516; Marder E, 2012, NEURON, V76, P1, DOI 10.1016/j.neuron.2012.09.010; Miles GB, 2011, PHYSIOLOGY, V26, P393, DOI 10.1152/physiol.00013.2011; MOHL B, 1993, J COMP PHYSIOL A, V172, P325, DOI 10.1007/BF00216614; Monastirioti M, 1996, J NEUROSCI, V16, P3900; Morris OT, 1999, J EXP BIOL, V202, P3555; Nusbaum MP, 2002, NATURE, V417, P343, DOI 10.1038/417343a; ORCHARD I, 1993, ANNU REV ENTOMOL, V38, P227, DOI 10.1146/annurev.en.38.010193.001303; Paripovic I, 1996, PHYSIOL ENTOMOL, V21, P223, DOI 10.1111/j.1365-3032.1996.tb00859.x; RAMIREZ JM, 1991, J NEUROPHYSIOL, V66, P1522, DOI 10.1152/jn.1991.66.5.1522; Ramirez JM, 1998, J NEUROPHYSIOL, V80, P3137, DOI 10.1152/jn.1998.80.6.3137; RAMIREZ JM, 1988, J NEUROBIOL, V19, P257, DOI 10.1002/neu.480190307; RAMIREZ JM, 1991, BRAIN RES, V549, P332, DOI 10.1016/0006-8993(91)90477-D; Rand D, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00288; Rast GF, 1997, J EXP BIOL, V200, P2197; Roeder T, 1998, EUR J PHARMACOL, V349, P171, DOI 10.1016/S0014-2999(98)00192-7; Roeder T, 2003, ARCH INSECT BIOCHEM, V54, P1, DOI 10.1002/arch.10102; Roeder T, 2005, ANNU REV ENTOMOL, V50, P447, DOI 10.1146/annurev.ento.50.071803.130404; RONACHER B, 1988, J COMP PHYSIOL A, V163, P749, DOI 10.1007/BF00604052; Rosenberg LA, 2007, J EXP BIOL, V210, P4411, DOI 10.1242/jeb.010488; ROWELL CHF, 1991, TISSUE CELL, V23, P75, DOI 10.1016/0040-8166(91)90068-5; RYCKEBUSCH S, 1993, J NEUROPHYSIOL, V69, P1583, DOI 10.1152/jn.1993.69.5.1583; Sachs L, 1992, ANGEW STAT, V7; Sadaf S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046405; Scheiner R, 2006, CURR NEUROPHARMACOL, V4, P259, DOI 10.2174/157015906778520791; SCHOFIELD PK, 1984, J EXP BIOL, V109, P333; Schoneich S, 2012, BRAIN BEHAV, V2, P707, DOI 10.1002/brb3.89; SIMPSON SJ, 2013, OXFORD HDB IN PRESS; SNODGRASS R. E., 1929, SMITHSONIAN MISCELLANEOUS COLLECTIONS, V82, P1; SOMBATI S, 1984, J NEUROBIOL, V15, P481, DOI 10.1002/neu.480150607; STEVENSON PA, 1988, J COMP PHYSIOL A, V162, P247, DOI 10.1007/BF00606089; Stevenson PA, 2005, J NEUROSCI, V25, P1431, DOI 10.1523/JNEUROSCI.4258-04.2005; STEVENSON PA, 1995, COMP BIOCHEM PHYS A, V110, P203, DOI 10.1016/0300-9629(94)00152-J; Stevenson PA, 1997, J COMP PHYSIOL A, V180, P91, DOI 10.1007/s003590050030; STEVENSON PA, 1987, J COMP PHYSIOL A, V161, P115, DOI 10.1007/BF00609460; Stevenson PA, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00118; THOMPSON KJ, 1986, J EXP BIOL, V122, P413; Verlinden H, 2010, J INSECT PHYSIOL, V56, P854, DOI 10.1016/j.jinsphys.2010.05.018; Vierk R, 2009, J COMP PHYSIOL A, V195, P265, DOI 10.1007/s00359-008-0404-5; Vierk R, 2010, J COMP PHYSIOL A, V196, P37, DOI 10.1007/s00359-009-0490-z; Weisel Eichler A., 1996, J COMP PHYSIOL A, V179, P103; WEISFOGH T, 1956, PHILOS T ROY SOC B, V239, P459, DOI 10.1098/rstb.1956.0008; WILSON DM, 1961, J EXP BIOL, V38, P471; WILSON DM, 1962, J EXP BIOL, V39, P669; Zilberstein Y, 2002, J EXP BIOL, V205, P2833	73	24	25	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e62899	10.1371/journal.pone.0062899	http://dx.doi.org/10.1371/journal.pone.0062899			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671643	Green Published, gold, Green Submitted			2022-12-25	WOS:000319737700027
J	Stegger, JG; Schmidt, EB; Berentzen, TL; Tjonneland, A; Vogel, U; Rimm, E; Sorensen, TIA; Overvad, K; Jensen, MK				Stegger, Jakob Gerhard; Schmidt, Erik Berg; Berentzen, Tina Landsvig; Tjonneland, Anne; Vogel, Ulla; Rimm, Eric; Sorensen, Thorkild I. A.; Overvad, Kim; Jensen, Majken K.			Interaction between Obesity and the NFKB1-94ins/delATTG Promoter Polymorphism in Relation to Incident Acute Coronary Syndrome: A Follow Up Study in Three Independent Cohorts	PLOS ONE			English	Article							FACTOR-KAPPA-B; HEART-DISEASE; MYOCARDIAL-INFARCTION; ALCOHOL-CONSUMPTION; ADIPOSE-TISSUE; BODY-FAT; RISK; HEALTH; CHOLESTEROL; MEN	Introduction: The NF-kappa B transcription factor family regulates several genes encoding pro-inflammatory and anti-inflammatory proteins in adipose tissues and in atherosclerotic plaques. The deletion variant allele of the NFKB1 - 94ins/delATTG promoter polymorphism leads to lower transcript levels of the p50 subunit, and the variant allele has been associated with the risk of several inflammatory diseases as well as coronary heart disease where inflammation is important in the pathogenesis. The objective of this study was to explore the potential interaction between the NFKB1-94ins/delATTG promoter polymorphism and general, abdominal, and gluteofemoral obesity in relation to the risk of incident acute coronary syndrome (ACS) in three large independent cohorts. Methods and Results: The analyses were conducted in the Danish prospective study Diet, Cancer and Health and the two US based cohorts; Nurses' Health Study and Health Professionals Follow-up Study. We conducted sex stratified analyses that included 1202 male and 708 female cases of incident ACS. We observed a positive association for general and abdominal obesity with risk of incident ACS, independent of genotype in both genders. Gluteofemoral obesity was negatively associated with ACS risk in women independent of genotype, whereas there was no clear association for men. We calculated the relative excess risk due to interaction (RERI) and observed a statistically significant excess risk among men jointly exposed to general or abdominal obesity and the variant allele of the NFKB1-94ATTG polymorphism, whereas there was a tendency towards sub-additivity for gluteofemoral obesity. The excess risks in all analyses were, however, small and could not clearly be demonstrated in women. Conclusion: The variant allele of the NFKB1-94ins/delATTG promoter polymorphism did not substantially modify the association between obesity and incident ACS.	[Stegger, Jakob Gerhard; Schmidt, Erik Berg; Overvad, Kim; Jensen, Majken K.] Aarhus Univ Hosp, Aalborg Hosp, Cardiovasc Res Ctr, Dept Cardiol, Aalborg, Denmark; [Stegger, Jakob Gerhard] Aalborg Univ Hosp, Dept Anesthesiol, Aalborg, Denmark; [Berentzen, Tina Landsvig; Sorensen, Thorkild I. A.] Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark; [Tjonneland, Anne] Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark; [Vogel, Ulla] Natl Res Ctr Working Environm, Copenhagen, Denmark; [Rimm, Eric; Jensen, Majken K.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Rimm, Eric; Jensen, Majken K.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Rimm, Eric] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Rimm, Eric] Harvard Univ, Sch Med, Boston, MA USA; [Sorensen, Thorkild I. A.] Univ Copenhagen, Fac Med & Hlth Sci, Sect Metab Genet, Novo Nordisk Fdn,Ctr Basic Metab Res, Copenhagen, Denmark; [Overvad, Kim] Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark	Aalborg University; Aalborg University Hospital; Aarhus University; Aalborg University; Aalborg University Hospital; University of Copenhagen; Danish Cancer Society; National Research Centre for the Working Environment; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Novo Nordisk Foundation; University of Copenhagen; Aarhus University	Stegger, JG (corresponding author), Aarhus Univ Hosp, Aalborg Hosp, Cardiovasc Res Ctr, Dept Cardiol, Aalborg, Denmark.	Jakob.stegger@rn.dk	Vogel, Ulla/ABC-2212-2020; Vogel, Ulla B/I-5048-2012	Vogel, Ulla/0000-0001-6807-1524; Vogel, Ulla B/0000-0001-6807-1524; Overvad, Kim/0000-0001-6429-7921; Jensen, Majken Karoline/0000-0003-4729-7545; Tjonneland, Anne/0000-0003-4385-2097; Schmidt, Erik Berg/0000-0002-0623-5666	Danish Cancer Society; Danish Heart Foundation [08-10-R68-A2176-B994-22514, 09-4-R72-A2346-22544]; Danish Obesity Research Centre (DanORC); Gene-diet Interactions in Obesity (GENDINOB); Hepatic and Adipose Tissue and Functions in the Metabolic Syndrome (HEPADIP); National Institutes of Health, Bethesda, MD [CA55075, HL35464, HL34594, CA87969]; NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034594, R01HL035464] Funding Source: NIH RePORTER	Danish Cancer Society(Danish Cancer Society); Danish Heart Foundation; Danish Obesity Research Centre (DanORC); Gene-diet Interactions in Obesity (GENDINOB); Hepatic and Adipose Tissue and Functions in the Metabolic Syndrome (HEPADIP); National Institutes of Health, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors would like to thank the Danish Cancer Society for the funding of the Diet, Cancer and Health study. The present study was funded by the Danish Heart Foundation (08-10-R68-A2176-B994-22514 and 09-4-R72-A2346-22544) as well as the Danish Obesity Research Centre (DanORC), Gene-diet Interactions in Obesity (GENDINOB), and the Hepatic and Adipose Tissue and Functions in the Metabolic Syndrome (HEPADIP). The HPFS and NHS were funded by grants from the National Institutes of Health, Bethesda, MD (CA55075, HL35464, HL34594, CA87969). The authors would like to thank Hardeep Ranu and Pati Soule from the DF/HCC Genotyping Core for genotyping. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen TF, 1999, DAN MED BULL, V46, P263; Bogers RP, 2007, ARCH INTERN MED, V167, P1720, DOI 10.1001/archinte.167.16.1720; Canoy D, 2008, CURR OPIN CARDIOL, V23, P591, DOI 10.1097/HCO.0b013e328313133a; Cao SJ, 2006, J BIOL CHEM, V281, P26041, DOI 10.1074/jbc.M602222200; Colditz GA, 1997, J WOMENS HEALTH, V6, P49, DOI 10.1089/jwh.1997.6.49; de Winther MPJ, 2005, ARTERIOSCL THROM VAS, V25, P904, DOI 10.1161/01.ATV.0000160340.72641.87; Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387; HOSMER DW, 1992, EPIDEMIOLOGY, V3, P452, DOI 10.1097/00001648-199209000-00012; Jensen MK, 2008, EUR HEART J, V29, P104, DOI 10.1093/eurheartj/ehm517; Jensen MK, 2009, EUR HEART J, V30, P1584, DOI 10.1093/eurheartj/ehp145; Joensen AM, 2009, J CLIN EPIDEMIOL, V62, P188, DOI 10.1016/j.jclinepi.2008.03.005; KALBFLEISCH JD, 1988, STAT MED, V7, P149, DOI 10.1002/sim.4780070116; Karban AS, 2004, HUM MOL GENET, V13, P35, DOI 10.1093/hmg/ddh008; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Korn EL, 1997, AM J EPIDEMIOL, V145, P72; Liou YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033598; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Pereira SG, 2008, INT J BIOCHEM CELL B, V40, P1425, DOI 10.1016/j.biocel.2007.05.004; Ridker Paul M., 2003, Cardiology Clinics, V21, P315, DOI 10.1016/S0733-8651(03)00079-1; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rothman K., 1998, MODERN EPIDEMIOLOGY; Stegger JG, 2011, INT J OBESITY, V35, P1433, DOI 10.1038/ijo.2010.278; Tjonneland A, 2007, SCAND J PUBLIC HEALT, V35, P432, DOI 10.1080/14034940601047986; Van der Heiden K, 2010, CLIN SCI, V118, P593, DOI 10.1042/CS20090557; Vogel U, 2011, ATHEROSCLEROSIS, V219, P200, DOI 10.1016/j.atherosclerosis.2011.06.018; Vogel U, 2010, ATHEROSCLEROSIS, V209, P155, DOI 10.1016/j.atherosclerosis.2009.08.036; Vogel U, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-52; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	31	11	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63004	10.1371/journal.pone.0063004	http://dx.doi.org/10.1371/journal.pone.0063004			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671649	gold, Green Published, Green Submitted			2022-12-25	WOS:000319737700032
J	Gou, SM; Cui, PF; Li, XS; Shi, PF; Liu, T; Wang, CY				Gou, Shanmiao; Cui, Pengfei; Li, Xiangsheng; Shi, Pengfei; Liu, Tao; Wang, Chunyou			Low Concentrations of Metformin Selectively Inhibit CD133(+) Cell Proliferation in Pancreatic Cancer and Have Anticancer Action	PLOS ONE			English	Article							STEM-CELLS; SOLID TUMORS; GROWTH; MTOR; RISK; CHEMOTHERAPY; METAANALYSIS; ACTIVATION; THERAPIES; VIABILITY	Pancreatic cancer is the fourth leading cause of cancer related deaths in the United States. The prognosis remains dismal with little advance in treatment. Metformin is a drug widely used for the treatment of type II diabetes. Recent epidemiologic data revealed that oral administration of metformin is associated with a reduced risk of pancreatic cancer, suggesting its potential as a novel drug for this disease. Many studies have demonstrated the in vitro anticancer action of metformin, but the typically used concentrations were much higher than the in vivo plasma and tissue concentrations achieved with recommended therapeutic doses of metformin, and low concentrations of metformin had little effect on the proliferation of pancreatic cancer cells. We examined the effect of low concentrations of metformin on different subpopulations of pancreatic cancer cells and found that these selectively inhibited the proliferation of CD133(+) but not CD24(+) CD44(+)ESA(+) cells. We also examined the effect of low concentrations of metformin on cell invasion and in vivo tumor formation, demonstrating in vitro and in vivo anticancer action. Metformin was associated with a reduction of phospho-Erk and phospho-mTOR independent of Akt and AMPK phosphorylation. CD133(+) pancreatic cancer cells are considered to be cancer stem cells that contribute to recurrence, metastasis and resistance to adjuvant therapies in pancreatic cancer. Our results provide a basis for combination of metformin with current therapies to improve the prognosis of this disease.	[Gou, Shanmiao; Cui, Pengfei; Li, Xiangsheng; Shi, Pengfei; Liu, Tao; Wang, Chunyou] HUST, Union Hosp, Dept Gen Surg, Pancreat Dis Inst, Wuhan, Peoples R China	Huazhong University of Science & Technology	Gou, SM (corresponding author), HUST, Union Hosp, Dept Gen Surg, Pancreat Dis Inst, Wuhan, Peoples R China.	gousm@163.com; chunyouwang52@126.com			National Natural Science Foundation of China [81001064]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by National Natural Science Foundation of China (No. 81001064) (Website: http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ailles LE, 2007, CURR OPIN BIOTECH, V18, P460, DOI 10.1016/j.copbio.2007.10.007; Andriulli A, 2012, ANN SURG ONCOL, V19, P1644, DOI 10.1245/s10434-011-2110-8; Bao B, 2012, CANCER PREV RES, V5, P355, DOI 10.1158/1940-6207.CAPR-11-0299; Barnhart BC, 2007, CANCER METAST REV, V26, P261, DOI 10.1007/s10555-007-9053-3; Ben Sahra I, 2011, CANCER RES, V71, P4366, DOI 10.1158/0008-5472.CAN-10-1769; Carriere A, 2011, J BIOL CHEM, V286, P567, DOI 10.1074/jbc.M110.159046; Currie CJ, 2009, DIABETOLOGIA, V52, P1766, DOI 10.1007/s00125-009-1440-6; Dancey J, 2010, NAT REV CLIN ONCOL, V7, P209, DOI 10.1038/nrclinonc.2010.21; Davis JL, 2012, PANCREAS, V41, P678, DOI 10.1097/MPA.0b013e318249955a; Del Barco S, 2011, ONCOTARGET, V2, P896, DOI 10.18632/oncotarget.387; Ding Q, 2012, HUM CELL, V25, P1, DOI 10.1007/s13577-011-0037-9; Dragovich Tomislav, 2012, Clin Adv Hematol Oncol, V10, P344; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Grotenhuis BA, 2012, J SURG ONCOL, V106, P209, DOI 10.1002/jso.23069; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hyun S, 2009, CELL, V139, P1096, DOI 10.1016/j.cell.2009.11.020; Ibanez L, 2006, J CLIN ENDOCR METAB, V91, P2888, DOI 10.1210/jc.2006-0336; JUNIEN JL, 1979, ARCH INT PHARMACOD T, V241, P165; Kirpichnikov D, 2002, ANN INTERN MED, V137, P25, DOI 10.7326/0003-4819-137-1-200207020-00009; Kisfalvi K, 2009, CANCER RES, V69, P6539, DOI 10.1158/0008-5472.CAN-09-0418; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li CW, 2009, METHODS MOL BIOL, V568, P161, DOI 10.1007/978-1-59745-280-9_10; Li DH, 2009, GASTROENTEROLOGY, V137, P482, DOI 10.1053/j.gastro.2009.04.013; Lord JM, 2003, BRIT MED J, V327, P951, DOI 10.1136/bmj.327.7421.951; Marchesini G, 2001, LANCET, V358, P893, DOI 10.1016/S0140-6736(01)06042-1; McCubrey JA, 2010, ADV ENZYME REGUL, V50, P285, DOI 10.1016/j.advenzreg.2009.10.016; Nentwich MF, 2012, ANTICANCER RES, V32, P1999; Poruk KE, 2013, ANN SURG, V257, P17, DOI 10.1097/SLA.0b013e31825ffbfb; Rocha GZ, 2011, CLIN CANCER RES, V17, P3993, DOI 10.1158/1078-0432.CCR-10-2243; Schneider MB, 2001, GASTROENTEROLOGY, V120, P1263, DOI 10.1053/gast.2001.23258; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Soares HP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057289; Tomic T, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.86; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang CY, 2008, J GASTROINTEST SURG, V12, P2183, DOI 10.1007/s11605-008-0621-9; Wang LW, 2008, WORLD J GASTROENTERO, V14, P7192, DOI 10.3748/wjg.14.7192; Wurth R, 2013, CELL CYCLE, V12, P145, DOI 10.4161/cc.23050; Zakikhani M, 2006, CANCER RES, V66, P10269, DOI 10.1158/0008-5472.CAN-06-1500; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104	40	78	86	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63969	10.1371/journal.pone.0063969	http://dx.doi.org/10.1371/journal.pone.0063969			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667692	Green Published, Green Submitted, gold			2022-12-25	WOS:000319055600083
J	Yao, S; Cheng, MG; Zhang, Q; Wasik, M; Kelsh, R; Winkler, C				Yao, Sheng; Cheng, Mangeng; Zhang, Qian; Wasik, Mariusz; Kelsh, Robert; Winkler, Christoph			Anaplastic Lymphoma Kinase Is Required for Neurogenesis in the Developing Central Nervous System of Zebrafish	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; MAMMALIAN ACHAETE-SCUTE; NON-HODGKINS-LYMPHOMA; NEUROBLASTOMA PREDISPOSITION; DROSOPHILA-MELANOGASTER; ACTIVATING MUTATIONS; THERAPEUTIC TARGET; ATONAL HOMOLOGS; ALK KINASE; GENE	Anaplastic Lymphoma Kinase (ALK) was initially discovered as an oncogene in human lymphoma and other cancers, including neuroblastoma. However, little is known about the physiological function of ALK. We identified the alk ortholog in zebrafish (Danio rerio) and found that it is highly expressed in the developing central nervous system (CNS). Heat-shock inducible transgenic zebrafish lines were generated to over-express alk during early neurogenesis. Its ectopic expression resulted in activation of the MEK/ERK pathway, increased cell proliferation, and aberrant neurogenesis leading to mis-positioning of differentiated neurons. Thus, overexpressed alk is capable of promoting cell proliferation in the nervous system, similar to the situation in ALK-related cancers. Next, we used Morpholino mediated gene knock-down and a pharmacological inhibitor to interfere with expression and function of endogenous Alk. Alk inhibition did not affect neuron progenitor formation but severely compromised neuronal differentiation and neuron survival in the CNS. These data indicate that tightly controlled alk expression is critical for the balance between neural progenitor proliferation, differentiation and survival during embryonic neurogenesis.	[Yao, Sheng; Winkler, Christoph] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Yao, Sheng; Winkler, Christoph] Natl Univ Singapore, Ctr BioImaging Sci, Singapore 117548, Singapore; [Cheng, Mangeng] Merck Res Lab, In Vitro Pharmacol, Boston, MA USA; [Zhang, Qian; Wasik, Mariusz] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA USA; [Kelsh, Robert] Univ Bath, Dept Biol & Biochem, Ctr Regenerat Med, Dev Biol Programme, Bath BA2 7AY, Avon, England	National University of Singapore; National University of Singapore; Merck & Company; University of Pennsylvania; University of Bath	Winkler, C (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbswcw@nus.edu.sg	Winkler, Christoph/G-4822-2012; Kelsh, Robert/B-6445-2008	Winkler, Christoph/0000-0003-4688-6241; Kelsh, Robert/0000-0002-9381-0066	Singapore Ministry of Education-Academic Research Fund grant [R-154-000-478-112]; United Kingdom Medical Research Council (MRC) grant [G0400806]; National Cancer Institute (NCI) [R01-CA96856]; MRC [G0400806] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [R01CA096856] Funding Source: NIH RePORTER; Medical Research Council [G0400806] Funding Source: researchfish	Singapore Ministry of Education-Academic Research Fund grant; United Kingdom Medical Research Council (MRC) grant; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This project was supported by a Singapore Ministry of Education-Academic Research Fund grant (R-154-000-478-112) to CW, an United Kingdom Medical Research Council (MRC) grant (G0400806) to RK, and a grant from the National Cancer Institute (NCI) R01-CA96856 to MW. SY is a National University of Singapore -Department of Biological Sciences graduate scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajoghli B, 2004, DEV BIOL, V271, P416, DOI 10.1016/j.ydbio.2004.04.006; BENZLEMOINE E, 1988, BLOOD, V72, P1045; Berry T, 2012, CANCER CELL, V22, P117, DOI 10.1016/j.ccr.2012.06.001; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Cheng MG, 2012, MOL CANCER THER, V11, P670, DOI 10.1158/1535-7163.MCT-11-0776; Chiarle R, 2008, NAT REV CANCER, V8, P11, DOI 10.1038/nrc2291; Cooper MS, 2005, DEV DYNAM, V232, P359, DOI 10.1002/dvdy.20252; Degoutin J, 2009, EUR J NEUROSCI, V29, P275, DOI 10.1111/j.1460-9568.2008.06593.x; Di Paolo D, 2011, MOL THER, V19, P2201, DOI 10.1038/mt.2011.142; Diez del Corral R, 2001, NAT REV NEUROSCI, V2, P835; Dirks WG, 2002, INT J CANCER, V100, P49, DOI 10.1002/ijc.10435; DOLBEARE F, 1995, HISTOCHEM J, V27, P339; Dong ZQ, 2012, NEURON, V74, P65, DOI 10.1016/j.neuron.2012.01.031; Englund C, 2003, NATURE, V425, P512, DOI 10.1038/nature01950; FISCHER P, 1988, BLOOD, V72, P234; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Godinho Leanne, 2011, Cold Spring Harb Protoc, V2011, P877, DOI 10.1101/pdb.prot5646; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; Hurley SP, 2006, J COMP NEUROL, V495, P202, DOI 10.1002/cne.20887; Iwahara T, 1997, ONCOGENE, V14, P439, DOI 10.1038/sj.onc.1200849; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Kageyama R, 2005, EXP CELL RES, V306, P343, DOI 10.1016/j.yexcr.2005.03.015; Kageyama R, 2008, DEV GROWTH DIFFER, V50, pS97, DOI 10.1111/j.1440-169X.2008.00993.x; Kim CH, 1996, NEUROSCI LETT, V216, P109, DOI 10.1016/0304-3940(96)13021-4; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Lee HH, 2003, NATURE, V425, P507, DOI 10.1038/nature01916; Liedtke D, 2008, DEV DYNAM, V237, P62, DOI 10.1002/dvdy.21384; Link V, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-1; Lo LC, 2002, DEVELOPMENT, V129, P1553; Loeb-Hennard C, 2005, GENE EXPR PATTERNS, V5, P341, DOI 10.1016/j.modgep.2004.10.003; Lopes SS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000026; Loren CE, 2003, EMBO REP, V4, P781, DOI 10.1038/sj.embor.embor897; Loren CE, 2001, GENES CELLS, V6, P531, DOI 10.1046/j.1365-2443.2001.00440.x; Lyons DA, 2003, DEVELOPMENT, V130, P3427, DOI 10.1242/dev.00569; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Morris SW, 1997, ONCOGENE, V14, P2175, DOI 10.1038/sj.onc.1201062; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Ott GR, 2010, ACS MED CHEM LETT, V1, P493, DOI 10.1021/ml100158s; Palmer RH, 2009, BIOCHEM J, V420, P345, DOI 10.1042/BJ20090387; Park HC, 2000, NEUROSCI LETT, V279, P81, DOI 10.1016/S0304-3940(99)00940-4; Pasini A, 2001, MECH DEVELOP, V100, P317, DOI 10.1016/S0925-4773(00)00538-4; Perez-Pinera P, 2007, J BIOL CHEM, V282, P28683, DOI 10.1074/jbc.M704505200; Pogoda HM, 2006, DEVELOPMENT, V133, P1079, DOI 10.1242/dev.02296; Reiff T, 2011, DEVELOPMENT, V138, P4699, DOI 10.1242/dev.072157; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Roll JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031733; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SHIOTA M, 1995, BLOOD, V86, P1954, DOI 10.1182/blood.V86.5.1954.bloodjournal8651954; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Thermes V, 2002, MECH DEVELOP, V118, P91, DOI 10.1016/S0925-4773(02)00218-6; To TT, 2012, DEVELOPMENT, V139, P141, DOI 10.1242/dev.071035; Tomita K, 2000, EMBO J, V19, P5460, DOI 10.1093/emboj/19.20.5460; Vernersson E, 2006, GENE EXPR PATTERNS, V6, P448, DOI 10.1016/j.modgep.2005.11.006; Weiss A, 1998, CELL, V94, P277, DOI 10.1016/S0092-8674(00)81469-5; Yi SH, 2008, MOL THER, V16, P1873, DOI 10.1038/mt.2008.189; Zhu SZ, 2012, CANCER CELL, V21, P362, DOI 10.1016/j.ccr.2012.02.010	59	41	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63757	10.1371/journal.pone.0063757	http://dx.doi.org/10.1371/journal.pone.0063757			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667670	Green Published, gold			2022-12-25	WOS:000319055600073
J	Cox, JL; Wilder, PJ; Gilmore, JM; Wuebben, EL; Washburn, MP; Rizzino, A				Cox, Jesse L.; Wilder, Phillip J.; Gilmore, Joshua M.; Wuebben, Erin L.; Washburn, Michael P.; Rizzino, Angie			The SOX2-Interactome in Brain Cancer Cells Identifies the Requirement of MSI2 and USP9X for the Growth of Brain Tumor Cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; TRANSFORMING GROWTH-FACTOR-BETA-2 GENE; AGGRESSIVE MYELOID-LEUKEMIA; FAM DEUBIQUITYLATING ENZYME; PROTEIN-INTERACTION NETWORK; GLIOBLASTOMA-MULTIFORME; HUMAN MEDULLOBLASTOMAS; INITIATING CELLS; BETA-CATENIN; IN-VITRO	Medulloblastomas and glioblastomas, the most common primary brain tumors in children and adults, respectively, are extremely difficult to treat. Efforts to identify novel proteins essential for the growth of these tumors may help to further our understanding of the biology of these tumors, as well as, identify targets for future therapies. The recent identification of multiple transcription factor-centric protein interaction landscapes in embryonic stem cells has identified numerous understudied proteins that are essential for the self-renewal of these stem cells. To identify novel proteins essential for the fate of brain tumor cells, we examined the protein interaction network of the transcription factor, SOX2, in medulloblastoma cells. For this purpose, Multidimensional Protein Identification Technology (MudPIT) identified >280 SOX2-associated proteins in the medulloblastoma cell line DAOY. To begin to understand the roles of SOX2-associated proteins in brain cancer, we focused on two SOX2-associated proteins, Musashi 2 (MSI2) and Ubiquitin Specific Protease 9x (USP9X). Recent studies have implicated MSI2, a putative RNA binding protein, and USP9X, a deubiquitinating enzyme, in several cancers, but not brain tumors. We demonstrate that knockdown of MSI2 significantly reduces the growth of DAOY cells as well as U87 and U118 glioblastoma cells. We also demonstrate that the knockdown of USP9X in DAOY, U87 and U118 brain tumor cells strongly reduces their growth. Together, our studies identify a large set of SOX2-associated proteins in DAOY medulloblastoma cells and identify two proteins, MSI2 and USP9X, that warrant further investigation to determine whether they are potential therapeutic targets for brain cancer.	[Cox, Jesse L.; Wilder, Phillip J.; Wuebben, Erin L.; Rizzino, Angie] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA; [Gilmore, Joshua M.; Washburn, Michael P.] Stowers Inst Med Res, Kansas City, MO USA; [Gilmore, Joshua M.; Washburn, Michael P.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA	University of Nebraska System; University of Nebraska Medical Center; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Rizzino, A (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA.	arizzino@unmc.edu		Washburn, Michael/0000-0001-7568-2585	Nebraska Department of Health [2011-29, 2012-33]; NCI training grant [CA009476]; Stowers Institute for Medical Research; NATIONAL CANCER INSTITUTE [T32CA009476] Funding Source: NIH RePORTER	Nebraska Department of Health; NCI training grant; Stowers Institute for Medical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by grants from the Nebraska Department of Health (2011-29, 2012-33). EW was supported in part by an NCI training grant (CA009476). JMG and MPW were supported by the Stowers Institute for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdouh M, 2009, J NEUROSCI, V29, P8884, DOI 10.1523/JNEUROSCI.0968-09.2009; Abreu RD, 2009, J BIOL CHEM, V284, P12125, DOI 10.1074/jbc.M809605200; Al-Hakim AK, 2008, BIOCHEM J, V411, P249, DOI 10.1042/BJ20080067; Cheng X, 2008, DEVELOPMENT, V135, P3447, DOI 10.1242/dev.025916; Cho YJ, 2011, J CLIN ONCOL, V29, P1424, DOI 10.1200/JCO.2010.28.5148; Connolly EC, 2012, INT J BIOL SCI, V8, P964, DOI 10.7150/ijbs.4564; Cox JL, 2011, J CELL SCI, V124, P2654, DOI 10.1242/jcs.083238; Cox JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015486; Di Marcotullio L, 2006, NAT CELL BIOL, V8, P1415, DOI 10.1038/ncb1510; Ding JJ, 2012, CELL RES, V22, P155, DOI 10.1038/cr.2011.179; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Eichhorn PJA, 2012, NAT MED, V18, P429, DOI 10.1038/nm.2619; Elias JE, 2005, NAT METHODS, V2, P667, DOI 10.1038/NMETH785; Euskirchen P, 2011, EXP CELL RES, V317, P2864, DOI 10.1016/j.yexcr.2011.09.002; Fang XF, 2011, PROTEOMICS, V11, P921, DOI 10.1002/pmic.201000419; Festa M, 2011, AM J PATHOL, V178, P2504, DOI 10.1016/j.ajpath.2011.02.002; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Gao ZH, 2012, J BIOL CHEM, V287, P11384, DOI 10.1074/jbc.M111.320143; Griner LN, 2010, CANCER BIOL THER, V10, P979, DOI 10.4161/cbt.10.10.14010; Huang Q, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-304; Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001; Ito T, 2010, NATURE, V466, P765, DOI 10.1038/nature09171; Katoh M, 2006, INT J MOL MED, V18, P517; KELLY D, 1995, MOL REPROD DEV, V40, P135, DOI 10.1002/mrd.1080400202; Kharas MG, 2010, NAT MED, V16, P903, DOI 10.1038/nm.2187; Kingsley-Kallesen M, 2001, IN VITRO CELL DEV-AN, V37, P684; Krex D, 2007, BRAIN, V130, P2596, DOI 10.1093/brain/awm204; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Mallanna SK, 2012, J CELL PHYSIOL, V227, P27, DOI 10.1002/jcp.22721; Mallanna SK, 2010, STEM CELLS, V28, P1715, DOI 10.1002/stem.494; Mouchantaf R, 2006, J BIOL CHEM, V281, P38738, DOI 10.1074/jbc.M605959200; Murray RZ, 2004, MOL BIOL CELL, V15, P1591, DOI 10.1091/mbc.E03-08-0630; Muto J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033431; Nagai H, 2009, MOL CELL, V36, P805, DOI 10.1016/j.molcel.2009.10.016; Nathan JA, 2008, TRAFFIC, V9, P1130, DOI 10.1111/j.1600-0854.2008.00747.x; Pantaleon M, 2001, MECH DEVELOP, V109, P151, DOI 10.1016/S0925-4773(01)00551-2; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; Perek D, 1998, CHILD NERV SYST, V14, P582, DOI 10.1007/s003810050276; Perez-Mancera PA, 2012, NATURE, V486, P266, DOI 10.1038/nature11114; Ringer L, 2011, CANCER BIOL THER, V12, P818, DOI 10.4161/cbt.12.9.17682; Rizzino A., 2013, STEM CELL IN PRESS; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Sanchez-Diaz PC, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-280; Schwickart M, 2010, NATURE, V463, P103, DOI 10.1038/nature08646; Shi DD, 2010, CANCER BIOL THER, V10, P737, DOI 10.4161/cbt.10.8.13417; Sutter R, 2010, ONCOGENE, V29, P1845, DOI 10.1038/onc.2009.472; Taya S, 1999, GENES CELLS, V4, P757, DOI 10.1046/j.1365-2443.1999.00297.x; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; Theard D, 2010, EMBO J, V29, P1499, DOI 10.1038/emboj.2010.46; Thompson MC, 2006, J CLIN ONCOL, V24, P1924, DOI 10.1200/JCO.2005.04.4974; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wiebe MS, 2007, CELL HOST MICROBE, V1, P187, DOI 10.1016/j.chom.2007.03.007; Wuebben EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034827; Zhang Y, 2010, ANAL CHEM, V82, P2272, DOI 10.1021/ac9023999	56	80	85	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62857	10.1371/journal.pone.0062857	http://dx.doi.org/10.1371/journal.pone.0062857			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667531	gold, Green Submitted, Green Published			2022-12-25	WOS:000319654700070
J	De La Fuente, L; Parker, JK; Oliver, JE; Granger, S; Brannen, PM; van Santen, E; Cobine, PA				De La Fuente, Leonardo; Parker, Jennifer K.; Oliver, Jonathan E.; Granger, Shea; Brannen, Phillip M.; van Santen, Edzard; Cobine, Paul A.			The Bacterial Pathogen Xylella fastidiosa Affects the Leaf Ionome of Plant Hosts during Infection	PLOS ONE			English	Article							PHONY PEACH DISEASE; VITIS-VINIFERA CV; PIERCES-DISEASE; NUTRITIONAL IMMUNITY; BIOFILM FORMATION; WATER-STRESS; CALCIUM; GRAPEVINE; CITRUS; SYMPTOMS	Xylella fastidiosa is a plant pathogenic bacterium that lives inside the host xylem vessels, where it forms biofilm believed to be responsible for disrupting the passage of water and nutrients. Here, Nicotiana tabacum was infected with X. fastidiosa, and the spatial and temporal changes in the whole-leaf ionome (i.e. the mineral and trace element composition) were measured as the host plant transitioned from healthy to diseased physiological status. The elemental composition of leaves was used as an indicator of the physiological changes in the host at a specific time and relative position during plant development. Bacterial infection was found to cause significant increases in concentrations of calcium prior to the appearance of symptoms and decreases in concentrations of phosphorous after symptoms appeared. Field-collected leaves from multiple varieties of grape, blueberry, and pecan plants grown in different locations over a four-year period in the Southeastern US showed the same alterations in Ca and P. This descriptive ionomics approach characterizes the existence of a mineral element-based response to X. fastidiosa using a model system suitable for further manipulation to uncover additional details of the role of mineral elements during plant-pathogen interactions. This is the first report on the dynamics of changes in the ionome of the host plant throughout the process of infection by a pathogen.	[De La Fuente, Leonardo; Parker, Jennifer K.; Oliver, Jonathan E.] Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA; [Granger, Shea; Cobine, Paul A.] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA; [Brannen, Phillip M.] Univ Georgia, Dept Plant Pathol, Athens, GA 30602 USA; [van Santen, Edzard] Auburn Univ, Dept Agron & Soils, Auburn, AL 36849 USA	Auburn University System; Auburn University; Auburn University System; Auburn University; University System of Georgia; University of Georgia; Auburn University System; Auburn University	De La Fuente, L (corresponding author), Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA.	lzd0005@auburn.edu	van Santen, Edzard/AAH-5979-2020; Parker, Jennifer/A-3273-2012; Cobine, Paul/AAH-6619-2020; Cobine, Paul A/G-3107-2011; Parker, Jennifer K/AGX-7067-2022; De La Fuente, Leonardo/A-2012-2013	Parker, Jennifer/0000-0002-4382-0741; Cobine, Paul/0000-0001-6012-0985; Cobine, Paul A/0000-0001-6012-0985; Parker, Jennifer K/0000-0002-4382-0741; De La Fuente, Leonardo/0000-0002-0027-4840; Oliver, Jonathan/0000-0003-2692-5055	Agriculture and Food Research Initiative Competitive Grants Program from the USDA National Institute of Food and Agriculture [2010-65108-20633]; Alabama Agricultural Experiment Station Hatch Grant Program	Agriculture and Food Research Initiative Competitive Grants Program from the USDA National Institute of Food and Agriculture; Alabama Agricultural Experiment Station Hatch Grant Program	This project was supported by Agriculture and Food Research Initiative Competitive Grants Program grant no. 2010-65108-20633 from the USDA National Institute of Food and Agriculture and the Alabama Agricultural Experiment Station Hatch Grant Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN PC, 1989, PHYSIOL PLANTARUM, V75, P63, DOI 10.1111/j.1399-3054.1989.tb02064.x; ANDERSEN PC, 1987, PHYSIOL MOL PLANT P, V31, P25, DOI 10.1016/0885-5765(87)90004-X; Andersen PC, 2007, FEMS MICROBIOL LETT, V274, P210, DOI 10.1111/j.1574-6968.2007.00827.x; Barker A. V., 2007, HDB PLANT NUTR; Barker A.V., 2007, HDB PLANT NUTR, V2nd ed., P3; Baxter IR, 2008, P NATL ACAD SCI USA, V105, P12081, DOI 10.1073/pnas.0804175105; BENGTSSON B, 1982, PHYSIOL PLANTARUM, V54, P107, DOI 10.1111/j.1399-3054.1982.tb06311.x; Chang CJ, 2009, HORTSCIENCE, V44, P413, DOI 10.21273/HORTSCI.44.2.413; Chatterjee S, 2008, ANNU REV PHYTOPATHOL, V46, P243, DOI 10.1146/annurev.phyto.45.062806.094342; Choat B, 2009, PHYSIOL PLANTARUM, V136, P384, DOI 10.1111/j.1399-3054.2009.01231.x; Choi H-K, 2013, MOL PLANT MICROBE IN; CLARKSON DT, 1984, PLANT CELL ENVIRON, V7, P449, DOI 10.1111/j.1365-3040.1984.tb01435.x; Cobine PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054936; Cruz LF, 2012, APPL ENVIRON MICROB, V78, P1321, DOI 10.1128/AEM.06501-11; Dandekar AM, 2012, P NATL ACAD SCI USA, V109, P3721, DOI 10.1073/pnas.1116027109; Datnoff LE., 2007, MINERAL NUTR PLANT D; DAVIS MJ, 1981, CURR MICROBIOL, V6, P309, DOI 10.1007/BF01566883; DOYLE JJ, 1987, TAXON, V36, P715, DOI 10.2307/1221122; EVERT DR, 1981, J AM SOC HORTIC SCI, V106, P780; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; Francis M, 2008, PLANT DIS, V92, P14, DOI 10.1094/PDIS-92-1-0014; Francis M, 2006, EUR J PLANT PATHOL, V115, P203, DOI 10.1007/s10658-006-9009-4; Fritschi FB, 2008, PLANT DIS, V92, P276, DOI 10.1094/PDIS-92-2-0276; Gomes MMA, 2003, PLANT GROWTH REGUL, V39, P263, DOI 10.1023/A:1022854405898; GOODWIN PH, 1988, PHYSIOL MOL PLANT P, V32, P17, DOI 10.1016/S0885-5765(88)80003-1; GOODWIN PH, 1988, PHYSIOL MOL PLANT P, V32, P1, DOI 10.1016/S0885-5765(88)80002-X; Habermann G, 2003, SCI HORTIC-AMSTERDAM, V98, P233, DOI 10.1016/S0304-4238(02)00228-5; Hansch R, 2009, CURR OPIN PLANT BIOL, V12, P259, DOI 10.1016/j.pbi.2009.05.006; Hirschi KD, 2003, TRENDS BIOTECHNOL, V21, P520, DOI 10.1016/j.tibtech.2003.09.013; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; HOPKINS DL, 1989, ANNU REV PHYTOPATHOL, V27, P271, DOI 10.1146/annurev.py.27.090189.001415; Hopkins DL, 2002, PLANT DIS, V86, P1056, DOI 10.1094/PDIS.2002.86.10.1056; Huber DM, 2007, LANDBAUFORSCH VOLK, V57, P313; Krivanek AF, 2005, PHYTOPATHOLOGY, V95, P36, DOI 10.1094/PHYTO-95-0036; Kudla J, 2010, PLANT CELL, V22, P541, DOI 10.1105/tpc.109.072686; Lahner B, 2003, NAT BIOTECHNOL, V21, P1215, DOI 10.1038/nbt865; Lecourieux D, 2006, NEW PHYTOL, V171, P249, DOI 10.1111/j.1469-8137.2006.01777.x; Leite B, 2002, BRAZ J MED BIOL RES, V35, P645, DOI 10.1590/S0100-879X2002000600003; Maathuis FJM, 2009, CURR OPIN PLANT BIOL, V12, P250, DOI 10.1016/j.pbi.2009.04.003; MARSCHNER H, 1995, MINERAL NUTR HIGHER, V15; MINSAVAGE GV, 1994, PHYTOPATHOLOGY, V84, P456, DOI 10.1094/Phyto-84-456; Musetti R, 2012, MOL PLANT MICROBE IN; Pilbeam DJ, 2007, HDB PLANT NUTR, P121; Purcell AH, 1996, ANNU REV PHYTOPATHOL, V34, P131, DOI 10.1146/annurev.phyto.34.1.131; Purcino RP, 2007, J EXP BOT, V58, P2733, DOI 10.1093/jxb/erm138; Reuter DJ., 1997, PLANT ANAL INTERPRET, P241, DOI 10.1071/9780643101265; Salt DE, 2008, ANNU REV PLANT BIOL, V59, P709, DOI 10.1146/annurev.arplant.59.032607.092942; Sanchez C., 2007, HDB PLANT NUTR, P51; Silva-Stenico ME, 2009, BRAZ J BIOL, V69, P859, DOI 10.1590/S1519-69842009000400013; Thorne ET, 2006, AM J ENOL VITICULT, V57, P1; Van Sluys MA, 2003, J BACTERIOL, V185, P1018, DOI 10.1128/JB.185.3.1018-1026.2003; Van Sluys MA, 2002, ANNU REV PHYTOPATHOL, V40, P169, DOI 10.1146/annurev.phyto.40.030402.090559; Wallis CM, 2012, PHYTOPATHOLOGY, V102, P816, DOI 10.1094/PHYTO-04-12-0074-R; WEINBERG ED, 1975, JAMA-J AM MED ASSOC, V231, P39, DOI 10.1001/jama.231.1.39; Williams L, 2009, CURR OPIN PLANT BIOL, V12, P247, DOI 10.1016/j.pbi.2009.05.009; Zaini PA, 2008, J BACTERIOL, V190, P2368, DOI 10.1128/JB.01495-07; Zhou T, 2012, DALTON T, V41, P6371, DOI 10.1039/c2dt12159j	57	51	52	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62945	10.1371/journal.pone.0062945	http://dx.doi.org/10.1371/journal.pone.0062945			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667547	gold, Green Submitted, Green Published			2022-12-25	WOS:000319654700085
J	Hernandez, L; Terradas, M; Martin, M; Feijoo, P; Soler, D; Tusell, L; Genesca, A				Hernandez, Laia; Terradas, Mariona; Martin, Marta; Feijoo, Purificacion; Soler, David; Tusell, Laura; Genesca, Anna			Increased Mammogram-Induced DNA Damage in Mammary Epithelial Cells Aged In Vitro	PLOS ONE			English	Article							CANCER-MORTALITY; BREAST-CANCER; IONIZING-RADIATION; TELOMERE DYSFUNCTION; GENOMIC INSTABILITY; HISTONE H2AX; EXPOSURE; RISKS; REPAIR; WORKERS	Concerned about the risks of mammography screening in the adult population, we analyzed the ability of human mammary epithelial cells to cope with mammogram-induced DNA damage. Our study shows that an X-ray dose of 20 mGy, which is the standard dose received by the breast surface per two-view mammogram X-ray exploration, induces increased frequencies of DNA double-strand breaks to in vitro aged-but not to young-human mammary epithelial cells. We provide evidence that aged epithelial breast cells are more radiosensitive than younger ones. Our studies point to an inefficient damage response of aged cells to low-dose radiation, this being due to both delayed and incomplete mobilization of repair proteins to DNA strand breaks. This inefficient damage response is translated into an important delay in double-strand break disappearance and consequent accumulation of unrepaired DNA breaks. The result of this is a significant increase in micronuclei frequency in the in vitro aged mammary epithelial cells exposed to doses equivalent to a single mammogram X-ray exploration. Since our experiments were carried out in primary epithelial cell cultures in which cells age at the same time as they undergo replication-dependent telomere shortening, we needed to determine the contribution of these two factors to their phenotype. In this paper, we report that the exogenous expression of human telomerase retrotranscriptase in late population doubling epithelial cells does not rescue its delayed repair phenotype. Therefore, retarded DNA break repair is a direct consequence of cellular aging itself, rather than a consequence of the presence of dysfunctional telomeres. Our findings of long-lasting double strand breaks and incomplete DNA break repair in the in vitro aged epithelial cells are in line with the increased carcinogenic risks of radiation exposures at older ages revealed by epidemiologic studies.	[Hernandez, Laia; Terradas, Mariona; Martin, Marta; Feijoo, Purificacion; Soler, David; Tusell, Laura; Genesca, Anna] Univ Autonoma Barcelona, Dept Cell Biol Physiol & Immunol, Bellaterra, Spain	Autonomous University of Barcelona	Genesca, A (corresponding author), Univ Autonoma Barcelona, Dept Cell Biol Physiol & Immunol, Bellaterra, Spain.	anna.genesca@uab.es	Martín Flix, Marta/J-4325-2017; Terradas, Mariona/K-5775-2017; Genesca, Anna/J-4195-2017; Tusell, Laura/H-8699-2017	Martín Flix, Marta/0000-0001-7849-3616; Terradas, Mariona/0000-0001-7813-1172; Genesca, Anna/0000-0002-0509-956X; Tusell, Laura/0000-0002-2848-345X	Consejo de Seguridad Nuclear [CSN 2012-0001]; EURATOM [GA 323216]; Instituto de Salud Carlos III [RD06/0020/1020]; Generalitat de Catalunya [2009SGR-282]	Consejo de Seguridad Nuclear; EURATOM; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Generalitat de Catalunya(Generalitat de Catalunya)	This work was funded by grants from Consejo de Seguridad Nuclear (CSN 2012-0001) and EURATOM (Dark. Risk GA 323216). AG laboratory is supported by Instituto de Salud Carlos III (RD06/0020/1020) and Generalitat de Catalunya (2009SGR-282). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autier P, 2011, ANN ONCOL, V22, P1726, DOI 10.1093/annonc/mdq633; Brenner DJ, 2003, P NATL ACAD SCI USA, V100, P13761, DOI 10.1073/pnas.2235592100; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Costes SV, 2010, MUTAT RES-REV MUTAT, V704, P78, DOI 10.1016/j.mrrev.2009.12.006; D'Angelo MA, 2009, CELL, V136, P284, DOI 10.1016/j.cell.2008.11.037; Esserman L, 2009, JAMA-J AM MED ASSOC, V302, P1685, DOI 10.1001/jama.2009.1498; FitzGerald JE, 2009, BIOCHEM SOC T, V37, P897, DOI 10.1042/BST0370897; Hong Z, 2007, J CELL PHYSIOL, V210, P567, DOI 10.1002/jcp.20919; Howe GR, 1996, RADIAT RES, V145, P694, DOI 10.2307/3579360; KNEALE GW, 1995, OCCUP ENVIRON MED, V52, P515, DOI 10.1136/oem.52.8.515; Kreiling JA, 2011, AGING CELL, V10, P292, DOI 10.1111/j.1474-9726.2010.00666.x; Krishnan V, 2011, AGING-US, V3, P943, DOI 10.18632/aging.100399; Lobrich M, 2007, NAT REV CANCER, V7, P861, DOI 10.1038/nrc2248; Ma HY, 2008, BREAST CANCER RES TR, V109, P77, DOI 10.1007/s10549-007-9625-5; MacPhail SH, 2003, RADIAT RES, V159, P759, DOI 10.1667/RR3003; Mao ZY, 2012, P NATL ACAD SCI USA, V109, P11800, DOI 10.1073/pnas.1200583109; Martin M, 2005, CANCER RES, V65, P10223, DOI 10.1158/0008-5472.CAN-05-0932; Martin M, 2003, INT J RADIAT BIOL, V79, P203, DOI 10.1080/0955300031000089601; Mullenders L, 2009, NAT REV CANCER, V9, P596, DOI 10.1038/nrc2677; Richardson DB, 1999, ENVIRON HEALTH PERSP, V107, P649, DOI 10.2307/3434457; Ritz B, 1999, EPIDEMIOLOGY, V10, P531, DOI 10.1097/00001648-199909000-00012; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Romanov SR, 2001, NATURE, V409, P633, DOI 10.1038/35054579; Ronckers CM, 2010, RADIAT RES, V174, P83, DOI 10.1667/RR2022.1; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Rothkamm K, 2001, CANCER RES, V61, P3886; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Sedelnikova OA, 2008, AGING CELL, V7, P89, DOI 10.1111/j.1474-9726.2007.00354.x; Seluanov A, 2004, P NATL ACAD SCI USA, V101, P7624, DOI 10.1073/pnas.0400726101; Seluanov A, 2007, DNA REPAIR, V6, P1740, DOI 10.1016/j.dnarep.2007.06.010; Shuryak I, 2010, JNCI-J NATL CANCER I, V102, P1628, DOI 10.1093/jnci/djq346; Soler D, 2005, GENE CHROMOSOME CANC, V44, P339, DOI 10.1002/gcc.20244; Soler D, 2009, AGING CELL, V8, P414, DOI 10.1111/j.1474-9726.2009.00488.x; Terradas M, 2012, MUTAT RES-FUND MOL M, V729, P35, DOI 10.1016/j.mrfmmm.2011.09.003; Wing S, 2005, OCCUP ENVIRON MED, V62, P465, DOI 10.1136/oem.2005.019760	36	24	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63052	10.1371/journal.pone.0063052	http://dx.doi.org/10.1371/journal.pone.0063052			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667571	Green Submitted, Green Published, gold			2022-12-25	WOS:000319654700103
J	Hogg, K; Blair, JD; McFadden, DE; von Dadelszen, P; Robinson, WP				Hogg, Kirsten; Blair, John D.; McFadden, Deborah E.; von Dadelszen, Peter; Robinson, Wendy P.			Early Onset Pre-Eclampsia Is Associated with Altered DNA Methylation of Cortisol-Signalling and Steroidogenic Genes in the Placenta	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-2; BETA-HYDROXYSTEROID DEHYDROGENASE; INTRAUTERINE GROWTH RESTRICTION; GLUCOCORTICOID-RECEPTOR; MESSENGER-RNA; HUMAN-FETAL; EPIGENETIC REGULATION; REDUCED EXPRESSION; MATERNAL PLASMA	Placental cortisol is inactivated in normotensive pregnancies, but is frequently present in pre-eclampsia associated placentae. Since glucocorticoids are strongly associated with the programming of long-term health, we assessed DNA methylation of genes involved in cortisol signalling and bioavailability, and hormonal signalling in the placenta of normotensive and hypertensive pregnancies. Candidate genes/CpG sites were selected through analysis of Illumina Infinium HumanMethylation450 BeadChip array data on control (n = 19) and early onset pre-eclampsia (EOPET; n = 19) placental samples. DNA methylation was further quantified by bisulfite pyrosequencing in a larger cohort of control (n = 111) cases, in addition to EOPET (n = 19), late onset pre-eclampsia (LOPET; n = 18) and normotensive intrauterine growth restriction (nIUGR; n = 13) cases. DNA methylation (percentage points) was increased at CpG sites within genes encoding the glucocorticoid receptor (NR3C1 exon 1D promoter; +8.46%; P<0.01) and corticotropin releasing hormone (CRH) binding protein (CRHBP intron 3; +9.14%; P<0.05), and decreased within CRH (5' UTR; -4.30%; P = 0.11) in EOPET-associated placentae, but not in LOPET nor nIUGR cases, compared to controls. Differential DNA methylation was not observed among groups at the 11 beta-hydroxysteroid dehydrogenase type 2 (HSD11B2) gene promoter. Significant hypomethylation was observed in pre-eclampsia but not nIUGR placentae for steroidogenic genes, including CYP11A1 (exon1; EOPET; -9.66%; P<0.00001, and LOPET; -5.77%; P<0.001), 3 beta-hydroxy-delta-5-steroid dehydrogenase type 1 (HSD3B1 exon 2; EOPET; -12.49%; P<0.00001, and LOPET; -6.88%; P<0.001), TEA domain family member 3 (TEAD3 intron 1; EOPET; -12.56%; P<0.00001) and CYP19 (placental-specific exon 1.1 promoter; EOPET; -10.62%, P<0.0001). These data represent dysregulation of the placental epigenome in pre-eclampsia related to genes involved in maintaining the hormonal environment during pregnancy and highlights particular susceptibility in the early onset syndrome.	[Hogg, Kirsten; Blair, John D.; Robinson, Wendy P.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [McFadden, Deborah E.] Univ British Columbia, Dept Pathol, Vancouver, BC, Canada; [von Dadelszen, Peter] Univ British Columbia, Dept Obstet & Gynaecol, Vancouver, BC V5Z 1M9, Canada; [Hogg, Kirsten; Blair, John D.; McFadden, Deborah E.; von Dadelszen, Peter; Robinson, Wendy P.] Child & Family Res Inst, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia; Child & Family Research Institute	Robinson, WP (corresponding author), Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada.	wrobinson@cfri.ca	Robinson, Wendy P/I-9590-2014; Robinson, Wendy/AAB-6420-2020; von Dadelszen, Peter/AAP-7480-2021	Robinson, Wendy P/0000-0002-2010-6174; Robinson, Wendy/0000-0002-2010-6174; McFadden, Deborah/0000-0002-0629-3436; von Dadelszen, Peter/0000-0003-4136-3070	Child & Family Research Institute (CFRI); CIHR grant [FRN-119402]; CFRI	Child & Family Research Institute (CFRI); CIHR grant(Canadian Institutes of Health Research (CIHR)); CFRI	KH is funded through a post-doctoral fellowship granted by the Child & Family Research Institute (CFRI), and work related to this study was funded through a CIHR grant (FRN-119402) to WPR. PvD and WPR receive salary support from the CFRI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikhani-Koopaei R, 2004, J CLIN INVEST, V114, P1146, DOI 10.1172/JCI200421647; Aufdenblatten M, 2009, PEDIATR RES, V65, P198, DOI 10.1203/PDR.0b013e31818d6c24; Avila L, 2010, PLACENTA, V31, P1070, DOI 10.1016/j.placenta.2010.09.011; Beaudoin C, 1997, J ENDOCRINOL, V154, P379, DOI 10.1677/joe.0.1540379; Ben-Zimra M, 2002, MOL ENDOCRINOL, V16, P1864, DOI 10.1210/me.2002-0056; Beshay VE, 2007, SEMIN REPROD MED, V25, P14, DOI 10.1055/s-2006-956772; Bourque DK, 2010, PLACENTA, V31, P197, DOI 10.1016/j.placenta.2009.12.003; Bromer C, 2013, DEV PSYCHOBIOL, V55, P673, DOI 10.1002/dev.21061; Bulun SE, 2004, SEMIN REPROD MED, V22, P5; Cao-Lei L, 2011, HUM GENET, V129, P533, DOI 10.1007/s00439-011-0949-1; Demura M, 2008, MOL CELL ENDOCRINOL, V283, P127, DOI 10.1016/j.mce.2007.12.003; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; Dy J, 2008, PLACENTA, V29, P193, DOI 10.1016/j.placenta.2007.10.010; EDWARDS CRW, 1993, LANCET, V341, P355, DOI 10.1016/0140-6736(93)90148-A; Egbor M, 2006, BJOG-INT J OBSTET GY, V113, P580, DOI 10.1111/j.1471-0528.2006.00882.x; Filiberto AC, 2011, EPIGENETICS-US, V6, P566, DOI 10.4161/epi.6.5.15236; Florio P, 2004, J CLIN ENDOCR METAB, V89, P4673, DOI 10.1210/jc.2004-0186; Galbiati S, 2010, CLIN CHEM LAB MED, V48, P791, DOI 10.1515/CCLM.2010.160; Gangestad SW, 2012, BIOL REV, V87, P856, DOI 10.1111/j.1469-185X.2012.00226.x; Goland RS, 1995, REPROD FERT DEVELOP, V7, P1227, DOI 10.1071/RD9951227; GOLAND RS, 1993, J CLIN ENDOCR METAB, V77, P1174, DOI 10.1210/jc.77.5.1174; GOLAND RS, 1994, AM J OBSTET GYNECOL, V171, P1287, DOI 10.1016/0002-9378(94)90149-X; GOLAND RS, 1995, PLACENTA, V16, P375, DOI 10.1016/0143-4004(95)90095-0; Goswami D, 2006, PLACENTA, V27, P56, DOI 10.1016/j.placenta.2004.11.007; Harris A, 2011, HORM BEHAV, V59, P279, DOI 10.1016/j.yhbeh.2010.06.007; HERMANN R, 1991, FEBS LETT, V281, P191, DOI 10.1016/0014-5793(91)80391-F; Hogg K, 2012, CLIN PHARMACOL THER, V92, P716, DOI 10.1038/clpt.2012.141; Hogg K, 2013, MOL CELL ENDOCRINOL, V367, P64, DOI 10.1016/j.mce.2012.12.018; HOLLENBERG SM, 1985, NATURE, V318, P635, DOI 10.1038/318635a0; Holmes MC, 2006, J NEUROSCI, V26, P3840, DOI 10.1523/JNEUROSCI.4464-05.2006; Jacquemin P, 1997, J BIOL CHEM, V272, P12928, DOI 10.1074/jbc.272.20.12928; Jiang XY, 2012, FASEB J, V26, P3563, DOI 10.1096/fj.12-207894; Johnson RF, 2008, J CLIN ENDOCR METAB, V93, P4887, DOI 10.1210/jc.2008-1077; JONES SA, 1989, J CLIN ENDOCR METAB, V68, P825, DOI 10.1210/jcem-68-4-825; Karteris E, 2003, J CLIN ENDOCR METAB, V88, P363, DOI 10.1210/jc.2002-020375; KHONG TY, 1986, BRIT J OBSTET GYNAEC, V93, P1049, DOI 10.1111/j.1471-0528.1986.tb07830.x; Khulan B, 2012, BEST PRACT RES CL EN, V26, P689, DOI 10.1016/j.beem.2012.03.007; King BR, 2001, PEPTIDES, V22, P1939, DOI 10.1016/S0196-9781(01)00485-5; Knower KC, 2010, MOL CELL ENDOCRINOL, V321, P123, DOI 10.1016/j.mce.2010.02.035; Kramer MS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e35; Lee KJ, 2010, PLACENTA, V31, P698, DOI 10.1016/j.placenta.2010.05.006; Lewis G, 2003, BRIT MED BULL, V67, P27, DOI 10.1093/bmb/ldg009; Lindsay RS, 1996, HYPERTENSION, V27, P1200, DOI 10.1161/01.HYP.27.6.1200; Lindsay RS, 1996, DIABETOLOGIA, V39, P1299, DOI 10.1007/s001250050573; Magee LA, 2008, J OBSTET GYNAECOL CA, V30, pS1, DOI 10.1016/S1701-2163(16)32776-1; Maksimovic J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r44; Marsit CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033794; Mayor-Lynn K, 2011, REPROD SCI, V18, P46, DOI 10.1177/1933719110374115; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; McTernan CL, 2001, J CLIN ENDOCR METAB, V86, P4979, DOI 10.1210/jc.86.10.4979; Mendelson CR, 2007, J STEROID BIOCHEM, V106, P62, DOI 10.1016/j.jsbmb.2007.05.001; Michael AE, 2008, HUM REPROD UPDATE, V14, P497, DOI 10.1093/humupd/dmn021; Mikeska T, 2011, METHODS MOL BIOL, V791, P33, DOI 10.1007/978-1-61779-316-5_4; Moldenhauer JS, 2003, AM J OBSTET GYNECOL, V189, P1173, DOI 10.1067/S0002-9378(03)00576-3; Mulligan CJ, 2012, EPIGENETICS-US, V7, P853, DOI 10.4161/epi.21180; MUNCK A, 1984, ENDOCR REV, V5, P25, DOI 10.1210/edrv-5-1-25; Ng EKO, 2003, CLIN CHEM, V49, P727, DOI 10.1373/49.5.727; Non AL, 2012, PLACENTA, V33, P183, DOI 10.1016/j.placenta.2011.12.013; Oberlander TF, 2008, EPIGENETICS-US, V3, P97, DOI 10.4161/epi.3.2.6034; Pena CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039791; Peng LH, 2004, MOL ENDOCRINOL, V18, P2049, DOI 10.1210/me.2004-0028; Perroud N, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.60; PLOTSKY PM, 1993, MOL BRAIN RES, V18, P195, DOI 10.1016/0169-328X(93)90189-V; Price EM, 2013, EPIGENETICS IN PRESS; Radtke KM, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.21; RILEY SC, 1991, J CLIN ENDOCR METAB, V72, P1001, DOI 10.1210/jcem-72-5-1001; Roberts JM, 2004, AM J OBSTET GYNECOL, V190, P1177, DOI 10.1016/j.ajog.2004.04.001; ROBINSON BG, 1988, P NATL ACAD SCI USA, V85, P5244, DOI 10.1073/pnas.85.14.5244; Rolfo A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013288; Rots NY, 1996, J NEUROENDOCRINOL, V8, P501, DOI 10.1046/j.1365-2826.1996.04843.x; Schoof E, 2001, J CLIN ENDOCR METAB, V86, P1313, DOI 10.1210/jc.86.3.1313; Shams M, 1998, HUM REPROD, V13, P799, DOI 10.1093/humrep/13.4.799; Shenker N, 2012, BRIT J CANCER, V106, P248, DOI 10.1038/bjc.2011.550; Sirianni R, 2005, J CLIN ENDOCR METAB, V90, P279, DOI 10.1210/jc.2004-0865; Strauss JF, 1996, BIOL REPROD, V54, P303, DOI 10.1095/biolreprod54.2.303; Takahashi LK, 1998, PSYCHONEUROENDOCRINO, V23, P571; Tamimi R, 2003, CANCER EPIDEM BIOMAR, V12, P647; Tuckey RC, 2004, ENDOCRINOLOGY, V145, P1700, DOI 10.1210/en.2003-1034; Turner JD, 2005, J MOL ENDOCRINOL, V35, P283, DOI 10.1677/jme.1.01822; Turner JD, 2008, NUCLEIC ACIDS RES, V36, P7207, DOI 10.1093/nar/gkn897; van der Merwe JL, 2010, HYPERTENS PREGNANCY, V29, P457, DOI 10.3109/10641950903572282; VINCE GS, 1995, BRIT J OBSTET GYNAEC, V102, P20, DOI 10.1111/j.1471-0528.1995.tb09020.x; von Dadelszen P, 2003, HYPERTENS PREGNANCY, V22, P143, DOI 10.1081/PRG-120021060; WALSH SW, 1988, OBSTET GYNECOL, V71, P222; Watari H, 1997, P NATL ACAD SCI USA, V94, P8462, DOI 10.1073/pnas.94.16.8462; Waterland RA, 2007, ANNU REV NUTR, V27, P363, DOI 10.1146/annurev.nutr.27.061406.093705; Weaver ICG, 2007, J NEUROSCI, V27, P1756, DOI 10.1523/JNEUROSCI.4164-06.2007; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Welberg LAM, 2000, EUR J NEUROSCI, V12, P1047, DOI 10.1046/j.1460-9568.2000.00958.x; Welberg LAM, 2001, J NEUROENDOCRINOL, V13, P113, DOI 10.1046/j.1365-2826.2001.00601.x; Wyrwoll CS, 2012, PLACENTA, V33, P220, DOI 10.1016/j.placenta.2011.12.017; Yang RF, 2006, J MOL ENDOCRINOL, V37, P533, DOI 10.1677/jme.1.02119; You XJ, 2006, BIOL REPROD, V74, P1067, DOI 10.1095/biolreprod.105.049361; Yuen RKC, 2010, EUR J HUM GENET, V18, P1006, DOI 10.1038/ejhg.2010.63; Yuen RKC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007389	95	83	88	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62969	10.1371/journal.pone.0062969	http://dx.doi.org/10.1371/journal.pone.0062969			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667551	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000319654700089
J	Sentoku, A; Ezaki, Y				Sentoku, Asuka; Ezaki, Yoichi			Intrinsic Constraints on Sympodial Growth Morphologies of Azooxanthellate Scleractinian Coral Dendrophyllia	PLOS ONE			English	Article							BUDDING MODE; PLASTICITY; REGULARITY; MADRACIS; COLONIES; POLARITY	Background: Asexual increase occurs in virtually all colonial organisms. However, little is known about the intrinsic mechanisms that control asexual reproduction and the resultant morphologies of colonies. Scleractinian corals, both symbiotic (zoaxanthellate) and non-symbiotic (azooxanthellate) corals are known to form elaborate colonies. To better understand the growth mechanisms that control species-specific type of colony in azooxanthellate dendrophyllid scleractinian corals, we have studied details of the budding pattern in the sympodial colonies of Dendrophyllia boschmai and Dendrophyllia cribrosa. Principal Findings: Budding exhibits the following regularities: (1) the two directive septa of offset corallites are oriented almost perpendicular to the growth direction of parent corallites; (2) offsets generally occur in either of the lateral primary septa that occur on one side of a corallite; the individuals thus show a definite polarity with respect to the directive septa, and only when branching dichotomously offsets occur in both primary septa; (3) the lateral corallites grow more-or-less diagonally upwards; and (4) the regularities and polarities are maintained throughout growth. Given these regularities, D. boschmai grows in a zigzag fashion by alternately budding on the right and left sites. In contrast, D. cribrosa grows helically by budding at a particular site. Conclusions/Significance: The strict constraints on budding regularities and shifts in budding sites observed in the sympodial growth forms of corals greatly affect resulting morphologies in azooxanthellate coral colonies. A precise understanding of these intrinsic constraints leads to a fundamental comprehension of colony-forming mechanisms in modular organisms.	[Sentoku, Asuka; Ezaki, Yoichi] Osaka City Univ, Grad Sch Sci, Dept Geosci, Osaka 558, Japan	Osaka Metropolitan University	Sentoku, A (corresponding author), Osaka City Univ, Grad Sch Sci, Dept Geosci, Osaka 558, Japan.	sentoku@sci.osaka-cu.ac.jp			Scientific Research Fund of the Japan Society for the Promotion of Science [24340130, 25610151]	Scientific Research Fund of the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants (24340130 and 25610151) from the Scientific Research Fund of the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruno JF, 1997, ECOLOGY, V78, P2177, DOI 10.2307/2265954; Cairns Stephen D., 2001, Smithsonian Contributions to Zoology, V615, P1; Cairns Stephen D., 1994, SMITHSONIAN CONTRIBU, V557, P1, DOI DOI 10.5479/SI.00810282.557.I; DAUGET JM, 1991, MAR BIOL, V111, P157, DOI 10.1007/BF01986357; Ezaki Y, 2004, PALAEONTOLOGY, V47, P1075, DOI 10.1111/j.0031-0239.2004.00401.x; Filatov MV, 2010, P ROY SOC B-BIOL SCI, V277, P3555, DOI 10.1098/rspb.2010.0957; GRAUS R R, 1982, Smithsonian Contributions to the Marine Sciences, P441; Jackson JBC, 1979, MORPHOLOGICAL, V11, P499; Kaandorp JA, 2001, VIRTUAL LAB, P1; Lasker HR, 2003, BIOL BULL-US, V205, P319, DOI 10.2307/1543295; Muko S, 2000, B MAR SCI, V66, P225; Rinkevich B, 2002, ISRAEL J ZOOL, V48, P71, DOI 10.1560/BCPA-UM3A-MKBP-HGL2; Sentoku A, 2012, CORAL REEFS, V31, P67, DOI 10.1007/s00338-011-0808-5; Sentoku A, 2012, PALEONTOL RES, V16, P252, DOI 10.2517/1342-8144-16.3.252; Sentoku A, 2012, LETHAIA, V45, P586, DOI 10.1111/j.1502-3931.2012.00321.x; Sentoku A, 2012, LETHAIA, V45, P62, DOI 10.1111/j.1502-3931.2011.00293.x; Shaish L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004095; Todd PA, 2008, BIOL REV, V83, P315, DOI 10.1111/j.1469-185X.2008.00045.x	18	2	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63790	10.1371/journal.pone.0063790	http://dx.doi.org/10.1371/journal.pone.0063790			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667672	gold, Green Published, Green Submitted			2022-12-25	WOS:000319654700186
J	Przewozniak, M; Czaplicka, I; Czerwinska, AM; Markowska-Zagrajek, A; Moraczewski, J; Streminska, W; Janczyk-Ilach, K; Ciemerych, MA; Brzoska, E				Przewozniak, Marta; Czaplicka, Iwona; Czerwinska, Areta M.; Markowska-Zagrajek, Agnieszka; Moraczewski, Jerzy; Streminska, Wladyslawa; Janczyk-Ilach, Katarzyna; Ciemerych, Maria A.; Brzoska, Edyta			Adhesion Proteins - An Impact on Skeletal Myoblast Differentiation	PLOS ONE			English	Article							MUSCLE SATELLITE CELLS; M-CADHERIN; MELTRIN-ALPHA; TERMINAL DIFFERENTIATION; FUSION; EXPRESSION; INTEGRIN; MYOGENESIS; MOLECULES; ADAM12	Formation of mammalian skeletal muscle myofibers, that takes place during embryogenesis, muscle growth or regeneration, requires precise regulation of myoblast adhesion and fusion. There are few evidences showing that adhesion proteins play important role in both processes. To follow the function of these molecules in myoblast differentiation we analysed integrin alpha3, integrin beta1, ADAM12, CD9, CD81, M-cadherin, and VCAM-1 during muscle regeneration. We showed that increase in the expression of these proteins accompanies myoblast fusion and myotube formation in vivo. We also showed that during myoblast fusion in vitro integrin alpha3 associates with integrin beta1 and ADAM12, and also CD9 and CD81, but not with M-cadherin or VCAM-1. Moreover, we documented that experimental modification in the expression of integrin alpha3 lead to the modification of myoblast fusion in vitro. Underexpression of integrin alpha3 decreased myoblasts' ability to fuse. This phenomenon was not related to the modifications in the expression of other adhesion proteins, i.e. integrin beta1, CD9, CD81, ADAM12, M-cadherin, or VCAM-1. Apparently, aberrant expression only of one partner of multiprotein adhesion complexes necessary for myoblast fusion, in this case integrin alpha3, prevents its proper function. Summarizing, we demonstrated the importance of analysed adhesion proteins in myoblast fusion both in vivo and in vitro.	[Przewozniak, Marta; Czaplicka, Iwona; Czerwinska, Areta M.; Markowska-Zagrajek, Agnieszka; Moraczewski, Jerzy; Streminska, Wladyslawa; Janczyk-Ilach, Katarzyna; Ciemerych, Maria A.; Brzoska, Edyta] Univ Warsaw, Fac Biol, Dept Cytol, Warsaw, Poland	University of Warsaw	Brzoska, E (corresponding author), Univ Warsaw, Fac Biol, Dept Cytol, Warsaw, Poland.	edbrzoska@biol.uw.edu.pl	Czerwinska, Areta/ABC-1239-2020; Gawor, Marta/AAC-4561-2021	Gawor, Marta/0000-0001-6757-9668; Czerwinska, Areta M./0000-0002-0862-4542; Brzoska, Edyta/0000-0002-7886-0436; Ciemerych, Maria A./0000-0003-0387-4179	Polish Ministry of Science and Higher Education [2P04C11230, N N301 422438]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This research was supported by Polish Ministry of Science and Higher Education grant number 2P04C11230 and N N301 422438. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe E, 1999, CALCIFIED TISSUE INT, V64, P508, DOI 10.1007/s002239900641; Abmayr SM, 2012, DEVELOPMENT, V139, P641, DOI 10.1242/dev.068353; BASSAGLIA Y, 1995, J MUSCLE RES CELL M, V16, P420, DOI 10.1007/BF00114507; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Berditchevski F, 1996, MOL BIOL CELL, V7, P193, DOI 10.1091/mbc.7.2.193; Berditchevski F, 2001, J CELL SCI, V114, P4143; Biressi S, 2007, DEV BIOL, V308, P281, DOI 10.1016/j.ydbio.2007.06.006; Biressi S, 2010, SEMIN CELL DEV BIOL, V21, P845, DOI 10.1016/j.semcdb.2010.09.003; BISCHOFF R, 1975, ANAT REC, V182, P215, DOI 10.1002/ar.1091820207; Blanco-Bose WE, 2001, EXP CELL RES, V265, P212, DOI 10.1006/excr.2001.5191; Bornemann A, 2000, J MUSCLE RES CELL M, V21, P475, DOI 10.1023/A:1005657607591; Brzoska E, 2006, DIFFERENTIATION, V74, P105, DOI 10.1111/j.1432-0436.2005.00059.x; Buckingham M, 2007, CR BIOL, V330, P530, DOI 10.1016/j.crvi.2007.03.015; CIFUENTESDIAZ C, 1995, MECH DEVELOP, V50, P85, DOI 10.1016/0925-4773(94)00327-J; Cornelison DDW, 2001, DEV BIOL, V239, P79, DOI 10.1006/dbio.2001.0416; DENNY-BROWN D, 1955, Am J Phys Med, V34, P210; Galliano MF, 2000, J BIOL CHEM, V275, P13933, DOI 10.1074/jbc.275.18.13933; Gullberg D, 2003, NATURE, V424, P138, DOI 10.1038/424138a; Gullberg Donald, 1998, Frontiers in Bioscience, V3, pD1039; Horsley V, 2004, CELLS TISSUES ORGANS, V176, P67, DOI 10.1159/000075028; IRINTCHEV A, 1994, DEV DYNAM, V199, P326, DOI 10.1002/aja.1001990407; Kassar-Duchossoy L, 2005, GENE DEV, V19, P1426, DOI 10.1101/gad.345505; Kaufmann U, 1999, J CELL SCI, V112, P55; Kreidberg JA, 2000, CURR OPIN CELL BIOL, V12, P548, DOI 10.1016/S0955-0674(00)00130-7; Kurisaki T, 2003, MOL CELL BIOL, V23, P55, DOI 10.1128/MCB.23.1.55-61.2003; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lafuste P, 2005, MOL BIOL CELL, V16, P861, DOI 10.1091/mbc.e04-03-0226; Maitra N, 2000, CARDIOVASC RES, V47, P715, DOI 10.1016/S0008-6363(00)00140-1; Marino M, 2011, GENE THER, V18, P109, DOI 10.1038/gt.2010.124; MCDONALD KA, 1995, J CELL SCI, V108, P2573; MEGE RM, 1992, J CELL SCI, V103, P897; Moraczewski J, 1988, Monogr Dev Biol, V21, P78; Nowak SJ, 2009, J CELL SCI, V122, P3282, DOI 10.1242/jcs.047597; Pavlath GK, 2010, EXP CELL RES, V316, P3067, DOI 10.1016/j.yexcr.2010.05.025; POULIOT Y, 1994, DEV DYNAM, V200, P305, DOI 10.1002/aja.1002000405; Quach NL, 2009, MOL BIOL CELL, V20, P3422, DOI 10.1091/mbc.E09-02-0175; ROSEN GD, 1992, CELL, V69, P1107, DOI 10.1016/0092-8674(92)90633-N; Rosenberg P, 1997, DEV BIOL, V187, P55, DOI 10.1006/dbio.1997.8602; Schwander M, 2003, DEV CELL, V4, P673, DOI 10.1016/S1534-5807(03)00118-7; Tachibana I, 1999, J CELL BIOL, V146, P893, DOI 10.1083/jcb.146.4.893; Takemura T, 1999, KIDNEY INT, V55, P71, DOI 10.1046/j.1523-1755.1999.00259.x; Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004; Verca MSB, 2001, MOL CELL NEUROSCI, V17, P303, DOI 10.1006/mcne.2000.0942; Wrobel E, 2007, EUR J CELL BIOL, V86, P99, DOI 10.1016/j.ejcb.2006.11.004; YAGAMIHIROMASA T, 1995, NATURE, V377, P652, DOI 10.1038/377652a0; Yang JT, 1996, J CELL BIOL, V135, P829, DOI 10.1083/jcb.135.3.829; Zammit PS, 2013, J CELL SCI, V8; Zhao ZF, 2004, EXP CELL RES, V298, P28, DOI 10.1016/j.yexcr.2004.04.005	48	30	31	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e61760	10.1371/journal.pone.0061760	http://dx.doi.org/10.1371/journal.pone.0061760			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671573	Green Published, gold, Green Submitted			2022-12-25	WOS:000321390200010
J	Dean, A; Mungall, W; McKinnell, C; Sharpe, RM				Dean, Afshan; Mungall, William; McKinnell, Chris; Sharpe, Richard M.			Prostaglandins, Masculinization and Its Disorders: Effects of Fetal Exposure of the Rat to the Cyclooxygenase Inhibitor- Indomethacin	PLOS ONE			English	Article							PROGRAMMING WINDOW; REPRODUCTIVE DEVELOPMENT; CRYPTORCHIDISM; PHTHALATE; TESTOSTERONE; PREGNANCY; INDUCTION; RUPTURE; RISK; ACID	Recent studies have established that masculinization of the male reproductive tract is programmed by androgens in a critical fetal 'masculinization programming window' (MPW). What is peculiar to androgen action during this period is, however, unknown. Studies from 20 years ago in mice implicated prostaglandin (PG)-mediation of androgen-induced masculinization, but this has never been followed up. We therefore investigated if PGs might mediate androgen effects in the MPW by exposing pregnant rats to indomethacin (which blocks PG production by inhibiting cyclooxygenase activity) during this period and then examining if androgen production or action (masculinization) was affected. Pregnant rats were treated with indomethacin (0.8 mg/kg/day; e15.5-e18.5) to encompass the MPW. Indomethacin exposure decreased fetal bodyweight (e21.5), testis weight (e21.5) and testicular PGE(2) (e17.5, e21.5), but had no effect on intratesticular testosterone (ITT; e17.5) or anogenital index (AGI; e21.5). Postnatally, AGI, testis weight and blood testosterone were unaffected by indomethacin exposure and no cryptorchidism or hypospadias occurred. Penis length was normal in indomethacin-exposed animals at Pnd25 but was reduced by 26% (p<0.001) in adulthood, an effect that is unexplained. Our results demonstrate that indomethacin can effectively decrease intra-testicular PGE(2) level. However, the resulting male phenotype does not support a role for PGs in mediating androgen-induced masculinization during the MPW in rats. The contrast with previous mouse studies is unexplained but may reflect a species difference.	[Dean, Afshan; Mungall, William; McKinnell, Chris; Sharpe, Richard M.] Univ Edinburgh, Queens Med Res Inst, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland	University of Edinburgh	Sharpe, RM (corresponding author), Univ Edinburgh, Queens Med Res Inst, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland.	r.sharpe@ed.ac.uk	Sharpe, Richard/D-2725-2013	Sharpe, Richard/0000-0003-1686-8085	UK Medical Research Council [G1100358]; European Union [FP7-ENV-2007-1-212844]; MRC [G1100358, G1002033] Funding Source: UKRI; Medical Research Council [G1100358, G1002033] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by grant G1100358 from the UK Medical Research Council and by grant FP7-ENV-2007-1-212844 from the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann R. P., 2006, Animal Reproduction, V3, P108; Amateau SK, 2004, NAT NEUROSCI, V7, P643, DOI 10.1038/nn1254; ARMSTRONG DT, 1981, J REPROD FERTIL, V62, P283; Berkowitz GS, 1996, PAEDIATR PERINAT EP, V10, P39, DOI 10.1111/j.1365-3016.1996.tb00024.x; Dean A, 2012, INT J ANDROL, V35, P330, DOI 10.1111/j.1365-2605.2011.01236.x; Drake AJ, 2009, ENDOCRINOLOGY, V150, P5055, DOI 10.1210/en.2009-0700; Eisenberg ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018973; Gaytan F, 2002, BIOL REPROD, V67, P1140, DOI 10.1095/biolreprod67.4.1140; Graham Garry G, 2005, Am J Ther, V12, P46, DOI 10.1097/00045391-200501000-00008; GUPTA C, 1986, P NATL ACAD SCI USA, V83, P4346, DOI 10.1073/pnas.83.12.4346; GUPTA C, 1989, ENDOCRINOLOGY, V124, P129, DOI 10.1210/endo-124-1-129; Hannah ME, 1996, NEW ENGL J MED, V334, P1005, DOI 10.1056/NEJM199604183341601; Hsieh Michael H, 2008, Curr Urol Rep, V9, P137; Jensen MS, 2010, EPIDEMIOLOGY, V21, P779, DOI 10.1097/EDE.0b013e3181f20bed; Kristensen D, 2010, HUMAN REPROD, V0, P1; Kristensen DM, 2012, INT J ANDROL, V35, P377, DOI 10.1111/j.1365-2605.2012.01282.x; MacLeod DJ, 2010, INT J ANDROL, V33, P279, DOI 10.1111/j.1365-2605.2009.01005.x; Mylchreest E, 2000, TOXICOL SCI, V55, P143, DOI 10.1093/toxsci/55.1.143; OATES JA, 1988, NEW ENGL J MED, V319, P689, DOI 10.1056/NEJM198809153191106; Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339; Sharpe Richard M, 2008, Fertil Steril, V89, pe33, DOI 10.1016/j.fertnstert.2007.12.026; Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972; Skakkebek NE, 2007, INT J ANDROL, V30, P198, DOI 10.1111/j.1365-2605.2007.00776.x; Snijder CA, 2012, HUM REPROD, V27, P1191, DOI 10.1093/humrep/der474; Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100; Thankamony A, 2009, ENVIRON HEALTH PERSP, V117, P1786, DOI 10.1289/ehp.0900881; van den Driesche S, 2011, INT J ANDROL, V34, pE578, DOI 10.1111/j.1365-2605.2011.01175.x; van den Driesche S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037064; Welsh M, 2008, J CLIN INVEST, V118, P1479, DOI 10.1172/JCI34241; Welsh M, 2010, INT J ANDROL, V33, pE144, DOI 10.1111/j.1365-2605.2009.00978.x	30	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62556	10.1371/journal.pone.0062556	http://dx.doi.org/10.1371/journal.pone.0062556			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23671609	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000321202100015
J	Grellety, E; Luquero, FJ; Mambula, C; Adamu, HH; Elder, G; Porten, K				Grellety, Emmanuel; Luquero, Francisco J.; Mambula, Christopher; Adamu, Hassana H.; Elder, Greg; Porten, Klaudia			Observational Bias during Nutrition Surveillance: Results of a Mixed Longitudinal and Cross-Sectional Data Collection System in Northern Nigeria	PLOS ONE			English	Article								Background: The Sahel is subject to seasonal hungry periods with increasing rates of malnutrition. In Northern Nigeria, there is no surveillance system and surveys are rare. The objectives were to analyse possible observational bias in a sentinel surveillance system using repeated mixed longitudinal/cross-sectional data and estimate the extent of seasonal variation. Methods: Thirty clusters were randomly selected using probability proportional to size (PPS) sampling from Kazaure Local Government Area, Jigawa State. In each cluster, all the children aged 6-59 months within 20 randomly selected households had their mid-upper arm circumference measured and were tested for oedema. The surveys were repeated every 2 or 4 weeks. At each survey round, three of the clusters were randomly selected to be replaced by three new clusters chosen at random by PPS. The seasonal variation of acute malnutrition was assessed using cyclical regression. The effect of repeated visits to the same cluster was examined using general linear mixed effects models adjusted for the seasonal change. Results: There was a significant seasonal fluctuation of Global Acute Malnutrition (GAM) with a peak in October. With each repeat survey of a cluster, the prevalence of GAM decreased by 1.6% (95% CI: 0.4 to 2.7; p = 0.012) relative to the prevalence observed during the previous visit after adjusting for seasonal change. Conclusions: Northern Nigeria has a seasonal variation in the prevalence of acute malnutrition. Repeated surveys in the same cluster-village, even if different children are selected, lead to a progressive improvement of the nutritional status of that village. Sentinel site surveillance of nutritional status is prone to observational bias, with the sentinel site progressively deviating from that of the community it is presumed to represent.	[Grellety, Emmanuel; Luquero, Francisco J.; Porten, Klaudia] Epictr, Paris, France; [Mambula, Christopher; Elder, Greg] Medecins Sans Frontieres, Paris, France	Doctors Without Borders	Grellety, E (corresponding author), Epictr, Paris, France.	Emmanuel.GRELLETY@epicentre.msf.org		Grellety Bosviel, Emmanuel/0000-0001-9736-414X	Medecins Sans Frontieres (MSF)	Medecins Sans Frontieres (MSF)	This study was funded by Medecins Sans Frontieres (MSF). MSF reviewed the final study protocol, contributed to the conception of the study, the interpretation of the data and preparation of the manuscript.	Beghin Ivan, 2002, Sante, V12, P112; Bilukha O, 2012, FOOD NUTR BULL, V33, P169, DOI 10.1177/156482651203300211; Central Intelligence Agency (United States), AFR NIG WORLD FACTB; Erhardt J, 2011, SOFTWARE EMERGENCY N; Famine Early Warning Systems Network (FEWS Net), NIG SEAS CAL CRIT EV; Grellety E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044549; Leo R, 2012, NIGERIA MALNUTRITION; Levy PS, 2008, SAMPLING POPULATIONS, V4th; McKinney P, 2011, NUTR INFORM SURVEILL; Naumova EN, 2007, STAT IND TECHNOL, P437, DOI 10.1007/978-0-8176-4542-7_28; Nnyepi M, 2011, J PUBLIC HEALTH POL, V32, P281, DOI 10.1057/jphp.2011.32; *R DEV COR TEAM, R LANG ENV STAT COMP; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Regional Technical Working Group Nairobi, 2010, Food Nutr Bull, V31, pS272; SACKETT DL, 1979, J CHRON DIS, V32, P51, DOI 10.1016/0021-9681(79)90012-2; Standardized Monitoring Assessment of Relief Transitions (SMART), 2006, MEAS MORT NUTR STAT; Stolwijk AM, 1999, J EPIDEMIOL COMMUN H, V53, P235, DOI 10.1136/jech.53.4.235; Tulane University School of Public Health and Tropical Medicine and the United Nations Children's Fund, 2007, NUTR INF PROJ HORN A; Vogel L, 2010, CAN MED ASSOC J, V182, pE555, DOI 10.1503/cmaj.109-3315; World Medical Association, 2001, B WORLD HEALTH ORGAN, V79, P373, DOI DOI 10.1111/DDG.13528	20	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62767	10.1371/journal.pone.0062767	http://dx.doi.org/10.1371/journal.pone.0062767			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23671632	Green Published, gold, Green Submitted			2022-12-25	WOS:000321202100037
J	Jacobi, CLJ; Rudigier, LJ; Scholz, H; Kirschner, KM				Jacobi, Charlotte L. J.; Rudigier, Lucas J.; Scholz, Holger; Kirschner, Karin M.			Transcriptional Regulation by the Wilms Tumor Protein, Wt1, Suggests a Role of the Metalloproteinase Adamts16 in Murine Genitourinary Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRKB NEUROTROPHIN RECEPTOR; SEX DETERMINATION; GENE-PRODUCT; MOUSE OVARY; THROMBOSPONDIN MOTIFS; SUPPRESSOR PROTEIN; KIDNEY DEVELOPMENT; PROGENITOR CELLS; GROWTH-FACTOR; IMMATURE RAT	ADAMTS16 (a disintegrin and metalloproteinase with thrombospondin motifs) is a secreted mammalian metalloproteinase with unknown function. We report here that murine Adamts16 is co-expressed with the Wilms tumor protein, Wt1, in the developing glomeruli of embryonic kidneys. Adamts16 mRNA levels were significantly reduced upon transfection of embryonic murine kidney explants with Wt1 antisense vivo-morpholinos. Antisense knockdown of Adamts16 inhibited branching morphogenesis in kidney organ cultures. Adamts16 was detected by in situ mRNA hybridization and/or immunohistochemistry also in embryonic gonads and in spermatids and granulosa cells of adult testes and ovaries, respectively. Silencing of Wt1 by transfection with antisense vivo-morpholinos significantly increased Adamts16 mRNA in cultured embryonic XY gonads (11.5 and 12.5 days postconception), and reduced Adamts16 transcripts in XX gonads (12.5 and 13.5 days postconception). Three predicted Wt1 consensus motifs could be identified in the promoter and the 5'-untranslated region of the murine Adamts16 gene. Binding of Wt1 protein to these elements was verified by EMSA and ChIP. A firefly luciferase reporter gene under control of the Adamts16 promoter was activated similar to 8-fold by transient co-transfection of human granulosa cells with a Wt1 expression construct. Gradual shortening of the 5'-flanking sequence successively reduced and eventually abrogated Adamts16 promoter activation by Wt1. These findings demonstrate that Wt1 differentially regulates the Adamts16 gene in XX and XY embryonic gonads. It is suggested that Adamts16 acts immediately downstream of Wt1 during murine urogenital development. We propose that Adamts16 is involved in branching morphogenesis of the kidneys in mice.	[Jacobi, Charlotte L. J.; Rudigier, Lucas J.; Scholz, Holger; Kirschner, Karin M.] Charite, Inst Vegetat Physiol, D-10117 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Scholz, H (corresponding author), Charite, Inst Vegetat Physiol, Charitepl 1, D-10117 Berlin, Germany.	holger.scholz@charite.de		Kirschner, Karin/0000-0003-0226-8636; Jacobi, Charlotte/0000-0001-6398-2812	Deutsche Forschungsgemeinschaft [Scho634/8-1]; Sonnenfeld-Stiftung; FAZIT-STIFTUNG	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Sonnenfeld-Stiftung; FAZIT-STIFTUNG	This work was supported in part by Deutsche Forschungsgemeinschaft Grant Scho634/8-1.; Recipient of fellowships from the Sonnenfeld-Stiftung and the FAZIT-STIFTUNG.	Apte SS, 2009, J BIOL CHEM, V284, P31493, DOI 10.1074/jbc.R109.052340; ARMSTRONG JF, 1993, MECH DEVELOP, V40, P85, DOI 10.1016/0925-4773(93)90090-K; Bor YC, 2006, GENE DEV, V20, P1597, DOI 10.1101/gad.1402306; BYSKOV AG, 1978, BIOL REPROD, V19, P720, DOI 10.1095/biolreprod19.4.720; Cal S, 2002, GENE, V283, P49, DOI 10.1016/S0378-1119(01)00861-7; Clapcote SJ, 2005, BIOTECHNIQUES, V38, P702, DOI 10.2144/05385BM05; Clark ME, 2000, GENOMICS, V67, P343, DOI 10.1006/geno.2000.6246; COLIGE A, 1995, J BIOL CHEM, V270, P16724, DOI 10.1074/jbc.270.28.16724; Colige A, 2004, J INVEST DERMATOL, V123, P656, DOI 10.1111/j.0022-202X.2004.23406.x; Dame C, 2006, BLOOD, V107, P4282, DOI 10.1182/blood-2005-07-2889; Davies JA, 2004, HUM MOL GENET, V13, P235, DOI 10.1093/hmg/ddh015; ENGLERT C, 1995, EMBO J, V14, P4662, DOI 10.1002/j.1460-2075.1995.tb00148.x; Espey LL, 2000, BIOL REPROD, V62, P1090, DOI 10.1095/biolreprod62.4.1090; Fernandes RJ, 2001, J BIOL CHEM, V276, P31502, DOI 10.1074/jbc.M103466200; Gao S, 2007, MOL HUM REPROD, V13, P465, DOI 10.1093/molehr/gam037; GONDOS B, 1975, AM J PATHOL, V81, P303; Gopalakrishnan K, 2012, P NATL ACAD SCI USA, V109, P20555, DOI 10.1073/pnas.1211290109; Guo JK, 2002, HUM MOL GENET, V11, P651, DOI 10.1093/hmg/11.6.651; HABER DA, 1991, P NATL ACAD SCI USA, V88, P9618, DOI 10.1073/pnas.88.21.9618; HAMILTON TB, 1995, NUCLEIC ACIDS RES, V23, P277, DOI 10.1093/nar/23.2.277; Hartwig S, 2010, DEVELOPMENT, V137, P1189, DOI 10.1242/dev.045732; Hossain A, 2001, J BIOL CHEM, V276, P16817, DOI 10.1074/jbc.M009056200; Hurskainen TL, 1999, J BIOL CHEM, V274, P25555, DOI 10.1074/jbc.274.36.25555; Joe B, 2009, HUM MOL GENET, V18, P2825, DOI 10.1093/hmg/ddp218; Kevorkian L, 2004, ARTHRITIS RHEUM-US, V50, P131, DOI 10.1002/art.11433; Kim JH, 2005, J VASC INTERV RADIOL, V16, P543, DOI 10.1097/01.RVI.0000150033.13928.D4; Kirschner KM, 2008, FASEB J, V22, P2690, DOI 10.1096/fj.07-097576; Klattig J, 2007, MOL CELL BIOL, V27, P4355, DOI 10.1128/MCB.01780-06; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Kuno K, 1997, J BIOL CHEM, V272, P556, DOI 10.1074/jbc.272.1.556; Kuno K, 1998, J BIOL CHEM, V273, P13912, DOI 10.1074/jbc.273.22.13912; Laity JH, 2000, P NATL ACAD SCI USA, V97, P11932, DOI 10.1073/pnas.97.22.11932; LARSSON SH, 1995, CELL, V81, P391, DOI 10.1016/0092-8674(95)90392-5; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; Madan P, 2003, BIOL REPROD, V69, P1506, DOI 10.1095/biolreprod.102.013714; MADDEN SL, 1991, SCIENCE, V253, P1550, DOI 10.1126/science.1654597; Martens LK, 2007, J BIOL CHEM, V282, P14379, DOI 10.1074/jbc.M609857200; Martinez-Estrada OM, 2010, NAT GENET, V42, P89, DOI 10.1038/ng.494; Michos O, 2009, CURR OPIN GENET DEV, V19, P484, DOI 10.1016/j.gde.2009.09.003; Miller-Hodges E, 2012, J PATHOL, V226, P229, DOI 10.1002/path.2977; Mittaz L, 2004, BIOL REPROD, V70, P1096, DOI 10.1095/biolreprod.103.023911; MORRIS JF, 1991, ONCOGENE, V6, P2339; Niaudet P, 2006, PEDIATR NEPHROL, V21, P1653, DOI 10.1007/s00467-006-0208-1; PELLETIER J, 1991, CELL, V67, P437, DOI 10.1016/0092-8674(91)90194-4; PETERS H, 1967, FERTIL STERIL, V18, P309; Pohl M, 2000, AM J PHYSIOL-RENAL, V279, pF891, DOI 10.1152/ajprenal.2000.279.5.F891; PRITCHARDJONES K, 1990, NATURE, V346, P194, DOI 10.1038/346194a0; Richards JS, 2005, BIOL REPROD, V72, P1241, DOI 10.1095/biolreprod.104.038083; Roberts SGE, 2006, BIOCHEM SOC SYMP, V73, P191; Robker RL, 2000, P NATL ACAD SCI USA, V97, P4689, DOI 10.1073/pnas.080073497; Roh J, 2009, FERTIL STERIL, V91, P1451, DOI 10.1016/j.fertnstert.2008.07.012; Sakamoto N, 2010, CANCER SCI, V101, P1038, DOI 10.1111/j.1349-7006.2009.01477.x; Sawyer HR, 2002, BIOL REPROD, V66, P1134, DOI 10.1095/biolreprod66.4.1134; Schumacher V, 1998, KIDNEY INT, V53, P1594, DOI 10.1046/j.1523-1755.1998.00948.x; Sciesielski LK, 2010, FEBS LETT, V584, P4665, DOI 10.1016/j.febslet.2010.10.045; Shimamura R, 1997, CLIN CANCER RES, V3, P2571; Stricker S, 2006, DEV DYNAM, V235, P3456, DOI 10.1002/dvdy.20993; Surridge AK, 2009, MATRIX BIOL, V28, P416, DOI 10.1016/j.matbio.2009.07.001; Swain A, 1999, GENE DEV, V13, P755, DOI 10.1101/gad.13.7.755; Tortorella MD, 1999, SCIENCE, V284, P1664, DOI 10.1126/science.284.5420.1664; Vazquez F, 1999, J BIOL CHEM, V274, P23349, DOI 10.1074/jbc.274.33.23349; Wagner KD, 2001, J AM SOC NEPHROL, V12, P1188, DOI 10.1681/ASN.V1261188; Wagner N, 2005, GENE DEV, V19, P2631, DOI 10.1101/gad.346405; Warburg O, 1942, BIOCHEM Z, V310, P384; Worley JR, 2003, J BIOL CHEM, V278, P51340, DOI 10.1074/jbc.M310865200; Yoon O, 2012, MOL REPROD DEV, V79, P368, DOI 10.1002/mrd.22036	66	25	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18811	18824		10.1074/jbc.M113.464644	http://dx.doi.org/10.1074/jbc.M113.464644			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23661704	hybrid, Green Published			2022-12-25	WOS:000321335800019
J	Darias, MJ; Andree, KB; Boglino, A; Fernandez, I; Estevez, A; Gisbert, E				Darias, Maria J.; Andree, Karl B.; Boglino, Anais; Fernandez, Ignacio; Estevez, Alicia; Gisbert, Enric			Coordinated Regulation of Chromatophore Differentiation and Melanogenesis during the Ontogeny of Skin Pigmentation of Solea senegalensis (Kaup, 1858)	PLOS ONE			English	Article							HALIBUT HIPPOGLOSSUS-HIPPOGLOSSUS; FLOUNDER PARALICHTHYS-OLIVACEUS; AGOUTI-SIGNALING PROTEIN; ZEBRAFISH NEURAL CREST; JAPANESE FLOUNDER; C-KIT; TRANSCRIPTION FACTOR; MELANOCORTIN SYSTEM; MICROARRAY ANALYSIS; ARTEMIA ENRICHMENT	Abnormal pigmentation of Senegalese sole has been described as one problem facing the full exploitation of its commercial production. To improve our understanding of flatfish pigmentation of this commercially important species we have evaluated eleven genes related to two different processes of pigmentation: melanophore differentiation, and melanin production. The temporal distribution of gene expression peaks corresponds well with changes in pigmentation patterns and the intensity of skin melanization. Several gene ratios were also examined to put in perspective possible genetic markers for the different stages of normal pigmentation development. Further, the phenotypic changes that occur during morphogenesis correspond well with the main transitions in gene expression that occur. Given the dramatic phenotypic alterations which flatfish undergo, including the asymmetric coloration that occurs between the ocular and the blind side, and the synchrony of the two processes of morphogenesis and pigmentation ontogenesis, these species constitute an interesting model for the study of pigmentation. In this study we present a first approximation towards explaining the genetic mechanisms for regulating pigmentation ontogeny in Senegalese sole, Solea senegalensis.	[Darias, Maria J.; Andree, Karl B.; Boglino, Anais; Estevez, Alicia; Gisbert, Enric] Inst Recerca & Tecnol Agroalimentaries, Ctr St Carles de la Rapita, Unitat Cultius Expt, San Carlos de la Rapita, Catalonia, Spain; [Fernandez, Ignacio] Univ Algarve, Ctr Ciencias Mar, Evolutionary & Dev Gene Express Dept, Faro, Portugal	IRTA; Universidade do Algarve	Darias, MJ (corresponding author), Inst Rech Dev, Inst Sci Evolut Montpellier, Dept Conservat & Domesticat, UMR226, Montpellier, Herault, France.	maria.darias@ird.fr	Gisbert, Enric/B-3654-2011; Gisbert, Enric/I-7224-2019; Fernandez, Ignacio/B-1527-2017; Darias, Maria J./D-5715-2012; Estevez, Alicia/AAE-1471-2021; Andree, Karl/L-7465-2014	Gisbert, Enric/0000-0002-7457-8468; Gisbert, Enric/0000-0002-7457-8468; Fernandez, Ignacio/0000-0002-8088-7902; Darias, Maria J./0000-0003-1954-6284; Estevez, Alicia/0000-0002-7776-0521; Andree, Karl/0000-0001-6564-0015; Estevez, Alicia/0000-0002-3690-0532	Ministry of Science and Innovation (MICIIN) of the Spanish Government [AGL2008-03897-C04-01/ACU]; European Community [FP7/2007-2013-222719-LIFECYCLE]; Spanish Government	Ministry of Science and Innovation (MICIIN) of the Spanish Government; European Community(European Commission); Spanish Government(Spanish GovernmentEuropean Commission)	This research was partially funded by the Ministry of Science and Innovation (MICIIN) of the Spanish Government (project AGL2008-03897-C04-01/ACU) and by the European Community's Seventh Framework program (FP7/2007-2013-222719-LIFECYCLE). I. F. and M.J.D. were supported by a pre-doctoral fellowship and a post-doctoral contract "Juan de la Cierva'' of the Spanish Government, respectively. The funders had no role in industry design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeev V, 2006, J INVEST DERMATOL, V126, P1102, DOI 10.1038/sj.jid.5700125; [Anonymous], 2002, GEN CLUST TREE VIEW; Bertolotto C, 1998, J CELL BIOL, V142, P827, DOI 10.1083/jcb.142.3.827; Boglino A, 2012, AQUACULTURE, V324, P290, DOI 10.1016/j.aquaculture.2011.11.018; Bolker JA, 2000, J FISH BIOL, V56, P1029, DOI 10.1111/j.1095-8649.2000.tb02121.x; Braasch I, 2009, PIGM CELL MELANOMA R, V22, P839, DOI 10.1111/j.1755-148X.2009.00614.x; Brenner Michaela, 2008, Drug Discov Today Dis Mech, V5, pe189, DOI 10.1016/j.ddmec.2008.02.001; BURCHILL SA, 1993, J ENDOCRINOL, V137, P189, DOI 10.1677/joe.0.1370189; Burton D, 2008, J FISH BIOL, V73, P639, DOI 10.1111/j.1095-8649.2008.01960.x; Burton D, 2002, MICROSC RES TECHNIQ, V58, P481, DOI 10.1002/jemt.10166; Burton D, 2010, REV FISH BIOL FISHER, V20, P31, DOI 10.1007/s11160-009-9119-0; Camacho-Hubner A, 2002, GENE, V285, P59, DOI 10.1016/S0378-1119(02)00411-0; Campinho MA, 2012, CELL TISSUE RES, V350, P333, DOI 10.1007/s00441-012-1473-x; Canavate JP, 2006, AQUACULTURE, V258, P368, DOI 10.1016/j.aquaculture.2006.04.009; Carlson JA, 2007, DERMATOL CLIN, V25, P541, DOI 10.1016/j.det.2007.06.005; Cerda-Reverter JM, 2003, ENDOCRINOLOGY, V144, P2336, DOI 10.1210/en.2002-0213; Cerda-Reverter JM, 2005, ENDOCRINOLOGY, V146, P1597, DOI 10.1210/en.2004-1346; Couldridge VCK, 2002, BEHAV ECOL, V13, P59, DOI 10.1093/beheco/13.1.59; Cunningham J. T., 1893, PHILOS T R SOC B, V184, P765; Curran K, 2010, DEV BIOL, V344, P107, DOI 10.1016/j.ydbio.2010.04.023; Darias MJ, 2008, MAR BIOTECHNOL, V10, P416, DOI 10.1007/s10126-007-9078-1; Dorsky RI, 2000, GENE DEV, V14, P158; Estevez A, 1995, AQUACULT NUTR, V1, P159, DOI 10.1111/j.1365-2095.1995.tb00040.x; Fu YS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022957; Fujii R, 2000, PIGM CELL RES, V13, P300, DOI 10.1034/j.1600-0749.2000.130502.x; Fukamachi S, 2004, P NATL ACAD SCI USA, V101, P10661, DOI 10.1073/pnas.0401278101; Fukamachi S, 2009, GENE, V442, P81, DOI 10.1016/j.gene.2009.04.010; Gantz I, 2003, AM J PHYSIOL-ENDOC M, V284, pE468, DOI 10.1152/ajpendo.00434.2002; Geffen AJ, 2007, J SEA RES, V58, P35, DOI 10.1016/j.seares.2007.02.004; Ginger RS, 2008, J BIOL CHEM, V283, P5486, DOI 10.1074/jbc.M707521200; Gross JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000326; Guillot R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048526; Guo XL, 2010, PIGM CELL MELANOMA R, V23, P252, DOI 10.1111/j.1755-148X.2010.00677.x; Haffter P, 1996, DEVELOPMENT, V123, P1; Hallsson JH, 2004, GENETICS, V167, P233, DOI 10.1534/genetics.167.1.233; Hamre K, 2007, AQUACULT NUTR, V13, P65, DOI 10.1111/j.1365-2095.2007.00467.x; Hamre K, 2008, AQUACULTURE, V277, P101, DOI 10.1016/j.aquaculture.2008.02.020; Hathaway Jessica Diann, 2011, Open Cancer J, V4, P1; Healey EG, 1999, J FISH BIOL, V55, P937; Hoekstra HE, 2006, SCIENCE, V313, P101, DOI 10.1126/science.1126121; Hoshino T, 2010, J BIOL CHEM, V285, P13254, DOI 10.1074/jbc.M110.103051; HUNT G, 1995, J INVEST DERMATOL, V104, P83, DOI 10.1111/1523-1747.ep12613565; INAGAKI H, 1994, GENE, V150, P319, DOI 10.1016/0378-1119(94)90445-6; Ito S, 2008, PHOTOCHEM PHOTOBIOL, V84, P582, DOI 10.1111/j.1751-1097.2007.00238.x; Jaattela M, 1998, EMBO J, V17, P6124, DOI 10.1093/emboj/17.21.6124; JOHNSON SL, 1995, DEV BIOL, V167, P27, DOI 10.1006/dbio.1995.1004; Kanazawa Akio, 1993, Journal of the World Aquaculture Society, V24, P162, DOI 10.1111/j.1749-7345.1993.tb00005.x; Kelsh RN, 1996, DEVELOPMENT, V123, P369; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Klovins J, 2004, MOL BIOL EVOL, V21, P563, DOI 10.1093/molbev/msh050; KOBAYASHI T, 1994, EMBO J, V13, P5818, DOI 10.1002/j.1460-2075.1994.tb06925.x; Kubic JD, 2008, PIGM CELL MELANOMA R, V21, P627, DOI 10.1111/j.1755-148X.2008.00514.x; Kuntz A., 1918, Bulletin of the Bureau of Fisheries Washington, V35; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Larribere L, 2005, GENE DEV, V19, P1980, DOI 10.1101/gad.335905; Lasker R., 1984, MARINE FISH LARVAE M, P33; Le Pape E, 2009, P NATL ACAD SCI USA, V106, P1802, DOI 10.1073/pnas.0806753106; Levy C, 2011, TRANSCR-AUSTIN, V2, P19, DOI 10.4161/trns.2.1.13650; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Lister JA, 1999, DEVELOPMENT, V126, P3757; LUO D, 1995, MELANOMA RES, V5, P303, DOI 10.1097/00008390-199510000-00002; Mast SO, 1914, B US BUR FISH, V34, P177; MATSUMOTO J, 1992, PIGM CELL RES, P275; Minchin JEN, 2008, DEV BIOL, V317, P508, DOI 10.1016/j.ydbio.2008.02.058; Nadeau N, 2008, GENETICS, V178, P777, DOI 10.1534/genetics.107.077073; Nakamasu A, 2009, P NATL ACAD SCI USA, V106, P8429, DOI 10.1073/pnas.0808622106; Nakamura M, 2010, FISHERIES SCI, V76, P243, DOI 10.1007/s12562-009-0209-7; Olivares C, 2001, BIOCHEM J, V354, P131, DOI 10.1042/0264-6021:3540131; Parichy DM, 1999, DEVELOPMENT, V126, P3425; Parichy DM, 2001, DEV GENES EVOL, V211, P319, DOI 10.1007/s004270100155; Parichy DM, 2003, DEVELOPMENT, V130, P817, DOI 10.1242/dev.00307; Parra G, 2001, J EXP BIOL, V204, P2175; Patton EE, 2010, PIGM CELL MELANOMA R, V23, P314, DOI 10.1111/j.1755-148X.2010.00693.x; Pederzoli A, 2003, PIGM CELL RES, V16, P50, DOI 10.1034/j.1600-0749.2003.00013.x; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Power DM, 2008, REV FISH SCI, V16, P95, DOI 10.1080/10641260802325377; Prota G, 1995, Fortschr Chem Org Naturst, V64, P93; Puebla O, 2007, P ROY SOC B-BIOL SCI, V274, P1265, DOI 10.1098/rspb.2006.0435; RANDALL JOHN E., 1960, BULL MAR SCI GULF AND CARIBBEAN, V10, P444; RANDWEAVER M, 1992, J ENDOCRINOL, V133, P393, DOI 10.1677/joe.0.1330393; Rawls JF, 2000, DEVELOPMENT, V127, P3715; ROBERTS RJ, 1972, J FISH BIOL, V4, P87, DOI 10.1111/j.1095-8649.1972.tb05656.x; Sarasquete C, 1996, HISTOL HISTOPATHOL, V11, P881; SCHIOTH HB, 1995, EUR J PHARM-MOLEC PH, V288, P311, DOI 10.1016/0922-4106(95)90043-8; SEIKAI T, 1987, PIGM CELL RES, V1, P143, DOI 10.1111/j.1600-0749.1987.tb00405.x; Seikai Tadahisa, 1994, Journal of the World Aquaculture Society, V25, P78, DOI 10.1111/j.1749-7345.1994.tb00807.x; Sumner FB, 1911, J EXP ZOOL, V11, P409; Sviderskaya EV, 2001, DEV DYNAM, V221, P373, DOI 10.1002/dvdy.1153; Villalta M, 2005, AQUACULTURE, V249, P353, DOI 10.1016/j.aquaculture.2005.03.037; Villalta M, 2005, AQUACULTURE, V245, P193, DOI 10.1016/j.aquaculture.2004.11.035; Vogel P, 2008, VET PATHOL, V45, P264, DOI 10.1354/vp.45-2-264; Yamada T, 2010, DEV DYNAM, V239, P3147, DOI 10.1002/dvdy.22440; Yamashita M, 2008, J EXP BIOL, V211, P1874, DOI 10.1242/jeb.012690; Yamashita Y, 2010, EXP DERMATOL, V19, pE340, DOI 10.1111/j.1600-0625.2009.01061.x; Zhu Y, 1997, GEN COMP ENDOCR, V105, P127, DOI 10.1006/gcen.1996.6810; Zhu Y, 1996, GEN COMP ENDOCR, V101, P21, DOI 10.1016/S0016-6480(96)90191-4	96	24	27	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63005	10.1371/journal.pone.0063005	http://dx.doi.org/10.1371/journal.pone.0063005			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671650	Green Submitted, Green Published, gold			2022-12-25	WOS:000319737700033
J	Pereira, F; Niu, XZ; deMello, AJ				Pereira, Fiona; Niu, Xize; deMello, Andrew J.			A Nano LC-MALDI Mass Spectrometry Droplet Interface for the Analysis of Complex Protein Samples	PLOS ONE			English	Article							LIQUID-CHROMATOGRAPHY; MS; MICROFLUIDICS; PROTEOMICS; PEPTIDES; ONLINE; FLOW	The integration of matrix-assisted laser desorption ionization (MALDI) mass spectrometry with an upstream analytical separations (such as liquid chromatography and electrophoresis) has opened up new opportunities for the automated investigation of complex protein and peptide mixtures. The ability to efficiently analyze complex proteomic mixtures in this manner is primarily determined by the ability to preserve spatial discrimination of sample components as they leave the separation column. Current interfacing methods are problematic in this respect since minimum fraction volumes are limited to several microliters. Herein we show for the first time an LC-MALDI interface based on the formation, processing and destruction of a segmented flow. The interface consists of a droplet-generator to fractionate LC effluent into nL-volume droplets and a deposition probe that transfers the sample (and MALDI matrix) onto a conventional MALDI-MS target. The efficacy of the method is demonstrated through the analysis of Trypsin digests of both BSA and Cytochrome C, with a 50% enhancement in analytical performance when compared to conventional interface technology.	[Pereira, Fiona; deMello, Andrew J.] Swiss Fed Inst Technol, Dept Chem & Appl Biosci, Inst Chem & Bioengn, Zurich, Switzerland; [Niu, Xize] Univ Southampton, Southampton, Hants, England; [Niu, Xize] Univ Southampton, Inst Life Sci, Southampton, Hants, England	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Southampton; University of Southampton	deMello, AJ (corresponding author), Swiss Fed Inst Technol, Dept Chem & Appl Biosci, Inst Chem & Bioengn, Zurich, Switzerland.	andrew.demello@chem.ethz.ch	Niu, Xize/D-4627-2013		University of Southampton; Swiss Federal Institute of Technology, ETH Zurich	University of Southampton; Swiss Federal Institute of Technology, ETH Zurich(ETH Zurich)	XN acknowledges an Annual Adventure in Research Grant from the University of Southampton. AdM and FP gratefully acknowledge financial support from the Swiss Federal Institute of Technology, ETH Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beavis R C, 1989, Rapid Commun Mass Spectrom, V3, P233, DOI 10.1002/rcm.1290030708; BIEMANN K, 1992, ANNU REV BIOCHEM, V61, P977, DOI 10.1146/annurev.bi.61.070192.004553; Cohen SL, 1996, ANAL CHEM, V68, P31, DOI 10.1021/ac9507956; Dutta D, 2006, MICROFLUID NANOFLUID, V2, P275, DOI 10.1007/s10404-005-0070-7; Edgar JS, 2009, ANGEW CHEM INT EDIT, V48, P2719, DOI 10.1002/anie.200805396; Fidalgo LM, 2009, ANGEW CHEM INT EDIT, V48, P3665, DOI 10.1002/anie.200806103; Hatakeyama T, 2006, J AM CHEM SOC, V128, P2518, DOI 10.1021/ja057720w; HILLENKAMP F, 1991, ANAL CHEM, V63, pA1193; KARAS M, 1988, ANAL CHEM, V60, P2299, DOI 10.1021/ac00171a028; Kelly RT, 2009, ANGEW CHEM INT EDIT, V48, P6832, DOI 10.1002/anie.200902501; Lazar IM, 2006, MASS SPECTROM REV, V25, P573, DOI 10.1002/mas.20081; Lee J, 2009, J MASS SPECTROM, V44, P579, DOI 10.1002/jms.1585; Li Q, 2010, ANAL CHEM, V82, P5260, DOI 10.1021/ac100669z; Lim CK, 2002, BIOL PHARM BULL, V25, P547, DOI 10.1248/bpb.25.547; Metzger J, 2009, CRIT REV CL LAB SCI, V46, P129, DOI 10.1080/10408360902805261; Mirgorodskaya E, 2005, PROTEOMICS, V5, P399, DOI 10.1002/pmic.200400984; Niu XZ, 2009, CHEM COMMUN, P6159, DOI 10.1039/b918100h; Ogilvie IRG, 2011, ANAL CHEM, V83, P4814, DOI 10.1021/ac200463y; Pereira F, 2011, CHROMATOGRAPHY TODAY, V4, P12; Pes O, 2010, J CHROMATOGR A, V1217, P3966, DOI 10.1016/j.chroma.2010.02.058; Ro KW, 2006, J CHROMATOGR A, V1111, P40, DOI 10.1016/j.chroma.2006.01.105; Smyth WF, 2004, ELECTROPHORESIS, V25, P1413, DOI 10.1002/elps.200305850; Srisa-Art M, 2008, ANAL CHEM, V80, P7063, DOI 10.1021/ac801199k; Zhang BY, 2004, ANAL CHEM, V76, P992, DOI 10.1021/ac034934s; Zhang X, 2004, J AM SOC MASS SPECTR, V15, P1471, DOI 10.1016/j.jasms.2004.06.016; Zhu Y, 2010, ANAL CHEM, V82, P8361, DOI 10.1021/ac101902c	26	24	25	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63087	10.1371/journal.pone.0063087	http://dx.doi.org/10.1371/journal.pone.0063087			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671657	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000319737700037
J	Westengen, OT; Jeppson, S; Guarino, L				Westengen, Ola T.; Jeppson, Simon; Guarino, Luigi			Global Ex-Situ Crop Diversity Conservation and the Svalbard Global Seed Vault: Assessing the Current Status	PLOS ONE			English	Article							PLANT GENETIC-RESOURCES; SECURITY; FOOD	Ex-situ conservation of crop diversity is a global concern, and the development of an efficient and sustainable conservation system is a historic priority recognized in international law and policy. We assess the completeness of the safety duplication collection in the Svalbard Global Seed Vault with respect to data on the world's ex-situ collections as reported by the Food and Agriculture Organization of the United Nations. Currently, 774,601 samples are deposited at Svalbard by 53 genebanks. We estimate that more than one third of the globally distinct accessions of 156 crop genera stored in genebanks as orthodox seeds are conserved in the Seed Vault. The numbers of safety duplicates of Triticum (wheat), Sorghum (sorghum), Pennisetum (pearl millet), Eleusine (finger millet), Cicer (chickpea) and Lens (lentil) exceed 50% of the estimated numbers of distinct accessions in global ex-situ collections. The number of accessions conserved globally generally reflects importance for food production, but there are significant gaps in the safety collection at Svalbard in some genera of high importance for food security in tropical countries, such as Amaranthus (amaranth), Chenopodium (quinoa), Eragrostis (teff) and Abelmoschus (okra). In the 29 food-crop genera with the largest number of accessions stored globally, an average of 5.5 out of the ten largest collections is already represented in the Seed Vault collection or is covered by existing deposit agreements. The high coverage of ITPGRFA Annex 1 crops and of those crops for which there is a CGIAR mandate in the current Seed Vault collection indicates that existence of international policies and institutions are important determinants for accessions to be safety duplicated at Svalbard. As a back-up site for the global conservation system, the Seed Vault plays not only a practical but also a symbolic role for enhanced integration and cooperation for conservation of crop diversity.	[Westengen, Ola T.; Jeppson, Simon] Nord Genet Resource Ctr NordGen, Alnarp, Sweden; [Westengen, Ola T.] Univ Oslo, Ctr Dev & Environm, Oslo, Norway; [Guarino, Luigi] Global Crop Divers Trust, Bonn, Germany	University of Oslo	Westengen, OT (corresponding author), Nord Genet Resource Ctr NordGen, Alnarp, Sweden.	ola.westengen@nordgen.org	jeppson, simon/R-2099-2019	jeppson, simon/0000-0003-1083-2022				CGRFA, 2012, CGRFAWGPGR612INF6 GL; CGRFA, 2007, 11 REG SESS COMM GEN; Darwin Charles, 2007, VARIATION ANIMALS PL, V1; Engels JMM, 2003, IPGRI HDB GENEBANKS, V6; Esquinas-Alcazar J, 2005, NAT REV GENET, V6, P946, DOI 10.1038/nrg1729; FAO, 2012, REV GEN STA IN PRESS; FAO, 2013, WORLD INF EARL WARN; FAO, 2010, 2 FAO; FAO-MAF, 2022, SANL STEPP CONS STRA; Food and Agriculture Organization of the United Nations (FAO), 1998, STAT WORLDS PLANT GE; Fowler C, 2004, ANNU REV ENV RESOUR, V29, P143, DOI 10.1146/annurev.energy.29.062403.102203; Fowler C., 2004, STUDY ASSESS FEASIBI; Fowler C, 2008, BIOSCIENCE, V58, P190, DOI 10.1641/B580302; Frankel O.H, 1987, DIVERSITY, V3, P25; Frankel OH., 1970, GENETIC RESOURCES PL; FRANKEL OH, 1975, CROP GENETIC RESOURC; Frison E, 1994, IPGRI HDB GENEBANKS, P107; GCDT, 2013, SVALB GLOB SEED VAUL; GeneSys, 2013, BIOV; Gepts P, 2006, CROP SCI, V46, P2278, DOI 10.2135/cropsci2006.03.0169gas; Harlan Jack R., 1995, LIVING FIELDS OUR AG; ITPGRFA, 2009, INT TREAT PLANT GEN; Khoury C, 2010, GENET RESOUR CROP EV, V57, P625, DOI 10.1007/s10722-010-9534-z; Kilian B, 2012, BRIEF FUNCT GENOMICS, V11, P38, DOI 10.1093/bfgp/elr046; Koo B, SAVING SEEDS EC CONS; Myers N, 1997, BIODIVERSITYS GENETI, p[255, 255]; NMAF GCDT NordGen, 2007, AGR ROYAL NORW MIN A; NMFA NordGen, 2012, STAND AGR DEP NORW M; Pistorius Robin, 1997, SCI PLANTS POLITICS; PRESCOTTALLEN R, 1990, CONSERV BIOL, V4, P365, DOI 10.1111/j.1523-1739.1990.tb00310.x; Qvenild M, 2008, DEV PRACT, V18, P110, DOI 10.1080/09614520701778934; Royal Botanical Gardens KEW, 2008, SEED INF DAT SID VER; Simmonds NW, 1997, POTATO RES, V40, P191, DOI 10.1007/BF02358245; The Government of the United Kingdom, 2006, AN WELF ACT 2006; van Hintum T, 2010, PLANT GENET RESOUR-C, V8, P182, DOI 10.1017/S1479262110000158; VANHINTUM TJL, 1995, GENET RESOUR CROP EV, V42, P135, DOI 10.1007/BF02539517; Vavilov NJ., 1992, ORIGIN GEOGRAPHY CUL	37	49	52	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e64146	10.1371/journal.pone.0064146	http://dx.doi.org/10.1371/journal.pone.0064146			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671707	Green Published, gold, Green Submitted			2022-12-25	WOS:000319737700065
J	Passilongo, D; Reby, D; Carranza, J; Apollonio, M				Passilongo, Daniela; Reby, David; Carranza, Juan; Apollonio, Marco			Roaring High and Low: Composition and Possible Functions of the Iberian Stag's Vocal Repertoire	PLOS ONE			English	Article							SOURCE-FILTER THEORY; RED DEER; BODY-SIZE; GEOGRAPHICAL VARIATION; FALLOW BUCKS; TRACT LENGTH; BEHAVIOR; COMMUNICATION; VOCALIZATIONS; ACOUSTICS	We provide a detailed description of the rutting vocalisations of free-ranging male Iberian deer (Cervus elaphus hispanicus, Hilzheimer 1909), a geographically isolated and morphologically differentiated subspecies of red deer Cervus elaphus. We combine spectrographic examinations, spectral analyses and automated classifications to identify different call types, and compare the composition of the vocal repertoire with that of other red deer subspecies. Iberian stags give bouts of roars (and more rarely, short series of barks) that are typically composed of two different types of calls. Long Common Roars are mostly given at the beginning or at the end of the bout, and are characterised by a high fundamental frequency (F0) resulting in poorly defined formant frequencies but a relatively high amplitude. In contrast, Short Common Roars are typically given in the middle or at the end of the bout, and are characterised by a lower F0 resulting in relatively well defined vocal tract resonances, but low amplitude. While we did not identify entirely Harsh Roars (as described in the Scottish red deer subspecies (Cervus elaphus scoticus)), a small percentage of Long Common Roars contained segments of deterministic chaos. We suggest that the evolution of two clearly distinct types of Common Roars may reflect divergent selection pressures favouring either vocal efficiency in high pitched roars or the communication of body size in low-pitched, high spectral density roars highlighting vocal tract resonances. The clear divergence of the Iberian red deer vocal repertoire from those of other documented European red deer populations reinforces the status of this geographical variant as a distinct subspecies.	[Passilongo, Daniela; Apollonio, Marco] Univ Sassari, Dept Sci Nat & Environm Resources, I-07100 Sassari, Italy; [Reby, David] Univ Sussex, Sch Psychol, Brighton, E Sussex, England; [Carranza, Juan] Univ Cordoba, Ungulate Res Unit, Game & Fish Res Ctr, Cordoba, Spain	University of Sassari; University of Sussex; Universidad de Cordoba	Passilongo, D (corresponding author), Univ Sassari, Dept Sci Nat & Environm Resources, I-07100 Sassari, Italy.	dpassilongo@uniss.it	Carranza, Juan/E-4472-2010; Passilongo, Daniela/F-2282-2018	Passilongo, Daniela/0000-0003-0005-0852; Reby, David/0000-0001-9261-1711; Carranza, Juan/0000-0002-0368-7173	University of Sassari; Italian Ministry of University and Research	University of Sassari; Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR))	DP was supported by the University of Sassari and the Italian Ministry of University and Research with a PhD grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boersma P, 2001, GLOT INT, V5, P341; Briefer E, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-35; Brumm H, 2009, ADV STUD BEHAV, V40, P1, DOI 10.1016/S0065-3454(09)40001-9; Campbell P, 2010, EVOLUTION, V64, P1955, DOI 10.1111/j.1558-5646.2010.00962.x; Cap H, 2008, CLADISTICS, V24, P917, DOI 10.1111/j.1096-0031.2008.00223.x; CARRANZA J, 1990, ANIM BEHAV, V40, P79, DOI 10.1016/S0003-3472(05)80667-0; CARRANZA J, 1991, APPL ANIM BEHAV SCI, V30, P363, DOI 10.1016/0168-1591(91)90141-J; Carranza J, 1999, BEHAV ECOL, V10, P525, DOI 10.1093/beheco/10.5.525; CARRANZA J, 1995, ANIM BEHAV, V50, P445, DOI 10.1006/anbe.1995.0258; Carranza J, 1996, ETHOLOGY, V102, P793; Carranza J., 2004, ENCICLOPEDIA VIRTUAL; Charlton BD, 2008, ETHOLOGY, V114, P1023, DOI 10.1111/j.1439-0310.2008.01539.x; Charlton BD, 2007, ANIM BEHAV, V74, P707, DOI 10.1016/j.anbehav.2006.09.021; Charlton BD, 2007, BIOL LETTERS, V3, P382, DOI 10.1098/rsbl.2007.0244; Charlton BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045420; Charlton BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021066; Charlton BD, 2009, ANIM BEHAV, V78, P893, DOI 10.1016/j.anbehav.2009.06.029; CLARIDGE MF, 1993, BIOL J LINN SOC, V48, P267, DOI 10.1111/j.1095-8312.1993.tb00891.x; Clutton-Brock TH., 1982, RED DEER BEHAV ECOLO; CLUTTONBROCK TH, 1979, BEHAVIOUR, V69, P145, DOI 10.1163/156853979X00449; DAVIES NB, 1979, ANIM BEHAV, V27, P1253, DOI 10.1016/0003-3472(79)90070-8; Ey E, 2007, PRIMATES, V48, P253, DOI 10.1007/s10329-006-0033-y; Fallow PM, 2010, ANIM BEHAV, V79, P411, DOI 10.1016/j.anbehav.2009.11.018; Fant G., 1960, ACOUSTIC THEORY SPEE; Fitch WT, 1997, J ACOUST SOC AM, V102, P1213, DOI 10.1121/1.421048; Fitch WT, 2001, P ROY SOC B-BIOL SCI, V268, P1669, DOI 10.1098/rspb.2001.1704; FORREST TG, 1994, AM ZOOL, V34, P644; Frey R, 2012, J ANAT, V220, P271, DOI 10.1111/j.1469-7580.2011.01467.x; Gamba M, 2012, J ETHOL, V30, P191, DOI 10.1007/s10164-011-0291-z; Geist V., 1998, DEER WORLD THEIR EVO; HUNTER ML, 1979, J ANIM ECOL, V48, P759, DOI 10.2307/4194; Kidjo N, 2008, BIOACOUSTICS, V18, P159, DOI 10.1080/09524622.2008.9753598; LASS NJ, 1978, J ACOUST SOC AM, V63, P1218, DOI 10.1121/1.381808; Ludt CJ, 2004, MOL PHYLOGENET EVOL, V31, P1064, DOI 10.1016/j.ympev.2003.10.003; Marshall AJ, 1999, ANIM BEHAV, V58, P825, DOI 10.1006/anbe.1999.1219; MCCOMB KE, 1991, ANIM BEHAV, V41, P79, DOI 10.1016/S0003-3472(05)80504-4; McCracken KG, 1997, P NATL ACAD SCI USA, V94, P3833, DOI 10.1073/pnas.94.8.3833; McElligott AG, 1999, ANIM BEHAV, V58, P1095, DOI 10.1006/anbe.1999.1237; Mendelson TC, 2005, NATURE, V433, P375, DOI 10.1038/433375a; MORTON ES, 1977, AM NAT, V111, P855, DOI 10.1086/283219; MORTON ES, 1975, AM NAT, V109, P17, DOI 10.1086/282971; Owren MJ, 1997, J ACOUST SOC AM, V101, P2951, DOI 10.1121/1.418523; Patten MA, 2004, EVOLUTION, V58, P2144; Peters Gustav, 1999, Journal of Mammalian Evolution, V6, P129, DOI 10.1023/A:1020620121416; Prohl H, 2006, EVOLUTION, V60, P1669; R Core Development Team, 2011, R LANG ENV STAT COMP; Reby D, 1998, J ZOOL, V245, P79, DOI 10.1017/S0952836998005093; Reby D, 2005, P ROY SOC B-BIOL SCI, V272, P941, DOI 10.1098/rspb.2004.2954; Reby D, 2003, ADV STUD BEHAV, V33, P231, DOI 10.1016/S0065-3454(03)33005-0; Reby D, 2003, ANIM BEHAV, V65, P519, DOI 10.1006/anbe.2003.2078; Reby D, 2006, J ACOUST SOC AM, V120, P4080, DOI 10.1121/1.2358006; Reby D, 2012, ANIM COGN, V15, P265, DOI 10.1007/s10071-011-0451-0; Reby D, 2010, P ROY SOC B-BIOL SCI, V277, P2747, DOI 10.1098/rspb.2010.0467; Rendall D, 2005, J ACOUST SOC AM, V117, P944, DOI 10.1121/1.1848011; Rendall D, 1998, J ACOUST SOC AM, V103, P602, DOI 10.1121/1.421104; Riede T, 1999, J EXP BIOL, V202, P2859; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; RYALLS JH, 1982, J ACOUST SOC AM, V72, P1631, DOI 10.1121/1.388499; RYAN MJ, 1990, EVOLUTION, V44, P1869, DOI 10.1111/j.1558-5646.1990.tb05256.x; Semple S, 2000, P ROY SOC B-BIOL SCI, V267, P707, DOI 10.1098/rspb.2000.1060; Soltis J, 2005, ANIM BEHAV, V70, P589, DOI 10.1016/j.anbehav.2004.11.016; Taylor AM, 2010, J ZOOL, V280, P221, DOI 10.1111/j.1469-7998.2009.00661.x; Templeton CN, 2005, SCIENCE, V308, P1934, DOI 10.1126/science.1108841; Titze IR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000897; Titze IR, 1994, PRINCIPLES VOICE PRO; Vannoni E, 2007, ETHOLOGY, V113, P223, DOI 10.1111/j.1439-0310.2006.01323.x; Vannoni E, 2009, ANIM BEHAV, V78, P3, DOI 10.1016/j.anbehav.2009.03.015; Vannoni E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003113; Volodin I, 2013, ACTA ETHOL, V16, P57, DOI 10.1007/s10211-012-0133-1; Wyman MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023296; Yu X, 2011, ETHOL ECOL EVOL, V23, P211, DOI 10.1080/03949370.2011.566581	71	23	24	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63841	10.1371/journal.pone.0063841	http://dx.doi.org/10.1371/journal.pone.0063841			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667678	Green Submitted, gold, Green Published			2022-12-25	WOS:000319055600077
J	Khademi, M; Dring, AM; Gilthorpe, JD; Wuolikainen, A; Al Nimer, F; Harris, RA; Andersson, M; Brundin, L; Piehl, F; Olsson, T; Svenningsson, A				Khademi, Mohsen; Dring, Ann M.; Gilthorpe, Jonathan D.; Wuolikainen, Anna; Al Nimer, Faiez; Harris, Robert A.; Andersson, Magnus; Brundin, Lou; Piehl, Fredrik; Olsson, Tomas; Svenningsson, Anders			Intense Inflammation and Nerve Damage in Early Multiple Sclerosis Subsides at Older Age: A Reflection by Cerebrospinal Fluid Biomarkers	PLOS ONE			English	Article							SECONDARY PROGRESSIVE MS; AUTOIMMUNE-DISEASES; PROGNOSTIC MARKER; NATURAL-HISTORY; INTERFERON-BETA; AXONAL DAMAGE; DOUBLE-BLIND; ACTIVE MS; B-CELLS; OSTEOPONTIN	Inflammatory mediators have crucial roles in leukocyte recruitment and subsequent central nervous system (CNS) neuroinflammation. The extent of neuronal injury and axonal loss are associated with the degree of CNS inflammation and determine physical disability in multiple sclerosis (MS). The aim of this study was to explore possible associations between a panel of selected cerebrospinal fluid biomarkers and robust clinical and demographic parameters in a large cohort of patients with MS and controls (n = 1066) using data-driven multivariate analysis. Levels of matrix metalloproteinase 9 (MMP9), chemokine (C-X-C motif) ligand 13 (CXCL13), osteopontin (OPN) and neurofilament-light chain (NFL) were measured by ELISA in 548 subjects comprising different MS subtypes (relapsing-remitting, secondary progressive and primary progressive), clinically isolated syndrome and persons with other neurological diseases with or without signs of inflammation/infection. Principal component analyses and orthogonal partial least squares methods were used for unsupervised and supervised interrogation of the data. Models were validated using data from a further 518 subjects in which one or more of the four selected markers were measured. There was a significant association between increased patient age and lower levels of CXCL13, MMP9 and NFL. CXCL13 levels correlated well with MMP9 in the younger age groups, but less so in older patients, and after approximately 54 years of age the levels of CXCL13 and MMP9 were consistently low. CXCL13 and MMP9 levels also correlated well with both NFL and OPN in younger patients. We demonstrate a strong effect of age on both inflammatory and neurodegenerative biomarkers in a large cohort of MS patients. The findings support an early use of adequate immunomodulatory disease modifying drugs, especially in younger patients, and may provide a biological explanation for the relative inefficacy of such treatments in older patients at later disease stages.	[Khademi, Mohsen; Al Nimer, Faiez; Harris, Robert A.; Brundin, Lou; Piehl, Fredrik; Olsson, Tomas] Karolinska Inst, Dept Clin Neurosci, Neuroimmunol Unit, Stockholm, Sweden; [Dring, Ann M.; Gilthorpe, Jonathan D.; Svenningsson, Anders] Umea Univ, Dept Pharmacol & Clin Neurosci, Umea, Sweden; [Wuolikainen, Anna] Umea Univ, Dept Chem, Umea, Sweden; [Al Nimer, Faiez; Andersson, Magnus; Brundin, Lou; Piehl, Fredrik; Olsson, Tomas] Karolinska Univ Hosp, Dept Neurol, Stockholm, Sweden	Karolinska Institutet; Umea University; Umea University; Karolinska Institutet; Karolinska University Hospital	Olsson, T (corresponding author), Karolinska Inst, Dept Clin Neurosci, Neuroimmunol Unit, Stockholm, Sweden.	Tomas.Olsson@ki.se	Nimer, Faiez Al/ABB-9465-2020; Harris, Robert A./I-6234-2019	Harris, Robert A./0000-0003-4990-509X; Svenningsson, Anders/0000-0003-0663-2220; Wuolikainen, Anna/0000-0003-0838-5526; Khademi, Mohsen/0000-0003-0801-1444; Al Nimer, Faiez/0000-0003-0937-5995; Brundin, Lou/0000-0003-4408-7817; Gilthorpe, Jonathan/0000-0002-6884-4774; Olsson, Tomas/0000-0002-2938-1877	BayerScheringPharma; BiogenIdec; MerckSerono; SanofiAventis; BayerSchering; Novartis; BiogenIdec Sweden AB; Genzyme; Amirall; Genzyme/SanofiAventis	BayerScheringPharma(Bayer AG); BiogenIdec(Biogen); MerckSerono(Merck & Company); SanofiAventis(Sanofi-Aventis); BayerSchering(Bayer AG); Novartis(Novartis); BiogenIdec Sweden AB; Genzyme(Sanofi-AventisGenzyme Corporation); Amirall; Genzyme/SanofiAventis	AS has received travel support and/or lecture honoraria from BiogenIdec, MerckSerono, Genzyme/SanofiAventis, and Baxter, and he has received unconditional research grants from BayerScheringPharma and BiogenIdec. TO has received personal compensation for consultancy or lecture fees from BiogenIdec, MerckSerono, SanofiAventis, BayerSchering and Novartis. BiogenIdec Sweden AB provided an unrestricted grant for this study. LB has recieved teaching and consultation fees from BiogenIdec, SanofiAventis, Novartis, Genzyme and Amirall. MK, AD, JG, AW, FA, RH, MA and FP have no conflicts to declare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.; AS has received travel support and/or lecture honoraria from BiogenIdec, MerckSerono, Genzyme/SanofiAventis, and Baxter, and he has received unconditional research grants from BayerScheringPharma and BiogenIdec. TO has received personal compensation for consultancy or lecture fees from BiogenIdec, MerckSerono, SanofiAventis, BayerSchering and Novartis. BiogenIdec Sweden AB provided an unrestricted grant for this study. LB has recieved teaching and consultation fees from BiogenIdec, SanofiAventis, Novartis, Genzyme and Amirall. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Bielekova B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048370; Bornsen L., 2012, MULTIPLE SCLEROSIS; Bornsen L, 2011, MULT SCLER J, V17, P32, DOI 10.1177/1352458510382247; Brettschneider J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011986; BRUCK W, 1995, ANN NEUROL, V38, P788, DOI 10.1002/ana.410380514; Buchanan RJ, 2009, NEUROREHABILITATION, V25, P271, DOI 10.3233/NRE-2009-0525; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; Clinical Trial of Recombinant Interferon-beta-la in MS (SPECTRIMS) Study Group, 2004, NEUROLOGY, V63, P1768; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Confavreux C, 2006, BRAIN, V129, P606, DOI 10.1093/brain/awl007; Confavreux C, 2006, BRAIN, V129, P595, DOI 10.1093/brain/awh714; Danilov AI, 2003, J NEUROIMMUNOL, V136, P112, DOI 10.1016/S0165-5728(02)00464-2; De Stefano N, 2001, ARCH NEUROL-CHICAGO, V58, P65, DOI 10.1001/archneur.58.1.65; Deryck O, 2006, J NEUROL, V253, P720, DOI 10.1007/s00415-006-0095-1; Ferguson B, 1997, BRAIN, V120, P393, DOI 10.1093/brain/120.3.393; Franceschi C, 2000, VACCINE, V18, P1717, DOI 10.1016/S0264-410X(99)00513-7; Frischer JM, 2009, BRAIN, V132, P1175, DOI 10.1093/brain/awp070; GIJBELS K, 1992, J NEUROIMMUNOL, V41, P29, DOI 10.1016/0165-5728(92)90192-N; Gunnarsson M, 2011, ANN NEUROL, V69, P83, DOI 10.1002/ana.22247; Harris VK, 2009, MOL DIAGN THER, V13, P225, DOI 10.2165/11313470-000000000-00000; Hawker K, 2009, ANN NEUROL, V66, P460, DOI 10.1002/ana.21867; Iacobaeus E, 2009, MULT SCLER J, V15, P28, DOI 10.1177/1352458508096870; Khademi M, 2009, EUR J NEUROL, V16, P528, DOI 10.1111/j.1468-1331.2009.02532.x; Khademi M, 2011, MULT SCLER J, V17, P335, DOI 10.1177/1352458510389102; Kieseier BC, 1999, NEUROLOGY, V53, P20, DOI 10.1212/WNL.53.1.20; Kipp M, 2012, CNS NEUROL DISORD-DR, V11, P506, DOI 10.2174/187152712801661248; Koch M, 2007, J NEUROL SCI, V255, P35, DOI 10.1016/j.jns.2007.01.067; Kornek B, 1999, BRAIN PATHOL, V9, P651; Kremenchutzky M, 1999, BRAIN, V122, P1941, DOI 10.1093/brain/122.10.1941; Krumbholz M, 2006, BRAIN, V129, P200, DOI 10.1093/brain/awh680; Kuenz B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002559; Leppert D, 1998, BRAIN, V121, P2327, DOI 10.1093/brain/121.12.2327; Linton PJ, 2005, IMMUNOL REV, V205, P207, DOI 10.1111/j.0105-2896.2005.00266.x; Lycke JN, 1998, J NEUROL NEUROSUR PS, V64, P402, DOI 10.1136/jnnp.64.3.402; Mazzali M, 2002, QJM-INT J MED, V95, P3, DOI 10.1093/qjmed/95.1.3; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Meinl E, 2008, J NEUROL SCI; MILLER RA, 1991, INT REV CYTOL, V124, P187; Norgren N, 2004, NEUROLOGY, V63, P1586, DOI 10.1212/01.WNL.0000142988.49341.D1; Panitch H, 2004, NEUROLOGY, V63, P1788; Ram M, 2006, J CLIN IMMUNOL, V26, P299, DOI 10.1007/s10875-006-9022-6; Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130; Ratchford JN, 2013, NEUROLOGY, V80, P47, DOI 10.1212/WNL.0b013e31827b1a1c; Salzer J, 2010, MULT SCLER J, V16, P287, DOI 10.1177/1352458509359725; Sellebjerg F, 2009, NEUROLOGY, V73, P2003, DOI 10.1212/WNL.0b013e3181c5b457; Sellebjerg F, 2003, BRAIN RES BULL, V61, P347, DOI 10.1016/S0361-9230(03)00097-2; Sorensen TL, 2002, J NEUROIMMUNOL, V122, P125, DOI 10.1016/S0165-5728(01)00453-2; Tektonidou MG, 2011, NAT REV RHEUMATOL, V7, P708, DOI 10.1038/nrrheum.2011.157; Tortorella C, 2005, J NEUROL SCI, V239, P95, DOI 10.1016/j.jns.2005.08.006; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Tremlett H, 2008, J NEUROL NEUROSUR PS, V79, P1368, DOI 10.1136/jnnp.2008.145805; Tremlett H, 2006, NEUROLOGY, V66, P172, DOI 10.1212/01.wnl.0000194259.90286.fe; Trojano M, 2002, ANN NEUROL, V51, P475, DOI 10.1002/ana.10147; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Tutuncu M, 2012, MULT SCLE; Wang KX, 2008, CYTOKINE GROWTH F R, V19, P333, DOI 10.1016/j.cytogfr.2008.08.001; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Wolinsky JS, 2007, ANN NEUROL, V61, P14, DOI 10.1002/ana.21079	59	55	55	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63172	10.1371/journal.pone.0063172	http://dx.doi.org/10.1371/journal.pone.0063172			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667585	Green Submitted, Green Published, gold			2022-12-25	WOS:000319654700115
J	Pages, JF; Gera, A; Romero, J; Farina, S; Garcia-Rubies, A; Hereu, B; Alcoverro, T				Pages, Jordi F.; Gera, Alessandro; Romero, Javier; Farina, Simone; Garcia-Rubies, Antoni; Hereu, Bernat; Alcoverro, Teresa			The Mediterranean Benthic Herbivores Show Diverse Responses to Extreme Storm Disturbances	PLOS ONE			English	Article							URCHIN PARACENTROTUS-LIVIDUS; SEA-URCHINS; SARPA-SALPA; HYDRODYNAMIC-FORCES; COMMUNITY STRUCTURE; ALGAL ASSEMBLAGES; PHASE-SHIFTS; HABITAT USE; PATTERNS; RESILIENCE	Catastrophic storms have been observed to be one of the major elements in shaping the standing structure of marine benthic ecosystems. Yet, little is known about the effect of catastrophic storms on ecosystem processes. Specifically, herbivory is the main control mechanism of macrophyte communities in the Mediterranean, with two main key herbivores: the sea urchin Paracentrotus lividus and the fish Sarpa salpa. Consequently, the effects of extreme storm events on these two herbivores (at the population level and on their behaviour) may be critical for the functioning of the ecosystem. With the aim of filling this gap, we took advantage of two parallel studies that were conducted before, during and after an unexpected catastrophic storm event. Specifically, fish and sea urchin abundance were assessed before and after the storm in monitored fixed areas (one site for sea urchin assessment and 3 sites for fish visual transects). Additionally, we investigated the behavioural response to the disturbance of S. salpa fishes that had been tagged with acoustic transmitters. Given their low mobility, sea urchins were severely affected by the storm (ca. 50% losses) with higher losses in those patches with a higher density of sea urchins. This may be due to a limited availability of refuges within each patch. In contrast, fish abundance was not affected, as fish were able to move to protected areas (i.e. deeper) as a result of the high mobility of this species. Our results highlight that catastrophic storms differentially affect the two dominant macroherbivores of rocky macroalgal and seagrass systems due to differences in mobility and escaping strategies. This study emphasises that under catastrophic disturbances, the presence of different responses among the key herbivores of the system may be critical for the maintenance of the herbivory function.	[Pages, Jordi F.; Gera, Alessandro; Farina, Simone; Garcia-Rubies, Antoni; Alcoverro, Teresa] Ctr Estudis Avancats Blanes CEAB CSIC, Blanes, Spain; [Romero, Javier; Hereu, Bernat] Univ Barcelona, Fac Biol, Dept Ecol, Barcelona, Spain; [Alcoverro, Teresa] Nat Conservat Fdn, Mysore, Karnataka, India	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); University of Barcelona	Pages, JF (corresponding author), Ctr Estudis Avancats Blanes CEAB CSIC, Blanes, Spain.	jpages@ceab.csic.es	Farina, Simone/ABF-4876-2021; Hereu, Bernat/K-9150-2015; Romero, Javier/A-8905-2013; Alcoverro, Teresa/J-9258-2012; Pagès, Jordi F/E-7107-2013; Farina, Simone/AAB-9308-2021	Hereu, Bernat/0000-0001-6247-7638; Romero, Javier/0000-0002-2772-8486; Alcoverro, Teresa/0000-0002-3910-9594; Pagès, Jordi F/0000-0001-9346-8312; Farina, Simone/0000-0003-0169-8044; Garcia-Rubies, Antoni/0000-0002-4824-9337	Spanish Ministry of Science and Innovation [CTM2010-22273-C02-01, CTM2010-22273-C02-02]; Spanish Ministry of Education [AP2008-01601]; Spanish National Research Council [JAEPre_08_00466]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Education(Spanish Government); Spanish National Research Council	This research has been funded by the Spanish Ministry of Science and Innovation (projects CTM2010-22273-C02-01 and 02). The Spanish Ministry of Education supported JP (scholarship AP2008-01601) and the Spanish National Research Council supported AG (scholarship JAEPre_08_00466). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis D, 2012, J APPL ICHTHYOL, V28, P126, DOI 10.1111/j.1439-0426.2011.01795.x; Alcoverro T, 2012, 200430E599 CEABCSIC, P147; Bellwood DR, 2006, P ROY SOC B-BIOL SCI, V273, P101, DOI 10.1098/rspb.2005.3276; BORTONE S A, 1976, Florida Scientist, V39, P245; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Coma R, 2012, ASSESSMENT ECOLOGICA, P67; CYR H, 1993, NATURE, V361, P148, DOI 10.1038/361148a0; DANCE C, 1987, MAR ECOL-P S Z N I, V8, P131, DOI 10.1111/j.1439-0485.1987.tb00179.x; DAYTON PK, 1992, ECOL MONOGR, V62, P421, DOI 10.2307/2937118; Denny M, 1996, J EXP BIOL, V199, P717; DENNY MW, 1985, ECOL MONOGR, V55, P69, DOI 10.2307/1942526; DENNY MW, 1994, J EXP BIOL, V194, P97; EBELING AW, 1985, MAR BIOL, V84, P287, DOI 10.1007/BF00392498; Elmqvist T, 2003, FRONT ECOL ENVIRON, V1, P488, DOI 10.2307/3868116; ESTES JA, 1974, SCIENCE, V185, P1058, DOI 10.1126/science.185.4156.1058; Farina S, 2009, MAR ECOL PROG SER, V377, P131, DOI 10.3354/meps07692; Fulton CJ, 2001, MAR BIOL, V139, P25; Garcia-Rubies A, 2012, ASSESSMENT ECOLOGICA, P201; Guidetti P, 2006, ECOL APPL, V16, P963, DOI 10.1890/1051-0761(2006)016[0963:MRRLPI]2.0.CO;2; HARROLD C, 1985, ECOLOGY, V66, P1160, DOI 10.2307/1939168; Heck KL, 2006, J EXP MAR BIOL ECOL, V330, P420, DOI 10.1016/j.jembe.2005.12.044; Hereu B, 2005, MAR ECOL-EVOL PERSP, V26, P54, DOI 10.1111/j.1439-0485.2005.00038.x; Hereu B, 2004, THESIS U BARCELONA B; Hereu B, 2012, 200430E599 CEABCSIC, P123; Hereu B, 2012, ASSESSMENT ECOLOGICA, P55; Hereu B, 2010, CARTOGRAFIA BIONOMIC; Hereu B, 2011, CARTOGRAFIA BIONOMIC; Hereu B, 2006, MAR ECOL PROG SER, V313, P95, DOI 10.3354/meps313095; Hereu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036901; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Jadot C, 2006, ICES J MAR SCI, V63, P128, DOI 10.1016/j.icesjms.2005.06.010; Jadot C, 2003, OCEANOL ACTA, V26, P497, DOI 10.1016/S0399-1784(03)00044-6; Kaufman L.S., 1983, Coral Reefs, V2, P43, DOI 10.1007/BF00304731; Koch EW, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P193; LASSIG BR, 1983, ENVIRON BIOL FISH, V9, P55, DOI 10.1007/BF00001058; LETOURNEUR Y, 1993, ENVIRON BIOL FISH, V37, P109, DOI 10.1007/BF00000586; MARBA N, 1995, J ECOL, V83, P381, DOI 10.2307/2261592; Mateo MA, 2012, ASSESSMENT ECOLOGICA; Navarro L, 2011, ESTUAR COAST SHELF S, V95, P52, DOI 10.1016/j.ecss.2011.08.002; Nystrom M, 2006, AMBIO, V35, P30, DOI 10.1639/0044-7447(2006)035[0030:RARDOF]2.0.CO;2; Pages JF, 2012, FUNCT ECOL, V26, P1015, DOI 10.1111/j.1365-2435.2012.02038.x; Palacin C, 1998, J SEA RES, V39, P281, DOI 10.1016/S1385-1101(97)00061-0; Palacin C, 1997, CAH BIOL MAR, V38, P267; Peterson G, 1998, ECOSYSTEMS, V1, P6, DOI 10.1007/s100219900002; Poore AGB, 2012, ECOL LETT, V15, P912, DOI 10.1111/j.1461-0248.2012.01804.x; Prado P, 2007, MAR ECOL PROG SER, V340, P63, DOI 10.3354/meps340063; Prado P, 2009, ESTUAR COAST SHELF S, V85, P472, DOI 10.1016/j.ecss.2009.09.012; RDevelopmentCoreTeam, 2012, R LANG ENV STAT COMP; Sanchez-Vidal A, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030395, 10.1371/journal.pone.0043943]; Siddon CE, 2003, MAR ECOL PROG SER, V261, P99, DOI 10.3354/meps261099; Sousa WP, 2001, MARINE COMMUNITY ECOLOGY, P85; SOUSA WP, 1980, OECOLOGIA, V45, P72, DOI 10.1007/BF00346709; Tomas F, 2005, MAR ECOL PROG SER, V301, P95, DOI 10.3354/meps301095; Trussell GC, 1997, MAR ECOL PROG SER, V151, P73, DOI 10.3354/meps151073; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Verges A, 2009, MAR ECOL PROG SER, V375, P1, DOI 10.3354/meps07778; Walsh W.J., 1983, Coral Reefs, V2, P49, DOI 10.1007/BF00304732; Winfree R, 2009, P R SOC B, V276, P229, DOI 10.1098/rspb.2008.0709; Zuur Alain F., 2009, P1	61	12	12	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62719	10.1371/journal.pone.0062719	http://dx.doi.org/10.1371/journal.pone.0062719			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667512	Green Published, Green Submitted, gold			2022-12-25	WOS:000319654700058
J	Smeets, MFMA; Chan, AC; Dagger, S; Bradley, CK; Wei, A; Izon, DJ				Smeets, Monique F. M. A.; Chan, Angela C.; Dagger, Samantha; Bradley, Cara K.; Wei, Andrew; Izon, David J.			Fli-1 Overexpression in Hematopoietic Progenitors Deregulates T Cell Development and Induces Pre-T Cell Lymphoblastic Leukaemia/Lymphoma	PLOS ONE			English	Article							GENE-TARGETED MICE; TRANSCRIPTION FACTOR; LINEAGE COMMITMENT; RAPID DEVELOPMENT; NOTCH1 MUTATIONS; ACTIVATED RAS; ETS FAMILY; LEUKEMIA; THYMOCYTES; EXPRESSION	The Ets transcription factor Fli-1 is preferentially expressed in hematopoietic tissues and cells, including immature T cells, but the role of Fli-1 in T cell development has not been closely examined. To address this we retrovirally overexpressed Fli-1 in various in vitro and in vivo settings and analysed its effect on T cell development. We found that Fli-1 overexpression perturbed the DN to DP transition and inhibited CD4 development whilst enhancing CD8 development both in vitro and in vivo. Surprisingly, Fli-1 overexpression in vivo eventuated in development of pre-T cell lymphoblastic leukaemia/lymphoma (pre-T LBL). Known Fli-1 target genes such as the pro-survival Bcl-2 family members were not found to be upregulated. In contrast, we found increased NOTCH1 expression in all Fli-1 T cells and detected Notch1 mutations in all tumours. These data show a novel function for Fli-1 in T cell development and leukaemogenesis and provide a new mouse model of pre-T LBL to identify treatment options that target the Fli-1 and Notch1 signalling pathways.	[Smeets, Monique F. M. A.; Izon, David J.] Univ Melbourne, St Vincents Inst, Haematol & Leukaemia Unit, Fitzroy, Vic 3065, Australia; [Chan, Angela C.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Dagger, Samantha] Univ Western Australia, Sch Pathol & Lab Med, Crawley, WA, Australia; [Bradley, Cara K.] Gennea, Sydney, NSW, Australia; [Wei, Andrew] Monash Univ, Alfred Hosp, Dept Clin Haematol, Melbourne, Vic 3181, Australia; [Wei, Andrew] Monash Univ, Australian Ctr Blood Dis, Melbourne, Vic 3004, Australia	St. Vincent's Institute of Medical Research; University of Melbourne; University of Melbourne; University of Western Australia; Florey Institute of Neuroscience & Mental Health; Monash University; Monash University	Izon, DJ (corresponding author), Univ Melbourne, St Vincents Inst, Haematol & Leukaemia Unit, Fitzroy, Vic 3065, Australia.	dizon@svi.edu.au		Bradley, Cara/0000-0001-9677-3363; Wei, Andrew/0000-0002-7514-3298	NHMRC [559004]; Victorian Government's OIS Program; Cancer Council of Victoria; Leukaemia Foundation of Australia; Victorian Cancer Agency	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's OIS Program; Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Leukaemia Foundation of Australia; Victorian Cancer Agency	This work was supported by an NHMRC Project Grant #559004 and in part by the Victorian Government's OIS Program. DI receives support from the Cancer Council of Victoria and the Leukaemia Foundation of Australia. AW receives support from the Leukaemia Foundation of Australia and the Victorian Cancer Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM KM, 1991, P NATL ACAD SCI USA, V88, P3977, DOI 10.1073/pnas.88.9.3977; Anderson G, 2000, SEMIN IMMUNOL, V12, P457, DOI 10.1006/smim.2000.0260; Anderson MK, 1999, DEVELOPMENT, V126, P3131; Armstrong SA, 2005, J CLIN ONCOL, V23, P6306, DOI 10.1200/JCO.2005.05.047; Ashworth TD, 2010, BLOOD, V116, P5455, DOI 10.1182/blood-2010-05-286328; Bain G, 1997, MOL CELL BIOL, V17, P4782, DOI 10.1128/MCB.17.8.4782; Balciunaite G, 2005, BLOOD, V105, P1930, DOI 10.1182/blood-2004-08-3087; Bell JJ, 2008, NATURE, V452, P764, DOI 10.1038/nature06840; BENDAVID Y, 1991, GENE DEV, V5, P908, DOI 10.1101/gad.5.6.908; Carlyle JR, 1997, J EXP MED, V186, P173, DOI 10.1084/jem.186.2.173; Craig FE, 2008, BLOOD, V111, P3941, DOI 10.1182/blood-2007-11-120535; DELATTRE O, 1994, NEW ENGL J MED, V331, P294, DOI 10.1056/NEJM199408043310503; Engel I, 2004, EMBO J, V23, P202, DOI 10.1038/sj.emboj.7600017; Feng H, 2010, CANCER CELL, V18, P353, DOI 10.1016/j.ccr.2010.09.009; Folpe AL, 2000, AM J SURG PATHOL, V24, P1657, DOI 10.1097/00000478-200012000-00010; Gartner F, 1999, IMMUNITY, V10, P537, DOI 10.1016/S1074-7613(00)80053-9; GODFREY DI, 1994, J IMMUNOL, V152, P4783; Gothert JR, 2007, BLOOD, V110, P3753, DOI 10.1182/blood-2006-12-063644; Grohar PJ, 2011, JNCI-J NATL CANCER I, V103, P962, DOI 10.1093/jnci/djr156; HAWLEY RG, 1995, ONCOGENE, V11, P1113; Haydu JE, 2012, BLOOD, V119, P5211, DOI 10.1182/blood-2011-10-388504; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Izon DJ, 2001, IMMUNITY, V14, P253, DOI 10.1016/S1074-7613(01)00107-8; Jeannet R, 2010, BLOOD, V116, P5443, DOI 10.1182/blood-2010-05-286658; Kamstrup MR, 2008, BRIT J DERMATOL, V158, P747, DOI 10.1111/j.1365-2133.2007.08427.x; Kawada H, 2001, INT J HEMATOL, V73, P463, DOI 10.1007/BF02994008; Kawamoto H, 2003, EUR J IMMUNOL, V33, P606, DOI 10.1002/eji.200323461; Kruisbeek AM, 2000, IMMUNOL TODAY, V21, P637, DOI 10.1016/S0167-5699(00)01744-8; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Li YJ, 2012, BLOOD CANCER J, V2, DOI 10.1038/bcj.2011.52; Lin YW, 2006, BLOOD, V107, P2540, DOI 10.1182/blood-2005-07-3013; Liu F, 2008, CURR BIOL, V18, P1234, DOI 10.1016/j.cub.2008.07.048; Masuya M, 2005, BLOOD, V105, P95, DOI 10.1182/blood-2003-12-4345; Mercer EM, 2011, IMMUNITY, V35, P413, DOI 10.1016/j.immuni.2011.06.013; Mhawech-Fauceglia P, 2007, J CLIN PATHOL, V60, P694, DOI 10.1136/jcp.2006.039230; Miyazaki M, 2011, NAT IMMUNOL, V12, P992, DOI 10.1038/ni.2086; Nie L, 2008, J BIOL CHEM, V283, P684, DOI 10.1074/jbc.M704981200; O'Neil J, 2006, BLOOD, V107, P781, DOI 10.1182/blood-2005-06-2553; O'Neil J, 2004, CANCER CELL, V5, P587, DOI 10.1016/j.ccr.2004.05.023; Palomero T, 2006, BLOOD, V108, P986, DOI 10.1182/blood-2005-08-3482; Pereira R, 1999, ONCOGENE, V18, P1597, DOI 10.1038/sj.onc.1202534; Quick CM, 2006, J CUTAN PATHOL, V33, P642, DOI 10.1111/j.1600-0560.2006.00535.x; Reschly EJ, 2006, BLOOD, V107, P4115, DOI 10.1182/blood-2005-09-3551; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Starck J, 2010, BLOOD, V116, P4795, DOI 10.1182/blood-2010-02-270405; Swat W, 1996, P NATL ACAD SCI USA, V93, P4683, DOI 10.1073/pnas.93.10.4683; Tremblay M, 2010, GENE DEV, V24, P1093, DOI 10.1101/gad.1897910; Wada H, 2008, NATURE, V452, P768, DOI 10.1038/nature06839; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wilson A, 1989, Int Immunol, V1, P605, DOI 10.1093/intimm/1.6.605; Wilson NK, CELL STEM CELL, V7, P532; WINANDY S, 1995, CELL, V83, P289, DOI 10.1016/0092-8674(95)90170-1; Wu L, 1996, J EXP MED, V184, P903, DOI 10.1084/jem.184.3.903; Yashiro-Ohtani Y, 2009, GENE DEV, V23, P1665, DOI 10.1101/gad.1793709; ZHANG LQ, 1995, MOL CELL BIOL, V15, P6961; Zhang XK, 2008, J IMMUNOL, V181, P1644, DOI 10.4049/jimmunol.181.3.1644	56	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62346	10.1371/journal.pone.0062346	http://dx.doi.org/10.1371/journal.pone.0062346			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667468	Green Published, gold			2022-12-25	WOS:000319654700030
J	Song, YP; Ma, KF; Ci, D; Zhang, ZY; Zhang, DQ				Song, Yuepeng; Ma, Kaifeng; Ci, Dong; Zhang, Zhiyi; Zhang, Deqiang			Sexual Dimorphism Floral MicroRNA Profiling and Target Gene Expression in Andromonoecious Poplar (Populus tomentosa)	PLOS ONE			English	Article							STRESS-RESPONSIVE MICRORNAS; BLACK-COTTONWOOD; DNA METHYLATION; FLOWERING TIME; SMALL RNAS; ARABIDOPSIS; APETALA2; FAMILY; AUXIN; IDENTIFICATION	Although the molecular basis of poplar sex-specific flower development remains largely unknown, increasing evidence indicates an essential role for microRNAs (miRNAs). The specific miRNA types and precise miRNA expression patterns in dioecious plant flower development remain unclear. Here, we used andromonoecious poplar, an exceptional model system, to eliminate the confounding effects of genetic background of dioecious plants. This system, combined with high-throughput sequencing and computational analysis, allowed us to characterize sex-specific miRNAomes from female and male flowers. Comparative miRNAome analysis combined with quantitative real-time PCR revealed the expression patterns of 27 miRNAs in poplar flower and showed that the targets of these miRNAs are involved in flower organogenesis, Ca2+ transport, phytohormone synthesis and metabolism, and DNA methylation. This paper describes a complex regulatory network consisting of these miRNAs expressed in sex-specific flower development in a dioecious plant. The conserved and novel miRNA locations were annotated in the Populus trichocarpa genome. Among these, miRNA Pto-F70 and 4 targets are located in the sex-determination regions of chromosome XIX. Furthermore, two novel miRNAs, Pto-F47 and Pto-F68, were shown for the first time to be regulatory factors in phytohormone interactions. To our knowledge, this report is the first systematic investigation of sex-specific flower-related miRNAs and their targets in poplar, and it deepens our understanding of the important regulatory functions of miRNAs in female and male flower development in this dioecious plant.	[Song, Yuepeng; Ma, Kaifeng; Ci, Dong; Zhang, Zhiyi; Zhang, Deqiang] Beijing Forestry Univ, Natl Engn Lab Tree Breeding, Coll Biol Sci & Technol, Beijing, Peoples R China; [Song, Yuepeng; Ma, Kaifeng; Ci, Dong; Zhang, Zhiyi; Zhang, Deqiang] Beijing Forestry Univ, Key Lab Genet & Breeding Forest Trees & Ornamenta, Coll Biol Sci & Technol, Beijing, Peoples R China	Beijing Forestry University; Beijing Forestry University	Zhang, DQ (corresponding author), Beijing Forestry Univ, Natl Engn Lab Tree Breeding, Coll Biol Sci & Technol, Beijing, Peoples R China.	DeqiangZhang@bjfu.edu.cn	Song, Yuepeng/T-8731-2019		Introduction of Foreign Advanced Agricultural Science and Technology into China [2009-4-22]; Project of the National Natural Science Foundation of China [31170622, 30872042]; Specific Programs in Graduate Science and Technology Innovation of Beijing Forestry University [BLYJ201202]	Introduction of Foreign Advanced Agricultural Science and Technology into China; Project of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specific Programs in Graduate Science and Technology Innovation of Beijing Forestry University	This work was supported by the Introduction of Foreign Advanced Agricultural Science and Technology into China (No. 2009-4-22), the Project of the National Natural Science Foundation of China (No. 31170622, 30872042), and the Specific Programs in Graduate Science and Technology Innovation of Beijing Forestry University (No.BLYJ201202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; An XM, 2011, PLANT CELL REP, V30, P89, DOI 10.1007/s00299-010-0947-0; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Baker CC, 2005, CURR BIOL, V15, P303, DOI 10.1016/j.cub.2005.02.017; Barakat Abdelali, 2007, BMC Genomics, V8, P481, DOI 10.1186/1471-2164-8-481; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; BOES TK, 1994, AM J BOT, V81, P562, DOI 10.2307/2445730; Brzeski J, 2003, J BIOL CHEM, V278, P823, DOI 10.1074/jbc.M209260200; Cerdan PD, 2003, NATURE, V423, P881, DOI 10.1038/nature01636; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Chen XM, 2010, PLANT J, V61, P941, DOI 10.1111/j.1365-313X.2009.04089.x; Cheng SH, 2002, PLANT PHYSIOL, V129, P469, DOI 10.1104/pp.005645; Chuck G, 2007, NAT GENET, V39, P1517, DOI 10.1038/ng.2007.20; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Finnegan EJ, 1998, ANNU REV PLANT PHYS, V49, P223, DOI 10.1146/annurev.arplant.49.1.223; Fu XD, 2003, NATURE, V421, P740, DOI 10.1038/nature01387; Gao ZH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-371; Gaudet M, 2008, TREE GENET GENOMES, V4, P25, DOI 10.1007/s11295-007-0085-1; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; Griffiths S, 2003, PLANT PHYSIOL, V131, P1855, DOI 10.1104/pp.102.016188; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hepworth SR, 2006, PLANTA, V223, P769, DOI 10.1007/s00425-005-0138-3; Ji LZ, 2011, PURE APPL MATH Q, V7, P1, DOI 10.1371/journal.pgen.1001358; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Klevebring D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-620; Kuno N, 2003, PLANT CELL, V15, P2476, DOI 10.1105/tpc.014217; Ledger Susan, 2001, Plant Journal, V26, P15, DOI 10.1046/j.1365-313x.2001.01003.x; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Lippman Z, 2004, NATURE, V431, P364, DOI 10.1038/nature02875; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Lu SF, 2005, PLANT CELL, V17, P2186, DOI 10.1105/tpc.105.033456; Lu SF, 2008, PLANT J, V55, P131, DOI 10.1111/j.1365-313X.2008.03497.x; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Nag A, 2010, CURR TOP DEV BIOL, V91, P349, DOI 10.1016/S0070-2153(10)91012-0; Nag R, 2005, PLANT MOL BIOL, V59, P821, DOI 10.1007/s11103-005-1387-z; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Okamuro JK, 1997, P NATL ACAD SCI USA, V94, P7076, DOI 10.1073/pnas.94.13.7076; Pakull B, 2009, TREE GENET GENOMES, V5, P505, DOI 10.1007/s11295-009-0204-2; Pantaleo V, 2010, PLANT J, V62, P960, DOI [10.1111/j.0960-7412.2010.04208.x, 10.1111/j.1365-313X.2010.04208.x]; Paolucci I, 2010, TREE GENET GENOMES, V6, P863, DOI 10.1007/s11295-010-0297-7; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Riechmann JL, 1998, BIOL CHEM, V379, P633; Rottmann WH, 2000, PLANT J, V22, P235, DOI 10.1046/j.1365-313x.2000.00734.x; Schmid M, 2003, DEVELOPMENT, V130, P6001, DOI 10.1242/dev.00842; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Sheppard LA, 2000, PLANT PHYSIOL, V124, P627, DOI 10.1104/pp.124.2.627; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Song YP, 2012, PLANT CELL REP, V31, P1393, DOI 10.1007/s00299-012-1255-7; Stepanova AN, 2007, PLANT CELL, V19, P2169, DOI 10.1105/tpc.107.052068; Sun YH, 2012, PLANT MOL BIOL, V80, P37, DOI 10.1007/s11103-011-9864-z; Tuskan GA, 2004, PLANT BIOLOGY, V6, P2, DOI 10.1055/s-2003-44715; Tuskan GA, 2012, TREE GENET GENOMES, V8, P559, DOI 10.1007/s11295-012-0495-6; Wang ZM, 2012, MOL PLANT, V5, P889, DOI 10.1093/mp/ssr094; WEIGEL D, 1995, PLANT CELL, V7, P388, DOI 10.1105/tpc.7.4.388; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Xiong LM, 2001, PLANT CELL, V13, P2063, DOI 10.1105/tpc.13.9.2063; Yin T, 2008, GENOME RES, V18, P422, DOI 10.1101/gr.7076308; Zhao CZ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-3; Zluvova J, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-208	64	31	36	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62681	10.1371/journal.pone.0062681	http://dx.doi.org/10.1371/journal.pone.0062681			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667507	Green Published, Green Submitted, gold			2022-12-25	WOS:000319654700055
J	Autore, F; Pfuhl, M; Quan, XP; Williams, A; Roberts, RG; Shanahan, CM; Fraternali, F				Autore, Flavia; Pfuhl, Mark; Quan, Xueping; Williams, Aisling; Roberts, Roland G.; Shanahan, Catherine M.; Fraternali, Franca			Large-Scale Modelling of the Divergent Spectrin Repeats in Nesprins: Giant Modular Proteins	PLOS ONE			English	Article							DREIFUSS MUSCULAR-DYSTROPHY; ALPHA-ACTININ ROD; NUCLEAR-ENVELOPE; ERYTHROID SPECTRIN; CRYSTAL-STRUCTURE; EVOLUTIONARY CONSERVATION; SEQUENCE ALIGNMENTS; MOLECULAR-DYNAMICS; LAMIN A/C; NESPRIN-1-ALPHA	Nesprin-1 and nesprin-2 are nuclear envelope (NE) proteins characterized by a common structure of an SR (spectrin repeat) rod domain and a C-terminal transmembrane KASH [Klarsicht-ANC-Syne-homology] domain and display N-terminal actin-binding CH (calponin homology) domains. Mutations in these proteins have been described in Emery-Dreifuss muscular dystrophy and attributed to disruptions of interactions at the NE with nesprins binding partners, lamin A/C and emerin. Evolutionary analysis of the rod domains of the nesprins has shown that they are almost entirely composed of unbroken SR-like structures. We present a bioinformatical approach to accurate definition of the boundaries of each SR by comparison with canonical SR structures, allowing for a large-scale homology modelling of the 74 nesprin-1 and 56 nesprin-2 SRs. The exposed and evolutionary conserved residues identify important pbs for protein-protein interactions that can guide tailored binding experiments. Most importantly, the bioinformatics analyses and the 3D models have been central to the design of selected constructs for protein expression. 1D NMR and CD spectra have been performed of the expressed SRs, showing a folded, stable, high content a-helical structure, typical of SRs. Molecular Dynamics simulations have been performed to study the structural and elastic properties of consecutive SRs, revealing insights in the mechanical properties adopted by these modules in the cell.	[Autore, Flavia; Pfuhl, Mark; Quan, Xueping; Williams, Aisling; Fraternali, Franca] Kings Coll London, Sch Phys Sci & Engn, Randall Div Cell & Mol Biophys, London WC2R 2LS, England; [Autore, Flavia; Williams, Aisling; Shanahan, Catherine M.] Kings Coll London, Div Cardiovasc Med, BHF Ctr Res Excellence, London WC2R 2LS, England; [Roberts, Roland G.] Kings Coll London, Guys Hosp, Div Med & Mol Genet, London WC2R 2LS, England; [Fraternali, Franca] Thomas Young Ctr Theory & Simulat Mat, London, England	University of London; King's College London; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Fraternali, F (corresponding author), Kings Coll London, Sch Phys Sci & Engn, Randall Div Cell & Mol Biophys, London WC2R 2LS, England.	franca.fraternali@kcl.ac.uk	Fraternali, Franca/C-8912-2009; Fraternali, Franca/D-4410-2011	Fraternali, Franca/0000-0002-3143-6574; Pfuhl, Mark/0000-0001-9592-6639; Shanahan, Catherine/0000-0002-8352-8171; Roberts, Roland/0000-0001-6636-1579	BHF Centre of Excellence; Leverhulme Trust [F/07040/AL]; British Heart Foundation [NH/12/2/29427, RG/11/14/29056] Funding Source: researchfish	BHF Centre of Excellence; Leverhulme Trust(Leverhulme Trust); British Heart Foundation(British Heart Foundation)	This work was supported the BHF Centre of Excellence. FF is funded by the Leverhulme Trust (grant No. F/07040/AL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Amann KJ, 1999, J BIOL CHEM, V274, P35375, DOI 10.1074/jbc.274.50.35375; An XL, 2006, BIOCHEMISTRY-US, V45, P13670, DOI 10.1021/bi061368x; An XL, 2006, J BIOL CHEM, V281, P10527, DOI 10.1074/jbc.M513725200; Apel ED, 2000, J BIOL CHEM, V275, P31986, DOI 10.1074/jbc.M004775200; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berendsen HJC, 1981, INTERMOLECULAR FORCE, P331, DOI [DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658-1_21]; Bhasin N, 2005, J MOL BIOL, V352, P795, DOI 10.1016/j.jmb.2005.07.064; Broderick MJF, 2005, ADV PROTEIN CHEM, V70, P203, DOI 10.1016/S0065-3233(04)70007-8; Cavallo L, 2003, NUCLEIC ACIDS RES, V31, P3364, DOI 10.1093/nar/gkg601; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Darden T, 1999, STRUCT FOLD DES, V7, pR55, DOI 10.1016/S0969-2126(99)80033-1; Davis L, 2009, J BIOL CHEM, V284, P6982, DOI 10.1074/jbc.M809245200; Djinovic-Carugo K, 2002, FEBS LETT, V513, P119, DOI 10.1016/S0014-5793(01)03304-X; Djinovic-Carugo K, 1999, CELL, V98, P537, DOI 10.1016/S0092-8674(00)81981-9; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fogl C, 2011, PROTEINS; Fraternali F, 2002, NUCLEIC ACIDS RES, V30, P2950, DOI 10.1093/nar/gkf373; Golji J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000389; Grum VL, 1999, CELL, V98, P523, DOI 10.1016/S0092-8674(00)81980-7; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ipsaro JJ, 2010, BLOOD, V115, P4843, DOI 10.1182/blood-2010-01-261396; Jerschow A, 1997, J MAGN RESON, V125, P372, DOI 10.1006/jmre.1997.1123; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kowalski K, 2004, J BIOMOL NMR, V29, P533, DOI 10.1023/B:JNMR.0000034342.20537.01; Kusunoki H, 2004, J MOL BIOL, V344, P495, DOI 10.1016/j.jmb.2004.09.019; Kusunoki H, 2004, STRUCTURE, V12, P645, DOI 10.1016/j.str.2004.02.022; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Libotte T, 2005, MOL BIOL CELL, V16, P3411, DOI 10.1091/mbc.E04-11-1009; Liu J, 2004, J MOL BIOL, V338, P115, DOI 10.1016/j.jmb.2004.02.034; Lupyan D, 2005, BIOINFORMATICS, V21, P3255, DOI 10.1093/bioinformatics/bti527; MacDonald RI, 2004, P NATL ACAD SCI USA, V101, P1502, DOI 10.1073/pnas.0308059100; Mirijanian DT, 2007, J MOL BIOL, V365, P523, DOI 10.1016/j.jmb.2006.10.003; Mislow JMK, 2002, FEBS LETT, V525, P135, DOI 10.1016/S0014-5793(02)03105-8; Mislow JMK, 2002, J CELL SCI, V115, P61; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; O'Sullivan O, 2004, J MOL BIOL, V340, P385, DOI 10.1016/j.jmb.2004.04.058; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Ortiz V, 2005, J MOL BIOL, V349, P638, DOI 10.1016/j.jmb.2005.03.086; Padmakumar VC, 2004, EXP CELL RES, V295, P330, DOI 10.1016/j.yexcr.2004.01.014; Pare GC, 2005, EXP CELL RES, V303, P388, DOI 10.1016/j.yexcr.2004.10.009; Park S, 2003, J BIOL CHEM, V278, P21837, DOI 10.1074/jbc.M300617200; Pascual J, 1996, FEBS LETT, V383, P201, DOI 10.1016/0014-5793(96)00251-7; Pascual J, 1997, J MOL BIOL, V273, P740, DOI 10.1006/jmbi.1997.1344; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Rajgor D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040098; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Rybakova IN, 2006, J BIOL CHEM, V281, P9996, DOI 10.1074/jbc.M513121200; Rybakova IN, 2005, J BIOL CHEM, V280, P23018, DOI 10.1074/jbc.M502530200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schneider M, 2004, PLANT PHYSIOL BIOCH, V42, P1013, DOI 10.1016/j.plaphy.2004.10.009; Schroder S, 2011, BIOCHEM J, V435, P651, DOI 10.1042/BJ20101810; Simpson JG, 2008, BIOCHEM SOC T, V36, P1359, DOI 10.1042/BST0361359; Stabach PR, 2009, BLOOD, V113, P5377, DOI 10.1182/blood-2008-10-184291; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vishwanatha KS, 2012, BIOCHEMISTRY-US, V51, P5663, DOI 10.1021/bi300583s; Vorobiev S.M., 2008, NE STRUCT GENOMICS C; Warren Derek T., 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405009294; Warren DT, 2010, J BIOL CHEM, V285, P1311, DOI 10.1074/jbc.M109.032557; Wheeler MA, 2007, EXP CELL RES, V313, P2845, DOI 10.1016/j.yexcr.2007.03.025; Wheeler MA, 2008, BIOCHEM SOC T, V36, P1354, DOI 10.1042/BST0361354; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; YAN Y, 1993, SCIENCE, V262, P2027, DOI 10.1126/science.8266097; Ylanne J, 2001, STRUCTURE, V9, P597, DOI 10.1016/S0969-2126(01)00619-0; Zhang QP, 2007, HUM MOL GENET, V16, P2816, DOI 10.1093/hmg/ddm238; Zhang QP, 2005, J CELL SCI, V118, P673, DOI 10.1242/jcs.01642; Zhang QP, 2001, J CELL SCI, V114, P4485	72	29	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e63633	10.1371/journal.pone.0063633	http://dx.doi.org/10.1371/journal.pone.0063633			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671687	Green Submitted, gold, Green Published			2022-12-25	WOS:000321390200053
J	Martin, E; Caubit, X; Airik, R; Vola, C; Fatmi, A; Kispert, A; Fasano, L				Martin, Elise; Caubit, Xavier; Airik, Rannar; Vola, Christine; Fatmi, Ahmed; Kispert, Andreas; Fasano, Laurent			TSHZ3 and SOX9 Regulate the Timing of Smooth Muscle Cell Differentiation in the Ureter by Reducing Myocardin Activity (Publication with Expression of Concern. See vol. 14, 2019)	PLOS ONE			English	Article; Publication with Expression of Concern							EXPRESSION; TEASHIRT; KIDNEY; GENES; PROTEINS; COFACTOR; TBX18	Smooth muscle cells are of key importance for the proper functioning of different visceral organs including those of the urogenital system. In the mouse ureter, the two transcriptional regulators TSHZ3 and SOX9 are independently required for initiation of smooth muscle differentiation from uncommitted mesenchymal precursor cells. However, it has remained unclear whether TSHZ3 and SOX9 act independently or as part of a larger regulatory network. Here, we set out to characterize the molecular function of TSHZ3 in the differentiation of the ureteric mesenchyme. Using a yeast-two-hybrid screen, we identified SOX9 as an interacting protein. We show that TSHZ3 also binds to the master regulator of the smooth muscle program, MYOCD, and displaces it from the coregulator SRF, thereby disrupting the activation of smooth muscle specific genes. We found that the initiation of the expression of smooth muscle specific genes in MYOCD-positive ureteric mesenchyme coincides with the down regulation of Sox9 expression, identifying SOX9 as a possible negative regulator of smooth muscle cell differentiation. To test this hypothesis, we prolonged the expression of Sox9 in the ureteric mesenchyme in vivo. We found that Sox9 does not affect Myocd expression but significantly reduces the expression of MYOCD/SRF-dependent smooth muscle genes, suggesting that down-regulation of Sox9 is a prerequisite for MYOCD activity. We propose that the dynamic expression of Sox9 and the interaction between TSHZ3, SOX9 and MYOCD provide a mechanism that regulates the pace of progression of the myogenic program in the ureter.	[Martin, Elise; Caubit, Xavier; Vola, Christine; Fatmi, Ahmed; Fasano, Laurent] Aix Marseille Univ, CNRS, IBDM UMR7288, Marseille, France; [Airik, Rannar; Kispert, Andreas] Hannover Med Sch, Inst Mol Biol, D-30623 Hannover, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Hannover Medical School	Fasano, L (corresponding author), Aix Marseille Univ, CNRS, IBDM UMR7288, Marseille, France.	laurent.fasano@univ-amu.fr	Fasano, Laurent/AAH-1688-2022; Airik, Rannar/AAS-7810-2021; Fasano, Laurent/AFL-9580-2022	Fasano, Laurent/0000-0003-2307-8428; Airik, Rannar/0000-0002-7055-6325; Fasano, Laurent/0000-0003-2307-8428	Centre National de la Recherche Scientifique (CNRS); Association Francaise contre les Myopathies (AFM) [12545, 13013]; Agence Nationale de la Recherche (ANR) [ANR-09-GENO-027-01]; Deutsche Forschungsgemeinschaft (German Research Council) [DFG Ki728/7-1]; Agence Nationale de la Recherche [ANR-10-INSB-04-01]	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Deutsche Forschungsgemeinschaft (German Research Council)(German Research Foundation (DFG)); Agence Nationale de la Recherche(French National Research Agency (ANR))	Research in the laboratory of LF was supported by the Centre National de la Recherche Scientifique (CNRS) with additional funding from the Association Francaise contre les Myopathies (AFM, grants 12545, 13013) and the Agence Nationale de la Recherche (ANR, grant ANR-09-GENO-027-01). Work in the laboratory of AK was supported by a grant (DFG Ki728/7-1) from the Deutsche Forschungsgemeinschaft (German Research Council). E. Martin was a fellow of the AFM. Part of this work was performed using France-BioImaging infrastructure supported by the Agence Nationale de la Recherche (ANR-10-INSB-04-01, call "Investissements d'Avenir"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airik R, 2006, J CLIN INVEST, V116, P663, DOI 10.1172/JCI26027; Airik R, 2010, HUM MOL GENET, V19, P4918, DOI 10.1093/hmg/ddq426; Brenner-Anantharam A, 2007, DEVELOPMENT, V134, P1967, DOI 10.1242/dev.004234; Cain JE, 2008, DIFFERENTIATION, V76, P831, DOI 10.1111/j.1432-0436.2008.00265.x; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Caubit X, 2005, J COMP NEUROL, V486, P76, DOI 10.1002/cne.20500; Caubit X, 2008, DEVELOPMENT, V135, P3301, DOI 10.1242/dev.022442; Chen JY, 2002, J MOL CELL CARDIOL, V34, P1345, DOI 10.1006/jmcc.2002.2086; Creemers EE, 2006, DEVELOPMENT, V133, P4245, DOI 10.1242/dev.02610; DELLAGNOLA CA, 1990, Z KINDERCHIR, V45, P286; Du KL, 2003, MOL CELL BIOL, V23, P2425, DOI 10.1128/MCB.23.7.2425-2437.2003; Faralli H, 2011, J BIOL CHEM, V286, P23498, DOI 10.1074/jbc.M110.206003; Gallet A, 2000, DEVELOPMENT, V127, P5509; GUNN TR, 1995, AM J OBSTET GYNECOL, V172, P479, DOI 10.1016/0002-9378(95)90560-X; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Huang JH, 2008, J CLIN INVEST, V118, P515, DOI [10.1172/JC133304, 10.1172/JCI33304]; Ismaili K, 2006, J PEDIATR-US, V148, P222, DOI 10.1016/j.jpeds.2005.09.037; Iwanaga Y, 2006, J MOL CELL CARDIOL, V41, P798, DOI 10.1016/j.yjmcc.2006.07.004; Kajiwara Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005071; Karsenty G, 2008, ANNU REV GENOM HUM G, V9, P183, DOI 10.1146/annurev.genom.9.081307.164437; Li SJ, 2003, P NATL ACAD SCI USA, V100, P9366, DOI 10.1073/pnas.1233635100; Liu ZP, 2005, DEV CELL, V9, P261, DOI 10.1016/j.devcel.2005.05.017; Lye CM, 2010, J AM SOC NEPHROL, V21, P24, DOI 10.1681/ASN.2008111206; MCHUGH KM, 1995, DEV DYNAM, V204, P278, DOI 10.1002/aja.1002040306; Michos O, 2007, DEVELOPMENT, V134, P2397, DOI 10.1242/dev.02861; Miyazaki Y, 2000, J CLIN INVEST, V105, P863, DOI 10.1172/JCI8256; Nie XG, 2010, DEVELOPMENT, V137, P755, DOI 10.1242/dev.045757; Onai T, 2007, EMBO J, V26, P2350, DOI 10.1038/sj.emboj.7601684; Raatikainen-Ahokas A, 2000, DEV DYNAM, V217, P146, DOI 10.1002/(SICI)1097-0177(200002)217:2<146::AID-DVDY2>3.3.CO;2-9; Reginensi A, 2011, HUM MOL GENET, V20, P1143, DOI 10.1093/hmg/ddq558; Schmidt K, 2003, J BIOL CHEM, V278, P29769, DOI 10.1074/jbc.M301539200; Taghli-Lamallem O, 2007, DEV BIOL, V307, P142, DOI 10.1016/j.ydbio.2007.04.028; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang GJ, 2009, J UROLOGY, V181, P401, DOI 10.1016/j.juro.2008.08.117; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Yu J, 2002, DEVELOPMENT, V129, P5301; Zacharias William J, 2011, Dev Biol, V355, P152, DOI 10.1016/j.ydbio.2011.04.025; Zhang PL, 2000, PEDIATR NEPHROL, V14, P820, DOI 10.1007/s004679900240; Zhou JL, 2005, J BIOL CHEM, V280, P10861, DOI 10.1074/jbc.M411586200	41	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e63721	10.1371/journal.pone.0063721	http://dx.doi.org/10.1371/journal.pone.0063721			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671695	gold, Green Published, Green Submitted			2022-12-25	WOS:000321390200058
J	Vos, M; te Beek, TAH; van Driel, MA; Huynen, MA; Eyre-Walker, A; van Passel, MWJ				Vos, Michiel; te Beek, Tim A. H.; van Driel, Marc A.; Huynen, Martijn A.; Eyre-Walker, Adam; van Passel, Mark W. J.			ODoSE: A Webserver for Genome-Wide Calculation of Adaptive Divergence in Prokaryotes	PLOS ONE			English	Article							POSITIVE SELECTION; EVOLUTION; RECOMBINATION; DROSOPHILA	Quantifying patterns of adaptive divergence between taxa is a major goal in the comparative and evolutionary study of prokaryote genomes. When applied appropriately, the McDonald-Kreitman (MK) test is a powerful test of selection based on the relative frequency of non-synonymous and synonymous substitutions between species compared to non-synonymous and synonymous polymorphisms within species. The webserver ODoSE (Ortholog Direction of Selection Engine) allows the calculation of a novel extension of the MK test, the Direction of Selection (DoS) statistic, as well as the calculation of a weighted-average Neutrality Index (NI) statistic for the entire core genome, allowing for systematic analysis of the evolutionary forces shaping core genome divergence in prokaryotes. ODoSE is hosted in a Galaxy environment, which makes it easy to use and amenable to customization and is freely available at www.odose.nl.	[Vos, Michiel] Univ Exeter, Sch Med, European Ctr Environm & Human Hlth, Truro, England; [te Beek, Tim A. H.; van Driel, Marc A.] Netherlands Bioinformat Ctr, Nijmegen, Netherlands; [te Beek, Tim A. H.; Huynen, Martijn A.] Radboud Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, NL-6525 ED Nijmegen, Netherlands; [Eyre-Walker, Adam] Univ Sussex, Sch Life Sci, Ctr Study Evolut, Brighton, E Sussex, England; [van Passel, Mark W. J.] Wageningen Univ, NL-6700 AP Wageningen, Netherlands	University of Exeter; Radboud University Nijmegen; University of Sussex; Wageningen University & Research	Vos, M (corresponding author), Univ Exeter, Sch Med, European Ctr Environm & Human Hlth, Truro, England.	michiel.vos@pcmd.ac.uk; mark.vanpassel@wur.nl	Eyre-Walker, Adam/G-6216-2011; Huynen, Martijn A/A-1530-2014; Huijnen, M.A./H-8051-2014	Eyre-Walker, Adam/0000-0001-5527-8729; Huynen, Martijn A/0000-0001-6189-5491; 	Netherlands Organization for Scientific Research (NWO) via a VENI grant; BioAssist/BRS programme of the Netherlands Bioinformatics Centre; Netherlands Genomics Initiative; NWO; European Regional Development Fund; European Social Fund Convergence Programme for Cornwall; Isles of Scilly	Netherlands Organization for Scientific Research (NWO) via a VENI grant(Netherlands Organization for Scientific Research (NWO)); BioAssist/BRS programme of the Netherlands Bioinformatics Centre; Netherlands Genomics Initiative; NWO(Netherlands Organization for Scientific Research (NWO)); European Regional Development Fund(European Commission); European Social Fund Convergence Programme for Cornwall; Isles of Scilly	MWJvP is funded by the Netherlands Organization for Scientific Research (NWO) via a VENI grant. TtB and MAvD are funded by the BioAssist/BRS programme of the Netherlands Bioinformatics Centre, which is supported by the Netherlands Genomics Initiative. This work is part of the programme of BiG Grid, the Dutch e-Science Grid, which is financially supported by the NWO. MV is supported by investment from the European Regional Development Fund and the European Social Fund Convergence Programme for Cornwall and the Isles of Scilly to the European Centre for the Environment and Human Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Charlesworth J, 2006, MOL BIOL EVOL, V23, P1348, DOI 10.1093/molbev/msk025; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eyre-Walker A, 2006, TRENDS ECOL EVOL, V21, P569, DOI 10.1016/j.tree.2006.06.015; Eyre-Walker A, 2009, MOL BIOL EVOL, V26, P2097, DOI 10.1093/molbev/msp119; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Hughes AL, 2008, MOL BIOL EVOL, V25, P2199, DOI 10.1093/molbev/msn166; Joseph B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018441; Lefebure T, 2010, GENOME BIOL EVOL, V2, P646, DOI 10.1093/gbe/evq048; Lefebure T, 2009, GENOME RES, V19, P1224, DOI 10.1101/gr.089250.108; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Presgraves DC, 2005, CURR BIOL, V15, P1651, DOI 10.1016/j.cub.2005.07.065; Rand DM, 1996, MOL BIOL EVOL, V13, P735, DOI 10.1093/oxfordjournals.molbev.a025634; Shapiro BJ, 2009, ISME J, V3, P1180, DOI 10.1038/ismej.2009.51; Shapiro BJ, 2008, PLOS GENET, V4, DOI [10.1371/journal.pgen.0040023.eor, 10.1371/journal.pgen.0040023]; Soyer Y, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-264; Stoletzki N, 2011, MOL BIOL EVOL, V28, P63, DOI 10.1093/molbev/msq249; van Passel MWJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000059; Vos M, 2011, TRENDS MICROBIOL, V19, P1, DOI 10.1016/j.tim.2010.10.003; Xu ZF, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-203; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	22	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e62447	10.1371/journal.pone.0062447	http://dx.doi.org/10.1371/journal.pone.0062447			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671597	Green Published, Green Submitted, gold			2022-12-25	WOS:000321390200023
J	Bily, J; Grycova, L; Holendova, B; Jirku, M; Janouskova, H; Bousova, K; Teisinger, J				Bily, Jan; Grycova, Lenka; Holendova, Blanka; Jirku, Michaela; Janouskova, Hana; Bousova, Kristyna; Teisinger, Jan			Characterization of the S100A1 Protein Binding Site on TRPC6 C-Terminus	PLOS ONE			English	Article							3-DIMENSIONAL SOLUTION STRUCTURE; RYANODINE RECEPTOR; SKELETAL-MUSCLE; CALMODULIN; CHANNELS; ASSOCIATION; EXPRESSION; COMPLEX; FAMILY; TRPV6	The transient receptor potential (TRP) protein superfamily consists of seven major groups, among them the "canonical TRP'' family. The TRPC proteins are calcium-permeable nonselective cation channels activated after the emptying of intracellular calcium stores and appear to be gated by various types of messengers. The TRPC6 channel has been shown to be expressed in various tissues and cells, where it modulates the calcium level in response to external signals. Calcium binding proteins such as Calmodulin or the family of S100A proteins are regulators of TRPC channels. Here we characterized the overlapping integrative binding site for S100A1 at the C-tail of TRPC6, which is also able to accomodate various ligands such as Calmodulin and phosphatidyl-inositol-(4,5)-bisphosphate. Several positively charged amino acid residues (Arg852, Lys856, Lys859, Arg860 and Arg864) were determined by fluorescence anisotropy measurements for their participation in the calcium-dependent binding of S100A1 to the C terminus of TRPC6. The triple mutation Arg852/Lys859/Arg860 exhibited significant disruption of the binding of S100A1 to TRPC6. This indicates a unique involvement of these three basic residues in the integrative overlapping binding site for S100A1 on the C tail of TRPC6.	[Bily, Jan; Grycova, Lenka; Holendova, Blanka; Jirku, Michaela; Janouskova, Hana; Bousova, Kristyna; Teisinger, Jan] Acad Sci Czech Republic, Inst Physiol, Dept Prot Struct, Prague, Czech Republic	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences	Teisinger, J (corresponding author), Acad Sci Czech Republic, Inst Physiol, Dept Prot Struct, Prague, Czech Republic.	teisingr@biomed.cas.cz	Bousova, Kristyna/AAT-8543-2020; Teisinger, Jan/B-7122-2012; Grycova, Lenka/B-7118-2012; Holendova, Blanka/A-7170-2016; Vodičková, Michaela/O-8121-2017	Bousova, Kristyna/0000-0001-9030-3811; Grycova, Lenka/0000-0002-6476-3627; Holendova, Blanka/0000-0002-3904-8189; Vodičková, Michaela/0000-0002-0163-1432	Grant Agency of the Czech Republic [301/10/1159, P205/10/P308]; Institute of Physiology (RVO) [67985823]; Institute of Microbiology, Academy of Sciences of the Czech Republic (RVO) [61388971]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Institute of Physiology (RVO); Institute of Microbiology, Academy of Sciences of the Czech Republic (RVO)	This work was supported by grant 301/10/1159 of the Grant Agency of the Czech Republic, grant P205/10/P308 of the Grant Agency of the Czech Republic and from institutional project of the Institute of Physiology (RVO: 67985823) and institutional project of the Institute of Microbiology, Academy of Sciences of the Czech Republic (RVO: 61388971). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borthwick LA, 2008, CELL CALCIUM, V44, P147, DOI 10.1016/j.ceca.2007.11.001; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Friedlova E, 2010, NEUROCHEM INT, V56, P363, DOI 10.1016/j.neuint.2009.11.009; Grycova L, 2008, BIOCHEM BIOPH RES CO, V375, P680, DOI 10.1016/j.bbrc.2008.08.094; Holakovska B, 2012, J BIOL CHEM, V287, P16645, DOI 10.1074/jbc.M112.350686; Holakovska B, 2011, AMINO ACIDS, V40, P741, DOI 10.1007/s00726-010-0712-2; JOHNSON JD, 1978, J BIOL CHEM, V253, P6451; KINCAID RL, 1982, J BIOL CHEM, V257, P638; Kwon Y, 2007, MOL CELL, V25, P491, DOI 10.1016/j.molcel.2007.01.021; Minke B, 2006, CELL CALCIUM, V40, P261, DOI 10.1016/j.ceca.2006.05.002; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Pedersen SF, 2005, CELL CALCIUM, V38, P233, DOI 10.1016/j.ceca.2005.06.028; Prochazkova K, 2005, J BIOL CHEM, V280, P3251, DOI 10.1074/jbc.M411232200; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Rustandi RR, 2002, BIOCHEMISTRY-US, V41, P788, DOI 10.1021/bi0118308; Santamaria-Kisiel L, 2006, BIOCHEM J, V396, P201, DOI 10.1042/BJ20060195; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Treves S, 1997, BIOCHEMISTRY-US, V36, P11496, DOI 10.1021/bi970160w; Van de Graaf SFJ, 2003, EMBO J, V22, P1478, DOI 10.1093/emboj/cdg162; Wright NT, 2008, J BIOL CHEM, V283, P26676, DOI 10.1074/jbc.M804432200; Wright Nathan T, 2009, Curr Chem Biol, V3, P138; Wright NT, 2005, J MOL BIOL, V353, P410, DOI 10.1016/j.jmb.2005.08.027; Zhu MX, 2005, PFLUG ARCH EUR J PHY, V451, P105, DOI 10.1007/s00424-005-1427-1; Zimmer DB, 2005, CELL MOL BIOL, V51, P201, DOI 10.1170/T620; ZIMMER DB, 1995, J NEUROCHEM, V64, P2727	25	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62677	10.1371/journal.pone.0062677	http://dx.doi.org/10.1371/journal.pone.0062677			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23671622	Green Submitted, gold, Green Published			2022-12-25	WOS:000321202100031
J	Sommer, LAM; Schaad, M; Dames, SA				Sommer, Lisa A. M.; Schaad, Martin; Dames, Sonja A.			NMR- and Circular Dichroism-monitored Lipid Binding Studies Suggest a General Role for the FATC Domain as Membrane Anchor of Phosphatidylinositol 3-Kinase-related Kinases (PIKK)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; STRAND BREAK REPAIR; DNA-PKCS; PHOSPHATIDIC-ACID; OXIDATIVE STRESS; PLASMA-MEMBRANE; HISTONE ACETYLTRANSFERASE; 3-DIMENSIONAL STRUCTURE; SIGNAL-TRANSDUCTION; MAMMALIAN TARGET	The FATC domain is shared by all members of the family of phosphatidylinositol-3 kinase-related kinases (PIKKs). It has been shown that the FATC domain plays an important role for the regulation of each PIKK. However, other than an involvement in protein-protein interactions, a common principle for the action of the FATC domain has not been detected. A detailed characterization of the structure and lipid binding properties of the FATC domain of the Ser/Thr kinase target of rapamycin (TOR) revealed that it contains a redox-sensitive membrane anchor in its C terminus. Because the C-terminal regions of the FATC domains of all known PIKKs are rather hydrophobic and especially rich in aromatic residues, we examined whether the ability to interact with lipids and membranes might be a general property. Here, we present the characterization of the interactions with lipids and different membrane mimetics for the FATC domains of human DNA-PKcs, human ATM, human ATR, human SMG-1, and human TRRAP by NMR and CD spectroscopy. The data indicate that all of these can interact with different membrane mimetics and may have different preferences only for membrane properties such as surface charge, curvature, and lipid packing. The oxidized form of the TOR FATC domain is well structured overall and forms an alpha-helix that is followed by a disulfide-bonded loop. In contrast, the FATC domains of the other PIKKs are rather unstructured in the isolated form and only significantly populate alpha-helical secondary structure upon interaction with membrane mimetics.	[Sommer, Lisa A. M.; Schaad, Martin; Dames, Sonja A.] Tech Univ Munich, Dept Chem, Chair Biomol NMR Spect, D-85747 Garching, Germany	Technical University of Munich	Dames, SA (corresponding author), Tech Univ Munich, Dept Chem, Chair Biomol NMR Spect, Lichtenbergstr 4, D-85747 Garching, Germany.	sonja.dames@tum.de		Dames, Sonja/0000-0001-7495-6943	German Research Foundation [DA 1195/3-1]	German Research Foundation(German Research Foundation (DFG))	This work was supported by Grant DA 1195/3-1 from the German Research Foundation (to S. A. D.).	Adami A, 2007, MOL CELL, V27, P509, DOI 10.1016/j.molcel.2007.05.040; Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379; Berchtold D, 2009, MOL BIOL CELL, V20, P1565, DOI 10.1091/mbc.E08-10-1001; Bosotti R, 2000, TRENDS BIOCHEM SCI, V25, P225, DOI 10.1016/S0968-0004(00)01563-2; Buerger C, 2006, BIOCHEM BIOPH RES CO, V344, P869, DOI 10.1016/j.bbrc.2006.03.220; Camargo DCR, 2012, BIOCHEMISTRY-US, V51, P4909, DOI 10.1021/bi3002133; Chen BPC, 2012, CANCER LETT, V327, P103, DOI 10.1016/j.canlet.2011.12.004; Chen RQ, 2009, J BIOL CHEM, V284, P16752, DOI 10.1074/jbc.M109.014316; Dames SA, 2005, J BIOL CHEM, V280, P20558, DOI 10.1074/jbc.M501116200; Dames SA, 2011, J BIOL CHEM, V286, P36907, DOI 10.1074/jbc.M111.225052; Dames SA, 2010, J BIOL CHEM, V285, P7766, DOI 10.1074/jbc.M109.058404; Dazert E, 2011, CURR OPIN CELL BIOL, V23, P744, DOI 10.1016/j.ceb.2011.09.003; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ditch S, 2012, TRENDS BIOCHEM SCI, V37, P15, DOI 10.1016/j.tibs.2011.10.002; Drenan RM, 2004, J BIOL CHEM, V279, P772, DOI 10.1074/jbc.M305912200; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Farrow NA, 1997, BIOCHEMISTRY-US, V36, P2390, DOI 10.1021/bi962548h; Flynn RL, 2011, TRENDS BIOCHEM SCI, V36, P133, DOI 10.1016/j.tibs.2010.09.005; Foster DA, 2009, BBA-MOL CELL BIOL L, V1791, P949, DOI 10.1016/j.bbalip.2009.02.009; Gonzalez-Estevez C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002619; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Grdzka I., 2013, BIOCHIM BIOPHYS ACTA, V1830, P2233; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Herceg Z, 2005, CELL CYCLE, V4, P383, DOI 10.4161/cc.4.3.1546; Hoke SMT, 2010, CURR GENET, V56, P447, DOI 10.1007/s00294-010-0313-3; Huth JR, 1997, PROTEIN SCI, V6, P2359; Jiang XF, 2006, J BIOL CHEM, V281, P15741, DOI 10.1074/jbc.M513172200; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Ju JH, 2010, J BIOL CHEM, V285, P41152, DOI 10.1074/jbc.M110.158352; KEITH CT, 1995, SCIENCE, V270, P50, DOI 10.1126/science.270.5233.50; Knutson BA, 2010, J STRUCT BIOL, V170, P354, DOI 10.1016/j.jsb.2010.01.002; Koenig BW, 2003, J BIOMOL NMR, V26, P193, DOI 10.1023/A:1023887412387; Kong XM, 2011, CELL SIGNAL, V23, P1273, DOI 10.1016/j.cellsig.2011.04.005; Kruger A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001959; Kunz J, 2000, J BIOL CHEM, V275, P37011, DOI 10.1074/jbc.M007296200; Kutateladze TG, 2004, J BIOL CHEM, V279, P3050, DOI 10.1074/jbc.M309007200; Lange OF, 2008, SCIENCE, V320, P1471, DOI 10.1126/science.1157092; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lazaridis T, 2005, J PHYS CHEM B, V109, P15098, DOI 10.1021/jp0516801; Lempiainen H, 2009, EMBO J, V28, P3067, DOI 10.1038/emboj.2009.281; Liu W, 2006, BIOCHEMISTRY-US, V45, P11713, DOI 10.1021/bi0608414; Lovejoy CA, 2009, DNA REPAIR, V8, P1004, DOI 10.1016/j.dnarep.2009.04.006; Lucero H, 2003, J BIOL CHEM, V278, P22136, DOI 10.1074/jbc.M301579200; Masse I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003354; Mordes DA, 2008, GENE DEV, V22, P1478, DOI 10.1101/gad.1666208; Morita T, 2007, J BIOL CHEM, V282, P7799, DOI 10.1074/jbc.M610159200; Myers GA, 2012, J AM CHEM SOC, V134, P19652, DOI 10.1021/ja306074k; Nakada D, 2005, MOL BIOL CELL, V16, P5227, DOI 10.1091/mbc.E05-05-0405; Oliveira V, 2008, J BIOL CHEM, V283, P13174, DOI 10.1074/jbc.M708008200; Pan Y, 2012, GERONTOLOGY, V58, P524, DOI 10.1159/000342204; Perry J, 2003, CELL, V112, P151, DOI 10.1016/S0092-8674(03)00033-3; Rivera-Calzada A, 2005, STRUCTURE, V13, P243, DOI 10.1016/j.str.2004.12.006; Robert F, 2006, MOL CELL BIOL, V26, P402, DOI 10.1128/MCB.26.2.402-412.2006; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Schanda P, 2005, J BIOMOL NMR, V33, P199, DOI 10.1007/s10858-005-4425-x; Seewald MJ, 2000, PROTEIN SCI, V9, P1177, DOI 10.1110/ps.9.6.1177; Sommer LAM, 2012, PROTEIN SCI, V21, P1566, DOI 10.1002/pro.2127; Spagnolo L, 2006, MOL CELL, V22, P511, DOI 10.1016/j.molcel.2006.04.013; STAFFORD RE, 1989, BIOCHEMISTRY-US, V28, P5113, DOI 10.1021/bi00438a031; Sun H, 2008, J BIOL CHEM, V283, P22233, DOI 10.1074/jbc.M802074200; Sun YL, 2007, MOL CELL BIOL, V27, P8502, DOI 10.1128/MCB.01382-07; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Takahashi T, 2000, GENES CELLS, V5, P765, DOI 10.1046/j.1365-2443.2000.00365.x; Tausk R. J., 1974, BIOPHYS CHEM, V1, P184, DOI DOI 10.1016/0301-4622(74)80005-0; TAUSK RJM, 1974, BIOPHYS CHEM, V2, P175, DOI 10.1016/0301-4622(74)80004-9; Tieleman DP, 2000, J PHYS CHEM B, V104, P6380, DOI 10.1021/jp001268f; Toulany M, 2012, MOL CANCER RES, V10, P945, DOI 10.1158/1541-7786.MCR-11-0592; Unno A, 2005, BIOCHEM BIOPH RES CO, V327, P933, DOI 10.1016/j.bbrc.2004.12.095; Veverka V, 2008, ONCOGENE, V27, P585, DOI 10.1038/sj.onc.1210693; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; Walsh JD, 2010, BIOPHYS J, V99, P2636, DOI 10.1016/j.bpj.2010.08.036; Watters D, 1997, ONCOGENE, V14, P1911, DOI 10.1038/sj.onc.1201037; Weschayanwiwat P, 2005, J SURFACTANTS DETERG, V8, P65, DOI 10.1007/s11743-005-0332-8; Whiles JA, 2002, BIOORG CHEM, V30, P431, DOI 10.1016/S0045-2068(02)00527-8; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yan J, 2000, INT J RADIAT BIOL, V76, P1025, DOI 10.1080/09553000050111497; Zhang LQ, 2006, CELL SIGNAL, V18, P1386, DOI 10.1016/j.cellsig.2005.10.017; Zhang XW, 2002, J BIOL CHEM, V277, P28127, DOI 10.1074/jbc.M202625200; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014	83	17	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					20046	20063		10.1074/jbc.M113.467233	http://dx.doi.org/10.1074/jbc.M113.467233			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23671275	Green Published, hybrid			2022-12-25	WOS:000321515800067
J	Tzarum, N; Komornik, N; Ben Chetrit, D; Engelberg, D; Livnah, O				Tzarum, Netanel; Komornik, Nadav; Ben Chetrit, Dorin; Engelberg, David; Livnah, Oded			DEF Pocket in p38 alpha Facilitates Substrate Selectivity and Mediates Autophosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE MUTANTS; DOCKING SITES; MAP KINASES; PROTEIN-KINASES; C-JUN; ACTIVATION; P38-ALPHA; ERK2; PHOSPHORYLATION; MOTIF	Signaling processes are primarily promoted by molecular recognition and corresponding protein-protein interactions. One of the key eukaryotic signaling pathways is the MAP kinase cascade involved in vital cellular processes such as cell proliferation, differentiation, apoptosis, and stress response. The principle recognition site of MAP kinases, the common docking (CD) region, forms selective interactions with substrates, upstream activators, and phosphatases. A second docking site, defined as the DEF site interaction pocket (DEF pocket), is formed subsequent to ERK2 and p38 alpha activation. Both crystal structures of p38 alpha in its dually phosphorylated form and of intrinsically active mutants showed the DEF pocket, giving motivation for studying its role in substrate activation and selectivity. Mutating selected DEF pocket residues significantly decreased the phosphorylation levels of three p38 alpha substrates (ATFII, Elk-1, and MBP) with no apparent effect on the phosphorylation of MK2 kinase. Conversely, mutating the CD region gave the opposite effect, suggesting p38 alpha substrates can be classified into DEF-dependent and DEF-independent substrates. In addition, mutating DEF pocket residues decreased the autophosphorylation capability of intrinsically active p38 alpha mutants, suggesting DEF-mediated trans-autophosphorylation in p38 alpha. These results could contribute to understanding substrate selectivity of p38 alpha and serve as a platform for designing p38 alpha-selective DEF site blockers, which partially inhibit p38 alpha binding DEF-dependent substrates, whereas maintaining its other functions intact. In this context, preliminary results using synthetic peptides reveal significant inhibition of substrate phosphorylation by activated p38 alpha.	[Tzarum, Netanel; Komornik, Nadav; Ben Chetrit, Dorin; Engelberg, David; Livnah, Oded] Hebrew Univ Jerusalem, Dept Biol Chem, Alexander Silverman Inst Life Sci, IL-91904 Jerusalem, Israel; [Tzarum, Netanel; Komornik, Nadav; Ben Chetrit, Dorin; Livnah, Oded] Hebrew Univ Jerusalem, Wolfson Ctr Appl Struct Biol, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Livnah, O (corresponding author), Hebrew Univ Jerusalem, Edmond J Safra Campus, IL-91904 Jerusalem, Israel.	oded.livnah@huji.ac.il		Tzarum, Netanel/0000-0001-6401-1356	ISF Research Center of Excellence [180/09]	ISF Research Center of Excellence	This work was supported by ISF Research Center of Excellence 180/09 awarded (to O. L. and D. E.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Askari N, 2007, J BIOL CHEM, V282, P91, DOI 10.1074/jbc.M608012200; Avitzour M, 2007, FEBS J, V274, P963, DOI 10.1111/j.1742-4658.2007.05644.x; Bardwell AJ, 2001, J BIOL CHEM, V276, P10374, DOI 10.1074/jbc.M010271200; Bardwell L, 1996, TRENDS BIOCHEM SCI, V21, P373, DOI 10.1016/S0968-0004(96)30032-7; Bell M, 2001, J BIOL CHEM, V276, P25351, DOI 10.1074/jbc.M101818200; BENLEVY R, 1995, EMBO J, V14, P5920, DOI 10.1002/j.1460-2075.1995.tb00280.x; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; BOTT CM, 1994, FEBS LETT, V352, P201, DOI 10.1016/0014-5793(94)00958-9; Callaway KA, 2006, BIOCHEMISTRY-US, V45, P13719, DOI 10.1021/bi0610451; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; Carlson SM, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002010; Chang CI, 2002, MOL CELL, V9, P1241, DOI 10.1016/S1097-2765(02)00525-7; Chu YF, 1996, J BIOL CHEM, V271, P6497, DOI 10.1074/jbc.271.11.6497; Dimitri CA, 2005, CURR BIOL, V15, P1319, DOI 10.1016/j.cub.2005.06.037; Diskin R, 2004, J BIOL CHEM, V279, P47040, DOI 10.1074/jbc.M404595200; Diskin R, 2007, J MOL BIOL, V365, P66, DOI 10.1016/j.jmb.2006.08.043; Enslen H, 2000, EMBO J, V19, P1301, DOI 10.1093/emboj/19.6.1301; Galanis A, 2001, J BIOL CHEM, V276, P965, DOI 10.1074/jbc.M007697200; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; Gills JJ, 2007, J BIOL CHEM, V282, P27020, DOI 10.1074/jbc.M701108200; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; KALLUNKI T, 1994, GENE DEV, V8, P2996, DOI 10.1101/gad.8.24.2996; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Lee T, 2004, MOL CELL, V14, P43, DOI 10.1016/S1097-2765(04)00161-3; Levin-Salomon V, 2008, J BIOL CHEM, V283, P34500, DOI 10.1074/jbc.M806443200; Mittelstadt PR, 2009, J BIOL CHEM, V284, P15469, DOI 10.1074/jbc.M901004200; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Murphy LO, 2004, MOL CELL BIOL, V24, P144, DOI 10.1128/MCB.24.1.144-153.2004; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rainey MA, 2005, J AM CHEM SOC, V127, P10494, DOI 10.1021/ja052915p; Salvador JM, 2005, NAT IMMUNOL, V6, P390, DOI 10.1038/ni1177; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Sheridan DL, 2008, J BIOL CHEM, V283, P19511, DOI 10.1074/jbc.M801074200; Shin S, 2010, MOL CELL, V38, P114, DOI 10.1016/j.molcel.2010.02.020; SMITH JA, 1993, MOL CELL BIOCHEM, V128, P51, DOI 10.1007/BF01076757; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Tzarum N, 2012, J MOL BIOL, V424, P339, DOI 10.1016/j.jmb.2012.10.007; Tzarum N, 2011, J MOL BIOL, V405, P1154, DOI 10.1016/j.jmb.2010.11.023; Vinciguerra M, 2004, J BIOL CHEM, V279, P9634, DOI 10.1074/jbc.M308721200; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zhang YY, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.203786	44	19	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19537	19547		10.1074/jbc.M113.464511	http://dx.doi.org/10.1074/jbc.M113.464511			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23671282	hybrid, Green Published			2022-12-25	WOS:000321515800020
J	Simon, P; Baumner, S; Busch, O; Rohrich, R; Kaese, M; Richterich, P; Wehrend, A; Muller, K; Gerardy-Schahn, R; Muhlenhoff, M; Geyer, H; Geyer, R; Middendorff, R; Galuska, SP				Simon, Peter; Baeumner, Soeren; Busch, Oliver; Roehrich, Rene; Kaese, Miriam; Richterich, Peter; Wehrend, Axel; Mueller, Karin; Gerardy-Schahn, Rita; Muehlenhoff, Martina; Geyer, Hildegard; Geyer, Rudolf; Middendorff, Ralf; Galuska, Sebastian P.			Polysialic Acid Is Present in Mammalian Semen as a Post-translational Modification of the Neural Cell Adhesion Molecule NCAM and the Polysialyltransferase ST8SiaII	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTROPHIL EXTRACELLULAR TRAPS; ULTRASENSITIVE CHEMICAL METHOD; FERTILITY-ASSOCIATED ANTIGEN; HUMAN DENDRITIC CELLS; HUMAN UTERINE CERVIX; IN-VIVO; N-CAM; LEUKOCYTIC REACTION; MOUSE-BRAIN; POLYSIALYLATION	Fertilization in animals is a complex sequence of several biochemical events beginning with the insemination into the female reproductive tract and, finally, leading to embryogenesis. Studies by Kitajima and co-workers (Miyata, S., Sato, C., and Kitajima, K. (2007) Trends Glycosci. Glyc, 19, 85-98) demonstrated the presence of polysialic acid (polySia) on sea urchin sperm. Based on these results, we became interested in the potential involvement of sialic acid polymers in mammalian fertilization. Therefore, we isolated human sperm and performed analyses, including Western blotting and mild 1,2-diamino-4,5-methylenedioxybenzene-HPLC, that revealed the presence alpha 2,8-linked polySia chains. Further analysis by a glyco-proteomics approach led to the identification of two polySia carriers. Interestingly, besides the neural cell adhesion molecule, the polysialyltransferase ST8SiaII has also been found to be a target for polysialylation. Further analysis of testis and epididymis tissue sections demonstrated that only epithelial cells of the caput were polySia-positive. During the epididymal transit, polySia carriers were partially integrated into the sperm membrane of the postacrosomal region. Because polySia is known to counteract histone as well as neutrophil extracellular trap-mediated cytotoxicity against host cells, which plays a role after insemination, we propose that polySia in semen represents a cytoprotective element to increase the number of vital sperm.	[Simon, Peter; Baeumner, Soeren; Busch, Oliver; Roehrich, Rene; Kaese, Miriam; Geyer, Hildegard; Geyer, Rudolf; Galuska, Sebastian P.] Univ Giessen, Fac Med, Inst Biochem, D-35392 Giessen, Germany; [Richterich, Peter; Wehrend, Axel] Univ Giessen, Clin Obstet Gynecol & Androl Small & Large Anim, D-35392 Giessen, Germany; [Mueller, Karin] Leibniz Inst Zoo & Wildlife Res, D-10315 Berlin, Germany; [Gerardy-Schahn, Rita; Muehlenhoff, Martina] Hannover Med Sch, Inst Cellular Chem, D-30625 Hannover, Germany; [Middendorff, Ralf] Univ Giessen, Fac Med, Inst Anat & Cell Biol, D-35385 Giessen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; Leibniz Institut fur Zoo und Wildtierforschung; Hannover Medical School; Justus Liebig University Giessen	Galuska, SP (corresponding author), Univ Giessen, Fac Med, Inst Biochem, D-35392 Giessen, Germany.	sebastian.galuska@biochemie.med.uni-giessen.de			Deutsche Forschungsgemeinschaft [GA 1755/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant GA 1755/1-1 (to S. P. G.).	Aitken RJ, 2007, ASIAN J ANDROL, V9, P554, DOI 10.1111/j.1745-7262.2007.00280.x; Alghamdi AS, 2005, BIOL REPROD, V73, P1174, DOI 10.1095/biolreprod.105.045666; Angata K, 1998, J BIOL CHEM, V273, P28524, DOI 10.1074/jbc.273.43.28524; Bax M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006987; Bellin ME, 1998, J ANIM SCI, V76, P2032; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2007, NAT REV MICROBIOL, V5, P577, DOI 10.1038/nrmicro1710; Bruses JL, 2001, BIOCHIMIE, V83, P635, DOI 10.1016/S0300-9084(01)01293-7; Close BE, 2001, GLYCOBIOLOGY, V11, P997, DOI 10.1093/glycob/11.11.997; Close BE, 2003, J BIOL CHEM, V278, P30796, DOI 10.1074/jbc.M305390200; Close BE, 2000, J BIOL CHEM, V275, P4484, DOI 10.1074/jbc.275.6.4484; Close BE, 1998, J BIOL CHEM, V273, P34586, DOI 10.1074/jbc.273.51.34586; Curreli S, 2007, J BIOL CHEM, V282, P30346, DOI 10.1074/jbc.M702965200; Drake PM, 2008, J IMMUNOL, V181, P6850, DOI 10.4049/jimmunol.181.10.6850; Drake PM, 2009, P NATL ACAD SCI USA, V106, P11995, DOI 10.1073/pnas.0905188106; Drobnis E Z, 1992, Oxf Rev Reprod Biol, V14, P1; FINNE J, 1982, J BIOL CHEM, V257, P1966; FROSCH M, 1985, P NATL ACAD SCI USA, V82, P1194, DOI 10.1073/pnas.82.4.1194; Fujimoto I, 2001, J BIOL CHEM, V276, P31745, DOI 10.1074/jbc.M104525200; Galuska SP, 2008, J BIOL CHEM, V283, P17, DOI 10.1074/jbc.M707024200; Galuska SP, 2006, J BIOL CHEM, V281, P31605, DOI 10.1074/jbc.M606516200; Galuska SP, 2012, J PROTEOMICS, V75, P5266, DOI 10.1016/j.jprot.2012.06.011; Galuska SP, 2010, P NATL ACAD SCI USA, V107, P10250, DOI 10.1073/pnas.0912103107; Gatti JL, 2004, ANIM REPROD SCI, V82-3, P321, DOI 10.1016/j.anireprosci.2004.05.011; GERARDYSCHAHN R, 1994, INT J CANCER, P27; Haselhorst T, 2006, CHEMBIOCHEM, V7, P1875, DOI 10.1002/cbic.200600252; Inoue S, 2000, J BIOL CHEM, V275, P29968, DOI 10.1074/jbc.M004150200; Inoue S, 2001, BIOCHIMIE, V83, P605, DOI 10.1016/S0300-9084(01)01307-4; Inoue S, 2001, J BIOL CHEM, V276, P31863, DOI 10.1074/jbc.M103336200; Inoue S, 2001, GLYCOBIOLOGY, V11, P759, DOI 10.1093/glycob/11.9.759; LACKIE PM, 1994, DIFFERENTIATION, V57, P119, DOI 10.1046/j.1432-0436.1994.5720119.x; LACKIE PM, 1990, DEVELOPMENT, V110, P933; Liedtke S, 2001, GLYCOBIOLOGY, V11, P373, DOI 10.1093/glycob/11.5.373; Marengo SR, 2008, ANIM REPROD SCI, V105, P52, DOI 10.1016/j.anireprosci.2007.11.018; McCauley TC, 1999, MOL REPROD DEV, V54, P145, DOI 10.1002/(SICI)1098-2795(199910)54:2&lt;145::AID-MRD6&gt;3.0.CO;2-6; Miyata S, 2007, TRENDS GLYCOSCI GLYC, V19, P85, DOI 10.4052/tigg.19.85; Miyata S, 2006, GLYCOBIOLOGY, V16, P1229, DOI 10.1093/glycob/cwl036; MOOLENAAR CECK, 1990, CANCER RES, V50, P1102; Muhlenhoff M, 2001, J BIOL CHEM, V276, P34066, DOI 10.1074/jbc.M101022200; Muhlenhoff M, 1996, EMBO J, V15, P6943, DOI 10.1002/j.1460-2075.1996.tb01086.x; Nakata D, 2005, J BIOL CHEM, V280, P38305, DOI 10.1074/jbc.M508762200; NELSON RW, 1995, J BIOL CHEM, V270, P17171, DOI 10.1074/jbc.270.29.17171; PANDYA IJ, 1985, FERTIL STERIL, V43, P417; Pang PC, 2007, J BIOL CHEM, V282, P36593, DOI 10.1074/jbc.M705134200; Rey-Gallardo A, 2011, GLYCOBIOLOGY, V21, P655, DOI 10.1093/glycob/cwq216; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; Rolland M, 2013, HUM REPROD, V28, P462, DOI 10.1093/humrep/des415; Rutishauser U, 1996, CURR OPIN CELL BIOL, V8, P679, DOI 10.1016/S0955-0674(96)80109-8; Rutishauser U., 1992, DEVELOPMENT S, V116, P99; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Saez F, 2003, J ANDROL, V24, P149; Saffarzadeh M, 2013, CURR OPIN HEMATOL, V20, P3, DOI 10.1097/MOH.0b013e32835a0025; Saffarzadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032366; Sato C, 1998, ANAL BIOCHEM, V261, P191, DOI 10.1006/abio.1998.2718; Stummeyer K, 2005, NAT STRUCT MOL BIOL, V12, P90, DOI 10.1038/nsmb874; Sullivan R, 2007, ASIAN J ANDROL, V9, P483, DOI 10.1111/j.1745-7262.2007.00281.x; Swan SH, 2000, ENVIRON HEALTH PERSP, V108, P961, DOI 10.2307/3435055; TANG J, 1992, NEURON, V8, P1031, DOI 10.1016/0896-6273(92)90125-W; Thimon V, 2008, HUM REPROD, V23, P1698, DOI 10.1093/humrep/den181; THOMPSON LA, 1992, AM J REPROD IMMUNOL, V28, P85, DOI 10.1111/j.1600-0897.1992.tb00765.x; TROY FA, 1992, GLYCOBIOLOGY, V2, P5, DOI 10.1093/glycob/2.1.5; Ulm C., 2013, CELL MOL LI IN PRESS; von der Ohe M, 2002, GLYCOBIOLOGY, V12, P47, DOI 10.1093/glycob/12.1.47; Wang Y, 2010, J NEUROSCI, V30, P3482, DOI 10.1523/JNEUROSCI.3940-09.2010; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; Yabe U, 2003, J BIOL CHEM, V278, P13875, DOI 10.1074/jbc.M300458200; ZUBER C, 1992, J BIOL CHEM, V267, P9965	67	43	45	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18825	18833		10.1074/jbc.M113.451112	http://dx.doi.org/10.1074/jbc.M113.451112			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23671285	Green Published, hybrid			2022-12-25	WOS:000321335800020
J	Hong, F; Liu, B; Chiosis, G; Gewirth, DT; Li, ZH				Hong, Feng; Liu, Bei; Chiosis, Gabriela; Gewirth, Daniel T.; Li, Zihai			alpha 7 Helix Region of alpha I Domain Is Crucial for Integrin Binding to Endoplasmic Reticulum Chaperone gp96 A POTENTIAL THERAPEUTIC TARGET FOR CANCER METASTASIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; SHOCK-PROTEIN GP96; CLINICAL-SIGNIFICANCE; MONOCLONAL-ANTIBODY; MALIGNANT-MELANOMA; MASTER CHAPERONE; CELL-LINES; EXPRESSION; TUMOR; ADHESION	Integrins play important roles in regulating a diverse array of cellular functions crucial to the initiation, progression, and metastasis of tumors. Previous studies have shown that a majority of integrins are folded by the endoplasmic reticulum chaperone gp96. Here, we demonstrate that the dimerization of integrin alpha L and beta 2 is highly dependent on gp96. The alpha I domain (AID), a ligand binding domain shared by seven integrin alpha-subunits, is a critical region for integrin binding to gp96. Deletion of AID significantly reduced the interaction between integrin alpha L and gp96. Overexpression of AID intracellularly decreased surface expression of gp96 clients (integrins and Toll-like receptors) and cancer cell invasion. The alpha 7 helix region is crucial for AID binding to gp96. A cell-permeable alpha 7 helix peptide competitively inhibited the interaction between gp96 and integrins and blocked cell invasion. Thus, targeting the binding site of alpha 7 helix of AID on gp96 is potentially a new strategy for treatment of cancer metastasis.	[Hong, Feng; Liu, Bei; Li, Zihai] Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA; [Chiosis, Gabriela] Hauptman Woodward Med Res Inst, Buffalo, NY 14203 USA; [Gewirth, Daniel T.] Mem Sloan Kettering Canc Ctr, Dept Mol Pharmacol & Chem, New York, NY 10065 USA	Medical University of South Carolina; Hauptman Woodward Medical Research Institute; Memorial Sloan Kettering Cancer Center	Li, ZH (corresponding author), Med Univ S Carolina, Dept Microbiol & Immunol, 86 Jonathan Lucas St, Charleston, SC 29425 USA.	zihai@musc.edu			National Institutes of Health [AI070603, AI077283]; Flow Cytometry Shared Resource, Hollings Cancer Center, Medical University of South Carolina [P30 CA138313]; SmartState Endowed Chair Program of South Carolina; NATIONAL CANCER INSTITUTE [R01CA172546, R01CA095130, R21CA158609, P30CA008748, P30CA138313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070603, U01AI125859, R01AI077283] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flow Cytometry Shared Resource, Hollings Cancer Center, Medical University of South Carolina; SmartState Endowed Chair Program of South Carolina; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants AI070603 and AI077283 (to Z. L.) and by the Flow Cytometry Shared Resource, Hollings Cancer Center, Medical University of South Carolina Grant P30 CA138313.; Abney Chair Remembering Sally Abney Rose in Stem Cell Biology & Therapy and supported by the SmartState Endowed Chair Program of South Carolina.	ALBELDA SM, 1990, CANCER RES, V50, P6757; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Bolli N, 2009, LEUKEMIA, V23, P501, DOI 10.1038/leu.2008.326; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Burkhart DJ, 2004, MOL CANCER THER, V3, P1593; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Dingemans AMC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-152; Eletto D, 2010, SEMIN CELL DEV BIOL, V21, P479, DOI 10.1016/j.semcdb.2010.03.004; Fujisaki T, 1999, CANCER RES, V59, P4427; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Gutheil JC, 2000, CLIN CANCER RES, V6, P3056; He HZ, 2006, J MED CHEM, V49, P381, DOI 10.1021/jm0508078; Heike M, 2000, INT J CANCER, V86, P489, DOI 10.1002/(SICI)1097-0215(20000515)86:4<489::AID-IJC7>3.3.CO;2-4; Hodorova I, 2008, NEOPLASMA, V55, P31; Li XM, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-8; Lin CY, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-136; Liu B, 2008, BLOOD, V112, P1223, DOI 10.1182/blood-2008-03-143107; Liu B, 2013, P NATL ACAD SCI USA, V110, P6877, DOI 10.1073/pnas.1302933110; Liu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039442; Liu B, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1070; Makrilia N, 2009, CANCER INVEST, V27, P1023, DOI 10.3109/07357900902769749; Matos DM, 2006, BRAZ J MED BIOL RES, V39, P1349, DOI 10.1590/S0100-879X2006001000011; McNeel DG, 2005, CLIN CANCER RES, V11, P7851, DOI 10.1158/1078-0432.CCR-05-0262; Missotten GS, 2003, INVEST OPHTH VIS SCI, V44, P3059, DOI 10.1167/iovs.02-1038; Morales C, 2009, J IMMUNOL, V183, P5121, DOI 10.4049/jimmunol.0900811; Natali PG, 1997, CANCER RES, V57, P1554; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Pontier SM, 2009, J CELL SCI, V122, P207, DOI 10.1242/jcs.040394; Raguse JD, 2004, ORAL ONCOL, V40, P228, DOI 10.1016/j.oraloncology.2003.08.003; Shen CY, 2002, LUNG CANCER, V38, P235, DOI 10.1016/S0169-5002(02)00300-8; Staron M, 2011, BLOOD, V117, P7136, DOI 10.1182/blood-2011-01-330464; Staron M, 2010, BLOOD, V115, P2380, DOI 10.1182/blood-2009-07-233031; Taldone T, 2009, CURR TOP MED CHEM, V9, P1436, DOI 10.2174/156802609789895737; Usmani SZ, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-40; Vincent AM, 1996, BLOOD, V87, P4780, DOI 10.1182/blood.V87.11.4780.bloodjournal87114780; Weaver VM, 2002, CANCER CELL, V2, P205, DOI 10.1016/S1535-6108(02)00125-3; Wu MFF, 2007, PROTEOMICS, V7, P1973, DOI 10.1002/pmic.200600643; Wu S, 2012, J BIOL CHEM, V287, P6735, DOI 10.1074/jbc.M111.309526; Yang Y, 2005, MOL CELLS, V20, P173; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; Zhao M, 2004, MED RES REV, V24, P1, DOI 10.1002/med.10056; Zheng HC, 2008, HUM PATHOL, V39, P1042, DOI 10.1016/j.humpath.2007.11.009	42	23	25	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18243	18248		10.1074/jbc.M113.468850	http://dx.doi.org/10.1074/jbc.M113.468850			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23671277	Green Published, hybrid			2022-12-25	WOS:000320721900028
J	Heffernan, JB; Watts, DL; Cohen, MJ				Heffernan, James B.; Watts, Danielle L.; Cohen, Matthew J.			Discharge Competence and Pattern Formation in Peatlands: A Meta-Ecosystem Model of the Everglades Ridge-Slough Landscape	PLOS ONE			English	Article							EARLY WARNING SIGNAL; REGIME SHIFTS; WATER-FLOW; ECOHYDROLOGICAL FEEDBACKS; SPATIAL HETEROGENEITY; SEDIMENT TRANSPORT; POSITIVE FEEDBACKS; SLOWING-DOWN; VEGETATION; DYNAMICS	Regular landscape patterning arises from spatially-dependent feedbacks, and can undergo catastrophic loss in response to changing landscape drivers. The central Everglades (Florida, USA) historically exhibited regular, linear, flow-parallel orientation of high-elevation sawgrass ridges and low-elevation sloughs that has degraded due to hydrologic modification. In this study, we use a meta-ecosystem approach to model a mechanism for the establishment, persistence, and loss of this landscape. The discharge competence (or self-organizing canal) hypothesis assumes non-linear relationships between peat accretion and water depth, and describes flow-dependent feedbacks of microtopography on water depth. Closed-form model solutions demonstrate that 1) this mechanism can produce spontaneous divergence of local elevation; 2) divergent and homogenous states can exhibit global bi-stability; and 3) feedbacks that produce divergence act anisotropically. Thus, discharge competence and non-linear peat accretion dynamics may explain the establishment, persistence, and loss of landscape pattern, even in the absence of other spatial feedbacks. Our model provides specific, testable predictions that may allow discrimination between the self-organizing canal hypotheses and competing explanations. The potential for global bi-stability suggested by our model suggests that hydrologic restoration may not re-initiate spontaneous pattern establishment, particularly where distinct soil elevation modes have been lost. As a result, we recommend that management efforts should prioritize maintenance of historic hydroperiods in areas of conserved pattern over restoration of hydrologic regimes in degraded regions. This study illustrates the value of simple meta-ecosystem models for investigation of spatial processes.	[Heffernan, James B.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Watts, Danielle L.] Univ Florida, Sch Nat Resources & Environm, Gainesville, FL USA; [Cohen, Matthew J.] Univ Florida, Sch Forest Resources & Conservat, Gainesville, FL 32611 USA	Duke University; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Heffernan, JB (corresponding author), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.	james.heffernan@duke.edu	Heffernan, James/D-1261-2010	Heffernan, James/0000-0001-7641-9949; Watts, Danielle/0000-0002-8648-2412	South Florida Water Management District; Army Corps of Engineers	South Florida Water Management District; Army Corps of Engineers(United States Department of DefenseUnited States Army)	This work has been supported by the South Florida Water Management District and the Army Corps of Engineers, but the conclusions presented here do not represent the position of any US Federal or State agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader MY, 2008, ARCT ANTARCT ALP RES, V40, P269, DOI 10.1657/1523-0430(07-024)[BADER]2.0.CO;2; Barbier N, 2006, J ECOL, V94, P537, DOI 10.1111/j.1365-2745.2006.01126.x; Belyea LR, 2007, HYDROL PROCESS, V21, P675, DOI 10.1002/hyp.6275; Belyea LR, 2006, ECOL MONOGR, V76, P299, DOI 10.1890/0012-9615(2006)076[0299:BTLTPB]2.0.CO;2; Bernhardt CE, 2009, ECOL APPL, V19, P1723, DOI 10.1890/08-0779.1; Bruland GL, 2006, SOIL SCI SOC AM J, V70, P1662, DOI 10.2136/sssaj2005.0134; Carpenter SR, 2008, ECOL LETT, V11, P128, DOI 10.1111/j.1461-0248.2007.01131.x; Cheng YW, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046091; Childers DL, 2003, J ENVIRON QUAL, V32, P344, DOI 10.2134/jeq2003.0344; Cohen MJ, 2011, CRIT REV ENV SCI TEC, V41, P395, DOI 10.1080/10643389.2010.531224; CRAFT CB, 1995, WETLANDS, V15, P258, DOI 10.1007/BF03160706; CRAFT CB, 1993, ECOL APPL, V3, P446, DOI 10.2307/1941914; D'Odorico P, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2006JG000176; D'Odorico P, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027499; D'Odorico P, 2011, ECOSYSTEMS, V14, P298, DOI 10.1007/s10021-011-9412-3; D'Odorico P, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000379; Dakos V, 2008, P NATL ACAD SCI USA, V105, P14308, DOI 10.1073/pnas.0802430105; Dakos V, 2011, AM NAT, V177, pE153, DOI 10.1086/659945; Dakos V, 2010, THEOR ECOL-NETH, V3, P163, DOI 10.1007/s12080-009-0060-6; Eppinga MB, 2009, PLANT ECOL, V200, P53, DOI 10.1007/s11258-007-9309-6; Eppinga MB, 2008, ECOSYSTEMS, V11, P520, DOI 10.1007/s10021-008-9138-z; Eppinga MB, 2010, ECOLOGY, V91, P2344, DOI 10.1890/09-1313.1; Eppinga MB, 2009, AM NAT, V173, P803, DOI 10.1086/598487; Ewe SML, 2006, HYDROBIOLOGIA, V569, P459, DOI 10.1007/s10750-006-0149-5; Foti R, 2012, P NATL ACAD SCI USA, V109, P19596, DOI 10.1073/pnas.1218056109; Gaucherel C, 2011, J ECOSYSTEM ECOGRAPH, V1, P2; Givnish TJ, 2008, GLOBAL ECOL BIOGEOGR, V17, P384, DOI 10.1111/j.1466-8238.2007.00371.x; Gravel D, 2010, AM NAT, V176, P289, DOI 10.1086/655426; Gravel D, 2010, ECOLOGY, V91, P2172, DOI 10.1890/09-0843.1; Guttal V, 2008, ECOL LETT, V11, P450, DOI 10.1111/j.1461-0248.2008.01160.x; Guttal V, 2009, THEOR ECOL-NETH, V2, P3, DOI 10.1007/s12080-008-0033-1; Hagerthey SE, 2008, ECOL MONOGR, V78, P547, DOI 10.1890/07-0538.1; Harvey JW, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR007129; Hua DY, 2007, CHINESE PHYS LETT, V24, P3586; Ives AR, 1998, ECOSYSTEMS, V1, P35, DOI 10.1007/s100219900004; Jenerette GD, 2012, ECOHYDROLOGY, V5, P184, DOI 10.1002/eco.217; Jordan F, 1997, WETLANDS, V17, P275, DOI 10.1007/BF03161415; Kaplan DA, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052754; Kefi S, 2007, THEOR POPUL BIOL, V71, P367, DOI 10.1016/j.tpb.2006.09.003; Kefi S, 2011, ECOL LETT, V14, P29, DOI 10.1111/j.1461-0248.2010.01553.x; Lago ME, 2010, ADV WATER RESOUR, V33, P1268, DOI 10.1016/j.advwatres.2010.07.009; Larsen L, 2011, CRIT REV ENV SCI TEC, V41, P344, DOI 10.1080/10643389.2010.531219; Larsen LG, 2007, ECOL MONOGR, V77, P591, DOI 10.1890/06-1267.1; Larsen LG, 2011, GEOMORPHOLOGY, V126, P279, DOI 10.1016/j.geomorph.2010.03.015; Larsen LG, 2010, AM NAT, V176, pE66, DOI 10.1086/655215; Larsen LG, 2009, ECOL ENG, V35, P1773, DOI 10.1016/j.ecoleng.2009.09.002; Larsen LG, 2009, WATER RESOURCES RES, V45; LIGHT SS, 1997, EVERGLADES ECOSYSTEM, P47; Lockwood JL, 2003, FRONT ECOL ENVIRON, V1, P462, DOI 10.1890/1540-9295(2003)001[0462:SOTWTI]2.0.CO;2; Loreau M, 2003, ECOL LETT, V6, P673, DOI 10.1046/j.1461-0248.2003.00483.x; Loreau M, 2004, AM NAT, V163, P606, DOI 10.1086/382600; Ludwig JA, 2005, ECOLOGY, V86, P288, DOI 10.1890/03-0569; Ludwig JA, 2000, ECOSYSTEMS, V3, P84, DOI 10.1007/s100210000012; Mauchamp A, 2001, ECOL STU AN, V149, P146; McVoy CWS, 2011, LANDSCAPES HYDROLOGY, P576; Min JH, 2010, J HYDROL, V390, P1, DOI 10.1016/j.jhydrol.2010.06.023; Moreno-de las Heras M, 2011, ECOL APPL, V21, P2793, DOI 10.1890/10-2113.1; Morris PJ, 2011, J ECOL, V99, P1190, DOI 10.1111/j.1365-2745.2011.01842.x; Nungesser MK, 2011, WETL ECOL MANAG, V19, P475, DOI 10.1007/s11273-011-9229-z; Nungesser MK, 2003, ECOL MODEL, V165, P175, DOI 10.1016/S0304-3800(03)00067-X; Ogden JC, 2005, WETLANDS, V25, P810, DOI 10.1672/0277-5212(2005)025[0810:ERASCE]2.0.CO;2; Qualls RG, 2003, BIOGEOCHEMISTRY, V62, P197, DOI 10.1023/A:1021150503664; Ridolfi L, 2008, ECOL SOC, V13; Rietkerk M, 2004, AM NAT, V163, P699, DOI 10.1086/383065; Rietkerk M, 2004, SCIENCE, V305, P1926, DOI 10.1126/science.1101867; Rietkerk M, 2002, AM NAT, V160, P524, DOI 10.1086/342078; Rietkerk M, 2008, TRENDS ECOL EVOL, V23, P169, DOI 10.1016/j.tree.2007.10.013; Ross MS, 2003, WETL ECOL MANAG, V11, P291, DOI 10.1023/B:WETL.0000005541.30283.11; Ross MS, 2006, HYDROBIOLOGIA, V569, P37, DOI 10.1007/s10750-006-0121-4; Ross MS, 2011, ECOSYSTEMS, V14, P632, DOI 10.1007/s10021-011-9433-y; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Science Coordinating Team, 2003, ROL FLOW EV RIDG SLO; SFWMD and USACE, 1999, CENTR SO FLOR FLOOD; SFWMD and USACE, 2012, DECOMP DEC WAT CONV; Silliman BR, 2005, SCIENCE, V310, P1803, DOI 10.1126/science.1118229; Slocum MG, 2007, NAT AREA J, V27, P41, DOI 10.3375/0885-8608(2007)27[41:DNAAFR]2.0.CO;2; Suding KN, 2009, TRENDS ECOL EVOL, V24, P271, DOI 10.1016/j.tree.2008.11.012; Suding KN, 2004, TRENDS ECOL EVOL, V19, P46, DOI 10.1016/j.tree.2003.10.005; Sullivan PL, 2011, HYDROGEOL J, V19, P367, DOI 10.1007/s10040-010-0691-0; Tongway DJ, 2001, ECOL STU AN, V149, P20; Troxler TG, 2009, AQUAT BOT, V91, P157, DOI 10.1016/j.aquabot.2009.04.003; Vaithiyanathan P, 1998, J ENVIRON QUAL, V27, P1439, DOI 10.2134/jeq1998.00472425002700060021x; van de Koppel J, 2005, AM NAT, V165, pE66; van de Koppel J, 2002, AM NAT, V159, P209, DOI 10.1086/324791; van Nes EH, 2005, ECOLOGY, V86, P1797, DOI 10.1890/04-0550; Wang X, 2011, BIOGEOCHEMISTRY, V104, P133, DOI 10.1007/s10533-010-9492-8; Watts DL, 2010, ECOSYSTEMS, V13, P813, DOI 10.1007/s10021-010-9356-z; Weerman EJ, 2010, AM NAT, V176, pE15, DOI 10.1086/652991; Wetzel PR, 2011, CRIT REV ENV SCI TEC, V41, P670, DOI 10.1080/10643389.2010.530908; Wu YG, 2006, ECOL COMPLEX, V3, P183, DOI 10.1016/j.ecocom.2005.12.002; Zweig CL, 2009, ECOLOGY, V90, P1900, DOI 10.1890/08-1392.1; Zweig CL, 2008, WETLANDS, V28, P1086, DOI 10.1672/08-96.1	92	21	22	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e64174	10.1371/journal.pone.0064174	http://dx.doi.org/10.1371/journal.pone.0064174			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671708	Green Published, gold, Green Submitted			2022-12-25	WOS:000319737700066
J	Jones, J; Estirado, A; Redondo, C; Martinez, S				Jones, Jonathan; Estirado, Alicia; Redondo, Carolina; Martinez, Salvador			Stem Cells from Wildtype and Friedreich's Ataxia Mice Present Similar Neuroprotective Properties in Dorsal Root Ganglia Cells	PLOS ONE			English	Article							OXIDATIVE STRESS; REPEAT EXPANSION; MITOCHONDRIAL DYSFUNCTION; ANTIOXIDANT TREATMENT; IDEBENONE TREATMENT; EPIGENETIC CHANGES; FRATAXIN; GENE; PATHOLOGY	Many neurodegenerative disorders share a common susceptibility to oxidative stress, including Alzheimer's, Parkinson Disease, Huntington Disease and Friedreich's ataxia. In a previous work, we proved that stem cell-conditioned medium increased the survival of cells isolated from Friedreich's ataxia patients, when submitted to oxidative stress. The aim of the present work is to confirm this same effect in dorsal root ganglia cells isolated from YG8 mice, a mouse model of Friedreich's ataxia. In this disorder, the neurons of the dorsal root ganglia are the first to degenerate. Also, in this work we cultured mesenchymal stem cells isolated from YG8 mice, in order to compare them with their wildtype counterpart. To this end, dorsal root ganglia primary cultures isolated from YG8 mice were exposed to oxidative stress and cultured with conditioned medium from either wildtype or YG8 stem cells. As a result, the conditioned medium increased the survival of the dorsal root ganglia cells. This coincided with an increase in oxidative stress-related markers and frataxin expression levels. BDNF, NT3 and NT4 trophic factors were detected in the conditioned medium of both wild-type and YG8 stem cells, all which bind to the various neuronal cell types present in the dorsal root ganglia. No differences were observed in the stem cells isolated from wildtype and YG8 mice. The results presented confirm the possibility that autologous stem cell transplantation may be a viable therapeutic approach in protecting dorsal root ganglia neurons of Friedreich's ataxia patients.	[Jones, Jonathan; Estirado, Alicia; Redondo, Carolina; Martinez, Salvador] UMH, Neurosci Inst, Dept Expt Embryol, CSIC, Alicante, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche	Jones, J (corresponding author), UMH, Neurosci Inst, Dept Expt Embryol, CSIC, Alicante, Spain.	jon@umh.es	Estirado, Alicia/L-8295-2014; Mratinez, Salvador/L-4896-2014	Estirado, Alicia/0000-0003-2191-5819; Mratinez, Salvador/0000-0002-9320-4103; Martinez, Salvador/0000-0002-2910-8926	FARA (Friedreich's Ataxia Research Alliance); ASOGAF (Friedreich's Ataxia association of Granada); Science and Innovation Ministry [MICINN BFU2010-27326]; GVA Prometeo grant [2009/028]; Tercel [RD06/0010/0023, RD06/0010/24]; MEC-CONSOLIDER [CSD2007-00023]; Cinco P menos Foundation; EUCOMM; Fundacion Diogenes-Elche city government; Walk on Project; MAPFRE Foundation	FARA (Friedreich's Ataxia Research Alliance); ASOGAF (Friedreich's Ataxia association of Granada); Science and Innovation Ministry; GVA Prometeo grant; Tercel; MEC-CONSOLIDER(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Cinco P menos Foundation; EUCOMM; Fundacion Diogenes-Elche city government; Walk on Project; MAPFRE Foundation	This work was supported by FARA (Friedreich's Ataxia Research Alliance), ASOGAF (Friedreich's Ataxia association of Granada), Science and Innovation Ministry (MICINN BFU2010-27326), GVA Prometeo grant 2009/028, Tercel (RD06/0010/0023 & RD06/0010/24), MEC-CONSOLIDER CSD2007-00023, Cinco P menos Foundation, EUCOMM, Fundacion Diogenes-Elche city government, Walk on Project, and MAPFRE Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mahdawi S, 2004, GENOMICS, V84, P301, DOI 10.1016/j.ygeno.2004.04.003; Al-Mahdawi S, 2008, HUM MOL GENET, V17, P735, DOI 10.1093/hmg/ddm346; Al-Mahdawi S, 2006, GENOMICS, V88, P580, DOI 10.1016/j.ygeno.2006.06.015; Bueno C, 2012, CELL TRANSPLANTATION; Buyse G, 2003, NEUROLOGY, V60, P1679, DOI 10.1212/01.WNL.0000068549.52812.0F; Calabrese V, 2005, J NEUROL SCI, V233, P145, DOI 10.1016/j.jns.2005.03.012; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Cooper JM, 2003, BIOFACTORS, V18, P163, DOI 10.1002/biof.5520180219; De Biase I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007914; Dusek P, 2012, NEUROBIOL DIS, V46, P1, DOI 10.1016/j.nbd.2011.12.054; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; Gordon DM, 1999, HUM MOL GENET, V8, P2255, DOI 10.1093/hmg/8.12.2255; Greene E, 2007, NUCLEIC ACIDS RES, V35, P3383, DOI 10.1093/nar/gkm271; Hart PE, 2005, ARCH NEUROL-CHICAGO, V62, P621, DOI 10.1001/archneur.62.4.621; Hausse AO, 2002, HEART, V87, P346, DOI 10.1136/heart.87.4.346; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Jones J, 2012, STEM CELLS DEV, V21, P2817, DOI 10.1089/scd.2012.0029; Jones J, 2010, NEUROBIOL DIS, V40, P415, DOI 10.1016/j.nbd.2010.07.001; Koeppen AH, 2011, J NEUROL SCI, V303, P1, DOI 10.1016/j.jns.2011.01.010; Koeppen AH, 2009, ACTA NEUROPATHOL, V118, P763, DOI 10.1007/s00401-009-0589-x; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lodi R, 2001, ANN NEUROL, V49, P590; Mariotti C, 2003, NEUROLOGY, V60, P1676, DOI 10.1212/01.WNL.0000055872.50364.FC; Marmolino D, 2011, BRAIN RES REV, V67, P311, DOI 10.1016/j.brainresrev.2011.04.001; Meng H, 2007, BRAIN RES, V1160, P47, DOI 10.1016/j.brainres.2007.05.048; Muller FL, 2007, FREE RADICAL BIO MED, V43, P477, DOI 10.1016/j.freeradbiomed.2007.03.034; Pandolfo M, 2009, J NEUROL, V256, P3, DOI 10.1007/s00415-009-1002-3; Rustin P, 1999, LANCET, V354, P477, DOI 10.1016/S0140-6736(99)01341-0; Saveliev A, 2003, NATURE, V422, P909, DOI 10.1038/nature01596; Sayre LM, 2008, CHEM RES TOXICOL, V21, P172, DOI 10.1021/tx700210j; Schulz JB, 2000, NEUROLOGY, V55, P1719, DOI 10.1212/WNL.55.11.1719; Schulz JB, 2009, NAT REV NEUROL, V5, P222, DOI 10.1038/nrneurol.2009.26; Sparaco M, 2009, J NEUROL SCI, V287, P111, DOI 10.1016/j.jns.2009.08.052; Terenghi G, 1999, J ANAT, V194, P1, DOI 10.1046/j.1469-7580.1999.19410001.x; Viana F, 2002, NAT NEUROSCI, V5, P254, DOI 10.1038/nn809	37	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e62807	10.1371/journal.pone.0062807	http://dx.doi.org/10.1371/journal.pone.0062807			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671637	Green Published, gold, Green Submitted			2022-12-25	WOS:000319737700022
J	Kiadaliri, AA; Gerdtham, UG; Nilsson, P; Eliasson, B; Gudbjornsdottir, S; Carlsson, KS				Kiadaliri, Aliasghar Ahmad; Gerdtham, Ulf-G.; Nilsson, Peter; Eliasson, Bjorn; Gudbjornsdottir, Soffia; Carlsson, Katarina Steen			Towards Renewed Health Economic Simulation of Type 2 Diabetes: Risk Equations for First and Second Cardiovascular Events from Swedish Register Data	PLOS ONE			English	Article							COST-EFFECTIVENESS; GLYCEMIC CONTROL; MODEL; DISEASE; VALIDATION; PREDICTION; MELLITUS; OUTCOMES; SCORE; PIOGLITAZONE	Objective: Predicting the risk of future events is an essential part of health economic simulation models. In pursuit of this goal, the current study aims to predict the risk of developing first and second acute myocardial infarction, heart failure, non-acute ischaemic heart disease, and stroke after diagnosis in patients with type 2 diabetes, using data from the Swedish National Diabetes Register. Material and Methods: Register data on 29,034 patients with type 2 diabetes were analysed over five years of follow up (baseline 2003). To develop and validate the risk equations, the sample was randomly divided into training (75%) and test (25%) subsamples. The Weibull proportional hazard model was used to estimate the coefficients of the risk equations, and these were validated in both the training and the test samples. Results: In total, 4,547 first and 2,418 second events were observed during the five years of follow up. Experiencing a first event substantially elevated the risk of subsequent events. There were heterogeneities in the effects of covariates within as well as between events; for example, while for females the hazard ratio of having a first acute myocardial infarction was 0.79 (0.70-0.90), the hazard ratio of a second was 1.21 (0.98-1.48). The hazards of second events decreased as the time since first events elapsed. The equations showed adequate calibration and discrimination (C statistics range: 0.70-0.84 in test samples). Conclusion: The accuracy of health economic simulation models of type 2 diabetes can be improved by ensuring that they account for the heterogeneous effects of covariates on the risk of first and second cardiovascular events. Thus it is important to extend such models by including risk equations for second cardiovascular events.	[Kiadaliri, Aliasghar Ahmad; Gerdtham, Ulf-G.; Carlsson, Katarina Steen] Lund Univ, Malmo Univ Hosp, Div Hlth Econ, Dept Clin Sci, Malmo, Sweden; [Kiadaliri, Aliasghar Ahmad; Gerdtham, Ulf-G.; Carlsson, Katarina Steen] Lund Univ, Inst Econ Res, Lund, Sweden; [Kiadaliri, Aliasghar Ahmad] Univ Tehran Med Sci, Dept Hlth Management & Econ, Sch Publ Hlth, Tehran, Iran; [Gerdtham, Ulf-G.] Lund Univ, Dept Econ, Lund, Sweden; [Nilsson, Peter] Lund Univ, Malmo Univ Hosp, Dept Clin Sci, Malmo, Sweden; [Eliasson, Bjorn; Gudbjornsdottir, Soffia] Univ Gothenburg, Sahlgrenska Univ Hosp, Dept Med, Gothenburg, Sweden	Lund University; Skane University Hospital; Lund University; Tehran University of Medical Sciences; Lund University; Lund University; Skane University Hospital; Sahlgrenska University Hospital; University of Gothenburg	Kiadaliri, AA (corresponding author), Lund Univ, Malmo Univ Hosp, Div Hlth Econ, Dept Clin Sci, Malmo, Sweden.	aliasghar.ahmad_kiadaliri@med.lu.se	Gerdtham, Ulf-Göran/I-6766-2018; Kiadaliri, Ali/E-8685-2017; Eliasson, Bjorn/H-5783-2016	Gerdtham, Ulf-Göran/0000-0002-0647-7817; Kiadaliri, Ali/0000-0002-4254-9099; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Steen Carlsson, Katarina/0000-0002-2325-5634; Eliasson, Bjorn/0000-0003-2569-4160	Health Ministry of Iran; Novo Nordisk Ltd; FAS [dnr. 2006-1660]; Government Grant for Clinical Research (ALF); Skane Region	Health Ministry of Iran; Novo Nordisk Ltd(Novo Nordisk); FAS; Government Grant for Clinical Research (ALF); Skane Region	A.A.K. received funds from the Health Ministry of Iran to perform this research as a part of his PhD thesis. An unrestricted educational grant from Novo Nordisk Ltd is gratefully acknowledged. The Health Economics Programme (HEP) at Lund University receives core funding from FAS (dnr. 2006-1660), a Government Grant for Clinical Research (ALF) and the Skane Region (Ulf-G. Gerdtham). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown JB, 2000, DIABETES RES CLIN PR, V50, pS15, DOI 10.1016/S0168-8227(00)00215-1; Caro JJ, 2000, CLIN THER, V22, P116, DOI 10.1016/S0149-2918(00)87983-7; Caro JJ, 2003, CAN J DIABETES, V27, P33; Cederholm J, 2008, DIABETES CARE, V31, P2038, DOI 10.2337/dc08-0662; Clarke PM, 2004, DIABETOLOGIA, V47, P1747, DOI 10.1007/s00125-004-1527-z; D'Agostino RB, 2004, HDB STAT SURVIVAL ME, V23; Donnan PT, 2006, DIABETES CARE, V29, P1231, DOI 10.2337/dc05-1911; Eastman RC, 1997, DIABETES CARE, V20, P725, DOI 10.2337/diacare.20.5.725; Ekstrom N, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001076; Elley CR, 2010, DIABETES CARE, V33, P1347, DOI 10.2337/dc09-1444; Erdmann E, 2007, J AM COLL CARDIOL, V49, P1772, DOI 10.1016/j.jacc.2006.12.048; Giorda CB, 2008, DIABETES CARE, V31, P2154, DOI 10.2337/dc08-1013; Glynn RJ, 1996, BMJ-BRIT MED J, V312, P364; Gould W., 1993, STATA TECHNICAL B, P13; Gronnesby J K, 1996, Lifetime Data Anal, V2, P315, DOI 10.1007/BF00127305; Gudbjornsdottir S, 2009, DIABETIC MED, V26, P53, DOI 10.1111/j.1464-5491.2008.02633.x; Gudbjornsdottir S, 2003, DIABETES CARE, V26, P1270, DOI 10.2337/diacare.26.4.1270; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hayes AJ, 2011, DIABETOLOGIA, V54, pS8; Hoelzel W, 2004, CLIN CHEM, V50, P166, DOI 10.1373/clinchem.2003.024802; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Juutilainen A, 2008, DIABETES CARE, V31, P714, DOI 10.2337/dc07-2124; Kahn R, 2004, DIABETES CARE, V27, P2262; KANNEL WB, 1979, CIRCULATION, V59, P8, DOI 10.1161/01.CIR.59.1.8; Kothari V, 2002, STROKE, V33, P1776, DOI 10.1161/01.STR.0000020091.07144.C7; Mueller E, 2006, DIABETES TECHNOL THE, V8, P219, DOI 10.1089/dia.2006.8.219; Palmer AJ, 2000, SCHWEIZ MED WSCHR, V130, P1034; Palmer AJ, 2004, CURR MED RES OPIN, V20, pS5, DOI 10.1185/030079904X1980; Palmer AJ, 2007, DIABETES CARE, V30, P1638, DOI 10.2337/dc07-9919; PRENTICE RL, 1981, BIOMETRIKA, V68, P373, DOI 10.1093/biomet/68.2.373; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; StataCorp, 2011, STAT STAT SOFTW REL, P173; Sukor JA, 2012, PHYSIOL MEAS, V33, P465, DOI 10.1088/0967-3334/33/3/465; Tarride JE, 2010, PHARMACOECONOMICS, V28, P255, DOI 10.2165/11531590-000000000-00000; Tilden DP, 2007, PHARMACOECONOMICS, V25, P39, DOI 10.2165/00019053-200725010-00005; TURNER RC, 1991, DIABETOLOGIA, V34, P877; van Dieren S, 2012, HEART, V98, P360, DOI 10.1136/heartjnl-2011-300734; Ward Alexandra J, 2004, Cost Eff Resour Alloc, V2, P2, DOI 10.1186/1478-7547-2-2; Yang XL, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-9; Yeo WW, 2001, DIABETIC MED, V18, P341, DOI 10.1046/j.1464-5491.2001.00510.x; Zethelius B, 2011, DIABETES RES CLIN PR, V93, P276, DOI 10.1016/j.diabres.2011.05.037	41	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e62650	10.1371/journal.pone.0062650	http://dx.doi.org/10.1371/journal.pone.0062650			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671618	Green Published, Green Submitted, gold			2022-12-25	WOS:000319737700016
J	Ryu, JS; Kang, SJ; Koo, HS				Ryu, Jin-Sun; Kang, Sang Jo; Koo, Hyeon-Sook			The 53BP1 Homolog in C. elegans Influences DNA Repair and Promotes Apoptosis in Response to Ionizing Radiation	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; DOUBLE-STRAND BREAKS; DAMAGE-RESPONSE; HISTONE-H4 LYSINE-20; CHECKPOINT PATHWAY; TUMOR-SUPPRESSOR; PROTEIN; METHYLATION; SITES; MDC1	53BP1 contributes to activation of the G2/M checkpoint downstream of ATM and MDC1 in response to ionizing radiation and promotes nonhomologous end-joining (NHEJ) in mammalian cells. In order to determine whether the cellular activities of 53BP1 are conserved in the model organism C. elegans, we analyzed the function of its homolog, HSR-9 in response to DNA damage. Deletion or Mos1-insertion in hsr-9 did not affect the sensitivity of worms to double strand DNA breaks (DSBs), as reflected in embryonic survival and larval development. Nevertheless, the hsr-9 mutations, as well as a lig-4 deletion, reversed the hypersensitivity of rad-54-deficient worms to DSBs. In addition, oocyte chromosomal aberrations, which were increased by rad-54 knockdown in response to DSBs, were also reduced by the hsr-9 mutations. The hsr-9 mutations did not prevent the cell cycle arrest induced by DSBs in mitotically proliferating germ cells. However, they attenuated apoptosis induced by DSBs, but not when CEP-1 (a p53 ortholog) was absent, suggesting that HSR-9 functions in the same pathway as CEP-1. We concluded that the 53BP1 homolog in C. elegans is not directly involved in cell cycle arrest in response to DSBs, but that it promotes apoptosis and also a form of NHEJ that occurs only when rad-54 is deficient.	[Ryu, Jin-Sun; Kang, Sang Jo; Koo, Hyeon-Sook] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 120749, South Korea	Yonsei University	Koo, HS (corresponding author), Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 120749, South Korea.	kooh@yonsei.ac.kr	Ryu, Jin-Sun/AAW-8104-2021; Ryu, Jin-Sun/T-7900-2017	Ryu, Jin-Sun/0000-0002-9644-1526; Ryu, Jin-Sun/0000-0002-9644-1526; Koo, Hyeon-Sook/0000-0002-5712-3875	Nuclear Research & Development Program [2010-0017583]; National Research Foundation of Korea (NRF); Korean government (MEST) [2012-029610]; NIH Office of Research Infrastructure Programs [P40 OD010440]	Nuclear Research & Development Program; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Nuclear Research & Development Program (grant code: 2010-0017583) and a National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (No. 2012-029610) to HSK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; C. elegans N2, hsr-9(ok759), atm-1(gk186), brd-1(gk297), lig-4(ok716), cep-1(lg12501), and brc-1(tm1145) were provided by the C. elegans Genetics Center (St. Paul, MN), which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). The hsr-9(ttTi14815) in UMS3421 was provided by Drs. Laurent Segalat (Universite Claude Bernard Lyon 1, France) and Maite Carre-Pierrat (Plateforme "Biologie de Caenorhabditis elegans", France). We thank Mi So Park (Yonsei Univ.) for assistance with rad-54 experiments.	Adamo A, 2010, MOL CELL, V39, P25, DOI 10.1016/j.molcel.2010.06.026; Anderson L, 2001, MOL CELL BIOL, V21, P1719, DOI 10.1128/MCB.21.5.1719-1729.2001; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Boulton SJ, 2002, SCIENCE, V295, P127, DOI 10.1126/science.1065986; Boulton SJ, 2004, CURR BIOL, V14, P33, DOI 10.1016/j.cub.2003.11.029; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Cao L, 2009, MOL CELL, V35, P534, DOI 10.1016/j.molcel.2009.06.037; Ceballos SJ, 2011, BBA-GENE REGUL MECH, V1809, P509, DOI 10.1016/j.bbagrm.2011.06.006; Clejan I, 2006, GENETICS, V173, P1301, DOI 10.1534/genetics.106.058628; Conradt B, 1998, CELL, V93, P519, DOI 10.1016/S0092-8674(00)81182-4; Craig AL, 2012, METHOD CELL BIOL, V107, P321, DOI 10.1016/B978-0-12-394620-1.00011-4; Crittenden SL, 2006, MOL BIOL CELL, V17, P3051, DOI 10.1091/mbc.E06-03-0170; Derry WB, 2001, SCIENCE, V294, P591, DOI 10.1126/science.1065486; Difilippantonio S, 2008, NATURE, V456, P529, DOI 10.1038/nature07476; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; DiTullio RA, 2002, NAT CELL BIOL, V4, P998, DOI 10.1038/ncb892; Eliezer Y, 2009, J BIOL CHEM, V284, P426, DOI 10.1074/jbc.M807375200; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Garcia-Muse T, 2005, EMBO J, V24, P4345, DOI 10.1038/sj.emboj.7600896; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; Greeson NT, 2008, J BIOL CHEM, V283, P33168, DOI 10.1074/jbc.M806857200; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; Hayashi M, 2007, PLOS GENET, V3, P2068, DOI 10.1371/journal.pgen.0030191; Higashitani A, 2000, FEBS LETT, V485, P35, DOI 10.1016/S0014-5793(00)02178-5; Hofmann ER, 2002, CURR BIOL, V12, P1908, DOI 10.1016/S0960-9822(02)01262-9; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; IWABUCHI K, 1994, P NATL ACAD SCI USA, V91, P6098, DOI 10.1073/pnas.91.13.6098; Jowsey P, 2007, DNA REPAIR, V6, P1536, DOI 10.1016/j.dnarep.2007.04.011; Lazzaro F, 2008, EMBO J, V27, P1502, DOI 10.1038/emboj.2008.81; Lee JH, 2010, EMBO J, V29, P574, DOI 10.1038/emboj.2009.372; Lee SJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000801; MacQueen AJ, 2001, GENE DEV, V15, P1674, DOI 10.1101/gad.902601; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Manis JP, 2004, NAT IMMUNOL, V5, P481, DOI 10.1038/ni1067; Mazina OM, 2012, J BIOL CHEM, V287, P11820, DOI 10.1074/jbc.M112.341347; Minter-Dykhouse K, 2008, J CELL BIOL, V181, P727, DOI 10.1083/jcb.200801083; Moser SC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000451; Nimonkar AV, 2012, J BIOL CHEM, V287, P28727, DOI 10.1074/jbc.M112.373290; Oda H, 2010, MOL CELL, V40, P364, DOI 10.1016/j.molcel.2010.10.011; Pei HD, 2011, NATURE, V470, P124, DOI 10.1038/nature09658; Penkner A, 2007, EMBO J, V26, P5071, DOI 10.1038/sj.emboj.7601916; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Sanders SL, 2004, CELL, V119, P603, DOI 10.1016/j.cell.2004.11.009; Schumacher B, 2001, CURR BIOL, V11, P1722, DOI 10.1016/S0960-9822(01)00534-6; Shibata A, 2010, MOL CELL BIOL, V30, P3371, DOI 10.1128/MCB.01644-09; Stergiou L, 2004, CELL DEATH DIFFER, V11, P21, DOI 10.1038/sj.cdd.4401340; Stergiou L, 2011, CELL DEATH DIFFER, V18, P897, DOI 10.1038/cdd.2010.158; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; Ward IM, 2003, MOL CELL BIOL, V23, P2556, DOI 10.1128/MCB.23.7.2556-2563.2003; Ward IM, 2004, J CELL BIOL, V165, P459, DOI 10.1083/jcb.200403021; Wu JX, 2009, J BIOL CHEM, V284, P18078, DOI 10.1074/jbc.M109.002527; Wysocki R, 2005, MOL CELL BIOL, V25, P8430, DOI 10.1128/MCB.25.19.8430-8443.2005; Xie AY, 2007, MOL CELL, V28, P1045, DOI 10.1016/j.molcel.2007.12.005; Yang HB, 2008, J BIOL CHEM, V283, P12085, DOI 10.1074/jbc.M707974200; Zgheib O, 2009, MOL CELL BIOL, V29, P1050, DOI 10.1128/MCB.01011-08	56	13	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e64028	10.1371/journal.pone.0064028	http://dx.doi.org/10.1371/journal.pone.0064028			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667696	Green Submitted, Green Published, gold			2022-12-25	WOS:000319055600084
J	Calzolari, M; Bonilauri, P; Bellini, R; Albieri, A; Defilippo, F; Tamba, M; Tassinari, M; Gelati, A; Cordioli, P; Angelini, P; Dottori, M				Calzolari, Mattia; Bonilauri, Paolo; Bellini, Romeo; Albieri, Alessandro; Defilippo, Francesco; Tamba, Marco; Tassinari, Massimo; Gelati, Antonio; Cordioli, Paolo; Angelini, Paola; Dottori, Michele			Usutu Virus Persistence and West Nile Virus Inactivity in the Emilia-Romagna Region (Italy) in 2011	PLOS ONE			English	Article							CULEX-PIPIENS-PIPIENS; HOST FEEDING PATTERNS; NEW-YORK-CITY; VERTICAL TRANSMISSION; PCR ASSAY; MOSQUITOS; DIPTERA; CULICIDAE; FLAVIVIRUSES; EMERGENCE	Background: The circulation of West Nile virus and Usutu virus was detected in the Emilia-Romagna region in 2008 and 2009. To evaluate the extent of circulation of both viruses, environmental surveillance, based on bird and mosquito testing, was conducted in 2008 and gradually improved over the years. Methods: In February-March 2009-2011, 5,993 hibernating mosquitoes were manually sampled, out of which 80.1% were Culex pipiens; none tested positive for the viruses. From 2008 to 2011, 946,213 mosquitoes, sampled between May and October, were tested; 86.5% were Cx. pipiens. West Nile virus was detected in 32 Cx. pipiens pools, and Usutu virus was detected in 229 mosquito pools (217 Cx. pipiens, 10 Aedes albopictus, one Anopheles maculipennis s.l., and one Aedes caspius). From 2009 to 2011, of 4,546 birds collected, 42 tested positive for West Nile virus and 48 for Usutu virus. West Nile virus and Usutu virus showed different patterns of activity during the 2008-2011 surveillance period. West Nile virus was detected in 2008, 2009, and 2010, but not in 2011. Usutu virus, however, was continuously active throughout 2009, 2010, and 2011. Conclusions: The data strongly suggest that both viruses overwinter in the surveyed area rather than being continually reintroduced every season. The lack of hibernating mosquitoes testing positive for the viruses and the presence of positive birds sampled early in the season support the hypothesis that the viruses overwinter in birds rather than in mosquitoes. Herd immunity in key bird species could explain the decline of West Nile virus observed in 2011, while the persistence of Usutu virus may be explained by not yet identified reservoirs. Reported results are comparable with a peri-Mediterranean circulation of the West Nile virus lineage 1 related strain, which became undetectable in the environment after two to three years of obvious circulation.	[Calzolari, Mattia; Bonilauri, Paolo; Defilippo, Francesco; Tamba, Marco; Cordioli, Paolo; Dottori, Michele] Ist Zooprofilatt Sperimentale Lombardia & Emilia, Brescia, Italy; [Bellini, Romeo; Albieri, Alessandro] Ctr Agr Ambiente G Nicoli CAA, Crevalcore, Italy; [Tassinari, Massimo; Gelati, Antonio] Serv Vet Azienda USL Ferrara, Ferrara, Italy; [Angelini, Paola] DG Sanita & Polit Sociali, Bologna, Regione Emilia, Italy	IZS Lombardia e Emilia	Calzolari, M (corresponding author), Ist Zooprofilatt Sperimentale Lombardia & Emilia, Brescia, Italy.	mattia.calzolari@izsler.it	Calzolari, Mattia/AAB-9487-2019; Tamba, Marco/J-5495-2016; dottori, michele/AAB-3815-2019	Calzolari, Mattia/0000-0001-7489-2556; Tamba, Marco/0000-0002-5878-4595; defilippo, francesco/0000-0002-1898-0997; Bonilauri, Paolo/0000-0002-2625-7993; Dottori, Michele/0000-0002-9975-0367	Regione Emilia-Romagna; Italian Ministry of Health [PRC2009004, PRC2008005]; Regional project on insect borne diseases [COMM07001]	Regione Emilia-Romagna(Regione Emilia Romagna); Italian Ministry of Health(Ministry of Health, Italy); Regional project on insect borne diseases	The Regione Emilia-Romagna (www.regione.emilia-romagna.it/) had partially funded this work to IZSLER (www.izsler.it) and CAA (www.caa.it) by the Regional project on insect borne diseases (COMM07001). Funds were also obtained by the IZSLER projects: "West Nile virus overwintering mechanisms in Emilia-Romagna region" (PRC2009004) and "Field evaluation of monitoring techniques of some arthropod vectors for their mapping" (PRC2008005) financed by the Italian Ministry of Health (http://www.salute.gov.it/). No other external funding was utilized for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JF, 2008, J MED ENTOMOL, V45, P445, DOI 10.1603/0022-2585(2008)45[445:EIPFHA]2.0.CO;2; Anderson JF, 2012, AM J TROP MED HYG, V86, P134, DOI 10.4269/ajtmh.2012.11-0473; Andreadis TG, 2010, J AM MOSQUITO CONTR, V26, P257, DOI 10.2987/10-6004.1; Angelini P, 2010, EUROSURVEILLANCE, V15, P11; BAQAR S, 1993, AM J TROP MED HYG, V48, P757, DOI 10.4269/ajtmh.1993.48.757; Becker N, 2010, MOSQUITOES AND THEIR CONTROL, SECOND EDITION, P3, DOI 10.1007/978-3-540-92874-4_1; Bellini R., 2002, 68 ANN M AM MOSQ CON; BirdLife International, 2004, BIRDS EUR POP EST TR; Bonds MH, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001456; Bugbee LM, 2004, J AM MOSQUITO CONTR, V20, P326; CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37; Calzolari M., 2011, Giornale Italiano di Medicina Tropicale, V16, P57; Calzolari M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038058; Calzolari M, 2012, J GEN VIROL, V93, P1215, DOI 10.1099/vir.0.040485-0; Calzolari M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014324; Calzolari M, 2010, VECTOR-BORNE ZOONOT, V10, P875, DOI 10.1089/vbz.2009.0176; Dohm DJ, 2002, J MED ENTOMOL, V39, P640, DOI 10.1603/0022-2585-39.4.640; Farajollahi A, 2005, J MED ENTOMOL, V42, P490, DOI 10.1603/0022-2585(2005)042[0490:DOWNVR]2.0.CO;2; Fornasari L, 2010, AVOCETTA, V34, P1; Fornasari Lorenzo, 2002, Avocetta, V26, P59; Gingrich JB, 2005, J AM MOSQUITO CONTR, V21, P194, DOI 10.2987/8756-971X(2005)21[194:HPOSWN]2.0.CO;2; Goddard LB, 2003, J MED ENTOMOL, V40, P743, DOI 10.1603/0022-2585-40.6.743; Hamer GL, 2008, VECTOR-BORNE ZOONOT, V8, P57, DOI 10.1089/vbz.2007.0123; Hubalek Z, 1999, EMERG INFECT DIS, V5, P643, DOI 10.3201/eid0505.990505; Hubalek Z, 2000, VIRAL IMMUNOL, V13, P415, DOI 10.1089/vim.2000.13.415; IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531; JAENSON TGT, 1987, MED VET ENTOMOL, V1, P151, DOI 10.1111/j.1365-2915.1987.tb00336.x; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Komar N, 2003, EMERG INFECT DIS, V9, P311, DOI 10.3201/eid0903.020628; Kramer LD, 2008, ANNU REV ENTOMOL, V53, P61, DOI 10.1146/annurev.ento.53.103106.093258; Kuno G, 2005, CLIN MICROBIOL REV, V18, P608, DOI 10.1128/CMR.18.4.608-637.2005; Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998; Kwan JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034127; Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066, DOI 10.1128/JCM.38.11.4066-4071.2000; Macini P, 2008, EURO SURVEILL, V13; Manarolla G, 2010, VET MICROBIOL, V141, P159, DOI 10.1016/j.vetmic.2009.07.036; Mannelli A, 2012, INVENTORY AVAILABLE; Meister T, 2008, VET MICROBIOL, V127, P237, DOI 10.1016/j.vetmic.2007.08.023; MITCHELL CJ, 1989, J MED ENTOMOL, V26, P318, DOI 10.1093/jmedent/26.4.318; Molaei G, 2006, EMERG INFECT DIS, V12, P468, DOI 10.3201/eid1203.051004; Murray K, 2010, J INFECT DIS, V201, P2, DOI 10.1086/648731; Nasci RS, 2001, EMERG INFECT DIS, V7, P742; Nemeth N, 2009, ARCH VIROL, V154, P783, DOI 10.1007/s00705-009-0369-x; Nemeth NM, 2008, AM J TROP MED HYG, V79, P283, DOI 10.4269/ajtmh.2008.79.283; Nemeth NM, 2009, AM J TROP MED HYG, V80, P864, DOI 10.4269/ajtmh.2009.80.864; ODA T, 1976, TROPENMED PARASITOL, V27, P101; Pfeffer M, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-35; Phillips RA, 2006, J AM MOSQUITO CONTR, V22, P561, DOI 10.2987/8756-971X(2006)22[561:FCELFN]2.0.CO;2; Ravasini M, 1995, AVIFAUNA NIDIFICANTE; Reisen WK, 2006, J MED ENTOMOL, V43, P344, DOI 10.1603/0022-2585(2006)043[0344:OOWNVI]2.0.CO;2; Reiter P, 2010, EUROSURVEILLANCE, V15, P4; Rossi P, 2010, CENSIMENTO AVIFAUNA; Rossini G, 2011, EMERG INFECT DIS, V17, P903, DOI 10.3201/eid1705.101569; Savage HM, 2004, J AM MOSQUITO CONTR, V20, P208; Scaramozzino N, 2001, J CLIN MICROBIOL, V39, P1922, DOI 10.1128/JCM.39.5.1922-1927.2001; Schaffner E., 2001, MOSQUITOES EUROPE; SERVICE MW, 1971, B ENTOMOL RES, V60, P653, DOI 10.1017/S0007485300042401; Severini Francesco, 2009, Fragmenta Entomologica, V41, P213; SLAFF ME, 1977, MOSQ NEWS, V37, P11; Spina F, 2008, ATLANTA MIGRAZIONE U; Stojanovich CJ, 1997, MOSQUITOES ITALIAN B; Sutherland GL, 2007, J AM MOSQUITO CONTR, V23, P389, DOI 10.2987/5630.1; Tamba M, 2011, VECTOR-BORNE ZOONOT, V11, P551, DOI 10.1089/vbz.2010.0055; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang YL, 2006, J CLIN VIROL, V36, P177, DOI 10.1016/j.jcv.2006.02.008; Tesh RB, 2005, J INFECT DIS, V192, P287, DOI 10.1086/431153; Turell MJ, 2001, J MED ENTOMOL, V38, P130, DOI 10.1603/0022-2585-38.2.130; Unlu I, 2010, J VECTOR ECOL, V35, P95, DOI 10.1111/j.1948-7134.2010.00034.x; Vazquez A, 2011, EUROSURVEILLANCE, V16, P22; Weissenbock H, 2002, EMERG INFECT DIS, V8, P652, DOI 10.3201/eid0807.020094; Weissenbock H, 2007, ECOL CONT VECTOR-BOR, V1, P153	71	44	45	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63978	10.1371/journal.pone.0063978	http://dx.doi.org/10.1371/journal.pone.0063978			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667694	gold, Green Published, Green Submitted			2022-12-25	WOS:000319654700198
J	Feizi, A; Osterlund, T; Petranovic, D; Bordel, S; Nielsen, J				Feizi, Amir; Osterlund, Tobias; Petranovic, Dina; Bordel, Sergio; Nielsen, Jens			Genome-Scale Modeling of the Protein Secretory Machinery in Yeast	PLOS ONE			English	Article							BIOSYNTHESIS; PATHWAY; PYROPHOSPHORYLASE; TRANSLOCATION; TRAFFICKING; INFORMATION; EUKARYOTES; MECHANISMS; EXPRESSION; PHENOTYPE	The protein secretory machinery in Eukarya is involved in post-translational modification (PTMs) and sorting of the secretory and many transmembrane proteins. While the secretory machinery has been well-studied using classic reductionist approaches, a holistic view of its complex nature is lacking. Here, we present the first genome-scale model for the yeast secretory machinery which captures the knowledge generated through more than 50 years of research. The model is based on the concept of a Protein Specific Information Matrix (PSIM: characterized by seven PTMs features). An algorithm was developed which mimics secretory machinery and assigns each secretory protein to a particular secretory class that determines the set of PTMs and transport steps specific to each protein. Protein abundances were integrated with the model in order to gain system level estimation of the metabolic demands associated with the processing of each specific protein as well as a quantitative estimation of the activity of each component of the secretory machinery.	[Feizi, Amir; Osterlund, Tobias; Petranovic, Dina; Bordel, Sergio; Nielsen, Jens] Chalmers Univ Technol, Novo Nordisk Fdn Ctr Biosustainabil, S-41296 Gothenburg, Sweden; [Nielsen, Jens] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Horsholm, Denmark	Chalmers University of Technology; Technical University of Denmark; Technical University of Denmark	Nielsen, J (corresponding author), Chalmers Univ Technol, Novo Nordisk Fdn Ctr Biosustainabil, S-41296 Gothenburg, Sweden.	nielsenj@chalmers.se	Bordel, Sergio/A-3325-2017; Nielsen, Jens/Q-1347-2017	Bordel, Sergio/0000-0001-6162-6478; Petranovic, Dina/0000-0001-8724-3942; Nielsen, Jens/0000-0002-9955-6003	Novo Nordisk Foundation; European Research Council (ERC) [247013]; Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); European Research Council (ERC)(European Research Council (ERC)European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation)	Novo Nordisk Foundation and the European Research Council (ERC grant no. 247013) provided the funding for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; BENNETT MK, 1993, P NATL ACAD SCI USA, V90, P2559, DOI 10.1073/pnas.90.7.2559; Bharadwaj P, 2010, FEMS YEAST RES, V10, P961, DOI 10.1111/j.1567-1364.2010.00658.x; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Chavrier P, 1999, CURR OPIN CELL BIOL, V11, P466, DOI 10.1016/S0955-0674(99)80067-2; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; Dacks JB, 2007, J CELL SCI, V120, P2977, DOI 10.1242/jcs.013250; DARAN JM, 1995, EUR J BIOCHEM, V233, P520, DOI 10.1111/j.1432-1033.1995.520_2.x; de Groot PWJ, 2001, COMP FUNCT GENOM, V2, P124, DOI 10.1002/cfg.85; Dempski RE, 2002, CURR OPIN CHEM BIOL, V6, P844, DOI 10.1016/S1367-5931(02)00390-3; Ding Y, 2012, TRENDS PLANT SCI, V17, P606, DOI 10.1016/j.tplants.2012.06.004; Engling A, 2002, J CELL SCI, V115, P3619, DOI 10.1242/jcs.00036; Ferreira T, 2002, J BIOL CHEM, V277, P21027, DOI 10.1074/jbc.M112281200; Freeze HH, 2006, NAT REV GENET, V7, P537, DOI 10.1038/nrg1894; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gupta R, 1999, NUCLEIC ACIDS RES, V27, P370, DOI 10.1093/nar/27.1.370; HANSEN W, 1986, CELL, V45, P397, DOI 10.1016/0092-8674(86)90325-9; Hashimoto H, 1997, J BIOL CHEM, V272, P16308, DOI 10.1074/jbc.272.26.16308; Horton AC, 2004, NAT CELL BIOL, V6, P585, DOI 10.1038/ncb0704-585; Hou J, 2012, FEMS YEAST RES; Idiris A, 2010, APPL MICROBIOL BIOT, V86, P403, DOI 10.1007/s00253-010-2447-0; Karr JR, 2012, CELL, V150, P389, DOI 10.1016/j.cell.2012.05.044; KLIONSKY DJ, 1989, EMBO J, V8, P2241, DOI 10.1002/j.1460-2075.1989.tb08348.x; Lee TY, 2006, NUCLEIC ACIDS RES, V34, pD622, DOI 10.1093/nar/gkj083; Lewis NE, 2012, NAT REV MICROBIOL, V10, P291, DOI 10.1038/nrmicro2737; Lipke PN, 1998, J BACTERIOL, V180, P3735, DOI 10.1128/JB.180.15.3735-3740.1998; Magrane M, 2011, UNIPROT KNOWLEDGEBAS; Matlack KES, 1999, CELL, V97, P553, DOI 10.1016/S0092-8674(00)80767-9; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; Mercado G, 2013, TRENDS MOL MED; Milewski S, 2006, YEAST, V23, P1, DOI 10.1002/yea.1337; Nickel W, 2011, UNCONVENTIONAL SECRE; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Nielsen J, 2013, BIOENGINEERED, V4, P207, DOI 10.4161/bioe.22856; Nombela C, 2006, TRENDS MICROBIOL, V14, P15, DOI 10.1016/j.tim.2005.11.009; NOVICK P, 1981, CELL, V25, P461, DOI 10.1016/0092-8674(81)90064-7; OGG SC, 1992, MOL BIOL CELL, V3, P895, DOI 10.1091/mbc.3.8.895; Orlean P., 1997, MOL CELLULAR BIOL YE, V21, P229; PARODI AJ, 1979, J BIOL CHEM, V254, P51; Payne T, 2008, APPL ENVIRON MICROB, V74, P7759, DOI 10.1128/AEM.01178-08; Reynaud EG, 2002, EMBO REP, V3, P828, DOI 10.1093/embo-reports/kvf185; Robinson AS, 1996, J BIOL CHEM, V271, P10017, DOI 10.1074/jbc.271.17.10017; Rocha Isabel, 2008, V416, P409, DOI 10.1007/978-1-59745-321-9_29; Schekman R, 2010, MOL BIOL CELL, V21, P3781, DOI 10.1091/mbc.E10-05-0416; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shao SC, 2011, ANNU REV CELL DEV BI, V27, P25, DOI 10.1146/annurev-cellbio-092910-154125; Shelikoff M, 1996, BIOTECHNOL BIOENG, V50, P73, DOI 10.1002/(SICI)1097-0290(19960405)50:1<73::AID-BIT9>3.0.CO;2-Z; SIMONS JF, 1995, J CELL BIOL, V130, P41, DOI 10.1083/jcb.130.1.41; Smits GJ, 2001, MICROBIOL-SGM, V147, P781, DOI 10.1099/00221287-147-4-781; Steel GJ, 2004, SCIENCE, V303, P98, DOI 10.1126/science.1092287; Stephanopoulos G., 1998, METAB ENG; Tenreiro S, 2010, FEMS YEAST RES, V10, P970, DOI 10.1111/j.1567-1364.2010.00649.x; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; Thiele I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000312; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; Tu BP, 2002, MOL CELL, V10, P983, DOI 10.1016/S1097-2765(02)00696-2; VALLS LA, 1990, J CELL BIOL, V111, P361, DOI 10.1083/jcb.111.2.361; Varki A, 2011, COLD SPRING HARBOR P, V3; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Winklhofer KF, 2006, HANDB EXP PHARM, V172, P221; Ye Y, 2001, MIGRATION, V276, P7327; Zanetti G, 2012, NAT CELL BIOL, V14, P20, DOI 10.1038/ncb2390; ZHOURAVLEVA G, 1995, EMBO J, V14, P4065, DOI 10.1002/j.1460-2075.1995.tb00078.x	63	50	52	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63284	10.1371/journal.pone.0063284	http://dx.doi.org/10.1371/journal.pone.0063284			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667601	gold, Green Published, Green Submitted			2022-12-25	WOS:000319654700131
J	Lin, YW; Li, AL; Grasso, V; Battaglia, D; Crino, A; Colombo, C; Barbetti, F; Nichols, CG				Lin, Yu-Wen; Li, Anlong; Grasso, Valeria; Battaglia, Domenica; Crino, Antonino; Colombo, Carlo; Barbetti, Fabrizio; Nichols, Colin G.			Functional Characterization of a Novel KCNJ11 in Frame Mutation-Deletion Associated with Infancy-Onset Diabetes and a Mild Form of Intermediate DEND: A Battle between K-ATP Gain of Channel Activity and Loss of Channel Expression	PLOS ONE			English	Article							ACTIVATING MUTATIONS; NEUROLOGICAL FEATURES; POTASSIUM CHANNELS; KIR6.2 MUTATIONS; INSULIN; REGION	ATP-sensitive potassium (K-ATP) channels are widely distributed in various tissues and cell types where they couple cell metabolism to cell excitability. Gain of channel function (GOF) mutations in the genes encoding Kir6.2 (KCNJ11) or the associated regulatory ssulfonylurea receptor 1 subunit (ABCC8), cause developmental delay, epilepsy and neonatal diabetes (DEND) due to suppressed cell excitability in pancreatic beta-cells and neurons. The objective of this study was to determine the molecular basis of infancy-onset diabetes and a mild form of intermediate DEND, resulting from a novel KCNJ11 in frame mutation plus deletion. The naturally occurring Kir6.2 mutation plus deletion (Ser225Thr, Pro226_Pro232del) as well as the isolated S225T mutation or isolated del226-232 deletion were coexpressed with SUR1 in COS cells in homozygous or heterozygous states. The protein expression and gating effects of the resulting channels were assessed biochemically and electrophysiologically. For both the deletion and point mutations, simulated heterozygous expression resulted in overall increased conductance in intact cells in basal conditions and rightward shifted ATP dose-response curves in excised patches, due to increased intrinsic open probability. Interestingly, homomeric channels for the combined deletion/mutation, or for the deletion alone, showed dramatically reduced channel expression at the cell membrane, which would underlie a reduced function in vivo. These results demonstrate that both the mis-sense mutation and the deleted region in the Kir6.2 subunit are important for control of the intrinsic channel gating and suggest that the clinical presentation could be affected by the competition between loss-of-function by reduced trafficking and enhanced channel gating.	[Lin, Yu-Wen; Li, Anlong; Nichols, Colin G.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Lin, Yu-Wen; Li, Anlong; Nichols, Colin G.] Washington Univ, Sch Med, Ctr Invest Membrane Excitabil Dis, St Louis, MO 63110 USA; [Grasso, Valeria; Colombo, Carlo; Barbetti, Fabrizio] Univ Roma Tor Vergata, Lab Mendelian Diabet, Bambino Gesu Childrens Hosp, Res Inst, Rome, Italy; [Battaglia, Domenica] Sacro Cuore Catholic Univ, Dept Pediat, Child Neurol Unit, Rome, Italy; [Crino, Antonino] Bambino Gesu Pediat Hosp, Res Inst, Dept Endocrinol, Autoimmune Endocrine Dis Unit, Rome, Italy; [Barbetti, Fabrizio] Univ Roma Tor Vergata, Dept Internal Med, Rome, Italy	Washington University (WUSTL); Washington University (WUSTL); IRCCS Bambino Gesu; University of Rome Tor Vergata; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS Bambino Gesu; University of Rome Tor Vergata	Nichols, CG (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.	cnichols@wustl.edu	Barbetti, Fabrizio/AAK-9106-2021; BATTAGLIA, DOMENICA IMMACOLATA/AAA-5951-2019; Barbetti, Fabrizio/I-7351-2018	Barbetti, Fabrizio/0000-0003-4687-980X; Barbetti, Fabrizio/0000-0003-4687-980X; Crino, Antonino/0000-0003-3548-7114; BATTAGLIA, Domenica Immacolata/0000-0003-0491-4021	grant Fondazione Roma' Molecular mechanisms in the pathogenesis of type 2 diabetes mellitus and its cardiovascular complications'; NIH [DK69445]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069445, P30DK020579] Funding Source: NIH RePORTER	grant Fondazione Roma' Molecular mechanisms in the pathogenesis of type 2 diabetes mellitus and its cardiovascular complications'; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the grant Fondazione Roma' Molecular mechanisms in the pathogenesis of type 2 diabetes mellitus and its cardiovascular complications' (to FB) and NIH grant DK69445 (to CGN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; Battaglia D, 2012, PEDIAT DIAB IN PRESS; Codner E, 2005, DIABETES CARE, V28, P758, DOI 10.2337/diacare.28.3.758; Edghill EL, 2010, REV ENDOCR METAB DIS, V11, P193, DOI 10.1007/s11154-010-9149-x; Enkvetchakul D, 2000, BIOPHYS J, V78, P2334, DOI 10.1016/S0006-3495(00)76779-8; Flanagan SE, 2006, DIABETOLOGIA, V49, P1190, DOI 10.1007/s00125-006-0246-z; FLANAGAN SE, 2008, HUM MUTAT; Girard CAJ, 2006, PFLUG ARCH EUR J PHY, V453, P323, DOI 10.1007/s00424-006-0112-3; Gloyn AL, 2004, NEW ENGL J MED, V350, P1838, DOI 10.1056/NEJMoa032922; Gloyn AL, 2006, EUR J HUM GENET, V14, P824, DOI 10.1038/sj.ejhg.5201629; Kline CF, 2009, P NATL ACAD SCI USA, V106, P16669, DOI 10.1073/pnas.0907138106; Koster JC, 2008, BIOPHYS J, V95, P4689, DOI 10.1529/biophysj.108.138685; Li JD, 2010, J BIOL CHEM, V285, P28723, DOI 10.1074/jbc.M110.147868; Loechner KJ, 2011, DIABETES, V60, P209, DOI 10.2337/db10-0731; Masia R, 2007, DIABETES, V56, P1357, DOI 10.2337/db06-1746; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Pearson ER, 2006, NEW ENGL J MED, V355, P467, DOI 10.1056/NEJMoa061759; Proks P, 2004, P NATL ACAD SCI USA, V101, P17539, DOI 10.1073/pnas.0404756101; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310	20	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63758	10.1371/journal.pone.0063758	http://dx.doi.org/10.1371/journal.pone.0063758			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667671	gold, Green Published, Green Submitted			2022-12-25	WOS:000319654700185
J	Sarafian, TA; Ryan, CM; Souda, P; Masliah, E; Kar, UK; Vinters, HV; Mathern, GW; Faull, KF; Whitelegge, JP; Watson, JB				Sarafian, Theodore A.; Ryan, Christopher M.; Souda, Puneet; Masliah, Eliezer; Kar, Upendra K.; Vinters, Harry V.; Mathern, Gary W.; Faull, Kym F.; Whitelegge, Julian P.; Watson, Joseph B.			Impairment of Mitochondria in Adult Mouse Brain Overexpressing Predominantly Full-Length, N-Terminally Acetylated Human alpha-Synuclein	PLOS ONE			English	Article							PARKINSONS-DISEASE; COMPLEX-I; POSTTRANSLATIONAL MODIFICATIONS; MICE; AGGREGATION; PLASTICITY; PROTEINS; MODEL; PHOSPHORYLATION; ACCUMULATION	While most forms of Parkinson's Disease (PD) are sporadic in nature, a small percentage of PD have genetic causes as first described for dominant, single base pair changes as well as duplication and triplication in the alpha-synuclein gene. The alpha-synuclein gene encodes a 140 amino acid residue protein that interacts with a variety of organelles including synaptic vesicles, lysosomes, endoplasmic reticulum/Golgi vesicles and, reported more recently, mitochondria. Here we examined the structural and functional interactions of human alpha-synuclein with brain mitochondria obtained from an early, pre-manifest mouse model for PD over-expressing human alpha-synuclein (ASOTg). The membrane potential in ASOTg brain mitochondria was decreased relative to wildtype (WT) mitochondria, while reactive oxygen species (ROS) were elevated in ASOTg brain mitochondria. No selective interaction of human alpha-synuclein with mitochondrial electron transport complexes cl-cV was detected. Monomeric human alpha-synuclein plus carboxyl terminally truncated forms were the predominant isoforms detected in ASOTg brain mitochondria by 2-dimensional PAGE (Native/SDS) and immunoblotting. Oligomers or fibrils were not detected with amyloid conformational antibodies. Mass spectrometry of human alpha-synuclein in both ASOTg brain mitochondria and homogenates from surgically resected human cortex demonstrated that the protein was full-length and postranslationally modified by N-terminal acetylation. Overall the study showed that accumulation of full-length, N-terminally acetylated human alpha-synuclein was sufficient to disrupt brain mitochondrial function in adult mice.	[Sarafian, Theodore A.; Ryan, Christopher M.; Souda, Puneet; Kar, Upendra K.; Mathern, Gary W.; Faull, Kym F.; Whitelegge, Julian P.; Watson, Joseph B.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Masliah, Eliezer] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; [Vinters, Harry V.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Mathern, Gary W.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California San Diego; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Watson, JB (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA.	jwatson@mednet.ucla.edu	Kar, Upendra K/H-5250-2012; Mathern, Gary W./J-2483-2016	Kar, Upendra K/0000-0003-4065-0860; 	Center for Gene Environment Studies in Parkinson's Disease (CGEP) at UCLA [NIH U54 ES016732]; UCLA Academic Senate's Committee on Research; NIH [AG18440, AG022074]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES016732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS049134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018440, P01AG022074, P50AG005131, R37AG018440] Funding Source: NIH RePORTER	Center for Gene Environment Studies in Parkinson's Disease (CGEP) at UCLA; UCLA Academic Senate's Committee on Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The project was supported by a Pilot Grant (JBW) from the Center for Gene Environment Studies in Parkinson's Disease (CGEP) at UCLA (NIH U54 ES016732), a Faculty Research Grant (JBW) from the UCLA Academic Senate's Committee on Research, and NIH AG18440 and AG022074 grants (EM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Banerjee K, 2010, FEBS LETT, V584, P1571, DOI 10.1016/j.febslet.2010.03.012; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bayir H, 2009, J BIOL CHEM, V284, P15951, DOI 10.1074/jbc.M900418200; Blumcke I, 2011, EPILEPSIA, V52, P158, DOI 10.1111/j.1528-1167.2010.02777.x; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Bueler H, 2009, EXP NEUROL, V218, P235, DOI 10.1016/j.expneurol.2009.03.006; Burre J, 2012, J NEUROSCI, V32, P15227, DOI 10.1523/JNEUROSCI.3545-12.2012; Cabin DE, 2002, J NEUROSCI, V22, P8797; Cannon JR, 2009, NEUROBIOL DIS, V34, P279, DOI 10.1016/j.nbd.2009.01.016; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chang JW, 2012, J NEUROSCI METH, V211, P289, DOI 10.1016/j.jneumeth.2012.09.005; Chang JW, 1997, J NEUROPATH EXP NEUR, V56, P1105, DOI 10.1097/00005072-199710000-00004; Chinta SJ, 2010, NEUROSCI LETT, V486, P235, DOI 10.1016/j.neulet.2010.09.061; Clayton DF, 1998, TRENDS NEUROSCI, V21, P249, DOI 10.1016/S0166-2236(97)01213-7; Cummings DM, 2012, J NEUROPHYSIOL, V107, P677, DOI 10.1152/jn.00762.2011; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; Dudkina NV, 2010, BBA-BIOENERGETICS, V1797, P664, DOI 10.1016/j.bbabio.2009.12.013; Ellis CE, 2005, MOL CELL BIOL, V25, P10190, DOI 10.1128/MCB.25.22.10190-10201.2005; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Fernagut PO, 2007, SYNAPSE, V61, P991, DOI 10.1002/syn.20456; Fleming SM, 2006, NEUROSCIENCE, V142, P1245, DOI 10.1016/j.neuroscience.2006.07.005; Fleming SM, 2008, EUR J NEUROSCI, V28, P247, DOI 10.1111/j.1460-9568.2008.06346.x; Fleming SM, 2004, J NEUROSCI, V24, P9434, DOI 10.1523/JNEUROSCI.3080-04.2004; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Graham J M, 1993, Methods Mol Biol, V19, P29; Gundersen CB, 2010, BRAIN RES, V1332, P1, DOI 10.1016/j.brainres.2010.03.044; Hsu LJ, 2000, AM J PATHOL, V157, P401, DOI 10.1016/S0002-9440(10)64553-1; Johnson MW, 1997, J NEUROSCI METH, V77, P151, DOI 10.1016/S0165-0270(97)00120-9; Kang LJ, 2012, PROTEIN SCI, V21, P911, DOI 10.1002/pro.2088; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; Kubo S, 2005, J BIOL CHEM, V280, P31664, DOI 10.1074/jbc.M504894200; Laganowsky A, 2012, SCIENCE, V335, P1228, DOI 10.1126/science.1213151; Lam HA, 2011, J NEUROSCI RES, V89, P1091, DOI 10.1002/jnr.22611; Larsen KE, 2006, J NEUROSCI, V26, P11915, DOI 10.1523/JNEUROSCI.3821-06.2006; Lee KW, 2011, J NEUROSCI, V31, P6963, DOI 10.1523/JNEUROSCI.6513-10.2011; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; Li WX, 2005, P NATL ACAD SCI USA, V102, P2162, DOI 10.1073/pnas.0406976102; Liu GW, 2009, NEUROSCI LETT, V454, P187, DOI 10.1016/j.neulet.2009.02.056; Loeb V, 2010, J BIOL CHEM, V285, P7334, DOI 10.1074/jbc.M109.061051; Manning-Bog AB, 2003, J NEUROSCI, V23, P3095; Maroteaux L, 1991, BRAIN RES MOL BRAIN, V11, P35; Martin I, 2011, ANNU REV GENOM HUM G, V12, P301, DOI 10.1146/annurev-genom-082410-101440; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; McLean JR, 2012, MOL CELL NEUROSCI, V49, P230, DOI 10.1016/j.mcn.2011.11.006; Muntane G, 2012, NEUROSCIENCE, V200, P106, DOI 10.1016/j.neuroscience.2011.10.042; Nakamura K, 2011, J BIOL CHEM, V286, P20710, DOI 10.1074/jbc.M110.213538; Nakamura K, 2008, J NEUROSCI, V28, P12305, DOI 10.1523/JNEUROSCI.3088-08.2008; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Oueslati A, 2010, PROG BRAIN RES, V183, P115, DOI 10.1016/S0079-6123(10)83007-9; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Rahimi F, 2008, CURR ALZHEIMER RES, V5, P319, DOI 10.2174/156720508784533358; Rockenstein E, 2002, J NEUROSCI RES, V68, P568, DOI 10.1002/jnr.10231; Ryan CM, 2010, MOL CELL PROTEOMICS, V9, P791, DOI 10.1074/mcp.M900516-MCP200; Ryan CM, 2010, J AM SOC MASS SPECTR, V21, P908, DOI 10.1016/j.jasms.2010.01.025; Sarafian TA, 2006, AM J PHYSIOL-LUNG C, V290, pL1202, DOI 10.1152/ajplung.00371.2005; Sarafian TA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009532; Sasse J., 1991, CURRENT PROTOCOLS MO, V2; SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x; Shaw BF, 2008, J BIOL CHEM, V283, P8340, DOI 10.1074/jbc.M707751200; Steiner JA, 2011, CELL DEATH DIFFER, V18, P1425, DOI 10.1038/cdd.2011.53; Trancikova A, 2012, ANTIOXID REDOX SIGN, V16, P896, DOI 10.1089/ars.2011.4200; Trexler AJ, 2012, PROTEIN SCI, V21, P601, DOI 10.1002/pro.2056; Ullman O, 2011, J AM CHEM SOC, V133, P19536, DOI 10.1021/ja208657z; Velde CV, 2008, P NATL ACAD SCI USA, V105, P4022, DOI 10.1073/pnas.0712209105; Wang W, 2011, P NATL ACAD SCI USA, V108, P17797, DOI 10.1073/pnas.1113260108; Watson JB, 2006, J NEUROSCI RES, V84, P1564, DOI 10.1002/jnr.21040; Watson JB, 2009, NEUROSCIENCE, V159, P501, DOI 10.1016/j.neuroscience.2009.01.021; Whitelegge JP, 2007, INT J MASS SPECTROM, V268, P190, DOI 10.1016/j.ijms.2007.08.008; Whitellegge JP, 2009, COMPR ANAL CHEM, V52; Wu N, 2010, J NEUROSCI RES, V88, P1764, DOI 10.1002/jnr.22327; Xie J, 2007, FEBS LETT, V581, P3545, DOI 10.1016/j.febslet.2007.06.052; Zeevalk GD, 2008, BIOMED PHARMACOTHER, V62, P236, DOI 10.1016/j.biopha.2008.01.017; Zhu YG, 2011, INT J BIOCHEM CELL B, V43, P732, DOI 10.1016/j.biocel.2011.01.014; Zigoneanu IG, 2012, BBA-BIOMEMBRANES, V1818, P512, DOI 10.1016/j.bbamem.2011.11.024	79	31	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63557	10.1371/journal.pone.0063557	http://dx.doi.org/10.1371/journal.pone.0063557			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667637	Green Published, gold			2022-12-25	WOS:000319654700160
J	Shih, HC; Hwang, TL; Chen, HC; Kuo, PC; Lee, EJ; Lee, KH; Wu, TS				Shih, Hung-Cheng; Hwang, Tsong-Long; Chen, Hung-Chung; Kuo, Ping-Chung; Lee, E-Jian; Lee, Kuo-Hsiung; Wu, Tian-Shung			Honokiol Dimers and Magnolol Derivatives with New Carbon Skeletons from the Roots of Magnolia officinalis and Their Inhibitory Effects on Superoxide Anion Generation and Elastase Release	PLOS ONE			English	Article							STEM BARK; NEOLIGNANS; MICE; EXTRACT; CELLS; PLANT	Two honokiol dimers, houpulins A and B (1 and 2), and two magnolol derivatives, houpulins C and D (3 and 4), were isolated and characterized from an ethanol extract obtained from the roots of Magnolia officinalis. The chemical structures were determined based on spectroscopic and physicochemical analyses, which included 1D and 2D NMR, as well as mass spectrometry data. These four oligomers possess new carbon skeletons postulated to be biosynthesized from the coupling of three or four C-6-C-3 subunits. In addition, the new oligomers were evaluated for inhibition of superoxide anion generation and elastase release, and houpulin B (2) was identified as a new anti-inflammatory lead compound.	[Shih, Hung-Cheng; Chen, Hung-Chung; Wu, Tian-Shung] Natl Cheng Kung Univ, Dept Chem, Tainan 70101, Taiwan; [Hwang, Tsong-Long] Chang Gung Univ, Grad Inst Nat Prod, Coll Med, Tao Yuan, Taiwan; [Hwang, Tsong-Long] Chang Gung Univ, Chinese Herbal Med Res Team, Hlth Aging Res Ctr, Coll Med, Tao Yuan, Taiwan; [Kuo, Ping-Chung] Natl Formosa Univ, Dept Biotechnol, Yunlin, Taiwan; [Lee, E-Jian] Natl Cheng Kung Univ, Med Ctr, Dept Surg, Tainan 70101, Taiwan; [Lee, E-Jian] Natl Cheng Kung Univ, Med Ctr, Dept Anesthesiol, Tainan 70101, Taiwan; [Lee, E-Jian] Natl Cheng Kung Univ, Med Ctr, Inst Biomed Engn, Tainan 70101, Taiwan; [Lee, E-Jian] Sch Med, Tainan, Taiwan; [Lee, Kuo-Hsiung] Univ N Carolina, Nat Prod Res Labs, UNC Eshelman Sch Pharm, Chapel Hill, NC USA; [Lee, Kuo-Hsiung; Wu, Tian-Shung] China Med Univ & Hosp, Chinese Med Res & Dev Ctr, Taichung, Taiwan; [Wu, Tian-Shung] China Med Univ, Dept Pharm, Taichung, Taiwan	National Cheng Kung University; Chang Gung University; Chang Gung University; National Formosa University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; University of North Carolina; University of North Carolina Chapel Hill; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Wu, TS (corresponding author), Natl Cheng Kung Univ, Dept Chem, Tainan 70101, Taiwan.	tswu@mail.ncku.edu.tw	Hwang, Tsong-Long/AAE-6944-2020	Hwang, Tsong-Long/0000-0002-5780-3977; Kuo, Ping-Chung/0000-0003-3019-1138	National Science Council, Taiwan, Republic of China; National Cheng Kung University	National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan); National Cheng Kung University	This work was supported by a grant from the National Science Council, Taiwan, Republic of China, which was awarded to T.S. Wu. This study was also supported, in part, by the National Cheng Kung University. The funders had no role in study design, data collections and analysis, decision to publish, or preparation of the manuscript.	Antus S, 2001, CHIRALITY, V13, P493, DOI 10.1002/chir.1067; Bae FA, 1998, BIOL PHARM BULL, V21, P990, DOI 10.1248/bpb.21.990; Chao LK, 2010, J AGR FOOD CHEM, V58, P3472, DOI 10.1021/jf904207m; Chen CR, 2011, BRIT J PHARMACOL, V164, P1534, DOI 10.1111/j.1476-5381.2011.01456.x; Ho KY, 2001, PHYTOTHER RES, V15, P139, DOI 10.1002/ptr.736; Hu YJ, 2011, J SCI FOOD AGR, V91, P1050, DOI 10.1002/jsfa.4280; KONOSHIMA T, 1991, J NAT PROD, V54, P816, DOI 10.1021/np50075a010; KOUNO I, 1994, CHEM PHARM BULL, V42, P112, DOI 10.1248/cpb.42.112; KOUNO I, 1989, CHEM PHARM BULL, V37, P1291; Munroe ME, 2010, J IMMUNOL, V185, P5586, DOI 10.4049/jimmunol.1000630; Nakazawa T, 2003, J PHARM PHARMACOL, V55, P1583, DOI 10.1211/0022357022188; Shen CC, 2009, J NAT PROD, V72, P168, DOI 10.1021/np800494e; Shigemura K, 2007, CANCER-AM CANCER SOC, V109, P1279, DOI 10.1002/cncr.22551; Sy LK, 1998, J CHEM RES-S, P476, DOI 10.1039/a801620h; Syu WJ, 2004, CHEM BIODIVERS, V1, P530, DOI 10.1002/cbdv.200490046; Tintinger Gregory R, 2009, Drug Des Devel Ther, V2, P95; Vaid M, 2010, CARCINOGENESIS, V31, P2004, DOI 10.1093/carcin/bgq186; Wang YM, 2005, PHYTOTHER RES, V19, P526, DOI 10.1002/ptr.1697; YAHARA S, 1991, CHEM PHARM BULL, V39, P2024, DOI 10.1248/cpb.39.2024; Yang ML, 2011, BIOORGAN MED CHEM, V19, P1674, DOI 10.1016/j.bmc.2011.01.034; Yang SE, 2003, BRIT J PHARMACOL, V138, P193, DOI 10.1038/sj.bjp.0705024; Yang Y, 2010, J ASIAN NAT PROD RES, V12, P194, DOI 10.1080/10286020903501577; Youn UJ, 2007, J NAT PROD, V70, P1687, DOI 10.1021/np070388c	23	20	21	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e59502	10.1371/journal.pone.0059502	http://dx.doi.org/10.1371/journal.pone.0059502			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667420	gold, Green Published, Green Submitted			2022-12-25	WOS:000319654700003
J	Stanton, CK; Rawlins, B; Drake, M; dos Anjos, M; Cantor, D; Chongo, L; Chavane, L; Vaz, MD; Ricca, J				Stanton, Cynthia K.; Rawlins, Barbara; Drake, Mary; dos Anjos, Matias; Cantor, David; Chongo, Lidia; Chavane, Leonardo; Vaz, Maria da Luz; Ricca, Jim			Measuring Coverage in MNCH: Testing the Validity of Women's Self-Report of Key Maternal and Newborn Health Interventions during the Peripartum Period in Mozambique	PLOS ONE			English	Article							MEDICAL-RECORDS; OBSTETRIC COMPLICATIONS; PERINATAL EVENTS; BIRTH-WEIGHT; RECALL BIAS; PREGNANCY; AGREEMENT; MOTHERS; CHILDBIRTH; VALIDATION	Background: As low-income countries strive to meet targets for Millennium Development Goals 4 and 5, there is growing need to track coverage and quality of high-impact peripartum interventions. At present, nationally representative household surveys conducted in low-income settings primarily measure contact with the health system, shedding little light on content or quality of care. The objective of this study is to validate the ability of women in Mozambique to report on facility-based care they and their newborns received during labor and one hour postpartum. Methods and Findings: The study involved household interviews with women in Mozambique whose births were observed eight to ten months previously as part of a survey of the quality of maternal and newborn care at government health facilities. Of 487 women whose births were observed and who agreed to a follow-up interview, 304 were interviewed (62.4%). The validity of 34 indicators was tested using two measures: area under receiver operator characteristic curve (AUC) and inflation factor (IF); 27 indicators had sufficient numbers for robust analysis, of which four met acceptability criteria for both (AUC >0.6 and 0.75<IF<1.25). Two of these indicators are considered high demand and are recommended for incorporation into international survey programs: presence of a support person during labor/delivery and placement of the newborn skin to skin against the mother. Nine indicators met acceptability criteria for one of the validity measures. All 13 indicators are recommended for use in in-depth maternal/newborn health surveys. Conclusions: Women are able to report on some aspects of peripartum care. Larger studies may be able to validate some indicators that this study could not assess due to the sample size. Future qualitative research may assist in improving question formulation for some indicators. Studies of similar design in other low-income settings are needed to confirm these results.	[Stanton, Cynthia K.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Rawlins, Barbara; Drake, Mary; Cantor, David; Ricca, Jim] Maternal & Child Hlth Integrated Program, Washington, DC USA; [dos Anjos, Matias; Chavane, Leonardo; Vaz, Maria da Luz] Maternal & Child Hlth Integrated Program, Maputo, Mozambique; [Chongo, Lidia] Mozamb Minist Hlth, Maputo, Mozambique	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Stanton, CK (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA.	cstanton@jhsph.edu	Chavane, Leonardo António/M-3198-2019	Chavane, Leonardo António/0000-0001-7382-0665	Maternal and Child Health Integrated Program; United States Agency for International Development in Washington, D.C.; Bill & Melinda Gates Foundation	Maternal and Child Health Integrated Program; United States Agency for International Development in Washington, D.C.(United States Agency for International Development (USAID)); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study was funded by the Maternal and Child Health Integrated Program, led by Jhpiego, via their funding from the United States Agency for International Development in Washington, D.C. Technical assistance was provided by the Child Health Epidemiology Reference Group (CHERG) for WHO and UNICEF, with financial support from The Bill & Melinda Gates Foundation through their grant to the US Fund for UNICEF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, WOMENS RECALL DELIVE; BENNETT A, 1985, BIRTH-ISS PERINAT C, V12, P153, DOI 10.1111/j.1523-536X.1985.tb00954.x; Brhlikova P, 2009, J HLTH STUD, V2, P33; BRYANT HE, 1989, AM J PUBLIC HEALTH, V79, P78, DOI 10.2105/AJPH.79.1.78; Bryce J, 2012, COUNTDOWN 2015 MATER; Buka SL, 2004, SCHIZOPHR RES, V71, P417, DOI 10.1016/j.schres.2004.04.004; Campbell H, 2008, CROAT MED J, V49, P402, DOI 10.3325/cmj.2008.3.402; CASEY R, 1992, CLIN PEDIATR, V31, P200, DOI 10.1177/000992289203100402; DELGADORODRIGUEZ M, 1995, J CLIN EPIDEMIOL, V48, P1133, DOI 10.1016/0895-4356(94)00241-H; Elkadry E, 2003, AM J OBSTET GYNECOL, V189, P195, DOI 10.1067/mob.2003.371; Elliott JP, 2010, POPUL HEALTH MANAG, V13, P27, DOI 10.1089/pop.2009.0008; Filippi V, 2000, STUD FAMILY PLANN, V31, P309, DOI 10.1111/j.1728-4465.2000.00309.x; GITHENS PB, 1993, BIRTH-ISS PERINAT C, V20, P136, DOI 10.1111/j.1523-536X.1993.tb00438.x; HAKIM RB, 1992, AM J EPIDEMIOL, V136, P566, DOI 10.1093/oxfordjournals.aje.a116534; HEWSON D, 1987, AM J EPIDEMIOL, V125, P484, DOI 10.1093/oxfordjournals.aje.a114554; Instituto Nacional de Estatistica Mocambique MEASURE DHS.ICF International, 2012, MOC AMBIQUE INQ DEM; Lederman S A, 1998, Matern Child Health J, V2, P123; Liu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060762; MCHIP, 2012, ASS QUAL HUM MAT ANC; Moran AC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001415; Olson JE, 1997, AM J EPIDEMIOL, V145, P58; Pacque M, 2005, SAVING NEWBORN LIVES; Pepe M. S., 2003, STAT EVALUATION MED; Quigley MA, 2007, BJOG-INT J OBSTET GY, V114, P195, DOI 10.1111/j.1471-0528.2006.01203.x; Rice F, 2007, EARLY HUM DEV, V83, P497, DOI 10.1016/j.earlhumdev.2006.09.015; Ronsmans C, 1997, STUD FAMILY PLANN, V28, P203, DOI 10.2307/2137888; Seoane G, 1998, INT J GYNECOL OBSTET, V62, P229, DOI 10.1016/S0020-7292(98)00104-0; Sloan NL, 2001, J HEALTH POPUL NUTR, V19, P45; Stewart MK, 1996, STUD FAMILY PLANN, V27, P29, DOI 10.2307/2138075; STEWART MK, 1995, INT J GYNECOL OBSTET, V48, pS53, DOI 10.1016/0020-7292(95)02320-C; Tate AR, 2005, INT J EPIDEMIOL, V34, P688, DOI 10.1093/ije/dyi029; TILLEY BC, 1985, AM J EPIDEMIOL, V121, P269, DOI 10.1093/oxfordjournals.aje.a113997; Troude P, 2008, EUR J EPIDEMIOL, V23, P557, DOI 10.1007/s10654-008-9268-9; United Nations, 2013, COUNTR PROF MOZ; VECCHIO TJ, 1966, NEW ENGL J MED, V274, P1171, DOI 10.1056/NEJM196605262742104; WHO, 2012, ACC MAT NEWB CHILD S; WHO UNICEF UNFPA, 2003, PREGN CHILDB POSTP N; World Health Organization, 2000, MAN COMPL PREGN CHIL; Yawn BP, 1998, J CLIN EPIDEMIOL, V51, P399, DOI 10.1016/S0895-4356(97)00304-1; Zhou X.H., 2002, STAT METHODS DIAGNOS, DOI 10.1002/9780470317082	40	100	100	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e60694	10.1371/journal.pone.0060694	http://dx.doi.org/10.1371/journal.pone.0060694			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	154EP	23667427	Green Published, Green Submitted, gold			2022-12-25	WOS:000319654700005
J	Stumhofer, JS; Silver, JS; Hunter, CA				Stumhofer, Jason S.; Silver, Jonathan S.; Hunter, Christopher A.			IL-21 Is Required for Optimal Antibody Production and T Cell Responses during Chronic Toxoplasma gondii Infection	PLOS ONE			English	Article							FOLLICULAR-HELPER-CELLS; CHRONIC VIRAL-INFECTION; ARYL-HYDROCARBON RECEPTOR; GERMINAL CENTER RESPONSES; B-CELLS; C-MAF; DIFFERENTIATION; INTERLEUKIN-21; GENERATION; AUTOIMMUNITY	Previous studies have indicated that Il21r(-/-) mice chronically infected with Toxoplasma gondii display a defect in serum IgG; however, the basis for this antibody defect was not defined and questions remain about the role of IL-21 in promoting the production of IL-10, which is required to limit infection-induced pathology during toxoplasmosis. Therefore, Il21(-/-) mice were challenged with T. gondii to determine whether IL-21 impacts the parasite-specific CD8(+) T cell response, its contribution to thymus-dependent antibody production after infection, and balance between protective and pathogenic responses. Whereas IL-21 has been implicated in the differentiation of IL-10 producing CD4(+) T cells no immune-mediated pathology was evident in Il21(-/-) mice during the acute response, nor was there a defect in the development of this population in chronically infected Il21(-/-) mice. However, Il21(-/-) mice displayed a defect in IgG production after infection that correlated with a decrease in GC B cell numbers, the CD4(+) and CD8(+) T cell numbers in the brain were reduced over the course of the chronic infection leading to a decrease in total IFN-gamma production and an increase in parasite numbers associated with susceptibility to toxoplasmic encephalitis. Together, these results identify a key role for IL-21 in shaping the humoral and cellular response to T. gondii, but indicate that IL-21 has a limited role in regulating immunopathology.	[Stumhofer, Jason S.] Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA; [Silver, Jonathan S.; Hunter, Christopher A.] Univ Penn, Dept Pathobiol, Sch Vet Med, Philadelphia, PA 19104 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Pennsylvania	Stumhofer, JS (corresponding author), Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA.	jstumhofer@uams.edu			Commonwealth of Pennsylvania; NIH [AI071302, AI084882, R21-AI090179, 1 P20 GM103625, AI007532]; Arkansas Biosciences Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007532, R01AI071302, R21AI090179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103625] Funding Source: NIH RePORTER	Commonwealth of Pennsylvania; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arkansas Biosciences Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Commonwealth of Pennsylvania, the Arkansas Biosciences Institute, NIH grants AI071302 and AI084882 (C.A.H.), R21-AI090179 and 1 P20 GM103625 (J.S. Stumhofer), T32 Training Grant AI007532 (J.S. Silver). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard EL, 2007, EUR J IMMUNOL, V37, P3069, DOI 10.1002/eji.200637017; Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Bessa J, 2010, J IMMUNOL, V184, P4615, DOI 10.4049/jimmunol.0903949; CROTTY S, 2011, ANN REV IMMUNOL; Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837; Dienz O, 2009, J EXP MED, V206, P69, DOI 10.1084/jem.20081571; Elsaesser H, 2009, SCIENCE, V324, P1569, DOI 10.1126/science.1174182; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; Ferrari-Lacraz S, 2008, INT IMMUNOL, V20, P1009, DOI 10.1093/intimm/dxn059; Frohlich A, 2009, SCIENCE, V324, P1576, DOI 10.1126/science.1172815; GAZZINELLI R, 1992, J IMMUNOL, V149, P175; Goenka R, 2011, J IMMUNOL, V187, P1091, DOI 10.4049/jimmunol.1100853; Johnson LL, 2002, INFECT IMMUN, V70, P185, DOI 10.1128/IAI.70.1.185-191.2002; Jordan KA, 2010, EXP PARASITOL, V126, P318, DOI 10.1016/j.exppara.2010.05.008; Jordan KA, 2009, INFECT IMMUN, V77, P3894, DOI 10.1128/IAI.00024-09; Kang H, 2000, J IMMUNOL, V164, P2629, DOI 10.4049/jimmunol.164.5.2629; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Novy P, 2011, J IMMUNOL, V186, P2729, DOI 10.4049/jimmunol.1003009; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Poholek AC, 2010, J IMMUNOL, V185, P313, DOI 10.4049/jimmunol.0904023; Pot C, 2009, J IMMUNOL, V183, P797, DOI 10.4049/jimmunol.0901233; Sayles PC, 2000, INFECT IMMUN, V68, P1026, DOI 10.1128/IAI.68.3.1026-1033.2000; SHARMA SD, 1983, J IMMUNOL, V131, P977; Spolski R, 2008, CURR OPIN IMMUNOL, V20, P295, DOI 10.1016/j.coi.2008.02.004; Spolski R, 2008, ANNU REV IMMUNOL, V26, P57, DOI 10.1146/annurev.immunol.26.021607.090316; Spolski R, 2010, INT IMMUNOL, V22, P7, DOI 10.1093/intimm/dxp112; Spolski R, 2009, J IMMUNOL, V182, P2859, DOI 10.4049/jimmunol.0802978; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Stumhofer JS, 2007, NAT IMMUNOL; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Villarino AV, 2006, J IMMUNOL, V176, P237, DOI 10.4049/jimmunol.176.1.237; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Williams LD, 2011, J VIROL, V85, P2316, DOI 10.1128/JVI.01476-10; Wilson EH, 2005, J NEUROIMMUNOL, V165, P63, DOI 10.1016/j.jneuroim.2005.04.018; Yi JS, 2009, SCIENCE, V324, P1572, DOI 10.1126/science.1175194; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	40	20	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62889	10.1371/journal.pone.0062889	http://dx.doi.org/10.1371/journal.pone.0062889			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667536	gold, Green Published, Green Submitted			2022-12-25	WOS:000319654700075
J	Doyle, VP; Oudemans, PV; Rehner, SA; Litt, A				Doyle, Vinson P.; Oudemans, Peter V.; Rehner, Stephen A.; Litt, Amy			Habitat and Host Indicate Lineage Identity in Colletotrichum gloeosporioides s.l. from Wild and Agricultural Landscapes in North America	PLOS ONE			English	Article							PHYLOGENETIC SPECIES RECOGNITION; CRANBERRY FRUIT ROT; MOLECULAR CHARACTERIZATION; ECOLOGICAL SPECIATION; GENEALOGICAL APPROACH; PATHOGENICITY; ANTHRACNOSE; COMPLEX; SPP.; CONCORDANCE	Understanding the factors that drive the evolution of pathogenic fungi is central to revealing the mechanisms of virulence and host preference, as well as developing effective disease control measures. Prerequisite to these pursuits is the accurate delimitation of species boundaries. Colletotrichum gloeosporioides s.l. is a species complex of plant pathogens and endophytic fungi for which reliable species recognition has only recently become possible through a multi-locus phylogenetic approach. By adopting an intensive regional sampling strategy encompassing multiple hosts within and beyond agricultural zones associated with cranberry (Vaccinium macrocarpon Aiton), we have integrated North America strains of Colletotrichum gloeosporioides s.l. from these habitats into a broader phylogenetic framework. We delimit species on the basis of genealogical concordance phylogenetic species recognition (GCPSR) and quantitatively assess the monophyly of delimited species at each of four nuclear loci and in the combined data set with the genealogical sorting index (gsi). Our analysis resolved two principal lineages within the species complex. Strains isolated from cranberry and sympatric host plants are distributed across both of these lineages and belong to seven distinct species or terminal clades. Strains isolated from V. macrocarpon in commercial cranberry beds belong to four species, three of which are described here as new. Another species, C. rhexiae Ellis & Everh., is epitypified. Intensive regional sampling has revealed a combination of factors, including the host species from which a strain has been isolated, the host organ of origin, and the habitat of the host species, as useful indicators of species identity in the sampled regions. We have identified three broadly distributed temperate species, C. fructivorum, C. rhexiae, and C. nupharicola, that could be useful for understanding the microevolutionary forces that may lead to species divergence in this important complex of endophytes and plant pathogens.	[Doyle, Vinson P.; Litt, Amy] New York Bot Garden, Bronx, NY 10458 USA; [Doyle, Vinson P.] CUNY, Grad Ctr, New York, NY USA; [Oudemans, Peter V.] Rutgers State Univ, Philip E Marucci Ctr Blueberry & Cranberry Res &, Chatsworth, NJ USA; [Rehner, Stephen A.] ARS, Systemat Mycol & Microbiol Lab, USDA, Beltsville, MD USA	New York Botanical Garden; City University of New York (CUNY) System; Rutgers State University New Brunswick; United States Department of Agriculture (USDA)	Doyle, VP (corresponding author), New York Bot Garden, Bronx, NY 10458 USA.	vinsonpdoyle@gmail.com		Oudemans, Peter/0000-0001-7564-0641; Doyle, Vinson/0000-0002-2350-782X	National Science Foundation [DBI 0749751, DEB 1011120]; Torrey Botanical Society; New York Botanical Garden	National Science Foundation(National Science Foundation (NSF)); Torrey Botanical Society; New York Botanical Garden	Financial support from the National Science Foundation [www.nsf.gov] (DBI 0749751 and DEB 1011120 - Doctoral Dissertation Improvement Grant), the Torrey Botanical Society Graduate Research Fellowship [www.torreybotanical.org], and The New York Botanical Garden [www.nybg.org] helped to fund this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Adaskaveg JE, 2000, COLLETOTRICHUM, P317; AGOSTINI JP, 1994, PHYTOPATHOLOGY, V84, P420, DOI 10.1094/Phyto-84-420; Ane C, 2007, MOL BIOL EVOL, V24, P412; [Anonymous], 1894, P ACAD NAT SCI PHILA; Bailey J. A., 1992, COLLETOTRICHUM BIOL; Bazinet AL, 2009, GENEALOGICALSORTING; BILLS G F, 1992, Sydowia, V44, P1; BRASIER CM, 1995, CAN J BOT, V73, pS1213, DOI 10.1139/b95-381; Cannon PF, 2008, MYCOTAXON, V104, P189; Chakraborty S, 2002, PHYTOPATHOLOGY, V92, P553, DOI 10.1094/PHYTO.2002.92.5.553; CHILTON SJP, 1945, AM J BOT, V32, P549, DOI 10.2307/2437685; Colon-Garay J, 2002, J AGR U PUERTO RICO, V86, P55; Crouch JA, 2006, PHYTOPATHOLOGY, V96, P46, DOI 10.1094/PHYTO-96-0046; Crouch JA, 2009, MYCOLOGIA, V101, P648, DOI 10.3852/08-231; Crouch JA, 2009, MOL ECOL, V18, P123, DOI 10.1111/j.1365-294X.2008.04008.x; Cummings MP, 2008, EVOLUTION, V62, P2411, DOI 10.1111/j.1558-5646.2008.00442.x; Dettman JR, 2003, EVOLUTION, V57, P2703, DOI 10.1554/03-073; Du MZ, 2005, MYCOLOGIA, V97, P641, DOI 10.3852/mycologia.97.3.641; EDGERTON CW, 1945, AM J BOT, V32, P115, DOI 10.2307/2437529; Edgerton CW, 1914, AM J BOT, V1, P244, DOI 10.2307/2435256; Freeman S, 1996, APPL ENVIRON MICROB, V62, P1014, DOI 10.1128/AEM.62.3.1014-1020.1996; Giraud T, 2010, TRENDS ECOL EVOL, V25, P387, DOI 10.1016/j.tree.2010.03.006; Gladieux P, 2011, MOL ECOL, V20, P4521, DOI 10.1111/j.1365-294X.2011.05288.x; Goloboff P, 2008, CLADISTICS, V24, P91; Gonzalez E, 2006, PHYTOPATHOLOGY, V96, P982, DOI 10.1094/PHYTO-96-0982; Halsted B, 1889, SOME FUNGUS DIS CRAN, P1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hyde KD, 2009, FUNGAL DIVERS, V39, P1; Hyde KD, 2009, FUNGAL DIVERS, V39, P147; Johnson DA, 1997, MYCOL RES, V101, P641, DOI 10.1017/S0953756296003115; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kaufmann PJ, 1996, PLANT DIS, V80, P1289, DOI 10.1094/PD-80-1289; Larget BR, 2010, BIOINFORMATICS, V26, P2910, DOI 10.1093/bioinformatics/btq539; Latunde-Dada AO, 2001, MOL PLANT PATHOL, V2, P187, DOI 10.1046/j.1464-6722.2001.00069.x; Legard DE, 2000, COLLETOTRICHUM, P292; Lu GZ, 2004, MYCOL RES, V108, P53, DOI 10.1017/S0953756203008906; MacKenzie SJ, 2007, PHYTOPATHOLOGY, V97, P1130, DOI 10.1094/PHYTO-97-9-1130; MacKenzie S.J., 2005, POPULATION STRUCTURE; Miller M. A., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; Morris CE, 2009, PLOS PATHOG, V5, P1; Nirenberg HI, 1976, MITT BIOL BUNDESANST, V169, P1, DOI DOI 10.1002/JPLN.19771400220; Nylander J. A. A., 2004, MRMODELTEST V2; ODonnell K, 1997, MOL PHYLOGENET EVOL, V7, P103, DOI 10.1006/mpev.1996.0376; Olatinwo RO, 2003, PLANT DIS, V87, P550, DOI 10.1094/PDIS.2003.87.5.550; Oudemans PV, 1998, PLANT DIS, V82, P1176, DOI 10.1094/PDIS.1998.82.11.1176; Photita W, 2005, FUNGAL DIVERS, V18, P117; Phoulivong S, 2010, MYCOTAXON, V114, P247, DOI 10.5248/114.247; Phoulivong S, 2010, FUNGAL DIVERS, V44, P33, DOI 10.1007/s13225-010-0046-0; Polashock JJ, 2009, PLANT PATHOL, V58, P1116, DOI 10.1111/j.1365-3059.2009.02120.x; Prihastuti H, 2009, FUNGAL DIVERS, V39, P89; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rambaut A, 2007, TRACER V 1 4; Rasband W., 2006, IMAGEJ; Rodriguez-Saona C, 2011, J EXP BOT, V62, P2633, DOI 10.1093/jxb/erq466; Rojas EI, 2010, MYCOLOGIA, V102, P1318, DOI 10.3852/09-244; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Seifert KA, 2009, MOL ECOL RESOUR, V9, P83, DOI 10.1111/j.1755-0998.2009.02635.x; Shear CL, 1907, BOT GAZ, V43, P0259, DOI 10.1086/329172; SHEAR CL, 1907, B TORREY BOT CLUB, V34, P305, DOI DOI 10.2307/2479158; Shear CL, 1907, CRANBERRY DIS; Silva DN, 2012, MOL ECOL, V21, P2655, DOI 10.1111/j.1365-294X.2012.05557.x; Silva DN, 2012, MYCOLOGIA, V104, P396, DOI 10.3852/11-145; SIMMONDS J. H., 1965, QUEENSLAND J AGR ANIM SCI, V22, P437; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stiles C. M., 1997, Phytopathology, V87, pS94; Stiles CM, 1999, PHYTOPATHOLOGY, V89, P218, DOI 10.1094/PHYTO.1999.89.3.218; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; SUTTON B, 1992, CL LIB APPL, P1; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; Than PP, 2008, FUNGAL DIVERS, V28, P97; Vorsa N, 2005, J AM SOC HORTIC SCI, V130, P711, DOI 10.21273/JASHS.130.5.711; Vorsa N, 1994, BREEDING AM CRANBERR; Weir BS, 2012, STUD MYCOL, P115, DOI 10.3114/sim0011; WHEELER HE, 1952, AM J BOT, V39, P110, DOI 10.2307/2438177; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Wikee S, 2011, FUNGAL DIVERS, V46, P171, DOI 10.1007/s13225-010-0049-x; Yang YL, 2009, FUNGAL DIVERS, V39, P123; Yang YL, 2012, TROP PLANT PATHOL, V37, P165, DOI 10.1590/S1982-56762012000300001; Zhu P, 1999, GENETIC DIVERSITY SY; [No title captured], DOI DOI 10.1371/J0URNAL.P0NE.0090910	83	75	80	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e62394	10.1371/journal.pone.0062394	http://dx.doi.org/10.1371/journal.pone.0062394			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671594	Green Published, gold, Green Submitted			2022-12-25	WOS:000321390200021
J	Peterman, WE; Semlitsch, RD				Peterman, William E.; Semlitsch, Raymond D.			Fine-Scale Habitat Associations of a Terrestrial Salamander: The Role of Environmental Gradients and Implications for Population Dynamics	PLOS ONE			English	Article							ESTIMATING SITE OCCUPANCY; GREAT SMOKY MOUNTAINS; PLETHODON-CINEREUS; IMPERFECT DETECTION; DETECTION PROBABILITIES; VEGETATION ANALYSIS; LANDSCAPE-SCALE; ABUNDANCE; MOISTURE; MODELS	Environmental gradients are instrumental in shaping the distribution and local abundance of species because at the most fundamental level, an organism's performance is constrained by the environment it inhabits. In topographically complex landscapes, slope, aspect, and vegetative cover interact to affect solar exposure, creating temperature-moisture gradients and unique microclimates. The significance of the interaction of abiotic gradients and biotic factors such as competition, movement, or physiology has long been recognized, but the scale at which these factors vary on the landscape has generally precluded their inclusion in spatial abundance models. We used fine-scale spatial data relating to surface-soil moisture, temperature, and canopy cover to describe the spatial distribution of abundance of a terrestrial salamander, Plethodon albagula, across the landscape. Abundance was greatest in dense-canopy ravine habitats with high moisture and low solar exposure, resulting in a patchy distribution of abundance. We hypothesize that these patterns reflect the physiological constraints of Plethodontid salamanders. Furthermore, demographic cohorts were not uniformly distributed among occupied plots on the landscape. The probability of gravid female occurrence was nearly uniform among occupied plots, but juveniles were much more likely to occur on plots with lower surface temperatures. The disconnect between reproductive effort and recruitment suggests that survival differs across the landscape and that local population dynamics vary spatially. Our study demonstrates a connection between abundance, fine-scale environmental gradients, and population dynamics, providing a foundation for future research concerning movement, population connectivity, and physiology.	[Peterman, William E.; Semlitsch, Raymond D.] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Peterman, WE (corresponding author), Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA.	bill.peterman@gmail.com	Peterman, William/H-7809-2013	Peterman, William/0000-0001-5229-9268; Semlitsch, Raymond/0000-0002-7999-5762	University of Missouri Research Board [CB000402]; Trans World Airline Scholarship; DoD Strategic Environmental Research and Development Program [RC2155]	University of Missouri Research Board; Trans World Airline Scholarship; DoD Strategic Environmental Research and Development Program	Support was provided by the University of Missouri Research Board (number CB000402), Trans World Airline Scholarship, and DoD Strategic Environmental Research and Development Program (http://www.serdp.org/; grant RC2155). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding from these sources does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	ADOLPH SC, 1990, ECOLOGY, V71, P315, DOI 10.2307/1940271; Albrecht MA, 2009, J ECOL, V97, P1037, DOI 10.1111/j.1365-2745.2009.01527.x; ANDREWARTHA HG, 1954, DISTRIBUTION ABUNDAN; Antvogel H, 2001, ECOGRAPHY, V24, P470, DOI 10.1034/j.1600-0587.2001.d01-203.x; Bailey LL, 2004, J HERPETOL, V38, P370, DOI 10.1670/194-03A; Bailey LL, 2004, ECOL APPL, V14, P692, DOI 10.1890/03-5012; BARRY RG, 1992, MT RES DEV, V12, P71, DOI 10.2307/3673749; BAUR B, 1995, ECOGRAPHY, V18, P123, DOI 10.1111/j.1600-0587.1995.tb00332.x; Bennie J, 2008, ECOL MODEL, V216, P47, DOI 10.1016/j.ecolmodel.2008.04.010; BOBKA MS, 1981, COPEIA, P417; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Cabe PR, 2007, HEREDITY, V98, P53, DOI 10.1038/sj.hdy.6800905; Chapman SS, 2002, ECOREGIONS IOWA MISS; Chen JQ, 1999, BIOSCIENCE, V49, P288, DOI 10.2307/1313612; Cushman Samuel A., 2013, Diversity-Basel, V5, P51; Daniel RE, 2012, ATLAS MISSOURI AMPHI; Deng YX, 2007, REMOTE SENS ENVIRON, V111, P122, DOI 10.1016/j.rse.2007.03.016; Dodd CK, 2004, HERPETOLOGICA, V60, P468, DOI 10.1655/03-60; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; FEDER ME, 1985, BIOL REV, V60, P1, DOI 10.1111/j.1469-185X.1985.tb00416.x; FEDER ME, 1983, HERPETOLOGICA, V39, P291; FRASER DF, 1976, ECOLOGY, V57, P459, DOI 10.2307/1936431; Fridley JD, 2009, J APPL METEOROL CLIM, V48, P1033, DOI 10.1175/2008JAMC2084.1; Gelman A, 1996, STAT SINICA, V6, P733; Gelman A., 2004, BAYESIAN DATA ANAL; Gifford ME, 2012, ECOGRAPHY, V35, P193, DOI 10.1111/j.1600-0587.2011.06866.x; Gillette Jennifer R., 2001, Herpetological Review, V32, P233; Graae BJ, 2011, OECOLOGIA, V166, P565, DOI 10.1007/s00442-010-1878-8; Grover MC, 1998, J HERPETOL, V32, P489, DOI 10.2307/1565202; Hairston N. G., 1987, COMMUNITY ECOLOGY SA; HALL CAS, 1992, OIKOS, V65, P377, DOI 10.2307/3545553; HARRISON S, 1994, OECOLOGIA, V99, P27, DOI 10.1007/BF00317080; HEATWOLE H, 1962, ECOLOGY, V43, P460, DOI 10.2307/1933374; Highton R, 1989, GEOGRAPHIC PROTEIN V, P1; Hutchinson TF, 1999, PLANT ECOL, V144, P177, DOI 10.1023/A:1009804020976; Hyde EJ, 2001, J WILDLIFE MANAGE, V65, P624, DOI 10.2307/3803013; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Indermaur L, 2009, AM NAT, V173, P60, DOI 10.1086/593355; Jenness J., 2006, TOPOGRAPHIC POSITION; Jorgensen CB, 1997, BIOL REV, V72, P153, DOI 10.1017/S0006323196004963; Kappes H, 2005, J MOLLUS STUD, V71, P85, DOI 10.1093/mollus/eyi011; KEEN WH, 1979, J HERPETOL, V13, P461, DOI 10.2307/1563483; KEEN WH, 1984, COPEIA, P684; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; Kery M, 2008, COMMUNITY ECOL, V9, P207, DOI 10.1556/ComEc.9.2008.2.10; Kery M., 2010, INTRO WINBUGS ECOLOG; Kery M, 2010, J ANIM ECOL, V79, P453, DOI 10.1111/j.1365-2656.2009.01632.x; Kery M, 2009, J APPL ECOL, V46, P1163, DOI 10.1111/j.1365-2664.2009.01724.x; Kery M, 2009, ENVIRON ECOL STAT SE, V3, P639, DOI 10.1007/978-0-387-78151-8_28; KLEEBERGER SR, 1982, COPEIA, P409, DOI 10.2307/1444622; Liebgold EB, 2011, MOL ECOL, V20, P249, DOI 10.1111/j.1365-294X.2010.04946.x; Lloyd P, 1998, AUK, V115, P404; Lookingbill T, 2004, LANDSCAPE ECOL, V19, P417, DOI 10.1023/B:LAND.0000030451.29571.8b; Lookingbill TR, 2003, AGR FOREST METEOROL, V114, P141, DOI 10.1016/S0168-1923(02)00196-X; Mackenzie DI, 2009, ECOLOGY, V90, P823, DOI 10.1890/08-0141.1; MacKenzie DI, 2005, AUST NZ J STAT, V47, P65, DOI 10.1111/j.1467-842X.2005.00372.x; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Marsh DM, 2008, CONSERV GENET, V9, P603, DOI 10.1007/s10592-007-9377-0; MENGE BA, 1987, AM NAT, V130, P730, DOI 10.1086/284741; Oliver T, 2010, ECOL LETT, V13, P473, DOI 10.1111/j.1461-0248.2010.01441.x; Pabijan M, 2012, J EVOLUTION BIOL, V25, P2310, DOI 10.1111/j.1420-9101.2012.02613.x; Pattison RR, 2009, OECOLOGIA, V158, P591, DOI 10.1007/s00442-008-1187-7; Pellet J, 2005, BIOL CONSERV, V123, P27, DOI 10.1016/j.biocon.2004.10.005; Petranka, 1998, SALAMANDERS US CANAD; PETRANKA JW, 1993, CONSERV BIOL, V7, P363, DOI 10.1046/j.1523-1739.1993.07020363.x; Pierce KB, 2005, LANDSCAPE ECOL, V20, P137, DOI 10.1007/s10980-004-1296-6; Royle J. A., 2004, Animal Biodiversity and Conservation, V27, P375; Royle J.A., 2008, HEIRARCHICAL MODELIN; Royle JA, 2007, ECOL MONOGR, V77, P465, DOI 10.1890/06-0912.1; Royle JA, 2004, BIOMETRICS, V60, P108, DOI 10.1111/j.0006-341X.2004.00142.x; Scherrer D, 2011, J BIOGEOGR, V38, P406, DOI 10.1111/j.1365-2699.2010.02407.x; Semlitsch RD, 2008, ECOL APPL, V18, P283, DOI 10.1890/07-0853.1; SEMLITSCH RD, 1980, HERPETOLOGICA, V36, P6; Spiegelhalter D., 2003, WINBUGS USER MANUAL; SPOTILA JR, 1972, ECOL MONOGR, V42, P95, DOI 10.2307/1942232; SPOTILA JR, 1976, COMP BIOCHEM PHYS A, V55, P407, DOI 10.1016/0300-9629(76)90069-4; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Suggitt AJ, 2011, OIKOS, V120, P1, DOI 10.1111/j.1600-0706.2010.18270.x; Theobold D.M., 2007, LCAP V 1 0 LANDSCAPE; TRACY CR, 1976, ECOL MONOGR, V46, P293, DOI 10.2307/1942256; Trauth S. E., 2004, AMPHIBIANS REPTILES, VFirst; TUCKER CJ, 1979, REMOTE SENS ENVIRON, V8, P127, DOI 10.1016/0034-4257(79)90013-0; Tyre AJ, 2003, ECOL APPL, V13, P1790, DOI 10.1890/02-5078; Wachob DG, 1996, CONDOR, V98, P114, DOI 10.2307/1369514; WEISS SB, 1988, ECOLOGY, V69, P1486, DOI 10.2307/1941646; WHITTAKER RH, 1956, ECOL MONOGR, V26, P1, DOI 10.2307/1943577	87	82	83	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e62184	10.1371/journal.pone.0062184	http://dx.doi.org/10.1371/journal.pone.0062184			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671586	Green Published, Green Submitted, gold			2022-12-25	WOS:000321390200015
J	Walsh, AD; Bimber, BN; Das, A; Piaskowski, SM; Rakasz, EG; Bean, AT; Mudd, PA; Ericsen, AJ; Wilson, NA; Hughes, AL; O'Connor, DH; Maness, NJ				Walsh, Andrew D.; Bimber, Benjamin N.; Das, Arpita; Piaskowski, Shari M.; Rakasz, Eva G.; Bean, Alexander T.; Mudd, Philip A.; Ericsen, Adam J.; Wilson, Nancy A.; Hughes, Austin L.; O'Connor, David H.; Maness, Nicholas J.			Acute Phase CD8+T Lymphocytes against Alternate Reading Frame Epitopes Select for Rapid Viral Escape during SIV Infection	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; T-CELL RESPONSES; CRYPTIC EPITOPES; RHESUS MACAQUES; IN-VIVO; AIDS; REPLICATION; SIVMAC239; MUTATIONS; SUBSTITUTIONS	CD8+ T Lymphocytes (CTL) can control AIDS virus replication. However, natural selection favoring viral variants that escape CTL recognition is a common feature of both simian immunodeficiency virus (SIV) infection of macaques and HIV infection of humans. Emerging data indicate that CTL directed against alternate reading frame (ARF)-derived epitopes (a.k.a. cryptic epitopes) are important components of the total virus-specific response in SIV and HIV infection but the contributions of these responses during the critical first several weeks of infection have not been determined. We used a focused deep sequencing approach to examine acute phase viral evolution in response to CTL targeting two polypeptides encoded by ARFs of SIVmac239 in SIV-infected rhesus macaques. We report high magnitude CTL responses as early as three weeks post-infection against epitopes within both ARFs, which both overlap the 5' end of the env gene. Further, mutations accumulated in the epitopes by three to four weeks post infection consistent with viral escape. Interestingly, these mutations largely maintained the primary amino acid sequence of the overlapping Envelope protein. Our data show that high frequency CTL target cryptic epitopes and exert selective pressure on SIV during the acute phase, underscoring the importance of these unique immune responses.	[Walsh, Andrew D.; Bean, Alexander T.; Mudd, Philip A.; Ericsen, Adam J.; Wilson, Nancy A.; O'Connor, David H.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI USA; [Bimber, Benjamin N.] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA; [Das, Arpita; Maness, Nicholas J.] Tulane Natl Primate Res Ctr, Div Microbiol, Covington, LA USA; [Piaskowski, Shari M.; Rakasz, Eva G.; O'Connor, David H.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI USA; [Mudd, Philip A.] Univ Wisconsin, Med Scientist Training Program, Madison, WI USA; [Hughes, Austin L.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Maness, Nicholas J.] Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA 70112 USA	University of Wisconsin System; University of Wisconsin Madison; Oregon Health & Science University; Oregon National Primate Research Center; Tulane University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Tulane University	Maness, NJ (corresponding author), Tulane Natl Primate Res Ctr, Div Microbiol, Covington, LA USA.	nmaness@tulane.edu	Rakasz, Eva G/H-9197-2019; Ericsen, Adam/AAW-1187-2020	Ericsen, Adam/0000-0003-4176-8270; Mudd, Philip/0000-0002-3860-5473; Bimber, Benjamin/0000-0001-8092-3080; o'connor, david/0000-0003-2139-470X	Foundation for AIDS Research (amfAR) [108340-51-RKVA]; National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) [P51 RR000167]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI078985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008692] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011106] Funding Source: NIH RePORTER	Foundation for AIDS Research (amfAR); National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded in part by a grant from the Foundation for AIDS Research (amfAR) to NJM: 108340-51-RKVA. This work was also made possible in part by grant number P51 RR000167 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), to the Wisconsin National Primate Research Center, University of Wisconsin-Madison. This publication's contents are solely the responsibility of the authors and do not necessarily represent the official views of the NCRR or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2005, J VIROL, V79, P13239, DOI 10.1128/JVI.79.21.13239-13249.2005; Bansal A, 2010, J EXP MED, V207, P51, DOI 10.1084/jem.20092060; Becker EA, 2012, GENOME BIOL EVOL, V4, P457, DOI 10.1093/gbe/evs029; Berger CT, 2010, J EXP MED, V207, P61, DOI 10.1084/jem.20091808; Bimber BN, 2010, J VIROL, V84, P12087, DOI 10.1128/JVI.01378-10; Bimber BN, 2009, J VIROL, V83, P8247, DOI 10.1128/JVI.00897-09; Burwitz BJ, 2011, J VIROL, V85, P13088, DOI 10.1128/JVI.05650-11; Cardinaud S, 2004, J EXP MED, V199, P1053, DOI 10.1084/jem.20031869; Cardinaud S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002049; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Champiat S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039311; Cline AN, 2005, J MED PRIMATOL, V34, P303; Fischer W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012303; Friedrich TC, 2004, NAT MED, V10, P275, DOI 10.1038/nm998; Friedrich TC, 2004, J VIROL, V78, P2581, DOI 10.1128/JVI.78.5.2581-2585.2004; Friedrich TC, 2007, J VIROL, V81, P3465, DOI 10.1128/JVI.02392-06; Garrison KE, 2009, CLIN VACCINE IMMUNOL, V16, P1369, DOI 10.1128/CVI.00410-08; Goonetilleke N, 2009, J EXP MED; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Henn MR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002529; Ho O, 2006, J IMMUNOL, V176, P2470, DOI 10.4049/jimmunol.176.4.2470; Kelleher AD, 2001, J EXP MED, V193, P375, DOI 10.1084/jem.193.3.375; LAHM HW, 1985, J CHROMATOGR, V326, P357, DOI 10.1016/S0021-9673(01)87461-6; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Loffredo JT, 2007, J VIROL, V81, P8827, DOI 10.1128/JVI.00895-07; Maness NJ, 2007, J EXP MED, V204, P2505, DOI 10.1084/jem.20071261; Maness NJ, 2010, J VIROL, V84, P11569, DOI 10.1128/JVI.01419-10; Maness NJ, 2009, J VIROL, V83, P10280, DOI 10.1128/JVI.00138-09; Matano T, 1998, J VIROL, V72, P164, DOI 10.1128/JVI.72.1.164-169.1998; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Moreland AJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-295; Mudd PA, 2011, J VIROL, V85, P12804, DOI 10.1128/JVI.05841-11; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nelson EK, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-71; O'Connor DH, 2002, NAT MED, V8, P493, DOI 10.1038/nm0502-493; O'Connor DH, 2004, J VIROL, V78, P14012, DOI 10.1128/JVI.78.24.14012-14022.2004; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Starck SR, 2011, CELL MOL LIFE SCI, V68, P1471, DOI 10.1007/s00018-011-0655-0; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wilson NA, 2006, J VIROL, V80, P5875, DOI 10.1128/JVI.00171-06; Yant LJ, 2006, J VIROL, V80, P5074, DOI 10.1128/JVI.80.10.5074-5077.2006	43	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e61383	10.1371/journal.pone.0061383	http://dx.doi.org/10.1371/journal.pone.0061383			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671565	Green Published, gold, Green Submitted			2022-12-25	WOS:000321390200005
J	Cao, M; Wang, P; Sun, CH; He, W; Wang, FJ				Cao, Min; Wang, Pei; Sun, Chunhong; He, Wen; Wang, Fengjun			Amelioration of IFN-gamma and TNF-alpha-Induced Intestinal Epithelial Barrier Dysfunction by Berberine via Suppression of MLCK-MLC Phosphorylation Signaling Pathway	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; TIGHT JUNCTION PERMEABILITY; INTERFERON-GAMMA; INFLAMMATORY RESPONSES; INDUCED INCREASE; IN-VITRO; KINASE; EXPRESSION; HIF-1-ALPHA; COLITIS	Intestinal barrier dysfunction occurs in many intestinal diseases, in which proinflammatory cytokines play critical roles. However, researchers are still on the way to defining the underlying mechanisms and to evaluate therapeutic strategies for restoring intestinal barrier function. Berberine, a drug that has clinically been used to treat gastroenteritis and diarrhea for thousands of years, has been shown to protect barrier function in both endothelial and epithelial cells, but the mechanisms are completely unknown. In this study, we investigate the protective actions of berberine on barrier function and the underlying mechanisms in Caco-2 monolayers challenged with IFN-gamma and TNF-alpha. Caco-2 monolayers were treated without or with simultaneous IFN-gamma and TNF-alpha in the absence or presence of berberine. Both transepithelial electrical resistance (TER) and paracellular permeability were measured to evaluate barrier function. The expression and distribution of tight junction proteins ZO-1, occluding, and claudin-1 were respectively analyzed by immunoblot or immunofluorescence. The expressions of phosphorylated myosin light chain (pMLC), MLC kinase (MLCK) and hypoxia-inducible factor-1 alpha (HIF-1 alpha) were determined by immunoblot. The translocation of NF-kappa B p65 to nuclei was analyzed by immunofluorescence and immunoblot, respectively. The results showed that berberine significantly attenuated TER decrease and paracellular permeability increase in Caco-2 monolayers treated with IFN-gamma and TNF-alpha. Berberine also dramatically alleviated IFN-gamma and TNF-alpha-induced morphological alteration of tight junction proteins ZO-1, occluding, and claudin-1. The increase of both MLC phosphorylation and MLCK protein expression induced by IFN-gamma and TNF-alpha was significantly inhibited by berberine treatment. Additionally, berberine suppressed the activation of HIF-1 alpha, but not NF-kappa B. Taken together, it is suggested that berberine attenuates IFN-gamma and TNF-alpha-induced intestinal epithelial barrier dysfunction by inhibiting the signaling pathway of MLCK-dependent MLC phosphorylation mediated by HIF-1 alpha.	[Cao, Min; Wang, Pei; Sun, Chunhong; He, Wen; Wang, Fengjun] Third Mil Med Univ, Southwest Hosp, Inst Burn Res, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China	Army Medical University	Wang, FJ (corresponding author), Third Mil Med Univ, Southwest Hosp, Inst Burn Res, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China.	wangfj@tmmu.edu.cn	Wang, Fengjun/A-4114-2009		National Natural Science Foundation of China [81070290]; State Key Laboratory of Trauma, Burns and Combined Injury [SKLZZ200818]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Trauma, Burns and Combined Injury	This work was supported by the National Natural Science Foundation of China (81070290), and the project from State Key Laboratory of Trauma, Burns and Combined Injury (SKLZZ200818). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sadi R, 2008, J IMMUNOL, V180, P5653, DOI 10.4049/jimmunol.180.8.5653; Amasheh M, 2010, J CELL SCI, V123, P4145, DOI 10.1242/jcs.070896; Amasheh M, 2009, SCAND J GASTROENTERO, V44, P1226, DOI 10.1080/00365520903131973; Beaurepaire C, 2009, J INTERF CYTOK RES, V29, P133, DOI 10.1089/jir.2008.0057; Boberek JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013745; Chen CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034946; Clayburgh DR, 2004, LAB INVEST, V84, P282, DOI 10.1038/labinvest.3700050; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Cui HS, 2007, JPN J OPHTHALMOL, V51, P64, DOI 10.1007/s10384-006-0395-0; Enk R, 2007, J ETHNOPHARMACOL, V109, P170, DOI 10.1016/j.jep.2006.07.013; Feinman R, 2010, AM J PHYSIOL-GASTR L, V299, pG833, DOI 10.1152/ajpgi.00065.2010; Frede S, 2007, METHOD ENZYMOL, V435, P405, DOI 10.1016/S0076-6879(07)35021-0; Graham WV, 2006, J BIOL CHEM, V281, P26205, DOI 10.1074/jbc.M602164200; Gu LL, 2011, J INFECT DIS, V203, P1602, DOI 10.1093/infdis/jir147; Gu LL, 2009, FITOTERAPIA, V80, P241, DOI 10.1016/j.fitote.2009.02.005; Hamsa TP, 2012, DRUG CHEM TOXICOL, V35, P57, DOI 10.3109/01480545.2011.589437; Hong T, 2012, IMMUNOPHARM IMMUNOT, V34, P391, DOI 10.3109/08923973.2011.609887; Irvine EJ, 2000, GASTROENTEROLOGY, V119, P1740, DOI 10.1053/gast.2000.20231; Kannan KB, 2011, AM J PHYSIOL-GASTR L, V300, pG853, DOI 10.1152/ajpgi.00459.2010; Kuo CL, 2004, CANCER LETT, V203, P127, DOI 10.1016/j.canlet.2003.09.002; Lee IA, 2010, EUR J PHARMACOL, V648, P162, DOI 10.1016/j.ejphar.2010.08.046; Li QR, 2008, CLIN IMMUNOL, V126, P67, DOI 10.1016/j.clim.2007.08.017; Lin SK, 2004, MOL PHARMACOL, V66, P612; Liu H, 2012, CELL PHYSIOL BIOCHEM, V29, P799, DOI 10.1159/000188076; Liu H, 2011, CYTOKINE, V56, P581, DOI 10.1016/j.cyto.2011.08.023; Ma TY, 2005, AM J PHYSIOL-GASTR L, V288, pG422, DOI 10.1152/ajpgi.00412.2004; Ma TY, 2004, AM J PHYSIOL-GASTR L, V286, pG367, DOI 10.1152/ajpgi.00173.2003; Ma XM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013489; Martinez C, 2012, GUT LIVER, V6, P305, DOI 10.5009/gnl.2012.6.3.305; McGuckin MA, 2009, INFLAMM BOWEL DIS, V15, P100, DOI 10.1002/ibd.20539; Ning L, 2010, EUR J PHARM SCI, V40, P1, DOI 10.1016/j.ejps.2010.02.001; Park J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031512; Qi HB, 2011, CELL PHYSIOL BIOCHEM, V27, P251, DOI 10.1159/000327951; Rosen MJ, 2011, INFLAMM BOWEL DIS, V17, P2224, DOI 10.1002/ibd.21628; Rosenberger P, 2007, FASEB J, V21, P2613, DOI 10.1096/fj.06-8004com; Saha P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018467; Salim SY, 2011, INFLAMM BOWEL DIS, V17, P362, DOI 10.1002/ibd.21403; Scharte M, 2003, AM J PHYSIOL-GASTR L, V284, pG373, DOI 10.1152/ajpgi.00076.2002; Schwarz BT, 2007, GASTROENTEROLOGY, V132, P2383, DOI 10.1053/j.gastro.2007.02.052; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; Su LP, 2009, GASTROENTEROLOGY, V136, P551, DOI 10.1053/j.gastro.2008.10.081; Sumbayev VV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034259; Suzuki T, 2013, CELL MOL LIFE SCI, V70, P631, DOI 10.1007/s00018-012-1070-x; Suzuki T, 2011, J BIOL CHEM, V286, P31263, DOI 10.1074/jbc.M111.238147; Tan Wen, 2011, Int J Nanomedicine, V6, P1773, DOI 10.2147/IJN.S22683; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Wang FJ, 2006, GASTROENTEROLOGY, V131, P1153, DOI 10.1053/j.gastro.2006.08.022; Wang FJ, 2005, AM J PATHOL, V166, P409, DOI 10.1016/S0002-9440(10)62264-X; Weber CR, 2012, ANN NY ACAD SCI, V1257, P77, DOI 10.1111/j.1749-6632.2012.06528.x; Weber CR, 2010, J BIOL CHEM, V285, P12037, DOI 10.1074/jbc.M109.064808; WYATT J, 1993, LANCET, V341, P1437, DOI 10.1016/0140-6736(93)90882-H; Yan F, 2012, AM J PHYSIOL-GASTR L, V302, pG504, DOI 10.1152/ajpgi.00312.2011; Yan JQ, 2012, CELL MOL LIFE SCI, V69, P115, DOI 10.1007/s00018-011-0731-5; Ye D, 2008, J CELL MOL MED, V12, P1331, DOI 10.1111/j.1582-4934.2008.00302.x; Yeh WL, 2007, MOL PHARMACOL, V72, P440, DOI 10.1124/mol.107.036418; Zhou HY, 2000, J PHARMACOL EXP THER, V294, P822	56	156	173	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e61944	10.1371/journal.pone.0061944	http://dx.doi.org/10.1371/journal.pone.0061944			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23671580	Green Submitted, gold, Green Published			2022-12-25	WOS:000321202100003
J	Pillow, JW; Shlens, J; Chichilnisky, EJ; Simoncelli, EP				Pillow, Jonathan W.; Shlens, Jonathon; Chichilnisky, E. J.; Simoncelli, Eero P.			A Model-Based Spike Sorting Algorithm for Removing Correlation Artifacts in Multi-Neuron Recordings	PLOS ONE			English	Article							CHAIN MONTE-CARLO; FIRING PATTERNS; CLASSIFICATION; IDENTIFICATION; SEPARATION; TETRODES	We examine the problem of estimating the spike trains of multiple neurons from voltage traces recorded on one or more extracellular electrodes. Traditional spike-sorting methods rely on thresholding or clustering of recorded signals to identify spikes. While these methods can detect a large fraction of the spikes from a recording, they generally fail to identify synchronous or near-synchronous spikes: cases in which multiple spikes overlap. Here we investigate the geometry of failures in traditional sorting algorithms, and document the prevalence of such errors in multi-electrode recordings from primate retina. We then develop a method for multi-neuron spike sorting using a model that explicitly accounts for the superposition of spike waveforms. We model the recorded voltage traces as a linear combination of spike waveforms plus a stochastic background component of correlated Gaussian noise. Combining this measurement model with a Bernoulli prior over binary spike trains yields a posterior distribution for spikes given the recorded data. We introduce a greedy algorithm to maximize this posterior that we call "binary pursuit". The algorithm allows modest variability in spike waveforms and recovers spike times with higher precision than the voltage sampling rate. This method substantially corrects cross-correlation artifacts that arise with conventional methods, and substantially outperforms clustering methods on both real and simulated data. Finally, we develop diagnostic tools that can be used to assess errors in spike sorting in the absence of ground truth.	[Pillow, Jonathan W.] Univ Texas Austin, Dept Psychol, Ctr Perceptual Syst, Austin, TX 78712 USA; [Pillow, Jonathan W.] Univ Texas Austin, Neurobiol Sect, Austin, TX 78712 USA; [Shlens, Jonathon; Chichilnisky, E. J.] Salk Inst Biol Studies, La Jolla, CA USA; [Simoncelli, Eero P.] NYU, Howard Hughes Med Inst, New York, NY USA; [Simoncelli, Eero P.] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Simoncelli, Eero P.] NYU, Courant Inst, New York, NY USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Salk Institute; Howard Hughes Medical Institute; New York University; New York University; New York University	Pillow, JW (corresponding author), Univ Texas Austin, Dept Psychol, Ctr Perceptual Syst, Austin, TX 78712 USA.	pillow@mail.utexas.edu		Pillow, Jonathan/0000-0002-3638-8831; Simoncelli, Eero/0000-0002-1206-527X; Chichilnisky, E.J./0000-0002-5613-0248	Royal Society Society USA/Canada Research Fellowship; Center for Perceptual Systems; Sloan Research Fellowship; Miller Institute for Basic Research in Science; National Eye Institute (NEI) [EY018003]; National Institutes of Health (NIH) [EY017736]; Howard Hughes Medical Institute; NATIONAL EYE INSTITUTE [R01EY018003, R01EY017736] Funding Source: NIH RePORTER	Royal Society Society USA/Canada Research Fellowship; Center for Perceptual Systems; Sloan Research Fellowship(Alfred P. Sloan Foundation); Miller Institute for Basic Research in Science; National Eye Institute (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by: Royal Society Society USA/Canada Research Fellowship (JWP) (http://royalsociety.org/grants/); Center for Perceptual Systems, startup funding (JP) (http://www.utexas.edu/cola/centers/cps/); Sloan Research Fellowship (JWP) (http://www.sloan.org/); Miller Institute for Basic Research in Science (JS) (http://millerinstitute.berkeley.edu/); National Eye Institute (NEI) grant EY018003 (EJC, EPS); National Institutes of Health (NIH) Grant EY017736 (EJC); and Howard Hughes Medical Institute (EPS) (http://www.hhmi.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, P ADV NEURAL PROCESS; Bar-Gad I, 2001, J NEUROSCI METH, V107, P1, DOI 10.1016/S0165-0270(01)00339-9; Blanche TJ, 2005, J NEUROPHYSIOL, V93, P2987, DOI 10.1152/jn.01023.2004; Brown EN, 2004, NAT NEUROSCI, V7, P456, DOI 10.1038/nn1228; Calabrese A, 2010, J NEUROSCIENCE METHO; Calabrese A, 2011, J NEUROSCI METH, V196, P159, DOI 10.1016/j.jneumeth.2010.12.002; Delescluse M, 2006, J NEUROSCI METH, V150, P16, DOI 10.1016/j.jneumeth.2005.05.023; DeVries SH, 1999, J NEUROPHYSIOL, V81, P908, DOI 10.1152/jn.1999.81.2.908; Field GD, 2007, ANNU REV NEUROSCI, V30, P1, DOI 10.1146/annurev.neuro.30.051606.094252; Gasthaus J, 2009, ADV NEURAL INFORM PR, P497; Ge D, 2011, IEEE T NEUR SYS REH, V19, P249, DOI 10.1109/TNSRE.2011.2112780; Gelman A., 2004, BAYESIAN DATA ANAL; GERSTEIN GL, 1964, SCIENCE, V143, P1325, DOI 10.1126/science.143.3612.1325; Gerwinn S, 2010, FRONTIERS COMPUTATIO; Gray CM, 1995, J NEUROSCI METH, V63, P43, DOI 10.1016/0165-0270(95)00085-2; Green D. M., 1974, SIGNAL DETECTION THE; Green DM, 1966, SIGNAL DETECTION THE; Greschner M, 2011, J PHYSIOL-LONDON, V589, P75, DOI 10.1113/jphysiol.2010.193888; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Hastie T., 2009, UNSUPERVISED LEARNIN; Herbst JA, 2008, J NEUROSCI METH, V174, P126, DOI 10.1016/j.jneumeth.2008.06.011; Johnston D, 1994, FDN CELLULAR NEUROPH; Kohavi J., 1994, P 11 INT C MACH LEAR, P121, DOI [DOI 10.1016/B978-1-55860-335-6.50023-4, 10.1016/B978-1-55860-335-6.50023-4]; Lewicki MS, 1998, NETWORK-COMP NEURAL, V9, pR53, DOI 10.1088/0954-898X/9/4/001; LEWICKI MS, 1994, NEURAL COMPUT, V6, P1005, DOI 10.1162/neco.1994.6.5.1005; Litke AM, 2004, IEEE T NUCL SCI, V51, P1434, DOI 10.1109/TNS.2004.832706; Luczak A, 2005, J NEUROSCI METH, V144, P53, DOI 10.1016/j.jneumeth.2004.10.009; MACKAY DJC, 1992, NEURAL COMPUT, V4, P590, DOI 10.1162/neco.1992.4.4.590; Marre O, 2012, J NEUROSCI, V32, P14859, DOI 10.1523/JNEUROSCI.0723-12.2012; MASTRONARDE DN, 1989, TRENDS NEUROSCI, V12, P75, DOI 10.1016/0166-2236(89)90140-9; McGill KC, 2002, IEEE T BIO-MED ENG, V49, P640, DOI 10.1109/TBME.2002.1010847; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; Nguyen DP, 2003, NETWORK-COMP NEURAL, V14, P61, DOI 10.1088/0954-898X/14/1/304; Obeid I, 2004, IEEE T BIO-MED ENG, V51, P905, DOI 10.1109/TBME.2004.826683; Pazienti A, 2006, J COMPUT NEUROSCI, V21, P329, DOI 10.1007/s10827-006-8899-7; Petrusca D, 2007, J NEUROSCI, V27, P11019, DOI 10.1523/JNEUROSCI.2836-07.2007; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Plexon, 2006, PLEX US GUID VERS 2; Pouzat C, 2004, J NEUROPHYSIOL, V91, P2910, DOI 10.1152/jn.00227.2003; Pouzat C, 2002, J NEUROSCI METH, V122, P43, DOI 10.1016/S0165-0270(02)00276-5; Prentice JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019884; Quiroga Quian Rodrigo, 2004, NEURAL COMPUTATION; Rebrik SP, 1999, NEUROCOMPUTING, V26-7, P1033, DOI 10.1016/S0925-2312(99)00101-0; RODIECK RW, 1967, J NEUROPHYSIOL, V30, P1043, DOI 10.1152/jn.1967.30.5.1043; Rutishauser U, 2006, J NEUROSCI METH, V154, P204, DOI 10.1016/j.jneumeth.2005.12.033; Sahani Bickel, 2006, THESIS UCL; Sahani M, 1999, THESIS CAL TECH; Sahani M, 1998, ADV NEURAL INFORM PR, V10; SCHMIDT EM, 1984, J NEUROSCI METH, V12, P95, DOI 10.1016/0165-0270(84)90009-8; Schnitzer MJ, 2003, NEURON, V37, P499, DOI 10.1016/S0896-6273(03)00004-7; Segev R, 2004, NAT NEUROSCI, V7, P1155, DOI 10.1038/nn1323; Shlens J, 2006, J NEUROSCI, V26, P8254, DOI 10.1523/JNEUROSCI.1282-06.2006; Shlens J, 2009, J NEUROSCI, V29, P5022, DOI 10.1523/JNEUROSCI.5187-08.2009; Shlens J, 2008, CURR OPIN NEUROBIOL, V18, P396, DOI 10.1016/j.conb.2008.09.010; Shoham S, 2003, J NEUROSCI METH, V127, P111, DOI 10.1016/S0165-0270(03)00120-1; Stevenson IH, 2009, IEEE T NEUR SYS REH, V17, P203, DOI 10.1109/TNSRE.2008.2010471; Takahashi S, 2003, J NEUROPHYSIOL, V89, P2245, DOI 10.1152/jn.00827.2002; Takekawa T, 2010, EUR J NEUROSCI, V31, P263, DOI 10.1111/j.1460-9568.2009.07068.x; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Trong PK, 2008, NAT NEUROSCI, V11, P1343, DOI 10.1038/nn.2199; TURIN GL, 1960, IRE T INFORM THEOR, V6, P311, DOI 10.1109/TIT.1960.1057571; Ventura V, 2009, NEURAL COMPUT, V21, P2466, DOI 10.1162/neco.2009.12-07-669; Ventura V, 2009, P NATL ACAD SCI USA, V106, P6921, DOI 10.1073/pnas.0901771106; Wood F, 2008, J NEUROSCI METH, V173, P1, DOI 10.1016/j.jneumeth.2008.04.030; Zhang PM, 2004, J NEUROSCI METH, V135, P55, DOI 10.1016/j.jneumeth.2003.12.001	65	79	80	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62123	10.1371/journal.pone.0062123	http://dx.doi.org/10.1371/journal.pone.0062123			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23671583	Green Published, gold, Green Submitted			2022-12-25	WOS:000321202100006
J	Quiblier, C; Seidl, K; Roschitzki, B; Zinkernagel, AS; Berger-Bachi, B; Senn, MM				Quiblier, Chantal; Seidl, Kati; Roschitzki, Bernd; Zinkernagel, Annelies S.; Berger-Baechi, Brigitte; Senn, Maria M.			Secretome Analysis Defines the Major Role of SecDF in Staphylococcus aureus Virulence	PLOS ONE			English	Article							FIBRONECTIN-BINDING-PROTEINS; CELL-WALL; EXPERIMENTAL ENDOCARDITIS; SUBCELLULAR-LOCALIZATION; ENDOTHELIAL-CELLS; SURFACE-PROTEINS; EXPRESSION; IDENTIFICATION; VANCOMYCIN; GENES	The Sec pathway plays a prominent role in protein export and membrane insertion, including the secretion of major bacterial virulence determinants. The accessory Sec constituent SecDF has been proposed to contribute to protein export. Deletion of Staphylococcus aureus secDF has previously been shown to reduce resistance, to alter cell separation, and to change the expression of certain virulence factors. To analyse the impact of the secDF deletion in S. aureus on protein secretion, a quantitative secretome analysis was performed. Numerous Sec signal containing proteins involved in virulence were found to be decreased in the supernatant of the secDF mutant. However, two Sec-dependent hydrolases were increased in comparison to the wild type, suggesting additional indirect, regulatory effects to occur upon deletion of secDF. Adhesion, invasion, and cytotoxicity of the secDF mutant were reduced in human umbilical vein endothelial cells. Virulence was significantly reduced using a Galleria mellonella insect model. Altogether, SecDF is a promising therapeutic target for controlling S. aureus infections.	[Quiblier, Chantal; Berger-Baechi, Brigitte; Senn, Maria M.] Univ Zurich, Inst Med Microbiol, Zurich, Switzerland; [Seidl, Kati; Zinkernagel, Annelies S.] Univ Zurich, Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland; [Roschitzki, Bernd] Swiss Fed Inst Technol, Funct Genom Ctr Zurich, Zurich, Switzerland; [Roschitzki, Bernd] Univ Zurich, Zurich, Switzerland	University of Zurich; University of Zurich; University Zurich Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Senn, MM (corresponding author), Univ Zurich, Inst Med Microbiol, Zurich, Switzerland.	msenn@imm.uzh.ch	Zinkernagel, Annelies S/F-1780-2017	Zinkernagel, Annelies S/0000-0003-4700-1118	Gottfried und Julia Bangerter-Rhyner-Stiftung; Foundation for Research at the Medical Faculty, University of Zurich; Matching Funds of the Clinical Trials Center, University Hospital Zurich; European Union Seventh Framework Programme (FP7) [241446]	Gottfried und Julia Bangerter-Rhyner-Stiftung; Foundation for Research at the Medical Faculty, University of Zurich; Matching Funds of the Clinical Trials Center, University Hospital Zurich; European Union Seventh Framework Programme (FP7)	This study was supported by the Gottfried und Julia Bangerter-Rhyner-Stiftung to CQ and by grants of the Foundation for Research at the Medical Faculty, University of Zurich and Matching Funds of the Clinical Trials Center, University Hospital Zurich to KS. The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no 241446 (project ANTIRESDEV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer GL, 1998, CLIN INFECT DIS, V26, P1179, DOI 10.1086/520289; Bae T, 2004, P NATL ACAD SCI USA, V101, P12312, DOI 10.1073/pnas.0404728101; Bae T, 2006, MOL MICROBIOL, V62, P1035, DOI 10.1111/j.1365-2958.2006.05441.x; Becher D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008176; Bendtsen JD, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-58; BERRIDGE MV, 1993, ARCH BIOCHEM BIOPHYS, V303, P474, DOI 10.1006/abbi.1993.1311; Buist G, 2008, MOL MICROBIOL, V68, P838, DOI 10.1111/j.1365-2958.2008.06211.x; Charpentier E, 2004, APPL ENVIRON MICROB, V70, P6076, DOI 10.1128/AEM.70.10.6076-6085.2004; Chatterjee SS, 2013, NAT MED, V19, P364, DOI 10.1038/nm.3047; Chaudhuri RR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-291; Chavakis T, 2005, THROMB HAEMOSTASIS, V94, P278, DOI 10.1160/TH05-05-0306; Cheung A.L, 2007, CURRENT PROTOCOLS MI; Clarke SR, 2006, ADV MICROB PHYSIOL, V51, P187, DOI 10.1016/S0065-2911(06)51004-5; De Lencastre H, 2007, CURR OPIN MICROBIOL, V10, P428, DOI 10.1016/j.mib.2007.08.003; Delaune A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017054; Dengler V, 2012, FEMS MICROBIOL LETT, V333, P109, DOI 10.1111/j.1574-6968.2012.02603.x; Desbois AP, 2011, J ANTIMICROB CHEMOTH, V66, P1785, DOI 10.1093/jac/dkr198; Diederen BMW, 2006, J INFECTION, V52, P157, DOI 10.1016/j.jinf.2005.09.001; Dreisbach A, 2011, PROTEOMICS, V11, P3154, DOI 10.1002/pmic.201000823; Du Plessis DJF, 2011, BBA-BIOMEMBRANES, V1808, P851, DOI 10.1016/j.bbamem.2010.08.016; Duong F, 1997, EMBO J, V16, P2756, DOI 10.1093/emboj/16.10.2756; DUTHIE ES, 1952, J GEN MICROBIOL, V6, P95, DOI 10.1099/00221287-6-1-2-95; Eidhin DN, 1998, MOL MICROBIOL, V30, P245; Ender M, 2008, THESIS U ZURICH SWIT; Ender M, 2008, INT J MED MICROBIOL, V298, P607, DOI 10.1016/j.ijmm.2008.01.015; Ender M, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-62; FILLER SG, 1995, INFECT IMMUN, V63, P976, DOI 10.1128/IAI.63.3.976-983.1995; Forsyth RA, 2002, MOL MICROBIOL, V43, P1387, DOI 10.1046/j.1365-2958.2002.02832.x; Gagnaire J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040660; Gao W, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000944; GREENE C, 1995, MOL MICROBIOL, V17, P1143, DOI 10.1111/j.1365-2958.1995.mmi_17061143.x; Grundmeier M, 2004, INFECT IMMUN, V72, P7155, DOI 10.1128/IAI.72.12.7155-7163.2004; Haggar A, 2003, INFECT IMMUN, V71, P2310, DOI 10.1128/IAI.71.5.2310-2317.2003; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; Haslinger-Loffler B, 2005, CELL MICROBIOL, V7, P1087, DOI 10.1111/j.1462-5822.2005.00533.x; Heilmann C, 2011, ADV EXP MED BIOL, V715, P105, DOI 10.1007/978-94-007-0940-9_7; Hussain M, 2001, J BACTERIOL, V183, P6778, DOI 10.1128/JB.183.23.6778-6786.2001; Jander G, 2000, J BACTERIOL, V182, P3843, DOI 10.1128/JB.182.13.3843-3845.2000; JONSSON K, 1991, EUR J BIOCHEM, V202, P1041, DOI 10.1111/j.1432-1033.1991.tb16468.x; Karlsson A, 2001, INFECT IMMUN, V69, P4742, DOI 10.1128/IAI.69.8.4742-4748.2001; Kavanagh K, 2004, FEMS MICROBIOL REV, V28, P101, DOI 10.1016/j.femsre.2003.09.002; Kouwen TRHM, 2009, PROTEOMICS, V9, P1018, DOI 10.1002/pmic.200800580; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Krut O, 2003, INFECT IMMUN, V71, P2716, DOI 10.1128/IAI.71.5.2716-2723.2003; LaPlante KL, 2004, ANTIMICROB AGENTS CH, V48, P4665, DOI 10.1128/AAC.48.12.4665-4672.2004; Latimer J, 2012, ANTIMICROB AGENTS CH, V56, P3092, DOI 10.1128/AAC.05904-11; Lee EY, 2009, PROTEOMICS, V9, P5425, DOI 10.1002/pmic.200900338; Li HM, 1999, ANNU REV IMMUNOL, V17, P435, DOI 10.1146/annurev.immunol.17.1.435; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Malen H, 2007, PROTEOMICS, V7, P1702, DOI 10.1002/pmic.200600853; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Mazmanian SK, 2001, MOL MICROBIOL, V40, P1049, DOI 10.1046/j.1365-2958.2001.02411.x; MCDEVITT D, 1992, INFECT IMMUN, V60, P1514, DOI 10.1128/IAI.60.4.1514-1523.1992; MCDEVITT D, 1995, MOL MICROBIOL, V16, P895, DOI 10.1111/j.1365-2958.1995.tb02316.x; McGavin MJ, 1997, INFECT IMMUN, V65, P2621, DOI 10.1128/IAI.65.7.2621-2628.1997; Mediavilla JR, 2012, CURR OPIN MICROBIOL, V15, P588, DOI 10.1016/j.mib.2012.08.003; Nijeholt JALA, 2012, PHILOS T R SOC B, V367, P1016, DOI 10.1098/rstb.2011.0201; Nouwen N, 2002, MOL MICROBIOL, V44, P1397, DOI 10.1046/j.1365-2958.2002.02972.x; O'Neill E, 2008, J BACTERIOL, V190, P3835, DOI 10.1128/JB.00167-08; Otto M, 2010, ANNU REV MICROBIOL, V64, P143, DOI 10.1146/annurev.micro.112408.134309; Over B, 2011, FEMS MICROBIOL LETT, V320, P142, DOI 10.1111/j.1574-6968.2011.02303.x; Palma M, 1999, J BACTERIOL, V181, P2840, DOI 10.1128/JB.181.9.2840-2845.1999; Palma M, 1998, J BIOL CHEM, V273, P13177, DOI 10.1074/jbc.273.21.13177; Papanikou E, 2007, NAT REV MICROBIOL, V5, P839, DOI 10.1038/nrmicro1771; Peleg AY, 2009, J INFECT DIS, V199, P532, DOI 10.1086/596511; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; POGLIANO KJ, 1994, J BACTERIOL, V176, P804, DOI 10.1128/jb.176.3.804-814.1994; Purves J, 2010, INFECT IMMUN, V78, P5223, DOI 10.1128/IAI.00762-10; Qi W, 2005, J CLIN MICROBIOL, V43, P5164, DOI 10.1128/JCM.43.10.5164-5170.2005; Quiblier C, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-72; Ramadurai L, 1997, J BACTERIOL, V179, P3625, DOI 10.1128/jb.179.11.3625-3631.1997; Ramadurai L, 1999, MICROBIOL-UK, V145, P801, DOI 10.1099/13500872-145-4-801; Ravipaty S, 2010, MOL CELL PROTEOMICS, V9, P1898, DOI 10.1074/mcp.M900494-MCP200; Salamitou S, 2000, MICROBIOL-UK, V146, P2825, DOI 10.1099/00221287-146-11-2825; Salzet M, 2001, TRENDS IMMUNOL, V22, P285, DOI 10.1016/S1471-4906(01)01895-6; Seidl K, 2013, J MICROBIOL METH, V92, P307, DOI 10.1016/j.mimet.2012.12.018; Seidl K, 2011, ANTIMICROB AGENTS CH, V55, P5631, DOI 10.1128/AAC.05251-11; Seidl K, 2011, CELL MICROBIOL, V13, P1530, DOI 10.1111/j.1462-5822.2011.01639.x; Serruto D, 2010, NAT REV MICROBIOL, V8, P393, DOI 10.1038/nrmicro2366; Sibbald MJJB, 2006, MICROBIOL MOL BIOL R, V70, P755, DOI 10.1128/MMBR.00008-06; Sibbald MJJB, 2010, J BACTERIOL, V192, P3788, DOI 10.1128/JB.01452-09; Siboo IR, 2008, J BACTERIOL, V190, P6188, DOI 10.1128/JB.00300-08; Sinha B, 2000, INFECT IMMUN, V68, P6871, DOI 10.1128/IAI.68.12.6871-6878.2000; Stapleton MR, 2007, J BACTERIOL, V189, P7316, DOI 10.1128/JB.00734-07; TAURA T, 1994, MOL GEN GENET, V243, P261, DOI 10.1007/BF00301061; Tjalsma H, 2004, MICROBIOL MOL BIOL R, V68, P207, DOI 10.1128/MMBR.68.2.207-233.2004; Tseng Tsai-Tien, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P107; Tsukazaki T, 2011, NATURE, V474, P235, DOI 10.1038/nature09980; Tuchscherr L, 2010, J INFECT DIS, V202, P1031, DOI 10.1086/656047; Ulbrandt ND, 1997, CELL, V88, P187, DOI 10.1016/S0092-8674(00)81839-5; VANN JM, 1987, INFECT IMMUN, V55, P2155, DOI 10.1128/IAI.55.9.2155-2163.1987; Wann ER, 2000, J BIOL CHEM, V275, P13863, DOI 10.1074/jbc.275.18.13863; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249	94	24	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e63513	10.1371/journal.pone.0063513	http://dx.doi.org/10.1371/journal.pone.0063513			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23658837	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000321202100070
J	Wong, TT; Tesfamichael, A; Collodi, P				Wong, Ten-Tsao; Tesfamichael, Abraham; Collodi, Paul			Production of Zebrafish Offspring from Cultured Female Germline Stem Cells	PLOS ONE			English	Article							LONG-TERM PROLIFERATION; RAINBOW-TROUT; IN-VITRO; GROWTH-FACTORS; SELF-RENEWAL; LINE; EXPRESSION; PIWI; GENES; SPERM	Zebrafish female germline stem cell (FGSC) cultures were generated from a transgenic line of fish that expresses Neo and DsRed under the control of the germ cell specific promoter, ziwi [Tg(ziwi:neo); Tg(ziwi:DsRed)]. Homogeneous FGSC cultures were established by G418 selection and continued to express ziwi for more than 6 weeks along with the germ cell markers nanos3, dnd, dazl and vasa. A key component of the cell culture system was the use of a feeder cell line that was initiated from ovaries of a transgenic line of fish [Tg(gsdf:neo)] that expresses Neo controlled by the zebrafish gonadal soma derived factor (gsdf) promoter. The feeder cell line was selected in G418 and engineered to express zebrafish leukemia inhibitory factor (Lif), basic fibroblast growth factor (Fgf2) and glial-cell-line derived neurotrophic factor (Gdnf). These factors were shown to significantly enhance FGSC growth, survival and germline competency in culture. Results from cell transplantation experiments revealed that the cultured FGSCs were able to successfully colonize the gonad of sterile recipient fish and generate functional gametes. Up to 20% of surviving recipient fish that were injected with the cultured FGSCs were fertile and generated multiple batches of normal offspring for at least 6 months. The FGSC cultures will provide an in vitro system for studies of zebrafish germ cell growth and differentiation and their high frequency of germline transmission following transplantation could form the basis of a stem cell-mediated strategy for gene transfer and manipulation of the zebrafish genome.	[Wong, Ten-Tsao; Tesfamichael, Abraham; Collodi, Paul] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Wong, TT (corresponding author), Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA.	Wong20@purdue.edu	Wong, Ten-Tsao/J-7524-2017	Wong, Ten-Tsao/0000-0001-5573-9767	National Institutes of Health [NIH R01GM069384, R01GM069384-7S1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069384] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the grants (NIH R01GM069384 and R01GM069384-7S1) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Briggs JP, 2002, AM J PHYSIOL-REG I, V282, pR3, DOI 10.1152/ajpregu.00589.2001; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Cox DN, 2000, DEVELOPMENT, V127, P503; Dranow DB, 2013, DEV BIOL IN PRESS; Draper BW, 2007, DEV BIOL, V305, P589, DOI 10.1016/j.ydbio.2007.03.007; Driever W, 1996, DEVELOPMENT, V123, P37; Durcova-Hills G, 2006, STEM CELLS, V24, P1441, DOI 10.1634/stemcells.2005-0424; Eisen JS, 1996, CELL, V87, P969, DOI 10.1016/S0092-8674(00)81792-4; Gautier A, 2011, BIOL REPROD, V85, P1240, DOI 10.1095/biolreprod.111.091892; Haffter P, 1996, DEVELOPMENT, V123, P1; Hofmann MC, 2005, DEV BIOL, V279, P114, DOI 10.1016/j.ydbio.2004.12.006; Hong YH, 2004, P NATL ACAD SCI USA, V101, P8011, DOI 10.1073/pnas.0308668101; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kanatsu-Shinohara M, 2007, BIOL REPROD, V76, P55, DOI 10.1095/biolreprod.106.055863; Kawakami K, 2005, DEV DYNAM, V234, P244, DOI 10.1002/dvdy.20516; Kawasaki T, 2012, GENES CELLS, V17, P316, DOI 10.1111/j.1365-2443.2012.01589.x; Knaut H, 2000, J CELL BIOL, V149, P875, DOI 10.1083/jcb.149.4.875; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Kurita K, 2004, P NATL ACAD SCI USA, V101, P1263, DOI 10.1073/pnas.0304265101; Leu DH, 2010, DEV DYNAM, V239, P2714, DOI 10.1002/dvdy.22404; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; McMillan DB, 2007, OVARIAN FOLLICLES FI, P67; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Nakamura S, 2010, SCIENCE, V328, P1561, DOI 10.1126/science.1185473; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; Saito T, 2008, BIOL REPROD, V78, P159, DOI 10.1095/biolreprod.107.060038; Sakai N, 2002, DEVELOPMENT, V129, P3359; Sawatari E, 2007, DEV BIOL, V301, P266, DOI 10.1016/j.ydbio.2006.10.001; Shibata Y, 2010, GENE EXPR PATTERNS, V10, P283, DOI 10.1016/j.gep.2010.06.005; Shikina S, 2010, BIOL REPROD, V83, P268, DOI 10.1095/biolreprod.109.082123; Slanchev K, 2005, P NATL ACAD SCI USA, V102, P4074, DOI 10.1073/pnas.0407475102; Tadokoro Y, 2002, MECH DEVELOP, V113, P29, DOI 10.1016/S0925-4773(02)00004-7; Tan CH, 2002, MECH DEVELOP, V119, pS221, DOI 10.1016/S0925-4773(03)00120-5; Villefranc JA, 2007, DEV DYNAM, V236, P3077, DOI 10.1002/dvdy.21354; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wong TT, 2013, BIOCHEM BIOPH RES CO, V430, P347, DOI 10.1016/j.bbrc.2012.11.014; Wong TT, 2011, BIOL REPROD, V84, P1190, DOI 10.1095/biolreprod.110.088427; Wong TT, 2004, ENDOCRINOLOGY, V145, P5210, DOI 10.1210/en.2004-0558; Yomogida K, 2003, BIOL REPROD, V69, P1303, DOI 10.1095/biolreprod.103.015958; Yoshizaki G, 2010, DEVELOPMENT, V137, P1227, DOI 10.1242/dev.044982; Zon LI, 1999, GENOME RES, V9, P99; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606; Zou K, 2009, NAT CELL BIOL, V11, P631, DOI 10.1038/ncb1869	44	17	21	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62660	10.1371/journal.pone.0062660	http://dx.doi.org/10.1371/journal.pone.0062660			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23671620	Green Published, Green Submitted, gold			2022-12-25	WOS:000321202100029
J	Liu, H; Zhao, B; Chen, YC; You, DW; Liu, R; Rong, MQ; Ji, WZ; Zheng, P; Lai, R				Liu, Huan; Zhao, Bo; Chen, Yongchang; You, Dewen; Liu, Rui; Rong, Mingqiang; Ji, Weizhi; Zheng, Ping; Lai, Ren			Multiple coagulation factor deficiency protein 2 contains the ability to support stem cell self-renewal	FASEB JOURNAL			English	Article						MCFD2; pluripotency	HUMAN EMBRYONIC STEM; RECEPTOR COMPLEX; FACTOR-VIII; PLURIPOTENCY; MAINTENANCE; GENE; DIFFERENTIATION; ACTIVATION; EXPRESSION; PATHWAYS	Defects in multiple coagulation factor deficiency protein 2 (MCFD2) are a cause of factor V and factor VIII combined deficiency type 2 (F5F8D). MCFD2 was also suggested to play an important role as an autocrine/paracrine factor in maintaining neural stem cell potential. The current work provided direct evidence that both amphibian and human MCFD2 can maintain stem cell pluripotency or stemness of rhesus monkey embryonic stem cells (rESCs) as basic fibroblast growth factor 2 (FGF-2) does. In most cases, MCFD2 had identical effects on stem cells as FGF-2. We investigated the possible mechanism of MCFD2 to support stem cell pluripotency by highlighting the effects of MCFD2 and FGF-2 on several signaling pathways in rESCs, namely MAPK, TGF-, Wnt, and Akt, and 3 core transcriptional factors (Oct4, Nanog, and Sox2). In addition, some features of signaling pathways (MAPK and Akt), which are different from human embryonic stem cells (hESCs) and mouse embryonic stem cells (mESCs), are found in rESCs, indicating that primate ESCs have unique signaling mechanisms. These results may shed light on the biological roles of MCFD2, the conserved protein family distributed in both vertebrates and invertebrates. The ability to support stem cell self-renewal may be the general function of the conserved protein family.Liu, H., Zhao, B., Chen, Y., You, D., Liu, R., Rong, M., Ji, W., Zheng, P., Lai, R. Multiple coagulation factor deficiency protein 2 contains the ability to support stem cell self-renewal.	[Liu, Huan; You, Dewen; Liu, Rui; Rong, Mingqiang; Lai, Ren] Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China; [Zhao, Bo; Zheng, Ping] Chinese Acad Sci, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China; [Chen, Yongchang; Ji, Weizhi] Chinese Acad Sci, Kunming Inst Zool, Kunming Primate Res Ctr, Kunming, Yunnan, Peoples R China; [Zhao, Bo; Chen, Yongchang] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Ji, WZ (corresponding author), Kunming Inst Zool, 32 Jiaochangdonglu, Kunming 650223, Yunnan, Peoples R China.	wji@mail.kiz.ac.cn; rlai@mail.kiz.ac.cn		Zhao, Bo/0000-0002-1000-8239; zheng, ping/0000-0003-0402-5507	China Ministry of Science and Technology [2010CB529800]; Chinese National Natural Science Foundation [31070701, 31000962, 31025025]; China Ministry of Agriculture [2009ZX08009-159B]; Chinese Academy of Sciences [KSCX2-EW-J-23, KSCX2-EW-R-11]; Key Laboratory of Animal Models and Human Disease Mechanisms of the Chinese Academy of Sciences; Yunnan Province	China Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); China Ministry of Agriculture(Ministry of Agriculture & Rural Affairs); Chinese Academy of Sciences(Chinese Academy of Sciences); Key Laboratory of Animal Models and Human Disease Mechanisms of the Chinese Academy of Sciences; Yunnan Province	This work was supported by the China Ministry of Science and Technology (2010CB529800), the Chinese National Natural Science Foundation (31070701, 31000962, 31025025), the China Ministry of Agriculture (2009ZX08009-159B), the Chinese Academy of Sciences (KSCX2-EW-J-23, KSCX2-EW-R-11), and the Key Laboratory of Animal Models and Human Disease Mechanisms of the Chinese Academy of Sciences and Yunnan Province. The authors declare no conflict of interests.	Armstrong L, 2006, HUM MOL GENET, V15, P1894, DOI 10.1093/hmg/ddl112; Besser D, 2004, J BIOL CHEM, V279, P45076, DOI 10.1074/jbc.M404979200; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brimble SN, 2004, STEM CELLS DEV, V13, P585, DOI 10.1089/scd.2004.13.585; DEKA N, 1988, GENE, V71, P123, DOI 10.1016/0378-1119(88)90084-4; Dreesen O, 2007, STEM CELL REV, V3, P7, DOI 10.1007/s12015-007-0004-8; Han XH, 2011, J BIOL CHEM, V286, P10649, DOI 10.1074/jbc.M110.169391; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Katz M, 2007, BBA-MOL CELL RES, V1773, P1161, DOI 10.1016/j.bbamcr.2007.01.002; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Mohanty D, 2005, AM J HEMATOL, V79, P262, DOI 10.1002/ajh.20397; Nyfeler B, 2006, TRAFFIC, V7, P1473, DOI 10.1111/j.1600-0854.2006.00483.x; Paling NRD, 2004, J BIOL CHEM, V279, P48063, DOI 10.1074/jbc.M406467200; Pankratz MT, 2007, STEM CELLS, V25, P1511, DOI 10.1634/stemcells.2006-0707; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Takahashi K, 2005, BIOCHEM SOC T, V33, P1522, DOI 10.1042/BST0331522; Toda H, 2003, J BIOL CHEM, V278, P35491, DOI 10.1074/jbc.M305342200; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; You DW, 2009, J BIOL CHEM, V284, P22079, DOI 10.1074/jbc.M109.013276; Zhang B, 2005, J BIOL CHEM, V280, P25881, DOI 10.1074/jbc.M502160200; Zhang B, 2003, NAT GENET, V34, P220, DOI 10.1038/ng1153; Zhang B, 2009, BRIT J HAEMATOL, V145, P15, DOI 10.1111/j.1365-2141.2008.07559.x; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267	26	5	6	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2013	27	8					3298	3305		10.1096/fj.13-228825	http://dx.doi.org/10.1096/fj.13-228825			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292BT	23660967				2022-12-25	WOS:000329877600034
J	Yang, N; Xie, W; Yang, X; Wang, SL; Wu, QJ; Li, RM; Pan, HP; Liu, BM; Shi, XB; Fang, Y; Xu, BY; Zhou, XG; Zhang, YJ				Yang, Nina; Xie, Wen; Yang, Xin; Wang, Shaoli; Wu, Qingjun; Li, Rumei; Pan, Huipeng; Liu, Baiming; Shi, Xiaobin; Fang, Yong; Xu, Baoyun; Zhou, Xuguo; Zhang, Youjun			Transcriptomic and Proteomic Responses of Sweetpotato Whitefly, Bemisia tabaci, to Thiamethoxam	PLOS ONE			English	Article							CYTOCHROME-C-OXIDASE; GLUTATHIONE-S-TRANSFERASE; INSECTICIDE-RESISTANCE; DROSOPHILA-MELANOGASTER; GENE-EXPRESSION; BROWN PLANTHOPPER; MULTIGENE FAMILY; MESSENGER-RNA; B-BIOTYPE; MECHANISMS	Background: The sweetpotato whitefly, Bemisia tabaci (Hemiptera: Aleyrodidae), is one of the most widely distributed agricultural pests. Although it has developed resistance to many registered insecticides including the neonicotinoid insecticide thiamethoxam, the mechanisms that regulate the resistance are poorly understood. To understand the molecular basis of thiamethoxam resistance, "omics" analyses were carried out to examine differences between resistant and susceptible B. tabaci at both transcriptional and translational levels. Results: A total of 1,338 mRNAs and 52 proteins were differentially expressed between resistant and susceptible B. tabaci. Among them, 11 transcripts had concurrent transcription and translation profiles. KEGG analysis mapped 318 and 35 differentially expressed genes and proteins, respectively, to 160 and 59 pathways (p<0.05). Thiamethoxam treatment activated metabolic pathways (e.g., drug metabolism), in which 118 transcripts were putatively linked to insecticide resistance, including up-regulated glutathione-S-transferase, UDP glucuronosyltransferase, glucosyl/glucuronosyl transferase, and cytochrome P450. Gene Ontology analysis placed these genes and proteins into protein complex, metabolic process, cellular process, signaling, and response to stimulus categories. Quantitative real-time PCR analysis validated "omics" response, and suggested a highly overexpressed P450, CYP6CX1, as a candidate molecular basis for the mechanistic study of thiamethoxam resistance in whiteflies. Finally, enzymatic activity assays showed elevated detoxification activities in the resistant B. tabaci. Conclusions: This study demonstrates the applicability of high-throughput omics tools for identifying molecular candidates related to thiamethoxam resistance in an agricultural important insect pest. In addition, transcriptomic and proteomic analyses provide a solid foundation for future functional investigations into the complex molecular mechanisms governing the neonicotinoid resistance in whiteflies.	[Yang, Nina; Xie, Wen; Yang, Xin; Wang, Shaoli; Wu, Qingjun; Li, Rumei; Pan, Huipeng; Liu, Baiming; Shi, Xiaobin; Fang, Yong; Xu, Baoyun; Zhang, Youjun] Chinese Acad Agr Sci, Dept Plant Protect, Inst Vegetables & Flowers, Beijing 100193, Peoples R China; [Zhou, Xuguo] Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA	Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; University of Kentucky	Zhou, XG (corresponding author), Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA.	xuguozhou@uky.edu; zhangyoujun@caas.cn	Yang, Xin/AAG-5375-2020; Zhang, Youjun/AAY-7948-2020	Zhang, Youjun/0000-0003-3508-6695	National Basic Research Program of China [2013CB127602]; National Technology Support Program [2012BAD19B06]; Beijing Key Laboratory for Pest Control and Sustainable Cultivation of Vegetables, P.R. China	National Basic Research Program of China(National Basic Research Program of China); National Technology Support Program; Beijing Key Laboratory for Pest Control and Sustainable Cultivation of Vegetables, P.R. China	This research was supported by the National Basic Research Program of China (2013CB127602), National Technology Support Program (2012BAD19B06) and Beijing Key Laboratory for Pest Control and Sustainable Cultivation of Vegetables, P.R. China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SJ, 2012, INSECT BIOCHEM MOLEC, V42, P133, DOI 10.1016/j.ibmb.2011.11.006; Alemany C, 2000, BBA-MOL CELL RES, V1495, P319, DOI 10.1016/S0167-4889(99)00159-7; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bolognani F, 2008, J NEUROSCI RES, V86, P481, DOI 10.1002/jnr.21473; CAPALDI RA, 1990, ANNU REV BIOCHEM, V59, P569, DOI 10.1146/annurev.bi.59.070190.003033; Carolan JC, 2011, J PROTEOME RES, V10, P1505, DOI 10.1021/pr100881q; Chaudhuri J, 1997, J BIOL CHEM, V272, P7883, DOI 10.1074/jbc.272.12.7883; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; De Barro P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025579; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; Elbert A, 2000, PEST MANAG SCI, V56, P60, DOI 10.1002/(SICI)1526-4998(200001)56:1<60::AID-PS88>3.0.CO;2-K; Emamzadeh R, 2010, ENZYME MICROB TECH, V47, P159, DOI 10.1016/j.enzmictec.2010.05.008; Feng JX, 2012, BIOINFORMATICS, V28, P2782, DOI 10.1093/bioinformatics/bts515; Feng YT, 2009, J APPL ENTOMOL, V133, P466, DOI 10.1111/j.1439-0418.2009.01383.x; Feng YT, 2010, PEST MANAG SCI, V66, P313, DOI 10.1002/ps.1877; Feyereisen R, 1995, TOXICOL LETT, V82-3, P83, DOI 10.1016/0378-4274(95)03470-6; Greenamyre JT, 1999, BIOCHEM SOC SYMP, V66, P85, DOI 10.1042/bss0660085; Hand SC, 2008, J EXP BIOL, V211, P1829, DOI 10.1242/jeb.000299; Hemingway J, 2000, INSECT BIOCHEM MOLEC, V30, P1009, DOI 10.1016/S0965-1748(00)00079-5; Hogenhout SA, 2008, ANNU REV PHYTOPATHOL, V46, P327, DOI 10.1146/annurev.phyto.022508.092135; Horowitz AR, 2004, J ECON ENTOMOL, V97, P2051, DOI 10.1603/0022-0493-97.6.2051; Huang FF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-563; HUNDLE BS, 1992, P NATL ACAD SCI USA, V89, P9321, DOI 10.1073/pnas.89.19.9321; James DG, 2002, J ECON ENTOMOL, V95, P729, DOI 10.1603/0022-0493-95.4.729; Joussen N, 2010, CHEM BIODIVERS, V7, P722, DOI 10.1002/cbdv.200900020; Karunker I, 2008, INSECT BIOCHEM MOLEC, V38, P634, DOI 10.1016/j.ibmb.2008.03.008; Kislinger T, 2006, CELL, V125, P173, DOI 10.1016/j.cell.2006.01.044; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Kostaropoulos I, 2001, INSECT BIOCHEM MOLEC, V31, P313, DOI 10.1016/S0965-1748(00)00123-5; Lee JS, 2002, BIOCHEM BIOPH RES CO, V291, P158, DOI 10.1006/bbrc.2002.6398; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Liu B., 2011, PLOS ONE, V6, P1, DOI [10.1371/journal.pone.0025794, DOI 10.1371/JOURNAL.PONE.0025794]; Liu N, 1998, INSECT BIOCHEM MOLEC, V28, P531, DOI 10.1016/S0965-1748(98)00039-3; Liu SS, 2007, SCIENCE, V318, P1769, DOI 10.1126/science.1149887; Liu ZW, 2005, P NATL ACAD SCI USA, V102, P8420, DOI 10.1073/pnas.0502901102; Low WY, 2007, GENETICS, V177, P1363, DOI 10.1534/genetics.107.075838; Lumjuan N, 2005, INSECT BIOCHEM MOLEC, V35, P861, DOI 10.1016/j.ibmb.2005.03.008; Luo Chen, 2002, Acta Entomologica Sinica, V45, P759; Luque T, 2002, INSECT BIOCHEM MOLEC, V32, P1597, DOI 10.1016/S0965-1748(02)00080-2; Markussen MDK, 2010, PESTIC BIOCHEM PHYS, V98, P50, DOI 10.1016/j.pestbp.2010.04.012; Miley MJ, 2007, J MOL BIOL, V369, P498, DOI 10.1016/j.jmb.2007.03.066; Misra JR, 2011, GENE DEV, V25, P1796, DOI 10.1101/gad.17280911; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muller P, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000286; Nie L, 2006, BIOCHEM BIOPH RES CO, V339, P603, DOI 10.1016/j.bbrc.2005.11.055; Oakeshott JG, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-202; Ono M, 1999, INSECT BIOCHEM MOLEC, V29, P1065, DOI 10.1016/S0965-1748(99)00082-X; Pereira C, 1998, PARASITOLOGY, V117, P63, DOI 10.1017/S003118209800273X; Perry T, 2011, INSECT BIOCHEM MOLEC, V41, P411, DOI 10.1016/j.ibmb.2011.03.003; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Popesku JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012338; Pridgeon JW, 2009, J MED ENTOMOL, V46, P810, DOI 10.1603/033.046.0411; Pridgeon JW, 2003, INSECT BIOCHEM MOLEC, V33, P1043, DOI 10.1016/S0965-1748(03)00120-6; Puinean AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000999; Qiu BL, 2009, INSECT SCI, V16, P237, DOI 10.1111/j.1744-7917.2009.01253.x; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; Rauch N, 2003, ARCH INSECT BIOCHEM, V54, P165, DOI 10.1002/arch.10114; Rausell C, 1997, ARCH INSECT BIOCHEM, V34, P347, DOI 10.1002/(SICI)1520-6327(1997)34:3<347::AID-ARCH8>3.0.CO;2-R; Roditakis E, 2009, PEST MANAG SCI, V65, P313, DOI 10.1002/ps.1690; Samokyszyn VM, 2000, J BIOL CHEM, V275, P6908, DOI 10.1074/jbc.275.10.6908; Scott JG, 1999, INSECT BIOCHEM MOLEC, V29, P757, DOI 10.1016/S0965-1748(99)00038-7; Small GJ, 2000, INSECT MOL BIOL, V9, P647, DOI 10.1046/j.1365-2583.2000.00229.x; Stansly P.A., 2010, BEMISIA BIONOMICS MA, DOI DOI 10.1007/978-90-481-2460-2; Stumpf N, 2002, PESTIC BIOCHEM PHYS, V72, P111, DOI 10.1006/pest.2001.2583; Syvanen M, 1996, J MOL EVOL, V43, P236, DOI 10.1007/PL00006082; Tijet N, 2001, GENE, V262, P189, DOI 10.1016/S0378-1119(00)00533-3; Tomizawa M, 2005, ANNU REV PHARMACOL, V45, P247, DOI 10.1146/annurev.pharmtox.45.120403.095930; Tomizawa M, 2003, ANNU REV ENTOMOL, V48, P339, DOI 10.1146/annurev.ento.48.091801.112731; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Vontas JG, 2002, BIOCHEM J, V362, P329, DOI 10.1042/bj3620329; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang ZY, 2010, PEST MANAG SCI, V66, P1360, DOI 10.1002/ps.2023; Wang ZY, 2009, PEST MANAG SCI, V65, P1189, DOI 10.1002/ps.1808; Wondji CS, 2009, GENOME RES, V19, P452, DOI 10.1101/gr.087916.108; Xie W, 2012, PLOS ONE, DOI [10.1371/journal.-pone.0035181, DOI 10.1371/J0URNAL.-P0NE.0035181]; Xie W, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.4601; ZHOU Y, 1949, ENTOMOL SINICA, V3, P1; Zhu F, 2010, P NATL ACAD SCI USA, V107, P8557, DOI 10.1073/pnas.1000059107; Zhuang HM, 2011, INSECT SCI, V18, P484, DOI 10.1111/j.1744-7917.2010.01380.x	83	55	62	2	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e61820	10.1371/journal.pone.0061820	http://dx.doi.org/10.1371/journal.pone.0061820			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671574	gold, Green Published, Green Submitted			2022-12-25	WOS:000319737700006
J	Persichetti, A; Sciuto, R; Rea, S; Basciani, S; Lubrano, C; Mariani, S; Ulisse, S; Nofroni, I; Maini, CL; Gnessi, L				Persichetti, Agnese; Sciuto, Rosa; Rea, Sandra; Basciani, Sabrina; Lubrano, Carla; Mariani, Stefania; Ulisse, Salvatore; Nofroni, Italo; Maini, Carlo Ludovico; Gnessi, Lucio			Prevalence, Mass, and Glucose-Uptake Activity of F-18-FDG-Detected Brown Adipose Tissue in Humans Living in a Temperate Zone of Italy	PLOS ONE			English	Article							RECEPTOR GENE-EXPRESSION; FDG UPTAKE; OUTDOOR TEMPERATURE; FAT; SEX; MECHANISMS; AGE	Background: The F-18-fluorodeoxyglucose (F-18-FDG)-detected brown adipose tissue (BAT), is enhanced by cold stimulus and modulated by other factors that still have to be disentangled. We investigated the prevalence, mass, and glucose-uptake activity of F-18-FDG-detected BAT in a population of adults living in the temperate climatic zone of the Rome area. Methods and Findings: We retrospectively analyzed 6454 patients who underwent F-18-FDG positron emission tomography/computed tomography (PET/CT) examinations. We found F-18-FDG BAT in 217 of the 6454 patients (3.36%). Some of them underwent more than one scan and the positive scans were 278 among 8004 (3.47%). The prevalence of patients with at least one positive scan was lower in men (1.77%; 56 of 3161) compared with women (4.88%; 161 of 3293). The BAT positive patients were most frequently younger, thinner and with lower plasma glucose levels compared with BAT negative patients. The amount of BAT in the defined region of interest, the activity of BAT and the number of positive sites of active BAT were similar in both sexes. The prevalence of patients with F-18-FDG positive PET/CT was highest in December-February, lower in March-May and September-November, and lowest in June-August and was positively correlated with night length and negatively correlated with ambient temperature. Changes in day length and variations of temperature, associated with the prevalence of positive BAT patients. Among the patients who had multiple scans, outdoor temperature was significantly lower and day length was shorter on the occasion when BAT was detected. Conclusions: This study identifies day length, outdoor temperature, age, sex, BMI, and plasma glucose levels as major determinants of the prevalence, mass, and activity of 18F-FDG-detected BAT.	[Persichetti, Agnese; Basciani, Sabrina; Lubrano, Carla; Mariani, Stefania; Ulisse, Salvatore; Gnessi, Lucio] Univ Roma La Sapienza, Dept Expt Med, Sect Med Pathophysiol Food Sci & Endocrinol, I-00185 Rome, Italy; [Sciuto, Rosa; Rea, Sandra; Maini, Carlo Ludovico] Regina Elena Inst Canc Res, Dept Nucl Med, Rome, Italy; [Nofroni, Italo] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis Med Stat & Biometry, I-00185 Rome, Italy	Sapienza University Rome; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Sapienza University Rome	Gnessi, L (corresponding author), Univ Roma La Sapienza, Dept Expt Med, Sect Med Pathophysiol Food Sci & Endocrinol, I-00185 Rome, Italy.	lucio.gnessi@uniroma1.it	Ulisse, Salvatore/H-5362-2019; Rea, Sandra/ABA-6207-2020; Gnessi, Lucio/K-8025-2016	Ulisse, Salvatore/0000-0002-7573-0759; Rea, Sandra/0000-0002-4336-7406; Gnessi, Lucio/0000-0001-8217-2372	Sapienza University of Rome, Italy	Sapienza University of Rome, Italy	This study was funded by the Sapienza University of Rome, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkas BE, 2011, REV ESP MED NUCL, V30, P14, DOI 10.1016/j.remn.2010.05.006; Au-Yong ITH, 2009, DIABETES, V58, P2583, DOI 10.2337/db09-0833; Bartness TJ, 2007, PHYSIOL BEHAV, V91, P343, DOI 10.1016/j.physbeh.2007.04.002; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cohade C, 2003, J NUCL MED, V44, P1267; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Demas GE, 2003, AM J PHYSIOL-REG I, V285, pR873, DOI 10.1152/ajpregu.00209.2003; Fain JN, 2010, METABOLISM, V59, P1379, DOI 10.1016/j.metabol.2009.12.027; Hany TF, 2002, EUR J NUCL MED MOL I, V29, P1393, DOI 10.1007/s00259-002-0902-6; HELDMAIER G, 1981, J COMP PHYSIOL, V142, P429, DOI 10.1007/BF00688972; Huang YC, 2012, SCI WORLD J, P1, DOI 10.1100/2012/793039; Huang YC, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-238; Johnston JD, 2004, J ENDOCRINOL, V180, P351, DOI 10.1677/joe.0.1800351; Kim S, 2008, EUR J NUCL MED MOL I, V35, P984, DOI 10.1007/s00259-007-0670-4; Klingenspor M, 1996, FEBS LETT, V399, P290, DOI 10.1016/S0014-5793(96)01343-9; Lacobellis G, 2008, HORM METAB RES, V40, P442, DOI 10.1055/s-2008-1062724; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Ling C, 2000, ENDOCRINOLOGY, V141, P3564, DOI 10.1210/en.141.10.3564; Lubrano C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047059; Mariani S, 2013, INT J CARDIOL, V167, P2244, DOI 10.1016/j.ijcard.2012.06.011; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Ouellet V, 2011, J CLIN ENDOCR METAB, V96, P192, DOI 10.1210/jc.2010-0989; Pfannenberg C, 2010, DIABETES, V59, P1789, DOI 10.2337/db10-0004; Quarta C, 2012, J MOL ENDOCRINOL, V49, pR1, DOI 10.1530/JME-12-0043; Sacks HS, 2009, J CLIN ENDOCR METAB, V94, P3611, DOI 10.1210/jc.2009-0571; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Symonds ME, 1998, J NEUROENDOCRINOL, V10, P885; Symonds Michael E., 2011, Frontiers in Genetics, V2, P24, DOI 10.3389/fgene.2011.00024; Tam CS, 2012, CIRCULATION, V125, P2782, DOI 10.1161/CIRCULATIONAHA.111.042929; Tan DX, 2011, OBES REV, V12, P167, DOI 10.1111/j.1467-789X.2010.00756.x; Truong MT, 2004, AM J ROENTGENOL, V183, P1127, DOI 10.2214/ajr.183.4.1831127; Viengchareun S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001535; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wehr TA, 1998, HORM RES, V49, P118, DOI 10.1159/000023157; Weil ZM, 2009, P NATL ACAD SCI USA, V106, P4525, DOI 10.1073/pnas.0810973106; Yeung HWD, 2003, J NUCL MED, V44, P1789; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	37	49	49	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63391	10.1371/journal.pone.0063391	http://dx.doi.org/10.1371/journal.pone.0063391			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667608	Green Submitted, Green Published, gold			2022-12-25	WOS:000319055600058
J	Kosaka, J; Morimatsu, H; Takahashi, T; Shimizu, H; Kawanishi, S; Omori, E; Endo, Y; Tamaki, N; Morita, M; Morita, K				Kosaka, Junko; Morimatsu, Hiroshi; Takahashi, Toru; Shimizu, Hiroko; Kawanishi, Susumu; Omori, Emiko; Endo, Yasumasa; Tamaki, Naofumi; Morita, Manabu; Morita, Kiyoshi			Effects of Biliverdin Administration on Acute Lung Injury Induced by Hemorrhagic Shock and Resuscitation in Rats	PLOS ONE			English	Article							MULTIPLE ORGAN FAILURE; RESPIRATORY-DISTRESS-SYNDROME; DECREASED PROGRESSION; REPERFUSION INJURY; HEME OXYGENASE-1; OXIDATIVE DAMAGE; PROTECTS; MODEL; INFLAMMATION; DYSFUNCTION	Hemorrhagic shock and resuscitation induces pulmonary inflammation that leads to acute lung injury. Biliverdin, a metabolite of heme catabolism, has been shown to have potent cytoprotective, anti-inflammatory, and anti-oxidant effects. This study aimed to examine the effects of intravenous biliverdin administration on lung injury induced by hemorrhagic shock and resuscitation in rats. Biliverdin or vehicle was administered to the rats 1 h before sham or hemorrhagic shock-inducing surgery. The sham-operated rats underwent all surgical procedures except bleeding. To induce hemorrhagic shock, rats were bled to achieve a mean arterial pressure of 30 mmHg that was maintained for 60 min, followed by resuscitation with shed blood. Histopathological changes in the lungs were evaluated by histopathological scoring analysis. Inflammatory gene expression was determined by Northern blot analysis, and oxidative DNA damage was assessed by measuring 8-hydroxy-2' deoxyguanosine levels in the lungs. Hemorrhagic shock and resuscitation resulted in prominent histopathological damage, including congestion, edema, cellular infiltration, and hemorrhage. Biliverdin administration prior to hemorrhagic shock and resuscitation significantly ameliorated these lung injuries as judged by histopathological improvement. After hemorrhagic shock and resuscitation, inflammatory gene expression of tumor necrosis factor-alpha and inducible nitric oxide synthase were increased by 18- and 8-fold, respectively. Inflammatory gene expression significantly decreased when biliverdin was administered prior to hemorrhagic shock and resuscitation. Moreover, after hemorrhagic shock and resuscitation, lung 8-hydroxy-2' deoxyguanosine levels in mitochondrial DNA expressed in the pulmonary interstitium increased by 1.5-fold. Biliverdin administration prior to hemorrhagic shock and resuscitation decreased mitochondrial 8-hydroxy-2' deoxyguanosine levels to almost the same level as that in the control animals. We also confirmed that biliverdin administration after hemorrhagic shock and resuscitation had protective effects on lung injury. Our findings suggest that biliverdin has a protective role, at least in part, against hemorrhagic shock and resuscitation-induced lung injury through anti-inflammatory and anti-oxidant mechanisms.	[Kosaka, Junko; Morimatsu, Hiroshi; Takahashi, Toru; Shimizu, Hiroko; Kawanishi, Susumu; Omori, Emiko; Morita, Kiyoshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Anesthesiol & Resuscitol, Okayama, Japan; [Takahashi, Toru] Okayama Prefectural Univ, Fac Hlth & Welf Sci, Okayama, Japan; [Endo, Yasumasa; Morita, Manabu] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Prevent Dent, Okayama, Japan; [Tamaki, Naofumi] Univ Tokushima, Grad Sch, Dept Prevent Dent, Inst Hlth Biosci, Tokushima 770, Japan	Okayama University; Okayama Prefectural University; Okayama University; Tokushima University	Morimatsu, H (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Anesthesiol & Resuscitol, Okayama, Japan.	morima-h@md.okayama-u.ac.jp	Morimatsu, Hiroshi/B-2236-2011	Morimatsu, Hiroshi/0000-0002-6744-0508	Grants-in-Aid for Scientific Research [24592735] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Anaya-Prado R, 2002, J SURG RES, V105, P248, DOI 10.1006/jsre.2002.6385; Baek JH, 2012, J CLIN INVEST, V122, P1444, DOI 10.1172/JCI59770; Baranano DE, 2002, P NATL ACAD SCI USA, V99, P16093, DOI 10.1073/pnas.252626999; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Ciesla DJ, 2006, SURGERY, V140, P640, DOI 10.1016/j.surg.2006.06.015; Ciesla DJ, 2005, SURGERY, V138, P749, DOI 10.1016/j.surg.2005.07.020; Deguchi K, 2008, BRAIN RES, V1188, P1, DOI 10.1016/j.brainres.2007.07.104; Dennery PA, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00115; Dewar D, 2009, INJURY, V40, P912, DOI 10.1016/j.injury.2009.05.024; Fondevila C, 2004, HEPATOLOGY, V40, P1333, DOI 10.1002/hep.20480; Franklin GA, 2006, SURGERY, V140, P647; Jansen T, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00030; Jiang HC, 2007, SURGERY, V141, P32, DOI 10.1016/j.surg.2006.03.024; Kanagawa F, 2010, J TRAUMA, V69, P185, DOI 10.1097/TA.0b013e3181bbd516; Kasai H, 2002, FREE RADICAL BIO MED, V33, P450, DOI 10.1016/S0891-5849(02)00818-3; Maeshima K, 2005, BIOCHEM PHARMACOL, V69, P1667, DOI 10.1016/j.bcp.2005.03.007; Malangoni MA, 2005, SURGERY, V138, P757; Murakami K, 2002, SHOCK, V18, P236, DOI 10.1097/00024382-200209000-00006; Nakao A, 2004, GASTROENTEROLOGY, V127, P595, DOI 10.1053/j.gastro.2004.05.059; Nicholson SE, 2011, J TRAUMA, V70, P466, DOI 10.1097/TA.0b013e3182032584; Rushing GD, 2008, ANN SURG, V247, P929, DOI 10.1097/SLA.0b013e31816757f7; Sarady-Andrews JK, 2005, AM J PHYSIOL-LUNG C, V289, pL1131, DOI 10.1152/ajplung.00458.2004; STEPHENS KE, 1988, AM REV RESPIR DIS, V137, P1364, DOI 10.1164/ajrccm/137.6.1364; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Tomofuji T, 2006, FEBS LETT, V580, P3601, DOI 10.1016/j.febslet.2006.05.041; Tomofuji T, 2011, BIOMED RES-TOKYO, V32, P343, DOI 10.2220/biomedres.32.343; Uehara K, 2005, CRIT CARE MED, V33, P381, DOI 10.1097/01.CCM.0000153407.14237.7F; Umeda K, 2009, SHOCK, V31, P40, DOI 10.1097/SHK.0b013e318177823a; Yamashita K, 2004, FASEB J, V18, P765, DOI 10.1096/fj.03-0839fje; Zegdi R, 2003, SHOCK, V20, P569, DOI 10.1097/01.shk.0000094765.36694.92	30	34	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63606	10.1371/journal.pone.0063606	http://dx.doi.org/10.1371/journal.pone.0063606			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667646	Green Published, Green Submitted, gold			2022-12-25	WOS:000319654700167
J	Moody, EK; Sabo, JL				Moody, Eric K.; Sabo, John L.			Crayfish Impact Desert River Ecosystem Function and Litter-Dwelling Invertebrate Communities through Association with Novel Detrital Resources	PLOS ONE			English	Article							RIPARIAN VEGETATION; LONG-TERM; PACIFASTACUS-LENIUSCULUS; TAMARIX-RAMOSISSIMA; SIGNAL CRAYFISH; COLORADO RIVER; LEAF-LITTER; STREAM; FLOW; DIVERSITY	Shifts in plant species distributions due to global change are increasing the availability of novel resources in a variety of ecosystems worldwide. In semiarid riparian areas, hydric pioneer tree species are being replaced by drought-tolerant plant species as water availability decreases. Additionally, introduced omnivorous crayfish, which feed upon primary producers, allochthonous detritus, and benthic invertebrates, can impact communities at multiple levels through both direct and indirect effects mediated by drought-tolerant plants. We tested the impact of both virile crayfish (Orconectes virilis) and litter type on benthic invertebrates and the effect of crayfish on detrital resources across a gradient of riparian vegetation drought-tolerance using field cages with leaf litter bags in the San Pedro River in Southeastern Arizona. Virile crayfish increased breakdown rate of novel drought-tolerant saltcedar (Tamarix ramosissima), but did not impact breakdown of drought-tolerant seepwillow (Baccharis salicifolia) or hydric Fremont cottonwood (Populus fremontii) and Gooding's willow (Salix goodingii). Effects on invertebrate diversity were observed at the litter bag scale, but no effects were found at the cage scale. Crayfish decreased alpha diversity of colonizing macroinvertebrates, but did not affect beta diversity. In contrast, the drought-tolerant litter treatment decreased beta diversity relative to hydric litter. As drought-tolerant species become more abundant in riparian zones, their litter will become a larger component of the organic matter budget of desert streams which may serve to homogenize the litter-dwelling community and support elevated populations of virile crayfish. Through impacts at multiple trophic levels, crayfish have a significant effect on desert stream ecosystems.	[Moody, Eric K.; Sabo, John L.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Moody, EK (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	eric.k.moody@asu.edu			Arizona Water Association	Arizona Water Association	Funding for the study was provided by a scholarship from the Arizona Water Association (www.azwater.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey JK, 2001, WETLANDS, V21, P442, DOI 10.1672/0277-5212(2001)021[0442:SCNABO]2.0.CO;2; Ball BA, 2010, BIOSCIENCE, V60, P590, DOI 10.1525/bio.2010.60.8.5; Bates D., 2011, PACKAGE LME4 LINEAR; Bobeldyk AM, 2010, CRUSTACEANA, V83, P641, DOI 10.1163/001121610X491031; Bogan MT, 2011, FRESHWATER BIOL, V56, P2070, DOI 10.1111/j.1365-2427.2011.02638.x; Bondar CA, 2009, J N AM BENTHOL SOC, V28, P294, DOI 10.1899/08-092.1; Carlisle DM, 2011, FRONT ECOL ENVIRON, V9, P264, DOI 10.1890/100053; Chao A, 2003, ENVIRON ECOL STAT, V10, P429, DOI 10.1023/A:1026096204727; Charlebois PM, 1996, J N AM BENTHOL SOC, V15, P551, DOI 10.2307/1467806; Clarke KR, 2006, J EXP MAR BIOL ECOL, V330, P55, DOI 10.1016/j.jembe.2005.12.017; CREED RP, 1994, ECOLOGY, V75, P2091, DOI 10.2307/1941613; Ermgassen PSEZ, 2011, HYDROBIOLOGIA, V658, P303, DOI 10.1007/s10750-010-0500-8; FISHER SG, 1973, ECOL MONOGR, V43, P421, DOI 10.2307/1942301; FISHER SG, 1981, SOUTHWEST NAT, V26, P31, DOI 10.2307/3671326; FLECKER AS, 1992, ECOLOGY, V73, P927, DOI 10.2307/1940169; Fox J., 2019, R COMPANION APPL REG, V3rd Edn; Frost PJ, 2002, J MANAGE INQUIRY, V11, P21, DOI 10.1177/1056492602111007; Going BM, 2008, BIOL INVASIONS, V10, P1041, DOI 10.1007/s10530-007-9182-1; Hauer F. R., 2006, METHODS STREAM ECOLO; Helms KR, 2002, ECOLOGY, V83, P2425, DOI 10.1890/0012-9658(2002)083[2425:WAOTIA]2.0.CO;2; Henseler J., 2010, HDB PARTIAL LEAST SQ, P713, DOI DOI 10.1007/978-3-540-32827-8_31; Hladyz S, 2009, FRESHWATER BIOL, V54, P957, DOI 10.1111/j.1365-2427.2008.02138.x; Hobbs RJ, 2006, GLOBAL ECOL BIOGEOGR, V15, P1, DOI 10.1111/j.1466-822x.2006.00212.x; Horton JL, 2001, PLANT CELL ENVIRON, V24, P293, DOI 10.1046/j.1365-3040.2001.00681.x; HURYN AD, 1987, FRESHWATER BIOL, V18, P277, DOI 10.1111/j.1365-2427.1987.tb01314.x; Kennedy TA, 2005, ECOL APPL, V15, P2072, DOI 10.1890/04-1533; Kennedy TA, 2004, FRESHWATER BIOL, V49, P65, DOI 10.1046/j.1365-2426.2003.01166.x; Kominoski JS, 2007, ECOLOGY, V88, P1167, DOI 10.1890/06-0674; Lennon JJ, 2001, J ANIM ECOL, V70, P966, DOI 10.1046/j.0021-8790.2001.00563.x; Ludlam JP, 2009, J N AM BENTHOL SOC, V28, P371, DOI 10.1899/08-149.1; Lytle DA, 2004, TRENDS ECOL EVOL, V19, P94, DOI 10.1016/j.tree.2003.10.002; Maechler M., 2011, SFSMISC UTILITIES SE; Martinez PJ, 2012, AQUAT INVASIONS, V7, P219, DOI 10.3391/ai.2012.7.2.008; McCarthy JM, 2006, FRESHWATER BIOL, V51, P224, DOI 10.1111/j.1365-2427.2005.01485.x; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; Moline AB, 2008, FRESHWATER BIOL, V53, P1012, DOI 10.1111/j.1365-2427.2008.01960.x; Moody E. K., 2012, SW NAT, V57, P343; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Olden JD, 2009, AQUAT ECOL, V43, P1073, DOI 10.1007/s10452-009-9244-9; Paine RT, 1998, ECOSYSTEMS, V1, P535, DOI 10.1007/s100219900049; Parkyn SM, 1997, NEW ZEAL J MAR FRESH, V31, P685, DOI 10.1080/00288330.1997.9516798; Pintor LM, 2006, BIOL CONSERV, V130, P584, DOI 10.1016/j.biocon.2006.01.021; Pomeroy KE, 2000, HYDROBIOLOGIA, V434, P193, DOI 10.1023/A:1004081309986; Sabo JL, 2008, ECOL MONOGR, V78, P19, DOI 10.1890/06-1340.1; Sabo JL, 2010, P NATL ACAD SCI USA, V107, P21263, DOI 10.1073/pnas.1009734108; Sabo JL, 2010, SCIENCE, V330, P965, DOI 10.1126/science.1196005; Sanchez G., 2012, PLSPM PARTIAL LEAST; Schade JD, 1997, J N AM BENTHOL SOC, V16, P612, DOI 10.2307/1468148; Schade JD, 2006, ECOSYSTEMS, V9, P740, DOI 10.1007/s10021-006-0159-1; Seager R, 2007, SCIENCE, V316, P1181, DOI 10.1126/science.1139601; SEEGRIST DW, 1972, T AM FISH SOC, V101, P478, DOI 10.1577/1548-8659(1972)101<478:EOFOTI>2.0.CO;2; Serrat-Capdevila A, 2007, J HYDROL, V347, P48, DOI 10.1016/j.jhydrol.2007.08.028; Sponseller RA, 2010, GLOBAL CHANGE BIOL, V16, P2891, DOI 10.1111/j.1365-2486.2010.02200.x; STANLEY EH, 1994, AM MIDL NAT, V131, P288, DOI 10.2307/2426255; Stromberg JC, 2010, RIVER RES APPL, V26, P712, DOI 10.1002/rra.1272; Stromberg JC, 2005, RIVER RES APPL, V21, P925, DOI 10.1002/rra.858; Turner DS, 2011, ENVIRON MANAGE, V47, P497, DOI 10.1007/s00267-010-9607-y; Usio N, 2000, OECOLOGIA, V124, P608, DOI 10.1007/s004420000422; Usio N, 2007, BIOL CONSERV, V134, P517, DOI 10.1016/j.biocon.2006.09.002; Vandersande MW, 2001, J ARID ENVIRON, V49, P147, DOI 10.1006/jare.2001.0839; VITOUSEK PM, 1994, ECOLOGY, V75, P1861, DOI 10.2307/1941591; Wallace JB, 1997, SCIENCE, V277, P102, DOI 10.1126/science.277.5322.102; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Wilson KA, 2004, CAN J FISH AQUAT SCI, V61, P2255, DOI [10.1139/f04-170, 10.1139/F04-170]	64	18	18	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63274	10.1371/journal.pone.0063274	http://dx.doi.org/10.1371/journal.pone.0063274			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667600	Green Published, gold, Green Submitted			2022-12-25	WOS:000319654700130
J	Na, YR; Yoon, YN; Son, DI; Seok, SH				Na, Yi-Rang; Yoon, Yi-Na; Son, Da-In; Seok, Seung-Hyeok			Cyclooxygenase-2 Inhibition Blocks M2 Macrophage Differentiation and Suppresses Metastasis in Murine Breast Cancer Model	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; ACTIVATED MACROPHAGES; STIMULATING FACTOR; MYELOID CELLS; POLARIZATION; PROGRESSION; LYMPHANGIOGENESIS; MICROENVIRONMENT; INFLAMMATION; EXPRESSION	Tumor cells are often associated with abundant macrophages that resemble the alternatively activated M2 subset. Tumor-associated macrophages (TAMs) inhibit anti-tumor immune responses and promote metastasis. Cyclooxygenase-2 (COX-2) inhibition is known to prevent breast cancer metastasis. This study hypothesized that COX-2 inhibition affects TAM characteristics potentially relevant to tumor cell metastasis. We found that the specific COX-2 inhibitor, etodolac, inhibited human M2 macrophage differentiation, as determined by decreased CD14 and CD163 expressions and increased TNF alpha production. Several key metastasis-related mediators, such as vascular endothelial growth factor-A, vascular endothelial growth factor-C, and matrix metalloproteinase-9, were inhibited in the presence of etodolac as compared to untreated M2 macrophages. Murine bone marrow derived M2 macrophages also showed enhanced surface MHCII IA/IE and CD80, CD86 expressions together with enhanced TNF alpha expressions with etodolac treatment during differentiation. Using a BALB/c breast cancer model, we found that etodolac significantly reduced lung metastasis, possibly due to macrophages expressing increased IA/IE and TNF alpha, but decreased M2 macrophage-related genes expressions (Ym1, TGF beta). In conclusion, COX-2 inhibition caused loss of the M2 macrophage characteristics of TAMs and may assist prevention of breast cancer metastasis.	[Seok, Seung-Hyeok] Seoul Natl Univ, Coll Med, Dept Microbiol & Immunol, Seoul, South Korea; Seoul Natl Univ, Coll Med, Inst Endem Dis, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Seok, SH (corresponding author), Seoul Natl Univ, Coll Med, Dept Microbiol & Immunol, Seoul, South Korea.	lamseok@snu.ac.kr	Seok, Seung Hyeok/J-3279-2012	Seok, Seung Hyeok/0000-0002-4315-0688	Ministry of Education, Science and Technology, Korea [2012-0004090]; Seoul National University Hospital Research Fund [04-2010-0240]	Ministry of Education, Science and Technology, Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Seoul National University Hospital Research Fund	This work was funded both by the Ministry of Education, Science and Technology, Korea (2012-0004090), and supported by the Seoul National University Hospital Research Fund (04-2010-0240). The funders only financially supported this study and had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achen MG, 2006, INT J CANCER, V119, P1755, DOI 10.1002/ijc.21899; Alitalo K, 2005, NATURE, V438, P946, DOI 10.1038/nature04480; Almand B, 2001, J IMMUNOL, V166, P678, DOI 10.4049/jimmunol.166.1.678; Beatty GL, 2011, SCIENCE, V331, P1612, DOI 10.1126/science.1198443; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Borrello IM, 2009, BLOOD, V114, P1736, DOI 10.1182/blood-2009-02-205278; Dannenberg AJ, 2001, LANCET ONCOL, V2, P544, DOI 10.1016/S1470-2045(01)00488-0; DeNardo D, 2010, CANCER METAST REV, V29, P309, DOI 10.1007/s10555-010-9223-6; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Ghassabeh GH, 2006, BLOOD, V108, P575, DOI 10.1182/blood-2005-04-1485; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; Gocheva V, 2010, GENE DEV, V24, P241, DOI 10.1101/gad.1874010; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Guiet R, 2011, J IMMUNOL, V187, P3806, DOI 10.4049/jimmunol.1101245; Hallam S, 2009, J PATHOL, V219, P143, DOI 10.1002/path.2602; Herlong JL, 2006, IMMUNOL LETT, V102, P121, DOI 10.1016/j.imlet.2005.10.004; Iwata C, 2007, CANCER RES, V67, P10181, DOI 10.1158/0008-5472.CAN-07-2366; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kim EH, 2006, BIOCHEM PHARMACOL, V72, P1516, DOI 10.1016/j.bcp.2006.07.030; Kozin SV, 2010, CANCER RES, V70, P5679, DOI 10.1158/0008-5472.CAN-09-4446; Leidi M, 2009, J IMMUNOL, V182, P4415, DOI 10.4049/jimmunol.0713732; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Meng YR, 2010, CANCER RES, V70, P1534, DOI 10.1158/0008-5472.CAN-09-2995; Murdoch C, 2007, J IMMUNOL, V178, P7405, DOI 10.4049/jimmunol.178.11.7405; Nakanishi Y, 2011, CARCINOGENESIS, V32, P1333, DOI 10.1093/carcin/bgr128; Pollard JW, 2008, J LEUKOCYTE BIOL, V84, P623, DOI 10.1189/jlb.1107762; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Qian BZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006562; Raes G, 2002, J LEUKOCYTE BIOL, V71, P597; Sica A, 2008, SEMIN CANCER BIOL, V18, P349, DOI 10.1016/j.semcancer.2008.03.004; Sinha P, 2007, J IMMUNOL, V179, P977, DOI 10.4049/jimmunol.179.2.977; Sinha P, 2007, CANCER RES, V67, P4507, DOI 10.1158/0008-5472.CAN-06-4174; Solinas G, 2010, J IMMUNOL, V185, P642, DOI 10.4049/jimmunol.1000413; Talmadge JE, 2007, CANCER METAST REV, V26, P373, DOI 10.1007/s10555-007-9072-0; Thun MJ, 2002, JNCI-J NATL CANCER I, V94, P252, DOI 10.1093/jnci/94.4.252; Tsujii M, 1998, CELL, V93, P705, DOI 10.1016/S0092-8674(00)81433-6; Wang DZ, 2005, GASTROENTEROLOGY, V128, P1445, DOI 10.1053/j.gastro.2004.09.080; Zhang WJ, 2011, J IMMUNOL, V187, P1764, DOI 10.4049/jimmunol.1002315	47	114	122	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63451	10.1371/journal.pone.0063451	http://dx.doi.org/10.1371/journal.pone.0063451			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667623	Green Published, gold, Green Submitted			2022-12-25	WOS:000319654700149
J	Saliasi, E; Geerligs, L; Lorist, MM; Maurits, NM				Saliasi, Emi; Geerligs, Linda; Lorist, Monicque M.; Maurits, Natasha M.			The Relationship between P3 Amplitude and Working Memory Performance Differs in Young and Older Adults	PLOS ONE			English	Article							AGE-RELATED-CHANGES; BRAIN ACTIVITY; COGNITIVE NEUROSCIENCE; ACTIVATION; INFORMATION; NOVELTY	While some elderly show deteriorations in cognitive performance, others achieve performance levels comparable to young adults. To examine whether age-related changes in brain activity varied with working memory performance efficiency, we recorded electroencephalography (EEG) from young and older healthy adults during performance on an n-back task with two loads (0- and 1-back) and two versions (identity and integrated). Young adults showed a typical P3 amplitude pattern with a parietal-maximum. Compared to young adults, the P3 amplitude of older adults was characterized by frontal hyperactivity coupled with posterior hypoactivity. Moreover, P3 amplitude in young and older adults varied with working memory performance efficiency. Among young adults, more efficient performance correlated with a larger P3 amplitude at parietal sites. In contrast, a higher P3 amplitude at midline electrode sites in older adults correlated with less efficient performance. Particularly, the enhanced frontal midline EEG activity in older adults during working memory performance seems to reflect inefficient use of neural resources due to frontal lobe dysfunction.	[Saliasi, Emi; Maurits, Natasha M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Geerligs, Linda; Lorist, Monicque M.] Univ Groningen, Dept Expt Psychol, Groningen, Netherlands; [Saliasi, Emi; Geerligs, Linda; Lorist, Monicque M.; Maurits, Natasha M.] Univ Groningen, Univ Med Ctr Groningen, BCN Neuroimaging Ctr, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Saliasi, E (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands.	e.saliasi@umcg.nl	Geerligs, Linda/D-5212-2013	Geerligs, Linda/0000-0002-1624-8380; Maurits, Natasha/0000-0001-6231-7044; Saliasi, Emi/0000-0003-1009-6010; Lorist, Monicque M./0000-0002-7361-093X				Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Cabeza R, 2004, CEREB CORTEX, V14, P364, DOI 10.1093/cercor/bhg133; Cabeza R, 1997, J NEUROSCI, V17, P391; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Cona G, 2012, NEUROPSYCHOLOGIA, V50, P2692, DOI 10.1016/j.neuropsychologia.2012.07.033; Daffner KR, 2011, J COGNITIVE NEUROSCI, V23, P1298, DOI 10.1162/jocn.2010.21540; Davis SW, 2008, CEREB CORTEX, V18, P1201, DOI 10.1093/cercor/bhm155; DONCHIN E, 1981, PSYCHOPHYSIOLOGY, V18, P493, DOI 10.1111/j.1469-8986.1981.tb01815.x; Fabiani M, 1998, PSYCHOPHYSIOLOGY, V35, P698, DOI 10.1017/S0048577298970780; FABIANI M, 1995, PSYCHOPHYSIOLOGY, V32, P579, DOI 10.1111/j.1469-8986.1995.tb01234.x; Fjell AM, 2001, BRAIN TOPOGR, V14, P25, DOI 10.1023/A:1012563605837; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Friedman D, 2001, NEUROSCI BIOBEHAV R, V25, P355, DOI 10.1016/S0149-7634(01)00019-7; Friedman D, 2003, J CLIN EXP NEUROPSYC, V25, P702, DOI 10.1076/jcen.25.5.702.14578; Gajewski PD, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.06.010; Grady C, 2012, NAT REV NEUROSCI, V13, P491, DOI 10.1038/nrn3256; Grady CL, 2008, ANN NY ACAD SCI, V1124, P127, DOI 10.1196/annals.1440.009; GRADY CL, 1994, J NEUROSCI, V14, P1450, DOI 10.1523/JNEUROSCI.14-03-01450.1994; Grady CL, 2000, BIOL PSYCHOL, V54, P259, DOI 10.1016/S0301-0511(00)00059-4; GRADY CL, 1995, SCIENCE, V269, P218, DOI 10.1126/science.7618082; GRATTON G, 1989, PSYCHOPHYSIOLOGY, V26, P222, DOI 10.1111/j.1469-8986.1989.tb03160.x; Jonides J, 2000, J COGNITIVE NEUROSCI, V12, P188, DOI 10.1162/089892900561823; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Logan JM, 2002, NEURON, V33, P827, DOI 10.1016/S0896-6273(02)00612-8; Mattay VS, 2006, NEUROSCI LETT, V392, P32, DOI 10.1016/j.neulet.2005.09.025; Missonnier P, 2004, J NEURAL TRANSM, V111, P1141, DOI 10.1007/s00702-004-0159-2; Mitchell KJ, 2000, COGNITIVE BRAIN RES, V10, P197, DOI 10.1016/S0926-6410(00)00029-X; Nagel IE, 2009, P NATL ACAD SCI USA, V106, P22552, DOI 10.1073/pnas.0908238106; Newman AJ, 2012, J COGNITIVE NEUROSCI, V24, P1205, DOI 10.1162/jocn_a_00143; Nieuwenhuis S, 2005, PSYCHOL BULL, V131, P510, DOI 10.1037/0033-2909.131.4.510; O'Connell RG, 2012, NEUROBIOL AGING, V33, P2448, DOI 10.1016/j.neurobiolaging.2011.12.021; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Pinheiro J, 2001, MIXED EFFECTS MODELS; POLICH J, 1995, BIOL PSYCHOL, V41, P103, DOI 10.1016/0301-0511(95)05130-9; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Reuter-Lorenz PA, 2000, J COGNITIVE NEUROSCI, V12, P174, DOI 10.1162/089892900561814; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Sandrini M, 2008, NEUROPSYCHOLOGIA, V46, P2056, DOI 10.1016/j.neuropsychologia.2008.02.003; Schmand B., 1992, NEDERLANDSE LEESTEST; Schneider-Garces NJ, 2010, J COGNITIVE NEUROSCI, V22, P655, DOI 10.1162/jocn.2009.21230; Segalowitz SJ, 2001, COGNITIVE BRAIN RES, V12, P451, DOI 10.1016/S0926-6410(01)00082-9; Soltani Maryam, 2000, Critical Reviews in Neurobiology, V14, P199; Turner GR, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.06.005; Uterwijk J., 2001, WAIS 3 NEDERLANDSTAL; van Rijn H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051134; Velanova K, 2007, CEREB CORTEX, V17, P1033, DOI 10.1093/cercor/bhl013; Wierda SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015024; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	51	59	61	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63701	10.1371/journal.pone.0063701	http://dx.doi.org/10.1371/journal.pone.0063701			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	154EP	23667658	Green Published, gold, Green Submitted			2022-12-25	WOS:000319654700176
J	Song, D; Cho, WK; Park, SH; Jo, Y; Kim, KH				Song, Dami; Cho, Won Kyong; Park, Sang-Ho; Jo, Yeonhwa; Kim, Kook-Hyung			Evolution of and Horizontal Gene Transfer in the Endornavirus Genus	PLOS ONE			English	Article							UDP-GLUCOSESTEROL GLUCOSYLTRANSFERASE; DIATOM THALASSIOSIRA-PSEUDONANA; VEIN-CLEARING VIRUS; DOUBLE-STRANDED-RNA; MOLECULAR CHARACTERIZATION; FUNCTIONAL EXPRESSION; PLANT PARARETROVIRUS; GENOME; MUTATIONS; SEQUENCES	The transfer of genetic information between unrelated species is referred to as horizontal gene transfer. Previous studies have demonstrated that both retroviral and non-retroviral sequences have been integrated into eukaryotic genomes. Recently, we identified many non-retroviral sequences in plant genomes. In this study, we investigated the evolutionary origin and gene transfer of domains present in endornaviruses which are double-stranded RNA viruses. Using the available sequences for endornaviruses, we found that Bell pepper endornavirus-like sequences homologous to the glycosyltransferase 28 domain are present in plants, fungi, and bacteria. The phylogenetic analysis revealed the glycosyltransferase 28 domain of Bell pepper endornavirus may have originated from bacteria. In addition, two domains of Oryza sativa endornavirus, a glycosyltransferase sugar-binding domain and a capsular polysaccharide synthesis protein, also exhibited high similarity to those of bacteria. We found evidence that at least four independent horizontal gene transfer events for the glycosyltransferase 28 domain have occurred among plants, fungi, and bacteria. The glycosyltransferase sugar-binding domains of two proteobacteria may have been horizontally transferred to the genome of Thalassiosira pseudonana. Our study is the first to show that three glycome-related viral genes in the genus Endornavirus have been acquired from marine bacteria by horizontal gene transfer.	[Song, Dami; Cho, Won Kyong; Park, Sang-Ho; Jo, Yeonhwa; Kim, Kook-Hyung] Seoul Natl Univ, Coll Agr & Life Sci, Inst Agr & Life Sci, Dept Agr Biotechnol,Plant Genom & Breeding Inst, Seoul, South Korea	Seoul National University (SNU)	Kim, KH (corresponding author), Seoul Natl Univ, Coll Agr & Life Sci, Inst Agr & Life Sci, Dept Agr Biotechnol,Plant Genom & Breeding Inst, Seoul, South Korea.	kookkim@snu.ac.kr	Cho, Won Kyong/I-5098-2012	Cho, Won Kyong/0000-0002-8416-5173	National Research Foundation of Korea (NRF); Korea government (MEST) [2011-0010027]; Next-Generation BioGreen 21 Program through the Rural Development Administration [PJ00798402]; Vegetable Breeding Research Center through the Agriculture Research Center program from the Ministry for Food, Agriculture, Forestry and Fisheries [710001-03]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Next-Generation BioGreen 21 Program through the Rural Development Administration; Vegetable Breeding Research Center through the Agriculture Research Center program from the Ministry for Food, Agriculture, Forestry and Fisheries	This research was supported in part by grants from the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 2011-0010027), the Next-Generation BioGreen 21 Program (No. PJ00798402) through the Rural Development Administration, and the Vegetable Breeding Research Center (No. 710001-03) through the Agriculture Research Center program from the Ministry for Food, Agriculture, Forestry and Fisheries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Alverson AJ, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-125; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; BENVENISTE RE, 1974, NATURE, V252, P456, DOI 10.1038/252456a0; Boeke J. D., 1997, P343; Bratlie MS, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-1; Cebulla CM, 2000, TRANSPLANTATION, V69, P1202, DOI 10.1097/00007890-200003270-00027; Chan CX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029138; Chiba S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002146; Dallot S, 2001, ARCH VIROL, V146, P2179, DOI 10.1007/s007050170028; DeBolt S, 2009, PLANT PHYSIOL, V151, P78, DOI 10.1104/pp.109.140582; Desbiez C, 2011, INFECT GENET EVOL, V11, P812, DOI 10.1016/j.meegid.2011.02.020; Dolja VV, 2006, VIRUS RES, V117, P38, DOI 10.1016/j.virusres.2006.02.002; Edwards K, 2009, PLANT BIOTECHNOL J, V7, P1, DOI 10.1111/j.1467-7652.2008.00392.x; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; FUKUHARA T, 1993, PLANT MOL BIOL, V21, P1121, DOI 10.1007/BF00023608; Gibbs MJ, 2000, J GEN VIROL, V81, P227, DOI 10.1099/0022-1317-81-1-227; Gilbert C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000495; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Hiraiwa N, 2003, BLOOD, V101, P3615, DOI 10.1182/blood-2002-07-2301; Holmes EC, 2011, CELL HOST MICROBE, V10, P368, DOI 10.1016/j.chom.2011.09.002; Hordijk W, 2005, BIOINFORMATICS, V21, P4338, DOI 10.1093/bioinformatics/bti713; Horie M, 2010, NATURE, V463, P84, DOI 10.1038/nature08695; Horiuchi H, 2004, VIRUS GENES, V29, P365, DOI 10.1007/s11262-004-7441-0; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Jiang SM, 2001, INFECT IMMUN, V69, P1244, DOI 10.1128/IAI.69.3.1244-1255.2001; Katzourakis A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001191; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; King A.M.Q., 2011, VIRUS TAXONOMY, V1st ed; Koonin EV, 2001, ANNU REV MICROBIOL, V55, P709, DOI 10.1146/annurev.micro.55.1.709; Linder-Basso D, 2005, VIROLOGY, V337, P192, DOI 10.1016/j.virol.2005.03.038; Liu HQ, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-91; Lockhart BE, 2000, J GEN VIROL, V81, P1579, DOI 10.1099/0022-1317-81-6-1579; Makarenkov U, 2001, BIOINFORMATICS, V17, P664, DOI 10.1093/bioinformatics/17.7.664; Markine-Goriaynoff N, 2004, J GEN VIROL, V85, P2741, DOI 10.1099/vir.0.80320-0; Mbanzibwa DR, 2009, J VIROL, V83, P6934, DOI 10.1128/JVI.00537-09; MENGINLECREULX D, 1991, J BACTERIOL, V173, P4625, DOI 10.1128/jb.173.15.4625-4636.1991; Monier A, 2009, GENOME RES, V19, P1441, DOI 10.1101/gr.091686.109; Okada R, 2011, J GEN VIROL, V92, P2664, DOI 10.1099/vir.0.034686-0; Potocka A, 2008, ACTA BIOCHIM POL, V55, P127, DOI 10.18388/abp.2008_3105; RichertPoggeler KR, 1997, VIROLOGY, V236, P137, DOI 10.1006/viro.1997.8712; Roossinck MJ, 2011, J GEN VIROL, V92, P2674, DOI 10.1099/vir.0.034702-0; Roossinck MJ, 2010, PHILOS T R SOC B, V365, P1899, DOI 10.1098/rstb.2010.0057; Rosewich UL, 2000, ANNU REV PHYTOPATHOL, V38, P325, DOI 10.1146/annurev.phyto.38.1.325; Staginnus C, 2006, TRENDS PLANT SCI, V11, P485, DOI 10.1016/j.tplants.2006.08.008; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; Warnecke D, 1999, J BIOL CHEM, V274, P13048, DOI 10.1074/jbc.274.19.13048; Warnecke DC, 1997, PLANT MOL BIOL, V35, P597, DOI 10.1023/A:1005806119807; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945; Xie J, 2006, J GEN VIROL, V87, P241, DOI 10.1099/vir.0.81522-0; Yaegashi H, 2012, VIRUS RES, V165, P143, DOI 10.1016/j.virusres.2012.02.008	52	21	21	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e64270	10.1371/journal.pone.0064270	http://dx.doi.org/10.1371/journal.pone.0064270			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667703	Green Published, gold, Green Submitted			2022-12-25	WOS:000319654700205
J	Hale, JD; Davies, G; Fairbrass, AJ; Matthews, TJ; Rogers, CDF; Sadler, JP				Hale, James D.; Davies, Gemma; Fairbrass, Alison J.; Matthews, Thomas J.; Rogers, Christopher D. F.; Sadler, Jon P.			Mapping Lightscapes: Spatial Patterning of Artificial Lighting in an Urban Landscape	PLOS ONE			English	Article							GRADIENT ANALYSIS; AERIAL SURVEY; DARK SIDE; NIGHT-SKY; POLLUTION; URBANIZATION; POPULATION; EMISSIONS; ECOLOGY	Artificial lighting is strongly associated with urbanisation and is increasing in its extent, brightness and spectral range. Changes in urban lighting have both positive and negative effects on city performance, yet little is known about how its character and magnitude vary across the urban landscape. A major barrier to related research, planning and governance has been the lack of lighting data at the city extent, particularly at a fine spatial resolution. Our aims were therefore to capture such data using aerial night photography and to undertake a case study of urban lighting. We present the finest scale multi-spectral lighting dataset available for an entire city and explore how lighting metrics vary with built density and land-use. We found positive relationships between artificial lighting indicators and built density at coarse spatial scales, whilst at a local level lighting varied with land-use. Manufacturing and housing are the primary land-use zones responsible for the city's brightly lit areas, yet manufacturing sites are relatively rare within the city. Our data suggests that efforts to address light pollution should broaden their focus from residential street lighting to include security lighting within manufacturing areas.	[Hale, James D.; Sadler, Jon P.] Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham, W Midlands, England; [Davies, Gemma] Univ Lancaster, Lancaster Environm Ctr, Lancaster, Lancs, England; [Fairbrass, Alison J.] UCL, Ctr Urban Sustainabil & Resilience, London, England; [Matthews, Thomas J.] Univ Oxford, Sch Geog & Environm, Oxford, Oxon, England; [Rogers, Christopher D. F.] Univ Birmingham, Sch Civil Engn, Birmingham B15 2TT, W Midlands, England	University of Birmingham; Lancaster University; University of London; University College London; University of Oxford; University of Birmingham	Hale, JD (corresponding author), Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham, W Midlands, England.	j.hale@bham.ac.uk	Fairbrass, Alison/K-6563-2016; Rogers, Christopher/AAE-2395-2020	Fairbrass, Alison/0000-0002-4907-9683; Rogers, Christopher/0000-0002-1693-1999; Davies, Gemma/0000-0002-7420-2479; Matthews, Thomas/0000-0002-7624-244X; Sadler, Jonathan/0000-0003-0443-4458; Hale, James/0000-0001-9662-1853	Urban Futures (SUE2) program [EP/E0216030]; EPSRC [EP/I035129/1, EP/J017698/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/J017698/1, EP/I035129/1] Funding Source: researchfish; Natural Environment Research Council [ceh010010] Funding Source: researchfish	Urban Futures (SUE2) program; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was undertaken as part of the Urban Futures (SUE2) program (EP/E0216030) (grant holder JPS) (http://www.epsrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti M, 2005, INT REGIONAL SCI REV, V28, P168, DOI 10.1177/0160017605275160; Andersson E, 2006, ECOL SOC, V11; Andersson E, 2009, LANDSCAPE ECOL, V24, P1331, DOI 10.1007/s10980-009-9385-1; [Anonymous], 2010, WORLD URB PROSP 2009; Antrop M, 2000, LANDSCAPE ECOL, V15, P257, DOI 10.1023/A:1008151109252; Aubrecht C, 2010, LIGHTING GOVERNANCE; Barducci A, 2003, APPL OPTICS, V42, P4349, DOI 10.1364/AO.42.004349; Bolund P, 1999, ECOL ECON, V29, P293, DOI 10.1016/S0921-8009(99)00013-0; Bruce-White C., 2011, REV IMPACT ARTIFICIA; Cadenasso ML, 2007, FRONT ECOL ENVIRON, V5, P80, DOI 10.1890/1540-9295(2007)5[80:SHIUER]2.0.CO;2; Cervero R, 2001, URBAN STUD, V38, P1651, DOI 10.1080/00420980120084804; Cinzano P, 2001, MON NOT R ASTRON SOC, V328, P689, DOI 10.1046/j.1365-8711.2001.04882.x; Cinzano P, 2006, 26 IAU GEN ASS; Dallimer M, 2011, BIOL LETTERS, V7, P763, DOI 10.1098/rsbl.2011.0025; Davies TW, 2012, BIOL LETT; Doll C, 2008, THEMATIC GUIDE NIGHT; Dunn R, 1995, PREPARATORY WORK LAN; Elvidge CD, 2007, INT J REMOTE SENS, V28, P2645, DOI 10.1080/01431160600981525; Elvidge CD, 1997, INT J REMOTE SENS, V18, P1373, DOI 10.1080/014311697218485; Elvidge CD, 1997, GLOBAL CHANGE BIOL, V3, P387, DOI 10.1046/j.1365-2486.1997.00115.x; Elvidge CD, 2010, SENSORS-BASEL, V10, P3961, DOI 10.3390/s100403961; Falchi F, 2011, J ENVIRON MANAGE, V92, P2714, DOI 10.1016/j.jenvman.2011.06.029; Farrington DP, 2002, JUSTICE Q, V19, P313, DOI 10.1080/07418820200095261; Flanders Government, ORD FLEM GOV 1 JUN 1; Foster RG, 2005, NAT REV NEUROSCI, V6, P407, DOI 10.1038/nrn1670; Fuller RA, 2009, BIOL LETTERS, V5, P352, DOI 10.1098/rsbl.2009.0010; Gallaway T, 2010, ECOL ECON, V69, P658, DOI 10.1016/j.ecolecon.2009.10.003; Glaeser E, 2011, SCIENCE, V333, P592, DOI 10.1126/science.1209264; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Hahs AK, 2006, LANDSCAPE URBAN PLAN, V78, P435, DOI 10.1016/j.landurbplan.2005.12.005; Holker F, 2010, ECOL SOC, V15; ILE, 2005, GUID NOT RED OBSTR L; Imhoff ML, 1997, REMOTE SENS ENVIRON, V61, P361; Kruse F. A., 2011, IDENTIFYING MAPPING, P1, DOI [10.1109/AERO.2011.5747396, DOI 10.1109/AERO.2011.5747396]; Kuechly HU, 2012, REMOTE SENS ENVIRON, V126, P39, DOI 10.1016/j.rse.2012.08.008; Kyba CCM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017307; Levin N, 2012, REMOTE SENS ENVIRON, V119, P1, DOI 10.1016/j.rse.2011.12.005; Longcore T, 2004, FRONT ECOL ENVIRON, V2, P191, DOI 10.1890/1540-9295(2004)002[0191:ELP]2.0.CO;2; Luginbuhl CB, 2009, PUBL ASTRON SOC PAC, V121, P185, DOI 10.1086/597625; Lyytimaki J, 2012, LAND USE POLICY, V29, P598, DOI 10.1016/j.landusepol.2011.10.002; Massey P, 2000, PUBL ASTRON SOC PAC, V112, P566, DOI 10.1086/316552; McDonnell MJ, 2008, LANDSCAPE ECOL, V23, P1143, DOI 10.1007/s10980-008-9253-4; MCDONNELL MJ, 1990, ECOLOGY, V71, P1232, DOI 10.2307/1938259; Mizon B., 2002, LIGHT POLLUTION RESP; Navara KJ, 2007, J PINEAL RES, V43, P215, DOI 10.1111/j.1600-079X.2007.00473.x; Neuman M, 2005, J PLAN EDUC RES, V25, P11, DOI 10.1177/0739456X04270466; Pimputkar S, 2009, NAT PHOTONICS, V3, P179, DOI 10.1038/nphoton.2009.32; RCEP, 2007, URB ENV ORYAL COMM E; Royal Commission on Environmental Pollution (RCEP), 2009, ART LIGHT ENV ROYAL; Small C, 2005, REMOTE SENS ENVIRON, V96, P277, DOI 10.1016/j.rse.2005.02.002; Smith M, 2009, NATURE, V457, P27, DOI 10.1038/457027a; Stevens RG, 2009, INT J EPIDEMIOL, V38, P963, DOI 10.1093/ije/dyp178; Sutton P, 2001, INT J REMOTE SENS, V22, P3061, DOI 10.1080/01431160010007015; Sutton P. C., 2007, URBAN REMOTE SENSING, P291; Taylor M.M., 2006, JPL, V8, P1114; Wanvik PO, 2009, ACCIDENT ANAL PREV, V41, P123, DOI 10.1016/j.aap.2008.10.003; Weng Q., 2007, URBAN REMOTE SENSING, P71; Williams K, 1999, LAND USE POLICY, V16, P167, DOI 10.1016/S0264-8377(99)00010-1; Wu JG, 2011, ECOL COMPLEX, V8, P1, DOI 10.1016/j.ecocom.2010.03.002; Zhang LQ, 2004, LANDSCAPE URBAN PLAN, V69, P1, DOI 10.1016/j.landurbplan.2003.08.006	60	81	83	5	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e61460	10.1371/journal.pone.0061460	http://dx.doi.org/10.1371/journal.pone.0061460			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671566	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000321390200006
J	Lecarpentier, E; Tsatsaris, V; Goffinet, F; Cabrol, D; Sibai, B; Haddad, B				Lecarpentier, Edouard; Tsatsaris, Vassilis; Goffinet, Francois; Cabrol, Dominique; Sibai, Baha; Haddad, Bassam			Risk Factors of Superimposed Preeclampsia in Women with Essential Chronic Hypertension Treated before Pregnancy	PLOS ONE			English	Article							BLOOD-PRESSURE; UNITED-STATES; FETAL-GROWTH; OUTCOMES	Objective: To determine risk factors of superimposed preeclampsia in women with essential chronic hypertension receiving antihypertensive therapy prior to conception. Methods: A retrospective study of 211 patients that analyzed risk factors of superimposed preeclampsia at first prenatal visit. Variables with a p < .1 at univariate analysis were included in a logistic regression analysis. P < .05 was considered as significant. Results: Superimposed preeclampsia occurred in 49 (23.2%) women. In logistic regression analysis, previous preeclampsia [OR: 4.05 (1.61-10.16)], and mean arterial blood pressure of 95 mmHg or higher [OR: 4.60 (1.94-10.93)] were associated with increased risk of superimposed preeclampsia. When both variables were present, sensitivity, specificity, positive predictive value, negative predictive value, and likelihood ratio for superimposed preeclampsia were 43%, 94%, 70%, 85%, and 7.71 (95% CI: 3.20-18.57), respectively. Conclusion: In essential chronic hypertensive women, previous preeclampsia and mean arterial blood pressure of 95 mmHg or higher are associated with increased risks of superimposed preeclampsia.	[Lecarpentier, Edouard; Haddad, Bassam] Univ Paris 12, CHI Creteil, Creteil, France; [Tsatsaris, Vassilis; Goffinet, Francois; Cabrol, Dominique] Univ Paris 05, AP HP Cochin Port Royal, Paris, France; [Sibai, Baha] Univ Cincinnati, Cincinnati, OH USA; [Tsatsaris, Vassilis; Goffinet, Francois; Cabrol, Dominique; Haddad, Bassam] PREMUP Fdn, Paris, France; [Haddad, Bassam] CRC CHI Creteil, Creteil, France	Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; University System of Ohio; University of Cincinnati; UDICE-French Research Universities; Universite Paris Cite	Haddad, B (corresponding author), Univ Paris 12, CHI Creteil, Creteil, France.	bhaddad@chicreteil.fr	Haddad, Bassam/Q-7767-2018; Lecarpentier, Edouard/Q-4557-2018	GOFFINET, Francois/0000-0001-9643-0299				Abalos E, 2007, COCHRANE DB SYST REV, V24; Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X; Askie LM, 2007, LANCET, V369, P1791, DOI 10.1016/S0140-6736(07)60712-0; Bujold E, 2010, OBSTET GYNECOL, V116, P402, DOI 10.1097/AOG.0b013e3181e9322a; Caritis S, 1998, NEW ENGL J MED, V338, P701, DOI 10.1056/NEJM199803123381101; Chappell LC, 2008, HYPERTENSION, V51, P1002, DOI 10.1161/HYPERTENSIONAHA.107.107565; Duckitt K, 2005, BRIT MED J, V330, P565, DOI 10.1136/bmj.38380.674340.E0; Elkadry E, 2003, AM J OBSTET GYNECOL, V189, P195, DOI 10.1067/mob.2003.371; Giannubilo SR, 2006, EUR J OBSTET GYN R B, V126, P63, DOI 10.1016/j.ejogrb.2005.06.042; McCowan LME, 1996, BRIT J OBSTET GYNAEC, V103, P123, DOI 10.1111/j.1471-0528.1996.tb09662.x; REY E, 1994, AM J OBSTET GYNECOL, V171, P410, DOI 10.1016/0002-9378(94)90276-3; SAFTLAS AF, 1990, AM J OBSTET GYNECOL, V163, P460, DOI 10.1016/0002-9378(90)91176-D; Sibai BM, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.11.027; Sibai BM, 2004, OBSTET GYNECOL, V103, P981, DOI 10.1097/01.AOG.0000126245.35811.2a; Sibai BM, 1998, NEW ENGL J MED, V339, P667, DOI 10.1056/NEJM199809033391004; Sibai BM, 2002, OBSTET GYNECOL, V100, P369, DOI 10.1016/S0029-7844(02)02128-2; Vernay M, 2012, J HYPERTENS, V30, P1920, DOI 10.1097/HJH.0b013e328356c59f; von Dadelszen P, 2000, LANCET, V355, P87, DOI 10.1016/S0140-6736(98)08049-0	18	29	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e62140	10.1371/journal.pone.0062140	http://dx.doi.org/10.1371/journal.pone.0062140			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671584	Green Published, gold, Green Submitted			2022-12-25	WOS:000321390200014
J	Wu, DL; Zhang, R; Zhao, R; Chen, G; Cai, Y; Jin, JJ				Wu, Donglu; Zhang, Rui; Zhao, Rui; Chen, Guang; Cai, Yong; Jin, Jingji			A Novel Function of Novobiocin: Disrupting the Interaction of HIF 1 alpha and p300/CBP through Direct Binding to the HIF1 alpha C-Terminal Activation Domain	PLOS ONE			English	Article							CARBONIC-ANHYDRASE-IX; RENAL-CELL CARCINOMA; STRUCTURAL BASIS; HYPOXIA; EXPRESSION; PROTEIN; CANCER; PROGNOSIS; INHIBITION; DIAGNOSIS	Hypoxia-inducible factor 1 alpha (HIF1 alpha) is an important cellular survival protein under hypoxic conditions, regulating the cellular response to low oxygen tension via recruitment of a transcriptional co-activator, p300/CBP.p300/CBP induces expression of multiple genes involved in cell survival, proliferation, angiogenesis, and tumor development. Thus, a strategy to inhibit hypoxic responses in tumors may be to target the protein-protein interaction between HIF1 alpha and p300/CBP. Here, we document, for the first time, that the aminocoumarin antibiotic, novobiocin, directly blocks the protein-protein interaction between the HIF1 alpha C-terminal activation domain (CTAD) and the cysteine-histidine rich (CH1) region of p300/CBP. Also, novobiocin down-regulated HIF1 alpha-controlled gene expression, specifically CA9, which is related to tumorigenesis. In a monolayer cell culture, novobiocin inhibited cell proliferation and colony formation in the MCF-7 human breast adenocarcinoma cell line and the A549 human lung cancer cell line. Rescue experiments revealed that the recombinant CTAD fragment of HIF1 alpha partially reversed novobiocin's inhibitory effects on cell proliferation and colony formation in MCF-7 cells. These findings suggest a novel mechanism of action for novobiocin which has the potential for innovative therapeutic use in tumor treatment.	[Wu, Donglu; Zhang, Rui; Zhao, Rui; Cai, Yong; Jin, Jingji] Jilin Univ, Coll Life Sci, Changchun 130023, Jilin, Peoples R China; [Wu, Donglu; Zhang, Rui; Zhao, Rui] Jilin Univ, Grad Sch, Changchun 130023, Jilin, Peoples R China; [Chen, Guang] Jilin Univ, Clin Hosp 1, Changchun 130023, Jilin, Peoples R China; [Cai, Yong; Jin, Jingji] Jilin Univ, Coll Life Sci, Natl Engn Lab AIDS Vaccine, Changchun 130023, Jilin, Peoples R China	Jilin University; Jilin University; Jilin University; Jilin University	Cai, Y (corresponding author), Jilin Univ, Coll Life Sci, Changchun 130023, Jilin, Peoples R China.	caiyong62@jlu.edu.cn; jjjin@jlu.edu.cn		Zhao, Shane/0000-0002-2137-5536	National Natural Science Foundation of China [31070668, 31071131]; Research Fund for the Doctoral Program of Colleges and Universities [20110061110020]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Colleges and Universities	This work was supported in part by National Natural Science Foundation of China (31070668 JJ and 31071131 YC) and Research Fund for the Doctoral Program of Colleges and Universities (20110061110020 JJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Akagi T, 2003, P NATL ACAD SCI USA, V100, P13567, DOI 10.1073/pnas.1834876100; Alqawi O, 2006, PROSTATE CANCER P D, V9, P126, DOI 10.1038/sj.pcan.4500852; Brandt GEL, 2009, CURR TOP MED CHEM, V9, P1447, DOI 10.2174/156802609789895683; Dames SA, 2002, P NATL ACAD SCI USA, V99, P5271, DOI 10.1073/pnas.082121399; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dorai T, 2005, EUR J CANCER, V41, P2935, DOI 10.1016/j.ejca.2005.09.011; EASTMAN A, 1987, PHARMACOL THERAPEUT, V34, P155, DOI 10.1016/0163-7258(87)90009-X; Freedman SJ, 2002, P NATL ACAD SCI USA, V99, P5367, DOI 10.1073/pnas.082117899; Ho V, 2010, ENVIRON MOL MUTAGEN, V51, P552, DOI 10.1002/em.20573; Hofr C, 2001, J BIOL CHEM, V276, P9655, DOI 10.1074/jbc.M010205200; Hussain SA, 2007, BRIT J CANCER, V96, P104, DOI 10.1038/sj.bjc.6603530; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Jubb AM, 2009, BRIT J CANCER, V101, P1749, DOI 10.1038/sj.bjc.6605368; Kim BR, 2012, CELL SIGNAL, V24, P1406, DOI 10.1016/j.cellsig.2012.03.002; Klatte T, 2009, CANCER-AM CANCER SOC, V115, P1448, DOI 10.1002/cncr.24163; Kung AL, 2004, CANCER CELL, V6, P33, DOI 10.1016/j.ccr.2004.06.009; Kung AL, 2000, NAT MED, V6, P1335, DOI 10.1038/82146; Kushal S, 2011, BIOPOLYMERS, V95, P8, DOI 10.1002/bip.21550; Kusuma BR, 2011, BIOORG MED CHEM LETT, V21, P7170, DOI 10.1016/j.bmcl.2011.09.073; Leibovich BC, 2007, J CLIN ONCOL, V25, P4757, DOI 10.1200/JCO.2007.12.1087; Liao SY, 1997, CANCER RES, V57, P2827; Luo XG, 2010, IUBMB LIFE, V62, P194, DOI 10.1002/iub.288; Marcu MG, 2000, JNCI-J NATL CANCER I, V92, P242, DOI 10.1093/jnci/92.3.242; Marcu MG, 2000, J BIOL CHEM, V275, P37181, DOI 10.1074/jbc.M003701200; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mooring SR, 2011, SCI CHINA CHEM, V54, P24, DOI 10.1007/s11426-010-4187-5; Newton AL, 2000, J BIOL CHEM, V275, P15128, DOI 10.1074/jbc.M910396199; Ratcliffe PJ, 1998, J EXP BIOL, V201, P1153; Ruan K, 2009, J CELL BIOCHEM, V107, P1053, DOI 10.1002/jcb.22214; Schwab LP, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3087; Seeber LMS, 2011, CRIT REV ONCOL HEMAT, V78, P173, DOI 10.1016/j.critrevonc.2010.05.003; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Stillebroer AB, 2010, EUR UROL, V58, P75, DOI 10.1016/j.eururo.2010.03.015; Swinson DEB, 2003, J CLIN ONCOL, V21, P473, DOI 10.1200/JCO.2003.11.132; Tostain J, 2010, EUR J CANCER, V46, P3141, DOI 10.1016/j.ejca.2010.07.020; Wan J, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-77; Yeo EJ, 2006, BLOOD, V107, P916, DOI 10.1182/blood-2005-06-2564	37	17	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e62014	10.1371/journal.pone.0062014	http://dx.doi.org/10.1371/journal.pone.0062014			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671581	gold, Green Published, Green Submitted			2022-12-25	WOS:000321390200013
J	Ferluga, S; Hantgan, R; Goldgur, Y; Himanen, JP; Nikolov, DB; Debinski, W				Ferluga, Sara; Hantgan, Roy; Goldgur, Yehuda; Himanen, Juha P.; Nikolov, Dimitar B.; Debinski, Waldemar			Biological and Structural Characterization of Glycosylation on Ephrin-A1, a Preferred Ligand for EphA2 Receptor Tyrosine Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; BINDING DOMAIN; CANCER-THERAPY; TUMOR-CELLS; GLYCOPROTEINS; RECOGNITION; ECTODOMAIN; COMPLEX; FAMILY	The EphA2 receptor tyrosine kinase is overexpressed in a number of malignancies and is activated by ephrin ligands, most commonly by ephrin-A1. The crystal structure of the ligand-receptor complex revealed a glycosylation on the Asn-26 of ephrin-A1. Here we report for the first time the significance of the glycosylation in the biology of EphA2 and ephrin-A1. Ephrin-A1 was enzymatically deglycosylated, and its activity was evaluated in several assays using glioblastoma (GBM) cells and recombinant EphA2. We found that deglycosylated ephrin-A1 does not efficiently induce EphA2 receptor internalization and degradation, and does not activate the downstream signaling pathways involved in cell migration and proliferation. Data obtained by surface plasmon resonance confirms that deglycosylated ephrin-A1 does not bind EphA2 with high affinity. Mutations in the glycosylation site on ephrin-A1 result in protein aggregation and mislocalization. Analysis of Eph/ephrin crystal structures reveals an interaction between the ligand's carbohydrates and two residues of EphA2:Asp-78 and Lys-136. These findings suggest that the glycosylation on ephrin-A1 plays a critical role in the binding and activation of the EphA2 receptor.	[Ferluga, Sara; Debinski, Waldemar] Wake Forest Univ, Dept Neurosurg, Brain Tumor Ctr Excellence, Ctr Comprehens Canc, Winston Salem, NC 27157 USA; [Hantgan, Roy] Wake Forest Univ, Wake Forest Sch Med, Dept Biochem & Mol Med, Winston Salem, NC 27157 USA; [Goldgur, Yehuda; Himanen, Juha P.; Nikolov, Dimitar B.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA	Wake Forest University; Wake Forest University; Memorial Sloan Kettering Cancer Center	Debinski, W (corresponding author), Wake Forest Sch Med, Brain Tumor Ctr Excellence, Thomas K Hearn Brain Tumor Res Ctr, Med Ctr Blvd, Winston Salem, NC 27157 USA.	debinski@wakehealth.edu		Ferluga, Sara/0000-0002-6151-5492	National Institutes of Health [NCI R01 CA139099, CA74145, NS38486]; NATIONAL CANCER INSTITUTE [R01CA074145, P30CA012197, R01CA139099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038486] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants NCI R01 CA139099 and CA74145 (to W. D.) and NS38486 (to D. B. N.).	Beauchamp A, 2012, MOL CELL BIOL, V32, P3253, DOI 10.1128/MCB.06791-11; Beauchamp A, 2012, SEMIN CELL DEV BIOL, V23, P109, DOI 10.1016/j.semcdb.2011.10.019; Cantor C.R., 1980, BIOPHYSICAL CHEM 2; Drickamer K., 2006, INTRO GLYCOBIOLOGY; ELBEIN AD, 1981, TRENDS BIOCHEM SCI, V6, P219, DOI 10.1016/0968-0004(81)90080-3; Flanagan JG, 1997, CELL, V90, P403; Gobin AM, 2008, INT J NANOMED, V3, P351; Himanen JP, 1998, NATURE, V396, P486, DOI 10.1038/24904; Himanen JP, 2001, NATURE, V414, P933, DOI 10.1038/414933a; Himanen JP, 2003, TRENDS NEUROSCI, V26, P46, DOI 10.1016/S0166-2236(02)00005-X; Himanen JP, 2010, P NATL ACAD SCI USA, V107, P10860, DOI 10.1073/pnas.1004148107; Himanen JP, 2009, EMBO REP, V10, P722, DOI 10.1038/embor.2009.91; Kalo MS, 1999, CELL TISSUE RES, V298, P1, DOI 10.1007/PL00008807; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Lee HY, 2011, J PHARM PHARMACOL, V63, P1401, DOI 10.1111/j.2042-7158.2011.01306.x; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Miao H, 2001, NAT CELL BIOL, V3, P527, DOI 10.1038/35074604; Nikolov DB, 2005, BIOCHEMISTRY-US, V44, P10947, DOI 10.1021/bi050789w; NISHIKAWA Y, 1980, BIOCHEM BIOPH RES CO, V97, P1296, DOI 10.1016/S0006-291X(80)80007-6; Parri M, 2007, J BIOL CHEM, V282, P19619, DOI 10.1074/jbc.M701319200; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pasquale EB, 1997, CURR OPIN CELL BIOL, V9, P608, DOI 10.1016/S0955-0674(97)80113-5; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; PLUMMER T H JR, 1991, Glycobiology, V1, P257, DOI 10.1093/glycob/1.3.257; ROBBINS PW, 1984, J BIOL CHEM, V259, P7577; Roth J, 2010, MOL CELLS, V30, P497, DOI 10.1007/s10059-010-0159-z; Singla N, 2010, BIOCHEM BIOPH RES CO, V399, P555, DOI 10.1016/j.bbrc.2010.07.109; Sun XL, 2011, CANCER LETT, V312, P168, DOI 10.1016/j.canlet.2011.07.035; Tandon M, 2011, EXPERT OPIN THER TAR, V15, P31, DOI 10.1517/14728222.2011.538682; Tome CML, 2012, J BIOL CHEM, V287, P14012, DOI 10.1074/jbc.M111.311670; Toth J, 2001, DEV CELL, V1, P83, DOI 10.1016/S1534-5807(01)00002-8; Walker-Daniels J, 2002, MOL CANCER RES, V1, P79; Wykosky J, 2005, MOL CANCER RES, V3, P541, DOI 10.1158/1541-7786.MCR-05-0056; Wykosky J, 2008, ONCOGENE, V27, P7260, DOI 10.1038/onc.2008.328; Wykosky J, 2007, MOL CANCER THER, V6, P3208, DOI 10.1158/1535-7163.MCT-07-0200; Wykosky J, 2008, MOL CANCER RES, V6, P1795, DOI 10.1158/1541-7786.MCR-08-0244; Xi HQ, 2012, J CELL MOL MED, V16, P2894, DOI 10.1111/j.1582-4934.2012.01612.x	37	23	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18448	18457		10.1074/jbc.M113.464008	http://dx.doi.org/10.1074/jbc.M113.464008			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23661698	hybrid, Green Published			2022-12-25	WOS:000320721900047
J	Aiyegbo, MS; Sapparapu, G; Spiller, BW; Eli, IM; Dewight, RW; Kim, R; Lee, DE; Liu, T; Li, S; Woods, VL; Nannemann, DP; Meiler, J; Stewart, PL; Crowe, JE				Aiyegbo, Mohammed S.; Sapparapu, Gopal; Spiller, Benjamin W.; Eli, Ilyas M.; Williams, Dewight R.; Kim, Robert; Lee, David E.; Liu, Tong; Li, Sheng; Woods, Virgil L., Jr.; Nannemann, David P.; Meiler, Jens; Stewart, Phoebe L.; Crowe, James E., Jr.			Human Rotavirus VP6-Specific Antibodies Mediate Intracellular Neutralization by Binding to a Quaternary Structure in the Transcriptional Pore	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; 3-DIMENSIONAL STRUCTURE; CRYOELECTRON MICROSCOPY; PROTECTIVE IMMUNITY; MASS-SPECTROMETRY; PROTEIN-STRUCTURE; YOUNG-CHILDREN; CRYO-EM; B-CELLS; VISUALIZATION	Several live attenuated rotavirus (RV) vaccines have been licensed, but the mechanisms of protective immunity are still poorly understood. The most frequent human B cell response is directed to the internal protein VP6 on the surface of double-layered particles, which is normally exposed only in the intracellular environment. Here, we show that the canonical VP6 antibodies secreted by humans bind to such particles and inhibit viral transcription. Polymeric IgA RV antibodies mediated an inhibitory effect against virus replication inside cells during IgA transcytosis. We defined the recognition site on VP6 as a quaternary epitope containing a high density of charged residues. RV human mAbs appear to bind to a negatively-charged patch on the surface of the Type I channel in the transcriptionally active particle, and they sterically block the channel. This unique mucosal mechanism of viral neutralization, which is not apparent from conventional immunoassays, may contribute significantly to human immunity to RV.	[Aiyegbo, Mohammed S.; Spiller, Benjamin W.; Eli, Ilyas M.; Crowe, James E., Jr.] Vanderbilt Univ Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37203 USA; [Sapparapu, Gopal; Crowe, James E., Jr.] Vanderbilt Univ Sch Med, Dept Pediat, Nashville, TN USA; [Williams, Dewight R.; Kim, Robert; Stewart, Phoebe L.] Vanderbilt Univ Sch Med, Dept Mol Physiol & Biophys, Nashville, TN USA; [Sapparapu, Gopal; Crowe, James E., Jr.] Vanderbilt Univ Sch Med, Vanderbilt Vaccine Ctr, Nashville, TN USA; [Nannemann, David P.; Meiler, Jens] Vanderbilt Univ, Dept Chem, Nashville, TN USA; [Lee, David E.; Liu, Tong; Li, Sheng; Woods, Virgil L., Jr.] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of California System; University of California San Diego	Crowe, JE (corresponding author), Vanderbilt Univ Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37203 USA.	james.crowe@vanderbilt.edu	Crowe, James/B-5549-2009	Crowe, James/0000-0002-0049-1079; Sapparapu, Gopal/0000-0001-9670-1757; Lee, David/0000-0001-7232-0968; Meiler, Jens/0000-0001-8945-193X; Nannemann, David/0000-0002-4946-3263	National Institutes of Health (NIH) [R21 AI083574, R21 AI092268, U01 AI078407-03S2]; Vanderbilt Digestive Disease Research Center [DK058404]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083574, R21AI092268, U01AI078407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Digestive Disease Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) grants R21 AI083574, R21 AI092268, and U01 AI078407-03S2. The Genome Sciences Resource was supported by the Vanderbilt Digestive Disease Research Center (DK058404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aoki ST, 2009, SCIENCE, V324, P1444, DOI 10.1126/science.1170481; Brunger AT, 1997, STRUCTURE, V5, P325, DOI 10.1016/S0969-2126(97)00190-1; Brunger AT, 1997, METHOD ENZYMOL, V277, P366, DOI 10.1016/S0076-6879(97)77021-6; Burns JW, 1996, SCIENCE, V272, P104, DOI 10.1126/science.272.5258.104; Chen JZ, 2009, P NATL ACAD SCI USA, V106, P10644, DOI 10.1073/pnas.0904024106; Chen SC, 1997, VACCINE, V15, P899; COHEN J, 1979, ARCH VIROL, V60, P177, DOI 10.1007/BF01317489; Corthesy B, 2006, J VIROL, V80, P10692, DOI 10.1128/JVI.00927-06; Diprose JM, 2001, EMBO J, V20, P7229, DOI 10.1093/emboj/20.24.7229; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Estes M.K., 2001, FIELDS VIROLOGY, V2., P1747; Estes MK, 2007, FIELDS VIROLOGY, V2, P1918; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Feng NG, 2002, J CLIN INVEST, V109, P1203, DOI 10.1172/JCI200214397; Fleishman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020161; Herrmann JE, 1996, J INFECT DIS, V174, pS93, DOI 10.1093/infdis/174.Supplement_1.S93; Hsu S, 2009, BIOCHEMISTRY-US, V48, P9891, DOI 10.1021/bi9008853; Johnson JE, 2000, CURR OPIN STRUC BIOL, V10, P229, DOI 10.1016/S0959-440X(00)00073-7; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kallewaard NL, 2008, J IMMUNOL, V180, P3980, DOI 10.4049/jimmunol.180.6.3980; Kapikian A. Z, 2001, NOVART FDN SYMP, V238, P171; Kapikian AZ, 2001, NOVART FDN SYMP, V238, P153; Kaufmann B, 2006, P NATL ACAD SCI USA, V103, P12400, DOI 10.1073/pnas.0603488103; Lawton JA, 1999, P NATL ACAD SCI USA, V96, P5428, DOI 10.1073/pnas.96.10.5428; Lawton JA, 1997, NAT STRUCT BIOL, V4, P118, DOI 10.1038/nsb0297-118; Li S, 2011, J BIOL CHEM, V286, P17889, DOI 10.1074/jbc.M111.224535; Libersou S, 2008, J VIROL, V82, P2844, DOI 10.1128/JVI.02268-07; Lu WYD, 2012, PROTEIN SCI, V21, P178, DOI 10.1002/pro.2000; LUDERT JE, 1986, J GEN VIROL, V67, P1721, DOI 10.1099/0022-1317-67-8-1721; McKinney Brett A, 2007, Immunome Res, V3, P8, DOI 10.1186/1745-7580-3-8; McLean GR, 2002, J IMMUNOL, V169, P1379, DOI 10.4049/jimmunol.169.3.1379; McLean GR, 2000, MOL IMMUNOL, V37, P837, DOI 10.1016/S0161-5890(00)00101-2; OFFIT PA, 1986, J VIROL, V57, P46, DOI 10.1128/JVI.57.1.46-49.1986; OFFIT PA, 1986, J VIROL, V57, P376, DOI 10.1128/JVI.57.1.376-378.1986; ONeal CM, 1997, J VIROL, V71, P8707, DOI 10.1128/JVI.71.11.8707-8717.1997; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Prasad BVV, 1996, NATURE, V382, P471, DOI 10.1038/382471a0; PRASAD BVV, 1988, J MOL BIOL, V199, P269, DOI 10.1016/0022-2836(88)90313-0; ROSETO A, 1979, VIROLOGY, V98, P471, DOI 10.1016/0042-6822(79)90571-3; Sauter NK, 2004, J APPL CRYSTALLOGR, V37, P399, DOI 10.1107/S0021889804005874; Schwarz BA, 2002, J VIROL METHODS, V105, P277, DOI 10.1016/S0166-0934(02)00118-0; SHAW AL, 1993, CELL, V74, P693, DOI 10.1016/0092-8674(93)90516-S; Stewart PL, 1997, EMBO J, V16, P1189, DOI 10.1093/emboj/16.6.1189; Thouvenin E, 2001, J MOL BIOL, V307, P161, DOI 10.1006/jmbi.2000.4479; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Weitkamp JH, 2006, HUM IMMUNOL, V67, P33, DOI 10.1016/j.humimm.2006.02.024; Weitkamp JH, 2005, HUM IMMUNOL, V66, P666, DOI 10.1016/j.humimm.2005.02.008; Weitkamp JH, 2005, J IMMUNOL, V174, P3454, DOI 10.4049/jimmunol.174.6.3454; Weitkamp JH, 2003, J IMMUNOL, V171, P4680, DOI 10.4049/jimmunol.171.9.4680; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Wolbank S, 2003, J VIROL, V77, P4095, DOI 10.1128/JVI.77.7.4095-4103.2003; YEAGER M, 1994, EMBO J, V13, P1011, DOI 10.1002/j.1460-2075.1994.tb06349.x; YEAGER M, 1990, J CELL BIOL, V110, P2133, DOI 10.1083/jcb.110.6.2133; Zhang X, 2008, P NATL ACAD SCI USA, V105, P1867, DOI 10.1073/pnas.0711623105; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522	59	43	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e61101	10.1371/journal.pone.0061101	http://dx.doi.org/10.1371/journal.pone.0061101			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671563	Green Submitted, Green Published, gold			2022-12-25	WOS:000319737700002
J	Burgstaller, G; Oehrle, B; Koch, I; Lindner, M; Eickelberg, O				Burgstaller, Gerald; Oehrle, Bettina; Koch, Ina; Lindner, Michael; Eickelberg, Oliver			Multiplex Profiling of Cellular Invasion in 3D Cell Culture Models	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; FIBROBLAST MIGRATION; EXTRACELLULAR-MATRIX; MORPHOLOGY; EXPRESSION; ADHESIONS	To-date, most invasion or migration assays use a modified Boyden chamber-like design to assess migration as single-cell or scratch assays on coated or uncoated planar plastic surfaces. Here, we describe a 96-well microplate-based, high-content, three-dimensional cell culture assay capable of assessing invasion dynamics and molecular signatures thereof. On applying our invasion assay, we were able to demonstrate significant effects on the invasion capacity of fibroblast cell lines, as well as primary lung fibroblasts. Administration of epidermal growth factor resulted in a substantial increase of cellular invasion, thus making this technique suitable for high-throughput pharmacological screening of novel compounds regulating invasive and migratory pathways of primary cells. Our assay also correlates cellular invasiveness to molecular events. Thus, we argue of having developed a powerful and versatile toolbox for an extensive profiling of invasive cells in a 96-well format. This will have a major impact on research in disease areas like fibrosis, metastatic cancers, or chronic inflammatory states.	[Burgstaller, Gerald; Oehrle, Bettina; Eickelberg, Oliver] Univ Munich, Univ Hosp, Comprehens Pneumol Ctr, Munich, Germany; [Burgstaller, Gerald; Oehrle, Bettina; Eickelberg, Oliver] Helmholtz Zentrum Munchen, Munich, Germany; [Koch, Ina; Lindner, Michael] Asklepios Clin Munich Gauting, Comprehens Pneumol Ctr, Asklepios Biobank Lung Dis, Ctr Thorac Surg, Munich, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Burgstaller, G (corresponding author), Univ Munich, Univ Hosp, Comprehens Pneumol Ctr, Munich, Germany.	gerald.burgstaller@helmholtz-muenchen.de; oliver.eickelberg@helmholtz-muenchen.de	lindner, michael/AAO-8653-2020; Burgstaller, Gerald/M-6753-2019	lindner, michael/0000-0002-2106-0286; 	Helmholtz Association	Helmholtz Association(Helmholtz Association)	The study was funded by the Helmholtz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artym Vira V, 2010, Curr Protoc Cell Biol, VChapter 10, DOI 10.1002/0471143030.cb1018s48; Birgersdotter A, 2005, SEMIN CANCER BIOL, V15, P405, DOI 10.1016/j.semcancer.2005.06.009; Booth AJ, 2012, AM J RESP CRIT CARE; Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Fraley SI, 2010, NAT CELL BIOL, V12, P598, DOI 10.1038/ncb2062; Freytag J, 2010, J INVEST DERMATOL, V130, P2179, DOI 10.1038/jid.2010.106; Friedl P, 1998, MICROSC RES TECHNIQ, V43, P369, DOI 10.1002/(SICI)1097-0029(19981201)43:5<369::AID-JEMT3>3.0.CO;2-6; Friedl P, 2012, NAT CELL BIOL, V14, P777, DOI 10.1038/ncb2548; Gobin AS, 2003, BIOTECHNOL PROGR, V19, P1781, DOI 10.1021/bp0341390; Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858; Hakkinen KM, 2011, TISSUE ENG PT A, V17, P713, DOI 10.1089/ten.TEA.2010.0273; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hulkower Keren I, 2011, Pharmaceutics, V3, P107, DOI 10.3390/pharmaceutics3010107; Klingberg F, 2012, J PATHOL; Kramer N, 2012, MUTAT RES; Lu ZM, 2001, MOL CELL BIOL, V21, P4016, DOI 10.1128/MCB.21.12.4016-4031.2001; Rhee S, 2009, EXP MOL MED, V41, P858, DOI 10.3858/emm.2009.41.12.096; Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030; Vasaturo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052251; Ware MF, 1998, J CELL SCI, V111, P2423; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; Wight TN, 2011, AM J PHYSIOL-GASTR L, V301, pG950, DOI 10.1152/ajpgi.00132.2011; Wilson R., 2012, MOL CELL PROTEOMICS, V11.1, DOI DOI 10.1074/MCP.M111.014159	24	28	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63121	10.1371/journal.pone.0063121	http://dx.doi.org/10.1371/journal.pone.0063121			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671660	gold, Green Submitted, Green Published			2022-12-25	WOS:000319737700039
J	Jacewicz, A; Izumi, A; Brunner, K; Schnell, R; Schneider, G				Jacewicz, Agata; Izumi, Atsushi; Brunner, Katharina; Schnell, Robert; Schneider, Gunter			Structural Insights into the UbiD Protein Family from the Crystal Structure of PA0254 from Pseudomonas aeruginosa	PLOS ONE			English	Article							ESCHERICHIA-COLI; UBIQUINONE BIOSYNTHESIS; MOLECULAR REPLACEMENT; COENZYME-Q; DECARBOXYLASE; CONSERVATION; SEQUENCE; ROLES	The 3-polyprenyl-4-hydroxybenzoate decarboxylase (UbiD) catalyzes the conversion of 3-polyprenyl-4-hydroxybenzoate to 2-polyprenylphenol in the biosynthesis of ubiquinone. Pseudomonas aeruginosa contains two genes (PA0254 and PA5237) that are related in sequence to putative UbiD enzymes. A bioinformatics analysis suggests that the UbiD sequence family can be divided into two subclasses, with PA5237 and PA0254 belonging to different branches of this family. The three-dimensional structure of PA0254 has been determined using single wavelength anomalous diffraction and molecular replacement in two different crystal forms to resolutions of 1.95 and 2.3 angstrom, respectively. The subunit of PA0254 consists of three domains, an N-terminal alpha/beta domain, a split beta-barrel with a similar fold of a family of flavin reductases and a C-terminal alpha/beta domain with a topology characteristic for the UbiD protein family. The middle domain contains a metal binding site adjacent to a large open cleft that may represent the active site. The two protein ligands binding a magnesium ion, His188 and Glu229, invariant in the PA0254 subclass, are also conserved in a corresponding metal site found in one of the FMN binding proteins from the split beta-barrel fold family. PA0254 forms, in contrast to the hexameric UbiD from E. coli and P. aeruginosa, a homo-dimer. Insertion of four residues in a loop region in the PA0254 type enzymes results in structural differences that are incompatible with hexamer assembly.	[Jacewicz, Agata; Izumi, Atsushi; Brunner, Katharina; Schnell, Robert; Schneider, Gunter] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden	Karolinska Institutet	Schnell, R (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden.	Robert.schnell@ki.se; gunter.schneider@ki.se		SCHNELL, ROBERT/0000-0001-7530-3629; Schneider, Gunter/0000-0003-0622-5713	European Commission through the 7th Framework program [HEALTH-F3-2008-223461]; Swedish Research Council	European Commission through the 7th Framework program; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the European Commission through the 7th Framework program (grant agreement HEALTH-F3-2008-223461), and the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bentinger M, 2010, BIOCHEM BIOPH RES CO, V396, P74, DOI 10.1016/j.bbrc.2010.02.147; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Christendat D, 2000, NAT STRUCT BIOL, V7, P903; COLLINS MD, 1981, MICROBIOL REV, V45, P316, DOI 10.1128/MMBR.45.2.316-354.1981; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gulmezian M, 2007, ARCH BIOCHEM BIOPHYS, V467, P144, DOI 10.1016/j.abb.2007.08.009; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim SH, 2008, INFECT IMMUN, V76, P4152, DOI 10.1128/IAI.01637-07; Kopec J, 2011, ACTA CRYSTALLOGR F, V67, P1184, DOI 10.1107/S174430911102923X; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Langridge GC, 2009, GENOME RES, V19, P2308, DOI 10.1101/gr.097097.109; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEPPIK RA, 1976, BIOCHIM BIOPHYS ACTA, V436, P800, DOI 10.1016/0005-2736(76)90407-7; Meganathan R, 2001, FEMS MICROBIOL LETT, V203, P131, DOI 10.1016/S0378-1097(01)00330-5; Moynie L, 2013, ACTA CRYSTALLOGR F, V69, P25, DOI 10.1107/S1744309112044739; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishihara K, 1998, APPL ENVIRON MICROB, V64, P1694; Rangarajan ES, 2004, PROTEIN SCI, V13, P3006, DOI 10.1110/ps.04953004; Salama NR, 2004, J BACTERIOL, V186, P7926, DOI 10.1128/JB.186.23.7926-7935.2004; Soballe B, 1999, MICROBIOL-SGM, V145, P1817, DOI 10.1099/13500872-145-8-1817; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	31	24	24	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63161	10.1371/journal.pone.0063161	http://dx.doi.org/10.1371/journal.pone.0063161			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671667	Green Published, Green Submitted, gold			2022-12-25	WOS:000319737700045
J	Riera, M; Burguera, D; Garcia-Fernandez, J; Gonzalez-Duarte, R				Riera, Marina; Burguera, Demian; Garcia-Fernandez, Jordi; Gonzalez-Duarte, Roser			CERKL Knockdown Causes Retinal Degeneration in Zebrafish	PLOS ONE			English	Article							CERAMIDE KINASE-LIKE; RECESSIVE RETINITIS-PIGMENTOSA; NUCLEAR-LOCALIZATION SIGNAL; CONE-ROD DYSTROPHY; EMBRYONIC-DEVELOPMENT; CELL-PROLIFERATION; ANALYSIS REVEALS; ANIMAL-MODELS; GENE; MUTATIONS	The human CERKL gene is responsible for common and severe forms of retinal dystrophies. Despite intense in vitro studies at the molecular and cellular level and in vivo analyses of the retina of murine knockout models, CERKL function remains unknown. In this study, we aimed to approach the developmental and functional features of cerkl in Danio rerio within an Evo-Devo framework. We show that gene expression increases from early developmental stages until the formation of the retina in the optic cup. Unlike the high mRNA-CERKL isoform multiplicity shown in mammals, the moderate transcriptional complexity in fish facilitates phenotypic studies derived from gene silencing. Moreover, of relevance to pathogenicity, teleost CERKL shares the two main human protein isoforms. Morpholino injection has been used to generate a cerkl knockdown zebrafish model. The morphant phenotype results in abnormal eye development with lamination defects, failure to develop photoreceptor outer segments, increased apoptosis of retinal cells and small eyes. Our data support that zebrafish Cerkl does not interfere with proliferation and neural differentiation during early developmental stages but is relevant for survival and protection of the retinal tissue. Overall, we propose that this zebrafish model is a powerful tool to unveil CERKL contribution to human retinal degeneration.	[Riera, Marina; Burguera, Demian; Garcia-Fernandez, Jordi; Gonzalez-Duarte, Roser] Univ Barcelona, Fac Biol, Dept Genet, Barcelona, Spain; [Riera, Marina; Burguera, Demian; Garcia-Fernandez, Jordi; Gonzalez-Duarte, Roser] Univ Barcelona, Inst Biomed IBUB, Barcelona, Spain; [Riera, Marina; Gonzalez-Duarte, Roser] Inst Salud Carlos III, CIBERER, Barcelona, Spain	University of Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III	Gonzalez-Duarte, R (corresponding author), Univ Barcelona, Fac Biol, Dept Genet, Barcelona, Spain.	rgonzalez@ub.edu	Garcia-Fernandez, Jordi/B-3839-2013	Garcia-Fernandez, Jordi/0000-0001-5677-5970; Burguera, Demian/0000-0001-8627-1634	Ministerio de Ciencia e Innovacion [SAF2009-08079, BFU2011-23291]; Generalitat de Catalunya [SGR2009-1427]; CIBERER [U718]; Retina Asturias; ICREA Academia Prize (Generalitat de Catalunya); ONCE	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat de Catalunya(Generalitat de Catalunya); CIBERER; Retina Asturias; ICREA Academia Prize (Generalitat de Catalunya)(ICREA); ONCE	This study was supported by grants SAF2009-08079 (Ministerio de Ciencia e Innovacion), SGR2009-1427 (Generalitat de Catalunya), CIBERER (U718), Retina Asturias and ONCE to RGD, and BFU2011-23291 (Ministerio de Ciencia e Innovacion) and ICREA Academia Prize (Generalitat de Catalunya) to JGF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman TS, 2009, INVEST OPHTH VIS SCI, V50, P5944, DOI 10.1167/iovs.09-3982; Ali M, 2008, MOL VIS, V14, P1960; Auslender N, 2007, INVEST OPHTH VIS SCI, V48, P5431, DOI 10.1167/iovs.07-0736; Avila-Fernandez A, 2008, INVEST OPHTH VIS SCI, V49, P2709, DOI 10.1167/iovs.07-0865; Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; Berger W, 2010, PROG RETIN EYE RES, V29, P335, DOI 10.1016/j.preteyeres.2010.03.004; Bornancin FR, 2005, BBA-MOL CELL BIOL L, V1687, P31, DOI 10.1016/j.bbalip.2004.11.012; Brockerhoff SE, 2011, CELL MOL LIFE SCI, V68, P651, DOI 10.1007/s00018-010-0563-8; Carre A, 2004, BIOCHEM BIOPH RES CO, V324, P1215, DOI 10.1016/j.bbrc.2004.09.181; Chakarova CF, 2011, HUM MOL GENET, V20, P975, DOI 10.1093/hmg/ddq543; den Hollander AI, 2010, J CLIN INVEST, V120, P3042, DOI 10.1172/JCI42258; Dowling J. E., 1987, RETINA APPROACHABLE; Dyer MA, 2001, J NEUROSCI, V21, P4259, DOI 10.1523/JNEUROSCI.21-12-04259.2001; Ellis JD, 2012, MOL CELL, V46, P884, DOI 10.1016/j.molcel.2012.05.037; Fadool JM, 2008, PROG RETIN EYE RES, V27, P89, DOI 10.1016/j.preteyeres.2007.08.002; Garanto A, 2013, EXPT EYE RE IN PRESS; Garanto A, 2012, BBA-MOL BASIS DIS, V1822, P1258, DOI 10.1016/j.bbadis.2012.04.004; Garanto A, 2011, INVEST OPHTH VIS SCI, V52, P5202, DOI 10.1167/iovs.10-7101; Gestri G, 2012, DEV NEUROBIOL, V72, P302, DOI 10.1002/dneu.20919; Gracheva EO, 2011, NATURE, V476, P88, DOI 10.1038/nature10245; Graf C, 2008, BIOCHEM BIOPH RES CO, V373, P159, DOI 10.1016/j.bbrc.2008.06.002; Haider NB, 2001, HUM MOL GENET, V10, P1619, DOI 10.1093/hmg/10.16.1619; Inagaki Y, 2006, BIOCHEM BIOPH RES CO, V343, P982, DOI 10.1016/j.bbrc.2006.03.056; Kay JN, 2005, DEVELOPMENT, V132, P2573, DOI 10.1242/dev.01831; Labbe RM, 2012, STEM CELLS, V30, P1734, DOI 10.1002/stem.1144; Lakowski J, 2007, DEV BIOL, V307, P498, DOI 10.1016/j.ydbio.2007.04.015; Li Z, 2000, DEV DYNAM, V219, P391, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1063>3.0.CO;2-G; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Littink KW, 2010, INVEST OPHTH VIS SCI, V51, P5943, DOI 10.1167/iovs.10-5797; Luo J, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-33; Mandal NA, 2013, EXP EYE RES, V106, P24, DOI 10.1016/j.exer.2012.10.014; Maurer CM, 2011, REV NEUROSCIENCE, V22, P5, DOI 10.1515/RNS.2011.003; Melamud E, 2009, NUCLEIC ACIDS RES, V37, P4862, DOI 10.1093/nar/gkp444; Melamud E, 2009, NUCLEIC ACIDS RES, V37, P4873, DOI 10.1093/nar/gkp471; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; Morris AC, 2011, BIRTH DEFECTS RES C, V93, P215, DOI 10.1002/bdrc.20211; Nevet MJ, 2012, INVEST OPHTH VIS SCI, V53, P4565, DOI 10.1167/iovs.12-9770; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; Pomares E, 2007, HUM MUTAT, V28, P511, DOI 10.1002/humu.20479; Rivas MA, 2009, HISTOL HISTOPATHOL, V24, P1295, DOI 10.14670/HH-24.1295; Rodriguez-Mari A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001034; Scott GR, 2012, P NATL ACAD SCI USA, V109, P14247, DOI 10.1073/pnas.1205012109; Shu XH, 2011, INVEST OPHTH VIS SCI, V52, P2960, DOI 10.1167/iovs.10-6800; Shu XH, 2010, HUM MOL GENET, V19, P657, DOI 10.1093/hmg/ddp533; Sugiura M, 2002, J BIOL CHEM, V277, P23294, DOI 10.1074/jbc.M201535200; Tang ZH, 2009, ARCH OPHTHALMOL-CHIC, V127, P1077, DOI 10.1001/archophthalmol.2009.207; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tuson M, 2004, AM J HUM GENET, V74, P128, DOI 10.1086/381055; Tuson M, 2009, MOL VIS, V15, P168; Ulitsky I, 2012, GENOME RES, V22, P2054, DOI 10.1101/gr.139733.112; Vekslin S, 2010, MOL VIS, V16, P2539; Veleri S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034389; Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301; Wittkopp N, 2009, MOL CELL BIOL, V29, P3517, DOI 10.1128/MCB.00177-09; Yan YL, 2002, DEVELOPMENT, V129, P5065; Yang DH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-319	57	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e64048	10.1371/journal.pone.0064048	http://dx.doi.org/10.1371/journal.pone.0064048			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671706	Green Submitted, gold, Green Published			2022-12-25	WOS:000319737700064
J	Huang, JW; Xu, XR; Weng, QY; Hong, HR; Guo, ZN; He, SZ; Niu, JJ				Huang, Jianwei; Xu, Xuerong; Weng, Qinyun; Hong, Huarong; Guo, Zhinan; He, Shuizhen; Niu, Jianjun			Serial Foodborne Norovirus Outbreaks Associated with Multiple Genotypes	PLOS ONE			English	Article							ACUTE GASTROENTERITIS; UNITED-STATES; VIRUS	Noroviruses (NoV) have been recognized as an important pathogen associated with acute gastroenteritis worldwide during the past three decades. In the spring of 2012, a series of foodborne outbreaks in tourist groups were reported to Xiamen Center for Disease Control and Prevention, Xiamen, Fujian province, China. Among a total of 268 tourists in 7 groups, the prevalence rate of acute gastroenteritis was 16.0% (43/268). Twenty-three feces or anal swabs were collected for laboratory tests of causative agents, no bacterial pathogen was identified, while 22 of them were positive for NoV RNA. In addition, thirteen NoV fragments were recovered from positive specimens and sequenced, belonging to five genotypes such as GI.3, GI.4, GII.4, GII.6, and GII.14, respectively. However, NoV fragments obtained from locally infected patients showed distinct genotypes. Therefore, epidemiological investigation and laboratory analyses demonstrated that the serial foodborne NoV outbreaks in tourists were co-infection of multiple genotypes induced acute gastroenteritis linked to a restaurant.	[Huang, Jianwei; Xu, Xuerong; Weng, Qinyun; Hong, Huarong; Guo, Zhinan; He, Shuizhen; Niu, Jianjun] Xiamen Ctr Dis Control & Prevent, Xiamen, Fujian Province, Peoples R China		Niu, JJ (corresponding author), Xiamen Ctr Dis Control & Prevent, Xiamen, Fujian Province, Peoples R China.	fjxmhjw@hotmail.com		Niu, Jianjun/0000-0003-1960-654X	Priority Discipline Construction Project, Xiamen Meciacal Centers; Xiamen municipal Bureau of Science Technology [350222007707]	Priority Discipline Construction Project, Xiamen Meciacal Centers; Xiamen municipal Bureau of Science Technology	This study was supported by the following grants: 1) Priority Discipline Construction Project, Xiamen Meciacal Centers; 2) Planned Instruction Projects in 2007, Xiamen municipal Bureau of Science & Technology (No. 350222007707). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanton LH, 2006, J INFECT DIS, V193, P413, DOI 10.1086/499315; Bull RA, 2011, TRENDS MICROBIOL, V19, P233, DOI 10.1016/j.tim.2011.01.002; China National Center for Food Safety Risk Assessment, 2012, MAN FOODB PATH SURV, P253; Gilgen M, 1997, INT J FOOD MICROBIOL, V37, P189, DOI 10.1016/S0168-1605(97)00075-5; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Green K. Y., 2007, FIELDS VIROLOGY, V1, P949; Guo L, 2009, J CLIN VIROL, V44, P94, DOI 10.1016/j.jcv.2008.10.002; Harris JP, 2010, J HOSP INFECT, V74, P1, DOI 10.1016/j.jhin.2009.07.025; [贾宁 Jia Ning], 2012, [中华医院感染学杂志, Chinese Journal of Nosocomiology], V22, P536; Jin M, 2008, J MED VIROL, V80, P1997, DOI 10.1002/jmv.21308; Kageyama T, 2004, J CLIN MICROBIOL, V42, P2988, DOI 10.1128/JCM.42.7.2988-2995.2004; Kapikian AZ, 1990, VIROLOGY, P671; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lindesmith L, 2003, NAT MED, V9, P548, DOI 10.1038/nm860; Nishida T, 2003, APPL ENVIRON MICROB, V69, P5782, DOI 10.1128/AEM.69.10.5782-5786.2003; Patel MM, 2009, J CLIN VIROL, V44, P1, DOI 10.1016/j.jcv.2008.10.009; Siebenga JJ, 2007, EMERG INFECT DIS, V13, P144; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vinje J, 2000, ARCH VIROL, V145, P223, DOI 10.1007/s007050050020; Widdowson MA, 2005, EMERG INFECT DIS, V11, P95, DOI 10.3201/eid1101.040426; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1; Zeng M, 2012, J MED VIROL, V84, P145, DOI 10.1002/jmv.22248; Zheng HN, 2008, CHIN J ZOONOSES, V26, P259	23	10	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63327	10.1371/journal.pone.0063327	http://dx.doi.org/10.1371/journal.pone.0063327			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667602	gold, Green Published, Green Submitted			2022-12-25	WOS:000319055600057
J	Muhly, TB; Hebblewhite, M; Paton, D; Pitt, JA; Boyce, MS; Musiani, M				Muhly, Tyler B.; Hebblewhite, Mark; Paton, Dale; Pitt, Justin A.; Boyce, Mark S.; Musiani, Marco			Humans Strengthen Bottom-Up Effects and Weaken Trophic Cascades in a Terrestrial Food Web	PLOS ONE			English	Article							RESOURCE SELECTION FUNCTIONS; HABITAT SELECTION; CONSEQUENCES; WOLVES; CONSERVATION; PREDATION; RESPONSES; DENSITY; IMPACT; RANGE	Ongoing debate about whether food webs are primarily regulated by predators or by primary plant productivity, cast as top-down and bottom-up effects, respectively, may becoming superfluous. Given that most of the world's ecosystems are human dominated we broadened this dichotomy by considering human effects in a terrestrial food-web. We studied a multiple human-use landscape in southwest Alberta, Canada, as opposed to protected areas where previous terrestrial food-web studies have been conducted. We used structural equation models (SEMs) to assess the strength and direction of relationships between the density and distribution of: (1) humans, measured using a density index; (2) wolves (Canis lupus), elk (Cervus elpahus) and domestic cattle (Bos taurus), measured using resource selection functions, and; (3) forage quality, quantity and utilization (measured at vegetation sampling plots). Relationships were evaluated by taking advantage of temporal and spatial variation in human density, including day versus night, and two landscapes with the highest and lowest human density in the study area. Here we show that forage-mediated effects of humans had primacy over predator-mediated effects in the food web. In our parsimonious SEM, occurrence of humans was most correlated with occurrence of forage (beta = 0.637, p < 0.0001). Elk and cattle distribution were correlated with forage (elk day: beta = 0.400, p < 0.0001; elk night: beta = 0.369, p < 0.0001; cattle day: beta = 0.403, p < 0.0001; cattle, night: beta = 0.436, p < 0.0001), and the distribution of elk or cattle and wolves were positively correlated during daytime (elk: beta = 0.293, p < 0.0001, cattle: beta = 0.303, p < 0.0001) and night-time (elk: beta = 0.460, p < 0.0001, cattle: beta = 0.482, p < 0.0001). Our results contrast with research conducted in protected areas that suggested human effects in the food web are primarily predator-mediated. Instead, human influence on vegetation may strengthen bottom-up predominance and weaken top-down trophic cascades in ecosystems. We suggest that human influences on ecosystems may usurp top-down and bottom-up effects.	[Muhly, Tyler B.; Paton, Dale; Musiani, Marco] Univ Calgary, Fac Environm Design, Calgary, AB T2N 1N4, Canada; [Muhly, Tyler B.] Alberta Innovates Technol Futures, Ecosyst Management, Vegreville, AB, Canada; [Hebblewhite, Mark] Univ Montana, Dept Ecosyst & Conservat Sci, Missoula, MT 59812 USA; [Pitt, Justin A.; Boyce, Mark S.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Calgary; Alberta Innovates; University of Montana System; University of Montana; University of Alberta	Muhly, TB (corresponding author), Univ Calgary, Fac Environm Design, Calgary, AB T2N 1N4, Canada.	tyler.muhly@albertainnovates.ca	hebblewhite, mark/G-6164-2013; Boyce, Mark S/A-2620-2014; Musiani, Marco/ABB-9387-2021; Hebblewhite, Mark/AAI-8101-2020	Boyce, Mark S/0000-0001-5811-325X; Musiani, Marco/0000-0002-6097-5841; Hebblewhite, Mark/0000-0001-5382-1361	Natural Science and Engineering Research Council (NSERC) of Canada; Shell Canada; Institute for Sustainable Energy; Environment and Economy; Canadian Wildlife Federation; Glaholt Scholarship; Parks Canada; Alberta Beef Producers; Alberta Conservation Association; Alberta Tourism; Parks and Recreation; Alberta Sustainable Resource Development; Alberta Community Development; Calgary Zoo; Alberta Ecotrust; Alberta Ingenuity; University of Calgary; University of Alberta; Safari Club International	Natural Science and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Shell Canada; Institute for Sustainable Energy; Environment and Economy; Canadian Wildlife Federation; Glaholt Scholarship; Parks Canada; Alberta Beef Producers; Alberta Conservation Association; Alberta Tourism; Parks and Recreation; Alberta Sustainable Resource Development; Alberta Community Development; Calgary Zoo; Alberta Ecotrust; Alberta Ingenuity; University of Calgary; University of Alberta(University of Alberta); Safari Club International	The authors' group's research on human impacts on wildlife species was funded by a substantial ($1.7 million) grant from the Natural Science and Engineering Research Council (NSERC) of Canada. The authors thank the following for their important financial contributions to this work: the Natural Science and Engineering Research Council of Canada, Shell Canada, the Institute for Sustainable Energy, Environment and Economy, the Canadian Wildlife Federation, the Glaholt Scholarship, Parks Canada, Alberta Beef Producers, Alberta Conservation Association, Alberta Tourism, Parks and Recreation, Alberta Sustainable Resource Development, Alberta Community Development, the Calgary Zoo, Alberta Ecotrust, Alberta Ingenuity, the University of Calgary, the University of Alberta, and Safari Club International. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, CAUSE CORRELATION BI; Apps CD, 2004, J WILDLIFE MANAGE, V68, P138, DOI 10.2193/0022-541X(2004)068[0138:EGBDAA]2.0.CO;2; Barnosky AD, 2004, SCIENCE, V306, P70, DOI 10.1126/science.1101476; Bork EW, 1999, J RANGE MANAGE, V52, P151, DOI 10.2307/4003509; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Boyce MS, 1999, CARNIVORES IN ECOSYSTEMS: THE YELLOWSTONE EXPERIENCE, P265; Darimont CT, 2009, P NATL ACAD SCI USA, V106, P952, DOI 10.1073/pnas.0809235106; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Fieberg J, 2010, PHILOS T R SOC B, V365, P2233, DOI 10.1098/rstb.2010.0079; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Grace JB., 2015, STRUCTURAL EQUATION; Hebblewhite M, 2005, ECOLOGY, V86, P2135, DOI 10.1890/04-1269; Hebblewhite M, 2008, J APPL ECOL, V45, P834, DOI 10.1111/j.1365-2664.2008.01466.x; IRVING BD, 1995, J RANGE MANAGE, V48, P358, DOI 10.2307/4002489; Johnson CJ, 2006, J WILDLIFE MANAGE, V70, P347, DOI 10.2193/0022-541X(2006)70[347:RSFBOU]2.0.CO;2; Joreskog K., 2005, LISREL 8 72; Kelloway E. K., 1998, USING LISREL STRUCTU; KREBS CJ, 1995, SCIENCE, V269, P1112, DOI 10.1126/science.269.5227.1112; Lele SR, 2009, J WILDLIFE MANAGE, V73, P122, DOI 10.2193/2007-535; Manly B.F.J., 2002, RESOURCE SELECTION A; McDermid GJ, 2009, FOREST ECOL MANAG, V257, P2262, DOI 10.1016/j.foreco.2009.03.005; Melis C, 2009, GLOBAL ECOL BIOGEOGR, V18, P724, DOI 10.1111/j.1466-8238.2009.00480.x; Muhly TB, 2010, OIKOS, V119, P1243, DOI 10.1111/j.1600-0706.2009.18350.x; Musiani M, 2003, CONSERV BIOL, V17, P1538, DOI 10.1111/j.1523-1739.2003.00063.x; Paine RT, 1980, J ANIM ECOL, V49, P666, DOI DOI 10.2307/4220; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Polis GA, 1999, OIKOS, V86, P3, DOI 10.2307/3546565; Ripple WJ, 2001, BIOL CONSERV, V102, P227, DOI 10.1016/S0006-3207(01)00107-0; Sawyer H, 2006, J WILDLIFE MANAGE, V70, P396, DOI 10.2193/0022-541X(2006)70[396:WHSOMD]2.0.CO;2; SCHULTZ RD, 1978, J WILDLIFE MANAGE, V42, P91, DOI 10.2307/3800694; Seaman DE, 1996, ECOLOGY, V77, P2075, DOI 10.2307/2265701; Sinclair ARE, 2000, SCIENCE, V289, P1875; Smith BD, 2007, SCIENCE, V315, P1797, DOI 10.1126/science.1137740; StataCorp LP, 2009, STATA SE 10 1 WIND; Stolzenburg W, 2008, CONSERVATION MAGAZIN; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431	36	57	57	2	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e64311	10.1371/journal.pone.0064311	http://dx.doi.org/10.1371/journal.pone.0064311			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667705	Green Published, Green Submitted, gold			2022-12-25	WOS:000319055600087
J	Wang, MP; Ho, SY; Lo, WS; Lam, TH				Wang, Man Ping; Ho, Sai Yin; Lo, Wing Sze; Lam, Tai Hing			Secondhand Smoke Exposure and Health Services Use among Adolescent Current Smokers	PLOS ONE			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; MEDICAL-CARE UTILIZATION; NICOTINE DEPENDENCE; CHILDREN; PATTERNS; DISEASE; BURDEN; FAMILY; HOME	Background: To investigate the associations of secondhand smoke (SHS) exposure with medical consultation and hospitalisation among adolescents in Hong Kong. Methods: A total of 35827 secondary 1 (US grade 7) to secondary 5 students from 85 randomly selected schools completed an anonymous questionnaire on smoking, SHS at home, SHS outside home, medical consultation in the past 14 days, hospitalisation in the past 12 months, and socio-demographic characteristics. Current smoking was defined as any smoking in the past 30 days. SHS exposure was classified as none (reference), 1-4 and 5-7 days/week. Logistic regression yielded adjusted odds ratios (AORs) for medical consultation and hospitalisation in relation to SHS exposure at home and outside home in current smokers. Analyses were also done among never-smokers for comparison. Results: Among all students, 15.9% had medical consultation and 5.2% had been hospitalised. Any SHS exposure at home was associated with AORs (95% CI) for medical consultation and hospitalisation of 1.69 (1.14-2.51) and 2.85 (1.47-5.52) in current smokers, and 1.03 (0.91-1.15) and 1.25 (1.02-1.54) in never-smokers, respectively, (P < 0.01 for interaction between smoking status and SHS exposure at home). SHS exposure outside home was generally not associated with medical consultation and hospitalisation in smokers and never-smokers. Conclusions: SHS exposure at home was associated with health services use among adolescent current smokers. Adolescent smokers should be aware of the harm of SHS in addition to that from their own smoking. The evidence helps health care professionals to advise adolescent smokers to avoid SHS exposure and stop smoking.	[Wang, Man Ping; Ho, Sai Yin; Lo, Wing Sze; Lam, Tai Hing] Univ Hong Kong, Sch Publ Hlth, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong	Ho, SY (corresponding author), Univ Hong Kong, Sch Publ Hlth, Pokfulam, Hong Kong, Peoples R China.	syho@hku.hk	; Lam, Tai Hing/C-4317-2009; Ho, Daniel Sai Yin/C-4307-2009	Wang, Man Ping/0000-0003-4000-2388; Lam, Tai Hing/0000-0002-2033-9971; Ho, Daniel Sai Yin/0000-0001-9485-0273	Hong Kong Council on Smoking and Health; Department of Health	Hong Kong Council on Smoking and Health; Department of Health	Funding from Hong Kong Council on Smoking and Health, and Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Census and Statistics Department, 1997, DOCT CONC HONG KONG; [Census and Statistics Department Social Survey Section Census and Statistics Department], 2003, THEM HOUS SURV REP; Crombie IK, 2001, THORAX, V56, P9, DOI 10.1136/thorax.56.1.9; Department of Health, 2011, HONG KONG FACTS; Hill SC, 2008, TOB CONTROL, V17, P32, DOI 10.1136/tc.2007.020990; Ho SY, 2010, TOB CONTROL, V19, P129, DOI 10.1136/tc.2009.032003; Ho SY, 2010, J PEDIATR-US, V157, P1012, DOI 10.1016/j.jpeds.2010.06.013; Ho SY, 2011, SCH BASED SMOK UNPUB; Kobus K, 2003, ADDICTION, V98, P37, DOI 10.1046/j.1360-0443.98.s1.4.x; Lai HK, 2009, PEDIATRICS, V124, P1306, DOI 10.1542/peds.2009-0669; Lam TH, 2005, TOB CONTROL, V14, P307, DOI 10.1136/tc.2005.011775; Lam TH, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.6.e91; Lau JTF, 2000, J ADOLESCENT HEALTH, V27, P443, DOI 10.1016/S1054-139X(99)00075-0; Lee A, 2001, PUBLIC HEALTH, V115, P30; Leung GM, 2004, ARCH PEDIAT ADOL MED, V158, P687, DOI 10.1001/archpedi.158.7.687; O'Callaghan FV, 2006, ADDICTION, V101, P282, DOI 10.1111/j.1360-0443.2006.01323.x; Oberg M, 2011, LANCET, V377, P139, DOI 10.1016/S0140-6736(10)61388-8; Okoli CTC, 2008, PUBLIC HEALTH NURS, V25, P46, DOI 10.1111/j.1525-1446.2008.00679.x; Piccardo MT, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-5; U. S. Department of Health and Human Services, 2007, CHILDR SEC SMOK EXP; VOGT TM, 1984, AM J PUBLIC HEALTH, V74, P30, DOI 10.2105/AJPH.74.1.30; Wang MP, 2013, NICOTINE TOB RES, V15, P185, DOI 10.1093/ntr/nts109; Wang MP, 2012, NICOTINE TOB RES, V14, P682, DOI 10.1093/ntr/ntr266; Wang MP, 2012, ADDICT BEHAV, V37, P743, DOI 10.1016/j.addbeh.2012.02.016; Warren CW, 2006, TOB CONTROL, V15, pII4, DOI 10.1136/tc.2006.015685; Warren CW, 2006, LANCET, V367, P749, DOI 10.1016/S0140-6736(06)68192-0; Wilson-Frederick SM, 2011, ADDICT BEHAV, V36, P412, DOI 10.1016/j.addbeh.2010.12.005; World Health Organization, 2001, GLOB CONS AD HLTH SE; Yach D, 2002, TOB CONTROL, V11, P252, DOI 10.1136/tc.11.3.252	29	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e64322	10.1371/journal.pone.0064322	http://dx.doi.org/10.1371/journal.pone.0064322			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	145YI	23667706	Green Published, gold, Green Submitted			2022-12-25	WOS:000319055600088
J	Wuerger, S				Wuerger, Sophie			Colour Constancy Across the Life Span: Evidence for Compensatory Mechanisms	PLOS ONE			English	Article							OPPONENT-PROCESS ADDITIVITY; CHROMATIC MECHANISMS; NEURAL BASIS; UNIQUE HUES; VISION; DISCRIMINATION	It is well known that the peripheral visual system declines with age: the yellowing of the lens causes a selective reduction of short-wavelength light and sensitivity losses occur in the cone receptor mechanisms. At the same time, our subjective experience of colour does not change with age. The main purpose of this large-scale study (n = 185) covering a wide age range of colour-normal observers (18-75 years of age) was to assess the extent to which the human visual system is able to compensate for the changes in the optical media and at which level of processing this compensation is likely to occur. We report two main results: (1) Supra-threshold parafoveal colour perception remains largely unaffected by the age-related changes in the optical media (yellowing of the lens) whereas our ability to discriminate between small colour differences is compromised with an increase in age. (2) Significant changes in colour appearance are only found for unique green settings under daylight viewing condition which is consistent with the idea that the yellow-blue mechanism is most affected by an increase in age due to selective attenuation of short-wavelength light. The data on the invariance of hue perception, in conjunction with the age-related decline in chromatic sensitivity, provides evidence for compensatory mechanisms that enable colour-normal human observers a large degree of colour constancy across the life span. These compensatory mechanisms are likely to originate at cortical sites.	Univ Liverpool, Dept Psychol Sci, Inst Psychol Hlth & Soc, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Wuerger, S (corresponding author), Univ Liverpool, Dept Psychol Sci, Inst Psychol Hlth & Soc, Liverpool L69 3BX, Merseyside, England.	s.m.wuerger@liverpool.ac.uk	Wuerger, Sophie/AAZ-1212-2020	Wuerger, Sophie/0000-0003-0080-5813	Wellcome Trust [GR/080205]; Spanish research project, Spanish Ministry of Science [TIN2008-04998]	Wellcome Trust(Wellcome TrustEuropean Commission); Spanish research project, Spanish Ministry of Science	The equipment has been supported by the Wellcome Trust (GR/080205). The data collection was supported by a Spanish research project, Spanish Ministry of Science (TIN2008-04998.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBUR JL, 1994, P ROY SOC B-BIOL SCI, V258, P327, DOI 10.1098/rspb.1994.0181; Bompas A, 2013, J VISION, V13, DOI 10.1167/13.1.19; Delahunt PB, 2004, VISUAL NEUROSCI, V21, P301, DOI 10.1017/S0952523804213025; DERRINGTON AM, 1984, J PHYSIOL-LONDON, V357, P241, DOI 10.1113/jphysiol.1984.sp015499; DeValois RL, 1997, VISION RES, V37, P885, DOI 10.1016/S0042-6989(96)00234-9; Gegenfurtner KR, 1997, J NEUROPHYSIOL, V77, P1906, DOI 10.1152/jn.1997.77.4.1906; HELMHOLTZ H, 2000, TREATISE PHYSL OPTIC; Hering E., 1964, OUTLINES THEORY LIGH; Hurlbert A, 2003, CURR BIOL, V13, pR270, DOI 10.1016/S0960-9822(03)00198-2; JAMESON D, 1955, J OPT SOC AM, V45, P546, DOI 10.1364/JOSA.45.000546; KNOBLAUCH K, 1987, APPL OPTICS, V26, P1441, DOI 10.1364/AO.26.001441; LARIMER J, 1975, VISION RES, V15, P723, DOI 10.1016/0042-6989(75)90291-6; LARIMER J, 1974, VISION RES, V14, P1127, DOI 10.1016/0042-6989(74)90209-0; MACLEOD DIA, 1979, J OPT SOC AM, V69, P1183, DOI 10.1364/JOSA.69.001183; Mateus C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055348; Mollon JD, 2009, CURR BIOL, V19, pR441, DOI 10.1016/j.cub.2009.05.008; MOLLON JD, 1982, ANNU REV PSYCHOL, V33, P41, DOI 10.1146/annurev.ps.33.020182.000353; Neitz J, 2002, NEURON, V35, P783, DOI 10.1016/S0896-6273(02)00818-8; Okajima K, 2001, OPT REV, V8, P64, DOI 10.1007/s10043-001-0064-y; Paramei GV, 2012, J OPT SOC AM A, V29, pA290, DOI 10.1364/JOSAA.29.00A290; Peters A., 2007, EFFECTS NORMAL AGING; POKORNY J, 1987, APPL OPTICS, V26, P1437, DOI 10.1364/AO.26.001437; REGAN BC, 1994, VISION RES, V34, P1279, DOI 10.1016/0042-6989(94)90203-8; SCHEFRIN BE, 1990, J OPT SOC AM A, V7, P305, DOI 10.1364/JOSAA.7.000305; Stockman A, 2000, VISION RES, V40, P1711, DOI 10.1016/S0042-6989(00)00021-3; Stoughton CM, 2008, CURR BIOL, V18, pR698, DOI 10.1016/j.cub.2008.06.018; VALBERG A, 1971, VISION RES, V11, P157, DOI 10.1016/0042-6989(71)90231-8; Webster MA, 2000, J OPT SOC AM A, V17, P1545, DOI 10.1364/JOSAA.17.001545; Webster MA, 2000, J OPT SOC AM A, V17, P1535, DOI 10.1364/JOSAA.17.001535; Webster MA, 2002, J OPT SOC AM A, V19, P1951, DOI 10.1364/JOSAA.19.001951; Webster MA, 2010, P ROY SOC B-BIOL SCI, V277, P1817, DOI 10.1098/rspb.2009.1832; Werner A, 2010, VISION RES, V50, P1641, DOI 10.1016/j.visres.2010.05.004; Werner JS, 1996, PROG RETIN EYE RES, V15, P621, DOI 10.1016/1350-9462(96)00001-8; Wuerger SM, 2005, VISION RES, V45, P3210, DOI 10.1016/j.visres.2005.06.016; Wyszecki G., 2000, COLOR SCI CONCEPTS M, V2nd ed., P117	35	31	32	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63921	10.1371/journal.pone.0063921	http://dx.doi.org/10.1371/journal.pone.0063921			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667689	Green Published, Green Submitted, gold			2022-12-25	WOS:000319055600082
J	Sanabani, SS; Pessoa, R; de Oliveira, ACS; Martinez, VP; Giret, MTM; Succi, RCD; Carvalho, K; Tomiyama, CS; Nixon, DF; Sabino, EC; Kallas, EG				Sanabani, Sabri Saeed; Pessoa, Rodrigo; Soares de Oliveira, Ana Carolina; Martinez, Vanessa Pouza; Giret, Maria Teresa Maidana; de Menezes Succi, Regina Celia; Carvalho, Karina; Tomiyama, Claudia Satiko; Nixon, Douglas F.; Sabino, Ester Cerdeira; Kallas, Esper Georges			Variability of HIV-1 Genomes among Children and Adolescents from Sao Paulo, Brazil	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CIRCULATING RECOMBINANT FORM; SUBTYPE-C; VERTICAL TRANSMISSION; MOLECULAR EPIDEMIOLOGY; GENOTYPIC RESISTANCE; DRUG-RESISTANCE; DUAL INFECTION; VIRAL LOAD; CLADE-B	Background: Genetic variability is a major feature of the human immunodeficiency virus type 1 (HIV-1) and considered the key factor to frustrating efforts to halt the virus epidemic. In this study, we aimed to investigate the genetic variability of HIV-1 strains among children and adolescents born from 1992 to 2009 in the state of Sao Paulo, Brazil. Methodology: Plasma and peripheral blood mononuclear cells (PBMC) were collected from 51 HIV-1-positive children and adolescents on ART followed between September 1992 and July 2009. After extraction, the genetic materials were used in a polymerase chain reaction (PCR) to amplify the viral near full length genomes (NFLGs) from 5 overlapped fragments. NFLGs and partial amplicons were directly sequenced and data were phylogenetically inferred. Results: Of the 51 samples studied, the NFLGs and partial fragments of HIV-1 from 42 PBMCs and 25 plasma were successfully subtyped. Results based on proviral DNA revealed that 22 (52.4%) patients were infected with subtype B, 16 (38.1%) were infected with BF1 mosaic variants and 4 (9.5%) were infected with sub-subtype F1. All the BF1 recombinants were unique and distinct from any previously identified unique or circulating recombinant forms in South America. Evidence of dual infections was detected in 3 patients coinfected with the same or distinct HIV-1 subtypes. Ten of the 31 (32.2%) and 12 of the 21 (57.1%) subjects with recovered proviral and plasma, respectively, protease sequences were infected with major mutants resistant to protease inhibitors. The V3 sequences of 14 patients with available sequences from PBMC/or plasma were predicted to be R5-tropic virus except for two patients who harbored an X4 strain. Conclusions: The high proportion of HIV-1 BF1 recombinant, coinfection rate and vertical transmission in Brazil merits urgent attention and effective measures to reduce the transmission of HIV among spouses and sex partners.	[Sanabani, Sabri Saeed] Univ Sao Paulo, Sch Med, Clin & Res Lab LIM 03, Sao Paulo, Brazil; [Sanabani, Sabri Saeed; Pessoa, Rodrigo; Soares de Oliveira, Ana Carolina; Martinez, Vanessa Pouza; Sabino, Ester Cerdeira] Univ Sao Paulo, Inst Trop Med, Virol Lab LIM HCFMUSP 52, Sao Paulo, Brazil; [Giret, Maria Teresa Maidana] Univ Florida, Miller Sch Med, Story Lab 2, Miami, FL USA; [de Menezes Succi, Regina Celia] Univ Fed Sao Paulo, Paulista Sch Med, Dept Pediat, Sao Paulo, Brazil; [Carvalho, Karina; Tomiyama, Claudia Satiko; Kallas, Esper Georges] Univ Sao Paulo, Sch Med, Div Clin Immunol & Allergy, Sao Paulo, Brazil; [Nixon, Douglas F.] Univ Calif San Francisco, Dept Med, Div Expt Med, San Francisco, CA USA	Universidade de Sao Paulo; Universidade de Sao Paulo; State University System of Florida; University of Florida; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; University of California System; University of California San Francisco	Sanabani, SS (corresponding author), Univ Sao Paulo, Sch Med, Clin & Res Lab LIM 03, Sao Paulo, Brazil.	sabyem_63@yahoo.com	Carvalho, Karina IL/J-6789-2012; Sanabani, Sabri Saeed/F-5600-2012; Sabino, Ester C/F-7750-2010; Pessôa, Rodrigo/B-7206-2018; Nixon, Douglas/AAU-5734-2020	Carvalho, Karina IL/0000-0002-7763-8139; Sanabani, Sabri Saeed/0000-0002-8876-8262; Sabino, Ester C/0000-0003-2623-5126; Nixon, Douglas/0000-0002-2801-1786; Kallas, Esper/0000-0003-2026-6925	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/09983-1, 2009/540055-5, 2009/52381-2, 2010/05845-0 2004/15856-9, 2006/50096-0]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [2571/2009]; National Institutes of Health [R01 AI060379]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060379] Funding Source: NIH RePORTER	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by grants 2011/09983-1, 2009/540055-5, 2009/52381-2 and 2010/05845-0 2004/15856-9 and 2006/50096-0 from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). The study was also partially supported by grant 2571/2009 from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). Additional support was provided by grant R01 AI060379 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantara KC, 2012, J CLIN VIROL, V54, P15, DOI 10.1016/j.jcv.2012.01.011; Almeida FJ, 2009, J PEDIAT, V85, P104, DOI [10.2223/JPED.1877, 10.1590/S0021-75572009000200004]; Altfeld M, 2002, NATURE, V420, P434, DOI 10.1038/nature01200; ARTENSTEIN AW, 1995, J INFECT DIS, V171, P805, DOI 10.1093/infdis/171.4.805; Aulicino PC, 2011, INFECT GENET EVOL, V11, P349, DOI 10.1016/j.meegid.2010.11.008; Barreto CC, 2006, JAIDS-J ACQ IMM DEF, V41, P338; Bimber BN, 2010, J VIROL, V84, P12087, DOI 10.1128/JVI.01378-10; Bitnun A, 2002, CAN MED ASSOC J, V166, P904; Passaes CPB, 2009, AIDS RES HUM RETROV, V25, P1339, DOI 10.1089/aid.2009.0167; Brindeiro PA, 2002, J CLIN MICROBIOL, V40, P4512, DOI 10.1128/JCM.40.12.4512-4519.2002; Bushman FD, 2008, AIDS, V22, P1411, DOI 10.1097/QAD.0b013e3282fc972e; Chueca N, 2009, J MED VIROL, V81, P763, DOI 10.1002/jmv.21425; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; da Silveira AA, 2012, AIDS RES HUM RETROV, V28, P304, DOI 10.1089/aid.2011.0128; de Oliveira CM, 2008, ARCH VIROL, V153, P1799, DOI 10.1007/s00705-008-0178-7; DIAZ RS, 1995, J VIROL, V69, P3273, DOI 10.1128/JVI.69.6.3273-3281.1995; Dudley DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036494; Guimaraes ML, 2008, AIDS, V22, P433, DOI 10.1097/QAD.0b013e3282f47ad0; Janini LM, 1998, J INFECT DIS, V177, P227, DOI 10.1086/517360; Koelsch KK, 2003, AIDS, V17, pF11, DOI 10.1097/00002030-200305020-00001; Korber B, 2001, BRIT MED BULL, V58, P19, DOI 10.1093/bmb/58.1.19; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Machado ES, 2004, J CLIN VIROL, V30, P24, DOI 10.1016/j.jcv.2003.08.001; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; McBurney SP, 2008, EXPERT REV VACCINES, V7, P1405, DOI 10.1586/14760584.7.9.1405; McGovern RA, 2010, AIDS, V24, P2512, DOI 10.1097/QAD.0b013e32833e6cfb; Peeters M, 2003, AIDS, V17, P2547, DOI 10.1097/00002030-200312050-00002; Peters V, 2003, PEDIATRICS, V111, P1186; Pitt J, 1997, J INFECT DIS, V175, P567, DOI 10.1093/infdis/175.3.567; Rambaut A, 2004, NAT REV GENET, V5, P52, DOI 10.1038/nrg1246; Ramos A, 1999, EMERG INFECT DIS, V5, P65, DOI 10.3201/eid0501.990108; Raymond S, 2008, AIDS, V22, pF11, DOI 10.1097/QAD.0b013e32830ebcd4; Russell ES, 2011, J VIROL, V85, P8253, DOI 10.1128/JVI.00197-11; SABINO EC, 1994, J VIROL, V68, P6340, DOI 10.1128/JVI.68.10.6340-6346.1994; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Samleerat T, 2008, J INFECT DIS, V198, P868, DOI 10.1086/591251; Sanabani S, 2006, AIDS RES HUM RETROV, V22, P171, DOI 10.1089/aid.2006.22.171; Sanabani S, 2006, INFECT GENET EVOL, V6, P368, DOI 10.1016/j.meegid.2006.01.003; Sanabani SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025869; Sanabani SS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-74; Sanabani SS, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-78; Santos AF, 2006, AIDS, V20, P2011; Schultz AK, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-265; Skrabal K, 2007, J CLIN MICROBIOL, V45, P279, DOI 10.1128/JCM.01118-06; de Oliveira ACS, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-223; Sperling RS, 1996, NEW ENGL J MED, V335, P1621, DOI 10.1056/NEJM199611283352201; Spira S, 2003, J ANTIMICROB CHEMOTH, V51, P229, DOI 10.1093/jac/dkg079; Templeton AR, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-54; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thomson MM, 2005, AIDS REV, V7, P210; Verhofstede C, 2003, J VIROL, V77, P3050, DOI 10.1128/JVI.77.5.3050-3057.2003; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Wiktor S Z, 1997, AIDS, V11 Suppl B, pS79; WOLINSKY SM, 1992, SCIENCE, V255, P1134, DOI 10.1126/science.1546316	55	16	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62552	10.1371/journal.pone.0062552	http://dx.doi.org/10.1371/journal.pone.0062552			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667488	Green Published, gold, Green Submitted			2022-12-25	WOS:000319654700046
J	Shepheard, MA; Fleming, VM; Connor, TR; Corander, J; Feil, EJ; Fraser, C; Hanage, WP				Shepheard, Marcus A.; Fleming, Vicki M.; Connor, Thomas R.; Corander, Jukka; Feil, Edward J.; Fraser, Christophe; Hanage, William P.			Historical Zoonoses and Other Changes in Host Tropism of Staphylococcus aureus, Identified by Phylogenetic Analysis of a Population Dataset	PLOS ONE			English	Article							METHICILLIN-RESISTANT; HOMOLOGOUS RECOMBINATION; ADAPTATION; REVEALS; SPREAD; MICROARRAY; DIVERSITY; VIRULENCE; GENOMICS; RUMINANT	Background: Staphylococcus aureus exhibits tropisms to many distinct animal hosts. While spillover events can occur wherever there is an interface between host species, changes in host tropism only occur with the establishment of sustained transmission in the new host species, leading to clonal expansion. Although the genomic variation underpinning adaptation in S. aureus genotypes infecting bovids and poultry has been well characterized the frequency of switches from one host to another remains obscure. We sought to identify sustained switches in host tropism in the S. aureus population, both anthroponotic and zoonotic, and their distribution over the species phylogeny. Methodologies/Results: We have used a sample of 3042 isolates, representing 696 distinct MLST genotypes, from a well-established database (www.mlst.net). Using an empirical parsimony approach (AdaptML) we have investigated the distribution of switches in host association between both human and non-human (henceforth referred to as animal) hosts. We reconstructed a credible description of past events in the form of a phylogenetic tree; the nodes and leaves of which are statistically associated with either human or animal habitats, estimated from extant host-association and the degree of sequence divergence between genotypes. We identified 15 likely historical switching events; 13 anthroponoses and two zoonoses. Importantly, we identified two human-associated clade candidates (CC25 and CC59) that have arisen from animal-associated ancestors; this demonstrates that a human-specific lineage can emerge from an animal host. We also highlight novel rabbit-associated genotypes arising from a human ancestor. Conclusions: S. aureus is an organism with the capacity to switch into and adapt to novel hosts, even after long periods of isolation in a single host species. Based on this evidence, animal-adapted S. aureus lineages exhibiting resistance to antibiotics must be considered a major threat to public health, as they can adapt to the human population.	[Shepheard, Marcus A.; Fraser, Christophe] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modelling, London, England; [Fleming, Vicki M.; Feil, Edward J.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Connor, Thomas R.] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Corander, Jukka] Univ Helsinki, Dept Math & Stat, Helsinki, Finland; [Hanage, William P.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Ctr Communicable Dis Dynam, Cambridge, MA 02138 USA	Imperial College London; University of Bath; Wellcome Trust Sanger Institute; University of Helsinki; Harvard University; Harvard T.H. Chan School of Public Health	Shepheard, MA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modelling, London, England.	mas03@ic.ac.uk	Connor, Thomas/ABE-5989-2020; Hanage, Bill/CAF-1813-2022; Fraser, Christophe/A-8109-2008; Fleming, Vicki M/CAF-2082-2022; Connor, Thomas/ABD-6533-2021	Connor, Thomas/0000-0003-2394-6504; Fraser, Christophe/0000-0003-2399-9657; Fleming, Vicki/0000-0002-0460-3533	Wellcome Trust; The Royal Society; National Institutes of Health (NIH)/National Institute of General Medical Sciences (NIGMS) MIDAS initiative; European Research Council (ERC); Academy of Finland; Biotechnology and Biological Sciences Research Council (BBSRC); Medical Research Council; EU (FP7 [HEALTH] TROCAR); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER; Medical Research Council [G0800596, MR/K010174/1, G0600719, MR/K010174/1B, G0600719B] Funding Source: researchfish; MRC [MR/K010174/1, G0600719, G0800596] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); The Royal Society(Royal Society of London); National Institutes of Health (NIH)/National Institute of General Medical Sciences (NIGMS) MIDAS initiative; European Research Council (ERC)(European Research Council (ERC)European Commission); Academy of Finland(Academy of Finland); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU (FP7 [HEALTH] TROCAR); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors wish to thank the Wellcome Trust, The Royal Society, the National Institutes of Health (NIH)/National Institute of General Medical Sciences (NIGMS) MIDAS initiative, the European Research Council (ERC), the Academy of Finland, the Biotechnology and Biological Sciences Research Council (BBSRC), the Medical Research Council and the EU (FP7 [HEALTH] TROCAR) for research funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armand-Lefevre L, 2005, EMERG INFECT DIS, V11, P711, DOI 10.3201/eid1105.040866; Bhat M, 2009, EMERG INFECT DIS, V15, P285, DOI 10.3201/eid1502.080609; de Boer E, 2009, INT J FOOD MICROBIOL, V134, P52, DOI 10.1016/j.ijfoodmicro.2008.12.007; Didelot X, 2010, GENETICS, V186, P1435, DOI 10.1534/genetics.110.120121; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Fan J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006216; Feil EJ, 2003, J BACTERIOL, V185, P3307, DOI 10.1128/JB.185.11.3307-3316.2003; Furia JP, 2010, J BONE JOINT SURG AM, V92A, P846, DOI 10.2106/JBJS.I.00653; Garcia-Alvarez L, 2011, LANCET INFECT DIS, V11, P595, DOI 10.1016/S1473-3099(11)70126-8; Grave K, 2010, J ANTIMICROB CHEMOTH, V65, P2037, DOI 10.1093/jac/dkq247; Graveland H, 2011, INT J MED MICROBIOL, V301, P630, DOI 10.1016/j.ijmm.2011.09.004; Graveland H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016830; Guinane CM, 2010, GENOME BIOL EVOL, V2, P454, DOI 10.1093/gbe/evq031; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hanage WP, 2006, J THEOR BIOL, V239, P210, DOI 10.1016/j.jtbi.2005.08.035; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Hasman H, 2010, VET MICROBIOL, V141, P326, DOI 10.1016/j.vetmic.2009.09.025; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Holt DC, 2011, GENOME BIOL EVOL; Huijsdens Xander W, 2006, Ann Clin Microbiol Antimicrob, V5, P26, DOI 10.1186/1476-0711-5-26; Hunt DE, 2008, SCIENCE, V320, P1081, DOI 10.1126/science.1157890; King LJ, 2008, JAVMA-J AM VET MED A, V233, P259, DOI 10.2460/javma.233.2.259; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Leverstein-van Hall MA, 2011, CLIN MICROBIOL INFEC, V17, P873, DOI 10.1111/j.1469-0691.2011.03497.x; Lloyd-Smith JO, 2009, SCIENCE, V326, P1362, DOI 10.1126/science.1177345; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; Monecke S, 2007, VET MICROBIOL, V125, P128, DOI 10.1016/j.vetmic.2007.05.016; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Rabello RF, 2007, J MED MICROBIOL, V56, P1505, DOI 10.1099/jmm.0.47357-0; Rasigade JP, 2010, EMERG INFECT DIS, V16, P1330, DOI 10.3201/eid1608.100317; Sakwinska O, 2011, APPL ENVIRON MICROB, V77, P5908, DOI 10.1128/AEM.00238-11; Smyth DS, 2009, J MED MICROBIOL, V58, P1343, DOI 10.1099/jmm.0.009837-0; Stegger M, 2010, CLIN MICROBIOL INFEC, V16, P1018, DOI 10.1111/j.1469-0691.2009.03003.x; Sung JML, 2008, MICROBIOL-SGM, V154, P1949, DOI 10.1099/mic.0.2007/015289-0; Sung JML, 2007, ANTIMICROB AGENTS CH, V51, P2189, DOI 10.1128/AAC.01442-06; Uhlemann AC, 2012, MBIO, V3, DOI 10.1128/mBio.00027-12; van Loo I, 2007, EMERG INFECT DIS, V13, P1834, DOI 10.3201/eid1312.070384; Viana D, 2010, MOL MICROBIOL, V77, P1583, DOI 10.1111/j.1365-2958.2010.07312.x; Vos M, 2009, ISME J, V3, P199, DOI 10.1038/ismej.2008.93; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428; Weinert LA, 2012, BIOL LETTERS, V8, P829, DOI 10.1098/rsbl.2012.0290; Wiles S, 2006, NAT REV MICROBIOL, V4, P307, DOI 10.1038/nrmicro1386; Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775; Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997	48	37	38	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62369	10.1371/journal.pone.0062369	http://dx.doi.org/10.1371/journal.pone.0062369			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667472	Green Published, gold, Green Accepted			2022-12-25	WOS:000319654700033
J	Umemura, M; Koyama, Y; Takeda, I; Hagiwara, H; Ikegami, T; Koike, H; Machida, M				Umemura, Myco; Koyama, Yoshinori; Takeda, Itaru; Hagiwara, Hiroko; Ikegami, Tsutomu; Koike, Hideaki; Machida, Masayuki			Fine De Novo Sequencing of a Fungal Genome Using only SOLiD Short Read Data: Verification on Aspergillus oryzae RIB40	PLOS ONE			English	Article							CORYNEBACTERIUM-PSEUDOTUBERCULOSIS I19; GENE-CLUSTER; BIOSYNTHESIS; PARALLEL	The development of next-generation sequencing (NGS) technologies has dramatically increased the throughput, speed, and efficiency of genome sequencing. The short read data generated from NGS platforms, such as SOLiD and Illumina, are quite useful for mapping analysis. However, the SOLiD read data with lengths of,60 bp have been considered to be too short for de novo genome sequencing. Here, to investigate whether de novo sequencing of fungal genomes is possible using only SOLiD short read sequence data, we performed de novo assembly of the Aspergillus oryzae RIB40 genome using only SOLiD read data of 50 bp generated from mate-paired libraries with 2.8- or 1.9-kb insert sizes. The assembled scaffolds showed an N50 value of 1.6 Mb, a 22-fold increase than those obtained using only SOLiD short read in other published reports. In addition, almost 99% of the reference genome was accurately aligned by the assembled scaffold fragments in long lengths. The sequences of secondary metabolite biosynthetic genes and clusters, whose products are of considerable interest in fungal studies due to their potential medicinal, agricultural, and cosmetic properties, were also highly reconstructed in the assembled scaffolds. Based on these findings, we concluded that de novo genome sequencing using only SOLiD short reads is feasible and practical for molecular biological study of fungi. We also investigated the effect of filtering low quality data, library insert size, and k-mer size on the assembly performance, and recommend for the assembly use of mild filtered read data where the N50 was not so degraded and the library has an insert size of similar to 2.0 kb, and k-mer size 33.	[Umemura, Myco; Machida, Masayuki] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Sapporo, Hokkaido, Japan; [Koyama, Yoshinori; Takeda, Itaru; Hagiwara, Hiroko; Koike, Hideaki] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba, Ibaraki, Japan; [Takeda, Itaru; Machida, Masayuki] Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, Koganei, Tokyo, Japan; [Ikegami, Tsutomu] Natl Inst Adv Ind Sci & Technol, Informat Technol Res Inst, Tsukuba, Ibaraki, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); Tokyo University of Agriculture & Technology; National Institute of Advanced Industrial Science & Technology (AIST)	Koike, H (corresponding author), Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba, Ibaraki, Japan.	hi-koike@aist.go.jp	IKEGAMI, TSUTOMU/N-3452-2016; Umemura, Maiko/M-4092-2018	IKEGAMI, TSUTOMU/0000-0003-2977-6390; Umemura, Maiko/0000-0001-8730-1380				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Brown DW, 1996, P NATL ACAD SCI USA, V93, P1418, DOI 10.1073/pnas.93.4.1418; Cane DE, 1999, CHEM BIOL, V6, pR319, DOI 10.1016/S1074-5521(00)80001-0; Cerdeira LT, 2011, J MICROBIOL METH, V86, P218, DOI 10.1016/j.mimet.2011.05.008; Cunningham C, 2010, J GEN VIROL, V91, P605, DOI 10.1099/vir.0.015891-0; den Bakker HC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-688; DiGuistini S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r94; Earl D, 2011, GENOME RES, V21, P2224, DOI 10.1101/gr.126599.111; Farrer RA, 2009, FEMS MICROBIOL LETT, V291, P103, DOI 10.1111/j.1574-6968.2008.01441.x; Frith MC, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq010; Frith MC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-80; Georgianna DR, 2010, MOL PLANT PATHOL, V11, P213, DOI 10.1111/j.1364-3703.2009.00594.x; Georgianna DR, 2009, FUNGAL GENET BIOL, V46, P113, DOI 10.1016/j.fgb.2008.10.011; Ghosh W, 2011, J BACTERIOL, V193, P5553, DOI 10.1128/JB.05781-11; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Haridas S, 2011, J MICROBIOL METH, V86, P368, DOI 10.1016/j.mimet.2011.06.019; Kielbasa SM, 2011, GENOME RES, V21, P487, DOI 10.1101/gr.113985.110; Kiyota T, 2011, J BIOSCI BIOENG, V111, P512, DOI 10.1016/j.jbiosc.2010.12.022; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Kusumoto K, 2000, CURR GENET, V37, P104, DOI 10.1007/s002940050016; Lee SW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-197; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Lin Y, 2011, BIOINFORMATICS, V27, P2031, DOI 10.1093/bioinformatics/btr319; MacCallum I, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r103; Machida M, 2005, NATURE, V438, P1157, DOI 10.1038/nature04300; Marroni F, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00133; Nowrousian M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000891; Palmer JM, 2010, CURR OPIN MICROBIOL, V13, P431, DOI 10.1016/j.mib.2010.04.008; Chaparro PJP, 2011, J MICROBIOL METH, V87, P208, DOI 10.1016/j.mimet.2011.08.003; Rumble SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000386; Sanchez JF, 2012, NAT PROD REP, V29, P351, DOI 10.1039/c2np00084a; Schwarzer D, 2003, NAT PROD REP, V20, P275, DOI 10.1039/b111145k; Silva A, 2011, J BACTERIOL, V193, P323, DOI 10.1128/JB.01211-10; Spanu PD, 2010, SCIENCE, V330, P1543, DOI 10.1126/science.1194573; States D J, 1994, J Comput Biol, V1, P39; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Terabayashi Y, 2010, FUNGAL GENET BIOL, V47, P953, DOI 10.1016/j.fgb.2010.08.014; Tominaga M, 2006, APPL ENVIRON MICROB, V72, P484, DOI 10.1128/AEM.72.1.484-490.2006; Umemura M, 2012, DNA RES, V19, P375, DOI 10.1093/dnares/dss019; Watson AJ, 1999, APPL ENVIRON MICROB, V65, P307; Yin WB, 2011, J MICROBIOL, V49, P329, DOI 10.1007/s12275-011-1009-1; Yu JJ, 2004, APPL ENVIRON MICROB, V70, P1253, DOI 10.1128/AEM.70.3.1253-1262.2004; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	43	14	14	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63673	10.1371/journal.pone.0063673	http://dx.doi.org/10.1371/journal.pone.0063673			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667655	Green Published, gold, Green Submitted			2022-12-25	WOS:000319654700175
J	Wang, JN; Fulford, T; Shao, Q; Javelle, A; Yang, HY; Zhu, WL; Merrick, M				Wang, Jinan; Fulford, Tim; Shao, Qiang; Javelle, Arnaud; Yang, Huaiyu; Zhu, Weiliang; Merrick, Mike			Ammonium Transport Proteins with Changes in One of the Conserved Pore Histidines Have Different Performance in Ammonia and Methylamine Conduction	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; AMTB-GLNK COMPLEX; ESCHERICHIA-COLI; CHANNEL AMTB; NITROSOMONAS-EUROPAEA; FUNCTIONAL-CHARACTERIZATION; CORYNEBACTERIUM-GLUTAMICUM; SACCHAROMYCES-CEREVISIAE; DEPROTONATION MECHANISM; CRYSTAL-STRUCTURE	Two conserved histidine residues are located near the mid-point of the conduction channel of ammonium transport proteins. The role of these histidines in ammonia and methylamine transport was evaluated by using a combination of in vivo studies, molecular dynamics (MD) simulation, and potential of mean force (PMF) calculations. Our in vivo results showed that a single change of either of the conserved histidines to alanine leads to the failure to transport methylamine but still facilitates good growth on ammonia, whereas double histidine variants completely lose their ability to transport both methylamine and ammonia. Molecular dynamics simulations indicated the molecular basis of the in vivo observations. They clearly showed that a single histidine variant (H168A or H318A) of AmtB confines the rather hydrophobic methylamine more strongly than ammonia around the mutated sites, resulting in dysfunction in conducting the former but not the latter molecule. PMF calculations further revealed that the single histidine variants form a potential energy well of up to 6 kcal/mol for methylamine, impairing conduction of this substrate. Unlike the single histidine variants, the double histidine variant, H168A/H318A, of AmtB was found to lose its unidirectional property of transporting both ammonia and methylamine. This could be attributed to a greatly increased frequency of opening of the entrance gate formed by F215 and F107, in this variant compared to wild-type, with a resultant lowering of the energy barrier for substrate to return to the periplasm.	[Wang, Jinan; Shao, Qiang; Yang, Huaiyu; Zhu, Weiliang] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Drug Discovery & Design Ctr, Shanghai 200031, Peoples R China; [Fulford, Tim; Javelle, Arnaud; Merrick, Mike] John Innes Ctr, Dept Mol Microbiol, Norwich, Norfolk, England	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Zhu, WL (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Drug Discovery & Design Ctr, Shanghai 200031, Peoples R China.	wlzhu@mail.shcnc.ac.cn; mike.merrick@jic.ac.uk	Shao, Qiang/O-4528-2019	Shao, Qiang/0000-0001-6460-3095	Biotechnology and Biological Sciences Research Council - BBSRC; BBSRC Committee Studentship; Ministry of Science and Technology [2010DFB73280, 2012AA01A305, 2012CB910403]; National Natural Science Foundation [21021063]; Computer Network Information Center (CNIC); Chinese Academy of Sciences (CAS); Shanghai Supercomputing Center (SCC)	Biotechnology and Biological Sciences Research Council - BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC Committee Studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Computer Network Information Center (CNIC); Chinese Academy of Sciences (CAS)(Chinese Academy of Sciences); Shanghai Supercomputing Center (SCC)	This research was supported by the Biotechnology and Biological Sciences Research Council - BBSRC (M.M. and A.J.), a BBSRC Committee Studentship (T.F.)(http://www.jic.ac.uk), the Ministry of Science and Technology (2010DFB73280, 2012AA01A305 & 2012CB910403, W.Z.) (http://www.most.gov.cn), and National Natural Science Foundation (21021063, W.Z.)(http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Computation resources were supported by Computer Network Information Center (CNIC), Chinese Academy of Sciences (CAS) and Shanghai Supercomputing Center (SCC).	Akgun U, 2011, P NATL ACAD SCI USA, V108, P3970, DOI 10.1073/pnas.1007240108; Andrade SLA, 2005, P NATL ACAD SCI USA, V102, P14994, DOI 10.1073/pnas.0506254102; BENNAIM A, 1984, J CHEM PHYS, V81, P2016, DOI 10.1063/1.447824; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bjelkmar P, 2010, J CHEM THEORY COMPUT, V6, P459, DOI 10.1021/ct900549r; Boeckstaens M, 2008, J BIOL CHEM, V283, P21362, DOI 10.1074/jbc.M801467200; Bostick DL, 2007, PLOS COMPUT BIOL, V3, P231, DOI 10.1371/journal.pcbi.0030022; Bostick DL, 2007, BIOPHYS J, V92, pL103, DOI 10.1529/biophysj.107.109165; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cao Z, 2007, ANGEW CHEM INT EDIT, V46, P6811, DOI 10.1002/anie.200701348; Cherif-Zahar B, 2007, J BACTERIOL, V189, P9090, DOI 10.1128/JB.01089-07; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Fong RN, 2007, P NATL ACAD SCI USA, V104, P18706, DOI 10.1073/pnas.0709267104; Gruswitz F, 2007, P NATL ACAD SCI USA, V104, P42, DOI 10.1073/pnas.0609796104; Gruswitz F, 2010, P NATL ACAD SCI USA, V107, P9638, DOI 10.1073/pnas.1003587107; Hall JA, 2011, P NATL ACAD SCI USA, V108, P13270, DOI 10.1073/pnas.1108451108; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hub JS, 2010, J CHEM THEORY COMPUT, V6, P3713, DOI 10.1021/ct100494z; Hub JS, 2010, J AM CHEM SOC, V132, P13251, DOI 10.1021/ja102133x; Ishikita H, 2007, J AM CHEM SOC, V129, P1210, DOI 10.1021/ja066208n; Javelle A, 2005, BIOCHEM J, V390, P215, DOI 10.1042/BJ20042094; Javelle A, 2004, J BIOL CHEM, V279, P8530, DOI 10.1074/jbc.M312399200; Javelle A, 2008, P NATL ACAD SCI USA, V105, P5040, DOI 10.1073/pnas.0711742105; Javelle A, 2007, J STRUCT BIOL, V158, P472, DOI 10.1016/j.jsb.2007.01.004; Javelle A, 2006, J BIOL CHEM, V281, P39492, DOI 10.1074/jbc.M608325200; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; KLEINER D, 1985, FEMS MICROBIOL LETT, V32, P87, DOI 10.1016/0378-1097(85)90059-X; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Lamoureux G, 2010, TRANSFUS CLIN BIOL, V17, P168, DOI 10.1016/j.tracli.2010.06.004; Lamoureux G, 2007, BIOPHYS J, V92, pL82, DOI 10.1529/biophysj.106.102756; Le Van Kim C, 2006, BLOOD REV, V20, P93, DOI 10.1016/j.blre.2005.04.002; Li X, 2007, P NATL ACAD SCI USA, V104, P19279, DOI 10.1073/pnas.0709710104; Lin YC, 2009, J PHYS CHEM B, V113, P4922, DOI 10.1021/jp810651m; Lin YC, 2006, J AM CHEM SOC, V128, P10876, DOI 10.1021/ja0631549; Liu YM, 2006, J PHYS CHEM A, V110, P1375, DOI 10.1021/jp054261c; Ludewig U, 2006, TRANSFUS CLIN BIOL, V13, P111, DOI 10.1016/j.tracli.2006.02.012; Ludewig U, 2003, J BIOL CHEM, V278, P45603, DOI 10.1074/jbc.M307424200; Lupo D, 2007, P NATL ACAD SCI USA, V104, P19303, DOI 10.1073/pnas.0706563104; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Marini AM, 2000, NAT GENET, V26, P341, DOI 10.1038/81656; Marini AM, 1997, MOL CELL BIOL, V17, P4282, DOI 10.1128/MCB.17.8.4282; Mayer M, 2006, PLANT BIOLOGY, V8, P522, DOI 10.1055/s-2006-923877; Mayer M, 2006, J GEN PHYSIOL, V127, P133, DOI 10.1085/jgp.200509369; Meier-Wagner J, 2001, MICROBIOL-UK, V147, P135, DOI 10.1099/00221287-147-1-135; MERRICK MJ, 1995, MICROBIOL REV, V59, P604, DOI 10.1128/MMBR.59.4.604-622.1995; NINNEMANN O, 1994, EMBO J, V13, P3464, DOI 10.1002/j.1460-2075.1994.tb06652.x; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; Nygaard TP, 2006, BIOPHYS J, V91, P4401, DOI 10.1529/biophysj.106.089714; Nygaard TP, 2010, J PHYS CHEM B, V114, P11859, DOI 10.1021/jp102338h; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Planelles G, 2007, NEPHRON PHYSIOL, V105, P11, DOI 10.1159/000096979; RENTSCH D, 1995, FEBS LETT, V370, P264, DOI 10.1016/0014-5793(95)00853-2; Rutherford JC, 2008, MOL BIOL CELL, V19, P3028, DOI 10.1091/mbc.E08-01-0033; Siewe RM, 1996, J BIOL CHEM, V271, P5398, DOI 10.1074/jbc.271.10.5398; Sohlenkamp C, 2002, PLANT PHYSIOL, V130, P1788, DOI 10.1104/pp.008599; Soupene E, 1998, P NATL ACAD SCI USA, V95, P7030, DOI 10.1073/pnas.95.12.7030; Soupene E, 2002, J BACTERIOL, V184, P3396, DOI 10.1128/JB.184.12.3396-3400.2002; Soupene E, 2002, P NATL ACAD SCI USA, V99, P3926, DOI 10.1073/pnas.062043799; Thomas G, 2000, TRENDS GENET, V16, P11, DOI 10.1016/S0168-9525(99)01887-9; Tremblay PL, 2008, J BACTERIOL, V190, P1588, DOI 10.1128/JB.01643-07; von Wiren N, 2000, CURR OPIN PLANT BIOL, V3, P254, DOI 10.1016/S1369-5266(00)00073-X; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang JN, 2010, J PHYS CHEM B, V114, P15172, DOI 10.1021/jp104508k; Wang SH, 2012, J AM CHEM SOC, V134, P10419, DOI 10.1021/ja300129x; Yang HY, 2007, BIOPHYS J, V92, P877, DOI 10.1529/biophysj.106.090191; Zheng L, 2004, P NATL ACAD SCI USA, V101, P17090, DOI 10.1073/pnas.0406475101; Zoete V, 2011, J COMPUT CHEM, V32, P2359, DOI 10.1002/jcc.21816	70	17	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62745	10.1371/journal.pone.0062745	http://dx.doi.org/10.1371/journal.pone.0062745			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667517	Green Accepted, Green Published, gold			2022-12-25	WOS:000319654700061
J	White, AM; Zipkin, EF; Manley, PN; Schlesinger, MD				White, Angela M.; Zipkin, Elise F.; Manley, Patricia N.; Schlesinger, Matthew D.			Conservation of Avian Diversity in the Sierra Nevada: Moving beyond a Single-Species Management Focus	PLOS ONE			English	Article							RESTORATION TREATMENTS; BIRD COMMUNITIES; FOREST STRUCTURE; FIRE SEVERITY; BIODIVERSITY; RICHNESS; IMPACTS; DISTURBANCE; CALIFORNIA; MODELS	Background: As a result of past practices, many of the dry coniferous forests of the western United States contain dense, even-aged stands with uncharacteristically high levels of litter and downed woody debris. These changes to the forest have received considerable attention as they elevate concerns regarding the outcome of wildland fire. However, attempts to reduce biomass through fuel reduction (i.e., thinning of trees) are often opposed by public interest groups whose objectives include maintaining habitat for species of concern such as the spotted owl, Strix occidentalis, the northern goshawk, Accipiter gentilis, and the Pacific fisher, Martes pennanti. Whether protection of these upper-trophic level species confers adequate conservation of avian forest diversity is unknown. Methodology and Principal Findings: We use a multi-species occurrence model to estimate the habitat associations of 47 avian species detected at 742 sampling locations within an 880-km(2) area in the Sierra Nevada. Our approach, which accounts for variations in detectability of species, estimates occurrence probabilities of all species in a community by linking species occurrence models into one hierarchical community model, thus improving inferences on all species, especially those that are rare or observed infrequently. We address how the avian community is influenced by covariates related to canopy cover, tree size and shrub cover while accounting for the impacts of abiotic variables known to affect species distributions. Conclusions and Significance: Environmental parameters estimated through our approach emphasize the importance of within and between stand-level heterogeneity in meeting biodiversity objectives and suggests that many avian species would increase under more open canopy habitat conditions than those favored by umbrella species of high conservation concern. Our results suggest that a more integrated approach that emphasizes maintaining a diversity of habitats across environmental gradients and minimizing urbanization may have a greater benefit to ecosystem functioning then a single-species management focus.	[White, Angela M.; Schlesinger, Matthew D.] US Forest Serv, Conservat Biodivers Grp, Pacific Southwest Res Stn, USDA, Davis, CA USA; [Zipkin, Elise F.] USGS Patuxent Wildlife Res Ctr, Laurel, MD USA; [Zipkin, Elise F.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Manley, Patricia N.] US Forest Serv, Conservat Biodivers Grp, Pacific Southwest Res Stn, USDA, Hilo, HI USA; [Schlesinger, Matthew D.] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA; [Schlesinger, Matthew D.] Univ Calif Davis, Grad Grp Ecol, Davis, CA 95616 USA; [Schlesinger, Matthew D.] New York Nat Heritage Program, Albany, NY USA	United States Department of Agriculture (USDA); United States Forest Service; United States Department of the Interior; United States Geological Survey; University System of Maryland; University of Maryland College Park; United States Department of Agriculture (USDA); United States Forest Service; University of California System; University of California Davis; University of California System; University of California Davis	White, AM (corresponding author), US Forest Serv, Conservat Biodivers Grp, Pacific Southwest Res Stn, USDA, Davis, CA USA.	angelawhite@fs.fed.us	White, Angela M/N-7088-2013; White, Angela/I-6436-2019	White, Angela M/0000-0001-7499-7390; White, Angela/0000-0001-7499-7390; Zipkin, Elise/0000-0003-4155-6139	U.S. Forest Service Lake Tahoe Basin Management Unit; U.S. Forest Service Pacific Southwest Research Station; Sierra Nevada Public Lands Management Act	U.S. Forest Service Lake Tahoe Basin Management Unit(United States Department of Agriculture (USDA)United States Forest Service); U.S. Forest Service Pacific Southwest Research Station(United States Department of Agriculture (USDA)United States Forest Service); Sierra Nevada Public Lands Management Act	Funding was provided by U.S. Forest Service Lake Tahoe Basin Management Unit, U.S. Forest Service Pacific Southwest Research Station, and the Sierra Nevada Public Lands Management Act. The funders had no rule in study design, data collection and analysis decision to publish, or preparation of the manuscript.	Aerts Raf, 2011, BMC Ecology, V11, P29, DOI 10.1186/1472-6785-11-29; Agee JK, 2005, FOREST ECOL MANAG, V211, P83, DOI 10.1016/j.foreco.2005.01.034; Anderson MK, 2005, TENDING THE WILD: NATIVE AMERICAN KNOWLEDGE AND THE MANAGEMENT OF CALIFORNIA'S NATURAL RESOURCES, P1; [Anonymous], 2013, THE FUTURE OF NATURE, DOI DOI 10.12987/9780300188479-039; Barbour M, 2002, J VEG SCI, V13, P461, DOI 10.1111/j.1654-1103.2002.tb02073.x; Beaty RM, 2007, J VEG SCI, V18, P879, DOI 10.1111/j.1654-1103.2007.tb02604.x; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Buckland ST, 2006, AUK, V123, P345, DOI 10.1642/0004-8038(2006)123[345:PSFSRM]2.0.CO;2; Caro T. M, 2010, CONSERVATION PROXY I; CDFG (California Department of Fish and Game), 2000, CAL WILDL HAB REL PR; Collins BM, 2010, J FOREST, V108, P24; Daly C, 2002, CLIM RES, V22, P99, DOI 10.3354/cr022099; Dobrowski SZ, 2006, ECOL MODEL, V192, P126, DOI 10.1016/j.ecolmodel.2005.09.006; Dorazio RM, 2006, ECOLOGY, V87, P842, DOI 10.1890/0012-9658(2006)87[842:ESRAAB]2.0.CO;2; Dorazio RM, 2005, J AM STAT ASSOC, V100, P389, DOI 10.1198/016214505000000015; Ehrlich A.H., 1981, EXTINCTION; ERDELEN M, 1984, OECOLOGIA, V61, P277, DOI 10.1007/BF00396773; Ferraro PJ, 2006, PLOS BIOL, V4, P482, DOI 10.1371/journal.pbio.0040105; Fischer J, 2004, J APPL ECOL, V41, P32, DOI 10.1111/j.1365-2664.2004.00869.x; Folke C, 1996, ECOL APPL, V6, P1018, DOI 10.2307/2269584; Gelman A., 2007, DATA ANAL USING REGR; Gill F. B., 1995, ORNITHOLOGY; Gutierrez R.J., 1996, Studies in Avian Biology, V17, P2; Hessburg PF, 2005, FOREST ECOL MANAG, V211, P117, DOI 10.1016/j.foreco.2005.02.016; Hessburg PF, 2003, FOREST ECOL MANAG, V178, P23, DOI 10.1016/S0378-1127(03)00052-5; Hirt PW., 1996, CONSPIRACY OPTIMISM; Huntzinger M, 2003, BIOL CONSERV, V113, P1, DOI 10.1016/S0006-3207(02)00356-7; Johnson DH, 2008, J WILDLIFE MANAGE, V72, P857, DOI 10.2193/2007-294; Kalies EL, 2010, FOREST ECOL MANAG, V259, P333, DOI 10.1016/j.foreco.2009.10.024; Keeley JE, 2003, ECOL APPL, V13, P1355, DOI 10.1890/02-5002; Kery M., 2010, INTRO WINBUGS ECOLOG; Kie JG, 1996, J RANGE MANAGE, V49, P482, DOI 10.2307/4002286; Kittel Timothy G. F., 1998, Madrono, V45, P75; LANDRES PB, 1988, CONSERV BIOL, V2, P316, DOI 10.1111/j.1523-1739.1988.tb00195.x; Lindenmayer D, 2008, ECOL LETT, V11, P78, DOI 10.1111/j.1461-0248.2007.01114.x; Lindenmayer DB, 2002, CONSERV BIOL, V16, P338, DOI 10.1046/j.1523-1739.2002.00450.x; LINDSTROM S, 2000, LAKE TAHOE WATERSHED; Long JN, 2000, J FOREST, V98, P25; Lydersen J, 2012, ECOSYSTEMS, P1; Mac Nally R, 2002, ECOL APPL, V12, P900, DOI 10.1890/1051-0761(2002)012[0900:HWDEBP]2.0.CO;2; MacKenzie DI, 2002, ECOLOGY, V83, P3532; Manley PN, 2009, LANDSCAPE URBAN PLAN, V89, P28, DOI 10.1016/j.landurbplan.2008.09.005; Manley PN, 2005, J WILDLIFE MANAGE, V69, P950, DOI 10.2193/0022-541X(2005)069[0950:AFEOAP]2.0.CO;2; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Matlock RB, 2006, BIODIVERS CONSERV, V15, P2987, DOI 10.1007/s10531-005-4873-3; Mayer K.E., 1988, GUIDE WILDLIFE HABIT; McKelvey KS, 1996, 37 U CAL WILDL RES C, V37, P1033; Miller JD, 2009, ECOSYSTEMS, V12, P16, DOI 10.1007/s10021-008-9201-9; Naeem S., 2009, BIODIVERSITY ECOSYST; Noon BR, 2009, MODELS FOR PLANNING WILDLIFE CONSERVATION IN LARGE LANDSCAPES, P51, DOI 10.1016/B978-0-12-373631-4.00003-4; Noon BR, 1996, ANNU REV ECOL SYST, V27, P135, DOI 10.1146/annurev.ecolsys.27.1.135; North M, 2005, PLANT ECOL, V177, P13, DOI 10.1007/s11258-005-2270-3; North M, 2009, GEN TECHNICAL REPORT; North M., 2012, PSWGTR237 USDA FOR S; North M, 2007, CAN J FOREST RES, V37, P331, DOI 10.1139/X06-236; Ozaki K, 2006, CONSERV BIOL, V20, P1507, DOI 10.1111/j.1523-1739.2006.00444.x; Pulliam HR, 2000, ECOL LETT, V3, P349, DOI 10.1046/j.1461-0248.2000.00143.x; Purcell Kathryn L., 2005, Studies in Avian Biology, V30, P33; Purcell KL, 2009, FOREST ECOL MANAG, V258, P2696, DOI 10.1016/j.foreco.2009.09.041; Ralph CJ, 1993, HDB FIELD METHODS MO; Roberge JM, 2004, CONSERV BIOL, V18, P76, DOI 10.1111/j.1523-1739.2004.00450.x; Russell RE, 2009, ECOL APPL, V19, P1253, DOI 10.1890/08-0910.1; Schlesinger MD, 2008, ECOLOGY, V89, P2302, DOI 10.1890/07-0256.1; Schluter D., 1993, SPECIES DIVERSITY EC; Sergio F, 2008, ANNU REV ECOL EVOL S, V39, P1, DOI 10.1146/annurev.ecolsys.39.110707.173545; Shrader-Frechette KS, 1993, METHOD ECOLOGY STRAT; Siegel RB, 2010, BIRD MONITORING PROT; Skinner CN, 1996, SIERRA NEVADA ECOSYS, V2, P1041; Stephens SL, 2012, BIOSCIENCE, V62, P549, DOI 10.1525/bio.2012.62.6.6; Stephens SL, 2009, ECOL APPL, V19, P305, DOI 10.1890/07-1755.1; Stephens Scott L., 2000, Madrono, V47, P43; Stephens SL, 2005, FOREST ECOL MANAG, V215, P21, DOI 10.1016/j.foreco.2005.03.070; Stephens SL, 2005, ECOL APPL, V15, P532, DOI 10.1890/04-0545; Taki H, 2010, FOREST ECOL MANAG, V259, P607, DOI 10.1016/j.foreco.2009.11.019; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; USDA, 2004, SIERR NEV FOR PLAN A; Verschuyl JP, 2008, ECOL APPL, V18, P1155, DOI 10.1890/07-0839.1; Waltz AEM, 2004, RESTOR ECOL, V12, P85, DOI 10.1111/j.1061-2971.2004.00262.x; Yi H, 2005, ENVIRON ENTOMOL, V34, P1071, DOI 10.1603/0046-225X(2005)034[1071:ROGATD]2.0.CO;2; Zielinski WJ, 2004, J WILDLIFE MANAGE, V68, P475, DOI 10.2193/0022-541X(2004)068[0475:RHSBFI]2.0.CO;2; Zipkin EF, 2012, ECOL APPL, V22, P1962, DOI 10.1890/11-1936.1; Zipkin EF, 2010, BIOL CONSERV, V143, P479, DOI 10.1016/j.biocon.2009.11.016; Zipkin EF, 2009, J APPL ECOL, V46, P815, DOI 10.1111/j.1365-2664.2009.01664.x	84	29	31	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63088	10.1371/journal.pone.0063088	http://dx.doi.org/10.1371/journal.pone.0063088			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667579	Green Published, gold			2022-12-25	WOS:000319654700111
J	Xue, L; Cohnstaedt, LW; Scott, HM; Scoglio, C				Xue, Ling; Cohnstaedt, Lee W.; Scott, H. Morgan; Scoglio, Caterina			A Hierarchical Network Approach for Modeling Rift Valley Fever Epidemics with Applications in North America	PLOS ONE			English	Article							AEDES-AEGYPTI DIPTERA; MOSQUITOS DIPTERA; CULICIDAE; TRANSMISSION; DISEASE; VIRUS; SURVIVAL; CLIMATE; AFRICA; SPREAD	Rift Valley fever is a vector-borne zoonotic disease which causes high morbidity and mortality in livestock. In the event Rift Valley fever virus is introduced to the United States or other non-endemic areas, understanding the potential patterns of spread and the areas at risk based on disease vectors and hosts will be vital for developing mitigation strategies. Presented here is a general network-based mathematical model of Rift Valley fever. Given a lack of empirical data on disease vector species and their vector competence, this discrete time epidemic model uses stochastic parameters following several PERT distributions to model the dynamic interactions between hosts and likely North American mosquito vectors in dispersed geographic areas. Spatial effects and climate factors are also addressed in the model. The model is applied to a large directed asymmetric network of 3,621 nodes based on actual farms to examine a hypothetical introduction to some counties of Texas, an important ranching area in the United States of America. The nodes of the networks represent livestock farms, livestock markets, and feedlots, and the links represent cattle movements and mosquito diffusion between different nodes. Cattle and mosquito (Aedes and Culex) populations are treated with different contact networks to assess virus propagation. Rift Valley fever virus spread is assessed under various initial infection conditions (infected mosquito eggs, adults or cattle). A surprising trend is fewer initial infectious organisms result in a longer delay before a larger and more prolonged outbreak. The delay is likely caused by a lack of herd immunity while the infection expands geographically before becoming an epidemic involving many dispersed farms and animals almost simultaneously. Cattle movement between farms is a large driver of virus expansion, thus quarantines can be efficient mitigation strategy to prevent further geographic spread.	[Xue, Ling; Scoglio, Caterina] Kansas State Univ, Dept Elect & Comp Engn, Kansas State Epictr, Manhattan, KS 66506 USA; [Cohnstaedt, Lee W.] USDA, Ctr Grain & Anim Hlth Res, Manhattan, KS USA; [Scott, H. Morgan] Kansas State Univ, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA	Kansas State University; United States Department of Agriculture (USDA); Kansas State University	Cohnstaedt, LW (corresponding author), USDA, Ctr Grain & Anim Hlth Res, Manhattan, KS USA.	lee.cohnstaedt@ars.usda.gov		Scoglio, Caterina/0000-0003-4486-9229; Scott, Harvey/0000-0002-0538-5961	U.S. Department of Homeland Security [2010-ST061-AG0001]; Kansas Biosciences Authority	U.S. Department of Homeland Security(United States Department of Homeland Security (DHS)); Kansas Biosciences Authority	This material is based upon work supported by the U.S. Department of Homeland Security under Grant Award Number 2010-ST061-AG0001 and a grant through the Kansas Biosciences Authority. The views and conclusions contained in this publication are those of the authors and should not be interpreted as necessarily representing the official policies, either explicit or implicit, of the U.S. Department of Homeland Security and Kansas Biosciences Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo-Salem S, 2011, TROP ANIM HEALTH PRO, V43, P471, DOI 10.1007/s11250-010-9719-7; Arino J, 2007, MATH BIOSCI, V206, P46, DOI 10.1016/j.mbs.2005.09.002; Bajardi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019869; Bates M., 1949, NATURAL HIST MOSQUIT; Brauer F, 2010, MATH BIOSCI ENG, V7, P1, DOI 10.3934/mbe.2010.7.1; Canyon DV, 1999, B ENTOMOL RES, V89, P35, DOI 10.1017/S000748539900005X; Chevalier V, 2010, EUROSURVEILLANCE, V15, P18; Daubney R, 1931, J PATHOL BACTERIOL, V34, P545, DOI 10.1002/path.1700340418; Davies FG, 2006, REV SCI TECH OIE, V25, P137, DOI 10.20506/rst.25.1.1648; Dominguez BJ, 2007, THESIS TEXAS A M U U; *EFSA, 2005, OP SCI PAN AN HLTH W; Erasmus B. J., 1981, Rift Valley fever. Proceedings of a workshop, Herzlia, Israel, 18th-21st March 1980., P77; Favier C, 2006, TROP MED INT HEALTH, V11, P1878, DOI 10.1111/j.1365-3156.2006.01746.x; FREIER JE, 1987, AM J TROP MED HYG, V37, P640, DOI 10.4269/ajtmh.1987.37.640; Gaff H, 2007, ELECTRON J DIFFER EQ, V115, P1, DOI DOI 10.1155/2012/138757; Gao DZ, 2013, B MATH BIOL, V75, P523, DOI 10.1007/s11538-013-9818-5; Gong HF, 2011, INT J BIOMETEOROL, V55, P435, DOI 10.1007/s00484-010-0354-9; HAYES RO, 1973, AM J TROP MED HYG, V22, P270, DOI 10.4269/ajtmh.1973.22.270; JONES CJ, 1985, J AM MOSQUITO CONTR, V1, P530; JOUAN A, 1988, ANN INST PASTEUR VIR, V139, P307, DOI 10.1016/S0769-2617(88)80046-7; Katriel G, 2013, INT J BIOMATH, V6, DOI 10.1142/S1793524512500660; Keeling MJ., 2008, MODELING INFECT DIS, DOI [DOI 10.1515/9781400841035, 10.1515/9781400841035]; Kilpatrick AM, 2011, SCIENCE, V334, P323, DOI 10.1126/science.1201010; LINACRE ET, 1977, AGR METEOROL, V18, P409, DOI 10.1016/0002-1571(77)90007-3; LINTHICUM KJ, 1985, J HYG-CAMBRIDGE, V95, P197, DOI 10.1017/S0022172400062434; Linthicum KJ, 1999, SCIENCE, V285, P397, DOI 10.1126/science.285.5426.397; LONGINI IM, 1986, MATH BIOSCI, V82, P19, DOI 10.1016/0025-5564(86)90003-9; Luz PM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000761; Ma S., 2009, MATH UNDERSTANDING I; MAGNARELLI LA, 1977, AM J TROP MED HYG, V26, P547, DOI 10.4269/ajtmh.1977.26.547; Manore C, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-55; Martin V, 2008, REV SCI TECH OIE, V27, P413, DOI 10.20506/rst.27.2.1802; Metras R, 2011, VECTOR-BORNE ZOONOT, V11, P761, DOI 10.1089/vbz.2010.0200; Moore C. G., 1993, GUIDELINES ARBOVIRUS; Mpeshe SC, 2011, ACTA BIOTHEOR, V59, P231, DOI 10.1007/s10441-011-9132-2; National Climatic Center, NOAA SAT INF SERV; National Institute for Communicable Diseases, 2012, INT REP RIFT VALL FE; Niu TC, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/138757; Otero M, 2010, MATH BIOSCI, V223, P32, DOI 10.1016/j.mbs.2009.10.005; Peters C. J., 1994, HDB ZOONOSES B, P125; Pratt H.D., 1993, VECTOR BORNE DIS CON; Radostits OM, 2001, HERD HLTH FOOD ANIMA; Riley S, 2010, P NATL ACAD SCI USA, V107, P957, DOI 10.1073/pnas.0913286107; Ross R, 1916, P R SOC LOND A-CONTA, V92, P204, DOI 10.1098/rspa.1916.0007; RUEDA LM, 1990, J MED ENTOMOL, V27, P892, DOI 10.1093/jmedent/27.5.892; SELLERS RF, 1982, VET REC, V110, P73, DOI 10.1136/vr.110.4.73; Sissoko D, 2009, EMERG INFECT DIS, V15, P568, DOI 10.3201/eid1504.081045; Turell MJ, 2010, J MED ENTOMOL, V47, P884, DOI 10.1603/ME10007; TURELL MJ, 1988, J MED ENTOMOL, V25, P262, DOI 10.1093/jmedent/25.4.262; Turell MJ, 1998, J MED ENTOMOL, V35, P132, DOI 10.1093/jmedent/35.2.132; TURELL MJ, 1987, J MED ENTOMOL, V24, P11, DOI 10.1093/jmedent/24.1.11; United States Department of Agriculture, 2007, 2007 CENS PUBL; Wekesa JW, 1997, J MED ENTOMOL, V34, P219, DOI 10.1093/jmedent/34.2.219; Wonham MJ, 2006, ECOL LETT, V9, P706, DOI 10.1111/j.1461-0248.2006.00912.x; World Health Organization, RIFT VALL FEV SUD UP; Xue L, 2012, J THEOR BIOL, V306, P129, DOI 10.1016/j.jtbi.2012.04.029; Zeller HG, 1997, AM J TROP MED HYG, V56, P265, DOI 10.4269/ajtmh.1997.56.265	57	14	14	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62049	10.1371/journal.pone.0062049	http://dx.doi.org/10.1371/journal.pone.0062049			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667453	gold, Green Published, Green Submitted			2022-12-25	WOS:000319654700022
J	Zheng, CX; Chen, LJ; Chen, XP; He, XB; Yang, JW; Shi, Y; Zhou, NM				Zheng, Congxia; Chen, Linjie; Chen, Xiaopan; He, Xiaobai; Yang, Jingwen; Shi, Ying; Zhou, Naiming			The Second Intracellular Loop of the Human Cannabinoid CB2 Receptor Governs G Protein Coupling in Coordination with the Carboxyl Terminal Domain	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; AMINO-ACID; FUNCTIONAL EXPRESSION; SIGNAL-TRANSDUCTION; PROSTAGLANDIN EP2; KEY ROLE; ACTIVATION; CELLS; PHARMACOLOGY; STIMULATION	The major effects of cannabinoids and endocannabinoids are mediated via two G protein-coupled receptors, CB1 and CB2, elucidation of the mechanism and structural determinants of the CB2 receptor coupling with G proteins will have a significant impact on drug discovery. In the present study, we systematically investigated the role of the intracellular loops in the interaction of the CB2 receptor with G proteins using chimeric receptors alongside the characterization of cAMP accumulation and ERK1/2 phosphorylation. We provided evidence that ICL2 was significantly involved in G protein coupling in coordination with the C-terminal end. Moreover, a single alanine substitution of the Pro-139 in the CB2 receptor that corresponds to Leu-222 in the CB1 receptor resulted in a moderate impairment in the inhibition of cAMP accumulation, whereas mutants P139F, P139M and P139L were able to couple to the G(s) protein in a CRE-driven luciferase assay. With the ERK activation experiments, we further found that P139L has the ability to activate ERK through both G(i)- and G(s)-mediated pathways. Our findings defined an essential role of the second intracellular loop of the CB2 receptor in coordination with the C-terminal tail in G protein coupling and receptor activation.	[Zheng, Congxia; Chen, Linjie; Chen, Xiaopan; He, Xiaobai; Shi, Ying; Zhou, Naiming] Zhejiang Univ, Coll Life Sci, Inst Biochem, Hangzhou 310003, Zhejiang, Peoples R China; [Yang, Jingwen] Zhejiang Univ, Coll Anim Sci, Inst Sericulture & Apiculture, Hangzhou 310003, Zhejiang, Peoples R China; [Zheng, Congxia] Zhejiang Int Studies Univ, Sch Art, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang International Studies University	Zhou, NM (corresponding author), Zhejiang Univ, Coll Life Sci, Inst Biochem, Hangzhou 310003, Zhejiang, Peoples R China.	znm2000@yahoo.com	Zhou, Naiming/AHC-1121-2022	Chen, Xiaopan/0000-0003-4289-7541	Ministry of Science and Technology [2012CB910402, 2012AA020303-05]; National Natural Science Foundation of China [30871292]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Ministry of Science and Technology [Grants 2012CB910402 and 2012AA020303-05], and the National Natural Science Foundation of China (30871292). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams IB, 1996, ADDICTION, V91, P1585, DOI 10.1111/j.1360-0443.1996.tb02264.x; ARORA KK, 1995, J BIOL CHEM, V270, P22820, DOI 10.1074/jbc.270.39.22820; Bab I, 2008, BRIT J PHARMACOL, V153, P182, DOI 10.1038/sj.bjp.0707593; Berg KA, 2008, J PHARMACOL EXP THER, V324, P1084, DOI 10.1124/jpet.107.131524; BLIN N, 1995, J BIOL CHEM, V270, P17741, DOI 10.1074/jbc.270.30.17741; Borner C, 2009, J BIOL CHEM, V284, P35450, DOI 10.1074/jbc.M109.006338; Bonhaus DW, 1998, J PHARMACOL EXP THER, V287, P884; Bouaboula M, 1996, EUR J BIOCHEM, V237, P704, DOI 10.1111/j.1432-1033.1996.0704p.x; Burstein ES, 1998, J BIOL CHEM, V273, P24322, DOI 10.1074/jbc.273.38.24322; Chen LJ, 2010, ANAL BIOCHEM, V407, P180, DOI 10.1016/j.ab.2010.08.018; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Demuth DG, 2006, LIFE SCI, V78, P549, DOI 10.1016/j.lfs.2005.05.055; Felder CC, 1998, J PHARMACOL EXP THER, V284, P291; FELDER CC, 1995, MOL PHARMACOL, V48, P443; Fernandez LM, 1997, MOL CELL ENDOCRINOL, V128, P161, DOI 10.1016/S0303-7207(97)04035-5; Gaborik Z, 2003, ENDOCRINOLOGY, V144, P2220, DOI 10.1210/en.2002-0135; Gershengorn MC, 2001, ENDOCRINOLOGY, V142, P2, DOI 10.1210/en.142.1.2; Guindon J, 2008, BRIT J PHARMACOL, V153, P319, DOI 10.1038/sj.bjp.0707531; HERKENHAM M, 1990, P NATL ACAD SCI USA, V87, P1932, DOI 10.1073/pnas.87.5.1932; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Jarrahian A, 2004, J PHARMACOL EXP THER, V308, P880, DOI 10.1124/jpet.103.057620; Kobayashi Y, 2001, J BIOCHEM-TOKYO, V129, P665, DOI 10.1093/oxfordjournals.jbchem.a002904; Koehler JA, 2005, MOL ENDOCRINOL, V19, P459, DOI 10.1210/me.2004-0196; Lambert D M, 2001, J Pharm Belg, V56, P111; Maccarrone M, 2008, BRIT J PHARMACOL, V153, P189, DOI 10.1038/sj.bjp.0707444; Marion S, 2006, J BIOL CHEM, V281, P2932, DOI 10.1074/jbc.M508074200; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; MORO O, 1993, J BIOL CHEM, V268, P22273; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Onaivi ES, 2006, ANN NY ACAD SCI, V1074, P514, DOI 10.1196/annals.1369.052; Pal-Ghosh R, 2003, ARCH BIOCHEM BIOPHYS, V415, P54, DOI 10.1016/S0003-9861(03)00217-0; Ramanjaneya M, 2009, J ENDOCRINOL, V202, P249, DOI 10.1677/JOE-08-0536; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Sanchez MG, 2003, CELL SIGNAL, V15, P851, DOI 10.1016/S0898-6568(03)00036-6; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; SEAMON KB, 1981, P NATL ACAD SCI-BIOL, V78, P3363, DOI 10.1073/pnas.78.6.3363; STRADER CD, 1994, ANNU REV BIOCHEM, V63, P101, DOI 10.1146/annurev.bi.63.070194.000533; Sugimoto Y, 2004, J BIOL CHEM, V279, P11016, DOI 10.1074/jbc.M307404200; Viscomi MT, 2009, J NEUROSCI, V29, P4564, DOI 10.1523/JNEUROSCI.0786-09.2009; Wacker JL, 2008, J BIOL CHEM, V283, P31068, DOI 10.1074/jbc.M805251200; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Werry TD, 2005, TRENDS ENDOCRIN MET, V16, P26, DOI 10.1016/j.tem.2004.11.008; Wess J, 1998, PHARMACOL THERAPEUT, V80, P231, DOI 10.1016/S0163-7258(98)00030-8; Zoratti C, 2003, BRIT J PHARMACOL, V140, P1351, DOI 10.1038/sj.bjp.0705529	45	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63262	10.1371/journal.pone.0063262	http://dx.doi.org/10.1371/journal.pone.0063262			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667597	Green Published, gold, Green Submitted			2022-12-25	WOS:000319654700127
J	Borgaro, JG; Benner, N; Zhu, ZY				Borgaro, Janine G.; Benner, Nicole; Zhu, Zhenyu			Fidelity Index Determination of DNA Methyltransferases	PLOS ONE			English	Article							HAEIII METHYLTRANSFERASE; SINGLE-MOLECULE; METHYLATION; RECOGNITION; ENZYMES; SITES	DNA methylation is the most frequent form of epigenetic modification in the cell, which involves gene regulation in eukaryotes and protection against restriction enzymes in prokaryotes. Even though many methyltransferases exclusively modify their cognate sites, there have been reports of those that exhibit promiscuity. Previous experimental approaches used to characterize these methyltransferases do not provide the exact concentration at which off-target methylation occurs. Here, we present the first reported fidelity index (FI) for a number of DNA methyltransferases. We define the FI as the ratio of the highest amount of methyltransferase that exhibits no star activity (off-target effects) to the lowest amount that exhibits complete modification of the cognate site. Of the methyltransferases assayed, M. MspI and M. AluI exhibited the highest fidelity of >= 250 and >= 500, respectively, and do not show star activity even at very high concentrations. In contrast, M. HaeIII, M.EcoKDam and M. BamHI have the lowest fidelity of 4, 4 and 2, respectively, and exhibit star activity at concentrations close to complete methylation of the cognate site. The fidelity indexes provide vital information on the usage of methyltransferases and are especially important in applications where site specific methylation is required.	[Borgaro, Janine G.; Benner, Nicole; Zhu, Zhenyu] New England Biolabs Inc, Ipswich, MA USA	New England Biolabs	Zhu, ZY (corresponding author), New England Biolabs Inc, Ipswich, MA USA.	zhuz@neb.com			New England Biolabs	New England Biolabs	New England Biolabs is the funder. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. However, the methylases studied in this paper are the current products of New England Biolabs.	Bandaru B, 1996, J BIOL CHEM, V271, P7851, DOI 10.1074/jbc.271.13.7851; BERKNER KL, 1978, NUCLEIC ACIDS RES, V5, P435, DOI 10.1093/nar/5.2.435; Casadesus J, 2006, MICROBIOL MOL BIOL R, V70, P830, DOI 10.1128/MMBR.00016-06; Clark TA, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1146; Cohen HM, 2004, PROTEIN ENG DES SEL, V17, P3, DOI 10.1093/protein/gzh001; Cohen HM, 2002, NUCLEIC ACIDS RES, V30, P3880, DOI 10.1093/nar/gkf507; DUBEY AK, 1992, NUCLEIC ACIDS RES, V20, P3167, DOI 10.1093/nar/20.12.3167; Fang G, 2012, NAT BIOTECHNOL, V30, P1232, DOI 10.1038/nbt.2432; Fuks F, 2005, CURR OPIN GENET DEV, V15, P490, DOI 10.1016/j.gde.2005.08.002; KUMAR S, 1994, NUCLEIC ACIDS RES, V22, P1, DOI 10.1093/nar/22.1.1; MALONE T, 1995, J MOL BIOL, V253, P618, DOI 10.1006/jmbi.1995.0577; NARDONE G, 1984, J BIOL CHEM, V259, P357; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; RAZIN A, 1994, CELL, V77, P473, DOI 10.1016/0092-8674(94)90208-9; Roberts RJ, 2001, NUCLEIC ACIDS RES, V29, P268, DOI 10.1093/nar/29.1.268; Rockah-Shmuel L, 2012, NUCLEIC ACIDS RES, V40, P11627, DOI 10.1093/nar/gks944; RUBIN RA, 1977, J BIOL CHEM, V252, P7265; TAYLOR JD, 1990, BIOCHEMISTRY-US, V29, P10727, DOI 10.1021/bi00500a003; Wei H, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn182; WOODBURY CP, 1980, J BIOL CHEM, V255, P1526; Youngblood B, 2006, BIOCHEMISTRY-US, V45, P15563, DOI 10.1021/bi061414t	21	8	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e63866	10.1371/journal.pone.0063866	http://dx.doi.org/10.1371/journal.pone.0063866			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671703	gold, Green Submitted, Green Published			2022-12-25	WOS:000321390200062
J	Schmidt, C; Athenstaedt, K; Koch, B; Ploier, B; Daum, G				Schmidt, Claudia; Athenstaedt, Karin; Koch, Barbara; Ploier, Birgit; Daum, Guenther			Regulation of the Yeast Triacylglycerol Lipase Tgl3p by Formation of Nonpolar Lipids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; NEUTRAL LIPIDS; PARTICLES; ACYLTRANSFERASE; PROTEINS; DROPLETS; STORAGE; CELLS; ESTERIFICATION	Tgl3p, the major triacylglycerol lipase of the yeast Saccharomyces cerevisiae, is a component of lipid droplets but is also present in the endoplasmic reticulum in a minor amount. Recently, it was shown that this enzyme can also serve as a lysophospholipid acyltransferase (Rajakumari, S., and Daum, G. (2010) Mol. Biol. Cell 21, 501-510). Here, we describe the effects of the presence/absence of triacylglycerols and lipid droplets on the functionality of Tgl3p. In a dga1 Delta lro1 Delta are1 Delta are2 Delta quadruple mutant lacking all four triacylglycerol- and steryl ester-synthesizing acyltransferases and consequently the lipid droplets, the gene expression of TGL3 was only slightly altered. In contrast, protein level and stability of Tgl3p were markedly reduced in the absence of lipid droplets. Under these conditions, the enzyme was localized to the endoplasmic reticulum. Even the lack of the substrate, triacylglycerol, affected stability and localization of Tgl3p to some extent. Interestingly, Tgl3p present in the endoplasmic reticulum seems to lack lipolytic as well as acyltransferase activity as shown by enzymatic analysis and lipid profiling. Thus, we propose that the activity of Tgl3p is restricted to lipid droplets, whereas the endoplasmic reticulum may serve as a parking lot for this enzyme.	[Schmidt, Claudia; Athenstaedt, Karin; Koch, Barbara; Ploier, Birgit; Daum, Guenther] Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria; [Athenstaedt, Karin] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria	Graz University of Technology; University of Graz	Daum, G (corresponding author), Graz Univ Technol, Inst Biochem, Petersgasse 12-2, A-8010 Graz, Austria.	guenther.daum@tugraz.at		Athenstaedt, Karin/0000-0001-7198-3989	Austrian Science Fund [W901 DK]; Molecular Enzymology [P23029, P21251]; Austrian Science Fund (FWF) [P 21251, P 23029, W 901] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Molecular Enzymology; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund Projects W901 DK Molecular Enzymology and P23029 (to G. D.) and P21251 (to K. A.).	Athenstaedt K, 2006, CELL MOL LIFE SCI, V63, P1355, DOI 10.1007/s00018-006-6016-8; Athenstaedt K, 2005, J BIOL CHEM, V280, P37301, DOI 10.1074/jbc.M507261200; Athenstaedt K, 2003, J BIOL CHEM, V278, P23317, DOI 10.1074/jbc.M302577200; Athenstaedt K, 1999, J BACTERIOL, V181, P6441, DOI 10.1128/JB.181.20.6441-6448.1999; Athenstaedt K, 2011, BBA-MOL CELL BIOL L, V1811, P587, DOI 10.1016/j.bbalip.2011.07.004; Brasaemle DL, 2012, J BIOL CHEM, V287, P2273, DOI 10.1074/jbc.R111.309088; BROEKHUYSE RM, 1968, BIOCHIM BIOPHYS ACTA, V152, P307, DOI 10.1016/0005-2760(68)90038-6; Czabany T, 2008, J BIOL CHEM, V283, P17065, DOI 10.1074/jbc.M800401200; Czabany T, 2007, BBA-MOL CELL BIOL L, V1771, P299, DOI 10.1016/j.bbalip.2006.07.001; Dahlqvist A, 2000, P NATL ACAD SCI USA, V97, P6487, DOI 10.1073/pnas.120067297; FOLCH J, 1957, J BIOL CHEM, V226, P497; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Grillitsch K, 2011, BBA-MOL CELL BIOL L, V1811, P1165, DOI 10.1016/j.bbalip.2011.07.015; HAID A, 1983, METHOD ENZYMOL, V96, P192; Horvath SE, 2011, BBA-MOL CELL BIOL L, V1811, P1030, DOI 10.1016/j.bbalip.2011.08.007; Jacquier N, 2011, J CELL SCI, V124, P2424, DOI 10.1242/jcs.076836; Kalantari F, 2010, MOL MEMBR BIOL, V27, P462, DOI 10.3109/09687688.2010.538936; Kohlwein SD, 2013, GENETICS, V193, P1, DOI 10.1534/genetics.112.143362; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leber R, 1998, MOL BIOL CELL, V9, P375, DOI 10.1091/mbc.9.2.375; LEBER R, 1994, YEAST, V10, P1421, DOI 10.1002/yea.320101105; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Murphy DJ, 1999, TRENDS BIOCHEM SCI, V24, P109, DOI 10.1016/S0968-0004(98)01349-8; Oelkers P, 2000, J BIOL CHEM, V275, P15609, DOI 10.1074/jbc.C000144200; Oelkers P, 2002, J BIOL CHEM, V277, P8877, DOI 10.1074/jbc.M111646200; Rajakumari S, 2010, BBA-MOL CELL BIOL L, V1801, P1314, DOI 10.1016/j.bbalip.2010.08.004; Rajakumari S, 2010, J BIOL CHEM, V285, P15769, DOI 10.1074/jbc.M109.076331; Rajakumari S, 2010, MOL BIOL CELL, V21, P501, DOI 10.1091/mbc.E09-09-0775; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; Sorger D, 2004, J BIOL CHEM, V279, P31190, DOI 10.1074/jbc.M403251200; Sorger D, 2002, J BACTERIOL, V184, P519, DOI 10.1128/JB.184.2.519-524.2002; Yang HY, 1996, SCIENCE, V272, P1353, DOI 10.1126/science.272.5266.1353; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991; ZINSER E, 1995, YEAST, V11, P493, DOI 10.1002/yea.320110602; Zweytick D, 2000, EUR J BIOCHEM, V267, P1075, DOI 10.1046/j.1432-1327.2000.01103.x; Zweytick D, 2000, BBA-REV BIOMEMBRANES, V1469, P101, DOI 10.1016/S0005-2736(00)00294-7	39	22	24	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19939	19948		10.1074/jbc.M113.459610	http://dx.doi.org/10.1074/jbc.M113.459610			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23673660	Green Published, hybrid			2022-12-25	WOS:000321515800059
J	Bos, J; Duverger, Y; Thouvenot, B; Chiaruttini, C; Branlant, C; Springer, M; Charpentier, B; Barras, F				Bos, Julia; Duverger, Yohann; Thouvenot, Benoit; Chiaruttini, Claude; Branlant, Christiane; Springer, Mathias; Charpentier, Bruno; Barras, Frederic			The sRNA RyhB Regulates the Synthesis of the Escherichia coli Methionine Sulfoxide Reductase MsrB but Not MsrA	PLOS ONE			English	Article							MESSENGER-RNA; ANTIOXIDANT DEFENSE; OXIDATIVE STRESS; BINDING-SITE; PROTEIN; EXPRESSION; OPERON; REPAIR; HFQ; TRANSLATION	Controlling iron homeostasis is crucial for all aerobically grown living cells that are exposed to oxidative damage by reactive oxygen species (ROS), as free iron increases the production of ROS. Methionine sulfoxide reductases (Msr) are key enzymes in repairing ROS-mediated damage to proteins, as they reduce oxidized methionine (MetSO) residues to methionine. E. coli synthesizes two Msr, A and B, which exhibit substrate diastereospecificity. The bacterial iron-responsive small RNA (sRNA) RyhB controls iron metabolism by modulating intracellular iron usage. We show in this paper that RyhB is a direct regulator of the msrB gene that encodes the MsrB enzyme. RyhB down-regulates msrB transcripts along with Hfq and RNaseE proteins since mutations in the ryhB, fur, hfq, or RNaseE-encoded genes resulted in iron-insensitive expression of msrB. Our results show that RyhB binds to two sequences within the short 5'UTR of msrB mRNA as identified by reverse transcriptase and RNase and lead (II) protection assays. Toeprinting analysis shows that RyhB pairing to msrB mRNA prevents efficient ribosome binding and thereby inhibits translation initiation. In vivo site directed-mutagenesis experiments in the msrB 5'UTR region indicate that both RyhB-pairing sites are required to decrease msrB expression. Thus, this study suggests a novel mechanism of translational regulation where a same sRNA can basepair to two different locations within the same mRNA species. In contrast, expression of msrA is not influenced by changes in iron levels.	[Bos, Julia; Duverger, Yohann; Barras, Frederic] Aix Marseille Univ, CNRS, Chim Bacterienne Lab, Inst Microbiol Mediterranee,UMR, Marseille, France; [Thouvenot, Benoit; Branlant, Christiane; Charpentier, Bruno] Univ Lorraine, CNRS, UMR, Vandoeuvre Les Nancy, France; [Chiaruttini, Claude; Springer, Mathias] Univ Paris 07, CNRS, Inst Biol Physicochim, Unite Propre Rech, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Barras, F (corresponding author), Aix Marseille Univ, CNRS, Chim Bacterienne Lab, Inst Microbiol Mediterranee,UMR, Marseille, France.	barras@imm.cnrs.fr		Barras, Frederic/0000-0003-3458-2574; Bos, Julia/0000-0002-4947-4675; Branlant, Christiane/0000-0003-4728-5499; CHARPENTIER, Bruno/0000-0003-2955-2987	Centre National de la Recherche Scientifique; French National Research Agency and Aix-Marseille University	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); French National Research Agency and Aix-Marseille University(French National Research Agency (ANR))	This work was made possible by grants from the Centre National de la Recherche Scientifique, the French National Research Agency and Aix-Marseille University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."	Afonyushkin T, 2005, NUCLEIC ACIDS RES, V33, P1678, DOI 10.1093/nar/gki313; Balbontin R, 2010, MOL MICROBIOL, V78, P380, DOI 10.1111/j.1365-2958.2010.07342.x; Boschi-Muller S, 2005, BBA-PROTEINS PROTEOM, V1703, P231, DOI 10.1016/j.bbapap.2004.09.016; Boschi-Muller S, 2008, ARCH BIOCHEM BIOPHYS, V474, P266, DOI 10.1016/j.abb.2008.02.007; Bouvier M, 2008, MOL CELL, V32, P827, DOI 10.1016/j.molcel.2008.10.027; Brosnan JT, 2006, J NUTR, V136, p1636S, DOI 10.1093/jn/136.6.1636S; Cornelis P, 2011, METALLOMICS, V3, P540, DOI 10.1039/c1mt00022e; Denkel LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026974; Desnoyers G, 2009, EMBO J, V28, P1551, DOI 10.1038/emboj.2009.116; Dhandayuthapani S, 2001, J BACTERIOL, V183, P5645, DOI 10.1128/JB.183.19.5645-5650.2001; Douglas T, 2004, J BACTERIOL, V186, P3590, DOI 10.1128/JB.186.11.3590-3598.2004; El Hassouni M, 1999, P NATL ACAD SCI USA, V96, P887, DOI 10.1073/pnas.96.3.887; Ezraty B, 2005, BBA-PROTEINS PROTEOM, V1703, P221, DOI 10.1016/j.bbapap.2004.08.017; Ezraty B, 2005, J BACTERIOL, V187, P231, DOI 10.1128/JB.187.1.231-237.2005; Ezraty B, 2004, EMBO J, V23, P1868, DOI 10.1038/sj.emboj.7600172; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Geissmann TA, 2004, EMBO J, V23, P396, DOI 10.1038/sj.emboj.7600058; Grimaud R, 2001, J BIOL CHEM, V276, P48915, DOI 10.1074/jbc.M105509200; Haentjens-Sitri J, 2008, J MOL BIOL, V375, P612, DOI 10.1016/j.jmb.2007.10.058; Hansel A, 2005, BBA-PROTEINS PROTEOM, V1703, P239, DOI 10.1016/j.bbapap.2004.09.010; Hansel A, 2003, REDOX REP, V8, P384, DOI 10.1179/135100003225003429; HUTTENHOFER A, 1994, EMBO J, V13, P3892, DOI 10.1002/j.1460-2075.1994.tb06700.x; Koc A, 2007, ANN NY ACAD SCI, V1100, P383, DOI 10.1196/annals.1395.042; Luo S, 2009, FASEB J, V23, P464, DOI 10.1096/fj.08-118414; Maisonneuve E, 2008, J BACTERIOL, V190, P6070, DOI 10.1128/JB.00736-08; Maisonneuve E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007269; MAKHNO VI, 1988, MOL BIOL+, V22, P528; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Masse E, 2005, J BACTERIOL, V187, P6962, DOI 10.1128/JB.187.20.6962-6971.2005; Masse E, 2003, GENE DEV, V17, P2374, DOI 10.1101/gad.1127103; Masse E, 2007, CURR OPIN MICROBIOL, V10, P140, DOI 10.1016/j.mib.2007.03.013; Moll I, 2003, RNA, V9, P1308, DOI 10.1261/rna.5850703; Morita T, 2005, GENE DEV, V19, P2176, DOI 10.1101/gad.1330405; Morita T, 2004, MOL MICROBIOL, V54, P1063, DOI 10.1111/j.1365-2958.2004.04329.x; Moskovitz J, 2005, CURR PHARM DESIGN, V11, P1451, DOI 10.2174/1381612053507846; Moskovitz J, 1997, P NATL ACAD SCI USA, V94, P9585, DOI 10.1073/pnas.94.18.9585; Moskovitz J, 2001, P NATL ACAD SCI USA, V98, P12920, DOI 10.1073/pnas.231472998; Moskovitz J, 2010, ANTIOXID REDOX SIGN, V12, P405, DOI 10.1089/ars.2009.2809; Olry A, 2005, PROTEIN SCI, V14, P2828, DOI 10.1110/ps.051711105; Papenfort K, 2010, P NATL ACAD SCI USA, V107, P20435, DOI 10.1073/pnas.1009784107; PLUMBRIDGE J, 1989, MOL GEN GENET, V216, P113, DOI 10.1007/BF00332238; POWELL BS, 1994, NUCLEIC ACIDS RES, V22, P5765, DOI 10.1093/nar/22.25.5765; Prevost K, 2007, MOL MICROBIOL, V64, P1260, DOI 10.1111/j.1365-2958.2007.05733.x; Prevost K, 2011, GENE DEV, V25, P385, DOI 10.1101/gad.2001711; Rice JB, 2012, P NATL ACAD SCI USA, V109, pE2691, DOI 10.1073/pnas.1207927109; Rouhier N, 2006, PHOTOSYNTH RES, V89, P247, DOI 10.1007/s11120-006-9097-1; Ruan H, 2002, P NATL ACAD SCI USA, V99, P2748, DOI 10.1073/pnas.032671199; Sharma CM, 2007, GENE DEV, V21, P2804, DOI 10.1101/gad.447207; Sharov VS, 1999, FEBS LETT, V455, P247, DOI 10.1016/S0014-5793(99)00888-1; Sharov VS, 2000, FREE RADICAL BIO MED, V29, P986, DOI 10.1016/S0891-5849(00)00400-7; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; Singh VK, 2003, MICROBIOL-SGM, V149, P2739, DOI 10.1099/mic.0.26442-0; Skaar EP, 2002, P NATL ACAD SCI USA, V99, P10108, DOI 10.1073/pnas.152334799; Wizemann TM, 1996, P NATL ACAD SCI USA, V93, P7985, DOI 10.1073/pnas.93.15.7985; You CH, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-128; Zhang XH, 2008, BIOL REV, V83, P249, DOI 10.1111/j.1469-185X.2008.00042.x; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	57	18	21	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63647	10.1371/journal.pone.0063647	http://dx.doi.org/10.1371/journal.pone.0063647			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671689	Green Submitted, Green Published, gold			2022-12-25	WOS:000319737700055
J	Cousins, S; Kaski, D; Cutfield, N; Seemungal, B; Golding, JF; Gresty, M; Glasauer, S; Bronstein, AM				Cousins, Sian; Kaski, Diego; Cutfield, Nicholas; Seemungal, Barry; Golding, John F.; Gresty, Michael; Glasauer, Stefan; Bronstein, Adolfo M.			Vestibular Perception following Acute Unilateral Vestibular Lesions	PLOS ONE			English	Article							SELF-MOTION PERCEPTION; QUALITATIVELY DIFFERENT MECHANISMS; EARTH-VERTICAL AXIS; VESTIBULOOCULAR REFLEX; NEURONAL-ACTIVITY; VELOCITY STORAGE; STIMULATION; THRESHOLDS; ROTATION; HABITUATION	Little is known about the vestibulo-perceptual (VP) system, particularly after a unilateral vestibular lesion. We investigated vestibulo-ocular (VO) and VP function in 25 patients with vestibular neuritis (VN) acutely (2 days after onset) and after compensation (recovery phase, 10 weeks). Since the effect of VN on reflex and perceptual function may differ at threshold and supra-threshold acceleration levels, we used two stimulus intensities, acceleration steps of 0.5 degrees/s(2) and velocity steps of 90 degrees/s (acceleration 180 degrees/s(2)). We hypothesised that the vestibular lesion or the compensatory processes could dissociate VO and VP function, particularly if the acute vertiginous sensation interferes with the perceptual tasks. Both in acute and recovery phases, VO and VP thresholds increased, particularly during ipsilesional rotations. In signal detection theory this indicates that signals from the healthy and affected side are still fused, but result in asymmetric thresholds due to a lesion-induced bias. The normal pattern whereby VP thresholds are higher than VO thresholds was preserved, indicating that any 'perceptual noise' added by the vertigo does not disrupt the cognitive decision-making processes inherent to the perceptual task. Overall, the parallel findings in VO and VP thresholds imply little or no additional cortical processing and suggest that vestibular thresholds essentially reflect the sensitivity of the fused peripheral receptors. In contrast, a significant VO-VP dissociation for supra-threshold stimuli was found. Acutely, time constants and duration of the VO and VP responses were reduced - asymmetrically for VO, as expected, but surprisingly symmetrical for perception. At recovery, VP responses normalised but VO responses remained shortened and asymmetric. Thus, unlike threshold data, supra-threshold responses show considerable VO-VP dissociation indicative of additional, higher-order processing of vestibular signals. We provide evidence of perceptual processes (ultimately cortical) participating in vestibular compensation, suppressing asymmetry acutely in unilateral vestibular lesions.	[Cousins, Sian; Kaski, Diego; Seemungal, Barry; Gresty, Michael; Bronstein, Adolfo M.] Univ London Imperial Coll Sci Technol & Med, Charing Cross Hosp, Neurootol Unit, Div Brain Sci, London, England; [Cutfield, Nicholas] Univ Otago, Dunedin Hosp, Dunedin, New Zealand; [Golding, John F.] Univ Westminster, Dept Psychol, London W1R 8AL, England; [Glasauer, Stefan] Univ Munich, Sensorimotor Res & German Vertigo Ctr, Munich, Germany	Imperial College London; Dunedin Public Hospital; University of Otago; University of Westminster; University of Munich	Bronstein, AM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Charing Cross Hosp, Neurootol Unit, Div Brain Sci, London, England.	a.bronstein@imperial.ac.uk	Kaski, Diego/GQY-5716-2022; Glasauer, Stefan/A-5898-2008	Glasauer, Stefan/0000-0002-4313-6210; Seemungal, Barry/0000-0002-6578-0904; Kaski, Diego/0000-0002-0591-646X	Medical Research Council [07/Q0406/48]; Academy of Medical Sciences (AMS) [AMS-CSF3-Seemungal] Funding Source: researchfish; Medical Research Council [MR/J004685/1, G0600183] Funding Source: researchfish; MRC [MR/J004685/1, G0600183] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study is funded by the Medical Research Council (www.mrc.ac.uk), study reference 07/Q0406/48. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALOH RW, 1984, ANN NEUROL, V16, P222, DOI 10.1002/ana.410160209; Benson AJ, 1990, PERCEPTION CONTROL S; Bertolini G, 2011, J NEUROPHYSIOL, V105, P209, DOI 10.1152/jn.00154.2010; Bertolini G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036763; BRANTBERG K, 1990, AM J OTOLARYNG, V11, P345, DOI 10.1016/0196-0709(90)90066-5; Bronstein AM, 2008, NEUROREPORT, V19, P691, DOI 10.1097/WNR.0b013e3282fbf9f6; Clement G, 2008, EXP BRAIN RES, V190, P307, DOI 10.1007/s00221-008-1471-0; COATS AC, 1966, ANN OTO RHINOL LARYN, V75, P1135, DOI 10.1177/000348946607500423; Cutfield NJ, 2011, ANN NY ACAD SCI, V1233, P256, DOI 10.1111/j.1749-6632.2011.06159.x; Dieterich M, 2008, BRAIN, V131, P2538, DOI 10.1093/brain/awn042; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; GOLDBERG JM, 1971, J NEUROPHYSIOL, V34, P635, DOI 10.1152/jn.1971.34.4.635; Grabherr L, 2008, EXP BRAIN RES, V186, P677, DOI 10.1007/s00221-008-1350-8; Graham BP, 2001, EXP BRAIN RES, V137, P387, DOI 10.1007/s002210100677; Green DM, 1966, SIGNAL DETECTION THE; Grunfeld EA, 2003, NEUROLOGY, V60, P1993, DOI 10.1212/01.WNL.0000067992.17185.60; GUEDRY FE, 1964, J APPL PHYSIOL, V19, P1005, DOI 10.1152/jappl.1964.19.5.1005; Guedry FE, 1965, CONTRIBUTIONS SENSOR, P93; Guldin WO, 1998, TRENDS NEUROSCI, V21, P254, DOI 10.1016/S0166-2236(97)01211-3; Haburcakova C, 2011, J NEUROPHYSIOLOGY; Haburcakova C, 2012, J NEUROPHYSIOL, V107, P973, DOI 10.1152/jn.00451.2011; Helmchen C, 2009, ANN NY ACAD SCI, V1164, P104, DOI 10.1111/j.1749-6632.2008.03745.x; Kahane P, 2003, ANN NEUROL, V54, P615, DOI 10.1002/ana.10726; Kandel E., 2000, PRINCIPLES NEURAL SC; Karmali F, 2012, J NEUROPHYSIOL, V108, P390, DOI 10.1152/jn.00883.2011; Klingner CM, 2013, BEHAV BRAIN RES, V236, P194, DOI 10.1016/j.bbr.2012.08.049; Leigh R. J., 2006, NEUROLOGY EYE MOVEME; Lopez C, 2012, NEUROSCIENCE, V212, P159, DOI 10.1016/j.neuroscience.2012.03.028; MacNeilage PR, 2008, J NEUROPHYSIOL, V100, P2981, DOI 10.1152/jn.90677.2008; Magnusson M, 1989, Acta Otolaryngol Suppl, V468, P329; Mallery RM, 2010, EXP BRAIN RES, V204, P11, DOI 10.1007/s00221-010-2288-1; Meng H, 2007, J NEUROSCI, V27, P13590, DOI 10.1523/JNEUROSCI.3931-07.2007; Merfeld DM, 2011, EXP BRAIN RES, V210, P389, DOI 10.1007/s00221-011-2557-7; Merfeld DM, 2005, J NEUROPHYSIOL, V94, P186, DOI 10.1152/jn.00904.2004; Merfeld DM, 2005, J NEUROPHYSIOL, V94, P199, DOI 10.1152/jn.00905.2004; MILLER EF, 1975, PERCEPT PSYCHOPHYS, V17, P329, DOI 10.3758/BF03203219; Okada T, 1999, BRAIN, V122, P1293, DOI 10.1093/brain/122.7.1293; Palermo A, 2011, EXP BRAIN RES, V212, P101, DOI 10.1007/s00221-011-2701-4; Pettorossi VE, 2013, J PHYSIOL-LONDON, V591, P1907, DOI 10.1113/jphysiol.2012.241182; Schmid-Priscoveanu A, 2001, JARO-J ASSOC RES OTO, V2, P72, DOI 10.1007/s101620010060; Seemungal BM, 2007, J NEUROPHYSIOL, V97, P4341, DOI 10.1152/jn.01321.2006; Seemungal Barry M, 2011, Front Neurol, V2, P2, DOI 10.3389/fneur.2011.00002; Seemungal BM, 2004, J VESTIBUL RES-EQUIL, V14, P461; Shaikh AG, 2013, CEREBELLUM, V12, P97, DOI 10.1007/s12311-012-0401-7; SHIMAZU H, 1966, J NEUROPHYSIOL, V29, P467, DOI 10.1152/jn.1966.29.3.467; Sinha N, 2008, PROG BRAIN RES, V171, P277, DOI 10.1016/S0079-6123(08)00639-0; SMITH PF, 1988, BRAIN RES, V444, P295, DOI 10.1016/0006-8993(88)90938-9; Viaud-Delmon I, 1999, COGNITIVE BRAIN RES, V7, P507, DOI 10.1016/S0926-6410(98)00052-4; WAESPE W, 1977, EXP BRAIN RES, V27, P523; Wickens Thomas D., 2002, ELEMENTARY SIGNAL DE; Zhang Z, 2011, FRONT AGING NEUROSCI, V3, DOI 10.3389/fnagi.2011.00018; Zwergal A, 2009, ANN NY ACAD SCI, V1164, P51, DOI 10.1111/j.1749-6632.2009.04461.x	52	63	64	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e61862	10.1371/journal.pone.0061862	http://dx.doi.org/10.1371/journal.pone.0061862			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671577	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000319737700008
J	Oyarzun, DA; Lopez-Caamal, F; Garcia, MR; Middleton, RH; Weisse, AY				Oyarzun, Diego A.; Lopez-Caamal, Fernando; Garcia, Miriam R.; Middleton, Richard H.; Weisse, Andrea Y.			Cumulative Signal Transmission in Nonlinear Reaction-Diffusion Networks	PLOS ONE			English	Article							SYSTEMS; OSCILLATIONS; COMPUTATION; MODELS	Quantifying signal transmission in biochemical systems is key to uncover the mechanisms that cells use to control their responses to environmental stimuli. In this work we use the time-integral of chemical species as a measure of a network's ability to cumulatively transmit signals encoded in spatiotemporal concentrations. We identify a class of nonlinear reaction-diffusion networks in which the time-integrals of some species can be computed analytically. The derived time-integrals do not require knowledge of the solution of the reaction-diffusion equation, and we provide a simple graphical test to check if a given network belongs to the proposed class. The formulae for the time-integrals reveal how the kinetic parameters shape signal transmission in a network under spatiotemporal stimuli. We use these to show that a canonical complex-formation mechanism behaves as a spatial low-pass filter, the bandwidth of which is inversely proportional to the diffusion length of the ligand.	[Oyarzun, Diego A.] Univ London Imperial Coll Sci Technol & Med, Ctr Synthet Biol & Innovat, Dept Bioengn, London, England; [Lopez-Caamal, Fernando; Garcia, Miriam R.] Natl Univ Ireland, Hamilton Inst, Maynooth, Kildare, Ireland; [Middleton, Richard H.] Univ Newcastle, Ctr Complex Dynam Syst & Control, Newcastle, NSW 2300, Australia; [Weisse, Andrea Y.] Univ Edinburgh, SynthSys Synthet & Syst Biol, Edinburgh, Midlothian, Scotland	Imperial College London; Maynooth University; University of Newcastle; University of Edinburgh	Oyarzun, DA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Synthet Biol & Innovat, Dept Bioengn, London, England.	d.oyarzun@imperial.ac.uk	García, Miriam/HGD-0780-2022; García, Míriam R./D-7185-2012; Middleton, Richard H/A-2950-2013	García, Míriam R./0000-0001-9538-6388; Middleton, Richard H/0000-0001-9885-8803; Oyarzun, Diego/0000-0002-0381-5278; Lopez-Caamal, Fernando/0000-0003-2861-7013	Engineering and Physical Sciences Research Council (EPSRC) through the Centre for Synthetic Biology and Innovation	Engineering and Physical Sciences Research Council (EPSRC) through the Centre for Synthetic Biology and Innovation	DAO is funded by Engineering and Physical Sciences Research Council (EPSRC) through the Centre for Synthetic Biology and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker V, 2010, SCIENCE, V328, P1404, DOI 10.1126/science.1184913; Britton N., 1986, REACTION DIFFUSION E; Buchler NE, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.30; CASTEN RG, 1977, SIAM J APPL MATH, V33, P353, DOI 10.1137/0133023; Chan G, 2008, TRENDS BIOTECHNOL, V26, P382, DOI 10.1016/j.tibtech.2008.03.011; Chandra FA, 2011, SCIENCE, V333, P187, DOI 10.1126/science.1200705; Cottrell D, 2012, P NATL ACAD SCI USA, V109, P9699, DOI 10.1073/pnas.1201103109; Craciun G, 2006, SIAM J APPL MATH, V66, P1321, DOI 10.1137/050634177; Grima R, 2008, ESSAYS BIOCHEM, V45, P41, DOI 10.1042/BSE0450041; Heinrich R, 2002, MOL CELL, V9, P957, DOI 10.1016/S1097-2765(02)00528-2; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; Krippendorff BF, 2012, J PHARMACOKINET PHAR, V39, P125, DOI 10.1007/s10928-012-9243-7; Lathi, 2009, SIGNAL PROCESSING LI; Lebiedz D, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.208301; Lopez-Caamal F, 2012, IEEE DECIS CONTR P, P1047, DOI 10.1109/CDC.2012.6426397; Schenk CP, 1997, PHYS REV LETT, V78, P3781, DOI 10.1103/PhysRevLett.78.3781; Shankaran H, 2007, PLOS COMPUT BIOL, V3, P986, DOI 10.1371/journal.pcbi.0030101; Sick S, 2006, SCIENCE, V314, P1447, DOI 10.1126/science.1130088; SNEYD J, 2009, MATH PHYSL CELLULAR, V1; Sontag ED, 2006, AUTOMATICA, V42, P1987, DOI 10.1016/j.automatica.2006.06.011; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Vilas C, 2008, PHYSICA D, V237, P2353, DOI 10.1016/j.physd.2008.02.019; WAGNER J, 1994, BIOPHYS J, V67, P447, DOI 10.1016/S0006-3495(94)80500-4	23	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62834	10.1371/journal.pone.0062834	http://dx.doi.org/10.1371/journal.pone.0062834			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667528	gold, Green Published, Green Submitted			2022-12-25	WOS:000319055600047
J	Soderstrom, L; Perez-Vicente, R; Juarez, S; Merlo, J				Soderstrom, Lovisa; Perez-Vicente, Raquel; Juarez, Sol; Merlo, Juan			Questioning the Causal Link between Maternal Smoking during Pregnancy and Offspring Use of Psychotropic Medication: A Sibling Design Analysis	PLOS ONE			English	Article							RISK-FACTOR; EXTERNALIZING PROBLEMS; HYPERKINETIC DISORDER; PATERNAL SMOKING; PRENATAL SMOKING; EXPOSURE; SYMPTOMS; CHILDREN; WOMEN; ADHD	A recent population-based, longitudinal study from Finland observed a dose-response association between smoking during pregnancy (SDP) and use of psychotropic medications in exposed children and young adults. However, this association may be confounded by unmeasured familial characteristics related to both SDP and offspring mental health. Consequently, we aim to investigate the effect of SDP by means of a sibling design that to some extent allows controlling for unknown environmental and genetic confounders. Using the Swedish Medical Birth Register (1987-1993), which was linked to the Swedish Prescribed Drugs Register (July 2005-December 2008), we investigated 579,543 children and among them 39, 007 were discordant for use of psychotropic medication and 4,021 siblings discordant for both use of psychotropic medication and for smoking exposure. Replicating the Finnish study using traditional logistic regression methods we found an association between exposure to >= 10 cigarettes per day during pregnancy and psychotropic drug use (odds ratio = 1.61, 95% confidence interval 1.56, 1.66). Similar in size to the association reported from Finland (odds ratio = 1.63; 95% confidence interval 1.53, 1.74). However, in the adjusted sibling analysis using conditional logistic regression, the association was considerably reduced (odds ratio 1.22; 95% confidence interval 1.08, 1.38). Preventing smoking is of major public health importance. However, SDP per se appears to have less influence on offspring psychotropic drug use than previously suggested.	[Soderstrom, Lovisa; Perez-Vicente, Raquel; Juarez, Sol; Merlo, Juan] Lund Univ, Fac Med, Dept Clin Sci, Unit Social Epidemiol, Malmo, Sweden; [Juarez, Sol] Lund Univ, Ctr Econ Demog, Malmo, Sweden	Lund University; Lund University	Merlo, J (corresponding author), Lund Univ, Fac Med, Dept Clin Sci, Unit Social Epidemiol, Malmo, Sweden.	juan.merlo@med.lu.se	Merlo, Juan/E-2136-2011	Merlo, Juan/0000-0001-8379-9708; Juarez, Sol Pia/0000-0001-9086-7588	Centre for Economic Demography at Lund University	Centre for Economic Demography at Lund University	This work was supported by the Centre for Economic Demography at Lund University http://www.ed.lu.se/EN/AboutCED/default.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sahab B, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-24; [Anonymous], 2002, FACTS MOTH CHILDB NE; Ashford J, 2008, J AM ACAD CHILD PSY, V47, P779, DOI 10.1097/CHI.0b013e318172eefb; CNATTINGIUS S, 1990, SCAND J SOC MED, V18, P143, DOI 10.1177/140349489001800209; D'Onofrio BM, 2011, PSYCHOL MED, P1; D'Onofrio BM, 2008, DEV PSYCHOPATHOL, V20, P139, DOI 10.1017/S0954579408000072; D'Onofrio BM, 2010, ARCH GEN PSYCHIAT, V67, P529, DOI 10.1001/archgenpsychiatry.2010.33; D'Onofrio BM, 2010, CHILD DEV, V81, P80, DOI 10.1111/j.1467-8624.2009.01382.x; Ekblad M, 2011, AM J EPIDEMIOL, V174, P681, DOI 10.1093/aje/kwr150; Ep C, 2003, SWEDISH MED BIRTH RE; Fergusson DM, 1998, ARCH GEN PSYCHIAT, V55, P721, DOI 10.1001/archpsyc.55.8.721; Frisell T, 2012, EPIDEMIOLOGY, V23, P713, DOI 10.1097/EDE.0b013e31825fa230; Knopik VS, 2009, DEV NEUROPSYCHOL, V34, P1, DOI 10.1080/87565640802564366; Lahey BB, 2010, CURR DIR PSYCHOL SCI, V19, P319, DOI 10.1177/0963721410383977; Langley K, 2012, AM J EPIDEMIOL, V176, P261, DOI 10.1093/aje/kwr510; Lavigne JV, 2011, J PEDIATR PSYCHOL, V36, P10, DOI 10.1093/jpepsy/jsq044; Lawlor DA, 2009, FAMILY MATTERS DESIG; Lindblad F, 2010, NICOTINE TOB RES, V12, P408, DOI 10.1093/ntr/ntq017; Lindqvist R, 2002, ACTA OBSTET GYN SCAN, V81, P240; Linnet KM, 2005, PEDIATRICS, V116, P462, DOI 10.1542/peds.2004-2054; Maxson PJ, 2012, ADDICT BEHAV, V37, P153, DOI 10.1016/j.addbeh.2011.08.011; Merlo J, 2012, SOCIAL SCI IN PRESS; Merlo J, 2010, INT J EPIDEMIOL, V39, P936; Milberger S, 1996, AM J PSYCHIAT, V153, P1138; Nomura Y, 2010, J NERV MENT DIS, V198, P672, DOI 10.1097/NMD.0b013e3181ef3489; Obel C, 2011, INT J EPIDEMIOL, V40, P338, DOI 10.1093/ije/dyq185; Ramsay MC, 2000, NEUROPSYCHOL REV, V10, P1, DOI 10.1023/A:1009065713389; Thapar A, 2009, BRIT J PSYCHIAT, V195, P100, DOI 10.1192/bjp.bp.109.062828; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294	29	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e63420	10.1371/journal.pone.0063420	http://dx.doi.org/10.1371/journal.pone.0063420			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	145YI	23667614	Green Submitted, Green Published, gold			2022-12-25	WOS:000319055600059
J	Henson, TM; Cory, W; Rutter, MT				Henson, Tessa M.; Cory, Wendy; Rutter, Matthew T.			Extensive Variation in Cadmium Tolerance and Accumulation among Populations of Chamaecrista fasciculata	PLOS ONE			English	Article							THLASPI-CAERULESCENS; HEAVY-METALS; GENETIC-VARIATION; EXTRAFLORAL NECTAR; ZINC ACCUMULATION; HYPERACCUMULATION; HONEY; SOIL; PHYTOREMEDIATION; METALLOIDS	Plant populations may vary substantially in their tolerance for and accumulation of heavy metals, and assessment of this variability is important when selecting species to use in restoration or phytoremediation projects. We examined the population variation in cadmium tolerance and accumulation in a leguminous pioneer species native to the eastern United States, the partridge pea (Chamaecrista fasciculata). We assayed growth, reproduction and patterns of cadmium accumulation in six populations of C. fasciculata grown on a range of cadmium-contaminated soils. In general, C. fasciculata exhibited tolerance in low to moderate soil cadmium concentrations. Both tolerance and accumulation patterns varied across populations. C. fasciculata exhibited many characteristics of a hyperaccumulator species, with high cadmium uptake in shoots and roots. However, cadmium was excluded from extrafloral nectar. As a legume with tolerance for moderate cadmium contamination, C. fasciculata has potential for phytoremediation. However, our findings also indicate the importance of considering the effects of genetic variation on plant performance when screening plant populations for utilization in remediation and restoration activities. Also, there is potential for cadmium contamination to affect other species through contamination of leaves, fruits, flowers, pollen and root nodules.	[Henson, Tessa M.; Rutter, Matthew T.] Coll Charleston, Dept Biol, Charleston, SC 29424 USA; [Cory, Wendy] Coll Charleston, Dept Chem & Biochem, Charleston, SC 29401 USA	College of Charleston; College of Charleston	Rutter, MT (corresponding author), Coll Charleston, Dept Biol, Charleston, SC 29424 USA.	rutterm@cofc.edu			College of Charleston	College of Charleston	This study was supported by funding from the College of Charleston. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SV, 2012, OCCUP ENVIRON MED, V69, P153, DOI 10.1136/oemed-2011-100111; Adriano D. C., 1986, Trace elements in the terrestrial environment.; Agrawal AA, 1998, OIKOS, V83, P227, DOI 10.2307/3546834; Assuncao AGL, 2003, NEW PHYTOL, V159, P411, DOI 10.1046/j.1469-8137.2003.00819.x; Assuncao AGL, 2003, NEW PHYTOL, V159, P383, DOI 10.1046/j.1469-8137.2003.00758.x; ATSDR (Agency for Toxic Substances and Disease Registry), 1997, TOX PROF CADM UPD; BALSBERG AM, 1982, OIKOS, V38, P91, DOI 10.2307/3544570; Belimov AA, 2007, ACTA PHYSIOL PLANT, V29, P473, DOI 10.1007/s11738-007-0057-y; Bert V, 2000, NEW PHYTOL, V146, P225, DOI 10.1046/j.1469-8137.2000.00634.x; Best EPH, 2007, TR0711 ERDC US ARM; Bogdanov S, 2007, J APICULT RES, V46, P269, DOI 10.1080/00218839.2007.11101407; Bolan NS, 2011, ADV AGRON, V112, P145, DOI 10.1016/B978-0-12-385538-1.00004-4; Bosiacki M, 2008, ACTA SCI POL-HORTORU, V7, P21; Broadley MR, 2001, NEW PHYTOL, V152, P9, DOI 10.1046/j.0028-646x.2001.00238.x; BROWN SL, 1994, J ENVIRON QUAL, V23, P1151, DOI 10.2134/jeq1994.00472425002300060004x; Chen H, 2001, CHEMOSPHERE, V45, P21, DOI 10.1016/S0045-6535(01)00031-5; Chen WM, 2008, J HAZARD MATER, V151, P364, DOI 10.1016/j.jhazmat.2007.05.082; Cobbett C, 2003, NEW PHYTOL, V159, P289, DOI 10.1046/j.1469-8137.2003.00832.x; Dierkes C, 1999, WATER SCI TECHNOL, V39, P201, DOI 10.1016/S0273-1223(99)00024-4; Escarre J, 2000, NEW PHYTOL, V145, P429, DOI 10.1046/j.1469-8137.2000.00599.x; Etterson JR, 2004, EVOLUTION, V58, P1459, DOI 10.1111/j.0014-3820.2004.tb01727.x; Feist LJ, 2001, NEW PHYTOL, V149, P61, DOI 10.1046/j.1469-8137.2001.00004.x; GUREVITCH J, 2006, ECOLOGY PLANTS; Ji PH, 2011, ENVIRON POLLUT, V159, P762, DOI 10.1016/j.envpol.2010.11.029; Kearns C. A., 1993, TECHNIQUES POLLINATI; KOPTUR S, 1994, BIOTROPICA, V26, P276, DOI 10.2307/2388848; Lin ZQ, 2007, DEV ENVIRONM SCI, V5, P487, DOI 10.1016/S1474-8177(07)05022-X; Liu ZL, 2009, J HAZARD MATER, V169, P170, DOI 10.1016/j.jhazmat.2009.03.090; Lombi E, 2000, NEW PHYTOL, V145, P11, DOI 10.1046/j.1469-8137.2000.00560.x; Macnair MR, 2002, NEW PHYTOL, V155, P59, DOI 10.1046/j.1469-8137.2002.00445.x; Macnair MR, 1999, P ROY SOC B-BIOL SCI, V266, P2175, DOI 10.1098/rspb.1999.0905; MACNAIR MR, 1993, NEW PHYTOL, V124, P541, DOI 10.1111/j.1469-8137.1993.tb03846.x; Mahieu S, 2011, PLANT SOIL, V342, P405, DOI 10.1007/s11104-010-0705-7; Manier N, 2009, J ENVIRON QUAL, V38, P685, DOI 10.2134/jeq2008.0013; Marschner H., 1995, MINERAL NUTR HIGHER, Vsecond, DOI DOI 10.1016/B978-0-12-473542-2.X5000-7; McGrath SP, 2002, ADV AGRON, V75, P1, DOI 10.1016/S0065-2113(02)75002-5; Meers E, 2006, ENVIRON MONIT ASSESS, V120, P243, DOI 10.1007/s10661-005-9059-7; Meerts P, 1997, PLANT ECOL, V133, P221, DOI 10.1023/A:1009717619579; Mogren CL, 2010, ENTOMOL EXP APPL, V135, P1, DOI 10.1111/j.1570-7458.2010.00967.x; Molitor M, 2005, NEW PHYTOL, V165, P503, DOI 10.1111/j.1469-8137.2004.01240.x; Morris JB, 2012, GENET RESOUR CROP EV, V59, P1577, DOI 10.1007/s10722-012-9881-z; Page A.L., 1987, LEAD MERCURY CADMIUM, P119; Pohl P, 2009, TRAC-TREND ANAL CHEM, V28, P117, DOI 10.1016/j.trac.2008.09.015; Pollard AJ, 2002, CRIT REV PLANT SCI, V21, P539, DOI 10.1080/0735-260291044359; Robinson BH, 2000, PLANT SOIL, V227, P301, DOI 10.1023/A:1026515007319; Roman A, 2010, POL J ENVIRON STUD, V19, P663; Roosens N, 2003, PLANT CELL ENVIRON, V26, P1657, DOI 10.1046/j.1365-3040.2003.01084.x; Rutter MT, 2005, EVOL ECOL RES, V7, P407; Rutter MT, 2004, EVOLUTION, V58, P2657, DOI 10.1111/j.0014-3820.2004.tb01619.x; Sahinler N, 2009, ASIAN J CHEM, V21, P1887; Shamsi IH, 2008, BIOL PLANTARUM, V52, P165, DOI 10.1007/s10535-008-0036-1; Singer SR, 2009, PLANT PHYSIOL, V151, P1041, DOI 10.1104/pp.109.144774; SMITH LL, 1990, ECOLOGY, V71, P107, DOI 10.2307/1940251; Stolt P, 2006, J AGRON CROP SCI, V192, P201, DOI 10.1111/j.1439-037X.2006.00202.x; Sun YB, 2009, J HAZARD MATER, V161, P808, DOI 10.1016/j.jhazmat.2008.04.030; USDA, 2013, USDA NAT RES CONS SE; Walker DJ, 2007, WATER AIR SOIL POLL, V184, P335, DOI 10.1007/s11270-007-9422-0; WILKINS DA, 1978, NEW PHYTOL, V80, P623, DOI 10.1111/j.1469-8137.1978.tb01595.x; Wu FY, 2009, ENVIRON POLLUT, V157, P2394, DOI 10.1016/j.envpol.2009.03.022; Wu FZ, 2010, J HAZARD MATER, V177, P268, DOI 10.1016/j.jhazmat.2009.12.028; Xiong ZT, 2001, ECOTOX ENVIRON SAFE, V48, P51, DOI 10.1006/eesa.2000.2002; Yazgan S, 2006, DEUT LEBENSM-RUNDSCH, V102, P192; Zacchini M, 2009, WATER AIR SOIL POLL, V197, P23, DOI 10.1007/s11270-008-9788-7; Zha HG, 2004, NEW PHYTOL, V163, P299, DOI 10.1111/j.1469-8137.2004.01113.x; Zhu Y, 2007, J AGR FOOD CHEM, V55, P1045, DOI 10.1021/jf062971p; Zorrig W, 2010, J PLANT PHYSIOL, V167, P1239, DOI 10.1016/j.jplph.2010.04.012; Zuur Alain F., 2009, P1	67	20	21	5	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63200	10.1371/journal.pone.0063200	http://dx.doi.org/10.1371/journal.pone.0063200			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667586	Green Published, Green Submitted, gold			2022-12-25	WOS:000319654700116
J	Schmidt, FM; Kratzsch, J; Gertz, HJ; Tittmann, M; Jahn, I; Pietsch, UC; Kaisers, UX; Thiery, J; Hegerl, U; Schoknecht, P				Schmidt, Frank M.; Kratzsch, Juergen; Gertz, Hermann-Josef; Tittmann, Mandy; Jahn, Ina; Pietsch, Uta-Carolin; Kaisers, Udo X.; Thiery, Joachim; Hegerl, Ulrich; Schoenknecht, Peter			Cerebrospinal Fluid Melanin-Concentrating Hormone (MCH) and Hypocretin-1 (HCRT-1, Orexin-A) in Alzheimer's Disease	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; SLEEP-WAKE CYCLE; MEMORY CONSOLIDATION; HEALTHY CONTROLS; MESSENGER-RNA; DEMENTIA; NEURONS; RAT; MICE; AGE	Ancillary to decline in cognitive abilities, patients with Alzheimer's disease (AD) frequently suffer from behavioural and psychological symptoms of dementia (BPSD). Hypothalamic polypeptides such as melanin-concentrating hormone (MCH) and hypocretin-1 (HCRT-1, orexin-A) are promoters of sleep-wake regulation and energy homeostasis and are found to impact on cognitive performance. To investigate the role of MCH and HCRT-1 in AD, cerebrospinal fluid (CSF) levels were measured in 33 patients with AD and 33 healthy subjects (HS) using a fluorescence immunoassay (FIA). A significant main effect of diagnosis (F(1,62) = 8.490, p<0.01) on MCH levels was found between AD (93.76 +/- 13.47 pg/mL) and HS (84.65 +/- 11.40 pg/mL). MCH correlated with T-tau (r = 0.47; p<0.01) and P-tau (r = 0.404; p<0.05) in the AD but not in the HS. CSF-MCH correlated negatively with MMSE scores in the AD (r = -0.362, p<0.05) and was increased in more severely affected patients (MMSE <= 20) compared to HS (p<0.001) and BPSD-positive patients compared to HS (p<0.05). In CSF-HCRT-1, a significant main effect of sex (F(1,31) = 4.400, p<0.05) with elevated levels in females (90.93 +/- 17.37 pg/mL vs. 82.73 +/- 15.39 pg/mL) was found whereas diagnosis and the sex*diagnosis interaction were not significant. Elevated levels of MCH in patients suffering from AD and correlation with Tau and severity of cognitive impairment point towards an impact of MCH in AD. Gender differences of CSF-HCRT-1 controversially portend a previously reported gender dependence of HCRT-1-regulation. Histochemical and actigraphic explorations are warranted to further elucidate alterations of hypothalamic transmitter regulation in AD.	[Schmidt, Frank M.; Gertz, Hermann-Josef; Tittmann, Mandy; Jahn, Ina; Hegerl, Ulrich; Schoenknecht, Peter] Univ Hosp Leipzig, Dept Psychiat & Psychotherapy, Leipzig, Germany; [Kratzsch, Juergen; Thiery, Joachim] Univ Hosp Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, Leipzig, Germany; [Pietsch, Uta-Carolin; Kaisers, Udo X.] Univ Hosp Leipzig, Dept Anesthesiol & Intens Care Med, Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University	Schmidt, FM (corresponding author), Univ Hosp Leipzig, Dept Psychiat & Psychotherapy, Leipzig, Germany.	frank.schmidt2@medizin.uni-leipzig.de		Hegerl, Ulrich/0000-0002-3039-7470				Adamantidis A, 2005, EUR J NEUROSCI, V21, P2837, DOI 10.1111/j.1460-9568.2005.04100.x; Adamantidis A, 2009, PEPTIDES, V30, P2066, DOI 10.1016/j.peptides.2009.06.024; Arrigoni E, 2010, ACTA PHYSIOL, V198, P223, DOI 10.1111/j.1748-1716.2009.02036.x; Baumann CR, 2006, J NEUROL, V253, P1232, DOI 10.1007/s00415-006-0146-7; Bayer L, 2005, NEUROSCIENCE, V130, P807, DOI 10.1016/j.neuroscience.2004.10.032; Burkart M, 1998, NERVENARZT, V69, P983, DOI 10.1007/s001150050373; Cecon E, 2011, RECENT PATENTS ENDOC, V5, P91, DOI 10.2174/187221411799015381; Chung SJ, 2011, J MOL NEUROSCI, V43, P115, DOI 10.1007/s12031-010-9411-4; Clinton LK, 2007, NEUROBIOL DIS, V28, P76, DOI 10.1016/j.nbd.2007.06.013; Delazer M, 2011, NEUROPSYCHOLOGY, V25, P477, DOI 10.1037/a0022357; Dubois B, 2010, LANCET NEUROL, V9, P1118, DOI 10.1016/S1474-4422(10)70223-4; Ellenbogen JM, 2006, CURR OPIN NEUROBIOL, V16, P716, DOI 10.1016/j.conb.2006.10.006; Fernandez M, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-87; Fetzner S, 2004, ARCH CLIN NEUROPSYCH, V19, P918; First M. B., 1997, STRUCTURED CLIN INTE; Friedman LF, 2007, NEUROLOGY, V68, P793, DOI 10.1212/01.wnl.0000256731.57544.f9; Fronczek R, 2012, NEUROBIOL AGING, V33, P1642, DOI 10.1016/j.neurobiolaging.2011.03.014; Gao S, 1998, ARCH GEN PSYCHIAT, V55, P809, DOI 10.1001/archpsyc.55.9.809; Gerashchenko D, 2003, EXP NEUROL, V184, P1010, DOI 10.1016/S0014-4886(03)00388-1; Gozzi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016406; Guyon A, 2009, PEPTIDES, V30, P2031, DOI 10.1016/j.peptides.2009.05.028; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hassani OK, 2009, P NATL ACAD SCI USA, V106, P2418, DOI 10.1073/pnas.0811400106; Hervieu GJ, 2000, EUR J NEUROSCI, V12, P1194, DOI 10.1046/j.1460-9568.2000.00008.x; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Johren O, 2002, PEPTIDES, V23, P1177, DOI 10.1016/S0196-9781(02)00052-9; Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; Kessler BA, 2011, NEUROSCIENCE, V178, P82, DOI 10.1016/j.neuroscience.2011.01.031; Lambe EK, 2005, J NEUROSCI, V25, P5225, DOI 10.1523/JNEUROSCI.0719-05.2005; Lessig S, 2010, NEUROREPORT, V21, P756, DOI 10.1097/WNR.0b013e32833bfb7c; McCurry S. M., 1985, CURR TREAT OPTION NE, V5, P261; MCDUFF T, 1985, NEUROLOGY, V35, P123, DOI 10.1212/WNL.35.1.123; Millan MJ, 2008, INT J NEUROPSYCHOPH, V11, P1105, DOI 10.1017/S1461145708008894; Monzon ME, 1999, PEPTIDES, V20, P1517, DOI 10.1016/S0196-9781(99)00164-3; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; MUNGAS D, 1991, GERIATRICS, V46, P54; Naumann A, 2003, BEHAV NEUROL, V14, P89, DOI 10.1155/2003/323060; OGOMORI K, 1989, AM J PATHOL, V134, P243; Peyron C, 2009, PEPTIDES, V30, P2052, DOI 10.1016/j.peptides.2009.07.022; Raggi A, 2011, NEUROSCI BIOBEHAV R, V35, P1144, DOI 10.1016/j.neubiorev.2010.12.001; Rolls A, 2011, P NATL ACAD SCI USA, V108, P13305, DOI 10.1073/pnas.1015633108; RUSSELL EW, 1982, PERCEPT MOTOR SKILL, V54, P971, DOI 10.2466/pms.1982.54.3.971; Sakamaki R, 2005, INT J MOL MED, V15, P1033; Salomon RM, 2003, BIOL PSYCHIAT, V54, P96, DOI 10.1016/S0006-3223(02)01740-7; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Schmidt FM, 2011, PSYCHIAT RES, V190, P240, DOI 10.1016/j.psychres.2011.06.004; Shimada M, 1998, NATURE, V396, P670, DOI 10.1038/25341; Shulman KI, 2000, INT J GERIATR PSYCH, V15, P548, DOI 10.1002/1099-1166(200006)15:6<548::AID-GPS242>3.0.CO;2-U; Silva A, 2008, BRAZ J MED BIOL RES, V41, P1067, DOI 10.1590/S0100-879X2008001200005; Silveyra P, 2009, REGUL PEPTIDES, V158, P121, DOI 10.1016/j.regpep.2009.08.002; SIMPSON J, 1988, NEUROPATH APPL NEURO, V14, P381, DOI 10.1111/j.1365-2990.1988.tb01140.x; Slats D, 2012, CURR ALZHEIMER RES, V9, P1119, DOI 10.2174/156720512804142840; Smith DG, 2006, NEUROPSYCHOPHARMACOL, V31, P1135, DOI 10.1038/sj.npp.1300913; Stanley EM, 2012, SYNAPSE, V66, P445, DOI 10.1002/syn.21533; van den Pol AN, 2004, NEURON, V42, P635, DOI 10.1016/S0896-6273(04)00251-X; Varas M, 2002, PEPTIDES, V23, P151, DOI 10.1016/S0196-9781(01)00591-5; Verret L, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-19; Wang G, 2011, TRENDS NEUROSCI, V34, P452, DOI 10.1016/j.tins.2011.07.005; Wennstrom M, 2012, J ALZHEIMERS DIS, V29, P125, DOI [10.3233/JAD-2011-111655, 10.3233/JAD-2012-111655]	59	50	54	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63136	10.1371/journal.pone.0063136	http://dx.doi.org/10.1371/journal.pone.0063136			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667582	Green Published, Green Submitted, gold			2022-12-25	WOS:000319654700113
J	Postlethwaite, CM; Dennis, TE				Postlethwaite, Claire M.; Dennis, Todd E.			Effects of Temporal Resolution on an Inferential Model of Animal Movement	PLOS ONE			English	Article							GPS COLLAR PERFORMANCE; STATE-SPACE MODELS; TRICHOSURUS-VULPECULA; SATELLITE TELEMETRY; LOCATION ERROR; SAMPLING RATE; RANDOM-WALKS; TRACKING; BEHAVIOR; ECOLOGY	Recently, there has been much interest in describing the behaviour of animals by fitting various movement models to tracking data. Despite this interest, little is known about how the temporal 'grain' of movement trajectories affects the outputs of such models, and how behaviours classified at one timescale may differ from those classified at other scales. Here, we present a study in which random-walk state-space models were fit both to nightly geospatial lifelines of common brushtail possums (Trichosurus vulpecula) and synthetic trajectories parameterised from empirical observations. Observed trajectories recorded by GPS collars at 5-min intervals were sub-sampled at periods varying between 10 and 60 min, to approximate the effect of collecting data at lower sampling frequencies. Markov-Chain Monte-Carlo fitting techniques, using information about movement rates and turning angles between sequential fixes, were employed using a Bayesian framework to assign distinct behavioural states to individual location estimates. We found that in trajectories with higher temporal granularities behaviours could be clearly differentiated into 'slow-area-restricted' and 'fast-transiting' states, but for trajectories with longer inter-fix intervals this distinction was markedly less obvious. Specifically, turning-angle distributions varied from being highly peaked around either 00 or 1800 at fine temporal scales, to being uniform across all angles at low sampling intervals. Our results highlight the difficulty of comparing model results amongst tracking-data sets that vary substantially in temporal grain, and demonstrate the importance of matching the observed temporal resolution of tracking devices to the timescales of behaviours of interest, otherwise inter-individual comparisons of inferred behaviours may be invalid, or important biological information may be obscured.	[Postlethwaite, Claire M.] Univ Auckland, Dept Math, Auckland, New Zealand; [Dennis, Todd E.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand	University of Auckland; University of Auckland	Postlethwaite, CM (corresponding author), Univ Auckland, Dept Math, Auckland, New Zealand.	c.postlethwaite@math.auckland.ac.nz	Postlethwaite, Claire M/D-4696-2009	Postlethwaite, Claire M/0000-0003-0654-6736	Nga Pae o te Maramatanga [08-RF1-22]; School of Biological Sciences at the University of Auckland; Department of Mathematics at the University of Auckland	Nga Pae o te Maramatanga; School of Biological Sciences at the University of Auckland; Department of Mathematics at the University of Auckland	The authors gratefully acknowledge the financial support by Nga Pae o te Maramatanga (08-RF1-22 to T.E.D.) and the School of Biological Sciences and the Department of Mathematics at the University of Auckland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin D, 2003, MAR MAMMAL SCI, V19, P371, DOI 10.1111/j.1748-7692.2003.tb01115.x; Benhamou S, 2004, J THEOR BIOL, V229, P209, DOI 10.1016/j.jtbi.2004.03.016; BOVET P, 1988, J THEOR BIOL, V131, P419, DOI 10.1016/S0022-5193(88)80038-9; Brooks C, 2008, J WILDLIFE MANAGE, V72, P527, DOI 10.2193/2007-061; Codling EA, 2005, J THEOR BIOL, V233, P573, DOI 10.1016/j.jtbi.2004.11.008; Cooke SJ, 2004, TRENDS ECOL EVOL, V19, P334, DOI 10.1016/j.tree.2004.04.003; COWAN PE, 1989, AUST WILDLIFE RES, V16, P63; D'Eon RG, 2005, J APPL ECOL, V42, P383, DOI 10.1111/j.1365-2664.2005.01010.x; D'Eon RG, 2002, WILDLIFE SOC B, V30, P430; Dennis T.E., 2010, Wildlife Biology in Practice, V6, P14; Di Orio AP, 2003, WILDLIFE SOC B, V31, P372; Egevang C, 2010, P NATL ACAD SCI USA, V107, P2078, DOI 10.1073/pnas.0909493107; Girard I, 2006, J WILDLIFE MANAGE, V70, P1249, DOI 10.2193/0022-541X(2006)70[1249:BNOLWN]2.0.CO;2; Herbert PA, 1999, AUST J ZOOL, V47, P579, DOI 10.1071/ZO99035; Holden C, 2006, SCIENCE, V313, P779, DOI 10.1126/science.313.5788.779; Horne JS, 2007, ECOLOGY, V88, P2354, DOI 10.1890/06-0957.1; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Jonsen ID, 2003, ECOLOGY, V84, P3055, DOI 10.1890/02-0670; KEATING KA, 1991, J WILDLIFE MANAGE, V55, P160, DOI 10.2307/3809254; Lewis JS, 2007, J APPL ECOL, V44, P663, DOI 10.1111/j.1365-2664.2007.01286.x; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; MacLennan D.G., 1984, P155; Mattisson J, 2010, J WILDLIFE MANAGE, V74, P557, DOI 10.2193/2009-157; Mills KJ, 2006, WILDLIFE SOC B, V34, P1463, DOI 10.2193/0091-7648(2006)34[1463:EOVSFO]2.0.CO;2; Moen R, 1996, J WILDLIFE MANAGE, V60, P659, DOI 10.2307/3802085; Morales JM, 2004, ECOLOGY, V85, P2436, DOI 10.1890/03-0269; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; Patterson TA, 2009, J ANIM ECOL, V78, P1113, DOI 10.1111/j.1365-2656.2009.01583.x; Ryan PG, 2004, MAR BIOL, V145, P215, DOI 10.1007/s00227-004-1328-4; Schick RS, 2008, ECOL LETT, V11, P1338, DOI 10.1111/j.1461-0248.2008.01249.x; Shaffer SA, 2005, MAR BIOL, V147, P833, DOI 10.1007/s00227-005-1631-8; Stephens M, 2000, J ROY STAT SOC B, V62, P795, DOI 10.1111/1467-9868.00265; Ward GD, 1978, P NATL ZOOLOGICAL PA, V1, P267	34	25	25	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e57640	10.1371/journal.pone.0057640	http://dx.doi.org/10.1371/journal.pone.0057640			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671558	Green Published, gold, Green Submitted			2022-12-25	WOS:000321390200001
J	Talamini, LM; Bringmann, LF; de Boer, M; Hofman, WF				Talamini, Lucia M.; Bringmann, Laura F.; de Boer, Marieke; Hofman, Winni F.			Sleeping Worries Away or Worrying Away Sleep? Physiological Evidence on Sleep-Emotion Interactions	PLOS ONE			English	Article							SLOW-WAVE SLEEP; POSTTRAUMATIC-STRESS-DISORDER; EYE-MOVEMENT SLEEP; REM-SLEEP; DECLARATIVE MEMORY; DEPRIVATION; DEPRESSION; ADAPTATION; INSOMNIA; CONSOLIDATION	Recent findings suggest that sleep might serve a role in emotional coping. However, most findings are based on subjective reports of sleep quality, while the relation with underlying sleep physiology is still largely unknown. In this study, the impact of an emotionally distressing experience on the EEG correlates of sleep was assessed. In addition, the association between sleep physiological parameters and the extent of emotional attenuation over sleep was determined. The experimental set up involved presentation of an emotionally neutral or distressing film fragment in the evening, followed by polysomnographic registration of undisturbed, whole-night sleep and assessment of emotional reactivity to film cues on the next evening. We found that emotional distress induced mild sleep deterioration, but also an increase in the proportion of slow wave sleep (SWS) and altered patterning of rapid eye movement (REM) sleep. Indeed, while REM sleep occurrence normally increases over the course of the night, emotional distress flattened this distribution and correlated with an increased number of REM periods. While sleep deterioration was negatively associated to emotional attenuation over sleep, the SWS response was positively related to such attenuation and may form part of a compensatory response to the stressor. Interestingly, trait-like SWS characteristics also correlated positively with the extent of emotion attenuation over sleep. The combined results provide strong evidence for an intimate reciprocal relation between sleep physiology and emotional processing. Moreover, individual differences in subjects' emotional and sleep responses suggest there may be a coupling of certain emotion and sleep traits into distinct emotional sleep types.	[Talamini, Lucia M.; Bringmann, Laura F.; de Boer, Marieke; Hofman, Winni F.] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Talamini, Lucia M.; de Boer, Marieke; Hofman, Winni F.] Univ Amsterdam, Cognit Sci Ctr Amsterdam, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam	Talamini, LM (corresponding author), Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands.	L.M.Talamini@uva.nl			NWO (Netherlands Organisation for Scientific Research) [452-08-013]	NWO (Netherlands Organisation for Scientific Research)(Netherlands Organization for Scientific Research (NWO))	This work was funded by NWO (Netherlands Organisation for Scientific Research) grant 452-08-013 (www.nwo.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babson KA, 2010, J ANXIETY DISORD, V24, P1, DOI 10.1016/j.janxdis.2009.08.002; BAEKELAND F, 1968, PSYCHOPHYSIOLOGY, V4, P436; Baldwin DC, 2004, SLEEP, V27, P217, DOI 10.1093/sleep/27.2.217; Borbely A A, 1982, Hum Neurobiol, V1, P195; BRUNNER DP, 1990, ELECTROEN CLIN NEURO, V75, P492, DOI 10.1016/0013-4694(90)90136-8; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Buysse DJ, 2008, SLEEP, V31, P473, DOI 10.1093/sleep/31.4.473; CARTWRIGHT RD, 1991, AM J PSYCHIAT, V148, P1530; Cluydts R, 1980, Waking Sleeping, V4, P199; COHEN DB, 1975, J ABNORM PSYCHOL, V84, P91, DOI 10.1037/h0076938; Cox R, 2012, LEARN MEMORY, V19, P264, DOI 10.1101/lm.026252.112; DEDIANA IPF, 1976, SLEEP RES, V5, P101; DEKONINCK JM, 1975, J ABNORM PSYCHOL, V84, P250, DOI 10.1037/h0076648; Deliens G., 2012, CORTEX, DOI 10.1016/j.cortex.2012.11.014; Dijk DJ, 2010, WORLD J BIOL PSYCHIA, V11, P22, DOI 10.3109/15622971003637645; Dinges DF, 1997, SLEEP, V20, P267; Ellenbogen JM, 2006, CURR BIOL, V16, P1290, DOI 10.1016/j.cub.2006.05.024; Franzen PL, 2009, BIOL PSYCHOL, V80, P300, DOI 10.1016/j.biopsycho.2008.10.010; Germain A, 2003, PSYCHOSOM MED, V65, P857, DOI 10.1097/01.PSY.0000079376.87711.B0; GREENBERG R, 1972, PSYCHOSOM MED, V34, P257, DOI 10.1097/00006842-197205000-00007; Groch S, 2013, NEUROBIOL LEARN MEM, V99, P1, DOI 10.1016/j.nlm.2012.10.006; Gujar N, 2011, J NEUROSCI, V31, P4466, DOI 10.1523/JNEUROSCI.3220-10.2011; Haack M, 2005, PAIN, V119, P56, DOI 10.1016/j.pain.2005.09.011; HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x; HOLM S, 1979, SCAND J STAT, V6, P65; Hu P, 2006, PSYCHOL SCI, V17, P891, DOI 10.1111/j.1467-9280.2006.01799.x; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Keklund G, 1997, J SLEEP RES, V6, P217, DOI 10.1111/j.1365-2869.1997.00217.x; Kim Eui-Joong, 2007, Behav Sleep Med, V5, P256; Kothe M, 2001, DREAMING, V11, P43, DOI 10.1023/A:1009468517557; KOULACK D, 1985, SLEEP, V8, P244, DOI 10.1093/sleep/8.3.244; Lara-Carrasco J, 2009, J SLEEP RES, V18, P178, DOI 10.1111/j.1365-2869.2008.00709.x; LAUER C, 1987, PSYCHOPHYSIOLOGY, V24, P263, DOI 10.1111/j.1469-8986.1987.tb00293.x; Manber R, 2008, SLEEP, V31, P489, DOI 10.1093/sleep/31.4.489; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Marshall L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016905; Meerlo P, 2001, PHYSIOL BEHAV, V73, P331, DOI 10.1016/S0031-9384(01)00451-6; Meerlo P, 2001, BRAIN RES, V907, P84, DOI 10.1016/S0006-8993(01)02603-8; Meerlo P, 1997, NEUROSCI LETT, V225, P41, DOI 10.1016/S0304-3940(97)00180-8; Mellman TA, 2002, AM J PSYCHIAT, V159, P1696, DOI 10.1176/appi.ajp.159.10.1696; Molle M, 2004, P NATL ACAD SCI USA, V101, P13963, DOI 10.1073/pnas.0402820101; Nielsen T, 2007, NEW SCI DREAMING, P253; Pace-Schott EF, 2011, NEUROBIOL LEARN MEM, V95, P24, DOI 10.1016/j.nlm.2010.10.006; Payne JD, 2008, PSYCHOL SCI, V19, P781, DOI 10.1111/j.1467-9280.2008.02157.x; Peigneux P, 2004, NEURON, V44, P535, DOI 10.1016/j.neuron.2004.10.007; Peyrache A, 2009, NAT NEUROSCI, V12, P919, DOI 10.1038/nn.2337; Pigeon WR, 2008, SLEEP, V31, P481, DOI 10.1093/sleep/31.4.481; Pilcher JJ, 1996, SLEEP, V19, P318, DOI 10.1093/sleep/19.4.318; RECHTSCHAFFEN A, 1968, PUBLICATION NIH, V204; Rosales-Lagarde A, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00025; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Spoormaker VI, 2008, SLEEP MED REV, V12, P169, DOI 10.1016/j.smrv.2007.08.008; Staner L, 2010, SLEEP MED REV, V14, P35, DOI 10.1016/j.smrv.2009.09.003; Sterpenich V, 2009, J NEUROSCI, V29, P5143, DOI 10.1523/JNEUROSCI.0561-09.2009; Stickgold R, 2001, SCIENCE, V294, P1052, DOI 10.1126/science.1063530; Talamini LM, 2008, LEARN MEMORY, V15, P233, DOI 10.1101/lm.771608; Tsuno N, 2005, J CLIN PSYCHIAT, V66, P1254, DOI 10.4088/JCP.v66n1008; Van der Ark L.A., 2003, HANDLEIDING VERANTWO; van der Helm E, 2011, CURR BIOL, V21, P2029, DOI 10.1016/j.cub.2011.10.052; Visser P, 1979, SLEEP RES, P135; Wagner U, 2001, LEARN MEMORY, V8, P112, DOI 10.1101/lm.36801; Wagner U, 2004, NATURE, V427, P352, DOI 10.1038/nature02223; Wagner U, 2006, BIOL PSYCHIAT, V60, P788, DOI 10.1016/j.biopsych.2006.03.061; Walker MP, 2009, PSYCHOL BULL, V135, P731, DOI 10.1037/a0016570; Yoo SS, 2007, CURR BIOL, V17, pR877, DOI 10.1016/j.cub.2007.08.007; Zohar D, 2005, SLEEP, V28, P47, DOI 10.1093/sleep/28.1.47; [No title captured]	67	46	46	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e62480	10.1371/journal.pone.0062480	http://dx.doi.org/10.1371/journal.pone.0062480			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	147KY	23671601	gold, Green Published, Green Submitted			2022-12-25	WOS:000319167000049
J	Lopez-Montero, I; Lopez-Navajas, P; Mingorance, J; Rivas, G; Velez, M; Vicente, M; Monroy, F				Lopez-Montero, Ivan; Lopez-Navajas, Pilar; Mingorance, Jesus; Rivas, German; Velez, Marisela; Vicente, Miguel; Monroy, Francisco			Intrinsic disorder of the bacterial cell division protein ZipA: coil-to-brush conformational transition	FASEB JOURNAL			English	Article						E; coli; Langmuir monolayers; polymer theory	AIR-WATER; UNSTRUCTURED PROTEINS; RHEOLOGICAL PROPERTIES; DILATATIONAL RHEOLOGY; ADSORPTION-KINETICS; SURFACE RHEOLOGY; RING STRUCTURE; FTSZ; INTERFACES; MEMBRANE	The full-length ZipA protein from Escherichia coli, one of the essential elements of the cell division machinery, was studied in a surface model built as adsorbed monolayers. The interplay between lateral packing and molecular conformation was probed using a combined methodology based on the scaling analysis of the surface pressure isotherms and ellipsometry measurements of the monolayer thickness. The observed behavior is compatible with the one expected for an intrinsically disordered and highly flexible protein that is preferentially structured in a random coil conformation. At low grafting densities, ZipA coils organize in a mushroom-like regime, whereas a coil-to-brush transition occurs on increasing lateral packing. The structural results suggest a functional scenario in which ZipA acts as a flexible tether anchoring bacterial proto-ring elements to the membrane during the earlier stages of division.Lopez-Montero, I., Lopez-Navajas, P., Mingorance, J., Rivas, G., Velez, M., Vicente, M., Monroy, F. Intrinsic disorder of the bacterial cell division protein ZipA: coil-to-brush conformational transition.	[Lopez-Montero, Ivan; Monroy, Francisco] Univ Complutense, Dept Quim Fis 1, E-28040 Madrid, Spain; [Lopez-Navajas, Pilar; Rivas, German] CSIC, CIB, Madrid, Spain; [Mingorance, Jesus] Hosp Univ La Paz, IdiPaz, Madrid, Spain; [Velez, Marisela] CSIC, Inst Catalisis & Petr Quim, Madrid, Spain; [Velez, Marisela] CSIC, Fac Ciencias, Inst Madrileno Estudios Avanzados Nanociencia IMD, Madrid, Spain; [Vicente, Miguel] CSIC, CNB, Madrid, Spain	Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Hospital Universitario La Paz; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Catalisis y Petroleoquimica (ICP); Consejo Superior de Investigaciones Cientificas (CSIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Monroy, F (corresponding author), Univ Complutense Madrid, Dept Quim Fis 1 1, Ciudad Univ S-N, E-28040 Madrid, Spain.	monroy@quim.ucm.es	López-Montero, Iván/A-5263-2017; Monroy, Francisco/N-2763-2013; Rivas, German/AAG-7458-2022; Rivas, German/AFL-7528-2022; Mingorance, Jesus/B-7562-2009; Velez, Marisela/F-2900-2013	López-Montero, Iván/0000-0001-8131-6063; Monroy, Francisco/0000-0001-6455-3083; Rivas, German/0000-0003-3450-7478; Rivas, German/0000-0003-3450-7478; Mingorance, Jesus/0000-0001-6173-5711; Velez, Marisela/0000-0002-9424-510X	Ministerio de Economia y Competitividad of Spain [FIS2012-35723, FIS2009-14650-C02-01, BIO2008-04478-C03, BIO2011-28941-C03-01, BIO2011-28941-C03-02, CSD2007-0010]; Comunidad de Madrid (CAM) [S2005MAT-0283, S2009MAT-1507, S2006-BIO-0260]; European Commission [DIVINOCELL FP7 HEALTH-F3-2009-223431]; Human Frontier Science Program [HFSP-RGP0050/2010]; Juan de la Cierva program (Ministerio de Economia y Competitividad); Research Consortium on Nanobiomaterials (NOBIMAT); Research Consortium on Nanobiomaterials (CAM); Programa de Formacion de Personal Investigador (FPI-CAM)	Ministerio de Economia y Competitividad of Spain(Spanish Government); Comunidad de Madrid (CAM)(Comunidad de Madrid); European Commission(European CommissionEuropean Commission Joint Research Centre); Human Frontier Science Program(Human Frontier Science Program); Juan de la Cierva program (Ministerio de Economia y Competitividad); Research Consortium on Nanobiomaterials (NOBIMAT); Research Consortium on Nanobiomaterials (CAM); Programa de Formacion de Personal Investigador (FPI-CAM)	This work was partially financed under grants from the Ministerio de Economia y Competitividad of Spain (FIS2012-35723 and FIS2009-14650-C02-01 to F. M.; BIO2008-04478-C03 to M. Vi., G. R., and M.Ve.; BIO2011-28941-C03-01 to M. Vi.; BIO2011-28941-C03-02 to G. R.; and Consolider Ingenio en Nanociencia Molecular CSD2007-0010 to F. M. and M. V.); Comunidad de Madrid (CAM; S2005MAT-0283 and S2009MAT-1507 to F. M. and M. V., and S2006-BIO-0260 to M. Vi., G. R., and J.M.); the European Commission (DIVINOCELL FP7 HEALTH-F3-2009-223431 to M. Vi., G. R., and M.Ve.); and the Human Frontier Science Program (HFSP-RGP0050/2010 to M. Vi. and G. R.). I. L.-M. was partially supported by the Juan de la Cierva program (Ministerio de Economia y Competitividad) and the Research Consortium on Nanobiomaterials (NOBIMAT; CAM). P.L.-N. thanks Programa de Formacion de Personal Investigador (FPI-CAM) for financial support. The authors thank the facility Centro de Asistencia a la Investigacion Infrarrojo-Raman-Correlador (Universidad Complutense) for BAM time.	Adamson A.W., 1990, PHYS CHEM SURFACES; Azzam R. M. A., 1992, ELLIPSOMETRY POLARIZ; Benjamins J, 1996, COLLOID SURFACE A, V114, P245, DOI 10.1016/0927-7757(96)03533-9; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; Brown DA, 2001, CURR BIOL, V11, pR446, DOI 10.1016/S0960-9822(01)00257-3; De Gennes P.-G., 1979, SCALING CONCEPTS POL; Dunker A. K., 2000, BIOCHEMISTRY-US, V41, P6573; Dunker A. K., 2008, CURR OPIN STRUC BIOL, V18, P1; Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Erickson HP, 2001, CURR OPIN CELL BIOL, V13, P55, DOI 10.1016/S0955-0674(00)00174-5; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Gorter E., 1941, ANNU REV BIOCHEM, V10, P619; GRAHAM DE, 1980, J COLLOID INTERF SCI, V76, P227, DOI 10.1016/0021-9797(80)90289-1; Gsponer J, 2008, SCIENCE, V322, P1365, DOI 10.1126/science.1163581; Hale CA, 1997, CELL, V88, P175, DOI 10.1016/S0092-8674(00)81838-3; Hernandez-Rocamora VM, 2012, J BIOL CHEM, V287, P30097, DOI 10.1074/jbc.M112.388959; Hoh JH, 1998, PROTEINS, V32, P223, DOI 10.1002/(SICI)1097-0134(19980801)32:2<223::AID-PROT8>3.0.CO;2-L; Indiana University Center for Computational Biology and Bioinformatics/Temple University Center for Information Science and Technology, 2012, DAT PROT DIS DISPROT; Jonnes R. A. L., 1999, POLYM SURFACES INTER; KAWAGUCHI M, 1993, PROG POLYM SCI, V18, P341, DOI 10.1016/0079-6700(93)90029-C; Langevin D, 2010, CURR OPIN COLLOID IN, V15, P283, DOI 10.1016/j.cocis.2010.02.002; Langmuir I, 1939, CHEM REV, V24, P181, DOI 10.1021/cr60078a002; Liu Z, 1999, MOL MICROBIOL, V31, P1853, DOI 10.1046/j.1365-2958.1999.01322.x; Lopez-Montero I, 2013, BBA-BIOMEMBRANES, V1828, P687, DOI 10.1016/j.bbamem.2012.11.003; Lopez-Montero I, 2008, LANGMUIR, V24, P4065, DOI 10.1021/la703350s; Lopez-Montero I, 2012, LANGMUIR, V28, P4744, DOI 10.1021/la204742b; Lopez-Montero I, 2010, CHEM PHYS LIPIDS, V163, P56, DOI 10.1016/j.chemphyslip.2009.10.002; Maldonado-Valderrama J, 2005, J PHYS CHEM B, V109, P17608, DOI 10.1021/jp050927r; Maldonado-Valderrama J, 2003, LANGMUIR, V19, P8436, DOI 10.1021/la034242z; Martos A, 2010, BIOCHEMISTRY-US, V49, P10780, DOI 10.1021/bi101495x; Mateos-Gil P, 2012, BBA-BIOMEMBRANES, V1818, P806, DOI 10.1016/j.bbamem.2011.12.012; Miller R, 1998, NAHRUNG, V42, P225, DOI 10.1002/(SICI)1521-3803(199808)42:03/04&lt;225::AID-FOOD225&gt;3.3.CO;2-Y; MILNER ST, 1991, SCIENCE, V251, P905, DOI 10.1126/science.251.4996.905; Minton AP, 2010, ANAL BIOCHEM, V397, P247, DOI 10.1016/j.ab.2009.10.023; Mobius D., 1998, STUDIES INTERFACE SC, V7; Monroy F, 1998, PHYS REV E, V58, P7629, DOI 10.1103/PhysRevE.58.7629; Monroy F, 2007, ADV COLLOID INTERFAC, V134-35, P175, DOI 10.1016/j.cis.2007.04.023; Mosyak L, 2000, EMBO J, V19, P3179, DOI 10.1093/emboj/19.13.3179; Moy FJ, 2000, BIOCHEMISTRY-US, V39, P9146, DOI 10.1021/bi0009690; MURAMATSU N, 1988, P NATL ACAD SCI USA, V85, P2984, DOI 10.1073/pnas.85.9.2984; Murray BS, 2002, CURR OPIN COLLOID IN, V7, P426, DOI 10.1016/S1359-0294(02)00077-8; Murray BS, 1996, LANGMUIR, V12, P5973, DOI 10.1021/la960748o; Namba K, 2001, GENES CELLS, V6, P1, DOI 10.1046/j.1365-2443.2001.00384.x; Netz RR, 2003, PHYS REP, V380, P1, DOI 10.1016/S0370-1573(03)00118-2; Nogales E, 1998, NAT STRUCT BIOL, V5, P451, DOI 10.1038/nsb0698-451; Ohashi T, 2002, J BACTERIOL, V184, P4313, DOI 10.1128/JB.184.15.4313-4315.2002; Ohashi T, 2007, PROTEIN SCI, V16, P1429, DOI 10.1110/ps.072845607; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P1989, DOI 10.1021/bi047993o; Orbulescu J, 2010, LANGMUIR, V26, P3268, DOI 10.1021/la903033x; Osawa M, 2008, SCIENCE, V320, P792, DOI 10.1126/science.1154520; Pazos M, 2013, J BIOL CHEM, V288, P3219, DOI 10.1074/jbc.M112.434944; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; Postel C, 2003, J COLLOID INTERF SCI, V266, P74, DOI 10.1016/S0021-9797(03)00571-X; Renault A, 1999, BIOPHYS J, V76, P1580, DOI 10.1016/S0006-3495(99)77317-0; Rivetti C, 1996, J MOL BIOL, V264, P919, DOI 10.1006/jmbi.1996.0687; Rubinstein M, 2003, POLYM PHYS; Rueda S, 2003, J BACTERIOL, V185, P3344, DOI 10.1128/JB.185.11.3344-3351.2003; Russev SC, 2000, COLLOID SURFACE B, V19, P89, DOI 10.1016/S0927-7765(99)00167-8; Sankaranarayanan K, 2010, J PHYS CHEM B, V114, P8067, DOI 10.1021/jp100896b; Sarkis J, 2011, J BIOL CHEM, V286, P30481, DOI 10.1074/jbc.M111.243881; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; Skoog K, 2012, BIOCHEMISTRY-US, V51, P1407, DOI 10.1021/bi2015647; Small DM, 2009, J LIPID RES, V50, pS329, DOI 10.1194/jlr.R800083-JLR200; Stricker J, 2002, P NATL ACAD SCI USA, V99, P3171, DOI 10.1073/pnas.052595099; TAUNTON HJ, 1988, NATURE, V332, P712, DOI 10.1038/332712a0; Tompa P, 2005, TRENDS BIOCHEM SCI, V30, P484, DOI 10.1016/j.tibs.2005.07.008; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tompa P, 2012, TRENDS BIOCHEM SCI, V37, P509, DOI 10.1016/j.tibs.2012.08.004; Tompa P, 2012, NAT CHEM BIOL, V8, P597, DOI 10.1038/nchembio.1009; Tompa P, 2011, CURR OPIN STRUC BIOL, V21, P419, DOI 10.1016/j.sbi.2011.03.012; Uversky VN, 2008, SCIENCE, V322, P1340, DOI 10.1126/science.1167453; Uversky VN, 2013, BBA-PROTEINS PROTEOM, V1834, P932, DOI 10.1016/j.bbapap.2012.12.008; Uversky VN, 2012, CURR PROTEIN PEPT SC, V13, P2; Uversky VN, 2011, INT J BIOCHEM CELL B, V43, P1090, DOI 10.1016/j.biocel.2011.04.001; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Vicente M, 2006, J BACTERIOL, V188, P19, DOI 10.1128/JB.188.1.19-27.2006; Voros J, 2004, BIOPHYS J, V87, P553, DOI 10.1529/biophysj.103.030072; Wang KH, 2011, LANGMUIR, V27, P7595, DOI 10.1021/la201496j; Wang LB, 2004, J LIPID RES, V45, P1704, DOI 10.1194/jlr.M400106-JLR200; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Williams A, 1996, COLLOID SURFACE A, V114, P267, DOI 10.1016/0927-7757(96)03534-0; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Xie HB, 2007, J PROTEOME RES, V6, P1882, DOI 10.1021/pr060392u	88	17	17	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2013	27	8					3363	3375		10.1096/fj.12-224337	http://dx.doi.org/10.1096/fj.12-224337			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292BT	23660966				2022-12-25	WOS:000329877600041
J	Sioud, M; Skorstad, G; Mobergslien, A; Sboe-Larssen, S				Sioud, Mouldy; Skorstad, Gjertrud; Mobergslien, Anne; Sboe-Larssen, Stein			A novel peptide carrier for efficient targeting of antigens and nucleic acids to dendritic cells	FASEB JOURNAL			English	Article						cancer vaccines; phage display; siRNA; cross presentation	POTENT ANTITUMOR IMMUNITY; REGULATORY T-CELLS; CANCER-CELLS; RECEPTOR; DELIVERY; EXPRESSION; RESPONSES; DEC-205; PROTEIN; TRANSPLANTATION	Dendritic cells (DCs) initiate host immune responses by presenting captured antigens to naive T cells. Hence, DC-binding peptides may be used for antigen targeting to boost naive and memory immune responses. By biopanning peptide phage libraries on human monocyte-derived DCs, we identified novel DC-binding peptides. One of the selected phages, displaying the NW peptide (NWYLPWLGTNDW), bound DCs with high affinity, and its binding was inhibited by the corresponding synthetic peptide. Antigenic peptides or proteins conjugated to the NW peptide bound to DCs and were internalized without negative effects on DC phenotype and function. Ex vivo targeted delivery of CMV-pp65 peptides to DCs via the NW peptide increased T-cell responses in HLA-A2(+)/CMV+ donors compared to untargeted peptides (P<0.001). Stimulation of CD45RO-depleted peripheral blood mononuclear cells from CMV- donors with the NW-pp65 fusion peptides expanded pp65-specific precursor T cells. Moreover, the NW peptide mediated small interfering RNA delivery to DCs, and a significant gene silencing was obtained. Collectively, the data reveal that proteins and nucleic acids can be directed to DCs through the NW peptide, enabling effective uptake and functional effects such as T-cell activation in the context of MHC class I and II molecules.Sioud, M., Skorstad, G., Mobergslien, A., SaebOe-Larssen, S. A novel peptide carrier for efficient targeting of antigens and nucleic acids to dendritic cells.	[Sioud, Mouldy; Skorstad, Gjertrud; Mobergslien, Anne] Univ Oslo, Radium Hosp, Dept Immunol, N-0310 Oslo, Norway; [Sboe-Larssen, Stein] Univ Oslo, Radium Hosp, Dept Cell Therapy, N-0310 Oslo, Norway	University of Oslo; University of Oslo	Sioud, M (corresponding author), Univ Oslo, Radium Hosp, Dept Immunol, N-0310 Oslo, Norway.	mosioud@medisin.uio.no			Norwegian Cancer Society; Gene Therapy Program at the Norwegian Radium Hospital	Norwegian Cancer Society(Norwegian Cancer Society); Gene Therapy Program at the Norwegian Radium Hospital	This work was supported in part by the Norwegian Cancer Society and the Gene Therapy Program at the Norwegian Radium Hospital to M. S. The authors thank Dr. Sebastian Patzke for helping with confocal microscopy and Dr. Anne Dybwad for critical reading of the manuscript.	Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Birkholz K, 2010, BLOOD, V116, P2277, DOI 10.1182/blood-2010-02-268425; Bozzacco L, 2007, P NATL ACAD SCI USA, V104, P1289, DOI 10.1073/pnas.0610383104; Costantini TW, 2012, PEPTIDES, V38, P94, DOI 10.1016/j.peptides.2012.08.015; DYBWAD A, 1993, EUR J IMMUNOL, V23, P3189, DOI 10.1002/eji.1830231222; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; FALCIABOOTH NJ, 2010, J IMMUNOL, V184, P4317; Flatekval GF, 2009, IMMUNOLOGY, V128, pe837, DOI 10.1111/j.1365-2567.2009.03093.x; Fry TJ, 2005, J IMMUNOL, V174, P6571, DOI 10.4049/jimmunol.174.11.6571; Goffinet C, 2006, FASEB J, V20, P500, DOI 10.1096/fj.05-4651fje; Hangalapura BN, 2011, CANCER RES, V71, P5827, DOI 10.1158/0008-5472.CAN-11-0804; Hansen MH, 2001, MOL MED, V7, P230, DOI 10.1007/BF03401842; He LZ, 2007, J IMMUNOL, V178, P6259, DOI 10.4049/jimmunol.178.10.6259; Jedema I, 2011, HAEMATOL-HEMATOL J, V96, P1204, DOI 10.3324/haematol.2010.039099; Johnson TS, 2008, CLIN CANCER RES, V14, P8169, DOI 10.1158/1078-0432.CCR-08-1474; Kato M, 2006, INT IMMUNOL, V18, P857, DOI 10.1093/intimm/dxl022; Kretz-Rommel A, 2007, J IMMUNOTHER, V30, P715, DOI 10.1097/CJI.0b013e318135472c; Kurts C, 2010, NAT REV IMMUNOL, V10, P403, DOI 10.1038/nri2780; Laakkonen P, 2002, NAT MED, V8, P751, DOI 10.1038/nm720; Leiriao P, 2012, EUR J IMMUNOL, V42, P2042, DOI 10.1002/eji.201142166; Liu Y, 2006, J IMMUNOL, V177, P8440, DOI 10.4049/jimmunol.177.12.8440; Luo H, 2011, FASEB J, V25, P1; MEYERS JD, 1986, J INFECT DIS, V153, P478, DOI 10.1093/infdis/153.3.478; Palucka K, 2010, IMMUNITY, V33, P464, DOI 10.1016/j.immuni.2010.10.007; Patel N, 2012, AM J TRANSPLANT, V12, P539, DOI 10.1111/j.1600-6143.2011.03837.x; Pira GL, 2004, INT IMMUNOL, V16, P635, DOI 10.1093/intimm/dxh065; Regnault A, 1999, J EXP MED, V189, P371, DOI 10.1084/jem.189.2.371; Sant AJ, 2012, J EXP MED, V209, P1391, DOI 10.1084/jem.20121517; Serre K, 1998, J IMMUNOL, V161, P6059; Shadidi M, 2003, DRUG RESIST UPDATE, V6, P363, DOI 10.1016/j.drup.2003.11.002; Shadidi M, 2002, FASEB J, V16, P256, DOI 10.1096/fj.02-0280fje; Sioud M, 2012, BIOCONJUGATE CHEM, V23, P1040, DOI 10.1021/bc300050j; SMITH GP, 1993, METHOD ENZYMOL, V217, P228; Tacken PJ, 2007, NAT REV IMMUNOL, V7, P790, DOI 10.1038/nri2173; Tacken PJ, 2011, SEMIN IMMUNOL, V23, P12, DOI 10.1016/j.smim.2011.01.001; Tacken PJ, 2005, BLOOD, V106, P1278, DOI 10.1182/blood-2005-01-0318; Trivedi D, 2005, BLOOD, V105, P2793, DOI 10.1182/blood-2003-05-1433; Tsuji T, 2011, J IMMUNOL, V186, P1218, DOI 10.4049/jimmunol.1000808; Wang XF, 2007, CANCER RES, V67, P3337, DOI 10.1158/0008-5472.CAN-06-2480; Wei HF, 2009, CLIN CANCER RES, V15, P4612, DOI 10.1158/1078-0432.CCR-08-3321; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742; Wills MR, 1996, J VIROL, V70, P7569, DOI 10.1128/JVI.70.11.7569-7579.1996; Yao JX, 2008, CLIN INFECT DIS, V46, pE96, DOI 10.1086/587749	44	18	22	2	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2013	27	8					3272	3283		10.1096/fj.12-224758	http://dx.doi.org/10.1096/fj.12-224758			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	292BT	23671272				2022-12-25	WOS:000329877600032
J	Hu, YL; Hung, AC; Cui, H; Dawkins, E; Bolos, M; Foa, L; Young, KM; Small, DH				Hu, Yanling; Hung, Amos C.; Cui, Hao; Dawkins, Edgar; Bolos, Marta; Foa, Lisa; Young, Kaylene M.; Small, David H.			Role of Cystatin C in Amyloid Precursor Protein-induced Proliferation of Neural Stem/Progenitor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; BETA; APP; DIFFERENTIATION; NEUROGENESIS; EXPRESSION; GENERATION; ASSOCIATION; ASTROCYTES; DEPOSITION	The amyloid precursor protein (APP) is well studied for its role in Alzheimer disease. However, little is known about its normal function. In this study, we examined the role of APP in neural stem/progenitor cell (NSPC) proliferation. NSPCs derived from APP-overexpressing Tg2576 transgenic mice proliferated more rapidly than NSPCs from the corresponding background strain (C57Bl/6xSJL) wild-type mice. In contrast, NSPCs from APP knock-out (APP-KO) mice had reduced proliferation rates when compared with NSPCs from the corresponding background strain (C57Bl/6). A secreted factor, identified as cystatin C, was found to be responsible for this effect. Levels of cystatin C were higher in the Tg2576 conditioned medium and lower in the APP-KO conditioned medium. Furthermore, immunodepletion of cystatin C from the conditioned medium completely removed the ability of the conditioned medium to increase NSPC proliferation. The results demonstrate that APP expression stimulates NSPC proliferation and that this effect is mediated via an increase in cystatin C secretion.	[Hu, Yanling; Hung, Amos C.; Cui, Hao; Dawkins, Edgar; Bolos, Marta; Foa, Lisa; Young, Kaylene M.; Small, David H.] Menzies Res Inst Tasmania, Hobart, Tas 7001, Australia; [Cui, Hao] Univ Tasmania, Sch Pharm, Hobart, Tas 7001, Australia; [Foa, Lisa] Univ Tasmania, Sch Med, Hobart, Tas 7001, Australia	University of Tasmania; Menzies Institute for Medical Research; University of Tasmania; University of Tasmania	Small, DH (corresponding author), Univ Tasmania, Private Bag 23, Hobart, Tas 7001, Australia.	d.h.small@menzies.utas.edu.au	Foa, Lisa/J-7781-2014; Bolos Jurado, Marta/J-7620-2014; Dawkins, Edgar/L-1720-2013	Foa, Lisa/0000-0003-4131-8341; Bolos Jurado, Marta/0000-0003-2652-8607; Dawkins, Edgar/0000-0003-1737-9435; Young, Kaylene/0000-0002-1686-3463; Hung, Chun-Tao/0000-0001-7572-8897	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by project grants from the National Health and Medical Research Council of Australia.	BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Chasseigneaux S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016301; CLARRIS HJ, 1995, DEV BRAIN RES, V88, P87, DOI 10.1016/0165-3806(95)00083-P; COCHRAN E, 1991, AM J PATHOL, V139, P485; CRAS P, 1991, P NATL ACAD SCI USA, V88, P7552, DOI 10.1073/pnas.88.17.7552; Cui P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023219; Freude KK, 2011, J BIOL CHEM, V286, P24264, DOI 10.1074/jbc.M111.227421; Gakhar-Koppole N, 2008, EUR J NEUROSCI, V28, P871, DOI 10.1111/j.1460-9568.2008.06398.x; GENTLEMAN SM, 1993, PROG BRAIN RES, V96, P237; Guruharsha KG, 2012, NAT REV GENET, V13, P654, DOI 10.1038/nrg3272; HAYASHI Y, 1994, BIOCHEM BIOPH RES CO, V205, P936, DOI 10.1006/bbrc.1994.2755; Hornsten A, 2007, P NATL ACAD SCI USA, V104, P1971, DOI 10.1073/pnas.0603997104; Hua Y, 2012, INT J NEUROSCI, V122, P431, DOI 10.3109/00207454.2012.672502; Itoh T, 2009, NEUROL RES, V31, P103, DOI 10.1179/016164108X323771; Jin KL, 2004, P NATL ACAD SCI USA, V101, P13363, DOI 10.1073/pnas.0403678101; Joshi P, 2009, DEV BIOL, V335, P1, DOI 10.1016/j.ydbio.2009.07.041; Kaeser SA, 2007, NAT GENET, V39, P1437, DOI 10.1038/ng.2007.23; Kato T, 2006, P NATL ACAD SCI USA, V103, P6019, DOI 10.1073/pnas.0509789103; Kaur G, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00079; Kohli BM, 2012, J PROTEOME RES, V11, P4075, DOI 10.1021/pr300123g; Kwak YD, 2006, STEM CELLS DEV, V15, P381, DOI 10.1089/scd.2006.15.381; Lazarov O, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00081; Lee HW, 2008, NEUROSCI LETT, V436, P245, DOI 10.1016/j.neulet.2008.03.038; Lee JA, 2007, ZEBRAFISH, V4, P277, DOI 10.1089/zeb.2007.0516; Lopez-Toledano MA, 2007, J ALZHEIMERS DIS, V12, P229; MATTSON MP, 1994, J NEUROBIOL, V25, P439, DOI 10.1002/neu.480250409; Mi W, 2007, NAT GENET, V39, P1440, DOI 10.1038/ng.2007.29; Millet P, 2005, NEUROBIOL DIS, V19, P57, DOI 10.1016/j.nbd.2004.11.006; MILWARD EA, 1992, NEURON, V9, P129, DOI 10.1016/0896-6273(92)90228-6; Moyse E, 2008, CURR STEM CELL RES T, V3, P163, DOI 10.2174/157488808785740334; MUCKE L, 1994, BRAIN RES, V666, P151, DOI 10.1016/0006-8993(94)90767-6; MULLER U, 1994, CELL, V79, P755, DOI 10.1016/0092-8674(94)90066-3; Nunan J, 2000, FEBS LETT, V483, P6, DOI 10.1016/S0014-5793(00)02076-7; Pardossi-Piquard R, 2012, J NEUROCHEM, V120, P109, DOI 10.1111/j.1471-4159.2011.07475.x; PATTERSON D, 1988, P NATL ACAD SCI USA, V85, P8266, DOI 10.1073/pnas.85.21.8266; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; RICHARDS LJ, 1992, P NATL ACAD SCI USA, V89, P8591, DOI 10.1073/pnas.89.18.8591; Rodgers SP, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-28; SMALL DH, 1994, J NEUROSCI, V14, P2117; SMALL DH, 1992, J NEUROSCI, V12, P4143; Small DH, 2001, NAT REV NEUROSCI, V2, P595, DOI 10.1038/35086072; Steinhoff T, 2001, NEUROBIOL DIS, V8, P647, DOI 10.1006/nbdi.2001.0412; TABATON M, 1992, BRAIN RES, V593, P299, DOI 10.1016/0006-8993(92)91323-7; Taupin P, 2000, NEURON, V28, P385, DOI 10.1016/S0896-6273(00)00119-7; Young KM, 2013, NEURON, V77, P873, DOI 10.1016/j.neuron.2013.01.006; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007; Zhou ZD, 2011, CELL ADHES MIGR, V5, P280, DOI 10.4161/cam.5.4.16986	47	25	26	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18853	18862		10.1074/jbc.M112.443671	http://dx.doi.org/10.1074/jbc.M112.443671			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23671283	hybrid, Green Published			2022-12-25	WOS:000321335800023
J	Campbell, KN; Wong, JS; Gupta, R; Asanuma, K; Sudol, M; He, JC; Mundel, P				Campbell, Kirk N.; Wong, Jenny S.; Gupta, Ritu; Asanuma, Katsuhiko; Sudol, Marius; He, John Cijiang; Mundel, Peter			Yes-associated Protein (YAP) Promotes Cell Survival by Inhibiting Proapoptotic Dendrin Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN-CONTAINING PROTEIN; WW DOMAIN; INDUCED APOPTOSIS; RAT-BRAIN; HIPPO; PODOCYTES; PATHWAY; KIBRA; DROSOPHILA; GENE	Kidney podocytes are highly specialized terminally differentiated cells that form the final barrier to urinary protein loss. Podocytes are a target for injury by metabolic, autoimmune, hereditary, inflammatory, and other stressors. Persistence of podocyte injury leads to podocyte death and loss, which results in progressive kidney damage and ultimately kidney failure. Dendrin is a dual compartment protein with proapoptotic signaling properties. Nuclear relocation of dendrin in response to glomerular injury promotes podocyte apoptosis. Here we show that Yes-associated protein (YAP), a downstream target of Hippo kinases and an inhibitor of apoptosis, is expressed in the nucleus of podocytes. The WW domains of YAP mediate the interaction with the PPXY motifs of dendrin. This interaction is functionally relevant because YAP binding to dendrin reduces dendrin-dependent, staurosporine-induced apoptosis in co-transfected HEK293 cells. Moreover gene silencing of YAP in podocytes increases adriamycin-induced podocyte apoptosis. It also increases staurosporine-induced caspase-3/7 activity, which is rescued by dendrin depletion in YAP knockdown cells. Our findings elucidate YAP binding to dendrin as a prosurvival mechanism. The antiapoptotic signaling properties of YAP in podocytes could hold significance in the quest for targeted therapeutics aimed at preventing podocyte loss.	[Campbell, Kirk N.; Wong, Jenny S.; Sudol, Marius; He, John Cijiang] Mt Sinai Sch Med, Div Nephrol, New York, NY 10029 USA; [Gupta, Ritu] Yale New Haven Med Ctr, Dept Med, New Haven, CT 06511 USA; [Asanuma, Katsuhiko] Kyoto Univ, Grad Sch Med, Med Innovat Ctr, Lab Kidney Res,TMK Project, Kyoto 6068501, Japan; [Sudol, Marius] Weis Ctr Res, Danville, PA 17822 USA; [Mundel, Peter] Massachusetts Gen Hosp, Dept Med, Boston, MA 02129 USA; [Mundel, Peter] Harvard Univ, Sch Med, Boston, MA 02129 USA	Icahn School of Medicine at Mount Sinai; Yale University; Kyoto University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Campbell, KN (corresponding author), Mt Sinai Sch Med, Div Nephrol, Box 1243,1 Gustave L Levy Pl, New York, NY 10029 USA.	kirk.campbell@mssm.edu; mundel.peter@mgh.harvard.edu			National Institutes of Health [DK57683, DK062472, DK09368201, DK081617]; NephCure Young Investigator grant; PA Breast Cancer Coalition [60707, 920093]; Geisinger Clinic; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057683, K08DK081617, R01DK062472] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NephCure Young Investigator grant; PA Breast Cancer Coalition; Geisinger Clinic; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK57683, DK062472, and DK09368201 (to P. M.), National Institutes of Health Grant DK081617 (to K. N. C.). This work was also supported by a NephCure Young Investigator grant (to K. N. C.) and by PA Breast Cancer Coalition Grants 60707 and 920093 and by a grant from the Geisinger Clinic (to M. S.).	Asanuma K, 2005, J CLIN INVEST, V115, P1188, DOI 10.1172/JCI200523371; Asanuma K, 2007, P NATL ACAD SCI USA, V104, P10134, DOI 10.1073/pnas.0700917104; Asanuma K, 2011, AM J NEPHROL, V33, P537, DOI 10.1159/000327995; Baumgartner R, 2010, DEV CELL, V18, P309, DOI 10.1016/j.devcel.2009.12.013; Biswas S, 2006, NEUROSCIENCE, V142, P315, DOI 10.1016/j.neuroscience.2006.06.026; BORK P, 1994, TRENDS BIOCHEM SCI, V19, P531, DOI 10.1016/0968-0004(94)90053-1; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Csibi A, 2012, NAT CELL BIOL, V14, P1244, DOI 10.1038/ncb2634; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Duning K, 2008, J AM SOC NEPHROL, V19, P1891, DOI 10.1681/ASN.2007080916; Gaffney CJ, 2012, GENE, V509, P215, DOI 10.1016/j.gene.2012.08.025; Genevet A, 2010, DEV CELL, V18, P300, DOI 10.1016/j.devcel.2009.12.011; Greka A, 2012, ANNU REV PHYSIOL, V74, P299, DOI 10.1146/annurev-physiol-020911-153238; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Harvey KF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011288; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Johansson AC, 2003, CELL DEATH DIFFER, V10, P1253, DOI 10.1038/sj.cdd.4401290; Komuro A, 2003, J BIOL CHEM, V278, P33334, DOI 10.1074/jbc.M305597200; Kremerskothen J, 2003, BIOCHEM BIOPH RES CO, V300, P862, DOI 10.1016/S0006-291X(02)02945-5; Kriz W, 2005, KIDNEY INT, V67, P404, DOI 10.1111/j.1523-1755.2005.67097.x; Moleirinho S, 2013, ONCOGENE, V32, P1821, DOI 10.1038/onc.2012.196; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; MUNDLOS S, 1993, DEVELOPMENT, V119, P1329; NeunerJehle M, 1996, J NEUROSCI RES, V46, P138, DOI 10.1002/(SICI)1097-4547(19961015)46:2<138::AID-JNR2>3.0.CO;2-I; PABST R, 1983, KIDNEY INT, V24, P626, DOI 10.1038/ki.1983.203; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Schiffer M, 2004, J BIOL CHEM, V279, P37004, DOI 10.1074/jbc.M403534200; Schiffer M, 2001, J CLIN INVEST, V108, P807, DOI 10.1172/JCI12367; Schwarz K, 2001, J CLIN INVEST, V108, P1621, DOI 10.1172/JCI200112849; SUDOL M, 1994, ONCOGENE, V9, P2145; SUDOL M, 1995, J BIOL CHEM, V270, P14733, DOI 10.1074/jbc.270.24.14733; Sudol M, 2010, TRENDS BIOCHEM SCI, V35, P627, DOI 10.1016/j.tibs.2010.05.010; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.01.06.db05-0894; Tharaux PL, 2012, SEMIN NEPHROL, V32, P394, DOI 10.1016/j.semnephrol.2012.06.011; Wang KN, 2009, BIOCHEM CELL BIOL, V87, P77, DOI 10.1139/O08-114; Yue TL, 1998, J MOL CELL CARDIOL, V30, P495, DOI 10.1006/jmcc.1997.0614; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, J CELL SCI, V123, P4001, DOI 10.1242/jcs.069070	38	44	44	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17057	17062		10.1074/jbc.C113.457390	http://dx.doi.org/10.1074/jbc.C113.457390			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23667252	Green Published, hybrid			2022-12-25	WOS:000320380600002
J	Dai, XF; Lu, DD; Guan, WB; Xia, P; Wang, HX; He, PX; Zhang, DS				Dai, Xinfeng; Lu, Douding; Guan, Weibing; Xia, Ping; Wang, Hongxia; He, Piaoxia; Zhang, Dongsheng			The Correlation between Prorocentrum donghaiense Blooms and the Taiwan Warm Current in the East China Sea - Evidence for the "Pelagic Seed Bank'' Hypothesis	PLOS ONE			English	Article							COCHLODINIUM-POLYKRIKOIDES; NITRATE; WATERS; LU	During the last two decades, large-scale high biomass algal blooms of the dinoflagellate Prorocentrum donghaiense Lu have occurred frequently in the East China Sea (ECS). The role of increasing nutrient concentrations in driving those blooms is well-established, but the source population that initiates them is poorly understood. We hypothesized that the front of Taiwan Warm Current (TWC) may serve as a 'seed bank' that initiates P. donghaiense blooms in the ECS, as the physiochemical conditions in the TWC are suitable for the growth of P. donghaiense. In order to test this hypothesis, two surveys at different spatio-temporal scales were conducted in 2010 and 2011. We found a strong correlation in space and time between the abundance of P. donghaiense and the TWC. The spatial extent of the P. donghaiense bloom coincided with the TWC front in both 2010 and 2011. During the early development of the blooms, P. donghaiense concentration was highest at the TWC front, and then the bloom mass shifted inshore over the course of our 2011 survey. The TWC also moved inshore, albeit after the appearance of P. donghaiense. Overall, these results support our hypothesis that P. donghaiense blooms develop from the population at the TWC front in the ECS, suggesting the role of the ocean current front as a seed bank to dinoflagellate blooms.	[Dai, Xinfeng; Lu, Douding; Guan, Weibing; Xia, Ping; Wang, Hongxia; He, Piaoxia; Zhang, Dongsheng] SOA, Inst Oceanog 2, State Key Lab Satellite Ocean Environm Dynam, Hangzhou, Zhejiang, Peoples R China	State Oceanic Administration	Lu, DD (corresponding author), SOA, Inst Oceanog 2, Hangzhou, Zhejiang, Peoples R China.	ludd21@126.com			CEOHAB-II National 973 Program [2010CB428702, 2010CB428704]; National Science Foundation [41176141]; scientific research fund of the Second Institute of Oceanography, SOA [SZ1040]; Foundation of Key Laboratory of Integrated Marine Monitoring and Applied Technologies for Harmful Algal Blooms, SOA [MATHAB20100310]; Zhejiang Provincial Natural Science Foundation [Y5110185]	CEOHAB-II National 973 Program(National Basic Research Program of China); National Science Foundation(National Science Foundation (NSF)); scientific research fund of the Second Institute of Oceanography, SOA; Foundation of Key Laboratory of Integrated Marine Monitoring and Applied Technologies for Harmful Algal Blooms, SOA; Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province)	This study was supported by CEOHAB-II National 973 Program (2010CB428702; 2010CB428704), National Science Foundation (41176141), Grant from the scientific research fund of the Second Institute of Oceanography, SOA (SZ1040), Foundation of Key Laboratory of Integrated Marine Monitoring and Applied Technologies for Harmful Algal Blooms, SOA (MATHAB20100310) and Zhejiang Provincial Natural Science Foundation (Y5110185). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; CHEN CTA, 1995, CONT SHELF RES, V15, P19, DOI 10.1016/0278-4343(93)E0001-O; Chen D.X., 1992, MARINE ATLAS BOHAI S, P13; Gentien P, 2008, GLOBAL ECOLOGY OCEAN; Jiao NZ, 2002, AQUAT MICROB ECOL, V30, P37; [经志友 JING Zhiyou], 2007, [河海大学学报. 自然科学版, Journal of Hohai University. Natural Sciences], V35, P464; Joyce LB, 2005, HARMFUL ALGAE, V4, P309, DOI 10.1016/j.hal.2004.08.001; Kremp A, 2001, MAR ECOL PROG SER, V216, P57, DOI 10.3354/meps216057; Lasker R., 1978, NATO Conference Series IV Marine Sciences, V3, P329; Lee DK, 2008, HARMFUL ALGAE, V7, P318, DOI 10.1016/j.hal.2007.12.014; Li J, 2010, HARMFUL ALGAE, V9, P531, DOI 10.1016/j.hal.2010.03.007; Li Y, 2011, HARMFUL ALGAE, V10, P426, DOI 10.1016/j.hal.2010.08.002; Lu D, 2008, P 12 INT C HARMF AL, P132; Lu D, 2001, DONGHAI MARINE SCI, V19, P11; Lu DD, 2005, HARMFUL ALGAE, V4, P493, DOI 10.1016/j.hal.2004.08.015; Luo Y. Y., 1998, T OCEANOLOGY LIMNOLO, V3, P1; Luo Y.Y., 1998, J OCEAN U, V28, P536, DOI [10.1088/0256-307X/15/3/016, DOI 10.1088/0256-307X/15/3/016]; Naimie CE, 2001, CONT SHELF RES, V21, P667; PACKARD TT, 1978, J MAR RES, V36, P59; Park GH, 2005, LIMNOL OCEANOGR, V50, P578, DOI 10.4319/lo.2005.50.2.0578; Qiao FL, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003264; Smayda Theodore J., 2002, Harmful Algae, V1, P95, DOI 10.1016/S1568-9883(02)00010-0; Wang H., 2011, J MARINE SCI, V29, P42; Wong GTF, 1998, ESTUAR COAST SHELF S, V46, P411, DOI 10.1006/ecss.1997.0287; Xia Wenjuan, 2011, Journal of Ocean University of China, V10, P135, DOI 10.1007/s11802-011-1732-6; Xu N, 2010, HARMFUL ALGAE, V9, P13, DOI 10.1016/j.hal.2009.06.002; Zhou MJ, 2008, CONT SHELF RES, V28, P1483, DOI 10.1016/j.csr.2007.02.009; Zhou Mingjiang, 2003, Yingyong Shengtai Xuebao, V14, P1031; Zhu D, 2008, ACTA OCEANOL SIN, V31, P31; Zhu MY, 2009, ACTA OCEANOL SIN, V28, P72	30	24	32	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e64188	10.1371/journal.pone.0064188	http://dx.doi.org/10.1371/journal.pone.0064188			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671709	gold, Green Published, Green Submitted			2022-12-25	WOS:000319737700067
J	Smidt, M; Battig, P; Verhaegh, SJC; Niebisch, A; Hanner, M; Selak, S; Schuler, W; Morfeldt, E; Hellberg, C; Nagy, E; Lundberg, U; Hays, JP; Meinke, A; Henriques-Normark, B				Smidt, Margarita; Battig, Patrick; Verhaegh, Suzanne J. C.; Niebisch, Axel; Hanner, Markus; Selak, Sanja; Schueler, Wolfgang; Morfeldt, Eva; Hellberg, Christel; Nagy, Eszter; Lundberg, Urban; Hays, John P.; Meinke, Andreas; Henriques-Normark, Birgitta			Comprehensive Antigen Screening Identifies Moraxella catarrhalis Proteins That Induce Protection in a Mouse Pulmonary Clearance Model	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; BRANHAMELLA-CATARRHALIS; CYTOCHROME-C; VACCINE DEVELOPMENT; IMMUNE-RESPONSE; M. CATARRHALIS; USPA2 PROTEIN; BINDING; RECEPTOR; IMMUNIZATION	Moraxella catarrhalis is one of the three most common causative bacterial pathogens of otitis media, however no effective vaccine against M. catarrhalis has been developed so far. To identify M. catarrhalis vaccine candidate antigens, we used carefully selected sera from children with otitis media and healthy individuals to screen small-fragment genomic libraries that are expressed to display frame-selected peptides on a bacterial cell surface. This ANTIGENome technology led to the identification of 214 antigens, 23 of which were selected by in vitro or in vivo studies for additional characterization. Eight of the 23 candidates were tested in a Moraxella mouse pulmonary clearance model, and 3 of these antigens induced significantly faster bacterial clearance compared to adjuvant or to the previously characterized antigen OmpCD. The most significant protection data were obtained with the antigen MCR_1416 (Msp22), which was further investigated for its biological function by in vitro studies suggesting that Msp22 is a heme binding protein. This study comprises one of the most exhaustive studies to identify potential vaccine candidate antigens against the bacterial pathogen M. catarrhalis.	[Smidt, Margarita; Niebisch, Axel; Hanner, Markus; Selak, Sanja; Schueler, Wolfgang; Nagy, Eszter; Lundberg, Urban; Meinke, Andreas] Intercell AG, Vienna, Austria; [Battig, Patrick; Morfeldt, Eva; Hellberg, Christel; Henriques-Normark, Birgitta] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Verhaegh, Suzanne J. C.; Hays, John P.] Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands	Intercell; Karolinska Institutet; Erasmus University Rotterdam; Erasmus MC	Meinke, A (corresponding author), Intercell AG, Campus Vienna Bioctr 3, Vienna, Austria.	ameinke@intercell.com	Hays, J/I-9007-2017	Hays, J/0000-0001-9183-4497	EU-project OMVac [LSHB-CT-2006-037653]; DG research within the 6th Framework Programme	EU-project OMVac; DG research within the 6th Framework Programme	This work was supported by the EU-project OMVac (LSHB-CT-2006-037653) granted by DG research within the 6th Framework Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi C, 1998, INFECT IMMUN, V66, P540, DOI 10.1128/IAI.66.2.540-548.1998; Aebi C, 1996, INFECT IMMUN, V64, P2024, DOI 10.1128/IAI.64.6.2024-2030.1996; Aebi C, 1998, INFECT IMMUN, V66, P3113, DOI 10.1128/IAI.66.7.3113-3119.1998; Afonina G, 2006, INFECT IMMUN, V74, P2224, DOI 10.1128/IAI.74.4.2224-2232.2006; Attia AS, 2005, INFECT IMMUN, V73, P2400, DOI 10.1128/IAI.73.4.2400-2410.2005; Balder R, 2009, INFECT IMMUN, V77, P4597, DOI 10.1128/IAI.00212-09; Becker PD, 2007, INFECT IMMUN, V75, P1778, DOI 10.1128/IAI.01081-06; Bijlsma JJE, 2007, APPL ENVIRON MICROB, V73, P1514, DOI 10.1128/AEM.01900-06; Bingham-Ramos LK, 2008, INFECT IMMUN, V76, P1105, DOI 10.1128/IAI.01430-07; Bonnah RA, 1999, INFECT IMMUN, V67, P1517, DOI 10.1128/IAI.67.3.1517-1520.1999; Caroppi P, 2009, CURR MED CHEM, V16, P4058, DOI 10.2174/092986709789378206; CATLIN BW, 1990, CLIN MICROBIOL REV, V3, P293, DOI 10.1128/CMR.3.4.293-320.1990; Chauhan D, 1997, J BIOL CHEM, V272, P29995, DOI 10.1074/jbc.272.48.29995; Chen DX, 1996, INFECT IMMUN, V64, P1900, DOI 10.1128/IAI.64.6.1900-1905.1996; Chen DX, 1999, INFECT IMMUN, V67, P1310, DOI 10.1128/IAI.67.3.1310-1316.1999; CHRISTENSEN JJ, 1994, FEMS MICROBIOL LETT, V119, P155; Cripps AW, 2006, EXPERT REV VACCINES, V5, P517, DOI 10.1586/14760584.5.4.517; Enright MC, 1997, J MED MICROBIOL, V46, P360, DOI 10.1099/00222615-46-5-360; Etz H, 2001, J BACTERIOL, V183, P6924, DOI 10.1128/JB.183.23.6924-6935.2001; FADEN H, 1992, INFECT IMMUN, V60, P3824, DOI 10.1128/IAI.60.9.3824-3829.1992; Feissner R, 2003, ANAL BIOCHEM, V315, P90, DOI 10.1016/S0003-2697(02)00658-9; Ferguson AD, 2004, CELL, V116, P15, DOI 10.1016/S0092-8674(03)01030-4; Ferguson AD, 2002, BBA-BIOMEMBRANES, V1565, P318, DOI 10.1016/S0005-2736(02)00578-3; Forsgren A, 2004, J INFECT DIS, V190, P352, DOI 10.1086/422155; Forsgren A, 2003, INFECT IMMUN, V71, P3302, DOI 10.1128/IAI.71.6.3302-3309.2003; Fritzer A, 2010, INFECT IMMUN, V78, P4051, DOI 10.1128/IAI.00295-10; Furano K, 2005, MICROBIOL-SGM, V151, P1151, DOI 10.1099/mic.0.27820-0; Furano K, 2004, INFECT IMMUN, V72, P6426, DOI 10.1128/IAI.72.11.6426-6432.2004; Garmory HS, 2004, INFECT IMMUN, V72, P6757, DOI 10.1128/IAI.72.12.6757-6763.2004; Hays JP, 2005, PLASMID, V53, P263, DOI 10.1016/j.plasmid.2004.11.003; Hoiczyk E, 2000, EMBO J, V19, P5989, DOI 10.1093/emboj/19.22.5989; Huttemann M, 2011, MITOCHONDRION, V11, P369, DOI 10.1016/j.mito.2011.01.010; JOHNSON MA, 1981, J CLIN MICROBIOL, V13, P1066, DOI 10.1128/JCM.13.6.1066-1069.1981; Lafontaine ER, 2000, J BACTERIOL, V182, P1364, DOI 10.1128/JB.182.5.1364-1373.2000; Liu DF, 2007, INFECT IMMUN, V75, P2818, DOI 10.1128/IAI.00074-07; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Locher KP, 1998, CELL, V95, P771, DOI 10.1016/S0092-8674(00)81700-6; Malmvall B E, 1984, Lakartidningen, V81, P3931; Mathers KE, 1997, FEMS IMMUNOL MED MIC, V19, P231, DOI 10.1016/S0928-8244(97)00088-6; Mawas F, 2009, EXPERT REV VACCINES, V8, P77, DOI 10.1586/14760584.8.1.77; Meier PS, 2003, INFECT IMMUN, V71, P6793, DOI 10.1128/IAI.71.12.6793-6798.2003; Meinke A, 2005, VACCINE, V23, P2035, DOI 10.1016/j.vaccine.2005.01.005; Meinke A, 2004, CURR OPIN MICROBIOL, V7, P314, DOI 10.1016/j.mib.2004.04.008; Meinke A, 2009, VACCINE, V27, P3251, DOI 10.1016/j.vaccine.2009.01.066; Mollenkvist A, 2003, J BACTERIOL, V185, P2285, DOI 10.1128/JB.185.7.2285-2295.2003; Murphy ER, 2002, INFECT IMMUN, V70, P5390, DOI 10.1128/IAI.70.10.5390-5403.2002; Murphy TF, 1998, THORAX, V53, P124, DOI 10.1136/thx.53.2.124; Murphy TF, 2005, VACCINE, V23, P2696, DOI 10.1016/j.vaccine.2004.12.014; Murphy TF, 1998, J INFECT DIS, V178, P1667, DOI 10.1086/314501; Murphy TF, 2005, EXPERT REV VACCINES, V4, P843, DOI 10.1586/14760584.4.6.843; Murphy TF, 2009, EXPERT REV VACCINES, V8, P655, DOI [10.1586/erv.09.28, 10.1586/ERV.09.28]; Murphy TF, 2009, CLIN INFECT DIS, V49, P124, DOI 10.1086/599375; NICOTRA B, 1986, ARCH INTERN MED, V146, P890, DOI 10.1001/archinte.146.5.890; OTTO BR, 1992, CRIT REV MICROBIOL, V18, P217, DOI 10.3109/10408419209114559; Pearson MM, 2002, INFECT IMMUN, V70, P4523, DOI 10.1128/IAI.70.8.4523-4533.2002; Rovers MM, 2004, LANCET, V363, P465, DOI 10.1016/S0140-6736(04)15495-0; Ruckdeschel EA, 2008, INFECT IMMUN, V76, P1599, DOI 10.1128/IAI.01253-07; Ruckdeschel EA, 2009, VACCINE, V27, P7065, DOI 10.1016/j.vaccine.2009.09.062; Sabirov A, 2008, VACCINE, V26, P1501, DOI 10.1016/j.vaccine.2008.01.029; Schaar V, 2011, CELL MICROBIOL, V13, P432, DOI 10.1111/j.1462-5822.2010.01546.x; Schellack C, 2006, VACCINE, V24, P5461, DOI 10.1016/j.vaccine.2006.03.071; SHANN F, 1986, AUST NZ J MED, V16, P718, DOI 10.1111/j.1445-5994.1986.tb00026.x; Tauseef I, 2011, MICROBIOL-SGM, V157, P1446, DOI 10.1099/mic.0.046946-0; Thony-Meyer L, 2000, BBA-BIOENERGETICS, V1459, P316, DOI 10.1016/S0005-2728(00)00167-5; UNHANAND M, 1992, J INFECT DIS, V165, P644, DOI 10.1093/infdis/165.4.644; Verhaegh SJC, 2011, VACCINE, V29, P5603, DOI 10.1016/j.vaccine.2011.06.019; Vidakovics MLAP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000724; WATERS MJ, 1985, AUST NZ J MED, V15, P579; Yang M, 2011, INFECT IMMUN, V79, P846, DOI 10.1128/IAI.00314-10; Yu RH, 1999, INFECT IMMUN, V67, P3793, DOI 10.1128/IAI.67.8.3793-3799.1999	70	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e64422	10.1371/journal.pone.0064422	http://dx.doi.org/10.1371/journal.pone.0064422			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671716	Green Published, Green Submitted, gold			2022-12-25	WOS:000319737700074
J	Yen, FL; Tsai, MH; Yang, CM; Liang, CJ; Lin, CC; Chiang, YC; Lee, HC; Ko, HH; Lee, CW				Yen, Feng-Lin; Tsai, Ming-Horng; Yang, Chuen-Mao; Liang, Chan-Jung; Lin, Chun-Ching; Chiang, Yao-Chang; Lee, Hui-Chun; Ko, Horng-Huey; Lee, Chiang-Wen			Curcumin Nanoparticles Ameliorate ICAM-1 Expression in TNF-alpha-Treated Lung Epithelial Cells through p47 (phox) and MAPKs/AP-1 Pathways	PLOS ONE			English	Article							NF-KAPPA-B; ADHESION MOLECULES; ENDOTHELIAL-CELLS; KINASE-ACTIVITY; ACTIVATION; INFLAMMATION; INHIBITION; AKT; PHOSPHORYLATION; INVOLVEMENT	Upregulation of intercellular adhesion molecule-1 (ICAM-1) involves adhesions between both circulating and resident leukocytes and the human lung epithelial cells during lung inflammatory reactions. We have previously demonstrated that curcumin-loaded polyvinylpyrrolidone nanoparticles (CURN) improve the anti-inflammatory and anti-oxidative properties of curcumin in hepatocytes. In this study, we focused on the effects of CURN on the expression of ICAM-1 in TNF-alpha-treated lung epithelial cells and compared these to the effects of curcumin water preparation (CURH). TNF-alpha induced ICAM-1 expression, ROS production, and cell-cell adhesion were significantly attenuated by the pretreatment with antioxidants (DPI, APO, or NAC) and CURN, but not by CURH, as revealed by western blot analysis, RT-PCR, promoter assay, and ROS detection and adhesion assay. In addition, treatment of TNF-alpha-treated cells with CURN and antioxidants also resulted in an inhibition of activation of p47 phox and phosphorylation of MAPKs, as compared to that using CURH. Our findings also suggest that phosphorylation of MAPKs may eventually lead to the activation of transcription factors. We also observed that the effects of TNF-alpha treatment for 30 min, which includes a significant increase in the binding activity of AP-1 and phosphorylation of c-jun and c-fos genes, were reduced by CURN treatment. In vivo studies have revealed that CURN improved the antiinflammation activities of CURH in the lung epithelial cells of TNF-a-treated mice. Our results indicate that curcumin-loaded polyvinylpyrrolidone nanoparticles may potentially serve as an anti-inflammatory drug for the treatment of respiratory diseases.	[Yen, Feng-Lin; Ko, Horng-Huey] Kaohsiung Med Univ, Coll Pharm, Dept Fragrance & Cosmet Sci, Kaohsiung, Taiwan; [Tsai, Ming-Horng] Chang Gung Mem Hosp, Dept Pediat, Div Neonatol & Pediat Hematol Oncol, Yunlin, Taiwan; [Yang, Chuen-Mao] Chang Gung Univ, Dept Physiol & Pharmacol, Tao Yuan, Taiwan; [Liang, Chan-Jung] Natl Taiwan Univ, Coll Med, Dept Anat & Cell Biol, Taipei 10764, Taiwan; [Lin, Chun-Ching] Kaohsiung Med Univ, Coll Pharm, Grad Inst Nat Prod, Kaohsiung, Taiwan; [Lin, Chun-Ching] Kaohsiung Med Univ, Coll Pharm, Sch Pharm, Kaohsiung, Taiwan; [Chiang, Yao-Chang] China Med Univ Hosp, Ctr Drug Abuse & Addict, Taichung, Taiwan; [Chiang, Yao-Chang] China Med Univ, Taichung, Taiwan; [Lee, Hui-Chun; Lee, Chiang-Wen] Chang Gung Inst Technol, Dept Nursing, Div Basic Med Sci, Chiayi, Taiwan; [Lee, Hui-Chun; Lee, Chiang-Wen] Chang Gung Inst Technol, Chron Dis & Hlth Promot Res Ctr, Chiayi, Taiwan	Kaohsiung Medical University; Chang Gung Memorial Hospital; Chang Gung University; National Taiwan University; Kaohsiung Medical University; Kaohsiung Medical University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Chang Gung University of Science & Technology; Chang Gung University of Science & Technology	Lee, CW (corresponding author), Chang Gung Inst Technol, Dept Nursing, Div Basic Med Sci, Chiayi, Taiwan.	cwlee@gw.cgust.edu.tw		Yang, Chuen-Mao/0000-0002-3208-5438; Chiang, Yao-Chang/0000-0002-7619-1902	National Science Council, Taiwan [NSC99-2313-B-255-001-MY3]; Chang Gung Medical Research Foundation, Taiwan [CMRPF6A0081]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Medical Research Foundation, Taiwan	This work was supported by NSC99-2313-B-255-001-MY3 from National Science Council, Taiwan; CMRPF6A0081 from Chang Gung Medical Research Foundation, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Al Ghouleh I, 2011, FREE RADICAL BIO MED, V51, P1271, DOI 10.1016/j.freeradbiomed.2011.06.011; Bhawana, 2011, J AGR FOOD CHEM, V59, P2056, DOI 10.1021/jf104402t; Brightling CE, 2012, CLIN EXP ALLERGY, V42, P638, DOI 10.1111/j.1365-2222.2011.03917.x; Brown DI, 2009, FREE RADICAL BIO MED, V47, P1239, DOI 10.1016/j.freeradbiomed.2009.07.023; Carnesecchi S, 2011, ANTIOXID REDOX SIGN, V15, P607, DOI 10.1089/ars.2010.3829; Carnesecchi S, 2009, AM J RESP CRIT CARE, V180, P972, DOI 10.1164/rccm.200902-0296OC; Chen CC, 2006, CURR PHARM DESIGN, V12, P3497, DOI 10.2174/138161206778343028; Chi PL, 2012, ARTHRITIS RHEUM, V63, P2905; Chiarugi P, 2005, FREE RADICAL RES, V39, P353, DOI 10.1080/10715760400027987; Decramer M, 2012, LANCET, V379, P1341, DOI 10.1016/S0140-6736(11)60968-9; Glauert HP, 2010, MOL NUTR FOOD RES, V54, P875, DOI 10.1002/mnfr.200900482; Golias C, 2011, CELL COMMUN ADHES, V18, P19, DOI 10.3109/15419061.2011.606381; Gong L, 2012, MOL MED REP, V5, P935, DOI 10.3892/mmr.2012.760; Griendling KK, 2000, ARTERIOSCL THROM VAS, V20, P2175, DOI 10.1161/01.ATV.20.10.2175; Hsieh HL, 2010, ANTIOXID REDOX SIGN, V13, P1829, DOI 10.1089/ars.2009.2957; Huang QR, 2010, J FOOD SCI, V75, pR50, DOI 10.1111/j.1750-3841.2009.01457.x; Huang WC, 2003, J BIOL CHEM, V278, P9944, DOI 10.1074/jbc.M208521200; Jang JH, 2012, INT J MOL MED, V30, P1357, DOI 10.3892/ijmm.2012.1158; Kakkar V, 2011, MOL NUTR FOOD RES, V55, P495, DOI 10.1002/mnfr.201000310; Kumar S, 2007, BIOCHEM PHARMACOL, V73, P1602, DOI 10.1016/j.bcp.2007.01.015; Lee CW, 2008, MOL PHARMACOL, V73, P1454, DOI 10.1124/mol.107.038091; Lee IT, 2013, J NUTR BIOCHEM, V24, P124, DOI 10.1016/j.jnutbio.2012.03.009; Lee IT, 2009, AM J PATHOL, V175, P519, DOI 10.2353/ajpath.2009.090016; Liang CJ, 2011, FREE RADICAL BIO MED, V51, P1337, DOI 10.1016/j.freeradbiomed.2011.06.023; Lin CC, 2007, J CELL PHYSIOL, V211, P771, DOI 10.1002/jcp.20987; Lin FS, 2005, J CELL PHYSIOL, V202, P464, DOI 10.1002/jcp.20142; Mathew A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032616; Mladenka P, 2010, FREE RADICAL BIO MED, V49, P963, DOI 10.1016/j.freeradbiomed.2010.06.010; Oh JH, 2010, INT IMMUNOPHARMACOL, V10, P572, DOI 10.1016/j.intimp.2010.02.004; Pendyala S, 2010, RESP PHYSIOL NEUROBI, V174, P265, DOI 10.1016/j.resp.2010.09.016; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Recio MC, 2012, CURR MED CHEM, V19, P2088; Rosanna D, 2012, CURR PHARM DESIGN, V18, P3889, DOI 10.2174/138161212802083716; Sareila O, 2011, ANTIOXID REDOX SIGN, V15, P2197, DOI 10.1089/ars.2010.3635; Schaffer M, 2011, CURR OPIN CLIN NUTR, V14, P588, DOI 10.1097/MCO.0b013e32834bfe94; Seldon MP, 2007, J IMMUNOL, V179, P7840, DOI 10.4049/jimmunol.179.11.7840; Song HY, 2011, FREE RADICAL BIO MED, V50, P576, DOI 10.1016/j.freeradbiomed.2010.12.019; Takemura Y, 2010, AM J PHYSIOL-LUNG C, V298, pL509, DOI 10.1152/ajplung.00230.2009; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Tsai YM, 2011, INT J PHARMACEUT, V416, P331, DOI 10.1016/j.ijpharm.2011.06.030; Yallapu MM, 2012, DRUG DISCOV TODAY, V17, P71, DOI 10.1016/j.drudis.2011.09.009; Yang CM, 2010, J CELL PHYSIOL, V224, P516, DOI 10.1002/jcp.22153; Yen FL, 2010, J AGR FOOD CHEM, V58, P7376, DOI 10.1021/jf100135h; Ying BW, 2009, MOL BIOL REP, V36, P1825, DOI 10.1007/s11033-008-9386-1; Zhang GX, 2007, CARDIOVASC RES, V76, P204, DOI 10.1016/j.cardiores.2007.07.014	45	30	31	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63845	10.1371/journal.pone.0063845	http://dx.doi.org/10.1371/journal.pone.0063845			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671702	Green Published, gold, Green Submitted			2022-12-25	WOS:000319737700061
J	Bender, RJ; Mac Gabhann, F				Bender, R. Joseph; Mac Gabhann, Feilim			Expression of VEGF and Semaphorin Genes Define Subgroups of Triple Negative Breast Cancer	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; RENAL-CELL CARCINOMA; PHASE-III TRIAL; NEOADJUVANT CHEMOTHERAPY; INDUCED ANGIOGENESIS; SIGNAL-TRANSDUCTION; TUMOR ANGIOGENESIS; RANDOMIZED-TRIAL; BEVACIZUMAB; LUNG	Triple negative breast cancers (TNBC) are difficult to treat due to a lack of targets and heterogeneity. Inhibition of angiogenesis is a promising therapeutic strategy, but has had limited effectiveness so far in breast cancer. To quantify heterogeneity in angiogenesis-related gene expression in breast cancer, we focused on two families - VEGFs and semaphorins - that compete for neuropilin co-receptors on endothelial cells. We compiled microarray data for over 2,600 patient tumor samples and analyzed the expression of VEGF-and semaphorin-related ligands and receptors. We used principal component analysis to identify patterns of gene expression, and clustering to group samples according to these patterns. We used available survival data to determine whether these clusters had prognostic as well as therapeutic relevance. TNBC was highly associated with dysregulation of VEGF- and semaphorin-related genes; in particular, it appeared that expression of both VEGF and semaphorin genes were altered in a pro-angiogenesis direction. A pattern of high VEGFA expression with low expression of secreted semaphorins was associated with 60% of triple-negative breast tumors. While all TNBC groups demonstrated poor prognosis, this signature also correlated with lower 5-year survival rates in non-TNBC samples. A second TNBC pattern, including high VEGFC expression, was also identified. These pro-angiogenesis signatures may identify cancers that are more susceptible to VEGF inhibition.	[Mac Gabhann, Feilim] Johns Hopkins Univ, Inst Computat Med, Baltimore, MD 21218 USA; Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Mac Gabhann, F (corresponding author), Johns Hopkins Univ, Inst Computat Med, Baltimore, MD 21218 USA.	feilim@jhu.edu			Open Access Promotion Fund of the Johns Hopkins University Libraries	Open Access Promotion Fund of the Johns Hopkins University Libraries	Publication of this article was funded in part by the Open Access Promotion Fund of the Johns Hopkins University Libraries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banu N, 2006, FASEB J, V20, P2150, DOI 10.1096/fj.05-5698fje; Basile JR, 2006, P NATL ACAD SCI USA, V103, P9017, DOI 10.1073/pnas.0508825103; Basile JR, 2005, MOL CELL BIOL, V25, P6889, DOI 10.1128/MCB.25.16.6889-6898.2005; Bear HD, 2012, NEW ENGL J MED, V366, P310, DOI 10.1056/NEJMoa1111097; Bertucci F, 2012, CURR MOL MED, V12, P96, DOI 10.2174/156652412798376134; Bielenberg DR, 2007, CANCER METAST REV, V26, P421, DOI 10.1007/s10555-007-9097-4; Bielenberg DR, 2006, EXP CELL RES, V312, P584, DOI 10.1016/j.yexcr.2005.11.024; Boersma BJ, 2008, INT J CANCER, V122, P1324, DOI 10.1002/ijc.23237; Casazza A, 2011, ARTERIOSCL THROM VAS, V31, P741, DOI 10.1161/ATVBAHA.110.211920; Castro-Rivera E, 2004, P NATL ACAD SCI USA, V101, P11432, DOI 10.1073/pnas.0403969101; Castro-Rivera E, 2008, CANCER RES, V68, P8295, DOI 10.1158/0008-5472.CAN-07-6601; Catalano A, 2009, CANCER RES, V69, P1485, DOI 10.1158/0008-5472.CAN-08-3659; Creighton CJ, 2012, BREAST CANCER RES TR, V132, P993, DOI 10.1007/s10549-011-1595-y; Demetri GD, 2006, LANCET, V368, P1329, DOI 10.1016/S0140-6736(06)69446-4; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Dhanabal M, 2005, CANCER BIOL THER, V4, P659, DOI 10.4161/cbt.4.6.1733; Escudier B, 2007, LANCET, V370, P2103, DOI 10.1016/S0140-6736(07)61904-7; Esselens C, 2010, J BIOL CHEM, V285, P2463, DOI 10.1074/jbc.M109.055129; Farmer P, 2005, ONCOGENE, V24, P4660, DOI 10.1038/sj.onc.1208561; Finley SD, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-193; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Gabrovska PN, 2011, GENE, V489, P63, DOI 10.1016/j.gene.2011.08.024; Gaur P, 2009, CLIN CANCER RES, V15, P6763, DOI 10.1158/1078-0432.CCR-09-1810; Ghanem RC, 2011, CURR EYE RES, V36, P989, DOI 10.3109/02713683.2011.593730; Gonzalez-Angulo AM, 2012, CLIN CANCER RES, V18, P1109, DOI 10.1158/1078-0432.CCR-11-2762; Graham K, 2010, BRIT J CANCER, V102, P1284, DOI 10.1038/sj.bjc.6605576; Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416; Guttmann-Raviv N, 2007, J BIOL CHEM, V282, P26294, DOI 10.1074/jbc.M609711200; Hatzis C, 2011, JAMA-J AM MED ASSOC, V305, P1873, DOI 10.1001/jama.2011.593; Heiser LM, 2012, P NATL ACAD SCI USA, V109, P2724, DOI 10.1073/pnas.1018854108; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Iwamoto T, 2011, J NATL CANCER I, V103, P264, DOI 10.1093/jnci/djq524; Iwamoto T, 2011, BREAST CANCER RES TR, V125, P785, DOI 10.1007/s10549-010-1280-6; Jubb AM, 2012, J PATHOL, V226, P50, DOI 10.1002/path.2989; Jubb AM, 2011, CLIN CANCER RES, V17, P372, DOI 10.1158/1078-0432.CCR-10-1791; Jubb AM, 2012, HISTOPATHOLOGY; Karn T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028403; Kessler O, 2004, CANCER RES, V64, P1008, DOI 10.1158/0008-5472.CAN-03-3090; Kigel B, 2011, BLOOD, V118, P4285, DOI 10.1182/blood-2011-03-341388; Kigel B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003287; Koch S, 2011, BIOCHEM J, V437, P169, DOI 10.1042/BJ20110301; Kutschera S, 2011, ARTERIOSCL THROM VAS, V31, P151, DOI 10.1161/ATVBAHA.110.215871; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Linderholm BK, 2009, ANN ONCOL, V20, P1639, DOI 10.1093/annonc/mdp062; Liu HT, 2009, INT J SURG PATHOL, V17, P426, DOI 10.1177/1066896909337505; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Mac Gabhann F, 2006, PLOS COMPUT BIOL, V2, P1649, DOI 10.1371/journal.pcbi.0020180; Miles DW, 2010, J CLIN ONCOL, V28, P3239, DOI 10.1200/JCO.2008.21.6457; Miller K, 2007, NEW ENGL J MED, V357, P2666, DOI 10.1056/NEJMoa072113; Miller KD, 2005, J CLIN ONCOL, V23, P792, DOI 10.1200/JCO.2005.05.098; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2007, P NATL ACAD SCI USA, V104, P6740, DOI 10.1073/pnas.0701138104; Mohammed RAA, 2011, MODERN PATHOL, V24, P774, DOI 10.1038/modpathol.2011.4; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Neufeld G, 2011, COLD SPRING HARB PER; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Palaskas N, 2011, CANCER RES, V71, P5164, DOI 10.1158/0008-5472.CAN-10-4633; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Parker MW, 2010, BIOCHEMISTRY-US, V49, P4068, DOI 10.1021/bi100327r; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Popovici V, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2468; Rakha EA, 2007, CANCER-AM CANCER SOC, V109, P25, DOI 10.1002/cncr.22381; Raymond E, 2011, NEW ENGL J MED, V364, P501, DOI 10.1056/NEJMoa1003825; Rody A, 2007, CLIN CANCER RES, V13, P1115, DOI 10.1158/1078-0432.CCR-06-2433; Ryden L, 2010, BREAST CANCER RES TR, V120, P491, DOI 10.1007/s10549-010-0758-6; Sadanandam A, 2010, MICROVASC RES, V79, P1, DOI 10.1016/j.mvr.2009.10.005; Sakurai A, 2010, MOL CELL BIOL, V30, P3086, DOI 10.1128/MCB.01652-09; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Staton CA, 2011, HISTOPATHOLOGY, V59, P274, DOI 10.1111/j.1365-2559.2011.03922.x; Stefanini MO, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-77; Tabchy A, 2010, CLIN CANCER RES, V16, P5351, DOI 10.1158/1078-0432.CCR-10-1265; Toyofuku T, 2007, EMBO J, V26, P1373, DOI 10.1038/sj.emboj.7601589; Urbich C, 2012, BLOOD, V119, P1607, DOI 10.1182/blood-2011-08-373886; Varshavsky A, 2008, CANCER RES, V68, P6922, DOI 10.1158/0008-5472.CAN-07-5408; von Minckwitz G, 2012, NEW ENGL J MED, V366, P299, DOI 10.1056/NEJMoa1111065; Vredenburgh JJ, 2011, CLIN CANCER RES, V17, P4119, DOI 10.1158/1078-0432.CCR-11-0120; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1	84	55	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e61788	10.1371/journal.pone.0061788	http://dx.doi.org/10.1371/journal.pone.0061788			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667446	Green Published, gold, Green Submitted			2022-12-25	WOS:000319055600015
J	Poudel, R; Stanley, JL; Rueda-Clausen, CF; Andersson, IJ; Sibley, CP; Davidge, ST; Baker, PN				Poudel, Rajan; Stanley, Joanna L.; Rueda-Clausen, Christian F.; Andersson, Irene J.; Sibley, Colin P.; Davidge, Sandra T.; Baker, Philip N.			Effects of Resveratrol in Pregnancy Using Murine Models with Reduced Blood Supply to the Uterus	PLOS ONE			English	Article							FETAL-GROWTH; NITRIC-OXIDE; CARDIOVASCULAR FUNCTION; TRANS-RESVERATROL; UTERINE ARTERIES; KNOCKOUT MOUSE; DOPPLER FLOW; PREECLAMPSIA; SYNTHASE; MICE	Preeclampsia (PE) and fetal growth restriction (FGR) contribute significantly to fetal and maternal morbidity and mortality. Although the causes of PE and FGR are not fully understood, both conditions are known to be associated with impaired uterine artery blood flow. Resveratrol, a polyphenol found in a number of plants, has been shown to induce relaxation of uterine arteries in vitro as well as improve many pathological conditions associated with PE and FGR. We hypothesized that treatment of endothelial nitric oxide synthase knockout mice (eNOS(-/-)) and catechol-O-methyltransferase knockout mice (COMT-/-) with resveratrol during pregnancy would improve uterine artery blood flow and therefore ameliorate the PE-like phenotype and FGR in these murine models. Pregnant C57BL/6J, eNOS(-/-) and COMT-/- mice received either resveratrol supplemented diet (4 g/kg diet) or control diet between gestational day (GD) 0.5 and GD 18.5. Resveratrol supplementation significantly increased uterine artery blood flow velocity and fetal weight in COMT-/- but not in eNOS(-/-) mice. There were no effects of resveratrol on litter size and placental weight among the groups. In conclusion, resveratrol increased uterine artery blood flow velocity and fetal weight in COMT-/- mice, suggesting potential as a therapeutic strategy for PE and FGR.	[Poudel, Rajan; Stanley, Joanna L.; Rueda-Clausen, Christian F.; Andersson, Irene J.; Davidge, Sandra T.; Baker, Philip N.] Univ Alberta, Edmonton, AB, Canada; [Sibley, Colin P.] Univ Manchester, Maternal & Fetal Hlth Res Ctr, Manchester M13 9PL, Lancs, England; [Sibley, Colin P.] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester, Lancs, England; [Poudel, Rajan; Stanley, Joanna L.; Rueda-Clausen, Christian F.; Andersson, Irene J.; Davidge, Sandra T.] Women & Childrens Hlth Res Inst, Edmonton, AB, Canada; [Stanley, Joanna L.; Baker, Philip N.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand	University of Alberta; University of Manchester; University of Manchester; University of Auckland	Stanley, JL (corresponding author), Univ Alberta, Edmonton, AB, Canada.	jlstanle@ualberta.ca	Rueda-Clausen, Christian/S-2428-2019	Rueda-Clausen, Christian/0000-0002-4077-6159; Davidge, Sandra/0000-0002-5559-4905; Stanley, Joanna/0000-0001-6364-3415; Baker, Philip/0000-0002-4592-6427	Medical Research Council Programme Grant (United Kingdom); Medical Research Council [G0802770] Funding Source: researchfish; MRC [G0802770] Funding Source: UKRI	Medical Research Council Programme Grant (United Kingdom); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by a Medical Research Council Programme Grant (United Kingdom) awarded to PNB and CPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aardema MW, 2001, PLACENTA, V22, P405, DOI 10.1053/plac.2001.0676; BARKER DJP, 1992, BRIT J OBSTET GYNAEC, V99, P275, DOI 10.1111/j.1471-0528.1992.tb13719.x; CAMPBELL S, 1983, LANCET, V1, P675; Chan V, 2011, CURR PHARM BIOTECHNO, V12, P429, DOI 10.2174/138920111794480552; Cnossen JS, 2008, CAN MED ASSOC J, V178, P701, DOI 10.1503/cmaj.070430; Das S, 2005, VASC PHARMACOL, V42, P281, DOI 10.1016/j.vph.2005.02.013; Dolinsky VW, 2011, DIABETES, V60, P2274, DOI 10.2337/db11-0374; Juan ME, 2012, PHARMACOL RES, V65, P584, DOI 10.1016/j.phrs.2012.03.010; Facchinetti F, 2011, J MATERN-FETAL NEO M, V24, P407, DOI 10.3109/14767058.2010.496880; Gagnon R, 2003, EUR J OBSTET GYN R B, V110, pS99, DOI 10.1016/S0301-2115(03)00179-9; HANRETTY KP, 1989, BRIT MED J, V299, P1205, DOI 10.1136/bmj.299.6709.1205; Harrington K, 1996, ULTRASOUND OBST GYN, V7, P182, DOI 10.1046/j.1469-0705.1996.07030182.x; Hefler LA, 2001, AM J PHYSIOL-REG I, V280, pR174, DOI 10.1152/ajpregu.2001.280.1.R174; Holthoff JH, 2012, KIDNEY INT, V81, P370, DOI 10.1038/ki.2011.347; Kanasaki K, 2008, NATURE, V453, P1117, DOI 10.1038/nature06951; Kennedy DO, 2010, AM J CLIN NUTR, V91, P1590, DOI 10.3945/ajcn.2009.28641; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; KHONG TY, 1986, BRIT J OBSTET GYNAEC, V93, P1049, DOI 10.1111/j.1471-0528.1986.tb07830.x; Kulandavelu S, 2006, HYPERTENSION, V47, P1175, DOI 10.1161/01.HYP.0000218440.71846.db; Kulandavelu S, 2012, HYPERTENSION, V60, P231, DOI 10.1161/HYPERTENSIONAHA.111.187559; Kusinski LC, 2012, AM J PHYSIOL-REG I, V303, pR86, DOI 10.1152/ajpregu.00600.2011; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lelfert WR, 2008, NUTR RES, V28, P842, DOI 10.1016/j.nutres.2008.09.001; Lewis G, 2007, 7 CEMACH, P114; Moore RJ, 2000, PLACENTA, V21, P726, DOI 10.1053/plac.2000.0567; Moraloglu O, 2011, J MATERN-FETAL NEO M, P1; Naderali EK, 2000, CLIN SCI, V98, P537, DOI 10.1042/CS19990303; Nihei T, 2001, LIFE SCI, V68, P2845, DOI 10.1016/S0024-3205(01)01061-X; Patel KR, 2011, ANN NY ACAD SCI, V1215, P161, DOI 10.1111/j.1749-6632.2010.05853.x; Rivera L, 2009, BIOCHEM PHARMACOL, V77, P1053, DOI 10.1016/j.bcp.2008.11.027; Shesely EG, 2001, AM J OBSTET GYNECOL, V185, P1198, DOI 10.1067/mob.2001.118142; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Singh CK, 2011, MOL NUTR FOOD RES, V55, P1186, DOI 10.1002/mnfr.201000457; Smith GN, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.06.035; Stanley JL, 2012, HYPERTENSION, V59, P1021, DOI 10.1161/HYPERTENSIONAHA.111.186270; Stanley JL, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.111.096198; Wang Zhi-rong, 2011, Zhonghua Xin Xue Guan Bing Za Zhi, V39, P946; Whitesall SE, 2004, AM J PHYSIOL-HEART C, V286, pH2408, DOI 10.1152/ajpheart.01089.2003; Williams LD, 2009, FOOD CHEM TOXICOL, V47, P2170, DOI 10.1016/j.fct.2009.06.002	39	56	57	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e64401	10.1371/journal.pone.0064401	http://dx.doi.org/10.1371/journal.pone.0064401			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667712	Green Published, Green Submitted, gold			2022-12-25	WOS:000319055600092
J	Aida, J; Yokoyama, A; Shimomura, N; Nakamura, K; Ishikawa, N; Terai, M; Poon, S; Matsuura, M; Fujiwara, M; Sawabe, M; Arai, T; Takubo, K				Aida, Junko; Yokoyama, Akira; Shimomura, Naotaka; Nakamura, Ken-ichi; Ishikawa, Naoshi; Terai, Masanori; Poon, Steven; Matsuura, Masaaki; Fujiwara, Mutsunori; Sawabe, Motoji; Arai, Tomio; Takubo, Kaiyo			Telomere Shortening in the Esophagus of Japanese Alcoholics: Relationships with Chromoendoscopic Findings, ALDH2 and ADH1B Genotypes and Smoking History	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; ALDEHYDE DEHYDROGENASE GENOTYPES; IODINE-UNSTAINED LESIONS; P53 PROTEIN ACCUMULATION; Q-FISH ANALYSIS; IN-SITU; CANCER; MEN; ASSOCIATION; LENGTH	Chromoendoscopy with Lugol iodine staining provides important information on the development of squamous cell carcinoma (SCC). In particular, distinct iodine-unstained lesions (DIULs) larger than 10 mm show a high prevalence in high-grade intraepithelial neoplasia. It has also been reported that inactive ALDH2*1/*2 and less-active ADH1B*1/*1, and smoking, are risk factors for esophageal SCC. We previously examined telomere shortening in the esophageal epithelium of alcoholics, and suggested a high prevalence of chromosomal instability in such individuals. In the present study, we attempted to analyze telomere lengths in 52 DIULs with reference to both their size and multiplicity, ALDH2 and ADH1B genotypes, and smoking history. Patients with DIULs <10 mm (n = 42) had significantly longer telomeres than those with DIULs >= 10 mm (n = 10, p = 0.008). No significant differences in telomere length were recognized between the ALDH2 and ADH1B genotypes (ALDH2 active/inactive = 35/17, ADH1B active/inactive = 32/20; p = 0.563, 0.784, respectively) or among four groups of patients divided according to smoking history (never-, ex-, light, and heavy smokers = 3, 6, 21, and 22 patients, respectively; p = 0.956). Patients without multiple DIULs (n = 17) had significantly longer telomeres than patients with multiple DIULs (n = 35, p = 0.040). It is suggested that alcoholism reduces telomere length in the esophagus, irrespective of genotype or smoking habit. Telomere shortening may not generate cancer directly, but may create conditions under which SCC can develop more easily, depending on subsequent exposure to carcinogens.	[Aida, Junko; Shimomura, Naotaka; Nakamura, Ken-ichi; Ishikawa, Naoshi; Terai, Masanori; Takubo, Kaiyo] Tokyo Metropolitan Inst Gerontol, Res Team Geriatr Pathol, Tokyo, Japan; [Yokoyama, Akira] Natl Hosp Org, Kurihama Med & Addict Ctr, Clin Res Unit, Yokosuka, Kanagawa, Japan; [Poon, Steven] British Columbia Canc Res Ctr, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; [Matsuura, Masaaki] Japanese Fdn Canc Res, Inst Canc, Dept Canc Genom, Tokyo 170, Japan; [Fujiwara, Mutsunori] Japanese Red Cross Med Ctr, Dept Pathol, Tokyo, Japan; [Sawabe, Motoji] Tokyo Med & Dent Univ, Dept Moleculogenet Sci, Div Biomed Lab Sci, Grad Sch Hlth Care Sci, Tokyo, Japan; [Sawabe, Motoji; Arai, Tomio] Tokyo Metropolitan Geriatr Hosp, Dept Pathol, Tokyo 173, Japan	Tokyo Metropolitan Institute of Gerontology; British Columbia Cancer Agency; Japanese Foundation for Cancer Research; Japanese Red Cross Medical Center; University of Tokyo; Tokyo Medical & Dental University (TMDU); Tokyo Metropolitan Institute of Gerontology	Aida, J (corresponding author), Tokyo Metropolitan Inst Gerontol, Res Team Geriatr Pathol, Tokyo, Japan.	aidajs@tmig.or.jp	Aida, Junko/Q-5697-2019	Aida, Junko/0000-0003-4923-5540	JSPS (Japan Society for the Promotion of Science) [21390109, 20590378, 23590440, 20590389, 1n3 22590343]	JSPS (Japan Society for the Promotion of Science)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by JSPS (Japan Society for the Promotion of Science) KAKENHI 21390109, 20590378, 23590440, 20590389, 1n3 22590343 (http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. But they took the role of purchase and maintenance of the equipments for FISH and FISH analysis, purchase instruments and reagents for FISH, and version up of telomere analysis application.	Aida J, 2008, EXP GERONTOL, V43, P833, DOI 10.1016/j.exger.2008.06.001; Aida J, 2007, HUM PATHOL, V38, P1192, DOI 10.1016/j.humpath.2006.11.023; Aida J, 2012, J ORAL PATHOL MED, V41, P372, DOI 10.1111/j.1600-0714.2011.01120.x; Aida J, 2011, J PATHOL, V223, P410, DOI 10.1002/path.2817; Aida J, 2010, EUR J CANCER, V46, P430, DOI 10.1016/j.ejca.2009.10.018; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Asakage T, 2007, CARCINOGENESIS, V28, P865, DOI 10.1093/carcin/bgl206; Baan R, 2009, LANCET ONCOL, V10, P1143, DOI 10.1016/S1470-2045(09)70358-4; BERGLUND M, 1984, ACTA PSYCHIAT SCAND, V70, P407, DOI 10.1111/j.1600-0447.1984.tb01228.x; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; HIGUCHI S, 1994, LANCET, V343, P741, DOI 10.1016/S0140-6736(94)91629-2; Kurabayashi R, 2008, HUM PATHOL, V39, P1647, DOI 10.1016/j.humpath.2008.04.005; Londono-Vallejo JA, 2008, BIOCHIMIE, V90, P73, DOI 10.1016/j.biochi.2007.07.009; Ma HX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020466; Montgomery E, 2010, WHO CLASSIFICATION T, P18; Muto M, 2000, GUT, V47, P256, DOI 10.1136/gut.47.2.256; Muto M, 2005, CARCINOGENESIS, V26, P1008, DOI 10.1093/carcin/bgi035; O'Sullivan JN, 2004, CYTOM PART A, V58A, P120, DOI 10.1002/cyto.a.20006; OHASHI M, 1980, EXP GERONTOL, V15, P121, DOI 10.1016/0531-5565(80)90083-2; Pavanello S, 2011, INT J CANCER, V129, P983, DOI 10.1002/ijc.25999; Poschl G, 2004, ALCOHOL ALCOHOLISM, V39, P155, DOI 10.1093/alcalc/agh057; Sanada Y, 2012, WORLD J SURG, V36, P908, DOI 10.1007/s00268-012-1453-z; SCHMIDT W, 1972, Q J STUD ALCOHOL, V33, P171; Shiraishi H, 2009, SCAND J GASTROENTERO, V44, P538, DOI 10.1080/00365520902718705; Takubo K, 2007, HISTOPATHOLOGY, V51, P733, DOI 10.1111/j.1365-2559.2007.02766.x; Takubo K, 1999, AGE, V22, P95, DOI 10.1007/s11357-999-0011-6; Takubo K, 2002, EXP GERONTOL, V37, P523, DOI 10.1016/S0531-5565(01)00218-2; Takubo K, 2007, PATHOLOGY ESOPHAGUS, P182; Takubo K, 2010, J PATHOL, V221, P201, DOI 10.1002/path.2704; Turkyilmaz A, 2009, DIS ESOPHAGUS, V22, P211, DOI 10.1111/j.1442-2050.2008.00890.x; Wentzensen IM, 2011, CANCER EPIDEM BIOMAR, V20, P1238, DOI 10.1158/1055-9965.EPI-11-0005; Yokoyama A, 2001, CARCINOGENESIS, V22, P433, DOI 10.1093/carcin/22.3.433; Yokoyama A, 2007, CANCER LETT, V247, P243, DOI 10.1016/j.canlet.2006.05.004; Yokoyama A, 2012, INT J CANCER, V130, P2949, DOI 10.1002/ijc.26296; Yokoyama A, 2011, CANCER LETT, V308, P112, DOI 10.1016/j.canlet.2011.04.020	37	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63860	10.1371/journal.pone.0063860	http://dx.doi.org/10.1371/journal.pone.0063860			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667679	Green Published, gold, Green Submitted			2022-12-25	WOS:000319654700189
J	Cheng, JJ; Yin, Y; Wu, HW; Zhang, Q; Hua, J; Hua, XL; Xu, JR				Cheng, Jiejun; Yin, Yan; Wu, Huawei; Zhang, Qing; Hua, Jia; Hua, Xiaolan; Xu, Jianrong			Optimal Monochromatic Energy Levels in Spectral CT Pulmonary Angiography for the Evaluation of Pulmonary Embolism	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; LUNG PERFUSION; IMAGE QUALITY; DIAGNOSIS	Background: The aim of this study was to determine the optimal monochromatic spectral CT pulmonary angiography (sCTPA) levels to obtain the highest image quality and diagnostic confidence for pulmonary embolism detection. Methods: The Institutional Review Board of the Shanghai Jiao Tong University School of Medicine approved this study, and written informed consent was obtained from all participating patients. Seventy-two patients with pulmonary embolism were scanned with spectral CT mode in the arterial phase. One hundred and one sets of virtual monochromatic spectral (VMS) images were generated ranging from 40 keV to 140 keV. Image noise, clot diameter and clot to artery contrast-to-noise ratio (CNR) from seven sets of VMS images at selected monochromatic levels in sCTPA were measured and compared. Subjective image quality and diagnostic confidence for these images were also assessed and compared. Data were analyzed by paired t test and Wilcoxon rank sum test. Results: The lowest noise and the highest image quality score for the VMS images were obtained at 65 keV. The VMS images at 65 keV also had the second highest CNR value behind that of 50 keV VMS images. There was no difference in the mean noise and CNR between the 65 keV and 70 keV VMS images. The apparent clot diameter correlated with the keV levels. Conclusions: The optimal energy level for detecting pulmonary embolism using dual-energy spectral CT pulmonary angiography was 65-70 keV. Virtual monochromatic spectral images at approximately 65-70 keV yielded the lowest image noise, high CNR and highest diagnostic confidence for the detection of pulmonary embolism.	[Cheng, Jiejun; Yin, Yan; Wu, Huawei; Zhang, Qing; Hua, Jia; Hua, Xiaolan; Xu, Jianrong] Shanghai Jiao Tong Univ, Renji Hosp, Dept Radiol, Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Wu, HW (corresponding author), Shanghai Jiao Tong Univ, Renji Hosp, Dept Radiol, Sch Med, Shanghai 200030, Peoples R China.	huawei_wu@yahoo.com.cn; xujianr@gmail.com			Shanghai Municipal Health Bureau [20120176]; key discipline project of Renji hospital, Shanghai Jiao Tong University School of Medicine [RJ4101309]	Shanghai Municipal Health Bureau; key discipline project of Renji hospital, Shanghai Jiao Tong University School of Medicine	This work was supported in part by research project of the Shanghai Municipal Health Bureau (20120176) and key discipline project of Renji hospital, Shanghai Jiao Tong University School of Medicine (RJ4101309). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ferda J, 2011, EUR J RADIOL, V77, P287, DOI 10.1016/j.ejrad.2009.08.005; Fink C, 2008, ROFO-FORTSCHR RONTG, V180, P879, DOI 10.1055/s-2008-1027724; Gorgos A, 2009, J COMPUT ASSIST TOMO, V33, P981, DOI 10.1097/RCT.0b013e3181a5cd0f; Gotway MB, 2000, J COMPUT ASSIST TOMO, V24, P267, DOI 10.1097/00004728-200003000-00016; Kang MJ, 2010, RADIOGRAPHICS, V30, P685, DOI 10.1148/rg.303095101; Krissak R, 2010, INVEST RADIOL, V45, P341, DOI 10.1097/RLI.0b013e3181dfda37; Lin XZ, 2011, J COMPUT ASSIST TOMO, V35, P294, DOI 10.1097/RCT.0b013e3182058d5c; Matsumoto K, 2011, RADIOLOGY, V259, P257, DOI 10.1148/radiol.11100978; Maturen KE, 2012, J COMPUT ASSIST TOMO, V36, P83, DOI 10.1097/RCT.0b013e31824258cb; Pontana F, 2008, ACAD RADIOL, V15, P1494, DOI 10.1016/j.acra.2008.05.018; Ragni MV, 2009, CURR OPIN PULM MED, V15, P430, DOI 10.1097/MCP.0b013e32832d860d; Renard B, 2011, EUR J RADIOL, V79, P467, DOI 10.1016/j.ejrad.2010.04.018; Sangwaiya MJ, 2010, J COMPUT ASSIST TOMO, V34, P46, DOI 10.1097/RCT.0b013e3181aac7ec; Schoepf UJ, 2004, RADIOLOGY, V230, P329, DOI 10.1148/radiol.2302021489; Stein PD, 2006, NEW ENGL J MED, V354, P2317, DOI 10.1056/NEJMoa052367; Sueyoshi E, 2011, EUR J RADIOL, V80, pE505, DOI 10.1016/j.ejrad.2010.10.011; Thieme SF, 2008, EUR J RADIOL, V68, P369, DOI 10.1016/j.ejrad.2008.07.031; Torbicki A, 2008, EUR HEART J, V29, P2276, DOI 10.1093/eurheartj/ehn310; Wu HW, 2012, INVEST RADIOL, V47, P85, DOI 10.1097/RLI.0b013e31823441a1; Yamada Y, 2012, INVEST RADIOL, V47, P292, DOI 10.1097/RLI.0b013e318240a874; Yuan R, 2012, RADIOLOGY, V262, P290, DOI 10.1148/radiol.11110648; Zhang LJ, 2009, RADIOLOGY, V252, P61, DOI 10.1148/radiol.2521081682; Zhao LQ, 2012, EUR J RADIOL, V81, P1677, DOI 10.1016/j.ejrad.2011.02.063	23	42	47	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63140	10.1371/journal.pone.0063140	http://dx.doi.org/10.1371/journal.pone.0063140			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667583	Green Published, Green Submitted, gold			2022-12-25	WOS:000319654700114
J	Klint, JK; Senff, S; Saez, NJ; Seshadri, R; Lau, HY; Bende, NS; Undheim, EAB; Rash, LD; Mobli, M; King, GF				Klint, Julie K.; Senff, Sebastian; Saez, Natalie J.; Seshadri, Radha; Lau, Ho Yee; Bende, Niraj S.; Undheim, Eivind A. B.; Rash, Lachlan D.; Mobli, Mehdi; King, Glenn F.			Production of Recombinant Disulfide-Rich Venom Peptides for Structural and Functional Analysis via Expression in the Periplasm of E. coli	PLOS ONE			English	Article							MACROMOLECULAR NMR-SPECTROSCOPY; SODIUM-CHANNEL INHIBITOR; SINGLE-STEP PURIFICATION; MALTOSE-BINDING PROTEIN; HIGH-LEVEL EXPRESSION; ESCHERICHIA-COLI; INSECTICIDAL PEPTIDES; FUSION PROTEINS; AFFINITY PURIFICATION; CAPSAICIN RECEPTOR	Disulfide-rich peptides are the dominant component of most animal venoms. These peptides have received much attention as leads for the development of novel therapeutic agents and bioinsecticides because they target a wide range of neuronal receptors and ion channels with a high degree of potency and selectivity. In addition, their rigid disulfide framework makes them particularly well suited for addressing the crucial issue of in vivo stability. Structural and functional characterization of these peptides necessitates the development of a robust, reliable expression system that maintains their native disulfide framework. The bacterium Escherichia coli has long been used for economical production of recombinant proteins. However, the expression of functional disulfide-rich proteins in the reducing environment of the E. coli cytoplasm presents a significant challenge. Thus, we present here an optimised protocol for the expression of disulfide-rich venom peptides in the periplasm of E. coli, which is where the endogenous machinery for production of disulfide-bonds is located. The parameters that have been investigated include choice of media, induction conditions, lysis methods, methods of fusion protein and peptide purification, and sample preparation for NMR studies. After each section a recommendation is made for conditions to use. We demonstrate the use of this method for the production of venom peptides ranging in size from 2 to 8 kDa and containing 2-6 disulfide bonds.	[Klint, Julie K.; Senff, Sebastian; Saez, Natalie J.; Seshadri, Radha; Lau, Ho Yee; Bende, Niraj S.; Undheim, Eivind A. B.; Rash, Lachlan D.; Mobli, Mehdi; King, Glenn F.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia	University of Queensland	Mobli, M (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia.	m.mobli@uq.edu.au; glenn.king@imb.uq.edu.au	Rash, Lachlan D/A-3858-2010; Klint, Julie/M-5458-2013; Mobli, Mehdi/O-7244-2014; SAEZ, Natalie/I-9620-2014; King, Glenn F/J-5059-2012	Rash, Lachlan D/0000-0003-3616-0279; Klint, Julie/0000-0001-7586-8216; Mobli, Mehdi/0000-0003-2420-4262; SAEZ, Natalie/0000-0002-1664-325X; King, Glenn F/0000-0002-2308-2200; Undheim, Eivind/0000-0002-8667-3999; Lau, Carus/0000-0002-4363-181X; Senff, Sebastian/0000-0001-9665-9376	Australian National Health and Medical Research Council [APP1044414]; Australian Research Council [FT100100027]; NHMRC [APP1044414, APP1012338, APP1034958]; ARC [DP1095728, DP110103129, LP110100509]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); ARC(Australian Research Council)	Australian National Health and Medical Research Council (APP1044414) and Australian Research Council (FT100100027). NHMRC Project Grants APP1012338 and APP1034958 and Research Fellowship APP1044414 to GFK, as well as ARC Discovery Grants DP1095728 and DP110103129 and ARC Linkage Grant LP110100509. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken A, 2002, PROTEIN PROTOCOLS HD, P3, DOI [10.1385/1-59259-169-8:3., DOI 10.1385/1-59259-169-8:3]; ANGLISTER J, 1993, J BIOMOL NMR, V3, P121; Annis I, 1997, METHOD ENZYMOL, V289, P198; Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; BASSFORD PJ, 1990, J BIOENERG BIOMEMBR, V22, P401, DOI 10.1007/BF00763175; Bell PA, 2001, MOL BIOL PROBLEM SOL, P461; Bende N, 2013, BICOH PHARM IN PRESS; Berrow NS, 2006, ACTA CRYSTALLOGR D, V62, P1218, DOI 10.1107/S0907444906031337; Berthold DA, 2012, 15 CAMBR IS LAB; Bieri M, 2011, FEBS J, V278, P704, DOI 10.1111/j.1742-4658.2011.08005.x; Bohlen CJ, 2010, CELL, V141, P834, DOI 10.1016/j.cell.2010.03.052; Bosmans F, 2006, MOL PHARMACOL, V69, P419, DOI 10.1124/mol.105.015941; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREMER H, 1975, J THEOR BIOL, V53, P115, DOI 10.1016/0022-5193(75)90106-X; Bulaj G, 2001, BIOCHEMISTRY-US, V40, P13201, DOI 10.1021/bi010683a; Cabrita LD, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-12; CHESSHYRE JA, 1989, APPL MICROBIOL BIOT, V31, P158, DOI 10.1007/BF00262455; Choi JH, 2004, APPL MICROBIOL BIOT, V64, P625, DOI 10.1007/s00253-004-1559-9; Choi SJ, 2004, FEBS LETT, V572, P109, DOI 10.1016/j.febslet.2004.07.019; CORDEIRO MD, 1993, TOXICON, V31, P35, DOI 10.1016/0041-0101(93)90354-L; CORDINGLEY MG, 1990, J BIOL CHEM, V265, P9062; Davis GD, 1999, BIOTECHNOL BIOENG, V65, P382, DOI 10.1002/(SICI)1097-0290(19991120)65:4<382::AID-BIT2>3.3.CO;2-9; De Marco V, 2004, BIOCHEM BIOPH RES CO, V322, P766, DOI 10.1016/j.bbrc.2004.07.189; Desjardins P., 2009, CURR PROTOC PROTEIN, V55, P10; DIGUAN C, 1988, GENE, V67, P21, DOI 10.1016/0378-1119(88)90004-2; DINGLEY AJ, 1995, J BIOMOL NMR, V6, P321; Dutertre S, 2007, EMBO J, V26, P3858, DOI 10.1038/sj.emboj.7601785; Dyson MR, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-32; Ebbinghaus J, 2004, TOXICON, V43, P923, DOI 10.1016/j.toxicon.2003.12.012; Einhauer A, 2001, J BIOCHEM BIOPH METH, V49, P455, DOI 10.1016/S0165-022X(01)00213-5; Fang L, 2007, PROTEIN EXPRES PURIF, V51, P102, DOI 10.1016/j.pep.2006.07.003; FORSBERG G, 1992, J PROTEIN CHEM, V11, P201, DOI 10.1007/BF01025226; Gaberc-Porekar V, 2001, J BIOCHEM BIOPH METH, V49, P335, DOI 10.1016/S0165-022X(01)00207-X; Gaberc-Porekar V, 2005, CHEM ENG TECHNOL, V28, P1306, DOI 10.1002/ceat.200500167; Goldberg Stanley, 2008, V424, P3, DOI 10.1007/978-1-60327-064-9_1; Golovanov AP, 2004, J AM CHEM SOC, V126, P8933, DOI 10.1021/ja049297h; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Hardy MC, 2012, PEST CONTROLLING AGE; Heras B, 2009, NAT REV MICROBIOL, V7, P215, DOI 10.1038/nrmicro2087; Jansson M, 1996, J BIOMOL NMR, V7, P131; Jenny RJ, 2003, PROTEIN EXPRES PURIF, V31, P1, DOI 10.1016/S1046-5928(03)00168-2; Jensen JE, 2009, TOXICON, V54, P56, DOI 10.1016/j.toxicon.2009.03.014; JOCELYN PC, 1967, EUR J BIOCHEM, V2, P327, DOI 10.1111/j.1432-1033.1967.tb00142.x; Johnson JH, 1998, ARCH INSECT BIOCHEM, V38, P19, DOI 10.1002/(SICI)1520-6327(1998)38:1&lt;19::AID-ARCH3&gt;3.0.CO;2-Q; Jung HJ, 2005, BIOCHEMISTRY-US, V44, P6015, DOI 10.1021/bi0477034; Kainosho M, 1997, NAT STRUCT BIOL, V4, P858; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Kapust RB, 2002, BIOCHEM BIOPH RES CO, V294, P949, DOI 10.1016/S0006-291X(02)00574-0; Kelly AE, 2002, J AM CHEM SOC, V124, P12013, DOI 10.1021/ja026121b; KIEFHABER T, 1991, BIO-TECHNOL, V9, P825, DOI 10.1038/nbt0991-825; King GF, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 9: MODERN METHODS IN NATURAL PRODUCTS CHEMISTRY, P279; King GF, 2013, ANNU REV ENTOMOL, V58, P475, DOI 10.1146/annurev-ento-120811-153650; King GF, 2011, EXPERT OPIN BIOL TH, V11, P1469, DOI 10.1517/14712598.2011.621940; KRAPCHO KJ, 1995, INSECT BIOCHEM MOLEC, V25, P991, DOI 10.1016/0965-1748(95)00029-U; Kurz M, 2006, PROTEIN EXPRES PURIF, V50, P68, DOI 10.1016/j.pep.2006.05.006; Kwan AH, 2011, FEBS J, V278, P687, DOI 10.1111/j.1742-4658.2011.08004.x; Lewis RJ, 2003, NAT REV DRUG DISCOV, V2, P790, DOI 10.1038/nrd1197; Li DL, 2003, FEBS LETT, V555, P616, DOI 10.1016/S0014-5793(03)01303-6; Lipkin A, 2002, TOXICON, V40, P125, DOI 10.1016/S0041-0101(01)00181-7; Listwan Pawel, 2010, Journal of Structural and Functional Genomics, V11, P41, DOI 10.1007/s10969-009-9077-8; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maertens B, 2010, PROTEIN SCI, V19, P1312, DOI 10.1002/pro.408; Maertens C, 2006, MOL PHARMACOL, V70, P405, DOI 10.1124/mol.106.022970; MAINA CV, 1988, GENE, V74, P365, DOI 10.1016/0378-1119(88)90170-9; Majerle A, 2000, J BIOMOL NMR, V18, P145, DOI 10.1023/A:1008362401928; Makrides SC, 1996, MICROBIOL REV, V60, P512, DOI 10.1128/MMBR.60.3.512-538.1996; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; MERTENS N, 1995, BIO-TECHNOL, V13, P175, DOI 10.1038/nbt0295-175; Middleton RE, 2002, BIOCHEMISTRY-US, V41, P14734, DOI 10.1021/bi026546a; Mobli M, 2009, ANGEW CHEM INT EDIT, V48, P9312, DOI 10.1002/anie.200905206; Morales RAV, 2010, CHEMBIOCHEM, V11, P1882, DOI 10.1002/cbic.201000330; NEU HC, 1965, J BIOL CHEM, V240, P3685; Nijeholt JALA, 2012, PHILOS T R SOC B, V367, P1016, DOI 10.1098/rstb.2011.0201; OTTING G, 1993, BIOCHEMISTRY-US, V32, P3571, DOI 10.1021/bi00065a008; OZOLS J, 1990, METHOD ENZYMOL, V182, P587; QIAGEN, 2003, QIAEXPRESSIONIST HDB; QUISTAD GB, 1994, J BIOL CHEM, V269, P11098; REILLY D, 1994, J BIOMOL NMR, V4, P459; Riggs P, 2001, CURRENT PROTOCOLS MO; Robosky LC, 2007, ANAL BIOANAL CHEM, V387, P529, DOI 10.1007/s00216-006-0982-4; Robson SA, 2006, P NATL ACAD SCI USA, V103, P6700, DOI 10.1073/pnas.0601397103; Rudolph R, 1996, FASEB J, V10, P49, DOI 10.1096/fasebj.10.1.8566547; Rutherfurd SM, 2011, CURRENT PROTOCOLS PR; Saez NJ, 2011, MOL PHARMACOL, V80, P796, DOI 10.1124/mol.111.072207; Salinas G, 2011, BIOTECHNOL J, V6, P686, DOI 10.1002/biot.201000335; Schaefer SA, 2013, J MOL BIOL, V425, P222, DOI 10.1016/j.jmb.2012.11.011; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; SCHATZ PJ, 1993, BIO-TECHNOL, V11, P1138, DOI 10.1038/nbt1093-1138; SCHEIN CH, 1990, BIO-TECHNOL, V8, P308, DOI 10.1038/nbt0490-308; SCHMIDT TGM, 1994, J CHROMATOGR A, V676, P337, DOI 10.1016/0021-9673(94)80434-6; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Siemens J, 2006, NATURE, V444, P208, DOI 10.1038/nature05285; Sivashanmugam A, 2009, PROTEIN SCI, V18, P936, DOI 10.1002/pro.102; SKINNER WS, 1992, TOXICON, V30, P1043, DOI 10.1016/0041-0101(92)90049-B; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Sollod BL, 2005, PEPTIDES, V26, P131, DOI 10.1016/j.peptides.2004.07.016; STOFKOHAHN RE, 1992, FEBS LETT, V302, P274, DOI 10.1016/0014-5793(92)80458-S; Tyler RC, 2005, PROTEIN EXPRES PURIF, V40, P268, DOI 10.1016/j.pep.2004.12.024; Tytgat J, 2001, FEBS LETT, V491, P217, DOI 10.1016/S0014-5793(01)02201-3; Vetter I, 2011, AMINO ACIDS, V40, P15, DOI 10.1007/s00726-010-0516-4; Walewska A, 2009, ANGEW CHEM INT EDIT, V48, P2221, DOI 10.1002/anie.200806085; WALKER PA, 1994, BIO-TECHNOL, V12, P601, DOI 10.1038/nbt0694-601; Waugh DS, 2011, PROTEIN EXPRES PURIF, V80, P283, DOI 10.1016/j.pep.2011.08.005; Waugh DS, 2005, TRENDS BIOTECHNOL, V23, P316, DOI 10.1016/j.tibtech.2005.03.012; Waugh DS, 2010, TEV PROTEASE FAQ; Xiao XC, 2003, EUR J PHARMACOL, V477, P1, DOI 10.1016/S0014-2999(03)02190-3; Xiao YC, 2003, TOXICON, V41, P643, DOI 10.1016/S0041-0101(02)00280-5; Yang S, 2012, MOL CELL PROTEOMICS, V11, P640, DOI 10.1074/mcp.M112.018853; Young CL, 2012, BIOTECHNOL J, V7, P620, DOI 10.1002/biot.201100155; Zhang YB, 2004, PROTEIN EXPRES PURIF, V36, P207, DOI 10.1016/j.pep.2004.04.020; Zheng CF, 1997, GENE, V186, P55, DOI 10.1016/S0378-1119(96)00680-4	111	117	122	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63865	10.1371/journal.pone.0063865	http://dx.doi.org/10.1371/journal.pone.0063865			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667680	gold, Green Published			2022-12-25	WOS:000319654700190
J	Sevilla-Reyes, EE; Chavaro-Perez, DA; Piten-Isidro, E; Gutierrez-Gonzalez, LH; Santos-Mendoza, T				Sevilla-Reyes, Edgar E.; Chavaro-Perez, David A.; Piten-Isidro, Elvira; Gutierrez-Gonzalez, Luis H.; Santos-Mendoza, Teresa			Protein Clustering and RNA Phylogenetic Reconstruction of the Influenza a Virus NS1 Protein Allow an Update in Classification and Identification of Motif Conservation	PLOS ONE			English	Article							NONSTRUCTURAL PROTEIN-1; CD-HIT; RIG-I; NEURAMINIDASE; REPLICATION; EXPRESSION; PHILOSOPHY; PROGRAM; TARGET; GENES	The non-structural protein 1 (NS1) of influenza A virus (IAV), coded by its third most diverse gene, interacts with multiple molecules within infected cells. NS1 is involved in host immune response regulation and is a potential contributor to the virus host range. Early phylogenetic analyses using 50 sequences led to the classification of NS1 gene variants into groups (alleles) A and B. We reanalyzed NS1 diversity using 14,716 complete NS IAV sequences, downloaded from public databases, without host bias. Removal of sequence redundancy and further structured clustering at 96.8% amino acid similarity produced 415 clusters that enhanced our capability to detect distinct subgroups and lineages, which were assigned a numerical nomenclature. Maximum likelihood phylogenetic reconstruction using RNA sequences indicated the previously identified deep branching separating group A from group B, with five distinct subgroups within A as well as two and five lineages within the A4 and A5 subgroups, respectively. Our classification model proposes that sequence patterns in thirteen amino acid positions are sufficient to fit >99.9% of all currently available NS1 sequences into the A subgroups/lineages or the B group. This classification reduces host and virus bias through the prioritization of NS1 RNA phylogenetics over host or virus phenetics. We found significant sequence conservation within the subgroups and lineages with characteristic patterns of functional motifs, such as the differential binding of CPSF30 and crk/crkL or the availability of a C-terminal PDZ-binding motif. To understand selection pressures and evolution acting on NS1, it is necessary to organize the available data. This updated classification may help to clarify and organize the study of NS1 interactions and pathogenic differences and allow the drawing of further functional inferences on sequences in each group, subgroup and lineage rather than on a strain-by-strain basis.	[Sevilla-Reyes, Edgar E.; Chavaro-Perez, David A.; Piten-Isidro, Elvira] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Dept Invest Enfermedades Infecciosas, Mexico City, DF, Mexico; [Gutierrez-Gonzalez, Luis H.] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Dept Virol & Micol, Mexico City, DF, Mexico; [Santos-Mendoza, Teresa] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Dept Inmunol, Mexico City, DF, Mexico		Sevilla-Reyes, EE (corresponding author), Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Dept Invest Enfermedades Infecciosas, Mexico City, DF, Mexico.	edgar.sevilla@gmail.com; tesalonster@gmail.com	Sevilla, Edgar/AAS-3300-2021; Santos-Mendoza, Teresa/AAK-8528-2021	Sevilla, Edgar/0000-0002-7047-0222; Santos-Mendoza, Teresa/0000-0003-1015-5631; Gutierrez-Gonzalez, Luis Horacio/0000-0003-0708-0448	Consejo Nacional de Ciencia y Tecnologia [CB2010-155382]; Instituto De Ciencia Y Tecnologia Del Distrito Federal [PIFUTP09-281]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Instituto De Ciencia Y Tecnologia Del Distrito Federal	Project supported by Consejo Nacional de Ciencia y Tecnologia grant CB2010-155382 and Instituto De Ciencia Y Tecnologia Del Distrito Federal grant PIFUTP09-281. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragon T, 2000, MOL CELL BIOL, V20, P6259, DOI 10.1128/MCB.20.17.6259-6268.2000; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; BELLETT A. J. D., 1967, J VIROL, V1, P245; Boni MF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010434; Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P1615; Chen GW, 2006, EMERG INFECT DIS, V12, P1353, DOI 10.3201/eid1209.060276; Chen RB, 2006, MOL BIOL EVOL, V23, P2336, DOI 10.1093/molbev/msl102; Chen RB, 2010, J MOL EVOL, V70, P98, DOI 10.1007/s00239-009-9312-8; COWAN ST, 1955, J GEN MICROBIOL, V12, P314, DOI 10.1099/00221287-12-2-314; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dugan VG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000076; Dundon WG, 2012, VIRUS GENES, V44, P363, DOI 10.1007/s11262-012-0714-0; Dundon WG, 2009, VIRUSES-BASEL, V1, P1057, DOI 10.3390/v1031057; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Guo Z, 2007, AM J RESP CELL MOL, V36, P263, DOI 10.1165/rcmb.2006-0283RC; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hale BG, 2010, J VIROL, V84, P6909, DOI 10.1128/JVI.00081-10; Heikkinen LS, 2008, J BIOL CHEM, V283, P5719, DOI 10.1074/jbc.M707195200; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Igarashi M, 2008, VIROLOGY, V376, P323, DOI 10.1016/j.virol.2008.03.036; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Jackson D, 2008, P NATL ACAD SCI USA, V105, P4381, DOI 10.1073/pnas.0800482105; Kainov DE, 2011, J BIOL CHEM, V286, P7239, DOI 10.1074/jbc.M110.203489; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kobasa D, 1997, J VIROL, V71, P6706, DOI 10.1128/JVI.71.9.6706-6713.1997; Kochs G, 2007, J VIROL, V81, P7011, DOI 10.1128/JVI.02581-06; Lazarevic V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-523; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; LUDWIG S, 1991, VIROLOGY, V183, P566, DOI 10.1016/0042-6822(91)90985-K; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Min JY, 2007, VIROLOGY, V363, P236, DOI 10.1016/j.virol.2007.01.038; Miotto O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009025; Munir M, 2011, J GEN VIROL, V92, P2111, DOI 10.1099/vir.0.031716-0; NELSON GJ, 1971, SYST ZOOL, V20, P373, DOI 10.2307/2412351; Noronha JM, 2012, J VIROL, V86, P5857, DOI 10.1128/JVI.06901-11; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Opitz B, 2007, CELL MICROBIOL, V9, P930, DOI 10.1111/j.1462-5822.2006.00841.x; Pal S, 2010, J VIROL METHODS, V163, P498, DOI 10.1016/j.jviromet.2009.11.010; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Russell CA, 2012, SCIENCE, V336, P1541, DOI 10.1126/science.1222526; Smith GJD, 2012, INFLUENZA OTHER RESP, V6, P1, DOI 10.1111/j.1750-2659.2011.00298.x; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Soubies SM, 2010, J VIROL, V84, P6733, DOI 10.1128/JVI.02427-09; Squires RB, 2012, INFLUENZA OTHER RESP, V6, P404, DOI 10.1111/j.1750-2659.2011.00331.x; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; TREANOR JJ, 1989, VIROLOGY, V171, P1, DOI 10.1016/0042-6822(89)90504-7; Twu KY, 2007, J VIROL, V81, P8112, DOI 10.1128/JVI.00006-07; VANREGENMORTEL MHV, 1991, ARCH VIROL, V120, P313, DOI 10.1007/BF01310487; VANREGENMORTEL MHV, 1989, ARCH VIROL, V104, P1, DOI 10.1007/BF01313804; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Xu K, 2011, J VIROL, V85, P1086, DOI 10.1128/JVI.00877-10	54	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63098	10.1371/journal.pone.0063098	http://dx.doi.org/10.1371/journal.pone.0063098			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667580	Green Published, Green Submitted, gold			2022-12-25	WOS:000319654700112
J	Carlin, J; George, R; Reyes, TM				Carlin, JesseLea; George, Robert; Reyes, Teresa M.			Methyl Donor Supplementation Blocks the Adverse Effects of Maternal High Fat Diet on Offspring Physiology	PLOS ONE			English	Article							BODY-MASS INDEX; GESTATIONAL WEIGHT-GAIN; DNA HYPOMETHYLATION; CHILDBEARING AGE; GENE-EXPRESSION; JUNK-FOOD; PREGNANCY; RAT; OBESITY; DOPAMINE	Maternal consumption of a high fat diet during pregnancy increases the offspring risk for obesity. Using a mouse model, we have previously shown that maternal consumption of a high fat (60%) diet leads to global and gene specific decreases in DNA methylation in the brain of the offspring. The present experiments were designed to attempt to reverse this DNA hypomethylation through supplementation of the maternal diet with methyl donors, and to determine whether methyl donor supplementation could block or attenuate phenotypes associated with maternal consumption of a HF diet. Metabolic and behavioral (fat preference) outcomes were assessed in male and female adult offspring. Expression of the mu-opioid receptor and dopamine transporter mRNA, as well as global DNA methylation were measured in the brain. Supplementation of the maternal diet with methyl donors attenuated the development of some of the adverse effects seen in offspring from dams fed a high fat diet; including weight gain, increased fat preference (males), changes in CNS gene expression and global hypomethylation in the prefrontal cortex. Notable sex differences were observed. These findings identify the importance of balanced methylation status during pregnancy, particularly in the context of a maternal high fat diet, for optimal offspring outcome.	[Carlin, JesseLea; George, Robert; Reyes, Teresa M.] Univ Penn, Sch Med, Dept Pharmacol, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Reyes, TM (corresponding author), Univ Penn, Sch Med, Dept Pharmacol, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA.	reyestm@mail.med.upenn.edu	Reyes, Teresa/GYI-8942-2022	Reyes, Teresa/0000-0003-3009-3749	National Institutes for Health [MH087978, MH091372]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH087978, R21MH091372] Funding Source: NIH RePORTER	National Institutes for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Research supported by National Institutes for Health grants MH087978 (Reyes) and MH091372 (Reyes). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashino NG, 2012, J NUTR BIOCHEM, V23, P341, DOI 10.1016/j.jnutbio.2010.12.011; Baccarelli A, 2009, CURR OPIN PEDIATR, V21, P243, DOI 10.1097/MOP.0b013e32832925cc; Bayol SA, 2007, BRIT J NUTR, V98, P843, DOI 10.1017/S0007114507812037; Berrendero F, 2010, NEUROSCI BIOBEHAV RE; Bouret SG, 2008, CELL METAB, V7, P179, DOI 10.1016/j.cmet.2007.12.001; Brawarsky P, 2005, INT J GYNECOL OBSTET, V91, P125, DOI 10.1016/j.ijgo.2005.08.008; Caudill MA, 2001, J AM COLL NUTR, V20, P129, DOI 10.1080/07315724.2001.10719024; Chang GQ, 2008, J NEUROSCI, V28, P12107, DOI 10.1523/JNEUROSCI.2642-08.2008; Chefer VI, 2009, EUR J NEUROSCI, V30, P272, DOI 10.1111/j.1460-9568.2009.06827.x; Chen XL, 2010, BIRTH DEFECTS RES A, V88, P575, DOI 10.1002/bdra.20670; Cropley JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009055; Davison JM, 2009, J BIOL CHEM, V284, P1982, DOI 10.1074/jbc.M807651200; Day CJ, 2012, APPETITE, V58, P679, DOI 10.1016/j.appet.2011.12.013; Engeham SF, 2010, BRIT J NUTR, V103, P996, DOI 10.1017/S0007114509992662; Fraser A, 2010, CIRCULATION, V121, P2557, DOI 10.1161/CIRCULATIONAHA.109.906081; Gago B, 2007, J COMP NEUROL, V502, P358, DOI 10.1002/cne.21327; Golshani Peyman, 2005, Thalamus & Related Systems, V3, P227, DOI 10.1017/S1472928807000222; Hoyo C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-46; Hutnick LK, 2009, HUM MOL GENET, V18, P2875, DOI 10.1093/hmg/ddp222; Ignar DM, 2011, J PHARMACOL EXP THER, V339, P24, DOI 10.1124/jpet.111.180943; Ke X, 2006, PHYSIOL GENOMICS, V25, P16, DOI 10.1152/physiolgenomics.00093.2005; Klein G, 2009, NEUROSCI LETT, V457, P115, DOI 10.1016/j.neulet.2009.04.012; Lanfer A, 2011, INT J OBES LOND; Langsdorf EF, 2011, SYNAPSE, V65, P858, DOI 10.1002/syn.20913; Laraia BA, 2007, PUBLIC HEALTH NUTR, V10, P920, DOI 10.1017/S1368980007657991; Le Merrer J, 2009, PHYSIOL REV, V89, P1379, DOI 10.1152/physrev.00005.2009; Leibowitz SF, 1998, ENDOCRINOLOGY, V139, P1771, DOI 10.1210/en.139.4.1771; Livy DJ, 2003, NEUROTOXICOL TERATOL, V25, P447, DOI 10.1016/S0892-0362(03)00030-8; Mena JD, 2011, J NEUROSCI, V31, P3249, DOI 10.1523/JNEUROSCI.2050-10.2011; Naef L, 2011, NEUROSCIENCE, V176, P225, DOI 10.1016/j.neuroscience.2010.12.037; Nathan PJ, 2011, J CLIN PHARM; Novikova SI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001919; Oken E, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.11.027; Ong ZY, 2011, FASEB J, V25, P2167, DOI 10.1096/fj.10-178392; Papaleo F, 2007, EUR J NEUROSCI, V25, P3398, DOI 10.1111/j.1460-9568.2007.05595.x; Rifas-Shiman SL, 2009, J AM DIET ASSOC, V109, P1004, DOI 10.1016/j.jada.2009.03.001; Rother E, 2012, ENDOCRINOLOGY, V153, P770, DOI 10.1210/en.2011-1589; Schack-Nielsen L, 2010, INT J OBESITY, V34, P67, DOI 10.1038/ijo.2009.206; Stuebe AM, 2009, INT J OBESITY, V33, P743, DOI 10.1038/ijo.2009.101; Sullivan EL, 2011, NEUROENDOCRINOLOGY, V93, P1, DOI 10.1159/000322038; Sun B, 2012, DIABETES, V61, P2833, DOI 10.2337/db11-0957; Tamashiro KLK, 2009, DIABETES, V58, P1116, DOI 10.2337/db08-1129; Teegarden SL, 2009, NEUROSCIENCE, V162, P924, DOI 10.1016/j.neuroscience.2009.05.029; Vucetic Z, 2010, ENDOCRINOLOGY, V151, P4756, DOI 10.1210/en.2010-0505; Wagner AK, 2005, EXP NEUROL, V195, P475, DOI 10.1016/j.expneurol.2005.06.009; Waterland RA, 2008, INT J OBESITY, V32, P1373, DOI 10.1038/ijo.2008.100; Wilson AS, 2007, BBA-REV CANCER, V1775, P138, DOI 10.1016/j.bbcan.2006.08.007; Wolff GL, 1988, FASEB J, V12; Yang QH, 2007, AM J CLIN NUTR, V85, P1409, DOI 10.1093/ajcn/85.5.1409; Zhang M, 2000, NEUROSCIENCE, V99, P267, DOI 10.1016/S0306-4522(00)00198-6	50	78	82	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63549	10.1371/journal.pone.0063549	http://dx.doi.org/10.1371/journal.pone.0063549			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658839	Green Published, gold, Green Submitted			2022-12-25	WOS:000321200500076
J	Laser-Azogui, A; Diamant-Levi, T; Israeli, S; Roytman, Y; Tsarfaty, I				Laser-Azogui, A.; Diamant-Levi, T.; Israeli, S.; Roytman, Y.; Tsarfaty, I.			Met-induced membrane blebbing leads to amoeboid cell motility and invasion	ONCOGENE			English	Article						Met; blebbing; amoeboid cell motility; invasion; metastasis	HEPATOCYTE GROWTH-FACTOR; FACTOR INHIBITS ANOIKIS; FC-EPSILON-RI; C-MET; PSEUDOPODIAL PROTRUSION; LUNG-CANCER; RECEPTOR; ACTIVATION; MICRODOMAINS; METASTASIS	Met tyrosine kinase has been implicated in tumorigenesis and metastasis; its overexpression and deregulation is often observed in cancer. Although Met's functions in cell motility has been studied extensively, its involvement in bleb-based, amoeboid motility is yet to be determined. The aim of this work is to study the role of Met in amoeboid cell motility and invasion. We show that aggressive breast cancer cells expressing high levels of endogenous Met, as well as HEK293T cells over expressing fluorescent Met, exhibit constitutive, ligand-independent Met activation, leading to Met-dependent membrane blebbing and amoeboid cell motility; HEK293T cells over expressing fluorescent Met were able to invade in three-dimensional matrix. Hyper-activated Met mutant significantly enhances blebbing and cell motility. Met inhibition by either a Met-specific inhibitor or by exogenous expression of a dominant-negative Met remarkably repressed membrane blebbing and invasion. Inhibition of Rho signaling pathway by a ROCK inhibitor also represses Met-induced blebbing, suggesting that Met regulates the blebbing machinery through Rho-ROCK pathway, which controls the actin-myosin contractile force. Either de-polymerization or hyper-polymerization of the actin cytoskeleton abrogates Met-induced blebbing, signifying that actin polymerization has a role in halting and retracting Met-induced mature blebs. Indeed, when blebs retract, membrane wrinkles containing high levels of Met and actin are generated, indicating localized formation of Met-signaling microdomains. We suggest that this bleb-based activity is induced by amplification of Met signaling in unique membrane domains generated by bleb retraction. Our results indicate that Met-induced blebbing has an important role in cell detachment, amoeboid motility and invasion ability, which are utilized by cancer cells for migration and metastasis.	[Laser-Azogui, A.; Diamant-Levi, T.; Israeli, S.; Roytman, Y.; Tsarfaty, I.] Tel Aviv Univ, Sackler Sch Med, Dept Clin Microbiol & Immunol, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine	Tsarfaty, I (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Clin Microbiol & Immunol, IL-69978 Tel Aviv, Israel.	ilants@post.tau.ac.il		Tsarfaty, Ilan/0000-0002-5230-7093	Breast Cancer Research Foundation; United States-Israel Binational Science Foundation; Federico Foundation Grants	Breast Cancer Research Foundation; United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Federico Foundation Grants	We thank Professor Iafa Keydar for T47D cells and Dr Joyce Taylor-Papadimitriou for HB2 cells. We also thank Dr Yifat Merbl (Harvard medical school) for her critical review of this manuscript. This work was supported by research grants from the Breast Cancer Research Foundation, the United States-Israel Binational Science Foundation and the Federico Foundation Grants.	Abella JV, 2010, J BIOL CHEM, V285, P24956, DOI 10.1074/jbc.M110.127985; Abella JV, 2010, J CELL SCI, V123, P1306, DOI 10.1242/jcs.062570; Andrews NL, 2008, NAT CELL BIOL, V10, P955, DOI 10.1038/ncb1755; Arni S, 1996, BIOCHEM BIOPH RES CO, V225, P801, DOI 10.1006/bbrc.1996.1254; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Charras GT, 2008, BIOPHYS J, V94, P1836, DOI 10.1529/biophysj.107.113605; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Christensen JG, 2005, CANCER LETT, V225, P1, DOI 10.1016/j.canlet.2004.09.044; Corso S, 2008, ONCOGENE, V27, P684, DOI 10.1038/sj.onc.1210697; CUNNINGHAM CC, 1995, J CELL BIOL, V129, P1589, DOI 10.1083/jcb.129.6.1589; Danilkovitch-Miagkova A, 2002, J CLIN INVEST, V109, P863; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Firon M, 2000, ONCOGENE, V19, P2386, DOI 10.1038/sj.onc.1203557; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Gadea G, 2007, J CELL BIOL, V178, P23, DOI 10.1083/jcb.200701120; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Holowka D, 2000, J CELL SCI, V113, P1009; Jeffers M, 1998, P NATL ACAD SCI USA, V95, P14417, DOI 10.1073/pnas.95.24.14417; Jia ZJ, 2006, BIOL CELL, V98, P337, DOI 10.1042/BC20050088; Jiang WG, 2005, CRIT REV ONCOL HEMAT, V53, P35, DOI 10.1016/j.critrevonc.2004.09.004; Jung KH, 2012, ARCH PHARM RES, V35, P595, DOI 10.1007/s12272-012-0402-6; Keller HU, 1996, CELL MOTIL CYTOSKEL, V33, P241, DOI 10.1002/(SICI)1097-0169(1996)33:4<241::AID-CM1>3.0.CO;2-C; Kitzing TM, 2007, GENE DEV, V21, P1478, DOI 10.1101/gad.424807; Ma PC, 2007, BRIT J CANCER, V97, P368, DOI 10.1038/sj.bjc.6603884; Maulik G, 2002, CLIN CANCER RES, V8, P620; Maxfield FR, 2002, CURR OPIN CELL BIOL, V14, P483, DOI 10.1016/S0955-0674(02)00351-4; Miller M, 2001, PROTEINS, V44, P32, DOI 10.1002/prot.1069; Moffatt OD, 1999, J IMMUNOL, V162, P6800; Moshitch-Moshkovitz S, 2006, NEOPLASIA, V8, P353, DOI 10.1593/neo.05634; Nguyen TN, 2000, EXP CELL RES, V258, P171, DOI 10.1006/excr.2000.4929; Peters S, 2012, NAT REV CLIN ONCOL, V9, P314, DOI 10.1038/nrclinonc.2012.71; Pinner S, 2008, NAT CELL BIOL, V10, P127, DOI 10.1038/ncb1675; RONG S, 1994, P NATL ACAD SCI USA, V91, P4731, DOI 10.1073/pnas.91.11.4731; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; SAMBROOK A, 1989, MOL CLONING LAB MANU; Tournaviti S, 2007, J CELL SCI, V120, P3820, DOI 10.1242/jcs.011130; Vadnais J, 2002, J BIOL CHEM, V277, P48342, DOI 10.1074/jbc.M209481200; Vasiliev JM, 2004, P NATL ACAD SCI USA, V101, P12526, DOI 10.1073/pnas.0404723101; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Yoshida K, 2006, J CELL SCI, V119, P3833, DOI 10.1242/jcs.03152; Zeng QH, 2002, J BIOL CHEM, V277, P50137, DOI 10.1074/jbc.M208952200; Zeng QH, 2002, J BIOL CHEM, V277, P25203, DOI 10.1074/jbc.M201598200	43	30	30	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 3	2014	33	14					1788	1798		10.1038/onc.2013.138	http://dx.doi.org/10.1038/onc.2013.138			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AE9RE	23665680				2022-12-25	WOS:000334345500005
J	Hou, YA; Chen, XQ; Tolmachova, T; Ernst, SA; Williams, JA				Hou, Yanan; Chen, Xuequn; Tolmachova, Tatyana; Ernst, Stephen A.; Williams, John A.			EPI64B Acts as a GTPase-activating Protein for Rab27B in Pancreatic Acinar Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATES AMYLASE RELEASE; GRISCELLI-SYNDROME; GDP/GTP EXCHANGE; RAB3 SUBFAMILY; SECRETION; MELANOCYTES; EXOCYTOSIS; MEMBRANE; GRANULES; MUTANTS	The small GTPase Rab27B localizes to the zymogen granule membranes and plays an important role in regulating protein secretion by pancreatic acinar cells, as does Rab3D. A common guanine nucleotide exchange factor (GEF) for Rab3 and Rab27 has been reported; however, the GTPase-activating protein (GAP) specific for Rab27B has not been identified. In this study, the expression in mouse pancreatic acini of two candidate Tre-2/Bub2/Cdc16 (TBC) domain-containing proteins, EPI64 (TBC1D10A) and EPI64B (TBC1D10B), was first demonstrated. Their GAP activity on digestive enzyme secretion was examined by adenovirus-mediated overexpression of EPI64 and EPI64B in isolated pancreatic acini. EPI64B almost completely abolished the GTP-bound form of Rab27B, without affecting GTP-Rab3D. Overexpression of EPI64B also enhanced amylase release. This enhanced release was independent of Rab27A, but dependent on Rab27B, as shown using acini from genetically modified mice. EPI64 had a mild effect on both GTP-Rab27B and amylase release. Co-overexpression of EPI64B with Rab27B can reverse the inhibitory effect of Rab27B on amylase release. Mutations that block the GAP activity decreased the inhibitory effect of EPI64B on the GTP-bound state of Rab27B and abolished the enhancing effect of EPI64B on the amylase release. These data suggest that EPI64B can serve as a potential physiological GAP for Rab27B and thereby participate in the regulation of exocytosis in pancreatic acinar cells.	[Hou, Yanan; Chen, Xuequn; Williams, John A.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Ernst, Stephen A.] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Williams, John A.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Tolmachova, Tatyana] Univ London Imperial Coll Sci Technol & Med, Mol Med Sect, Natl Heart & Lung Inst, London SW7 2AZ, England	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Imperial College London	Hou, YA (corresponding author), Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	ynhou@umich.edu; xchen@med.wayne.edu; jawillms@umich.edu		Williams, John/0000-0002-6063-7615	National Institutes of Health [R37DK041122]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK041122, P30DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R37DK041122 (to J. A. W.).	Albert S, 1999, EMBO J, V18, P5216, DOI 10.1093/emboj/18.19.5216; [Anonymous], 2010, PANCREAPEDIA EXOCRIN, DOI DOI 10.3998/PANC.2010.18; [Anonymous], 2012, PHYSL GASTROINTESTIN; Barr F, 2010, CURR OPIN CELL BIOL, V22, P461, DOI 10.1016/j.ceb.2010.04.007; Barral DC, 2002, J CLIN INVEST, V110, P247, DOI 10.1172/JCI200215058; Bernards A, 2003, BBA-REV CANCER, V1603, P47, DOI 10.1016/S0304-419X(02)00082-3; Bi Y, 2005, AM J PHYSIOL-GASTR L, V289, pG561, DOI 10.1152/ajpgi.00508.2004; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Chen D, 1997, BIOCHEM MOL MED, V60, P27, DOI 10.1006/bmme.1996.2559; Chen XW, 2011, MOL BIOL CELL, V22, P141, DOI 10.1091/mbc.E10-08-0665; Chen XQ, 2002, J BIOL CHEM, V277, P18002, DOI 10.1074/jbc.M201248200; Chen XQ, 2006, MOL CELL PROTEOMICS, V5, P306, DOI 10.1074/mcp.M500172-MCP200; Chen XQ, 2004, BIOCHEM BIOPH RES CO, V323, P1157, DOI 10.1016/j.bbrc.2004.08.212; Chen XQ, 2003, J BIOL CHEM, V278, P50053, DOI 10.1074/jbc.M309910200; Chen XQ, 2008, MOL CELL PROTEOMICS, V7, P2323, DOI 10.1074/mcp.M700575-MCP200; Chen YR, 2003, P NATL ACAD SCI USA, V100, P14012, DOI 10.1073/pnas.2436350100; Chen YR, 2002, J INVEST DERMATOL, V118, P933, DOI 10.1046/j.1523-1747.2002.01754.x; Chiang LL, 2011, AM J PHYSIOL-CELL PH, V301, pC507, DOI 10.1152/ajpcell.00355.2010; Figueiredo AC, 2008, J BIOL CHEM, V283, P23209, DOI 10.1074/jbc.M804134200; Frasa MAM, 2012, NAT REV MOL CELL BIO, V13, P67, DOI 10.1038/nrm3267; Fuchs E, 2007, J CELL BIOL, V177, P1133, DOI 10.1083/jcb.200612068; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; Fukui K, 1997, J BIOL CHEM, V272, P4655, DOI 10.1074/jbc.272.8.4655; Gomi H, 2007, MOL BIOL CELL, V18, P4377, DOI 10.1091/mbc.E07-05-0409; Hokanson DE, 2012, MOL BIOL CELL, V23, P701, DOI 10.1091/mbc.E11-06-0521; Hsu C, 2010, J CELL BIOL, V189, P223, DOI 10.1083/jcb.200911018; Imai A, 2004, J CELL SCI, V117, P1945, DOI 10.1242/jcs.01048; Imai A, 2011, J BIOL CHEM, V286, P33854, DOI 10.1074/jbc.M111.281394; Imai A, 2009, EUR J ORAL SCI, V117, P224, DOI 10.1111/j.1600-0722.2009.00618.x; Itoh T, 2006, J BIOL CHEM, V281, P31823, DOI 10.1074/jbc.M603808200; Johnson JL, 2010, TRAFFIC, V11, P533, DOI 10.1111/j.1600-0854.2009.01029.x; Kondo H, 2006, J BIOL CHEM, V281, P28657, DOI 10.1074/jbc.M603227200; Lam AD, 2010, BIOPHYS J, V99, P1311, DOI 10.1016/j.bpj.2010.06.014; Menasche G, 2000, NAT GENET, V25, P173, DOI 10.1038/76024; Merrins MJ, 2008, J PHYSIOL-LONDON, V586, P5367, DOI 10.1113/jphysiol.2008.158477; Mizuno K, 2007, TRAFFIC, V8, P883, DOI 10.1111/j.1600-0854.2007.00571.x; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Patino-Lopez G, 2008, J BIOL CHEM, V283, P18323, DOI 10.1074/jbc.M800056200; Petersen OH, 2008, ANNU REV PHYSIOL, V70, P273, DOI 10.1146/annurev.physiol.70.113006.100618; Saegusa C, 2008, ARCH BIOCHEM BIOPHYS, V475, P87, DOI 10.1016/j.abb.2008.04.031; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Suda J, 2011, GASTROENTEROLOGY, V140, P868, DOI 10.1053/j.gastro.2010.09.044; Tolmachova T, 2007, P NATL ACAD SCI USA, V104, P5872, DOI 10.1073/pnas.0609879104; Vincent S, 1998, P NATL ACAD SCI USA, V95, P2210, DOI 10.1073/pnas.95.5.2210; Wada M, 1997, J BIOL CHEM, V272, P3875, DOI 10.1074/jbc.272.7.3875; Westbroek W, 2004, PIGM CELL RES, V17, P498, DOI 10.1111/j.1600-0749.2004.00173.x; WILLIAMS JA, 1978, AM J PHYSIOL, V235, pE517, DOI 10.1152/ajpendo.1978.235.5.E517; Williams JA, 2009, AM J PHYSIOL-ENDOC M, V296, pE405, DOI 10.1152/ajpendo.90874.2008; Wilson SM, 2000, P NATL ACAD SCI USA, V97, P7933, DOI 10.1073/pnas.140212797; Zhao SL, 2002, ENDOCRINOLOGY, V143, P1817, DOI 10.1210/en.143.5.1817	50	11	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19548	19557		10.1074/jbc.M113.472134	http://dx.doi.org/10.1074/jbc.M113.472134			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23671284	hybrid, Green Published			2022-12-25	WOS:000321515800021
J	Molitor, B; Stassen, M; Modi, A; El-Mashtoly, SF; Laurich, C; Lubitz, W; Dawson, JH; Rother, M; Frankenberg-Dinkel, N				Molitor, Bastian; Stassen, Marc; Modi, Anuja; El-Mashtoly, Samir F.; Laurich, Christoph; Lubitz, Wolfgang; Dawson, John H.; Rother, Michael; Frankenberg-Dinkel, Nicole			A Heme-based Redox Sensor in the Methanogenic Archaeon Methanosarcina acetivorans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DESULFOVIBRIO-VULGARIS HILDENBOROUGH; RESONANCE RAMAN-SPECTRA; IN-VITRO FORMATION; C-TYPE CYTOCHROME; COLI EC DOS; ESCHERICHIA-COLI; LIGAND-BINDING; OXYGEN SENSOR; AUTOCATALYTIC FORMATION; SIGNAL-TRANSDUCTION	Based on a bioinformatics study, the protein MA4561 from the methanogenic archaeon Methanosarcina acetivorans was originally predicted to be a multidomain phytochrome-like photosensory kinase possibly binding open-chain tetrapyrroles. Although we were able to show that recombinantly produced and purified protein does not bind any known phytochrome chromophores, UV-visible spectroscopy revealed the presence of a heme tetrapyrrole cofactor. In contrast to many other known cytoplasmic heme-containing proteins, the heme was covalently attached via one vinyl side chain to cysteine 656 in the second GAF domain. This GAF domain by itself is sufficient for covalent attachment. Resonance Raman and magnetic circular dichroism data support a model of a six-coordinate heme species with additional features of a five-coordination structure. The heme cofactor is redox-active and able to coordinate various ligands like imidazole, dimethyl sulfide, and carbon monoxide depending on the redox state. Interestingly, the redox state of the heme cofactor has a substantial influence on autophosphorylation activity. Although reduced protein does not autophosphorylate, oxidized protein gives a strong autophosphorylation signal independent from bound external ligands. Based on its genomic localization, MA4561 is most likely a sensor kinase of a two-component system effecting regulation of the Mts system, a set of three homologous corrinoid/methyltransferase fusion protein isoforms involved in methyl sulfide metabolism. Consistent with this prediction, an M. acetivorans mutant devoid of MA4561 constitutively synthesized MtsF. On the basis of our results, we postulate a heme-based redox/dimethyl sulfide sensory function of MA4561 and propose to designate it MsmS (methyl sulfide methyltransferase-associated sensor).	[Molitor, Bastian; El-Mashtoly, Samir F.; Frankenberg-Dinkel, Nicole] Ruhr Univ Bochum, Fac Biol & Biotechnol, D-44780 Bochum, Germany; [Stassen, Marc; Rother, Michael] Goethe Univ Frankfurt, Inst Mol Biosci, D-60438 Frankfurt, Germany; [Modi, Anuja; Dawson, John H.] Univ S Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA; [Laurich, Christoph; Lubitz, Wolfgang] Max Planck Inst Chem Energy Convers, D-45470 Mulheim, Germany; [Rother, Michael] Tech Univ Dresden, Inst Microbiol, D-01217 Dresden, Germany	Ruhr University Bochum; Goethe University Frankfurt; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Max Planck Society; Technische Universitat Dresden	Frankenberg-Dinkel, N (corresponding author), Ruhr Univ Bochum, Fac Biol & Biotechnol, Univ Str 150, D-44780 Bochum, Germany.	nicole.frankenberg@rub.de	El-Mashtoly, Samir/C-8761-2014; Molitor, Bastian/GNP-4969-2022; Modi, Anuja/R-3788-2017; Frankenberg-Dinkel, Nicole/C-1058-2011; Molitor, Bastian/A-9684-2018; Dawson, John/HDM-6702-2022	El-Mashtoly, Samir/0000-0001-6087-8817; Molitor, Bastian/0000-0002-0776-1668; Frankenberg-Dinkel, Nicole/0000-0002-7757-6839; Molitor, Bastian/0000-0002-0776-1668; Rother, Michael/0000-0002-2306-8783; Dawson, John H/0000-0002-4902-4295	Ruhr University Bochum Research School scholarship; National Institutes of Health [GM26730]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026730] Funding Source: NIH RePORTER	Ruhr University Bochum Research School scholarship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Ruhr University Bochum Research School scholarship (to B. M.) and National Institutes of Health Grant GM26730 (to J. H. D.).	ABE M, 1978, J CHEM PHYS, V69, P4526, DOI 10.1063/1.436450; Aono S, 1996, BIOCHEM BIOPH RES CO, V228, P752, DOI 10.1006/bbrc.1996.1727; Aono S, 2002, J BIOL CHEM, V277, P13528, DOI 10.1074/jbc.M112256200; Ashby Mark K., 2006, Archaea, V2, P11, DOI 10.1155/2006/562404; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Boccazzi P, 2000, J BACTERIOL, V182, P2611, DOI 10.1128/JB.182.9.2611-2618.2000; Boon EM, 2005, J INORG BIOCHEM, V99, P892, DOI 10.1016/j.jinorgbio.2004.12.016; Bose A, 2008, MOL MICROBIOL, V67, P649, DOI 10.1111/j.1365-2958.2007.06075.x; Bose A, 2009, MOL MICROBIOL, V74, P227, DOI 10.1111/j.1365-2958.2009.06864.x; Chang AL, 2001, BIOCHEMISTRY-US, V40, P3420, DOI 10.1021/bi0100236; Cheek J, 1999, J BIOL INORG CHEM, V4, P64, DOI 10.1007/s007750050290; Daltrop O, 2003, J BIOL CHEM, V278, P24308, DOI 10.1074/jbc.M301967200; Daltrop O, 2002, P NATL ACAD SCI USA, V99, P7872, DOI 10.1073/pnas.132259099; DAWSON JH, 1992, J INORG BIOCHEM, V45, P179, DOI 10.1016/0162-0134(92)80043-U; Delgado-Nixon VM, 2000, BIOCHEMISTRY-US, V39, P2685, DOI 10.1021/bi991911s; DOLLA A, 1992, J BACTERIOL, V174, P1726, DOI 10.1128/jb.174.6.1726-1733.1992; Du J, 2011, J PORPHYR PHTHALOCYA, V15, P29, DOI 10.1142/S1088424610002872; Duff SMG, 1997, J BIOL CHEM, V272, P16746, DOI 10.1074/jbc.272.27.16746; El-Mashtoly SF, 2008, J RAMAN SPECTROSC, V39, P1614, DOI 10.1002/jrs.2035; FU RD, 1994, J BACTERIOL, V176, P344, DOI 10.1128/JB.176.2.344-350.1994; Galagan JE, 2002, GENOME RES, V12, P532, DOI 10.1101/gr.223902; Galperin MY, 2010, CURR OPIN MICROBIOL, V13, P150, DOI 10.1016/j.mib.2010.01.005; Gilles-Gonzalez MA, 2004, J APPL PHYSIOL, V96, P774, DOI 10.1152/japplphysiol.00941.2003; GILLESGONZALEZ MA, 1994, BIOCHEMISTRY-US, V33, P8067, DOI 10.1021/bi00192a011; GILLESGONZALEZ MA, 1993, J BIOL CHEM, V268, P16293; Green J, 2009, CURR OPIN MICROBIOL, V12, P145, DOI 10.1016/j.mib.2009.01.008; Guss Adam M., 2008, Archaea, V2, P193, DOI 10.1155/2008/534081; Hou SB, 2000, NATURE, V403, P540, DOI 10.1038/35000570; HUFF AM, 1993, INORG CHEM, V32, P1460, DOI 10.1021/ic00060a023; Ikeuchi M, 2008, PHOTOCH PHOTOBIO SCI, V7, P1159, DOI 10.1039/b802660m; Ioanoviciu A, 2007, BIOCHEMISTRY-US, V46, P4250, DOI 10.1021/bi602422p; Karniol B, 2005, BIOCHEM J, V392, P103, DOI 10.1042/BJ20050826; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kitanishi K, 2011, J BIOL CHEM, V286, P35522, DOI 10.1074/jbc.M111.274811; Kitanishi K, 2010, BIOCHEMISTRY-US, V49, P10381, DOI 10.1021/bi100733q; Koretke KK, 2000, MOL BIOL EVOL, V17, P1956, DOI 10.1093/oxfordjournals.molbev.a026297; Kranz RG, 2009, MICROBIOL MOL BIOL R, V73, P510, DOI 10.1128/MMBR.00001-09; Kumar A, 2007, P NATL ACAD SCI USA, V104, P11568, DOI 10.1073/pnas.0705054104; Kuzelova K, 1997, BBA-GEN SUBJECTS, V1336, P497, DOI 10.1016/S0304-4165(97)00062-7; LI XY, 1988, J AM CHEM SOC, V110, P6024, DOI 10.1021/ja00226a017; Masuda S, 2002, CELL, V110, P613, DOI 10.1016/S0092-8674(02)00876-0; Metcalf WW, 1997, P NATL ACAD SCI USA, V94, P2626, DOI 10.1073/pnas.94.6.2626; Metcalf WW, 1996, J BACTERIOL, V178, P5797, DOI 10.1128/jb.178.19.5797-5802.1996; Moran JJ, 2008, APPL ENVIRON MICROB, V74, P540, DOI 10.1128/AEM.01750-07; Moran James J., 2005, Archaea, V1, P303, DOI 10.1155/2005/650670; Moskvin OV, 2007, J BIOL CHEM, V282, P28740, DOI 10.1074/jbc.M703261200; Oelgeschlager E, 2009, MOL MICROBIOL, V72, P1260, DOI 10.1111/j.1365-2958.2009.06723.x; Pipirou Z, 2007, BIOCHEMISTRY-US, V46, P13269, DOI 10.1021/bi7015316; Pipirou Z, 2007, BIOCHEMISTRY-US, V46, P2174, DOI 10.1021/bi062274q; Poulos TL, 2006, CURR OPIN STRUC BIOL, V16, P736, DOI 10.1016/j.sbi.2006.09.006; Pritchett MA, 2004, APPL ENVIRON MICROB, V70, P1425, DOI 10.1128/AEM.70.3.1425-1433.2004; Sasakura Y, 2006, ACCOUNTS CHEM RES, V39, P37, DOI 10.1021/ar0501525; Shelver D, 1997, P NATL ACAD SCI USA, V94, P11216, DOI 10.1073/pnas.94.21.11216; Sousa EHS, 2007, PROTEIN SCI, V16, P1708, DOI 10.1110/ps.072897707; SPIRO TG, 1979, J AM CHEM SOC, V101, P2648, DOI 10.1021/ja00504a027; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Tanaka A, 2007, J BIOL CHEM, V282, P21301, DOI 10.1074/jbc.M701920200; Tanaka A, 2008, BIOCHEMISTRY-US, V47, P13438, DOI 10.1021/bi8012017; TEALE FWJ, 1959, BIOCHIM BIOPHYS ACTA, V35, P543, DOI 10.1016/0006-3002(59)90407-X; Thony-Meyer L, 2002, BIOCHEM SOC T, V30, P633; Tietze M, 2003, CHEMBIOCHEM, V4, P333, DOI 10.1002/cbic.200390053; Tomlinson EJ, 2000, J BIOL CHEM, V275, P32530, DOI 10.1074/jbc.M004022200; Tuckerman JR, 2009, BIOCHEMISTRY-US, V48, P9764, DOI 10.1021/bi901409g; Ulrich LE, 2005, TRENDS MICROBIOL, V13, P52, DOI 10.1016/j.tim.2004.12.006; VARGAS C, 1993, ANAL BIOCHEM, V209, P323, DOI 10.1006/abio.1993.1127; Wass MN, 2010, NUCLEIC ACIDS RES, V38, pW469, DOI 10.1093/nar/gkq406; Yoshioka S, 2005, BIOCHEMISTRY-US, V44, P15406, DOI 10.1021/bi0513352	67	15	16	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18458	18472		10.1074/jbc.M113.476267	http://dx.doi.org/10.1074/jbc.M113.476267			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23661702	Green Submitted, hybrid, Green Published			2022-12-25	WOS:000320721900048
J	Dos Santos, HG; Abia, D; Janowski, R; Mortuza, G; Bertero, MG; Boutin, M; Guarin, N; Mendez-Giraldez, R; Nunez, A; Pedrero, JG; Redondo, P; Sanz, M; Speroni, S; Teichert, F; Bruix, M; Carazo, JM; Gonzalez, C; Reina, J; Valpuesta, JM; Vernos, I; Zabala, JC; Montoya, G; Coll, M; Bastolla, U; Serrano, L				Dos Santos, Helena G.; Abia, David; Janowski, Robert; Mortuza, Gulnahar; Bertero, Michela G.; Boutin, Mailys; Guarin, Nayibe; Mendez-Giraldez, Raul; Nunez, Alfonso; Pedrero, Juan G.; Redondo, Pilar; Sanz, Maria; Speroni, Silvia; Teichert, Florian; Bruix, Marta; Carazo, Jose M.; Gonzalez, Cayetano; Reina, Jose; Valpuesta, Jose M.; Vernos, Isabelle; Zabala, Juan C.; Montoya, Guillermo; Coll, Miquel; Bastolla, Ugo; Serrano, Luis			Structure and Non-Structure of Centrosomal Proteins	PLOS ONE			English	Article							FUNCTIONAL-ANALYSIS; PREDICTION; DATABASE; DISORDER; SEQUENCE; TOOL; RECOGNITION; COMPLEXITY; NETWORKS; BINDING	Here we perform a large-scale study of the structural properties and the expression of proteins that constitute the human Centrosome. Centrosomal proteins tend to be larger than generic human proteins (control set), since their genes contain in average more exons (20.3 versus 14.6). They are rich in predicted disordered regions, which cover 57% of their length, compared to 39% in the general human proteome. They also contain several regions that are dually predicted to be disordered and coiled-coil at the same time: 55 proteins (15%) contain disordered and coiled-coil fragments that cover more than 20% of their length. Helices prevail over strands in regions homologous to known structures (47% predicted helical residues against 17% predicted as strands), and even more in the whole centrosomal proteome (52% against 7%), while for control human proteins 34.5% of the residues are predicted as helical and 12.8% are predicted as strands. This difference is mainly due to residues predicted as disordered and helical (30% in centrosomal and 9.4% in control proteins), which may correspond to alpha-helix forming molecular recognition features (alpha-MoRFs). We performed expression assays for 120 full-length centrosomal proteins and 72 domain constructs that we have predicted to be globular. These full-length proteins are often insoluble: Only 39 out of 120 expressed proteins (32%) and 19 out of 72 domains (26%) were soluble. We built or retrieved structural models for 277 out of 361 human proteins whose centrosomal localization has been experimentally verified. We could not find any suitable structural template with more than 20% sequence identity for 84 centrosomal proteins (23%), for which around 74% of the residues are predicted to be disordered or coiled-coils. The three-dimensional models that we built are available at http://ub.cbm.uam.es/centrosome/models/index.php.	[Dos Santos, Helena G.; Abia, David; Mendez-Giraldez, Raul; Nunez, Alfonso; Teichert, Florian; Bastolla, Ugo] CSIC UAM, CBMSO, Madrid, Spain; [Janowski, Robert; Boutin, Mailys; Guarin, Nayibe; Coll, Miquel] IBMB, Barcelona, Spain; [Janowski, Robert; Boutin, Mailys; Guarin, Nayibe; Gonzalez, Cayetano; Reina, Jose; Coll, Miquel] Inst Res Biomed IRB Barcelona, Barcelona, Spain; [Mortuza, Gulnahar; Pedrero, Juan G.; Redondo, Pilar; Montoya, Guillermo] CNIO, Madrid, Spain; [Bertero, Michela G.; Sanz, Maria; Speroni, Silvia; Vernos, Isabelle; Serrano, Luis] CRG, Barcelona, Spain; [Bruix, Marta] CSIC, IQFR, Madrid, Spain; [Carazo, Jose M.; Valpuesta, Jose M.] CSIC, CNB, Madrid, Spain; [Reina, Jose] ICREA, Barcelona, Spain; [Zabala, Juan C.] Univ Cantabria, IFIMAV, E-39005 Santander, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Centro Nacional de Investigaciones Oncologicas (CNIO); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); ICREA; Universidad de Cantabria	Bastolla, U (corresponding author), CSIC UAM, CBMSO, Madrid, Spain.	ubastolla@cbm.uam.es; luis.serrano@crg.eu	Gonzalez, Cayetano/K-3933-2019; Bastolla, Ugo/H-6330-2015; Zabala, Juan Carlos/K-5163-2014; Garcia, Jose Maria Carazo/E-9234-2016; Redondo, Pilar/L-7612-2014; Valpuesta, Jose M/AAA-6002-2019; Valpuesta, José M/T-1977-2017; Serrano, Luis/B-3355-2013; Bruix, Marta/H-4161-2011; Gonzalez, Cayetano/K-3055-2019; Coll, Miquel/L-5999-2014; Vernos, Isabelle/C-1687-2015	Bastolla, Ugo/0000-0001-9342-4678; Zabala, Juan Carlos/0000-0003-2679-5473; Garcia, Jose Maria Carazo/0000-0003-0788-8447; Redondo, Pilar/0000-0002-6723-0818; Valpuesta, José M/0000-0001-7468-8053; Serrano, Luis/0000-0002-5276-1392; Bruix, Marta/0000-0002-0096-3558; Gonzalez, Cayetano/0000-0002-5259-3608; Coll, Miquel/0000-0003-4471-8674; Vernos, Isabelle/0000-0003-1469-9214; Reina, Jose/0000-0003-3789-4514; Bertero, Michela/0000-0002-2012-6706; Speroni, Silvia/0000-0001-5501-087X; Janowski, Robert/0000-0002-9940-2143; Abia, David/0000-0003-0401-7590	Spanish Ministry of Science [CSD2006-00023]; Madrid Community [S2010/BMD-2305]; ICREA Funding Source: Custom	Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Madrid Community; ICREA(ICREA)	The authors gratefully acknowledge financial support from the Spanish Ministry of Science, grant CSD2006-00023, and from the Madrid Community, grant S2010/BMD-2305. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bastolla U, 2001, PROTEINS, V44, P79, DOI 10.1002/prot.1075; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; Bond J, 2006, CURR OPIN CELL BIOL, V18, P95, DOI 10.1016/j.ceb.2005.11.004; Boveri T, 1914, CELL SCI, V121, P1; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Durbin R., 1998, BIOL SEQUENCE ANAL P; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; Garcia-Mayoral MF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025912; Follis AV, 2008, CHEM BIOL, V15, P1149, DOI 10.1016/j.chembiol.2008.09.011; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Gruber M, 2006, J STRUCT BIOL, V155, P140, DOI 10.1016/j.jsb.2006.03.009; Hatch E, 2010, COLD SH Q B, V75, P425, DOI 10.1101/sqb.2010.75.054; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jakobsen L, 2011, EMBO J, V30, P1520, DOI 10.1038/emboj.2011.63; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Letunic I., 2010, NUCL AC RES, V40, pD302; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; Marshall WF, 2009, CURR OPIN CELL BIOL, V21, P14, DOI 10.1016/j.ceb.2009.01.008; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Muller H, 2010, EMBO J, V29, P3344, DOI 10.1038/emboj.2010.210; Newman M., 2010, NETWORKS INTRO, DOI [10.1162/artl_r_00062, 10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; Nido GS, 2012, MOL BIOSYST, V8, P353, DOI 10.1039/c1mb05199g; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pD175, DOI 10.1093/nar/gkn815; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; Ou Y, 2004, CELL MOTIL CYTOSKEL, V57, P1, DOI 10.1002/cm.10154; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Ren J, 2010, NUCLEIC ACIDS RES, V38, pD155, DOI 10.1093/nar/gkp784; Romero P, 1999, FEBS LETT, V462, P363, DOI 10.1016/S0014-5793(99)01557-4; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Sirota FL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S1-S15; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Teichert F, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-251; The evolution of the Protein Data Bank, 2011, NATURE STRUCTURAL MO, V18, P1310; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Zanzoni A, 2002, FEBS LETT, V513, P135, DOI 10.1016/S0014-5793(01)03293-8	55	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e62633	10.1371/journal.pone.0062633	http://dx.doi.org/10.1371/journal.pone.0062633			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671615	Green Published, gold			2022-12-25	WOS:000319737700015
J	Rockett, RJ; Sloots, TP; Bowes, S; O'Neill, N; Ye, SF; Robson, J; Whiley, DM; Lambert, SB; Wang, D; Nissen, MD; Bialasiewicz, S				Rockett, Rebecca J.; Sloots, Theo P.; Bowes, Sharleen; O'Neill, Nicholas; Ye, Suifang; Robson, Jenny; Whiley, David M.; Lambert, Stephen B.; Wang, David; Nissen, Michael D.; Bialasiewicz, Seweryn			Detection of Novel Polyomaviruses, TSPyV, HPyV6, HPyV7, HPyV9 and MWPyV in Feces, Urine, Blood, Respiratory Swabs and Cerebrospinal Fluid	PLOS ONE			English	Article							MERKEL CELL POLYOMAVIRUS; TRANSCRIPTASE-PCR ASSAY; REAL-TIME PCR; BK VIRUS; KI POLYOMAVIRUSES; DNA-SEQUENCES; JC VIRUS; WU; TRACT; CHILDREN	Eight novel human polyomaviruses have been discovered since 2007. Prevalence rates and tissue tropism for the most recent members HPyV 6, 7, 9, TSPyV and MWPyV are largely unknown. We used real-time PCR to determine the presence of HPyV 6, 7, 9, TSPyV and MWPyV in feces (n = 263), urine (n = 189), blood (n = 161), respiratory swabs (n = 1385) and cerebrospinal fluid (n = 171) from both healthy control children and children and adults undergoing diagnostic testing. Whole genome sequencing was able to be performed on 9 MWPyV positive specimens. Novel polyomaviruses were only detected in respiratory swabs and feces, with no detections of HPyV 9 in any sample type. MWPyV was found to be the most prevalent novel polyomavirus, being detected in 18 (1.5%) respiratory specimens from symptomatic patients, 16 (9.8%) respiratory sample from healthy control children, 11 (5.9%) fecal specimens from patient suffering gastrointestinal illness, and in 13 (15.3%) of feces from healthy control children. MWPyV was found only in respiratory and fecal specimens from children, the oldest being 9 years old. HPyV 6, 7, 9 and TSPyV were also detected in respiratory specimens and fecal specimens at low prevalence (<1.3%). The majority of these detections were found in immunocompromised patients. Our findings suggest that MWPyV can result in a subclinical infection, persistent or intermittent shedding, particularly in young children. The other novel polyomaviruses were also found in respiratory and fecal specimens, but at lower prevalence and most commonly in immunocompromised individuals.	[Rockett, Rebecca J.; Sloots, Theo P.; Bowes, Sharleen; O'Neill, Nicholas; Ye, Suifang; Whiley, David M.; Lambert, Stephen B.; Nissen, Michael D.; Bialasiewicz, Seweryn] Univ Queensland, Queensland Childrens Med Res Inst, Queensland Paediat Infect Dis Lab, Brisbane, Qld, Australia; [Robson, Jenny] Sullivan Nicolaides Pathol, Dept Microbiol, Brisbane, Qld, Australia; [Lambert, Stephen B.] Queensland Hlth, Communicable Dis Branch, Immunisat Program, Herston, Qld, Australia; [Wang, David] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Wang, David] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Nissen, Michael D.] Pathol Queensland Cent Lab, Div Microbiol, Herston, Qld, Australia	University of Queensland; Queensland Health; Washington University (WUSTL); Washington University (WUSTL)	Rockett, RJ (corresponding author), Univ Queensland, Queensland Childrens Med Res Inst, Queensland Paediat Infect Dis Lab, Brisbane, Qld, Australia.	r.rockett@uq.edu.au	Whiley, David M/E-8955-2011; Bialasiewicz, Seweryn/F-1414-2010; Nissen, Michael D/M-6823-2013; Lambert, Stephen/N-7819-2019	Whiley, David M/0000-0001-5969-3161; Bialasiewicz, Seweryn/0000-0001-9474-6943; Nissen, Michael D/0000-0003-1686-3313; Lambert, Stephen/0000-0002-2709-193X	Queensland Children's Medical Research Institute [10298]; Children's Health foundation, Queensland [50006]; Woolworths	Queensland Children's Medical Research Institute; Children's Health foundation, Queensland; Woolworths	Funding is generously supplied by the Queensland Children's Medical Research Institute (PhD Scholarship 10298) and program grant #50006 from Children's Health foundation, Queensland and Woolworths. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedi Kiasari B, 2011, J MED VIROL, V83, P2220, DOI [10.1002/jmv, DOI 10.1002/JMV]; Allander T, 2007, J VIROL, V81, P4130, DOI 10.1128/JVI.00028-07; Antonsson A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039842; Arden KE, 2006, J MED VIROL, V78, P1232, DOI 10.1002/jmv.20689; Babakir-Mina M, 2011, NEW MICROBIOL, V34, P1; Babakir-Mina M, 2009, J CLIN VIROL, V46, P75, DOI 10.1016/j.jcv.2009.06.009; Babakir-Mina M, 2009, J MED VIROL, V81, P1668, DOI 10.1002/jmv.21559; Barzon L, 2009, J CLIN VIROL, V45, P370, DOI 10.1016/j.jcv.2009.05.026; Bialasiewicz S, 2009, SEX TRANSM INFECT, V85, P102, DOI 10.1136/sti.2008.032607; Bialasiewicz S, 2009, EMERG INFECT DIS, V15, P492, DOI 10.3201/eid1503.081067; Bialasiewicz S, 2009, J CLIN VIROL, V45, P249, DOI 10.1016/j.jcv.2009.05.002; Bialasiewicza S, 2007, J CLIN VIROL, V40, P15, DOI 10.1016/j.jcv.2007.07.001; Bofill-Mas S, 2001, J VIROL, V75, P10290, DOI 10.1128/JVI.75.21.10290-10299.2001; Bogdanovic G, 2004, J CLIN MICROBIOL, V42, P5394, DOI 10.1128/JCM.42.11.5394-5396.2004; Buck CB, 2012, J VIROL, V86, P10887, DOI 10.1128/JVI.01690-12; Champeau W, 2011, DETECTION MERKEL CEL, V1439, P1435, DOI [10.1002/jmv, DOI 10.1002/JMV]; CHESTERS PM, 1983, J INFECT DIS, V147, P676, DOI 10.1093/infdis/147.4.676; Csoma E, 2011, J MED VIROL, V83, P1275, DOI 10.1002/jmv.22083; Doerries K, 2006, ADV EXP MED BIOL, V577, P102; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Foulongne V, 2010, BRIT J DERMATOL, V162, P59, DOI 10.1111/j.1365-2133.2009.09381.x; GARDNER SD, 1971, LANCET, V1, P1253; Gaynor AM, 2007, PLOS PATHOG, V3, P595, DOI 10.1371/journal.ppat.0030064; GOUDSMIT J, 1982, J MED VIROL, V10, P91, DOI 10.1002/jmv.1890100203; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; HERITAGE J, 1981, J MED VIROL, V8, P143, DOI 10.1002/jmv.1890080208; Hirsch HH, 2002, AM J TRANSPLANT, V2, P25, DOI 10.1034/j.1600-6143.2002.020106.x; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lu XY, 2008, J CLIN MICROBIOL, V46, P533, DOI 10.1128/JCM.01739-07; Mackay IM, 2007, REAL TIME PCR MICROB, P2679; Maertzdorf J, 2004, J CLIN MICROBIOL, V42, P981, DOI 10.1128/JCM.42.3.981-986.2004; Mourez T, 2009, EMERG INFECT DIS, V15, P107, DOI [10.3201/eid1501.080758, 10.3201/1501.080758]; Neske F, 2009, J CLIN VIROL, V44, P115, DOI 10.1016/j.jcv.2008.12.004; PADGETT BL, 1971, LANCET, V1, P1257; Rao S, 2011, J CLIN VIROL, V52, P28, DOI 10.1016/j.jcv.2011.05.024; Schowalter RM, 2010, CELL HOST MICROBE, V7, P509, DOI 10.1016/j.chom.2010.05.006; Scuda N, 2011, J VIROL, V85, P4586, DOI 10.1128/JVI.02602-10; Shishido-Hara Y, 2010, ACTA NEUROPATHOL, V120, P403, DOI 10.1007/s00401-010-0694-x; Siebrasse EA, 2012, J VIROLOGY; Siebrasse EA, 2012, EMERG INFECT DIS, V18, P1676, DOI 10.3201/eid1810.120359; Stoner GL, 2000, MICROBES INFECT, V2, P1905, DOI 10.1016/S1286-4579(00)01339-3; Syrmis MW, 2004, J MOL DIAGN, V6, P125, DOI 10.1016/S1525-1578(10)60500-4; Tolstov YL, 2011, EMERG INFECT DIS, V17, P1371, DOI 10.3201/eid1708.110079; Wang CYT, 2012, J CLIN VIROL, V54, P83, DOI 10.1016/j.jcv.2012.01.013; Yu GX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049449; Zhong S, 2009, J GEN VIROL, V90, P144, DOI 10.1099/vir.0.83611-0; [No title captured]	47	44	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62764	10.1371/journal.pone.0062764	http://dx.doi.org/10.1371/journal.pone.0062764			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667518	Green Submitted, Green Published, gold			2022-12-25	WOS:000319055600043
J	Steven, R; Castley, JG; Buckley, R				Steven, Rochelle; Castley, J. Guy; Buckley, Ralf			Tourism Revenue as a Conservation Tool for Threatened Birds in Protected Areas	PLOS ONE			English	Article							OKAVANGO DELTA; IMPACTS; SEYCHELLES; RECREATION; ATTITUDES	Many bird populations worldwide are at risk of extinction, and rely heavily on protected area networks for their continued conservation. Tourism to these areas contributes to conservation by generating revenue for management. Here we quantify the contribution of tourism revenue for bird species in the IUCN Red List, using a simple accounting method. Relevant data are available for 90 (16%) of the 562 critically endangered and endangered species. Contributions of tourism to bird conservation are highest, 10-64%, in South America, Africa, and their neighbouring islands. Critically endangered bird species rely on tourism more heavily than endangered species (p < 0.02). Many protected areas could also enhance their management budgets by promoting birdwatching tourism specifically.	[Steven, Rochelle; Castley, J. Guy; Buckley, Ralf] Griffith Univ, Int Ctr Ecotourism Res, Gold Coast, Qld, Australia	Griffith University	Steven, R (corresponding author), Griffith Univ, Int Ctr Ecotourism Res, Gold Coast, Qld, Australia.	r.steven@griffith.edu.au	Castley, James Guy/A-7056-2010; Steven, Rochelle/AAD-5898-2020; Buckley, Ralf/G-7032-2014	Castley, James Guy/0000-0002-8418-5828; Buckley, Ralf/0000-0003-0442-5818; Steven, Rochelle/0000-0002-3474-6818	Griffith Scool of Environment, Griffith University	Griffith Scool of Environment, Griffith University(Griffith University)	This project was supported by funding from the Griffith Scool of Environment, Griffith University (www.griffith.edu.au).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, SUSTAINABLE FINANCIN; [Anonymous], 2010, CONSERVATION TOURISM; Balmford A, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000144; Benitez SP, 2001, ECOTOURISM PROGRAM T, V3; Beresford AE, 2011, ANIM CONSERV, V14, P99, DOI 10.1111/j.1469-1795.2010.00398.x; Biggs D., 2011, Conservation and Society, V9, P80, DOI 10.4103/0972-4923.79198; Birdlife International, 2011, IUCN RED LIST BIRDS; Bookbinder MP, 1998, CONSERV BIOL, V12, P1399, DOI 10.1046/j.1523-1739.1998.97229.x; Booth JE, 2011, BIOL CONSERV, V144, P2728, DOI 10.1016/j.biocon.2011.02.018; Bovarnick A, 2010, FINANCIAL SUSTAINABI; Buckley R., 2003, Journal of Sustainable Tourism, V11, P56, DOI 10.1080/09669580308667193; Buckley R., 2004, Environmental impacts of ecotourism, DOI 10.1079/9780851998107.0000; Buckley R, 2012, ANN TOURISM RES, V39, P528, DOI 10.1016/j.annals.2012.02.003; Buckley R, 2011, ANNU REV ENV RESOUR, V36, P397, DOI 10.1146/annurev-environ-041210-132637; Buckley R, 2010, NATURE, V467, P1047, DOI 10.1038/4671047d; Buckley R, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000143; Buckley RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044134; Buckley RC, 2012, NATURE, V489, P33, DOI 10.1038/489033b; Butchart Stuart H M, 2012, PLoS One, V7, pe32529, DOI 10.1371/journal.pone.0032529; Castley G, 2009, EVOLUTION INNOVATION, P307; Castley G, 2010, CONSERVATION TOURISM, P145, DOI 10.1079/9781845936655.0145; Connell J, 2009, AUST GEOGR, V40, P203, DOI 10.1080/00049180902964942; Cousins JA, 2008, ECOL SOC, V13; Department of Conservation New Zealand (DOC), 2011, KAK; Department of Conservation New Zealand (DOC), 2011, OFFSH ISL CONS MAN I; Department of Conservation New Zealand (DOC), 2011, BLACK ROB; Eagles P. F., 2002, SUSTAINABLE TOURISM; Hilton-Taylor C, 2009, WILDLIFE CHANGING WO, P15, DOI DOI 10.2305/IUCN.CH.2009.17.EN; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Hvenegaard Glen T., 2002, Human Dimensions of Wildlife, V7, P21, DOI 10.1080/108712002753574765; IUCN, 2019, IUCN RED LIST THREAT; Langholz Jeffrey A., 2004, Journal of International Wildlife Law and Policy, V7, P9, DOI 10.1080/13880290490480112; Lockwood M, 2010, J ENVIRON MANAGE, V91, P754, DOI 10.1016/j.jenvman.2009.10.005; Mansourian S., 2008, PUBLIC FUNDS PROTECT; Mbaiwa JE, 2003, J ARID ENVIRON, V54, P447, DOI 10.1006/jare.2002.1101; McCarthy DP, 2012, SCIENCE, V338, P946, DOI 10.1126/science.1229803; Mmopelwa G, 2006, S AFR J ECON MANAG S, V9, P113; Morrison C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043757; Puhakka L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026786; Rocamora G., 2001, IMPORTANT BIRD AREAS, P751; Rodrigues ASL, 2004, BIOSCIENCE, V54, P1092, DOI 10.1641/0006-3568(2004)054[1092:GGAPRF]2.0.CO;2; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Sekercioglu CH, 2002, ENVIRON CONSERV, V29, P282, DOI 10.1017/S0376892902000206; Sekhar NU, 2003, J ENVIRON MANAGE, V69, P339, DOI 10.1016/j.jenvman.2003.09.002; Shah NJ, 2001, BIODIVERS CONSERV, V10, P1219, DOI 10.1023/A:1016764124890; Shareef R, 2008, MATH COMPUT SIMULAT, V78, P459, DOI 10.1016/j.matcom.2008.01.025; Smeral E, 2010, J TRAVEL RES, V49, P31, DOI 10.1177/0047287509353192; Steven R, 2011, J ENVIRON MANAGE, V92, P2287, DOI 10.1016/j.jenvman.2011.05.005; Tisdell C, 2012, NATURE-BASED TOURISM AND CONSERVATION: NEW ECONOMIC INSIGHTS AND CASE STUDIES, P1; Verissimo D, 2009, ANIM CONSERV, V12, P549, DOI 10.1111/j.1469-1795.2009.00282.x; Walpole MJ, 2001, ENVIRON CONSERV, V28, P160, DOI 10.1017/S0376892901000169; WHITTAKER RJ, 1995, TRENDS ECOL EVOL, V10, P421, DOI 10.1016/S0169-5347(00)89164-8	52	52	52	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62598	10.1371/journal.pone.0062598	http://dx.doi.org/10.1371/journal.pone.0062598			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667498	Green Published, gold			2022-12-25	WOS:000319055600033
J	Bermudez, O; Hennen, E; Koch, I; Lindner, M; Eickelberg, O				Bermudez, Olga; Hennen, Elisabeth; Koch, Ina; Lindner, Michael; Eickelberg, Oliver			Gli1 Mediates Lung Cancer Cell Proliferation and Sonic Hedgehog-Dependent Mesenchymal Cell Activation	PLOS ONE			English	Article							IDIOPATHIC-PULMONARY-FIBROSIS; GROWTH-FACTOR-BETA; SIGNALING PATHWAY; MITOCHONDRIAL METABOLISM; TUMOR MICROENVIRONMENT; BREAST-CANCER; IN-VIVO; CARCINOGENESIS; ANGIOGENESIS; EXPRESSION	Non-Small-Cell-Lung-Cancer (NSCLC) represents approximately 85% of all lung cancers and remains poorly understood. While signaling pathways operative during organ development, including Sonic Hedgehog (Shh) and associated Gli transcription factors (Gli1-3), have recently been found to be reactivated in NSCLC, their functional role remains unclear. Here, we hypothesized that Shh/Gli1-3 could mediate NSCLC autonomous proliferation and epithelial/stromal signaling in the tumoral tissue. In this context, we have investigated the activity of Shh/Gli1-3 signaling in NSCLC in both, cancer and stromal cells. We report here that inhibition of Shh signaling induces a significant decrease in the proliferation of NSCLC cells. This effect is mediated by Gli1 and Gli2, but not Gli3, through regulation of cyclin D1 and cyclin D2 expression. While exogenous Shh was unable to induce signaling in either A549 lung adenocarcinoma or H520 lung squamous carcinoma cells, both cells were found to secrete Shh ligand, which induced fibroblast proliferation, survival, migration, invasion, and collagen synthesis. Furthermore, Shh secreted by NSCLC mediates the production of proangiogenic and metastatic factors in lung fibroblasts. Our results thus provide evidence that Shh plays an important role in mediating epithelial/mesenchymal crosstalk in NSCLC. While autonomous Gli activity controls NSCLC proliferation, increased Shh expression by NSCLC is associated with fibroblast activation in tumor-associated stroma. Our study highlights the relevance of studying stromal-associated cells in the context of NSCLC regarding new prognosis and therapeutic options.	[Bermudez, Olga; Hennen, Elisabeth; Eickelberg, Oliver] Univ Munich, Comprehens Pneumol Ctr, Univ Hosp, Munich, Germany; [Bermudez, Olga; Hennen, Elisabeth; Eickelberg, Oliver] Helmholtz Zentrum Munchen, Munich, Germany; [Koch, Ina; Lindner, Michael] Asklepios Clin Munich Gauting, Comprehens Pneumol Ctr, Ctr Thorac Surg, Asklepios Biobank Lung Dis, Gauting, Germany; [Koch, Ina; Lindner, Michael] Univ Munich, Gauting, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich	Eickelberg, O (corresponding author), Univ Munich, Comprehens Pneumol Ctr, Univ Hosp, Munich, Germany.	oliver.eickelberg@helmholtz-muenchen.de	lindner, michael/AAO-8653-2020	lindner, michael/0000-0002-2106-0286	Helmholtz Association	Helmholtz Association(Helmholtz Association)	This study was supported by the Helmholtz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai CYB, 2001, DEVELOPMENT, V128, P5161; Beachy PA, 2010, GENE DEV, V24, P2001, DOI 10.1101/gad.1951710; Bray F, 2013, INT J CANCER, V132, P1133, DOI 10.1002/ijc.27711; Brentnall TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030219; Castello-Cros R, 2011, CELL CYCLE, V10, P2021, DOI 10.4161/cc.10.12.16002; Chen WW, 2011, P NATL ACAD SCI USA, V108, P9589, DOI 10.1073/pnas.1017945108; Chi SM, 2006, CANCER LETT, V244, P53, DOI 10.1016/j.canlet.2005.11.036; Chinchilla P, 2010, CELL CYCLE, V9, P570, DOI 10.4161/cc.9.3.10591; Cigna N, 2012, AM J PATHOL, V181, P2126, DOI 10.1016/j.ajpath.2012.08.019; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; Dennler S, 2009, J BIOL CHEM, V284, P31523, DOI 10.1074/jbc.M109.059964; Fan QP, 2010, J BIOL CHEM, V285, P36570, DOI 10.1074/jbc.C110.164442; Franco OE, 2011, CANCER RES, V71, P1272, DOI 10.1158/0008-5472.CAN-10-3142; Giraudo E, 2004, J CLIN INVEST, V114, P623, DOI 10.1172/JCI200422087; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Johnson RW, 2011, CANCER RES, V71, P822, DOI 10.1158/0008-5472.CAN-10-2993; Kinzel D, 2010, DEV CELL, V19, P66, DOI 10.1016/j.devcel.2010.06.005; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Li GH, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0437-z; Li Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052093; Loewen GM, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-145; Low WC, 2008, DEV BIOL, V321, P188, DOI 10.1016/j.ydbio.2008.06.014; Bolanos AL, 2012, AM J PHYSIOL-LUNG C, V303, pL978, DOI 10.1152/ajplung.00184.2012; Meyers-Needham M, 2012, MOL CANCER THER, V11, P1092, DOI 10.1158/1535-7163.MCT-11-0705; Migneco G, 2010, CELL CYCLE, V9, P2412, DOI 10.4161/cc.9.12.11989; Moran CM, 2012, DEV DYNAM, V241, P1034, DOI 10.1002/dvdy.23795; Moreno-Barriuso N, 2006, DEV DYNAM, V235, P2040, DOI 10.1002/dvdy.20842; Motoyama J, 1998, NAT GENET, V20, P54, DOI 10.1038/1711; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; O'Toole SA, 2011, CANCER RES, V71, P4002, DOI 10.1158/0008-5472.CAN-10-3738; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Park KS, 2011, NAT MED, V17, P1504, DOI 10.1038/nm.2473; Pu X, 2012, CLIN CANCER RES, V18, P5983, DOI 10.1158/1078-0432.CCR-12-0774; Salem AF, 2012, CELL CYCLE, V11, P2545, DOI 10.4161/cc.20920; Seton-Rogers S, 2011, NAT REV CANCER, V11, P831, DOI 10.1038/nrc3176; Shin JE, 2011, MOL CELLS, V31, P181, DOI 10.1007/s10059-011-0020-z; Slusarz A, 2010, CANCER RES, V70, P3382, DOI 10.1158/0008-5472.CAN-09-3012; Stecca B, 2010, J MOL CELL BIOL, V2, P84, DOI 10.1093/jmcb/mjp052; Stewart GA, 2003, J PATHOL, V199, P488, DOI 10.1002/path.1295; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486; van Kempen LCL, 2002, CANCER CELL, V2, P251, DOI 10.1016/S1535-6108(02)00157-5; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Wallace JA, 2011, CANCER RES, V71, P1203, DOI 10.1158/0008-5472.CAN-10-3263; Wang CB, 2010, DEVELOPMENT, V137, P2001, DOI 10.1242/dev.052126; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; Wysoczynski M, 2007, CANCER RES, V67, P2131, DOI 10.1158/0008-5472.CAN-06-1021; Yamazaki M, 2008, CANCER SCI, V99, P1131, DOI 10.1111/j.1349-7006.2008.00795.x; Yoo YA, 2011, CANCER RES, V71, P7061, DOI 10.1158/0008-5472.CAN-11-1338; Yoon JW, 2002, J BIOL CHEM, V277, P5548, DOI 10.1074/jbc.M105708200; Yuan Z, 2007, ONCOGENE, V26, P1046, DOI 10.1038/sj.onc.1209860; Zhang XM, 2009, BREAST CANCER RES TR, V115, P505, DOI 10.1007/s10549-008-0093-3	53	73	76	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63226	10.1371/journal.pone.0063226	http://dx.doi.org/10.1371/journal.pone.0063226			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667589	Green Submitted, Green Published, gold			2022-12-25	WOS:000319654700119
J	Das, DS; Wadhwa, N; Kunj, N; Sarda, K; Pradhan, BS; Majumdar, SS				Das, Deepika Sharma; Wadhwa, Neerja; Kunj, Neetu; Sarda, Kanchan; Pradhan, Bhola Shankar; Majumdar, Subeer S.			Dickkopf Homolog 3 (DKK3) Plays a Crucial Role Upstream of WNT/beta-CATENIN Signaling for Sertoli Cell Mediated Regulation of Spermatogenesis	PLOS ONE			English	Article							MESSENGER-RNA; GENE; FSH; HORMONE; SECRETION; DIFFERENTIATION; PROLIFERATION; REPLACEMENT; INFERTILITY; ACTIVATION	Testicular Sertoli cells (Sc) are main somatic component of seminiferous tubules that govern the differentiation of germ cells (Gc) and provide them physical support. Sc are the target of follicle stimulating hormone (FSH) and testosterone (T) which are known to regulate spermatogenesis. FSH and T levels in human and sub-human male primates remain high during infancy (4-6 months post birth), similar to those during puberty. Subsequently, juvenile phase is marked with low levels of these hormones. In spite of prolonged hormonal exposure, spermatogenesis is not discerned during infancy unlike that during puberty. Situation during infancy is similar to certain idiopathic male infertility, where prolonged hormone supplementation fails to initiate spermatogenesis. In our quest to determine non hormonal causes of idiopathic infertility which may reside within the Sc, we investigated the association between spermatogenesis and Sc specific gene(s) expressed differentially during puberty and infancy. Although products of several genes may be necessary for quantitatively normal spermatogenesis, one needs to investigate their roles one by one. Differential display and real time PCR analysis revealed higher expression of a known tumor suppressor, Dickkopf homolog 3 (DKK3), by pubertal monkey Sc as compared to infant Sc. To evaluate role of DKK3 in spermatogenesis, we generated DKK3 knock down mice (DKDM) using shRNA construct targeted to DKK3. In testis of adult DKDM, expression of DKK3 mRNA and protein were significantly (p<0.05) low and was associated with elevated WNT-4/beta-CATENIN activity. Elevated beta-CATENIN activity is known to restrict Sc maturation. Abundant expression of infant Sc marker, Mullerian inhibiting substance (MIS), in the testes of adult DKDM confirmed lack of Sc maturation in DKDM. Gc differentiation and fertility was severely compromised in DKDM. This is the first report of role of DKK3 in the testis and DKK3 mediated regulation of spermatogenesis via WNT-4/beta-CATENIN modulation.	[Das, Deepika Sharma; Sarda, Kanchan; Pradhan, Bhola Shankar; Majumdar, Subeer S.] Natl Inst Immunol, Div Cellular Endocrinol, New Delhi 110067, India; [Wadhwa, Neerja; Kunj, Neetu; Majumdar, Subeer S.] Natl Inst Immunol, Div Embryo Biotechnol, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Majumdar, SS (corresponding author), Natl Inst Immunol, Div Cellular Endocrinol, Aruna Asaf Ali Marg, New Delhi 110067, India.	subeer@nii.ac.in		PRADHAN, BHOLA/0000-0002-6346-2523; Majumdar, Subeer/0000-0003-1724-7483	Department of Biotechnology [BT/PR11313/AAQ/01/376/2008]; Indian Council of Medical Research [5/10/FR/8/2010-RHN]; National Institute of Immunology, India	Department of Biotechnology; Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); National Institute of Immunology, India	This study was supported by a grant from Department of Biotechnology (Grant number BT/PR11313/AAQ/01/376/2008 SSM), grant from Indian Council of Medical Research (Grant number 5/10/FR/8/2010-RHN to SSM) and National Institute of Immunology, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel MH, 2009, J MOL ENDOCRINOL, V42, P291, DOI 10.1677/JME-08-0107; Bandapalli OR, 2009, J PATHOL, V218, P370, DOI 10.1002/path.2539; Barrantes ID, 2006, MOL CELL BIOL, V26, P2317, DOI 10.1128/MCB.26.6.2317-2326.2006; BEHRINGER RR, 1990, NATURE, V345, P167, DOI 10.1038/345167a0; Bhattacharya I, 2012, AM J PHYSIOL-ENDOC M, V303, pE886, DOI 10.1152/ajpendo.00293.2012; Boyer A, 2008, BIOL REPROD, V79, P475, DOI 10.1095/biolreprod.108.068627; Boyer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029764; Chang H, 2008, DEVELOPMENT, V135, P1875, DOI 10.1242/dev.018572; Devi YS, 2006, J CLIN ENDOCR METAB, V91, P1062, DOI 10.1210/jc.2005-2072; Dhup S, 2008, NAT METHODS, V5, P601, DOI 10.1038/nmeth.1225; Diep DB, 2004, DEV BRAIN RES, V153, P261, DOI 10.1016/j.devbrainres.2004.09.008; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Golestaneh N, 2009, REPRODUCTION, V138, P151, DOI 10.1530/REP-08-0510; Gossen M, 2002, ANNU REV GENET, V36, P153, DOI 10.1146/annurev.genet.36.041002.120114; Grima J, 1997, J BIOL CHEM, V272, P6499, DOI 10.1074/jbc.272.10.6499; Griswold MD, 1998, SEMIN CELL DEV BIOL, V9, P411, DOI 10.1006/scdb.1998.0203; Hogan B, 1994, MANIPULATING MOUSE E; Ikawa M, 2002, P NATL ACAD SCI USA, V99, P7524, DOI 10.1073/pnas.072207299; Krupnik VE, 1999, GENE, V238, P301, DOI 10.1016/S0378-1119(99)00365-0; Kunath T, 2003, NAT BIOTECHNOL, V21, P559, DOI 10.1038/nbt813; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee EJ, 2009, INT J CANCER, V124, P287, DOI 10.1002/ijc.23913; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; Lo KC, 2004, FERTIL STERIL, V82, pS22, DOI 10.1016/j.fertnstert.2004.07.062; Majumdar SS, 1998, BIOL REPROD, V58, P633, DOI 10.1095/biolreprod58.3.633; MAJUMDAR SS, 1995, ENDOCRINOLOGY, V136, P1969, DOI 10.1210/en.136.5.1969; Majumdar SS, 2012, PROG BIOPHYS MOL BIO, V27, P2515; Majumdar SS, 2012, HUM REPROD, V27, P2515, DOI 10.1093/humrep/des184; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; MULLER SR, 1990, DNA CELL BIOL, V9, P221, DOI 10.1089/dna.1990.9.221; Nakanishi Y, 2004, BIOL PHARM BULL, V27, P13, DOI 10.1248/bpb.27.13; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Okabe S, 1996, MECH DEVELOP, V59, P89, DOI 10.1016/0925-4773(96)00572-2; ORTH JM, 1988, ENDOCRINOLOGY, V122, P787, DOI 10.1210/endo-122-3-787; Plant TM, 2005, ANN NY ACAD SCI, V1061, P149, DOI 10.1196/annals.1336.016; Plant TM, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P2177; Racine C, 1998, P NATL ACAD SCI USA, V95, P594, DOI 10.1073/pnas.95.2.594; SCHAISON G, 1993, J CLIN ENDOCR METAB, V77, P1545, DOI 10.1210/jc.77.6.1545; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sharpe RM, 2003, REPRODUCTION, V125, P769, DOI 10.1530/rep.0.1250769; SKINNER MK, 1982, BIOL REPROD, V27, P211, DOI 10.1095/biolreprod27.1.211; Tanimoto R, 2007, INT J MOL MED, V19, P363; Tanwar PS, 2010, BIOL REPROD, V82, P422, DOI 10.1095/biolreprod.109.079335; Veeck J, 2012, BBA-REV CANCER, V1825, P18, DOI 10.1016/j.bbcan.2011.09.003; Walker WH, 2005, REPRODUCTION, V130, P15, DOI 10.1530/rep.1.00358; WELSH MJ, 1975, ENDOCRINOLOGY, V96, P618, DOI 10.1210/endo-96-3-618; Xia HB, 2002, NAT BIOTECHNOL, V20, P1006, DOI 10.1038/nbt739	49	31	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63603	10.1371/journal.pone.0063603	http://dx.doi.org/10.1371/journal.pone.0063603			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667645	Green Published, gold, Green Submitted			2022-12-25	WOS:000319654700166
J	Gong, L; Chen, Y; Hu, Z; Hu, MY				Gong, Liang; Chen, Yong; Hu, Zhen; Hu, Meiying			Testing Insecticidal Activity of Novel Chemically Synthesized siRNA against Plutella xylostella under Laboratory and Field Conditions	PLOS ONE			English	Article							RNA INTERFERENCE; DIAMONDBACK MOTH; ACETYLCHOLINESTERASE GENE; LEPIDOPTERA PLUTELLIDAE; LARVAL GROWTH; RESISTANCE; CHITOSAN; MANAGEMENT; TRIBOLIUM; L.	Background: Over the last 60 years, synthetic chemical pesticides have served as a main tactic in the field of crop protection, but their availability is now declining as a result of the development of insect resistance. Therefore, alternative pest management agents are needed. However, the demonstration of RNAi gene silencing in insects and its successful usage in disrupting the expression of vital genes opened a door to the development of a variety of novel, environmentally sound approaches for insect pest management. Methodology/Principal Findings: Six small interfering RNAs (siRNAs) were chemically synthesized and modified according to the cDNA sequence of P. xylostella acetylcholine esterase genes AChE1 and AChE2. All of them were formulated and used in insecticide activity screening against P. xylostella. Bioassay data suggested that Si-ace1_003 and Si-ace2_001 at a concentration of 3 mu g cm(-2) displayed the best insecticidal activity with 73.7% and 89.0%, mortality, respectively. Additional bioassays were used to obtain the acute lethal concentrations of LC50 and LC90 for Si-ace2_001, which were 53.66 mu g/ml and 759.71 mu g/ml, respectively. Quantitative Real-time PCR was used to confirm silencing and detected that the transcript levels of P. xylostella AChE2 (PxAChE2) were reduced by 5.7-fold compared to the control group. Consequently, AChE activity was also reduced by 1.7-fold. Finally, effects of the siRNAs on treated plants of Brassica oleracea and Brassica alboglabra were investigated with different siRNA doses. Our results showed that Si-ace2_001 had no negative effects on plant morphology, color and growth of vein under our experimental conditions. Conclusions: The most important finding of this study is the discovery that chemically synthesized and modified siRNA corresponding to P. xylostella AChE genes cause significant mortality of the insect both under laboratory and field conditions, which provides a novel strategy to control P. xylostella and to develop bio-pesticides based on the RNA interference technology.	[Gong, Liang; Chen, Yong; Hu, Zhen; Hu, Meiying] South China Agr Univ, Key Lab Pesticide & Chem Biol, Coll Nat Resources & Environm, Guangzhou, Guangdong, Peoples R China	South China Agricultural University	Hu, MY (corresponding author), South China Agr Univ, Key Lab Pesticide & Chem Biol, Coll Nat Resources & Environm, Guangzhou, Guangdong, Peoples R China.	humy@scau.edu.cn			National Nature Science Foundation, People's Republic of China [31171870]	National Nature Science Foundation, People's Republic of China(National Natural Science Foundation of China (NSFC))	We thank the National Nature Science Foundation, People's Republic of China for funding this work under grant no. 31171870. The authors also thank the Guangdong Province guided program of university industry cooperation (2010B090400138). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT WS, 1925, J ECON ENTOMOL, V18, P256; Badawy MEI, 2012, PLANT PROTECT SCI, V48, P131, DOI 10.17221/67/2010-PPS; BOESE Q, 2003, TARGETS, V2, P93; Boller EF, 2006, WORKING DOCUMENT SEL; Bolognesi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047534; Burand JP, 2013, J INVERTEBR PATHOL, V112, pS68, DOI 10.1016/j.jip.2012.07.012; Chandler D, 2011, PHILOS T R SOC B, V366, P1987, DOI 10.1098/rstb.2010.0390; Chen ZZ, 2001, INSECT BIOCHEM MOLEC, V31, P805, DOI 10.1016/S0965-1748(00)00186-7; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Endersby NM, 2011, B ENTOMOL RES, V101, P393, DOI 10.1017/S0007485310000684; Fire AZ, 2007, ANGEW CHEM INT EDIT, V46, P6967, DOI 10.1002/anie.200701979; Furlong MJ, 2013, ANNU REV ENTOMOL, V58, P517, DOI 10.1146/annurev-ento-120811-153605; Gary DJ, 2007, J CONTROL RELEASE, V121, P64, DOI 10.1016/j.jconrel.2007.05.021; Gong L, 2012, B ENTOMOL RES, V102, P600, DOI 10.1017/S0007485312000168; Gong LA, 2011, PEST MANAG SCI, V67, P514, DOI 10.1002/ps.2086; Grzywacz D, 2010, CROP PROT, V29, P68, DOI 10.1016/j.cropro.2009.08.009; Helle W, 1985, TOXICOLOGICAL METHOD, P183; Hsu JC, 2008, INSECT BIOCHEM MOLEC, V38, P146, DOI 10.1016/j.ibmb.2007.10.002; Huang Z, 2009, GENE THER, V16, P1271, DOI 10.1038/gt.2009.76; Hui XM, 2011, INSECT MOL BIOL, V20, P507, DOI 10.1111/j.1365-2583.2011.01081.x; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Jiang XJ, 2009, BIOCHEM BIOPH RES CO, V378, P269, DOI 10.1016/j.bbrc.2008.11.046; Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755; Kakani EG, 2013, B ENTOMOL RES, V103, P36, DOI 10.1017/S0007485312000478; Kao CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034969; Khalaf SA., 2004, INT J AGRIC BIOL, V6, P1033; Kumar M, 2009, J INSECT PHYSIOL, V55, P273, DOI 10.1016/j.jinsphys.2008.12.005; LASOTA JA, 1991, ANNU REV ENTOMOL, V36, P91, DOI 10.1146/annurev.en.36.010191.000515; Lee DW, 2007, BIOCHEM BIOPH RES CO, V353, P591, DOI 10.1016/j.bbrc.2006.12.088; Lee DW, 2006, BBA-GEN SUBJECTS, V1760, P125, DOI 10.1016/j.bbagen.2005.10.009; Li XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017788; Linden JC, 2000, AGRO FOOD IND HI TEC, V11, P32; Liu H, 2004, INT J FOOD MICROBIOL, V95, P147, DOI 10.1016/j.ijfoodmicro.2004.01.022; Liu XX, 2012, J ECON ENTOMOL, V105, P354, DOI 10.1603/EC11299; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032288; Lu YH, 2012, SCI REP-UK, V2, DOI 10.1038/srep00288; Mao JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048718; Marrone PG, 1999, OUTLOOK AGR, V28, P149, DOI 10.5367/000000099101292917; Pang YP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004349; Rabea EI, 2005, PEST MANAG SCI, V61, P951, DOI 10.1002/ps.1085; Revuelta L, 2009, INSECT BIOCHEM MOLEC, V39, P913, DOI 10.1016/j.ibmb.2009.11.001; Santos VC, 2011, NEOTROP ENTOMOL, V40, P264, DOI 10.1590/S1519-566X2011000200017; Silva AX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036366; TALEKAR NS, 1993, ANNU REV ENTOMOL, V38, P275, DOI 10.1146/annurev.en.38.010193.001423; TAYLOR P, 1994, ANNU REV PHARMACOL, V34, P281, DOI 10.1146/annurev.pa.34.040194.001433; Temeyer KB, 2007, DNA SEQUENCE, V18, P85, DOI 10.1080/10425170601060558; Teng XL, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.6001; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; Thacker JRM., 2002, INTRO ARTHROPOD PEST; Tomoyasu Y, 2004, DEV GENES EVOL, V214, P575, DOI 10.1007/s00427-004-0434-0; Tomoyasu Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r10; Weill M, 2002, P ROY SOC B-BIOL SCI, V269, P2007, DOI 10.1098/rspb.2002.2122; Whangbo JS, 2008, TRENDS GENET, V24, P297, DOI 10.1016/j.tig.2008.03.007; Wuriyanghan H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027736; Zhang M, 2003, J BIOACT COMPAT POL, V18, P391, DOI 10.1177/0883911503039019; Zhang PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047861; Zhang X, 2010, INSECT MOL BIOL, V19, P683, DOI 10.1111/j.1365-2583.2010.01029.x; Zhao JZ, 2006, J ECON ENTOMOL, V99, P176, DOI 10.1603/0022-0493(2006)099[0176:MODMLP]2.0.CO;2; Zhou LJ, 2011, CROP PROT, V30, P272, DOI 10.1016/j.cropro.2010.10.006; Zhu JQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038572	61	40	49	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62990	10.1371/journal.pone.0062990	http://dx.doi.org/10.1371/journal.pone.0062990			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667556	Green Published, gold, Green Submitted			2022-12-25	WOS:000319654700094
J	Ito, M; Ohba, S; Gaensler, K; Ronen, SM; Mukherjee, J; Pieper, RO				Ito, Motokazu; Ohba, Shigeo; Gaensler, Karin; Ronen, Sabrina M.; Mukherjee, Joydeep; Pieper, Russell O.			Early Chk1 Phosphorylation Is Driven by Temozolomide-Induced, DNA Double Strand Break- and Mismatch Repair-Independent DNA Damage	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; HUMAN GLIOBLASTOMA CELLS; METHYLATING AGENTS; G(2) CHECKPOINT; GLIOMA-CELLS; O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE; ESCHERICHIA-COLI; O-6-METHYLGUANINE; APOPTOSIS; SYSTEM	Temozolomide (TMZ) is a DNA methylating agent used to treat brain cancer. TMZ-induced O6-methylguanine adducts, in the absence of repair by O6-methylguanine DNA methyltransferase (MGMT), mispair during DNA replication and trigger cycles of futile mismatch repair (MMR). Futile MMR in turn leads to the formation of DNA single and double strand breaks, Chk1 and Chk2 phosphorylation/activation, cell cycle arrest, and ultimately cell death. Although both pChk1 and pChk2 are considered to be biomarkers of TMZ-induced DNA damage, cell-cycle arrest, and TMZ induced cytotoxicity, we found that levels of pChk1 (ser345), its downstream target pCdc25C (ser216), and the activity of its upstream activator ATR, were elevated within 3 hours of TMZ exposure, long before the onset of TMZ-induced DNA double strand breaks, Chk2 phosphorylation/activation, and cell cycle arrest. Furthermore, TMZ-induced early phosphorylation of Chk1 was noted in glioma cells regardless of whether they were MGMT-proficient or MGMT-deficient, and regardless of their MMR status. Early Chk1 phosphorylation was not associated with TMZ-induced reactive oxygen species, but was temporally associated with TMZ-induced alkalai-labile DNA damage produced by the non-O6-methylguanine DNA adducts and which, like Chk1 phosphorylation, was transient in MGMT-proficient cells but persistent in MGMT-deficient cells. These results re-define the TMZ-induced DNA damage response, and show that Chk1 phosphorylation is driven by TMZ-induced mismatch repair-independent DNA damage independently of DNA double strand breaks, Chk2 activation, and cell cycle arrest, and as such is a suboptimal biomarker of TMZ-induced drug action.	[Ito, Motokazu; Ohba, Shigeo; Mukherjee, Joydeep; Pieper, Russell O.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Gaensler, Karin] Univ Calif San Francisco, Dept Hematol Oncol, San Francisco, CA 94143 USA; [Ronen, Sabrina M.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Ito, Motokazu; Ohba, Shigeo; Ronen, Sabrina M.; Mukherjee, Joydeep; Pieper, Russell O.] Univ Calif San Francisco, Brain Tumor Res Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Pieper, RO (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.	rpieper@cc.ucsf.edu			United States National Institutes of Health [CA136774, CA097257, CA154915]; NATIONAL CANCER INSTITUTE [P50CA097257, R01CA154915, R01CA136774] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by United States National Institutes of Health Grants CA136774 and CA097257 (SPORE) to ROP and CA154915 to SMR, http://www.cancer.gov/researchandfunding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abbotts R, 2010, CANCER TREAT REV, V36, P425, DOI 10.1016/j.ctrv.2009.12.006; Adamson AW, 2005, MOL BIOL CELL, V16, P1513, DOI 10.1091/mbc.E04-02-0089; Adamson AW, 2002, J BIOL CHEM, V277, P38222, DOI 10.1074/jbc.M204409200; AU KG, 1992, J BIOL CHEM, V267, P12142; Boysen G, 2009, MUTAT RES-GEN TOX EN, V678, P76, DOI 10.1016/j.mrgentox.2009.05.006; Caporali S, 2004, MOL PHARMACOL, V66, P478; Chen CC, 2009, CNS CANC CANC DRUG D, P680; D'Atri S, 1998, MOL PHARMACOL, V54, P334, DOI 10.1124/mol.54.2.334; Dai Y, 2010, CLIN CANCER RES, V16, P376, DOI 10.1158/1078-0432.CCR-09-1029; Dianov GL, 2003, MUTAT RES-FUND MOL M, V531, P157, DOI 10.1016/j.mrfmmm.2003.09.003; Friedman HS, 1997, CANCER RES, V57, P2933; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; Hirose Y, 2001, CANCER RES, V61, P5843; Hirose Y, 2003, MOL CELL BIOL, V23, P8306, DOI 10.1128/MCB.23.22.8306-8315.2003; Hirose Y, 2001, CANCER RES, V61, P1957; Hirose Y, 2005, CANCER RES, V65, P4587; Huang XJ, 2008, PHARMACOLOGY, V82, P1, DOI 10.1159/000125673; Johnson DR, 2012, J NEURO-ONCOL, V107, P359, DOI 10.1007/s11060-011-0749-4; KARRAN P, 1982, NATURE, V296, P868, DOI 10.1038/296868a0; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Margison GP, 2002, MUTAGENESIS, V17, P483, DOI 10.1093/mutage/17.6.483; Mir SE, 2010, CANCER CELL, V18, P244, DOI 10.1016/j.ccr.2010.08.011; Mirzoeva OK, 2006, MOL CANCER THER, V5, P2757, DOI 10.1158/1535-7163.MCT-06-0183; Naidu MD, 2010, J RADIAT RES, V51, P393, DOI 10.1269/jrr.09077; Neidle S, 2005, NAT REV CANCER, V5, P285, DOI 10.1038/nrc1587; Newlands ES, 1997, CANCER TREAT REV, V23, P35, DOI 10.1016/S0305-7372(97)90019-0; Osoba D, 2000, J CLIN ONCOL, V18, P1481, DOI 10.1200/JCO.2000.18.7.1481; Park I, 2011, J MAGN RESON IMAGING, V33, P1284, DOI 10.1002/jmri.22563; PEGG AE, 1990, CANCER RES, V50, P6119; PEGG AE, 1983, J BIOL CHEM, V258, P2327; Plummer ER, 2005, CLIN CANCER RES, V11, P3402, DOI 10.1158/1078-0432.CCR-04-2353; Quiros S, 2010, CELL CYCLE, V9, P168, DOI 10.4161/cc.9.1.10363; RIAZUDDIN S, 1978, BIOCHEMISTRY-US, V17, P2110, DOI 10.1021/bi00604a014; Roos WP, 2007, ONCOGENE, V26, P186, DOI 10.1038/sj.onc.1209785; SINGER B, 1981, P NATL ACAD SCI-BIOL, V78, P856, DOI 10.1073/pnas.78.2.856; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; Stojic L, 2005, CELL CYCLE, V4, P473, DOI 10.4161/cc.4.3.1528; Stojic L, 2004, GENE DEV, V18, P1331, DOI 10.1101/gad.294404; Wang XZ, 2011, AM J CANCER RES, V1, P301; WESTPHAL M, 1994, ACTA NEUROCHIR, V126, P17, DOI 10.1007/BF01476489; Wyatt MD, 1999, BIOESSAYS, V21, P668, DOI 10.1002/(SICI)1521-1878(199908)21:8<668::AID-BIES6>3.3.CO;2-4; Xu-Welliver M, 1998, CANCER RES, V58, P1936; Zhang WB, 2010, J BIOL CHEM, V285, P40461, DOI 10.1074/jbc.M110.164046; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001	44	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62351	10.1371/journal.pone.0062351	http://dx.doi.org/10.1371/journal.pone.0062351			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667469	Green Published, gold, Green Submitted			2022-12-25	WOS:000319654700031
J	Lobato, NS; Filgueira, FP; Prakash, R; Giachini, FR; Ergul, A; Carvalho, MHC; Webb, RC; Tostes, RC; Fortes, ZB				Lobato, Nubia S.; Filgueira, Fernando P.; Prakash, Roshini; Giachini, Fernanda R.; Ergul, Adviye; Carvalho, Maria Helena C.; Webb, R. Clinton; Tostes, Rita C.; Fortes, Zuleica B.			Reduced Endothelium-Dependent Relaxation to Anandamide in Mesenteric Arteries from Young Obese Zucker Rats	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SENSITIVE SENSORY NERVES; NITRIC-OXIDE SYNTHASE; ENDOCANNABINOID SYSTEM; CANNABINOID RECEPTORS; CORONARY-ARTERY; ENDOGENOUS CANNABINOIDS; CARDIOMETABOLIC RISK; VANILLOID RECEPTORS; RESISTANCE VESSELS	Impaired vascular function, manifested by an altered ability of the endothelium to release endothelium-derived relaxing factors and endothelium-derived contracting factors, is consistently reported in obesity. Considering that the endothelium plays a major role in the relaxant response to the cannabinoid agonist anandamide, the present study tested the hypothesis that vascular relaxation to anandamide is decreased in obese rats. Mechanisms contributing to decreased anandamideinduced vasodilation were determined. Resistance mesenteric arteries from young obese Zucker rats (OZRs) and their lean counterparts (LZRs) were used. Vascular reactivity was evaluated in a myograph for isometric tension recording. Protein expression and localization were analyzed by Western blotting and immunofluorescence, respectively. Vasorelaxation to anandamide, acetylcholine, and sodium nitroprusside, as well as to CB1, CB2, and TRPV1 agonists was decreased in endothelium-intact mesenteric arteries from OZRs. Incubation with an AMP-dependent protein kinase (AMPK) activator or a fatty acid amide hydrolase inhibitor restored anandamide-induced vascular relaxation in OZRs. CB1 and CB2 receptors protein expression was decreased in arteries from OZRs. Incubation of mesenteric arteries with anandamide evoked endothelial nitric oxide synthase (eNOS), AMPK and acetyl CoA carboxylase phosphorylation in LZRs, whereas it decreased phosphorylation of these proteins in OZRs. In conclusion, obesity decreases anandamide-induced relaxation in resistance arteries. Decreased cannabinoid receptors expression, increased anandamide degradation, decreased AMPK/eNOS activity as well as impairment of the response mediated by TRPV1 activation seem to contribute to reduce responses to cannabinoid agonists in obesity.	[Lobato, Nubia S.; Filgueira, Fernando P.] Univ Fed Goias, Dept Biol Sci, Jatai, Go, Brazil; [Lobato, Nubia S.; Filgueira, Fernando P.; Prakash, Roshini; Giachini, Fernanda R.; Ergul, Adviye; Webb, R. Clinton] Georgia Hlth Sci Univ, Dept Physiol, Augusta, GA USA; [Lobato, Nubia S.; Filgueira, Fernando P.; Carvalho, Maria Helena C.; Fortes, Zuleica B.] Univ Sao Paulo, Inst Biomed Sci, Dept Pharmacol, Sao Paulo, Brazil; [Tostes, Rita C.] Univ Sao Paulo, Dept Pharmacol, Sch Med Ribeirao Preto, BR-14049 Ribeirao Preto, SP, Brazil	Universidade Federal de Goias; University System of Georgia; Augusta University; Universidade de Sao Paulo; Universidade de Sao Paulo	Fortes, ZB (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Pharmacol, Sao Paulo, Brazil.	zbfortes@icb.usp.br	Giachini, Fernanda R/J-7958-2012; Carvalho, Maria Helena C/C-8539-2013; Filgueira, Fernando/C-5668-2013; Tostes, Rita C/C-1025-2012	Giachini, Fernanda R/0000-0003-2688-7204; Filgueira, Fernando/0000-0001-8910-1796; Tostes, Rita C/0000-0002-9446-0707; Prakash, Roshini/0000-0003-4309-3078	National Institutes of Health [HL71138, HL74167]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); INCT Obesity and Diabetes; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) Brazil; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071138, P01HL074167] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); INCT Obesity and Diabetes; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health (HL71138 and HL74167), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), INCT Obesity and Diabetes and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batkai S, 2004, CIRCULATION, V110, P1996, DOI 10.1161/01.CIR.0000143230.23252.D2; BEVAN S, 1992, BRIT J PHARMACOL, V107, P544, DOI 10.1111/j.1476-5381.1992.tb12781.x; Bluher M, 2006, DIABETES, V55, P3053, DOI 10.2337/db06-0812; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chen Z, 2009, CIRC RES, V104, P496, DOI 10.1161/CIRCRESAHA.108.187567; Chen ZP, 1999, FEBS LETT, V443, P285, DOI 10.1016/S0014-5793(98)01705-0; Cota D, 2003, J CLIN INVEST, V112, P423, DOI 10.1172/JCI17725; Cote M, 2007, INT J OBESITY, V31, P692, DOI 10.1038/sj.ijo.0803539; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Deutsch DG, 1997, J CLIN INVEST, V100, P1538, DOI 10.1172/JCI119677; Di Marzo V, 2008, NAT REV DRUG DISCOV, V7, P438, DOI 10.1038/nrd2553; DRAY A, 1990, NEUROSCI LETT, V110, P52, DOI 10.1016/0304-3940(90)90786-9; Echahidi N, 2007, CIRCULATION, V116, pI213, DOI 10.1161/CIRCULATIONAHA.106.681304; Engeli S, 2005, DIABETES, V54, P2838, DOI 10.2337/diabetes.54.10.2838; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Gardiner SM, 2009, BRIT J PHARMACOL, V158, P1143, DOI 10.1111/j.1476-5381.2009.00363.x; Gaskari SA, 2005, BRIT J PHARMACOL, V146, P315, DOI 10.1038/sj.bjp.0706331; Goirand F, 2007, J PHYSIOL-LONDON, V581, P1163, DOI 10.1113/jphysiol.2007.132589; Gokce N, 2003, J AM COLL CARDIOL, V41, P1769, DOI 10.1016/S0735-1097(03)00333-4; Grainger J, 2001, BRIT J PHARMACOL, V134, P1003, DOI 10.1038/sj.bjp.0704340; Gunthorpe MJ, 2002, TRENDS PHARMACOL SCI, V23, P183, DOI 10.1016/S0165-6147(02)01999-5; Herradon E, 2007, BRIT J PHARMACOL, V152, P699, DOI 10.1038/sj.bjp.0707404; Hill JO, 2006, ENDOCR REV, V27, P750, DOI 10.1210/er.2006-0032; Hillard CJ, 2000, J PHARMACOL EXP THER, V294, P27; HOLZER P, 1991, PHARMACOL REV, V43, P143; Jiang SX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000641; Kaczocha M, 2009, P NATL ACAD SCI USA, V106, P6375, DOI 10.1073/pnas.0901515106; Kadoi Y, 2005, CRIT CARE MED, V33, P2629, DOI 10.1097/01.CCM.0000187010.14426.CC; KAWASAKI H, 1988, NATURE, V335, P164, DOI 10.1038/335164a0; Kola B, 2005, J BIOL CHEM, V280, P25196, DOI 10.1074/jbc.C500175200; Kotsis V, 2010, HYPERTENS RES, V33, P386, DOI 10.1038/hr.2010.9; Lerman A, 2005, CIRCULATION, V111, P363, DOI 10.1161/01.CIR.0000153339.27064.14; Liu J, 2008, NEUROPHARMACOLOGY, V54, P1, DOI 10.1016/j.neuropharm.2007.05.020; Lobato NS, 2011, NUTR METAB CARDIOVAS, V21, P808, DOI 10.1016/j.numecd.2010.02.006; Lopez-Miranda V, 2008, CURR VASC PHARMACOL, V6, P335, DOI 10.2174/157016108785909706; Mackie K, 2006, AAPS J, V8, pE298, DOI 10.1007/BF02854900; Matias I, 2008, MOL CELL ENDOCRINOL, V286, pS66, DOI 10.1016/j.mce.2008.01.026; Mitchell GF, 2004, HYPERTENSION, V44, P134, DOI 10.1161/01.HYP.0000137305.77635.68; MONCADA S, 1991, P NATL ACAD SCI USA, V88, P2166, DOI 10.1073/pnas.88.6.2166; Mukhopadhyay P, 2007, J AM COLL CARDIOL, V50, P528, DOI 10.1016/j.jacc.2007.03.057; MULVANY MJ, 1977, CIRC RES, V41, P19, DOI 10.1161/01.RES.41.1.19; O'Sullivan SE, 2004, BRIT J PHARMACOL, V142, P435, DOI 10.1038/sj.bjp.0705810; Pratt PF, 1998, AM J PHYSIOL-HEART C, V274, pH375, DOI 10.1152/ajpheart.1998.274.1.H375; Ralevic V, 2000, BRIT J PHARMACOL, V130, P1483, DOI 10.1038/sj.bjp.0703456; Randall MD, 2004, BRIT J PHARMACOL, V142, P20, DOI 10.1038/sj.bjp.0705725; Rayment SJ, 2007, FASEB J, V21, P577, DOI 10.1096/fj.06-7050com; Sarzani R, 2008, J NEUROENDOCRINOL, V20, P58, DOI 10.1111/j.1365-2826.2008.01677.x; Scotland RS, 2004, CIRC RES, V95, P1027, DOI 10.1161/01.RES.0000148633.93110.24; Shaul PW, 2002, ANNU REV PHYSIOL, V64, P749, DOI 10.1146/annurev.physiol.64.081501.155952; Stapleton Phoebe A, 2008, Pathophysiology, V15, P79, DOI 10.1016/j.pathophys.2008.04.007; Stepp DW, 2007, AM J PHYSIOL-HEART C, V293, pH2537, DOI 10.1152/ajpheart.01081.2006; Subramanian R, 2003, EUR J PHARMACOL, V477, P143, DOI 10.1016/j.ejphar.2003.08.003; Szmitko PE, 2008, ATHEROSCLEROSIS, V199, P248, DOI 10.1016/j.atherosclerosis.2008.03.011; Varga K, 1998, FASEB J, V12, P1035, DOI 10.1096/fasebj.12.11.1035; Wagner JA, 2001, J AM COLL CARDIOL, V38, P2048, DOI 10.1016/S0735-1097(01)01671-0; Wagner JA, 1997, NATURE, V390, P518, DOI 10.1038/37371; Wagner JA, 1999, HYPERTENSION, V33, P429, DOI 10.1161/01.HYP.33.1.429; Wheal AJ, 2007, BRIT J PHARMACOL, V152, P717, DOI 10.1038/sj.bjp.0707410; ZUCKER LM, 1972, ENDOCRINOLOGY, V90, P1320, DOI 10.1210/endo-90-5-1320; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761; Zygmunt PM, 2002, J NEUROSCI, V22, P4720, DOI 10.1523/JNEUROSCI.22-11-04720.2002	61	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63449	10.1371/journal.pone.0063449	http://dx.doi.org/10.1371/journal.pone.0063449			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667622	gold, Green Submitted, Green Published			2022-12-25	WOS:000319654700148
J	Ke, F; He, LB; Zhang, QY				Ke, Fei; He, Li-Bo; Zhang, Qi-Ya			Nonstructural Protein NS80 Is Crucial in Recruiting Viral Components to Form Aquareoviral Factories	PLOS ONE			English	Article							RANA-GRYLIO VIRUS; GRASS CARP REOVIRUS; MU-NS; SIGMA-NS; FUNCTIONAL DOMAINS; GENUS AQUAREOVIRUS; INCLUSIONS; IDENTIFICATION; ASSOCIATIONS; REPLICATION	Background: Replication and assembly of vertebrate reoviruses occur in specific intracellular compartments known as viral factories. Recently, NS88 and NS80, the nonstructural proteins from aquareoviruses, have been proposed to share common traits with mu NS from orthoreoviruses, which are involved in the formation of viral factories. Methodology/Principal Findings: In this study, the NS80 characteristics and its interactions with other viral components were investigated. We observed that the NS80 structure ensured its self-aggregation and selective recruitment of viral proteins to viral factories like structures (VFLS). The minimum amino acids (aa) of NS80 required for VFLS formation included 193 aa at the C-terminal. However, this truncated protein only contained one aa coil and located in the nucleus. Its N-terminal residual regions, aa 1-55 and aa 55-85, were required for recruiting viral nonstructural protein NS38 and structural protein VP3, respectively. A conserved N-terminal region of NS38, which was responsible for the interaction with NS80, was also identified. Moreover, the minimal region of C-terminal residues, aa 506-742 (Delta 505), required for NS80 self-aggregation in the cytoplasm, and aa 550-742 (Delta 549), which are sufficient for recruiting viral structure proteins VP1, VP2, and VP4 were also identified. Conclusions/Significance: The present study shows detailed interactions between NS80 and NS38 or other viral proteins. Sequence and structure characteristics of NS80 ensures its self-aggregation to form VFLS (either in the cytoplasm or nucleus) and recruitment of viral structural or nonstructural proteins.	[Ke, Fei; He, Li-Bo; Zhang, Qi-Ya] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Zhang, QY (corresponding author), Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China.	zhangqy@ihb.ac.cn			National Major Basic Research Program [2009CB118704, 2010CB126303]; National Natural Science Foundation of China [30871938, 31072239]; Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-Z-3]; Project of State Key Laboratory of Freshwater Ecology and Biotechnology [2011FBZ12, 2013FB13]	National Major Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); Project of State Key Laboratory of Freshwater Ecology and Biotechnology	This work is supported by grants from the National Major Basic Research Program (2009CB118704, 2010CB126303), the National Natural Science Foundation of China (30871938, 31072239), the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-Z-3) and the Project of State Key Laboratory of Freshwater Ecology and Biotechnology (2011FBZ12, 2013FB13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Attoui H, 2002, J GEN VIROL, V83, P1941, DOI 10.1099/0022-1317-83-8-1941; Attoui H., 2011, VIRUS TAXONOMY, P541; Becker MM, 2003, J VIROL, V77, P5948, DOI 10.1128/JVI.77.10.5948-5963.2003; Becker MM, 2001, J VIROL, V75, P1459, DOI 10.1128/JVI.75.3.1459-1475.2001; Brandariz-Nunez A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013785; Brandariz-Nunez A, 2010, J VIROL, V84, P4289, DOI 10.1128/JVI.02534-09; Broering TJ, 2005, J VIROL, V79, P6194, DOI 10.1128/JVI.79.10.6194-6206.2005; Broering TJ, 2004, J VIROL, V78, P1882, DOI 10.1128/JVI.78.4.1882-1892.2004; Broering TJ, 2002, J VIROL, V76, P8285, DOI 10.1128/JVI.76.16.8285-8297.2002; Busch LK, 2011, J GEN VIROL, V92, P2566, DOI 10.1099/vir.0.036459-0; Cai L, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-168; Danthi P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000248; Du CS, 2004, VIRUS RES, V101, P119, DOI 10.1016/j.virusres.2003.12.034; Fang Q, 2000, BIOCHEM BIOPH RES CO, V274, P762, DOI 10.1006/bbrc.2000.3215; Gao EB, 2012, J VIROL, V86, P236, DOI 10.1128/JVI.06282-11; Gui JF, 2012, CHINESE SCI BULL, V57, P1751, DOI 10.1007/s11434-012-5213-0; Huang XH, 2006, J VIROL METHODS, V133, P117, DOI 10.1016/j.jviromet.2005.10.029; Huang XH, 2007, MICRON, V38, P599, DOI 10.1016/j.micron.2006.10.001; Huang YH, 2007, APOPTOSIS, V12, P1569, DOI 10.1007/s10495-007-0089-1; Ivanovic T, 2008, EMBO J, V27, P1289, DOI 10.1038/emboj.2008.60; Ivanovic T, 2011, TRAFFIC, V12, P1179, DOI 10.1111/j.1600-0854.2011.01233.x; Kaufer S, 2012, J VIROL, V86, P1079, DOI 10.1128/JVI.02662-10; Ke F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-323; Ke F, 2009, MOL BIOL REP, V36, P1651, DOI 10.1007/s11033-008-9365-6; Kim YS, 2009, FISH SHELLFISH IMMUN, V27, P336, DOI 10.1016/j.fsi.2009.06.006; Kim YS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010308; Kirchner E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000235; Kobayashi T, 2009, J VIROL, V83, P2892, DOI 10.1128/JVI.01495-08; KOZAK M, 1991, J BIOL CHEM, V266, P19867; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; McCutcheon AM, 1999, VIROLOGY, V264, P16, DOI 10.1006/viro.1999.9990; Miller CL, 2007, MOL CELL PROTEOMICS, V6, P1027, DOI 10.1074/mcp.M700056-MCP200; Miller CL, 2010, J VIROL, V84, P867, DOI 10.1128/JVI.01571-09; Miller CL, 2003, J VIROL, V77, P4566, DOI 10.1128/JVI.77.8.4566-4576.2003; Novoa RR, 2005, BIOL CELL, V97, P147, DOI 10.1042/BC20040058; Schmitz AM, 2009, NAT METHODS, V6, P500, DOI 10.1038/nmeth.1337; Tao YJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000943; Tao YZ, 2002, CELL, V111, P733, DOI 10.1016/S0092-8674(02)01110-8; Touris-Otero F, 2004, VIROLOGY, V319, P94, DOI 10.1016/j.virol.2003.10.034; Trask SD, 2012, NAT REV MICROBIOL, V10, P165, DOI 10.1038/nrmicro2673; WIENER JR, 1989, VIROLOGY, V169, P293, DOI 10.1016/0042-6822(89)90154-2; Yan XD, 2011, J VIROL, V85, P7483, DOI 10.1128/JVI.00729-11; Zhang Q.Y., 2003, HIGH TECHNOL LETT, V9, P7; Zhang QY, 2000, DIS AQUAT ORGAN, V42, P1, DOI 10.3354/dao042001; Zhang QY, 2004, J VIROL, V78, P6982, DOI 10.1128/JVI.78.13.6982-6994.2004; Zhang QY, 2003, DIS AQUAT ORGAN, V57, P27, DOI 10.3354/dao057027; Zhang QY, 2001, DIS AQUAT ORGAN, V48, P27, DOI 10.3354/dao048027; Zhang QY, 2012, ATLAS AQUATIC VIRUSE; Zhang X, 2010, CELL, V141, P472, DOI 10.1016/j.cell.2010.03.041; Zhao Z, 2008, J GEN VIROL, V89, P1866, DOI 10.1099/vir.0.2008/000810-0; Zhao Z, 2008, VIROLOGY, V372, P118, DOI 10.1016/j.virol.2007.10.028; Zhu R, 2008, J VIROL, V82, P6889, DOI 10.1128/JVI.02385-07; Zurney J, 2009, J VIROL, V83, P2178, DOI 10.1128/JVI.01787-08	54	16	20	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e63737	10.1371/journal.pone.0063737	http://dx.doi.org/10.1371/journal.pone.0063737			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671697	gold, Green Submitted, Green Published			2022-12-25	WOS:000321390200059
J	Vujovic, P; Stamenkovic, S; Jasnic, N; Lakic, I; Djurasevic, SF; Cvijic, G; Djordjevic, J				Vujovic, Predrag; Stamenkovic, Stefan; Jasnic, Nebojsa; Lakic, Iva; Djurasevic, Sinisa F.; Cvijic, Gordana; Djordjevic, Jelena			Fasting Induced Cytoplasmic Fto expression in Some Neurons of Rat Hypothalamus	PLOS ONE			English	Article							FOOD-INTAKE; GENE-EXPRESSION; OBESITY GENE; FAT MASS; DEPRIVATION; METHYLATION; TRANSPORT; VARIANT; ACID; BODY	Fat mass and obesity associated protein (Fto) is a nucleic acid demethylase, with a preference for thymine or uracil, according to the recent structural data. This fact suggests that methylated single-stranded RNA, rather than DNA, may be the primary Fto substrate. Fto is abundantly expressed in all hypothalamic sites governing feeding behavior. Considering that selective modulation of Fto levels in the hypothalamus can influence food intake, we set out to investigate the effect of 48 h fasting on the Fto expression in lateral hypothalamic area, paraventricular, ventromedial and arcuate nucleus, the regulatory centres of energy homeostasis. We have demonstrated that 48 h fasting causes not only an increase in the overall hypothalamic levels of both Fto mRNA and protein, but also alters Fto intracellular distribution. This switch happens in some neurons of paraventricular and ventromedial nucleus, as well as lateral hypothalamic area, resulting in the majority of the enzyme being localized outside the cell nuclei. Interestingly, the change in the Fto intracellular localization was not observed in neurons of arcuate nucleus, suggesting that fasting did not universally affect Fto in all of the hypothalmic sites involved in energy homeostasis regulation. Both Fto mRNA and catechol-O-methyltransferaze mRNA were upregulated in the identical time-dependent manner in fasting animals. This fact, combined with the knowledge of the Fto substrate preference, may provide further insight into monoamine metabolism in the state of disturbed energy homeostasis.	[Vujovic, Predrag; Jasnic, Nebojsa; Lakic, Iva; Djurasevic, Sinisa F.; Cvijic, Gordana; Djordjevic, Jelena] Univ Belgrade, Fac Biol, Inst Physiol & Biochem, Belgrade, Serbia; [Stamenkovic, Stefan] Univ Belgrade, Fac Biol, Ctr Laser Microscopy, Belgrade, Serbia	University of Belgrade; University of Belgrade	Vujovic, P (corresponding author), Univ Belgrade, Fac Biol, Inst Physiol & Biochem, Belgrade, Serbia.	predragv@bio.bg.ac.rs	Djordjevic, Jelena/HIK-1329-2022; Djurasevic, Sinisa/G-4064-2016	Djordjevic, Jelena/0000-0002-6510-1027; Djurasevic, Sinisa/0000-0003-4406-8376; Stamenkovic, Stefan/0000-0002-3443-9156; Vujovic, Predrag/0000-0002-9444-4758; Jasnic, Nebojsa/0000-0003-0333-333X	Serbian Ministry of Education, Science and Technological Development Grant [173023]	Serbian Ministry of Education, Science and Technological Development Grant	The experimental work was funded by the Serbian Ministry of Education, Science and Technological Development Grant No 173023. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHEREL Y, 1991, CLIN SCI, V81, P611, DOI 10.1042/cs0810611; Fetissov SO, 2000, NEUROSCIENCE, V101, P657, DOI 10.1016/S0306-4522(00)00374-2; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fredriksson R, 2008, ENDOCRINOLOGY, V149, P2062, DOI 10.1210/en.2007-1457; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; GLICK SD, 1973, RES COMMUN CHEM PATH, V6, P775; Han ZF, 2010, NATURE, V464, P1205, DOI 10.1038/nature08921; Haupt A, 2009, EXP CLIN ENDOCR DIAB, V117, P194, DOI 10.1055/s-0028-1087176; Jans DA, 1996, PHYSIOL REV, V76, P651, DOI 10.1152/physrev.1996.76.3.651; Larder R, 2011, TRENDS ENDOCRIN MET, V22, P53, DOI 10.1016/j.tem.2010.11.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Micura R, 2001, NUCLEIC ACIDS RES, V29, P3997, DOI 10.1093/nar/29.19.3997; NEGRE D, 1989, P NATL ACAD SCI USA, V86, P4902, DOI 10.1073/pnas.86.13.4902; Olszewski PK, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-129; Otis KO, 2006, CURR OPIN NEUROBIOL, V16, P329, DOI 10.1016/j.conb.2006.05.001; Qi L, 2008, DIABETES, V57, P3145, DOI 10.2337/db08-0006; Ramos EJB, 2005, NUTRITION, V21, P269, DOI 10.1016/j.nut.2004.06.021; Sanchez-Pulido Luis, 2007, BMC Biochemistry, V8, P23, DOI 10.1186/1471-2091-8-23; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Stratigopoulos G, 2008, AM J PHYSIOL-REG I, V294, pR1185, DOI 10.1152/ajpregu.00839.2007; Tung YCL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008771	23	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e63694	10.1371/journal.pone.0063694	http://dx.doi.org/10.1371/journal.pone.0063694			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671692	Green Submitted, Green Published, gold			2022-12-25	WOS:000321390200057
J	Furusawa, C; Kaneko, K				Furusawa, Chikara; Kaneko, Kunihiko			Epigenetic Feedback Regulation Accelerates Adaptation and Evolution	PLOS ONE			English	Article							GENE-REGULATION; EXPRESSION	A simple cell model consisting of a gene regulatory network with epigenetic feedback regulation is studied to evaluate the effect of epigenetic dynamics on adaptation and evolution. We find that, the type of epigenetic dynamics considered enables a cell to adapt to unfamiliar environmental changes, for which no regulatory program has been prepared, through noise-driven selection of a cellular state with a high growth rate. Furthermore, we demonstrate that the inclusion of epigenetic regulation promotes evolutionary development of a regulatory network that can respond to environmental changes in a fast and precise manner. These results strongly suggest that epigenetic feedback regulation in gene expression dynamics provides a significant increase in fitness by engendering an increase in cellular plasticity during adaptation and evolution.	[Furusawa, Chikara] RIKEN, Quantitat Biol Ctr QBiC, Suita, Osaka, Japan; [Kaneko, Kunihiko] Univ Tokyo, Res Ctr Complex Syst Biol, Meguro Ku, Tokyo, Japan	RIKEN; University of Tokyo	Furusawa, C (corresponding author), RIKEN, Quantitat Biol Ctr QBiC, Suita, Osaka, Japan.	chikara.furusawa@riken.jp	Furusawa, Chikara/N-6103-2015; Furusawa, Chikara/ABB-6516-2021	Furusawa, Chikara/0000-0003-3554-4975; Furusawa, Chikara/0000-0003-3554-4975	Japan Society for the Promotion of Science [23680030]; Ministry of Education, Culture, Sports, Science & Technology, Japan [23128509, 21120004]; Grants-in-Aid for Scientific Research [23650152] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science & Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by a Grant-in-Aid for Young Scientists (A) to CF (No. 23680030) from the Japan Society for the Promotion of Science, and a Grant-in-Aid for Scientific Research on Innovative Areas to CF (No. 23128509) and to KK (No. 21120004) from the Ministry of Education, Culture, Sports, Science & Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angel A, 2011, NATURE, V476, P105, DOI 10.1038/nature10241; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bremer H, 1996, ESCHERICHIA COLI SAL; Casadesus J, 2006, MICROBIOL MOL BIOL R, V70, P830, DOI 10.1128/MMBR.00016-06; Dodd IB, 2007, CELL, V129, P813, DOI 10.1016/j.cell.2007.02.053; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Fong SS, 2004, NAT GENET, V36, P1056, DOI 10.1038/ng1432; Furusawa C, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040003; Furusawa Chikara, 2005, Biophysics (Nagoya-shi), V1, P25, DOI 10.2142/biophysics.1.25; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jin DJ, 2012, FEMS MICROBIOL REV, V36, P269, DOI 10.1111/j.1574-6976.2011.00279.x; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kashiwagi A, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000049; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Rohlf T, 2012, EPIGENOMICS-UK, V4, P205, DOI [10.2217/epi.11.117, 10.2217/EPI.11.117]; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Satory D, 2011, CURR OPIN MICROBIOL, V14, P212, DOI 10.1016/j.mib.2010.12.004; Shinfuku Y, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-43; Sneppen K, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.21; Stolovicki E, 2006, GENETICS, V173, P75, DOI 10.1534/genetics.106.055442; Thon G, 1997, GENETICS, V145, P685	23	17	17	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e61251	10.1371/journal.pone.0061251	http://dx.doi.org/10.1371/journal.pone.0061251			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667436	Green Published, gold, Green Submitted			2022-12-25	WOS:000319055600010
J	Agarwal, JJ; Zhu, Y; Zhang, QY; Mongin, AA; Hough, LB				Agarwal, Jay J.; Zhu, Yi; Zhang, Qing-Yu; Mongin, Alexander A.; Hough, Lindsay B.			TRAM-34, a Putatively Selective Blocker of Intermediate-Conductance, Calcium-Activated Potassium Channels, Inhibits Cytochrome P450 Activity	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNEL; KCNN4 CHANNELS; SECRETION; PROLIFERATION; KCNN4/KCA3.1; CONTRIBUTES; PROTECTION; STRATEGY; K(CA)3.1	TRAM-34, a clotrimazole analog characterized as a potent and selective inhibitor of intermediate-conductance, calcium-activated K+ (IKCa) channels, has been used extensively in vitro and in vivo to study the biological roles of these channels. The major advantage of TRAM-34 over clotrimazole is the reported lack of inhibition of the former drug on cytochrome P450 (CYP) activity. CYPs, a large family of heme-containing oxidases, play essential roles in endogenous signaling and metabolic pathways, as well as in xenobiotic metabolism. However, previously published work has only characterized the effects of TRAM-34 on a single CYP isoform. To test the hypothesis that TRAM-34 may inhibit some CYP isoforms, the effects of this compound were presently studied on the activities of four rat and five human CYP isoforms. TRAM-34 inhibited recombinant rat CYP2B1, CYP2C6 and CYP2C11 and human CYP2B6, CYP2C19 and CYP3A4 with IC50 values ranging from 0.9 mu M to 12.6 mu M, but had no inhibitory effects (up to 80 mu M) on recombinant rat CYP1A2, human CYP1A2, or human CYP19A1. TRAM-34 also had both stimulatory and inhibitory effects on human CYP3A4 activity, depending on the substrate used. These results show that low micromolar concentrations of TRAM-34 can inhibit several rat and human CYP isoforms, and suggest caution in the use of high concentrations of this drug as a selective IKCa channel blocker. In addition, in vivo use of TRAM-34 could lead to CYP-related drug-drug interactions.	[Agarwal, Jay J.; Mongin, Alexander A.; Hough, Lindsay B.] Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA; [Zhu, Yi; Zhang, Qing-Yu] SUNY Albany, Wadsworth Ctr, New York State Dept Hlth, Albany, NY 12222 USA; [Zhu, Yi; Zhang, Qing-Yu] SUNY Albany, Sch Publ Hlth, Albany, NY USA	Albany Medical College; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Hough, LB (corresponding author), Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA.	houghl@mail.amc.edu	Mongin, Alexander A./A-5526-2008	Mongin, Alexander A./0000-0002-2501-3778	National Institute on Drug Abuse [DA027835]; National Institute of Neurological Disorders and Stroke [NS061953]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027835] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the National Institute on Drug Abuse (DA027835 to LBH) and the National Institute of Neurological Disorders and Stroke (NS061953 to AAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullaev IF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012304; Basalingappa KM, 2011, AM J PHYSIOL-GASTR L, V301, pG905, DOI 10.1152/ajpgi.00558.2010; Begenisich T, 2004, J BIOL CHEM, V279, P47681, DOI 10.1074/jbc.M409627200; Bouhy D, 2011, J NEUROSCI, V31, P16298, DOI 10.1523/JNEUROSCI.0047-11.2011; Chia Elizabeth, 2011, BMC Pharmacology, V11, P10, DOI 10.1186/1471-2210-11-10; Crankshaw DL, 2009, P BRIT PHARM SOC, V7; Crespi CL, 1997, ANAL BIOCHEM, V248, P188, DOI 10.1006/abio.1997.2145; Cruse G, 2006, THORAX, V61, P880, DOI 10.1136/thx.2006.060319; DEFRANCESCHI L, 1994, J CLIN INVEST, V93, P1670, DOI 10.1172/JCI117149; Gaete PS, 2012, FREE RADICAL BIO MED, V52, P860, DOI 10.1016/j.freeradbiomed.2011.11.036; Grgic I, 2009, TRANSPL P, V41, P2601, DOI 10.1016/j.transproceed.2009.06.025; Henderson GL, 1999, LIFE SCI, V65, pPL209, DOI 10.1016/S0024-3205(99)00407-5; Itoh T, 2012, BRIT J PHARMACOL, V167, P682, DOI 10.1111/j.1476-5381.2012.02038.x; Kaushal V, 2007, J NEUROSCI, V27, P234, DOI 10.1523/JNEUROSCI.3593-06.2007; Kohler R, 2003, CIRCULATION, V108, P1119, DOI 10.1161/01.CIR.0000086464.04719.DD; Kumar NSN, 2010, AM J PHYSIOL-GASTR L, V299, pG707, DOI 10.1152/ajpgi.00101.2010; Lin JH, 1998, CLIN PHARMACOKINET, V35, P361, DOI 10.2165/00003088-199835050-00003; Mene P, 2010, NEPHROL DIAL TRANSPL, V25, P353, DOI 10.1093/ndt/gfp634; Millership JE, 2011, AM J PHYSIOL-CELL PH, V300, pC792, DOI 10.1152/ajpcell.00274.2010; Nelson David R., 2009, Human Genomics, V4, P59; Ortiz de Montellano P. R., 2005, CYTOCHROME P450 STRU; Quast SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039290; Reich EP, 2005, EUR J IMMUNOL, V35, P1027, DOI 10.1002/eji.200425954; Roy JW, 2010, BRIT J PHARMACOL, V159, P650, DOI 10.1111/j.1476-5381.2009.00557.x; Schilling T, 2004, EUR J NEUROSCI, V19, P1469, DOI 10.1111/j.1460-9568.2004.03265.x; Schilling T, 2007, PFLUG ARCH EUR J PHY, V454, P559, DOI 10.1007/s00424-007-0232-4; Schmidt J, 2010, CELL RES, V20, P1224, DOI 10.1038/cr.2010.121; Sciaccaluga M, 2010, AM J PHYSIOL-CELL PH, V299, pC175, DOI 10.1152/ajpcell.00344.2009; Singh SK, 2012, AM J PHYSIOL-CELL PH, V302, pC1353, DOI 10.1152/ajpcell.00216.2011; Stresser DM, 2000, DRUG METAB DISPOS, V28, P1440; Suzuki S, 2000, EUR J DRUG METAB PH, V25, P121, DOI 10.1007/BF03190078; Toyama K, 2008, J CLIN INVEST, V118, P3025, DOI 10.1172/JCI30836; Ueng YF, 1997, BIOCHEMISTRY-US, V36, P370, DOI 10.1021/bi962359z; VanAlstine MA, 2011, DRUG METAB DISPOS, V39, P1221, DOI 10.1124/dmd.110.037424; Wang BX, 2010, FASEB J, V24, P4078, DOI 10.1096/fj.09-153841; Wang ZH, 2007, ONCOGENE, V26, P5107, DOI 10.1038/sj.onc.1210308; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151; Wulff Heike, 2010, Expert Rev Clin Pharmacol, V3, P385, DOI 10.1586/ecp.10.11; Yano JK, 2006, J MED CHEM, V49, P6987, DOI 10.1021/jm060519r; Zhang WJ, 2002, DRUG METAB DISPOS, V30, P314, DOI 10.1124/dmd.30.3.314; Zhu Y, 2011, DRUG METAB DISPOS, V39, P939, DOI 10.1124/dmd.110.037861	41	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63028	10.1371/journal.pone.0063028	http://dx.doi.org/10.1371/journal.pone.0063028			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667566	Green Published, Green Submitted, gold			2022-12-25	WOS:000319654700098
J	Chow, WZ; Ong, LY; Razak, SH; Lee, YM; Ng, KT; Yong, YK; Azmel, A; Takebe, Y; Al-Darraji, HAA; Kamarulzaman, A; Tee, KK				Chow, Wei Zhen; Ong, Lai Yee; Razak, Siti Humaira; Lee, Yeat Mei; Ng, Kim Tien; Yong, Yean Kong; Azmel, Azureen; Takebe, Yutaka; Al-Darraji, Haider Abdulrazzaq Abed; Kamarulzaman, Adeeba; Tee, Kok Keng			Molecular Diversity of HIV-1 among People Who Inject Drugs in Kuala Lumpur, Malaysia: Massive Expansion of Circulating Recombinant Form (CRF) 33_01B and Emergence of Multiple Unique Recombinant Clusters	PLOS ONE			English	Article							CRF01-AE/B RECOMBINANT; RISK POPULATIONS; TYPE-1 SUBTYPES; IDENTIFICATION; EPIDEMIOLOGY; USERS; CRF33-01B; SEROCONVERTERS; RESISTANCE; CRF15-01B	Since the discovery of HIV-1 circulating recombinant form (CRF) 33_01B in Malaysia in the early 2000 s, continuous genetic diversification and active recombination involving CRF33_01B and other circulating genotypes in the region including CRF01_AE and subtype B' of Thai origin, have led to the emergence of novel CRFs and unique recombinant forms. The history and magnitude of CRF33_01B transmission among various risk groups including people who inject drugs (PWID) however have not been investigated despite the high epidemiological impact of CRF33_01B in the region. We update the most recent molecular epidemiology of HIV-1 among PWIDs recruited in Malaysia between 2010 and 2011 by population sequencing and phylogenetic analysis of 128 gag-pol sequences. HIV-1 CRF33_01B was circulating among 71% of PWIDs whilst a lower prevalence of other previously dominant HIV-1 genotypes [subtype B' (11%) and CRF01_AE (5%)] and CRF01_AE/B' unique recombinants (13%) were detected, indicating a significant shift in genotype replacement in this population. Three clusters of CRF01_AE/B' recombinants displaying divergent yet phylogenetically-related mosaic genomes to CRF33_01B were identified and characterized, suggestive of an abrupt emergence of multiple novel CRF clades. Using rigorous maximum likelihood approach and the Bayesian Markov chain Monte Carlo (MCMC) sampling of CRF33_01B(pol) sequences to elucidate the past population dynamics, we found that the founder lineages of CRF33_01B were likely to have first emerged among PWIDs in the early 1990 s before spreading exponentially to various high and low-risk populations (including children who acquired infections from their mothers) and later on became endemic around the early 2000 s. Taken together, our findings provide notable genetic evidence indicating the widespread expansion of CRF33_01B among PWIDs and into the general population. The emergence of numerous previously unknown recombinant clades highlights the escalating genetic complexity of HIV-1 in the Southeast Asian region.	[Chow, Wei Zhen; Ong, Lai Yee; Razak, Siti Humaira; Lee, Yeat Mei; Ng, Kim Tien; Yong, Yean Kong; Azmel, Azureen; Takebe, Yutaka; Al-Darraji, Haider Abdulrazzaq Abed; Kamarulzaman, Adeeba; Tee, Kok Keng] Univ Malaya, Fac Med, Dept Med, Ctr Excellence Res AIDS CERiA, Kuala Lumpur, Malaysia; [Takebe, Yutaka] Natl Inst Infect Dis, AIDS Res Ctr, Shinjuku Ku, Tokyo 1628640, Japan	Universiti Malaya; National Institute of Infectious Diseases (NIID)	Tee, KK (corresponding author), Univ Malaya, Fac Med, Dept Med, Ctr Excellence Res AIDS CERiA, Kuala Lumpur, Malaysia.	k2tee@um.edu.my	Yong, Yean/B-9202-2017; KAMARULZAMAN, ADEEBA/B-5216-2010; Yong, Yean Kong/Q-5318-2016; Chow, Wei Zhen/L-8228-2013; Tee, Kok Keng/A-8148-2008; Al-Darraji, Haider Abdulrazzaq Abed/B-7978-2012; Ng, Kim Tien/K-7667-2013	Yong, Yean/0000-0002-8409-6251; Tee, Kok Keng/0000-0002-7923-5448; Al-Darraji, Haider Abdulrazzaq Abed/0000-0003-2576-3218; Ng, Kim Tien/0000-0002-4097-9984	Ministry of Higher Education, Malaysia: High Impact Research [E-000001-20001, H-500001-00-A000011-000001, H-500001-00-A000012-000001, J-50001-73596]	Ministry of Higher Education, Malaysia: High Impact Research	This work was supported by grants from the Ministry of Higher Education, Malaysia: High Impact Research E-000001-20001 to A.K., and High Impact Research H-500001-00-A000011-000001, H-500001-00-A000012-000001 and J-50001-73596 to K.K.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldous JL, 2012, CLIN INFECT DIS, V55, P1135, DOI 10.1093/cid/cis612; [Anonymous], 2012, GLOB REP UNAIDS REP; Beyrer C, 1998, AIDS RES HUM RETROV, V14, P1687, DOI 10.1089/aid.1998.14.1687; Beyrer C, 2000, AIDS, V14, P75, DOI 10.1097/00002030-200001070-00009; Beyrer C, 2010, LANCET, V376, P551, DOI 10.1016/S0140-6736(10)60928-2; Brenner BG, 2011, J INFECT DIS, V204, P1115, DOI 10.1093/infdis/jir468; Brown TM, 1996, AIDS RES HUM RETROV, V12, P1655, DOI 10.1089/aid.1996.12.1655; Chen J, 2010, RADIAT PROT DOSIM, V142, P1, DOI 10.1093/rpd/ncq205; Dennis AM, 2012, AIDS, V26, P1813, DOI 10.1097/QAD.0b013e3283573244; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lau KA, 2008, CURR HIV RES, V6, P108, DOI 10.2174/157016208783885010; Lau KA, 2007, AIDS RES HUM RETROV, V23, P1139, DOI 10.1089/aid.2007.0056; Lee CC, 2009, HIV MED, V10, P370, DOI 10.1111/j.1468-1293.2009.00698.x; Li Y, 2010, JAIDS-J ACQ IMM DEF, V54, P129, DOI 10.1097/QAI.0b013e3181d82ce5; Liu YL, 2012, J OCUL PHARMACOL TH, V28, P1, DOI 10.1089/jop.2011.0182; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Ministry of Health, 2012, GLOB AIDS RESP COUNT; Mohamad S, 2012, BRAZ J INFECT DIS, V16, P284, DOI 10.1590/S1413-86702012000300012; Ng OT, 2012, AIDS RES HUM RETROV, V28, P527, DOI [10.1089/aid.2011.0177, 10.1089/AID.2011.0177]; Ng OT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015738; OU CY, 1993, LANCET, V341, P1171, DOI 10.1016/0140-6736(93)91001-3; Robbins KE, 2003, J VIROL, V77, P6359, DOI 10.1128/JVI.77.11.6359-6366.2003; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; SahBandar IN, 2011, AIDS RES HUM RETROV, V27, P97, DOI 10.1089/aid.2010.0163; Sahbandar IN, 2009, AIDS RES HUM RETROV, V25, P637, DOI 10.1089/aid.2008.0266; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Saraswathy T. S., 2000, Southeast Asian Journal of Tropical Medicine and Public Health, V31, P283; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tee KK, 2005, AIDS RES HUM RETROV, V21, P1046, DOI 10.1089/aid.2005.21.1046; Tee KK, 2005, AIDS, V19, P119, DOI 10.1097/00002030-200501280-00003; Tee KK, 2006, JAIDS-J ACQ IMM DEF, V43, P523; Tee KK, 2009, VIROLOGY, V387, P229, DOI 10.1016/j.virol.2009.02.020; Thomson MM, 2002, LANCET INFECT DIS, V2, P461, DOI 10.1016/S1473-3099(02)00343-2; Tovanabutra S, 2001, AIDS, V15, P1063, DOI 10.1097/00002030-200105250-00018; Tovanabutra S, 2003, AIDS RES HUM RETROV, V19, P561, DOI 10.1089/088922203322230923; Tovanabutra S, 2004, AIDS RES HUM RETROV, V20, P465, DOI 10.1089/088922204323087705; Tovanabutra S, 2007, AIDS RES HUM RETROV, V23, P829, DOI 10.1089/aid.2006.0300; Wang B, 2007, VIROLOGY, V367, P288, DOI 10.1016/j.virol.2007.05.033; WENIGER BG, 1994, AIDS, V8, pS13; Weniger BG, 1996, NEW ENGL J MED, V335, P343, DOI 10.1056/NEJM199608013350510; Wolfe D, 2010, LANCET, V376, P355, DOI 10.1016/S0140-6736(10)60832-X; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154	49	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62560	10.1371/journal.pone.0062560	http://dx.doi.org/10.1371/journal.pone.0062560			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667490	gold, Green Submitted, Green Published			2022-12-25	WOS:000319654700048
J	Dusetzina, SB; Mack, CD; Sturmer, T				Dusetzina, Stacie B.; Mack, Christina D.; Stuermer, Til			Propensity Score Estimation to Address Calendar Time-Specific Channeling in Comparative Effectiveness Research of Second Generation Antipsychotics	PLOS ONE			English	Article							TRENDS; RISK	Background: Channeling occurs when a medication and its potential comparators are selectively prescribed based on differences in underlying patient characteristics. Drug safety advisories can provide new information regarding the relative safety or effectiveness of a drug product which might increase selective prescribing. In particular, when reported adverse effects vary among drugs within a therapeutic class, clinicians may channel patients toward or away from a drug based on the patient's underlying risk for an adverse outcome. If channeling is not identified and appropriately managed it might lead to confounding in observational comparative effectiveness studies. Objective: To demonstrate channeling among new users of second generation antipsychotics following a Food and Drug Administration safety advisory and to evaluate the impact of channeling on cardiovascular risk estimates over time. Data Source: Florida Medicaid data from 2001-2006. Study Design: Retrospective cohort of adults initiating second generation antipsychotics. We used propensity scores to match olanzapine initiators with other second generation antipsychotic initiators. To evaluate channeling away from olanzapine following an FDA safety advisory, we estimated calendar time-specific propensity scores. We compare the performance of these calendar time-specific propensity scores with conventionally-estimated propensity scores on estimates of cardiovascular risk. Principal Findings: Increased channeling away from olanzapine was evident for some, but not all, cardiovascular risk factors and corresponded with the timing of the FDA advisory. Covariate balance was optimized within period and across all periods when using the calendar time-specific propensity score. Hazard ratio estimates for cardiovascular outcomes did not differ across models (Conventional PS: 0.97, 95% CI: 0.81-3.18 versus calendar time-specific PS: 0.93, 95% CI: 0.77-3.04). Conclusions: Changes in channeling over time was evident for several covariates but had limited impact on cardiovascular risk estimates, possibly due to unmeasured confounding. Although calendar time-specific propensity scores appear to improve covariate balance, the impact on comparative effectiveness results is limited in this setting.	[Dusetzina, Stacie B.] Univ N Carolina, Sch Med, Div Gen Med & Clin Epidemiol, Chapel Hill, NC 27515 USA; [Dusetzina, Stacie B.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Hlth Policy & Management, Chapel Hill, NC USA; [Dusetzina, Stacie B.] Univ N Carolina, Cecil G Sheps Ctr Hlth Serv Res, Chapel Hill, NC USA; [Mack, Christina D.; Stuermer, Til] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Dusetzina, SB (corresponding author), Univ N Carolina, Sch Med, Div Gen Med & Clin Epidemiol, Chapel Hill, NC 27515 USA.	Dusetzina@unc.edu	Stürmer, Til/AAB-5459-2022; Dusetzina, Stacie B/J-6682-2019	Dusetzina, Stacie B/0000-0002-3907-9196	Agency for Healthcare Research and Quality [RO1 HS0189960]; NIMH; Harvard Medical School, Department of Health Care Policy [T32MH019733-17]; Christina D. Mack: Fellowship; Merck; NIH [R01 AG023178]; National Institute on Aging at the NIH [AG023178, R01 AG018833]; UNC-DEcIDE center from AHRQ; Center for Pharmacoepidemiology; Department of Epidemiology; UNC; GSK; Sanofi; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH019733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018833, R01AG023178] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Harvard Medical School, Department of Health Care Policy; Christina D. Mack: Fellowship; Merck(Merck & Company); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging at the NIH; UNC-DEcIDE center from AHRQ; Center for Pharmacoepidemiology; Department of Epidemiology; UNC; GSK(GlaxoSmithKline); Sanofi; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Agency for Healthcare Research and Quality (RO1 HS0189960). The funding sources had no role in the design and conduct of the study; collection, management, analysis, or interpretation of the data; and preparation, review, or approval of the manuscript for publication.; The authors have read the journal's policy and have the following conflicts: Stacie B. Dusetzina: Received funding through a Ruth L. Kirschstein-National Service Research Award Post-Doctoral Traineeship sponsored by NIMH and Harvard Medical School, Department of Health Care Policy, Grant No. T32MH019733-17. The funding sources had no role in the design and conduct of the study; collection, management, analysis, or interpretation of the data; and preparation, review, or approval of the manuscript for publication. Dr. Dusetzina has no conflicts of interest. Christina D. Mack: Fellowship, Merck; NIH grant R01 AG023178; Consultant to Roche and AHRQ through Outcome, A Quintiles Company. No perceived conflicts of interest. Til Sturmer: R01 AG023178, R01 AG018833 from the National Institute on Aging at the NIH; UNC-DEcIDE center from AHRQ; salary support from Center for Pharmacoepidemiology, Department of Epidemiology, UNC, and unrestricted research and other grants from pharmaceutical companies (GSK, Merck, Sanofi) to UNC. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Amer Diabet Assoc, 2004, DIABETES CARE, V27, P596, DOI 10.2337/diacare.27.2.596; Amiel JM, 2008, CURR OPIN PSYCHIATR, V21, P613, DOI 10.1097/YCO.0b013e328314b74b; Anand G, 2003, WALL STREET J; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Brookhart MA, 2006, AM J EPIDEMIOL, V163, P1149, DOI 10.1093/aje/kwj149; Center for Medicare and Medicaid Services, 2007, MED AN EXTR CHARTB; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Constantine R, 2008, PSYCHIAT SERV, V59, P1162, DOI 10.1176/appi.ps.59.10.1162; Donohue JM, 2009, HEALTH AFFAIR, V28, P746, DOI 10.1377/hlthaff.28.3.746; Dusetzina SB, 2012, PHARMACOEPIDEM DR S, V21, P1251, DOI 10.1002/pds.3272; Ellis AR, 2013, PHARMACOEPIDEM DR S, V22, P138, DOI 10.1002/pds.3396; F.D.A, 2004, FDA SAFETY NEWS; F.D.A, 2004, MEDWATCH SAF INF GEO; F.D.A, 2005, MEDWATCH SAF INF AT; Frank RG, 2009, HEALTH AFFAIR, V28, P649, DOI 10.1377/hlthaff.28.3.649; Goode E, 2003, NEW YORK TIMES; Hughes MD, 2007, NEW ENGL J MED, V356, P1705, DOI 10.1056/NEJMp078038; Koro CE, 2002, ARCH GEN PSYCHIAT, V59, P1021, DOI 10.1001/archpsyc.59.11.1021; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Mack CD, 2013, PHARMACOEPIDEM DR S, V22, P810, DOI 10.1002/pds.3386; Morrato EH, 2010, ARCH GEN PSYCHIAT, V67, P17, DOI 10.1001/archgenpsychiatry.2009.179; Parsons L, 2001, REDUCING BIAS PROPEN; PETRI H, 1991, STAT MED, V10, P577, DOI 10.1002/sim.4780100409; Signorovitch J, 2011, J CLIN PSYCHIAT, V72, P787, DOI 10.4088/JCP.09m05868yel; Sox HC, 2009, ANN INTERN MED, V151, P203, DOI 10.7326/0003-4819-151-3-200908040-00125	25	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63973	10.1371/journal.pone.0063973	http://dx.doi.org/10.1371/journal.pone.0063973			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667693	Green Submitted, Green Published, gold			2022-12-25	WOS:000319654700197
J	Jia, CC; Wang, TT; Liu, W; Fu, BS; Hua, X; Wang, GY; Li, TJ; Li, X; Wu, XY; Tai, Y; Zhou, J; Chen, GH; Zhang, Q				Jia, Chang-Chang; Wang, Tian-Tian; Liu, Wei; Fu, Bin-Sheng; Hua, XueFeng; Wang, Guo-Ying; Li, Tuan-Jie; Li, Xing; Wu, Xiang-Yuan; Tai, Yan; Zhou, Jie; Chen, Gui-Hua; Zhang, Qi			Cancer-Associated Fibroblasts from Hepatocellular Carcinoma Promote Malignant Cell Proliferation by HGF Secretion	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; TUMOR-GROWTH; MESENCHYMAL TRANSITION; STROMAL FIBROBLASTS; PROGRESSION; BREAST; ACTIVATION; MICROENVIRONMENT; PATHWAYS; MODEL	Cancer-associated fibroblasts (CAFs) are reported to support tumorigenesis by stimulating angiogenesis, cancer cell proliferation, and invasion in most solid tumors. However, the roles of CAFs in the liver cancer microenvironment have not been thoroughly studied. In our previous study, we successfully isolated CAFs from hepatocellular carcinoma (HCC) (H-CAFs) and proved that H-CAFs suppressed the activation of NK cells and thereby created favorable conditions for HCC progression. In our present study, we found that the proliferation of MHCC97L and Hep3B cells was significantly promoted by treatment with conditioned medium from H-CAFs. Pathological analysis also revealed that H-CAFs increased the proportion of Ki-67 (+) malignant cells and prevented them from undergoing necrosis. Moreover, the concentration of hepatocyte growth factor (HGF) cytokine in the conditioned medium of H-CAFs was higher than conditioned medium from normal skin fibroblasts (NSFs). Anti-HGF significantly reduced the proliferation-promoting capability of H-CAFs. In addition, we found that the abundance of H-CAFs correlated positively with tumor size. These results indicate that H-CAFs are an important factor for promoting the growth of HCC in vitro and in vivo, and that HGF plays a key role in HCC proliferation induced by H-CAFs.	[Jia, Chang-Chang; Fu, Bin-Sheng; Hua, XueFeng; Wang, Guo-Ying; Li, Tuan-Jie; Tai, Yan; Chen, Gui-Hua] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Hepat Surg, Guangzhou 510275, Guangdong, Peoples R China; [Jia, Chang-Chang; Wang, Tian-Tian; Liu, Wei; Hua, XueFeng; Wang, Guo-Ying; Li, Tuan-Jie; Tai, Yan; Chen, Gui-Hua; Zhang, Qi] Guangdong Prov Key Lab Liver Dis Res, Guangzhou, Guangdong, Peoples R China; [Wang, Tian-Tian; Li, Xing; Wu, Xiang-Yuan] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Qi] Sun Yat Sen Univ, Affiliated Hosp 3, Cell Gene Therapy Translat Med Res Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Zhou, Jie] Southern Med Univ, Dept Hepatobiliary Surg, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Southern Medical University - China	Zhou, J (corresponding author), Southern Med Univ, Dept Hepatobiliary Surg, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China.	zhoujie01@medmail.com.cn; keekee77@126.com	LI, TUANJIE/S-3903-2018	LI, TUANJIE/0000-0002-5540-6345	State 973 National Basic Research Program of China [2009CB522404]; National Natural Science Foundation of China [NSFC-30972914, 81000936, 81172036, 81170451, 81170452]; 985 Project [82000-3281901]; Fundamental Research Funds for the Central Universities [10ykpy05]; State Key Projects on Infection Diseases of China [2012ZX10002016-023, 2012ZX10002010-001-007]; National Natural Science Foundation of Guangdong Province [10151008901000208]; Key project of Medical Science in Sun Yat-sen University [10YKJC03]	State 973 National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 985 Project(Jilin UniversityXiamen University); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); State Key Projects on Infection Diseases of China; National Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Key project of Medical Science in Sun Yat-sen University	This work was supported by: State 973 National Basic Research Program of China (2009CB522404), National Natural Science Foundation of China (NSFC-30972914, 81000936, 81172036, 81170451, 81170452), 985 Project (82000-3281901), Fundamental Research Funds for the Central Universities (10ykpy05), State Key Projects on Infection Diseases of China (2012ZX10002016-023, 2012ZX10002010-001-007), National Natural Science Foundation of Guangdong Province (10151008901000208) as well as Key project of Medical Science in Sun Yat-sen University (10YKJC03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann T, 2009, CANCER SCI, V100, P646, DOI 10.1111/j.1349-7006.2009.01087.x; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Dong G, 2001, CANCER RES, V61, P5911; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Fu L, 2011, GUT, V60, P1635, DOI 10.1136/gut.2011.241638; Giulianelli S, 2008, INT J CANCER, V123, P2518, DOI 10.1002/ijc.23802; Gonda TA, 2010, SEMIN CELL DEV BIOL, V21, P2, DOI 10.1016/j.semcdb.2009.10.001; Haviv I, 2009, CELL CYCLE, V8, P589, DOI 10.4161/cc.8.4.7669; Hawsawi NM, 2008, CANCER RES, V68, P2717, DOI 10.1158/0008-5472.CAN-08-0192; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Jiang WG, 2005, CRIT REV ONCOL HEMAT, V53, P35, DOI 10.1016/j.critrevonc.2004.09.004; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Koukourakis MI, 2006, CANCER RES, V66, P632, DOI 10.1158/0008-5472.CAN-05-3260; Li Q, 2011, AM J PATHOL, V179, P1483, DOI 10.1016/j.ajpath.2011.05.060; Li TJ, 2012, CANCER LETT, V318, P154, DOI 10.1016/j.canlet.2011.12.020; Liao D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007965; Mazzocca A, 2011, HEPATOLOGY, V54, P920, DOI 10.1002/hep.24485; Ostman A, 2009, CURR OPIN GENET DEV, V19, P67, DOI 10.1016/j.gde.2009.01.003; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Paland N, 2009, MOL CANCER RES, V7, P1212, DOI 10.1158/1541-7786.MCR-09-0073; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Rasanen K, 2010, EXP CELL RES, V316, P2713, DOI 10.1016/j.yexcr.2010.04.032; Saito RA, 2010, CANCER RES, V70, P2644, DOI 10.1158/0008-5472.CAN-09-3644; Sonnenberg M, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-364; Spaeth EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004992; Sun R, 2012, ONCOL LETT, V3, P1124, DOI 10.3892/ol.2012.613; Tsukada Y, 2001, J BIOL CHEM, V276, P40968, DOI 10.1074/jbc.M010890200; Vered M, 2010, INT J CANCER, V127, P1356, DOI 10.1002/ijc.25358; Xing F, 2010, FRONT BIOSCI-LANDMRK, V15, P166, DOI 10.2741/3613; Yan XL, 2012, BREAST CANCER RES TR, V132, P153, DOI 10.1007/s10549-011-1577-0; Yuen MF, 2009, J HEPATOL, V50, P80, DOI 10.1016/j.jhep.2008.07.023; Zeisberg EM, 2007, CANCER RES, V67, P10123, DOI 10.1158/0008-5472.CAN-07-3127	32	104	110	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63243	10.1371/journal.pone.0063243	http://dx.doi.org/10.1371/journal.pone.0063243			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667593	gold, Green Published, Green Submitted			2022-12-25	WOS:000319654700123
J	Menke, J; Weber, J; Broz, K; Kistler, HC				Menke, Jon; Weber, Jakob; Broz, Karen; Kistler, H. Corby			Cellular Development Associated with Induced Mycotoxin Synthesis in the Filamentous Fungus Fusarium graminearum	PLOS ONE			English	Article							SUBCELLULAR-LOCALIZATION; PENICILLIN BIOSYNTHESIS; ASPERGILLUS-PARASITICUS; FUNCTIONAL EXPRESSION; GENE; ACTIN; DYNAMICS; REVEALS; ACCUMULATION; CHRYSOGENUM	Several species of the filamentous fungus Fusarium colonize plants and produce toxic small molecules that contaminate agricultural products, rendering them unsuitable for consumption. Among the most destructive of these species is F. graminearum, which causes disease in wheat and barley and often infests the grain with harmful trichothecene mycotoxins. Synthesis of these secondary metabolites is induced during plant infection or in culture in response to chemical signals. Our results show that trichothecene biosynthesis involves a complex developmental process that includes dynamic changes in cell morphology and the biogenesis of novel subcellular structures. Two cytochrome P-450 oxygenases (Tri4p and Tri1p) involved in early and late steps in trichothecene biosynthesis were tagged with fluorescent proteins and shown to co-localize to vesicles we provisionally call "toxisomes.'' Toxisomes, the inferred site of trichothecene biosynthesis, dynamically interact with motile vesicles containing a predicted major facilitator superfamily protein (Tri12p) previously implicated in trichothecene export and tolerance. The immediate isoprenoid precursor of trichothecenes is the primary metabolite farnesyl pyrophosphate. Changes occur in the cellular localization of the isoprenoid biosynthetic enzyme HMG CoA reductase when cultures non-induced for trichothecene biosynthesis are transferred to trichothecene biosynthesis inducing medium. Initially localized in the cellular endomembrane system, HMG CoA reductase, upon induction of trichothecene biosynthesis, increasingly is targeted to toxisomes. Metabolic pathways of primary and secondary metabolism thus may be coordinated and co-localized under conditions when trichothecene biosynthesis occurs.	[Menke, Jon; Weber, Jakob; Kistler, H. Corby] Univ Minnesota, Dept Plant Pathol, St Paul, MN 55108 USA; [Weber, Jakob] Univ Hamburg, Hamburg, Germany; [Broz, Karen; Kistler, H. Corby] ARS, USDA, Cereal Dis Lab, St Paul, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Hamburg; United States Department of Agriculture (USDA)	Kistler, HC (corresponding author), Univ Minnesota, Dept Plant Pathol, St Paul, MN 55108 USA.	hckist@umn.edu	Kistler, Harold/AAC-1645-2019	Kistler, Harold/0000-0001-5312-6297; Broz, Karen/0000-0001-7928-7216	United States Department of Agriculture, Agriculture and Food Research Initiative, National Institute of Food and Agriculture [2010-65108-20642]; United States Wheat and Barley Scab Initiative [FY09-KI-016, FY08-KI-118, FY07-KI-12]	United States Department of Agriculture, Agriculture and Food Research Initiative, National Institute of Food and Agriculture; United States Wheat and Barley Scab Initiative	This work was funded by the United States Department of Agriculture, Agriculture and Food Research Initiative, National Institute of Food and Agriculture award number 2010-65108-20642, as well as the United States Wheat and Barley Scab Initiative awards FY09-KI-016, FY08-KI-118 and FY07-KI-12. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albermann S, 2013, APPL MICROBIOL BIOT, V97, P2979, DOI 10.1007/s00253-012-4377-5; Alexander NJ, 2009, TOXIN REV, V28, P198, DOI 10.1080/15569540903092142; Alexander NJ, 1999, MOL GEN GENET, V261, P977, DOI 10.1007/s004380051046; Bennett JW, 2003, CLIN MICROBIOL REV, V16, P497, DOI 10.1128/CMR.16.3.497-516.2003; Berepiki A, 2011, NAT REV MICROBIOL, V9, P876, DOI 10.1038/nrmicro2666; Chanda A, 2010, EUKARYOT CELL, V9, P1724, DOI 10.1128/EC.00118-10; Chanda A, 2009, P NATL ACAD SCI USA, V106, P19533, DOI 10.1073/pnas.0907416106; Coleman JJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000486; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; Gaffoor I, 2005, EUKARYOT CELL, V4, P1926, DOI 10.1128/EC.4.11.1926-1933.2005; Gardiner DM, 2009, FUNGAL GENET BIOL, V46, P604, DOI 10.1016/j.fgb.2009.04.004; Goswami RS, 2005, PHYTOPATHOLOGY, V95, P1397, DOI 10.1094/PHYTO-95-1397; Hoffmeister D, 2007, NAT PROD REP, V24, P393, DOI 10.1039/b603084j; Honda S, 2009, GENETICS, V182, P11, DOI 10.1534/genetics.108.098707; Hong SY, 2008, APPL ENVIRON MICROB, V74, P6385, DOI 10.1128/AEM.01185-08; Hong SY, 2009, MYCOL RES, V113, P591, DOI 10.1016/j.mycres.2009.01.013; Lee LW, 2004, ARCH MICROBIOL, V181, P204, DOI 10.1007/s00203-003-0643-3; LENDENFELD T, 1993, J BIOL CHEM, V268, P665; Maggio-Hall LA, 2005, MOL PLANT MICROBE IN, V18, P783, DOI 10.1094/MPMI-18-0783; McCormick SP, 2006, CAN J MICROBIOL, V52, P220, DOI 10.1139/W05-124; McCormick SP, 2004, APPL ENVIRON MICROB, V70, P2044, DOI 10.1128/AEM.70.4.2044-2051.2004; McCormick SP, 2006, CAN J MICROBIOL, V52, P636, DOI 10.1139/W06-011; McLaughlin JE, 2009, P NATL ACAD SCI USA, V106, P21883, DOI 10.1073/pnas.0909777106; Meijer WH, 2010, APPL ENVIRON MICROB, V76, P5702, DOI 10.1128/AEM.02327-09; Menke J, 2012, MOL PLANT MICROBE IN, V25, P1408, DOI 10.1094/MPMI-04-12-0081-R; Morton WM, 2000, NAT CELL BIOL, V2, P376, DOI 10.1038/35014075; MULLER WH, 1992, BIOCHIM BIOPHYS ACTA, V1116, P210, DOI 10.1016/0304-4165(92)90118-E; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Pestka JJ, 2005, J TOXICOL ENV HEAL B, V8, P39, DOI 10.1080/10937400590889458; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rosewich UL, 1998, PHYTOPATHOLOGY, V88, P1087, DOI 10.1094/PHYTO.1998.88.10.1087; Roze LV, 2011, FUNGAL GENET BIOL, V48, P35, DOI 10.1016/j.fgb.2010.05.006; Seong K, 2006, FUNGAL GENET BIOL, V43, P34, DOI 10.1016/j.fgb.2005.10.002; Seong KY, 2009, MOL MICROBIOL, V72, P354, DOI 10.1111/j.1365-2958.2009.06649.x; Sprote P, 2009, EUKARYOT CELL, V8, P421, DOI 10.1128/EC.00374-08; Stadler M, 2008, MYCOL RES, V112, P127, DOI 10.1016/j.mycres.2007.12.002; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Teijeira F, 2009, BIOCHEM J, V418, P113, DOI 10.1042/BJ20081180; Yang HC, 2002, P NATL ACAD SCI USA, V99, P751, DOI 10.1073/pnas.022462899	39	70	75	3	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63077	10.1371/journal.pone.0063077	http://dx.doi.org/10.1371/journal.pone.0063077			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667578	gold, Green Published, Green Submitted			2022-12-25	WOS:000319654700110
J	Saraheimo, S; Hepojoki, J; Nurmi, V; Lahtinen, A; Hemmila, I; Vaheri, A; Vapalahti, O; Hedman, K				Saraheimo, Satu; Hepojoki, Jussi; Nurmi, Visa; Lahtinen, Anne; Hemmila, Ilkka; Vaheri, Antti; Vapalahti, Olli; Hedman, Klaus			Time-Resolved FRET-Based Approach for Antibody Detection - A New Serodiagnostic Concept	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; PROBING MOLECULAR-INTERACTIONS; ASSAY	Forster resonance energy transfer (FRET) is a phenomenon widely utilized in biomedical research of macromolecular interactions. In FRET energy is transferred between two fluorophores, the donor and the acceptor. Herein we describe a novel approach utilizing time-resolved FRET (TR-FRET) for the detection of antibodies not only in a solution-phase homogenous assay but also in single- and two-step solid-phase assays. Our method is based on the principle that the Y-shaped immunoglobulin G molecule is able to simultaneously bind two identical antigen molecules. Hence, if a specific IgG is mixed with donor- and acceptor-labeled antigens, the binding of antigens can be measured by TR-FRET. Using donor- and acceptor-labeled streptavidins (SAs) in conjunction with a polyclonal and a monoclonal anti-SA antibody we demonstrate that this approach is fully functional. In addition we characterize the immune complexes responsible for the TR-FRET signal using density gradient ultracentrifugation and solid-phase immunoassays. The homogenous TR-FRET assay described provides a rapid and robust tool for antibody detection, with a wide potential in medical diagnostics.	[Saraheimo, Satu; Hepojoki, Jussi; Nurmi, Visa; Lahtinen, Anne; Vaheri, Antti; Vapalahti, Olli; Hedman, Klaus] Univ Helsinki, Dept Virol, Infect Biol Res Program, Haartman Inst, Helsinki, Finland; [Hemmila, Ilkka] BN Prod & Serv, Finland Lab Div, Turku, Finland; [Vaheri, Antti; Vapalahti, Olli; Hedman, Klaus] Univ Helsinki, Cent Hosp, Lab Div, Helsinki, Finland; [Vapalahti, Olli] Univ Helsinki, Dept Vet Biosci, Helsinki, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki	Saraheimo, S (corresponding author), Univ Helsinki, Dept Virol, Infect Biol Res Program, Haartman Inst, Helsinki, Finland.	satu.saraheimo@helsinki.fi; klaus.hedman@helsinki.fi	Vaheri, Antti/AAV-1523-2020; Hedman, Klaus/D-5379-2009; Hepojoki, Jussi/W-4667-2017	Hepojoki, Jussi/0000-0001-5699-214X; Nurmi, Visa/0000-0001-8052-5592; Vapalahti, Olli/0000-0003-2270-6824; Hepojoki, Satu/0000-0002-0696-1879; Hedman, Klaus/0000-0003-1779-7960	Magnus Ehrnrooth Foundation; Finnish Funding Agency for Technology and Innovation (TEKES) [40140/11]; Foundation for Finnish Inventions; Sigrid Juselius Foundation	Magnus Ehrnrooth Foundation; Finnish Funding Agency for Technology and Innovation (TEKES)(Finnish Funding Agency for Technology & Innovation (TEKES)); Foundation for Finnish Inventions; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	Magnus Ehrnrooth Foundation, the Finnish Funding Agency for Technology and Innovation (TEKES, grant number 40140/11), The Foundation for Finnish Inventions, and Sigrid Juselius Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazin H, 2001, SPECTROCHIM ACTA A, V57, P2197, DOI 10.1016/S1386-1425(01)00493-0; Blomberg K, 1999, CLIN CHEM, V45, P855; Bongini L, 2004, P NATL ACAD SCI USA, V101, P6466, DOI 10.1073/pnas.0400119101; Clegg Robert M., 1995, Current Opinion in Biotechnology, V6, P103, DOI 10.1016/0958-1669(95)80016-6; DIAMANDIS EP, 1988, CLIN BIOCHEM, V21, P139, DOI 10.1016/S0009-9120(88)80104-8; EKINS RP, 1985, PURE APPL CHEM, V57, P473, DOI 10.1351/pac198557030473; EVANGELISTA RA, 1988, CLIN BIOCHEM, V21, P173, DOI 10.1016/0009-9120(88)90006-9; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; HEMMILA I, 1988, SCAND J CLIN LAB INV, V48, P389, DOI 10.3109/00365518809085747; Hepojoki J, 2010, J VIROL, V84, P227, DOI 10.1128/JVI.00481-09; Hildebrandt N, 2007, J BIOMED BIOTECHNOL, DOI 10.1155/2007/79169; Hu LA, 2008, ASSAY DRUG DEV TECHN, V6, P543, DOI 10.1089/adt.2008.152; Huiskonen JT, 2010, J VIROL, V84, P4889, DOI 10.1128/JVI.00057-10; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; Kolb J. M., 1996, J BIOMOL SCREENING, V1, P203; Kramer HEA, 2011, CHEMPHYSCHEM, V12, P555, DOI 10.1002/cphc.201000733; Liu LZ, 2008, ANAL CHEM, V80, P7735, DOI 10.1021/ac801106w; Loura LMS, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00082; MATHIS G, 1995, CLIN CHEM, V41, P1391; MCEWEN CR, 1967, ANAL BIOCHEM, V20, P114, DOI 10.1016/0003-2697(67)90271-0; MORRISON LE, 1988, ANAL BIOCHEM, V174, P101, DOI 10.1016/0003-2697(88)90524-6; Roux KH, 1997, J IMMUNOL, V159, P3372; Sahoo H, 2011, J PHOTOCH PHOTOBIO C, V12, P20, DOI 10.1016/j.jphotochemrev.2011.05.001; Saphire EO, 2002, J MOL BIOL, V319, P9, DOI 10.1016/S0022-2836(02)00244-9; Stenroos K, 1998, CYTOKINE, V10, P495, DOI 10.1006/cyto.1997.0321; WU PG, 1994, ANAL BIOCHEM, V218, P1, DOI 10.1006/abio.1994.1134	26	18	20	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62739	10.1371/journal.pone.0062739	http://dx.doi.org/10.1371/journal.pone.0062739			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667515	gold, Green Published, Green Submitted			2022-12-25	WOS:000319654700059
J	Serre, MC; El Arnaout, T; Brooks, MA; Durand, D; Lisboa, J; Lazar, N; Raynal, B; van Tilbeurgh, H; Quevillon-Cheruel, S				Serre, Marie-Claude; El Arnaout, Toufic; Brooks, Mark A.; Durand, Dominique; Lisboa, Johnny; Lazar, Noureddine; Raynal, Bertrand; van Tilbeurgh, Herman; Quevillon-Cheruel, Sophie			The Carboxy-Terminal alpha N Helix of the Archaeal XerA Tyrosine Recombinase Is a Molecular Switch to Control Site-Specific Recombination	PLOS ONE			English	Article							DNA CLEAVAGE; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; ACTIVE-SITE; INTEGRASE; FLP; SCATTERING; MECHANISM; ULTRACENTRIFUGATION; MACROMOLECULES	Tyrosine recombinases are conserved in the three kingdoms of life. Here we present the first crystal structure of a full-length archaeal tyrosine recombinase, XerA from Pyrococcus abyssi, at 3.0 angstrom resolution. In the absence of DNA substrate XerA crystallizes as a dimer where each monomer displays a tertiary structure similar to that of DNA-bound Tyr-recombinases. Active sites are assembled in the absence of dif except for the catalytic Tyr, which is extruded and located equidistant from each active site within the dimer. Using XerA active site mutants we demonstrate that XerA follows the classical cis-cleavage reaction, suggesting rearrangements of the C-terminal domain upon DNA binding. Surprisingly, XerA C-terminal aN helices dock in cis in a groove that, in bacterial tyrosine recombinases, accommodates in trans aN helices of neighbour monomers in the Holliday junction intermediates. Deletion of the XerA C-terminal aN helix does not impair cleavage of suicide substrates but prevents recombination catalysis. We propose that the enzymatic cycle of XerA involves the switch of the aN helix from cis to trans packing, leading to (i) repositioning of the catalytic Tyr in the active site in cis and (ii) dimer stabilisation via aN contacts in trans between monomers.	[Serre, Marie-Claude] Univ Paris 11, Inst Genet & Microbiol, F-91405 Orsay, France; [El Arnaout, Toufic; Brooks, Mark A.; Durand, Dominique; Lisboa, Johnny; Lazar, Noureddine; van Tilbeurgh, Herman; Quevillon-Cheruel, Sophie] Univ Paris 11, Inst Biochim & Biophys Mol & Cellulaire, Orsay, France; [Serre, Marie-Claude; Durand, Dominique; Quevillon-Cheruel, Sophie] CNRS, F-91405 Orsay, France; [Raynal, Bertrand] Inst Pasteur, Dept Biol Struct & Chim, Paris, France	UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Serre, MC (corresponding author), Univ Paris 11, Inst Genet & Microbiol, F-91405 Orsay, France.	marie-claude.serre@igmors.u-psud.fr; sophie.quevillon-cheruel@u-psud.fr	Lisboa, Johnny/V-9696-2019; Serre, Marie-Claude/B-4159-2008	Lisboa, Johnny/0000-0001-7329-8993; SERRE, Marie-Claude/0000-0002-7899-9833; Brooks, Mark/0000-0003-2614-6115; El Arnaout, Toufic/0000-0003-2570-9668	Centre National de la Recherche Scientifique; University Paris-Sud [UMR8619, UMR8621]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); University Paris-Sud	This work was supported by funds from the Centre National de la Recherche Scientifique and the University Paris-Sud (UMR8619 and UMR8621). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonine PV, 2007, ACTA CRYSTALLOGR D, V63, P1194, DOI 10.1107/S0907444907046148; Aihara H, 2003, MOL CELL, V12, P187, DOI 10.1016/S1097-2765(03)00268-5; Aihara H, 2007, MOL CELL, V27, P901, DOI 10.1016/j.molcel.2007.07.026; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Brookes E, 2010, EUR BIOPHYS J BIOPHY, V39, P423, DOI 10.1007/s00249-009-0418-0; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; CHEN JW, 1992, CELL, V69, P647, DOI 10.1016/0092-8674(92)90228-5; Chen Y, 2000, MOL CELL, V6, P885, DOI 10.1016/S1097-2765(05)00088-2; Cheng CH, 1998, CELL, V92, P841, DOI 10.1016/S0092-8674(00)81411-7; Conway AB, 2003, J MOL BIOL, V326, P425, DOI 10.1016/S0022-2836(02)01370-0; Cortez D, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001166; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Duggin IG, 2011, EMBO J, V30, P145, DOI 10.1038/emboj.2010.301; Eilers BJ, 2012, J VIROL, V86, P8309, DOI 10.1128/JVI.00547-12; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ghosh K, 2007, J BIOL CHEM, V282, P24004, DOI 10.1074/jbc.M703283200; Gibb B, 2010, NUCLEIC ACIDS RES, V38, P5817, DOI 10.1093/nar/gkq384; Gopaul DN, 1998, EMBO J, V17, P4175, DOI 10.1093/emboj/17.14.4175; Grindley NDF, 2006, ANNU REV BIOCHEM, V75, P567, DOI 10.1146/annurev.biochem.73.011303.073908; Guo F, 1997, NATURE, V389, P40, DOI 10.1038/37925; Hickman AB, 1997, CELL, V89, P227, DOI 10.1016/S0092-8674(00)80202-0; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jayaram M, 1997, SCIENCE, V276, P49, DOI 10.1126/science.276.5309.49; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kamadurai HB, 2008, ACTA CRYSTALLOGR F, V64, P470, DOI 10.1107/S174430910801381X; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kwon HJ, 1997, SCIENCE, V276, P126, DOI 10.1126/science.276.5309.126; Lesterlin C, 2004, MOL MICROBIOL, V54, P1151, DOI 10.1111/j.1365-2958.2004.04356.x; Letzelter C, 2004, J BIOL CHEM, V279, P28936, DOI 10.1074/jbc.M403971200; MacDonald D, 2006, NATURE, V440, P1157, DOI 10.1038/nature04643; Maupetit J, 2006, NUCLEIC ACIDS RES, V34, pW147, DOI 10.1093/nar/gkl289; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MUSKHELISHVILI G, 1993, MOL GEN GENET, V237, P334, DOI 10.1007/BF00279436; NUNESDUBY SE, 1989, CELL, V59, P197, DOI 10.1016/0092-8674(89)90881-7; Patel A, 2006, J BIOL CHEM, V281, P6030, DOI 10.1074/jbc.M512332200; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Serre MC, 2002, J BIOL CHEM, V277, P16758, DOI 10.1074/jbc.M200707200; SERRE MC, 1992, J MOL BIOL, V225, P621, DOI 10.1016/0022-2836(92)90390-6; Sherratt DJ, 2004, PHILOS T R SOC B, V359, P61, DOI 10.1098/rstb.2003.1365; Spiers AJ, 1999, MOL MICROBIOL, V32, P1031, DOI 10.1046/j.1365-2958.1999.01418.x; Subramanya HS, 1997, EMBO J, V16, P5178, DOI 10.1093/emboj/16.17.5178; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Van Duyne G.D., 2002, MOBILE DNA, VII, P93; Zhan ZY, 2012, ACTA CRYSTALLOGR D, V68, P659, DOI 10.1107/S0907444912007202	52	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63010	10.1371/journal.pone.0063010	http://dx.doi.org/10.1371/journal.pone.0063010			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667562	Green Submitted, Green Published, gold			2022-12-25	WOS:000319654700097
J	Singh, P; Sharma, L; Kulothungan, SR; Adkar, BV; Prajapati, RS; Ali, PSS; Krishnan, B; Varadarajan, R				Singh, Pranveer; Sharma, Likhesh; Kulothungan, S. Rajendra; Adkar, Bharat V.; Prajapati, Ravindra Singh; Ali, P. Shaik Syed; Krishnan, Beena; Varadarajan, Raghavan			Effect of Signal Peptide on Stability and Folding of Escherichia coli Thioredoxin	PLOS ONE			English	Article							MALTOSE-BINDING PROTEIN; IMMUNOGLOBULIN LIGHT-CHAINS; MULTIVARIATE DATA-ANALYSIS; AMINO-ACID-SEQUENCE; CONFORMATIONAL TRANSITIONS; GUANIDINE-HYDROCHLORIDE; CHAPERONE SECB; EXPORT; TRANSLOCATION; MEMBRANE	The signal peptide plays a key role in targeting and membrane insertion of secretory and membrane proteins in both prokaryotes and eukaryotes. In E. coli, recombinant proteins can be targeted to the periplasmic space by fusing naturally occurring signal sequences to their N-terminus. The model protein thioredoxin was fused at its N-terminus with malE and pelB signal sequences. While WT and the pelB fusion are soluble when expressed, the malE fusion was targeted to inclusion bodies and was refolded in vitro to yield a monomeric product with identical secondary structure to WT thioredoxin. The purified recombinant proteins were studied with respect to their thermodynamic stability, aggregation propensity and activity, and compared with wild type thioredoxin, without a signal sequence. The presence of signal sequences leads to thermodynamic destabilization, reduces the activity and increases the aggregation propensity, with malE having much larger effects than pelB. These studies show that besides acting as address labels, signal sequences can modulate protein stability and aggregation in a sequence dependent manner.	[Singh, Pranveer; Sharma, Likhesh; Kulothungan, S. Rajendra; Adkar, Bharat V.; Prajapati, Ravindra Singh; Ali, P. Shaik Syed; Krishnan, Beena; Varadarajan, Raghavan] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Varadarajan, Raghavan] Jawaharlal NehruCtr Adv Sci Res, Chem Biol Unit, Bangalore, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Varadarajan, R (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	varadar@mbu.iisc.ernet.in	Adkar, Bharat Vighnahar/AAP-2634-2021	Adkar, Bharat Vighnahar/0000-0002-9168-051X	Department of Biotechnology and Department of Science and Technology, Government of India; University Grant Commission, India	Department of Biotechnology and Department of Science and Technology, Government of India; University Grant Commission, India(University Grants Commission, India)	This work was funded by grants from Department of Biotechnology and Department of Science and Technology, Government of India. P.S. was supported by the DS Kothari post doctoral fellowship of University Grant Commission, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGASHE VR, 1995, BIOCHEMISTRY-US, V34, P3286, DOI 10.1021/bi00010a019; Beena K, 2004, BIOCHEMISTRY-US, V43, P3608, DOI 10.1021/bi0360509; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; Chakrabarti A, 1999, PROTEIN SCI, V8, P2455; Chakraborty K, 2005, BIOCHEMISTRY-US, V44, P14638, DOI 10.1021/bi050921s; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Cristobal S, 1999, EMBO J, V18, P2982, DOI 10.1093/emboj/18.11.2982; Das M, 2007, J MOL BIOL, V372, P1278, DOI 10.1016/j.jmb.2007.07.033; Debarbieux L, 1998, P NATL ACAD SCI USA, V95, P10751, DOI 10.1073/pnas.95.18.10751; DeLisa MP, 2003, P NATL ACAD SCI USA, V100, P6115, DOI 10.1073/pnas.0937838100; Du Plessis DJF, 2011, BBA-BIOMEMBRANES, V1808, P851, DOI 10.1016/j.bbamem.2010.08.016; Edman M, 1999, PROTEINS, V35, P195, DOI 10.1002/(SICI)1097-0134(19990501)35:2<195::AID-PROT6>3.3.CO;2-G; EKLUND H, 1991, PROTEINS, V11, P13, DOI 10.1002/prot.340110103; Fekkes P, 1999, MICROBIOL MOL BIOL R, V63, P161, DOI 10.1128/MMBR.63.1.161-173.1999; Francetic O, 1996, J BACTERIOL, V178, P5954, DOI 10.1128/jb.178.20.5954-5959.1996; Ganesh C, 1997, BIOCHEMISTRY-US, V36, P5020, DOI 10.1021/bi961967b; Ghoshal AK, 1999, BIOCHEM J, V339, P721, DOI 10.1042/0264-6021:3390721; HARDY SJS, 1991, SCIENCE, V251, P439, DOI 10.1126/science.1989077; HARTL FU, 1990, CELL, V63, P269, DOI 10.1016/0092-8674(90)90160-G; HOFFSCHUTE HK, 1994, J BIOL CHEM, V269, P12833; HOLMGREN A, 1972, J BIOL CHEM, V247, P1992; HOLMGREN A, 1968, EUR J BIOCHEM, V6, P475, DOI 10.1111/j.1432-1033.1968.tb00470.x; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Huber D, 2005, P NATL ACAD SCI USA, V102, P18872, DOI 10.1073/pnas.0509583102; Huber D, 2005, J BACTERIOL, V187, P2983, DOI 10.1128/JB.187.9.2983-2991.2005; Humphreys DP, 2000, PROTEIN EXPRES PURIF, V20, P252, DOI 10.1006/prep.2000.1286; IZARD JW, 1994, MOL MICROBIOL, V13, P765, DOI 10.1111/j.1365-2958.1994.tb00469.x; JENG MF, 1994, STRUCTURE, V2, P853, DOI 10.1016/S0969-2126(94)00086-7; JOSEFSSON LG, 1983, METHOD ENZYMOL, V97, P77; KATTI SK, 1990, J MOL BIOL, V212, P167, DOI 10.1016/0022-2836(90)90313-B; KELLEY RF, 1987, BIOCHEMISTRY-US, V26, P1406, DOI 10.1021/bi00379a029; KELLEY RF, 1984, BIOCHEMISTRY-US, V23, P5095, DOI 10.1021/bi00317a003; Krishnan B, 2009, J MOL BIOL, V385, P1243, DOI 10.1016/j.jmb.2008.10.094; Kulothungan SR, 2009, LANGMUIR, V25, P6637, DOI 10.1021/la900198h; KUSUKAWA N, 1989, EMBO J, V8, P3517, DOI 10.1002/j.1460-2075.1989.tb08517.x; LEI SP, 1987, J BACTERIOL, V169, P4379, DOI 10.1128/jb.169.9.4379-4383.1987; MILSTEIN C, 1972, NATURE-NEW BIOL, V239, P117, DOI 10.1038/newbio239117a0; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Pedone E, 2003, BIOCHEM J, V373, P875, DOI 10.1042/BJ20021747; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; RANDALL LL, 1995, TRENDS BIOCHEM SCI, V20, P65, DOI 10.1016/S0968-0004(00)88959-8; RANDALL LL, 1986, CELL, V46, P921, DOI 10.1016/0092-8674(86)90074-7; ROBBENS J, 1995, PROTEIN EXPRES PURIF, V6, P481, DOI 10.1006/prep.1995.1064; SCHATZ PJ, 1990, ANNU REV GENET, V24, P215, DOI 10.1146/annurev.ge.24.120190.001243; Schierle CF, 2003, J BACTERIOL, V185, P5706, DOI 10.1128/JB.185.19.5706-5713.2003; Sheshadri S, 1999, PROTEIN SCI, V8, P1689, DOI 10.1110/ps.8.8.1689; SJOSTROM M, 1987, EMBO J, V6, P823, DOI 10.1002/j.1460-2075.1987.tb04825.x; Slaby I, 1996, J BIOL CHEM, V271, P3091, DOI 10.1074/jbc.271.6.3091; Steiner D, 2006, NAT BIOTECHNOL, V24, P823, DOI 10.1038/nbt1218; Stuart RA, 2000, NATURE, V406, P575, DOI 10.1038/35020668; Tartaglia GG, 2008, CHEM SOC REV, V37, P1395, DOI 10.1039/b706784b; Trovato A, 2007, PROTEIN ENG DES SEL, V20, P521, DOI 10.1093/protein/gzm042; Varadarajan R, 1996, P NATL ACAD SCI USA, V93, P13908, DOI 10.1073/pnas.93.24.13908; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511; Wan EWM, 1998, PROTEIN EXPRES PURIF, V14, P13, DOI 10.1006/prep.1998.0941; WILD J, 1992, GENE DEV, V6, P1165, DOI 10.1101/gad.6.7.1165; WOODY RW, 1995, METHOD ENZYMOL, V246, P34; Zalucki YM, 2011, BBA-BIOMEMBRANES, V1808, P2544, DOI 10.1016/j.bbamem.2011.06.004; Zalucki YM, 2010, BBA-BIOMEMBRANES, V1798, P1244, DOI 10.1016/j.bbamem.2010.03.010; ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331	61	44	48	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63442	10.1371/journal.pone.0063442	http://dx.doi.org/10.1371/journal.pone.0063442			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667620	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000319654700146
J	Southon, A; Greenough, MA; Ganio, G; Bush, AI; Burke, R; Camakaris, J				Southon, Adam; Greenough, Mark A.; Ganio, George; Bush, Ashley I.; Burke, Richard; Camakaris, James			Presenilin Promotes Dietary Copper Uptake	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE; DROSOPHILA-MELANOGASTER; ALZHEIMERS-DISEASE; HOMEOSTASIS; ZINC; DEFICIENCY; TOXICITY; GENE; TRAFFICKING; ABSORPTION	Dietary copper is essential for multicellular organisms. Copper is redox active and required as a cofactor for enzymes such as the antioxidant Superoxide Dismutase 1 (SOD1). Copper dyshomeostasis has been implicated in Alzheimer's disease. Mutations in the presenilin genes encoding PS1 and PS2 are major causes of early-onset familial Alzheimer's disease. PS1 and PS2 are required for efficient copper uptake in mammalian systems. Here we demonstrate a conserved role for presenilin in dietary copper uptake in the fly Drosophila melanogaster. Ubiquitous RNA interference-mediated knockdown of the single Drosophila presenilin (PSN) gene is lethal. However, PSN knockdown in the midgut produces viable flies. These flies have reduced copper levels and are more tolerant to excess dietary copper. Expression of a copper-responsive EYFP construct was also lower in the midgut of these larvae, indicative of reduced dietary copper uptake. SOD activity was reduced by midgut PSN knockdown, and these flies were sensitive to the superoxide-inducing chemical paraquat. These data support presenilin being needed for dietary copper uptake in the gut and so impacting on SOD activity and tolerance to oxidative stress. These results are consistent with previous studies of mammalian presenilins, supporting a conserved role for these proteins in mediating copper uptake.	[Southon, Adam; Greenough, Mark A.; Camakaris, James] Univ Melbourne, Dept Genet, Melbourne, Vic 3010, Australia; [Greenough, Mark A.; Ganio, George; Bush, Ashley I.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic 3010, Australia; [Burke, Richard] Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia	University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Monash University	Camakaris, J (corresponding author), Univ Melbourne, Dept Genet, Melbourne, Vic 3010, Australia.	j.camakaris@unimelb.edu.au	Bush, Ashley/Y-2457-2019; Bush, Ashley I/A-1186-2007; Greenough, Mark/AAK-1615-2021	Bush, Ashley/0000-0001-8259-9069; Bush, Ashley I/0000-0001-8259-9069; Greenough, Mark/0000-0001-6767-0584; Burke, Richard/0000-0003-0086-0767	J.N. Peters Bequest postdoctoral fellowship from the University of Melbourne	J.N. Peters Bequest postdoctoral fellowship from the University of Melbourne	Adam Southon is a recipient of the J.N. Peters Bequest postdoctoral fellowship from the University of Melbourne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arquier N, 2007, CELL METAB, V5, P83, DOI 10.1016/j.cmet.2007.01.006; Balamurugan K, 2006, BBA-MOL CELL RES, V1763, P737, DOI 10.1016/j.bbamcr.2006.05.001; Binks T, 2010, J BIOL INORG CHEM, V15, P621, DOI 10.1007/s00775-010-0629-y; Chung H, 2007, GENETICS, V175, P1071, DOI 10.1534/genetics.106.066597; Dow JAT, 2006, J INSECT PHYSIOL, V52, P365, DOI 10.1016/j.jinsphys.2005.10.007; Greenough MA, 2013, NEUROCHEM INT, V62, P540, DOI 10.1016/j.neuint.2012.08.014; Greenough MA, 2011, J BIOL CHEM, V286, P9776, DOI 10.1074/jbc.M110.163964; Hua HQ, 2011, BIOL CHEM, V392, P919, DOI 10.1515/BC.2011.084; Kirby K, 2008, J BIOL CHEM, V283, P35393, DOI 10.1074/jbc.M807131200; Li A, 2011, CURR ALZHEIMER RES, V8, P313, DOI 10.2174/156720511795563746; Li DX, 2006, AM J HUM GENET, V79, P1030, DOI 10.1086/509900; Marcus DL, 1998, EXP NEUROL, V150, P40, DOI 10.1006/exnr.1997.6750; Maynard CJ, 2006, J INORG BIOCHEM, V100, P952, DOI 10.1016/j.jinorgbio.2006.02.010; Murakami K, 2011, J BIOL CHEM, V286, P44557, DOI 10.1074/jbc.M111.279208; Naruse S, 1998, NEURON, V21, P1213, DOI 10.1016/S0896-6273(00)80637-6; Norgate M, 2006, MOL BIOL CELL, V17, P475, DOI 10.1091/mbc.E05-06-0492; Norgate M, 2007, BIOMETALS, V20, P683, DOI 10.1007/s10534-006-9075-2; Norgate M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014303; Peskin AV, 2000, CLIN CHIM ACTA, V293, P157, DOI 10.1016/S0009-8981(99)00246-6; Phillips MD, 2006, J CELL SCI, V119, P1361, DOI 10.1242/jcs.02839; Sanokawa-Akakura R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008626; Selvaraj A, 2005, GENE DEV, V19, P891, DOI 10.1101/gad.1301805; Southon A, 2004, BIOCHEM J, V383, P303, DOI 10.1042/BJ20040745; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Tuerk MJ, 2009, CURR OPIN GASTROEN, V25, P136, DOI 10.1097/MOG.0b013e328321b395; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; van den Berghe PVE, 2009, NUTR REV, V67, P658, DOI 10.1111/j.1753-4887.2009.00250.x; Vetrivel KS, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-4; Vontas JG, 2001, GENOME, V44, P597, DOI 10.1139/gen-44-4-597; Wang RS, 2006, P NATL ACAD SCI USA, V103, P353, DOI 10.1073/pnas.0509822102; Wang XX, 2009, FASEB J, V23, P2650, DOI 10.1096/fj.08-126649; Wolfe MS, 2009, CHEM REV, V109, P1599, DOI 10.1021/cr8004197; Wong PC, 2000, P NATL ACAD SCI USA, V97, P2886, DOI 10.1073/pnas.040461197; Yu JT, 2009, PROG NEUROBIOL, V89, P240, DOI 10.1016/j.pneurobio.2009.07.009; Zhang M, 2006, FASEB J, V20, P1176, DOI 10.1096/fj.05-5531fje; Zhang XL, 2012, J NEUROSCI, V32, P8633, DOI 10.1523/JNEUROSCI.0556-12.2012	36	21	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62811	10.1371/journal.pone.0062811	http://dx.doi.org/10.1371/journal.pone.0062811			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667524	Green Published, Green Submitted, gold			2022-12-25	WOS:000319654700065
J	Basu, D; Reyes-Mugica, M; Rebbaa, A				Basu, Dipanjan; Reyes-Mugica, Miguel; Rebbaa, Abdelhadi			Histone Acetylation-Mediated Regulation of the Hippo Pathway	PLOS ONE			English	Article							CELL SELF-RENEWAL; PROMOTES APOPTOSIS; EPITHELIAL-CELLS; PROTEIN-KINASE; GROWTH-CONTROL; SIZE CONTROL; LUNG-CANCER; WNT PATHWAY; YAP; PROLIFERATION	The Hippo pathway is a signaling cascade recently found to play a key role in tumorigenesis therefore understanding the mechanisms that regulate it should open new opportunities for cancer treatment. Available data indicate that this pathway is controlled by signals from cell-cell junctions however the potential role of nuclear regulation has not yet been described. Here we set out to verify this possibility and define putative mechanism(s) by which it might occur. By using a luciferase reporter of the Hippo pathway, we measured the effects of different nuclear targeting drugs and found that chromatin-modifying agents, and to a lesser extent certain DNA damaging drugs, strongly induced activity of the reporter. This effect was not mediated by upstream core components (i.e. Mst, Lats) of the Hippo pathway, but through enhanced levels of the Hippo transducer TAZ. Investigation of the underlying mechanism led to the finding that cancer cell exposure to histone deacetylase inhibitors induced secretion of growth factors and cytokines, which in turn activate Akt and inhibit the GSK3 beta associated protein degradation complex in drug-affected as well as in their neighboring cells. Consequently, expression of EMT genes, cell migration and resistance to therapy were induced. These processes were suppressed by using pyrvinium, a recently described small molecule activator of the GSK 3 beta associated degradation complex. Overall, these findings shed light on a previously unrecognized phenomenon by which certain anti-cancer agents may paradoxically promote tumor progression by facilitating stabilization of the Hippo transducer TAZ and inducing cancer cell migration and resistance to therapy. Pharmacological targeting of the GSK3 beta associated degradation complex may thus represent a unique approach to treat cancer.	[Rebbaa, Abdelhadi] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA; UPMC, Childrens Hosp Pittsburgh, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Rebbaa, A (corresponding author), Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA.	abr25@pitt.edu	Basu, Dipanjan/J-8043-2019; Reyes-Mugica, Miguel/C-2483-2008	Basu, Dipanjan/0000-0002-3083-2954; Reyes-Mugica, Miguel/0000-0001-5698-3702	University of Pittsburgh	University of Pittsburgh(University of Pittsburgh)	This work was supported by startup funds from the University of Pittsburgh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Avruch J, 2012, CELL CYCLE, V11, P1090, DOI 10.4161/cc.11.6.19453; Azzolin L, 2012, CELL, V151, P1443, DOI 10.1016/j.cell.2012.11.027; Basu D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052188; Chen HJ, 2011, DEV BIOL, V357, P370, DOI 10.1016/j.ydbio.2011.07.003; Cho HH, 2010, J CELL PHYSIOL, V223, P168, DOI 10.1002/jcp.22024; Chu F, 2008, AGING CELL, V7, P516, DOI 10.1111/j.1474-9726.2008.00403.x; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; de Cristofaro T, 2011, EUR J CANCER, V47, P926, DOI 10.1016/j.ejca.2010.11.008; Grusche FA, 2010, CURR BIOL, V20, pR574, DOI 10.1016/j.cub.2010.05.023; Grzeschik NA, 2010, CURR BIOL, V20, P573, DOI 10.1016/j.cub.2010.01.055; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Harvey KF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011288; Huang W, 2012, J BIOL CHEM, V287, P26245, DOI 10.1074/jbc.M112.382036; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Konsavage Jr WM, 2012, ACTA BIOCH BIOPHYS S; Konsavage WM, 2012, J BIOL CHEM, V287, P11730, DOI 10.1074/jbc.M111.327767; Lai D, 2011, CANCER RES, V71, P2728, DOI 10.1158/0008-5472.CAN-10-2711; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Li XJ, 2012, CARCINOGENESIS, V33, P1302, DOI 10.1093/carcin/bgs181; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Liu YQ, 2010, INVEST OPHTH VIS SCI, V51, P3372, DOI 10.1167/iovs.09-4321; Lyons JP, 2004, EXP CELL RES, V298, P369, DOI 10.1016/j.yexcr.2004.04.036; Mardin BR, 2010, NAT CELL BIOL, V12, P1166, DOI 10.1038/ncb2120; Martin-Belmonte F, 2012, NAT REV CANCER, V12, P23, DOI 10.1038/nrc3169; McCaffrey LM, 2011, TRENDS CELL BIOL, V21, P727, DOI 10.1016/j.tcb.2011.06.005; Miller E, 2012, CHEM BIOL, V19, P955, DOI 10.1016/j.chembiol.2012.07.005; Mirkin BL, 2005, ONCOGENE, V24, P4965, DOI 10.1038/sj.onc.1208671; Mousa SA, 2010, CANCER LETT, V289, P208, DOI 10.1016/j.canlet.2009.08.018; Oh H, 2008, DEVELOPMENT, V135, P1081, DOI 10.1242/dev.015255; Oh H, 2010, TRENDS CELL BIOL, V20, P410, DOI 10.1016/j.tcb.2010.04.005; Pazolli E, 2012, CANCER RES, V72, P2251, DOI 10.1158/0008-5472.CAN-11-3386; Prince HM, 2009, CLIN CANCER RES, V15, P3958, DOI 10.1158/1078-0432.CCR-08-2785; Rebbaa A, 2001, MOL MED, V7, P393, DOI 10.1007/BF03402185; Robinson BS, 2010, CURR BIOL, V20, P582, DOI 10.1016/j.cub.2010.03.019; Salic A, 2000, MOL CELL, V5, P523, DOI 10.1016/S1097-2765(00)80446-3; St John MAR, 1999, NAT GENET, V21, P182, DOI 10.1038/5965; Sudol Marius, 2010, Genes Cancer, V1, P1115, DOI 10.1177/1947601911401911; Thorne CA, 2010, NAT CHEM BIOL, V6, P829, DOI 10.1038/NCHEMBIO.453; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; Varelas X, 2010, DEV CELL, V18, P579, DOI 10.1016/j.devcel.2010.03.007; Wang Y, 2010, CANCER SCI, V101, P1279, DOI 10.1111/j.1349-7006.2010.01511.x; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; XU TA, 1995, DEVELOPMENT, V121, P1053; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang CY, 2009, CANCER RES, V69, P828, DOI 10.1158/0008-5472.CAN-08-2588; Zhang JM, 2008, CANCER RES, V68, P2789, DOI 10.1158/0008-5472.CAN-07-6205; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhao LM, 2010, TISSUE ENG PT A, V16, P725, DOI [10.1089/ten.tea.2009.0495, 10.1089/ten.TEA.2009.0495]; Zhou Z, 2011, ONCOGENE, V30, P2181, DOI 10.1038/onc.2010.606	56	14	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e62478	10.1371/journal.pone.0062478	http://dx.doi.org/10.1371/journal.pone.0062478			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671600	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000321390200024
J	Forristal, CE; Christensen, DR; Chinnery, FE; Petruzzelli, R; Parry, KL; Sanchez-Elsner, T; Houghton, FD				Forristal, Catherine E.; Christensen, David R.; Chinnery, Fay E.; Petruzzelli, Raffaella; Parry, Kate L.; Sanchez-Elsner, Tilman; Houghton, Franchesca D.			Environmental Oxygen Tension Regulates the Energy Metabolism and Self-Renewal of Human Embryonic Stem Cells	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; AMINO-ACID TURNOVER; GLUCOSE-TRANSPORTER; HUMAN BLASTOCYSTS; MOUSE BLASTOCYST; TARGET GENES; EXPRESSION; DIFFERENTIATION; IDENTIFICATION; TRANSCRIPTION	Energy metabolism is intrinsic to cell viability but surprisingly has been little studied in human embryonic stem cells (hESCs). The current study aims to investigate the effect of environmental O-2 tension on carbohydrate utilisation of hESCs. Highly pluripotent hESCs cultured at 5% O-2 consumed significantly more glucose, less pyruvate and produced more lactate compared to those maintained at 20% O-2. Moreover, hESCs cultured at atmospheric O-2 levels expressed significantly less OCT4, SOX2 and NANOG than those maintained at 5% O-2. To determine whether this difference in metabolism was a reflection of the pluripotent state, hESCs were cultured at 5% O-2 in the absence of FGF2 for 16 hours leading to a significant reduction in the expression of SOX2. In addition, these cells consumed less glucose and produced significantly less lactate compared to those cultured in the presence of FGF2. hESCs maintained at 5% O2 were found to consume significantly less O-2 than those cultured in the absence of FGF2, or at 20% (O)2. GLUT1 expression correlated with glucose consumption and using siRNA and chromatin immunoprecipitation was found to be directly regulated by hypoxia inducible factor (HIF)-2 alpha at 5% O-2. In conclusion, highly pluripotent cells associated with hypoxic culture consume low levels of O-2, high levels of glucose and produce large amounts of lactate, while at atmospheric conditions glucose consumption and lactate production are reduced and there is an increase in oxidative metabolism. These data suggest that environmental O-2 regulates energy metabolism and is intrinsic to the self-renewal of hESCs.	[Forristal, Catherine E.; Christensen, David R.; Chinnery, Fay E.; Petruzzelli, Raffaella; Parry, Kate L.; Sanchez-Elsner, Tilman; Houghton, Franchesca D.] Univ Southampton, Fac Med, Ctr Human Dev Stem Cells & Regenerat, Southampton SO9 5NH, Hants, England	University of Southampton	Houghton, FD (corresponding author), Univ Southampton, Fac Med, Ctr Human Dev Stem Cells & Regenerat, Southampton SO9 5NH, Hants, England.	F.D.Houghton@soton.ac.uk	Petruzzelli, Raffaella/ABH-7049-2020; , Catherine/D-9925-2019	Petruzzelli, Raffaella/0000-0003-2868-4486; , Catherine/0000-0002-6304-1286; Houghton, Franchesca/0000-0002-5167-1694; Sanchez-Elsner, Tilman/0000-0003-1915-2410; Christensen, David/0000-0003-4018-3537	Gerald Kerkut Charitable Trust; UK Medical Research Council [G0701153]; Medical Research Council [974249, G0701153] Funding Source: researchfish; MRC [G0701153] Funding Source: UKRI	Gerald Kerkut Charitable Trust; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Gerald Kerkut Charitable Trust (http://www.soton.ac.uk/gktrust/) and the UK Medical Research Council, grant number G0701153 (www.mrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit M, 2003, BIOL REPROD, V68, P2150, DOI 10.1095/biolreprod.102.012583; Brison DR, 2004, HUM REPROD, V19, P2319, DOI 10.1093/humrep/deh409; Chen CT, 2008, STEM CELLS, V26, P960, DOI 10.1634/stemcells.2007-0509; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Draper JS, 2003, ARCH MED RES, V34, P558, DOI 10.1016/j.arcmed.2003.08.006; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; FLIER JS, 1987, J CLIN INVEST, V79, P657, DOI 10.1172/JCI112864; Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011; Forristal CE, 2010, REPRODUCTION, V139, P85, DOI 10.1530/REP-09-0300; Forsyth NR, 2006, CLONING STEM CELLS, V8, P16, DOI 10.1089/clo.2006.8.16; FROEHNER SC, 1988, J NEUROCYTOL, V17, P173, DOI 10.1007/BF01674204; Hayashi M, 2004, J ENDOCRINOL, V183, P145, DOI 10.1677/joe.1.05599; Henderson JK, 2002, STEM CELLS, V20, P329, DOI 10.1634/stemcells.20-4-329; HEWITSON LC, 1993, J EXP ZOOL, V267, P337, DOI 10.1002/jez.1402670310; Houghton FD, 2006, DIFFERENTIATION, V74, P11, DOI 10.1111/j.1432-0436.2006.00052.x; Houghton FD, 2002, HUM REPROD, V17, P999, DOI 10.1093/humrep/17.4.999; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; KAHN BB, 1990, DIABETES CARE, V13, P548, DOI 10.2337/diacare.13.6.548; Kihira Y, 2011, INT J BIOCHEM CELL B, V43, P1602, DOI 10.1016/j.biocel.2011.07.009; Kondoh H, 2007, ANTIOXID REDOX SIGN, V9, P293, DOI 10.1089/ars.2006.1467; Lee SH, 2007, CELL PHYSIOL BIOCHEM, V19, P269, DOI 10.1159/000100646; Lofstedt T, 2007, CELL CYCLE, V6, P919, DOI 10.4161/cc.6.8.4133; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Panopoulos AD, 2012, CELL RES, V22, P168, DOI 10.1038/cr.2011.177; Petruzzelli R, 2010, BRIT J HAEMATOL, V150, P689, DOI 10.1111/j.1365-2141.2010.08303.x; Prigione A, 2010, STEM CELLS, V28, P721, DOI 10.1002/stem.404; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Sathananthan Henry, 2002, Reprod Biomed Online, V4, P56; Seagroves TN, 2001, MOL CELL BIOL, V21, P3436, DOI 10.1128/MCB.21.10.3436-3444.2001; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Tay JI, 1997, HUM REPROD, V12, P2451, DOI 10.1093/humrep/12.11.2451; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Van Blerkom J, 2002, HUM REPROD, V17, P393, DOI 10.1093/humrep/17.2.393; Varum S, 2009, STEM CELL RES, V3, P142, DOI 10.1016/j.scr.2009.07.002; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; Weinmann AS, 2002, METHODS, V26, P37, DOI 10.1016/S1046-2023(02)00006-3; Westfall SD, 2008, STEM CELLS DEV, V17, P869, DOI 10.1089/scd.2007.0240; Wright G, 2003, J BIOL CHEM, V278, P20235, DOI 10.1074/jbc.M301391200; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Zelzer E, 1998, EMBO J, V17, P5085, DOI 10.1093/emboj/17.17.5085	41	56	58	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e62507	10.1371/journal.pone.0062507	http://dx.doi.org/10.1371/journal.pone.0062507			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671606	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000321390200026
J	Jannot, AS; Pelet, A; Henrion-Caude, A; Chaoui, A; Masse-Morel, M; Arnold, S; Sanlaville, D; Ceccherini, I; Borrego, S; Hofstra, RMW; Munnich, A; Bondurand, N; Chakravarti, A; Clerget-Darpoux, F; Amiel, J; Lyonnet, S				Jannot, Anne-Sophie; Pelet, Anna; Henrion-Caude, Alexandra; Chaoui, Asma; Masse-Morel, Marine; Arnold, Stacey; Sanlaville, Damien; Ceccherini, Isabella; Borrego, Salud; Hofstra, Robert M. W.; Munnich, Arnold; Bondurand, Nadege; Chakravarti, Aravinda; Clerget-Darpoux, Francoise; Amiel, Jeanne; Lyonnet, Stanislas			Chromosome 21 Scan in Down Syndrome Reveals DSCAM as a Predisposing Locus in Hirschsprung Disease	PLOS ONE			English	Article							CONGENITAL HEART-DEFECTS; ESTROGEN-RECEPTOR-BETA; NETRIN RECEPTOR; RET ENHANCER; GENE; MUTATION; DISEQUILIBRIUM; HYDROCEPHALUS; ASSOCIATION; EXPRESSION	Hirschsprung disease (HSCR) genetics is a paradigm for the study and understanding of multigenic disorders. Association between Down syndrome and HSCR suggests that genetic factors that predispose to HSCR map to chromosome 21. To identify these additional factors, we performed a dose-dependent association study on chromosome 21 in Down syndrome patients with HSCR. Assessing 10,895 SNPs in 26 Caucasian cases and their parents led to identify two associated SNPs (rs2837770 and rs8134673) at chromosome-wide level. Those SNPs, which were located in intron 3 of the DSCAM gene within a 19 kb-linkage disequilibrium block region were in complete association and are consistent with DSCAM expression during enteric nervous system development. We replicated the association of HSCR with this region in an independent sample of 220 non-syndromic HSCR Caucasian patients and their parents. At last, we provide the functional rationale to the involvement of DSCAM by network analysis and assessment of SOX10 regulation. Our results reveal the involvement of DSCAM as a HSCR susceptibility locus, both in Down syndrome and HSCR isolated cases. This study further ascertains the chromosome-scan dose-dependent methodology used herein as a mean to map the genetic bases of other sub-phenotypes both in Down syndrome and other aneuploidies.	[Jannot, Anne-Sophie; Pelet, Anna; Henrion-Caude, Alexandra; Masse-Morel, Marine; Munnich, Arnold; Clerget-Darpoux, Francoise; Amiel, Jeanne; Lyonnet, Stanislas] Hop Necker Enfants Malad, AP HP, INSERM, U781, Paris, France; [Jannot, Anne-Sophie; Pelet, Anna; Henrion-Caude, Alexandra; Masse-Morel, Marine; Munnich, Arnold; Clerget-Darpoux, Francoise; Amiel, Jeanne; Lyonnet, Stanislas] Univ Paris 05, Dept Genet, Fac Med, Paris, France; [Chaoui, Asma; Bondurand, Nadege] Hop Henri Mondor, INSERM, U955, F-94010 Creteil, France; [Arnold, Stacey; Chakravarti, Aravinda] Johns Hopkins Univ, Sch Med, Ctr Complex Dis Genom, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Sanlaville, Damien] HCL, Serv Genet, Bron, France; [Sanlaville, Damien] Univ Lyon 1, INSERM, CNRS, Equipe TIGER,U1028,UMRS5292, F-69365 Lyon, France; [Ceccherini, Isabella] Ist Giannina Gaslini, Lab Genet Mol, I-16148 Genoa, Italy; [Borrego, Salud] Univ Seville, CSIC, Unidad Gest Clin Genet Reprod & Med Fetal, Inst Biomed Sevilla IBIS,Hosp Univ Virgen Rocio, Seville, Spain; [Borrego, Salud] CIBER Enfermedades Raras, ISCIII, Seville, Spain; [Hofstra, Robert M. W.] Univ Rotterdam, Dept Clin Genet, ErasmusMC, Rotterdam, Netherlands	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Johns Hopkins University; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Genoa; IRCCS Istituto Giannina Gaslini; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Erasmus University Rotterdam; Erasmus MC	Lyonnet, S (corresponding author), Hop Necker Enfants Malad, AP HP, INSERM, U781, Paris, France.	stanislas.lyonnet@inserm.fr	amiel, jeanne/H-3501-2017; Bondurand, Nadege/H-4737-2017; IBIS, REPRODUCCION/P-3399-2015; IBIS, GENETICA/P-3384-2015; Ceccherini, Isabella/P-8195-2014; Lyonnet, Stanislas/H-5483-2017; amiel, jeanne/AGX-1124-2022; Sanlaville, Damien/M-4716-2014; Borrego, Salud/M-6314-2015; Caude, Alexandra A Henrion/I-2778-2016; Clerget-Darpoux, Francoise/I-4825-2017	amiel, jeanne/0000-0001-5973-4728; Bondurand, Nadege/0000-0002-1531-1544; Ceccherini, Isabella/0000-0001-8732-1955; Lyonnet, Stanislas/0000-0001-5426-9417; Sanlaville, Damien/0000-0001-9939-2849; Caude, Alexandra A Henrion/0000-0002-8170-2260; Clerget-Darpoux, Francoise/0000-0003-4816-6619; PELET, Anastella/0000-0002-8353-1725; Hofstra, Robert/0000-0001-7498-3829; Jannot, Anne-Sophie/0000-0002-8001-8539	French National Research Agency (ANR); French National Research Agency (ANR, ERare-HSCR Consortium); Fondation pour la Recherche Medicale (FRM); Fondation Jerome Lejeune; USA National Institutes of Health [R37 HD28088]; Italian Telethon [GGP04257]; Fondo de Investigacion Sanitaria. Instituto de Salud Carlos III [PI10/01290]; Consejeria de Innovacion, Ciencia y Empresa de la Junta de Andalucia [CTS-2590]; NWO Bernoulle Foundation [901-04-225]; Ubbo Emmius Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD028088] Funding Source: NIH RePORTER	French National Research Agency (ANR)(French National Research Agency (ANR)); French National Research Agency (ANR, ERare-HSCR Consortium)(French National Research Agency (ANR)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Fondation Jerome Lejeune; USA National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Telethon(Fondazione Telethon); Fondo de Investigacion Sanitaria. Instituto de Salud Carlos III(Instituto de Salud Carlos III); Consejeria de Innovacion, Ciencia y Empresa de la Junta de Andalucia(Junta de Andalucia); NWO Bernoulle Foundation; Ubbo Emmius Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by the French National Research Agency (ANR, grants MRARE-HirGenet to SL, EvoDevoMut Grant, and ERare-HSCR Consortium to SL, IC, and SB), the Fondation pour la Recherche Medicale (FRM) to SL and JA; Fondation Jerome Lejeune; the USA National Institutes of Health (R37 HD28088 to A. C.); the Italian Telethon (GGP04257 to IC); Fondo de Investigacion Sanitaria. Instituto de Salud Carlos III (PI10/01290) and Consejeria de Innovacion, Ciencia y Empresa de la Junta de Andalucia (CTS-2590) to S. B.; the NWO (901-04-225) Bernoulle Foundation and Ubbo Emmius Foundation to R. M. W. H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affymetrix, 2006, BRLMM IMPR GEN CALL; Amano K, 2009, J NEUROSCI, V29, P2984, DOI 10.1523/JNEUROSCI.3624-08.2009; Amiel J, 2008, J MED GENET, V45, P1, DOI 10.1136/jmg.2007.053959; Anderson RB, 2006, GASTROENTEROLOGY, V130, P1221, DOI 10.1053/j.gastro.2006.01.002; Arnold S, 2009, HUM MUTAT, V30, P771, DOI 10.1002/humu.20944; Bondurand N, 2000, HUM MOL GENET, V9, P1907, DOI 10.1093/hmg/9.13.1907; Bondurand N, 2001, HUM MOL GENET, V10, P2783, DOI 10.1093/hmg/10.24.2783; Britsch S, 1998, GENE DEV, V12, P1825, DOI 10.1101/gad.12.12.1825; Campbell-Thompson M, 2001, J ENDOCRINOL, V171, P65, DOI 10.1677/joe.0.1710065; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Carvalho B, OLIGOCLASSES CLASSES; Carvalho B, PD GENOMEWIDESNP 6 P; de Pontual L, 2007, HUM MUTAT, V28, P790, DOI 10.1002/humu.20517; Emison ES, 2005, NATURE, V434, P857, DOI 10.1038/nature03467; Gabriel SB, 2002, NAT GENET, V31, P89, DOI 10.1038/ng868; Garcia-Barcelo MM, 2009, P NATL ACAD SCI USA, V106, P2694, DOI 10.1073/pnas.0809630105; Gershon Michael D, 2004, Semin Pediatr Surg, V13, P224, DOI 10.1053/j.sempedsurg.2004.10.019; Gershon MD, 2010, TRENDS NEUROSCI, V33, P446, DOI 10.1016/j.tins.2010.06.002; Heanue TA, 2006, P NATL ACAD SCI USA, V103, P6919, DOI 10.1073/pnas.0602152103; Herbarth B, 1998, P NATL ACAD SCI USA, V95, P5161, DOI 10.1073/pnas.95.9.5161; Jiang Y, 2003, DEV BIOL, V258, P364, DOI 10.1016/S0012-1606(03)00136-2; Kazeem GR, 2005, ANN HUM GENET, V69, P329, DOI 10.1046/j.1529-8817.2005.00156.x; Kerstann KF, 2004, GENET EPIDEMIOL, V27, P240, DOI 10.1002/gepi.20019; Korbel JO, 2009, P NATL ACAD SCI USA, V106, P12031, DOI 10.1073/pnas.0813248106; Lin Y, 2008, BIOINFORMATICS, V24, P2665, DOI 10.1093/bioinformatics/btn509; Liu GF, 2009, P NATL ACAD SCI USA, V106, P2951, DOI 10.1073/pnas.0811083106; Liu Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S5-S4; Locke AE, 2010, GENET EPIDEMIOL, V34, P613, DOI 10.1002/gepi.20518; Luzon-Toro B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036524; Ly A, 2008, CELL, V133, P1241, DOI 10.1016/j.cell.2008.05.030; McCallion AS, 2003, COLD SPRING HARB SYM, V68, P373, DOI 10.1101/sqb.2003.68.373; Moore SW, J PEDIAT SURG, V47, P299; Nielsen DM, 1998, AM J HUM GENET, V63, P1531, DOI 10.1086/302114; Okamoto N, 2004, J HUM GENET, V49, P334, DOI 10.1007/s10038-004-0153-4; Okamoto N, 1997, J MED GENET, V34, P670, DOI 10.1136/jmg.34.8.670; Parisi MA, 2002, AM J MED GENET, V108, P51, DOI 10.1002/ajmg.10185; Peirano RI, 2000, NUCLEIC ACIDS RES, V28, P3047, DOI 10.1093/nar/28.16.3047; Peirano RI, 2000, MOL CELL BIOL, V20, P3198, DOI 10.1128/MCB.20.9.3198-3209.2000; PUFFENBERGER EG, 1994, HUM MOL GENET, V3, P1217; Southard-Smith EM, 1998, NAT GENET, V18, P60, DOI 10.1038/ng0198-60; St-Laurent V, 2005, J STEROID BIOCHEM, V94, P23, DOI 10.1016/j.jsbmb.2005.02.001; Stine ZE, HUMAN MOL GENETICS, V20, P3746; Tang CSM, 2012, HUM GENET, V131, P67, DOI 10.1007/s00439-011-1035-4; Wallace AS, 2010, NEUROBIOL DIS, V40, P622, DOI 10.1016/j.nbd.2010.08.006; Xu ZY, 2004, GENET EPIDEMIOL, V26, P125, DOI 10.1002/gepi.10302; Yamakawa K, 1998, HUM MOL GENET, V7, P227, DOI 10.1093/hmg/7.2.227	46	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e62519	10.1371/journal.pone.0062519	http://dx.doi.org/10.1371/journal.pone.0062519			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671607	Green Submitted, Green Published, gold			2022-12-25	WOS:000321390200027
J	Nel, R; Punt, AE; Hughes, GR				Nel, Ronel; Punt, Andre E.; Hughes, George R.			Are Coastal Protected Areas Always Effective in Achieving Population Recovery for Nesting Sea Turtles?	PLOS ONE			English	Article							PELAGIC LONGLINE FISHERY; DERMOCHELYS-CORIACEA; LEATHERBACK TURTLES; CHELONIA-MYDAS; INDIAN-OCEAN; BYCATCH; PACIFIC; MANAGEMENT; ALBATROSSES; BENEFITS	Sea turtles are highly migratory and usually dispersed, but aggregate off beaches during the nesting season, rendering them vulnerable to coastal threats. Consequently, coastal Marine Protection Areas (MPAs) have been used to facilitate the recovery of turtle populations, but the effectiveness of these programs is uncertain as most have been operating for less than a single turtle generation (or<20 yr). South Africa, however, hosts one of the longest running conservation programs, protecting nesting loggerhead (Caretta caretta) and leatherback (Dermochelys coriacea) turtles since 1963 in a series of coastal MPAs. This provides a unique opportunity to evaluate the long-term effect of spatial protection on the abundance of two highly migratory turtle species with different life history characteristics. Population responses were assessed by modeling the number of nests over time in an index area (13 km) and an expanded monitoring area (53 km) with varying survey effort. Loggerhead abundance increased dramatically from similar to 250 to>1700 nests pa (index area) especially over the last decade, while leatherback abundance increased initially similar to 10 to 70 nests pa (index area), but then stabilized. Although leatherbacks have higher reproductive output per female and comparable remigration periods and hatching success to loggerheads, the leatherback population failed to expand. Our results suggest that coastal MPAs can work but do not guarantee the recovery of sea turtle populations as pressures change over time. Causes considered for the lack of population growth include factors in the MPA (expansion into unmonitored areas or incubation environment) of outside of the MPA (including carrying capacity and fishing mortality). Conservation areas for migratory species thus require careful design to account for species-specific needs, and need to be monitored to keep track of changing pressures.	[Nel, Ronel] Nelson Mandela Metropolitan Univ, Dept Zool, Port Elizabeth, South Africa; [Punt, Andre E.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Hughes, George R.] Retired Conservator, Howick, South Africa	Nelson Mandela University; University of Washington; University of Washington Seattle	Nel, R (corresponding author), Nelson Mandela Metropolitan Univ, Dept Zool, Port Elizabeth, South Africa.	Ronel.Nel@nmmu.ac.za		Punt, Andre/0000-0001-8489-2488	South African National Research Foundation/Thuthuka grant; Nelson Mandela Metropolitan University, Port Elizabeth	South African National Research Foundation/Thuthuka grant; Nelson Mandela Metropolitan University, Port Elizabeth	RN was funded by the South African National Research Foundation/Thuthuka grant (www.nrf.ac.za) and a Faculty Grant from Nelson Mandela Metropolitan University, Port Elizabeth. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker GB, 2002, EMU, V102, P71, DOI 10.1071/MU01036; Balazs GH, 2004, MAR BIOL, V145, P1043, DOI 10.1007/s00227-004-1387-6; Baldwin R, 2003, LOGGERHEAD SEA TURTL, P218; Beare D, 2010, NATURWISSENSCHAFTEN, V97, P797, DOI 10.1007/s00114-010-0696-5; Boonzaaier MK, 2011, THESIS N MANDELA MET, P111; Botha M, 2010, THESIS N MANDELA MET, P122; Botsford LW, 2009, REV FISH BIOL FISHER, V19, P69, DOI 10.1007/s11160-008-9092-z; Bourjea J., 2008, Western Indian Ocean Journal of Marine Science, V7, P137; Brazier W, 2012, AFR J MAR SCI, V34, P249, DOI 10.2989/1814232X.2012.709967; Carroll E, 2011, MAR ECOL PROG SER, V432, P257, DOI 10.3354/meps09145; Chaloupka M, 2001, BIOL CONSERV, V102, P235, DOI 10.1016/S0006-3207(01)00106-9; Couturier LIE, 2011, MAR FRESHWATER RES, V62, P628, DOI 10.1071/MF10148; Crawford RJM, 2007, ICES J MAR SCI, V64, P570, DOI 10.1093/icesjms/fsm009; Donlan CJ, 2010, CONSERV BIOL, V24, P1586, DOI 10.1111/j.1523-1739.2010.01541.x; Donoso M, 2010, BIOL CONSERV, V143, P2672, DOI 10.1016/j.biocon.2010.07.011; Dunn DC, 2011, FISH FISH, V12, P110, DOI 10.1111/j.1467-2979.2010.00388.x; Dutton DL, 2005, BIOL CONSERV, V126, P186, DOI 10.1016/j.biocon.2005.05.013; Fennessy ST, 2007, AFR J MAR SCI, V29, P453, DOI 10.2989/AJMS.2007.29.3.12.342; Fossette S, 2008, J EXP MAR BIOL ECOL, V356, P69, DOI 10.1016/j.jembe.2007.12.024; Gaspar P, 2012, MARINE ECOLOGY PROGR; Godley BJ, 2001, BIOL CONSERV, V97, P151, DOI 10.1016/S0006-3207(00)00107-5; Halpern BS, 2003, P ROY SOC B-BIOL SCI, V270, P1871, DOI 10.1098/rspb.2003.2405; Hays GC, 2004, TRENDS ECOL EVOL, V19, P349, DOI 10.1016/j.tree.2004.05.009; Hays GC, 2003, GLOBAL CHANGE BIOL, V9, P642, DOI 10.1046/j.1365-2486.2003.00606.x; Hilborn R, 2004, OCEAN COAST MANAGE, V47, P197, DOI 10.1016/j.ocecoaman.2004.04.001; Hinch PR, 2011, MAR POLICY, V35, P163, DOI 10.1016/j.marpol.2010.09.002; Hughes G.R., 1975, Lammergeyer, VNo. 22, P9; Hughes G.R., 1989, P230; Hughes G.R., 1972, Lammergeyer, V17, P40; HUGHES G. R., 1967, LAMMERGEYER, V7, P55; Hughes G.R., 1980, P288; Hughes G.R., 1967, LAMMERGEYER, V7, P5; Hughes G.R., 1974, SEA TURTLES S E AFRI; Hughes George R., 1996, Chelonian Conservation and Biology, V2, P153; Humber F, 2011, ANIM CONSERV, V14, P175, DOI 10.1111/j.1469-1795.2010.00413.x; Ismar SMH, 2011, WILSON J ORNITHOL, V123, P121, DOI 10.1676/10-072.1; Jensen OP, 2010, PROG OCEANOGR, V86, P176, DOI 10.1016/j.pocean.2010.04.020; Jorgensen SJ, 2010, P ROY SOC B-BIOL SCI, V277, P679, DOI 10.1098/rspb.2009.1155; Koldewey HJ, 2010, MAR POLLUT BULL, V60, P1906, DOI 10.1016/j.marpolbul.2010.10.002; Lauret-Stepler M., 2007, Endangered Species Research, V3, P217, DOI 10.3354/esr003217; Lewison RL, 2007, CONSERV BIOL, V21, P79, DOI 10.1111/j.1523-1739.2006.00592.x; Louzao M, 2011, J APPL ECOL, V48, P121, DOI 10.1111/j.1365-2664.2010.01910.x; Luschi P, 2006, S AFR J SCI, V102, P51; Luschi P, 2003, P ROY SOC B-BIOL SCI, V270, pS129, DOI 10.1098/rsbl.2003.0036; Lynam CP, 2006, CURR BIOL, V16, pR492, DOI 10.1016/j.cub.2006.06.018; Mackley EK, 2010, MAR ECOL PROG SER, V406, P291, DOI 10.3354/meps08532; MAXWELL JA, 1988, S AFR J ZOOL, V23, P342; McAllister HJ, 1965, LAMMERGEYER, V3, P12; McClellan CM, 2009, ECOL APPL, V19, P1660, DOI 10.1890/08-1091.1; Micheli F, 2004, ECOL APPL, V14, P1709, DOI 10.1890/03-5260; Mortimer J.A., 1985, Oryx, V19, P146; Mortimer J. A., 2000, MARINE COASTAL PROTE, P327; Nada M, 2011, ORYX, V45, P143, DOI 10.1017/S0030605310001286; Nel DC, 2002, POLAR BIOL, V25, P81, DOI 10.1007/s003000100315; Nel R, 2010, SEA TURTLES KWAZULU; Okkonen SR, 2011, REMOTE SENS ENVIRON, V115, P2168, DOI 10.1016/j.rse.2011.04.024; Peckham SH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001041; Perrault JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031841; Petersen SL, 2009, AFR J MAR SCI, V31, P87, DOI 10.2989/AJMS.2009.31.1.8.779; Piatt JF, 2006, DEEP-SEA RES PT II, V53, P387, DOI 10.1016/j.dsr2.2006.01.008; Pike DA, 2008, BIOL LETTERS, V4, P704, DOI 10.1098/rsbl.2008.0359; Plug I, 2004, S AFR J SCI, V100, P151; Rakotonirina Berthin, 1994, Oryx, V28, P51; Spotila JR, 2000, NATURE, V405, P529, DOI 10.1038/35014729; Steckenreuter A, 2010, CHELONIAN CONSERV BI, V9, P123, DOI 10.2744/CCB-0763.1; Stewart K, 2011, ECOL APPL, V21, P263, DOI 10.1890/09-1838.1; Thorson JT, 2012, J APPL ECOL, V49, P601, DOI 10.1111/j.1365-2664.2012.02143.x; Tomillo PS, 2008, CONSERV BIOL, V22, P1216, DOI 10.1111/j.1523-1739.2008.00987.x; Tomillo PS, 2009, MAR BIOL, V156, P2021, DOI 10.1007/s00227-009-1234-x; Tuck GN, 2001, J APPL ECOL, V38, P1182, DOI 10.1046/j.0021-8901.2001.00661.x; Van Houtan KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019043; Videira EJS, 2011, ANN REP 2010 11 AICM; Wakefield ED, 2011, ECOL MONOGR, V81, P141, DOI 10.1890/09-0763.1; Walker Ryan C.J., 2005, Western Indian Ocean Journal of Marine Science, V4, P219; Wallace BP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024510; Wallace BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015465; Witt MJ, 2009, BIOL CONSERV, V142, P1719, DOI 10.1016/j.biocon.2009.03.009; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; WOOD VE, 1986, BIOL CONSERV, V37, P321, DOI 10.1016/0006-3207(86)90076-5; Zbinden Judith A., 2007, Endangered Species Research, V3, P305, DOI 10.3354/esr00058	80	44	45	0	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e63525	10.1371/journal.pone.0063525	http://dx.doi.org/10.1371/journal.pone.0063525			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23671683	gold, Green Submitted, Green Published			2022-12-25	WOS:000321202100071
J	Hackel, D; Pflucke, D; Neumann, A; Viebahn, J; Mousa, S; Wischmeyer, E; Roewer, N; Brack, A; Rittner, HL				Hackel, Dagmar; Pfluecke, Diana; Neumann, Annick; Viebahn, Johannes; Mousa, Shaaban; Wischmeyer, Erhard; Roewer, Norbert; Brack, Alexander; Rittner, Heike Lydia			The Connection of Monocytes and Reactive Oxygen Species in Pain	PLOS ONE			English	Article							OPIOID-PEPTIDES; SENSORY NEURONS; NADPH OXIDASE; ARTHRITIS; RECRUITMENT; ACTIVATION; RECEPTOR; RELEASE; IDENTIFICATION; TOLERANCE	The interplay of specific leukocyte subpopulations, resident cells and proalgesic mediators results in pain in inflammation. Proalgesic mediators like reactive oxygen species (ROS) and downstream products elicit pain by stimulation of transient receptor potential (TRP) channels. The contribution of leukocyte subpopulations however is less clear. Local injection of neutrophilic chemokines elicits neutrophil recruitment but no hyperalgesia in rats. In meta-analyses the monocytic chemoattractant, CCL2 (monocyte chemoattractant protein-1; MCP-1), was identified as an important factor in the pathophysiology of human and animal pain. In this study, intraplantar injection of CCL2 elicited thermal and mechanical pain in Wistar but not in Dark Agouti (DA) rats, which lack p47(phox), a part of the NADPH oxidase complex. Inflammatory hyperalgesia after complete Freund's adjuvant (CFA) as well as capsaicin-induced hyperalgesia and capsaicin-induced current flow in dorsal root ganglion neurons in DA were comparable to Wistar rats. Macrophages from DA expressed lower levels of CCR2 and thereby migrated less towards CCL2 and formed limited amounts of ROS in vitro and 4-hydroxynonenal (4-HNE) in the tissue in response to CCL2 compared to Wistar rats. Local adoptive transfer of peritoneal macrophages from Wistar but not from DA rats reconstituted CCL2-triggered hyperalgesia in leukocyte-depleted DA and Wistar rats. A pharmacological stimulator of ROS production (phytol) restored CCL2-induced hyperalgesia in vivo in DA rats. In Wistar rats, CCL2-induced hyperalgesia was completely blocked by superoxide dismutase (SOD), catalase or tempol. Likewise, inhibition of NADPH oxidase by apocynin reduced CCL2-elicited hyperalgesia but not CFA-induced inflammatory hyperalgesia. In summary, we provide a link between CCL2, CCR2 expression on macrophages, NADPH oxidase, ROS and the development CCL2-triggered hyperalgesia, which is different from CFA-induced hyperalgesia. The study further supports the impact of CCL2 and ROS as potential targets in pain therapy.	[Hackel, Dagmar; Pfluecke, Diana; Neumann, Annick; Roewer, Norbert; Brack, Alexander; Rittner, Heike Lydia] Univ Klinikum, Klin & Poliklin Anaesthesiol, Wurzburg, Germany; [Hackel, Dagmar] Charite Univ Med Berlin, Klin Anesthaesiol MS Operat Intens Med, Berlin, Germany; [Viebahn, Johannes; Wischmeyer, Erhard] Univ Wurzburg, Inst Physiol, Wurzburg, Germany; [Mousa, Shaaban] Charite Univ Med Berlin, Klin Anaesthesiol, Berlin, Germany	University of Wurzburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Wurzburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Rittner, HL (corresponding author), Univ Klinikum, Klin & Poliklin Anaesthesiol, Wurzburg, Germany.	rittner_h@klinik.uni-wuerzburg.de	RIttner, Heike/AAC-6523-2019	RIttner, Heike/0000-0003-4867-0188	Interdisciplinary Center of Clinical Studies University of Wuerzburg [N-113]; German Research Foundation (DFG); University of Wuerzburg	Interdisciplinary Center of Clinical Studies University of Wuerzburg; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This study was supported by the Interdisciplinary Center of Clinical Studies University of Wuerzburg N-113. This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbadie C, 2003, P NATL ACAD SCI USA, V100, P7947, DOI 10.1073/pnas.1331358100; Andersson DA, 2008, J NEUROSCI, V28, P2485, DOI 10.1523/JNEUROSCI.5369-07.2008; Aukrust P, 2001, J AM COLL CARDIOL, V37, P485, DOI 10.1016/S0735-1097(00)01110-4; Azuma EK, 1996, EXP HEMATOL, V24, P169; Brack A, 2004, ANESTHESIOLOGY, V100, P149, DOI 10.1097/00000542-200401000-00024; Cao L, 2012, J IMMUNOL, V189, P3724, DOI 10.4049/jimmunol.1201313; Cathcart MK, 2004, ARTERIOSCL THROM VAS, V24, P23, DOI 10.1161/01.ATV.0000097769.47306.12; Cunha TM, 2005, P NATL ACAD SCI USA, V102, P1755, DOI 10.1073/pnas.0409225102; Dimitrijevic M, 2001, BRAIN BEHAV IMMUN, V15, P255, DOI 10.1006/brbi.2000.0599; Dobler T, 2007, J PHYSIOL-LONDON, V585, P867, DOI 10.1113/jphysiol.2007.145649; Doyle T, 2011, PAIN, V152, P643, DOI 10.1016/j.pain.2010.12.011; Endres-Becker J, 2007, MOL PHARMACOL, V71, P12, DOI 10.1124/mol.106.026740; Fidanboylu M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025212; Hackel D, 2011, J NEUROIMMUNOL, V230, P65, DOI 10.1016/j.jneuroim.2010.08.027; Heo SK, 2008, BIOCHEM BIOPH RES CO, V371, P834, DOI 10.1016/j.bbrc.2008.04.184; Hultqvist M, 2007, J IMMUNOL, V179, P1431, DOI 10.4049/jimmunol.179.3.1431; Hultqvist M, 2006, PLOS MED, V3, P1625, DOI 10.1371/journal.pmed.0030348; Ibi M, 2008, J NEUROSCI, V28, P9486, DOI 10.1523/JNEUROSCI.1857-08.2008; Juniantito V, 2010, HISTOL HISTOPATHOL, V25, P985, DOI 10.14670/HH-25.985; Keeble JE, 2009, PAIN, V141, P135, DOI 10.1016/j.pain.2008.10.025; Khattab MM, 2006, EUR J PHARMACOL, V548, P167, DOI 10.1016/j.ejphar.2006.08.007; Kuiper JWP, 2011, BLOOD, V118, P6164, DOI 10.1182/blood-2010-09-310383; LaCroix-Fralish ML, 2011, PAIN, V152, P1888, DOI 10.1016/j.pain.2011.04.014; Miletic T, 2007, IMMUNOBIOLOGY, V212, P95, DOI 10.1016/j.imbio.2006.11.012; Mousa SA, 2010, BRAIN BEHAV IMMUN, V24, P1310, DOI 10.1016/j.bbi.2010.06.008; Olofsson P, 2003, NAT GENET, V33, P25, DOI 10.1038/ng1058; Qin XM, 2005, J NEUROSCI RES, V82, P51, DOI 10.1002/jnr.20612; Quick ML, 2012, AM J PHYSIOL-REG I, V303, pR580, DOI 10.1152/ajpregu.00240.2012; Rattan V, 1997, AM J PHYSIOL-ENDOC M, V273, pE369, DOI 10.1152/ajpendo.1997.273.2.E369; Rittner HL, 2008, BRIT J ANAESTH, V101, P40, DOI 10.1093/bja/aen078; Rittner HL, 2007, BRAIN BEHAV IMMUN, V21, P1021, DOI 10.1016/j.bbi.2007.05.002; Rittner HL, 2006, FASEB J, V20, P2627, DOI 10.1096/fj.06-6077fje; Rittner HL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000362; Rittner HL, 2006, J LEUKOCYTE BIOL, V79, P1022, DOI 10.1189/jlb.0805452; Rittner HL, 2006, J LEUKOCYTE BIOL, V80, P729, DOI 10.1189/jlb.0506337; Rittner HL, 2001, ANESTHESIOLOGY, V95, P500, DOI 10.1097/00000542-200108000-00036; ROLLINS BJ, 1991, BLOOD, V78, P1112; Schwartz ES, 2009, J NEUROSCI, V29, P159, DOI 10.1523/JNEUROSCI.3792-08.2009; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Trevisani M, 2007, P NATL ACAD SCI USA, V104, P13519, DOI 10.1073/pnas.0705923104; White FA, 2005, P NATL ACAD SCI USA, V102, P14092, DOI 10.1073/pnas.0503496102; Xu XJ, 2001, PAIN, V89, P135, DOI 10.1016/S0304-3959(00)00356-0; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4; Zollner C, 2008, J CLIN INVEST, V118, P1065, DOI 10.1172/JCI25911	44	52	52	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63564	10.1371/journal.pone.0063564	http://dx.doi.org/10.1371/journal.pone.0063564			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658840	Green Published, gold			2022-12-25	WOS:000321200500077
J	Nielsen, MJ; Andersen, CBF; Moestrup, SK				Nielsen, Marianne Jensby; Andersen, Christian Brix Folsted; Moestrup, Soren Kragh			CD163 Binding to Haptoglobin-Hemoglobin Complexes Involves a Dual-point Electrostatic Receptor-Ligand Pairing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-RICH DOMAIN; SCAVENGER; RECOGNITION; LIPOPROTEIN; REVEALS; PROTEIN; CHAIN; MICE	Formation of the haptoglobin (Hp)-hemoglobin (Hb) complex in human plasma leads to a high affinity recognition by the endocytic macrophage receptor CD163. A fast segregation of Hp-Hb from CD163 occurs at endosomal conditions (pH <6.5). The ligand binding site of CD163 has previously been shown to involve the scavenger receptor cysteine-rich (SRCR) domain 3. This domain and the adjacent SRCR domain 2 of CD163 contain a consensus motif for a calcium-coordinated acidic amino acid triad cluster as originally identified in the SRCR domain of the scavenger receptor MARCO. Here we show that site-directed mutagenesis in each of these acidic triads of SRCR domains 2 and 3 abrogates the high affinity binding of recombinant CD163 to Hp-Hb. In the ligand, Hp Arg-252 and Lys-262, both present in a previously identified CD163 binding loop of Hp, were revealed as essential residues for the high affinity receptor binding. These findings are in accordance with pairing of the calcium-coordinated acidic clusters in SRCR domains 2 and 3 with the two basic Arg/Lys residues in the Hp loop. Such a two-point electrostatic pairing is mechanistically similar to the pH-sensitive pairings disclosed in crystal structures of ligands in complex with tandem LDL receptor repeats or tandem CUB domains in other endocytic receptors.	[Nielsen, Marianne Jensby; Andersen, Christian Brix Folsted; Moestrup, Soren Kragh] Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark; [Moestrup, Soren Kragh] Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus C, Denmark	Aarhus University; Aarhus University	Moestrup, SK (corresponding author), Aarhus Univ, Dept Biomed, Ole Worms Alle,Bldg 1170, DK-8000 Aarhus C, Denmark.	skm@biokemi.au.dk	Moestrup, Søren Kragh/A-1403-2014; Moestrup, Søren Kragh/AAD-1735-2019	Moestrup, Søren Kragh/0000-0003-3862-2107; 	Danish Council for Independent Research (Medical Sciences); Novo Nordisk Foundation; Foundation for the Advancement of Medical Science; European Research Council; Lundbeck Foundation [R54-2010-5637] Funding Source: researchfish	Danish Council for Independent Research (Medical Sciences)(Det Frie Forskningsrad (DFF)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Foundation for the Advancement of Medical Science; European Research Council(European Research Council (ERC)European Commission); Lundbeck Foundation(Lundbeckfonden)	This work was supported by The Danish Council for Independent Research (Medical Sciences), The Novo Nordisk Foundation, The Foundation for the Advancement of Medical Science, and The European Research Council (to the TROJA project).	Andersen CBF, 2012, NATURE, V489, P456, DOI 10.1038/nature11369; Andersen CBF, 2010, NATURE, V464, P445, DOI 10.1038/nature08874; BENSI G, 1985, EMBO J, V4, P119, DOI 10.1002/j.1460-2075.1985.tb02325.x; Buehler PW, 2009, BLOOD, V113, P2578, DOI 10.1182/blood-2008-08-174466; Etzerodt A, 2013, ANTIOXID REDOX SIGN, V18, P2352, DOI 10.1089/ars.2012.4834; Etzerodt A, 2013, ANTIOXID REDOX SIGN, V18, P2254, DOI 10.1089/ars.2012.4605; Fabriek BO, 2007, BLOOD, V109, P5223, DOI 10.1182/blood-2006-08-036467; Fisher C, 2006, MOL CELL, V22, P277, DOI 10.1016/j.molcel.2006.02.021; Martinez VG, 2011, PHARMACOL REV, V63, P967, DOI 10.1124/pr.111.004523; Gerasimenko JV, 1998, CURR BIOL, V8, P1335, DOI 10.1016/S0960-9822(07)00565-9; GREER J, 1980, P NATL ACAD SCI-BIOL, V77, P3393, DOI 10.1073/pnas.77.6.3393; Gronlund J, 2000, J IMMUNOL, V165, P6406, DOI 10.4049/jimmunol.165.11.6406; HWANG PK, 1980, J BIOL CHEM, V255, P3038; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; KUROSKY A, 1974, BIOCHEM GENET, V11, P279, DOI 10.1007/BF00485995; KUROSKY A, 1980, P NATL ACAD SCI-BIOL, V77, P3388, DOI 10.1073/pnas.77.6.3388; LAW SKA, 1993, EUR J IMMUNOL, V23, P2320, DOI 10.1002/eji.1830230940; Lim SK, 1998, BLOOD, V92, P1870, DOI 10.1182/blood.V92.6.1870.418k38_1870_1877; Madsen M, 2004, J BIOL CHEM, V279, P51561, DOI 10.1074/jbc.M409629200; MAEDA N, 1985, J BIOL CHEM, V260, P6698; MAEDA N, 1984, NATURE, V309, P131, DOI 10.1038/309131a0; Moeller JB, 2012, J IMMUNOL, V188, P2399, DOI 10.4049/jimmunol.1103150; Moller HJ, 2010, IMMUNOBIOLOGY, V215, P406, DOI 10.1016/j.imbio.2009.05.003; Nielsen M. J., 2007, BLOOD, V282, P1072; Nielsen MJ, 2006, FUTURE LIPIDOL, V1, P729, DOI 10.2217/17460875.1.6.729; Nielsen MJ, 2006, BLOOD, V108, P2846, DOI 10.1182/blood-2006-05-022327; Nielsen MJ, 2010, ANTIOXID REDOX SIGN, V12, P261, DOI 10.1089/ars.2009.2792; Nielsen MJ, 2009, BLOOD, V114, P764, DOI 10.1182/blood-2009-01-198309; Ojala JRM, 2007, J BIOL CHEM, V282, P16654, DOI 10.1074/jbc.M701750200; SADRZADEH SMH, 1984, J BIOL CHEM, V259, P4354; Van Gorp H, 2010, MOL IMMUNOL, V47, P1650, DOI 10.1016/j.molimm.2010.02.008	31	39	40	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18834	18841		10.1074/jbc.M113.471060	http://dx.doi.org/10.1074/jbc.M113.471060			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23671278	Green Published, hybrid			2022-12-25	WOS:000321335800021
J	Vannier, C; Mock, K; Brabletz, T; Driever, W				Vannier, Corinne; Mock, Kerstin; Brabletz, Thomas; Driever, Wolfgang			Zeb1 Regulates E-cadherin and Epcam (Epithelial Cell Adhesion Molecule) Expression to Control Cell Behavior in Early Zebrafish Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESENCHYMAL TRANSITION; ZINC-FINGER; TRANSCRIPTION FACTOR; GASTRULATION MOVEMENTS; MOUSE EMBRYO; CANCER-CELLS; GENE; DELTA-EF1; FAMILY; METASTASIS	The ZEB1 transcription factor is best known as an inducer of epithelial-mesenchymal transitions (EMT) in cancer metastasis, acting through transcriptional repression of CDH1 (encoding E-cadherin) and the EMT-suppressing microRNA-200s (miR-200s). Here we analyze roles of the ZEB1 zebrafish orthologs, Zeb1a and Zeb1b, and of miR-200s in control of cell adhesion and morphogenesis during gastrulation and segmentation stages. Loss and gain of function analyses revealed that Zeb1 represses cdh1 expression to fine-tune adhesiveness of migrating deep blastodermal cells. Furthermore, Zeb1 acts as a repressor of epcam in the deep cells of the blastoderm and may contribute to control of epithelial integrity of enveloping layer cells, the outermost cells of the blastoderm. We found a similar ZEB1-dependent repression of EPCAM expression in human pancreatic and breast cancer cell lines, mediated through direct binding of ZEB1 to the EPCAM promoter. Thus, Zeb1 proteins employ several evolutionary conserved mechanisms to regulate cell-cell adhesion during development and cancer.	[Vannier, Corinne; Mock, Kerstin; Driever, Wolfgang] Univ Freiburg, Inst Biol 1, Fac Biol, D-79104 Freiburg, Germany; [Vannier, Corinne; Mock, Kerstin; Brabletz, Thomas] Univ Freiburg, Dept Visceral Surg, D-79106 Freiburg, Germany; [Brabletz, Thomas; Driever, Wolfgang] BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg	Driever, W (corresponding author), Univ Freiburg, Inst Biol 1, Hauptstr 1, D-79104 Freiburg, Germany.	driever@biologie.uni-freiburg.de		Driever, Wolfgang/0000-0002-9551-9141	Deutsche Forschungsgemeinschaft DFG [SFB850A1, SFB850B2]; Deutsche Krebshilfe [109430]; Excellence Initiative of the German Federal Government [EXC 294]; Excellence Initiative of the German State Government [EXC 294]	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); Excellence Initiative of the German Federal Government; Excellence Initiative of the German State Government	This work was supported by Deutsche Forschungsgemeinschaft DFG Grants SFB850A1 (to W. D.) and SFB850B2 (to T. B.), Deutsche Krebshilfe Grant 109430 (to T. B.), and by the Excellence Initiative of the German Federal and State Governments (EXC 294; to W. D. and T. B.).	Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; Aigner K, 2007, FEBS LETT, V581, P1617, DOI 10.1016/j.febslet.2007.03.026; Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036; Arumugam T, 2009, CANCER RES, V69, P5820, DOI 10.1158/0008-5472.CAN-08-2819; Babb SG, 2004, DEV DYNAM, V230, P263, DOI 10.1002/dvdy.20057; Babb SG, 2001, DEV DYNAM, V221, P231, DOI 10.1002/dvdy.1132; Blanco MJ, 2007, DEVELOPMENT, V134, P4073, DOI 10.1242/dev.006858; Brabletz T, 2012, NAT REV CANCER, V12, P425, DOI 10.1038/nrc3265; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; Cha YI, 2006, GENE DEV, V20, P77, DOI 10.1101/gad.1374506; Choi PS, 2008, NEURON, V57, P41, DOI 10.1016/j.neuron.2007.11.018; Drake JM, 2010, J BIOL CHEM, V285, P33940, DOI 10.1074/jbc.M110.136044; FUNAHASHI J, 1993, DEVELOPMENT, V119, P433; Gemmill RM, 2011, CANCER LETT, V300, P66, DOI 10.1016/j.canlet.2010.09.007; Goudarzi M, 2012, DEV CELL, V23, P210, DOI 10.1016/j.devcel.2012.05.007; Hajra KM, 2002, CANCER RES, V62, P1613; Hammerschmidt M, 2008, DEVELOPMENT, V135, P3625, DOI 10.1242/dev.015701; Harrington MJ, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-130; Horio M, 2012, ANN SURG ONCOL, V19, pS634, DOI 10.1245/s10434-011-2142-0; Kane DA, 2005, DEVELOPMENT, V132, P1105, DOI 10.1242/dev.01668; Kawahara Atsuo, 2002, Gene Expression Patterns, V2, P201, DOI 10.1016/S1567-133X(02)00062-5; KRAUSS S, 1991, DEVELOPMENT, V113, P1193; LEPTIN M, 1990, DEVELOPMENT, V110, P73; Lin F, 2009, J CELL BIOL, V184, P909, DOI 10.1083/jcb.200805148; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Maghzal N, 2010, J CELL BIOL, V191, P645, DOI 10.1083/jcb.201004074; Malaga-Trillo E, 2009, PRION, V3, P129, DOI 10.4161/pri.3.3.9651; McFarland KN, 2005, DEV DYNAM, V233, P390, DOI 10.1002/dvdy.20325; Miyoshi T, 2006, DEV DYNAM, V235, P1941, DOI 10.1002/dvdy.20799; Montero JA, 2005, DEVELOPMENT, V132, P1187, DOI 10.1242/dev.01667; Muraoka O, 2000, DEV BIOL, V228, P29, DOI 10.1006/dbio.2000.9909; NIETO MA, 1994, SCIENCE, V264, P835, DOI 10.1126/science.7513443; OXTOBY E, 1993, NUCLEIC ACIDS RES, V21, P1087, DOI 10.1093/nar/21.5.1087; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Riazuddin SA, 2010, AM J HUM GENET, V86, P45, DOI 10.1016/j.ajhg.2009.12.001; SCHULTEMERKER S, 1994, DEVELOPMENT, V120, P843; SCHULTEMERKER S, 1992, DEVELOPMENT, V116, P1021; Shestopalov IA, 2012, NAT CHEM BIOL, V8, P270, DOI [10.1038/nchembio.772, 10.1038/NCHEMBIO.772]; Shimizu T, 2005, MECH DEVELOP, V122, P747, DOI 10.1016/j.mod.2005.03.008; Shin JO, 2012, HISTOCHEM CELL BIOL, V137, P459, DOI 10.1007/s00418-012-0915-6; Slanchev K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000563; Solnica-Krezel L, 2006, CURR OPIN GENET DEV, V16, P433, DOI 10.1016/j.gde.2006.06.009; Song SM, 2013, DEV CELL, V24, P486, DOI 10.1016/j.devcel.2013.01.016; Spaderna S, 2008, CANCER RES, V68, P537, DOI 10.1158/0008-5472.CAN-07-5682; Spaderna S, 2006, GASTROENTEROLOGY, V131, P830, DOI 10.1053/j.gastro.2006.06.016; Speirs CK, 2010, DEVELOPMENT, V137, P1327, DOI 10.1242/dev.045971; Takagi T, 1998, DEVELOPMENT, V125, P21; TAM PPL, 1993, MICROSC RES TECHNIQ, V26, P301, DOI 10.1002/jemt.1070260405; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; van der Gun BTF, 2010, CARCINOGENESIS, V31, P1913, DOI 10.1093/carcin/bgq187; Van Grunsven LA, 2006, DEV DYNAM, V235, P1491, DOI 10.1002/dvdy.20727; Villablanca EJ, 2006, DEV DYNAM, V235, P1578, DOI 10.1002/dvdy.20743; Warga RM, 2007, DEV BIOL, V310, P211, DOI 10.1016/j.ydbio.2007.06.023; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Yamashita S, 2004, NATURE, V429, P298, DOI 10.1038/nature02545	62	57	57	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18643	18659		10.1074/jbc.M113.467787	http://dx.doi.org/10.1074/jbc.M113.467787			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23667256	Green Published, hybrid			2022-12-25	WOS:000321335800002
J	Allmann, S; Morand, P; Ebikeme, C; Gales, L; Biran, M; Hubert, J; Brennand, A; Mazet, M; Franconi, JM; Michels, PAM; Portais, JC; Boshart, M; Bringaud, F				Allmann, Stefan; Morand, Pauline; Ebikeme, Charles; Gales, Lara; Biran, Marc; Hubert, Jane; Brennand, Ana; Mazet, Muriel; Franconi, Jean-Michel; Michels, Paul A. M.; Portais, Jean-Charles; Boshart, Michael; Bringaud, Frederic			Cytosolic NADPH Homeostasis in Glucose-starved Procyclic Trypanosoma brucei Relies on Malic Enzyme and the Pentose Phosphate Pathway Fed by Gluconeogenic Flux	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON REGULATORY PROTEIN-1; MOLECULAR CHARACTERIZATION; PARASITIC PROTOZOA; OXIDATIVE STRESS; PLASMODIUM-FALCIPARUM; AFRICAN TRYPANOSOMES; PROLINE METABOLISM; HYDROGEN-PEROXIDE; TRYPANOTHIONE; LEISHMANIA	All living organisms depend on NADPH production to feed essential biosyntheses and for oxidative stress defense. Protozoan parasites such as the sleeping sickness pathogen Trypanosoma brucei adapt to different host environments, carbon sources, and oxidative stresses during their infectious life cycle. The procyclic stage develops in the midgut of the tsetse insect vector, where they rely on proline as carbon source, although they prefer glucose when grown in rich media. Here, we investigate the flexible and carbon source-dependent use of NADPH synthesis pathways in the cytosol of the procyclic stage. The T. brucei genome encodes two cytosolic NADPH-producing pathways, the pentose phosphate pathway (PPP) and the NADP-dependent malic enzyme (MEc). Reverse genetic blocking of those pathways and a specific inhibitor (dehydroepiandrosterone) of glucose-6-phosphate dehydrogenase together established redundancy with respect to H2O2 stress management and parasite growth. Blocking both pathways resulted in similar to 10-fold increase of susceptibility to H2O2 stress and cell death. Unexpectedly, the same pathway redundancy was observed in glucose-rich and glucose-depleted conditions, suggesting that gluconeogenesis can feed the PPP to provide NADPH. This was confirmed by (i) a lethal phenotype of RNAi-mediated depletion of glucose-6-phosphate isomerase (PGI) in the glucose-depleted Delta mec/Delta mec null background, (ii) an similar to 10-fold increase of susceptibility to H2O2 stress observed for the Delta mec/Delta mec/(RNAi)PGI double mutant when compared with the single mutants, and (iii) the C-13 enrichment of glycolytic and PPP intermediates from cells incubated with [U-C-13] proline, in the absence of glucose. Gluconeogenesis-supported NADPH supply may also be important for nucleotide and glycoconjugate syntheses in the insect host.	[Allmann, Stefan; Brennand, Ana; Boshart, Michael] Univ Munich, Biozentrum, Fac Biol, Genet Sect, D-82152 Martinsried, Germany; [Morand, Pauline; Ebikeme, Charles; Biran, Marc; Mazet, Muriel; Franconi, Jean-Michel; Bringaud, Frederic] Univ Bordeaux Segalen, Ctr Resonance Magnet Syst Biol RMSB, CNRS, UMR5536, F-33076 Bordeaux, France; [Gales, Lara; Hubert, Jane; Portais, Jean-Charles] Univ Toulouse, INSA, UPS, INP,LISBP, F-31077 Toulouse, France; [Gales, Lara; Hubert, Jane; Portais, Jean-Charles] INRA, Ingn Syst Biol & Proc UMR792, F-31400 Toulouse, France; [Gales, Lara; Hubert, Jane; Portais, Jean-Charles] CNRS, UMR5504, F-31400 Toulouse, France; [Michels, Paul A. M.] Catholic Univ Louvain, de Duve Inst, Trop Dis Res Unit, B-1200 Brussels, Belgium; [Michels, Paul A. M.] Catholic Univ Louvain, Biochem Lab, B-1200 Brussels, Belgium	University of Munich; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Universite Catholique Louvain; Universite Catholique Louvain	Boshart, M (corresponding author), Univ Munich, Biozentrum, Fac Biol, Genet Sect, Grosshadernerstr 2-4, D-82152 Martinsried, Germany.	boshart@lmu.de; bringaud@rmsb.u-bordeaux2.fr	Boshart, Michael/A-2700-2011; Michels, Paul A/A-5637-2009	Boshart, Michael/0000-0002-5070-2663; Michels, Paul A/0000-0003-3726-6104; Portais, Jean-Charles/0000-0002-3480-0933; Ebikeme, Charles/0000-0002-9989-6489	Region Midi-Pyrenees; European Regional Development Fund (ERDF); INRA; CNRS	Region Midi-Pyrenees(Region Provence-Alpes-Cote d'AzurRegion Occitanie); European Regional Development Fund (ERDF)(European Commission); INRA; CNRS(Centre National de la Recherche Scientifique (CNRS))	We are grateful to Larissa Ivanova (Ludwig-Maximilians Universitat Munich) and Nicolas Plazolle (Universite Bordeaux Segalen) for invaluable technical support. We thank Artur Cordeiro for providing DHEA. The mass spectrometry equipment and nuclear magnetic resonance equipment used in this study are part of the MetaToul platform (Toulouse, France) that is funded by the Region Midi-Pyrenees, the European Regional Development Fund (ERDF), the INRA, and the CNRS, which are gratefully acknowledged.	AHMED SA, 1994, J IMMUNOL METHODS, V170, P211, DOI 10.1016/0022-1759(94)90396-4; Akerman SE, 2005, J BIOL CHEM, V280, P564, DOI 10.1074/jbc.M406367200; ARRICK BA, 1981, J EXP MED, V153, P720, DOI 10.1084/jem.153.3.720; Azema L, 2004, BIOCHEM PHARMACOL, V67, P459, DOI 10.1016/j.bcp.2003.09.005; Barrett Michael P., 2002, Current Topics in Medicinal Chemistry, V2, P471, DOI 10.2174/1568026024607427; Barrett MP, 1997, PARASITOL TODAY, V13, P11, DOI 10.1016/S0169-4758(96)10075-2; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Birkholtz LM, 2011, BIOCHEM J, V438, P229, DOI 10.1042/BJ20110362; Bolten CJ, 2007, ANAL CHEM, V79, P3843, DOI 10.1021/ac0623888; BOVERIS A, 1980, BIOCHEM J, V188, P643, DOI 10.1042/bj1880643; Bringaud F, 2000, MOL BIOCHEM PARASIT, V111, P283, DOI 10.1016/S0166-6851(00)00319-4; Bringaud F, 1998, P NATL ACAD SCI USA, V95, P7963, DOI 10.1073/pnas.95.14.7963; Bringaud F, 2012, FRONT BIOSCI-LANDMRK, V17, P349, DOI 10.2741/3931; BRUN R, 1979, ACTA TROP, V36, P289; Bursell E., 1981, P135; CANNATA JJB, 1979, BIOCHEM J, V184, P409, DOI 10.1042/bj1840409; Comini MA, 2007, BIOCHEM J, V402, P43, DOI 10.1042/BJ20061341; Cordeiro AT, 2009, BIOORGAN MED CHEM, V17, P2483, DOI 10.1016/j.bmc.2009.01.068; Coustou V, 2005, J BIOL CHEM, V280, P16559, DOI 10.1074/jbc.M500343200; Coustou V, 2008, J BIOL CHEM, V283, P16342, DOI 10.1074/jbc.M709592200; Coustou V, 2006, J BIOL CHEM, V281, P26832, DOI 10.1074/jbc.M601377200; Creek DJ, 2012, ANAL CHEM, V84, P8442, DOI 10.1021/ac3018795; CRONIN CN, 1989, FEBS LETT, V244, P26, DOI 10.1016/0014-5793(89)81154-8; Duffieux F, 2000, J BIOL CHEM, V275, P27559; Ebikeme C, 2010, J BIOL CHEM, V285, P32312, DOI 10.1074/jbc.M110.124917; FAIRLAMB AH, 1985, SCIENCE, V227, P1485, DOI 10.1126/science.3883489; Garami A, 2001, EMBO J, V20, P3657, DOI 10.1093/emboj/20.14.3657; Ghozlane Amine, 2012, Advances in Bioinformatics, V2012, P159423, DOI 10.1155/2012/159423; Gupta S, 2011, MOL BIOCHEM PARASIT, V176, P112, DOI 10.1016/j.molbiopara.2010.12.006; Hannaert V, 2003, P NATL ACAD SCI USA, V100, P1067, DOI 10.1073/pnas.0335769100; Hao ZG, 2003, INSECT BIOCHEM MOLEC, V33, P1155, DOI 10.1016/j.ibmb.2003.07.001; Harlow E, 1988, ANTIBODIES LABORATOR, P471; He SS, 2012, ANTIMICROB AGENTS CH, V56, P2428, DOI 10.1128/AAC.06386-11; Heise N, 1999, MOL BIOCHEM PARASIT, V99, P21, DOI 10.1016/S0166-6851(98)00176-5; Huynh TT, 2003, J BIOL CHEM, V278, P39794, DOI 10.1074/jbc.M306306200; Igoillo-Esteve M, 2007, AN ACAD BRAS CIENC, V79, P649, DOI 10.1590/S0001-37652007000400007; Ingram AK, 2000, MOL BIOCHEM PARASIT, V111, P309, DOI 10.1016/S0166-6851(00)00322-4; Jiang P, 2013, NATURE, V493, P689, DOI 10.1038/nature11776; Kiefer P, 2007, ANAL BIOCHEM, V360, P182, DOI 10.1016/j.ab.2006.06.032; KLEIN RA, 1975, PARASITOLOGY, V71, P93, DOI 10.1017/S003118200005318X; Kohl L, 1999, J EUKARYOT MICROBIOL, V46, P105, DOI 10.1111/j.1550-7408.1999.tb04592.x; Krauth-Siegel RL, 2008, BBA-GEN SUBJECTS, V1780, P1236, DOI 10.1016/j.bbagen.2008.03.006; Krieger S, 2000, MOL MICROBIOL, V35, P542, DOI 10.1046/j.1365-2958.2000.01721.x; Lamour N, 2005, J BIOL CHEM, V280, P11902, DOI 10.1074/jbc.M414274200; Lee SH, 2007, NAT REV MICROBIOL, V5, P287, DOI 10.1038/nrmicro1617; Leroux AE, 2011, FEMS MICROBIOL LETT, V314, P25, DOI 10.1111/j.1574-6968.2010.02142.x; Luscher A, 2007, CURR PHARM DESIGN, V13, P555, DOI 10.2174/138161207780162809; Mannaert A, 2012, TRENDS PARASITOL, V28, P370, DOI 10.1016/j.pt.2012.06.003; McConville MJ, 2011, ANNU REV MICROBIOL, V65, P543, DOI 10.1146/annurev-micro-090110-102913; Michels PAM, 2006, BBA-MOL CELL RES, V1763, P1463, DOI 10.1016/j.bbamcr.2006.08.019; Millard P, 2012, BIOINFORMATICS, V28, P1294, DOI 10.1093/bioinformatics/bts127; Muller IB, 2008, MOL BIOCHEM PARASIT, V160, P1, DOI 10.1016/j.molbiopara.2008.03.008; Mueller S, 2000, FREE RADICAL BIO MED, V29, P410, DOI 10.1016/S0891-5849(00)00261-6; Muller S, 2004, MOL MICROBIOL, V53, P1291, DOI 10.1111/j.1365-2958.2004.04257.x; Naderer T, 2006, P NATL ACAD SCI USA, V103, P5502, DOI 10.1073/pnas.0509196103; Ngo H, 1998, P NATL ACAD SCI USA, V95, P14687, DOI 10.1073/pnas.95.25.14687; ORELLANO E, 1981, MOL BIOCHEM PARASIT, V3, P1, DOI 10.1016/0166-6851(81)90072-4; Pantopoulos K, 1997, J BIOL CHEM, V272, P9802; Raz B, 1997, ACTA TROP, V68, P139, DOI 10.1016/S0001-706X(97)00079-X; Riviere L, 2004, J BIOL CHEM, V279, P45337, DOI 10.1074/jbc.M407513200; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Suga H, 2013, APPL MICROBIOL BIOT, V97, P1669, DOI 10.1007/s00253-012-4298-3; Sureda A, 2005, FREE RADICAL RES, V39, P817, DOI 10.1080/10715760500164045; Tetaud E, 2001, MOL BIOCHEM PARASIT, V116, P171, DOI 10.1016/S0166-6851(01)00320-6; van Weelden SWH, 2003, J BIOL CHEM, V278, P12854, DOI 10.1074/jbc.M213190200; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X	66	49	50	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18494	18505		10.1074/jbc.M113.462978	http://dx.doi.org/10.1074/jbc.M113.462978			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23665470	Green Published, hybrid			2022-12-25	WOS:000320721900051
J	Goto, K; Kumarendran, B; Mettananda, S; Gunasekara, D; Fujii, Y; Kaneko, S				Goto, Kensuke; Kumarendran, Balachandran; Mettananda, Sachith; Gunasekara, Deepa; Fujii, Yoshito; Kaneko, Satoshi			Analysis of Effects of Meteorological Factors on Dengue Incidence in Sri Lanka Using Time Series Data	PLOS ONE			English	Article							CLIMATE VARIABLES; CHOLERA; MALARIA; PLAGUE; MODELS	In tropical and subtropical regions of eastern and South-eastern Asia, dengue fever (DF) and dengue hemorrhagic fever (DHF) outbreaks occur frequently. Previous studies indicate an association between meteorological variables and dengue incidence using time series analyses. The impacts of meteorological changes can affect dengue outbreak. However, difficulties in collecting detailed time series data in developing countries have led to common use of monthly data in most previous studies. In addition, time series analyses are often limited to one area because of the difficulty in collecting meteorological and dengue incidence data in multiple areas. To gain better understanding, we examined the effects of meteorological factors on dengue incidence in three geographically distinct areas (Ratnapura, Colombo, and Anuradhapura) of Sri Lanka by time series analysis of weekly data. The weekly average maximum temperature and total rainfall and the total number of dengue cases from 2005 to 2011 (7 years) were used as time series data in this study. Subsequently, time series analyses were performed on the basis of ordinary least squares regression analysis followed by the vector autoregressive model (VAR). In conclusion, weekly average maximum temperatures and the weekly total rainfall did not significantly affect dengue incidence in three geographically different areas of Sri Lanka. However, the weekly total rainfall slightly influenced dengue incidence in the cities of Colombo and Anuradhapura.	[Goto, Kensuke; Fujii, Yoshito; Kaneko, Satoshi] Nagasaki Univ, Inst Trop Med, Dept Ecoepidemiol, Nagasaki 852, Japan; [Kumarendran, Balachandran] Univ Kelaniya, Fac Med, Dept Publ Hlth, Kelaniya, Western Provinc, Sri Lanka; [Mettananda, Sachith] Univ Kelaniya, Fac Med, Dept Paediat, Kelaniya, Western Provinc, Sri Lanka; [Gunasekara, Deepa] Univ Kelaniya, Fac Med, Dept Biochem & Clin Med, Kelaniya, Western Provinc, Sri Lanka	Nagasaki University; University Kelaniya; University Kelaniya; University Kelaniya	Goto, K (corresponding author), Nagasaki Univ, Inst Trop Med, Dept Ecoepidemiol, Nagasaki 852, Japan.	k-goto@nagasaki-u.ac.jp	Mettananda, Sachith/H-4640-2019	Mettananda, Sachith/0000-0002-0760-0418; Kaneko, Satoshi/0000-0001-9464-0911	FY2011 SATREPS Special Project Formation Investigation: Young Research Team Feasibility Studies	FY2011 SATREPS Special Project Formation Investigation: Young Research Team Feasibility Studies	This work was supported by FY2011 SATREPS Special Project Formation Investigation: Young Research Team Feasibility Studies. (http://www.jst.go.jp/ global/english/fskoubo.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinboade OA, 2010, INT J TOUR RES, V12, P149, DOI 10.1002/jtr.743; Ari TB, 2010, AM J TROP MED HYG, V83, P624, DOI 10.4269/ajtmh.2010.09-0775; Ben Ari T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002160; Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760; Chastel C, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00070; de Magny GC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044577; de Magny GC, 2008, P NATL ACAD SCI USA, V105, P17676, DOI 10.1073/pnas.0809654105; Descloux E, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001470; Egbendewe-Mondzozo A, 2011, INT J ENV RES PUB HE, V8, P913, DOI 10.3390/ijerph8030913; Epidemiology Unit MoH Sri Lanka, 2011, SURV CAS DEF NORT DI; Epidemiology Unit MoH Sri Lanka, 2011, EP B SRI LANK, P1; Gharbi M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-166; Haque U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014341; Hii Y. L., 2009, GLOB HLTH ACTION, V2; Honda Y, 2009, GLOB HLTH ACTION, V2; Huang F, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-54; Ji X., 2012, ADV INFORM TECHNOLOG, V2, P268; Kanakaratne N, 2009, EMERG INFECT DIS, V15, P192, DOI 10.3201/eid1502.080926; Kularatne SAM, 2007, T ROY SOC TROP MED H, V101, P804, DOI 10.1016/j.trstmh.2007.02.021; Kumar S, 2012, ENERG ECON, V34, P215, DOI 10.1016/j.eneco.2011.03.002; Mohammed HP, 2010, J TRAVEL MED, V17, P8, DOI 10.1111/j.1708-8305.2009.00374.x; Opgen-Rhein R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S2-S3; Pesaran HH, 1998, ECON LETT, V58, P17, DOI 10.1016/S0165-1765(97)00214-0; Pinto E, 2011, INT J ENVIRON HEAL R, V21, P415, DOI 10.1080/09603123.2011.572279; Rajapakse Senaka, 2012, Infect Drug Resist, V5, P103, DOI 10.2147/IDR.S22613; Rasgon JL, 2011, NATURE, V476, P407, DOI 10.1038/476407a; Reller ME, 2012, EMERG INFECT DIS, V18, P256, DOI 10.3201/eid1802.110962; Tissera HA, 2011, EMERG INFECT DIS, V17, P2053, DOI 10.3201/eid1711.101893; Traerup SLM, 2011, INT J ENV RES PUB HE, V8, P4386, DOI 10.3390/ijerph8124386; Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003; Weerakoon Kosala Gad, 2011, BMC Res Notes, V4, P268, DOI 10.1186/1756-0500-4-268; WHO, 2009, WHO TECH REP SER, V958, P1; WHO, 2010, COMM DIS EP PROF; Xu L, 2011, P NATL ACAD SCI USA, V108, P10214, DOI 10.1073/pnas.1019486108	34	44	44	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e63717	10.1371/journal.pone.0063717	http://dx.doi.org/10.1371/journal.pone.0063717			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671694	Green Published, gold, Green Submitted			2022-12-25	WOS:000319737700057
J	Orellana, MV; Pang, WL; Durand, PM; Whitehead, K; Baliga, NS				Orellana, Monica V.; Pang, Wyming L.; Durand, Pierre M.; Whitehead, Kenia; Baliga, Nitin S.			A Role for Programmed Cell Death in the Microbial Loop	PLOS ONE			English	Article							CO2 CONCENTRATING MECHANISMS; MAJOR BACTERIAL CONTRIBUTION; GREAT SALT LAKE; MARINE-PHYTOPLANKTON; ORGANIC-CARBON; DUNALIELLA; STRESS; IDENTIFICATION; POPULATIONS; EXOCYTOSIS	The microbial loop is the conventional model by which nutrients and minerals are recycled in aquatic eco-systems. Biochemical pathways in different organisms become metabolically inter-connected such that nutrients are utilized, processed, released and re-utilized by others. The result is that unrelated individuals end up impacting each others' fitness directly through their metabolic activities. This study focused on the impact of programmed cell death (PCD) on a population's growth as well as its role in the exchange of carbon between two naturally co-occurring halophilic organisms. Flow cytometric, biochemical, C-14 radioisotope tracing assays, and global transcriptomic analyses show that organic algal photosynthate released by Dunalliela salina cells undergoing PCD complements the nutritional needs of other non-PCD D. salina cells. This occurs in vitro in a carbon limited environment and enhances the growth of the population. In addition, a co-occurring heterotroph Halobacterium salinarum re-mineralizes the carbon providing elemental nutrients for the mixoheterotrophic chlorophyte. The significance of this is uncertain and the archaeon can also subsist entirely on the lysate of apoptotic algae. PCD is now well established in unicellular organisms; however its ecological relevance has been difficult to decipher. In this study we found that PCD in D. salina causes the release of organic nutrients such as glycerol, which can be used by others in the population as well as a co-occurring halophilic archaeon. H. salinarum also re-mineralizes the dissolved material promoting algal growth. PCD in D. salina was the mechanism for the flow of dissolved photosynthate between unrelated organisms. Ironically, programmed death plays a central role in an organism's own population growth and in the exchange of nutrients in the microbial loop.	[Orellana, Monica V.; Pang, Wyming L.; Whitehead, Kenia; Baliga, Nitin S.] Inst Syst Biol, Seattle, WA USA; [Orellana, Monica V.] Univ Washington, Appl Phys Lab, Polar Sci Ctr, Seattle, WA 98105 USA; [Pang, Wyming L.] Genomatica Inc, San Diego, CA USA; [Durand, Pierre M.] Univ Witwatersrand, Dept Mol Med, Parktown, South Africa; [Durand, Pierre M.] Natl Hlth Lab Serv, Parktown, South Africa; [Durand, Pierre M.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA; [Whitehead, Kenia] Integral Consulting Inc, Seattle, WA USA; [Baliga, Nitin S.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA	Institute for Systems Biology (ISB); University of Washington; University of Washington Seattle; University of Witwatersrand; University of Arizona; University of Washington; University of Washington Seattle	Baliga, NS (corresponding author), Inst Syst Biol, Seattle, WA USA.	Nitin.Baliga@systemsbiology.org		Durand, Pierre M./0000-0002-9614-1371; , ENIGMA/0000-0002-0894-2831; baliga, nitin/0000-0001-9157-5974; Orellana, Monica/0000-0001-5990-9380	National Institutes of Health (NIH) [P50GM076547, 1R01GM077398-01A2]; U.S. Department of Energy (DOE) (ENIGMA) [DE-FG02-07ER64327]; National Science Foundation (NSF) [EF-0313754, EIA-0220153, MCB-0425825, DBI-0640950, OCE-0452563, OCE-0434087, ARC-0707555]; NIH Ruth L. Kirchstein NSRA [1F32GM086077-01A1]; National Health Laboratory Service, University of the Witwatersrand and Medical Research Council, South Africa; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076547, R01GM077398, F32GM086077] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy (DOE) (ENIGMA); National Science Foundation (NSF)(National Science Foundation (NSF)); NIH Ruth L. Kirchstein NSRA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health Laboratory Service, University of the Witwatersrand and Medical Research Council, South Africa; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from National Institutes of Health (NIH) (P50GM076547 and 1R01GM077398-01A2), U.S. Department of Energy (DOE) (ENIGMA: DE-FG02-07ER64327 and DE-FG02-07ER64327), and National Science Foundation (NSF) (EF-0313754, EIA-0220153, MCB-0425825, DBI-0640950) to NB; NSF OCE-0452563, OCE-0434087, and ARC-0707555 to MVO; and NIH Ruth L. Kirchstein NSRA 1F32GM086077-01A1 to WLP. Grants from the National Health Laboratory Service, University of the Witwatersrand and Medical Research Council, South Africa, to PMD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aluwihare LI, 2005, SCIENCE, V308, P1007, DOI 10.1126/science.1108925; Aluwihare LI, 1997, NATURE, V387, P166, DOI 10.1038/387166a0; Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; Azam F, 2001, NATURE, V414, P495, DOI 10.1038/35107174; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747; Baliga NS, 2004, GENOME RES, V14, P1025, DOI 10.1101/gr.1993504; Bardavid RE, 2008, EXTREMOPHILES, V12, P5, DOI 10.1007/s00792-006-0053-y; BENAMOTZ A, 1973, PLANT PHYSIOL, V51, P875, DOI 10.1104/pp.51.5.875; BenAmotz A., 2009, ALGA DUNALIELLA BIOD; Berges JA, 1998, LIMNOL OCEANOGR, V43, P129, DOI 10.4319/lo.1998.43.1.0129; Berman-Frank I, 2004, LIMNOL OCEANOGR, V49, P997, DOI 10.4319/lo.2004.49.4.0997; Bidle KD, 2008, EUKARYOT CELL, V7, P223, DOI 10.1128/EC.00296-07; Bidle KD, 1999, NATURE, V397, P508, DOI 10.1038/17351; Bidle KD, 2004, NAT REV MICROBIOL, V2, P643, DOI 10.1038/nrmicro956; Blackburn N, 1998, SCIENCE, V282, P2254, DOI 10.1126/science.282.5397.2254; BOGOMOLNI RA, 1982, P NATL ACAD SCI-BIOL, V79, P6250, DOI 10.1073/pnas.79.20.6250; Bonneau R, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-r52; Bonneau R, 2007, CELL, V131, P1354, DOI 10.1016/j.cell.2007.10.053; BRECKENRIDGE LJ, 1987, P NATL ACAD SCI USA, V84, P1945, DOI 10.1073/pnas.84.7.1945; Brooun A, 1998, J BACTERIOL, V180, P1642, DOI 10.1128/JB.180.7.1642-1646.1998; Chanley MH, 1975, CULT MAR INV AN P 1; Chin WC, 2004, PLANT CELL PHYSIOL, V45, P535, DOI 10.1093/pcp/pch062; Croft MT, 2005, NATURE, V438, P90, DOI 10.1038/nature04056; DASSARMA S, 1994, J BACTERIOL, V176, P7646, DOI 10.1128/JB.176.24.7646-7652.1994; DasSarma S, 1995, ARCHAEA LAB MANUAL H; DECHO AW, 1990, OCEANOGR MAR BIOL, V28, P73; DeLong EE, 2001, SYST BIOL, V50, P470, DOI 10.1080/106351501750435040; Dickson A.G., 2007, GUIDE BEST PRACTICES, V3; Droop MR, 2007, J PLANKTON RES, V29, P107, DOI 10.1093/plankt/fbm009; DROOP MR, 1973, J PHYCOL, V9, P264; Durand PM, 2011, AM NAT, V177, P224, DOI 10.1086/657686; Engelbrecht D, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/646534; Fabrizio P, 2004, J CELL BIOL, V166, P1055, DOI 10.1083/jcb.200404002; Falkowski P.G., 2007, AQUATIC PHOTOSYNTHES; FERNANDEZ JM, 1991, BIOPHYS J, V59, P1022, DOI 10.1016/S0006-3495(91)82317-7; Franklin DJ, 2006, EUR J PHYCOL, V41, P1, DOI 10.1080/09670260500505433; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Giordano M, 2005, ANNU REV PLANT BIOL, V56, P99, DOI 10.1146/annurev.arplant.56.032604.144052; Gonzalez MA, 2001, J PHYCOL, V37, P604, DOI 10.1046/j.1529-8817.2001.037004604.x; HALLADAY JT, 1993, J BACTERIOL, V175, P684, DOI 10.1128/JB.175.3.684-692.1993; Ideker T, 2000, J COMPUT BIOL, V7, P805, DOI 10.1089/10665270050514945; IVERSON RL, 1976, LIMNOL OCEANOGR, V21, P756, DOI 10.4319/lo.1976.21.5.0756; Jiao N, 2010, NAT REV MICROBIOL, V8, P593, DOI 10.1038/nrmicro2386; Jimenez C, 2009, J EXP BOT, V60, P815, DOI 10.1093/jxb/ern330; Kaiser K, 2008, LIMNOL OCEANOGR, V53, P99, DOI 10.4319/lo.2008.53.1.0099; Kaplan A, 1999, ANNU REV PLANT PHYS, V50, P539, DOI 10.1146/annurev.arplant.50.1.539; Kaur A, 2006, GENOME RES, V16, P841, DOI 10.1101/gr.5189606; Kirchman D.L., 2008, MICROBIAL ECOLOGY OC, Vsecond; Kirchman DL, 2005, DEEP-SEA RES PT II, V52, P3386, DOI 10.1016/j.dsr2.2005.09.005; Kokoeva MV, 2000, MOL MICROBIOL, V35, P647, DOI 10.1046/j.1365-2958.2000.01735.x; Kottemann M, 2005, EXTREMOPHILES, V9, P219, DOI 10.1007/s00792-005-0437-4; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Lau WWY, 2007, APPL ENVIRON MICROB, V73, P2440, DOI 10.1128/AEM.01965-06; Leigh EG, 2010, J EVOLUTION BIOL, V23, P2507, DOI 10.1111/j.1420-9101.2010.02114.x; Lewis J, 2001, PHYCOLOGIA, V40, P280, DOI 10.2216/i0031-8884-40-3-280.1; Liow LH, 2011, TRENDS ECOL EVOL, V26, P349, DOI 10.1016/j.tree.2011.03.016; Liska AJ, 2004, PLANT PHYSIOL, V136, P2806, DOI 10.1104/pp.104.039438; Marie D, 1997, APPL ENVIRON MICROB, V63, P186, DOI 10.1128/AEM.63.1.186-193.1997; Mary I, 2008, ENVIRON MICROBIOL, V10, P2124, DOI 10.1111/j.1462-2920.2008.01633.x; McCarthy MD, 1998, SCIENCE, V281, P231, DOI 10.1126/science.281.5374.231; Moharikar S, 2006, J PHYCOL, V42, P423, DOI 10.1111/j.1529-8817.2006.00207.x; Muller JA, 2005, J BACTERIOL, V187, P1659, DOI 10.1128/JB.187.5.1659-1667.2005; Nagata T, 1997, ADV MICROB ECOL, V15, P81; Nedelcu AM, 2011, EVOLUTION, V65, P3, DOI 10.1111/j.1558-5646.2010.01103.x; Ng WV, 2000, P NATL ACAD SCI USA, V97, P12176, DOI 10.1073/pnas.190337797; Orellana MV, 2011, J PHYCOL, V47, P112, DOI 10.1111/j.1529-8817.2010.00936.x; OREN A, 1993, FEMS MICROBIOL ECOL, V12, P15, DOI 10.1016/0168-6496(93)90020-8; Pace ML, 1996, LIMNOL OCEANOGR, V41, P1448, DOI 10.4319/lo.1996.41.7.1448; PAYNE JW, 1980, MICROORGANISMS NITRO, P212; POMEROY LR, 1974, BIOSCIENCE, V24, P499, DOI 10.2307/1296885; POST FJ, 1981, HYDROBIOLOGIA, V81-2, P59, DOI 10.1007/BF00048706; PRALONG WF, 1990, EMBO J, V9, P53, DOI 10.1002/j.1460-2075.1990.tb08079.x; PROCTOR LM, 1990, NATURE, V343, P60, DOI 10.1038/343060a0; Rao SDV, 2009, CULTIVATION GROWTH M; RIEBESELL U, 1993, NATURE, V361, P249, DOI 10.1038/361249a0; Riemann L, 2000, APPL ENVIRON MICROB, V66, P578, DOI 10.1128/AEM.66.2.578-587.2000; ROSENZWEIG ML, 1977, Q REV BIOL, V52, P371, DOI 10.1086/410124; SCHIDLOWSKI M, 1984, NATURWISSENSCHAFTEN, V71, P303, DOI 10.1007/BF00396613; Segovia M, 2003, PLANT PHYSIOL, V132, P99, DOI 10.1104/pp.102.017129; SPUDICH EN, 1989, P NATL ACAD SCI USA, V86, P7746, DOI 10.1073/pnas.86.20.7746; SPUDICH JL, 1993, J BACTERIOL, V175, P7755, DOI 10.1128/JB.175.24.7755-7761.1993; STEPHENS DW, 1976, LIMNOL OCEANOGR, V21, P74, DOI 10.4319/lo.1976.21.1.0074; Storch KF, 1999, EMBO J, V18, P1146, DOI 10.1093/emboj/18.5.1146; Strickland J.D.H., 1972, PRACTICAL HDB SEWATE, DOI [10.2307/1979241, DOI 10.2307/1979241]; Strom SL, 1997, LIMNOL OCEANOGR, V42, P1364, DOI 10.4319/lo.1997.42.6.1364; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Sverdrup Hu, 1957, OCEANS; Tafreshi AH, 2006, WORLD J MICROB BIOT, V22, P1003, DOI 10.1007/s11274-006-9145-1; Van PT, 2008, J PROTEOME RES, V7, P3755, DOI 10.1021/pr800031f; Vardi A, 2007, ENVIRON MICROBIOL, V9, P360, DOI 10.1111/j.1462-2920.2006.01146.x; Vardi A, 2012, P NATL ACAD SCI USA, V109, P19327, DOI 10.1073/pnas.1208895109; Vardi A, 2009, SCIENCE, V326, P861, DOI 10.1126/science.1177322; Verdugo P, 2012, ANNU REV MAR SCI, V4, P375, DOI 10.1146/annurev-marine-120709-142759; Whitehead K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005485; Wilkerson CR, 1987, SCIENCE, V236; Williams G. C., 1966, P307; Zhang HN, 1996, MAR CHEM, V52, P17, DOI 10.1016/0304-4203(95)00076-3	98	41	43	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62595	10.1371/journal.pone.0062595	http://dx.doi.org/10.1371/journal.pone.0062595			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667496	Green Submitted, Green Published, gold			2022-12-25	WOS:000319055600031
J	Schanen, BC; Das, S; Reilly, CM; Warren, WL; Self, WT; Seal, S; Drake, DR				Schanen, Brian C.; Das, Soumen; Reilly, Christopher M.; Warren, William L.; Self, William T.; Seal, Sudipta; Drake, Donald R., III			Immunomodulation and T Helper TH1/TH2 Response Polarization by CeO2 and TiO2 Nanoparticles	PLOS ONE			English	Article							CERIUM OXIDE NANOPARTICLES; DENDRITIC CELL MATURATION; ANTIGEN-PRESENTING CELLS; REACTIVE OXYGEN; IN-VITRO; TITANIUM-DIOXIDE; CYTOKINE RELEASE; SURFACE; ACTIVATION; MODEL	Immunomodulation by nanoparticles, especially as related to the biochemical properties of these unique materials, has scarcely been explored. In an in vitro model of human immunity, we demonstrate two catalytic nanoparticles, TiO2 (oxidant) and CeO2 (antioxidant), have nearly opposite effects on human dendritic cells and T helper (T-H) cells. For example, whereas TiO2 nanoparticles potentiated DC maturation that led towards T(H)1-biased responses, treatment with antioxidant CeO2 nanoparticles induced APCs to secrete the anti-inflammatory cytokine, IL-10, and induce a T(H)2-dominated T cell profile. In subsequent studies, we demonstrate these results are likely explained by the disparate capacities of the nanoparticles to modulate ROS, since TiO2, but not CeO2 NPs, induced inflammatory responses through an ROS/inflammasome/IL-1 beta pathway. This novel capacity of metallic NPs to regulate innate and adaptive immunity in profoundly different directions via their ability to modulate dendritic cell function has strong implications for human health since unintentional exposure to these materials is common in modern societies.	[Schanen, Brian C.; Warren, William L.; Drake, Donald R., III] Sanofi Pasteur, Orlando, FL USA; [Schanen, Brian C.; Warren, William L.; Self, William T.] UCF Coll Med, Dept Mol Biol & Microbiol, Burnett Sch Biomed Sci, Orlando, FL USA; [Das, Soumen; Seal, Sudipta] Nanosci & Technol Ctr NSTC, Dept Mech Mat & Aerosp Engn MMAE, AMPAC, Orlando, FL USA; [Reilly, Christopher M.] Virginia Tech, Virginia Maryland Reg Coll Vet Med, Virginia Coll Osteopath Med Res, Blacksburg, VA USA	Sanofi-Aventis; State University System of Florida; University of Central Florida; Virginia Polytechnic Institute & State University	Drake, DR (corresponding author), Sanofi Pasteur, VaxDesign Campus, Orlando, FL USA.	Donald.Drake@sanofipasteur.com	Self, William/Q-4113-2019; Self, William/A-6704-2008; Seal, Sudipta/A-7698-2012	Self, William/0000-0001-9874-0194	NSF [CBET-0711239]	NSF(National Science Foundation (NSF))	This work was funded by NSF Grant CBET-0711239 (http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allouni ZE, 2012, TOXICOL IN VITRO, V26, P469, DOI 10.1016/j.tiv.2012.01.019; Asati A, 2010, ACS NANO, V4, P5321, DOI 10.1021/nn100816s; Bar-Ilan O, NANOTOXICOLOGY, V0, P1; Boonstra A, 2006, J IMMUNOL, V177, P7551, DOI 10.4049/jimmunol.177.11.7551; Boscolo P, 2010, J BIOL REG HOMEOS AG, V24, P207; Bruchhausen S, 2003, J INVEST DERMATOL, V121, P1039, DOI 10.1046/j.1523-1747.2003.12510.x; Byers AM, 2009, BIOLOGICALS, V37, P148, DOI 10.1016/j.biologicals.2009.02.018; Cai X, 2012, BIOMATERIALS, V33, P8771, DOI 10.1016/j.biomaterials.2012.08.030; Chauveau C, 2005, BLOOD, V106, P1694, DOI 10.1182/blood-2005-02-0494; Churg A, 1998, AM J PHYSIOL-LUNG C, V274, pL81, DOI 10.1152/ajplung.1998.274.1.L81; Colon J, 2010, NANOMED-NANOTECHNOL, V6, P698, DOI 10.1016/j.nano.2010.01.010; Deng ZJ, 2011, NAT NANOTECHNOL, V6, P39, DOI [10.1038/nnano.2010.250, 10.1038/NNANO.2010.250]; Dhir V, 2011, J IMMUNOTOXICOL; Dhir V, 2012, J IMMUNOTOXICOL, V9, P34, DOI 10.3109/1547691X.2011.613419; Donaldson K, 1996, TOXICOL LETT, V88, P293, DOI 10.1016/0378-4274(96)03752-6; Dowding JM, 2012, CHEM COMMUN, V48, P4896, DOI 10.1039/c2cc30485f; Drake DR, 2012, DISRUPTIVE SCI TECHN, V1, P28; Duffin R, 2007, INHAL TOXICOL, V19, P849, DOI 10.1080/08958370701479323; Fan AM, 2010, J NANOSCI NANOTECHNO, V10, P8646, DOI 10.1166/jnn.2010.2493; Fialkow L, 2007, FREE RADICAL BIO MED, V42, P153, DOI 10.1016/j.freeradbiomed.2006.09.030; Finkel T, 2000, FEBS LETT, V476, P52, DOI 10.1016/S0014-5793(00)01669-0; Gaiser BK, 2012, ENVIRON TOXICOL CHEM, V31, P144, DOI 10.1002/etc.703; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; Goncalves DM, 2010, TOXICOL IN VITRO, V24, P1002, DOI 10.1016/j.tiv.2009.12.007; Hanley C, 2009, NANOSCALE RES LETT, V4, P1409, DOI 10.1007/s11671-009-9413-8; Higbee RG, 2009, ATLA-ALTERN LAB ANIM, V37, P19, DOI 10.1177/026119290903701S05; Hirst SM, 2009, SMALL, V5, P2848, DOI 10.1002/smll.200901048; Karakoti AS, 2009, J AM CHEM SOC, V131, P14144, DOI 10.1021/ja9051087; Kotake Y, 2003, SHOCK, V19, P252, DOI 10.1097/00024382-200303000-00009; Lamkanfi M, 2009, J BIOL CHEM, V284, P20574, DOI 10.1074/jbc.M109.023689; Lander HM, 1996, NATURE, V381, P380, DOI 10.1038/381380a0; Laouini D, 2003, J CLIN INVEST, V112, P1058, DOI 10.1172/JCI200318246; Liu Y, 2009, BIOMATERIALS, V30, P3934, DOI 10.1016/j.biomaterials.2009.04.001; Lutsiak MEC, 2006, J PHARM PHARMACOL, V58, P739, DOI 10.1211/jpp.58.6.0004; Ma YF, 2010, IMMUNOLOGY, V130, P374, DOI 10.1111/j.1365-2567.2009.03237.x; Mayer A, 2009, TOXICOLOGY, V258, P139, DOI 10.1016/j.tox.2009.01.015; MNneil SE, 2005, J LEUKOCYTE BIOL, V78, P585, DOI 10.1189/jlb.0205074; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Moser JM, 2010, J IMMUNOL METHODS, V353, P8, DOI 10.1016/j.jim.2009.11.006; Patil S, 2007, BIOMATERIALS, V28, P4600, DOI 10.1016/j.biomaterials.2007.07.029; Paulsen M, 2011, CELL DEATH DIFFER, V18, P619, DOI 10.1038/cdd.2010.134; Rutault K, 1999, FREE RADICAL BIO MED, V26, P232, DOI 10.1016/S0891-5849(98)00194-4; Schanen BC, 2008, J IMMUNOL METHODS, V335, P53, DOI 10.1016/j.jim.2008.02.021; Schanen BC, 2011, VACCINE, V29, P3299, DOI 10.1016/j.vaccine.2011.02.019; Schanen BC, 2009, ACS NANO, V3, P2523, DOI 10.1021/nn900403h; Schroecksnadel Katharina, 2007, Drug Metab Lett, V1, P166; Shin SH, 2007, INT IMMUNOPHARMACOL, V7, P1813, DOI 10.1016/j.intimp.2007.08.025; Song HF, 2010, VACCINE, V28, P5524, DOI 10.1016/j.vaccine.2010.06.044; Stringer B, 1996, AM J RESP CELL MOL, V14, P155, DOI 10.1165/ajrcmb.14.2.8630265; Sun Q, 2012, J BIOMED MAT RES A; Tang H, 2010, NAT IMMUNOL, V11, P608, DOI 10.1038/ni.1883; Thevenot P, 2008, CURR TOP MED CHEM, V8, P270; Thevenot P, 2008, NANOMED-NANOTECHNOL, V4, P226, DOI 10.1016/j.nano.2008.04.001; Tse HM, 2004, FREE RADICAL BIO MED, V36, P233, DOI 10.1016/j.freeradbiomed.2003.10.029; Warheit David B, 2009, Inhal Toxicol, V21 Suppl 1, P61, DOI 10.1080/08958370902942640; Wason MS, 2012, NANOMEDICINE; Wittman V, 2010, IDRUGS, V13, P248; Xu MH, 1998, SUPRAMOL SCI, V5, P449, DOI 10.1016/S0968-5677(98)00048-0; Yang D, 2010, ACS NANO, V4, P1178, DOI 10.1021/nn901478z; Yang HY, 2004, J APPL POLYM SCI, V92, P3201, DOI 10.1002/app.20327; Yazdi AS, 2010, P NATL ACAD SCI USA, V107, P19449, DOI 10.1073/pnas.1008155107; Zhang AP, 2004, WORLD J GASTROENTERO, V10, P3191; Zhu ZJ, 2008, J AM CHEM SOC, V130, P14139, DOI 10.1021/ja805392f	63	62	66	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62816	10.1371/journal.pone.0062816	http://dx.doi.org/10.1371/journal.pone.0062816			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667525	Green Published, gold, Green Submitted			2022-12-25	WOS:000319055600046
J	Tesei, A; Leonetti, C; Di Donato, M; Gabucci, E; Porru, M; Varchi, G; Guerrini, A; Amadori, D; Arienti, C; Pignatta, S; Paganelli, G; Caraglia, M; Castoria, G; Zoli, W				Tesei, Anna; Leonetti, Carlo; Di Donato, Marzia; Gabucci, Elisa; Porru, Manuela; Varchi, Greta; Guerrini, Andrea; Amadori, Dino; Arienti, Chiara; Pignatta, Sara; Paganelli, Giulia; Caraglia, Michele; Castoria, Gabriella; Zoli, Wainer			Effect of Small Molecules Modulating Androgen Receptor (SARMs) in Human Prostate Cancer Models	PLOS ONE			English	Article							DEPENDENT NUCLEAR EXPORT; ESTRADIOL-RECEPTOR; BICALUTAMIDE MONOTHERAPY; DNA-SYNTHESIS; CASTRATION; CELLS; GENE; AMPLIFICATION; PROGRESSION; MUTATION	The management of hormone-refractory prostate cancer represents a major challenge in the therapy of this tumor, and identification of novel androgen receptor antagonists is needed to render treatment more effective. We analyzed the activity of two novel androgen receptor antagonists, (S)-11 and (R)-9, in in vitro and in vivo experimental models of hormone-sensitive or castration-resistant prostate cancer (CRPC). In vitro experiments were performed on LNCaP, LNCaP-AR, LNCaP-Rbic and VCaP human prostate cancer cells. Cytotoxic activity was assessed by SRB and BrdU uptake, AR transactivation by luciferase reporter assay and PSA levels by Real Time RT-PCR and ELISA assays. Cell cycle progression-related markers were evaluated by western blot. In vivo experiments were performed on SCID mice xenografted with cells with different sensitivity to hormonal treatment. In hormone-sensitive LNCaP and LNCaP-AR cells, the latter expressing high androgen receptor levels, (R)-9 and (S)-11 exhibited a higher cytotoxic effect compared to that of the reference compound ((R)-bicalutamide), also in the presence of the synthetic androgen R1881. Furthermore, the cytotoxic effect produced by (R)9 was higher than that of (S)-11 in the two hormone-resistant LNCaP-AR and VCaP cells. A significant reduction in PSA levels was observed after exposure to both molecules. Moreover, (S)-11 and (R)-9 inhibited DNA synthesis by blocking the androgen-induced increase in cyclin D1 protein levels. In vivo studies on the toxicological profile of (R)-9 did not reveal the presence of adverse events. Furthermore, (R)-9 inhibited tumor growth in various in vivo models, especially LNCaP-Rbic xenografts, representative of recurrent disease. Our in vitro results highlight the antitumor activity of the two novel molecules (R)-9 and (S)-11, making them a potentially attractive option for the treatment of CRPC.	[Tesei, Anna; Gabucci, Elisa; Arienti, Chiara; Pignatta, Sara; Paganelli, Giulia; Zoli, Wainer] IRCCS Ist Sci Romagnolo Studio & Cura Tumori IRST, Biosci Lab, Meldola, Italy; [Leonetti, Carlo; Porru, Manuela] Natl Canc Inst Regina Elena, Lab Expt Preclin Chemotherapy, Dept Expt Oncol, Rome, Italy; [Di Donato, Marzia; Castoria, Gabriella] Univ Naples 2, Dept Gen Pathol, Naples, Italy; [Varchi, Greta; Guerrini, Andrea] Italian Natl Res Council, Inst Organ Chem & Photoreact, Bologna, Italy; [Amadori, Dino] IRCCS Ist Sci Romagnolo Studio & Cura Tumori IRST, Dept Med Oncol, Meldola, Italy; [Caraglia, Michele] Univ Naples 2, Dept Biochem & Biophys, Naples, Italy	IRCCS Meldola (IRST); Universita della Campania Vanvitelli; Consiglio Nazionale delle Ricerche (CNR); IRCCS Meldola (IRST); Universita della Campania Vanvitelli	Tesei, A (corresponding author), IRCCS Ist Sci Romagnolo Studio & Cura Tumori IRST, Biosci Lab, Meldola, Italy.	anna.tesei@irst.emr.it; leonetti@ifo.it	Varchi, Greta/CAG-3391-2022; Castoria, Gabriella/I-3349-2019; Tesei, Anna/C-7748-2016; Caraglia, Michele/AFY-9729-2022; Porru, Manuela/AAA-5510-2021; Leonetti, Carlo/B-2860-2018; PORRU, MANUELA/K-4809-2018; Caraglia, Michele/AAK-4569-2020; Caraglia, Michele/N-5670-2015; Arienti, Chiara/K-4443-2016; arienti, chiara/AAA-9493-2021; Varchi, Greta/J-9722-2018; Pignatta, Sara/X-1508-2018; Di Donato, Marzia/M-3114-2018	Varchi, Greta/0000-0002-8358-3437; Castoria, Gabriella/0000-0002-0576-4494; Tesei, Anna/0000-0002-8351-5952; Caraglia, Michele/0000-0003-2408-6091; Porru, Manuela/0000-0002-6614-9110; Leonetti, Carlo/0000-0002-3526-7827; PORRU, MANUELA/0000-0002-6614-9110; Caraglia, Michele/0000-0003-2408-6091; Caraglia, Michele/0000-0003-2408-6091; arienti, chiara/0000-0002-2265-828X; Varchi, Greta/0000-0002-8358-3437; Pignatta, Sara/0000-0001-5464-0052; Di Donato, Marzia/0000-0001-7207-826X	Associazione Italiana per la Ricerca sul Cancro [A.I.R.C.-IG11520]; Ministero Italiano per la Ricerca Scientifica [PRIN 2010NFEB9L_002]	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Ministero Italiano per la Ricerca Scientifica	Gabriella Castoria and Marzia Di Donato received funds from the Associazione Italiana per la Ricerca sul Cancro (A.I.R.C.-IG11520) and Ministero Italiano per la Ricerca Scientifica (PRIN 2010NFEB9L_002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson DS, 2007, MOL CELL ENDOCRINOL, V270, P50, DOI 10.1016/j.mce.2007.02.006; AIRT Working Group, 2006, Epidemiol Prev, V30, P8; Bai VU, 2005, J CELL PHYSIOL, V204, P381, DOI 10.1002/jcp.20422; Boccardo F, 1999, J CLIN ONCOL, V17, P2027, DOI 10.1200/JCO.1999.17.7.2027; Castoria G, 2001, EMBO J, V20, P6050, DOI 10.1093/emboj/20.21.6050; Castoria G, 2012, ONCOGENE, V31, P4868, DOI 10.1038/onc.2011.642; Castoria G, 2003, J CELL BIOL, V161, P547, DOI 10.1083/jcb.200211099; Castoria G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017218; CHANG CS, 1987, J STEROID BIOCHEM, V27, P123, DOI 10.1016/0022-4731(87)90303-7; CHANG CS, 1988, P NATL ACAD SCI USA, V85, P7211, DOI 10.1073/pnas.85.19.7211; Chen Y, 2009, LANCET ONCOL, V10, P981, DOI 10.1016/S1470-2045(09)70229-3; Comstock CES, 2011, J BIOL CHEM, V286, P8117, DOI 10.1074/jbc.M110.170720; Dehm SM, 2008, CANCER RES, V68, P5469, DOI 10.1158/0008-5472.CAN-08-0594; DEVOOGT HJ, 1992, PROSTATE, P91; Edwards J, 2005, BJU INT, V95, P1327, DOI 10.1111/j.1464-410X.2005.05527.x; Edwards J, 2003, BRIT J CANCER, V89, P552, DOI 10.1038/sj.bjc.6601127; Feau C, 2011, METHODS MOL BIOL, V776, P59, DOI 10.1007/978-1-61779-243-4_4; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; FURR BJA, 1995, ANN NY ACAD SCI, V761, P79, DOI 10.1111/j.1749-6632.1995.tb31371.x; GADDIPATI JP, 1994, CANCER RES, V54, P2861; Guo ZY, 2006, CANCER CELL, V10, P309, DOI 10.1016/j.ccr.2006.08.021; Halkidou K, 2003, ONCOGENE, V22, P2466, DOI 10.1038/sj.onc.1206342; Han GZ, 2005, P NATL ACAD SCI USA, V102, P1151, DOI 10.1073/pnas.0408925102; Hedlund PO, 2000, PROSTATE, P32; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; Iversen P, 2000, J UROLOGY, V164, P1579, DOI 10.1016/S0022-5347(05)67032-2; Jordan VC, 2004, CANCER CELL, V5, P207, DOI 10.1016/S1535-6108(04)00059-5; Joyce R, 1998, J UROLOGY, V159, P149, DOI 10.1016/S0022-5347(01)64039-4; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Knudsen KE, 1998, J BIOL CHEM, V273, P20213, DOI 10.1074/jbc.273.32.20213; Linja MJ, 2001, CANCER RES, V61, P3550; Lombardi M, 2008, J CELL BIOL, V182, P327, DOI 10.1083/jcb.200712125; Migliaccio A, 2000, EMBO J, V19, P5406, DOI 10.1093/emboj/19.20.5406; O'Donnell A, 2004, BRIT J CANCER, V90, P2317, DOI 10.1038/sj.bjc.6601879; Pienta KJ, 2005, CA-CANCER J CLIN, V55, P300, DOI 10.3322/canjclin.55.5.300; Sasaki M, 2002, J NATL CANCER I, V94, P384; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Schweizer L, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-4; See WA, 2002, J UROLOGY, V168, P429, DOI 10.1016/S0022-5347(05)64652-6; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Small EJ, 2004, J CLIN ONCOL, V22, P1025, DOI 10.1200/JCO.2004.06.037; SONNENSCHEIN C, 1989, CANCER RES, V49, P3474; Taplin ME, 2007, NAT CLIN PRACT ONCOL, V4, P236, DOI 10.1038/ncponc0765; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Uemura M, 2008, CANCER SCI, V99, P81, DOI 10.1111/j.1349-7006.2007.00656.x; Varchi Greta, 2010, Patent No. [WO/2010/092546, 2010092546]; VELDSCHOLTE J, 1990, BIOCHEM BIOPH RES CO, V173, P534, DOI 10.1016/S0006-291X(05)80067-1; Verrijdt G, 2000, J BIOL CHEM, V275, P12298, DOI 10.1074/jbc.275.16.12298; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Wu Y, 2007, ENDOCRINOLOGY, V148, P2984, DOI 10.1210/en.2006-1653; Yuan X, 2009, UROL ONCOL-SEMIN ORI, V27, P36, DOI 10.1016/j.urolonc.2008.03.021; Zhang YX, 2008, MOL CANCER THER, V7, P3176, DOI 10.1158/1535-7163.MCT-08-0526	52	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2013	8	5							e62657	10.1371/journal.pone.0062657	http://dx.doi.org/10.1371/journal.pone.0062657			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	145YI	23667504	Green Published, Green Submitted, gold			2022-12-25	WOS:000319055600038
J	Ignatius, MS; Eroglu, AU; Malireddy, S; Gallagher, G; Nambiar, RM; Henion, PD				Ignatius, Myron S.; Eroglu, Arife Unal; Malireddy, Smitha; Gallagher, Glen; Nambiar, Roopa M.; Henion, Paul D.			Distinct Functional and Temporal Requirements for Zebrafish Hdac1 during Neural Crest-Derived Craniofacial and Peripheral Neuron Development	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; TRANSCRIPTION FACTOR HAND2; II COLLAGEN; NORADRENERGIC NEURONS; MOLECULAR-MECHANISMS; GENE-EXPRESSION; DORSAL-ROOT; SOX9; DIFFERENTIATION; SPECIFICATION	The regulation of gene expression is accomplished by both genetic and epigenetic means and is required for the precise control of the development of the neural crest. In hdac1(b382) mutants, craniofacial cartilage development is defective in two distinct ways. First, fewer hoxb3a, dlx2 and dlx3-expressing posterior branchial arch precursors are specified and many of those that are consequently undergo apoptosis. Second, in contrast, normal numbers of progenitors are present in the anterior mandibular and hyoid arches, but chondrocyte precursors fail to terminally differentiate. In the peripheral nervous system, there is a disruption of enteric, DRG and sympathetic neuron differentiation in hdac1(b382) mutants compared to wildtype embryos. Specifically, enteric and DRG-precursors differentiate into neurons in the anterior gut and trunk respectively, while enteric and DRG neurons are rarely present in the posterior gut and tail. Sympathetic neuron precursors are specified in hdac1(b382) mutants and they undergo generic neuronal differentiation but fail to undergo noradrenergic differentiation. Using the HDAC inhibitor TSA, we isolated enzyme activity and temporal requirements for HDAC function that reproduce hdac1(b382) defects in craniofacial and sympathetic neuron development. Our study reveals distinct functional and temporal requirements for zebrafish hdac1 during neural crest-derived craniofacial and peripheral neuron development.	[Malireddy, Smitha; Gallagher, Glen; Henion, Paul D.] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA; [Ignatius, Myron S.; Eroglu, Arife Unal; Nambiar, Roopa M.; Henion, Paul D.] Ohio State Univ, Mol Cellular & Dev Biol Program, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Henion, PD (corresponding author), Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA.	henion.1@osu.edu			NSF [IBN0315765]; NIH [GM074505]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM074505] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NSF grant IBN0315765 and NIH grant GM074505 to P.D.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahringer J, 2000, TRENDS GENET, V16, P351, DOI 10.1016/S0168-9525(00)02066-7; AKIMENKO MA, 1994, J NEUROSCI, V14, P3475; ALLFREY VG, 1966, CANCER RES, V26, P2026; An M, 2002, J COMP NEUROL, V446, P267, DOI 10.1002/cne.10214; Barembaum M, 2005, SEMIN CELL DEV BIOL, V16, P642, DOI 10.1016/j.semcdb.2005.06.006; Barrallo-Gimeno A, 2004, DEVELOPMENT, V131, P1463, DOI 10.1242/dev.01033; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; Carney TJ, 2006, DEVELOPMENT, V133, P4619, DOI 10.1242/dev.02668; Cornell RA, 2005, SEMIN CELL DEV BIOL, V16, P663, DOI 10.1016/j.semcdb.2005.06.009; Cunliffe VT, 2006, MECH DEVELOP, V123, P24, DOI 10.1016/j.mod.2005.10.005; Cunliffe VT, 2004, DEVELOPMENT, V131, P2983, DOI 10.1242/dev.01166; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; del Barrio MG, 2002, DEVELOPMENT, V129, P1583; Dokmanovic M, 2007, MOL CANCER RES, V5, P981, DOI 10.1158/1541-7786.MCR-07-0324; Dutton KA, 2001, DEVELOPMENT, V128, P4113; EPSTEIN DJ, 1991, CELL, V67, P767, DOI 10.1016/0092-8674(91)90071-6; Etchevers HC, 2006, ADV EXP MED BIOL, V589, P213; Guo S, 1999, NEURON, V24, P555, DOI 10.1016/S0896-6273(00)81112-5; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Holzschuh J, 2003, DEVELOPMENT, V130, P5741, DOI 10.1242/dev.00816; Howard MJ, 2005, DEV BIOL, V277, P271, DOI 10.1016/j.ydbio.2004.09.034; Huber K, 2006, DEV BIOL, V298, P335, DOI 10.1016/j.ydbio.2006.07.010; Hunter MP, 2002, DEV BIOL, V247, P367, DOI 10.1006/dbio.2002.0701; Ignatius MS, 2008, DEV BIOL, V313, P568, DOI 10.1016/j.ydbio.2007.10.045; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kelsh RN, 2000, DEVELOPMENT, V127, P515; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Knapik EW, 1998, NAT GENET, V18, P338, DOI 10.1038/ng0498-338; Knapik EW, 1996, DEVELOPMENT, V123, P451; Knight RD, 2003, DEVELOPMENT, V130, P5755, DOI 10.1242/dev.00575; Knight RD, 2006, ADV EXP MED BIOL, V589, P120; Kos R, 2001, DEVELOPMENT, V128, P1467; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Le Douarin NM, 1999, NEURAL CREST, V2; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Lister JA, 2006, DEV BIOL, V290, P92, DOI 10.1016/j.ydbio.2005.11.014; Lucas ME, 2006, DEVELOPMENT, V133, P4015, DOI 10.1242/dev.02574; Luo RS, 2001, DEV DYNAM, V220, P169, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1097>3.0.CO;2-1; Marks PA, 2003, CURR OPIN PHARMACOL, V3, P344, DOI 10.1016/S1471-4892(03)00084-5; Medeiros DM, 2012, DEV BIOL, V371, P121, DOI 10.1016/j.ydbio.2012.08.026; Minoux M, 2010, DEVELOPMENT, V137, P2605, DOI 10.1242/dev.040048; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Nambiar RM, 2004, DEV BIOL, V267, P165, DOI 10.1016/j.ydbio.2003.11.019; Nambiar RM, 2007, MECH DEVELOP, V124, P682, DOI 10.1016/j.mod.2007.07.003; Ng LJ, 1997, DEV BIOL, V183, P108, DOI 10.1006/dbio.1996.8487; O'Brien EK, 2004, DEV BIOL, V265, P246, DOI 10.1016/j.ydbio.2003.09.029; Pillai R, 2004, DEV DYNAM, V231, P647, DOI 10.1002/dvdy.20168; Piotrowski T, 2003, DEVELOPMENT, V130, P5043, DOI 10.1242/dev.00704; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Rubinstein AL, 2000, GENESIS, V26, P86, DOI 10.1002/(SICI)1526-968X(200001)26:1<86::AID-GENE11>3.0.CO;2-Q; Sasai N, 2001, DEVELOPMENT, V128, P2525; SCHILLING TF, 1994, DEVELOPMENT, V120, P483; Sefton M, 1998, DEVELOPMENT, V125, P3111; Sonnenberg-Riethmacher E, 2001, MECH DEVELOP, V109, P253, DOI 10.1016/S0925-4773(01)00547-0; Spotswood HT, 2002, J CLIN INVEST, V110, P577, DOI 10.1172/JCI200216547; Stadler JA, 2005, DEV DYNAM, V233, P883, DOI 10.1002/dvdy.20427; Steventon B, 2005, SEMIN CELL DEV BIOL, V16, P647, DOI 10.1016/j.semcdb.2005.06.001; Stewart RA, 2004, METHOD CELL BIOL, V76, P237; Stewart RA, 2006, DEV BIOL, V292, P174, DOI 10.1016/j.ydbio.2005.12.035; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; THISSE C, 1993, DEVELOPMENT, V119, P1203; Turner BM, 2007, NAT CELL BIOL, V9, P2, DOI 10.1038/ncb0107-2; VANDENBERG P, 1991, P NATL ACAD SCI USA, V88, P7640, DOI 10.1073/pnas.88.17.7640; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yamaguchi M, 2005, DEVELOPMENT, V132, P3027, DOI 10.1242/dev.01881; YAN YL, 1995, DEV DYNAM, V203, P363, DOI 10.1002/aja.1002030308; Yan YL, 2005, DEVELOPMENT, V132, P1069, DOI 10.1242/dev.01674; Yan YL, 2002, DEVELOPMENT, V129, P5065; Yelon D, 2000, DEVELOPMENT, V127, P2573; Zhao Q, 1997, DEV DYNAM, V209, P377, DOI 10.1002/(SICI)1097-0177(199708)209:4<377::AID-AJA5>3.0.CO;2-F	74	35	35	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63218	10.1371/journal.pone.0063218	http://dx.doi.org/10.1371/journal.pone.0063218			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667588	Green Published, Green Submitted, gold			2022-12-25	WOS:000319654700118
J	McCaughan, JA; Duffy, S; O'Hagan, T; Courtney, AE; Borrows, R; Conlon, PJ; Maxwell, AP; McKnight, AJ				McCaughan, Jennifer A.; Duffy, Seamus; O'Hagan, Thomas; Courtney, Aisling E.; Borrows, Richard; Conlon, Peter J.; Maxwell, Alexander P.; McKnight, Amy Jayne			Comprehensive Investigation of the Caveolin 2 Gene: Resequencing and Association for Kidney Transplant Outcomes	PLOS ONE			English	Article							CHRONIC ALLOGRAFT NEPHROPATHY; RENAL-TRANSPLANTATION; TISSUE FIBROSIS; UNITED-STATES; IN-VITRO; EXPRESSION; SURVIVAL; CELLS; REJECTION; GENOME	Caveolae are plasma membrane structures formed from a complex of the proteins caveolin-1 and caveolin-2. Caveolae interact with pro-inflammatory cytokines and are dysregulated in fibrotic disease. Although caveolae are present infrequently in healthy kidneys, they are abundant during kidney injury. An association has been identified between a CAV1 gene variant and long term kidney transplant survival. Chronic, gradual decline in transplant function is a persistent problem in kidney transplantation. The aetiology of this is diverse but fibrosis within the transplanted organ is the common end point. This study is the first to investigate the association of CAV2 gene variants with kidney transplant outcomes. Genomic DNA from donors and recipients of 575 kidney transplants performed in Belfast was investigated for common variation in CAV2 using a tag SNP approach. The CAV2 SNP rs13221869 was nominally significant for kidney transplant failure. Validation was sought in an independent group of kidney transplant donors and recipients from Dublin, Ireland using a second genotyping technology. Due to the unexpected absence of rs13221869 from this cohort, the CAV2 gene was resequenced. One novel SNP and a novel insertion/deletion in CAV2 were identified; rs13221869 is located in a repetitive region and was not a true variant in resequenced populations. CAV2 is a plausible candidate gene for association with kidney transplant outcomes given its proximity to CAV1 and its role in attenuating fibrosis. This study does not support an association between CAV2 variation and kidney transplant survival. Further analysis of CAV2 should be undertaken with an awareness of the sequence complexities and genetic variants highlighted by this study.	[McCaughan, Jennifer A.; Duffy, Seamus; O'Hagan, Thomas; Maxwell, Alexander P.; McKnight, Amy Jayne] Queens Univ Belfast, Nephrol Res Grp, Belfast, Antrim, North Ireland; [McCaughan, Jennifer A.; Courtney, Aisling E.; Maxwell, Alexander P.] Belfast City Hosp, Reg Nephrol Unit, Belfast BT9 7AD, Antrim, North Ireland; [Borrows, Richard] Univ Hosp Birmingham, Dept Nephrol & Transplantat, Birmingham, W Midlands, England; [Conlon, Peter J.] Beaumont Hosp, Renal Unit, Dublin Kidney Transplant Res Grp, Dublin 9, Ireland	Queens University Belfast; Belfast City Hospital; University of Birmingham	McCaughan, JA (corresponding author), Queens Univ Belfast, Nephrol Res Grp, Belfast, Antrim, North Ireland.	jamccaughan@doctors.org.uk	McKnight, Amy Jayne/ABF-4492-2020	McKnight, Amy Jayne/0000-0002-7482-709X; Maxwell, Alexander P./0000-0002-6110-7253	Kidney Research UK [TF20/2012]; Northern Ireland Kidney Research Fund; Public Health Agency [STL/3714/07] Funding Source: researchfish	Kidney Research UK(Kidney Research UK (KRUK)); Northern Ireland Kidney Research Fund; Public Health Agency	Dr. Jennifer McCaughan is the recipient of a Clinical Training Fellowship from Kidney Research UK [TF20/2012] (www.kidneyresearchuk.org). This study was supported by the Northern Ireland Kidney Research Fund (www.kidneyresearchni.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Ando T, 2007, ONCOL REP, V18, P601; Barrett JC, 2009, COLD SPRING HARB PRO; Cardenas CLL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003291; Courtney AE, 2007, AM J TRANSPLANT, V7, P908, DOI 10.1111/j.1600-6143.2006.01726.x; Courtney AE, 2008, QJM-INT J MED, V101, P967, DOI 10.1093/qjmed/hcn136; DeFrancesco L, 2012, NAT BIOTECHNOL, V30, P126, DOI 10.1038/nbt0212-126a; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Djamali A, 2009, TRANSPLANTATION, V88, P1149, DOI 10.1097/TP.0b013e3181bcccea; Fajardo KVF, 2012, HUM MUTAT, V33, P609, DOI 10.1002/humu.22033; Fisher E, 2011, J NUTR, V141, P177, DOI 10.3945/jn.110.124206; Grimm PC, 2001, NEW ENGL J MED, V345, P93, DOI 10.1056/NEJM200107123450203; Hariharan S, 2000, NEW ENGL J MED, V342, P605, DOI 10.1056/NEJM200003023420901; Joosten SA, 2005, KIDNEY INT, V68, P1, DOI 10.1111/j.1523-1755.2005.00376.x; Lamb KE, 2011, AM J TRANSPLANT, V11, P450, DOI 10.1111/j.1600-6143.2010.03283.x; Laupacis A, 1996, KIDNEY INT, V50, P235, DOI 10.1038/ki.1996.307; Manetti M, 2012, ANN RHEUM DIS, V71, P1034, DOI 10.1136/annrheumdis-2011-200986; McMorrow T, 2005, NEPHROL DIAL TRANSPL, V20, P2215, DOI 10.1093/ndt/gfh967; Meier-Kriesche HU, 2004, AM J TRANSPLANT, V4, P1289, DOI 10.1111/j.1600-6143.2004.00515.x; Moore J, 2012, J AM SOC NEPHROL, V23, P1891, DOI 10.1681/ASN.2012030260; Moore J, 2010, JAMA-J AM MED ASSOC, V303, P1282, DOI 10.1001/jama.2010.356; Moriyama T, 2011, J CLIN PATHOL, V64, P504, DOI 10.1136/jcp.2010.087023; Park HC, 2010, AM J PHYSIOL-RENAL, V298, pF357, DOI 10.1152/ajprenal.00542.2009; Paul LC, 1999, KIDNEY INT, V56, P783, DOI 10.1046/j.1523-1755.1999.00611.x; Pfeufer A, 2010, NAT GENET, V42, P153, DOI 10.1038/ng.517; Phimister EG, 2012, NEW ENGL J MED, V366, P757, DOI 10.1056/NEJMe1200749; Racusen LC, 2010, KIDNEY INT, V78, pS27, DOI 10.1038/ki.2010.419; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Razani B, 2001, J BIOL CHEM, V276, P6727, DOI 10.1074/jbc.M008340200; Reeves-Daniel AM, 2011, AM J TRANSPLANT, V11, P1025, DOI 10.1111/j.1600-6143.2011.03513.x; Rienstra H, 2009, AM J TRANSPLANT, V9, P463, DOI 10.1111/j.1600-6143.2008.02534.x; Sandholm N, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002921; Savage K, 2008, BREAST CANCER RES TR, V110, P245, DOI 10.1007/s10549-007-9718-1; Scherer PE, 1997, J BIOL CHEM, V272, P29337, DOI 10.1074/jbc.272.46.29337; SCHMID CW, 1975, CELL, V6, P345, DOI 10.1016/0092-8674(75)90184-1; Solez K, 2007, AM J TRANSPLANT, V7, P518, DOI 10.1111/j.1600-6143.2006.01688.x; Stanescu HC, 2011, NEW ENGL J MED, V364, P616, DOI 10.1056/NEJMoa1009742; THIEL G, 1994, TRANSPLANT P, V26, P2493; Thorleifsson G, 2010, NAT GENET, V42, P906, DOI 10.1038/ng.661; Tourkina E, 2008, AM J PHYSIOL-LUNG C, V294, pL843, DOI 10.1152/ajplung.00295.2007; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303; Yamamoto I, 2008, AM J TRANSPLANT, V8, P2627, DOI 10.1111/j.1600-6143.2008.02421.x; Yamamoto I, 2007, AM J TRANSPLANT, V7, P1954, DOI 10.1111/j.1600-6143.2007.01876.x; Zhang GY, 2011, BRIT J DERMATOL, V164, P623, DOI 10.1111/j.1365-2133.2010.10111.x	46	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e63358	10.1371/journal.pone.0063358	http://dx.doi.org/10.1371/journal.pone.0063358			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667606	gold, Green Published, Green Submitted			2022-12-25	WOS:000319654700135
J	Schnegg, A; Burgisser, P; Andre, C; Kenfak-Foguena, A; Canellini, G; Moradpour, D; Abravanel, F; Izopet, J; Cavassini, M; Darling, KEA				Schnegg, Annatina; Buergisser, Philippe; Andre, Cyril; Kenfak-Foguena, Alain; Canellini, Giorgia; Moradpour, Darius; Abravanel, Florence; Izopet, Jacques; Cavassini, Matthias; Darling, Katharine E. A.			An Analysis of the Benefit of Using HEV Genotype 3 Antigens in Detecting Anti-HEV IgG in a European Population	PLOS ONE			English	Article							HEPATITIS-E VIRUS; BLOOD-DONORS; ANTIBODIES; INFECTION; SEROPREVALENCE; PREVALENCE; DIAGNOSIS; COUNTRIES; AVIDITY; ASSAYS	Background: The benefit of using serological assays based on HEV genotype 3 in industrialised settings is unclear. We compared the performance of serological kits based on antigens from different HEV genotypes. Methods: Taking 20 serum samples from patients in southwest France with acute HEV infection (positive PCR for HEV genotype 3) and 550 anonymised samples from blood donors in southwest Switzerland, we tested for anti-HEV IgG using three enzyme immunoassays (EIAs) (MP Diagnostics, Dia. Pro and Fortress) based on genotype 1 and 2 antigens, and one immunodot assay (Mikrogen Diagnostik recomLine HEV IgG/IgM) based on genotype 1 and 3 antigens. Results: All acute HEV samples and 124/550 blood donor samples were positive with >= 1 assay. Of PCR-confirmed patient samples, 45%, 65%, 95% and 55% were positive with MP Diagnostics, Dia. Pro, Fortress and recomLine, respectively. Of blood donor samples positive with >= 1 assay, 120/124 (97%), were positive with Fortress, 19/124 (15%) were positive with all EIAs and 51/124 (41%) were positive with recomLine. Of 11/20 patient samples positive with recomLine, stronger reactivity for HEV genotype 3 was observed in 1/11(9%), and equal reactivity for both genotypes in 5/11 (45.5%). Conclusions: Although recomLine contains HEV genotype 3, it has lower sensitivity than Fortress in acute HEV infection and fails to identify infection as being due to this genotype in approximately 45% of patients. In our single blood donor population, we observe wide variations in measured seroprevalence, from 4.2% to 21.8%, depending on the assay used.	[Schnegg, Annatina; Moradpour, Darius] Univ Lausanne, Fac Biol & Med, Lausanne, Switzerland; [Buergisser, Philippe; Andre, Cyril] Univ Lausanne, Univ Lausanne Hosp, Serv Immunol & Allergy, Lausanne, Switzerland; [Kenfak-Foguena, Alain; Cavassini, Matthias; Darling, Katharine E. A.] Univ Lausanne, Univ Lausanne Hosp, Lausanne, Switzerland; [Canellini, Giorgia] Serv Reg Vaudois Transfus Sanguine, Epalinges, Switzerland; [Abravanel, Florence; Izopet, Jacques] Ctr Physiopathol Toulouse Purpan, INSERM, U1043, Toulouse, France; [Abravanel, Florence; Izopet, Jacques] Hop Purpan, CHU Toulouse, Virol Lab, Inst Federatif Biol Purpan, Toulouse, France	University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse	Darling, KEA (corresponding author), Univ Lausanne, Univ Lausanne Hosp, Lausanne, Switzerland.	Katharine.Darling@chuv.ch	ABRAVANEL, Florence/AAC-2993-2021; Abrvaanel, florence/K-3776-2014; IZOPET, Jacques/L-5756-2014; cavassini, matthias/F-8987-2017; Moradpour, Darius/G-7918-2017	ABRAVANEL, Florence/0000-0002-1753-1065; Darling, Katharine/0000-0003-1449-3873; Schnegg-Kaufmann, Annatina/0000-0001-7716-3340; Kenfak Foguena, Alain/0000-0002-8213-2490; cavassini, matthias/0000-0003-0933-7833; Moradpour, Darius/0000-0003-1977-6792	outpatients department of the service of Infectious Diseases of the Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland	outpatients department of the service of Infectious Diseases of the Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland	The study has been funded by the research fund of the outpatients department of the service of Infectious Diseases of the Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abravanel F, 2012, J CLIN MICROBIOL, V50, P897, DOI 10.1128/JCM.05942-11; Aggarwal R, 2011, VIRUS RES, V161, P15, DOI 10.1016/j.virusres.2011.03.017; Bendall R, 2010, J MED VIROL, V82, P799, DOI 10.1002/jmv.21656; Bigaillon C, 2010, J VIROL METHODS, V164, P127, DOI 10.1016/j.jviromet.2009.11.028; Christensen PB, 2008, CLIN INFECT DIS, V47, P1026, DOI 10.1086/591970; Clemente-Casares P, 2003, EMERG INFECT DIS, V9, P448; Dalekos GN, 1998, TRANSFUSION, V38, P589, DOI 10.1046/j.1537-2995.1998.38698326339.x; Herremans M, 2007, CLIN VACCINE IMMUNOL, V14, P562, DOI 10.1128/CVI.00231-06; Kamar N, 2008, NEW ENGL J MED, V358, P811, DOI 10.1056/NEJMoa0706992; Kamar N, 2012, LANCET, V379, P2477, DOI 10.1016/S0140-6736(11)61849-7; Kaufmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021150; Kenfak-Foguena A, 2011, EMERG INFECT DIS, V17, P1074, DOI [10.3201/eid1706.101067, 10.3201/eid/1706.101067]; Khudyakov Y, 2011, VIRUS RES, V161, P84, DOI 10.1016/j.virusres.2011.06.006; Li RC, 2006, EMERG INFECT DIS, V12, P1682, DOI 10.3201/eid1211.060332; Lin CC, 2000, J CLIN MICROBIOL, V38, P3915, DOI 10.1128/JCM.38.11.3915-3918.2000; Mansuy JM, 2011, EMERG INFECT DIS, V17, P2309, DOI 10.3201/eid1712.110371; Mast EE, 1998, HEPATOLOGY, V27, P857, DOI 10.1002/hep.510270331; Mitsui T, 2005, J MED VIROL, V76, P526, DOI 10.1002/jmv.20393; Turner J, 2010, J MED VIROL, V82, P1899, DOI 10.1002/jmv.21905; YARBOUGH PO, 1991, J VIROL, V65, P5790, DOI 10.1128/JVI.65.11.5790-5797.1991; Zhang JZ, 2002, J MED VIROL, V66, P40, DOI 10.1002/jmv.2109	21	46	47	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62980	10.1371/journal.pone.0062980	http://dx.doi.org/10.1371/journal.pone.0062980			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667554	Green Submitted, Green Published, gold			2022-12-25	WOS:000319654700092
J	Zhu, F; Wu, BY; Li, P; Wang, JB; Tang, HY; Liu, Y; Zuo, XB; Cheng, H; Ding, YT; Wang, W; Zhai, YJ; Qian, FF; Wang, WJ; Yuan, XF; Wang, J; Ha, WW; Hou, JS; Zhou, FS; Wang, Y; Gao, JP; Sheng, YJ; Sun, LD; Liu, JJ; Yang, S; Zhang, XJ				Zhu, Fei; Wu, Baoyu; Li, Ping; Wang, Jianbo; Tang, Huayang; Liu, Ye; Zuo, Xianbo; Cheng, Hui; Ding, Yantao; Wang, Wen; Zhai, Yujuan; Qian, Fangfang; Wang, Wenju; Yuan, Xiangfeng; Wang, Jing; Ha, Weiwei; Hou, Junsheng; Zhou, Fusheng; Wang, Yin; Gao, Jinping; Sheng, Yujun; Sun, Liangdan; Liu, Jianjun; Yang, Sen; Zhang, Xuejun			Association Study Confirmed Susceptibility Loci with Keloid in the Chinese Han Population	PLOS ONE			English	Article							GENETIC SUSCEPTIBILITY; TGF-BETA; FIBROBLAST PROLIFERATION; DISEASE; POLYMORPHISMS; DEGRADATION; EXPRESSION; RECEPTOR; LIGASE; NEDD4	Keloid is benign fibroproliferative dermal tumors with unknown etiology. Recently, a genome-wide association study (GWAS) in Japanese population has identified 3 susceptibility loci (rs873549 at 1q41, rs940187 and rs1511412 at 3q22.3, rs8032158 at 15p21.3) for keloid. In order to examine whether these susceptibility loci are associated with keloid in the Chinese Han population, twelve previously reported SNPs were selected for replication in 714 cases and 2,944 controls by using Sequenom MassArray system. We found three SNPs in two regions showed significant association with keloid in the Chinese Han population: 1q41 (rs873549, P = 3.03 x 10(-33), OR = 2.05, 95% CI: 1.82-2.31 and rs1442440, P = 9.85 x 10(-18), OR = 0.56, 95% CI: 0.49-0.64, respectively) and 15q21.3 (rs2271289 located in NEDD4, P = 1.02 x 10(-11), OR = 0.66, 95% CI: 0.58-0.74). We also detected one risk haplotype AG (P = 1.36 x 10(-31), OR = 2.02) and two protective haplotypes of GA and AA (GA, P = 1.94 x 10(-19), OR = 0.53, AA, P = 0.00043, OR = 0.78, respectively) from the two SNPs (rs873549 and rs1442440). Our study confirmed two previously reported loci 1q41 and 15q21.3 for keloid in the Chinese Han population, which suggested the common genetic factor predisposing to the development of keloid shared by the Chinese Han and Japanese populations.	[Zhu, Fei; Wu, Baoyu; Li, Ping; Wang, Jianbo; Tang, Huayang; Cheng, Hui; Ding, Yantao; Wang, Wen; Zhai, Yujuan; Qian, Fangfang; Wang, Wenju; Yuan, Xiangfeng; Wang, Jing; Ha, Weiwei; Hou, Junsheng; Gao, Jinping; Sheng, Yujun; Sun, Liangdan; Yang, Sen; Zhang, Xuejun] Anhui Med Univ, Hosp 1, Inst Dermatol, Hefei, Anhui, Peoples R China; [Zhu, Fei; Wu, Baoyu; Li, Ping; Wang, Jianbo; Tang, Huayang; Cheng, Hui; Ding, Yantao; Wang, Wen; Zhai, Yujuan; Qian, Fangfang; Wang, Wenju; Yuan, Xiangfeng; Wang, Jing; Ha, Weiwei; Hou, Junsheng; Gao, Jinping; Sheng, Yujun; Sun, Liangdan; Yang, Sen; Zhang, Xuejun] Anhui Med Univ, Hosp 1, Dept Dermatol, Hefei, Anhui, Peoples R China; [Zhu, Fei; Wu, Baoyu; Li, Ping; Wang, Jianbo; Tang, Huayang; Zuo, Xianbo; Cheng, Hui; Ding, Yantao; Wang, Wen; Zhai, Yujuan; Qian, Fangfang; Wang, Wenju; Yuan, Xiangfeng; Wang, Jing; Ha, Weiwei; Hou, Junsheng; Zhou, Fusheng; Gao, Jinping; Sheng, Yujun; Sun, Liangdan; Liu, Jianjun; Yang, Sen; Zhang, Xuejun] Anhui Med Univ, Minist Educ, Key Lab Dermatol, Hefei, Anhui, Peoples R China; [Zhu, Fei; Wu, Baoyu; Li, Ping; Wang, Jianbo; Tang, Huayang; Zuo, Xianbo; Cheng, Hui; Ding, Yantao; Wang, Wen; Zhai, Yujuan; Qian, Fangfang; Wang, Wenju; Yuan, Xiangfeng; Wang, Jing; Ha, Weiwei; Hou, Junsheng; Zhou, Fusheng; Gao, Jinping; Sheng, Yujun; Sun, Liangdan; Liu, Jianjun; Yang, Sen] Anhui Med Univ, State Key Lab Incubat Base Dermatol, Hefei, Anhui, Peoples R China; [Zhu, Fei; Liu, Ye; Wang, Yin] Anhui Med Univ, Hosp 1, Dept Plast Surg, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University; Anhui Medical University; Anhui Medical University	Liu, JJ (corresponding author), Anhui Med Univ, Minist Educ, Key Lab Dermatol, Hefei, Anhui, Peoples R China.	liuj3@gis.a-star.edu.sg; ayzxj@vip.sina.com	Chen, Gang/G-2722-2010; Liu, Jianjun/AAK-4989-2020; SHENG, Yu/GXZ-8269-2022	Liu, Jianjun/0000-0002-3255-3019; Wang, Wen/0000-0001-6620-1049; zhu, fei/0000-0002-9122-1161	General Program of National Natural Science Foundation of China [30973124]	General Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by General Program of National Natural Science Foundation of China (30973124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anan T, 1998, GENES CELLS, V3, P751, DOI 10.1046/j.1365-2443.1998.00227.x; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bayat A, 2005, BRIT J PLAST SURG, V58, P28, DOI 10.1016/j.bjps.2004.04.024; Bayat A, 2004, EXP DERMATOL, V13, P120, DOI 10.1111/j.0906-6705.2004.00165.x; Bayat A, 2003, PLAST RECONSTR SURG, V111, P535, DOI 10.1097/01.PRS.0000041536.02524.A3; Bayat A, 2003, BRIT MED J, V326, P88, DOI 10.1136/bmj.326.7380.88; Bettinger DA, 1996, PLAST RECONSTR SURG, V98, P827, DOI 10.1097/00006534-199610000-00012; Brown BC, 2008, J PLAST RECONSTR AES, V61, P1049, DOI 10.1016/j.bjps.2008.03.020; Brown JJ, 2009, BRIT J DERMATOL, V161, P8, DOI 10.1111/j.1365-2133.2009.09258.x; Brown JJ, 2008, EXP DERMATOL, V17, P610, DOI 10.1111/j.1600-0625.2007.00654.x; Cordell HJ, 2005, LANCET, V366, P1121, DOI 10.1016/S0140-6736(05)67424-7; Izzi L, 2004, ONCOGENE, V23, P2071, DOI 10.1038/sj.onc.1207412; Izzi L, 2006, NEOPLASIA, V8, P677, DOI 10.1593/neo.06472; Kelly A Paul, 2004, Dermatol Ther, V17, P212, DOI 10.1111/j.1396-0296.2004.04022.x; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Kumar S, 1997, GENOMICS, V40, P435, DOI 10.1006/geno.1996.4582; Lua WS, 2011, BURNS, V37, P794, DOI 10.1016/j.burns.2011.01.003; Marneros AG, 2004, J INVEST DERMATOL, V122, P1126, DOI 10.1111/j.0022-202X.2004.22327.x; Marneros Alexander G, 2004, J Dtsch Dermatol Ges, V2, P905, DOI 10.1046/j.1439-0353.2004.04077.x; Moren A, 2005, J BIOL CHEM, V280, P22115, DOI 10.1074/jbc.M414027200; Nakashima M, 2010, NAT GENET, V42, P768, DOI 10.1038/ng.645; Phan TT, 2003, AM J PHYSIOL-CELL PH, V284, pC860, DOI 10.1152/ajpcell.00350.2002; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Shih B, 2010, ARCH DERMATOL RES, V302, P319, DOI 10.1007/s00403-009-1014-y; Vecchione A, 2003, MOL CELL BIOL, V23, P3363, DOI 10.1128/MCB.23.9.3363-3372.2003; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039	26	29	31	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62377	10.1371/journal.pone.0062377	http://dx.doi.org/10.1371/journal.pone.0062377			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667473	gold, Green Published			2022-12-25	WOS:000319654700034
J	Horacek, I; Knitlova, M; Wagner, J; Kordos, L; Nadachowski, A				Horacek, Ivan; Knitlova, Marketa; Wagner, Jan; Kordos, Laszlo; Nadachowski, Adam			Late Cenozoic History of the Genus Micromys (Mammalia, Rodentia) in Central Europe	PLOS ONE			English	Article							MURIDAE RODENTIA; PLIOCENE; NEOGENE; BASIN; PLEISTOCENE; MIOCENE; SPAIN; CHRONOLOGY; GRANADA; GREECE	Molecular phylogeography suggests that Micromys minutus, the sole extant species of the genus, colonized its extensive range quite recently, during the Late Pleistocene-Holocene period. Rich Pliocene and Pleistocene fossil records both from Europe and China suggest rather continuous and gradual in situ phenotype rearrangements from the Pliocene to the Recent periods. To elucidate the discrepancy we reexamined a considerable part of the European fossil record of the genus (14 sites from MN15 to Q3, 0.4-4.2 Ma, including the type series of M. preaminutus from MN15 Csarnota 2), analyzed them with the aid of detailed morphometric comparisons, and concluded that: (a) The European Pliocene form, M. praeminutus, differs significantly from the extant species; (b) it exhibits a broad phenotypic variation covering the presumptive diagnostic characters of MN16 M. caesaris; (c) despite having smaller dimensions, the Early and Middle Pleistocene forms (MN17-Q3, 2.6-0.4 Ma) seem to be closer to M. praeminutus than to the extant species; (d) the extinction of M. praeminutus during Q3 and the re-occupation of its niche by the recent expansion of M. minutus from E-European - C Asiatic sources (suggested by phylogeographic hypotheses) cannot be excluded. Discussing interpretations of the phylogenetic past of the genus we emphasize the distinct history of the West Palearctic clade (Late Miocene-Early Pleistocene) terminating with M. praeminutus and the East Asiatic clade (chalceus, tedfordi, minutus), and the possible identity of the Western clade with the Late Miocene genus Parapodemus.	[Horacek, Ivan; Knitlova, Marketa] Charles Univ Prague, Dept Zool, Prague, Czech Republic; [Wagner, Jan] Inst Geol AS CR, Vvi, Prague, Czech Republic; [Kordos, Laszlo] Magyar Foldtani & Geofizikai Intezet, Budapest, Hungary; [Nadachowski, Adam] Inst Systemat & Evolut Anim PAS, Krakow, Poland	Charles University Prague; Czech Academy of Sciences; Institute of Geology of the Czech Academy of Sciences; Polish Academy of Sciences; Institute of Systematics & Evolution of Animals of the Polish Academy of Sciences	Horacek, I (corresponding author), Charles Univ Prague, Dept Zool, Prague, Czech Republic.	horacek@natur.cuni.cz	Horacek, Ivan/V-9741-2017; Knitlova, Marketa/Q-1044-2017	Horacek, Ivan/0000-0002-8356-5554; Nadachowski, Adam/0000-0001-6452-3028; Knitlova, Marketa/0000-0001-6271-9991	Grant Agency of the Czech Republic [GA205/09/0184]; GAUK [355511]; Institute of Geology AS CR, v.v.i. [AVOZ30130516, RVO67985831]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); GAUK; Institute of Geology AS CR, v.v.i.(Czech Academy of Sciences)	The study was supported by grant No. GA205/09/0184 from the Grant Agency of the Czech Republic (to JW and IH), GAUK 355511 (to MK), and by institutional project AVOZ30130516 and RVO67985831 of the Institute of Geology AS CR, v.v.i. (JW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar Jean-Pierre, 2002, Geologie de la France, V4, P17; Aguilar Jean-Pierre, 1996, Acta Zoologica Cracoviensia, V39, P35; Agusti J, 2001, EARTH-SCI REV, V52, P247, DOI 10.1016/S0012-8252(00)00025-8; Agusti J, 2010, QUATERN INT, V223, P162, DOI 10.1016/j.quaint.2009.12.011; Alpaslan Fadime Suata, 2010, Cumhuriyet Universitesi Fen Edebiyat Fakultesi Fen Bilimleri Dergisi, V31, P1; Antonanzas RL, 2002, PALAEOGEOGR PALAEOCL, V186, P311; BERGGREN WA, 1995, GEOL SOC AM BULL, V107, P1272, DOI 10.1130/0016-7606(1995)107<1272:LNCNPI>2.3.CO;2; Bernor R.L., 1996, P449; de Bruijn H., 1989, Bollettino della Societa Paleontologica Italiana, V28, P189; de Bruijn H., 1996, P253; De Bruijn H, 1976, P KON NEDERL AKAD B, V79, P361; Dehm R., 1962, Mitteilungen der Bayerischen Staatssammlung fuer Palaeontologie und Historische Geologie, V2, P17; Fejfar O., 1990, Senckenbergiana Lethaea, V71, P139; Fejfar O., 1983, Schriftenreihe fuer Geologische Wissenschaften, V19-20, P61; Fejfar O., 1983, Schriftenreihe fuer Geologische Wissenschaften, V19-20, P111; Garcia-Alix A, 2008, NEUES JAHRB GEOL P-A, V248, P183, DOI 10.1127/0077-7749/2008/0248-0183; Heinrich W.-D., 1983, Wissenschaftliche Zeitschrift der Humboldt-Universitaet zu Berlin Mathematisch-Naturwissenschaftliche Reihe, V32, P729; HELLER F., 1936, NEUES JB MINERALOGIE, V76, P99, DOI [10.1007/BF03042849, DOI 10.1007/BF03042849]; HORACEK I, 1988, Rozpravy Ceskoslovenske Akademie Ved Rada Matematickych a Prirodnich Ved, V98, P1; Horacek I., 1985, Casopis pro Mineralogii a Geologii, V30, P353; JAEGER JJ, 1989, PHILOS T ROY SOC B, V325, P401, DOI 10.1098/rstb.1989.0096; Jannosy D, 1986, QUARTARPALAONTOLOGIE; Janossy D, 1986, PALEOBIOLOGIE CONTIN; Janossy D, 1976, KARSZT BARLANGKUTATA, V8, P3; Jeannet Marcel, 2009, Revue de Paleobiologie, V28, P139; Kormos T., 1911, FOLDTANI KOZLONY, V41, P171; Koufos G. D., 2006, Hellenic Journal of Geosciences, V41, P183; Kowalski K., 2001, FOLIA QUATERNARIA, V72, P1; KOWALSKI KAZIMIREZ, 1956, ACTA PALEONTOL POLONICA, V1, P331; KOWALSKL KAZIMIERZ, 1960, ACTA ZOOL CRACOVIENSIA, V5, P155; Kretzoi M., 1959, Vertebrata Hungarica, V1, P237; Kretzoi M, 1962, MAGYAR ALLAMI FOLDTA, V1959, P297; Krokhmal AI, 2010, LOCALITIES SMALL PLE; Lazzari V, 2010, PALEOBIOLOGY, V36, P641, DOI 10.1666/09046.1; Lecompte E, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-199; Lisiecki LE, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001071; Lungu A. N, 1981, HIPPARION FAUNA MIDD; Marquet J.C., 1993, CAHIERS CLAISE S, V2, P1; Martin Suarez E., 1993, Scripta Geologica, V103, P65; Martin-Suarez E, 1998, GEOBIOS-LYON, V31, P839, DOI 10.1016/S0016-6995(98)80113-7; Mein P., 1993, Scripta Geologica, V103, P41; MEIN P, 1989, NATO ADV SCI I A-LIF, V180, P73; MEIN P, 1978, Geobios (Villeurbanne), V11, P389, DOI 10.1016/S0016-6995(78)80038-2; MEIN P, 1983, CR ACAD SCI II, V296, P1603; MEIN P, 1978, DOCUMENTS LAB GEOLOG, V72, P99; Mein P, 1976, P 6 C R C M N S, V2, P78; Michaux J, 2007, J ZOOL SYST EVOL RES, V45, P263, DOI 10.1111/j.1439-0469.2006.00390.x; Michaux J., 1969, Palaeovertebrata (Montpellier), V3, P1; Michaux J, 1971, PAL OBIOLOGIE CONTIN, V2, P1; Minwer-Barakat R, 2005, J VERTEBR PALEONTOL, V25, P426, DOI 10.1671/0272-4634(2005)025[0426:MRFTPO]2.0.CO;2; Minwer-Barakat R, 2008, J PALEONTOL, V82, P436, DOI 10.1666/06-030.1; Nadachowski Adam, 1990, Quartaerpalaeontologie, V8, P215; Nesin Valentin A., 2004, Senckenbergiana Lethaea, V84, P351; Papp A., 1947, Sitzungsberichte Akademie der Wissenschaften Wien Abt 1, V156, P371; Qiu Z.D., 1990, J VERTEBR PALEONTOL, V10, P467, DOI DOI 10.1080/02724634.1990.10011829; Rekovets LI, 1994, SMALL PLEISTOCENE MA; Reumer JWF, 2003, TORNO FOSILES MAMIFE, P269; Rowe KC, 2008, MOL PHYLOGENET EVOL, V47, P84, DOI 10.1016/j.ympev.2008.01.001; Schaub S., 1938, Abhandlungen der Schweizerischen Palaeontologischen Gesellschaft Geneve, V61, P1; Sen S., 2003, P125; Storch G, 2002, GEOBIOS-LYON, V35, P515, DOI 10.1016/S0016-6995(02)00043-8; Storch G., 1987, Senckenbergiana Lethaea, V67, P401; STORCH G, 1973, Senckenbergiana Lethaea, V54, P311; Storch G, 2004, TERRA NOSTRA, V2004; Storch Gerhard, 1995, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V28, P121; Suarez EM, 1998, GEOBIOS-LYON, V31, P87; SULIMSKI ANDRZEJ, 1964, ACTA PALAEONTOL POL, V9, P149; Van Dam Jan A., 1997, Geologica Ultraiectina, V156, P1; van de Weerd A., 1978, Geobios (Villeurbanne), V11, P921; van de Weerd A, 1976, UTRECHT MICROPALEONT, V2; van der Meulen A.J., 1988, Memorie della Societa Geologica Italiana, V31, P201; VANDEWEERD A, 1979, P K NED AKAD B PHYS, V82, P127; Vasileiadou Katerina, 2012, Palaeobiodiversity and Palaeoenvironments, V92, P211, DOI 10.1007/s12549-012-0075-7; Vasileiadou Katerina V., 2003, Deinsea (Rotterdam), V10, P549; Wessels W., 2009, GEOL ULTRAIECTINA, V307; Wu Wenyu, 1992, Vertebrata Palasiatica, V30, P17; Yasuda SP, 2005, CAN J ZOOL, V83, P1411, DOI 10.1139/Z05-139	77	7	10	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 6	2013	8	5							e62498	10.1371/journal.pone.0062498	http://dx.doi.org/10.1371/journal.pone.0062498			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	177QL	23671605	Green Published, gold			2022-12-25	WOS:000321390200025
J	Dou, XL; Qin, RL; Qu, J; Liao, YH; Lu, YC; Zhang, T; Shao, C; Li, YQ				Dou, Xiao Liang; Qin, Rong Liang; Qu, Juan; Liao, Yong Hui; Lu, Ya Cheng; Zhang, Ting; Shao, Chen; Li, Yun Qing			Synaptic Connections between Endomorphin 2-Immunoreactive Terminals and mu-Opioid Receptor-Expressing Neurons in the Sacral Parasympathetic Nucleus of the Rat	PLOS ONE			English	Article							URINARY-BLADDER CONTRACTIONS; CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD; PREGANGLIONIC NEURONS; IMMUNOHISTOCHEMICAL LOCALIZATION; AUTORADIOGRAPHIC LOCALIZATION; IMMUNOPOSITIVE FIBERS; MICTURITION REFLEX; INTERSTITIAL-CELLS; PRIMARY AFFERENTS	The urinary bladder is innervated by parasympathetic preganglionic neurons (PPNs) that express mu-opioid receptors (MOR) in the sacral parasympathetic nucleus (SPN) at lumbosacral segments L6-S1. The SPN also contains endomorphin 2 (EM2)-immunoreactive (IR) fibers and terminals. EM2 is the endogenous ligand of MOR. In the present study, retrograde tract-tracing with cholera toxin subunit b (CTb) or wheat germ agglutinin-conjugated horseradish peroxidase (WGA-HRP) via the pelvic nerve combined with immunohistochemical staining for EM2 and MOR to identify PPNs within the SPN as well as synaptic connections between the EM2-IR terminals and MOR-expressing PPNs in the SPN of the rat. After CTb was injected into the pelvic nerve, CTb retrogradely labeled neurons were almost exclusively located in the lateral part of the intermediolateral gray matter at L6-S1 of the lumbosacral spinal cord. All of the them also expressed MOR. EM2-IR terminals formed symmetric synapses with MOR-IR, WGA-HRP-labeled and WGA-HRP/MOR double-labeled neuronal cell bodies and dendrites within the SPN. These results provided morphological evidence that EM2-containing axon terminals formed symmetric synapses with MOR-expressing PPNs in the SPN. The present results also show that EM2 and MOR might be involved in both the homeostatic control and information transmission of micturition.	[Dou, Xiao Liang; Qin, Rong Liang; Shao, Chen] Fourth Mil Med Univ, Xijing Hosp, Dept Urol, Xian 710032, Peoples R China; [Qu, Juan; Liao, Yong Hui; Lu, Ya Cheng; Zhang, Ting; Li, Yun Qing] Fourth Mil Med Univ, Dept Anat Histol & Embryol, Xian 710032, Peoples R China; [Qu, Juan; Liao, Yong Hui; Lu, Ya Cheng; Zhang, Ting; Li, Yun Qing] Fourth Mil Med Univ, KK Leung Brain Res Ctr, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Shao, C (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Urol, Xian 710032, Peoples R China.	shaochen@fmmu.edu.cn; deptanat@fmmu.edu.cn			National Natural Science Foundation of China [30771133, 31010103909]; International Cooperation Program [2011DFA3311]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Cooperation Program	This work was supported by grants from the National Natural Science Foundation of China(http://www.nsfc.gov.cn/Portal0/default152.htm)(Nos. 30771133, 31010103909) and the International Cooperation Program (http://www.nsfc.gov.cn/Portal0/default152.htm)(No. 2011DFA3311). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banrezes B, 2002, NEUROSCIENCE, V115, P97, DOI 10.1016/S0306-4522(02)00405-0; Beckel Jonathan M, 2011, Handb Exp Pharmacol, P99, DOI 10.1007/978-3-642-16499-6_6; Blok BFM, 1998, BEHAV BRAIN RES, V92, P119, DOI 10.1016/S0166-4328(97)00184-8; Blok BFM, 2002, SCAND J UROL NEPHROL, V36, P11, DOI 10.1080/003655902320765908; Buss RR, 2003, J PHYSIOL-LONDON, V551, P387, DOI 10.1113/jphysiol.2003.041996; Carter R. R., 1995, IEEE Transactions on Rehabilitation Engineering, V3, P206, DOI 10.1109/86.392367; de Groat WC, 2006, BRIT J PHARMACOL, V147, pS25, DOI 10.1038/sj.bjp.0706604; DEGROAT WC, 1993, UROL CLIN N AM, V20, P383; DEGROAT WC, 1981, J AUTONOM NERV SYST, V3, P135, DOI 10.1016/0165-1838(81)90059-X; DEGROAT WC, 1982, J AUTONOM NERV SYST, V5, P23, DOI 10.1016/0165-1838(82)90087-X; DEGROAT WC, 1975, BRAIN RES, V87, P201, DOI 10.1016/0006-8993(75)90417-5; Ding YQ, 1997, J COMP NEUROL, V389, P149, DOI 10.1002/(SICI)1096-9861(19971208)389:1<149::AID-CNE11>3.0.CO;2-G; Ding YQ, 1996, J COMP NEUROL, V367, P375; Dmitrieva N, 2002, J NEUROSCI, V22, P7147; DRAY A, 1984, J PHARMACOL EXP THER, V231, P254; DRAY A, 1987, NEUROPHARMACOLOGY, V26, P753, DOI 10.1016/0028-3908(87)90238-3; DRAY A, 1985, BRAIN RES, V337, P142, DOI 10.1016/0006-8993(85)91619-1; DRAY A, 1984, EUR J PHARMACOL, V104, P47, DOI 10.1016/0014-2999(84)90367-4; Farquhar-Smith WP, 2001, ANESTHESIOLOGY, V94, P507, DOI 10.1097/00000542-200103000-00023; GOUARDERES C, 1991, NEUROSCIENCE, V43, P197, DOI 10.1016/0306-4522(91)90427-P; Grill WM, 1999, BRAIN RES, V836, P19, DOI 10.1016/S0006-8993(99)01581-4; Gu Y. M., 1991, CHINESE J NEUROANAT, V7, P124; HANCOCK MB, 1979, NEUROSCI LETT, V11, P1, DOI 10.1016/0304-3940(79)90046-6; Hiragata S, 2007, UROLOGY, V70, P202, DOI 10.1016/j.urology.2007.02.069; HISAMITSU T, 1984, BRAIN RES, V298, P51, DOI 10.1016/0006-8993(84)91146-6; HONDA CN, 1995, NEUROREPORT, V6, P1025, DOI 10.1097/00001756-199505090-00019; Hui R, 2010, NEUROSCIENCE, V169, P422, DOI 10.1016/j.neuroscience.2010.05.006; IGAWA Y, 1993, BRIT J PHARMACOL, V110, P257, DOI 10.1111/j.1476-5381.1993.tb13802.x; JUBELIN B, 1984, LIFE SCI, V34, P2015, DOI 10.1016/0024-3205(84)90366-7; KONTANI H, 1988, JPN J PHARMACOL, V48, P31, DOI 10.1254/jjp.48.31; KRUSE MN, 1992, AM J PHYSIOL, V262, pR478, DOI 10.1152/ajpregu.1992.262.3.R478; Lagou M, 2006, BJU INT, V97, P1332, DOI 10.1111/j.1464-410X.2006.06203.x; LAPLANE D, 1981, J NEUROL SCI, V51, P289, DOI 10.1016/0022-510X(81)90107-6; Li JL, 1998, BRAIN RES, V794, P347, DOI 10.1016/S0006-8993(98)00332-1; MAGGI CA, 1989, J AUTONOM NERV SYST, V26, P11, DOI 10.1016/0165-1838(89)90102-1; Mannen T, 2000, NEUROPATHOLOGY, V20, pS30; MANSOUR A, 1994, BRAIN RES, V643, P245, DOI 10.1016/0006-8993(94)90031-0; Mansour A., 1993, OPIOIDS, P79, DOI [10.1007/978-3-642-77460-7, DOI 10.1007/978-3-642-77460-7_5]; Martin RS, 2000, BRIT J PHARMACOL, V129, P1707, DOI 10.1038/sj.bjp.0703229; Martin-Schild S, 1997, PEPTIDES, V18, P1641, DOI 10.1016/S0196-9781(97)00320-3; Martin-Schild S, 1998, PEPTIDES, V19, P1783, DOI 10.1016/S0196-9781(98)00136-3; Moriwaki A, 1996, NEUROCHEM RES, V21, P1315, DOI 10.1007/BF02532373; MOSKOWITZ AS, 1984, J NEUROSCI, V4, P1331; NADELHAFT I, 1984, J COMP NEUROL, V226, P238, DOI 10.1002/cne.902260207; Nagasaka Y, 2007, INT J UROL, V14, P226, DOI 10.1111/j.1442-2042.2007.01700.x; Okada M, 1986, Masui, V35, P877; PASCUAL JI, 1993, J UROLOGY, V150, P500, DOI 10.1016/S0022-5347(17)35535-0; Pertwee RG, 1996, BRIT J PHARMACOL, V118, P2053, DOI 10.1111/j.1476-5381.1996.tb15643.x; Pierce TL, 1998, NEUROREPORT, V9, P385, DOI 10.1097/00001756-199802160-00005; Rivero G, 2012, MOL PHARMACOL, V82, P178, DOI 10.1124/mol.112.078659; SHELDON RJ, 1987, J PHARMACOL EXP THER, V243, P234; Shimizu I, 2000, BRIT J PHARMACOL, V131, P610, DOI 10.1038/sj.bjp.0703593; Spetea M, 1998, BIOCHEM BIOPH RES CO, V250, P720, DOI 10.1006/bbrc.1998.9395; SUGAYA K, 1987, NEUROSCI LETT, V80, P197, DOI 10.1016/0304-3940(87)90653-7; Tai CF, 2004, EXP NEUROL, V190, P171, DOI 10.1016/j.expneurol.2004.07.001; Wang YQ, 2010, J SURG RES, V164, pE213, DOI 10.1016/j.jss.2010.04.040; Yoshimora N, 2007, CAMPBELLWALSH UROLOG, P1922; Zadina JE, 1997, NATURE, V386, P499, DOI 10.1038/386499a0; Zadina JE, 1999, ANN NY ACAD SCI, V897, P136, DOI 10.1111/j.1749-6632.1999.tb07885.x; Zhu C, 2011, BRAIN RES, V1410, P38, DOI 10.1016/j.brainres.2011.06.067	60	7	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 3	2013	8	5							e62028	10.1371/journal.pone.0062028	http://dx.doi.org/10.1371/journal.pone.0062028			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AS	23671582	gold, Green Published, Green Submitted			2022-12-25	WOS:000321202100004
J	Ji, LN; Li, HM; Guo, XH; Li, Y; Hu, RM; Zhu, ZY				Ji, Linong; Li, Hongmei; Guo, Xiaohui; Li, Yan; Hu, Renming; Zhu, Zhengying			Impact of Baseline BMI on Glycemic Control and Weight Change with Metformin Monotherapy in Chinese Type 2 Diabetes Patients: Phase IV Open-Label Trial	PLOS ONE			English	Article							BODY-MASS INDEX; NONOBESE PATIENTS; RISK-FACTORS; THERAPY; HYPERGLYCEMIA; EFFICACY; ADULTS	Background: Differences exist between treatment recommendations regarding the choice of metformin as first-line therapy for type 2 diabetes patients according to body mass index (BMI). This study compared the efficacy of metformin monotherapy among normal-weight, overweight, and obese patients with newly diagnosed type 2 diabetes. Methods: In this prospective, multicenter, open-label study in China, patients aged 23-77 years were enrolled 1: 1: 1 according to baseline BMI: normal-weight (BMI 18.5-23.9 kg/m(2); n = 125); overweight (BMI 24.0-27.9 kg/m(2); n = 122) or obese (BMI >= 28 kg/m(2); n = 124). Extended-release metformin was administered for 16 weeks (500 mg/day, up-titrated weekly to a maximum 2,000 mg/day). The primary efficacy endpoint was the effect of baseline BMI on glycemic control with metformin monotherapy, measured as the change from baseline in glycosylated hemoglobin (HbA(1c)) at week 16 compared among BMI groups using ANCOVA. Other endpoints included comparisons of metformin's effects on fasting plasma glucose (FPG), lipid levels and body weight. Results: Mean HbA1c decreases at week 16, adjusted for baseline values, were -1.84%, -1.78% and -1.78% in normal-weight, overweight and obese patients, (P = 0.664); body weight decreased by 2.4%, 3.9% and 3.5%, respectively. FPG levels decreased similarly over time in all BMI groups (P = 0.461) and changes from baseline in high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C) did not differ significantly among BMI groups at week 16 (P = 0.143 and 0.451, respectively). Conclusions: Baseline BMI had no impact on glycemic control, weight change or other efficacy measures with metformin monotherapy. These data suggest that normal-weight type 2 diabetes patients would derive the same benefits from first-line treatment with metformin as overweight and obese patients, and are not at increased risk of excess weight loss.	[Ji, Linong] Peking Univ, Peoples Hosp, Dept Endocrinol & Metab, Beijing 100871, Peoples R China; [Li, Hongmei] Sino Amer Shanghai Squibb Pharmaceut Ltd, Clin Res, China Res & Dev, Shanghai, Peoples R China; [Guo, Xiaohui] Peking Univ, Peoples Hosp, Dept Endocrinol, Beijing 100871, Peoples R China; [Li, Yan] Sun Yat Sen Univ, Dept Endocrinol, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China; [Hu, Renming] Fudan Univ, Huashan Hosp, Dept Endocrinol & Metab, Shanghai 200433, Peoples R China; [Zhu, Zhengying] Bristol Myers Squibb, China Res & Dev, Clin Res, Shanghai, Peoples R China	Peking University; Peking University; Sun Yat Sen University; Fudan University; Bristol-Myers Squibb	Ji, LN (corresponding author), Peking Univ, Peoples Hosp, Dept Endocrinol & Metab, Beijing 100871, Peoples R China.	jiln@bjmu.edu.cn	Linong, Ji/AAB-6543-2020		Bristol-Myers Squibb	Bristol-Myers Squibb(Bristol-Myers Squibb)	This study was funded by Bristol-Myers Squibb. Statistical analyses were performed by Mei Ji and Xianyi Kong of Pharmaceutical Product Development, Inc., paid for by Bristol-Myers Squibb. Editorial assistance with preparation of the manuscript was provided by Samantha Santangelo, PhD, of MediTech Media Asia Pacific Pte Ltd, paid for by Bristol-Myers Squibb. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors LJ, XG and RH have received honoraria for attending Advisory Board meetings for Bristol-Myers Squibb and have received payment for lectures. LJ and XG are investigators in clinical trials of other compounds under development by Bristol-Myers Squibb. ZZ is an employee of Bristol-Myers Squibb and has received stock/stock options from Bristol-Myers Squibb. This study was funded by Bristol-Myers Squibb. Statistical analyses were performed by MJ and XK of Pharmaceutical Product Development, Inc., paid for by Bristol-Myers Squibb. Editorial assistance with preparation of the manuscript was provided by Samantha Santangelo, PhD, of MediTech Media Asia Pacific Pte Ltd, paid for by Bristol-Myers Squibb. HL is an employee of Sino-American Shanghai Squibb Pharmaceutical Ltd. Metformin which was used in this study is a product of Bristol-Myers Squibb. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS12, DOI 10.2337/dc08-S012; American Diabetes Association, 2007, Diabetes Care, V30 Suppl 1, pS4; [Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc35-S011, 10.2337/dc12-s004, 10.2337/dc12-s011]; Asian-Pacific Type 2 Diabetes Policy Group, 2005, TYP 2 DIAB PRACT TAR; Bei-Fan Z, 2002, ASIA PAC J CLIN NUTR, V11, pS685, DOI 10.1046/j.1440-6047.11.s8.9.x; Blonde L, 2004, CURR MED RES OPIN, V20, P565, DOI 10.1185/030079904125003278; Boffetta P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019930; Chan WB, 2004, DIABETIC MED, V21, P349, DOI 10.1111/j.1464-5491.2004.01158.x; Chinese Diabetes Society, 2010, CHIN INV CORP ANN RE, P1; Consoli A, 2004, DIABETES METAB, V30, P509, DOI 10.1016/S1262-3636(07)70148-9; Donnelly LA, 2006, DIABETIC MED, V23, P128, DOI 10.1111/j.1464-5491.2005.01755.x; Garber A, 2003, DIABETES OBES METAB, V5, P171, DOI 10.1046/j.1463-1326.2003.00259.x; Home P, 2006, DIABETIC MED, V23, P579; Ito H, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-83; Lund SS, 2007, DIABETES OBES METAB, V9, P394, DOI 10.1111/j.1463-1326.2007.00713.x; Nathan D, 2009, DIABETOLOGIA, V52, P17, DOI 10.1007/s00125-008-1157-y; Ong CR, 2006, DIABETES CARE, V29, P2361, DOI 10.2337/dc06-0827; Sambol NC, 1996, J CLIN PHARMACOL, V36, P1012, DOI 10.1177/009127009603601105; Scarpello JHB, 2008, DIABETES VASC DIS RE, V5, P157, DOI 10.3132/dvdr.2008.027; West DS, 2008, OBESITY, V16, P1413, DOI 10.1038/oby.2008.224; Xu H, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-683	21	39	58	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57222	10.1371/journal.pone.0057222	http://dx.doi.org/10.1371/journal.pone.0057222			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23667609	gold, Green Published, Green Submitted			2022-12-25	WOS:000315524900060
J	Oliver, RE; Tinker, NA; Lazo, GR; Chao, SM; Jellen, EN; Carson, ML; Rines, HW; Obert, DE; Lutz, JD; Shackelford, I; Korol, AB; Wight, CP; Gardner, KM; Hattori, J; Beattie, AD; Bjornstad, A; Bonman, JM; Jannink, JL; Sorrells, ME; Brown-Guedira, GL; Fetch, JWM; Harrison, SA; Howarth, CJ; Ibrahim, A; Kolb, FL; McMullen, MS; Murphy, JP; Ohm, HW; Rossnagel, BG; Yan, WK; Miclaus, KJ; Hiller, J; Maughan, PJ; Hulse, RRR; Anderson, JM; Islamovic, E; Jackson, EW				Oliver, Rebekah E.; Tinker, Nicholas A.; Lazo, Gerard R.; Chao, Shiaoman; Jellen, Eric N.; Carson, Martin L.; Rines, Howard W.; Obert, Donald E.; Lutz, Joseph D.; Shackelford, Irene; Korol, Abraham B.; Wight, Charlene P.; Gardner, Kyle M.; Hattori, Jiro; Beattie, Aaron D.; Bjornstad, Asmund; Bonman, J. Michael; Jannink, Jean-Luc; Sorrells, Mark E.; Brown-Guedira, Gina L.; Fetch, Jennifer W. Mitchell; Harrison, Stephen A.; Howarth, Catherine J.; Ibrahim, Amir; Kolb, Frederic L.; McMullen, Michael S.; Murphy, J. Paul; Ohm, Herbert W.; Rossnagel, Brian G.; Yan, Weikai; Miclaus, Kelci J.; Hiller, Jordan; Maughan, Peter J.; Hulse, Rachel R. Redman; Anderson, Joseph M.; Islamovic, Emir; Jackson, Eric W.			SNP Discovery and Chromosome Anchoring Provide the First Physically-Anchored Hexaploid Oat Map and Reveal Synteny with Model Species	PLOS ONE			English	Article							LINKAGE MAP; C-GENOME; MARKERS; IDENTIFICATION; MONOSOMICS; ASSIGNMENT; BARLEY	A physically anchored consensus map is foundational to modern genomics research; however, construction of such a map in oat (Avena sativa L., 2n = 6x = 42) has been hindered by the size and complexity of the genome, the scarcity of robust molecular markers, and the lack of aneuploid stocks. Resources developed in this study include a modified SNP discovery method for complex genomes, a diverse set of oat SNP markers, and a novel chromosome-deficient SNP anchoring strategy. These resources were applied to build the first complete, physically-anchored consensus map of hexaploid oat. Approximately 11,000 high-confidence in silico SNPs were discovered based on nine million inter-varietal sequence reads of genomic and cDNA origin. GoldenGate genotyping of 3,072 SNP assays yielded 1,311 robust markers, of which 985 were mapped in 390 recombinant-inbred lines from six bi-parental mapping populations ranging in size from 49 to 97 progeny. The consensus map included 985 SNPs and 68 previously-published markers, resolving 21 linkage groups with a total map distance of 1,838.8 cM. Consensus linkage groups were assigned to 21 chromosomes using SNP deletion analysis of chromosome-deficient monosomic hybrid stocks. Alignments with sequenced genomes of rice and Brachypodium provide evidence for extensive conservation of genomic regions, and renewed encouragement for orthology-based genomic discovery in this important hexaploid species. These results also provide a framework for high-resolution genetic analysis in oat, and a model for marker development and map construction in other species with complex genomes and limited resources.	[Oliver, Rebekah E.; Lutz, Joseph D.; Jackson, Eric W.] Gen Mills Crop Biosci, Kannapolis, NC USA; [Tinker, Nicholas A.; Wight, Charlene P.; Gardner, Kyle M.; Hattori, Jiro; Yan, Weikai] Agr & Agri Food Canada, Eastern Cereal & Oilseed Res Ctr, Ottawa, ON, Canada; [Lazo, Gerard R.] USDA ARS, Western Reg Res Ctr, Albany, CA 94710 USA; [Chao, Shiaoman] USDA ARS, Biosci Res Lab, Fargo, ND 58105 USA; [Jellen, Eric N.; Maughan, Peter J.; Hulse, Rachel R. Redman] Brigham Young Univ, Dept Plant & Wildlife Sci, Provo, UT 84602 USA; [Carson, Martin L.] USDA ARS, Cereal Dis Lab, St Paul, MN USA; [Rines, Howard W.] Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN USA; [Obert, Donald E.] Limagrain Cereal Seeds, Lafayette, IN USA; [Shackelford, Irene; Bonman, J. Michael] USDA ARS, Small Grains & Potato Germplasm Res Unit, Aberdeen, ID USA; [Korol, Abraham B.] Univ Haifa, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel; [Korol, Abraham B.] Univ Haifa, Inst Evolut, IL-31999 Haifa, Israel; [Beattie, Aaron D.; Rossnagel, Brian G.] Univ Saskatchewan, Ctr Crop Dev, Dept Plant Sci, Saskatoon, SK S7N 0W0, Canada; [Bjornstad, Asmund; Islamovic, Emir] Norwegian Univ Life Sci, Dept Plant & Environm Sci, As, Norway; [Jannink, Jean-Luc] USDA ARS, Robert W Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA; [Sorrells, Mark E.] Cornell Univ, Dept Plant Breeding & Genet, Ithaca, NY USA; [Brown-Guedira, Gina L.] N Carolina State Univ, USDA ARS, Eastern Reg Small Grains Genotyping Lab, Raleigh, NC 27695 USA; [Fetch, Jennifer W. Mitchell] Agr & Agri Food Canada, Cereal Res Ctr, Winnipeg, MB, Canada; [Harrison, Stephen A.] Louisiana State Univ, Sch Plant Environm & Soil Sci, Baton Rouge, LA 70803 USA; [Howarth, Catherine J.] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Ceredigion, Wales; [Ibrahim, Amir] Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA; [Kolb, Frederic L.] Univ Illinois, Dept Crop Sci, Urbana, IL USA; [McMullen, Michael S.] N Dakota State Univ, Dept Plant Sci, Fargo, ND 58105 USA; [Murphy, J. Paul] N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA; [Ohm, Herbert W.; Anderson, Joseph M.] Purdue Univ, Dept Agron, W Lafayette, IN 47907 USA; [Miclaus, Kelci J.; Hiller, Jordan] SAS Inst Inc, JMP, Cary, NC USA	Agriculture & Agri Food Canada; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Brigham Young University; United States Department of Agriculture (USDA); University of Minnesota System; University of Minnesota Twin Cities; United States Department of Agriculture (USDA); University of Haifa; University of Haifa; University of Saskatchewan; Norwegian University of Life Sciences; United States Department of Agriculture (USDA); Cornell University; United States Department of Agriculture (USDA); University of North Carolina; North Carolina State University; Agriculture & Agri Food Canada; Louisiana State University System; Louisiana State University; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); Texas A&M University System; Texas A&M University College Station; University of Illinois System; University of Illinois Urbana-Champaign; North Dakota State University Fargo; University of North Carolina; North Carolina State University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; SAS Institute Inc	Tinker, NA (corresponding author), Agr & Agri Food Canada, Eastern Cereal & Oilseed Res Ctr, Ottawa, ON, Canada.	Nick.Tinker@agr.gc.ca	Lazo, Gerard/A-8900-2009; Jellen, Eric/S-1166-2019; Jellen, Eric/K-4443-2019; Maughan, Peter/G-1600-2013; Columbus, Linda/F-5877-2010	Lazo, Gerard/0000-0002-9160-2052; Jellen, Eric/0000-0002-7906-4845; Jannink, Jean-Luc/0000-0003-4849-628X; Tinker, Nicholas/0000-0002-2452-4779; Brown-Guedira, Gina/0000-0002-1958-2827; Oliver, Ryan/0000-0003-4489-0861; Yan, Weikai/0000-0003-2399-1452; Howarth, Catherine/0000-0001-9364-0880; Bonman, John/0000-0002-7414-044X; Lipfert, Jan/0000-0003-3613-7896; Columbus, Linda/0000-0002-2574-0561	United States Department of Agriculture National Food Research Initiative; North American Millers' Association; Prairie Oat Growers Association, General Mills Inc.; United States Department of Agriculture - Agricultural Research Service CRIS project [301]; Agriculture and Agri-Food Canada; General Mills; Biotechnology and Biological Sciences Research Council [BBS/E/W/10962A01C, BBS/E/W/10962A01D, BBS/E/G/00003012, BB/H009582/1] Funding Source: researchfish; BBSRC [BBS/E/W/10962A01D, BB/H009582/1, BBS/E/W/10962A01C] Funding Source: UKRI	United States Department of Agriculture National Food Research Initiative; North American Millers' Association; Prairie Oat Growers Association, General Mills Inc.; United States Department of Agriculture - Agricultural Research Service CRIS project; Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada); General Mills; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by grants from the United States Department of Agriculture National Food Research Initiative, the North American Millers' Association, the Prairie Oat Growers Association, General Mills Inc., the United States Department of Agriculture - Agricultural Research Service CRIS project 301, and by Agriculture and Agri-Food Canada. Scientists REO and EWJ contributed to data collection, decision to publish, and preparation of the manuscript prior to employment at General Mills Inc., and these authors declare that the work presented was not in any way influenced by their current relationship with their employer. Staff scientist JDL from General Mills Inc. engaged in discussions leading to experimental design, and participated in manuscript preparation, but this was entirely limited to scientific input. Author DEO is currently employed at Limagrain Cereal Seeds, but contributed all work except for manuscript revision prior to this employment. Staff Scientists KJM and JH from SAS Institute Inc. contributed scientific input and data analysis. In no other way did the funders play a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funding from General Mills and the contributions of employees from General Mills, Limagrain and SAS does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.; Scientists REO and EWJ contributed to data collection, decision to publish, and preparation of the manuscript prior to employment at General Mills Inc., and these authors declare that the work presented was not in any way influenced by their current relationship with their employer. Staff scientist JDL from General Mills Inc. engaged in discussions leading to experimental design, and participated in manuscript preparation, but this was entirely limited to scientific input. Author DEO is currently employed at Limagrain Cereal Seeds, but contributed all work except for manuscript revision prior to this employment. The funding from General Mills and the contributions of employees from General Mills and Limagrain does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Akhunov E, 2009, THEOR APPL GENET, V119, P507, DOI 10.1007/s00122-009-1059-5; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andon MB, 2008, AM J LIFESTYLE MED, V2, P51, DOI [10.1177/1559827607309130., 10.1177/1559827607309130]; BENNETT MD, 1976, PHILOS T R SOC B, V274, P227, DOI 10.1098/rstb.1976.0044; Close TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-582; Fox SL, 2001, THEOR APPL GENET, V102, P320, DOI 10.1007/s001220051648; Gutierrez-Gonzalez JJ, 2011, PLANT GENOME-US, V4, P178, DOI 10.3835/plantgenome2011.01.0004; HELENTJARIS T, 1986, P NATL ACAD SCI USA, V83, P6035, DOI 10.1073/pnas.83.16.6035; Hyten DL, 2010, CROP SCI, V50, P960, DOI 10.2135/cropsci2009.06.0360; Jannink JL, 2005, CROP SCI, V45, P2383, DOI 10.2135/cropsci2005.0285; JELLEN EN, 1993, GENOME, V36, P962, DOI 10.1139/g93-126; JELLEN EN, 1994, GENOME, V37, P613, DOI 10.1139/g94-087; JELLEN EN, 1993, GENOME, V36, P1129, DOI 10.1139/g93-151; Jellen EN, 1997, THEOR APPL GENET, V95, P1190, DOI 10.1007/s001220050680; Jellen EN, 2000, CROP SCI, V40, P256, DOI 10.2135/cropsci2000.401256x; Kianian SF, 1997, GENOME, V40, P386, DOI 10.1139/g97-052; Korol A, 2009, PLANT GENET GENOMICS, V7, P163, DOI 10.1007/978-0-387-77489-3_6; LADIZINSKY G, 1970, HEREDITY, V25, P457, DOI 10.1038/hdy.1970.46; LEGGETT JM, 1995, GENOME, V38, P747, DOI 10.1139/g95-094; Mester DI, 2003, THEOR APPL GENET, V107, P1102, DOI 10.1007/s00122-003-1305-1; Mochida K., 2003, MGG Molecular Genetics and Genomics, V270, P371, DOI 10.1007/s00438-003-0939-7; MORIKAWA T, 1985, THEOR APPL GENET, V70, P271, DOI 10.1007/BF00304911; ODONOUGHUE LS, 1995, GENOME, V38, P368, DOI 10.1139/g95-048; Oliver RE, 2010, GENOME, V53, P458, DOI [10.1139/G10-021, 10.1139/g10-021]; Oliver RE, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-77; Peng JH, 2003, P NATL ACAD SCI USA, V100, P2489, DOI 10.1073/pnas.252763199; Portyanko VA, 2001, GENOME, V44, P249, DOI 10.1139/gen-44-2-249; Rajhathy T., 1974, MISC PUBL GENET SOC, V2, P1; Rickert AM, 2002, BIOTECHNIQUES, V32, P592, DOI 10.2144/02323rr01; Rostoks N, 2005, MOL GENET GENOMICS, V274, P515, DOI 10.1007/s00438-005-0046-z; Rostoks N, 2006, P NATL ACAD SCI USA, V103, P18656, DOI 10.1073/pnas.0606133103; Sanz MJ, 2010, THEOR APPL GENET, V121, P1541, DOI 10.1007/s00122-010-1409-3; SEARS ER, 1969, ANNU REV GENET, V3, P451, DOI 10.1146/annurev.ge.03.120169.002315; Tinker NA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-39; Van Ooijen JW., 2006, JOINMAP 4 SOFTWARE C, V4; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; WERNER JE, 1992, P NATL ACAD SCI USA, V89, P11307, DOI 10.1073/pnas.89.23.11307; Wight CP, 2003, GENOME, V46, P28, DOI [10.1139/g02-099, 10.1139/G02-099]; Wu JZ, 2002, PLANT CELL, V14, P525, DOI 10.1105/tpc.010274; Yan JB, 2010, MOL BREEDING, V25, P441, DOI 10.1007/s11032-009-9343-2; Yu JK, 2004, GENOME, V47, P805, DOI [10.1139/g04-057, 10.1139/G04-057]	41	99	104	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2013	8	3							e58068	10.1371/journal.pone.0058068	http://dx.doi.org/10.1371/journal.pone.0058068			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	111VQ	23533580	Green Submitted, Green Published, gold			2022-12-25	WOS:000316549400017
J	Chang, CL; Mills, GD; Karalus, NC; Jennings, LC; Laing, R; Murdoch, DR; Chambers, ST; Vettise, D; Tuffery, CM; Hancox, RJ				Chang, Catherina L.; Mills, Graham D.; Karalus, Noel C.; Jennings, Lance C.; Laing, Richard; Murdoch, David R.; Chambers, Stephen T.; Vettise, Dominic; Tuffery, Christine M.; Hancox, Robert J.			Biomarkers of Cardiac Dysfunction and Mortality from Community-Acquired Pneumonia in Adults	PLOS ONE			English	Article							BRAIN NATRIURETIC PEPTIDE; ACUTE PULMONARY-EMBOLISM; HOSPITALIZED-PATIENTS; RISK STRATIFICATION; PROGNOSTIC VALUE; PREDICTION RULE; TERM MORTALITY; DISEASE; MARKER; COMPLICATIONS	Background: Cardiac dysfunction is common in acute respiratory diseases and may influence prognosis. We hypothesised that blood levels of N-terminal B-type natriuretic peptide (NT-proBNP) and high-sensitivity Troponin T would predict mortality in adults with community-acquired pneumonia. Methods and Findings: A prospective cohort of 474 consecutive patients admitted with community-acquired pneumonia to two New Zealand hospitals over one year. Blood taken on admission was available for 453 patients and was analysed for NT-proBNP and Troponin T. Elevated levels of NT-proBNP (>220 pmol/L) were present in 148 (33%) and 86 (19%) of these patients respectively. Among the 26 patients who died within 30 days of admission, 23 (89%) had a raised NT-proBNP and 14 (53%) had a raised Troponin T level on admission compared to 125 (29%) and 72 (17%) of the 427 who survived (p values<0.001). Both NT-proBNP and Troponin T predicted 30-day mortality in age-adjusted analysis but after mutual adjustment for the other cardiac biomarker and the Pneumonia Severity Index, a raised N-terminal pro-brain natriuretic peptide remained a predictor of 30-day mortality (OR = 5.3, 95% CI 1.4-19.8, p = 0.013) but Troponin T did not (OR = 1.3, 95% CI 0.5-3.2, p = 0.630). The areas under the receiver-operating curves to predict 30-day mortality were similar for NT-proBNP (0.88) and the Pneumonia Severity Index (0.87). Conclusions: Elevated N-terminal B-type natriuretic peptide is a strong predictor of mortality from community-acquired pneumonia independent of clinical prognostic indicators. The pathophysiological basis for this is unknown but suggests that cardiac involvement may be an under-recognised determinant of outcome in pneumonia and may require a different approach to treatment. In the meantime, measurement of B-type natriuretic peptides may help to assess prognosis.	[Chang, Catherina L.; Mills, Graham D.; Karalus, Noel C.; Vettise, Dominic; Tuffery, Christine M.; Hancox, Robert J.] Waikato Hosp, Dept Resp Med, Hamilton, New Zealand; [Mills, Graham D.] Waikato Hosp, Dept Gen Med, Hamilton, New Zealand; [Jennings, Lance C.; Murdoch, David R.] Canterbury Hlth Labs, Christchurch, New Zealand; [Jennings, Lance C.; Murdoch, David R.; Chambers, Stephen T.] Univ Otago, Dept Pathol, Christchurch, New Zealand; [Laing, Richard] Canterbury Dist Hlth Board, Canterbury Resp Serv, Christchurch, New Zealand; [Hancox, Robert J.] Univ Otago, Dept Prevent & Social Med, Dunedin, New Zealand	Waikato Hospital; Waikato Hospital; Canterbury Health Laboratories; University of Otago; University of Otago	Hancox, RJ (corresponding author), Waikato Hosp, Dept Resp Med, Hamilton, New Zealand.	bob.hancox@otago.ac.nz	Murdoch, David/A-2012-2009	Lee, Gon-Ann/0000-0001-8433-8268; Chambers, Stephen/0000-0002-0698-3285	Health Research Council of New Zealand [00/349]; Waikato Respiratory Research Fund; NZ Heart Foundation summer studentship via the Waikato Clinical School, University of Auckland	Health Research Council of New Zealand(Health Research Council of New Zealand); Waikato Respiratory Research Fund; NZ Heart Foundation summer studentship via the Waikato Clinical School, University of Auckland	The pneumonia cohort was funded by the Health Research Council of New Zealand, grant 00/349 (http://www.hrc.govt.nz/). Analysis of the cardiac biomarkers for this report was funded internally by the Waikato Respiratory Research Fund. Dominic Vettise was supported by a NZ Heart Foundation summer studentship via the Waikato Clinical School, University of Auckland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becattini C, 2007, CIRCULATION, V116, P427, DOI 10.1161/CIRCULATIONAHA.106.680421; Chang CL, 2011, THORAX, V66, P764, DOI 10.1136/thx.2010.155333; Charles PGP, 2008, CLIN INFECT DIS, V47, P375, DOI 10.1086/589754; Christ-Crain M, 2008, J INTERN MED, V264, P166, DOI 10.1111/j.1365-2796.2008.01934.x; Corrales-Medina VF, 2012, CIRCULATION, V125, P773, DOI 10.1161/CIRCULATIONAHA.111.040766; Corrales-Medina VF, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001048; Espana PP, 2006, AM J RESP CRIT CARE, V174, P1249, DOI 10.1164/rccm.200602-177OC; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Goritsas C, 2010, EUR J EMERG MED, V17, P293, DOI 10.1097/MEJ.0b013e328332354b; Ilva TJ, 2010, J EMERG MED, V38, P1, DOI 10.1016/j.jemermed.2007.09.060; Ishii J, 2000, CLIN CHIM ACTA, V301, P19, DOI 10.1016/S0009-8981(00)00312-0; Jeong KY, 2011, EMERG MED J, V28, P122, DOI 10.1136/emj.2009.089383; Jimenez D, 2009, CHEST, V136, P974, DOI 10.1378/chest.09-0608; Kucher N, 2003, CIRCULATION, V107, P2545, DOI 10.1161/01.CIR.0000074039.45523.BE; Laing R, 2001, NEW ZEAL MED J, V114, P488; Leuchte HH, 2006, AM J RESP CRIT CARE, V173, P744, DOI 10.1164/rccm.200510-1545OC; Leuchte HH, 2004, J AM COLL CARDIOL, V43, P764, DOI 10.1016/j.jacc.2003.09.051; Lim WS, 2009, THORAX, V64, P1, DOI 10.1136/thx.2009.121434; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Maeder M, 2006, CHEST, V129, P1349, DOI 10.1378/chest.129.5.1349; Mandal P, 2011, QJM-INT J MED, V104, P489, DOI 10.1093/qjmed/hcq247; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Moammar MQ, 2010, HEART LUNG CIRC, V19, P90, DOI 10.1016/j.hlc.2009.08.009; Nagaya N, 2000, CIRCULATION, V102, P865; Nowak A, 2012, CHEST, V141, P974, DOI 10.1378/chest.11-0824; Ramirez J, 2008, CLIN INFECT DIS, V47, P182, DOI 10.1086/589246; Singanayagam A, 2012, EUR RESPIR J, V39, P187, DOI 10.1183/09031936.00049111; Tulevski II, 2001, THROMB HAEMOSTASIS, V86, P1193, DOI 10.1055/s-0037-1616050; Viasus D, 2013, J INFECTION, V66, P27, DOI 10.1016/j.jinf.2012.09.003; WOODHEAD MA, 1987, LANCET, V1, P671	30	55	58	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 7	2013	8	5							e62612	10.1371/journal.pone.0062612	http://dx.doi.org/10.1371/journal.pone.0062612			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154EP	23667500	Green Published, Green Submitted, gold			2022-12-25	WOS:000319654700051
J	Kim, SO; Sakchaisri, K; Thimmegowda, NR; Soung, NK; Jang, JH; Kim, YS; Lee, KS; Kwon, YT; Asami, Y; Ahn, JS; Erikson, RL; Kim, BY				Kim, Sun-Ok; Sakchaisri, Krisada; Thimmegowda, N. R.; Soung, Nak Kyun; Jang, Jae-Hyuk; Kim, Young Sang; Lee, Kyung Sang; Kwon, Yong Tae; Asami, Yukihiro; Ahn, Jong Seog; Erikson, Raymond Leo; Kim, Bo Yeon			STK295900, a Dual Inhibitor of Topoisomerase 1 and 2, Induces G(2) Arrest in the Absence of DNA Damage	PLOS ONE			English	Article							CDC25 PHOSPHATASES; CELL-CYCLE; I INHIBITORS; G2/M TRANSITION; CANCER-THERAPY; HISTONE H3; PHOSPHORYLATION; CHECKPOINT; CAMPTOTHECIN; MECHANISM	STK295900, a small synthetic molecule belonging to a class of symmetric bibenzimidazoles, exhibits antiproliferative activity against various human cancer cell lines from different origins. Examining the effect of STK295900 in HeLa cells indicates that it induces G(2) phase arrest without invoking DNA damage. Further analysis shows that STK295900 inhibits DNA relaxation that is mediated by topoisomerase 1 (Top 1) and topoisomerase 2 (Top 2) in vitro. In addition, STK295900 also exhibits protective effect against DNA damage induced by camptothecin. However, STK295900 does not affect etoposide-induced DNA damage. Moreover, STK295900 preferentially exerts cytotoxic effect on cancer cell lines while camptothecin, etoposide, and Hoechst 33342 affected both cancer and normal cells. Therefore, STK295900 has a potential to be developed as an anticancer chemotherapeutic agent.	[Kim, Sun-Ok; Sakchaisri, Krisada; Thimmegowda, N. R.; Soung, Nak Kyun; Jang, Jae-Hyuk; Ahn, Jong Seog; Kim, Bo Yeon] Korea Res Inst Biosci & Biotechnol KRIBB, Ochang, Cheongwon, South Korea; [Kim, Sun-Ok; Kim, Young Sang] Chungnam Natl Univ, Coll Nat Sci, Dept Biochem, Taejon, South Korea; [Lee, Kyung Sang] NCI, Lab Metab, NIH, Bethesda, MD 20892 USA; [Kwon, Yong Tae] Seoul Natl Univ, World Class Univ, Grad Sch Convergence Sci & Technol, Seoul, South Korea; [Kwon, Yong Tae] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Kwon, Yong Tae] Univ Pittsburgh, Ctr Pharmacogenet, Pittsburgh, PA USA; [Kwon, Yong Tae] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA; [Asami, Yukihiro] RIKEN Adv Sci Inst, Dept Biol Chem, Wako, Saitama, Japan; [Erikson, Raymond Leo] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chungnam National University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Seoul National University (SNU); Seoul National University (SNU); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; RIKEN; Harvard University	Ahn, JS (corresponding author), Korea Res Inst Biosci & Biotechnol KRIBB, Ochang, Cheongwon, South Korea.	jsahn@kribb.re.kr; bykim@kribb.re.kr	Damschroder, Laura/A-1142-2007; Appelbaum, Paul/AFU-3908-2022	Appelbaum, Paul/0000-0002-1940-0042; timmusk, s/0000-0001-8465-1043; Damschroder, Laura/0000-0002-3657-8459; Ryan, Kerry/0000-0002-0582-3693; Asami, Yukihiro/0000-0003-1821-9169; De Vries, Raymond/0000-0003-3087-3040	World Class Institute [2009-002]; Global RD Center (GRDC); World Class University [R31-2008-000-10103-0]; KRIBB Research Initiative program; Ministry of Education, Science and Technology (MEST) of Korea	World Class Institute; Global RD Center (GRDC); World Class University; KRIBB Research Initiative program; Ministry of Education, Science and Technology (MEST) of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the World Class Institute (2009-002), Global R&D Center (GRDC), World Class University (R31-2008-000-10103-0) programs and a grant from KRIBB Research Initiative program funded by the Ministry of Education, Science and Technology (MEST) of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Antoni L, 2007, NAT REV CANCER, V7, P925, DOI 10.1038/nrc2251; Balmain A, 2002, CELL, V108, P145, DOI 10.1016/S0092-8674(02)00622-0; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Bonnet J, 2008, BIOCHEM BIOPH RES CO, V370, P483, DOI 10.1016/j.bbrc.2008.03.117; Bower JJ, 2010, ONCOGENE, V29, P4787, DOI 10.1038/onc.2010.232; Bulavin DV, 2003, NAT CELL BIOL, V5, P545, DOI 10.1038/ncb994; Cai XM, 2009, CANCER TREAT REV, V35, P437, DOI 10.1016/j.ctrv.2009.02.004; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; CHEN AY, 1993, P NATL ACAD SCI USA, V90, P8131, DOI 10.1073/pnas.90.17.8131; Chiu CC, 2005, CANCER LETT, V223, P249, DOI 10.1016/j.canlet.2004.10.049; Clifford B, 2003, CANCER RES, V63, P4074; Dale AG, 2012, BIOCHEMISTRY; DOWNES CS, 1994, NATURE, V372, P467, DOI 10.1038/372467a0; Foijer F, 2006, CELL CYCLE, V5, P831, DOI 10.4161/cc.5.8.2687; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Hans F, 2001, ONCOGENE, V20, P3021, DOI 10.1038/sj.onc.1204326; He L, 2007, CELL SIGNAL, V19, P1713, DOI 10.1016/j.cellsig.2007.03.006; HSIANG YH, 1985, J BIOL CHEM, V260, P4873; Jin S, 2000, BIOORG MED CHEM LETT, V10, P719, DOI 10.1016/S0960-894X(00)00087-1; JORDAN MA, 1992, J CELL SCI, V102, P401; Kellogg DR, 2003, J CELL SCI, V116, P4883, DOI 10.1242/jcs.00908; Kim BY, 2005, CARCINOGENESIS, V26, P1395, DOI 10.1093/carcin/bgi081; Kristjansdottir K, 2004, CHEM BIOL, V11, P1043, DOI 10.1016/j.chembiol.2004.07.007; Larsen AK, 2003, PHARMACOL THERAPEUT, V99, P167, DOI 10.1016/S0163-7258(03)00058-5; Mann J, 2001, J MED CHEM, V44, P138, DOI 10.1021/jm000297b; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Narasimhan B, 2012, MED CHEM RES, V21, P269, DOI 10.1007/s00044-010-9533-9; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Patel S, 2000, MOL PHARMACOL, V58, P560, DOI 10.1124/mol.58.3.560; PINES J, 1991, J CELL BIOL, V115, P1, DOI 10.1083/jcb.115.1.1; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rudolph J, 2007, BIOCHEMISTRY-US, V46, P3595, DOI 10.1021/bi700026j; Satyanarayana A, 2009, ONCOGENE, V28, P2925, DOI 10.1038/onc.2009.170; Shiloh Y, 2001, CURR OPIN GENET DEV, V11, P71, DOI 10.1016/S0959-437X(00)00159-3; Smits VAJ, 2001, BBA-GENE STRUCT EXPR, V1519, P1, DOI 10.1016/S0167-4781(01)00204-4; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Trembley JH, 1996, CELL GROWTH DIFFER, V7, P903; TSAO YP, 1992, CANCER RES, V52, P1823; Uto K, 2004, EMBO J, V23, P3386, DOI 10.1038/sj.emboj.7600328; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; Vos SM, 2011, NAT REV MOL CELL BIO, V12, P827, DOI 10.1038/nrm3228; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7	46	111	116	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e53908	10.1371/journal.pone.0053908	http://dx.doi.org/10.1371/journal.pone.0053908			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349762	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000314019100036
J	Kim, SYH; Kim, HM; Ryan, KA; Appelbaum, PS; Knopman, DS; Damschroder, L; De Vries, R				Kim, Scott Y. H.; Kim, H. Myra; Ryan, Kerry A.; Appelbaum, Paul S.; Knopman, David S.; Damschroder, Laura; De Vries, Raymond			How Important Is 'Accuracy' of Surrogate Decision-Making for Research Participation?	PLOS ONE			English	Article							DEMENTIA-RESEARCH; ADVANCE DIRECTIVES; CARE RESEARCH; CONSENT; DELIBERATION; BIOETHICS; CAPACITY; DISEASE; MAKERS; FAMILY	Background: There is a longstanding concern about the accuracy of surrogate consent in representing the health care and research preferences of those who lose their ability to decide for themselves. We sought informed, deliberative views of the older general public (>= 50 years old) regarding their willingness to participate in dementia research and to grant leeway to future surrogates to choose an option contrary to their stated wishes. Methodology/Principal Findings: 503 persons aged 50+ recruited by random digit dialing were randomly assigned to one of three groups: deliberation, education, or control. The deliberation group attended an all-day education/peer deliberation session; the education group received written information only. Participants were surveyed at baseline, after the deliberation session (or equivalent time), and one month after the session, regarding their willingness to participate in dementia research and to give leeway to surrogates, regarding studies of varying risk-benefit profiles (a lumbar puncture study, a drug randomized controlled trial, a vaccine randomized controlled trial, and an early phase gene transfer trial). At baseline, 48% (gene transfer scenario) to 92% (drug RCT) were willing to participate in future dementia research. A majority of respondents (57-71% depending on scenario) were willing to give leeway to future surrogate decision-makers. Democratic deliberation increased willingness to participate in all scenarios, to grant leeway in 3 of 4 scenarios (lumbar puncture, vaccine, and gene transfer), and to enroll loved ones in research in all scenarios. On average, respondents were more willing to volunteer themselves for research than to enroll their loved ones. Conclusions/Significance: Most people were willing to grant leeway to their surrogates, and this willingness was either sustained or increased after democratic deliberation, suggesting that the attitude toward leeway is a reliable opinion. Eliciting a person's current preferences about future research participation should also involve eliciting his or her leeway preferences.	[Kim, Scott Y. H.; Ryan, Kerry A.; De Vries, Raymond] Univ Michigan, Ctr Bioeth & Social Sci Med, Ann Arbor, MI 48109 USA; [Kim, Scott Y. H.] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [Kim, H. Myra] Univ Michigan, Ctr Stat Consultat & Res, Ann Arbor, MI 48109 USA; [Appelbaum, Paul S.] Columbia Univ, Dept Psychiat, Div Law Eth & Psychiat, New York, NY USA; [Appelbaum, Paul S.] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Knopman, David S.] Mayo Clin, Dept Neurol, Rochester, MN USA; [Damschroder, Laura] Ann Arbor VA Med Ctr, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Columbia University; New York State Psychiatry Institute; Mayo Clinic	Kim, SYH (corresponding author), Univ Michigan, Ctr Bioeth & Social Sci Med, Ann Arbor, MI 48109 USA.	scottkim@med.umich.edu	Damschroder, Laura/A-1142-2007; Appelbaum, Paul/AFU-3908-2022	Appelbaum, Paul/0000-0002-1940-0042; timmusk, s/0000-0001-8465-1043; Damschroder, Laura/0000-0002-3657-8459; Ryan, Kerry/0000-0002-0582-3693; Asami, Yukihiro/0000-0003-1821-9169; De Vries, Raymond/0000-0003-3087-3040	National Institute of Health [R01AG029550]; Greenwall Foundation Faculty Scholars Award in Bioethics; Janssen Pharmaceuticals	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Greenwall Foundation Faculty Scholars Award in Bioethics; Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	Supported by National Institute of Health R01AG029550 and the Greenwall Foundation Faculty Scholars Award in Bioethics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Scott Kim, H. Myra Kim, Kerry Ryan, Paul Appelbaum, Laura Damschroder, and Raymond De Vries have declared that they have no competing interests. David Knopman has read the journal's policy and has the following conflicts: he serves as Deputy Editor for Neurology (R); serves on a Data Safety Monitoring Board for Lilly Pharmaceuticals; is an investigator in clinical trials sponsored by Janssen Pharmaceuticals, and receives research support from the National Institute of Health. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ciroldi M, 2007, INTENS CARE MED, V33, P807, DOI 10.1007/s00134-007-0582-6; Coppolino M, 2001, CHEST, V119, P603, DOI 10.1378/chest.119.2.603; De Vries R, 2011, J EMPIR RES HUM RES, V6, P3, DOI 10.1525/jer.2011.6.3.3; Fagerlin A, 2004, HASTINGS CENT REP, V34, P30, DOI 10.2307/3527683; Hawkins NA, 2005, GERONTOLOGIST, V45, P107, DOI 10.1093/geront/45.1.107; Karlawish J, 2009, AM J PSYCHIAT, V166, P182, DOI 10.1176/appi.ajp.2008.08050645; Kim SYH, 2011, NEUROLOGY, V77, P2097, DOI 10.1212/WNL.0b013e31823648cb; Kim SYH, 2009, NEUROLOGY, V72, P149, DOI 10.1212/01.wnl.0000339039.18931.a2; Kim SYH, 2011, ARCH GEN PSYCHIAT, V68, P214, DOI 10.1001/archgenpsychiatry.2010.191; Kim SYH, 2010, ALZHEIMERS DEMENT, V6, P342, DOI 10.1016/j.jalz.2009.06.001; Kim SYH, 2009, J EMPIR RES HUM RES, V4, P3, DOI 10.1525/jer.2009.4.4.3; Kim SYH, 2001, AM J PSYCHIAT, V158, P712, DOI 10.1176/appi.ajp.158.5.712; Kirchhoff KT, 2010, J AM GERIATR SOC, V58, P1233, DOI 10.1111/j.1532-5415.2010.02760.x; Okonkwo O, 2007, NEUROLOGY, V69, P1528, DOI 10.1212/01.wnl.0000277639.90611.d9; Puchalski CM, 2000, J AM GERIATR SOC, V48, pS84, DOI 10.1111/j.1532-5415.2000.tb03146.x; SEHGAL A, 1992, JAMA-J AM MED ASSOC, V267, P59, DOI 10.1001/jama.267.1.59; Shalowitz DI, 2006, ARCH INTERN MED, V166, P493, DOI 10.1001/archinte.166.5.493; Stocking CB, 2006, NEUROLOGY, V66, P1361, DOI 10.1212/01.wnl.0000216424.66098.55; Wendler D, 2002, AM J PSYCHIAT, V159, P585, DOI 10.1176/appi.ajp.159.4.585	19	111	116	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54790	10.1371/journal.pone.0054790	http://dx.doi.org/10.1371/journal.pone.0054790			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	085JH	23349762	Green Submitted, Green Published, gold			2022-12-25	WOS:000314610600042
J	Zhang, GL; Huang, SQ; Duan, QH; Shu, W; Hou, YC; Zhu, SY; Miao, XP; Nie, SF; Wei, S; Guo, N; Shan, H; Xu, YH				Zhang, Guoliang; Huang, Shuqiong; Duan, Qionghong; Shu, Wen; Hou, Yongchun; Zhu, Shiyu; Miao, Xiaoping; Nie, Shaofa; Wei, Sheng; Guo, Nan; Shan, Hua; Xu, Yihua			Application of a Hybrid Model for Predicting the Incidence of Tuberculosis in Hubei, China	PLOS ONE			English	Article							TIME-SERIES; HEALTH SYSTEM; SEASONALITY; TRANSMISSION	Background: A prediction model for tuberculosis incidence is needed in China which may be used as a decision-supportive tool for planning health interventions and allocating health resources. Methods: The autoregressive integrated moving average (ARIMA) model was first constructed with the data of tuberculosis report rate in Hubei Province from Jan 2004 to Dec 2011. The data from Jan 2012 to Jun 2012 were used to validate the model. Then the generalized regression neural network (GRNN)-ARIMA combination model was established based on the constructed ARIMA model. Finally, the fitting and prediction accuracy of the two models was evaluated. Results: A total of 465,960 cases were reported between Jan 2004 and Dec 2011 in Hubei Province. The report rate of tuberculosis was highest in 2005 (119.932 per 100,000 population) and lowest in 2010 (84.724 per 100,000 population). The time series of tuberculosis report rate show a gradual secular decline and a striking seasonal variation. The ARIMA (2, 1, 0) x (0, 1, 1) 12 model was selected from several plausible ARIMA models. The residual mean square error of the GRNN-ARIMA model and ARIMA model were 0.4467 and 0.6521 in training part, and 0.0958 and 0.1133 in validation part, respectively. The mean absolute error and mean absolute percentage error of the hybrid model were also less than the ARIMA model. Discussion and Conclusions: The gradual decline in tuberculosis report rate may be attributed to the effect of intensive measures on tuberculosis. The striking seasonal variation may have resulted from several factors. We suppose that a delay in the surveillance system may also have contributed to the variation. According to the fitting and prediction accuracy, the hybrid model outperforms the traditional ARIMA model, which may facilitate the allocation of health resources in China.	[Zhang, Guoliang; Shu, Wen; Hou, Yongchun; Zhu, Shiyu; Miao, Xiaoping; Nie, Shaofa; Wei, Sheng; Xu, Yihua] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China; [Huang, Shuqiong] Hubei Prov Ctr Dis Control & Prevent, Wuhan, Peoples R China; [Duan, Qionghong] TB Inst TB Control & Prevent Wuhan City, Wuhan, Peoples R China; [Guo, Nan] Johns Hopkins Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Shan, Hua] Johns Hopkins Med Inst, Dept Pathol, Div Blood Transfus, Baltimore, MD 21205 USA	Huazhong University of Science & Technology; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine	Xu, YH (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China.	xuyihua_6@hotmail.com	miao, xiaoping/C-4336-2011	miao, xiaoping/0000-0002-6818-9722; Wenzel, Sally/0000-0002-4242-0164; Dow, Max/0000-0001-8245-2294; Zhang, An/0000-0002-9338-6250; Wang, Jinfeng/0000-0002-6687-9420	NCATS NIH HHS [UL1 TR000005] Funding Source: Medline; NHLBI NIH HHS [R01 HL088264] Funding Source: Medline	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BuHamra S, 2003, APPL MATH MODEL, V27, P805, DOI 10.1016/S0307-904X(03)00079-9; Cao SY, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-56; Chen XY, 2004, LANCET, V364, P417; Cheng G, 2005, T ROY SOC TROP MED H, V99, P355, DOI 10.1016/j.trstmh.2004.07.005; Debanne SM, 2000, EMERG INFECT DIS, V6, P148, DOI 10.3201/eid0602.000207; He GX, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-166; Hu WB, 2004, AM J TROP MED HYG, V71, P129, DOI 10.4269/ajtmh.2004.71.129; Jain A, 2007, APPL SOFT COMPUT, V7, P585, DOI 10.1016/j.asoc.2006.03.002; Jia ZW, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000371; Koh GCKW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057752; Leung CC, 2005, INT J EPIDEMIOL, V34, P924, DOI 10.1093/ije/dyi080; Leung MT, 2000, COMPUT OPER RES, V27, P1093, DOI 10.1016/S0305-0548(99)00144-6; Li Q, 2012, AM J TROP MED HYG, V87, P364, DOI 10.4269/ajtmh.2012.11-0472; Li WM, 2008, NEURAL COMPUT APPL, V17, P441, DOI 10.1007/s00521-007-0131-9; Li XZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0068102, 10.1371/journal.pone.0067744]; Luquero FJ, 2008, INT J TUBERC LUNG D, V12, P221; MacLachlan JH, 2012, EMERG INFECT DIS, V18, P1879, DOI 10.3201/eid1811.120456; Medeiros MC, 2000, IEEE T NEURAL NETWOR, V11, P1402, DOI 10.1109/72.883463; Medina DC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001181; Ozyildirim BM, 2013, NEURAL NETWORKS, V39, P18, DOI 10.1016/j.neunet.2012.12.001; Parrinello CM, 2012, INT J TUBERC LUNG D, V16, P32, DOI 10.5588/ijtld.11.0145; Riley S, 2007, SCIENCE, V316, P1298, DOI 10.1126/science.1134695; Soebiyanto RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009450; SPECHT DF, 1991, IEEE T NEURAL NETWOR, V2, P568, DOI 10.1109/72.97934; Thorpe LE, 2004, LANCET, V364, P1613, DOI 10.1016/S0140-6736(04)17316-9; Wang LX, 2010, B WORLD HEALTH ORGAN, V88, P937, DOI 10.2471/BLT.09.071753; Wang LD, 2008, LANCET, V372, P1598, DOI 10.1016/S0140-6736(08)61365-3; Wang LD, 2007, LANCET, V369, P691, DOI 10.1016/S0140-6736(07)60316-X; Willis MD, 2012, CLIN INFECT DIS, V54, P1553, DOI 10.1093/cid/cis235; Zhang GP, 2003, NEUROCOMPUTING, V50, P159, DOI 10.1016/S0925-2312(01)00702-0; Zhang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031076	31	271	318	9	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2013	8	11							e80969	10.1371/journal.pone.0080969	http://dx.doi.org/10.1371/journal.pone.0080969			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247XD	23658832	Green Published, gold, Green Submitted			2022-12-25	WOS:000326656200125
J	Zhang, A; Qi, QW; Jiang, LL; Zhou, F; Wang, JF				Zhang, An; Qi, Qingwen; Jiang, Lili; Zhou, Fang; Wang, Jinfeng			Population Exposure to PM2.5 in the Urban Area of Beijing	PLOS ONE			English	Article							COARSE PARTICLES; FINE PARTICLES; AIR-QUALITY	The air quality in Beijing, especially its PM2.5 level, has become of increasing public concern because of its importance and sensitivity related to health risks. A set of monitored PM2.5 data from 31 stations, released for the first time by the Beijing Environmental Protection Bureau, covering 37 days during autumn 2012, was processed using spatial interpolation and overlay analysis. Following analyses of these data, a distribution map of cumulative exceedance days of PM2.5 and a temporal variation map of PM2.5 for Beijing have been drawn. Computational and analytical results show periodic and directional trends of PM2.5 spreading and congregating in space, which reveals the regulation of PM2.5 overexposure on a discontinuous medium-term scale. With regard to the cumulative effect of PM2.5 on the human body, the harm from lower intensity overexposure in the medium term, and higher overexposure in the short term, are both obvious. Therefore, data of population distribution were integrated into the aforementioned PM2.5 spatial spectrum map. A spatial statistical analysis revealed the patterns of PM2.5 gross exposure and exposure probability of residents in the Beijing urban area. The methods and conclusions of this research reveal relationships between long-term overexposure to PM2.5 and people living in high-exposure areas of Beijing, during the autumn of 2012.	[Zhang, An; Qi, Qingwen; Jiang, Lili; Zhou, Fang; Wang, Jinfeng] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Qi, QW (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing, Peoples R China.	qiqw@igsnrr.ac.cn	miao, xiaoping/C-4336-2011	miao, xiaoping/0000-0002-6818-9722; Wenzel, Sally/0000-0002-4242-0164; Dow, Max/0000-0001-8245-2294; Zhang, An/0000-0002-9338-6250; Wang, Jinfeng/0000-0002-6687-9420	National Natural Science Foundation of China [41201412]; NCATS NIH HHS [UL1 TR000005] Funding Source: Medline; NHLBI NIH HHS [R01 HL088264] Funding Source: Medline	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Natural Science Foundation of China (41201412). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayraktar H, 2005, STOCH ENV RES RISK A, V19, P301, DOI 10.1007/s00477-005-0234-8; Bureau BCA Mapping BIoSa, 2005, BEIJ ADM DISTR ATL; Bureau BCA Mapping BIoSa, 2007, BEIJ ADM DISTR TUZH; China's Ministry of Environmental Protection, 2012, AMB AIR QUAL STAND; Du XA, 2010, J ENVIRON SCI-CHINA, V22, P1757, DOI 10.1016/S1001-0742(09)60316-8; Fann N, 2011, RISK ANAL, DOI DOI 10.1111/J.1539-6924.2011.01630.X; Gavett SH, 2001, INT ARCH ALLERGY IMM, V124, P109, DOI 10.1159/000053685; Haley VB, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-42; Hao YP, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-3; Jorgensen NW, 2012, J AM COLL CARDIOL, V60; Kan HD, 2007, ENVIRON INT, V33, P376, DOI 10.1016/j.envint.2006.12.001; Kunii O, 2002, ARCH ENVIRON HEALTH, V57, P16, DOI 10.1080/00039890209602912; Li P, 2012, PLOS ONE; Lippmann M, 1998, ISSUES ENV SCI TECHN, V10, P75; Matheron G., 1963, ECON GEOL, V58, P1246, DOI DOI 10.2113/GSECONGEO.58.8.1246; Municipality OftSPCoB Statistics BMBo Beijing SOotNBoSi, 2012, TAB 2010 POP CENS BE; Pang W, 2010, ENVIRONMETRICS, V21, P305, DOI 10.1002/env.1007; Qiu F, 2012, GISCI REMOTE SENS, V49, P644, DOI 10.2747/1548-1603.49.5.644; Schwartz J, 2000, EPIDEMIOLOGY, V11, P6, DOI 10.1097/00001648-200001000-00004; Sun YL, 2006, ENVIRON SCI TECHNOL, V40, P3148, DOI 10.1021/es051533g; Urbat M, 2004, ATMOS ENVIRON, V38, P3781, DOI 10.1016/j.atmosenv.2004.03.061; Vallejo M, 2006, J EXPO SCI ENV EPID, V16, P125, DOI 10.1038/sj.jea.7500447; Wang JF, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053400, 10.1371/journal.pone.0070519]; [袁杨森 YUAN Yangsen], 2007, [生态环境, Ecology and Environment], V16, P18; Zhao W, 2012, GEOGRAPHICAL RES, V417-428	25	271	318	9	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 2	2013	8	5							e63486	10.1371/journal.pone.0063486	http://dx.doi.org/10.1371/journal.pone.0063486			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175AF	23658832	Green Published, Green Submitted, gold			2022-12-25	WOS:000321200500073
J	Li, K; Chi, Y; Gao, K; Yan, QJ; Matsue, H; Takeda, M; Kitamura, M; Yao, J				Li, Kai; Chi, Yuan; Gao, Kun; Yan, Qiaojing; Matsue, Hiroyuki; Takeda, Masayuki; Kitamura, Masanori; Yao, Jian			Connexin43 Hemichannel-Mediated Regulation of Connexin43	PLOS ONE			English	Article							JUNCTIONAL INTERCELLULAR COMMUNICATION; GAP-JUNCTIONS; SIGNAL-TRANSDUCTION; OXIDATIVE STRESS; GENE-EXPRESSION; LLC-PK1 CELLS; CADMIUM CD2+; C-JUN; PLASMA-MEMBRANE; UP-REGULATION	Background: Many signaling molecules and pathways that regulate gap junctions (GJs) protein expression and function are, in fact, also controlled by GJs. We, therefore, speculated an existence of the GJ channel-mediated self-regulation of GJs. Using a cell culture model in which nonjunctional connexin43 (Cx43) hemichannels were activated by cadmium (Cd2+), we tested this hypothesis. Principal Findings: Incubation of Cx43-transfected LLC-PK1 cells with Cd2+ led to an increased expression of Cx43. This effect of Cd2+ was tightly associated with JNK activation. Inhibition of JNK abolished the elevation of Cx43. Further analysis revealed that the changes of JNK and Cx43 were controlled by GSH. Supplement of a membrane-permeable GSH analogue GSH ethyl ester or GSH precursor N-acetyl-cystein abrogated the effects of Cd2+ on JNK activation and Cx43 expression. Indeed, Cd2+ induced extracellular release of GSH. Blockade of Cx43 hemichannels with heptanol or Cx43 mimetic peptide Gap26 to prevent the efflux of GSH significantly attenuated the Cx43-elevating effects of Cd2+. Conclusions: Collectively, our results thus indicate that Cd2+-induced upregulation of Cx43 is through activation of nonjunctional Cx43 hemichannels. Our findings thus support the existence of a hemichannel-mediated self-regulation of Cx43 and provide novel insights into the molecular mechanisms of Cx43 expression and function.	[Li, Kai; Chi, Yuan; Gao, Kun; Yan, Qiaojing; Kitamura, Masanori; Yao, Jian] Univ Yamanashi, Dept Mol Signaling, Interdisciplinary Grad Sch Med & Engn, Chuo Ku, Yamanashi, Japan; [Li, Kai; Takeda, Masayuki] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Urol, Chuo Ku, Yamanashi, Japan; [Li, Kai] China Med Univ, Hosp 1, Dept Surg Oncol & Gen Surg, Shenyang, Peoples R China; [Matsue, Hiroyuki] Chiba Univ, Sch Med, Dept Dermatol, Chiba 280, Japan	University of Yamanashi; University of Yamanashi; China Medical University; Chiba University	Li, K (corresponding author), Univ Yamanashi, Dept Mol Signaling, Interdisciplinary Grad Sch Med & Engn, Chuo Ku, Yamanashi, Japan.	cmu_likai@hotmail.com; yao@yamanashi.ac.jp	; Li, Ke/I-3804-2013	Yao, Jian/0000-0003-2622-0215; Li, Ke/0000-0003-4869-5393	Ministry of Education, Culture, Sports, Science and Technology, Japan [17659255, 20590953, B21390324]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (17659255 and 20590953 to JY; B21390324 to HM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthoud VM, 2009, ANTIOXID REDOX SIGN, V11, P339, DOI 10.1089/ars.2008.2119; Carmeli C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029341; Chaytor AT, 1998, J PHYSIOL-LONDON, V508, P561, DOI 10.1111/j.1469-7793.1998.561bq.x; Cherian PP, 2005, MOL BIOL CELL, V16, P3100, DOI 10.1091/mbc.E04-10-0912; D'hondt C, 2007, INVEST OPHTH VIS SCI, V48, P120, DOI 10.1167/iovs.06-0770; Evans WH, 2006, BIOCHEM J, V397, P1, DOI 10.1042/BJ20060175; Evans WH, 2012, J MEMBRANE BIOL, V245, P437, DOI 10.1007/s00232-012-9488-5; Fang X, 2011, ANTIOXID REDOX SIGN, V14, P2427, DOI 10.1089/ars.2010.3150; Gao FH, 2007, BIOCHEM BIOPH RES CO, V356, P505, DOI 10.1016/j.bbrc.2007.03.009; Gennari A, 2003, TOXICOLOGY, V183, P211, DOI 10.1016/S0300-483X(02)00546-2; Giepmans BNG, 2004, CARDIOVASC RES, V62, P233, DOI 10.1016/j.cardiores.2003.12.009; HEW KW, 1993, BIOL REPROD, V49, P840, DOI 10.1095/biolreprod49.4.840; Huang T, 2010, CANCER SCI, V101, P713, DOI 10.1111/j.1349-7006.2009.01421.x; Lawal AO, 2010, J TOXICOL SCI, V35, P465, DOI 10.2131/jts.35.465; Li K, 2011, J BIOL CHEM, V286, P41552, DOI 10.1074/jbc.M111.274449; Liu J, 2009, TOXICOL APPL PHARM, V238, P209, DOI 10.1016/j.taap.2009.01.029; Loch-Caruso R, 2005, TOXICOL SCI, V85, P694, DOI 10.1093/toxsci/kfi123; Majoul IV, 2009, HISTOCHEM CELL BIOL, V132, P263, DOI 10.1007/s00418-009-0617-x; Martin PEM, 2001, J CELL SCI, V114, P3845; Mendoza-Naranjo A, 2007, J IMMUNOL, V178, P6949, DOI 10.4049/jimmunol.178.11.6949; Mitchell JA, 2001, CELL COMMUN ADHES, V8, P299, DOI 10.3109/15419060109080741; Oviedo-Orta E, 2001, FASEB J, V15, P768, DOI 10.1096/fj.00-0288com; Ponsaerts R, 2010, FASEB J, V24, P4378, DOI 10.1096/fj.09-153007; PROZIALECK WC, 1991, TOXICOL APPL PHARM, V107, P81, DOI 10.1016/0041-008X(91)90333-A; PROZIALECK WC, 1995, TOXICOL APPL PHARM, V134, P285, DOI 10.1006/taap.1995.1194; Prozialeck WC, 1997, IN VITRO CELL DEV-AN, V33, P516; Prozialeck WC, 1998, TOXICOL IN VITRO, V12, P633, DOI 10.1016/S0887-2333(98)00054-X; Ramachandran S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000712; Retamal MA, 2007, P NATL ACAD SCI USA, V104, P8322, DOI 10.1073/pnas.0702456104; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Salameh A, 2008, J PHARMACOL EXP THER, V326, P315, DOI 10.1124/jpet.108.136663; Shyu KG, 2004, CARDIOVASC RES, V63, P98, DOI 10.1016/j.cardiores.2004.02.018; Son MH, 2001, BIOCHEM PHARMACOL, V62, P1379, DOI 10.1016/S0006-2952(01)00780-8; Stridh MH, 2008, J BIOL CHEM, V283, P10347, DOI 10.1074/jbc.M704153200; Stridh MH, 2010, NEUROCHEM RES, V35, P1231, DOI 10.1007/s11064-010-0179-2; Tacheau C, 2008, J CELL PHYSIOL, V217, P759, DOI 10.1002/jcp.21551; Thevenod F, 2000, J BIOL CHEM, V275, P1887, DOI 10.1074/jbc.275.3.1887; Thomas T, 2005, J CELL SCI, V118, P4451, DOI 10.1242/jcs.02569; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Upham BL, 1997, CARCINOGENESIS, V18, P37, DOI 10.1093/carcin/18.1.37; Upham BL, 2009, ANTIOXID REDOX SIGN, V11, P297, DOI 10.1089/ars.2008.2146; Wilhelm D, 1997, MOL CELL BIOL, V17, P4792, DOI 10.1128/MCB.17.8.4792; Yao J, 2003, CIRC RES, V93, P338, DOI 10.1161/01.RES.0000086802.21850.5D; Yao J, 2010, BRIT J PHARM, P9999; Yao J, 2007, J MEMBRANE BIOL, V217, P123, DOI 10.1007/s00232-007-9023-2; Yao J, 2009, AM J PHYSIOL-RENAL, V296, pF939, DOI 10.1152/ajprenal.90612.2008; Yokouchi M, 2008, J BIOL CHEM, V283, P4252, DOI 10.1074/jbc.M705951200	47	256	266	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e58057	10.1371/journal.pone.0058057	http://dx.doi.org/10.1371/journal.pone.0058057			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23874530	Green Submitted, Green Published, gold			2022-12-25	WOS:000315519000181
J	Zhang, YB; Wei, C; Jiang, WD; Wang, L; Li, CR; Wang, YY; Dow, JM; Sun, WX				Zhang, Yuanbao; Wei, Chao; Jiang, Wendi; Wang, Lei; Li, Churui; Wang, Yunyue; Dow, John Maxwell; Sun, Wenxian			The HD-GYP Domain Protein RpfG of Xanthomonas oryzae pv. oryzicola Regulates Synthesis of Extracellular Polysaccharides that Contribute to Biofilm Formation and Virulence on Rice	PLOS ONE			English	Article							DIFFUSIBLE SIGNAL FACTOR; 2-COMPONENT SYSTEM; GENE-EXPRESSION; CAMPESTRIS; VESICATORIA; PHOSPHODIESTERASE; SEQUENCES; ACTIVATOR; BACTERIA; CLUSTER	Bacterial leaf streak caused by Xanthomonas oryzae pv. oryzicola (Xoc) is one of the most important diseases in rice. However, little is known about the pathogenicity mechanisms of Xoc. Here we have investigated the function of three HD-GYP domain regulatory proteins in biofilm formation, the synthesis of virulence factors and virulence of Xoc. Deletion of rpfG resulted in altered production of extracellular polysaccharides (EPS), abolished virulence on rice and enhanced biofilm formation, but had little effect on the secretion of proteases and motility. In contrast, mutational analysis showed that the other two HD-GYP domain proteins had no effect on virulence factor synthesis and tested phenotypes. Mutation of rpfG led to up-regulation of the type III secretion system and altered expression of three putative glycosyltransferase genes gumD, pgaC and xagB, which are part of operons directing the synthesis of different extracellular polysaccharides. The pgaABCD and xagABCD operons were greatly up-regulated in the Xoc Delta rpfG mutant, whereas the expression of the gum genes was unaltered or slightly enhanced. The elevated biofilm formation of the Xoc Delta rpfG mutant was dramatically reduced upon deletion of gumD, xagA and xagB, but not when pgaA and pgaC were deleted. Interestingly, only the Delta gumD mutant, among these single gene mutants, exhibits multiple phenotype alterations including reduced biofilm and EPS production and attenuated virulence on rice. These data indicate that RpfG is a global regulator that controls biofilm formation, EPS production and bacterial virulence in Xoc and that both gumD- and xagB-dependent EPS contribute to biofilm formation under different conditions.	[Zhang, Yuanbao; Jiang, Wendi; Wang, Lei; Li, Churui; Sun, Wenxian] China Agr Univ, Dept Plant Pathol, Beijing, Peoples R China; [Zhang, Yuanbao; Jiang, Wendi; Wang, Lei; Li, Churui; Sun, Wenxian] China Agr Univ, Minist Agr, Key Lab Plant Pathol, Beijing, Peoples R China; [Wei, Chao; Wang, Yunyue] Yunnan Agr Univ, Minist Educ, Key Lab Agr Biodivers & Plant Dis Management, Kunming, Peoples R China; [Dow, John Maxwell] Univ Coll Cork, Biosci Inst, Dept Microbiol, BIOMERIT Res Ctr, Cork, Ireland	China Agricultural University; China Agricultural University; Ministry of Agriculture & Rural Affairs; Yunnan Agricultural University; University College Cork	Zhang, YB (corresponding author), China Agr Univ, Dept Plant Pathol, Beijing, Peoples R China.	wxs@cau.edu.cn	miao, xiaoping/C-4336-2011	miao, xiaoping/0000-0002-6818-9722; Wenzel, Sally/0000-0002-4242-0164; Dow, Max/0000-0001-8245-2294; Zhang, An/0000-0002-9338-6250; Wang, Jinfeng/0000-0002-6687-9420	973 program [2011CB100700]; National Natural Science Foundation of China (NSFC) [31272007]; PCSIRT Program [IRT1042, NCET-09-0736]; Ph.D. Programs Foundation of Ministry of Education of China; NCATS NIH HHS [UL1 TR000005] Funding Source: Medline; NHLBI NIH HHS [R01 HL088264] Funding Source: Medline	973 program(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); PCSIRT Program(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported by the 973 program 2011CB100700, National Natural Science Foundation of China (NSFC) grant 31272007, PCSIRT Program IRT1042, NCET-09-0736 and Ph.D. Programs Foundation of Ministry of Education of China to WS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade MO, 2006, MOL MICROBIOL, V62, P537, DOI 10.1111/j.1365-2958.2006.05386.x; Astua-Monge G, 2000, MOL PLANT MICROBE IN, V13, P911, DOI 10.1094/MPMI.2000.13.9.911; AWODERU VA, 1991, TROP PEST MANAGE, V37, P356, DOI 10.1080/09670879109371614; Bobrov AG, 2005, FEMS MICROBIOL LETT, V247, P123, DOI 10.1016/j.femsle.2005.04.036; Bogdanove AJ, 2011, J BACTERIOL, V193, P5450, DOI 10.1128/JB.05262-11; BOYER MH, 1984, J BIOTECHNOL, V1, P241, DOI 10.1016/0168-1656(84)90009-9; CANNON FC, 1979, MOL GEN GENET, V174, P59, DOI 10.1007/BF00433306; Castaneda A, 2005, MOL PLANT MICROBE IN, V18, P1306, DOI 10.1094/MPMI-18-1306; Choi KH, 2006, NAT PROTOC, V1, P153, DOI 10.1038/nprot.2006.24; Cotter PA, 2007, CURR OPIN MICROBIOL, V10, P17, DOI 10.1016/j.mib.2006.12.006; Crossman L, 2004, MICROBES INFECT, V6, P623, DOI 10.1016/j.micinf.2004.01.013; DiLuzio WR, 2005, NATURE, V435, P1271, DOI 10.1038/nature03660; Dow J M, 1994, Curr Top Microbiol Immunol, V192, P29; Dow JM, 2006, MOL PLANT MICROBE IN, V19, P1378, DOI 10.1094/MPMI-19-1378; Dow JM, 2003, P NATL ACAD SCI USA, V100, P10995, DOI 10.1073/pnas.1833360100; Dow M, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.121pe23; Feng JX, 2009, MICROBIOL-SGM, V155, P3033, DOI 10.1099/mic.0.028910-0; Galperin Michael Y., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P303; Galperin MY, 2010, CURR OPIN MICROBIOL, V13, P150, DOI 10.1016/j.mib.2010.01.005; Galperin MY, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-35; Galperin MY, 2001, FEMS MICROBIOL LETT, V203, P11, DOI 10.1111/j.1574-6968.2001.tb10814.x; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; Guo YP, 2012, MOL PLANT MICROBE IN, V25, P165, DOI 10.1094/MPMI-07-11-0184; Han SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029192; HARDING NE, 1987, J BACTERIOL, V169, P2854, DOI 10.1128/jb.169.6.2854-2861.1987; He YW, 2006, MOL MICROBIOL, V59, P610, DOI 10.1111/j.1365-2958.2005.04961.x; Hickman JW, 2005, P NATL ACAD SCI USA, V102, P14422, DOI 10.1073/pnas.0507170102; Huang DL, 2008, NUCLEIC ACIDS RES, V36, P4295, DOI 10.1093/nar/gkn328; Itoh Y, 2008, J BACTERIOL, V190, P3670, DOI 10.1128/JB.01920-07; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; JIANG J, 2009, ACTA MICROBIOL SIN, V49, P1018; Koebnik R, 2006, J BACTERIOL, V188, P7652, DOI 10.1128/JB.00795-06; Lee SW, 2008, J BACTERIOL, V190, P2183, DOI 10.1128/JB.01406-07; Li YR, 2011, APPL ENVIRON MICROB, V77, P3809, DOI 10.1128/AEM.02849-10; LOPER JE, 1987, PHYTOPATHOLOGY, V77, P1449, DOI 10.1094/Phyto-77-1449; Meng FH, 2011, J BACTERIOL, V193, P2477, DOI 10.1128/JB.01360-10; MOFFETT ML, 1983, PLANT BACTERIAL DIS, P393; Nino-Liu DO, 2006, MOL PLANT PATHOL, V7, P303, DOI 10.1111/j.1364-3703.2006.00344.x; OTOOLE GA, 1998, MOL MICROBIOL, V30, P295, DOI [10.1046/j.1365-2958.1998.01062.x, DOI 10.1046/J.1365-2958.1998.01062.X]; OU SH, 1985, ROCE DIS; Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504; Plate L, 2012, MOL CELL, V46, P449, DOI 10.1016/j.molcel.2012.03.023; Rai R, 2012, MOL PLANT MICROBE IN, V25, P789, DOI 10.1094/MPMI-11-11-0285-R; RIED JL, 1987, GENE, V57, P239, DOI 10.1016/0378-1119(87)90127-2; Romling U, 2005, CELL MOL LIFE SCI, V62, P1234, DOI 10.1007/s00018-005-4557-x; ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0; Ryan RP, 2007, MOL MICROBIOL, V63, P429, DOI 10.1111/j.1365-2958.2006.05531.x; Ryan RP, 2010, P NATL ACAD SCI USA, V107, P5989, DOI 10.1073/pnas.0912839107; Ryan RP, 2009, ENVIRON MICROBIOL, V11, P1126, DOI 10.1111/j.1462-2920.2008.01842.x; Ryan RP, 2006, P NATL ACAD SCI USA, V103, P6712, DOI 10.1073/pnas.0600345103; Ryder C, 2007, CURR OPIN MICROBIOL, V10, P644, DOI 10.1016/j.mib.2007.09.010; Salzberg SL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-204; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Slater H, 2000, MOL MICROBIOL, V38, P986, DOI 10.1046/j.1365-2958.2000.02196.x; Solano C, 2009, P NATL ACAD SCI USA, V106, P7997, DOI 10.1073/pnas.0812573106; Souza LCA, 2006, FEMS MICROBIOL LETT, V257, P236, DOI 10.1111/j.1574-6968.2006.00176.x; Sultan SZ, 2011, INFECT IMMUN, V79, P3273, DOI 10.1128/IAI.05153-11; Sultan SZ, 2010, FEMS MICROBIOL LETT, V302, P22, DOI 10.1111/j.1574-6968.2009.01837.x; Sun WX, 2011, MOL PLANT PATHOL, V12, P731, DOI [10.1111/j.1364-3703.2011.00707.x, 10.1111/J.1364-3703.2011.00707.X]; Sun WX, 2006, PLANT CELL, V18, P764, DOI 10.1105/tpc.105.037648; Swift S, 1999, INFECT IMMUN, V67, P5192, DOI 10.1128/IAI.67.10.5192-5199.1999; TANG JL, 1991, MOL GEN GENET, V226, P409, DOI 10.1007/BF00260653; Tao F, 2010, ENVIRON MICROBIOL, V12, P3159, DOI 10.1111/j.1462-2920.2010.02288.x; Tao F, 2010, J BACTERIOL, V192, P1020, DOI 10.1128/JB.01253-09; Wang L, 2007, APPL ENVIRON MICROB, V73, P8023, DOI 10.1128/AEM.01414-07; Wang X, 2004, J BACTERIOL, V186, P2724, DOI 10.1128/JB.186.9.2724-2734.2004; Wengelnik K, 1999, J BACTERIOL, V181, P6828, DOI 10.1128/JB.181.21.6828-6831.1999; Wengelnik K, 1996, MOL PLANT MICROBE IN, V9, P704, DOI 10.1094/MPMI-9-0704; Yang FH, 2012, MOL PLANT MICROBE IN, V25, P1361, DOI 10.1094/MPMI-01-12-0014-R; Yi XA, 2010, MOL MICROBIOL, V77, P787, DOI 10.1111/j.1365-2958.2010.07246.x; Zou HS, 2011, CURR MICROBIOL, V62, P908, DOI 10.1007/s00284-010-9804-1	73	271	318	9	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2013	8	3							e59428	10.1371/journal.pone.0059428	http://dx.doi.org/10.1371/journal.pone.0059428			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	124QO	23658832	Green Published, Green Submitted, gold			2022-12-25	WOS:000317480700121
J	Li, KR; Zhang, ZQ; Yao, J; Zhao, YX; Duan, J; Cao, C; Jiang, Q				Li, Ke-ran; Zhang, Zhi-qing; Yao, Jin; Zhao, Yu-xia; Duan, Jing; Cao, Cong; Jiang, Qin			Ginsenoside Rg-1 Protects Retinal Pigment Epithelium (RPE) Cells from Cobalt Chloride (CoCl2) and Hypoxia Assaults	PLOS ONE			English	Article							N-TERMINAL KINASE; SIGNALING PATHWAY; INDUCED APOPTOSIS; OXIDATIVE STRESS; IN-VITRO; RG1 PROTECTS; CANCER CELLS; PC12 CELLS; P38 MAPK; ACTIVATION	Severe retinal ischemia causes persistent visual impairments in eye diseases. Retinal pigment epithelium (RPE) cells are located near the choroidal capillaries, and are easily affected by ischemic or hypoxia. Ginsenoside Rg-1 has shown significant neuroprotective effects. This study was performed to test the cytoprotective effect of ginsenoside Rg-1 in RPE cells against hypoxia and cobalt chloride (CoCl2) assaults, and to understand the underlying mechanisms. We found that Rg-1 pre-administration significantly inhibited CoCl2- and hypoxia-induced RPE cell death and apoptosis. Reactive oxygen specisis (ROS)-dependent p38 and c-Jun NH(2)-terminal kinases (JNK) MAPK activation was required for CoCl2-induced RPE cell death, and Rg-1 pre-treatment significantly inhibited ROS production and following p38/JNK activation. Further, CoCl2 suppressed pro-survival mTOR complex 1 (mTORC1) activation in RPE cells through activating of AMP-activated protein kinase (AMPK), while Rg-1 restored mTORC1 activity through inhibiting AMPK activation. CoCl2-induced AMPK activation was also dependent on ROS production, and anti-oxidant N-acetylcysteine (NAC) prevented AMPK activation and RPE cell death by CoCl2. Our results indicated that Rg-1 could be further investigated as a novel cell-protective agent for retinal ischemia.	[Li, Ke-ran; Yao, Jin; Zhao, Yu-xia; Jiang, Qin] Nanjing Med Univ, Affiliated Eye Hosp, Dept Eye, Nanjing, Jiangsu, Peoples R China; [Zhang, Zhi-qing; Cao, Cong] Soochow Univ, Inst Neurosci, Suzhou, Jiangsu, Peoples R China; [Duan, Jing] China Pharmaceut Univ, Acad Inst Pharmaceut Sci, Ctr Safety Evaluat Drugs, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Soochow University - China; China Pharmaceutical University	Cao, C (corresponding author), Soochow Univ, Inst Neurosci, Suzhou, Jiangsu, Peoples R China.	caocong@suda.edu.cn; dryaojin@yahoo.com	; Li, Ke/I-3804-2013	Yao, Jian/0000-0003-2622-0215; Li, Ke/0000-0003-4869-5393	National Natural Science Foundation of China [81070744, 81271028]; Jiangsu Province [1002009B]; Medical Science and Technology Development Project Fund of Nanjing [ZKX12047, YKK12208, YKK12207]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province; Medical Science and Technology Development Project Fund of Nanjing	This work was generously supported by grants from the National Natural Science Foundation of China (Nos. 81070744, 81271028), post-doc fund of Jiangsu Province (No. 1002009B) and Medical Science and Technology Development Project Fund of Nanjing (ZKX12047, YKK12208, YKK12207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borutaite Vilmante, 2008, Biochem J, V412, pe15, DOI 10.1042/BJ20080712; Boulton M, 2001, EYE, V15, P384, DOI 10.1038/eye.2001.141; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Buettner C, 2006, ANN PHARMACOTHER, V40, P83, DOI 10.1345/aph.1G216; Cao C, 2008, J BIOL CHEM, V283, P28897, DOI 10.1074/jbc.M804144200; Chen L, 2010, LAB INVEST, V90, P762, DOI 10.1038/labinvest.2010.36; Chen MB, 2012, INT J CANC; Chen MB, 2011, J CELL PHYSIOL, V226, P1915, DOI 10.1002/jcp.22522; Chen MB, 2011, CELL BIOCHEM BIOPHYS, V60, P311, DOI 10.1007/s12013-011-9153-0; Chen WF, 2013, NEUROCHEM INT, V62, P1065, DOI 10.1016/j.neuint.2013.03.018; Chen XC, 2002, ACTA PHARMACOL SIN, V23, P829; Chen ZY, 2013, MOL CELL BIOCHEM, V377, P35, DOI 10.1007/s11010-013-1568-z; Du JH, 2005, BIOCHEM BIOPH RES CO, V337, P1139, DOI 10.1016/j.bbrc.2005.09.174; Du ZJ, 2011, INVEST OPHTH VIS SCI, V52, P987, DOI 10.1167/iovs.10-5557; Fang F, 2012, BBA-MOL BASIS DIS, V1822, P286, DOI 10.1016/j.bbadis.2011.10.004; Fernandes AF, 2008, J BIOL CHEM, V283, P20745, DOI 10.1074/jbc.M800268200; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardy P, 2005, PROSTAG LEUKOTR ESS, V72, P301, DOI 10.1016/j.plefa.2005.02.004; Hayashi T, 2000, DIABETES, V49, P527, DOI 10.2337/diabetes.49.4.527; Huong NTT, 1998, BIOL PHARM BULL, V21, P978, DOI 10.1248/bpb.21.978; Imamura K, 2001, BIOCHEM BIOPH RES CO, V287, P562, DOI 10.1006/bbrc.2001.5627; Inoki K, 2012, ANNU REV PHARMACOL, V52, P381, DOI 10.1146/annurev-pharmtox-010611-134537; Joo SS, 2005, PLANTA MED, V71, P476, DOI 10.1055/s-2005-864145; Kang MR, 2012, ONCOL REP, V27, P1407, DOI 10.3892/or.2012.1644; Kefas BA, 2003, J MOL ENDOCRINOL, V30, P151, DOI 10.1677/jme.0.0300151; Kim HJ, 2013, J GINSENG RES, V37, P8, DOI 10.5142/jgr.2013.37.8; Kim MH, 2008, APOPTOSIS, V13, P295, DOI 10.1007/s10495-007-0160-y; Kunz M, 2001, CELL GROWTH DIFFER, V12, P137; Lee MS, 2010, PHYTOTHER RES, V24, P1857, DOI 10.1002/ptr.3210; Leung KW, 2007, NEUROPHARMACOLOGY, V52, P827, DOI 10.1016/j.neuropharm.2006.10.001; Li CY, 2002, AM J PHYSIOL-CELL PH, V282, pC227, DOI 10.1152/ajpcell.00112.2001; Li J, 2005, CIRC RES, V97, P872, DOI 10.1161/01.RES.0000187458.77026.10; Li J. Q., 1997, Yaoxue Xuebao, V32, P406; Li W, 2012, BRAIN RES BULL, V88, P501, DOI 10.1016/j.brainresbull.2012.05.002; Liao BS, 2002, EXP NEUROL, V173, P224, DOI 10.1006/exnr.2001.7841; Liu QA, 2011, NEUROCHEM INT, V58, P119, DOI 10.1016/j.neuint.2010.11.004; Liu ZJ, 2010, BRAIN RES, V1333, P1, DOI 10.1016/j.brainres.2010.03.096; Meisse D, 2002, FEBS LETT, V526, P38, DOI 10.1016/S0014-5793(02)03110-1; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Mizushina Y, 2000, BIOCHEM J, V350, P757, DOI 10.1042/0264-6021:3500757; Mu Yan-Yue, 2012, Zhongguo Zhong Xi Yi Jie He Za Zhi, V32, P1539; Nag SA, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00025; Okoshi R, 2008, J BIOL CHEM, V283, P3979, DOI 10.1074/jbc.M705232200; Osborne NN, 2004, PROG RETIN EYE RES, V23, P91, DOI 10.1016/j.preteyeres.2003.12.001; Shen L, 2007, ACTA PHARMACOL SIN, V28, P392, DOI 10.1111/j.1745-7254.2007.00511.x; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Terai K, 2005, MOL CELL BIOL, V25, P9554, DOI 10.1128/MCB.25.21.9554-9575.2005; Vogler BK, 1999, EUR J CLIN PHARMACOL, V55, P567, DOI 10.1007/s002280050674; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990; Wang Qiao-Yun, 2013, Zhongguo Zhong Xi Yi Jie He Za Zhi, V33, P229; Wang Wei-xia, 2005, Zhongguo Zhong Xi Yi Jie He Za Zhi, V25, P89; Wu CF, 2007, INT IMMUNOPHARMACOL, V7, P313, DOI 10.1016/j.intimp.2006.04.021; Wu JY, 2012, NEUROPHARMACOLOGY, V63, P349, DOI 10.1016/j.neuropharm.2012.04.005; Xu HM, 2010, NEUROPHARMACOLOGY, V58, P488, DOI 10.1016/j.neuropharm.2009.09.002; Yang XH, 2010, WORLD J GASTROENTERO, V16, P3385, DOI 10.3748/wjg.v16.i27.3385; Yao J, 2013, INT J MOL SCI, V14, P10355, DOI 10.3390/ijms140510355; Yap TA, 2011, J CLIN ONCOL, V29, P4688, DOI 10.1200/JCO.2011.35.5263; Zhang XY, 2008, INVEST OPHTH VIS SCI, V49, P3622, DOI 10.1167/iovs.07-1559; Zheng QY, 2012, BIOCH BIOPHYS RES CO; Zhu D, 2009, J CELL BIOCHEM, V108, P117, DOI 10.1002/jcb.22233; Zong Y, 2012, CURR MED CHEM, V19, P770, DOI 10.2174/092986712798992066	62	256	266	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84171	10.1371/journal.pone.0084171	http://dx.doi.org/10.1371/journal.pone.0084171			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	23874530	Green Published, Green Submitted, gold			2022-12-25	WOS:000329117900080
